PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Kim, S; Guzman, SJ; Hu, H; Jonas, P				Kim, Sooyun; Guzman, Segundo J.; Hu, Hua; Jonas, Peter			Active dendrites support efficient initiation of dendritic spikes in hippocampal CA3 pyramidal neurons	NATURE NEUROSCIENCE			English	Article							ACTION-POTENTIAL INITIATION; SYNAPTIC INTEGRATION; NMDA RECEPTORS; GRANULE CELLS; PLASTICITY; MEMORY; PROPAGATION; TERM; NORMALIZATION; ACTIVATION	CA3 pyramidal neurons are important for memory formation and pattern completion in the hippocampal network. It is generally thought that proximal synapses from the mossy fibers activate these neurons most efficiently, whereas distal inputs from the perforant path have a weaker modulatory influence. We used confocally targeted patch-clamp recording from dendrites and axons to map the activation of rat CA3 pyramidal neurons at the subcellular level. Our results reveal two distinct dendritic domains. In the proximal domain, action potentials initiated in the axon backpropagate actively with large amplitude and fast time course. In the distal domain, Na+ channel-mediated dendritic spikes are efficiently initiated by waveforms mimicking synaptic events. CA3 pyramidal neuron dendrites showed a high Na+-to-K+ conductance density ratio, providing ideal conditions for active backpropagation and dendritic spike initiation. Dendritic spikes may enhance the computational power of CA3 pyramidal neurons in the hippocampal network.	[Kim, Sooyun; Guzman, Segundo J.; Hu, Hua; Jonas, Peter] IST Austria, Klosterneuburg, Austria	Institute of Science & Technology - Austria	Jonas, P (corresponding author), IST Austria, Klosterneuburg, Austria.	peter.jonas@ist.ac.at	Guzman, Jose/H-2785-2019; Kim, Sooyun/J-9071-2014; Kim, Sooyun/AAH-6262-2020	Guzman, Jose/0000-0003-2209-5242; Kim, Sooyun/0000-0002-2035-3247; Kim, Sooyun/0000-0002-2035-3247; Jonas, Peter/0000-0001-5001-4804; Hu, Hua/0000-0001-8187-4735	Deutsche Forschungsgemcinschaft [TR 3/B10]; European Union (European Research Council)	Deutsche Forschungsgemcinschaft(German Research Foundation (DFG)); European Union (European Research Council)(European Research Council (ERC)European Commission)	We thank G. Buzsaki and J. Lisman for critically reading previous manuscript versions. We also thank F. Marr and I. Koeva for technical assistance and E. Kramberger for perfect editorial support. This work was supported by the Deutsche Forschungsgemcinschaft (TR 3/B10) and the European Union (European Research Council Advanced grant to P.J.).	Bi GQ, 1998, J NEUROSCI, V18, P10464, DOI 10.1523/jneurosci.18-24-10464.1998; Bischofberger J, 2006, NAT PROTOC, V1, P2075, DOI 10.1038/nprot.2006.312; Colbert CM, 1996, J NEUROSCI, V16, P6676; Debanne D, 1998, J PHYSIOL-LONDON, V507, P237, DOI 10.1111/j.1469-7793.1998.237bu.x; Frick A, 2003, J NEUROSCI, V23, P3243; Gasparini S, 2004, J NEUROSCI, V24, P11046, DOI 10.1523/JNEUROSCI.2520-04.2004; Golding NL, 2002, NATURE, V418, P326, DOI 10.1038/nature00854; Golding NL, 1998, NEURON, V21, P1189, DOI 10.1016/S0896-6273(00)80635-2; Hafting T, 2005, NATURE, V436, P801, DOI 10.1038/nature03721; Henze DA, 2002, NAT NEUROSCI, V5, P790, DOI 10.1038/nn887; Hoffman DA, 1997, NATURE, V387, P869, DOI 10.1038/43119; HOLMES WR, 1989, BRAIN RES, V478, P127, DOI 10.1016/0006-8993(89)91484-4; Hu H, 2010, SCIENCE, V327, P52, DOI 10.1126/science.1177876; Jaffe DB, 1999, J NEUROPHYSIOL, V82, P3268, DOI 10.1152/jn.1999.82.6.3268; Jarsky T, 2005, NAT NEUROSCI, V8, P1667, DOI 10.1038/nn1599; Kamondi A, 1998, J NEUROSCI, V18, P3919; Kampa BM, 2004, J PHYSIOL-LONDON, V556, P337, DOI 10.1113/jphysiol.2003.058842; kandel, 1977, NERVOUS SYSTEM, V1; Kobayashi K, 2004, NEURON, V41, P445, DOI 10.1016/S0896-6273(03)00873-0; Korngreen A, 2000, J PHYSIOL-LONDON, V525, P621, DOI 10.1111/j.1469-7793.2000.00621.x; Krueppel R, 2011, NEURON, V71, P512, DOI 10.1016/j.neuron.2011.05.043; Larkum ME, 2009, SCIENCE, V325, P756, DOI 10.1126/science.1171958; Lisman JE, 1999, NEURON, V22, P233, DOI 10.1016/S0896-6273(00)81085-5; Losonczy A, 2008, NATURE, V452, P436, DOI 10.1038/nature06725; Magee JC, 1997, SCIENCE, V275, P209, DOI 10.1126/science.275.5297.209; MAJOR G, 1994, J NEUROSCI, V14, P4613; MARR D, 1971, PHILOS T ROY SOC B, V262, P23, DOI 10.1098/rstb.1971.0078; McMahon DBT, 2002, J NEUROPHYSIOL, V88, P528, DOI 10.1152/jn.2002.88.1.528; MCNAUGHTON BL, 1987, TRENDS NEUROSCI, V10, P408, DOI 10.1016/0166-2236(87)90011-7; Meeks JP, 2007, J NEUROPHYSIOL, V97, P3460, DOI 10.1152/jn.01288.2006; Nakazawa K, 2002, SCIENCE, V297, P211, DOI 10.1126/science.1071795; Nakazawa K, 2004, NAT REV NEUROSCI, V5, P361, DOI 10.1038/nrn1385; Nevian T, 2007, NAT NEUROSCI, V10, P206, DOI 10.1038/nn1826; Pelkey KA, 2005, NEURON, V45, P327, DOI 10.1016/j.neuron.2005.01.018; Poirazi P, 2001, NEURON, V29, P779, DOI 10.1016/S0896-6273(01)00252-5; Shu YS, 2006, NATURE, V441, P761, DOI 10.1038/nature04720; SOFTKY W, 1994, NEUROSCIENCE, V58, P13, DOI 10.1016/0306-4522(94)90154-6; SPRUSTON N, 1992, J NEUROPHYSIOL, V67, P508, DOI 10.1152/jn.1992.67.3.508; SPRUSTON N, 1995, SCIENCE, V268, P297, DOI 10.1126/science.7716524; Spruston N, 2008, NAT REV NEUROSCI, V9, P206, DOI 10.1038/nrn2286; Stuart G, 2007, DENDRITES; STUART GJ, 1994, NATURE, V367, P69, DOI 10.1038/367069a0; Traub R.D., 1991, NEURONAL NETWORKS HI; Urban NN, 1998, P NATL ACAD SCI USA, V95, P11450, DOI 10.1073/pnas.95.19.11450; Urban NN, 1998, J NEUROPHYSIOL, V80, P1558, DOI 10.1152/jn.1998.80.3.1558	45	65	65	1	17	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	APR	2012	15	4					600	606		10.1038/nn.3060	http://dx.doi.org/10.1038/nn.3060			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	916PA	22388958	Green Accepted			2022-12-28	WOS:000302114500020
J	McKinnon, PJ				McKinnon, Peter J.			Maintaining genome stability in the nervous system	NATURE NEUROSCIENCE			English	Review							STRAND BREAK REPAIR; DNA-DAMAGE RESPONSE; TELANGIECTASIA-LIKE DISORDER; ATAXIA-TELANGIECTASIA; CHROMATIN STATE; SECKEL-SYNDROME; MITOTIC ENTRY; DEVELOPMENTAL DELAY; ADULT NEUROGENESIS; NEURAL DEVELOPMENT	Active maintenance of genome stability is a prerequisite for the development and function of the nervous system. The high replication index during neurogenesis and the long life of mature neurons highlight the need for efficient cellular programs to safeguard genetic fidelity. Multiple DNA damage response pathways ensure that replication stress and other types of DNA lesions, such as oxidative damage, do not affect neural homeostasis. Numerous human neurologic syndromes result from defective DNA damage signaling and compromised genome integrity. These syndromes can involve different neuropathology, which highlights the diverse maintenance roles that are required for genome stability in the nervous system. Understanding how DNA damage signaling pathways promote neural development and preserve homeostasis is essential for understanding fundamental brain function.	St Jude Childrens Res Hosp, Dept Genet, Memphis, TN 38105 USA	St Jude Children's Research Hospital	McKinnon, PJ (corresponding author), St Jude Childrens Res Hosp, Dept Genet, 332 N Lauderdale St, Memphis, TN 38105 USA.	peter.mckinnon@stjude.org			US National Institutes of Health [NS-37956, CA-96832]; Cancer Center Support grant [P30 CA21765]; American Lebanese and Syrian Associated Charities of St. Jude Children's Research Hospital; NATIONAL CANCER INSTITUTE [P30CA021765, P01CA096832] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R56NS037956, R01NS037956] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Center Support grant; American Lebanese and Syrian Associated Charities of St. Jude Children's Research Hospital(American Lebanese Syrian Associated Charities (ALSAC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	P.J.M. is supported by the US National Institutes of Health (NS-37956, CA-96832), a Cancer Center Support grant (P30 CA21765) and the American Lebanese and Syrian Associated Charities of St. Jude Children's Research Hospital.	Aguilera A, 2012, MOL CELL, V46, P115, DOI 10.1016/j.molcel.2012.04.009; Ahel I, 2006, NATURE, V443, P713, DOI 10.1038/nature05164; Alderton GK, 2006, NAT CELL BIOL, V8, P725, DOI 10.1038/ncb1431; Anttinen A, 2008, BRAIN, V131, P1979, DOI 10.1093/brain/awn126; Arai Y, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1155; Baker SA, 2013, CELL, V152, P984, DOI 10.1016/j.cell.2013.01.038; Barnes DE, 1998, CURR BIOL, V8, P1395, DOI 10.1016/S0960-9822(98)00021-9; Barres BA, 2008, NEURON, V60, P430, DOI 10.1016/j.neuron.2008.10.013; Barzilai A, 2007, ANTIOXID REDOX SIGN, V9, P211, DOI 10.1089/ars.2007.9.211; Borgesius NZ, 2011, J NEUROSCI, V31, P12543, DOI 10.1523/JNEUROSCI.1589-11.2011; Breslin C, 2009, MOL CELL BIOL, V29, P4653, DOI 10.1128/MCB.00677-09; Caldecott KW, 2008, NAT REV GENET, V9, P619, DOI 10.1038/nrg2380; Carney JP, 1998, CELL, V93, P477, DOI 10.1016/S0092-8674(00)81175-7; Catez F, 2004, MOL CELL BIOL, V24, P4321, DOI 10.1128/MCB.24.10.4321-4328.2004; Caviness VS, 2009, TRENDS NEUROSCI, V32, P443, DOI 10.1016/j.tins.2009.05.003; Chapman JR, 2012, MOL CELL, V47, P497, DOI 10.1016/j.molcel.2012.07.029; Chen HC, 2010, CELL, V141, P280, DOI 10.1016/j.cell.2010.02.026; Cimprich KA, 2008, NAT REV MOL CELL BIO, V9, P616, DOI 10.1038/nrm2450; Compe E, 2012, NAT REV MOL CELL BIO, V13, P343, DOI 10.1038/nrm3350; Copeland WC, 2008, ANNU REV MED, V59, P131, DOI 10.1146/annurev.med.59.053006.104646; Date H, 2001, NAT GENET, V29, P184, DOI 10.1038/ng1001-184; de Souza-Pinto NC, 2008, DNA REPAIR, V7, P1098, DOI 10.1016/j.dnarep.2008.03.011; Deans AJ, 2011, NAT REV CANCER, V11, P467, DOI 10.1038/nrc3088; Deans B, 2000, EMBO J, V19, P6675, DOI 10.1093/emboj/19.24.6675; Dehay C, 2007, NAT REV NEUROSCI, V8, P438, DOI 10.1038/nrn2097; DiMauro S, 2008, ANNU REV NEUROSCI, V31, P91, DOI 10.1146/annurev.neuro.30.051606.094302; Du F, 2008, P NATL ACAD SCI USA, V105, P6409, DOI 10.1073/pnas.0710766105; Fortini P, 2013, MUTAT RES-FUND MOL M, V743, P160, DOI 10.1016/j.mrfmmm.2013.03.004; Frappart PO, 2005, NAT MED, V11, P538, DOI 10.1038/nm1228; Gao YK, 2011, NATURE, V471, P240, DOI 10.1038/nature09773; Gao YJ, 1998, CELL, V95, P891, DOI 10.1016/S0092-8674(00)81714-6; Garinis GA, 2008, NAT CELL BIOL, V10, P1241, DOI 10.1038/ncb1108-1241; Ge WP, 2012, NATURE, V484, P376, DOI 10.1038/nature10959; Gotz M, 2005, NAT REV MOL CELL BIO, V6, P777, DOI 10.1038/nrm1739; Griffith E, 2008, NAT GENET, V40, P232, DOI 10.1038/ng.2007.80; Gruber R, 2011, NAT CELL BIOL, V13, P1325, DOI 10.1038/ncb2342; Hanawalt PC, 2008, NAT REV MOL CELL BIO, V9, P958, DOI 10.1038/nrm2549; Herzog KH, 1998, SCIENCE, V280, P1089, DOI 10.1126/science.280.5366.1089; Higginbotham HR, 2007, TRENDS NEUROSCI, V30, P276, DOI 10.1016/j.tins.2007.04.001; Huang E, 2010, NAT CELL BIOL, V12, P563, DOI 10.1038/ncb2058; Ikura T, 2000, CELL, V102, P463, DOI 10.1016/S0092-8674(00)00051-9; Jackson SP, 2009, NATURE, V461, P1071, DOI 10.1038/nature08467; Jiricny J, 2006, NAT REV MOL CELL BIO, V7, P335, DOI 10.1038/nrm1907; Ju BG, 2006, SCIENCE, V312, P1798, DOI 10.1126/science.1127196; Kalay E, 2011, NAT GENET, V43, P23, DOI 10.1038/ng.725; Kamileri I, 2012, TRENDS GENET, V28, P566, DOI 10.1016/j.tig.2012.06.004; Karanjawala ZE, 2002, CURR BIOL, V12, P397, DOI 10.1016/S0960-9822(02)00684-X; Kee Y, 2010, GENE DEV, V24, P1680, DOI 10.1101/gad.1955310; Kishi Y, 2012, NAT NEUROSCI, V15, P1127, DOI 10.1038/nn.3165; Klingseisen A, 2011, GENE DEV, V25, P2011, DOI 10.1101/gad.169037; Kumagai A, 2006, CELL, V124, P943, DOI 10.1016/j.cell.2005.12.041; Latella L, 2004, MOL CELL BIOL, V24, P6350, DOI 10.1128/MCB.24.14.6350-6361.2004; Lee YS, 2012, NAT NEUROSCI, V15, P819, DOI 10.1038/nn.3097; Lee Y, 2012, EMBO J, V31, P1177, DOI 10.1038/emboj.2011.493; Li XL, 2006, GENE DEV, V20, P1838, DOI 10.1101/gad.1438306; Lieber MR, 2010, ANNU REV BIOCHEM, V79, P181, DOI 10.1146/annurev.biochem.052308.093131; Lu T, 2004, NATURE, V429, P883, DOI 10.1038/nature02661; McKinnon PJ, 2012, ANNU REV PATHOL-MECH, V7, P303, DOI 10.1146/annurev-pathol-011811-132509; McKinnon PJ, 2009, NAT REV NEUROSCI, V10, P100, DOI 10.1038/nrn2559; Mellen M, 2012, CELL, V151, P1417, DOI 10.1016/j.cell.2012.11.022; Ming GL, 2011, NEURON, V70, P687, DOI 10.1016/j.neuron.2011.05.001; Moreira MC, 2001, NAT GENET, V29, P189, DOI 10.1038/ng1001-189; Murga M, 2007, J CELL BIOL, V178, P1101, DOI 10.1083/jcb.200704140; Murr R, 2006, NAT CELL BIOL, V8, P91, DOI 10.1038/ncb1343; Nijhawan D, 2000, ANNU REV NEUROSCI, V23, P73, DOI 10.1146/annurev.neuro.23.1.73; Nouspikel T, 2003, BIOESSAYS, V25, P168, DOI 10.1002/bies.10227; O'Driscoll M, 2003, NAT GENET, V33, P497, DOI 10.1038/ng1129; O'Driscoll M, 2006, NAT REV GENET, V7, P45, DOI 10.1038/nrg1746; O'Driscoll M, 2001, MOL CELL, V8, P1175, DOI 10.1016/S1097-2765(01)00408-7; O'Driscoll M, 2007, AM J HUM GENET, V81, P77, DOI 10.1086/518696; Orii KE, 2006, P NATL ACAD SCI USA, V103, P10017, DOI 10.1073/pnas.0602436103; Reynolds JJ, 2012, NUCLEIC ACIDS RES, V40, P6608, DOI 10.1093/nar/gks318; Ronan JL, 2013, NAT REV GENET, V14, P347, DOI 10.1038/nrg3413; Sartori AA, 2007, NATURE, V450, P509, DOI 10.1038/nature06337; Saxowsky TT, 2006, CHEM REV, V106, P474, DOI 10.1021/cr040466q; Shen J, 2010, NAT GENET, V42, P245, DOI 10.1038/ng.526; Shiloh Y, 2013, NAT REV MOL CELL BIO, V14, P197, DOI 10.1038/nrm3546; Shimada M, 2009, J RADIAT RES, V50, P295, DOI 10.1269/jrr.09039; Shull ERP, 2009, GENE DEV, V23, P171, DOI 10.1101/gad.1746609; Skene PJ, 2010, MOL CELL, V37, P457, DOI 10.1016/j.molcel.2010.01.030; Soria G, 2012, MOL CELL, V46, P722, DOI 10.1016/j.molcel.2012.06.002; Spalding KL, 2013, CELL, V153, P1219, DOI 10.1016/j.cell.2013.05.002; Stewart GS, 1999, CELL, V99, P577, DOI 10.1016/S0092-8674(00)81547-0; Stracker TH, 2011, NAT REV MOL CELL BIO, V12, P90, DOI 10.1038/nrm3047; Suberbielle E, 2013, NAT NEUROSCI, V16, P613, DOI 10.1038/nn.3356; Sugo N, 2000, EMBO J, V19, P1397, DOI 10.1093/emboj/19.6.1397; Sulli G, 2012, NAT REV CANCER, V12, DOI 10.1038/nrc3344; Sun YL, 2009, NAT CELL BIOL, V11, P1376, DOI 10.1038/ncb1982; Sykora P, 2011, P NATL ACAD SCI USA, V108, P7437, DOI 10.1073/pnas.1100084108; Takashima H, 2002, NAT GENET, V32, P267, DOI 10.1038/ng987; Taylor AMR, 2004, DNA REPAIR, V3, P1219, DOI 10.1016/j.dnarep.2004.04.009; Thornton GK, 2009, TRENDS GENET, V25, P501, DOI 10.1016/j.tig.2009.09.011; Tibelius A, 2009, J CELL BIOL, V185, P1149, DOI 10.1083/jcb.200810159; Wang XQ, 2009, NATURE, V461, P947, DOI 10.1038/nature08435; Weinfeld M, 2011, TRENDS BIOCHEM SCI, V36, P262, DOI 10.1016/j.tibs.2011.01.006; Woodbine L, 2013, J CLIN INVEST, V123, P2969, DOI 10.1172/JCI67349; Yoshida H, 1998, CELL, V94, P739, DOI 10.1016/S0092-8674(00)81733-X; Zhao CM, 2008, CELL, V132, P645, DOI 10.1016/j.cell.2008.01.033; ZHAO K, 1993, EMBO J, V12, P3237, DOI 10.1002/j.1460-2075.1993.tb05993.x	99	146	152	0	17	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	NOV	2013	16	11					1523	1529		10.1038/nn.3537	http://dx.doi.org/10.1038/nn.3537			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	241YX	24165679	Green Accepted			2022-12-28	WOS:000326205700007
J	Jacobs, J; Weidemann, CT; Miller, JF; Solway, A; Burke, JF; Wei, XX; Suthana, N; Sperling, MR; Sharan, AD; Fried, I; Kahana, MJ				Jacobs, Joshua; Weidemann, Christoph T.; Miller, Jonathan F.; Solway, Alec; Burke, John F.; Wei, Xue-Xin; Suthana, Nanthia; Sperling, Michael R.; Sharan, Ashwini D.; Fried, Itzhak; Kahana, Michael J.			Direct recordings of grid-like neuronal activity in human spatial navigation	NATURE NEUROSCIENCE			English	Article							ENTORHINAL CORTEX; CELLS; HIPPOCAMPUS; REPRESENTATION; MEMORY; MAP; EXPERIENCE; NETWORK; PLACE; SPACE	Grid cells in the entorhinal cortex appear to represent spatial location via a triangular coordinate system. Such cells, which have been identified in rats, bats and monkeys, are believed to support a wide range of spatial behaviors. Recording neuronal activity from neurosurgical patients performing a virtual-navigation task, we identified cells exhibiting grid-like spiking patterns in the human brain, suggesting that humans and simpler animals rely on homologous spatial-coding schemes.	[Jacobs, Joshua; Miller, Jonathan F.] Drexel Univ, Sch Biomed Engn Sci & Hlth Syst, Philadelphia, PA 19104 USA; [Weidemann, Christoph T.] Swansea Univ, Dept Psychol, Swansea, W Glam, Wales; [Solway, Alec] Princeton Univ, Princeton Neurosci Inst, Princeton, NJ 08544 USA; [Burke, John F.; Wei, Xue-Xin; Kahana, Michael J.] Univ Penn, Dept Psychol, Philadelphia, PA 19104 USA; [Suthana, Nanthia; Fried, Itzhak] Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurosurg, Los Angeles, CA 90095 USA; [Suthana, Nanthia; Fried, Itzhak] Univ Calif Los Angeles, Semel Inst Neurosci & Human Behav, Los Angeles, CA 90024 USA; [Sperling, Michael R.] Thomas Jefferson Univ, Dept Neurol, Philadelphia, PA 19107 USA; [Sharan, Ashwini D.] Thomas Jefferson Univ, Dept Neurosurg, Philadelphia, PA 19107 USA; [Fried, Itzhak] Tel Aviv Univ, Tel Aviv Med Ctr, Funct Neurosurg Unit, IL-69978 Tel Aviv, Israel; [Fried, Itzhak] Tel Aviv Univ, Sackler Fac Med, IL-69978 Tel Aviv, Israel	Drexel University; Swansea University; Princeton University; University of Pennsylvania; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; Jefferson University; Jefferson University; Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv University; Sackler Faculty of Medicine	Jacobs, J (corresponding author), Drexel Univ, Sch Biomed Engn Sci & Hlth Syst, Philadelphia, PA 19104 USA.	joshua.jacobs@drexel.edu; ifried@mednet.ucla.edu	Jacobs, Joshua/E-9500-2013; Weidemann, Christoph T./E-8857-2011	Jacobs, Joshua/0000-0003-1807-6882; Weidemann, Christoph T./0000-0002-4280-2744; Burke, John/0000-0002-6190-5116; Suthana, Nanthia/0000-0002-8796-3277	US National Institutes of Health [MH061975, NS033221]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH061975] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS084017, R56NS033221, R01NS033221] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We are grateful to the patients for participating in our study. We thank K. Lee, D. Wyeth, E. Wyeth, D. Pourshaban, E. Behnke and T. Fields for technical assistance. This work was supported by US National Institutes of Health grants MH061975 and NS033221.	Bird CM, 2008, NAT REV NEUROSCI, V9, P182, DOI 10.1038/nrn2335; Buzsaki G, 2013, NAT NEUROSCI, V16, P130, DOI 10.1038/nn.3304; Doeller CF, 2010, NATURE, V463, P657, DOI 10.1038/nature08704; Ekstrom AD, 2003, NATURE, V425, P184, DOI 10.1038/nature01964; Hafting T, 2005, NATURE, V436, P801, DOI 10.1038/nature03721; Hargreaves EL, 2005, SCIENCE, V308, P1792, DOI 10.1126/science.1110449; Hill DN, 2011, J NEUROSCI, V31, P8699, DOI 10.1523/JNEUROSCI.0971-11.2011; Jacobs J, 2010, TRENDS COGN SCI, V14, P162, DOI 10.1016/j.tics.2010.01.005; Jacobs J, 2010, P NATL ACAD SCI USA, V107, P6487, DOI 10.1073/pnas.0911213107; Killian NJ, 2012, NATURE, V491, P761, DOI 10.1038/nature11587; Krupic J, 2012, SCIENCE, V337, P853, DOI 10.1126/science.1222403; McHugh TJ, 1996, CELL, V87, P1339, DOI 10.1016/S0092-8674(00)81828-0; MULLER RU, 1987, J NEUROSCI, V7, P1935; OKEEFE J, 1971, BRAIN RES, V34, P171, DOI 10.1016/0006-8993(71)90358-1; QUIRK GJ, 1990, J NEUROSCI, V10, P2008; Quiroga RQ, 2004, NEURAL COMPUT, V16, P1661, DOI 10.1162/089976604774201631; Rolls ET, 1999, HIPPOCAMPUS, V9, P467; Sargolini F, 2006, SCIENCE, V312, P758, DOI 10.1126/science.1125572; Terrazas A, 2005, J NEUROSCI, V25, P8085, DOI 10.1523/JNEUROSCI.0693-05.2005; Tsao A, 2013, CURR BIOL, V23, P399, DOI 10.1016/j.cub.2013.01.036; Ulanovsky N, 2007, NAT NEUROSCI, V10, P224, DOI 10.1038/nn1829; Yartsev MM, 2011, NATURE, V479, P103, DOI 10.1038/nature10583	22	266	274	1	88	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	SEP	2013	16	9					1188	1190		10.1038/nn.3466	http://dx.doi.org/10.1038/nn.3466			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	207KN	23912946	Green Accepted			2022-12-28	WOS:000323597500009
J	Hess, ME; Hess, S; Meyer, KD; Verhagen, LAW; Koch, L; Bronneke, HS; Dietrich, MO; Jordan, SD; Saletore, Y; Elemento, O; Belgardt, BF; Franz, T; Horvath, TL; Ruther, U; Jaffrey, SR; Kloppenburg, P; Bruning, JC				Hess, Martin E.; Hess, Simon; Meyer, Kate D.; Verhagen, Linda A. W.; Koch, Linda; Broenneke, Hella S.; Dietrich, Marcelo O.; Jordan, Sabine D.; Saletore, Yogesh; Elemento, Olivier; Belgardt, Bengt F.; Franz, Thomas; Horvath, Tamas L.; Ruether, Ulrich; Jaffrey, Samie R.; Kloppenburg, Peter; Bruening, Jens C.			The fat mass and obesity associated gene (Fto) regulates activity of the dopaminergic midbrain circuitry	NATURE NEUROSCIENCE			English	Article							SUBSTANTIA-NIGRA; D2 RECEPTORS; MICE LACKING; ADDICTION; COCAINE; REWARD; BRAIN; RNA; CHILDHOOD; NEURONS	Dopaminergic (DA) signaling governs the control of complex behaviors, and its deregulation has been implicated in a wide range of diseases. Here we demonstrate that inactivation of the Fto gene, encoding a nucleic acid demethylase, impairs dopamine receptor type 2 (D2R) and type 3 (D3R) (collectively, 'D2-like receptor')-dependent control of neuronal activity and behavioral responses. Conventional and DA neuron-specific Fto knockout mice show attenuated activation of G protein-coupled inwardly-rectifying potassium (GIRK) channel conductance by cocaine and quinpirole. Impaired D2-like receptor-mediated autoinhibition results in attenuated quinpirole-mediated reduction of locomotion and an enhanced sensitivity to the locomotor-and reward-stimulatory actions of cocaine. Analysis of global N-6-methyladenosine (m(6)A) modification of mRNAs using methylated RNA immunoprecipitation coupled with next-generation sequencing in the midbrain and striatum of Fto-deficient mice revealed increased adenosine methylation in a subset of mRNAs important for neuronal signaling, including many in the DA signaling pathway. Several proteins encoded by these mRNAs had altered expression levels. Collectively, FTO regulates the demethylation of specific mRNAs in vivo, and this activity relates to the control of DA transmission.	[Hess, Martin E.; Verhagen, Linda A. W.; Broenneke, Hella S.; Bruening, Jens C.] Max Planck Inst Neurol Res, D-50931 Cologne, Germany; [Hess, Martin E.; Verhagen, Linda A. W.; Koch, Linda; Broenneke, Hella S.; Jordan, Sabine D.; Belgardt, Bengt F.; Bruening, Jens C.] Univ Cologne, Inst Genet, Dept Mouse Genet & Metab, Cologne, Germany; [Hess, Martin E.; Hess, Simon; Verhagen, Linda A. W.; Koch, Linda; Broenneke, Hella S.; Jordan, Sabine D.; Belgardt, Bengt F.; Kloppenburg, Peter; Bruening, Jens C.] Ctr Mol Med Cologne, Cologne, Germany; [Hess, Martin E.; Hess, Simon; Verhagen, Linda A. W.; Koch, Linda; Broenneke, Hella S.; Jordan, Sabine D.; Belgardt, Bengt F.; Kloppenburg, Peter; Bruening, Jens C.] Cologne Excellence Cluster Cellular Stress Respon, Cologne, Germany; [Hess, Martin E.; Verhagen, Linda A. W.; Koch, Linda; Broenneke, Hella S.; Jordan, Sabine D.; Belgardt, Bengt F.; Bruening, Jens C.] Univ Hosp Cologne, Ctr Endocrinol Diabet & Prevent Med, Cologne, Germany; [Hess, Simon; Kloppenburg, Peter] Univ Cologne, Inst Zool, Cologne, Germany; [Meyer, Kate D.; Jaffrey, Samie R.] Cornell Univ, Weill Med Coll, Dept Pharmacol, New York, NY 10021 USA; [Broenneke, Hella S.] CECAD, Mouse Phenotyping Facil, Cologne, Germany; [Dietrich, Marcelo O.; Horvath, Tamas L.] Yale Univ, Sch Med, Comparat Med Sect, New Haven, CT 06510 USA; [Dietrich, Marcelo O.; Horvath, Tamas L.] Yale Univ, Sch Med, Dept Obstet Gynecol & Reprod Sci, New Haven, CT USA; [Dietrich, Marcelo O.; Horvath, Tamas L.] Yale Univ, Sch Med, Dept Neurobiol, New Haven, CT USA; [Saletore, Yogesh; Elemento, Olivier] Cornell Univ, Weill Med Coll, Inst Computat Biomed, New York, NY 10021 USA; [Franz, Thomas] Max Planck Inst Biol Ageing, Cologne, Germany; [Ruether, Ulrich] Univ Dusseldorf, Inst Anim Dev & Mol Biol, D-40225 Dusseldorf, Germany	Max Planck Society; University of Cologne; University of Cologne; University of Cologne; University of Cologne; University of Cologne; Cornell University; University of Cologne; Yale University; Yale University; Yale University; Cornell University; Max Planck Society; Heinrich Heine University Dusseldorf	Bruning, JC (corresponding author), Max Planck Inst Neurol Res, Gleueler Str 50, D-50931 Cologne, Germany.	bruening@nf.mpg.de	Dietrich, Marcelo/A-9928-2009	Dietrich, Marcelo/0000-0001-9781-2221; Jaffrey, Samie/0000-0003-3615-6958; Belgardt, Bengt-Frederik/0000-0003-4537-9002; Koch, Linda/0000-0002-2943-1993; Meyer, Kate/0000-0001-7197-4054	US National Institutes of Health [R01 NS056306]; Deutsche Forschungsgemeinschaft [Br1492-7/1, KL 762/2-2]; Kompetenznetz Adipositas (Competence Network for Obesity); German Federal Ministry of Education and Research (FKZ) [01GI1122A]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS056306] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Kompetenznetz Adipositas (Competence Network for Obesity); German Federal Ministry of Education and Research (FKZ)(Federal Ministry of Education & Research (BMBF)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank J. Alber, B. Hampel, H. Wratil and Y. Masekowitz for excellent technical assistance. We also thank C. Mason for assistance with MeRIP-Seq peak calling. We thank the European Conditional Mouse Mutagenesis Program (EUCOMM) for providing mice with knock in of the beta-galactosidase gene into the Fto gene and N.G. Larsson (Max Planck Institute for Biology of Ageing, Cologne, Germany) for providing Dat-Cre mice. This work was supported by US National Institutes of Health grant R01 NS056306 (S. R. J.), the Deutsche Forschungsgemeinschaft (Br1492-7/1 to J. C. B. and KL 762/2-2 to P. K.) and the Kompetenznetz Adipositas (Competence Network for Obesity) funded by the German Federal Ministry of Education and Research (FKZ: 01GI1122A to J.C.B.).	Anzalone A, 2012, J NEUROSCI, V32, P9023, DOI 10.1523/JNEUROSCI.0918-12.2012; Bello EP, 2011, NAT NEUROSCI, V14, P1033, DOI 10.1038/nn.2862; Boissel S, 2009, AM J HUM GENET, V85, P106, DOI 10.1016/j.ajhg.2009.06.002; Cecil JE, 2008, NEW ENGL J MED, V359, P2558, DOI 10.1056/NEJMoa0803839; Cheung MK, 2013, INT J OBESITY, V37, P744, DOI 10.1038/ijo.2012.77; Choudhry Z, 2013, OBESITY, V21, pE738, DOI 10.1002/oby.20444; Cruz HG, 2004, NAT NEUROSCI, V7, P153, DOI 10.1038/nn1181; Di Chiara G, 2007, CURR OPIN PHARMACOL, V7, P69, DOI 10.1016/j.coph.2006.11.003; Diaz-Torga G, 2002, ENDOCRINOLOGY, V143, P1270, DOI 10.1210/en.143.4.1270; Dina C, 2007, NAT GENET, V39, P724, DOI 10.1038/ng2048; Dominissini D, 2012, NATURE, V485, P201, DOI 10.1038/nature11112; Ekstrand MI, 2007, P NATL ACAD SCI USA, V104, P1325, DOI 10.1073/pnas.0605208103; Fischer J, 2009, NATURE, V458, P894, DOI 10.1038/nature07848; Frayling TM, 2007, SCIENCE, V316, P889, DOI 10.1126/science.1141634; Garcia-Tornadu I, 2010, FRONT HORM RES, V38, P59, DOI 10.1159/000318495; Gerken T, 2007, SCIENCE, V318, P1469, DOI 10.1126/science.1151710; Goodarzi H, 2009, MOL CELL, V36, P900, DOI 10.1016/j.molcel.2009.11.016; Gulati P, 2013, P NATL ACAD SCI USA, V110, P2557, DOI 10.1073/pnas.1222796110; Ho AJ, 2010, P NATL ACAD SCI USA, V107, P8404, DOI 10.1073/pnas.0910878107; Hommel JD, 2006, NEURON, V51, P801, DOI 10.1016/j.neuron.2006.08.023; HOPE BT, 1994, NEURON, V13, P1235, DOI 10.1016/0896-6273(94)90061-2; Jia GF, 2011, NAT CHEM BIOL, V7, P885, DOI [10.1038/NCHEMBIO.687, 10.1038/nchembio.687]; Johnson PM, 2010, NAT NEUROSCI, V13, P635, DOI 10.1038/nn.2519; Jones SR, 1999, NAT NEUROSCI, V2, P649, DOI 10.1038/10204; Klein TA, 2007, SCIENCE, V318, P1642, DOI 10.1126/science.1145044; Klockener T, 2011, NAT NEUROSCI, V14, P911, DOI 10.1038/nn.2847; KYROZIS A, 1995, J NEUROSCI METH, V57, P27, DOI 10.1016/0165-0270(94)00116-X; LACEY MG, 1989, J NEUROSCI, V9, P1233; LACEY MG, 1988, J PHYSIOL-LONDON, V401, P437, DOI 10.1113/jphysiol.1988.sp017171; Le Foll B, 2009, BEHAV PHARMACOL, V20, P1, DOI 10.1097/FBP.0b013e3283242f05; McTaggart JS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027968; Meyer KD, 2012, CELL, V149, P1635, DOI 10.1016/j.cell.2012.05.003; Richards CD, 1997, NEUROSCIENCE, V80, P545, DOI 10.1016/S0306-4522(97)00093-6; Seeman P, 2006, EXPERT OPIN THER TAR, V10, P515, DOI 10.1517/14728222.10.4.515; Sibley DR, 1999, ANNU REV PHARMACOL, V39, P313, DOI 10.1146/annurev.pharmtox.39.1.313; Sobczyk-Kopciol A, 2011, ADDICTION, V106, P739, DOI 10.1111/j.1360-0443.2010.03248.x; Takigawa T, 1999, J PHYSIOL-LONDON, V517, P385, DOI 10.1111/j.1469-7793.1999.0385t.x; Ungless MA, 2001, NATURE, V411, P583, DOI 10.1038/35079077; Wang GJ, 2001, LANCET, V357, P354, DOI 10.1016/S0140-6736(00)03643-6; Wardle J, 2009, INT J OBESITY, V33, P42, DOI 10.1038/ijo.2008.174; Yeo GSH, 2012, J NEUROENDOCRINOL, V24, P393, DOI 10.1111/j.1365-2826.2011.02254.x	41	325	337	3	102	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	AUG	2013	16	8					1042	U96		10.1038/nn.3449	http://dx.doi.org/10.1038/nn.3449			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	190EV	23817550				2022-12-28	WOS:000322323000014
J	Ke, MT; Fujimoto, S; Imai, T				Ke, Meng-Tsen; Fujimoto, Satoshi; Imai, Takeshi			SeeDB: a simple and morphology-preserving optical clearing agent for neuronal circuit reconstruction	NATURE NEUROSCIENCE			English	Article							RAT OLFACTORY-BULB; MITRAL CELLS; IN-VIVO; NERVOUS-SYSTEM; TUFTED CELLS; MOUSE-BRAIN; CORTEX; EXPRESSION; PATHWAYS; VISUALIZATION	We report a water-based optical clearing agent, SeeDB, which clears fixed brain samples in a few days without quenching many types of fluorescent dyes, including fluorescent proteins and lipophilic neuronal tracers. Our method maintained a constant sample volume during the clearing procedure, an important factor for keeping cellular morphology intact, and facilitated the quantitative reconstruction of neuronal circuits. Combined with two-photon microscopy and an optimized objective lens, we were able to image the mouse brain from the dorsal to the ventral side. We used SeeDB to describe the near-complete wiring diagram of sister mitral cells associated with a common glomerulus in the mouse olfactory bulb. We found the diversity of dendrite wiring patterns among sister mitral cells, and our results provide an anatomical basis for non-redundant odor coding by these neurons. Our simple and efficient method is useful for imaging intact morphological architecture at large scales in both the adult and developing brains.	[Ke, Meng-Tsen; Fujimoto, Satoshi; Imai, Takeshi] RIKEN Ctr Dev Biol, Lab Sensory Circuit Format, Kobe, Hyogo, Japan; [Ke, Meng-Tsen; Imai, Takeshi] Kyoto Univ, Grad Sch Biostudies, Kyoto, Japan; [Imai, Takeshi] Japan Sci & Technol Agcy, PRESTO, Saitama, Japan	RIKEN; Kyoto University; Japan Science & Technology Agency (JST)	Imai, T (corresponding author), RIKEN Ctr Dev Biol, Lab Sensory Circuit Format, Kobe, Hyogo, Japan.	imai@cdb.riken.jp	Fujimoto, Satoshi/C-9221-2017; Imai, Takeshi/L-2201-2013	Fujimoto, Satoshi/0000-0002-7618-5502; Imai, Takeshi/0000-0002-8449-0080; Ke, Meng-Tsen/0000-0002-4444-0804	PRESTO program of the Japan Science and Technology Agency; Sumitomo Foundation; Nakajima Foundation; Mitsubishi Foundation; Strategic Programs for R&D (President's Discretionary Fund) of RIKEN; Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan; Grants-in-Aid for Scientific Research [23680038] Funding Source: KAKEN	PRESTO program of the Japan Science and Technology Agency(Japan Science & Technology Agency (JST)); Sumitomo Foundation; Nakajima Foundation; Mitsubishi Foundation; Strategic Programs for R&D (President's Discretionary Fund) of RIKEN; Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank J.R. Sanes (Harvard) (Thy1-YFP-G, H) and P. Mombaerts (Max Planck Institute) (OMP-GFP) for providing mouse strains. We are also grateful to M. Eiraku and K. Muguruma for assistance with two-photon microscopy setup, Olympus for the customized objective lens, Y. Mimori-Kiyosue for equipment, J. Nabekura and T. Nemoto for instructions on in vivo two-photon imaging, and R. Iwata and H. Hiraga for valuable comments on the manuscript. This work was supported by grants from the PRESTO program of the Japan Science and Technology Agency, the Sumitomo Foundation, the Nakajima Foundation, the Mitsubishi Foundation, the Strategic Programs for R&D (President's Discretionary Fund) of RIKEN, and the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan (to T.I.). The imaging experiments were supported by the RIKEN Center for Developmental Biology Imaging Facility and the Four-dimensional Tissue Analysis Unit. Animal experiments were supported by the Laboratory for Animal Resources and Genetic Engineering at the RIKEN Center for Developmental Biology.	Bancroft J., 2007, THEORY PRACTICE HIST, V6 ed; Becker K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033916; Chen TW, 2009, P NATL ACAD SCI USA, V106, P2401, DOI 10.1073/pnas.0810151106; Chung K, 2013, NATURE, V497, P332, DOI 10.1038/nature12107; DENT JA, 1989, DEVELOPMENT, V105, P61; Dhawale AK, 2010, NAT NEUROSCI, V13, P1404, DOI 10.1038/nn.2673; DILLS WL, 1993, AM J CLIN NUTR, V58, P779, DOI 10.1093/ajcn/58.5.779S; DINGERKUS G, 1977, STAIN TECHNOL, V52, P229, DOI 10.3109/10520297709116780; Dodt HU, 2007, NAT METHODS, V4, P331, DOI 10.1038/NMETH1036; Erturk A, 2012, NAT MED, V18, P166, DOI 10.1038/nm.2600; Fantana AL, 2008, NEURON, V59, P802, DOI 10.1016/j.neuron.2008.07.039; Feng GP, 2000, NEURON, V28, P41, DOI 10.1016/S0896-6273(00)00084-2; Ghosh S, 2011, NATURE, V472, P217, DOI 10.1038/nature09945; Gonzalez-Bellido P. T., 2012, COLD SPRING HARB PRO, DOI DOI 10.1101/PDB.PR0T069625; Hama H, 2011, NAT NEUROSCI, V14, P1481, DOI 10.1038/nn.2928; Helmchen F, 2005, NAT METHODS, V2, P932, DOI 10.1038/NMETH818; HINDS JW, 1977, J COMP NEUROL, V171, P345, DOI 10.1002/cne.901710304; Hofer S, 2006, NEUROIMAGE, V32, P989, DOI 10.1016/j.neuroimage.2006.05.044; Igarashi KM, 2012, J NEUROSCI, V32, P7970, DOI 10.1523/JNEUROSCI.0154-12.2012; Imai T, 2009, SCIENCE, V325, P585, DOI 10.1126/science.1173596; KAPLAN MS, 1985, J COMP NEUROL, V239, P117, DOI 10.1002/cne.902390110; Kazama H, 2009, NAT NEUROSCI, V12, P1136, DOI 10.1038/nn.2376; Kikuta S, 2013, NEURON, V77, P1122, DOI 10.1016/j.neuron.2013.01.022; Kim DH, 2011, FRONT NEURAL CIRCUIT, V5, DOI 10.3389/fncir.2011.00005; Kim J, 2012, NAT METHODS, V9, P96, DOI [10.1038/NMETH.1784, 10.1038/nmeth.1784]; KLYMKOWSKY MW, 1991, METHOD CELL BIOL, V36, P419; Li Y, 2012, NATURE, V486, P118, DOI 10.1038/nature11110; Lin DM, 2000, NEURON, V26, P69, DOI 10.1016/S0896-6273(00)81139-3; Livet J, 2007, NATURE, V450, P56, DOI 10.1038/nature06293; Lo LC, 2011, NEURON, V72, P938, DOI 10.1016/j.neuron.2011.12.002; Marshel JH, 2010, NEURON, V67, P562, DOI 10.1016/j.neuron.2010.08.001; Miyamichi K, 2011, NATURE, V472, P191, DOI 10.1038/nature09714; Miyasaka N, 2009, J NEUROSCI, V29, P4756, DOI 10.1523/JNEUROSCI.0118-09.2009; MORI K, 1983, J COMP NEUROL, V219, P339, DOI 10.1002/cne.902190308; Murthy VN, 2011, ANNU REV NEUROSCI, V34, P233, DOI 10.1146/annurev-neuro-061010-113738; Nagayama S, 2007, NEURON, V53, P789, DOI 10.1016/j.neuron.2007.02.018; Nagayama S, 2010, FRONT NEURAL CIRCUIT, V4, DOI 10.3389/fncir.2010.00120; Nishikimi M, 2011, J NEUROSCI, V31, P16251, DOI 10.1523/JNEUROSCI.3303-11.2011; Ohtsuki G, 2012, NEURON, V75, P65, DOI 10.1016/j.neuron.2012.05.023; ORONA E, 1983, J COMP NEUROL, V217, P227, DOI 10.1002/cne.902170209; ORONA E, 1984, J COMP NEUROL, V226, P346, DOI 10.1002/cne.902260305; Potter SM, 2001, J NEUROSCI, V21, P9713, DOI 10.1523/JNEUROSCI.21-24-09713.2001; Saito T, 2006, NAT PROTOC, V1, P1552, DOI 10.1038/nprot.2006.276; Schoppa NE, 2001, NEURON, V31, P639, DOI 10.1016/S0896-6273(01)00389-0; Sosulski DL, 2011, NATURE, V472, P213, DOI 10.1038/nature09868; Staudt T, 2007, MICROSC RES TECHNIQ, V70, P1, DOI 10.1002/jemt.20396; Taylor W. R., 1967, Proceedings of the United States National Museum, V122, P1; Tsai PS, 2009, J NEUROSCI, V29, P14553, DOI 10.1523/JNEUROSCI.3287-09.2009; Tuchin V. V., 2007, TISSUE OPTICS LIGHT, V2nd; Yu YC, 2012, NATURE, V486, P113, DOI 10.1038/nature10958	50	594	614	7	149	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	AUG	2013	16	8					1154	U246		10.1038/nn.3447	http://dx.doi.org/10.1038/nn.3447			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	190EV	23792946				2022-12-28	WOS:000322323000028
J	Schmidt, R; Leventhal, DK; Mallet, N; Chen, FJ; Berke, JD				Schmidt, Robert; Leventhal, Daniel K.; Mallet, Nicolas; Chen, Fujun; Berke, Joshua D.			Canceling actions involves a race between basal ganglia pathways	NATURE NEUROSCIENCE			English	Article							NIGRA PARS RETICULATA; CHOICE-REACTION-TIME; FAST-SPIKING INTERNEURONS; MONKEY SUBSTANTIA-NIGRA; SUBTHALAMIC NUCLEUS; RESPONSE-INHIBITION; STOP-SIGNAL; SUPERIOR COLLICULUS; SACCADE INITIATION; DECISION THRESHOLD	Salient cues can prompt the rapid interruption of planned actions. It has been proposed that fast, reactive behavioral inhibition involves specific basal ganglia pathways, and we tested this by comparing activity in multiple rat basal ganglia structures during performance of a stop-signal task. Subthalamic nucleus (STN) neurons exhibited low-latency responses to 'Stop' cues, irrespective of whether actions were canceled or not. By contrast, neurons downstream in the substantia nigra pars reticulata (SNr) only responded to Stop cues in trials with successful cancellation. Recordings and simulations together indicate that this sensorimotor gating arises from the relative timing of two distinct inputs to neurons in the SNr dorsolateral 'core' subregion: cue-related excitation from STN and movement-related inhibition from striatum. Our results support race models of action cancellation, with stopping requiring Stop-cue information to be transmitted from STN to SNr before increased striatal input creates a point of no return.	[Schmidt, Robert; Mallet, Nicolas; Chen, Fujun; Berke, Joshua D.] Univ Michigan, Dept Psychol, Ann Arbor, MI 48109 USA; [Leventhal, Daniel K.] Univ Michigan, Dept Neurol, Ann Arbor, MI USA; [Mallet, Nicolas] Univ Victor Segalen, Inst Malad Neurodegenerat, CNRS, Bordeaux, France	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite de Bordeaux	Berke, JD (corresponding author), Univ Michigan, Dept Psychol, Ann Arbor, MI 48109 USA.	jdberke@umich.edu	Schmidt, Robert/H-6125-2017	Schmidt, Robert/0000-0002-2474-3744; Leventhal, Daniel/0000-0001-8174-5933	Deutsche Forschungsgemeinschaft [SCHM 2745/1-1]; US National Institute on Drug Abuse, National Institute on Neurological Disorders and Stroke; University of Michigan; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS078435] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA014318] Funding Source: NIH RePORTER	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); US National Institute on Drug Abuse, National Institute on Neurological Disorders and Stroke; University of Michigan(University of Michigan System); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank V. Stuphorn, D. Weissman, A. Aron, G. Morris, M. Churchland, M. Bevan and D. Meyer for their helpful comments. J. Pettibone and A. Case provided valuable assistance. This work was supported by Deutsche Forschungsgemeinschaft grant SCHM 2745/1-1, the US National Institute on Drug Abuse, National Institute on Neurological Disorders and Stroke, and the University of Michigan.	ALBIN RL, 1989, TRENDS NEUROSCI, V12, P366, DOI 10.1016/0166-2236(89)90074-X; Aron AR, 2011, BIOL PSYCHIAT, V69, pE55, DOI 10.1016/j.biopsych.2010.07.024; Aron AR, 2006, J NEUROSCI, V26, P2424, DOI 10.1523/JNEUROSCI.4682-05.2006; Ballanger B, 2009, ANN NEUROL, V66, P817, DOI 10.1002/ana.21795; Basso MA, 2011, NEUROSCIENCE, V198, P205, DOI 10.1016/j.neuroscience.2011.08.026; Baunez C, 2001, EUR J NEUROSCI, V13, P1609, DOI 10.1046/j.0953-816x.2001.01521.x; BERGMAN H, 1990, SCIENCE, V249, P1436, DOI 10.1126/science.2402638; Berke JD, 2008, J NEUROSCI, V28, P10075, DOI 10.1523/JNEUROSCI.2192-08.2008; BEVAN MD, 1994, EUR J NEUROSCI, V6, P320, DOI 10.1111/j.1460-9568.1994.tb00275.x; BLOMFIELD S, 1974, BRAIN RES, V69, P115, DOI 10.1016/0006-8993(74)90375-8; Boucher L, 2007, PSYCHOL REV, V114, P376, DOI 10.1037/0033-295X.114.2.376; Brown JW, 2008, EXP BRAIN RES, V190, P135, DOI 10.1007/s00221-008-1455-0; Cavanagh JF, 2011, NAT NEUROSCI, V14, P1462, DOI 10.1038/nn.2925; Cheruel F, 1996, EXP BRAIN RES, V108, P206; Connelly WM, 2010, J NEUROSCI, V30, P14854, DOI 10.1523/JNEUROSCI.3895-10.2010; Cui GH, 2013, NATURE, V494, P238, DOI 10.1038/nature11846; Deniau JM, 2007, PROG BRAIN RES, V160, P151, DOI 10.1016/S0079-6123(06)60009-5; Deschenes M, 1996, EUR J NEUROSCI, V8, P329, DOI 10.1111/j.1460-9568.1996.tb01217.x; Ding JB, 2010, NEURON, V67, P294, DOI 10.1016/j.neuron.2010.06.017; Eagle DM, 2008, CEREB CORTEX, V18, P178, DOI 10.1093/cercor/bhm044; Frank MJ, 2007, SCIENCE, V318, P1309, DOI 10.1126/science.1146157; Frank MJ, 2006, NEURAL NETWORKS, V19, P1120, DOI 10.1016/j.neunet.2006.03.006; Gage GJ, 2010, NEURON, V67, P466, DOI 10.1016/j.neuron.2010.06.034; Gerstner W, 2002, SPIKING NEURON MODEL; Handel A, 1999, J NEUROPHYSIOL, V82, P3458, DOI 10.1152/jn.1999.82.6.3458; Hanes DP, 1996, SCIENCE, V274, P427, DOI 10.1126/science.274.5286.427; HIKOSAKA O, 1983, J NEUROPHYSIOL, V49, P1230; HIKOSAKA O, 1983, BRAIN RES, V272, P368, DOI 10.1016/0006-8993(83)90586-3; Humphries MD, 2006, J NEUROSCI, V26, P12921, DOI 10.1523/JNEUROSCI.3486-06.2006; Humphries MD, 2001, NEURAL NETWORKS, V14, P845, DOI 10.1016/S0893-6080(01)00060-0; Jahfari S, 2011, J NEUROSCI, V31, P6891, DOI 10.1523/JNEUROSCI.5253-10.2011; Kimura M, 2004, NEUROSCI RES, V48, P355, DOI 10.1016/j.neures.2003.12.002; Kita T, 2011, EUR J NEUROSCI, V33, P433, DOI 10.1111/j.1460-9568.2010.07537.x; Kravitz AV, 2010, NATURE, V466, P622, DOI 10.1038/nature09159; Leventhal DK, 2012, NEURON, V73, P523, DOI 10.1016/j.neuron.2011.11.032; Levy BJ, 2011, ANN NY ACAD SCI, V1224, P40, DOI 10.1111/j.1749-6632.2011.05958.x; Lo CC, 2006, NAT NEUROSCI, V9, P956, DOI 10.1038/nn1722; LOGAN GD, 1984, J EXP PSYCHOL HUMAN, V10, P276, DOI 10.1037/0096-1523.10.2.276; Majid DSA, 2012, CEREB CORTEX, V22, P363, DOI 10.1093/cercor/bhr112; Matsumoto N, 2001, J NEUROPHYSIOL, V85, P960, DOI 10.1152/jn.2001.85.2.960; McHaffie JG, 2005, TRENDS NEUROSCI, V28, P401, DOI 10.1016/j.tins.2005.06.006; OSMAN A, 1986, J EXP PSYCHOL HUMAN, V12, P243, DOI 10.1037/0096-1523.12.3.243; Pan WX, 2005, J NEUROSCI, V25, P4725, DOI 10.1523/JNEUROSCI.0277-05.2005; Pare M, 2003, J NEUROSCI, V23, P6480; Paxinos G., 2005, RAT BRAIN STEREOTAXI, V5th Edn, DOI 10.1016/c2009-0-63235-9; Robbins TW, 2012, TRENDS COGN SCI, V16, P81, DOI 10.1016/j.tics.2011.11.009; SCHULTZ W, 1986, J NEUROPHYSIOL, V55, P660, DOI 10.1152/jn.1986.55.4.660; Segev I., 1998, HDB BRAIN THEORY NEU, P282; Sharp DJ, 2010, P NATL ACAD SCI USA, V107, P6106, DOI 10.1073/pnas.1000175107; Shulman GL, 2009, J NEUROSCI, V29, P4392, DOI 10.1523/JNEUROSCI.5609-08.2009; Stuphorn V, 2010, J NEUROPHYSIOL, V103, P801, DOI 10.1152/jn.00221.2009; Verbruggen F, 2009, NEUROSCI BIOBEHAV R, V33, P647, DOI 10.1016/j.neubiorev.2008.08.014; Watanabe M, 2009, EUR J NEUROSCI, V30, P2165, DOI 10.1111/j.1460-9568.2009.06998.x; Wiecki TV, 2013, PSYCHOL REV, V120, P329, DOI 10.1037/a0031542; Wiltschko AB, 2008, J NEUROSCI METH, V173, P34, DOI 10.1016/j.jneumeth.2008.05.016; Zandbelt BB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013848	56	249	249	2	76	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	AUG	2013	16	8					1118	U194		10.1038/nn.3456	http://dx.doi.org/10.1038/nn.3456			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	190EV	23852117	Green Accepted			2022-12-28	WOS:000322323000023
J	Chowdhury, R; Guitart-Masip, M; Lambert, C; Dayan, P; Huys, Q; Duzel, E; Dolan, RJ				Chowdhury, Rumana; Guitart-Masip, Marc; Lambert, Christian; Dayan, Peter; Huys, Quentin; Duezel, Emrah; Dolan, Raymond J.			Dopamine restores reward prediction errors in old age	NATURE NEUROSCIENCE			English	Article							REINFORCEMENT LEARNING SIGNALS; PARKINSONS-DISEASE; DECISION-MAKING; HUMAN STRIATUM; DIFFUSION MRI; NEUROMODULATION; BRAIN	Senescence affects the ability to utilize information about the likelihood of rewards for optimal decision-making. Using functional magnetic resonance imaging in humans, we found that healthy older adults had an abnormal signature of expected value, resulting in an incomplete reward prediction error (RPE) signal in the nucleus accumbens, a brain region that receives rich input projections from substantia nigra/ventral tegmental area (SN/VTA) dopaminergic neurons. Structural connectivity between SN/VTA and striatum, measured by diffusion tensor imaging, was tightly coupled to inter-individual differences in the expression of this expected reward value signal. The dopamine precursor levodopa (L-DOPA) increased the task-based learning rate and task performance in some older adults to the level of young adults. This drug effect was linked to restoration of a canonical neural RPE. Our results identify a neurochemical signature underlying abnormal reward processing in older adults and indicate that this can be modulated by L-DOPA.	[Chowdhury, Rumana; Duezel, Emrah] UCL, Inst Cognit Neurosci, London, England; [Chowdhury, Rumana; Guitart-Masip, Marc; Lambert, Christian; Huys, Quentin; Dolan, Raymond J.] UCL, Wellcome Trust Ctr Neuroimaging, London, England; [Guitart-Masip, Marc] Karolinska Inst, Aging Res Ctr, Stockholm, Sweden; [Lambert, Christian] St Georges Univ London, Stroke & Dementia Res Ctr, London, England; [Dayan, Peter; Huys, Quentin] UCL, Gatsby Computat Neurosci Unit, London, England; [Huys, Quentin] Swiss Fed Inst Technol, Dept Biol Engn, Translat Neuroimaging Unit, Zurich, Switzerland; [Huys, Quentin] Univ Zurich, Zurich, Switzerland; [Huys, Quentin] Zurich Univ Hosp Psychiat, Dept Psychiat Psychotherapy & Psychosomat, Zurich, Switzerland; [Duezel, Emrah] Univ Magdeburg, Inst Cognit Neurol & Dementia Res, D-39106 Magdeburg, Germany; [Duezel, Emrah] German Ctr Neurodegenerat Dis DZNE, Magdeburg, Germany	University of London; University College London; University of London; University College London; Karolinska Institutet; St Georges University London; University of London; University College London; Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Zurich; Otto von Guericke University; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE)	Chowdhury, R (corresponding author), UCL, Inst Cognit Neurosci, London, England.	rumana.neuro@gmail.com	Duzel, Emrah/A-1794-2010	Dayan, Peter/0000-0003-3476-1839; Guitart Masip, Marc/0000-0002-2294-6492; Dolan, Ray/0000-0001-9356-761X; Huys, Quentin/0000-0002-8999-574X; Lambert, Christian/0000-0001-8281-4611; Duzel, Emrah/0000-0002-0139-5388	Wellcome Trust [078865/Z/05/Z, 091593/Z/10/Z, WT088286MA]; Academy of Medical Sciences (AMS) [AMS-SGCL8-Lambert] Funding Source: researchfish; National Institute for Health Research [CL-2012-16-501] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); Academy of Medical Sciences (AMS)(Academy of Medical Sciences (AMS)); National Institute for Health Research(National Institute for Health Research (NIHR))	We thank J. Medhora and L. Sasse for their assistance with data collection, and H. Barron and M. Klein-Flugge for their assistance with time course analyses. R.C. is supported by a Wellcome Trust Research Training Fellowship (WT088286MA). R.J.D. is supported by the Wellcome Trust (grant number 078865/Z/05/Z). The Wellcome Trust Centre for Neuroimaging is supported by core funding from the Wellcome Trust (091593/Z/10/Z).	Andersson JLR, 2003, NEUROIMAGE, V20, P870, DOI 10.1016/S1053-8119(03)00336-7; Ashburner J, 2007, NEUROIMAGE, V38, P95, DOI 10.1016/j.neuroimage.2007.07.007; Backman L, 2006, NEUROSCI BIOBEHAV R, V30, P791, DOI 10.1016/j.neubiorev.2006.06.005; Behrens TEJ, 2008, NATURE, V456, P245, DOI 10.1038/nature07538; Brett M., 2002, NEUROIMAGE, V16, P1140, DOI DOI 10.1016/S1053-8119(02)90013-3; Choi WY, 2005, J NEUROSCI, V25, P6729, DOI 10.1523/JNEUROSCI.1498-05.2005; Cools R, 2011, BIOL PSYCHIAT, V69, pE113, DOI 10.1016/j.biopsych.2011.03.028; Cox KM, 2008, COGN AFFECT BEHAV NE, V8, P304, DOI 10.3758/CABN.8.3.304; Coxon JP, 2012, J NEUROSCI, V32, P8401, DOI 10.1523/JNEUROSCI.6360-11.2012; Daw ND, 2006, NATURE, V441, P876, DOI 10.1038/nature04766; Daw ND, 2011, NEURON, V69, P1204, DOI 10.1016/j.neuron.2011.02.027; de Wit S, 2012, PSYCHOPHARMACOLOGY, V219, P621, DOI 10.1007/s00213-011-2563-2; Dickinson A, 2000, BEHAV NEUROSCI, V114, P468, DOI 10.1037/0735-7044.114.3.468; Dickinson A., 2002, STEVENS HDB EXPT PSY; Draganski B, 2011, NEUROIMAGE, V55, P1423, DOI 10.1016/j.neuroimage.2011.01.052; Duzel E, 2010, NEUROSCI BIOBEHAV R, V34, P660, DOI 10.1016/j.neubiorev.2009.08.006; Eppinger B, 2008, NEUROPSYCHOLOGIA, V46, P521, DOI 10.1016/j.neuropsychologia.2007.09.001; Eppinger B, 2011, ANN NY ACAD SCI, V1235, P1, DOI 10.1111/j.1749-6632.2011.06230.x; FEARNLEY JM, 1991, BRAIN, V114, P2283, DOI 10.1093/brain/114.5.2283; Forstmann BU, 2012, NEUROIMAGE, V60, P370, DOI 10.1016/j.neuroimage.2011.12.044; Forstmann BU, 2011, J NEUROSCI, V31, P17242, DOI 10.1523/JNEUROSCI.0309-11.2011; Glascher J, 2010, NEURON, V66, P585, DOI 10.1016/j.neuron.2010.04.016; Guitart-Masip M, 2012, NEUROIMAGE, V62, P154, DOI 10.1016/j.neuroimage.2012.04.024; Guitart-Masip M, 2012, P NATL ACAD SCI USA, V109, P7511, DOI 10.1073/pnas.1202229109; Haber SN, 2000, J NEUROSCI, V20, P2369; Huys QJM, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002028; Jocham G, 2011, J NEUROSCI, V31, P1606, DOI 10.1523/JNEUROSCI.3904-10.2011; Klein-Flugge MC, 2011, NEURON, V72, P654, DOI 10.1016/j.neuron.2011.08.024; Knutson B, 2005, CURR OPIN NEUROL, V18, P411, DOI 10.1097/01.wco.0000173463.24758.f6; Knutson B, 2007, PSYCHOPHARMACOLOGY, V191, P813, DOI 10.1007/s00213-006-0686-7; Le Bihan D, 2012, NEUROIMAGE, V61, P324, DOI 10.1016/j.neuroimage.2011.11.006; Li JA, 2011, J NEUROSCI, V31, P5504, DOI 10.1523/JNEUROSCI.6316-10.2011; Li SC, 2002, NEUROSCI BIOBEHAV R, V26, P795, DOI 10.1016/S0149-7634(02)00066-0; Lutti A, 2010, MAGN RESON MED, V64, P229, DOI 10.1002/mrm.22421; Mell T, 2005, NEUROPSYCHOLOGIA, V43, P554, DOI 10.1016/j.neuropsychologia.2004.07.010; Nagy Z, 2007, MAGN RESON MED, V58, P763, DOI 10.1002/mrm.21379; Nicola SM, 2000, ANNU REV NEUROSCI, V23, P185, DOI 10.1146/annurev.neuro.23.1.185; O'Doherty J, 2004, SCIENCE, V304, P452, DOI 10.1126/science.1094285; O'Doherty JP, 2003, NEURON, V38, P329, DOI 10.1016/S0896-6273(03)00169-7; Pessiglione M, 2006, NATURE, V442, P1042, DOI 10.1038/nature05051; Reese TG, 2003, MAGN RESON MED, V49, P177, DOI 10.1002/mrm.10308; Rutledge RB, 2009, J NEUROSCI, V29, P15104, DOI 10.1523/JNEUROSCI.3524-09.2009; Salamone JD, 2005, CURR OPIN PHARMACOL, V5, P34, DOI 10.1016/j.coph.2004.09.004; Samanez-Larkin GR, 2011, SOC COGN AFFECT NEUR, V6, P207, DOI 10.1093/scan/nsq043; Samanez-Larkin GR, 2010, J NEUROSCI, V30, P1426, DOI 10.1523/JNEUROSCI.4902-09.2010; Schonberg T, 2007, J NEUROSCI, V27, P12860, DOI 10.1523/JNEUROSCI.2496-07.2007; Schott BH, 2007, BRAIN, V130, P2412, DOI 10.1093/brain/awm147; Schultz W, 1997, SCIENCE, V275, P1593, DOI 10.1126/science.275.5306.1593; Schwarzkopf DS, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00200; Shohamy D, 2010, TRENDS COGN SCI, V14, P464, DOI 10.1016/j.tics.2010.08.002; Simon DA, 2011, J NEUROSCI, V31, P5526, DOI 10.1523/JNEUROSCI.4647-10.2011; Vaillancourt DE, 2012, NEUROBIOL AGING, V33, P35, DOI 10.1016/j.neurobiolaging.2010.02.006; Worthy DA, 2011, PSYCHOL SCI, V22, P1375, DOI 10.1177/0956797611420301; Wunderlich K, 2012, NEURON, V75, P418, DOI 10.1016/j.neuron.2012.03.042	54	169	173	0	51	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAY	2013	16	5					648	+		10.1038/nn.3364	http://dx.doi.org/10.1038/nn.3364			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	131WT	23525044	Green Accepted, Green Published			2022-12-28	WOS:000318029300022
J	Ueno, M; Fujita, Y; Tanaka, T; Nakamura, Y; Kikuta, J; Ishii, M; Yamashita, T				Ueno, Masaki; Fujita, Yuki; Tanaka, Tatsuhide; Nakamura, Yuka; Kikuta, Junichi; Ishii, Masaru; Yamashita, Toshihide			Layer V cortical neurons require microglial support for survival during postnatal development	NATURE NEUROSCIENCE			English	Article							PROJECTION NEURONS; CELL-DEATH; MACROPHAGES; ACTIVATION; GROWTH; RECEPTOR; CALLOSAL; PROLIFERATION; DEGENERATION; EXPRESSION	Neurons require trophic support during neural circuit formation; however, how the cellular milieu contributes to neuronal survival remains unclear. We found that layer V cortical neurons require support from microglia for survival during postnatal development. Specifically, we found that microglia accumulated close to the subcerebral and callosal projection axons in the postnatal brain. Inactivation of microglia by minocycline treatment or transient ablation of microglia in CD11b-DTR transgenic mice led to increased apoptosis, specifically in layer V subcerebral and callosal projection neurons. CX3CR1 in microglia was required for the survival of layer V neurons. Microglia consistently promoted the survival of cortical neurons in vitro. In addition, we identified microglia-derived IGF1 as a trophic factor that maintained neuronal survival. Our results highlight a neuron-glia interaction that is indispensable for network formation during a specific period in the developing brain.	[Ueno, Masaki; Fujita, Yuki; Tanaka, Tatsuhide; Nakamura, Yuka; Yamashita, Toshihide] Osaka Univ, Grad Sch Med, Dept Mol Neurosci, Osaka, Japan; [Ueno, Masaki; Fujita, Yuki; Nakamura, Yuka; Yamashita, Toshihide] Japan Sci & Technol Agcy JST, CREST, Tokyo, Japan; [Tanaka, Tatsuhide] Asahikawa Med Univ, Dept Funct Anat & Neurosci, Sapporo, Hokkaido, Japan; [Kikuta, Junichi; Ishii, Masaru] Osaka Univ, Immunol Frontier Res Ctr, Lab Cellular Dynam, Osaka, Japan	Osaka University; Japan Science & Technology Agency (JST); Osaka University	Ueno, M (corresponding author), Osaka Univ, Grad Sch Med, Dept Mol Neurosci, Osaka, Japan.	ms-ueno@umin.ac.jp; yamashita@molneu.med.osaka-u.ac.jp	Kikuta, Junichi/HHS-8875-2022; Ueno, Masaki/J-1216-2019	Ueno, Masaki/0000-0003-1484-9921; Tanaka, Tatsuhide/0000-0002-3373-9093; Yamashita, Toshihide/0000-0003-4559-7018	Core Research for Evolutional Science and Technology (CREST) from the Japan Science and Technology Agency (JST); Japan Society for the Promotion of Science	Core Research for Evolutional Science and Technology (CREST) from the Japan Science and Technology Agency (JST)(Japan Science & Technology Agency (JST)Core Research for Evolutional Science and Technology (CREST)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	We thank H. Ozawa for experimental technical support, M.K. Yamada (University of Tokyo), P. Osten (Cold Spring Harbor Laboratory) and H. Miyoshi (RIKEN) for their kind gift of the lentivirus plasmid and helpful suggestions, and Y. Yoshida (Cincinnati Children's Hospital Medical Center) for critical comments on the manuscript. This work was supported by a grant for Core Research for Evolutional Science and Technology (CREST) from the Japan Science and Technology Agency (JST) to T.Y. and a Grant-in-Aid for Young Scientists (B) from Japan Society for the Promotion of Science to M.U.	Akazawa H, 2004, J BIOL CHEM, V279, P41095, DOI 10.1074/jbc.M313084200; Alcamo EA, 2008, NEURON, V57, P364, DOI 10.1016/j.neuron.2007.12.012; Alliot F, 1999, DEV BRAIN RES, V117, P145, DOI 10.1016/S0165-3806(99)00113-3; Antony JM, 2011, J NEUROSCI RES, V89, P286, DOI 10.1002/jnr.22533; Arlotta P, 2005, NEURON, V45, P207, DOI 10.1016/j.neuron.2004.12.036; BECK KD, 1995, NEURON, V14, P717, DOI 10.1016/0896-6273(95)90216-3; BREWER GJ, 1995, J NEUROSCI RES, V42, P674, DOI 10.1002/jnr.490420510; Cailhier JF, 2005, J IMMUNOL, V174, P2336, DOI 10.4049/jimmunol.174.4.2336; Canty AJ, 2008, PROG NEUROBIOL, V85, P214, DOI 10.1016/j.pneurobio.2008.02.001; Cardona AE, 2006, NAT NEUROSCI, V9, P917, DOI 10.1038/nn1715; Catapano LA, 2001, J NEUROSCI, V21, P8863, DOI 10.1523/JNEUROSCI.21-22-08863.2001; Chan WY, 2007, BRAIN RES REV, V53, P344, DOI 10.1016/j.brainresrev.2006.11.002; Chen SK, 2010, CELL, V141, P775, DOI 10.1016/j.cell.2010.03.055; Chesik D, 2004, NEUROREPORT, V15, P1033, DOI 10.1097/00001756-200404290-00020; Del Rio P, 2011, GLIA, V59, P821, DOI 10.1002/glia.21155; Dittgen T, 2004, P NATL ACAD SCI USA, V101, P18206, DOI 10.1073/pnas.0407976101; Duffield JS, 2005, J CLIN INVEST, V115, P56, DOI 10.1172/JCI200522675; Dugas JC, 2008, J NEUROSCI, V28, P8294, DOI 10.1523/JNEUROSCI.2010-08.2008; Firth SM, 2002, ENDOCR REV, V23, P824, DOI 10.1210/er.2001-0033; Frade JM, 1998, NEURON, V20, P35, DOI 10.1016/S0896-6273(00)80432-8; Gianino S, 1999, DEV BRAIN RES, V112, P189, DOI 10.1016/S0165-3806(98)00168-0; Ginhoux F, 2010, SCIENCE, V330, P841, DOI 10.1126/science.1194637; Haynes SE, 2006, NAT NEUROSCI, V9, P1512, DOI 10.1038/nn1805; Hristova M, 2010, GLIA, V58, P11, DOI 10.1002/glia.20896; Huang EJ, 2001, ANNU REV NEUROSCI, V24, P677, DOI 10.1146/annurev.neuro.24.1.677; Jung S, 2000, MOL CELL BIOL, V20, P4106, DOI 10.1128/MCB.20.11.4106-4114.2000; Kitayama M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025234; KOESTER SE, 1993, DEV BIOL, V160, P1, DOI 10.1006/dbio.1993.1281; Lalancette-Hebert M, 2007, J NEUROSCI, V27, P2596, DOI 10.1523/JNEUROSCI.5360-06.2007; Ling E A, 2001, Prog Brain Res, V132, P61; Luo LQ, 2005, ANNU REV NEUROSCI, V28, P127, DOI 10.1146/annurev.neuro.28.061604.135632; Marin-Teva JL, 2004, NEURON, V41, P535, DOI 10.1016/S0896-6273(04)00069-8; MILLIGAN CE, 1991, J COMP NEUROL, V314, P125, DOI 10.1002/cne.903140112; Murase S, 1998, J NEUROSCI, V18, P10481; Neumann H, 2009, BRAIN, V132, P288, DOI 10.1093/brain/awn109; Nimmerjahn A, 2005, SCIENCE, V308, P1314, DOI 10.1126/science.1110647; OLEARY DDM, 1988, NEURON, V1, P901, DOI 10.1016/0896-6273(88)90147-X; Oppenheim R. W., 2003, PROGRAMMED CELL DEAT; Ozdinler PH, 2006, NAT NEUROSCI, V9, P1371, DOI 10.1038/nn1789; Paolicelli RC, 2011, SCIENCE, V333, P1456, DOI 10.1126/science.1202529; PIETRZKOWSKI Z, 1992, CANCER RES, V52, P6447; Ransohoff RM, 2009, IMMUNITY, V31, P711, DOI 10.1016/j.immuni.2009.09.010; Streit WJ, 2001, NEUROTOXICOLOGY, V22, P619, DOI 10.1016/S0161-813X(01)00033-X; Tanaka T, 2009, J BIOL CHEM, V284, P21626, DOI 10.1074/jbc.M109.005603; Tikka T, 2001, J NEUROSCI, V21, P2580, DOI 10.1523/JNEUROSCI.21-08-02580.2001; Ueno M, 2012, BRAIN, V135, P1253, DOI 10.1093/brain/aws053; Ueno Masaki, 2008, Biologics, V2, P253; VALVERDE F, 1995, J NEUROSCI, V15, P5014; Wake H, 2009, J NEUROSCI, V29, P3974, DOI 10.1523/JNEUROSCI.4363-08.2009; Wang CL, 2007, J NEUROSCI, V27, P11334, DOI 10.1523/JNEUROSCI.3380-07.2007; Yrjanheikki J, 1998, P NATL ACAD SCI USA, V95, P15769, DOI 10.1073/pnas.95.26.15769	51	474	484	6	63	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAY	2013	16	5					543	+		10.1038/nn.3358	http://dx.doi.org/10.1038/nn.3358			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	131WT	23525041				2022-12-28	WOS:000318029300010
J	Puehringer, D; Orel, N; Luningschror, P; Subramanian, N; Herrmann, T; Chao, MV; Sendtner, M				Puehringer, Dirk; Orel, Nadiya; Lueningschroer, Patrick; Subramanian, Narayan; Herrmann, Thomas; Chao, Moses V.; Sendtner, Michael			EGF transactivation of Trk receptors regulates the migration of newborn cortical neurons	NATURE NEUROSCIENCE			English	Article							PROGENITOR-CELL PROLIFERATION; GROWTH-FACTOR; NEUROTROPHIN RECEPTORS; MICE LACKING; N-GLYCOSYLATION; NERVOUS-SYSTEM; DIFFERENTIATION; MEMBRANE; GUIDANCE; SURVIVAL	The development of neuronal networks in the neocortex depends on control mechanisms for mitosis and migration that allow newborn neurons to find their accurate position. Multiple mitogens, neurotrophic factors, guidance molecules and their corresponding receptors are involved in this process, but the mechanisms by which these signals are integrated are only poorly understood. We found that TrkB and TrkC, the receptors for brain-derived neurotrophic factor (BDNF) and neurotrophin-3 (NT-3), are activated by epidermal growth factor receptor (EGFR) signaling rather than by BDNF or NT-3 in embryonic mouse cortical precursor cells. This transactivation event regulated migration of early neuronal cells to their final position in the developing cortex. Transactivation by EGF led to membrane translocation of TrkB, promoting its signaling responsiveness. Our results provide genetic evidence that TrkB and TrkC activation in early cortical neurons do not depend on BDNF and NT-3, but instead on transactivation by EGFR signaling.	[Puehringer, Dirk; Orel, Nadiya; Lueningschroer, Patrick; Subramanian, Narayan; Herrmann, Thomas; Sendtner, Michael] Univ Wurzburg, Inst Clin Neurobiol, Wurzburg, Germany; [Chao, Moses V.] NYU, Sch Med, Kimmel Ctr Biol & Med, Skirball Inst Biomol Med,Mol Neurobiol Program, New York, NY USA	University of Wurzburg; New York University	Sendtner, M (corresponding author), Univ Wurzburg, Inst Clin Neurobiol, Wurzburg, Germany.	sendtner_m@klinik.uni-wuerzburg.de	Sendtner, Michael/M-8137-2014; Subramanian, Narayan/H-7449-2019; Sendtner, Michael/J-1542-2012	Sendtner, Michael/0000-0002-4737-2974; Subramanian, Narayan/0000-0002-0234-9092; Sendtner, Michael/0000-0002-4737-2974; Chao, Moses/0000-0002-6969-3744; Luningschror, Patrick/0000-0002-3883-6554	Deutsche Forschungsgemeinschaft [SFB 487, C4, SFB 581, B4]; ForNeuroCell; US National Institutes of Health [NS21072-24]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS021072, R56NS021072] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG025970] Funding Source: NIH RePORTER	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); ForNeuroCell; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We would like to thank M. Sibilia (Medical University of Vienna) for providing Egfr<SUP>-/-</SUP> mice, Y.A. Barde (University of Basel) for the HA-TrkB construct, K. Walter for excellent technical assistance, and W. Fouquet and S. Sigrist for their help in STED microscopy. This work was supported by the Deutsche Forschungsgemeinschaft, grants SFB 487, C4 (N.O.) and SFB 581, B4 (D.P. and M.S.), ForNeuroCell (M.S.) and by US National Institutes of Health grant NS21072-24 (M.V.C.).	Alvarez-Buylla A, 2001, NAT REV NEUROSCI, V2, P287, DOI 10.1038/35067582; ANGEVINE JB, 1961, NATURE, V192, P766, DOI 10.1038/192766b0; Arevalo JC, 2006, NEURON, V50, P549, DOI 10.1016/j.neuron.2006.03.044; Ayala R, 2007, CELL, V128, P29, DOI 10.1016/j.cell.2006.12.021; Bartkowska K, 2007, DEVELOPMENT, V134, P4369, DOI 10.1242/dev.008227; Bayer S.A., 1991, NEOCORTICAL DEV; Behar TN, 1997, EUR J NEUROSCI, V9, P2561, DOI 10.1111/j.1460-9568.1997.tb01685.x; Bergami M, 2008, P NATL ACAD SCI USA, V105, P15570, DOI 10.1073/pnas.0803702105; Burrows RC, 1997, NEURON, V19, P251, DOI 10.1016/S0896-6273(00)80937-X; Caric D, 2001, DEVELOPMENT, V128, P4203; Cheng AW, 2003, DEV BIOL, V258, P319, DOI 10.1016/S0012-1606(03)00120-9; Doetsch F, 1999, CELL, V97, P703, DOI 10.1016/S0092-8674(00)80783-7; Doetsch F, 2002, NEURON, V36, P1021, DOI 10.1016/S0896-6273(02)01133-9; Dontchev VD, 2002, J NEUROSCI, V22, P6659; ERNFORS P, 1994, NATURE, V368, P147, DOI 10.1038/368147a0; ERNFORS P, 1994, CELL, V77, P503, DOI 10.1016/0092-8674(94)90213-5; FRY DW, 1994, SCIENCE, V265, P1093, DOI 10.1126/science.8066447; Gotz M, 2005, NAT REV MOL CELL BIO, V6, P777, DOI 10.1038/nrm1739; Gotz R, 2005, NAT NEUROSCI, V8, P1169, DOI 10.1038/nn1524; Gupta A, 2002, NAT REV GENET, V3, P342, DOI 10.1038/nrg799; Gut A, 1998, EMBO J, V17, P1919, DOI 10.1093/emboj/17.7.1919; Iwakura Y, 2008, J BIOL CHEM, V283, P15799, DOI 10.1074/jbc.M801553200; Jablonka S, 2007, J CELL BIOL, V179, P139, DOI 10.1083/jcb.200703187; Knoll B, 2007, NAT PROTOC, V2, P1216, DOI 10.1038/nprot.2007.157; Lee FS, 2002, J BIOL CHEM, V277, P9096, DOI 10.1074/jbc.M107421200; Lee FS, 2001, P NATL ACAD SCI USA, V98, P3555, DOI 10.1073/pnas.061020198; Li Y, 2008, NEURON, V59, P399, DOI 10.1016/j.neuron.2008.06.023; Lotto RB, 2001, J NEUROSCI, V21, P3904, DOI 10.1523/JNEUROSCI.21-11-03904.2001; MAISONPIERRE PC, 1990, NEURON, V5, P501, DOI 10.1016/0896-6273(90)90089-X; Medina DL, 2004, EMBO J, V23, P3803, DOI 10.1038/sj.emboj.7600399; Meyer-Franke A, 1998, NEURON, V21, P681, DOI 10.1016/S0896-6273(00)80586-3; Ming GL, 2002, NATURE, V417, P411, DOI 10.1038/nature745; Molyneaux BJ, 2007, NAT REV NEUROSCI, V8, P427, DOI 10.1038/nrn2151; MUKHOPADHYAY D, 1995, NATURE, V375, P577, DOI 10.1038/375577a0; Paves H, 1997, CELL TISSUE RES, V290, P285, DOI 10.1007/s004410050933; Qiu LH, 2006, INT J ONCOL, V29, P1003; Rajagopal R, 2004, J NEUROSCI, V24, P6650, DOI 10.1523/JNEUROSCI.0010-04.2004; Rajagopal R, 2006, MOL CELL NEUROSCI, V33, P36, DOI 10.1016/j.mcn.2006.06.002; RAKIC P, 1972, J COMP NEUROL, V145, P61, DOI 10.1002/cne.901450105; Rakic P, 2009, NAT REV NEUROSCI, V10, P724, DOI 10.1038/nrn2719; Rasmussen R, 2001, RAPID CYCLE REAL TIM, P21, DOI [10.1007/978-3-642-59524-0_3, DOI 10.1007/978-3-642-59524-0_3]; Resh MD, 1998, INT J BIOCHEM CELL B, V30, P1159, DOI 10.1016/S1357-2725(98)00089-2; Rohrer B, 1999, J NEUROSCI, V19, P8919, DOI 10.1523/JNEUROSCI.19-20-08919.1999; Sibilia M, 1998, EMBO J, V17, P719, DOI 10.1093/emboj/17.3.719; SIBILIA M, 1995, SCIENCE, V269, P234, DOI 10.1126/science.7618085; Sun Y, 2005, NEURON, V45, P873, DOI 10.1016/j.neuron.2005.01.045; Takahashi H, 2011, NEURON, V69, P287, DOI 10.1016/j.neuron.2010.12.024; Tropepe V, 1997, J NEUROSCI, V17, P7850; Vagin O, 2005, J BIOL CHEM, V280, P43159, DOI 10.1074/jbc.M508262200; Vagin O, 2009, AM J PHYSIOL-RENAL, V296, pF459, DOI 10.1152/ajprenal.90340.2008; VIELMETTER J, 1990, EXP BRAIN RES, V81, P283; Visel A, 2007, PLOS GENET, V3, P1867, DOI 10.1371/journal.pgen.0030178; Wiese S, 2007, P NATL ACAD SCI USA, V104, P17210, DOI 10.1073/pnas.0705267104; Xu BJ, 2000, NEURON, V26, P233, DOI 10.1016/S0896-6273(00)81153-8	54	61	62	0	10	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	APR	2013	16	4					407	U63		10.1038/nn.3333	http://dx.doi.org/10.1038/nn.3333			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	114EM	23416450	Green Accepted			2022-12-28	WOS:000316723700010
J	Nithianantharajah, J; Komiyama, NH; McKechanie, A; Johnstone, M; Blackwood, DH; St Clair, D; Emes, RD; van de Lagemaat, LN; Saksida, LM; Bussey, TJ; Grant, SGN				Nithianantharajah, Jess; Komiyama, Noboru H.; McKechanie, Andrew; Johnstone, Mandy; Blackwood, Douglas H.; St Clair, David; Emes, Richard D.; van de Lagemaat, Louie N.; Saksida, Lisa M.; Bussey, Timothy J.; Grant, Seth G. N.			Synaptic scaffold evolution generated components of vertebrate cognitive complexity	NATURE NEUROSCIENCE			English	Article							LONG-TERM POTENTIATION; GENOME DUPLICATION; NMDA RECEPTOR; MICE; GENE; SCHIZOPHRENIA; IMPAIRMENTS; MUTATIONS; ATTENTION; CINGULATE	The origins and evolution of higher cognitive functions, including complex forms of learning, attention and executive functions, are unknown. A potential mechanism driving the evolution of vertebrate cognition early in the vertebrate lineage (550 million years ago) was genome duplication and subsequent diversification of postsynaptic genes. Here we report, to our knowledge, the first genetic analysis of a vertebrate gene family in cognitive functions measured using computerized touchscreens. Comparison of mice carrying mutations in each of the four Dlg paralogs showed that simple associative learning required Dlg4, whereas Dlg2 and Dlg3 diversified to have opposing functions in complex cognitive processes. Exploiting the translational utility of touchscreens in humans and mice, testing Dlg2 mutations in both species showed that Dlg2's role in complex learning, cognitive flexibility and attention has been highly conserved over 100 million years. Dlg-family mutations underlie psychiatric disorders, suggesting that genome evolution expanded the complexity of vertebrate cognition at the cost of susceptibility to mental illness.	[Nithianantharajah, Jess; Komiyama, Noboru H.; van de Lagemaat, Louie N.; Grant, Seth G. N.] Univ Edinburgh, Ctr Clin Brain Sci, Genes Cognit Programme, Edinburgh, Midlothian, Scotland; [Nithianantharajah, Jess; Komiyama, Noboru H.; van de Lagemaat, Louie N.; Grant, Seth G. N.] Univ Edinburgh, Ctr Neuroregenerat, Edinburgh, Midlothian, Scotland; [Nithianantharajah, Jess; Komiyama, Noboru H.; van de Lagemaat, Louie N.; Grant, Seth G. N.] Wellcome Trust Sanger Inst, Genes Cognit Programme, Hinxton, England; [McKechanie, Andrew; Johnstone, Mandy; Blackwood, Douglas H.] Univ Edinburgh, Royal Edinburgh Hosp, Div Psychiat, Edinburgh, Midlothian, Scotland; [McKechanie, Andrew] Univ Edinburgh, Patrick Wild Ctr, Edinburgh, Midlothian, Scotland; [St Clair, David] Univ Aberdeen, Inst Med Sci, Aberdeen, Scotland; [Emes, Richard D.] Univ Nottingham, Sch Vet Med & Sci, Loughborough, England; [Saksida, Lisa M.; Bussey, Timothy J.] Univ Cambridge, Dept Expt Psychol, Cambridge CB2 3EB, England; [Saksida, Lisa M.; Bussey, Timothy J.] Univ Cambridge, MRC, Cambridge, England; [Saksida, Lisa M.; Bussey, Timothy J.] Univ Cambridge, Wellcome Trust Behav & Clin Neurosci Inst, Cambridge, England	University of Edinburgh; University of Edinburgh; Wellcome Trust Sanger Institute; Royal Infirmary of Edinburgh; University of Edinburgh; University of Edinburgh; University of Aberdeen; University of Nottingham; University of Cambridge; University of Cambridge; University of Cambridge	Grant, SGN (corresponding author), Univ Edinburgh, Ctr Clin Brain Sci, Genes Cognit Programme, Edinburgh, Midlothian, Scotland.	seth.grant@ed.ac.uk	Johnstone, Mandy/AAI-1952-2019; Saksida, Lisa M/M-2753-2016; Nithianantharajah, Jess/AAF-2347-2019; blackwood, douglas/AIB-8874-2022; St Clair, David/AAN-2412-2021; Bussey, Timothy J/M-2758-2016; Emes, Richard D/C-5341-2008	Johnstone, Mandy/0000-0002-8398-0862; Saksida, Lisa M/0000-0002-8416-8171; Nithianantharajah, Jess/0000-0002-3501-1143; Bussey, Timothy J/0000-0001-7518-4041; Emes, Richard D/0000-0001-6855-5481; McKechanie, Andrew/0000-0003-4273-9906; Grant, Seth/0000-0001-8732-8735	Wellcome Trust; Genes to Cognition Program; Medical Research Council (MRC); European Union [241995, 242498, 242167]; RS Macdonald Charitable Trust; Academy of Medical Sciences/The Wellcome Trust; Medical Research Council [G0001354B, G1000183B, G0001354] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); Genes to Cognition Program; Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); European Union(European Commission); RS Macdonald Charitable Trust; Academy of Medical Sciences/The Wellcome Trust; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank K. Elsegood and D. Fricker for mouse husbandry and genotyping, T. W. Robbins for advice on CANTAB, J. Barnett for assistance with CANTAB control data and T. W. Robbins and T. J. O'Dell for comments on the manuscript. Figure illustration contribution by D. J. Maizels. J.N., N.H.K., L.N.L. and S.G.N.G. was supported by The Wellcome Trust, Genes to Cognition Program, The Medical Research Council (MRC) and European Union programs (Project GENCODYS no. 241995, Project EUROSPIN no. 242498 and Project SYNSYS no. 242167). M. J. was supported by grants from RS Macdonald Charitable Trust and Academy of Medical Sciences/The Wellcome Trust.	Adams KL, 2005, CURR OPIN PLANT BIOL, V8, P135, DOI 10.1016/j.pbi.2005.01.001; Barnett JH, 2010, NEUROSCI BIOBEHAV R, V34, P1161, DOI 10.1016/j.neubiorev.2010.01.012; Barnett JH, 2005, PSYCHOL MED, V35, P1031, DOI 10.1017/S0033291704004301; Bartko SJ, 2011, NEUROPHARMACOLOGY, V61, P1366, DOI 10.1016/j.neuropharm.2011.08.023; Bartko SJ, 2011, PSYCHOPHARMACOLOGY, V214, P537, DOI 10.1007/s00213-010-2050-1; Bayes A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046683; Bayes A, 2011, NAT NEUROSCI, V14, P19, DOI 10.1038/nn.2719; Bossinger O, 2001, DEV BIOL, V230, P29, DOI 10.1006/dbio.2000.0113; Brigman JL, 2008, LEARN MEMORY, V15, P50, DOI 10.1101/lm.777308; Bussey TJ, 2012, NEUROPHARMACOLOGY, V62, P1191, DOI 10.1016/j.neuropharm.2011.04.011; Bussey TJ, 1997, BEHAV NEUROSCI, V111, P908, DOI 10.1037/0735-7044.111.5.908; Bussey TJ, 1997, BEHAV NEUROSCI, V111, P920, DOI 10.1037/0735-7044.111.5.920; Carlisle HJ, 2008, J PHYSIOL-LONDON, V586, P5885, DOI 10.1113/jphysiol.2008.163469; Carroll SB, 2008, CELL, V134, P25, DOI 10.1016/j.cell.2008.06.030; Caruana G, 2001, MOL CELL BIOL, V21, P1475, DOI 10.1128/MCB.21.5.1475-1483.2001; Chudasama Y, 2003, J NEUROSCI, V23, P8771; Conant GC, 2008, NAT REV GENET, V9, P938, DOI 10.1038/nrg2482; Conrad B, 2007, ANNU REV GENOM HUM G, V8, P17, DOI 10.1146/annurev.genom.8.021307.110233; Cuthbert PC, 2007, J NEUROSCI, V27, P2673, DOI 10.1523/JNEUROSCI.4457-06.2007; Dehal P, 2005, PLOS BIOL, V3, P1700, DOI 10.1371/journal.pbio.0030314; Emes RD, 2008, NAT NEUROSCI, V11, P799, DOI 10.1038/nn.2135; Fernandez E, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.27; Fray PJ, 1996, NEUROTOXICOL TERATOL, V18, P499, DOI 10.1016/0892-0362(96)00027-X; Grant SGN, 2009, COLD SH Q B, V74, P249, DOI 10.1101/sqb.2009.74.033; Gregory Richard L., 1987, OXFORD COMPANION MIN, DOI 10.1007/978-1-4939-2236-9_11; Hawrylycz MJ, 2012, NATURE, V489, P391, DOI 10.1038/nature11405; Holt DJ, 2009, BIOL PSYCHIAT, V65, P455, DOI 10.1016/j.biopsych.2008.09.017; Kellis M, 2004, NATURE, V428, P617, DOI 10.1038/nature02424; Kirov G, 2012, MOL PSYCHIATR, V17, P142, DOI 10.1038/mp.2011.154; Koechlin E, 2003, SCIENCE, V302, P1181, DOI 10.1126/science.1088545; Konopka G, 2012, NEURON, V75, P601, DOI 10.1016/j.neuron.2012.05.034; Leeson VC, 2009, BIOL PSYCHIAT, V66, P586, DOI 10.1016/j.biopsych.2009.05.016; Luck SJ, 2008, BIOL PSYCHIAT, V64, P34, DOI 10.1016/j.biopsych.2008.02.014; McGee AW, 2001, J NEUROSCI, V21, P3085, DOI 10.1523/JNEUROSCI.21-09-03085.2001; Migaud M, 1998, NATURE, V396, P433, DOI 10.1038/24790; Moore BR, 2004, BIOL REV, V79, P301, DOI 10.1017/S1464793103006225; Morton AJ, 2006, NAT METHODS, V3, P767, DOI 10.1038/nmeth1006-767; Mottron L, 2006, J AUTISM DEV DISORD, V36, P27, DOI 10.1007/s10803-005-0040-7; Robbins TW, 2012, BEHAV BRAIN RES, V231, P337, DOI 10.1016/j.bbr.2012.03.005; Robbins TW, 2002, PSYCHOPHARMACOLOGY, V163, P362, DOI 10.1007/s00213-002-1154-7; Romberg C, 2011, J NEUROSCI, V31, P3500, DOI 10.1523/JNEUROSCI.5242-10.2011; Ryan TJ, 2013, NAT NEUROSCI, V16, P25, DOI 10.1038/nn.3277; Stone JL, 2008, NATURE, V455, P237, DOI 10.1038/nature07239; Suls A, 2006, HUM MUTAT, V27, P914, DOI 10.1002/humu.20350; Talpos JC, 2009, PSYCHOPHARMACOLOGY, V205, P157, DOI 10.1007/s00213-009-1526-3; Tarpey P, 2004, AM J HUM GENET, V75, P318, DOI 10.1086/422703; van de Lagemaat LN, 2010, NEURON, V67, P8, DOI 10.1016/j.neuron.2010.06.026; Van de Peer Y, 2009, NAT REV GENET, V10, P725, DOI 10.1038/nrg2600; Walsh T, 2008, SCIENCE, V320, P539, DOI 10.1126/science.1155174; Waltz JA, 2007, SCHIZOPHR RES, V93, P296, DOI 10.1016/j.schres.2007.03.010; Woods DF, 1996, J CELL BIOL, V134, P1469, DOI 10.1083/jcb.134.6.1469; Xu B, 2008, NAT GENET, V40, P880, DOI 10.1038/ng.162	52	188	188	2	59	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JAN	2013	16	1					16	U37		10.1038/nn.3276	http://dx.doi.org/10.1038/nn.3276			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	058KZ	23201973	Green Published, Green Accepted			2022-12-28	WOS:000312633900008
J	O'Connell, RG; Dockree, PM; Kelly, SP				O'Connell, Redmond G.; Dockree, Paul M.; Kelly, Simon P.			A supramodal accumulation-to-bound signal that determines perceptual decisions in humans	NATURE NEUROSCIENCE			English	Article							GENERAL MECHANISM; NEURAL BASIS; REPRESENTATION; INTEGRATION; RESPONSES; COMPONENT; DYNAMICS; NEURONS; P3	In theoretical accounts of perceptual decision-making, a decision variable integrates noisy sensory evidence and determines action through a boundary-crossing criterion. Signals bearing these very properties have been characterized in single neurons in monkeys, but have yet to be directly identified in humans. Using a gradual target detection task, we isolated a freely evolving decision variable signal in human subjects that exhibited every aspect of the dynamics observed in its single-neuron counterparts. This signal could be continuously tracked in parallel with fully dissociable sensory encoding and motor preparation signals, and could be systematically perturbed mid-flight during decision formation. Furthermore, we found that the signal was completely domain general: it exhibited the same decision-predictive dynamics regardless of sensory modality and stimulus features and tracked cumulative evidence even in the absence of overt action. These findings provide a uniquely clear view on the neural determinants of simple perceptual decisions in humans.	[Kelly, Simon P.] CUNY City Coll, Dept Biomed Engn, New York, NY 10031 USA; [O'Connell, Redmond G.; Dockree, Paul M.] Trinity Coll Dublin, Trin Coll Inst Neurosci, Dublin, Ireland; [O'Connell, Redmond G.; Dockree, Paul M.] Trinity Coll Dublin, Sch Psychol, Dublin, Ireland	City University of New York (CUNY) System; City College of New York (CUNY); Trinity College Dublin; Trinity College Dublin	Kelly, SP (corresponding author), CUNY City Coll, Dept Biomed Engn, New York, NY 10031 USA.	skelly2@ccny.cuny.edu		Kelly, Simon/0000-0003-4981-3099; Kelly, Simon/0000-0001-9983-3595; O'Connell, Redmond/0000-0001-6949-2793	Irish Research Council for Science Engineering and Technology EMPOWER fellowship	Irish Research Council for Science Engineering and Technology EMPOWER fellowship	The authors thank S. Hillyard, I. Robertson, M. Bellgrove, E. Lalor and J. Balsters for helpful comments, and P. Collins, E. Lacey, C. Devine and D. Allen for their assistance with data collection. This work was supported by an Irish Research Council for Science Engineering and Technology EMPOWER fellowship (R.G.O.).	Bennur S, 2011, J NEUROSCI, V31, P913, DOI 10.1523/JNEUROSCI.4417-10.2011; Britten KH, 1996, VISUAL NEUROSCI, V13, P87, DOI 10.1017/S095252380000715X; Cook EP, 2002, NAT NEUROSCI, V5, P985, DOI 10.1038/nn924; Delorme A, 2004, J NEUROSCI METH, V134, P9, DOI 10.1016/j.jneumeth.2003.10.009; Di Russo F, 2007, HUM BRAIN MAPP, V28, P323, DOI 10.1002/hbm.20276; DONCHIN E, 1988, BEHAV BRAIN SCI, V11, P357, DOI 10.1017/S0140525X00058027; Donner TH, 2009, CURR BIOL, V19, P1581, DOI 10.1016/j.cub.2009.07.066; Fitzgerald JK, 2011, NAT NEUROSCI, V14, P1075, DOI 10.1038/nn.2878; Gold JI, 2007, ANNU REV NEUROSCI, V30, P535, DOI 10.1146/annurev.neuro.29.051605.113038; Green DM, 1966, SIGNAL DETECTION THE; Hanes DP, 1996, SCIENCE, V274, P427, DOI 10.1126/science.274.5286.427; Heekeren HR, 2008, NAT REV NEUROSCI, V9, P467, DOI 10.1038/nrn2374; Heekeren HR, 2004, NATURE, V431, P859, DOI 10.1038/nature02966; HILLYARD SA, 1971, SCIENCE, V172, P1357, DOI 10.1126/science.172.3990.1357; Ho TC, 2009, J NEUROSCI, V29, P8675, DOI 10.1523/JNEUROSCI.5984-08.2009; Horwitz GD, 2004, J NEUROPHYSIOL, V91, P2281, DOI 10.1152/jn.00872.2003; Huk AC, 2005, J NEUROSCI, V25, P10420, DOI 10.1523/JNEUROSCI.4684-04.2005; Hunt LT, 2012, NAT NEUROSCI, V15, P470, DOI 10.1038/nn.3017; Kiani R, 2008, J NEUROSCI, V28, P3017, DOI 10.1523/JNEUROSCI.4761-07.2008; Kiani R, 2009, SCIENCE, V324, P759, DOI 10.1126/science.1169405; Kok A, 2001, PSYCHOPHYSIOLOGY, V38, P557, DOI 10.1017/S0048577201990559; Kopp B., 2007, COGNITIVE SCI, V2, P113; Mars RB, 2008, J NEUROSCI, V28, P12539, DOI 10.1523/JNEUROSCI.2925-08.2008; Nieuwenhuis S, 2005, PSYCHOL BULL, V131, P510, DOI 10.1037/0033-2909.131.4.510; O'Connell RG, 2009, J NEUROSCI, V29, P8604, DOI 10.1523/JNEUROSCI.5967-08.2009; Parker AJ, 1998, ANNU REV NEUROSCI, V21, P227, DOI 10.1146/annurev.neuro.21.1.227; Pfurtscheller G, 1999, CLIN NEUROPHYSIOL, V110, P1842, DOI 10.1016/S1388-2457(99)00141-8; Philiastides MG, 2006, J NEUROSCI, V26, P8965, DOI 10.1523/JNEUROSCI.1655-06.2006; Polich J, 2006, INT J PSYCHOPHYSIOL, V60, P172, DOI 10.1016/j.ijpsycho.2005.12.012; Ratcliff R, 2009, P NATL ACAD SCI USA, V106, P6539, DOI 10.1073/pnas.0812589106; Romo R, 2001, ANNU REV NEUROSCI, V24, P107, DOI 10.1146/annurev.neuro.24.1.107; Rorie AE, 2005, TRENDS COGN SCI, V9, P41, DOI 10.1016/j.tics.2004.12.007; Shadlen MN, 2001, J NEUROPHYSIOL, V86, P1916, DOI 10.1152/jn.2001.86.4.1916; SMITH PL, 1988, J MATH PSYCHOL, V32, P135, DOI 10.1016/0022-2496(88)90043-0; Smith PL, 2004, TRENDS NEUROSCI, V27, P161, DOI 10.1016/j.tins.2004.01.006; Tosoni A, 2008, NAT NEUROSCI, V11, P1446, DOI 10.1038/nn.2221; Verleger R, 2005, J PSYCHOPHYSIOL, V19, P165, DOI 10.1027/0269-8803.19.3.165; WOODS DL, 1980, SCIENCE, V207, P655, DOI 10.1126/science.7352278	38	387	388	1	55	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	DEC	2012	15	12					1729	+		10.1038/nn.3248	http://dx.doi.org/10.1038/nn.3248			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	045OR	23103963				2022-12-28	WOS:000311706700020
J	Oliveira, AMM; Hemstedt, TJ; Bading, H				Oliveira, Ana M. M.; Hemstedt, Thekla J.; Bading, Hilmar			Rescue of aging-associated decline in Dnmt3a2 expression restores cognitive abilities	NATURE NEUROSCIENCE			English	Article							DNA METHYLATION; AGE; 5-METHYLCYTOSINE; RATS	Cognitive abilities decline in normal aging, yet the underlying molecular mechanisms are poorly understood. We found that aging was associated with a decrease in the expression of the DNA methyltransferase Dnmt3a2 in the hippocampus and that rescuing Dnmt3a2 levels restored cognitive functions. Moreover, we found that Dnmt3a2 is an activity-regulated immediate early gene that is partly dependent on nuclear calcium signaling and that hippocampal Dnmt3a2 levels determine cognitive abilities in both young adult and aged mice.	[Oliveira, Ana M. M.; Hemstedt, Thekla J.; Bading, Hilmar] Heidelberg Univ, Dept Neurobiol, Interdisciplinary Ctr Neurosci IZN, D-6900 Heidelberg, Germany	Ruprecht Karls University Heidelberg	Bading, H (corresponding author), Heidelberg Univ, Dept Neurobiol, Interdisciplinary Ctr Neurosci IZN, D-6900 Heidelberg, Germany.	hilmar.bading@uni-hd.de	Oliveira, Ana M.M./AFF-2561-2022	Oliveira, Ana M.M./0000-0002-2729-9036	Alexander von Humboldt Foundation; ERC; Deutsche Forschungsgemeinschaft [Sonderforschungsbereich (SFB) 488, SFB 636]; Foundation for Science and Technology, Portugal	Alexander von Humboldt Foundation(Alexander von Humboldt Foundation); ERC(European Research Council (ERC)European Commission); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Foundation for Science and Technology, Portugal(Portuguese Foundation for Science and Technology)	We thank I. Bunzli-Ehret for her help with the preparation of hippocampal cultures and U. Weiss for the western blot experiments. We thank D. Tkachev and M. Klugmann for their contributions at the initial stages of this project and the tools that they provided. We thank A. M. Hagenston for comments on the manuscript. This work was supported by the Alexander von Humboldt Foundation (Wolfgang Paul Prize to H. B.), an ERC Advanced Grant (to H. B.), the Sonderforschungsbereich (SFB) 488 and SFB 636 of the Deutsche Forschungsgemeinschaft. H. B. is a member of the Excellence Cluster CellNetworks at Heidelberg University. A.M.M.O. is recipient of a Postdoctoral Fellowship by the Foundation for Science and Technology, Portugal.	BADING H, 1991, SCIENCE, V253, P912, DOI 10.1126/science.1715095; Chahrour M, 2008, SCIENCE, V320, P1224, DOI 10.1126/science.1153252; Chen TP, 2002, J BIOL CHEM, V277, P38746, DOI 10.1074/jbc.M205312200; Erickson CA, 2003, EXP GERONTOL, V38, P61, DOI 10.1016/S0531-5565(02)00160-2; Feng J, 2010, NAT NEUROSCI, V13, P423, DOI 10.1038/nn.2514; Fuke C, 2004, ANN HUM GENET, V68, P196, DOI 10.1046/j.1529-8817.2004.00081.x; Guo JJU, 2011, NAT NEUROSCI, V14, P1345, DOI 10.1038/nn.2900; Hardingham GE, 1997, NATURE, V385, P260, DOI 10.1038/385260a0; Kang YK, 2001, FEBS LETT, V498, P1, DOI 10.1016/S0014-5793(01)02472-3; Klose RJ, 2006, TRENDS BIOCHEM SCI, V31, P89, DOI 10.1016/j.tibs.2005.12.008; Klugmann M, 2005, MOL CELL NEUROSCI, V28, P347, DOI 10.1016/j.mcn.2004.10.002; Kotini AG, 2011, MOL CELL BIOL, V31, P1577, DOI 10.1128/MCB.01093-10; Miller CA, 2007, NEURON, V53, P857, DOI 10.1016/j.neuron.2007.02.022; Monsey MS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019958; SHOLL DA, 1953, J ANAT, V87, P387; Suzuki MM, 2008, NAT REV GENET, V9, P465, DOI 10.1038/nrg2341; VANYUSHI.BF, 1973, GERONTOLOGY, V19, P138, DOI 10.1159/000211967; WILSON VL, 1987, J BIOL CHEM, V262, P9948; Zhang SJ, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000604	19	183	191	0	29	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	AUG	2012	15	8					1111	+		10.1038/nn.3151	http://dx.doi.org/10.1038/nn.3151			5	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	979UE	22751036				2022-12-28	WOS:000306844500015
J	de Anda, FC; Rosario, AL; Durak, O; Tran, T; Graff, J; Meletis, K; Rei, D; Soda, T; Madabhushi, R; Ginty, DD; Kolodkin, AL; Tsai, LH				de Anda, Froylan Calderon; Rosario, Ana Lucia; Durak, Omer; Tran, Tracy; Graeff, Johannes; Meletis, Konstantinos; Rei, Damien; Soda, Takahiro; Madabhushi, Ram; Ginty, David D.; Kolodkin, Alex L.; Tsai, Li-Huei			Autism spectrum disorder susceptibility gene TAOK2 affects basal dendrite formation in the neocortex	NATURE NEUROSCIENCE			English	Article							ACTIVATED PROTEIN-KINASE; N-TERMINAL KINASE; NEURONAL POLARITY; PYRAMIDAL NEURONS; AXON FORMATION; SEMAPHORIN 3A; PHOSPHORYLATION; ASSOCIATION; ELONGATION; MECHANISMS	How neurons develop their morphology is an important question in neurobiology. Here we describe a new pathway that specifically affects the formation of basal dendrites and axonal projections in cortical pyramidal neurons. We report that thousand-and-one-amino acid 2 kinase (TAOK2), also known as TAO2, is essential for dendrite morphogenesis. TAOK2 downregulation impairs basal dendrite formation in vivo without affecting apical dendrites. Moreover, TAOK2 interacts with Neuropilin 1 (Nrp1), a receptor protein that binds the secreted guidance cue Semaphorin 3A (Sema3A). TAOK2 overexpression restores dendrite formation in cultured cortical neurons from Nrp1(Sema-) mice, which express Nrp1 receptors incapable of binding Sema3A. TAOK2 overexpression also ameliorates the basal dendrite impairment resulting from Nrp1 downregulation in vivo. Finally, Sema3A and TAOK2 modulate the formation of basal dendrites through the activation of the c-Jun N-terminal kinase (JNK). These results delineate a pathway whereby Sema3A and Nrp1 transduce signals through TAOK2 and JNK to regulate basal dendrite development in cortical neurons.	[de Anda, Froylan Calderon; Rosario, Ana Lucia; Durak, Omer; Graeff, Johannes; Meletis, Konstantinos; Rei, Damien; Soda, Takahiro; Madabhushi, Ram; Tsai, Li-Huei] MIT, Dept Brain & Cognit Sci, Picower Inst Learning & Memory, Cambridge, MA 02139 USA; [de Anda, Froylan Calderon; Rosario, Ana Lucia; Durak, Omer; Tran, Tracy; Graeff, Johannes; Meletis, Konstantinos; Rei, Damien; Soda, Takahiro; Madabhushi, Ram; Ginty, David D.; Kolodkin, Alex L.; Tsai, Li-Huei] Howard Hughes Med Inst, Cambridge, MA USA; [Durak, Omer; Meletis, Konstantinos; Tsai, Li-Huei] Broad Inst, Stanley Ctr Psychiat Res, Cambridge, MA USA; [Tran, Tracy; Ginty, David D.; Kolodkin, Alex L.] Johns Hopkins Univ, Sch Med, Solomon H Snyder Dept Neurosci, Baltimore, MD USA	Massachusetts Institute of Technology (MIT); Northwell Health; Howard Hughes Medical Institute; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Johns Hopkins University	Tsai, LH (corresponding author), MIT, Dept Brain & Cognit Sci, Picower Inst Learning & Memory, E25-618, Cambridge, MA 02139 USA.	lhtsai@mit.edu	Tran, Tracy/M-2173-2019; de Anda, Froylan Calderon/AAQ-4811-2021; Meletis, Konstantinos/ABE-6777-2020; Soda, Takahiro/AHC-3347-2022	Soda, Takahiro/0000-0001-6268-2965; Calderon de Anda, Froylan/0000-0003-2743-7774; Tran, Tracy/0000-0002-2179-5725; Graff, Johannes/0000-0002-3219-3578; Durak, Omer/0000-0001-8426-6188; Rebelo do Rosario, Ana Lucia/0000-0003-2342-1978; Meletis, Konstantinos/0000-0001-5665-4781	Simons Foundation (Simons Center for the Social Brain, Massachusetts Institute of Technology); US National Institutes of Health [R01 MH59199]; Simons Foundation Autism Research Initiative; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007753] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH059199] Funding Source: NIH RePORTER	Simons Foundation (Simons Center for the Social Brain, Massachusetts Institute of Technology); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Simons Foundation Autism Research Initiative; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank A. Mungenast, E.J. Kwon, M.H. Cobb (University of Texas Southwestern Medical Center) and Y. Gotoh (University of Tokyo) for critical reading of the manuscript, providing vectors, antibodies, and suggestions. The Simons Foundation Autism Research Initiative supported this work. F.C.d.A. is supported by a postdoctoral fellowship from the Simons Foundation (Simons Center for the Social Brain, Massachusetts Institute of Technology). US National Institutes of Health grant R01 MH59199 to A.L.K. and D.D.G. supported this work. L.-H.T., A.L.K. and D.D.G. are investigators of the Howard Hughes Medical Institute.	Arimura N, 2007, NAT REV NEUROSCI, V8, P194, DOI 10.1038/nrn2056; BAAS PW, 1989, J CELL BIOL, V109, P3085, DOI 10.1083/jcb.109.6.3085; Barnat M, 2010, J NEUROSCI, V30, P7804, DOI 10.1523/JNEUROSCI.0372-10.2010; Barnes AP, 2008, CURR OPIN NEUROBIOL, V18, P44, DOI 10.1016/j.conb.2008.05.003; Ben-Zvi A, 2006, J NEUROCHEM, V96, P585, DOI 10.1111/j.1471-4159.2005.03580.x; Bjorkblom B, 2005, J NEUROSCI, V25, P6350, DOI 10.1523/JNEUROSCI.1517-05.2005; Bradke F, 1999, SCIENCE, V283, P1931, DOI 10.1126/science.283.5409.1931; Chang LF, 2003, DEV CELL, V4, P521, DOI 10.1016/S1534-5807(03)00094-7; Chen G, 2008, NAT NEUROSCI, V11, P36, DOI 10.1038/nn2018; Chen Z, 2003, J BIOL CHEM, V278, P22278, DOI 10.1074/jbc.M301173200; Chen Z, 2001, J BIOL CHEM, V276, P16070, DOI 10.1074/jbc.M100681200; Chen Z, 1999, J BIOL CHEM, V274, P28803, DOI 10.1074/jbc.274.40.28803; Darnell JC, 2011, CELL, V146, P247, DOI 10.1016/j.cell.2011.06.013; de Anda FC, 2010, J NEUROSCI, V30, P10391, DOI 10.1523/JNEUROSCI.0381-10.2010; Fenstermaker V, 2004, J NEUROBIOL, V58, P403, DOI 10.1002/neu.10304; Geschwind DH, 2007, CURR OPIN NEUROBIOL, V17, P103, DOI 10.1016/j.conb.2007.01.009; Gu CH, 2003, DEV CELL, V5, P45, DOI 10.1016/S1534-5807(03)00169-2; Horton AC, 2005, NEURON, V48, P757, DOI 10.1016/j.neuron.2005.11.005; HuangFu WC, 2006, J BIOL CHEM, V281, P28802, DOI 10.1074/jbc.M603627200; Jan YN, 2010, NAT REV NEUROSCI, V11, P316, DOI 10.1038/nrn2836; Jeanneteau F, 2010, NAT NEUROSCI, V13, P1373, DOI 10.1038/nn.2655; Just MA, 2007, CEREB CORTEX, V17, P951, DOI 10.1093/cercor/bhl006; Kelleher RJ, 2008, CELL, V135, P401, DOI 10.1016/j.cell.2008.10.017; King I, 2011, J NEUROSCI, V31, P1139, DOI 10.1523/JNEUROSCI.4416-10.2011; Kwan AC, 2008, P NATL ACAD SCI USA, V105, P11370, DOI 10.1073/pnas.0805199105; LARKMAN AU, 1991, J COMP NEUROL, V306, P332, DOI 10.1002/cne.903060209; Lei K, 2002, MOL CELL BIOL, V22, P4929, DOI 10.1128/MCB.22.13.4929-4942.2002; McCarthy SE, 2009, NAT GENET, V41, P1223, DOI 10.1038/ng.474; Moore TM, 2000, J BIOL CHEM, V275, P4311, DOI 10.1074/jbc.275.6.4311; Mukaetova-Ladinska EB, 2004, NEUROPATH APPL NEURO, V30, P615, DOI 10.1111/j.1365-2990.2004.00574.x; Nishiyama M, 2011, NAT CELL BIOL, V13, P676, DOI 10.1038/ncb2255; Oliva AA, 2006, J NEUROSCI, V26, P9462, DOI 10.1523/JNEUROSCI.2625-06.2006; Pinto D, 2010, NATURE, V466, P368, DOI 10.1038/nature09146; Polleux F, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001925; Polleux F, 2000, NATURE, V404, P567, DOI 10.1038/35007001; Raymond GV, 1996, ACTA NEUROPATHOL, V91, P117; Romand S, 2011, FRONT NEUROANAT, V5, DOI 10.3389/fnana.2011.00005; Rosso SB, 2005, NAT NEUROSCI, V8, P34, DOI 10.1038/nn1374; Shelly M, 2011, NEURON, V71, P433, DOI 10.1016/j.neuron.2011.06.041; Spruston N, 2008, NAT REV NEUROSCI, V9, P206, DOI 10.1038/nrn2286; Tararuk T, 2006, J CELL BIOL, V173, P265, DOI 10.1083/jcb.200511055; Tran TS, 2009, NATURE, V462, P1065, DOI 10.1038/nature08628; Walsh CA, 2008, CELL, V135, P396, DOI 10.1016/j.cell.2008.10.015; Weiss LA, 2008, NEW ENGL J MED, V358, P667, DOI 10.1056/NEJMoa075974; Weiss LA, 2009, NATURE, V461, P802, DOI 10.1038/nature08490; Witte H, 2008, CURR OPIN NEUROBIOL, V18, P479, DOI 10.1016/j.conb.2008.09.019; Yamasaki T, 2011, J NEUROSCI, V31, P16872, DOI 10.1523/JNEUROSCI.1111-11.2011; Yasuda S, 2007, NEURON, V56, P456, DOI 10.1016/j.neuron.2007.08.020; Zhou TJ, 2004, STRUCTURE, V12, P1891, DOI 10.1016/j.str.2004.07.021; Zihni C, 2007, J BIOL CHEM, V282, P6484, DOI 10.1074/jbc.M608336200	50	115	116	0	57	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUL	2012	15	7					1022	1031		10.1038/nn.3141	http://dx.doi.org/10.1038/nn.3141			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	966EE	22683681	Green Accepted, Green Submitted			2022-12-28	WOS:000305819600021
J	Paton, JJ; Louie, K				Paton, Joseph J.; Louie, Kenway			Reward and punishment illuminated	NATURE NEUROSCIENCE			English	Editorial Material							BASAL GANGLIA; PLASTICITY; CIRCUITRY; BRAIN	How do outcomes affect future behavior? A study using precise optogenetic stimulation finds that learning from positive reinforcement is mediated by striatal pathways distinct from those that mediate learning from punishment.	[Paton, Joseph J.] Champalimaud Neurosci Program, Lisbon, Portugal; [Louie, Kenway] NYU, Ctr Neural Sci, New York, NY 10003 USA	Fundacao Champalimaud; New York University	Paton, JJ (corresponding author), Champalimaud Neurosci Program, Lisbon, Portugal.	klouie@cns.nyu.edu		Louie, Kenway/0000-0002-9665-5436; Paton, Joseph/0000-0002-1663-6455				ALBIN RL, 1989, TRENDS NEUROSCI, V12, P366, DOI 10.1016/0166-2236(89)90074-X; Dang MT, 2006, P NATL ACAD SCI USA, V103, P15254, DOI 10.1073/pnas.0601758103; Frank MJ, 2011, CURR OPIN NEUROBIOL, V21, P381, DOI 10.1016/j.conb.2011.02.013; Graybiel AM, 2000, CURR BIOL, V10, pR509, DOI 10.1016/S0960-9822(00)00593-5; Koralek AC, 2012, NATURE, V483, P331, DOI 10.1038/nature10845; Kravitz AV, 2012, NAT NEUROSCI, V15, P816, DOI 10.1038/nn.3100; Kravitz AV, 2010, NATURE, V466, P622, DOI 10.1038/nature09159; Kreitzer AC, 2008, NEURON, V60, P543, DOI 10.1016/j.neuron.2008.11.005; OLDS J, 1954, J COMP PHYSIOL PSYCH, V47, P419, DOI 10.1037/h0058775; Penfield W., 1958, EXCITABLE CORTEX CON; Schultz W, 1997, SCIENCE, V275, P1593, DOI 10.1126/science.275.5306.1593; Surmeier DJ, 2007, TRENDS NEUROSCI, V30, P228, DOI 10.1016/j.tins.2007.03.008; Taylor CSR, 2003, NEUROSCIENTIST, V9, P332, DOI 10.1177/1073858403257037; Wickens JR, 2003, CURR OPIN NEUROBIOL, V13, P685, DOI 10.1016/j.conb.2003.10.013; Wise RA, 2002, NEURON, V36, P229, DOI 10.1016/S0896-6273(02)00965-0	15	6	7	0	8	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JUN	2012	15	6					807	809		10.1038/nn.3122	http://dx.doi.org/10.1038/nn.3122			4	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	949AI	22627791				2022-12-28	WOS:000304546700003
J	Li, C; Hisamoto, N; Nix, P; Kanao, S; Mizuno, T; Bastiani, M; Matsumoto, K				Li, Chun; Hisamoto, Naoki; Nix, Paola; Kanao, Shuka; Mizuno, Tomoaki; Bastiani, Michael; Matsumoto, Kunihiro			The growth factor SVH-1 regulates axon regeneration in C. elegans via the JNK MAPK cascade	NATURE NEUROSCIENCE			English	Article							KINASE; RPM-1; GENE; IDENTIFICATION; ACTIVATION; REQUIRES; PATHWAY; DLK-1; P38; RON	The ability of neurons to undergo regenerative growth after injury is governed by cell-intrinsic and cell-extrinsic regeneration pathways. These pathways represent potential targets for therapies to enhance regeneration. However, the signaling pathways that orchestrate axon regeneration are not well understood. In Caenorhabditis elegans, the Jun N-terminal kinase (JNK) and p38 MAP kinase (MAPK) pathways are important for axon regeneration. We found that the C. elegans SVH-1 growth factor and its receptor, SVH-2 tyrosine kinase, regulate axon regeneration. Loss of SVH-1-SVH-2 signaling resulted in a substantial defect in the ability of neurons to regenerate, whereas its activation improved regeneration. Furthermore, SVH-1-SVH-2 signaling was initiated extrinsically by a pair of sensory neurons and functioned upstream of the JNK-MAPK pathway. Thus, SVH-1-SVH-2 signaling via activation of the MAPK pathway acts to coordinate neuron regeneration response after axon injury.	[Li, Chun; Hisamoto, Naoki; Kanao, Shuka; Mizuno, Tomoaki; Matsumoto, Kunihiro] Nagoya Univ, Grad Sch Sci, Dept Mol Biol, Chikusa Ku, Nagoya, Aichi 4648601, Japan; [Nix, Paola; Bastiani, Michael] Univ Utah, Dept Biol, Salt Lake City, UT 84112 USA	Nagoya University; Utah System of Higher Education; University of Utah	Hisamoto, N (corresponding author), Nagoya Univ, Grad Sch Sci, Dept Mol Biol, Chikusa Ku, Nagoya, Aichi 4648601, Japan.	i45556a@cc.nagoya-u.ac.jp; g44177a@nucc.cc.nagoya-u.ac.jp			Ministry of Education, Culture and Science of Japan; Sumitomo Foundation; Nakajima Science Foundation; National Science Foundation; McKnight Endowment Fund for Neuroscience; Christopher and Dana Reeve Foundation; Amerisure Charitable Foundation; Japan Society for the Promotion of Science; Division Of Integrative Organismal Systems [0950955] Funding Source: National Science Foundation	Ministry of Education, Culture and Science of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Sumitomo Foundation; Nakajima Science Foundation; National Science Foundation(National Science Foundation (NSF)); McKnight Endowment Fund for Neuroscience; Christopher and Dana Reeve Foundation; Amerisure Charitable Foundation; Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Division Of Integrative Organismal Systems(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	We thank Y. Kohara, S. Mitani, the Caenorhabditis Genetic Center and the C. elegans Knockout Consortium for materials. This work was supported by grants from Ministry of Education, Culture and Science of Japan, the Sumitomo Foundation (to KM., T.M. and N.H.), the Nakajima Science Foundation (to T.M.), the National Science Foundation, the McKnight Endowment Fund for Neuroscience, the Christopher and Dana Reeve Foundation, and the Amerisure Charitable Foundation (to M.B. and P.N.). C.L. was supported by a Japan Society for the Promotion of Science Research Fellowship.	Camps M, 2000, FASEB J, V14, P6, DOI 10.1096/fasebj.14.1.6; DONATE LE, 1994, PROTEIN SCI, V3, P2378, DOI 10.1002/pro.5560031222; FERRACINI R, 1991, J BIOL CHEM, V266, P19558; GAUDINO G, 1994, EMBO J, V13, P3524, DOI 10.1002/j.1460-2075.1994.tb06659.x; Hammarlund M, 2007, J CELL BIOL, V176, P269, DOI 10.1083/jcb.200611117; Hammarlund M, 2009, SCIENCE, V323, P802, DOI 10.1126/science.1165527; HART AC, 1995, NATURE, V378, P82, DOI 10.1038/378082a0; Knobel KM, 1999, DEVELOPMENT, V126, P4489; McCarroll SA, 2005, CURR BIOL, V15, P347, DOI 10.1016/j.cub.2005.02.023; Mizuno T, 2004, EMBO J, V23, P2226, DOI 10.1038/sj.emboj.7600226; Mizuno T, 2008, MOL CELL BIOL, V28, P7041, DOI 10.1128/MCB.00938-08; Nakata K, 2005, CELL, V120, P407, DOI 10.1016/j.cell.2004.12.017; Nix P, 2011, P NATL ACAD SCI USA, V108, P10738, DOI 10.1073/pnas.1104830108; O'Brien GS, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.269pe30; RODRIGUES GA, 1993, MOL CELL BIOL, V13, P6711, DOI 10.1128/MCB.13.11.6711; Santoro MM, 1996, MOL CELL BIOL, V16, P7072; Schaefer AM, 2000, NEURON, V26, P345, DOI 10.1016/S0896-6273(00)81168-X; Trusolino L, 2010, NAT REV MOL CELL BIO, V11, P834, DOI 10.1038/nrm3012; Yan D, 2009, CELL, V138, P1005, DOI 10.1016/j.cell.2009.06.023; Yanik MF, 2004, NATURE, V432, P822, DOI 10.1038/432822a; Zhen M, 2000, NEURON, V26, P331, DOI 10.1016/S0896-6273(00)81167-8	21	55	67	1	14	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	APR	2012	15	4					551	557		10.1038/nn.3052	http://dx.doi.org/10.1038/nn.3052			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	916PA	22388962				2022-12-28	WOS:000302114500014
J	Likhtik, E; Stujenske, JM; Topiwala, MA; Harris, AZ; Gordon, JA				Likhtik, Ekaterina; Stujenske, Joseph M.; Topiwala, Mihir A.; Harris, Alexander Z.; Gordon, Joshua A.			Prefrontal entrainment of amygdala activity signals safety in learned fear and innate anxiety	NATURE NEUROSCIENCE			English	Article							CONDITIONED FEAR; PRELIMBIC CORTEX; BASOLATERAL AMYGDALA; VENTRAL HIPPOCAMPUS; EXTINCTION; EXPRESSION; RAT; MEMORY; CONSOLIDATION; OSCILLATIONS	Successfully differentiating safety from danger is an essential skill for survival. While decreased activity in the medial prefrontal cortex (mPFC) is associated with fear generalization in animals and humans, the circuit-level mechanisms used by the mPFC to discern safety are not clear. To answer this question, we recorded activity in the mPFC, basolateral amygdala (BLA) and dorsal and ventral hippocampus in mice during exposure to learned (differential fear conditioning) and innate (open field) anxiety. We found increased synchrony between the mPFC and BLA in the theta frequency range (4-12 Hz) only in animals that differentiated between averseness and safety. Moreover, during recognized safety across learned and innate protocols, BLA firing became entrained to theta input from the mPFC. These data suggest that selective tuning of BLA firing to mPFC input provides a safety-signaling mechanism whereby the mPFC taps into the microcircuitry of the amygdala to diminish fear.	[Likhtik, Ekaterina; Topiwala, Mihir A.; Harris, Alexander Z.; Gordon, Joshua A.] Columbia Univ, Coll Phys & Surg, Dept Psychiat, New York, NY 10027 USA; [Stujenske, Joseph M.] Columbia Univ, Coll Phys & Surg, Dept Neurosci, New York, NY USA; [Harris, Alexander Z.] Weill Cornell Med Coll, Dept Psychiat, New York, NY USA; [Topiwala, Mihir A.; Harris, Alexander Z.; Gordon, Joshua A.] New York State Psychiat Inst & Hosp, Div Integrat Neurosci, New York, NY 10032 USA	Columbia University; Columbia University; Cornell University; New York State Psychiatry Institute	Gordon, JA (corresponding author), Columbia Univ, Coll Phys & Surg, Dept Psychiat, New York, NY 10027 USA.	jg343@columbia.edu	Harris, Alexander/GPT-0688-2022	Harris, Alexander/0000-0001-9089-0366	US NIMH [R01 MH081968, P50 MH096891, F32 MH088103]; International Mental Health Research Organization; Charles H. Revson Foundation; Columbia University Medical Scientist Training Program; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH081968, T32MH015144] Funding Source: NIH RePORTER	US NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); International Mental Health Research Organization; Charles H. Revson Foundation; Columbia University Medical Scientist Training Program; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We would like to thank T. Spellman and other members of the Gordon laboratory for technical assistance and discussions. This work was supported by grants from the US NIMH to J.A.G. (R01 MH081968 and P50 MH096891) and E.L. (F32 MH088103), by the International Mental Health Research Organization (J.A.G.) and by the Charles H. Revson Foundation (E.L.). J.M.S. is supported through the Columbia University Medical Scientist Training Program.	Adhikari A, 2011, NEURON, V71, P898, DOI 10.1016/j.neuron.2011.07.027; Adhikari A, 2010, J NEUROSCI METH, V191, P191, DOI 10.1016/j.jneumeth.2010.06.019; Adhikari A, 2010, NEURON, V65, P257, DOI 10.1016/j.neuron.2009.12.002; Amano T, 2010, NAT NEUROSCI, V13, P489, DOI 10.1038/nn.2499; Bannerman DM, 2003, BEHAV BRAIN RES, V139, P197, DOI 10.1016/S0166-4328(02)00268-1; BrinleyReed M, 1995, NEUROSCI LETT, V202, P45, DOI 10.1016/0304-3940(95)12212-5; Burgos-Robles A, 2007, NEURON, V53, P871, DOI 10.1016/j.neuron.2007.02.021; Busti D, 2011, J NEUROSCI, V31, P5131, DOI 10.1523/JNEUROSCI.6100-10.2011; Carmichael ST, 1995, J COMP NEUROL, V363, P615, DOI 10.1002/cne.903630408; CRAWLEY JN, 1985, NEUROSCI BIOBEHAV R, V9, P37, DOI 10.1016/0149-7634(85)90030-2; Dunsmoor JE, 2009, LEARN MEMORY, V16, P460, DOI 10.1101/lm.1431609; Gazendam FJ, 2013, BIOL PSYCHOL, V92, P342, DOI 10.1016/j.biopsycho.2012.11.006; Gordon JA, 2005, J NEUROSCI, V25, P6509, DOI 10.1523/JNEUROSCI.1211-05.2005; Greenberg T, 2013, DEPRESS ANXIETY, V30, P242, DOI 10.1002/da.22016; Hauner KK, 2012, P NATL ACAD SCI USA, V109, P9203, DOI 10.1073/pnas.1205242109; Heldt SA, 2012, TRANSL PSYCHIAT, V2, DOI 10.1038/tp.2012.101; Herry C, 2004, EUR J NEUROSCI, V20, P781, DOI 10.1111/j.1460-9568.2004.03542.x; Herry C, 2008, NATURE, V454, P600, DOI 10.1038/nature07166; JAY TM, 1991, J COMP NEUROL, V313, P574, DOI 10.1002/cne.903130404; Jovanovic T, 2012, NEUROPHARMACOLOGY, V62, P695, DOI 10.1016/j.neuropharm.2011.02.023; Kjelstrup KG, 2002, P NATL ACAD SCI USA, V99, P10825, DOI 10.1073/pnas.152112399; Knapska E, 2009, LEARN MEMORY, V16, P486, DOI 10.1101/lm.1463909; Laurent V, 2009, LEARN MEMORY, V16, P520, DOI 10.1101/lm.1474609; LeDoux JE, 2000, ANNU REV NEUROSCI, V23, P155, DOI 10.1146/annurev.neuro.23.1.155; Lesting J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021714; Likhtik E, 2005, J NEUROSCI, V25, P7429, DOI 10.1523/JNEUROSCI.2314-05.2005; Likhtik E, 2008, NATURE, V454, P642, DOI 10.1038/nature07167; Milad MR, 2005, P NATL ACAD SCI USA, V102, P10706, DOI 10.1073/pnas.0502441102; Narayanan NS, 2006, NEUROSCIENCE, V139, P865, DOI 10.1016/j.neuroscience.2005.11.072; Pape HC, 2010, PHYSIOL REV, V90, P419, DOI 10.1152/physrev.00037.2009; Pape HC, 1998, J NEUROPHYSIOL, V79, P205, DOI 10.1152/jn.1998.79.1.205; Pare D, 2000, J NEUROSCI, V20, P2701; Phelps EA, 2004, NEURON, V43, P897, DOI 10.1016/j.neuron.2004.08.042; Popa D, 2010, P NATL ACAD SCI USA, V107, P6516, DOI 10.1073/pnas.0913016107; Rauch SL, 2006, BIOL PSYCHIAT, V60, P376, DOI 10.1016/j.biopsych.2006.06.004; Reinecke A, 2010, DEPRESS ANXIETY, V27, P252, DOI 10.1002/da.20662; Resnik J, 2011, NAT NEUROSCI, V14, P791, DOI 10.1038/nn.2802; Sangha S, 2009, J NEUROSCI, V29, P15713, DOI 10.1523/JNEUROSCI.2620-09.2009; Seidenbecher T, 2003, SCIENCE, V301, P846, DOI 10.1126/science.1085818; SESACK SR, 1989, J COMP NEUROL, V290, P213, DOI 10.1002/cne.902900205; Shaban H, 2006, NAT NEUROSCI, V9, P1028, DOI 10.1038/nn1732; Siapas AG, 2005, NEURON, V46, P141, DOI 10.1016/j.neuron.2005.02.028; Sotres-Bayon F, 2012, NEURON, V76, P804, DOI 10.1016/j.neuron.2012.09.028; Truitt WA, 2009, NEUROSCIENCE, V160, P284, DOI 10.1016/j.neuroscience.2009.01.083; Vertes RP, 2004, SYNAPSE, V51, P32, DOI 10.1002/syn.10279; Vidal-Gonzalez I, 2006, LEARN MEMORY, V13, P728, DOI 10.1101/lm.306106; Woodruff AR, 2007, J NEUROPHYSIOL, V98, P2956, DOI 10.1152/jn.00739.2007	47	307	314	4	118	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JAN	2014	17	1					106	113		10.1038/nn.3582	http://dx.doi.org/10.1038/nn.3582			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	281DL	24241397	Green Accepted			2022-12-28	WOS:000329080000020
J	Miron, VE; Boyd, A; Zhao, JW; Yuen, TJ; Ruckh, JM; Shadrach, JL; van Wijngaarden, P; Wagers, AJ; Williams, A; Franklin, RJM; Ffrench-Constant, C				Miron, Veronique E.; Boyd, Amanda; Zhao, Jing-Wei; Yuen, Tracy J.; Ruckh, Julia M.; Shadrach, Jennifer L.; van Wijngaarden, Peter; Wagers, Amy J.; Williams, Anna; Franklin, Robin J. M.; Ffrench-Constant, Charles			M2 microglia and macrophages drive oligodendrocyte differentiation during CNS remyelination	NATURE NEUROSCIENCE			English	Article							GADOLINIUM CHLORIDE; PROGENITOR CELLS; GENE-EXPRESSION; ACTIVIN-A; IDENTIFICATION; MONOCYTES; INJURY; BETA; REGENERATION; PROGRESSION	The lack of therapies for progressive multiple sclerosis highlights the need to understand the regenerative process of remyelination that can follow CNS demyelination. This involves an innate immune response consisting of microglia and macrophages, which can be polarized to distinct functional phenotypes: pro-inflammatory (M1) and anti-inflammatory or immunoregulatory (M2). We found that a switch from an M1- to an M2-dominant response occurred in microglia and peripherally derived macrophages as remyelination started. Oligodendrocyte differentiation was enhanced in vitro with M2 cell conditioned media and impaired in vivo following intra-lesional M2 cell depletion. M2 cell densities were increased in lesions of aged mice in which remyelination was enhanced by parabiotic coupling to a younger mouse and in multiple sclerosis lesions that normally show remyelination. Blocking M2 cell-derived activin-A inhibited oligodendrocyte differentiation during remyelination in cerebellar slice cultures. Thus, our results indicate that M2 cell polarization is essential for efficient remyelination and identify activin-A as a therapeutic target for CNS regeneration.	[Miron, Veronique E.; Boyd, Amanda; Yuen, Tracy J.; Williams, Anna; Ffrench-Constant, Charles] Univ Edinburgh, Multiple Sclerosis Soc Ctr Translat Res, MRC Ctr Regenerat Med, Edinburgh, Midlothian, Scotland; [Zhao, Jing-Wei; Yuen, Tracy J.; Ruckh, Julia M.; van Wijngaarden, Peter; Franklin, Robin J. M.] Univ Cambridge, Dept Vet Med, MRC Cambridge Stem Cell Inst, Wellcome Trust, Cambridge, England; [Shadrach, Jennifer L.; Wagers, Amy J.] Harvard Univ, Howard Hughes Med Inst, Dept Stem Cell & Regenerat Biol, Harvard Stem Cell Inst, Cambridge, MA 02138 USA; [Shadrach, Jennifer L.; Wagers, Amy J.] Joslin Diabet Ctr, Cambridge, MA USA	University of Edinburgh; University of Cambridge; Wellcome Trust Sanger Institute; Harvard University; Howard Hughes Medical Institute; Harvard University; Joslin Diabetes Center, Inc.	Miron, VE (corresponding author), Univ Edinburgh, Multiple Sclerosis Soc Ctr Translat Res, MRC Ctr Regenerat Med, Edinburgh, Midlothian, Scotland.	vmiron@staffmail.ed.ac.uk	Zhao, Jing-Wei/A-6887-2012; Miron, Veronique E./H-4280-2019; Zhao, Jing-Wei/L-9964-2014	Miron, Veronique E./0000-0003-1738-0647; Zhao, Jing-Wei/0000-0002-1135-9743; Yuen, Tracy/0000-0002-3451-9279; Franklin, Robin/0000-0001-6522-2104; Williams, Anna/0000-0002-6329-382X; van Wijngaarden, Peter/0000-0002-8800-7834	UK Multiple Sclerosis Society; Wellcome Trust; Multiple Sclerosis Society of Canada; MRC [G0300336, G0802545] Funding Source: UKRI; Medical Research Council [G0300336, G0802545, MR/K017047/1B] Funding Source: researchfish	UK Multiple Sclerosis Society; Wellcome Trust(Wellcome TrustEuropean Commission); Multiple Sclerosis Society of Canada; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank the UK Multiple Sclerosis Tissue Bank for providing human brain tissue, F. Roncaroli (Imperial College London) for neuropathological diagnosis of lesions and R. Nicholas (Imperial College London) for providing clinical history of patients. We also thank W. Mungall, J. Huang, M. Harrisingh, A. Jarjour, M. Bechler, M. Swire, A.-C. Nunes-Fonseca, D. Morrison, and C. Watkins for technical assistance. This work was funded by the UK Multiple Sclerosis Society (R.J.M.F. and C.ff.-C.) and the Wellcome Trust (A.W. and C.ff.-C.), and V.E.M. holds a post-doctoral fellowship from the Multiple Sclerosis Society of Canada.	Abdel-Zaher AO, 2007, TOXICOLOGY, V234, P124, DOI 10.1016/j.tox.2007.02.014; Ahn M, 2012, BRAIN RES, V1453, P77, DOI 10.1016/j.brainres.2012.03.023; Ajami B, 2011, NAT NEUROSCI, V14, P1142, DOI 10.1038/nn.2887; Arnett HA, 2004, SCIENCE, V306, P2111, DOI 10.1126/science.1103709; Attisano L, 1996, MOL CELL BIOL, V16, P1066; BANATI RB, 1993, GLIA, V7, P111, DOI 10.1002/glia.440070117; CASH E, 1993, CELL IMMUNOL, V147, P129, DOI 10.1006/cimm.1993.1053; Das J, 2001, NAT IMMUNOL, V2, P45, DOI 10.1038/83158; Dayan V, 2011, BASIC RES CARDIOL, V106, P1299, DOI 10.1007/s00395-011-0221-9; de Kretser DM, 2012, MOL CELL ENDOCRINOL, V359, P101, DOI 10.1016/j.mce.2011.10.009; Deonarine K, 2007, J TRANSL MED, V5, DOI 10.1186/1479-5876-5-11; Diemel LT, 2003, J NEUROSCI RES, V74, P858, DOI 10.1002/jnr.10837; Edwards JP, 2006, J LEUKOCYTE BIOL, V80, P1298, DOI 10.1189/jlb.0406249; Etxeberria A, 2010, NAT NEUROSCI, V13, P287, DOI 10.1038/nn.2500; Fancy SPJ, 2011, NAT NEUROSCI, V14, P1009, DOI 10.1038/nn.2855; Flores AI, 2008, J NEUROSCI, V28, P7174, DOI 10.1523/JNEUROSCI.0150-08.2008; Gensert JM, 1997, NEURON, V19, P197, DOI 10.1016/S0896-6273(00)80359-1; Guardiola-Diaz HM, 2012, GLIA, V60, P476, DOI 10.1002/glia.22281; HARDONK MJ, 1992, J LEUKOCYTE BIOL, V52, P296, DOI 10.1002/jlb.52.3.296; He JT, 2012, MOLECULES, V17, P315, DOI 10.3390/molecules17010315; Huang JK, 2011, NAT NEUROSCI, V14, P45, DOI 10.1038/nn.2702; Jang E, 2013, FASEB J, V27, P1176, DOI 10.1096/fj.12-222257; Kigerl KA, 2009, J NEUROSCI, V29, P13435, DOI 10.1523/JNEUROSCI.3257-09.2009; Kotter MR, 2006, J NEUROSCI, V26, P328, DOI 10.1523/JNEUROSCI.2615-05.2006; Kotter MR, 2005, NEUROBIOL DIS, V18, P166, DOI 10.1016/j.nbd.2004.09.019; Kuhlmann T, 2008, BRAIN, V131, P1749, DOI 10.1093/brain/awn096; Liang XQ, 2004, J NEUROSCI, V24, P7140, DOI 10.1523/JNEUROSCI.5319-03.2004; Liao B, 2012, EXP NEUROL, V237, P147, DOI 10.1016/j.expneurol.2012.06.011; Marin-Teva JL, 2004, NEURON, V41, P535, DOI 10.1016/S0896-6273(04)00069-8; MATZUK MM, 1995, NATURE, V374, P356, DOI 10.1038/374356a0; MATZUK MM, 1995, TRENDS ENDOCRIN MET, V6, P120, DOI 10.1016/1043-2760(95)00032-D; MCKINNON RD, 1993, J CELL BIOL, V121, P1397, DOI 10.1083/jcb.121.6.1397; Mikita J, 2011, MULT SCLER J, V17, P2, DOI 10.1177/1352458510379243; Mizgerd JP, 1996, J LEUKOCYTE BIOL, V59, P189, DOI 10.1002/jlb.59.2.189; Nait-Oumesmar B, 1999, EUR J NEUROSCI, V11, P4357, DOI 10.1046/j.1460-9568.1999.00873.x; Olah M, 2012, GLIA, V60, P306, DOI 10.1002/glia.21266; PENDINO KJ, 1995, AM J RESP CELL MOL, V13, P125, DOI 10.1165/ajrcmb.13.2.7542894; Ruckh JM, 2012, CELL STEM CELL, V10, P96, DOI 10.1016/j.stem.2011.11.019; Ruffell D, 2009, P NATL ACAD SCI USA, V106, P17475, DOI 10.1073/pnas.0908641106; Saederup N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013693; Sakai T, 2012, CELL TRANSPLANT, V21, P355, DOI 10.3727/096368911X580545; Schaier M, 2009, AM J PHYSIOL-RENAL, V297, pF769, DOI 10.1152/ajprenal.90530.2008; Serrats J, 2010, NEURON, V65, P94, DOI 10.1016/j.neuron.2009.11.032; Thurnherr T, 2006, J NEUROSCI, V26, P10110, DOI 10.1523/JNEUROSCI.2158-06.2006; Voss EV, 2012, NEUROBIOL DIS, V45, P519, DOI 10.1016/j.nbd.2011.09.008; Weber MS, 2007, NAT MED, V13, P935, DOI 10.1038/nm1620; Woodruff RH, 1999, NEUROPATH APPL NEURO, V25, P226; Yuen TJ, 2013, BRAIN, V136, P1035, DOI 10.1093/brain/awt024	48	1055	1085	11	193	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	SEP	2013	16	9					1211	U75		10.1038/nn.3469	http://dx.doi.org/10.1038/nn.3469			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	207KN	23872599	Green Accepted			2022-12-28	WOS:000323597500012
J	Cvetkovska, V; Hibbert, AD; Emran, F; Chen, BE				Cvetkovska, Vedrana; Hibbert, Alexa D.; Emran, Farida; Chen, Brian E.			Overexpression of Down syndrome cell adhesion molecule impairs precise synaptic targeting	NATURE NEUROSCIENCE			English	Article							MENTAL-RETARDATION PROTEIN; FRAGILE-X-SYNDROME; MESSENGER-RNA; DROSOPHILA-MELANOGASTER; NERVOUS-SYSTEM; DSCAM; FMRP; REGION; DIVERSITY; BINDING	Fragile X syndrome is caused by the loss of Fragile X mental retardation protein (FMRP), an RNA-binding protein that suppresses protein translation. We found that FMRP binds to Down syndrome cell adhesion molecule (Dscam) RNA, a molecule that is involved in neural development and has been implicated in Down syndrome. Elevated Dscam protein levels in FMRP null Drosophila and in flies with three copies of the Dscam gene both produced specific and similar synaptic targeting errors in a hard-wired neural circuit, which impaired the flies' sensory perception. Reducing Dscam levels in FMRP null flies reduced synaptic targeting errors and rescued behavioral responses. Our results indicate that excess Dscam protein may be a common molecular mechanism underlying altered neural wiring in intellectual disabilities such as Fragile X and Down syndromes.	[Cvetkovska, Vedrana; Hibbert, Alexa D.; Emran, Farida; Chen, Brian E.] McGill Univ, Ctr Res Neurosci, Ctr Hlth, Res Inst, Montreal, PQ H3A 2T5, Canada; [Chen, Brian E.] McGill Univ, Dept Med, Montreal, PQ H3A 2T5, Canada; [Chen, Brian E.] McGill Univ, Dept Neurol & Neurosurg, Montreal, PQ H3A 2T5, Canada	McGill University; McGill University; McGill University	Chen, BE (corresponding author), McGill Univ, Ctr Res Neurosci, Ctr Hlth, Res Inst, Montreal, PQ H3A 2T5, Canada.	brian.chen@mcgill.ca		Cvetkovska, Vedrana/0000-0002-8876-6662	Alfred P. Sloan Research Fellowship; Canada Research Chair grant [950-212462]; Department of Medicine at McGill University; Research Institute of the McGill University Health Centre	Alfred P. Sloan Research Fellowship(Alfred P. Sloan Foundation); Canada Research Chair grant(Canada Research Chairs); Department of Medicine at McGill University; Research Institute of the McGill University Health Centre	The authors thank T.-J. Lin, I. Kays and V. Stoudenikina for assistance with experiments, R. Suciu for assistance in pyrosequencing analysis, A. Staffa and the Massively Parallel Sequencing Unit at Genome Quebec for pyrosequencing assistance, and B. Douba for graphic arts assistance in the fly drawing. This work was supported by an Alfred P. Sloan Research Fellowship and a Canada Research Chair grant 950-212462 (to B.E.C.) and by funds from the Department of Medicine at McGill University and the Research Institute of the McGill University Health Centre.	Alves-Sampaio A, 2010, J NEUROSCI, V30, P13537, DOI 10.1523/JNEUROSCI.3457-10.2010; Antonarakis SE, 1998, GENOMICS, V51, P1, DOI 10.1006/geno.1998.5335; Ascano M, 2012, NATURE, V492, P382, DOI 10.1038/nature11737; ASHLEY CT, 1993, SCIENCE, V262, P563, DOI 10.1126/science.7692601; Bagni C, 2005, NAT REV NEUROSCI, V6, P376, DOI 10.1038/nrn1667; Barlow GM, 2001, GENET MED, V3, P91, DOI 10.1097/00125817-200103000-00002; Bassell GJ, 2008, NEURON, V60, P201, DOI 10.1016/j.neuron.2008.10.004; Blank M, 2011, J NEUROSCI, V31, P5764, DOI 10.1523/JNEUROSCI.6015-10.2011; Bolduc FV, 2008, NAT NEUROSCI, V11, P1143, DOI 10.1038/nn.2175; Brown V, 2001, CELL, V107, P477, DOI 10.1016/S0092-8674(01)00568-2; Canal I, 1998, J NEUROSCI, V18, P999; Chen BE, 2006, CELL, V125, P607, DOI 10.1016/j.cell.2006.03.034; CORFAS G, 1989, J NEUROSCI, V9, P56; Darnell JC, 2005, GENE DEV, V19, P903, DOI 10.1101/gad.1276805; Darnell JC, 2011, CELL, V146, P247, DOI 10.1016/j.cell.2011.06.013; Darnell JC, 2009, HUM MOL GENET, V18, P3164, DOI 10.1093/hmg/ddp255; Didiot MC, 2008, NUCLEIC ACIDS RES, V36, P4902, DOI 10.1093/nar/gkn472; Dierssen M, 2006, GENES BRAIN BEHAV, V5, P48, DOI 10.1111/j.1601-183X.2006.00224.x; Dockendorff TC, 2002, NEURON, V34, P973, DOI 10.1016/S0896-6273(02)00724-9; Dong YM, 2006, PLOS BIOL, V4, P1137, DOI 10.1371/journal.pbio.0040229; GHYSEN A, 1980, DEV BIOL, V78, P521, DOI 10.1016/0012-1606(80)90351-6; Grossman TR, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002344; Guruharsha KG, 2011, CELL, V147, P690, DOI 10.1016/j.cell.2011.08.047; Hildmann T, 1999, GENOME RES, V9, P360; Hilgers V, 2012, GENE DEV, V26, P2259, DOI 10.1101/gad.199653.112; HINZ U, 1994, CELL, V76, P77, DOI 10.1016/0092-8674(94)90174-0; Kaufmann WE, 2000, CEREB CORTEX, V10, P981, DOI 10.1093/cercor/10.10.981; KORENBERG JR, 1994, P NATL ACAD SCI USA, V91, P4997, DOI 10.1073/pnas.91.11.4997; Li HL, 2009, NEURON, V61, P527, DOI 10.1016/j.neuron.2009.01.010; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Monzo K, 2006, P NATL ACAD SCI USA, V103, P18160, DOI 10.1073/pnas.0606508103; Neufeld SQ, 2011, MOL BRAIN, V4, DOI 10.1186/1756-6606-4-15; Nimchinsky EA, 2001, J NEUROSCI, V21, P5139, DOI 10.1523/JNEUROSCI.21-14-05139.2001; Parks AL, 2004, NAT GENET, V36, P288, DOI 10.1038/ng1312; PHILLIS RW, 1993, GENETICS, V133, P581; Rachidi M, 2007, NEUROSCI RES, V59, P349, DOI 10.1016/j.neures.2007.08.007; Raj A, 2008, NAT METHODS, V5, P877, DOI 10.1038/NMETH.1253; Reeve SR, 2005, CURR BIOL, V15, P1156, DOI 10.1016/j.cub.2005.05.050; Schmucker D, 2000, CELL, V101, P671, DOI 10.1016/S0092-8674(00)80878-8; Schmucker D, 2009, GENE DEV, V23, P147, DOI 10.1101/gad.1752909; Stetler A, 2006, HUM MOL GENET, V15, P87, DOI 10.1093/hmg/ddi429; TAKASHIMA S, 1981, BRAIN RES, V225, P1, DOI 10.1016/0006-8993(81)90314-0; VANDERVORST P, 1980, NATURE, V286, P65, DOI 10.1038/286065a0; Venken KJT, 2006, SCIENCE, V314, P1747, DOI 10.1126/science.1134426; Watson FL, 2005, SCIENCE, V309, P1874, DOI 10.1126/science.1116887; Watthanasurorot A, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002062; Yamakawa K, 1998, HUM MOL GENET, V7, P227, DOI 10.1093/hmg/7.2.227; Zalfa F, 2007, NAT NEUROSCI, V10, P578, DOI 10.1038/nn1893; Zhang YQ, 2001, CELL, V107, P591, DOI 10.1016/S0092-8674(01)00589-X	49	48	49	1	15	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JUN	2013	16	6					677	U36		10.1038/nn.3396	http://dx.doi.org/10.1038/nn.3396			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	152DE	23666178	Green Accepted			2022-12-28	WOS:000319509600008
J	Schulz, A; Baader, SL; Niwa-Kawakita, M; Jung, MJ; Bauer, R; Garcia, C; Zoch, A; Schacke, S; Hagel, C; Mautner, VF; Hanemann, CO; Dun, XP; Parkinson, DB; Weis, J; Schroder, JM; Gutmann, DH; Giovannini, M; Morrison, H				Schulz, Alexander; Baader, Stephan L.; Niwa-Kawakita, Michiko; Jung, Marie Juliane; Bauer, Reinhard; Garcia, Cynthia; Zoch, Ansgar; Schacke, Stephan; Hagel, Christian; Mautner, Victor-Felix; Hanemann, C. Oliver; Dun, Xin-Peng; Parkinson, David B.; Weis, Joachim; Schroeder, J. Michael; Gutmann, David H.; Giovannini, Marco; Morrison, Helen			Merlin isoform 2 in neurofibromatosis type 2-associated polyneuropathy	NATURE NEUROSCIENCE			English	Article							SUPPRESSOR GENE-PRODUCT; NEUROFILAMENT; MICE; RHO; EXPRESSION; NEURONS; PHOSPHORYLATION; PROTEIN; GTPASES; GROWTH	The autosomal dominant disorder neurofibromatosis type 2 (NF2) is a hereditary tumor syndrome caused by inactivation of the NF2 tumor suppressor gene, encoding merlin. Apart from tumors affecting the peripheral and central nervous systems, most NF2 patients develop peripheral neuropathies. This peripheral nerve disease can occur in the absence of nerve-damaging tumors, suggesting an etiology that is independent of gross tumor burden. We discovered that merlin isoform 2 (merlin-iso2) has a specific function in maintaining axonal integrity and propose that reduced axonal NF2 gene dosage leads to NF2-associated polyneuropathy. We identified a merlin-iso2-dependent complex that promotes activation of the GTPase RhoA, enabling downstream Rho-associated kinase to promote neurofilament heavy chain phosphorylation. Merlin-iso2-deficient mice exhibited impaired locomotor capacities, delayed sensory reactions and electrophysiological signs of axonal neuropathy. Sciatic nerves from these mice and sural nerve biopsies from NF2 patients revealed reduced phosphorylation of the neurofilament H subunit, decreased interfilament spacings and irregularly shaped axons.	[Schulz, Alexander; Jung, Marie Juliane; Zoch, Ansgar; Schacke, Stephan; Morrison, Helen] Fritz Lipmann Inst, Leibniz Inst Age Res, Jena, Germany; [Baader, Stephan L.] Univ Bonn, Inst Anat Anat & Cell Biol, Bonn, Germany; [Niwa-Kawakita, Michiko] Univ Paris, INSERM, U674, F-75252 Paris, France; [Bauer, Reinhard] Univ Jena, Jena Univ Hosp, Inst Mol Cell Biol, Jena, Germany; [Bauer, Reinhard] Univ Jena, Jena Univ Hosp, Ctr Sepsis Control & Care, Jena, Germany; [Garcia, Cynthia; Gutmann, David H.] Washington Univ, Sch Med, Dept Neurol, St Louis, MO 63110 USA; [Hagel, Christian] Univ Med Ctr Hamburg Eppendorf, Dept Neuropathol, Hamburg, Germany; [Mautner, Victor-Felix] Univ Med Ctr Hamburg Eppendorf, Dept Neurol, Hamburg, Germany; [Hanemann, C. Oliver; Dun, Xin-Peng; Parkinson, David B.] Univ Plymouth, Peninsula Sch Med, Plymouth PL4 8AA, Devon, England; [Hanemann, C. Oliver; Dun, Xin-Peng; Parkinson, David B.] Univ Plymouth, Peninsula Sch Dent, Plymouth PL4 8AA, Devon, England; [Weis, Joachim; Schroeder, J. Michael] Rhein Westfal TH Aachen, Univ Hosp Aachen, Inst Neuropathol, D-52062 Aachen, Germany; [Giovannini, Marco] Ctr Neural Tumor Res, House Ear Inst, Los Angeles, CA USA	Leibniz Institut fur Alternsforschung - Fritz-Lipmann-Institut (FLI); University of Bonn; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Friedrich Schiller University of Jena; Friedrich Schiller University of Jena; Washington University (WUSTL); University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Plymouth; University of Plymouth; RWTH Aachen University; RWTH Aachen University Hospital; House Research Institute	Morrison, H (corresponding author), Fritz Lipmann Inst, Leibniz Inst Age Res, Jena, Germany.	helen@fli-leibniz.de	Morrison, Helen/B-3984-2017; Weis, Joachim/G-1984-2014; Hanemann, C Oliver/AAV-6257-2020; Morrison, Helen/F-9748-2014	Morrison, Helen/0000-0003-4938-1409; Weis, Joachim/0000-0003-3280-6773; Hanemann, C Oliver/0000-0002-1951-1025; Morrison, Helen/0000-0003-4938-1409; Zoch, Ansgar/0000-0003-2071-1590; Gutmann, David/0000-0002-3127-5045; Dun, Xin-peng/0000-0003-2837-4672; Kawakita, Michiko/0000-0002-9450-583X	Deutsche Forschungsgemeinschaft [MO 1421/2-1]; Children's Tumor Foundation;  [Sonderforschungsbereich 604];  [Krebshilfe 107089]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Children's Tumor Foundation; ; 	The authors would like to thank U. Petz, C. Poser and S. Ramrath for their expert technical assistance, H. Rosemann, F. Kaufmann and D. Galendo for their skilled breeding and husbandry of animals, and R.E. Ferner for discussions and support. Mpz-cre mice were kindly provided M.L. Feltri (Hunter James Kelly Research Institute). This work was supported by Sonderforschungsbereich 604, Deutsche Forschungsgemeinschaft MO 1421/2-1 and Krebshilfe 107089. A.S. is recipient of a Young Investigator Award from the Children's Tumor Foundation.	Asthagiri AR, 2009, LANCET, V373, P1974, DOI 10.1016/S0140-6736(09)60259-2; Baader SL, 1996, J NEUROSCI, V16, P1440; Bremer J, 2010, NAT NEUROSCI, V13, P310, DOI 10.1038/nn.2483; DEWAEGH SM, 1992, CELL, V68, P451, DOI 10.1016/0092-8674(92)90183-D; Dubois M, 2005, J NEUROSCI RES, V80, P751, DOI 10.1002/jnr.20493; Elder GA, 1999, J CELL BIOL, V146, P181; England JD, 2004, LANCET, V363, P2151, DOI 10.1016/S0140-6736(04)16508-2; Feltri ML, 2002, J CELL BIOL, V156, P199, DOI 10.1083/jcb.200109021; Gianola S, 2001, J COMP NEUROL, V430, P101, DOI 10.1002/1096-9861(20010129)430:1<101::AID-CNE1017>3.0.CO;2-Z; Giovannini M, 2000, GENE DEV, V14, P1617; Hagel C, 2002, ACTA NEUROPATHOL, V104, P179, DOI 10.1007/s00401-002-0535-7; Hanemann CO, 2007, BRAIN PATHOL, V17, P371, DOI 10.1111/j.1750-3639.2007.00086.x; Hashimoto R, 1998, BIOCHEM BIOPH RES CO, V245, P407, DOI 10.1006/bbrc.1998.8446; Iseki Chifumi, 2009, Rinsho Shinkeigaku, V49, P419; Jackson SJ, 2005, NEUROSCIENCE, V134, P261, DOI 10.1016/j.neuroscience.2005.02.045; Jankowski J, 2009, CEREBELLUM, V8, P277, DOI 10.1007/s12311-009-0093-9; JONESVILLENEUVE EMV, 1982, J CELL BIOL, V94, P253, DOI 10.1083/jcb.94.2.253; Luo LQ, 2000, NAT REV NEUROSCI, V1, P173, DOI 10.1038/35044547; Maeda M, 1999, ONCOGENE, V18, P4788, DOI 10.1038/sj.onc.1202871; Malin SA, 2007, NAT PROTOC, V2, P152, DOI 10.1038/nprot.2006.461; Michailov GV, 2004, SCIENCE, V304, P700, DOI 10.1126/science.1095862; Moorman JP, 1999, ONCOGENE, V18, P47, DOI 10.1038/sj.onc.1202262; Morrison H, 2001, GENE DEV, V15, P968, DOI 10.1101/gad.189601; MORRISON JH, 1987, BRAIN RES, V416, P331, DOI 10.1016/0006-8993(87)90914-0; Mulisch M, 2010, ROMEIS MIKROSKOPISCH; Mundegar RR, 2008, J HISTOCHEM CYTOCHEM, V56, P969, DOI 10.1369/jhc.2008.950105; Perrot R, 2008, MOL NEUROBIOL, V38, P27, DOI 10.1007/s12035-008-8033-0; Scherer SS, 1996, J NEUROSCI RES, V46, P595, DOI 10.1002/(SICI)1097-4547(19961201)46:5<595::AID-JNR8>3.3.CO;2-2; Schulz A, 2010, J NEUROSCI, V30, P10177, DOI 10.1523/JNEUROSCI.0840-10.2010; Sherman L, 1997, ONCOGENE, V15, P2505, DOI 10.1038/sj.onc.1201418; Sperfeld AD, 2002, BRAIN, V125, P996, DOI 10.1093/brain/awf115; Watanabe SY, 1999, NEUROSCI RES, V33, P71, DOI 10.1016/S0168-0102(98)00113-8; Xia RH, 2010, MUSCLE NERVE, V41, P850, DOI 10.1002/mus.21588; Yamashita T, 2003, NAT NEUROSCI, V6, P461, DOI 10.1038/nn1045; Zhu QZ, 1997, EXP NEUROL, V148, P299, DOI 10.1006/exnr.1997.6654	35	44	44	0	15	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	APR	2013	16	4					426	U86		10.1038/nn.3348	http://dx.doi.org/10.1038/nn.3348			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	114EM	23455610				2022-12-28	WOS:000316723700012
J	Beltramo, R; D'Urso, G; Dal Maschio, M; Farisello, P; Bovetti, S; Clovis, Y; Lassi, G; Tucci, V; Tonelli, DD; Fellin, T				Beltramo, Riccardo; D'Urso, Giulia; Dal Maschio, Marco; Farisello, Pasqualina; Bovetti, Serena; Clovis, Yoanne; Lassi, Glenda; Tucci, Valter; Tonelli, Davide De Pietri; Fellin, Tommaso			Layer-specific excitatory circuits differentially control recurrent network dynamics in the neocortex	NATURE NEUROSCIENCE			English	Article							LESS-THAN-1 HZ OSCILLATION; BARREL CORTEX; IN-VIVO; SENSORY RESPONSES; CORTICAL CIRCUITS; VISUAL-CORTEX; SLEEP; NEURONS; STIMULATION; RHYTHMS	In the absence of external stimuli, the mammalian neocortex shows intrinsic network oscillations. These dynamics are characterized by translaminar assemblies of neurons whose activity synchronizes rhythmically in space and time. How different cortical layers influence the formation of these spontaneous cellular assemblies is poorly understood. We found that excitatory neurons in supragranular and infragranular layers have distinct roles in the regulation of intrinsic low-frequency oscillations in mice in vivo. Optogenetic activation of infragranular neurons generated network activity that resembled spontaneous events, whereas photoinhibition of these same neurons substantially attenuated slow ongoing dynamics. In contrast, light activation and inhibition of supragranular cells had modest effects on spontaneous slow activity. This study represents, to the best of our knowledge, the first causal demonstration that excitatory circuits located in distinct cortical layers differentially control spontaneous low-frequency dynamics.	[Beltramo, Riccardo; D'Urso, Giulia; Dal Maschio, Marco; Farisello, Pasqualina; Bovetti, Serena; Clovis, Yoanne; Lassi, Glenda; Tucci, Valter; Tonelli, Davide De Pietri; Fellin, Tommaso] Ist Italiano Tecnol, Dept Neurosci & Brain Technol, Genoa, Italy	Istituto Italiano di Tecnologia - IIT	Fellin, T (corresponding author), Ist Italiano Tecnol, Dept Neurosci & Brain Technol, Genoa, Italy.	tommaso.fellin@iit.it	De Pietri Tonelli, Davide/AAD-8055-2021; De Pietri Tonelli, Davide/E-2102-2011; Dal Maschio, Marco/G-3871-2017	De Pietri Tonelli, Davide/0000-0001-9537-8900; De Pietri Tonelli, Davide/0000-0001-9537-8900; Bovetti, Serena/0000-0002-0471-4081; Lassi, Glenda/0000-0001-5102-3294; Tucci, Valter/0000-0002-3796-3826; dal maschio, marco/0000-0003-0150-6647	Italian Institute of Technology; San Paolo "Programma in Neuroscienze", MIUR FIRB [RBAP11X42L]; Telethon-Italy [GGP10138]	Italian Institute of Technology(Istituto Italiano di Tecnologia - IIT); San Paolo "Programma in Neuroscienze", MIUR FIRB; Telethon-Italy(Fondazione Telethon)	We thank J. Assad, A. Bacci, E Benfenati, A. Blau and G. Carmignoto for critical reading and helpful comments on the manuscript. We thank C. Gerfen (US National Institute of Mental Health) for Rbp4-cre mice, K. Deisseroth (Stanford University) for pAAV-EF1a.DIO.hChR2(H134R)-EYFP.WPRE.hGH (Addgene 20298), pAAV-EF1.dflox.hChR2(H134R)-mCherry.WPRE.hGH (Addgene 20297) and pAAV-EFla.DIO.eNpHR-eYFP.WP.hGH (Addgene 20949), K. Svoboda (Howard Hughes Medical Institute, Janelia Farm) for pCAGGS-ChR2-Venus (Addgene 15753), E. Boyden (Massachusetts Institute of Technology) for pAAV-CAG-ArchT-GFP (Addgene 29777), FCK-Arch-GFP (Addgene 22217) and AAV2/1.flex.CBA.Arch-GFP.WPRE.SV40 (Addgene 22222) and S. Guazzi for subcloning and amplification of some of the plasmids used in this study. This work was supported by the Italian Institute of Technology and grants from San Paolo "Programma in Neuroscienze", MIUR FIRB (RBAP11X42L) and Telethon-Italy (GGP10138) to T.F.	Adesnik H, 2010, NATURE, V464, P1155, DOI 10.1038/nature08935; Amzica F, 1998, NEUROSCIENCE, V82, P671; Arenkiel BR, 2007, NEURON, V54, P205, DOI 10.1016/j.neuron.2007.03.005; Boyden ES, 2005, NAT NEUROSCI, V8, P1263, DOI 10.1038/nn1525; Brecht M, 2007, CURR OPIN NEUROBIOL, V17, P408, DOI 10.1016/j.conb.2007.07.008; Brown SP, 2009, CURR OPIN NEUROBIOL, V19, P415, DOI 10.1016/j.conb.2009.07.011; Chance FS, 2002, NEURON, V35, P773, DOI 10.1016/S0896-6273(02)00820-6; Chauvette S, 2010, CEREB CORTEX, V20, P2660, DOI 10.1093/cercor/bhq009; Chow BY, 2010, NATURE, V463, P98, DOI 10.1038/nature08652; Contreras D, 2004, NEURAL NETWORKS, V17, P633, DOI 10.1016/j.neunet.2004.04.003; CONTRERAS D, 1995, J NEUROSCI, V15, P604; Cossart R, 2003, NATURE, V423, P283, DOI 10.1038/nature01614; Dal Maschio M, 2010, OPT EXPRESS, V18, P18720, DOI 10.1364/OE.18.018720; Destexhe A, 2011, CURR OPIN NEUROBIOL, V21, P717, DOI 10.1016/j.conb.2011.06.002; Douglas RJ, 2004, ANNU REV NEUROSCI, V27, P419, DOI 10.1146/annurev.neuro.27.070203.144152; Feldmeyer D, 2012, FRONT NEUROANAT, V6, DOI 10.3389/fnana.2012.00024; Fiser J, 2004, NATURE, V431, P573, DOI 10.1038/nature02907; Frank MG, 2001, NEURON, V30, P275, DOI 10.1016/S0896-6273(01)00279-3; Gradinaru V, 2008, BRAIN CELL BIOL, V36, P129, DOI 10.1007/s11068-008-9027-6; Jha SK, 2005, J NEUROSCI, V25, P9266, DOI 10.1523/JNEUROSCI.2722-05.2005; Ji DY, 2007, NAT NEUROSCI, V10, P100, DOI 10.1038/nn1825; Katz LC, 1996, SCIENCE, V274, P1133, DOI 10.1126/science.274.5290.1133; Kerr JND, 2005, P NATL ACAD SCI USA, V102, P14063, DOI 10.1073/pnas.0506029102; Kirov R, 2009, P NATL ACAD SCI USA, V106, P15460, DOI 10.1073/pnas.0904438106; Le Bon-Jegoa M, 2007, FRONT NEUROSCI-SWITZ, V1, P123, DOI 10.3389/neuro.01.1.1.009.2007; Lefort S, 2009, NEURON, V61, P301, DOI 10.1016/j.neuron.2008.12.020; Luczak A, 2007, P NATL ACAD SCI USA, V104, P347, DOI 10.1073/pnas.0605643104; Luczak A, 2009, NEURON, V62, P413, DOI 10.1016/j.neuron.2009.03.014; MacLean JN, 2005, NEURON, V48, P811, DOI 10.1016/j.neuron.2005.09.035; Marshall L, 2006, NATURE, V444, P610, DOI 10.1038/nature05278; Massimini M, 2007, P NATL ACAD SCI USA, V104, P8496, DOI 10.1073/pnas.0702495104; METHERATE R, 1992, J NEUROSCI, V12, P4701; Meyer HS, 2010, CEREB CORTEX, V20, P2277, DOI 10.1093/cercor/bhq067; Nagel G, 2003, P NATL ACAD SCI USA, V100, P13940, DOI 10.1073/pnas.1936192100; Olsen SR, 2012, NATURE, V483, P47, DOI 10.1038/nature10835; Papagiakoumou E, 2010, NAT METHODS, V7, P848, DOI [10.1038/NMETH.1505, 10.1038/nmeth.1505]; Peters A., 1990, CEREBRAL CORTEX COMP; Petersen CCH, 2007, NEURON, V56, P339, DOI 10.1016/j.neuron.2007.09.017; Petersen CCH, 2003, P NATL ACAD SCI USA, V100, P13638, DOI 10.1073/pnas.2235811100; Petreanu L, 2007, NAT NEUROSCI, V10, P663, DOI 10.1038/nn1891; Poulet JFA, 2008, NATURE, V454, P881, DOI 10.1038/nature07150; Sakata S, 2009, NEURON, V64, P404, DOI 10.1016/j.neuron.2009.09.020; Sanchez-Vives MV, 2000, NAT NEUROSCI, V3, P1027, DOI 10.1038/79848; Sohal VS, 2009, NATURE, V459, P698, DOI 10.1038/nature07991; Steriade M, 2006, NEUROSCIENCE, V137, P1087, DOI 10.1016/j.neuroscience.2005.10.029; STERIADE M, 1993, J NEUROSCI, V13, P3284; STERIADE M, 1993, J NEUROSCI, V13, P3266; STERIADE M, 1993, J NEUROSCI, V13, P3252, DOI 10.1523/jneurosci.13-08-03252.1993; Vyazovskiy VV, 2008, NAT NEUROSCI, V11, P200, DOI 10.1038/nn2035; Wester JC, 2012, J NEUROSCI, V32, P5454, DOI 10.1523/JNEUROSCI.5006-11.2012	50	146	146	0	36	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	FEB	2013	16	2					227	234		10.1038/nn.3306	http://dx.doi.org/10.1038/nn.3306			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	080RE	23313909				2022-12-28	WOS:000314260200020
J	Buzsaki, G; Moser, EI				Buzsaki, Gyoergy; Moser, Edvard I.			Memory, navigation and theta rhythm in the hippocampal-entorhinal system	NATURE NEUROSCIENCE			English	Review							MULTIITEM WORKING-MEMORY; PLACE CELLS; PATH-INTEGRATION; GRID CELLS; SPATIAL REPRESENTATION; PATTERN SEPARATION; PHASE PRECESSION; NEURAL BASIS; OSCILLATIONS; DYNAMICS	Theories on the functions of the hippocampal system are based largely on two fundamental discoveries: the amnestic consequences of removing the hippocampus and associated structures in the famous patient H.M. and the observation that spiking activity of hippocampal neurons is associated with the spatial position of the rat. In the footsteps of these discoveries, many attempts were made to reconcile these seemingly disparate functions. Here we propose that mechanisms of memory and planning have evolved from mechanisms of navigation in the physical world and hypothesize that the neuronal algorithms underlying navigation in real and mental space are fundamentally the same. We review experimental data in support of this hypothesis and discuss how specific firing patterns and oscillatory dynamics in the entorhinal cortex and hippocampus can support both navigation and memory.	[Buzsaki, Gyoergy] NYU, NYU Neurosci Inst, New York, NY USA; [Buzsaki, Gyoergy] NYU, Ctr Neural Sci, New York, NY USA; [Moser, Edvard I.] Norwegian Univ Sci & Technol, Kavli Inst Syst Neurosci, N-7034 Trondheim, Norway	New York University; New York University; Norwegian University of Science & Technology (NTNU)	Buzsaki, G (corresponding author), NYU, NYU Neurosci Inst, New York, NY USA.	gyorgy.buzsaki@nyumc.org		Buzsaki, Gyorgy/0000-0002-3100-4800	US National Institutes of Health [NS34994, MH54671, NS 074015]; International Human Frontiers Science Program Organization [RGP0032/2011]; James S. McDonnell Foundation; Global Institute for Scientific Thinking; European Research Council ('CIRCUIT' Advanced Investigator Grant) [232608]; Louis-Jeantet Prize for Medicine; Kavli Foundation; Centre of Excellence scheme of the Research Council of Norway; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS034994, R01NS074015] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); International Human Frontiers Science Program Organization(Human Frontier Science Program); James S. McDonnell Foundation; Global Institute for Scientific Thinking; European Research Council ('CIRCUIT' Advanced Investigator Grant); Louis-Jeantet Prize for Medicine; Kavli Foundation; Centre of Excellence scheme of the Research Council of Norway; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank G. Fishell for comments, Heather McKellar for assistance, and the US National Institutes of Health (NS34994; MH54671; NS 074015), International Human Frontiers Science Program Organization (RGP0032/2011), James S. McDonnell Foundation, Global Institute for Scientific Thinking, European Research Council ('CIRCUIT' Advanced Investigator Grant, Grant Agreement 232608), Louis-Jeantet Prize for Medicine, Kavli Foundation and Centre of Excellence scheme of the Research Council of Norway for support.	Axmacher N, 2010, P NATL ACAD SCI USA, V107, P3228, DOI 10.1073/pnas.0911531107; Boccara CN, 2010, NAT NEUROSCI, V13, P987, DOI 10.1038/nn.2602; BRAGIN A, 1995, J NEUROSCI, V15, P47; Buckner RL, 2007, TRENDS COGN SCI, V11, P49, DOI 10.1016/j.tics.2006.11.004; Buckner RL, 2010, ANNU REV PSYCHOL, V61, P27, DOI 10.1146/annurev.psych.60.110707.163508; Burgess N, 2002, NEURON, V35, P625, DOI 10.1016/S0896-6273(02)00830-9; Burgess N, 2011, CURR OPIN NEUROBIOL, V21, P734, DOI 10.1016/j.conb.2011.07.002; Buzsaki G, 2005, HIPPOCAMPUS, V15, P827, DOI 10.1002/hipo.20113; Buzsaki G, 2004, SCIENCE, V304, P1926, DOI 10.1126/science.1099745; Buzsaki G, 2012, ANNU REV NEUROSCI, V35, P203, DOI 10.1146/annurev-neuro-062111-150444; Buzsaki G, 2010, NEURON, V68, P362, DOI 10.1016/j.neuron.2010.09.023; Canolty RT, 2006, SCIENCE, V313, P1626, DOI 10.1126/science.1128115; Colgin LL, 2009, NATURE, V462, P353, DOI 10.1038/nature08573; Derdikman D, 2009, NAT NEUROSCI, V12, P1325, DOI 10.1038/nn.2396; Diba K, 2008, J NEUROSCI, V28, P13448, DOI 10.1523/JNEUROSCI.3824-08.2008; Dragoi G, 2006, NEURON, V50, P145, DOI 10.1016/j.neuron.2006.02.023; Dusek JA, 1997, P NATL ACAD SCI USA, V94, P7109, DOI 10.1073/pnas.94.13.7109; Eichenbaum H, 1999, NEURON, V23, P209, DOI 10.1016/S0896-6273(00)80773-4; Ekstrom AD, 2005, HIPPOCAMPUS, V15, P881, DOI 10.1002/hipo.20109; Fell J, 2002, REV NEUROSCIENCE, V13, P299; Frank LM, 2000, NEURON, V27, P169, DOI 10.1016/S0896-6273(00)00018-0; Fujisawa S, 2008, NAT NEUROSCI, V11, P823, DOI 10.1038/nn.2134; Fyhn M, 2007, NATURE, V446, P190, DOI 10.1038/nature05601; Geisler C, 2007, P NATL ACAD SCI USA, V104, P8149, DOI 10.1073/pnas.0610121104; Geisler C, 2010, P NATL ACAD SCI USA, V107, P7957, DOI 10.1073/pnas.0912478107; Gothard KM, 1996, J NEUROSCI, V16, P823; Griesmayr B, 2010, NEUROBIOL LEARN MEM, V93, P208, DOI 10.1016/j.nlm.2009.09.013; Gupta AS, 2012, NAT NEUROSCI, V15, P1032, DOI 10.1038/nn.3138; Hafting T, 2005, NATURE, V436, P801, DOI 10.1038/nature03721; Hampson RE, 1996, HIPPOCAMPUS, V6, P281, DOI 10.1002/(SICI)1098-1063(1996)6:3<281::AID-HIPO6>3.0.CO;2-Q; Harris KD, 2003, NATURE, V424, P552, DOI 10.1038/nature01834; Harvey CD, 2012, NATURE, V484, P62, DOI 10.1038/nature10918; Hasselmo ME, 2012, WE REMEMBER BRAIN ME; Hasselmo ME, 2007, LEARN MEMORY, V14, P782, DOI 10.1101/lm.686607; HEIT G, 1988, NATURE, V333, P773, DOI 10.1038/333773a0; Howard MW, 1999, J EXP PSYCHOL LEARN, V25, P923, DOI 10.1037/0278-7393.25.4.923; Itskov V, 2008, J NEUROSCI, V28, P5959, DOI 10.1523/JNEUROSCI.5262-07.2008; Jensen O, 2005, TRENDS NEUROSCI, V28, P67, DOI 10.1016/j.tins.2004.12.001; Jezek K, 2011, NATURE, V478, P246, DOI 10.1038/nature10439; Johnson A, 2007, J NEUROSCI, V27, P12176, DOI 10.1523/JNEUROSCI.3761-07.2007; Kjelstrup KB, 2008, SCIENCE, V321, P140, DOI 10.1126/science.1157086; Knierim JJ, 1998, J NEUROPHYSIOL, V80, P425, DOI 10.1152/jn.1998.80.1.425; Koch C, 1996, CEREB CORTEX, V6, P93, DOI 10.1093/cercor/6.2.93; Koenig J, 2011, SCIENCE, V332, P592, DOI 10.1126/science.1201685; Krupic J, 2012, SCIENCE, V337, P853, DOI 10.1126/science.1222403; Kumaran D, 2012, PSYCHOL REV, V119, P573, DOI 10.1037/a0028681; Leutgeb JK, 2007, SCIENCE, V315, P961, DOI 10.1126/science.1135801; Leutgeb S, 2004, SCIENCE, V305, P1295, DOI 10.1126/science.1100265; Lever C, 2002, NATURE, V416, P90, DOI 10.1038/416090a; LI XG, 1994, J COMP NEUROL, V339, P181, DOI 10.1002/cne.903390204; LISMAN JE, 1995, SCIENCE, V267, P1512, DOI 10.1126/science.7878473; Lisman JE, 1999, NEURON, V22, P233, DOI 10.1016/S0896-6273(00)81085-5; MacDonald CJ, 2011, NEURON, V71, P737, DOI 10.1016/j.neuron.2011.07.012; Mankin EA, 2012, P NATL ACAD SCI USA, V109, P19462, DOI 10.1073/pnas.1214107109; Manns JR, 2003, NEURON, V37, P171, DOI 10.1016/S0896-6273(02)01147-9; Maurer AP, 2006, J NEUROSCI, V26, P13485, DOI 10.1523/JNEUROSCI.2882-06.2006; MCCLELLAND JL, 1995, PSYCHOL REV, V102, P419, DOI 10.1037/0033-295X.102.3.419; McNaughton BL, 1996, J EXP BIOL, V199, P173; MCNAUGHTON BL, 1983, EXP BRAIN RES, V52, P41; McNaughton BL, 2006, NAT REV NEUROSCI, V7, P663, DOI 10.1038/nrn1932; Menzel R, 1998, ANIM BEHAV, V55, P139, DOI 10.1006/anbe.1997.0574; Miyashita Y, 2004, SCIENCE, V306, P435, DOI 10.1126/science.1101864; Mizuseki K, 2012, HIPPOCAMPUS, V22, P1659, DOI 10.1002/hipo.22002; Mizuseki K, 2009, NEURON, V64, P267, DOI 10.1016/j.neuron.2009.08.037; Moser EI, 2008, ANNU REV NEUROSCI, V31, P69, DOI 10.1146/annurev.neuro.31.061307.090723; Muller RU, 1996, J GEN PHYSIOL, V107, P663, DOI 10.1085/jgp.107.6.663; MULLER RU, 1987, J NEUROSCI, V7, P1951; MULLER RU, 1994, J NEUROSCI, V14, P7235; Nadel L, 1997, CURR OPIN NEUROBIOL, V7, P217, DOI 10.1016/S0959-4388(97)80010-4; Nakashiba T, 2012, CELL, V149, P188, DOI 10.1016/j.cell.2012.01.046; Navigli R, 2010, IEEE T PATTERN ANAL, V32, P678, DOI 10.1109/TPAMI.2009.36; Naya Y, 2011, SCIENCE, V333, P773, DOI 10.1126/science.1206773; O'Keefe J, 1978, HIPPOCAMPUS COGNITIV; OKeefe J, 1996, NATURE, V381, P425, DOI 10.1038/381425a0; OKEEFE J, 1993, HIPPOCAMPUS, V3, P317, DOI 10.1002/hipo.450030307; Pastalkova E, 2008, SCIENCE, V321, P1322, DOI 10.1126/science.1159775; Quiroga RQ, 2005, NATURE, V435, P1102, DOI 10.1038/nature03687; Royer S, 2012, NAT NEUROSCI, V15, P769, DOI 10.1038/nn.3077; Royer S, 2010, J NEUROSCI, V30, P1777, DOI 10.1523/JNEUROSCI.4681-09.2010; Sargolini F, 2006, SCIENCE, V312, P758, DOI 10.1126/science.1125572; SCOVILLE WB, 1957, J NEUROL NEUROSUR PS, V20, P11, DOI 10.1136/jnnp.20.1.11; Shrager Y, 2008, P NATL ACAD SCI USA, V105, P12034, DOI 10.1073/pnas.0805414105; Skaggs WE, 1996, HIPPOCAMPUS, V6, P149, DOI 10.1002/(SICI)1098-1063(1996)6:2<149::AID-HIPO6>3.0.CO;2-K; Solstad T, 2008, SCIENCE, V322, P1865, DOI 10.1126/science.1166466; SQUIRE LR, 1992, PSYCHOL REV, V99, P195, DOI 10.1037/0033-295X.99.2.195; Stensola H, 2012, NATURE, V492, P72, DOI 10.1038/nature11649; Suddendorf T, 2007, BEHAV BRAIN SCI, V30, P299, DOI 10.1017/S0140525X07001975; Suzuki WA, 1997, J NEUROPHYSIOL, V78, P1062, DOI 10.1152/jn.1997.78.2.1062; Thompson E, 2001, TRENDS COGN SCI, V5, P418, DOI 10.1016/S1364-6613(00)01750-2; Tort ABL, 2009, P NATL ACAD SCI USA, V106, P20942, DOI 10.1073/pnas.0911331106; TREVES A, 1994, HIPPOCAMPUS, V4, P374, DOI 10.1002/hipo.450040319; Trope Y, 2010, PSYCHOL REV, V117, P440, DOI 10.1037/a0018963; Tulving E., 2002, PRINCIPLES FRONTAL L, P311, DOI [10.1093/acprof:oso/9780195134971.003.0020, DOI 10.1093/ACPROF:OSO/9780195134971.003.0020]; Tulving E., 1972, ORG MEMORY, P423; Ulanovsky N, 2007, NAT NEUROSCI, V10, P224, DOI 10.1038/nn1829; Whittington MA, 2000, INT J PSYCHOPHYSIOL, V38, P315, DOI 10.1016/S0167-8760(00)00173-2; Wickelgren WA, 1999, CAN J EXP PSYCHOL, V53, P118, DOI 10.1037/h0087304; WILSON MA, 1993, SCIENCE, V261, P1055, DOI 10.1126/science.8351520; Wood ER, 2000, NEURON, V27, P623, DOI 10.1016/S0896-6273(00)00071-4; Yartsev MM, 2011, NATURE, V479, P103, DOI 10.1038/nature10583	100	891	908	19	334	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	FEB	2013	16	2					130	138		10.1038/nn.3304	http://dx.doi.org/10.1038/nn.3304			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	080RE	23354386	Green Accepted			2022-12-28	WOS:000314260200008
J	Krey, JF; Pasca, SP; Shcheglovitov, A; Yazawa, M; Schwemberger, R; Rasmusson, R; Dolmetsch, RE				Krey, Jocelyn F.; Pasca, Sergiu P.; Shcheglovitov, Aleksandr; Yazawa, Masayuki; Schwemberger, Rachel; Rasmusson, Randall; Dolmetsch, Ricardo E.			Timothy syndrome is associated with activity-dependent dendritic retraction in rodent and human neurons	NATURE NEUROSCIENCE			English	Article							CA2+ CHANNEL; CALCIUM-CHANNEL; DISTINCT ROLES; BETA-SUBUNITS; RHO-KINASE; CELL-SHAPE; AUTISM; PROTEINS; GROWTH; MUTATIONS	L-type voltage gated calcium channels have an important role in neuronal development by promoting dendritic growth and arborization. A point mutation in the gene encoding Ca(V)1.2 causes Timothy syndrome, a neurodevelopmental disorder associated with autism spectrum disorders (ASDs). We report that channels with the Timothy syndrome alteration cause activity-dependent dendrite retraction in rat and mouse neurons and in induced pluripotent stem cell (iPSC)-derived neurons from individuals with Timothy syndrome. Dendrite retraction was independent of calcium permeation through the mutant channel, was associated with ectopic activation of RhoA and was inhibited by overexpression of the channel-associated GTPase Gem. These results suggest that Ca(V)1.2 can activate RhoA signaling independently of Ca2+ and provide insights into the cellular basis of Timothy syndrome and other ASDs.	[Krey, Jocelyn F.; Pasca, Sergiu P.; Shcheglovitov, Aleksandr; Yazawa, Masayuki; Schwemberger, Rachel; Dolmetsch, Ricardo E.] Stanford Univ, Sch Med, Dept Neurobiol, Stanford, CA 94305 USA; [Rasmusson, Randall] SUNY Buffalo, Dept Physiol & Biophys, Buffalo, NY 14260 USA; [Dolmetsch, Ricardo E.] Allen Inst Brain Sci, Seattle, WA USA	Stanford University; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; Allen Institute for Brain Science	Dolmetsch, RE (corresponding author), Stanford Univ, Sch Med, Dept Neurobiol, Stanford, CA 94305 USA.	ricardo.dolmetsch@stanford.edu	Pasca, Sergiu/AAY-3949-2021	Pasca, Sergiu/0000-0002-3216-3248	National Institutes of Health under Ruth L. Kirschstein National Research Service Award from the National Institute of Neurological Disorders and Stroke [F31 NS055549-03]; US National Institutes of Health; Simons Foundation; International Brain Research Organization; Tashia and John Morgridge Endowed Fellowship; Japan Society of the Promotion for Science; American Heart Association; California Institute for Regenerative Medicine Postdoctoral Fellowship; NATIONAL INSTITUTE OF MENTAL HEALTH [DP1MH099904, T32MH020016] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F31NS055549] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD003889] Funding Source: NIH RePORTER	National Institutes of Health under Ruth L. Kirschstein National Research Service Award from the National Institute of Neurological Disorders and Stroke; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Simons Foundation; International Brain Research Organization; Tashia and John Morgridge Endowed Fellowship; Japan Society of the Promotion for Science; American Heart Association(American Heart Association); California Institute for Regenerative Medicine Postdoctoral Fellowship; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank K. Timothy and the individuals with Timothy syndrome who participated in this study, J. Bernstein and J. Hallmayer for recruiting the subjects for this study, and E. Nigh for critical reading of the manuscript. J.F.K. was supported by the National Institutes of Health under Ruth L. Kirschstein National Research Service Award (F31 NS055549-03) from the National Institute of Neurological Disorders and Stroke. Financial support was provided by a US National Institutes of Health Director's Pioneer Award and a Simons Foundation Grant to R.E.D.; the International Brain Research Organization Outstanding Research Fellowship and the Tashia and John Morgridge Endowed Fellowship to S.P.P.; a Japan Society of the Promotion for Science Postdoctoral Fellowship for Research Abroad and American Heart Association Western States to MY.; and a California Institute for Regenerative Medicine Postdoctoral Fellowship to O.S. We are grateful for funding from B. and F. Horowitz, M. McCafferey, B. and J. Packard, P. Kwan and K. Wang.	Aizawa H, 2004, SCIENCE, V303, P197, DOI 10.1126/science.1089845; Aresta S, 2002, BIOCHEM J, V367, P57, DOI 10.1042/BJ20020829; Bader PL, 2011, P NATL ACAD SCI USA, V108, P15432, DOI 10.1073/pnas.1112667108; Barrett CF, 2008, P NATL ACAD SCI USA, V105, P2157, DOI 10.1073/pnas.0710501105; Beguin P, 2005, J CELL SCI, V118, P1923, DOI 10.1242/jcs.02321; Beguin P, 2001, NATURE, V411, P701, DOI 10.1038/35079621; Beguin P, 2007, J BIOL CHEM, V282, P11509, DOI 10.1074/jbc.M606423200; Belmonte MK, 2006, NAT NEUROSCI, V9, P1221, DOI 10.1038/nn1765; Belmonte MK, 2004, J NEUROSCI, V24, P9228, DOI 10.1523/JNEUROSCI.3340-04.2004; Casanova MF, 2006, ACTA NEUROPATHOL, V112, P287, DOI 10.1007/s00401-006-0085-5; Catterall WA, 2000, ANNU REV CELL DEV BI, V16, P521, DOI 10.1146/annurev.cellbio.16.1.521; Cohen-Kutner M, 2010, CHANNELS, V4, P266, DOI 10.4161/chan.4.4.12130; Dolmetsch RE, 2001, SCIENCE, V294, P333, DOI 10.1126/science.1063395; Dolmetsch R, 2011, CELL, V145, P831, DOI 10.1016/j.cell.2011.05.034; Dolmetsch Ricardo, 2003, Sci STKE, V2003, pPE4; Fink CC, 2003, NEURON, V39, P283, DOI 10.1016/S0896-6273(03)00428-8; Finlin BS, 2006, J BIOL CHEM, V281, P23557, DOI 10.1074/jbc.M604867200; Finlin BS, 2005, J BIOL CHEM, V280, P41864, DOI 10.1074/jbc.M414261200; Geschwind DH, 2007, CURR OPIN NEUROBIOL, V17, P103, DOI 10.1016/j.conb.2007.01.009; HELL JW, 1993, J CELL BIOL, V123, P949, DOI 10.1083/jcb.123.4.949; Hoda JC, 2006, J NEUROCHEM, V96, P1648, DOI 10.1111/j.1471-4159.2006.03678.x; Kaufmann WE, 2000, CEREB CORTEX, V10, P981, DOI 10.1093/cercor/10.10.981; Kranenburg O, 1999, MOL BIOL CELL, V10, P1851, DOI 10.1091/mbc.10.6.1851; Lee TM, 2000, NEURON, V25, P307, DOI 10.1016/S0896-6273(00)80896-X; Lohmann C, 2002, NATURE, V418, P177, DOI 10.1038/nature00850; Lohmann C, 2005, CELL CALCIUM, V37, P403, DOI 10.1016/j.ceca.2005.01.008; Mahalakshmi RN, 2007, TRAFFIC, V8, P1164, DOI 10.1111/j.1600-0854.2007.00599.x; McAllister AK, 1996, NEURON, V17, P1057, DOI 10.1016/S0896-6273(00)80239-1; Nyegaard M, 2010, MOL PSYCHIATR, V15, P119, DOI 10.1038/mp.2009.69; Oyama F, 2004, J BIOL CHEM, V279, P27272, DOI 10.1074/jbc.M401634200; Parent L, 1995, BIOPHYS J, V69, P1801, DOI 10.1016/S0006-3495(95)80050-0; Pasca SP, 2011, NAT MED, V17, P1657, DOI 10.1038/nm.2576; Pravettoni E, 2000, DEV BIOL, V227, P581, DOI 10.1006/dbio.2000.9872; Redmond L, 2002, NEURON, V34, P999, DOI 10.1016/S0896-6273(02)00737-7; Richards MW, 2004, TRENDS PHARMACOL SCI, V25, P626, DOI 10.1016/j.tips.2004.10.008; Splawski I, 2004, CELL, V119, P19, DOI 10.1016/j.cell.2004.09.011; Splawski I, 2005, P NATL ACAD SCI USA, V102, P8089, DOI 10.1073/pnas.0502506102; Splawski I, 2006, J BIOL CHEM, V281, P22085, DOI 10.1074/jbc.M603316200; Swetman CA, 2002, EUR J IMMUNOL, V32, P2074, DOI 10.1002/1521-4141(200207)32:7<2074::AID-IMMU2074>3.0.CO;2-S; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; TANABE T, 1990, NATURE, V346, P567, DOI 10.1038/346567a0; Tonelli A, 2006, J NEUROL SCI, V241, P13, DOI 10.1016/j.jns.2005.10.007; Totsukawa G, 2000, J CELL BIOL, V150, P797, DOI 10.1083/jcb.150.4.797; Tottene A, 2002, P NATL ACAD SCI USA, V99, P13284, DOI 10.1073/pnas.192242399; Wang K, 2009, NATURE, V459, P528, DOI 10.1038/nature07999; Ward Y, 2002, J CELL BIOL, V157, P291, DOI 10.1083/jcb.200111026; Wiser O, 1999, P NATL ACAD SCI USA, V96, P248, DOI 10.1073/pnas.96.1.248; Wong ROL, 2002, NAT REV NEUROSCI, V3, P803, DOI 10.1038/nrn941; YANG J, 1993, NATURE, V366, P158, DOI 10.1038/366158a0; Yazawa M, 2011, NATURE, V471, P230, DOI 10.1038/nature09855	50	176	183	2	27	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	FEB	2013	16	2					201	209		10.1038/nn.3307	http://dx.doi.org/10.1038/nn.3307			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	080RE	23313911	Green Accepted			2022-12-28	WOS:000314260200017
J	Liu, S; Gu, Y; DeAngelis, GC; Angelaki, DE				Liu, Sheng; Gu, Yong; DeAngelis, Gregory C.; Angelaki, Dora E.			Choice-related activity and correlated noise in subcortical vestibular neurons	NATURE NEUROSCIENCE			English	Article							SUPERIOR TEMPORAL AREA; PRIMARY VISUAL-CORTEX; STEREOSCOPIC DEPTH-PERCEPTION; SUBJECTIVE SENSORY EXPERIENCE; HEADING PERCEPTION; CORTICAL AREA; PSYCHOPHYSICAL PERFORMANCE; INTERNEURONAL CORRELATIONS; DISPARITY DISCRIMINATION; CEREBELLAR NUCLEI	Functional links between neuronal activity and perception are studied by examining trial-by-trial correlations (choice probabilities) between neural responses and perceptual decisions. We addressed fundamental issues regarding the nature and origin of choice probabilities by recording from subcortical (brainstem and cerebellar) neurons in rhesus monkeys during a vestibular heading discrimination task. Subcortical neurons showed robust choice probabilities that exceeded those seen in cortex (area MSTd) under identical conditions. The greater choice probabilities of subcortical neurons could be predicted by a stronger dependence of correlated noise on tuning similarity, as revealed by population decoding. Significant choice probabilities were observed almost exclusively for neurons that responded selectively to translation, whereas neurons that represented net gravito-inertial acceleration did not show choice probabilities. These findings suggest that the emergence of choice probabilities in the vestibular system depends on a critical signal transformation that occurs in subcortical pathways to distinguish translation from orientation relative to gravity.	[Liu, Sheng; Gu, Yong; Angelaki, Dora E.] Washington Univ, Sch Med, Dept Neurobiol, St Louis, MO 63130 USA; [Liu, Sheng; Angelaki, Dora E.] Baylor Coll Med, Dept Neurosci, Houston, TX 77030 USA; [DeAngelis, Gregory C.] Univ Rochester, Dept Brain & Cognit Sci, Rochester, NY USA	Washington University (WUSTL); Baylor College of Medicine; University of Rochester	Angelaki, DE (corresponding author), Washington Univ, Sch Med, Dept Neurobiol, St Louis, MO 63130 USA.	angelaki@bcm.edu		Liu, Sheng/0000-0002-2497-8666; DeAngelis, Gregory/0000-0002-1635-1273	US National Institutes of Health [EY12814, DC04260];  [EY016178]; NATIONAL EYE INSTITUTE [R01EY016178, R01EY012814] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC004260] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported by grants from the US National Institutes of Health (EY12814 and DC04260). G. C. D. was supported by grant EY016178.	Angelaki DE, 2004, NATURE, V430, P560, DOI 10.1038/nature02754; Angelaki DE, 2008, ANNU REV NEUROSCI, V31, P125, DOI 10.1146/annurev.neuro.31.060407.125555; Averbeck BB, 2006, NAT REV NEUROSCI, V7, P358, DOI 10.1038/nrn1888; Britten KH, 1996, VISUAL NEUROSCI, V13, P87, DOI 10.1017/S095252380000715X; BRITTEN KH, 1992, J NEUROSCI, V12, P4745; CELEBRINI S, 1994, J NEUROSCI, V14, P4109; Chen AH, 2011, J NEUROSCI, V31, P12036, DOI 10.1523/JNEUROSCI.0395-11.2011; Chen AH, 2011, J NEUROSCI, V31, P3082, DOI 10.1523/JNEUROSCI.4476-10.2011; Cohen MR, 2008, NEURON, V60, P162, DOI 10.1016/j.neuron.2008.08.007; Cohen MR, 2011, NAT NEUROSCI, V14, P811, DOI 10.1038/nn.2842; Cohen MR, 2009, NAT NEUROSCI, V12, P1594, DOI 10.1038/nn.2439; Cohen MR, 2009, J NEUROSCI, V29, P6635, DOI 10.1523/JNEUROSCI.5179-08.2009; CORTES C, 1995, MACH LEARN, V20, P273, DOI 10.1023/A:1022627411411; de Lafuente V, 2005, NAT NEUROSCI, V8, P1698, DOI 10.1038/nn1587; de Lafuente V, 2006, P NATL ACAD SCI USA, V103, P14266, DOI 10.1073/pnas.0605826103; Dodd JV, 2001, J NEUROSCI, V21, P4809, DOI 10.1523/JNEUROSCI.21-13-04809.2001; Ecker AS, 2010, SCIENCE, V327, P584, DOI 10.1126/science.1179867; Fetsch CR, 2007, J NEUROSCI, V27, P700, DOI 10.1523/JNEUROSCI.3553-06.2007; GONZALORUIZ A, 1990, EXP BRAIN RES, V80, P600; Graf ABA, 2011, NAT NEUROSCI, V14, P239, DOI 10.1038/nn.2733; Green AM, 2005, J NEURAL ENG, V2, DOI 10.1088/1741-2560/2/3/S02; Gu Y, 2006, J NEUROSCI, V26, P73, DOI 10.1523/JNEUROSCI.2356-05.2006; Gu Y, 2008, NAT NEUROSCI, V11, P1201, DOI 10.1038/nn.2191; Gu Y, 2007, NAT NEUROSCI, V10, P1038, DOI 10.1038/nn1935; Gu Y, 2011, NEURON, V71, P750, DOI 10.1016/j.neuron.2011.06.015; Gu Y, 2010, NEURON, V66, P596, DOI 10.1016/j.neuron.2010.04.026; Huang X, 2009, J NEUROPHYSIOL, V101, P3012, DOI 10.1152/jn.00010.2009; Jazayeri M, 2006, NAT NEUROSCI, V9, P690, DOI 10.1038/nn1691; Kohn A, 2005, J NEUROSCI, V25, P3661, DOI 10.1523/JNEUROSCI.5106-04.2005; Krug K, 2004, PHILOS T R SOC B, V359, P929, DOI 10.1098/rstb.2003.1415; Krug K, 2011, J NEUROSCI, V31, P17892, DOI 10.1523/JNEUROSCI.2658-11.2011; Liu J, 2005, J NEUROSCI, V25, P711, DOI 10.1523/JNEUROSCI.4034-04.2005; Liu S, 2010, J NEUROSCI, V30, P439, DOI 10.1523/JNEUROSCI.3192-09.2010; Liu S, 2009, J NEUROSCI, V29, P8936, DOI 10.1523/JNEUROSCI.1607-09.2009; Meng H, 2005, J NEUROPHYSIOL, V93, P3418, DOI 10.1152/jn.01259.2004; Meng H, 2007, J NEUROSCI, V27, P13590, DOI 10.1523/JNEUROSCI.3931-07.2007; Meng H, 2010, J NEUROPHYSIOL, V103, P817, DOI 10.1152/jn.00729.2009; Newlands SD, 2003, BRAIN RES BULL, V60, P475, DOI 10.1016/S0361-9230(03)00051-0; Nienborg H, 2007, NAT NEUROSCI, V10, P1608, DOI 10.1038/nn1991; Nienborg H, 2006, J NEUROSCI, V26, P9567, DOI 10.1523/JNEUROSCI.2256-06.2006; Nienborg H, 2010, CURR OPIN NEUROBIOL, V20, P376, DOI 10.1016/j.conb.2010.05.002; Nienborg H, 2009, NATURE, V459, P89, DOI 10.1038/nature07821; Prince SJD, 2000, J NEUROSCI, V20, P3387, DOI 10.1523/JNEUROSCI.20-09-03387.2000; Purushothaman G, 2005, NAT NEUROSCI, V8, P99, DOI 10.1038/nn1373; Ron K., 1995, P 14 INT JOINT C ART, V2, P1137; Sanger TD, 1996, J NEUROPHYSIOL, V76, P2790, DOI 10.1152/jn.1996.76.4.2790; Shadlen MN, 1996, J NEUROSCI, V16, P1486; Shaikh AG, 2005, J NEUROPHYSIOL, V93, P853, DOI 10.1152/jn.00879.2004; Smith MA, 2008, J NEUROSCI, V28, P12591, DOI 10.1523/JNEUROSCI.2929-08.2008; Uka T, 2005, J NEUROSCI, V25, P10796, DOI 10.1523/JNEUROSCI.1637-05.2005; Uka T, 2004, NEURON, V42, P297, DOI 10.1016/S0896-6273(04)00186-2; Uka T, 2006, J NEUROSCI, V26, P6791, DOI 10.1523/JNEUROSCI.5435-05.2006; Vapnik V.N., 1995, NATURE STAT LEARNING; WYLIE DR, 1994, J COMP NEUROL, V349, P448, DOI 10.1002/cne.903490309; Yakusheva TA, 2007, NEURON, V54, P973, DOI 10.1016/j.neuron.2007.06.003; ZOHARY E, 1994, NATURE, V370, P140, DOI 10.1038/370140a0	56	53	53	0	18	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JAN	2013	16	1					89	U131		10.1038/nn.3267	http://dx.doi.org/10.1038/nn.3267			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	058KZ	23178975	Green Accepted			2022-12-28	WOS:000312633900017
J	Gu, Y; Arruda-Carvalho, M; Wang, J; Janoschka, SR; Josselyn, SA; Frankland, PW; Ge, SY				Gu, Yan; Arruda-Carvalho, Maithe; Wang, Jia; Janoschka, Stephen R.; Josselyn, Sheena A.; Frankland, Paul W.; Ge, Shaoyu			Optical controlling reveals time-dependent roles for adult-born dentate granule cells	NATURE NEUROSCIENCE			English	Article							ENHANCED SYNAPTIC PLASTICITY; NEWLY GENERATED NEURONS; HIPPOCAMPAL NEUROGENESIS; CRITICAL PERIOD; T-TYPE; PATTERN SEPARATION; GYRUS; INVOLVEMENT; INTEGRATION; RESPONSES	Accumulating evidence suggests that global depletion of adult hippocampal neurogenesis influences its function and that the timing of the depletion affects the deficits. However, the behavioral roles of adult-born neurons during their establishment of projections to CA3 pyramidal neurons remain largely unknown. We used a combination of retroviral and optogenetic approaches to birth date and reversibly control a group of adult-born neurons in adult mice. Adult-born neurons formed functional synapses on CA3 pyramidal neurons as early as 2 weeks after birth, and this projection to the CA3 area became stable by 4 weeks in age. Newborn neurons at this age were more plastic than neurons at other stages. Notably, we found that reversibly silencing this cohort of similar to 4-week-old cells after training, but not cells of other ages, substantially disrupted retrieval of hippocampal memory. Our results identify a restricted time window for adult-born neurons essential in hippocampal memory retrieval.	[Gu, Yan; Wang, Jia; Janoschka, Stephen R.; Ge, Shaoyu] SUNY Stony Brook, Dept Neurobiol & Behav, Stony Brook, NY 11794 USA; [Arruda-Carvalho, Maithe; Josselyn, Sheena A.; Frankland, Paul W.] Hosp Sick Children, Program Neurosci & Mental Hlth, Toronto, ON M5G 1X8, Canada; [Arruda-Carvalho, Maithe; Josselyn, Sheena A.; Frankland, Paul W.] Univ Toronto, Inst Med Sci, Toronto, ON M5S 1A1, Canada; [Janoschka, Stephen R.; Ge, Shaoyu] SUNY Stony Brook, Program Neurosci, Stony Brook, NY 11794 USA; [Josselyn, Sheena A.; Frankland, Paul W.] Univ Toronto, Dept Physiol, Toronto, ON, Canada	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; University of Toronto	Ge, SY (corresponding author), SUNY Stony Brook, Dept Neurobiol & Behav, Stony Brook, NY 11794 USA.	paul.frankland@sickkids.ca; sge@notes.cc.sunysb.edu	Carvalho, Maithe Arruda/AAW-2490-2021; Gu, Yan/K-4702-2017	Gu, Yan/0000-0001-5562-6279; Arruda-Carvalho, Maithe/0000-0002-7832-3729	US National Institutes of Health [NS065915]; American Heart Association [0930067N]; Feldstein Medical Foundation; State University of New York Research Excellence in Academic Health; Canadian Institutes of Health Research [MOP86762, MOP74650]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS065915] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); Feldstein Medical Foundation; State University of New York Research Excellence in Academic Health; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank J. Bischofberger, G. Matthews, L. Role and H. Song for their critical comments, and Q. Xiong and J. Tucciarone for technical support. We thank the members of F. Gage's laboratory for sharing their behavioral protocols. This work was supported by US National Institutes of Health (NS065915), American Heart Association (0930067N), Feldstein Medical Foundation and State University of New York Research Excellence in Academic Health grants to S. G. and Canadian Institutes of Health Research grants to P. W. F. (MOP86762) and S. A. J. (MOP74650).	Aimone JB, 2011, NEURON, V70, P589, DOI 10.1016/j.neuron.2011.05.010; Alle H, 2006, SCIENCE, V311, P1290, DOI 10.1126/science.1119055; Arruda-Carvalho M, 2011, J NEUROSCI, V31, P15113, DOI 10.1523/JNEUROSCI.3432-11.2011; Bergquist F, 2003, NEUROSCIENCE, V120, P757, DOI 10.1016/S0306-4522(03)00385-3; BEZPROZVANNY L, 1995, MOL PHARMACOL, V48, P540; Cameron HA, 2001, J COMP NEUROL, V435, P406, DOI 10.1002/cne.1040; Chow BY, 2010, NATURE, V463, P98, DOI 10.1038/nature08652; Deng W, 2010, NAT REV NEUROSCI, V11, P339, DOI 10.1038/nrn2822; Drew MR, 2010, BEHAV NEUROSCI, V124, P446, DOI 10.1037/a0020081; Esposito MS, 2005, J NEUROSCI, V25, P10074, DOI 10.1523/JNEUROSCI.3114-05.2005; Faulkner RL, 2008, P NATL ACAD SCI USA, V105, P14157, DOI 10.1073/pnas.0806658105; Ge SY, 2008, J PHYSIOL-LONDON, V586, P3759, DOI 10.1113/jphysiol.2008.155655; Ge SY, 2007, NEURON, V54, P559, DOI 10.1016/j.neuron.2007.05.002; Ge SY, 2006, NATURE, V439, P589, DOI 10.1038/nature04404; Gunaydin LA, 2010, NAT NEUROSCI, V13, P387, DOI 10.1038/nn.2495; Hastings NB, 2002, J COMP NEUROL, V452, P324, DOI 10.1002/cne.10386; Kee N, 2007, NAT NEUROSCI, V10, P355, DOI 10.1038/nn1847; Kempermann G, 2002, ANN NEUROL, V52, P135, DOI 10.1002/ana.10262; Kerr AM, 2008, NEURON, V57, P5, DOI 10.1016/j.neuron.2007.12.015; KIM JJ, 1992, SCIENCE, V256, P675, DOI 10.1126/science.1585183; Kim WR, 2012, BEHAV BRAIN RES, V227, P470, DOI 10.1016/j.bbr.2011.07.012; Lin JY, 2009, BIOPHYS J, V96, P1803, DOI 10.1016/j.bpj.2008.11.034; Marin-Burgin A, 2012, SCIENCE, V335, P1238, DOI 10.1126/science.1214956; Ming GL, 2011, NEURON, V70, P687, DOI 10.1016/j.neuron.2011.05.001; MORRIS RGM, 1982, NATURE, V297, P681, DOI 10.1038/297681a0; Nagel G, 2003, P NATL ACAD SCI USA, V100, P13940, DOI 10.1073/pnas.1936192100; Nakashiba T, 2012, CELL, V149, P188, DOI 10.1016/j.cell.2012.01.046; Nicoll RA, 2005, NAT REV NEUROSCI, V6, P863, DOI 10.1038/nrn1786; Randall AD, 1997, NEUROPHARMACOLOGY, V36, P879, DOI 10.1016/S0028-3908(97)00086-5; Sahay A, 2011, NEURON, V70, P582, DOI 10.1016/j.neuron.2011.05.012; Sahay A, 2011, NATURE, V472, P466, DOI 10.1038/nature09817; Schmidt-Hieber C, 2004, NATURE, V429, P184, DOI 10.1038/nature02553; Snyder JS, 2011, NATURE, V476, P458, DOI 10.1038/nature10287; Snyder JS, 2001, J NEUROPHYSIOL, V85, P2423, DOI 10.1152/jn.2001.85.6.2423; Tashiro A, 2007, J NEUROSCI, V27, P3252, DOI 10.1523/JNEUROSCI.4941-06.2007; Teixeira CM, 2006, J NEUROSCI, V26, P7555, DOI 10.1523/JNEUROSCI.1068-06.2006; Toni N, 2008, NAT NEUROSCI, V11, P901, DOI 10.1038/nn.2156; van Praag H, 2002, NATURE, V415, P1030, DOI 10.1038/4151030a; Wadiche LO, 2005, J NEUROPHYSIOL, V94, P4528, DOI 10.1152/jn.00633.2005; Yoshimura Y, 2008, EUR J NEUROSCI, V28, P730, DOI 10.1111/j.1460-9568.2008.06384.x; Zhang F, 2007, NATURE, V446, P633, DOI 10.1038/nature05744; Zhao CM, 2006, J NEUROSCI, V26, P3, DOI 10.1523/JNEUROSCI.3648-05.2006	42	278	284	1	43	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	DEC	2012	15	12					1700	+		10.1038/nn.3260	http://dx.doi.org/10.1038/nn.3260			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	045OR	23143513	Green Accepted			2022-12-28	WOS:000311706700016
J	Shanechi, MM; Hu, RC; Powers, M; Wornell, GW; Brown, EN; Williams, ZM				Shanechi, Maryam M.; Hu, Rollin C.; Powers, Marissa; Wornell, Gregory W.; Brown, Emery N.; Williams, Ziv M.			Neural population partitioning and a concurrent brain-machine interface for sequential motor function	NATURE NEUROSCIENCE			English	Article							DORSAL PREMOTOR CORTEX; PREFRONTAL CORTEX; NEURONAL-ACTIVITY; TEMPORAL ORGANIZATION; CORTICAL CONTROL; SPIKING ACTIVITY; MOVEMENT; SUPPLEMENTARY; MONKEY; AREAS	Although brain-machine interfaces (BMIs) have focused largely on performing single-targeted movements, many natural tasks involve planning a complete sequence of such movements before execution. For these tasks, a BMI that can concurrently decode the full planned sequence before its execution may also consider the higher-level goal of the task to reformulate and perform it more effectively. Using population-wide modeling, we discovered two distinct subpopulations of neurons in the rhesus monkey premotor cortex that allow two planned targets of a sequential movement to be simultaneously held in working memory without degradation. Such marked stability occurred because each subpopulation encoded either only currently held or only newly added target information irrespective of the exact sequence. On the basis of these findings, we developed a BMI that concurrently decodes a full motor sequence in advance of movement and can then accurately execute it as desired.	[Shanechi, Maryam M.; Hu, Rollin C.; Powers, Marissa; Williams, Ziv M.] Massachusetts Gen Hosp, Dept Neurosurg, Boston, MA 02114 USA; [Shanechi, Maryam M.; Wornell, Gregory W.] MIT, Dept Elect Engn & Comp Sci, Cambridge, MA 02139 USA; [Shanechi, Maryam M.; Hu, Rollin C.; Brown, Emery N.; Williams, Ziv M.] Harvard Univ, Sch Med, Boston, MA USA; [Brown, Emery N.] MIT, Dept Brain & Cognit Sci, Cambridge, MA 02139 USA; [Brown, Emery N.] Massachusetts Gen Hosp, Dept Anesthesia Crit Care & Pain Med, Boston, MA 02114 USA; [Brown, Emery N.] MIT, Inst Med Engn & Sci, Cambridge, MA 02139 USA; [Brown, Emery N.] MIT, Harvard MIT Hlth Sci & Technol Program, Cambridge, MA 02139 USA	Harvard University; Massachusetts General Hospital; Massachusetts Institute of Technology (MIT); Harvard University; Harvard Medical School; Massachusetts Institute of Technology (MIT); Harvard University; Massachusetts General Hospital; Massachusetts Institute of Technology (MIT); Harvard University; Massachusetts Institute of Technology (MIT)	Williams, ZM (corresponding author), Massachusetts Gen Hosp, Dept Neurosurg, Boston, MA 02114 USA.	zwilliams@partners.org			Neuroscience Research and Education Foundation; US National Institutes of Health (NIH) [DP1 OD003646]; NIH [5R01-HD059852]; Whitehall Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD059852] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD003646] Funding Source: NIH RePORTER	Neuroscience Research and Education Foundation; US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Whitehall Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	R.C.H. is funded by the Neuroscience Research and Education Foundation, E.N.B. is funded by US National Institutes of Health (NIH) DP1 OD003646, and Z.M.W. is funded by NIH 5R01-HD059852, a Presidential Early Career Award for Scientists and Engineers and the Whitehall Foundation.	Averbeck BB, 2002, P NATL ACAD SCI USA, V99, P13172, DOI 10.1073/pnas.162485599; Averbeck BB, 2006, NAT NEUROSCI, V9, P276, DOI 10.1038/nn1634; Baldauf D, 2008, J NEUROSCI, V28, P10081, DOI 10.1523/JNEUROSCI.3423-08.2008; Batista AP, 2001, J NEUROPHYSIOL, V85, P539, DOI 10.1152/jn.2001.85.2.539; Boussaoud D, 1999, EXP BRAIN RES, V128, P170, DOI 10.1007/s002210050832; Brown EN, 2004, MATH COMP BIOL SER, P253; Carmena JM, 2003, PLOS BIOL, V1, P193, DOI 10.1371/journal.pbio.0000042; Chapin JK, 1999, NAT NEUROSCI, V2, P664, DOI 10.1038/10223; Chase SM, 2009, NEURAL NETWORKS, V22, P1203, DOI 10.1016/j.neunet.2009.05.005; Cisek P, 2005, NEURON, V45, P801, DOI 10.1016/j.neuron.2005.01.027; Crammond DJ, 2000, J NEUROPHYSIOL, V84, P986, DOI 10.1152/jn.2000.84.2.986; Crammond DJ, 1996, EXP BRAIN RES, V108, P45; CRAMMOND DJ, 1994, J NEUROPHYSIOL, V71, P1281, DOI 10.1152/jn.1994.71.3.1281; Crutcher MD, 2004, EXP BRAIN RES, V158, P278, DOI 10.1007/s00221-004-1895-0; DEMPSTER AP, 1977, J ROY STAT SOC B MET, V39, P1, DOI 10.1111/j.2517-6161.1977.tb01600.x; Ganguly K, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000153; GOODMAN LA, 1960, J AM STAT ASSOC, V55, P708, DOI 10.2307/2281592; Hochberg LR, 2006, NATURE, V442, P164, DOI 10.1038/nature04970; HOCHERMAN S, 1991, EXP BRAIN RES, V83, P285; Hoshi E, 2000, NATURE, V408, P466, DOI 10.1038/35044075; Hoshi E, 2002, J NEUROPHYSIOL, V87, P1123, DOI 10.1152/jn.00496.2001; Hoshi E, 2006, J NEUROPHYSIOL, V95, P3596, DOI 10.1152/jn.01126.2005; Kettner RE, 1996, EXP BRAIN RES, V112, P347, DOI 10.1007/BF00227941; Kim SP, 2008, J NEURAL ENG, V5, P455, DOI 10.1088/1741-2560/5/4/010; KURATA K, 1993, J NEUROPHYSIOL, V69, P187, DOI 10.1152/jn.1993.69.1.187; Li Z, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006243; Lu XF, 2005, NEURON, V45, P967, DOI 10.1016/j.neuron.2005.01.036; Messier J, 2000, J NEUROPHYSIOL, V84, P152, DOI 10.1152/jn.2000.84.1.152; Moritz CT, 2008, NATURE, V456, P639, DOI 10.1038/nature07418; Mulliken GH, 2008, J NEUROSCI, V28, P12913, DOI 10.1523/JNEUROSCI.1463-08.2008; Musallam S, 2004, SCIENCE, V305, P258, DOI 10.1126/science.1097938; MUSHIAKE H, 1990, EXP BRAIN RES, V82, P208; Mushiake H, 2006, NEURON, V50, P631, DOI 10.1016/j.neuron.2006.03.045; Nakajima T, 2009, J NEUROPHYSIOL, V101, P1883, DOI 10.1152/jn.90636.2008; Ninokura Y, 2003, J NEUROPHYSIOL, V89, P2868, DOI 10.1152/jn.00647.2002; Ohbayashi M, 2003, SCIENCE, V301, P233, DOI 10.1126/science.1084884; Saito N, 2005, CEREB CORTEX, V15, P1535, DOI 10.1093/cercor/bhi032; Santhanam G, 2006, NATURE, V442, P195, DOI 10.1038/nature04968; Serruya MD, 2002, NATURE, V416, P141, DOI 10.1038/416141a; Shanechi MM, 2013, IEEE T NEUR SYS REH, V21, P129, DOI 10.1109/TNSRE.2012.2221743; Shanechi MM, 2011, COMPUTATIONAL SYSTEM; Shima K, 1998, J NEUROPHYSIOL, V80, P3247, DOI 10.1152/jn.1998.80.6.3247; Shima K, 2000, J NEUROPHYSIOL, V84, P2148, DOI 10.1152/jn.2000.84.4.2148; Shima K, 2007, NATURE, V445, P315, DOI 10.1038/nature05470; Smith Anne C., 2010, Computational Intelligence & Neuroscience, DOI 10.1155/2010/426539; Smith AC, 2003, NEURAL COMPUT, V15, P965, DOI 10.1162/089976603765202622; TANJI J, 1994, NATURE, V371, P413, DOI 10.1038/371413a0; Tanji J, 2001, ANNU REV NEUROSCI, V24, P631, DOI 10.1146/annurev.neuro.24.1.631; Taylor DM, 2002, SCIENCE, V296, P1829, DOI 10.1126/science.1070291; Truccolo W, 2005, J NEUROPHYSIOL, V93, P1074, DOI 10.1152/jn.00697.2004; Velliste M, 2008, NATURE, V453, P1098, DOI 10.1038/nature06996; Wessberg J, 2000, NATURE, V408, P361, DOI 10.1038/35042582; Wolpaw JR, 2004, P NATL ACAD SCI USA, V101, P17849, DOI 10.1073/pnas.0403504101	53	50	50	0	17	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	DEC	2012	15	12					1715	+		10.1038/nn.3250	http://dx.doi.org/10.1038/nn.3250			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	045OR	23143511	Green Accepted, Green Submitted			2022-12-28	WOS:000311706700018
J	Bendor, D; Wilson, MA				Bendor, Daniel; Wilson, Matthew A.			Biasing the content of hippocampal replay during sleep	NATURE NEUROSCIENCE			English	Article							PLACE CELLS; MEMORY; REACTIVATION; SEQUENCES; RIPPLES	The hippocampus is essential for encoding self-experienced events into memory. During sleep, neural activity in the hippocampus related to a recent experience has been observed to spontaneously reoccur, and this 'replay' has been postulated to be important for memory consolidation. Task-related cues can enhance memory consolidation when presented during a post-training sleep session, and, if memories are consolidated by hippocampal replay, a specific enhancement for this replay should be observed. To test this, we trained rats on an auditory-spatial association task while recording from neuronal ensembles in the hippocampus. We found that, during sleep, a task-related auditory cue biased reactivation events toward replaying the spatial memory associated with that cue. These results indicate that sleep replay can be manipulated by external stimulation and provide further evidence for the role of hippocampal replay in memory consolidation.	[Bendor, Daniel; Wilson, Matthew A.] MIT, Dept Brain & Cognit Sci, Picower Inst Learning & Memory, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Northwell Health	Bendor, D (corresponding author), MIT, Dept Brain & Cognit Sci, Picower Inst Learning & Memory, E25-618, Cambridge, MA 02139 USA.	dbendor@mit.edu		Bendor, Daniel/0000-0001-6621-793X	Merck Award/Helen Hay Whitney Postdoctoral Fellowship; Charles King Trust Postdoctoral Fellowship; US National Institutes of Health grants [1-K99-DC012321-01, 5R01MH061976]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH061976] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [K99DC012321] Funding Source: NIH RePORTER	Merck Award/Helen Hay Whitney Postdoctoral Fellowship; Charles King Trust Postdoctoral Fellowship; US National Institutes of Health grants(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	We thank M. Fee, H. Tanila and members of the Wilson laboratory for their helpful comments and suggestions. We would also like to thank C. Varela, J. Yamamoto, J. Siegle, E. Kuo, A. Hussain and E. Molina for technical assistance. This work was supported by a Merck Award/Helen Hay Whitney Postdoctoral Fellowship (D.B.), a Charles King Trust Postdoctoral Fellowship (D.B.), US National Institutes of Health grants 1-K99-DC012321-01 (D.B.) and 5R01MH061976 (M.A.W.).	Antony JW, 2012, NAT NEUROSCI, V15, P1114, DOI 10.1038/nn.3152; Davidson TJ, 2009, NEURON, V63, P497, DOI 10.1016/j.neuron.2009.07.027; Diba K, 2007, NAT NEUROSCI, V10, P1241, DOI 10.1038/nn1961; Diekelmann S, 2011, NAT NEUROSCI, V14, P381, DOI 10.1038/nn.2744; Dupret D, 2010, NAT NEUROSCI, V13, P995, DOI 10.1038/nn.2599; Ego-Stengel V, 2010, HIPPOCAMPUS, V20, P1, DOI 10.1002/hipo.20707; Foster DJ, 2006, NATURE, V440, P680, DOI 10.1038/nature04587; Girardeau G, 2009, NAT NEUROSCI, V12, P1222, DOI 10.1038/nn.2384; Issa EB, 2008, J NEUROSCI, V28, P14467, DOI 10.1523/JNEUROSCI.3086-08.2008; Itskov PM, 2012, J NEUROPHYSIOL, V107, P1822, DOI 10.1152/jn.00404.2011; Ji DY, 2007, NAT NEUROSCI, V10, P100, DOI 10.1038/nn1825; Kali S, 2004, NAT NEUROSCI, V7, P286, DOI 10.1038/nn1202; Karlsson MP, 2009, NAT NEUROSCI, V12, P913, DOI 10.1038/nn.2344; Lee AK, 2002, NEURON, V36, P1183, DOI 10.1016/S0896-6273(02)01096-6; Lesburgueres E, 2011, SCIENCE, V331, P924, DOI 10.1126/science.1196164; Louie K, 2001, NEURON, V29, P145, DOI 10.1016/S0896-6273(01)00186-6; Marshall L, 2006, NATURE, V444, P610, DOI 10.1038/nature05278; Marshall U, 2007, TRENDS COGN SCI, V11, P442, DOI 10.1016/j.tics.2007.09.001; Moser EI, 2008, ANNU REV NEUROSCI, V31, P69, DOI 10.1146/annurev.neuro.31.061307.090723; OKEEFE J, 1971, BRAIN RES, V34, P171, DOI 10.1016/0006-8993(71)90358-1; Peigneux P, 2004, NEURON, V44, P535, DOI 10.1016/j.neuron.2004.10.007; Plihal W, 1999, PSYCHOPHYSIOLOGY, V36, P571, DOI 10.1111/1469-8986.3650571; Rasch B, 2007, SCIENCE, V315, P1426, DOI 10.1126/science.1138581; Rudoy JD, 2009, SCIENCE, V326, P1079, DOI 10.1126/science.1179013; Schabus Manuel, 2012, Front Neurol, V3, P40, DOI 10.3389/fneur.2012.00040; Siapas AG, 1998, NEURON, V21, P1123, DOI 10.1016/S0896-6273(00)80629-7; Sirota A, 2003, P NATL ACAD SCI USA, V100, P2065, DOI 10.1073/pnas.0437938100; SQUIRE LR, 1992, PSYCHOL REV, V99, P195, DOI 10.1037/0033-295X.99.2.195; Tahvildari B, 2007, HIPPOCAMPUS, V17, P257, DOI 10.1002/hipo.20270; Walker MP, 2004, NEURON, V44, P121, DOI 10.1016/j.neuron.2004.08.031; Wierzynski CM, 2009, NEURON, V61, P587, DOI 10.1016/j.neuron.2009.01.011; WILSON MA, 1994, SCIENCE, V265, P676, DOI 10.1126/science.8036517; Zhang KC, 1998, J NEUROPHYSIOL, V79, P1017, DOI 10.1152/jn.1998.79.2.1017	33	198	208	0	64	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	OCT	2012	15	10					1439	1444		10.1038/nn.3203	http://dx.doi.org/10.1038/nn.3203			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	013VZ	22941111	Green Accepted, Green Submitted			2022-12-28	WOS:000309335300025
J	Hillman, KL; Bilkey, DK				Hillman, Kristin L.; Bilkey, David K.			Neural encoding of competitive effort in the anterior cingulate cortex	NATURE NEUROSCIENCE			English	Article							MEDIAL FRONTAL-CORTEX; PREFRONTAL CORTEX; DECISION-MAKING; SOCIAL-BEHAVIOR; COST-BENEFIT; DISTURBANCES; VALUATION; SELECTION; DISTINCT; NEURONS	In social environments, animals often compete to obtain limited resources. Strategically electing to work against another animal represents a cost-benefit decision. Is the resource worth an investment of competitive effort? The anterior cingulate cortex (ACC) has been implicated in cost-benefit decision-making, but its role in competitive effort has not been examined. We recorded ACC neurons in freely moving rats as they performed a competitive foraging choice task. When at least one of the two choice options demanded competitive effort, the majority of ACC neurons exhibited heightened and differential firing between the goal trajectories. Inter-and intrasession manipulations revealed that differential firing was not attributable to effort or reward in isolation; instead ACC encoding patterns appeared to indicate net utility assessments of available choice options. Our findings suggest that the ACC is important for encoding competitive effort, a cost-benefit domain that has received little neural-level investigation despite its predominance in nature.	[Hillman, Kristin L.; Bilkey, David K.] Univ Otago, Dept Psychol, Dunedin, New Zealand	University of Otago	Hillman, KL (corresponding author), Univ Otago, Dept Psychol, Dunedin, New Zealand.	khillman@psy.otago.ac.nz		Hillman, Kristin/0000-0002-8541-0134	Marsden Fund	Marsden Fund(Royal Society of New ZealandMarsden Fund (NZ))	Funding was provided by the Marsden Fund.	ALCOCK J, 1994, ETHOLOGY, V96, P58, DOI 10.1111/j.1439-0310.1994.tb00881.x; Alexander WH, 2011, NAT NEUROSCI, V14, P1338, DOI 10.1038/nn.2921; Amiez C, 2006, CEREB CORTEX, V16, P1040, DOI 10.1093/cercor/bhj046; Amodio DM, 2006, NAT REV NEUROSCI, V7, P268, DOI 10.1038/nrn1884; Archer J., 1988, BEHAV BIOL AGGRESSIO, DOI DOI 10.1046/J.1420-9101.1991.4030515.X; Barrash J, 2000, DEV NEUROPSYCHOL, V18, P355, DOI 10.1207/S1532694205Barrash; Behrens TEJ, 2007, NAT NEUROSCI, V10, P1214, DOI 10.1038/nn1954; Croxson PL, 2009, J NEUROSCI, V29, P4531, DOI 10.1523/JNEUROSCI.4515-08.2009; Danchin E., 2008, BEHAV ECOLOGY; DEVINSKY O, 1995, BRAIN, V118, P279, DOI 10.1093/brain/118.1.279; Forstmann BU, 2006, J COGNITIVE NEUROSCI, V18, P388, DOI 10.1162/089892906775990589; Frith CD, 1999, SCIENCE, V286, P1692, DOI 10.1126/science.286.5445.1692; FRITH CD, 1991, P ROY SOC B-BIOL SCI, V244, P241, DOI 10.1098/rspb.1991.0077; Gemmell C, 2002, BEHAV BRAIN RES, V133, P1; Hadland KA, 2003, NEUROPSYCHOLOGIA, V41, P919, DOI 10.1016/S0028-3932(02)00325-1; Hayden BY, 2011, NAT NEUROSCI, V14, P933, DOI 10.1038/nn.2856; Hillman KL, 2010, J NEUROSCI, V30, P7705, DOI 10.1523/JNEUROSCI.1273-10.2010; Hull C., 1943, PRINCIPLES BEHAV; Jung MW, 1998, CEREB CORTEX, V8, P437, DOI 10.1093/cercor/8.5.437; Kennerley SW, 2006, NAT NEUROSCI, V9, P940, DOI 10.1038/nn1724; Kennerley SW, 2009, J COGNITIVE NEUROSCI, V21, P1162, DOI 10.1162/jocn.2009.21100; Lapish CC, 2008, P NATL ACAD SCI USA, V105, P11963, DOI 10.1073/pnas.0804045105; Lavretsky H, 2007, AM J GERIAT PSYCHIAT, V15, P386, DOI 10.1097/JGP.0b013e3180325a16; LOONEY TA, 1982, NEUROSCI BIOBEHAV R, V6, P15, DOI 10.1016/0149-7634(82)90004-5; Mars RB, 2005, NEUROIMAGE, V28, P1007, DOI 10.1016/j.neuroimage.2005.06.041; Marsh R, 2009, AM J PSYCHIAT, V166, P664, DOI 10.1176/appi.ajp.2009.08091354; Matsumoto K, 2003, SCIENCE, V301, P229, DOI 10.1126/science.1084204; Matsumoto M, 2007, NAT NEUROSCI, V10, P647, DOI 10.1038/nn1890; Mayberg HS, 2005, NEURON, V45, P651, DOI 10.1016/j.neuron.2005.02.014; Naccache L, 2005, NEUROPSYCHOLOGIA, V43, P1318, DOI 10.1016/j.neuropsychologia.2004.11.024; Procyk E, 2000, NAT NEUROSCI, V3, P502, DOI 10.1038/74880; Quilodran R, 2008, NEURON, V57, P314, DOI 10.1016/j.neuron.2007.11.031; RAICHLE ME, 1994, CEREB CORTEX, V4, P8, DOI 10.1093/cercor/4.1.8; Rilling JK, 2002, NEURON, V35, P395, DOI 10.1016/S0896-6273(02)00755-9; Rilling JK, 2004, NEUROIMAGE, V22, P1694, DOI 10.1016/j.neuroimage.2004.04.015; Rudebeck PH, 2006, SCIENCE, V313, P1310, DOI 10.1126/science.1128197; Rudebeck PH, 2007, EUR J NEUROSCI, V26, P2315, DOI 10.1111/j.1460-9568.2007.05844.x; Sallet J, 2007, COGN AFFECT BEHAV NE, V7, P327, DOI 10.3758/CABN.7.4.327; Schweimer J, 2005, BEHAV NEUROSCI, V119, P1687, DOI 10.1037/0735-7044.119.6.1687; SCOTT JP, 1951, PHYSIOL ZOOL, V24, P273, DOI 10.1086/physzool.24.4.30152137; Seo H, 2007, J NEUROSCI, V27, P8366, DOI 10.1523/JNEUROSCI.2369-07.2007; Shidara M, 2002, SCIENCE, V296, P1709, DOI 10.1126/science.1069504; SMITH JM, 1973, NATURE, V246, P15, DOI 10.1038/246015a0; Stephens D.W., 1986, pi; Tomlin D, 2006, SCIENCE, V312, P1047, DOI 10.1126/science.1125596; Torrance G W, 1989, Int J Technol Assess Health Care, V5, P559; Walton ME, 2004, NAT NEUROSCI, V7, P1259, DOI 10.1038/nn1339; Walton ME, 2003, J NEUROSCI, V23, P6475; Yoshida W, 2006, NEURON, V50, P781, DOI 10.1016/j.neuron.2006.05.006	50	76	78	0	19	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	SEP	2012	15	9					1290	U161		10.1038/nn.3187	http://dx.doi.org/10.1038/nn.3187			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	996GJ	22885851				2022-12-28	WOS:000308072600020
J	Ousman, SS; Kubes, P				Ousman, Shalina S.; Kubes, Paul			Immune surveillance in the central nervous system	NATURE NEUROSCIENCE			English	Review							WEST-NILE-VIRUS; BLOOD-BRAIN-BARRIER; T-CELL TRAFFICKING; MHC CLASS-II; DENDRITIC CELLS; CEREBROSPINAL-FLUID; CHOROID-PLEXUS; MICROGLIAL CELLS; BONE-MARROW; PERIVASCULAR CELLS	The CNS, which consists of the brain and spinal cord, is continuously monitored by resident microglia and blood-borne immune cells such as macrophages, dendritic cells and T cells to detect for damaging agents that would disrupt homeostasis and optimal functioning of these vital organs. Further, the CNS must balance between vigilantly detecting for potentially harmful factors and resolving any immunological responses that in themselves can create damage if left unabated. We discuss the physiological roles of the immune sentinels that patrol the CNS, the molecular markers that underlie their surveillance duties, and the consequences of interrupting their functions following injury and infection by viruses such as JC virus, human immunodeficiency virus, herpes simplex virus and West Nile virus.	[Kubes, Paul] Univ Calgary, Dept Crit Care Med, Calgary, AB, Canada; [Kubes, Paul] Univ Calgary, Dept Physiol & Pharmacol, Calgary, AB, Canada; [Kubes, Paul] Univ Calgary, Snyder Inst Chron Dis, Calgary, AB, Canada; [Ousman, Shalina S.] Univ Calgary, Dept Clin Neurol Sci, Calgary, AB, Canada; [Ousman, Shalina S.] Univ Calgary, Dept Cell Biol & Anat, Calgary, AB, Canada; [Ousman, Shalina S.] Univ Calgary, Hotchkiss Brain Inst, Calgary, AB, Canada	University of Calgary; University of Calgary; University of Calgary; University of Calgary; University of Calgary; University of Calgary	Kubes, P (corresponding author), Univ Calgary, Dept Crit Care Med, Calgary, AB, Canada.	sousman@ucalgary.ca; pkubes@ucalgary.ca			Canadian Institutes of Health Research; Alberta Innovates-Health Solutions; Canada Foundation for Innovation; Multiple Sclerosis Society of Canada	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Alberta Innovates-Health Solutions; Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); Multiple Sclerosis Society of Canada	This work was supported by the Canadian Institutes of Health Research, Alberta Innovates-Health Solutions, Canada Foundation for Innovation and the Multiple Sclerosis Society of Canada.	AKIYAMA H, 1990, J NEUROIMMUNOL, V30, P81, DOI 10.1016/0165-5728(90)90055-R; AKIYAMA H, 1988, J NEUROSCI RES, V20, P147, DOI 10.1002/jnr.490200202; ALLIOT F, 1991, P NATL ACAD SCI USA, V88, P1541, DOI 10.1073/pnas.88.4.1541; Aloisi F, 1997, J IMMUNOL, V159, P1604; Arima Y, 2012, CELL, V148, P447, DOI 10.1016/j.cell.2012.01.022; Bechmann I, 2001, EXP NEUROL, V168, P242, DOI 10.1006/exnr.2000.7618; Campbell GL, 2002, LANCET INFECT DIS, V2, P519, DOI 10.1016/S1473-3099(02)00368-7; Carrithers MD, 2002, J NEUROIMMUNOL, V129, P51, DOI 10.1016/S0165-5728(02)00172-8; Carson KR, 2009, LANCET ONCOL, V10, P816, DOI 10.1016/S1470-2045(09)70161-5; Carvalho-Tavares J, 2000, CIRC RES, V87, P1141, DOI 10.1161/01.RES.87.12.1141; Celum Connie L, 2004, Herpes, V11 Suppl 1, p36A; Chen SK, 2010, CELL, V141, P775, DOI 10.1016/j.cell.2010.03.055; Cheng PY, 2009, INFECT IMMUN, V77, P4284, DOI 10.1128/IAI.00628-09; Conrady CD, 2010, J NEUROIMMUNOL, V220, P1, DOI 10.1016/j.jneuroim.2009.09.013; Damani MR, 2011, AGING CELL, V10, P263, DOI 10.1111/j.1474-9726.2010.00660.x; Davis LE, 2006, ANN NEUROL, V60, P286, DOI 10.1002/ana.20959; Elhofy A, 2009, J NEUROIMMUNOL, V213, P91, DOI 10.1016/j.jneuroim.2009.05.011; Fischer HG, 2000, J IMMUNOL, V164, P4826, DOI 10.4049/jimmunol.164.9.4826; Flugel A, 2000, BRAIN PATHOL, V10, P353; Ford AL, 1996, J EXP MED, V184, P1737, DOI 10.1084/jem.184.5.1737; Gasser O, 2007, PLOS MED, V4, P556, DOI 10.1371/journal.pmed.0040096; Ginhoux F, 2010, SCIENCE, V330, P841, DOI 10.1126/science.1194637; Glass WG, 2005, J EXP MED, V202, P1087, DOI 10.1084/jem.20042530; GRAEBER MB, 1992, J NEUROPATH EXP NEUR, V51, P303, DOI 10.1097/00005072-199205000-00009; Grovit-Ferbas K, 2010, IMMUNOL RES, V48, P40, DOI 10.1007/s12026-010-8166-x; HARLINGBERG C, 1989, J NEUROIMMUNOL, V25, P185, DOI 10.1016/0165-5728(89)90136-7; Hatterer E, 2006, BLOOD, V107, P806, DOI 10.1182/blood-2005-01-0154; Hawkes CA, 2009, P NATL ACAD SCI USA, V106, P1261, DOI 10.1073/pnas.0805453106; HAYES GM, 1987, J NEUROL SCI, V80, P25, DOI 10.1016/0022-510X(87)90218-8; Henkel JS, 2004, ANN NEUROL, V55, P221, DOI 10.1002/ana.10805; Hickey WF, 1999, SEMIN IMMUNOL, V11, P125, DOI 10.1006/smim.1999.0168; Hickey WF, 2001, GLIA, V36, P118, DOI 10.1002/glia.1101; HICKEY WF, 1991, J NEUROSCI RES, V28, P254, DOI 10.1002/jnr.490280213; HICKEY WF, 1988, SCIENCE, V239, P290, DOI 10.1126/science.3276004; Hoek RM, 2000, SCIENCE, V290, P1768, DOI 10.1126/science.290.5497.1768; HOUFF SA, 1988, NEW ENGL J MED, V318, P301, DOI 10.1056/NEJM198802043180507; Inungu J, 2002, AIDS PATIENT CARE ST, V16, P107, DOI 10.1089/108729102317330445; Kaminski M, 2012, J LEUKOCYTE BIOL, V92, P31, DOI 10.1189/jlb.0511241; Kerschensteiner M, 1999, J EXP MED, V189, P865, DOI 10.1084/jem.189.5.865; Khanna KM, 2004, CURR OPIN IMMUNOL, V16, P463, DOI 10.1016/j.coi.2004.05.003; KIDA SY, 1993, ACTA NEUROPATHOL, V85, P646, DOI 10.1007/BF00334675; Kivisakk P, 2002, CLIN EXP IMMUNOL, V129, P510, DOI 10.1046/j.1365-2249.2002.01947.x; Kivisakk P, 2004, ANN NEUROL, V55, P627, DOI 10.1002/ana.20049; Kivisakk P, 2003, P NATL ACAD SCI USA, V100, P8389, DOI 10.1073/pnas.1433000100; Kleine TO, 2006, CYTOM PART A, V69A, P147, DOI 10.1002/cyto.a.20225; Knickelbein JE, 2008, SCIENCE, V322, P268, DOI 10.1126/science.1164164; KOVACS JA, 1985, ANN INTERN MED, V103, P533, DOI 10.7326/0003-4819-103-4-533; KULKARNI AB, 1991, IMMUNOL CELL BIOL, V69, P71, DOI 10.1038/icb.1991.12; Langmann T, 2007, J LEUKOCYTE BIOL, V81, P1345, DOI 10.1189/jlb.0207114; Laschinger M, 2002, EUR J IMMUNOL, V32, P3598, DOI 10.1002/1521-4141(200212)32:12<3598::AID-IMMU3598>3.0.CO;2-6; Li WW, 2005, J NEUROIMMUNOL, V158, P58, DOI 10.1016/j.jneuroim.2004.08.011; Loeffler C, 2011, NEUROPATHOLOGY, V31, P230, DOI 10.1111/j.1440-1789.2010.01167.x; Mack CL, 2003, J NEUROIMMUNOL, V144, P68, DOI 10.1016/j.jneuroim.2003.08.032; Malone KE, 2008, GLIA, V56, P426, DOI 10.1002/glia.20625; Matyszak MK, 1998, J NEUROIMMUNOL, V82, P73, DOI 10.1016/S0165-5728(97)00190-2; McCandless EE, 2008, P NATL ACAD SCI USA, V105, P11270, DOI 10.1073/pnas.0800898105; McDonald B, 2010, SCIENCE, V330, P362, DOI 10.1126/science.1195491; McGavern DB, 2011, NAT REV IMMUNOL, V11, P318, DOI 10.1038/nri2971; McMahon EJ, 2005, NAT MED, V11, P335, DOI 10.1038/nm1202; McMenamin PG, 1999, J COMP NEUROL, V405, P553, DOI 10.1002/(SICI)1096-9861(19990322)405:4<553::AID-CNE8>3.0.CO;2-6; Mildner A, 2011, J NEUROSCI, V31, P11159, DOI 10.1523/JNEUROSCI.6209-10.2011; Nahrendorf M, 2007, J EXP MED, V204, P3037, DOI 10.1084/jem.20070885; Neumann H, 1998, P NATL ACAD SCI USA, V95, P5779, DOI 10.1073/pnas.95.10.5779; Neumann H, 2001, GLIA, V36, P191, DOI 10.1002/glia.1108; Nimmerjahn A, 2005, SCIENCE, V308, P1314, DOI 10.1126/science.1110647; Pashenkov M, 2001, BRAIN, V124, P480, DOI 10.1093/brain/124.3.480; Poluektova LY, 2002, J IMMUNOL, V168, P3941, DOI 10.4049/jimmunol.168.8.3941; Ponzoni M, 2007, BRIT J HAEMATOL, V138, P316, DOI 10.1111/j.1365-2141.2007.06661.x; Popovich PG, 2008, NAT REV NEUROSCI, V9, P481, DOI 10.1038/nrn2398; Prinz M, 2011, NAT NEUROSCI, V14, P1227, DOI 10.1038/nn.2923; Raivich G, 2005, TRENDS NEUROSCI, V28, P571, DOI 10.1016/j.tins.2005.09.001; Ransohoff RM, 2005, NAT NEUROSCI, V8, P1275, DOI 10.1038/nn1005-1275; Ransohoff RM, 2003, NAT REV IMMUNOL, V3, P569, DOI 10.1038/nri1130; Reboldi A, 2009, NAT IMMUNOL, V10, P514, DOI 10.1038/ni.1716; Reichmann G, 2002, J NEUROIMMUNOL, V129, P125, DOI 10.1016/S0165-5728(02)00184-4; ROSENBLUM ML, 1988, ANN NEUROL, V23, pS13, DOI 10.1002/ana.410230707; Schleich A, 2004, ACTA NEUROPATHOL, V108, P366; Schulz C, 2012, SCIENCE, V336, P86, DOI 10.1126/science.1219179; Schwartz Michal, 2003, J Spinal Cord Med, V26 Suppl 1, pS6; Shaked I, 2005, J NEUROCHEM, V92, P997, DOI 10.1111/j.1471-4159.2004.02954.x; Shrestha B, 2006, J VIROL, V80, P119, DOI 10.1128/JVI.80.1.119-129.2006; Shrikant P, 1996, J IMMUNOL, V157, P1819; Simard AR, 2006, NEURON, V49, P489, DOI 10.1016/j.neuron.2006.01.022; Sitati EM, 2006, J VIROL, V80, P12060, DOI 10.1128/JVI.01650-06; Sparano JA, 1999, J ACQ IMMUN DEF SYND, V21, pS18; Svenningsson A, 1995, J NEUROIMMUNOL, V63, P39, DOI 10.1016/0165-5728(95)00126-3; Tanner J E, 2001, Transpl Infect Dis, V3, P60, DOI 10.1034/j.1399-3062.2001.003002060.x; Town T, 2008, NAT MED, V14, P681, DOI 10.1038/nm1781; Tran EH, 1998, J IMMUNOL, V161, P3767; Tremblay ME, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000527; UNGER ER, 1993, J NEUROPATH EXP NEUR, V52, P460, DOI 10.1097/00005072-199309000-00004; Villares R, 2009, EUR J IMMUNOL, V39, P1671, DOI 10.1002/eji.200839123; Vincent VAM, 1997, GLIA, V19, P190, DOI 10.1002/(SICI)1098-1136(199703)19:3<190::AID-GLIA2>3.0.CO;2-3; Wang T, 2003, J IMMUNOL, V171, P2524, DOI 10.4049/jimmunol.171.5.2524; Wei RT, 1999, J NEUROIMMUNOL, V95, P8, DOI 10.1016/S0165-5728(98)00248-3; WELCH K, 1984, JAMA-J AM MED ASSOC, V252, P1152, DOI 10.1001/jama.252.9.1152; Wojcik E, 2011, NEUROSCI LETT, V495, P115, DOI 10.1016/j.neulet.2011.03.051; Wyss-Coray T, 2001, NAT MED, V7, P612, DOI 10.1038/87945; Zhang B, 2008, J IMMUNOL, V180, P2641, DOI 10.4049/jimmunol.180.4.2641; Zhang SY, 2007, SCIENCE, V317, P1522, DOI 10.1126/science.1139522	100	244	249	0	62	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	AUG	2012	15	8					1096	1101		10.1038/nn.3161	http://dx.doi.org/10.1038/nn.3161			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	979UE	22837040	Bronze, Green Published			2022-12-28	WOS:000306844500011
J	Geng, Y; Xiong, DZ; Mosyak, L; Malito, DL; Kniazeff, J; Chen, Y; Burmakina, S; Quick, M; Bush, M; Javitch, JA; Pin, JP; Fan, QR				Geng, Yong; Xiong, Dazhi; Mosyak, Lidia; Malito, David L.; Kniazeff, Julie; Chen, Yan; Burmakina, Svetlana; Quick, Matthias; Bush, Martin; Javitch, Jonathan A.; Pin, Jean-Philippe; Fan, Qing R.			Structure and functional interaction of the extracellular domain of human GABA(B) receptor GBR2	NATURE NEUROSCIENCE			English	Article							METABOTROPIC GLUTAMATE RECEPTORS; AMINOBUTYRIC ACID(B) RECEPTORS; LIGAND-BINDING; B-RECEPTOR; SIGNAL-TRANSDUCTION; COUPLED RECEPTOR; GB2 SUBUNITS; PROTEIN; ACTIVATION; MECHANISM	Inhibitory neurotransmission is mediated primarily by GABA. The metabotropic GABA(B) receptor is a G protein-coupled receptor central to mammalian brain function. Malfunction of GABA(B) receptor has been implicated in several neurological disorders. GABA(B) receptor functions as a heterodimeric assembly of GBR1 and GBR2 subunits, where GBR1 is responsible for ligand-binding and GBR2 is responsible for G protein coupling. Here we demonstrate that the GBR2 ectodomain directly interacts with the GBR1 ectodomain to increase agonist affinity by selectively stabilizing the agonist-bound conformation of GBR1. We present the crystal structure of the GBR2 ectodomain, which reveals a polar heterodimeric interface. We also identify specific heterodimer contacts from both subunits, and GBR1 residues involved in ligand recognition. Lastly, our structural and functional data indicate that the GBR2 ectodomain adopts a constitutively open conformation, suggesting a structural asymmetry in the active state of GABA(B) receptor that is unique to the GABAergic system.	[Geng, Yong; Xiong, Dazhi; Mosyak, Lidia; Chen, Yan; Burmakina, Svetlana; Bush, Martin; Javitch, Jonathan A.; Fan, Qing R.] Columbia Univ, Dept Pharmacol, New York, NY 10027 USA; [Malito, David L.] Columbia Univ, Dept Neurosci, New York, NY USA; [Kniazeff, Julie; Pin, Jean-Philippe] CNRS, Unite Mixte Rech UMR 5203, Montpellier, France; [Kniazeff, Julie; Pin, Jean-Philippe] INSERM, U661, Montpellier, France; [Kniazeff, Julie; Pin, Jean-Philippe] Univ Montpellier I, Inst Genom Fonct, Montpellier, France; [Quick, Matthias; Javitch, Jonathan A.] Columbia Univ, Dept Psychiat, New York, NY USA; [Fan, Qing R.] Columbia Univ, Dept Pathol & Cell Biol, New York, NY USA	Columbia University; Columbia University; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; Universite de Montpellier; Columbia University; Columbia University	Fan, QR (corresponding author), Columbia Univ, Dept Pharmacol, New York, NY 10027 USA.	qf13@columbia.edu	Pin, Jean-Philippe/Y-6668-2019	Pin, Jean-Philippe/0000-0002-1423-345X; Kniazeff, Julie/0000-0002-0426-0999; Javitch, Jonathan/0000-0001-7395-2967	American Heart Association [SDG0835183N]; US National Institutes of Health [R01GM088454]; Agence Nationale de la Recherche (France) [ANR-09-BLANC-0272]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM088454] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [K05DA022413] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Agence Nationale de la Recherche (France)(French National Research Agency (ANR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank W.A. Hendrickson for advice and for generously providing lab space at the initial stage of this project, R. Kass for support and advice on electrophysiology experiments, L. Jan (University of California, San Francisco) for the cDNA clones encoding GIRK channels, V. Frasca for isothermal titration calorimetry and DSC measurements, C. Brouillette and I. Protassevitch for DSC measurements, L. Shapiro and J. Hunt for advice, M. Gawinowicz for mass spectrometry and protein sequencing, K. Rajashankar at the Advanced Proton Source and J. Schwanof at the National Synchrotron Light Source for help with data collection, L. Geneve for analyzing the glycosylation mutants, the ARPEGE platform facility at Institute of Functional Genomics (Montpellier, France) for inositol phosphate and Tag-lite (Cisbio) assays, and W.A. Hendrickson and M. Evelyn for critical reading of the manuscript. This work was supported by American Heart Association grant SDG0835183N, US National Institutes of Health grant R01GM088454 (both to Q.R.F.) and Agence Nationale de la Recherche (France) grant ANR-09-BLANC-0272 (to J.-P.P.). Q.R.F. is an Irma Hirschl Career Scientist, Pew Scholar and McKnight Scholar.	Armstrong N, 1998, NATURE, V395, P913, DOI 10.1038/27692; Bettler B, 2004, PHYSIOL REV, V84, P835, DOI 10.1152/physrev.00036.2003; Bowery NG, 2002, PHARMACOL REV, V54, P247, DOI 10.1124/pr.54.2.247; Duthey B, 2002, J BIOL CHEM, V277, P3236, DOI 10.1074/jbc.M108900200; Galvez T, 2001, EMBO J, V20, P2152, DOI 10.1093/emboj/20.9.2152; Galvez T, 2000, J BIOL CHEM, V275, P41166, DOI 10.1074/jbc.M007848200; Galvez T, 1999, J BIOL CHEM, V274, P13362, DOI 10.1074/jbc.274.19.13362; Goudet C, 2005, J BIOL CHEM, V280, P24380, DOI 10.1074/jbc.M502642200; Han Y, 2009, NAT CHEM BIOL, V5, P688, DOI 10.1038/nchembio.199; Havlickova M, 2002, MOL PHARMACOL, V62, P343, DOI 10.1124/mol.62.2.343; He XL, 2006, J MOL BIOL, V361, P698, DOI 10.1016/j.jmb.2006.06.060; He XL, 2001, SCIENCE, V293, P1657, DOI 10.1126/science.1062246; Jones KA, 1998, NATURE, V396, P674, DOI 10.1038/25348; Kaupmann K, 1998, NATURE, V396, P683, DOI 10.1038/25360; Kaupmann K, 1997, NATURE, V386, P239, DOI 10.1038/386239a0; Kniazeff J, 2002, J NEUROSCI, V22, P7352; Kniazeff J, 2004, NAT STRUCT MOL BIOL, V11, P706, DOI 10.1038/nsmb794; Kuner R, 1999, SCIENCE, V283, P74, DOI 10.1126/science.283.5398.74; Kunishima N, 2000, NATURE, V407, P971, DOI 10.1038/35039564; Liu JF, 2004, J BIOL CHEM, V279, P15824, DOI 10.1074/jbc.M313639200; MACDONALD RL, 1994, ANNU REV NEUROSCI, V17, P569, DOI 10.1146/annurev.neuro.17.1.569; Malitschek B, 1999, MOL PHARMACOL, V56, P448, DOI 10.1124/mol.56.2.448; Margeta-Mitrovic M, 2000, NEURON, V27, P97, DOI 10.1016/S0896-6273(00)00012-X; Margeta-Mitrovic M, 2001, P NATL ACAD SCI USA, V98, P14643, DOI 10.1073/pnas.251554798; Margeta-Mitrovic M, 2001, P NATL ACAD SCI USA, V98, P14649, DOI 10.1073/pnas.251554498; Matsushita S, 2010, J BIOL CHEM, V285, P10291, DOI 10.1074/jbc.M109.077990; Milligan G, 2009, BRIT J PHARMACOL, V158, P5, DOI 10.1111/j.1476-5381.2009.00169.x; Monnier C, 2011, EMBO J, V30, P32, DOI 10.1038/emboj.2010.270; Muto T, 2007, P NATL ACAD SCI USA, V104, P3759, DOI 10.1073/pnas.0611577104; Ng GYK, 1999, J BIOL CHEM, V274, P7607, DOI 10.1074/jbc.274.12.7607; Nomura R, 2008, J BIOL CHEM, V283, P4665, DOI 10.1074/jbc.M705202200; Ogawa H, 2004, J BIOL CHEM, V279, P28625, DOI 10.1074/jbc.M313222200; Pin JP, 2004, BIOL CELL, V96, P335, DOI 10.1016/j.biolcel.2004.03.005; Quick M, 2007, P NATL ACAD SCI USA, V104, P3603, DOI 10.1073/pnas.0609573104; Robbins MJ, 2001, J NEUROSCI, V21, P8043, DOI 10.1523/JNEUROSCI.21-20-08043.2001; Rondard P, 2008, EMBO J, V27, P1321, DOI 10.1038/emboj.2008.64; Rovira X, 2010, TRENDS PHARMACOL SCI, V31, P15, DOI 10.1016/j.tips.2009.10.008; SACK JS, 1989, J MOL BIOL, V206, P171, DOI 10.1016/0022-2836(89)90531-7; Tsuchiya D, 2002, P NATL ACAD SCI USA, V99, P2660, DOI 10.1073/pnas.052708599; Tsuji Y, 2000, J BIOL CHEM, V275, P28144; van den Akker F, 2000, NATURE, V406, P101, DOI 10.1038/35017602; White JH, 1998, NATURE, V396, P679, DOI 10.1038/25354	42	50	53	0	38	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JUL	2012	15	7					970	978		10.1038/nn.3133	http://dx.doi.org/10.1038/nn.3133			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	966EE	22660477	Green Accepted			2022-12-28	WOS:000305819600015
J	Davidson, RJ; McEwen, BS				Davidson, Richard J.; McEwen, Bruce S.			Social influences on neuroplasticity: stress and interventions to promote well-being	NATURE NEUROSCIENCE			English	Review							EMOTION REGULATION; BRAIN PLASTICITY; AMYGDALA VOLUME; VISUAL-CORTEX; COMPASSION MEDITATION; STRUCTURAL PLASTICITY; DENDRITIC MORPHOLOGY; PSYCHOSOCIAL STRESS; HIPPOCAMPAL VOLUME; PREFRONTAL CORTEX	Experiential factors shape the neural circuits underlying social and emotional behavior from the prenatal period to the end of life. These factors include both incidental influences, such as early adversity, and intentional influences that can be produced in humans through specific interventions designed to promote prosocial behavior and well-being. Here we review important extant evidence in animal models and humans. Although the precise mechanisms of plasticity are still not fully understood, moderate to severe stress appears to increase the growth of several sectors of the amygdala, whereas the effects in the hippocampus and prefrontal cortex tend to be opposite. Structural and functional changes in the brain have been observed with cognitive therapy and certain forms of meditation and lead to the suggestion that well-being and other prosocial characteristics might be enhanced through training.	[Davidson, Richard J.] Univ Wisconsin, Waisman Lab Brain Imaging & Behav, Madison, WI 53706 USA; [Davidson, Richard J.] Univ Wisconsin, Ctr Invest Hlth Minds, Madison, WI USA; [McEwen, Bruce S.] Rockefeller Univ, Harold & Margaret Milliken Hatch Lab Neuroendocri, New York, NY 10021 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; Rockefeller University	Davidson, RJ (corresponding author), Univ Wisconsin, Waisman Lab Brain Imaging & Behav, Madison, WI 53706 USA.	rjdavids@wisc.edu; mcewen@mail.rockefeller.edu	McEwen, Bruce/Z-1630-2019; Carroll, Joseph/D-1158-2011	Carroll, Joseph/0000-0003-2656-1378; Davidson, Richard/0000-0002-8506-4964	National Institute of Mental Health [R01-MH43454, P50-MH084051]; National Center for Complementary and Alternative Medicine [P01-AT004952]; Fetzer Institute; John Templeton Foundation; John W Kluge Foundation; US National Institutes of Health [R01 MH41256, 5P01 MH58911]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD003352] Funding Source: NIH RePORTER; National Center for Complementary & Integrative Health [P01AT004952] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH041256, P50MH058911, R01MH043454, P50MH084051] Funding Source: NIH RePORTER	National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Center for Complementary and Alternative Medicine(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine); Fetzer Institute; John Templeton Foundation; John W Kluge Foundation; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Center for Complementary & Integrative Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	R.J.D. is supported by grants from the National Institute of Mental Health (R01-MH43454 and P50-MH084051), the National Center for Complementary and Alternative Medicine (P01-AT004952), the Fetzer Institute, the John Templeton Foundation, and gifts from Bryant Wangard and Ralph Robinson, Ann Down, Keith and Arlene Bronstein, and the John W Kluge Foundation. B.S.M. is supported by US National Institutes of Health grants R01 MH41256 and 5P01 MH58911.	Adolphs R, 2010, NEURON, V65, P752, DOI 10.1016/j.neuron.2010.03.006; Akers KG, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002840; ALTMAN J, 1990, J COMP NEUROL, V301, P325, DOI 10.1002/cne.903010302; Anda RF, 2010, AM J PREV MED, V39, P93, DOI 10.1016/j.amepre.2010.03.015; Bavelier D, 2010, J NEUROSCI, V30, P14964, DOI 10.1523/JNEUROSCI.4812-10.2010; BENNETT EL, 1964, SCIENCE, V146, P610, DOI 10.1126/science.146.3644.610; Bloss EB, 2010, J NEUROSCI, V30, P6726, DOI 10.1523/JNEUROSCI.0759-10.2010; Brewer JA, 2011, P NATL ACAD SCI USA, V108, P20254, DOI 10.1073/pnas.1112029108; Brown J, 2003, EUR J NEUROSCI, V17, P2042, DOI 10.1046/j.1460-9568.2003.02647.x; Buss C, 2007, J NEUROSCI, V27, P2592, DOI 10.1523/JNEUROSCI.3252-06.2007; Cameron H. A., 1996, RECEPTOR DYNAMICS NE, P141; Carlson MC, 2009, J GERONTOL A-BIOL, V64, P1275, DOI 10.1093/gerona/glp117; Castren E, 2010, DEV NEUROBIOL, V70, P289, DOI 10.1002/dneu.20758; Chambers R, 2009, CLIN PSYCHOL REV, V29, P560, DOI 10.1016/j.cpr.2009.06.005; Chen JR, 2009, CEREB CORTEX, V19, P2719, DOI 10.1093/cercor/bhp048; Choi J, 2009, BIOL PSYCHIAT, V65, P227, DOI 10.1016/j.biopsych.2008.06.022; Chollet F, 2011, LANCET NEUROL, V10, P123, DOI 10.1016/S1474-4422(10)70314-8; Christoff K, 2009, P NATL ACAD SCI USA, V106, P8719, DOI 10.1073/pnas.0900234106; Christoffel DJ, 2011, J NEUROSCI, V31, P314, DOI 10.1523/JNEUROSCI.4763-10.2011; Clark DA, 2010, TRENDS COGN SCI, V14, P418, DOI 10.1016/j.tics.2010.06.007; Coan JA, 2006, PSYCHOL SCI, V17, P1032, DOI 10.1111/j.1467-9280.2006.01832.x; Coplan JD, 2001, BIOL PSYCHIAT, V50, P200, DOI 10.1016/S0006-3223(01)01175-1; Davidson RJ, 2000, SCIENCE, V289, P591, DOI 10.1126/science.289.5479.591; Davidson RJ, 2004, PHILOS T R SOC B, V359, P1395, DOI 10.1098/rstb.2004.1510; de Lange FP, 2008, BRAIN, V131, P2172, DOI 10.1093/brain/awn140; DeRubeis RJ, 2008, NAT REV NEUROSCI, V9, P788, DOI 10.1038/nrn2345; Diamond A, 2011, SCIENCE, V333, P959, DOI 10.1126/science.1204529; DIAMOND MC, 1978, AM SCI, V66, P66; Disner SG, 2011, NAT REV NEUROSCI, V12, P467, DOI 10.1038/nrn3027; Duman RS, 2006, BIOL PSYCHIAT, V59, P1116, DOI 10.1016/j.biopsych.2006.02.013; Dumitriu D, 2010, ANN NY ACAD SCI, V1204, P104, DOI 10.1111/j.1749-6632.2010.05529.x; Durlak JA, 2011, CHILD DEV, V82, P405, DOI 10.1111/j.1467-8624.2010.01564.x; Erickson KI, 2011, P NATL ACAD SCI USA, V108, P3017, DOI 10.1073/pnas.1015950108; Farb NAS, 2007, SOC COGN AFFECT NEUR, V2, P313, DOI 10.1093/scan/nsm030; Fava GA, 1998, PSYCHOL MED, V28, P475, DOI 10.1017/S0033291797006363; Gould E, 1997, J NEUROSCI, V17, P2492; Gould F, 2012, J PSYCHIATR RES, V46, P500, DOI 10.1016/j.jpsychires.2012.01.005; Hanson JL, 2010, J NEUROSCI, V30, P7466, DOI 10.1523/JNEUROSCI.0859-10.2010; Hebb D.O., 1949, ORG BEHAV NEUROPSYCH; Heim C, 2010, DEV PSYCHOBIOL, V52, P671, DOI 10.1002/dev.20494; Holzel BK, 2010, SOC COGN AFFECT NEUR, V5, P11, DOI 10.1093/scan/nsp034; Hofmann SG, 2011, CLIN PSYCHOL REV, V31, P1126, DOI 10.1016/j.cpr.2011.07.003; Isgor C, 2004, HIPPOCAMPUS, V14, P636, DOI 10.1002/hipo.10207; Johnstone T, 2007, J NEUROSCI, V27, P8877, DOI 10.1523/JNEUROSCI.2063-07.2007; Kaplan MS, 2001, TRENDS NEUROSCI, V24, P617, DOI 10.1016/S0166-2236(00)01967-6; Katz M, 2009, DEV NEUROSCI-BASEL, V31, P293, DOI 10.1159/000216540; Kaufman D, 2005, J CLIN ENDOCR METAB, V90, P404, DOI 10.1210/jc.2004-0452; Kemeny M.E, 2011, EMOTION; Killingsworth MA, 2010, SCIENCE, V330, P932, DOI 10.1126/science.1192439; Kim MJ, 2009, J NEUROSCI, V29, P11614, DOI 10.1523/JNEUROSCI.2335-09.2009; Kozorovitskiy Y, 2004, J NEUROSCI, V24, P6755, DOI 10.1523/JNEUROSCI.0345-04.2004; Kuhl PK, 2010, NEURON, V67, P713, DOI 10.1016/j.neuron.2010.08.038; LEVINE S, 1967, PHYSIOL BEHAV, V2, P55, DOI 10.1016/0031-9384(67)90011-X; Liston C, 2006, J NEUROSCI, V26, P7870, DOI 10.1523/JNEUROSCI.1184-06.2006; Liston C, 2011, P NATL ACAD SCI USA, V108, P16074, DOI 10.1073/pnas.1110444108; Loman MM, 2010, NEUROSCI BIOBEHAV R, V34, P867, DOI 10.1016/j.neubiorev.2009.05.007; Lupien SJ, 2011, P NATL ACAD SCI USA, V108, P14324, DOI 10.1073/pnas.1105371108; Lutz A, 2004, P NATL ACAD SCI USA, V101, P16369, DOI 10.1073/pnas.0407401101; Lutz A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001897; Lutz A, 2008, TRENDS COGN SCI, V12, P163, DOI 10.1016/j.tics.2008.01.005; Magarinos AM, 1996, J NEUROSCI, V16, P3534; Markham JA, 2004, NEURON GLIA BIOL, V1, P351, DOI 10.1017/S1740925X05000219; Maya-Vetencourt JF, 2008, SCIENCE, V320, P385, DOI 10.1126/science.1150516; McEwen BS, 2007, BRAIN RES REV, V55, P343, DOI 10.1016/j.brainresrev.2007.02.006; McEwen BS, 2007, PHYSIOL REV, V87, P873, DOI 10.1152/physrev.00041.2006; McEwen BS, 2011, ANNU REV MED, V62, P431, DOI 10.1146/annurev-med-052209-100430; Mcewen BS, 1999, ENDOCR REV, V20, P279, DOI 10.1210/er.20.3.279; McGowan PO, 2009, NAT NEUROSCI, V12, P342, DOI 10.1038/nn.2270; Meaney Michael J, 2005, Dialogues Clin Neurosci, V7, P103; Miczek KA, 2008, PHARMACOL THERAPEUT, V120, P102, DOI 10.1016/j.pharmthera.2008.07.006; Moffitt TE, 2011, P NATL ACAD SCI USA, V108, P2693, DOI 10.1073/pnas.1010076108; Morey RA, 2009, NEUROIMAGE, V45, P855, DOI 10.1016/j.neuroimage.2008.12.033; Moriceau S, 2006, NAT NEUROSCI, V9, P1004, DOI 10.1038/nn1733; Mosconi MW, 2009, ARCH GEN PSYCHIAT, V66, P509, DOI 10.1001/archgenpsychiatry.2009.19; Nacewicz BM, 2006, ARCH GEN PSYCHIAT, V63, P1417, DOI 10.1001/archpsyc.63.12.1417; Nelson CA, 2007, SCIENCE, V318, P1937, DOI 10.1126/science.1143921; NOTTEBOHM F, 1989, SCI AM, V260, P74, DOI 10.1038/scientificamerican0289-74; Ochsner KN, 2005, TRENDS COGN SCI, V9, P242, DOI 10.1016/j.tics.2005.03.010; Parker KJ, 2011, NEUROSCI BIOBEHAV R, V35, P1466, DOI 10.1016/j.neubiorev.2010.09.003; Parker KJ, 2005, BIOL PSYCHIAT, V57, P848, DOI 10.1016/j.biopsych.2004.12.024; Parker KJ, 2004, ARCH GEN PSYCHIAT, V61, P933, DOI 10.1001/archpsyc.61.9.933; Popoli M, 2012, NAT REV NEUROSCI, V13, P22, DOI 10.1038/nrn3138; Robinson TE, 2004, NEUROPHARMACOLOGY, V47, P33, DOI 10.1016/j.neuropharm.2004.06.025; Roitman MF, 2002, J NEUROSCI, V22, DOI 10.1523/JNEUROSCI.22-11-j0001.2002; Russo SJ, 2010, TRENDS NEUROSCI, V33, P267, DOI 10.1016/j.tins.2010.02.002; Shonkoff JP, 2012, PEDIATRICS, V129, pE232, DOI 10.1542/peds.2011-2663; Shonkoff JP, 2011, SCIENCE, V333, P982, DOI 10.1126/science.1206014; Shonkoff JP, 2009, JAMA-J AM MED ASSOC, V301, P2252, DOI 10.1001/jama.2009.754; Southwell DG, 2010, SCIENCE, V327, P1145, DOI 10.1126/science.1183962; Spolidoro M, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1323; Sullivan RM, 2010, NEUROSCI BIOBEHAV R, V34, P835, DOI 10.1016/j.neubiorev.2009.11.010; Tang AC, 2006, P NATL ACAD SCI USA, V103, P15716, DOI 10.1073/pnas.0607374103; Tottenham N, 2010, FRONT HUM NEUROSCI, V3, DOI 10.3389/neuro.09.068.2009; Tottenham N, 2010, DEVELOPMENTAL SCI, V13, P46, DOI 10.1111/j.1467-7687.2009.00852.x; Uchino BN, 1996, PSYCHOL BULL, V119, P488, DOI 10.1037/0033-2909.119.3.488; Uhlhaas PJ, 2010, TRENDS COGN SCI, V14, P72, DOI 10.1016/j.tics.2009.12.002; Urry HL, 2006, J NEUROSCI, V26, P4415, DOI 10.1523/JNEUROSCI.3215-05.2006; van Hasselt FN, 2012, HIPPOCAMPUS, V22, P255, DOI 10.1002/hipo.20892; Vyas A, 2002, J NEUROSCI, V22, P6810; Wager TD, 2008, NEURON, V59, P1037, DOI 10.1016/j.neuron.2008.09.006	100	459	468	17	304	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAY	2012	15	5					689	695		10.1038/nn.3093	http://dx.doi.org/10.1038/nn.3093			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	932DI	22534579	Green Accepted			2022-12-28	WOS:000303270200011
J	Benard, G; Massa, F; Puente, N; Lourenco, J; Bellocchio, L; Soria-Gomez, E; Matias, I; Delamarre, A; Metna-Laurent, M; Cannich, A; Hebert-Chatelain, E; Mulle, C; Ortega-Gutierrez, S; Martin-Fontecha, M; Klugmann, M; Guggenhuber, S; Lutz, B; Gertsch, J; Chaouloff, F; Lopez-Rodriguez, ML; Grandes, P; Rossignol, R; Marsicano, G				Benard, Giovanni; Massa, Federico; Puente, Nagore; Lourenco, Joana; Bellocchio, Luigi; Soria-Gomez, Edgar; Matias, Isabel; Delamarre, Anna; Metna-Laurent, Mathilde; Cannich, Astrid; Hebert-Chatelain, Etienne; Mulle, Christophe; Ortega-Gutierrez, Silvia; Martin-Fontecha, Mar; Klugmann, Matthias; Guggenhuber, Stephan; Lutz, Beat; Gertsch, Juerg; Chaouloff, Francis; Lopez-Rodriguez, Maria Luz; Grandes, Pedro; Rossignol, Rodrigue; Marsicano, Giovanni			Mitochondrial CB1 receptors regulate neuronal energy metabolism	NATURE NEUROSCIENCE			English	Article							CANNABINOID RECEPTOR; COMPLEX-I; ENDOCANNABINOID SYSTEM; PHOSPHORYLATION; PHARMACOLOGY; HIPPOCAMPUS; INHIBITION; TRANSPORT; OXIDASE	The mammalian brain is one of the organs with the highest energy demands, and mitochondria are key determinants of its functions. Here we show that the type-1 cannabinoid receptor (CB1) is present at the membranes of mouse neuronal mitochondria (mtCB(1)), where it directly controls cellular respiration and energy production. Through activation of mtCB(1) receptors, exogenous cannabinoids and in situ endocannabinoids decreased cyclic AMP concentration, protein kinase A activity, complex I enzymatic activity and respiration in neuronal mitochondria. In addition, intracellular CB1 receptors and mitochondria, mechanisms contributed to endocannabinoid-dependent depolarization-induced suppression of inhibition in the hippocampus. Thus, mtCB(1) receptors directly modulate neuronal energy metabolism, revealing a new mechanism of action of G protein-coupled receptor signaling in the brain.	[Benard, Giovanni; Massa, Federico; Lourenco, Joana; Bellocchio, Luigi; Soria-Gomez, Edgar; Matias, Isabel; Delamarre, Anna; Metna-Laurent, Mathilde; Cannich, Astrid; Hebert-Chatelain, Etienne; Chaouloff, Francis; Marsicano, Giovanni] INSERM, U862, Neuroctr Magendie, Bordeaux, France; [Benard, Giovanni; Rossignol, Rodrigue] Univ Bordeaux, EA 4576, Bordeaux, France; [Benard, Giovanni; Massa, Federico; Lourenco, Joana; Bellocchio, Luigi; Soria-Gomez, Edgar; Matias, Isabel; Delamarre, Anna; Metna-Laurent, Mathilde; Cannich, Astrid; Hebert-Chatelain, Etienne; Mulle, Christophe; Chaouloff, Francis; Rossignol, Rodrigue; Marsicano, Giovanni] Univ Bordeaux, Neuroctr Magendie, U862, Bordeaux, France; [Puente, Nagore; Grandes, Pedro] Univ Basque Country, Fac Med & Dent, Dept Neurosci, UPV EHU, Leioa, Spain; [Lourenco, Joana; Mulle, Christophe] Ctr Natl Rech Sci, Lab Physiol Cellulaire Synapse, UMR 5091, Bordeaux, France; [Ortega-Gutierrez, Silvia; Martin-Fontecha, Mar; Lopez-Rodriguez, Maria Luz] Univ Complutense, Dept Organ Chem, E-28040 Madrid, Spain; [Klugmann, Matthias; Guggenhuber, Stephan; Lutz, Beat] Johannes Gutenberg Univ Mainz, Univ Med Ctr, Inst Physiol Chem, Mainz, Germany; [Klugmann, Matthias] Univ New S Wales, Sch Med Sci, Dept Physiol, Sydney, NSW, Australia; [Gertsch, Juerg] Inst Biochem & Mol Med, Bern, Switzerland	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux; UDICE-French Research Universities; Universite de Bordeaux; UDICE-French Research Universities; Universite de Bordeaux; University of Basque Country; Centre National de la Recherche Scientifique (CNRS); Complutense University of Madrid; Johannes Gutenberg University of Mainz; University of New South Wales Sydney	Marsicano, G (corresponding author), INSERM, U862, Neuroctr Magendie, Bordeaux, France.	giovanni.marsicano@inserm.fr	Lutz, Beat/AAG-4538-2022; Soria-Gomez, Edgar/AAH-3567-2019; Grandes, Pedro/AAA-1627-2019; Puente, Nagore/H-7054-2015; Ortega-Gutierrez, Silvia/ABC-7653-2021; Marsicano, Giovanni/I-9603-2016; Lutz, Beat/AFK-6229-2022; Rossignol, Rodrigue/K-7821-2014; Bénard, Giovanni/M-3485-2014; Massa, Federico/C-5697-2011; , Ivan/D-6804-2012; Ortega-Gutierrez, Silvia/I-1935-2017; Martin-Fontecha, Mar/D-3428-2014; Chaouloff, Francis/N-7003-2017; Grandes, Pedro/H-7494-2015; LOPEZ-RODRIGUEZ, MARIA L./S-6342-2016	Soria-Gomez, Edgar/0000-0002-1361-5915; Puente, Nagore/0000-0003-0866-5747; Bénard, Giovanni/0000-0003-0036-9425; Massa, Federico/0000-0002-9427-3418; Mulle, Christophe/0000-0003-2709-6615; , Ivan/0000-0002-3108-058X; Ortega-Gutierrez, Silvia/0000-0002-0257-6754; Martin-Fontecha, Mar/0000-0002-4848-0109; Chaouloff, Francis/0000-0001-9036-4067; Grandes, Pedro/0000-0003-3947-4230; Delamarre, Anna/0000-0002-5916-7433; Marsicano, Giovanni/0000-0003-3804-1951; LOPEZ-RODRIGUEZ, MARIA L./0000-0001-8607-1085; Gertsch, Jurg/0000-0003-0978-1555	AVENIR/INSERM; INSERM-Agence Nationale de la Recherche [ANR-09RDPOC-006-01]; European Union (REPROBESITY) [HEALTH-F2-2008-223713]; European Research Council (ENDOFOOD) [ERC-2010-StG-260515]; Fondation pour la Recherche Medicate; Region Aquitaine; Fyssen Foundation; University of Bordeaux; Red de Trastornos Adictivos, Instituto de Salud Carlos III [RD07/0001/2001]; Basque Country Government [GIC07/70-IT-432-07]; University of the Basque Country UPV/EHU [UFI11/41]; Comunidad de Madrid [S2010/BMD-2353]; MICINN [SAF2009-07065, SAF2010-22198-C02-01]; Ramon y Cajal program; Deutsche Forschungsgemeinschaft [FOR926]; CONACyT	AVENIR/INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)); INSERM-Agence Nationale de la Recherche(Institut National de la Sante et de la Recherche Medicale (Inserm)French National Research Agency (ANR)); European Union (REPROBESITY); European Research Council (ENDOFOOD)(European Research Council (ERC)); Fondation pour la Recherche Medicate(Fondation pour la Recherche Medicale); Region Aquitaine(Region Nouvelle-Aquitaine); Fyssen Foundation; University of Bordeaux; Red de Trastornos Adictivos, Instituto de Salud Carlos III(Instituto de Salud Carlos III); Basque Country Government(Basque Government); University of the Basque Country UPV/EHU; Comunidad de Madrid(Comunidad de Madrid); MICINN(Ministry of Science and Innovation, Spain (MICINN)Spanish GovernmentEuropean Commission); Ramon y Cajal program(Spanish Government); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); CONACyT(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	We thank D. Gonzales, N. Aubailly and all the personnel of the Animal Facility of the NeuroCentre Magendie for mouse care and genotyping; all the members of G.M.'s laboratory for discussions; and A. Bacci, D. Cota, M. Guzman, U. Pagotto, P.V. Piazza and C. Wotjak for critically reading the manuscript. Supported by AVENIR/INSERM (G.M.), INSERM-Agence Nationale de la Recherche (Retour Post-Doc ANR-09RDPOC-006-01 (G.B.), European Union 7th Framework Program (REPROBESITY, HEALTH-F2-2008-223713, G.M. and B.L.), European Research Council (ENDOFOOD, ERC-2010-StG-260515, G.M.), Fondation pour la Recherche Medicate (G.M. and M.M.-L.), Region Aquitaine (G.M.), Fyssen Foundation (E.S.-G.), University of Bordeaux (J.L.), Red de Trastornos Adictivos, Instituto de Salud Carlos III (RD07/0001/2001, P.G.), Basque Country Government (GIC07/70-IT-432-07, PG.), University of the Basque Country UPV/EHU (UFI11/41, P.G.), Comunidad de Madrid (S2010/BMD-2353, M.L.L.-R.), MICINN (SAF2009-07065, PG.; SAF2010-22198-C02-01, M.L.L.-R.), Ramon y Cajal program (S.O.-G.), Deutsche Forschungsgemeinschaft (FOR926, B.L.) and CONACyT (E.S.-G.).	Acin-Perez R, 2011, J BIOL CHEM, V286, P30423, DOI 10.1074/jbc.M111.266379; Acin-Perez R, 2009, CELL METAB, V9, P265, DOI 10.1016/j.cmet.2009.01.012; Andreeva AV, 2008, FASEB J, V22, P2821, DOI 10.1096/fj.07-104224; Aquila S, 2010, ANAT REC, V293, P298, DOI 10.1002/ar.21042; Attwell D, 2001, J CEREBR BLOOD F MET, V21, P1133, DOI 10.1097/00004647-200110000-00001; BARTOVA A, 1976, J BIOL CHEM, V251, P5002; Bellocchio L, 2010, NAT NEUROSCI, V13, P281, DOI 10.1038/nn.2494; Belous AE, 2006, J CELL BIOCHEM, V99, P1165, DOI 10.1002/jcb.20985; Chen RM, 2004, J BIOL CHEM, V279, P26036, DOI 10.1074/jbc.M402710200; Claros MG, 1996, EUR J BIOCHEM, V241, P779, DOI 10.1111/j.1432-1033.1996.00779.x; Costa C, 2008, J NEUROSCI, V28, P8040, DOI 10.1523/JNEUROSCI.1947-08.2008; Gomes I, 2010, AAPS J, V12, P658, DOI 10.1208/s12248-010-9217-x; Guggenhuber S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015707; Gulyas AI, 2004, EUR J NEUROSCI, V20, P441, DOI 10.1111/j.1460-9568.2004.03428.x; Heimann AS, 2007, P NATL ACAD SCI USA, V104, P20588, DOI 10.1073/pnas.0706980105; Helling S, 2008, MOL CELL PROTEOMICS, V7, P1714, DOI 10.1074/mcp.M800137-MCP200; Kano M, 2009, PHYSIOL REV, V89, P309, DOI 10.1152/physrev.00019.2008; Kilbride SM, 2008, J NEUROCHEM, V106, P826, DOI 10.1111/j.1471-4159.2008.05441.x; Laughlin SB, 1998, NAT NEUROSCI, V1, P36, DOI 10.1038/236; Long JZ, 2009, P NATL ACAD SCI USA, V106, P20270, DOI 10.1073/pnas.0909411106; Lyssand JS, 2007, FEBS LETT, V581, P5765, DOI 10.1016/j.febslet.2007.11.044; MacAskill AF, 2010, TRENDS CELL BIOL, V20, P102, DOI 10.1016/j.tcb.2009.11.002; Marsicano G, 2006, J Endocrinol Invest, V29, P27; Marsicano G, 2002, NATURE, V418, P530, DOI 10.1038/nature00839; Marsicano Giovanni, 2008, P161, DOI 10.1007/978-0-387-74349-3_10; MARTIN BR, 1986, PHARMACOL REV, V38, P45; MATSUDA LA, 1990, NATURE, V346, P561, DOI 10.1038/346561a0; Mattson MP, 2008, NEURON, V60, P748, DOI 10.1016/j.neuron.2008.10.010; Monory K, 2006, NEURON, V51, P455, DOI 10.1016/j.neuron.2006.07.006; Nicholls D., 2002, BIOENERGETICS, V3; Papa S, 2006, IUBMB LIFE, V58, P173, DOI 10.1080/15216540500494516; Pertwee RG, 1999, CURR MED CHEM, V6, P635; Piomelli D, 2003, NAT REV NEUROSCI, V4, P873, DOI 10.1038/nrn1247; Rozenfeld R, 2008, FASEB J, V22, P2311, DOI 10.1096/fj.07-102731; Ryu H, 2005, P NATL ACAD SCI USA, V102, P13915, DOI 10.1073/pnas.0502878102; Tedesco L, 2010, DIABETES, V59, P2826, DOI 10.2337/db09-1881; Zippin JH, 2002, FASEB J, V16, P82, DOI 10.1096/fj.02-0598fje	37	335	342	3	57	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	APR	2012	15	4					558	564		10.1038/nn.3053	http://dx.doi.org/10.1038/nn.3053			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	916PA	22388959				2022-12-28	WOS:000302114500015
J	Loweth, JA; Scheyer, AF; Milovanovic, M; LaCrosse, AL; Flores-Barrera, E; Werner, CT; Li, X; Ford, KA; Le, T; Olive, MF; Szumlinski, KK; Tseng, KY; Wolf, ME				Loweth, Jessica A.; Scheyer, Andrew F.; Milovanovic, Mike; LaCrosse, Amber L.; Flores-Barrera, Eden; Werner, Craig T.; Li, Xuan; Ford, Kerstin A.; Le, Tuan; Olive, M. Foster; Szumlinski, Karen K.; Tseng, Kuei Y.; Wolf, Marina E.			Synaptic depression via mGIuR1 positive allosteric modulation suppresses cue-induced cocaine craving	NATURE NEUROSCIENCE			English	Article							LONG-TERM DEPRESSION; METABOTROPIC GLUTAMATE RECEPTORS; PERMEABLE AMPA RECEPTORS; NUCLEUS-ACCUMBENS SYNAPSES; SUBUNIT COMPOSITION; IN-VIVO; CALCIUM; DRUG; INCUBATION; PLASTICITY	Cue-induced cocaine craving is a major cause of relapse in abstinent addicts. In rats, cue-induced craving progressively intensifies (incubates) during withdrawal from extended-access cocaine self-administration. After 1 month of withdrawal, incubated craving is mediated by Ca2+-permeable AMPA receptors (CP-AMPARs) that accumulate in the nucleus accumbens (NAc). We found that decreased mGluR1 surface expression in the NAc preceded and enabled CP-AMPAR accumulation. Thus, restoring mGluR1 transmission by administering repeated injections of an mGluR1 positive allosteric modulator (PAM) prevented CP-AMPAR accumulation and incubation, whereas blocking mGluR1 transmission at even earlier withdrawal times accelerated CP-AMPAR accumulation. In studies conducted after prolonged withdrawal, when CP-AMPAR levels and cue-induced craving are high, we found that systemic administration of an mGluR1 PAM attenuated the expression of incubated craving by reducing CP-AMPAR transmission in the NAc to control levels. These results suggest a strategy in which recovering addicts could use a systemically active compound to protect against cue-induced relapse.	[Loweth, Jessica A.; Scheyer, Andrew F.; Milovanovic, Mike; Werner, Craig T.; Li, Xuan; Ford, Kerstin A.; Le, Tuan; Wolf, Marina E.] Rosalind Franklin Univ Med & Sci, Dept Neurosci, N Chicago, IL USA; [Scheyer, Andrew F.; Flores-Barrera, Eden; Ford, Kerstin A.; Tseng, Kuei Y.] Rosalind Franklin Univ Med & Sci, Dept Cellular & Mol Pharmacol, N Chicago, IL USA; [LaCrosse, Amber L.; Olive, M. Foster] Arizona State Univ, Dept Psychol, Tempe, AZ 85287 USA; [Szumlinski, Karen K.] Univ Calif Santa Barbara, Dept Psychol & Brain Sci, Santa Barbara, CA 93106 USA; [Szumlinski, Karen K.] Univ Calif Santa Barbara, Neurosci Res Inst, Santa Barbara, CA 93106 USA	Rosalind Franklin University Medical & Science; Rosalind Franklin University Medical & Science; Arizona State University; Arizona State University-Tempe; University of California System; University of California Santa Barbara; University of California System; University of California Santa Barbara	Wolf, ME (corresponding author), Rosalind Franklin Univ Med & Sci, Dept Neurosci, N Chicago, IL USA.	marina.wolf@rosalindfranklin.edu	Flores-Barrera, Eden/AGX-7638-2022; Szumlinski, Karen K./J-9617-2015	Flores-Barrera, Eden/0000-0003-4912-3741; Szumlinski, Karen K./0000-0003-1078-1077; Olive, Foster/0000-0002-2517-0351; /0000-0002-6737-1223; Werner, Craig/0000-0001-8387-777X; Scheyer, Andrew/0000-0002-1177-1359	US Public Health Service [DA009621, DA015835, DA029099, DA024355]; Rosalind Franklin University of Medicine and Science; postdoctoral National Research Service Award [DA030844]; NATIONAL INSTITUTE ON DRUG ABUSE [K05DA029099, R01DA024355, R01DA009621, R01DA015835, R37DA015835, F31DA036327, F32DA030844] Funding Source: NIH RePORTER	US Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); Rosalind Franklin University of Medicine and Science; postdoctoral National Research Service Award; NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by US Public Health Service grants DA009621 (M.E.W. and K.Y.T.), DA015835 (M.E.W.), DA029099 (M.E.W.), DA024355 (M.F.O.), Rosalind Franklin University of Medicine and Science (K.Y.T.), and postdoctoral National Research Service Award DA030844 (J.A.L).	Argilli E, 2008, J NEUROSCI, V28, P9092, DOI 10.1523/JNEUROSCI.1001-08.2008; Bellone C, 2006, NAT NEUROSCI, V9, P636, DOI 10.1038/nn1682; Bellone C, 2005, EUR J NEUROSCI, V21, P1280, DOI 10.1111/j.1460-9568.2005.03979.x; Bellone C, 2011, NAT NEUROSCI, V14, P1439, DOI 10.1038/nn.2930; Ben-Shahar O, 2009, SYNAPSE, V63, P598, DOI 10.1002/syn.20640; Bock R, 2013, NAT NEUROSCI, V16, P632, DOI 10.1038/nn.3369; Clem RL, 2010, SCIENCE, V330, P1108, DOI 10.1126/science.1195298; Conrad KL, 2008, NATURE, V454, P118, DOI 10.1038/nature06995; Dravolina OA, 2006, PSYCHOPHARMACOLOGY, V187, P397, DOI 10.1007/s00213-006-0440-1; Edwards S, 2011, ADDICT BIOL, V16, P450, DOI 10.1111/j.1369-1600.2010.00296.x; Ferrario CR, 2011, NEUROPHARMACOLOGY, V61, P1141, DOI 10.1016/j.neuropharm.2011.01.021; Fourgeaud L, 2004, J NEUROSCI, V24, P6939, DOI 10.1523/JNEUROSCI.0671-04.2004; Gardner SM, 2005, NEURON, V45, P903, DOI 10.1016/j.neuron.2005.02.026; Grueter BA, 2010, NAT NEUROSCI, V13, P1519, DOI 10.1038/nn.2685; Hu JH, 2012, NAT NEUROSCI, V15, P836, DOI 10.1038/nn.3103; Huang CC, 2011, J NEUROSCI, V31, P4194, DOI 10.1523/JNEUROSCI.5239-10.2011; Kalivas PW, 2009, NAT REV NEUROSCI, V10, P561, DOI 10.1038/nrn2515; Kalivas PW, 2005, AM J PSYCHIAT, V162, P1403, DOI 10.1176/appi.ajp.162.8.1403; Kammermeier PJ, 2008, J NEUROSCI, V28, P8560, DOI 10.1523/JNEUROSCI.1830-08.2008; Kammermeier PJ, 2007, P NATL ACAD SCI USA, V104, P6055, DOI 10.1073/pnas.0608991104; Kammermeier PJ, 2000, J NEUROSCI, V20, P7238; Kelly L, 2009, NAT NEUROSCI, V12, P593, DOI 10.1038/nn.2309; Lee BR, 2013, NAT NEUROSCI, V16, P1644, DOI 10.1038/nn.3533; Lobo MK, 2010, SCIENCE, V330, P385, DOI 10.1126/science.1188472; Lovinger David M., 2008, V184, P435; Loweth JA, 2013, CURR OPIN NEUROBIOL, V23, P500, DOI 10.1016/j.conb.2013.01.009; Mameli M, 2007, SCIENCE, V317, P530, DOI 10.1126/science.1142365; Mameli M, 2009, NAT NEUROSCI, V12, P1036, DOI 10.1038/nn.2367; McCutcheon JE, 2011, J NEUROSCI, V31, P14536, DOI 10.1523/JNEUROSCI.3625-11.2011; McCutcheon JE, 2011, J NEUROSCI, V31, P5737, DOI 10.1523/JNEUROSCI.0350-11.2011; Milton AL, 2012, NEUROSCI BIOBEHAV R, V36, P1119, DOI 10.1016/j.neubiorev.2012.01.002; Moussawi K, 2009, NAT NEUROSCI, V12, P182, DOI 10.1038/nn.2250; Ngomba RT, 2011, NEUROPHARMACOLOGY, V60, P1281, DOI 10.1016/j.neuropharm.2011.01.007; Olive MF, 2012, PHARMACOL BIOCHEM BE, V100, P801, DOI 10.1016/j.pbb.2011.04.015; Olive MF, 2010, EUR J PHARMACOL, V639, P47, DOI 10.1016/j.ejphar.2010.01.029; Olive M Foster, 2009, Curr Drug Abuse Rev, V2, P83; Pickens CL, 2011, TRENDS NEUROSCI, V34, P411, DOI 10.1016/j.tins.2011.06.001; Purgianto A, 2013, NEUROPSYCHOPHARMACOL, V38, P1789, DOI 10.1038/npp.2013.78; Reichel Carmela M, 2009, Curr Drug Abuse Rev, V2, P184; Reimers JM, 2011, BRAIN RES, V1367, P223, DOI 10.1016/j.brainres.2010.10.016; Robbe D, 2002, P NATL ACAD SCI USA, V99, P8384, DOI 10.1073/pnas.122149199; Sesack SR, 2010, NEUROPSYCHOPHARMACOL, V35, P27, DOI 10.1038/npp.2009.93; Szumlinski KK, 2008, BIOCHEM PHARMACOL, V75, P112, DOI 10.1016/j.bcp.2007.07.031; Szumlinski KK, 2006, NEUROPSYCHOPHARMACOL, V31, P768, DOI 10.1038/sj.npp.1300890; Szumlinski KK, 2004, NEURON, V43, P401, DOI 10.1016/j.neuron.2004.07.019; Vanderschuren LJMJ, 2013, CSH PERSPECT MED, V3, DOI 10.1101/cshperspect.a011932; Wolf ME, 2012, FRONT MOL NEUROSCI, V5, DOI 10.3389/fnmol.2012.00072; Xiao B, 1998, NEURON, V21, P707, DOI 10.1016/S0896-6273(00)80588-7	48	102	104	0	17	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JAN	2014	17	1					73	80		10.1038/nn.3590	http://dx.doi.org/10.1038/nn.3590			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	281DL	24270186	Green Accepted, Green Submitted			2022-12-28	WOS:000329080000016
J	Hansen, DV; Lui, JH; Flandin, P; Yoshikawa, K; Rubenstein, JL; Alvarez-Buylla, A; Kriegstein, AR				Hansen, David V.; Lui, Jan H.; Flandin, Pierre; Yoshikawa, Kazuaki; Rubenstein, John L.; Alvarez-Buylla, Arturo; Kriegstein, Arnold R.			Non-epithelial stem cells and cortical interneuron production in the human ganglionic eminences	NATURE NEUROSCIENCE			English	Article							FATE MAPPING REVEALS; GABAERGIC NEURONS; NEOCORTICAL INTERNEURONS; MOLECULAR SPECIFICATION; SUBVENTRICULAR ZONE; GLOBUS-PALLIDUS; VISUAL-CORTEX; RADIAL GLIA; MIGRATION; ORIGINS	GABAergic cortical interneurons underlie the complexity of neural circuits and are particularly numerous and diverse in humans. In rodents, cortical interneurons originate in the subpallial ganglionic eminences, but their developmental origins in humans are controversial. We characterized the developing human ganglionic eminences and found that the subventricular zone (SVZ) expanded massively during the early second trimester, becoming densely populated with neural stem cells and intermediate progenitor cells. In contrast with the cortex, most stem cells in the ganglionic eminence SVZ did not maintain radial fibers or orientation. The medial ganglionic eminence exhibited unique patterns of progenitor cell organization and clustering, and markers revealed that the caudal ganglionic eminence generated a greater proportion of cortical interneurons in humans than in rodents. On the basis of labeling of newborn neurons in slice culture and mapping of proliferating interneuron progenitors, we conclude that the vast majority of human cortical interneurons are produced in the ganglionic eminences, including an enormous contribution from non-epithelial SVZ stem cells.	[Hansen, David V.; Lui, Jan H.; Rubenstein, John L.; Alvarez-Buylla, Arturo; Kriegstein, Arnold R.] Univ Calif San Francisco, Eli & Edythe Broad Ctr Regenerat Med & Stem Cell, San Francisco, CA 94143 USA; [Hansen, David V.; Lui, Jan H.; Kriegstein, Arnold R.] Univ Calif San Francisco, Dept Neurol, San Francisco, CA USA; [Flandin, Pierre; Rubenstein, John L.] Univ Calif San Francisco, Dept Psychiat, San Francisco, CA USA; [Yoshikawa, Kazuaki] Osaka Univ, Inst Prot Res, Lab Regulat Neuronal Dev, Suita, Osaka 565, Japan; [Alvarez-Buylla, Arturo] Univ Calif San Francisco, Dept Neurosurg, San Francisco, CA USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Osaka University; University of California System; University of California San Francisco	Kriegstein, AR (corresponding author), Univ Calif San Francisco, Eli & Edythe Broad Ctr Regenerat Med & Stem Cell, San Francisco, CA 94143 USA.	john.rubenstein@ucsf.edu; abuylla@stemcell.ucsf.edu; kriegsteina@stemcell.ucsf.edu		Hansen, David/0000-0001-9679-7189; Alvarez-Buylla, Arturo/0000-0003-4426-8925	National Institute of Neurological Disorders and Stroke of the US National Institutes of Health; National Institute of Mental Health of the US National Institutes of Health; California Institute for Regenerative Medicine; John G. Bowes Research Fund; Bernard Osher; NATIONAL INSTITUTE OF MENTAL HEALTH [R37MH049428] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS021223] Funding Source: NIH RePORTER	National Institute of Neurological Disorders and Stroke of the US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Institute of Mental Health of the US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); California Institute for Regenerative Medicine(California Institute for Regenerative Medicine); John G. Bowes Research Fund; Bernard Osher; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank the staff at San Francisco General Hospital Women's Options Center for their consideration in allowing access to donated human fetal tissue. We thank S. Davis and co-workers at the California National Primate Research Center for providing fixed brain tissue from fetal macaques. We also thank W Walantus, K. Wang, S. Wang, Y. Wang and other University of California at San Francisco personnel for technical and administrative support. We are very grateful to J. Kohtz (Northwestern University) for sharing her final aliquot of pan-Dlx antibody. The NKX2-2 antibody developed by T. Jessell and S. Brenner-Morton was obtained from the Developmental Studies Hybridoma Bank, developed under the auspices of the National Institute of Child Health and Human Development and maintained by the University of Iowa Department of Biology. This work was supported by grants from the National Institute of Neurological Disorders and Stroke and the National Institute of Mental Health of the US National Institutes of Health, California Institute for Regenerative Medicine, John G. Bowes Research Fund and from Bernard Osher.	Alifragis P, 2004, J NEUROSCI, V24, P5643, DOI 10.1523/JNEUROSCI.1245-04.2004; Anderson SA, 1997, SCIENCE, V278, P474, DOI 10.1126/science.278.5337.474; Azim E, 2009, NAT NEUROSCI, V12, P1238, DOI 10.1038/nn.2387; Battista D, 2010, J NEUROSCI, V30, P3995, DOI 10.1523/JNEUROSCI.4382-09.2010; Brown KN, 2011, SCIENCE, V334, P480, DOI 10.1126/science.1208884; Butt SJB, 2005, NEURON, V48, P591, DOI 10.1016/j.neuron.2005.09.034; Cai YQ, 2013, J COMP NEUROL, V521, P479, DOI 10.1002/cne.23186; Carney RSE, 2006, J NEUROSCI, V26, P11562, DOI 10.1523/JNEUROSCI.3092-06.2006; CONNOR JR, 1984, NEUROSCIENCE, V12, P1027, DOI 10.1016/0306-4522(84)90002-2; DEACON TW, 1994, BRAIN RES, V668, P211, DOI 10.1016/0006-8993(94)90526-6; delRio MR, 1997, J CHEM NEUROANAT, V13, P243, DOI 10.1016/S0891-0618(97)00050-1; FELDMAN ML, 1978, J COMP NEUROL, V179, P761, DOI 10.1002/cne.901790406; Fertuzinhos S, 2009, CEREB CORTEX, V19, P2196, DOI 10.1093/cercor/bhp009; Flames N, 2007, J NEUROSCI, V27, P9682, DOI 10.1523/JNEUROSCI.2750-07.2007; Flandin P, 2010, J NEUROSCI, V30, P2812, DOI 10.1523/JNEUROSCI.4228-09.2010; Gelman D, 2011, J NEUROSCI, V31, P16570, DOI 10.1523/JNEUROSCI.4068-11.2011; GUILLEMOT F, 1993, MECH DEVELOP, V42, P171, DOI 10.1016/0925-4773(93)90006-J; Hansen DV, 2010, NATURE, V464, P554, DOI 10.1038/nature08845; Inta D, 2008, P NATL ACAD SCI USA, V105, P20994, DOI 10.1073/pnas.0807059105; Jakovcevski I, 2011, CEREB CORTEX, V21, P1771, DOI 10.1093/cercor/bhq245; Jones EG, 2009, CEREB CORTEX, V19, P1953, DOI 10.1093/cercor/bhp088; Kageyama R, 2005, EXP CELL RES, V306, P343, DOI 10.1016/j.yexcr.2005.03.015; Kanatani S, 2008, J NEUROSCI, V28, P13582, DOI 10.1523/JNEUROSCI.2132-08.2008; Kawaguchi Y, 1996, J NEUROSCI, V16, P2701; Letinic K, 2002, NATURE, V417, P645, DOI 10.1038/nature00779; Lui JH, 2011, CELL, V146, P18, DOI 10.1016/j.cell.2011.06.030; Ma T, 2012, CEREB CORTEX, V22, P2120, DOI 10.1093/cercor/bhr296; Marin O, 2000, J NEUROSCI, V20, P6063; Menezes JRL, 1995, MOL CELL NEUROSCI, V6, P496, DOI 10.1006/mcne.1995.0002; Miyoshi G, 2010, J NEUROSCI, V30, P1582, DOI 10.1523/JNEUROSCI.4515-09.2010; Nadarajah B, 2002, NAT NEUROSCI, V5, P218, DOI 10.1038/nn813; Nery S, 2002, NAT NEUROSCI, V5, P1279, DOI 10.1038/nn971; Nobrega-Pereira S, 2010, J NEUROSCI, V30, P2824, DOI 10.1523/JNEUROSCI.4023-09.2010; OLSSON M, 1995, NEUROSCIENCE, V69, P1169, DOI 10.1016/0306-4522(95)00325-D; Petanjek Z, 2009, FRONT NEUROANAT, V3, DOI 10.3389/neuro.05.026.2009; Petanjek Z, 2009, CEREB CORTEX, V19, P249, DOI 10.1093/cercor/bhn078; Petryniak MA, 2007, NEURON, V55, P417, DOI 10.1016/j.neuron.2007.06.036; Riccio O, 2012, CEREB CORTEX, V22, P86, DOI 10.1093/cercor/bhr086; SOMOGYI P, 1981, J COMP NEUROL, V195, P547, DOI 10.1002/cne.901950402; Sussel L, 1999, DEVELOPMENT, V126, P3359; Ventura RE, 2007, J NEUROSCI, V27, P4297, DOI 10.1523/JNEUROSCI.0399-07.2007; Wichterle H, 2001, DEVELOPMENT, V128, P3759; Wonders CP, 2006, NAT REV NEUROSCI, V7, P687, DOI 10.1038/nrn1954; Wu SX, 2011, DEVELOPMENT, V138, P2499, DOI 10.1242/dev.063032; Xu Q, 2003, CEREB CORTEX, V13, P670, DOI 10.1093/cercor/13.6.670; Xu Q, 2010, NEURON, V65, P328, DOI 10.1016/j.neuron.2010.01.004; Yu XJ, 2011, J NEUROSCI, V31, P2413, DOI 10.1523/JNEUROSCI.5249-10.2011; Yun K, 2002, DEVELOPMENT, V129, P5029; Zecevic N, 2005, J COMP NEUROL, V491, P109, DOI 10.1002/cne.20714; Zecevic N, 2011, DEV NEUROBIOL, V71, P18, DOI 10.1002/dneu.20812	50	184	185	0	17	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	NOV	2013	16	11					1576	1587		10.1038/nn.3541	http://dx.doi.org/10.1038/nn.3541			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	241YX	24097039	Green Accepted			2022-12-28	WOS:000326205700015
J	Hauner, KK; Howard, JD; Zelano, C; Gottfried, JA				Hauner, Katherina K.; Howard, James D.; Zelano, Christina; Gottfried, Jay A.			Stimulus-specific enhancement of fear extinction during slow-wave sleep	NATURE NEUROSCIENCE			English	Article							MEMORY; CONTEXT; HIPPOCAMPUS; HUMANS	Sleep can strengthen memory for emotional information, but whether emotional memories can be specifically targeted and modified during sleep is unknown. In human subjects who underwent olfactory contextual fear conditioning, re-exposure to the odorant context in slow-wave sleep promoted stimulus-specific fear extinction, with parallel reductions of hippocampal activity and reorganization of amygdala ensemble patterns. Thus, fear extinction may be selectively enhanced during sleep, even without re-exposure to the feared stimulus itself.	[Hauner, Katherina K.; Howard, James D.; Zelano, Christina; Gottfried, Jay A.] Northwestern Univ, Dept Neurol, Feinberg Sch Med, Chicago, IL 60611 USA	Northwestern University; Feinberg School of Medicine	Hauner, KK (corresponding author), Northwestern Univ, Dept Neurol, Feinberg Sch Med, Chicago, IL 60611 USA.	hauner@u.northwestern.edu			US National Institutes of Health [F32MH091967, T32NS047987, R01DC010014, R21DC012014]; Northwestern University Center for Translational Imaging; NATIONAL INSTITUTE OF MENTAL HEALTH [F32MH091967] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [T32NS047987] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R21DC012014, F31DC013500, R01DC010014] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Northwestern University Center for Translational Imaging; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	We thank P. Zee, C. Westerberg and K.N. Wu for technical assistance, and J. Radulovic and K. Paller for insightful discussions. Support was provided from the US National Institutes of Health to K.K.H. (F32MH091967, T32NS047987) and to J.A.G. (R01DC010014, R21DC012014), and from the Northwestern University Center for Translational Imaging.	Anagnostaras SG, 2001, HIPPOCAMPUS, V11, P8; Antony JW, 2012, NAT NEUROSCI, V15, P1114, DOI 10.1038/nn.3152; Arzi A, 2012, NAT NEUROSCI, V15, P1460, DOI 10.1038/nn.3193; Barnes DC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018130; Bendor D, 2012, NAT NEUROSCI, V15, P1439, DOI 10.1038/nn.3203; Bouton ME, 2002, BIOL PSYCHIAT, V52, P976, DOI 10.1016/S0006-3223(02)01546-9; Burwell RD, 1998, J COMP NEUROL, V398, P179, DOI 10.1002/(SICI)1096-9861(19980824)398:2<179::AID-CNE3>3.0.CO;2-Y; Diekelmann S, 2011, NAT NEUROSCI, V14, P381, DOI 10.1038/nn.2744; Gottfried JA, 2004, NAT NEUROSCI, V7, P1145, DOI 10.1038/nn1314; Han JH, 2009, SCIENCE, V323, P1492, DOI 10.1126/science.1164139; Herry C, 2008, NATURE, V454, P600, DOI 10.1038/nature07166; Hobin JA, 2006, HIPPOCAMPUS, V16, P174, DOI 10.1002/hipo.20144; Huff NC, 2009, BEHAV NEUROSCI, V123, P834, DOI 10.1037/a0016511; Mednick SC, 2011, TRENDS NEUROSCI, V34, P504, DOI 10.1016/j.tins.2011.06.003; Milad MR, 2007, BIOL PSYCHIAT, V62, P446, DOI 10.1016/j.biopsych.2006.10.011; Payne JD, 2011, J COGNITIVE NEUROSCI, V23, P1285, DOI 10.1162/jocn.2010.21526; Rasch B, 2007, SCIENCE, V315, P1426, DOI 10.1126/science.1138581; Stout SC, 2004, BEHAV PROCESS, V66, P7, DOI 10.1016/j.beproc.2003.11.003; Walker MP, 2004, NEURON, V44, P121, DOI 10.1016/j.neuron.2004.08.031; Wang SH, 2009, NAT NEUROSCI, V12, P253, DOI 10.1038/nn.2263	20	110	114	0	54	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	NOV	2013	16	11					1553	1555		10.1038/nn.3527	http://dx.doi.org/10.1038/nn.3527			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	241YX	24056700	Green Accepted			2022-12-28	WOS:000326205700012
J	Jego, S; Glasgow, SD; Herrera, CG; Ekstrand, M; Reed, SJ; Boyce, R; Friedman, J; Burdakov, D; Adamantidis, AR				Jego, Sonia; Glasgow, Stephen D.; Herrera, Carolina Gutierrez; Ekstrand, Mats; Reed, Sean J.; Boyce, Richard; Friedman, Jeffrey; Burdakov, Denis; Adamantidis, Antoine R.			Optogenetic identification of a rapid eye movement sleep modulatory circuit in the hypothalamus	NATURE NEUROSCIENCE			English	Article							MELANIN-CONCENTRATING HORMONE; PARADOXICAL REM SLEEP; STEM GABAERGIC NEURONS; LOCUS-COERULEUS; GLUTAMATERGIC TRANSMISSION; OREXIN NEURONS; WAKING CYCLE; RAT-BRAIN; IN-SITU; MICE	Rapid-eye movement (REM) sleep correlates with neuronal activity in the brainstem, basal forebrain and lateral hypothalamus. Lateral hypothalamus melanin-concentrating hormone (MCH)-expressing neurons are active during sleep, but their effects on REM sleep remain unclear. Using optogenetic tools in newly generated Tg(Pmch-cre) mice, we found that acute activation of MCH neurons (ChETA, SSFO) at the onset of REM sleep extended the duration of REM, but not non-REM, sleep episodes. In contrast, their acute silencing (eNpHR3.0, archaerhodopsin) reduced the frequency and amplitude of hippocampal theta rhythm without affecting REM sleep duration. In vitro activation of MCH neuron terminals induced GABA(A)-mediated inhibitory postsynaptic currents in wake-promoting histaminergic neurons of the tuberomammillary nucleus (TMN), and in vivo activation of MCH neuron terminals in TMN or medial septum also prolonged REM sleep episodes. Collectively, these results suggest that activation of MCH neurons maintains REM sleep, possibly through inhibition of arousal circuits in the mammalian brain.	[Jego, Sonia; Glasgow, Stephen D.; Herrera, Carolina Gutierrez; Reed, Sean J.; Boyce, Richard; Adamantidis, Antoine R.] McGill Univ, Dept Psychiat, Douglas Inst, Montreal, PQ, Canada; [Ekstrand, Mats; Friedman, Jeffrey] Rockefeller Univ, Howard Hughes Med Inst, Mol Genet Lab, New York, NY 10021 USA; [Burdakov, Denis] Natl Inst Med Res, MRC, London NW7 1AA, England; [Burdakov, Denis] Kings Coll London, London WC2R 2LS, England	McGill University; Howard Hughes Medical Institute; Rockefeller University; MRC National Institute for Medical Research; University of London; King's College London	Adamantidis, AR (corresponding author), McGill Univ, Dept Psychiat, Douglas Inst, Montreal, PQ, Canada.	antoine.adamantidis@mcgill.ca		Gutierrez Herrera, Carolina/0000-0002-7916-3341; Burdakov, Denis/0000-0002-9134-9165; Adamantidis, Antoine/0000-0003-2531-5175; Glasgow, Stephen/0000-0002-9809-4812	Fonds de la Recherche du Quebec - Sante; Human Frontier Science Program; Douglas Foundation; McGill University; Canadian Fund for Innovation; Canadian Research Chair (Tier 2); Canadian Institute for Health Research; Natural Science and Engineering Council of Canada; MRC [MC_UP_1202/2] Funding Source: UKRI; Medical Research Council [MC_UP_1202/2] Funding Source: researchfish	Fonds de la Recherche du Quebec - Sante(Fonds de la Recherche en Sante du Quebec); Human Frontier Science Program(Human Frontier Science Program); Douglas Foundation; McGill University; Canadian Fund for Innovation; Canadian Research Chair (Tier 2); Canadian Institute for Health Research(Canadian Institutes of Health Research (CIHR)); Natural Science and Engineering Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank B. Jones, M.E. Carter and L. de Lecea for helpful comments on a previous version of the manuscript. We thank the members of the Adamantidis laboratory for their technical help and comments. Optogenetic plasmids were kindly provided by K. Deisseroth (Stanford University). S.D.G. was supported by the Fonds de la Recherche du Quebec - Sante. D.B. and A.R.A. were supported by the Human Frontier Science Program. A.R.A. was supported by the Douglas Foundation, McGill University, Canadian Fund for Innovation, Canadian Research Chair (Tier 2), Canadian Institute for Health Research and the Natural Science and Engineering Council of Canada.	Adamantidis A, 2005, EUR J NEUROSCI, V21, P2837, DOI 10.1111/j.1460-9568.2005.04100.x; Adamantidis A, 2008, EUR J NEUROSCI, V27, P1793, DOI 10.1111/j.1460-9568.2008.06129.x; ASTONJONES G, 1981, J NEUROSCI, V1, P876; Atasoy D, 2008, J NEUROSCI, V28, P7025, DOI 10.1523/JNEUROSCI.1954-08.2008; Berndt A, 2009, NAT NEUROSCI, V12, P229, DOI 10.1038/nn.2247; BITTENCOURT JC, 1992, J COMP NEUROL, V319, P218, DOI 10.1002/cne.903190204; Boissard R, 2003, EUR J NEUROSCI, V18, P1627, DOI 10.1046/j.1460-9568.2003.02861.x; Burdakov D, 2005, J NEUROSCI, V25, P2429, DOI 10.1523/JNEUROSCI.4925-04.2005; Chee MJS, 2013, J COMP NEUROL, V521, P2208, DOI 10.1002/cne.23273; Chow BY, 2010, NATURE, V463, P98, DOI 10.1038/nature08652; Clement O, 2012, J NEUROSCI, V32, P16763, DOI 10.1523/JNEUROSCI.1885-12.2012; del Cid-Pellitero E, 2012, NEUROSCIENCE, V223, P269, DOI 10.1016/j.neuroscience.2012.07.072; Elias CF, 2001, J COMP NEUROL, V432, P1, DOI 10.1002/cne.1085; Fort P, 2008, NEUROSCIENCE, V155, P174, DOI 10.1016/j.neuroscience.2008.05.035; Gradinaru V, 2010, CELL, V141, P154, DOI 10.1016/j.cell.2010.02.037; Gunaydin LA, 2010, NAT NEUROSCI, V13, P387, DOI 10.1038/nn.2495; Han X, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000299; Hanriot L, 2007, J COMP NEUROL, V505, P147, DOI 10.1002/cne.21482; Hassani OK, 2009, P NATL ACAD SCI USA, V106, P2418, DOI 10.1073/pnas.0811400106; HOBSON JA, 1975, SCIENCE, V189, P55, DOI 10.1126/science.1094539; JOUVET M, 1962, Arch Ital Biol, V100, P125; Konadhode RR, 2013, J NEUROSCI, V33, P10257, DOI 10.1523/JNEUROSCI.1225-13.2013; Lagos P, 2011, BRAIN RES, V1369, P112, DOI 10.1016/j.brainres.2010.11.027; Lee MG, 2005, J NEUROSCI, V25, P6716, DOI 10.1523/JNEUROSCI.1887-05.2005; Lu J, 2002, J NEUROSCI, V22, P4568, DOI 10.1523/JNEUROSCI.22-11-04568.2002; Lu J, 2006, NATURE, V441, P589, DOI 10.1038/nature04767; Lu ZH, 2013, PEPTIDES, V44, P32, DOI 10.1016/j.peptides.2013.03.015; Luppi P.-H., 2013, CURR OPIN NEUROBIOL, DOI [10.1016/j.conb.2013.02.006, DOI 10.1016/J.C0NB.2013.02.006]; MCCARLEY RW, 1975, SCIENCE, V189, P58, DOI 10.1126/science.1135627; MCGINTY DJ, 1976, BRAIN RES, V101, P569, DOI 10.1016/0006-8993(76)90480-7; Mileykovskiy BY, 2005, NEURON, V46, P787, DOI 10.1016/j.neuron.2005.04.035; Modirrousta M, 2005, EUR J NEUROSCI, V21, P2807, DOI 10.1111/j.1460-9568.2005.04104.x; Monti JM, 2013, SLEEP MED REV, V17, P293, DOI 10.1016/j.smrv.2012.10.002; Pace-Schott EF, 2002, NAT REV NEUROSCI, V3, P591, DOI 10.1038/nrn895; Pachoud B, 2010, J NEUROPHYSIOL, V104, P1417, DOI 10.1152/jn.01052.2009; Saito Y, 2001, J COMP NEUROL, V435, P26, DOI 10.1002/cne.1191; Saper CB, 2010, NEURON, V68, P1023, DOI 10.1016/j.neuron.2010.11.032; Sapin E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011766; Sapin E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004272; Schone C, 2012, J NEUROSCI, V32, P12437, DOI 10.1523/JNEUROSCI.0706-12.2012; Takahashi K, 2006, J NEUROSCI, V26, P10292, DOI 10.1523/JNEUROSCI.2341-06.2006; Tan CP, 2002, GENOMICS, V79, P785, DOI 10.1006/geno.2002.6771; Tsai HC, 2009, SCIENCE, V324, P1080, DOI 10.1126/science.1168878; van den Pol AN, 2004, NEURON, V42, P635, DOI 10.1016/S0896-6273(04)00251-X; van den Pol AN, 2012, NEURON, V76, P98, DOI 10.1016/j.neuron.2012.09.014; Verret L, 2006, J COMP NEUROL, V495, P573, DOI 10.1002/cne.20891; Verret L, 2003, BMC NEUROSCI, V4, DOI 10.1186/1471-2202-4-19; Willie JT, 2008, NEUROSCIENCE, V156, P819, DOI 10.1016/j.neuroscience.2008.08.048; Wu M, 2009, P NATL ACAD SCI USA, V106, P17217, DOI 10.1073/pnas.0908200106; Zhang F, 2007, NATURE, V446, P633, DOI 10.1038/nature05744	50	254	261	0	69	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	NOV	2013	16	11					1637	1643		10.1038/nn.3522	http://dx.doi.org/10.1038/nn.3522			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	241YX	24056699	Green Accepted			2022-12-28	WOS:000326205700021
J	Laurens, J; Meng, H; Angelaki, DE				Laurens, Jean; Meng, Hui; Angelaki, Dora E.			Computation of linear acceleration through an internal model in the macaque cerebellum	NATURE NEUROSCIENCE			English	Article							VISUAL GRAVITATIONAL MOTION; VESTIBULOOCULAR REFLEX; SQUIRREL-MONKEY; VESTIBULAR SIGNALS; INERTIAL MOTION; EYE-MOVEMENTS; CORIOLIS; NEURONS; OTOLITH; STIMULATION	A combination of theory and behavioral findings support a role for internal models in the resolution of sensory ambiguities and sensorimotor processing. Although the cerebellum has been proposed as a candidate for implementation of internal models, concrete evidence from neural responses is lacking. Using unnatural motion stimuli, which induce incorrect self-motion perception and eye movements, we explored the neural correlates of an internal model that has been proposed to compensate for Einstein's equivalence principle and generate neural estimates of linear acceleration and gravity. We found that caudal cerebellar vermis Purkinje cells and cerebellar nuclei neurons selective for actual linear acceleration also encoded erroneous linear acceleration, as would be expected from the internal model hypothesis, even when no actual linear acceleration occurred. These findings provide strong evidence that the cerebellum might be involved in the implementation of internal models that mimic physical principles to interpret sensory signals, as previously hypothesized.	[Laurens, Jean] Washington Univ, Sch Med, Dept Otolaryngol, St Louis, MO 63110 USA; [Meng, Hui; Angelaki, Dora E.] Baylor Coll Med, Dept Neurosci, Houston, TX 77030 USA	Washington University (WUSTL); Baylor College of Medicine	Angelaki, DE (corresponding author), Baylor Coll Med, Dept Neurosci, Houston, TX 77030 USA.	angelaki@bcm.edu			US National Institutes of Health [EY12814]; NATIONAL EYE INSTITUTE [R01EY012814] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	We would like to thank E. Klier, P. Blazquez and T. Yakusheva for critically reading the manuscript. This work was supported by a grant from the US National Institutes of Health (EY12814).	Angelaki DE, 1999, J NEUROSCI, V19, P316, DOI 10.1523/JNEUROSCI.19-01-00316.1999; Angelaki DE, 2004, NATURE, V430, P560, DOI 10.1038/nature02754; Angelaki DE, 2009, ANN NY ACAD SCI, V1164, P19, DOI 10.1111/j.1749-6632.2009.03939.x; Barmack NH, 1995, J NEUROPHYSIOL, V74, P2573, DOI 10.1152/jn.1995.74.6.2573; Berkes P, 2011, SCIENCE, V331, P83, DOI 10.1126/science.1195870; Bles W, 1998, BRAIN RES BULL, V47, P543, DOI 10.1016/S0361-9230(98)00089-6; Bo J, 2008, J NEUROPHYSIOL, V100, P2825, DOI 10.1152/jn.90221.2008; Bos JE, 2002, BIOL CYBERN, V86, P191, DOI 10.1007/s00422-001-0289-7; Cullen KE, 2011, EXP BRAIN RES, V210, P377, DOI 10.1007/s00221-011-2555-9; DIZIO P, 1987, AVIAT SPACE ENVIR MD, V58, pA218; FERNANDEZ C, 1972, J NEUROPHYSIOL, V35, P978, DOI 10.1152/jn.1972.35.6.978; GOLDBERG JM, 1971, J NEUROPHYSIOL, V34, P635, DOI 10.1152/jn.1971.34.4.635; Green AM, 1998, J NEUROPHYSIOL, V80, P2222, DOI 10.1152/jn.1998.80.4.2222; Green AM, 2004, J NEUROPHYSIOL, V92, P905, DOI 10.1152/jn.01234.2003; Green AM, 2005, J NEURAL ENG, V2, DOI 10.1088/1741-2560/2/3/S02; GUEDRY FE, 1961, AEROSPACE MED, V32, P487; HESS BJM, 1993, EXP BRAIN RES, V95, P77; Holly JE, 2004, J VESTIBUL RES-EQUIL, V14, P443; Indovina I, 2005, SCIENCE, V308, P416, DOI 10.1126/science.1107961; Keller GB, 2009, NATURE, V457, P187, DOI 10.1038/nature07467; Kennedy R.S., 1965, RES REP US NAV SCH A, V18, P1; KORTE GE, 1979, J COMP NEUROL, V184, P265, DOI 10.1002/cne.901840204; Laurens J, 2007, BIOL CYBERN, V96, P389, DOI 10.1007/s00422-006-0133-1; Laurens J, 2011, J NEUROSCI, V31, P8093, DOI 10.1523/JNEUROSCI.5900-10.2011; Laurens J, 2011, EXP BRAIN RES, V210, P407, DOI 10.1007/s00221-011-2568-4; Laurens J, 2010, J NEUROPHYSIOL, V104, P1370, DOI 10.1152/jn.00143.2010; Lisberger SG, 2009, NEUROSCIENCE, V162, P763, DOI 10.1016/j.neuroscience.2009.03.059; Liu S, 2011, CEREB CORTEX, V21, P563, DOI 10.1093/cercor/bhq123; Liu S, 2009, J NEUROSCI, V29, P8936, DOI 10.1523/JNEUROSCI.1607-09.2009; Maklad A, 2003, DEV BRAIN RES, V140, P223, DOI 10.1016/S0165-3806(02)00609-0; Meng H, 2007, J NEUROSCI, V27, P13590, DOI 10.1523/JNEUROSCI.3931-07.2007; MERFELD DM, 1995, EXP BRAIN RES, V106, P123; Merfeld DM, 1999, NATURE, V398, P615, DOI 10.1038/19303; MILES FA, 1980, J NEUROPHYSIOL, V43, P1437, DOI 10.1152/jn.1980.43.5.1437; Newlands SD, 2003, J COMP NEUROL, V466, P31, DOI 10.1002/cne.10876; Pasalar S, 2006, NAT NEUROSCI, V9, P1404, DOI 10.1038/nn1783; Raphan T, 2002, EXP BRAIN RES, V145, P1, DOI 10.1007/s00221-002-1067-z; Raphan T, 1977, CONTROL GAZE BRAIN S, V1, P37; SHADMEHR R, 1994, J NEUROSCI, V14, P3208; Shadmehr R, 2008, EXP BRAIN RES, V185, P359, DOI 10.1007/s00221-008-1280-5; Shaikh AG, 2005, CURR BIOL, V15, P1657, DOI 10.1016/j.cub.2005.08.009; Shaikh AG, 2005, J NEUROPHYSIOL, V93, P853, DOI 10.1152/jn.00879.2004; Shaikh AG, 2004, J NEUROSCI, V24, P4491, DOI 10.1523/JNEUROSCI.0109-04.2004; Tribukait A, 2006, J VESTIBUL RES-EQUIL, V16, P105; WOLPERT DM, 1995, SCIENCE, V269, P1880, DOI 10.1126/science.7569931; Yakusheva T, 2008, J NEUROSCI, V28, P9997, DOI 10.1523/JNEUROSCI.2232-08.2008; Yakusheva TA, 2007, NEURON, V54, P973, DOI 10.1016/j.neuron.2007.06.003; Zago M, 2008, VISION RES, V48, P1532, DOI 10.1016/j.visres.2008.04.005; Zupan LH, 2002, BIOL CYBERN, V86, P209, DOI 10.1007/s00422-001-0290-1	50	55	55	0	10	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	NOV	2013	16	11					1701	1708		10.1038/nn.3530	http://dx.doi.org/10.1038/nn.3530			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	241YX	24077562	Green Accepted			2022-12-28	WOS:000326205700029
J	Lee, Y; Karuppagounder, SS; Shin, JH; Lee, YI; Ko, HS; Swing, D; Jiang, HS; Kang, SU; Lee, BD; Kang, HC; Kim, D; Tessarollo, L; Dawson, VL; Dawson, TM				Lee, Yunjong; Karuppagounder, Senthilkumar S.; Shin, Joo-Ho; Lee, Yun-Il; Ko, Han Seok; Swing, Debbie; Jiang, Haisong; Kang, Sung-Ung; Lee, Byoung Dae; Kang, Ho Chul; Kim, Donghoon; Tessarollo, Lino; Dawson, Valina L.; Dawson, Ted M.			Parthanatos mediates AIMP2-activated age-dependent dopaminergic neuronal loss	NATURE NEUROSCIENCE			English	Article							RNA SYNTHETASE COMPLEX; POLYMERASE-1-DEPENDENT CELL-DEATH; APOPTOSIS-INDUCING FACTOR; PARKINSONS-DISEASE; S-NITROSYLATION; ALPHA-SYNUCLEIN; PHOSPHORYLATION; UBIQUITINATION; EXPRESSION; BINDING	The defining pathogenic feature of Parkinson's disease is the age-dependent loss of dopaminergic neurons. Mutations and inactivation of parkin, an ubiquitin E3 ligase, induce Parkinson's disease through accumulation of pathogenic substrates. We found that transgenic overexpression of a parkin substrate, aminoacyl-tRNA synthetase complex interacting multifunctional protein-2 (AIMP2), led to a selective, age-dependent, progressive loss of dopaminergic neurons via activation of poly(ADP-ribose) polymerase-1 (PARP1). AIMP2 accumulation in vitro and in vivo resulted in PARP1 overactivation and dopaminergic cell toxicity via direct association of these proteins in the nucleus, providing a path to PARP1 activation other than DNA damage. Inhibition of PARP1 through gene deletion or drug inhibition reversed behavioral deficits and protected against dopamine neuron death in AIMP2 transgenic mice. These data indicate that brain-permeable PARP inhibitors could effectively delay or prevent disease progression in Parkinson's disease.	[Lee, Yunjong; Karuppagounder, Senthilkumar S.; Shin, Joo-Ho; Lee, Yun-Il; Ko, Han Seok; Jiang, Haisong; Kang, Sung-Ung; Lee, Byoung Dae; Kang, Ho Chul; Kim, Donghoon; Dawson, Valina L.; Dawson, Ted M.] Johns Hopkins Univ, Sch Med, Inst Cell Engn, Neuroregenerat & Stem Cell Programs, Baltimore, MD 21218 USA; [Lee, Yunjong] Johns Hopkins Univ, Sch Med, Dept Physiol, Baltimore, MD 21205 USA; [Lee, Yunjong; Karuppagounder, Senthilkumar S.; Shin, Joo-Ho; Lee, Yun-Il; Ko, Han Seok; Jiang, Haisong; Kang, Sung-Ung; Lee, Byoung Dae; Kang, Ho Chul; Kim, Donghoon; Dawson, Valina L.; Dawson, Ted M.] Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21205 USA; [Lee, Yunjong; Karuppagounder, Senthilkumar S.; Shin, Joo-Ho; Jiang, Haisong; Kang, Sung-Ung; Dawson, Valina L.; Dawson, Ted M.] Adrienne Helis Malvin Med Res Fdn, New Orleans, LA USA; [Shin, Joo-Ho] Sungkyunkwan Univ, Sch Med, Samsung Biomed Res Inst, Div Pharmacol,Dept Mol Cell Biol, Suwon, South Korea; [Ko, Han Seok; Kim, Donghoon] Diana Helis Henry Med Res Fdn, New Orleans, LA USA; [Swing, Debbie; Tessarollo, Lino] NCI, Neural Dev Sect, Mouse Canc Genet Program, Ctr Canc Res, Frederick, MD 21701 USA; [Lee, Byoung Dae] Kyung Hee Univ, Dept Neurosci, Age Related & Brain Dis Res Ctr, Seoul, South Korea; [Kang, Ho Chul] Ajou Univ, Sch Med, Dept Biomed Sci, Suwon 441749, South Korea; [Kang, Ho Chul] Ajou Univ, Sch Med, Dept Physiol, Suwon 441749, South Korea; [Dawson, Valina L.; Dawson, Ted M.] Johns Hopkins Univ, Sch Med, Solomon H Snyder Dept Neurosci, Baltimore, MD USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Sungkyunkwan University (SKKU); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Kyung Hee University; Ajou University; Ajou University; Johns Hopkins University	Dawson, VL (corresponding author), Johns Hopkins Univ, Sch Med, Inst Cell Engn, Neuroregenerat & Stem Cell Programs, Baltimore, MD 21218 USA.	vdawson@jhmi.edu; tdawson@jhmi.edu	Dawson, Valina/Y-9757-2019; Karuppagounder, Senthilkumar/I-6752-2013; Shin, Joo-Ho/P-1417-2018	Karuppagounder, Senthilkumar/0000-0002-3281-9913; Dawson, Valina/0000-0002-2915-3970; Lee, Yunjong/0000-0003-0182-2279	US National Institutes of Health [NS38377]; JPB Foundation; Samsung Scholarship Foundation; Adrienne Helis Malvin Medical Research Foundation; Diana Helis Henry Medical Research Foundation; Intramural Research Program of the National Cancer Institute, Center for Cancer Research; NATIONAL CANCER INSTITUTE [ZICBC010903] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS067525, P50NS038377] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); JPB Foundation; Samsung Scholarship Foundation(Samsung); Adrienne Helis Malvin Medical Research Foundation; Diana Helis Henry Medical Research Foundation; Intramural Research Program of the National Cancer Institute, Center for Cancer Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by grants from the US National Institutes of Health (NS38377) and the JPB Foundation. Y.-I.L. was supported by the Samsung Scholarship Foundation. T.M.D. is the Leonard and Madlyn Abramson Professor in Neurodegenerative Diseases. The authors acknowledge the joint participation and support by the Adrienne Helis Malvin Medical Research Foundation and the Diana Helis Henry Medical Research Foundation through its direct engagement in the continuous active conduct of medical research in conjunction with the Johns Hopkins Hospital and the Johns Hopkins University School of Medicine and the Foundation's Parkinson's Disease Programs. D.S. and L.T. were supported by the Intramural Research Program of the National Cancer Institute, Center for Cancer Research, US National Institutes of Health.	Abbas N, 1999, HUM MOL GENET, V8, P567, DOI 10.1093/hmg/8.4.567; Andrabi SA, 2006, P NATL ACAD SCI USA, V103, P18308, DOI 10.1073/pnas.0606526103; Chan CS, 2007, NATURE, V447, P1081, DOI 10.1038/nature05865; Chesselet MF, 2011, LANCET NEUROL, V10, P1108, DOI 10.1016/S1474-4422(11)70227-7; Chung KKK, 2004, SCIENCE, V304, P1328, DOI 10.1126/science.1093891; Cookson MR, 2003, NEUROMOL MED, V3, P1, DOI 10.1385/NMM:3:1:1; Corti O, 2003, HUM MOL GENET, V12, P1427, DOI 10.1093/hmg/ddg159; Corti O, 2013, CURR OPIN NEUROBIOL, V23, P100, DOI 10.1016/j.conb.2012.11.002; Corti O, 2011, PHYSIOL REV, V91, P1161, DOI 10.1152/physrev.00022.2010; Dawson TM, 2006, J NEURAL TRANSM-SUPP, P209; Dawson TM, 2010, NEURON, V66, P646, DOI 10.1016/j.neuron.2010.04.034; DEMURCIA G, 1994, MOL CELL BIOCHEM, V138, P15, DOI 10.1007/BF00928438; Geisler S, 2010, NAT CELL BIOL, V12, P119, DOI 10.1038/ncb2012; GERMAN DC, 1989, ANN NEUROL, V26, P507, DOI 10.1002/ana.410260403; Guzman JN, 2010, NATURE, V468, P696, DOI 10.1038/nature09536; Han JM, 2008, P NATL ACAD SCI USA, V105, P11206, DOI 10.1073/pnas.0800297105; Imam SZ, 2011, J NEUROSCI, V31, P157, DOI 10.1523/JNEUROSCI.1833-10.2011; Kim JY, 2002, P NATL ACAD SCI USA, V99, P7912, DOI 10.1073/pnas.122110199; Kim MY, 2004, CELL, V119, P803, DOI 10.1016/j.cell.2004.11.002; Kirik D, 2003, P NATL ACAD SCI USA, V100, P2884, DOI 10.1073/pnas.0536383100; Kistner A, 1996, P NATL ACAD SCI USA, V93, P10933, DOI 10.1073/pnas.93.20.10933; Kitada T, 1998, NATURE, V392, P605, DOI 10.1038/33416; Ko HS, 2006, J BIOL CHEM, V281, P16193, DOI 10.1074/jbc.C600041200; Ko HS, 2010, P NATL ACAD SCI USA, V107, P16691, DOI 10.1073/pnas.1006083107; Ko HS, 2005, J NEUROSCI, V25, P7968, DOI 10.1523/JNEUROSCI.2172-05.2005; LaVoie MJ, 2005, NAT MED, V11, P1214, DOI 10.1038/nm1314; Lee BD, 2010, NAT MED, V16, P998, DOI 10.1038/nm.2199; Lee Y, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a009324; Lin X, 2012, J NEUROSCI, V32, P9248, DOI 10.1523/JNEUROSCI.1731-12.2012; Lin X, 2009, NEURON, V64, P807, DOI 10.1016/j.neuron.2009.11.006; MacCallum PR, 2006, J GEN VIROL, V87, P3251, DOI 10.1099/vir.0.82051-0; Mandir AS, 1999, P NATL ACAD SCI USA, V96, P5774, DOI 10.1073/pnas.96.10.5774; Mayford M, 1996, SCIENCE, V274, P1678, DOI 10.1126/science.274.5293.1678; Meng FJ, 2011, MOL NEURODEGENER, V6, DOI 10.1186/1750-1326-6-34; Moore DJ, 2006, BIOCHEM SOC T, V34, P749, DOI 10.1042/BST0340749; Obeso JA, 2010, NAT MED, V16, P653, DOI 10.1038/nm.2165; Olzmann JA, 2008, AUTOPHAGY, V4, P85, DOI 10.4161/auto.5172; Park SG, 2010, IUBMB LIFE, V62, P296, DOI 10.1002/iub.324; Plummer R, 2008, CLIN CANCER RES, V14, P7917, DOI 10.1158/1078-0432.CCR-08-1223; Rouleau M, 2010, NAT REV CANCER, V10, P293, DOI 10.1038/nrc2812; Royo NC, 2008, BRAIN RES, V1190, P15, DOI 10.1016/j.brainres.2007.11.015; Rudow G, 2008, ACTA NEUROPATHOL, V115, P461, DOI 10.1007/s00401-008-0352-8; Shin JH, 2011, CELL, V144, P689, DOI 10.1016/j.cell.2011.02.010; Sprengel R, 2007, Handb Exp Pharmacol, P49; von Coelln R, 2004, P NATL ACAD SCI USA, V101, P10744, DOI 10.1073/pnas.0401297101; Wang C, 2005, HUM MOL GENET, V14, P3885, DOI 10.1093/hmg/ddi413; Wang HM, 2003, ANN NY ACAD SCI, V991, P132; Wang YF, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2000902; Wang YF, 2009, EXP NEUROL, V218, P193, DOI 10.1016/j.expneurol.2009.03.020; WEST MJ, 1993, NEUROBIOL AGING, V14, P275, DOI 10.1016/0197-4580(93)90112-O; Yao DD, 2004, P NATL ACAD SCI USA, V101, P10810, DOI 10.1073/pnas.0404161101; Yu SW, 2002, SCIENCE, V297, P259, DOI 10.1126/science.1072221	52	148	154	1	21	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	OCT	2013	16	10					1392	+		10.1038/nn.3500	http://dx.doi.org/10.1038/nn.3500			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	223HM	23974709	Green Accepted			2022-12-28	WOS:000324795300011
J	Huang, F; Wang, XD; Ostertag, EM; Nuwal, T; Huang, B; Jan, YN; Basbaum, AI; Jan, LY				Huang, Fen; Wang, Xidao; Ostertag, Eric M.; Nuwal, Tulip; Huang, Bo; Jan, Yuh-Nung; Basbaum, Allan I.; Jan, Lily Yeh			TMEM16C facilitates Na+-activated K+ currents in rat sensory neurons and regulates pain processing	NATURE NEUROSCIENCE			English	Article							ROOT GANGLION NEURONS; CHLORIDE CHANNEL ACTIVITY; PRIMARY AFFERENT NEURONS; SODIUM-CHANNELS; MOLECULAR-MECHANISMS; POTASSIUM CHANNEL; CALCIUM-CHANNELS; FAMILY; SLACK; ELECTROGENESIS	TMEM16C belongs to the TMEM16 family, which includes the Ca2+-activated Cl- channels TMEM16A and TMEM16B and a small-conductance, Ca2+-activated, nonselective cation channel (SCAN), TMEM16F. We found that in rat dorsal root ganglia (DRG) TMEM16C was expressed mainly in the IB4-positive, non-peptidergic nociceptors that also express the sodium-activated potassium (K-Na) channel Slack. Together these channel proteins promote K-Na channel activity and dampen neuronal excitability. DRG from TMEM16C knockout rats had diminished Slack expression, broadened action potentials and increased excitability. Moreover, the TMEM16C knockout rats, as well as rats with Slack knockdown by intrathecal injection of short interfering RNA, exhibited increased thermal and mechanical sensitivity. Experiments involving heterologous expression in HEK293 cells further showed that TMEM16C modulated the single-channel activity of Slack channels and increased its sodium sensitivity. Our study thus reveals that TMEM16C enhances K-Na channel activity in DRG neurons and regulates the processing of pain messages.	[Huang, Fen; Jan, Yuh-Nung; Jan, Lily Yeh] Univ Calif San Francisco, Dept Physiol, San Francisco, CA 94143 USA; [Huang, Fen; Jan, Yuh-Nung; Jan, Lily Yeh] Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA USA; [Wang, Xidao; Basbaum, Allan I.] Univ Calif San Francisco, Dept Anat, San Francisco, CA 94143 USA; [Ostertag, Eric M.] Transposagen Biopharmaceut Inc, Lexington, KY USA; [Nuwal, Tulip; Huang, Bo] Univ Calif San Francisco, Dept Pharmaceut Chem, San Francisco, CA USA; [Jan, Yuh-Nung; Jan, Lily Yeh] Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Jan, LY (corresponding author), Univ Calif San Francisco, Dept Physiol, Box 0444, San Francisco, CA 94143 USA.	lily.jan@ucsf.edu		Jan, Lily/0000-0003-3938-8498; Jan, Yuh Nung/0000-0003-1367-6299	US National Institutes of Health (NIH); NIH; Commonwealth of Kentucky; Howard Hughes Medical Institute; NATIONAL INSTITUTE OF MENTAL HEALTH [R37MH065334] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS069229] Funding Source: NIH RePORTER	US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Commonwealth of Kentucky; Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank M. Tynan La Fontaine and D. Wang for the assistance with the rodent genotyping and husbandry. We thank T. Jin, H. Yang, W. Zhang, W. Ge, T. Wang, C. Peters, S. Xiao, T. Cheng, J. Berg and Z. Guan for technical help and discussions. We thank J. Crawford at Transposagen for administrative assistance. This study is supported by grants from the US National Institutes of Health (NIH) to L.Y.J. and A. I. B. and grants from the NIH and the Commonwealth of Kentucky to E.M.O. Y.-N.J. and L.Y.J. are supported by the Howard Hughes Medical Institute.	Basbaum AI, 2009, CELL, V139, P267, DOI 10.1016/j.cell.2009.09.028; Beaudoin GMJ, 2012, J NEUROSCI, V32, P99, DOI 10.1523/JNEUROSCI.4565-11.2012; Bhattacharjee A, 2005, TRENDS NEUROSCI, V28, P422, DOI 10.1016/j.tins.2005.06.003; Bhattacharjee A, 2003, J NEUROSCI, V23, P11681; Billig GM, 2011, NAT NEUROSCI, V14, P763, DOI 10.1038/nn.2821; Blair NT, 2002, J NEUROSCI, V22, P10277; Briones N, 2012, BMC MED GENET, V13, DOI 10.1186/1471-2350-13-7; Brown MR, 2008, J PHYSIOL-LONDON, V586, P5161, DOI 10.1113/jphysiol.2008.160861; Budelli G, 2009, NAT NEUROSCI, V12, P745, DOI 10.1038/nn.2313; Caputo A, 2008, SCIENCE, V322, P590, DOI 10.1126/science.1163518; Catterall WA, 2005, PHARMACOL REV, V57, P411, DOI 10.1124/pr.57.4.5; Cavanaugh DJ, 2011, J NEUROSCI, V31, P10119, DOI 10.1523/JNEUROSCI.1299-11.2011; Charlesworth G, 2012, AM J HUM GENET, V91, P1041, DOI 10.1016/j.ajhg.2012.10.024; Cho H, 2012, NAT NEUROSCI, V15, P1015, DOI 10.1038/nn.3111; Dani A, 2010, NEURON, V68, P843, DOI 10.1016/j.neuron.2010.11.021; Davis JB, 2000, NATURE, V405, P183, DOI 10.1038/35012076; Dhaka A, 2007, NEURON, V54, P371, DOI 10.1016/j.neuron.2007.02.024; Dong XZ, 2001, CELL, V106, P619, DOI 10.1016/S0092-8674(01)00483-4; Duran C, 2012, AM J PHYSIOL-CELL PH, V302, pC482, DOI 10.1152/ajpcell.00140.2011; Fang X, 2005, J PHYSIOL-LONDON, V565, P927, DOI 10.1113/jphysiol.2005.086199; Fang X, 2002, J NEUROSCI, V22, P7425; Heninger A. K., 2007, CSH PROTOC, V2007; Huang F, 2012, P NATL ACAD SCI USA, V109, P16354, DOI 10.1073/pnas.1214596109; Huang F, 2009, P NATL ACAD SCI USA, V106, P21413, DOI 10.1073/pnas.0911935106; Huang WC, 2012, NEURON, V74, P179, DOI 10.1016/j.neuron.2012.01.033; HUANG Y, 1989, BIOPHYS J, V56, P1023, DOI 10.1016/S0006-3495(89)82747-X; Joiner WJ, 1998, NAT NEUROSCI, V1, P462, DOI 10.1038/2176; Julius D, 2001, NATURE, V413, P203, DOI 10.1038/35093019; Kamiyama D, 2012, DEV CELL, V23, P1103, DOI 10.1016/j.devcel.2012.10.003; Kittler R, 2007, NAT METHODS, V4, P337, DOI 10.1038/NMETH1025; Kuo CC, 2002, J GEN PHYSIOL, V120, P159, DOI 10.1085/jgp.20018536; Leffler A, 2005, PFLUG ARCH EUR J PHY, V451, P454, DOI 10.1007/s00424-005-1463-x; Lu BS, 2007, MAMM GENOME, V18, P338, DOI 10.1007/s00335-007-9025-5; Luo MC, 2005, MOL PAIN, V1, DOI 10.1186/1744-8069-1-29; Nanou E, 2008, P NATL ACAD SCI USA, V105, P20941, DOI 10.1073/pnas.0806403106; Noel J, 2009, EMBO J, V28, P1308, DOI 10.1038/emboj.2009.57; Oldham MC, 2006, P NATL ACAD SCI USA, V103, P17973, DOI 10.1073/pnas.0605938103; Renganathan M, 2001, J NEUROPHYSIOL, V86, P629, DOI 10.1152/jn.2001.86.2.629; Rush AM, 2007, J PHYSIOL-LONDON, V579, P1, DOI 10.1113/jphysiol.2006.121483; Ryglewski S, 2007, PLOS BIOL, V5, P818, DOI 10.1371/journal.pbio.0050066; Schroeder BC, 2008, CELL, V134, P1019, DOI 10.1016/j.cell.2008.09.003; Snider WD, 1998, NEURON, V20, P629, DOI 10.1016/S0896-6273(00)81003-X; Stohr H, 2009, J NEUROSCI, V29, P6809, DOI 10.1523/JNEUROSCI.5546-08.2009; Stucky CL, 1999, J NEUROSCI, V19, P6497; Suzuki J, 2010, NATURE, V468, P834, DOI 10.1038/nature09583; Tamsett TJ, 2009, J NEUROSCI, V29, P5127, DOI 10.1523/JNEUROSCI.0859-09.2009; Tian YM, 2012, J CELL SCI, V125, P4991, DOI 10.1242/jcs.109553; Vivancos GG, 2004, BRAZ J MED BIOL RES, V37, P391, DOI 10.1590/S0100-879X2004000300017; Yang B, 2007, J NEUROSCI, V27, P2617, DOI 10.1523/JNEUROSCI.5308-06.2007; Yang HH, 2012, CELL, V151, P111, DOI 10.1016/j.cell.2012.07.036; Yang YD, 2008, NATURE, V455, P1210, DOI 10.1038/nature07313; Yuan A, 2003, NEURON, V37, P765, DOI 10.1016/S0896-6273(03)00096-5	52	86	90	0	20	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	SEP	2013	16	9					1284	U166		10.1038/nn.3468	http://dx.doi.org/10.1038/nn.3468			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	207KN	23872594	Green Submitted, Green Accepted			2022-12-28	WOS:000323597500020
J	Han, TW; Jan, LY				Han, Tina W.; Jan, Lily Yeh			Making antisense of pain	NATURE NEUROSCIENCE			English	Editorial Material							ROOT GANGLION NEURONS; LONG NONCODING RNAS; POTASSIUM CHANNELS; AXOTOMY	A study now identifies a long noncoding antisense RNA that contributes to neuropathic pain through the suppression of potassium channel expression.	[Han, Tina W.] Univ Calif San Francisco, Howard Hughes Med Inst, Dept Physiol, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Biochem, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Biophys, San Francisco, CA 94143 USA	Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Han, TW (corresponding author), Univ Calif San Francisco, Howard Hughes Med Inst, Dept Physiol, San Francisco, CA 94143 USA.	lily.jan@ucsf.edu		Jan, Lily/0000-0003-3938-8498	Howard Hughes Medical Institute Funding Source: Medline	Howard Hughes Medical Institute(Howard Hughes Medical Institute)		Bao L., 2002, GENOME BIOL, V16, P175; Basbaum AI, 2009, CELL, V139, P267, DOI 10.1016/j.cell.2009.09.028; Everill B, 1999, J NEUROPHYSIOL, V82, P700, DOI 10.1152/jn.1999.82.2.700; Guttman M., 2009, CELL, V458, P223; Ishikawa K, 1999, MUSCLE NERVE, V22, P502, DOI 10.1002/(SICI)1097-4598(199904)22:4<502::AID-MUS12>3.0.CO;2-K; Jan LY, 2012, J PHYSIOL-LONDON, V590, P2591, DOI 10.1113/jphysiol.2011.224212; Rasband MN, 2001, P NATL ACAD SCI USA, V98, P13373, DOI 10.1073/pnas.231376298; Rinn JL, 2012, ANNU REV BIOCHEM, V81, P145, DOI 10.1146/annurev-biochem-051410-092902; Wapinski O, 2011, TRENDS CELL BIOL, V21, P354, DOI 10.1016/j.tcb.2011.04.001; WOOLF CJ, 1995, J COMP NEUROL, V360, P121, DOI 10.1002/cne.903600109; Zhao XL, 2013, NAT NEUROSCI, V16, P1024, DOI 10.1038/nn.3438	11	6	7	0	10	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	AUG	2013	16	8					986	987		10.1038/nn.3475	http://dx.doi.org/10.1038/nn.3475			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	190EV	23887131				2022-12-28	WOS:000322323000003
J	Lee, SH; Kravitz, DJ; Baker, CI				Lee, Sue-Hyun; Kravitz, Dwight J.; Baker, Chris I.			Goal-dependent dissociation of visual and prefrontal cortices during working memory	NATURE NEUROSCIENCE			English	Article							SHORT-TERM-MEMORY; NEURAL FRAMEWORK; CORTEX; OBJECTS; REPRESENTATIONS; VISUALIZATION; INFORMATION; AREAS	To determine the specific contribution of brain regions to working memory, human participants performed two distinct tasks on the same visually presented objects. During the maintenance of visual properties, object identity could be decoded from extrastriate, but not prefrontal, cortex, whereas the opposite held for nonvisual properties. Thus, the ability to maintain information during working memory is a general and flexible cortical property, with the role of individual regions being goal-dependent.	[Lee, Sue-Hyun; Kravitz, Dwight J.; Baker, Chris I.] NIMH, Lab Brain & Cognit, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH)	Lee, SH (corresponding author), NIMH, Lab Brain & Cognit, NIH, Bethesda, MD 20892 USA.	sue-hyun.lee@nih.gov	Baker, Chris/P-8442-2019; Kravitz, Dwight/AAO-5860-2020; Lee, Sue-Hyun/F-5490-2015	Baker, Chris/0000-0001-6861-8964; Kravitz, Dwight/0000-0002-8108-1329; Lee, Sue-Hyun/0000-0002-5318-5657	US National Institute of Mental Health Intramural Research Program; NATIONAL INSTITUTE OF MENTAL HEALTH [ZIAMH002909] Funding Source: NIH RePORTER	US National Institute of Mental Health Intramural Research Program; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by the US National Institute of Mental Health Intramural Research Program. Thanks to S. Marrett and S. Inati for help with data acquisition, E. Bilger and E. Aguila for data collection, A. Harel and A. Martin for comments and members of the Laboratory of Brain and Cognition for discussion.	Brady MJ, 2003, J VISION, V3, P413, DOI 10.1167/3.6.2; Buckner RL, 2001, NAT REV NEUROSCI, V2, P624, DOI 10.1038/35090048; Christophel TB, 2012, J NEUROSCI, V32, P12983, DOI 10.1523/JNEUROSCI.0184-12.2012; Cox RW, 1996, COMPUT BIOMED RES, V29, P162, DOI 10.1006/cbmr.1996.0014; Curtis CE, 2003, TRENDS COGN SCI, V7, P415, DOI 10.1016/S1364-6613(03)00197-9; D'Esposito M, 2007, PHILOS T R SOC B, V362, P761, DOI 10.1098/rstb.2007.2086; Desikan RS, 2006, NEUROIMAGE, V31, P968, DOI 10.1016/j.neuroimage.2006.01.021; FUNAHASHI S, 1989, J NEUROPHYSIOL, V61, P331, DOI 10.1152/jn.1989.61.2.331; Harrison SA, 2009, NATURE, V458, P632, DOI 10.1038/nature07832; Haxby JV, 2001, SCIENCE, V293, P2425, DOI 10.1126/science.1063736; Kravitz DJ, 2013, TRENDS COGN SCI, V17, P26, DOI 10.1016/j.tics.2012.10.011; Kravitz DJ, 2011, NAT REV NEUROSCI, V12, P217, DOI 10.1038/nrn3008; Kravitz DJ, 2010, CEREB CORTEX, V20, P2916, DOI 10.1093/cercor/bhq042; Kriegeskorte N, 2006, P NATL ACAD SCI USA, V103, P3863, DOI 10.1073/pnas.0600244103; Lee SH, 2012, NEUROIMAGE, V59, P4064, DOI 10.1016/j.neuroimage.2011.10.055; Lee TG, 2012, J NEUROSCI, V32, P15458, DOI 10.1523/JNEUROSCI.0627-12.2012; Lewis-Peacock JA, 2012, NEUROPSYCHOLOGIA, V50, P470, DOI 10.1016/j.neuropsychologia.2011.11.006; Linden DEJ, 2012, J NEUROPHYSIOL, V107, P628, DOI 10.1152/jn.00105.2011; Riggall AC, 2012, J NEUROSCI, V32, P12990, DOI 10.1523/JNEUROSCI.1892-12.2012; Romero L, 2006, J COGNITIVE NEUROSCI, V18, P1147, DOI 10.1162/jocn.2006.18.7.1147; Saad ZS, 2012, NEUROIMAGE, V62, P768, DOI 10.1016/j.neuroimage.2011.09.016; Serences JT, 2009, PSYCHOL SCI, V20, P207, DOI 10.1111/j.1467-9280.2009.02276.x; Simmons WK, 2007, NEUROPSYCHOLOGIA, V45, P2802, DOI 10.1016/j.neuropsychologia.2007.05.002; Sligte IG, 2013, J NEUROSCI, V33, P1293, DOI 10.1523/JNEUROSCI.4860-12.2013; Van de Moortele PF, 2009, NEUROIMAGE, V46, P432, DOI 10.1016/j.neuroimage.2009.02.009	25	120	120	2	35	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	AUG	2013	16	8					997	U35		10.1038/nn.3452	http://dx.doi.org/10.1038/nn.3452			5	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	190EV	23817547	Green Accepted			2022-12-28	WOS:000322323000008
J	Buckner, RL; Krienen, FM; Yeo, BTT				Buckner, Randy L.; Krienen, Fenna M.; Yeo, B. T. Thomas			Opportunities and limitations of intrinsic functional connectivity MRI	NATURE NEUROSCIENCE			English	Review							RESTING-STATE NETWORKS; GLOBAL SIGNAL REGRESSION; DEFAULT MODE NETWORK; HUMAN BRAIN; STRUCTURAL CONNECTIVITY; CORPUS-CALLOSUM; CORTEX; ORGANIZATION; ARCHITECTURE; DISTINCT	Intrinsic functional connectivity magnetic resonance imaging (fcMRI) has emerged as a powerful tool for mapping large-scale networks in the human brain. Robust and reliable functionally coupled networks can be detected in individuals that echo many known features of anatomical organization. Features of brain organization have been discovered, including descriptions of distributed large-scale networks interwoven throughout association cortex, interactions (including anticorrelations) between brain networks and insights into the topography of subcortical structures. But interpreting fcMRI is complicated by several factors. Functional coupling changes dynamically, suggesting that it is constrained by, but not fully dictated by, anatomic connectivity. Critically to study of between-group differences, fcMRI is sensitive to head motion and to differences in the mental states of participants during the scans. We discuss the potential of fcMRI in the context of its limitations.	[Buckner, Randy L.; Krienen, Fenna M.] Harvard Univ, Dept Psychol, Ctr Brain Sci, Cambridge, MA 02138 USA; [Buckner, Randy L.] Massachusetts Gen Hosp, Dept Psychiat, Boston, MA 02114 USA; [Buckner, Randy L.; Krienen, Fenna M.] Massachusetts Gen Hosp, Dept Radiol, Athinoula A Martinos Ctr Biomed Imaging, Charlestown, MA USA; [Yeo, B. T. Thomas] Duke NUS Grad Med Sch, Ctr Cognit Neurosci, Singapore, Singapore	Harvard University; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; National University of Singapore	Buckner, RL (corresponding author), Harvard Univ, Dept Psychol, Ctr Brain Sci, 33 Kirkland St, Cambridge, MA 02138 USA.	randy_buckner@harvard.edu	Yeo, B.T. Thomas/X-2860-2019	Yeo, B.T. Thomas/0000-0002-0119-3276	Medical Research Council [G0600717B] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)		Andrews-Hanna JR, 2012, NEUROSCIENTIST, V18, P251, DOI 10.1177/1073858411403316; Birn RM, 2008, NEUROIMAGE, V40, P644, DOI 10.1016/j.neuroimage.2007.11.059; BISWAL B, 1995, MAGNET RESON MED, V34, P537, DOI 10.1002/mrm.1910340409; Bleuler E., 1950, DEMENTIA PRAECOX GRO; Buckner RL, 2011, J NEUROPHYSIOL, V106, P2322, DOI 10.1152/jn.00339.2011; Chai XQJ, 2012, NEUROIMAGE, V59, P1420, DOI 10.1016/j.neuroimage.2011.08.048; Cohen AL, 2008, NEUROIMAGE, V41, P45, DOI 10.1016/j.neuroimage.2008.01.066; Damoiseaux JS, 2006, P NATL ACAD SCI USA, V103, P13848, DOI 10.1073/pnas.0601417103; Damoiseaux JS, 2009, BRAIN STRUCT FUNCT, V213, P525, DOI 10.1007/s00429-009-0208-6; De Luca M, 2006, NEUROIMAGE, V29, P1359, DOI 10.1016/j.neuroimage.2005.08.035; Deco G, 2011, NEUROSCIENTIST, V17, P107, DOI 10.1177/1073858409354384; Dosenbach NUF, 2007, P NATL ACAD SCI USA, V104, P11073, DOI 10.1073/pnas.0704320104; Fox MD, 2005, P NATL ACAD SCI USA, V102, P9673, DOI 10.1073/pnas.0504136102; Fox MD, 2006, P NATL ACAD SCI USA, V103, P10046, DOI 10.1073/pnas.0604187103; Fransson P, 2005, HUM BRAIN MAPP, V26, P15, DOI 10.1002/hbm.20113; GOLDMANRAKIC PS, 1988, ANNU REV NEUROSCI, V11, P137, DOI 10.1146/annurev.neuro.11.1.137; Greicius MD, 2003, P NATL ACAD SCI USA, V100, P253, DOI 10.1073/pnas.0135058100; Greicius M, 2008, CURR OPIN NEUROL, V21, P424, DOI 10.1097/WCO.0b013e328306f2c5; Greicius MD, 2009, CEREB CORTEX, V19, P72, DOI 10.1093/cercor/bhn059; Habas C, 2009, J NEUROSCI, V29, P8586, DOI 10.1523/JNEUROSCI.1868-09.2009; Handwerker DA, 2012, NEUROIMAGE, V62, P1017, DOI 10.1016/j.neuroimage.2012.02.015; He BYJ, 2008, P NATL ACAD SCI USA, V105, P16039, DOI 10.1073/pnas.0807010105; Hill J, 2010, P NATL ACAD SCI USA, V107, P13135, DOI 10.1073/pnas.1001229107; Honey CJ, 2009, P NATL ACAD SCI USA, V106, P2035, DOI 10.1073/pnas.0811168106; HUTCHISON RM, 2012, HUM BRAIN MAPP, V34, P2154, DOI DOI 10.1002/HBM.22058; Johnston JM, 2008, J NEUROSCI, V28, P6453, DOI 10.1523/JNEUROSCI.0573-08.2008; KAAS JH, 1987, ANNU REV PSYCHOL, V38, P129, DOI 10.1146/annurev.ps.38.020187.001021; Lewisa CM, 2009, P NATL ACAD SCI USA, V106, P17558, DOI 10.1073/pnas.0902455106; Lu J, 2011, J NEUROSCI, V31, P15065, DOI 10.1523/JNEUROSCI.2364-11.2011; Manni E, 2004, NAT REV NEUROSCI, V5, P241, DOI 10.1038/nrn1347; Margulies DS, 2007, NEUROIMAGE, V37, P579, DOI 10.1016/j.neuroimage.2007.05.019; Margulies DS, 2009, P NATL ACAD SCI USA, V106, P20069, DOI 10.1073/pnas.0905314106; Mars RB, 2011, J NEUROSCI, V31, P4087, DOI 10.1523/JNEUROSCI.5102-10.2011; MAUNSELL JHR, 1983, J NEUROSCI, V3, P2563; Mesulam M, 2012, NEUROIMAGE, V62, P2182, DOI 10.1016/j.neuroimage.2011.12.033; Mueller S, 2013, NEURON, V77, P586, DOI 10.1016/j.neuron.2012.12.028; Murphy K, 2009, NEUROIMAGE, V44, P893, DOI 10.1016/j.neuroimage.2008.09.036; Nolen-Hoeksema S, 2000, J ABNORM PSYCHOL, V109, P504, DOI 10.1037/0021-843X.109.3.504; O'Reilly JX, 2010, CEREB CORTEX, V20, P953, DOI 10.1093/cercor/bhp157; OGAWA S, 1993, BIOPHYS J, V64, P803, DOI 10.1016/S0006-3495(93)81441-3; Passingham RE, 2002, NAT REV NEUROSCI, V3, P606, DOI 10.1038/nrn893; Power JD, 2012, NEUROIMAGE, V59, P2142, DOI 10.1016/j.neuroimage.2011.10.018; Power JD, 2011, NEURON, V72, P665, DOI 10.1016/j.neuron.2011.09.006; RAKIC P, 1988, SCIENCE, V241, P170, DOI 10.1126/science.3291116; Rosa MGP, 2005, PHILOS T R SOC B, V360, P665, DOI 10.1098/rstb.2005.1626; Seeley WW, 2007, J NEUROSCI, V27, P2349, DOI 10.1523/JNEUROSCI.5587-06.2007; Shirer WR, 2012, CEREB CORTEX, V22, P158, DOI 10.1093/cercor/bhr099; Smith SM, 2009, P NATL ACAD SCI USA, V106, P13040, DOI 10.1073/pnas.0905267106; Spreng RN, 2009, J COGNITIVE NEUROSCI, V21, P489, DOI 10.1162/jocn.2008.21029; Strick PL, 2009, ANNU REV NEUROSCI, V32, P413, DOI 10.1146/annurev.neuro.31.060407.125606; Tyszka JM, 2011, J NEUROSCI, V31, P15154, DOI 10.1523/JNEUROSCI.1453-11.2011; Van Dijk KRA, 2012, NEUROIMAGE, V59, P431, DOI 10.1016/j.neuroimage.2011.07.044; Vincent JL, 2007, NATURE, V447, P83, DOI 10.1038/nature05758; Wang L, 2012, NEURON, V76, P1010, DOI 10.1016/j.neuron.2012.09.033; Whitfield-Gabrieli S, 2012, ANNU REV CLIN PSYCHO, V8, P49, DOI 10.1146/annurev-clinpsy-032511-143049; Wig GS, 2011, ANN NY ACAD SCI, V1224, P126, DOI 10.1111/j.1749-6632.2010.05947.x; Yeo BTT, 2011, J NEUROPHYSIOL, V106, P1125, DOI 10.1152/jn.00338.2011; Zhang DY, 2010, NAT REV NEUROL, V6, P15, DOI 10.1038/nrneurol.2009.198	58	573	589	5	157	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUL	2013	16	7					832	837		10.1038/nn.3423	http://dx.doi.org/10.1038/nn.3423			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	174UM	23799476				2022-12-28	WOS:000321180900013
J	Dayan, E; Censor, N; Buch, ER; Sandrini, M; Cohen, LG				Dayan, Eran; Censor, Nitzan; Buch, Ethan R.; Sandrini, Marco; Cohen, Leonardo G.			Noninvasive brain stimulation: from physiology to network dynamics and back	NATURE NEUROSCIENCE			English	Review							TRANSCRANIAL MAGNETIC STIMULATION; HUMAN MOTOR CORTEX; THETA-BURST-STIMULATION; HIGH-FREQUENCY STIMULATION; POSTERIOR PARIETAL CORTEX; VENTRAL PREMOTOR CORTEX; CORTICAL PLASTICITY; SYNAPTIC PLASTICITY; EXCITABILITY SHIFTS; PREFRONTAL CORTEX	Noninvasive brain stimulation techniques have been widely used for studying the physiology of the CNS, identifying the functional role of specific brain structures and, more recently, exploring large-scale network dynamics. Here we review key findings that contribute to our understanding of the mechanisms underlying the physiological and behavioral effects of these techniques. We highlight recent innovations using noninvasive stimulation to investigate global brain network dynamics and organization. New combinations of these techniques, in conjunction with neuroimaging, will further advance the utility of their application.	[Dayan, Eran; Censor, Nitzan; Buch, Ethan R.; Sandrini, Marco; Cohen, Leonardo G.] NINDS, Human Cort Physiol & Neurorehabil Sect, US Natl Inst Hlth, Bethesda, MD 20892 USA; [Buch, Ethan R.; Sandrini, Marco] Uniformed Serv Univ Hlth Sci, Ctr Neurosci & Regenerat Med, Bethesda, MD 20814 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS); Uniformed Services University of the Health Sciences - USA	Cohen, LG (corresponding author), NINDS, Human Cort Physiol & Neurorehabil Sect, US Natl Inst Hlth, Bldg 36,Rm 4D04, Bethesda, MD 20892 USA.	cohenl@ninds.nih.gov	Censor, Nitzan/ABC-1739-2021; Buch, Ethan/AAB-4549-2021; Sandrini, Marco/J-2276-2014; Dayan, Eran/C-3449-2009	Sandrini, Marco/0000-0002-1664-5722; Dayan, Eran/0000-0001-9710-9210	Intramural Research Program of the US National Institute of Neurological Disorders and Stroke (NINDS; US National Institutes of Health); US Department of Defense in the Center for Neuroscience and Regenerative Medicine; NINDS Ruth L. Kirschstein National Research Service Award; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [ZIANS003030, ZIANS002978] Funding Source: NIH RePORTER	Intramural Research Program of the US National Institute of Neurological Disorders and Stroke (NINDS; US National Institutes of Health); US Department of Defense in the Center for Neuroscience and Regenerative Medicine(United States Department of Defense); NINDS Ruth L. Kirschstein National Research Service Award; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank S.-L. Liew for suggestions. This work was supported by the Intramural Research Program of the US National Institute of Neurological Disorders and Stroke (NINDS; US National Institutes of Health) and by funding from US Department of Defense in the Center for Neuroscience and Regenerative Medicine to M.S. and E.R.B. N.C. was supported by an NINDS Ruth L. Kirschstein National Research Service Award.	Agostino R, 2007, EXP BRAIN RES, V180, P105, DOI 10.1007/s00221-006-0838-3; Antal A, 2004, J COGNITIVE NEUROSCI, V16, P521, DOI 10.1162/089892904323057263; Antal A, 2010, BRAIN STIMUL, V3, P230, DOI 10.1016/j.brs.2009.12.003; Avenanti A, 2007, CURR BIOL, V17, P2129, DOI 10.1016/j.cub.2007.11.045; Avenanti A, 2013, CEREB CORTEX, V23, P570, DOI 10.1093/cercor/bhs040; BARKER AT, 1985, LANCET, V1, P1106; Bastos AM, 2012, NEURON, V76, P695, DOI 10.1016/j.neuron.2012.10.038; Bestmann S, 2008, EXP BRAIN RES, V191, P383, DOI 10.1007/s00221-008-1601-8; Bikson M, 2012, CLIN EEG NEUROSCI, V43, P176, DOI 10.1177/1550059412445138; BINDMAN LJ, 1964, J PHYSIOL-LONDON, V172, P369, DOI 10.1113/jphysiol.1964.sp007425; BLISS TVP, 1973, J PHYSIOL-LONDON, V232, P331, DOI 10.1113/jphysiol.1973.sp010273; Buch ER, 2011, J NEUROSCI, V31, P17669, DOI 10.1523/JNEUROSCI.1513-11.2011; Buch ER, 2010, J NEUROSCI, V30, P1395, DOI 10.1523/JNEUROSCI.4882-09.2010; Bullmore ET, 2012, NAT REV NEUROSCI, V13, P336, DOI 10.1038/nrn3214; Butefisch CM, 2004, J NEUROPHYSIOL, V91, P2110, DOI 10.1152/jn.01038.2003; Cattaneo L, 2010, CEREB CORTEX, V20, P2252, DOI 10.1093/cercor/bhp291; Censor N, 2011, J PHYSIOL-LONDON, V589, P21, DOI 10.1113/jphysiol.2010.198077; Censor N, 2010, CURR BIOL, V20, P1545, DOI 10.1016/j.cub.2010.07.047; Chambers CD, 2004, NAT NEUROSCI, V7, P217, DOI 10.1038/nn1203; Chanes L, 2013, J NEUROSCI, V33, P5000, DOI 10.1523/JNEUROSCI.4401-12.2013; Cheeran B, 2008, J PHYSIOL-LONDON, V586, P5717, DOI 10.1113/jphysiol.2008.159905; Chen R, 1997, NEUROLOGY, V48, P1398, DOI 10.1212/WNL.48.5.1398; Civardi C, 2001, NEUROIMAGE, V14, P1444, DOI 10.1006/nimg.2001.0918; COHEN D, 1991, J CLIN NEUROPHYSIOL, V8, P102, DOI 10.1097/00004691-199101000-00013; Cohen LG, 1997, NATURE, V389, P180, DOI 10.1038/38278; Daskalakis ZJ, 2004, J PHYSIOL-LONDON, V557, P689, DOI 10.1113/jphysiol.2003.059808; Datta A, 2009, BRAIN STIMUL, V2, P201, DOI 10.1016/j.brs.2009.03.005; Davare M, 2008, J PHYSIOL-LONDON, V586, P2735, DOI 10.1113/jphysiol.2008.152603; Deng ZD, 2013, BRAIN STIMUL, V6, P1, DOI 10.1016/j.brs.2012.02.005; Di Lazzaro V, 2008, J PHYSIOL-LONDON, V586, P3871, DOI 10.1113/jphysiol.2008.152736; DUDEK SM, 1993, J NEUROSCI, V13, P2910; Dugue L, 2011, J NEUROSCI, V31, P11889, DOI 10.1523/JNEUROSCI.1161-11.2011; Feldman DE, 2012, NEURON, V75, P556, DOI 10.1016/j.neuron.2012.08.001; Fertonani A, 2011, J NEUROSCI, V31, P15416, DOI 10.1523/JNEUROSCI.2002-11.2011; Figurov A, 1996, NATURE, V381, P706, DOI 10.1038/381706a0; Fregni F, 2005, EXP BRAIN RES, V166, P23, DOI 10.1007/s00221-005-2334-6; Fritsch B, 2010, NEURON, V66, P198, DOI 10.1016/j.neuron.2010.03.035; Groppa S, 2012, HUM BRAIN MAPP, V33, P419, DOI 10.1002/hbm.21221; Hallett M, 2007, NEURON, V55, P187, DOI 10.1016/j.neuron.2007.06.026; Hasan A, 2013, J COGNITIVE NEUROSCI, V25, P558, DOI 10.1162/jocn_a_00338; Huang YZ, 2007, CLIN NEUROPHYSIOL, V118, P1028, DOI 10.1016/j.clinph.2007.01.021; Huang YZ, 2005, NEURON, V45, P201, DOI 10.1016/j.neuron.2004.12.033; Huerta PT, 2009, J NEUROENG REHABIL, V6, DOI 10.1186/1743-0003-6-7; Hummel F, 2005, BRAIN, V128, P490, DOI 10.1093/brain/awh369; Kadosh RC, 2010, CURR BIOL, V20, P2016, DOI 10.1016/j.cub.2010.10.007; Kim YH, 2004, NEUROSCI LETT, V367, P181, DOI 10.1016/j.neulet.2004.05.113; Knoch D, 2006, SCIENCE, V314, P829, DOI 10.1126/science.1129156; Koch G, 2007, J NEUROSCI, V27, P6815, DOI 10.1523/JNEUROSCI.0598-07.2007; Koch G, 2009, J PHYSIOL-LONDON, V587, P4281, DOI 10.1113/jphysiol.2009.174086; Kuo MF, 2012, CLIN EEG NEUROSCI, V43, P192, DOI 10.1177/1550059412444975; Liebetanz D, 2002, BRAIN, V125, P2238, DOI 10.1093/brain/awf238; Mars RB, 2009, J NEUROSCI, V29, P6926, DOI 10.1523/JNEUROSCI.1396-09.2009; Miniussi C, 2008, BRAIN STIMUL, V1, P326, DOI 10.1016/j.brs.2008.07.002; Moliadze V, 2010, J PHYSIOL-LONDON, V588, P4891, DOI 10.1113/jphysiol.2010.196998; Monte-Silva K, 2011, NEUROPSYCHOPHARMACOL, V36, P2097, DOI 10.1038/npp.2011.100; Monte-Silva K, 2010, J PHYSIOL-LONDON, V588, P3415, DOI 10.1113/jphysiol.2010.190181; Muellbacher W, 2002, NATURE, V415, P640, DOI 10.1038/nature712; Ni Z, 2011, BRAIN STIMUL, V4, P281, DOI 10.1016/j.brs.2011.01.002; Nitsche MA, 2007, J NEUROPHYSIOL, V97, P3109, DOI 10.1152/jn.01312.2006; Nitsche MA, 2004, EUR J NEUROSCI, V19, P2720, DOI 10.1111/j.0953-816X.2004.03398.x; Nitsche MA, 2000, J PHYSIOL-LONDON, V527, P633, DOI 10.1111/j.1469-7793.2000.t01-1-00633.x; Nitsche MA, 2003, J PHYSIOL-LONDON, V553, P293, DOI 10.1113/jphysiol.2003.049916; Nitsche MA, 2005, J PHYSIOL-LONDON, V568, P291, DOI 10.1113/jphysiol.2005.092429; Nitsche MA, 2012, J PHYSIOL-LONDON, V590, P4641, DOI 10.1113/jphysiol.2012.232975; O'Shea J, 2007, EUR J NEUROSCI, V26, P2085, DOI 10.1111/j.1460-9568.2007.05795.x; Pascual-Leone A, 2001, SCIENCE, V292, P510, DOI 10.1126/science.1057099; PASCUALLEONE A, 1994, SCIENCE, V263, P1287, DOI 10.1126/science.8122113; Pasley BN, 2009, NEURON, V62, P291, DOI 10.1016/j.neuron.2009.03.012; Paus T, 2005, PHILOS T R SOC B, V360, P1109, DOI 10.1098/rstb.2005.1652; Perini F, 2012, J NEUROSCI, V32, P12361, DOI 10.1523/JNEUROSCI.5864-11.2012; Plewnia C, 2013, CORTEX, V49, P1801, DOI 10.1016/j.cortex.2012.11.002; Polania R, 2012, CURR BIOL, V22, P1314, DOI 10.1016/j.cub.2012.05.021; Polania R, 2011, HUM BRAIN MAPP, V32, P1236, DOI 10.1002/hbm.21104; Ragert P, 2008, CLIN NEUROPHYSIOL, V119, P805, DOI 10.1016/j.clinph.2007.12.001; Reis J, 2008, J PHYSIOL-LONDON, V586, P325, DOI 10.1113/jphysiol.2007.144824; Reis J, 2009, P NATL ACAD SCI USA, V106, P1590, DOI 10.1073/pnas.0805413106; Ridding MC, 2010, J PHYSIOL-LONDON, V588, P2291, DOI 10.1113/jphysiol.2010.190314; Rizzo V, 2009, CEREB CORTEX, V19, P907, DOI 10.1093/cercor/bhn144; Romei V, 2011, CURR BIOL, V21, P334, DOI 10.1016/j.cub.2011.01.035; Rossi S, 2001, NAT NEUROSCI, V4, P948, DOI 10.1038/nn0901-948; Rossi S, 2007, CLIN NEUROPHYSIOL, V118, P709, DOI 10.1016/j.clinph.2006.11.005; Roth Y, 2007, J CLIN NEUROPHYSIOL, V24, P31, DOI 10.1097/WNP.0b013e31802fa393; Salinas E, 2001, NAT REV NEUROSCI, V2, P539, DOI 10.1038/35086012; Sandrini M, 2011, NEUROSCI BIOBEHAV R, V35, P516, DOI 10.1016/j.neubiorev.2010.06.005; Shafi MM, 2012, EUR J NEUROSCI, V35, P805, DOI 10.1111/j.1460-9568.2012.08035.x; Silvanto J, 2006, J NEUROPHYSIOL, V96, P941, DOI 10.1152/jn.00015.2006; Silvanto J, 2008, TRENDS COGN SCI, V12, P447, DOI 10.1016/j.tics.2008.09.004; Sparing R, 2009, BRAIN, V132, P3011, DOI 10.1093/brain/awp154; Stagg CJ, 2011, NEUROSCIENTIST, V17, P37, DOI 10.1177/1073858410386614; Stagg CJ, 2009, J NEUROSCI, V29, P5202, DOI 10.1523/JNEUROSCI.4432-08.2009; Stefan K, 2002, J PHYSIOL-LONDON, V543, P699, DOI 10.1113/jphysiol.2002.023317; Stefan K, 2000, BRAIN, V123, P572, DOI 10.1093/brain/123.3.572; Thut G, 2011, CURR BIOL, V21, P1176, DOI 10.1016/j.cub.2011.05.049; UGAWA Y, 1995, ANN NEUROL, V37, P703, DOI 10.1002/ana.410370603; Utz KS, 2010, NEUROPSYCHOLOGIA, V48, P2789, DOI 10.1016/j.neuropsychologia.2010.06.002; Wagner T, 2009, CORTEX, V45, P1025, DOI 10.1016/j.cortex.2008.10.002; Wolters A, 2003, J NEUROPHYSIOL, V89, P2339, DOI 10.1152/jn.00900.2002; Woo NH, 2005, NAT NEUROSCI, V8, P1069, DOI 10.1038/nn1510; Yuste R, 2005, NEURON, V48, P524, DOI 10.1016/j.neuron.2005.11.012; Ziemann U, 1996, J PHYSIOL-LONDON, V496, P873, DOI 10.1113/jphysiol.1996.sp021734	100	352	362	4	126	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUL	2013	16	7					838	844		10.1038/nn.3422	http://dx.doi.org/10.1038/nn.3422			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	174UM	23799477	Green Accepted			2022-12-28	WOS:000321180900014
J	Brandon, MP; Bogaard, AR; Schultheiss, NW; Hasselmo, ME				Brandon, Mark P.; Bogaard, Andrew R.; Schultheiss, Nathan W.; Hasselmo, Michael E.			Segregation of cortical head direction cell assemblies on alternating theta cycles	NATURE NEUROSCIENCE			English	Article							FREELY MOVING RATS; PHASE PRECESSION; GABAERGIC MODULATION; MEMORY IMPAIRMENTS; GRID CELLS; HIPPOCAMPAL; OSCILLATIONS; PLACE; RHYTHM; POSTSUBICULUM	High-level cortical systems for spatial navigation, including entorhinal grid cells, critically depend on input from the head direction system. We examined spiking rhythms and modes of synchrony between neurons participating in head direction networks for evidence of internal processing, independent of direct sensory drive, which may be important for grid cell function. We found that head direction networks of rats were segregated into at least two populations of neurons firing on alternate theta cycles (theta cycle skipping) with fixed synchronous or anti-synchronous relationships. Pairs of anti-synchronous theta cycle skipping neurons exhibited larger differences in head direction tuning, with a minimum difference of 40 degrees of head direction. Septal inactivation preserved the head direction signal, but eliminated theta cycle skipping of head direction cells and grid cell spatial periodicity. We propose that internal mechanisms underlying cycle skipping in head direction networks may be critical for downstream spatial computation by grid cells.	[Brandon, Mark P.; Bogaard, Andrew R.; Schultheiss, Nathan W.; Hasselmo, Michael E.] Boston Univ, Dept Psychol, Grad Program Neurosci, Ctr Memory & Brain, Boston, MA 02215 USA	Boston University	Brandon, MP (corresponding author), Univ Calif San Diego, Ctr Neural Circuits & Behav, Neurobiol Sect, Div Biol Sci, San Diego, CA 92103 USA.	mbrandon@ucsd.edu		Hasselmo, Michael/0000-0002-9925-6377	National Institute of Mental Health [R01 MH60013, MH61492]; Office of Naval Research Multidisciplinary University Research Initiative [N00014-10-1-0936]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH060013, R01MH061492] Funding Source: NIH RePORTER	National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Office of Naval Research Multidisciplinary University Research Initiative(MURIOffice of Naval Research); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We kindly thank S. Gillet, J. Hinman, E. Newman and L. Ewell for their invaluable consultations and comments on previous versions of this manuscript, as well as M. Connerney, S. Eriksson, C. Libby and T. Ware for technical assistance and behavioral training. This work was supported by grants from the National Institute of Mental Health (R01 MH60013 and MH61492) and the Office of Naval Research Multidisciplinary University Research Initiative (N00014-10-1-0936).	Barry C, 2012, FRONT NEURAL CIRCUIT, V6, DOI [10.3389/fncir.2012.00030, 10.3389/fncir.2012.00005]; Boccara CN, 2010, NAT NEUROSCI, V13, P987, DOI 10.1038/nn.2602; Brandon MP, 2012, HIPPOCAMPUS, V22, P604, DOI 10.1002/hipo.20924; Brandon MP, 2011, SCIENCE, V332, P595, DOI 10.1126/science.1201652; Burgalossi A, 2011, NEURON, V70, P773, DOI 10.1016/j.neuron.2011.04.003; Burgess N, 2007, HIPPOCAMPUS, V17, P801, DOI 10.1002/hipo.20327; Burgess N, 2008, HIPPOCAMPUS, V18, P1157, DOI 10.1002/hipo.20518; Buzsaki G, 2010, NEURON, V68, P362, DOI 10.1016/j.neuron.2010.09.023; Cho JW, 2001, BEHAV NEUROSCI, V115, P3, DOI 10.1037//0735-7044.115.1.3; CHROBAK JJ, 1989, BEHAV NEURAL BIOL, V52, P357, DOI 10.1016/S0163-1047(89)90472-X; Colgin LL, 2009, NATURE, V462, P353, DOI 10.1038/nature08573; Deshmukh SS, 2010, J NEUROPHYSIOL, V104, P994, DOI 10.1152/jn.01141.2009; Fujisawa S, 2011, NEURON, V72, P153, DOI 10.1016/j.neuron.2011.08.018; Gevins A, 1997, CEREB CORTEX, V7, P374, DOI 10.1093/cercor/7.4.374; Giocomo LM, 2007, SCIENCE, V315, P1719, DOI 10.1126/science.1139207; GIVENS B, 1995, NEUROBIOL LEARN MEM, V63, P269, DOI 10.1006/nlme.1995.1031; GIVENS BS, 1990, BEHAV NEUROSCI, V104, P849, DOI 10.1037/0735-7044.104.6.849; GREEN JD, 1954, J NEUROPHYSIOL, V17, P533, DOI 10.1152/jn.1954.17.6.533; Hafting T, 2008, NATURE, V453, P1248, DOI 10.1038/nature06957; Harris KD, 2003, NATURE, V424, P552, DOI 10.1038/nature01834; Harris KD, 2002, NATURE, V417, P738, DOI 10.1038/nature00808; Hasselmo ME, 2005, HIPPOCAMPUS, V15, P936, DOI 10.1002/hipo.20116; Hasselmo ME, 2007, HIPPOCAMPUS, V17, P1252, DOI 10.1002/hipo.20374; Howard MW, 2003, CEREB CORTEX, V13, P1369, DOI 10.1093/cercor/bhg084; Huxter J, 2003, NATURE, V425, P828, DOI 10.1038/nature02058; JEFFERY KJ, 1995, NEUROREPORT, V6, P2166, DOI 10.1097/00001756-199511000-00017; Jensen O, 1996, LEARN MEMORY, V3, P257, DOI 10.1101/lm.3.2-3.257; Jezek K, 2011, NATURE, V478, P246, DOI 10.1038/nature10439; Kahana MJ, 1999, NATURE, V399, P781, DOI 10.1038/21645; King C, 1998, EUR J NEUROSCI, V10, P464, DOI 10.1046/j.1460-9568.1998.00026.x; Klausberger T, 2003, NATURE, V421, P844, DOI 10.1038/nature01374; Lisman J, 2008, SCHIZOPHRENIA BULL, V34, P974, DOI 10.1093/schbul/sbn060; McNaughton BL, 2006, NAT REV NEUROSCI, V7, P663, DOI 10.1038/nrn1932; Mehta MR, 2002, NATURE, V417, P741, DOI 10.1038/nature00807; Mizuseki K, 2009, NEURON, V64, P267, DOI 10.1016/j.neuron.2009.08.037; Navratilova Z, 2012, HIPPOCAMPUS, V22, P772, DOI 10.1002/hipo.20939; O'Keefe J, 2005, HIPPOCAMPUS, V15, P853, DOI 10.1002/hipo.20115; OKEEFE J, 1993, HIPPOCAMPUS, V3, P317, DOI 10.1002/hipo.450030307; Royer S, 2010, J NEUROSCI, V30, P1777, DOI 10.1523/JNEUROSCI.4681-09.2010; Sargolini F, 2006, SCIENCE, V312, P758, DOI 10.1126/science.1125572; Seager MA, 2002, P NATL ACAD SCI USA, V99, P1616, DOI 10.1073/pnas.032662099; Skaggs WE, 1996, HIPPOCAMPUS, V6, P149, DOI 10.1002/(SICI)1098-1063(1996)6:2<149::AID-HIPO6>3.0.CO;2-K; Taube JS, 1998, PROG NEUROBIOL, V55, P225, DOI 10.1016/S0301-0082(98)00004-5; TAUBE JS, 1990, J NEUROSCI, V10, P420; TAUBE JS, 1995, J NEUROSCI, V15, P70; TAUBE JS, 1990, J NEUROSCI, V10, P436; Tsodyks MV, 1996, HIPPOCAMPUS, V6, P271, DOI 10.1002/(SICI)1098-1063(1996)6:3<271::AID-HIPO5>3.3.CO;2-Q; Vertes RP, 1997, NEUROSCIENCE, V81, P893; Wallenstein GV, 1997, J NEUROPHYSIOL, V78, P393, DOI 10.1152/jn.1997.78.1.393; Welday AC, 2011, J NEUROSCI, V31, P16157, DOI 10.1523/JNEUROSCI.0712-11.2011; WINSON J, 1978, SCIENCE, V201, P160, DOI 10.1126/science.663646	51	64	64	3	17	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUN	2013	16	6					739	+		10.1038/nn.3383	http://dx.doi.org/10.1038/nn.3383			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	152DE	23603709	Green Accepted			2022-12-28	WOS:000319509600016
J	Hughes, EG; Kang, SH; Fukaya, M; Bergles, DE				Hughes, Ethan G.; Kang, Shin H.; Fukaya, Masahiro; Bergles, Dwight E.			Oligodendrocyte progenitors balance growth with self-repulsion to achieve homeostasis in the adult brain	NATURE NEUROSCIENCE			English	Article							CHONDROITIN-SULFATE PROTEOGLYCAN; NG2-POSITIVE CELLS; GLIAL PROGENITORS; PRECURSOR CELLS; WHITE-MATTER; NG2 CELLS; LONG-TERM; PROLIFERATION; DYNAMICS; ORIGIN	The adult CNS contains an abundant population of oligodendrocyte precursor cells (NG2(+) cells) that generate oligodendrocytes and repair myelin, but how these ubiquitous progenitors maintain their density is unknown. We generated NG2-mEGFP mice and used in vivo two-photon imaging to study their dynamics in the adult brain. Time-lapse imaging revealed that NG2(+) cells in the cortex were highly dynamic; they surveyed their local environment with motile filopodia, extended growth cones and continuously migrated. They maintained unique territories though self-avoidance, and NG2(+) cell loss though death, differentiation or ablation triggered rapid migration and proliferation of adjacent cells to restore their density. NG2(+) cells recruited to sites of focal CNS injury were similarly replaced by a proliferative burst surrounding the injury site. Thus, homeostatic control of NG2(+) cell density through a balance of active growth and self-repulsion ensures that these progenitors are available to replace oligodendrocytes and participate in tissue repair.	[Hughes, Ethan G.; Kang, Shin H.; Fukaya, Masahiro; Bergles, Dwight E.] Johns Hopkins Univ, Sch Med, Solomon H Snyder Dept Neurosci, Baltimore, MD 21218 USA	Johns Hopkins University	Bergles, DE (corresponding author), Johns Hopkins Univ, Sch Med, Solomon H Snyder Dept Neurosci, Baltimore, MD 21218 USA.	dbergles@jhmi.edu	Bergles, Dwight/U-8343-2019	Bergles, Dwight/0000-0002-7133-7378; Hughes, Ethan/0000-0003-3243-7429	Kirschstein National Research Service Award grant from the US National Institutes of Health [F32NS076098]; US National Institutes of Health [NS051509, NS050274]; Brain Science Institute at Johns Hopkins University; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F32NS076098, P30NS050274, R01NS051509] Funding Source: NIH RePORTER	Kirschstein National Research Service Award grant from the US National Institutes of Health; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Brain Science Institute at Johns Hopkins University; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank M. Pucak, N. Ye and T. Lee for technical assistance, B. Cudmore (Johns Hopkins University) and S. Wang (Princeton University) for advice on cranial window implantation, W.-B. Gan (New York University) for advice on preparing thinned skull windows, and members of the Bergles laboratory for discussions. E.G.H. was supported by a Kirschstein National Research Service Award grant from the US National Institutes of Health (F32NS076098). Funding was provided by grants from the US National Institutes of Health (NS051509, NS050274) and the Brain Science Institute at Johns Hopkins University.	Ajami B, 2007, NAT NEUROSCI, V10, P1538, DOI 10.1038/nn2014; Assanah MC, 2009, GLIA, V57, P1835, DOI 10.1002/glia.20895; Benediktsson AM, 2005, J NEUROSCI METH, V141, P41, DOI 10.1016/j.jneumeth.2004.05.013; Bengtsson SL, 2005, NAT NEUROSCI, V8, P1148, DOI 10.1038/nn1516; Bergles DE, 2000, NATURE, V405, P187, DOI 10.1038/35012083; Biteau B, 2011, CELL STEM CELL, V9, P402, DOI 10.1016/j.stem.2011.10.004; Busch SA, 2007, CURR OPIN NEUROBIOL, V17, P120, DOI 10.1016/j.conb.2006.09.004; Calver AR, 1998, NEURON, V20, P869, DOI 10.1016/S0896-6273(00)80469-9; Chang A, 2000, J NEUROSCI, V20, P6404, DOI 10.1523/JNEUROSCI.20-17-06404.2000; Chittajallu R, 2004, J PHYSIOL-LONDON, V561, P109, DOI 10.1113/jphysiol.2004.074252; Chung SH, 2009, APPL PHYS A-MATER, V96, P335, DOI 10.1007/s00339-009-5201-7; Davalos D, 2005, NAT NEUROSCI, V8, P752, DOI 10.1038/nn1472; Dawson MRL, 2003, MOL CELL NEUROSCI, V24, P476, DOI 10.1016/S1044-7431(03)00210-0; De Biase LM, 2010, J NEUROSCI, V30, P3600, DOI 10.1523/JNEUROSCI.6000-09.2010; De Paola V, 2006, NEURON, V49, P861, DOI 10.1016/j.neuron.2006.02.017; Dimou L, 2008, J NEUROSCI, V28, P10434, DOI 10.1523/JNEUROSCI.2831-08.2008; Franklin RJM, 1997, J NEUROSCI RES, V50, P337, DOI 10.1002/(SICI)1097-4547(19971015)50:2<337::AID-JNR21>3.0.CO;2-3; Fuerst PG, 2008, NATURE, V451, P470, DOI 10.1038/nature06514; Gallo V, 1996, J NEUROSCI, V16, P2659, DOI 10.1523/jneurosci.16-08-02659.1996; Goritz C, 2011, SCIENCE, V333, P238, DOI 10.1126/science.1203165; Haber M, 2009, GLIA, V57, P1000, DOI 10.1002/glia.20824; Haberlandt C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017575; Holtmaat A, 2009, NAT PROTOC, V4, P1128, DOI 10.1038/nprot.2009.89; Ivkovic S, 2008, J NEUROSCI, V28, P914, DOI 10.1523/JNEUROSCI.4327-07.2008; Jones LL, 2002, J NEUROSCI, V22, P2792, DOI 10.1523/JNEUROSCI.22-07-02792.2002; Kang SH, 2010, NEURON, V68, P668, DOI 10.1016/j.neuron.2010.09.009; Kay JN, 2012, NATURE, V483, P465, DOI 10.1038/nature10877; Kessaris N, 2006, NAT NEUROSCI, V9, P173, DOI 10.1038/nn1620; Kirby BB, 2006, NAT NEUROSCI, V9, P1506, DOI 10.1038/nn1803; Kriegstein A, 2009, ANNU REV NEUROSCI, V32, P149, DOI 10.1146/annurev.neuro.051508.135600; Larsen PH, 2003, J NEUROSCI, V23, P11127, DOI 10.1523/jneurosci.23-35-11127.2003; Lefebvre JL, 2012, NATURE, V488, P517, DOI 10.1038/nature11305; LEVINE JM, 1994, J NEUROSCI, V14, P4716; Levine JM, 1999, EXP NEUROL, V160, P333, DOI 10.1006/exnr.1999.7224; Liu C, 2011, CELL, V146, P209, DOI 10.1016/j.cell.2011.06.014; Magnus T, 2008, GLIA, V56, P200, DOI 10.1002/glia.20604; McTigue DM, 2001, J NEUROSCI, V21, P3392, DOI 10.1523/JNEUROSCI.21-10-03392.2001; Menn B, 2006, J NEUROSCI, V26, P7907, DOI 10.1523/JNEUROSCI.1299-06.2006; MOORE BR, 1980, BIOMETRIKA, V67, P175; Nimmerjahn A, 2005, SCIENCE, V308, P1314, DOI 10.1126/science.1110647; Nishiyama A, 2009, NAT REV NEUROSCI, V10, P9, DOI 10.1038/nrn2495; Persson AI, 2010, CANCER CELL, V18, P669, DOI 10.1016/j.ccr.2010.10.033; Psachoulia K, 2009, NEURON GLIA BIOL, V5, P57, DOI 10.1017/S1740925X09990354; Rivers LE, 2008, NAT NEUROSCI, V11, P1392, DOI 10.1038/nn.2220; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Simons BD, 2011, CELL, V145, P851, DOI 10.1016/j.cell.2011.05.033; Spassky N, 2002, J NEUROSCI, V22, P5992; Sugiarto S, 2011, CANCER CELL, V20, P328, DOI 10.1016/j.ccr.2011.08.011; Trapp BD, 1997, J CELL BIOL, V137, P459, DOI 10.1083/jcb.137.2.459; Tripathi RB, 2010, J NEUROSCI, V30, P16383, DOI 10.1523/JNEUROSCI.3411-10.2010; Xu HT, 2007, NAT NEUROSCI, V10, P549, DOI 10.1038/nn1883; Yang G, 2010, NAT PROTOC, V5, P201, DOI 10.1038/nprot.2009.222; Yang XDW, 1997, NAT BIOTECHNOL, V15, P859, DOI 10.1038/nbt0997-859; Young KM, 2013, NEURON, V77, P873, DOI 10.1016/j.neuron.2013.01.006; Zhang H, 1996, J NEUROSCI, V16, P6886; Zhao CM, 2008, CELL, V132, P645, DOI 10.1016/j.cell.2008.01.033	56	470	477	3	53	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUN	2013	16	6					668	+		10.1038/nn.3390	http://dx.doi.org/10.1038/nn.3390			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	152DE	23624515	Green Accepted			2022-12-28	WOS:000319509600007
J	Monosov, IE; Hikosaka, O				Monosov, Ilya E.; Hikosaka, Okihide			Selective and graded coding of reward uncertainty by neurons in the primate anterodorsal septal region	NATURE NEUROSCIENCE			English	Article							ORBITOFRONTAL CORTEX; DECISION-MAKING; RISK; CONNECTIONS; ANXIETY; MONKEY; REPRESENTATION; INFORMATION; PROJECTIONS; DISTINCT	Natural environments are uncertain. Uncertainty of emotional outcomes can induce anxiety and raise vigilance, promote and signal the opportunity for learning, modulate economic choice and regulate risk-seeking. Here we demonstrate that a subset of neurons in the anterodorsal region of the primate septum (ADS) are primarily devoted to processing uncertainty in a highly specific manner. Those neurons were selectively activated by visual cues indicating probabilistic delivery of reward (for example, 25%, 50% and 75% reward) and did not respond to cues indicating certain outcomes (0% and 100% reward). The average ADS uncertainty response was graded with the magnitude of reward uncertainty and selectively signaled uncertainty about rewards rather than punishments. The selective and graded information about reward uncertainty encoded by many neurons in the ADS may underlie modulation of uncertainty of value-and sensorimotor-related areas to regulate goal-directed behavior.	[Monosov, Ilya E.; Hikosaka, Okihide] NEI, Sensorimotor Res Lab, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Eye Institute (NEI)	Monosov, IE (corresponding author), NEI, Sensorimotor Res Lab, NIH, Bldg 10, Bethesda, MD 20892 USA.	ilya.monosov@gmail.com			Intramural NIH HHS [ZIA EY000415-11] Funding Source: Medline; NATIONAL EYE INSTITUTE [ZIAEY000415] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Anselme P, 2010, BEHAV BRAIN RES, V208, P291, DOI 10.1016/j.bbr.2009.12.020; Bach DR, 2012, NAT REV NEUROSCI, V13, P572, DOI 10.1038/nrn3289; Behrens TEJ, 2007, NAT NEUROSCI, V10, P1214, DOI 10.1038/nn1954; Bromberg-Martin ES, 2009, NEURON, V63, P119, DOI 10.1016/j.neuron.2009.06.009; Cavada C, 2000, CEREB CORTEX, V10, P220, DOI 10.1093/cercor/10.3.220; Christopoulos GI, 2009, J NEUROSCI, V29, P12574, DOI 10.1523/JNEUROSCI.2614-09.2009; Coates JM, 2008, P NATL ACAD SCI USA, V105, P6167, DOI 10.1073/pnas.0704025105; Dayan P, 2000, NAT NEUROSCI, V3, P1218, DOI 10.1038/81504; Daye PM, 2013, J NEUROSCI METH, V213, P123, DOI 10.1016/j.jneumeth.2012.12.012; Esber GR, 2011, P ROY SOC B-BIOL SCI, V278, P2553, DOI 10.1098/rspb.2011.0836; Fiorillo CD, 2003, SCIENCE, V299, P1898, DOI 10.1126/science.1077349; GRAY JA, 1983, NEUROSCI BIOBEHAV R, V7, P119, DOI 10.1016/0149-7634(83)90014-3; Hirsh JB, 2012, PSYCHOL REV, V119, P304, DOI 10.1037/a0026767; Hsu M, 2005, SCIENCE, V310, P1680, DOI 10.1126/science.1115327; Matsumoto M, 2009, NAT NEUROSCI, V12, P77, DOI 10.1038/nn.2233; McCoy AN, 2005, NAT NEUROSCI, V8, P1220, DOI 10.1038/nn1523; McNaughton N, 2000, J AFFECT DISORDERS, V61, P161, DOI 10.1016/S0165-0327(00)00344-X; Menard J, 1996, PHYSIOL BEHAV, V60, P845; Monosov IE, 2012, J NEUROSCI, V32, P10318, DOI 10.1523/JNEUROSCI.1801-12.2012; Neuringer A, 2002, PSYCHON B REV, V9, P672, DOI 10.3758/BF03196324; Nishijo H, 1997, HIPPOCAMPUS, V7, P536, DOI 10.1002/(SICI)1098-1063(1997)7:5<536::AID-HIPO9>3.0.CO;2-E; Nishijo H, 1997, HIPPOCAMPUS, V7, P460, DOI 10.1002/(SICI)1098-1063(1997)7:5<460::AID-HIPO2>3.0.CO;2-L; O'Neill M, 2010, NEURON, V68, P789, DOI 10.1016/j.neuron.2010.09.031; Ogawa M, 2013, NEURON, V77, P251, DOI 10.1016/j.neuron.2012.11.006; Padoa-Schioppa C, 2006, NATURE, V441, P223, DOI 10.1038/nature04676; PEARCE JM, 1980, PSYCHOL REV, V87, P532, DOI 10.1037/0033-295X.87.6.532; Platt ML, 2008, NAT NEUROSCI, V11, P398, DOI 10.1038/nn2062; POWELL EW, 1973, EXP BRAIN RES, V17, P394; Preuschoff K, 2008, J NEUROSCI, V28, P2745, DOI 10.1523/JNEUROSCI.4286-07.2008; Preuschoff K, 2007, ANN NY ACAD SCI, V1104, P135, DOI 10.1196/annals.1390.005; Preuschoff K, 2006, NEURON, V51, P381, DOI 10.1016/j.neuron.2006.06.024; Ressler KJ, 2007, NAT NEUROSCI, V10, P1116, DOI 10.1038/nn1944; Risold PY, 1997, BRAIN RES REV, V24, P115, DOI 10.1016/S0165-0173(97)00009-X; Risold PY, 1997, BRAIN RES REV, V24, P91, DOI 10.1016/S0165-0173(97)00008-8; Rosen JB, 1998, PSYCHOL REV, V105, P325, DOI 10.1037/0033-295X.105.2.325; Rushworth MFS, 2008, NAT NEUROSCI, V11, P389, DOI 10.1038/nn2066; Schmitz A, 2012, NAT PROTOC, V7, P527, DOI 10.1038/nprot.2012.001; Schultz W, 2008, PHILOS T R SOC B, V363, P3801, DOI 10.1098/rstb.2008.0152; SHANNON CE, 1948, BELL SYST TECH J, V27, P379, DOI 10.1002/j.1538-7305.1948.tb01338.x; Sheehan TP, 2004, BRAIN RES REV, V46, P71, DOI 10.1016/j.brainresrev.2004.04.009; STAIGER JF, 1991, CELL TISSUE RES, V264, P415, DOI 10.1007/BF00319032; SWANSON LW, 1979, J COMP NEUROL, V186, P621, DOI 10.1002/cne.901860408; Tsuchida A, 2010, J NEUROSCI, V30, P16868, DOI 10.1523/JNEUROSCI.1958-10.2010; TVERSKY A, 1974, SCIENCE, V185, P1124, DOI 10.1126/science.185.4157.1124; VOGT BA, 1987, J COMP NEUROL, V262, P256, DOI 10.1002/cne.902620207; VOGT BA, 1992, CEREB CORTEX, V2, P435, DOI 10.1093/cercor/2.6.435-a; Walton ME, 2011, ANN NY ACAD SCI, V1239, P14, DOI 10.1111/j.1749-6632.2011.06257.x; Weber EU, 2004, PSYCHOL REV, V111, P430, DOI 10.1037/0033-295X.111.2.430; Yu AJ, 2005, NEURON, V46, P681, DOI 10.1016/j.neuron.2005.04.026	49	51	51	0	20	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUN	2013	16	6					756	+		10.1038/nn.3398	http://dx.doi.org/10.1038/nn.3398			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	152DE	23666181	Green Accepted			2022-12-28	WOS:000319509600018
J	Li, WH; Prazak, L; Chatterjee, N; Gruninger, S; Krug, L; Theodorou, D; Dubnau, J				Li, Wanhe; Prazak, Lisa; Chatterjee, Nabanita; Grueninger, Servan; Krug, Lisa; Theodorou, Delphine; Dubnau, Josh			Activation of transposable elements during aging and neuronal decline in Drosophila	NATURE NEUROSCIENCE			English	Article							L1 RETROTRANSPOSITION; OLFACTORY MEMORY; GYPSY	We found that several transposable elements were highly active in Drosophila brain during normal aging. In addition, we found that mutations in Drosophila Argonaute 2 (Ago2) resulted in exacerbated transposon expression in the brain, progressive and age-dependent memory impairment, and shortened lifespan. These findings suggest that transposon activation may contribute to age-dependent loss of neuronal function.	[Li, Wanhe; Prazak, Lisa; Chatterjee, Nabanita; Dubnau, Josh] Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA; [Li, Wanhe] SUNY Stony Brook, Grad Program Mol & Cellular Biol, Stony Brook, NY 11794 USA; [Grueninger, Servan] Univ Zurich, Inst Neuroinformat, Zurich, Switzerland; [Grueninger, Servan; Krug, Lisa; Dubnau, Josh] Cold Spring Harbor Lab, Watson Sch Biol Sci, Cold Spring Harbor, NY 11724 USA; [Theodorou, Delphine] Univ Paris Diderot, Magistere Genet Grad Program, Paris, France	Cold Spring Harbor Laboratory; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; University of Zurich; Cold Spring Harbor Laboratory; UDICE-French Research Universities; Universite Paris Cite	Dubnau, J (corresponding author), Cold Spring Harbor Lab, POB 100, Cold Spring Harbor, NY 11724 USA.	dubnau@cshl.edu		Gruninger, Servan/0000-0003-2900-1376; Dubnau, Josh/0000-0002-9285-7444	US National Institutes of Health [TR01(5R01NS067690-03)]; DART NeuroScience LLC award; Shakespeare Fellowship; Ernst Gohner Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS067690] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); DART NeuroScience LLC award; Shakespeare Fellowship; Ernst Gohner Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank B. Czech and G. Hannon (Cold Spring Harbor Laboratory) for the Ago2<SUP>414</SUP> and loki RNAi fly lines, F.-B. Gao (University of Massachusetts Medical School) for the Ago2<SUP>51B</SUP> fly line, B. Dickson (Institute of Molecular Pathology) for the UAS::Ago2 transgenic fly line, M. Welte (University of Rochester) for the Ago2<SUP>454</SUP> fly line, T. Lee (Janelia Farm Research Campus) for the pTub-GAL80 in Casper4 plasmid, J. Boek (Johns Hopkins University School of Medicine) for the 7B3 hybridoma cell line, and C. Bautista at the Cold Spring Harbor Laboratory shared resources for ascites production. We thank T. Russel for technical assistance in construction of the gypsy reporter system. We also are grateful to S. Waddell, J. Beshel, M. Cressy, B. Czech, G. Hannon, K. Honegger, J. Huang, M. Kernan, R. Martienssen, H. Qin, C. Sandoval, Y. Shuai, G. Turner, T. Zador and Y. Zhong for helpful discussions or comments on the manuscript. This work was supported by US National Institutes of Health grant TR01(5R01NS067690-03) and DART NeuroScience LLC awarded to J.D. S.G. received additional support from the Shakespeare Fellowship and the Ernst Gohner Foundation.	Baillie JK, 2011, NATURE, V479, P534, DOI 10.1038/nature10531; Belancio VP, 2008, GENOME RES, V18, P343, DOI 10.1101/gr.5558208; Chen GX, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000026; Chen Y, 2007, CURR BIOL, V17, P637, DOI 10.1016/j.cub.2007.02.027; Coufal NG, 2011, P NATL ACAD SCI USA, V108, P20382, DOI 10.1073/pnas.1100273108; Coufal NG, 2009, NATURE, V460, P1127, DOI 10.1038/nature08248; Czech B, 2011, NAT REV GENET, V12, P19, DOI 10.1038/nrg2916; Douville R, 2011, ANN NEUROL, V69, P141, DOI 10.1002/ana.22149; Dubnau J, 2013, CURR OPIN NEUROBIOL, V23, P84, DOI 10.1016/j.conb.2012.09.006; Goodier JL, 2008, CELL, V135, P23, DOI 10.1016/j.cell.2008.09.022; Jeong BH, 2010, J CLIN VIROL, V47, P136, DOI 10.1016/j.jcv.2009.11.016; Kaneko H, 2011, NATURE, V471, P325, DOI 10.1038/nature09830; Labrador M, 2008, GENETICS, V180, P1367, DOI 10.1534/genetics.108.094318; Lathe R, 2009, J MOL BIOL, V392, P813, DOI 10.1016/j.jmb.2009.07.045; Li WD, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0044230, 10.1371/journal.pone.0044099]; Lim DH, 2011, FEBS LETT, V585, P3079, DOI 10.1016/j.febslet.2011.08.034; Liu N, 2012, NATURE, V482, P519, DOI 10.1038/nature10810; Muotri AR, 2010, NATURE, V468, P443, DOI 10.1038/nature09544; Muotri AR, 2005, NATURE, V435, P903, DOI 10.1038/nature03663; Qin HT, 2012, CURR BIOL, V22, P608, DOI 10.1016/j.cub.2012.02.014; Schwaerzel M, 2002, NEURON, V35, P951, DOI 10.1016/S0896-6273(02)00832-2; SONG SU, 1994, GENE DEV, V8, P2046, DOI 10.1101/gad.8.17.2046; Tan HP, 2012, HUM MOL GENET, V21, P57, DOI 10.1093/hmg/ddr437; TULLY T, 1994, CELL, V79, P35, DOI 10.1016/0092-8674(94)90398-0	24	196	204	1	40	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAY	2013	16	5					529	+		10.1038/nn.3368	http://dx.doi.org/10.1038/nn.3368			4	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	131WT	23563579	Green Accepted			2022-12-28	WOS:000318029300008
J	Wamsteeker Cusulin, JI; Fuzesi, T; Inoue, W; Bains, JS				Wamsteeker Cusulin, Jaclyn I.; Fuezesi, Tamas; Inoue, Wataru; Bains, Jaideep S.			Glucocorticoid feedback uncovers retrograde opioid signaling at hypothalamic synapses	NATURE NEUROSCIENCE			English	Article							CORTICOTROPIN-RELEASING-FACTOR; PARAVENTRICULAR NUCLEUS; NEUROPEPTIDE RELEASE; ACUTE STRESS; ENKEPHALIN; TRANSMISSION; ACTIVATION; INHIBITION; EXPRESSION; PLASTICITY	Stressful experience initiates a neuroendocrine response culminating in the release of glucocorticoid hormones into the blood. Glucocorticoids feed back to the brain, causing adaptations that prevent excessive hormone responses to subsequent challenges. How these changes occur remains unknown. We found that glucocorticoid receptor activation in rodent hypothalamic neuroendocrine neurons following in vivo stress is a metaplastic signal that allows GABA synapses to undergo activity-dependent long-term depression (LTDGABA). LTDGABA was unmasked through glucocorticoid receptor-dependent inhibition of Regulator of G protein Signaling 4 (RGS4), which amplified signaling through postsynaptic metabotropic glutamate receptors. This drove somatodendritic opioid release, resulting in a persistent retrograde suppression of synaptic transmission through presynaptic mu receptors. Together, our data provide new evidence for retrograde opioid signaling at synapses in neuroendocrine circuits and represent a potential mechanism underlying glucocorticoid contributions to stress adaptation.	[Wamsteeker Cusulin, Jaclyn I.; Fuezesi, Tamas; Inoue, Wataru; Bains, Jaideep S.] Hotchkiss Brain Inst, Calgary, AB, Canada; [Wamsteeker Cusulin, Jaclyn I.; Fuezesi, Tamas; Inoue, Wataru; Bains, Jaideep S.] Univ Calgary, Dept Physiol & Pharmacol, Calgary, AB, Canada	University of Calgary	Bains, JS (corresponding author), Hotchkiss Brain Inst, Calgary, AB, Canada.	jsbains@ucalgary.ca	Inoue, Wataru/M-2163-2015	Inoue, Wataru/0000-0002-2438-5123; Bains, Jaideep/0000-0002-3634-6463	Canadian Institutes of Health Research [MOP 86501]; Alberta Innovates-Health Solutions; Hotchkiss Brain Institute	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Alberta Innovates-Health Solutions; Hotchkiss Brain Institute	We acknowledge members of the Bains laboratory for thoughtful discussion and C. Sank and R. Cantrup for technical assistance. We thank Q. Pittman and K. Iremonger for helpful comments on the manuscript, and K. Sharkey (University of Calgary) for providing Cnr1<SUP>-/-</SUP> mice. We thank the Hotchkiss Brain Institute support of the optogenetics core. J.S.B. is an Alberta Innovates-Health Solutions Senior Scholar. This work was supported by an operating grant from the Canadian Institutes of Health Research (MOP 86501 to J.S.B.). W.I. and T.F. are supported by postdoctoral fellowships, and J.I.W.C. by a PhD scholarship from Alberta Innovates-Health Solutions. W.I. and J.I.W.C. also received fellowship and scholarship support from the Hotchkiss Brain Institute.	Bilkei-Gorzo A, 2008, PSYCHONEUROENDOCRINO, V33, P425, DOI 10.1016/j.psyneuen.2007.12.010; Billups D, 2006, J NEUROSCI, V26, P9983, DOI 10.1523/JNEUROSCI.2773-06.2006; BUCKINGHAM JC, 1982, NEUROENDOCRINOLOGY, V35, P111, DOI 10.1159/000123364; Carter AG, 2004, NEURON, V44, P483, DOI 10.1016/j.neuron.2004.10.013; Castillo PE, 2011, CURR OPIN NEUROBIOL, V21, P328, DOI 10.1016/j.conb.2011.01.006; CECCATELLI S, 1989, NEUROENDOCRINOLOGY, V49, P309, DOI 10.1159/000125133; Chaouloff F, 2007, J NEUROSCI, V27, P7130, DOI 10.1523/JNEUROSCI.1150-07.2007; Chevaleyre V, 2003, NEURON, V38, P461, DOI 10.1016/S0896-6273(03)00235-6; COHEN GA, 1992, NEURON, V9, P325, DOI 10.1016/0896-6273(92)90171-9; Contet C, 2006, NEUROPSYCHOPHARMACOL, V31, P1733, DOI 10.1038/sj.npp.1300934; de Kloet ER, 2005, NAT REV NEUROSCI, V6, P463, DOI 10.1038/nrn1683; DECAVEL C, 1992, J COMP NEUROL, V316, P104, DOI 10.1002/cne.903160109; Droste SK, 2008, ENDOCRINOLOGY, V149, P3244, DOI 10.1210/en.2008-0103; Dumont EC, 2000, J NEUROCHEM, V75, P2200, DOI 10.1046/j.1471-4159.2000.0752200.x; Garcia-Garcia L, 1998, BRAIN RES, V786, P215, DOI 10.1016/S0006-8993(97)01416-9; Hewitt SA, 2009, NAT NEUROSCI, V12, P438, DOI 10.1038/nn.2274; Inoue W, 2013, NAT NEUROSCI, V16, P605, DOI 10.1038/nn.3373; Iremonger KJ, 2011, J NEUROSCI, V31, P12011, DOI 10.1523/JNEUROSCI.2925-11.2011; Iremonger KJ, 2009, J NEUROSCI, V29, P7349, DOI 10.1523/JNEUROSCI.0381-09.2009; Joels M, 2009, NAT REV NEUROSCI, V10, P459, DOI 10.1038/nrn2632; KELLERWOOD ME, 1984, ENDOCR REV, V5, P1, DOI 10.1210/edrv-5-1-1; Kim G, 2010, MOL CELLS, V30, P161, DOI 10.1007/s10059-010-0102-3; KIRITSYROY JA, 1986, J PHARMACOL EXP THER, V239, P814; Kuzmiski JB, 2010, NAT NEUROSCI, V13, P1257, DOI 10.1038/nn.2629; Lafourcade CA, 2008, PSYCHOPHARMACOLOGY, V198, P539, DOI 10.1007/s00213-007-1040-4; LARSEN PJ, 1994, PEPTIDES, V15, P783, DOI 10.1016/0196-9781(94)90030-2; Lerner TN, 2012, NEURON, V73, P347, DOI 10.1016/j.neuron.2011.11.015; LIGHTMAN SL, 1989, P NATL ACAD SCI USA, V86, P4306, DOI 10.1073/pnas.86.11.4306; Ludwig M, 2002, NATURE, V418, P85, DOI 10.1038/nature00822; Ludwig M, 2003, TRENDS NEUROSCI, V26, P255, DOI 10.1016/S0166-2236(03)00072-9; Miklos IH, 2002, NEUROSCIENCE, V113, P581, DOI 10.1016/S0306-4522(02)00147-1; Nakamura T, 1999, NEURON, V24, P727, DOI 10.1016/S0896-6273(00)81125-3; Ni YG, 1999, J NEUROSCI, V19, P3674; NICOLL RA, 1980, NATURE, V287, P22, DOI 10.1038/287022a0; Nugent FS, 2007, NATURE, V446, P1086, DOI 10.1038/nature05726; PRETEL S, 1990, J COMP NEUROL, V294, P192, DOI 10.1002/cne.902940204; Puente N, 2011, NAT NEUROSCI, V14, P1542, DOI 10.1038/nn.2974; Regehr WG, 2009, NEURON, V63, P154, DOI 10.1016/j.neuron.2009.06.021; Ronesi J, 2005, J PHYSIOL-LONDON, V562, P245, DOI 10.1113/jphysiol.2004.068460; Sarkar J, 2011, J NEUROSCI, V31, P18198, DOI 10.1523/JNEUROSCI.2560-11.2011; Saugstad JA, 1998, J NEUROSCI, V18, P905; SIMMONS ML, 1995, NEURON, V14, P1265, DOI 10.1016/0896-6273(95)90273-2; Sumislawski JJ, 2011, NEUROPSYCHOPHARMACOL, V36, P2750, DOI 10.1038/npp.2011.166; Verkuyl JM, 2005, EUR J NEUROSCI, V21, P113, DOI 10.1111/j.1460-9568.2004.03846.x; WAGNER JJ, 1993, NATURE, V363, P451, DOI 10.1038/363451a0; Wamsteeker JI, 2010, J NEUROSCI, V30, P11188, DOI 10.1523/JNEUROSCI.1046-10.2010; Watts AG, 2005, FRONT NEUROENDOCRIN, V26, P109, DOI 10.1016/j.yfrne.2005.09.001; Williams JT, 2001, PHYSIOL REV, V81, P299, DOI 10.1152/physrev.2001.81.1.299; Yang YL, 2011, CELL, V146, P991, DOI 10.1016/j.cell.2011.07.039; ZIEGLGANSBERGER W, 1979, SCIENCE, V205, P415, DOI 10.1126/science.451610	50	44	44	0	13	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAY	2013	16	5					596	+		10.1038/nn.3374	http://dx.doi.org/10.1038/nn.3374			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	131WT	23563581	Green Accepted			2022-12-28	WOS:000318029300016
J	Huilgol, D; Udin, S; Shimogori, T; Saha, B; Roy, A; Aizawa, S; Hevner, RF; Meyer, G; Ohshima, T; Pleasure, SJ; Zhao, YG; Tole, S				Huilgol, Dhananjay; Udin, Susan; Shimogori, Tomomi; Saha, Bhaskar; Roy, Achira; Aizawa, Shinichi; Hevner, Robert F.; Meyer, Gundela; Ohshima, Toshio; Pleasure, Samuel J.; Zhao, Yangu; Tole, Shubha			Dual origins of the mammalian accessory olfactory bulb revealed by an evolutionarily conserved migratory stream	NATURE NEUROSCIENCE			English	Article							CAJAL-RETZIUS CELLS; CEREBRAL-CORTEX; VOMERONASAL SYSTEM; DIFFERENTIAL EXPRESSION; LAMINAR ORGANIZATION; GANGLIONIC EMINENCE; SUBVENTRICULAR ZONE; NEURONAL MIGRATION; MOUSE; AMYGDALA	The accessory olfactory bulb (AOB) is a critical olfactory structure that has been implicated in mediating social behavior. It receives input from the vomeronasal organ and projects to targets in the amygdaloid complex. Its anterior and posterior components (aAOB and pAOB) display molecular, connectional and functional segregation in processing reproductive and defensive and aggressive behaviors, respectively. We observed a dichotomy in the development of the projection neurons of the aAOB and pAOB in mice. We found that they had distinct sites of origin and that different regulatory molecules were required for their specification and migration. aAOB neurons arose locally in the rostral telencephalon, similar to main olfactory bulb neurons. In contrast, pAOB neurons arose caudally, from the neuroepithelium of the diencephalic-telencephalic boundary, from which they migrated rostrally to reach their destination. This unusual origin and migration is conserved in Xenopus, providing an insight into the origin of a key component of this system in evolution.	[Huilgol, Dhananjay; Saha, Bhaskar; Roy, Achira; Tole, Shubha] Tata Inst Fundamental Res, Dept Biol Sci, Mumbai 400005, Maharashtra, India; [Udin, Susan] SUNY Buffalo, Dept Physiol & Biophys, Buffalo, NY 14260 USA; [Shimogori, Tomomi] RIKEN, Brain Sci Inst, Wako, Saitama, Japan; [Aizawa, Shinichi] RIKEN, Ctr Dev Biol, Kobe, Hyogo, Japan; [Hevner, Robert F.] Univ Washington, Dept Pathol, Seattle, WA 98195 USA; [Meyer, Gundela] Univ La Laguna, Tenerife, Spain; [Ohshima, Toshio] Waseda Univ, Ctr Adv Biomed Sci, Tokyo, Japan; [Pleasure, Samuel J.] Univ Calif San Francisco, Dept Neurol, San Francisco, CA USA; [Zhao, Yangu] US Natl Inst Hlth, Bethesda, MD USA	Tata Institute of Fundamental Research (TIFR); State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; RIKEN; RIKEN; University of Washington; University of Washington Seattle; Universidad de la Laguna; Waseda University; University of California System; University of California San Francisco; National Institutes of Health (NIH) - USA	Tole, S (corresponding author), Tata Inst Fundamental Res, Dept Biol Sci, Homi Bhabha Rd, Mumbai 400005, Maharashtra, India.	shubhatole@gmail.com	Roy, Achira/ABG-2660-2020; Huilgol, Dhananjay/AAM-7793-2020; Shimogori, Tomomi/L-2893-2013	Roy, Achira/0000-0002-6274-0667; Huilgol, Dhananjay/0000-0003-4393-7242; Shimogori, Tomomi/0000-0002-6931-5401; Udin, Susan/0000-0001-5542-6314; Meyer, Gundela/0000-0002-5730-828X	Swarnajayanti Fellowship (Department of Science and Technology, India); Department of Biotechnology; Lady Tata Memorial Trust; Kanwal Rekhi Career Development Award (Tata Institute of Fundamental Research Endowment Fund); Grants-in-Aid for Scientific Research [23247037] Funding Source: KAKEN	Swarnajayanti Fellowship (Department of Science and Technology, India)(Department of Science & Technology (India)); Department of Biotechnology; Lady Tata Memorial Trust; Kanwal Rekhi Career Development Award (Tata Institute of Fundamental Research Endowment Fund); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank A. Faedo (University of California, San Francisco), E.A. Grove (University of Chicago), R. Kageyama (Kyoto University), F.D. Porter (US National Institute of Child Health and Human Development), S. Retaux (Centre national de la recherche scientifique, France), T. Sargent (US National Institute of Child Health and Human Development), N. Tamamaki (Kumamoto University) and T. Williams (University of Colorado, Denver) for gifts of plasmid DNA, and the Tata Institute of Fundamental Research Animal House staff for excellent support. We thank M. Hynes (Stanford University) for Netrin1 mutants and L. Richards (Queensland Brain Institute) for Slit1; Slit2 double mutants. This work was supported by a Swarnajayanti Fellowship (Department of Science and Technology, India), a grant from the Department of Biotechnology and a grant from the Lady Tata Memorial Trust to S.T., and a Kanwal Rekhi Career Development Award (Tata Institute of Fundamental Research Endowment Fund) to B.S.	Abellan A, 2010, J COMP NEUROL, V518, P3512, DOI 10.1002/cne.22410; Anderson SA, 2001, DEVELOPMENT, V128, P353; Angot E, 2008, STEM CELLS, V26, P2311, DOI 10.1634/stemcells.2008-0297; Balordi F, 2007, J NEUROSCI, V27, P5936, DOI 10.1523/JNEUROSCI.1040-07.2007; Bulfone A, 1998, NEURON, V21, P1273, DOI 10.1016/S0896-6273(00)80647-9; Choi GB, 2005, NEURON, V46, P647, DOI 10.1016/j.neuron.2005.04.011; Corbin JG, 2001, NAT NEUROSCI, V4, P1177, DOI 10.1038/nn749; Del Punta K, 2002, NEURON, V35, P1057, DOI 10.1016/S0896-6273(02)00904-2; Faedo A, 2002, MECH DEVELOP, V116, P157, DOI 10.1016/S0925-4773(02)00114-4; Garcia-Moreno F, 2010, NAT NEUROSCI, V13, P680, DOI 10.1038/nn.2556; Gilmore EC, 1998, J NEUROSCI, V18, P6370; Hagino-Yamagishi K, 2004, J COMP NEUROL, V472, P246, DOI 10.1002/cne.20073; Halpern M, 2003, PROG NEUROBIOL, V70, P245, DOI 10.1016/S0301-0082(03)00103-5; HALPERN M, 1987, ANNU REV NEUROSCI, V10, P325, DOI 10.1146/annurev.ne.10.030187.001545; Halpern M, 1998, CHEM SENSES, V23, P477, DOI 10.1093/chemse/23.4.477; Hevner RF, 2003, DEV BRAIN RES, V141, P39, DOI 10.1016/S0165-3806(02)00641-7; Hirasawa M, 2004, P NATL ACAD SCI USA, V101, P6249, DOI 10.1073/pnas.0307322101; Holmgren N, 1922, J COMP NEUROL, V34, P391, DOI 10.1002/cne.900340502; Imayoshi I, 2008, DEVELOPMENT, V135, P2531, DOI 10.1242/dev.021535; Inaki K, 2004, J COMP NEUROL, V479, P243, DOI 10.1002/cne.20270; Jia CP, 1996, BRAIN RES, V719, P117, DOI 10.1016/0006-8993(96)00110-2; Kawasaki T, 2006, DEVELOPMENT, V133, P845, DOI 10.1242/dev.02257; KRUG L, 1993, NEUROSCI LETT, V149, P145, DOI 10.1016/0304-3940(93)90757-C; Kumar A, 1999, J NEUROSCI, V19, DOI 10.1523/JNEUROSCI.19-20-j0003.1999; Lavdas AA, 1999, J NEUROSCI, V19, P7881; McGregor IS, 2004, J NEUROSCI, V24, P4134, DOI 10.1523/JNEUROSCI.0187-04.2004; Meyer G, 2004, J NEUROSCI, V24, P9878, DOI 10.1523/JNEUROSCI.3060-04.2004; Meyer G, 2002, J NEUROSCI, V22, P4973, DOI 10.1523/JNEUROSCI.22-12-04973.2002; Miquelajauregui A, 2010, J NEUROSCI, V30, P10551, DOI 10.1523/JNEUROSCI.5563-09.2010; Miyoshi G, 2011, CEREB CORTEX, V21, P845, DOI 10.1093/cercor/bhq155; Mohedano-Moriano A, 2007, EUR J NEUROSCI, V25, P2065, DOI 10.1111/j.1460-9568.2007.05472.x; Moreno N, 2008, BRAIN RES BULL, V75, P241, DOI 10.1016/j.brainresbull.2007.10.027; Nguyen-Ba-Charvet KT, 2004, J NEUROSCI, V24, P1497, DOI 10.1523/JNEUROSCI.4729-03.2004; Nguyen-Ba-Charvet KT, 2002, J NEUROSCI, V22, P5473; Ohshima T, 2007, DEVELOPMENT, V134, P2273, DOI 10.1242/dev.02854; Paredes MF, 2006, J NEUROSCI, V26, P9404, DOI 10.1523/JNEUROSCI.2575-06.2006; RAKIC P, 1990, EXPERIENTIA, V46, P882, DOI 10.1007/BF01939380; Rakic S, 2009, CEREB CORTEX, V19, P1857, DOI 10.1093/cercor/bhn213; Remedios R, 2007, NAT NEUROSCI, V10, P1141, DOI 10.1038/nn1955; Saha B, 2007, J NEUROSCI, V27, P2290, DOI 10.1523/JNEUROSCI.5571-06.2007; Sato Y, 2007, DEV BIOL, V305, P616, DOI 10.1016/j.ydbio.2007.01.043; Schiffmann SN, 1997, EUR J NEUROSCI, V9, P1055, DOI 10.1111/j.1460-9568.1997.tb01456.x; Shinozaki K, 2002, DEVELOPMENT, V129, P3479; Soma M, 2009, J COMP NEUROL, V513, P113, DOI 10.1002/cne.21945; TAKAMI S, 1992, BRAIN RES, V598, P337, DOI 10.1016/0006-8993(92)90204-M; Takiguchi-Hayashi K, 2004, J NEUROSCI, V24, P2286, DOI 10.1523/JNEUROSCI.4671-03.2004; Taniguchi K, 2008, J VET MED SCI, V70, P1, DOI 10.1292/jvms.70.1; Tissir F, 2009, P NATL ACAD SCI USA, V106, P16871, DOI 10.1073/pnas.0903191106; TSAI LH, 1993, DEVELOPMENT, V119, P1029; Wagner S, 2006, NEURON, V50, P697, DOI 10.1016/j.neuron.2006.04.033	50	37	38	0	21	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	FEB	2013	16	2					157	165		10.1038/nn.3297	http://dx.doi.org/10.1038/nn.3297			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	080RE	23292680				2022-12-28	WOS:000314260200012
J	Vassoler, FM; White, SL; Schmidt, HD; Sadri-Vakili, G; Pierce, RC				Vassoler, Fair M.; White, Samantha L.; Schmidt, Heath D.; Sadri-Vakili, Ghazaleh; Pierce, R Christopher			Epigenetic inheritance of a cocaine-resistance phenotype	NATURE NEUROSCIENCE			English	Article							MEDIAL PREFRONTAL CORTEX; HUNTINGTONS-DISEASE; OFFSPRING VIABILITY; DNA METHYLATION; GENE-EXPRESSION; FEMALE RATS; DRUG-ABUSE; BDNF; BRAIN; MICE	We delineated a heritable phenotype resulting from the self-administration of cocaine in rats. We observed delayed acquisition and reduced maintenance of cocaine self-administration in male, but not female, offspring of sires that self-administered cocaine. Brain-derived neurotrophic factor (Bdnf) mRNA and BDNF protein were increased in the medial prefrontal cortex (mPFC), and there was an increased association of acetylated histone H3 with Bdnf promoters in only the male offspring of cocaine-experienced sires. Administration of a BDNF receptor antagonist (the TrkB receptor antagonist ANA-12) reversed the diminished cocaine self-administration in male cocaine-sired rats. In addition, the association of acetylated histone H3 with Bdnf promoters was increased in the sperm of sires that self-administered cocaine. Collectively, these findings indicate that voluntary paternal ingestion of cocaine results in epigenetic reprogramming of the germline, having profound effects on mPFC gene expression and resistance to cocaine reinforcement in male offspring.	[Vassoler, Fair M.; White, Samantha L.; Schmidt, Heath D.; Pierce, R Christopher] Univ Penn, Dept Psychiat, Perelman Sch Med, Ctr Neurobiol & Behav, Philadelphia, PA 19104 USA; [Sadri-Vakili, Ghazaleh] Massachusetts Gen Hosp, MassGen Inst Neurodegenerat Dis, Boston, MA 02114 USA	University of Pennsylvania; Pennsylvania Medicine; Harvard University; Massachusetts General Hospital	Pierce, RC (corresponding author), Univ Penn, Dept Psychiat, Perelman Sch Med, Ctr Neurobiol & Behav, Philadelphia, PA 19104 USA.	rcpierce@mail.med.upenn.edu		Vassoler, Fair/0000-0001-5317-7174	US National Institutes of Health [R01s DA15214, DA22339, DA33641, K02 DA18678, K01 DA30445, F31 DA31535, T32s DA28874, MH86599]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007517] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R56MH086599, R01MH086599] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [T32DA028874, R01DA033641, F31DA031535, R01DA015214, R01DA022339, K02DA018678, K01DA030445] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank R. Schassburger, T. Hopkins, B. Kimmey, S. Friedman, A. Lee, S. Darnell and G. Sangrey for technical assistance, and L. Briand for advice on experimental design. This work was supported by grants from the US National Institutes of Health (R01s DA15214, DA22339, DA33641, K02 DA18678, K01 DA30445, F31 DA31535, T32s DA28874 and MH86599).	ABEL EL, 1989, J ANDROL, V10, P17; Alter MD, 2009, BIOL PSYCHIAT, V66, P1061, DOI 10.1016/j.biopsych.2009.05.026; Anker JJ, 2011, CURR TOP BEHAV NEURO, V8, P73, DOI 10.1007/7854_2010_93; Anway MD, 2005, SCIENCE, V308, P1466, DOI 10.1126/science.1108190; Becker JB, 2008, FRONT NEUROENDOCRIN, V29, P36, DOI 10.1016/j.yfrne.2007.07.003; Berglind WJ, 2007, EUR J NEUROSCI, V26, P757, DOI 10.1111/j.1460-9568.2007.05692.x; Braveman Melissa W., 2004, V277, P261; BURLEY N, 1988, AM NAT, V132, P611, DOI 10.1086/284877; Byrnes EM, 2005, PSYCHOPHARMACOLOGY, V182, P537, DOI 10.1007/s00213-005-0122-4; Byrnes JJ, 2011, BEHAV BRAIN RES, V218, P200, DOI 10.1016/j.bbr.2010.11.059; Carone BR, 2010, CELL, V143, P1084, DOI 10.1016/j.cell.2010.12.008; Cazorla M, 2011, J CLIN INVEST, V121, P1846, DOI 10.1172/JCI43992; Champagne DL, 2008, J NEUROSCI, V28, P6037, DOI 10.1523/JNEUROSCI.0526-08.2008; Champagne FA, 2010, DEV PSYCHOBIOL, V52, P299, DOI 10.1002/dev.20436; Chen WG, 2003, SCIENCE, V302, P885, DOI 10.1126/science.1086446; Chen-Plotkin AS, 2006, NEUROBIOL DIS, V22, P233, DOI 10.1016/j.nbd.2005.11.001; Chung WCJ, 2000, J NEUROBIOL, V43, P234, DOI 10.1002/(SICI)1097-4695(20000605)43:3<234::AID-NEU2>3.3.CO;2-V; Drickamer LC, 2000, ANIM BEHAV, V59, P371, DOI 10.1006/anbe.1999.1316; Dunn GA, 2009, ENDOCRINOLOGY, V150, P4999, DOI 10.1210/en.2009-0500; Goldman D, 2005, NAT REV GENET, V6, P521, DOI 10.1038/nrg1635; Gowaty PA, 2007, P NATL ACAD SCI USA, V104, P15023, DOI 10.1073/pnas.0706622104; Graham DL, 2007, NAT NEUROSCI, V10, P1029, DOI 10.1038/nn1929; Guerrero-Bosagna C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013100; He F, 2006, NEUROTOXICOL TERATOL, V28, P198, DOI 10.1016/j.ntt.2005.12.003; Kaati G, 2002, EUR J HUM GENET, V10, P682, DOI 10.1038/sj.ejhg.5200859; Kendler KS, 2003, AM J PSYCHIAT, V160, P687, DOI 10.1176/appi.ajp.160.4.687; Koob GF, 2010, BRAIN RES, V1314, P3, DOI 10.1016/j.brainres.2009.11.008; Li HK, 1997, J UROLOGY, V158, P962, DOI 10.1016/S0022-5347(01)64371-4; Martini M, 2012, PSYCHOPHARMACOLOGY, V219, P149, DOI 10.1007/s00213-011-2385-2; Martinowich K, 2003, SCIENCE, V302, P890, DOI 10.1126/science.1090842; Maze I, 2011, ANN NY ACAD SCI, V1216, P99, DOI 10.1111/j.1749-6632.2010.05893.x; McElligott ZA, 2009, PROG NEURO-PSYCHOPH, V33, P1329, DOI 10.1016/j.pnpbp.2009.05.022; Merikangas KR, 1998, ARCH GEN PSYCHIAT, V55, P973, DOI 10.1001/archpsyc.55.11.973; MISRA AL, 1977, DRUG ALCOHOL DEPEN, V2, P261, DOI 10.1016/0376-8716(77)90004-7; Morgan CP, 2011, J NEUROSCI, V31, P11748, DOI 10.1523/JNEUROSCI.1887-11.2011; Ng SF, 2010, NATURE, V467, P963, DOI 10.1038/nature09491; Novikova SI, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001919; Pembrey ME, 2006, EUR J HUM GENET, V14, P159, DOI 10.1038/sj.ejhg.5201538; Pierce RC, 2001, REV NEUROSCIENCE, V12, P95; Quinones-Jenab V, 2010, HORM BEHAV, V58, P22, DOI 10.1016/j.yhbeh.2009.10.002; Sadri-Vakili G, 2007, HUM MOL GENET, V16, P1293, DOI 10.1093/hmg/ddm078; Sadri-Vakili G, 2010, J NEUROSCI, V30, P11735, DOI 10.1523/JNEUROSCI.2328-10.2010; Sakuma Y, 2009, J NEUROENDOCRINOL, V21, P410, DOI 10.1111/j.1365-2826.2009.01856.x; Sheldon TA, 2000, HEALTH ECON, V9, P571, DOI 10.1002/1099-1050(200010)9:7<571::AID-HEC555>3.0.CO;2-8; Steger K, 2011, INT J ANDROL, V34, P513, DOI 10.1111/j.1365-2605.2010.01129.x; Tsuang MT, 1998, ARCH GEN PSYCHIAT, V55, P967, DOI 10.1001/archpsyc.55.11.967; Weaver ICG, 2004, NAT NEUROSCI, V7, P847, DOI 10.1038/nn1276; Whitfield TW, 2011, J NEUROSCI, V31, P834, DOI 10.1523/JNEUROSCI.4986-10.2011	48	270	281	0	94	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JAN	2013	16	1					42	U67		10.1038/nn.3280	http://dx.doi.org/10.1038/nn.3280			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	058KZ	23242310	Green Submitted, Green Accepted			2022-12-28	WOS:000312633900011
J	Soskis, MJ; Ho, HYH; Bloodgood, BL; Robichaux, MA; Malik, AN; Ataman, B; Rubin, AA; Zieg, J; Zhang, C; Shokat, KM; Sharma, N; Cowan, CW; Greenberg, ME				Soskis, Michael J.; Ho, Hsin-Yi Henry; Bloodgood, Brenda L.; Robichaux, Michael A.; Malik, Athar N.; Ataman, Bulent; Rubin, Alex A.; Zieg, Janine; Zhang, Chao; Shokat, Kevan M.; Sharma, Nikhil; Cowan, Christopher W.; Greenberg, Michael E.			A chemical genetic approach reveals distinct EphB signaling mechanisms during brain development	NATURE NEUROSCIENCE			English	Article							COMMISSURAL AXONS; OPTIC CHIASM; RECEPTORS; KINASE; EPHRIN-B2; GUIDANCE; MORPHOGENESIS; COOPERATE; COUPLE; GROWTH	EphB receptor tyrosine kinases control multiple steps in nervous system development. However, it remains unclear whether EphBs regulate these different developmental processes directly or indirectly. In addition, given that EphBs signal through multiple mechanisms, it has been challenging to define which signaling functions of EphBs regulate particular developmental events. To address these issues, we engineered triple knock-in mice in which the kinase activity of three neuronally expressed EphBs can be rapidly, reversibly and specifically blocked. We found that the tyrosine kinase activity of EphBs was required for axon guidance in vivo. In contrast, EphB-mediated synaptogenesis occurred normally when the kinase activity of EphBs was inhibited, suggesting that EphBs mediate synapse development by an EphB tyrosine kinase-independent mechanism. Taken together, our data indicate that EphBs control axon guidance and synaptogenesis by distinct mechanisms and provide a new mouse model for dissecting EphB function in development and disease.	[Soskis, Michael J.; Ho, Hsin-Yi Henry; Bloodgood, Brenda L.; Malik, Athar N.; Ataman, Bulent; Rubin, Alex A.; Zieg, Janine; Sharma, Nikhil; Greenberg, Michael E.] Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA; [Robichaux, Michael A.; Cowan, Christopher W.] Univ Texas SW Med Ctr Dallas, Dept Psychiat, Dallas, TX 75390 USA; [Zhang, Chao; Shokat, Kevan M.] Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94143 USA	Harvard University; Harvard Medical School; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of California System; University of California San Francisco	Greenberg, ME (corresponding author), Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA.	michael_greenberg@hms.harvard.edu	Cowan, Christopher W/I-2497-2014	Robichaux, Michael/0000-0002-2559-4912; Bloodgood, Brenda/0000-0002-4797-9119	US National Institutes of Health [RO1-NS-045500, RO1-EY-018207]; Damon Runyon Cancer Research Foundation; US National Institutes of Health; National Science Foundation; National Institute on Drug Abuse [T32 DA07290]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD018655] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY018207] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007753] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS045500, P30NS072030] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [T32AG000222] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [T32DA007290] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Damon Runyon Cancer Research Foundation; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank M. Thompson, Y. Zhou and H. Ye of the Children's Hospital Boston Intellectual and Developmental Disabilities Research Center Mouse Gene Manipulation Core for ES cell work and blastocyst injection, T. Kuwajima and members of C. Mason's laboratory for advice on retinal explants and DiI labeling, M. Lopez for help selecting and generating PP1 analogs, Z. Wills and A. Mardinly for help with synapse analysis, S. Cohen for advice on electrophysiological recordings, P. Zhang for assistance with animal management, and L. Hu for antibody work. This research was funded by US National Institutes of Health grants RO1-NS-045500 (M. E. G.) and RO1-EY-018207 (C. W. C.). H.-Y.H.H. was supported by the Marion Abbe Fellowship of the Damon Runyon Cancer Research Foundation and US National Institutes of Health training grants in neurodegeneration and cancer biology. M.J.S. was supported by a National Science Foundation Graduate Research Fellowship. M. A. R. was supported by a training grant from the National Institute on Drug Abuse (T32 DA07290).	Alaimo PJ, 2001, CURR OPIN CHEM BIOL, V5, P360, DOI 10.1016/S1367-5931(00)00215-5; Banko MR, 2011, MOL CELL, V44, P878, DOI 10.1016/j.molcel.2011.11.005; Batlle E, 2005, NATURE, V435, P1126, DOI 10.1038/nature03626; Bishop AC, 2000, NATURE, V407, P395, DOI 10.1038/35030148; Bishop AC, 1998, CURR BIOL, V8, P257, DOI 10.1016/S0960-9822(98)70198-8; Blethrow J., 2004, CURR PROTOC MOL BIOL, V18, P1811; Bush JO, 2009, GENE DEV, V23, P1586, DOI 10.1101/gad.1807209; Chen X, 2005, NEURON, V46, P13, DOI 10.1016/j.neuron.2005.03.009; Chenaux G, 2011, EUR J NEUROSCI, V34, P1620, DOI 10.1111/j.1460-9568.2011.07845.x; Choi Y, 2009, BIOORG MED CHEM LETT, V19, P4467, DOI 10.1016/j.bmcl.2009.05.029; Chumley MJ, 2007, J NEUROSCI, V27, P13481, DOI 10.1523/JNEUROSCI.4158-07.2007; Cisse M, 2011, NATURE, V469, P47, DOI 10.1038/nature09635; Cowan CA, 2004, DEV BIOL, V271, P263, DOI 10.1016/j.ydbio.2004.03.026; Cowan CW, 2005, NEURON, V46, P205, DOI 10.1016/j.neuron.2005.03.019; Dalva MB, 2000, CELL, V103, P945, DOI 10.1016/S0092-8674(00)00197-5; Ethell IM, 2001, NEURON, V31, P1001, DOI 10.1016/S0896-6273(01)00440-8; Genander M, 2010, CURR OPIN CELL BIOL, V22, P611, DOI 10.1016/j.ceb.2010.08.005; Grunwald IC, 2001, NEURON, V32, P1027, DOI 10.1016/S0896-6273(01)00550-5; Henderson JT, 2001, NEURON, V32, P1041, DOI 10.1016/S0896-6273(01)00553-0; Henkemeyer M, 2003, J CELL BIOL, V163, P1313, DOI 10.1083/jcb.200306033; Henkemeyer M, 1996, CELL, V86, P35, DOI 10.1016/S0092-8674(00)80075-6; Himanen JP, 2007, CURR OPIN CELL BIOL, V19, P534, DOI 10.1016/j.ceb.2007.08.004; Holmberg J, 2002, TRENDS NEUROSCI, V25, P239, DOI 10.1016/S0166-2236(02)02149-5; Kayser MS, 2008, NEURON, V59, P56, DOI 10.1016/j.neuron.2008.05.007; Kayser MS, 2006, J NEUROSCI, V26, P12152, DOI 10.1523/JNEUROSCI.3072-06.2006; Klein R, 2004, CURR OPIN CELL BIOL, V16, P580, DOI 10.1016/j.ceb.2004.07.002; Knight ZA, 2007, CELL, V128, P425, DOI 10.1016/j.cell.2007.01.021; Lai KO, 2009, CURR OPIN NEUROBIOL, V19, P275, DOI 10.1016/j.conb.2009.04.009; Luria V, 2008, NEURON, V60, P1039, DOI 10.1016/j.neuron.2008.11.011; McClelland AC, 2009, P NATL ACAD SCI USA, V106, P20487, DOI 10.1073/pnas.0811862106; Mendes SW, 2006, J NEUROSCI, V26, P882, DOI 10.1523/JNEUROSCI.3162-05.2006; Merlos-Suarez A, 2008, CURR OPIN CELL BIOL, V20, P194, DOI 10.1016/j.ceb.2008.01.011; Moeller ML, 2006, J BIOL CHEM, V281, P1587, DOI 10.1074/jbc.M511756200; Moon MS, 2010, MOL CELL NEUROSCI, V44, P118, DOI 10.1016/j.mcn.2010.03.001; Nolt MJ, 2011, J NEUROSCI, V31, P5353, DOI 10.1523/JNEUROSCI.0282-11.2011; O'Donnell M, 2009, ANNU REV NEUROSCI, V32, P383, DOI 10.1146/annurev.neuro.051508.135614; Orioli D, 1996, EMBO J, V15, P6035, DOI 10.1002/j.1460-2075.1996.tb00992.x; Palmer A, 2002, MOL CELL, V9, P725, DOI 10.1016/S1097-2765(02)00488-4; Pasquale EB, 2010, NAT REV CANCER, V10, P165, DOI 10.1038/nrc2806; Petros TJ, 2010, DEV NEUROBIOL, V70, P781, DOI 10.1002/dneu.20821; Petros TJ, 2009, J NEUROSCI, V29, P3463, DOI 10.1523/JNEUROSCI.5655-08.2009; Plump AS, 2002, NEURON, V33, P219, DOI 10.1016/S0896-6273(01)00586-4; Qiu RX, 2008, J CELL BIOL, V181, P973, DOI 10.1083/jcb.200708091; Risley M, 2009, MECH DEVELOP, V126, P230, DOI 10.1016/j.mod.2008.10.009; ROZAKISADCOCK M, 1993, NATURE, V363, P83, DOI 10.1038/363083a0; Sanders SJ, 2012, NATURE, V485, P237, DOI 10.1038/nature10945; Sheffler-Collins SI, 2012, TRENDS NEUROSCI, V35, P293, DOI 10.1016/j.tins.2012.03.003; Takasu MA, 2002, SCIENCE, V295, P491, DOI 10.1126/science.1065983; Torres R, 1998, NEURON, V21, P1453, DOI 10.1016/S0896-6273(00)80663-7; Williams SE, 2004, CURR OPIN NEUROBIOL, V14, P51, DOI 10.1016/j.conb.2004.01.010; Williams SE, 2003, NEURON, V39, P919, DOI 10.1016/j.neuron.2003.08.017; Xu-Friedman MA, 1999, BIOPHYS J, V76, P2029, DOI 10.1016/S0006-3495(99)77360-1; Yucel Selcuk, 2007, J Pediatr Urol, V3, P354, DOI 10.1016/j.jpurol.2007.01.199	53	25	25	0	27	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	DEC	2012	15	12					1645	+		10.1038/nn.3249	http://dx.doi.org/10.1038/nn.3249			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	045OR	23143520	Green Submitted, Green Accepted			2022-12-28	WOS:000311706700010
J	Wu, KN; Tan, BK; Howard, JD; Conley, DB; Gottfried, JA				Wu, Keng Nei; Tan, Bruce K.; Howard, James D.; Conley, David B.; Gottfried, Jay A.			Olfactory input is critical for sustaining odor quality codes in human orbitofrontal cortex	NATURE NEUROSCIENCE			English	Article							PIRIFORM CORTEX; DEPENDENT CHANGES; NARIS OCCLUSION; VISUAL-CORTEX; ADULT MICE; DEPRIVATION; PLASTICITY; RAT; BULB; DISCRIMINATION	Ongoing sensory input is critical for shaping internal representations of the external world. Conversely, a lack of sensory input can profoundly perturb the formation of these representations. The olfactory system is particularly vulnerable to sensory deprivation, owing to the widespread prevalence of allergic, viral and chronic rhinosinusitis, but how the brain encodes and maintains odor information under such circumstances remains poorly understood. Here we combined functional magnetic resonance imaging (fMRI) with multivariate (pattern-based) analyses and psychophysical approaches to show that a 7-d period of olfactory deprivation induces reversible changes in odor-evoked fMRI activity in piriform cortex and orbitofrontal cortex (OFC). Notably, multivoxel ensemble codes of odor quality in OFC became decorrelated after deprivation, and the magnitude of these changes predicted subsequent olfactory perceptual plasticity. Our findings suggest that transient changes in these key olfactory brain regions are instrumental in sustaining odor perception integrity in the wake of disrupted sensory input.	[Wu, Keng Nei; Howard, James D.; Gottfried, Jay A.] Northwestern Univ, Dept Neurol, Feinberg Sch Med, Chicago, IL 60611 USA; [Tan, Bruce K.; Conley, David B.] Northwestern Univ, Dept Otolaryngol Head & Neck Surg, Feinberg Sch Med, Chicago, IL 60611 USA; [Gottfried, Jay A.] Northwestern Univ, Cognit Neurol & Alzheimers Dis Ctr, Feinberg Sch Med, Chicago, IL 60611 USA; [Gottfried, Jay A.] Northwestern Univ, Dept Psychol, Weinberg Coll Arts & Sci, Evanston, IL USA	Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine; Northwestern University	Wu, KN (corresponding author), Northwestern Univ, Dept Neurol, Feinberg Sch Med, Chicago, IL 60611 USA.	kengwu2008@u.northwestern.edu; j-gottfried@northwestern.edu			Northwestern Institutional Predoctoral Training Awards [T32NS047987, 2T32 MH067564]; US National Institute on Deafness and Other Communication Disorders [R01DC010014, K08DC007653]; US National Institutes of Health from the National Center for Research Resources [M01-RR00048]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000150] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000048] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [T32MH067564] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [T32NS047987] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [K08DC007653, R01DC010014] Funding Source: NIH RePORTER	Northwestern Institutional Predoctoral Training Awards; US National Institute on Deafness and Other Communication Disorders(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); US National Institutes of Health from the National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	The authors would like to thank M. Cahill for assistance in nasal endoscopy and acoustic rhinometry measurements, N. Sandalow and K. Phillips for technical assistance and data collection, and S. Warrenburg (International Flavors and Fragrances) for providing the odorless grade solvents. This work was supported by Northwestern Institutional Predoctoral Training Awards to K. N. W. (T32NS047987) and to J.D.H. (2T32 MH067564), grants R01DC010014 and K08DC007653 from the US National Institute on Deafness and Other Communication Disorders to J.A.G., and US National Institutes of Health grant M01-RR00048 from the National Center for Research Resources to Northwestern University Feinberg School of Medicine.	Angely CJ, 2010, BEHAV BRAIN FUNCT, V6, DOI 10.1186/1744-9081-6-26; BARTOSHUK LM, 1978, AM J CLIN NUTR, V31, P1068, DOI 10.1093/ajcn/31.6.1068; BENTON A L, 1978, Archives of Neurology, V35, P364; Best AR, 2003, BRAIN RES, V961, P81, DOI 10.1016/S0006-8993(02)03847-7; Boroojerdi B, 2000, CEREB CORTEX, V10, P529, DOI 10.1093/cercor/10.5.529; BRUNJES PC, 1983, BRAIN RES BULL, V11, P501, DOI 10.1016/0361-9230(83)90121-1; CARMICHAEL ST, 1994, J COMP NEUROL, V346, P403, DOI 10.1002/cne.903460306; Cohen Y, 2008, J NEUROSCI, V28, P6664, DOI 10.1523/JNEUROSCI.0178-08.2008; COROTTO FS, 1994, NEUROSCIENCE, V61, P739, DOI 10.1016/0306-4522(94)90397-2; Critchley HD, 1996, J NEUROPHYSIOL, V75, P1659, DOI 10.1152/jn.1996.75.4.1659; DOTY RL, 1984, LARYNGOSCOPE, V94, P176, DOI 10.1288/00005537-198402000-00004; Esterman M, 2010, NEUROIMAGE, V50, P572, DOI 10.1016/j.neuroimage.2009.10.092; Finnell JT, 2004, ACAD EMERG MED, V11, P710, DOI 10.1197/j.aem.2003.11.022; Friston KJ, 2005, NEUROIMAGE, V25, P661, DOI 10.1016/j.neuroimage.2005.01.013; Gottfried JA, 2005, BRAIN RES REV, V50, P287, DOI 10.1016/j.brainresrev.2005.08.004; Gottfried JA, 2002, J NEUROSCI, V22, P10819; GRAZIADEI PPC, 1979, J NEUROCYTOL, V8, P1, DOI 10.1007/BF01206454; GUTHRIE KM, 1990, J NEUROSCI, V10, P3402; HASEGAWA M, 1977, MAYO CLIN PROC, V52, P28; Hilberg O, 2002, ALLERGY, V57, P5, DOI 10.1046/j.0908-665x.2001.all.doc.x; Hofer SB, 2006, NAT NEUROSCI, V9, P127, DOI 10.1038/nn1610; Holbrook Eric H, 2006, Curr Opin Otolaryngol Head Neck Surg, V14, P23, DOI 10.1097/01.moo.0000193174.77321.39; Howard JD, 2009, NAT NEUROSCI, V12, P932, DOI 10.1038/nn.2324; HUBEL DH, 1970, J PHYSIOL-LONDON, V206, P419, DOI 10.1113/jphysiol.1970.sp009022; Hummel T, 1997, CHEM SENSES, V22, P39, DOI 10.1093/chemse/22.1.39; HUNT NL, 1991, CHEM SENSES, V16, P131, DOI 10.1093/chemse/16.2.131; Illig KR, 2005, J COMP NEUROL, V488, P224, DOI 10.1002/cne.20595; Kim HH, 2006, J NEUROSCI, V26, P9548, DOI 10.1523/JNEUROSCI.1727-06.2006; KOROL DL, 1990, DEV BRAIN RES, V52, P75, DOI 10.1016/0165-3806(90)90223-L; Li W, 2008, SCIENCE, V319, P1842, DOI 10.1126/science.1152837; Li W, 2006, NEURON, V52, P1097, DOI 10.1016/j.neuron.2006.10.026; Linkenhoker BA, 2002, NATURE, V419, P293, DOI 10.1038/nature01002; Livneh Y, 2012, NAT NEUROSCI, V15, P26, DOI 10.1038/nn.2980; Lledo PM, 2005, TRENDS NEUROSCI, V28, P248, DOI 10.1016/j.tins.2005.03.005; LUSKIN MB, 1983, J COMP NEUROL, V216, P264, DOI 10.1002/cne.902160305; Mai J. K., 1997, ATLAS HUMAN BRAIN; MARUNIAK JA, 1989, DEV BRAIN RES, V47, P27, DOI 10.1016/0165-3806(89)90105-3; Merabet LB, 2010, NAT REV NEUROSCI, V11, P44, DOI 10.1038/nrn2758; MERZENICH MM, 1984, J COMP NEUROL, V224, P591, DOI 10.1002/cne.902240408; Nichols T, 2005, NEUROIMAGE, V25, P653, DOI 10.1016/j.neuroimage.2004.12.005; Pantev C, 1999, BRAIN RES, V842, P192, DOI 10.1016/S0006-8993(99)01835-1; Philpot BD, 1997, J NEUROBIOL, V33, P374, DOI 10.1002/(SICI)1097-4695(199710)33:4<374::AID-NEU3>3.0.CO;2-7; Pitskel NB, 2007, NEUROREPORT, V18, P1703, DOI 10.1097/WNR.0b013e3282f0d2c1; Plailly J, 2008, J NEUROSCI, V28, P5257, DOI 10.1523/JNEUROSCI.5607-07.2008; Roesch MR, 2007, CEREB CORTEX, V17, P643, DOI 10.1093/cercor/bhk009; Rolls ET, 2010, J COGNITIVE NEUROSCI, V22, P1069, DOI 10.1162/jocn.2009.21231; ROSSINI PM, 1994, BRAIN RES, V642, P169, DOI 10.1016/0006-8993(94)90919-9; Scheiman MM, 2005, ARCH OPHTHALMOL-CHIC, V123, P437; SCHOENBAUM G, 1995, J NEUROPHYSIOL, V74, P751, DOI 10.1152/jn.1995.74.2.751; Sireteanu R, 2008, PERCEPTION, V37, P1805, DOI 10.1068/p6034; van Wingerden M, 2010, J NEUROSCI, V30, P7078, DOI 10.1523/JNEUROSCI.3860-09.2010; VANDERLO.H, 1973, SCIENCE, V179, P395, DOI 10.1126/science.179.4071.395; Waggener CT, 2007, NEUROSCI LETT, V427, P112, DOI 10.1016/j.neulet.2007.09.013; Weiler E, 1997, J NEUROSCI, V17, P3610; WIESEL TN, 1963, J NEUROPHYSIOL, V26, P1003, DOI 10.1152/jn.1963.26.6.1003; WILSON DA, 1992, NEUROSCIENCE, V49, P183, DOI 10.1016/0306-4522(92)90086-H; Wilson DA, 2000, BRAIN RES, V853, P317, DOI 10.1016/S0006-8993(99)02287-8; WILSON DA, 1995, J NEUROSCI, V15, P5574; Worsley KJ, 1996, HUM BRAIN MAPP, V4, P58, DOI 10.1002/(SICI)1097-0193(1996)4:1<58::AID-HBM4>3.0.CO;2-O; Zelano C, 2011, NEURON, V72, P178, DOI 10.1016/j.neuron.2011.08.010	60	40	41	1	39	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	SEP	2012	15	9					1313	U189		10.1038/nn.3186	http://dx.doi.org/10.1038/nn.3186			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	996GJ	22885850	Green Accepted			2022-12-28	WOS:000308072600023
J	Dietrich, MO; Horvath, TL				Dietrich, Marcelo O.; Horvath, Tamas L.			Fat incites tanycytes to neurogenesis	NATURE NEUROSCIENCE			English	Editorial Material							CELL-PROLIFERATION; ARCUATE NUCLEUS; ADULT; HYPOTHALAMUS; BARRIER; NEURONS; ROLES; SIRT1	Tanycytes in the hypothalamic median eminence have now been found to form a metabolically sensitive neurogenic niche in the brain. In adult mice, tanycytes give rise to hypothalamic regulatory neurons in response to a high-fat diet.	[Dietrich, Marcelo O.; Horvath, Tamas L.] Yale Univ, Sch Med, Comparat Med Sect, Program Integrat Cell Signaling & Neurobiol Metab, New Haven, CT 06510 USA	Yale University	Dietrich, MO (corresponding author), Yale Univ, Sch Med, Comparat Med Sect, Program Integrat Cell Signaling & Neurobiol Metab, New Haven, CT 06510 USA.	marcelo.dietrich@yale.edu; tamas.horvath@yale.edu	Dietrich, Marcelo/A-9928-2009	Dietrich, Marcelo/0000-0001-9781-2221				BROADWELL RD, 1983, P NATL ACAD SCI-BIOL, V80, P7352, DOI 10.1073/pnas.80.23.7352; Cifuentes M, 2011, J NEUROSCI METH, V201, P307, DOI 10.1016/j.jneumeth.2011.08.006; Diano S, 1998, ENDOCRINOLOGY, V139, P2879, DOI 10.1210/en.139.6.2879; Diano S, 1998, J NEUROENDOCRINOL, V10, P239, DOI 10.1046/j.1365-2826.1998.00195.x; Diano S, 1998, J NEUROENDOCRINOL, V10, P731, DOI 10.1046/j.1365-2826.1998.00204.x; Dietrich MO, 2010, J NEUROSCI, V30, P11815, DOI 10.1523/JNEUROSCI.2234-10.2010; GarciaSegura LM, 1996, FRONT NEUROENDOCRIN, V17, P180, DOI 10.1006/frne.1996.0005; Kokoeva MV, 2007, J COMP NEUROL, V505, P209, DOI 10.1002/cne.21492; Kokoeva MV, 2005, SCIENCE, V310, P679, DOI 10.1126/science.1115360; Lee DA, 2012, NAT NEUROSCI, V15, P700, DOI 10.1038/nn.3079; Norsted E, 2008, J CHEM NEUROANAT, V36, P107, DOI 10.1016/j.jchemneu.2008.06.002; Perez-Martin M, 2010, EUR J NEUROSCI, V31, P1533, DOI 10.1111/j.1460-9568.2010.07220.x; Pierce AA, 2010, J NEUROSCI, V30, P723, DOI 10.1523/JNEUROSCI.2479-09.2010; Prozorovski T, 2008, NAT CELL BIOL, V10, P385, DOI 10.1038/ncb1700; Xu Y, 2005, EXP NEUROL, V192, P251, DOI 10.1016/j.expneurol.2004.12.021	15	9	9	0	9	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAY	2012	15	5					651	653		10.1038/nn.3091	http://dx.doi.org/10.1038/nn.3091			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	932DI	22534576				2022-12-28	WOS:000303270200004
J	Sprague, TC; Serences, JT				Sprague, Thomas C.; Serences, John T.			Attention modulates spatial priority maps in the human occipital, parietal and frontal cortices	NATURE NEUROSCIENCE			English	Article							HUMAN VISUAL-CORTEX; MACAQUE AREA V4; RECEPTIVE-FIELDS; WORKING-MEMORY; SELECTIVE ATTENTION; NEURAL MECHANISMS; TOPOGRAPHIC MAPS; MT NEURONS; EYE-FIELD; RESPONSES	Computational theories propose that attention modulates the topographical landscape of spatial 'priority' maps in regions of the visual cortex so that the location of an important object is associated with higher activation levels. Although studies of single-unit recordings have demonstrated attention-related increases in the gain of neural responses and changes in the size of spatial receptive fields, the net effect of these modulations on the topography of region-level priority maps has not been investigated. Here we used functional magnetic resonance imaging and a multivariate encoding model to reconstruct spatial representations of attended and ignored stimuli using activation patterns across entire visual areas. These reconstructed spatial representations reveal the influence of attention on the amplitude and size of stimulus representations within putative priority maps across the visual hierarchy. Our results suggest that attention increases the amplitude of stimulus representations in these spatial maps, particularly in higher visual areas, but does not substantively change their size.	[Sprague, Thomas C.; Serences, John T.] Univ Calif San Diego, Grad Program Neurosci, La Jolla, CA 92093 USA; [Serences, John T.] Univ Calif San Diego, Dept Psychol, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego	Sprague, TC (corresponding author), Univ Calif San Diego, Grad Program Neurosci, La Jolla, CA 92093 USA.	tsprague@ucsd.edu; jserences@ucsd.edu		Sprague, Thomas/0000-0001-9530-2463	National Science Foundation Graduate Research Fellowship; National Institutes of Health [ROT MH-092345]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH092345] Funding Source: NIH RePORTER	National Science Foundation Graduate Research Fellowship(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank E Vul and S. Itthipuripat for assistance with statistical methods and M. Scolari and M. Smith for assistance with parietal cortex mapping protocols. This work was supported by a National Science Foundation Graduate Research Fellowship to T.C.S. and by US National Institutes of Health grant ROT MH-092345 and a fames S. McDonnell Scholar Award to J.T.S.	Anton-Erxleben K, 2013, NAT REV NEUROSCI, V14, P188, DOI 10.1038/nrn3443; Anton-Erxleben K, 2009, CEREB CORTEX, V19, P2466, DOI 10.1093/cercor/bhp002; Awh E, 2001, TRENDS COGN SCI, V5, P119, DOI 10.1016/S1364-6613(00)01593-X; Bichot NP, 1999, NAT NEUROSCI, V2, P549, DOI 10.1038/9205; Brefczynski JA, 1999, NAT NEUROSCI, V2, P370, DOI 10.1038/7280; Brouwer GJ, 2009, J NEUROSCI, V29, P13992, DOI 10.1523/JNEUROSCI.3577-09.2009; Conner CE, 1997, J NEUROSCI, V17, P3201; Dumoulin SO, 2008, NEUROIMAGE, V39, P647, DOI 10.1016/j.neuroimage.2007.09.034; Fecteau JH, 2006, TRENDS COGN SCI, V10, P382, DOI 10.1016/j.tics.2006.06.011; Fischer J, 2009, CURR BIOL, V19, P1356, DOI 10.1016/j.cub.2009.06.059; Gandhi SP, 1999, P NATL ACAD SCI USA, V96, P3314, DOI 10.1073/pnas.96.6.3314; Gattass R, 2005, PHILOS T R SOC B, V360, P709, DOI 10.1098/rstb.2005.1629; Hamed SB, 2002, CEREB CORTEX, V12, P234, DOI 10.1093/cercor/12.3.234; Itti L, 1998, IEEE T PATTERN ANAL, V20, P1254, DOI 10.1109/34.730558; Itti L, 2001, NAT REV NEUROSCI, V2, P194, DOI 10.1038/35058500; Jehee JFM, 2011, J NEUROSCI, V31, P8210, DOI 10.1523/JNEUROSCI.6153-09.2011; Jerde TA, 2012, J NEUROSCI, V32, P17382, DOI 10.1523/JNEUROSCI.3810-12.2012; Kastner S, 2001, J NEUROPHYSIOL, V86, P1398, DOI 10.1152/jn.2001.86.3.1398; Kastner S, 1999, NEURON, V22, P751, DOI 10.1016/S0896-6273(00)80734-5; Kastner S, 2007, J NEUROPHYSIOL, V97, P3494, DOI 10.1152/jn.00010.2007; KOCH C, 1985, HUM NEUROBIOL, V4, P219; Liu TS, 2005, NEURON, V45, P469, DOI 10.1016/j.neuron.2004.12.039; Luck SJ, 1997, J NEUROPHYSIOL, V77, P24, DOI 10.1152/jn.1997.77.1.24; McAdams CJ, 2000, J NEUROPHYSIOL, V83, P1751, DOI 10.1152/jn.2000.83.3.1751; McAdams CJ, 1999, J NEUROSCI, V19, P431, DOI 10.1523/JNEUROSCI.19-01-00431.1999; MOHLER CW, 1973, BRAIN RES, V61, P385, DOI 10.1016/0006-8993(73)90543-X; MORAN J, 1985, SCIENCE, V229, P782, DOI 10.1126/science.4023713; MOTTER BC, 1993, J NEUROPHYSIOL, V70, P909, DOI 10.1152/jn.1993.70.3.909; MURRAY SO, 2008, J VIS, V8; Naselaris T, 2011, NEUROIMAGE, V56, P400, DOI 10.1016/j.neuroimage.2010.07.073; Niebergall R, 2011, J NEUROSCI, V31, P15499, DOI 10.1523/JNEUROSCI.2822-11.2011; Paus T, 1996, NEUROPSYCHOLOGIA, V34, P475, DOI 10.1016/0028-3932(95)00134-4; Reynolds JH, 1999, J NEUROSCI, V19, P1736; Reynolds JH, 2000, NEURON, V26, P703, DOI 10.1016/S0896-6273(00)81206-4; Saproo S, 2010, J NEUROPHYSIOL, V104, P885, DOI 10.1152/jn.00369.2010; Saygin AP, 2008, CEREB CORTEX, V18, P2158, DOI 10.1093/cercor/bhm242; Scolari M, 2012, J NEUROSCI, V32, P7723, DOI 10.1523/JNEUROSCI.5558-11.2012; Seidemann E, 1999, J NEUROPHYSIOL, V81, P1783, DOI 10.1152/jn.1999.81.4.1783; Serences JT, 2012, NEUROPSYCHOLOGIA, V50, P435, DOI 10.1016/j.neuropsychologia.2011.07.013; Serences JT, 2006, TRENDS COGN SCI, V10, P38, DOI 10.1016/j.tics.2005.11.008; Sereno MI, 2001, SCIENCE, V294, P1350, DOI 10.1126/science.1063695; Silver MA, 2005, J NEUROPHYSIOL, V94, P1358, DOI 10.1152/jn.01316.2004; Silver MA, 2007, J NEUROPHYSIOL, V97, P229, DOI 10.1152/jn.00677.2006; Srimal R, 2008, NEUROIMAGE, V39, P455, DOI 10.1016/j.neuroimage.2007.08.040; Swisher JD, 2007, J NEUROSCI, V27, P5326, DOI 10.1523/JNEUROSCI.0991-07.2007; Tootell RBH, 1998, NEURON, V21, P1409, DOI 10.1016/S0896-6273(00)80659-5; Treue S, 1996, NATURE, V382, P539, DOI 10.1038/382539a0; Treue S, 1999, J NEUROSCI, V19, P7591, DOI 10.1523/JNEUROSCI.19-17-07591.1999; Womelsdorf T, 2008, J NEUROSCI, V28, P8934, DOI 10.1523/JNEUROSCI.4030-07.2008; Womelsdorf T, 2006, NAT NEUROSCI, V9, P1156, DOI 10.1038/nn1748	50	124	127	3	28	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	DEC	2013	16	12					1879	1887		10.1038/nn.3574	http://dx.doi.org/10.1038/nn.3574			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	257VV	24212672	Green Submitted, Green Accepted			2022-12-28	WOS:000327416800027
J	Bhanji, JP; Delgado, MR				Bhanji, Jamil P.; Delgado, Mauricio R.			Should I buy this book? How we construct prospective value	NATURE NEUROSCIENCE			English	Editorial Material							MEMORY; HIPPOCAMPUS	People are able to form preferences for unfamiliar items, such as new books or foods, before experiencing them. A study in this issue of Nature Neuroscience finds that prospective evaluations of unfamiliar items can be based on stored neural representations of relevant, familiar items.	[Bhanji, Jamil P.; Delgado, Mauricio R.] Rutgers State Univ, Dept Psychol, Newark, NJ 07102 USA	Rutgers State University Newark; Rutgers State University New Brunswick	Bhanji, JP (corresponding author), Rutgers State Univ, Dept Psychol, Newark, NJ 07102 USA.	bhanji@psychology.rutgers.edu; delgado@psychology.rutgers.edu		Bhanji, Jamil/0000-0003-3451-8732				Austen Jane, 2009, PRIDE PREJUDICE ZOMB; Barron HC, 2013, NAT NEUROSCI, V16, P1492, DOI 10.1038/nn.3515; Fink A, 2010, NEUROIMAGE, V52, P1687, DOI 10.1016/j.neuroimage.2010.05.072; Grill-Spector K, 2006, TRENDS COGN SCI, V10, P14, DOI 10.1016/j.tics.2005.11.006; Grill-Spector K, 1999, NEURON, V24, P187, DOI 10.1016/S0896-6273(00)80832-6; Knutson B, 2009, NEUROECONOMICS: DECISION MAKING AND THE BRAIN, P389, DOI 10.1016/B978-0-12-374176-9.00025-7; Rangel A, 2008, NAT REV NEUROSCI, V9, P545, DOI 10.1038/nrn2357; Schacter DL, 2007, PHILOS T R SOC B, V362, P773, DOI 10.1098/rstb.2007.2087; Sedikides C, 2008, CURR DIR PSYCHOL SCI, V17, P304, DOI 10.1111/j.1467-8721.2008.00595.x; SQUIRE LR, 1992, PSYCHOL REV, V99, P195, DOI 10.1037/0033-295X.99.2.195; Wilson TD, 2005, CURR DIR PSYCHOL SCI, V14, P131, DOI 10.1111/j.0963-7214.2005.00355.x; Wimmer GE, 2012, SCIENCE, V338, P270, DOI 10.1126/science.1223252; Xue G, 2010, SCIENCE, V330, P97, DOI 10.1126/science.1193125	13	2	2	0	24	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	OCT	2013	16	10					1357	1359		10.1038/nn.3521	http://dx.doi.org/10.1038/nn.3521			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	223HM	24067284				2022-12-28	WOS:000324795300001
J	Cole, MW; Reynolds, JR; Power, JD; Repovs, G; Anticevic, A; Braver, TS				Cole, Michael W.; Reynolds, Jeremy R.; Power, Jonathan D.; Repovs, Grega; Anticevic, Alan; Braver, Todd S.			Multi-task connectivity reveals flexible hubs for adaptive task control	NATURE NEUROSCIENCE			English	Article							HUMAN CEREBRAL-CORTEX; FUNCTIONAL CONNECTIVITY; PREFRONTAL CORTEX; PSYCHOPHYSIOLOGICAL INTERACTIONS; COGNITIVE CONTROL; HUMAN BRAIN; NETWORK; REGIONS; RULES; REPRESENTATION	Extensive evidence suggests that the human ability to adaptively implement a wide variety of tasks is preferentially a result of the operation of a fronto-parietal brain network (FPN). We hypothesized that this network's adaptability is made possible by flexible hubs: brain regions that rapidly update their pattern of global functional connectivity according to task demands. Using recent advances in characterizing brain network organization and dynamics, we identified mechanisms consistent with the flexible hub theory. We found that the FPN's brain-wide functional connectivity pattern shifted more than those of other networks across a variety of task states and that these connectivity patterns could be used to identify the current task. Furthermore, these patterns were consistent across practiced and novel tasks, suggesting that reuse of flexible hub connectivity patterns facilitates adaptive (novel) task performance. Together, these findings support a central role for fronto-parietal flexible hubs in cognitive control and adaptive implementation of task demands.	[Cole, Michael W.; Braver, Todd S.] Washington Univ, Dept Psychol, St Louis, MO 63130 USA; [Reynolds, Jeremy R.] Univ Denver, Dept Psychol, Denver, CO 80208 USA; [Power, Jonathan D.] Washington Univ, Dept Psychol, St Louis, MO USA; [Repovs, Grega] Univ Ljubljana, Dept Psychol, Ljubljana 61000, Slovenia; [Anticevic, Alan] Yale Univ, Dept Psychiat, New Haven, CT 06520 USA; [Anticevic, Alan] Yale Univ, Abraham Ribicoff Res Facil, New Haven, CT USA; [Anticevic, Alan] Natl Inst Alcohol Abuse, New Haven, CT USA; [Anticevic, Alan] Alcoholism Ctr Translat Neurosci Alcoholism, New Haven, CT USA	Washington University (WUSTL); University of Denver; Washington University (WUSTL); University of Ljubljana; Yale University; Yale University; National Institutes of Health (NIH) - USA; NIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)	Cole, MW (corresponding author), Washington Univ, Dept Psychol, St Louis, MO 63130 USA.	mwcole@mwcole.net	Cole, Michael W/G-1056-2010	Cole, Michael W/0000-0003-4329-438X; Power, Jonathan/0000-0002-6922-100X; Braver, Todd/0000-0002-2631-3393; Repovs, Grega/0000-0003-1837-3879	US National Institutes of Health [K99MH096801, DP5OD012109-01]; Brain and Behavior Research Foundation (NARSAD) Young Investigator Award; NATIONAL INSTITUTE OF MENTAL HEALTH [R37MH066078, K99MH096801, R00MH096801] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP5OD012109] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Brain and Behavior Research Foundation (NARSAD) Young Investigator Award; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank S. Petersen, D. Bassett and J. Etzel for helpful feedback and suggestions during preparation of this manuscript. We also thank W. Schneider for access to data from his laboratory. Our work was supported by the US National Institutes of Health under awards K99MH096801 (M.W.C.), DP5OD012109-01 (A.A.) and a Brain and Behavior Research Foundation (NARSAD) Young Investigator Award (A.A.).	Allen EA, 2014, CEREB CORTEX, V24, P663, DOI 10.1093/cercor/bhs352; Bassettt DS, 2006, P NATL ACAD SCI USA, V103, P19518, DOI 10.1073/pnas.0606005103; Botvinick MM, 2001, PSYCHOL REV, V108, P624, DOI 10.1037//0033-295X.108.3.624; Buckner RL, 2009, J NEUROSCI, V29, P1860, DOI 10.1523/JNEUROSCI.5062-08.2009; Buschman TJ, 2012, NEURON, V76, P838, DOI 10.1016/j.neuron.2012.09.029; Chang CC, 2011, ACM T INTEL SYST TEC, V2, DOI 10.1145/1961189.1961199; Cohen AL, 2008, NEUROIMAGE, V41, P45, DOI 10.1016/j.neuroimage.2008.01.066; Cole MW, 2007, NEUROIMAGE, V37, P343, DOI 10.1016/j.neuroimage.2007.03.071; Cole MW, 2013, COGN AFFECT BEHAV NE, V13, P1, DOI 10.3758/s13415-012-0125-7; Cole MW, 2012, J NEUROSCI, V32, P8988, DOI 10.1523/JNEUROSCI.0536-12.2012; Cole MW, 2011, FRONT HUM NEUROSCI, V5, DOI 10.3389/fnhum.2011.00142; Cole MW, 2010, J NEUROSCI, V30, P14245, DOI 10.1523/JNEUROSCI.1662-10.2010; Cole MW, 2010, NEUROIMAGE, V49, P3132, DOI 10.1016/j.neuroimage.2009.11.001; Cox RW, 1996, COMPUT BIOMED RES, V29, P162, DOI 10.1006/cbmr.1996.0014; Cromer JA, 2010, NEURON, V66, P796, DOI 10.1016/j.neuron.2010.05.005; Desikan RS, 2006, NEUROIMAGE, V31, P968, DOI 10.1016/j.neuroimage.2006.01.021; DESIMONE R, 1995, ANNU REV NEUROSCI, V18, P193, DOI 10.1146/annurev.ne.18.030195.001205; Desimone R, 1998, PHILOS T R SOC B, V353, P1245, DOI 10.1098/rstb.1998.0280; Dosenbach NUF, 2006, NEURON, V50, P799, DOI 10.1016/j.neuron.2006.04.031; Dosenbach NUF, 2010, SCIENCE, V329, P1358, DOI 10.1126/science.1194144; Dumontheil I, 2011, J COGNITIVE NEUROSCI, V23, P168, DOI 10.1162/jocn.2010.21439; Duncan J, 2001, NAT REV NEUROSCI, V2, P820, DOI 10.1038/35097575; Duncan J, 2010, TRENDS COGN SCI, V14, P172, DOI 10.1016/j.tics.2010.01.004; Fox MD, 2005, P NATL ACAD SCI USA, V102, P9673, DOI 10.1073/pnas.0504136102; Fox MD, 2007, NAT REV NEUROSCI, V8, P700, DOI 10.1038/nrn2201; Friston KJ, 2011, BRAIN CONNECT, V1, P13, DOI 10.1089/brain.2011.0008; FUSTER JM, 1985, BRAIN RES, V330, P299, DOI 10.1016/0006-8993(85)90689-4; Gazzaley A, 2007, CEREB CORTEX, V17, pI125, DOI 10.1093/cercor/bhm113; Guimera R, 2005, P NATL ACAD SCI USA, V102, P7794, DOI 10.1073/pnas.0407994102; Handwerker DA, 2004, NEUROIMAGE, V21, P1639, DOI 10.1016/j.neuroimage.2003.11.029; HEBB D. O., 1949; Heinzle J, 2012, J NEUROSCI, V32, P9960, DOI 10.1523/JNEUROSCI.1604-12.2012; Kim J, 2008, MAGN RESON IMAGING, V26, P583, DOI 10.1016/j.mri.2007.10.011; Kriegeskorte Nikolaus, 2008, Front Syst Neurosci, V2, P4, DOI 10.3389/neuro.06.004.2008; McLaren DG, 2012, NEUROIMAGE, V61, P1277, DOI 10.1016/j.neuroimage.2012.03.068; Miller EK, 2001, ANNU REV NEUROSCI, V24, P167, DOI 10.1146/annurev.neuro.24.1.167; Murphy K, 2009, NEUROIMAGE, V44, P893, DOI 10.1016/j.neuroimage.2008.09.036; Niendam T.A., 2012, COGN AFFECT BEHAV NE; O'Reilly JX, 2012, SOC COGN AFFECT NEUR, V7, P604, DOI 10.1093/scan/nss055; Power JD, 2013, CURR OPIN NEUROBIOL, V23, P223, DOI 10.1016/j.conb.2012.12.009; Power JD, 2011, NEURON, V72, P665, DOI 10.1016/j.neuron.2011.09.006; Repovs G, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00137; Rubinov M, 2010, NEUROIMAGE, V52, P1059, DOI 10.1016/j.neuroimage.2009.10.003; Sakai K, 2006, J NEUROSCI, V26, P1211, DOI 10.1523/JNEUROSCI.3887-05.2006; Sakai K, 2003, NAT NEUROSCI, V6, P75, DOI 10.1038/nn987; Sakai K, 2008, ANNU REV NEUROSCI, V31, P219, DOI 10.1146/annurev.neuro.31.060407.125642; Schneider W., 2002, E PRIME USERS GUIDE; Seeley WW, 2007, J NEUROSCI, V27, P2349, DOI 10.1523/JNEUROSCI.5587-06.2007; SHALLICE T, 1991, BRAIN, V114, P727, DOI 10.1093/brain/114.2.727; Shirer WR, 2012, CEREB CORTEX, V22, P158, DOI 10.1093/cercor/bhr099; SINGLEY MK, 1985, INT J MAN MACH STUD, V22, P403, DOI 10.1016/S0020-7373(85)80047-X; Sporns O, 2000, NEURAL NETWORKS, V13, P909, DOI 10.1016/S0893-6080(00)00053-8; Todd MT, 2013, NEUROIMAGE, V77, P157, DOI 10.1016/j.neuroimage.2013.03.039; Urfer-Parnas A, 2010, PSYCHOL MED, V40, P547, DOI 10.1017/S0033291709990754; Van Essen DC, 2012, CEREB CORTEX, V22, P2241, DOI 10.1093/cercor/bhr291; Wig GS, 2011, ANN NY ACAD SCI, V1224, P126, DOI 10.1111/j.1749-6632.2010.05947.x; Woolgar A, 2011, NEUROIMAGE, V56, P744, DOI 10.1016/j.neuroimage.2010.04.035; Yeo BTT, 2011, J NEUROPHYSIOL, V106, P1125, DOI 10.1152/jn.00338.2011	58	910	920	15	200	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	SEP	2013	16	9					1348	U247		10.1038/nn.3470	http://dx.doi.org/10.1038/nn.3470			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	207KN	23892552	Green Published, Green Accepted			2022-12-28	WOS:000323597500028
J	Freeman, J; Ziemba, CM; Heeger, DJ; Simoncelli, EP; Movshon, A				Freeman, Jeremy; Ziemba, Corey M.; Heeger, David J.; Simoncelli, Eero P.; Movshon, Anthony			A functional and perceptual signature of the second visual area in primates	NATURE NEUROSCIENCE			English	Article							HUMAN OCCIPITAL CORTEX; NATURAL SCENES; BORDER OWNERSHIP; V2; MOTION; CELLS; REPRESENTATION; SELECTIVITY; STATISTICS; MODELS	There is no generally accepted account of the function of the second visual cortical area (V2), partly because no simple response properties robustly distinguish V2 neurons from those in primary visual cortex (V1). We constructed synthetic stimuli replicating the higher-order statistical dependencies found in natural texture images and used them to stimulate macaque V1 and V2 neurons. Most V2 cells responded more vigorously to these textures than to control stimuli lacking naturalistic structure; V1 cells did not. Functional magnetic resonance imaging (fMRI) measurements in humans revealed differences between V1 and V2 that paralleled the neuronal measurements. The ability of human observers to detect naturalistic structure in different types of texture was well predicted by the strength of neuronal and fMRI responses in V2 but not in V1. Together, these results reveal a particular functional role for V2 in the representation of natural image structure.	[Freeman, Jeremy; Ziemba, Corey M.; Heeger, David J.; Simoncelli, Eero P.; Movshon, Anthony] NYU, Ctr Neural Sci, New York, NY 10003 USA; [Heeger, David J.; Simoncelli, Eero P.; Movshon, Anthony] NYU, Dept Psychol, New York, NY 10003 USA; [Simoncelli, Eero P.] NYU, Howard Hughes Med Inst, New York, NY USA; [Simoncelli, Eero P.] NYU, Courant Inst Math Sci, New York, NY USA	New York University; New York University; Howard Hughes Medical Institute; New York University; New York University	Freeman, J (corresponding author), Howard Hughes Med Inst, Janelia Farm Res Campus, Ashburn, VA USA.	freemanj11@janelia.hhmi.org	Ziemba, Corey/AAE-1531-2022	Ziemba, Corey/0000-0002-6808-2087; Simoncelli, Eero/0000-0002-1206-527X	US National Institutes of Health [EY04440]; Howard Hughes Medical Institute; New York University Center for Brain Imaging; US National Science Foundation Graduate Research Fellowships; NATIONAL EYE INSTITUTE [R37EY004440, R01EY022428, R01EY004440] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); New York University Center for Brain Imaging; US National Science Foundation Graduate Research Fellowships(National Science Foundation (NSF)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	We are grateful to G. Boynton for discussions, to M. Landy for comments on the manuscript, to M. Brotzmang for help programming the Mechanical Turk experiments and to members of the Movshon laboratory for help with physiological experiments. This work was supported by US National Institutes of Health grant EY04440, the Howard Hughes Medical Institute, the New York University Center for Brain Imaging and US National Science Foundation Graduate Research Fellowships to J.F. and C.M.Z.	ADELSON EH, 1985, J OPT SOC AM A, V2, P284, DOI 10.1364/JOSAA.2.000284; Adelson EH, 2001, PROC SPIE, V4299, P1, DOI 10.1117/12.429489; Angelucci A, 2002, J NEUROSCI, V22, P8633; Anzai A, 2007, NAT NEUROSCI, V10, P1313, DOI 10.1038/nn1975; Balas B, 2008, PATTERN RECOGN, V41, P972, DOI 10.1016/j.patcog.2007.08.007; Carandini M, 2012, NAT REV NEUROSCI, V13, P51, DOI 10.1038/nrn3136; Cavanaugh JR, 2002, J NEUROPHYSIOL, V88, P2530, DOI 10.1152/jn.00692.2001; Craft E, 2007, J NEUROPHYSIOL, V97, P4310, DOI 10.1152/jn.00203.2007; Dawid A.P., 1979, J ROYAL STAT SOC C, V28, P20, DOI [10.2307/2346806, DOI 10.2307/2346806]; El-Shamayleh Y, 2011, J NEUROSCI, V31, P8543, DOI 10.1523/JNEUROSCI.5974-10.2011; Fang F, 2009, J NEUROSCI, V29, P460, DOI 10.1523/JNEUROSCI.4628-08.2009; Felsen G, 2005, PLOS BIOL, V3, P1819, DOI 10.1371/journal.pbio.0030342; Felsen G, 2005, NAT NEUROSCI, V8, P1643, DOI 10.1038/nn1608; Ferster D, 1996, NATURE, V380, P249, DOI 10.1038/380249a0; Freeman J, 2011, NAT NEUROSCI, V14, P1195, DOI 10.1038/nn.2889; Gardner JL, 2008, J NEUROSCI, V28, P3988, DOI 10.1523/JNEUROSCI.5476-07.2008; Geisler WS, 2001, VISION RES, V41, P711, DOI 10.1016/S0042-6989(00)00277-7; Glickfeld LL, 2013, NAT NEUROSCI, V16, P219, DOI 10.1038/nn.3300; Gromping U, 2007, AM STAT, V61, P139, DOI 10.1198/000313007X188252; Heeger D.J., 1995, P 22 ANN C COMP GRAP, P229, DOI DOI 10.1145/218380.218446; Heeger DJ, 1999, J NEUROSCI, V19, P7162, DOI 10.1523/JNEUROSCI.19-16-07162.1999; Heeger DJ, 1996, P NATL ACAD SCI USA, V93, P623, DOI 10.1073/pnas.93.2.623; Hegde J, 2000, J NEUROSCI, V20, part. no.; Hegde J, 2007, CEREB CORTEX, V17, P1100, DOI 10.1093/cercor/bhl020; Hillis JM, 2002, SCIENCE, V298, P1627, DOI 10.1126/science.1075396; Ito M, 2004, J NEUROSCI, V24, P3313, DOI 10.1523/JNEUROSCI.4364-03.2004; Karklin Y, 2009, NATURE, V457, P83, DOI 10.1038/nature07481; Larsson J, 2006, J NEUROSCI, V26, P13128, DOI 10.1523/JNEUROSCI.1657-06.2006; Lee TS, 2001, P NATL ACAD SCI USA, V98, P1907, DOI 10.1073/pnas.031579998; Mahon LE, 2001, VISUAL NEUROSCI, V18, P973, DOI 10.1017/S0952523801186141; MALACH R, 1995, P NATL ACAD SCI USA, V92, P8135, DOI 10.1073/pnas.92.18.8135; McDermott JH, 2011, NEURON, V71, P926, DOI 10.1016/j.neuron.2011.06.032; Nestares O, 2000, MAGNET RESON MED, V43, P705, DOI 10.1002/(SICI)1522-2594(200005)43:5<705::AID-MRM13>3.0.CO;2-R; OGAWA S, 1990, P NATL ACAD SCI USA, V87, P9868, DOI 10.1073/pnas.87.24.9868; Paolacci G, 2010, JUDGM DECIS MAK, V5, P411; PETERHANS E, 1989, J NEUROSCI, V9, P1749; Portilla J, 2000, INT J COMPUT VISION, V40, P49, DOI 10.1023/A:1026553619983; Qiu FTT, 2007, NAT NEUROSCI, V10, P1492, DOI 10.1038/nn1989; Ress D, 2000, NAT NEUROSCI, V3, P940, DOI 10.1038/78856; Rust NC, 2005, NAT NEUROSCI, V8, P1647, DOI 10.1038/nn1606; Rust NC, 2006, NAT NEUROSCI, V9, P1421, DOI 10.1038/nn1786; SCHILLER PH, 1977, BRAIN RES, V126, P366, DOI 10.1016/0006-8993(77)90734-X; Schwartz O, 2001, NAT NEUROSCI, V4, P819, DOI 10.1038/90526; Sigman M, 2001, P NATL ACAD SCI USA, V98, P1935, DOI 10.1073/pnas.031571498; Simoncelli E.P., 1997, 31 AS C SIGN SYST CO, V1, P673, DOI DOI 10.1109/ACSSC.1997.680530; Sincich LC, 2005, ANNU REV NEUROSCI, V28, P303, DOI 10.1146/annurev.neuro.28.061604.135731; Smith AM, 1999, NEUROIMAGE, V9, P526, DOI 10.1006/nimg.1999.0435; Thomas OM, 2002, NAT NEUROSCI, V5, P472, DOI 10.1038/nn837; Thomson MGA, 2000, PERCEPTION, V29, P1057, DOI 10.1068/p2867; Vintch Brett, 2012, Adv Neural Inf Process Syst, V25, P3113; Wandell BA, 2007, NEURON, V56, P366, DOI 10.1016/j.neuron.2007.10.012; Wichmann FA, 2001, PERCEPT PSYCHOPHYS, V63, P1293, DOI 10.3758/BF03194544; Willmore BDB, 2010, J NEUROSCI, V30, P2102, DOI 10.1523/JNEUROSCI.4099-09.2010; Zhou H, 2000, J NEUROSCI, V20, P6594, DOI 10.1523/JNEUROSCI.20-17-06594.2000	54	172	172	1	48	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JUL	2013	16	7					974	+		10.1038/nn.3402	http://dx.doi.org/10.1038/nn.3402			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	174UM	23685719	Green Accepted			2022-12-28	WOS:000321180900033
J	Haddad, R; Lanjuin, A; Madisen, L; Zeng, HK; Murthy, VN; Uchida, N				Haddad, Rafi; Lanjuin, Anne; Madisen, Linda; Zeng, Hongkui; Murthy, Venkatesh N.; Uchida, Naoshige			Olfactory cortical neurons read out a relative time code in the olfactory bulb	NATURE NEUROSCIENCE			English	Article							LIGHT-INDUCED ACTIVATION; ODOR REPRESENTATIONS; TRANSGENIC MICE; TEMPORAL STRUCTURE; CORTEX; INHIBITION; INPUT; CELLS; CIRCUITS; DISCRIMINATION	Odor stimulation evokes complex spatiotemporal activity in the olfactory bulb, suggesting that both the identity of activated neurons and the timing of their activity convey information about odors. However, whether and how downstream neurons decipher these temporal patterns remains unknown. We addressed this question by measuring the spiking activity of downstream neurons while optogenetically stimulating two foci in the olfactory bulb with varying relative timing in mice. We found that the overall spike rates of piriform cortex neurons (PCNs) were sensitive to the relative timing of activation. Posterior PCNs showed higher sensitivity to relative input times than neurons in the anterior piriform cortex. In contrast, olfactory bulb neurons rarely showed such sensitivity. Thus, the brain can transform a relative time code in the periphery into a firing rate-based representation in central brain areas, providing evidence for the relevance of a relative time-based code in the olfactory bulb.	[Haddad, Rafi; Lanjuin, Anne; Murthy, Venkatesh N.; Uchida, Naoshige] Harvard Univ, Dept Mol & Cellular Biol, Ctr Brain Sci, Cambridge, MA 02138 USA; [Madisen, Linda; Zeng, Hongkui] Allen Inst Brain Sci, Seattle, WA USA	Harvard University; Allen Institute for Brain Science	Uchida, N (corresponding author), Harvard Univ, Dept Mol & Cellular Biol, Ctr Brain Sci, Cambridge, MA 02138 USA.	uchida@mcb.harvard.edu		Murthy, Venkatesh/0000-0003-2443-4252; Uchida, Naoshige/0000-0002-5755-9409	Human Frontier Science Program; Howard Hughes Medical Institute Collaborative Innovation Award; Smith Family New Investigator Award; Alfred Sloan Foundation; US National Institutes of Health; Milton Fund; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC011291] Funding Source: NIH RePORTER	Human Frontier Science Program(Human Frontier Science Program); Howard Hughes Medical Institute Collaborative Innovation Award(Howard Hughes Medical Institute); Smith Family New Investigator Award; Alfred Sloan Foundation(Alfred P. Sloan Foundation); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Milton Fund; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	We thank C. Dulac (Harvard University) for sharing resources generously, comments on the manuscript and providing Tbet-cre; ChR2<SUP>loxP/loxP</SUP> mice (generated by A.L.). We thank E. Soucy and T. Sato for technical support and D. F. Albeanu and A.K. Dhawale for technical advice. We thank Y. Ben-Shaul, C. Poo, N. Eshel and J.Y. Cohen for their comments on the manuscript. This work was supported by Human Frontier Science Program (R.H.), a Howard Hughes Medical Institute Collaborative Innovation Award, a Smith Family New Investigator Award, the Alfred Sloan Foundation and the Milton Fund (N.U.), and a grant from the US National Institutes of Health (V.N.M.).	Adrian ED, 1926, J PHYSIOL-LONDON, V61, P49, DOI 10.1113/jphysiol.1926.sp002273; Angelo K, 2012, NATURE, V488, P375, DOI 10.1038/nature11291; Apicella A, 2010, J NEUROSCI, V30, P14255, DOI 10.1523/JNEUROSCI.2747-10.2010; Arenkiel BR, 2007, NEURON, V54, P205, DOI 10.1016/j.neuron.2007.03.005; Bathellier B, 2009, J NEUROSCI, V29, P12641, DOI 10.1523/JNEUROSCI.1124-09.2009; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Blumhagen F, 2011, NATURE, V479, P493, DOI 10.1038/nature10633; Boyden ES, 2005, NAT NEUROSCI, V8, P1263, DOI 10.1038/nn1525; Branco T, 2010, SCIENCE, V329, P1671, DOI 10.1126/science.1189664; Buck LB, 2000, CELL, V100, P611, DOI 10.1016/S0092-8674(00)80698-4; Cang JH, 2003, J NEUROSCI, V23, P4108; Carey RM, 2011, J NEUROSCI, V31, P10615, DOI 10.1523/JNEUROSCI.1805-11.2011; Carey RM, 2009, J NEUROPHYSIOL, V101, P1073, DOI 10.1152/jn.90902.2008; Cury KM, 2010, NEURON, V68, P570, DOI 10.1016/j.neuron.2010.09.040; Davison IG, 2007, J NEUROSCI, V27, P2091, DOI 10.1523/JNEUROSCI.3779-06.2007; Davison IG, 2011, NEURON, V70, P82, DOI 10.1016/j.neuron.2011.02.047; Dhawale AK, 2010, NAT NEUROSCI, V13, P1404, DOI 10.1038/nn.2673; Franks KM, 2011, NEURON, V72, P49, DOI 10.1016/j.neuron.2011.08.020; HABERLY LB, 1973, J NEUROPHYSIOL, V36, P775, DOI 10.1152/jn.1973.36.4.775; Hagiwara A, 2012, FRONT NEURAL CIRCUIT, V6, DOI 10.3389/fncir.2012.00018; HOPFIELD JJ, 1995, NATURE, V376, P33, DOI 10.1038/376033a0; Junek S, 2010, NEURON, V67, P872, DOI 10.1016/j.neuron.2010.08.005; Kadohisa M, 2006, J NEUROPHYSIOL, V95, P1888, DOI 10.1152/jn.00812.2005; Laurent G, 1999, SCIENCE, V286, P723, DOI 10.1126/science.286.5440.723; Luna VM, 2008, J NEUROSCI, V28, P8851, DOI 10.1523/JNEUROSCI.2385-08.2008; MACRIDES F, 1972, SCIENCE, V175, P84, DOI 10.1126/science.175.4017.84; Madisen L, 2012, NAT NEUROSCI, V15, P793, DOI 10.1038/nn.3078; Margrie TW, 2003, J PHYSIOL-LONDON, V546, P363, DOI 10.1113/jphysiol.2002.031245; Miura K, 2012, NEURON, V74, P1087, DOI 10.1016/j.neuron.2012.04.021; Mori K, 2011, ANNU REV NEUROSCI, V34, P467, DOI 10.1146/annurev-neuro-112210-112917; Mouly AM, 1998, EUR J NEUROSCI, V10, P1128, DOI 10.1046/j.1460-9568.1998.00126.x; Nagayama S, 2004, J NEUROPHYSIOL, V91, P2532, DOI 10.1152/jn.01266.2003; Oswald AMM, 2012, J NEUROSCI, V32, P6092, DOI 10.1523/JNEUROSCI.6285-11.2012; Padmanabhan K, 2010, NAT NEUROSCI, V13, P1276, DOI 10.1038/nn.2630; Perez-Orive J, 2002, SCIENCE, V297, P359, DOI 10.1126/science.1070502; Poo C, 2011, NEURON, V72, P41, DOI 10.1016/j.neuron.2011.08.015; Poo C, 2009, NEURON, V62, P850, DOI 10.1016/j.neuron.2009.05.022; SATOU M, 1983, J NEUROPHYSIOL, V50, P89, DOI 10.1152/jn.1983.50.1.89; Schaefer AT, 2007, TRENDS NEUROSCI, V30, P92, DOI 10.1016/j.tins.2007.01.001; Schmitzer-Torbert N, 2004, J NEUROPHYSIOL, V91, P2259, DOI 10.1152/jn.00687.2003; Shusterman R, 2011, NAT NEUROSCI, V14, P1039, DOI 10.1038/nn.2877; Smear M, 2011, NATURE, V479, P397, DOI 10.1038/nature10521; Spors H, 2002, NEURON, V34, P301, DOI 10.1016/S0896-6273(02)00644-X; Stettler DD, 2009, NEURON, V63, P854, DOI 10.1016/j.neuron.2009.09.005; Stokes CCA, 2010, NEURON, V67, P452, DOI 10.1016/j.neuron.2010.06.029; Stopfer M, 2003, NEURON, V39, P991, DOI 10.1016/j.neuron.2003.08.011; Suzuki N, 2006, J NEUROSCI, V26, P11938, DOI 10.1523/JNEUROSCI.3473-06.2006; Suzuki N, 2012, J NEUROSCI, V32, P919, DOI 10.1523/JNEUROSCI.4112-11.2012; Uchida N, 2003, NAT NEUROSCI, V6, P1224, DOI 10.1038/nn1142; VanRullen R, 2005, TRENDS NEUROSCI, V28, P1, DOI 10.1016/j.tins.2004.10.010; Wachowiak M, 2011, NEURON, V71, P962, DOI 10.1016/j.neuron.2011.08.030; Wehr M, 1996, NATURE, V384, P162, DOI 10.1038/384162a0; Wesson DW, 2008, PLOS BIOL, V6, P717, DOI 10.1371/journal.pbio.0060082; Yang XDW, 1997, NAT BIOTECHNOL, V15, P859, DOI 10.1038/nbt0997-859	54	114	116	2	32	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUL	2013	16	7					949	U227		10.1038/nn.3407	http://dx.doi.org/10.1038/nn.3407			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	174UM	23685720	Green Submitted, Green Accepted			2022-12-28	WOS:000321180900030
J	Dolev, I; Fogel, H; Milshtein, H; Berdichevsky, Y; Lipstein, N; Brose, N; Gazit, N; Slutsky, I				Dolev, Iftach; Fogel, Hilla; Milshtein, Hila; Berdichevsky, Yevgeny; Lipstein, Noa; Brose, Nils; Gazit, Neta; Slutsky, Inna			Spike bursts increase amyloid-beta 40/42 ratio by inducing a presenilin-1 conformational change	NATURE NEUROSCIENCE			English	Article							ALZHEIMERS-DISEASE; RELEASE PROBABILITY; PROTEIN-PRECURSOR; TALKING POINT; CELL BIOLOGY; IN-VIVO; MUTATIONS; PEPTIDE; SYNAPSES; HIPPOCAMPUS	Accumulated genetic evidence suggests that attenuation of the ratio between cerebral amyloid-beta A beta 40 and A beta 42 isoforms is central to familial Alzheimer's disease (FAD) pathogenesis. However, FAD mutations account for only 1-2% of Alzheimer's disease cases, leaving the experience-dependent mechanisms regulating A beta 40/42 an enigma. Here we explored regulation of A beta 40/42 ratio by temporal spiking patterns in the rodent hippocampus. Spike bursts boosted A beta 40/42 through a conformational change in presenilin1 (PS1), the catalytic subunit of gamma-secretase, and subsequent increase in A beta 40 production. Conversely, single spikes did not alter basal PS1 conformation and A beta 40/42. Burst-induced PS1 conformational shift was mediated by means of Ca2+-dependent synaptic vesicle exocytosis. Presynaptic inhibition in vitro and visual deprivation in vivo augmented synaptic and A beta 40/42 facilitation by bursts in the hippocampus. Thus, burst probability and transfer properties of synapses represent fundamental features regulating A beta 40/42 by experience and may contribute to the initiation of the common, sporadic Alzheimer's disease.	[Dolev, Iftach; Fogel, Hilla; Milshtein, Hila; Berdichevsky, Yevgeny; Gazit, Neta; Slutsky, Inna] Tel Aviv Univ, Sackler Fac Med, Dept Physiol & Pharmacol, IL-69978 Tel Aviv, Israel; [Milshtein, Hila; Gazit, Neta; Slutsky, Inna] Tel Aviv Univ, Sagol Sch Neurosci, IL-69978 Tel Aviv, Israel; [Lipstein, Noa; Brose, Nils] Max Planck Inst Expt Med, Dept Mol Neurobiol, D-37075 Gottingen, Germany	Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv University; Max Planck Society	Slutsky, I (corresponding author), Tel Aviv Univ, Sackler Fac Med, Dept Physiol & Pharmacol, IL-69978 Tel Aviv, Israel.	islutsky@post.tau.ac.il		Berdichevsky, Yevgeny/0000-0002-5038-6816; Lipstein, Noa/0000-0002-0755-5899; Slutsky, Inna/0000-0002-0700-2266	European Research Council [281403]; Legacy Heritage Biomedical Program of the Israel Science Foundation [1925/08]; Alzheimer's Association [NIRG-10-172308]; Israel Science Foundation [993/08, 170/08]; SynSys Consortia [FP7-HEALTH-F2-2009-241498, FP7-HEALTH-F2-2009-242167]; Center for Nanoscience and Nanotechnology of Tel Aviv University; Azrieli Foundation; EUROSPIN	European Research Council(European Research Council (ERC)European Commission); Legacy Heritage Biomedical Program of the Israel Science Foundation; Alzheimer's Association(Alzheimer's Association); Israel Science Foundation(Israel Science Foundation); SynSys Consortia; Center for Nanoscience and Nanotechnology of Tel Aviv University; Azrieli Foundation; EUROSPIN	We thank B. De Strooper for discussions, O. Berezovska (Harvard Medical School) for providing GFP-PS1-RFP cDNA, S. Frere for comments on the manuscript, Y. Amitai for suggestions on an early version of the manuscript and all laboratory members for discussions. This work was supported by European Research Council (281403), Legacy Heritage Biomedical Program of the Israel Science Foundation (1925/08), Alzheimer's Association (NIRG-10-172308) and Israel Science Foundation (993/08 and 170/08) grants to I.S. and EUROSPIN and SynSys Consortia (FP7-HEALTH-F2-2009-241498 and FP7-HEALTH-F2-2009-242167) grants to N.B.I.D. is grateful to the Center for Nanoscience and Nanotechnology of Tel Aviv University and Azrieli Foundation for the award of doctoral fellowships.	Abramov E, 2009, NAT NEUROSCI, V12, P1567, DOI 10.1038/nn.2433; Bentahir M, 2006, J NEUROCHEM, V96, P732, DOI 10.1111/j.1471-4159.2005.03578.x; Berezovska O, 2005, J NEUROSCI, V25, P3009, DOI 10.1523/JNEUROSCI.0364-05.2005; Bertram L, 2010, NEURON, V68, P270, DOI 10.1016/j.neuron.2010.10.013; Brouwers N, 2008, ANN MED, V40, P562, DOI 10.1080/07853890802186905; Buxbaum JD, 1998, J NEUROSCI, V18, P9629; Cirrito JR, 2008, NEURON, V58, P42, DOI 10.1016/j.neuron.2008.02.003; Cirrito JR, 2005, NEURON, V48, P913, DOI 10.1016/j.neuron.2005.10.028; de Kock CPJ, 2008, J PHYSIOL-LONDON, V586, P3353, DOI 10.1113/jphysiol.2008.155580; De Strooper B, 2000, J CELL SCI, V113, P1857; De Strooper B, 2007, EMBO REP, V8, P141, DOI 10.1038/sj.embor.7400897; De Strooper B, 2010, ANNU REV CELL DEV BI, V26, P235, DOI 10.1146/annurev-cellbio-100109-104117; Debanne D, 1996, J PHYSIOL-LONDON, V491, P163, DOI 10.1113/jphysiol.1996.sp021204; DEUPREE DL, 1993, NEUROBIOL AGING, V14, P249, DOI 10.1016/0197-4580(93)90009-Z; Duff K, 1996, NATURE, V383, P710, DOI 10.1038/383710a0; HAASS C, 1992, NATURE, V359, P322, DOI 10.1038/359322a0; Haass C, 2004, EMBO J, V23, P483, DOI 10.1038/sj.emboj.7600061; Haass C, 2007, NAT REV MOL CELL BIO, V8, P101, DOI 10.1038/nrm2101; Harris KD, 2001, NEURON, V32, P141, DOI 10.1016/S0896-6273(01)00447-0; Hasegawa K, 1999, BIOCHEMISTRY-US, V38, P15514, DOI 10.1021/bi991161m; Herring A, 2011, NEUROBIOL DIS, V42, P530, DOI 10.1016/j.nbd.2011.03.007; HUBEL DH, 1963, J NEUROPHYSIOL, V26, P994, DOI 10.1152/jn.1963.26.6.994; Jankowsky JL, 2004, HUM MOL GENET, V13, P159, DOI 10.1093/hmg/ddh019; JARRETT JT, 1993, BIOCHEMISTRY-US, V32, P4693, DOI 10.1021/bi00069a001; Kamenetz F, 2003, NEURON, V37, P925, DOI 10.1016/S0896-6273(03)00124-7; KATZMAN R, 1993, NEUROLOGY, V43, P13, DOI 10.1212/WNL.43.1_Part_1.13; Kuperstein I, 2010, EMBO J, V29, P3408, DOI 10.1038/emboj.2010.211; Laviv T, 2011, J NEUROSCI, V31, P12523, DOI 10.1523/JNEUROSCI.1527-11.2011; Laviv T, 2010, NEURON, V67, P253, DOI 10.1016/j.neuron.2010.06.022; Lazarov O, 2005, CELL, V120, P701, DOI 10.1016/j.cell.2005.01.015; Lisman JE, 1997, TRENDS NEUROSCI, V20, P38, DOI 10.1016/S0166-2236(96)10070-9; Lleo A, 2004, NAT MED, V10, P1065, DOI 10.1038/nm1112; Murthy VN, 2003, ANNU REV NEUROSCI, V26, P701, DOI 10.1146/annurev.neuro.26.041002.131445; Newton AJ, 2006, P NATL ACAD SCI USA, V103, P17955, DOI 10.1073/pnas.0606212103; Palop JJ, 2010, NAT NEUROSCI, V13, P812, DOI 10.1038/nn.2583; Philpot BD, 2001, NEURON, V29, P157, DOI 10.1016/S0896-6273(01)00187-8; Rosenzweig ES, 2003, PROG NEUROBIOL, V69, P143, DOI 10.1016/S0301-0082(02)00126-0; Scheuner D, 1996, NAT MED, V2, P864, DOI 10.1038/nm0896-864; SEUBERT P, 1992, NATURE, V359, P325, DOI 10.1038/359325a0; SHOJI M, 1992, SCIENCE, V258, P126, DOI 10.1126/science.1439760; STERN Y, 1994, JAMA-J AM MED ASSOC, V271, P1004, DOI 10.1001/jama.271.13.1004; SUZUKI N, 1994, SCIENCE, V264, P1336, DOI 10.1126/science.8191290; Tanzi RE, 2005, CELL, V120, P545, DOI 10.1016/j.cell.2005.02.008; Uemura K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007893; Varoqueaux F, 2002, P NATL ACAD SCI USA, V99, P9037, DOI 10.1073/pnas.122623799; Wei W, 2010, NAT NEUROSCI, V13, P190, DOI 10.1038/nn.2476; Witter MP, 2000, HIPPOCAMPUS, V10, P398; Wolfe MS, 2007, EMBO REP, V8, P136, DOI 10.1038/sj.embor.7400896; Wolfe MS, 1999, NATURE, V398, P513, DOI 10.1038/19077; Xu W, 2012, NEURON, V73, P990, DOI 10.1016/j.neuron.2011.12.036; ZHENG H, 1995, CELL, V81, P525, DOI 10.1016/0092-8674(95)90073-X; Zucker RS, 2002, ANNU REV PHYSIOL, V64, P355, DOI 10.1146/annurev.physiol.64.092501.114547	52	64	66	0	28	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAY	2013	16	5					587	+		10.1038/nn.3376	http://dx.doi.org/10.1038/nn.3376			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	131WT	23563578				2022-12-28	WOS:000318029300015
J	Scofield, MD; Kalivas, PW				Scofield, Michael D.; Kalivas, Peter W.			Forgiving the sins of the fathers	NATURE NEUROSCIENCE			English	Editorial Material							EPIGENETICS; NUTRITION	In a case of sex-linked epigenetic inheritance, paternal cocaine use results in a heritable increase in cortical Bdnf gene expression that confers a cocaine-resistant phenotype in male, but not female, progeny.	[Scofield, Michael D.; Kalivas, Peter W.] Univ S Carolina, Sch Med, Dept Neurosci, Charleston, SC 29425 USA	University of South Carolina	Scofield, MD (corresponding author), Univ S Carolina, Sch Med, Dept Neurosci, Charleston, SC 29425 USA.	scofield@musc.edu		Scofield, Michael/0000-0002-2330-6999	NIDA NIH HHS [R01 DA012513, P50 DA015369, R01 DA003906] Funding Source: Medline; NATIONAL INSTITUTE ON DRUG ABUSE [P50DA015369, R01DA012513, R01DA003906] Funding Source: NIH RePORTER	NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)		Bohacek J, 2013, NEUROPSYCHOPHARMACOL, V38, P220, DOI 10.1038/npp.2012.110; Brower V, 2011, NATURE, V471, pS12, DOI 10.1038/471S12a; Ducci F, 2012, PSYCHIAT CLIN N AM, V35, P495, DOI 10.1016/j.psc.2012.03.010; Franklin TB, 2010, BIOL PSYCHIAT, V68, P408, DOI 10.1016/j.biopsych.2010.05.036; Kaati G, 2002, EUR J HUM GENET, V10, P682, DOI 10.1038/sj.ejhg.5200859; Kaati G, 2007, EUR J HUM GENET, V15, P784, DOI 10.1038/sj.ejhg.5201832; Maze I, 2011, P NATL ACAD SCI USA, V108, P3035, DOI 10.1073/pnas.1015483108; McGinty JF, 2010, BRAIN RES, V1314, P183, DOI 10.1016/j.brainres.2009.08.078; Renthal W, 2009, NEURON, V62, P335, DOI 10.1016/j.neuron.2009.03.026; Saavedra-Rodriguez L, 2013, BIOL PSYCHIAT, V73, P44, DOI 10.1016/j.biopsych.2012.06.035; Struhl K, 1998, GENE DEV, V12, P599, DOI 10.1101/gad.12.5.599; Van Speybroeck L, 2002, ANN NY ACAD SCI, V981, P61; Vassoler FM, 2013, NAT NEUROSCI, V16, P42, DOI 10.1038/nn.3280	13	2	3	0	26	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JAN	2013	16	1					4	5		10.1038/nn.3288	http://dx.doi.org/10.1038/nn.3288			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	058KZ	23257926	Green Accepted			2022-12-28	WOS:000312633900003
J	Suzuki, M; Gottlieb, J				Suzuki, Mototaka; Gottlieb, Jacqueline			Distinct neural mechanisms of distractor suppression in the frontal and parietal lobe	NATURE NEUROSCIENCE			English	Article							LATERAL INTRAPARIETAL AREA; VISUOSPATIAL WORKING-MEMORY; CORTICAL NETWORK MODEL; PREFRONTAL CORTEX; EYE FIELD; ACCUMULATOR MODEL; VISUAL-ATTENTION; DECISION-MAKING; MONKEY; NEURONS	The posterior parietal cortex and the prefrontal cortex are associated with eye movements and visual attention, but their specific contributions are poorly understood. We compared the dorsolateral prefrontal cortex (dlPFC) and the lateral intraparietal area (LIP) in monkeys using a memory saccade task in which a salient distractor flashed at a variable timing and location during the memory delay. We found that the two areas had similar responses to target selection, but made distinct contributions to distractor suppression. Distractor responses were more strongly suppressed and more closely correlated with performance in the dlPFC relative to LIP. Moreover, reversible inactivation of the dlPFC produced much larger increases in distractibility than inactivation of LIP. These findings suggest that LIP and dlPFC mediate different aspects of selective attention. Although both areas can contribute to the perceptual selection of salient information, the dlPFC has a decisive influence on whether and how attended stimulus is linked with actions.	[Suzuki, Mototaka; Gottlieb, Jacqueline] Dept Neurosci, New York, NY USA; [Gottlieb, Jacqueline] Columbia Univ, Kavli Inst Brain Res, New York, NY USA	Columbia University	Gottlieb, J (corresponding author), Dept Neurosci, New York, NY USA.	jg2141@columbia.edu	Suzuki, Mototaka/A-1457-2008	Suzuki, Mototaka/0000-0002-2151-4882	Swiss National Science Foundation Fellowship [PBELB-120948]; Human Frontier Science Program Cross-Disciplinary Fellowship [LT00934/2008-C]; NATIONAL EYE INSTITUTE [P30EY019007] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R03MH091590] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R21DA030095] Funding Source: NIH RePORTER	Swiss National Science Foundation Fellowship(Swiss National Science Foundation (SNSF)); Human Frontier Science Program Cross-Disciplinary Fellowship(Human Frontier Science Program); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank M. Golberg, D. Salzman and V. Ferrera for their comments on an earlier version of the manuscript. This work was supported by a Swiss National Science Foundation Fellowship (PBELB-120948) and a Human Frontier Science Program Cross-Disciplinary Fellowship to M. S. (LT00934/2008-C).	Anderson JC, 2011, J NEUROSCI, V31, P10872, DOI 10.1523/JNEUROSCI.0622-11.2011; Badre D, 2007, NEUROPSYCHOLOGIA, V45, P2883, DOI 10.1016/j.neuropsychologia.2007.06.015; Balan PF, 2009, J NEUROSCI, V29, P8166, DOI 10.1523/JNEUROSCI.0243-09.2009; BARASH S, 1991, J NEUROPHYSIOL, V66, P1095, DOI 10.1152/jn.1991.66.3.1095; Bays PM, 2010, J NEUROSCI, V30, P5968, DOI 10.1523/JNEUROSCI.0997-10.2010; Bisley JW, 2010, ANNU REV NEUROSCI, V33, P1, DOI 10.1146/annurev-neuro-060909-152823; Bisley JW, 2006, J NEUROPHYSIOL, V95, P1696, DOI 10.1152/jn.00848.2005; Bisley JW, 2003, SCIENCE, V299, P81, DOI 10.1126/science.1077395; Boehnke SE, 2011, EUR J NEUROSCI, V34, P766, DOI 10.1111/j.1460-9568.2011.07805.x; Brown GG, 2010, CURR TOP BEHAV NEURO, V4, P181, DOI 10.1007/7854_2010_54; BRUCE CJ, 1985, J NEUROPHYSIOL, V54, P714, DOI 10.1152/jn.1985.54.3.714; Brunel N, 2001, J COMPUT NEUROSCI, V11, P63, DOI 10.1023/A:1011204814320; Buschman TJ, 2007, SCIENCE, V315, P1860, DOI 10.1126/science.1138071; Chafee MV, 2000, J NEUROPHYSIOL, V83, P1550, DOI 10.1152/jn.2000.83.3.1550; Chafee MV, 1998, J NEUROPHYSIOL, V79, P2919, DOI 10.1152/jn.1998.79.6.2919; Compte A, 2000, CEREB CORTEX, V10, P910, DOI 10.1093/cercor/10.9.910; Corbetta M, 2002, NAT REV NEUROSCI, V3, P201, DOI 10.1038/nrn755; Doyle AE, 2006, J CLIN PSYCHIAT, V67, P21; Egeth HE, 1997, ANNU REV PSYCHOL, V48, P269, DOI 10.1146/annurev.psych.48.1.269; Furman M, 2008, NEURON, V60, P1153, DOI 10.1016/j.neuron.2008.12.003; Ganguli S, 2008, NEURON, V58, P15, DOI 10.1016/j.neuron.2008.01.038; GOLDMANRAKIC PS, 1995, NEURON, V14, P477, DOI 10.1016/0896-6273(95)90304-6; Gottlieb J, 2007, NEURON, V53, P9, DOI 10.1016/j.neuron.2006.12.009; Hasegawa RP, 2004, NEURON, V43, P415, DOI 10.1016/j.neuron.2004.07.013; Isoda M, 2007, NAT NEUROSCI, V10, P240, DOI 10.1038/nn1830; Katsuki F, 2012, NAT NEUROSCI, V15, P1160, DOI 10.1038/nn.3164; Katsuki F, 2012, FRONT INTEGR NEUROSC, V6, DOI 10.3389/fnint.2012.00017; Kisvarday ZF, 2002, J NEUROCYTOL, V31, P255, DOI 10.1023/A:1024122009448; Klingberg T, 2006, NEUROPSYCHOLOGIA, V44, P2171, DOI 10.1016/j.neuropsychologia.2005.11.019; KOWLER E, 1995, VISION RES, V35, P1897, DOI 10.1016/0042-6989(94)00279-U; Lo CC, 2006, NAT NEUROSCI, V9, P956, DOI 10.1038/nn1722; Mayo JP, 2008, J NEUROPHYSIOL, V100, P1923, DOI 10.1152/jn.90549.2008; Miller EK, 2001, ANNU REV NEUROSCI, V24, P167, DOI 10.1146/annurev.neuro.24.1.167; Moore T, 2003, NATURE, V421, P370, DOI 10.1038/nature01341; Noudoost B, 2011, NATURE, V474, P372, DOI 10.1038/nature09995; Oristaglio J, 2006, J NEUROSCI, V26, P8310, DOI 10.1523/JNEUROSCI.1779-06.2006; Pearce J.M., 2010, 2 THEORIES ATTENTION; Powell KD, 2000, J NEUROPHYSIOL, V84, P301, DOI 10.1152/jn.2000.84.1.301; Premereur E, 2012, J NEUROPHYSIOL, V108, P1392, DOI 10.1152/jn.00323.2012; Premereur E, 2011, J NEUROSCI, V31, P12307, DOI 10.1523/JNEUROSCI.2241-11.2011; Purcell BA, 2012, J NEUROSCI, V32, P3433, DOI 10.1523/JNEUROSCI.4622-11.2012; Reynolds JH, 2009, NEURON, V61, P168, DOI 10.1016/j.neuron.2009.01.002; Sawaguchi T, 2001, J NEUROPHYSIOL, V86, P2041, DOI 10.1152/jn.2001.86.4.2041; Schall JD, 2011, EUR J NEUROSCI, V33, P1991, DOI 10.1111/j.1460-9568.2011.07715.x; Silberberg G, 2007, NEURON, V53, P735, DOI 10.1016/j.neuron.2007.02.012; Somogyi P, 1998, BRAIN RES REV, V26, P113, DOI 10.1016/S0165-0173(97)00061-1; Theeuwes J, 2010, ACTA PSYCHOL, V135, P77, DOI 10.1016/j.actpsy.2010.02.006; Wang X.J., 2009, ENCY NEUROSCIENCE, P667; Wang XJ, 2004, P NATL ACAD SCI USA, V101, P1368, DOI 10.1073/pnas.0305337101; Wardak C, 2006, J NEUROSCI, V26, P4228, DOI 10.1523/JNEUROSCI.3336-05.2006; Wardak C, 2004, NEURON, V42, P501, DOI 10.1016/S0896-6273(04)00185-0; Wardak C, 2002, J NEUROSCI, V22, P9877	52	162	162	2	54	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JAN	2013	16	1					98	U139		10.1038/nn.3282	http://dx.doi.org/10.1038/nn.3282			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	058KZ	23242309	Green Accepted			2022-12-28	WOS:000312633900018
J	Boulin, T; Rapti, G; Briseno-Roa, L; Stigloher, C; Richmond, JE; Paoletti, P; Bessereau, JL				Boulin, Thomas; Rapti, Georgia; Briseno-Roa, Luis; Stigloher, Christian; Richmond, Janet E.; Paoletti, Pierre; Bessereau, Jean-Louis			Positive modulation of a Cys-loop acetylcholine receptor by an auxiliary transmembrane subunit	NATURE NEUROSCIENCE			English	Article							CAENORHABDITIS-ELEGANS; LEVAMISOLE RESISTANCE; NICOTINIC RECEPTOR; PHOTOSYSTEM-II; GENE ENCODES; FUNCTIONAL RECONSTITUTION; PROTEINS; IDENTIFICATION; MUTAGENESIS; ACTIVATION	Auxiliary subunits regulate the trafficking, localization or gating kinetics of voltage- and ligand-gated ion channels by associating tightly and specifically with pore-forming subunits. However, no auxiliary subunits have been identified for members of the Cys-loop receptor superfamily. Here we identify MOLO-1, a positive regulator of levamisole-sensitive acetylcholine receptors (L-AChRs) at the Caenorhabditis elegans neuromuscular junction. MOLO-1 is a one-pass transmembrane protein that contains a single extracellular globular domain-the TPM domain, found in bacteria, plants and invertebrates, including nonvertebrate chordates. Loss of MOLO-1 impairs locomotion and renders worms resistant to the anthelmintic drug levamisole. In mobo-1 mutants, L-AChR-dependent synaptic transmission is reduced by half, while the number and localization of receptors at synapses remain unchanged. In a heterologous expression system, MOLO-1 physically interacts with L-AChRs and directly enhances channel gating without affecting unitary conductance. The identification of MOLO-1 expands the mechanisms for generating functional and pharmacological diversity in the Cys-loop superfamily.	[Boulin, Thomas; Rapti, Georgia; Briseno-Roa, Luis; Stigloher, Christian; Paoletti, Pierre; Bessereau, Jean-Louis] Ecole Normale Super, Inst Biol, Dept Biol, F-75231 Paris, France; [Boulin, Thomas; Rapti, Georgia; Briseno-Roa, Luis; Stigloher, Christian; Paoletti, Pierre; Bessereau, Jean-Louis] INSERM, U1024, Paris, France; [Boulin, Thomas; Rapti, Georgia; Briseno-Roa, Luis; Stigloher, Christian; Paoletti, Pierre; Bessereau, Jean-Louis] CNRS, Unite Mixte Rech 8197, Paris, France; [Richmond, Janet E.] Univ Illinois, Dept Biol Sci, Chicago, IL 60680 USA	UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS); Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Boulin, T (corresponding author), Ecole Normale Super, Inst Biol, Dept Biol, 24 Rue Lhomond, F-75231 Paris, France.	boulin@biologie.ens.fr; jlbesse@biologie.ens.fr	Boulin, Thomas/D-6907-2011; Paoletti, Pierre/L-7358-2013; Bessereau, Jean-Louis/M-2988-2017; Stigloher, Christian/E-4762-2015; Rapti, Georgia/Q-9345-2019	Boulin, Thomas/0000-0002-1734-1915; Paoletti, Pierre/0000-0002-3681-4845; Bessereau, Jean-Louis/0000-0002-3088-7621; Stigloher, Christian/0000-0001-6941-2669; Rapti, Georgia/0000-0003-4836-8640	US National Institutes of Health [RO1 MH073156]; European Molecular Biology Organization (Longterm Fellowship); Human Frontier Science Program (Longterm Fellowship); INSERM; Centre National de la Recherche Scientifique; Agence Nationale de la Recherche [ANR-07-NEURO-032-01]; Fondation pour la Recherche Medicale ("Equipe FRM" grant); Association Francaise contre les Myopathies; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH073156] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); European Molecular Biology Organization (Longterm Fellowship)(European Molecular Biology Organization (EMBO)); Human Frontier Science Program (Longterm Fellowship)(Human Frontier Science Program); INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); Agence Nationale de la Recherche(French National Research Agency (ANR)); Fondation pour la Recherche Medicale ("Equipe FRM" grant)(Fondation pour la Recherche Medicale); Association Francaise contre les Myopathies(Association Francaise contre les Myopathies); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank V. Robert for collaborating on the TGV levamisole-resistance screen, Herve Gendrot for technical help, I. Callebaut (IMPMC, Paris) for expert assistance with sequence analysis and M. Ulbrich (Universitat Freiburg) for reagents. This work was funded by the US National Institutes of Health (RO1 MH073156 to J.E.R.), European Molecular Biology Organization (Longterm Fellowship to T.B. and C.S.), Human Frontier Science Program (Longterm Fellowship to C.S.), INSERM (P.P. and J.-L.B.: "Contrat Junior" to TB.), Centre National de la Recherche Scientifique (T.B.), the Agence Nationale de la Recherche (ANR-07-NEURO-032-01 to J.-L.B.), the Fondation pour la Recherche Medicale ("Equipe FRM" grant to RP. and J.-L.B.) and the Association Francaise contre les Myopathies G.R.).	Ballivet M, 1996, J MOL BIOL, V258, P261, DOI 10.1006/jmbi.1996.0248; Bessereau JL, 2001, NATURE, V413, P70, DOI 10.1038/35092567; Boulin T, 2011, BRIT J PHARMACOL, V164, P1421, DOI 10.1111/j.1476-5381.2011.01420.x; Boulin T, 2008, P NATL ACAD SCI USA, V105, P18590, DOI 10.1073/pnas.0806933105; Boulin T, 2007, NAT PROTOC, V2, P1276, DOI 10.1038/nprot.2007.192; Chimienti F, 2003, HUM MOL GENET, V12, P3017, DOI 10.1093/hmg/ddg320; Colquhoun D, 1998, BRIT J PHARMACOL, V125, P924; Culetto E, 2004, J BIOL CHEM, V279, P42476, DOI 10.1074/jbc.M404370200; Dent JA, 2000, P NATL ACAD SCI USA, V97, P2674, DOI 10.1073/pnas.97.6.2674; Eimer S, 2007, EMBO J, V26, P4313, DOI 10.1038/sj.emboj.7601858; Eletsky Alexander, 2012, Journal of Structural and Functional Genomics, V13, P9, DOI 10.1007/s10969-011-9122-2; Fleming JT, 1997, J NEUROSCI, V17, P5843; Gally C, 2004, NATURE, V431, P578, DOI 10.1038/nature02893; Gendrel M, 2009, NATURE, V461, P992, DOI 10.1038/nature08430; Gottschalk A, 2006, J NEUROSCI METH, V154, P68, DOI 10.1016/j.jneumeth.2005.11.016; Halevi S, 2002, EMBO J, V21, P1012, DOI 10.1093/emboj/21.5.1012; Hibbs RE, 2011, NATURE, V474, P54, DOI 10.1038/nature10139; Jackson AC, 2011, NEURON, V70, P178, DOI 10.1016/j.neuron.2011.04.007; Kaminsky R, 2008, NATURE, V452, P176, DOI 10.1038/nature06722; Kashino Y, 2002, BIOCHEMISTRY-US, V41, P8004, DOI 10.1021/bi026012+; Kato AS, 2010, NEURON, V68, P1082, DOI 10.1016/j.neuron.2010.11.026; Letts VA, 1998, NAT GENET, V19, P340, DOI 10.1038/1228; LEWIS JA, 1980, GENETICS, V95, P905; Lyukmanova EN, 2011, J BIOL CHEM, V286, P10618, DOI 10.1074/jbc.M110.189100; Miwa JM, 1999, NEURON, V23, P105, DOI 10.1016/S0896-6273(00)80757-6; Miwa JM, 2011, NEURON, V70, P20, DOI 10.1016/j.neuron.2011.03.014; Morishita H, 2010, SCIENCE, V330, P1238, DOI 10.1126/science.1195320; NEHER E, 1978, J PHYSIOL-LONDON, V277, P153, DOI 10.1113/jphysiol.1978.sp012267; Qian H, 2008, FASEB J, V22, P3247, DOI 10.1096/fj.08-110502; Rapti G, 2011, EMBO J, V30, P706, DOI 10.1038/emboj.2010.355; Rayes D, 2007, MOL PHARMACOL, V71, P1407, DOI 10.1124/mol.106.033514; Richmond JE, 1999, NAT NEUROSCI, V2, P791, DOI 10.1038/12160; Robert V, 2007, EMBO J, V26, P170, DOI 10.1038/sj.emboj.7601463; Sancar F, 2011, J BIOL CHEM, V286, P33501, DOI 10.1074/jbc.M111.227678; Schwenk J, 2009, SCIENCE, V323, P1313, DOI 10.1126/science.1167852; Sirpio S, 2007, BIOCHEM J, V406, P415, DOI 10.1042/BJ20070460; Straub C, 2011, NAT NEUROSCI, V14, P866, DOI 10.1038/nn.2837; Sumioka A, 2011, NAT NEUROSCI, V14, P1410, DOI 10.1038/nn.2952; Tomita S, 2003, J CELL BIOL, V161, P805, DOI 10.1083/jcb.200212116; Touroutine D, 2005, J BIOL CHEM, V280, P27013, DOI 10.1074/jbc.M502818200; Towers PR, 2005, J NEUROCHEM, V93, P1, DOI 10.1111/j.1471-4159.2004.02951.x; von Engelhardt J, 2010, SCIENCE, V327, P1518, DOI 10.1126/science.1184178; Walker CS, 2006, P NATL ACAD SCI USA, V103, P10787, DOI 10.1073/pnas.0604520103; Wegener KM, 2011, MOL PLANT, V4, P1052, DOI 10.1093/mp/ssr044; Williams DC, 2005, GENETICS, V169, P1779, DOI 10.1534/genetics.104.038265; Williamson SM, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000517; Wu HY, 2011, PLANT PHYSIOL, V157, P1015, DOI 10.1104/pp.111.184739; Zhang W, 2009, NEURON, V61, P385, DOI 10.1016/j.neuron.2008.12.014	48	37	39	1	15	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	OCT	2012	15	10					1374	1381		10.1038/nn.3197	http://dx.doi.org/10.1038/nn.3197			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	013VZ	22922783				2022-12-28	WOS:000309335300017
J	Henry, KS; Heinz, MG				Henry, Kenneth S.; Heinz, Michael G.			Diminished temporal coding with sensorineural hearing loss emerges in background noise	NATURE NEUROSCIENCE			English	Article							AUDITORY-NERVE FIBERS; FINE-STRUCTURE; SPEECH-PERCEPTION; DEGENERATION; TONES	Behavioral studies in humans suggest that sensorineural hearing loss (SNHL) decreases sensitivity to the temporal structure of sound, but neurophysiological studies in mammals provide little evidence for diminished temporal coding. We found that SNHL in chinchillas degraded peripheral temporal coding in background noise substantially more than in quiet. These results resolve discrepancies between previous studies and help to explain why perceptual difficulties in hearing-impaired listeners often emerge in noisy situations.	[Henry, Kenneth S.; Heinz, Michael G.] Purdue Univ, Dept Speech Language & Hearing Sci, W Lafayette, IN 47907 USA; [Heinz, Michael G.] Purdue Univ, Weldon Sch Biomed Engn, W Lafayette, IN 47907 USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus; Purdue University System; Purdue University; Purdue University West Lafayette Campus	Heinz, MG (corresponding author), Purdue Univ, Dept Speech Language & Hearing Sci, W Lafayette, IN 47907 USA.	mheinz@purdue.edu		Henry, Kenneth S./0000-0003-1364-318X	US National Institutes of Health [R01-DC009838]; National Institute on Deafness and Other Communication Disorders [F32-DC012236]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [F32DC012236, R01DC009838] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute on Deafness and Other Communication Disorders(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	We thank J. Boley and M. Walls for assisting with surgeries and K. Kluender and E. Davies-Venn for providing feedback on a previous draft of the manuscript. This research was supported by US National Institutes of Health grant R01-DC009838 to M.G.H. and grant F32-DC012236 to K.S.H. from the National Institute on Deafness and Other Communication Disorders.	HARRISON RV, 1979, ARCH OTO-RHINO-LARYN, V224, P71, DOI 10.1007/BF00455226; JOHNSON DH, 1980, J ACOUST SOC AM, V68, P1115, DOI 10.1121/1.384982; Kale S, 2010, JARO-J ASSOC RES OTO, V11, P657, DOI 10.1007/s10162-010-0223-6; Kujawa SG, 2009, J NEUROSCI, V29, P14077, DOI 10.1523/JNEUROSCI.2845-09.2009; LIBERMAN MC, 1984, HEARING RES, V16, P55, DOI 10.1016/0378-5955(84)90025-X; Lorenzi C, 2006, P NATL ACAD SCI USA, V103, P18866, DOI 10.1073/pnas.0607364103; Lorenzi C, 2009, J ACOUST SOC AM, V125, P27, DOI 10.1121/1.2939125; Miller RL, 1997, J ACOUST SOC AM, V101, P3602, DOI 10.1121/1.418321; Moore BCJ, 2008, JARO-J ASSOC RES OTO, V9, P399, DOI 10.1007/s10162-008-0143-x; Moore BCJ, 2006, HEARING RES, V222, P16, DOI 10.1016/j.heares.2006.08.007; Wilson RH, 2007, J SPEECH LANG HEAR R, V50, P844, DOI 10.1044/1092-4388(2007/059); WOOLF NK, 1981, HEARING RES, V4, P335, DOI 10.1016/0378-5955(81)90017-4	12	55	58	0	23	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	OCT	2012	15	10					1362	1364		10.1038/nn.3216	http://dx.doi.org/10.1038/nn.3216			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	013VZ	22960931	Green Accepted			2022-12-28	WOS:000309335300013
J	Roberts, TF; Gobes, SMH; Murugan, M; Olveczky, BP; Mooney, R				Roberts, Todd F.; Gobes, Sharon M. H.; Murugan, Malavika; Oelveczky, Bence P.; Mooney, Richard			Motor circuits are required to encode a sensory model for imitative learning	NATURE NEUROSCIENCE			English	Article							ADULT ZEBRA FINCHES; AUDITORY REPRESENTATIONS; NEURAL MECHANISMS; MIRROR NEURONS; SYNAPTIC BASIS; FIELD-L; SONG; BIRDSONG; HVC; PATHWAYS	Premotor circuits help generate imitative behaviors and can be activated during observation of another animal's behavior, leading to speculation that these circuits participate in sensory learning that is important to imitation. Here we tested this idea by focally manipulating the brain activity of juvenile zebra finches, which learn to sing by memorizing and vocally copying the song of an adult tutor. Tutor song contingent optogenetic or electrical disruption of neural activity in the pupil's song premotor nucleus HVC prevented song copying, indicating that a premotor structure important to the temporal control of birdsong also helps encode the tutor song. In vivo multiphoton imaging and neural manipulations delineated a pathway and a candidate synaptic mechanism through which tutor song information is encoded by premotor circuits. These findings provide evidence that premotor circuits help encode sensory information about the behavioral model before shaping and executing imitative behaviors.	[Roberts, Todd F.; Murugan, Malavika; Mooney, Richard] Duke Univ, Med Ctr, Dept Neurobiol, Durham, NC 27710 USA; [Gobes, Sharon M. H.; Oelveczky, Bence P.] Harvard Univ, Dept Organism & Evolutionary Biol, Boston, MA 02115 USA; [Gobes, Sharon M. H.] Wellesley Coll, Neurosci Program, Wellesley, MA 02181 USA	Duke University; Harvard University; Wellesley College	Mooney, R (corresponding author), Duke Univ, Med Ctr, Dept Neurobiol, Durham, NC 27710 USA.	mooney@neuro.duke.edu	Core, Vector/CAF-4832-2022; Murugan, Malavika/AAB-8060-2019	Murugan, Malavika/0000-0003-1300-0379; Gobes, Sharon/0000-0001-9598-7116; Olveczky, Bence/0000-0003-2499-2705; Mooney, Richard/0000-0002-3308-1367	National Science Foundation; US National Institutes of Health [R01 DC02524, R01 NS066408]; Netherlands Organization for Scientific Research (NWO); Klingenstein, Sloan and McKnight Foundations; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS066408] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC002524] Funding Source: NIH RePORTER; Direct For Biological Sciences [0821914] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); Klingenstein, Sloan and McKnight Foundations; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	The authors thank H. Greenside, S. Lisberger, D. Purves, K. Tschida and F. Wang for reading and commenting on the manuscript, K. Hamaguchi (Duke University Medical Center) for data analysis software support and design of microdialysis probes, T. Otchy, K. Bohon, A. Bae and S. Lotfi for technical assistance and assistance with data processing and J. Baltzegar for animal husbandry and laboratory support. This research was supported by grants from the National Science Foundation (R.M.), the US National Institutes of Health (R.M. (R01 DC02524) and B.P.O. (R01 NS066408)), a Rubicon fellowship from the Netherlands Organization for Scientific Research (NWO) to S.M.H.G. and grants from the Klingenstein, Sloan and McKnight Foundations (B.P.O.).	Akutagawa E, 2010, J COMP NEUROL, V518, P3086, DOI 10.1002/cne.22383; Arbib MA, 2008, J PHYSIOL-PARIS, V102, P4, DOI 10.1016/j.jphysparis.2008.03.001; Arbib MA, 2008, CURR ANTHROPOL, V49, P1052, DOI 10.1086/593015; Basham ME, 1996, NEUROBIOL LEARN MEM, V66, P295, DOI 10.1006/nlme.1996.0071; Bauer EE, 2008, J NEUROSCI, V28, P1509, DOI 10.1523/JNEUROSCI.3838-07.2008; Bolhuis JJ, 2006, NAT REV NEUROSCI, V7, P347, DOI 10.1038/nrn1904; Bolhuis JJ, 2001, EUR J NEUROSCI, V13, P2165, DOI 10.1046/j.0953-816x.2001.01588.x; Boyden ES, 2005, NAT NEUROSCI, V8, P1263, DOI 10.1038/nn1525; Cardin JA, 2005, J NEUROPHYSIOL, V93, P2157, DOI 10.1152/jn.01001.2004; Coleman MJ, 2004, J NEUROSCI, V24, P7251, DOI 10.1523/JNEUROSCI.0947-04.2004; Dehaene-Lambertz G, 2006, P NATL ACAD SCI USA, V103, P14240, DOI 10.1073/pnas.0606302103; Doupe AJ, 1999, ANNU REV NEUROSCI, V22, P567, DOI 10.1146/annurev.neuro.22.1.567; Engert F, 1999, NATURE, V399, P66, DOI 10.1038/19978; Fabbri-Destro M, 2008, PHYSIOLOGY, V23, P171, DOI 10.1152/physiol.00004.2008; Ferrari PF, 2003, EUR J NEUROSCI, V17, P1703, DOI 10.1046/j.1460-9568.2003.02601.x; FORTUNE ES, 1992, J COMP NEUROL, V325, P388, DOI 10.1002/cne.903250306; FORTUNE ES, 1995, J COMP NEUROL, V360, P413, DOI 10.1002/cne.903600305; Gallese V, 1996, BRAIN, V119, P593, DOI 10.1093/brain/119.2.593; Gobes SMH, 2007, CURR BIOL, V17, P789, DOI 10.1016/j.cub.2007.03.059; Hahnloser RHR, 2002, NATURE, V419, P65, DOI 10.1038/nature00974; Hahnloser RHR, 2007, J NEUROPHYSIOL, V97, P423, DOI 10.1152/jn.00547.2006; Hahnloser RHR, 2010, CURR OPIN NEUROBIOL, V20, P332, DOI 10.1016/j.conb.2010.02.011; Iacoboni M, 1999, SCIENCE, V286, P2526, DOI 10.1126/science.286.5449.2526; Immelmann K., 1969, P61; KELLEY DB, 1979, J COMP NEUROL, V183, P455, DOI 10.1002/cne.901830302; London SE, 2008, NAT NEUROSCI, V11, P579, DOI 10.1038/nn.2103; Long MA, 2008, NATURE, V456, P189, DOI 10.1038/nature07448; MARLER P, 1964, SCIENCE, V146, P1483, DOI 10.1126/science.146.3650.1483; Matsuzaki M, 2004, NATURE, V429, P761, DOI 10.1038/nature02617; Mooney R, 2005, J NEUROSCI, V25, P1952, DOI 10.1523/JNEUROSCI.3726-04.2005; Mooney R, 2009, LEARN MEMORY, V16, P655, DOI 10.1101/lm.1065209; Nagel G, 2005, CURR BIOL, V15, P2279, DOI 10.1016/j.cub.2005.11.032; Nick TA, 2005, J NEUROBIOL, V62, P231, DOI 10.1002/neu.20087; NOTTEBOHM F, 1976, J COMP NEUROL, V165, P457, DOI 10.1002/cne.901650405; Phan ML, 2006, P NATL ACAD SCI USA, V103, P1088, DOI 10.1073/pnas.0510136103; Prather JF, 2008, NATURE, V451, P305, DOI 10.1038/nature06492; Prather JF, 2010, J NEUROSCI, V30, P10586, DOI 10.1523/JNEUROSCI.6042-09.2010; Rizzolatti G, 2001, NAT REV NEUROSCI, V2, P661, DOI 10.1038/35090060; Rizzolatti G, 1998, TRENDS NEUROSCI, V21, P188, DOI 10.1016/S0166-2236(98)01260-0; Roberts TF, 2010, NATURE, V463, P948, DOI 10.1038/nature08759; Roy A, 2009, J NEUROPHYSIOL, V102, P979, DOI 10.1152/jn.00293.2009; Terpstra NJ, 2004, J NEUROSCI, V24, P4971, DOI 10.1523/JNEUROSCI.0570-04.2004; Tumer EC, 2007, NATURE, V450, P1240, DOI 10.1038/nature06390; Vates GE, 1996, J COMP NEUROL, V366, P613, DOI 10.1002/(SICI)1096-9861(19960318)366:4<613::AID-CNE5>3.0.CO;2-7; VU ET, 1994, J NEUROSCI, V14, P6924; Wild JM, 2005, J COMP NEUROL, V483, P76, DOI 10.1002/cne.20403; Yizhar O, 2011, NEURON, V71, P9, DOI 10.1016/j.neuron.2011.06.004; Yu AC, 1996, SCIENCE, V273, P1871, DOI 10.1126/science.273.5283.1871; Zhang F, 2007, NATURE, V446, P633, DOI 10.1038/nature05744	49	100	104	1	48	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	OCT	2012	15	10					1454	1459		10.1038/nn.3206	http://dx.doi.org/10.1038/nn.3206			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	013VZ	22983208	Green Submitted, Green Accepted			2022-12-28	WOS:000309335300027
J	Rudinskiy, N; Hawkes, JM; Betensky, RA; Eguchi, M; Yamaguchi, S; Spires-Jones, TL; Hyman, BT				Rudinskiy, Nikita; Hawkes, Jonathan M.; Betensky, Rebecca A.; Eguchi, Megumi; Yamaguchi, Shun; Spires-Jones, Tara L.; Hyman, Bradley T.			Orchestrated experience-driven Arc responses are disrupted in a mouse model of Alzheimer's disease	NATURE NEUROSCIENCE			English	Article							LONG-TERM POTENTIATION; AMYLOID-BETA; SYNAPTIC PLASTICITY; IN-VIVO; NEURONAL DYSFUNCTION; PROTEIN EXPRESSION; TRANSGENIC MICE; A-BETA; ARC/ARG3.1; PLAQUES	Experience-induced expression of immediate-early gene Arc (also known as Arg3.1) is known to be important for consolidation of memory. Using in vivo longitudinal multiphoton imaging, we found orchestrated activity-dependent expression of Arc in the mouse extrastriate visual cortex in response to a structured visual stimulation. In wild-type mice, the amplitude of the Arc response in individual neurons strongly predicted the probability of reactivation by a subsequent presentation of the same stimulus. In a mouse model of Alzheimer's disease, this association was markedly disrupted in the cortex, specifically near senile plaques. Neurons in the vicinity of plaques were less likely to respond, but, paradoxically, there were stronger responses in those few neurons around plaques that did respond. To the extent that the orchestrated pattern of Arc expression reflects nervous system responses to and physiological consolidation of behavioral experience, the disruption in Arc patterns reveals plaque-associated interference with neural network integration.	[Rudinskiy, Nikita; Hawkes, Jonathan M.; Spires-Jones, Tara L.; Hyman, Bradley T.] Harvard Univ, Massachusetts Gen Hosp, MassGen Inst Neurodegenerat Dis, Alzheimers Dis Res Lab,Dept Neurol,Sch Med, Charlestown, MA USA; [Hawkes, Jonathan M.] Northeastern Univ, Behav Neurosci Program, Boston, MA 02115 USA; [Betensky, Rebecca A.] Harvard Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02115 USA; [Eguchi, Megumi; Yamaguchi, Shun] Gifu Univ, Grad Sch Med, Div Morphol Neurosci, Gifu, Japan	Harvard University; Massachusetts General Hospital; Northeastern University; Harvard University; Harvard T.H. Chan School of Public Health; Gifu University	Hyman, BT (corresponding author), Harvard Univ, Massachusetts Gen Hosp, MassGen Inst Neurodegenerat Dis, Alzheimers Dis Res Lab,Dept Neurol,Sch Med, Charlestown, MA USA.	bhyman@partners.org	Spires-Jones, Tara/AAR-7697-2020	Spires-Jones, Tara/0000-0003-2530-0598	Swiss National Science Foundation; Swiss Foundation for Grants in Biology and Medicine; Gilbert fund; US National Institutes of Health [AG033670, AG08487]; Harvard NeuroDiscovery Center; NATIONAL INSTITUTE ON AGING [P50AG005134, R00AG033670, K99AG033670, R01AG008487, R29AG008487, R01AG026249] Funding Source: NIH RePORTER	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Swiss Foundation for Grants in Biology and Medicine; Gilbert fund; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Harvard NeuroDiscovery Center; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank A. Muzikansky (Harvard), B. Urbanc and B. Cohen (Drexel) for their help with statistical analysis. We also thank all the members of the Hyman laboratory for their input, discussions and help with the equipment. N.R. is supported by the fellowships from the Swiss National Science Foundation and the Swiss Foundation for Grants in Biology and Medicine. This research is supported by a gift from the Gilbert fund, grants from the US National Institutes of Health (AG033670 to T.L.S.-J. and AG08487 to B.T.H.) and a grant from the Harvard NeuroDiscovery Center to R.A.B.	BLAKEMORE C, 1971, BRAIN RES, V31, P366, DOI 10.1016/0006-8993(71)90193-4; Busche MA, 2008, SCIENCE, V321, P1686, DOI 10.1126/science.1162844; Chen TJ, 2009, J NEUROSCI RES, V87, P2297, DOI 10.1002/jnr.22057; Chin J, 2005, J NEUROSCI, V25, P9694, DOI 10.1523/JNEUROSCI.2980-05.2005; Chowdhury S, 2006, NEURON, V52, P445, DOI 10.1016/j.neuron.2006.08.033; Cleary JP, 2005, NAT NEUROSCI, V8, P79, DOI 10.1038/nn1372; Cuadrado-Tejedor M, 2011, BRIT J PHARMACOL, V164, P2029, DOI 10.1111/j.1476-5381.2011.01517.x; Dickey CA, 2004, J NEUROCHEM, V88, P434, DOI 10.1046/j.1471-4159.2003.02185.x; Dickey CA, 2003, J NEUROSCI, V23, P5219; Dickson TC, 2001, NEUROSCIENCE, V105, P99, DOI 10.1016/S0306-4522(01)00169-5; Drzezga A, 2011, BRAIN, V134, P1635, DOI 10.1093/brain/awr066; Echeverria V, 2007, CURR ALZHEIMER RES, V4, P518, DOI 10.2174/156720507783018190; Eguchi M, 2009, NEUROIMAGE, V44, P1274, DOI 10.1016/j.neuroimage.2008.10.046; Fox LM, 2011, J NEUROPATH EXP NEUR, V70, P588, DOI 10.1097/NEN.0b013e318220a658; Ginsberg SD, 2000, ANN NEUROL, V48, P77, DOI 10.1002/1531-8249(200007)48:1<77::AID-ANA12>3.3.CO;2-1; Grinevich V, 2009, J NEUROSCI METH, V184, P25, DOI 10.1016/j.jneumeth.2009.07.015; Guzowski JF, 2000, J NEUROSCI, V20, P3993; Herring A, 2012, FASEB J, V26, P117, DOI 10.1096/fj.11-193193; HYMAN BT, 1995, P NATL ACAD SCI USA, V92, P3586, DOI 10.1073/pnas.92.8.3586; Jankowsky JL, 2003, J NEUROPATH EXP NEUR, V62, P1220, DOI 10.1093/jnen/62.12.1220; Jankowsky JL, 2001, BIOMOL ENG, V17, P157, DOI 10.1016/S1389-0344(01)00067-3; Koffie RM, 2011, MOL NEURODEGENER, V6, DOI 10.1186/1750-1326-6-63; Koffie RM, 2009, P NATL ACAD SCI USA, V106, P4012, DOI 10.1073/pnas.0811698106; Korb E, 2011, TRENDS NEUROSCI, V34, P591, DOI 10.1016/j.tins.2011.08.007; Kuchibhotla KV, 2008, NEURON, V59, P214, DOI 10.1016/j.neuron.2008.06.008; Lacor PN, 2004, J NEUROSCI, V24, P10191, DOI 10.1523/JNEUROSCI.3432-04.2004; Maddox SA, 2011, J NEUROSCI, V31, P7073, DOI 10.1523/JNEUROSCI.1120-11.2011; Messaoudi E, 2007, J NEUROSCI, V27, P10445, DOI 10.1523/JNEUROSCI.2883-07.2007; Meyer-Luehmann M, 2008, NATURE, V451, P720, DOI 10.1038/nature06616; Palop JJ, 2005, J NEUROSCI, V25, P9686, DOI 10.1523/JNEUROSCI.2829-05.2005; Palop JJ, 2007, NEURON, V55, P697, DOI 10.1016/j.neuron.2007.07.025; Palop JJ, 2010, NAT NEUROSCI, V13, P812, DOI 10.1038/nn.2583; Perez-Cruz C, 2011, J NEUROSCI, V31, P3926, DOI 10.1523/JNEUROSCI.6142-10.2011; Plath N, 2006, NEURON, V52, P437, DOI 10.1016/j.neuron.2006.08.024; Ramirez-Amaya V, 2005, J NEUROSCI, V25, P1761, DOI 10.1523/JNEUROSCI.4342-04.2005; Rosi S, 2005, J NEUROSCI, V25, P723, DOI 10.1523/JNEUROSCI.4469-04.2005; Rozkalne A, 2011, NEUROBIOL DIS, V41, P650, DOI 10.1016/j.nbd.2010.11.014; Sengpiel F, 1999, NAT NEUROSCI, V2, P727, DOI 10.1038/11192; Shankar GM, 2008, NAT MED, V14, P837, DOI 10.1038/nm1782; Shepherd JD, 2006, NEURON, V52, P475, DOI 10.1016/j.neuron.2006.08.034; Shepherd JD, 2011, NAT NEUROSCI, V14, P279, DOI 10.1038/nn.2708; Sperling RA, 2009, NEURON, V63, P178, DOI 10.1016/j.neuron.2009.07.003; Spires TL, 2005, J NEUROSCI, V25, P7278, DOI 10.1523/JNEUROSCI.1879-05.2005; Tagawa Y, 2005, NAT NEUROSCI, V8, P380, DOI 10.1038/nn1410; Urbanc B, 2002, P NATL ACAD SCI USA, V99, P13990, DOI 10.1073/pnas.222433299; Verde EMR, 2006, NEURON, V52, P461, DOI 10.1016/j.neuron.2006.09.031; Wang DC, 2006, NEUROSCI LETT, V398, P78, DOI 10.1016/j.neulet.2005.12.057; Wang KH, 2006, CELL, V126, P389, DOI 10.1016/j.cell.2006.06.038; Wegenast-Braun BM, 2009, AM J PATHOL, V175, P271, DOI 10.2353/ajpath.2009.090044; Wu J, 2011, CELL, V147, P615, DOI 10.1016/j.cell.2011.09.036	50	69	71	1	17	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	OCT	2012	15	10					1422	1429		10.1038/nn.3199	http://dx.doi.org/10.1038/nn.3199			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	013VZ	22922786	Green Accepted, Green Submitted			2022-12-28	WOS:000309335300023
J	Horwitz, GD; Hass, CA				Horwitz, Gregory D.; Hass, Charles A.			Nonlinear analysis of macaque V1 color tuning reveals cardinal directions for cortical color processing	NATURE NEUROSCIENCE			English	Article							PRIMARY VISUAL-CORTEX; LATERAL GENICULATE-NUCLEUS; FOVEAL STRIATE CORTEX; RETINAL GANGLION-CELLS; COMPLEX CELLS; RHESUS-MONKEY; CONE INPUTS; CHROMATIC MECHANISMS; LUMINANCE CONTRAST; RECEPTIVE-FIELD	Understanding color vision requires knowing how signals from the three classes of cone photoreceptor are combined in the cortex. We recorded from individual neurons in the primary visual cortex (V1) of awake monkeys while an automated, closed-loop system identified stimuli that differed in cone contrast but evoked the same response. We found that isoresponse surfaces for half the neurons were planar, which is consistent with linear processing. The remaining isoresponse surfaces were nonplanar. Some were cup-shaped, indicating sensitivity to only a narrow region of color space. Others were ellipsoidal, indicating sensitivity to all color directions. The major and minor axes of these nonplanar surfaces were often aligned to a set of three color directions that were previously identified in perceptual experiments. These results suggest that many V1 neurons combine cone signals nonlinearly and provide a new framework in which to decipher color processing in V1.	[Horwitz, Gregory D.] Univ Washington, Dept Physiol & Biophys, Seattle, WA 98195 USA; [Hass, Charles A.] Univ Washington, Program Neurobiol & Behav, Seattle, WA USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Horwitz, GD (corresponding author), Univ Washington, Dept Physiol & Biophys, Seattle, WA 98195 USA.	ghorwitz@u.washington.edu		Horwitz, Gregory/0000-0001-5130-5259; Hass, Charles/0000-0002-7499-1674	US National Institutes of Health (National Institute of General Medical Sciences); Achievement Rewards for College Scientists Foundation; McKnight Foundation; US National Institutes of Health [RR000166, EY018849]; NATIONAL CENTER FOR RESEARCH RESOURCES [P51RR000166] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [P30EY001730, R01EY018849] Funding Source: NIH RePORTER	US National Institutes of Health (National Institute of General Medical Sciences)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Achievement Rewards for College Scientists Foundation(General Electric); McKnight Foundation; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	The authors would like to thank A. Pasupathy, M. Shadlen, E.J. Chichilnisky, F. Rieke and G. Field for comments on the manuscript, J.P. Weller for modeling the adaptive sampling procedure, J. Gold for supplying UDP communication software, and E. Grover and L. Tait for technical assistance. This work was supported by a US National Institutes of Health (National Institute of General Medical Sciences) Training Grant (C. A. H.), the Achievement Rewards for College Scientists Foundation (C. A. H.), the McKnight Foundation (G. D. H.), and US National Institutes of Health grants RR000166 and EY018849 (G.D.H.).	ADELSON EH, 1985, J OPT SOC AM A, V2, P284, DOI 10.1364/JOSAA.2.000284; Benardete EA, 1999, J PHYSIOL-LONDON, V519, P775, DOI 10.1111/j.1469-7793.1999.0775n.x; Benardete EA, 1997, VISUAL NEUROSCI, V14, P187, DOI 10.1017/S0952523800008865; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; COLE GR, 1993, J OPT SOC AM A, V10, P38, DOI 10.1364/JOSAA.10.000038; Conway BR, 2006, J NEUROSCI, V26, P10826, DOI 10.1523/JNEUROSCI.2091-06.2006; Cottaris NP, 1998, NATURE, V395, P896, DOI 10.1038/27666; Dacey DM, 1999, PROG RETIN EYE RES, V18, P737, DOI 10.1016/S1350-9462(98)00013-5; De Valois RL, 2000, P NATL ACAD SCI USA, V97, P4997, DOI 10.1073/pnas.97.9.4997; DERRINGTON AM, 1984, J PHYSIOL-LONDON, V357, P241, DOI 10.1113/jphysiol.1984.sp015499; DEVALOIS RL, 1966, J OPT SOC AM, V56, P966, DOI 10.1364/JOSA.56.000966; DOW BM, 1973, J NEUROPHYSIOL, V36, P79, DOI 10.1152/jn.1973.36.1.79; Duda R. O., 2001, PATTERN CLASSIFICATI; EMERSON RC, 1992, VISION RES, V32, P203, DOI 10.1016/0042-6989(92)90130-B; GOURAS P, 1974, J PHYSIOL-LONDON, V238, P583, DOI 10.1113/jphysiol.1974.sp010545; Hanazawa A, 2000, EUR J NEUROSCI, V12, P1753, DOI 10.1046/j.1460-9568.2000.00041.x; HEEGER DJ, 1992, VISUAL NEUROSCI, V9, P181, DOI 10.1017/S0952523800009640; Horwitz GD, 2005, J NEUROPHYSIOL, V93, P2263, DOI 10.1152/jn.00743.2004; Horwitz GD, 2007, J NEUROPHYSIOL, V97, P3070, DOI 10.1152/jn.00965.2006; HUBEL DH, 1962, J PHYSIOL-LONDON, V160, P106, DOI 10.1113/jphysiol.1962.sp006837; HURVICH LM, 1957, PSYCHOL REV, V64, P384, DOI 10.1037/h0041403; INGLING CR, 1977, VISION RES, V17, P1075, DOI 10.1016/0042-6989(77)90013-X; Johnson EN, 2004, J NEUROPHYSIOL, V91, P2501, DOI 10.1152/jn.01043.2003; Johnson EN, 2001, NAT NEUROSCI, V4, P409, DOI 10.1038/86061; KOCH C, 1983, P NATL ACAD SCI-BIOL, V80, P2799, DOI 10.1073/pnas.80.9.2799; KRAUSKOPF J, 1982, VISION RES, V22, P1123, DOI 10.1016/0042-6989(82)90077-3; Lankheet MJM, 1998, VISUAL NEUROSCI, V15, P37, DOI 10.1017/S0952523898151027; LEE BB, 1990, J OPT SOC AM A, V7, P2223, DOI 10.1364/JOSAA.7.002223; LEE BB, 1989, J NEUROSCI, V9, P1433; LENNIE P, 1990, J NEUROSCI, V10, P649; Liu JJ, 2005, J NEUROSCI, V25, P3459, DOI 10.1523/JNEUROSCI.4206-04.2005; MOVSHON JA, 1978, J PHYSIOL-LONDON, V283, P79, DOI 10.1113/jphysiol.1978.sp012489; NAGY AL, 1987, J OPT SOC AM A, V4, P756, DOI 10.1364/JOSAA.4.000756; Olmsted J.M.H., 1947, SOLID ANAL GEOMETRY; POIRSON AB, 1990, VISION RES, V30, P647, DOI 10.1016/0042-6989(90)90075-V; Sankeralli MJ, 1996, J OPT SOC AM A, V13, P906, DOI 10.1364/JOSAA.13.000906; SCHILLER PH, 1983, VISION RES, V23, P1631, DOI 10.1016/0042-6989(83)90177-3; SHAPLEY R, 1989, Investigative Ophthalmology and Visual Science, V30, P323; Sharpee T, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000646; SKOTTUN BC, 1991, VISION RES, V31, P1079, DOI 10.1016/0042-6989(91)90033-2; Solomon SG, 2010, J NEUROPHYSIOL, V104, P1884, DOI 10.1152/jn.01118.2009; Solomon SG, 2005, J NEUROSCI, V25, P4779, DOI 10.1523/JNEUROSCI.5316-04.2005; STOCKMAN A, 1993, J OPT SOC AM A, V10, P2491, DOI 10.1364/JOSAA.10.002491; TORRE V, 1978, PROC R SOC SER B-BIO, V202, P409, DOI 10.1098/rspb.1978.0075; VAUTIN RG, 1985, J NEUROPHYSIOL, V54, P273, DOI 10.1152/jn.1985.54.2.273; WIESEL TN, 1966, J NEUROPHYSIOL, V29, P1115, DOI 10.1152/jn.1966.29.6.1115; Yoshioka T, 1996, BEHAV BRAIN RES, V76, P51, DOI 10.1016/0166-4328(95)00183-2; ZEKI S, 1980, NATURE, V284, P412, DOI 10.1038/284412a0	48	52	52	0	17	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUN	2012	15	6					913	U145		10.1038/nn.3105	http://dx.doi.org/10.1038/nn.3105			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	949AI	22581184	Green Accepted			2022-12-28	WOS:000304546700020
J	Li, JL; Hart, RP; Mallimo, EM; Swerdel, MR; Kusnecov, AW; Herrup, K				Li, Jiali; Hart, Ronald P.; Mallimo, Elyse M.; Swerdel, Mavis R.; Kusnecov, Alexander W.; Herrup, Karl			EZH2-mediated H3K27 trimethylation mediates neurodegeneration in ataxia-telangiectasia	NATURE NEUROSCIENCE			English	Article							EZH2 SUPPRESSES METHYLATION; HISTONE METHYLTRANSFERASE; SELF-RENEWAL; DNA-REPAIR; POLYCOMB; ATM; PHOSPHORYLATION; PROTEIN; PRC2; DIFFERENTIATION	The symptoms of ataxia-telangiectasia (A-T) include a progressive neurodegeneration caused by ATM protein deficiency. We previously found that nuclear accumulation of histone deacetylase-4, HDAC4, contributes to this degeneration; we now report that increased trimethylation of histone H3 on Lys27 (H3K27me3) mediated by polycomb repressive complex 2 (PRC2) is also important in the A-T phenotype. Enhancer of zeste homolog 2 (EZH2), a core catalytic component of PRC2, is a new ATM kinase target, and ATM-mediated phosphorylation of EZH2 on Ser734 reduces protein stability. Thus, PRC2 formation is elevated along with H3K27me3 in ATM deficiency. Chromatin immunoprecipitation and sequencing showed an increase in H3K27me3 'marks' and a dramatic shift in their location. The change of H3K27me3 chromatin-binding pattern is directly related to cell cycle reentry and cell death of ATM-deficient neurons. Lentiviral knockdown of EZH2 rescued Purkinje cell degeneration and behavioral abnormalities in Atm(-/-) mice, demonstrating that EZH2 hyperactivity is another key factor in A-T neurodegeneration.	[Li, Jiali; Hart, Ronald P.; Swerdel, Mavis R.; Herrup, Karl] Rutgers State Univ, Dept Cell Biol & Neurosci, Piscataway, NJ 08854 USA; [Mallimo, Elyse M.; Kusnecov, Alexander W.] Rutgers State Univ, Dept Psychol, Piscataway, NJ USA; [Herrup, Karl] Hong Kong Univ Sci & Technol, Div Life Sci, Kowloon, Hong Kong, Peoples R China	Rutgers State University New Brunswick; Rutgers State University New Brunswick; Hong Kong University of Science & Technology	Li, JL (corresponding author), Rutgers State Univ, Dept Cell Biol & Neurosci, Piscataway, NJ 08854 USA.	jli@dls.rutgers.edu; herrup@ust.hk	Hart, Ronald P/G-6530-2019; li, Jiali/HGF-2395-2022; Hart, Ronald P/D-5219-2009; Herrup, Karl/C-5313-2014	Hart, Ronald P/0000-0003-4836-8712; li, Jiali/0000-0001-6202-7741; Hart, Ronald P/0000-0003-4836-8712; Herrup, Karl/0000-0001-7786-5844; Li, Jiali/0000-0002-0039-3671	US National Institutes of Health [NS20591, NS71022, RC1 CA147187, MH60706, NIEHS P30 ES05022]; NATIONAL CANCER INSTITUTE [RC1CA147187] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES005022] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R21MH085088, R01MH060706] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS020591, R01NS071022] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank Y. Xu (University of California, San Diego) for providing the AtmtmlBal mutant strain. We thank R. Gatti (University of California, Los Angeles) for sharing human A-T paraffin-embedded samples. Human frozen tissue was obtained from NICHD Brain and Tissue Bank of Developmental Disorders at the University of Maryland, Baltimore. Special thanks to R. Ma for the help in stereological analysis of Purkinje cells. We thank M.B. Kastan (Duke University), H. Huang (State University of New York at Stony Brook) and M.-c. Hung (University of Texas M.D. Anderson Cancer Center) for providing the Flag-ATM, myc-EZH2 and GSTEZH2 plasmids, respectively. The long-term support of the A-T Children's Project is gratefully acknowledged, as is the support of Rutgers University and the Hong Kong University of Science and Technology. This work was also funded by grants from the US National Institutes of Health: NS20591 and NS71022 to KR; RC1 CA147187 to R.P.H., and MH60706 and NIEHS P30 ES05022 to A.K. AUTHOR CONTRIBUTIONS J.L. and K.H. designed the experiments, analyzed data and wrote the manuscript. J.L. carried out biochemistry experiments and ChIP-qPCR and semiquantitative PCR. M.R.S. and R.P.H. developed, carried out and analyzed data for ChIPseq analyses. J.L., E.M.M. and A.K. carried out the mouse cerebellar lentiviral injections and behavioral tests.	Stefansson OA, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2871; Bakkenist CJ, 2003, NATURE, V421, P499, DOI 10.1038/nature01368; Barlow C, 2000, P NATL ACAD SCI USA, V97, P871, DOI 10.1073/pnas.97.2.871; Barlow C, 1996, CELL, V86, P159, DOI 10.1016/S0092-8674(00)80086-0; Biton S, 2008, DNA REPAIR, V7, P1028, DOI 10.1016/j.dnarep.2008.03.006; Biton S, 2006, J BIOL CHEM, V281, P17482, DOI 10.1074/jbc.M601895200; Boder E, 1975, Birth Defects Orig Artic Ser, V11, P255; Bracken AP, 2003, EMBO J, V22, P5323, DOI 10.1093/emboj/cdg542; Browne SE, 2004, FREE RADICAL BIO MED, V36, P938, DOI 10.1016/j.freeradbiomed.2004.01.003; Cao R, 2004, CURR OPIN GENET DEV, V14, P155, DOI 10.1016/j.gde.2004.02.001; Cao R, 2004, MOL CELL, V15, P57, DOI 10.1016/j.molcel.2004.06.020; Cha TL, 2005, SCIENCE, V310, P306, DOI 10.1126/science.1118947; Chen P, 2003, J NEUROSCI, V23, P11453; Chen SA, 2010, NAT CELL BIOL, V12, P1108, DOI 10.1038/ncb2116; Chou DM, 2010, P NATL ACAD SCI USA, V107, P18475, DOI 10.1073/pnas.1012946107; Chouliaras L, 2010, PROG NEUROBIOL, V90, P498, DOI 10.1016/j.pneurobio.2010.01.002; Dar I, 2006, J NEUROSCI, V26, P7767, DOI 10.1523/JNEUROSCI.2055-06.2006; Demonacos C, 2004, NAT CELL BIOL, V6, P968, DOI 10.1038/ncb1170; Fagiolini M, 2009, CURR OPIN NEUROBIOL, V19, P207, DOI 10.1016/j.conb.2009.05.009; Francis NJ, 2009, CELL, V137, P110, DOI 10.1016/j.cell.2009.02.017; Goodarzi AA, 2010, DNA REPAIR, V9, P1273, DOI 10.1016/j.dnarep.2010.09.013; Gueven N, 2006, FREE RADICAL BIO MED, V41, P992, DOI 10.1016/j.freeradbiomed.2006.06.018; Hirabayashi Y, 2009, NEURON, V63, P600, DOI 10.1016/j.neuron.2009.08.021; Juan AH, 2011, GENE DEV, V25, P789, DOI 10.1101/gad.2027911; Kaneko S, 2010, GENE DEV, V24, P2615, DOI 10.1101/gad.1983810; Kuljis RO, 1997, P NATL ACAD SCI USA, V94, P12688, DOI 10.1073/pnas.94.23.12688; Lavin MF, 1996, CURR OPIN IMMUNOL, V8, P459, DOI 10.1016/S0952-7915(96)80030-6; Li JL, 2012, NAT MED, V18, P783, DOI 10.1038/nm.2709; Li JL, 2011, J NEUROSCI, V31, P7568, DOI 10.1523/JNEUROSCI.0778-11.2011; Li JL, 2009, CURR BIOL, V19, P2091, DOI 10.1016/j.cub.2009.10.039; Margueron R, 2011, NATURE, V469, P343, DOI 10.1038/nature09784; Mohn F, 2008, MOL CELL, V30, P755, DOI 10.1016/j.molcel.2008.05.007; Pereira JD, 2010, P NATL ACAD SCI USA, V107, P15957, DOI 10.1073/pnas.1002530107; Rimkus SA, 2008, GENE DEV, V22, P1205, DOI 10.1101/gad.1639608; Sauvageau M, 2010, CELL STEM CELL, V7, P299, DOI 10.1016/j.stem.2010.08.002; SAVITSKY K, 1995, SCIENCE, V268, P1749, DOI 10.1126/science.7792600; SEDGWICK RP, 1960, NEUROLOGY, V10, P705, DOI 10.1212/WNL.10.7.705; Su I, 2005, CELL, V121, P425, DOI 10.1016/j.cell.2005.02.029; Surface LE, 2010, CELL STEM CELL, V7, P288, DOI 10.1016/j.stem.2010.08.004; Tian B, 2009, NAT CELL BIOL, V11, P211, DOI 10.1038/ncb1829; Varambally S, 2008, SCIENCE, V322, P1695, DOI 10.1126/science.1165395; Wei YK, 2011, NAT CELL BIOL, V13, P87, DOI 10.1038/ncb2139; Yang Y, 2005, J NEUROSCI, V25, P2522, DOI 10.1523/JNEUROSCI.4946-04.2005; Zeidler M, 2005, NEOPLASIA, V7, P1011, DOI 10.1593/neo.05472; Zeng XZ, 2011, CELL CYCLE, V10, P579, DOI 10.4161/cc.10.4.14722	45	100	101	1	19	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	DEC	2013	16	12					1745	1753		10.1038/nn.3564	http://dx.doi.org/10.1038/nn.3564			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	257VV	24162653	Green Accepted			2022-12-28	WOS:000327416800012
J	Sivyer, B; Williams, SR				Sivyer, Benjamin; Williams, Stephen R.			Direction selectivity is computed by active dendritic integration in retinal ganglion cells	NATURE NEUROSCIENCE			English	Article							STARBURST AMACRINE CELLS; RABBIT RETINA; ACTION-POTENTIALS; SYNAPTIC ORGANIZATION; BASAL DENDRITES; NMDA SPIKES; INPUT; NEURONS; PROPAGATION; MECHANISM	Active dendritic integration is thought to enrich the computational power of central neurons. However, a direct role of active dendritic processing in the execution of defined neuronal computations in intact neural networks has not been established. Here we used multi-site electrophysiological recording techniques to demonstrate that active dendritic integration underlies the computation of direction selectivity in rabbit retinal ganglion cells. Direction-selective retinal ganglion cells fire action potentials in response to visual image movement in a preferred direction. Dendritic recordings revealed that preferred-direction moving-light stimuli led to dendritic spike generation in terminal dendrites, which were further integrated and amplified as they spread through the dendritic arbor to the axon to drive action potential output. In contrast, when light bars moved in a null direction, synaptic inhibition vetoed neuronal output by directly inhibiting terminal dendritic spike initiation. Active dendritic integration therefore underlies a physiologically engaged circuit-based computation in the retina.	[Sivyer, Benjamin; Williams, Stephen R.] Univ Queensland, Queensland Brain Inst, Brisbane, Qld, Australia	University of Queensland	Williams, SR (corresponding author), Univ Queensland, Queensland Brain Inst, Brisbane, Qld, Australia.	srw@uq.edu.au		Williams, Stephen/0000-0001-5352-7947	Australian Research Council [FT100100502, DP130101630]; National Health and Medical Research Council [APP1004575]; University of Queensland Early Career Researcher Award [2012003384]	Australian Research Council(Australian Research Council); National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); University of Queensland Early Career Researcher Award	We are grateful to D. Vaney, W Taylor, W Levick, M. Harnett, R. Tweedale and G. Murphy for critically reading the manuscript. This work was supported by grants from the Australian Research Council (FT100100502 and DP130101630) and National Health and Medical Research Council (APP1004575) to S.R.W. and a University of Queensland Early Career Researcher Award (2012003384) to B.S.	AMES A, 1981, J NEUROCHEM, V37, P867, DOI 10.1111/j.1471-4159.1981.tb04473.x; Ariav G, 2003, J NEUROSCI, V23, P7750; BARLOW HB, 1963, SCIENCE, V139, P412, DOI 10.1126/science.139.3553.412; BARLOW HB, 1965, J PHYSIOL-LONDON, V178, P477, DOI 10.1113/jphysiol.1965.sp007638; Beier KT, 2013, J NEUROSCI, V33, P35, DOI 10.1523/JNEUROSCI.0245-12.2013; Branco T, 2010, SCIENCE, V329, P1671, DOI 10.1126/science.1189664; BRANDON C, 1987, BRAIN RES, V426, P119, DOI 10.1016/0006-8993(87)90431-8; Briggman KL, 2011, NATURE, V471, P183, DOI 10.1038/nature09818; Chen WR, 1997, SCIENCE, V278, P463, DOI 10.1126/science.278.5337.463; Euler T, 2002, NATURE, V418, P845, DOI 10.1038/nature00931; FAMIGLIETTI EV, 1991, J COMP NEUROL, V309, P40, DOI 10.1002/cne.903090105; Famiglietti EV, 2005, J COMP NEUROL, V484, P357, DOI 10.1002/cne.20433; Fried SI, 2002, NATURE, V420, P411, DOI 10.1038/nature01179; Gidon A, 2012, NEURON, V75, P330, DOI 10.1016/j.neuron.2012.05.015; Gollisch T, 2010, NEURON, V65, P150, DOI 10.1016/j.neuron.2009.12.009; Harnett MT, 2013, NEURON, V79, P516, DOI 10.1016/j.neuron.2013.06.005; Harnett MT, 2012, NATURE, V491, P599, DOI 10.1038/nature11554; Hausser M, 2000, SCIENCE, V290, P739, DOI 10.1126/science.290.5492.739; He SG, 1999, J NEUROSCI, V19, P8049; Jadi M, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002550; Johnston D, 2008, TRENDS NEUROSCI, V31, P309, DOI 10.1016/j.tins.2008.03.004; KOCH C, 1983, P NATL ACAD SCI-BIOL, V80, P2799, DOI 10.1073/pnas.80.9.2799; Larkum ME, 2009, SCIENCE, V325, P756, DOI 10.1126/science.1171958; Larkum ME, 1999, NATURE, V398, P338, DOI 10.1038/18686; Lavzin M, 2012, NATURE, V490, P397, DOI 10.1038/nature11451; Lee S, 2010, NEURON, V68, P1159, DOI 10.1016/j.neuron.2010.11.031; London M, 2005, ANNU REV NEUROSCI, V28, P503, DOI 10.1146/annurev.neuro.28.061604.135703; Losonczy A, 2006, NEURON, V50, P291, DOI 10.1016/j.neuron.2006.03.016; Masland RH, 2012, NEURON, V76, P266, DOI 10.1016/j.neuron.2012.10.002; Murayama M, 2009, NATURE, V457, P1137, DOI 10.1038/nature07663; Oesch N, 2005, NEURON, V47, P739, DOI 10.1016/j.neuron.2005.06.036; OYSTER CW, 1967, SCIENCE, V155, P841, DOI 10.1126/science.155.3764.841; Poirazi P, 2003, NEURON, V37, P989, DOI 10.1016/S0896-6273(03)00149-1; RALL W, 1973, BIOPHYS J, V13, P648, DOI 10.1016/S0006-3495(73)86014-X; Remy S, 2009, NEURON, V61, P906, DOI 10.1016/j.neuron.2009.01.032; Rhodes P, 2006, J NEUROSCI, V26, P6704, DOI 10.1523/JNEUROSCI.3791-05.2006; Schachter MJ, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000899; Schiller J, 2000, NATURE, V404, P285, DOI 10.1038/35005094; STUART GJ, 1994, NATURE, V367, P69, DOI 10.1038/367069a0; Taylor WR, 2000, SCIENCE, V289, P2347, DOI 10.1126/science.289.5488.2347; Vaney DI, 2012, NAT REV NEUROSCI, V13, P194, DOI 10.1038/nrn3165; Velte TJ, 1999, J NEUROPHYSIOL, V81, P1412, DOI 10.1152/jn.1999.81.3.1412; Wassle H, 2004, NAT REV NEUROSCI, V5, P747, DOI 10.1038/nrn1497; Wei W, 2011, NATURE, V469, P402, DOI 10.1038/nature09600; Williams SR, 2004, NAT NEUROSCI, V7, P961, DOI 10.1038/nn1305; Williams SR, 2002, SCIENCE, V295, P1907, DOI 10.1126/science.1067903; Xu NL, 2012, NATURE, V492, P247, DOI 10.1038/nature11601; Yonehara K, 2013, NEURON, V79, P1078, DOI 10.1016/j.neuron.2013.08.005; Yonehara K, 2011, NATURE, V469, P407, DOI 10.1038/nature09711; Yoshida K, 2001, NEURON, V30, P771, DOI 10.1016/S0896-6273(01)00316-6	50	58	60	1	33	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	DEC	2013	16	12					1848	1856		10.1038/nn.3565	http://dx.doi.org/10.1038/nn.3565			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	257VV	24162650				2022-12-28	WOS:000327416800023
J	Lin, JY; Knutsen, PM; Muller, A; Kleinfeld, D; Tsien, RY				Lin, John Y.; Knutsen, Per Magne; Muller, Arnaud; Kleinfeld, David; Tsien, Roger Y.			ReaChR: a red-shifted variant of channelrhodopsin enables deep transcranial optogenetic excitation	NATURE NEUROSCIENCE			English	Article							MOTOR CORTEX; FACIAL NUCLEUS; IN-VITRO; WHISKER; STIMULATION; MOVEMENTS; ACTIVATION; CHANNEL; CELLS	Channelrhodopsins (ChRs) are used to optogenetically depolarize neurons. We engineered a variant of ChR, denoted red-activatable ChR (ReaChR), that is optimally excited with orange to red light (lambda similar to 590-630 nm) and offers improved membrane trafficking, higher photocurrents and faster kinetics compared to existing red-shifted ChRs. Red light is less scattered by tissue and is absorbed less by blood than the blue to green wavelengths that are required by other ChR variants. We used ReaChR expressed in the vibrissa motor cortex to drive spiking and vibrissa motion in awake mice when excited with red light through intact skull. Precise vibrissa movements were evoked by expressing ReaChR in the facial motor nucleus in the brainstem and illumination with red light through the external auditory canal. Thus, ReaChR enables transcranial optical activation of neurons in deep brain structures without the need to surgically thin the skull, form a transcranial window or implant optical fibers.	[Lin, John Y.; Tsien, Roger Y.] Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92093 USA; [Knutsen, Per Magne; Muller, Arnaud; Kleinfeld, David] Univ Calif San Diego, Dept Phys, La Jolla, CA 92093 USA; [Kleinfeld, David] Univ Calif San Diego, Neurobiol Sect, La Jolla, CA 92093 USA; [Tsien, Roger Y.] Howard Hughes Med Inst, La Jolla, CA USA	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; Howard Hughes Medical Institute	Lin, JY (corresponding author), Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92093 USA.	j8lin@ucsd.edu		Lin, John/0000-0002-1723-4597	Foundation of Research, Science and Technology New Zealand; Human Frontier Science Program (HFSP); US National Institutes of Health [NS027177, DA029706, OD006831, NS058668]; Howard Hughes Medical Institute; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB003832] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH059867] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R37NS027177, DP1NS082097, R01NS027177, R01NS058668] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA029706] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD006831] Funding Source: NIH RePORTER	Foundation of Research, Science and Technology New Zealand(New Zealand Foundation for Research, Science and Technology); Human Frontier Science Program (HFSP)(Human Frontier Science Program); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	J.Y.L. was funded by the Foundation of Research, Science and Technology New Zealand, and P.M.K. was supported by a long-term fellowship from the Human Frontier Science Program (HFSP). The project was supported by grants to R.Y.T. from the US National Institutes of Health (NS027177) and the Howard Hughes Medical Institute and grants to D.K. from the US National Institutes of Health (DA029706, OD006831 and NS058668). We thank P. Tsai for suggesting the name ReaChR. We thank K. Deisseroth (Stanford University) for the hChR2<SUP>H134R</SUP>-eYFP construct, K. Svoboda (Howard Hughes Medical Institute Janelia Farm Research Campus) for the CAG promoter vector, E. Boyden (Massachusetts Institute of Technology) for the lentiviral vector, L. Tian (Howard Hughes Medical Institute Janelia Farm Research Campus) for the AAV2 vector and D. Trono (Ecole Polytechnique Federale De Lausane) for the psPAX2 and pMD2.G lentivirus packaging vectors. AAV2-ReaChR-Citrine and pLenti-ReaChR-Citrine constructs can be requested from http://tsienlab.ucsd.edu/Samples.htm.	Adamantidis AR, 2007, NATURE, V450, P420, DOI 10.1038/nature06310; Aravanis AM, 2007, J NEURAL ENG, V4, pS143, DOI 10.1088/1741-2560/4/3/S02; ARMSTRONG CM, 1992, METHOD ENZYMOL, V207, P100; Arrenberg AB, 2010, SCIENCE, V330, P971, DOI 10.1126/science.1195929; Berg RW, 2003, J NEUROPHYSIOL, V90, P2950, DOI 10.1152/jn.00511.2003; Berndt A, 2011, P NATL ACAD SCI USA, V108, P7595, DOI 10.1073/pnas.1017210108; Berndt A, 2009, NAT NEUROSCI, V12, P229, DOI 10.1038/nn.2247; Boyden ES, 2005, NAT NEUROSCI, V8, P1263, DOI 10.1038/nn1525; Brecht M, 2004, NATURE, V427, P704, DOI 10.1038/nature02266; Bruegmann T, 2010, NAT METHODS, V7, P897, DOI 10.1038/nmeth.1512; DORFL J, 1982, J ANAT, V135, P147; Drew PJ, 2010, NAT METHODS, V7, P981, DOI 10.1038/NMETH.1530; Govorunova EG, 2011, MBIO, V2, DOI 10.1128/mBio.00115-11; Gradinaru V, 2007, J NEUROSCI, V27, P14231, DOI 10.1523/JNEUROSCI.3578-07.2007; Griesbeck O, 2001, J BIOL CHEM, V276, P29188, DOI 10.1074/jbc.M102815200; Grutzendler J, 2002, NATURE, V420, P812, DOI 10.1038/nature01276; Gunaydin LA, 2010, NAT NEUROSCI, V13, P387, DOI 10.1038/nn.2495; Haiss F, 2005, J NEUROSCI, V25, P1579, DOI 10.1523/JNEUROSCI.3760-04.2005; Hauss-Wegrzyniak B, 2002, EXP NEUROL, V176, P336, DOI 10.1006/exnr.2002.7966; Herfst LJ, 2008, J NEUROPHYSIOL, V99, P2821, DOI 10.1152/jn.01014.2007; Hill DN, 2011, NEURON, V72, P344, DOI 10.1016/j.neuron.2011.09.020; Kato HE, 2012, NATURE, V482, P369, DOI 10.1038/nature10870; Kleinlogel S, 2011, NAT NEUROSCI, V14, P513, DOI 10.1038/nn.2776; Knutsen PM, 2005, J NEUROPHYSIOL, V93, P2294, DOI 10.1152/jn.00718.2004; Lin JY, 2011, EXP PHYSIOL, V96, P19, DOI 10.1113/expphysiol.2009.051961; Lin JY, 2009, BIOPHYS J, V96, P1803, DOI 10.1016/j.bpj.2008.11.034; MARTIN MR, 1977, BRAIN RES, V123, P1, DOI 10.1016/0006-8993(77)90639-4; Mattis J, 2012, NAT METHODS, V9, P159, DOI [10.1038/nmeth.1808, 10.1038/NMETH.1808]; Nagel G, 2002, SCIENCE, V296, P2395, DOI 10.1126/science.1072068; Nagel G, 2003, P NATL ACAD SCI USA, V100, P13940, DOI 10.1073/pnas.1936192100; Nagel G, 2005, CURR BIOL, V15, P2279, DOI 10.1016/j.cub.2005.11.032; Osakada F, 2011, NEURON, V71, P617, DOI 10.1016/j.neuron.2011.07.005; SHICHIDA Y, 1983, BIOCHIM BIOPHYS ACTA, V723, P240, DOI 10.1016/0005-2728(83)90123-8; Sohler TP, 1941, J PHARMACOL EXP THER, V71, P325; Tromberg BJ, 2000, NEOPLASIA, V2, P26, DOI 10.1038/sj.neo.7900082; Wang HX, 2009, J BIOL CHEM, V284, P5685, DOI 10.1074/jbc.M807632200; Wen L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012893; Xu HT, 2007, NAT NEUROSCI, V10, P549, DOI 10.1038/nn1883; Yizhar O, 2011, NATURE, V477, P171, DOI 10.1038/nature10360; Zhang F, 2008, NAT NEUROSCI, V11, P631, DOI 10.1038/nn.2120	40	492	514	3	96	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	OCT	2013	16	10					1499	+		10.1038/nn.3502	http://dx.doi.org/10.1038/nn.3502			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	223HM	23995068	Green Accepted, Green Submitted			2022-12-28	WOS:000324795300024
J	Pagan, M; Urban, LS; Wohl, MP; Rust, NC				Pagan, Marino; Urban, Luke S.; Wohl, Margot P.; Rust, Nicole C.			Signals in inferotemporal and perirhinal cortex suggest an untangling of visual target information	NATURE NEUROSCIENCE			English	Article							INVARIANT OBJECT RECOGNITION; INFERIOR TEMPORAL CORTEX; MACAQUE AREA V4; PARAHIPPOCAMPAL CORTICES; PREFRONTAL CORTEX; NEURAL MECHANISMS; SENSORY STIMULI; MEMORY; MONKEY; RESPONSES	Finding sought visual targets requires our brains to flexibly combine working memory information about what we are looking for with visual information about what we are looking at. To investigate the neural computations involved in finding visual targets, we recorded neural responses in inferotemporal cortex (IT) and perirhinal cortex (PRH) as macaque monkeys performed a task that required them to find targets in sequences of distractors. We found similar amounts of total task-specific information in both areas; however, information about whether a target was in view was more accessible using a linear read-out or, equivalently, was more untangled in PRH. Consistent with the flow of information from IT to PRH, we also found that task-relevant information arrived earlier in IT. PRH responses were well-described by a functional model in which computations in PRH untangle input from IT by combining neurons with asymmetric tuning correlations for target matches and distractors.	[Pagan, Marino; Urban, Luke S.; Wohl, Margot P.; Rust, Nicole C.] Univ Penn, Dept Psychol, Philadelphia, PA 19104 USA	University of Pennsylvania	Rust, NC (corresponding author), Univ Penn, Dept Psychol, 3815 Walnut St, Philadelphia, PA 19104 USA.	nrust@sas.upenn.edu			National Eye Institute of the US National Institutes of Health [R01EY020851]; Sloan Foundation; National Eye Institute [P30EY001583]; NATIONAL EYE INSTITUTE [P30EY001583, R01EY020851] Funding Source: NIH RePORTER	National Eye Institute of the US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Sloan Foundation(Alfred P. Sloan Foundation); National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	We thank Y. Cohen, J.A. Movshon, E. Simoncelli and A. Stocker for helpful discussions. We are especially grateful to D. Brainard and J. Gold for detailed comments on the work and on the manuscript. We also thank J. Deutsch for technical assistance and C. Veeder for veterinary support. This work was supported by the National Eye Institute of the US National Institutes of Health (award number R01EY020851), a Sloan Foundation award to N.C.R. and contributions from a National Eye Institute core grant (award number P30EY001583).	ADELSON EH, 1985, J OPT SOC AM A, V2, P284, DOI 10.1364/JOSAA.2.000284; Arbib M., 1969, IEEE T INFORM THEORY, V15, P738; Averbeck BB, 2006, J NEUROPHYSIOL, V95, P3633, DOI 10.1152/jn.00919.2005; Bichot NP, 2005, SCIENCE, V308, P529, DOI 10.1126/science.1109676; Buffalo EA, 2000, LEARN MEMORY, V7, P375, DOI 10.1101/lm.32100; CHELAZZI L, 1993, NATURE, V363, P345, DOI 10.1038/363345a0; Chelazzi L, 2001, CEREB CORTEX, V11, P761, DOI 10.1093/cercor/11.8.761; Cohen MR, 2009, NAT NEUROSCI, V12, P1594, DOI 10.1038/nn.2439; DiCarlo JJ, 2007, TRENDS COGN SCI, V11, P333, DOI 10.1016/j.tics.2007.06.010; DiCarlo JJ, 2012, NEURON, V73, P415, DOI 10.1016/j.neuron.2012.01.010; Edmonds J., 1970, COMB STRUCT THEIR AP; Efron B, 1994, INTRO BOOSTRAP; Engel TA, 2011, J NEUROSCI, V31, P6982, DOI 10.1523/JNEUROSCI.6150-10.2011; ESKANDAR EN, 1992, J NEUROPHYSIOL, V68, P1277, DOI 10.1152/jn.1992.68.4.1277; FUSTER JM, 1981, SCIENCE, V212, P952, DOI 10.1126/science.7233192; Gibson JR, 1997, J NEUROPHYSIOL, V78, P1263, DOI 10.1152/jn.1997.78.3.1263; Gold JI, 2002, NEURON, V36, P299, DOI 10.1016/S0896-6273(02)00971-6; Graf ABA, 2011, NAT NEUROSCI, V14, P239, DOI 10.1038/nn.2733; HAENNY PE, 1988, EXP BRAIN RES, V69, P245, DOI 10.1007/BF00247570; HEEGER DJ, 1992, VISUAL NEUROSCI, V9, P181, DOI 10.1017/S0952523800009640; Hung CP, 2005, SCIENCE, V310, P863, DOI 10.1126/science.1117593; Kelly RC, 2007, J NEUROSCI, V27, P261, DOI 10.1523/JNEUROSCI.4906-06.2007; Lavenex P, 2002, J COMP NEUROL, V447, P394, DOI 10.1002/cne.10243; Law CT, 2009, NAT NEUROSCI, V12, P655, DOI 10.1038/nn.2304; Liu Z, 2000, J NEUROPHYSIOL, V83, P1677, DOI 10.1152/jn.2000.83.3.1677; LUESCHOW A, 1994, CEREB CORTEX, V4, P523, DOI 10.1093/cercor/4.5.523; Marr D., 1982, VISION; MAUNSELL JHR, 1991, VISUAL NEUROSCI, V7, P561, DOI 10.1017/S095252380001035X; Maunsell JHR, 2006, TRENDS NEUROSCI, V29, P317, DOI 10.1016/j.tins.2006.04.001; MILLER EK, 1994, SCIENCE, V263, P520, DOI 10.1126/science.8290960; Miller EK, 1996, J NEUROSCI, V16, P5154; Najemnik J, 2005, NATURE, V434, P387, DOI 10.1038/nature03390; Reynolds JH, 2009, NEURON, V61, P168, DOI 10.1016/j.neuron.2009.01.002; Rigotti M, 2010, FRONT COMPUT NEUROSC, V4, DOI 10.3389/fncom.2010.00024; Rust NC, 2006, NAT NEUROSCI, V9, P1421, DOI 10.1038/nn1786; Rust NC, 2010, J NEUROSCI, V30, P12978, DOI 10.1523/JNEUROSCI.0179-10.2010; Salinas E, 2004, J NEUROSCI, V24, P1113, DOI 10.1523/JNEUROSCI.4569-03.2004; Salinas E, 2009, SPR SER COMPUT NEURO, V3, P121, DOI 10.1007/978-1-4419-0389-1_7; Shadlen MN, 2001, J NEUROPHYSIOL, V86, P1916, DOI 10.1152/jn.2001.86.4.1916; Simoncelli EP, 1998, VISION RES, V38, P743, DOI 10.1016/S0042-6989(97)00183-1; Sugase-Miyamoto Y, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000073; SUZUKI WA, 1994, J COMP NEUROL, V350, P497, DOI 10.1002/cne.903500402; Tomita H, 1999, NATURE, V401, P699, DOI 10.1038/44372; Wang P, 2011, FRONT HUM NEUROSCI, V5, DOI 10.3389/fnhum.2011.00085	44	69	69	0	20	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	AUG	2013	16	8					1132	U217		10.1038/nn.3433	http://dx.doi.org/10.1038/nn.3433			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	190EV	23792943	Green Accepted			2022-12-28	WOS:000322323000025
J	Seif, T; Chang, SJ; Simms, JA; Gibb, SL; Dadgar, J; Chen, BT; Harvey, BK; Ron, D; Messing, RO; Bonci, A; Hopf, FW				Seif, Taban; Chang, Shao-Ju; Simms, Jeffrey A.; Gibb, Stuart L.; Dadgar, Jahan; Chen, Billy T.; Harvey, Brandon K.; Ron, Dorit; Messing, Robert O.; Bonci, Antonello; Hopf, F. Woodward			Cortical activation of accumbens hyperpolarization-active NMDARs mediates aversion-resistant alcohol intake	NATURE NEUROSCIENCE			English	Article							CUE-INDUCED REINSTATEMENT; COCAINE-SEEKING BEHAVIOR; NUCLEUS-ACCUMBENS; PREFRONTAL CORTEX; GABA(A) RECEPTORS; ETHANOL-CONSUMPTION; ANIMAL-MODEL; RATS; CORE; ADDICTION	Compulsive drinking despite serious adverse medical, social and economic consequences is a characteristic of alcohol use disorders in humans. Although frontal cortical areas have been implicated in alcohol use disorders, little is known about the molecular mechanisms and pathways that sustain aversion-resistant intake. Here, we show that nucleus accumbens core (NAcore) NMDA-type glutamate receptors and medial prefrontal (mPFC) and insula glutamatergic inputs to the NAcore are necessary for aversion-resistant alcohol consumption in rats. Aversion-resistant intake was associated with a new type of NMDA receptor adaptation, in which hyperpolarization-active NMDA receptors were present at mPFC and insula but not amygdalar inputs in the NAcore. Accordingly, inhibition of Grin2c NMDA receptor subunits in the NAcore reduced aversion-resistant alcohol intake. None of these manipulations altered intake when alcohol was not paired with an aversive consequence. Our results identify a mechanism by which hyperpolarization-active NMDA receptors under mPFC- and insula-to-NAcore inputs sustain aversion-resistant alcohol intake.	[Seif, Taban; Chang, Shao-Ju; Simms, Jeffrey A.; Gibb, Stuart L.; Dadgar, Jahan; Ron, Dorit; Messing, Robert O.; Hopf, F. Woodward] Univ Calif San Francisco, Ernest Gallo Clin & Res Ctr, San Francisco, CA 94143 USA; [Chen, Billy T.; Harvey, Brandon K.; Bonci, Antonello] Natl Inst Drug Abuse, Intramural Res Program, Baltimore, MD USA; [Ron, Dorit; Messing, Robert O.; Bonci, Antonello; Hopf, F. Woodward] Univ Calif San Francisco, Sch Med, Dept Neurol, San Francisco, CA USA; [Bonci, Antonello] Johns Hopkins Univ, Sch Med, Solomon H Snyder Dept Neurosci, Baltimore, MD USA	University of California System; University of California San Francisco; Ernest Gallo Clinic & Research Center; National Institutes of Health (NIH) - USA; NIH National Institute on Drug Abuse (NIDA); University of California System; University of California San Francisco; Johns Hopkins University	Hopf, FW (corresponding author), Univ Calif San Francisco, Ernest Gallo Clin & Res Ctr, San Francisco, CA 94143 USA.	antonello.bonci@nih.gov; woody@gallo.ucsf.edu	Harvey, Brandon Keith/AAY-4080-2021; Messing, Robert/D-3642-2015	Harvey, Brandon Keith/0000-0002-4036-1383; Messing, Robert/0000-0002-5345-4431	NIAAA [RO1AA015358]; National Institute on Drug Abuse [F32DA028065]; NIAAA/NIH [RO1A/MH13438]; State of California for medical research for alcohol substance abuse through the University of California San Francisco; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA015358, P50AA017072] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [ZIADA000526, ZIADA000579, ZICDA000555, F32DA028065] Funding Source: NIH RePORTER	NIAAA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NIAAA/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); State of California for medical research for alcohol substance abuse through the University of California San Francisco; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank V. Kharazia and the Gallo Center P50 National Institute on Alcohol Abuse and Alcoholism (NIAAA) AA017072 Histology Core for assistance with histology and R. Maiya for shRNA assistance. Supported by NIAAA RO1AA015358 (F.W.H.), National Institute on Drug Abuse F32DA028065 (T.S.), NIAAA/NIH RO1A/MH13438 (D.R.) and funds provided by the State of California for medical research for alcohol substance abuse through the University of California San Francisco (D.R., A.B., R.O.M.).	Backstrom P, 2007, PSYCHOPHARMACOLOGY, V192, P571, DOI 10.1007/s00213-007-0753-8; Balleine BW, 2010, NEUROPSYCHOPHARMACOL, V35, P48, DOI 10.1038/npp.2009.131; Bassareo V, 2002, J NEUROSCI, V22, P4709, DOI 10.1523/JNEUROSCI.22-11-04709.2002; Belin D, 2011, NEUROPSYCHOPHARMACOL, V36, P569, DOI 10.1038/npp.2010.188; BERENDSE HW, 1992, J COMP NEUROL, V316, P314, DOI 10.1002/cne.903160305; Breese GR, 2011, PHARMACOL THERAPEUT, V129, P149, DOI 10.1016/j.pharmthera.2010.09.007; Britt JP, 2012, NEURON, V76, P790, DOI 10.1016/j.neuron.2012.09.040; Chaudhri N, 2009, PSYCHOPHARMACOLOGY, V207, P303, DOI 10.1007/s00213-009-1657-6; Chen BT, 2013, NATURE, V496, P359, DOI 10.1038/nature12024; Cooper A, 2007, PSYCHOPHARMACOLOGY, V194, P117, DOI 10.1007/s00213-007-0827-7; Craig AD, 2009, NAT REV NEUROSCI, V10, P59, DOI 10.1038/nrn2555; Cull-Candy Stuart G, 2004, Sci STKE, V2004, pre16, DOI 10.1126/stke.2552004re16; da Cunha IC, 2008, BEHAV BRAIN RES, V188, P91, DOI 10.1016/j.bbr.2007.10.023; de Visser L, 2011, FRONT NEUROSCI-SWITZ, V5, DOI [10.3389/fnins.2011.00109, 10.3389/fnins.2011.00102]; Deroche-Gamonet V, 2004, SCIENCE, V305, P1014, DOI 10.1126/science.1099020; Di Ciano P, 2001, NEUROPSYCHOPHARMACOL, V25, P341, DOI 10.1016/S0893-133X(01)00235-4; Di Pietro NC, 2006, EUR J NEUROSCI, V24, P3285, DOI 10.1111/j.1460-9568.2006.05193.x; Filbey FM, 2008, NEUROPSYCHOPHARMACOL, V33, P1391, DOI 10.1038/sj.npp.1301513; Gerfen C.R., 2004, RAT NERVOUS SYSTEM, P455, DOI DOI 10.1016/B978-012547638-6/50019-5; Gibb SL, 2011, J NEUROSCI, V31, P2180, DOI 10.1523/JNEUROSCI.5540-10.2011; Gremel CM, 2009, NEUROPSYCHOPHARMACOL, V34, P1443, DOI 10.1038/npp.2008.179; Hagino Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013722; Hodge CW, 1998, PSYCHOPHARMACOLOGY, V139, P95, DOI 10.1007/s002130050694; Hopf FW, 2010, NEURON, V65, P682, DOI 10.1016/j.neuron.2010.02.015; Hopf FW, 2010, ALCOHOL CLIN EXP RES, V34, P1565, DOI 10.1111/j.1530-0277.2010.01241.x; June HL, 2001, J NEUROSCI, V21, P2166, DOI 10.1523/JNEUROSCI.21-06-02166.2001; Koob GF, 2010, NEUROPSYCHOPHARMACOL, V35, P217, DOI 10.1038/npp.2009.110; LaLumiere RT, 2008, J NEUROSCI, V28, P3170, DOI 10.1523/JNEUROSCI.5129-07.2008; Lasek AW, 2007, GENES BRAIN BEHAV, V6, P728, DOI 10.1111/j.1601-183X.2007.00303.x; Li J, 2011, ADDICT BIOL, V16, P600, DOI 10.1111/j.1369-1600.2011.00344.x; Low CM, 2010, MOL PHARMACOL, V78, P1, DOI 10.1124/mol.110.064006; MALDONADOIRIZARRY CS, 1994, PSYCHOPHARMACOLOGY, V116, P65, DOI 10.1007/BF02244872; McFarland K, 2004, J NEUROSCI, V24, P1551, DOI 10.1523/JNEUROSCI.4177-03.2004; Naqvi NH, 2010, BRAIN STRUCT FUNCT, V214, P435, DOI 10.1007/s00429-010-0268-7; Obiang P, 2012, J NEUROSCI, V32, P12726, DOI 10.1523/JNEUROSCI.6202-11.2012; Peters J, 2009, LEARN MEMORY, V16, P279, DOI 10.1101/lm.1041309; Raeder H, 2008, DRUG ALCOHOL DEPEN, V96, P16, DOI 10.1016/j.drugalcdep.2007.12.013; RASSNICK S, 1992, PSYCHOPHARMACOLOGY, V109, P92, DOI 10.1007/BF02245485; Rhodes JS, 2007, GENES BRAIN BEHAV, V6, P1, DOI 10.1111/j.1601-183X.2006.00210.x; Roberts AJ, 1996, ALCOHOL CLIN EXP RES, V20, P1289, DOI 10.1111/j.1530-0277.1996.tb01125.x; Roitman MF, 2005, NEURON, V45, P587, DOI 10.1016/j.neuron.2004.12.055; Sesack SR, 2010, NEUROPSYCHOPHARMACOL, V35, P27, DOI 10.1038/npp.2009.93; Shi MM, 2011, NEUROREPORT, V22, P762, DOI 10.1097/WNR.0b013e32834ae32e; Simms JA, 2008, ALCOHOL CLIN EXP RES, V32, P1816, DOI 10.1111/j.1530-0277.2008.00753.x; Sinclair CM, 2012, PHARMACOL BIOCHEM BE, V101, P329, DOI 10.1016/j.pbb.2012.01.014; Singh T, 2010, FRONT INTEGR NEUROSC, V4, DOI 10.3389/fnint.2010.00126; Spanagel R, 2009, PHYSIOL REV, V89, P649, DOI 10.1152/physrev.00013.2008; Sparta DR, 2012, NAT PROTOC, V7, P12, DOI 10.1038/nprot.2011.413; Stefanik MT, 2013, ADDICT BIOL, V18, P50, DOI 10.1111/j.1369-1600.2012.00479.x; Stuber GD, 2011, NATURE, V475, P377, DOI 10.1038/nature10194; Tiffany ST, 2000, ADDICTION, V95, pS145, DOI 10.1046/j.1360-0443.95.8s2.3.x; Tye KM, 2011, NATURE, V471, P358, DOI 10.1038/nature09820; Vanderschuren LJMJ, 2004, SCIENCE, V305, P1017, DOI 10.1126/science.1098975; Wang J, 2007, J NEUROSCI, V27, P3593, DOI 10.1523/JNEUROSCI.4749-06.2007; Wenzel A, 1995, NEUROREPORT, V7, P45, DOI 10.1097/00001756-199512290-00010; Witten IB, 2010, SCIENCE, V330, P1677, DOI 10.1126/science.1193771; Wolffgramm J, 2000, J NEURAL TRANSM, V107, P649, DOI 10.1007/s007020070067; Yamamoto T, 2006, ARCH HISTOL CYTOL, V69, P243, DOI 10.1679/aohc.69.243; Zahm DS, 1999, ANN NY ACAD SCI, V877, P113, DOI 10.1111/j.1749-6632.1999.tb09264.x; Zhang YC, 2009, FRONT NEURAL CIRCUIT, V3, DOI 10.3389/neuro.04.020.2009	60	192	196	1	30	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	AUG	2013	16	8					1094	U162		10.1038/nn.3445	http://dx.doi.org/10.1038/nn.3445			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	190EV	23817545	Green Accepted			2022-12-28	WOS:000322323000020
J	Komura, Y; Nikkuni, A; Hirashima, N; Uetake, T; Miyamoto, A				Komura, Yutaka; Nikkuni, Akihiko; Hirashima, Noriko; Uetake, Teppei; Miyamoto, Aki			Responses of pulvinar neurons reflect a subject's confidence in visual categorization	NATURE NEUROSCIENCE			English	Article							LATERAL GENICULATE-NUCLEUS; SPATIAL ATTENTION; BEHAVING MACAQUE; RHESUS-MONKEY; CORTEX; THALAMUS; DECISION; CONSCIOUSNESS; AWARENESS; HUMANS	When we recognize a sensory event, we experience a confident feeling that we certainly know the perceived world 'here and now'. However, it is unknown how and where the brain generates such 'perceptual confidence'. Here we found neural correlates of confidence in the primate pulvinar, a visual thalamic nucleus that has been expanding markedly through evolution. During a categorization task, the majority of pulvinar responses did not correlate with any 'perceptual content'. During an opt-out task, pulvinar responses decreased when monkeys chose 'escape' options, suggesting less confidence in their perceptual categorization. Functional silencing of the pulvinar increased monkeys' escape choices in the opt-out task without affecting categorization performance; this effect was specific to the contralateral visual target. These data were supported by a theoretical model of confidence, indicating that pulvinar activities encode a subject's certainty of visual categorization and contribute to perceptual confidence.	[Komura, Yutaka; Nikkuni, Akihiko; Hirashima, Noriko; Uetake, Teppei; Miyamoto, Aki] Natl Inst Adv Ind Sci & Technol, Human Technol Res Inst, Tsukuba, Ibaraki, Japan; [Komura, Yutaka] Japan Sci & Technol Agcy, Precursory Res Embryon Sci & Technol, Saitama, Japan	National Institute of Advanced Industrial Science & Technology (AIST); Japan Science & Technology Agency (JST)	Komura, Y (corresponding author), Natl Inst Adv Ind Sci & Technol, Human Technol Res Inst, Tsukuba, Ibaraki, Japan.	komura-y@aist.go.jp			Japan Science and Technology Agency; Ministry of Education, Culture, Sports, Science and Technology, Japan	Japan Science and Technology Agency(Japan Science & Technology Agency (JST)); Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	We thank K. Kawano, S. Dehaene, R. Kanai and S. Phillips for valuable comments and critical discussions; R. Tamura and K. Numata for continuous encouragement; T.Mega and A.Muramatsu for technical help and animal care. This work was supported in part by Precursory Research for Embryonic Science and Technology program from Japan Science and Technology Agency, Grant-in-Aids for Young Scientists (A) and Scientific Research on Innovative Areas from Ministry of Education, Culture, Sports, Science and Technology, Japan (to Y.K.).	Bender DB, 2001, J NEUROPHYSIOL, V85, P219, DOI 10.1152/jn.2001.85.1.219; BENEVENTO LA, 1995, VISUAL NEUROSCI, V12, P523, DOI 10.1017/S0952523800008439; Berman RA, 2008, PROG BRAIN RES, V171, P467, DOI 10.1016/S0079-6123(08)00668-7; Casanova C., 2003, VISUAL NEUROSCIENCES, P592; Crick F, 1998, NATURE, V391, P245, DOI 10.1038/34584; CRIST CF, 1988, J NEUROSCI METH, V26, P117, DOI 10.1016/0165-0270(88)90160-4; Dayan P, 2000, NAT NEUROSCI, V3, P1218, DOI 10.1038/81504; DESIMONE R, 1990, COLD SPRING HARB SYM, V55, P963; Driver J, 2001, COGNITION, V79, P39, DOI 10.1016/S0010-0277(00)00124-4; Frith C, 1999, TRENDS COGN SCI, V3, P105, DOI 10.1016/S1364-6613(99)01281-4; Guillery RW, 2002, NEURON, V33, P163, DOI 10.1016/S0896-6273(01)00582-7; Gutierrez C, 2000, J COMP NEUROL, V419, P61, DOI 10.1002/(SICI)1096-9861(20000327)419:1<61::AID-CNE4>3.0.CO;2-I; Haynes JD, 2005, NATURE, V438, P496, DOI 10.1038/nature04169; Imura K, 2006, J COMP NEUROL, V498, P649, DOI 10.1002/cne.21085; Inaba N, 2007, J NEUROPHYSIOL, V97, P3473, DOI 10.1152/jn.01054.2006; Itti L, 2009, VISION RES, V49, P1295, DOI 10.1016/j.visres.2008.09.007; Kaas JH, 2007, BRAIN RES REV, V55, P285, DOI 10.1016/j.brainresrev.2007.02.008; Karnath HO, 2002, BRAIN, V125, P350, DOI 10.1093/brain/awf032; Kastner Sabine, 2004, Cognitive Affective & Behavioral Neuroscience, V4, P483, DOI 10.3758/CABN.4.4.483; Kepecs A, 2008, NATURE, V455, P227, DOI 10.1038/nature07200; Kepecs A, 2012, PHILOS T R SOC B, V367, P1322, DOI 10.1098/rstb.2012.0037; Kiani R, 2009, SCIENCE, V324, P759, DOI 10.1126/science.1169405; Koch C, 2007, NAT NEUROSCI, V10, P140, DOI 10.1038/nn0207-140; KOLB FC, 1995, NATURE, V377, P336, DOI 10.1038/377336a0; Komura Y, 2001, NATURE, V412, P546, DOI 10.1038/35087595; Komura Y, 2005, NAT NEUROSCI, V8, P1203, DOI 10.1038/nn1528; Kornell N, 2007, PSYCHOL SCI, V18, P64, DOI 10.1111/j.1467-9280.2007.01850.x; Kunimoto C, 2001, CONSCIOUS COGN, V10, P294, DOI 10.1006/ccog.2000.0494; Kusama T., 1970, STEREOTAXIC ATLAS BR; LABERGE D, 1990, J NEUROSCI, V10, P613; Lau HC, 2008, PROG BRAIN RES, V168, P35, DOI 10.1016/S0079-6123(07)68004-2; Luck SJ, 1996, J EXP PSYCHOL HUMAN, V22, P725, DOI 10.1037/0096-1523.22.3.725; MALPELI JG, 1975, J COMP NEUROL, V161, P569, DOI 10.1002/cne.901610407; MARTIN JH, 1991, NEUROSCI LETT, V127, P160, DOI 10.1016/0304-3940(91)90784-Q; olszewski j, 1952, THALAMUS MACACA MULA; Persaud N, 2007, NAT NEUROSCI, V10, P257, DOI 10.1038/nn1840; PETERSEN SE, 1985, J NEUROPHYSIOL, V54, P867, DOI 10.1152/jn.1985.54.4.867; PETERSEN SE, 1987, NEUROPSYCHOLOGIA, V25, P97, DOI 10.1016/0028-3932(87)90046-7; Pierce CS., 1885, MEMOIRS NATL ACAD SC, V3, P73; Purushothaman G, 2012, NAT NEUROSCI, V15, P905, DOI 10.1038/nn.3106; RAFAL RD, 1987, P NATL ACAD SCI USA, V84, P7349, DOI 10.1073/pnas.84.20.7349; ROBINSON DL, 1990, EXP BRAIN RES, V82, P235; Romanski LM, 1997, J COMP NEUROL, V379, P313; Saalmann YB, 2012, SCIENCE, V337, P753, DOI 10.1126/science.1223082; Sahraie A, 1998, BEHAV BRAIN RES, V96, P71, DOI 10.1016/S0166-4328(97)00194-0; Seth AK, 2005, CONSCIOUS COGN, V14, P119, DOI 10.1016/j.concog.2004.08.006; Shields WE, 2005, J GEN PSYCHOL, V132, P165; Tononi Giulio, 2004, BMC Neurosci, V5, P42, DOI 10.1186/1471-2202-5-42; Wilke M, 2009, P NATL ACAD SCI USA, V106, P9465, DOI 10.1073/pnas.0900714106; Yu AJ, 2005, NEURON, V46, P681, DOI 10.1016/j.neuron.2005.04.026; ZIHL J, 1979, BRAIN, V102, P835, DOI 10.1093/brain/102.4.835	52	116	116	0	12	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JUN	2013	16	6					749	+		10.1038/nn.3393	http://dx.doi.org/10.1038/nn.3393			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	152DE	23666179				2022-12-28	WOS:000319509600017
J	Mysore, SP; Knudsen, EI				Mysore, Shreesh P.; Knudsen, Eric I.			A shared inhibitory circuit for both exogenous and endogenous control of stimulus selection	NATURE NEUROSCIENCE			English	Article							FRONTAL EYE FIELD; SACCADE TARGET SELECTION; TOP-DOWN CONTROL; WORKING-MEMORY; FLEXIBLE CATEGORIZATION; ATTENTIONAL MODULATION; SURROUND SUPPRESSION; NORMALIZATION MODEL; VISUAL-ATTENTION; MIDBRAIN NETWORK	The mechanisms by which the brain suppresses distracting stimuli to control the locus of attention are unknown. We found that focal, reversible inactivation of a single inhibitory circuit in the barn owl midbrain tegmentum, the nucleus isthmi pars magnocellularis (Imc), abolished both stimulus-driven (exogenous) and internally driven (endogenous) competitive interactions in the optic tectum (superior colliculus in mammals), which are vital to the selection of a target among distractors in behaving animals. Imc neurons transformed spatially precise multisensory and endogenous input into powerful inhibitory output that suppressed competing representations across the entire tectal space map. We identified a small, but highly potent, circuit that is employed by both exogenous and endogenous signals to exert competitive suppression in the midbrain selection network. Our findings reveal, to the best of our knowledge, for the first time, a neural mechanism for the construction of a priority map that is critical for the selection of the most important stimulus for gaze and attention.	[Mysore, Shreesh P.; Knudsen, Eric I.] Stanford Univ, Dept Neurobiol, Stanford, CA 94305 USA	Stanford University	Mysore, SP (corresponding author), Stanford Univ, Dept Neurobiol, Stanford, CA 94305 USA.	shreesh@stanford.edu		Mysore, Shreesh/0000-0002-7781-8252	US National Institutes of Health [9R01 EY019179]; NATIONAL EYE INSTITUTE [R01EY019179] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	We thank P. Knudsen for the immunohistochemistry. We are grateful to A. Asadollahi, A. Bryant, A. Goddard, J. Schwarz and N. Steinmetz for critically reading the manuscript. This work was supported by funding from the US National Institutes of Health (9R01 EY019179, E.I.K.).	Awh E, 2012, TRENDS COGN SCI, V16, P437, DOI 10.1016/j.tics.2012.06.010; Bair W, 2003, J NEUROSCI, V23, P7690; Basso MA, 1997, NATURE, V389, P66, DOI 10.1038/37975; Bisley JW, 2011, J PHYSIOL-LONDON, V589, P49, DOI 10.1113/jphysiol.2010.192666; BRUCE CJ, 1985, J NEUROPHYSIOL, V54, P714, DOI 10.1152/jn.1985.54.3.714; Carrasco M, 2006, PROG BRAIN RES, V154, P33; Carrasco M, 2011, VISION RES, V51, P1484, DOI 10.1016/j.visres.2011.04.012; Cavanaugh JR, 2002, J NEUROPHYSIOL, V88, P2530, DOI 10.1152/jn.00692.2001; DESIMONE R, 1995, ANNU REV NEUROSCI, V18, P193, DOI 10.1146/annurev.ne.18.030195.001205; DESIMONE R, 1993, VISUAL NEUROSCI, V10, P159, DOI 10.1017/S095252380000328X; Dias EC, 1999, J NEUROPHYSIOL, V81, P2191, DOI 10.1152/jn.1999.81.5.2191; Falkner AL, 2010, J NEUROSCI, V30, P12787, DOI 10.1523/JNEUROSCI.2327-10.2010; Fecteau JH, 2006, TRENDS COGN SCI, V10, P382, DOI 10.1016/j.tics.2006.06.011; Gazzaley A, 2005, J COGNITIVE NEUROSCI, V17, P507, DOI 10.1162/0898929053279522; Gazzaley A, 2005, NAT NEUROSCI, V8, P1298, DOI 10.1038/nn1543; Kastner S, 2000, ANNU REV NEUROSCI, V23, P315, DOI 10.1146/annurev.neuro.23.1.315; Kastner S, 1999, NEURON, V22, P751, DOI 10.1016/S0896-6273(00)80734-5; KNUDSEN EI, 1995, J NEUROSCI, V15, P5139; Knudsen EI, 1996, NATURE, V383, P428, DOI 10.1038/383428a0; Knudsen EI, 2007, ANNU REV NEUROSCI, V30, P57, DOI 10.1146/annurev.neuro.30.051606.094256; Knudsen EI, 2011, EUR J NEUROSCI, V33, P1961, DOI 10.1111/j.1460-9568.2011.07696.x; Lee DK, 1999, NAT NEUROSCI, V2, P375, DOI 10.1038/7286; Lee J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004651; Lovejoy LP, 2010, NAT NEUROSCI, V13, P261, DOI 10.1038/nn.2470; Marin G, 2005, J NEUROSCI, V25, P7081, DOI 10.1523/JNEUROSCI.1379-05.2005; Marin G, 2007, J NEUROSCI, V27, P8112, DOI 10.1523/JNEUROSCI.1420-07.2007; McMains S, 2011, J NEUROSCI, V31, P587, DOI 10.1523/JNEUROSCI.3766-10.2011; McPeek RM, 2004, NAT NEUROSCI, V7, P757, DOI 10.1038/nn1269; Moore T, 2001, P NATL ACAD SCI USA, V98, P1273, DOI 10.1073/pnas.021549498; Moore T, 2003, NATURE, V421, P370, DOI 10.1038/nature01341; Mysore SP, 2012, NEURON, V73, P193, DOI 10.1016/j.neuron.2011.10.037; Mysore SP, 2011, CURR OPIN NEUROBIOL, V21, P653, DOI 10.1016/j.conb.2011.05.024; Mysore SP, 2011, J NEUROSCI, V31, P7745, DOI 10.1523/JNEUROSCI.5425-10.2011; Mysore SP, 2011, J NEUROSCI, V31, P5186, DOI 10.1523/JNEUROSCI.4592-10.2011; Mysore SP, 2010, J NEUROSCI, V30, P1727, DOI 10.1523/JNEUROSCI.3740-09.2010; Nummela SU, 2010, J NEUROPHYSIOL, V104, P1538, DOI 10.1152/jn.00406.2010; Reynolds JH, 2004, ANNU REV NEUROSCI, V27, P611, DOI 10.1146/annurev.neuro.26.041002.131039; Reynolds JH, 2009, NEURON, V61, P168, DOI 10.1016/j.neuron.2009.01.002; SCHALL JD, 1995, J NEUROSCI, V15, P6905; STANTON GB, 1988, J COMP NEUROL, V271, P493, DOI 10.1002/cne.902710403; Sundberg KA, 2009, NEURON, V61, P952, DOI 10.1016/j.neuron.2009.02.023; Wang Y, 2004, J COMP NEUROL, V469, P275, DOI 10.1002/cne.11007; Winkowski DE, 2007, J NEUROSCI, V27, P13279, DOI 10.1523/JNEUROSCI.3937-07.2007; Winkowski DE, 2008, NEURON, V60, P698, DOI 10.1016/j.neuron.2008.09.013; Winkowski DE, 2006, NATURE, V439, P336, DOI 10.1038/nature04411; Witten IB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010396; Zanto TP, 2009, J NEUROSCI, V29, P3059, DOI 10.1523/JNEUROSCI.4621-08.2009; Zenon A, 2012, NATURE, V489, P434, DOI 10.1038/nature11497	48	69	70	0	37	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	APR	2013	16	4					473	U143		10.1038/nn.3352	http://dx.doi.org/10.1038/nn.3352			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	114EM	23475112	Green Accepted			2022-12-28	WOS:000316723700018
J	Nauhaus, I; Nielsen, KJ; Disney, AA; Callaway, EM				Nauhaus, Ian; Nielsen, Kristina J.; Disney, Anita A.; Callaway, Edward M.			Orthogonal micro-organization of orientation and spatial frequency in primate primary visual cortex	NATURE NEUROSCIENCE			English	Article							OCULAR-DOMINANCE COLUMNS; FUNCTIONAL ARCHITECTURE; RECEPTIVE-FIELDS; NEURONS; MAPS; PREFERENCE; PATTERNS; DOMAINS	Orientation and spatial frequency tuning are highly salient properties of neurons in primary visual cortex (V1). The combined organization of these particular tuning properties in the cortical space will strongly shape the V1 population response to different visual inputs, yet it is poorly understood. In this study, we used two-photon imaging in macaque monkey V1 to demonstrate the three-dimensional cell-by-cell layout of both spatial frequency and orientation tuning. We first found that spatial frequency tuning was organized into highly structured maps that remained consistent across the depth of layer II/III, similarly to orientation tuning. Next, we found that orientation and spatial frequency maps were intimately related at the fine spatial scale observed with two-photon imaging. Not only did the map gradients tend notably toward orthogonality, but they also co-varied negatively from cell to cell at the spatial scale of cortical columns.	[Nauhaus, Ian; Nielsen, Kristina J.; Disney, Anita A.; Callaway, Edward M.] Salk Inst Biol Studies, Syst Neurobiol Labs, La Jolla, CA 92037 USA	Salk Institute	Callaway, EM (corresponding author), Salk Inst Biol Studies, Syst Neurobiol Labs, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.	callaway@salk.edu	Nielsen, Kristina/M-2298-2016; Callaway, Edward/D-4336-2011	Nielsen, Kristina/0000-0002-9155-2972; Callaway, Edward/0000-0002-6366-5267; Disney, Anita/0000-0003-3390-0681	US National Eye Institute [EY-010742, EY-019821, MH093567]; NATIONAL EYE INSTITUTE [R01EY010742, F32EY021122, F32EY019821] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [K99MH093567] Funding Source: NIH RePORTER	US National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We are grateful to S. Chatterjee, K. Ohki and C. Reid for preliminary designs of the imaging chamber and for graciously helping us to get started with monkey two-photon imaging. We also thank D. Ringach for comments on an earlier version of the manuscript. Finally, we thank M. De La Parra for technical assistance with the experiments. This work was supported by US National Eye Institute grants EY-010742 to E. M. C., EY-019821 to I.N and MH093567 to A.A.D.	BARTFELD E, 1992, P NATL ACAD SCI USA, V89, P11905, DOI 10.1073/pnas.89.24.11905; BERARDI N, 1982, J PHYSIOL-LONDON, V323, P603, DOI 10.1113/jphysiol.1982.sp014094; Blasdel G, 2001, J NEUROSCI, V21, P8286, DOI 10.1523/JNEUROSCI.21-20-08286.2001; BLASDEL GG, 1986, NATURE, V321, P579, DOI 10.1038/321579a0; BORN RT, 1991, P NATL ACAD SCI USA, V88, P7066, DOI 10.1073/pnas.88.16.7066; Boyd JD, 1996, J COMP NEUROL, V365, P659; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Callaway EM, 1998, ANNU REV NEUROSCI, V21, P47, DOI 10.1146/annurev.neuro.21.1.47; Crair MC, 1997, J NEUROPHYSIOL, V77, P3381, DOI 10.1152/jn.1997.77.6.3381; DeAngelis GC, 1999, J NEUROSCI, V19, P4046; DURBIN R, 1990, NATURE, V343, P644, DOI 10.1038/343644a0; EDWARDS DP, 1995, VISION RES, V35, P1501, DOI 10.1016/0042-6989(94)00253-I; Everson RM, 1998, P NATL ACAD SCI USA, V95, P8334, DOI 10.1073/pnas.95.14.8334; Ferster D, 2000, ANNU REV NEUROSCI, V23, P441, DOI 10.1146/annurev.neuro.23.1.441; GILBERT CD, 1983, ANNU REV NEUROSCI, V6, P217, DOI 10.1146/annurev.ne.06.030183.001245; Horton JC, 2005, PHILOS T R SOC B, V360, P837, DOI 10.1098/rstb.2005.1623; HORTON JC, 1984, PHILOS T ROY SOC B, V304, P199, DOI 10.1098/rstb.1984.0021; HUBEL DH, 1968, J PHYSIOL-LONDON, V195, P215, DOI 10.1113/jphysiol.1968.sp008455; HUBEL DH, 1977, PROC R SOC SER B-BIO, V198, P1, DOI 10.1098/rspb.1977.0085; HUBEL DH, 1962, J PHYSIOL-LONDON, V160, P106, DOI 10.1113/jphysiol.1962.sp006837; Hubener M, 1997, J NEUROSCI, V17, P9270; Issa NP, 2000, J NEUROSCI, V20, P8504, DOI 10.1523/JNEUROSCI.20-22-08504.2000; Issa NP, 1999, J NEUROSCI, V19, P6965, DOI 10.1523/JNEUROSCI.19-16-06965.1999; Kara P, 2009, NATURE, V458, P627, DOI 10.1038/nature07721; Kaschube M, 2010, SCIENCE, V330, P1113, DOI 10.1126/science.1194869; Kim DS, 1999, NEUROREPORT, V10, P2515, DOI 10.1097/00001756-199908200-00015; Koulakov AA, 2001, NEURON, V29, P519, DOI 10.1016/S0896-6273(01)00223-9; Li Y, 2008, NATURE, V456, P952, DOI 10.1038/nature07417; MAFFEI L, 1977, VISION RES, V17, P257, DOI 10.1016/0042-6989(77)90089-X; Martin K.A.C., 1984, CEREB CORTEX; McLaughlin D, 2003, J PHYSIOL-PARIS, V97, P237, DOI 10.1016/j.jphysparis.2003.09.019; Molotchnikoff S, 2007, NEUROSCI LETT, V418, P242, DOI 10.1016/j.neulet.2007.03.043; Nassi JJ, 2009, NAT REV NEUROSCI, V10, P360, DOI 10.1038/nrn2619; Nauhaus I, 2012, J NEUROPHYSIOL, V107, P923, DOI 10.1152/jn.00725.2011; Nimmerjahn A, 2004, NAT METHODS, V1, P31, DOI 10.1038/nmeth706; OBERMAYER K, 1993, J NEUROSCI, V13, P4114; Ohki K, 2006, NATURE, V442, P925, DOI 10.1038/nature05019; Paik SB, 2011, NAT NEUROSCI, V14, P919, DOI 10.1038/nn.2824; Pelli DG, 1997, SPATIAL VISION, V10, P437, DOI 10.1163/156856897X00366; Pologruto TA, 2003, BIOMED ENG ONLINE, V2, DOI 10.1186/1475-925X-2-13; Ringach DL, 1997, VISION RES, V37, P2455, DOI 10.1016/S0042-6989(96)00247-7; Shoham D, 1997, NATURE, V385, P529, DOI 10.1038/385529a0; SILVERMAN MS, 1989, P NATL ACAD SCI USA, V86, P711, DOI 10.1073/pnas.86.2.711; Sirovich L, 2004, P NATL ACAD SCI USA, V101, P16941, DOI 10.1073/pnas.0407450101; Stosiek C, 2003, P NATL ACAD SCI USA, V100, P7319, DOI 10.1073/pnas.1232232100; Swindale NV, 1996, NETWORK-COMP NEURAL, V7, P161, DOI 10.1088/0954-898X/7/2/002; Swindale NV, 2000, NAT NEUROSCI, V3, P822, DOI 10.1038/77731; TOLHURST DJ, 1982, EXP BRAIN RES, V48, P217; TOOTELL RB, 1981, SCIENCE, V214, P813, DOI 10.1126/science.7292014; TOOTELL RBH, 1988, J NEUROSCI, V8, P1610; TSO DY, 1990, SCIENCE, V249, P417, DOI 10.1126/science.2165630; White LE, 2001, VISUAL NEUROSCI, V18, P65, DOI 10.1017/S095252380118106X; Xu XM, 2007, J COMP NEUROL, V501, P741, DOI 10.1002/cne.21277; Yu H, 2005, NEURON, V47, P267, DOI 10.1016/j.neuron.2005.06.011	54	102	101	2	28	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	DEC	2012	15	12					1683	+		10.1038/nn.3255	http://dx.doi.org/10.1038/nn.3255			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	045OR	23143516	Green Accepted			2022-12-28	WOS:000311706700014
J	Ruediger, S; Spirig, D; Donato, F; Caroni, P				Ruediger, Sarah; Spirig, Dominique; Donato, Flavio; Caroni, Pico			Goal-oriented searching mediated by ventral hippocampus early in trial-and-error learning	NATURE NEUROSCIENCE			English	Article							TRANSGENIC MICE; BETA-ADDUCIN; WATER-MAZE; MEMORY; BEHAVIOR; DORSAL; STRATEGIES; PREDICTION; NAVIGATION; DYNAMICS	Most behavioral learning in biology is trial and error, but how these learning processes are influenced by individual brain systems is poorly understood. Here we show that ventral-to-dorsal hippocampal subdivisions have specific and sequential functions in trial-and-error maze navigation, with ventral hippocampus (vH) mediating early task-specific goal-oriented searching. Although performance and strategy deployment progressed continuously at the population level, individual mice showed discrete learning phases, each characterized by particular search habits. Transitions in learning phases reflected feedforward inhibitory connectivity (FFI) growth occurring sequentially in ventral, then intermediate, then dorsal hippocampal subdivisions. FFI growth at vH occurred abruptly upon behavioral learning of goal-task relationships. vH lesions or the absence of vH FFI growth delayed early learning and disrupted performance consistency. Intermediate hippocampus lesions impaired intermediate place learning, whereas dorsal hippocampus lesions specifically disrupted late spatial learning. Trial-and-error navigational learning processes in naive mice thus involve a stereotype sequence of increasingly precise subtasks learned through distinct hippocampal subdivisions. Because of its unique connectivity, vH may relate specific goals to internal states in learning under healthy and pathological conditions.	[Ruediger, Sarah; Spirig, Dominique; Donato, Flavio; Caroni, Pico] Friedrich Miescher Inst, Basel, Switzerland	Friedrich Miescher Institute for Biomedical Research	Caroni, P (corresponding author), Friedrich Miescher Inst, Basel, Switzerland.	caroni@fmi.ch	Ruediger Lee, Sarah/ABG-6969-2021	Ruediger, Sarah/0000-0001-6684-4693; Ruediger, Sarah/0000-0001-9140-872X; Donato, Flavio/0000-0002-0732-1654				Amemori KI, 2011, FRONT HUM NEUROSCI, V5, DOI 10.3389/fnhum.2011.00047; BANNERMAN DM, 1995, NATURE, V378, P182, DOI 10.1038/378182a0; Barnes TD, 2005, NATURE, V437, P1158, DOI 10.1038/nature04053; Bast T, 2009, PLOS BIOL, V7, P730, DOI 10.1371/journal.pbio.1000089; Bednarek E, 2011, NEURON, V69, P1132, DOI 10.1016/j.neuron.2011.02.034; Bethus I, 2010, J NEUROSCI, V30, P1610, DOI 10.1523/JNEUROSCI.2721-09.2010; Bird CM, 2008, NAT REV NEUROSCI, V9, P182, DOI 10.1038/nrn2335; Botvinick MM, 2009, COGNITION, V113, P262, DOI 10.1016/j.cognition.2008.08.011; Dayan P, 2002, NEURON, V36, P285, DOI 10.1016/S0896-6273(02)00963-7; Desrochers TM, 2010, P NATL ACAD SCI USA, V107, P20512, DOI 10.1073/pnas.1013470107; Dong HW, 2009, P NATL ACAD SCI USA, V106, P11794, DOI 10.1073/pnas.0812608106; Fanselow MS, 2010, NEURON, V65, P7, DOI 10.1016/j.neuron.2009.11.031; Gallistel CR, 2004, P NATL ACAD SCI USA, V101, P13124, DOI 10.1073/pnas.0404965101; Garthe A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005464; Graybiel AM, 2008, ANNU REV NEUROSCI, V31, P359, DOI 10.1146/annurev.neuro.29.051605.112851; Hoh T, 1999, J Neurosci, V19, pRC2; Janus C, 2004, LEARN MEMORY, V11, P337, DOI 10.1101/lm.70104; Kjelstrup KG, 2002, P NATL ACAD SCI USA, V99, P10825, DOI 10.1073/pnas.152112399; Luo AH, 2011, SCIENCE, V333, P353, DOI 10.1126/science.1204622; MORRIS R, 1984, J NEUROSCI METH, V11, P47, DOI 10.1016/0165-0270(84)90007-4; MORRIS RGM, 1982, NATURE, V297, P681, DOI 10.1038/297681a0; Moser EI, 2008, ANNU REV NEUROSCI, V31, P69, DOI 10.1146/annurev.neuro.31.061307.090723; Moser MB, 1998, HIPPOCAMPUS, V8, P608, DOI 10.1002/(SICI)1098-1063(1998)8:6<608::AID-HIPO3>3.0.CO;2-7; MOSER MB, 1995, P NATL ACAD SCI USA, V92, P9697, DOI 10.1073/pnas.92.21.9697; O'Keefe J, 1978, HIPPOCAMPUS COGNITIV; Pennartz CMA, 2011, TRENDS NEUROSCI, V34, P548, DOI 10.1016/j.tins.2011.08.001; Rabenstein RL, 2005, J NEUROSCI, V25, P2138, DOI 10.1523/JNEUROSCI.3530-04.2005; Royer S, 2010, J NEUROSCI, V30, P1777, DOI 10.1523/JNEUROSCI.4681-09.2010; Ruediger S, 2011, NATURE, V473, P514, DOI 10.1038/nature09946; Schultz W, 1997, SCIENCE, V275, P1593, DOI 10.1126/science.275.5306.1593; Thompson CL, 2008, NEURON, V60, P1010, DOI 10.1016/j.neuron.2008.12.008; Thorn CA, 2010, NEURON, V66, P781, DOI 10.1016/j.neuron.2010.04.036; Viard A, 2011, J NEUROSCI, V31, P4613, DOI 10.1523/JNEUROSCI.4640-10.2011; Wiltgen BJ, 2010, CURR BIOL, V20, P1336, DOI 10.1016/j.cub.2010.06.068; Wolfer DP, 2000, EXP PHYSIOL, V85, P627, DOI 10.1017/S0958067000020959; Young JJ, 2011, J NEUROSCI, V31, P5989, DOI 10.1523/JNEUROSCI.5436-10.2011	37	84	85	0	30	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	NOV	2012	15	11					1563	1571		10.1038/nn.3224	http://dx.doi.org/10.1038/nn.3224			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	028LX	23001061				2022-12-28	WOS:000310424900017
J	Mire, E; Mezzera, C; Leyva-Diaz, E; Paternain, AV; Squarzoni, P; Bluy, L; Castillo-Paterna, M; Lopez, MJ; Peregrin, S; Tessier-Lavigne, M; Garel, S; Galceran, J; Lerma, J; Lopez-Bendito, G				Mire, Erik; Mezzera, Cecilia; Leyva-Diaz, Eduardo; Paternain, Ana V.; Squarzoni, Paola; Bluy, Lisa; Castillo-Paterna, Mar; Lopez, Maria Jose; Peregrin, Sandra; Tessier-Lavigne, Marc; Garel, Sonia; Galceran, Joan; Lerma, Juan; Lopez-Bendito, Guillermina			Spontaneous activity regulates Robo1 transcription to mediate a switch in thalamocortical axon growth	NATURE NEUROSCIENCE			English	Article							RAT CORTICAL-NEURONS; ELECTRICAL-ACTIVITY; SPINAL-CORD; NEUROTRANSMITTER SPECIFICATION; DEPENDENT REGULATION; MAMMALIAN FOREBRAIN; CALCIUM TRANSIENTS; NEURITE OUTGROWTH; PROTEIN-SYNTHESIS; CONE MOTILITY	Developing axons must control their growth rate to follow the appropriate pathways and establish specific connections. However, the regulatory mechanisms involved remain elusive. By combining live imaging with transplantation studies in mice, we found that spontaneous calcium activity in the thalamocortical system and the growth rate of thalamocortical axons were developmentally and intrinsically regulated. Indeed, the spontaneous activity of thalamic neurons governed axon growth and extension through the cortex in vivo. This activity-dependent modulation of growth was mediated by transcriptional regulation of Robo1 through an NF-kappa B binding site. Disruption of either the Robo1 or Slit1 genes accelerated the progression of thalamocortical axons in vivo, and interfering with Robo1 signaling restored normal axon growth in electrically silent neurons. Thus, modifications to spontaneous calcium activity encode a switch in the axon outgrowth program that allows the establishment of specific neuronal connections through the transcriptional regulation of Slit1 and Robo1 signaling.	[Mire, Erik; Mezzera, Cecilia; Leyva-Diaz, Eduardo; Paternain, Ana V.; Bluy, Lisa; Castillo-Paterna, Mar; Lopez, Maria Jose; Peregrin, Sandra; Galceran, Joan; Lerma, Juan; Lopez-Bendito, Guillermina] UMH CSIC, Inst Neurociencias Alicante, Sant Joan dAlacant, Spain; [Squarzoni, Paola; Garel, Sonia] Ecole Normale Super, Inst Biol ENS, F-75231 Paris, France; [Squarzoni, Paola; Garel, Sonia] INSERM, U1024, Avenir Team, Paris, France; [Squarzoni, Paola; Garel, Sonia] CNRS, UMR 8197, Paris, France; [Tessier-Lavigne, Marc] Genentech Inc, San Francisco, CA USA; [Tessier-Lavigne, Marc] Rockefeller Univ, New York, NY 10021 USA	Consejo Superior de Investigaciones Cientificas (CSIC); Universidad Miguel Hernandez de Elche; CSIC-UMH - Instituto de Neurociencias de Alicante (IN); UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS); Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Roche Holding; Genentech; Rockefeller University	Lopez-Bendito, G (corresponding author), UMH CSIC, Inst Neurociencias Alicante, Sant Joan dAlacant, Spain.	g.lbendito@umh.es	Lerma, Juan/G-7907-2015; Garel, Sonia/P-4538-2017; Galceran, Juan/K-6744-2014; Leyva-Diaz, Eduardo/GPF-9563-2022; Mire, Erik/AAD-3123-2020; Lopez-Bendito, Guillermina/E-4028-2014	Lerma, Juan/0000-0001-7838-5199; Garel, Sonia/0000-0003-2984-3645; Galceran, Juan/0000-0002-5247-2726; Leyva-Diaz, Eduardo/0000-0001-6750-9168; Mire, Erik/0000-0002-6793-0566; Lopez-Gonzalez, Maria Jose/0000-0002-0011-3086; Lopez-Bendito, Guillermina/0000-0002-8965-6836; Mezzera, Cecilia/0000-0002-3621-2799	CSIC; Spanish Ministerio de Ciencia e Innovacion [BFU2006-07138, BFU2009-08261]; Human Frontier Science Program Organization grant [RGP29/2008]; European Research Council [ERC-2009-StG_20081210];  [CSD2007-00023]	CSIC; Spanish Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Human Frontier Science Program Organization grant(Human Frontier Science Program); European Research Council(European Research Council (ERC)European Commission); 	We thank N. Garcia and E. San Martin for outstanding technical assistance. We are also grateful to A. Nagy (Samuel Lunenfeld Research Institute) for the EGFP mice, M. Valdeolmillos (Instituto de Neurociencias de Alicante) for providing the calcium imaging set-up and helping with quantification of calcium activity in growth cones, F. Martini for advice on calcium imaging, G. Exposito for advice on two-photon imaging, O. Marin (Instituto de Neurociencias de Alicante) for reagents, M. Maravall for advice on data analysis, F. Viana (Instituto de Neurociencias de Alicante) for providing the inducible CHO-A1 cells, and M. Dominguez and A. Gontijo for access and advice on qPCR equipment. We are grateful to A. Nieto, P. Arlotta, E. Herrera and M. Valdeolmillos for advice and critical reading of the manuscript. We are also grateful to members of the Lopez-Bendito laboratory and Herrera laboratory for stimulating discussions and comments. C. M. is recipient of a JAE-Predoctoral Fellowship from the CSIC. This work was supported by grants from the Spanish Ministerio de Ciencia e Innovacion (BFU2006-07138 to J.L. and BFU2009-08261 to G.L.-B.), an Human Frontier Science Program Organization grant (RGP29/2008), the Consolider programme (CSD2007-00023) and an European Research Council grant (ERC-2009-StG_20081210 to G.L.-B.).	AGMON A, 1991, NEUROSCIENCE, V41, P365, DOI 10.1016/0306-4522(91)90333-J; Andrews W, 2008, DEV BIOL, V313, P648, DOI 10.1016/j.ydbio.2007.10.052; Andrews W, 2006, DEVELOPMENT, V133, P2243, DOI 10.1242/dev.02379; Bagri A, 2002, NEURON, V33, P233, DOI 10.1016/S0896-6273(02)00561-5; Bahrey HLP, 2003, J NEUROPHYSIOL, V89, P1761, DOI 10.1152/jn.00972.2002; Blackmore M, 2006, J NEUROBIOL, V66, P348, DOI 10.1002/neu.20224; Borodinsky LN, 2004, NATURE, V429, P523, DOI 10.1038/nature02518; Braisted JE, 2000, J NEUROSCI, V20, P5792, DOI 10.1523/JNEUROSCI.20-15-05792.2000; Burrone J, 2002, NATURE, V420, P414, DOI 10.1038/nature01242; Butler AK, 2001, J COMP NEUROL, V430, P321, DOI 10.1002/1096-9861(20010212)430:3<321::AID-CNE1033>3.0.CO;2-7; COHAN CS, 1986, SCIENCE, V232, P1638, DOI 10.1126/science.3715470; Demarque M, 2010, NEURON, V67, P321, DOI 10.1016/j.neuron.2010.06.006; Dolmetsch RE, 1997, NATURE, V386, P855, DOI 10.1038/386855a0; Fajardo O, 2008, CHANNELS, V2, P429, DOI 10.4161/chan.2.6.7126; FIELDS RD, 1990, J NEUROSCI, V10, P2950; Filbin MT, 2003, NAT REV NEUROSCI, V4, P703, DOI 10.1038/nrn1195; Garel S, 2004, TRENDS NEUROSCI, V27, P533, DOI 10.1016/j.tins.2004.06.014; Goldberg JL, 2002, NEURON, V33, P689, DOI 10.1016/S0896-6273(02)00602-5; Gomez TM, 2006, NAT REV NEUROSCI, V7, P115, DOI 10.1038/nrn1844; Gomez TM, 1999, NATURE, V397, P350, DOI 10.1038/16927; Gutierrez H, 2008, J NEUROSCI, V28, P8246, DOI 10.1523/JNEUROSCI.1941-08.2008; Gutierrez H, 2011, TRENDS NEUROSCI, V34, P316, DOI 10.1016/j.tins.2011.03.001; Hadjantonakis AK, 1998, MECH DEVELOP, V76, P79, DOI 10.1016/S0925-4773(98)00093-8; Hanson MG, 2004, NEURON, V43, P687, DOI 10.1016/j.neuron.2004.08.018; Ibarretxe G, 2007, J NEUROSCI, V27, P7684, DOI 10.1523/JNEUROSCI.1070-07.2007; Itoh K, 1997, J NEUROBIOL, V33, P735, DOI 10.1002/(SICI)1097-4695(19971120)33:6<735::AID-NEU3>3.0.CO;2-A; Jung HS, 2012, NAT REV NEUROSCI, V13, P308, DOI 10.1038/nrn3210; Long H, 2004, NEURON, V42, P213, DOI 10.1016/S0896-6273(04)00179-5; Lopez-Bendito G, 2006, CELL, V125, P127, DOI 10.1016/j.cell.2006.01.042; Lopez-Bendito G, 2003, NAT REV NEUROSCI, V4, P276, DOI 10.1038/nrn1075; Lopez-Bendito G, 2007, J NEUROSCI, V27, P3395, DOI 10.1523/JNEUROSCI.4605-06.2007; Marek KW, 2010, NAT NEUROSCI, V13, P944, DOI 10.1038/nn.2582; Metin C, 1997, DEVELOPMENT, V124, P5063; Ming GL, 2001, NEURON, V29, P441, DOI 10.1016/S0896-6273(01)00217-3; Mizuno H, 2007, J NEUROSCI, V27, P6760, DOI 10.1523/JNEUROSCI.1215-07.2007; Nishimaru H, 1996, J PHYSIOL-LONDON, V497, P131, DOI 10.1113/jphysiol.1996.sp021755; PORTER BE, 1995, NEURON, V14, P549, DOI 10.1016/0896-6273(95)90311-9; Riquelme D, 2011, ANTIOXID REDOX SIGN, V14, P1245, DOI 10.1089/ars.2010.3238; Sann SB, 2008, J NEUROSCI, V28, P2366, DOI 10.1523/JNEUROSCI.3828-07.2008; Scain AL, 2010, J NEUROSCI, V30, P390, DOI 10.1523/JNEUROSCI.2115-09.2010; Skaliora I, 2000, J NEUROSCI, V20, P3650, DOI 10.1523/JNEUROSCI.20-10-03650.2000; Spitzer NC, 2006, NATURE, V444, P707, DOI 10.1038/nature05300; Stein E, 2001, SCIENCE, V291, P1928, DOI 10.1126/science.1058445; Sugiyama C, 2007, NEUROCHEM INT, V51, P467, DOI 10.1016/j.neuint.2007.04.025; Tang FJ, 2003, J NEUROSCI, V23, P927; Tcherkezian J, 2010, CELL, V141, P632, DOI 10.1016/j.cell.2010.04.008; Tucker KL, 2001, NAT NEUROSCI, V4, P29, DOI 10.1038/82868; Uesaka N, 2007, J NEUROSCI, V27, P5215, DOI 10.1523/JNEUROSCI.4685-06.2007; Xiang GX, 2007, J CELL PHYSIOL, V212, P126, DOI 10.1002/jcp.21008; Xiao Q, 2010, J NEUROSCI, V30, P5792, DOI 10.1523/JNEUROSCI.5659-09.2010; Zallen JA, 1998, CELL, V92, P217, DOI 10.1016/S0092-8674(00)80916-2	51	65	66	0	24	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	AUG	2012	15	8					1134	+		10.1038/nn.3160	http://dx.doi.org/10.1038/nn.3160			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	979UE	22772332				2022-12-28	WOS:000306844500020
J	Chamberlain, SEL; Gonzalez-Gonzalez, IM; Wilkinson, KA; Konopacki, FA; Kantamneni, S; Henley, JM; Mellor, JR				Chamberlain, Sophie E. L.; Gonzalez-Gonzalez, Inmaculada M.; Wilkinson, Kevin A.; Konopacki, Filip A.; Kantamneni, Sriharsha; Henley, Jeremy M.; Mellor, Jack R.			SUMOylation and phosphorylation of GluK2 regulate kainate receptor trafficking and synaptic plasticity	NATURE NEUROSCIENCE			English	Article							PROTEIN-KINASE-C; DIFFERENTIAL REGULATION; SURFACE EXPRESSION; CELL BIOLOGY; TRANSMISSION; MEMBRANE; GLUR6; SUMO; AMPA; MECHANISMS	Phosphorylation or SUMOylation of the kainate receptor (KAR) subunit GluK2 have both individually been shown to regulate KAR surface expression. However, it is unknown whether phosphorylation and SUMOylation of GluK2 are important for activity-dependent KAR synaptic plasticity. We found that protein kinase C-mediated phosphorylation of GluK2 at serine 868 promotes GluK2 SUMOylation at lysine 886 and that both of these events are necessary for the internalization of GluK2-containing KARs that occurs during long-term depression of KAR-mediated synaptic transmission at rat hippocampal mossy fiber synapses. Conversely, phosphorylation of GluK2 at serine 868 in the absence of SUMOylation led to an increase in KAR surface expression by facilitating receptor recycling between endosomal compartments and the plasma membrane. Our results suggest a role for the dynamic control of synaptic SUMOylation in the regulation of KAR synaptic transmission and plasticity.	[Chamberlain, Sophie E. L.; Mellor, Jack R.] Univ Bristol, Sch Physiol & Pharmacol, Med Res Council Ctr Synapt Plast, Bristol, Avon, England; [Gonzalez-Gonzalez, Inmaculada M.; Wilkinson, Kevin A.; Konopacki, Filip A.; Kantamneni, Sriharsha; Henley, Jeremy M.] Univ Bristol, Sch Biochem, Med Res Council Ctr Synapt Plast, Bristol, Avon, England	University of Bristol; University of Bristol	Mellor, JR (corresponding author), Univ Bristol, Sch Physiol & Pharmacol, Med Res Council Ctr Synapt Plast, Bristol, Avon, England.	jack.mellor@bristol.ac.uk	Wilkinson, Kevin/AAM-2888-2020; MELLOR, Jack/B-4548-2019; Kantamneni, Sriharsha/G-6504-2012	Wilkinson, Kevin/0000-0002-8115-8592; MELLOR, Jack/0000-0002-7706-8105; Kantamneni, Sriharsha/0000-0002-3750-9447; Henley, Jeremy/0000-0003-3589-8335; Konopacki, Filip/0000-0001-6679-1966; Gonzalez-Gonzalez, Maria Inmaculada/0000-0001-9888-0760	Biotechnology and Biological Sciences Research Council; European Research Council; Medical Research Council; Wellcome Trust; BBSRC [BB/F00723X/1] Funding Source: UKRI; MRC [G0601810] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/F00723X/1] Funding Source: researchfish; Medical Research Council [G0601810] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); European Research Council(European Research Council (ERC)European Commission); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank A. Randall for providing electrophysiological facilities for experiments on cultured preparations, and S. Martin and J. Hanley for comments on previous versions of the manuscript. This work was funded by Biotechnology and Biological Sciences Research Council (S.E.L.C., J.R.M. and J.M.H.), the European Research Council (J.A.W. and J.M.H.), Medical Research Council (F.A.K., S.K. and J.M.H.) and the Wellcome Trust (J.R.M., J.M.H.). I.M.G.-G. is a European Molecular Biology Organization Fellow.	Blanpied TA, 2002, NEURON, V36, P435, DOI 10.1016/S0896-6273(02)00979-0; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; Bolte S, 2006, J MICROSC-OXFORD, V224, P213, DOI 10.1111/j.1365-2818.2006.01706.x; Cho K, 2003, J PHYSIOL-LONDON, V548, P723, DOI 10.1113/jphysiol.2003.040188; Cognet L., 2006, SCI STKE, V2006, ppe13, DOI DOI 10.1126/STKE.3272006PE13; Coussen F, 2005, NEURON, V47, P555, DOI 10.1016/j.neuron.2005.06.033; Hietakangas V, 2006, P NATL ACAD SCI USA, V103, P45, DOI 10.1073/pnas.0503698102; Hirbec H, 2003, NEURON, V37, P625, DOI 10.1016/S0896-6273(02)01191-1; HOUSE C, 1987, SCIENCE, V238, P1726, DOI 10.1126/science.3686012; Huettner JE, 2003, PROG NEUROBIOL, V70, P387, DOI 10.1016/S0301-0082(03)00122-9; Isaac JTR, 2004, PHARMACOL THERAPEUT, V104, P163, DOI 10.1016/j.pharmthera.2004.08.006; Jaskolski F, 2005, TRENDS PHARMACOL SCI, V26, P20, DOI 10.1016/j.tips.2004.11.008; Jaskolski F, 2004, J NEUROSCI, V24, P2506, DOI 10.1523/JNEUROSCI.5116-03.2004; Konopacki FA, 2011, P NATL ACAD SCI USA, V108, P19772, DOI 10.1073/pnas.1111575108; Martin S, 2004, EMBO J, V23, P4749, DOI 10.1038/sj.emboj.7600483; Martin S, 2007, NAT REV NEUROSCI, V8, P948, DOI 10.1038/nrn2276; Martin S, 2007, NATURE, V447, P321, DOI 10.1038/nature05736; Martin S, 2008, J BIOL CHEM, V283, P36435, DOI 10.1074/jbc.M806447200; Nasu-Nishimura Y, 2010, J BIOL CHEM, V285, P2847, DOI 10.1074/jbc.M109.081141; Palmer CL, 2005, PHARMACOL REV, V57, P253, DOI 10.1124/pr.57.2.7; Park YY, 2006, NEURON, V49, P95, DOI 10.1016/j.neuron.2005.11.035; Ren Z, 2003, J NEUROSCI, V23, P6608; Rivera R, 2007, EMBO J, V26, P4359, DOI 10.1038/sj.emboj.7601865; Santos SD, 2009, NEUROSCIENCE, V158, P105, DOI 10.1016/j.neuroscience.2008.02.037; Seeler JS, 2003, NAT REV MOL CELL BIO, V4, P690, DOI 10.1038/nrm1200; Selak S, 2009, NEURON, V63, P357, DOI 10.1016/j.neuron.2009.07.017; Shepherd JD, 2007, ANNU REV CELL DEV BI, V23, P613, DOI 10.1146/annurev.cellbio.23.090506.123516; van Weert AWM, 2000, EUR J CELL BIOL, V79, P394, DOI 10.1078/0171-9335-00062; Wilkinson KA, 2010, BRAIN RES REV, V64, P195, DOI 10.1016/j.brainresrev.2010.04.002; Wilkinson KA, 2010, BIOCHEM J, V428, P133, DOI 10.1042/BJ20100158; Yan S, 2004, J NEUROSCI, V24, P679, DOI 10.1523/JNEUROSCI.4985-03.2004; Yang SH, 2003, MOL CELL, V12, P63, DOI 10.1016/S1097-2765(03)00265-X; Yang SH, 2003, CELL CYCLE, V2, P528, DOI 10.4161/cc.2.6.597	33	77	81	0	28	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JUN	2012	15	6					845	U65		10.1038/nn.3089	http://dx.doi.org/10.1038/nn.3089			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	949AI	22522402	Green Accepted			2022-12-28	WOS:000304546700011
J	Logan, MA; Hackett, R; Doherty, J; Sheehan, A; Speese, SD; Freeman, MR				Logan, Mary A.; Hackett, Rachel; Doherty, Johnna; Sheehan, Amy; Speese, Sean D.; Freeman, Marc R.			Negative regulation of glial engulfment activity by Draper terminates glial responses to axon injury	NATURE NEUROSCIENCE			English	Article							PROTEIN-TYROSINE PHOSPHATASES; INHIBITORY ITAMS; RECEPTOR DRAPER; NERVOUS-SYSTEM; NITRIC-OXIDE; TNF-ALPHA; DROSOPHILA; MICROGLIA; BRAIN; CELLS	Neuronal injury elicits potent cellular responses from glia, but molecular pathways modulating glial activation, phagocytic function and termination of reactive responses remain poorly defined. Here we show that positive or negative regulation of glial responses to axon injury is molecularly encoded by unique isoforms of the Drosophila melanogaster engulfment receptor Draper. Draper-I promotes engulfment of axonal debris through an immunoreceptor tyrosine based activation motif (ITAM). In contrast, Draper-II, an alternative splice variant, potently inhibits glial engulfment function. Draper-II suppresses Draper-I signaling through a previously undescribed immunoreceptor tyrosine based inhibitory motif (ITIM)-like domain and the tyrosine phosphatase Corkscrew (Csw). Intriguingly, loss of Draper-II Csw signaling prolongs expression of glial engulfment genes after axotomy and reduces the ability of glia to respond to secondary axotomy. Our work highlights a novel role for Draper-II in inhibiting glial responses to neurodegeneration, and indicates that a balance of opposing Draper-I and Draper-II signaling events is essential to maintain glial sensitivity to brain injury.	[Freeman, Marc R.] Univ Massachusetts, Sch Med, Howard Hughes Med Inst, Dept Neurobiol, Worcester, MA 01605 USA	Howard Hughes Medical Institute; University of Massachusetts System; University of Massachusetts Worcester	Logan, MA (corresponding author), Oregon Hlth & Sci Univ, Jungers Ctr Neurosci Res, Portland, OR 97201 USA.	loganm@ohsu.edu		Speese, Sean/0000-0002-3965-9828; Freeman, Marc/0000-0003-3481-3715	US National Institutes of Health (NIH) [1RO1NS053538]; NIH [P30NS069346 P30]; American Cancer Society [PF-07-258-01-CSM]; Medical Research Foundation of Oregon; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS069346, R01NS053538] Funding Source: NIH RePORTER	US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society(American Cancer Society); Medical Research Foundation of Oregon; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank T. Awasaki, M. Simon, E. Perkins, B. Dickson and the Vienna Drosophila RNAi Center (VDRC) for sharing fly lines and antibodies. We thank K. Kerr for technical advice and expertise. This work was supported by US National Institutes of Health (NIH) Grant 1RO1NS053538 (M.R.F.), NIH New Faculty Recruitment Grant P30NS069346 P30 (M.A.L.), an American Cancer Society Postdoctoral Fellowship (PF-07-258-01-CSM) (M.A.L.) and the Medical Research Foundation of Oregon (M.A.L.). M.R.F. is a Howard Hughes Medical Institute Early Career Scientist.	Awasaki T, 2006, NEURON, V50, P855, DOI 10.1016/j.neuron.2006.04.027; Bamberger ME, 2003, J NEUROSCI, V23, P2665; Barrow AD, 2006, EUR J IMMUNOL, V36, P1646, DOI 10.1002/eji.200636195; Blank U, 2009, IMMUNOL REV, V232, P59, DOI 10.1111/j.1600-065X.2009.00832.x; Blasioli J, 1999, J BIOL CHEM, V274, P2303, DOI 10.1074/jbc.274.4.2303; Block ML, 2007, NAT REV NEUROSCI, V8, P57, DOI 10.1038/nrn2038; Brambilla R, 2005, J EXP MED, V202, P145, DOI 10.1084/jem.20041918; Cahoy JD, 2008, J NEUROSCI, V28, P264, DOI 10.1523/JNEUROSCI.4178-07.2008; Chitnis T, 2007, AM J PATHOL, V170, P1695, DOI 10.2353/ajpath.2007.060677; Cho S, 2005, J NEUROSCI, V25, P2504, DOI 10.1523/JNEUROSCI.0035-05.2005; Cuttell L, 2008, CELL, V135, P524, DOI 10.1016/j.cell.2008.08.033; da Silva FP, 2008, TRENDS IMMUNOL, V29, P366, DOI 10.1016/j.it.2008.05.001; Daeron M, 2008, IMMUNOL REV, V224, P11, DOI 10.1111/j.1600-065X.2008.00666.x; Doherty J, 2009, J NEUROSCI, V29, P4768, DOI 10.1523/JNEUROSCI.5951-08.2009; Flint AJ, 1997, P NATL ACAD SCI USA, V94, P1680, DOI 10.1073/pnas.94.5.1680; Freeman MR, 2003, NEURON, V38, P567, DOI 10.1016/S0896-6273(03)00289-7; Fuentes-Medel Y, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000184; Gebicke-Haerter PJ, 2005, J NEUROSCI RES, V81, P327, DOI 10.1002/jnr.20479; Hamby ME, 2006, GLIA, V54, P566, DOI 10.1002/glia.20411; Herbst R, 1996, CELL, V85, P899, DOI 10.1016/S0092-8674(00)81273-8; Hoek RM, 2000, SCIENCE, V290, P1768, DOI 10.1126/science.290.5497.1768; Husemann J, 2002, GLIA, V40, P195, DOI 10.1002/glia.10148; Jenmalm MC, 2006, J IMMUNOL, V176, P191, DOI 10.4049/jimmunol.176.1.191; Koning N, 2009, J NEUROPATH EXP NEUR, V68, P159, DOI 10.1097/NEN.0b013e3181964113; Lalancette-Hebert M, 2007, J NEUROSCI, V27, P2596, DOI 10.1523/JNEUROSCI.5360-06.2007; Lee SM, 2011, IMMUNOLOGY, V134, P224, DOI 10.1111/j.1365-2567.2011.03481.x; Logan MA, 2007, NEURON GLIA BIOL, V3, P63, DOI [10.1017/S1740925X0700049X, 10.1017/S1740925X07000646]; MacDonald JM, 2006, NEURON, V50, P869, DOI 10.1016/j.neuron.2006.04.028; McPhee CK, 2010, NATURE, V465, P1093, DOI 10.1038/nature09127; Napoli I, 2009, NEUROSCIENCE, V158, P1030, DOI 10.1016/j.neuroscience.2008.06.046; Neumann H, 2009, BRAIN, V132, P288, DOI 10.1093/brain/awn109; Olcese L, 1996, J IMMUNOL, V156, P4531; Perkins LA, 1996, DEV BIOL, V180, P63, DOI 10.1006/dbio.1996.0285; PERRIMON N, 1985, GENETICS, V111, P23; Perry VH, 2010, NAT REV NEUROL, V6, P193, DOI 10.1038/nrneurol.2010.17; Qin IY, 2005, FASEB J, V19, P550, DOI 10.1096/fj.04-2857com; Rothstein JD, 1996, NEURON, V16, P675, DOI 10.1016/S0896-6273(00)80086-0; Singh TD, 2010, FEBS LETT, V584, P3936, DOI 10.1016/j.febslet.2010.08.050; Sofroniew MV, 2009, TRENDS NEUROSCI, V32, P638, DOI 10.1016/j.tins.2009.08.002; Su HP, 2002, J BIOL CHEM, V277, P11772, DOI 10.1074/jbc.M109336200; Takahashi K, 2007, PLOS MED, V4, P675, DOI 10.1371/journal.pmed.0040124; Underhill DM, 2007, TRENDS IMMUNOL, V28, P66, DOI 10.1016/j.it.2006.12.004; Wu HH, 2009, NAT NEUROSCI, V12, P1534, DOI 10.1038/nn.2446; Xie ZH, 2000, J IMMUNOL, V164, P1521, DOI 10.4049/jimmunol.164.3.1521; Zhao J, 2006, GLIA, V53, P304, DOI 10.1002/glia.20283; Ziegenfuss JS, 2008, NATURE, V453, P935, DOI 10.1038/nature06901	46	56	59	0	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAY	2012	15	5					722	730		10.1038/nn.3066	http://dx.doi.org/10.1038/nn.3066			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	932DI	22426252	Green Accepted			2022-12-28	WOS:000303270200016
J	Day, JJ; Childs, D; Guzman-Karlsson, MC; Kibe, M; Moulden, J; Song, E; Tahir, A; Sweatt, JD				Day, Jeremy J.; Childs, Daniel; Guzman-Karlsson, Mikael C.; Kibe, Mercy; Moulden, Jerome; Song, Esther; Tahir, Absar; Sweatt, J. David			DNA methylation regulates associative reward learning	NATURE NEUROSCIENCE			English	Article							NUCLEUS-ACCUMBENS CORE; VENTRAL TEGMENTAL AREA; EPIGENETIC MECHANISMS; GENE-TRANSCRIPTION; EXPRESSION; DOPAMINE; BEHAVIOR; NEURONS; ADDICTION; AMYGDALA	Reward-related memories are essential for adaptive behavior and evolutionary fitness, but they are also a core component of maladaptive brain diseases such as addiction. Reward learning requires dopamine neurons located in the ventral tegmental area (VTA), which encode relationships between predictive cues and future rewards. Recent evidence suggests that epigenetic mechanisms, including DNA methylation, are essential regulators of neuronal plasticity and experience-driven behavioral change. However, the role of epigenetic mechanisms in reward learning is poorly understood. Here we show that the formation of reward-related associative memories in rats upregulates key plasticity genes in the VTA, which are correlated with memory strength and associated with gene-specific changes in DNA methylation. Moreover, DNA methylation in the VTA is required for the formation of stimulus-reward associations. These results provide the first evidence that that activity-dependent methylation and demethylation of DNA is an essential substrate for the behavioral and neuronal plasticity driven by reward-related experiences.	[Day, Jeremy J.; Childs, Daniel; Guzman-Karlsson, Mikael C.; Kibe, Mercy; Moulden, Jerome; Song, Esther; Tahir, Absar; Sweatt, J. David] Univ Alabama Birmingham, Dept Neurobiol, Birmingham, AL 35294 USA; [Day, Jeremy J.; Childs, Daniel; Guzman-Karlsson, Mikael C.; Kibe, Mercy; Moulden, Jerome; Song, Esther; Tahir, Absar; Sweatt, J. David] Univ Alabama Birmingham, Evelyn F McKnight Brain Inst, Birmingham, AL USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham	Sweatt, JD (corresponding author), Univ Alabama Birmingham, Dept Neurobiol, Birmingham, AL 35294 USA.	dsweatt@uab.edu	Day, Jeremy/AAW-2464-2020	Day, Jeremy/0000-0002-7361-3399; Sweatt, J. David/0000-0003-3567-485X; Childs, Daniel/0000-0001-7643-2836	US National Institute on Drug Abuse [DA029419]; US National Institutes of Mental Health [MH091122, MH057014]; Evelyn F. McKnight Brain Research Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH091122, R01MH057014] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [T32NS061788] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [F32DA029419] Funding Source: NIH RePORTER	US National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); US National Institutes of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Evelyn F. McKnight Brain Research Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We would like to thank all members of the Sweatt laboratory, particularly G. Kaas and I. Zovkic, for comments and suggestions during the completion of these studies. We would also like to thank the Intellectual and Developmental Disabilities Research Core at the University of Alabama at Birmingham for assistance with cell culture experiments. This work is supported by the US National Institute on Drug Abuse (DA029419 to J.J.D.), the US National Institutes of Mental Health (MH091122 and MH057014 to J.D.S.) and the Evelyn F. McKnight Brain Research Foundation.	Borrelli E, 2008, NEURON, V60, P961, DOI 10.1016/j.neuron.2008.10.012; Bramham CR, 2008, J NEUROSCI, V28, P11760, DOI 10.1523/JNEUROSCI.3864-08.2008; Brueckner B, 2005, CANCER RES, V65, P6305, DOI 10.1158/0008-5472.CAN-04-2957; Day JJ, 2007, NAT NEUROSCI, V10, P1020, DOI 10.1038/nn1923; Day JJ, 2011, NEURON, V70, P813, DOI 10.1016/j.neuron.2011.05.019; Day JJ, 2010, NAT NEUROSCI, V13, P1319, DOI 10.1038/nn.2666; Deng JV, 2010, NAT NEUROSCI, V13, P1128, DOI 10.1038/nn.2614; Deroche-Gamonet V, 2004, SCIENCE, V305, P1014, DOI 10.1126/science.1099020; Di Ciano P, 2001, J NEUROSCI, V21, P9471, DOI 10.1523/JNEUROSCI.21-23-09471.2001; Feng J, 2010, NAT NEUROSCI, V13, P423, DOI 10.1038/nn.2514; Fields HL, 2007, ANNU REV NEUROSCI, V30, P289, DOI 10.1146/annurev.neuro.30.051606.094341; Flagel SB, 2011, NATURE, V469, P53, DOI 10.1038/nature09588; Flagel SB, 2010, NEUROPSYCHOPHARMACOL, V35, P388, DOI 10.1038/npp.2009.142; Greer PL, 2008, NEURON, V59, P846, DOI 10.1016/j.neuron.2008.09.002; Guo JJU, 2011, NAT NEUROSCI, V14, P1345, DOI 10.1038/nn.2900; Guo JU, 2011, CELL, V145, P423, DOI 10.1016/j.cell.2011.03.022; Hyman SE, 2006, ANNU REV NEUROSCI, V29, P565, DOI 10.1146/annurev.neuro.29.051605.113009; Im HI, 2010, NAT NEUROSCI, V13, P1120, DOI 10.1038/nn.2615; Johnson DS, 2007, SCIENCE, V316, P1497, DOI 10.1126/science.1141319; Jones MW, 2001, NAT NEUROSCI, V4, P289, DOI 10.1038/85138; Kim TK, 2010, NATURE, V465, P182, DOI 10.1038/nature09033; Kreek MJ, 2005, NAT NEUROSCI, V8, P1450, DOI 10.1038/nn1583; Kriaucionis S, 2009, SCIENCE, V324, P929, DOI 10.1126/science.1169786; Lamprecht R, 1996, LEARN MEMORY, V3, P31, DOI 10.1101/lm.3.1.31; Landt SG, 2012, GENOME RES, V22, P1813, DOI 10.1101/gr.136184.111; LaPlant Q, 2010, NAT NEUROSCI, V13, P1137, DOI 10.1038/nn.2619; Levenson JM, 2005, NAT REV NEUROSCI, V6, P108, DOI 10.1038/nrn1604; Levenson JM, 2006, J BIOL CHEM, V281, P15763, DOI 10.1074/jbc.M511767200; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lubin FD, 2008, J NEUROSCI, V28, P10576, DOI 10.1523/JNEUROSCI.1786-08.2008; Maddox SA, 2011, LEARN MEMORY, V18, P579, DOI 10.1101/lm.2243411; Margolis EB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042365; Margolis EB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015222; Metivier R, 2008, NATURE, V452, P45, DOI 10.1038/nature06544; Miller CA, 2007, NEURON, V53, P857, DOI 10.1016/j.neuron.2007.02.022; Miller CA, 2010, NAT NEUROSCI, V13, P664, DOI 10.1038/nn.2560; Parkinson JA, 2000, BEHAV NEUROSCI, V114, P42, DOI 10.1037/0735-7044.114.1.42; Paxinos G., 2005, RAT BRAIN STEREOTAXI, V5th Edn, DOI 10.1016/c2009-0-63235-9; Rajasethupathy P, 2012, CELL, V149, P693, DOI 10.1016/j.cell.2012.02.057; Roth TL, 2009, BIOL PSYCHIAT, V65, P760, DOI 10.1016/j.biopsych.2008.11.028; Saunders BT, 2013, NEUROSCI BIOBEHAV R, V37, P1955, DOI 10.1016/j.neubiorev.2013.02.008; Saunders BT, 2013, NEUROPSYCHOPHARMACOL, V38, P249, DOI 10.1038/npp.2012.161; Schirrmacher E, 2006, BIOCONJUGATE CHEM, V17, P261, DOI 10.1021/bc050300b; Schultz W, 1997, SCIENCE, V275, P1593, DOI 10.1126/science.275.5306.1593; Stuber GD, 2008, SCIENCE, V321, P1690, DOI 10.1126/science.1160873; Suzuki MM, 2008, NAT REV GENET, V9, P465, DOI 10.1038/nrg2341; Tahiliani M, 2009, SCIENCE, V324, P930, DOI 10.1126/science.1170116; Tsai HC, 2009, SCIENCE, V324, P1080, DOI 10.1126/science.1168878; Tye KM, 2008, NATURE, V453, P1253, DOI 10.1038/nature06963; van Zessen R, 2012, NEURON, V73, P1184, DOI 10.1016/j.neuron.2012.02.016; Weaver ICG, 2004, NAT NEUROSCI, V7, P847, DOI 10.1038/nn1276; Weber M, 2005, NAT GENET, V37, P853, DOI 10.1038/ng1598; Yun IA, 2004, J NEUROSCI, V24, P2923, DOI 10.1523/JNEUROSCI.5282-03.2004	53	155	159	2	56	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	OCT	2013	16	10					1445	+		10.1038/nn.3504	http://dx.doi.org/10.1038/nn.3504			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	223HM	23974711	Green Accepted			2022-12-28	WOS:000324795300017
J	Lu, L; Leutgeb, JK; Tsao, A; Henriksen, EJ; Leutgeb, S; Barnes, CA; Witter, MP; Moser, MB; Moser, EI				Lu, Li; Leutgeb, Jill K.; Tsao, Albert; Henriksen, Espen J.; Leutgeb, Stefan; Barnes, Carol A.; Witter, Menno P.; Moser, May-Britt; Moser, Edvard I.			Impaired hippocampal rate coding after lesions of the lateral entorhinal cortex	NATURE NEUROSCIENCE			English	Article							PLACE CELLS; GRID CELLS; SPATIAL REPRESENTATION; MEMORY REPRESENTATIONS; DENTATE GYRUS; ORGANIZATION; DYNAMICS; MAP; TRANSFORMATION; CORTICES	In the hippocampus, spatial and non-spatial parameters may be represented by a dual coding scheme, in which coordinates in space are expressed by the collective firing locations of place cells and the diversity of experience at these locations is encoded by orthogonal variations in firing rates. Although the spatial signal may reflect input from medial entorhinal cortex, the sources of the variations in firing rate have not been identified. We found that rate variations in rat CA3 place cells depended on inputs from the lateral entorhinal cortex (LEC). Hippocampal rate remapping, induced by changing the shape or the color configuration of the environment, was impaired by lesions in those parts of the ipsilateral LEC that provided the densest input to the hippocampal recording position. Rate remapping was not observed in LEC itself. The findings suggest that LEC inputs are important for efficient rate coding in the hippocampus.	[Lu, Li; Leutgeb, Jill K.; Tsao, Albert; Henriksen, Espen J.; Leutgeb, Stefan; Barnes, Carol A.; Witter, Menno P.; Moser, May-Britt; Moser, Edvard I.] Norwegian Univ Sci & Technol, Kavli Inst Syst Neurosci, N-7034 Trondheim, Norway; [Lu, Li; Leutgeb, Jill K.; Tsao, Albert; Henriksen, Espen J.; Leutgeb, Stefan; Barnes, Carol A.; Witter, Menno P.; Moser, May-Britt; Moser, Edvard I.] Norwegian Univ Sci & Technol, Ctr Neural Computat, N-7034 Trondheim, Norway; [Leutgeb, Jill K.; Leutgeb, Stefan] Univ Calif San Diego, Neurobiol Sect, La Jolla, CA 92093 USA; [Leutgeb, Jill K.; Leutgeb, Stefan] Univ Calif San Diego, Ctr Neural Circuits & Behav, Div Biol Sci, La Jolla, CA 92093 USA; [Barnes, Carol A.] Univ Arizona, Evelyn F McKnight Brain Inst, Div Neural Syst Memory & Aging, Tucson, AZ USA	Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU); University of California System; University of California San Diego; University of California System; University of California San Diego; University of Arizona	Lu, L (corresponding author), Norwegian Univ Sci & Technol, Kavli Inst Syst Neurosci, N-7034 Trondheim, Norway.	li.lu@ntnu.no; jleutgeb@ucsd.edu; edvard.moser@ntnu.no		Leutgeb, Jill/0000-0002-2014-842X	Kavli Foundation; Centre of Excellence from Research Council of Norway	Kavli Foundation; Centre of Excellence from Research Council of Norway	We thank A. M. Amundgard, K. Haugen, K. Jenssen, E. Krakvik, R. Skjerpeng and H. Waade for technical assistance. This work was supported by the Kavli Foundation and a Centre of Excellence grant from the Research Council of Norway.	Blumenfeld B, 2006, NEURON, V52, P383, DOI 10.1016/j.neuron.2006.08.016; Boccara CN, 2010, NAT NEUROSCI, V13, P987, DOI 10.1038/nn.2602; Buckner RL, 2001, NAT REV NEUROSCI, V2, P624, DOI 10.1038/35090048; Burke SN, 2012, HIPPOCAMPUS, V22, P2032, DOI 10.1002/hipo.22060; Burwell RD, 1998, J COMP NEUROL, V398, P179, DOI 10.1002/(SICI)1096-9861(19980824)398:2<179::AID-CNE3>3.0.CO;2-Y; Deshmukh SS, 2012, HIPPOCAMPUS, V22, P2045, DOI 10.1002/hipo.22046; Deshmukh SS, 2011, FRONT BEHAV NEUROSCI, V5, DOI 10.3389/fnbeh.2011.00069; Dolorfo CL, 1998, J COMP NEUROL, V398, P49, DOI 10.1002/(SICI)1096-9861(19980817)398:1<49::AID-CNE4>3.0.CO;2-9; Dolorfo CL, 1998, J COMP NEUROL, V398, P25; Eichenbaum H, 2000, NAT REV NEUROSCI, V1, P41, DOI 10.1038/35036213; Fenton AA, 1998, P NATL ACAD SCI USA, V95, P3182, DOI 10.1073/pnas.95.6.3182; Fyhn M, 2004, SCIENCE, V305, P1258, DOI 10.1126/science.1099901; Fyhn M, 2007, NATURE, V446, P190, DOI 10.1038/nature05601; Hafting T, 2005, NATURE, V436, P801, DOI 10.1038/nature03721; Hargreaves EL, 2005, SCIENCE, V308, P1792, DOI 10.1126/science.1110449; ITO HT, 2013, SOC NEUROSCI; Jezek K, 2011, NATURE, V478, P246, DOI 10.1038/nature10439; Kentros CG, 2004, NEURON, V42, P283, DOI 10.1016/S0896-6273(04)00192-8; KOHLER C, 1985, J COMP NEUROL, V236, P504, DOI 10.1002/cne.902360407; Komorowski RW, 2009, J NEUROSCI, V29, P9918, DOI 10.1523/JNEUROSCI.1378-09.2009; Leutgeb JK, 2005, NEURON, V48, P345, DOI 10.1016/j.neuron.2005.09.007; Leutgeb S, 2005, SCIENCE, V309, P619, DOI 10.1126/science.1114037; Leutgeb S, 2004, SCIENCE, V305, P1295, DOI 10.1126/science.1100265; MacDonald CJ, 2011, NEURON, V71, P737, DOI 10.1016/j.neuron.2011.07.012; MARKUS EJ, 1995, J NEUROSCI, V15, P7079; McHugh TJ, 2007, SCIENCE, V317, P94, DOI 10.1126/science.1140263; Moita MAP, 2004, J NEUROSCI, V24, P7015, DOI 10.1523/JNEUROSCI.5492-03.2004; Moser EI, 2008, ANNU REV NEUROSCI, V31, P69, DOI 10.1146/annurev.neuro.31.061307.090723; MULLER RU, 1987, J NEUROSCI, V7, P1951; Navawongse R, 2013, J NEUROSCI, V33, P1002, DOI 10.1523/JNEUROSCI.3891-12.2013; O'Keefe J, 1978, HIPPOCAMPUS COGNITIV; Pastalkova E, 2008, SCIENCE, V321, P1322, DOI 10.1126/science.1159775; Renno-Costa C, 2010, NEURON, V68, P1051, DOI 10.1016/j.neuron.2010.11.024; Rolls ET, 2006, NETWORK-COMP NEURAL, V17, P447, DOI 10.1080/09548980601064846; ROOM P, 1985, J COMP NEUROL, V242, P40, DOI 10.1002/cne.902420104; RUTH RE, 1988, J COMP NEUROL, V270, P506, DOI 10.1002/cne.902700404; Savelli F, 2010, J NEUROPHYSIOL, V103, P3167, DOI 10.1152/jn.00932.2009; Skaggs WE, 1996, HIPPOCAMPUS, V6, P149, DOI 10.1002/(SICI)1098-1063(1996)6:2<149::AID-HIPO6>3.0.CO;2-K; Stensola H, 2012, NATURE, V492, P72, DOI 10.1038/nature11649; Suzuki WA, 1997, J NEUROPHYSIOL, V78, P1062, DOI 10.1152/jn.1997.78.2.1062; Tsao A, 2013, CURR BIOL, V23, P399, DOI 10.1016/j.cub.2013.01.036; Vertes RP, 2007, BRAIN RES BULL, V71, P601, DOI 10.1016/j.brainresbull.2006.12.002; Wills TJ, 2005, SCIENCE, V308, P873, DOI 10.1126/science.1108905; WILSON MA, 1993, SCIENCE, V261, P1055, DOI 10.1126/science.8351520; Witter M., 2004, RAT NERVOUS SYSTEM, V3, P635, DOI [10.1016/B978-012547638-6/50022-5, DOI 10.1016/B978-012547638-6/50022-5]; WITTER MP, 1989, PROG NEUROBIOL, V33, P161, DOI 10.1016/0301-0082(89)90009-9; Wood ER, 1999, NATURE, V397, P613, DOI 10.1038/17605; Xu W, 2013, SCIENCE, V339, P1290, DOI 10.1126/science.1229534; Young BJ, 1997, J NEUROSCI, V17, P5183; YOUNG BJ, 1994, J NEUROSCI, V14, P6553; Zhang SJ, 2013, SCIENCE, V340, P44, DOI 10.1126/science.1232627	51	66	66	0	29	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	AUG	2013	16	8					1085	U153		10.1038/nn.3462	http://dx.doi.org/10.1038/nn.3462			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	190EV	23852116				2022-12-28	WOS:000322323000019
J	Conductier, G; Brau, F; Viola, A; Langlet, F; Ramkumar, N; Dehouck, B; Lemaire, T; Chapot, R; Lucas, L; Rovere, C; Maitre, P; Hosseiny, S; Petit-Paitel, A; Adamantidis, A; Lakaye, B; Risold, PY; Prevot, V; Meste, O; Nahon, JL; Guyon, A				Conductier, Gregory; Brau, Frederic; Viola, Angele; Langlet, Fanny; Ramkumar, Navean; Dehouck, Benedicte; Lemaire, Thibault; Chapot, Raphael; Lucas, Laurianne; Rovere, Carole; Maitre, Priscilla; Hosseiny, Salma; Petit-Paitel, Agnes; Adamantidis, Antoine; Lakaye, Bernard; Risold, Pierre-Yves; Prevot, Vincent; Meste, Olivier; Nahon, Jean-Louis; Guyon, Alice			Melanin-concentrating hormone regulates beat frequency of ependymal cilia and ventricular volume	NATURE NEUROSCIENCE			English	Article							PROTEIN-COUPLED-RECEPTORS; RAT-BRAIN; LOCALIZATION; NEURONS; SYSTEM; IDENTIFICATION; HYPOTHALAMUS	Ependymal cell cilia help move cerebrospinal fluid through the cerebral ventricles, but the regulation of their beat frequency remains unclear. Using in vitro, high-speed video microscopy and in vivo magnetic resonance imaging in mice, we found that the metabolic peptide melanin-concentrating hormone (MCH) positively controlled cilia beat frequency, specifically in the ventral third ventricle, whereas a lack of MCH receptor provoked a ventricular size increase.	[Conductier, Gregory; Brau, Frederic; Lemaire, Thibault; Chapot, Raphael; Lucas, Laurianne; Rovere, Carole; Maitre, Priscilla; Hosseiny, Salma; Petit-Paitel, Agnes; Nahon, Jean-Louis; Guyon, Alice] CNRS, Inst Pharmacol Mol & Cellulaire, UMR 7275, F-06560 Valbonne, France; [Conductier, Gregory; Brau, Frederic; Ramkumar, Navean; Lemaire, Thibault; Chapot, Raphael; Lucas, Laurianne; Rovere, Carole; Maitre, Priscilla; Hosseiny, Salma; Petit-Paitel, Agnes; Meste, Olivier; Nahon, Jean-Louis; Guyon, Alice] Univ Nice Sophia Antipolis, F-06189 Nice, France; [Viola, Angele] Aix Marseille Univ, Fac Med Timone, Ctr Resonance Magnet Biolog & Med, UMR 7339,CNRS, Marseille, France; [Langlet, Fanny; Dehouck, Benedicte; Prevot, Vincent] Univ Lille 2, INSERM, U837, Lille, France; [Ramkumar, Navean; Meste, Olivier] CNRS, UMR 7271, I3S, Sophia Antipolis, France; [Adamantidis, Antoine] Douglass Mental Hlth Univ Intitute, Montreal, PQ, Canada; [Lakaye, Bernard] Univ Liege, GIGA Neurosci, Liege, Belgium; [Risold, Pierre-Yves] Fac Med & Pharm, SFR FED 4234, EA3922, Lab Histol, Besancon, France; [Nahon, Jean-Louis] CNRS, UPS 846, Stn Primatol, Rousset Sur Arc, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Cote d'Azur; UDICE-French Research Universities; Universite Cote d'Azur; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Engineering & Systems Sciences (INSIS); UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Universite de Lille - ISITE; Universite de Lille; Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Cote d'Azur; University of Liege; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB)	Guyon, A (corresponding author), CNRS, Inst Pharmacol Mol & Cellulaire, UMR 7275, 660 Route Lucioles, F-06560 Valbonne, France.	nahonjl@ipmc.cnrs.fr; alice.guyon@ipmc.cnrs.fr	NAHON, Jean-Louis/O-7977-2016; Risold, Pierre-Yves/M-7730-2018; Risold, Pierre-Yves/AAJ-9535-2021; Prevot, Vincent/E-5720-2016; meste, olivier/L-1917-2017; Rovere-Jovene, Carole/O-4557-2016; GUYON, Alice/P-5192-2016	NAHON, Jean-Louis/0000-0001-9572-7779; Risold, Pierre-Yves/0000-0001-6801-591X; Prevot, Vincent/0000-0001-7185-3615; Rovere-Jovene, Carole/0000-0001-9400-7972; GUYON, Alice/0000-0003-3346-8411; Adamantidis, Antoine/0000-0003-2531-5175; meste, olivier/0000-0002-1405-0194; Petit-Paitel, Agnes/0000-0003-1138-9966	Agence Nationale de la Recherche (ANR) [ANR-08-MNPS-018-01, ANR-09-BLAN-0267]; CNRS Institut National des Sciences Biologiques (INSB); European Union [STREPS/NEST-APES 28594]; Projets Exploratoires Premier Soutien (INSB); Fondation de la Recherche Medicale; CNRS (INSB); Societe Francaise de Nutrition; Institut Danone; Douglas Foundation; McGill University; Canadian Fund for Innovation, Research Chair (Tier 2); Institute for Health Research; Natural Science and Engineering Council of Canada	Agence Nationale de la Recherche (ANR)(French National Research Agency (ANR)); CNRS Institut National des Sciences Biologiques (INSB); European Union(European Commission); Projets Exploratoires Premier Soutien (INSB); Fondation de la Recherche Medicale(Fondation pour la Recherche Medicale); CNRS (INSB); Societe Francaise de Nutrition; Institut Danone(Danone Nutricia); Douglas Foundation; McGill University; Canadian Fund for Innovation, Research Chair (Tier 2); Institute for Health Research; Natural Science and Engineering Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC))	We thank J. M. Friedman (Rockefeller University) for Pmch-CFP mice, J. Boutin (Institut de Recherche Servier) for the MCHR1 antagonists, F. Kober and T. Troalen for cine phase-contrast MRI tests, A. Le Troter for assistance in three-dimensional reconstruction of brain MRI, C. Houdayer for laser-capture dissections, V. Thieffin for animal care, I. Larre for help with immunoassays, F. Aguila for artwork, J. Chabry and P. Mollard for discussions, G. Agarwal for help with Matlab, and S. Rasika and P. Haghighi for corrections and remarks on the manuscript. Supported by the Agence Nationale de la Recherche (ANR; ANR-08-MNPS-018-01 to J.-L.N., ANR Gliodiabesity project to V.P. and ANR-09-BLAN-0267 to V.P.), the CNRS Institut National des Sciences Biologiques (INSB), European Union 6th Framework Program STREPS/NEST-APES 28594 (J.L.N.), Projets Exploratoires Premier Soutien (INSB; A.G. and J.-L.N.), the Fondation de la Recherche Medicale (J.-L.N.), and postdoctoral fellowships from the ANR-08-MNPS-018-01 and CNRS (INSB) and awards from the Societe Francaise de Nutrition 2011 and the Institut Danone 2012 (G.C.). A.A. was supported by the Douglas Foundation, McGill University, Canadian Fund for Innovation, Research Chair (Tier 2), and Institute for Health Research and the Natural Science and Engineering Council of Canada.	Berbari NF, 2008, MOL BIOL CELL, V19, P1540, DOI 10.1091/mbc.E07-09-0942; Berbari NF, 2008, P NATL ACAD SCI USA, V105, P4242, DOI 10.1073/pnas.0711027105; BITTENCOURT JC, 1992, J COMP NEUROL, V319, P218, DOI 10.1002/cne.903190204; Chee MJS, 2013, J COMP NEUROL, V521, P2208, DOI 10.1002/cne.23273; Davis RE, 2007, P NATL ACAD SCI USA, V104, P19422, DOI 10.1073/pnas.0708571104; Garcia MD, 2003, J NEUROCHEM, V86, P709, DOI 10.1046/j.1471-4159.2003.01892.x; Guyon A, 2009, J NEUROSCI, V29, P2528, DOI 10.1523/JNEUROSCI.5764-08.2009; Hervieu G, 2003, EXPERT OPIN THER TAR, V7, P495, DOI 10.1517/eott.7.4.495.22496; Marshall WF, 2008, CURR OPIN CELL BIOL, V20, P48, DOI 10.1016/j.ceb.2007.11.009; Mirzadeh Z, 2010, J NEUROSCI, V30, P2600, DOI 10.1523/JNEUROSCI.3744-09.2010; NELSON DJ, 1974, J PHYSIOL-LONDON, V243, P63, DOI 10.1113/jphysiol.1974.sp010742; PATURLELAFANECHERE L, 1994, J CELL SCI, V107, P1529; Penet MF, 2006, BEHAV GENET, V36, P732, DOI 10.1007/s10519-006-9077-4; Prevot V, 2002, J NEUROENDOCRINOL, V14, P247, DOI 10.1046/j.0007-1331.2001.00772.x; Prochnow N, 2008, HISTOCHEM CELL BIOL, V130, P71, DOI 10.1007/s00418-008-0434-7; Psarra AMG, 1998, J NEUROCYTOL, V27, P779, DOI 10.1023/A:1006970429961; Stanley S, 2010, P NATL ACAD SCI USA, V107, P7024, DOI 10.1073/pnas.1002790107; Tissir F, 2010, NAT NEUROSCI, V13, P700, DOI 10.1038/nn.2555; Veening JG, 2010, FLUIDS BARRIERS CNS, V7, DOI 10.1186/1743-8454-7-1; Vigh B, 2004, HISTOL HISTOPATHOL, V19, P607, DOI 10.14670/HH-19.607	20	47	47	0	22	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JUL	2013	16	7					845	U262		10.1038/nn.3401	http://dx.doi.org/10.1038/nn.3401			5	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	174UM	23708141				2022-12-28	WOS:000321180900015
J	Dus, M; Ai, MR; Suh, GSB				Dus, Monica; Ai, Minrong; Suh, Greg S. B.			Taste-independent nutrient selection is mediated by a brain-specific Na+/solute co-transporter in Drosophila	NATURE NEUROSCIENCE			English	Article							GLUCOSE; MIDGUT; MEMORY; SUGAR	Animals can determine the nutritional value of sugar without the influence of taste. We examined a Drosophila mutant that is insensitive to the nutritional value of sugars, responding only to the concentration (that is, sweetness). The affected gene encodes a sodium/solute co-transporter-like protein, designated SLC5A11 (or cupcake), which is structurally similar to mammalian sodium/glucose co-transporters that transport sugar across the intestinal and renal lumen. However, SLC5A11 was prominently expressed in 10-13 pairs of R4 neurons of the ellipsoid body in the brain and functioned in these neurons for selecting appropriate foods.	[Dus, Monica; Ai, Minrong; Suh, Greg S. B.] NYU, Sch Med, Dept Cell Biol, Skirball Inst Biomol Med,Mol Neurobiol Program, New York, NY 10016 USA	New York University	Suh, GSB (corresponding author), NYU, Sch Med, Dept Cell Biol, Skirball Inst Biomol Med,Mol Neurobiol Program, New York, NY 10016 USA.	greg.suh@med.nyu.edu	Suh, Seong Bae/K-2434-2016	Suh, Greg/0000-0003-4381-658X	Hilda and Preston Davis Foundation; Ruth L. Kirschstein National Research Service Award; Klarman Foundation; Hirschl/Caulier Trust award; US National Institutes of Health grants from the National Institute of General Medical Sciences; National Institute on Deafness and Other Communication Disorders; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R00DK097141, K99DK097141] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM089746] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC012791] Funding Source: NIH RePORTER	Hilda and Preston Davis Foundation; Ruth L. Kirschstein National Research Service Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Klarman Foundation; Hirschl/Caulier Trust award; US National Institutes of Health grants from the National Institute of General Medical Sciences; National Institute on Deafness and Other Communication Disorders(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	We thank C. Perdigoto for assistance with gut immunohistochemistry, members of the Suh laboratory, R. Davis, S. Burden and N. Ringstad for comments on the manuscript, and the Belasco laboratory and the New York University fly community at Skirball Institute for sharing their equipment. Financial support was provided by the Hilda and Preston Davis Foundation (M.D.), Ruth L. Kirschstein National Research Service Award (M.A.), the Klarman Foundation, a Hirschl/Caulier Trust award, and US National Institutes of Health RO1 grants from the National Institute of General Medical Sciences and the National Institute on Deafness and Other Communication Disorders (G.S.B.S.).	BOGDANOVE EM, 1950, P SOC EXP BIOL MED, V75, P77; Boll W, 2002, DEVELOPMENT, V129, P5667, DOI 10.1242/dev.00157; Burke CJ, 2011, CURR BIOL, V21, P746, DOI 10.1016/j.cub.2011.03.032; de Araujo IE, 2008, NEURON, V57, P930, DOI 10.1016/j.neuron.2008.01.032; Dus M, 2011, P NATL ACAD SCI USA, V108, P11644, DOI 10.1073/pnas.1017096108; Fujita M, 2011, CURR BIOL, V21, P751, DOI 10.1016/j.cub.2011.03.058; McGuire SE, 2003, SCIENCE, V302, P1765, DOI 10.1126/science.1089035; Micchelli CA, 2006, NATURE, V439, P475, DOI 10.1038/nature04371; Neuser K, 2008, NATURE, V453, P1244, DOI 10.1038/nature07003; Nitabach MN, 2002, CELL, V109, P485, DOI 10.1016/S0092-8674(02)00737-7; O'Malley D, 2006, DIABETES, V55, P3381, DOI 10.2337/db06-0531; Ofstad TA, 2011, NATURE, V474, P204, DOI 10.1038/nature10131; Ohlstein B, 2006, NATURE, V439, P470, DOI 10.1038/nature04333; Renn SCP, 1999, J NEUROBIOL, V41, P189; Ruta V, 2010, NATURE, V468, P686, DOI 10.1038/nature09554; Sclafani A, 2001, APPETITE, V36, P79, DOI 10.1006/appe.2000.0370; Stafford JW, 2012, J NEUROSCI, V32, P14767, DOI 10.1523/JNEUROSCI.1887-12.2012; Wright EM, 2011, PHYSIOL REV, V91, P733, DOI 10.1152/physrev.00055.2009	18	80	81	0	32	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAY	2013	16	5					526	+		10.1038/nn.3372	http://dx.doi.org/10.1038/nn.3372			4	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	131WT	23542692	Green Accepted			2022-12-28	WOS:000318029300007
J	Lomniczi, A; Loche, A; Castellano, JM; Ronnekleiv, OK; Bosch, M; Kaidar, G; Knoll, JG; Wright, H; Pfeifer, GP; Ojeda, SR				Lomniczi, Alejandro; Loche, Alberto; Castellano, Juan Manuel; Ronnekleiv, Oline K.; Bosch, Martha; Kaidar, Gabi; Knoll, J. Gabriel; Wright, Hollis; Pfeifer, Gerd P.; Ojeda, Sergio R.			Epigenetic control of female puberty	NATURE NEUROSCIENCE			English	Article							ARCUATE NUCLEUS; HORMONE NEURONS; HYPOGONADOTROPIC HYPOGONADISM; NEUROKININ B; LIFE-SPAN; CHROMATIN; KISSPEPTIN; COMPLEX; GENE; MECHANISMS	The timing of puberty is controlled by many genes. The elements coordinating this process have not, however, been identified. Here we show that an epigenetic mechanism of transcriptional repression times the initiation of female puberty in rats. We identify silencers of the Polycomb group (PcG) as principal contributors to this mechanism and show that PcG proteins repress Kiss1, a puberty-activating gene. Hypothalamic expression of two key PcG genes, Eed and Cbx7, decreased and methylation of their promoters increased before puberty. Inhibiting DNA methylation blocked both events and resulted in pubertal failure. The pubertal increase in Kiss1 expression was accompanied by EED loss from the Kiss1 promoter and enrichment of histone H3 modifications associated with gene activation. Preventing the eviction of EED from the Kiss1 promoter disrupted pulsatile gonadotropin-releasing hormone release, delayed puberty and compromised fecundity. Our results identify epigenetic silencing as a mechanism underlying the neuroendocrine control of female puberty.	[Lomniczi, Alejandro; Loche, Alberto; Castellano, Juan Manuel; Ronnekleiv, Oline K.; Kaidar, Gabi; Knoll, J. Gabriel; Wright, Hollis; Ojeda, Sergio R.] Oregon Natl Primate Res Ctr, Div Neurosci, Beaverton, OR USA; [Ronnekleiv, Oline K.; Bosch, Martha] Oregon Hlth & Sci Univ, Dept Physiol & Pharmacol, Portland, OR 97201 USA; [Pfeifer, Gerd P.] City Hope Natl Med Ctr, Beckman Res Inst, Div Biol, Duarte, CA USA	Oregon Health & Science University; Oregon National Primate Research Center; Oregon Health & Science University; City of Hope; Beckman Research Institute of City of Hope	Lomniczi, A (corresponding author), Oregon Natl Primate Res Ctr, Div Neurosci, Beaverton, OR USA.	lomniczi@ohsu.edu; ojedas@ohsu.edu	Castellano, Juan Manuel/AAI-2052-2019	Castellano, Juan Manuel/0000-0003-3981-6683; Loche, Alberto/0000-0001-5974-6008; Lomniczi, Alejandro/0000-0003-4535-0103	US National Institute of Health (NIH) [HD025123-ARRA, 8P51OD011092]; US National Science Foundation [IOS1121691]; NIH [NS43330, DK68098]; European Community; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD007133] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD025123] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK068098] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS043330] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P51OD011092] Funding Source: NIH RePORTER	US National Institute of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US National Science Foundation(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); European Community(European Commission); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank M.E. Costa for technical assistance with the in situ hybridization procedures and the preparation of ovaries for morphological observation. This work was supported by US National Institute of Health (NIH; HD025123-ARRA and 8P51OD011092) and US National Science Foundation (IOS1121691) grants to S.R.O. and by NIH grants NS43330 and DK68098 to O.K.R., and by a Marie Curie International Outgoing Fellowship within the 7th European Community Framework Programme (FP7-PEOPLE-2010-IOF) to J.M.C.	Bedecarrats GY, 2007, SEMIN REPROD MED, V25, P368, DOI 10.1055/s-2007-984743; Berger SL, 2007, NATURE, V447, P407, DOI 10.1038/nature05915; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Bernstein BE, 2007, CELL, V128, P669, DOI 10.1016/j.cell.2007.01.033; Bilger M, 2001, ENDOCRINOLOGY, V142, P2102, DOI 10.1210/en.142.5.2102; BROADWELL RD, 1976, J COMP NEUROL, V166, P257, DOI 10.1002/cne.901660302; Christian CA, 2009, BIOL REPROD, V80, P1128, DOI 10.1095/biolreprod.108.075077; Chu C, 2011, MOL CELL, V44, P667, DOI 10.1016/j.molcel.2011.08.027; de Roux N, 2003, P NATL ACAD SCI USA, V100, P10972, DOI 10.1073/pnas.1834399100; Elks CE, 2010, NAT GENET, V42, P1077, DOI 10.1038/ng.714; Ghoshal K, 2007, DRUG TODAY, V43, P395, DOI 10.1358/dot.2007.43.6.1062666; Gil J, 2004, NAT CELL BIOL, V6, P67, DOI 10.1038/ncb1077; Gottsch ML, 2011, ENDOCRINOLOGY, V152, P4298, DOI 10.1210/en.2011-1521; Greer EL, 2010, NATURE, V466, P383, DOI 10.1038/nature09195; Han SK, 2005, J NEUROSCI, V25, P11349, DOI 10.1523/JNEUROSCI.3328-05.2005; Herbison AE, 2011, J NEUROENDOCRINOL, V23, P557, DOI 10.1111/j.1365-2826.2011.02145.x; Herde MK, 2011, ENDOCRINOLOGY, V152, P3832, DOI 10.1210/en.2011-1228; Herman JG, 2003, NEW ENGL J MED, V349, P2042, DOI 10.1056/NEJMra023075; Iremonger KJ, 2010, BRAIN RES, V1364, P35, DOI 10.1016/j.brainres.2010.08.071; Komashko Vitalina M, 2010, Epigenetics, V5, P229; Krewson TD, 2004, ENDOCRINOLOGY, V145, P4447, DOI 10.1210/en.2004-0543; Kurian JR, 2010, ENDOCRINOLOGY, V151, P5359, DOI 10.1210/en.2010-0555; Lapatto R, 2007, ENDOCRINOLOGY, V148, P4927, DOI 10.1210/en.2007-0078; Lehman MN, 2010, ENDOCRINOLOGY, V151, P3479, DOI 10.1210/en.2010-0022; Meng S, 2010, J BIOL CHEM, V285, P33219, DOI 10.1074/jbc.M110.133686; Messager S, 2005, P NATL ACAD SCI USA, V102, P1761, DOI 10.1073/pnas.0409330102; Neill JD, 1994, PHYSL REPRODUCTION, V1, P1621; NOWAK KW, 1995, LIFE SCI, V57, P833, DOI 10.1016/0024-3205(95)02015-B; Oakley AE, 2009, ENDOCR REV, V30, P713, DOI 10.1210/er.2009-0005; Ojeda SR, 2006, KNOBIL AND NEILL'S PHYSIOLOGY OF REPRODUCTION, VOLS 1 AND 2, 3RD EDITON, P2061; Ojeda SR, 2010, EUR J NEUROSCI, V32, P2003, DOI 10.1111/j.1460-9568.2010.07515.x; Ojeda SR, 2010, BRAIN RES, V1364, P164, DOI 10.1016/j.brainres.2010.09.039; Ojeda SR, 2006, ENDOCRINOLOGY, V147, P1166, DOI 10.1210/en.2005-1136; Otte AP, 2003, CURR OPIN GENET DEV, V13, P448, DOI 10.1016/S0959-437X(03)00108-4; Plant TM, 2006, KNOBIL AND NEILL'S PHYSIOLOGY OF REPRODUCTION, VOLS 1 AND 2, 3RD EDITON, P2177; Ruthenburg AJ, 2007, NAT REV MOL CELL BIO, V8, P983, DOI 10.1038/nrm2298; Sawarkar R, 2010, DEV CELL, V19, P651, DOI 10.1016/j.devcel.2010.10.012; Schaefer M, 2009, CANCER RES, V69, P8127, DOI 10.1158/0008-5472.CAN-09-0458; Schwartz YB, 2007, NAT REV GENET, V8, P9, DOI 10.1038/nrg1981; Seminara SB, 2003, NEW ENGL J MED, V349, P1614, DOI 10.1056/NEJMoa035322; Seminara SB, 2001, ENDOCRINOLOGY, V142, P2173, DOI 10.1210/en.142.6.2173; SHRIVASTAVA A, 1994, NUCLEIC ACIDS RES, V22, P5151, DOI 10.1093/nar/22.24.5151; Simon JA, 2009, NAT REV MOL CELL BIO, V10, P697, DOI 10.1038/nrm2763; Sing A, 2009, CELL, V138, P885, DOI 10.1016/j.cell.2009.08.020; Suter KJ, 2004, NEUROSCIENCE, V128, P443, DOI 10.1016/j.neuroscience.2004.06.044; Topaloglu AK, 2009, NAT GENET, V41, P354, DOI 10.1038/ng.306; Wakabayashi Y, 2010, J NEUROSCI, V30, P3124, DOI 10.1523/JNEUROSCI.5848-09.2010; Wang ZB, 2008, NAT GENET, V40, P897, DOI 10.1038/ng.154; Woo CJ, 2010, CELL, V140, P99, DOI 10.1016/j.cell.2009.12.022; Young MD, 2011, NUCLEIC ACIDS RES, V39, P7415, DOI 10.1093/nar/gkr416	50	182	188	2	43	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAR	2013	16	3					281	289		10.1038/nn.3319	http://dx.doi.org/10.1038/nn.3319			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	097LE	23354331	Green Accepted			2022-12-28	WOS:000315474800010
J	Stanley, GB				Stanley, Garrett B.			Reading and writing the neural code	NATURE NEUROSCIENCE			English	Article							LATERAL GENICULATE-NUCLEUS; HIPPOCAMPAL PLACE CELLS; RETINAL GANGLION-CELLS; EARLY VISUAL-SYSTEM; PSYCHOPHYSICAL PERFORMANCE; NEURONAL POPULATION; THALAMIC SYNCHRONY; NATURAL SCENES; CORTEX; INFORMATION	It has been more than 20 years since Bialek and colleagues published a landmark paper asking a seemingly innocuous question: what can we extract about the outside world from the spiking activity of sensory neurons? Can we read the neural code? Although this seemingly simple question has helped us shed light on the neural code, we still do not understand the anatomical and neurophysiological constraints that enable these codes to propagate across synapses and form the basis for computations that we need to interact with our environment. The sensitivity of neuronal activity to the timing of synaptic inputs naturally suggests that synchrony determines the form of the neural code, and, in turn, regulation of synchrony is a critical element in 'writing' the neural code through the artificial control of microcircuits to activate downstream structures. In this way, reading and writing the neural code are inextricably linked.	[Stanley, Garrett B.] Georgia Inst Technol, Coulter Dept Biomed Engn, Atlanta, GA 30332 USA; [Stanley, Garrett B.] Emory Univ, Atlanta, GA 30322 USA	University System of Georgia; Georgia Institute of Technology; Emory University	Stanley, GB (corresponding author), Georgia Inst Technol, Coulter Dept Biomed Engn, Atlanta, GA 30332 USA.	garrett.stanley@bme.gatech.edu		Stanley, Garrett/0000-0003-2039-7706	US National Science Foundation [IIS-0904630, IOS-1131948]; US National Institutes of Health National Institute of Neurological Disorders and Stroke [2R01NS048285]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS048285] Funding Source: NIH RePORTER	US National Science Foundation(National Science Foundation (NSF)); US National Institutes of Health National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	I would like to thank D.A. Butts, J.-M. Alonso, C. Schwarz and D.C. Millard for comments on the manuscript. G.B.S. was supported by US National Science Foundation Collaborative Research in Computational Neuroscience grants IIS-0904630 and IOS-1131948, and US National Institutes of Health National Institute of Neurological Disorders and Stroke grant 2R01NS048285.	Abbott LF, 1999, NEURAL COMPUT, V11, P91, DOI 10.1162/089976699300016827; Alonso JM, 1996, NATURE, V383, P815, DOI 10.1038/383815a0; Barlow H. B., 1961, SENS COMMUN, P217, DOI DOI 10.7551/MITPRESS/9780262518420.003.0013; Bazhenov M, 2005, PHYS REV E, V72, DOI 10.1103/PhysRevE.72.041903; Bernstein JG, 2008, PROC SPIE, V6854, DOI 10.1117/12.768798; BIALEK W, 1991, SCIENCE, V252, P1854, DOI 10.1126/science.2063199; Brette R, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002561; BRITTEN KH, 1992, J NEUROSCI, V12, P4745; Brown EN, 1998, J NEUROSCI, V18, P7411; Bruno RM, 2006, SCIENCE, V312, P1622, DOI 10.1126/science.1124593; Butovas S, 2003, J NEUROPHYSIOL, V90, P3024, DOI 10.1152/jn.00245.2003; Butts DA, 2007, NATURE, V449, P92, DOI [10.1038/nature06105, 10.1038/natureO6105]; Chase SM, 2007, P NATL ACAD SCI USA, V104, P5175, DOI 10.1073/pnas.0610368104; CREUTZFELDT OD, 1978, NATURWISSENSCHAFTEN, V65, P307, DOI 10.1007/BF00368371; Desbordes G, 2008, PLOS BIOL, V6, P2672, DOI 10.1371/journal.pbio.0060324; Fellous JM, 2004, J NEUROSCI, V24, P2989, DOI 10.1523/JNEUROSCI.4649-03.2004; Gabernet L, 2005, NEURON, V48, P315, DOI 10.1016/j.neuron.2005.09.022; GEORGOPOULOS AP, 1988, J NEUROSCI, V8, P2928; Gollisch T, 2008, SCIENCE, V319, P1108, DOI 10.1126/science.1149639; Gunaydin LA, 2010, NAT NEUROSCI, V13, P387, DOI 10.1038/nn.2495; Halassa MM, 2011, NAT NEUROSCI, V14, P1118, DOI 10.1038/nn.2880; Jacobs AL, 2009, P NATL ACAD SCI USA, V106, P5936, DOI 10.1073/pnas.0900573106; Johansson RS, 2004, NAT NEUROSCI, V7, P170, DOI 10.1038/nn1177; Lesica NA, 2004, J NEUROSCI, V24, P10731, DOI 10.1523/JNEUROSCI.3059-04.2004; Lesica NA, 2006, PLOS BIOL, V4, P1201, DOI 10.1371/journal.pbio.0040209; Lesica NA, 2007, NEURON, V55, P479, DOI 10.1016/j.neuron.2007.07.013; Masquelier T, 2012, J COMPUT NEUROSCI, V32, P425, DOI 10.1007/s10827-011-0361-9; Miyawaki Y, 2008, NEURON, V60, P915, DOI 10.1016/j.neuron.2008.11.004; Nirenberg S, 2003, P NATL ACAD SCI USA, V100, P7348, DOI 10.1073/pnas.1131895100; Ohiorhenuan IE, 2010, NATURE, V466, P617, DOI 10.1038/nature09178; PARADISO MA, 1988, BIOL CYBERN, V58, P35, DOI 10.1007/BF00363954; Quiroga RQ, 2009, NAT REV NEUROSCI, V10, P173, DOI 10.1038/nrn2578; Schneidman E, 2003, J NEUROSCI, V23, P11539; Seki K, 2012, J NEUROSCI, V32, P890, DOI 10.1523/JNEUROSCI.4958-11.2012; Shadlen MN, 1998, J NEUROSCI, V18, P3870; Sharma J, 2000, NATURE, V404, P841, DOI 10.1038/35009043; Sherman SM, 2001, NAT NEUROSCI, V4, P344, DOI 10.1038/85973; Smith MA, 2008, J NEUROSCI, V28, P12591, DOI 10.1523/JNEUROSCI.2929-08.2008; Stanley GB, 2012, J NEUROSCI, V32, P9073, DOI 10.1523/JNEUROSCI.4968-11.2012; Stanley GB, 1999, J NEUROSCI, V19, P8036, DOI 10.1523/jneurosci.19-18-08036.1999; Stoelzel CR, 2009, J NEUROSCI, V29, P6851, DOI 10.1523/JNEUROSCI.5983-08.2009; Swadlow HA, 2002, NAT NEUROSCI, V5, P403, DOI 10.1038/nn847; Szuts TA, 2011, NAT NEUROSCI, V14, P263, DOI 10.1038/nn.2730; Van Rullen R, 2001, NEURAL COMPUT, V13, P1255, DOI 10.1162/08997660152002852; Wang HP, 2010, SCIENCE, V328, P106, DOI 10.1126/science.1183108; Wang Q, 2012, J NEURAL ENG, V9, DOI 10.1088/1741-2560/9/2/026008; Wang Q, 2010, NAT NEUROSCI, V13, P1534, DOI 10.1038/nn.2670; Warland DK, 1997, J NEUROPHYSIOL, V78, P2336, DOI 10.1152/jn.1997.78.5.2336; Zhang KC, 1998, J NEUROPHYSIOL, V79, P1017, DOI 10.1152/jn.1998.79.2.1017; ZOHARY E, 1994, NATURE, V370, P140, DOI 10.1038/370140a0	50	63	65	0	79	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	MAR	2013	16	3					259	263		10.1038/nn.3330	http://dx.doi.org/10.1038/nn.3330			5	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	097LE	23434978				2022-12-28	WOS:000315474800005
J	Bannerman, DM; Bus, T; Taylor, A; Sanderson, DJ; Schwarz, I; Jensen, V; Hvalby, O; Rawlins, JNP; Seeburg, PH; Sprengel, R				Bannerman, David M.; Bus, Thorsten; Taylor, Amy; Sanderson, David J.; Schwarz, Inna; Jensen, Vidar; Hvalby, Oivind; Rawlins, J. Nicholas P.; Seeburg, Peter H.; Sprengel, Rolf			Dissecting spatial knowledge from spatial choice by hippocampal NMDA receptor deletion	NATURE NEUROSCIENCE			English	Article							LONG-TERM POTENTIATION; SYNAPTIC PLASTICITY; REFERENCE MEMORY; WORKING-MEMORY; DENTATE GYRUS; PATTERN SEPARATION; LEARNING-DEFICITS; OLFACTORY-BULB; KNOCKOUT MICE; LESIONS	Hippocampal NMDA receptors (NMDARs) and NMDAR-dependent synaptic plasticity are widely considered crucial substrates of long-term spatial memory, although their precise role remains uncertain. Here we show that Grin1(Delta DGCA1) mice, lacking GluN1 and hence NMDARs in all dentate gyrus and dorsal CA1 principal cells, acquired the spatial reference memory water maze task as well as controls, despite impairments on the spatial reference memory radial maze task. When we ran a spatial discrimination water maze task using two visually identical beacons, Grin1(Delta DGCA1) mice were impaired at using spatial information to inhibit selecting the decoy beacon, despite knowing the platform's actual spatial location. This failure could suffice to impair radial maze performance despite spatial memory itself being normal. Thus, these hippocampal NMDARs are not essential for encoding or storing long-term, associative spatial memories. Instead, we demonstrate an important function of the hippocampus in using spatial knowledge to select between alternative responses that arise from competing or overlapping memories.	[Bannerman, David M.; Taylor, Amy; Sanderson, David J.; Rawlins, J. Nicholas P.] Univ Oxford, Dept Expt Psychol, Oxford OX1 3UD, England; [Bus, Thorsten; Schwarz, Inna; Seeburg, Peter H.; Sprengel, Rolf] Max Planck Inst Met Res, Heidelberg, Germany; [Jensen, Vidar; Hvalby, Oivind] Univ Oslo, Dept Psychol, Inst Basic Med Sci, Oslo, Norway	University of Oxford; Max Planck Society; University of Oslo	Bannerman, DM (corresponding author), Univ Oxford, Dept Expt Psychol, S Parks Rd, Oxford OX1 3UD, England.	david.bannerman@psy.ox.ac.uk; peter.seeburg@mpimf-heidelberg.mpg.de	Sanderson, David J/E-5285-2011	Sanderson, David J/0000-0002-3560-5507; Bannerman, David/0000-0002-3024-7595; Taylor, Amy/0000-0002-8635-7953	European Commission [LSHM-CT-2005-019055]; Wellcome Trust [074385, 087736]; German Research Foundation [SFB636/A4, BMFT: NGFN/SP10, DFG-GA 427/8-1]; Bauer-Stiftung; Letten Foundation	European Commission(European CommissionEuropean Commission Joint Research Centre); Wellcome Trust(Wellcome TrustEuropean Commission); German Research Foundation(German Research Foundation (DFG)); Bauer-Stiftung; Letten Foundation	We thank U. Amtmann, H. Monyer and I. Bertocchi for in situ hybridization, and W. Tang and D. Arcos Diaz for recombinant adeno-associated virus injections. We thank R. Deacon for assistance with lesion surgeries. This work was supported by a grant from the European Commission to the EUSynapse project (LSHM-CT-2005-019055) to P.H.S., Wellcome Trust Senior Research Fellowships 074385 and 087736 to D.M.B., a grant from the German Research Foundation (SFB636/A4; BMFT: NGFN/SP10, DFG-GA 427/8-1) to R.S. and a grant from the Bauer-Stiftung to T.B. O.H. and V.J. were supported by the Letten Foundation.	[Anonymous], 1998, NEURAL NETWORKS BRAI; BANNERMAN DM, 1995, NATURE, V378, P182, DOI 10.1038/378182a0; Bannerman DM, 1999, BEHAV NEUROSCI, V113, P1170, DOI 10.1037/0735-7044.113.6.1170; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; Brigman JL, 2010, J NEUROSCI, V30, P4590, DOI 10.1523/JNEUROSCI.0640-10.2010; Brun VH, 2002, SCIENCE, V296, P2243, DOI 10.1126/science.1071089; Deacon RMJ, 2002, BEHAV BRAIN RES, V133, P57, DOI 10.1016/S0166-4328(01)00451-X; Dillon GM, 2008, NEUROBIOL LEARN MEM, V90, P426, DOI 10.1016/j.nlm.2008.05.008; Fukaya M, 2003, P NATL ACAD SCI USA, V100, P4855, DOI 10.1073/PNAS.0830996100; Fyhn M, 2002, NEURON, V35, P555, DOI 10.1016/S0896-6273(02)00784-5; Gray JA, 2000, NEUROPSYCHOLOGY ANXI; Hoeffer CA, 2008, NEURON, V60, P832, DOI 10.1016/j.neuron.2008.09.037; Hollerman JR, 1998, NAT NEUROSCI, V1, P304, DOI 10.1038/1124; Honey RC, 1998, J NEUROSCI, V18, P2226; Jensen V, 2003, J PHYSIOL-LONDON, V553, P843, DOI 10.1113/jphysiol.2003.053637; Jerecic J, 2001, MOL BRAIN RES, V94, P96, DOI 10.1016/S0169-328X(01)00221-2; Krestel HE, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.7.e39; Kumaran D, 2007, J NEUROSCI, V27, P8517, DOI 10.1523/JNEUROSCI.1677-07.2007; Kumaran D, 2006, PLOS BIOL, V4, P2372, DOI 10.1371/journal.pbio.0040424; Lee G, 1998, GENE, V216, P55, DOI 10.1016/S0378-1119(98)00325-4; Logue SE, 1997, BEHAV NEUROSCI, V111, P104, DOI 10.1037/0735-7044.111.1.104; Lyon L, 2011, NEUROPSYCHOPHARMACOL, V36, P2616, DOI 10.1038/npp.2011.145; MARR D, 1971, PHILOS T ROY SOC B, V262, P23, DOI 10.1098/rstb.1971.0078; Martin SJ, 2000, ANNU REV NEUROSCI, V23, P649, DOI 10.1146/annurev.neuro.23.1.649; McHugh TJ, 2007, SCIENCE, V317, P94, DOI 10.1126/science.1140263; MORRIS RGM, 1990, PHILOS T ROY SOC B, V329, P187, DOI 10.1098/rstb.1990.0164; MORRIS RGM, 1990, EUR J NEUROSCI, V2, P1016, DOI 10.1111/j.1460-9568.1990.tb00014.x; MORRIS RGM, 1986, Q J EXP PSYCHOL-B, V38, P365; MORRIS RGM, 1986, NATURE, V319, P774, DOI 10.1038/319774a0; MOSER MB, 1995, P NATL ACAD SCI USA, V92, P9697, DOI 10.1073/pnas.92.21.9697; Murray AJ, 2011, NAT NEUROSCI, V14, P297, DOI 10.1038/nn.2751; Neves G, 2008, NAT REV NEUROSCI, V9, P65, DOI 10.1038/nrn2303; Niewoehner B, 2007, EUR J NEUROSCI, V25, P837, DOI 10.1111/j.1460-9568.2007.05312.x; O'Keefe J, 1978, HIPPOCAMPUS COGNITIV; OKEEFE J, 1976, EXP NEUROL, V51, P78, DOI 10.1016/0014-4886(76)90055-8; Ploghaus A, 2000, P NATL ACAD SCI USA, V97, P9281, DOI 10.1073/pnas.160266497; Pothuizen HHJ, 2004, EUR J NEUROSCI, V19, P705, DOI 10.1111/j.0953-816X.2004.03170.x; Reisel D, 2002, NAT NEUROSCI, V5, P868, DOI 10.1038/nn910; Rondi-Reig L, 2006, J NEUROSCI, V26, P4071, DOI 10.1523/JNEUROSCI.3408-05.2006; Sahay A, 2011, NEURON, V70, P582, DOI 10.1016/j.neuron.2011.05.012; SAUCIER D, 1995, NATURE, V378, P186, DOI 10.1038/378186a0; Schmitt WB, 2003, J NEUROSCI, V23, P3953; Shimshek DR, 2005, PLOS BIOL, V3, P2017, DOI 10.1371/journal.pbio.0030354; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Steffenach HA, 2005, NEURON, V45, P301, DOI 10.1016/j.neuron.2004.12.044; Suchanek B, 1997, BIOL CHEM, V378, P929; Tang W, 2009, J NEUROSCI, V29, P8621, DOI 10.1523/JNEUROSCI.0359-09.2009; Tashiro A, 2006, NATURE, V442, P929, DOI 10.1038/nature05028; Tsien JZ, 1996, CELL, V87, P1327, DOI 10.1016/S0092-8674(00)81827-9; Tsien JZ, 1996, CELL, V87, P1317, DOI 10.1016/S0092-8674(00)81826-7; Uekita T, 2009, BEHAV NEUROSCI, V123, P520, DOI 10.1037/a0015672; von Engelhardt J, 2008, NEURON, V60, P846, DOI 10.1016/j.neuron.2008.09.039; Wiltgen BJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012818; [No title captured]	54	109	109	1	45	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	AUG	2012	15	8					1153	+		10.1038/nn.3166	http://dx.doi.org/10.1038/nn.3166			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	979UE	22797694	Green Accepted			2022-12-28	WOS:000306844500022
J	Katsuki, F; Constantinidis, C				Katsuki, Fumi; Constantinidis, Christos			Early involvement of prefrontal cortex in visual bottom-up attention	NATURE NEUROSCIENCE			English	Article							POSTERIOR PARIETAL CORTEX; FRONTAL EYE FIELD; SACCADE TARGET SELECTION; TOP-DOWN; SUPERIOR COLLICULUS; NEURONAL RESPONSES; RHESUS-MONKEY; SEARCH; STIMULI; LOBE	Visual attention is guided to stimuli either on the basis of their intrinsic saliency against their background (bottom-up factors) or through willful search of known targets (top-down factors). Posterior parietal cortex (PPC) is thought to be important for the guidance of visual bottom-up attention, whereas dorsolateral prefrontal cortex is thought to represent top-down factors. Contrary to this established view, we found that, when monkeys were tested in a task requiring detection of a salient stimulus defined purely by bottom-up factors and whose identity was unknown before the presentation of a visual display, prefrontal neurons represented the salient stimulus no later than those in the PPC. This was true even though visual response latency was shorter in parietal than in prefrontal cortex. These results suggest an early involvement of the prefrontal cortex in the bottom-up guidance of visual attention.	[Katsuki, Fumi; Constantinidis, Christos] Wake Forest Univ, Bowman Gray Sch Med, Dept Neurobiol & Anat, Winston Salem, NC 27106 USA	Wake Forest University; Wake Forest Baptist Medical Center	Constantinidis, C (corresponding author), Wake Forest Univ, Bowman Gray Sch Med, Dept Neurobiol & Anat, Winston Salem, NC 27106 USA.	cconstan@wfubmc.edu	Constantinidis, Christos/ABB-5760-2021; Katsuki, Fumi/AAA-7248-2019	Katsuki, Fumi/0000-0002-1411-6317; Constantinidis, Christos/0000-0001-7441-022X	National Eye Institute of the US National Institutes of Health [R01 EY016773]; Tab Williams Family Endowment Fund; NATIONAL EYE INSTITUTE [R01EY016773] Funding Source: NIH RePORTER	National Eye Institute of the US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Tab Williams Family Endowment Fund; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	We wish to thank K. Palaninathan, K. Roberts and J. Rawley for helping with the experiments, and R. Ramachandran, T. Stanford and E. Salinas for comments. This work was supported by the National Eye Institute of the US National Institutes of Health under award number R01 EY016773 and by the Tab Williams Family Endowment Fund.	Arcizet F, 2011, CEREB CORTEX, V21, P2498, DOI 10.1093/cercor/bhr035; Badre D, 2009, NAT REV NEUROSCI, V10, P659, DOI 10.1038/nrn2667; Bichot NP, 1996, NATURE, V381, P697, DOI 10.1038/381697a0; Bisley JW, 2010, ANNU REV NEUROSCI, V33, P1, DOI 10.1146/annurev-neuro-060909-152823; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Burrows BE, 2009, J NEUROSCI, V29, P15169, DOI 10.1523/JNEUROSCI.3710-09.2009; Buschman TJ, 2007, SCIENCE, V315, P1860, DOI 10.1126/science.1138071; CAVADA C, 1989, J COMP NEUROL, V287, P393, DOI 10.1002/cne.902870402; CAVADA C, 1989, J COMP NEUROL, V287, P422, DOI 10.1002/cne.902870403; Connor CE, 2004, CURR BIOL, V14, pR850, DOI 10.1016/j.cub.2004.09.041; Constantinidis C, 2005, J NEUROSCI, V25, P233, DOI 10.1523/JNEUROSCI.3379-04.2005; Constantinidis C, 2001, CEREB CORTEX, V11, P581, DOI 10.1093/cercor/11.7.581; Constantinidis C, 2006, REV NEUROSCIENCE, V17, P415; Corbetta M, 2002, NAT REV NEUROSCI, V3, P201, DOI 10.1038/nrn755; Davison AC, 1997, BOOTSTRAP METHODS TH; Dayan, 2001, THEORETICAL NEUROSCI; Felleman DJ, 1991, CEREB CORTEX, V1, P1, DOI 10.1093/cercor/1.1.1; Gottlieb JP, 1998, NATURE, V391, P481, DOI 10.1038/35135; Harris KD, 2000, J NEUROPHYSIOL, V84, P401, DOI 10.1152/jn.2000.84.1.401; Hegde J, 2003, J NEUROSCI, V23, P9968; Itti L, 2001, NAT REV NEUROSCI, V2, P194, DOI 10.1038/35058500; Katsuki F, 2012, FRONT INTEGR NEUROSC, V6, DOI 10.3389/fnint.2012.00017; KNIERIM JJ, 1992, J NEUROPHYSIOL, V67, P961, DOI 10.1152/jn.1992.67.4.961; KOCH C, 1985, HUM NEUROBIOL, V4, P219; Kustov AA, 1996, NATURE, V384, P74, DOI 10.1038/384074a0; McPeek RM, 2002, J NEUROPHYSIOL, V88, P2019, DOI 10.1152/jn.2002.88.4.2019; Meyer T, 2005, J NEUROSCI METH, V142, P27, DOI 10.1016/j.jneumeth.2004.07.009; Moore T, 2001, P NATL ACAD SCI USA, V98, P1273, DOI 10.1073/pnas.021549498; Niebur E., 1996, NEURAL INFORM PROCES, P802; Noudoost B, 2010, CURR OPIN NEUROBIOL, V20, P183, DOI 10.1016/j.conb.2010.02.003; Premereur E, 2011, J NEUROSCI, V31, P12307, DOI 10.1523/JNEUROSCI.2241-11.2011; PREUSS TM, 1991, J COMP NEUROL, V310, P429, DOI 10.1002/cne.903100402; Rowland BA, 2007, J NEUROSCI, V27, P5879, DOI 10.1523/JNEUROSCI.4986-06.2007; Sato TR, 2003, EXP BRAIN RES, V151, P356, DOI 10.1007/s00221-003-1461-1; SCHALL JD, 1993, NATURE, V366, P467, DOI 10.1038/366467a0; Schall JD, 2002, PHILOS T ROY SOC B, V357, P1073, DOI 10.1098/rstb.2002.1098; Serre T, 2007, P NATL ACAD SCI USA, V104, P6424, DOI 10.1073/pnas.0700622104; Thomas NWD, 2007, J NEUROPHYSIOL, V97, P942, DOI 10.1152/jn.00413.2006; Thompson KG, 1996, J NEUROPHYSIOL, V76, P4040, DOI 10.1152/jn.1996.76.6.4040; TOLHURST DJ, 1983, VISION RES, V23, P775, DOI 10.1016/0042-6989(83)90200-6; TREISMAN AM, 1980, COGNITIVE PSYCHOL, V12, P97, DOI 10.1016/0010-0285(80)90005-5; Ungerleider L.G., 1982, ANAL VISUAL BEHAV, P549; Wardak C, 2010, CEREB CORTEX, V20, P2464, DOI 10.1093/cercor/bhp315; White BJ, 2011, J NEUROSCI, V31, P1570, DOI 10.1523/JNEUROSCI.5349-10.2011; WOLFE JM, 1994, PSYCHON B REV, V1, P202, DOI 10.3758/BF03200774	45	86	90	3	31	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	AUG	2012	15	8					1160	+		10.1038/nn.3164	http://dx.doi.org/10.1038/nn.3164			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	979UE	22820465	Green Submitted, Green Accepted			2022-12-28	WOS:000306844500023
J	Sher, A; DeVries, SH				Sher, Alexander; DeVries, Steven H.			A non-canonical pathway for mammalian blue-green color vision	NATURE NEUROSCIENCE			English	Article							OPTIC-NERVE FIBERS; GANGLION-CELLS; PRIMATE RETINA; GROUND-SQUIRREL	The dynamic range of visual coding is extended by having separate ganglion cell types that respond to light increments and decrements. Although the primordial color vision system in mammals contains a well-characterized ganglion cell that responds to blue light increments (a blue On center cell), less is known about ganglion cells that respond to blue light decrements (blue Off center cells). We identified a regular mosaic of blue Off center ganglion cells in the ground squirrel. Contrary to the standard scheme, blue Off responses came from a blue On bipolar and inverting amacrine cell.	[Sher, Alexander] Univ Calif Santa Cruz, Santa Cruz Inst Particle Phys, Santa Cruz, CA 95064 USA; [DeVries, Steven H.] Northwestern Univ, Dept Ophthalmol, Feinberg Sch Med, Chicago, IL 60611 USA; [DeVries, Steven H.] Northwestern Univ, Dept Physiol, Feinberg Sch Med, Chicago, IL 60611 USA	University of California System; University of California Santa Cruz; Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine	Sher, A (corresponding author), Univ Calif Santa Cruz, Santa Cruz Inst Particle Phys, Santa Cruz, CA 95064 USA.	sasha@scipp.ucsc.edu; s-devries@northwestern.edu		Sher, Alexander/0000-0001-6655-6456	US National Institutes of Health [R01EY018204]; Burroughs Wellcome Fund Career Award at the Scientific Interface; NATIONAL EYE INSTITUTE [R01EY018204] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Burroughs Wellcome Fund Career Award at the Scientific Interface(Burroughs Wellcome Fund); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	We thank A.M. Litke for technical development and scientific discussions, W. Dabrowski, K. Mathieson, P. Hottowy and S. Kachiguine for technical development, M. Krause and). Roebber for technical assistance with the experiments, and G.D. Field and B. Szmajda for providing comments on the manuscript. This work was supported by a US National Institutes of Health grant (R01EY018204) to S.H.D. and a Burroughs Wellcome Fund Career Award at the Scientific Interface to A.S.	Crook JD, 2009, J NEUROSCI, V29, P8372, DOI 10.1523/JNEUROSCI.1218-09.2009; Dacey D, 2004, COGNITIVE NEUROSCIENCES III, THIRD EDITION, P281; Dacey DM, 2005, NATURE, V433, P749, DOI 10.1038/nature03387; DACEY DM, 1994, NATURE, V367, P731, DOI 10.1038/367731a0; Field GD, 2007, J NEUROSCI, V27, P13261, DOI 10.1523/JNEUROSCI.3437-07.2007; Hemmi JM, 2002, J VISION, V2, P608, DOI 10.1167/2.9.3; JACOBS GH, 1981, J NEUROPHYSIOL, V45, P891, DOI 10.1152/jn.1981.45.5.891; Kryger Z, 1998, VISUAL NEUROSCI, V15, P685, DOI 10.1017/S0952523898154081; Li W, 2006, NAT NEUROSCI, V9, P669, DOI 10.1038/nn1686; Litke AM, 2004, IEEE T NUCL SCI, V51, P1434, DOI 10.1109/TNS.2004.832706; Manookin MB, 2008, J NEUROSCI, V28, P4136, DOI 10.1523/JNEUROSCI.4274-07.2008; MICHAEL CR, 1968, J NEUROPHYSIOL, V31, P268, DOI 10.1152/jn.1968.31.2.268; Tailby C, 2008, J PHYSIOL-LONDON, V586, P5947, DOI 10.1113/jphysiol.2008.161893; WIESEL TN, 1966, J NEUROPHYSIOL, V29, P1115, DOI 10.1152/jn.1966.29.6.1115; Yin L, 2009, J NEUROSCI, V29, P2706, DOI 10.1523/JNEUROSCI.5471-08.2009	15	47	47	1	21	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JUL	2012	15	7					952	953		10.1038/nn.3127	http://dx.doi.org/10.1038/nn.3127			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	966EE	22634728	Green Accepted			2022-12-28	WOS:000305819600010
J	Rahman, M; Ham, HL; Liu, XR; Sugiura, Y; Orth, K; Kramer, H				Rahman, Mokhlasur; Ham, Hyeilin; Liu, Xinran; Sugiura, Yoshie; Orth, Kim; Kraemer, Helmut			Visual neurotransmission in Drosophila requires expression of Fic in glial capitate projections	NATURE NEUROSCIENCE			English	Article							PHOTORECEPTOR TERMINALS; LEGIONELLA-PNEUMOPHILA; OPTIC NEUROPIL; NERVOUS-SYSTEM; PROTEIN; HISTAMINE; ADENYLYLATION; AMPYLATION; EBONY; ELECTRORETINOGRAM	Fic domains can catalyze the addition of adenosine monophosphate to target proteins. To date, the function of Fic domain proteins in eukaryotic physiology remains unknown. We generated genetic models of the single Drosophila Fic domain-containing protein, Fic. Flies lacking Fic were viable and fertile, but blind. Photoreceptor cells depolarized normally following light stimulation, but failed to activate postsynaptic neurons, as indicated by the loss of ON transients in electroretinograms, consistent with a neurotransmission defect. Functional rescue of neurotransmission required expression of enzymatically active Fic on capitate projections of glia cells, but not neurons, supporting a role in the recycling of the visual neurotransmitter histamine. Histamine levels were reduced in the lamina of Fic null flies, and dietary histamine partially restored ON transients. These findings establish a previously unknown regulatory mechanism in visual neurotransmission and provide, to the best of our knowledge, the first evidence for a role of glial capitate projections in neurotransmitter recycling.	[Rahman, Mokhlasur; Liu, Xinran; Sugiura, Yoshie; Kraemer, Helmut] Univ Texas SW Med Ctr Dallas, Dept Neurosci, Dallas, TX 75390 USA; [Ham, Hyeilin; Orth, Kim] Univ Texas SW Med Ctr Dallas, Dept Biol Mol, Dallas, TX 75390 USA; [Kraemer, Helmut] Univ Texas SW Med Ctr Dallas, Dept Cell Biol, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	Kramer, H (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Neurosci, Dallas, TX 75390 USA.	helmut.kramer@utsouthwestern.edu	Orth, Kim/AAV-4421-2021	Orth, Kim/0000-0002-0678-7620; Kramer, Helmut/0000-0002-1167-2676	US National Institutes of Health National Eye Institute [EY10199, EY021922, EY020799]; US National Institutes of Health (Allergy and Infectious Disease) [R01-AI056404, R01-AI087808]; Welch Foundation [I-1561]; NATIONAL EYE INSTITUTE [R01EY021922, P30EY020799, R01EY010199] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI087808, R01AI056404] Funding Source: NIH RePORTER	US National Institutes of Health National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); US National Institutes of Health (Allergy and Infectious Disease); Welch Foundation(The Welch Foundation); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We are grateful to R. Hiesinger for help and advice with the ERG measurements and the use of his ERG setup, W. Pak, B. Hoveman and the Bloomington Stock center for fly lines, M. Buszczak for antibodies, C. Gilpin from the Molecular and Cellular Imaging Facility at UT Southwestern, S. H. Kim and B. Tu for technical help, and to E. Kavalali and A. Haberman for helpful discussions. This work was supported by grants to H. K. from the US National Institutes of Health National Eye Institute (EY10199 and EY021922) and Visual Science Core grant EY020799. K.O. and H. H. are supported by grants from the US National Institutes of Health (Allergy and Infectious Disease, R01-AI056404 and R01-AI087808) and the Welch Foundation (I-1561). K.O. is a Burroughs Wellcome Investigator in Pathogenesis of Infectious Disease and a W. W. Caruth Jr. Biomedical Scholar.	Akbar MA, 2009, MOL BIOL CELL, V20, P1705, DOI 10.1091/mbc.E08-03-0282; ALAWI AA, 1971, SCIENCE, V172, P1055, DOI 10.1126/science.172.3987.1055; BENZER S, 1967, P NATL ACAD SCI USA, V58, P1112, DOI 10.1073/pnas.58.3.1112; Borycz J, 2002, J NEUROSCI, V22, P10549; Borycz JA, 2005, J NEUROPHYSIOL, V93, P1611, DOI 10.1152/jn.00894.2004; Broberg CA, 2010, CURR OPIN MICROBIOL, V13, P34, DOI 10.1016/j.mib.2009.12.004; BROWN MS, 1971, P NATL ACAD SCI USA, V68, P2949, DOI 10.1073/pnas.68.12.2949; BURG MG, 1993, EMBO J, V12, P911, DOI 10.1002/j.1460-2075.1993.tb05732.x; Edwards TN, 2010, PROG NEUROBIOL, V90, P471, DOI 10.1016/j.pneurobio.2010.01.001; Engel P, 2012, NATURE, V482, P107, DOI 10.1038/nature10729; Fabian-Fine R, 2003, J NEUROSCI, V23, P10732; Gavin BA, 2007, PLOS GENET, V3, P2358, DOI 10.1371/journal.pgen.0030206; HEISENBERG M, 1971, J EXP BIOL, V55, P85; Kinch LN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005818; LIN DM, 1994, NEURON, V13, P507, DOI 10.1016/0896-6273(94)90022-1; Meinertzhagen I.A., 1997, NEUROBIOLOGY MEMBRAN, VII, P457; Melzig J, 1998, J NEUROSCI, V18, P7160; Melzig J, 1996, J COMP PHYSIOL A, V179, P763, DOI 10.1007/BF00207355; Muller MP, 2010, SCIENCE, V329, P946, DOI 10.1126/science.1192276; Mukherjee S, 2011, NATURE, V477, P103, DOI 10.1038/nature10335; Neunuebel MR, 2011, SCIENCE, V333, P453, DOI 10.1126/science.1207193; Pantazis A, 2008, J NEUROSCI, V28, P7250, DOI 10.1523/JNEUROSCI.1654-08.2008; Richardt A, 2003, J BIOL CHEM, V278, P41160, DOI 10.1074/jbc.M304303200; Richardt A, 2002, J COMP NEUROL, V452, P93, DOI 10.1002/cne.10360; Romero-Calderon R, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000245; Rost B, 2004, NUCLEIC ACIDS RES, V32, pW321, DOI 10.1093/nar/gkh377; Sepp KJ, 2001, DEV BIOL, V238, P47, DOI 10.1006/dbio.2001.0411; Sharma A, 2010, METHODS MOL BIOL, V619, P339, DOI 10.1007/978-1-60327-412-8_20; STARK WS, 1986, CELL TISSUE RES, V246, P481, DOI 10.1007/BF00215187; Stowers RS, 2002, NEURON, V36, P1063, DOI 10.1016/S0896-6273(02)01094-2; Stowers RS, 1999, GENETICS, V152, P1631; Sunio A, 1999, MOL BIOL CELL, V10, P847, DOI 10.1091/mbc.10.4.847; Tan YH, 2011, NATURE, V475, P506, DOI 10.1038/nature10307; Wagner S, 2007, J COMP NEUROL, V500, P601, DOI 10.1002/cne.21138; Williamson WR, 2010, J CELL BIOL, V189, P885, DOI 10.1083/jcb.201003062; Worby CA, 2009, MOL CELL, V34, P93, DOI 10.1016/j.molcel.2009.03.008; Yarbrough ML, 2009, SCIENCE, V323, P269, DOI 10.1126/science.1166382; Zhu Y, 2009, CURR BIOL, V19, P613, DOI 10.1016/j.cub.2009.02.053	38	57	57	0	12	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JUN	2012	15	6					871	U92		10.1038/nn.3102	http://dx.doi.org/10.1038/nn.3102			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	949AI	22544313	Green Accepted			2022-12-28	WOS:000304546700014
J	Smith, CJ; Watson, JD; VanHovene, MK; Colon-Ramos, DA; Miller, DM				Smith, Cody J.; Watson, Joseph D.; VanHovene, Miri K.; Colon-Ramos, Daniel A.; Miller, David M., III			Netrin (UNC-6) mediates dendritic self-avoidance	NATURE NEUROSCIENCE			English	Article							PIONEER AXON MIGRATIONS; CAENORHABDITIS-ELEGANS; GUIDES CELL; GUIDANCE; PROTEIN; MECHANISMS; OUTGROWTH; HOMOLOG; RECOGNITION; ATTRACTION	Dendrites from a single neuron may be highly branched but typically do not overlap. Self-avoidance behavior has been shown to depend on cell-specific membrane proteins that trigger mutual repulsion. Here we report the unexpected discovery that a diffusible cue, the axon guidance protein UNC-6 (Netrin), is required for self-avoidance of sister dendrites from the PVD nociceptive neuron in Caenorhabditis elegans. We used time-lapse imaging to show that dendrites fail to withdraw upon mutual contact in the absence of UNC-6 signaling. We propose a model in which the UNC-40 (Deleted in Colorectal Cancer; DCC) receptor captures UNC-6 at the tips of growing dendrites for interaction with UNC-5 on the apposing branch to induce mutual repulsion. UNC-40 also responds to dendritic contact through another pathway that is independent of UNC-6. Our findings offer a new model for how an evolutionarily conserved morphogenic cue and its cognate receptors can pattern a fundamental feature of dendritic architecture.	[Smith, Cody J.; Watson, Joseph D.; Miller, David M., III] Vanderbilt Univ, Dept Cell & Dev Biol, Nashville, TN 37235 USA; [Watson, Joseph D.; Miller, David M., III] Vanderbilt Univ, Neurosci Program, Nashville, TN USA; [Watson, Joseph D.; Miller, David M., III] Vanderbilt Univ, Vanderbilt Kennedy Ctr, Nashville, TN USA; [VanHovene, Miri K.] San Jose State Univ, Dept Biol Sci, San Jose, CA 95192 USA; [Colon-Ramos, Daniel A.] Yale Univ, Dept Cell Biol, New Haven, CT USA; [Colon-Ramos, Daniel A.] Yale Univ, Program Cellular Neurosci & Neurodegenerat & Repa, New Haven, CT USA	Vanderbilt University; Vanderbilt University; Vanderbilt University; California State University System; San Jose State University; Yale University; Yale University	Miller, DM (corresponding author), Vanderbilt Univ, Dept Cell & Dev Biol, Nashville, TN 37235 USA.	david.miller@vanderbilt.edu		VanHoven, Miri/0000-0001-7714-1555	US National Institutes of Health (NIH) National Center for Research Resources; NIH [R01 NS26115, R21 NS06882, F31 NS071801, R00 NS057931, MBRS SC3 GM089595]; Klingenstein Foundation; Alfred P. Sloan Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [SC3GM089595] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [T32MH064913] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS066882, R00NS057931, R01NS026115, F31NS071801] Funding Source: NIH RePORTER	US National Institutes of Health (NIH) National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Klingenstein Foundation(Klingenstein Philanthropies); Alfred P. Sloan Foundation(Alfred P. Sloan Foundation); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank C. Bargmann (Rockefeller University) for unc-86::UNC-40::GFP, hspl6.2:: UNC-6::HA and the CX6488 strain; W. Wadsworth (Rutgers University) for the pIM97 unc-6 expression construct and unc-6(rh46); K. Shen (Stanford University) for constructs used to make pCJS01, F49H12.4::gateway::mcherry; P. Roy (University of Toronto) for the unc-40(e271) sequence; Y. Goshima (Yokohama City University) for ghls9; J. Culotti (Mount Sinai Hospital, Toronto) for the unc-5 rescue construct and for the modified UNC-5 protein strains used for structure function analysis and members of the D.M.M., R.B. and D.A.C.-R. laboratories for technical advice and for comments on the manuscript. Some of the strains used in this work were provided by the C. elegans Genetics Center, which is supported by the US National Institutes of Health (NIH) National Center for Research Resources. This work was supported by NIH R01 NS26115 (D.M.M.), NIH R21 NS06882 (D.M.M.), NIH F31 NS071801 (C.J.S.), NIH R00 NS057931 (D.A.C.-R.), the Klingenstein Foundation and an Alfred P. Sloan Foundation fellowship (D.A.C.-R.), and NIH MBRS SC3 GM089595 (M.K.V.).	Adler CE, 2006, NAT NEUROSCI, V9, P511, DOI 10.1038/nn1666; Aguirre-Chen C, 2011, DEVELOPMENT, V138, P507, DOI 10.1242/dev.060939; Albeg A, 2011, MOL CELL NEUROSCI, V46, P308, DOI 10.1016/j.mcn.2010.10.001; Alexander M, 2009, DEVELOPMENT, V136, P911, DOI 10.1242/dev.030759; Asakura T, 2007, DEV BIOL, V304, P800, DOI 10.1016/j.ydbio.2007.01.028; Bashaw GJ, 1999, CELL, V97, P917, DOI 10.1016/S0092-8674(00)80803-X; Chan SSY, 1996, CELL, V87, P187, DOI 10.1016/S0092-8674(00)81337-9; Chang C, 2006, CURR BIOL, V16, P854, DOI 10.1016/j.cub.2006.03.083; Colon-Ramos DA, 2007, SCIENCE, V318, P103, DOI 10.1126/science.1143762; Corty MM, 2009, DEVELOPMENT, V136, P1049, DOI 10.1242/dev.014423; Eastman C, 1999, J NEUROSCI, V19, P6225; Emoto K, 2006, NATURE, V443, P210, DOI 10.1038/nature05090; Fleming T, 2010, DEV BIOL, V344, P94, DOI 10.1016/j.ydbio.2010.04.025; Gitai Z, 2003, NEURON, V37, P53, DOI 10.1016/S0896-6273(02)01149-2; Grueber WB, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001750; Hall DH, 2011, TRENDS NEUROSCI, V34, P443, DOI 10.1016/j.tins.2011.07.004; Hattori D, 2008, ANNU REV CELL DEV BI, V24, P597, DOI 10.1146/annurev.cellbio.24.110707.175250; Hiramoto M, 2000, NATURE, V406, P886, DOI 10.1038/35022571; Hiramoto M, 2006, NAT NEUROSCI, V9, P58, DOI 10.1038/nn1612; Hughes ME, 2007, NEURON, V54, P417, DOI 10.1016/j.neuron.2007.04.013; ISHII N, 1992, NEURON, V9, P873, DOI 10.1016/0896-6273(92)90240-E; Jan YN, 2010, NAT REV NEUROSCI, V11, P316, DOI 10.1038/nrn2836; Keleman K, 2001, NEURON, V32, P605, DOI 10.1016/S0896-6273(01)00505-0; Killeen M, 2002, DEV BIOL, V251, P348, DOI 10.1006/dbio.2002.0825; Kuzina I, 2011, DEVELOPMENT, V138, P1839, DOI 10.1242/dev.062471; Leonardo ED, 1997, NATURE, V386, P833, DOI 10.1038/386833a0; LEUNGHAGESTEIJN CY, 1992, CELL, V71, P289, DOI 10.1016/0092-8674(92)90357-I; Long H, 2009, DEVELOPMENT, V136, P3475, DOI 10.1242/dev.040220; MacNeil LT, 2009, NAT NEUROSCI, V12, P150, DOI 10.1038/nn.2256; Matsubara D, 2011, GENE DEV, V25, P1982, DOI 10.1101/gad.16531611; Matthews BJ, 2007, CELL, V129, P593, DOI 10.1016/j.cell.2007.04.013; Merz DC, 2001, GENETICS, V158, P1071; Mitchell KJ, 1996, NEURON, V17, P203, DOI 10.1016/S0896-6273(00)80153-1; Oren-Suissa M, 2010, SCIENCE, V328, P1285, DOI 10.1126/science.1189095; Park J, 2011, NEURAL DEV, V6, DOI 10.1186/1749-8104-6-28; Quinn CC, 2008, CURR BIOL, V18, P808, DOI 10.1016/j.cub.2008.04.050; Schwarz V, 2009, NEURAL DEV, V4, DOI 10.1186/1749-8104-4-13; SERAFINI T, 1994, CELL, V78, P409, DOI 10.1016/0092-8674(94)90420-0; Smith CJ, 2010, DEV BIOL, V345, P18, DOI 10.1016/j.ydbio.2010.05.502; Teichmann HM, 2011, NAT NEUROSCI, V14, P165, DOI 10.1038/nn.2717; Tsalik EL, 2003, J NEUROBIOL, V56, P178, DOI 10.1002/neu.10245; Wadsworth WG, 1996, NEURON, V16, P35, DOI 10.1016/S0896-6273(00)80021-5; Watson JD, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-84; Xu ZN, 2009, GENETICS, V183, P941, DOI 10.1534/genetics.109.108654; Yang L, 2009, SCIENCE, V324, P944, DOI 10.1126/science.1171320; Zipursky SL, 2010, CELL, V143, P343, DOI 10.1016/j.cell.2010.10.009	46	69	77	0	19	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAY	2012	15	5					731	737		10.1038/nn.3065	http://dx.doi.org/10.1038/nn.3065			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	932DI	22426253	Green Accepted			2022-12-28	WOS:000303270200017
J	Ofengeim, D; Chen, YB; Miyawaki, T; Li, HM; Sacchetti, S; Flannery, RJ; Alavian, KN; Pontarelli, F; Roelofs, BA; Hickman, JA; Hardwick, JM; Zukin, RS; Jonas, EA				Ofengeim, Dimitry; Chen, Ying-bei; Miyawaki, Takahiro; Li, Hongmei; Sacchetti, Silvio; Flannery, Richard J.; Alavian, Kambiz N.; Pontarelli, Fabrizio; Roelofs, Brian A.; Hickman, John A.; Hardwick, J. Marie; Zukin, R. Suzanne; Jonas, Elizabeth A.			N-terminally cleaved Bcl-x(L) mediates ischemia-induced neuronal death	NATURE NEUROSCIENCE			English	Article							CYTOCHROME-C RELEASE; BCL-X-L; CELL-DEATH; CASPASE-3 ACTIVATION; CHANNEL ACTIVITY; APOPTOSIS; BAX; PROTEIN; MITOCHONDRIA; ABT-737	Transient global ischemia in rats induces delayed death of hippocampal CA1 neurons. Early events include caspase activation, cleavage of anti-death Bcl-2 family proteins and large mitochondrial channel activity. However, whether these events have a causal role in ischemia-induced neuronal death is unclear. We found that the Bcl-2 and Bcl-x(L) inhibitor ABT-737, which enhances death of tumor cells, protected rats against neuronal death in a clinically relevant model of brain ischemia. Bcl-x(L) is prominently expressed in adult neurons and can be cleaved by caspases to generate a pro-death fragment, Delta N-Bcl-x(L). We found that ABT-737 administered before or after ischemia inhibited Delta N-Bcl-x(L)-induced mitochondrial channel activity and neuronal death. To establish a causal role for Delta N-Bcl-x(L), we generated knock-in mice expressing a caspase-resistant form of Bcl-x(L). The knock-in mice exhibited markedly reduced mitochondrial channel activity and reduced vulnerability to ischemia-induced neuronal death. These findings suggest that truncated Bcl-x(L) could be a potentially important therapeutic target in ischemic brain injury.	[Li, Hongmei; Sacchetti, Silvio; Flannery, Richard J.; Alavian, Kambiz N.; Jonas, Elizabeth A.] Yale Univ, Sch Med, Dept Internal Med, New Haven, CT 06510 USA; [Ofengeim, Dimitry; Miyawaki, Takahiro; Pontarelli, Fabrizio; Zukin, R. Suzanne] Albert Einstein Coll Med, Dominick P Purpura Dept Neurosci, Bronx, NY 10467 USA; [Chen, Ying-bei; Hardwick, J. Marie] Johns Hopkins Univ, Sch Med, Dept Pharmacol & Mol Sci, Baltimore, MD 21205 USA; [Roelofs, Brian A.; Hardwick, J. Marie] Johns Hopkins Univ, Sch Publ Hlth, Dept Biochem & Mol Biol, Baltimore, MD USA; [Hickman, John A.] Inst Rech Servier, Croissy Sur Seine, France; [Hardwick, J. Marie] Johns Hopkins Univ, Sch Publ Hlth, Dept Mol Microbiol & Immunol, Baltimore, MD USA; [Jonas, Elizabeth A.] Yale Univ, Sch Med, Dept Neurobiol, New Haven, CT USA	Yale University; Yeshiva University; Albert Einstein College of Medicine; Johns Hopkins University; Johns Hopkins University; Servier; Institut de Recherches Internationales Servier; Johns Hopkins University; Yale University	Jonas, EA (corresponding author), Yale Univ, Sch Med, Dept Internal Med, New Haven, CT 06510 USA.	mhardwic@jhsph.edu; suzanne.zukin@einstein.yu.edu; elizabeth.jonas@yale.edu	Alavian, Kambiz/O-2831-2017; Alavian, Kambiz N/D-7720-2012; chen, ying/HHS-8254-2022	Alavian, Kambiz/0000-0002-0653-3057; 	US National Institutes of Health [NS045876, NS46742, NS37402]; McKnight Foundation; F.M. Kirby Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS045876, R01NS046742, R01NS045693, R01NS037402, R37NS045876] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); McKnight Foundation; F.M. Kirby Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank A. Latuszek-Barrantes for excellent technical assistance, and J. Hickman, R. Kitsis and L.K. Kaczmarek for insightful scientific discussion and constructive review of the manuscript. We thank C. Kinnally and N. Danial for the gift of Bax<SUP>-/-</SUP>; Bak<SUP>-/-</SUP> MEFs and the Institut de Recherches Servier for ABT-737. This work was supported by grants from the US National Institutes of Health (NS045876 to E.A.J., NS46742 to R.S.Z. and NS37402 to J.M.H.), a McKnight Foundation Brain Disorders Award (to R.S.Z.) and a generous grant from the F.M. Kirby Foundation (to R.S.Z.). R.S.Z. is the F.M. Kirby Professor of Neural Repair and Protection.	Alavian KN, 2011, NAT CELL BIOL, V13, P1224, DOI 10.1038/ncb2330; Basanez G, 2001, J BIOL CHEM, V276, P31083, DOI 10.1074/jbc.M103879200; Bonanni L, 2006, J NEUROSCI, V26, P6851, DOI 10.1523/JNEUROSCI.5444-05.2006; Calderone A, 2003, J NEUROSCI, V23, P2112; Cao GD, 2002, J CEREBR BLOOD F MET, V22, P534, DOI 10.1097/00004647-200205000-00005; Chen J, 1998, J NEUROSCI, V18, P4914; Chen YB, 2011, J CELL BIOL, V195, P263, DOI 10.1083/jcb.201108059; Cheng EHY, 1997, SCIENCE, V278, P1966, DOI 10.1126/science.278.5345.1966; Clem RJ, 1998, P NATL ACAD SCI USA, V95, P554, DOI 10.1073/pnas.95.2.554; Colbourne F, 1999, J NEUROSCI, V19, P4200; Cragg MS, 2009, NAT REV CANCER, V9, P321, DOI 10.1038/nrc2615; Dejean LM, 2005, MOL BIOL CELL, V16, P2424, DOI 10.1091/mbc.E04-12-1111; Fannjiang Y, 2003, DEV CELL, V4, P575, DOI 10.1016/S1534-5807(03)00091-1; Fujita N, 1998, ONCOGENE, V17, P1295, DOI 10.1038/sj.onc.1202065; Galonek HL, 2006, NAT CELL BIOL, V8, P1317, DOI 10.1038/ncb1206-1317; Graham SH, 2001, J CEREBR BLOOD F MET, V21, P99, DOI 10.1097/00004647-200102000-00001; Hara H, 1997, J CEREBR BLOOD F MET, V17, P370, DOI 10.1097/00004647-199704000-00002; Hetz C, 2005, J BIOL CHEM, V280, P42960, DOI 10.1074/jbc.M505843200; Hickman JA, 2008, J NEUROPHYSIOL, V99, P1515, DOI 10.1152/jn.00598.2007; Hochhauser E, 2003, AM J PHYSIOL-HEART C, V284, pH2351, DOI 10.1152/ajpheart.00783.2002; Jonas EA, 2003, J NEUROSCI, V23, P8423; Jover T, 2002, J NEUROSCI, V22, P2115, DOI 10.1523/JNEUROSCI.22-06-02115.2002; Kirsch DG, 1999, J BIOL CHEM, V274, P21155, DOI 10.1074/jbc.274.30.21155; Krajewska M, 2002, CELL DEATH DIFFER, V9, P145, DOI 10.1038/sj/cdd/4400934; Lewis J, 1999, NAT MED, V5, P832, DOI 10.1038/10556; Li HL, 1998, CELL, V94, P491, DOI 10.1016/S0092-8674(00)81590-1; Li Z, 2010, CELL, V141, P859, DOI 10.1016/j.cell.2010.03.053; Liou AKF, 2003, PROG NEUROBIOL, V69, P103, DOI 10.1016/S0301-0082(03)00005-4; Luo X, 1998, CELL, V94, P481, DOI 10.1016/S0092-8674(00)81589-5; Miyawaki T, 2008, P NATL ACAD SCI USA, V105, P4892, DOI 10.1073/pnas.0800628105; Moskowitz MA, 2010, NEURON, V67, P181, DOI 10.1016/j.neuron.2010.07.002; Nakagawa T, 2000, J CELL BIOL, V150, P887, DOI 10.1083/jcb.150.4.887; Northington FJ, 2011, ANN NEUROL, V69, P743, DOI 10.1002/ana.22419; Ofengeim D, 2011, STROKE PATHOPHYSIOLO, P1; Okuno S, 2004, J NEUROSCI, V24, P7879, DOI 10.1523/JNEUROSCI.1745-04.2004; Oltersdorf T, 2005, NATURE, V435, P677, DOI 10.1038/nature03579; Richardson Alan, 2008, Curr Mol Pharmacol, V1, P244; Sugawara T, 1999, J NEUROSCI, V19, part. no.; Tanaka H, 2004, J NEUROSCI, V24, P2750, DOI 10.1523/JNEUROSCI.5475-03.2004; van Delft MF, 2006, CANCER CELL, V10, P389, DOI 10.1016/j.ccr.2006.08.027; Vogler M, 2009, BLOOD, V113, P4403, DOI 10.1182/blood-2008-08-173310; Wang XY, 2009, J NEUROSCI, V29, P2588, DOI 10.1523/JNEUROSCI.5832-08.2009; Youle RJ, 2008, NAT REV MOL CELL BIO, V9, P47, DOI 10.1038/nrm2308; Yuan JY, 2009, APOPTOSIS, V14, P469, DOI 10.1007/s10495-008-0304-8; Zukin R.S., 2004, STROKE, Vfourth, P829	45	55	56	0	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	APR	2012	15	4					574	580		10.1038/nn.3054	http://dx.doi.org/10.1038/nn.3054			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	916PA	22366758	Green Accepted			2022-12-28	WOS:000302114500017
J	Pinto, L; Goard, MJ; Estandian, D; Xu, M; Kwan, AC; Lee, SH; Harrison, TC; Feng, GP; Dan, Y				Pinto, Lucas; Goard, Michael J.; Estandian, Daniel; Xu, Min; Kwan, Alex C.; Lee, Seung-Hee; Harrison, Thomas C.; Feng, Guoping; Dan, Yang			Fast modulation of visual perception by basal forebrain cholinergic neurons	NATURE NEUROSCIENCE			English	Article							NUCLEUS BASALIS; SPATIAL ATTENTION; GAIN MODULATION; BARREL CORTEX; BRAIN-STEM; STATE; PROJECTIONS; MECHANISMS; TRANSMISSION; STIMULATION	The basal forebrain provides the primary source of cholinergic input to the cortex, and it has a crucial function in promoting wakefulness and arousal. However, whether rapid changes in basal forebrain neuron spiking in awake animals can dynamically influence sensory perception is unclear. Here we show that basal forebrain cholinergic neurons rapidly regulate cortical activity and visual perception in awake, behaving mice. Optogenetic activation of the cholinergic neurons or their V1 axon terminals improved performance of a visual discrimination task on a trial-by-trial basis. In V1, basal forebrain activation enhanced visual responses and desynchronized neuronal spiking; these changes could partly account for the behavioral improvement. Conversely, optogenetic basal forebrain inactivation decreased behavioral performance, synchronized cortical activity and impaired visual responses, indicating the importance of cholinergic activity in normal visual processing. These results underscore the causal role of basal forebrain cholinergic neurons in fast, bidirectional modulation of cortical processing and sensory perception.	[Pinto, Lucas; Goard, Michael J.; Estandian, Daniel; Xu, Min; Kwan, Alex C.; Lee, Seung-Hee; Harrison, Thomas C.; Dan, Yang] Univ Calif Berkeley, Howard Hughes Med Inst, Div Neurobiol, Dept Mol & Cell Biol,Helen Wills Neurosci Inst, Berkeley, CA 94720 USA; [Feng, Guoping] MIT, Dept Brain & Cognit Sci, McGovern Inst Brain Res, Cambridge, MA 02139 USA	Howard Hughes Medical Institute; University of California System; University of California Berkeley; Massachusetts Institute of Technology (MIT)	Pinto, L (corresponding author), Univ Calif Berkeley, Howard Hughes Med Inst, Div Neurobiol, Dept Mol & Cell Biol,Helen Wills Neurosci Inst, Berkeley, CA 94720 USA.	lucaspinto@berkeley.edu; ydan@berkeley.edu	Xu, Min/AGD-5135-2022; Feng, Guoping/Y-2827-2019	Xu, Min/0000-0002-6936-7543; Dan, Yang/0000-0002-3818-877X; Kwan, Alex/0000-0003-2169-1667; Goard, Michael/0000-0002-5366-8501	US National Institutes of Health [R01 EY018861]; National Science Foundation [22250400-42533]; National Institute of Mental Health [RC1-MH088434]; Ruth L. Kirschstein National Research Service Award [F31NS059258]; National Institute of Neurological Disorders and Stroke; NATIONAL EYE INSTITUTE [R01EY018861] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [RC1MH088434] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F31NS084696, F31NS059258] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Ruth L. Kirschstein National Research Service Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank H.J. Alitto for helpful discussions, and E. Rothenberg, J. Cox, G. Pho, S. Zhang, J. Jin, S. Harding-Forrester, C. Oldfield, Y.-C. Kuo, C. Niell, M. Stryker and M. Sur for technical assistance. This work was supported by US National Institutes of Health grant R01 EY018861, National Science Foundation grant 22250400-42533 (Y.D.), National Institute of Mental Health grant RC1-MH088434 (G.F.) and a Ruth L. Kirschstein National Research Service Award (F31NS059258) from the National Institute of Neurological Disorders and Stroke (M.J.G.).	Bauer M, 2012, CURR BIOL, V22, P397, DOI 10.1016/j.cub.2012.01.022; Bezdudnaya T, 2006, NEURON, V49, P421, DOI 10.1016/j.neuron.2006.01.010; Boynton GM, 2009, VISION RES, V49, P1129, DOI 10.1016/j.visres.2008.11.001; BUZSAKI G, 1988, J NEUROSCI, V8, P4007; Castro-Alamancos MA, 2004, NEURON, V41, P455, DOI 10.1016/S0896-6273(03)00853-5; Chiba AA, 1999, NEUROREPORT, V10, P3119, DOI 10.1097/00001756-199909290-00044; Chubykin AA, 2013, NEURON, V77, P723, DOI 10.1016/j.neuron.2012.12.039; Cohen MR, 2009, NAT NEUROSCI, V12, P1594, DOI 10.1038/nn.2439; Crochet S, 2006, NAT NEUROSCI, V9, P608, DOI 10.1038/nn1690; Disney AA, 2007, NEURON, V56, P701, DOI 10.1016/j.neuron.2007.09.034; Froemke RC, 2013, NAT NEUROSCI, V16, P79, DOI 10.1038/nn.3274; Goard M, 2009, NAT NEUROSCI, V12, P1444, DOI 10.1038/nn.2402; Guillem K, 2011, SCIENCE, V333, P888, DOI 10.1126/science.1207079; Hasenstaub A, 2007, J NEUROSCI, V27, P9607, DOI 10.1523/JNEUROSCI.2184-07.2007; Herrero JL, 2008, NATURE, V454, P1110, DOI 10.1038/nature07141; Jones BE, 2005, TRENDS PHARMACOL SCI, V26, P578, DOI 10.1016/j.tips.2005.09.009; Kalmbach A, 2012, J NEUROPHYSIOL, V107, P2008, DOI 10.1152/jn.00870.2011; Keller GB, 2012, NEURON, V74, P809, DOI 10.1016/j.neuron.2012.03.040; Kilgard MP, 1998, SCIENCE, V279, P1714, DOI 10.1126/science.279.5357.1714; Kuo MC, 2009, NEUROSCIENCE, V163, P430, DOI 10.1016/j.neuroscience.2009.06.026; Laplante F, 2005, NEUROSCIENCE, V132, P501, DOI 10.1016/j.neuroscience.2004.11.059; Lee MG, 2005, J NEUROSCI, V25, P4365, DOI 10.1523/JNEUROSCI.0178-05.2005; Ma M, 2012, J NEUROSCI, V32, P10105, DOI 10.1523/JNEUROSCI.0058-12.2012; Marguet SL, 2011, J NEUROSCI, V31, P6414, DOI 10.1523/JNEUROSCI.5773-10.2011; METHERATE R, 1993, SYNAPSE, V14, P132, DOI 10.1002/syn.890140206; Mitchell JF, 2009, NEURON, V63, P879, DOI 10.1016/j.neuron.2009.09.013; Niell CM, 2010, NEURON, V65, P472, DOI 10.1016/j.neuron.2010.01.033; PARENT A, 1988, J COMP NEUROL, V277, P281, DOI 10.1002/cne.902770209; Parikh V, 2007, NEURON, V56, P141, DOI 10.1016/j.neuron.2007.08.025; Polack PO, 2013, NAT NEUROSCI, V16, P1331, DOI 10.1038/nn.3464; Poulet JFA, 2008, NATURE, V454, P881, DOI 10.1038/nature07150; PRICE JL, 1983, BRAIN RES, V269, P352, DOI 10.1016/0006-8993(83)90145-2; Reynolds JH, 2000, NEURON, V26, P703, DOI 10.1016/S0896-6273(00)81206-4; Rokem A, 2010, NEUROPSYCHOPHARMACOL, V35, P2538, DOI 10.1038/npp.2010.118; RYE DB, 1984, NEUROSCIENCE, V13, P627, DOI 10.1016/0306-4522(84)90083-6; Sarter M, 2005, BRAIN RES REV, V48, P98, DOI 10.1016/j.brainresrev.2004.08.006; Sarter M, 2009, NAT REV NEUROSCI, V10, P383, DOI 10.1038/nrn2635; SATO H, 1987, J NEUROPHYSIOL, V58, P765, DOI 10.1152/jn.1987.58.4.765; SILLITO AM, 1983, BRAIN RES, V289, P143, DOI 10.1016/0006-8993(83)90015-X; Thiele A, 2012, J NEUROSCI, V32, P16602, DOI 10.1523/JNEUROSCI.0554-12.2012; Tye KM, 2011, NATURE, V471, P358, DOI 10.1038/nature09820; Warden MR, 2012, NATURE, V492, P428, DOI 10.1038/nature11617; Williford T, 2006, J NEUROPHYSIOL, V96, P40, DOI 10.1152/jn.01207.2005; Worgotter F, 1998, NATURE, V396, P165, DOI 10.1038/24157; Xu SJ, 2012, NAT NEUROSCI, V15, P449, DOI 10.1038/nn.3036; Yu AJ, 2005, NEURON, V46, P681, DOI 10.1016/j.neuron.2005.04.026; Zaborszky L, 2003, FRONT BIOSCI-LANDMRK, V8, pD1146, DOI 10.2741/1112; Zhao SL, 2011, NAT METHODS, V8, P745, DOI 10.1038/nmeth.1668	48	306	306	3	78	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	DEC	2013	16	12					1857	1863		10.1038/nn.3552	http://dx.doi.org/10.1038/nn.3552			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	257VV	24162654	Green Submitted, Green Accepted			2022-12-28	WOS:000327416800024
J	Goldmann, T; Wieghofer, P; Muller, PF; Wolf, Y; Varol, D; Yona, S; Brendecke, SM; Kierdorf, K; Staszewski, O; Datta, M; Luedde, T; Heikenwalder, M; Jung, S; Prinz, M				Goldmann, Tobias; Wieghofer, Peter; Mueller, Philippe F.; Wolf, Yochai; Varol, Diana; Yona, Simon; Brendecke, Stefanie M.; Kierdorf, Katrin; Staszewski, Ori; Datta, Moumita; Luedde, Tom; Heikenwalder, Mathias; Jung, Steffen; Prinz, Marco			A new type of microglia gene targeting shows TAK1 to be pivotal in CNS autoimmune inflammation	NATURE NEUROSCIENCE			English	Article							CENTRAL-NERVOUS-SYSTEM; NF-KAPPA-B; ANTIGEN-PRESENTING CELLS; FRACTALKINE RECEPTOR; MYELOID CELLS; T-CELLS; ACTIVATION; MACROPHAGES; MONOCYTES; ENCEPHALOMYELITIS	Microglia are brain macrophages and, as such, key immune-competent cells that can respond to environmental changes. Understanding the mechanisms of microglia-specific responses during pathologies is hence vital for reducing disease burden. The definition of microglial functions has so far been hampered by the lack of genetic in vivo approaches that allow discrimination of microglia from closely related peripheral macrophage populations in the body. Here we introduce a mouse experimental system that specifically targets microglia to examine the role of a mitogen-associated protein kinase kinase kinase (MAP3K), transforming growth factor (TGF)-beta-activated kinase 1 (TAK1), during autoimmune inflammation. Conditional depletion of TAK1 in microglia only, not in neuroectodermal cells, suppressed disease, significantly reduced CNS inflammation and diminished axonal and myelin damage by cell-autonomous inhibition of the NE-kappa B, JNK and ERK1/2 pathways. Thus, we found TAK1 to be pivotal in CNS autoimmunity, and we present a tool for future investigations of microglial function in the CNS.	[Goldmann, Tobias; Wieghofer, Peter; Mueller, Philippe F.; Brendecke, Stefanie M.; Kierdorf, Katrin; Staszewski, Ori; Datta, Moumita; Prinz, Marco] Univ Freiburg, Inst Neuropathol, D-79106 Freiburg, Germany; [Wieghofer, Peter] Univ Freiburg, Fac Biol, D-79106 Freiburg, Germany; [Wolf, Yochai; Varol, Diana; Yona, Simon; Jung, Steffen] Weizmann Inst Sci, Dept Immunol, IL-76100 Rehovot, Israel; [Luedde, Tom] Univ Hosp Rhein Westfal TH Aachen, Dept Internal Med 3, Aachen, Germany; [Heikenwalder, Mathias] Tech Univ Munich, Helmholtz Zentrum Munchen, Inst Virol, D-80290 Munich, Germany; [Prinz, Marco] Univ Freiburg, BIOSS Ctr Biol Signalling Studies, D-79106 Freiburg, Germany	University of Freiburg; University of Freiburg; Weizmann Institute of Science; RWTH Aachen University; RWTH Aachen University Hospital; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Technical University of Munich; University of Freiburg	Prinz, M (corresponding author), Univ Freiburg, Inst Neuropathol, Hugstetter Str 55, D-79106 Freiburg, Germany.	s.jung@weizmann.ac.il; marco.prinz@uniklinik-freiburg.de	Datta, Moumita/AAU-8006-2021; Wieghofer, Peter/AAV-9572-2020; Heikenwalder, Mathias/AAA-2269-2020; Luedde, Tom/AAE-9135-2022; Yona, Simon/ABE-6572-2020; Jung, Steffen/K-1409-2012; Kierdorf, Katrin/AAO-6288-2021	Luedde, Tom/0000-0002-6288-8821; Jung, Steffen/0000-0003-4290-5716; Yona, Simon/0000-0002-3984-2008; Goldmann, Tobias/0000-0001-9754-9144; Kierdorf, Katrin/0000-0002-9272-4780; Staszewski, Ori/0000-0002-0579-6701; Wolf, Yochai/0000-0003-0270-2025; Pohlmann, Philippe-Fabian/0000-0001-8578-7452	Bundesministerium fur Bildung und Forschung; Deutsche Forschungsgemeinschaft [SFB 992, FOR1336, PR 577/8-1]; Fritz-Thyssen Foundation; Gemeinnutzige Hertie Foundation (GHST); Biogen Idec; Helmholtz Foundation; European Research Council; Helmholtz Alliance Preclinical Comprehensive Cancer Center; Israel Science Foundation;  [SFB620];  [SFB-TR36]	Bundesministerium fur Bildung und Forschung(Federal Ministry of Education & Research (BMBF)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Fritz-Thyssen Foundation; Gemeinnutzige Hertie Foundation (GHST); Biogen Idec(Biogen); Helmholtz Foundation(Helmholtz Association); European Research Council(European Research Council (ERC)European Commission); Helmholtz Alliance Preclinical Comprehensive Cancer Center; Israel Science Foundation(Israel Science Foundation); ; 	We thank M. Oberle, C. Fix and S. Gaupp for excellent technical assistance. Special thanks to M. Olschewski for help with the thorough statistical analysis of our data. M.P. was supported by the Bundesministerium fur Bildung und Forschung-funded competence network of multiple sclerosis (KKNMS), the competence network of neurodegenerative disorders (KNDD), the Deutsche Forschungsgemeinschaft (SFB 992, FOR1336, PR 577/8-1), the Fritz-Thyssen Foundation, the Gemeinnutzige Hertie Foundation (GHST) and Biogen Idec. P.F.M. was supported by an MD educational grant of the SFB620. M.H. was funded by the Helmholtz Foundation, the SFB-TR36, a European Research Council starting grant and the Helmholtz Alliance Preclinical Comprehensive Cancer Center. S.J. was supported by the Deutsche Forschungsgemeinschaft (FOR1336) and by the Israel Science Foundation.	Adhikari A, 2007, ONCOGENE, V26, P3214, DOI 10.1038/sj.onc.1210413; Ajami B, 2007, NAT NEUROSCI, V10, P1538, DOI 10.1038/nn2014; Ajibade AA, 2012, IMMUNITY, V36, P43, DOI 10.1016/j.immuni.2011.12.010; Becher B, 2001, J EXP MED, V193, P967, DOI 10.1084/jem.193.8.967; Bettermann K, 2010, CANCER CELL, V17, P481, DOI 10.1016/j.ccr.2010.03.021; Cardona AE, 2006, NAT NEUROSCI, V9, P917, DOI 10.1038/nn1715; Derecki NC, 2012, NATURE, V484, P105, DOI 10.1038/nature10907; DIGHE AS, 1995, IMMUNITY, V3, P657, DOI 10.1016/1074-7613(95)90136-1; Flugel A, 2001, J NEUROSCI RES, V66, P74, DOI 10.1002/jnr.1198; FORD AL, 1995, J IMMUNOL, V154, P4309; Geissmann F, 2003, IMMUNITY, V19, P71, DOI 10.1016/S1074-7613(03)00174-2; Ginhoux F, 2010, SCIENCE, V330, P841, DOI 10.1126/science.1194637; Hanisch UK, 2002, GLIA, V40, P140, DOI 10.1002/glia.10161; Heppner FL, 2005, NAT MED, V11, P146, DOI 10.1038/nm1177; Jung S, 2000, MOL CELL BIOL, V20, P4106, DOI 10.1128/MCB.20.11.4106-4114.2000; Jung S, 2002, IMMUNITY, V17, P211, DOI 10.1016/S1074-7613(02)00365-5; Karin M, 2009, IMMUNOL REV, V228, P225, DOI 10.1111/j.1600-065X.2008.00755.x; Kerschensteiner M, 2003, ANN NEUROL, V53, P292, DOI 10.1002/ana.10446; Kierdorf K, 2013, NAT NEUROSCI, V16, P273, DOI 10.1038/nn.3318; Kim KW, 2011, BLOOD, V118, pE156, DOI 10.1182/blood-2011-04-348946; Marin-Teva JL, 2004, NEURON, V41, P535, DOI 10.1016/S0896-6273(04)00069-8; Matyszak MK, 1999, EUR J IMMUNOL, V29, P3063, DOI 10.1002/(SICI)1521-4141(199910)29:10<3063::AID-IMMU3063>3.0.CO;2-G; Mildner A, 2007, NAT NEUROSCI, V10, P1544, DOI 10.1038/nn2015; Mildner A, 2009, BRAIN, V132, P2487, DOI 10.1093/brain/awp144; Paolicelli RC, 2011, SCIENCE, V333, P1456, DOI 10.1126/science.1202529; Pfrieger FW, 2012, GLIA, V60, P681, DOI 10.1002/glia.22283; Prinz M, 2011, GLIA, V59, P177, DOI 10.1002/glia.21104; Raasch J, 2011, BRAIN, V134, P1184, DOI 10.1093/brain/awq359; Rajasekaran K, 2011, J BIOL CHEM, V286, P31213, DOI 10.1074/jbc.M111.261917; Ransohoff RM, 2010, NATURE, V468, P253, DOI 10.1038/nature09615; Ransohoff RM, 2009, ANNU REV IMMUNOL, V27, P119, DOI 10.1146/annurev.immunol.021908.132528; Rong LL, 2004, FASEB J, V18, P1818, DOI 10.1096/fj.04-1900com; Sakurai H, 2012, TRENDS PHARMACOL SCI, V33, P522, DOI 10.1016/j.tips.2012.06.007; Sato S, 2005, NAT IMMUNOL, V6, P1087, DOI 10.1038/ni1255; Schulz C, 2012, SCIENCE, V336, P86, DOI 10.1126/science.1219179; Schwartz M, 2001, J NEUROIMMUNOL, V113, P185, DOI 10.1016/S0165-5728(00)00447-1; Sheppard KA, 1999, MOL CELL BIOL, V19, P6367; Siao CJ, 2003, J NEUROSCI, V23, P3234; Steinman L, 2002, ANNU REV NEUROSCI, V25, P491, DOI 10.1146/annurev.neuro.25.112701.142913; Tang MH, 2008, J EXP MED, V205, P1611, DOI 10.1084/jem.20080297; Town T, 2008, NAT MED, V14, P681, DOI 10.1038/nm1781; Tremblay ME, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000527; ULVESTAD E, 1994, J LEUKOCYTE BIOL, V56, P732, DOI 10.1002/jlb.56.6.732; van Loo G, 2006, NAT IMMUNOL, V7, P954, DOI 10.1038/ni1372; Wang YY, 2012, P NATL ACAD SCI USA, V109, pE343, DOI 10.1073/pnas.1115635109; Yona S, 2013, IMMUNITY, V38, P79, DOI 10.1016/j.immuni.2012.12.001; Zehntner SP, 2003, FASEB J, V17, P1910, DOI 10.1096/fj.03-0199fje	47	442	446	4	74	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	NOV	2013	16	11					1618	1626		10.1038/nn.3531	http://dx.doi.org/10.1038/nn.3531			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	241YX	24077561				2022-12-28	WOS:000326205700019
J	Jia, JM; Zhao, J; Hu, ZH; Lindberg, D; Li, Z				Jia, Jie-Min; Zhao, Jun; Hu, Zhonghua; Lindberg, Daniel; Li, Zheng			Age-dependent regulation of synaptic connections by dopamine D2 receptors	NATURE NEUROSCIENCE			English	Article							DENDRITIC SPINE DENSITY; CORTICAL PYRAMIDAL NEURONS; ENTORHINAL CORTEX; ANTIPSYCHOTIC-DRUGS; PREFRONTAL CORTEX; SCHIZOPHRENIA; MECHANISMS; PHOSPHORYLATION; INHIBITION; PLASTICITY	Dopamine D2 receptors (D2R) are G protein-coupled receptors that modulate synaptic transmission and are important for various brain functions, including learning and working memory. Abnormal D2R signaling has been implicated in psychiatric disorders such as schizophrenia. Here we report a new function of D2R in dendritic spine morphogenesis. Activation of D2R reduced spine number via GluN2B- and cAMP-dependent mechanisms in mice. Notably, this regulation occurred only during adolescence. During this period, D2R overactivation caused by mutations in the schizophrenia risk gene Dtnbp1 led to spine deficiency, dysconnectivity in the entorhinal-hippocampal circuit and impairment of spatial working memory. Notably, these defects could be ameliorated by D2R blockers administered during adolescence. Our findings suggest an age-dependent function of D2R in spine development, provide evidence that D2R dysfunction during adolescence impairs neuronal circuits and working memory, and indicate that adolescent interventions to prevent aberrant D2R activity protect against cognitive impairment.	[Jia, Jie-Min; Zhao, Jun; Hu, Zhonghua; Lindberg, Daniel; Li, Zheng] NIMH, Unit Synapse Dev & Plast, US NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH)	Li, Z (corresponding author), NIMH, Unit Synapse Dev & Plast, US NIH, Bethesda, MD 20892 USA.	lizheng2@mail.nih.gov	Zhao, Jun/AGS-2355-2022; Li, Zheng/I-8016-2014; Hu, Zhonghua/HIR-8712-2022; Jia, Jie-Min/O-1150-2013; Hu, Zhonghua/J-1169-2016; Hu, Zhonghua/F-9493-2014	Zhao, Jun/0000-0003-3663-1595; Li, Zheng/0000-0002-2978-2531; Hu, Zhonghua/0000-0002-0117-7081; Jia, Jie-Min/0000-0001-8446-3819; Hu, Zhonghua/0000-0002-0117-7081; 	National Institute of Mental Health [ZIA MH002281]; NATIONAL INSTITUTE OF MENTAL HEALTH [Z01MH002281, ZIAMH002881] Funding Source: NIH RePORTER	National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank H. Arnheiter (NINDS/NIH) for critical discussion of the manuscript and E.J. Sherman for editing the manuscript. This work was supported by the Intramural Research Program of the National Institute of Mental Health (ZIA MH002281 to Z.L.).	Andersen P., 2007, HIPPOCAMPUS BOOK; Arranz MJ, 2007, MOL PSYCHIATR, V12, P707, DOI 10.1038/sj.mp.4002009; BALK JH, 1995, NATURE, V377, P424; Beazely MA, 2006, J NEUROCHEM, V98, P1657, DOI 10.1111/j.1471-4159.2006.04064.x; Bonci A, 2005, NEURON, V47, P335, DOI 10.1016/j.neuron.2005.07.015; Bourne JN, 2008, ANNU REV NEUROSCI, V31, P47, DOI 10.1146/annurev.neuro.31.060407.125646; Boyer C, 1998, J NEUROSCI, V18, P5294, DOI 10.1523/JNEUROSCI.18-14-05294.1998; Brennand KJ, 2011, NATURE, V473, P221, DOI 10.1038/nature09915; Chen XW, 2008, J CELL BIOL, V181, P791, DOI 10.1083/jcb.200711021; CHO YH, 1995, NEUROBIOL LEARN MEM, V64, P285, DOI 10.1006/nlme.1995.0011; DRAGO J, 1994, P NATL ACAD SCI USA, V91, P12564, DOI 10.1073/pnas.91.26.12564; Fox J, 2007, MOUSE BIOMEDICAL RES, DOI DOI 10.1016/B978-012369454-6/50094-7; Garey LJ, 1998, J NEUROL NEUROSUR PS, V65, P446, DOI 10.1136/jnnp.65.4.446; Giovanni G.D., 2008, SERITONIN DOPAMINE I; Glantz LA, 2000, ARCH GEN PSYCHIAT, V57, P65, DOI 10.1001/archpsyc.57.1.65; Glazer WM, 1999, J CLIN PSYCHIAT, V60, P42; Green MF, 2007, ANNU REV CLIN PSYCHO, V3, P159, DOI 10.1146/annurev.clinpsy.3.022806.091529; Hakansson K, 2006, J NEUROCHEM, V96, P482, DOI 10.1111/j.1471-4159.2005.03558.x; Harris KM, 1999, CURR OPIN NEUROBIOL, V9, P343, DOI 10.1016/S0959-4388(99)80050-6; Hasselmo ME, 2006, TRENDS COGN SCI, V10, P487, DOI 10.1016/j.tics.2006.09.005; Howes OD, 2009, SCHIZOPHRENIA BULL, V35, P549, DOI 10.1093/schbul/sbp006; Iizuka Y, 2007, J NEUROSCI, V27, P12390, DOI 10.1523/JNEUROSCI.1689-07.2007; Jaaro-Peled H, 2009, TRENDS NEUROSCI, V32, P485, DOI 10.1016/j.tins.2009.05.007; Ji YY, 2009, P NATL ACAD SCI USA, V106, P19593, DOI 10.1073/pnas.0904289106; Ji YY, 2005, NAT NEUROSCI, V8, P164, DOI 10.1038/nn1381; Kolluri N, 2005, AM J PSYCHIAT, V162, P1200, DOI 10.1176/appi.ajp.162.6.1200; Kolomeets NS, 2005, SYNAPSE, V57, P47, DOI 10.1002/syn.20153; Kotecha SA, 2002, NEURON, V35, P1111, DOI 10.1016/S0896-6273(02)00859-0; Lewis DA, 2002, ANNU REV NEUROSCI, V25, P409, DOI 10.1146/annurev.neuro.25.112701.142754; Li YC, 2009, J NEUROSCI, V29, P15551, DOI 10.1523/JNEUROSCI.3336-09.2009; Li Z, 2003, NAT REV MOL CELL BIO, V4, P833, DOI 10.1038/nrm1242; Liu XY, 2006, NEURON, V52, P897, DOI 10.1016/j.neuron.2006.10.011; Meltzer HY, 2011, CURR OPIN PHARMACOL, V11, P59, DOI 10.1016/j.coph.2011.02.007; Miyamoto S, 2005, MOL PSYCHIATR, V10, P79, DOI 10.1038/sj.mp.4001556; Nagai T, 2002, NAT BIOTECHNOL, V20, P87, DOI 10.1038/nbt0102-87; Papaleo F, 2012, MOL PSYCHIATR, V17, P85, DOI 10.1038/mp.2010.106; PETERS A, 1970, AM J ANAT, V127, P321, DOI 10.1002/aja.1001270402; Schultz H, 2012, J NEUROSCI, V32, P4716, DOI 10.1523/JNEUROSCI.5126-11.2012; Stephan KE, 2006, BIOL PSYCHIAT, V59, P929, DOI 10.1016/j.biopsych.2005.10.005; Suh J, 2011, SCIENCE, V334, P1415, DOI 10.1126/science.1210125; Talbot K, 2009, PROG BRAIN RES, V179, P87, DOI 10.1016/S0079-6123(09)17910-4; Tau GZ, 2010, NEUROPSYCHOPHARMACOL, V35, P147, DOI 10.1038/npp.2009.115; Traynelis SF, 2010, PHARMACOL REV, V62, P405, DOI 10.1124/pr.109.002451; Tseng KY, 2004, J NEUROSCI, V24, P5131, DOI 10.1523/JNEUROSCI.1021-04.2004; Wang HD, 2009, BRAIN RES, V1300, P58, DOI 10.1016/j.brainres.2009.09.008; XU M, 1994, CELL, V79, P729, DOI 10.1016/0092-8674(94)90557-6; Yuste R, 2004, NAT REV NEUROSCI, V5, P24, DOI 10.1038/nrn1300	47	62	62	2	33	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	NOV	2013	16	11					1627	1636		10.1038/nn.3542	http://dx.doi.org/10.1038/nn.3542			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	241YX	24121738	Green Accepted			2022-12-28	WOS:000326205700020
J	Barron, HC; Dolan, RJ; Behrens, TEJ				Barron, Helen C.; Dolan, Raymond J.; Behrens, Timothy E. J.			Online evaluation of novel choices by simultaneous representation of multiple memories	NATURE NEUROSCIENCE			English	Article							ORBITOFRONTAL CORTEX; EPISODIC MEMORY; DECISION-MAKING; MECHANISMS; HIPPOCAMPAL; PREDICTION; REPETITION; SUPPORTS; REMEMBER; FUTURE	Prior experience is critical for decision-making. It enables explicit representation of potential outcomes and provides training to valuation mechanisms. However, we can also make choices in the absence of prior experience by merely imagining the consequences of a new experience. Using functional magnetic resonance imaging repetition suppression in humans, we examined how neuronal representations of novel rewards can be constructed and evaluated. A likely novel experience was constructed by invoking multiple independent memories in hippocampus and medial prefrontal cortex. This construction persisted for only a short time period, during which new associations were observed between the memories for component items. Together, these findings suggest that, in the absence of direct experience, coactivation of multiple relevant memories can provide a training signal to the valuation system that allows the consequences of new experiences to be imagined and acted on.	[Barron, Helen C.; Dolan, Raymond J.; Behrens, Timothy E. J.] UCL, Inst Neurol, Wellcome Trust Ctr Neuroimaging, London, England; [Behrens, Timothy E. J.] Univ Oxford, Oxford Ctr Funct Magnet Resonance Imaging Brain, Oxford, England	University of London; University College London; University of Oxford	Barron, HC (corresponding author), UCL, Inst Neurol, Wellcome Trust Ctr Neuroimaging, London, England.	helen.barron.10@ucl.ac.uk; behrens@fmrib.ox.ac.uk		Dolan, Ray/0000-0001-9356-761X; Behrens, Timothy/0000-0003-0048-1177	Wellcome Trust [WT088312AIA, 098362/Z/12/Z, 091593/Z/10/Z]; Medical Research Council [G1000411]	Wellcome Trust(Wellcome Trust); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank P. Dayan, E.A. Maguire, N. Burgess, S.W. Kennerley, L.T. Hunt, M.C. Klein-Flugge and E.D. Boorman for helpful comments on an earlier draft of the manuscript, and H. Blumenthal's Fat Duck Cookbook for recipe inspiration. This study was supported by the Wellcome Trust (grant WT088312AIA to T.E.J.B. and a Senior Investigator Award to R.J.D., 098362/Z/12/Z), the Medical Research Council (grant G1000411 to H.C.B.). The Wellcome Trust Centre for Neuroimaging is supported by core funding from the Wellcome Trust Strategic Award Grant 091593/Z/10/Z.	Addis DR, 2007, NEUROPSYCHOLOGIA, V45, P1363, DOI 10.1016/j.neuropsychologia.2006.10.016; Balleine BW, 1998, NEUROPHARMACOLOGY, V37, P407, DOI 10.1016/S0028-3908(98)00033-1; BECKER GM, 1964, BEHAV SCI, V9, P226, DOI 10.1002/bs.3830090304; Behrens TEJ, 2008, NATURE, V456, P245, DOI 10.1038/nature07538; Boorman ED, 2009, NEURON, V62, P733, DOI 10.1016/j.neuron.2009.05.014; Buckner RL, 2010, ANNU REV PSYCHOL, V61, P27, DOI 10.1146/annurev.psych.60.110707.163508; Davachi L, 2006, CURR OPIN NEUROBIOL, V16, P693, DOI 10.1016/j.conb.2006.10.012; Daw ND, 2011, NEURON, V69, P1204, DOI 10.1016/j.neuron.2011.02.027; Daw ND, 2005, NAT NEUROSCI, V8, P1704, DOI 10.1038/nn1560; Desimone R, 1996, P NATL ACAD SCI USA, V93, P13494, DOI 10.1073/pnas.93.24.13494; Doeller CF, 2008, P NATL ACAD SCI USA, V105, P5909, DOI 10.1073/pnas.0711433105; Doeller CF, 2010, NATURE, V463, P657, DOI 10.1038/nature08704; Dragoi G, 2011, NATURE, V469, P397, DOI 10.1038/nature09633; FitzGerald THB, 2009, J NEUROSCI, V29, P8388, DOI 10.1523/JNEUROSCI.0717-09.2009; Gershman SJ, 2014, J EXP PSYCHOL GEN, V143, P182, DOI 10.1037/a0030844; Glascher J, 2010, NEURON, V66, P585, DOI 10.1016/j.neuron.2010.04.016; Grill-Spector K, 2006, TRENDS COGN SCI, V10, P14, DOI 10.1016/j.tics.2005.11.006; Hampton AN, 2006, J NEUROSCI, V26, P8360, DOI 10.1523/JNEUROSCI.1010-06.2006; Harris A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021074; Hassabis D, 2007, J NEUROSCI, V27, P14365, DOI 10.1523/JNEUROSCI.4549-07.2007; Hassabis D, 2007, TRENDS COGN SCI, V11, P299, DOI 10.1016/j.tics.2007.05.001; Hunt LT, 2012, NAT NEUROSCI, V15, P470, DOI 10.1038/nn.3017; Janowski V, 2013, SOC COGN AFFECT NEUR, V8, P201, DOI 10.1093/scan/nsr086; Jocham G, 2012, NAT NEUROSCI, V15, P960, DOI 10.1038/nn.3140; Johnson A, 2005, NEURAL NETWORKS, V18, P1163, DOI 10.1016/j.neunet.2005.08.009; Johnson A, 2007, CURR OPIN NEUROBIOL, V17, P692, DOI 10.1016/j.conb.2008.01.003; Johnson A, 2007, J NEUROSCI, V27, P12176, DOI 10.1523/JNEUROSCI.3761-07.2007; Jones JL, 2012, SCIENCE, V338, P953, DOI 10.1126/science.1227489; Kable JW, 2007, NAT NEUROSCI, V10, P1625, DOI 10.1038/nn2007; Kable JW, 2009, NEURON, V63, P733, DOI 10.1016/j.neuron.2009.09.003; Klein SB, 2002, SOC COGNITION, V20, P353, DOI 10.1521/soco.20.5.353.21125; Klein-Flugge MC, 2013, J NEUROSCI, V33, P3202, DOI 10.1523/JNEUROSCI.2532-12.2013; Kohn A, 2007, J NEUROPHYSIOL, V97, P3155, DOI 10.1152/jn.00086.2007; Kourtzi Z, 2001, SCIENCE, V293, P1506, DOI 10.1126/science.1061133; Kumaran D, 2009, NEURON, V63, P889, DOI 10.1016/j.neuron.2009.07.030; Levy I, 2011, J NEUROSCI, V31, P118, DOI 10.1523/JNEUROSCI.3214-10.2011; McDannald MA, 2012, EUR J NEUROSCI, V35, P991, DOI 10.1111/j.1460-9568.2011.07982.x; Nicolle A, 2012, NEURON, V75, P1114, DOI 10.1016/j.neuron.2012.07.023; Peters J, 2010, NEURON, V66, P138, DOI 10.1016/j.neuron.2010.03.026; Plassmann H, 2007, J NEUROSCI, V27, P9984, DOI 10.1523/JNEUROSCI.2131-07.2007; RUDY JW, 1989, BEHAV BRAIN RES, V34, P97, DOI 10.1016/S0166-4328(89)80093-2; Schacter DL, 2007, PHILOS T R SOC B, V362, P773, DOI 10.1098/rstb.2007.2087; Schacter DL, 2007, NATURE, V445, P27, DOI 10.1038/445027a; Steiner AP, 2012, FRONT NEUROSCI-SWITZ, V6, DOI 10.3389/fnins.2012.00131; Summerfield C, 2008, NAT NEUROSCI, V11, P1004, DOI 10.1038/nn.2163; Sutton R.S., 1990, P 7 INT C MACH LEARN, V216, P224; TOLMAN EC, 1948, PSYCHOL REV, V55, P189, DOI 10.1037/h0061626; Wiggs CL, 1998, CURR OPIN NEUROBIOL, V8, P227, DOI 10.1016/S0959-4388(98)80144-X; Wimmer GE, 2012, SCIENCE, V338, P270, DOI 10.1126/science.1223252; Zeithamova D, 2012, NEURON, V75, P168, DOI 10.1016/j.neuron.2012.05.010	50	148	148	2	41	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	OCT	2013	16	10					1492	+		10.1038/nn.3515	http://dx.doi.org/10.1038/nn.3515			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	223HM	24013592	Green Accepted, Green Published			2022-12-28	WOS:000324795300023
J	Lee, S; Song, B; Kim, J; Park, K; Hong, I; An, B; Song, S; Lee, J; Park, S; Kim, J; Park, D; Lee, CJ; Kim, K; Shin, KS; Tsien, RW; Choi, S				Lee, Sukwon; Song, Beomjong; Kim, Jeongyeon; Park, Kyungjoon; Hong, Ingie; An, Bobae; Song, Sangho; Lee, Jiwon; Park, Sungmo; Kim, Jihye; Park, Dongeun; Lee, C. Justin; Kim, Kyungjin; Shin, Ki Soon; Tsien, Richard W.; Choi, Sukwoo			GluA1 phosphorylation at serine 831 in the lateral amygdala is required for fear renewal	NATURE NEUROSCIENCE			English	Article							LONG-TERM POTENTIATION; DEPENDENT NEURONAL-ACTIVITY; AMPA RECEPTOR ENDOCYTOSIS; SYNAPTIC PLASTICITY; CONDITIONED FEAR; GLUTAMATE RECEPTORS; CHANNEL CONDUCTANCE; KINASE-II; EXTINCTION; MEMORY	Fear renewal, a widely pursued model of post-traumatic stress disorder and phobias, refers to the context-specific relapse of conditioned fear after extinction. However, its molecular mechanisms are largely unknown. We found that renewal-inducing stimuli, generally believed to be insufficient to induce synaptic plasticity, enhanced excitatory synaptic strength, activity of synaptic GluA2-lacking AMPA receptors and Ser831 phosphorylation of synaptic surface GluA1 in the lateral nucleus of the amygdala (LAn) of fear-extinguished rats. Consistently, the induction threshold for LAn synaptic potentiation was considerably lowered after extinction, and renewal occluded this low-threshold potentiation. The low-threshold potentiation (a potential cellular substrate for renewal), but not long-term potentiation, was attenuated by dialysis into LAn neurons of a GluA1-derived peptide that competes with Ser831-phosphorylated GluA1. Microinjections of the same peptide into the LAn attenuated fear renewal, but not fear learning. Our findings suggest that GluA1 phosphorylation constitutes a promising target for clinical treatment of aberrant fear-related disorders.	[Lee, Sukwon; Song, Beomjong; Hong, Ingie; An, Bobae; Song, Sangho; Lee, Jiwon; Park, Sungmo; Kim, Jihye; Park, Dongeun; Kim, Kyungjin; Choi, Sukwoo] Seoul Natl Univ, Coll Nat Sci, Sch Biol Sci, Seoul 151742, South Korea; [Kim, Jeongyeon; Lee, C. Justin] Korea Inst Sci & Technol, Ctr Neural Sci, Seoul, South Korea; [Kim, Jeongyeon; Lee, C. Justin] Korea Inst Sci & Technol, Ctr Funct Connect, Seoul, South Korea; [Park, Kyungjoon; Shin, Ki Soon] Kyung Hee Univ, Dept Biol, Seoul, South Korea; [Park, Kyungjoon; Shin, Ki Soon] Kyung Hee Univ, Dept Life & Nanopharmaceut Sci, Seoul, South Korea; [Tsien, Richard W.] NYU, Langone Med Ctr, Inst Neurosci, Dept Physiol & Neurosci, New York, NY USA	Seoul National University (SNU); Korea Institute of Science & Technology (KIST); Korea Institute of Science & Technology (KIST); Kyung Hee University; Kyung Hee University; New York University; NYU Langone Medical Center	Choi, S (corresponding author), Seoul Natl Univ, Coll Nat Sci, Sch Biol Sci, Seoul 151742, South Korea.	kyungjin@snu.ac.kr; kisoon_shin@khu.ac.kr; sukwoo12@snu.ac.kr	Park, Kyungjoon/AAL-8086-2020; Lee, C. Justin/AAC-1663-2019; Shin, Ki Soon/AAK-1939-2020; Lee, Sukwon/I-7375-2013	Park, Kyungjoon/0000-0002-7518-636X; Shin, Ki Soon/0000-0002-5701-3596; Lee, Sukwon/0000-0001-7654-5769; Hong, Ingie/0000-0002-7246-9233; Song, Beomjong/0000-0001-8820-7310; Lee, C Justin/0000-0002-3555-0980; Park, Sung Mo/0000-0001-8352-3533	National Research Foundation of Korea; Ministry of Education, Science and Technology [2011-0018209, 2011-0019226]; Original Technology Research Program for Brain Science through the National Research Foundation of Korea; Korean World Class Institute program; Brain Korea 21 Research Fellowships from the Korean Ministry of Education	National Research Foundation of Korea(National Research Foundation of Korea); Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea); Original Technology Research Program for Brain Science through the National Research Foundation of Korea(National Research Foundation of Korea); Korean World Class Institute program; Brain Korea 21 Research Fellowships from the Korean Ministry of Education(Ministry of Education (MOE), Republic of Korea)	This paper is dedicated in loving memory to Sang-Soon Choi. We thank P. Sah for his valuable comments on our manuscript. This work was supported by a National Research Foundation of Korea grant funded by the Ministry of Education, Science and Technology (No. 2011-0018209, S.C.), by the Original Technology Research Program for Brain Science through the National Research Foundation of Korea funded by the Ministry of Education, Science and Technology (No. 2011-0019226, S.C.) and by the Korean World Class Institute program (C.J.L.). B.S., Jeongyeon Kim, K.P., I.H., B.A., S.S., J.L., S.P. and Jihye Kim were supported by Brain Korea 21 Research Fellowships from the Korean Ministry of Education.	Abraham WC, 1996, TRENDS NEUROSCI, V19, P126, DOI 10.1016/S0166-2236(96)80018-X; Ahmadian G, 2004, EMBO J, V23, P1040, DOI 10.1038/sj.emboj.7600126; Amano T, 2011, J NEUROSCI, V31, P15481, DOI 10.1523/JNEUROSCI.3410-11.2011; Anglada-Figueroa D, 2005, J NEUROSCI, V25, P9680, DOI 10.1523/JNEUROSCI.2600-05.2005; Boehm J, 2006, NEURON, V51, P213, DOI 10.1016/j.neuron.2006.06.013; Bouton ME, 2006, BIOL PSYCHIAT, V60, P352, DOI 10.1016/j.biopsych.2005.12.015; BOUTON ME, 1988, BEHAV RES THER, V26, P137, DOI 10.1016/0005-7967(88)90113-1; BOWIE D, 1995, NEURON, V15, P453, DOI 10.1016/0896-6273(95)90049-7; Chung HJ, 2000, J NEUROSCI, V20, P7258; Corcoran KA, 2001, J NEUROSCI, V21, P1720, DOI 10.1523/JNEUROSCI.21-05-01720.2001; Crombag HS, 2008, BEHAV BRAIN RES, V191, P178, DOI 10.1016/j.bbr.2008.03.026; Dalton GL, 2008, NEUROPSYCHOPHARMACOL, V33, P2416, DOI 10.1038/sj.npp.1301642; Derkach V, 1999, P NATL ACAD SCI USA, V96, P3269, DOI 10.1073/pnas.96.6.3269; Derkach VA, 2007, NAT REV NEUROSCI, V8, P101, DOI 10.1038/nrn2055; Dunah AW, 2001, J NEUROSCI, V21, P5546, DOI 10.1523/JNEUROSCI.21-15-05546.2001; Gale GD, 2004, J NEUROSCI, V24, P3810, DOI 10.1523/JNEUROSCI.4100-03.2004; Gogolla N, 2009, SCIENCE, V325, P1258, DOI 10.1126/science.1174146; Hermans D, 2006, BIOL PSYCHIAT, V60, P361, DOI 10.1016/j.biopsych.2005.10.006; Herry C, 2008, NATURE, V454, P600, DOI 10.1038/nature07166; Hobin JA, 2003, J NEUROSCI, V23, P8410; Hu HL, 2007, CELL, V131, P160, DOI 10.1016/j.cell.2007.09.017; Kessels HW, 2009, NAT NEUROSCI, V12, P888, DOI 10.1038/nn.2340; Kim J, 2007, P NATL ACAD SCI USA, V104, P20955, DOI 10.1073/pnas.0710548105; Kim J, 2007, BIOCHEM BIOPH RES CO, V355, P188, DOI 10.1016/j.bbrc.2007.01.125; Kim J, 2010, J NEUROSCI, V30, P9631, DOI 10.1523/JNEUROSCI.0940-10.2010; Kindt M, 2009, NAT NEUROSCI, V12, P256, DOI 10.1038/nn.2271; Knapska E, 2009, LEARN MEMORY, V16, P486, DOI 10.1101/lm.1463909; Kristensen AS, 2011, NAT NEUROSCI, V14, P727, DOI 10.1038/nn.2804; LeDoux JE, 2000, ANNU REV NEUROSCI, V23, P155, DOI 10.1146/annurev.neuro.23.1.155; Lee HK, 2010, J NEUROPHYSIOL, V103, P479, DOI 10.1152/jn.00835.2009; Lee HK, 2003, CELL, V112, P631, DOI 10.1016/S0092-8674(03)00122-3; Lee HK, 2000, NATURE, V405, P955, DOI 10.1038/35016089; Lin CH, 2003, MOL PHARMACOL, V63, P44, DOI 10.1124/mol.63.1.44; MALINOW R, 1990, NATURE, V346, P177, DOI 10.1038/346177a0; Mao SC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059580; Maren S, 2005, NEURON, V47, P783, DOI 10.1016/j.neuron.2005.08.009; Maren S, 2004, NAT REV NEUROSCI, V5, P844, DOI 10.1038/nrn1535; Maren S, 2007, LEARN MEMORY, V14, P318, DOI 10.1101/lm.477007; Maren S, 2011, NEURON, V70, P830, DOI 10.1016/j.neuron.2011.04.023; Monfils MH, 2009, SCIENCE, V324, P951, DOI 10.1126/science.1167975; Myers KM, 2002, NEURON, V36, P567, DOI 10.1016/S0896-6273(02)01064-4; Oh MC, 2006, J BIOL CHEM, V281, P752, DOI 10.1074/jbc.M509677200; Orsini CA, 2011, J NEUROSCI, V31, P17269, DOI 10.1523/JNEUROSCI.4095-11.2011; Otmakhov N, 1997, J NEUROSCI, V17, P5357; Pare D, 2004, J NEUROPHYSIOL, V92, P1, DOI 10.1152/jn.00153.2004; Paxinos G., 1998, RAT BRAIN STEROTAXIC; Pitkanen A, 1997, TRENDS NEUROSCI, V20, P517, DOI 10.1016/S0166-2236(97)01125-9; RACHMAN S, 1989, CLIN PSYCHOL REV, V9, P147, DOI 10.1016/0272-7358(89)90025-1; Rodrigues SM, 2004, J NEUROSCI, V24, P3281, DOI 10.1523/JNEUROSCI.5303-03.2004; Selvakumar B, 2013, P NATL ACAD SCI USA, V110, P1077, DOI 10.1073/pnas.1221295110; Shepherd JD, 2007, ANNU REV CELL DEV BI, V23, P613, DOI 10.1146/annurev.cellbio.23.090506.123516; Sotres-Bayon F, 2004, LEARN MEMORY, V11, P525, DOI 10.1101/lm.79504; Whitlock JR, 2006, SCIENCE, V313, P1093, DOI 10.1126/science.1128134; Woods AM, 2006, BEHAV NEUROSCI, V120, P1159, DOI 10.1037/0735-7044.120.5.1159	54	35	36	0	13	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	OCT	2013	16	10					1436	+		10.1038/nn.3491	http://dx.doi.org/10.1038/nn.3491			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	223HM	23974710				2022-12-28	WOS:000324795300016
J	Leinwand, SG; Chalasani, SH				Leinwand, Sarah G.; Chalasani, Sreekanth H.			Neuropeptide signaling remodels chemosensory circuit composition in Caenorhabditis elegans	NATURE NEUROSCIENCE			English	Article							SENSORY NEURONS; LIFE-SPAN; INSULIN; CHEMOTAXIS; GENE; MODULATION; BEHAVIOR; CELL; IDENTIFICATION; INHIBITION	Neural circuits detect environmental changes and drive behavior. The routes of information flow through dense neural networks are dynamic, but the mechanisms underlying this circuit flexibility are poorly understood. Here, we define a sensory context-dependent and neuropeptide-regulated switch in the composition of a C. elegans salt sensory circuit. The primary salt detectors, ASE sensory neurons, used BLI-4 endoprotease-dependent cleavage to release the insulin-like peptide INS-6 in response to large, but not small, changes in external salt stimuli. Insulins, signaling through the insulin receptor DAF-2, functionally switched the AWC olfactory sensory neuron into an interneuron in the salt circuit. Worms with disrupted insulin signaling had deficits in salt attraction, suggesting that peptidergic signaling potentiates responses to high salt stimuli, which may promote ion homeostasis. Our results indicate that sensory context and neuropeptide signaling modify neural networks and suggest general mechanisms for generating flexible behavioral outputs by modulating neural circuit composition.	[Leinwand, Sarah G.; Chalasani, Sreekanth H.] Univ Calif San Diego, Grad Program Neurosci, La Jolla, CA 92093 USA; [Leinwand, Sarah G.; Chalasani, Sreekanth H.] Salk Inst Biol Studies, Mol Neurobiol Lab, La Jolla, CA 92037 USA	University of California System; University of California San Diego; Salk Institute	Chalasani, SH (corresponding author), Univ Calif San Diego, Grad Program Neurosci, La Jolla, CA 92093 USA.	schalasani@salk.edu		Leinwand, Sarah/0000-0001-5328-0462	Searle Scholars Program; March of Dimes; Whitehall Foundation; Rita Allen Foundation; US National Institutes of Health [R01MH096881-01A1]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH096881] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [T32NS061847] Funding Source: NIH RePORTER	Searle Scholars Program; March of Dimes(March of Dimes); Whitehall Foundation; Rita Allen Foundation; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank the Caenorhabditis Genetics Center, the National Brain Research Project (Japan), C. Bargmann, P. Sengupta, P. Sternberg and A. Zaslaver for worm strains, M. Ailion for unc-31 cDNA, and Y. Jin, C. Stevens, T. Sejnowski, E.J. Chichilnisky and H. Karten for helpful discussions. We also acknowledge J. Fitzpatrick and J. Kasuboski of the Waitt Advanced Biophotonics Center for providing the resources and training to perform confocal imaging and J. Simon for help with the illustrations. We are grateful to A. Tong, C. Yang and other members of the Chalasani laboratory for critical help, advice and insights. This work was funded by grants from The Searle Scholars Program, March of Dimes, Whitehall Foundation, Rita Allen Foundation and US National Institutes of Health grant R01MH096881-01A1 (S.H.C.). S.G.L. holds a graduate research fellowship from the NSF.	Aburto NJ, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f1326; Baldridge WH, 1998, SEMIN CELL DEV BIOL, V9, P311, DOI 10.1006/scdb.1998.0235; BARGMANN CI, 1991, NEURON, V7, P729, DOI 10.1016/0896-6273(91)90276-6; Bargmann CI., 2006, WORMBOOK, P1, DOI [10.1895/wormbook.1.123.1, DOI 10.1895/WORMBOOK.1.123.1]; Beverly M, 2011, J NEUROSCI, V31, P11718, DOI 10.1523/JNEUROSCI.1098-11.2011; BRENNER S, 1974, GENETICS, V77, P71; Chalasani SH, 2007, NATURE, V450, P63, DOI 10.1038/nature06292; Chalasani SH, 2010, NAT NEUROSCI, V13, P615, DOI 10.1038/nn.2526; Chandrashekar J, 2010, NATURE, V464, P297, DOI 10.1038/nature08783; Chen BL, 2006, P NATL ACAD SCI USA, V103, P4723, DOI 10.1073/pnas.0506806103; Chen ZN, 2013, NEURON, V77, P572, DOI 10.1016/j.neuron.2012.11.025; Chronis N, 2007, NAT METHODS, V4, P727, DOI 10.1038/NMETH1075; Clark DA, 2006, J NEUROSCI, V26, P7444, DOI 10.1523/JNEUROSCI.1137-06.2006; Collet J, 1998, GENETICS, V148, P187; de Bono M, 2005, ANNU REV NEUROSCI, V28, P451, DOI 10.1146/annurev.neuro.27.070203.144259; DICKINSON PS, 1990, NATURE, V344, P155, DOI 10.1038/344155a0; DORMAN JB, 1995, GENETICS, V141, P1399; Esposito G, 2007, GENE, V395, P170, DOI 10.1016/j.gene.2007.03.002; Gracheva EO, 2007, J PHYSIOL-LONDON, V585, P705, DOI 10.1113/jphysiol.2007.138321; HOOPER SL, 1989, SCIENCE, V244, P1587, DOI 10.1126/science.2740903; Hua QX, 2003, GENE DEV, V17, P826, DOI 10.1101/gad.1058003; Hung WL, 2013, EMBO J, V32, P1745, DOI 10.1038/emboj.2013.91; Husson SJ, 2006, J NEUROCHEM, V98, P1999, DOI 10.1111/j.1471-4159.2006.04014.x; Kauffman AL, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000372; Kimura KD, 1997, SCIENCE, V277, P942, DOI 10.1126/science.277.5328.942; Klockener T, 2011, NAT NEUROSCI, V14, P911, DOI 10.1038/nn.2847; Lee RYN, 1999, J NEUROSCI, V19, P159, DOI 10.1523/JNEUROSCI.19-01-00159.1999; Li Chris, 2008, WormBook, P1, DOI 10.1895/wormbook.1.142.1; Markov NT, 2014, CEREB CORTEX, V24, P17, DOI 10.1093/cercor/bhs270; Murakami H, 2005, J NEUROSCI, V25, P10894, DOI 10.1523/JNEUROSCI.3600-04.2005; Qi YCB, 2012, P NATL ACAD SCI USA, V109, P7499, DOI 10.1073/pnas.1204096109; Ramot D, 2008, NAT NEUROSCI, V11, P908, DOI 10.1038/nn.2157; Richmond Janet E, 2006, WormBook, P1, DOI 10.1895/wormbook.1.112.1; Richmond JE, 1999, NAT NEUROSCI, V2, P791, DOI 10.1038/12160; Root CM, 2008, NEURON, V59, P311, DOI 10.1016/j.neuron.2008.07.003; Savigner A, 2009, J NEUROPHYSIOL, V101, P2898, DOI 10.1152/jn.91169.2008; Speese S, 2007, J NEUROSCI, V27, P6150, DOI 10.1523/JNEUROSCI.1466-07.2007; Su CY, 2012, NATURE, V492, P66, DOI 10.1038/nature11712; Suzuki H, 2008, NATURE, V454, P114, DOI 10.1038/nature06927; Taguchi A, 2008, ANNU REV PHYSIOL, V70, P191, DOI 10.1146/annurev.physiol.70.113006.100533; Thacker C, 2006, CELL MOL LIFE SCI, V63, P1193, DOI 10.1007/s00018-006-6012-z; THACKER C, 1995, GENE DEV, V9, P956, DOI 10.1101/gad.9.8.956; Thiele TR, 2009, J NEUROSCI, V29, P11904, DOI 10.1523/JNEUROSCI.0594-09.2009; Tissenbaum HA, 2012, J GERONTOL A-BIOL, V67, P503, DOI 10.1093/gerona/gls088; Tomioka M, 2006, NEURON, V51, P613, DOI 10.1016/j.neuron.2006.07.024; Touhara K, 2009, ANNU REV PHYSIOL, V71, P307, DOI 10.1146/annurev.physiol.010908.163209; Uchida O, 2003, DEVELOPMENT, V130, P1215, DOI 10.1242/dev.00341; WARD S, 1973, P NATL ACAD SCI USA, V70, P817, DOI 10.1073/pnas.70.3.817; WEIMANN JM, 1991, J NEUROPHYSIOL, V65, P111, DOI 10.1152/jn.1991.65.1.111; WEIMANN JM, 1994, CURR BIOL, V4, P896, DOI 10.1016/S0960-9822(00)00199-8; Wes PD, 2001, NATURE, V410, P698, DOI 10.1038/35070581; WHITE JG, 1986, PHILOS T R SOC B, V314, P1, DOI 10.1098/rstb.1986.0056; Xia XB, 2004, VISUAL NEUROSCI, V21, P791, DOI 10.1017/S0952523804215127	53	59	64	0	27	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	OCT	2013	16	10					1461	+		10.1038/nn.3511	http://dx.doi.org/10.1038/nn.3511			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	223HM	24013594	Green Accepted			2022-12-28	WOS:000324795300019
J	Zhang, YV; Raghuwanshi, RP; Shen, WL; Montell, C				Zhang, Yali V.; Raghuwanshi, Rakesh P.; Shen, Wei L.; Montell, Craig			Food experience-induced taste desensitization modulated by the Drosophila TRPL channel	NATURE NEUROSCIENCE			English	Article							RECEPTOR POTENTIAL CHANNEL; ANGELMAN-SYNDROME; GUSTATORY SYSTEM; BINDING PROTEIN; BITTER TASTE; IN-VIVO; GENE; PLASTICITY; PHOTOTRANSDUCTION; ADAPTATION	Animals tend to reject bitter foods. However, long-term exposure to some unpalatable tastants increases acceptance of these foods. Here we show that dietary exposure to an unappealing but safe additive, camphor, caused the fruit fly Drosophila melanogaster to decrease camphor rejection. The transient receptor potential-like (TRPL) cation channel was a direct target for camphor in gustatory receptor neurons, and long-term feeding on a camphor diet led to reversible downregulation of TRPL protein concentrations. The turnover of TRPL was controlled by an E3 ubiquitin ligase, Ube3a. The decline in TRPL levels and increased acceptance of camphor reversed after returning the flies to a camphor-free diet long term. We propose that dynamic regulation of taste receptors by ubiquitin-mediated protein degradation comprises an important molecular mechanism that allows an animal to alter its taste behavior in response to a changing food environment.	[Zhang, Yali V.; Raghuwanshi, Rakesh P.; Shen, Wei L.; Montell, Craig] Johns Hopkins Univ, Sch Med, Dept Biol Chem, Baltimore, MD 21205 USA; [Montell, Craig] Univ Calif Santa Barbara, Neurosci Res Inst, Santa Barbara, CA 93106 USA; [Montell, Craig] Univ Calif Santa Barbara, Dept Mol Cellular & Dev Biol, Santa Barbara, CA 93106 USA	Johns Hopkins University; University of California System; University of California Santa Barbara; University of California System; University of California Santa Barbara	Montell, C (corresponding author), Johns Hopkins Univ, Sch Med, Dept Biol Chem, Baltimore, MD 21205 USA.	craig.montell@lifesci.ucsb.edu	Montell, Craig/AAH-3357-2021; Raghuwanshi, Rakesh/AAS-3918-2020	Montell, Craig/0000-0001-5637-1482; Zhang, Yali/0000-0003-4083-4352	US National Institute on Deafness and Other Communication Disorders [DC007864]; US National Eye Institute [EY010852]; NATIONAL EYE INSTITUTE [R01EY010852] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC007864] Funding Source: NIH RePORTER	US National Institute on Deafness and Other Communication Disorders(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); US National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	We thank J. Fischer (University of Texas at Austin), K. Scott (University of California, Berkeley) and the Bloomington Stock Center for providing fly stocks, FlyBase for genomic information and B. Minke (Hebrew University, Jerusalem) for the pMT-trpl-eGFP construct. This work was supported by grants to C.M. from the US National Institute on Deafness and Other Communication Disorders (DC007864) and the US National Eye Institute (EY010852).	Ackroff K, 2012, PHYSIOL BEHAV, V107, P207, DOI 10.1016/j.physbeh.2012.06.022; BLOOMQUIST BT, 1988, CELL, V54, P723, DOI 10.1016/S0092-8674(88)80017-5; Colbert HA, 1997, J NEUROSCI, V17, P8259; Cooke L, 2007, J HUM NUTR DIET, V20, P294, DOI 10.1111/j.1365-277X.2007.00804.x; COSENS DJ, 1969, NATURE, V224, P285, DOI 10.1038/224285a0; Dahanukar A, 2001, NAT NEUROSCI, V4, P1182, DOI 10.1038/nn765; del Campo ML, 2009, INSECT TASTE, P205; DiAntonio A, 2001, NATURE, V412, P449, DOI 10.1038/35086595; Donlea JM, 2009, SCIENCE, V324, P105, DOI 10.1126/science.1166657; Eddison M, 2011, NEURON, V70, P979, DOI 10.1016/j.neuron.2011.03.030; Elkobi A, 2008, NAT NEUROSCI, V11, P1149, DOI 10.1038/nn.2190; Fischler W, 2007, NATURE, V448, P1054, DOI 10.1038/nature06101; Foeller E, 2004, CURR OPIN NEUROBIOL, V14, P89, DOI 10.1016/j.conb.2004.01.011; Galindo MM, 2012, PROG MOL BIOL TRANSL, V108, P383, DOI 10.1016/B978-0-12-398397-8.00015-0; Gerber B, 2009, RESULTS PROBL CELL D, V47, P139, DOI 10.1007/400_2008_9; GLENDINNING JI, 1994, PHYSIOL BEHAV, V56, P1217, DOI 10.1016/0031-9384(94)90369-7; Glendinning JI, 2001, J EXP BIOL, V204, P3355; HARDIE RC, 1992, NEURON, V8, P643, DOI 10.1016/0896-6273(92)90086-S; Hegde AN, 2010, LEARN MEMORY, V17, P314, DOI 10.1101/lm.1504010; HU YF, 1994, BIOCHEM BIOPH RES CO, V201, P1050, DOI 10.1006/bbrc.1994.1808; Jansen G, 2002, EMBO J, V21, P986, DOI 10.1093/emboj/21.5.986; Jeong YT, 2013, NEURON, V79, P725, DOI 10.1016/j.neuron.2013.06.025; Kang K, 2010, NATURE, V464, P597, DOI 10.1038/nature08848; Kim J, 2003, NATURE, V424, P81, DOI 10.1038/nature01733; Kim SH, 2010, P NATL ACAD SCI USA, V107, P8440, DOI 10.1073/pnas.1001425107; Kwon Y, 2008, NAT NEUROSCI, V11, P871, DOI 10.1038/nn.2170; Kwon Y, 2010, CURR BIOL, V20, P1672, DOI 10.1016/j.cub.2010.08.016; Lee T, 1999, NEURON, V22, P451, DOI 10.1016/S0896-6273(00)80701-1; Lee Y, 2005, NAT GENET, V37, P305, DOI 10.1038/ng1513; Lu YB, 2009, HUM MOL GENET, V18, P454, DOI 10.1093/hmg/ddn373; Masek P, 2010, P NATL ACAD SCI USA, V107, P14833, DOI 10.1073/pnas.1009318107; Mennella JA, 2012, ANN NUTR METAB, V60, P40, DOI 10.1159/000335337; Meunier N, 2003, J NEUROBIOL, V56, P139, DOI 10.1002/neu.10235; MONTELL C, 1989, NEURON, V2, P1313, DOI 10.1016/0896-6273(89)90069-X; Montell C, 2009, CURR OPIN NEUROBIOL, V19, P345, DOI 10.1016/j.conb.2009.07.001; Moon SJ, 2006, CURR BIOL, V16, P1812, DOI 10.1016/j.cub.2006.07.024; Moon SJ, 2009, CURR BIOL, V19, P1623, DOI 10.1016/j.cub.2009.07.061; Niemeyer BA, 1996, CELL, V85, P651, DOI 10.1016/S0092-8674(00)81232-5; Parnas M, 2009, CELL CALCIUM, V45, P300, DOI 10.1016/j.ceca.2008.11.009; PHILLIPS AM, 1992, NEURON, V8, P631, DOI 10.1016/0896-6273(92)90085-R; Ramsey IS, 2006, ANNU REV PHYSIOL, V68, P619, DOI 10.1146/annurev.physiol.68.040204.100431; SCOTT K, 1995, NEURON, V15, P919, DOI 10.1016/0896-6273(95)90182-5; Shuler MG, 2004, J COMP NEUROL, V472, P183, DOI 10.1002/cne.11017; Thorne N, 2004, CURR BIOL, V14, P1065, DOI 10.1016/j.cub.2004.05.019; Tracey WD, 2003, CELL, V113, P261, DOI 10.1016/S0092-8674(03)00272-1; Venkatachalam K, 2007, ANNU REV BIOCHEM, V76, P387, DOI 10.1146/annurev.biochem.75.103004.142819; Venkatachalam K, 2008, CELL, V135, P838, DOI 10.1016/j.cell.2008.09.041; Vosshall LB, 2007, ANNU REV NEUROSCI, V30, P505, DOI 10.1146/annurev.neuro.30.051606.094306; Wang T, 2005, J CELL BIOL, V171, P685, DOI 10.1083/jcb.200508030; Wang ZR, 2004, CELL, V117, P981, DOI 10.1016/j.cell.2004.06.011; Watnick TJ, 2003, CURR BIOL, V13, P2179, DOI 10.1016/S0960-9822(03)00913-8; Watts RJ, 2003, NEURON, V38, P871, DOI 10.1016/S0896-6273(03)00295-2; Weiss LA, 2011, NEURON, V69, P258, DOI 10.1016/j.neuron.2011.01.001; Wu Y, 2008, P NATL ACAD SCI USA, V105, P12399, DOI 10.1073/pnas.0805291105; Xu XZS, 1997, CELL, V89, P1155, DOI 10.1016/S0092-8674(00)80302-5; Yang YF, 2003, NEURON, V37, P911, DOI 10.1016/S0896-6273(03)00143-0; Zhang YQ, 2002, GENESIS, V34, P142, DOI 10.1002/gene.10144	57	53	55	1	35	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	OCT	2013	16	10					1468	+		10.1038/nn.3513	http://dx.doi.org/10.1038/nn.3513			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	223HM	24013593	Green Accepted, Green Submitted			2022-12-28	WOS:000324795300020
J	Brigman, JL; Daut, RA; Wright, T; Gunduz-Cinar, O; Graybeal, C; Davis, MI; Jiang, ZH; Saksida, LM; Jinde, S; Pease, M; Bussey, TJ; Lovinger, DM; Nakazawa, K; Holmes, A				Brigman, Jonathan L.; Daut, Rachel A.; Wright, Tara; Gunduz-Cinar, Ozge; Graybeal, Carolyn; Davis, Margaret I.; Jiang, Zhihong; Saksida, Lisa M.; Jinde, Seiichiro; Pease, Matthew; Bussey, Timothy J.; Lovinger, David M.; Nakazawa, Kazu; Holmes, Andrew			GluN2B in corticostriatal circuits governs choice learning and choice shifting	NATURE NEUROSCIENCE			English	Article							MEDIAL PREFRONTAL CORTEX; RECEPTOR NR2A SUBUNIT; LONG-TERM DEPRESSION; NMDA RECEPTORS; DORSOMEDIAL STRIATUM; BASAL-GANGLIA; MICE LACKING; BEHAVIORAL FLEXIBILITY; ORBITOFRONTAL CORTEX; SYNAPTIC PLASTICITY	A choice that reliably produces a preferred outcome can be automated to liberate cognitive resources for other tasks. Should an outcome become less desirable, behavior must adapt in parallel or it becomes perseverative. Corticostriatal systems are known to mediate choice learning and flexibility, but the molecular mechanisms of these processes are not well understood. We integrated mouse behavioral, immunocytochemical, in vivo electrophysiological, genetic and pharmacological approaches to study choice. We found that the dorsal striatum (DS) was increasingly activated with choice learning, whereas reversal of learned choice engaged prefrontal regions. In vivo, DS neurons showed activity associated with reward anticipation and receipt that emerged with learning and relearning. Corticostriatal or striatal deletion of Grin2b (encoding the NMDA-type glutamate receptor subunit GluN2B) or DS-restricted GluN2B antagonism impaired choice learning, whereas cortical Grin2b deletion or OFC GluN2B antagonism impaired shifting. Our convergent data demonstrate how corticostriatal GluN2B circuits govern the ability to learn and shift choice behavior.	[Brigman, Jonathan L.; Daut, Rachel A.; Wright, Tara; Gunduz-Cinar, Ozge; Graybeal, Carolyn; Pease, Matthew; Holmes, Andrew] NIAAA, Lab Behav & Genom Neurosci, NIH, Bethesda, MD USA; [Davis, Margaret I.; Lovinger, David M.] NIAAA, Lab Integrat Neurosci, NIH, Bethesda, MD USA; [Jiang, Zhihong; Jinde, Seiichiro; Nakazawa, Kazu] NIMH, Unit Genet Cognit & Behav, NIH, Bethesda, MD 20892 USA; [Saksida, Lisa M.; Bussey, Timothy J.] Univ Cambridge, Dept Expt Psychol, Cambridge CB2 3EB, England; [Saksida, Lisa M.; Bussey, Timothy J.] MRC, Cambridge, England; [Saksida, Lisa M.; Bussey, Timothy J.] Wellcome Trust Behav & Clin Neurosci Inst, Cambridge, England	National Institutes of Health (NIH) - USA; NIH National Institute on Alcohol Abuse & Alcoholism (NIAAA); National Institutes of Health (NIH) - USA; NIH National Institute on Alcohol Abuse & Alcoholism (NIAAA); National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH); University of Cambridge; University of Cambridge	Holmes, A (corresponding author), NIAAA, Lab Behav & Genom Neurosci, NIH, Bethesda, MD USA.	andrew.holmes@mail.nih.gov	Saksida, Lisa M/M-2753-2016; Brigman, Jonathan/O-4978-2016; Bussey, Timothy J/M-2758-2016; Nakazawa, Kazutoshi/J-6195-2015; Gunduz Cinar, Ozge/E-5756-2010	Saksida, Lisa M/0000-0002-8416-8171; Bussey, Timothy J/0000-0001-7518-4041; Nakazawa, Kazutoshi/0000-0001-5699-9093; Davis, Margaret/0000-0002-0489-8351; Gunduz Cinar, Ozge/0000-0002-3826-8905	NIAAA Intramural Research Program; Wellcome Trust; National Institute of Mental Health Intramural Research Program; NATIONAL INSTITUTE OF MENTAL HEALTH [ZIAMH002895] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [K22AA020303, ZIAAA000411, ZIAAA000416] Funding Source: NIH RePORTER; Medical Research Council [G1000183B, G0001354B, G0001354] Funding Source: researchfish	NIAAA Intramural Research Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); Wellcome Trust(Wellcome TrustEuropean Commission); National Institute of Mental Health Intramural Research Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We are very grateful to G. Schoenbaum and A. Kravitz for discussions of the in vivo recording results and to G. Luo for mutant genotyping. J.L.B., C.G., T.W., M.I.D., R.A.D., M.P., O.G.-C., D.M.L. and A.H. were supported by the NIAAA Intramural Research Program. L. M. S. and T.J.B. were supported by The Wellcome Trust. Z.J. and K.N. were supported by the National Institute of Mental Health Intramural Research Program.	Alexander WH, 2011, NAT NEUROSCI, V14, P1338, DOI 10.1038/nn.2921; Ashby FG, 2010, TRENDS COGN SCI, V14, P208, DOI 10.1016/j.tics.2010.02.001; Balleine BW, 2010, NEUROPSYCHOPHARMACOL, V35, P48, DOI 10.1038/npp.2009.131; Barnes TD, 2005, NATURE, V437, P1158, DOI 10.1038/nature04053; Bohn I, 2003, CEREB CORTEX, V13, P968, DOI 10.1093/cercor/13.9.968; Boyce-Rustay JM, 2006, PSYCHOPHARMACOLOGY, V187, P455, DOI 10.1007/s00213-006-0448-6; Brigman JL, 2008, LEARN MEMORY, V15, P50, DOI 10.1101/lm.777308; Brigman JL, 2010, CEREB CORTEX, V20, P1955, DOI 10.1093/cercor/bhp266; Brigman JL, 2010, J NEUROSCI, V30, P4590, DOI 10.1523/JNEUROSCI.0640-10.2010; Bussey TJ, 2012, NEUROPHARMACOLOGY, V62, P1191, DOI 10.1016/j.neuropharm.2011.04.011; CALABRESI P, 1992, J NEUROSCI, V12, P4224; Carli M, 2006, NEUROPSYCHOPHARMACOL, V31, P757, DOI 10.1038/sj.npp.1300893; Corbit LH, 2010, EUR J NEUROSCI, V31, P1312, DOI 10.1111/j.1460-9568.2010.07153.x; Costa RM, 2004, CURR BIOL, V14, P1124, DOI 10.1016/j.cub.2004.06.053; Dahlin E, 2008, SCIENCE, V320, P1510, DOI 10.1126/science.1155466; Dalton GL, 2008, NEUROPSYCHOPHARMACOL, V33, P2416, DOI 10.1038/sj.npp.1301642; Dang MT, 2006, P NATL ACAD SCI USA, V103, P15254, DOI 10.1073/pnas.0601758103; Dix S, 2010, PSYCHOPHARMACOLOGY, V212, P227, DOI 10.1007/s00213-010-1945-1; Duffy S, 2008, NEUROPSYCHOPHARMACOL, V33, P1004, DOI 10.1038/sj.npp.1301486; Erickson KI, 2007, CEREB CORTEX, V17, P192, DOI 10.1093/cercor/bhj137; Floresco SB, 2011, NEUROPSYCHOPHARMACOL, V36, P227, DOI 10.1038/npp.2010.158; Floresco SB, 2009, BEHAV BRAIN RES, V204, P396, DOI 10.1016/j.bbr.2008.12.001; Fukaya M, 2003, P NATL ACAD SCI USA, V100, P4855, DOI 10.1073/PNAS.0830996100; Gage GJ, 2010, NEURON, V67, P466, DOI 10.1016/j.neuron.2010.06.034; Graybeal C, 2011, NAT NEUROSCI, V14, P1507, DOI 10.1038/nn.2954; Graybiel AM, 2008, ANNU REV NEUROSCI, V31, P359, DOI 10.1146/annurev.neuro.29.051605.112851; Hefner K, 2008, J NEUROSCI, V28, P8074, DOI 10.1523/JNEUROSCI.4904-07.2008; Higgins GA, 2005, PSYCHOPHARMACOLOGY, V179, P85, DOI 10.1007/s00213-005-2203-9; Higgins GA, 2003, NEUROPHARMACOLOGY, V44, P324, DOI 10.1016/S0028-3908(02)00402-1; Holmes A, 2012, NAT NEUROSCI, V15, P1359, DOI 10.1038/nn.3204; Izquierdo A, 2006, BEHAV BRAIN RES, V171, P181, DOI 10.1016/j.bbr.2006.03.029; Jin X, 2010, NATURE, V466, P457, DOI 10.1038/nature09263; Karlsson RM, 2008, BIOL PSYCHIAT, V64, P810, DOI 10.1016/j.biopsych.2008.05.001; Karlsson RM, 2009, NEUROPSYCHOPHARMACOL, V34, P1578, DOI 10.1038/npp.2008.215; Kos T, 2011, PSYCHOPHARMACOLOGY, V214, P911, DOI 10.1007/s00213-010-2102-6; Kravitz AV, 2010, NATURE, V466, P622, DOI 10.1038/nature09159; Mainen ZF, 2009, CURR OPIN NEUROBIOL, V19, P84, DOI 10.1016/j.conb.2009.03.010; Middleton FA, 2002, CEREB CORTEX, V12, P926, DOI 10.1093/cercor/12.9.926; Montague PR, 2006, ANNU REV NEUROSCI, V29, P417, DOI 10.1146/annurev.neuro.29.051605.112903; Montague PR, 1996, J NEUROSCI, V16, P1936, DOI 10.1523/jneurosci.16-05-01936.1996; MONYER H, 1994, NEURON, V12, P529, DOI 10.1016/0896-6273(94)90210-0; Olesen PJ, 2004, NAT NEUROSCI, V7, P75, DOI 10.1038/nn1165; Parker JG, 2011, J NEUROSCI, V31, P11362, DOI 10.1523/JNEUROSCI.2411-11.2011; Pasupathy A, 2005, NATURE, V433, P873, DOI 10.1038/nature03287; Ragozzino ME, 2007, ANN NY ACAD SCI, V1121, P355, DOI 10.1196/annals.1401.013; Ryan TJ, 2013, NAT NEUROSCI, V16, P25, DOI 10.1038/nn.3277; Schoenbaum G, 2009, NAT REV NEUROSCI, V10, P885, DOI 10.1038/nrn2753; Schultz W, 2008, PHILOS T R SOC B, V363, P3801, DOI 10.1098/rstb.2008.0152; Tang CK, 2007, EUR J NEUROSCI, V25, P1212, DOI 10.1111/j.1460-9568.2007.05353.x; Tang YP, 1999, NATURE, V401, P63, DOI 10.1038/43432; Vanderschuren LJMJ, 2005, J NEUROSCI, V25, P8665, DOI 10.1523/JNEUROSCI.0925-05.2005; von Engelhardt J, 2008, NEURON, V60, P846, DOI 10.1016/j.neuron.2008.09.039; Wang LP, 2011, NEURON, V72, P1055, DOI 10.1016/j.neuron.2011.10.019; Wickens JR, 2007, J NEUROSCI, V27, P8181, DOI 10.1523/JNEUROSCI.1671-07.2007; Yin HH, 2006, NAT REV NEUROSCI, V7, P464, DOI 10.1038/nrn1919; Yin HH, 2009, NAT NEUROSCI, V12, P333, DOI 10.1038/nn.2261; Yin HH, 2005, EUR J NEUROSCI, V22, P505, DOI 10.1111/j.1460-9568.2005.04219.x	57	102	104	0	25	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	AUG	2013	16	8					1101	U176		10.1038/nn.3457	http://dx.doi.org/10.1038/nn.3457			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	190EV	23831965	Green Accepted			2022-12-28	WOS:000322323000021
J	Kramer, RH; Mourot, A; Adesnik, H				Kramer, Richard H.; Mourot, Alexandre; Adesnik, Hillel			Optogenetic pharmacology for control of native neuronal signaling proteins	NATURE NEUROSCIENCE			English	Review							OPTICAL CONTROL; ION CHANNELS; PHOTOCHEMICAL CONTROL; GLUTAMATE-RECEPTOR; VISUAL RESPONSES; DENDRITIC SPINES; CAGED GLUTAMATE; REMOTE-CONTROL; LIGHT; 2-PHOTON	The optical neuroscience revolution is transforming how we study neural circuits. By providing a precise way to manipulate endogenous neuronal signaling proteins, it also has the potential to transform our understanding of molecular neuroscience. Recent advances in chemical biology have produced light-sensitive compounds that photoregulate a wide variety of proteins underlying signaling between and within neurons. Chemical tools for optopharmacology include caged agonists and antagonists and reversibly photoswitchable ligands. These reagents act on voltage-gated ion channels and neurotransmitter receptors, enabling control of neuronal signaling with a high degree of spatial and temporal precision. By covalently attaching photoswitch molecules to genetically tagged proteins, the newly emerging methodology of optogenetic pharmacology allows biochemically precise control in targeted subsets of neurons. Now that the tools for manipulating endogenous neuronal signaling proteins are available, they can be implemented in vivo to enhance our understanding of the molecular bases of brain function and dysfunctions.	[Kramer, Richard H.; Adesnik, Hillel] Univ Calif Berkeley, Berkeley, CA 94720 USA; [Mourot, Alexandre] Univ Paris 06, CNRS, UMR 7102, Paris, France	University of California System; University of California Berkeley; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite	Kramer, RH (corresponding author), Univ Calif Berkeley, Berkeley, CA 94720 USA.	rhkramer@berkeley.edu	Mourot, Alexandre/H-4636-2013	Mourot, Alexandre/0000-0002-8839-7481	National Eye Institute; US National Institutes of Health; NATIONAL EYE INSTITUTE [P30EY003176] Funding Source: NIH RePORTER	National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by grants to R.H.K. from the National Eye Institute and the US National Institutes of Health.	Adesnik H, 2005, NEURON, V48, P977, DOI 10.1016/j.neuron.2005.11.030; Adesnik H, 2012, NATURE, V490, P226, DOI 10.1038/nature11526; Airan RD, 2009, NATURE, V458, P1025, DOI 10.1038/nature07926; Banghart M, 2004, NAT NEUROSCI, V7, P1381, DOI 10.1038/nn1356; Banghart MR, 2012, NEURON, V73, P249, DOI 10.1016/j.neuron.2011.11.016; Banghart MR, 2009, ANGEW CHEM INT EDIT, V48, P9097, DOI 10.1002/anie.200904504; Baranauskas G, 2003, NAT NEUROSCI, V6, P258, DOI 10.1038/nn1019; Bartos M, 2007, NAT REV NEUROSCI, V8, P45, DOI 10.1038/nrn2044; CALLAWAY EM, 1993, P NATL ACAD SCI USA, V90, P7661, DOI 10.1073/pnas.90.16.7661; Canepari M, 2001, J NEUROSCI METH, V112, P29, DOI 10.1016/S0165-0270(01)00451-4; Caporale N, 2011, MOL THER, V19, P1212, DOI 10.1038/mt.2011.103; Carter AG, 2004, NEURON, V44, P483, DOI 10.1016/j.neuron.2004.10.013; Carter ME, 2010, NAT NEUROSCI, V13, P1526, DOI 10.1038/nn.2682; Donaldson ZR, 2013, CURR OPIN NEUROBIOL, V23, P399, DOI 10.1016/j.conb.2013.01.011; Donato L, 2012, ANGEW CHEM INT EDIT, V51, P1840, DOI 10.1002/anie.201106559; Ellis-Davies GCR, 2011, ACS CHEM NEUROSCI, V2, P185, DOI 10.1021/cn100111a; Fehrentz T, 2011, ANGEW CHEM INT EDIT, V50, P12156, DOI 10.1002/anie.201103236; Feldbauer K, 2009, P NATL ACAD SCI USA, V106, P12317, DOI 10.1073/pnas.0905852106; Fenno L, 2011, ANNU REV NEUROSCI, V34, P389, DOI 10.1146/annurev-neuro-061010-113817; Fino E, 2009, FRONT NEURAL CIRCUIT, V3, DOI 10.3389/neuro.04.002.2009; Fortin DL, 2008, NAT METHODS, V5, P331, DOI [10.1038/NMETH.1187, 10.1038/nmeth.1187]; Fortin DL, 2011, J NEUROPHYSIOL, V106, P488, DOI 10.1152/jn.00251.2011; Howe JR, 1996, J NEUROPHYSIOL, V76, P510, DOI 10.1152/jn.1996.76.1.510; Kokel D, 2013, NAT CHEM BIOL, V9, P257, DOI [10.1038/NCHEMBIO.1183, 10.1038/nchembio.1183]; LESTER HA, 1980, J GEN PHYSIOL, V75, P207, DOI 10.1085/jgp.75.2.207; Levitz J., 2013, NAT NEUROSCI; Lutz C, 2008, NAT METHODS, V5, P821, DOI 10.1038/NMETH.1241; Matsuzaki M, 2001, NAT NEUROSCI, V4, P1086, DOI 10.1038/nn736; Mourot A, 2012, NAT METHODS, V9, P396, DOI [10.1038/NMETH.1897, 10.1038/nmeth.1897]; Mourot A, 2011, ACS CHEM NEUROSCI, V2, P536, DOI 10.1021/cn200037p; Muller K, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt002; Noguchi J, 2011, J PHYSIOL-LONDON, V589, P2447, DOI 10.1113/jphysiol.2011.207100; Palma-Cerda F, 2012, NEUROPHARMACOLOGY, V63, P624, DOI 10.1016/j.neuropharm.2012.05.010; Polosukhina A, 2012, NEURON, V75, P271, DOI 10.1016/j.neuron.2012.05.022; Royer S, 2012, NAT NEUROSCI, V15, P769, DOI 10.1038/nn.3077; Sandoz G, 2012, NEURON, V74, P1005, DOI 10.1016/j.neuron.2012.04.026; Schroder-Lang S, 2007, NAT METHODS, V4, P39, DOI 10.1038/NMETH975; Shepherd GMG, 2003, NEURON, V38, P277, DOI 10.1016/S0896-6273(03)00152-1; Stein M, 2012, ANGEW CHEM INT EDIT, V51, P10500, DOI 10.1002/anie.201205475; Strickland D, 2012, NAT METHODS, V9, P379, DOI [10.1038/NMETH.1904, 10.1038/nmeth.1904]; Stuber GD, 2010, J NEUROSCI, V30, P8229, DOI 10.1523/JNEUROSCI.1754-10.2010; Szobota S, 2007, NEURON, V54, P535, DOI 10.1016/j.neuron.2007.05.010; Tochitsky I, 2012, NAT CHEM, V4, P105, DOI [10.1038/NCHEM.1234, 10.1038/nchem.1234]; Verde EMR, 2008, FRONT NEURAL CIRCUIT, V2, DOI 10.3389/neuro.04.002.2008; Volgraf M, 2006, NAT CHEM BIOL, V2, P47, DOI 10.1038/nchembio756; Volgraf M, 2007, J AM CHEM SOC, V129, P260, DOI 10.1021/ja067269o; Wu YI, 2009, NATURE, V461, P104, DOI 10.1038/nature08241; Wyart C, 2009, NATURE, V461, P407, DOI 10.1038/nature08323; Yue L, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2094; Zhou XX, 2012, SCIENCE, V338, P810, DOI 10.1126/science.1226854	50	165	177	3	110	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUL	2013	16	7					816	823		10.1038/nn.3424	http://dx.doi.org/10.1038/nn.3424			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	174UM	23799474	Green Accepted			2022-12-28	WOS:000321180900011
J	Wilson, S; Bautista, D				Wilson, Sarah; Bautista, Diana			Itching for relief	NATURE NEUROSCIENCE			English	Editorial Material							NOCICEPTORS; PAIN	Little is known about the molecular and cellular mechanisms underlying acute and chronic itch. A new technique for silencing peripheral itch neurons defines two independent itch circuits that transmit signals to the CNS.	[Wilson, Sarah; Bautista, Diana] Univ Calif Berkeley, Dept Mol Cell Biol, Berkeley, CA 94720 USA; [Wilson, Sarah; Bautista, Diana] Univ Calif Berkeley, Helen Wills Neurosci Inst, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley	Wilson, S (corresponding author), Univ Calif Berkeley, Dept Mol Cell Biol, Berkeley, CA 94720 USA.	dbautista@berkeley.edu						Binshtok AM, 2007, NATURE, V449, P607, DOI 10.1038/nature06191; Davidson S, 2010, TRENDS NEUROSCI, V33, P550, DOI 10.1016/j.tins.2010.09.002; Han L, 2013, NAT NEUROSCI, V16, P174, DOI 10.1038/nn.3289; Ikoma A, 2006, NAT REV NEUROSCI, V7, P535, DOI 10.1038/nrn1950; Imamachi N, 2009, P NATL ACAD SCI USA, V106, P11330, DOI 10.1073/pnas.0905605106; Jeffry J, 2011, PHYSIOLOGY, V26, P286, DOI 10.1152/physiol.00007.2011; Liu Q, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001925; Liu Q, 2009, CELL, V139, P1353, DOI 10.1016/j.cell.2009.11.034; Liu Y, 2010, NEURON, V68, P543, DOI 10.1016/j.neuron.2010.09.008; Ma QF, 2010, J CLIN INVEST, V120, P3773, DOI 10.1172/JCI43426; Papoiu ADP, 2012, NEUROIMAGE, V59, P3611, DOI 10.1016/j.neuroimage.2011.10.099; Roberson DP, 2013, NAT NEUROSCI, V16, P910, DOI 10.1038/nn.3404; Wilson SR, 2011, NAT NEUROSCI, V14, P595, DOI 10.1038/nn.2789; Yosipovitch G., 2004, International Journal of Cosmetic Science, V26, P1, DOI 10.1111/j.0142-5463.2004.00199.x; Yosipovitch G, 2003, AM J CLIN DERMATOL, V4, P617, DOI 10.2165/00128071-200304090-00004	15	4	4	0	14	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JUL	2013	16	7					775	777		10.1038/nn.3442	http://dx.doi.org/10.1038/nn.3442			4	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	174UM	23799467				2022-12-28	WOS:000321180900004
J	Wang, XD; Su, YA; Wagner, KV; Avrabos, C; Scharf, SH; Hartmann, J; Wolf, M; Liebl, C; Kuhne, C; Wurst, W; Holsboer, F; Eder, M; Deussing, JM; Muller, MB; Schmidt, MV				Wang, Xiao-Dong; Su, Yun-Ai; Wagner, Klaus V.; Avrabos, Charilaos; Scharf, Sebastian H.; Hartmann, Jakob; Wolf, Miriam; Liebl, Claudia; Kuehne, Claudia; Wurst, Wolfgang; Holsboer, Florian; Eder, Matthias; Deussing, Jan M.; Mueller, Marianne B.; Schmidt, Mathias V.			Nectin-3 links CRHR1 signaling to stress-induced memory deficits and spine loss	NATURE NEUROSCIENCE			English	Article							CORTICOTROPIN-RELEASING HORMONE; EARLY-LIFE STRESS; ANXIETY-RELATED BEHAVIOR; CELL-ADHESION MOLECULES; COGNITIVE DEFICITS; DENDRITIC SPINES; RECEPTOR 1; HIPPOCAMPUS; MAINTENANCE; MECHANISMS	Stress impairs cognition via corticotropin-releasing hormone receptor 1 (CRHR1), but the molecular link between abnormal CRHR1 signaling and stress-induced cognitive impairments remains unclear. We investigated whether the cell adhesion molecule nectin-3 is required for the effects of CRHR1 on cognition and structural remodeling after early-life stress exposure. Postnatally stressed adult mice had decreased hippocampal nectin-3 levels, which could be attenuated by CRHR1 inactivation and mimicked by corticotropin-releasing hormone (CRH) overexpression in forebrain neurons. Acute stress dynamically reduced hippocampal nectin-3 levels, which involved CRH-CRHR1, but not glucocorticoid receptor, signaling. Suppression of hippocampal nectin-3 caused spatial memory deficits and dendritic spine loss, whereas enhancing hippocampal nectin-3 expression rescued the detrimental effects of early-life stress on memory and spine density in adulthood. Our findings suggest that hippocampal nectin-3 is necessary for the effects of stress on memory and structural plasticity and indicate that the CRH-CRHR1 system interacts with the nectin-afadin complex to mediate such effects.	[Wang, Xiao-Dong; Su, Yun-Ai; Wagner, Klaus V.; Avrabos, Charilaos; Scharf, Sebastian H.; Hartmann, Jakob; Wolf, Miriam; Liebl, Claudia; Kuehne, Claudia; Wurst, Wolfgang; Holsboer, Florian; Eder, Matthias; Deussing, Jan M.; Mueller, Marianne B.; Schmidt, Mathias V.] Max Planck Inst Psychiat, Munich, Germany; [Wurst, Wolfgang] Helmholtz Ctr Munich, German Res Ctr Environm Hlth, Inst Dev Genet, Neuherberg, Germany; [Wurst, Wolfgang] Tech Univ Munich, Lehrstuhl Entwicklungsgenet, Helmholtz Zentrum Munchen, Neuherberg, Germany; [Wurst, Wolfgang] Deutsch Zentrum Neurodegenerat Erkrankungen, Munich, Germany	Max Planck Society; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Technical University of Munich; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE)	Schmidt, MV (corresponding author), Max Planck Inst Psychiat, Munich, Germany.	mschmidt@mpipsykl.mpg.de	Müller, Marianne B./AAL-8911-2021; Wang, Xiao-Dong/A-9610-2010; Deussing, Jan M/ABB-5993-2021; Hartmann, Jakob/GPF-5919-2022	Müller, Marianne B./0000-0002-0269-6131; Wang, Xiao-Dong/0000-0001-7730-3710; Hartmann, Jakob/0000-0002-1960-8177; Eder, Matthias/0000-0002-2579-2628; Wurst, Wolfgang/0000-0003-4422-7410; Scharf, Sebastian/0000-0002-9129-4723; Deussing, Jan/0000-0002-9329-5252; SU, YUNAI/0000-0001-8445-9633; Schmidt, Mathias/0000-0002-3788-2268				Arikkath J, 2008, TRENDS NEUROSCI, V31, P487, DOI 10.1016/j.tins.2008.07.001; Beaudoin GMJ, 2012, J NEUROSCI, V32, P99, DOI 10.1523/JNEUROSCI.4565-11.2012; Brunson KL, 2005, J NEUROSCI, V25, P9328, DOI 10.1523/JNEUROSCI.2281-05.2005; Chen Y, 2013, MOL PSYCHIATR, V18, P485, DOI 10.1038/mp.2012.17; Chen YC, 2008, J NEUROSCI, V28, P2903, DOI 10.1523/JNEUROSCI.0225-08.2008; Chen Y, 2012, FRONT CELL NEUROSCI, V6, DOI 10.3389/fncel.2012.00013; Conrad Cheryl D, 2006, Behav Cogn Neurosci Rev, V5, P41, DOI 10.1177/1534582306289043; Dalva MB, 2007, NAT REV NEUROSCI, V8, P206, DOI 10.1038/nrn2075; Dumitriu D, 2011, NAT PROTOC, V6, P1391, DOI 10.1038/nprot.2011.389; Giagtzoglou N, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a003079; Heck N, 2012, BRAIN STRUCT FUNCT, V217, P421, DOI 10.1007/s00429-011-0340-y; Ivy AS, 2010, J NEUROSCI, V30, P13005, DOI 10.1523/JNEUROSCI.1784-10.2010; Kuhne C, 2012, J COMP NEUROL, V520, P3150, DOI 10.1002/cne.23082; Li YW, 2003, J PHARMACOL EXP THER, V305, P86, DOI 10.1124/jpet.102.045914; Lim ST, 2008, J COMP NEUROL, V507, P1228, DOI 10.1002/cne.21608; Lin YC, 2010, ANNU REV NEUROSCI, V33, P349, DOI 10.1146/annurev-neuro-060909-153204; Lu A, 2008, MOL PSYCHIATR, V13, P1028, DOI 10.1038/mp.2008.51; Lupien SJ, 2009, NAT REV NEUROSCI, V10, P434, DOI 10.1038/nrn2639; Majima T, 2009, BIOCHEM BIOPH RES CO, V385, P539, DOI 10.1016/j.bbrc.2009.05.097; Maras PM, 2012, TRENDS NEUROSCI, V35, P315, DOI 10.1016/j.tins.2012.01.005; Mizoguchi A, 2002, J CELL BIOL, V156, P555, DOI 10.1083/jcb.200103113; Muller MB, 2003, NAT NEUROSCI, V6, P1100, DOI 10.1038/nn1123; Parrish JZ, 2007, ANNU REV NEUROSCI, V30, P399, DOI 10.1146/annurev.neuro.29.051605.112907; Paxinos G., 2001, MOUSE BRAIN STEREOTA; Refojo D, 2005, P NATL ACAD SCI USA, V102, P6183, DOI 10.1073/pnas.0502070102; Refojo D, 2011, SCIENCE, V333, P1903, DOI 10.1126/science.1202107; Rice CJ, 2008, ENDOCRINOLOGY, V149, P4892, DOI 10.1210/en.2008-0633; Sandi C, 2004, NAT REV NEUROSCI, V5, P917, DOI 10.1038/nrn1555; Schmidt MV, 2011, P NATL ACAD SCI USA, V108, P17213, DOI 10.1073/pnas.1103318108; Schmidt MV, 2010, J NEUROSCI, V30, P16949, DOI 10.1523/JNEUROSCI.4668-10.2010; Schrick C, 2007, NEURON, V55, P786, DOI 10.1016/j.neuron.2007.07.034; Shapiro L, 2007, ANNU REV NEUROSCI, V30, P451, DOI 10.1146/annurev.neuro.29.051605.113034; Srivastava DP, 2012, J BIOL CHEM, V287, P35964, DOI 10.1074/jbc.M112.363358; Sudhof TC, 2008, NATURE, V455, P903, DOI 10.1038/nature07456; Suzuki K, 2000, NAT GENET, V25, P427, DOI 10.1038/78119; Tan ZJ, 2010, P NATL ACAD SCI USA, V107, P9873, DOI 10.1073/pnas.1003480107; Thompson CL, 2008, NEURON, V60, P1010, DOI 10.1016/j.neuron.2008.12.008; Togashi H, 2006, J CELL BIOL, V174, P141, DOI 10.1083/jcb.200601089; von Wolff G, 2011, J PSYCHIATR RES, V45, P256, DOI 10.1016/j.jpsychires.2010.06.007; Wagner KV, 2013, J NEUROSCI, V33, P3857, DOI 10.1523/JNEUROSCI.4333-12.2013; Wagner KV, 2012, NEUROPSYCHOPHARMACOL, V37, P2797, DOI 10.1038/npp.2012.150; Wang XD, 2012, EUR J NEUROSCI, V36, P2360, DOI 10.1111/j.1460-9568.2012.08148.x; Wang XD, 2011, J NEUROSCI, V31, P13625, DOI 10.1523/JNEUROSCI.2259-11.2011; Wang XD, 2011, NEUROBIOL DIS, V42, P300, DOI 10.1016/j.nbd.2011.01.020; Xie Z, 2008, J NEUROSCI, V28, P6079, DOI 10.1523/JNEUROSCI.1170-08.2008	46	89	93	0	19	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JUN	2013	16	6					706	+		10.1038/nn.3395	http://dx.doi.org/10.1038/nn.3395			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	152DE	23644483				2022-12-28	WOS:000319509600012
J	Lu, BX; Al-Ramahi, I; Valencia, A; Wang, Q; Berenshteyn, F; Yang, HD; Gallego-Flores, T; Ichcho, S; Lacoste, A; Hild, M; DiFiglia, M; Botas, J; Palacino, J				Lu, Boxun; Al-Ramahi, Ismael; Valencia, Antonio; Wang, Qiong; Berenshteyn, Frada; Yang, Haidi; Gallego-Flores, Tatiana; Ichcho, Salah; Lacoste, Arnaud; Hild, Marc; DiFiglia, Marian; Botas, Juan; Palacino, James			Identification of NUB1 as a suppressor of mutant Huntingtin toxicity via enhanced protein clearance	NATURE NEUROSCIENCE			English	Article							IN MOUSE MODEL; PROTEASOMAL DEGRADATION; DISEASE; CELLS; NEDD8; MODIFIERS; MOTOR; NEUROPATHOLOGY; INACTIVATION; PROTEOLYSIS	Huntington's disease is caused by expanded CAG repeats in HTT, conferring toxic gain of function on mutant HTT (mHTT) protein. Reducing mHTT amounts is postulated as a strategy for therapeutic intervention. We conducted genome-wide RNA interference screens for genes modifying mHTT abundance and identified 13 hits. We tested 10 in vivo in a Drosophila melanogaster Huntington's disease model, and 6 exhibited activity consistent with the in vitro screening results. Among these, negative regulator of ubiquitin-like protein 1 (NUB1) overexpression lowered mHTT in neuronal models and rescued mHTT-induced death. NUB1 reduces mHTT amounts by enhancing polyubiquitination and proteasomal degradation of mHTT protein. The process requires CUL3 and the ubiquitin-like protein NEDD8 necessary for CUL3 activation. As a potential approach to modulating NUB1 for treatment, interferon-beta lowered mHTT and rescued neuronal toxicity through induction of NUB1. Thus, we have identified genes modifying endogenous mHTT using high-throughput screening and demonstrate NUB1 as an exemplar entry point for therapeutic intervention of Huntington's disease.	[Lu, Boxun] Fudan Univ, Sch Life Sci, Shanghai 200433, Peoples R China; [Lu, Boxun; Wang, Qiong; Berenshteyn, Frada; Yang, Haidi; Ichcho, Salah; Lacoste, Arnaud; Hild, Marc; Palacino, James] Novartis Inst BioMed Res Inc, Dev & Mol Pathways, Cambridge, MA USA; [Al-Ramahi, Ismael; Gallego-Flores, Tatiana; Botas, Juan] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Al-Ramahi, Ismael; Gallego-Flores, Tatiana; Botas, Juan] Texas Childrens Hosp, Jan & Dan Duncan Neurol Res Inst, Houston, TX 77030 USA; [Valencia, Antonio; DiFiglia, Marian] Harvard Univ, Sch Med, Dept Neurol, Boston, MA 02115 USA; [Valencia, Antonio; DiFiglia, Marian] Massachusetts Gen Hosp, MassGen Inst Neurodegenerat Dis, Boston, MA 02114 USA	Fudan University; Novartis; Baylor College of Medicine; Baylor College of Medicine; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital	Palacino, J (corresponding author), Novartis Inst BioMed Res Inc, Dev & Mol Pathways, Cambridge, MA USA.	luboxun@fudan.edu.cn; james.palacino@novartis.com	Al-Ramahi, Ismael/B-4000-2017	Al-Ramahi, Ismael/0000-0002-1275-1114; Gallego, Tatiana/0000-0003-0773-0578	John J. Wasmuth postdoctoral fellowship from the Hereditary Disease Foundation; Hereditary Disease Foundation; US National Institutes of Health grant [NS074381]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [T32NS043124, R01NS074381] Funding Source: NIH RePORTER	John J. Wasmuth postdoctoral fellowship from the Hereditary Disease Foundation; Hereditary Disease Foundation; US National Institutes of Health grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The authors wish to thank D. Curtis for discussions and suggestions during the project, X. Shi for performing the control screening on SMN level changes, C. Mazur for assistance with cloning and sample processing, P. Manos and C. Littlefield for assistance with the hESC and human iPSC experiments, and E. Kim for assistance with the fly experiments. I.A. was funded by a John J. Wasmuth postdoctoral fellowship from the Hereditary Disease Foundation. A.V. was funded by the Hereditary Disease Foundation. M.D. was funded by US National Institutes of Health grant NS074381.	Al-Ramahi I, 2006, J BIOL CHEM, V281, P26714, DOI 10.1074/jbc.M601603200; Baldo B, 2012, CHEM BIOL, V19, P264, DOI 10.1016/j.chembiol.2011.12.020; Bauer PO, 2010, NAT BIOTECHNOL, V28, P256, DOI 10.1038/nbt.1608; Bauer PO, 2009, AUTOPHAGY, V5, P747, DOI 10.4161/auto.5.5.8704; Boudreau RL, 2009, MOL THER, V17, P1053, DOI 10.1038/mt.2009.17; BRAND AH, 1993, DEVELOPMENT, V118, P401; Cattaneo E, 2005, NAT REV NEUROSCI, V6, P919, DOI 10.1038/nrn1806; Chambers SM, 2009, NAT BIOTECHNOL, V27, P275, DOI 10.1038/nbt.1529; Chew EH, 2007, J BIOL CHEM, V282, P17032, DOI 10.1074/jbc.M701153200; DiFiglia M, 2007, P NATL ACAD SCI USA, V104, P17204, DOI 10.1073/pnas.0708285104; Doumanis J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007275; Drouet V, 2009, ANN NEUROL, V65, P276, DOI 10.1002/ana.21569; DUYAO MP, 1995, SCIENCE, V269, P407, DOI 10.1126/science.7618107; Filimonenko M, 2010, MOL CELL, V38, P265, DOI 10.1016/j.molcel.2010.04.007; Grondin R, 2012, BRAIN, V135, P1197, DOI 10.1093/brain/awr333; Gutekunst CA, 1999, J NEUROSCI, V19, P2522; Harper SQ, 2005, P NATL ACAD SCI USA, V102, P5820, DOI 10.1073/pnas.0501507102; HD iPSC Consortium, 2012, CELL STEM CELL, V11, P264, DOI 10.1016/j.stem.2012.04.027; Hipp MS, 2004, J BIOL CHEM, V279, P16503, DOI 10.1074/jbc.M310114200; Jana NR, 2005, J BIOL CHEM, V280, P11635, DOI 10.1074/jbc.M412042200; Kaltenbach LS, 2007, PLOS GENET, V3, P689, DOI 10.1371/journal.pgen.0030082; Kamitani T, 2001, J BIOL CHEM, V276, P46655, DOI 10.1074/jbc.M108636200; Kito K, 2001, J BIOL CHEM, V276, P20603, DOI 10.1074/jbc.M100920200; Ko J, 2001, BRAIN RES BULL, V56, P319, DOI 10.1016/S0361-9230(01)00599-8; Lacoste A, 2009, CELL STEM CELL, V5, P332, DOI 10.1016/j.stem.2009.07.011; Landles C, 2010, J BIOL CHEM, V285, P8808, DOI 10.1074/jbc.M109.075028; Liew CW, 2010, J CLIN INVEST, V120, P2876, DOI 10.1172/JCI36849; Lu BX, 2013, FASEB J, V27, P1820, DOI 10.1096/fj.12-219220; MACDONALD ME, 1993, CELL, V72, P971, DOI 10.1016/0092-8674(93)90585-E; MacDonald ME, 1996, COLD SPRING HARB SYM, V61, P627; Menalled LB, 2003, J COMP NEUROL, V465, P11, DOI 10.1002/cne.10776; Miller JP, 2010, NEURON, V67, P199, DOI 10.1016/j.neuron.2010.06.021; Nagashima Y, 2011, J BIOL CHEM, V286, P29594, DOI 10.1074/jbc.M111.261032; PATY DW, 1993, NEUROLOGY, V43, P662, DOI 10.1212/WNL.43.4.662; Rodriguez-Lebron E, 2005, MOL THER, V12, P618, DOI 10.1016/j.ymthe.2005.05.006; Rubinsztein David C, 2003, Expert Rev Mol Med, V5, P1, DOI 10.1017/S1462399403006549; Sarkar S, 2009, CELL DEATH DIFFER, V16, P46, DOI 10.1038/cdd.2008.110; Shirasaki DI, 2012, NEURON, V75, P41, DOI 10.1016/j.neuron.2012.05.024; Soucy TA, 2009, NATURE, V458, P732, DOI 10.1038/nature07884; Subramaniam S, 2009, SCIENCE, V324, P1327, DOI 10.1126/science.1172871; Tanaka T, 2003, J BIOL CHEM, V278, P32905, DOI 10.1074/jbc.M212057200; Tanji K, 2007, ACTA NEUROPATHOL, V114, P365, DOI 10.1007/s00401-007-0238-1; Tanji K, 2006, AM J PATHOL, V169, P553, DOI 10.2353/ajpath.2006.051067; Thompson LM, 2009, J CELL BIOL, V187, P1083, DOI 10.1083/jcb.200909067; Valencia A, 2010, J NEUROSCI RES, V88, P179, DOI 10.1002/jnr.22184; Walker FO, 2007, LANCET, V369, P218, DOI 10.1016/S0140-6736(07)60111-1; Weiss A, 2012, J CLIN INVEST, V122, P3731, DOI 10.1172/JCI64565; Weiss A, 2009, ANAL BIOCHEM, V395, P8, DOI 10.1016/j.ab.2009.08.001; Weiss A, 2009, MOL NEURODEGENER, V4, DOI 10.1186/1750-1326-4-11; Yamamoto A, 2000, CELL, V101, P57, DOI 10.1016/S0092-8674(00)80623-6; Zhang S, 2010, GENETICS, V184, P1165, DOI 10.1534/genetics.109.112516	51	71	73	0	34	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAY	2013	16	5					562	+		10.1038/nn.3367	http://dx.doi.org/10.1038/nn.3367			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	131WT	23525043				2022-12-28	WOS:000318029300012
J	Shih, AY; Blinder, P; Tsai, PS; Friedman, B; Stanley, G; Lyden, PD; Kleinfeld, D				Shih, Andy Y.; Blinder, Pablo; Tsai, Philbert S.; Friedman, Beth; Stanley, Geoffrey; Lyden, Patrick D.; Kleinfeld, David			The smallest stroke: occlusion of one penetrating vessel leads to infarction and a cognitive deficit	NATURE NEUROSCIENCE			English	Article							RAT BARREL CORTEX; CEREBRAL MICROINFARCTS; BLOOD-FLOW; VASCULAR DEMENTIA; MEMANTINE; BRAIN; MICROCIRCULATION; ORGANIZATION; ANTAGONISTS; ARTERIOLES	Microinfarctions are present in the aged and injured human brain. Their clinical relevance is controversial, with postulated sequelae ranging from cognitive sparing to vascular dementia. To address the consequences of microinfarcts, we used controlled optical methods to create occlusions of individual penetrating arterioles or venules in rat cortex. Single microinfarcts, targeted to encompass all or part of a cortical column, impaired performance in a macrovibrissa-based behavioral task. Furthermore, the targeting of multiple vessels resulted in tissue damage that coalesced across cortex, even though the intervening penetrating vessels were acutely patent. Post-occlusion administration of memantine, a glutamate receptor antagonist that reduces cognitive decline in Alzheimer's disease, ameliorated tissue damage and perceptual deficits. Collectively, these data imply that microinfarcts likely contribute to cognitive decline. Strategies that have received limited success in the treatment of ischemic injury, which include therapeutics against excitotoxicity, may be successful against the progressive nature of vascular dementia.	[Shih, Andy Y.; Blinder, Pablo; Tsai, Philbert S.; Stanley, Geoffrey; Kleinfeld, David] Univ Calif San Diego, Dept Phys, La Jolla, CA 92093 USA; [Friedman, Beth] Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92093 USA; [Lyden, Patrick D.] Cedars Sinai Med Ctr, Dept Neurol, Los Angeles, CA USA; [Kleinfeld, David] Univ Calif San Diego, Neurobiol Sect, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; Cedars Sinai Medical Center; University of California System; University of California San Diego	Kleinfeld, D (corresponding author), Univ Calif San Diego, Dept Phys, La Jolla, CA 92093 USA.	dk@physics.ucsd.edu	Blinder, Pablo/D-2472-2009; Blinder, Pablo/GQI-2237-2022; Blinder, Pablo/AAX-7980-2020	Blinder, Pablo/0000-0002-4042-214X; Stanley, Geoffrey/0000-0003-4911-3279	American Heart Association; US National Institutes of Health [MH085499, EB003832, OD006831]; University of California, San Diego Neuroscience Shared Microscopy Core [NS047101]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB003832] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH085499] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS047101] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD006831] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of California, San Diego Neuroscience Shared Microscopy Core; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank A. Schweitzer for constructing the behavioral apparatus, S. E. Black, M. Deschenes, M. E. Diamond, F. F. Ebner, E. E. Smith and R. Swanson for discussions, and C. Mateo for comments on an early version of the manuscript. This work was supported by the American Heart Association (Post-doctoral fellowship to A.Y.S.) and the US National Institutes of Health (MH085499, EB003832 and OD006831 to D. K.), which further supported the University of California, San Diego Neuroscience Shared Microscopy Core (NS047101), which was used to image histological tissue.	ARMSTRONGJAMES M, 1992, J NEUROPHYSIOL, V68, P1345, DOI 10.1152/jn.1992.68.4.1345; Arvanitakis Z, 2011, STROKE, V42, P722, DOI 10.1161/STROKEAHA.110.595082; Bar T., 1980, ADV ANAT EMBRYOL CEL, V59, P1, DOI DOI 10.1007/978-3-642-67432-7_1; Blinder P, 2010, P NATL ACAD SCI USA, V107, P12670, DOI 10.1073/pnas.1007239107; Brown WR, 2011, NEUROPATH APPL NEURO, V37, P56, DOI 10.1111/j.1365-2990.2010.01139.x; Brundel M, 2012, J CEREBR BLOOD F MET, V32, P425, DOI 10.1038/jcbfm.2011.200; Calabrese V, 2007, NAT REV NEUROSCI, V8, P766, DOI 10.1038/nrn2214; Carmichael ST, 2003, NEUROSCIENTIST, V9, P64, DOI 10.1177/1073858402239592; Cassot F, 2010, BRAIN RES, V1313, P62, DOI 10.1016/j.brainres.2009.12.007; Cevik IU, 2003, CELL DEATH DIFFER, V10, P928, DOI 10.1038/sj.cdd.4401250; Chen B, 2009, STROKE, V40, pE666, DOI 10.1161/STROKEAHA.109.551341; Drew PJ, 2010, NAT METHODS, V7, P981, DOI 10.1038/NMETH.1530; Friedman B, 2009, STROKE, V40, P2182, DOI 10.1161/STROKEAHA.108.523720; FROSTIG RD, 1990, P NATL ACAD SCI USA, V87, P6082, DOI 10.1073/pnas.87.16.6082; Gorelick PB, 2011, STROKE, V42, P2672, DOI 10.1161/STR.0b013e3182299496; HUTSON KA, 1986, J NEUROPHYSIOL, V56, P1196, DOI 10.1152/jn.1986.56.4.1196; Nguyen J, 2011, J CEREBR BLOOD F MET, V31, P2243, DOI 10.1038/jcbfm.2011.95; Jouvent E, 2011, STROKE, V42, pE27, DOI 10.1161/STROKEAHA.110.594218; Kleinfeld D, 1998, P NATL ACAD SCI USA, V95, P15741, DOI 10.1073/pnas.95.26.15741; Kleinfeld D, 1996, J COMP NEUROL, V375, P89, DOI 10.1002/(SICI)1096-9861(19961104)375:1<89::AID-CNE6>3.0.CO;2-K; Kleinfeld D, 2011, NEURON, V72, P455, DOI 10.1016/j.neuron.2011.10.009; Kovari E, 2007, NEUROLOGY, V68, P927, DOI 10.1212/01.wnl.0000257094.10655.9a; Lashley KS, 1931, SCIENCE, V73, P245, DOI 10.1126/science.73.1888.245; Lauwers F, 2008, NEUROIMAGE, V39, P936, DOI 10.1016/j.neuroimage.2007.09.024; MASINO SA, 1993, P NATL ACAD SCI USA, V90, P9998, DOI 10.1073/pnas.90.21.9998; Mehta SB, 2007, PLOS BIOL, V5, P309, DOI 10.1371/journal.pbio.0050015; Mohajerani MH, 2011, P NATL ACAD SCI USA, V108, pE183, DOI 10.1073/pnas.1101914108; Murphy TH, 2008, J NEUROSCI, V28, P1756, DOI 10.1523/JNEUROSCI.5128-07.2008; Nguyen QT, 2009, FRONT NEUROSCI, P117; Nimmerjahn A, 2004, NAT METHODS, V1, P31, DOI 10.1038/nmeth706; Nishimura N, 2006, NAT METHODS, V3, P99, DOI 10.1038/NMETH844; Nishimura N, 2007, P NATL ACAD SCI USA, V104, P365, DOI 10.1073/pnas.0609551104; Nishimura N, 2010, J CEREBR BLOOD F MET, V30, P1914, DOI 10.1038/jcbfm.2010.157; Olivares D, 2012, CURR ALZHEIMER RES, V9, P746; Orgogozo JM, 2002, STROKE, V33, P1834, DOI 10.1161/01.STR.0000020094.08790.49; Reisberg B, 2003, NEW ENGL J MED, V348, P1333, DOI 10.1056/NEJMoa013128; Rosidi NL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026612; Schaffer CB, 2006, PLOS BIOL, V4, P258, DOI 10.1371/journal.pbio.0040022; Shih A.Y., 2011, IMAGING NEUROSCIENCE, P939; Shih AY, 2012, J CEREBR BLOOD F MET, V32, P1277, DOI 10.1038/jcbfm.2011.196; Shih AY, 2009, J CEREBR BLOOD F MET, V29, P738, DOI 10.1038/jcbfm.2008.166; SIESJO BK, 1989, J CEREBR BLOOD F MET, V9, P127, DOI 10.1038/jcbfm.1989.20; Smith EE, 2012, LANCET NEUROL, V11, P272, DOI 10.1016/S1474-4422(11)70307-6; Sofroniew MV, 2010, ACTA NEUROPATHOL, V119, P7, DOI 10.1007/s00401-009-0619-8; Soontornniyomkij V, 2010, BRAIN PATHOL, V20, P459, DOI 10.1111/j.1750-3639.2009.00322.x; Stosiek C, 2003, P NATL ACAD SCI USA, V100, P7319, DOI 10.1073/pnas.1232232100; Svoboda K, 1997, NATURE, V385, P161, DOI 10.1038/385161a0; SWANSON LW, 1980, NEUROENDOCRINOLOGY, V31, P410, DOI 10.1159/000123111; Troncoso E, 2004, CEREB CORTEX, V14, P332, DOI 10.1093/cercor/bhg131; Tsai PS, 2009, J NEUROSCI, V29, P14553, DOI 10.1523/JNEUROSCI.3287-09.2009; Tsai PS, 2009, FRONT NEUROSCI, P59; Valmianski I, 2010, J NEUROPHYSIOL, V104, P1803, DOI 10.1152/jn.00484.2010; VILLRINGER A, 1994, J NEURORADIOLOGY, V21, P72; Vinters HV, 2000, J NEUROPATH EXP NEUR, V59, P931, DOI 10.1093/jnen/59.11.931; Weber B, 2008, CEREB CORTEX, V18, P2318, DOI 10.1093/cercor/bhm259; Wilcock GK, 2003, LANCET NEUROL, V2, P503, DOI 10.1016/S1474-4422(03)00486-1; Woolsey TA, 1996, CEREB CORTEX, V6, P647, DOI 10.1093/cercor/6.5.647; WOOLSEY TA, 1970, BRAIN RES, V17, P205, DOI 10.1016/0006-8993(70)90079-X; Yuste, 2011, IMAGING NEUROSCIENCE, P927; Zhang SX, 2007, PLOS BIOL, V5, P1152, DOI 10.1371/journal.pbio.0050119	60	207	212	1	60	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JAN	2013	16	1					55	U88		10.1038/nn.3278	http://dx.doi.org/10.1038/nn.3278			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	058KZ	23242312	Green Accepted			2022-12-28	WOS:000312633900013
J	Gilman, SR; Chang, J; Xu, B; Bawa, TS; Gogos, JA; Karayiorgou, M; Vitkup, D				Gilman, Sarah R.; Chang, Jonathan; Xu, Bin; Bawa, Tejdeep S.; Gogos, Joseph A.; Karayiorgou, Maria; Vitkup, Dennis			Diverse types of genetic variation converge on functional gene networks involved in schizophrenia	NATURE NEUROSCIENCE			English	Article							DENDRITIC SPINE PATHOLOGY; GENOME-WIDE ASSOCIATION; COPY-NUMBER VARIATION; RARE DE-NOVO; COMMON VARIANTS; AUTISM; MICRODELETIONS; DISORDERS; MUTATIONS; PATHWAYS	Despite the successful identification of several relevant genomic loci, the underlying molecular mechanisms of schizophrenia remain largely unclear. We developed a computational approach (NETBAG+) that allows an integrated analysis of diverse disease-related genetic data using a unified statistical framework. The application of this approach to schizophrenia-associated genetic variations, obtained using unbiased whole-genome methods, allowed us to identify several cohesive gene networks related to axon guidance, neuronal cell mobility, synaptic function and chromosomal remodeling. The genes forming the networks are highly expressed in the brain, with higher brain expression during prenatal development. The identified networks are functionally related to genes previously implicated in schizophrenia, autism and intellectual disability. A comparative analysis of copy number variants associated with autism and schizophrenia suggests that although the molecular networks implicated in these distinct disorders may be related, the mutations associated with each disease are likely to lead, at least on average, to different functional consequences.	[Gilman, Sarah R.; Chang, Jonathan; Bawa, Tejdeep S.; Vitkup, Dennis] Columbia Univ, Ctr Computat Biol & Bioinformat, New York, NY 10027 USA; [Gilman, Sarah R.; Chang, Jonathan; Bawa, Tejdeep S.; Vitkup, Dennis] Columbia Univ, Dept Biomed Informat, New York, NY USA; [Xu, Bin; Karayiorgou, Maria] Columbia Univ, Dept Psychiat, New York, NY USA; [Gogos, Joseph A.] Columbia Univ, Dept Physiol & Cellular Biophys, New York, NY USA; [Gogos, Joseph A.] Columbia Univ, Dept Neurosci, New York, NY USA	Columbia University; Columbia University; Columbia University; Columbia University; Columbia University	Vitkup, D (corresponding author), Columbia Univ, Ctr Computat Biol & Bioinformat, New York, NY 10027 USA.	dv2121@columbia.edu			Simons Foundation (SFARI award) [SF51]; US National Centers for Biomedical Computing (MAGNet) [U54CA121852]; US National Institute of Mental Health [MH061399, MH077235]; Lieber Center for Schizophrenia Research at Columbia University; US National Institute of General Medical Sciences [T32 GM082797]; US National Alliance for Research in Schizophrenia and Depression (NARSAD); NATIONAL CANCER INSTITUTE [U54CA121852] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM079759, T32GM082797] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH061399, R01MH077235] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [T15LM007079] Funding Source: NIH RePORTER	Simons Foundation (SFARI award); US National Centers for Biomedical Computing (MAGNet); US National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Lieber Center for Schizophrenia Research at Columbia University; US National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); US National Alliance for Research in Schizophrenia and Depression (NARSAD); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	We are grateful to all participating families and to clinical collaborators J.L. Roos and H. Pretorius, as well as to nursing sisters R. van Wyk, C. Botha and H. van den Berg for subject recruitment and evaluation. We would also like to sincerely thank M. Wigler, D. Geschwind, G. Fischbach and all members of the Vitkup laboratory for discussions. This work was supported in part by a grant from the Simons Foundation (SFARI award number SF51), US National Centers for Biomedical Computing (MAGNet) grant U54CA121852 to Columbia University, US National Institute of Mental Health grants MH061399 (to M. K.) and MH077235 (to J.A.G.) and the Lieber Center for Schizophrenia Research at Columbia University. S. R. G. was supported in part by US National Institute of General Medical Sciences training grant T32 GM082797. B. X. was partially supported by a US National Alliance for Research in Schizophrenia and Depression (NARSAD) Young Investigator Award.	Allen NC, 2008, NAT GENET, V40, P827, DOI 10.1038/ng.171; Arguello PA, 2012, TRENDS NEUROSCI, V35, P3, DOI 10.1016/j.tins.2011.11.007; Bassett AS, 2010, J PSYCHIATR RES, V44, P1005, DOI 10.1016/j.jpsychires.2010.06.013; Berriz GF, 2009, BIOINFORMATICS, V25, P3043, DOI 10.1093/bioinformatics/btp498; Brennand KJ, 2011, NATURE, V473, P221, DOI 10.1038/nature09915; Chen LF, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-2-r17; Feldman I, 2008, P NATL ACAD SCI USA, V105, P4323, DOI 10.1073/pnas.0701722105; Fiala JC, 2002, BRAIN RES REV, V39, P29, DOI 10.1016/S0165-0173(02)00158-3; Gilman SR, 2011, NEURON, V70, P898, DOI 10.1016/j.neuron.2011.05.021; Girard SL, 2012, CURR NEUROL NEUROSCI, V12, P261, DOI 10.1007/s11910-012-0266-7; Girard SL, 2011, NAT GENET, V43, P860, DOI 10.1038/ng.886; Glantz LA, 2000, ARCH GEN PSYCHIAT, V57, P65, DOI 10.1001/archpsyc.57.1.65; Goh KI, 2007, P NATL ACAD SCI USA, V104, P8685, DOI 10.1073/pnas.0701361104; Guilmatre A, 2009, ARCH GEN PSYCHIAT, V66, P947, DOI 10.1001/archgenpsychiatry.2009.80; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Hutsler JJ, 2010, BRAIN RES, V1309, P83, DOI 10.1016/j.brainres.2009.09.120; Iossifov I, 2008, GENOME RES, V18, P1150, DOI 10.1101/gr.075622.107; Irwin SA, 2001, AM J MED GENET, V98, P161, DOI 10.1002/1096-8628(20010115)98:2<161::AID-AJMG1025>3.0.CO;2-B; Jia P, 2010, MOL PSYCHIATR, V15, P453, DOI 10.1038/mp.2009.93; Kang HJ, 2011, NATURE, V478, P483, DOI 10.1038/nature10523; Kirov G, 2009, MOL PSYCHIATR, V14, P796, DOI 10.1038/mp.2008.33; Kirov G, 2012, MOL PSYCHIATR, V17, P142, DOI 10.1038/mp.2011.154; Kirov G, 2008, HUM MOL GENET, V17, P458, DOI 10.1093/hmg/ddm323; Kvajo M, 2010, CURR TOP BEHAV NEURO, V4, P629, DOI 10.1007/7854_2010_41; Lencz T, 2007, MOL PSYCHIATR, V12, P572, DOI 10.1038/sj.mp.4001983; Levy D, 2011, NEURON, V70, P886, DOI 10.1016/j.neuron.2011.05.015; Malhotra D, 2012, CELL, V148, P1223, DOI 10.1016/j.cell.2012.02.039; Malhotra D, 2011, NEURON, V72, P951, DOI 10.1016/j.neuron.2011.11.007; Mulle JG, 2010, AM J HUM GENET, V87, P229, DOI 10.1016/j.ajhg.2010.07.013; O'Donovan MC, 2008, NAT GENET, V40, P1053, DOI 10.1038/ng.201; O'Roak BJ, 2011, NAT GENET, V43, P585, DOI 10.1038/ng.835; Peca J, 2011, NATURE, V472, P437, DOI 10.1038/nature09965; Penzes P, 2011, NAT NEUROSCI, V14, P285, DOI 10.1038/nn.2741; Pickard B, 2011, EXPERT REV MOL MED, V13, DOI 10.1017/S1462399411001955; Pinto D, 2010, NATURE, V466, P368, DOI 10.1038/nature09146; Purcell SM, 2009, NATURE, V460, P748, DOI 10.1038/nature08185; Ripke S, 2011, NAT GENET, V43, P969, DOI 10.1038/ng.940; Rossin EJ, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001273; Sanders SJ, 2012, NATURE, V485, P237, DOI 10.1038/nature10945; Shi JX, 2009, NATURE, V460, P753, DOI 10.1038/nature08192; Stefansson H, 2008, NATURE, V455, P232, DOI 10.1038/nature07229; Stefansson H, 2009, NATURE, V460, P744, DOI 10.1038/nature08186; Sullivan PF, 2008, MOL PSYCHIATR, V13, P570, DOI 10.1038/mp.2008.25; Sun J, 2008, AM J MED GENET B, V147B, P1173, DOI 10.1002/ajmg.b.30743; Tandon R, 2008, SCHIZOPHR RES, V100, P4, DOI 10.1016/j.schres.2008.01.022; Walsh T, 2008, SCIENCE, V320, P539, DOI 10.1126/science.1155174; Xu B, 2008, NAT GENET, V40, P880, DOI 10.1038/ng.162; Xu B, 2012, NAT GENET, V44, P1365, DOI 10.1038/ng.2446; Yue WH, 2011, NAT GENET, V43, P1228, DOI 10.1038/ng.979	49	132	137	0	36	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	DEC	2012	15	12					1723	+		10.1038/nn.3261	http://dx.doi.org/10.1038/nn.3261			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	045OR	23143521	Green Accepted			2022-12-28	WOS:000311706700019
J	Holmes, A; Fitzgerald, PJ; MacPherson, KP; DeBrouse, L; Colacicco, G; Flynn, SM; Masneuf, S; Pleil, KE; Li, C; Marcinkiewcz, CA; Kash, TL; Gunduz-Cinar, O; Camp, M				Holmes, Andrew; Fitzgerald, Paul J.; MacPherson, Kathryn P.; DeBrouse, Lauren; Colacicco, Giovanni; Flynn, Shaun M.; Masneuf, Sophie; Pleil, Kristen E.; Li, Chia; Marcinkiewcz, Catherine A.; Kash, Thomas L.; Gunduz-Cinar, Ozge; Camp, Marguerite			Chronic alcohol remodels prefrontal neurons and disrupts NMDAR-mediated fear extinction encoding	NATURE NEUROSCIENCE			English	Article							EXPRESSION; ETHANOL; CONSOLIDATION; DYSFUNCTION; WITHDRAWAL; RESISTANCE; AMYGDALA; CORTEX; MEMORY	Alcoholism is frequently co-morbid with post-traumatic stress disorder, but it is unclear how alcohol affects the neural circuits mediating recovery from trauma. We found that chronic intermittent ethanol (CIE) impaired fear extinction and remodeled the dendritic arbor of medial prefrontal cortical (mPFC) neurons in mice. CIE impaired extinction encoding by infralimbic mPFC neurons in vivo and functionally downregulated burst-mediating NMDA GluN1 receptors. These findings suggest that alcohol may increase risk for trauma-related anxiety disorders by disrupting mPFC-mediated extinction of fear.	[Holmes, Andrew; Fitzgerald, Paul J.; MacPherson, Kathryn P.; DeBrouse, Lauren; Colacicco, Giovanni; Flynn, Shaun M.; Masneuf, Sophie; Gunduz-Cinar, Ozge; Camp, Marguerite] NIAAA, Lab Behav & Genom Neurosci, US Natl Inst Hlth, Bethesda, MD 90034 USA; [Flynn, Shaun M.; Gunduz-Cinar, Ozge] Uniformed Serv Univ Hlth Sci, Ctr Neurosci & Regenerat Med, Bethesda, MD 20814 USA; [Pleil, Kristen E.; Li, Chia; Marcinkiewcz, Catherine A.; Kash, Thomas L.] Univ N Carolina, Dept Pharmacol, Bowles Ctr Alcohol Studies, Chapel Hill, NC USA	National Institutes of Health (NIH) - USA; NIH National Institute on Alcohol Abuse & Alcoholism (NIAAA); Uniformed Services University of the Health Sciences - USA; University of North Carolina; University of North Carolina Chapel Hill	Holmes, A (corresponding author), NIAAA, Lab Behav & Genom Neurosci, US Natl Inst Hlth, Bethesda, MD 90034 USA.	andrew.holmes@nih.gov	Gunduz Cinar, Ozge/B-2970-2009; Kash, Thomas/G-9625-2013; Marcinkiewcz, Catherine/X-2339-2019; Gunduz Cinar, Ozge/E-5756-2010	Marcinkiewcz, Catherine/0000-0001-7161-7815; Gunduz Cinar, Ozge/0000-0002-3826-8905	US Department of Defense in the Center for Neuroscience and Regenerative Medicine; US National Institutes of Health grants [AA019454, AA017668, AA020911, AA021043]; US Department of Defense grant [PT090344]; US National Alliance for Research on Schizophrenia and Depression; Bowles Center for Alcohol Studies; US National Institute on Alcohol Abuse and Alcoholism Intramural Research Program; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [ZIAAA000411, U01AA020911, K99AA017668, R00AA017668, F32AA021043, R01AA019454] Funding Source: NIH RePORTER	US Department of Defense in the Center for Neuroscience and Regenerative Medicine(United States Department of Defense); US National Institutes of Health grants(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US Department of Defense grant; US National Alliance for Research on Schizophrenia and Depression(NARSAD); Bowles Center for Alcohol Studies; US National Institute on Alcohol Abuse and Alcoholism Intramural Research Program; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	We thank Y. Shaham and C. Wellman for valuable comments, and B. Hurd, A. Plitt, D. Fisher and R. Daut for assistance with the CIE procedure. This work was supported by the US Department of Defense in the Center for Neuroscience and Regenerative Medicine (A.H., S.M.F. and O.G.-C.), US National Institutes of Health grants AA019454, AA017668 and AA020911 to T.L.K., C.L. and C,A,M., and AA021043 to K.E.P., US Department of Defense grant PT090344 (T.L.K. and K.E.P.), US National Alliance for Research on Schizophrenia and Depression (T.L.K.), Bowles Center for Alcohol Studies (T.L.K.), and the US National Institute on Alcohol Abuse and Alcoholism Intramural Research Program (A.H., P.J.F., K.P.M., L.D., S.M., G.C., O.G.-C. and M.C.).	BAUM M, 1969, J COMP PHYSIOL PSYCH, V69, P238, DOI 10.1037/h0028188; Bertotto ME, 2006, NEUROSCIENCE, V142, P979, DOI 10.1016/j.neuroscience.2006.07.013; Burgos-Robles A, 2007, NEURON, V53, P871, DOI 10.1016/j.neuron.2007.02.021; Burgos-Robles A, 2009, J NEUROSCI, V29, P8474, DOI 10.1523/JNEUROSCI.0378-09.2009; Goldstein RZ, 2004, NEUROPSYCHOLOGIA, V42, P1447, DOI 10.1016/j.neuropsychologia.2004.04.002; Herry C, 2006, EUR J NEUROSCI, V24, P261, DOI 10.1111/j.1460-9568.2006.04893.x; Holmes A, 2009, NEUROSCI BIOBEHAV R, V33, P773, DOI 10.1016/j.neubiorev.2008.11.005; Izquierdo A, 2006, J NEUROSCI, V26, P5733, DOI 10.1523/JNEUROSCI.0474-06.2006; Lattal KM, 2007, BEHAV NEUROSCI, V121, P1280, DOI 10.1037/0735-7044.121.6.1280; Martin KP, 2011, CEREB CORTEX, V21, P2366, DOI 10.1093/cercor/bhr021; Milad MR, 2009, BIOL PSYCHIAT, V66, P1075, DOI 10.1016/j.biopsych.2009.06.026; Milad MR, 2002, NATURE, V420, P70, DOI 10.1038/nature01138; Pfefferbaum A, 1998, ARCH GEN PSYCHIAT, V55, P905, DOI 10.1001/archpsyc.55.10.905; Ripley TL, 2003, EUR J NEUROSCI, V18, P441, DOI 10.1046/j.1460-9568.2003.02759.x; Sierra-Mercado D, 2011, NEUROPSYCHOPHARMACOL, V36, P529, DOI 10.1038/npp.2010.184; Whittle N, 2010, J NEUROSCI, V30, P13586, DOI 10.1523/JNEUROSCI.0849-10.2010; World Health Organization (WHO), 2006, WORLD HLTH REP 2006	17	155	156	0	19	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	OCT	2012	15	10					1359	1361		10.1038/nn.3204	http://dx.doi.org/10.1038/nn.3204			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	013VZ	22941108	Green Accepted, Green Submitted			2022-12-28	WOS:000309335300012
J	Williams, C; Chen, WY; Lee, CH; Yaeger, D; Vyleta, NP; Smith, SM				Williams, Courtney; Chen, Wenyan; Lee, Chia-Hsueh; Yaeger, Daniel; Vyleta, Nicholas P.; Smith, Stephen M.			Coactivation of multiple tightly coupled calcium channels triggers spontaneous release of GABA	NATURE NEUROSCIENCE			English	Article							SYNAPTIC-TRANSMISSION; TRANSMITTER RELEASE; SENSING RECEPTOR; CA2+ SENSOR; NEURONS; BLOCKADE; REST; IONS	Voltage-activated Ca2+ channels (VACCs) mediate Ca2+ influx to trigger action potential-evoked neurotransmitter release, but the mechanism by which Ca2+ regulates spontaneous transmission is unclear. We found that VACCs are the major physiological triggers for spontaneous release at mouse neocortical inhibitory synapses. Moreover, despite the absence of a synchronizing action potential, we found that spontaneous fusion of a GABA-containing vesicle required the activation of multiple tightly coupled VACCs of variable type.	[Williams, Courtney; Chen, Wenyan; Lee, Chia-Hsueh; Yaeger, Daniel; Vyleta, Nicholas P.; Smith, Stephen M.] Oregon Hlth & Sci Univ, Div Pulm & Crit Care Med, Portland, OR 97201 USA	Oregon Health & Science University	Smith, SM (corresponding author), Oregon Hlth & Sci Univ, Div Pulm & Crit Care Med, Portland, OR 97201 USA.	smisteph@ohsu.edu	Chen, Wenyan/V-7000-2019	Smith, Stephen/0000-0002-0331-7615; Yaeger, Daniel/0000-0003-1613-8701	US National Institutes of Health [DA027110, GM097433]; OCTRI; National Heart, Lung, and Blood Institute [T32HL033808]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007680] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM097433] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R21DA027110] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); OCTRI; National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank M. Andresen and K. Khodakhah for helpful comments. The work was supported by the US National Institutes of Health (DA027110 and GM097433) and OCTRI. C. W. and N.P.V. were supported by a grant from the National Heart, Lung, and Blood Institute (T32HL033808).	Autry AE, 2011, NATURE, V475, P91, DOI 10.1038/nature10130; BOLAND LM, 1994, J NEUROSCI, V14, P5011; Bucurenciu I, 2010, NAT NEUROSCI, V13, P19, DOI 10.1038/nn.2461; Cao YQ, 2005, P NATL ACAD SCI USA, V102, P2590, DOI 10.1073/pnas.0409896102; Eggermann E, 2012, NAT REV NEUROSCI, V13, P7, DOI 10.1038/nrn3125; HUGHES D, 1987, J PHYSIOL-LONDON, V392, P231, DOI 10.1113/jphysiol.1987.sp016778; Lou XL, 2005, NATURE, V435, P497, DOI 10.1038/nature03568; MINTZ IM, 1995, NEURON, V15, P675, DOI 10.1016/0896-6273(95)90155-8; Navedo MF, 2010, CIRC RES, V106, P748, DOI 10.1161/CIRCRESAHA.109.213363; Neher E, 2008, NEURON, V59, P861, DOI 10.1016/j.neuron.2008.08.019; Phillips CG, 2008, J NEUROSCI, V28, P12062, DOI 10.1523/JNEUROSCI.4134-08.2008; RANDALL A, 1995, J NEUROSCI, V15, P2995; Sara Y, 2005, NEURON, V45, P563, DOI 10.1016/j.neuron.2004.12.056; Sidach SS, 2000, J NEUROSCI, V20, P7174; Stanley EF, 1997, TRENDS NEUROSCI, V20, P404, DOI 10.1016/S0166-2236(97)01091-6; Vyleta NP, 2011, J NEUROSCI, V31, P4593, DOI 10.1523/JNEUROSCI.6398-10.2011; Xu J, 2009, NAT NEUROSCI, V12, P759, DOI 10.1038/nn.2320	17	31	31	0	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	SEP	2012	15	9					1195	U38		10.1038/nn.3162	http://dx.doi.org/10.1038/nn.3162			4	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	996GJ	22842148	Green Accepted			2022-12-28	WOS:000308072600008
J	Ferenczi, E; Deisseroth, K				Ferenczi, Emily; Deisseroth, Karl			When the electricity (and the lights) go out: transient changes in excitability	NATURE NEUROSCIENCE			English	Editorial Material							OPTOGENETIC CONTROL; STRATEGIES; BRAIN	Natural or artificially induced electrical activity changes can alter ion balance so as to briefly influence firing. An optogenetics study delineates one mechanism: Cl- shifts causing seconds-long excitability changes after silencing.	[Ferenczi, Emily; Deisseroth, Karl] Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA; [Ferenczi, Emily; Deisseroth, Karl] Stanford Univ, Neurosci Program, Stanford, CA 94305 USA; [Deisseroth, Karl] Stanford Univ, Dept Psychiat & Behav Sci, Stanford, CA 94305 USA; [Deisseroth, Karl] Stanford Univ, Howard Hughes Med Inst, Stanford, CA 94305 USA	Stanford University; Stanford University; Stanford University; Howard Hughes Medical Institute; Stanford University	Ferenczi, E (corresponding author), Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA.	deissero@stanford.edu						Arrenberg AB, 2010, SCIENCE, V330, P971, DOI 10.1126/science.1195929; Chow BY, 2010, NATURE, V463, P98, DOI 10.1038/nature08652; Diester I, 2011, NAT NEUROSCI, V14, P387, DOI 10.1038/nn.2749; GARDNERMEDWIN AR, 1983, J PHYSIOL-LONDON, V335, P375, DOI 10.1113/jphysiol.1983.sp014540; Goshen I, 2011, CELL, V147, P678, DOI 10.1016/j.cell.2011.09.033; Gradinaru V, 2007, J NEUROSCI, V27, P14231, DOI 10.1523/JNEUROSCI.3578-07.2007; Han X, 2011, FRONT SYST NEUROSCI, V5, DOI 10.3389/fnsys.2011.00018; JEFFERYS JGR, 1995, PHYSIOL REV, V75, P689, DOI 10.1152/physrev.1995.75.4.689; Mattis J, 2012, NAT METHODS, V9, P159, DOI [10.1038/nmeth.1808, 10.1038/NMETH.1808]; Raimondo JV, 2012, NAT NEUROSCI, V15, P1102, DOI 10.1038/nn.3143; Tonnesen J, 2009, P NATL ACAD SCI USA, V106, P12162, DOI 10.1073/pnas.0901915106; Tye KM, 2011, NATURE, V471, P358, DOI 10.1038/nature09820; Witten IB, 2010, SCIENCE, V330, P1677, DOI 10.1126/science.1193771; Yizhar O, 2011, NEURON, V71, P9, DOI 10.1016/j.neuron.2011.06.004; Zhang F, 2007, NATURE, V446, P633, DOI 10.1038/nature05744	15	13	16	0	10	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	AUG	2012	15	8					1058	1060		10.1038/nn.3172	http://dx.doi.org/10.1038/nn.3172			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	979UE	22837032				2022-12-28	WOS:000306844500003
J	Suo, D; Park, J; Harrington, AW; Zweifel, LS; Mihalas, S; Deppmann, CD				Suo, Dong; Park, Juyeon; Harrington, Anthony W.; Zweifel, Larry S.; Mihalas, Stefan; Deppmann, Christopher D.			Coronin-1 is a neurotrophin endosomal effector that is required for developmental competition for survival	NATURE NEUROSCIENCE			English	Article							RETROGRADE TRANSPORT; SYMPATHETIC NEURONS; AXONAL-TRANSPORT; NGF; TRKA; PATHWAY; PROTEIN; MYCOBACTERIA; TRAFFICKING; ENDOCYTOSIS	Retrograde communication from axonal targets to neuronal cell bodies is critical for both the development and function of the nervous system. Much progress has been made in recent years linking long-distance, retrograde signaling to a signaling endosome, yet the mechanisms governing the trafficking and signaling of these endosomes remain mostly uncharacterized. Here we report that in mouse sympathetic neurons, the target-derived nerve growth factor (NGF)-tropomyosin-related kinase type 1 (TrkA, also called Ntrk1) signaling endosome, on arrival at the cell body, induces the expression and recruitment of a new effector protein known as Coronin-1 (also called Coro1a). In the absence of Coronin-1, the NGF-TrkA signaling endosome fuses to lysosomes sixfold to tenfold faster than when Coronin-1 is intact. We also define a new Coronin-l-dependent trafficking event in which signaling endosomes recycle and re-internalize on arrival at the cell body. Beyond influencing endosomal trafficking, Coronin-1 is also required for several NGF-TrkA-dependent signaling events, including calcium release, calcineurin activation and phosphorylation of cAMP responsive element binding protein (CREB). These results establish Coronin-1 as an essential component of a feedback loop that mediates NGF-TrkA endosome stability, recycling and signaling as a critical mechanism governing developmental competition for survival.	[Suo, Dong; Park, Juyeon; Deppmann, Christopher D.] Univ Virginia, Dept Biol, Charlottesville, VA 22903 USA; [Harrington, Anthony W.; Zweifel, Larry S.] Johns Hopkins Univ, Sch Med, Solomon Snyder Dept Neurosci, Baltimore, MD USA; [Harrington, Anthony W.; Zweifel, Larry S.] Johns Hopkins Univ, Sch Med, Howard Hughes Med Inst, Baltimore, MD 21205 USA	University of Virginia; Johns Hopkins University; Howard Hughes Medical Institute; Johns Hopkins University	Deppmann, CD (corresponding author), Univ Virginia, Dept Biol, Charlottesville, VA 22903 USA.	deppmann@virginia.edu	Zweifel, Larry/O-3284-2017	Zweifel, Larry/0000-0003-3465-5331	US National Institutes of Health (NIH) [5R01NS034814]; Howard Hughes Medical Institute; Sloan Foundation; University of Virginia Fund for Excellence in Science and Technology; NIH National Institute of Neurological Disorders and Stroke [1R01NS072388]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F32NS053187, R01NS072388, R01NS034814] Funding Source: NIH RePORTER	US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Sloan Foundation(Alfred P. Sloan Foundation); University of Virginia Fund for Excellence in Science and Technology; NIH National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We are grateful to D. Ginty (Harvard Medical School), in whose lab the initial phases of this work were conceived, conducted and supported (US National Institutes of Health (NIH) grant 5R01NS034814 and the Howard Hughes Medical Institute) and for providing Ntrk1<SUP>Flag</SUP> mice and other mouse lines. We thank J. Pieters (Biozentrum, University of Basel) for providing Coro1a<SUP>-/-</SUP> mice. We also thank P. Neff, J.S. Cauley and the Keck Center for Biological Imaging for technical support. We are grateful to B. Condron, D. Ginty, R. Kuruvilla, N. Sharma, N. Watson, B. Winckler, M. Wheeler and the members of the Deppmann laboratory for helpful discussion. This work was supported by the Sloan Foundation, the University of Virginia Fund for Excellence in Science and Technology and the NIH National Institute of Neurological Disorders and Stroke (1R01NS072388).	[Anonymous], 2005, J CELL BIOL, V170, P338, DOI 10.1083/jcb1703fta1; Ascano M, 2009, J NEUROSCI, V29, P11674, DOI 10.1523/JNEUROSCI.1542-09.2009; Bodmer D, 2011, NEURON, V70, P1085, DOI 10.1016/j.neuron.2011.04.025; CARPENTER G, 1976, J CELL BIOL, V71, P159, DOI 10.1083/jcb.71.1.159; Chan KT, 2012, BIOCHEM J, V444, P89, DOI 10.1042/BJ20120209; Chen ZY, 2005, MOL BIOL CELL, V16, P5761, DOI 10.1091/mbc.E05-07-0651; CROWLEY C, 1994, CELL, V76, P1001, DOI 10.1016/0092-8674(94)90378-6; Cui BX, 2007, P NATL ACAD SCI USA, V104, P13666, DOI 10.1073/pnas.0706192104; Dabrowski A, 2011, J BIOCHEM, V149, P641, DOI 10.1093/jb/mvr047; Deckwerth TL, 1996, NEURON, V17, P401, DOI 10.1016/S0896-6273(00)80173-7; Delcroix JD, 2003, NEURON, V39, P69, DOI 10.1016/S0896-6273(03)00397-0; Deppmann CD, 2008, SCIENCE, V320, P369, DOI 10.1126/science.1152677; EHLERS MD, 1995, J CELL BIOL, V130, P149, DOI 10.1083/jcb.130.1.149; FERGUSON IA, 1991, J COMP NEUROL, V313, P680, DOI 10.1002/cne.903130411; Ferrari G, 1999, CELL, V97, P435, DOI 10.1016/S0092-8674(00)80754-0; Foger N, 2006, SCIENCE, V313, P839, DOI 10.1126/science.1130563; Frampton JP, 2012, J NEUROSCI RES, V90, P1533, DOI 10.1002/jnr.23041; Gatfield J, 2005, MOL BIOL CELL, V16, P2786, DOI 10.1091/mbc.E05-01-0042; Glebov OO, 2006, NAT CELL BIOL, V8, P46, DOI 10.1038/ncb1342; Grimes ML, 1996, J NEUROSCI, V16, P7950; HAMBURGER V, 1949, J EXP ZOOL, V111, P457, DOI 10.1002/jez.1401110308; Harrington AW, 2013, NAT REV NEUROSCI, V14, P177, DOI 10.1038/nrn3253; Harrington AW, 2011, CELL, V146, P421, DOI 10.1016/j.cell.2011.07.008; HENDRY IA, 1974, BRAIN RES, V68, P103, DOI 10.1016/0006-8993(74)90536-8; Huang SH, 2013, J NEUROSCI, V33, P9214, DOI 10.1523/JNEUROSCI.3256-12.2013; Jayachandran R, 2007, CELL, V130, P37, DOI 10.1016/j.cell.2007.04.043; Jullien J, 2002, J BIOL CHEM, V277, P38700, DOI 10.1074/jbc.M202348200; Kuruvilla R, 2004, CELL, V118, P243, DOI 10.1016/j.cell.2004.06.021; Kuruvilla R, 2000, NEURON, V27, P499, DOI 10.1016/S0896-6273(00)00061-1; Lazo OM, 2013, J NEUROSCI, V33, P6112, DOI 10.1523/JNEUROSCI.4630-12.2013; Lewin GR, 1996, ANNU REV NEUROSCI, V19, P289, DOI 10.1146/annurev.ne.19.030196.001445; Lonze BE, 2002, NEURON, V35, P605, DOI 10.1016/S0896-6273(02)00828-0; Nguyen L, 2005, TRENDS CELL BIOL, V15, P269, DOI 10.1016/j.tcb.2005.03.009; Park JW, 2006, NAT PROTOC, V1, P2128, DOI 10.1038/nprot.2006.316; Philippidou P, 2011, P NATL ACAD SCI USA, V108, P852, DOI 10.1073/pnas.1015981108; Sharma N, 2010, NEURON, V67, P422, DOI 10.1016/j.neuron.2010.07.018; SUZUKI K, 1995, FEBS LETT, V364, P283, DOI 10.1016/0014-5793(95)00393-N; Valdez G, 2005, J NEUROSCI, V25, P5236, DOI 10.1523/JNEUROSCI.5104-04.2005; Watson FL, 2001, NAT NEUROSCI, V4, P981, DOI 10.1038/nn720; Wu CB, 2001, J NEUROSCI, V21, P5406, DOI 10.1523/JNEUROSCI.21-15-05406.2001; Ye HH, 2003, NEURON, V39, P57, DOI 10.1016/S0896-6273(03)00266-6	41	62	62	0	14	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JAN	2014	17	1					36	45		10.1038/nn.3593	http://dx.doi.org/10.1038/nn.3593			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	281DL	24270184	Green Accepted			2022-12-28	WOS:000329080000012
J	Hickman, SE; Kingery, ND; Ohsumi, TK; Borowsky, ML; Wang, LC; Means, TK; El Khoury, J				Hickman, Suzanne E.; Kingery, Nathan D.; Ohsumi, Toshiro K.; Borowsky, Mark L.; Wang, Li-chong; Means, Terry K.; El Khoury, Joseph			The microglial sensome revealed by direct RNA sequencing	NATURE NEUROSCIENCE			English	Article							GENE-EXPRESSION; ALZHEIMERS-DISEASE; ALTERNATIVE ACTIVATION; BRAIN; NEURODEGENERATION; NEUROTOXICITY; TRANSCRIPTION; MACROPHAGES; PHENOTYPE; PATHWAYS	Microglia, the principal neuroimmune sentinels of the brain, continuously sense changes in their environment and respond to invading pathogens, toxins and cellular debris. Microglia exhibit plasticity and can assume neurotoxic or neuroprotective priming states that determine their responses to danger. We used direct RNA sequencing, without amplification or cDNA synthesis, to determine the quantitative transcriptomes of microglia of healthy adult and aged mice. We validated our findings using fluorescence dual in situ hybridization, unbiased proteomic analysis and quantitative PCR. We found that microglia have a distinct transcriptomic signature and express a unique cluster of transcripts encoding proteins for sensing endogenous ligands and microbes that we refer to as the sensome. With aging, sensome transcripts for endogenous ligand recognition were downregulated, whereas those involved in microbe recognition and host defense were upregulated. In addition, aging was associated with an overall increase in the expression of microglial genes involved in neuroprotection.	[Hickman, Suzanne E.; Kingery, Nathan D.; Means, Terry K.; El Khoury, Joseph] Massachusetts Gen Hosp, Ctr Immunol & Inflammatory Dis, Charlestown, MA 02129 USA; [Ohsumi, Toshiro K.; Borowsky, Mark L.] Massachusetts Gen Hosp, Dept Mol Biol, Charlestown, MA USA; [Ohsumi, Toshiro K.; Borowsky, Mark L.] Harvard Univ, Sch Med, Dept Genet, Boston, MA USA; [Wang, Li-chong] Adv Cell Diagnost, Hayward, CA USA; [El Khoury, Joseph] Massachusetts Gen Hosp, Div Infect Dis, Charlestown, MA USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital	Hickman, SE (corresponding author), Massachusetts Gen Hosp, Ctr Immunol & Inflammatory Dis, Charlestown, MA 02129 USA.	shickman@partners.org; jelkhoury@partners.org			National Institute of Neurological Disorders and Stroke [NS059005]; National Institute of Aging [AG032349]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI084884] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS059005] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG032349] Funding Source: NIH RePORTER	National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Institute of Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank F. Ozsolak (Helicos) for supervising the sequencing experiments, R. Mylvaganam for performing cell sorting and J. Liao (Applied Biomics) for analysis of the proteomic data. This work was supported by grants from the National Institute of Neurological Disorders and Stroke (NS059005) and the National Institute of Aging (AG032349) to J.E.K.	Berchtold NC, 2008, P NATL ACAD SCI USA, V105, P15605, DOI 10.1073/pnas.0806883105; Block ML, 2007, NAT REV NEUROSCI, V8, P57, DOI 10.1038/nrn2038; Bradshaw EM, 2013, NAT NEUROSCI, V16, P848, DOI 10.1038/nn.3435; Colantuoni C, 2011, NATURE, V478, P519, DOI 10.1038/nature10524; Colton CA, 2009, J NEUROIMMUNE PHARM, V4, P399, DOI 10.1007/s11481-009-9164-4; Cribbs DH, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-179; Dziennis S, 2008, REV NEUROSCIENCE, V19, P341; El Khoury JB, 2003, J EXP MED, V197, P1657, DOI 10.1084/jem.20021546; El Khoury J, 2007, NAT MED, V13, P432, DOI 10.1038/nm1555; El Khoury J, 2010, NAT MED, V16, P1369, DOI 10.1038/nm1210-1369; ElKhoury J, 1996, NATURE, V382, P716; Gautier EL, 2012, NAT IMMUNOL, V13, P1118, DOI 10.1038/ni.2419; Geiss GK, 2008, NAT BIOTECHNOL, V26, P317, DOI 10.1038/nbt1385; Gomes-Leal W, 2012, BRAIN BEHAV, V2, P345, DOI 10.1002/brb3.51; Gordon S, 2010, IMMUNITY, V32, P593, DOI 10.1016/j.immuni.2010.05.007; Griciuc A, 2013, NEURON, V78, P631, DOI 10.1016/j.neuron.2013.04.014; Guerreiro R, 2013, NEW ENGL J MED, V368, P117, DOI 10.1056/NEJMoa1211851; Heneka MT, 2013, NATURE, V493, P674, DOI 10.1038/nature11729; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Jonsson T, 2013, NEW ENGL J MED, V368, P107, DOI 10.1056/NEJMoa1211103; Kang HJ, 2011, NATURE, V478, P483, DOI 10.1038/nature10523; Kettenmann H, 2011, PHYSIOL REV, V91, P461, DOI 10.1152/physrev.00011.2010; Kigerl KA, 2009, J NEUROSCI, V29, P13435, DOI 10.1523/JNEUROSCI.3257-09.2009; Kremsky I, 2012, BRAIN BEHAV IMMUN, V26, P797, DOI 10.1016/j.bbi.2011.12.008; LAWSON LJ, 1990, NEUROSCIENCE, V39, P151, DOI 10.1016/0306-4522(90)90229-W; Lee CK, 2000, NAT GENET, V25, P294, DOI 10.1038/77046; Lee DC, 2013, NEUROBIOL AGING, V34, P1610, DOI 10.1016/j.neurobiolaging.2012.12.014; Liao B, 2012, EXP NEUROL, V237, P147, DOI 10.1016/j.expneurol.2012.06.011; Martinez FO, 2009, ANNU REV IMMUNOL, V27, P451, DOI 10.1146/annurev.immunol.021908.132532; Muzio L, 2007, J NEUROIMMUNOL, V191, P39, DOI 10.1016/j.jneuroim.2007.09.016; Nagalakshmi U, 2008, SCIENCE, V320, P1344, DOI 10.1126/science.1158441; Nagalakshmi Ugrappa, 2010, Curr Protoc Mol Biol, VChapter 4, DOI 10.1002/0471142727.mb0411s89; Nimmerjahn A, 2005, SCIENCE, V308, P1314, DOI 10.1126/science.1110647; Ohsumi TK, 2012, BIOINFORMATICS, V28, P2412, DOI 10.1093/bioinformatics/bts458; Ozsolak F, 2009, NATURE, V461, P814, DOI 10.1038/nature08390; Reynolds A, 2007, INT REV NEUROBIOL, V82, P297, DOI 10.1016/S0074-7742(07)82016-2; Rezaie Payam, 2002, J Hist Neurosci, V11, P325, DOI 10.1076/jhin.11.4.325.8531; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; SANGO K, 1995, NAT GENET, V11, P170, DOI 10.1038/ng1095-170; Schena M, 1998, TRENDS BIOTECHNOL, V16, P301, DOI 10.1016/S0167-7799(98)01219-0; SCHENA M, 1995, SCIENCE, V270, P467, DOI 10.1126/science.270.5235.467; SEDGWICK JD, 1991, P NATL ACAD SCI USA, V88, P7438, DOI 10.1073/pnas.88.16.7438; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Thrash JC, 2009, NEUROCHEM RES, V34, P38, DOI 10.1007/s11064-008-9657-1; VanGuilder HD, 2008, BIOTECHNIQUES, V44, P619, DOI 10.2144/000112776; Villeda SA, 2011, NATURE, V477, P90, DOI 10.1038/nature10357; von Mering C, 2003, NUCLEIC ACIDS RES, V31, P258, DOI 10.1093/nar/gkg034; Wang F, 2012, J MOL DIAGN, V14, P22, DOI 10.1016/j.jmoldx.2011.08.002; Xu ZF, 2005, NEUROBIOL DIS, V19, P461, DOI 10.1016/j.nbd.2005.01.027	50	908	919	4	93	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	DEC	2013	16	12					1896	1905		10.1038/nn.3554	http://dx.doi.org/10.1038/nn.3554			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	257VV	24162652	Green Submitted, Green Accepted			2022-12-28	WOS:000327416800029
J	Darnell, JC; Klann, E				Darnell, Jennifer C.; Klann, Eric			The translation of translational control by FMRP: therapeutic targets for FXS	NATURE NEUROSCIENCE			English	Review							FRAGILE-X-SYNDROME; MENTAL-RETARDATION PROTEIN; LONG-TERM DEPRESSION; P70 S6 KINASE; MOUSE MODEL; SYNAPTIC PLASTICITY; DENDRITIC SPINES; RNA-BINDING; DEPENDENT REGULATION; GABA(A) RECEPTOR	De novo protein synthesis is necessary for long-lasting modifications in synaptic strength and dendritic spine dynamics that underlie cognition. Fragile X syndrome (FXS), characterized by intellectual disability and autistic behaviors, holds promise for revealing the molecular basis for these long-term changes in neuronal function. Loss of function of the fragile X mental retardation protein (FMRP) results in defects in synaptic plasticity and cognition in many models of the disease. FMRP is a polyribosome-associated RNA-binding protein that regulates the synthesis of a set of plasticity-reated proteins by stalling ribosomal translocation on target mRNAs. The recent identification of mRNA targets of FMRP and its upstream regulators, and the use of small molecules to stall ribosomes in the absence of FMRP, have the potential to be translated into new therapeutic avenues for the treatment of FXS.	[Darnell, Jennifer C.] Rockefeller Univ, Mol Neurooncol Lab, New York, NY 10021 USA; [Klann, Eric] NYU, Ctr Neural Sci, New York, NY 10003 USA	Rockefeller University; New York University	Klann, E (corresponding author), NYU, Ctr Neural Sci, New York, NY 10003 USA.	darneje@mail.rockefeller.edu; eklann@cns.nyu.edu			US National Institutes of Health [HD040647, NS047384]; US Department of Defense [W81-XWH-11-1-0389]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD040647] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS047384] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US Department of Defense(United States Department of Defense); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by US National Institutes of Health grants HD040647 (J.C.D.) and NS047384 (E.K.), and Congressionally Directed Medical Research Program Award W81-XWH-11-1-0389 from the US Department of Defense (E.K.).	Adusei DC, 2010, NEUROPHARMACOLOGY, V59, P167, DOI 10.1016/j.neuropharm.2010.05.002; Akins MR, 2009, FRONT NEURAL CIRCUIT, V3, DOI 10.3389/neuro.04.017.2009; Antar LN, 2006, MOL CELL NEUROSCI, V32, P37, DOI 10.1016/j.mcn.2006.02.001; ASHLEY CT, 1993, SCIENCE, V262, P563, DOI 10.1126/science.7692601; Auerbach BD, 2011, NATURE, V480, P63, DOI 10.1038/nature10658; Bear MF, 2004, TRENDS NEUROSCI, V27, P370, DOI 10.1016/j.tins.2004.04.009; Berry-Kravis E, 2009, J MED GENET, V46, P266, DOI 10.1136/jmg.2008.063701; Berry-Kravis EM, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004214; BERRYKRAVIS E, 1993, AM J MED GENET, V45, P81, DOI 10.1002/ajmg.1320450120; Bhakar AL, 2012, ANNU REV NEUROSCI, V35, P417, DOI 10.1146/annurev-neuro-060909-153138; Bhattacharya A, 2012, NEURON, V76, P325, DOI 10.1016/j.neuron.2012.07.022; Bilousova TV, 2009, J MED GENET, V46, P94, DOI 10.1136/jmg.2008.061796; Bolduc FV, 2008, NAT NEUROSCI, V11, P1143, DOI 10.1038/nn.2175; Budkevich TV, 2008, NUCLEIC ACIDS RES, V36, P4736, DOI 10.1093/nar/gkn424; Chang S, 2008, NAT CHEM BIOL, V4, P256, DOI 10.1038/nchembio.78; Christie SB, 2009, J NEUROSCI, V29, P1514, DOI 10.1523/JNEUROSCI.3937-08.2009; Comery TA, 1997, P NATL ACAD SCI USA, V94, P5401, DOI 10.1073/pnas.94.10.5401; Corbin F, 1997, HUM MOL GENET, V6, P1465, DOI 10.1093/hmg/6.9.1465; Costa-Mattioli M, 2009, NEURON, V61, P10, DOI 10.1016/j.neuron.2008.10.055; Cruz-Martin A, 2010, J NEUROSCI, V30, P7793, DOI 10.1523/JNEUROSCI.0577-10.2010; D'Hulst C, 2006, BRAIN RES, V1121, P238, DOI 10.1016/j.brainres.2006.08.115; Darnell JC, 2005, GENE DEV, V19, P903, DOI 10.1101/gad.1276805; Darnell JC, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a012344; Darnell JC, 2011, CELL, V146, P247, DOI 10.1016/j.cell.2011.06.013; Darnell RB, 2010, WIRES RNA, V1, P266, DOI 10.1002/wrna.31; DEBOULLE K, 1993, NAT GENET, V3, P31, DOI 10.1038/ng0193-31; Deng PY, 2011, J NEUROSCI, V31, P10971, DOI 10.1523/JNEUROSCI.2021-11.2011; Dolen G, 2007, NEURON, V56, P955, DOI 10.1016/j.neuron.2007.12.001; El Idrissi A, 2005, NEUROSCI LETT, V377, P141, DOI 10.1016/j.neulet.2004.11.087; Feng Y, 1997, MOL CELL, V1, P109, DOI 10.1016/S1097-2765(00)80012-X; Gatto CL, 2009, MOL NEUROBIOL, V39, P107, DOI 10.1007/s12035-009-8057-0; Gibson JR, 2008, J NEUROPHYSIOL, V100, P2615, DOI 10.1152/jn.90752.2008; Goebel-Goody SM, 2012, GENES BRAIN BEHAV, V11, P586, DOI 10.1111/j.1601-183X.2012.00781.x; Gross C, 2012, MOL MED, V18, P336, DOI 10.2119/molmed.2011.00363; Gross C, 2010, J NEUROSCI, V30, P10624, DOI 10.1523/JNEUROSCI.0402-10.2010; Guo WX, 2012, HUM MOL GENET, V21, P681, DOI 10.1093/hmg/ddr501; Hanson JE, 2007, J NEUROSCI, V27, P4014, DOI 10.1523/JNEUROSCI.4717-06.2007; Harlow EG, 2010, NEURON, V65, P385, DOI 10.1016/j.neuron.2010.01.024; Henderson C, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004218; Heulens I, 2012, BEHAV BRAIN RES, V229, P244, DOI 10.1016/j.bbr.2012.01.031; Hoeffer CA, 2012, GENES BRAIN BEHAV, V11, P332, DOI 10.1111/j.1601-183X.2012.00768.x; Hoeffer CA, 2010, TRENDS NEUROSCI, V33, P67, DOI 10.1016/j.tins.2009.11.003; Hou LF, 2006, NEURON, V51, P441, DOI 10.1016/j.neuron.2006.07.005; Huber KM, 2002, P NATL ACAD SCI USA, V99, P7746, DOI 10.1073/pnas.122205699; Huber KM, 2000, SCIENCE, V288, P1254, DOI 10.1126/science.288.5469.1254; Kelleher RJ, 2008, CELL, V135, P401, DOI 10.1016/j.cell.2008.10.017; Kelley DJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000931; Khandjian EW, 2004, P NATL ACAD SCI USA, V101, P13357, DOI 10.1073/pnas.0405398101; Kim HS, 2009, BEHAV BRAIN RES, V196, P168, DOI 10.1016/j.bbr.2008.09.040; Klann E, 2004, LEARN MEMORY, V11, P365, DOI 10.1101/lm.79004; Klann E, 2004, NAT REV NEUROSCI, V5, P931, DOI 10.1038/nrn1557; Klann E, 2008, NEUROBIOL LEARN MEM, V89, P247, DOI 10.1016/j.nlm.2007.08.009; Krueger DD, 2011, P NATL ACAD SCI USA, V108, P2587, DOI 10.1073/pnas.1013855108; Kwiatkowski DJ, 2005, HUM MOL GENET, V14, pR251, DOI 10.1093/hmg/ddi260; Laggerbauer B, 2001, HUM MOL GENET, V10, P329, DOI 10.1093/hmg/10.4.329; Lee HY, 2011, NEURON, V72, P630, DOI 10.1016/j.neuron.2011.09.033; Lewis HA, 2000, CELL, V100, P323, DOI 10.1016/S0092-8674(00)80668-6; Li JX, 2002, MOL CELL NEUROSCI, V19, P138, DOI 10.1006/mcne.2001.1085; Li ZZ, 2001, NUCLEIC ACIDS RES, V29, P2276, DOI 10.1093/nar/29.11.2276; McBride SMJ, 2005, NEURON, V45, P753, DOI 10.1016/j.neuron.2005.01.038; Michalon A, 2012, NEURON, V74, P49, DOI 10.1016/j.neuron.2012.03.009; Mines MA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009706; Napoli I, 2008, CELL, V134, P1042, DOI 10.1016/j.cell.2008.07.031; Neves-Pereira M, 2009, J MED GENET, V46, P759, DOI 10.1136/jmg.2009.066852; Newey SE, 2005, J NEUROBIOL, V64, P58, DOI 10.1002/neu.20153; Nimchinsky EA, 2001, J NEUROSCI, V21, P5139, DOI 10.1523/JNEUROSCI.21-14-05139.2001; Nosyreva ED, 2006, J NEUROPHYSIOL, V95, P3291, DOI 10.1152/jn.01316.2005; Osterweil EK, 2013, NEURON, V77, P243, DOI 10.1016/j.neuron.2012.01.034; Osterweil EK, 2010, J NEUROSCI, V30, P15616, DOI 10.1523/JNEUROSCI.3888-10.2010; Ozean U, 2008, MOL CELL, V29, P541, DOI [10.1016/j.moicel.2007.12.023, 10.1016/j.molcel.2007.12.023]; Pan F, 2010, P NATL ACAD SCI USA, V107, P17768, DOI 10.1073/pnas.1012496107; Paribello C, 2010, BMC NEUROL, V10, DOI 10.1186/1471-2377-10-91; Pinto D, 2010, NATURE, V466, P368, DOI 10.1038/nature09146; Qin M, 2005, J NEUROSCI, V25, P5087, DOI 10.1523/JNEUROSCI.0093-05.2005; Ramos A, 2003, RNA, V9, P293, DOI 10.1261/rna.2168503; Richter JD, 2009, GENE DEV, V23, P1, DOI 10.1101/gad.1735809; Romanelli A, 1999, MOL CELL BIOL, V19, P2921; Ronesi JA, 2008, J NEUROSCI, V28, P543, DOI 10.1523/JNEUROSCI.5019-07.2008; Ronesi JA, 2012, NAT NEUROSCI, V15, P431, DOI 10.1038/nn.3033; Rumbaugh G, 2006, P NATL ACAD SCI USA, V103, P4344, DOI 10.1073/pnas.0600084103; Santini E, 2013, NATURE, V493, P411, DOI 10.1038/nature11782; Santoro MR, 2012, ANNU REV PATHOL-MECH, V7, P219, DOI 10.1146/annurev-pathol-011811-132457; Schutt J, 2009, J BIOL CHEM, V284, P25479, DOI 10.1074/jbc.M109.042663; Sebeo J, 2009, J NEUROSCI, V29, P9778, DOI 10.1523/JNEUROSCI.2613-09.2009; Shanks NF, 2012, CELL REP, V1, P590, DOI 10.1016/j.celrep.2012.05.004; Sharma A, 2010, J NEUROSCI, V30, P694, DOI 10.1523/JNEUROSCI.3696-09.2010; Siller SS, 2011, DIS MODEL MECH, V4, P673, DOI 10.1242/dmm.008045; SIOMI H, 1993, CELL, V74, P291, DOI 10.1016/0092-8674(93)90420-U; Stefani G, 2004, J NEUROSCI, V24, P7272, DOI 10.1523/JNEUROSCI.2306-04.2004; Strumbos JG, 2010, J NEUROSCI, V30, P10263, DOI 10.1523/JNEUROSCI.1125-10.2010; Suvrathan A, 2010, P NATL ACAD SCI USA, V107, P11591, DOI 10.1073/pnas.1002262107; Till SM, 2012, HUM MOL GENET, V21, P2143, DOI 10.1093/hmg/dds030; VERKERK AJMH, 1991, CELL, V65, P905, DOI 10.1016/0092-8674(91)90397-H; Zalfa F, 2003, CELL, V112, P317, DOI 10.1016/S0092-8674(03)00079-5; Zang JB, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000758; Zhang J, 2009, J NEUROPHYSIOL, V101, P2572, DOI 10.1152/jn.90558.2008; Zhang YQ, 2001, CELL, V107, P591, DOI 10.1016/S0092-8674(01)00589-X	97	308	313	4	62	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	NOV	2013	16	11					1530	1536		10.1038/nn.3379	http://dx.doi.org/10.1038/nn.3379			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	241YX	23584741	Green Accepted			2022-12-28	WOS:000326205700008
J	Zembrzycki, A; Chou, SJ; Ashery-Padan, R; Stoykova, A; O'Leary, DDM				Zembrzycki, Andreas; Chou, Shen-Ju; Ashery-Padan, Ruth; Stoykova, Anastassia; O'Leary, Dennis D. M.			Sensory cortex limits cortical maps and drives top-down plasticity in thalamocortical circuits	NATURE NEUROSCIENCE			English	Article							AUTISM SPECTRUM DISORDERS; RAT SOMATOSENSORY CORTEX; HUMAN VISUAL-CORTEX; CEREBRAL-CORTEX; BARREL CORTEX; EVOLUTION; COMPLEX; PAX6; NEOCORTEX; MAMMALS	The primary somatosensory cortex (S1) contains a complete body map that mirrors the subcortical maps developed by peripheral sensory input projecting to the sensory hindbrain, the thalamus and then S1. Peripheral changes during development alter these maps through 'bottom-up' plasticity. Unknown is how S1 size influences map organization and whether an altered S1 map feeds back to affect subcortical maps. We show that the size of S1 in mice is significantly reduced by cortex-specific deletion of Pax6, resulting in a reduced body map and loss of body representations by an exclusion of later-differentiating sensory thalamocortical input. An initially normal sensory thalamus was repatterned to match the aberrant S1 map by apoptotic deletion of thalamic neurons representing body parts with axons excluded from S1. Deleted representations were rescued by altering competition between thalamocortical axons using sensory deprivation or increasing the size of S1. Thus, S1 size determined the resolution and completeness of body maps and engaged 'top-down' plasticity that repatterned the sensory thalamus to match S1.	[Zembrzycki, Andreas; Chou, Shen-Ju; O'Leary, Dennis D. M.] Salk Inst Biol Studies, Mol Neurobiol Lab, La Jolla, CA 92037 USA; [Ashery-Padan, Ruth; Stoykova, Anastassia] Max Planck Inst Biophys Chem, Dept Mol Cell Biol, D-37077 Gottingen, Germany	Salk Institute; Max Planck Society	O'Leary, DDM (corresponding author), Salk Inst Biol Studies, Mol Neurobiol Lab, La Jolla, CA 92037 USA.	doleary@salk.edu	Zembrzycki, Andreas/D-7607-2013	Zembrzycki, Andreas/0000-0001-8468-4195	US National Institutes of Health [R01 NS31558, R01 MH086147]; Vincent J. Coates Chair of Molecular Neurobiology; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH086147] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R37NS031558, R01NS031558] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Vincent J. Coates Chair of Molecular Neurobiology; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank B. Higgins and H. Gutierrez for technical assistance, J. Simon (Salk Institute MultiMedia Resources) for help making Adobe Illustrator schematics, Y. Dayn (Salk Institute Transgenic Core) for help producing the nestin-Pax6TG conditional transgenic mice, K. Jones (University of Colorado) for the Emx1-IRES-cre mice, M. Goulding (Salk Institute) for the ROSA26-GAP43-eGFP mice and members of the O'Leary lab for discussion. This work was supported by US National Institutes of Health grants R01 NS31558 and R01 MH086147 and the Vincent J. Coates Chair of Molecular Neurobiology (D.D.M.O.).	Andrews TJ, 1997, J NEUROSCI, V17, P2859; Ashery-Padan R, 2000, GENE DEV, V14, P2701, DOI 10.1101/gad.184000; BELFORD GR, 1980, J COMP NEUROL, V193, P335, DOI 10.1002/cne.901930203; Bishop KM, 2000, SCIENCE, V288, P344, DOI 10.1126/science.288.5464.344; Cheon KA, 2011, BRAIN RES, V1417, P77, DOI 10.1016/j.brainres.2011.08.020; Chou SJ, 2013, SCIENCE, V340, P1239, DOI 10.1126/science.1232806; Chou SJ, 2009, NAT NEUROSCI, V12, P1381, DOI 10.1038/nn.2427; Courchesne E, 2007, NEURON, V56, P399, DOI 10.1016/j.neuron.2007.10.016; Courchesne E, 2011, JAMA-J AM MED ASSOC, V306, P2001, DOI 10.1001/jama.2011.1638; Diaz F, 2012, HUM MOL GENET, V21, P5066, DOI 10.1093/hmg/dds350; Diaz F, 2010, BBA-MOL BASIS DIS, V1802, P100, DOI 10.1016/j.bbadis.2009.07.013; Dougherty RF, 2003, J VISION, V3, P586, DOI 10.1167/3.10.1; DURHAM D, 1984, J COMP NEUROL, V223, P424, DOI 10.1002/cne.902230308; Erzurumlu RS, 2012, EUR J NEUROSCI, V35, P1540, DOI 10.1111/j.1460-9568.2012.08075.x; Erzurumlu RS, 2010, NAT REV NEUROSCI, V11, P252, DOI 10.1038/nrn2804; Feldman DE, 1999, J NEUROBIOL, V41, P92, DOI 10.1002/(SICI)1097-4695(199910)41:1<92::AID-NEU12>3.0.CO;2-U; Fox K, 2005, NEURON, V48, P465, DOI 10.1016/j.neuron.2005.10.013; Fox K, 2008, BARREL CORTEX, P1, DOI 10.1017/CBO9780511541636.003; Gorski JA, 2002, J NEUROSCI, V22, P6309; Grant E, 2012, FRONT NEUROSCI-SWITZ, V6, DOI 10.3389/fnins.2012.00053; Higginbotham H, 2011, CEREB CORTEX, V21, P1465, DOI 10.1093/cercor/bhq197; Huttemann M, 2012, BBA-BIOENERGETICS, V1817, P598, DOI 10.1016/j.bbabio.2011.07.001; KAAS JH, 1989, J EXP BIOL, V146, P165; Krubitzer L, 2005, CURR OPIN NEUROBIOL, V15, P444, DOI 10.1016/j.conb.2005.07.003; Krubitzer L, 2003, PROG NEUROBIOL, V70, P33, DOI 10.1016/S0301-0082(03)00088-1; Krubitzer L, 2009, ANN NY ACAD SCI, V1156, P44, DOI 10.1111/j.1749-6632.2009.04421.x; Krubitzer LA, 2012, P NATL ACAD SCI USA, V109, P10647, DOI 10.1073/pnas.1201891109; Leingartner A, 2007, P NATL ACAD SCI USA, V104, P4153, DOI 10.1073/pnas.0611723104; MA PM, 1984, BRAIN RES, V306, P374, DOI 10.1016/0006-8993(84)90390-1; Molnar Z, 2012, EUR J NEUROSCI, V35, P1573, DOI 10.1111/j.1460-9568.2012.08119.x; O'Leary DDM, 2007, NEURON, V56, P252, DOI 10.1016/j.neuron.2007.10.010; Petersen CCH, 2007, NEURON, V56, P339, DOI 10.1016/j.neuron.2007.09.017; Pinon MC, 2008, J NEUROSCI, V28, P8724, DOI 10.1523/JNEUROSCI.2565-08.2008; Rasband W., 2006, IMAGEJ; RHOADES RW, 1990, J COMP NEUROL, V293, P190, DOI 10.1002/cne.902930204; Rubenstein JLR, 2011, J CHILD PSYCHOL PSYC, V52, P339, DOI 10.1111/j.1469-7610.2010.02307.x; Sapir T, 2004, J NEUROSCI, V24, P1255, DOI 10.1523/JNEUROSCI.3187-03.2004; SCHLAGGAR BL, 1994, J COMP NEUROL, V346, P80, DOI 10.1002/cne.903460106; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Tamura R, 2010, PSYCHIAT RES-NEUROIM, V184, P186, DOI 10.1016/j.pscychresns.2010.07.001; VANDERLOOS H, 1976, NEUROSCI LETT, V2, P1, DOI 10.1016/0304-3940(76)90036-7; Vitalis T, 1998, J COMP NEUROL, V393, P169, DOI 10.1002/(SICI)1096-9861(19980406)393:2<169::AID-CNE3>3.0.CO;2-0; Voineagu I, 2011, NATURE, V474, P380, DOI 10.1038/nature10110; WAITE PME, 1992, NEUROREPORT, V3, P485, DOI 10.1097/00001756-199206000-00007; Wallace H, 1999, J NEUROBIOL, V41, P58, DOI 10.1002/(SICI)1097-4695(199910)41:1<58::AID-NEU8>3.0.CO;2-F; White LE, 1997, CEREB CORTEX, V7, P31, DOI 10.1093/cercor/7.1.31; WOOLSEY TA, 1970, BRAIN RES, V17, P205, DOI 10.1016/0006-8993(70)90079-X; Yaworsky PJ, 1999, DEV BIOL, V205, P309, DOI 10.1006/dbio.1998.9035; Zembrzycki A, 2007, NEURAL DEV, V2, DOI 10.1186/1749-8104-2-8; Zhou LB, 2010, J NEUROSCI, V30, P7928, DOI 10.1523/JNEUROSCI.6005-09.2010	50	48	48	0	19	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	AUG	2013	16	8					1060	1067		10.1038/nn.3454	http://dx.doi.org/10.1038/nn.3454			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	190EV	23831966	Green Accepted			2022-12-28	WOS:000322323000016
J	Renart, A				Renart, Alfonso			Recurrent networks learn to tell time	NATURE NEUROSCIENCE			English	Editorial Material							NEURAL-NETWORKS; DYNAMICS; CHAOS		Champalimaud Ctr Unknown, Champalimaud Neurosci Programme, Lisbon, Portugal	Fundacao Champalimaud	Renart, A (corresponding author), Champalimaud Ctr Unknown, Champalimaud Neurosci Programme, Lisbon, Portugal.	alfonso.renart@neuro.fchampalimaud.org		Renart, Alfonso/0000-0001-7916-9930				Durstewitz D, 2003, J NEUROSCI, V23, P5342; Fujisawa S, 2008, NAT NEUROSCI, V11, P823, DOI 10.1038/nn.2134; Gallistel C. R., 1993, ORG LEARNING; Goldman MS, 2009, NEURON, V61, P621, DOI 10.1016/j.neuron.2008.12.012; Haykin S., 2001, ADAPTIVE FILTER THEO; Komura Y, 2001, NATURE, V412, P546, DOI 10.1038/35087595; Laje R, 2013, NAT NEUROSCI, V16, P925, DOI 10.1038/nn.3405; Maass W, 2002, NEURAL COMPUT, V14, P2531, DOI 10.1162/089976602760407955; Matell MS, 2004, COGNITIVE BRAIN RES, V21, P139, DOI 10.1016/j.cogbrainres.2004.06.012; Mauk MD, 1997, LEARN MEMORY, V4, P130, DOI 10.1101/lm.4.1.130; Monteforte M, 2012, PHYS REV X, V2, DOI 10.1103/PhysRevX.2.041007; SOMPOLINSKY H, 1988, PHYS REV LETT, V61, P259, DOI 10.1103/PhysRevLett.61.259; Sussillo D, 2009, NEURON, V63, P544, DOI 10.1016/j.neuron.2009.07.018; vanVreeswijk C, 1996, SCIENCE, V274, P1724, DOI 10.1126/science.274.5293.1724	15	5	5	1	14	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JUL	2013	16	7					772	774		10.1038/nn.3441	http://dx.doi.org/10.1038/nn.3441			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	174UM	23799465				2022-12-28	WOS:000321180900002
J	Benucci, A; Saleem, AB; Carandini, M				Benucci, Andrea; Saleem, Aman B.; Carandini, Matteo			Adaptation maintains population homeostasis in primary visual cortex	NATURE NEUROSCIENCE			English	Article							UNDERLYING CONTRAST ADAPTATION; CORTICAL-NEURONS; RAPID ADAPTATION; AUDITORY-CORTEX; IN-VIVO; ORIENTATION; PLASTICITY; INFORMATION; MOTION; SENSITIVITY	Sensory systems exhibit mechanisms of neural adaptation, which adjust neuronal activity on the basis of recent stimulus history. In primary visual cortex (V1) in particular, adaptation controls the responsiveness of individual neurons and shifts their visual selectivity. What benefits does adaptation confer on a neuronal population? We measured adaptation in the responses of populations of cat V1 neurons to stimulus ensembles with markedly different statistics of stimulus orientation. We found that adaptation served two homeostatic goals. First, it maintained equality in the time-averaged responses across the population. Second, it maintained independence in selectivity across the population. Adaptation scaled and distorted population activity according to a simple multiplicative rule that depended on neuronal orientation preference and on stimulus orientation. We conclude that adaptation in V1 acts as a mechanism of homeostasis, enforcing a tendency toward equality and independence in neural activity across the population.	[Benucci, Andrea; Saleem, Aman B.; Carandini, Matteo] UCL, UCL Inst Ophthalmol, London, England	University of London; University College London	Benucci, A (corresponding author), UCL, UCL Inst Ophthalmol, London, England.	a.benucci@ucl.ac.uk	Carandini, Matteo/ABD-8296-2021; Benucci, Andrea/N-6361-2015	Carandini, Matteo/0000-0003-4880-7682; Benucci, Andrea/0000-0002-7698-6289; Saleem, Aman/0000-0002-7100-1954	US National Institutes of Health; European Research Council; Wellcome Trust; NATIONAL EYE INSTITUTE [R01EY017396] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); European Research Council(European Research Council (ERC)European Commission); Wellcome Trust(Wellcome TrustEuropean Commission); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	We thank L. Busse and S. Katzner for help with data acquisition, and numerous colleagues for useful suggestions. This work was supported by the US National Institutes of Health, the European Research Council and the Wellcome Trust. M.C. holds the GlaxoSmithKline/Fight for Sight Chair in Visual Neuroscience.	Anstis S, 1998, TRENDS COGN SCI, V2, P111, DOI 10.1016/S1364-6613(98)01142-5; BARLOW H, 1989, COMP NEUR S, P54; Benucci A, 2009, NAT NEUROSCI, V12, P1317, DOI 10.1038/nn.2398; BLAKEMORE C, 1969, J PHYSIOL-LONDON, V203, P237, DOI 10.1113/jphysiol.1969.sp008862; BLAKEMORE C, 1970, J PHYSIOL-LONDON, V210, P727, DOI 10.1113/jphysiol.1970.sp009238; Blakemore C., 2010, VISION CODING EFFICI, P363, DOI 10.1017/cbo9780511626197.034; Brenner N, 2000, NEURON, V26, P695, DOI 10.1016/S0896-6273(00)81205-2; Carandini M, 1997, SCIENCE, V276, P949, DOI 10.1126/science.276.5314.949; Chance FS, 2001, NEUROCOMPUTING, V38, P141, DOI 10.1016/S0925-2312(01)00550-1; Chung S, 2002, NEURON, V34, P437, DOI 10.1016/S0896-6273(02)00659-1; Clifford CWG, 2007, VISION RES, V47, P3125, DOI 10.1016/j.visres.2007.08.023; Clifford CWG, 2000, P ROY SOC B-BIOL SCI, V267, P1705, DOI 10.1098/rspb.2000.1198; Cohen MR, 2011, NAT NEUROSCI, V14, P811, DOI 10.1038/nn.2842; CONDON CD, 1991, BEHAV NEUROSCI, V105, P416, DOI 10.1037/0735-7044.105.3.416; Dayan P, 2001, COMPUTATIONAL NEUROS; Dean I, 2005, NAT NEUROSCI, V8, P1684, DOI 10.1038/nn1541; Dragoi V, 2000, NEURON, V28, P287, DOI 10.1016/S0896-6273(00)00103-3; Dragoi V, 2002, NAT NEUROSCI, V5, P883, DOI 10.1038/nn900; Fairhall AL, 2001, NATURE, V412, P787, DOI 10.1038/35090500; Gardner JL, 2004, J NEUROSCI, V24, P9035, DOI 10.1523/JNEUROSCI.0337-04.2004; Gibson JJ, 1937, J EXP PSYCHOL, V20, P453, DOI 10.1037/h0059826; Graham N.V.S, 1989, VISUAL PATTERN ANAL; Gutnisky DA, 2008, NATURE, V452, P220, DOI 10.1038/nature06563; Jin DZ, 2005, J NEUROPHYSIOL, V94, P4038, DOI 10.1152/jn.00571.2004; Katzner S, 2009, NEURON, V61, P35, DOI 10.1016/j.neuron.2008.11.016; Kohn A, 2003, NEURON, V39, P681, DOI 10.1016/S0896-6273(03)00438-0; Kohn A, 2004, NAT NEUROSCI, V7, P764, DOI 10.1038/nn1267; Kohn A, 2007, J NEUROPHYSIOL, V97, P3155, DOI 10.1152/jn.00086.2007; Maravall M, 2007, PLOS BIOL, V5, P323, DOI 10.1371/journal.pbio.0050019; MOVSHON JA, 1979, NATURE, V278, P850, DOI 10.1038/278850a0; MOVSHON JA, 1978, J PHYSIOL-LONDON, V283, P101, DOI 10.1113/jphysiol.1978.sp012490; Muller JR, 1999, SCIENCE, V285, P1405, DOI 10.1126/science.285.5432.1405; Nagel KI, 2006, NEURON, V51, P845, DOI 10.1016/j.neuron.2006.08.030; OHZAWA I, 1982, NATURE, V298, P266, DOI 10.1038/298266a0; Reich DS, 2001, SCIENCE, V294, P2566, DOI 10.1126/science.1065839; Sanchez-Vives MV, 2000, J NEUROSCI, V20, P4267; Schwartz O, 2007, NAT REV NEUROSCI, V8, P522, DOI 10.1038/nrn2155; SEKULER R, 1967, VISION RES, V7, P427, DOI 10.1016/0042-6989(67)90050-8; Simoncelli EP, 2004, COGNITIVE NEUROSCIENCES III, THIRD EDITION, P327; Stocker AA, 2009, J VISION, V9, DOI 10.1167/9.9.9; Turrigiano GG, 2004, NAT REV NEUROSCI, V5, P97, DOI 10.1038/nrn1327; Ulanovsky N, 2004, J NEUROSCI, V24, P10440, DOI 10.1523/JNEUROSCI.1905-04.2004; Ulanovsky N, 2003, NAT NEUROSCI, V6, P391, DOI 10.1038/nn1032; ULLMAN S, 1982, PROC R SOC SER B-BIO, V216, P299, DOI 10.1098/rspb.1982.0076; Wark B, 2007, CURR OPIN NEUROBIOL, V17, P423, DOI 10.1016/j.conb.2007.07.001; Wark B, 2009, NEURON, V61, P750, DOI 10.1016/j.neuron.2009.01.019; Wissig SC, 2012, J NEUROPHYSIOL, V107, P3370, DOI 10.1152/jn.00739.2011; Yao HS, 2004, P NATL ACAD SCI USA, V101, P5081, DOI 10.1073/pnas.0302510101	49	100	101	0	36	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JUN	2013	16	6					724	+		10.1038/nn.3382	http://dx.doi.org/10.1038/nn.3382			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	152DE	23603708	Green Accepted			2022-12-28	WOS:000319509600014
J	Bagdasarian, K; Szwed, M; Knutsen, PM; Deutsch, D; Derdikman, D; Pietr, M; Simony, E; Ahissar, E				Bagdasarian, Knarik; Szwed, Marcin; Knutsen, Per Magne; Deutsch, Dudi; Derdikman, Dori; Pietr, Maciej; Simony, Erez; Ahissar, Ehud			Pre-neuronal morphological processing of object location by individual whiskers	NATURE NEUROSCIENCE			English	Article							RADIAL DISTANCE DETERMINATION; TRIGEMINAL GANGLION NEURONS; FUNCTIONAL PLASTICITY; VIBRISSAL SYSTEM; BARREL CORTEX; RAT-VIBRISSAE; WHISKING; LOCALIZATION; RESPONSES; MOVEMENTS	In the vibrissal system, touch information is conveyed by a receptorless whisker hair to follicle mechanoreceptors, which then provide input to the brain. We examined whether any processing, that is, meaningful transformation, occurs in the whisker itself. Using high-speed videography and tracking the movements of whiskers in anesthetized and behaving rats, we found that whisker-related morphological phase planes, based on angular and curvature variables, can represent the coordinates of object position after contact in a reliable manner, consistent with theoretical predictions. By tracking exposed follicles, we found that the follicle-whisker junction is rigid, which enables direct readout of whisker morphological coding by mechanoreceptors. Finally, we found that our behaving rats pushed their whiskers against objects during localization in a way that induced meaningful morphological coding and, in parallel, improved their localization performance, which suggests a role for pre-neuronal morphological computation in active vibrissal touch.	[Bagdasarian, Knarik; Deutsch, Dudi; Pietr, Maciej; Ahissar, Ehud] Weizmann Inst Sci, Dept Neurobiol, IL-76100 Rehovot, Israel; [Szwed, Marcin] Jagiellonian Univ, Inst Psychol, Psychophysiol Lab, Krakow, Poland; [Knutsen, Per Magne] Univ Calif San Diego, Dept Phys, La Jolla, CA 92093 USA; [Derdikman, Dori] Technion Israel Inst Technol, Rappaport Fac Med, Haifa, Israel; [Simony, Erez] Princeton Univ, Dept Psychol, Princeton, NJ 08544 USA; [Simony, Erez] Princeton Univ, Inst Neurosci, Princeton, NJ 08544 USA	Weizmann Institute of Science; Jagiellonian University; University of California System; University of California San Diego; Technion Israel Institute of Technology; Rappaport Faculty of Medicine; Princeton University; Princeton University	Ahissar, E (corresponding author), Weizmann Inst Sci, Dept Neurobiol, IL-76100 Rehovot, Israel.	ehud.ahissar@weizmann.ac.il	simony, erez/AAA-9757-2020		Israel Science Foundation [749/10]; Minerva Foundation; Federal German Ministry for Education and Research; United States-Israel Binational Science Foundation [2011432]; Ministry of Science and Technology (Israel); Ministry of Research (Taiwan); Israeli Ministry of Health; KAMEA program; Long-Term Fellowship from the Human Frontier Science Program	Israel Science Foundation(Israel Science Foundation); Minerva Foundation; Federal German Ministry for Education and Research(Federal Ministry of Education & Research (BMBF)); United States-Israel Binational Science Foundation(US-Israel Binational Science Foundation); Ministry of Science and Technology (Israel); Ministry of Research (Taiwan)(Ministry of Education, Taiwan); Israeli Ministry of Health; KAMEA program; Long-Term Fellowship from the Human Frontier Science Program(Human Frontier Science Program)	We thank D. Goldian and S. Haidarliu for technical assistance, N. Rubin for programming, B. Schick for reviewing, M. Hartmann and J. Solomon for critically reading the manuscript and for extensive and helpful discussions, and C. Moore, J. Ritt, L. Gomez, S. Barash and G. Bi for helpful suggestions. The article is dedicated to our late friend and colleague Maciej Pietr for his significant contribution to this work. This work was supported by the Israel Science Foundation (grant 749/10), the Minerva Foundation funded by the Federal German Ministry for Education and Research, the United States-Israel Binational Science Foundation (grant 2011432), the Ministry of Science and Technology (Israel), the Ministry of Research (Taiwan), and the Chief Scientist, Israeli Ministry of Health. K.B. acknowledges support by the KAMEA program administered by the Ministry of Absorption (Israel). P.M.K. was supported by a Long-Term Fellowship from the Human Frontier Science Program. E.A. holds the Helen Diller Family Professorial Chair of Neurobiology.	Ahissar E, 1998, NEUROPHARMACOLOGY, V37, P633, DOI 10.1016/S0028-3908(98)00068-9; Ahissar E, 2008, BIOL CYBERN, V98, P449, DOI 10.1007/s00422-008-0214-4; Andermann ML, 2004, NEURON, V42, P451, DOI 10.1016/S0896-6273(04)00198-9; Arabzadeh E, 2005, PLOS BIOL, V3, P155, DOI 10.1371/journal.pbio.0030017; Bahar A, 2004, J NEUROPHYSIOL, V92, P3298, DOI 10.1152/jn.00198.2004; Birdwell JA, 2007, J NEUROPHYSIOL, V98, P2439, DOI 10.1152/jn.00707.2006; Boubenec Y, 2012, FRONT BEHAV NEUROSCI, V6, DOI 10.3389/fnbeh.2012.00074; Chiel HJ, 2009, J NEUROSCI, V29, P12807, DOI 10.1523/JNEUROSCI.3338-09.2009; Cramer NP, 2006, J NEUROPHYSIOL, V96, P209, DOI 10.1152/jn.00071.2006; Deutsch D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044272; Diamond ME, 2008, NAT REV NEUROSCI, V9, P601, DOI 10.1038/nrn2411; Ebara S, 2002, J COMP NEUROL, V449, P103, DOI 10.1002/cne.10277; Ego-Stengel V, 2001, J NEUROPHYSIOL, V86, P422, DOI 10.1152/jn.2001.86.1.422; Euler L., 1744, ENESTROM 65 METHODUS; Gordon G, 2012, NEURAL NETWORKS, V32, P119, DOI 10.1016/j.neunet.2012.02.024; Haidarliu S, 2010, ANAT REC, V293, P1192, DOI 10.1002/ar.21156; Harish O, 2010, J NEUROPHYSIOL, V103, P2684, DOI 10.1152/jn.01016.2009; Hartmann MJ, 2003, J NEUROSCI, V23, P6510; Herfst LJ, 2008, J NEUROPHYSIOL, V99, P2821, DOI 10.1152/jn.01014.2007; Hill DN, 2008, J NEUROSCI, V28, P3438, DOI 10.1523/JNEUROSCI.5008-07.2008; Hill DN, 2011, NEURON, V72, P344, DOI 10.1016/j.neuron.2011.09.020; Horev G, 2011, PHILOS T R SOC B, V366, P3070, DOI 10.1098/rstb.2011.0157; Kleinfeld D, 2006, CURR OPIN NEUROBIOL, V16, P435, DOI 10.1016/j.conb.2006.06.009; Kleinfeld D, 2011, NEURON, V72, P455, DOI 10.1016/j.neuron.2011.10.009; Knutsen PM, 2008, NEURON, V59, P35, DOI 10.1016/j.neuron.2008.05.013; Knutsen PM, 2006, J NEUROSCI, V26, P8451, DOI 10.1523/JNEUROSCI.1516-06.2006; Knutsen PM, 2009, TRENDS NEUROSCI, V32, P101, DOI 10.1016/j.tins.2008.10.002; Knutsen PM, 2005, J NEUROPHYSIOL, V93, P2294, DOI 10.1152/jn.00718.2004; Lottem E, 2008, J NEUROPHYSIOL, V100, P2852, DOI 10.1152/jn.90302.2008; Lottem E, 2011, J NEUROSCI, V31, P8520, DOI 10.1523/JNEUROSCI.6695-10.2011; Mitchinson B, 2004, P ROY SOC B-BIOL SCI, V271, P2509, DOI 10.1098/rspb.2004.2882; Mitchinson B, 2007, P R SOC B, V274, P1035, DOI 10.1098/rspb.2006.0347; O'Connor DH, 2010, NEURON, V67, P1048, DOI 10.1016/j.neuron.2010.08.026; O'Connor DH, 2010, J NEUROSCI, V30, P1947, DOI 10.1523/JNEUROSCI.3762-09.2010; O'Regan JK, 2001, BEHAV BRAIN SCI, V24, P939, DOI 10.1017/S0140525X01000115; Pammer L., 2013, J NEUROSCI IN PRESS; Pearson MJ, 2011, PHILOS T R SOC B, V366, P3085, DOI 10.1098/rstb.2011.0164; Pfeifer R, 2009, LECT NOTES ARTIF INT, V5436, P66, DOI 10.1007/978-3-642-00616-6_5; Pietr MD, 2010, J NEUROPHYSIOL, V104, P2532, DOI 10.1152/jn.01039.2009; Prescott TJ, 2009, IEEE ROBOT AUTOM MAG, V16, P42, DOI 10.1109/MRA.2009.933624; Quist BW, 2012, J NEUROPHYSIOL, V107, P2298, DOI 10.1152/jn.00372.2011; Ritt JT, 2008, NEURON, V57, P599, DOI 10.1016/j.neuron.2007.12.024; Sachdev RNS, 2002, J NEUROPHYSIOL, V87, P1440, DOI 10.1152/jn.00539.2001; Saig A, 2012, J NEUROSCI, V32, P14022, DOI 10.1523/JNEUROSCI.2432-12.2012; Simony E, 2010, J NEUROSCI, V30, P8935, DOI 10.1523/JNEUROSCI.0172-10.2010; Solomon JH, 2011, PHILOS T R SOC B, V366, P3049, DOI 10.1098/rstb.2011.0166; Stuttgen MC, 2008, J NEUROPHYSIOL, V100, P1879, DOI 10.1152/jn.90511.2008; Szwed M, 2006, J NEUROPHYSIOL, V95, P791, DOI 10.1152/jn.00571.2005; Szwed M, 2003, NEURON, V40, P621, DOI 10.1016/S0896-6273(03)00671-8; Towal RB, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001120; Weisstein JS, 2005, J AM ACAD ORTHOP SUR, V13, P544, DOI 10.5435/00124635-200512000-00007; Wolfe J, 2008, PLOS BIOL, V6, P1661, DOI 10.1371/journal.pbio.0060215	52	65	65	0	30	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAY	2013	16	5					622	+		10.1038/nn.3378	http://dx.doi.org/10.1038/nn.3378			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	131WT	23563582				2022-12-28	WOS:000318029300019
J	Shonesy, BC; Wang, XH; Rose, KL; Ramikie, TS; Cavener, VS; Rentz, T; Baucum, AJ; Jalan-Sakrikar, N; Mackie, K; Winder, DG; Patel, S; Colbran, RJ				Shonesy, Brian C.; Wang, Xiaohan; Rose, Kristie L.; Ramikie, Teniel S.; Cavener, Victoria S.; Rentz, Tyler; Baucum, Anthony J., II; Jalan-Sakrikar, Nidhi; Mackie, Ken; Winder, Danny G.; Patel, Sachin; Colbran, Roger J.			CaMKII regulates diacylglycerol lipase-alpha and striatal endocannabinoid signaling	NATURE NEUROSCIENCE			English	Article							PROTEIN-KINASE-II; DEPOLARIZED POSTSYNAPTIC NEURONS; LONG-TERM DEPRESSION; ENDOGENOUS CANNABINOIDS; METABOTROPIC GLUTAMATE; SYNAPTIC PLASTICITY; DOPAMINERGIC CONTROL; MOTOR DEFICITS; RECEPTOR; MODULATION	The endocannabinoid 2-arachidonoylglycerol (2-AG) mediates activity-dependent depression of excitatory neurotransmission at central synapses, but the molecular regulation of 2-AG synthesis is not well understood. Here we identify a functional interaction between the 2-AG synthetic enzyme diacylglycerol lipase-alpha (DGL alpha) and calcium/calmodulin dependent protein kinase II (CaMKII). Activated CaMKII interacted with the C-terminal domain of DGL alpha, phosphorylated two serine residues and inhibited DGL alpha activity. Consistent with an inhibitory role for CaMKII in 2-AG synthesis, in vivo genetic inhibition of CaMKII increased striatal DGL activity and basal levels of 2-AG, and CaMKII inhibition augmented short-term retrograde endocannabinoid signaling at striatal glutamatergic synapses. Lastly, blockade of 2-AG breakdown using concentrations of JZL-184 that have no effect in wild-type mice produced a hypolocomotor response in mice with reduced CaMKII activity. These findings provide mechanistic insights into the molecular regulation of striatal endocannabinoid signaling with implications for physiological control of motor function.	[Shonesy, Brian C.; Rentz, Tyler; Baucum, Anthony J., II; Jalan-Sakrikar, Nidhi; Winder, Danny G.; Patel, Sachin; Colbran, Roger J.] Vanderbilt Univ, Sch Med, Dept Mol Physiol & Biophys, Nashville, TN 37212 USA; [Shonesy, Brian C.; Wang, Xiaohan; Ramikie, Teniel S.; Cavener, Victoria S.; Winder, Danny G.; Patel, Sachin; Colbran, Roger J.] Vanderbilt Univ, Sch Med, Vanderbilt Brain Inst, Nashville, TN 37212 USA; [Wang, Xiaohan] Vanderbilt Univ, Sch Med, Vanderbilt Int Scholar Program, Nashville, TN 37212 USA; [Rose, Kristie L.] Vanderbilt Univ, Sch Med, Dept Biochem, Nashville, TN 37212 USA; [Ramikie, Teniel S.; Patel, Sachin] Vanderbilt Univ, Sch Med, Dept Psychiat, Nashville, TN 37212 USA; [Mackie, Ken] Indiana Univ, Gill Ctr, Bloomington, IN USA; [Mackie, Ken] Indiana Univ, Dept Psychol & Brain Sci, Bloomington, IN USA; [Winder, Danny G.; Patel, Sachin; Colbran, Roger J.] Vanderbilt Univ, Sch Med, Vanderbilt Kennedy Ctr Res Human Dev, Nashville, TN 37212 USA	Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; Vanderbilt University	Colbran, RJ (corresponding author), Vanderbilt Univ, Sch Med, Dept Mol Physiol & Biophys, Nashville, TN 37212 USA.	sachin.patel@vanderbilt.edu; roger.colbran@vanderbilt.edu	Patel, Sachin/E-5608-2012; Colbran, Roger/AAU-7708-2021; Baucum, Anthony/I-5109-2013; Mackie, Ken/E-3715-2013; Shonesy, Brian/AAP-7569-2021; Wang, Xiaohan/V-3920-2019; Winder, Danny G./H-4857-2013; Jalan-Sakrikar, Nidhi/S-8653-2019	Colbran, Roger/0000-0001-7401-8244; Baucum, Anthony/0000-0002-4756-9865; Mackie, Ken/0000-0001-8501-6199; Wang, Xiaohan/0000-0001-7895-2333; Jalan-Sakrikar, Nidhi/0000-0001-6795-0121; Shonesy, Brian/0000-0003-3791-9339	US National Institutes of Health [T32-NS007491, T32-MH065215, K01-NS073700, K05-DA021696, R01-DA011322, R01-AA019455, K08-MH090412, R01-MH063232, R01-NS078291]; Michael J. Fox Foundation; Luton Society; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH063232, K08MH090412, T32MH065215] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [T32NS007491, K01NS073700, R01NS078291] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA019455] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [K05DA021696, R01DA011322] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Michael J. Fox Foundation; Luton Society; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by US National Institutes of Health (T32-NS007491 and T32-MH065215 to B.C.S.; K01-NS073700 to A.J.B.; K05-DA021696 and R01-DA011322 to K.M.; R01-AA019455 to D.G.W.; K08-MH090412 to S.P.; and R01-MH063232 and R01-NS078291 to R.J.C.), the Michael J. Fox Foundation (R.J.C.) and the Luton Society (S.P.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the US National Institutes of Health. Behavioral studies were performed in the Murine Neurobehavior Core and mass spectrometry and proteomics studies were performed at the Mass Spectrometry Research Center, both at Vanderbilt University Medical Center. We thank B. Cravatt (The Scripps Research Institute) for plasmids encoding DGL alpha-V5 and DGL beta-V5.	Ade KK, 2007, J NEUROSCI, V27, P2403, DOI 10.1523/JNEUROSCI.2916-06.2007; Aravanis AM, 2007, J NEURAL ENG, V4, pS143, DOI 10.1088/1741-2560/4/3/S02; Bisogno T, 2003, J CELL BIOL, V163, P463, DOI 10.1083/jcb.200305129; Blazquez C, 2011, BRAIN, V134, P119, DOI 10.1093/brain/awq278; Brown AM, 2005, EUR J NEUROSCI, V22, P247, DOI 10.1111/j.1460-9568.2005.04190.x; DEVANE WA, 1994, P NATL ACAD SCI USA, V91, P6698, DOI 10.1073/pnas.91.14.6698; Di Filippo M, 2008, CURR PHARM DESIGN, V14, P2337, DOI 10.2174/138161208785740072; Dinh TP, 2002, P NATL ACAD SCI USA, V99, P10819, DOI 10.1073/pnas.152334899; ENG JK, 1994, J AM SOC MASS SPECTR, V5, P976, DOI 10.1016/1044-0305(94)80016-2; Gao Y, 2010, J NEUROSCI, V30, P2017, DOI 10.1523/JNEUROSCI.5693-09.2010; Gerdeman GL, 2002, NAT NEUROSCI, V5, P446, DOI 10.1038/nn832; Giese KP, 1998, SCIENCE, V279, P870, DOI 10.1126/science.279.5352.870; Gong SC, 2003, NATURE, V425, P917, DOI 10.1038/nature02033; GRAYBIEL AM, 1994, SCIENCE, V265, P1826, DOI 10.1126/science.8091209; Grueter CE, 2006, MOL CELL, V23, P641, DOI 10.1016/j.molcel.2006.07.006; Gustin RM, 2011, MOL CELL NEUROSCI, V47, P286, DOI 10.1016/j.mcn.2011.05.006; Hashimotodani Y, 2005, NEURON, V45, P257, DOI 10.1016/j.neuron.2005.01.004; Jenkins MA, 2010, J NEUROSCI, V30, P5125, DOI 10.1523/JNEUROSCI.4367-09.2010; Jung KM, 2007, MOL PHARMACOL, V72, P612, DOI 10.1124/mol.107.037796; Katona I, 2006, J NEUROSCI, V26, P5628, DOI 10.1523/JNEUROSCI.0309-06.2006; Keimpema E, 2010, J NEUROSCI, V30, P13992, DOI 10.1523/JNEUROSCI.2126-10.2010; Kravitz AV, 2012, NAT NEUROSCI, V15, P816, DOI 10.1038/nn.3100; Kreitzer AC, 2001, NEURON, V29, P717, DOI 10.1016/S0896-6273(01)00246-X; Kreitzer AC, 2005, J NEUROSCI, V25, P10537, DOI 10.1523/JNEUROSCI.2959-05.2005; Kreitzer AC, 2002, CURR OPIN NEUROBIOL, V12, P324, DOI 10.1016/S0959-4388(02)00328-8; Kreitzer AC, 2007, NATURE, V445, P643, DOI 10.1038/nature05506; Lerner TN, 2012, NEURON, V73, P347, DOI 10.1016/j.neuron.2011.11.015; Lerner TN, 2010, J NEUROSCI, V30, P2160, DOI 10.1523/JNEUROSCI.5844-09.2010; Long JZ, 2009, NAT CHEM BIOL, V5, P37, DOI 10.1038/nchembio.129; Ma ZQ, 2009, J PROTEOME RES, V8, P3872, DOI 10.1021/pr900360j; MacLean B, 2010, BIOINFORMATICS, V26, P966, DOI 10.1093/bioinformatics/btq054; Maejima T, 2001, NEUROSCI RES, V40, P205, DOI 10.1016/S0168-0102(01)00241-3; Maejima T, 2001, NEURON, V31, P463, DOI 10.1016/S0896-6273(01)00375-0; Maejima T, 2005, J NEUROSCI, V25, P6826, DOI 10.1523/JNEUROSCI.0945-05.2005; MILLER SG, 1988, NEURON, V1, P593, DOI 10.1016/0896-6273(88)90109-2; MILLER SG, 1986, CELL, V44, P861, DOI 10.1016/0092-8674(86)90008-5; Muller-Vahl KR, 1999, AM J PSYCHIAT, V156, P495; Nikandrova YA, 2010, J BIOL CHEM, V285, P923, DOI 10.1074/jbc.M109.033985; Ohno-Shosaku T, 2005, CELL CALCIUM, V38, P369, DOI 10.1016/j.ceca.2005.06.014; Ohno-Shosaku T, 2001, NEURON, V29, P729, DOI 10.1016/S0896-6273(01)00247-1; Oudin MJ, 2011, EUR J NEUROSCI, V34, P1634, DOI 10.1111/j.1460-9568.2011.07831.x; Packard MG, 2002, ANNU REV NEUROSCI, V25, P563, DOI 10.1146/annurev.neuro.25.112701.142937; Patel S, 2009, NEUROPSYCHOPHARMACOL, V34, P2699, DOI 10.1038/npp.2009.101; Picconi B, 2004, J NEUROSCI, V24, P5283, DOI 10.1523/JNEUROSCI.1224-04.2004; Robison AJ, 2005, J BIOL CHEM, V280, P39316, DOI 10.1074/jbc.M508189200; Robison AJ, 2005, J BIOL CHEM, V280, P35329, DOI 10.1074/jbc.M502191200; Shen WX, 2008, SCIENCE, V321, P848, DOI 10.1126/science.1160575; Shen YS, 2005, J COMPUT NEUROSCI, V18, P25, DOI 10.1007/s10827-005-5475-5; SUGIURA T, 1995, BIOCHEM BIOPH RES CO, V215, P89, DOI 10.1006/bbrc.1995.2437; Sumislawski JJ, 2011, NEUROPSYCHOPHARMACOL, V36, P2750, DOI 10.1038/npp.2011.166; Tanimura A, 2010, NEURON, V65, P320, DOI 10.1016/j.neuron.2010.01.021; Uchigashima M, 2007, J NEUROSCI, V27, P3663, DOI 10.1523/JNEUROSCI.0448-07.2007; Wiley JL, 2003, EUR J PHARMACOL, V471, P185, DOI 10.1016/S0014-2999(03)01856-9; Wilson RI, 2001, NEURON, V31, P453, DOI 10.1016/S0896-6273(01)00372-5; Wilson RI, 2001, NATURE, V410, P588, DOI 10.1038/35069076; Yoshino H, 2011, J PHYSIOL-LONDON, V589, P4857, DOI 10.1113/jphysiol.2011.212225; Zhang L, 2011, PLOS ONE, V6	57	52	52	0	8	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	APR	2013	16	4					456	U124		10.1038/nn.3353	http://dx.doi.org/10.1038/nn.3353			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	114EM	23502535	Green Accepted			2022-12-28	WOS:000316723700016
J	Wilhelm, I; Rose, M; Imhof, KI; Rasch, B; Buchel, C; Born, J				Wilhelm, Ines; Rose, Michael; Imhof, Kathrin I.; Rasch, Bjoern; Buechel, Christian; Born, Jan			The sleeping child outplays the adult's capacity to convert implicit into explicit knowledge	NATURE NEUROSCIENCE			English	Article							MEMORY; CONSOLIDATION; FMRI	When sleep followed implicit training on a motor sequence, children showed greater gains in explicit sequence knowledge after sleep than adults. This greater explicit knowledge in children was linked to their higher sleep slow-wave activity and to stronger hippocampal activation at explicit knowledge retrieval. Our data indicate the superiority of children in extracting invariant features from complex environments, possibly as a result of enhanced reprocessing of hippocampal memory representations during slow-wave sleep.	[Wilhelm, Ines; Imhof, Kathrin I.; Born, Jan] Univ Tubingen, Dept Med Psychol & Behav Neurobiol, Tubingen, Germany; [Wilhelm, Ines] Univ Childrens Hosp Zuerich, Child Dev Ctr, Zurich, Switzerland; [Rose, Michael; Buechel, Christian] Univ Med Ctr Hamburg Eppendorf, Dept Syst Neurosci, NeuroImage Nord, Hamburg, Germany; [Rasch, Bjoern] Univ Zuerich, Div Biopsychol, Zurich, Switzerland; [Born, Jan] Univ Lubeck, Dept Neuroendocrinol, Lubeck, Germany	Eberhard Karls University of Tubingen; University Children's Hospital Zurich; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Lubeck	Wilhelm, I (corresponding author), Univ Tubingen, Dept Med Psychol & Behav Neurobiol, Tubingen, Germany.	ines.wilhelm@kispi.uzh.ch; jan.born@uni-tuebingen.de	Born, Jan/K-2596-2016; Rasch, Björn/A-3119-2015	Born, Jan/0000-0002-1847-6248; Rasch, Björn/0000-0001-7607-3415	Deutsche Forschungsgemeinschaft [SFB 654]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	The authors are grateful to S. Diekelmann, S. Groch, T. Ole Bergmann, K. Mueller, K. Wendt, T. Kraemer, H. Neumeyer, M. Menz, A. Marschner, G. Feld and D. McMakin for technical support and helpful discussions. This study was supported by the Deutsche Forschungsgemeinschaft (SFB 654 'Plasticity and Sleep').	Albouy G, 2008, NEURON, V58, P261, DOI 10.1016/j.neuron.2008.02.008; Cleeremans A, 2008, PROG BRAIN RES, V168, P19, DOI 10.1016/S0079-6123(07)68003-0; Darsaud A, 2011, J COGNITIVE NEUROSCI, V23, P1900, DOI 10.1162/jocn.2010.21550; Debas K, 2010, P NATL ACAD SCI USA, V107, P17839, DOI 10.1073/pnas.1013176107; Destrebecqz A, 2005, LEARN MEMORY, V12, P480, DOI 10.1101/lm.95605; Diekelmann S, 2010, NAT REV NEUROSCI, V11, P114, DOI 10.1038/nrn2762; Dienes Z, 1999, BEHAV BRAIN SCI, V22, P735, DOI 10.1017/S0140525X99002186; Fischer S, 2006, J COGNITIVE NEUROSCI, V18, P311, DOI 10.1162/089892906775990598; Gais S, 2007, P NATL ACAD SCI USA, V104, P18778, DOI 10.1073/pnas.0705454104; Kurth S, 2010, SLEEP, V33, P475, DOI 10.1093/sleep/33.4.475; Lewis PA, 2011, TRENDS COGN SCI, V15, P343, DOI 10.1016/j.tics.2011.06.004; Ohayon MM, 2004, SLEEP, V27, P1255, DOI 10.1093/sleep/27.7.1255; Payne JD, 2011, J COGNITIVE NEUROSCI, V23, P1285, DOI 10.1162/jocn.2010.21526; Payne JD, 2009, NEUROBIOL LEARN MEM, V92, P327, DOI 10.1016/j.nlm.2009.03.007; Rasch B, 2007, SCIENCE, V315, P1426, DOI 10.1126/science.1138581; Rechtschaffen A., 1968, BRAIN INFORM SERVICE; Rose M, 2010, CEREB CORTEX, V20, P2787, DOI 10.1093/cercor/bhq025; Schendan HE, 2003, NEURON, V37, P1013, DOI 10.1016/S0896-6273(03)00123-5; SEGER CA, 1994, PSYCHOL BULL, V115, P163, DOI 10.1037/0033-2909.115.2.163; Thomas KM, 2004, J COGNITIVE NEUROSCI, V16, P1339, DOI 10.1162/0898929042304688; Wagner U, 2004, NATURE, V427, P352, DOI 10.1038/nature02223; Wilhelm I, 2012, NEUROSCI BIOBEHAV R, V36, P1718, DOI 10.1016/j.neubiorev.2012.03.002; Yordanova J, 2008, LEARN MEMORY, V15, P508, DOI 10.1101/lm.897908	23	97	99	0	44	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	APR	2013	16	4					391	U37		10.1038/nn.3343	http://dx.doi.org/10.1038/nn.3343			5	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	114EM	23434910				2022-12-28	WOS:000316723700008
J	Jiang, XL; Wang, GF; Lee, AJ; Stornetta, RL; Zhu, JJ				Jiang, Xiaolong; Wang, Guangfu; Lee, Alice J.; Stornetta, Ruth L.; Zhu, J. Julius			The organization of two new cortical interneuronal circuits	NATURE NEUROSCIENCE			English	Article							LAYER-5 PYRAMIDAL NEURONS; EVOKED SYNAPTIC RESPONSES; VISUAL-CORTEX; BARREL CORTEX; GABAERGIC NEURONS; ACTION-POTENTIALS; AUDITORY-CORTEX; RAT NEOCORTEX; INHIBITION; DENDRITES	Deciphering the interneuronal circuitry is central to understanding brain functions, yet it remains a challenging task in neurobiology. Using simultaneous quadruple-octuple in vitro and dual in vivo whole-cell recordings, we found two previously unknown interneuronal circuits that link cortical layer 1-3 (L1-3) interneurons and L5 pyramidal neurons in the rat neocortex. L1 single-bouquet cells (SBCs) preferentially formed unidirectional inhibitory connections on L2/3 interneurons that inhibited the entire dendritic-somato-axonal axis of similar to 1% of L5 pyramidal neurons located in the same column. In contrast, L elongated neurogliaform cells (ENGCs) frequently formed mutual inhibitory and electric connections with L2/3 interneurons, and these L1-3 interneurons inhibited the distal apical dendrite of >60% of L5 pyramidal neurons across multiple columns. Functionally, SBC -> L2/3 interneuron -> L5 pyramidal neuronal circuits disinhibited and ENGC <-> L2/3 interneuron -> L5 pyramidal neuronal circuits inhibited the initiation of dendritic complex spikes in L5 pyramidal neurons. As dendritic complex spikes can serve coincidence detection, these cortical interneuronal circuits may be essential for salience selection.	[Jiang, Xiaolong; Wang, Guangfu; Lee, Alice J.; Stornetta, Ruth L.; Zhu, J. Julius] Univ Virginia, Sch Med, Dept Pharmacol, Charlottesville, VA 22908 USA; [Lee, Alice J.] Univ Virginia, Dept Biol, Coll Arts & Sci, Charlottesville, VA USA; [Zhu, J. Julius] Univ Virginia, Sch Med, Dept Neurosci, Charlottesville, VA 22908 USA	University of Virginia; University of Virginia; University of Virginia	Zhu, JJ (corresponding author), Univ Virginia, Sch Med, Dept Pharmacol, Charlottesville, VA 22908 USA.	jjzhu@virginia.edu		Stornetta, Ruth/0000-0001-7278-8923	Epilepsy Foundation; College of Arts and Sciences of the University of Virginia; US National Institutes of Health; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS053570] Funding Source: NIH RePORTER	Epilepsy Foundation; College of Arts and Sciences of the University of Virginia; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank E. Callaway, A. Erisir, J. Huang, J. Kapur and G. Tamas for technical advice and invaluable discussions, and members of the Zhu laboratory for comments and technical assistance. This study was supported in part by a postdoctoral fellowship from the Epilepsy Foundation (X.J.), a small research grant from the College of Arts and Sciences of the University of Virginia (A.J.L.) and the US National Institutes of Health.	Adesnik H, 2012, NATURE, V490, P226, DOI 10.1038/nature11526; Anderson JS, 2000, SCIENCE, V290, P1968, DOI 10.1126/science.290.5498.1968; Antic SD, 2003, J PHYSIOL-LONDON, V550, P35, DOI 10.1113/jphysiol.2002.033746; Ascoli GA, 2008, NAT REV NEUROSCI, V9, P557, DOI 10.1038/nrn2402; Baluchi F, 2011, TRENDS NEUROSCI, V34, P210, DOI 10.1016/j.tins.2011.02.003; Bartos M, 2007, NAT REV NEUROSCI, V8, P45, DOI 10.1038/nrn2044; Batista-Brito R, 2009, CURR TOP DEV BIOL, V87, P81, DOI 10.1016/S0070-2153(09)01203-4; Brown SP, 2009, CURR OPIN NEUROBIOL, V19, P415, DOI 10.1016/j.conb.2009.07.011; Burkhalter A, 2008, FRONT NEUROSCI-SWITZ, V2, P155, DOI 10.3389/neuro.01.026.2008; Cauller LJ, 1998, J COMP NEUROL, V390, P297; CAULLER LJ, 1991, EXP BRAIN RES, V84, P607; Chu ZG, 2003, J NEUROSCI, V23, P96; Corbetta M, 2002, NAT REV NEUROSCI, V3, P201, DOI 10.1038/nrn755; Foldy C, 2007, NAT NEUROSCI, V10, P1128, DOI 10.1038/nn1952; Gentet LJ, 2012, NAT NEUROSCI, V15, P607, DOI 10.1038/nn.3051; Gilbert CD, 2007, NEURON, V54, P677, DOI 10.1016/j.neuron.2007.05.019; Glickfeld LL, 2006, NAT NEUROSCI, V9, P807, DOI 10.1038/nn1688; Gonchar Y, 2003, J NEUROSCI, V23, P10904; Klausberger T, 2008, SCIENCE, V321, P53, DOI 10.1126/science.1149381; Kopell N, 2004, P NATL ACAD SCI USA, V101, P15482, DOI 10.1073/pnas.0406343101; Kubota Y, 2011, CEREB CORTEX, V21, P1803, DOI 10.1093/cercor/bhq252; Larkum ME, 2008, CURR OPIN NEUROBIOL, V18, P321, DOI 10.1016/j.conb.2008.08.013; Larkum ME, 1999, NATURE, V398, P338, DOI 10.1038/18686; Larkum ME, 2002, J NEUROSCI, V22, P6991; Larkum ME, 2001, J PHYSIOL-LONDON, V533, P447, DOI 10.1111/j.1469-7793.2001.0447a.x; Letzkus JJ, 2011, NATURE, V480, P331, DOI 10.1038/nature10674; Lisman JE, 1997, TRENDS NEUROSCI, V20, P38, DOI 10.1016/S0166-2236(96)10070-9; Luo L, 2008, NEURON, V57, P634, DOI 10.1016/j.neuron.2008.01.002; Markram H, 2004, NAT REV NEUROSCI, V5, P793, DOI 10.1038/nrn1519; Markram H, 1997, J PHYSIOL-LONDON, V500, P409, DOI 10.1113/jphysiol.1997.sp022031; McBain CJ, 2001, NAT REV NEUROSCI, V2, P11, DOI 10.1038/35049047; Nevian T, 2007, NAT NEUROSCI, V10, P206, DOI 10.1038/nn1826; Palmer LM, 2012, SCIENCE, V335, P989, DOI 10.1126/science.1217276; Perez-Garci E, 2006, NEURON, V50, P603, DOI 10.1016/j.neuron.2006.04.019; Petersen CCH, 2003, P NATL ACAD SCI USA, V100, P13638, DOI 10.1073/pnas.2235811100; Petreanu L, 2009, NATURE, V457, P1142, DOI 10.1038/nature07709; Purushothaman G, 2012, NAT NEUROSCI, V15, P905, DOI 10.1038/nn.3106; Reyes A, 2001, ANNU REV NEUROSCI, V24, P653, DOI 10.1146/annurev.neuro.24.1.653; ROBINSON DL, 1992, TRENDS NEUROSCI, V15, P127, DOI 10.1016/0166-2236(92)90354-B; Rubio-Garrido P, 2009, CEREB CORTEX, V19, P2380, DOI 10.1093/cercor/bhn259; Sjostrom PJ, 2008, PHYSIOL REV, V88, P769, DOI 10.1152/physrev.00016.2007; Sun YJ, 2010, NATURE, V465, P927, DOI 10.1038/nature09079; Tamas G, 2003, SCIENCE, V299, P1902, DOI 10.1126/science.1082053; Tamas G, 2000, NAT NEUROSCI, V3, P366, DOI 10.1038/73936; Tricoire L, 2010, J NEUROSCI, V30, P2165, DOI 10.1523/JNEUROSCI.5123-09.2010; Wozny C, 2011, CEREB CORTEX, V21, P1818, DOI 10.1093/cercor/bhq257; Wu GYK, 2011, NEUROSCI BIOBEHAV R, V35, P2094, DOI 10.1016/j.neubiorev.2011.05.004; Zhu JJ, 1999, J NEUROPHYSIOL, V81, P1171, DOI 10.1152/jn.1999.81.3.1171; Zhu YH, 2004, J NEUROSCI, V24, P5101, DOI 10.1523/JNEUROSCI.0544-04.2004; Zhu YH, 2004, J NEUROSCI, V24, P1272, DOI 10.1523/JNEUROSCI.4805-03.2004	50	220	224	1	48	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	FEB	2013	16	2					210	218		10.1038/nn.3305	http://dx.doi.org/10.1038/nn.3305			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	080RE	23313910	Green Accepted			2022-12-28	WOS:000314260200018
J	Schacter, DL; Loftus, EF				Schacter, Daniel L.; Loftus, Elizabeth F.			Memory and law: what can cognitive neuroscience contribute?	NATURE NEUROSCIENCE			English	Article							FALSE MEMORIES; IMAGINATION INFLATION; NEURAL ACTIVITY; LIE DETECTION; TRUE; MISINFORMATION; RECONSOLIDATION; RETRIEVAL; LEAD; FMRI	A recent decision in the United States by the New Jersey Supreme Court has led to improved jury instructions that incorporate psychological research showing that memory does not operate like a video recording. Here we consider how cognitive neuroscience could contribute to addressing memory in the courtroom. We discuss conditions in which neuroimaging can distinguish true and false memories in the laboratory and note reasons to be skeptical about its use in courtroom cases. We also discuss neuroscience research concerning false and imagined memories, misinformation effects and reconsolidation phenomena that may enhance understanding of why memory does not operate like a video recording.	[Schacter, Daniel L.] Harvard Univ, Dept Psychol, Cambridge, MA 02138 USA; [Loftus, Elizabeth F.] Univ Calif Irvine, Dept Psychol & Social Behav, Irvine, CA USA	Harvard University; University of California System; University of California Irvine	Schacter, DL (corresponding author), Harvard Univ, Dept Psychol, 33 Kirkland St, Cambridge, MA 02138 USA.	dls@wjh.harvard.edu	Loftus, Elizabeth F./W-2726-2019	Schacter, Daniel/0000-0002-2460-6061				Abe N, 2008, CEREB CORTEX, V18, P2811, DOI 10.1093/cercor/bhn037; Abe N, 2011, NEUROSCIENTIST, V17, P560, DOI 10.1177/1073858410393359; Agren T, 2012, SCIENCE, V337, P1550, DOI 10.1126/science.1223006; [Anonymous], 2006, ASS ILLUSIONS MEMORY; [Anonymous], 2012, CRIMINAL JURY CHARGE; Baym CL, 2010, COGN AFFECT BEHAV NE, V10, P339, DOI 10.3758/CABN.10.3.339; Bernstein DM, 2009, PERSPECT PSYCHOL SCI, V4, P370, DOI 10.1111/j.1745-6924.2009.01140.x; Brainerd C. J., 2005, SCI FALSE MEMORY; Brewer N, 2011, CURR DIR PSYCHOL SCI, V20, P24, DOI 10.1177/0963721410389169; Brown T, 2010, STANFORD LAW REV, V62, P1119; Chua E.F., 2012, MEMORY LAW, P119; Deffenbacher KA, 2004, LAW HUMAN BEHAV, V28, P687, DOI 10.1007/s10979-004-0565-x; Dudai Y, 2012, ANNU REV NEUROSCI, V35, P227, DOI 10.1146/annurev-neuro-062111-150500; Edelson M, 2011, SCIENCE, V333, P108, DOI 10.1126/science.1203557; Frenda SJ, 2011, CURR DIR PSYCHOL SCI, V20, P20, DOI 10.1177/0963721410396620; Ganis G, 2011, NEUROIMAGE, V55, P312, DOI 10.1016/j.neuroimage.2010.11.025; Garoff-Eaton RJ, 2007, LEARN MEMORY, V14, P684, DOI 10.1101/lm.695707; Garoff-Eaton RJ, 2006, CEREB CORTEX, V16, P1645, DOI 10.1093/cercor/bhj101; Garrett B. L., 2011, CONVICTING INNOCENT; Garry M, 1996, PSYCHON B REV, V3, P208, DOI 10.3758/BF03212420; Gazzaniga MS, 2011, SCI AM, V304, P54, DOI 10.1038/scientificamerican0411-54; Goff LM, 1998, MEM COGNITION, V26, P20, DOI 10.3758/BF03211367; Gonsalves B, 2004, PSYCHOL SCI, V15, P655, DOI 10.1111/j.0956-7976.2004.00736.x; Greely HT, 2007, AM J LAW MED, V33, P377, DOI 10.1177/009885880703300211; Guerin SA, 2012, NEURON, V75, P1122, DOI 10.1016/j.neuron.2012.08.020; Gutchess AH, 2012, NEUROIMAGE, V59, P3418, DOI 10.1016/j.neuroimage.2011.11.078; Hardt O, 2010, ANNU REV PSYCHOL, V61, P141, DOI 10.1146/annurev.psych.093008.100455; Hupbach A, 2008, LEARN MEMORY, V15, P574, DOI 10.1101/lm.1022308; Kensinger EA, 2006, CEREB CORTEX, V16, P1126, DOI 10.1093/cercor/bhj054; Laris M., 2012, WASHINGTON POST; Lee Jonathan L C, 2009, Trends Neurosci, V32, P413, DOI 10.1016/j.tins.2009.05.002; Loftus EF, 2005, LEARN MEMORY, V12, P361, DOI 10.1101/lm.94705; Loftus EF, 2003, AM PSYCHOL, V58, P867, DOI 10.1037/0003-066X.58.11.867; McCabe DP, 2008, COGNITION, V107, P343, DOI 10.1016/j.cognition.2007.07.017; McCabe DP, 2011, BEHAV SCI LAW, V29, P566, DOI 10.1002/bsl.993; McDermott KB, 2009, NEUROPSYCHOLOGIA, V47, P2290, DOI 10.1016/j.neuropsychologia.2008.12.025; Meissner CA, 2001, PSYCHOL PUBLIC POL L, V7, P3, DOI 10.1037//1076-8971.7.1.3; Okado Y, 2005, LEARN MEMORY, V12, P3, DOI 10.1101/lm.87605; Rissman J, 2010, P NATL ACAD SCI USA, V107, P9849, DOI 10.1073/pnas.1001028107; Rosenfeld J.P., 2012, MEMORY LAW, P263, DOI DOI 10.1093/ACPROF:OSO/9780199920754.003.0011; Schacter D. L., 2012, MEMORY LAW, P233, DOI DOI 10.1093/ACPROF:OSO/9780199920754.003.0010; Schacter D. L., 2001, 7 SINS MEMORY MIND F; Schacter D.L., PSYCHOL SCI IN PRESS; Schacter DL, 2012, NEURON, V76, P677, DOI 10.1016/j.neuron.2012.11.001; Schacter DL, 2011, TRENDS COGN SCI, V15, P467, DOI 10.1016/j.tics.2011.08.004; Schacter DL, 1998, ANNU REV PSYCHOL, V49, P289, DOI 10.1146/annurev.psych.49.1.289; Schacter DL, 2004, NEURON, V44, P149, DOI 10.1016/j.neuron.2004.08.017; Schacter DL, 1996, NEURON, V17, P267, DOI 10.1016/S0896-6273(00)80158-0; Schiller D, 2010, NATURE, V463, P49, DOI 10.1038/nature08637; Schmechel RS, 2006, JURIMETRICS, V46, P177, DOI DOI 10.1371/J0URNAL.P0NE.0022757; SCHOOLER JW, 1986, J EXP PSYCHOL LEARN, V12, P171, DOI 10.1037/0278-7393.12.2.171; Schweitzer NJ, 2011, PSYCHOL PUBLIC POL L, V17, P357, DOI 10.1037/a0023581; Simons DJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022757; Slotnick SD, 2004, NAT NEUROSCI, V7, P664, DOI 10.1038/nn1252; Squire LR, 1995, MEMORY DISTORTION, P197; Stark CEL, 2010, LEARN MEMORY, V17, P485, DOI 10.1101/lm.1845710; Straube B, 2012, BEHAV BRAIN FUNCT, V8, DOI 10.1186/1744-9081-8-35	57	74	77	1	153	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	FEB	2013	16	2					119	123		10.1038/nn.3294	http://dx.doi.org/10.1038/nn.3294			5	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	080RE	23354384	Green Submitted			2022-12-28	WOS:000314260200006
J	Huang, H; Kong, D; Byun, KH; Ye, CP; Koda, S; Lee, DH; Oh, BC; Lee, SW; Lee, B; Zabolotny, JM; Kim, MS; Bjorbaek, C; Lowell, BB; Kim, YB				Huang, Hu; Kong, Dong; Byun, Kyung Hee; Ye, Chianping; Koda, Shuichi; Lee, Dae Ho; Oh, Byung-Chul; Lee, Sam W.; Lee, Bonghee; Zabolotny, Janice M.; Kim, Min Seon; Bjorbaek, Christian; Lowell, Bradford B.; Kim, Young-Bum			Rho-kinase regulates energy balance by targeting hypothalamic leptin receptor signaling	NATURE NEUROSCIENCE			English	Article							PROOPIOMELANOCORTIN MESSENGER-RNA; BODY-WEIGHT; POMC NEURONS; FOOD-INTAKE; ARCUATE NUCLEUS; GLUCOSE-HOMEOSTASIS; IN-VIVO; INSULIN; MICE; ROCK1	Leptin regulates energy balance. However, knowledge of the critical intracellular transducers of leptin signaling remains incomplete. We found that Rho-kinase 1 (ROCK1) regulates leptin action on body weight homeostasis by activating JAK2, an initial trigger of leptin receptor signaling. Leptin promoted the physical interaction of JAK2 and ROCK1, thereby increasing phosphorylation of JAK2 and downstream activation of Stat3 and FOXO1. Mice lacking ROCK1 in either pro-opiomelanocortin (POMC) or agouti-related protein neurons, mediators of leptin action, displayed obesity and impaired leptin sensitivity. In addition, deletion of ROCK1 in the arcuate nucleus markedly enhanced food intake, resulting in severe obesity. Notably, ROCK1 was a specific mediator of leptin, but not insulin, regulation of POMC neuronal activity. Our data identify ROCK1 as a key regulator of leptin action on energy homeostasis.	[Huang, Hu; Kong, Dong; Ye, Chianping; Koda, Shuichi; Lee, Dae Ho; Zabolotny, Janice M.; Bjorbaek, Christian; Lowell, Bradford B.; Kim, Young-Bum] Beth Israel Deaconess Med Ctr, Div Endocrinol Diabet & Metab, Boston, MA 02215 USA; [Huang, Hu; Kong, Dong; Ye, Chianping; Koda, Shuichi; Lee, Dae Ho; Zabolotny, Janice M.; Bjorbaek, Christian; Lowell, Bradford B.; Kim, Young-Bum] Harvard Univ, Sch Med, Boston, MA USA; [Byun, Kyung Hee; Oh, Byung-Chul; Lee, Bonghee; Kim, Young-Bum] Gachon Univ Med & Sci, Grad Sch Med, Lee Gil Ya Canc & Diabet Inst, Inchon, South Korea; [Lee, Sam W.] Massachusetts Gen Hosp, Cutaneous Biol Res Ctr, Charlestown, MA USA; [Lee, Sam W.] Harvard Univ, Sch Med, Charlestown, MA USA; [Kim, Min Seon] Univ Ulsan, Coll Med, Asan Inst Life Sci, Dept Internal Med, Seoul, South Korea	Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School; Gachon University; Harvard University; Massachusetts General Hospital; Harvard University; University of Ulsan	Kim, YB (corresponding author), Beth Israel Deaconess Med Ctr, Div Endocrinol Diabet & Metab, Boston, MA 02215 USA.	ykim2@bidmc.harvard.edu	Bjorbaek, Christian/S-4727-2019	Oh, Byung-Chul/0000-0002-4277-7083	US National Institutes of Health [1R01DK083567, 5R01CA127247, P30DK05752]; American Diabetes Association [1-09-RA-87]; NATIONAL CANCER INSTITUTE [P01CA080058, R01CA127247] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK094040, R01DK083567, P30DK057521] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Diabetes Association(American Diabetes Association); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We would like to thank B. Kahn and T. Flier for valuable suggestions; L. Huo, S.D. Ha, S. Bayer, S. Yee, T. Liu, S.-M. Hong, N. Wang, D. Kim, B. Enkhjargal for technical assistance, and L. Wei for DN-Rockl cDNA. This work was supported by grants from the US National Institutes of Health (1R01DK083567 to Y.-B.K., 5R01CA127247 to S.W.L. and P30DK05752 Ito D.K.) and the American Diabetes Association (1-09-RA-87 to Y.-B.K.).	Al-Qassab H, 2009, CELL METAB, V10, P343, DOI 10.1016/j.cmet.2009.09.008; Balthasar N, 2004, NEURON, V42, P983, DOI 10.1016/j.neuron.2004.06.004; Bates SH, 2003, NATURE, V421, P856, DOI 10.1038/nature01388; Begum N, 2002, J BIOL CHEM, V277, P6214, DOI 10.1074/jbc.M110508200; Bjorbaek C, 2009, J INVEST MED, V57, P789, DOI 10.2310/JIM.0b013e3181bb0d49; Cheung CC, 1997, ENDOCRINOLOGY, V138, P4489, DOI 10.1210/en.138.10.4489; Chun KH, 2012, ENDOCRINOLOGY, V153, P1649, DOI 10.1210/en.2011-1036; Chun KH, 2011, AM J PHYSIOL-ENDOC M, V300, pE536, DOI 10.1152/ajpendo.00538.2010; Coppari R, 2005, CELL METAB, V1, P63; Cota D, 2006, SCIENCE, V312, P927, DOI 10.1126/science.1124147; Cowley MA, 2001, NATURE, V411, P480, DOI 10.1038/35078085; de Wall EV, 2008, ENDOCRINOLOGY, V149, P1773, DOI 10.1210/en.2007-1132; Dhillon H, 2006, NEURON, V49, P191, DOI 10.1016/j.neuron.2005.12.021; Elmquist JK, 2005, J COMP NEUROL, V493, P63, DOI 10.1002/cne.20786; Elmquist JK, 1999, NEURON, V22, P221, DOI 10.1016/S0896-6273(00)81084-3; Fukuda M, 2008, J NEUROSCI, V28, P13640, DOI 10.1523/JNEUROSCI.4023-08.2008; Furukawa N, 2005, CELL METAB, V2, P119, DOI 10.1016/j.cmet.2005.06.011; Hill JW, 2008, J CLIN INVEST, V118, P1796, DOI 10.1172/JCI32964; Hu E, 2005, EXPERT OPIN THER TAR, V9, P715, DOI 10.1517/14728222.9.4.715; Huo L, 2009, CELL METAB, V9, P537, DOI 10.1016/j.cmet.2009.05.003; Lee DH, 2009, J BIOL CHEM, V284, P11776, DOI 10.1074/jbc.C900014200; Matsui T, 1996, EMBO J, V15, P2208, DOI 10.1002/j.1460-2075.1996.tb00574.x; Mizuno TM, 1998, DIABETES, V47, P294, DOI 10.2337/diabetes.47.2.294; Morton GJ, 2006, NATURE, V443, P289, DOI 10.1038/nature05026; Myers MG, 2008, ANNU REV PHYSIOL, V70, P537, DOI 10.1146/annurev.physiol.70.113006.100707; Myers MG, 2009, CELL METAB, V9, P117, DOI 10.1016/j.cmet.2008.12.001; Plum L, 2006, J CLIN INVEST, V116, P1886, DOI 10.1172/JCI27123; Ren DC, 2005, CELL METAB, V2, P95, DOI 10.1016/j.cmet.2005.07.004; Schwartz MW, 1997, DIABETES, V46, P2119, DOI 10.2337/diabetes.46.12.2119; Thornton JE, 1997, ENDOCRINOLOGY, V138, P5063, DOI 10.1210/en.138.11.5063; van den Top M, 2004, NAT NEUROSCI, V7, P493, DOI 10.1038/nn1226; Wilson BD, 1999, ENDOCRINOLOGY, V140, P2387, DOI 10.1210/en.140.5.2387; Xu AW, 2007, ENDOCRINOLOGY, V148, P72, DOI 10.1210/en.2006-1119; Yoshii A, 2010, DEV NEUROBIOL, V70, P304, DOI 10.1002/dneu.20765	34	63	64	0	14	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	OCT	2012	15	10					1391	1398		10.1038/nn.3207	http://dx.doi.org/10.1038/nn.3207			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	013VZ	22941110	Green Accepted, Green Submitted			2022-12-28	WOS:000309335300019
J	Tai, LH; Lee, AM; Benavidez, N; Bonci, A; Wilbrecht, L				Tai, Lung-Hao; Lee, A. Moses; Benavidez, Nora; Bonci, Antonello; Wilbrecht, Linda			Transient stimulation of distinct subpopulations of striatal neurons mimics changes in action value	NATURE NEUROSCIENCE			English	Article							MEDIUM SPINY NEURONS; BASAL GANGLIA; DECISION-MAKING; DORSOMEDIAL STRIATUM; SUPERIOR COLLICULUS; MATCHING BEHAVIOR; PREFRONTAL CORTEX; PRIMATE STRIATUM; TRANSGENIC MICE; MOTOR PROGRAMS	In changing environments, animals must adaptively select actions to achieve their goals. In tasks involving goal-directed action selection, striatal neural activity has been shown to represent the value of competing actions. Striatal representations of action value could potentially bias responses toward actions of higher value. However, no study to date has demonstrated the direct effect of distinct striatal pathways in goal-directed action selection. We found that transient optogenetic stimulation of dorsal striatal dopamine D1 and D2 receptor-expressing neurons during decision-making in mice introduced opposing biases in the distribution of choices. The effect of stimulation on choice was dependent on recent reward history and mimicked an additive change in the action value. Although stimulation before and during movement initiation produced a robust bias in choice behavior, this bias was substantially diminished when stimulation was delayed after response initiation. Together, our data suggest that striatal activity is involved in goal-directed action selection.	[Tai, Lung-Hao; Lee, A. Moses; Benavidez, Nora; Wilbrecht, Linda] Ernest Gallo Clin & Res Ctr, Emeryville, CA USA; [Lee, A. Moses] Univ Calif San Francisco, Neurosci Grad Program, Med Scientist Training Program, San Francisco, CA 94143 USA; [Benavidez, Nora] Univ Calif Berkeley, Cognit Sci Program, Berkeley, CA 94720 USA; [Bonci, Antonello; Wilbrecht, Linda] Univ Calif San Francisco, Dept Neurol, San Francisco, CA USA; [Bonci, Antonello] Natl Inst Drug Abuse, Intramural Program, Baltimore, MD USA; [Bonci, Antonello] Johns Hopkins Sch Med, Solomon H Snyder Dept Neurosci, Baltimore, MD USA	University of California System; University of California San Francisco; Ernest Gallo Clinic & Research Center; University of California System; University of California San Francisco; University of California System; University of California Berkeley; University of California System; University of California San Francisco; National Institutes of Health (NIH) - USA; NIH National Institute on Drug Abuse (NIDA); Johns Hopkins University; Johns Hopkins Medicine	Wilbrecht, L (corresponding author), Ernest Gallo Clin & Res Ctr, Emeryville, CA USA.	lwilbrecht@gallo.ucsf.edu	Lee, A Moses/GPP-4361-2022; Wilbrecht, Linda/J-7988-2013		State of California; US National Institutes of Health [1RC2NS069350, R01MH087542, R01DA029150]; P. Royer and K. Clayton Family; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007618] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH087542] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [RC2NS069350] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA029150] Funding Source: NIH RePORTER	State of California; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); P. Royer and K. Clayton Family; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank G. Stuber, F. Ambroggi, D. Niell, K. Berger, C. Wu and H. Peckler for assistance with experiments, V. Kharazia for immunostaining and histological quantification, K. Deisseroth (Stanford University) for advice and reagents, and C. Niell for comments on the manuscript. This work was supported by the State of California, the US National Institutes of Health (1RC2NS069350; R01MH087542 and R01DA029150), and the P. Royer and K. Clayton Family.	ALBIN RL, 1989, TRENDS NEUROSCI, V12, P366, DOI 10.1016/0166-2236(89)90074-X; Ariano MA, 2005, J NEUROPHYSIOL, V93, P2565, DOI 10.1152/jn.00791.2004; Balleine BW, 2007, J NEUROSCI, V27, P8161, DOI 10.1523/JNEUROSCI.1554-07.2007; Barnes TD, 2005, NATURE, V437, P1158, DOI 10.1038/nature04053; Brainard MS, 2000, NATURE, V404, P762, DOI 10.1038/35008083; Castane A, 2010, BEHAV BRAIN RES, V210, P74, DOI 10.1016/j.bbr.2010.02.017; Cromwell HC, 2003, J NEUROPHYSIOL, V89, P2823, DOI 10.1152/jn.01014.2002; DELONG MR, 1990, TRENDS NEUROSCI, V13, P281, DOI 10.1016/0166-2236(90)90110-V; Desmurget M, 2010, J NEUROSCI, V30, P7685, DOI 10.1523/JNEUROSCI.0163-10.2010; Felsen G, 2008, NEURON, V60, P137, DOI 10.1016/j.neuron.2008.09.019; GERFEN CR, 1992, TRENDS NEUROSCI, V15, P133, DOI 10.1016/0166-2236(92)90355-C; Gold JI, 2007, ANNU REV NEUROSCI, V30, P535, DOI 10.1146/annurev.neuro.29.051605.113038; Grillner S, 2005, TRENDS NEUROSCI, V28, P364, DOI 10.1016/j.tins.2005.05.004; Grillner S, 2008, BRAIN RES REV, V57, P2, DOI 10.1016/j.brainresrev.2007.06.027; Hikosaka O, 2006, J NEUROPHYSIOL, V95, P567, DOI 10.1152/jn.00458.2005; Hikosaka O, 2010, TRENDS COGN SCI, V14, P154, DOI 10.1016/j.tics.2010.01.006; Ikeda T, 2003, NEURON, V39, P693, DOI 10.1016/S0896-6273(03)00464-1; Isoda M, 2011, EUR J NEUROSCI, V33, P2058, DOI 10.1111/j.1460-9568.2011.07698.x; Jiang H, 2003, NATURE, V423, P982, DOI 10.1038/nature01698; Jin X, 2010, NATURE, V466, P457, DOI 10.1038/nature09263; Kable JW, 2009, NEURON, V63, P733, DOI 10.1016/j.neuron.2009.09.003; KAWAGUCHI Y, 1995, TRENDS NEUROSCI, V18, P527, DOI 10.1016/0166-2236(95)98374-8; Kim H, 2009, J NEUROSCI, V29, P14701, DOI 10.1523/JNEUROSCI.2728-09.2009; Kimchi EY, 2009, J NEUROSCI, V29, P14891, DOI 10.1523/JNEUROSCI.4060-09.2009; Kravitz AV, 2012, NAT NEUROSCI, V15, P816, DOI 10.1038/nn.3100; Kravitz AV, 2010, NATURE, V466, P622, DOI 10.1038/nature09159; Kreitzer AC, 2011, NEUROSCIENCE, V198, P19, DOI 10.1016/j.neuroscience.2011.08.018; Kreitzer AC, 2008, NEURON, V60, P543, DOI 10.1016/j.neuron.2008.11.005; Kubota Y, 2009, J NEUROPHYSIOL, V102, P2142, DOI 10.1152/jn.00522.2009; Lau B, 2005, J EXP ANAL BEHAV, V84, P555, DOI 10.1901/jeab.2005.110-04; Lau B, 2008, NEURON, V58, P451, DOI 10.1016/j.neuron.2008.02.021; Lauwereyns J, 2002, NATURE, V418, P413, DOI 10.1038/nature00892; Lo CC, 2006, NAT NEUROSCI, V9, P956, DOI 10.1038/nn1722; Lobo MK, 2011, FRONT NEUROANAT, V5, DOI 10.3389/fnana.2011.00041; Mink JW, 1996, PROG NEUROBIOL, V50, P381, DOI 10.1016/S0301-0082(96)00042-1; Pasupathy A, 2005, NATURE, V433, P873, DOI 10.1038/nature03287; Ragozzino ME, 2007, ANN NY ACAD SCI, V1121, P355, DOI 10.1196/annals.1401.013; Rangel A, 2008, NAT REV NEUROSCI, V9, P545, DOI 10.1038/nrn2357; Redgrave P, 1999, TRENDS NEUROSCI, V22, P146, DOI 10.1016/S0166-2236(98)01373-3; Redgrave P, 1999, NEUROSCIENCE, V89, P1009, DOI 10.1016/S0306-4522(98)00319-4; Rymar VV, 2004, J COMP NEUROL, V469, P325, DOI 10.1002/cne.11008; SALZMAN CD, 1990, NATURE, V346, P174, DOI 10.1038/346174a0; Samejima K, 2005, SCIENCE, V310, P1337, DOI 10.1126/science.1115270; Schultz W, 1997, SCIENCE, V275, P1593, DOI 10.1126/science.275.5306.1593; Schwarting RKW, 1996, PROG NEUROBIOL, V50, P275, DOI 10.1016/S0301-0082(96)00040-8; Shuen JA, 2008, J NEUROSCI, V28, P2681, DOI 10.1523/JNEUROSCI.5492-07.2008; Sparta DR, 2012, NAT PROTOC, V7, P12, DOI 10.1038/nprot.2011.413; Sugrue LP, 2005, NAT REV NEUROSCI, V6, P363, DOI 10.1038/nrn1666; Thorn CA, 2010, NEURON, V66, P781, DOI 10.1016/j.neuron.2010.04.036; Turner RS, 2010, CURR OPIN NEUROBIOL, V20, P704, DOI 10.1016/j.conb.2010.08.022; Watanabe K, 2005, J NEUROPHYSIOL, V94, P1879, DOI 10.1152/jn.00012.2005	52	210	209	0	34	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	SEP	2012	15	9					1281	U152		10.1038/nn.3188	http://dx.doi.org/10.1038/nn.3188			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	996GJ	22902719	Green Accepted, Green Submitted			2022-12-28	WOS:000308072600019
J	Chiu, IM; von Hehn, CA; Woolf, CJ				Chiu, Isaac M.; von Hehn, Christian A.; Woolf, Clifford J.			Neurogenic inflammation and the peripheral nervous system in host defense and immunopathology	NATURE NEUROSCIENCE			English	Article							GENE-RELATED PEPTIDE; ALLERGIC AIRWAY INFLAMMATION; SUBSTANCE-P; CELL-FUNCTION; INNATE IMMUNITY; DENDRITIC CELL; MICE LACKING; MAST-CELLS; T-CELLS; RECEPTOR	The peripheral nervous and immune systems are traditionally thought of as serving separate functions. The line between them is, however, becoming increasingly blurred by new insights into neurogenic inflammation. Nociceptor neurons possess many of the same molecular recognition pathways for danger as immune cells, and, in response to danger, the peripheral nervous system directly communicates with the immune system, forming an integrated protective mechanism. The dense innervation network of sensory and autonomic fibers in peripheral tissues and high speed of neural transduction allows rapid local and systemic neurogenic modulation of immunity. Peripheral neurons also seem to contribute to immune dysfunction in autoimmune and allergic diseases. Therefore, understanding the coordinated interaction of peripheral neurons with immune cells may advance therapeutic approaches to increase host defense and suppress immunopathology.	[Chiu, Isaac M.; von Hehn, Christian A.; Woolf, Clifford J.] Childrens Hosp Boston, FM Kirby Neurobiol Ctr, Boston, MA 02115 USA; [Chiu, Isaac M.; von Hehn, Christian A.; Woolf, Clifford J.] Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA USA	Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School	Woolf, CJ (corresponding author), Childrens Hosp Boston, FM Kirby Neurobiol Ctr, Boston, MA 02115 USA.	clifford.woolf@childrens.harvard.edu	Woolf, Clifford/A-9784-2010; Chiu, Isaac/R-3803-2016	Chiu, Isaac/0000-0002-0723-4841	US National Institutes of Health [2R37NS039518]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F32NS076297, R37NS039518] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank the US National Institutes of Health for support (2R37NS039518).	Andersson U, 2012, ANNU REV IMMUNOL, V30, P313, DOI 10.1146/annurev-immunol-020711-075015; ANSEL JC, 1993, J IMMUNOL, V150, P4478; Bessac BF, 2009, FASEB J, V23, P1102, DOI 10.1096/fj.08-117812; Bianchi ME, 2007, J LEUKOCYTE BIOL, V81, P1, DOI 10.1189/jlb.0306164; Binshtok AM, 2008, J NEUROSCI, V28, P14062, DOI 10.1523/JNEUROSCI.3795-08.2008; BRAIN SD, 1989, BRIT J PHARMACOL, V97, P77, DOI 10.1111/j.1476-5381.1989.tb11926.x; Brogden KA, 2005, NAT IMMUNOL, V6, P558, DOI 10.1038/ni1209; Caceres AI, 2009, P NATL ACAD SCI USA, V106, P9099, DOI 10.1073/pnas.0900591106; Caterina MJ, 2000, SCIENCE, V288, P306, DOI 10.1126/science.288.5464.306; Cockayne DA, 2000, NATURE, V407, P1011, DOI 10.1038/35039519; Cruz-Orengo L, 2008, MOL PAIN, V4, DOI 10.1186/1744-8069-4-30; Cunin P, 2011, J IMMUNOL, V186, P4175, DOI 10.4049/jimmunol.1002535; Cyphert JM, 2009, J IMMUNOL, V182, P7430, DOI 10.4049/jimmunol.0900039; Czepielewski RS, 2012, P NATL ACAD SCI USA, V109, P547, DOI 10.1073/pnas.1110996109; de Jonge WJ, 2005, NAT IMMUNOL, V6, P844, DOI 10.1038/ni1229; Ding WH, 2008, J IMMUNOL, V181, P6020, DOI 10.4049/jimmunol.181.9.6020; Diogenes A, 2011, J DENT RES, V90, P759, DOI 10.1177/0022034511400225; Dunzendorfer S, 1998, J LEUKOCYTE BIOL, V64, P828, DOI 10.1002/jlb.64.6.828; EDVINSSON L, 1987, J CEREBR BLOOD F MET, V7, P720, DOI 10.1038/jcbfm.1987.126; Engel MA, 2011, GASTROENTEROLOGY, V141, P1346, DOI 10.1053/j.gastro.2011.07.002; Fryer AD, 2006, J CLIN INVEST, V116, P228, DOI 10.1172/JCI25423; Ganor Y, 2003, J IMMUNOL, V170, P4362, DOI 10.4049/jimmunol.170.8.4362; HOSOI J, 1993, NATURE, V363, P159, DOI 10.1038/363159a0; Janeway CA, 1998, SEMIN IMMUNOL, V10, P349, DOI 10.1006/smim.1998.0142; Jimeno R, 2012, IMMUNOL CELL BIOL, V90, P178, DOI 10.1038/icb.2011.23; LEVINE JD, 1984, SCIENCE, V226, P547, DOI 10.1126/science.6208609; Levine JD, 2006, ANN NY ACAD SCI, V1069, P155, DOI 10.1196/annals.1351.014; Link TM, 2010, NAT IMMUNOL, V11, P232, DOI 10.1038/ni.1842; Liu T, 2010, NAT NEUROSCI, V13, P1460, DOI 10.1038/nn.2683; Mariathasan S, 2006, NATURE, V440, P228, DOI 10.1038/nature04515; Matzinger P, 2002, ANN NY ACAD SCI, V961, P341, DOI 10.1111/j.1749-6632.2002.tb03118.x; MCCORMACK DG, 1989, J APPL PHYSIOL, V67, P1265, DOI 10.1152/jappl.1989.67.3.1265; Mikami N, 2011, J IMMUNOL, V186, P6886, DOI 10.4049/jimmunol.1100028; Ostrowski SM, 2011, J INVEST DERMATOL, V131, P1530, DOI 10.1038/jid.2011.60; Qi J, 2011, J IMMUNOL, V186, P6417, DOI 10.4049/jimmunol.1001241; Razavi R, 2006, CELL, V127, P1123, DOI 10.1016/j.cell.2006.10.038; Rochlitzer S, 2011, CLIN EXP ALLERGY, V41, P1609, DOI 10.1111/j.1365-2222.2011.03822.x; Rosas-Ballina M, 2011, SCIENCE, V334, P98, DOI 10.1126/science.1209985; Samad TA, 2001, NATURE, V410, P471, DOI 10.1038/35068566; SARIA A, 1984, BRIT J PHARMACOL, V82, P217, DOI 10.1111/j.1476-5381.1984.tb16461.x; Sauer SK, 2001, EUR J NEUROSCI, V14, P1203, DOI 10.1046/j.0953-816x.2001.01741.x; SMITH CH, 1993, J IMMUNOL, V151, P3274; Souslova V, 2000, NATURE, V407, P1015, DOI 10.1038/35039526; Trevisani M, 2007, P NATL ACAD SCI USA, V104, P13519, DOI 10.1073/pnas.0705923104; Turner H., 2007, V179, P457; Vaccari JPDR, 2008, J NEUROSCI, V28, P3404, DOI 10.1523/JNEUROSCI.0157-08.2008; Veres TZ, 2007, AM J RESP CELL MOL, V37, P553, DOI 10.1165/rcmb.2007-0087OC; Wang H, 2003, NATURE, V421, P384, DOI 10.1038/nature01339; Wong CHY, 2011, SCIENCE, V334, P101, DOI 10.1126/science.1210301; Zhang XC, 2011, PAIN, V152, P140, DOI 10.1016/j.pain.2010.10.002	50	355	364	4	54	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	AUG	2012	15	8					1063	1067		10.1038/nn.3144	http://dx.doi.org/10.1038/nn.3144			5	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	979UE	22837035	Green Accepted			2022-12-28	WOS:000306844500006
J	Li, YL; Tsien, RW				Li, Yulong; Tsien, Richard W.			pHTomato, a red, genetically encoded indicator that enables multiplex interrogation of synaptic activity	NATURE NEUROSCIENCE			English	Article							FLUORESCENT PROTEIN; VESICLE RETRIEVAL; INTRACELLULAR PH; MONOMERIC RED; ORANGE; CELLS; ENDOCYTOSIS; TRANSIENTS; EXCITATION; TERMINALS	The usefulness of genetically encoded probes for optical monitoring of neuronal activity and brain circuits would be greatly advanced by the generation of multiple indicators with non-overlapping color spectra. Most existing indicators are derived from or spectrally convergent on GFP. We generated a bright, red, pH-sensitive fluorescent protein, pHTomato, that can be used in parallel with green probes to monitor neuronal activity. SypHTomato, made by fusing pHTomato to the vesicular membrane protein synaptophysin, reported activity-dependent exocytosis as efficiently as green reporters. When expressed with the GFP-based indicator GCaMP3 in the same neuron, sypHTomato enabled concomitant imaging of transmitter release and presynaptic Ca2+ transients at single nerve terminals. Expressing sypHTomato and GCaMP3 in separate cells enabled the simultaneous determination of presynaptic vesicular turnover and postsynaptic sub- and supra-threshold responses from a connected pair of neurons. With these new tools, we observed a close size matching between pre- and postsynaptic compartments, as well as interesting target cell dependent regulation of presynaptic vesicle pools. Lastly, by coupling expression of pHTomato- and GFP-based probes with distinct variants of channelrhodopsin, we provided proof-of-principle for an all-optical approach to multiplex control and tracking of distinct circuit pathways.	[Li, Yulong; Tsien, Richard W.] Stanford Univ, Dept Mol & Cellular Physiol, Sch Med, Stanford, CA 94305 USA; [Tsien, Richard W.] NYU, NYU Neurosci Inst, New York, NY USA; [Tsien, Richard W.] NYU, Dept Physiol & Neurosci, New York, NY USA; [Tsien, Richard W.] NYU, Ctr Neural Sci, New York, NY 10003 USA	Stanford University; New York University; New York University; New York University	Li, YL (corresponding author), Stanford Univ, Dept Mol & Cellular Physiol, Sch Med, Stanford, CA 94305 USA.	yulong@gmail.com; richard.tsien@nyumc.org		Li, Yulong/0000-0002-9166-9919	US National Institute of Neurological Disorders and Stroke [NS074785, NS24067]; US National Institute of Mental Health [MH064070]; Mathers Foundation; Burnett family fund; NATIONAL INSTITUTE OF MENTAL HEALTH [R56MH064070, R01MH064070] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS024067, R01NS074785] Funding Source: NIH RePORTER	US National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); US National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Mathers Foundation; Burnett family fund; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank M. Lin for help with quantum yield measurements. We thank J. Emery for technical assistance and L. Li for help with transfections. We thank L. Luo and Tsien laboratory members, especially M. Tadross, S. Owen, H. Park and R. Groth, for discussions throughout the execution of this project. This work was supported by grants from the US National Institute of Neurological Disorders and Stroke (NS074785 and NS24067), the US National Institute of Mental Health (MH064070), the Mathers Foundation and the Burnett family fund (to R.W.T.).	Auld DS, 2003, NEURON, V40, P389, DOI 10.1016/S0896-6273(03)00607-X; BORON WF, 1976, J GEN PHYSIOL, V67, P91, DOI 10.1085/jgp.67.1.91; Boyden ES, 2005, NAT NEUROSCI, V8, P1263, DOI 10.1038/nn1525; Branco T, 2008, NEURON, V59, P475, DOI 10.1016/j.neuron.2008.07.006; Campbell RE, 2002, P NATL ACAD SCI USA, V99, P7877, DOI 10.1073/pnas.082243699; Chow BY, 2010, NATURE, V463, P98, DOI 10.1038/nature08652; Granseth B, 2006, NEURON, V51, P773, DOI 10.1016/j.neuron.2006.08.029; HARRIS KM, 1989, J NEUROSCI, V9, P2982; Helmchen F, 2005, NAT METHODS, V2, P932, DOI 10.1038/NMETH818; Jach G, 2006, NAT METHODS, V3, P597, DOI 10.1038/NMETH901; Johnson DE, 2009, J BIOL CHEM, V284, P20499, DOI 10.1074/jbc.M109.019042; Kremers GJ, 2009, NAT METHODS, V6, P355, DOI [10.1038/NMETH.1319, 10.1038/nmeth.1319]; Kuner T, 2000, NEURON, V27, P447, DOI 10.1016/S0896-6273(00)00056-8; Li HY, 2011, FRONT MOL NEUROSCI, V4, DOI 10.3389/fnmol.2011.00034; Micheva KD, 2003, NAT NEUROSCI, V6, P925, DOI 10.1038/nn1114; Miesenbock G, 2005, ANNU REV NEUROSCI, V28, P533, DOI 10.1146/annurev.neuro.28.051804.101610; Miesenbock G, 1998, NATURE, V394, P192, DOI 10.1038/28190; Miyawaki A, 1997, NATURE, V388, P882, DOI 10.1038/42264; Miyawaki A, 2011, ANNU REV BIOCHEM, V80, P357, DOI 10.1146/annurev-biochem-072909-094736; Murthy VN, 1999, NAT NEUROSCI, V2, P503, DOI 10.1038/9149; Mutoh H, 2011, EXP PHYSIOL, V96, P13, DOI 10.1113/expphysiol.2010.053942; PIERCE JP, 1994, NEUROSCIENCE, V58, P441, DOI 10.1016/0306-4522(94)90071-X; Ramirez DMO, 2012, NEURON, V73, P121, DOI 10.1016/j.neuron.2011.10.034; Reid CA, 1997, J NEUROSCI, V17, P2738; REUTER H, 1995, NEURON, V14, P773, DOI 10.1016/0896-6273(95)90221-X; Rickgauer JP, 2009, P NATL ACAD SCI USA, V106, P15025, DOI 10.1073/pnas.0907084106; Sankaranarayanan S, 2000, BIOPHYS J, V79, P2199, DOI 10.1016/S0006-3495(00)76468-X; Shaner NC, 2008, NAT METHODS, V5, P545, DOI 10.1038/nmeth.1209; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; Shaner NC, 2005, NAT METHODS, V2, P905, DOI 10.1038/NMETH819; Shcherbo D, 2007, NAT METHODS, V4, P741, DOI 10.1038/NMETH1083; Siegel MS, 1997, NEURON, V19, P735, DOI 10.1016/S0896-6273(00)80955-1; Tantama M, 2011, J AM CHEM SOC, V133, P10034, DOI 10.1021/ja202902d; Tian L, 2009, NAT METHODS, V6, P875, DOI 10.1038/nmeth.1398; Voglmaier SM, 2006, NEURON, V51, P71, DOI 10.1016/j.neuron.2006.05.027; Zhang F, 2008, NAT NEUROSCI, V11, P631, DOI 10.1038/nn.2120; Zhu YL, 2009, NEURON, V61, P397, DOI 10.1016/j.neuron.2008.12.024	37	118	119	3	44	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUL	2012	15	7					1047	1053		10.1038/nn.3126	http://dx.doi.org/10.1038/nn.3126			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	966EE	22634730	Green Accepted			2022-12-28	WOS:000305819600024
J	Busch, KE; Laurent, P; Soltesz, Z; Murphy, RJ; Faivre, O; Hedwig, B; Thomas, M; Smith, HL; de Bono, M				Busch, Karl Emanuel; Laurent, Patrick; Soltesz, Zoltan; Murphy, Robin Joseph; Faivre, Olivier; Hedwig, Berthold; Thomas, Martin; Smith, Heather L.; de Bono, Mario			Tonic signaling from O-2 sensors sets neural circuit activity and behavioral state	NATURE NEUROSCIENCE			English	Article							CAENORHABDITIS-ELEGANS; C-ELEGANS; GUANYLATE CYCLASES; BODY-FLUID; NEURONS; OXYGEN; NEUROPEPTIDES; AGGREGATION; ENDOCYTOSIS; ADAPTATION	Tonic receptors convey stimulus duration and intensity and are implicated in homeostatic control. However, how tonic homeostatic signals are generated and how they reconfigure neural circuits and modify animal behavior is poorly understood. Here we show that Caenorhabditis elegans O-2-sensing neurons are tonic receptors that continuously signal ambient [O-2] to set the animal's behavioral state. Sustained signaling relied on a Ca2+ relay involving L-type voltage-gated Ca2+ channels, the ryanodine and the inositol-1,4,5-trisphosphate receptors. Tonic activity evoked continuous neuropeptide release, which helps elicit the enduring behavioral state associated with high [O-2]. Sustained O-2 receptor signaling was propagated to downstream neural circuits, including the hub interneuron RMG. O-2 receptors evoked similar locomotory states at particular O-2 concentrations, regardless of previous d[O-2]/dt However, a phasic component of the URX receptors' response to high d[O-2]/dt, as well as tonic-to-phasic transformations in downstream interneurons, enabled transient reorientation movements shaped by d[O-2]/dt. Our results highlight how tonic homeostatic signals can generate both transient and enduring behavioral change.	[Busch, Karl Emanuel; Laurent, Patrick; Soltesz, Zoltan; Murphy, Robin Joseph; Smith, Heather L.; de Bono, Mario] MRC, Mol Biol Lab, Cambridge CB2 2QH, England; [Faivre, Olivier; Hedwig, Berthold] Univ Cambridge, Dept Zool, Cambridge, England	MRC Laboratory Molecular Biology; University of Cambridge	de Bono, M (corresponding author), MRC, Mol Biol Lab, Hills Rd, Cambridge CB2 2QH, England.	debono@mrc-lmb.cam.ac.uk	laurent, patrick/ABD-9373-2021	laurent, patrick/0000-0001-5360-5597; de Bono, Mario/0000-0001-8347-0443; Busch, Karl Emanuel/0000-0001-7886-3226	European Union; EMBO; Swiss National Science Foundation; German Academic Exchange Service (DAAD); Wiener-Anspach Foundation; Advanced European Research Council [269058-ACMO]; MRC [MC_U105178786] Funding Source: UKRI; Medical Research Council [MC_U105178786] Funding Source: researchfish	European Union(European Commission); EMBO(European Molecular Biology Organization (EMBO)); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); German Academic Exchange Service (DAAD)(Deutscher Akademischer Austausch Dienst (DAAD)); Wiener-Anspach Foundation; Advanced European Research Council(European Research Council (ERC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank the Caenorhabditis Genetics Center and the C. elegans Knockout Consortium for strains, members of the Schafer and de Bono laboratories for comments and insights in the course of this work and E Dear for assistance with microfabrication. K.E.B. acknowledges support by European Union Marie Curie Actions, EMBO, the Swiss National Science Foundation and German Academic Exchange Service (DAAD). P.L. acknowledges support by EMBO and the Wiener-Anspach Foundation. Supported by Advanced European Research Council grant 269058-ACMO.	Arellano-Carbajal F, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001341; Barth F.G., 1964, J COMP PHYSIOL A, V48, P181; Ben Arous J, 2010, J NEUROSCI METH, V187, P229, DOI 10.1016/j.jneumeth.2010.01.011; CHALFIE M, 1985, J NEUROSCI, V5, P956; Cheung BHH, 2005, CURR BIOL, V15, P905, DOI 10.1016/j.cub.2005.04.017; Cheung BHH, 2004, CURR BIOL, V14, P1105, DOI 10.1016/j.cub.2004.06.027; Coates JC, 2002, NATURE, V419, P925, DOI 10.1038/nature01170; Craig AD, 2009, NAT REV NEUROSCI, V10, P59, DOI 10.1038/nrn2555; Dampney RAL, 2005, CLIN EXP PHARMACOL P, V32, P419, DOI 10.1111/j.1440-1681.2005.04205.x; Fares H, 2002, TRAFFIC, V3, P11, DOI 10.1034/j.1600-0854.2002.30103.x; Fares H, 2001, GENETICS, V159, P133; Feldman JL, 2003, ANNU REV NEUROSCI, V26, P239, DOI 10.1146/annurev.neuro.26.041002.131103; Gold MS, 2010, NAT MED, V16, P1248, DOI 10.1038/nm.2235; Gray JM, 2004, NATURE, V430, P317, DOI 10.1038/nature02714; Hilliard MA, 2005, EMBO J, V24, P63, DOI 10.1038/sj.emboj.7600493; Husson SJ, 2007, J NEUROCHEM, V102, P246, DOI 10.1111/j.1471-4159.2007.04474.x; Jacob TC, 2003, J NEUROSCI, V23, P2122; Kimura KD, 2004, CURR BIOL, V14, P1291, DOI 10.1016/j.cub.2004.06.060; Kleineidam C, 2000, ARTHROPOD STRUCT DEV, V29, P43, DOI 10.1016/S1467-8039(00)00012-8; Lancer J. T., 2010, CSH PERSPECT BIOL, V2; Li C, 1999, BRAIN RES, V848, P26, DOI 10.1016/S0006-8993(99)01972-1; Macosko EZ, 2009, NATURE, V458, P1171, DOI 10.1038/nature07886; Madrid R, 2003, BIOPHYS J, V84, P4167, DOI 10.1016/S0006-3495(03)75141-8; Matthews G, 2010, NAT REV NEUROSCI, V11, P812, DOI 10.1038/nrn2924; McGlone F, 2010, NEUROSCI BIOBEHAV R, V34, P148, DOI 10.1016/j.neubiorev.2009.08.004; Morrison SF, 2008, EXP PHYSIOL, V93, P773, DOI 10.1113/expphysiol.2007.041848; Nagai T, 2004, P NATL ACAD SCI USA, V101, P10554, DOI 10.1073/pnas.0400417101; Nassel DR, 2009, INVERTEBR NEUROSCI, V9, P57, DOI 10.1007/s10158-009-0090-1; PEARSON KG, 1977, ANN NY ACAD SCI, V290, P114, DOI 10.1111/j.1749-6632.1977.tb39721.x; Persson A, 2009, NATURE, V458, P1030, DOI 10.1038/nature07820; Proske U, 2009, J PHYSIOL-LONDON, V587, P4139, DOI 10.1113/jphysiol.2009.175372; Rockman MV, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000419; Rogers C, 2006, CURR BIOL, V16, P649, DOI 10.1016/j.cub.2006.03.023; Schiavo G, 2000, PHYSIOL REV, V80, P717, DOI 10.1152/physrev.2000.80.2.717; Sieburth D, 2007, NAT NEUROSCI, V10, P49, DOI 10.1038/nn1810; Stern MD, 2004, CELL CALCIUM, V35, P591, DOI 10.1016/j.ceca.2004.01.013; Suzuki H, 2003, NEURON, V39, P1005, DOI 10.1016/j.neuron.2003.08.015; Suzuki H, 2008, NATURE, V454, P114, DOI 10.1038/nature06927; Taylor CW, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a004010; Weber KP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013922; WHITE JG, 1986, PHILOS T R SOC B, V314, P1, DOI 10.1098/rstb.1986.0056; Zhang F, 2007, NATURE, V446, P633, DOI 10.1038/nature05744; Zimmer M, 2009, NEURON, V61, P865, DOI 10.1016/j.neuron.2009.02.013; Zufall F, 2000, CHEM SENSES, V25, P473, DOI 10.1093/chemse/25.4.473	44	78	79	0	11	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	APR	2012	15	4					581	591		10.1038/nn.3061	http://dx.doi.org/10.1038/nn.3061			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	916PA	22388961	Green Accepted			2022-12-28	WOS:000302114500018
J	Gentet, LJ; Kremer, Y; Taniguchi, H; Huang, ZJ; Staiger, JF; Petersen, CCH				Gentet, Luc J.; Kremer, Yves; Taniguchi, Hiroki; Huang, Z. Josh; Staiger, Jochen F.; Petersen, Carl C. H.			Unique functional properties of somatostatin-expressing GABAergic neurons in mouse barrel cortex	NATURE NEUROSCIENCE			English	Article							PRIMARY SOMATOSENSORY CORTEX; GREEN FLUORESCENT PROTEIN; CONTAINING INTERNEURONS; SYNAPTIC INTEGRATION; SENSORIMOTOR SYSTEM; CORTICAL-NEURONS; MARTINOTTI CELLS; PYRAMIDAL CELLS; TRANSGENIC MICE; CEREBRAL-CORTEX	Neocortical GABAergic neurons have diverse molecular, structural and electrophysiological features, but the functional correlates of this diversity are largely unknown. We found unique membrane potential dynamics of somatostatin-expressing (SOM) neurons in layer 2/3 of the primary somatosensory barrel cortex of awake behaving mice. SOM neurons were spontaneously active during periods of quiet wakefulness. However, SOM neurons hyperpolarized and reduced action potential firing in response to both passive and active whisker sensing, in contrast with all other recorded types of nearby neurons, which were excited by sensory input. Optogenetic inhibition of SOM neurons increased burst firing in nearby excitatory neurons. We hypothesize that the spontaneous activity of SOM neurons during quiet wakefulness provides a tonic inhibition to the distal dendrites of excitatory pyramidal neurons. Conversely, the inhibition of SOM cells during active cortical processing likely enhances distal dendritic excitability, which may be important for top-down computations and sensorimotor integration.	[Gentet, Luc J.; Kremer, Yves; Petersen, Carl C. H.] EPFL, Fac Life Sci, Brain Mind Inst, Lab Sensory Proc, Zurich, Switzerland; [Gentet, Luc J.] Univ Amsterdam, Swammerdam Inst Life Sci, NL-1012 WX Amsterdam, Netherlands; [Taniguchi, Hiroki; Huang, Z. Josh] Cold Spring Harbor, Cold Spring Harbor Lab, New York, NY USA; [Staiger, Jochen F.] Univ Gottingen, Dept Neuroanat, Gottingen, Germany	Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; University of Amsterdam; Cold Spring Harbor Laboratory; University of Gottingen	Petersen, CCH (corresponding author), EPFL, Fac Life Sci, Brain Mind Inst, Lab Sensory Proc, Zurich, Switzerland.	carl.petersen@epfl.ch	Gentet, Luc J/H-5127-2017; Petersen, Carl/M-5123-2017; Gentet, Luc/GNN-0460-2022	Gentet, Luc J/0000-0001-6509-1001; Petersen, Carl/0000-0003-3344-4495; Gentet, Luc/0000-0001-6509-1001; Huang, Z. Josh/0000-0003-0592-028X; Kremer, Yves/0000-0002-2319-1394	Swiss National Science Foundation; Human Frontiers in Science Program; SystemsX.ch; Deutsche Forschungsgemeinschaft [Sta 431/8-1, 10-1]; Deutsche Forschungsgemeinschaft/Swiss National Science Foundation	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Human Frontiers in Science Program(Human Frontier Science Program); SystemsX.ch; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Deutsche Forschungsgemeinschaft/Swiss National Science Foundation	We thank L. Looger (Howard Hughes Medical Institute, Janelia Farm) for GCaMP3 and K. Deisseroth (Stanford University) for eNpHR3.0. This work was funded by grants from the Swiss National Science Foundation (C.C.H.P.), Human Frontiers in Science Program (C.C.H.P.), SystemsX.ch (C.C.H.P.) and Deutsche Forschungsgemeinschaft (Sta 431/8-1, 10-1 to J.E.S.), and a joint Deutsche Forschungsgemeinschaft/Swiss National Science Foundation grant Bacofun (C.C.H.P. and J.E.S.).	Acsady L, 1996, NEUROSCIENCE, V73, P317, DOI 10.1016/0306-4522(95)00609-5; Ascoli GA, 2008, NAT REV NEUROSCI, V9, P557, DOI 10.1038/nrn2402; Bartos M, 2007, NAT REV NEUROSCI, V8, P45, DOI 10.1038/nrn2044; Branco T, 2011, NEURON, V69, P885, DOI 10.1016/j.neuron.2011.02.006; Brecht M, 2007, CURR OPIN NEUROBIOL, V17, P408, DOI 10.1016/j.conb.2007.07.008; Burkhalter A, 2008, FRONT NEUROSCI-SWITZ, V2, P155, DOI 10.3389/neuro.01.026.2008; Crochet S, 2011, NEURON, V69, P1160, DOI 10.1016/j.neuron.2011.02.022; Curtis JC, 2009, NAT NEUROSCI, V12, P492, DOI 10.1038/nn.2283; Dalezios Y, 2002, CEREB CORTEX, V12, P961, DOI 10.1093/cercor/12.9.961; David C, 2007, EUR J NEUROSCI, V25, P2329, DOI 10.1111/j.1460-9568.2007.05496.x; Diamond ME, 2008, NAT REV NEUROSCI, V9, P601, DOI 10.1038/nrn2411; Fanselow EE, 2008, J NEUROPHYSIOL, V100, P2640, DOI 10.1152/jn.90691.2008; Fino E, 2011, NEURON, V69, P1188, DOI 10.1016/j.neuron.2011.02.025; Freund TF, 2007, NEURON, V56, P33, DOI 10.1016/j.neuron.2007.09.012; Freund TF, 1996, HIPPOCAMPUS, V6, P347, DOI 10.1002/(SICI)1098-1063(1996)6:4<347::AID-HIPO1>3.0.CO;2-I; Gentet LJ, 2010, NEURON, V65, P422, DOI 10.1016/j.neuron.2010.01.006; Gilbert CD, 2007, NEURON, V54, P677, DOI 10.1016/j.neuron.2007.05.019; Gradinaru V, 2010, CELL, V141, P154, DOI 10.1016/j.cell.2010.02.037; Kapfer C, 2007, NAT NEUROSCI, V10, P743, DOI 10.1038/nn1909; Klausberger T, 2008, SCIENCE, V321, P53, DOI 10.1126/science.1149381; Larkum ME, 2009, SCIENCE, V325, P756, DOI 10.1126/science.1171958; Larkum ME, 1999, NATURE, V398, P338, DOI 10.1038/18686; Lee S, 2010, J NEUROSCI, V30, P16796, DOI 10.1523/JNEUROSCI.1869-10.2010; Losonczy A, 2008, NATURE, V452, P436, DOI 10.1038/nature06725; Ma YY, 2006, J NEUROSCI, V26, P5069, DOI 10.1523/JNEUROSCI.0661-06.2006; Margrie TW, 2003, NEURON, V39, P911, DOI 10.1016/j.neuron.2003.08.012; Markram H, 2004, NAT REV NEUROSCI, V5, P793, DOI 10.1038/nrn1519; Mateo C, 2011, CURR BIOL, V21, P1593, DOI 10.1016/j.cub.2011.08.028; McGarry LM, 2010, FRONT NEURAL CIRCUIT, V4, DOI 10.3389/fncir.2010.00012; O'Connor DH, 2010, NEURON, V67, P1048, DOI 10.1016/j.neuron.2010.08.026; Okun M, 2008, NAT NEUROSCI, V11, P535, DOI 10.1038/nn.2105; Olah S, 2009, NATURE, V461, P1278, DOI 10.1038/nature08503; Oliva AA, 2000, J NEUROSCI, V20, P3354, DOI 10.1523/JNEUROSCI.20-09-03354.2000; Packer AM, 2011, J NEUROSCI, V31, P13260, DOI 10.1523/JNEUROSCI.3131-11.2011; Petersen CCH, 2007, NEURON, V56, P339, DOI 10.1016/j.neuron.2007.09.017; Petreanu L, 2009, NATURE, V457, P1142, DOI 10.1038/nature07709; Poulet JFA, 2008, NATURE, V454, P881, DOI 10.1038/nature07150; Reyes A, 1998, NAT NEUROSCI, V1, P279, DOI 10.1038/1092; Silberberg G, 2007, NEURON, V53, P735, DOI 10.1016/j.neuron.2007.02.012; SOMOGYI P, 1977, BRAIN RES, V136, P345, DOI 10.1016/0006-8993(77)90808-3; Staiger JF, 2004, J COMP NEUROL, V468, P179, DOI 10.1002/cne.10953; Suzuki N, 2010, J COMP NEUROL, V518, P1670, DOI 10.1002/cne.22295; Tamamaki N, 2003, J COMP NEUROL, V467, P60, DOI 10.1002/cne.10905; Taniguchi H, 2011, NEURON, V71, P995, DOI 10.1016/j.neuron.2011.07.026; Tian L, 2009, NAT METHODS, V6, P875, DOI 10.1038/nmeth.1398; Wang Y, 2004, J PHYSIOL-LONDON, V561, P65, DOI 10.1113/jphysiol.2004.073353; Xu XM, 2009, J NEUROSCI, V29, P70, DOI 10.1523/JNEUROSCI.4104-08.2009	47	302	304	0	40	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	APR	2012	15	4					607	612		10.1038/nn.3051	http://dx.doi.org/10.1038/nn.3051			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	916PA	22366760				2022-12-28	WOS:000302114500021
J	Angueyra, JM; Rieke, F				Angueyra, Juan M.; Rieke, Fred			Origin and effect of phototransduction noise in primate cone photoreceptors	NATURE NEUROSCIENCE			English	Article							MONKEY MACACA-FASCICULARIS; ROD OUTER SEGMENTS; LIGHT ADAPTATION; DARK NOISE; ABSOLUTE THRESHOLD; VISUAL-ADAPTATION; RETINAL CONES; SENSITIVITY; VISION; MECHANISMS	Noise in the responses of cone photoreceptors sets a fundamental limit on visual sensitivity, yet the origin of noise in mammalian cones and its relation to behavioral sensitivity are poorly understood. Our work here on primate cones improves understanding of these issues in three ways. First, we found that cone noise was not dominated by spontaneous photopigment activation or by quantal fluctuations in photon absorption, but was instead dominated by other sources, namely channel noise and fluctuations in cyclic GMP. Second, adaptation in cones, unlike that in rods, affected signal and noise differently. This difference helps to explain why thresholds for rod- and cone-mediated signals have different dependencies on background light level. Third, past estimates of noise in mammalian cones are too high to explain behavioral sensitivity. Our measurements indicate a lower level of cone noise and therefore help to reconcile physiological and behavioral estimates of cone noise and sensitivity.	[Angueyra, Juan M.; Rieke, Fred] Univ Washington, Howard Hughes Med Inst, Dept Physiol & Biophys, Seattle, WA 98195 USA	Howard Hughes Medical Institute; University of Washington; University of Washington Seattle	Rieke, F (corresponding author), Univ Washington, Howard Hughes Med Inst, Dept Physiol & Biophys, Seattle, WA 98195 USA.	rieke@uw.edu	Angueyra, Juan/HCI-8722-2022	Angueyra, Juan/0000-0002-9217-3069	Howard Hughes Medical Institute; National Eye Institute of the US National Institutes of Health [RO1EY11850]; US National Institutes of Health grant [RR00166]; National Center for Research Resources; Office of Research Infrastructure Programs of the National Institutes of Health [P51 OD 010425]; NATIONAL CENTER FOR RESEARCH RESOURCES [P51RR000166] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY011850] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P51OD010425] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); National Eye Institute of the US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); US National Institutes of Health grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Office of Research Infrastructure Programs of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank C. Asbury, F. Dunn, G. Horwitz and R. Sinha for helpful comments on an earlier version of the paper, and M. Cafaro and P. Newman for excellent technical assistance. Color scales were developed and made freely available for Matlab by M. Niccoli. Support was provided by the Howard Hughes Medical Institute (F.R.) and the National Eye Institute of the US National Institutes of Health (RO1EY11850 to ER.). Retinas were obtained from the Washington National Primate Research Center at the University of Washington, US National Institutes of Health grant RR00166, and from the National Center for Research Resources and the Office of Research Infrastructure Programs of the National Institutes of Health through grant Number P51 OD 010425.	Ala-Laurila P, 2011, NAT NEUROSCI, V14, P1309, DOI 10.1038/nn.2927; BARLOW HB, 1956, J OPT SOC AM, V46, P634, DOI 10.1364/JOSA.46.000634; BAYLOR DA, 1984, J PHYSIOL-LONDON, V357, P575, DOI 10.1113/jphysiol.1984.sp015518; BAYLOR DA, 1980, J PHYSIOL-LONDON, V309, P591, DOI 10.1113/jphysiol.1980.sp013529; Borghuis BG, 2009, J NEUROSCI, V29, P3045, DOI 10.1523/JNEUROSCI.5071-08.2009; BURKHARDT DA, 1994, J NEUROSCI, V14, P1091, DOI 10.1523/JNEUROSCI.14-03-01091.1994; Demb JB, 2008, J PHYSIOL-LONDON, V586, P4377, DOI 10.1113/jphysiol.2008.156638; DONNER K, 1990, J GEN PHYSIOL, V95, P733, DOI 10.1085/jgp.95.4.733; DONNER K, 1992, VISION RES, V32, P853, DOI 10.1016/0042-6989(92)90028-H; Dunn FA, 2007, NATURE, V449, P603, DOI 10.1038/nature06150; Fechner G. T., 1860, ELEMENTE PSYCHOPHYSI; Field GD, 2005, ANNU REV PHYSIOL, V67, P491, DOI 10.1146/annurev.physiol.67.031103.151256; Field GD, 2002, NEURON, V35, P733, DOI 10.1016/S0896-6273(02)00822-X; Fu YB, 2008, NAT NEUROSCI, V11, P565, DOI 10.1038/nn.2110; Fu YB, 2007, PFLUG ARCH EUR J PHY, V454, P805, DOI 10.1007/s00424-006-0194-y; Holcman D, 2005, J GEN PHYSIOL, V125, P641, DOI 10.1085/jgp.200509277; Hornstein EP, 2005, J NEUROSCI, V25, P11201, DOI 10.1523/JNEUROSCI.3416-05.2005; Kefalov VJ, 2005, NEURON, V46, P879, DOI 10.1016/j.neuron.2005.05.009; Koenig D, 2011, J VISION, V11, DOI 10.1167/11.1.21; Luo DG, 2011, SCIENCE, V332, P1307, DOI 10.1126/science.1200172; Rieke F, 1996, BIOPHYS J, V71, P2553, DOI 10.1016/S0006-3495(96)79448-1; Rieke F, 1998, REV MOD PHYS, V70, P1027, DOI 10.1103/RevModPhys.70.1027; Rieke F, 2000, NEURON, V26, P181, DOI 10.1016/S0896-6273(00)81148-4; Rieke F, 2001, J NEUROSCI, V21, P9445, DOI 10.1523/JNEUROSCI.21-23-09445.2001; Rieke F, 2009, NEURON, V64, P605, DOI 10.1016/j.neuron.2009.11.028; SCHNAPF JL, 1990, J PHYSIOL-LONDON, V427, P681, DOI 10.1113/jphysiol.1990.sp018193; Schneeweis DM, 1999, J NEUROSCI, V19, P1203; Schneeweis DM, 2000, VISUAL NEUROSCI, V17, P659, DOI 10.1017/S0952523800175017; SWARUP G, 1983, BIOCHEMISTRY-US, V22, P1102, DOI 10.1021/bi00274a017; TRANCHINA D, 1984, NATURE, V310, P314, DOI 10.1038/310314a0	30	51	51	0	11	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	NOV	2013	16	11					1692	1700		10.1038/nn.3534	http://dx.doi.org/10.1038/nn.3534			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	241YX	24097042	Green Accepted			2022-12-28	WOS:000326205700028
J	Gottlieb, J				Gottlieb, Jacqueline			Slicing a pie is no piece of cake	NATURE NEUROSCIENCE			English	Editorial Material							PREFRONTAL CORTEX; TOP-DOWN; CATEGORIZATION; ATTENTION	The ability to categorize objects depending on task demands is critical. A primate study finds that the prefrontal cortex signals to the parietal cortex during categorization, indicating an asymmetric, top-down interaction.	[Gottlieb, Jacqueline] Columbia Univ, Dept Neurosci, New York, NY 10027 USA; [Gottlieb, Jacqueline] Columbia Univ, Kavli Inst Brain Sci, New York, NY USA	Columbia University; Columbia University	Gottlieb, J (corresponding author), Columbia Univ, Dept Neurosci, New York, NY 10027 USA.	jg2141@columbia.edu						Buschman TJ, 2007, SCIENCE, V315, P1860, DOI 10.1126/science.1138071; Cromer JA, 2011, J COGNITIVE NEUROSCI, V23, P3355, DOI 10.1162/jocn_a_00032; Crowe DA, 2013, NAT NEUROSCI, V16, P1484, DOI 10.1038/nn.3509; Ferrera VP, 2009, NAT NEUROSCI, V12, P1458, DOI 10.1038/nn.2434; Katsuki F, 2012, NAT NEUROSCI, V15, P1160, DOI 10.1038/nn.3164; Merchant H, 2011, FRONT SYST NEUROSCI, V5, DOI 10.3389/fnsys.2011.00069; Rossi AF, 2007, J NEUROSCI, V27, P11306, DOI 10.1523/JNEUROSCI.2939-07.2007; Roy JE, 2010, J NEUROSCI, V30, P8519, DOI 10.1523/JNEUROSCI.4837-09.2010; Suzuki M, 2013, NAT NEUROSCI, V16, P98, DOI 10.1038/nn.3282; Swaminathan SK, 2012, NAT NEUROSCI, V15, P315, DOI 10.1038/nn.3016	10	1	1	0	5	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	OCT	2013	16	10					1364	1366		10.1038/nn.3520	http://dx.doi.org/10.1038/nn.3520			4	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	223HM	24067288				2022-12-28	WOS:000324795300005
J	Ciceri, G; Dehorter, N; Sols, I; Huang, ZJ; Maravall, M; Marin, O				Ciceri, Gabriele; Dehorter, Nathalie; Sols, Ignasi; Huang, Z. Josh; Maravall, Miguel; Marin, Oscar			Lineage-specific laminar organization of cortical GABAergic interneurons	NATURE NEUROSCIENCE			English	Article							CAUDAL GANGLIONIC EMINENCE; FATE MAPPING REVEALS; CEREBRAL-CORTEX; IMMUNOREACTIVE NEURONS; INHIBITORY INTERNEURONS; MONKEY NEOCORTEX; BASAL FOREBRAIN; MIGRATION; SUBTYPES; CELLS	In the cerebral cortex, pyramidal cells and interneurons are generated in distant germinal zones, and so the mechanisms that control their precise assembly into specific microcircuits remain an enigma. Here we report that cortical interneurons labeled at the clonal level do not distribute randomly but rather have a strong tendency to cluster in the mouse neocortex. This behavior is common to different classes of interneurons, independently of their origin. Interneuron clusters are typically contained within one or two adjacent cortical layers, are largely formed by isochronically generated neurons and populate specific layers, as revealed by unbiased hierarchical clustering methods. Our results suggest that different progenitor cells give rise to interneurons populating infra- and supragranular cortical layers, which challenges current views of cortical neurogenesis. Thus, specific lineages of cortical interneurons seem to be produced to primarily mirror the laminar structure of the cerebral cortex, rather than its columnar organization.	[Ciceri, Gabriele; Dehorter, Nathalie; Sols, Ignasi; Maravall, Miguel; Marin, Oscar] CSIC, Inst Neurociencias, Sant Joan dAlacant, Spain; [Ciceri, Gabriele; Dehorter, Nathalie; Sols, Ignasi; Maravall, Miguel; Marin, Oscar] Univ Miguel Hernandez, Sant Joan dAlacant, Spain; [Huang, Z. Josh] Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA	Consejo Superior de Investigaciones Cientificas (CSIC); Universidad Miguel Hernandez de Elche; CSIC-UMH - Instituto de Neurociencias de Alicante (IN); Universidad Miguel Hernandez de Elche; Cold Spring Harbor Laboratory	Maravall, M (corresponding author), CSIC, Inst Neurociencias, Sant Joan dAlacant, Spain.	mmaravall@umh.es; o.marin@umh.es	Marin, Oscar/F-3856-2012; Maravall, Miguel/AAW-4328-2021	Marin, Oscar/0000-0001-6264-7027; Maravall, Miguel/0000-0002-8869-7206; Huang, Z. Josh/0000-0003-0592-028X; Dehorter, Nathalie/0000-0001-7599-2866; Ciceri, Gabriele/0000-0002-8481-9771	Spanish Ministry of Economy and Innovation (MINECO) [SAF2011-28845, BFU2011-23049]; CONSOLIDER [CSD2007-00023]; European Research Council [ERC-2011-AdG 293683]; MINECO; European Molecular Biology Organization (EMBO)	Spanish Ministry of Economy and Innovation (MINECO)(Spanish Government); CONSOLIDER(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); European Research Council(European Research Council (ERC)European Commission); MINECO(Spanish Government); European Molecular Biology Organization (EMBO)(European Molecular Biology Organization (EMBO))	We thank A. Casillas, T. Gil and M. Perez for excellent technical assistance, D. Gelman for contributing to the development of conditional retroviruses, S. A. Anderson (University of Pennsylvania School of Medicine; Nkx2-1-Cre), S. Arber (University of Basel; PV-Cre), and A. Barco (Instituto de Neurociencias; Nestin-Cre) for mouse strains, F.H. Gage (The Salk Institute for Biological Studies) for retroviral vectors and N. Tamamaki (Kumamoto University) for the CAG-Fucci-G plasmid. We are grateful to members of the Marin and Rico laboratories for discussions and ideas. Supported by grants from Spanish Ministry of Economy and Innovation (MINECO) SAF2011-28845 to O.M., BFU2011-23049 to M.M. and CONSOLIDER CSD2007-00023 to O.M. and M. M., and from the European Research Council (ERC-2011-AdG 293683) to O.M. G.C. and I.S. are recipients of "Formacion de Personal Investigador" (FPI) fellowships from the MINECO. N.D. is the recipient of a European Molecular Biology Organization (EMBO) long-term fellowship.	Anderson SA, 1997, SCIENCE, V278, P474, DOI 10.1126/science.278.5337.474; Ang ESBC, 2003, J NEUROSCI, V23, P5805; Ascoli GA, 2008, NAT REV NEUROSCI, V9, P557, DOI 10.1038/nrn2402; Brown KN, 2011, SCIENCE, V334, P480, DOI 10.1126/science.1208884; Butt SJB, 2005, NEURON, V48, P591, DOI 10.1016/j.neuron.2005.09.034; Cardin JA, 2009, NATURE, V459, P663, DOI 10.1038/nature08002; Carugo O, 2010, METHODS MOL BIOL, V609, P175, DOI 10.1007/978-1-60327-241-4_11; CAVANAGH ME, 1989, J COMP NEUROL, V284, P637, DOI 10.1002/cne.902840410; Cepko CL, 1998, METHODS, V14, P393, DOI 10.1006/meth.1998.0594; DEFELIPE J, 1992, PROG NEUROBIOL, V39, P563, DOI 10.1016/0301-0082(92)90015-7; FAIREN A, 1986, J COMP NEUROL, V251, P67, DOI 10.1002/cne.902510105; Flames N, 2007, J NEUROSCI, V27, P9682, DOI 10.1523/JNEUROSCI.2750-07.2007; Fogarty M, 2007, J NEUROSCI, V27, P10935, DOI 10.1523/JNEUROSCI.1629-07.2007; Franco SJ, 2012, SCIENCE, V337, P746, DOI 10.1126/science.1223616; Gaiano N, 1999, NAT NEUROSCI, V2, P812, DOI 10.1038/12186; Gelman DM, 2009, J NEUROSCI, V29, P9380, DOI 10.1523/JNEUROSCI.0604-09.2009; HENDRY SHC, 1984, J NEUROSCI, V4, P2497; Hensch TK, 2005, NAT REV NEUROSCI, V6, P877, DOI 10.1038/nrn1787; Hevner RF, 2004, NEUROSCIENCE, V124, P605, DOI 10.1016/j.neuroscience.2003.11.033; Hippenmeyer S, 2005, PLOS BIOL, V3, P878, DOI 10.1371/journal.pbio.0030159; Isaacson JS, 2011, NEURON, V72, P231, DOI 10.1016/j.neuron.2011.09.027; Jones EG, 2010, CEREB CORTEX, V20, P2261, DOI 10.1093/cercor/bhq127; Kawaguchi Y, 1997, CEREB CORTEX, V7, P476, DOI 10.1093/cercor/7.6.476; Klausberger T, 2008, SCIENCE, V321, P53, DOI 10.1126/science.1149381; Li Y, 2012, NATURE, V486, P118, DOI 10.1038/nature11110; Lodato S, 2011, NEURON, V69, P763, DOI 10.1016/j.neuron.2011.01.015; Ma YY, 2006, J NEUROSCI, V26, P5069, DOI 10.1523/JNEUROSCI.0661-06.2006; Marin O, 2001, NAT REV NEUROSCI, V2, P780, DOI 10.1038/35097509; Markram H, 2004, NAT REV NEUROSCI, V5, P793, DOI 10.1038/nrn1519; MILLER MW, 1985, DEV BRAIN RES, V23, P187, DOI 10.1016/0165-3806(85)90040-9; Miyoshi G, 2007, J NEUROSCI, V27, P7786, DOI 10.1523/JNEUROSCI.1807-07.2007; Miyoshi G, 2011, CEREB CORTEX, V21, P845, DOI 10.1093/cercor/bhq155; Miyoshi G, 2010, J NEUROSCI, V30, P1582, DOI 10.1523/JNEUROSCI.4515-09.2010; Molyneaux BJ, 2007, NAT REV NEUROSCI, V8, P427, DOI 10.1038/nrn2151; Mountcastle VB, 1997, BRAIN, V120, P701, DOI 10.1093/brain/120.4.701; Nery S, 2002, NAT NEUROSCI, V5, P1279, DOI 10.1038/nn971; Noctor SC, 2001, NATURE, V409, P714, DOI 10.1038/35055553; Ohtsuki G, 2012, NEURON, V75, P65, DOI 10.1016/j.neuron.2012.05.023; Pla R, 2006, J NEUROSCI, V26, P6924, DOI 10.1523/JNEUROSCI.0245-06.2006; RAKIC P, 1988, SCIENCE, V241, P170, DOI 10.1126/science.3291116; RAKIC P, 1971, BRAIN RES, V33, P471, DOI 10.1016/0006-8993(71)90119-3; Rymar VV, 2007, J COMP NEUROL, V501, P369, DOI 10.1002/cne.21250; Sakaue-Sawano A, 2008, CELL, V132, P487, DOI 10.1016/j.cell.2007.12.033; Silberberg G, 2002, TRENDS NEUROSCI, V25, P227, DOI 10.1016/S0166-2236(02)02151-3; Sousa VH, 2009, CEREB CORTEX, V19, pI1, DOI 10.1093/cercor/bhp038; Stancik EK, 2010, J NEUROSCI, V30, P7028, DOI 10.1523/JNEUROSCI.6131-09.2010; Sussel L, 1999, DEVELOPMENT, V126, P3359; Tanaka DH, 2009, J NEUROSCI, V29, P1300, DOI 10.1523/JNEUROSCI.5446-08.2009; Taniguchi H, 2011, NEURON, V71, P995, DOI 10.1016/j.neuron.2011.07.026; Tashiro A, 2006, NATURE, V442, P929, DOI 10.1038/nature05028; Turrigiano G, 2011, ANNU REV NEUROSCI, V34, P89, DOI 10.1146/annurev-neuro-060909-153238; Valcanis H, 2003, J NEUROSCI, V23, P5113; WALSH C, 1988, SCIENCE, V241, P1342, DOI 10.1126/science.3137660; Wichterle H, 2001, DEVELOPMENT, V128, P3759; Wonders CP, 2006, NAT REV NEUROSCI, V7, P687, DOI 10.1038/nrn1954; Xu Q, 2004, J NEUROSCI, V24, P2612, DOI 10.1523/JNEUROSCI.5667-03.2004; Xu Q, 2008, J COMP NEUROL, V506, P16, DOI 10.1002/cne.21529; Yozu M, 2005, J NEUROSCI, V25, P7268, DOI 10.1523/JNEUROSCI.2072-05.2005; Yu YC, 2009, NATURE, V458, P501, DOI 10.1038/nature07722	59	91	91	0	18	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	SEP	2013	16	9					1199	U64		10.1038/nn.3485	http://dx.doi.org/10.1038/nn.3485			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	207KN	23933753				2022-12-28	WOS:000323597500011
J	Robertson, SD; Plummer, NW; de Marchena, J; Jensen, P				Robertson, Sabrina D.; Plummer, Nicholas W.; de Marchena, Jacqueline; Jensen, Patricia			Developmental origins of central norepinephrine neuron diversity	NATURE NEUROSCIENCE			English	Article							DOPAMINE-BETA-HYDROXYLASE; LOCUS-COERULEUS NEURONS; NORADRENERGIC NEURONS; RAT-BRAIN; DEVELOPING HINDBRAIN; NERVOUS-SYSTEM; MESSENGER-RNA; EXPOSURE; MICE; DISEASE	Central norepinephrine-producing neurons comprise a diverse population of cells differing in anatomical location, connectivity, function and response to disease and environmental insult. The mechanisms that generate this diversity are unknown. Here we elucidate the lineal relationship between molecularly distinct progenitor populations in the developing mouse hindbrain and mature norepinephrine neuron subtype identity. We have identified four genetically separable subpopulations of mature norepinephrine neurons differing in their anatomical location, axon morphology and efferent projection pattern. One of the subpopulations showed an unexpected projection to the prefrontal cortex, challenging the long-held belief that the locus coeruleus is the sole source of norepinephrine projections to the cortex. These findings reveal the embryonic origins of central norepinephrine neurons and provide multiple molecular points of entry for future study of individual norepinephrine circuits in complex behavioral and physiological processes including arousal, attention, mood, memory, appetite and homeostasis.	[Robertson, Sabrina D.; Plummer, Nicholas W.; de Marchena, Jacqueline; Jensen, Patricia] NIEHS, Neurobiol Lab, NIH, Dept Hlth & Human Serv, Res Triangle Pk, NC 27709 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS)	Jensen, P (corresponding author), NIEHS, Neurobiol Lab, NIH, Dept Hlth & Human Serv, POB 12233, Res Triangle Pk, NC 27709 USA.	patricia.jensen@nih.gov	Jensen, Patricia/Z-1523-2018	Jensen, Patricia/0000-0001-6459-7289; Robertson, Sabrina/0000-0003-4598-6929; /0000-0003-2971-814X	Intramural Research Program of the US National Institutes of Health, National Institute of Environmental Health Sciences [ZIA-ES-102805]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [ZICES102425, ZIAES102805] Funding Source: NIH RePORTER	Intramural Research Program of the US National Institutes of Health, National Institute of Environmental Health Sciences; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	We thank S. Dymecki (Harvard Medical School) for Hoxa2-cre and RC:: FrePe mice and P. Charnay (INSERM) for Krox20cre mice. We thank T. Wolfgang, G. Keeley and the National Institute of Environmental Health Sciences Fluorescence Microscopy, Vivarium, Knockout Mice and Statistics services for assistance. This research was supported by the Intramural Research Program of the US National Institutes of Health, National Institute of Environmental Health Sciences (ZIA-ES-102805).	Adams DJ, 2005, GENOMICS, V86, P753, DOI 10.1016/j.ygeno.2005.08.003; Aroca P, 2006, J COMP NEUROL, V496, P802, DOI 10.1002/cne.20957; Aston-Jones G, 2005, ANNU REV NEUROSCI, V28, P403, DOI 10.1146/annurev.neuro.28.061604.135709; Awatramani R, 2003, NAT GENET, V35, P70, DOI 10.1038/ng1228; Bang SJ, 2012, EUR J NEUROSCI, V35, P85, DOI 10.1111/j.1460-9568.2011.07936.x; Benarroch EE, 2008, ACTA NEUROPATHOL, V115, P629, DOI 10.1007/s00401-008-0351-9; Berridge CW, 2003, BRAIN RES REV, V42, P33, DOI 10.1016/S0165-0173(03)00143-7; Bertrand E, 1997, FOLIA NEUROPATHOL, V35, P80; Brunnstrom H, 2011, CLIN NEUROPATHOL, V30, P104, DOI 10.5414/NPP30104; Busch C, 1997, NEUROBIOL AGING, V18, P401, DOI 10.1016/S0197-4580(97)00035-3; Chambers D, 2009, NEURAL DEV, V4, DOI 10.1186/1749-8104-4-6; Champagnat J, 2009, PHILOS T R SOC B, V364, P2469, DOI 10.1098/rstb.2009.0090; Chandler D, 2012, FRONT BEHAV NEUROSCI, V6, DOI 10.3389/fnbeh.2012.00020; DAHLSTROM A, 1964, ACTA PHYSIOL SCAND, V62, P1; Dasen JS, 2009, CURR TOP DEV BIOL, V88, P169, DOI 10.1016/S0070-2153(09)88006-X; Davenport PW, 2009, RESP PHYSIOL NEUROBI, V167, P72, DOI 10.1016/j.resp.2008.10.001; Del Pino J, 2011, TOXICOLOGY, V287, P145, DOI 10.1016/j.tox.2011.06.009; Engleka KA, 2012, CIRC RES, V110, P922, DOI 10.1161/CIRCRESAHA.112.266510; Farago AF, 2006, NEURON, V50, P205, DOI 10.1016/j.neuron.2006.03.014; Forray MI, 2000, BRAIN RES BULL, V52, P163, DOI 10.1016/S0361-9230(00)00229-X; FRITSCHY JM, 1990, J COMP NEUROL, V293, P616, DOI 10.1002/cne.902930407; Garel S, 2000, DEVELOPMENT, V127, P5297; Gaufo GO, 2004, DEVELOPMENT, V131, P1259, DOI 10.1242/dev.01029; GERMAN DC, 1992, ANN NEUROL, V32, P667, DOI 10.1002/ana.410320510; Goridis C, 2002, NAT REV NEUROSCI, V3, P531, DOI 10.1038/nrn871; Gray PA, 2010, J NEUROSCI, V30, P14883, DOI 10.1523/JNEUROSCI.4031-10.2010; Grossmann KS, 2010, PROG BRAIN RES, V187, P19, DOI [10.1016/S0079-6123(10)87002-5, 10.1016/B978-0-444-53613-6.00002-2]; GRZANNA R, 1991, PROG BRAIN RES, V88, P89; HOKFELT T, 1973, ACTA PHYSIOL SCAND, V89, P286, DOI 10.1111/j.1748-1716.1973.tb05522.x; Jensen P, 2008, NAT NEUROSCI, V11, P417, DOI 10.1038/nn2050; Jin SH, 2004, J COMP NEUROL, V477, P300, DOI 10.1002/cne.20263; Kimmel RA, 2000, GENE DEV, V14, P1377; KRUMLAUF R, 1993, J NEUROBIOL, V24, P1328, DOI 10.1002/neu.480241006; Lewandoski M, 1997, COLD SPRING HARB SYM, V62, P159; Li JYH, 2002, NEURON, V36, P31, DOI 10.1016/S0896-6273(02)00935-2; Liu PT, 2003, GENOME RES, V13, P476, DOI 10.1101/gr.749203; LORANG D, 1994, J NEUROSCI, V14, P4903; Lumsden A, 1996, SCIENCE, V274, P1109, DOI 10.1126/science.274.5290.1109; Mejias-Aponte CA, 2009, J NEUROSCI, V29, P3613, DOI 10.1523/JNEUROSCI.4632-08.2009; Miller MA, 1999, J NEUROCHEM, V73, P2028; Mohideen SS, 2011, TOXICOLOGY, V285, P67, DOI 10.1016/j.tox.2011.04.005; Myers EA, 2005, J COMP NEUROL, V492, P426, DOI 10.1002/cne.20727; O'Gorman S, 2005, DEV DYNAM, V234, P124, DOI 10.1002/dvdy.20402; Paxinos G, 2004, MOUSE BRAIN STEREOTA; Raymond CS, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000162; Rinaman L, 2011, AM J PHYSIOL-REG I, V300, pR222, DOI 10.1152/ajpregu.00556.2010; Sara SJ, 2012, NEURON, V76, P130, DOI 10.1016/j.neuron.2012.09.011; SAWCHENKO PE, 1981, SCIENCE, V214, P685, DOI 10.1126/science.7292008; Schofield Brett R, 2008, Curr Protoc Neurosci, VChapter 1, DOI 10.1002/0471142301.ns0117s43; Simon HH, 2005, MOL CELL NEUROSCI, V28, P96, DOI 10.1016/j.mcn.2004.08.016; Slotkin TA, 2011, BRAIN RES BULL, V86, P435, DOI 10.1016/j.brainresbull.2011.08.009; Soulage C, 2004, NEUROCHEM INT, V45, P979, DOI 10.1016/j.neuint.2004.06.015; SWANSON LW, 1976, BRAIN RES, V110, P39, DOI 10.1016/0006-8993(76)90207-9; Thomas SA, 1998, J NEUROCHEM, V70, P2468; THOMAS SA, 1995, NATURE, V374, P643, DOI 10.1038/374643a0; Voiculescu O, 2000, GENESIS, V26, P123, DOI 10.1002/(SICI)1526-968X(200002)26:2<123::AID-GENE7>3.0.CO;2-O; Warming S, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni035	57	149	151	1	18	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	AUG	2013	16	8					1016	U65		10.1038/nn.3458	http://dx.doi.org/10.1038/nn.3458			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	190EV	23852112	Green Accepted			2022-12-28	WOS:000322323000011
J	Chittajallu, R; Pelkey, KA; McBain, CJ				Chittajallu, Ramesh; Pelkey, Kenneth A.; McBain, Chris J.			Neurogliaform cells dynamically regulate somatosensory integration via synapse-specific modulation	NATURE NEUROSCIENCE			English	Article							INHIBITION; RECEPTOR; CORTEX; ACTIVATION; NEOCORTEX; RESPONSES; AMYGDALA; NEURONS; DRIVEN	Despite the prevailing idea that neurogliaform cells produce a spatially unrestricted widespread inhibition, we demonstrate here that their activity attenuates thalamic-evoked feed-forward inhibition in layer IV barrel cortex but has no effect on feed-forward excitation. The result of this circuit selectivity is a dynamic regulation in the temporal window for integration of excitatory thalamic input, thus revealing a new role for neurogliaform cells in shaping sensory processing.	[Chittajallu, Ramesh; Pelkey, Kenneth A.; McBain, Chris J.] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Program Dev Neurobiol, NIH, Bethesda, MD USA	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	McBain, CJ (corresponding author), Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Program Dev Neurobiol, NIH, Bethesda, MD USA.	mcbainc@mail.nih.gov	Chittajallu, Ramesh/AAX-3749-2020	Chittajallu, Ramesh/0000-0002-9794-0052	National Institute of Child Health and Human Development; National Institute of Neurological Disorders and Stroke Intramural Programs; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD001205] Funding Source: NIH RePORTER	National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Institute of Neurological Disorders and Stroke Intramural Programs; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	We thank J. Isaac for comments, and M. Craig for the IGOR procedures used to automate analyses of the modeling data. This work was supported by the National Institute of Child Health and Human Development and National Institute of Neurological Disorders and Stroke Intramural Programs.	AGMON A, 1991, NEUROSCIENCE, V41, P365, DOI 10.1016/0306-4522(91)90333-J; Belachew S, 2003, J CELL BIOL, V161, P169, DOI 10.1083/jcb.200210110; Bruno RM, 2006, SCIENCE, V312, P1622, DOI 10.1126/science.1124593; Chittajallu R, 2010, NAT NEUROSCI, V13, P1240, DOI 10.1038/nn.2639; Cruikshank SJ, 2007, NAT NEUROSCI, V10, P462, DOI 10.1038/nn1861; Fino E, 2013, NEUROSCIENTIST, V19, P228, DOI 10.1177/1073858412456743; Gabernet L, 2005, NEURON, V48, P315, DOI 10.1016/j.neuron.2005.09.022; Gonzalez-Burgos G, 2010, ADV PHARMACOL, V58, P175, DOI 10.1016/S1054-3589(10)58008-6; Karayannis T, 2010, J NEUROSCI, V30, P9898, DOI 10.1523/JNEUROSCI.5883-09.2010; Lee S, 2010, J NEUROSCI, V30, P16796, DOI 10.1523/JNEUROSCI.1869-10.2010; Manko M, 2012, J PHYSIOL-LONDON, V590, P5611, DOI 10.1113/jphysiol.2012.236745; Olah S, 2009, NATURE, V461, P1278, DOI 10.1038/nature08503; Pan BX, 2009, NEURON, V61, P917, DOI 10.1016/j.neuron.2009.01.029; Schwenk J, 2010, NATURE, V465, P231, DOI 10.1038/nature08964; Szabadics J, 2007, P NATL ACAD SCI USA, V104, P14831, DOI 10.1073/pnas.0707204104; Tamas G, 2003, SCIENCE, V299, P1902, DOI 10.1126/science.1082053; Vitellaro-Zuccarello L, 2003, CELL TISSUE RES, V313, P245, DOI 10.1007/s00441-003-0746-9; Xu Q, 2008, J COMP NEUROL, V506, P16, DOI 10.1002/cne.21529	18	46	48	1	8	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JAN	2013	16	1					13	U167		10.1038/nn.3284	http://dx.doi.org/10.1038/nn.3284			4	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	058KZ	23222912	Green Accepted			2022-12-28	WOS:000312633900007
J	Barrios, A; Ghosh, R; Fang, C; Emmons, SW; Barr, MM				Barrios, Arantza; Ghosh, Rajarshi; Fang, Chunhui; Emmons, Scott W.; Barr, Maureen M.			PDF-1 neuropeptide signaling modulates a neural circuit for mate-searching behavior in C. elegans	NATURE NEUROSCIENCE			English	Article							CAENORHABDITIS-ELEGANS; DECISION-MAKING; TRANSCRIPTION FACTOR; SEX-DIFFERENCES; GENE; NEURONS; INSULIN; MODEL; CONNECTOME; LONGEVITY	Appetitive behaviors require complex decision making that involves the integration of environmental stimuli and physiological needs. C. elegans mate searching is a male-specific exploratory behavior regulated by two competing needs: food and reproductive appetite. We found that the pigment dispersing factor receptor (PDFR-1) modulates the circuit that encodes the male reproductive drive that promotes male exploration following mate deprivation. PDFR-1 and its ligand, PDF-1, stimulated mate searching in the male, but not in the hermaphrodite. pdf-1 was required in the gender-shared interneuron AIM, and the receptor acted in internal and external environment-sensing neurons of the shared nervous system (URY, PQR and PHA) to produce mate-searching behavior. Thus, the pdf-1 and pdfr-1 pathway functions in non-sex-specific neurons to produce a male-specific, goal-oriented exploratory behavior. Our results indicate that secretin neuropeptidergic signaling is involved in regulating motivational internal states.	[Barrios, Arantza; Barr, Maureen M.] Rutgers State Univ, Dept Genet, Piscataway, NJ 08855 USA; [Ghosh, Rajarshi; Fang, Chunhui; Emmons, Scott W.] Albert Einstein Coll Med, Dept Mol Genet, Bronx, NY 10467 USA	Rutgers State University New Brunswick; Yeshiva University; Albert Einstein College of Medicine	Barrios, A (corresponding author), Rutgers State Univ, Dept Genet, Piscataway, NJ 08855 USA.	a.barrios@ucl.ac.uk		Barrios, Arantza/0000-0001-6153-8830	US National Institutes of Health [2R01DK059418]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK059418] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM066897] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank the Maricq (University of Utah), Rongo (Rutgers University) and Hobert (Columbia University) laboratories for strains and reagents, and the Mitani laboratory (Tokyo Women's Medical College) and Japan's National BioResource Project for mutants. Additional strains were obtained from the Caenorhabditis Genetics Center. We thank R. Poole and members of the Barr laboratory for advice and many helpful discussions on the manuscript and L. Vaynerchuk for experimental aid. This research was supported by US National Institutes of Health grant 2R01DK059418 to M.M.B.	Altun ZF, 2009, DEV DYNAM, V238, P1936, DOI 10.1002/dvdy.22025; Aurelio O, 2002, SCIENCE, V295, P686, DOI 10.1126/science.1066642; Bargmann CI, 1995, METHOD CELL BIOL, V48, P225; Bargmann CI, 2012, BIOESSAYS, V34, P458, DOI 10.1002/bies.201100185; Barr MM, 1999, NATURE, V401, P386, DOI 10.1038/43916; Barr MM, 2001, CURR BIOL, V11, P1341, DOI 10.1016/S0960-9822(01)00423-7; Barrios A, 2008, CURR BIOL, V18, P1865, DOI 10.1016/j.cub.2008.10.050; Bendesky A, 2011, NAT REV GENET, V12, P809, DOI 10.1038/nrg3065; Bendesky A, 2011, NATURE, V472, P313, DOI 10.1038/nature09821; Bermant G, 1974, BIOL BASES SEXUAL BE; Boulin Thomas, 2006, WormBook, P1, DOI 10.1895/wormbook.1.106.1; Cardoso JCR, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-108; Chalasani SH, 2007, NATURE, V450, P63, DOI 10.1038/nature06292; Coates JC, 2002, NATURE, V419, P925, DOI 10.1038/nature01170; Dickson L, 2009, PHARMACOL THERAPEUT, V121, P294, DOI 10.1016/j.pharmthera.2008.11.006; Flowers EB, 2010, DEVELOPMENT, V137, P1799, DOI 10.1242/dev.046219; Frisch von O., 1969, ANIMAL MIGRATION; Fujii S, 2010, P NATL ACAD SCI USA, V107, P10590, DOI 10.1073/pnas.0912457107; Gloria-Soria A, 2008, CURR BIOL, V18, P1694, DOI 10.1016/j.cub.2008.09.043; Gray JM, 2005, P NATL ACAD SCI USA, V102, P3184, DOI 10.1073/pnas.0409009101; Hills T, 2004, J NEUROSCI, V24, P1217, DOI 10.1523/JNEUROSCI.1569-03.2004; Janke DL, 1997, GENOME RES, V7, P974, DOI 10.1101/gr.7.10.974; Janssen T, 2008, J BIOL CHEM, V283, P15241, DOI 10.1074/jbc.M709060200; Janssen T, 2009, J NEUROCHEM, V111, P228, DOI 10.1111/j.1471-4159.2009.06323.x; Jarrell TA, 2012, SCIENCE, V337, P437, DOI 10.1126/science.1221762; Kage E, 2005, CURR BIOL, V15, P1554, DOI 10.1016/j.cub.2005.07.057; Kimura KD, 1997, SCIENCE, V277, P942, DOI 10.1126/science.277.5328.942; Kleemann G, 2008, GENETICS, V180, P2111, DOI 10.1534/genetics.108.093773; Lee RYN, 1999, J NEUROSCI, V19, P159, DOI 10.1523/JNEUROSCI.19-01-00159.1999; Lickteig KM, 2001, J NEUROSCI, V21, P2001, DOI 10.1523/JNEUROSCI.21-06-02001.2001; Lipton J, 2004, J NEUROSCI, V24, P7427, DOI 10.1523/JNEUROSCI.1746-04.2004; MARICQ AV, 1995, NATURE, V378, P78, DOI 10.1038/378078a0; Morsci NS, 2011, CURR BIOL, V21, P1239, DOI 10.1016/j.cub.2011.06.027; Mowrey WR, 2012, BIOL SEX DIFFER, V3, DOI 10.1186/2042-6410-3-8; Ogg S, 1997, NATURE, V389, P994, DOI 10.1038/40194; Olofsson B., 2011, P NATL ACAD SCI US; Pfaff DW, 1982, PHYSL MECH MOTIVATIO; Portman DS, 2007, ADV GENET, V59, P1, DOI 10.1016/S0065-2660(07)59001-2; Pujol N, 2001, CURR BIOL, V11, P809, DOI 10.1016/S0960-9822(01)00241-X; Reppert SM, 2006, CELL, V124, P233, DOI 10.1016/j.cell.2006.01.009; Ressler KJ, 2011, NATURE, V470, P492, DOI 10.1038/nature09856; Soria V, 2010, NEUROPSYCHOPHARMACOL, V35, P1279, DOI 10.1038/npp.2009.230; Stewart HI, 1998, MOL GEN GENET, V260, P280, DOI 10.1007/PL00013816; Tursun B, 2011, SCIENCE, V331, P304, DOI 10.1126/science.1199082; Wakabayashi T, 2004, NEUROSCI RES, V50, P103, DOI 10.1016/j.neures.2004.06.005; Wicks SR, 2001, NAT GENET, V28, P160, DOI 10.1038/88878; You YJ, 2008, CELL METAB, V7, P249, DOI 10.1016/j.cmet.2008.01.005; Yu S, 1997, P NATL ACAD SCI USA, V94, P3384, DOI 10.1073/pnas.94.7.3384; Zhang Y, 2002, NATURE, V418, P331, DOI 10.1038/nature00891	49	70	82	0	28	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	DEC	2012	15	12					1675	+		10.1038/nn.3253	http://dx.doi.org/10.1038/nn.3253			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	045OR	23143519	Green Accepted			2022-12-28	WOS:000311706700013
J	Asari, H; Meister, M				Asari, Hiroki; Meister, Markus			Divergence of visual channels in the inner retina	NATURE NEUROSCIENCE			English	Article							TEMPORAL CONTRAST ADAPTATION; TIGER SALAMANDER RETINA; BIPOLAR CELLS; GANGLION-CELLS; SYNAPTIC DEPRESSION; MAMMALIAN RETINA; AMACRINE CELLS; OBJECT MOTION; MOUSE RETINA; EXCITATION	Bipolar cells form parallel channels that carry visual signals from the outer to the inner retina. Each type of bipolar cell is thought to carry a distinct visual message to select types of amacrine cells and ganglion cells. However, the number of ganglion cell types exceeds that of the bipolar cells providing their input, suggesting that bipolar cell signals diversify on transmission to ganglion cells. We explored in the salamander retina how signals from individual bipolar cells feed into multiple ganglion cells and found that each bipolar cell was able to evoke distinct responses among ganglion cells, differing in kinetics, adaptation and rectification properties. This signal divergence resulted primarily from interactions with amacrine cells that allowed each bipolar cell to send distinct signals to its target ganglion cells. Our findings indicate that individual bipolar cell-ganglion cell connections have distinct transfer functions. This expands the number of visual channels in the inner retina and enhances the computational power and feature selectivity of early visual processing.	[Asari, Hiroki; Meister, Markus] Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA; [Asari, Hiroki; Meister, Markus] Harvard Univ, Ctr Brain Sci, Cambridge, MA 02138 USA	Harvard University; Harvard University	Meister, M (corresponding author), CALTECH, Div Biol, Pasadena, CA 91125 USA.	meister@caltech.edu		Asari, Hiroki/0000-0003-3396-1935; Meister, Markus/0000-0003-2136-6506	Japan Society for the Promotion of Science; US National Institutes of Health; NATIONAL EYE INSTITUTE [R01EY014737] Funding Source: NIH RePORTER	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	We gratefully acknowledge E. Soucy for his extensive help with the experiments, as well as all of the members of the Meister laboratory for many useful discussions. This work was supported by a Postdoctoral Fellowship for Research Abroad from the Japan Society for the Promotion of Science (H.A.) and grants from the US National Institutes of Health (M.M.).	Arai I, 2010, J NEUROSCI, V30, P9260, DOI 10.1523/JNEUROSCI.1590-10.2010; Baccus SA, 2008, J NEUROSCI, V28, P6807, DOI 10.1523/JNEUROSCI.4206-07.2008; BARLOW HB, 1965, J PHYSIOL-LONDON, V178, P477, DOI 10.1113/jphysiol.1965.sp007638; BOYCOTT BB, 1991, EUR J NEUROSCI, V3, P1069, DOI 10.1111/j.1460-9568.1991.tb00043.x; Brandstatter JH, 1996, J NEUROSCI, V16, P4749; Burrone J, 2000, J NEUROSCI, V20, P568, DOI 10.1523/JNEUROSCI.20-02-00568.2000; Cook PB, 1998, NAT NEUROSCI, V1, P714, DOI 10.1038/3714; Demb JB, 2001, J NEUROSCI, V21, P7447, DOI 10.1523/JNEUROSCI.21-19-07447.2001; Demb JB, 2007, NEURON, V55, P179, DOI 10.1016/j.neuron.2007.07.001; DeVries SH, 2000, NEURON, V28, P847, DOI 10.1016/S0896-6273(00)00158-6; Dong CJ, 1998, J NEUROPHYSIOL, V79, P2171, DOI 10.1152/jn.1998.79.4.2171; Dowling J.E., 1971, VISION RES        S3, V11, P1; Dreosti E, 2011, NAT NEUROSCI, V14, P951, DOI 10.1038/nn.2841; ENROTHCUGELL C, 1966, J PHYSIOL-LONDON, V187, P517, DOI 10.1113/jphysiol.1966.sp008107; ENROTHCUGELL C, 1987, J PHYSIOL-LONDON, V384, P49, DOI 10.1113/jphysiol.1987.sp016443; FAMIGLIETTI EV, 1992, J COMP NEUROL, V316, P391, DOI 10.1002/cne.903160402; Geffen MN, 2007, PLOS BIOL, V5, P640, DOI 10.1371/journal.pbio.0050065; Ghosh KK, 2004, J COMP NEUROL, V469, P70, DOI 10.1002/cne.10985; Gollisch T, 2010, NEURON, V65, P150, DOI 10.1016/j.neuron.2009.12.009; HEIDELBERGER R, 1994, NATURE, V371, P513, DOI 10.1038/371513a0; Hosoya T, 2005, NATURE, V436, P71, DOI 10.1038/nature03689; Jones SM, 2009, J NEUROPHYSIOL, V102, P691, DOI 10.1152/jn.00285.2009; Kim KJ, 2003, J NEUROSCI, V23, P1506, DOI 10.1523/JNEUROSCI.23-04-01506.2003; Kim KJ, 2001, J NEUROSCI, V21, P287, DOI 10.1523/JNEUROSCI.21-01-00287.2001; Lagnado L, 1996, NEURON, V17, P957, DOI 10.1016/S0896-6273(00)80226-3; LUKASIEWICZ PD, 1995, J NEUROSCI, V15, P6189; MARIANI AP, 1984, NATURE, V308, P184, DOI 10.1038/308184a0; Masland RH, 2001, NAT NEUROSCI, V4, P877, DOI 10.1038/nn0901-877; Matsui K, 1998, J NEUROSCI, V18, P4500; MITTMAN S, 1990, J PHYSIOL-LONDON, V428, P175, DOI 10.1113/jphysiol.1990.sp018206; Olveczky BP, 2007, NEURON, V56, P689, DOI 10.1016/j.neuron.2007.09.030; Oesch NW, 2011, NAT NEUROSCI, V14, P1555, DOI 10.1038/nn.2945; Rieke F, 2001, J NEUROSCI, V21, P9445, DOI 10.1523/JNEUROSCI.21-23-09445.2001; Roska B, 1998, J NEUROSCI, V18, P3451; Roska B, 2006, J NEUROPHYSIOL, V95, P3810, DOI 10.1152/jn.00113.2006; Singer JH, 2006, J NEUROPHYSIOL, V95, P3191, DOI 10.1152/jn.01309.2005; SLAUGHTER MM, 1981, SCIENCE, V211, P182, DOI 10.1126/science.6255566; TACHIBANA M, 1988, VISUAL NEUROSCI, V1, P297, DOI 10.1017/S0952523800001954; Taylor WR, 1996, VISUAL NEUROSCI, V13, P979, DOI 10.1017/S0952523800009202; vonGersdorff H, 1997, J NEUROSCI, V17, P1919; Wassle H, 2009, J NEUROSCI, V29, P106, DOI 10.1523/JNEUROSCI.4442-08.2009; Wassle H, 2004, NAT REV NEUROSCI, V5, P747, DOI 10.1038/nrn1497; Wu SM, 2000, J NEUROSCI, V20, P4462, DOI 10.1523/JNEUROSCI.20-12-04462.2000; Zhang AJ, 2010, VISION RES, V50, P614, DOI 10.1016/j.visres.2010.01.009; Zhang AJ, 2009, J NEUROSCI, V29, P789, DOI 10.1523/JNEUROSCI.4984-08.2009	50	63	64	0	29	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	NOV	2012	15	11					1581	1589		10.1038/nn.3241	http://dx.doi.org/10.1038/nn.3241			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	028LX	23086336	Green Accepted			2022-12-28	WOS:000310424900019
J	Mosher, KI; Andres, RH; Fukuhara, T; Bieri, G; Hasegawa-Moriyama, M; He, YB; Guzman, R; Wyss-Coray, T				Mosher, Kira I.; Andres, Robert H.; Fukuhara, Takeshi; Bieri, Gregor; Hasegawa-Moriyama, Maiko; He, Yingbo; Guzman, Raphael; Wyss-Coray, Tony			Neural progenitor cells regulate microglia functions and activity	NATURE NEUROSCIENCE			English	Article							ADULT HIPPOCAMPAL NEUROGENESIS; ENDOTHELIAL GROWTH-FACTOR; RECOVERY; BRAIN	We found mouse neural progenitor cells (NPCs) to have a secretory protein profile distinct from other brain cells and to modulate microglial activation, proliferation and phagocytosis. NPC-derived vascular endothelial growth factor was necessary and sufficient to exert at least some of these effects in mice. Thus, neural precursor cells may not only be shaped by microglia, but also regulate microglia functions and activity.	[Mosher, Kira I.; Fukuhara, Takeshi; Bieri, Gregor; Hasegawa-Moriyama, Maiko; He, Yingbo; Wyss-Coray, Tony] Stanford Univ, Sch Med, Dept Neurol & Neurol Sci, Stanford, CA 94305 USA; [Mosher, Kira I.; Bieri, Gregor] Stanford Univ, Sch Med, Neurosci IDP Program, Stanford, CA 94305 USA; [Andres, Robert H.; Guzman, Raphael] Stanford Univ, Med Ctr, Dept Neurosurg, Stanford, CA 94305 USA; [Wyss-Coray, Tony] Vet Adm Palo Alto Hlth Care Syst, Ctr Tissue Regenerat Repair & Restorat, Palo Alto, CA USA	Stanford University; Stanford University; Stanford University	Wyss-Coray, T (corresponding author), Stanford Univ, Sch Med, Dept Neurol & Neurol Sci, Stanford, CA 94305 USA.	raphaelg@stanford.edu; twc@stanford.edu	Fukuhara, Takeshi/GLN-6928-2022; Wyss-Coray, Tony/AAF-3380-2019	Wyss-Coray, Tony/0000-0001-5893-0831; Guzman, Raphael/0000-0001-9620-0581; Mosher, Kira/0000-0002-3041-3186	National Institute of Neurological Disorders and Stroke [NS069375-01A1]; Department of Veterans Affairs; US National Institutes of Health Institute on Aging [R01 AG027505]; California Initiative for Regenerative Medicine; National Science Foundation; Ruth L. Kirschstein NRSA [1 F31 AG040877-01A1]; Swiss National Science Foundation [PBBEB-117034, PASMP3-123221/1]; Evelyn L. Neizer Fund; American Heart Association [AHA 083527N]; Bechtel Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS069375] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG027505, F31AG040877] Funding Source: NIH RePORTER	National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Department of Veterans Affairs(US Department of Veterans Affairs); US National Institutes of Health Institute on Aging; California Initiative for Regenerative Medicine; National Science Foundation(National Science Foundation (NSF)); Ruth L. Kirschstein NRSA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Evelyn L. Neizer Fund; American Heart Association(American Heart Association); Bechtel Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The authors wish to thank S. Villeda and R. Wabl for assistance with the neural progenitor cell cultures and M. Lochrie and the Stanford Neuroscience Gene Vector and Virus Core for generating the shRNA lentiviruses (supported by National Institute of Neurological Disorders and Stroke P30 core grant, NS069375-01A1). This work was supported by grants from the Department of Veterans Affairs (T.W.-C.) and US National Institutes of Health Institute on Aging (R01 AG027505, T.W.-C.), a California Initiative for Regenerative Medicine Award (T.W.-C.), a National Science Foundation predoctoral fellowship (K.I.M.), a Ruth L. Kirschstein NRSA predoctoral fellowship (1 F31 AG040877-01A1, K.I.M.), the Swiss National Science Foundation (PBBEB-117034 and PASMP3-123221/1, R.H.A.), the Evelyn L. Neizer Fund (R.H.A.), the American Heart Association (AHA 083527N, R.G.), and the Bechtel Foundation (R.G.).	Ajami B, 2007, NAT NEUROSCI, V10, P1538, DOI 10.1038/nn2014; Forstreuter F, 2002, J NEUROIMMUNOL, V132, P93, DOI 10.1016/S0165-5728(02)00315-6; Hanisch UK, 2007, NAT NEUROSCI, V10, P1387, DOI 10.1038/nn1997; Klassen HJ, 2003, CYTOKINE, V22, P101, DOI 10.1016/S1043-4666(03)00120-0; Lu ZJ, 2011, NAT CELL BIOL, V13, P1076, DOI 10.1038/ncb2299; Ming GL, 2011, NEURON, V70, P687, DOI 10.1016/j.neuron.2011.05.001; Monje ML, 2003, SCIENCE, V302, P1760, DOI 10.1126/science.1088417; Moriyama M, 2011, J NEUROSCI, V31, P3981, DOI 10.1523/JNEUROSCI.3617-10.2011; Pluchino S, 2003, NATURE, V422, P688, DOI 10.1038/nature01552; Pluchino S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005959; Schanzer A, 2004, BRAIN PATHOL, V14, P237; Skalnikova H, 2011, PROTEOMICS, V11, P691, DOI 10.1002/pmic.201000402; Ziv Y, 2006, P NATL ACAD SCI USA, V103, P13174, DOI 10.1073/pnas.0603747103; ZSEBO KM, 1990, CELL, V63, P195, DOI 10.1016/0092-8674(90)90300-4	14	156	165	0	20	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	NOV	2012	15	11					1485	1487		10.1038/nn.3233	http://dx.doi.org/10.1038/nn.3233			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	028LX	23086334	Green Published, Green Accepted			2022-12-28	WOS:000310424900007
J	Nitz, DA				Nitz, Douglas A.			Spaces within spaces: rat parietal cortex neurons register position across three reference frames	NATURE NEUROSCIENCE			English	Article							NEURAL ENSEMBLE; REPRESENTATION; HIPPOCAMPUS; DIRECTION; VELOCITY	We recorded parietal cortex neurons as rats traversed squared spiral tracks. Spatial firing patterns distinguished the behaviorally identical track segments composing loops, yet recurred with increasing or decreasing amplitude across the five loops composing the full track. These results indicate that parietal cortex neurons simultaneously respond to spatial relationships in multiple external reference frames, a phenomenon that may reflect a neural mechanism for relating parts to a whole.	Univ Calif San Diego, Dept Cognit Sci, San Diego, CA 92103 USA	University of California System; University of California San Diego	Nitz, DA (corresponding author), Univ Calif San Diego, Dept Cognit Sci, San Diego, CA 92103 USA.	dnitz@ucsd.edu			Neurosciences Research Foundation	Neurosciences Research Foundation	The author wishes to thank K. Papaefthimiou, L. Quinn, S. Cowen, D. Tingley, A. Chiba, S. Kolbu, A. Alexander and J. Wiles for discussion of the data and assistance in constructing analyses. This work was supported by the Neurosciences Research Foundation.	BROTCHIE PR, 1995, NATURE, V375, P232, DOI 10.1038/375232a0; Crowe DA, 2008, J NEUROSCI, V28, P5218, DOI 10.1523/JNEUROSCI.5105-07.2008; Markram H, 1996, NATURE, V382, P807, DOI 10.1038/382807a0; MCNAUGHTON BL, 1994, CEREB CORTEX, V4, P27, DOI 10.1093/cercor/4.1.27; MCNAUGHTON BL, 1983, EXP BRAIN RES, V52, P41; Nitz DA, 2006, NEURON, V49, P747, DOI 10.1016/j.neuron.2006.01.037; REEP RL, 1994, EXP BRAIN RES, V100, P67; Rogers JL, 2006, BEHAV NEUROSCI, V120, P852, DOI 10.1037/0735-7044.120.4.852; Sargolini F, 2006, SCIENCE, V312, P758, DOI 10.1126/science.1125572; Truccolo W, 2005, J NEUROPHYSIOL, V93, P1074, DOI 10.1152/jn.00697.2004; Whitlock JR, 2012, NEURON, V73, P789, DOI 10.1016/j.neuron.2011.12.028	11	62	62	0	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	OCT	2012	15	10					1365	1367		10.1038/nn.3213	http://dx.doi.org/10.1038/nn.3213			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	013VZ	22960933				2022-12-28	WOS:000309335300014
J	Yang, YT; Wang, CL; Van Aelst, L				Yang, Yu-Ting; Wang, Chia-Lin; Van Aelst, Linda			DOCK7 interacts with TACC3 to regulate interkinetic nuclear migration and cortical neurogenesis	NATURE NEUROSCIENCE			English	Article							NEURAL STEM-CELLS; RADIAL GLIAL-CELLS; PROGENITOR CELLS; ASYMMETRIC DIVISION; CEREBRAL-CORTEX; NEURONS ARISE; CYCLE CONTROL; SELF-RENEWAL; NEOCORTEX; PROTEINS	Neurogenesis in the developing neocortex relies on the ability of radial glial progenitor cells (RGCs) to switch from proliferative to differentiative neuron-generating divisions, but the molecular mechanisms that control this switch in a correct temporal manner are not well understood. Here, we show that DOCK7, a member of the DOCK180 family of proteins, regulates RGC proliferation versus differentiation. Silencing of DOCK7 in RGCs of developing mouse embryos impedes neuronal differentiation and maintains cells as cycling progenitors. In contrast, DOCK7 overexpression promotes RGC differentiation to basal progenitors and neurons. We further present evidence that DOCK7 influences neurogenesis by controlling apically directed interkinetic nuclear migration of RGCs. DOCK7 exerts its effects by antagonizing the microtubule growth-promoting function of the centrosome-associated protein TACC3. Thus, DOCK7 interaction with TACC3 controls interkinetic nuclear migration and the genesis of neurons from RGCs during cortical development.	[Yang, Yu-Ting; Wang, Chia-Lin; Van Aelst, Linda] Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA; [Yang, Yu-Ting] SUNY Stony Brook, Mol & Cellular Biol Program, Stony Brook, NY 11794 USA	Cold Spring Harbor Laboratory; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Van Aelst, L (corresponding author), Cold Spring Harbor Lab, POB 100, Cold Spring Harbor, NY 11724 USA.	vanaelst@cshl.edu			US National Institutes of Health [MH082808, T32 CA 148056-1]; New York STARR consortium; NATIONAL CANCER INSTITUTE [T32CA148056] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH082808] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); New York STARR consortium; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank members of the Van Aelst laboratory, E.-E. Govek and J. Skowronski for discussions and/or critical reading of the manuscript. We thank N. Gray and J. W. Tsai for technical advice regarding the in utero electroporation procedure and K. John for yeast two-hybrid screening. We also thank F. Matsuzaki (RIKEN Center for Developmental Biology) and L.-H. Tsai (Massachusetts Institute of Technology) for reagents. This work was supported by US National Institutes of Health grant MH082808 and a New York STARR consortium grant to L. V. A. C.-L. W. is supported by US National Institutes of Health research training grant T32 CA 148056-1.	Anthony TE, 2004, NEURON, V41, P881, DOI 10.1016/S0896-6273(04)00140-0; Barenz F, 2011, EUR J CELL BIOL, V90, P983, DOI 10.1016/j.ejcb.2011.07.007; Baye LM, 2007, J NEUROSCI, V27, P10143, DOI 10.1523/JNEUROSCI.2754-07.2007; Blasius AL, 2009, P NATL ACAD SCI USA, V106, P2706, DOI 10.1073/pnas.0813208106; Bultje RS, 2009, NEURON, V63, P189, DOI 10.1016/j.neuron.2009.07.004; Cappello S, 2006, NAT NEUROSCI, V9, P1099, DOI 10.1038/nn1744; Chen Q, 2009, J NEUROSCI, V29, P118, DOI 10.1523/JNEUROSCI.3985-08.2009; Cote JF, 2002, J CELL SCI, V115, P4901, DOI 10.1242/jcs.00219; Dehay C, 2007, NAT REV NEUROSCI, V8, P438, DOI 10.1038/nrn2097; Del Bene F, 2008, CELL, V134, P1055, DOI 10.1016/j.cell.2008.07.017; Doe CQ, 2008, DEVELOPMENT, V135, P1575, DOI 10.1242/dev.014977; Farkas LM, 2008, CURR OPIN CELL BIOL, V20, P707, DOI 10.1016/j.ceb.2008.09.008; Fukui Y, 2001, NATURE, V412, P826, DOI 10.1038/35090591; Gauthier-Fisher A, 2009, NAT NEUROSCI, V12, P735, DOI 10.1038/nn.2339; Ge XC, 2010, NEURON, V65, P191, DOI 10.1016/j.neuron.2010.01.011; Gergely F, 2000, P NATL ACAD SCI USA, V97, P14352, DOI 10.1073/pnas.97.26.14352; Gotz M, 2005, NAT REV MOL CELL BIO, V6, P777, DOI 10.1038/nrm1739; Haubensak W, 2004, P NATL ACAD SCI USA, V101, P3196, DOI 10.1073/pnas.0308600100; Janas J, 2006, METHOD ENZYMOL, V406, P593, DOI 10.1016/S0076-6879(06)06046-0; Latasa MJ, 2009, INT J DEV BIOL, V53, P895, DOI 10.1387/ijdb.082721ml; Johansson PA, 2010, CURR OPIN NEUROBIOL, V20, P400, DOI 10.1016/j.conb.2010.04.003; Kim WY, 2009, NAT NEUROSCI, V12, P1390, DOI 10.1038/nn.2408; Kosodo Y, 2011, EMBO J, V30, P1690, DOI 10.1038/emboj.2011.81; Lange C, 2009, CELL STEM CELL, V5, P320, DOI 10.1016/j.stem.2009.05.026; Laurin M, 2008, P NATL ACAD SCI USA, V105, P15446, DOI 10.1073/pnas.0805546105; Liu XX, 2010, J NEUROSCI, V30, P4197, DOI 10.1523/JNEUROSCI.4187-09.2010; Malatesta P, 2000, DEVELOPMENT, V127, P5253; Manzini MC, 2011, CURR OPIN GENET DEV, V21, P333, DOI 10.1016/j.gde.2011.01.006; MCCONNELL SK, 1995, NEURON, V15, P761, DOI 10.1016/0896-6273(95)90168-X; Meller N, 2005, J CELL SCI, V118, P4937, DOI 10.1242/jcs.02671; Minobe S, 2009, NEUROSCI RES, V63, P294, DOI 10.1016/j.neures.2009.01.006; Miyamoto Y, 2010, CELL SIGNAL, V22, P175, DOI 10.1016/j.cellsig.2009.09.036; Miyata T, 2004, DEVELOPMENT, V131, P3133, DOI 10.1242/dev.01173; Miyata T, 2001, NEURON, V31, P727, DOI 10.1016/S0896-6273(01)00420-2; Miyata T, 2010, CURR OPIN NEUROBIOL, V20, P22, DOI 10.1016/j.conb.2010.01.001; Murciano A, 2002, MOL CELL NEUROSCI, V21, P285, DOI 10.1006/mcne.2002.1174; Noctor SC, 2001, NATURE, V409, P714, DOI 10.1038/35055553; Noctor SC, 2004, NAT NEUROSCI, V7, P136, DOI 10.1038/nn1172; Noctor SC, 2008, J COMP NEUROL, V508, P28, DOI 10.1002/cne.21669; Peset I, 2008, TRENDS CELL BIOL, V18, P379, DOI 10.1016/j.tcb.2008.06.005; Schenk J, 2009, P NATL ACAD SCI USA, V106, P16487, DOI 10.1073/pnas.0908928106; Schwamborn JC, 2009, CELL, V136, P913, DOI 10.1016/j.cell.2008.12.024; Shitamukai A, 2011, J NEUROSCI, V31, P3683, DOI 10.1523/JNEUROSCI.4773-10.2011; Takahashi T, 1996, J NEUROSCI, V16, P6183; Tamamaki N, 2001, NEUROSCI RES, V41, P51, DOI 10.1016/S0168-0102(01)00259-0; Taverna E, 2010, NEURON, V67, P906, DOI 10.1016/j.neuron.2010.08.027; Tsai JW, 2010, NAT NEUROSCI, V13, P1463, DOI 10.1038/nn.2665; Tsai JW, 2005, J CELL BIOL, V170, P935, DOI 10.1083/jcb.200505166; Wang XQ, 2009, NATURE, V461, P947, DOI 10.1038/nature08435; Watabe-Uchida M, 2006, NEURON, V51, P727, DOI 10.1016/j.neuron.2006.07.020; Willardsen MI, 2011, DEV DYNAM, V240, P1865, DOI 10.1002/dvdy.22684; Xie ZG, 2007, NEURON, V56, P79, DOI 10.1016/j.neuron.2007.08.026; Yamauchi J, 2008, J CELL BIOL, V181, P351, DOI 10.1083/jcb.200709033	53	69	71	0	11	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	SEP	2012	15	9					1201	U55		10.1038/nn.3171	http://dx.doi.org/10.1038/nn.3171			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	996GJ	22842144	Green Accepted			2022-12-28	WOS:000308072600010
J	Yoshida, K; Saito, N; Iriki, A; Isoda, M				Yoshida, Kyoko; Saito, Nobuhito; Iriki, Atsushi; Isoda, Masaki			Social error monitoring in macaque frontal cortex	NATURE NEUROSCIENCE			English	Article							ANTERIOR CINGULATE CORTEX; PREFRONTAL CORTEX; PREMOTOR AREAS; MOTOR AREAS; REWARD; MONKEY; SIGNALS; SUPPLEMENTARY; ARCHITECTURE; CONNECTIONS	Although much learning occurs through direct experience of errors, humans and other animals can learn from the errors of other individuals. The medial frontal cortex (MFC) processes self-generated errors, but the neuronal architecture and mechanisms underlying the monitoring of others' errors are poorly understood. Exploring such mechanisms is important, as they underlie observational learning and allow adaptive behavior in uncertain social environments. Using two paired monkeys that monitored each other's action for their own action selection, we identified a group of neurons in the MFC that exhibited a substantial activity increase that was associated with another's errors. Nearly half of these neurons showed activity changes consistent with general reward-omission signals, whereas the remaining neurons specifically responded to another's erroneous actions. These findings indicate that the MFC contains a dedicated circuit for monitoring others' mistakes during social interactions.	[Yoshida, Kyoko; Iriki, Atsushi; Isoda, Masaki] RIKEN Brain Sci Inst, Lab Symbol Cognit Dev, Wako, Saitama, Japan; [Yoshida, Kyoko; Saito, Nobuhito] Univ Tokyo, Grad Sch Med, Dept Neurosurg, Hongo, Tokyo, Japan; [Isoda, Masaki] Japan Sci & Technol Agcy, Precursory Res Embryon Sci & Technol, Kawaguchi, Saitama, Japan; [Yoshida, Kyoko; Isoda, Masaki] Okinawa Inst Sci & Technol, Unit Neural Syst & Behav, Onna, Okinawa, Japan	RIKEN; University of Tokyo; Japan Science & Technology Agency (JST); Okinawa Institute of Science & Technology Graduate University	Isoda, M (corresponding author), Kansai Med Univ, Sch Med, Dept Physiol, Moriguchi, Osaka 570, Japan.	iriki@brain.riken.jp; isodam@takii.kmu.ac.jp			Precursory Research for Embryonic Science and Technology	Precursory Research for Embryonic Science and Technology	We are grateful to O. Hikosaka and C. Yokoyama for valuable comments. This work was supported by a Grant-in-Aid for Japan Society for the Promotion of Science Fellows (K.Y.) and a Precursory Research for Embryonic Science and Technology (M. I.). The monkeys used in this study were provided by the National BioResource Project 'Japanese Monkeys' of the Ministry of Education, Culture, Sports, Science and Technology, Japan.	ADLER LL, 1977, DEV PSYCHOBIOL, V10, P267, DOI 10.1002/dev.420100310; Alexander WH, 2011, NAT NEUROSCI, V14, P1338, DOI 10.1038/nn.2921; Amiez C, 2005, EUR J NEUROSCI, V21, P3447, DOI 10.1111/j.1460-9568.2005.04170.x; Amodio DM, 2006, NAT REV NEUROSCI, V7, P268, DOI 10.1038/nrn1884; BARBAS H, 1989, J COMP NEUROL, V286, P353, DOI 10.1002/cne.902860306; Bates AT, 2005, J PSYCHOPHYSIOL, V19, P281, DOI 10.1027/0269-8803.19.4.281; Behrens TEJ, 2008, NATURE, V456, P245, DOI 10.1038/nature07538; BIEDERMAN GB, 1986, J EXP ANAL BEHAV, V46, P45, DOI 10.1901/jeab.1986.46-45; Burke CJ, 2010, P NATL ACAD SCI USA, V107, P14431, DOI 10.1073/pnas.1003111107; Carter CS, 1998, SCIENCE, V280, P747, DOI 10.1126/science.280.5364.747; de Bruijn ERA, 2009, J NEUROSCI, V29, P12183, DOI 10.1523/JNEUROSCI.1751-09.2009; DUM RP, 1991, J NEUROSCI, V11, P667; FALKENSTEIN M, 1991, ELECTROEN CLIN NEURO, V78, P447, DOI 10.1016/0013-4694(91)90062-9; Frith CD, 2007, CURR BIOL, V17, pR724, DOI 10.1016/j.cub.2007.05.068; Gallagher HL, 2003, TRENDS COGN SCI, V7, P77, DOI 10.1016/S1364-6613(02)00025-6; GEHRING WJ, 1993, PSYCHOL SCI, V4, P385, DOI 10.1111/j.1467-9280.1993.tb00586.x; Gentsch A, 2009, NEUROIMAGE, V47, P2023, DOI 10.1016/j.neuroimage.2009.05.064; Hayden BY, 2009, SCIENCE, V324, P948, DOI 10.1126/science.1168488; Hikosaka O, 2010, TRENDS COGN SCI, V14, P154, DOI 10.1016/j.tics.2010.01.006; Holroyd CB, 2004, NAT NEUROSCI, V7, P497, DOI 10.1038/nn1238; Holroyd CB, 2002, PSYCHOL REV, V109, P679, DOI 10.1037/0033-295X.109.4.679; Isoda M, 2007, NAT NEUROSCI, V10, P240, DOI 10.1038/nn1830; Ito S, 2003, SCIENCE, V302, P120, DOI 10.1126/science.1087847; Jessup RK, 2010, J NEUROSCI, V30, P3467, DOI 10.1523/JNEUROSCI.4130-09.2010; Kennerley SW, 2009, J NEUROPHYSIOL, V102, P3352, DOI 10.1152/jn.00273.2009; Krutzen M, 2005, P NATL ACAD SCI USA, V102, P8939, DOI 10.1073/pnas.0500232102; LU MT, 1994, J COMP NEUROL, V341, P375, DOI 10.1002/cne.903410308; LUPPINO G, 1993, J COMP NEUROL, V338, P114, DOI 10.1002/cne.903380109; MATELLI M, 1991, J COMP NEUROL, V311, P445, DOI 10.1002/cne.903110402; Matsumoto M, 2007, NAT NEUROSCI, V10, P647, DOI 10.1038/nn1890; MATSUZAKA Y, 1992, J NEUROPHYSIOL, V68, P653, DOI 10.1152/jn.1992.68.3.653; Miltner W., 2004, ERRORS CONFLICTS BRA, P124; Nachev P, 2008, NAT REV NEUROSCI, V9, P856, DOI 10.1038/nrn2478; NIKI H, 1979, BRAIN RES, V171, P213, DOI 10.1016/0006-8993(79)90328-7; Picard N, 1996, CEREB CORTEX, V6, P342, DOI 10.1093/cercor/6.3.342; Picard N, 2001, CURR OPIN NEUROBIOL, V11, P663, DOI 10.1016/S0959-4388(01)00266-5; Quilodran R, 2008, NEURON, V57, P314, DOI 10.1016/j.neuron.2007.11.031; Ridderinkhof KR, 2004, SCIENCE, V306, P443, DOI 10.1126/science.1100301; Rudebeck PH, 2006, SCIENCE, V313, P1310, DOI 10.1126/science.1128197; Rushworth MFS, 2011, NEURON, V70, P1054, DOI 10.1016/j.neuron.2011.05.014; Rushworth MFS, 2004, TRENDS COGN SCI, V8, P410, DOI 10.1016/j.tics.2004.07.009; Sallet J, 2011, SCIENCE, V334, P697, DOI 10.1126/science.1210027; Shane MS, 2008, NEUROIMAGE, V42, P450, DOI 10.1016/j.neuroimage.2007.12.067; Shidara M, 2002, SCIENCE, V296, P1709, DOI 10.1126/science.1069504; Shima K, 1998, SCIENCE, V282, P1335, DOI 10.1126/science.282.5392.1335; Subiaul F, 2004, SCIENCE, V305, P407, DOI 10.1126/science.1099136; Taylor SF, 2007, NEUROSCIENTIST, V13, P160, DOI 10.1177/1073858406298184; Tomasello M., 1987, HUM EVOL, V2, P175, DOI DOI 10.1007/BF02436405; van Schie HT, 2004, NAT NEUROSCI, V7, P549, DOI 10.1038/nn1239; Yoshida K, 2011, CURR BIOL, V21, P249, DOI 10.1016/j.cub.2011.01.004	50	98	98	0	23	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	SEP	2012	15	9					1307	U180		10.1038/nn.3180	http://dx.doi.org/10.1038/nn.3180			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	996GJ	22864610				2022-12-28	WOS:000308072600022
J	Dietz, DM; Sun, HS; Lobo, MK; Cahill, ME; Chadwick, B; Gao, V; Koo, JW; Mazei-Robison, MS; Dias, C; Maze, I; Damez-Werno, D; Dietz, KC; Scobie, KN; Ferguson, D; Christoffel, D; Ohnishi, Y; Hodes, GE; Zheng, Y; Neve, RL; Hahn, KM; Russo, SJ; Nestler, EJ				Dietz, David M.; Sun, Haosheng; Lobo, Mary Kay; Cahill, Michael E.; Chadwick, Benjamin; Gao, Virginia; Koo, Ja Wook; Mazei-Robison, Michelle S.; Dias, Caroline; Maze, Ian; Damez-Werno, Diane; Dietz, Karen C.; Scobie, Kimberly N.; Ferguson, Deveroux; Christoffel, Daniel; Ohnishi, Yoko; Hodes, Georgia E.; Zheng, Yi; Neve, Rachael L.; Hahn, Klaus M.; Russo, Scott J.; Nestler, Eric J.			Rac1 is essential in cocaine-induced structural plasticity of nucleus accumbens neurons	NATURE NEUROSCIENCE			English	Article							DENDRITIC SPINES; GLUTAMATE TRANSMISSION; BEHAVIORAL-RESPONSES; SYNAPTIC PLASTICITY; DRUG-SEEKING; LIM-KINASE; ADDICTION; ACTIN; GTPASE; REWARD	Repeated cocaine administration increases the dendritic arborization of nucleus accumbens neurons, but the underlying signaling events remain unknown. Here we show that repeated exposure to cocaine negatively regulates the active form of Rac1, a small GTPase that controls actin remodeling in other systems. Further, we show, using viral-mediated gene transfer, that overexpression of a dominant negative mutant of Rac1 or local knockout of Rac1 is sufficient to increase the density of immature dendritic spines on nucleus accumbens neurons, whereas overexpression of a constitutively active Rac1 or light activation of a photoactivatable form of Rac1 blocks the ability of repeated cocaine exposure to produce this effect. Downregulation of Rac1 activity likewise promotes behavioral responses to cocaine exposure, with activation of Rac1 producing the opposite effect. These findings establish that Rac1 signaling mediates structural and behavioral plasticity in response to cocaine exposure.	[Dietz, David M.; Sun, Haosheng; Lobo, Mary Kay; Cahill, Michael E.; Chadwick, Benjamin; Gao, Virginia; Koo, Ja Wook; Mazei-Robison, Michelle S.; Dias, Caroline; Maze, Ian; Damez-Werno, Diane; Dietz, Karen C.; Scobie, Kimberly N.; Ferguson, Deveroux; Christoffel, Daniel; Ohnishi, Yoko; Hodes, Georgia E.; Russo, Scott J.; Nestler, Eric J.] Mt Sinai Sch Med, Fishberg Dept Neurosci, New York, NY 10029 USA; [Dietz, David M.; Sun, Haosheng; Lobo, Mary Kay; Cahill, Michael E.; Chadwick, Benjamin; Gao, Virginia; Koo, Ja Wook; Mazei-Robison, Michelle S.; Dias, Caroline; Maze, Ian; Dietz, Karen C.; Scobie, Kimberly N.; Ferguson, Deveroux; Christoffel, Daniel; Ohnishi, Yoko; Hodes, Georgia E.; Russo, Scott J.; Nestler, Eric J.] Mt Sinai Sch Med, Friedman Brain Inst, New York, NY USA; [Zheng, Yi] Univ Cincinnati, Childrens Hosp Res Fdn, Div Expt Hematol & Canc Biol, Cincinnati, OH USA; [Neve, Rachael L.] MIT, Dept Brain & Cognit Sci, Cambridge, MA 02139 USA; [Hahn, Klaus M.] Univ N Carolina, Dept Pharmacol, Chapel Hill, NC USA	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Research Foundation; University System of Ohio; University of Cincinnati; Massachusetts Institute of Technology (MIT); University of North Carolina; University of North Carolina Chapel Hill	Nestler, EJ (corresponding author), Mt Sinai Sch Med, Fishberg Dept Neurosci, New York, NY 10029 USA.	eric.nestler@mssm.edu	Dietz, David/AAW-4574-2021; Zheng, Yi/J-7235-2015; Lobo, Mary Kay/K-7734-2015; Maze, Ian/P-8077-2018; Russo, Scott/R-7107-2019; Hodes, Georgia/L-8022-2016; Dietz, David/J-9458-2015; Mazei-Robison, Michelle/I-4304-2017	Dietz, David/0000-0002-6927-9236; Zheng, Yi/0000-0001-7089-6074; Lobo, Mary Kay/0000-0002-9419-2079; Russo, Scott/0000-0002-6470-1805; Hodes, Georgia/0000-0002-1551-2178; Dietz, David/0000-0002-6927-9236; Mazei-Robison, Michelle/0000-0002-2372-1420; Sun, Haosheng/0000-0003-3919-559X; Maze, Ian/0000-0003-1490-7781; Ferguson, Deveroux/0000-0001-9302-5992; Gao, Virginia/0000-0002-5595-1175; Christoffel, Dan/0000-0002-6303-5134; Cahill, Michael/0000-0003-0574-2655; Hahn, Klaus/0000-0002-1970-7562	US National Institute on Drug Abuse [R01 DA14133, P01 DA08227]; US National Institute of Mental Health [R01 MH51399]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM090317] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH051399, K99MH094405] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [P01DA008227, R01DA014133] Funding Source: NIH RePORTER	US National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); US National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank S. Golden, A. Robison and V. Vialou for helpful discussions and comments on the manuscript. This work was supported by grants from the US National Institute on Drug Abuse (R01 DA14133, P01 DA08227) and US National Institute of Mental Health (R01 MH51399).	Barrot M, 2002, P NATL ACAD SCI USA, V99, P11435, DOI 10.1073/pnas.172091899; Bosco EE, 2009, CELL MOL LIFE SCI, V66, P370, DOI 10.1007/s00018-008-8552-x; Chen BT, 2008, NEURON, V59, P288, DOI 10.1016/j.neuron.2008.05.024; Chen L, 2009, DEV BIOL, V325, P162, DOI 10.1016/j.ydbio.2008.10.023; Deng JV, 2010, NAT NEUROSCI, V13, P1128, DOI 10.1038/nn.2614; Edwards DC, 1999, NAT CELL BIOL, V1, P253, DOI 10.1038/12963; Fard SS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009647; Garey LJ, 1998, J NEUROL NEUROSUR PS, V65, P446, DOI 10.1136/jnnp.65.4.446; Ghosh M, 2004, SCIENCE, V304, P743, DOI 10.1126/science.1094561; Gu Y, 2003, SCIENCE, V302, P445, DOI 10.1126/science.1088485; Halpain S, 2000, TRENDS NEUROSCI, V23, P141, DOI 10.1016/S0166-2236(00)01576-9; Hayashi-Takagi A, 2010, NAT NEUROSCI, V13, P327, DOI 10.1038/nn.2487; Hering H, 2001, NAT REV NEUROSCI, V2, P880, DOI 10.1038/35104061; Holtmaat A, 2009, NAT REV NEUROSCI, V10, P647, DOI 10.1038/nrn2699; Huang YHH, 2009, NEURON, V63, P40, DOI 10.1016/j.neuron.2009.06.007; Hyman SE, 2006, ANNU REV NEUROSCI, V29, P565, DOI 10.1146/annurev.neuro.29.051605.113009; Kalivas PW, 2009, NAT REV NEUROSCI, V10, P561, DOI 10.1038/nrn2515; Kalivas PW, 2005, NEURON, V45, P647, DOI 10.1016/j.neuron.2005.02.005; Kim WY, 2009, NEUROSCIENCE, V163, P501, DOI 10.1016/j.neuroscience.2009.06.067; Kiraly DD, 2010, BIOL PSYCHIAT, V68, P249, DOI 10.1016/j.biopsych.2010.03.024; LaPlant Q, 2010, NAT NEUROSCI, V13, P1137, DOI 10.1038/nn.2619; Lobo MK, 2010, SCIENCE, V330, P385, DOI 10.1126/science.1188472; Luo LQ, 1996, NATURE, V379, P837, DOI 10.1038/379837a0; Marinissen MJ, 2004, MOL CELL, V14, P29, DOI 10.1016/S1097-2765(04)00153-4; Maze I, 2010, SCIENCE, V327, P213, DOI 10.1126/science.1179438; McCutcheon JE, 2011, J NEUROSCI, V31, P5737, DOI 10.1523/JNEUROSCI.0350-11.2011; McFarland K, 2003, J NEUROSCI, V23, P3531; Miyamoto Y, 2006, P NATL ACAD SCI USA, V103, P10444, DOI 10.1073/pnas.0603914103; Nimchinsky EA, 2002, ANNU REV PHYSIOL, V64, P313, DOI 10.1146/annurev.physiol.64.081501.160008; Nobes CD, 1999, J CELL BIOL, V144, P1235, DOI 10.1083/jcb.144.6.1235; Norrholm SD, 2003, NEUROSCIENCE, V116, P19, DOI 10.1016/S0306-4522(02)00560-2; Oh D, 2010, J NEUROSCI, V30, P14134, DOI 10.1523/JNEUROSCI.1711-10.2010; Penzes P, 2008, TRENDS NEUROSCI, V31, P419, DOI 10.1016/j.tins.2008.06.001; Pulipparacharuvil S, 2008, NEURON, V59, P621, DOI 10.1016/j.neuron.2008.06.020; Robinson TE, 2004, NEUROPHARMACOLOGY, V47, P33, DOI 10.1016/j.neuropharm.2004.06.025; Russo SJ, 2010, TRENDS NEUROSCI, V33, P267, DOI 10.1016/j.tins.2010.02.002; Russo SJ, 2009, J NEUROSCI, V29, P3529, DOI 10.1523/JNEUROSCI.6173-08.2009; Schmidt HD, 2010, ANN NY ACAD SCI, V1187, P35, DOI 10.1111/j.1749-6632.2009.05144.x; Shen HW, 2009, J NEUROSCI, V29, P2876, DOI 10.1523/JNEUROSCI.5638-08.2009; Soetanto A, 2010, ARCH GEN PSYCHIAT, V67, P448, DOI 10.1001/archgenpsychiatry.2010.48; Tashiro A, 2000, CEREB CORTEX, V10, P927, DOI 10.1093/cercor/10.10.927; Tashiro A, 2004, MOL CELL NEUROSCI, V26, P429, DOI 10.1016/j.mcn.2004.04.001; Thomas MJ, 2008, BRIT J PHARMACOL, V154, P327, DOI 10.1038/bjp.2008.77; Thomas MJ, 2001, NAT NEUROSCI, V4, P1217, DOI 10.1038/nn757; Toda S, 2006, J NEUROSCI, V26, P1579, DOI 10.1523/JNEUROSCI.4132-05.2006; Toda S, 2010, NEUROTOX RES, V18, P410, DOI 10.1007/s12640-010-9193-z; Trachtenberg JT, 2002, NATURE, V420, P788, DOI 10.1038/nature01273; Wolf ME, 2010, TRENDS NEUROSCI, V33, P391, DOI 10.1016/j.tins.2010.06.003; Wu YI, 2009, NATURE, V461, P104, DOI 10.1038/nature08241; Yang N, 1998, NATURE, V393, P809, DOI 10.1038/31735	50	126	130	0	15	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUN	2012	15	6					891	U117		10.1038/nn.3094	http://dx.doi.org/10.1038/nn.3094			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	949AI	22522400	Green Accepted, Green Submitted			2022-12-28	WOS:000304546700017
J	Pan, PY; Ryan, TA				Pan, Ping-Yue; Ryan, Timothy A.			Calbindin controls release probability in ventral tegmental area dopamine neurons	NATURE NEUROSCIENCE			English	Article							PARKINSONS-DISEASE; CA2+; SYNAPSES; SYSTEM	Relatively little is known about the molecular control of midbrain dopamine release. Using high-fidelity imaging of pHluorin-tagged vesicular monoamine transporter 2 in dopamine neurons, we found that exocytosis was more loosely coupled to calcium entry than in fast synapses. In ventral tegmental area neurons, this allows exocytosis to be efficiently controlled by a native fast calcium buffer, calbindin-D28k, maintaining a lower vesicular release probability compared with substantia nigra neurons.	[Pan, Ping-Yue; Ryan, Timothy A.] Weill Cornell Med Coll, Dept Biochem, New York, NY USA	Cornell University	Ryan, TA (corresponding author), Weill Cornell Med Coll, Dept Biochem, New York, NY USA.	taryan@med.cornell.edu	Ryan, Timothy/AAO-8286-2020	Pan, Pingyue/0000-0002-2805-6810; Ryan, Timothy/0000-0003-2533-9548	National Institute on Drug Abuse [DA0101540]; National Institute of Mental Health [MH085783]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH085783] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [P01DA010154] Funding Source: NIH RePORTER	National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We wish to thank R. Edwards (University of California San Francisco) for generously providing VMAT-pHluorin, A. Lee (University of Iowa) for providing pcDNA3.1-calbindin-D28k, A. Miyawaki (RIKEN) for providing CY3.60 and members of the Ryan laboratory for helpful discussions. This work was supported by funds from the National Institute on Drug Abuse (DA0101540) and the National Institute of Mental Health (MH085783).	Ariel P, 2010, FRONT NEURAL CIRCUIT, V4, DOI 10.3389/fncir.2010.00018; Cicchetti F, 2000, BRAIN RES REV, V34, P80, DOI 10.1016/S0165-0173(00)00039-4; Conway KA, 2001, SCIENCE, V294, P1346, DOI 10.1126/science.1063522; Faas GC, 2011, NAT NEUROSCI, V14, P301, DOI 10.1038/nn.2746; Grace AA, 2000, BRAIN RES REV, V31, P330, DOI 10.1016/S0165-0173(99)00049-1; Hornykiewicz O, 1998, NEUROLOGY, V51, pS2, DOI 10.1212/WNL.51.2_Suppl_2.S2; Kim SH, 2010, NEURON, V67, P797, DOI 10.1016/j.neuron.2010.08.003; Liang CL, 1996, NEURODEGENERATION, V5, P313, DOI 10.1006/neur.1996.0042; Mani M, 2009, FRONT NEURAL CIRCUIT, V3, DOI 10.3389/neuro.04.003.2009; Nagai T, 2004, P NATL ACAD SCI USA, V101, P10554, DOI 10.1073/pnas.0400417101; NEDERGAARD S, 1993, J PHYSIOL-LONDON, V466, P727; Onoa B, 2010, J NEUROSCI, V30, P7917, DOI 10.1523/JNEUROSCI.5298-09.2010; Sankaranarayanan S, 2000, BIOPHYS J, V79, P2199, DOI 10.1016/S0006-3495(00)76468-X; Sankaranarayanan S, 2000, NAT CELL BIOL, V2, P197, DOI 10.1038/35008615; Schwaller B, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a004051; Sulzer D, 2007, TRENDS NEUROSCI, V30, P244, DOI 10.1016/j.tins.2007.03.009	16	35	35	0	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JUN	2012	15	6					813	U19		10.1038/nn.3099	http://dx.doi.org/10.1038/nn.3099			4	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	949AI	22544312	Green Accepted			2022-12-28	WOS:000304546700006
J	Whelan, R; Conrod, PJ; Poline, JB; Lourdusamy, A; Banaschewski, T; Barker, GJ; Bellgrove, MA; Buchel, C; Byrne, M; Cummins, TDR; Fauth-Buhler, M; Flor, H; Gallinat, J; Heinz, A; Ittermann, B; Mann, K; Martinot, JL; Lalor, EC; Lathrop, M; Loth, E; Nees, F; Paus, T; Rietschel, M; Smolka, MN; Spanagel, R; Stephens, DN; Struve, M; Thyreau, B; Vollstaedt-Klein, S; Robbins, TW; Schumann, G; Garavan, H				Whelan, Robert; Conrod, Patricia J.; Poline, Jean-Baptiste; Lourdusamy, Anbarasu; Banaschewski, Tobias; Barker, Gareth J.; Bellgrove, Mark A.; Buechel, Christian; Byrne, Mark; Cummins, Tarrant D. R.; Fauth-Buehler, Mira; Flor, Herta; Gallinat, Juergen; Heinz, Andreas; Ittermann, Bernd; Mann, Karl; Martinot, Jean-Luc; Lalor, Edmund C.; Lathrop, Mark; Loth, Eva; Nees, Frauke; Paus, Tomas; Rietschel, Marcella; Smolka, Michael N.; Spanagel, Rainer; Stephens, David N.; Struve, Maren; Thyreau, Benjamin; Vollstaedt-Klein, Sabine; Robbins, Trevor W.; Schumann, Gunter; Garavan, Hugh		IMAGEN Consortium	Adolescent impulsivity phenotypes characterized by distinct brain networks	NATURE NEUROSCIENCE			English	Article							RESPONSE-INHIBITION; INDIVIDUAL-DIFFERENCES; ORBITOFRONTAL CORTEX; DRUG-ADDICTION; ACTIVATION; ATOMOXETINE; CHILDHOOD; DISORDER; BEHAVIOR; AGE	The impulsive behavior that is often characteristic of adolescence may reflect underlying neurodevelopmental processes. Moreover, impulsivity is a multi-dimensional construct, and it is plausible that distinct brain networks contribute to its different cognitive, clinical and behavioral aspects. As these networks have not yet been described, we identified distinct cortical and subcortical networks underlying successful inhibitions and inhibition failures in a large sample (n = 1,896) of 14-year-old adolescents. Different networks were associated with drug use (n = 1,593) and attention-deficit hyperactivity disorder symptoms (n = 342). Hypofunctioning of a specific orbitofrontal cortical network was associated with likelihood of initiating drug use in early adolescence. Right inferior frontal activity was related to the speed of the inhibition process (n = 826) and use of illegal substances and associated with genetic variation in a norepinephrine transporter gene (n = 819). Our results indicate that both neural endophenotypes and genetic variation give rise to the various manifestations of impulsive behavior.	[Whelan, Robert; Garavan, Hugh] Univ Vermont, Dept Psychiat & Psychol, Burlington, VT 05405 USA; [Whelan, Robert; Byrne, Mark; Lalor, Edmund C.; Garavan, Hugh] Trinity Coll Dublin, Inst Neurosci, Dublin, Ireland; [Conrod, Patricia J.; Lourdusamy, Anbarasu; Barker, Gareth J.; Loth, Eva; Schumann, Gunter] Kings Coll London, Inst Psychiat, London WC2R 2LS, England; [Conrod, Patricia J.] Univ Montreal, Dept Psychiat, CHU Ste Justine Hosp, Montreal, PQ H3C 3J7, Canada; [Poline, Jean-Baptiste; Thyreau, Benjamin] Neurospin, Commissariat Energie Atom, Gif Sur Yvette, France; [Cummins, Tarrant D. R.] Cent Inst Mental Hlth, Dept Child & Adolescent Psychiat & Psychotherapy, D-6800 Mannheim, Germany; [Bellgrove, Mark A.; Cummins, Tarrant D. R.] Univ Queensland, Queensland Brain Inst, St Lucia, Qld, Australia; [Bellgrove, Mark A.; Cummins, Tarrant D. R.] Univ Queensland, Sch Psychol, St Lucia, Qld, Australia; [Buechel, Christian] Univ klinikum Hamburg Eppendorf, Hamburg, Germany; [Fauth-Buehler, Mira; Mann, Karl; Vollstaedt-Klein, Sabine] Cent Inst Mental Hlth, Dept Addict Behav & Addict Med, D-6800 Mannheim, Germany; [Flor, Herta; Nees, Frauke; Struve, Maren] Heidelberg Univ, Med Fac Mannheim, Cent Inst Mental Hlth, Dept Cognit & Clin Neurosci, D-6800 Mannheim, Germany; [Gallinat, Juergen; Heinz, Andreas] Charite, Dept Psychiat & Psychotherapy, D-13353 Berlin, Germany; [Ittermann, Bernd] Physikalisch Tech Bundesanstalt, Berlin, Germany; [Martinot, Jean-Luc] Univ Paris Sud, INSERM CEA Unit Imaging & Psychiat 1000, Inst Natl Sante & Rech Med, Orsay, France; [Martinot, Jean-Luc] Univ Paris 05, Assistance Publ Hop Paris, Dept Adolescent Psychopathol & Med, Paris, France; [Lathrop, Mark] Ctr Natl Genptypage, Evry, France; [Loth, Eva; Schumann, Gunter] MRC Social, Genet & Dev Psychiat Ctr, London, England; [Paus, Tomas] Univ Toronto, Rotman Res Inst, Toronto, ON, Canada; [Paus, Tomas] Univ Nottingham, Sch Psychol, Nottingham NG7 2RD, England; [Paus, Tomas] McGill Univ, Montreal Neurol Inst, Montreal, PQ, Canada; [Rietschel, Marcella] Cent Inst Mental Hlth, Dept Genet Epidemiol Psychiat, D-6800 Mannheim, Germany; [Smolka, Michael N.] Tech Univ, Dept Psychiat & Psychotherapy, Dresden, Germany; [Smolka, Michael N.] Tech Univ, Dept Psychol, Neuroimaging Ctr, Dresden, Germany; [Spanagel, Rainer] Heidelberg Univ, Med Fac Mannheim, Cent Inst Mental Hlth, Inst Psychopharmacol, D-6800 Mannheim, Germany; [Stephens, David N.] Univ Sussex, Dept Psychol, Brighton BN1 9RH, E Sussex, England; [Robbins, Trevor W.] Univ Cambridge, Dept Expt Psychol, Cambridge CB2 3EB, England; [Robbins, Trevor W.] Univ Cambridge, Behav & Clin Neurosci Inst, Cambridge CB2 3EB, England; [IMAGEN Consortium] Kings Coll London, Inst Psychiat, London WC2R 2LS, England	University of Vermont; Trinity College Dublin; University of London; King's College London; Universite de Montreal; CEA; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Universite Paris Saclay; Central Institute of Mental Health; University of Queensland; University of Queensland; University of Hamburg; University Medical Center Hamburg-Eppendorf; Central Institute of Mental Health; Central Institute of Mental Health; Ruprecht Karls University Heidelberg; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Physikalisch-Technische Bundesanstalt (PTB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Universite Paris Cite; University of London; King's College London; University of Toronto; University Toronto Affiliates; Baycrest; University of Nottingham; McGill University; Central Institute of Mental Health; Technische Universitat Dresden; Technische Universitat Dresden; Central Institute of Mental Health; Ruprecht Karls University Heidelberg; University of Sussex; University of Cambridge; University of Cambridge; University of London; King's College London	Whelan, R (corresponding author), Univ Vermont, Dept Psychiat & Psychol, Burlington, VT 05405 USA.	robert.whelan@uvm.edu; hugh.garavan@uvm.edu	Stephens, David/G-2384-2012; Bellgrove, Mark/AAB-3114-2019; Heinz, Andreas/ABB-7736-2020; Vollstädt-Klein, Sabine/C-6744-2012; Whelan, Robert/E-5365-2010; Banaschewski, Tobias/ABE-5985-2020; Conrod, Patricia J/P-4187-2018; Robbins, Trevor W/A-7551-2008; Schumann, Gunter/H-1013-2013; Barker, Gareth J/C-9616-2009; Smolka, Michael/B-4865-2011; Martinot, Jean-Luc/N-3704-2018; Nees, Frauke/AAZ-2150-2020; Lourdusamy, Anbarasu/G-3387-2011; Lourdusamy, Anbarasu/P-6606-2014; Cummins, Tarrant/I-3086-2014	Heinz, Andreas/0000-0001-5405-9065; Vollstädt-Klein, Sabine/0000-0002-6210-672X; Whelan, Robert/0000-0002-2790-7281; Banaschewski, Tobias/0000-0003-4595-1144; Barker, Gareth J/0000-0002-5214-7421; Smolka, Michael/0000-0001-5398-5569; Cummins, Tarrant/0000-0003-2324-3366; Bellgrove, Mark/0000-0003-0186-8349; Robbins, Trevor/0000-0003-0642-5977; Lalor, Edmund/0000-0002-2498-6631; Flor, Herta/0000-0003-4809-5398; Loth, Eva/0000-0001-9458-9167; Nees, Frauke/0000-0002-7796-8234; Lourdusamy, Anbarasu/0000-0002-1978-6301	European Community [LSHM-CT-2007-037286]; FP7 projects ADAMS [242257]; Innovative Medicine Initiative Project EU-AIMS [115300-2]; UK National Institute for Health Research Biomedical Research Centre Mental Health; Medical Research Council [93558]; Medical Research Council [G0001354B, G0400568, G9817803B, G1000183B, G0001354, G0901858] Funding Source: researchfish; MRC [G0400568, G0901858] Funding Source: UKRI	European Community(European Commission); FP7 projects ADAMS; Innovative Medicine Initiative Project EU-AIMS; UK National Institute for Health Research Biomedical Research Centre Mental Health; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The IMAGEN study receives research funding from the European Community's Sixth Framework Programme (LSHM-CT-2007-037286). Further support was provided by the FP7 projects ADAMS (genomic variations underlying common neuropsychiatric diseases and disease-related cognitive traits in different human populations; 242257) and the Innovative Medicine Initiative Project EU-AIMS (115300-2), as well as the UK National Institute for Health Research Biomedical Research Centre Mental Health and the Medical Research Council Programme Grant 'Developmental pathways into adolescent substance abuse' (93558).	Albrecht B, 2008, BIOL PSYCHIAT, V64, P615, DOI 10.1016/j.biopsych.2007.12.016; American Psychiatric Association, 2000, DSM 4 DIAGN STAT MAN, V4th ed., DOI DOI 10.1001/JAMA.1994.03520100096; Aron AR, 2007, NEUROSCIENTIST, V13, P214, DOI 10.1177/1073858407299288; Aron AR, 2011, BIOL PSYCHIAT, V69, pE55, DOI 10.1016/j.biopsych.2010.07.024; Aron AR, 2006, J NEUROSCI, V26, P2424, DOI 10.1523/JNEUROSCI.4682-05.2006; Aron AR, 2003, NAT NEUROSCI, V6, P115, DOI 10.1038/nn1003; Band GPH, 2003, ACTA PSYCHOL, V112, P105, DOI 10.1016/S0001-6918(02)00079-3; Bellgrove MA, 2004, NEUROPSYCHOLOGIA, V42, P1910, DOI 10.1016/j.neuropsychologia.2004.05.007; Bevilacqua L, 2010, NATURE, V468, P1061, DOI 10.1038/nature09629; Braet W, 2009, NEUROPSYCHOLOGIA, V47, P3143, DOI 10.1016/j.neuropsychologia.2009.07.018; Chamberlain SR, 2009, BIOL PSYCHIAT, V65, P550, DOI 10.1016/j.biopsych.2008.10.014; Chamberlain SR, 2006, SCIENCE, V311, P861, DOI 10.1126/science.1121218; CHURCHILL GA, 1994, GENETICS, V138, P963; Congdon E, 2010, NEUROIMAGE, V53, P653, DOI 10.1016/j.neuroimage.2010.06.062; Costello A.B., 2005, PRACTICAL ASSESSMENT, V10, P1, DOI [DOI 10.7275/JYJ1-4868, 10.4135/9781412995627.d8, DOI 10.4135/9781412995627.D8]; Crombag HS, 2005, CEREB CORTEX, V15, P341, DOI 10.1093/cercor/bhh136; Dalley JW, 2011, NEURON, V69, P680, DOI 10.1016/j.neuron.2011.01.020; Diamond A, 2011, SCIENCE, V333, P959, DOI 10.1126/science.1204529; Ersche KD, 2012, SCIENCE, V335, P601, DOI 10.1126/science.1214463; Fillmore MT, 2002, DRUG ALCOHOL DEPEN, V66, P265, DOI 10.1016/S0376-8716(01)00206-X; Franklin TR, 2002, BIOL PSYCHIAT, V51, P134, DOI 10.1016/S0006-3223(01)01269-0; Friedman NP, 2008, J EXP PSYCHOL GEN, V137, P201, DOI 10.1037/0096-3445.137.2.201; Goldstein RZ, 2002, AM J PSYCHIAT, V159, P1642, DOI 10.1176/appi.ajp.159.10.1642; Goodman A, 2011, SOC PSYCH PSYCH EPID, V46, P521, DOI 10.1007/s00127-010-0219-x; Goodman R, 2000, J CHILD PSYCHOL PSYC, V41, P645, DOI 10.1017/S0021963099005909; Goudriaan AE, 2006, ADDICTION, V101, P534, DOI 10.1111/j.1360-0443.2006.01380.x; Hibell B, 1997, 1995 ESPAD REPORT AL; Ivanov I, 2008, AM J DRUG ALCOHOL AB, V34, P239, DOI 10.1080/00952990802013334; Johnston LD, 2009, NIH PUBLICATION, VII; Kelly AMC, 2008, NEUROIMAGE, V39, P527, DOI 10.1016/j.neuroimage.2007.08.008; Konrad K, 2010, HUM BRAIN MAPP, V31, P904, DOI 10.1002/hbm.21058; Lancaster JL, 2000, HUM BRAIN MAPP, V10, P120, DOI 10.1002/1097-0193(200007)10:3<120::AID-HBM30>3.0.CO;2-8; Lee SS, 2011, CLIN PSYCHOL REV, V31, P328, DOI 10.1016/j.cpr.2011.01.006; Li CSR, 2007, NEUROIMAGE, V38, P640, DOI 10.1016/j.neuroimage.2007.07.021; Li CSR, 2006, J NEUROSCI, V26, P186, DOI 10.1523/JNEUROSCI.3741-05.2006; Logan Gordon D., 1994, P189; Maldjian JA, 2003, NEUROIMAGE, V19, P1233, DOI 10.1016/S1053-8119(03)00169-1; Monti PM, 2005, ALCOHOL CLIN EXP RES, V29, P207, DOI 10.1097/01.ALC.0000153551.11000.F3; O'Shea M, 2004, J PSYCHOPHARMACOL, V18, P502, DOI 10.1177/0269881104047277; Overbey GA, 2011, J ATTEN DISORD, V15, P67, DOI 10.1177/1087054709347257; Patton GC, 2009, LANCET, V374, P881, DOI 10.1016/S0140-6736(09)60741-8; Paus T, 2005, TRENDS COGN SCI, V9, P60, DOI 10.1016/j.tics.2004.12.008; Peters J, 2011, AM J PSYCHIAT, V168, P540, DOI 10.1176/appi.ajp.2010.10071024; Ramoz N, 2009, NEUROPSYCHOPHARMACOL, V34, P2135, DOI 10.1038/npp.2009.39; Robinson TE, 2001, SYNAPSE, V39, P257; Rolls ET, 2000, CEREB CORTEX, V10, P284, DOI 10.1093/cercor/10.3.284; Rubia K, 2005, AM J PSYCHIAT, V162, P1067, DOI 10.1176/appi.ajp.162.6.1067; Scangos KW, 2010, J NEUROSCI, V30, P1968, DOI 10.1523/JNEUROSCI.4509-09.2010; Schoenbaum G, 2008, BIOL PSYCHIAT, V63, P256, DOI 10.1016/j.biopsych.2007.06.003; Schumann G, 2010, MOL PSYCHIATR, V15, P1128, DOI 10.1038/mp.2010.4; Spear LP, 2000, NEUROSCI BIOBEHAV R, V24, P417, DOI 10.1016/S0149-7634(00)00014-2; Tapert SF, 1999, J INT NEUROPSYCH SOC, V5, P481, DOI 10.1017/S1355617799566010; Tarter RE, 2003, AM J PSYCHIAT, V160, P1078, DOI 10.1176/appi.ajp.160.6.1078; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; Zhang S, 2012, HUM BRAIN MAPP, V33, P89, DOI 10.1002/hbm.21197	55	291	293	1	77	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUN	2012	15	6					920	U153		10.1038/nn.3092	http://dx.doi.org/10.1038/nn.3092			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	949AI	22544311				2022-12-28	WOS:000304546700021
J	Silva, BA; Mattucci, C; Krzywkowski, P; Murana, E; Illarionova, A; Grinevich, V; Canteras, NS; Ragozzino, D; Gross, CT				Silva, Bianca A.; Mattucci, Camilla; Krzywkowski, Piotr; Murana, Emanuele; Illarionova, Anna; Grinevich, Valery; Canteras, Newton S.; Ragozzino, Davide; Gross, Cornelius T.			Independent hypothalamic circuits for social and predator fear	NATURE NEUROSCIENCE			English	Article							PROTEIN-COUPLED RECEPTORS; VENTROMEDIAL HYPOTHALAMUS; ORGANIZATION; REVEALS; SYSTEM; RATS	The neural circuits mediating fear to naturalistic threats are poorly understood. We found that functionally independent populations of neurons in the ventromedial hypothalamus (VMH), a region that has been implicated in feeding, sex and aggression, are essential for predator and social fear in mice. Our results establish a critical role for VMH in fear and have implications for selective intervention in pathological fear in humans.	[Silva, Bianca A.; Mattucci, Camilla; Krzywkowski, Piotr; Gross, Cornelius T.] European Mol Biol Lab, Mouse Biol Unit, Monterotondo, Italy; [Murana, Emanuele; Ragozzino, Davide] Univ Roma La Sapienza, Inst Pasteur, Fdn Cenci Bolognetti, I-00185 Rome, Italy; [Murana, Emanuele; Ragozzino, Davide] Univ Roma La Sapienza, Dept Human Physiol & Pharmacol, I-00185 Rome, Italy; [Illarionova, Anna; Grinevich, Valery] Heidelberg Univ, Schaller Res Grp Neuropeptides, German Canc Res Ctr DKFZ, CellNetwork Cluster Excellence, Heidelberg, Germany; [Canteras, Newton S.] Univ Sao Paulo, Inst Biomed Sci, Dept Anat, Sao Paulo, Brazil; [Ragozzino, Davide] IRCCS Neuromed, Pozzilli, Italy	European Molecular Biology Laboratory (EMBL); Fondazione Cenci Bolognetti; Sapienza University Rome; Sapienza University Rome; Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; Universidade de Sao Paulo; IRCCS Neuromed	Gross, CT (corresponding author), European Mol Biol Lab, Mouse Biol Unit, Monterotondo, Italy.	gross@embl.it	ragozzino, davide/K-6521-2016; Canteras, Newton/F-2402-2013; Silva, Bianca Ambrogina/AAE-3354-2020	ragozzino, davide/0000-0002-3290-7665; Silva, Bianca Ambrogina/0000-0003-3877-1356; Canteras, Newton/0000-0002-7205-5372; Grinevich, Valery/0000-0002-6337-8866	US National Institutes of Health [MH093887-01]; EMBL; German Research Foundation (DFG) [GR 3619/2-1, 3619/3-1, GR 3619/4-11]; Chica and Heinz Schaller Research Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH [R21MH093887] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EMBL; German Research Foundation (DFG)(German Research Foundation (DFG)); Chica and Heinz Schaller Research Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank F. Zonfrillo, R. Migliozzi, E. Audero, P. Hublitz, L. Carbonari, E. Amendola, B. Klaus and the EMBL Transgenic Facility and Mechanical Workshop for experimental support, M. Yang and S. Motta for critical advice, and R. Sotillo and M. Jechlinger (Mouse Biology Unit, EMBL) for antibodies. This work was supported by funds from the US National Institutes of Health (MH093887-01) to C.T.G., from the EMBL to C.T.G., B.A.S., C.M. and P.K., and from the German Research Foundation (DFG, GR 3619/2-1, 3619/3-1, GR 3619/4-1) and Chica and Heinz Schaller Research Foundation to V.G.	Alexander GM, 2009, NEURON, V63, P27, DOI 10.1016/j.neuron.2009.06.014; Armbruster BN, 2007, P NATL ACAD SCI USA, V104, P5163, DOI 10.1073/pnas.0700293104; Brandao ML, 2008, BEHAV BRAIN RES, V188, P1, DOI 10.1016/j.bbr.2007.10.018; CANTERAS NS, 1994, J COMP NEUROL, V348, P41, DOI 10.1002/cne.903480103; Canteras NS, 2002, PHARMACOL BIOCHEM BE, V71, P481, DOI 10.1016/S0091-3057(01)00685-2; Dhillon H, 2006, NEURON, V49, P191, DOI 10.1016/j.neuron.2005.12.021; Gross CT, 2012, NAT REV NEUROSCI, V13, P651, DOI 10.1038/nrn3301; KRUK MR, 1983, BRAIN RES, V260, P61, DOI 10.1016/0006-8993(83)90764-3; Kurrasch DM, 2007, J NEUROSCI, V27, P13624, DOI 10.1523/JNEUROSCI.2858-07.2007; Lin DY, 2011, NATURE, V470, P221, DOI 10.1038/nature09736; Motta SC, 2009, P NATL ACAD SCI USA, V106, P4870, DOI 10.1073/pnas.0900939106; Wilent WB, 2010, J NEUROSURG, V112, P1295, DOI 10.3171/2009.9.JNS09577	12	126	126	2	51	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	DEC	2013	16	12					1731	1733		10.1038/nn.3573	http://dx.doi.org/10.1038/nn.3573			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	257VV	24212674	Green Accepted, Green Submitted			2022-12-28	WOS:000327416800009
J	Okamoto, M; Namba, T; Shinoda, T; Kondo, T; Watanabe, T; Inoue, Y; Takeuchi, K; Enomoto, Y; Ota, K; Oda, K; Wada, Y; Sagou, K; Saito, K; Sakakibara, A; Kawaguchi, A; Nakajima, K; Adachi, T; Fujimori, T; Ueda, M; Hayashi, S; Kaibuchi, K; Miyata, T				Okamoto, Mayumi; Namba, Takashi; Shinoda, Tomoyasu; Kondo, Takefumi; Watanabe, Tadashi; Inoue, Yasuhiro; Takeuchi, Kosei; Enomoto, Yukiko; Ota, Kumiko; Oda, Kanako; Wada, Yoshino; Sagou, Ken; Saito, Kanako; Sakakibara, Akira; Kawaguchi, Ayano; Nakajima, Kazunori; Adachi, Taiji; Fujimori, Toshihiko; Ueda, Masahiro; Hayashi, Shigeo; Kaibuchi, Kozo; Miyata, Takaki			TAG-1-assisted progenitor elongation streamlines nuclear migration to optimize subapical crowding	NATURE NEUROSCIENCE			English	Article							DEVELOPING MOUSE NEOCORTEX; OUTER SUBVENTRICULAR ZONE; ASYMMETRIC INHERITANCE; MAMMALIAN NEUROGENESIS; NEURAL PROGENITORS; PLANAR DIVISIONS; CEREBRAL-CORTEX; CELL-MIGRATION; NEURONS; BRAIN	Neural progenitors exhibit cell cycle-dependent interkinetic nuclear migration (INM) along the apicobasal axis. Despite recent advances in understanding its underlying molecular mechanisms, the processes to which INM contributes mechanically and the regulation of INM by the apicobasally elongated morphology of progenitors remain unclear. We found that knockdown of the cell-surface molecule TAG-1 resulted in retraction of neocortical progenitors' basal processes. Highly shortened stem-like progenitors failed to undergo basalward INM and became overcrowded in the periventricular (subapical) space. Surprisingly, the overcrowded progenitors left the apical surface and migrated into basal neuronal territories. These observations, together with the results of in toto imaging and physical tests, suggest that progenitors may sense and respond to excessive mechanical stress. Although, unexpectedly, the heterotopic progenitors remained stem-like and continued to sequentially produce neurons until the late embryonic period, histogenesis was severely disrupted. Thus, INM is essential for preventing overcrowding of nuclei and their somata, thereby ensuring normal brain histogenesis.	[Okamoto, Mayumi; Shinoda, Tomoyasu; Enomoto, Yukiko; Ota, Kumiko; Sagou, Ken; Saito, Kanako; Sakakibara, Akira; Kawaguchi, Ayano; Miyata, Takaki] Nagoya Univ, Grad Sch Med, Dept Anat & Cell Biol, Nagoya, Aichi 4648601, Japan; [Namba, Takashi; Kaibuchi, Kozo] Nagoya Univ, Grad Sch Med, Dept Cell Pharmacol, Nagoya, Aichi 4648601, Japan; [Kondo, Takefumi; Hayashi, Shigeo] RIKEN, Ctr Dev Biol, Lab Morphogenet Signaling, Kobe, Hyogo, Japan; [Watanabe, Tadashi; Inoue, Yasuhiro; Adachi, Taiji] Kyoto Univ, Inst Frontier Med Sci, Dept Biomech, Kyoto, Japan; [Takeuchi, Kosei; Oda, Kanako; Wada, Yoshino] Niigata Univ, Grad Sch Med & Dent Sci, Div Mol & Cellular Biol, Niigata, Japan; [Takeuchi, Kosei] Niigata Univ, Ctr Transdisciplinary Res, Niigata, Japan; [Oda, Kanako] Brain Res Inst, Dept Comparat & Expt Med, Niigata, Japan; [Nakajima, Kazunori] Keio Univ, Sch Med, Dept Anat, Tokyo, Japan; [Fujimori, Toshihiko] Natl Inst Basic Biol, Div Embryol, Okazaki, Aichi 444, Japan; [Ueda, Masahiro] Osaka Univ, Grad Sch Sci, Dept Biol Sci, Toyonaka, Osaka 560, Japan; [Ueda, Masahiro] Japan Sci & Technol Agcy, CREST, Toyonaka, Osaka, Japan; [Ueda, Masahiro] RIKEN, Quantitat Biol Ctr, Lab Cell Signaling Dynam, Suita, Osaka, Japan	Nagoya University; Nagoya University; RIKEN; Kyoto University; Niigata University; Niigata University; Keio University; National Institutes of Natural Sciences (NINS) - Japan; National Institute for Basic Biology (NIBB); Osaka University; Japan Science & Technology Agency (JST); RIKEN	Miyata, T (corresponding author), Nagoya Univ, Grad Sch Med, Dept Anat & Cell Biol, Nagoya, Aichi 4648601, Japan.	tmiyata@med.nagoya-u.ac.jp	Hayashi, Shigeo/J-9628-2019; Nakajima, Kazunori/L-3396-2013; Takeuchi, Kosei/AAV-3577-2021; MIYATA, TAKAKI/I-7066-2014; Fujimori, Toshihiko/L-7711-2016; Namba, Takashi/AAE-4439-2022; Namba, Takashi/ABF-4571-2020; Adachi, Taiji/P-8981-2016; Kaibuchi, Kozo/M-4887-2014; Inoue, Yasuhiro/AAE-3409-2019; Kawaguchi, Ayano/I-7286-2014	Hayashi, Shigeo/0000-0001-7785-1290; Nakajima, Kazunori/0000-0003-1864-9425; Takeuchi, Kosei/0000-0001-6397-2243; Fujimori, Toshihiko/0000-0001-5200-4634; Namba, Takashi/0000-0003-4875-666X; Adachi, Taiji/0000-0001-5280-4156; Kaibuchi, Kozo/0000-0003-0714-1992; Inoue, Yasuhiro/0000-0002-1968-8883; Kawaguchi, Ayano/0000-0002-0339-3992; Kondo, Takefumi/0000-0001-8127-1141; Ueda, Masahiro/0000-0002-9354-3404	Japan Ministry of Education, Culture, Sports, Science and Technology [22111006]; Japan Society for the Promotion of Science (JSPS) [21240027, 23700378]; MEXT Global COE (Center of Excellence) program "Integrated Functional Molecular Medicine for Neuronal and Neoplastic Disorders"	Japan Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); MEXT Global COE (Center of Excellence) program "Integrated Functional Molecular Medicine for Neuronal and Neoplastic Disorders"	We thank T. Shimogori for instruction in utero electroporation at E10; S. Nakagawa (RIKEN Advanced Science Institute), K. Ohta (Kumamoto University), S. Takada (Japan National Institute for Basic Biology), F. Matsuzaki (RIKEN Center for Developmental Biology), H. Kimura (Osaka University), S. Okabe (University of Tokyo) and T. Sapir (Weizmann Institute of Science) for plasmids; Y. Itoh and Y. Gotoh (both University of Tokyo) for antibodies; F. Matsuzaki and M. Ogawa for critical reading of an earlier version of the manuscript; S. Okuda, H. Takagi, K. Nagayama, T. Matsumoto for suggestions; members of the Matsuzaki, Nakajima and Ueda laboratories for discussions; and M. Masaoka, T. Kawaue, J. Yamada and N. Noguchi for excellent technical assistance. This work was supported by Japan Ministry of Education, Culture, Sports, Science and Technology Grant-in-Aid for Scientific Research on Innovative Areas "Cross-talk between moving cells and microenvironment as a basis of emerging order" 22111006 (T.M.), Japan Society for the Promotion of Science (JSPS) Grant-in-Aid for Scientific Research (A) 21240027 (T.M.), MEXT Global COE (Center of Excellence) program "Integrated Functional Molecular Medicine for Neuronal and Neoplastic Disorders" (T.M.), and JSPS Grant-in-Aid for Young Scientists (B) 23700378 (M.O.).	Abe T, 2011, GENESIS, V49, P579, DOI 10.1002/dvg.20753; Barkovich AJ, 2012, BRAIN, V135, P1348, DOI 10.1093/brain/aws019; Bayer S.A., 2006, ATLAS HUMAN CENTRAL, V4; Bizzoca A, 2012, DEV BIOL, V365, P133, DOI 10.1016/j.ydbio.2012.02.011; Chenn A, 2002, SCIENCE, V297, P365, DOI 10.1126/science.1074192; CHENN A, 1995, CELL, V82, P631, DOI 10.1016/0092-8674(95)90035-7; Fietz SA, 2010, NAT NEUROSCI, V13, P690, DOI 10.1038/nn.2553; Fitzgerald MP, 2011, NEUROSCIENCE, V176, P455, DOI 10.1016/j.neuroscience.2010.12.003; Fukamauchi F, 2001, BIOCHEM BIOPH RES CO, V281, P220, DOI 10.1006/bbrc.2001.4334; FURLEY AJ, 1990, CELL, V61, P157, DOI 10.1016/0092-8674(90)90223-2; Gotz M, 2005, NAT REV MOL CELL BIO, V6, P777, DOI 10.1038/nrm1739; Hansen DV, 2010, NATURE, V464, P554, DOI 10.1038/nature08845; Heisenberg CP, 2013, CELL, V153, P948, DOI 10.1016/j.cell.2013.05.008; Inglis-Broadgate SL, 2005, DEV BIOL, V279, P73, DOI 10.1016/j.ydbio.2004.11.035; Itoh Y, 2013, NAT NEUROSCI, V16, P416, DOI 10.1038/nn.3336; Konno D, 2008, NAT CELL BIOL, V10, P93, DOI 10.1038/ncb1673; Kosodo Y, 2011, EMBO J, V30, P1690, DOI 10.1038/emboj.2011.81; KUSUMI A, 1993, BIOPHYS J, V65, P2021, DOI 10.1016/S0006-3495(93)81253-0; Leung L, 2011, DEVELOPMENT, V138, P5003, DOI 10.1242/dev.071522; Lui JH, 2011, CELL, V146, P18, DOI 10.1016/j.cell.2011.06.030; Marinari E, 2012, NATURE, V484, P542, DOI 10.1038/nature10984; Milev P, 1996, J BIOL CHEM, V271, P15716, DOI 10.1074/jbc.271.26.15716; Miyanaga Y, 2009, METHODS MOL BIOL, V571, P417, DOI 10.1007/978-1-60761-198-1_28; Miyata T, 2001, NEURON, V31, P727, DOI 10.1016/S0896-6273(01)00420-2; Miyata T, 2007, CURR BIOL, V17, P146, DOI 10.1016/j.cub.2006.11.023; Molyneaux BJ, 2007, NAT REV NEUROSCI, V8, P427, DOI 10.1038/nrn2151; Morin X, 2007, NAT NEUROSCI, V10, P1440, DOI 10.1038/nn1984; Munji RN, 2011, J NEUROSCI, V31, P1676, DOI 10.1523/JNEUROSCI.5404-10.2011; Nishizawa Y, 2007, DEV DYNAM, V236, P3061, DOI 10.1002/dvdy.21351; Noctor SC, 2001, NATURE, V409, P714, DOI 10.1038/35055553; Norden C, 2009, CELL, V138, P1195, DOI 10.1016/j.cell.2009.06.032; Postiglione MP, 2011, NEURON, V72, P269, DOI 10.1016/j.neuron.2011.09.022; Qian H, 1991, BIOPHYS J, V60, P910, DOI 10.1016/S0006-3495(91)82125-7; Reiner O, 2012, J MOL NEUROSCI, V46, P516, DOI 10.1007/s12031-011-9633-0; Rorth P, 2012, EMBO REP, V13, P984, DOI 10.1038/embor.2012.149; SANES JR, 1989, TRENDS NEUROSCI, V12, P21, DOI 10.1016/0166-2236(89)90152-5; Sauer FC, 1935, J COMP NEUROL, V62, P377, DOI 10.1002/cne.900620207; Schaper A, 1897, SCIENCE, V5, P430; Schenk J, 2009, P NATL ACAD SCI USA, V106, P16487, DOI 10.1073/pnas.0908928106; Shimogori T, 2008, DEV GROWTH DIFFER, V50, P499, DOI [10.1111/j.1440-169x.2008.01045.x, 10.1111/j.1440-169X.2008.01045.x]; Shitamukai A, 2011, J NEUROSCI, V31, P3683, DOI 10.1523/JNEUROSCI.4773-10.2011; Siegenthaler JA, 2009, CELL, V139, P597, DOI 10.1016/j.cell.2009.10.004; Sittaramane V, 2009, DEV BIOL, V325, P363, DOI 10.1016/j.ydbio.2008.10.030; SMART IHM, 1965, J ANAT, V99, P941; Taverna E, 2010, NEURON, V67, P906, DOI 10.1016/j.neuron.2010.08.027; Tsai JW, 2010, NAT NEUROSCI, V13, P1463, DOI 10.1038/nn.2665; Tsai JW, 2005, J CELL BIOL, V170, P935, DOI 10.1083/jcb.200505166; Tsunekawa Y, 2012, EMBO J, V31, P1879, DOI 10.1038/emboj.2012.43; Xie ZG, 2007, NEURON, V56, P79, DOI 10.1016/j.neuron.2007.08.026; Zedevic N., 1993, EARLY HUM DEV, V32, P131	50	66	66	0	17	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	NOV	2013	16	11					1556	1566		10.1038/nn.3525	http://dx.doi.org/10.1038/nn.3525			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	241YX	24056697				2022-12-28	WOS:000326205700013
J	Kaifosh, P; Lovett-Barron, M; Turi, GF; Reardon, TR; Losonczy, A				Kaifosh, Patrick; Lovett-Barron, Matthew; Turi, Gergely F.; Reardon, Thomas R.; Losonczy, Attila			Septo-hippocampal GABAergic signaling across multiple modalities in awake mice	NATURE NEUROSCIENCE			English	Article							HIPPOCAMPAL PLACE CELLS; MEDIAL SEPTUM; CELLULAR RESOLUTION; NEURONS; INTERNEURONS; EXPRESSION; LONG	Hippocampal interneurons receive GABAergic input from the medial septum. Using two-photon Ca2+ imaging of axonal boutons in hippocampal CA1 of behaving mice, we found that populations of septo-hippocampal GABAergic boutons were activated during locomotion and salient sensory events; sensory responses scaled with stimulus intensity and were abolished by anesthesia. We found similar activity patterns among boutons with common putative postsynaptic targets, with low-dimensional bouton population dynamics being driven primarily by presynaptic spiking.	[Kaifosh, Patrick; Lovett-Barron, Matthew; Turi, Gergely F.; Reardon, Thomas R.; Losonczy, Attila] Columbia Univ, Dept Neurosci, New York, NY 10027 USA; [Kaifosh, Patrick] Columbia Univ, Ctr Theoret Neurosci, New York, NY USA; [Losonczy, Attila] Columbia Univ, Kavli Inst Brain Sci, New York, NY USA	Columbia University; Columbia University; Columbia University	Kaifosh, P (corresponding author), Columbia Univ, Dept Neurosci, New York, NY 10027 USA.	pwk2108@columbia.edu; al2856@columbia.edu	Turi, Gergely/E-7631-2013; Turi, Gergely/G-5054-2019	Turi, Gergely/0000-0001-5651-9459; Kaifosh, Patrick/0000-0002-1470-5701; Lovett-Barron, Matthew/0000-0003-1425-5277	Howard Hughes Medical Institute International Student Research Fellowship Program; Natural Sciences and Engineering Research Council of Canada; Searle Scholars Program; Human Frontier Science Program; Kavli Institute at Columbia University	Howard Hughes Medical Institute International Student Research Fellowship Program; Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Searle Scholars Program; Human Frontier Science Program(Human Frontier Science Program); Kavli Institute at Columbia University	We thank C. Lacefield for advice on the behavioral apparatus, L. Paninski for advice on the motion correction algorithm, J. Zaremba, N. Danielson, K. Shakman and A. Castro for programming assistance, M. Morishima for help with immuno-histochemistry, and B.V. Zemelman for help with mice and viruses. We thank J.C. Magee, S.A. Siegelbaum, L.F. Abbott and T.M. Jessell for comments on the manuscript. The authors thank the GENIE Program and the Janelia Farm Research Campus of the Howard Hughes Medical Institute for the kind gift of the GCaMP variant 354. This work was funded by the Howard Hughes Medical Institute International Student Research Fellowship Program (P.K.), Natural Sciences and Engineering Research Council of Canada Postgraduate Scholarships (P.K. and M.L.-B.), the Searle Scholars Program, the Human Frontier Science Program, and the Kavli Institute at Columbia University (A.L.).	Hangya B, 2009, J NEUROSCI, V29, P8094, DOI 10.1523/JNEUROSCI.5665-08.2009; BOUTON ME, 1979, J EXP PSYCHOL ANIM B, V5, P368, DOI 10.1037/0097-7403.5.4.368; Chen TW, 2013, NATURE, V499, P295, DOI 10.1038/nature12354; Chowdhury N, 2005, BEHAV NEUROSCI, V119, P1396, DOI 10.1037/0735-7044.119.5.1396; Dombeck DA, 2007, NEURON, V56, P43, DOI 10.1016/j.neuron.2007.08.003; Dombeck DA, 2010, NAT NEUROSCI, V13, P1433, DOI 10.1038/nn.2648; Dong H.W., 2008, ALLEN REFERENCE ATLA; Dragoi G, 1999, J NEUROSCI, V19, P6191, DOI 10.1523/JNEUROSCI.19-14-06191.1999; FREUND TF, 1988, NATURE, V336, P170, DOI 10.1038/336170a0; Gulyas AI, 2003, EUR J NEUROSCI, V17, P1861, DOI 10.1046/j.1460-9568.2003.02630.x; Hassani OK, 2009, J NEUROSCI, V29, P11828, DOI 10.1523/JNEUROSCI.1259-09.2009; Holtmaat A, 2009, NAT PROTOC, V4, P1128, DOI 10.1038/nprot.2009.89; Lovett-Barron M, 2012, NAT NEUROSCI, V15, P423, DOI 10.1038/nn.3024; McClure C, 2011, JOVE-J VIS EXP, DOI 10.3791/3348; MERCER LF, 1979, BRAIN RES BULL, V4, P483, DOI 10.1016/0361-9230(79)90032-7; MILLER CL, 1993, NEUROSCIENCE, V55, P373, DOI 10.1016/0306-4522(93)90506-B; Royer S, 2012, NAT NEUROSCI, V15, P769, DOI 10.1038/nn.3077; Simon AP, 2006, J NEUROSCI, V26, P9038, DOI 10.1523/JNEUROSCI.1401-06.2006; Ugolini G, 2010, J NEUROSCI METH, V194, P2, DOI 10.1016/j.jneumeth.2009.12.001; VINOGRADOVA OS, 1995, PROG NEUROBIOL, V45, P523, DOI 10.1016/0301-0082(94)00051-I; Watabe-Uchida M, 2012, NEURON, V74, P858, DOI 10.1016/j.neuron.2012.03.017; Wickersham IR, 2007, NEURON, V53, P639, DOI 10.1016/j.neuron.2007.01.033; Wickersham IR, 2007, NAT METHODS, V4, P47, DOI 10.1038/NMETH999; Wickersham IR, 2010, NAT PROTOC, V5, P595, DOI 10.1038/nprot.2009.248; Zhang H, 2011, J NEUROPHYSIOL, V106, P2749, DOI 10.1152/jn.00267.2011	25	101	101	1	19	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	SEP	2013	16	9					1182	U31		10.1038/nn.3482	http://dx.doi.org/10.1038/nn.3482			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	207KN	23912949				2022-12-28	WOS:000323597500007
J	Mazzoni, EO; Mahony, S; Peljto, M; Patel, T; Thornton, SR; McCuine, S; Reeder, C; Boyer, LA; Young, RA; Gifford, DK; Wichterle, H				Mazzoni, Esteban O.; Mahony, Shaun; Peljto, Mirza; Patel, Tulsi; Thornton, Seraphim R.; McCuine, Scott; Reeder, Christopher; Boyer, Laurie A.; Young, Richard A.; Gifford, David K.; Wichterle, Hynek			Saltatory remodeling of Hox chromatin in response to rostrocaudal patterning signals	NATURE NEUROSCIENCE			English	Article							POLYCOMB GROUP PROTEINS; RETINOIC ACID; GENE-EXPRESSION; NUCLEAR REORGANIZATION; COLUMNAR ORGANIZATION; POOL IDENTITY; STEM-CELLS; COMPLEX; BINDING; CDX2	Hox genes controlling motor neuron subtype identity are expressed in rostrocaudal patterns that are spatially and temporally collinear with their chromosomal organization. Here we demonstrate that Hox chromatin is subdivided into discrete domains that are controlled by rostrocaudal patterning signals that trigger rapid, domain-wide clearance of repressive histone H3 Lys27 trimethylation (H3K27me3) polycomb modifications. Treatment of differentiating mouse neural progenitors with retinoic acid leads to activation and binding of retinoic acid receptors (RARs) to the Hox1-Hox5 chromatin domains, which is followed by a rapid domain-wide removal of H3K27me3 and acquisition of cervical spinal identity. Wnt and fibroblast growth factor (FGF) signals induce expression of the Cdx2 transcription factor that binds and clears H3K27me3 from the Hox1-Hox9 chromatin domains, leading to specification of brachial or thoracic spinal identity. We propose that rapid clearance of repressive modifications in response to transient patterning signals encodes global rostrocaudal neural identity and that maintenance of these chromatin domains ensures the transmission of positional identity to postmitotic motor neurons later in development.	[Mazzoni, Esteban O.; Peljto, Mirza; Patel, Tulsi; Wichterle, Hynek] Columbia Univ, Columbia Stem Cell Initiat, Ctr Motor Neuron Biol & Dis, Dept Pathol & Cell Biol,Med Ctr, New York, NY 10027 USA; [Mazzoni, Esteban O.; Peljto, Mirza; Patel, Tulsi; Wichterle, Hynek] Columbia Univ, Dept Neurol, Med Ctr, New York, NY USA; [Mazzoni, Esteban O.; Peljto, Mirza; Patel, Tulsi; Wichterle, Hynek] Columbia Univ, Dept Neurosci, Med Ctr, New York, NY USA; [Mazzoni, Esteban O.] NYU, Dept Biol, New York, NY 10003 USA; [Mahony, Shaun; Reeder, Christopher; Gifford, David K.] MIT, Comp Sci & Artificial Intelligence Lab, Cambridge, MA 02139 USA; [Mahony, Shaun] Penn State Univ, Dept Biochem & Mol Biol, Ctr Eukaryot Gene Regulat, University Pk, PA 16802 USA; [Thornton, Seraphim R.; Boyer, Laurie A.] MIT, Dept Biol, Cambridge, MA USA; [McCuine, Scott; Young, Richard A.] Whitehead Inst Biomed Res, Cambridge, MA 02142 USA	Columbia University; Columbia University; Columbia University; New York University; Massachusetts Institute of Technology (MIT); Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Whitehead Institute	Mazzoni, EO (corresponding author), Columbia Univ, Columbia Stem Cell Initiat, Ctr Motor Neuron Biol & Dis, Dept Pathol & Cell Biol,Med Ctr, New York, NY 10027 USA.	eom204@nyu.edu; gifford@mit.edu; hw350@columbia.edu	Mahony, Shaun/C-5699-2014; Young, Richard A/F-6495-2012	Mahony, Shaun/0000-0002-2641-1807; Young, Richard A/0000-0001-8855-8647; mazzoni, esteban/0000-0001-8994-681X; Wichterle, Hynek/0000-0002-7817-0080	Leona M. and Harry B. Helmsley Charitable Trust; US National Institutes of Health [P01 NS055923, R01 NS058502, NS078097]; Richard and Susan Smith Family Foundation, Chestnut Hill, Massachusetts; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007088] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS058502, R56NS078097, P01NS055923, R01NS078097] Funding Source: NIH RePORTER	Leona M. and Harry B. Helmsley Charitable Trust; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Richard and Susan Smith Family Foundation, Chestnut Hill, Massachusetts; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank V. Korinek (Institute of Molecular Genetics, Prague) for purified Wnt3A protein, G. Daley (Harvard Medical School) for the Cdx2 construct, M. Kyba (University of Minnesota) for sharing reagents for construction of the inducible Cdx2 ESC line and T. Jessell (Columbia University) and J. Dasen (New York University) for sharing antibodies and for constructive discussion of our findings. E.O.M. was the David and Sylvia Lieb Fellow of the Damon Runyon Cancer Research Foundation (DRG-1937-07), and this work was supported by The Leona M. and Harry B. Helmsley Charitable Trust, US National Institutes of Health grants P01 NS055923 (D.K.G. and H.W.) and R01 NS058502 and NS078097 (H.W.) and The Richard and Susan Smith Family Foundation, Chestnut Hill, Massachusetts (L.A.B.).	Akasaka T, 2001, DEVELOPMENT, V128, P1587; Bel-Vialar S, 2002, DEVELOPMENT, V129, P5103; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Berger MF, 2008, CELL, V133, P1266, DOI 10.1016/j.cell.2008.05.024; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Beuchle D, 2001, DEVELOPMENT, V128, P993; Bickmore WA, 2004, COLD SPRING HARB SYM, V69, P251, DOI 10.1101/sqb.2004.69.251; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Boyer LA, 2006, NATURE, V441, P349, DOI 10.1038/nature04733; Chambeyron S, 2005, DEVELOPMENT, V132, P2215, DOI 10.1242/dev.01813; Chambeyron S, 2004, GENE DEV, V18, P1119, DOI 10.1101/gad.292104; Chawengsaksophak K, 2004, P NATL ACAD SCI USA, V101, P7641, DOI 10.1073/pnas.0401654101; Dasen JS, 2008, CELL, V134, P304, DOI 10.1016/j.cell.2008.06.019; Dasen JS, 2005, CELL, V123, P477, DOI 10.1016/j.cell.2005.09.009; Ensini M, 1998, DEVELOPMENT, V125, P969; Eskeland R, 2010, MOL CELL, V38, P452, DOI 10.1016/j.molcel.2010.02.032; Fullwood MJ, 2009, NATURE, V462, P58, DOI 10.1038/nature08497; Golden MG, 2012, GENE DEV, V26, P2236, DOI 10.1101/gad.199133.112; Guo YC, 2010, BIOINFORMATICS, V26, P3028, DOI 10.1093/bioinformatics/btq590; Jung H, 2010, NEURON, V67, P781, DOI 10.1016/j.neuron.2010.08.008; Kashyap V, 2010, J BIOL CHEM, V285, P14534, DOI 10.1074/jbc.M110.115345; Krogan NJ, 2003, MOL CELL, V11, P721, DOI 10.1016/S1097-2765(03)00091-1; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Liu JP, 2006, DEVELOPMENT, V133, P2865, DOI 10.1242/dev.02478; Liu JP, 2001, NEURON, V32, P997, DOI 10.1016/S0896-6273(01)00544-X; Mahony S, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-1-r2; Mazzoni EO, 2013, NAT NEUROSCI, V16, P1219, DOI 10.1038/nn.3467; Mazzoni EO, 2011, NAT METHODS, V8, P1056, DOI [10.1038/NMETH.1775, 10.1038/nmeth.1775]; Montavon T, 2011, CELL, V147, P1132, DOI 10.1016/j.cell.2011.10.023; Montgomery ND, 2005, CURR BIOL, V15, P942, DOI 10.1016/j.cub.2005.04.051; Moreno E, 1999, NATURE, V400, P873, DOI 10.1038/23709; Niwa H, 2005, CELL, V123, P917, DOI 10.1016/j.cell.2005.08.040; Nordstrom U, 2006, PLOS BIOL, V4, P1438, DOI 10.1371/journal.pbio.0040252; PAPALOPULU N, 1991, NUCLEIC ACIDS RES, V19, P5497, DOI 10.1093/nar/19.20.5497; Pasini D, 2007, MOL CELL BIOL, V27, P3769, DOI 10.1128/MCB.01432-06; Peljto M, 2010, CELL STEM CELL, V7, P355, DOI 10.1016/j.stem.2010.07.013; Rinn JL, 2007, CELL, V129, P1311, DOI 10.1016/j.cell.2007.05.022; Rousso DL, 2008, NEURON, V59, P226, DOI 10.1016/j.neuron.2008.06.025; Shen XH, 2008, MOL CELL, V32, P491, DOI 10.1016/j.molcel.2008.10.016; Shimizu T, 2006, DEVELOPMENT, V133, P4709, DOI 10.1242/dev.02660; SIMEONE A, 1990, NATURE, V346, P763, DOI 10.1038/346763a0; Skromne I, 2007, DEVELOPMENT, V134, P2147, DOI 10.1242/dev.002980; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [10.2202/1544-6115.1027, DOI 10.2202/1544-6115.1027]; Soshnikova N, 2009, SCIENCE, V324, P1320, DOI 10.1126/science.1171468; Surface LE, 2010, CELL STEM CELL, V7, P288, DOI 10.1016/j.stem.2010.08.004; Taylor JK, 1997, NUCLEIC ACIDS RES, V25, P2293, DOI 10.1093/nar/25.12.2293; Wettenhall JM, 2006, BIOINFORMATICS, V22, P897, DOI 10.1093/bioinformatics/btl025; Wichterle H, 2002, CELL, V110, P385, DOI 10.1016/S0092-8674(02)00835-8; Wu Y, 2008, DEVELOPMENT, V135, P171, DOI 10.1242/dev.009225; Wu ZJ, 2004, J AM STAT ASSOC, V99, P909, DOI 10.1198/016214504000000683	50	102	102	0	15	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	SEP	2013	16	9					1191	U50		10.1038/nn.3490	http://dx.doi.org/10.1038/nn.3490			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	207KN	23955559	Green Accepted, Green Submitted			2022-12-28	WOS:000323597500010
J	Pfeffer, CK; Xue, MS; He, M; Huang, ZJ; Scanziani, M				Pfeffer, Carsten K.; Xue, Mingshan; He, Miao; Huang, Z. Josh; Scanziani, Massimo			Inhibition of inhibition in visual cortex: the logic of connections between molecularly distinct interneurons	NATURE NEUROSCIENCE			English	Article							PRIMARY SOMATOSENSORY CORTEX; GREEN FLUORESCENT PROTEIN; GABAERGIC CELL SUBTYPES; RAT FRONTAL-CORTEX; CEREBRAL-CORTEX; JUVENILE RAT; TRANSGENIC MICE; LAYER 2/3; NEURONS; NEOCORTEX	Cortical inhibitory neurons contact each other to form a network of inhibitory synaptic connections. Our knowledge of the connectivity pattern underlying this inhibitory network is, however, still incomplete. Here we describe a simple and complementary interaction scheme between three large, molecularly distinct interneuron populations in mouse visual cortex: parvalbumin-expressing interneurons strongly inhibit one another but provide little inhibition to other populations. In contrast, somatostatin-expressing interneurons avoid inhibiting one another yet strongly inhibit all other populations. Finally, vasoactive intestinal peptide-expressing interneurons preferentially inhibit somatostatin-expressing interneurons. This scheme occurs in supragranular and infragranular layers, suggesting that inhibitory networks operate similarly at the input and output of the visual cortex. Thus, as the specificity of connections between excitatory neurons forms the basis for the cortical canonical circuit, the scheme described here outlines a standard connectivity pattern among cortical inhibitory neurons.	[Pfeffer, Carsten K.; Scanziani, Massimo] Univ Calif San Diego, Howard Hughes Med Inst, La Jolla, CA 92093 USA; [Xue, Mingshan; He, Miao; Scanziani, Massimo] Univ Calif San Diego, Ctr Neural Circuits & Behav, Neurobiol Sect, La Jolla, CA 92093 USA; [Xue, Mingshan; He, Miao; Scanziani, Massimo] Univ Calif San Diego, Dept Neurosci, La Jolla, CA 92093 USA; [He, Miao; Huang, Z. Josh] Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA	Howard Hughes Medical Institute; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; Cold Spring Harbor Laboratory	Pfeffer, CK (corresponding author), Univ Calif San Diego, Howard Hughes Med Inst, La Jolla, CA 92093 USA.	cpfeffer10@gmail.com; massimo@ucsd.edu	He, Miao/AAQ-1044-2020	He, Miao/0000-0003-0731-6801; Huang, Z. Josh/0000-0003-0592-028X; Xue, Mingshan/0000-0003-1463-8884	National Alliance for Research on Schizophrenia and Depression; US National Institutes of Health [NS047101]; European Molecular Biology Organization [EMBO LTF 1114_2009]; Howard Hughes Medical Institute; Jane Coffin Childs Memorial Fund for Medical Research; Gatsby charitable foundation; NATIONAL INSTITUTE OF MENTAL HEALTH [U01MH078844] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS047101] Funding Source: NIH RePORTER	National Alliance for Research on Schizophrenia and Depression(NARSAD); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); European Molecular Biology Organization(European Molecular Biology Organization (EMBO)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Jane Coffin Childs Memorial Fund for Medical Research; Gatsby charitable foundation; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank J. Evora for help with genotyping and mouse husbandry, M. Chan for immunohistochemical labeling, J. Isaacson for critical reading of the manuscript and the members of the Scanziani and Isaacson laboratories for advice during the course of the study. This work was supported in part by grants from the National Alliance for Research on Schizophrenia and Depression and US National Institutes of Health (NS047101). C. K. P. was supported by a European Molecular Biology Organization long-term fellowship (EMBO LTF 1114_2009) and the Howard Hughes Medical Institute. M. X. was supported by a fellowship from Jane Coffin Childs Memorial Fund for Medical Research. M. S. was supported by the Gatsby charitable foundation and the Howard Hughes Medical Institute.	Ascoli GA, 2008, NAT REV NEUROSCI, V9, P557, DOI 10.1038/nrn2402; Atallah BV, 2012, NEURON, V73, P159, DOI 10.1016/j.neuron.2011.12.013; Avermann M, 2012, J NEUROPHYSIOL, V107, P3116, DOI 10.1152/jn.00917.2011; Bartos M, 2007, NAT REV NEUROSCI, V8, P45, DOI 10.1038/nrn2044; Blatow M, 2003, NEURON, V38, P805, DOI 10.1016/S0896-6273(03)00300-3; Caputi A, 2009, CEREB CORTEX, V19, P1345, DOI 10.1093/cercor/bhn175; Cauli B, 1997, J NEUROSCI, V17, P3894; Chattopadhyaya B, 2004, J NEUROSCI, V24, P9598, DOI 10.1523/JNEUROSCI.1851-04.2004; Dalezios Y, 2002, CEREB CORTEX, V12, P961, DOI 10.1093/cercor/12.9.961; DeFelipe J, 2013, NAT REV NEUROSCI, V14, P202, DOI 10.1038/nrn3444; Dumitriu D, 2007, CEREB CORTEX, V17, P81, DOI 10.1093/cercor/bhj126; Fenno L, 2011, ANNU REV NEUROSCI, V34, P389, DOI 10.1146/annurev-neuro-061010-113817; Fino E, 2011, NEURON, V69, P1188, DOI 10.1016/j.neuron.2011.02.025; Freund TF, 1996, HIPPOCAMPUS, V6, P347, DOI 10.1002/(SICI)1098-1063(1996)6:4<347::AID-HIPO1>3.0.CO;2-I; Galarreta M, 1999, NATURE, V402, P72, DOI 10.1038/47029; Galarreta M, 2008, CEREB CORTEX, V18, P2296, DOI 10.1093/cercor/bhm253; Gibson JR, 1999, NATURE, V402, P75, DOI 10.1038/47035; Glickfeld LL, 2006, NAT NEUROSCI, V9, P807, DOI 10.1038/nn1688; Hippenmeyer S, 2005, PLOS BIOL, V3, P878, DOI 10.1371/journal.pbio.0030159; Hu H, 2011, J NEUROSCI, V31, P3351, DOI 10.1523/JNEUROSCI.4881-10.2011; Isaacson JS, 2011, NEURON, V72, P231, DOI 10.1016/j.neuron.2011.09.027; Jiang XL, 2013, NAT NEUROSCI, V16, P210, DOI 10.1038/nn.3305; Kaneko T, 1998, NEUROSCIENCE, V86, P765, DOI 10.1016/S0306-4522(98)00036-0; Kawaguchi Y, 1997, CEREB CORTEX, V7, P476, DOI 10.1093/cercor/7.6.476; Kawaguchi Y, 1996, J NEUROSCI, V16, P2701; Kubota Y, 2011, CEREB CORTEX, V21, P1803, DOI 10.1093/cercor/bhq252; LAMBOLEZ B, 1992, NEURON, V9, P247, DOI 10.1016/0896-6273(92)90164-9; Lee S, 2010, J NEUROSCI, V30, P16796, DOI 10.1523/JNEUROSCI.1869-10.2010; Ma YY, 2006, J NEUROSCI, V26, P5069, DOI 10.1523/JNEUROSCI.0661-06.2006; Ma YY, 2012, J NEUROSCI, V32, P983, DOI 10.1523/JNEUROSCI.5007-11.2012; Madisen L, 2010, NAT NEUROSCI, V13, P133, DOI 10.1038/nn.2467; Markram H, 2004, NAT REV NEUROSCI, V5, P793, DOI 10.1038/nrn1519; McGarry LM, 2010, FRONT NEURAL CIRCUIT, V4, DOI 10.3389/fncir.2010.00012; Olah S, 2007, FRONT NEURAL CIRCUIT, V1, DOI [10.3389/neuro.04/004.2007, 10.3389/neuro.04.004.2007]; Oliva AA, 2000, J NEUROSCI, V20, P3354, DOI 10.1523/JNEUROSCI.20-09-03354.2000; Packer AM, 2011, J NEUROSCI, V31, P13260, DOI 10.1523/JNEUROSCI.3131-11.2011; Pouille F, 2004, NATURE, V429, P717, DOI 10.1038/nature02615; Reyes A, 1998, NAT NEUROSCI, V1, P279, DOI 10.1038/1092; Somogyi P, 1998, BRAIN RES REV, V26, P113, DOI 10.1016/S0165-0173(97)00061-1; Staiger JF, 1997, EUR J NEUROSCI, V9, P2259, DOI 10.1111/j.1460-9568.1997.tb01644.x; Staiger JF, 2004, J COMP NEUROL, V468, P179, DOI 10.1002/cne.10953; Staiger JF, 2002, EUR J NEUROSCI, V16, P11, DOI 10.1046/j.1460-9568.2002.02048.x; Sugino K, 2006, NAT NEUROSCI, V9, P99, DOI 10.1038/nn1618; Tamamaki N, 2003, J COMP NEUROL, V467, P60, DOI 10.1002/cne.10905; Tang FC, 2009, NAT METHODS, V6, P377, DOI [10.1038/NMETH.1315, 10.1038/nmeth.1315]; Taniguchi H, 2011, NEURON, V71, P995, DOI 10.1016/j.neuron.2011.07.026; Toledo-Rodriguez M, 2005, J PHYSIOL-LONDON, V567, P401, DOI 10.1113/jphysiol.2005.089250; Vruwink M, 2001, J COMP NEUROL, V441, P288, DOI 10.1002/cne.1413; Vucurovic K, 2010, CEREB CORTEX, V20, P2333, DOI 10.1093/cercor/bhp310; Wang Y, 2004, J PHYSIOL-LONDON, V561, P65, DOI 10.1113/jphysiol.2004.073353; Williams SR, 2008, NAT NEUROSCI, V11, P790, DOI 10.1038/nn.2137; Woodruff A, 2009, FRONT NEURAL CIRCUIT, V3, DOI 10.3389/neuro.04.015.2009; Xu XM, 2006, J COMP NEUROL, V499, P144, DOI 10.1002/cne.21101; Xu XM, 2010, J COMP NEUROL, V518, P389, DOI 10.1002/cne.22229	54	752	759	9	96	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	AUG	2013	16	8					1068	U130		10.1038/nn.3446	http://dx.doi.org/10.1038/nn.3446			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	190EV	23817549	Green Accepted, Green Submitted			2022-12-28	WOS:000322323000017
J	Pozzorini, C; Naud, R; Mensi, S; Gerstner, W				Pozzorini, Christian; Naud, Richard; Mensi, Skander; Gerstner, Wulfram			Temporal whitening by power-law adaptation in neocortical neurons	NATURE NEUROSCIENCE			English	Article							MULTIPLE TIME SCALES; PYRAMIDAL NEURONS; SLOW INACTIVATION; MODEL; DECORRELATION; MOUSE; MECHANISMS; HISTORY; ENERGY	Spike-frequency adaptation (SFA) is widespread in the CNS, but its function remains unclear. In neocortical pyramidal neurons, adaptation manifests itself by an increase in the firing threshold and by adaptation currents triggered after each spike. Combining electrophysiological recordings in mice with modeling, we found that these adaptation processes lasted for more than 20 s and decayed over multiple timescales according to a power law. The power-law decay associated with adaptation mirrored and canceled the temporal correlations of input current received in vivo at the somata of layer 2/3 somatosensory pyramidal neurons. These findings suggest that, in the cortex, SFA causes temporal decorrelation of output spikes (temporal whitening), an energy-efficient coding procedure that, at high signal-to-noise ratio, improves the information transfer.	[Pozzorini, Christian] Ecole Polytech Fed Lausanne, Sch Comp & Commun Sci, Lausanne, Switzerland; Ecole Polytech Fed Lausanne, Sch Life Sci, Brain Mind Inst, Lausanne, Switzerland	Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne	Pozzorini, C (corresponding author), Ecole Polytech Fed Lausanne, Sch Comp & Commun Sci, Lausanne, Switzerland.	christian.pozzorini@epfl.ch	Naud, Richard/V-2586-2019	Naud, Richard/0000-0001-7383-3095	Swiss National Science Foundation [200020 132871/1]; European Community's Seventh Framework Program (BrainScaleS) [269921]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); European Community's Seventh Framework Program (BrainScaleS)	We thank C.C.H. Petersen, B.N. Lundstrom, G. Hennequin and A. Seeholzer for helpful discussions. We are also grateful to S. Crochet for sharing in vivo recordings and to B.N. Lundstrom for sharing the data that inspired this work. Finally, we thank S. Naskar for his help with the in vitro recordings. This project was funded by the Swiss National Science Foundation (grant no. 200020 132871/1; C.P. and S.M.) and by the European Community's Seventh Framework Program (BrainScaleS, grant no. 269921; S.M. and R.N.).	Aticky JJ, 2011, NETWORK-COMP NEURAL, V22, P4, DOI [10.1088/0954-898X/3/2/009, 10.3109/0954898X.2011.638888]; Attwell D, 2001, J CEREBR BLOOD F MET, V21, P1133, DOI 10.1097/00004647-200110000-00001; Avermann M, 2012, J NEUROPHYSIOL, V107, P3116, DOI 10.1152/jn.00917.2011; Avila-Akerberg O, 2011, EXP BRAIN RES, V210, P353, DOI [10.1007/s00221-011-2553-y, 10.1007/s00221-011-2639-6]; Badel L, 2008, J NEUROPHYSIOL, V99, P656, DOI 10.1152/jn.01107.2007; Barlow H. B., 1961, SENS COMMUN, P217, DOI DOI 10.7551/MITPRESS/9780262518420.003.0013; Benda J, 2003, NEURAL COMPUT, V15, P2523, DOI 10.1162/089976603322385063; Bohte S.M., 2010, ADV NEURAL INFORM PR, V23, P253; Brenner N, 2000, NEURON, V26, P695, DOI 10.1016/S0896-6273(00)81205-2; Brette R, 2005, J NEUROPHYSIOL, V94, P3637, DOI 10.1152/jn.00686.2005; Brette R, 2008, NEURON, V59, P379, DOI 10.1016/j.neuron.2008.06.021; BRILLINGER DR, 1988, BIOL CYBERN, V59, P189, DOI 10.1007/BF00318010; Chacron MJ, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.080601; Crochet S, 2011, NEURON, V69, P1160, DOI 10.1016/j.neuron.2011.02.022; Dan Y, 1996, J NEUROSCI, V16, P3351; DONG DW, 1995, NETWORK-COMP NEURAL, V6, P159, DOI 10.1088/0954-898X/6/2/003; Drew PJ, 2006, J NEUROPHYSIOL, V96, P826, DOI 10.1152/jn.00134.2006; Fairhall AL, 2001, NATURE, V412, P787, DOI 10.1038/35090500; Fleidervish IA, 1996, J PHYSIOL-LONDON, V493, P83, DOI 10.1113/jphysiol.1996.sp021366; Gerstner W, 2002, SPIKING NEURON MODEL; Gilboa G, 2005, J NEUROSCI, V25, P6479, DOI 10.1523/JNEUROSCI.0763-05.2005; Izhikevich EM, 2003, IEEE T NEURAL NETWOR, V14, P1569, DOI 10.1109/TNN.2003.820440; Jolivet R, 2008, BIOL CYBERN, V99, P417, DOI 10.1007/s00422-008-0261-x; Jolivet R, 2006, J COMPUT NEUROSCI, V21, P35, DOI 10.1007/s10827-006-7074-5; Kondgen H, 2008, CEREB CORTEX, V18, P2086, DOI 10.1093/cercor/bhm235; La Camera G, 2006, J NEUROPHYSIOL, V96, P3448, DOI 10.1152/jn.00453.2006; Laughlin SB, 2001, CURR OPIN NEUROBIOL, V11, P475, DOI 10.1016/S0959-4388(00)00237-3; Lefort S, 2009, NEURON, V61, P301, DOI 10.1016/j.neuron.2008.12.020; Lowen SB, 1999, PHYS REV E, V59, P5970, DOI 10.1103/PhysRevE.59.5970; Lundstrom BN, 2008, NAT NEUROSCI, V11, P1335, DOI 10.1038/nn.2212; MADISON DV, 1984, J PHYSIOL-LONDON, V354, P319, DOI 10.1113/jphysiol.1984.sp015378; Mar DJ, 1999, P NATL ACAD SCI USA, V96, P10450, DOI 10.1073/pnas.96.18.10450; Maravall M, 2007, PLOS BIOL, V5, P323, DOI 10.1371/journal.pbio.0050019; Melnick IV, 2004, J PHYSIOL-LONDON, V559, P383, DOI 10.1113/jphysiol.2004.066415; Mensi S, 2012, J NEUROPHYSIOL, V107, P1756, DOI 10.1152/jn.00408.2011; Mickus T, 1999, BIOPHYS J, V76, P846, DOI 10.1016/S0006-3495(99)77248-6; Naud R, 2011, NEURAL COMPUT, V23, P3016, DOI 10.1162/NECO_a_00208; Paninski L, 2004, NETWORK-COMP NEURAL, V15, P243, DOI 10.1088/0954-898X/15/4/002; Paninski L, 2005, NEUROCOMPUTING, V65, P379, DOI 10.1016/j.neucom.2004.10.032; Pillow JW, 2008, NATURE, V454, P995, DOI 10.1038/nature07140; Pitkow X, 2012, NAT NEUROSCI, V15, P628, DOI 10.1038/nn.3064; Rieke F., 1999, SPIKES EXPLORING NEU; Sanchez-Vives MV, 2000, J NEUROSCI, V20, P4286; SCHWINDT PC, 1989, J NEUROPHYSIOL, V61, P233, DOI 10.1152/jn.1989.61.2.233; Shin JH, 2001, NEURAL NETWORKS, V14, P907, DOI 10.1016/S0893-6080(01)00077-6; Simoncelli EP, 2001, ANNU REV NEUROSCI, V24, P1193, DOI 10.1146/annurev.neuro.24.1.1193; SPAIN WJ, 1991, J PHYSIOL-LONDON, V434, P591, DOI 10.1113/jphysiol.1991.sp018488; SRINIVASAN MV, 1982, PROC R SOC SER B-BIO, V216, P427, DOI 10.1098/rspb.1982.0085; Toib A, 1998, J NEUROSCI, V18, P1893; Truccolo W, 2005, J NEUROPHYSIOL, V93, P1074, DOI 10.1152/jn.00697.2004; Ulanovsky N, 2004, J NEUROSCI, V24, P10440, DOI 10.1523/JNEUROSCI.1905-04.2004; Wainwright MJ, 1999, VISION RES, V39, P3960, DOI 10.1016/S0042-6989(99)00101-7; Wang XJ, 2003, J NEUROPHYSIOL, V89, P3279, DOI 10.1152/jn.00242.2003; Wark B, 2007, CURR OPIN NEUROBIOL, V17, P423, DOI 10.1016/j.conb.2007.07.001	55	108	108	0	33	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUL	2013	16	7					942	U216		10.1038/nn.3431	http://dx.doi.org/10.1038/nn.3431			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	174UM	23749146	Green Published			2022-12-28	WOS:000321180900029
J	Hunt, RF; Girskis, KM; Rubenstein, JL; Alvarez-Buylla, A; Baraban, SC				Hunt, Robert F.; Girskis, Kelly M.; Rubenstein, John L.; Alvarez-Buylla, Arturo; Baraban, Scott C.			GABA progenitors grafted into the adult epileptic brain control seizures and abnormal behavior	NATURE NEUROSCIENCE			English	Article							MEDIAL GANGLIONIC EMINENCE; TEMPORAL-LOBE EPILEPSY; OPTOGENETIC CONTROL; PILOCARPINE MODEL; INHIBITION; PRECURSORS; ORIGINS; NEURONS; MICE	Impaired GABA-mediated neurotransmission has been implicated in many neurologic diseases, including epilepsy, intellectual disability and psychiatric disorders. We found that inhibitory neuron transplantation into the hippocampus of adult mice with confirmed epilepsy at the time of grafting markedly reduced the occurrence of electrographic seizures and restored behavioral deficits in spatial learning, hyperactivity and the aggressive response to handling. In the recipient brain, GABA progenitors migrated up to 1,500 mu m from the injection site, expressed genes and proteins characteristic for interneurons, differentiated into functional inhibitory neurons and received excitatory synaptic input. In contrast with hippocampus, cell grafts into basolateral amygdala rescued the hyperactivity deficit, but did not alter seizure activity or other abnormal behaviors. Our results highlight a critical role for interneurons in epilepsy and suggest that interneuron cell transplantation is a powerful approach to halting seizures and rescuing accompanying deficits in severely epileptic mice.	[Hunt, Robert F.; Girskis, Kelly M.; Baraban, Scott C.] Univ Calif San Francisco, Epilepsy Res Lab, San Francisco, CA 94143 USA; [Hunt, Robert F.; Girskis, Kelly M.; Alvarez-Buylla, Arturo; Baraban, Scott C.] Univ Calif San Francisco, Dept Neurol Surg, San Francisco, CA 94143 USA; [Rubenstein, John L.] Univ Calif San Francisco, Dept Psychiat, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Hunt, RF (corresponding author), Univ Calif San Francisco, Epilepsy Res Lab, San Francisco, CA 94143 USA.	robert.huntiii@ucsf.edu; scott.baraban@ucsf.edu	Ritter, Stefanie L/D-9312-2012	Baraban, Scott/0000-0003-1975-9781; Alvarez-Buylla, Arturo/0000-0003-4426-8925; Hunt, Robert/0000-0003-4490-8718	US National Institutes of Health from the National Institute of Neurological Disorders and Stroke [RO1-NS071785, F32-NS077747]; California Institute of Regenerative Medicine [TR2-01749]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F32NS077747, R01NS071785] Funding Source: NIH RePORTER	US National Institutes of Health from the National Institute of Neurological Disorders and Stroke; California Institute of Regenerative Medicine(California Institute for Regenerative Medicine); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank M. Dinday and W. Hindle-Katel for assistance with pilocarpine injections, J. Sebe for tissue dissection training, G. Hortopan for advice on the single-cell RT-PCR procedure, R. Palmiter for the ZnT3 antibody, and S. Canchola for training on behavior assays. This work was supported by funding from US National Institutes of Health grants from the National Institute of Neurological Disorders and Stroke (RO1-NS071785 to S.C.B., J.L.R. and A.A.-B., and F32-NS077747 to R.F.H.), and a grant from the California Institute of Regenerative Medicine (#TR2-01749 to A.A.-B. and S.C.B.).	Alvarez-Dolado M, 2006, J NEUROSCI, V26, P7380, DOI 10.1523/JNEUROSCI.1540-06.2006; Andrews-Zwilling Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040555; [Anonymous], 2012, EPILEPSY FACT SHEET; BABB TL, 1991, NEUROSCIENCE, V42, P351, DOI 10.1016/0306-4522(91)90380-7; Baraban SC, 2009, P NATL ACAD SCI USA, V106, P15472, DOI 10.1073/pnas.0900141106; Berenyi A, 2012, SCIENCE, V337, P735, DOI 10.1126/science.1223154; Bortel A, 2010, NEUROBIOL DIS, V40, P478, DOI 10.1016/j.nbd.2010.07.015; Butt SJB, 2005, NEURON, V48, P591, DOI 10.1016/j.neuron.2005.09.034; Can A, 2012, JOVE-J VIS EXP, DOI 10.3791/3638; CHAGNACAMITAI Y, 1989, J NEUROPHYSIOL, V61, P747, DOI 10.1152/jn.1989.61.4.747; Clasadonte J., 2012, JASPERS BASIC MECH E; Cossart R, 2001, NAT NEUROSCI, V4, P52, DOI 10.1038/82900; D'Hooge R, 2001, BRAIN RES REV, V36, P60, DOI 10.1016/S0165-0173(01)00067-4; Goffin K, 2007, EXP NEUROL, V205, P501, DOI 10.1016/j.expneurol.2007.03.008; Groticke I, 2007, EXP NEUROL, V207, P329, DOI 10.1016/j.expneurol.2007.06.021; Hadjantonakis AK, 1998, MECH DEVELOP, V76, P79, DOI 10.1016/S0925-4773(98)00093-8; Han S, 2012, NATURE, V489, P385, DOI 10.1038/nature11356; Hermann B, 2008, LANCET NEUROL, V7, P151, DOI 10.1016/S1474-4422(08)70018-8; Hirsch JC, 1999, NAT NEUROSCI, V2, P499, DOI 10.1038/9142; Kobayashi M, 2003, J NEUROSCI, V23, P2440; Krook-Magnuson E, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2376; Lavdas AA, 1999, J NEUROSCI, V19, P7881; Loscher W., 2012, JASPERS BASIC MECH E, Vfourth; LOTHMAN EW, 1991, PROG NEUROBIOL, V37, P1, DOI 10.1016/0301-0082(91)90011-O; Marchenko Steven, 2007, J Vis Exp, P262, DOI 10.3791/262; Mortazavi F, 2005, EPILEPSY BEHAV, V7, P629, DOI 10.1016/j.yebeh.2005.08.019; Palmiter RD, 1996, P NATL ACAD SCI USA, V93, P14934, DOI 10.1073/pnas.93.25.14934; Palop JJ, 2003, P NATL ACAD SCI USA, V100, P9572, DOI 10.1073/pnas.1133381100; Paz JT, 2013, NAT NEUROSCI, V16, P64, DOI 10.1038/nn.3269; Raber J, 2002, J NEUROSCI, V22, P5204, DOI 10.1523/JNEUROSCI.22-12-05204.2002; RACINE RJ, 1972, ELECTROEN CLIN NEURO, V32, P281, DOI 10.1016/0013-4694(72)90177-0; Schevon CA, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2056; Shibley H, 2002, EPILEPSY RES, V49, P109, DOI 10.1016/S0920-1211(02)00012-8; Southwell DG, 2012, NATURE, V491, P109, DOI 10.1038/nature11523; Trevelyan AJ, 2007, J NEUROSCI, V27, P3383, DOI 10.1523/JNEUROSCI.0145-07.2007; Tricoire L, 2011, J NEUROSCI, V31, P10948, DOI 10.1523/JNEUROSCI.0323-11.2011; Verret L, 2012, CELL, V149, P708, DOI 10.1016/j.cell.2012.02.046; Vignoli T, 2012, BRAIN RES, V1450, P125, DOI 10.1016/j.brainres.2012.02.028; Vucurovic K, 2010, CEREB CORTEX, V20, P2333, DOI 10.1093/cercor/bhp310; Wichterle H, 1999, NAT NEUROSCI, V2, P461, DOI 10.1038/8131; Xu Q, 2004, J NEUROSCI, V24, P2612, DOI 10.1523/JNEUROSCI.5667-03.2004; Zipancic I, 2010, CELL TRANSPLANT, V19, P549, DOI 10.3727/096368910X491383	42	203	205	0	43	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUN	2013	16	6					692	+		10.1038/nn.3392	http://dx.doi.org/10.1038/nn.3392			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	152DE	23644485	Green Submitted, Green Accepted			2022-12-28	WOS:000319509600010
J	Lattal, KM; Wood, MA				Lattal, K. Matthew; Wood, Marcelo A.			Epigenetics and persistent memory: implications for reconsolidation and silent extinction beyond the zero	NATURE NEUROSCIENCE			English	Article							LONG-TERM-MEMORY; SYNAPTIC PLASTICITY; FEAR EXTINCTION; HISTONE ACETYLATION; MECHANISMS; INHIBITORS; ENHANCEMENT; HDAC3	Targeting epigenetic mechanisms during initial learning or memory retrieval can lead to persistent memory. Retrieval induces plasticity that may result in reconsolidation of the original memory, in which critical molecular events are needed to stabilize the memory, or extinction, in which new learning during the retrieval trial creates an additional memory that reflects the changed environmental contingencies. A canonical feature of extinction is that the original response is temporarily suppressed, but returns under various conditions. These characteristics have defined whether a given manipulation alters extinction (when persistence does not occur) or reconsolidation (when persistence does occur). A problem arises with these behavioral definitions when considering the potential for persistent memory of extinction. Recent studies have found that epigenetic modulation of memory processes leads to surprisingly robust and persistent extinction. We discuss evidence from behavioral epigenetic approaches that forces a re-evaluation of widely used behavioral definitions of extinction and reconsolidation.	[Lattal, K. Matthew] Oregon Hlth & Sci Univ, Portland, OR 97201 USA; [Wood, Marcelo A.] Univ Calif Irvine, Irvine, CA USA	Oregon Health & Science University; University of California System; University of California Irvine	Lattal, KM (corresponding author), Oregon Hlth & Sci Univ, Portland, OR 97201 USA.	lattalm@ohsu.edu; mwood@uci.edu	Lattal, K/W-8386-2019		US National Institutes of Health [DA018165, DA025922, DA031989, MH077111, MH081004]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH081004, R01MH077111] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA025922, R21DA031989, P50DA018165] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank K. Bieszczad and M. Malvaez for helpful comments. Preparation of this manuscript was supported by grants from the US National Institutes of Health (DA018165, DA025922, DA031989, MH077111 and MH081004). The order of authorship was determined by lot.	Alberini CM, 2008, NEUROBIOL LEARN MEM, V89, P234, DOI 10.1016/j.nlm.2007.08.007; Bahari-Javan S, 2012, J NEUROSCI, V32, P5062, DOI 10.1523/JNEUROSCI.0079-12.2012; Baker KD, 2012, LEARN MEMORY, V19, P461, DOI 10.1101/lm.026674.112; Bredy TW, 2007, LEARN MEMORY, V14, P268, DOI 10.1101/lm.500907; Brogden WJ, 1938, AM J PSYCHOL, V51, P109, DOI 10.2307/1416419; Davis Michael, 2006, NeuroRx, V3, P82, DOI 10.1016/j.nurx.2005.12.008; Day JJ, 2012, NEUROPSYCHOPHARMACOL, V37, P247, DOI 10.1038/npp.2011.85; Delamater AR, 2012, BEHAV PROCESS, V90, P9, DOI 10.1016/j.beproc.2012.03.006; Denniston JC, 2003, LEARN MOTIV, V34, P68, DOI 10.1016/S0023-9690(02)00508-8; Franklin TB, 2012, NEURON, V75, P747, DOI 10.1016/j.neuron.2012.08.016; Jakovcevski M, 2012, NAT MED, V18, P1194, DOI 10.1038/nm.2828; Katada S, 2012, CELL, V148, P24, DOI 10.1016/j.cell.2012.01.001; Kilgore M, 2010, NEUROPSYCHOPHARMACOL, V35, P870, DOI 10.1038/npp.2009.197; Kramar EA, 2012, P NATL ACAD SCI USA, V109, P5121, DOI 10.1073/pnas.1120700109; Lahm A, 2007, P NATL ACAD SCI USA, V104, P17335, DOI 10.1073/pnas.0706487104; Lai CSW, 2012, NATURE, V483, P87, DOI 10.1038/nature10792; Lattal KM, 2007, BEHAV NEUROSCI, V121, P1125, DOI 10.1037/0735-7044.121.5.1125; Lattal KM, 2012, BEHAV PROCESS, V90, P1, DOI 10.1016/j.beproc.2012.03.009; Lee JLC, 2009, TRENDS NEUROSCI, V32, P413, DOI 10.1016/j.tins.2009.05.002; Lesburgueres E, 2011, SCIENCE, V331, P924, DOI 10.1126/science.1196164; Lester BM, 2011, ANN NY ACAD SCI, V1226, P14, DOI 10.1111/j.1749-6632.2011.06037.x; Leung HT, 2008, J EXP PSYCHOL-ANIM B, V34, P461, DOI 10.1037/0097-7403.34.4.461; Lynch G, 2013, NEUROPHARMACOLOGY, V64, P27, DOI 10.1016/j.neuropharm.2012.07.006; Malvaez M, 2013, P NATL ACAD SCI USA, V110, P2647, DOI 10.1073/pnas.1213364110; Malvaez M, 2010, BIOL PSYCHIAT, V67, P36, DOI 10.1016/j.biopsych.2009.07.032; Marek R, 2011, J NEUROSCI, V31, P7486, DOI 10.1523/JNEUROSCI.0133-11.2011; Maren S, 2011, NEURON, V70, P830, DOI 10.1016/j.neuron.2011.04.023; McGaugh JL, 2009, PSYCHOPHARMACOLOGY, V202, P3, DOI 10.1007/s00213-008-1285-6; McQuown SC, 2011, NEUROBIOL LEARN MEM, V96, P27, DOI [10.1016/j.nlm.2011.04.005, 10.1016/j.nlm.2011.04.002]; McQuown SC, 2011, J NEUROSCI, V31, P764, DOI 10.1523/JNEUROSCI.5052-10.2011; Pavlov I.P., 1927, CONDITIONED REFLEXES; Peixoto L, 2013, NEUROPSYCHOPHARMACOL, V38, P62, DOI 10.1038/npp.2012.86; Qi ZH, 2009, LEARN MEMORY, V16, P308, DOI 10.1101/lm.1333409; Quirk GJ, 2010, J NEUROSCI, V30, P14993, DOI 10.1523/JNEUROSCI.4268-10.2010; Radulovic J, 2010, REV NEUROSCIENCE, V21, P1; Rescorla R.A., 1972, CLASSICAL CONDITION, P64, DOI DOI 10.1101/GR.110528.110; Rescorla RA, 2004, LEARN MEMORY, V11, P501, DOI 10.1101/lm.77504; Rescorla RA, 2006, J EXP PSYCHOL ANIM B, V32, P135, DOI 10.1037/0097-7403.32.2.135; REYNOLDS GS, 1964, J EXP ANAL BEHAV, V7, P173, DOI 10.1901/jeab.1964.7-173; Stafford JM, 2012, BIOL PSYCHIAT, V72, P25, DOI 10.1016/j.biopsych.2011.12.012; Stafford JM, 2011, NEUROBIOL LEARN MEM, V96, P35, DOI 10.1016/j.nlm.2011.04.012; Stefanko DP, 2009, P NATL ACAD SCI USA, V106, P9447, DOI 10.1073/pnas.0903964106; Torregrossa MM, 2013, PSYCHOPHARMACOLOGY, V226, P659, DOI 10.1007/s00213-012-2750-9; Tronson NC, 2012, TRENDS NEUROSCI, V35, P145, DOI 10.1016/j.tins.2011.10.003; Turner BM, 2002, CELL, V111, P285, DOI 10.1016/S0092-8674(02)01080-2; Vecsey CG, 2007, J NEUROSCI, V27, P6128, DOI 10.1523/JNEUROSCI.0296-07.2007; Vogel-Ciernia A, 2012, REV NEUROSCIENCE, V23, P607, DOI 10.1515/revneuro-2012-0050; Wang L, 2010, NEUROPSYCHOPHARMACOL, V35, P913, DOI 10.1038/npp.2009.193; Wei W, 2012, J NEUROSCI, V32, P11930, DOI 10.1523/JNEUROSCI.0178-12.2012; Zovkic IB, 2013, NEUROPSYCHOPHARMACOL, V38, P77, DOI 10.1038/npp.2012.79	50	78	79	0	33	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	FEB	2013	16	2					124	129		10.1038/nn.3302	http://dx.doi.org/10.1038/nn.3302			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	080RE	23354385	Green Accepted			2022-12-28	WOS:000314260200007
J	Ransohoff, RM				Ransohoff, Richard M.			Animal models of multiple sclerosis: the good, the bad and the bottom line	NATURE NEUROSCIENCE			English	Article							CENTRAL-NERVOUS-SYSTEM; EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS; EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; ENVIRONMENTAL RISK-FACTORS; CD8(+) T-CELLS; DEMYELINATING DISEASE; AXONAL DAMAGE; MOUSE MODELS; SPINAL-CORD; REMYELINATION	Multiple sclerosis (MS) is a spontaneous, acquired, inflammatory demyelinating disease of the human CNS. Because it involves a complex interaction between two of the most intricate biological systems, immune system and CNS, animal modeling has been critical for addressing MS pathogenesis. MS models were originally developed serendipitously more than 75 years ago. Immune-mediated, toxic, viral and genetic models of demyelination are now used to understand the manifold aspects of MS. MS treatments evolved in part from animal model research, and further progress is envisaged in large part because these systems have been continually refined and their use focused on questions whose relevance was established by studying the human disease.	Cleveland Clin, Lerner Res Inst, Neuroinflammat Res Ctr, Cleveland, OH 44106 USA	Cleveland Clinic Foundation	Ransohoff, RM (corresponding author), Cleveland Clin, Lerner Res Inst, Neuroinflammat Res Ctr, Cleveland, OH 44106 USA.	ransohr@ccf.org			US National Institutes of Health; National Multiple Sclerosis Society; Williams Family Fund for MS Research	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Multiple Sclerosis Society(National Multiple Sclerosis Society); Williams Family Fund for MS Research	Research in the Ransohoff laboratory is supported by the US National Institutes of Health, the National Multiple Sclerosis Society and the Williams Family Fund for MS Research. The invaluable aid of other philanthropic donors is gratefully recognized.	Aboul-Enein F, 2005, ACTA NEUROPATHOL, V109, P49, DOI 10.1007/s00401-004-0954-8; Arnett HA, 2001, NAT NEUROSCI, V4, P1116, DOI 10.1038/nn738; Ascherio A, 2007, ANN NEUROL, V61, P504, DOI 10.1002/ana.21141; Ascherio A, 2007, ANN NEUROL, V61, P288, DOI 10.1002/ana.21117; Babbe H, 2000, J EXP MED, V192, P393, DOI 10.1084/jem.192.3.393; Berer K, 2011, MOL IMMUNOL, V48, P1332, DOI 10.1016/j.molimm.2010.10.025; Bergmann CC, 2006, NAT REV MICROBIOL, V4, P121, DOI 10.1038/nrmicro1343; BERNARD CCA, 1976, EUR J IMMUNOL, V6, P655, DOI 10.1002/eji.1830060912; Blakemore WF, 2008, CURR TOP MICROBIOL, V318, P193; BLAKEMORE WF, 1977, J NEUROL SCI, V33, P31, DOI 10.1016/0022-510X(77)90179-4; Croxford AL, 2011, BBA-MOL BASIS DIS, V1812, P177, DOI 10.1016/j.bbadis.2010.06.010; DALCANTO MC, 1995, MICROSC RES TECHNIQ, V32, P215, DOI 10.1002/jemt.1070320305; Ferguson B, 1997, BRAIN, V120, P393, DOI 10.1093/brain/120.3.393; Foote AK, 2005, BRAIN, V128, P528, DOI 10.1093/brain/awh417; Frohman EM, 2006, NEW ENGL J MED, V354, P942, DOI 10.1056/NEJMra052130; Fugger L, 2009, NAT REV IMMUNOL, V9, P408, DOI 10.1038/nri2554; Furtado GD, 2001, IMMUNOL REV, V182, P122; Hauser SL, 2008, NEW ENGL J MED, V358, P676, DOI 10.1056/NEJMoa0706383; Huseby ES, 2001, J EXP MED, V194, P669, DOI 10.1084/jem.194.5.669; Kornek B, 2000, AM J PATHOL, V157, P267, DOI 10.1016/S0002-9440(10)64537-3; Lassmann H, 2004, TRENDS IMMUNOL, V25, P132, DOI 10.1016/j.it.2004.01.007; Linares D, 2006, J NEUROSCI, V26, P12672, DOI 10.1523/JNEUROSCI.0294-06.2006; LIPTON HL, 1975, INFECT IMMUN, V11, P1147, DOI 10.1128/IAI.11.5.1147-1155.1975; Liu LP, 2010, NAT NEUROSCI, V13, P319, DOI 10.1038/nn.2491; Lucchinetti C, 2000, ANN NEUROL, V47, P707, DOI 10.1002/1531-8249(200006)47:6<707::AID-ANA3>3.0.CO;2-Q; Lucchinetti CF, 2011, NEW ENGL J MED, V365, P2188, DOI 10.1056/NEJMoa1100648; LUDWIN SK, 1978, LAB INVEST, V39, P597; Matsushima GK, 2001, BRAIN PATHOL, V11, P107; Miller RH, 2010, DIS MODEL MECH, V3, P535, DOI 10.1242/dmm.001958; Miller SD, 1997, NAT MED, V3, P1133, DOI 10.1038/nm1097-1133; PATERSON PY, 1979, REV INFECT DIS, V1, P468; Patrikios P, 2006, BRAIN, V129, P3165, DOI 10.1093/brain/awl217; Pelletier D, 2012, NEW ENGL J MED, V366, P339, DOI 10.1056/NEJMct1101691; Pohl HBF, 2011, J NEUROSCI, V31, P1069, DOI 10.1523/JNEUROSCI.5035-10.2011; PRINEAS JW, 1981, ANN NEUROL, V10, P149, DOI 10.1002/ana.410100205; Ransohoff RM, 2006, J CLIN INVEST, V116, P2313, DOI 10.1172/JCI29834; Ransohoff RM, 2002, TRENDS IMMUNOL, V23, P512, DOI 10.1016/S1471-4906(02)02321-9; Rivera-Quinones C, 1998, NAT MED, V4, P187, DOI 10.1038/nm0298-187; Sawcer S, 2011, NATURE, V476, P214, DOI 10.1038/nature10251; Skripuletz T, 2011, HISTOL HISTOPATHOL, V26, P1585, DOI 10.14670/HH-26.1585; Steinman L, 2006, ANN NEUROL, V60, P12, DOI 10.1002/ana.20913; 't Hart BA, 1998, AM J PATHOL, V153, P649, DOI 10.1016/S0002-9440(10)65606-4; Traka M, 2010, BRAIN, V133, P3017, DOI 10.1093/brain/awq247; Trapp BD, 1998, NEW ENGL J MED, V338, P278, DOI 10.1056/NEJM199801293380502; Uccelli A, 2003, Int MS J, V10, P6; Waksman BH, 1999, NEUROCHEM RES, V24, P491, DOI 10.1023/A:1022527628192; WAKSMAN BH, 1962, AM J PATHOL, V41, P135; YASUDA T, 1975, JPN J EXP MED, V45, P423; YEDNOCK TA, 1992, NATURE, V356, P63, DOI 10.1038/356063a0; Zhang GX, 2000, MULT SCLER J, V6, P3, DOI 10.1191/135245800678827446	50	222	259	4	51	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	AUG	2012	15	8					1074	1077		10.1038/nn.3168	http://dx.doi.org/10.1038/nn.3168			4	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	979UE	22837037	Green Published			2022-12-28	WOS:000306844500008
J	McCall, C; Singer, T				McCall, Cade; Singer, Tania			The animal and human neuroendocrinology of social cognition, motivation and behavior	NATURE NEUROSCIENCE			English	Review							OXYTOCIN RECEPTOR DENSITY; EXOGENOUS TESTOSTERONE; ARGININE-VASOPRESSIN; INTRANASAL OXYTOCIN; AGGRESSIVE-BEHAVIOR; PATERNAL BEHAVIOR; NUCLEUS-ACCUMBENS; STRESS RESPONSES; NEURAL CIRCUITRY; INCREASES TRUST	Extensive animal and recent human research have helped inform neuroendocrinological models of social cognition, motivation and behavior. In this review, we first summarize important findings regarding oxytocin, arginine vasopressin and testosterone in the domains of affiliation, social cognition, aggression and stress/anxiety. We then suggest ways in which human research can continue to profit from animal research, particularly by exploring the interactive nature of neuromodulatory effects at neurochemical, organismic and contextual levels. We further propose methods inspired by the animal literature for the ecologically valid assessment of affiliative behavior in humans. We conclude with suggestions for how human research could advance by directly assessing specific social cognitive and motivational mechanisms as intermediate variables. We advocate a more comprehensive look at the distinct networks identified by social neuroscience and the importance of a motivational state, in addition to approach and avoidance, associated with quiescence and homeostatic regulation.	[McCall, Cade; Singer, Tania] Max Planck Inst Human Cognit & Brain Sci, Dept Social Neurosci, Leipzig, Germany	Max Planck Society	Singer, T (corresponding author), Max Planck Inst Human Cognit & Brain Sci, Dept Social Neurosci, Leipzig, Germany.	singer@cbs.mpg.de	Carroll, Joseph/D-1158-2011	Carroll, Joseph/0000-0003-2656-1378; McCall, Cade/0000-0003-0746-8899				Adolphs R, 2002, CURR OPIN NEUROBIOL, V12, P169, DOI 10.1016/S0959-4388(02)00301-X; Adolphs R, 2001, J COGNITIVE NEUROSCI, V13, P232, DOI 10.1162/089892901564289; Amico JA, 2004, J NEUROENDOCRINOL, V16, P319, DOI 10.1111/j.0953-8194.2004.01161.x; Baron-Cohen S, 2001, J CHILD PSYCHOL PSYC, V42, P241, DOI 10.1111/1469-7610.00715; Baron -Cohen S., 1997, MINDBLINDNESS ESSAY; Bartz JA, 2011, TRENDS COGN SCI, V15, P301, DOI 10.1016/j.tics.2011.05.002; Born J, 2002, NAT NEUROSCI, V5, P514, DOI 10.1038/nn849; Bos PA, 2012, FRONT NEUROENDOCRIN, V33, P17, DOI 10.1016/j.yfrne.2011.01.002; Bos PA, 2010, P NATL ACAD SCI USA, V107, P9991, DOI 10.1073/pnas.0911700107; Bosch OJ, 2010, EUR J NEUROSCI, V31, P883, DOI 10.1111/j.1460-9568.2010.07115.x; Brown CH, 2000, NEUROSCI RES, V36, P97, DOI 10.1016/S0168-0102(99)00121-2; Burgdorf J, 2006, NEUROSCI BIOBEHAV R, V30, P173, DOI 10.1016/j.neubiorev.2005.06.001; Caldwell HK, 2008, PROG NEUROBIOL, V84, P1, DOI 10.1016/j.pneurobio.2007.10.007; Carter CS, 2009, DEV NEUROSCI-BASEL, V31, P332, DOI 10.1159/000216544; Chen FS, 2011, P NATL ACAD SCI USA, V108, pE45, DOI 10.1073/pnas.1101633108; CSIFFARY A, 1992, NEUROENDOCRINOLOGY, V56, P429, DOI 10.1159/000126259; Cushing BS, 2003, J NEUROENDOCRINOL, V15, P1021, DOI 10.1046/j.1365-2826.2003.01097.x; D'Cunha TM, 2011, HORM BEHAV, V59, P14, DOI 10.1016/j.yhbeh.2010.09.007; De Dreu CKW, 2011, P NATL ACAD SCI USA, V108, P1262, DOI 10.1073/pnas.1015316108; De Dreu CKW, 2010, SCIENCE, V328, P1408, DOI 10.1126/science.1189047; Declerck CH, 2010, HORM BEHAV, V57, P368, DOI 10.1016/j.yhbeh.2010.01.006; Depue RA, 2005, BEHAV BRAIN SCI, V28, P313; Detillion CE, 2004, PSYCHONEUROENDOCRINO, V29, P1004, DOI 10.1016/j.psyneuen.2003.10.003; Ditzen B, 2009, BIOL PSYCHIAT, V65, P728, DOI 10.1016/j.biopsych.2008.10.011; Domes G, 2007, BIOL PSYCHIAT, V61, P731, DOI 10.1016/j.biopsych.2006.07.015; Domes G, 2010, PSYCHONEUROENDOCRINO, V35, P83, DOI 10.1016/j.psyneuen.2009.06.016; Donaldson ZR, 2008, SCIENCE, V322, P900, DOI 10.1126/science.1158668; Eisenegger C, 2010, NATURE, V463, P356, DOI 10.1038/nature08711; Eisenegger C, 2011, TRENDS COGN SCI, V15, P263, DOI 10.1016/j.tics.2011.04.008; Engelmann M, 2004, FRONT NEUROENDOCRIN, V25, P132, DOI 10.1016/j.yfrne.2004.09.001; Ferguson JN, 2002, FRONT NEUROENDOCRIN, V23, P200, DOI 10.1006/frne.2002.0229; FERRIS CF, 1992, ANN NY ACAD SCI, V652, P456, DOI 10.1111/j.1749-6632.1992.tb34382.x; Frye CA, 2001, COGN AFFECT BEHAV NE, V1, P371, DOI 10.3758/CABN.1.4.371; Gallagher HL, 2003, TRENDS COGN SCI, V7, P77, DOI 10.1016/S1364-6613(02)00025-6; Gallese V, 1996, BRAIN, V119, P593, DOI 10.1093/brain/119.2.593; Gamer M, 2010, P NATL ACAD SCI USA, V107, P9400, DOI 10.1073/pnas.1000985107; Gordon I, 2011, DEV COGN NEUROS-NETH, V1, P471, DOI 10.1016/j.dcn.2011.07.007; Guastella AJ, 2008, BIOL PSYCHIAT, V63, P3, DOI 10.1016/j.biopsych.2007.06.026; Guastella AJ, 2011, PSYCHONEUROENDOCRINO, V36, P294, DOI 10.1016/j.psyneuen.2010.07.023; Guastella AJ, 2010, BIOL PSYCHIAT, V67, P1220, DOI 10.1016/j.biopsych.2010.03.014; HANDA RJ, 1994, HORM BEHAV, V28, P464, DOI 10.1006/hbeh.1994.1044; Heim C, 2009, MOL PSYCHIATR, V14, P954, DOI 10.1038/mp.2008.112; Heinrichs M, 2003, BIOL PSYCHIAT, V54, P1389, DOI 10.1016/S0006-3223(03)00465-7; Heinrichs M, 2008, PROG BRAIN RES, V170, P337, DOI 10.1016/S0079-6123(08)00428-7; Hermans EJ, 2006, BIOL PSYCHIAT, V59, P872, DOI 10.1016/j.biopsych.2005.11.015; Hermans EJ, 2008, BIOL PSYCHIAT, V63, P263, DOI 10.1016/j.biopsych.2007.05.013; Hermans EJ, 2007, PSYCHONEUROENDOCRINO, V32, P1052, DOI 10.1016/j.psyneuen.2007.08.006; Hermans EJ, 2010, NEUROIMAGE, V52, P277, DOI 10.1016/j.neuroimage.2010.04.019; Hurlemann R, 2010, J NEUROSCI, V30, P4999, DOI 10.1523/JNEUROSCI.5538-09.2010; Insel TR, 2010, NEURON, V65, P768, DOI 10.1016/j.neuron.2010.03.005; Kanwisher N, 2006, PHILOS T R SOC B, V361, P2109, DOI 10.1098/rstb.2006.1934; Keri S, 2009, COGN AFFECT BEHAV NE, V9, P237, DOI 10.3758/CABN.9.3.237; Keysers C, 2010, NAT REV NEUROSCI, V11, P417, DOI 10.1038/nrn2833; Kirsch P, 2005, J NEUROSCI, V25, P11489, DOI 10.1523/JNEUROSCI.3984-05.2005; KOOLHAAS JM, 1990, AGGRESSIVE BEHAV, V16, P223; Kosfeld M, 2005, NATURE, V435, P673, DOI 10.1038/nature03701; Lamm C, 2011, NEUROIMAGE, V54, P2492, DOI 10.1016/j.neuroimage.2010.10.014; Landgraf R, 2004, FRONT NEUROENDOCRIN, V25, P150, DOI 10.1016/j.yfrne.2004.05.001; Lee HJ, 2009, PROG NEUROBIOL, V88, P127, DOI 10.1016/j.pneurobio.2009.04.001; Lim MM, 2004, NEUROSCIENCE, V125, P35, DOI 10.1016/j.neuroscience.2003.12.008; McCall C, 2009, SOC INFLUENCE, V4, P138, DOI 10.1080/15534510802517418; Meyer-Lindenberg A, 2011, NAT REV NEUROSCI, V12, P524, DOI 10.1038/nrn3044; Mikolajczak M, 2010, BIOL PSYCHOL, V85, P182, DOI 10.1016/j.biopsycho.2010.05.010; Mitchell JP, 2009, PHILOS T R SOC B, V364, P1309, DOI 10.1098/rstb.2008.0318; Muller MN, 2004, ANIM BEHAV, V67, P113, DOI 10.1016/j.anbehav.2003.03.013; Naber F, 2010, PSYCHONEUROENDOCRINO, V35, P1583, DOI 10.1016/j.psyneuen.2010.04.007; Nelson EE, 1998, NEUROSCI BIOBEHAV R, V22, P437, DOI 10.1016/S0149-7634(97)00052-3; Nelson RJ, 2007, NAT REV NEUROSCI, V8, P536, DOI 10.1038/nrn2174; Olazabal DE, 2006, HORM BEHAV, V49, P681, DOI 10.1016/j.yhbeh.2005.12.010; Pace TWW, 2009, PSYCHONEUROENDOCRINO, V34, P87, DOI 10.1016/j.psyneuen.2008.08.011; Petrovic P, 2008, J NEUROSCI, V28, P6607, DOI 10.1523/JNEUROSCI.4572-07.2008; PREMACK D, 1978, BEHAV BRAIN SCI, V1, P515, DOI 10.1017/S0140525X00076512; Riem MME, 2011, BIOL PSYCHIAT, V70, P291, DOI 10.1016/j.biopsych.2011.02.006; Rimmele U, 2009, J NEUROSCI, V29, P38, DOI 10.1523/JNEUROSCI.4260-08.2009; Rizzolatti G, 1996, COGNITIVE BRAIN RES, V3, P131, DOI 10.1016/0926-6410(95)00038-0; Rockliff H, 2011, EMOTION, V11, P1388, DOI 10.1037/a0023861; Ross HE, 2009, NEUROSCIENCE, V162, P892, DOI 10.1016/j.neuroscience.2009.05.055; Ross HE, 2009, J NEUROSCI, V29, P1312, DOI 10.1523/JNEUROSCI.5039-08.2009; Saxe R, 2003, NEUROIMAGE, V19, P1835, DOI 10.1016/S1053-8119(03)00230-1; Shalev I, 2011, HORM BEHAV, V60, P121, DOI 10.1016/j.yhbeh.2011.04.005; Shamay-Tsoory SG, 2009, BIOL PSYCHIAT, V66, P864, DOI 10.1016/j.biopsych.2009.06.009; Singer T, 2008, EMOTION, V8, P781, DOI 10.1037/a0014195; Theodoridou A, 2009, HORM BEHAV, V56, P128, DOI 10.1016/j.yhbeh.2009.03.019; Thompson RR, 2006, P NATL ACAD SCI USA, V103, P7889, DOI 10.1073/pnas.0600406103; Trainor BC, 2002, P ROY SOC B-BIOL SCI, V269, P823, DOI 10.1098/rspb.2001.1954; van Anders SM, 2011, PSYCHONEUROENDOCRINO, V36, P1265, DOI 10.1016/j.psyneuen.2011.06.001; van Honk J, 2004, PSYCHONEUROENDOCRINO, V29, P937, DOI 10.1016/j.psyneuen.2003.08.007; van Ijzendoorn MH, 2012, PSYCHONEUROENDOCRINO, V37, P438, DOI 10.1016/j.psyneuen.2011.07.008; WANG ZX, 1994, P NATL ACAD SCI USA, V91, P400, DOI 10.1073/pnas.91.1.400; Wersinger SR, 2007, GENES BRAIN BEHAV, V6, P653, DOI 10.1111/j.1601-183X.2006.00294.x; WILLIAMS JR, 1992, HORM BEHAV, V26, P339, DOI 10.1016/0018-506X(92)90004-F; WIMMER H, 1983, COGNITION, V13, P103, DOI 10.1016/0010-0277(83)90004-5; WINGFIELD JC, 1990, AM NAT, V136, P829, DOI 10.1086/285134; Winslow JT, 2003, NEUROPSYCHOPHARMACOL, V28, P910, DOI 10.1038/sj.npp.1300128; WINSLOW JT, 1993, NATURE, V365, P545, DOI 10.1038/365545a0; Young LJ, 2004, NAT NEUROSCI, V7, P1048, DOI 10.1038/nn1327; Zak PJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001128; Zink CF, 2010, J NEUROSCI, V30, P7017, DOI 10.1523/JNEUROSCI.4899-09.2010	100	185	192	3	118	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAY	2012	15	5					681	688		10.1038/nn.3084	http://dx.doi.org/10.1038/nn.3084			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	932DI	22504348				2022-12-28	WOS:000303270200010
J	Munoz-Cuevas, FJ; Athilingam, J; Piscopo, D; Wilbrecht, L				Munoz-Cuevas, Francisco Javier; Athilingam, Jegath; Piscopo, Denise; Wilbrecht, Linda			Cocaine-induced structural plasticity in frontal cortex correlates with conditioned place preference	NATURE NEUROSCIENCE			English	Article							NEOCORTEX IN-VIVO; DENDRITIC SPINES; PREFRONTAL CORTEX; CORTICAL CIRCUITS; NUCLEUS-ACCUMBENS; LONG-TERM; MORPHOLOGY; TRANSIENT; STABILITY; RATS	Contextual cues associated with previous drug exposure can trigger drug craving and seeking, and form a substantial obstacle in substance use recovery. Using in vivo imaging in mice, we found that cocaine administration induced a rapid increase in the formation and accumulation of new dendritic spines, and that measures of new persistent spine gain correlated with cocaine conditioned place preference. Our data suggest that new persistent spine formation in the frontal cortex may be involved in stimulant-related learning driving appetitive behavior.	[Munoz-Cuevas, Francisco Javier; Athilingam, Jegath; Piscopo, Denise; Wilbrecht, Linda] Univ Calif San Francisco, Dept Neurol, Ernest Gallo Clin & Res Ctr, San Francisco, CA USA; [Piscopo, Denise] Univ Oregon, Dept Biol, Eugene, OR 97403 USA; [Wilbrecht, Linda] Univ Calif Berkeley, Dept Psychol, Berkeley, CA 94720 USA	University of California System; University of California San Francisco; Ernest Gallo Clinic & Research Center; University of Oregon; University of California System; University of California Berkeley	Wilbrecht, L (corresponding author), Univ Calif San Francisco, Dept Neurol, Ernest Gallo Clin & Res Ctr, San Francisco, CA USA.	wilbrecht@berkeley.edu			National Institute on Drug Abuse [R01DA029150]; State of California, University of California San Francisco; P. Royer and K. Clayton Family; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA029150] Funding Source: NIH RePORTER	National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); State of California, University of California San Francisco; P. Royer and K. Clayton Family; NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank J. Whistler, P. Janak, S. Jurado, C. Johnson and C. Bates for comments on the manuscript. This work was supported by the National Institute on Drug Abuse (R01DA029150), the State of California, University of California San Francisco, and the P. Royer and K. Clayton Family.	Bourne J, 2007, CURR OPIN NEUROBIOL, V17, P381, DOI 10.1016/j.conb.2007.04.009; Chudasama Y, 2006, BIOL PSYCHOL, V73, P19, DOI 10.1016/j.biopsycho.2006.01.005; Feng GP, 2000, NEURON, V28, P41, DOI 10.1016/S0896-6273(00)00084-2; Hofer SB, 2009, NATURE, V457, P313, DOI 10.1038/nature07487; Holtmaat AJGD, 2005, NEURON, V45, P279, DOI 10.1016/j.neuron.2005.01.003; Holtmaat A, 2009, NAT PROTOC, V4, P1128, DOI 10.1038/nprot.2009.89; Kasai H, 2003, TRENDS NEUROSCI, V26, P360, DOI 10.1016/S0166-2236(03)00162-0; Knott GW, 2006, NAT NEUROSCI, V9, P1117, DOI 10.1038/nn1747; McLaughlin J, 2003, PSYCHOPHARMACOLOGY, V168, P57, DOI 10.1007/s00213-002-1196-x; Pierce RC, 1998, NEUROSCIENCE, V82, P1103; Robinson TE, 1999, EUR J NEUROSCI, V11, P1598, DOI 10.1046/j.1460-9568.1999.00576.x; Robinson TE, 2001, SYNAPSE, V39, P257; Robinson TE, 2004, NEUROPHARMACOLOGY, V47, P33, DOI 10.1016/j.neuropharm.2004.06.025; Tai LH, 2012, NAT NEUROSCI, V15, P1281, DOI 10.1038/nn.3188; Wilbrecht L, 2010, J NEUROSCI, V30, P4927, DOI 10.1523/JNEUROSCI.6403-09.2010; Xu TH, 2009, NATURE, V462, P915, DOI 10.1038/nature08389; Zuo Y, 2005, NEURON, V46, P181, DOI 10.1016/j.neuron.2005.04.001	17	60	61	0	20	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	OCT	2013	16	10					1367	+		10.1038/nn.3498	http://dx.doi.org/10.1038/nn.3498			5	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	223HM	23974707	Green Accepted, Green Submitted			2022-12-28	WOS:000324795300007
J	Toth, AB; Terauchi, A; Zhang, LY; Johnson-Venkatesh, EM; Larsen, DJ; Sutton, MA; Umemori, H				Toth, Anna B.; Terauchi, Akiko; Zhang, Lily Y.; Johnson-Venkatesh, Erin M.; Larsen, David J.; Sutton, Michael A.; Umemori, Hisashi			Synapse maturation by activity-dependent ectodomain shedding of SIRP alpha	NATURE NEUROSCIENCE			English	Article							SIGNAL REGULATORY PROTEINS; PRESYNAPTIC ORGANIZING MOLECULES; NEURONAL-ACTIVITY; DEFICIENT MICE; MECHANISMS; BRAIN; METALLOPROTEINASES; DIFFERENTIATION; NEUROLIGIN-1; LOCALIZATION	Formation of appropriate synaptic connections is critical for proper functioning of the brain. After initial synaptic differentiation, active synapses are stabilized by neural activity-dependent signals to establish functional synaptic connections. However, the molecular mechanisms underlying activity-dependent synapse maturation remain to be elucidated. Here we show that activity-dependent ectodomain shedding of signal regulatory protein-alpha (SIRP alpha) mediates presynaptic maturation. Two target-derived molecules, fibroblast growth factor 22 and SIRP alpha, sequentially organize the glutamatergic presynaptic terminals during the initial synaptic differentiation and synapse maturation stages, respectively, in the mouse hippocampus. SIRP alpha drives presynaptic maturation in an activity-dependent fashion. Remarkably, neural activity cleaves the extracellular domain of SIRP alpha, and the shed ectodomain in turn promotes the maturation of the presynaptic terminal. This process involves calcium/calmodulin-dependent protein kinase, matrix metalloproteinases and the presynaptic receptor CD47. Finally, SIRP alpha-dependent synapse maturation has an impact on synaptic function and plasticity. Thus, ectodomain shedding of SIRP alpha is an activity-dependent trans-synaptic mechanism for the maturation of functional synapses.	[Toth, Anna B.; Terauchi, Akiko; Zhang, Lily Y.; Johnson-Venkatesh, Erin M.; Larsen, David J.; Sutton, Michael A.; Umemori, Hisashi] Univ Michigan, Sch Med, Mol & Behav Neurosci Inst, Ann Arbor, MI 48109 USA; [Sutton, Michael A.] Univ Michigan, Sch Med, Dept Mol & Integrat Physiol, Ann Arbor, MI USA; [Umemori, Hisashi] Univ Michigan, Sch Med, Dept Biol Chem, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Umemori, H (corresponding author), Univ Michigan, Sch Med, Mol & Behav Neurosci Inst, Ann Arbor, MI 48109 USA.	umemoh@umich.edu		Sutton, Michael/0000-0002-0692-6459; Umemori, Hisashi/0000-0001-7198-2062	Ester A. & Joseph Klingenstein Fund; Edward Mallinckrodt Jr. Foundation; March of Dimes Foundation; Whitehall Foundation; US National Institutes of Health [MH091429, NS070005, MH092614]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD018655] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007315] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R21MH092614, R01MH091429] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS070005] Funding Source: NIH RePORTER	Ester A. & Joseph Klingenstein Fund; Edward Mallinckrodt Jr. Foundation; March of Dimes Foundation(March of Dimes); Whitehall Foundation; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank J. Sanes for critical comments on the manuscript; H. Enomoto for pSV loxP sv40 intron polyA EGFP FRTneo plasmid; A. Murayama and L. Kee for plasmid construction; E. Gibbs for help with in situ hybridization; D. Sorenson for help with electron microscopy; M. Zhang, R. Carson and A. Williams for technical assistance; and E. Hughes, Y. Qu, K. Childs, G. Gavrilina, D. Vanheyningen and the Transgenic Animal Model Core of the University of Michigan for preparation of SIRP alpha knockout mice. Core support was provided by the University of Michigan Center for Organogenesis. This work was supported by the Ester A. & Joseph Klingenstein Fund, the Edward Mallinckrodt Jr. Foundation, the March of Dimes Foundation, the Whitehall Foundation and US National Institutes of Health grants MH091429, NS070005 and MH092614 (H.U.).	Bai G, 2011, NEURON, V72, P9, DOI 10.1016/j.neuron.2011.09.012; Barclay AN, 2006, NAT REV IMMUNOL, V6, P457, DOI 10.1038/nri1859; Biederer T, 2007, NAT PROTOC, V2, P670, DOI 10.1038/nprot.2007.92; Bleckert A, 2011, BIOESSAYS, V33, P61, DOI 10.1002/bies.201000095; Bouvier D, 2008, J NEUROCHEM, V106, P682, DOI 10.1111/j.1471-4159.2008.05416.x; Chang HP, 1999, LEARN MEMORY, V6, P448, DOI 10.1101/lm.6.5.448; Dalva MB, 2007, NAT REV NEUROSCI, V8, P206, DOI 10.1038/nrn2075; Danglot L, 2006, HIPPOCAMPUS, V16, P1032, DOI 10.1002/hipo.20225; Edwards DR, 2008, MOL ASPECTS MED, V29, P258, DOI 10.1016/j.mam.2008.08.001; Ethell IM, 2007, J NEUROSCI RES, V85, P2813, DOI 10.1002/jnr.21273; Flavell SW, 2008, ANNU REV NEUROSCI, V31, P563, DOI 10.1146/annurev.neuro.31.060407.125631; Fox MA, 2007, J COMP NEUROL, V503, P280, DOI 10.1002/cne.21381; Fox MA, 2006, J NEUROCHEM, V97, P1215, DOI 10.1111/j.1471-4159.2006.03834.x; Goda Y, 2003, NEURON, V40, P243, DOI 10.1016/S0896-6273(03)00608-1; Guo CY, 2002, GENESIS, V32, P8, DOI 10.1002/gene.10021; Hahn CG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005251; Hatherley D, 2008, MOL CELL, V31, P266, DOI 10.1016/j.molcel.2008.05.026; Hatherley D, 2009, J BIOL CHEM, V284, P26613, DOI 10.1074/jbc.M109.017566; Kano M, 2009, CURR OPIN NEUROBIOL, V19, P154, DOI 10.1016/j.conb.2009.05.002; Kasai H, 2010, TRENDS NEUROSCI, V33, P121, DOI 10.1016/j.tins.2010.01.001; Kay L, 2011, NAT NEUROSCI, V14, P688, DOI 10.1038/nn.2826; Lindberg FP, 1996, SCIENCE, V274, P795, DOI 10.1126/science.274.5288.795; Lipska BK, 2002, J NEUROSCI, V22, P2835, DOI 10.1523/JNEUROSCI.22-07-02835.2002; Matozaki T, 2009, TRENDS CELL BIOL, V19, P72, DOI 10.1016/j.tcb.2008.12.001; Ohnishi H, 2004, J BIOL CHEM, V279, P27878, DOI 10.1074/jbc.M313085200; Ohnishi H, 2010, J NEUROSCI, V30, P10472, DOI 10.1523/JNEUROSCI.0257-10.2010; Oldenborg PA, 2000, SCIENCE, V288, P2051, DOI 10.1126/science.288.5473.2051; Peixoto RT, 2012, NEURON, V76, P396, DOI 10.1016/j.neuron.2012.07.006; Pfeiffer BE, 2010, NEURON, V66, P191, DOI 10.1016/j.neuron.2010.03.017; Reiss K, 2009, SEMIN CELL DEV BIOL, V20, P126, DOI 10.1016/j.semcdb.2008.11.002; Sanes JR, 1999, ANNU REV NEUROSCI, V22, P389, DOI 10.1146/annurev.neuro.22.1.389; SCHAERENWIEMERS N, 1993, HISTOCHEMISTRY, V100, P431, DOI 10.1007/BF00267823; Shen K, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001842; Siddiqui TJ, 2011, CURR OPIN NEUROBIOL, V21, P132, DOI 10.1016/j.conb.2010.08.016; STEWARD O, 1991, J COMP NEUROL, V314, P545, DOI 10.1002/cne.903140311; Suzuki K, 2012, NEURON, V76, P410, DOI 10.1016/j.neuron.2012.10.003; Terauchi A, 2010, NATURE, V465, P783, DOI 10.1038/nature09041; Tessier CR, 2009, FRONT MOL NEUROSCI, V2, DOI 10.3389/neuro.02.008.2009; Uesaka T, 2007, DEVELOPMENT, V134, P2171, DOI 10.1242/dev.001388; Umemori H, 2004, CELL, V118, P257, DOI 10.1016/j.cell.2004.06.025; Umemori H, 2008, J BIOL CHEM, V283, P34053, DOI 10.1074/jbc.M805729200; van Beek EM, 2005, J IMMUNOL, V175, P7781, DOI 10.4049/jimmunol.175.12.7781; Waites CL, 2005, ANNU REV NEUROSCI, V28, P251, DOI 10.1146/annurev.neuro.27.070203.144336; Wang XXX, 2006, J CELL SCI, V119, P172, DOI 10.1242/jcs.02710; Wayman GA, 2008, NEURON, V59, P914, DOI 10.1016/j.neuron.2008.08.021; Williams ME, 2010, NEURON, V68, P9, DOI 10.1016/j.neuron.2010.09.007; WOODHAMS PL, 1989, J NEUROSCI, V9, P2170; Yasuda M, 2011, NEURON, V70, P1128, DOI 10.1016/j.neuron.2011.04.027; Zhang LI, 2001, NAT NEUROSCI, V4, P1207, DOI 10.1038/nn753	49	37	38	1	22	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	OCT	2013	16	10					1417	+		10.1038/nn.3516	http://dx.doi.org/10.1038/nn.3516			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	223HM	24036914	Green Accepted			2022-12-28	WOS:000324795300014
J	Pouget, A; Beck, JM; Ma, WJ; Latham, PE				Pouget, Alexandre; Beck, Jeffrey M.; Ma, Wei Ji; Latham, Peter E.			Probabilistic brains: knowns and unknowns	NATURE NEUROSCIENCE			English	Review							NEURAL IMPLEMENTATION; BAYESIAN-INFERENCE; POPULATION CODES; INTEGRATION; INFORMATION; MODEL; REPRESENTATION; ORIENTATION; COMPUTATION; RESPONSES	There is strong behavioral and physiological evidence that the brain both represents probability distributions and performs probabilistic inference. Computational neuroscientists have started to shed light on how these probabilistic representations and computations might be implemented in neural circuits. One particularly appealing aspect of these theories is their generality: they can be used to model a wide range of tasks, from sensory processing to high-level cognition. To date, however, these theories have only been applied to very simple tasks. Here we discuss the challenges that will emerge as researchers start focusing their efforts on real-life computations, with a focus on probabilistic learning, structural learning and approximate inference.	[Pouget, Alexandre; Beck, Jeffrey M.] Univ Rochester, Dept Brain & Cognit Sci, Rochester, NY 14627 USA; [Pouget, Alexandre] Univ Geneva, Dept Basic Neurosci, Geneva, Switzerland; [Pouget, Alexandre; Latham, Peter E.] UCL, Gatsby Computat Neurosci Unit, London, England; [Ma, Wei Ji] Baylor Coll Med, Dept Neurosci, Houston, TX 77030 USA	University of Rochester; University of Geneva; University of London; University College London; Baylor College of Medicine	Pouget, A (corresponding author), Univ Rochester, Dept Brain & Cognit Sci, Rochester, NY 14627 USA.	alexandre.pouget@unige.ch		Pouget, Alexandre/0000-0003-3054-6365; Ma, Wei Ji/0000-0002-9835-9083	Gatsby Charitable Foundation; National Eye Institute grant [R01EY020958-01]; National Science Foundation [IIS-1132009, BCS0446730]; Army Research Office grant [W911NF-12-1-0262]; Multi-University Research Initiative grant [N00014-07-1-0937]; National Institute on Drug Abuse [BCS0346785]; Swiss National Fund [31003A 143707]; James S. McDonnell Foundation; NATIONAL EYE INSTITUTE [R01EY020958] Funding Source: NIH RePORTER	Gatsby Charitable Foundation; National Eye Institute grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); National Science Foundation(National Science Foundation (NSF)); Army Research Office grant; Multi-University Research Initiative grant; National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); Swiss National Fund(Swiss National Science Foundation (SNSF)); James S. McDonnell Foundation; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	P.E.L. is supported by the Gatsby Charitable Foundation, W.J.M. by National Eye Institute grant R01EY020958-01, National Science Foundation grant IIS-1132009 (Collaborative Research in Computational Neuroscience), and Army Research Office grant W911NF-12-1-0262, and A.P. by National Science Foundation grant #BCS0446730, Multi-University Research Initiative grant #N00014-07-1-0937, National Institute on Drug Abuse grants #BCS0346785, the Swiss National Fund (31003A 143707) and a research grant from the James S. McDonnell Foundation.	Achler T, 2008, FR ART INT, V171, P15; Alais D, 2004, CURR BIOL, V14, P257, DOI 10.1016/j.cub.2004.01.029; Anastasio TJ, 2000, NEURAL COMPUT, V12, P1165, DOI 10.1162/089976600300015547; ANDERSON CH, 1994, COMPUTATIONAL INTELL, P213; Anderson JS, 2000, SCIENCE, V290, P1968, DOI 10.1126/science.290.5498.1968; [Anonymous], 2003, NEURAL ENG COMPUTATI; [Anonymous], 1993, THEORY PROBABILITY C; Ballard DH, 1997, BEHAV BRAIN SCI, V20, P723, DOI 10.1017/S0140525X97001611; Barber MJ, 2003, NEURAL COMPUT, V15, P1843, DOI 10.1162/08997660360675062; BARLOW HB, 1969, ANN NY ACAD SCI, V156, P872, DOI 10.1111/j.1749-6632.1969.tb14019.x; Bayes T., 1764, PHILOS T ROY SOC LON, V53, P370, DOI [10.1098/rstl.1763.0053, DOI 10.1098/RSTL.1763.0053]; Beck J., 2012, ADV NEURAL INFORM PR, V25, P3059; Beck JM, 2007, NEURAL COMPUT, V19, P1344, DOI 10.1162/neco.2007.19.5.1344; Beck JM, 2012, NEURON, V74, P30, DOI 10.1016/j.neuron.2012.03.016; Beck JM, 2011, J NEUROSCI, V31, P15310, DOI 10.1523/JNEUROSCI.1706-11.2011; Beck JM, 2008, NEURON, V60, P1142, DOI 10.1016/j.neuron.2008.09.021; Berens P, 2012, J NEUROSCI, V32, P10618, DOI 10.1523/JNEUROSCI.1335-12.2012; Bishop Christopher M., 2006, PATTERN RECOGNITION; Bogacz R, 2007, NEURAL COMPUT, V19, P442, DOI 10.1162/neco.2007.19.2.442; Bohte SM, 2007, NEURAL COMPUT, V19, P371, DOI 10.1162/neco.2007.19.2.371; Bowers JS, 2012, PSYCHOL BULL, V138, P389, DOI 10.1037/a0026450; Braun DA, 2010, BEHAV BRAIN RES, V206, P157, DOI 10.1016/j.bbr.2009.08.031; Chater N, 2006, TRENDS COGN SCI, V10, P287, DOI 10.1016/j.tics.2006.05.007; Chomsky Noam., 1965, ASPECTS THEORY SYNTA; Churchland AK, 2011, NEURON, V69, P818, DOI 10.1016/j.neuron.2010.12.037; Collins A, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001293; Deneve S, 1999, NAT NEUROSCI, V2, P740, DOI 10.1038/11205; Deneve S, 2001, NAT NEUROSCI, V4, P826, DOI 10.1038/90541; Deneve S, 2007, J NEUROSCI, V27, P5744, DOI 10.1523/JNEUROSCI.3985-06.2007; Ernst MO, 2002, NATURE, V415, P429, DOI 10.1038/415429a; Fajen BR, 2007, EXP BRAIN RES, V180, P303, DOI 10.1007/s00221-007-0859-6; Fetsch CR, 2012, NAT NEUROSCI, V15, P146, DOI 10.1038/nn.2983; Fiser J, 2010, TRENDS COGN SCI, V14, P119, DOI 10.1016/j.tics.2010.01.003; FOLDIAK P, 1993, COMPUTATION AND NEURAL SYSTEMS, P55; Gallistel C., 2009, MEMORY COMPUTATIONAL, DOI 10.1002/9781444310498; Gold JI, 2001, TRENDS COGN SCI, V5, P10, DOI 10.1016/S1364-6613(00)01567-9; Gopnik A, 2004, PSYCHOL REV, V111, P3, DOI 10.1037/0033-295X.111.1.3; Graf ABA, 2011, NAT NEUROSCI, V14, P239, DOI 10.1038/nn.2733; Griffiths TL, 2012, PSYCHOL BULL, V138, P415, DOI 10.1037/a0026884; Holtmaat A, 2006, NATURE, V441, P979, DOI 10.1038/nature04783; Hoyer PO, 2003, ADV NEURAL INFORM PR, V15, P293; Hsu AS, 2011, COGNITION, V120, P380, DOI 10.1016/j.cognition.2011.02.013; Huys QJM, 2007, NEURAL COMPUT, V19, P404, DOI 10.1162/neco.2007.19.2.404; Isope P, 2002, J NEUROSCI, V22, P9668; Jacobs RA, 1999, VISION RES, V39, P3621, DOI 10.1016/S0042-6989(99)00088-7; Jazayeri M, 2006, NAT NEUROSCI, V9, P690, DOI 10.1038/nn1691; Jurafsky D, 1996, COGNITIVE SCI, V20, P137, DOI 10.1207/s15516709cog2002_1; Kappen HJ, 2012, MACH LEARN, V87, P159, DOI 10.1007/s10994-012-5278-7; Kemp C, 2008, P NATL ACAD SCI USA, V105, P10687, DOI 10.1073/pnas.0802631105; Knill DC, 2004, TRENDS NEUROSCI, V27, P712, DOI 10.1016/j.tins.2004.10.007; Knill DC, 1998, VISION RES, V38, P1655, DOI 10.1016/S0042-6989(97)00324-6; Knill DC, 1996, PERCEPTION BAYESIAN; Koechlin E, 1999, BIOL CYBERN, V80, P25, DOI 10.1007/s004220050502; Kording KP, 2004, NATURE, V427, P244, DOI 10.1038/nature02169; Krajbich I, 2010, NAT NEUROSCI, V13, P1292, DOI 10.1038/nn.2635; Laplace P.-S., 1812, THEORIE ANAL PROBABI; Lee TS, 2003, J OPT SOC AM A, V20, P1434, DOI 10.1364/JOSAA.20.001434; Ma WJ, 2006, NAT NEUROSCI, V9, P1432, DOI 10.1038/nn1790; Ma WJ, 2011, NAT NEUROSCI, V14, P783, DOI 10.1038/nn.2814; Mach E, 1897, CONTRIBUTIONS ANAL S, P63; MacKay D. J. C., 2003, INFORM THEORY INFERE; MACKAY DJC, 1992, NEURAL COMPUT, V4, P415, DOI 10.1162/neco.1992.4.3.448; Mazurek ME, 2003, CEREB CORTEX, V13, P1257, DOI 10.1093/cercor/bhg097; Moreno-Bote R, 2011, P NATL ACAD SCI USA, V108, P12491, DOI 10.1073/pnas.1101430108; Parra LC, 2009, NEURAL COMPUT, V21, P2991, DOI 10.1162/neco.2009.04-06-184; Paulin MG, 2005, J NEURAL ENG, V2, DOI 10.1088/1741-2560/2/3/S06; Plate TA, 2003, HOLOGRAPHIC REDUCED; POGGIO T, 1990, COLD SPRING HARB SYM, V55, P899; POGGIO T, 1990, NATURE, V343, P263, DOI 10.1038/343263a0; Quartz SR, 1997, BEHAV BRAIN SCI, V20, P537; Rao RPN, 2004, NEURAL COMPUT, V16, P1, DOI 10.1162/08997660460733976; Ratcliff R, 1998, PSYCHOL SCI, V9, P347, DOI 10.1111/1467-9280.00067; Sanger TD, 1996, J NEUROPHYSIOL, V76, P2790, DOI 10.1152/jn.1996.76.4.2790; Simard Patrice Y., 2012, Neural Networks: Tricks of the Trade. Second Edition: LNCS 7700, P235, DOI 10.1007/978-3-642-35289-8_17; Stewart T., 2011, OXFORD HDB COMPOSITI; Steyvers M, 2006, TRENDS COGN SCI, V10, P327, DOI 10.1016/j.tics.2006.05.005; Stigler Stephen M., 1980, SCI SOCIAL STRUCTURE, P147, DOI [10.1111/j.2164-0947.1980.tb02775.x, DOI 10.1111/J.2164-0947.1980.TB02775.X]; Tenenbaum J. B., 2003, ADV NEURAL INFORM PR, V15, P35; Tenenbaum JB, 2006, TRENDS COGN SCI, V10, P309, DOI 10.1016/j.tics.2006.05.009; Tenenbaum JB, 2011, SCIENCE, V331, P1279, DOI 10.1126/science.1192788; Todd P.M., 1999, SIMPLE HEURISTICS MA; Todorov E, 2004, NAT NEUROSCI, V7, P907, DOI 10.1038/nn1309; Todorov E, 2008, IEEE DECIS CONTR P, P4286, DOI 10.1109/CDC.2008.4739438; Toyoizumi T, 2005, P NATL ACAD SCI USA, V102, P5239, DOI 10.1073/pnas.0500495102; van Beers RJ, 1999, J NEUROPHYSIOL, V81, P1355, DOI 10.1152/jn.1999.81.3.1355; Van Horn KS, 2003, INT J APPROX REASON, V34, P3, DOI 10.1016/S0888-613X(03)00051-3; vanBeers RJ, 1996, EXP BRAIN RES, V111, P253, DOI 10.1007/BF00227302; von Helmholtz H, 1891, Z PSYCHOL PHYSL SINN, V2, P1; WOLPERT DM, 1995, SCIENCE, V269, P1880, DOI 10.1126/science.7569931; Zemel RS, 1998, NEURAL COMPUT, V10, P403, DOI 10.1162/089976698300017818	92	305	305	4	117	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	SEP	2013	16	9					1170	1178		10.1038/nn.3495	http://dx.doi.org/10.1038/nn.3495			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	207KN	23955561	Green Accepted			2022-12-28	WOS:000323597500005
J	Studniarczyk, D; Coombs, I; Cull-Candy, SG; Farrant, M				Studniarczyk, Dorota; Coombs, Ian; Cull-Candy, Stuart G.; Farrant, Mark			TARP gamma-7 selectively enhances synaptic expression of calcium-permeable AMPARs	NATURE NEUROSCIENCE			English	Article							2 DISTINCT MECHANISMS; RECEPTOR SUBUNIT; GLUTAMATE RECEPTORS; AUXILIARY SUBUNITS; CA2+ PERMEABILITY; MOUSE STARGAZER; MESSENGER-RNAS; PLASTICITY; TRAFFICKING; CHANNELS	Regulation of calcium-permeable AMPA receptors (CP-AMPARs) is crucial in normal synaptic function and neurological disease states. Although transmembrane AMPAR regulatory proteins (TARPs) such as stargazin (gamma-2) modulate the properties of calciumimpermeable AMPARs (CI-AMPARs) and promote their synaptic targeting, the TARP-specific rules governing CP-AMPAR synaptic trafficking remain unclear. We used RNA interference to manipulate AMPAR-subunit and TARP expression in gamma-2-lacking stargazer cerebellar granule cells-the classic model of TARP deficiency. We found that TARP gamma-7 selectively enhanced the synaptic expression of CP-AMPARs and suppressed CI-AMPARs, identifying a pivotal role of gamma-7 in regulating the prevalence of CP-AMPARs. In the absence of associated TARPs, both CP-AMPARs and CI-AMPARs were able to localize to synapses and mediate transmission, although their properties were altered. Our results also establish that TARPed synaptic receptors in granule cells require both gamma-2 and gamma-7 and reveal an unexpected basis for the loss of AMPAR-mediated transmission in stargazer mice.	[Studniarczyk, Dorota; Coombs, Ian; Cull-Candy, Stuart G.; Farrant, Mark] UCL, Dept Neurosci Physiol & Pharmacol, London, England	University of London; University College London	Farrant, M (corresponding author), UCL, Dept Neurosci Physiol & Pharmacol, London, England.	s.cull-candy@ucl.ac.uk; m.farrant@ucl.ac.uk		Cull-Candy, Stuart G/0000-0002-0831-8326; Coombs, Ian/0000-0003-1006-7471; Studniarczyk, Dorota/0000-0003-4109-7956; Farrant, Mark/0000-0002-9918-0376	Wellcome Trust; Medical Research Council; MRC [MR/J002976/1] Funding Source: UKRI; Medical Research Council [MR/J002976/1] Funding Source: researchfish	Wellcome Trust(Wellcome Trust); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by Programme Grants from the Wellcome Trust and the Medical Research Council (S.G.C.-C. and M. F.). We thank M. Watanabe for antibodies against gamma-2 and gamma-7, R. Nicoll for TARP gamma-2 cDNA, C. Bats for invaluable discussions and M. Zonouzi and M. Watanabe for advice on coimmunoprecipitation.	Bats C, 2007, NEURON, V53, P719, DOI 10.1016/j.neuron.2007.01.030; Bats C, 2012, NAT NEUROSCI, V15, P853, DOI 10.1038/nn.3107; Bedoukian MA, 2006, J BIOL CHEM, V281, P23908, DOI 10.1074/jbc.M600679200; BLASCHKE M, 1993, P NATL ACAD SCI USA, V90, P6528, DOI 10.1073/pnas.90.14.6528; Bowie D, 1998, J NEUROSCI, V18, P8175; BURNASHEV N, 1992, NEURON, V8, P189, DOI 10.1016/0896-6273(92)90120-3; Cathala L, 2005, NAT NEUROSCI, V8, P1310, DOI 10.1038/nn1534; Chen L, 2000, NATURE, V408, P936, DOI 10.1038/35050030; Cho CH, 2007, NEURON, V55, P890, DOI 10.1016/j.neuron.2007.08.024; Chung CH, 2008, J NEUROPHYSIOL, V100, P2089, DOI 10.1152/jn.90404.2008; Cull-Candy S, 2006, CURR OPIN NEUROBIOL, V16, P288, DOI 10.1016/j.conb.2006.05.012; Ferron L, 2008, J NEUROSCI, V28, P10604, DOI 10.1523/JNEUROSCI.2709-08.2008; Fukaya M, 2005, NEUROSCI RES, V53, P376, DOI 10.1016/j.neures.2005.08.009; GALLO V, 1992, J NEUROSCI, V12, P1010; Gangadharan V, 2011, J CLIN INVEST, V121, P1608, DOI 10.1172/JCI44911; Gardner SM, 2005, NEURON, V45, P903, DOI 10.1016/j.neuron.2005.02.026; GEIGER JRP, 1995, NEURON, V15, P193, DOI 10.1016/0896-6273(95)90076-4; Hashimoto K, 1999, J NEUROSCI, V19, P6027, DOI 10.1523/JNEUROSCI.19-14-06027.1999; HOLLMANN M, 1991, SCIENCE, V252, P851, DOI 10.1126/science.1709304; Isaac JTR, 2007, NEURON, V54, P859, DOI 10.1016/j.neuron.2007.06.001; Jackson AC, 2011, J NEUROSCI, V31, P3939, DOI 10.1523/JNEUROSCI.5134-10.2011; Kato AS, 2008, NEURON, V59, P986, DOI 10.1016/j.neuron.2008.07.034; Kato AS, 2007, J NEUROSCI, V27, P4969, DOI 10.1523/JNEUROSCI.5561-06.2007; Kim KS, 2010, J NEUROSCI, V30, P1064, DOI 10.1523/JNEUROSCI.3909-09.2010; Koike M, 1997, NEUROSCI RES, V29, P27, DOI 10.1016/S0168-0102(97)00067-9; Kott S, 2009, NEUROSCIENCE, V158, P78, DOI 10.1016/j.neuroscience.2007.12.047; Kudoh SN, 2002, BIOSENS BIOELECTRON, V17, P773, DOI 10.1016/S0956-5663(02)00053-2; Kunert R, 2005, P NATL ACAD SCI USA, V102, P5826, DOI 10.1073/pnas.0501316102; Letts VA, 1998, NAT GENET, V19, P340, DOI 10.1038/1228; Liu BS, 2006, J NEUROSCI, V26, P5309, DOI 10.1523/JNEUROSCI.0567-06.2006; Liu SJ, 2007, TRENDS NEUROSCI, V30, P126, DOI 10.1016/j.tins.2007.01.006; Liu SQJ, 2000, NATURE, V405, P454, DOI 10.1038/35013064; Maechler M., 2012, CLUSTER ANAL BASICS; Man HY, 2011, CURR OPIN NEUROBIOL, V21, P291, DOI 10.1016/j.conb.2011.01.001; Menuz K, 2008, J NEUROSCI, V28, P8740, DOI 10.1523/JNEUROSCI.1319-08.2008; MOSBACHER J, 1994, SCIENCE, V266, P1059, DOI 10.1126/science.7973663; Park JS, 2009, J NEUROSCI, V29, P3206, DOI 10.1523/JNEUROSCI.4514-08.2009; Passafaro M, 2003, NATURE, V424, P677, DOI 10.1038/nature01781; Priel A, 2005, J NEUROSCI, V25, P2682, DOI 10.1523/JNEUROSCI.4834-04.2005; Rosenthal JJC, 2012, NEURON, V74, P432, DOI 10.1016/j.neuron.2012.04.010; Rouach N, 2005, NAT NEUROSCI, V8, P1525, DOI 10.1038/nn1551; Rozov A, 1999, NATURE, V401, P594, DOI 10.1038/44151; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Schwenk J, 2009, SCIENCE, V323, P1313, DOI 10.1126/science.1167852; Shi Y, 2010, P NATL ACAD SCI USA, V107, P16315, DOI 10.1073/pnas.1011706107; Shi Y, 2009, NEURON, V62, P633, DOI 10.1016/j.neuron.2009.05.016; SOMMER B, 1991, CELL, V67, P11, DOI 10.1016/0092-8674(91)90568-J; Soto D, 2007, NAT NEUROSCI, V10, P1260, DOI 10.1038/nn1966; Soto D, 2009, NAT NEUROSCI, V12, P277, DOI 10.1038/nn.2266; Tomita S, 2005, NATURE, V435, P1052, DOI 10.1038/nature03624; Tomita S, 2003, J CELL BIOL, V161, P805, DOI 10.1083/jcb.200212116; TRAYNELIS SF, 1993, NEURON, V11, P279, DOI 10.1016/0896-6273(93)90184-S; Traynelis SF, 2010, PHARMACOL REV, V62, P405, DOI 10.1124/pr.109.002451; Turetsky D, 2005, J NEUROSCI, V25, P7438, DOI 10.1523/JNEUROSCI.1108-05.2005; Washburn MS, 1996, J PHARMACOL EXP THER, V278, P669; Wilcox R. R., 2012, INTRO ROBUST ESTIMAT; Yamazaki M, 2010, EUR J NEUROSCI, V31, P2204, DOI 10.1111/j.1460-9568.2010.07254.x; Yan D, 2012, J PHYSIOL-LONDON, V590, P21, DOI 10.1113/jphysiol.2011.213868	58	38	38	0	13	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	SEP	2013	16	9					1266	U146		10.1038/nn.3473	http://dx.doi.org/10.1038/nn.3473			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	207KN	23872597	Green Submitted, Green Accepted			2022-12-28	WOS:000323597500018
J	Gundersen, B				Gundersen, Brigitta			Pair-bonding through epigenetics	NATURE NEUROSCIENCE			English	Editorial Material														Gundersen, Brigitta/0000-0002-7801-9348					0	3	3	0	17	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JUL	2013	16	7					779	779		10.1038/nn0713-779	http://dx.doi.org/10.1038/nn0713-779			1	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	174UM	23799469	Bronze			2022-12-28	WOS:000321180900006
J	Schapiro, AC; Rogers, TT; Cordova, NI; Turk-Browne, NB; Botvinick, MM				Schapiro, Anna C.; Rogers, Timothy T.; Cordova, Natalia I.; Turk-Browne, Nicholas B.; Botvinick, Matthew M.			Neural representations of events arise from temporal community structure	NATURE NEUROSCIENCE			English	Article							SEGMENTATION; REPETITION; LANGUAGE; MODEL; INFORMATION; HIERARCHIES; PERCEPTION; CORTEX; COMMON; BRAIN	Our experience of the world seems to divide naturally into discrete, temporally extended events, yet the mechanisms underlying the learning and identification of events are poorly understood. Research on event perception has focused on transient elevations in predictive uncertainty or surprise as the primary signal driving event segmentation. We present human behavioral and functional magnetic resonance imaging (fMRI) evidence in favor of a different account, in which event representations coalesce around clusters or 'communities' of mutually predicting stimuli. Through parsing behavior, fMRI adaptation and multivoxel pattern analysis, we demonstrate the emergence of event representations in a domain containing such community structure, but in which transition probabilities (the basis of uncertainty and surprise) are uniform. We present a computational account of how the relevant representations might arise, proposing a direct connection between event learning and the learning of semantic categories.	[Schapiro, Anna C.; Cordova, Natalia I.; Turk-Browne, Nicholas B.; Botvinick, Matthew M.] Princeton Univ, Dept Psychol, Princeton, NJ 08544 USA; [Schapiro, Anna C.; Cordova, Natalia I.; Turk-Browne, Nicholas B.; Botvinick, Matthew M.] Princeton Univ, Princeton Neurosci Inst, Princeton, NJ 08544 USA; [Rogers, Timothy T.] Univ Wisconsin, Dept Psychol, Madison, WI 53706 USA	Princeton University; Princeton University; University of Wisconsin System; University of Wisconsin Madison	Schapiro, AC (corresponding author), Princeton Univ, Dept Psychol, Princeton, NJ 08544 USA.	schapiro@princeton.edu		Schapiro, Anna/0000-0001-8086-0331	John Templeton Foundation; US National Science Foundation [DGE-0646086, IIS-1207833]; US National Institutes of Health [R01-EY021755]; James S. McDonnell Foundation; NATIONAL EYE INSTITUTE [R01EY021755] Funding Source: NIH RePORTER	John Templeton Foundation; US National Science Foundation(National Science Foundation (NSF)); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); James S. McDonnell Foundation; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	We thank M. Arcaro, J. McGuire, K. Norman, F. Pereira and M. Todd for helpful discussions. This project was made possible through the support of a grant from the John Templeton Foundation. The opinions expressed in this publication are those of the authors and do not necessarily reflect the views of the John Templeton Foundation. This work was also supported by US National Science Foundation Graduate Research Fellowship DGE-0646086 to A.C.S., US National Institutes of Health grant R01-EY021755 to N.B.T.-B., and US National Science Foundation grant IIS-1207833 and a James S. McDonnell Foundation grant to M.M.B.	Addis DR, 2007, NEUROPSYCHOLOGIA, V45, P1363, DOI 10.1016/j.neuropsychologia.2006.10.016; AVRAHAMI J, 1994, COGNITION, V53, P239, DOI 10.1016/0010-0277(94)90050-7; Baird J.A., 2001, INTENTIONS INTENTION, P193; Baldwin D, 2008, COGNITION, V106, P1382, DOI 10.1016/j.cognition.2007.07.005; Bar M, 2007, HIPPOCAMPUS, V17, P420, DOI 10.1002/hipo.20287; Bornkessel I, 2005, NEUROIMAGE, V26, P221, DOI 10.1016/j.neuroimage.2005.01.032; Botvinick M, 2004, PSYCHOL REV, V111, P395, DOI 10.1037/0033-295X.111.2.395; CLEEREMANS A, 1991, J EXP PSYCHOL GEN, V120, P235, DOI 10.1037/0096-3445.120.3.235; ELMAN JL, 1990, COGNITIVE SCI, V14, P179, DOI 10.1207/s15516709cog1402_1; Ezzyat Y, 2011, PSYCHOL SCI, V22, P243, DOI 10.1177/0956797610393742; Fiser J, 2002, J EXP PSYCHOL LEARN, V28, P458, DOI 10.1037//0278-7393.28.3.458; Fortunato S, 2010, PHYS REP, V486, P75, DOI 10.1016/j.physrep.2009.11.002; Gelfand JR, 2003, NEURON, V38, P831, DOI 10.1016/S0896-6273(03)00285-X; Girvan M, 2002, P NATL ACAD SCI USA, V99, P7821, DOI 10.1073/pnas.122653799; Griffiths TL, 2007, PSYCHOL REV, V114, P211, DOI 10.1037/0033-295X.114.2.211; Grill-Spector K, 2006, TRENDS COGN SCI, V10, P14, DOI 10.1016/j.tics.2005.11.006; Homae F, 2002, NEUROIMAGE, V16, P883, DOI 10.1006/nimg.2002.1138; Howard MW, 2011, TOP COGN SCI, V3, P48, DOI 10.1111/j.1756-8765.2010.01112.x; James TW, 2006, HUM BRAIN MAPP, V27, P37, DOI 10.1002/hbm.20165; Kilner JM, 2009, J NEUROSCI, V29, P10153, DOI 10.1523/JNEUROSCI.2668-09.2009; Koechlin E, 2000, P NATL ACAD SCI USA, V97, P7651, DOI 10.1073/pnas.130177397; Krueger F, 2009, NEUROREPORT, V20, P1093, DOI 10.1097/WNR.0b013e32832e7ea5; Landauer TK, 1997, PSYCHOL REV, V104, P211, DOI 10.1037/0033-295X.104.2.211; MEDIN DL, 1978, PSYCHOL REV, V85, P207, DOI 10.1037/0033-295X.85.3.207; Moss HE, 2005, CEREB CORTEX, V15, P1723, DOI 10.1093/cercor/bhi049; Newman MEJ, 2006, P NATL ACAD SCI USA, V103, P8577, DOI 10.1073/pnas.0601602103; Newman MEJ, 2003, SIAM REV, V45, P167, DOI 10.1137/S003614450342480; NEWTSON D, 1973, J PERS SOC PSYCHOL, V28, P28, DOI 10.1037/h0035584; Pereira F, 2011, NEUROIMAGE, V56, P476, DOI 10.1016/j.neuroimage.2010.05.026; Perruchet P, 2002, Q J EXP PSYCHOL-A, V55, P485, DOI 10.1080/02724980143000451; Perruchet P, 1998, J MEM LANG, V39, P246, DOI 10.1006/jmla.1998.2576; Petersson KM, 2004, COGNITIVE SCI, V28, P383, DOI 10.1016/j.cogsci.2003.12.003; Pothos EM, 2007, PSYCHOL BULL, V133, P227, DOI 10.1037/0033-2909.133.2.227; Press C, 2012, NEUROIMAGE, V60, P1671, DOI 10.1016/j.neuroimage.2012.01.118; Remillard G, 2010, MEM COGNITION, V38, P905, DOI 10.3758/MC.38.7.905; Reynolds JR, 2007, COGNITIVE SCI, V31, P613, DOI 10.1080/15326900701399913; Rogers T. T., 2004, SEMANTIC COGNITION P; ROSCH E, 1975, COGNITIVE PSYCHOL, V7, P573, DOI 10.1016/0010-0285(75)90024-9; Rosvall M, 2008, P NATL ACAD SCI USA, V105, P1118, DOI 10.1073/pnas.0706851105; Saffran JR, 1996, SCIENCE, V274, P1926, DOI 10.1126/science.274.5294.1926; Schapiro AC, 2012, CURR BIOL, V22, P1622, DOI 10.1016/j.cub.2012.06.056; Speer NK, 2003, COGN AFFECT BEHAV NE, V3, P335, DOI 10.3758/CABN.3.4.335; Sridharan D, 2007, NEURON, V55, P521, DOI 10.1016/j.neuron.2007.07.003; Thompson-Schill SL, 2003, NEUROPSYCHOLOGIA, V41, P280, DOI 10.1016/S0028-3932(02)00161-6; Turk-Browne NB, 2007, CEREB CORTEX, V17, P425, DOI 10.1093/cercor/bhj159; Turk-Browne NB, 2008, FRONT HUM NEUROSCI, V2, DOI 10.3389/neuro.09.016.2008; Ueno T, 2011, NEURON, V72, P385, DOI 10.1016/j.neuron.2011.09.013; Vandenberghe R, 1996, NATURE, V383, P254, DOI 10.1038/383254a0; Wood JN, 2005, CEREB CORTEX, V15, P1155, DOI 10.1093/cercor/bhh215; Zacks JM, 2011, J COGNITIVE NEUROSCI, V23, P4057, DOI 10.1162/jocn_a_00078; Zacks JM, 2001, NAT NEUROSCI, V4, P651, DOI 10.1038/88486	51	191	190	2	44	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	APR	2013	16	4					486	U161		10.1038/nn.3331	http://dx.doi.org/10.1038/nn.3331			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	114EM	23416451	Green Accepted			2022-12-28	WOS:000316723700020
J	Trovo, L; Ahmed, T; Callaerts-Vegh, Z; Buzzi, A; Bagni, C; Chuah, M; VandenDriessche, T; D'Hooge, R; Balschun, D; Dotti, CG				Trovo, Laura; Ahmed, Tariq; Callaerts-Vegh, Zsuzsanna; Buzzi, Andrea; Bagni, Claudia; Chuah, Marinee; VandenDriessche, Thierry; D'Hooge, Rudi; Balschun, Detlef; Dotti, Carlos G.			Low hippocampal PI(4,5)P-2 contributes to reduced cognition in old mice as a result of loss of MARCKS	NATURE NEUROSCIENCE			English	Article							PHOSPHATIDYLINOSITOL 4,5-BISPHOSPHATE; PHOSPHOLIPASE-C; NEURONAL EXCITABILITY; SYNAPTIC PLASTICITY; AKT PHOSPHORYLATION; ALZHEIMERS-DISEASE; CHOLESTEROL LOSS; MEMBRANE-LIPIDS; MUTANT MICE; HUMAN BRAIN	Cognitive and motor performances decline during aging. Although it is clear that such signs reflect synaptic compromise, the underlying mechanisms have not been defined. We found that the levels and activity of the synaptic plasticity modulators phosphatidylinositol-(4,5)-bisphosphate (PI(4,5)P-2) and phospholipase C gamma (PLC gamma) were substantially reduced in hippocampal synaptic membranes from old mice. In addition, these membranes contained reduced levels of the PI(4,5)P-2-clustering molecule myristoylated alanine-rich C kinase substrate (MARCKS). Consistent with a cause-effect relationship, raising MARCKS levels in the brain of old mice led to increased synaptic membrane clustering of PI(4,5)P-2 and to PLC gamma activation. MARCKS overexpression in the hippocampus of old mice or intraventricular perfusion of MARCKS peptide resulted in enhanced long-term potentiation and improved memory. These results reveal one of the mechanisms involved in brain dysfunction during aging.	[Trovo, Laura; Buzzi, Andrea; Bagni, Claudia; Dotti, Carlos G.] VIB Ctr Biol Dis, Louvain, Belgium; [Trovo, Laura; Buzzi, Andrea; Bagni, Claudia; Dotti, Carlos G.] Katholieke Univ Leuven, Univ Louvain, Ctr Human Genet, Louvain, Belgium; [Ahmed, Tariq; Callaerts-Vegh, Zsuzsanna; D'Hooge, Rudi; Balschun, Detlef] Univ Louvain, Fac Psychol & Educ Sci, Lab Biol Psychol, Louvain, Belgium; [Chuah, Marinee; VandenDriessche, Thierry] Free Univ Brussels, Univ Med Ctr, Fac Med & Pharm, Dept Gene Therapy & Regenerat Med, Brussels, Belgium; [Chuah, Marinee; VandenDriessche, Thierry] Univ Louvain, Dept Mol & Cellular Med, Louvain, Belgium; [Dotti, Carlos G.] Ctr Biol Mol Severo Ochoa CSIC UAM, Madrid, Spain	Flanders Institute for Biotechnology (VIB); KU Leuven; Universite Libre de Bruxelles; Vrije Universiteit Brussel; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Biologia Molecular Severo Ochoa (CBM)	Dotti, CG (corresponding author), VIB Ctr Biol Dis, Louvain, Belgium.	cdotti@cbm.uam.es	Dotti, Carlos G/I-5533-2015	Dotti, Carlos G/0000-0003-4052-1719; Vandendriessche, Thierry/0000-0003-4230-745X; Trovo, Laura/0000-0002-8227-3429; Chuah, Marinee/0000-0001-8569-0175; Ahmed, Tariq/0000-0002-0998-1103; Bagni, Claudia/0000-0002-4419-210X	Fund for Scientific Research Flanders (FWO); Federal Office for Scientific Affairs [IUAP P6/43]; Flemish Government; Belgian Government [IAP 7/16]; Spanish Ministry of Science and Innovation [CSD2010-00064, SAF2010-14906]; Katholieke University of Leuven; K.U. Leuven GOA [12/008]	Fund for Scientific Research Flanders (FWO)(FWO); Federal Office for Scientific Affairs; Flemish Government(European Commission); Belgian Government; Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Katholieke University of Leuven; K.U. Leuven GOA(KU Leuven)	We thank K. Vennekens for technical assistance and P.J. Blackshear (National Institute of Environmental Health) for the MARCKS plasmids. This research was supported by the Fund for Scientific Research Flanders (FWO), the Federal Office for Scientific Affairs (IUAP P6/43), the Flemish Government's Methusalem Grant, a NEUROBRAINNET grant from the Belgian Government (IAP 7/16), and grants from the Spanish Ministry of Science and Innovation Ingenio-Consolider (CSD2010-00064 and SAF2010-14906) to C.G.D. L.T. is the recipient of a BOF-Post Doctoral Fellowship from the Research Fund of Katholieke University of Leuven. D.B. and R.D. are supported by a K.U. Leuven GOA (12/008) grant.	Arbuzova A, 1998, BBA-REV BIOMEMBRANES, V1376, P369, DOI 10.1016/S0304-4157(98)00011-2; Berman DE, 2008, NAT NEUROSCI, V11, P547, DOI 10.1038/nn.2100; Boyl PP, 2007, EMBO J, V26, P2991, DOI 10.1038/sj.emboj.7601737; Calabrese B, 2005, NEURON, V48, P77, DOI 10.1016/j.neuron.2005.08.027; Cearley CN, 2006, MOL THER, V13, P528, DOI 10.1016/j.ymthe.2005.11.015; Cremona O, 1999, CELL, V99, P179, DOI 10.1016/S0092-8674(00)81649-9; D'Hooge R, 2001, BRAIN RES REV, V36, P60, DOI 10.1016/S0165-0173(01)00067-4; Datta SR, 1997, CELL, V91, P231, DOI 10.1016/S0092-8674(00)80405-5; Denayer E, 2008, J NEUROSCI, V28, P14443, DOI 10.1523/JNEUROSCI.4698-08.2008; Di Paolo G, 2004, NATURE, V431, P415, DOI 10.1038/nature02896; Di Paolo G, 2006, NATURE, V443, P651, DOI 10.1038/nature05185; Disterhoft JF, 2007, AGING CELL, V6, P327, DOI 10.1111/j.1474-9726.2007.00297.x; Fitzjohn SM, 2002, CELL CALCIUM, V32, P405, DOI 10.1016/S0143416002001999; Foster TC, 2007, AGING CELL, V6, P319, DOI 10.1111/j.1474-9726.2007.00283.x; Frere Samuel G, 2012, Subcell Biochem, V59, P131, DOI 10.1007/978-94-007-3015-1_5; Gartner A, 2006, J NEUROSCI, V26, P3496, DOI 10.1523/JNEUROSCI.3792-05.2006; Glaser M, 1996, J BIOL CHEM, V271, P26187, DOI 10.1074/jbc.271.42.26187; Gong LW, 2008, P NATL ACAD SCI USA, V105, P17561, DOI 10.1073/pnas.0809221105; Gray A, 2003, ANAL BIOCHEM, V313, P234, DOI 10.1016/S0003-2697(02)00607-3; Hansen SB, 2011, NATURE, V477, P495, DOI 10.1038/nature10370; Hetman M, 2000, J NEUROSCI, V20, P2567; Hof PR, 2004, TRENDS NEUROSCI, V27, P607, DOI 10.1016/j.tins.2004.07.013; Horne EA, 2007, J NEUROSCI, V27, P3523, DOI 10.1523/JNEUROSCI.4340-06.2007; Hussain RJ, 2006, HIPPOCAMPUS, V16, P495, DOI 10.1002/hipo.20177; Irie F, 2005, NAT CELL BIOL, V7, P501, DOI 10.1038/ncb1252; Kalwa H, 2011, J BIOL CHEM, V286, P2320, DOI 10.1074/jbc.M110.196022; Kim JY, 2012, EMBO J, V31, P2144, DOI 10.1038/emboj.2012.57; Koch M, 2012, BBA-MOL CELL BIOL L, V1821, P1114, DOI 10.1016/j.bbalip.2012.02.008; Landman N, 2006, P NATL ACAD SCI USA, V103, P19524, DOI 10.1073/pnas.0604954103; Laux T, 2000, J CELL BIOL, V149, P1455, DOI 10.1083/jcb.149.7.1455; Ledesma MD, 1998, P NATL ACAD SCI USA, V95, P3966, DOI 10.1073/pnas.95.7.3966; Li HM, 2008, MOL BIOL CELL, V19, P4804, DOI 10.1091/mbc.E08-03-0294; LISCOVITCH M, 1994, J BIOL CHEM, V269, P21403; Lukowski S, 1998, BIOCHEM BIOPH RES CO, V248, P278, DOI 10.1006/bbrc.1998.8942; Martin MG, 2008, MOL BIOL CELL, V19, P2101, DOI 10.1091/mbc.E07-09-0897; McLaughlin S, 2005, NATURE, V438, P605, DOI 10.1038/nature04398; McNamara RK, 1998, P NATL ACAD SCI USA, V95, P14517, DOI 10.1073/pnas.95.24.14517; Morrison JH, 1997, SCIENCE, V278, P412, DOI 10.1126/science.278.5337.412; Morrison JH, 2012, NAT REV NEUROSCI, V13, P240, DOI 10.1038/nrn3200; Murray CA, 1998, J NEUROSCI, V18, P2974; Napoli I, 2008, CELL, V134, P1042, DOI 10.1016/j.cell.2008.07.031; Noshita N, 2002, NEUROBIOL DIS, V9, P294, DOI 10.1006/nbdi.2002.0482; Palmer MJ, 1997, NEUROPHARMACOLOGY, V36, P1517, DOI 10.1016/S0028-3908(97)00181-0; Pike LJ, 1998, J BIOL CHEM, V273, P22298, DOI 10.1074/jbc.273.35.22298; Radulovic J, 1998, BEHAV BRAIN RES, V95, P179, DOI 10.1016/S0166-4328(98)00039-4; Rhee SG, 2001, ANNU REV BIOCHEM, V70, P281, DOI 10.1146/annurev.biochem.70.1.281; Rivera GM, 2009, MOL CELL, V36, P525, DOI 10.1016/j.molcel.2009.10.025; Sodero AO, 2012, EMBO J, V31, P1764, DOI 10.1038/emboj.2012.31; Spizz G, 2001, J BIOL CHEM, V276, P32264, DOI 10.1074/jbc.M103960200; SVENNERHOLM L, 1994, J NEUROCHEM, V63, P1802; SVENNERHOLM L, 1991, J NEUROCHEM, V56, P2051, DOI 10.1111/j.1471-4159.1991.tb03466.x; Svennerholm L, 1997, ACTA NEUROPATHOL, V94, P345, DOI 10.1007/s004010050717; Thelen KM, 2006, NEUROSCI LETT, V403, P15, DOI 10.1016/j.neulet.2006.04.034; Thibault O, 2007, AGING CELL, V6, P307, DOI 10.1111/j.1474-9726.2007.00295.x; Trovo L, 2011, J CELL SCI, V124, P1308, DOI 10.1242/jcs.078766; West AE, 2001, P NATL ACAD SCI USA, V98, P11024, DOI 10.1073/pnas.191352298; Yamaguchi H, 2009, J CELL PHYSIOL, V220, P748, DOI 10.1002/jcp.21822	57	45	47	0	25	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	APR	2013	16	4					449	U114		10.1038/nn.3342	http://dx.doi.org/10.1038/nn.3342			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	114EM	23434911				2022-12-28	WOS:000316723700015
J	Noudoost, B; Moore, T				Noudoost, Behrad; Moore, Tirin			Parietal and prefrontal neurons driven to distraction	NATURE NEUROSCIENCE			English	Editorial Material							ATTENTION; CORTEX; MEMORY; DOPAMINE; DISORDER; SIGNALS	The ability to filter out distracting sensory information is crucial to adaptive behavior. A primate study finds that prefrontal cortex is more important than parietal cortex in that function.	[Noudoost, Behrad] Stanford Univ, Sch Med, Dept Neurobiol, Stanford, CA 94305 USA; Stanford Univ, Sch Med, Howard Hughes Med Inst, Stanford, CA 94305 USA	Stanford University; Howard Hughes Medical Institute; Stanford University	Noudoost, B (corresponding author), Stanford Univ, Sch Med, Dept Neurobiol, Stanford, CA 94305 USA.	tirin@stanford.edu			Howard Hughes Medical Institute Funding Source: Medline	Howard Hughes Medical Institute(Howard Hughes Medical Institute)		Armstrong KM, 2009, J NEUROSCI, V29, P15621, DOI 10.1523/JNEUROSCI.4465-09.2009; Barkley RA, 2002, J CLIN PSYCHIAT, V63, P10; FUSTER JM, 1971, SCIENCE, V173, P652, DOI 10.1126/science.173.3997.652; Gerbella M, 2010, CEREB CORTEX, V20, P141, DOI 10.1093/cercor/bhp087; GOLDMANRAKIC PS, 1995, NEURON, V14, P477, DOI 10.1016/0896-6273(95)90304-6; Liu YQ, 2010, NAT NEUROSCI, V13, P495, DOI 10.1038/nn.2496; Miller EK, 2001, ANNU REV NEUROSCI, V24, P167, DOI 10.1146/annurev.neuro.24.1.167; Monosov IE, 2009, J NEUROPHYSIOL, V102, P3656, DOI 10.1152/jn.00750.2009; Moore T, 2003, NATURE, V421, P370, DOI 10.1038/nature01341; Noudoost B, 2011, NATURE, V474, P372, DOI 10.1038/nature09995; Noudoost B, 2010, CURR OPIN NEUROBIOL, V20, P183, DOI 10.1016/j.conb.2010.02.003; Stevens AA, 2012, J INT NEUROPSYCH SOC, V18, P511, DOI 10.1017/S1355617712000033; Suzuki M, 2013, NAT NEUROSCI, V16, P98, DOI 10.1038/nn.3282; WILLIAMS GV, 1995, NATURE, V376, P572, DOI 10.1038/376572a0	14	0	0	0	23	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JAN	2013	16	1					8	9		10.1038/nn.3291	http://dx.doi.org/10.1038/nn.3291			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	058KZ	23257928				2022-12-28	WOS:000312633900005
J	Bogdan, R; Hariri, AR				Bogdan, Ryan; Hariri, Ahmad R.			Neural embedding of stress reactivity	NATURE NEUROSCIENCE			English	Editorial Material							MEDIAL PREFRONTAL CORTEX; ESTROGEN-RECEPTOR-ALPHA; AMYGDALA; HIPPOCAMPUS; BRAIN		[Bogdan, Ryan] Washington Univ, Dept Psychol, St Louis, MO 63130 USA; [Hariri, Ahmad R.] Duke Univ, Inst Genome Sci & Policy, Dept Psychol & Neurosci, Durham, NC USA	Washington University (WUSTL); Duke University	Bogdan, R (corresponding author), Washington Univ, Dept Psychol, St Louis, MO 63130 USA.	rbogdan@artsci.wustl.edu; ahmad.hariri@duke.edu	Hariri, Ahmad/D-5761-2011	Bogdan, Ryan/0000-0002-1430-1045	NIDA NIH HHS [R01 DA033369] Funding Source: Medline; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA033369] Funding Source: NIH RePORTER	NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)		Burghy CA, 2012, NAT NEUROSCI, V15, P1736, DOI 10.1038/nn.3257; Czeh B, 2008, BEHAV BRAIN RES, V190, P1, DOI 10.1016/j.bbr.2008.02.031; Edelmann MN, 2011, BRAIN BEHAV IMMUN, V25, P1299, DOI 10.1016/j.bbi.2011.02.009; Giedd JN, 1996, J COMP NEUROL, V366, P223, DOI 10.1002/(SICI)1096-9861(19960304)366:2<223::AID-CNE3>3.0.CO;2-7; Green JG, 2010, ARCH GEN PSYCHIAT, V67, P113, DOI 10.1001/archgenpsychiatry.2009.186; Johnstone T, 2007, J NEUROSCI, V27, P8877, DOI 10.1523/JNEUROSCI.2063-07.2007; Kim MJ, 2011, BEHAV BRAIN RES, V223, P403, DOI 10.1016/j.bbr.2011.04.025; McEwen BS, 2010, ANN NY ACAD SCI, V1186, P190, DOI 10.1111/j.1749-6632.2009.05331.x; Oyola MG, 2012, ENDOCRINOLOGY, V153, P837, DOI 10.1210/en.2011-1674; Raichle ME, 2009, J NEUROSCI, V29, P12729, DOI 10.1523/JNEUROSCI.4366-09.2009; Spiteri T, 2010, BEHAV BRAIN RES, V210, P211, DOI 10.1016/j.bbr.2010.02.033; Tottenham N, 2010, FRONT HUM NEUROSCI, V3, DOI 10.3389/neuro.09.068.2009; Urry HL, 2006, J NEUROSCI, V26, P4415, DOI 10.1523/JNEUROSCI.3215-05.2006; Weaver ICG, 2004, NAT NEUROSCI, V7, P847, DOI 10.1038/nn1276; Zeidan MA, 2011, BIOL PSYCHIAT, V70, P920, DOI 10.1016/j.biopsych.2011.05.016	15	16	16	0	24	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	DEC	2012	15	12					1605	1607		10.1038/nn.3270	http://dx.doi.org/10.1038/nn.3270			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	045OR	23187689	Green Accepted			2022-12-28	WOS:000311706700001
J	Kheirbek, MA; Klemenhagen, KC; Sahay, A; Hen, R				Kheirbek, Mazen A.; Klemenhagen, Kristen C.; Sahay, Amar; Hen, Rene			Neurogenesis and generalization: a new approach to stratify and treat anxiety disorders	NATURE NEUROSCIENCE			English	Review							ADULT HIPPOCAMPAL NEUROGENESIS; POSTTRAUMATIC-STRESS-DISORDER; ENHANCED SYNAPTIC PLASTICITY; LEARNING-THEORY PERSPECTIVE; SPATIAL-PATTERN SEPARATION; IDENTICAL-TWINS DISCORDANT; NEWLY GENERATED NEURONS; DENTATE GYRUS; GRANULE CELLS; VENTRAL HIPPOCAMPUS	Although an influence of adult neurogenesis in mediating some of the effects of antidepressants has received considerable attention in recent years, much less is known about how alterations in this form of plasticity may contribute to psychiatric disorders such as anxiety and depression. One way to begin to address this question is to link the functions of adult-born hippocampal neurons with specific endophenotypes of these disorders. Recent studies have implicated adult-born hippocampal neurons in pattern separation, a process by which similar experiences or events are transformed into discrete, non-overlapping representations. Here we propose that impaired pattern separation underlies the overgeneralization often seen in anxiety disorders, specifically post-traumatic stress disorder and panic disorder, and therefore represents an endophenotype for these disorders. The development of new, pro-neurogenic compounds may therefore have therapeutic potential for patients who display pattern separation deficits.	[Kheirbek, Mazen A.; Hen, Rene] Columbia Univ, Dept Neurosci, New York, NY 10027 USA; [Kheirbek, Mazen A.; Hen, Rene] Columbia Univ, Dept Psychiat, New York, NY USA; [Kheirbek, Mazen A.; Hen, Rene] New York State Psychiat Inst & Hosp, Div Integrat Neurosci, New York, NY 10032 USA; [Klemenhagen, Kristen C.] Washington Univ, Sch Med, Dept Neurol, St Louis, MO 63110 USA; [Sahay, Amar] Massachusetts Gen Hosp, Ctr Regenerat Med, Boston, MA 02114 USA; [Sahay, Amar] Massachusetts Gen Hosp, Dept Psychiat, Boston, MA 02114 USA; [Sahay, Amar] Harvard Stem Cell Inst, Boston, MA USA; [Sahay, Amar] Harvard Univ, Sch Med, Boston, MA USA; [Hen, Rene] Columbia Univ, Dept Pharmacol, New York, NY USA	Columbia University; Columbia University; New York State Psychiatry Institute; Washington University (WUSTL); Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard University; Harvard Medical School; Columbia University	Hen, R (corresponding author), Columbia Univ, Dept Neurosci, New York, NY 10027 USA.	sahay.amar@mgh.harvard.edu; rh95@columbia.edu	Sahay, Amar/J-3696-2014; Kheirbek, Mazen A/J-3656-2015	Kheirbek, Mazen A/0000-0001-9157-7363	US National Institute of Mental Health [1F32MH092101-01A1, 1K01MH099371-01, 4R00MH086615-03]; Sackler Institute Award; NARSAD Young Investigator Award; Ellison Medical Foundation New Scholar in Aging; Whitehall Foundation; NARSAD; New York Stem Cell Initiative; US National Institutes of Health [R01 MH068542]; Hope for Depression Research Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH [R00MH086615, F32MH092101, R37MH068542, R01MH068542, K01MH099371] Funding Source: NIH RePORTER	US National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Sackler Institute Award; NARSAD Young Investigator Award(NARSAD); Ellison Medical Foundation New Scholar in Aging(Lawrence Ellison Foundation); Whitehall Foundation; NARSAD(NARSAD); New York Stem Cell Initiative; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Hope for Depression Research Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank L. Drew for comments on the manuscript. The authors are supported by US National Institute of Mental Health grants 1F32MH092101-01A1 and 1K01MH099371-01; a Sackler Institute Award and a NARSAD Young Investigator Award (M. A. K.); US National Institute of Mental Health grant 4R00MH086615-03, the Ellison Medical Foundation New Scholar in Aging and the Whitehall Foundation (A. S.); and NARSAD, the New York Stem Cell Initiative, US National Institutes of Health grant R01 MH068542, and Hope for Depression Research Foundation grants (R.H.).	Adhikari A, 2010, NEURON, V65, P257, DOI 10.1016/j.neuron.2009.12.002; Aimone JB, 2011, NEURON, V70, P589, DOI 10.1016/j.neuron.2011.05.010; Alvarez RP, 2008, J NEUROSCI, V28, P6211, DOI 10.1523/JNEUROSCI.1246-08.2008; AMARAL DG, 1989, NEUROSCIENCE, V31, P571, DOI 10.1016/0306-4522(89)90424-7; Bakker A, 2008, SCIENCE, V319, P1640, DOI 10.1126/science.1152882; Banasr M, 2006, BIOL PSYCHIAT, V59, P1087, DOI 10.1016/j.biopsych.2005.11.025; Bergmann O, 2012, NEURON, V74, P634, DOI 10.1016/j.neuron.2012.03.030; Bienvenu TCM, 2012, NEURON, V74, P1059, DOI 10.1016/j.neuron.2012.04.022; Boldrini M, 2009, NEUROPSYCHOPHARMACOL, V34, P2376, DOI 10.1038/npp.2009.75; Bouton ME, 2001, PSYCHOL REV, V108, P4, DOI 10.1037//0033-295X.108.1.4; Brohawn KH, 2010, BIOL PSYCHIAT, V68, P1023, DOI 10.1016/j.biopsych.2010.07.018; BUHL EH, 1994, NATURE, V368, P823, DOI 10.1038/368823a0; Burghardt NS, 2012, HIPPOCAMPUS, V22, P1795, DOI 10.1002/hipo.22013; CLAIBORNE BJ, 1986, J COMP NEUROL, V246, P435, DOI 10.1002/cne.902460403; Clelland CD, 2009, SCIENCE, V325, P210, DOI 10.1126/science.1173215; Cohen LJ, 1996, J NEUROPSYCH CLIN N, V8, P82; Creer DJ, 2010, P NATL ACAD SCI USA, V107, P2367, DOI 10.1073/pnas.0911725107; Czerniawski J, 2012, HIPPOCAMPUS, V22, P1528, DOI 10.1002/hipo.20992; Dannlowski U, 2012, BIOL PSYCHIAT, V71, P286, DOI 10.1016/j.biopsych.2011.10.021; David DJ, 2009, NEURON, V62, P479, DOI 10.1016/j.neuron.2009.04.017; Davis M, 2006, BIOL PSYCHIAT, V60, P369, DOI 10.1016/j.biopsych.2006.03.084; DeCarolis NA, 2010, NEUROPHARMACOLOGY, V58, P884, DOI 10.1016/j.neuropharm.2009.12.013; Dolcos F, 2004, NEURON, V42, P855, DOI 10.1016/S0896-6273(04)00289-2; Dranovsky A, 2011, NEURON, V70, P908, DOI 10.1016/j.neuron.2011.05.022; DuPont RL, 1996, ANXIETY, V2, P167, DOI 10.1002/(SICI)1522-7154(1996)2:4<167::AID-ANXI2>3.0.CO;2-L; Fanselow MS, 2010, NEURON, V65, P7, DOI 10.1016/j.neuron.2009.11.031; Fenton AA, 2007, SCIENCE, V315, P947, DOI 10.1126/science.1139146; Freund TF, 1996, HIPPOCAMPUS, V6, P347, DOI 10.1002/(SICI)1098-1063(1996)6:4<347::AID-HIPO1>3.0.CO;2-I; Ge SY, 2007, NEURON, V54, P559, DOI 10.1016/j.neuron.2007.05.002; Ge SY, 2006, NATURE, V439, P589, DOI 10.1038/nature04404; Gilbert PE, 2001, HIPPOCAMPUS, V11, P626, DOI 10.1002/hipo.1077; Gilbertson MW, 2007, BIOL PSYCHIAT, V62, P513, DOI 10.1016/j.biopsych.2006.12.023; Gilbertson MW, 2010, J CLIN PSYCHIAT, V71, P1324, DOI 10.4088/JCP.10m06121blu; Gilbertson MW, 2002, NAT NEUROSCI, V5, P1242, DOI 10.1038/nn958; Guo WX, 2011, NAT MED, V17, P559, DOI 10.1038/nm.2336; Hayes JP, 2011, J PSYCHIATR RES, V45, P660, DOI 10.1016/j.jpsychires.2010.10.007; Henze DA, 2002, NAT NEUROSCI, V5, P790, DOI 10.1038/nn887; Huff NC, 2011, FRONT BEHAV NEUROSCI, V5, DOI 10.3389/fnbeh.2011.00075; Hunsaker MR, 2008, HIPPOCAMPUS, V18, P1064, DOI 10.1002/hipo.20464; Hunsaker MR, 2008, NEUROBIOL LEARN MEM, V89, P61, DOI 10.1016/j.nlm.2007.08.016; Imayoshi I, 2008, NAT NEUROSCI, V11, P1153, DOI 10.1038/nn.2185; Irle E, 2010, J PSYCHIATR NEUROSCI, V35, P126, DOI 10.1503/jpn.090041; Jovanovic T, 2010, AM J PSYCHIAT, V167, P648, DOI 10.1176/appi.ajp.2009.09071074; JUNG MW, 1994, J NEUROSCI, V14, P7347; Karl A, 2006, BIOL PSYCHOL, V71, P123, DOI 10.1016/j.biopsycho.2005.03.004; KESSLER RC, 1995, ARCH GEN PSYCHIAT, V52, P1048, DOI 10.1001/archpsyc.1995.03950240066012; Kessler RC, 2005, ARCH GEN PSYCHIAT, V62, P593, DOI 10.1001/archpsyc.62.6.593; Kheirbek MA, 2012, J NEUROSCI, V32, P8696, DOI 10.1523/JNEUROSCI.1692-12.2012; Kim J, 2011, HIPPOCAMPUS, V21, P609, DOI 10.1002/hipo.20784; Kitayama N, 2005, J AFFECT DISORDERS, V88, P79, DOI 10.1016/j.jad.2005.05.014; Lacefield CO, 2012, HIPPOCAMPUS, V22, P106, DOI 10.1002/hipo.20860; Lacy JW, 2011, LEARN MEMORY, V18, P15, DOI [10.1101/lm.1971110, 10.1101/lm.1971111]; Lau JYF, 2010, NEUROIMAGE, V53, P952, DOI 10.1016/j.neuroimage.2009.11.026; Leutgeb JK, 2007, SCIENCE, V315, P961, DOI 10.1126/science.1135801; Lisman J, 2011, J PHYSIOL-LONDON, V589, P1905, DOI 10.1113/jphysiol.2010.201137; Lissek S, 2008, AM J PSYCHIAT, V165, P124, DOI 10.1176/appi.ajp.2007.06091513; Lissek S, 2010, AM J PSYCHIAT, V167, P47, DOI 10.1176/appi.ajp.2009.09030410; Luo AH, 2011, SCIENCE, V333, P353, DOI 10.1126/science.1204622; Maren S, 2004, BEHAV NEUROSCI, V118, P97, DOI 10.1037/0735-7044.118.1.97; MAREN S, 1995, J NEUROSCI, V15, P7548; MARR D, 1971, PHILOS T ROY SOC B, V262, P23, DOI 10.1098/rstb.1971.0078; McEwen BS, 1999, ANNU REV NEUROSCI, V22, P105, DOI 10.1146/annurev.neuro.22.1.105; McHugh TJ, 2007, SCIENCE, V317, P94, DOI 10.1126/science.1140263; MCNAUGHTON BL, 1987, TRENDS NEUROSCI, V10, P408, DOI 10.1016/0166-2236(87)90011-7; Milad MR, 2006, BIOL PSYCHOL, V73, P61, DOI 10.1016/j.biopsycho.2006.01.008; Milad MR, 2012, ANNU REV PSYCHOL, V63, P129, DOI 10.1146/annurev.psych.121208.131631; Mineka S, 2006, AM PSYCHOL, V61, P10, DOI 10.1037/0003-066X.61.1.10; Nakashiba T, 2012, CELL, V149, P188, DOI 10.1016/j.cell.2012.01.046; OREILLY RC, 1994, HIPPOCAMPUS, V4, P661, DOI 10.1002/hipo.450040605; PATTON PE, 1995, HIPPOCAMPUS, V5, P245, DOI 10.1002/hipo.450050402; Peri T, 2000, BIOL PSYCHIAT, V47, P512, DOI 10.1016/S0006-3223(99)00144-4; Pittenger C, 2008, NEUROPSYCHOPHARMACOL, V33, P88, DOI 10.1038/sj.npp.1301574; Reif A, 2006, MOL PSYCHIATR, V11, P514, DOI 10.1038/sj.mp.4001791; Ressler KJ, 2004, ARCH GEN PSYCHIAT, V61, P1136, DOI 10.1001/archpsyc.61.11.1136; Rolls ET, 2007, LEARN MEMORY, V14, P714, DOI 10.1101/lm.631207; Rolls ET, 2006, PROG NEUROBIOL, V79, P1, DOI 10.1016/j.pneurobio.2006.04.005; Sahay A, 2007, NAT NEUROSCI, V10, P1110, DOI 10.1038/nn1969; Sahay A, 2011, NEURON, V70, P582, DOI 10.1016/j.neuron.2011.05.012; Sahay A, 2011, NATURE, V472, P466, DOI 10.1038/nature09817; Sanai N, 2011, NATURE, V478, P382, DOI 10.1038/nature10487; Santarelli L, 2003, SCIENCE, V301, P805, DOI 10.1126/science.1083328; Schloesser RJ, 2010, MOL PSYCHIATR, V15, P1152, DOI 10.1038/mp.2010.34; Schmidt-Hieber C, 2004, NATURE, V429, P184, DOI 10.1038/nature02553; Sierra A, 2011, FRONT NEUROSCI-SWITZ, V5, DOI 10.3389/fnins.2011.00047; Singer BH, 2011, P NATL ACAD SCI USA, V108, P5437, DOI 10.1073/pnas.1015425108; Snyder JS, 2011, NATURE, V476, P458, DOI 10.1038/nature10287; Sodic L, 2007, CROAT MED J, V48, P140; Stark SM, 2010, LEARN MEMORY, V17, P284, DOI 10.1101/lm.1768110; Surget A, 2011, MOL PSYCHIATR, V16, P1177, DOI 10.1038/mp.2011.48; Suthana N, 2011, HIPPOCAMPUS, V21, P694, DOI 10.1002/hipo.20833; Toni N, 2008, NAT NEUROSCI, V11, P901, DOI 10.1038/nn.2156; Toni N, 2007, NAT NEUROSCI, V10, P727, DOI 10.1038/nn1908; Treves A, 2008, NEUROSCIENCE, V154, P1155, DOI 10.1016/j.neuroscience.2008.04.073; Tronel S, 2012, HIPPOCAMPUS, V22, P292, DOI 10.1002/hipo.20895; van Praag H, 2002, NATURE, V415, P1030, DOI 10.1038/4151030a; Wang S.H., 2012, HIPPOCAMPUS; Wang Z, 2010, ARCH GEN PSYCHIAT, V67, P296, DOI 10.1001/archgenpsychiatry.2009.205; WOLPE J, 1988, BEHAV RES THER, V26, P441, DOI 10.1016/0005-7967(88)90138-6	98	348	370	4	125	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	DEC	2012	15	12					1613	1620		10.1038/nn.3262	http://dx.doi.org/10.1038/nn.3262			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	045OR	23187693	Green Accepted			2022-12-28	WOS:000311706700005
J	Schwartz, GW; Okawa, H; Dunn, FA; Morgan, JL; Kerschensteiner, D; Wong, RO; Rieke, F				Schwartz, Gregory W.; Okawa, Haruhisa; Dunn, Felice A.; Morgan, Josh L.; Kerschensteiner, Daniel; Wong, Rachel O.; Rieke, Fred			The spatial structure of a nonlinear receptive field	NATURE NEUROSCIENCE			English	Article							RETINAL GANGLION-CELLS; MOUSE RETINA; BIPOLAR CELLS; QUANTITATIVE-ANALYSIS; PRIMATE RETINA; IN-VIVO; CAT; SENSITIVITY; CONTACTS; IDENTIFICATION	Understanding a sensory system implies the ability to predict responses to a variety of inputs from a common model. In the retina, this includes predicting how the integration of signals across visual space shapes the outputs of retinal ganglion cells. Existing models of this process generalize poorly to predict responses to new stimuli. This failure arises in part from properties of the ganglion cell response that are not well captured by standard receptive-field mapping techniques: nonlinear spatial integration and fine-scale heterogeneities in spatial sampling. Here we characterize a ganglion cell's spatial receptive field using a mechanistic model based on measurements of the physiological properties and connectivity of only the primary excitatory circuitry of the retina. The resulting simplified circuit model successfully predicts ganglion-cell responses to a variety of spatial patterns and thus provides a direct correspondence between circuit connectivity and retinal output.	[Schwartz, Gregory W.; Okawa, Haruhisa; Dunn, Felice A.; Wong, Rachel O.; Rieke, Fred] Univ Washington, Dept Physiol & Biophys, Seattle, WA 98195 USA; [Morgan, Josh L.] Harvard Univ, Dept Mol & Cell Biol, Cambridge, MA 02138 USA; [Kerschensteiner, Daniel] Washington Univ, Dept Ophthalmol & Visual Sci, St Louis, MO 63130 USA; [Kerschensteiner, Daniel] Washington Univ, Dept Anat & Neurobiol, St Louis, MO USA; [Rieke, Fred] Howard Hughes Med Inst, Seattle, WA USA	University of Washington; University of Washington Seattle; Harvard University; Washington University (WUSTL); Washington University (WUSTL); Howard Hughes Medical Institute	Schwartz, GW (corresponding author), Univ Washington, Dept Physiol & Biophys, Seattle, WA 98195 USA.	gregws@uw.edu		Schwartz, Greg/0000-0001-8909-4397	US National Institutes of Health [EY11850, EY10699, EY017101, EY 01730]; Howard Hughes Medical Institute; Helen Hay Whitney Foundation; NATIONAL EYE INSTITUTE [R01EY011850, R01EY010699, P30EY001730, R01EY017101] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Helen Hay Whitney Foundation; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	We thank D. Perkel, G. Field, M. Berry and W. Bair for helpful comments on the manuscript. This research was made possible by support from the US National Institutes of Health (EY11850 to ER., EY10699 and EY017101 to R.O.W. and the Vision Core Grant EY 01730), the Howard Hughes Medical Institute (F.R.) and the Helen Hay Whitney Foundation (G.W.S.).	Ala-Laurila P, 2011, NAT NEUROSCI, V14, P1309, DOI 10.1038/nn.2927; AMTHOR FR, 1989, J COMP NEUROL, V280, P97, DOI 10.1002/cne.902800108; Badea TC, 2004, J COMP NEUROL, V480, P331, DOI 10.1002/cne.20304; Berntson A, 2000, J PHYSIOL-LONDON, V524, P879, DOI 10.1111/j.1469-7793.2000.00879.x; Bock DD, 2011, NATURE, V471, P177, DOI 10.1038/nature09802; Brown SP, 2000, NEURON, V27, P371, DOI 10.1016/S0896-6273(00)00044-1; CALDWELL JH, 1978, J PHYSIOL-LONDON, V276, P257, DOI 10.1113/jphysiol.1978.sp012232; Chichilnisky EJ, 2001, NETWORK-COMP NEURAL, V12, P199, DOI 10.1088/0954-898X/12/2/306; COHEN E, 1991, J NEUROPHYSIOL, V65, P352, DOI 10.1152/jn.1991.65.2.352; Coombs J, 2006, NEUROSCIENCE, V140, P123, DOI 10.1016/j.neuroscience.2006.02.079; CREUTZFELDT OD, 1970, J NEUROPHYSIOL, V33, P654, DOI 10.1152/jn.1970.33.5.654; Dacey D, 2000, VISION RES, V40, P1801, DOI 10.1016/S0042-6989(00)00039-0; Demb JB, 2001, J NEUROSCI, V21, P7447, DOI 10.1523/JNEUROSCI.21-19-07447.2001; Demb JB, 1999, J NEUROSCI, V19, P9756; ENROTHCUGELL C, 1966, J PHYSIOL-LONDON, V187, P517, DOI 10.1113/jphysiol.1966.sp008107; FREED MA, 1992, P NATL ACAD SCI USA, V89, P236, DOI 10.1073/pnas.89.1.236; Gauthier JL, 2009, PLOS BIOL, V7, P747, DOI 10.1371/journal.pbio.1000063; Gollisch T, 2010, NEURON, V65, P150, DOI 10.1016/j.neuron.2009.12.009; Helmstaedter M, 2011, NAT NEUROSCI, V14, P1081, DOI 10.1038/nn.2868; HOCHSTEIN S, 1976, J PHYSIOL-LONDON, V262, P265, DOI 10.1113/jphysiol.1976.sp011595; HOCHSTEIN S, 1976, J PHYSIOL-LONDON, V262, P237, DOI 10.1113/jphysiol.1976.sp011594; Jakobs TC, 2008, J COMP NEUROL, V510, P221, DOI 10.1002/cne.21795; Kerschensteiner D, 2009, NATURE, V460, P1016, DOI 10.1038/nature08236; KIER CK, 1995, J NEUROSCI, V15, P7673; Kim IJ, 2008, NATURE, V452, P478, DOI 10.1038/nature06739; KOCH C, 1982, PHILOS T R SOC B, V298, P227, DOI 10.1098/rstb.1982.0084; Koizumi A, 2011, J COMP NEUROL, V519, P341, DOI 10.1002/cne.22522; Kong JH, 2005, J COMP NEUROL, V489, P293, DOI 10.1002/cne.20631; Lin B, 2005, EUR J NEUROSCI, V21, P1257, DOI 10.1111/j.1460-9568.2005.03967.x; Masland RH, 2001, NAT NEUROSCI, V4, P877, DOI 10.1038/nn0901-877; MILLS SL, 1995, NATURE, V377, P734, DOI 10.1038/377734a0; Morgan JL, 2008, NEURAL DEV, V3, DOI 10.1186/1749-8104-3-8; Morgan JL, 2011, NEURON, V71, P1014, DOI 10.1016/j.neuron.2011.08.025; Murphy GJ, 2006, NEURON, V52, P511, DOI 10.1016/j.neuron.2006.09.014; Pang JJ, 2003, J NEUROSCI, V23, P6063, DOI 10.1523/JNEUROSCI.23-14-06063.2003; Passaglia CL, 2002, VISION RES, V42, P683, DOI 10.1016/S0042-6989(01)00312-1; Petrusca D, 2007, J NEUROSCI, V27, P11019, DOI 10.1523/JNEUROSCI.2836-07.2007; Pillow JW, 2008, NATURE, V454, P995, DOI 10.1038/nature07140; Pillow JW, 2005, J NEUROSCI, V25, P11003, DOI 10.1523/JNEUROSCI.3305-05.2005; Schwartz G, 2011, J GEN PHYSIOL, V138, P283, DOI 10.1085/jgp.201110629; Soo FS, 2011, J NEUROSCI, V31, P2145, DOI 10.1523/JNEUROSCI.5129-10.2011; STONE C, 1993, VISUAL NEUROSCI, V10, P31, DOI 10.1017/S0952523800003205; Sun WZ, 2002, J COMP NEUROL, V451, P115, DOI 10.1002/cne.10323; THIBOS LN, 1983, VISION RES, V23, P1561, DOI 10.1016/0042-6989(83)90170-0; VICTOR JD, 1979, J GEN PHYSIOL, V74, P671, DOI 10.1085/jgp.74.6.671; Volgyi B, 2009, J COMP NEUROL, V512, P664, DOI 10.1002/cne.21912; Wassle H, 2009, J NEUROSCI, V29, P106, DOI 10.1523/JNEUROSCI.4442-08.2009; WASSLE H, 1981, NATURE, V292, P344, DOI 10.1038/292344a0; Yamagata M, 2008, NATURE, V451, P465, DOI 10.1038/nature06469; Zeck GM, 2005, EUR J NEUROSCI, V22, P2016, DOI 10.1111/j.1460-9568.2005.04390.x	50	132	132	0	22	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	NOV	2012	15	11					1572	1580		10.1038/nn.3225	http://dx.doi.org/10.1038/nn.3225			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	028LX	23001060	Green Accepted, Green Submitted			2022-12-28	WOS:000310424900018
J	Chen, S; Li, W				Chen, Shan; Li, Wei			A color-coding amacrine cell may provide a blue-Off signal in a mammalian retina	NATURE NEUROSCIENCE			English	Article							GANGLION-CELLS; PRIMATE RETINA; OPPONENT PATHWAY; MACAQUE RETINA; BIPOLAR CELLS; VISION; CONES	Retinal amacrine cells are thought to lack chromatic or color-selective light responses and have only a minor role in color processing. We found that a type of mammalian (Ictidomys tridecemlineatus) amacrine cell selectively carries a blue-On signal, which is received from a blue or short wavelength sensitive (S) cone On bipolar cell. This glycinergic inhibitory S-cone amacrine cell is ideally placed for driving blue-Off responses in downstream ganglion cells.	[Chen, Shan; Li, Wei] NEI, Unit Retinal Neurophysiol, US Natl Inst Hlth, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Eye Institute (NEI)	Li, W (corresponding author), NEI, Unit Retinal Neurophysiol, US Natl Inst Hlth, Bethesda, MD 20892 USA.	liwei2@nei.nih.gov		Li, Wei/0000-0002-2897-649X	Intramural Research Program of the National Eye Institute [ZIA EY000508-01]; NATIONAL EYE INSTITUTE [ZIAEY000508] Funding Source: NIH RePORTER	Intramural Research Program of the National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	We thank D. Merriman and T. Rosenberg for editing and S. DeVries and B. Szmajda for critically reading the manuscript. This work was supported by the Intramural Research Program of the National Eye Institute (ZIA EY000508-01).	Calkins DJ, 1998, J NEUROSCI, V18, P3373; Calkins DJ, 1996, NATURE, V381, P613, DOI 10.1038/381613a0; Chichilnisky EJ, 1999, NAT NEUROSCI, V2, P889, DOI 10.1038/13189; Dacey D, 2004, COGNITIVE NEUROSCIENCES III, THIRD EDITION, P281; Dacey DM, 2005, NATURE, V433, P749, DOI 10.1038/nature03387; DACEY DM, 1994, NATURE, V367, P731, DOI 10.1038/367731a0; Field GD, 2009, NAT NEUROSCI, V12, P1159, DOI 10.1038/nn.2353; Hemmi JM, 2002, J VISION, V2, P608, DOI 10.1167/2.9.3; JACOBS GH, 1980, VISION RES, V20, P9, DOI 10.1016/0042-6989(80)90136-4; KOUYAMA N, 1992, J NEUROSCI, V12, P1233; Li W, 2006, NAT NEUROSCI, V9, P669, DOI 10.1038/nn1686; MARIANI AP, 1984, NATURE, V308, P184, DOI 10.1038/308184a0; MOLLON JD, 1989, J EXP BIOL, V146, P21; Neitz J, 2011, VISION RES, V51, P633, DOI 10.1016/j.visres.2010.12.002; Yin L, 2009, J NEUROSCI, V29, P2706, DOI 10.1523/JNEUROSCI.5471-08.2009	15	34	35	0	16	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JUL	2012	15	7					954	956		10.1038/nn.3128	http://dx.doi.org/10.1038/nn.3128			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	966EE	22634731	Green Accepted			2022-12-28	WOS:000305819600011
J	Dickendesher, TL; Baldwin, KT; Mironova, YA; Koriyama, Y; Raiker, SJ; Askew, KL; Wood, A; Geoffroy, CG; Zheng, BH; Liepmann, CD; Katagiri, Y; Benowitz, LI; Geller, HM; Giger, RJ				Dickendesher, Travis L.; Baldwin, Katherine T.; Mironova, Yevgeniya A.; Koriyama, Yoshiki; Raiker, Stephen J.; Askew, Kim L.; Wood, Andrew; Geoffroy, Cedric G.; Zheng, Binhai; Liepmann, Claire D.; Katagiri, Yasuhiro; Benowitz, Larry I.; Geller, Herbert M.; Giger, Roman J.			NgR1 and NgR3 are receptors for chondroitin sulfate proteoglycans	NATURE NEUROSCIENCE			English	Article							RETINAL GANGLION-CELLS; OLIGODENDROCYTE-MYELIN GLYCOPROTEIN; CORTICOSPINAL TRACT REGENERATION; SPINAL-CORD-INJURY; AXON REGENERATION; NOGO-66 RECEPTOR; NEURITE GROWTH; OPTIC-NERVE; FUNCTIONAL RECEPTOR; RECOVERY	In the adult mammalian CNS, chondroitin sulfate proteoglycans (CSPGs) and myelin-associated inhibitors (MAIs) stabilize neuronal structure and restrict compensatory sprouting following injury. The Nogo receptor family members NgR1 and NgR2 bind to MAIs and have been implicated in neuronal inhibition. We found that NgR1 and NgR3 bind with high affinity to the glycosaminoglycan moiety of proteoglycans and participate in CSPG inhibition in cultured neurons. Nogo receptor triple mutants (Ngr1(-/-); Ngr2(-/-); Ngr3(-/-); which are also known as Rtn4r, Rtn4rI2 and Rtn4rI1, respectively), but not single mutants, showed enhanced axonal regeneration following retro-orbital optic nerve crush injury. The combined loss of Ngr1 and Ngr3 (Ngr1(-/-); Ngr3(-/-)), but not Ngr1 and Ngr2 (Ngr1(-/-); Ngr2(-/-)), was sufficient to mimic the triple mutant regeneration phenotype. Regeneration in Ngr1(-/-); Ngr3(-/-) mice was further enhanced by simultaneous ablation of Rptp sigma (also known as Ptprs), a known CSPG receptor. Collectively, our results identify NgR1 and NgR3 as CSPG receptors, suggest that there is functional redundancy among CSPG receptors, and provide evidence for shared mechanisms of MAI and CSPG inhibition.	[Dickendesher, Travis L.; Giger, Roman J.] Univ Michigan, Sch Med, Neurosci Program, Ann Arbor, MI 48109 USA; [Dickendesher, Travis L.; Baldwin, Katherine T.; Mironova, Yevgeniya A.; Raiker, Stephen J.; Giger, Roman J.] Univ Michigan, Sch Med, Dept Cell & Dev Biol, Ann Arbor, MI USA; [Baldwin, Katherine T.; Mironova, Yevgeniya A.; Giger, Roman J.] Univ Michigan, Sch Med, Cellular & Mol Biol Program, Ann Arbor, MI USA; [Koriyama, Yoshiki; Benowitz, Larry I.] Harvard Univ, Childrens Hosp, Sch Med, FM Kirby Neurobiol Ctr, Boston, MA 02115 USA; [Koriyama, Yoshiki; Benowitz, Larry I.] Harvard Univ, Childrens Hosp, Sch Med, Lab Neurosci Res Neurosurg, Boston, MA 02115 USA; [Koriyama, Yoshiki; Benowitz, Larry I.] Harvard Univ, Sch Med, Dept Surg, Boston, MA 02115 USA; [Raiker, Stephen J.] Univ Rochester, Sch Med & Dent, Dept Biomed Genet, Rochester, NY USA; [Askew, Kim L.; Wood, Andrew] Pfizer Global Res & Dev, Neurosci Res Unit, Groton, CT USA; [Geoffroy, Cedric G.; Zheng, Binhai] Univ Calif San Diego, Sch Med, Dept Neurosci, La Jolla, CA 92093 USA; [Liepmann, Claire D.; Katagiri, Yasuhiro; Geller, Herbert M.] NHLBI, Dev Neurobiol Sect, Div Intramural Res, NIH, Bethesda, MD 20892 USA; [Benowitz, Larry I.] Harvard Univ, Sch Med, Program Neurosci, Boston, MA 02115 USA; [Giger, Roman J.] Univ Michigan, Sch Med, Dept Neurol, Ann Arbor, MI USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Harvard University; Boston Children's Hospital; Harvard Medical School; Harvard University; Boston Children's Hospital; Harvard Medical School; Harvard University; Harvard Medical School; University of Rochester; Pfizer; University of California System; University of California San Diego; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Harvard University; Harvard Medical School; University of Michigan System; University of Michigan	Giger, RJ (corresponding author), Univ Michigan, Sch Med, Neurosci Program, Ann Arbor, MI 48109 USA.	rgiger@umich.edu	Koriyama, Yoshiki/AAA-1830-2022; geoffroy, cedric/AAK-5855-2020	Geller, Herbert/0000-0002-7048-6144; Baldwin, Katherine/0000-0002-4423-5712; geoffroy, cedric g/0000-0002-7671-147X; Benowitz, Larry/0000-0002-0277-7222; Koriyama, Yoshiki/0000-0001-8777-329X	Neuroscience Training Grant [T32EY017878]; University of Michigan; Cellular and Molecular Biology Training Grant [T32GM007315]; National Research Service Award Ruth Kirschstein Fellowship [F31NS061589]; New York State Spinal Cord Injury Research Program; Dr. Miriam and Sheldon G. Adelson Medical Foundation on Neural Repair and Rehabilitation; US Department of Veterans Affairs [1I0IRX000229-01]; National Institute of Neurological Disorders and Stroke [R56NSO47333]; National Eye Institute; NATIONAL EYE INSTITUTE [T32EY017878] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL006021] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007315] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [T32NS076401, R01NS054734, F31NS061589, R56NS047333, T32NS007489, R01NS047333] Funding Source: NIH RePORTER; Veterans Affairs [I01RX000229] Funding Source: NIH RePORTER	Neuroscience Training Grant; University of Michigan(University of Michigan System); Cellular and Molecular Biology Training Grant; National Research Service Award Ruth Kirschstein Fellowship(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); New York State Spinal Cord Injury Research Program; Dr. Miriam and Sheldon G. Adelson Medical Foundation on Neural Repair and Rehabilitation; US Department of Veterans Affairs(US Department of Veterans Affairs); National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Veterans Affairs(US Department of Veterans Affairs)	We thank M. Tremblay for Rptp sigma<SUP>-/-</SUP> mice, M. Greenberg for Ngr3<SUP>-/-</SUP> mice, B. Pierchala for p75<SUP>NTR-/-</SUP> mice, B. Bates, D. Howland and M.L. Mercado for their assistance in the generation and initial analysis of Ngr1<SUP>-/-</SUP>; Ngr2<SUP>-/-</SUP>; Ngr3<SUP>-/-</SUP> mice, U. Rutishauser for Endo-N, D. Figge and Y. Yasui for assistance in ELISA binding assays, Y. Yin for training in optic nerve surgery, Y. Duan for generation of the RPTP sigma(Igl-3)-Fc construct,). Barbieri for technical assistance and M.M. Zaleska for project administration. This work was supported by Neuroscience Training Grant T32EY017878 and the University of Michigan Rackham Merit Fellowship (T.L.D.), Cellular and Molecular Biology Training Grant T32GM007315 (K.T.B. and Y.A.M.), National Research Service Award Ruth Kirschstein Fellowship F31NS061589 (S.J.R.), the New York State Spinal Cord Injury Research Program, the Dr. Miriam and Sheldon G. Adelson Medical Foundation on Neural Repair and Rehabilitation, the US Department of Veterans Affairs (1I0IRX000229-01), the National Institute of Neurological Disorders and Stroke (R56NSO47333, R.J.G.) and the National Eye Institute (L.I.B.).	Aricescu AR, 2002, MOL CELL BIOL, V22, P1881, DOI 10.1128/MCB.22.6.1881-1892.2002; Atwal JK, 2008, SCIENCE, V322, P967, DOI 10.1126/science.1161151; Barton WA, 2003, EMBO J, V22, P3291, DOI 10.1093/emboj/cdg325; Bradbury EJ, 2002, NATURE, V416, P636, DOI 10.1038/416636a; BREGMAN BS, 1995, NATURE, V378, P498, DOI 10.1038/378498a0; Cafferty WBJ, 2010, J NEUROSCI, V30, P6825, DOI 10.1523/JNEUROSCI.6239-09.2010; Chivatakarn O, 2007, J NEUROSCI, V27, P7117, DOI 10.1523/JNEUROSCI.1541-07.2007; Fischer D, 2004, J NEUROSCI, V24, P1646, DOI 10.1523/JNEUROSCI.5119-03.2004; Fischer D, 2004, J NEUROSCI, V24, P8726, DOI 10.1523/JNEUROSCI.2774-04.2004; Fisher D, 2011, J NEUROSCI, V31, P14051, DOI 10.1523/JNEUROSCI.1737-11.2011; Fournier AE, 2001, NATURE, V409, P341, DOI 10.1038/35053072; Fry EJ, 2010, GLIA, V58, P423, DOI 10.1002/glia.20934; Fujita Y, 2011, EMBO J, V30, P1389, DOI 10.1038/emboj.2011.55; Garcia-Alias G, 2009, NAT NEUROSCI, V12, P1145, DOI 10.1038/nn.2377; Houle JD, 2006, J NEUROSCI, V26, P7405, DOI 10.1523/JNEUROSCI.1166-06.2006; Kadoya K, 2009, NEURON, V64, P165, DOI 10.1016/j.neuron.2009.09.016; Kantor DB, 2004, NEURON, V44, P961, DOI 10.1016/j.neuron.2004.12.002; Karlen A, 2009, P NATL ACAD SCI USA, V106, P20476, DOI 10.1073/pnas.0905390106; Kim JE, 2004, NEURON, V44, P439, DOI 10.1016/j.neuron.2004.10.015; Lee HJ, 2008, J NEUROSCI, V28, P2753, DOI 10.1523/JNEUROSCI.5586-07.2008; Lee JK, 2010, NEURON, V66, P663, DOI 10.1016/j.neuron.2010.05.002; Leibinger M, 2009, J NEUROSCI, V29, P14334, DOI 10.1523/JNEUROSCI.2770-09.2009; Li SX, 2004, J NEUROSCI, V24, P10511, DOI 10.1523/JNEUROSCI.2828-04.2004; Liu BP, 2006, PHILOS T R SOC B, V361, P1593, DOI 10.1098/rstb.2006.1891; Massey JM, 2006, J NEUROSCI, V26, P4406, DOI 10.1523/JNEUROSCI.5467-05.2006; McGee AW, 2005, SCIENCE, V309, P2222, DOI 10.1126/science.1114362; MCKEON RJ, 1995, EXP NEUROL, V136, P32, DOI 10.1006/exnr.1995.1081; Niederost BP, 1999, J NEUROSCI, V19, P8979, DOI 10.1523/JNEUROSCI.19-20-08979.1999; Ohlsson M, 2004, RESTOR NEUROL NEUROS, V22, P1; Park KK, 2008, SCIENCE, V322, P963, DOI 10.1126/science.1161566; Pizzorusso T, 2002, SCIENCE, V298, P1248, DOI 10.1126/science.1072699; Powell EM, 2001, GLIA, V33, P288, DOI 10.1002/1098-1136(20010315)33:4<288::AID-GLIA1027>3.0.CO;2-R; Raiker SJ, 2010, J NEUROSCI, V30, P12432, DOI 10.1523/JNEUROSCI.0895-10.2010; Rhodes KE, 2004, J ANAT, V204, P33, DOI 10.1111/j.1469-7580.2004.00261.x; Sapieha PS, 2005, MOL CELL NEUROSCI, V28, P625, DOI 10.1016/j.mcn.2004.10.011; Schweigreiter R, 2004, MOL CELL NEUROSCI, V27, P163, DOI 10.1016/j.mcn.2004.06.004; Shen YJ, 2009, SCIENCE, V326, P592, DOI 10.1126/science.1178310; Shypitsyna A, 2011, MOL BIOL EVOL, V28, P1363, DOI 10.1093/molbev/msq313; Silver J, 2004, NAT REV NEUROSCI, V5, P146, DOI 10.1038/nrn1326; Sivasankaran R, 2004, NAT NEUROSCI, V7, P261, DOI 10.1038/nn1193; Venkatesh K, 2005, J NEUROSCI, V25, P808, DOI 10.1523/JNEUROSCI.4464-04.2005; Williams G, 2008, J BIOL CHEM, V283, P16641, DOI 10.1074/jbc.M802067200; Winzeler AM, 2011, J NEUROSCI, V31, P6481, DOI 10.1523/JNEUROSCI.3004-10.2011; Yamashita T, 2005, MOL NEUROBIOL, V32, P105, DOI 10.1385/MN:32:2:105; Yin YQ, 2009, P NATL ACAD SCI USA, V106, P19587, DOI 10.1073/pnas.0907085106; Zagrebelsky M, 2010, J NEUROSCI, V30, P13220, DOI 10.1523/JNEUROSCI.1044-10.2010; Zhang L, 2011, J GENET GENOMICS, V38, P515, DOI 10.1016/j.jgg.2011.10.001; Zheng BH, 2005, P NATL ACAD SCI USA, V102, P1205, DOI 10.1073/pnas.0409026102	48	324	333	5	56	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAY	2012	15	5					703	712		10.1038/nn.3070	http://dx.doi.org/10.1038/nn.3070			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	932DI	22406547	Green Accepted, Green Submitted			2022-12-28	WOS:000303270200014
J	Rossi, DJ				Rossi, David J.			Astrocytes join the plasticity party	NATURE NEUROSCIENCE			English	Editorial Material							TIMING-DEPENDENT PLASTICITY; LONG-TERM DEPRESSION; SOMATOSENSORY CORTEX; PRESYNAPTIC NMDA; BARREL CORTEX; RECEPTORS	In the developing cortex, spike timing-dependent long-term depression requires cannabinoid-induced glutamate release from astrocytes. Astrocytes may be integral to the coincidence detection that guides plasticity and map formation.	Oregon Hlth & Sci Univ, Dept Behav Neurosci, Portland, OR 97201 USA	Oregon Health & Science University	Rossi, DJ (corresponding author), Oregon Hlth & Sci Univ, Dept Behav Neurosci, Portland, OR 97201 USA.	rossid@ohsu.edu			NINDS NIH HHS [R01 NS051561] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS051561] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Banerjee A, 2009, CEREB CORTEX, V19, P2959, DOI 10.1093/cercor/bhp067; Bender VA, 2006, J NEUROSCI, V26, P4166, DOI 10.1523/JNEUROSCI.0176-06.2006; Corlew R, 2007, J NEUROSCI, V27, P9835, DOI 10.1523/JNEUROSCI.5494-06.2007; Feldman DE, 2005, SCIENCE, V310, P810, DOI 10.1126/science.1115807; Foeller E, 2004, CURR OPIN NEUROBIOL, V14, P89, DOI 10.1016/j.conb.2004.01.011; Hensch TK, 2005, NAT REV NEUROSCI, V6, P877, DOI 10.1038/nrn1787; Inan M, 2007, NEUROSCIENTIST, V13, P49, DOI 10.1177/1073858406296257; Larsen RS, 2011, NAT NEUROSCI, V14, P338, DOI 10.1038/nn.2750; Min R, 2012, NAT NEUROSCI, V15, P746, DOI 10.1038/nn.3075; Nevian T, 2006, J NEUROSCI, V26, P11001, DOI 10.1523/JNEUROSCI.1749-06.2006; Rodriguez-Moreno A, 2008, NAT NEUROSCI, V11, P744, DOI 10.1038/nn.2125; Rodriguez-Moreno A, 2011, J NEUROSCI, V31, P8564, DOI 10.1523/JNEUROSCI.0274-11.2011; Sjostrom PJ, 2003, NEURON, V39, P641, DOI 10.1016/S0896-6273(03)00476-8	13	7	7	0	10	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	MAY	2012	15	5					649	651		10.1038/nn.3095	http://dx.doi.org/10.1038/nn.3095			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	932DI	22534575	Green Accepted			2022-12-28	WOS:000303270200003
J	Bialas, AR; Stevens, B				Bialas, Allison R.; Stevens, Beth			TGF-beta signaling regulates neuronal Clq expression and developmental synaptic refinement	NATURE NEUROSCIENCE			English	Article							CLASS-I MHC; RETINOGENICULATE AXONS; NEURITE OUTGROWTH; RETINAL GANGLION; GENE-EXPRESSION; GROWTH; CNS; C1Q; PROTEINS; GLIA	Immune molecules, including complement proteins Clq and C3, have emerged as critical mediators of synaptic refinement and plasticity. Complement localizes to synapses and refines the developing visual system through C3-dependent microglial phagocytosis of synapses. Retinal ganglion cells (RGCs) express Clq, the initiating protein of the classical complement cascade, during retinogeniculate refinement; however, the signals controlling Clq expression and function remain elusive. Previous work implicated an astrocyte-derived factor in regulating neuronal Clq expression. Here we identify retinal transforming growth factor (TGF)-beta as a key regulator of neuronal Clq expression and synaptic pruning in the developing visual system. Mice lacking TGF-beta receptor II (TGF beta R11) in retinal neurons had reduced Clq expression in RGCs and reduced synaptic localization of complement, and phenocopied refinement defects observed in complement-deficient mice, including reduced eye-specific segregation and microglial engulfment of RGC inputs. These data implicate TGF-beta in regulating neuronal Clq expression to initiate complement- and microglia-mediated synaptic pruning.	[Bialas, Allison R.; Stevens, Beth] Harvard Univ, Sch Med, Dept Neurol, FM Kirby Neurobiol Ctr,Boston Childrens Hosp, Boston, MA 02115 USA; [Bialas, Allison R.; Stevens, Beth] Harvard Univ, Sch Med, Program Neurosci, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Harvard Medical School; Harvard University; Harvard Medical School	Bialas, AR (corresponding author), Harvard Univ, Sch Med, Dept Neurol, FM Kirby Neurobiol Ctr,Boston Childrens Hosp, Boston, MA 02115 USA.	beth.stevens@childrens.harvard.edu			Smith Family Foundation; Dana Foundation; Ellison Foundation; John Merck Scholars Program; NINDS [R01-NS-07100801]; NIDA [R01-DA-15043]; NIH [P30-HD-18655]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD018655] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS071008] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA015043] Funding Source: NIH RePORTER	Smith Family Foundation; Dana Foundation; Ellison Foundation(Lawrence Ellison Foundation); John Merck Scholars Program; NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIDA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank C. Chen, L. Benowitz, D.P. Schafer and M. Buckwalter for comments on the manuscript and critical discussion. In addition we thank A. Stephan, B. Barres and A. Tenner for assistance with anti-Clq antibody production and characterization. We also thank M. Rasband (Baylor College of Medicine) for the 13IV spectrin antibody. Thank you to D.P. Schafer and E.K. Lehrman for technical expertise on the microglial engulfment assay and Imaris image analysis, T. Nelson for technical assistance, and the imaging core at Boston Children's Hospital, including T. Hill, for technical support. This work was supported by grants from the Smith Family Foundation (B.S.), Dana Foundation (B.S.), Ellison Foundation (B.S.), John Merck Scholars Program (B.S.), NINDS (R01-NS-07100801; B.S.), NIDA (R01-DA-15043; B.A. Barres) and NIH (P30-HD-18655; MRDDRC Imaging Core).	Afagh A, 1996, EXP NEUROL, V138, P22, DOI 10.1006/exnr.1996.0043; Allen NJ, 2012, NATURE, V486, P410, DOI 10.1038/nature11059; Awasaki T, 2011, NAT NEUROSCI, V14, P821, DOI 10.1038/nn.2833; Ball RW, 2010, NEURON, V66, P536, DOI 10.1016/j.neuron.2010.04.011; BARRES BA, 1988, NEURON, V1, P791, DOI 10.1016/0896-6273(88)90127-4; Beier M, 2006, NEUROSCI RES, V56, P193, DOI 10.1016/j.neures.2006.07.002; Bjartmar L, 2006, J NEUROSCI, V26, P6269, DOI 10.1523/jneurosci.4212-05.2006; Boulanger LM, 2009, NEURON, V64, P93, DOI 10.1016/j.neuron.2009.09.001; CAMPBELL G, 1992, J NEUROSCI, V12, P1847; Chin J, 2002, J NEUROSCI, V22; Christopherson KS, 2005, CELL, V120, P421, DOI 10.1016/j.cell.2004.12.020; Corriveau RA, 1998, NEURON, V21, P505, DOI 10.1016/S0896-6273(00)80562-0; de Melo J, 2003, J COMP NEUROL, V461, P187, DOI 10.1002/cne.10674; Diniz LP, 2012, J BIOL CHEM, V287, P41432, DOI 10.1074/jbc.M112.380824; Feng Z, 2008, J NEUROSCI, V28, P9599, DOI 10.1523/JNEUROSCI.2589-08.2008; Fonseca MI, 2004, J NEUROSCI, V24, P6457, DOI 10.1523/JNEUROSCI.0901-04.2004; Foo LC, 2011, NEURON, V71, P799, DOI 10.1016/j.neuron.2011.07.022; Fuentes-Medel Y, 2012, CURR BIOL, V22, P1831, DOI 10.1016/j.cub.2012.07.063; Heupel K, 2008, NEURAL DEV, V3, DOI 10.1186/1749-8104-3-25; Hooks BM, 2006, NEURON, V52, P281, DOI 10.1016/j.neuron.2006.07.007; Huang LC, 2007, DEVELOPMENT, V134, P2925, DOI 10.1242/dev.001925; Huh GS, 2000, SCIENCE, V290, P2155, DOI 10.1126/science.290.5499.2155; Inman GJ, 2002, MOL PHARMACOL, V62, P65, DOI 10.1124/mol.62.1.65; Lu CC, 2011, J NEUROSCI, V31, P10903, DOI 10.1523/JNEUROSCI.2358-11.2011; Massague J, 2000, NAT REV MOL CELL BIO, V1, P169, DOI 10.1038/35043051; MCCARTHY KD, 1980, J CELL BIOL, V85, P890, DOI 10.1083/jcb.85.3.890; Peterziel H, 2002, J CELL BIOL, V159, P157, DOI 10.1083/jcb.200203115; Rowan S, 2004, DEV BIOL, V271, P388, DOI 10.1016/j.ydbio.2004.03.039; Schafer DP, 2013, GLIA, V61, P24, DOI 10.1002/glia.22389; Schafer DP, 2012, NEURON, V74, P691, DOI 10.1016/j.neuron.2012.03.026; SRETAVAN D, 1984, NATURE, V308, P845, DOI 10.1038/308845a0; Stephan AH, 2013, J NEUROSCI, V33, P13460, DOI 10.1523/JNEUROSCI.1333-13.2013; Stevens B, 2007, CELL, V131, P1164, DOI 10.1016/j.cell.2007.10.036; Torborg CL, 2004, J NEUROSCI METH, V135, P17, DOI 10.1016/j.jneumeth.2003.11.019; Town T, 2008, NAT MED, V14, P681, DOI 10.1038/nm1781; Tremblay ME, 2011, J NEUROSCI, V31, P16064, DOI 10.1523/JNEUROSCI.4158-11.2011; Tsui CC, 1996, J NEUROSCI, V16, P2463; Ullian EM, 2004, GLIA, V47, P209, DOI 10.1002/glia.20082; Ullian EM, 2001, SCIENCE, V291, P657, DOI 10.1126/science.291.5504.657; WyssCoray T, 1997, NATURE, V389, P603, DOI 10.1038/39321; Yi JJ, 2010, CELL, V142, P144, DOI 10.1016/j.cell.2010.06.010; Yu XMM, 2013, NEURON, V78, P456, DOI 10.1016/j.neuron.2013.03.004; Yuzaki M, 2010, EUR J NEUROSCI, V32, P191, DOI 10.1111/j.1460-9568.2010.07346.x	43	395	403	4	54	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	DEC	2013	16	12					1773	1782		10.1038/nn.3560	http://dx.doi.org/10.1038/nn.3560			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	257VV	24162655	Green Submitted, Green Accepted			2022-12-28	WOS:000327416800015
J	Suzuki, N; Maroof, AM; Merkle, FT; Koszka, K; Intoh, A; Armstrong, I; Moccia, R; Davis-Dusenbery, BN; Eggan, K				Suzuki, Naoki; Maroof, Asif M.; Merkle, Florian T.; Koszka, Kathryn; Intoh, Atsushi; Armstrong, Ian; Moccia, Rob; Davis-Dusenbery, Brandi N.; Eggan, Kevin			The mouse C9ORF72 ortholog is enriched in neurons known to degenerate in ALS and FTD	NATURE NEUROSCIENCE			English	Article							HEXANUCLEOTIDE REPEAT; EXPANSION	Using transgenic mice harboring a targeted LacZ insertion, we studied the expression pattern of the C90RF72 mouse ortholog (3110043021Rik). Unlike most genes that are mutated in amyotrophic lateral sclerosis (ALS), which are ubiquitously expressed, the C90RF72 ortholog was most highly transcribed in the neuronal populations that are sensitive to degeneration in ALS and frontotemporal dementia. Thus, our results provide a potential explanation for the cell type specificity of neuronal degeneration caused by C90RF72 mutations.	[Suzuki, Naoki; Maroof, Asif M.; Merkle, Florian T.; Koszka, Kathryn; Intoh, Atsushi; Armstrong, Ian; Moccia, Rob; Davis-Dusenbery, Brandi N.; Eggan, Kevin] Harvard Univ, Howard Hughes Med Inst, Harvard Stem Cell Inst, Dept Stem Cell & Regenerat Biol, Cambridge, MA 02138 USA	Harvard University; Howard Hughes Medical Institute	Eggan, K (corresponding author), Harvard Univ, Howard Hughes Med Inst, Harvard Stem Cell Inst, Dept Stem Cell & Regenerat Biol, Cambridge, MA 02138 USA.	eggan@mcb.harvard.edu	Suzuki, Naoki/J-6331-2019; Eggan, Kevin/P-7119-2018; Davis-Dusenbery, Brandi/N-2798-2013	Suzuki, Naoki/0000-0001-8880-8554; Merkle, Florian/0000-0002-8513-2998; Davis-Dusenbery, Brandi/0000-0001-7811-8613	Howard Hughes Medical Institute; Project ALS; p2ALS; Target ALS; National Institute of Neurological Disorders and Stroke [164520]; Lilly Scientific Fellowship Program; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [RC2NS069395] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); Project ALS; p2ALS; Target ALS; National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Lilly Scientific Fellowship Program; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The authors wish to thank all members of the Eggan laboratory for their technical support and helpful discussions. We also thank the Harvard Stem Cell and Regenerative Biology Histology Core. This work was supported by the Howard Hughes Medical Institute, Project ALS, p2ALS, Target ALS and National Institute of Neurological Disorders and Stroke grant #164520. N.S. was supported by the 2011 Lilly Scientific Fellowship Program.	Ash PEA, 2013, NEURON, V77, P639, DOI 10.1016/j.neuron.2013.02.004; DeJesus-Hernandez M, 2011, NEURON, V72, P245, DOI 10.1016/j.neuron.2011.09.011; Gijselinck I, 2012, LANCET NEUROL, V11, P54, DOI 10.1016/S1474-4422(11)70261-7; Henry AM, 2012, MAMM GENOME, V23, P539, DOI 10.1007/s00335-012-9406-2; Ludolph AC, 2012, CURR OPIN NEUROL, V25, P530, DOI 10.1097/WCO.0b013e328356d328; Mackenzie IRA, 2009, ACTA NEUROPATHOL, V117, P15, DOI 10.1007/s00401-008-0460-5; Majounie E, 2012, LANCET NEUROL, V11, P323, DOI 10.1016/S1474-4422(12)70043-1; Mori K, 2013, SCIENCE, V339, P1335, DOI 10.1126/science.1232927; Rademakers R, 2012, NAT REV NEUROL, V8, P423, DOI 10.1038/nrneurol.2012.117; Reddy K, 2013, J BIOL CHEM, V288, P9860, DOI 10.1074/jbc.C113.452532; Renton AE, 2011, NEURON, V72, P257, DOI 10.1016/j.neuron.2011.09.010; Skarnes WC, 2011, NATURE, V474, P337, DOI 10.1038/nature10163	12	55	57	0	16	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	DEC	2013	16	12					1725	1727		10.1038/nn.3566	http://dx.doi.org/10.1038/nn.3566			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	257VV	24185425	Green Accepted, Green Submitted			2022-12-28	WOS:000327416800007
J	Viney, TJ; Lasztoczi, B; Katona, L; Crump, MG; Tukker, JJ; Klausberger, T; Somogyi, P				Viney, Tim J.; Lasztoczi, Balint; Katona, Linda; Crump, Michael G.; Tukker, John J.; Klausberger, Thomas; Somogyi, Peter			Network state-dependent inhibition of identified hippocampal CA3 axo-axonic cells in vivo	NATURE NEUROSCIENCE			English	Article							RAT HIPPOCAMPUS; PYRAMIDAL CELLS; GABAERGIC NEURONS; CORTICAL INTERNEURONS; MEDIAL-SEPTUM; BEHAVING RAT; BASKET CELLS; SHARP WAVES; OSCILLATIONS; PARVALBUMIN	Hippocampal sharp waves are population discharges initiated by an unknown mechanism in pyramidal cell networks of CA3. Axo-axonic cells (AACs) regulate action potential generation through GABAergic synapses on the axon initial segment. We found that CA3 AACs in anesthetized rats and AACs in freely moving rats stopped firing during sharp waves, when pyramidal cells fire most. AACs fired strongly and rhythmically around the peak of theta oscillations, when pyramidal cells fire at low probability. Distinguishing AACs from other parvalbumin-expressing interneurons by their lack of detectable SATB1 transcription factor immunoreactivity, we discovered a somatic GABAergic input originating from the medial septum that preferentially targets AACs. We recorded septo-hippocampal GABAergic cells that were activated during hippocampal sharp waves and projected to CA3. We hypothesize that inhibition of AACs, and the resulting subcellular redistribution of inhibition from the axon initial segment to other pyramidal cell domains, is a necessary condition for the emergence of sharp waves promoting memory consolidation.	[Viney, Tim J.; Lasztoczi, Balint; Katona, Linda; Crump, Michael G.; Tukker, John J.; Klausberger, Thomas; Somogyi, Peter] Univ Oxford, Dept Pharmacol, Med Res Council Anat Neuropharmacol Unit, Oxford OX1 3QT, England; [Lasztoczi, Balint; Klausberger, Thomas; Somogyi, Peter] Med Univ Vienna, Ctr Brain Res, Vienna, Austria	University of Oxford; Medical University of Vienna	Viney, TJ (corresponding author), Univ Oxford, Dept Pharmacol, Med Res Council Anat Neuropharmacol Unit, S Parks Rd, Oxford OX1 3QT, England.	tim.viney@pharm.ox.ac.uk; balint.lasztoczi@meduniwien.ac.at; peter.somogyi@pharm.ox.ac.uk	Tukker, John/AAX-4005-2020; Katona, Linda/ABB-7768-2021	Katona, Linda/0000-0002-9942-4502; Viney, Tim/0000-0001-6444-1188; Tukker, John/0000-0002-4394-199X	Blaschko European Visiting Research Fellowship at Oxford [242689]; European Research Council [SCICO3]; Vienna Science and Technology Fund; Medical Research Council; MRC [MC_U138197110, MC_U138197107, MC_UU_12020/3, MC_UU_12020/6] Funding Source: UKRI; Medical Research Council [MC_U138197107, MC_UU_12020/6, MC_UU_12020/3, MC_U138197110] Funding Source: researchfish	Blaschko European Visiting Research Fellowship at Oxford; European Research Council(European Research Council (ERC)European Commission); Vienna Science and Technology Fund; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This paper celebrates the contributions of Janos Szentagothai (1912-1994) to neuroscience. We thank the excellent assistance of K. Detzner, D. Kotzadimitriou, B. Micklem and S. Biro. We thank J. Somogyi for advice on confocal microscopy and T. Forro, K. Hartwich and 0. Valenti for the use of identified interneurons that they labeled in vivo. We are grateful to R. Shigemoto (National Institute for Physiological Sciences, Okazaki, Japan) and M. Watanabe (Department of Anatomy, Hokkaido University Graduate School of Medicine) for the gift of antibodies. We thank T. Ellender and P. Magill for Comments on an earlier version of the manuscript. B.L. was supported by the Blaschko European Visiting Research Fellowship at Oxford; we acknowledge grant 242689 of the European Research Council, grant SCICO3 of the Vienna Science and Technology Fund and the Medical Research Council.	Acsady L, 1998, J NEUROSCI, V18, P3386; Baude A, 2007, CEREB CORTEX, V17, P2094, DOI 10.1093/cercor/bhl117; Borhegyi Z, 2004, J NEUROSCI, V24, P8470, DOI 10.1523/JNEUROSCI.1413-04.2004; BUZSAKI G, 1986, BRAIN RES, V398, P242, DOI 10.1016/0006-8993(86)91483-6; BUZSAKI G, 1992, SCIENCE, V256, P1025, DOI 10.1126/science.1589772; Chaudhry FA, 1998, J NEUROSCI, V18, P9733; Close J, 2012, J NEUROSCI, V32, P17690, DOI 10.1523/JNEUROSCI.3583-12.2012; Csicsvari J, 2000, NEURON, V28, P585, DOI 10.1016/S0896-6273(00)00135-5; Csicsvari J, 1999, J NEUROSCI, V19, P274, DOI 10.1523/JNEUROSCI.19-01-00274.1999; David C, 2007, EUR J NEUROSCI, V25, P2329, DOI 10.1111/j.1460-9568.2007.05496.x; Denaxa M, 2012, CELL REP, V2, P1351, DOI 10.1016/j.celrep.2012.10.003; Dragoi G, 1999, J NEUROSCI, V19, P6191, DOI 10.1523/JNEUROSCI.19-14-06191.1999; Dugladze T, 2012, SCIENCE, V336, P1458, DOI 10.1126/science.1222017; Fisahn A, 2009, CEREB CORTEX, V19, P612, DOI 10.1093/cercor/bhn107; FREUND TF, 1989, BRAIN RES, V478, P375, DOI 10.1016/0006-8993(89)91520-5; FREUND TF, 1988, NATURE, V336, P170, DOI 10.1038/336170a0; Fritschy JM, 2008, TRENDS NEUROSCI, V31, P257, DOI 10.1016/j.tins.2008.02.006; Girardeau G, 2009, NAT NEUROSCI, V12, P1222, DOI 10.1038/nn.2384; Glickfeld LL, 2009, NAT NEUROSCI, V12, P21, DOI 10.1038/nn.2230; GULYAS AI, 1993, EUR J NEUROSCI, V5, P1729, DOI 10.1111/j.1460-9568.1993.tb00240.x; Gulyas AI, 2010, J NEUROSCI, V30, P15134, DOI 10.1523/JNEUROSCI.4104-10.2010; Huang Y, 2011, NEUROSCI RES, V71, P12, DOI 10.1016/j.neures.2011.05.015; ISHIZUKA N, 1995, J COMP NEUROL, V362, P17, DOI 10.1002/cne.903620103; Jenkins SM, 2001, J CELL BIOL, V155, P739, DOI 10.1083/jcb.200109026; Klausberger T, 2003, NATURE, V421, P844, DOI 10.1038/nature01374; Klausberger T, 2004, NAT NEUROSCI, V7, P41, DOI 10.1038/nn1159; KOSAKA T, 1980, J NEUROCYTOL, V9, P861, DOI 10.1007/BF01205024; Lapray D, 2012, NAT NEUROSCI, V15, P1265, DOI 10.1038/nn.3176; Lasztoczi B, 2011, J NEUROSCI, V31, P18073, DOI 10.1523/JNEUROSCI.3573-11.2011; MILES R, 1990, J PHYSIOL-LONDON, V428, P61, DOI 10.1113/jphysiol.1990.sp018200; Mizuseki K, 2009, NEURON, V64, P267, DOI 10.1016/j.neuron.2009.08.037; Nielsen JV, 2010, CEREB CORTEX, V20, P1904, DOI 10.1093/cercor/bhp261; O'Keefe J, 1978, HIPPOCAMPUS COGNITIV; Papp OI, 2013, HIPPOCAMPUS, V23, P903, DOI 10.1002/hipo.22147; Righter K, 1999, J COMP NEUROL, V408, P437, DOI 10.1002/(SICI)1096-9861(19990607)408:3<437::AID-CNE9>3.0.CO;2-5; Shigemoto R, 1997, J NEUROSCI, V17, P7503, DOI 10.1523/jneurosci.17-19-07503.1997; SOMOGYI P, 1977, BRAIN RES, V136, P345, DOI 10.1016/0006-8993(77)90808-3; Somogyi P, 2010, HDB BRAIN MICROCIRCU, P148; Sugita S, 2002, NEUROSCIENCE, V112, P51, DOI 10.1016/S0306-4522(02)00063-5; SWANSON LW, 1979, J COMP NEUROL, V186, P621, DOI 10.1002/cne.901860408; Szabadics J, 2006, SCIENCE, V311, P233, DOI 10.1126/science.1121325; Szabadics J, 2010, J NEUROSCI, V30, P8296, DOI 10.1523/JNEUROSCI.5602-09.2010; Szentagothai J, 1974, Neurosci Res Program Bull, V12, P305; Tukker JJ, 2007, J NEUROSCI, V27, P8184, DOI 10.1523/JNEUROSCI.1685-07.2007; Tukker JJ, 2013, J NEUROSCI, V33, P6809, DOI 10.1523/JNEUROSCI.5052-12.2013; Varga C, 2012, P NATL ACAD SCI USA, V109, pE2726, DOI 10.1073/pnas.1210929109; Varga V, 2008, J PHYSIOL-LONDON, V586, P3893, DOI 10.1113/jphysiol.2008.155242; WILSON MA, 1994, SCIENCE, V265, P676, DOI 10.1126/science.8036517; Woodruff AR, 2011, J NEUROSCI, V31, P17872, DOI 10.1523/JNEUROSCI.3894-11.2011; Zhang L, 2012, HIPPOCAMPUS, V22, P1781, DOI 10.1002/hipo.22012	50	95	95	0	25	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	DEC	2013	16	12					1802	1811		10.1038/nn.3550	http://dx.doi.org/10.1038/nn.3550			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	257VV	24141313	Green Accepted			2022-12-28	WOS:000327416800018
J	Zhu, PX; Frank, T; Friedrich, RW				Zhu, Peixin; Frank, Thomas; Friedrich, Rainer W.			Equalization of odor representations by a network of electrically coupled inhibitory interneurons	NATURE NEUROSCIENCE			English	Article							ZEBRAFISH OLFACTORY-BULB; DROSOPHILA ANTENNAL LOBE; MAMMALIAN NEURONS; IN-VIVO; SYSTEM; RESPONSES; EXPRESSION; GLOMERULI; CELLS; CHANNELRHODOPSIN-2	Robustness of neuronal activity patterns against variations in input intensity is critical for neuronal computations. We found that odor representations in the olfactory bulb were stabilized by interneurons that were densely coupled to the output neurons by electrical and GABAergic synapses. This interneuron network modulated responses of output neurons as a function of stimulus intensity in two ways: it globally boosted responses to weak odors, but attenuated responses to strong odors, and it increased the sensitivity of some output neurons, but decreased the sensitivity of others. These effects are closely related to strategies used in engineering to increase dynamic range. Together, they maintained not only the mean, but also the distribution, of activity across the population of output neurons within narrow limits, which is important for pattern classification. Neuronal circuits in the olfactory bulb therefore stabilize combinatorial sensory representations against variations in stimulus intensity by generic mechanisms.	[Zhu, Peixin; Frank, Thomas; Friedrich, Rainer W.] Friedrich Miescher Inst Biomed Res, Basel, Switzerland; [Friedrich, Rainer W.] Univ Basel, Basel, Switzerland	Friedrich Miescher Institute for Biomedical Research; University of Basel	Friedrich, RW (corresponding author), Friedrich Miescher Inst Biomed Res, Basel, Switzerland.	rainer.friedrich@fmi.ch	Frank, Thomas/F-5273-2012	Frank, Thomas/0000-0002-5113-176X; Friedrich, Rainer/0000-0001-9107-0482	Novartis Research Foundation; European Molecular Biology Organization; Human Frontiers Science Program; Swiss National Science Foundation	Novartis Research Foundation; European Molecular Biology Organization(European Molecular Biology Organization (EMBO)); Human Frontiers Science Program(Human Frontier Science Program); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	We thank G. Jacobson, I. Namekawa, G. Keller and F. Albeanu for comments on the manuscript and members of the Friedrich laboratory for fruitful discussions. We are grateful to K. Deisseroth (Stanford University) for DNA constructs containing NpHR3.0-YFP and ChR2-YFP, and to E. Callaway (Salk Institute) for DNA constructs containing AlstR. This work was supported by the Novartis Research Foundation, the European Molecular Biology Organization, the Human Frontiers Science Program and the Swiss National Science Foundation.	Aungst JL, 2003, NATURE, V426, P623, DOI 10.1038/nature02185; Bamann C, 2008, J MOL BIOL, V375, P686, DOI 10.1016/j.jmb.2007.10.072; Barbour DL, 2011, NEUROSCI BIOBEHAV R, V35, P2064, DOI 10.1016/j.neubiorev.2011.04.009; Blumhagen F, 2011, NATURE, V479, P493, DOI 10.1038/nature10633; Bundschuh ST, 2012, J NEUROSCI, V32, P6830, DOI 10.1523/JNEUROSCI.6026-11.2012; Carandini M, 2012, NAT REV NEUROSCI, V13, P51, DOI 10.1038/nrn3136; Christiani N., 2000, INTRO SUPPORT VECTOR; Cleland TA, 2007, P NATL ACAD SCI USA, V104, P1953, DOI 10.1073/pnas.0608564104; Connors BW, 2004, ANNU REV NEUROSCI, V27, P393, DOI 10.1146/annurev.neuro.26.041002.131128; Friedrich RW, 2013, ANNU REV NEUROSCI, V36, P383, DOI 10.1146/annurev-neuro-062111-150504; Friedrich RW, 2004, J NEUROPHYSIOL, V91, P2658, DOI 10.1152/jn.01143.2003; Friedrich RW, 1997, NEURON, V18, P737, DOI 10.1016/S0896-6273(00)80314-1; Friedrich RW, 2001, SCIENCE, V291, P889, DOI 10.1126/science.291.5505.889; Gradinaru V, 2010, CELL, V141, P154, DOI 10.1016/j.cell.2010.02.037; GROSSISSEROFF R, 1988, CHEM SENSES, V13, P191, DOI 10.1093/chemse/13.2.191; HEEGER DJ, 1992, VISUAL NEUROSCI, V9, P181, DOI 10.1017/S0952523800009640; Huang J, 2010, NEURON, V67, P1021, DOI 10.1016/j.neuron.2010.08.025; Kiyokage E, 2010, J NEUROSCI, V30, P1185, DOI 10.1523/JNEUROSCI.3497-09.2010; Kosaka Katsuko, 2005, Anatomical Science International, V80, P80, DOI 10.1111/j.1447-073x.2005.00092.x; Kosaka T, 2005, NEUROSCIENCE, V131, P611, DOI 10.1016/j.neuroscience.2004.11.050; Kosaka T, 2008, NEUROSCI RES, V60, P349, DOI 10.1016/j.neures.2007.11.012; Lechner HAE, 2002, J NEUROSCI, V22, P5287; LEVETEAU J, 1966, SCIENCE, V153, P175, DOI 10.1126/science.153.3732.175; Li J, 2005, J NEUROSCI, V25, P5784, DOI 10.1523/JNEUROSCI.0922-05.2005; LIBERMAN MC, 1978, J ACOUST SOC AM, V63, P442, DOI 10.1121/1.381736; Liu SL, 2013, J NEUROSCI, V33, P2916, DOI 10.1523/JNEUROSCI.3607-12.2013; Luo SX, 2010, P NATL ACAD SCI USA, V107, P10713, DOI 10.1073/pnas.1005635107; MARR D, 1971, PHILOS T ROY SOC B, V262, P23, DOI 10.1098/rstb.1971.0078; MCNAUGHTON BL, 1987, TRENDS NEUROSCI, V10, P408, DOI 10.1016/0166-2236(87)90011-7; Niessing J, 2010, NATURE, V465, P47, DOI 10.1038/nature08961; Olsen SR, 2007, NEURON, V54, P89, DOI 10.1016/j.neuron.2007.03.010; Olsen SR, 2010, NEURON, V66, P287, DOI 10.1016/j.neuron.2010.04.009; PINCHING AJ, 1971, J CELL SCI, V9, P347; Rickgauer JP, 2009, P NATL ACAD SCI USA, V106, P15025, DOI 10.1073/pnas.0907084106; Rubin BD, 1999, NEURON, V23, P499, DOI 10.1016/S0896-6273(00)80803-X; Sato Y, 2005, J NEUROSCI, V25, P4889, DOI 10.1523/JNEUROSCI.0679-05.2005; Tallini YN, 2006, P NATL ACAD SCI USA, V103, P4753, DOI 10.1073/pnas.0509378103; Tan EM, 2006, NEURON, V51, P157, DOI 10.1016/j.neuron.2006.06.018; Volgyi B, 2004, J NEUROSCI, V24, P11182, DOI 10.1523/JNEUROSCI.3096-04.2004; Wachowiak M, 2001, NEURON, V32, P723, DOI 10.1016/S0896-6273(01)00506-2; Wilson DA, 2011, NEURON, V72, P506, DOI 10.1016/j.neuron.2011.10.027; Yaksi E, 2006, NAT METHODS, V3, P377, DOI 10.1038/NMETH874; Yaksi E, 2007, PLOS BIOL, V5, P1453, DOI 10.1371/journal.pbio.0050178; Yaksi E, 2010, NEURON, V67, P1034, DOI 10.1016/j.neuron.2010.08.041; Zerucha T, 2000, J NEUROSCI, V20, P709, DOI 10.1523/JNEUROSCI.20-02-00709.2000; Zhang CB, 2003, J COMP NEUROL, V459, P426, DOI 10.1002/cne.10617; Zhang CB, 2002, BRAIN RES, V929, P37, DOI 10.1016/S0006-8993(01)03372-8; Zhu PX, 2012, NAT PROTOC, V7, P1410, DOI 10.1038/nprot.2012.072; Zhu PX, 2009, FRONT NEURAL CIRCUIT, V3, DOI 10.3389/neuro.04.021.2009	50	41	42	0	9	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	NOV	2013	16	11					1678	1686		10.1038/nn.3528	http://dx.doi.org/10.1038/nn.3528			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	241YX	24077563				2022-12-28	WOS:000326205700026
J	Maglione, M; Sigrist, SJ				Maglione, Marta; Sigrist, Stephan J.			Seeing the forest tree by tree: super-resolution light microscopy meets the neurosciences	NATURE NEUROSCIENCE			English	Review							STED MICROSCOPY; LIVE CELLS; ACTIVE ZONE; FLUORESCENCE MICROSCOPY; STIMULATED-EMISSION; DENDRITIC SPINES; RESOLUTION LIMIT; PROTEIN; NANOSCOPY; DYNAMICS	Light microscopy can be applied in vivo and can sample large tissue volumes, features crucial for the study of single neurons and neural circuits. However, light microscopy per se is diffraction-limited in resolution, and the substructure of core signaling compartments of neuronal circuits-axons, presynaptic active zones, postsynaptic densities and dendritic spines-can be only insufficiently characterized by standard light microscopy. Recently, several forms of super-resolution light microscopy breaking the diffraction-imposed resolution limit have started to allow highly resolved, dynamic imaging in the cell-biologically highly relevant 10-100 nanometer range ('mesoscale'). New, sometimes surprising answers concerning how protein mobility and protein architectures shape neuronal communication have already emerged. Here we start by briefly introducing super-resolution microscopy techniques, before we describe their use in the analysis of neuronal compartments. We conclude with long-term prospects for super-resolution light microscopy in the molecular and cellular neurosciences.	[Maglione, Marta; Sigrist, Stephan J.] Free Univ Berlin, Inst Biol, Dept Genet, Berlin, Germany; [Sigrist, Stephan J.] Charite, NeuroCure Cluster Excellence, Berlin, Germany	Free University of Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Sigrist, SJ (corresponding author), Free Univ Berlin, Inst Biol, Dept Genet, Berlin, Germany.	stephan.sigrist@fu-berlin.de			Deutsche Forschungsgemeinschaft [TP A3/SFB 958, SI849 7-1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	We would like to thank D. Choquet, T. Kuner and S. Smith for sharing unpublished data and for scientific discussions. We thank T.A. Blanpied, H. Ewers, S. Hell, V. Nagerl, O. Shupliakov and X. Zhuang for permission to use their work. The authors are supported by grants from the Deutsche Forschungsgemeinschaft (TP A3/SFB 958; SI849 7-1).	Anderson JR, 2011, MOL VIS, V17; Anderson JR, 2009, PLOS BIOL, V7, P493, DOI 10.1371/journal.pbio.1000074; Aoyagi K, 2005, J BIOL CHEM, V280, P17346, DOI 10.1074/jbc.M413307200; Arenkiel BR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029423; Arenkiel BR, 2009, NATURE, V461, P900, DOI 10.1038/nature08536; Bar-On D, 2012, J BIOL CHEM, V287, P27158, DOI 10.1074/jbc.M112.353250; Bates M, 2007, SCIENCE, V317, P1749, DOI 10.1126/science.1146598; Bates M, 2012, CHEMPHYSCHEM, V13, P99, DOI 10.1002/cphc.201100735; Berning S, 2012, SCIENCE, V335, P551, DOI 10.1126/science.1215369; Betzig E, 2006, SCIENCE, V313, P1642, DOI 10.1126/science.1127344; Bosch M, 2012, CURR OPIN NEUROBIOL, V22, P383, DOI 10.1016/j.conb.2011.09.002; Buckers J, 2011, OPT EXPRESS, V19, P3130, DOI 10.1364/OE.19.003130; Choquet D, 2010, EUR J NEUROSCI, V32, P250, DOI 10.1111/j.1460-9568.2010.07350.x; Cognet Laurent, 2006, Sci STKE, V2006, ppe13, DOI 10.1126/stke.3272006pe13; Dani A, 2010, NEURON, V68, P843, DOI 10.1016/j.neuron.2010.11.021; Fiolka R, 2012, P NATL ACAD SCI USA, V109, P5311, DOI 10.1073/pnas.1119262109; Fouquet W, 2009, J CELL BIOL, V186, P129, DOI 10.1083/jcb.200812150; Frank T, 2010, NEURON, V68, P724, DOI 10.1016/j.neuron.2010.10.027; Frost NA, 2010, NEURON, V67, P86, DOI 10.1016/j.neuron.2010.05.026; Gold MG, 2012, BIOESSAYS, V34, P599, DOI 10.1002/bies.201200009; Gould TJ, 2012, OPT EXPRESS, V20, P20998, DOI 10.1364/OE.20.020998; Gustafsson MGL, 2008, BIOPHYS J, V94, P4957, DOI 10.1529/biophysj.107.120345; Gustafsson MGL, 2000, J MICROSC-OXFORD, V198, P82, DOI 10.1046/j.1365-2818.2000.00710.x; Hallermann S, 2010, J NEUROSCI, V30, P14340, DOI 10.1523/JNEUROSCI.2495-10.2010; Harnett MT, 2012, NATURE, V491, P599, DOI 10.1038/nature11554; Heilemann M, 2008, ANGEW CHEM INT EDIT, V47, P6172, DOI 10.1002/anie.200802376; Hein B, 2008, P NATL ACAD SCI USA, V105, P14271, DOI 10.1073/pnas.0807705105; Heine M, 2008, SCIENCE, V320, P201, DOI 10.1126/science.1152089; Hell SW, 2007, SCIENCE, V316, P1153, DOI 10.1126/science.1137395; HELL SW, 1994, OPT LETT, V19, P780, DOI 10.1364/OL.19.000780; Hess ST, 2007, P NATL ACAD SCI USA, V104, P17370, DOI 10.1073/pnas.0708066104; Hess ST, 2006, BIOPHYS J, V91, P4258, DOI 10.1529/biophysj.106.091116; Hoze N, 2012, P NATL ACAD SCI USA, V109, P17052, DOI 10.1073/pnas.1204589109; Hua YF, 2011, NAT NEUROSCI, V14, P833, DOI 10.1038/nn.2838; Huang B, 2008, SCIENCE, V319, P810, DOI 10.1126/science.1153529; Huang B, 2010, CELL, V143, P1047, DOI 10.1016/j.cell.2010.12.002; Huang B, 2009, ANNU REV BIOCHEM, V78, P993, DOI 10.1146/annurev.biochem.77.061906.092014; Izeddin I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015611; Jia N, 2012, P NATL ACAD SCI USA, V109, P22, DOI 10.1073/pnas.1109202108; Jiao W, 2010, J STRUCT BIOL, V172, P389, DOI 10.1016/j.jsb.2010.07.007; Jones SA, 2011, NAT METHODS, V8, P499, DOI [10.1038/NMETH.1605, 10.1038/nmeth.1605]; Juette MF, 2008, NAT METHODS, V5, P527, DOI 10.1038/nmeth.1211; Kerr JM, 2012, J NEUROSCI, V32, P658, DOI 10.1523/JNEUROSCI.2927-11.2012; Kittel RJ, 2006, SCIENCE, V312, P1051, DOI 10.1126/science.1126308; Kner P, 2009, NAT METHODS, V6, P339, DOI [10.1038/NMETH.1324, 10.1038/nmeth.1324]; Kwon HB, 2011, NATURE, V474, P100, DOI 10.1038/nature09986; Lakadamyali M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030826; Lau L, 2012, BIOPHYS J, V102, P2926, DOI 10.1016/j.bpj.2012.05.015; Lichtman JW, 2011, SCIENCE, V334, P618, DOI 10.1126/science.1209168; Liu KSY, 2011, SCIENCE, V334, P1565, DOI 10.1126/science.1212991; Livet J, 2007, NATURE, V450, P56, DOI 10.1038/nature06293; MacGillavry HD, 2011, MOL CELL NEUROSCI, V48, P321, DOI 10.1016/j.mcn.2011.09.001; Manley S, 2008, NAT METHODS, V5, P155, DOI 10.1038/NMETH.1176; Meyer L, 2008, SMALL, V4, P1095, DOI 10.1002/smll.200800055; Micheva KD, 2007, NEURON, V55, P25, DOI 10.1016/j.neuron.2007.06.014; Nagerl UV, 2008, P NATL ACAD SCI USA, V105, P18982, DOI 10.1073/pnas.0810028105; Nanguneri S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038098; Neher E, 2008, NEURON, V59, P861, DOI 10.1016/j.neuron.2008.08.019; Newpher TM, 2008, NEURON, V58, P472, DOI 10.1016/j.neuron.2008.04.030; Opazo F, 2012, NAT METHODS, V9, P938, DOI 10.1038/nmeth.2179; Owald D, 2010, J CELL BIOL, V188, P565, DOI 10.1083/jcb.200908055; Patterson G, 2010, ANNU REV PHYS CHEM, V61, P345, DOI 10.1146/annurev.physchem.012809.103444; Patterson GH, 2002, SCIENCE, V297, P1873, DOI 10.1126/science.1074952; Ries J, 2012, NAT METHODS, V9, P582, DOI [10.1038/NMETH.1991, 10.1038/nmeth.1991]; Rostaing P, 2006, EUR J NEUROSCI, V24, P3463, DOI 10.1111/j.1460-9568.2006.05234.x; Rueckel M, 2006, P NATL ACAD SCI USA, V103, P17137, DOI 10.1073/pnas.0604791103; Rust MJ, 2006, NAT METHODS, V3, P793, DOI 10.1038/nmeth929; Saka S, 2012, BIOESSAYS, V34, P386, DOI 10.1002/bies.201100080; Schermelleh L, 2008, SCIENCE, V320, P1332, DOI 10.1126/science.1156947; Schermelleh L, 2010, J CELL BIOL, V190, P165, DOI 10.1083/jcb.201002018; Schmidt R, 2008, NAT METHODS, V5, P539, DOI 10.1038/nmeth.1214; Schmidt R, 2009, NANO LETT, V9, P2508, DOI 10.1021/nl901398t; Shao L, 2011, NAT METHODS, V8, P1044, DOI [10.1038/NMETH.1734, 10.1038/nmeth.1734]; Shim SH, 2012, P NATL ACAD SCI USA, V109, P13978, DOI 10.1073/pnas.1201882109; Shtengel G, 2009, P NATL ACAD SCI USA, V106, P3125, DOI 10.1073/pnas.0813131106; Sieber JJ, 2007, SCIENCE, V317, P1072, DOI 10.1126/science.1141727; Sigrist SJ, 2012, CURR OPIN NEUROBIOL, V22, P86, DOI 10.1016/j.conb.2011.10.014; Sigrist SJ, 2011, CURR OPIN NEUROBIOL, V21, P144, DOI 10.1016/j.conb.2010.08.012; Sochacki KA, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2158; Sudhof TC, 2012, NEURON, V75, P11, DOI 10.1016/j.neuron.2012.06.012; Tatavarty V, 2012, MOL BIOL CELL, V23, P3167, DOI 10.1091/mbc.E12-02-0165; Tatavarty V, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007724; Tonnesen J, 2013, EXP NEUROL, V242, P33, DOI 10.1016/j.expneurol.2012.10.004; Toomre D, 2010, ANNU REV CELL DEV BI, V26, P285, DOI 10.1146/annurev-cellbio-100109-104048; Triller A, 2005, TRENDS NEUROSCI, V28, P133, DOI 10.1016/j.tins.2005.01.001; Triller A, 2008, NEURON, V59, P359, DOI 10.1016/j.neuron.2008.06.022; Urban NT, 2011, BIOPHYS J, V101, P1277, DOI 10.1016/j.bpj.2011.07.027; van de Linde S, 2010, J BIOTECHNOL, V149, P260, DOI 10.1016/j.jbiotec.2010.02.010; van den Bogaart G, 2011, NATURE, V479, P552, DOI 10.1038/nature10545; Wagh DA, 2006, NEURON, V49, P833, DOI 10.1016/j.neuron.2006.02.008; Watanabe S, 2011, NAT METHODS, V8, P80, DOI 10.1038/NMETH.1537; Westphal V, 2008, SCIENCE, V320, P246, DOI 10.1126/science.1154228; Wildanger D, 2009, J MICROSC-OXFORD, V236, P35, DOI [10.1111/j.1365-2818.2009.03.188.x, 10.1111/j.1365-2818.2009.03188.x]; Willig KI, 2006, NATURE, V440, P935, DOI 10.1038/nature04592; Wilmes S, 2012, ANGEW CHEM INT EDIT, V51, P4868, DOI 10.1002/anie.201200853; Wombacher R, 2010, NAT METHODS, V7, P717, DOI [10.1038/NMETH.1489, 10.1038/nmeth.1489]; Xu K, 2013, SCIENCE, V339, P452, DOI 10.1126/science.1232251; Xu K, 2012, NAT METHODS, V9, P185, DOI [10.1038/nmeth.1841, 10.1038/NMETH.1841]; York AG, 2012, NAT METHODS, V9, P749, DOI [10.1038/NMETH.2025, 10.1038/nmeth.2025]; Zhang MS, 2012, NAT METHODS, V9, P727, DOI [10.1038/NMETH.2021, 10.1038/nmeth.2021]	100	124	128	4	171	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUL	2013	16	7					790	797		10.1038/nn.3403	http://dx.doi.org/10.1038/nn.3403			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	174UM	23799471				2022-12-28	WOS:000321180900008
J	Wang, H; Duclot, F; Liu, Y; Wang, ZX; Kabbaj, M				Wang, Hui; Duclot, Florian; Liu, Yan; Wang, Zuoxin; Kabbaj, Mohamed			Histone deacetylase inhibitors facilitate partner preference formation in female prairie voles	NATURE NEUROSCIENCE			English	Article							PAIR-BOND FORMATION; ESTROGEN-RECEPTOR-ALPHA; MICROTUS-OCHROGASTER; NUCLEUS-ACCUMBENS; MATERNAL-CARE; AFFILIATIVE BEHAVIOR; SOCIAL-ORGANIZATION; DNA METHYLATION; OXYTOCIN; VASOPRESSIN	In the socially monogamous prairie vole (Microtus ochrogaster), mating induces enduring pair-bonds that are initiated by partner preference formation and regulated by a variety of neurotransmitters, including oxytocin, vasopressin and dopamine. We examined potential epigenetic mechanisms mediating pair-bond regulation and found that the histone deacetylase inhibitors sodium butyrate and trichostatin A (TSA) facilitated partner preference formation in female prairie voles in the absence of mating. This was associated with a specific upregulation of oxytocin receptor (OTR, oxtr) and vasopressin V1a receptor (V1aR, avpr1a) in the nucleus accumbens (NAcc), through an increase in histone acetylation at their respective promoters. Furthermore, TSA-facilitated partner preference was prevented by OTR or V1aR blockade in the NAcc. Notably, mating-induced partner preference triggered the same epigenetic regulation of oxtr and avpr1a gene promoters as TSA. These observations indicate that TSA and mating facilitate partner preference through epigenetic events, providing, to the best of our knowledge, the first direct evidence for epigenetic regulation of pair-bonding.	[Wang, Hui; Duclot, Florian; Kabbaj, Mohamed] Florida State Univ, Dept Biomed Sci, Tallahassee, FL 32306 USA; [Wang, Hui; Duclot, Florian; Liu, Yan; Wang, Zuoxin; Kabbaj, Mohamed] Florida State Univ, Program Neurosci, Tallahassee, FL 32306 USA; [Wang, Hui; Liu, Yan; Wang, Zuoxin] Florida State Univ, Dept Psychol, Tallahassee, FL 32306 USA	State University System of Florida; Florida State University; State University System of Florida; Florida State University; State University System of Florida; Florida State University	Kabbaj, M (corresponding author), Florida State Univ, Dept Biomed Sci, Tallahassee, FL 32306 USA.	zwang@psy.fsu.edu; mohamed.kabbaj@med.fsu.edu	Duclot, Florian/E-4669-2013; Kabbaj, Mohamed/M-9240-2016	Duclot, Florian/0000-0003-0121-5807; 	National Institute of Mental Health [MHR21-083128, MHR01-058616]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH058616, R21MH083128] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [K02DA023048] Funding Source: NIH RePORTER	National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We also thank M. Manning for the generous gift of the OTR antagonist OTA(T) (University of Toledo). This work was supported by grants from the National Institute of Mental Health (MHR21-083128 to M.K. and Z.W., and MHR01-058616 to Z.W.).	Aragona BJ, 2006, NAT NEUROSCI, V9, P133, DOI 10.1038/nn1613; Bonthuis PJ, 2011, ENDOCRINOLOGY, V152, P3172, DOI 10.1210/en.2010-1001; Bora E, 2009, CURR OPIN PSYCHIATR, V22, P320, DOI 10.1097/YCO.0b013e328329e970; Champagne FA, 2006, ENDOCRINOLOGY, V147, P2909, DOI 10.1210/en.2005-1119; Cho MM, 1999, BEHAV NEUROSCI, V113, P1071, DOI 10.1037/0735-7044.113.5.1071; Francis DD, 2002, J NEUROENDOCRINOL, V14, P349, DOI 10.1046/j.0007-1331.2002.00776.x; GETZ LL, 1986, BEHAV ECOL SOCIOBIOL, V18, P275, DOI 10.1007/BF00300004; Gingrich B, 2000, BEHAV NEUROSCI, V114, P173, DOI 10.1037/0735-7044.114.1.173; Halsall J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033453; Hawk JD, 2011, LEARN MEMORY, V18, P367, DOI 10.1101/lm.2097411; Hollis F, 2011, HORM BEHAV, V59, P331, DOI 10.1016/j.yhbeh.2010.09.005; Iannitti T, 2011, DRUGS R&D, V11, P227, DOI 10.2165/11591280-000000000-00000; INSEL TR, 1994, J NEUROSCI, V14, P5381; INSEL TR, 1992, PSYCHONEUROENDOCRINO, V17, P3, DOI 10.1016/0306-4530(92)90073-G; INSEL TR, 1995, BEHAV NEUROSCI, V109, P782, DOI 10.1037/0735-7044.109.4.782; Ito K, 2002, MOL BIOTECHNOL, V20, P99, DOI 10.1385/MB:20:1:099; Keebaugh AC, 2011, HORM BEHAV, V60, P498, DOI 10.1016/j.yhbeh.2011.07.018; Kumar A, 2005, NEURON, V48, P303, DOI 10.1016/j.neuron.2005.09.023; Lim MM, 2004, NEUROSCIENCE, V125, P35, DOI 10.1016/j.neuroscience.2003.12.008; Liu Y, 2003, NEUROSCIENCE, V121, P537, DOI 10.1016/S0306-4522(03)00555-4; Liu Y, 2001, BEHAV NEUROSCI, V115, P910, DOI 10.1037//0735-7044.115.4.910; Liu Y, 2010, P NATL ACAD SCI USA, V107, P1217, DOI 10.1073/pnas.0911998107; Manning M, 2008, PROG BRAIN RES, V170, P473, DOI 10.1016/S0079-6123(08)00437-8; Mariadason JM, 2000, CANCER RES, V60, P4561; Molfese DL, 2011, DEV NEUROPSYCHOL, V36, P810, DOI 10.1080/87565641.2011.606395; Monneret C, 2005, EUR J MED CHEM, V40, P1, DOI 10.1016/j.ejmech.2004.10.001; Monsey MS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019958; Murgatroyd C, 2009, NAT NEUROSCI, V12, P1559, DOI 10.1038/nn.2436; Pitkow LJ, 2001, J NEUROSCI, V21, P7392, DOI 10.1523/JNEUROSCI.21-18-07392.2001; Ross HE, 2009, NEUROSCIENCE, V162, P892, DOI 10.1016/j.neuroscience.2009.05.055; Ross HE, 2009, J NEUROSCI, V29, P1312, DOI 10.1523/JNEUROSCI.5039-08.2009; Schroeder FA, 2007, BIOL PSYCHIAT, V62, P55, DOI 10.1016/j.biopsych.2006.06.036; Stefanko DP, 2009, P NATL ACAD SCI USA, V106, P9447, DOI 10.1073/pnas.0903964106; Stimson L, 2009, CANCER LETT, V280, P177, DOI 10.1016/j.canlet.2009.03.016; THOMAS JA, 1979, BEHAV ECOL SOCIOBIOL, V5, P171, DOI 10.1007/BF00293304; VanLint C, 1996, GENE EXPRESSION, V5, P245; Vecsey CG, 2007, J NEUROSCI, V27, P6128, DOI 10.1523/JNEUROSCI.0296-07.2007; Veenema AH, 2012, HORM BEHAV, V61, P304, DOI 10.1016/j.yhbeh.2011.12.002; Weaver ICG, 2006, P NATL ACAD SCI USA, V103, P3480, DOI 10.1073/pnas.0507526103; Weaver ICG, 2004, NAT NEUROSCI, V7, P847, DOI 10.1038/nn1276; WILLIAMS JR, 1992, HORM BEHAV, V26, P339, DOI 10.1016/0018-506X(92)90004-F; WINSLOW JT, 1993, NATURE, V365, P545, DOI 10.1038/365545a0; WITT DM, 1991, ENDOCRINOLOGY, V128, P3269, DOI 10.1210/endo-128-6-3269; Witt O, 2009, CANCER LETT, V277, P8, DOI 10.1016/j.canlet.2008.08.016; Yang XJ, 2008, MOL CELL, V31, P449, DOI 10.1016/j.molcel.2008.07.002; YOSHIDA M, 1995, BIOESSAYS, V17, P423, DOI 10.1002/bies.950170510; Young KA, 2011, FRONT NEUROENDOCRIN, V32, P53, DOI 10.1016/j.yfrne.2010.07.006; Young LJ, 1996, J NEUROENDOCRINOL, V8, P777, DOI 10.1046/j.1365-2826.1996.05188.x; Young LJ, 2001, HORM BEHAV, V40, P133, DOI 10.1006/hbeh.2001.1691; Zhong S, 2007, ONCOGENE, V26, P2621, DOI 10.1038/sj.onc.1210041	50	85	85	0	67	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JUL	2013	16	7					919	U184		10.1038/nn.3420	http://dx.doi.org/10.1038/nn.3420			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	174UM	23727821	Green Accepted			2022-12-28	WOS:000321180900026
J	Kennedy, PJ; Feng, J; Robison, AJ; Maze, I; Badimon, A; Mouzon, E; Chaudhury, D; Damez-Werno, DM; Haggarty, SJ; Han, MH; Bassel-Duby, R; Olson, EN; Nestler, EJ				Kennedy, Pamela J.; Feng, Jian; Robison, A. J.; Maze, Ian; Badimon, Ana; Mouzon, Ezekiell; Chaudhury, Dipesh; Damez-Werno, Diane M.; Haggarty, Stephen J.; Han, Ming-Hu; Bassel-Duby, Rhonda; Olson, Eric N.; Nestler, Eric J.			Class I HDAC inhibition blocks cocaine-induced plasticity by targeted changes in histone methylation	NATURE NEUROSCIENCE			English	Article							NUCLEUS-ACCUMBENS; BEHAVIORAL SENSITIZATION; DEACETYLASE INHIBITORS; DELTA-FOSB; AMPHETAMINE; EXPRESSION; ACETYLATION; ACTIVATION; GLUTAMATE; MECHANISM	Induction of histone acetylation in the nucleus accumbens (NAc), a key brain reward region, promotes cocaine-induced alterations in gene expression. Histone deacetylases (HDACs) tightly regulate the acetylation of histone tails, but little is known about the functional specificity of different HDAC isoforms in the development and maintenance of cocaine-induced plasticity, and previous studies of HDAC inhibitors report conflicting effects on cocaine-elicited behavioral adaptations. Here we demonstrate that specific and prolonged blockade of HDAC1 in NAc of mice increased global levels of histone acetylation, but also induced repressive histone methylation and antagonized cocaine-induced changes in behavior, an effect mediated in part through a chromatin-mediated suppression of GABA(A) receptor subunit expression and inhibitory tone on NAc neurons. Our findings suggest a new mechanism by which prolonged and selective HDAC inhibition can alter behavioral and molecular adaptations to cocaine and inform the development of therapeutics for cocaine addiction.	[Kennedy, Pamela J.; Feng, Jian; Robison, A. J.; Badimon, Ana; Mouzon, Ezekiell; Damez-Werno, Diane M.; Nestler, Eric J.] Icahn Sch Med Mt Sinai, Fishberg Dept Neurosci, New York, NY USA; [Kennedy, Pamela J.; Feng, Jian; Robison, A. J.; Badimon, Ana; Mouzon, Ezekiell; Damez-Werno, Diane M.; Nestler, Eric J.] Icahn Sch Med Mt Sinai, Friedman Brain Inst, New York, NY USA; [Maze, Ian] Rockefeller Univ, Lab Chromatin Biol & Epigenet, New York, NY 10021 USA; [Chaudhury, Dipesh; Han, Ming-Hu] Mt Sinai Sch Med, Friedman Brain Inst, Dept Pharmacol & Syst Therapeut, New York, NY USA; [Haggarty, Stephen J.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Ctr Human Genet Res,Dept Neurol, Boston, MA USA; [Bassel-Duby, Rhonda; Olson, Eric N.] Univ Texas SW Med Ctr Dallas, Dept Mol Biol, Dallas, TX 75390 USA	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Rockefeller University; Icahn School of Medicine at Mount Sinai; Harvard University; Harvard Medical School; Massachusetts General Hospital; University of Texas System; University of Texas Southwestern Medical Center Dallas	Nestler, EJ (corresponding author), Icahn Sch Med Mt Sinai, Fishberg Dept Neurosci, New York, NY USA.	eric.nestler@mssm.edu	Maze, Ian/P-8077-2018; Han, Ming-Hu/G-8836-2012; Robison, Alfred J/P-8521-2018; Haggarty, Stephen J/M-9495-2016	Robison, Alfred J/0000-0002-4150-9570; Haggarty, Stephen J/0000-0002-7872-168X; Maze, Ian/0000-0003-1490-7781	US National Institute on Drug Abuse; US National Institute of Mental Health; Canadian Institutes for Health Research [MFE 90086]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH092306] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA028301, R01DA007359, P01DA008227] Funding Source: NIH RePORTER	US National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); US National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	The authors would like to thank R. Neve (Massachusetts Institute of Technology) for viral vectors and M. Baxter for statistical expertise. This work was supported by grants from the US National Institute on Drug Abuse and National Institute of Mental Health (E.J.N.) and the Canadian Institutes for Health Research (P.J.K.; MFE 90086).	Badiani A, 2004, BEHAV PHARMACOL, V15, P327, DOI 10.1097/00008877-200409000-00004; Bahari-Javan S, 2012, J NEUROSCI, V32, P5062, DOI 10.1523/JNEUROSCI.0079-12.2012; Bertran-Gonzalez J, 2008, J NEUROSCI, V28, P5671, DOI 10.1523/JNEUROSCI.1039-08.2008; Boudreau AC, 2005, J NEUROSCI, V25, P9144, DOI 10.1523/JNEUROSCI.2252-05.2005; Broide RS, 2007, J MOL NEUROSCI, V31, P47, DOI 10.1007/BF02686117; Brown TE, 2011, J NEUROSCI, V31, P8163, DOI 10.1523/JNEUROSCI.0016-11.2011; Churchill L, 1999, J NEUROCHEM, V72, P2397, DOI 10.1046/j.1471-4159.1999.0722397.x; Covington HE, 2011, NEURON, V71, P656, DOI 10.1016/j.neuron.2011.06.007; Dion MF, 2007, SCIENCE, V315, P1405, DOI 10.1126/science.1134053; Dixon CI, 2010, P NATL ACAD SCI USA, V107, P2289, DOI 10.1073/pnas.0910117107; Fischer A, 2010, TRENDS PHARMACOL SCI, V31, P605, DOI 10.1016/j.tips.2010.09.003; Gregoretti IV, 2004, J MOL BIOL, V338, P17, DOI 10.1016/j.jmb.2004.02.006; Guan JS, 2009, NATURE, V459, P55, DOI 10.1038/nature07925; Heiman M, 2008, CELL, V135, P738, DOI 10.1016/j.cell.2008.10.028; Kalda A, 2007, BEHAV BRAIN RES, V181, P76, DOI 10.1016/j.bbr.2007.03.027; Kauer JA, 2007, NAT REV NEUROSCI, V8, P844, DOI 10.1038/nrn2234; Kelz MB, 1999, NATURE, V401, P272, DOI 10.1038/45790; Khan N, 2008, BIOCHEM J, V409, P581, DOI 10.1042/BJ20070779; Kim WY, 2008, NEUROSCI LETT, V432, P54, DOI 10.1016/j.neulet.2007.12.005; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Kumar A, 2005, NEURON, V48, P303, DOI 10.1016/j.neuron.2005.09.023; Kurita M, 2012, NAT NEUROSCI, V15, P1245, DOI 10.1038/nn.3181; Lagger G, 2002, EMBO J, V21, P2672, DOI 10.1093/emboj/21.11.2672; Lee KW, 2006, P NATL ACAD SCI USA, V103, P3399, DOI 10.1073/pnas.0511244103; Lee TI, 2006, NAT PROTOC, V1, P729, DOI 10.1038/nprot.2006.98; Levine AA, 2005, P NATL ACAD SCI USA, V102, P19186, DOI 10.1073/pnas.0509735102; Levine A, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3003062; Lobo MK, 2010, SCIENCE, V330, P385, DOI 10.1126/science.1188472; Malvaez M, 2011, J NEUROSCI, V31, P16941, DOI 10.1523/JNEUROSCI.2747-11.2011; Malvaez M, 2010, BIOL PSYCHIAT, V67, P36, DOI 10.1016/j.biopsych.2009.07.032; Maze I, 2011, P NATL ACAD SCI USA, V108, P3035, DOI 10.1073/pnas.1015483108; Maze I, 2010, SCIENCE, V327, P213, DOI 10.1126/science.1179438; McQuown SC, 2011, J NEUROSCI, V31, P764, DOI 10.1523/JNEUROSCI.5052-10.2011; Montgomery RL, 2008, J CLIN INVEST, V118, P3588, DOI 10.1172/JCI35847; Montgomery RL, 2007, GENE DEV, V21, P1790, DOI 10.1101/gad.1563807; Pierce RC, 1997, BRAIN RES REV, V25, P192, DOI 10.1016/S0165-0173(97)00021-0; Pierce RC, 1996, J NEUROSCI, V16, P1550; Renthal W, 2007, NEURON, V56, P517, DOI 10.1016/j.neuron.2007.09.032; Renthal W, 2009, NEURON, V62, P335, DOI 10.1016/j.neuron.2009.03.026; Romieu P, 2008, J NEUROSCI, V28, P9342, DOI 10.1523/JNEUROSCI.0379-08.2008; Schroeder FA, 2008, NEUROPSYCHOPHARMACOL, V33, P2981, DOI 10.1038/npp.2008.15; Shen HY, 2008, NEUROSCIENCE, V157, P644, DOI 10.1016/j.neuroscience.2008.09.019; Sun J, 2008, NEUROSCI LETT, V441, P72, DOI 10.1016/j.neulet.2008.05.010; Wang L, 2010, NEUROPSYCHOPHARMACOL, V35, P913, DOI 10.1038/npp.2009.193; WHITE FJ, 1995, J PHARMACOL EXP THER, V273, P445	45	122	127	0	37	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	APR	2013	16	4					434	U95		10.1038/nn.3354	http://dx.doi.org/10.1038/nn.3354			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	114EM	23475113	Green Accepted, Green Submitted			2022-12-28	WOS:000316723700013
J	Kim, J; Marlow, PJ; Anderson, BL				Kim, Juno; Marlow, Phillip J.; Anderson, Barton L.			The dark side of gloss	NATURE NEUROSCIENCE			English	Article							REAL-WORLD ILLUMINATION; PERCEIVED GLOSSINESS; SURFACE GLOSS; IMAGE STATISTICS; PERCEPTION; HIGHLIGHTS; LIGHTNESS; CONGRUENCE; REFLECTION; DISPARITY	Our visual system relies on the image structure generated by the interaction of light with objects to infer their material properties. One widely studied surface property is gloss, which can provide information that an object is smooth, shiny or wet. Studies have historically focused on the role of specular highlights in modulating perceived gloss. Here we show in human observers that glossy surfaces can generate both bright specular highlights and dark specular 'lowlights', and that the presence of either is sufficient to generate compelling percepts of gloss. We show that perceived gloss declines when the image structure generated by specular lowlights is blurred or misaligned with surrounding surface shading and that perceived gloss can arise from the presence of lowlights in surface regions isolated from highlights. These results suggest that the image structure generated by specular highlights and lowlights is used to construct our experience of surface gloss.	[Kim, Juno; Marlow, Phillip J.; Anderson, Barton L.] Univ Sydney, Sch Psychol, Sydney, NSW 2006, Australia	University of Sydney	Kim, J (corresponding author), Univ Sydney, Sch Psychol, Sydney, NSW 2006, Australia.	juno@psych.usyd.edu.au; barta@psych.usyd.edu.au		Anderson, Barton/0000-0003-0313-4285	Australian Research Council	Australian Research Council(Australian Research Council)	We thank M. Niemela for 3D printing of physical surface models, R. Fleming for advice on rendering techniques, K. Grady for artistic inspiration, and an anonymous reviewer for insight about the optics of paints. This project was funded by an Australian Research Council Discovery Project awarded to B.L.A., J.K. and R. Fleming, and an Australian Research Council fellowship to B.L.A.	Anderson BL, 2009, J VISION, V9, DOI 10.1167/9.11.10; BECK J, 1981, PERCEPT PSYCHOPHYS, V30, P407, DOI 10.3758/BF03206160; BLAKE A, 1990, NATURE, V343, P165, DOI 10.1038/343165a0; Doerschner K, 2010, J VISION, V10, DOI 10.1167/10.9.11; Ferwerda JA, 2001, PROC SPIE, V4299, P291, DOI 10.1117/12.429501; Fleming RW, 2004, J VISION, V4, P798, DOI 10.1167/4.9.10; Fleming RW, 2003, J VISION, V3, P347, DOI 10.1167/3.5.3; Hunter R.S., 1987, MEASUREMENT APPEARAN, V2nd; Kim J, 2011, J VISION, V11, DOI 10.1167/11.9.4; Kim J, 2010, J VISION, V10, DOI 10.1167/10.9.3; KLINKER GJ, 1988, INT J COMPUT VISION, V2, P7, DOI 10.1007/BF00836279; KOENDERINK JJ, 1980, OPT ACTA, V27, P981, DOI 10.1080/713820338; Marlow P, 2011, J VISION, V11, DOI 10.1167/11.9.16; Motoyoshi I, 2007, NATURE, V447, P206, DOI 10.1038/nature05724; Olkkonen M, 2010, J VISION, V10, DOI 10.1167/10.9.5; Pellacini F, 2000, COMP GRAPH, P55, DOI 10.1145/344779.344812; Todd JT, 2004, PSYCHOL SCI, V15, P33, DOI 10.1111/j.0963-7214.2004.01501006.x; Wendt G, 2010, J VISION, V10, DOI 10.1167/10.9.7; Wendt G, 2008, J VISION, V8, DOI 10.1167/8.1.14; Wijntjes MWA, 2010, J VISION, V10, DOI 10.1167/10.9.13	20	61	61	0	19	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	NOV	2012	15	11					1590	1595		10.1038/nn.3221	http://dx.doi.org/10.1038/nn.3221			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	028LX	23001059				2022-12-28	WOS:000310424900020
J	Quintana, A; Sanz, E; Wang, WG; Storey, GP; Guller, AD; Wanat, MJ; Roller, BA; La Torre, A; Amieux, PS; McKnight, GS; Bamford, NS; Palmiter, RD				Quintana, Albert; Sanz, Elisenda; Wang, Wengang; Storey, Granville P.; Gueller, Ali D.; Wanat, Matthew J.; Roller, Bryan A.; La Torre, Anna; Amieux, Paul S.; McKnight, G. Stanley; Bamford, Nigel S.; Palmiter, Richard D.			Lack of GPR88 enhances medium spiny neuron activity and alters motor- and cue-dependent behaviors	NATURE NEUROSCIENCE			English	Article							BASAL GANGLIA; PREPULSE INHIBITION; OPTOGENETIC CONTROL; NUCLEUS-ACCUMBENS; DORSAL STRIATUM; DOPAMINE; SCHIZOPHRENIA; RECEPTORS; ASSOCIATION; MODULATION	The striatum regulates motor control, reward and learning. Abnormal function of striatal GABAergic medium spiny neurons (MSNs) is believed to contribute to the deficits in these processes that are observed in many neuropsychiatric diseases. The orphan G protein-coupled receptor GPR88 is robustly expressed in MSNs and is regulated by neuropharmacological drugs, but its contribution to MSN physiology and behavior is unclear. We found that, in the absence of GPR88, MSNs showed increased glutamatergic excitation and reduced GABAergic inhibition, which promoted enhanced firing rates in vivo, resulting in hyperactivity, poor motor coordination and impaired cue-based learning in mice. Targeted viral expression of GPR88 in MSNs rescued the molecular and electrophysiological properties and normalized behavior, suggesting that aberrant MSN activation in the absence of GPR88 underlies behavioral deficits and its dysfunction may contribute to behaviors observed in neuropsychiatric disease.	[Quintana, Albert; Gueller, Ali D.; Roller, Bryan A.; Palmiter, Richard D.] Univ Washington, Dept Biochem, Howard Hughes Med Inst, Seattle, WA 98195 USA; [Sanz, Elisenda; Wanat, Matthew J.; Amieux, Paul S.; McKnight, G. Stanley] Univ Washington, Dept Pharmacol, Seattle, WA 98195 USA; [Wang, Wengang; Storey, Granville P.; Bamford, Nigel S.] Univ Washington, Dept Neurol, Seattle, WA 98195 USA; [Wanat, Matthew J.] Univ Washington, Dept Psychiat & Behav Sci, Seattle, WA 98195 USA; [La Torre, Anna] Univ Washington, Dept Biol Struct, Seattle, WA 98195 USA; [Bamford, Nigel S.] Univ Washington, Dept Pediat, Grad Program Neurobiol & Behav, Seattle, WA 98195 USA; [Bamford, Nigel S.] Univ Washington, Ctr Human Dev & Disabil, Seattle, WA 98195 USA; [Bamford, Nigel S.] Seattle Childrens Hosp, Seattle, WA USA	Howard Hughes Medical Institute; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Seattle Children's Hospital	Palmiter, RD (corresponding author), Univ Washington, Dept Biochem, Howard Hughes Med Inst, Seattle, WA 98195 USA.	palmiter@uw.edu	Quintana, Albert/N-5544-2015; Sanz, Elisenda/I-2765-2015; Amieux, Paul/AAG-4102-2021; Bamford, Nigel/S-9141-2019	Quintana, Albert/0000-0003-1674-7160; Sanz, Elisenda/0000-0002-7932-8556; Bamford, Nigel/0000-0003-3375-1022; La Torre, Anna/0000-0003-2103-4376; Guler, Ali Deniz/0000-0001-8218-850X; Wanat, Matthew/0000-0003-1643-6557	US National Institutes of Health [NS052536, NS060803, HD02274, MH086386, DA007278, GM032875]; Spanish Ministry of Science and Innovation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD002274] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM032875] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH086386] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS060803, K02NS052536] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [T32DA007278] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	The authors thank G. Froelick for assistance with histology,). Parker for help making the targeting construct, L. Zweifel and M. Carter for helpful discussions, and D. Durnam for editing. This work was supported by grants NS052536, NS060803, HD02274 (N.S.B.), MH086386 (G.S.M. and P.S.A.), DA007278 (G.P.S.) and GM032875 (G.S.M.) from the US National Institutes of Health. A.Q. and E.S. were recipients of Spanish Ministry of Science and Innovation postdoctoral mobility program fellowships.	Ade KK, 2008, J NEUROSCI, V28, P1185, DOI 10.1523/JNEUROSCI.3908-07.2008; Balleine BW, 2007, J NEUROSCI, V27, P8161, DOI 10.1523/JNEUROSCI.1554-07.2007; Befort K, 2008, EUR J NEUROSCI, V27, P2973, DOI 10.1111/j.1460-9568.2008.06273.x; Berke JD, 2004, NEURON, V43, P883, DOI 10.1016/j.neuron.2004.08.035; Berman DM, 1996, CELL, V86, P445, DOI 10.1016/S0092-8674(00)80117-8; Boehm C, 2006, J NEUROCHEM, V97, P44, DOI 10.1111/j.1471-4159.2006.03750.x; Braff DL, 2001, PSYCHOPHARMACOLOGY, V156, P234, DOI 10.1007/s002130100810; Brandish PE, 2005, NEURON, V45, P861, DOI 10.1016/j.neuron.2005.02.006; Chen XN, 2008, AM J MED GENET B, V147B, P1231, DOI 10.1002/ajmg.b.30759; Chowdari KV, 2002, HUM MOL GENET, V11, P1373, DOI 10.1093/hmg/11.12.1373; Conti B, 2007, MOL PSYCHIATR, V12, P167, DOI 10.1038/sj.mp.4001897; Corvin AP, 2004, MOL PSYCHIATR, V9, P208, DOI 10.1038/sj.mp.4001412; Darvas M, 2011, BIOL PSYCHIAT, V69, P704, DOI 10.1016/j.biopsych.2010.09.033; Darvas M, 2010, J NEUROSCI, V30, P1158, DOI 10.1523/JNEUROSCI.4576-09.2010; Ding J, 2006, NAT NEUROSCI, V9, P832, DOI 10.1038/nn1700; Drew MR, 2007, J NEUROSCI, V27, P7731, DOI 10.1523/JNEUROSCI.1736-07.2007; Farrant M, 2005, NAT REV NEUROSCI, V6, P215, DOI 10.1038/nrn1625; Ferguson SM, 2012, NEUROPSYCHOPHARMACOL, V37, P296, DOI 10.1038/npp.2011.179; GERFEN CR, 1992, ANNU REV NEUROSCI, V15, P285, DOI 10.1146/annurev.neuro.15.1.285; GRAYBIEL AM, 1994, SCIENCE, V265, P1826, DOI 10.1126/science.8091209; Jacob TC, 2008, NAT REV NEUROSCI, V9, P331, DOI 10.1038/nrn2370; Janssen MJ, 2009, J NEUROSCI, V29, P5116, DOI 10.1523/JNEUROSCI.4737-08.2009; Joshi PR, 2009, J NEUROSCI, V29, P2414, DOI 10.1523/JNEUROSCI.5687-08.2009; KODSI MH, 1994, BRAIN RES, V643, P59, DOI 10.1016/0006-8993(94)90008-6; Kravitz AV, 2010, NATURE, V466, P622, DOI 10.1038/nature09159; Lerner TN, 2012, NEURON, V73, P347, DOI 10.1016/j.neuron.2011.11.015; Lobo MK, 2010, SCIENCE, V330, P385, DOI 10.1126/science.1188472; Logue SF, 2009, MOL CELL NEUROSCI, V42, P438, DOI 10.1016/j.mcn.2009.09.007; Madisen L, 2010, NAT NEUROSCI, V13, P133, DOI 10.1038/nn.2467; Massart R, 2009, EUR J NEUROSCI, V30, P397, DOI 10.1111/j.1460-9568.2009.06842.x; MCDONALD RJ, 1994, BEHAV NEURAL BIOL, V61, P260, DOI 10.1016/S0163-1047(05)80009-3; Nicola SM, 2000, ANNU REV NEUROSCI, V23, P185, DOI 10.1146/annurev.neuro.23.1.185; Nunez-Abades PA, 2000, J NEUROPHYSIOL, V84, P2317, DOI 10.1152/jn.2000.84.5.2317; Ogden CA, 2004, MOL PSYCHIATR, V9, P1007, DOI 10.1038/sj.mp.4001547; Packard MG, 2002, ANNU REV NEUROSCI, V25, P563, DOI 10.1146/annurev.neuro.25.112701.142937; Parker JG, 2011, J NEUROSCI, V31, P17103, DOI 10.1523/JNEUROSCI.1715-11.2011; Ralph-Williams RJ, 2002, J NEUROSCI, V22, P9604; Russell VA, 2007, J NEUROSCI METH, V161, P185, DOI 10.1016/j.jneumeth.2006.12.005; Sanz E, 2009, P NATL ACAD SCI USA, V106, P13939, DOI 10.1073/pnas.0907143106; Song I, 2002, TRENDS NEUROSCI, V25, P578, DOI 10.1016/S0166-2236(02)02270-1; Surmeier DJ, 2010, PROG BRAIN RES, V183, P149, DOI 10.1016/S0079-6123(10)83008-0; Surmeier DJ, 2009, CURR OPIN NEUROBIOL, V19, P621, DOI 10.1016/j.conb.2009.10.003; VANDERHEYDEN JAM, 1988, BEHAV BRAIN RES, V31, P61, DOI 10.1016/0166-4328(88)90158-1; Wang WG, 2012, J PHYSIOL-LONDON, V590, P3743, DOI 10.1113/jphysiol.2012.235200; Wilson CJ, 1996, J NEUROSCI, V16, P2397; Zhang FQ, 2008, BMC MED GENET, V9, DOI 10.1186/1471-2350-9-119; Zweifel LS, 2009, P NATL ACAD SCI USA, V106, P7281, DOI 10.1073/pnas.0813415106	47	80	81	0	19	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	NOV	2012	15	11					1547	1555		10.1038/nn.3239	http://dx.doi.org/10.1038/nn.3239			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	028LX	23064379	Green Accepted			2022-12-28	WOS:000310424900015
J	Hallermann, S; de Kock, CPJ; Stuart, GJ; Kole, MHP				Hallermann, Stefan; de Kock, Christiaan P. J.; Stuart, Greg J.; Kole, Maarten H. P.			State and location dependence of action potential metabolic cost in cortical pyramidal neurons	NATURE NEUROSCIENCE			English	Article							GATED POTASSIUM CHANNELS; AXON INITIAL SEGMENT; MOSSY FIBER BOUTONS; CEREBELLAR PURKINJE NEURONS; SODIUM-CHANNELS; INCOMPLETE INACTIVATION; MAMMALIAN BRAIN; WHITE-MATTER; KV1 CHANNELS; ACTIVATION	Action potential generation and conduction requires large quantities of energy to restore Na+ and K+ ion gradients. We investigated the subcellular location and voltage dependence of this metabolic cost in rat neocortical pyramidal neurons. Using Na+/K+ charge overlap as a measure of action potential energy efficiency, we found that action potential initiation in the axon initial segment (AIS) and forward propagation into the axon were energetically inefficient, depending on the resting membrane potential. In contrast, action potential backpropagation into dendrites was efficient. Computer simulations predicted that, although the AIS and nodes of Ranvier had the highest metabolic cost per membrane area, action potential backpropagation into the dendrites and forward propagation into axon collaterals dominated energy consumption in cortical pyramidal neurons. Finally, we found that the high metabolic cost of action potential initiation and propagation down the axon is a trade-off between energy minimization and maximization of the conduction reliability of high-frequency action potentials.	[Stuart, Greg J.; Kole, Maarten H. P.] Australian Natl Univ, John Curtin Sch Med Res, Eccles Inst Neurosci, Canberra, ACT 2601, Australia; [Hallermann, Stefan] European Neurosci Inst Gottingen, Gottingen, Germany; [Hallermann, Stefan] Univ Leipzig, Fac Med, Carl Ludwig Inst Physiol, Leipzig, Germany; [de Kock, Christiaan P. J.] Vrije Univ Amsterdam, Ctr Neurogen & Cognit Res, Dept Integrat Neurophysiol, Amsterdam, Netherlands; [Kole, Maarten H. P.] Netherlands Inst Neurosci, Dept Axonal Signaling, Amsterdam, Netherlands	Australian National University; John Curtin School of Medical Research; Leipzig University; Vrije Universiteit Amsterdam; Royal Netherlands Academy of Arts & Sciences; Netherlands Institute for Neuroscience (NIN-KNAW)	Kole, MHP (corresponding author), Australian Natl Univ, John Curtin Sch Med Res, Eccles Inst Neurosci, Canberra, ACT 2601, Australia.	m.kole@nin.knaw.nl		de Kock, Christiaan/0000-0002-6697-0179; Hallermann, Stefan/0000-0001-9376-7048; stuart, greg/0000-0001-9395-2219; Kole, Maarten/0000-0002-3883-5682	European Research Council under the European Community [P261114]; Australian National Health and Medical Research Council (NHMRC) [525437]; Heisenberg Program of the German Research Foundation [HA 6386/1-1, HA 6386/2-1]	European Research Council under the European Community(European Research Council (ERC)); Australian National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Heisenberg Program of the German Research Foundation(German Research Foundation (DFG))	The research leading to these results has received funding from the European Research Council under the European Community's Seventh Framework Program (FP7/2007-2013)/ERC Grant agreement no P261114 and from the Australian National Health and Medical Research Council (NHMRC) Project Grant no 525437 to M.H.P.K. S.H. received funding from the Heisenberg Program of the German Research Foundation (HA 6386/1-1 and 2-1). The authors are grateful to Henrik Alle and Christoph Schmidt-Hieber for discussions on earlier versions of this manuscript.	AIELLO LC, 1995, CURR ANTHROPOL, V36, P199, DOI 10.1086/204350; Alle H, 2011, J NEUROSCI, V31, P8001, DOI 10.1523/JNEUROSCI.0972-11.2011; Alle H, 2009, SCIENCE, V325, P1405, DOI 10.1126/science.1174331; Attwell D, 2001, J CEREBR BLOOD F MET, V21, P1133, DOI 10.1097/00004647-200110000-00001; Carter BC, 2011, J NEUROPHYSIOL, V105, P860, DOI 10.1152/jn.01056.2010; Carter BC, 2009, NEURON, V64, P898, DOI 10.1016/j.neuron.2009.12.011; Cole KS, 1939, J GEN PHYSIOL, V22, P649, DOI 10.1085/jgp.22.5.649; Crotty P, 2006, J NEUROPHYSIOL, V96, P1237, DOI 10.1152/jn.01204.2005; de Kock CPJ, 2008, J PHYSIOL-LONDON, V586, P3353, DOI 10.1113/jphysiol.2008.155580; DEHAAS V, 1989, EUR BIOPHYS J BIOPHY, V17, P49, DOI 10.1007/BF00257145; Engel D, 2005, NEURON, V45, P405, DOI 10.1016/j.neuron.2004.12.048; FRANKENHAEUSER B, 1964, J PHYSIOL-LONDON, V171, P302, DOI 10.1113/jphysiol.1964.sp007378; Geiger JRP, 2000, NEURON, V28, P927, DOI 10.1016/S0896-6273(00)00164-1; Gittis AH, 2010, J NEUROPHYSIOL, V104, P1625, DOI 10.1152/jn.00378.2010; Harris JJ, 2012, J NEUROSCI, V32, P356, DOI 10.1523/JNEUROSCI.3430-11.2012; Hasenstaub A, 2010, P NATL ACAD SCI USA, V107, P12329, DOI 10.1073/pnas.0914886107; Herculano-Houzel S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017514; HODGKIN A, 1975, PHILOS T ROY SOC B, V270, P297, DOI 10.1098/rstb.1975.0010; HODGKIN AL, 1952, J PHYSIOL-LONDON, V117, P500, DOI 10.1113/jphysiol.1952.sp004764; Hopkins WF, 1998, J PHARMACOL EXP THER, V285, P1051; Juusola M, 2007, BIOESSAYS, V29, P178, DOI 10.1002/bies.20532; Kole MHP, 2007, NEURON, V55, P633, DOI 10.1016/j.neuron.2007.07.031; Kole MHP, 2012, NEURON, V73, P235, DOI 10.1016/j.neuron.2012.01.007; Kole MHP, 2011, NEURON, V71, P671, DOI 10.1016/j.neuron.2011.06.024; Lennie P, 2003, CURR BIOL, V13, P493, DOI 10.1016/S0960-9822(03)00135-0; Levy WB, 1996, NEURAL COMPUT, V8, P531, DOI 10.1162/neco.1996.8.3.531; Lorincz A, 2010, SCIENCE, V328, P906, DOI 10.1126/science.1187958; Lorincz A, 2008, J NEUROSCI, V28, P14329, DOI 10.1523/JNEUROSCI.4833-08.2008; Niven JE, 2008, J EXP BIOL, V211, P1792, DOI 10.1242/jeb.017574; Oberlaender M, 2011, CEREB CORTEX; Oberlaender M, 2011, P NATL ACAD SCI USA, V108, P4188, DOI 10.1073/pnas.1100647108; Ogawa Y, 2008, J NEUROSCI, V28, P5731, DOI 10.1523/JNEUROSCI.4431-07.2008; Popovic MA, 2011, J PHYSIOL-LONDON, V589, P4167, DOI 10.1113/jphysiol.2011.209015; Raman IM, 1997, J NEUROSCI, V17, P4517, DOI 10.1523/jneurosci.17-12-04517.1997; Rhodes KJ, 1997, J NEUROSCI, V17, P8246; Schmidt-Hieber C, 2010, J NEUROSCI, V30, P10233, DOI 10.1523/JNEUROSCI.6335-09.2010; Schoppa NE, 1998, J GEN PHYSIOL, V111, P313, DOI 10.1085/jgp.111.2.313; Sengupta B, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000840; Shu YS, 2007, P NATL ACAD SCI USA, V104, P11453, DOI 10.1073/pnas.0702041104; Shu YS, 2006, NATURE, V441, P761, DOI 10.1038/nature04720; STUHMER W, 1989, EMBO J, V8, P3235, DOI 10.1002/j.1460-2075.1989.tb08483.x; WANG H, 1994, J NEUROSCI, V14, P4588; Wang SSH, 2008, J NEUROSCI, V28, P4047, DOI 10.1523/JNEUROSCI.5559-05.2008; Yellen G, 2002, NATURE, V419, P35, DOI 10.1038/nature00978; ZAGOTTA WN, 1994, J GEN PHYSIOL, V103, P321, DOI 10.1085/jgp.103.2.321	45	94	95	1	29	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JUL	2012	15	7					1007	1014		10.1038/nn.3132	http://dx.doi.org/10.1038/nn.3132			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	966EE	22660478				2022-12-28	WOS:000305819600019
J	Nassar, MR; Rumsey, KM; Wilson, RC; Parikh, K; Heasly, B; Gold, JI				Nassar, Matthew R.; Rumsey, Katherine M.; Wilson, Robert C.; Parikh, Kinjan; Heasly, Benjamin; Gold, Joshua I.			Rational regulation of learning dynamics by pupil-linked arousal systems	NATURE NEUROSCIENCE			English	Article							ADAPTIVE GAIN; HUMAN BRAIN; UNCERTAINTY; NOREPINEPHRINE; NEUROMODULATION; NORADRENALINE; RESPONSES; DIAMETER; STIMULUS	The ability to make inferences about the current state of a dynamic process requires ongoing assessments of the stability and reliability of data generated by that process. We found that these assessments, as defined by a normative model, were reflected in nonluminance-mediated changes in pupil diameter of human subjects performing a predictive-inference task. Brief changes in pupil diameter reflected assessed instabilities in a process that generated noisy data. Baseline pupil diameter reflected the reliability with which recent data indicate the current state of the data-generating process and individual differences in expectations about the rate of instabilities. Together these pupil metrics predicted the influence of new data on subsequent inferences. Moreover, a task- and luminance-independent manipulation of pupil diameter predictably altered the influence of new data. Thus, pupil-linked arousal systems can help to regulate the influence of incoming data on existing beliefs in a dynamic environment.	[Nassar, Matthew R.; Rumsey, Katherine M.; Parikh, Kinjan; Heasly, Benjamin; Gold, Joshua I.] Univ Penn, Dept Neurosci, Philadelphia, PA 19104 USA; [Wilson, Robert C.] Princeton Univ, Dept Psychol, Princeton, NJ 08544 USA	University of Pennsylvania; Princeton University	Gold, JI (corresponding author), Univ Penn, Dept Neurosci, Philadelphia, PA 19104 USA.	jigold@mail.med.upenn.edu	nassar, matthew r/H-4663-2019	nassar, matthew r/0000-0002-5397-535X	US National Institutes of Health [R01 EY015260, F31 MH093099, T90 DA22763]; McKnight Endowment Fund for Neuroscience; Burroughs-Wellcome Fund; Sloan Foundation; NATIONAL EYE INSTITUTE [R01EY015260] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R21MH093904, F31MH093099] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [T90DA022763] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); McKnight Endowment Fund for Neuroscience; Burroughs-Wellcome Fund(Burroughs Wellcome Fund); Sloan Foundation(Alfred P. Sloan Foundation); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank J. Cohen, S. du Lac, L. Ding, Y. Li and J. Nassar for helpful comments. This work was supported by the US National Institutes of Health (R01 EY015260, F31 MH093099 and T90 DA22763), the McKnight Endowment Fund for Neuroscience, the Burroughs-Wellcome Fund and the Sloan Foundation.	Adams R.P., 2007, BAYESIAN ONLINE CHAN; Aston-Jones G, 2005, ANNU REV NEUROSCI, V28, P403, DOI 10.1146/annurev.neuro.28.061604.135709; ASTONJONES G, 1986, SCIENCE, V234, P734, DOI 10.1126/science.3775363; AstonJones G, 1997, NEUROSCIENCE, V80, P697, DOI 10.1016/S0306-4522(97)00060-2; Behrens TEJ, 2007, NAT NEUROSCI, V10, P1214, DOI 10.1038/nn1954; Bouret S, 2005, TRENDS NEUROSCI, V28, P574, DOI 10.1016/j.tins.2005.09.002; Corbetta M, 2008, NEURON, V58, P306, DOI 10.1016/j.neuron.2008.04.017; Critchley HD, 2005, J COMP NEUROL, V493, P154, DOI 10.1002/cne.20749; Critchley HD, 2001, NEURON, V29, P537, DOI 10.1016/S0896-6273(01)00225-2; Einhauser W, 2008, P NATL ACAD SCI USA, V105, P1704, DOI 10.1073/pnas.0707727105; Fearnhead P, 2007, J ROY STAT SOC B, V69, P589, DOI 10.1111/j.1467-9868.2007.00601.x; FRIEDMAN D, 1973, ELECTROEN CLIN NEURO, V34, P475, DOI 10.1016/0013-4694(73)90065-5; Gilzenrat MS, 2010, COGN AFFECT BEHAV NE, V10, P252, DOI 10.3758/CABN.10.2.252; Granholm E, 2004, INT J PSYCHOPHYSIOL, V52, P1, DOI 10.1016/j.ijpsycho.2003.12.001; HAKEREM G, 1964, ANN NY ACAD SCI, V105, P820, DOI 10.1111/j.1749-6632.1964.tb42965.x; HARLEY CW, 1987, PROG NEURO-PSYCHOPH, V11, P419, DOI 10.1016/0278-5846(87)90015-7; Jepma M, 2011, J COGNITIVE NEUROSCI, V23, P1587, DOI 10.1162/jocn.2010.21548; KAHNEMAN D, 1966, SCIENCE, V154, P1583, DOI 10.1126/science.154.3756.1583; Krugel LK, 2009, P NATL ACAD SCI USA, V106, P17951, DOI 10.1073/pnas.0905191106; KRUGMAN HE, 1964, J MARKETING RES, V1, P15, DOI 10.2307/3150372; Matsumoto M, 2007, NAT NEUROSCI, V10, P647, DOI 10.1038/nn1890; Nassar MR, 2010, J NEUROSCI, V30, P12366, DOI 10.1523/JNEUROSCI.0822-10.2010; Nieuwenhuis S, 2011, PSYCHOPHYSIOLOGY, V48, P162, DOI 10.1111/j.1469-8986.2010.01057.x; Preuschoff K, 2011, FRONT NEUROSCI-SWITZ, V5, DOI 10.3389/fnins.2011.00115; Raisig S, 2010, INT J PSYCHOPHYSIOL, V76, P1, DOI 10.1016/j.ijpsycho.2010.01.006; RICHER F, 1987, PSYCHOPHYSIOLOGY, V24, P258, DOI 10.1111/j.1469-8986.1987.tb00291.x; SARA SJ, 1994, BRAIN RES BULL, V35, P457, DOI 10.1016/0361-9230(94)90159-7; Schmidt H.S., 1982, SLEEPING WAKING DISO, P127; Tully K, 2010, MOL BRAIN, V3, DOI 10.1186/1756-6606-3-15; Van Olst E.H., 1979, ORIENTING REFLEX HUM, P521; Wilson RC, 2010, NEURAL COMPUT, V22, P2452, DOI 10.1162/NECO_a_00007; Yerkes RM, 1908, J COMP NEUROL PSYCHO, V18, P459, DOI 10.1002/cne.920180503; Yu AJ, 2005, NEURON, V46, P681, DOI 10.1016/j.neuron.2005.04.026	34	348	351	3	68	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUL	2012	15	7					1040	1046		10.1038/nn.3130	http://dx.doi.org/10.1038/nn.3130			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	966EE	22660479	Green Accepted			2022-12-28	WOS:000305819600023
J	Radulovic, J; Tronson, NC				Radulovic, Jelena; Tronson, Natalie C.			Preso1, mGluR5 and the machinery of pain	NATURE NEUROSCIENCE			English	Editorial Material							METABOTROPIC GLUTAMATE RECEPTORS; PROTEIN; ACTIVATION; BEHAVIORS; COMPLEXES; NEURONS; HOMER; LINKS; ERK	By bringing mGluR1/5 and proline-directed kinases together, the scaffold protein Preso1 stabilizes the interaction between mGluR1/5 and Homer. This mechanism may attenuate calcium influx into spinal neurons and reduce pain.	[Radulovic, Jelena; Tronson, Natalie C.] Northwestern Univ, Feinberg Sch Med, Asher Ctr Study & Treatment Depress Disorders, Dept Psychiat & Behav Sci, Chicago, IL USA	Northwestern University; Feinberg School of Medicine	Radulovic, J (corresponding author), Northwestern Univ, Feinberg Sch Med, Asher Ctr Study & Treatment Depress Disorders, Dept Psychiat & Behav Sci, Chicago, IL USA.	j-radulovic@northwestern.edu		Tronson, Natalie/0000-0001-5676-1579; Radulovic, Jelena/0000-0002-0268-2426	NIMH NIH HHS [R01 MH078064] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH078064] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Adwanikar H, 2004, PAIN, V111, P125, DOI 10.1016/j.pain.2004.06.009; Ango F, 2001, NATURE, V411, P962, DOI 10.1038/35082096; Collins M. O., 2007, V43, P185, DOI 10.1007/978-1-4020-5943-8_9; Hu JH, 2012, NAT NEUROSCI, V15, P836, DOI 10.1038/nn.3103; Kitano J, 2002, J NEUROSCI, V22, P1280, DOI 10.1523/JNEUROSCI.22-04-01280.2002; Lee HW, 2008, J NEUROSCI, V28, P14546, DOI 10.1523/JNEUROSCI.3112-08.2008; Mao LM, 2005, J NEUROSCI, V25, P2741, DOI 10.1523/JNEUROSCI.4360-04.2005; Menard C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0028666; Paquet M, 2006, J BIOL CHEM, V281, P29949, DOI 10.1074/jbc.M602262200; Ronesi JA, 2012, NAT NEUROSCI, V15, P431, DOI 10.1038/nn.3033; Tappe A, 2006, NAT MED, V12, P677, DOI 10.1038/nm1406; Tappe-Theodor A, 2011, MOL PAIN, V7, DOI 10.1186/1744-8069-7-38; Tronson NC, 2010, BIOL PSYCHIAT, V68, P1007, DOI 10.1016/j.biopsych.2010.09.004; Tu JC, 1999, NEURON, V23, P583, DOI 10.1016/S0896-6273(00)80810-7; Zhuang ZY, 2004, J NEUROSCI, V24, P8300, DOI 10.1523/JNEUROSCI.2893-04.2004	15	7	8	1	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JUN	2012	15	6					805	807		10.1038/nn.3118	http://dx.doi.org/10.1038/nn.3118			4	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	949AI	22627790	Green Accepted			2022-12-28	WOS:000304546700002
J	Amemori, KI; Graybiel, AM				Amemori, Ken-ichi; Graybiel, Ann M.			Localized microstimulation of primate pregenual cingulate cortex induces negative decision-making	NATURE NEUROSCIENCE			English	Article							REWARD SIGNALS; AVOIDANCE GOALS; NEURONS; DEPRESSION; CONFLICT; ANXIETY; NEUROBIOLOGY; INFORMATION; PREDICTOR; HUMANS	The pregenual anterior cingulate cortex (pACC) has been implicated in human anxiety disorders and depression, but the circuit-level mechanisms underlying these disorders are unclear. In healthy individuals, the pACC is involved in cost-benefit evaluation. We developed a macaque version of an approach-avoidance decision task used to evaluate anxiety and depression in humans and, with multi-electrode recording and cortical microstimulation, we probed pACC function as monkeys performed this task. We found that the macaque pACC has an opponent process-like organization of neurons representing motivationally positive and negative subjective value. Spatial distribution of these two neuronal populations overlapped in the pACC, except in one subzone, where neurons with negative coding were more numerous. Notably, microstimulation in this subzone, but not elsewhere in the pACC, increased negative decision-making, and this negative biasing was blocked by anti-anxiety drug treatment. This cortical zone could be critical for regulating negative emotional valence and anxiety in decision-making.	[Graybiel, Ann M.] MIT, McGovern Inst Brain Res, Cambridge, MA 02139 USA; MIT, Dept Brain & Cognit Sci, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT)	Graybiel, AM (corresponding author), MIT, McGovern Inst Brain Res, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	graybiel@mit.edu	Amemori, Ken-ichi/L-4206-2013	Amemori, Ken-ichi/0000-0001-8500-6820; Graybiel, Ann/0000-0002-4326-7720	US National Institutes of Health [R01 NS025529]; Office of Naval Research [N000140710903]; National Parkinson Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS025529] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Office of Naval Research(Office of Naval Research); National Parkinson Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank S. Amemori and M. Cantor for their help with animal training and surgical procedures, P. Tierney, H. Shimazu, T. Desrochers, J. Feingold and Y. Ninokura and H. Hall for their technical advice, and D. Pizzagalli, R. Desimone, K. Goosens, J. Goldberg, D. Pfaff and Y. Kubota for reading the manuscript in draft form. This work was supported by a US National Institutes of Health Javits Merit grant (R01 NS025529), the Office of Naval Research (N000140710903), the Lynn Diamond Fellowship of the National Parkinson Foundation and Mr. Ira J. Jaffe.	Botvinick MM, 2004, TRENDS COGN SCI, V8, P539, DOI 10.1016/j.tics.2004.10.003; Bush G, 2000, TRENDS COGN SCI, V4, P215, DOI 10.1016/S1364-6613(00)01483-2; Croxson PL, 2009, J NEUROSCI, V29, P4531, DOI 10.1523/JNEUROSCI.4515-08.2009; Dickson JM, 2004, COGNITIVE THER RES, V28, P415, DOI 10.1023/B:COTR.0000031809.20488.ee; Dickson JM, 2006, PERS INDIV DIFFER, V41, P1527, DOI 10.1016/j.paid.2006.06.005; EBLEN F, 1995, J NEUROSCI, V15, P5999; Elliot AJ, 2002, J PERS SOC PSYCHOL, V82, P804, DOI 10.1037/0022-3514.82.5.804; Elliot AJ, 2008, HANDBOOK OF APPROACH AND AVOIDANCE MOTIVATION, P1; Etkin A, 2006, NEURON, V51, P871, DOI 10.1016/j.neuron.2006.07.029; Fitzgerald KD, 2005, BIOL PSYCHIAT, V57, P287, DOI 10.1016/j.biopsych.2004.10.038; Fujiyama F, 2011, EUR J NEUROSCI, V33, P668, DOI 10.1111/j.1460-9568.2010.07564.x; Ghashghaei H, 2007, NEUROIMAGE, V34, P905, DOI 10.1016/j.neuroimage.2006.09.046; Goldstein RZ, 2009, P NATL ACAD SCI USA, V106, P9453, DOI 10.1073/pnas.0900491106; Graybiel AM, 2008, ANNU REV NEUROSCI, V31, P359, DOI 10.1146/annurev.neuro.29.051605.112851; Hayden BY, 2010, J NEUROSCI, V30, P3339, DOI 10.1523/JNEUROSCI.4874-09.2010; Hayden BY, 2009, SCIENCE, V324, P948, DOI 10.1126/science.1168488; Ito S, 2003, SCIENCE, V302, P120, DOI 10.1126/science.1087847; Kasai K, 2008, BIOL PSYCHIAT, V63, P550, DOI 10.1016/j.biopsych.2007.06.022; Kennerley SW, 2009, EUR J NEUROSCI, V29, P2061, DOI 10.1111/j.1460-9568.2009.06743.x; Kennerley SW, 2009, J COGNITIVE NEUROSCI, V21, P1162, DOI 10.1162/jocn.2009.21100; Lee D, 2007, J NEUROSCI, V27, P8170, DOI 10.1523/JNEUROSCI.1561-07.2007; Levy I, 2010, J NEUROPHYSIOL, V103, P1036, DOI 10.1152/jn.00853.2009; Lewin K., 1935, DYNAMIC THEORY PERS; Machens CK, 2005, SCIENCE, V307, P1121, DOI 10.1126/science.1104171; Matsumoto M, 2007, NAT NEUROSCI, V10, P647, DOI 10.1038/nn1890; Matsumoto M, 2007, NATURE, V447, P1111, DOI 10.1038/nature05860; Mayberg HS, 2005, NEURON, V45, P651, DOI 10.1016/j.neuron.2005.02.014; Mayberg HS, 1997, NEUROREPORT, V8, P1057, DOI 10.1097/00001756-199703030-00048; Millan MJ, 2003, PROG NEUROBIOL, V70, P83, DOI 10.1016/s0301-0082(03)00087-X; Miller N.E., 1971, SELECTED PAPERS CONF; Ottenbreit ND, 2004, BEHAV RES THER, V42, P293, DOI 10.1016/S0005-7967(03)00140-2; Padoa-Schioppa C, 2006, NATURE, V441, P223, DOI 10.1038/nature04676; Padoa-Schioppa C, 2011, ANNU REV NEUROSCI, V34, P333, DOI 10.1146/annurev-neuro-061010-113648; Pardo B., 2002, Computer Music Journal, V26, P27, DOI 10.1162/014892602760137167; Paton JJ, 2006, NATURE, V439, P865, DOI 10.1038/nature04490; Pizzagalli D, 2001, AM J PSYCHIAT, V158, P405, DOI 10.1176/appi.ajp.158.3.405; Pizzagalli DA, 2011, NEUROPSYCHOPHARMACOL, V36, P183, DOI 10.1038/npp.2010.166; RAJAKUMAR N, 1993, J COMP NEUROL, V331, P286, DOI 10.1002/cne.903310210; Rowlett JK, 2006, PSYCHOPHARMACOLOGY, V184, P201, DOI 10.1007/s00213-005-0228-8; Rudebeck PH, 2006, SCIENCE, V313, P1310, DOI 10.1126/science.1128197; Seo H, 2007, J NEUROSCI, V27, P8366, DOI 10.1523/JNEUROSCI.2369-07.2007; SMITH WK, 1945, J NEUROPHYSIOL, V8, P241, DOI 10.1152/jn.1945.8.4.241; Talmi D, 2009, J NEUROSCI, V29, P14617, DOI 10.1523/JNEUROSCI.2026-09.2009; Tom SM, 2007, SCIENCE, V315, P515, DOI 10.1126/science.1134239; TREIT D, 1985, NEUROSCI BIOBEHAV R, V9, P203, DOI 10.1016/0149-7634(85)90046-6; Tye KM, 2011, NATURE, V471, P358, DOI 10.1038/nature09820; VOGEL JR, 1971, PSYCHOPHARMACOLOGIA, V21, P1, DOI 10.1007/BF00403989; Vogt BA, 2005, J COMP NEUROL, V485, P218, DOI 10.1002/cne.20512; VOGT BA, 1987, J COMP NEUROL, V262, P271, DOI 10.1002/cne.902620208; von Neumann J., 1947, THEORY GAMES EC BEHA, V2nd ed	50	171	172	1	35	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAY	2012	15	5					776	785		10.1038/nn.3088	http://dx.doi.org/10.1038/nn.3088			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	932DI	22484571	Green Accepted, Green Submitted			2022-12-28	WOS:000303270200023
J	Narayanan, NS; Cavanagh, JF; Frank, MJ; Laubach, M				Narayanan, Nandakumar S.; Cavanagh, James F.; Frank, Michael J.; Laubach, Mark			Common medial frontal mechanisms of adaptive control in humans and rodents	NATURE NEUROSCIENCE			English	Article							ANTERIOR CINGULATE CORTEX; DORSOMEDIAL PREFRONTAL CORTEX; COGNITIVE CONTROL; MOTOR CORTEX; RAT; INACTIVATIONS; SCHIZOPHRENIA; STIMULATION; MODULATION; ENSEMBLES	In this report we describe how common brain networks within the medial frontal cortex (MFC) facilitate adaptive behavioral control in rodents and humans. We demonstrate that after errors, low-frequency oscillations below 12 Hz are modulated over the midfrontal cortex in humans and within the prelimbic and anterior cingulate regions of the MFC in rats. These oscillations were phase locked between the MFC and motor areas in both rats and humans. In rats, single neurons that encoded prior behavioral outcomes were phase coherent with low-frequency field oscillations, particularly after errors. Inactivating the medial frontal regions in rats led to impaired behavioral adjustments after errors, eliminated the differential expression of low-frequency oscillations after errors and increased low-frequency spike-field coupling within the motor cortex. Our results describe a new mechanism for behavioral adaptation through low-frequency oscillations and elucidate how medial frontal networks synchronize brain activity to guide performance.	[Narayanan, Nandakumar S.] Univ Iowa, Dept Neurol, Carver Coll Med, Iowa City, IA 52242 USA; [Cavanagh, James F.; Frank, Michael J.] Brown Univ, Providence, RI 02912 USA; [Frank, Michael J.] Brown Univ, Dept Psychiat, Providence, RI 02912 USA; [Frank, Michael J.] Brown Univ, Brown Inst Brain Sci, Providence, RI 02912 USA; [Laubach, Mark] Yale Univ, Sch Med, John B Pierce Lab, New Haven, CT 06520 USA; [Laubach, Mark] Yale Univ, Sch Med, Dept Neurobiol, New Haven, CT USA	University of Iowa; Brown University; Brown University; Brown University; Yale University; The John B Pierce Laboratory, Inc; Yale University	Laubach, M (corresponding author), Yale Univ, Sch Med, John B Pierce Lab, New Haven, CT 06520 USA.	mlaubach@jbpierce.org	Cavanagh, James F/I-5222-2015	Laubach, Mark/0000-0002-2403-4497; Narayanan, Nandakumar/0000-0002-0427-0003	National Institute of Neurological Disorders and Stroke [K08 NS078100]; US National Institutes of Health (NIH) [MH080066-01]; National Science Foundation (NSF) [1125788]; NIH [P0I-AG030004-01A1]; NSF [1121147]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH080066] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K08NS078100] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG030004] Funding Source: NIH RePORTER; Division Of Integrative Organismal Systems [1121147] Funding Source: National Science Foundation	National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation (NSF)(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Division Of Integrative Organismal Systems(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	We thank S Masters for help with human data acquisition, N. Horst for technical editing and G.R. Yang for help with spike-field coherence code and simulations. This work was funded by National Institute of Neurological Disorders and Stroke grant K08 NS078100 to N.S.N., US National Institutes of Health (NIH) grant MH080066-01 and National Science Foundation (NSF) grant 1125788 to M.J.F., and NIH grant P0I-AG030004-01A1 and NSF grant 1121147 to M.L.	Allen TA, 2008, J NEUROSCI METH, V171, P30, DOI 10.1016/j.jneumeth.2008.01.033; Allman JM, 2001, ANN NY ACAD SCI, V935, P107, DOI 10.1111/j.1749-6632.2001.tb03476.x; BELLMAN R, 1959, P NATL ACAD SCI USA, V45, P1288, DOI 10.1073/pnas.45.8.1288; Buzsaki G, 2011, RHYTHMS BRAIN; Carter CS, 1998, SCIENCE, V280, P747, DOI 10.1126/science.280.5364.747; Cavanagh JF, 2012, PSYCHOPHYSIOLOGY, V49, P220, DOI 10.1111/j.1469-8986.2011.01293.x; Cavanagh JF, 2011, NAT NEUROSCI, V14, P1462, DOI 10.1038/nn.2925; Cavanagh JF, 2009, J NEUROSCI, V29, P98, DOI 10.1523/JNEUROSCI.4137-08.2009; Danielmeier C, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00233; Davidson RJ, 2002, ANNU REV PSYCHOL, V53, P545, DOI 10.1146/annurev.psych.53.100901.135148; Dutilh G, 2012, ATTEN PERCEPT PSYCHO, V74, P454, DOI 10.3758/s13414-011-0243-2; Dzirasa K, 2010, J NEUROSCI, V30, P6387, DOI 10.1523/JNEUROSCI.0764-10.2010; Fitzgerald KD, 2005, BIOL PSYCHIAT, V57, P287, DOI 10.1016/j.biopsych.2004.10.038; Fujisawa S, 2008, NAT NEUROSCI, V11, P823, DOI 10.1038/nn.2134; Hampson RE, 2012, J NEURAL ENG, V9, DOI 10.1088/1741-2560/9/5/056012; Holroyd CB, 2002, PSYCHOL REV, V109, P679, DOI 10.1037/0033-295X.109.4.679; KORNBLUM S, 1973, PERCEPT PSYCHOPHYS, V13, P108, DOI 10.3758/BF03207243; Laubach M, 2000, NATURE, V405, P567, DOI 10.1038/35014604; Lee TG, 2012, J NEUROSCI, V32, P15458, DOI 10.1523/JNEUROSCI.0627-12.2012; McClintock SM, 2011, BIOL PSYCHIAT, V70, P19, DOI 10.1016/j.biopsych.2011.02.031; Miller EK, 2001, ANNU REV NEUROSCI, V24, P167, DOI 10.1146/annurev.neuro.24.1.167; Modirrousta M, 2008, J NEUROSCI, V28, P14000, DOI 10.1523/JNEUROSCI.4450-08.2008; Narayanan NS, 2006, NEUROSCIENCE, V139, P865, DOI 10.1016/j.neuroscience.2005.11.072; Narayanan NS, 2008, J NEUROPHYSIOL, V100, P520, DOI 10.1152/jn.00035.2008; Narayanan NS, 2006, NEURON, V52, P921, DOI 10.1016/j.neuron.2006.10.021; Narayanan NS, 2005, J NEUROSCI, V25, P4207, DOI 10.1523/JNEUROSCI.4697-04.2005; Newman EL, 2012, FRONT BEHAV NEUROSCI, V6, DOI 10.3389/fnbeh.2012.00024; RABBITT PMA, 1966, J EXP PSYCHOL, V71, P264, DOI 10.1037/h0022853; Ridderinkhof KR, 2004, SCIENCE, V306, P443, DOI 10.1126/science.1100301; Robbins TW, 2007, PHILOS T R SOC B, V362, P917, DOI 10.1098/rstb.2007.2097; ROSENBERG JR, 1989, PROG BIOPHYS MOL BIO, V53, P1, DOI 10.1016/0079-6107(89)90004-7; Rushworth MFS, 2008, NAT NEUROSCI, V11, P389, DOI 10.1038/nn2066; Sheth SA, 2012, NATURE, V488, P218, DOI 10.1038/nature11239; Stefanics G, 2010, J NEUROSCI, V30, P13578, DOI 10.1523/JNEUROSCI.0703-10.2010; van Meel CS, 2007, PSYCHIAT RES, V151, P211, DOI 10.1016/j.psychres.2006.05.011; Velligan DI, 2002, PSYCHIAT RES, V113, P227, DOI 10.1016/S0165-1781(02)00264-0; Vertes RP, 2006, J COMP NEUROL, V499, P768, DOI 10.1002/cne.21135; von Stein A, 2000, P NATL ACAD SCI USA, V97, P14748, DOI 10.1073/pnas.97.26.14748; Wise SP, 2008, TRENDS NEUROSCI, V31, P599, DOI 10.1016/j.tins.2008.08.008; Womelsdorf T, 2010, P NATL ACAD SCI USA, V107, P5248, DOI 10.1073/pnas.0906194107	40	177	177	0	24	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	DEC	2013	16	12					1888	1895		10.1038/nn.3549	http://dx.doi.org/10.1038/nn.3549			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	257VV	24141310	Green Accepted			2022-12-28	WOS:000327416800028
J	Nguyen-Vu, TDB; Kimpo, RR; Rinaldi, JM; Kohli, A; Zeng, HK; Deisseroth, K; Raymond, JL				Nguyen-Vu, T. D. Barbara; Kimpo, Rhea R.; Rinaldi, Jacob M.; Kohli, Arunima; Zeng, Hongkui; Deisseroth, Karl; Raymond, Jennifer L.			Cerebellar Purkinje cell activity drives motor learning	NATURE NEUROSCIENCE			English	Article							VESTIBULOOCULAR REFLEX; EYE-MOVEMENTS; PLASTICITY; STIMULATION; GAIN; POTENTIATION; FLOCCULUS; COMPLEX; NUCLEI	The climbing fiber input to the cerebellar cortex is thought to provide instructive signals that drive the induction of motor skill learning. We found that optogenetic activation of Purkinje cells, the sole output neurons of the cerebellar cortex, can also drive motor learning in mice. This dual control over the induction of learning by climbing fibers and Purkinje cells can expand the learning capacity of motor circuits.	[Nguyen-Vu, T. D. Barbara; Kimpo, Rhea R.; Rinaldi, Jacob M.; Kohli, Arunima; Raymond, Jennifer L.] Stanford Sch Med, Dept Neurobiol, Stanford, CA 94305 USA; [Nguyen-Vu, T. D. Barbara] Stanford Sch Med, Dept Mol & Cellular Physiol, Stanford, CA USA; [Zeng, Hongkui] Allen Inst Brain Sci, Seattle, WA USA; [Deisseroth, Karl] Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA; [Deisseroth, Karl] Stanford Sch Med, Dept Psychiat, Stanford, CA USA; [Deisseroth, Karl] Stanford Univ, Howard Hughes Med Inst, Stanford, CA 94305 USA	Stanford University; Stanford University; Allen Institute for Brain Science; Stanford University; Stanford University; Howard Hughes Medical Institute; Stanford University	Raymond, JL (corresponding author), Stanford Sch Med, Dept Neurobiol, Stanford, CA 94305 USA.	jenr@stanford.edu	Core, Vector/CAF-4832-2022	Nguyen-Vu, T.D. Barbara/0000-0002-4708-1982; Raymond, Jennifer/0000-0002-8145-747X	US National Institutes of Health [RO1 DC04154, RO1 NS072406, P01 NS053862, F31DC010547, K01 NS069617, P30 DC10363, P30 NS069375]; James S. McDonnell Foundation; US National Science Foundation Graduate Research Fellowship Program; US National Institutes of Health and Defense Advanced Research Projects Agency; NATIONAL INSTITUTE OF MENTAL HEALTH [T32MH020016] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS069375, R21NS057488, R01NS072406, P01NS053862, K01NS069617] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [F31DC010547, P30DC010363, R01DC004154] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); James S. McDonnell Foundation; US National Science Foundation Graduate Research Fellowship Program(National Science Foundation (NSF)); US National Institutes of Health and Defense Advanced Research Projects Agency; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	We thank E. Knudsen, T. Moore, C. Shatz, D. Madison, G. Zhao, O. Winter, S. Umamoto, A. Adamantidis, M. Carter, H. Nguyen and R. Hemmati for discussions and assistance. This study was supported by grants from the US National Institutes of Health (RO1 DC04154, RO1 NS072406 and P01 NS053862) and the James S. McDonnell Foundation to J.L.R., from the US National Science Foundation Graduate Research Fellowship Program and US National Institutes of Health (F31DC010547) to T.D.B.N.-V., from the US National Institutes of Health and Defense Advanced Research Projects Agency to K.D., from the US National Institutes of Health (K01 NS069617) to R.R.K., and from the US National Institutes of Health (P30 DC10363 and P30 NS069375) for imaging and virus core facilities.	Aizenman CD, 1998, NEURON, V21, P827, DOI 10.1016/S0896-6273(00)80598-X; Babalian AL, 2000, J NEUROPHYSIOL, V84, P2514, DOI 10.1152/jn.2000.84.5.2514; Belmeguenai A, 2010, J NEUROSCI, V30, P13630, DOI 10.1523/JNEUROSCI.3226-10.2010; Catz N, 2005, CURR BIOL, V15, P2179, DOI 10.1016/j.cub.2005.11.037; CREPEL F, 1991, J PHYSIOL-LONDON, V432, P123, DOI 10.1113/jphysiol.1991.sp018380; Heuer HW, 2008, J NEUROPHYSIOL, V100, P1320, DOI 10.1152/jn.90492.2008; ITO M, 1989, ANNU REV NEUROSCI, V12, P85, DOI 10.1146/annurev.ne.12.030189.000505; ITO M, 1974, BRAIN RES, V65, P170, DOI 10.1016/0006-8993(74)90344-8; Ke MC, 2009, NAT NEUROSCI, V12, P1171, DOI 10.1038/nn.2366; LISBERGER SG, 1974, BRAIN RES, V69, P347, DOI 10.1016/0006-8993(74)90013-4; Mauk MD, 1997, LEARN MEMORY, V4, P130, DOI 10.1101/lm.4.1.130; MAUK MD, 1986, P NATL ACAD SCI USA, V83, P5349, DOI 10.1073/pnas.83.14.5349; MCCORMICK DA, 1984, SCIENCE, V223, P296, DOI 10.1126/science.6701513; McElvain LE, 2010, NEURON, V68, P763, DOI 10.1016/j.neuron.2010.09.025; Menzies JRW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013182; MILES FA, 1981, ANNU REV NEUROSCI, V4, P273, DOI 10.1146/annurev.ne.04.030181.001421; Pugh JR, 2006, NEURON, V51, P113, DOI 10.1016/j.neuron.2006.05.021; Raymond JL, 1998, J NEUROSCI, V18, P9112; Shutoh F, 2006, NEUROSCIENCE, V139, P767, DOI 10.1016/j.neuroscience.2005.12.035; Stahl JS, 2004, J NEUROPHYSIOL, V91, P2066, DOI 10.1152/jn.01068.2003	20	88	89	1	30	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	DEC	2013	16	12					1734	1736		10.1038/nn.3576	http://dx.doi.org/10.1038/nn.3576			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	257VV	24162651	Green Accepted			2022-12-28	WOS:000327416800010
J	Guzman, YF; Tronson, NC; Jovasevic, V; Sato, K; Guedea, AL; Mizukami, H; Nishimori, K; Radulovic, J				Guzman, Yomayra F.; Tronson, Natalie C.; Jovasevic, Vladimir; Sato, Keisuke; Guedea, Anita L.; Mizukami, Hiroaki; Nishimori, Katsuhiko; Radulovic, Jelena			Fear-enhancing effects of septal oxytocin receptors	NATURE NEUROSCIENCE			English	Article							SOCIAL DEFEAT; MICE; STRESS; VASOPRESSIN; RELEASE; NEURONS; ANXIETY	The nonapeptide oxytocin is considered beneficial to mental health due to its anxiolytic, prosocial and antistress effects, but evidence for anxiogenic actions of oxytocin in humans has recently emerged. Using region-specific manipulations of the mouse oxytocin receptor (Oxtr) gene (Oxtr), we identified the lateral septum as the brain region mediating fear-enhancing effects of Oxtr. These effects emerge after social defeat and require Oxtr specifically coupled to the extracellular signal-regulated protein kinase pathway.	[Guzman, Yomayra F.; Tronson, Natalie C.; Jovasevic, Vladimir; Guedea, Anita L.; Radulovic, Jelena] Northwestern Univ, Dept Psychiat & Behav Sci, Chicago, IL 60611 USA; [Tronson, Natalie C.] Univ Michigan, Dept Psychol, Ann Arbor, MI USA; [Sato, Keisuke; Nishimori, Katsuhiko] Tohoku Univ, Grad Sch Agr Sci, Dept Mol & Cell Biol, Sendai, Miyagi 980, Japan; [Mizukami, Hiroaki] Jichi Med Univ, Ctr Mol Med, Div Genet Therapeut, Shimotsuke, Tochigi, Japan	Northwestern University; University of Michigan System; University of Michigan; Tohoku University; Jichi Medical University	Radulovic, J (corresponding author), Northwestern Univ, Dept Psychiat & Behav Sci, Chicago, IL 60611 USA.	j-radulovic@northwestern.edu	Mizukami, Hiroaki/D-7674-2013	Mizukami, Hiroaki/0000-0001-8954-874X; Guzman, Yomayra F./0000-0003-4802-8304; Tronson, Natalie/0000-0001-5676-1579; Radulovic, Jelena/0000-0002-0268-2426	US National Institutes of Health [R01 MH078064, MH092065]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH073669, R01MH078064, F31MH092065] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This research was supported by US National Institutes of Health grants R01 MH078064 (J.R.) and MH092065 (Y.F.G.). Part of this study carried out by K.N. and K.S. was the result of "Molecular study of the functional mechanism of oxytocin in brain" carried out under the Strategic Research Program for Brain Sciences by the Ministry of Education, Culture, Sports, Science and Technology of Japan. We thank P. Osten (Cold Spring Harbor) for providing the rAAV-Cre vector, and L. Li and W. G. Tourtellotte (Department of Pathology, Northwestern University) for providing B6.129S4-Gt(ROSA) mice and their help with the beta-galactosidase staining.	Ayers LW, 2011, NEUROPSYCHOPHARMACOL, V36, P2488, DOI 10.1038/npp.2011.138; Bartz JA, 2010, P NATL ACAD SCI USA, V107, P21371, DOI 10.1073/pnas.1012669107; Cao JL, 2010, J NEUROSCI, V30, P16453, DOI 10.1523/JNEUROSCI.3177-10.2010; Carter CS, 1998, PSYCHONEUROENDOCRINO, V23, P779; Devost D, 2008, PROG BRAIN RES, V170, P167, DOI 10.1016/S0079-6123(08)00415-9; Ebner K, 2000, BRAIN RES, V872, P87, DOI 10.1016/S0006-8993(00)02464-1; Eldredge LC, 2008, DEVELOPMENT, V135, P2949, DOI 10.1242/dev.023960; Ferguson JN, 2002, FRONT NEUROENDOCRIN, V23, P200, DOI 10.1006/frne.2002.0229; Grillon C., 2012, MOL PSYCHIATR, DOI [10.1038/mp.2012.156, DOI 10.1038/MP.2012.156.(13]; IsHak WW, 2011, J AFFECT DISORDERS, V130, P1, DOI 10.1016/j.jad.2010.06.001; Knobloch HS, 2012, NEURON, V73, P553, DOI 10.1016/j.neuron.2011.11.030; Mutso AA, 2012, J NEUROSCI, V32, P5747, DOI 10.1523/JNEUROSCI.0587-12.2012; Pagani JH, 2011, GENES BRAIN BEHAV, V10, P710, DOI 10.1111/j.1601-183X.2011.00709.x; Paxinos G., 2001, MOUSE BRAIN STEREOTA; Radulovic J, 1999, J NEUROSCI, V19, P5016; Revest JM, 2005, NAT NEUROSCI, V8, P664, DOI 10.1038/nn1441; ROCHE KE, 1979, SCIENCE, V204, P1343, DOI 10.1126/science.221973; Sato K, 2009, BIOSCI BIOTECH BIOCH, V73, P2145, DOI 10.1271/bbb.90287; Sheehan TP, 2004, BRAIN RES REV, V46, P71, DOI 10.1016/j.brainresrev.2004.04.009; Stanciu M, 2001, MOL BRAIN RES, V94, P15, DOI 10.1016/S0169-328X(01)00174-7; Striepens N, 2012, P NATL ACAD SCI USA, V109, P18144, DOI 10.1073/pnas.1208852109; Tabak BA, 2011, PSYCHONEUROENDOCRINO, V36, P115, DOI 10.1016/j.psyneuen.2010.07.004; Takayanagi Y, 2005, P NATL ACAD SCI USA, V102, P16096, DOI 10.1073/pnas.0505312102; THOR DH, 1982, J COMP PHYSIOL PSYCH, V96, P1000, DOI 10.1037/0735-7036.96.6.1000; Tronson NC, 2008, NEUROPSYCHOPHARMACOL, V33, P1570, DOI 10.1038/sj.npp.1301550; Tronson NC, 2010, BIOL PSYCHIAT, V68, P1007, DOI 10.1016/j.biopsych.2010.09.004; Yoshida M, 2009, J NEUROSCI, V29, P2259, DOI 10.1523/JNEUROSCI.5593-08.2009	27	151	155	1	55	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	SEP	2013	16	9					1185	U36		10.1038/nn.3465	http://dx.doi.org/10.1038/nn.3465			5	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	207KN	23872596	Green Accepted			2022-12-28	WOS:000323597500008
J	Stoll, G; Pietilainen, OPH; Linder, B; Suvisaari, J; Brosi, C; Hennah, W; Leppa, V; Torniainen, M; Ripatti, S; Ala-Mello, S; Plottner, O; Rehnstrom, K; Tuulio-Henriksson, A; Varilo, T; Tallila, J; Kristiansson, K; Isohanni, M; Kaprio, J; Eriksson, JG; Raitakari, OT; Lehtimaki, T; Jarvelin, MR; Salomaa, V; Hurles, M; Stefansson, H; Peltonen, L; Sullivan, PF; Paunio, T; Lonnqvist, J; Daly, MJ; Fischer, U; Freimer, NB; Palotie, A				Stoll, Georg; Pietilainen, Olli P. H.; Linder, Bastian; Suvisaari, Jaana; Brosi, Cornelia; Hennah, William; Leppa, Virpi; Torniainen, Minna; Ripatti, Samuli; Ala-Mello, Sirpa; Plottner, Oliver; Rehnstrom, Karola; Tuulio-Henriksson, Annamari; Varilo, Teppo; Tallila, Jonna; Kristiansson, Kati; Isohanni, Matti; Kaprio, Jaakko; Eriksson, Johan G.; Raitakari, Olli T.; Lehtimaki, Terho; Jarvelin, Marjo-Riitta; Salomaa, Veikko; Hurles, Matthew; Stefansson, Hreinn; Peltonen, Leena; Sullivan, Patrick F.; Paunio, Tiina; Lonnqvist, Jouko; Daly, Mark J.; Fischer, Utz; Freimer, Nelson B.; Palotie, Aarno			Deletion of TOP3 beta, a component of FMRP-containing mRNPs, contributes to neurodevelopmental disorders	NATURE NEUROSCIENCE			English	Article							FRAGILE-X-SYNDROME; MENTAL-RETARDATION PROTEIN; GENOME-WIDE ASSOCIATION; HIDDEN-MARKOV MODEL; DIGEORGE-SYNDROME; RNA; JUNCTION; SCHIZOPHRENIA; COMPLEX; PATTERNS	Implicating particular genes in the generation of complex brain and behavior phenotypes requires multiple lines of evidence. The rarity of most high-impact genetic variants typically precludes the possibility of accruing statistical evidence that they are associated with a given trait. We found that the enrichment of a rare chromosome 22q11.22 deletion in a recently expanded Northern Finnish sub-isolate enabled the detection of association between TOP3B and both schizophrenia and cognitive impairment. Biochemical analysis of TOP3 beta revealed that this topoisomerase was a component of cytosolic messenger ribonucleoproteins (mRNPs) and was catalytically active on RNA. The recruitment of TOP3 beta to mRNPs was independent of RNA cis-elements and was coupled to the co-recruitment of FMRP, the disease gene product in fragile X mental retardation syndrome. Our results indicate a previously unknown role for TOP3 beta in mRNA metabolism and suggest that it is involved in neurodevelopmental disorders.	Univ Wurzburg, Dept Biochem, D-97070 Wurzburg, Germany; [Pietilainen, Olli P. H.; Ripatti, Samuli; Rehnstrom, Karola; Tallila, Jonna; Hurles, Matthew; Peltonen, Leena; Palotie, Aarno] Wellcome Trust Sanger Inst, Cambridge, England; [Hennah, William; Leppa, Virpi; Ripatti, Samuli; Kaprio, Jaakko; Paunio, Tiina; Palotie, Aarno] Inst Mol Med Finland, Helsinki, Finland; [Pietilainen, Olli P. H.; Varilo, Teppo; Peltonen, Leena; Paunio, Tiina] Natl Inst Hlth & Welf, Publ Hlth Genom Unit, Helsinki, Finland; [Suvisaari, Jaana; Hennah, William; Torniainen, Minna; Tuulio-Henriksson, Annamari; Kaprio, Jaakko; Lonnqvist, Jouko] Natl Inst Hlth & Welf, Dept Mental Hlth, Helsinki, Finland; [Suvisaari, Jaana; Hennah, William; Torniainen, Minna; Tuulio-Henriksson, Annamari; Kaprio, Jaakko; Lonnqvist, Jouko] Natl Inst Hlth & Welf, Substance Abuse Serv, Helsinki, Finland; [Ala-Mello, Sirpa; Lonnqvist, Jouko] Univ Helsinki, Cent Hosp, Dept Clin Genet, Helsinki, Finland; [Plottner, Oliver] Roche Diagnost GmbH, Pharma Res & Early Dev, Penzberg, Germany; [Isohanni, Matti] Univ Oulu, Dept Psychiat, Inst Clin Med, Oulu, Finland; [Kaprio, Jaakko] Univ Helsinki, Dept Publ Hlth, Helsinki, Finland; [Eriksson, Johan G.] Natl Inst Hlth & Welf Chron Dis Epidemiol & Preve, Helsinki, Finland; [Eriksson, Johan G.] Univ Helsinki, Dept Gen Practice & Primary Hlth Care, Helsinki, Finland; [Eriksson, Johan G.] Vaasa Cent Hosp, Vaasa, Finland; [Eriksson, Johan G.] Folkhalsan Res Ctr, Helsinki, Finland; [Eriksson, Johan G.] Univ Helsinki, Cent Hosp, Unit Gen Practice, Helsinki, Finland; [Raitakari, Olli T.] Univ Turku, Dept Clin Physiol Nucl Med, Turku, Finland; [Raitakari, Olli T.] Turku Univ Hosp, FIN-20520 Turku, Finland; [Raitakari, Olli T.] Univ Turku, Res Ctr Appl & Prevent Cardiovasc Med, Turku, Finland; [Raitakari, Olli T.] Turku Univ, Cent Hosp, Turku, Finland; [Lehtimaki, Terho] Univ Tampere, Dept Clin Chem, FIN-33101 Tampere, Finland; [Lehtimaki, Terho] Tampere Univ Hosp, Tampere, Finland; [Jarvelin, Marjo-Riitta] Imperial Coll London, Dept Epidemiol & Biostat, London, England; [Jarvelin, Marjo-Riitta] Imperial Coll London, MRC HPA Ctr Environm & Hlth, London, England; [Jarvelin, Marjo-Riitta] Natl Inst Hlth & Welf, Dept Children Young People & Families, Oulu, Finland; [Jarvelin, Marjo-Riitta] Univ Oulu, Inst Hlth Sci, Oulu, Finland; [Salomaa, Veikko] Natl Inst Hlth & Welf, Dept Chron Dis Prevent, Helsinki, Finland; [Stefansson, Hreinn] deCODE Genet, Reykjavik, Iceland; [Peltonen, Leena] Univ Helsinki, Dept Med Genet, Helsinki, Finland; [Sullivan, Patrick F.] Univ N Carolina, Dept Genet, Chapel Hill, NC USA; [Sullivan, Patrick F.] Univ N Carolina, Dept Psychiat & Epidemiol, Chapel Hill, NC USA; [Paunio, Tiina] Univ Helsinki, Cent Hosp, Dept Psychiat, Helsinki, Finland; [Daly, Mark J.] Massachusetts Gen Hosp, Anal & Translat Genet Unit, Boston, MA 02114 USA; [Daly, Mark J.; Palotie, Aarno] Broad Inst MIT & Harvard, Program Med & Populat Genet, Cambridge, MA USA; [Freimer, Nelson B.] Univ Calif Los Angeles, Semel Inst Neurosci & Human Behav, Ctr Neurobehav Genet, Los Angeles, CA 90024 USA	University of Wurzburg; Wellcome Trust Sanger Institute; Finland National Institute for Health & Welfare; Finland National Institute for Health & Welfare; Finland National Institute for Health & Welfare; University of Helsinki; Helsinki University Central Hospital; Roche Holding; University of Oulu; University of Helsinki; University of Helsinki; Vaasa Central Hospital; Folkhalsan Research Center; University of Helsinki; Helsinki University Central Hospital; University of Turku; University of Turku; University of Turku; University of Turku; Tampere University; Tampere University; Tampere University Hospital; Imperial College London; Imperial College London; Finland National Institute for Health & Welfare; University of Oulu; Finland National Institute for Health & Welfare; University of Helsinki; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of Helsinki; Helsinki University Central Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; University of California System; University of California Los Angeles	Freimer, NB (corresponding author), Univ Wurzburg, Dept Biochem, D-97070 Wurzburg, Germany.	utz.fischer@biozentrum.uni-wuerzburg.de; nfreimer@mednet.ucla.edu	Daly, Mark J/B-2453-2017; Lehtimäki, Terho/AAD-1094-2022; Kaprio, Jaakko/A-1820-2008; Raitakari, Olli/AAQ-7389-2021; Linder, Bastian/G-5111-2012; Linder, Bastian/W-4923-2019; Fischer, Utz/AAT-8422-2020; Fischer, Utz/A-4090-2016; Ripatti, Samuli/H-9446-2014	Daly, Mark J/0000-0002-0949-8752; Lehtimäki, Terho/0000-0002-2555-4427; Kaprio, Jaakko/0000-0002-3716-2455; Linder, Bastian/0000-0003-1203-3136; Fischer, Utz/0000-0002-1465-6591; Fischer, Utz/0000-0002-1465-6591; Ripatti, Samuli/0000-0002-0504-1202; Eriksson, Johan/0000-0002-2516-2060; Suvisaari, Jaana/0000-0001-7167-0990; Hennah, William/0000-0002-4462-4208; Stefansson, Hreinn/0000-0002-9331-6666; Tuulio-Henriksson, Annamari/0000-0002-3580-3693; Kristiansson, Kati/0000-0003-4688-107X; Jarvelin, Marjo-Riitta/0000-0002-2149-0630; Leppa, Virpi/0000-0003-2942-2656; Palotie, Aarno/0000-0002-2527-5874; Varilo, Teppo/0000-0002-5839-8854; Holm, Minna/0000-0003-2149-855X	Wellcome Trust [WT089062, WT098051]; Academy of Finland [200923, 251704, 136635, 128504, 132071]; Academy of Finland Center of Excellence in Complex Disease Genetics [213506, 129680]; EuroHead project [LSM-CT-2004-504837]; European Community's Seventh Framework Programme; ENGAGE Consortium [HEALTH-F4-2007-201413]; EU/SYNSYS-Synaptic Systems [242167]; National Alliance for Research in Schizophrenia and Depression; Sigrid Juselius Foundation; Biomedicum Helsinki Foundation; Jalmari and Rauha Ahokas Foundation; Paivikki and Sakari Sohlberg Foundation; Orion Farmos Research Foundation; US National Institutes of Health [RL1MH083268, P30NS062691]; DFG [FOR 855]; NATIONAL INSTITUTE OF MENTAL HEALTH [RL1MH083268] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS062691] Funding Source: NIH RePORTER; Medical Research Council [G0801056B] Funding Source: researchfish	Wellcome Trust(Wellcome Trust); Academy of Finland(Academy of Finland); Academy of Finland Center of Excellence in Complex Disease Genetics(Academy of Finland); EuroHead project(European Commission); European Community's Seventh Framework Programme(European Commission); ENGAGE Consortium; EU/SYNSYS-Synaptic Systems; National Alliance for Research in Schizophrenia and Depression(NARSAD); Sigrid Juselius Foundation(Sigrid Juselius Foundation); Biomedicum Helsinki Foundation; Jalmari and Rauha Ahokas Foundation; Paivikki and Sakari Sohlberg Foundation; Orion Farmos Research Foundation; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); DFG(German Research Foundation (DFG)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank R. Durbin for providing genotype data from the 173 individuals who constitute the sub-isolate population sample, C. Sabatti for helpful suggestions, and B. Laggerbauer and A. Hirmer for critically reading the manuscript. This work was supported by The Wellcome Trust (grant numbers WT089062 and WT098051 to A.P.), the Academy of Finland (project grants 200923 and 251704 to A. P., 136635 to V.S., 128504 to W.H., and 132071 to M.I.), the Academy of Finland Center of Excellence in Complex Disease Genetics (grant numbers 213506 and 129680 to A.P. and J. K.), the EuroHead project (LSM-CT-2004-504837), the European Community's Seventh Framework Programme (FP7/2007-2013), the ENGAGE Consortium (grant agreement HEALTH-F4-2007-201413), EU/SYNSYS-Synaptic Systems (grant number 242167 to A.P.), the National Alliance for Research in Schizophrenia and Depression, Sigrid Juselius Foundation (to J. L. and A. P.), the Biomedicum Helsinki Foundation (to O.P.H.P.), the Jalmari and Rauha Ahokas Foundation (to O.P.H.P.), the Paivikki and Sakari Sohlberg Foundation (to A. P.), the Orion Farmos Research Foundation (to W.H.), grants RL1MH083268 and P30NS062691 from the US National Institutes of Health (to N.B.F.), and grants of the RVZ-network and the DFG (FOR 855) to U.F.	Ascano M, 2012, NATURE, V492, P382, DOI 10.1038/nature11737; Barch DM, 2005, ANNU REV CLIN PSYCHO, V1, P321, DOI 10.1146/annurev.clinpsy.1.102803.143959; Barker DJP, 2005, NEW ENGL J MED, V353, P1802, DOI 10.1056/NEJMoa044160; Bassell GJ, 2008, NEURON, V60, P201, DOI 10.1016/j.neuron.2008.10.004; Ben-Shachar S, 2008, AM J HUM GENET, V82, P214, DOI 10.1016/j.ajhg.2007.09.014; Bergen SE, 2012, MOL PSYCHIATR, V17, P880, DOI 10.1038/mp.2012.73; Bhakar AL, 2012, ANNU REV NEUROSCI, V35, P417, DOI 10.1146/annurev-neuro-060909-153138; Buchan JR, 2009, MOL CELL, V36, P932, DOI 10.1016/j.molcel.2009.11.020; Colella S, 2007, NUCLEIC ACIDS RES, V35, P2013, DOI 10.1093/nar/gkm076; Cooper GM, 2011, NAT GENET, V43, P838, DOI 10.1038/ng.909; Cooper TA, 2009, CELL, V136, P777, DOI 10.1016/j.cell.2009.02.011; Darnell JC, 2005, GENE DEV, V19, P903, DOI 10.1101/gad.1276805; Darnell JC, 2011, CELL, V146, P247, DOI 10.1016/j.cell.2011.06.013; Fridell RA, 1996, EMBO J, V15, P5408, DOI 10.1002/j.1460-2075.1996.tb00924.x; Haukka J, 2001, PSYCHOL MED, V31, P1045, DOI 10.1017/S0033291701004299; Hooper SR, 2008, NEUROPSYCHOLOGY, V22, P36, DOI 10.1037/0894-4105.22.1.36; Hovatta I, 1997, AM J MED GENET, V74, P353, DOI 10.1002/(SICI)1096-8628(19970725)74:4<353::AID-AJMG3>3.3.CO;2-I; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Imoto I, 2006, CANCER RES, V66, P4617, DOI 10.1158/0008-5472.CAN-05-4437; Inouye M, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001113; Jaaskelainen A., 2005, INT J OBES LOND, V35, P1289; Jakkula E, 2008, AM J HUM GENET, V83, P787, DOI 10.1016/j.ajhg.2008.11.005; Jelenkovic A, 2011, AM J HUM BIOL, V23, P764, DOI 10.1002/ajhb.21208; Karayiorgou M, 2010, NAT REV NEUROSCI, V11, P402, DOI 10.1038/nrn2841; Kashima I, 2010, GENE DEV, V24, P2440, DOI 10.1101/gad.604610; Kobrynski LJ, 2007, LANCET, V370, P1443, DOI 10.1016/S0140-6736(07)61601-8; Kolb FA, 2000, EMBO J, V19, P5905, DOI 10.1093/emboj/19.21.5905; Kristiansson K, 2012, CIRC-CARDIOVASC GENE, V5, P242, DOI 10.1161/CIRCGENETICS.111.961482; Laggerbauer B, 2001, HUM MOL GENET, V10, P329, DOI 10.1093/hmg/10.4.329; Levinson DF, 2011, AM J PSYCHIAT, V168, P302, DOI 10.1176/appi.ajp.2010.10060876; Linder B, 2008, HUM MOL GENET, V17, P3236, DOI 10.1093/hmg/ddn219; Listgarten J, 2013, NAT GENET, V45, P470, DOI 10.1038/ng.2620; Maquat LE, 2010, CELL, V142, P368, DOI 10.1016/j.cell.2010.07.022; Mathieson I, 2012, NAT GENET, V44, P243, DOI 10.1038/ng.1074; Max X, 2008, CELL, V133, P303, DOI 10.1016/j.cell.2008.02.031; O'Roak BJ, 2012, NATURE, V485, P246, DOI 10.1038/nature10989; Palmgren K., 1964, PUBLICATIONS NATL A, VA15; Palotie A, 2013, NEW BIOTECHNOL, V30, P291, DOI 10.1016/j.nbt.2012.11.013; Peltonen L, 1999, HUM MOL GENET, V8, P1913, DOI 10.1093/hmg/8.10.1913; Perala J, 2008, SCHIZOPHR RES, V106, P337, DOI 10.1016/j.schres.2008.08.017; Pietilainen OPH, 2011, HUM MOL GENET, V20, P2686, DOI 10.1093/hmg/ddr162; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Raynard S, 2006, J BIOL CHEM, V281, P13861, DOI 10.1074/jbc.C600051200; Sabatti C, 2009, NAT GENET, V41, P35, DOI 10.1038/ng.271; Sims RJ, 2011, SCIENCE, V332, P99, DOI 10.1126/science.1202663; Siomi MC, 1996, MOL CELL BIOL, V16, P3825; Smith EN, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001094; Stefansson H, 2008, NATURE, V455, P232, DOI 10.1038/nature07229; Stone JL, 2008, NATURE, V455, P237, DOI 10.1038/nature07239; Tan TY, 2011, AM J MED GENET A, V155A, P1623, DOI 10.1002/ajmg.a.34051; The Social Insurance Institution of Finland, 2011, OFF STAT FINL 2011; Toulopoulou T, 2010, ARCH GEN PSYCHIAT, V67, P905, DOI 10.1001/archgenpsychiatry.2010.99; Tuulio-Henriksson A, 2004, BRIT J PSYCHIAT, V185, P215, DOI 10.1192/bjp.185.3.215; Vartiainen E, 2010, INT J EPIDEMIOL, V39, P504, DOI 10.1093/ije/dyp330; Viard T, 2007, BIOCHIMIE, V89, P456, DOI 10.1016/j.biochi.2006.10.013; Wang K, 2007, GENOME RES, V17, P1665, DOI 10.1101/gr.6861907; Wechsler T, 2011, NATURE, V471, P642, DOI 10.1038/nature09790; Xu B, 2012, NAT GENET, V44, P1365, DOI 10.1038/ng.2446; Xu DY, 2013, NAT NEUROSCI, V16, P1238, DOI 10.1038/nn.3479; Yang YZ, 2010, MOL CELL, V40, P1016, DOI 10.1016/j.molcel.2010.11.024; Yu Michael C, 2011, Mol Biol Int, V2011, P163827, DOI 10.4061/2011/163827	61	109	110	0	24	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	SEP	2013	16	9					1228	U99		10.1038/nn.3484	http://dx.doi.org/10.1038/nn.3484			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	207KN	23912948	Green Accepted, Green Submitted			2022-12-28	WOS:000323597500014
J	Zhao, XL; Tang, ZX; Zhang, HK; Atianjoh, FE; Zhao, JY; Liang, LL; Wang, W; Guan, XW; Kao, SC; Tiwari, V; Gao, YJ; Hoffman, PN; Cui, HM; Li, M; Dong, XZ; Tao, YX				Zhao, Xiuli; Tang, Zongxiang; Zhang, Hongkang; Atianjoh, Fidelis E.; Zhao, Jian-Yuan; Liang, Lingli; Wang, Wei; Guan, Xiaowei; Kao, Sheng-Chin; Tiwari, Vinod; Gao, Yong-Jing; Hoffman, Paul N.; Cui, Hengmi; Li, Min; Dong, Xinzhong; Tao, Yuan-Xiang			A long noncoding RNA contributes to neuropathic pain by silencing Kcna2 in primary afferent neurons	NATURE NEUROSCIENCE			English	Article							ROOT GANGLION NEURONS; PRIMARY SENSORY NEURONS; ALPHA-GENE EXPRESSION; POTASSIUM CHANNELS; DOWN-REGULATION; MESSENGER-RNA; NERVE INJURY; DORSAL-HORN; RAT; CONDUCTANCE	Neuropathic pain is a refractory disease characterized by maladaptive changes in gene transcription and translation in the sensory pathway. Long noncoding RNAs (lncRNAs) are emerging as new players in gene regulation, but how lncRNAs operate in the development of neuropathic pain is unclear. Here we identify a conserved lncRNA, named Kcna2 antisense RNA, for a voltage-dependent potassium channel mRNA, Kcna2, in first-order sensory neurons of rat dorsal root ganglion (DRG). Peripheral nerve injury increased Kcna2 antisense RNA expression in injured DRG through activation of myeloid zinc finger protein 1, a transcription factor that binds to the Kcna2 antisense RNA gene promoter. Mimicking this increase downregulated Kcna2, reduced total voltage-gated potassium current, increased excitability in DRG neurons and produced neuropathic pain symptoms. Blocking this increase reversed nerve injury-induced downregulation of DRG Kcna2 and attenuated development and maintenance of neuropathic pain. These findings suggest endogenous Kcna2 antisense RNA as a therapeutic target for the treatment of neuropathic pain.	[Zhao, Xiuli; Atianjoh, Fidelis E.; Zhao, Jian-Yuan; Liang, Lingli; Wang, Wei; Guan, Xiaowei; Kao, Sheng-Chin; Tiwari, Vinod; Tao, Yuan-Xiang] Johns Hopkins Univ, Sch Med, Dept Anesthesiol & Crit Care Med, Baltimore, MD 21205 USA; [Tang, Zongxiang] Nanjing Univ Chinese Med, Coll Basic Med, Nanjing, Jiangsu, Peoples R China; [Zhang, Hongkang; Li, Min; Dong, Xinzhong] Johns Hopkins Univ, Sch Med, Solomon H Snyder Dept Neurosci, Baltimore, MD 21205 USA; [Gao, Yong-Jing] Nantong Univ, Jiangsu Key Lab Neuroregenerat, Inst Naut Med, Nantong, Peoples R China; [Hoffman, Paul N.] Johns Hopkins Univ, Sch Med, Dept Ophthalmol, Baltimore, MD 21205 USA; [Cui, Hengmi] Yangzhou Univ, Biomed Innovat Inst, Yangzhou, Peoples R China; [Dong, Xinzhong] Johns Hopkins Univ, Sch Med, Howard Hughes Med Inst, Baltimore, MD 21205 USA	Johns Hopkins University; Nanjing University of Chinese Medicine; Johns Hopkins University; Nantong University; Johns Hopkins University; Yangzhou University; Howard Hughes Medical Institute; Johns Hopkins University	Tao, YX (corresponding author), Johns Hopkins Univ, Sch Med, Dept Anesthesiol & Crit Care Med, Baltimore, MD 21205 USA.	ytao1@jhmi.edu	Core, Vector/CAF-4832-2022; TIWARI, VINOD K/L-9595-2019; Gao, Yong-Jing/E-6939-2015	TIWARI, VINOD K/0000-0001-9244-8889; Gao, Yong-Jing/0000-0002-7432-7458; Tiwari, Vinod/0000-0002-8491-2255; Zhao, Jian-Yuan/0000-0001-9861-0330	Howard Hughes Medical Institute; US National Institutes of Health (NIH) [NS054791, GM087369]; NIH [MH084691, GM078579, DA033390, NS072206]; Rita Allen Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM078579, R01GM087369] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [U54MH084691] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS054791, R01NS094664, R01NS072206] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA033390] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Rita Allen Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank R.J. Samulski (University of North Carolina) for the rAAV5 plasmid, J. Zhou (Institute of Biochemistry of Cell Biology, Chinese Academy of Sciences) for the full-length EGFP-MZF1 plasmid and D.Y.H. Tuan (Georgia Health Sciences University) for MZF1 antibody. We thank C. F. Levine for editorial assistance. This work was supported by the Howard Hughes Medical Institute and US National Institutes of Health (NIH) grants (NS054791 and GM087369) to X. D., by NIH grants (MH084691 and GM078579) to M. L. and by NIH grants (DA033390, NS072206) and the grants from the Rita Allen Foundation to Y.-X.T.	BENNETT GJ, 1988, PAIN, V33, P87, DOI 10.1016/0304-3959(88)90209-6; Campbell JN, 2006, NEURON, V52, P77, DOI 10.1016/j.neuron.2006.09.021; Cardenas CG, 1999, J PHYSIOL-LONDON, V518, P507, DOI 10.1111/j.1469-7793.1999.0507p.x; Castle NA, 2003, MOL PHARMACOL, V63, P409, DOI 10.1124/mol.63.2.409; CHABAL C, 1989, PAIN, V36, P321, DOI 10.1016/0304-3959(89)90091-2; Chien LY, 2007, J NEUROSCI, V27, P9855, DOI 10.1523/JNEUROSCI.0604-07.2007; Chung Jin Mo, 2002, Pain Pract, V2, P87, DOI 10.1046/j.1533-2500.2002.02011.x; Coggeshall RE, 1996, J COMP NEUROL, V364, P6, DOI 10.1002/(SICI)1096-9861(19960101)364:1<6::AID-CNE2>3.0.CO;2-9; Costa FF, 2008, GENE, V410, P9, DOI 10.1016/j.gene.2007.12.008; Costigan M, 2009, ANNU REV NEUROSCI, V32, P1, DOI 10.1146/annurev.neuro.051508.135531; DEVOR M, 1983, NEUROSCI LETT, V40, P181, DOI 10.1016/0304-3940(83)90299-9; Devor M, 2009, EXP BRAIN RES, V196, P115, DOI 10.1007/s00221-009-1724-6; Dodson PD, 2002, J NEUROSCI, V22, P6953; Dong XZ, 2001, CELL, V106, P619, DOI 10.1016/S0092-8674(01)00483-4; Esumi S, 2006, NAT PROTOC, V1, P2143, DOI 10.1038/nprot.2006.343; Everill B, 2000, NEUROSCIENCE, V100, P417, DOI 10.1016/S0306-4522(00)00263-3; Faghihi MA, 2009, NAT REV MOL CELL BIO, V10, P637, DOI 10.1038/nrm2738; Fulton S, 2011, J BIOL CHEM, V286, P9360, DOI 10.1074/jbc.M110.153262; Gallagher PE, 2001, METH MOLEC MED, V51, P205, DOI 10.1385/1-59259-087-X:205; Gibb EA, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-38; Guan XW, 2009, N-S ARCH PHARMACOL, V380, P459, DOI 10.1007/s00210-009-0451-7; Han PJ, 2004, EXP NEUROL, V189, P293, DOI 10.1016/j.expneurol.2004.03.010; Hsieh YH, 2006, BIOCHEM BIOPH RES CO, V339, P217, DOI 10.1016/j.bbrc.2005.11.015; Ishikawa K, 1999, MUSCLE NERVE, V22, P502, DOI 10.1002/(SICI)1097-4598(199904)22:4<502::AID-MUS12>3.0.CO;2-K; Kim DS, 2002, MOL BRAIN RES, V105, P146, DOI 10.1016/S0169-328X(02)00388-1; Kim YI, 1998, NEUROSCIENCE, V86, P301, DOI 10.1016/S0306-4522(98)00022-0; Lavorgna G, 2004, TRENDS BIOCHEM SCI, V29, P88, DOI 10.1016/j.tibs.2003.12.002; Liang LL, 2013, J PAIN, V14, P638, DOI 10.1016/j.jpain.2013.01.778; Liu CN, 2000, PAIN, V85, P503, DOI 10.1016/S0304-3959(00)00251-7; Luo JL, 2011, J PAIN, V12, P600, DOI 10.1016/j.jpain.2010.11.005; Luo XY, 2009, J NEUROCHEM, V108, P952, DOI 10.1111/j.1471-4159.2008.05845.x; Nehme B, 2011, J NEUROSCI METH, V196, P281, DOI 10.1016/j.jneumeth.2011.01.018; Nicol GD, 1997, J NEUROPHYSIOL, V77, P167, DOI 10.1152/jn.1997.77.1.167; Park JS, 2009, J NEUROSCI, V29, P3206, DOI 10.1523/JNEUROSCI.4514-08.2009; Park SY, 2003, MOL CELLS, V16, P256; Ponting CP, 2009, CELL, V136, P629, DOI 10.1016/j.cell.2009.02.006; Rasband MN, 2001, P NATL ACAD SCI USA, V98, P13373, DOI 10.1073/pnas.231376298; REHM H, 1991, FASEB J, V5, P164, DOI 10.1096/fasebj.5.2.2004663; Rinke I, 2010, J NEUROSCI, V30, P4776, DOI 10.1523/JNEUROSCI.6299-09.2010; Robbins CA, 2012, EPILEPSIA, V53, P134, DOI 10.1111/j.1528-1167.2012.03484.x; Singh OV, 2009, PROTEOMICS, V9, P1241, DOI 10.1002/pmic.200800636; Tal M, 1999, BRAIN RES, V824, P218, DOI 10.1016/S0006-8993(99)01190-7; TARG EF, 1986, BRAIN RES, V363, P1, DOI 10.1016/0006-8993(86)90652-9; Vacher H, 2011, PFLUG ARCH EUR J PHY, V462, P631, DOI 10.1007/s00424-011-1004-8; Visan V, 2004, MOL PHARMACOL, V66, P1103, DOI 10.1124/mol.104.002774; Wapinski O, 2011, TRENDS CELL BIOL, V21, P354, DOI 10.1016/j.tcb.2011.04.001; Weissner W, 2006, J COMP NEUROL, V497, P78, DOI 10.1002/cne.20981; Xu JT, 2010, BRAIN RES, V1336, P46, DOI 10.1016/j.brainres.2010.04.010; Xu Y, 2003, P NATL ACAD SCI USA, V100, P6204, DOI 10.1073/pnas.0930324100; Yang EK, 2004, NEUROSCIENCE, V123, P867, DOI 10.1016/j.neuroscience.2003.11.014; Zhang BS, 2003, PAIN, V106, P187, DOI 10.1016/j.pain.2003.08.003; Zheng Q, 2012, MOL PAIN, V8, DOI 10.1186/1744-8069-8-24	52	243	256	2	74	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	AUG	2013	16	8					1024	U76		10.1038/nn.3438	http://dx.doi.org/10.1038/nn.3438			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	190EV	23792947	Green Accepted			2022-12-28	WOS:000322323000012
J	Kishimoto, N; Asakawa, K; Madelaine, R; Blader, P; Kawakami, K; Sawamoto, K				Kishimoto, Norihito; Asakawa, Kazuhide; Madelaine, Romain; Blader, Patrick; Kawakami, Koichi; Sawamoto, Kazunobu			Interhemispheric asymmetry of olfactory input-dependent neuronal specification in the adult brain	NATURE NEUROSCIENCE			English	Article							GENE TRAP APPROACH; NEURAL STEM-CELLS; ZEBRAFISH; NEUROGENESIS; BULB; RESPONSES; CIRCUITS; NOTCH	The vertebrate brain is anatomically and functionally asymmetric. The left and right cerebral hemispheres harbor neural stem cell niches at the ventricular-subventricular zone (V-SVZ) of the ventricular walls, where new neurons are continuously generated throughout life. However, any interhemispheric asymmetry of neural stem cell niches remains unclear. We performed gene-trap screens in adult zebrafish to identify genes that are differentially expressed in the two hemispheres and found that adult-born neurons expressing the neural zinc-finger protein Myt1 exist predominantly in the left V-SVZ. This lateralization could be reversed by left olfactory sensory deprivation-induced inactivation of Notch signaling. The olfactory behavioral preference for attractive amino acids was also impaired by sensory deprivation of the left olfactory system, but not of the right olfactory system. Our findings suggest that olfactory input generates interhemispheric differences in the fate of adult-born neurons in the zebrafish brain.	[Kishimoto, Norihito; Sawamoto, Kazunobu] Nagoya City Univ, Grad Sch Med Sci, Dept Dev & Regenerat Biol, Nagoya, Aichi, Japan; [Asakawa, Kazuhide; Kawakami, Koichi] Grad Univ Adv Studies SOKENDAI, Div Mol & Dev Biol, Natl Inst Genet, Mishima, Shizuoka, Japan; [Asakawa, Kazuhide; Kawakami, Koichi] Grad Univ Adv Studies SOKENDAI, Dept Genet, Mishima, Shizuoka, Japan; [Madelaine, Romain; Blader, Patrick] Univ Toulouse, UPS, Ctr Biol Dev, Toulouse, France; [Madelaine, Romain; Blader, Patrick] Ctr Dev Biol, CNRS, UMR 5547, Toulouse, France	Nagoya City University; Graduate University for Advanced Studies - Japan; Research Organization of Information & Systems (ROIS); National Institute of Genetics (NIG) - Japan; Graduate University for Advanced Studies - Japan; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Toulouse; Universite Toulouse III - Paul Sabatier	Sawamoto, K (corresponding author), Nagoya City Univ, Grad Sch Med Sci, Dept Dev & Regenerat Biol, Nagoya, Aichi, Japan.	sawamoto@med.nagoya-cu.ac.jp	Kawakami, Koichi/AAF-1380-2019; Asakawa, Kazuhide/ABD-2065-2020	Asakawa, Kazuhide/0000-0003-0628-1176; Blader, Patrick/0000-0003-3299-6108; Sawamoto, Kazunobu/0000-0003-1984-5129	Funding Program for Next Generation World-Leading Researchers from the Japan Society for the Promotion of Science [LS104]; National BioResource Project; Ministry of Education, Culture, Sports, Science and Technology [20509005, 23241063]	Funding Program for Next Generation World-Leading Researchers from the Japan Society for the Promotion of Science; National BioResource Project(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	We thank T. Seki (Tokyo Medical University) for the antibody to PSA-NCAM, U. Strahle (Karlsruhe Institute of Technology) for the Tg(neurog1:gfp) fish, A. Alvarez-Buylla and Y. Yoshihara for helpful comments on the manuscript, and members of the Sawamoto laboratory for discussions. This work was supported by the Funding Program for Next Generation World-Leading Researchers from the Japan Society for the Promotion of Science (LS104 to K.S.), the National BioResource Project (K.K.), a Grant-in-Aid for Scientific Research (C) (20509005 to N.K.) and a Grant-in-Aid for Scientific Research (A) (23241063 to K.K.) from the Ministry of Education, Culture, Sports, Science and Technology.	Agetsuma M, 2010, NAT NEUROSCI, V13, P1354, DOI 10.1038/nn.2654; Aizawa H, 2005, CURR BIOL, V15, P238, DOI 10.1016/j.cub.2005.01.014; Aizawa H, 2007, DEV CELL, V12, P87, DOI 10.1016/j.devcel.2006.10.004; Asakawa K, 2008, P NATL ACAD SCI USA, V105, P1255, DOI 10.1073/pnas.0704963105; Bellefroid EJ, 1996, CELL, V87, P1191, DOI 10.1016/S0092-8674(00)81815-2; Bertrand N, 2002, NAT REV NEUROSCI, V3, P517, DOI 10.1038/nrn874; Blader P, 2003, MECH DEVELOP, V120, P211, DOI 10.1016/S0925-4773(02)00413-6; Byrd CA, 2000, BRAIN RES, V866, P92, DOI 10.1016/S0006-8993(00)02252-6; Chapouton P, 2010, J NEUROSCI, V30, P7961, DOI 10.1523/JNEUROSCI.6170-09.2010; Fuentealba LC, 2012, CELL STEM CELL, V10, P698, DOI 10.1016/j.stem.2012.05.012; Kawakami K, 2004, DEV CELL, V7, P133, DOI 10.1016/j.devcel.2004.06.005; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Kishimoto N, 2012, DIS MODEL MECH, V5, P200, DOI 10.1242/dmm.007336; Kishimoto N, 2011, J COMP NEUROL, V519, P3549, DOI 10.1002/cne.22722; Kizil C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027395; Koide T, 2009, P NATL ACAD SCI USA, V106, P9884, DOI 10.1073/pnas.0900470106; Liang JO, 2000, DEVELOPMENT, V127, P5101; Lindsay SM, 2004, CHEM SENSES, V29, P93, DOI 10.1093/chemse/bjh009; Lledo PM, 2006, NAT REV NEUROSCI, V7, P179, DOI 10.1038/nrn1867; Madelaine R, 2011, DEV BIOL, V350, P198, DOI 10.1016/j.ydbio.2010.10.025; Miyasaka N, 2009, J NEUROSCI, V29, P4756, DOI 10.1523/JNEUROSCI.0118-09.2009; Roussigne M, 2009, DEVELOPMENT, V136, P1549, DOI 10.1242/dev.034793; Scheer N, 2001, DEVELOPMENT, V128, P1099; Shinohara Y, 2008, P NATL ACAD SCI USA, V105, P19498, DOI 10.1073/pnas.0807461105; Westerfield M, 1995, ZEBRAFISH BOOK	25	11	11	0	11	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JUL	2013	16	7					884	U139		10.1038/nn.3409	http://dx.doi.org/10.1038/nn.3409			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	174UM	23685722				2022-12-28	WOS:000321180900021
J	Bardehle, S; Kruger, M; Buggenthin, F; Schwausch, J; Ninkovic, J; Clevers, H; Snippert, HJ; Theis, FJ; Meyer-Luehmann, M; Bechmann, I; Dimou, L; Gotz, M				Bardehle, Sophia; Krueger, Martin; Buggenthin, Felix; Schwausch, Julia; Ninkovic, Jovica; Clevers, Hans; Snippert, Hugo J.; Theis, Fabian J.; Meyer-Luehmann, Melanie; Bechmann, Ingo; Dimou, Leda; Goetz, Magdalena			Live imaging of astrocyte responses to acute injury reveals selective juxtavascular proliferation	NATURE NEUROSCIENCE			English	Article							IN-VITRO; MOUSE MODEL; RHO-GTPASE; GLIA; CELLS; CDC42; TOOL; REGENERATION; EXPRESSION; DELETION	Astrocytes are thought to have important roles after brain injury, but their behavior has largely been inferred from postmortem analysis. To examine the mechanisms that recruit astrocytes to sites of injury, we used in vivo two-photon laser-scanning microscopy to follow the response of GFP-labeled astrocytes in the adult mouse cerebral cortex over several weeks after acute injury. Live imaging revealed a marked heterogeneity in the reaction of individual astrocytes, with one subset retaining their initial morphology, another directing their processes toward the lesion, and a distinct subset located at juxtavascular sites proliferating. Although no astrocytes actively migrated toward the injury site, selective proliferation of juxtavascular astrocytes was observed after the introduction of a lesion and was still the case, even though the extent was reduced, after astrocyte-specific deletion of the RhoGTPase Cdc42. Thus, astrocyte recruitment after injury relies solely on proliferation in a specific niche.	[Bardehle, Sophia; Dimou, Leda; Goetz, Magdalena] Univ Munich, Inst Physiol, D-80539 Munich, Germany; [Bardehle, Sophia; Schwausch, Julia; Ninkovic, Jovica; Dimou, Leda; Goetz, Magdalena] Helmholtz Zentrum Munich, Inst Stem Cell Res, Neuherberg, Germany; [Krueger, Martin; Bechmann, Ingo] Univ Leipzig, Inst Anat, D-04109 Leipzig, Germany; [Buggenthin, Felix; Theis, Fabian J.] Helmholtz Zentrum Munich, Inst Bioinformat & Syst Biol, Neuherberg, Germany; [Buggenthin, Felix; Theis, Fabian J.] Tech Univ Munich, Dept Math, D-80290 Munich, Germany; [Clevers, Hans; Snippert, Hugo J.] Koninklijke Nederlandse Akad Wetenschappen, Hubrecht Inst, Connecticut Utrecht, Netherlands; [Clevers, Hans; Snippert, Hugo J.] Univ Med Ctr Utrecht, Connecticut Utrecht, Netherlands; [Meyer-Luehmann, Melanie] Univ Munich, Dept Biochem, Adolf Butenandt Inst, Munich, Germany; [Meyer-Luehmann, Melanie] Univ Freiburg, Dept Neurol, Neuroctr, Freiburg, Germany; [Goetz, Magdalena] Munich Cluster Syst Neurol SyNergy, Munich, Germany	University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Leipzig University; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Technical University of Munich; Royal Netherlands Academy of Arts & Sciences; Hubrecht Institute (KNAW); Utrecht University; Utrecht University Medical Center; University of Munich; University of Freiburg; University of Munich	Gotz, M (corresponding author), Univ Munich, Inst Physiol, Pettenkoferstr 12, D-80539 Munich, Germany.	magdalena.goetz@helmholtz-muenchen.de	Ninkovic, Jovica/AAH-5220-2019; Dimou, Leda/E-7968-2012; Theis, Fabian J/ABD-5212-2021	Ninkovic, Jovica/0000-0002-4381-0041; Theis, Fabian J/0000-0002-2419-1943; Meyer-Luehmann, Melanie/0000-0003-3661-2220	DFG (German Research foundation) [SFB 870, SPP1356, DFG-FOR 1336]; BMBF (Ministry of Science and Education); Helmholtz Association (Helmholtz Alliance ICEMED); Helmholtz Association (Helmholtz Alliance on Systems Biology); Emmy Noether Program of the DFG [ME 3542/1-1]; European Research Council; Munich Cluster for Systems Neurology; European Commission under the Seventh Framework Program (FP7)	DFG (German Research foundation)(German Research Foundation (DFG)); BMBF (Ministry of Science and Education); Helmholtz Association (Helmholtz Alliance ICEMED); Helmholtz Association (Helmholtz Alliance on Systems Biology); Emmy Noether Program of the DFG(German Research Foundation (DFG)); European Research Council(European Research Council (ERC)European Commission); Munich Cluster for Systems Neurology; European Commission under the Seventh Framework Program (FP7)	We are indebted to C. Brakebusch for the Cdc42<SUP>loxP/loxP</SUP> mice, S. Robel for initial help in setting up the two-photon live-imaging procedure, and C. Straube and S. Falkner for sharing their imaging expertise. We would also like to thank R. Waberer, C. Meyer, D. Franzen, I. Muhlhahn and G. Jager for technical assistance, and M. Hubener, D.E. Bergles, J. McCarter and P. Hardy for critical comments on the manuscript. We thank the DFG (German Research foundation) whose support (particularly via the Leibniz Prize and SFB 870) allowed us to invest into this new experimental area and for funding M.G. and F.J.T. by SPP1356 and I.B. by DFG-FOR 1336. In addition, this work was supported by the BMBF (Ministry of Science and Education) to M.G. and F.J.T., the Helmholtz Association (Helmholtz Alliance ICEMED to M.G., I.B. and F.J.T.; Helmholtz Alliance on Systems Biology to M.G. and F.J.T.), the Emmy Noether Program of the DFG (ME 3542/1-1 to M.M.-L.), the European Research Council (starting grant 'LatentCauses' to F.J.T.) and Munich Cluster for Systems Neurology. The Initial Training Network Edu-GLIA (PITN-GA-2009-237956) funded by the European Commission under the Seventh Framework Program (FP7) provided a wonderful discussion platform for glial research.	Abr?moff M.D., 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; Bolte S, 2006, J MICROSC-OXFORD, V224, P213, DOI 10.1111/j.1365-2818.2006.01706.x; Buffo A, 2008, P NATL ACAD SCI USA, V105, P3581, DOI 10.1073/pnas.0709002105; Bush TG, 1999, NEURON, V23, P297, DOI 10.1016/S0896-6273(00)80781-3; Cahoy JD, 2008, J NEUROSCI, V28, P264, DOI 10.1523/JNEUROSCI.4178-07.2008; Davalos D, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2230; Dibaj P, 2011, NEUROSCI LETT, V497, P148, DOI 10.1016/j.neulet.2011.04.049; Erturk A, 2012, NAT MED, V18, P166, DOI 10.1038/nm.2600; Etienne-Manneville S, 2006, METHOD ENZYMOL, V406, P565, DOI 10.1016/S0076-6879(06)06044-7; Fuchs S, 2009, CELL STEM CELL, V4, P236, DOI 10.1016/j.stem.2009.01.017; Fuhrmann M, 2010, NAT NEUROSCI, V13, P411, DOI 10.1038/nn.2511; Ge WP, 2012, NATURE, V484, P376, DOI 10.1038/nature10959; Goritz C, 2011, SCIENCE, V333, P238, DOI 10.1126/science.1203165; Heintz N, 2004, NAT NEUROSCI, V7, P483, DOI 10.1038/nn0504-483; Hellal F, 2011, SCIENCE, V331, P928, DOI 10.1126/science.1201148; Holtje M, 2005, J NEUROCHEM, V95, P1237, DOI 10.1111/j.1471-4159.2005.03443.x; Holtmaat A, 2009, NAT PROTOC, V4, P1128, DOI 10.1038/nprot.2009.89; Klein S, 2007, IEEE T IMAGE PROCESS, V16, P2879, DOI 10.1109/TIP.2007.909412; Klein S, 2010, IEEE T MED IMAGING, V29, P196, DOI 10.1109/TMI.2009.2035616; Krueger M, 2010, GLIA, V58, P1, DOI 10.1002/glia.20898; Mathiisen TM, 2010, GLIA, V58, P1094, DOI 10.1002/glia.20990; McCaslin AFH, 2011, J CEREBR BLOOD F MET, V31, P795, DOI 10.1038/jcbfm.2010.204; Metz CT, 2011, MED IMAGE ANAL, V15, P238, DOI 10.1016/j.media.2010.10.003; Meyer-Luehmann M, 2008, NATURE, V451, P720, DOI 10.1038/nature06616; Middeldorp J, 2011, PROG NEUROBIOL, V93, P421, DOI 10.1016/j.pneurobio.2011.01.005; Misgeld T, 2007, NAT PROTOC, V2, P263, DOI 10.1038/nprot.2007.24; Mori T, 2006, GLIA, V54, P21, DOI 10.1002/glia.20350; Nakamura T, 2006, CIRC RES, V98, P1547, DOI 10.1161/01.RES.0000227505.19472.69; Nimmerjahn A, 2005, SCIENCE, V308, P1314, DOI 10.1126/science.1110647; Nolte C, 2001, GLIA, V33, P72; Oberheim NA, 2008, J NEUROSCI, V28, P3264, DOI 10.1523/JNEUROSCI.4980-07.2008; Pekny M, 2005, GLIA, V50, P427, DOI 10.1002/glia.20207; Prodinger C, 2011, ACTA NEUROPATHOL, V121, P445, DOI 10.1007/s00401-010-0774-y; Regan MR, 2007, J NEUROSCI, V27, P6607, DOI 10.1523/JNEUROSCI.0790-07.2007; Robel S, 2011, J NEUROSCI, V31, P12471, DOI 10.1523/JNEUROSCI.2696-11.2011; Robel S, 2011, NAT REV NEUROSCI, V12, P88, DOI 10.1038/nrn2978; Silver J, 2004, NAT REV NEUROSCI, V5, P146, DOI 10.1038/nrn1326; Simon C, 2011, GLIA, V59, P869, DOI 10.1002/glia.21156; Sirko S., 2013, CELL STEM C IN PRESS; Snippert HJ, 2010, CELL, V143, P134, DOI 10.1016/j.cell.2010.09.016; Sofroniew MV, 2009, TRENDS NEUROSCI, V32, P638, DOI 10.1016/j.tins.2009.08.002; Tsai HH, 2012, SCIENCE, V337, P358, DOI 10.1126/science.1222381; Warner SJ, 2010, CURR BIOL, V20, P677, DOI 10.1016/j.cub.2010.03.025; Wolburg H, 2005, NEUROGLIA, V2, P19, DOI [10.1093/acprof:oso/9780195152227.001.0001/acprof-9780195152227-chapter-2, DOI 10.1093/ACPROF:OSO/9780195152227.003]; Wu XW, 2006, GENE DEV, V20, P571, DOI 10.1101/gad.361406; Zamanian JL, 2012, J NEUROSCI, V32, P6391, DOI 10.1523/JNEUROSCI.6221-11.2012	46	261	266	2	60	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAY	2013	16	5					580	+		10.1038/nn.3371	http://dx.doi.org/10.1038/nn.3371			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	131WT	23542688				2022-12-28	WOS:000318029300014
J	Labouebe, G; Liu, S; Dias, C; Zou, HY; Wong, JCY; Karunakaran, S; Clee, SM; Phillips, AG; Boutrel, B; Borgland, SL				Labouebe, Gwenael; Liu, Shuai; Dias, Carine; Zou, Haiyan; Wong, Jovi C. Y.; Karunakaran, Subashini; Clee, Susanne M.; Phillips, Anthony G.; Boutrel, Benjamin; Borgland, Stephanie L.			Insulin induces long-term depression of ventral tegmental area dopamine neurons via endocannabinoids	NATURE NEUROSCIENCE			English	Article							AMPA RECEPTOR TRAFFICKING; SYNAPTIC PLASTICITY; INTRAVENTRICULAR INSULIN; NUCLEUS-ACCUMBENS; SUCROSE INTAKE; FOOD-INTAKE; LEPTIN; BRAIN; RATS; TRANSMISSION	The prevalence of obesity has markedly increased over the past few decades. Exploration of how hunger and satiety signals influence the reward system can help us understand non-homeostatic feeding. Insulin may act in the ventral tegmental area (VIA), a critical site for reward-seeking behavior, to suppress feeding. However, the neural mechanisms underlying insulin effects in the VIA remain unknown. We demonstrate that insulin, a circulating catabolic peptide that inhibits feeding, can induce long-term depression (LTD) of mouse excitatory synapses onto VIA dopamine neurons. This effect requires endocannabinoid-mediated presynaptic inhibition of glutamate release. Furthermore, after a sweetened high-fat meal, which elevates endogenous insulin, insulin-induced LTD is occluded. Finally, insulin in the VIA reduces food anticipatory behavior in mice and conditioned place preference for food in rats. Taken together, these results suggest that insulin in the VIA suppresses excitatory synaptic transmission and reduces anticipatory activity and preference for food-related cues.	[Labouebe, Gwenael; Liu, Shuai; Zou, Haiyan; Wong, Jovi C. Y.; Borgland, Stephanie L.] Univ British Columbia, Dept Anesthesiol Pharmacol & Therapeut, Vancouver, BC V5Z 1M9, Canada; [Labouebe, Gwenael; Boutrel, Benjamin] Univ Lausanne Hosp, Ctr Psychiat Neurosci, Dept Psychiat, Lausanne, Switzerland; [Liu, Shuai; Borgland, Stephanie L.] Fudan Univ, Shanghai Med Coll, State Key Lab Med Neurobiol, Shanghai 200433, Peoples R China; [Dias, Carine; Phillips, Anthony G.] Univ British Columbia, Dept Psychiat, Vancouver, BC V5Z 1M9, Canada; [Karunakaran, Subashini; Clee, Susanne M.] Univ British Columbia, Dept Cellular & Physiol Sci, Vancouver, BC V5Z 1M9, Canada	University of British Columbia; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); Fudan University; University of British Columbia; University of British Columbia	Borgland, SL (corresponding author), Univ British Columbia, Dept Anesthesiol Pharmacol & Therapeut, Vancouver, BC V5Z 1M9, Canada.	borgland@mail.ubc.ca	Borgland, Stephanie/GPC-5260-2022; Clee, Susanne/AAC-4278-2020; Clee, Susanne/F-7312-2010; Borgland, Stephanie/M-2936-2016	Borgland, Stephanie/0000-0001-7546-5687; Clee, Susanne/0000-0001-7946-688X; Borgland, Stephanie/0000-0001-7546-5687; Wong, Jovi/0000-0001-7980-9352; Boutrel, Benjamin/0000-0003-4988-759X	Canadian Institute of Health Research [102617]; Swiss National Science Foundation [31003A-133056]	Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR)); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	The authors would like to thank K. Lee for performing the insulin measurements and K. Haas, B. MacVicar and Y.T. Wang for suggestions on the manuscript. This research was supported by a Canadian Institute of Health Research operating grant (102617) and a Canadian Institute of Health Research new investigator award to S.L.B. G.L. was supported by a Swiss National Science Foundation postdoctoral fellowship. Behavioral experiments done in B.B.'s laboratory were supported by the Swiss National Science Foundation (31003A-133056).	Abizaid A, 2006, J CLIN INVEST, V116, P3229, DOI 10.1172/JCI29867; Ahn S, 1999, J NEUROSCI, V19; Asnaghi L, 2004, PHARMACOL RES, V50, P545, DOI 10.1016/j.phrs.2004.03.007; BALTENSPERGER K, 1992, P NATL ACAD SCI USA, V89, P7885, DOI 10.1073/pnas.89.17.7885; Baskin DG, 1999, BRAIN RES, V848, P114, DOI 10.1016/S0006-8993(99)01974-5; Bisogno T, 1999, BIOCHEM BIOPH RES CO, V256, P377, DOI 10.1006/bbrc.1999.0254; Blum ID, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036117; Bonci A, 1999, J NEUROSCI, V19, P3723; Borgland SL, 2006, NEURON, V49, P589, DOI 10.1016/j.neuron.2006.01.016; Borgland SL, 2009, J NEUROSCI, V29, P11215, DOI 10.1523/JNEUROSCI.6096-08.2009; Bruijnzeel AW, 2011, BEHAV BRAIN RES, V219, P254, DOI 10.1016/j.bbr.2011.01.020; Duckworth WC, 1998, ENDOCR REV, V19, P608, DOI 10.1210/er.19.5.608; Figlewicz DP, 2008, AM J PHYSIOL-REG I, V295, pR388, DOI 10.1152/ajpregu.90334.2008; Figlewicz DP, 2006, PHYSIOL BEHAV, V89, P611, DOI 10.1016/j.physbeh.2006.07.023; Figlewicz DP, 2003, BRAIN RES, V964, P107, DOI 10.1016/S0006-8993(02)04087-8; Figlewicz DP, 2004, BEHAV NEUROSCI, V118, P479, DOI 10.1037/0735-7044.118.3.479; Fulton S, 2006, NEURON, V51, P811, DOI 10.1016/j.neuron.2006.09.006; Gerdeman GL, 2002, NAT NEUROSCI, V5, P446, DOI 10.1038/nn832; Gerozissis K, 2008, EUR J PHARMACOL, V585, P38, DOI 10.1016/j.ejphar.2008.01.050; Grueter BA, 2010, NAT NEUROSCI, V13, P1519, DOI 10.1038/nn.2685; Heifets BD, 2009, ANNU REV PHYSIOL, V71, P283, DOI 10.1146/annurev.physiol.010908.163149; Henny P, 2012, NAT NEUROSCI, V15, P613, DOI 10.1038/nn.3048; Hommel JD, 2006, NEURON, V51, P801, DOI 10.1016/j.neuron.2006.08.023; KATZ B, 1971, SCIENCE, V173, P123, DOI 10.1126/science.173.3992.123; Kauer JA, 2007, NAT REV NEUROSCI, V8, P844, DOI 10.1038/nrn2234; Lee SH, 2002, NEURON, V36, P661, DOI 10.1016/S0896-6273(02)01024-3; Luscher C, 2011, NEURON, V69, P650, DOI 10.1016/j.neuron.2011.01.017; Luscher C, 1999, NEURON, V24, P649, DOI 10.1016/S0896-6273(00)81119-8; Malinow R, 2002, ANNU REV NEUROSCI, V25, P103, DOI 10.1146/annurev.neuro.25.112701.142758; Mameli M, 2007, SCIENCE, V317, P530, DOI 10.1126/science.1142365; Man HY, 2000, NEURON, V25, P649, DOI 10.1016/S0896-6273(00)81067-3; Massa F, 2010, J NEUROSCI, V30, P6273, DOI 10.1523/JNEUROSCI.2648-09.2010; Mebel DM, 2012, EUR J NEUROSCI, V36, P2336, DOI 10.1111/j.1460-9568.2012.08168.x; Melis M, 2004, J NEUROSCI, V24, P53, DOI 10.1523/JNEUROSCI.4503-03.2004; Overton PG, 1997, BRAIN RES REV, V25, P312, DOI 10.1016/S0165-0173(97)00039-8; Overton PG, 1999, NEUROREPORT, V10, P221, DOI 10.1097/00001756-199902050-00004; Palmiter RD, 2007, TRENDS NEUROSCI, V30, P375, DOI 10.1016/j.tins.2007.06.004; Pan B, 2008, J NEUROSCI, V28, P1385, DOI 10.1523/JNEUROSCI.4033-07.2008; Ronesi J, 2004, J NEUROSCI, V24, P1673, DOI 10.1523/JNEUROSCI.5214-03.2004; Sanchis-Segura C, 2006, ADDICT BIOL, V11, P2, DOI 10.1111/j.1369-1600.2006.00012.x; Schaffer L, 2008, BIOCHEM BIOPH RES CO, V376, P380, DOI 10.1016/j.bbrc.2008.08.151; Sipols AJ, 2002, PEPTIDES, V23, P2181, DOI 10.1016/S0196-9781(02)00246-2; Stuber GD, 2008, SCIENCE, V321, P1690, DOI 10.1126/science.1160873; Thompson JL, 2011, BEHAV BRAIN RES, V217, P446, DOI 10.1016/j.bbr.2010.09.028; Tsai HC, 2009, SCIENCE, V324, P1080, DOI 10.1126/science.1168878; Vigneri R, 2010, ACTA DIABETOL, V47, P271, DOI 10.1007/s00592-010-0215-3; Wang YT, 2000, NEURON, V25, P635, DOI 10.1016/S0896-6273(00)81066-1; Watabe-Uchida M, 2012, NEURON, V74, P858, DOI 10.1016/j.neuron.2012.03.017; Woods SC, 2003, CURR PHARM DESIGN, V9, P795, DOI 10.2174/1381612033455323; Yin HH, 2006, J NEUROSCI, V26, P11811, DOI 10.1523/JNEUROSCI.3196-06.2006	50	164	168	4	55	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	MAR	2013	16	3					300	308		10.1038/nn.3321	http://dx.doi.org/10.1038/nn.3321			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	097LE	23354329	Green Accepted, Green Submitted			2022-12-28	WOS:000315474800012
J	Ryan, TJ; Kopanitsa, MV; Indersmitten, T; Nithianantharajah, J; Afinowi, NO; Pettit, C; Stanford, LE; Sprengel, R; Saksida, LM; Bussey, TJ; O'Dell, TJ; Grant, SGN; Komiyama, NH				Ryan, Tomas J.; Kopanitsa, Maksym V.; Indersmitten, Tim; Nithianantharajah, Jess; Afinowi, Nurudeen O.; Pettit, Charles; Stanford, Lianne E.; Sprengel, Rolf; Saksida, Lisa M.; Bussey, Timothy J.; O'Dell, Thomas J.; Grant, Seth G. N.; Komiyama, Noboru H.			Evolution of GluN2A/B cytoplasmic domains diversified vertebrate synaptic plasticity and behavior	NATURE NEUROSCIENCE			English	Article							LONG-TERM POTENTIATION; NMDA RECEPTOR SUBTYPES; MICE LACKING; POSTSYNAPTIC DENSITY-95; MOLECULAR-BIOLOGY; HIPPOCAMPAL; SUBUNIT; MEMORY; NR2A; EXPRESSION	Two genome duplications early in the vertebrate lineage expanded gene families, including GluN2 subunits of the NMDA receptor. Diversification between the four mammalian GluN2 proteins occurred primarily at their intracellular C-terminal domains (CTDs). To identify shared ancestral functions and diversified subunit-specific functions, we exchanged the exons encoding the GluN2A (also known as Grin2a) and GluN2B (also known as Grin2b) CTDs in two knock-in mice and analyzed the mice's biochemistry, synaptic physiology, and multiple learned and innate behaviors. The eight behaviors were genetically separated into four groups, including one group comprising three types of learning linked to conserved GluN2A/B regions. In contrast, the remaining five behaviors exhibited subunit-specific regulation. GluN2A/B CTD diversification conferred differential binding to cytoplasmic MAGUK proteins and differential forms of long-term potentiation. These data indicate that vertebrate behavior and synaptic signaling acquired increased complexity from the duplication and diversification of ancestral GluN2 genes.	[Ryan, Tomas J.; Kopanitsa, Maksym V.; Nithianantharajah, Jess; Afinowi, Nurudeen O.; Pettit, Charles; Stanford, Lianne E.; Grant, Seth G. N.; Komiyama, Noboru H.] Wellcome Trust Sanger Inst, Genes Cognit Programme, Cambridge, England; [Ryan, Tomas J.] Univ Cambridge Wolfson Coll, Cambridge CB3 9BB, England; [Kopanitsa, Maksym V.; Afinowi, Nurudeen O.] Synome Ltd, Cambridge, England; [Indersmitten, Tim] Univ Calif Los Angeles, Interdept PhD Program Neurosci, Los Angeles, CA USA; [Nithianantharajah, Jess; Grant, Seth G. N.; Komiyama, Noboru H.] Univ Edinburgh, Genes Cognit Programme, Ctr Clin Brain Sci, Edinburgh, Midlothian, Scotland; [Nithianantharajah, Jess; Grant, Seth G. N.; Komiyama, Noboru H.] Univ Edinburgh, Ctr Neuroregenerat, Edinburgh, Midlothian, Scotland; [Nithianantharajah, Jess; Saksida, Lisa M.; Bussey, Timothy J.; Grant, Seth G. N.] Univ Cambridge, Dept Expt Psychol, Cambridge CB2 3EB, England; [Nithianantharajah, Jess; Saksida, Lisa M.; Bussey, Timothy J.; Grant, Seth G. N.] Univ Cambridge, MRC, Cambridge, England; [Nithianantharajah, Jess; Saksida, Lisa M.; Bussey, Timothy J.; Grant, Seth G. N.] Univ Cambridge, Wellcome Trust Behav & Clin Neurosci Inst, Cambridge, England; [Sprengel, Rolf] Max Planck Inst Med Res, Heidelberg, Germany; [O'Dell, Thomas J.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Physiol, Los Angeles, CA 90095 USA; [O'Dell, Thomas J.] Univ Calif Los Angeles, Integrat Ctr Learning & Memory, Los Angeles, CA USA	Wellcome Trust Sanger Institute; University of Cambridge; University of California System; University of California Los Angeles; University of Edinburgh; University of Edinburgh; University of Cambridge; University of Cambridge; University of Cambridge; Max Planck Society; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles	Komiyama, NH (corresponding author), Wellcome Trust Sanger Inst, Genes Cognit Programme, Cambridge, England.	nkomiya2@staffmail.ed.ac.uk	Saksida, Lisa M/M-2753-2016; Kopanitsa, Maksym/I-4668-2019; Nithianantharajah, Jess/AAF-2347-2019; Bussey, Timothy J/M-2758-2016	Saksida, Lisa M/0000-0002-8416-8171; Nithianantharajah, Jess/0000-0002-3501-1143; Bussey, Timothy J/0000-0001-7518-4041; Ryan, Tomas/0000-0003-0121-8514; Grant, Seth/0000-0001-8732-8735	Wellcome Trust; Genes to Cognition Program; UK Medical Research Council; European Union [241995, 242498, 242167, SME-2008-1-232554]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH060919] Funding Source: NIH RePORTER; Medical Research Council [G0802238] Funding Source: researchfish; MRC [G0802238] Funding Source: UKRI	Wellcome Trust(Wellcome TrustEuropean Commission); Genes to Cognition Program; UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); European Union(European Commission); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank D. Fricker and E. Tuck for technical support, M. Price for animal care, K. Elsegood for management of the GluN2A<SUP>Delta C</SUP> and GluN2B<SUP>Delta C</SUP> mouse colonies, and D. Maizels for artwork. We thank P. Seeburg (Max Planck Institute for Medical Research) for providing the GluN2A<SUP>Delta C</SUP> and GluN2B<SUP>Delta C</SUP> mouse lines, and P. Kind (University of Edinburgh) for sharing unpublished data. We are grateful to A. Bayes, G. Hardingham, T. Kitamura, A. McLysaght, R. Redondo, J. Sarinana and D. Wyllie for critical reading of early manuscript drafts, and R. Frank, I. Greger, D. Stemple, A. Bari, L. van de Lagemaat, S. Manakov and J. Symonds for discussions. This project was supported by the Wellcome Trust, Genes to Cognition Program, the UK Medical Research Council and European Union programs (Project GENCODYS No. 241995, Project EUROSPIN No. 242498, Project SYNSYS No. 242167 and Project PharMEA No. SME-2008-1-232554). T. J. R. was supported by a Wellcome Trust PhD Studentship for most of this project.	Bannerman DM, 2008, J NEUROSCI, V28, P3623, DOI 10.1523/JNEUROSCI.3639-07.2008; Barkus C, 2010, EUR J PHARMACOL, V626, P49, DOI 10.1016/j.ejphar.2009.10.014; Boyce-Rustay JM, 2006, NEUROPSYCHOPHARMACOL, V31, P2405, DOI 10.1038/sj.npp.1301039; Boyce-Rustay JM, 2006, PSYCHOPHARMACOLOGY, V187, P455, DOI 10.1007/s00213-006-0448-6; Brigman J.L., 2012, PHYSIOL BEHAV, DOI [10.1016/physbeh.2011.12.024, DOI 10.1016/PHYSBEH.2011.12.024]; Brigman JL, 2008, LEARN MEMORY, V15, P50, DOI 10.1101/lm.777308; Brigman JL, 2010, J NEUROSCI, V30, P4590, DOI 10.1523/JNEUROSCI.0640-10.2010; Bussey TJ, 2012, NEUROPHARMACOLOGY, V62, P1191, DOI 10.1016/j.neuropharm.2011.04.011; Carlisle HJ, 2008, J PHYSIOL-LONDON, V586, P5885, DOI 10.1113/jphysiol.2008.163469; Chen BS, 2007, NEUROPHARMACOLOGY, V53, P362, DOI 10.1016/j.neuropharm.2007.05.018; Cousins SL, 2008, J NEUROCHEM, V104, P903, DOI 10.1111/j.1471-4159.2007.05067.x; Emes RD, 2008, NAT NEUROSCI, V11, P799, DOI 10.1038/nn.2135; Endele S, 2010, NAT GENET, V42, P1021, DOI 10.1038/ng.677; Fineberg NA, 2010, NEUROPSYCHOPHARMACOL, V35, P591, DOI 10.1038/npp.2009.185; Glanzman DL, 2010, CURR BIOL, V20, pR31, DOI 10.1016/j.cub.2009.10.023; Greer JM, 2000, NATURE, V403, P661, DOI 10.1038/35001077; Husi H, 2000, NAT NEUROSCI, V3, P661, DOI 10.1038/76615; Ito H, 2007, BRAIN BEHAV EVOLUT, V69, P76, DOI 10.1159/000095196; Jiao JW, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001684; Kandel ER, 2001, SCIENCE, V294, P1030, DOI 10.1126/science.1067020; Keller MJ, 2001, P ROY SOC B-BIOL SCI, V268, P341, DOI 10.1098/rspb.2000.1391; Kishimoto Y, 1997, NEUROREPORT, V8, P3717, DOI 10.1097/00001756-199712010-00012; Kiyama Y, 1998, J NEUROSCI, V18, P6704; Kohr G, 2003, J NEUROSCI, V23, P10791; Komiyama NH, 2002, J NEUROSCI, V22, P9721; Kopanitsa MV, 2006, BMC NEUROSCI, V7, DOI 10.1186/1471-2202-7-61; Kutsuwada T, 1996, NEURON, V16, P333, DOI 10.1016/S0896-6273(00)80051-3; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; LeDoux J.E., 2002, SYNAPTIC SELF OUR BR; LeDoux J, 2012, NEURON, V73, P653, DOI 10.1016/j.neuron.2012.02.004; Margulies C, 2005, CURR BIOL, V15, pR700, DOI 10.1016/j.cub.2005.08.024; McLysaght A, 2002, NAT GENET, V31, P200, DOI 10.1038/ng884; Migaud M, 1998, NATURE, V396, P433, DOI 10.1038/24790; MONYER H, 1994, NEURON, V12, P529, DOI 10.1016/0896-6273(94)90210-0; Moody TD, 2011, LEARN MEMORY, V18, P118, DOI 10.1101/lm.2045311; Moore BR, 2004, BIOL REV, V79, P301, DOI 10.1017/S1464793103006225; Mori H, 1998, NEURON, V21, P571, DOI 10.1016/S0896-6273(00)80567-X; Morton AJ, 2006, NAT METHODS, V3, P767, DOI 10.1038/nmeth1006-767; Nakazawa K, 2004, NAT REV NEUROSCI, V5, P361, DOI 10.1038/nrn1385; Nakazawa T, 2006, EMBO J, V25, P2867, DOI 10.1038/sj.emboj.7601156; Nithianantharajah J, 2013, NAT NEUROSCI, V16, P16, DOI 10.1038/nn.3276; O'Roak BJ, 2012, NATURE, V485, P246, DOI 10.1038/nature10989; Ohno S., 1970, EVOLUTION GENE DUPLI; Okubo K, 2008, ACTA PHYSIOL, V193, P3, DOI 10.1111/j.1748-1716.2008.01832.x; Paoletti P, 2011, EUR J NEUROSCI, V33, P1351, DOI 10.1111/j.1460-9568.2011.07628.x; Prince VE, 2002, NAT REV GENET, V3, P827, DOI 10.1038/nrg928; RAMIREZSOLIS R, 1993, METHOD ENZYMOL, V225, P855; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Ryan TJ, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-6; Ryan TJ, 2009, NAT REV NEUROSCI, V10, P701, DOI 10.1038/nrn2717; SAKIMURA K, 1995, NATURE, V373, P151, DOI 10.1038/373151a0; Sprengel R, 1998, CELL, V92, P279, DOI 10.1016/S0092-8674(00)80921-6; Talkowski ME, 2012, CELL, V149, DOI 10.1016/j.cell.2012.03.028; von Engelhardt J, 2008, NEURON, V60, P846, DOI 10.1016/j.neuron.2008.09.039; Xia SZ, 2005, CURR BIOL, V15, P603, DOI 10.1016/j.cub.2005.02.059	55	72	73	0	37	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JAN	2013	16	1					25	U1		10.1038/nn.3277	http://dx.doi.org/10.1038/nn.3277			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	058KZ	23201971	Green Accepted			2022-12-28	WOS:000312633900009
J	Estebanez, L; El Boustani, S; Destexhe, A; Shulz, DE				Estebanez, Luc; El Boustani, Sami; Destexhe, Alain; Shulz, Daniel E.			Correlated input reveals coexisting coding schemes in a sensory cortex	NATURE NEUROSCIENCE			English	Article							TEMPORAL VISUAL AREA; BARREL CORTEX; RECEPTIVE-FIELDS; SPATIAL STRUCTURE; RAT; INTEGRATION; MOTION; ORGANIZATION; RESPONSES; NEURONS	As in other sensory modalities, one function of the somatosensory system is to detect coherence and contrast in the environment. To investigate the neural bases of these computations, we applied different spatiotemporal patterns of stimuli to rat whiskers while recording multiple neurons in the barrel cortex. Model-based analysis of the responses revealed different coding schemes according to the level of input correlation. With uncorrelated stimuli on 24 whiskers, we identified two distinct functional categories of neurons, analogous in the temporal domain to simple and complex cells of the primary visual cortex. With correlated stimuli, however, a complementary coding scheme emerged: two distinct cell populations, similar to reinforcing and antagonist neurons described in the higher visual area MT, responded specifically to correlations. We suggest that similar context-dependent coexisting coding strategies may be present in other sensory systems to adapt sensory integration to specific stimulus statistics.	[Estebanez, Luc; El Boustani, Sami; Destexhe, Alain; Shulz, Daniel E.] CNRS, UPR 3293, Unite Neurosci Informat & Complexite, Gif Sur Yvette, France; [Estebanez, Luc] CNRS, INSERM, Inst Biol, Ecole Normale Super,U1024,UMR8197, Paris, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS)	Destexhe, A (corresponding author), CNRS, UPR 3293, Unite Neurosci Informat & Complexite, Gif Sur Yvette, France.	destexhe@unic.cnrs-gif.fr; shulz@unic.cnrs-gif.fr		Destexhe, Alain/0000-0001-7405-0455; El-Boustani, Sami/0000-0003-1733-4341	ANR (NATACS); ANR (HR-CORTEX); ANR (TRANSTACT); European Community (FET) [FACETS FP6-015879, BrainScaleS FP7-269921, Brain-i-Nets FP7-243914]; Fondation pour la Recherche Medicale	ANR (NATACS)(French National Research Agency (ANR)); ANR (HR-CORTEX)(French National Research Agency (ANR)); ANR (TRANSTACT)(French National Research Agency (ANR)); European Community (FET); Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale)	We thank Y. Boubenec for providing the natural whisker stimuli, L. Abbott, L. Bourdieu, A. Davison, V. Ego-Stengel, Y. Fregnac, O. Marre, M. Maravall and H. Sompolinsky for comments on the manuscript, and J. Fournier for advice on the protocol. Funding was provided by ANR (NATACS, HR-CORTEX and TRANSTACT) and the European Community (FET grants FACETS FP6-015879, BrainScaleS FP7-269921 and Brain-i-Nets FP7-243914). S. E. B. was supported by Fondation pour la Recherche Medicale.	Aguilar JR, 2005, J NEUROSCI, V25, P10990, DOI 10.1523/JNEUROSCI.3229-05.2005; Born RT, 2000, J NEUROPHYSIOL, V84, P2658, DOI 10.1152/jn.2000.84.5.2658; BORN RT, 1992, NATURE, V357, P497, DOI 10.1038/357497a0; Brecht M, 2002, J PHYSIOL-LONDON, V543, P49, DOI 10.1113/jphysiol.2002.018465; Brumberg JC, 1996, J NEUROPHYSIOL, V76, P130, DOI 10.1152/jn.1996.76.1.130; Cardona A, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000502; CARVELL GE, 1990, J NEUROSCI, V10, P2638; de Kock CPJ, 2009, P NATL ACAD SCI USA, V106, P16446, DOI 10.1073/pnas.0904143106; DiCarlo JJ, 1996, J NEUROSCI METH, V64, P75, DOI 10.1016/0165-0270(95)00113-1; Ego-Stengel V, 2005, J NEUROPHYSIOL, V93, P1450, DOI 10.1152/jn.00912.2004; Ego-Stengel V, 2012, J NEUROSCI, V32, P3339, DOI 10.1523/JNEUROSCI.3890-11.2012; Ferezou I, 2007, NEURON, V56, P907, DOI 10.1016/j.neuron.2007.10.007; Friedberg MH, 1999, J NEUROPHYSIOL, V81, P2243, DOI 10.1152/jn.1999.81.5.2243; Geffen MN, 2009, NEURON, V61, P570, DOI 10.1016/j.neuron.2009.01.021; Ghazanfar AA, 1997, J NEUROPHYSIOL, V78, P506, DOI 10.1152/jn.1997.78.1.506; Ghazanfar AA, 1999, CEREB CORTEX, V9, P348, DOI 10.1093/cercor/9.4.348; Hartmann MJ, 2003, J NEUROSCI, V23, P6510; Hirata A, 2008, J NEUROPHYSIOL, V100, P358, DOI 10.1152/jn.90538.2008; Jacob V, 2010, J NEUROSCI METH, V189, P65, DOI 10.1016/j.jneumeth.2010.03.020; Jacob V, 2008, NEURON, V60, P1112, DOI 10.1016/j.neuron.2008.10.017; Jadhav SP, 2009, NAT NEUROSCI, V12, P792, DOI 10.1038/nn.2328; Jones HE, 2002, J NEUROPHYSIOL, V88, P2796, DOI 10.1152/jn.00403.2001; Le Cam J, 2011, J NEUROPHYSIOL, V106, P986, DOI 10.1152/jn.00044.2011; Lee SH, 2004, J NEUROPHYSIOL, V91, P223, DOI 10.1152/jn.00541.2003; Maravall M, 2007, PLOS BIOL, V5, P323, DOI 10.1371/journal.pbio.0050019; Matyas F, 2010, SCIENCE, V330, P1240, DOI 10.1126/science.1195797; Mirabella G, 2001, CEREB CORTEX, V11, P164, DOI 10.1093/cercor/11.2.164; Moore CI, 1998, J NEUROPHYSIOL, V80, P2882, DOI 10.1152/jn.1998.80.6.2882; NEWSOME WT, 1985, J NEUROSCI, V5, P825; Pei YC, 2008, P NATL ACAD SCI USA, V105, P8130, DOI 10.1073/pnas.0800028105; Pei YC, 2011, NEURON, V69, P536, DOI 10.1016/j.neuron.2010.12.033; Petersen RS, 2008, NEURON, V60, P890, DOI 10.1016/j.neuron.2008.09.041; PETTIGREW JD, 1968, EXP BRAIN RES, V6, P373; Ritt JT, 2008, NEURON, V57, P599, DOI 10.1016/j.neuron.2007.12.024; Roy NC, 2011, J NEUROPHYSIOL, V105, P2421, DOI 10.1152/jn.00939.2010; Rust NC, 2005, NEURON, V46, P945, DOI 10.1016/j.neuron.2005.05.021; Schwartz O, 2006, J VISION, V6, P484, DOI 10.1167/6.4.13; Shimegi S, 1999, J NEUROSCI, V19, P10164; Shimegi S, 2000, J NEUROSCI, V20, P6241, DOI 10.1523/JNEUROSCI.20-16-06241.2000; SIMONS DJ, 1978, J NEUROPHYSIOL, V41, P798, DOI 10.1152/jn.1978.41.3.798; SIMONS DJ, 1989, J NEUROPHYSIOL, V61, P311, DOI 10.1152/jn.1989.61.2.311; SIMONS DJ, 1985, J NEUROPHYSIOL, V54, P615, DOI 10.1152/jn.1985.54.3.615; Sincich LC, 2004, NAT NEUROSCI, V7, P1123, DOI 10.1038/nn1318; SKOTTUN BC, 1991, VISION RES, V31, P1079, DOI 10.1016/0042-6989(91)90033-2; Smyth D, 2003, J NEUROSCI, V23, P4746; Touryan J, 2005, NEURON, V45, P781, DOI 10.1016/j.neuron.2005.01.029; VANSTEVENINCK RD, 1988, PROC R SOC SER B-BIO, V234, P379; Wilent WB, 2005, NAT NEUROSCI, V8, P1364, DOI 10.1038/nn1545; Wolfe J, 2008, PLOS BIOL, V6, P1661, DOI 10.1371/journal.pbio.0060215; Zhu JJ, 1999, J NEUROPHYSIOL, V81, P1171, DOI 10.1152/jn.1999.81.3.1171	50	55	54	1	18	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	DEC	2012	15	12					1691	+		10.1038/nn.3258	http://dx.doi.org/10.1038/nn.3258			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	045OR	23160042				2022-12-28	WOS:000311706700015
J	Mayford, M				Mayford, Mark			Navigating uncertain waters	NATURE NEUROSCIENCE			English	Editorial Material							NMDA RECEPTORS; ENTORHINAL CORTEX; SPATIAL MEMORY; DENTATE GYRUS; BLOCKADE	Mice lacking NMDA receptors in the dentate gyrus and CA1 subfields of the hippocampus form spatial memories just as well as wild-type mice, but they disregard them when confounded by ambiguous local cues. Hippocampal NMDA receptors may influence spatial memory more subtly than previously thought.	[Mayford, Mark] Scripps Res Inst, Dept Cell Biol, La Jolla, CA 92037 USA; [Mayford, Mark] Scripps Res Inst, Dorris Neurosci Ctr, La Jolla, CA 92037 USA	Scripps Research Institute; Scripps Research Institute	Mayford, M (corresponding author), Scripps Res Inst, Dept Cell Biol, La Jolla, CA 92037 USA.	mmayford@scripps.edu		Mayford, Mark/0000-0002-9001-5024				Bannerman DM, 2012, NAT NEUROSCI, V15, P1153, DOI 10.1038/nn.3166; BANNERMAN DM, 1995, NATURE, V378, P182, DOI 10.1038/378182a0; Derdikman D, 2010, TRENDS COGN SCI, V14, P561, DOI 10.1016/j.tics.2010.09.004; Hafting T, 2005, NATURE, V436, P801, DOI 10.1038/nature03721; McHugh TJ, 2007, SCIENCE, V317, P94, DOI 10.1126/science.1140263; Mei B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019326; MORRIS RGM, 1986, NATURE, V319, P774, DOI 10.1038/319774a0; Nakazawa K, 2002, SCIENCE, V297, P211, DOI 10.1126/science.1071795; Niewoehner B, 2007, EUR J NEUROSCI, V25, P837, DOI 10.1111/j.1460-9568.2007.05312.x; Tsien JZ, 1996, CELL, V87, P1327, DOI 10.1016/S0092-8674(00)81827-9; Yasuda M, 2006, NEURON, V50, P309, DOI 10.1016/j.neuron.2006.03.035	11	2	2	0	10	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	AUG	2012	15	8					1056	1057		10.1038/nn.3174	http://dx.doi.org/10.1038/nn.3174			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	979UE	22837031				2022-12-28	WOS:000306844500002
J	Bai, L; Lennon, DP; Caplan, AI; DeChant, A; Hecker, J; Kranso, J; Zaremba, A; Miller, RH				Bai, Lianhua; Lennon, Donald P.; Caplan, Arnold I.; DeChant, Anne; Hecker, Jordan; Kranso, Janet; Zaremba, Anita; Miller, Robert H.			Hepatocyte growth factor mediates mesenchymal stem cell-induced recovery in multiple sclerosis models	NATURE NEUROSCIENCE			English	Article							C-MET; BONE-MARROW; LIVER-REGENERATION; ENDOGENOUS REPAIR; IMMUNE-RESPONSE; TYROSINE KINASE; FACTOR RECEPTOR; SCATTER FACTOR; FACTOR GENE; CROSS-TALK	Mesenchymal stem cells (MSCs) have emerged as a potential therapy for a range of neural insults. In animal models of multiple sclerosis, an autoimmune disease that targets oligodendrocytes and myelin, treatment with human MSCs results in functional improvement that reflects both modulation of the immune response and myelin repair. Here we demonstrate that conditioned medium from human MSCs (MSC-CM) reduces functional deficits in mouse MOG(35-55)-induced experimental autoimmune encephalomyelitis (EAE) and promotes the development of oligodendrocytes and neurons. Functional assays identified hepatocyte growth factor (HGF) and its primary receptor cMet as critical in MSC-stimulated recovery in EAE, neural cell development and remyelination. Active MSC-CM contained HGF, and exogenously supplied HGF promoted recovery in EAE, whereas cMet and antibodies to HGF blocked the functional recovery mediated by HGF and MSC-CM. Systemic treatment with HGF markedly accelerated remyelination in lysolecithin-induced rat dorsal spinal cord lesions and in slice cultures. Together these data strongly implicate HGF in mediating MSC-stimulated functional recovery in animal models of multiple sclerosis.	[Bai, Lianhua; DeChant, Anne; Hecker, Jordan; Kranso, Janet; Zaremba, Anita; Miller, Robert H.] Case Western Reserve Univ, Dept Neurosci, Case Sch Med, Ctr Translat Neurosci, Cleveland, OH 44106 USA; Case Western Reserve Univ, Skeletal Res Ctr, Cleveland, OH 44106 USA	Case Western Reserve University; Case Western Reserve University	Miller, RH (corresponding author), Case Western Reserve Univ, Dept Neurosci, Case Sch Med, Ctr Translat Neurosci, Cleveland, OH 44106 USA.	rhm3@case.edu		Caplan, Arnold/0000-0002-8677-6621	Myelin Repair Foundation; US National Institutes of Health [NS 30800]; Virginia and David Baldwin Fund; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS030800] Funding Source: NIH RePORTER	Myelin Repair Foundation; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Virginia and David Baldwin Fund; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank M. Hitomi for electron microscopy support, D. Carrino for help with fractionation, S. Miller for microfluidics and A. Kerstetter for help with cell culture. This study was supported by the Myelin Repair Foundation and US National Institutes of Health grant NS 30800 (R.H.M.) and the Virginia and David Baldwin Fund (A.I.C., D.P.L.).	Achim CL, 1997, DEV BRAIN RES, V102, P299, DOI 10.1016/S0165-3806(97)00108-9; Anan F, 2007, METABOLISM, V56, P593, DOI 10.1016/j.metabol.2007.01.003; Bai LH, 2007, NEUROCHEM RES, V32, P353, DOI 10.1007/s11064-006-9212-x; Bai LH, 2009, GLIA, V57, P1192, DOI 10.1002/glia.20841; Barhum Y, 2010, J MOL NEUROSCI, V41, P129, DOI 10.1007/s12031-009-9302-8; Ben-Hur T, 2008, ANN NY ACAD SCI, V1142, P218, DOI 10.1196/annals.1444.014; Benkhoucha M, 2010, P NATL ACAD SCI USA, V107, P6424, DOI 10.1073/pnas.0912437107; Birchmeier C, 1998, TRENDS CELL BIOL, V8, P404, DOI 10.1016/S0962-8924(98)01359-2; BOTTARO DP, 1991, SCIENCE, V251, P802, DOI 10.1126/science.1846706; Busch SA, 2010, J NEUROSCI, V30, P255, DOI 10.1523/JNEUROSCI.3705-09.2010; Caplan AI, 2006, J CELL BIOCHEM, V98, P1076, DOI 10.1002/jcb.20886; Deuse T, 2009, CIRCULATION, V120, pS247, DOI 10.1161/CIRCULATIONAHA.108.843680; DIRENZO MF, 1993, ONCOGENE, V8, P219; Ebens A, 1996, NEURON, V17, P1157, DOI 10.1016/S0896-6273(00)80247-0; Franklin RJM, 2008, NAT REV NEUROSCI, V9, P839, DOI 10.1038/nrn2480; Futamatsu H, 2005, CIRC RES, V96, P823, DOI 10.1161/01.RES.0000163016.52653.2e; Gerdoni E, 2007, ANN NEUROL, V61, P219, DOI 10.1002/ana.21076; Ghasemlou N, 2007, GLIA, V55, P294, DOI 10.1002/glia.20449; Hayashi S, 1996, BIOCHEM BIOPH RES CO, V220, P539, DOI 10.1006/bbrc.1996.0440; ISHIKI Y, 1992, HEPATOLOGY, V16, P1227, DOI 10.1016/0270-9139(92)90019-6; Jung DI, 2009, J NEUROL SCI, V285, P67, DOI 10.1016/j.jns.2009.05.027; Karussis D, 2008, CLIN NEUROL NEUROSUR, V110, P889, DOI 10.1016/j.clineuro.2008.02.008; Kerstetter AE, 2009, EXP NEUROL, V220, P44, DOI 10.1016/j.expneurol.2009.07.010; Kitamura K, 2007, J NEUROSCI RES, V85, P2332, DOI 10.1002/jnr.21372; Koc ON, 2002, BONE MARROW TRANSPL, V30, P215, DOI 10.1038/sj.bmt.1703650; Krampera M, 2007, BONE, V40, P382, DOI 10.1016/j.bone.2006.09.006; Kuroiwa T, 2001, J CLIN INVEST, V107, P1365, DOI 10.1172/JCI11808; Lazarus HM, 2005, BIOL BLOOD MARROW TR, V11, P389, DOI 10.1016/j.bbmt.2005.02.001; Lennon DP, 2006, EXP HEMATOL, V34, P1604, DOI 10.1016/j.exphem.2006.07.014; MICHALOPOULOS GK, 1990, FASEB J, V4, P176, DOI 10.1096/fasebj.4.2.2404819; Miller RH, 2010, DIS MODEL MECH, V3, P535, DOI 10.1242/dmm.001958; Pan WH, 2006, EXP NEUROL, V201, P99, DOI 10.1016/j.expneurol.2006.03.026; Pluchino S, 2003, NATURE, V422, P688, DOI 10.1038/nature01552; Polisetti N, 2010, MOL VIS, V16, P1227; Prineas J.W., 1985, HDB CLIN NEUROLOGY, P15; Rafei M, 2009, MOL THER, V17, P1799, DOI 10.1038/mt.2009.157; REYNOLDS BA, 1992, SCIENCE, V255, P1707, DOI 10.1126/science.1553558; Sheth PR, 2008, BIOCHEMISTRY-US, V47, P4028, DOI 10.1021/bi701892f; Siatskas C, 2010, STEM CELL REV REP, V6, P500, DOI 10.1007/s12015-010-9173-y; SONNENBERG E, 1993, J CELL BIOL, V123, P223, DOI 10.1083/jcb.123.1.223; Sulpice E, 2009, BIOL CELL, V101, P525, DOI 10.1042/BC20080221; Sun W, 2002, MOL BRAIN RES, V103, P36, DOI 10.1016/S0169-328X(02)00168-7; Tanaka F, 2008, LIFE SCI, V83, P771, DOI 10.1016/j.lfs.2008.09.016; Trapp BD, 1998, NEW ENGL J MED, V338, P278, DOI 10.1056/NEJM199801293380502; Uccelli A, 2007, TRENDS IMMUNOL, V28, P219, DOI 10.1016/j.it.2007.03.001; van der Horst E, 2009, NEOPLASIA, V11, P355, DOI 10.1593/neo.81536; Wang Y, 2009, AM J PHYSIOL-CELL PH, V297, pC1284, DOI 10.1152/ajpcell.00183.2009; WOLSWIJK G, 1989, DEVELOPMENT, V105, P387; Yan HL, 2002, J NEUROSCI RES, V69, P597, DOI 10.1002/jnr.10323; Yoo SW, 2008, EXP MOL MED, V40, P387, DOI 10.3858/emm.2008.40.4.387	50	297	307	0	81	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUN	2012	15	6					862	U86		10.1038/nn.3109	http://dx.doi.org/10.1038/nn.3109			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	949AI	22610068	Green Accepted			2022-12-28	WOS:000304546700013
J	Lee, YS; Katyal, S; Downing, SM; Zhao, JF; Russell, HR; McKinnon, PJ				Lee, Youngsoo; Katyal, Sachin; Downing, Susanna M.; Zhao, Jingfeng; Russell, Helen R.; McKinnon, Peter J.			Neurogenesis requires TopBP1 to prevent catastrophic replicative DNA damage in early progenitors	NATURE NEUROSCIENCE			English	Article							NERVOUS-SYSTEM DEVELOPMENT; DOUBLE-STRAND BREAKS; CEREBRAL-CORTEX; CONTAINING PROTEIN; CHK1 ACTIVATION; BRCT DOMAIN; IN-VIVO; ATR; CHECKPOINT; REPAIR	The rapid proliferation of progenitors during neurogenesis requires a stringent genomic maintenance program to ensure transmission of genetic fidelity. However the essential factors that govern neural progenitor genome integrity are unknown. Here we report that conditional inactivation of mouse TopBP1, a protein linked to DNA replication, and a key activator of the DNA damage response kinase ATR (ataxia telangiectasia and rad3-related) is critical for maintenance of early-born neural progenitors. During cortical development TopBP1 prevented replication-associated DNA damage in Emx1-progenitors which otherwise resulted in profound tissue ablation. Notably, disrupted neurogenesis in TopBP1-depleted tissues was substantially rescued by inactivation of p53 but not of ATM. Our data establish that TopBP1 is essential for preventing replication-associated DNA strand breaks, but is not essential per se for DNA replication. Thus, TopBP1 is crucial for maintaining genome integrity in the early progenitors that drive neurogenesis.	[Lee, Youngsoo; Katyal, Sachin; Downing, Susanna M.; Zhao, Jingfeng; Russell, Helen R.; McKinnon, Peter J.] St Jude Childrens Hosp, Dept Genet, Memphis, TN 38105 USA	St Jude Children's Research Hospital	McKinnon, PJ (corresponding author), St Jude Childrens Hosp, Dept Genet, 332 N Lauderdale St, Memphis, TN 38105 USA.	peter.mckinnon@stjude.org		Lee, Youngsoo/0000-0003-4773-6464; Katyal, Sachin/0000-0002-7790-4054	US National Institutes of Health [NS-37956, CA-21765]; Cancer Center [P30 CA21765]; American Lebanese and Syrian Associated Charities of St. Jude Children's Research Hospital; NATIONAL CANCER INSTITUTE [P30CA021765, P01CA096832] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS037956, R56NS037956] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Center; American Lebanese and Syrian Associated Charities of St. Jude Children's Research Hospital(American Lebanese Syrian Associated Charities (ALSAC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank the Hartwell Center for biotech support, the Transgenic Core Facility for blastocyst injections and chimera production and the ARC for animal husbandry. P.J.M. is supported by the US National Institutes of Health (NS-37956, CA-21765), a Cancer Center support grant (P30 CA21765) and the American Lebanese and Syrian Associated Charities of St. Jude Children's Research Hospital. S.K. is a Neoma Boadway Academic Programs Endowed Fellow.	Arai Y, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1155; Balestrini A, 2010, NAT CELL BIOL, V12, P484, DOI 10.1038/ncb2050; Branzei D, 2010, NAT REV MOL CELL BIO, V11, P208, DOI 10.1038/nrm2852; Brown EJ, 2000, GENE DEV, V14, P397; Caviness VS, 2009, TRENDS NEUROSCI, V32, P443, DOI 10.1016/j.tins.2009.05.003; Chou SJ, 2009, NAT NEUROSCI, V12, P1381, DOI 10.1038/nn.2427; Cimprich KA, 2008, NAT REV MOL CELL BIO, V9, P616, DOI 10.1038/nrm2450; Cortez D, 2001, SCIENCE, V294, P1713, DOI 10.1126/science.1065521; Cotta-Ramusino C, 2011, SCIENCE, V332, P1313, DOI 10.1126/science.1203430; Dehay C, 2007, NAT REV NEUROSCI, V8, P438, DOI 10.1038/nrn2097; Delacroix S, 2007, GENE DEV, V21, P1472, DOI 10.1101/gad.1547007; Furuya K, 2004, GENE DEV, V18, P1154, DOI 10.1101/gad.291104; Garcia V, 2005, DNA REPAIR, V4, P1227, DOI 10.1016/j.dnarep.2005.04.001; Gong ZH, 2010, MOL CELL, V37, P438, DOI 10.1016/j.molcel.2010.01.002; Gorski JA, 2002, J NEUROSCI, V22, P6309; Gotz M, 2005, NAT REV MOL CELL BIO, V6, P777, DOI 10.1038/nrm1739; Greer DA, 2003, CANCER RES, V63, P4829; Herzog KH, 1998, SCIENCE, V280, P1089, DOI 10.1126/science.280.5366.1089; Jackson SP, 2009, NATURE, V461, P1071, DOI 10.1038/nature08467; Jeon Y, 2011, J BIOL CHEM, V286, P5414, DOI 10.1074/jbc.M110.189704; Katyal S, 2007, EMBO J, V26, P4720, DOI 10.1038/sj.emboj.7601869; Kumagai A, 2006, CELL, V124, P943, DOI 10.1016/j.cell.2005.12.041; Kumagai A, 2010, CELL, V140, P349, DOI 10.1016/j.cell.2009.12.049; Lee J, 2010, MOL BIOL CELL, V21, P926, DOI 10.1091/mbc.E09-11-0958; Lee Y, 2000, GENE DEV, V14, P2576, DOI 10.1101/gad.837100; Lee Y, 2001, J NEUROSCI, V21, P6687, DOI 10.1523/JNEUROSCI.21-17-06687.2001; Lee Y, 2012, EMBO J, V31, P1177, DOI 10.1038/emboj.2011.493; Lee Y, 2009, NAT NEUROSCI, V12, P973, DOI 10.1038/nn.2375; Leung CCY, 2011, J BIOL CHEM, V286, P4292, DOI 10.1074/jbc.M110.189555; Liu QH, 2000, GENE DEV, V14, P1448; Liu S, 2006, MOL CELL BIOL, V26, P6056, DOI 10.1128/MCB.00492-06; Makiniemi M, 2001, J BIOL CHEM, V276, P30399, DOI 10.1074/jbc.M102245200; McKinnon PJ, 2007, ANNU REV GENOM HUM G, V8, P37, DOI 10.1146/annurev.genom.7.080505.115648; McKinnon PJ, 2009, NAT REV NEUROSCI, V10, P100, DOI 10.1038/nrn2559; Molyneaux BJ, 2007, NAT REV NEUROSCI, V8, P427, DOI 10.1038/nrn2151; Mordes DA, 2008, GENE DEV, V22, P1478, DOI 10.1101/gad.1666208; Murga M, 2009, NAT GENET, V41, P891, DOI 10.1038/ng.420; Navadgi-Patil VM, 2009, DNA REPAIR, V8, P996, DOI 10.1016/j.dnarep.2009.03.011; Orii KE, 2006, P NATL ACAD SCI USA, V103, P10017, DOI 10.1073/pnas.0602436103; Pulvers JN, 2009, DEVELOPMENT, V136, P1859, DOI 10.1242/dev.033498; Remus D, 2009, CURR OPIN CELL BIOL, V21, P771, DOI 10.1016/j.ceb.2009.08.002; Rogakou EP, 1999, J CELL BIOL, V146, P905, DOI 10.1083/jcb.146.5.905; Ruzankina Y, 2009, NAT GENET, V41, P1144, DOI 10.1038/ng.441; Sansam CL, 2010, GENE DEV, V24, P183, DOI 10.1101/gad.1860310; Shull ERP, 2009, GENE DEV, V23, P171, DOI 10.1101/gad.1746609; Tercero JA, 2003, MOL CELL, V11, P1323, DOI 10.1016/S1097-2765(03)00169-2; Yamane K, 1997, EUR J BIOCHEM, V250, P794, DOI 10.1111/j.1432-1033.1997.00794.x; Yamane K, 2002, MOL CELL BIOL, V22, P555, DOI 10.1128/MCB.22.2.555-566.2002; Yu XC, 2003, SCIENCE, V302, P639, DOI 10.1126/science.1088753; Zegerman P, 2009, DNA REPAIR, V8, P1077, DOI 10.1016/j.dnarep.2009.04.023	50	45	45	0	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JUN	2012	15	6					819	U33		10.1038/nn.3097	http://dx.doi.org/10.1038/nn.3097			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	949AI	22522401	Green Accepted			2022-12-28	WOS:000304546700008
J	Purushothaman, G; Marion, R; Li, K; Casagrande, VA				Purushothaman, Gopathy; Marion, Roan; Li, Keji; Casagrande, Vivien A.			Gating and control of primary visual cortex by pulvinar	NATURE NEUROSCIENCE			English	Article							LATERAL GENICULATE-NUCLEUS; SUPERIOR COLLICULUS; CORTICOCORTICAL CONNECTIONS; ORIENTATION SELECTIVITY; INFERIOR PULVINAR; SPATIAL ATTENTION; MACAQUE MONKEY; CAT; THALAMUS; LESIONS	The primary visual cortex (V1) receives its driving input from the eyes via the lateral geniculate nucleus (LGN) of the thalamus. The lateral pulvinar nucleus of the thalamus also projects to V1, but this input is not well understood. We manipulated lateral pulvinar neural activity in prosimian primates and assessed the effect on supra-granular layers of V1 that project to higher visual cortex. Reversibly inactivating lateral pulvinar prevented supra-granular V1 neurons from responding to visual stimulation. Reversible, focal excitation of lateral pulvinar receptive fields increased the visual responses in coincident V1 receptive fields fourfold and shifted partially overlapping V1 receptive fields toward the center of excitation. V1 responses to regions surrounding the excited lateral pulvinar receptive fields were suppressed. LGN responses were unaffected by these lateral pulvinar manipulations. Excitation of lateral pulvinar after LGN lesion activated supra-granular layer V1 neurons. Thus, lateral pulvinar is able to powerfully control and gate information outflow from V1.	[Purushothaman, Gopathy; Casagrande, Vivien A.] Vanderbilt Univ, Dept Cell & Dev Biol, Nashville, TN 37203 USA; [Marion, Roan] Vanderbilt Univ, Grad Program Neurosci, Nashville, TN USA; [Li, Keji; Casagrande, Vivien A.] Vanderbilt Univ, Dept Psychol, Nashville, TN 37240 USA	Vanderbilt University; Vanderbilt University; Vanderbilt University	Casagrande, VA (corresponding author), Vanderbilt Univ, Dept Cell & Dev Biol, Nashville, TN 37203 USA.	gopathy.purushothaman@vanderbilt.edu; vivien.casagrande@vanderbilt.edu			US National Institutes of Health [R01-EY01778, P30-EY008126, T32-EY07135, P30-HD15052]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD015052] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [T32EY007135, R01EY001778, P30EY008126] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [T32MH064913] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank J. Mavity-Hudson for histology, S. Walston, Y. Jiang, D. Yampolsky, J. Mavity-Hudson, J. Patel and D. Rinker for help with experiments, D. Yampolsky for technical and computational assistance, and M. Feurtado for veterinary assistance. We thank F. Ebner, J. Kaas, R. Khumbani, J. Schall, P. Wallisch and K.-W. Yao for their suggestions and comments on the work. This work was supported by US National Institutes of Health grants R01-EY01778, P30-EY008126, T32-EY07135 and P30-HD15052.	Arend I, 2008, PROG BRAIN RES, V171, P475, DOI 10.1016/S0079-6123(08)00669-9; BENDER DB, 1987, EXP BRAIN RES, V69, P140; Bender DB, 2001, J NEUROPHYSIOL, V85, P219, DOI 10.1152/jn.2001.85.1.219; BENEVENTO LA, 1976, BRAIN RES, V108, P1, DOI 10.1016/0006-8993(76)90160-8; Berman RA, 2011, J NEUROSCI, V31, P373, DOI 10.1523/JNEUROSCI.4738-10.2011; BISHOP PO, 1971, J PHYSIOL-LONDON, V216, P39, DOI 10.1113/jphysiol.1971.sp009508; Borg-Graham LJ, 1998, NATURE, V393, P369, DOI 10.1038/30735; Callaway EM, 1998, ANNU REV NEUROSCI, V21, P47, DOI 10.1146/annurev.neuro.21.1.47; Casanova C., 2004, VISUAL NEUROSCIENCES, P592; CHALUPA LM, 1977, BEHAV BIOL, V20, P149, DOI 10.1016/S0091-6773(77)90721-0; Crick F, 1998, NATURE, V391, P245, DOI 10.1038/34584; De Pasquale R, 2011, J NEUROSCI, V31, P16494, DOI 10.1523/JNEUROSCI.3664-11.2011; DESIMONE R, 1995, ANNU REV NEUROSCI, V18, P193, DOI 10.1146/annurev.ne.18.030195.001205; DESIMONE R, 1990, COLD SPRING HARB SYM, V55, P963; Felleman DJ, 1991, CEREB CORTEX, V1, P1, DOI 10.1093/cercor/1.1.1; FERSTER D, 1986, J NEUROSCI, V6, P1284; Fischer J, 2009, HUM BRAIN MAPP, V30, P101, DOI 10.1002/hbm.20485; HIKOSAKA O, 1985, J NEUROPHYSIOL, V53, P292, DOI 10.1152/jn.1985.53.1.292; Ivanov I, 2010, AM J PSYCHIAT, V167, P397, DOI 10.1176/appi.ajp.2009.09030398; Kaas JH, 2007, BRAIN RES REV, V55, P285, DOI 10.1016/j.brainresrev.2007.02.008; Kandel E., 2000, PRINCIPLES NEURAL SC; Karnath HO, 2002, BRAIN, V125, P350, DOI 10.1093/brain/awf032; KARNOVSKY MJ, 1964, J HISTOCHEM CYTOCHEM, V12, P219, DOI 10.1177/12.3.219; Kastner S, 2004, J NEUROPHYSIOL, V91, P438, DOI 10.1152/jn.00553.2003; Logothetis NK, 2010, NAT NEUROSCI, V13, P1283, DOI 10.1038/nn.2631; Marino J, 2005, NAT NEUROSCI, V8, P194, DOI 10.1038/nn1391; MARTIN JH, 1991, NEUROSCI LETT, V127, P160, DOI 10.1016/0304-3940(91)90784-Q; McCormick D. A., 2003, EXCITATORY INHIBITOR, P113; MIZE RR, 1989, NEUROSCI LETT, V104, P31, DOI 10.1016/0304-3940(89)90324-8; Molotchnikoff S, 1996, VISION RES, V36, P2037, DOI 10.1016/0042-6989(95)00311-8; OGREN MP, 1977, BRAIN RES, V137, P343, DOI 10.1016/0006-8993(77)90344-4; OLSHAUSEN BA, 1993, J NEUROSCI, V13, P4700; PETERSEN SE, 1987, NEUROPSYCHOLOGIA, V25, P97, DOI 10.1016/0028-3932(87)90046-7; Purves D., 2004, NEUROSCIENCEZ; RAFAL RD, 1987, P NATL ACAD SCI USA, V84, P7349, DOI 10.1073/pnas.84.20.7349; RAMACHANDRAN VS, 1991, NATURE, V350, P699, DOI 10.1038/350699a0; REID RC, 1995, NATURE, V378, P281, DOI 10.1038/378281a0; REZAK M, 1979, BRAIN RES, V167, P19, DOI 10.1016/0006-8993(79)90260-9; ROBINSON DL, 1992, TRENDS NEUROSCI, V15, P127, DOI 10.1016/0166-2236(92)90354-B; Rockland KS, 1998, J COMP NEUROL, V390, P515, DOI 10.1002/(SICI)1096-9861(19980126)390:4<515::AID-CNE5>3.0.CO;2-3; Sherman SM, 2011, J NEUROPHYSIOL, V106, P1068, DOI 10.1152/jn.00429.2011; Smith AT, 2009, J NEUROPHYSIOL, V101, P917, DOI 10.1152/jn.90963.2008; Snow JC, 2009, P NATL ACAD SCI USA, V106, P4054, DOI 10.1073/pnas.0810086106; SOFTKY WR, 1993, J NEUROSCI, V13, P334; SOMERS DC, 1995, J NEUROSCI, V15, P5448; UNGERLEIDER LG, 1979, NEUROPSYCHOLOGIA, V17, P493, DOI 10.1016/0028-3932(79)90056-3; Van Essen DC, 2005, PROG BRAIN RES, V149, P173, DOI 10.1016/S0079-6123(05)49013-5; VANESSEN DC, 1992, SCIENCE, V255, P419, DOI 10.1126/science.1734518; Ward R, 2002, NAT NEUROSCI, V5, P99, DOI 10.1038/nn794; Wilke M, 2010, J NEUROSCI, V30, P8650, DOI 10.1523/JNEUROSCI.0953-10.2010; Wilke M, 2009, P NATL ACAD SCI USA, V106, P9465, DOI 10.1073/pnas.0900714106	51	144	145	4	33	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JUN	2012	15	6					905	U136		10.1038/nn.3106	http://dx.doi.org/10.1038/nn.3106			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	949AI	22561455	Green Accepted			2022-12-28	WOS:000304546700019
J	Crowe, DA; Goodwin, SJ; Blackman, RK; Sakellaridi, S; Sponheim, SR; MacDonald, AW; Chafee, MV				Crowe, David A.; Goodwin, Shikha J.; Blackman, Rachael K.; Sakellaridi, Sofia; Sponheim, Scott R.; MacDonald, Angus W., III; Chafee, Matthew V.			Prefrontal neurons transmit signals to parietal neurons that reflect executive control of cognition	NATURE NEUROSCIENCE			English	Article							POSTERIOR PARIETAL; CORTICOCORTICAL CONNECTIONS; DECISION-MAKING; NEURAL ACTIVITY; WORKING-MEMORY; RHESUS-MONKEY; CORTEX; ATTENTION; REPRESENTATION; CORTICES	Prefrontal cortex influences behavior largely through its connections with other association cortices; however, the nature of the information conveyed by prefrontal output signals and what effect these signals have on computations performed by target structures is largely unknown. To address these questions, we simultaneously recorded the activity of neurons in prefrontal and posterior parietal cortices of monkeys performing a rule-based spatial categorization task. Parietal cortex receives direct prefrontal input, and parietal neurons, like their prefrontal counterparts, exhibit signals that reflect rule-based cognitive processing in this task. By analyzing rapid fluctuations in the cognitive information encoded by activity in the two areas, we obtained evidence that signals reflecting rule-dependent categories were selectively transmitted in a top-down direction from prefrontal to parietal neurons, suggesting that prefrontal output is important for the executive control of distributed cognitive processing.	[Crowe, David A.; Goodwin, Shikha J.; Blackman, Rachael K.; Chafee, Matthew V.] Univ Minnesota, Dept Neurosci, Minneapolis, MN 55455 USA; [Crowe, David A.; Goodwin, Shikha J.; Blackman, Rachael K.; Sakellaridi, Sofia; Sponheim, Scott R.; Chafee, Matthew V.] Vet Affairs Med Ctr, Brain Sci Ctr, Minneapolis, MN USA; [Crowe, David A.] Augsburg Coll, Dept Biol, Minneapolis, MN USA; [Blackman, Rachael K.] Univ Minnesota, Med Scientist Training Program MD PhD, Minneapolis, MN USA; [Sakellaridi, Sofia; MacDonald, Angus W., III; Chafee, Matthew V.] Univ Minnesota, Ctr Cognit Sci, Minneapolis, MN USA; [Sponheim, Scott R.; MacDonald, Angus W., III] Univ Minnesota, Dept Psychiat, Minneapolis, MN 55455 USA; [MacDonald, Angus W., III] Univ Minnesota, Dept Psychol, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities; US Department of Veterans Affairs; Veterans Health Administration (VHA); Minneapolis VA Health Care System; Augsburg University; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Chafee, MV (corresponding author), Univ Minnesota, Dept Neurosci, Minneapolis, MN 55455 USA.	chafe001@umn.edu	MacDonald, Angus/M-9855-2016; Sponheim, Scott/J-3857-2017	MacDonald, Angus/0000-0003-4588-931X; Sponheim, Scott/0000-0002-2782-0856; Goodwin, Shikha/0000-0001-9935-4359	US National Institutes of Health [R01 MH077779, R24MH069675, T32 GM008244]; Department of Veterans Affairs; American Legion Brain Sciences Chair; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008244] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH077779, R24MH069675] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Veterans Affairs(US Department of Veterans Affairs); American Legion Brain Sciences Chair; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank A. Georgopoulos for fundamental intellectual contributions to, and longstanding support of, this work. We thank P. Goldman-Rakic for critical insights into the network basis of prefrontal cortex function that strongly influenced this study. We thank D. Evans and D. Boeff for excellent technical assistance. We thank J. Ortiz and S. Te Nelson for assistance in training of nonhuman primates. Supported by the US National Institutes of Health (grant R01 MH077779 and R24MH069675), the Department of Veterans Affairs and the American Legion Brain Sciences Chair. R.K. Blackman was supported by US National Institutes of Health grant T32 GM008244. The views and opinions expressed in this work are those of the authors solely and not those of the United States Federal Government.	ANDERSEN RA, 1990, J COMP NEUROL, V296, P65, DOI 10.1002/cne.902960106; Andersen RA, 2009, NEURON, V63, P568, DOI 10.1016/j.neuron.2009.08.028; Barraclough DJ, 2004, NAT NEUROSCI, V7, P404, DOI 10.1038/nn1209; Box GEP., 2008, TIME SERIES ANAL, DOI [10.1002/9781118619193, DOI 10.1002/9781118619193]; Buschman TJ, 2007, SCIENCE, V315, P1860, DOI 10.1126/science.1138071; CAVADA C, 1989, J COMP NEUROL, V287, P422, DOI 10.1002/cne.902870403; Chafee MV, 2000, J NEUROPHYSIOL, V83, P1550, DOI 10.1152/jn.2000.83.3.1550; Chafee MV, 1998, J NEUROPHYSIOL, V79, P2919, DOI 10.1152/jn.1998.79.6.2919; Christova P, 2011, J NEURAL ENG, V8, DOI 10.1088/1741-2560/8/4/046025; DESIMONE R, 1995, ANNU REV NEUROSCI, V18, P193, DOI 10.1146/annurev.ne.18.030195.001205; Ferraina S, 2002, J NEUROPHYSIOL, V87, P845, DOI 10.1152/jn.00317.2001; Fitzgerald JK, 2013, NEURON, V77, P180, DOI 10.1016/j.neuron.2012.11.014; FUNAHASHI S, 1993, NATURE, V365, P753, DOI 10.1038/365753a0; GNADT JW, 1988, EXP BRAIN RES, V70, P216; GOLDMANRAKIC PS, 1987, HDB PHYSL NERVOUS SY, P373; Goodwin SJ, 2012, J NEUROSCI, V32, P3499, DOI 10.1523/JNEUROSCI.3585-11.2012; Gottlieb J, 2010, TRENDS COGN SCI, V14, P240, DOI 10.1016/j.tics.2010.03.001; Granger, 2014, FORECASTING EC TIME, DOI 10.1016/B978-0-12-295183-1.50013-3; Gregoriou GG, 2012, NEURON, V73, P581, DOI 10.1016/j.neuron.2011.12.019; Gregoriou GG, 2009, SCIENCE, V324, P1207, DOI 10.1126/science.1171402; Medalla M, 2006, EUR J NEUROSCI, V23, P161, DOI 10.1111/j.1460-9568.2005.04522.x; Merchant H, 2011, FRONT SYST NEUROSCI, V5, DOI 10.3389/fnsys.2011.00069; Nee DE, 2013, CEREB CORTEX, V23, P2146, DOI 10.1093/cercor/bhs194; Nieder A, 2004, P NATL ACAD SCI USA, V101, P7457, DOI 10.1073/pnas.0402239101; Nieder A, 2002, SCIENCE, V297, P1708, DOI 10.1126/science.1072493; Peck CJ, 2009, J NEUROSCI, V29, P11182, DOI 10.1523/JNEUROSCI.1929-09.2009; Platt ML, 1999, NATURE, V400, P233, DOI 10.1038/22268; Qi XL, 2010, FRONT SYST NEUROSCI, V4, DOI 10.3389/fnsys.2010.00012; SCHWARTZ ML, 1984, J COMP NEUROL, V226, P403, DOI 10.1002/cne.902260309; Sherman SM, 2011, J NEUROPHYSIOL, V106, P1068, DOI 10.1152/jn.00429.2011; Sugrue LP, 2004, SCIENCE, V304, P1782, DOI 10.1126/science.1094765; Swaminathan SK, 2012, NAT NEUROSCI, V15, P315, DOI 10.1038/nn.3016; Tudusciuc O, 2009, J NEUROPHYSIOL, V101, P2984, DOI 10.1152/jn.90713.2008; Vallentin D, 2010, EUR J NEUROSCI, V32, P1380, DOI 10.1111/j.1460-9568.2010.07427.x	34	97	97	0	14	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	OCT	2013	16	10					1484	+		10.1038/nn.3509	http://dx.doi.org/10.1038/nn.3509			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	223HM	23995071	Green Accepted			2022-12-28	WOS:000324795300022
J	Wang, WY; Pan, L; Su, SC; Quinn, EJ; Sasaki, M; Jimenez, JC; Mackenzie, IRA; Huang, EJ; Tsai, LH				Wang, Wen-Yuan; Pan, Ling; Su, Susan C.; Quinn, Emma J.; Sasaki, Megumi; Jimenez, Jessica C.; Mackenzie, Ian R. A.; Huang, Eric J.; Tsai, Li-Huei			Interaction of FUS and HDAC1 regulates DNA damage response and repair in neurons	NATURE NEUROSCIENCE			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; PRO-ONCOPROTEIN TLS/FUS; STRAND BREAK REPAIR; RNA-BINDING PROTEIN; GENOMIC STABILITY; DENDRITIC SPINES; MAMMALIAN-CELLS; DISEASE; CHROMATIN; MICE	Defects in DNA repair have been extensively linked to neurodegenerative diseases, but the exact mechanisms remain poorly understood. We found that FUS, an RNA/DNA-binding protein that has been linked to amyotrophic lateral sclerosis (ALS) and frontotemporal lobar degeneration, is important for the DNA damage response (DDR). The function of FUS in DDR involved a direct interaction with histone deacetylase 1 (HDAC1), and the recruitment of FUS to double-stranded break sites was important for proper DDR signaling. Notably, FUS proteins carrying familial ALS mutations were defective in DDR and DNA repair and showed a diminished interaction with HDAC1. Moreover, we observed increased DNA damage in human ALS patients harboring FUS mutations. Our findings suggest that an impaired DDR and DNA repair may contribute to the pathogenesis of neurodegenerative diseases linked to FUS mutations.	[Wang, Wen-Yuan; Pan, Ling; Su, Susan C.; Quinn, Emma J.; Sasaki, Megumi; Jimenez, Jessica C.; Tsai, Li-Huei] MIT, Dept Brain & Cognit Sci, Picower Inst Learning & Memory, Cambridge, MA 02139 USA; [Wang, Wen-Yuan; Pan, Ling; Su, Susan C.; Quinn, Emma J.; Sasaki, Megumi; Jimenez, Jessica C.; Tsai, Li-Huei] Howard Hughes Med Inst, Chevy Chase, MD USA; [Mackenzie, Ian R. A.] Univ British Columbia, Dept Pathol, Vancouver, BC, Canada; [Huang, Eric J.] Univ Calif San Francisco, Dept Pathol, San Francisco, CA 94140 USA; [Huang, Eric J.] VA Med Ctr, Pathol Serv, San Francisco, CA USA	Massachusetts Institute of Technology (MIT); Northwell Health; Howard Hughes Medical Institute; University of British Columbia; University of California System; University of California San Francisco	Tsai, LH (corresponding author), MIT, Dept Brain & Cognit Sci, Picower Inst Learning & Memory, E25-618, Cambridge, MA 02139 USA.	lhtsai@mit.edu	Huang, Eric J./AAH-7997-2019; Pan, Ling/K-9333-2013	Huang, Eric J./0000-0002-5381-3801; Pan, Ling/0000-0001-9947-9071	Simons Foundation; Howard Hughes Medical Institute Exceptional Research Opportunities Program; National Institute of Neurological Disorders and Stroke [NS078839]; Department of Veterans Affairs [BX001108]; Muscular Dystrophy Association [MDA217592]; Howard Hughes Medical Institute; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS078839] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [R21OD011915] Funding Source: NIH RePORTER; Veterans Affairs [I01BX001108, I21BX001625] Funding Source: NIH RePORTER	Simons Foundation; Howard Hughes Medical Institute Exceptional Research Opportunities Program; National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Department of Veterans Affairs(US Department of Veterans Affairs); Muscular Dystrophy Association(Muscular Dystrophy Association); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Veterans Affairs(US Department of Veterans Affairs)	We thank T. Misteli (National Cancer Institute) for kindly providing the NIH2/4 cell line and Lac-R constructs, M. Dobbin (Massachusetts Institute of Technology) for technical assistance on microirradiation experiments, A. Mungenast, R. Madabhushi, A. Bero, J. Penney and A. Nott for critical reading of the manuscript, and other members of the Tsai and Huang laboratories for helpful discussions. We also thank R.H. Brown Jr and L.J. Hayward for insightful discussions. W.-Y.W. was supported by a Postdoctoral Fellowship from the Simons Foundation, J.C.J. was supported by the Howard Hughes Medical Institute Exceptional Research Opportunities Program. This work is also supported by grants from National Institute of Neurological Disorders and Stroke (NS078839 to L.-H.T.), the Department of Veterans Affairs (BX001108 to E.J.H.) and the Muscular Dystrophy Association (MDA217592 to E.J.H.). L.-H.T. is a member of the Neurodegeneration Consortium. E.J.H. is a member of the Consortium for Frontotemporal Dementia Research. L.-H.T. receives funding from the Howard Hughes Medical Institute.	Anderson AJ, 1996, J NEUROSCI, V16, P1710, DOI 10.1523/jneurosci.16-05-01710.1996; Anderson L, 2001, MOL CELL BIOL, V21, P1719, DOI 10.1128/MCB.21.5.1719-1729.2001; Baechtold H, 1999, J BIOL CHEM, V274, P34337, DOI 10.1074/jbc.274.48.34337; Bender A, 2006, NAT GENET, V38, P515, DOI 10.1038/ng1769; Bertrand P, 1999, ONCOGENE, V18, P4515, DOI 10.1038/sj.onc.1203048; Carpenter AE, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-10-r100; Celeste A, 2002, SCIENCE, V296, P922, DOI 10.1126/science.1069398; Collins AR, 2004, MOL BIOTECHNOL, V26, P249, DOI 10.1385/MB:26:3:249; CROZAT A, 1993, NATURE, V363, P640, DOI 10.1038/363640a0; de Waard MC, 2010, ACTA NEUROPATHOL, V120, P461, DOI 10.1007/s00401-010-0715-9; Dinant C, 2008, EPIGENET CHROMATIN, V1, DOI 10.1186/1756-8935-1-9; Dobbin MM, 2013, NAT NEUROSCI, V16, P1008, DOI 10.1038/nn.3460; Ferguson DO, 2000, P NATL ACAD SCI USA, V97, P6630, DOI 10.1073/pnas.110152897; Ferrante RJ, 1997, J NEUROCHEM, V69, P2064; Fillingham J, 2006, BIOCHEM CELL BIOL, V84, P568, DOI 10.1139/O06-072; Fujii R, 2005, J CELL SCI, V118, P5755, DOI 10.1242/jcs.02692; Fujii R, 2005, CURR BIOL, V15, P587, DOI 10.1016/j.cub.2005.01.058; Gao J, 2010, NATURE, V466, P1105, DOI 10.1038/nature09271; Gardiner M, 2008, BIOCHEM J, V415, P297, DOI 10.1042/BJ20081135; Graff J, 2012, NATURE, V483, P222, DOI 10.1038/nature10849; Guan JS, 2009, NATURE, V459, P55, DOI 10.1038/nature07925; Hande KR, 1998, EUR J CANCER, V34, P1514, DOI 10.1016/S0959-8049(98)00228-7; Hicks GG, 2000, NAT GENET, V24, P175, DOI 10.1038/72842; Huang EJ, 2010, BRAIN PATHOL, V20, P1069, DOI 10.1111/j.1750-3639.2010.00413.x; Keramaris E, 2003, J BIOL CHEM, V278, P37782, DOI 10.1074/jbc.M304049200; Kim D, 2008, NEURON, V60, P803, DOI 10.1016/j.neuron.2008.10.015; Kruhlak Michael J., 2009, V523, P125, DOI 10.1007/978-1-59745-190-1_9; Kuroda M, 2000, EMBO J, V19, P453, DOI 10.1093/emboj/19.3.453; Kwiatkowski TJ, 2009, SCIENCE, V323, P1205, DOI 10.1126/science.1166066; Lois C, 2002, SCIENCE, V295, P868, DOI 10.1126/science.1067081; Lu T, 2004, NATURE, V429, P883, DOI 10.1038/nature02661; Lukas J, 2011, NAT CELL BIOL, V13, P1161, DOI 10.1038/ncb2344; McKinnon PJ, 2009, NAT REV NEUROSCI, V10, P100, DOI 10.1038/nrn2559; Millecamps S, 2012, J MED GENET, V49, P258, DOI 10.1136/jmedgenet-2011-100699; Miller KM, 2010, NAT STRUCT MOL BIOL, V17, P1144, DOI 10.1038/nsmb.1899; Patel KJ, 1998, MOL CELL, V1, P347, DOI 10.1016/S1097-2765(00)80035-0; Pegoraro G, 2009, NAT CELL BIOL, V11, P1261, DOI 10.1038/ncb1971; Pierce AJ, 1999, GENE DEV, V13, P2633, DOI 10.1101/gad.13.20.2633; Pilch DR, 2003, BIOCHEM CELL BIOL, V81, P123, DOI 10.1139/o03-042; Rass U, 2007, CELL, V130, P991, DOI 10.1016/j.cell.2007.08.043; Seluanov A, 2004, P NATL ACAD SCI USA, V101, P7624, DOI 10.1073/pnas.0400726101; Sharma S, 2007, BRAIN RES BULL, V73, P48, DOI 10.1016/j.brainresbull.2007.02.001; Soutoglou E, 2008, SCIENCE, V320, P1507, DOI [10.1126/science.1159051, 10.1126/science.ll59051]; Stark JM, 2002, J BIOL CHEM, V277, P20185, DOI 10.1074/jbc.M112132200; Tan AY, 2009, J MOL CELL BIOL, V1, P82, DOI 10.1093/jmcb/mjp025; Vance C, 2009, SCIENCE, V323, P1208, DOI 10.1126/science.1165942; Wang WY, 2007, NAT NEUROSCI, V10, P1063, DOI 10.1038/nn1932; Wang XT, 2008, NATURE, V454, P126, DOI 10.1038/nature06992; Weinstock DM, 2006, METHOD ENZYMOL, V409, P524, DOI 10.1016/S0076-6879(05)09031-2; Xu Y, 1996, GENE DEV, V10, P2411, DOI 10.1101/gad.10.19.2411	50	257	260	0	36	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	OCT	2013	16	10					1383	+		10.1038/nn.3514	http://dx.doi.org/10.1038/nn.3514			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	223HM	24036913	Green Accepted			2022-12-28	WOS:000324795300010
J	Mazzoni, EO; Mahony, S; Closser, M; Morrison, CA; Nedelec, S; Williams, DJ; An, DS; Gifford, DK; Wichterle, H				Mazzoni, Esteban O.; Mahony, Shaun; Closser, Michael; Morrison, Carolyn A.; Nedelec, Stephane; Williams, Damian J.; An, Disi; Gifford, David K.; Wichterle, Hynek			Synergistic binding of transcription factors to cell-specific enhancers programs motor neuron identity	NATURE NEUROSCIENCE			English	Article							EMBRYONIC STEM-CELLS; DIRECT CONVERSION; SPINAL-CORD; HUMAN FIBROBLASTS; DEFINED FACTORS; PHOX2 GENES; EXPRESSION; MOUSE; MOTONEURONS; DIFFERENTIATION	Efficient transcriptional programming promises to open new frontiers in regenerative medicine. However, mechanisms by which programming factors transform cell fate are unknown, preventing more rational selection of factors to generate desirable cell types. Three transcription factors, Ngn2, Isl1 and Lhx3, were sufficient to program rapidly and efficiently spinal motor neuron identity when expressed in differentiating mouse embryonic stem cells. Replacement of Lhx3 by Phox2a led to specification of cranial, rather than spinal, motor neurons. Chromatin immunoprecipitation-sequencing analysis of Isl1, Lhx3 and Phox2a binding sites revealed that the two cell fates were programmed by the recruitment of Isl1-Lhx3 and Isl1-Phox2a complexes to distinct genomic locations characterized by a unique grammar of homeodomain binding motifs. Our findings suggest that synergistic interactions among transcription factors determine the specificity of their recruitment to cell type-specific binding sites and illustrate how a single transcription factor can be repurposed to program different cell types.	[Mazzoni, Esteban O.; Closser, Michael; Morrison, Carolyn A.; Nedelec, Stephane; Wichterle, Hynek] Columbia Univ, Ctr Motor Neuron Biol & Dis, Columbia Stem Cell Initiat, Dept Pathol & Cell Biol,Med Ctr, New York, NY 10027 USA; [Mazzoni, Esteban O.; Closser, Michael; Morrison, Carolyn A.; Nedelec, Stephane; Wichterle, Hynek] Columbia Univ, Ctr Motor Neuron Biol & Dis, Columbia Stem Cell Initiat, Dept Neurol,Med Ctr, New York, NY USA; [Mazzoni, Esteban O.; Closser, Michael; Morrison, Carolyn A.; Nedelec, Stephane; Wichterle, Hynek] Columbia Univ, Ctr Motor Neuron Biol & Dis, Columbia Stem Cell Initiat, Dept Neurosci,Med Ctr, New York, NY USA; [Mazzoni, Esteban O.; An, Disi] NYU, Dept Biol, New York, NY 10003 USA; [Mahony, Shaun; Gifford, David K.] MIT, Comp Sci & Artificial Intelligence Lab, Cambridge, MA 02139 USA; [Mahony, Shaun] Penn State Univ, Ctr Eukaryot Gene Regulat, Dept Biochem & Mol Biol, University Pk, PA 16802 USA; [Williams, Damian J.] Columbia Univ, Med Ctr, Dept Physiol & Cellular Biophys, New York, NY USA	Columbia University; Columbia University; Columbia University; New York University; Massachusetts Institute of Technology (MIT); Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Columbia University	Mazzoni, EO (corresponding author), Columbia Univ, Ctr Motor Neuron Biol & Dis, Columbia Stem Cell Initiat, Dept Pathol & Cell Biol,Med Ctr, New York, NY 10027 USA.	eom204@nyu.edu; gifford@mit.edu; hw350@columbia.edu	Mahony, Shaun/C-5699-2014; Young, Richard A/F-6495-2012; Nedelec, Stéphane/G-8469-2017; Williams, Damian/K-4023-2014; Martinat, Cecile/F-6777-2010	Mahony, Shaun/0000-0002-2641-1807; Young, Richard A/0000-0001-8855-8647; Nedelec, Stéphane/0000-0001-8044-2498; Martinat, Cecile/0000-0002-5234-1064; mazzoni, esteban/0000-0001-8994-681X; Wichterle, Hynek/0000-0002-7817-0080; Williams, Damian/0000-0001-5891-6300; An, Disi/0000-0002-3821-7497	Damon Runyon Cancer Research Foundation [DRG-1937-07]; Project ALS foundation; US National Institutes of Health [P01 NS055923, R01 NS078097]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U01HG007037] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS055923, R01NS078097] Funding Source: NIH RePORTER	Damon Runyon Cancer Research Foundation; Project ALS foundation; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We would like to thank I. Lieberam (King's College) for assistance introducing the Hb9-GFP transgene, members of the Wichterle laboratory for helpful comments, S. Brenner-Morton and T. Jessell (Columbia University) for sharing clones of Isl monoclonal antibodies, J.-F. Brunet for Phox2a and Phox2b antibodies, and I. Schieren for technical assistance with flow cytometry. E.O.M. receives funding from the Damon Runyon Cancer Research Foundation (DRG-1937-07). Personnel and work were supported by the Project ALS foundation and US National Institutes of Health grants P01 NS055923 (D.K.G. and H.W.) and R01 NS078097 (H.W.).	Albuquerque C., 2009, COLD SPRING HARBOR P, V8; Berger MF, 2008, CELL, V133, P1266, DOI 10.1016/j.cell.2008.05.024; Boulting GL, 2011, NAT BIOTECHNOL, V29, P279, DOI 10.1038/nbt.1783; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Brunet JF, 2002, CURR OPIN GENET DEV, V12, P435, DOI 10.1016/S0959-437X(02)00322-2; Coppola E, 2005, EMBO J, V24, P4392, DOI 10.1038/sj.emboj.7600897; Dasen JS, 2009, CURR TOP DEV BIOL, V88, P169, DOI 10.1016/S0070-2153(09)88006-X; Dillon AK, 2005, J NEUROSCI, V25, P10119, DOI 10.1523/JNEUROSCI.3455-05.2005; Gao BX, 1998, J NEUROPHYSIOL, V80, P3047, DOI 10.1152/jn.1998.80.6.3047; Grillet N, 2003, J NEUROSCI, V23, P10613; Guo YC, 2010, BIOINFORMATICS, V26, P3028, DOI 10.1093/bioinformatics/btq590; Hasan KB, 2010, DEVELOPMENT, V137, P1205, DOI 10.1242/dev.041251; Hester ME, 2011, MOL THER, V19, P1905, DOI 10.1038/mt.2011.135; Hirsch MR, 2007, DEV BIOL, V303, P687, DOI 10.1016/j.ydbio.2006.12.006; Holmes G, 2001, DEV DYNAM, V222, P301, DOI 10.1002/dvdy.1182; Jessell TM, 2000, NAT REV GENET, V1, P20, DOI 10.1038/35049541; Kim JW, 2008, CELL, V132, P1049, DOI 10.1016/j.cell.2008.02.039; Kim J, 2010, CELL, V143, P313, DOI 10.1016/j.cell.2010.09.010; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lee S, 2012, P NATL ACAD SCI USA, V109, P3383, DOI 10.1073/pnas.1114515109; Lee SK, 2003, NEURON, V38, P731, DOI 10.1016/S0896-6273(03)00296-4; Li XJ, 2005, NAT BIOTECHNOL, V23, P215, DOI 10.1038/nbt1063; Mahony S, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-1-r2; Mann RS, 2002, CURR OPIN GENET DEV, V12, P592, DOI 10.1016/S0959-437X(02)00344-1; Mazzoni EO, 2011, NAT METHODS, V8, P1056, DOI [10.1038/NMETH.1775, 10.1038/nmeth.1775]; Miles GB, 2004, J NEUROSCI, V24, P7848, DOI 10.1523/JNEUROSCI.1972-04.2004; Mizuguchi R, 2001, NEURON, V31, P757, DOI 10.1016/S0896-6273(01)00413-5; MOORE RY, 1989, J COMP NEUROL, V282, P512, DOI 10.1002/cne.902820404; Novitch BG, 2001, NEURON, V31, P773, DOI 10.1016/S0896-6273(01)00407-X; Pattyn A, 1997, DEVELOPMENT, V124, P4065; Perrier AL, 2004, P NATL ACAD SCI USA, V101, P12543, DOI 10.1073/pnas.0404700101; Peter IS, 2011, CELL, V144, P970, DOI 10.1016/j.cell.2011.02.017; Pfaff SL, 1996, CELL, V84, P309, DOI 10.1016/S0092-8674(00)80985-X; Pfisterer U, 2011, P NATL ACAD SCI USA, V108, P10343, DOI 10.1073/pnas.1105135108; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Sanges R, 2007, BIOINFORMATICS, V23, P3406, DOI 10.1093/bioinformatics/btm469; Sekiya S, 2011, NATURE, V475, P390, DOI 10.1038/nature10263; Sharma K, 1998, CELL, V95, P817, DOI 10.1016/S0092-8674(00)81704-3; Shen Y, 2012, NATURE, V488, P116, DOI 10.1038/nature11243; Slattery M, 2011, CELL, V147, P1270, DOI 10.1016/j.cell.2011.10.053; Son EY, 2011, CELL STEM CELL, V9, P205, DOI 10.1016/j.stem.2011.07.014; Song MR, 2006, DEVELOPMENT, V133, P4945, DOI 10.1242/dev.02694; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; TAPSCOTT SJ, 1988, SCIENCE, V242, P405, DOI 10.1126/science.3175662; Thaler JP, 2002, CELL, V110, P237, DOI 10.1016/S0092-8674(02)00823-1; Vierbuchen T, 2010, NATURE, V463, P1035, DOI 10.1038/nature08797; Wichterle H, 2002, CELL, V110, P385, DOI 10.1016/S0092-8674(02)00835-8; Wichterle Hynek, 2009, V482, P171, DOI 10.1007/978-1-59745-060-7_11; Zhou Q, 2008, NATURE, V455, P627, DOI 10.1038/nature07314	49	132	136	0	27	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	SEP	2013	16	9					1219	U86		10.1038/nn.3467	http://dx.doi.org/10.1038/nn.3467			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	207KN	23872598	Green Accepted, Green Published			2022-12-28	WOS:000323597500013
J	Dobbin, MM; Madabhushi, R; Pan, L; Chen, Y; Kim, D; Gao, J; Ahanonu, B; Pao, PC; Qiu, Y; Zhao, YM; Tsai, LH				Dobbin, Matthew M.; Madabhushi, Ram; Pan, Ling; Chen, Yue; Kim, Dohoon; Gao, Jun; Ahanonu, Biafra; Pao, Ping-Chieh; Qiu, Yi; Zhao, Yingming; Tsai, Li-Huei			SIRT1 collaborates with ATM and HDAC1 to maintain genomic stability in neurons	NATURE NEUROSCIENCE			English	Article							DNA-DAMAGE; CROSS-LINKING; STRAND BREAKS; I-TASSER; CHROMATIN; ACTIVATION; ACETYLATION; PROTEINS; REPAIR; P53	Defects in DNA repair have been linked to cognitive decline with age and neurodegenerative disease, yet the mechanisms that protect neurons from genotoxic stress remain largely obscure. We sought to characterize the roles of the NAD+-dependent deacetylase SIRT1 in the neuronal response to DNA double-strand breaks (DSBs). We found that SIRT1 was rapidly recruited to DSBs in postmitotic neurons, where it showed a synergistic relationship with ataxia telangiectasia mutated (ATM). SIRT1 recruitment to breaks was ATM dependent; however, SIRT1 also stimulated ATM autophosphorylation and activity and stabilized ATM at DSB sites. After DSB induction, SIRT1 also bound the neuroprotective class I histone deacetylase HDAC1. We found that SIRT1 deacetylated HDAC1 and stimulated its enzymatic activity, which was necessary for DSB repair through the nonhomologous end-joining pathway. HDAC1 mutations that mimic a constitutively acetylated state rendered neurons more susceptible to DNA damage, whereas pharmacological SIRT1 activators that promoted HDAC1 deacetylation also reduced DNA damage in two mouse models of neurodegeneration. We propose that SIRT1 is an apical transducer of the DSB response and that SIRT1 activation offers an important therapeutic avenue in neurodegeneration.	[Dobbin, Matthew M.; Madabhushi, Ram; Pan, Ling; Gao, Jun; Ahanonu, Biafra; Pao, Ping-Chieh; Tsai, Li-Huei] MIT, Picower Inst Learning & Memory, Cambridge, MA 02139 USA; [Dobbin, Matthew M.; Madabhushi, Ram; Pan, Ling; Gao, Jun; Ahanonu, Biafra; Pao, Ping-Chieh; Tsai, Li-Huei] MIT, Dept Brain & Cognit Sci, Cambridge, MA 02139 USA; [Dobbin, Matthew M.; Madabhushi, Ram; Pan, Ling; Gao, Jun; Ahanonu, Biafra; Pao, Ping-Chieh; Tsai, Li-Huei] MIT, Howard Hughes Med Inst, Cambridge, MA 02139 USA; [Chen, Yue; Zhao, Yingming] Univ Chicago, Ben May Dept Canc Res, Chicago, IL 60637 USA; [Chen, Yue; Zhao, Yingming] Chinese Acad Sci, Shanghai Inst Mat Med, Shanghai 200031, Peoples R China; [Kim, Dohoon] Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; [Qiu, Yi] Univ Florida, Dept Anat & Cell Biol, Gainesville, FL USA	Massachusetts Institute of Technology (MIT); Northwell Health; Massachusetts Institute of Technology (MIT); Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT); University of Chicago; Chinese Academy of Sciences; Shanghai Institute of Materia Medica, CAS; Massachusetts Institute of Technology (MIT); Whitehead Institute; State University System of Florida; University of Florida	Tsai, LH (corresponding author), MIT, Picower Inst Learning & Memory, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	lhtsai@mit.edu	Ahanonu, Biafra/AAY-8776-2020; Pan, Ling/K-9333-2013; Pao, Ping-Chieh/AAG-9742-2019	Ahanonu, Biafra/0000-0002-2021-5848; Pan, Ling/0000-0001-9947-9071; Pao, Ping-Chieh/0000-0001-6788-7185; , Yi/0000-0002-3282-6072	US National Institutes of Health (NIH) [AG27916]; Howard Hughes Medical Institute; Neurodegeneration Consortium; Glenn award for research in biological mechanisms of aging; NIH [R01 HL095674, U54 RR020389, T32 GM007484, T32 MH081728]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL095674] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007484] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R36MH081728] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG027916, R01AG046174] Funding Source: NIH RePORTER	US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Neurodegeneration Consortium; Glenn award for research in biological mechanisms of aging; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank F. W. Alt (Harvard Medical School) and E.N. Olson (University of Texas Southwestern Medical Center) for providing the Sirt1<SUP>loxP/loxP</SUP> and Hdac1<SUP>loxP/loxP</SUP> mice, respectively; R. Huganir (Johns Hopkins University) for providing the lentiviral Cre constructs; V. Suri, J. Ellis and G. Vlasuk (Sirtris) for providing compound # 10 and, together with J. Graff, for critical comments on the manuscript; M. Kastan (St. Jude's Medical Research Hospital) for gifting the I-PpoI-ER construct; and V. Gorbunova (University of Rochester) for providing the NHEJ constructs. This work was supported by funding from US National Institutes of Health (NIH) PO1 grant AG27916, the Howard Hughes Medical Institute, the Neurodegeneration Consortium and the Glenn award for research in biological mechanisms of aging to L.-H. T., NIH grant R01 HL095674 to Y.Q. and NIH grant U54 RR020389 to Y.Z.M.M.D. was supported by NIH training grants T32 GM007484 and T32 MH081728.	Adamec E, 1999, BRAIN RES, V849, P67, DOI 10.1016/S0006-8993(99)02004-1; Ball AR, 2011, CURR OPIN CELL BIOL, V23, P277, DOI 10.1016/j.ceb.2011.03.012; Berkovich E, 2008, NAT PROTOC, V3, P915, DOI 10.1038/nprot.2008.54; Berkovich E, 2007, NAT CELL BIOL, V9, P683, DOI 10.1038/ncb1599; Bouras T, 2005, J BIOL CHEM, V280, P10264, DOI 10.1074/jbc.M408748200; Carpenter AE, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-10-r100; Cheng HL, 2003, P NATL ACAD SCI USA, V100, P10794, DOI 10.1073/pnas.1934713100; Cruz JC, 2003, NEURON, V40, P471, DOI 10.1016/S0896-6273(03)00627-5; Cruz JC, 2006, J NEUROSCI, V26, P10536, DOI 10.1523/JNEUROSCI.3133-06.2006; Dai H, 2010, J BIOL CHEM, V285, P32695, DOI 10.1074/jbc.M110.133892; DAVIS JB, 1994, BRAIN RES, V652, P169, DOI 10.1016/0006-8993(94)90334-4; Dundr M, 2003, CURR PROTOC CELL BIO; Ferrante RJ, 1997, J NEUROCHEM, V69, P2064; Finnin MS, 1999, NATURE, V401, P188, DOI 10.1038/43710; Gan L, 2008, NEURON, V58, P10, DOI 10.1016/j.neuron.2008.03.015; Gao J, 2010, NATURE, V466, P1105, DOI 10.1038/nature09271; Haumaitre C, 2008, MOL CELL BIOL, V28, P6373, DOI 10.1128/MCB.00413-08; Ikura T, 2000, CELL, V102, P463, DOI 10.1016/S0092-8674(00)00051-9; Kim D, 2007, EMBO J, V26, P3169, DOI 10.1038/sj.emboj.7601758; Kim D, 2008, NEURON, V60, P803, DOI 10.1016/j.neuron.2008.10.015; Kruhlak Michael J., 2009, V523, P125, DOI 10.1007/978-1-59745-190-1_9; Lee JH, 2007, ONCOGENE, V26, P7741, DOI 10.1038/sj.onc.1210872; Lu T, 2004, NATURE, V429, P883, DOI 10.1038/nature02661; Luo Y, 2009, J BIOL CHEM, V284, P34901, DOI 10.1074/jbc.M109.038356; Miller KM, 2010, NAT STRUCT MOL BIOL, V17, P1144, DOI 10.1038/nsmb.1899; Montgomery RL, 2007, GENE DEV, V21, P1790, DOI 10.1101/gad.1563807; Nowak DE, 2005, BIOTECHNIQUES, V39, P715, DOI 10.2144/000112014; Oberdoerffer P, 2008, CELL, V135, P907, DOI 10.1016/j.cell.2008.10.025; Peng LR, 2012, MOL CELL BIOL, V32, P2823, DOI 10.1128/MCB.00496-12; Polo SE, 2010, EMBO J, V29, P3130, DOI 10.1038/emboj.2010.188; Qiu Y, 2006, MOL CELL, V22, P669, DOI 10.1016/j.molcel.2006.04.019; Rass U, 2007, CELL, V130, P991, DOI 10.1016/j.cell.2007.08.043; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; Seluanov A, 2004, P NATL ACAD SCI USA, V101, P7624, DOI 10.1073/pnas.0400726101; Shiloh Y, 2003, NAT REV CANCER, V3, P155, DOI 10.1038/nrc1011; SINGH NP, 1988, EXP CELL RES, V175, P184, DOI 10.1016/0014-4827(88)90265-0; Snapp Erik L, 2003, Curr Protoc Cell Biol, VChapter 21, DOI 10.1002/0471143030.cb2101s19; Sun YL, 2005, P NATL ACAD SCI USA, V102, P13182, DOI 10.1073/pnas.0504211102; Sykes SM, 2006, MOL CELL, V24, P841, DOI 10.1016/j.molcel.2006.11.026; Takamiya K, 2008, J NEUROSCI, V28, P5752, DOI 10.1523/JNEUROSCI.0654-08.2008; Vonesch C, 2008, IEEE T IMAGE PROCESS, V17, P539, DOI 10.1109/TIP.2008.917103; Yang T, 2012, J BIOL CHEM, V287, P40279, DOI 10.1074/jbc.M112.349704; Yang XJ, 2008, NAT REV MOL CELL BIO, V9, P206, DOI 10.1038/nrm2346; Yankner BA, 2008, ANNU REV PATHOL-MECH, V3, P41, DOI 10.1146/annurev.pathmechdis.2.010506.092044; Yoshiyama Y, 2007, NEURON, V53, P337, DOI 10.1016/j.neuron.2007.01.010; Yuan Z, 2007, MOL CELL, V27, P149, DOI 10.1016/j.molcel.2007.05.029; Yuan ZM, 1999, J BIOL CHEM, V274, P1883, DOI 10.1074/jbc.274.4.1883; Zeng PY, 2006, BIOTECHNIQUES, V41, P694, DOI 10.2144/000112297; Zhang Y, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-40; Zhao YX, 2003, ANAL CHEM, V75, P3751, DOI 10.1021/ac034184m	50	165	172	0	34	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	AUG	2013	16	8					1008	U54		10.1038/nn.3460	http://dx.doi.org/10.1038/nn.3460			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	190EV	23852118	Green Accepted, Green Submitted			2022-12-28	WOS:000322323000010
J	Kash, TL; Crabbe, JC				Kash, Thomas L.; Crabbe, John C.			Drinking through the pain	NATURE NEUROSCIENCE			English	Editorial Material							NUCLEUS-ACCUMBENS; ALCOHOL; EXPOSURE; SEEKING	A feature of abusive alcohol drinking has been modeled successfully in experiments with rats. The experiments show that changes in NMDA signaling in specific neural circuits accompany the transition to aversion-resistant drinking.	[Kash, Thomas L.] Univ N Carolina, Dept Pharmacol, Bowles Ctr Alcohol Studies, Chapel Hill, NC 27515 USA; [Crabbe, John C.] Oregon Hlth & Sci Univ, Vet Affairs Med Ctr, Portland Alcohol Res Ctr, Portland, OR 97201 USA; [Crabbe, John C.] Oregon Hlth & Sci Univ, Dept Behav Neurosci, Portland, OR 97201 USA	University of North Carolina; University of North Carolina Chapel Hill; Oregon Health & Science University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Oregon Health & Science University	Kash, TL (corresponding author), Univ N Carolina, Dept Pharmacol, Bowles Ctr Alcohol Studies, Chapel Hill, NC 27515 USA.	tkash@email.unc.edu; crabbe@ohsu.edu	Kash, Thomas/G-9625-2013		NIAAA NIH HHS [P60 AA011605, R01 AA019454, U01 AA020911] Funding Source: Medline; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA019454, P60AA011605, U01AA020911] Funding Source: NIH RePORTER	NIAAA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))		Becker HC, 2013, CURR TOP BEHAV NEURO, V13, P355, DOI 10.1007/7854_2012_203; Britt JP, 2012, NEURON, V76, P790, DOI 10.1016/j.neuron.2012.09.040; Chen BT, 2013, NATURE, V496, P359, DOI 10.1038/nature12024; Crabbe JC, 2011, ANN NY ACAD SCI, V1216, P24, DOI 10.1111/j.1749-6632.2010.05895.x; Kash TL, 2009, NEUROPSYCHOPHARMACOL, V34, P2420, DOI 10.1038/npp.2009.69; Lesscher HMB, 2010, ALCOHOL CLIN EXP RES, V34, P1219, DOI 10.1111/j.1530-0277.2010.01199.x; National Institute on Alcohol Abuse and Alcoholism, 2004, NIAAA NEWSLETTER, V3; Seif T, 2013, NAT NEUROSCI, V16, P1094, DOI 10.1038/nn.3445; Stuber GD, 2011, NATURE, V475, P377, DOI 10.1038/nature10194; WISE RA, 1973, PSYCHOPHARMACOLOGIA, V29, P203, DOI 10.1007/BF00414034	10	0	0	0	14	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	AUG	2013	16	8					987	988		10.1038/nn.3476	http://dx.doi.org/10.1038/nn.3476			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	190EV	23887132	Green Accepted			2022-12-28	WOS:000322323000004
J	Bradshaw, EM; Chibnik, LB; Keenan, BT; Ottoboni, L; Raj, T; Tang, A; Rosenkrantz, LL; Imboywa, S; Lee, M; Von Korff, A; Morris, MC; Evans, DA; Johnson, K; Sperling, RA; Schneider, JA; Bennett, DA; De Jager, PL				Bradshaw, Elizabeth M.; Chibnik, Lori B.; Keenan, Brendan T.; Ottoboni, Linda; Raj, Towfique; Tang, Anna; Rosenkrantz, Laura L.; Imboywa, Selina; Lee, Michelle; Von Korff, Alina; Morris, Martha C.; Evans, Denis A.; Johnson, Keith; Sperling, Reisa A.; Schneider, Julie A.; Bennett, David A.; De Jager, Philip L.		Alzheimer's Dis Neuroimaging Initi	CD33 Alzheimer's disease locus: altered monocyte function and amyloid biology	NATURE NEUROSCIENCE			English	Article							GENOME-WIDE ASSOCIATION; COGNITIVE IMPAIRMENT; IDENTIFIES VARIANTS; COMMON VARIANTS; EPHA1; PET; DEMENTIA; BINDING; CD2AP; BETA	In our functional dissection of the CD33 Alzheimer's disease susceptibility locus, we found that the rs3865444(C) risk allele was associated with greater cell surface expression of CD33 in the monocytes ( t(50) = 10.06, P-joint = 1.3 x 10(-13)) of young and older individuals. It was also associated with diminished internalization of amyloid-beta 42 peptide, accumulation of neuritic amyloid pathology and fibrillar amyloid on in vivo imaging, and increased numbers of activated human microglia.	[Bradshaw, Elizabeth M.; Chibnik, Lori B.; Keenan, Brendan T.; Ottoboni, Linda; Raj, Towfique; Tang, Anna; Rosenkrantz, Laura L.; Imboywa, Selina; Lee, Michelle; Von Korff, Alina; De Jager, Philip L.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Ctr Neurol Dis, Boston, MA 02115 USA; [Bradshaw, Elizabeth M.; Chibnik, Lori B.; Keenan, Brendan T.; Ottoboni, Linda; Raj, Towfique; Tang, Anna; Rosenkrantz, Laura L.; Imboywa, Selina; Lee, Michelle; Von Korff, Alina; De Jager, Philip L.] Brigham & Womens Hosp, Dept Neurol, Inst Neurosci, Program Translat NeuroPsychiat Genom, Boston, MA 02115 USA; [Bradshaw, Elizabeth M.; Chibnik, Lori B.; Ottoboni, Linda; Raj, Towfique; Johnson, Keith; Sperling, Reisa A.; De Jager, Philip L.] Harvard Univ, Sch Med, Boston, MA USA; [Bradshaw, Elizabeth M.; Chibnik, Lori B.; Keenan, Brendan T.; Ottoboni, Linda; Raj, Towfique; Tang, Anna; Rosenkrantz, Laura L.; Imboywa, Selina; De Jager, Philip L.] Broad Inst, Program Med & Populat Genet, Cambridge, MA USA; [Morris, Martha C.; Schneider, Julie A.; Bennett, David A.] Rush Univ, Med Ctr, Rush Alzheimers Dis Ctr, Chicago, IL 60612 USA; [Evans, Denis A.] Rush Univ, Med Ctr, Rush Inst Hlth Aging, Chicago, IL 60612 USA; [Johnson, Keith; Sperling, Reisa A.] Massachusetts Gen Hosp, Dept Neurol, Boston, MA 02114 USA; [Sperling, Reisa A.] Brigham & Womens Hosp, Dept Neurol, Ctr Alzheimers Res & Treatment, Boston, MA 02115 USA; [Johnson, Keith; Sperling, Reisa A.] Massachusetts Gen Hosp, Athinoula A Martinos Ctr Biomed Imaging, Boston, MA 02114 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Rush University; Rush University; Harvard University; Massachusetts General Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Massachusetts General Hospital	De Jager, PL (corresponding author), Harvard Univ, Brigham & Womens Hosp, Sch Med, Ctr Neurol Dis, Boston, MA 02115 USA.	pdejager@partners.org	Preda, Adrian/K-8889-2013; Ottoboni, Linda/AAC-4508-2022; Raj, Towfique/ABD-7620-2021; Hsiung, Robin/AAT-1661-2021; Saykin, Andrew/A-1318-2007	Preda, Adrian/0000-0003-3373-2438; Ottoboni, Linda/0000-0001-5412-7785; Hsiung, Robin/0000-0002-8017-0856; Ponto, Laura/0000-0003-1197-6714; Saykin, Andrew/0000-0002-1376-8532; Chibnik, Lori/0000-0001-6293-806X	US National Institutes of Health [R01 AG031553, R01 AG30146, R01 AG17917, R01 AG15819, P30 AG10161, R01 AG11101]; Illinois Department of Public Health; JDRF; American Diabetes Association; Boston Area Diabetes and Endocrinology Research Center; Harvard NeuroDiscovery Center;  [R01 NS067305];  [RC2 GM093080];  [R01 AG043617]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [RC2GM093080, R25GM076321] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS067305] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P50AG008702, P30AG008051, R01AG043617, R01AG017917, R01AG030146, K25AG041906, R01AG031553, R01AG011101, R01AG036042, U24AG021886, P30AG010161, P50AG005138, R01AG015819, P30AG013846] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Illinois Department of Public Health; JDRF(Juvenile Diabetes Research Foundation); American Diabetes Association(American Diabetes Association); Boston Area Diabetes and Endocrinology Research Center; Harvard NeuroDiscovery Center; ; ; ; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The authors are grateful to the participants of the ROS, MAP, CHAP, Harvard Aging Brain Study (HAB) and Alzheimer's Disease Neuroimaging Initiative (ADNI) studies. Data used in preparation of this article were obtained from the ADNI database (http://adni.loni.ucla.edu/). As such, the investigators within the ADNI contributed to the design and implementation of ADNI and/or provided data but did not participate in analysis or writing of this report. We also thank the participants of the Brigham and Women's PhenoGenetic Project. This work is supported by the US National Institutes of Health (grants R01 AG031553, R01 AG30146, R01 AG17917, R01 AG15819, P30 AG10161 and R01 AG11101) and the Illinois Department of Public Health. This work was supported by grants R01 NS067305, RC2 GM093080 and R01 AG043617. E.M.B. receives support from the JDRF, American Diabetes Association, Boston Area Diabetes and Endocrinology Research Center and the Harvard NeuroDiscovery Center.	[Anonymous], 1997, Neurobiol Aging, V18, pS1; Bennett DA, 2006, NEUROLOGY, V66, P1837, DOI 10.1212/01.wnl.0000219668.47116.e6; Bennett DA, 2005, NEUROLOGY, V64, P834, DOI 10.1212/01.WNL.0000152982.47274.9E; Bennett DA, 2012, CURR ALZHEIMER RES, V9, P646; Bennett DA, 2012, CURR ALZHEIMER RES, V9, P628; Bienias JL, 2003, J ALZHEIMERS DIS, V5, P349, DOI 10.3233/JAD-2003-5501; Carrasquillo MM, 2011, MOL NEURODEGENER, V6, DOI 10.1186/1750-1326-6-54; Ciaramella A, 2010, J ALZHEIMERS DIS, V19, P559, DOI 10.3233/JAD-2010-1257; Fagan AM, 2006, ANN NEUROL, V59, P512, DOI 10.1002/ana.20730; Fiala M, 2007, J ALZHEIMERS DIS, V11, P457; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Gomperts SN, 2008, NEUROLOGY, V71, P903, DOI 10.1212/01.wnl.0000326146.60732.d6; Griciuc A, 2013, NEURON, V78, P631, DOI 10.1016/j.neuron.2013.04.014; Harold D, 2009, NAT GENET, V41, P1088, DOI 10.1038/ng.440; Hedden T, 2009, J NEUROSCI, V29, P12686, DOI 10.1523/JNEUROSCI.3189-09.2009; Hollingworth P, 2011, NAT GENET, V43, P429, DOI 10.1038/ng.803; Hollingworth P, 2011, INT J GERIATR PSYCH, V26, P793, DOI 10.1002/gps.2628; Johnson KA, 2007, ANN NEUROL, V62, P229, DOI 10.1002/ana.21164; Johnson WE, 2007, BIOSTATISTICS, V8, P118, DOI 10.1093/biostatistics/kxj037; Karch CM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050976; Klunk WE, 2004, ANN NEUROL, V55, P306, DOI 10.1002/ana.20009; Lajaunias F, 2005, EUR J IMMUNOL, V35, P243, DOI 10.1002/eji.200425273; Lambert JC, 2009, NAT GENET, V41, P1094, DOI 10.1038/ng.439; LOGAN J, 1990, J CEREBR BLOOD F MET, V10, P740, DOI 10.1038/jcbfm.1990.127; Lopresti BJ, 2005, J NUCL MED, V46, P1959; Mackenzie IRA, 2000, NEUROLOGY, V55, P132, DOI 10.1212/WNL.55.1.132; Mathis CA, 2003, J MED CHEM, V46, P2740, DOI 10.1021/jm030026b; MORRIS JC, 1993, NEUROLOGY, V43, P2412, DOI 10.1212/WNL.43.11.2412-a; Naj AC, 2011, NAT GENET, V43, P436, DOI 10.1038/ng.801; Okello A, 2009, NEUROLOGY, V73, P754, DOI 10.1212/WNL.0b013e3181b23564; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Price JC, 2005, J CEREBR BLOOD F MET, V25, P1528, DOI 10.1038/sj.jcbfm.9600146; Reich M, 2006, NAT GENET, V38, P500, DOI 10.1038/ng0506-500; Salloway S, 2009, NEUROLOGY, V73, P2061, DOI 10.1212/WNL.0b013e3181c67808; Schneider JA, 2004, NEUROLOGY, V62, P1148, DOI 10.1212/01.WNL.0000118211.78503.F5; Seshadri S, 2010, JAMA-J AM MED ASSOC, V303, P1832, DOI 10.1001/jama.2010.574; Sperling RA, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002609; Sperling RA, 2011, ALZHEIMERS DEMENT, V7, P280, DOI 10.1016/j.jalz.2011.03.003; Wechsler D., 1945, WECHSLER MEMORY SCAL; Winblad B, 2012, LANCET NEUROL, V11, P597, DOI 10.1016/S1474-4422(12)70140-0; YESAVAGE JA, 1983, J PSYCHIATR RES, V17, P37, DOI 10.1016/0022-3956(82)90033-4	41	371	383	0	57	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUL	2013	16	7					848	U92		10.1038/nn.3435	http://dx.doi.org/10.1038/nn.3435			5	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	174UM	23708142	Green Accepted, Green Submitted			2022-12-28	WOS:000321180900016
J	Xiao, L; Michalski, N; Kronander, E; Gjoni, E; Genoud, C; Knott, G; Schneggenburger, R				Xiao, Le; Michalski, Nicolas; Kronander, Elin; Gjoni, Enida; Genoud, Christel; Knott, Graham; Schneggenburger, Ralf			BMP signaling specifies the development of a large and fast CNS synapse	NATURE NEUROSCIENCE			English	Article							MORPHOGENETIC PROTEIN RECEPTORS; HELD SYNAPSE; POSTNATAL-DEVELOPMENT; AUDITORY SYNAPSE; NERVOUS-SYSTEM; TRAPEZOID BODY; MEDIAL NUCLEUS; II RECEPTOR; BRAIN-STEM; CALYX	excitatory synapses with multiple active zones ensure reliable and fast information transfer at specific points in neuronal circuits. However, the mechanisms that determine synapse size in CNS circuits are largely unknown. Here we use the calyx of Held synapse, a major relay in the auditory system, to identify and study signaling pathways that specify large nerve terminal size and fast synaptic transmission. Using genome-wide screening, we identified bone morphogenetic proteins (BMPs) as candidate signaling molecules in the area of calyx synapses. Conditional deletion of BMP receptors in the auditory system of mice led to aberrations of synapse morphology and function specifically at the calyx of Held, with impaired nerve terminal growth, loss of monoinnervation and less mature transmitter release properties. Thus, BMP signaling specifies large and fast-transmitting synapses in the auditory system in a process that shares homologies with, but also extends beyond, retrograde BMP signaling at Drosophila neuromuscular synapses.	[Xiao, Le; Michalski, Nicolas; Kronander, Elin; Gjoni, Enida; Schneggenburger, Ralf] Ecole Polytech Fed Lausanne, Sch Life Sci, Brain Mind Inst, Lab Synapt Mech, CH-1015 Lausanne, Switzerland; [Genoud, Christel] Friedrich Miescher Inst Biomed Res FMI, Facil Adv Imaging & Microscopy, Basel, Switzerland; [Knott, Graham] Ecole Polytech Fed Lausanne, Interdisciplinary Ctr Electron Microscopy CIME, CH-1015 Lausanne, Switzerland	Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Friedrich Miescher Institute for Biomedical Research; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne	Schneggenburger, R (corresponding author), Ecole Polytech Fed Lausanne, Sch Life Sci, Brain Mind Inst, Lab Synapt Mech, CH-1015 Lausanne, Switzerland.	ralf.schneggenburger@epfl.ch		Kronander, Elin/0000-0003-0280-6318; Knott, Graham W/0000-0002-2956-9052; genoud, christel/0000-0002-0933-9911; Xiao, Le/0000-0001-9703-1265; michalski, nicolas/0000-0002-1287-2709; Gjoni, Enida/0000-0003-4028-9294	Swiss National Foundation Science (SNF) [Sinergia CRSI33_127440/1]; National Center of Competence in Research of the SNF 'Synaptic Bases of Mental Disease'; Deutsche Forschungsgemeinschaft (DFG) [PP 1608]; Marie-Curie Fellowship [IEF-235223-CALYX MMFF]	Swiss National Foundation Science (SNF); National Center of Competence in Research of the SNF 'Synaptic Bases of Mental Disease'; Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Marie-Curie Fellowship(European Commission)	We thank A. Grapin-Botton, E. Robertson, P. Scheiffele, M. Muller, O. Kochubey and D. Perkel for discussions, R. Behringer (University of Texas) and K. Lyons (University of California Los Angeles) for sharing mice, D. Constam (Ecole Polytechnique Federale de Lausanne) for providing ISH probes, H. Murray for expert technical assistance and O. Burri for help with image analysis. The cDNA array analyses were performed in the DNA array facility Lausanne (DAFL); image acquisition was done at the Bio-optical imaging platform of EPFL. The work was supported by the Swiss National Foundation Science (SNF; Sinergia CRSI33_127440/1), the National Center of Competence in Research of the SNF 'Synaptic Bases of Mental Disease', the Deutsche Forschungsgemeinschaft (DFG; PP 1608) (all to R.S.) and a Marie-Curie Fellowship (IEF-235223-CALYX MMFF; to N.M.).	Aberle H, 2002, NEURON, V33, P545, DOI 10.1016/S0896-6273(02)00589-5; Augsburger A, 1999, NEURON, V24, P127, DOI 10.1016/S0896-6273(00)80827-2; Ball RW, 2010, NEURON, V66, P536, DOI 10.1016/j.neuron.2010.04.011; Bergsman JB, 2004, J NEUROPHYSIOL, V92, P545, DOI 10.1152/jn.00927.2003; Bond AM, 2012, DEV NEUROBIOL, V72, P1068, DOI 10.1002/dneu.22022; Borst JGG, 2012, ANNU REV PHYSIOL, V74, P199, DOI 10.1146/annurev-physiol-020911-153236; Cant NB, 2003, BRAIN RES BULL, V60, P457, DOI 10.1016/S0361-9230(03)00050-9; Carulli D, 2006, J COMP NEUROL, V494, P559, DOI 10.1002/cne.20822; Case DT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020756; Chuhma N, 2001, J PHYSIOL-LONDON, V530, P93, DOI 10.1111/j.1469-7793.2001.0093m.x; Denk W, 2004, PLOS BIOL, V2, P1900, DOI 10.1371/journal.pbio.0020329; Eaton BA, 2005, NEURON, V47, P695, DOI 10.1016/j.neuron.2005.08.010; Erazo-Fischer E, 2007, J NEUROSCI, V27, P1725, DOI 10.1523/JNEUROSCI.4116-06.2007; Farago AF, 2006, NEURON, V50, P205, DOI 10.1016/j.neuron.2006.03.014; Foletta VC, 2003, J CELL BIOL, V163, P421; Friedland DR, 2006, NEUROSCIENCE, V142, P753, DOI 10.1016/j.neuroscience.2006.06.060; Futai K, 2001, J NEUROSCI, V21, P3342, DOI 10.1523/JNEUROSCI.21-10-03342.2001; GRAHAM A, 1994, NATURE, V372, P684, DOI 10.1038/372684a0; Grothe B, 2010, PHYSIOL REV, V90, P983, DOI 10.1152/physrev.00026.2009; Han YY, 2011, NEURON, V69, P304, DOI 10.1016/j.neuron.2010.12.014; Hoffpauir BK, 2006, J NEUROSCI, V26, P5511, DOI 10.1523/JNEUROSCI.5525-05.2006; Hoffpauir BK, 2010, J PHYSIOL-LONDON, V588, P4365, DOI 10.1113/jphysiol.2010.198564; Ji SJ, 2012, NEURON, V74, P95, DOI 10.1016/j.neuron.2012.02.022; Kalinovsky A, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001013; Kim G, 2003, NAT NEUROSCI, V6, P282, DOI 10.1038/nn1015; Knott GW, 2002, NEURON, V34, P265, DOI 10.1016/S0896-6273(02)00663-3; Koehl A, 2004, EUR J NEUROSCI, V20, P3244, DOI 10.1111/j.1460-9568.2004.03791.x; Koike-Tani M, 2005, J NEUROSCI, V25, P199, DOI 10.1523/JNEUROSCI.3861-04.2005; Lee-Hoeflich ST, 2004, EMBO J, V23, P4792, DOI 10.1038/sj.emboj.7600418; LIEM KF, 1995, CELL, V82, P969, DOI 10.1016/0092-8674(95)90276-7; Marques G, 2002, NEURON, V33, P529, DOI 10.1016/S0896-6273(02)00595-0; McCabe BD, 2004, NEURON, V41, P891, DOI 10.1016/S0896-6273(04)00073-X; McCabe BD, 2003, NEURON, V39, P241, DOI 10.1016/S0896-6273(03)00426-4; Meyer AC, 2001, J NEUROSCI, V21, P7889, DOI 10.1523/JNEUROSCI.21-20-07889.2001; Mishina Y, 2002, GENESIS, V32, P69, DOI 10.1002/gene.10038; Miyagi M, 2011, NEUROSCIENCE, V183, P278, DOI 10.1016/j.neuroscience.2011.03.053; Miyazono K, 2010, J BIOCHEM, V147, P35, DOI 10.1093/jb/mvp148; Peterson RS, 2004, J CELL BIOL, V166, P1081, DOI 10.1083/jcb.200402138; Rawson JM, 2003, J NEUROBIOL, V55, P134, DOI 10.1002/neu.10189; Renier N, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000325; Rodriguez-Contreras A, 2006, J COMP NEUROL, V496, P214, DOI 10.1002/cne.20918; Rodriguez-Contreras A, 2008, P NATL ACAD SCI USA, V105, P5603, DOI 10.1073/pnas.0801395105; Ruediger S, 2011, NATURE, V473, P514, DOI 10.1038/nature09946; Sanes JR, 2009, ANNU REV CELL DEV BI, V25, P161, DOI 10.1146/annurev.cellbio.24.110707.175402; Satzler K, 2002, J NEUROSCI, V22, P10567; Schneggenburger R, 1999, NEURON, V23, P399, DOI 10.1016/S0896-6273(00)80789-8; Sherman SM, 1998, P NATL ACAD SCI USA, V95, P7121, DOI 10.1073/pnas.95.12.7121; Taschenberger H, 2000, J NEUROSCI, V20, P9162; Toyoshima M, 2009, DEV BIOL, V336, P192, DOI 10.1016/j.ydbio.2009.09.043; Voiculescu O, 2000, GENESIS, V26, P123, DOI 10.1002/(SICI)1526-968X(200002)26:2<123::AID-GENE7>3.0.CO;2-O; Walmsley B, 1998, TRENDS NEUROSCI, V21, P81, DOI 10.1016/S0166-2236(97)01170-3; Xiao L, 2010, MOL CELL NEUROSCI, V44, P374, DOI 10.1016/j.mcn.2010.05.002; Yang YM, 2011, J PHYSIOL-LONDON, V589, P4209, DOI 10.1113/jphysiol.2011.208066; Yi SE, 2000, DEVELOPMENT, V127, P621; Zhang DM, 1998, J NEUROSCI, V18, P3314	55	66	68	0	19	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JUL	2013	16	7					856	U109		10.1038/nn.3414	http://dx.doi.org/10.1038/nn.3414			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	174UM	23708139				2022-12-28	WOS:000321180900018
J	Longordo, F; To, MS; Ikeda, K; Stuart, GJ				Longordo, Fabio; To, Minh-Son; Ikeda, Kaori; Stuart, Greg J.			Sublinear integration underlies binocular processing in primary visual cortex	NATURE NEUROSCIENCE			English	Article							NEOCORTICAL PYRAMIDAL NEURONS; IN-VIVO; CORTICAL-NEURONS; COMPLEX CELLS; ORIENTATION SELECTIVITY; DENDRITIC INTEGRATION; SYNAPTIC INPUTS; BARREL CORTEX; SUMMATION; ORGANIZATION	Although we know much about the capacity of neurons to integrate synaptic inputs in vitro, less is known about synaptic integration in vivo. Here we address this issue by investigating the integration of inputs from the two eyes in mouse primary visual cortex. We find that binocular inputs to layer 2/3 pyramidal neurons are integrated sublinearly in an amplitude-dependent manner. Sublinear integration was greatest when binocular responses were largest, as occurs at the preferred orientation and binocular disparity, and highest contrast. Using voltage-clamp experiments and modeling, we show that sublinear integration occurs postsynaptically. The extent of sublinear integration cannot be accounted for solely by nonlinear integration of excitatory inputs, even when they are activated closely in space and time, but requires balanced recruitment of inhibition. Finally, we show that sublinear binocular integration acts as a divisive form of gain control, linearizing the output of binocular neurons and enhancing orientation selectivity.	[Longordo, Fabio; To, Minh-Son; Ikeda, Kaori; Stuart, Greg J.] Australian Natl Univ, John Curtin Sch Med Res, Eccles Inst Neurosci, Canberra, ACT 2601, Australia; [To, Minh-Son] Flinders Univ Adelaide, Dept Human Physiol, Adelaide, SA, Australia; [To, Minh-Son] Flinders Univ Adelaide, Ctr Neurosci, Adelaide, SA, Australia	Australian National University; John Curtin School of Medical Research; Flinders University South Australia; Flinders University South Australia	Longordo, F (corresponding author), Australian Natl Univ, John Curtin Sch Med Res, Eccles Inst Neurosci, Canberra, ACT 2601, Australia.	fabio.longordo@anu.edu.au; greg.stuart@anu.edu.au		stuart, greg/0000-0001-9395-2219	European Community's Seventh Framework Program (FP7) [201600]; Bundesministerium fur Bildung und Forschung within the framework of the NGFN-Plus (FKZ) [01GS08151, 01GS08155]; Initiative and Networking Fund of the Helmholtz Association in the framework of the Helmholtz Alliance for Mental Health in an Ageing Society [HA-215]	European Community's Seventh Framework Program (FP7); Bundesministerium fur Bildung und Forschung within the framework of the NGFN-Plus (FKZ); Initiative and Networking Fund of the Helmholtz Association in the framework of the Helmholtz Alliance for Mental Health in an Ageing Society	We are grateful to D. Harbich and B. Schmid for technical assistance. This work was supported by the European Community's Seventh Framework Program (FP7, Project No. 201600), the Bundesministerium fur Bildung und Forschung within the framework of the NGFN-Plus (FKZ: 01GS08151 and 01GS08155) and by the Initiative and Networking Fund of the Helmholtz Association in the framework of the Helmholtz Alliance for Mental Health in an Ageing Society (HA-215).	Anzai A, 1999, J NEUROPHYSIOL, V82, P874, DOI 10.1152/jn.1999.82.2.874; Atallah BV, 2012, NEURON, V73, P159, DOI 10.1016/j.neuron.2011.12.013; Borg-Graham LJ, 1998, NATURE, V393, P369, DOI 10.1038/30735; Branco T, 2011, NEURON, V69, P885, DOI 10.1016/j.neuron.2011.02.006; Carandini M, 2000, J NEUROSCI, V20, P470, DOI 10.1523/JNEUROSCI.20-01-00470.2000; Cash S, 1998, J NEUROSCI, V18, P10; Cash S, 1999, NEURON, V22, P383, DOI 10.1016/S0896-6273(00)81098-3; Chen XW, 2011, NATURE, V475, P501, DOI 10.1038/nature10193; Cruikshank SJ, 2007, NAT NEUROSCI, V10, P462, DOI 10.1038/nn1861; DEANGELIS GC, 1991, NATURE, V352, P156, DOI 10.1038/352156a0; Enoki R, 2002, NEUROSCIENCE, V113, P1003, DOI 10.1016/S0306-4522(02)00169-0; Haider B, 2009, NEURON, V62, P171, DOI 10.1016/j.neuron.2009.04.008; Hoffman DA, 1997, NATURE, V387, P869, DOI 10.1038/43119; Jagadeesh B, 1997, J NEUROPHYSIOL, V78, P2772, DOI 10.1152/jn.1997.78.5.2772; Jaubert-Miazza L, 2005, VISUAL NEUROSCI, V22, P661, DOI 10.1017/S0952523805225154; Jia HB, 2010, NATURE, V464, P1307, DOI 10.1038/nature08947; Kleindienst T, 2011, NEURON, V72, P1012, DOI 10.1016/j.neuron.2011.10.015; KOCH C, 1983, P NATL ACAD SCI-BIOL, V80, P2799, DOI 10.1073/pnas.80.9.2799; Kole MHP, 2007, J PHYSIOL-LONDON, V578, P507, DOI 10.1113/jphysiol.2006.122028; Krueppel R, 2011, NEURON, V71, P512, DOI 10.1016/j.neuron.2011.05.043; Larkum ME, 1999, NATURE, V398, P338, DOI 10.1038/18686; Lavzin M, 2012, NATURE, V490, P397, DOI 10.1038/nature11451; Lee SH, 2012, NATURE, V488, P379, DOI 10.1038/nature11312; Losonczy A, 2006, NEURON, V50, P291, DOI 10.1016/j.neuron.2006.03.016; Magee JC, 1999, NAT NEUROSCI, V2, P508, DOI 10.1038/9158; MAGEE JC, 1995, SCIENCE, V268, P301, DOI 10.1126/science.7716525; Margrie TW, 2002, PFLUG ARCH EUR J PHY, V444, P491, DOI 10.1007/s00424-002-0831-z; Medini P, 2011, J NEUROSCI, V31, P17134, DOI 10.1523/JNEUROSCI.2951-11.2011; Muir-Robinson G, 2002, J NEUROSCI, V22, P5259; Murayama M, 2009, NATURE, V457, P1137, DOI 10.1038/nature07663; Niell CM, 2008, J NEUROSCI, V28, P7520, DOI 10.1523/JNEUROSCI.0623-08.2008; OHZAWA I, 1986, J NEUROPHYSIOL, V56, P243, DOI 10.1152/jn.1986.56.1.243; OHZAWA I, 1986, J NEUROPHYSIOL, V56, P221, DOI 10.1152/jn.1986.56.1.221; OHZAWA I, 1990, SCIENCE, V249, P1037, DOI 10.1126/science.2396096; Palmer LM, 2012, SCIENCE, V335, P989, DOI 10.1126/science.1217276; Polsky A, 2004, NAT NEUROSCI, V7, P621, DOI 10.1038/nn1253; Priebe NJ, 2004, NAT NEUROSCI, V7, P1113, DOI 10.1038/nn1310; Restani L, 2009, NEURON, V64, P707, DOI 10.1016/j.neuron.2009.10.019; Ringach DL, 2002, J NEUROSCI, V22, P5639; Schiller J, 2000, NATURE, V404, P285, DOI 10.1038/35005094; Schiller J, 1997, J PHYSIOL-LONDON, V505, P605, DOI 10.1111/j.1469-7793.1997.605ba.x; Silver RA, 2003, SCIENCE, V302, P1981, DOI 10.1126/science.1087160; SKOTTUN BC, 1991, VISION RES, V31, P1079, DOI 10.1016/0042-6989(91)90033-2; STUART G, 1995, NEURON, V15, P1065, DOI 10.1016/0896-6273(95)90095-0; Stuart G, 1997, J PHYSIOL-LONDON, V505, P617, DOI 10.1111/j.1469-7793.1997.617ba.x; Takahashi N, 2012, SCIENCE, V335, P353, DOI 10.1126/science.1210362; Tan AYY, 2011, J NEUROSCI, V31, P12339, DOI 10.1523/JNEUROSCI.2039-11.2011; Varga Z, 2011, P NATL ACAD SCI USA, V108, P15420, DOI 10.1073/pnas.1112355108; Wang BS, 2010, NEURON, V65, P246, DOI 10.1016/j.neuron.2010.01.002; Williams SR, 2002, SCIENCE, V295, P1907, DOI 10.1126/science.1067903; Williams SR, 2008, NAT NEUROSCI, V11, P790, DOI 10.1038/nn.2137; Wilson NR, 2012, NATURE, V488, P343, DOI 10.1038/nature11347; Xu NL, 2012, NATURE, V492, P247, DOI 10.1038/nature11601; Yizhar O, 2011, NATURE, V477, P171, DOI 10.1038/nature10360; Ziburkus J, 2006, J NEUROPHYSIOL, V96, P2775, DOI 10.1152/jn.01321.2004	55	41	42	0	27	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JUN	2013	16	6					714	+		10.1038/nn.3394	http://dx.doi.org/10.1038/nn.3394			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	152DE	23644484	Green Submitted			2022-12-28	WOS:000319509600013
J	Sekine, SU; Haraguchi, S; Chao, KH; Kato, T; Luo, LQ; Miura, M; Chihara, T				Sekine, Sayaka U.; Haraguchi, Shuka; Chao, Kinhong; Kato, Tomoko; Luo, Liqun; Miura, Masayuki; Chihara, Takahiro			Meigo governs dendrite targeting specificity by modulating Ephrin level and N-glycosylation	NATURE NEUROSCIENCE			English	Article							UNFOLDED PROTEIN RESPONSE; OLFACTORY PROJECTION NEURONS; DROSOPHILA EMBRYONIC CNS; REPRESSIBLE CELL MARKER; ENDOPLASMIC-RETICULUM; WIRING SPECIFICITY; HEPARAN-SULFATE; TRANSCRIPTIONAL CONTROL; TERMINAL ARBORIZATION; MOSAIC ANALYSIS	Neural circuit assembly requires precise dendrite and axon targeting. We identified an evolutionarily conserved endoplasmic reticulum (ER) protein, Meigo, from a mosaic genetic screen in Drosophila melanogaster. Meigo was cell-autonomously required in olfactory receptor neurons and projection neurons to target their axons and dendrites to the lateral antennal lobe and to refine projection neuron dendrites into individual glomeruli. Loss of Meigo induced an unfolded protein response and reduced the amount of neuronal cell surface proteins, including Ephrin. Ephrin overexpression specifically suppressed the projection neuron dendrite refinement defect present in meigo mutant flies, and ephrin knockdown caused a similar projection neuron dendrite refinement defect. Meigo positively regulated the level of Ephrin N-glycosylation, which was required for its optimal function in vivo. Thus, Meigo, an ER-resident protein, governs neuronal targeting specificity by regulating ER folding capacity and protein N-glycosylation. Furthermore, Ephrin appears to be an important substrate that mediates Meigo's function in refinement of glomerular targeting.	[Sekine, Sayaka U.; Haraguchi, Shuka; Chao, Kinhong; Kato, Tomoko; Miura, Masayuki; Chihara, Takahiro] Univ Tokyo, Grad Sch Pharmaceut Sci, Dept Genet, Tokyo, Japan; [Luo, Liqun] Stanford Univ, Howard Hughes Med Inst, Stanford, CA 94305 USA; [Luo, Liqun] Stanford Univ, Dept Biol, Stanford, CA 94305 USA; [Miura, Masayuki] Japan Sci & Technol Agcy, Core Res Evolut Sci & Technol, Tokyo, Japan; [Chihara, Takahiro] Japan Sci & Technol Agcy, Precursory Res Embryon Sci & Technol, Tokyo, Japan	University of Tokyo; Howard Hughes Medical Institute; Stanford University; Stanford University; Japan Science & Technology Agency (JST); Japan Science & Technology Agency (JST)	Chihara, T (corresponding author), Univ Tokyo, Grad Sch Pharmaceut Sci, Dept Genet, Tokyo, Japan.	tchihara@mol.f.u-tokyo.ac.jp	Chihara, Takahiro/G-7639-2019	Chihara, Takahiro/0000-0001-9989-3619; Sekine, Sayaka/0000-0001-5656-2959	Ministry of Education, Culture, Sports, Science and Technology in Japan; Japan Society for the Promotion of Science; Japan Science and Technology Agency; US National Institutes of Health [R01 DC005982]; Howard Hughes Medical Institute; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC005982] Funding Source: NIH RePORTER	Ministry of Education, Culture, Sports, Science and Technology in Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Japan Science and Technology Agency(Japan Science & Technology Agency (JST)); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	We thank J.B. Thomas, Bloomington and the Kyoto Drosophila Stock Center for fly stocks, A.H. Brand (University of Cambridge) for the Ephrin antibody and fly stocks, S. Goto (Rikkyo University) for the dGLG1 (120 kDa) antibody, C. Field (Harvard University) for the Lava Lamp antibody, T. Uemura (Kyoto University) for the UAS-DNcadherin plasmid, H.D. Ryoo (New York University) and P.M. Domingos (Instituto de Tecnologia Quimica e Biologica) for xbp1:EGFP-related reagents and the Hsc3 antibody, C.-H. Chen for advice on constructing shRNAs, G. Thomas and M. Khanna for advice on performing OptiPrep density gradient centrifugation, and all of the members of the Miura and Luo laboratories for comments on this study. We especially thank T. Mosca for improving the manuscript and M. Okumura and T.C. for the blind test. L.L. is funded by the Howard Hughes Medical Institute. This work was supported by grants from the Ministry of Education, Culture, Sports, Science and Technology in Japan to M.M. and T.C., the Japan Society for the Promotion of Science to S.U.S., M.M. and T.C., the Japan Science and Technology Agency to M.M. and T.C., and the US National Institutes of Health (R01 DC005982) to L.L.	Bossing T, 2002, DEVELOPMENT, V129, P4205; Chen CH, 2007, SCIENCE, V316, P597, DOI [10.1126/science. 1138595, 10.1126/science.1138595]; Chihara T, 2007, NAT NEUROSCI, V10, P828, DOI 10.1038/nn1910; Cudna RE, 2003, BIOTECHNOL BIOENG, V81, P56, DOI 10.1002/bit.10445; Cutforth T, 2003, CELL, V114, P311, DOI 10.1016/S0092-8674(03)00568-3; Dejima K, 2009, FASEB J, V23, P2215, DOI 10.1096/fj.08-123737; Elefant F, 1999, MOL BIOL CELL, V10, P2101, DOI 10.1091/mbc.10.7.2101; Goto S, 2001, NAT CELL BIOL, V3, P816, DOI 10.1038/ncb0901-816; Haecker A, 2008, DEVELOPMENT, V135, P1745, DOI 10.1242/dev.020891; Hollien J, 2006, SCIENCE, V313, P104, DOI 10.1126/science.1129631; Hong WZ, 2012, NATURE, V484, P201, DOI 10.1038/nature10926; Hong WZ, 2009, NAT NEUROSCI, V12, P1542, DOI 10.1038/nn.2442; Ishida N, 2004, PFLUG ARCH EUR J PHY, V447, P768, DOI 10.1007/s00424-003-1093-0; Ishikawa HO, 2010, J BIOL CHEM, V285, P4122, DOI 10.1074/jbc.M109.016964; Iwai Y, 1997, NEURON, V19, P77, DOI 10.1016/S0896-6273(00)80349-9; Iwawaki T, 2004, NAT MED, V10, P98, DOI 10.1038/nm970; Jefferis GSXE, 2006, SEMIN CELL DEV BIOL, V17, P50, DOI 10.1016/j.semcdb.2005.12.002; Jefferis GSXE, 2004, DEVELOPMENT, V131, P117, DOI 10.1242/dev.00896; Kamimura K, 2006, J CELL BIOL, V174, P773, DOI 10.1083/jcb.200603129; Khanna MR, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-302; Kobayashi T, 2006, BIOCHEM J, V400, P281, DOI 10.1042/BJ20060429; Komiyama T, 2004, NAT NEUROSCI, V7, P819, DOI 10.1038/nn1284; Komiyama T, 2003, CELL, V112, P157, DOI 10.1016/S0092-8674(03)00030-8; Komiyama T, 2007, CELL, V128, P399, DOI 10.1016/j.cell.2006.12.028; Lee T, 1999, NEURON, V22, P451, DOI 10.1016/S0896-6273(00)80701-1; Lehrman MA, 2006, CRIT REV BIOCHEM MOL, V41, P51, DOI 10.1080/10409230500542575; Leonard R, 2006, J BIOL CHEM, V281, P4867, DOI 10.1074/jbc.M511023200; Lin XH, 1999, NATURE, V400, P281, DOI 10.1038/22343; Lin YR, 2008, DEV DYNAM, V237, P3703, DOI 10.1002/dvdy.21775; Luders F, 2003, EMBO J, V22, P3635, DOI 10.1093/emboj/cdg345; Mosca TJ, 2012, NATURE, V484, P237, DOI 10.1038/nature10923; Mumm JS, 2006, NEURON, V52, P609, DOI 10.1016/j.neuron.2006.10.004; Murray JI, 2004, MOL BIOL CELL, V15, P2361, DOI 10.1091/mbc.E03-11-0799; Nakanishi H, 2001, YEAST, V18, P543, DOI 10.1002/yea.707; Newsome TP, 2000, DEVELOPMENT, V127, P851; Papoulas O, 2005, NAT CELL BIOL, V7, P612, DOI 10.1038/ncb1264; Repnikova E, 2010, J NEUROSCI, V30, P6466, DOI 10.1523/JNEUROSCI.5253-09.2010; Reyes F, 2010, PLANT J, V61, P423, DOI 10.1111/j.1365-313X.2009.04066.x; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Ryoo HD, 2007, EMBO J, V26, P242, DOI 10.1038/sj.emboj.7601477; Schroder M, 2005, MUTAT RES-FUND MOL M, V569, P29, DOI 10.1016/j.mrfmmm.2004.06.056; Selva EM, 2001, NAT CELL BIOL, V3, P809, DOI 10.1038/ncb0901-809; Souid S, 2007, DEV GENES EVOL, V217, P159, DOI 10.1007/s00427-006-0124-1; Spletter ML, 2007, NEURAL DEV, V2, DOI 10.1186/1749-8104-2-14; Sweeney LB, 2011, NEURON, V72, P734, DOI 10.1016/j.neuron.2011.09.026; Takei Y, 2004, DEVELOPMENT, V131, P73, DOI 10.1242/dev.00913; Tanaka NK, 2004, CURR BIOL, V14, P449, DOI 10.1016/j.cub.2004.03.006; Tien AC, 2008, J CELL BIOL, V182, P1113, DOI 10.1083/jcb.200805001; Toth J, 2001, DEV CELL, V1, P83, DOI 10.1016/S1534-5807(01)00002-8; Vrieseling E, 2006, CELL, V127, P1439, DOI 10.1016/j.cell.2006.10.042; Wu JS, 2006, NAT PROTOC, V1, P2583, DOI 10.1038/nprot.2006.320; Yamamoto-Hino M, 2012, CELL STRUCT FUNCT, V37, P55, DOI 10.1247/csf.11037; Zhu HT, 2006, NAT NEUROSCI, V9, P349, DOI 10.1038/nn1652; Zhu HT, 2004, NEURON, V42, P63, DOI 10.1016/S0896-6273(04)00142-4	54	21	21	0	11	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JUN	2013	16	6					683	+		10.1038/nn.3389	http://dx.doi.org/10.1038/nn.3389			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	152DE	23624514	Green Accepted			2022-12-28	WOS:000319509600009
J	Schmidt-Hieber, C; Hausser, M				Schmidt-Hieber, Christoph; Haeusser, Michael			Cellular mechanisms of spatial navigation in the medial entorhinal cortex	NATURE NEUROSCIENCE			English	Article							GRID CELLS; STELLATE CELLS; SUBTHRESHOLD OSCILLATIONS; PHASE PRECESSION; PATH-INTEGRATION; LAYER-II; THETA; INTERFERENCE; ORGANIZATION; FREQUENCY	Neurons in the medial entorhinal cortex exhibit a grid-like spatial pattern of spike rates that has been proposed to represent a neural code for path integration. To understand how grid cell firing arises from the combination of intrinsic conductances and synaptic input in medial entorhinal stellate cells, we performed patch-clamp recordings in mice navigating in a virtual-reality environment. We found that the membrane potential signature of stellate cells during firing field crossings consisted of a slow depolarization driving spike output. This was best predicted by network models in which neurons receive sustained depolarizing synaptic input during a field crossing, such as continuous attractor network models of grid cell firing. Another key feature of the data, phase precession of intracellular theta oscillations and spiking with respect to extracellular theta oscillations, was best captured by an oscillatory interference model. Thus, these findings provide crucial new information for a quantitative understanding of the cellular basis of spatial navigation in the entorhinal cortex.	[Schmidt-Hieber, Christoph; Haeusser, Michael] UCL, Wolfson Inst Biomed Res, London, England; [Schmidt-Hieber, Christoph; Haeusser, Michael] UCL, Dept Neurosci Physiol & Pharmacol, London, England	University of London; University College London; University of London; University College London	Schmidt-Hieber, C (corresponding author), UCL, Wolfson Inst Biomed Res, London, England.	c.schmidt-hieber@ucl.ac.uk; m.hausser@ucl.ac.uk	Hausser, Michael/AAW-6827-2020	Hausser, Michael/0000-0002-2673-8957; Schmidt-Hieber, Christoph/0000-0002-5328-9704	Wellcome Trust; European Research Council; Gatsby Charitable Foundation; Alexander von Humboldt Foundation	Wellcome Trust(Wellcome TrustEuropean Commission); European Research Council(European Research Council (ERC)European Commission); Gatsby Charitable Foundation; Alexander von Humboldt Foundation(Alexander von Humboldt Foundation)	We are grateful to N. Burgess, B. Clark, P. Dayan, K. Harris, P. Latham, J. O'Keefe, A. Packer, A. Roth, S. Turaga and C. Wilms for helpful discussions and for comments on the manuscript, and to A. Naeem for assistance with histology. This work was supported by grants from the Wellcome Trust, European Research Council and Gatsby Charitable Foundation, and by a fellowship to C. S.-H. from the Alexander von Humboldt Foundation.	ALONSO A, 1993, J NEUROPHYSIOL, V70, P128, DOI 10.1152/jn.1993.70.1.128; Barry C, 2012, FRONT NEURAL CIRCUIT, V6, DOI [10.3389/fncir.2012.00030, 10.3389/fncir.2012.00005]; Brandon MP, 2011, SCIENCE, V332, P595, DOI 10.1126/science.1201652; Brun VH, 2008, HIPPOCAMPUS, V18, P1200, DOI 10.1002/hipo.20504; Burak Y, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000291; Burgess N, 2007, HIPPOCAMPUS, V17, P801, DOI 10.1002/hipo.20327; Burgess N, 2011, CURR OPIN NEUROBIOL, V21, P734, DOI 10.1016/j.conb.2011.07.002; Burgess N, 2008, HIPPOCAMPUS, V18, P1157, DOI 10.1002/hipo.20518; Couey JJ, 2013, NAT NEUROSCI, V16, P318, DOI 10.1038/nn.3310; Dodson PD, 2011, J PHYSIOL-LONDON, V589, P2993, DOI 10.1113/jphysiol.2011.205021; Fernandez FR, 2008, J NEUROSCI, V28, P3790, DOI 10.1523/JNEUROSCI.5658-07.2008; Fuhs MC, 2006, J NEUROSCI, V26, P4266, DOI 10.1523/JNEUROSCI.4353-05.2006; Fyhn M, 2008, HIPPOCAMPUS, V18, P1230, DOI 10.1002/hipo.20472; Garden DLF, 2008, NEURON, V60, P875, DOI 10.1016/j.neuron.2008.10.044; Giocomo LM, 2007, SCIENCE, V315, P1719, DOI 10.1126/science.1139207; Haas JS, 2002, J NEUROPHYSIOL, V88, P2422, DOI 10.1152/jn.00598.2002; Hafting T, 2005, NATURE, V436, P801, DOI 10.1038/nature03721; Hafting T, 2008, NATURE, V453, P1248, DOI 10.1038/nature06957; Harvey CD, 2009, NATURE, V461, P941, DOI 10.1038/nature08499; Hasselmo ME, 2007, HIPPOCAMPUS, V17, P1252, DOI 10.1002/hipo.20374; Holscher C, 2005, J EXP BIOL, V208, P561, DOI 10.1242/jeb.01371; Koenig J, 2011, SCIENCE, V332, P592, DOI 10.1126/science.1201685; Kropff E, 2008, HIPPOCAMPUS, V18, P1256, DOI 10.1002/hipo.20520; McNaughton BL, 2006, NAT REV NEUROSCI, V7, P663, DOI 10.1038/nrn1932; Mehta MR, 2002, NATURE, V417, P741, DOI 10.1038/nature00807; Navratilova Z, 2012, HIPPOCAMPUS, V22, P772, DOI 10.1002/hipo.20939; Nolan MF, 2007, J NEUROSCI, V27, P12440, DOI 10.1523/JNEUROSCI.2358-07.2007; OKEEFE J, 1993, HIPPOCAMPUS, V3, P317, DOI 10.1002/hipo.450030307; Pastoll H, 2013, NEURON, V77, P141, DOI 10.1016/j.neuron.2012.11.032; Quilichini P, 2010, J NEUROSCI, V30, P11128, DOI 10.1523/JNEUROSCI.1327-10.2010; Reifenstein ET, 2012, P NATL ACAD SCI USA, V109, P6301, DOI 10.1073/pnas.1109599109; Sargolini F, 2006, SCIENCE, V312, P758, DOI 10.1126/science.1125572; Welday AC, 2011, J NEUROSCI, V31, P16157, DOI 10.1523/JNEUROSCI.0712-11.2011; Yartsev MM, 2011, NATURE, V479, P103, DOI 10.1038/nature10583; Zilli EA, 2012, FRONT NEURAL CIRCUIT, V6, DOI 10.3389/fncir.2012.00016; Zilli EA, 2010, J NEUROSCI, V30, P13850, DOI 10.1523/JNEUROSCI.0547-10.2010	36	186	188	2	50	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAR	2013	16	3					325	331		10.1038/nn.3340	http://dx.doi.org/10.1038/nn.3340			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	097LE	23396102				2022-12-28	WOS:000315474800015
J	Glickfeld, LL; Andermann, ML; Bonin, V; Reid, RC				Glickfeld, Lindsey L.; Andermann, Mark L.; Bonin, Vincent; Reid, R. Clay			Cortico-cortical projections in mouse visual cortex are functionally target specific	NATURE NEUROSCIENCE			English	Article							RECEPTIVE-FIELD PROPERTIES; EFFERENT CONNECTIONS; NEURONS; AREA; ORGANIZATION; STRIATE; STREAMS; CELLS; V2; SPECIALIZATION	Neurons in primary sensory cortex have diverse response properties, whereas higher cortical areas are specialized. Specific connectivity may be important for areal specialization, particularly in the mouse, where neighboring neurons are functionally diverse. To examine whether higher visual areas receive functionally specific input from primary visual cortex (V1), we used two-photon calcium imaging to measure responses of axons from V1 arborizing in three areas with distinct spatial and temporal frequency preferences. We found that visual preferences of presynaptic boutons in each area were distinct and matched the average preferences of recipient neurons. This specificity could not be explained by organization within V1 and instead was due to both a greater density and greater response amplitude of functionally matched boutons. Projections from a single layer (layer 5) and from secondary visual cortex were also matched to their target areas. Thus, transmission of specific information to downstream targets may be a general feature of cortico-cortical communication.	[Glickfeld, Lindsey L.; Andermann, Mark L.; Bonin, Vincent; Reid, R. Clay] Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA	Harvard University; Harvard Medical School	Reid, RC (corresponding author), Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA.	clay_reid@hms.harvard.edu	Bonin, Vincent/AAQ-3833-2020	Bonin, Vincent/0000-0002-9437-8092	US National Institutes of Health [R01 EY018742, R01 EY010115]; Helen Hay Whitney Foundation; Ludcke Foundation; Pierce Charitable Trust; NATIONAL EYE INSTITUTE [R01EY010115, R01EY018742] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Helen Hay Whitney Foundation; Ludcke Foundation; Pierce Charitable Trust; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	We thank A. Caiado, G. Goldey, M. Kirk, C. Mazur and D. Roumis for surgical assistance; J. Curry, A. Moffa and W. Wray for behavioral habituation of mice; S. Yurgenson for technical contributions to visual stimulation and eye-tracking software; and A. Vagodny for technical assistance. We also thank V. Berezovskii, R. Born, S. Chatterjee, M. Histed, C. Hull, A. Kerlin, W. Lee, J. Maunsell and W. Regehr for advice and discussion at all stages of the project. This work was supported by the US National Institutes of Health (R01 EY018742 and R01 EY010115) and by fellowships from the Helen Hay Whitney Foundation (L.L.G. and M.L.A.) and the Ludcke Foundation and Pierce Charitable Trust (M.L.A.).	Allen CB, 2003, NAT NEUROSCI, V6, P291, DOI 10.1038/nn1012; Andermann ML, 2011, NEURON, V72, P1025, DOI 10.1016/j.neuron.2011.11.013; Berezovskii VK, 2011, J COMP NEUROL, V519, P3672, DOI 10.1002/cne.22675; Bock DD, 2011, NATURE, V471, P177, DOI 10.1038/nature09802; Bonin V, 2011, J NEUROSCI, V31, P18506, DOI 10.1523/JNEUROSCI.2974-11.2011; Bosking WH, 1997, J NEUROSCI, V17, P2112; Brenowitz SD, 2007, J NEUROSCI, V27, P7888, DOI 10.1523/JNEUROSCI.1064-07.2007; Brown SP, 2009, NATURE, V457, P1133, DOI 10.1038/nature07658; Churchland AK, 2005, J NEUROPHYSIOL, V94, P1084, DOI 10.1152/jn.00196.2005; COOGAN TA, 1993, J NEUROSCI, V13, P3749; DEYOE EA, 1985, NATURE, V317, P58, DOI 10.1038/317058a0; Dong HW, 2004, VISION RES, V44, P3389, DOI 10.1016/j.visres.2004.09.007; DRAGER UC, 1975, J COMP NEUROL, V160, P269, DOI 10.1002/cne.901600302; Dreosti E, 2009, NAT METHODS, V6, P883, DOI 10.1038/nmeth.1399; Felleman DJ, 1991, CEREB CORTEX, V1, P1, DOI 10.1093/cercor/1.1.1; Ferraina S, 2002, J NEUROPHYSIOL, V87, P845, DOI 10.1152/jn.00317.2001; Gao EQ, 2010, J NEUROSCI, V30, P5912, DOI 10.1523/JNEUROSCI.6456-09.2010; Hata Y, 1999, NEURON, V22, P375, DOI 10.1016/S0896-6273(00)81097-1; Hofer SB, 2011, NAT NEUROSCI, V14, P1045, DOI 10.1038/nn.2876; Jarosiewicz B, 2012, CURR BIOL, V22, P269, DOI 10.1016/j.cub.2012.01.011; Jia HB, 2010, NATURE, V464, P1307, DOI 10.1038/nature08947; Johnson RR, 1997, J NEUROSCI, V17, P7129; Ko H, 2011, NATURE, V473, P87, DOI 10.1038/nature09880; LIVINGSTONE MS, 1987, J NEUROSCI, V7, P3371; LIVINGSTONE MS, 1983, NATURE, V304, P531, DOI 10.1038/304531a0; Marshel JH, 2011, NEURON, V72, P1040, DOI 10.1016/j.neuron.2011.12.004; Molyneaux BJ, 2009, J NEUROSCI, V29, P12343, DOI 10.1523/JNEUROSCI.6108-08.2009; Morishima M, 2006, J NEUROSCI, V26, P4394, DOI 10.1523/JNEUROSCI.0252-06.2006; Movshon JA, 1996, J NEUROSCI, V16, P7733; Nassi JJ, 2007, NEURON, V55, P799, DOI 10.1016/j.neuron.2007.07.037; Nassi JJ, 2009, NAT REV NEUROSCI, V10, P360, DOI 10.1038/nrn2619; Niell CM, 2008, J NEUROSCI, V28, P7520, DOI 10.1523/JNEUROSCI.0623-08.2008; Niell CM, 2010, NEURON, V65, P472, DOI 10.1016/j.neuron.2010.01.033; Nikolaou N, 2012, NEURON, V76, P317, DOI 10.1016/j.neuron.2012.08.040; Ohki K, 2005, NATURE, V433, P597, DOI 10.1038/nature03274; Ohki K, 2007, CURR OPIN NEUROBIOL, V17, P401, DOI 10.1016/j.conb.2007.07.007; Petreanu L, 2012, NATURE, V489, P299, DOI 10.1038/nature11321; Roth MM, 2012, J NEUROSCI, V32, P9716, DOI 10.1523/JNEUROSCI.0110-12.2012; Sato TR, 2010, J NEUROSCI, V30, P4256, DOI 10.1523/JNEUROSCI.3774-09.2010; SHIPP S, 1989, EUR J NEUROSCI, V1, P333, DOI 10.1111/j.1460-9568.1989.tb00799.x; SIMMONS PA, 1982, J COMP NEUROL, V211, P295, DOI 10.1002/cne.902110308; Sincich LC, 2003, J NEUROSCI, V23, P5684; Swadlow HA, 1998, J NEUROSCI METH, V79, P131, DOI 10.1016/S0165-0270(97)00176-3; SWADLOW HA, 1981, J COMP NEUROL, V203, P799, DOI 10.1002/cne.902030415; Van den Bergh G, 2010, J COMP NEUROL, V518, P2051, DOI 10.1002/cne.22321; Wang QX, 2007, J COMP NEUROL, V502, P339, DOI 10.1002/cne.21286; Wang QX, 2012, J NEUROSCI, V32, P4386, DOI 10.1523/JNEUROSCI.6063-11.2012; Wang QX, 2011, J NEUROSCI, V31, P1905, DOI 10.1523/JNEUROSCI.3488-10.2011; Yoshimura Y, 2005, NATURE, V433, P868, DOI 10.1038/nature03252; Zhao CJ, 2011, J NEUROSCI, V31, P7492, DOI 10.1523/JNEUROSCI.6636-10.2011	50	185	187	0	35	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	FEB	2013	16	2					219	226		10.1038/nn.3300	http://dx.doi.org/10.1038/nn.3300			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	080RE	23292681	Green Published, Green Accepted			2022-12-28	WOS:000314260200019
J	Haefner, RM; Gerwinn, S; Macke, JH; Bethge, M				Haefner, Ralf M.; Gerwinn, Sebastian; Macke, Jakob H.; Bethge, Matthias			Inferring decoding strategies from choice probabilities in the presence of correlated variability	NATURE NEUROSCIENCE			English	Article							DECISION-RELATED ACTIVITY; AREA MT; SENSORY NEURONS; CORTICAL AREA; POPULATION CODE; TASK STRATEGY; VISUAL-CORTEX; SINGLE-NEURON; V2 NEURONS; MACAQUE MT	The activity of cortical neurons in sensory areas covaries with perceptual decisions, a relationship that is often quantified by choice probabilities. Although choice probabilities have been measured extensively, their interpretation has remained fraught with difficulty. We derive the mathematical relationship between choice probabilities, read-out weights and correlated variability in the standard neural decision-making model. Our solution allowed us to prove and generalize earlier observations on the basis of numerical simulations and to derive new predictions. Notably, our results indicate how the read-out weight profile, or decoding strategy, can be inferred from experimentally measurable quantities. Furthermore, we developed a test to decide whether the decoding weights of individual neurons are optimal for the task, even without knowing the underlying correlations. We confirmed the practicality of our approach using simulated data from a realistic population model. Thus, our findings provide a theoretical foundation for a growing body of experimental results on choice probabilities and correlations.	[Haefner, Ralf M.; Macke, Jakob H.] Max Planck Inst Biol Cybernet, Neural Computat & Behav Grp, D-72076 Tubingen, Germany; [Haefner, Ralf M.; Macke, Jakob H.; Bethge, Matthias] Bernstein Ctr Computat Neurosci, Tubingen, Germany; [Haefner, Ralf M.] Brandeis Univ, Volen Natl Ctr Complex Syst, Waltham, MA USA; [Gerwinn, Sebastian; Macke, Jakob H.; Bethge, Matthias] Werner Reichhardt Ctr Integrat Neurosci, Tubingen, Germany; [Gerwinn, Sebastian] Inst Informat Technol OFFIS, R&D Div Transportat, Oldenburg, Germany; [Bethge, Matthias] Univ Tubingen, Inst Theoret Phys, Tubingen, Germany	Max Planck Society; Brandeis University; Eberhard Karls University of Tubingen; Eberhard Karls University of Tubingen	Haefner, RM (corresponding author), Max Planck Inst Biol Cybernet, Neural Computat & Behav Grp, Spemannstr 38, D-72076 Tubingen, Germany.	ralf.haefner@gmail.com	Bethge, Matthias/B-1554-2008	Haefner, Ralf M/0000-0002-5031-0379	German Ministry of Education, Science, Research and Technology through the Bernstein Award [FKZ 01GQ0601]; Bernstein Center for Computational Neuroscience [FKZ 01GQ1002]; German Excellency Initiative through the Centre for Integrative Neuroscience Tubingen [EXC307]; European Commission [FP7-ICT-257005]; Swartz Foundation	German Ministry of Education, Science, Research and Technology through the Bernstein Award; Bernstein Center for Computational Neuroscience; German Excellency Initiative through the Centre for Integrative Neuroscience Tubingen; European Commission(European CommissionEuropean Commission Joint Research Centre); Swartz Foundation	We thank A. Ecker and P. Berens for stimulating discussions and detailed comments on an earlier version of the manuscript, and H. Nienborg and B.G. Cumming for many helpful conversations. This work was partially supported by the German Ministry of Education, Science, Research and Technology through the Bernstein Award (FKZ 01GQ0601) (M.B.), the Bernstein Center for Computational Neuroscience (FKZ 01GQ1002), the German Excellency Initiative through the Centre for Integrative Neuroscience Tubingen (EXC307) and the European Commission (FP7-ICT-257005). R.M.H. acknowledges the hospitality of the Fiser laboratory at Brandeis University where this study was completed and financial support from the Swartz Foundation. Part of this research was done while J.H.M. was at the Gatsby Computational Neuroscience Unit, University College London.	Abbott LF, 1999, NEURAL COMPUT, V11, P91, DOI 10.1162/089976699300016827; Averbeck BB, 2006, NAT REV NEUROSCI, V7, P358, DOI 10.1038/nrn1888; Bishop C.M., 2006, PATTERN RECOGN; Britten KH, 1996, VISUAL NEUROSCI, V13, P87, DOI 10.1017/S095252380000715X; Buzsaki G, 2004, NAT NEUROSCI, V7, P446, DOI 10.1038/nn1233; CELEBRINI S, 1994, J NEUROSCI, V14, P4109; Chen YZ, 2006, NAT NEUROSCI, V9, P1412, DOI 10.1038/nn1792; Churchland MM, 2007, J NEUROPHYSIOL, V97, P4235, DOI 10.1152/jn.00095.2007; Cohen MR, 2008, NEURON, V60, P162, DOI 10.1016/j.neuron.2008.08.007; Cohen MR, 2011, NAT NEUROSCI, V14, P811, DOI 10.1038/nn.2842; Cohen MR, 2009, J NEUROSCI, V29, P6635, DOI 10.1523/JNEUROSCI.5179-08.2009; Cook EP, 2002, NAT NEUROSCI, V5, P985, DOI 10.1038/nn924; Dodd JV, 2001, J NEUROSCI, V21, P4809, DOI 10.1523/JNEUROSCI.21-13-04809.2001; Ecker AS, 2011, J NEUROSCI, V31, P14272, DOI 10.1523/JNEUROSCI.2539-11.2011; Gold JI, 2007, ANNU REV NEUROSCI, V30, P535, DOI 10.1146/annurev.neuro.29.051605.113038; Grunewald A, 2002, J NEUROSCI, V22, P6195; Gu Y, 2008, NAT NEUROSCI, V11, P1201, DOI 10.1038/nn.2191; Gu Y, 2011, NEURON, V71, P750, DOI 10.1016/j.neuron.2011.06.015; Jazayeri M, 2008, CURR OPIN NEUROBIOL, V18, P431, DOI 10.1016/j.conb.2008.09.004; Kerr JND, 2008, NAT REV NEUROSCI, V9, P195, DOI 10.1038/nrn2338; Law CT, 2008, NAT NEUROSCI, V11, P505, DOI 10.1038/nn2070; Law CT, 2009, NAT NEUROSCI, V12, P655, DOI 10.1038/nn.2304; Liu J, 2005, J NEUROSCI, V25, P711, DOI 10.1523/JNEUROSCI.4034-04.2005; Liu J, 2006, J NEUROSCI, V26, P7779, DOI 10.1523/JNEUROSCI.5052-05.2006; Marder E, 2011, P NATL ACAD SCI USA, V108, P15542, DOI 10.1073/pnas.1010674108; NEWSOME WT, 1989, NATURE, V341, P52, DOI 10.1038/341052a0; Nienborg H, 2007, NAT NEUROSCI, V10, P1608, DOI 10.1038/nn1991; Nienborg H, 2006, J NEUROSCI, V26, P9567, DOI 10.1523/JNEUROSCI.2256-06.2006; Nienborg H, 2012, ANNU REV NEUROSCI, V35, P463, DOI 10.1146/annurev-neuro-062111-150403; Nienborg H, 2010, CURR OPIN NEUROBIOL, V20, P376, DOI 10.1016/j.conb.2010.05.002; Nienborg H, 2009, NATURE, V459, P89, DOI 10.1038/nature07821; Padmanabhan K, 2010, NAT NEUROSCI, V13, P1276, DOI 10.1038/nn.2630; Parker AJ, 2002, PHILOS T ROY SOC B, V357, P1053, DOI 10.1098/rstb.2002.1112; Parker AJ, 1998, ANNU REV NEUROSCI, V21, P227, DOI 10.1146/annurev.neuro.21.1.227; Purushothaman G, 2005, NAT NEUROSCI, V8, P99, DOI 10.1038/nn1373; Shadlen MN, 1996, J NEUROSCI, V16, P1486; Shadlen MN, 1998, J NEUROSCI, V18, P3870; Stevenson IH, 2011, NAT NEUROSCI, V14, P139, DOI 10.1038/nn.2731; Uka T, 2005, J NEUROSCI, V25, P10796, DOI 10.1523/JNEUROSCI.1637-05.2005; Uka T, 2004, NEURON, V42, P297, DOI 10.1016/S0896-6273(04)00186-2; Wang XJ, 2008, NEURON, V60, P215, DOI 10.1016/j.neuron.2008.09.034	41	100	100	0	47	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	FEB	2013	16	2					235	242		10.1038/nn.3309	http://dx.doi.org/10.1038/nn.3309			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	080RE	23313912				2022-12-28	WOS:000314260200021
J	Szyf, M				Szyf, Moshe			How do environments talk to genes?	NATURE NEUROSCIENCE			English	Editorial Material							STRESS	A report elucidates the widely recognized, but poorly understood, concept of gene-environment interaction, finding a molecular mechanism in the case of post-traumatic stress disorder: demethylation of a glucocorticoid response element in the stress response regulator FKBP5 that depends on both the risk allele and childhood trauma.	McGill Univ, Fac Med, Dept Pharmacol & Therapeut, Montreal, PQ, Canada	McGill University	Szyf, M (corresponding author), McGill Univ, Fac Med, Dept Pharmacol & Therapeut, Montreal, PQ, Canada.	moshe.szyf@mcgill.ca						Binder EB, 2008, JAMA-J AM MED ASSOC, V299, P1291, DOI 10.1001/jama.299.11.1291; Caspi A, 2003, SCIENCE, V301, P386, DOI 10.1126/science.1083968; D'Alessio AC, 2007, MOL CELL BIOL, V27, P7462, DOI 10.1128/MCB.01120-07; Klengel T, 2013, NAT NEUROSCI, V16, P33, DOI 10.1038/nn.3275; RAZIN A, 1984, BIOCHIM BIOPHYS ACTA, V782, P331, DOI 10.1016/0167-4781(84)90043-5; Szyf M, 2012, CLIN GENET, V81, P341, DOI 10.1111/j.1399-0004.2012.01843.x; Uddin M, 2011, DIS MARKERS, V30, P111, DOI [10.1155/2011/513659, 10.3233/DMA-2011-0750]; Uddin M, 2010, P NATL ACAD SCI USA, V107, P9470, DOI 10.1073/pnas.0910794107; Wang DS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039501; Weaver ICG, 2004, NAT NEUROSCI, V7, P847, DOI 10.1038/nn1276; Yehuda R, 2009, BIOL PSYCHIAT, V66, P708, DOI 10.1016/j.biopsych.2009.02.034	11	46	47	0	35	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JAN	2013	16	1					2	4		10.1038/nn.3286	http://dx.doi.org/10.1038/nn.3286			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	058KZ	23257925				2022-12-28	WOS:000312633900002
J	Beggs, S; Trang, T; Salter, MW				Beggs, Simon; Trang, Tuan; Salter, Michael W.			P2X4R(+) microglia drive neuropathic pain	NATURE NEUROSCIENCE			English	Article							PERIPHERAL-NERVE INJURY; LAMINA-I NEURONS; RECEPTOR UP-REGULATION; CNS GLIAL MODULATOR; SPINAL MICROGLIA; P2X(4) RECEPTORS; DIFFERENTIAL RESPONSES; RODENT MICROGLIA; ANION GRADIENT; VITRO EVIDENCE	Neuropathic pain, the most debilitating of all clinical pain syndromes, may be a consequence of trauma, infection or pathology from diseases that affect peripheral nerves. Here we provide a framework for understanding the spinal mechanisms of neuropathic pain as distinct from those of acute pain or inflammatory pain. Recent work suggests that a specific microglia response phenotype characterized by de novo expression of the purinergic receptor P2X4 is critical for the pathogenesis of pain hypersensitivity caused by injury to peripheral nerves. Stimulating P2X4 receptors initiates a core pain signaling pathway mediated by release of brain-derived neurotrophic factor, which produces a disinhibitory increase in intracellular chloride in nociceptive (pain-transmitting) neurons in the spinal dorsal horn. The changes caused by signaling from P2X4R(+) microglia to nociceptive transmission neurons may account for the main symptoms of neuropathic pain in humans, and they point to specific interventions to alleviate this debilitating condition.	[Beggs, Simon; Trang, Tuan; Salter, Michael W.] Hosp Sick Children, Neurosci & Mental Hlth Program, Toronto, ON M5G 1X8, Canada; [Beggs, Simon; Trang, Tuan; Salter, Michael W.] Univ Toronto, Ctr Study Pain, Toronto, ON, Canada; [Beggs, Simon; Salter, Michael W.] Univ Toronto, Fac Dent, Toronto, ON, Canada; [Trang, Tuan; Salter, Michael W.] Univ Turin, Fac Med, Dept Phys, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University of Toronto; University of Turin	Salter, MW (corresponding author), Hosp Sick Children, Neurosci & Mental Hlth Program, 555 Univ Ave, Toronto, ON M5G 1X8, Canada.	mike.salter@utoronto.ca	Beggs, Simon/AAI-4438-2021	Beggs, Simon/0000-0002-1582-8391	Canadian Institutes of Health Research [MT-11219]; Krembil Foundation; Ontario Research Fund Research Excellence Program; Canada Research Chair (Tier I) in Neuroplasticity and Pain; Anne and Max Tanenbaum Chair in Molecular Medicine at the Hospital for Sick Children; Canadian Institutes of Health Research	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Krembil Foundation; Ontario Research Fund Research Excellence Program; Canada Research Chair (Tier I) in Neuroplasticity and Pain; Anne and Max Tanenbaum Chair in Molecular Medicine at the Hospital for Sick Children; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	The work of the authors is supported by grants from the Canadian Institutes of Health Research (MT-11219), the Krembil Foundation and the Ontario Research Fund Research Excellence Program. M. W. S. is supported by a Canada Research Chair (Tier I) in Neuroplasticity and Pain, and the Anne and Max Tanenbaum Chair in Molecular Medicine at the Hospital for Sick Children. T. T. was supported by a Canadian Institutes of Health Research fellowship.	Abbadie C, 2009, BRAIN RES REV, V60, P125, DOI 10.1016/j.brainresrev.2008.12.002; Asiedu M, 2010, PAIN, V148, P302, DOI 10.1016/j.pain.2009.11.015; Beggs S, 2012, BRAIN, V135, P404, DOI 10.1093/brain/awr288; Biber K, 2011, EMBO J, V30, P1864, DOI 10.1038/emboj.2011.89; Cammermeyer J, 1965, Ergeb Anat Entwicklungsgesch, V38, P1; Clark AK, 2007, EUR J PAIN, V11, P223, DOI 10.1016/j.ejpain.2006.02.003; Coull JAM, 2005, NATURE, V438, P1017, DOI 10.1038/nature04223; Coull JAM, 2003, NATURE, V424, P938, DOI 10.1038/nature01868; de Jong EK, 2008, FASEB J, V22, P4136, DOI 10.1096/fj.07-101907; de Jong EK, 2005, J NEUROSCI, V25, P7548, DOI 10.1523/JNEUROSCI.1019-05.2005; ERIKSSON NP, 1993, EXP BRAIN RES, V96, P19, DOI 10.1007/BF00230435; Fam SR, 2000, J NEUROSCI, V20, P2800; Foley JC, 2011, MOL PAIN, V7, DOI 10.1186/1744-8069-7-93; GEHRMANN J, 1991, RESTOR NEUROL NEUROS, V2, P181, DOI 10.3233/RNN-1991-245605; GRAEBER MB, 1988, NEUROSCI LETT, V85, P317, DOI 10.1016/0304-3940(88)90585-X; Hanisch UK, 2007, NAT NEUROSCI, V10, P1387, DOI 10.1038/nn1997; Honore P, 2000, NEUROSCIENCE, V98, P585, DOI 10.1016/S0306-4522(00)00110-X; JAHR CE, 1983, NATURE, V304, P730, DOI 10.1038/304730a0; Keller AF, 2007, MOL PAIN, V3, DOI 10.1186/1744-8069-3-27; Kettenmann H, 2011, PHYSIOL REV, V91, P461, DOI 10.1152/physrev.00011.2010; Knabl J, 2008, NATURE, V451, P330, DOI 10.1038/nature06493; Kreutzberg GW, 1996, TRENDS NEUROSCI, V19, P312, DOI 10.1016/0166-2236(96)10049-7; Landry RP, 2012, EXP NEUROL, V234, P340, DOI 10.1016/j.expneurol.2011.11.006; Lin T, 2007, J NEUROIMMUNOL, V192, P40, DOI 10.1016/j.jneuroim.2007.09.003; Liu L, 1998, GLIA, V23, P221, DOI 10.1002/(SICI)1098-1136(199807)23:3<221::AID-GLIA5>3.3.CO;2-Z; Milligan ED, 2009, NAT REV NEUROSCI, V10, P23, DOI 10.1038/nrn2533; Nasu-Tada K, 2006, GLIA, V53, P769, DOI 10.1002/glia.20339; Nissl F., 1899, ARCH PSYCHIAT NERVEN, V32, P656; Penfield W., 1965, CYTOLOGY CELLULAR PA; Prescott SA, 2006, MOL PAIN, V2, DOI 10.1186/1744-8069-2-32; Rezaie Payam, 2002, J Hist Neurosci, V11, P325, DOI 10.1076/jhin.11.4.325.8531; Rivest S, 2009, NAT REV IMMUNOL, V9, P429, DOI 10.1038/nri2565; SALTER MW, 1993, PROG NEUROBIOL, V41, P125, DOI 10.1016/0301-0082(93)90006-E; Sorge RE, 2011, J NEUROSCI, V31, P15450, DOI 10.1523/JNEUROSCI.3859-11.2011; Suleman S., 2008, P 12 WORLD C PAIN; Suter MR, 2009, MOL PAIN, V5, DOI 10.1186/1744-8069-5-53; SVENSSON M, 1994, NEUROPATH APPL NEURO, V20, P185; Toyomitsu E, 2012, PURINERG SIGNAL, V8, P301, DOI 10.1007/s11302-011-9288-x; Tozaki-Saitoh H, 2008, J NEUROSCI, V28, P4949, DOI 10.1523/JNEUROSCI.0323-08.2008; Trang T, 2009, J NEUROSCI, V29, P3518, DOI 10.1523/JNEUROSCI.5714-08.2009; Tsuda M, 2003, NATURE, V424, P778, DOI 10.1038/nature01786; Tsuda M, 2008, GLIA, V56, P579, DOI 10.1002/glia.20641; Tsuda M, 2008, GLIA, V56, P50, DOI 10.1002/glia.20591; Tsuda M, 2009, J CELL MOL MED, V13, P3251, DOI 10.1111/j.1582-4934.2009.00719.x; Tsuda M, 2009, MOL PAIN, V5, DOI 10.1186/1744-8069-5-28; Tsuda M, 2009, P NATL ACAD SCI USA, V106, P8032, DOI 10.1073/pnas.0810420106; Ulmann L, 2008, J NEUROSCI, V28, P11263, DOI 10.1523/JNEUROSCI.2308-08.2008; Watkins LR, 2012, EXP NEUROL, V234, P351, DOI 10.1016/j.expneurol.2012.01.006; Yuan HB, 2010, J NEUROSCI RES, V88, P1348, DOI 10.1002/jnr.22304; Zhang J, 2007, J NEUROSCI, V27, P12396, DOI 10.1523/JNEUROSCI.3016-07.2007	50	251	265	2	35	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	AUG	2012	15	8					1068	1073		10.1038/nn.3155	http://dx.doi.org/10.1038/nn.3155			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	979UE	22837036	Green Accepted			2022-12-28	WOS:000306844500007
J	Jocham, G; Hunt, LT; Near, J; Behrens, TEJ				Jocham, Gerhard; Hunt, Laurence T.; Near, Jamie; Behrens, Timothy E. J.			A mechanism for value-guided choice based on the excitation-inhibition balance in prefrontal cortex	NATURE NEUROSCIENCE			English	Article							DECISION-MAKING; ORBITOFRONTAL CORTEX	Although the ventromedial prefrontal cortex (vmPFC) has long been implicated in reward-guided decision making, its exact role in this process has remained an unresolved issue. Here we show that, in accordance with models of decision making, vmPFC concentrations of GABA and glutamate in human volunteers predict both behavioral performance and the dynamics of a neural value comparison signal. These data provide evidence for a neural competition mechanism in vmPFC that supports value-guided choice.	[Jocham, Gerhard; Hunt, Laurence T.; Near, Jamie; Behrens, Timothy E. J.] Univ Oxford, John Radcliffe Hosp, Oxford Ctr Funct MRI Brain, FMRIB Ctr, Oxford OX3 9DU, England; [Hunt, Laurence T.] Univ Oxford, Dept Expt Psychol, Oxford OX1 3UD, England; [Behrens, Timothy E. J.] UCL, Wellcome Trust Ctr Neuroimaging, London, England	University of Oxford; University of Oxford; University of London; University College London	Jocham, G (corresponding author), Univ Oxford, John Radcliffe Hosp, Oxford Ctr Funct MRI Brain, FMRIB Ctr, Oxford OX3 9DU, England.	gjocham@fmrib.ox.ac.uk	Hunt, Laurence/ABA-1691-2021	Hunt, Laurence/0000-0002-8393-8533; Behrens, Timothy/0000-0003-0048-1177	Wellcome Trust Research Career Development fellowship [WT088312AIA]; Wellcome Trust [WT080540MA]; UK Medical Research Council	Wellcome Trust Research Career Development fellowship(Wellcome Trust); Wellcome Trust(Wellcome TrustEuropean Commission); UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by a Wellcome Trust Research Career Development fellowship to T.E.J.B. (WT088312AIA). L.T.H. was supported by a 4-year D.Phil. studentship from the Wellcome Trust (WT080540MA). J.N. is supported by the UK Medical Research Council. We are very grateful to A. Soltani for providing the MATLAB code for the biophysical model. We thank S. Knight for his valuable help in data acquisition.	Bechara A, 2000, BRAIN, V123, P2189, DOI 10.1093/brain/123.11.2189; Boorman ED, 2009, NEURON, V62, P733, DOI 10.1016/j.neuron.2009.05.014; Cai XY, 2011, NEURON, V69, P170, DOI 10.1016/j.neuron.2010.11.041; Gershman SJ, 2009, J NEUROSCI, V29, P13524, DOI 10.1523/JNEUROSCI.2469-09.2009; Hare TA, 2011, P NATL ACAD SCI USA, V108, P18120, DOI 10.1073/pnas.1109322108; Hasler G, 2007, ARCH GEN PSYCHIAT, V64, P193, DOI 10.1001/archpsyc.64.2.193; Hunt LT, 2012, NAT NEUROSCI, V15, P470, DOI 10.1038/nn.3017; Padoa-Schioppa C, 2006, NATURE, V441, P223, DOI 10.1038/nature04676; Ratcliff R, 1998, PSYCHOL SCI, V9, P347, DOI 10.1111/1467-9280.00067; Rushworth MFS, 2011, NEURON, V70, P1054, DOI 10.1016/j.neuron.2011.05.014; Schoenbaum G, 2009, NAT REV NEUROSCI, V10, P885, DOI 10.1038/nrn2753; Stagg CJ, 2011, CURR BIOL, V21, P480, DOI 10.1016/j.cub.2011.01.069; Wong KF, 2006, J NEUROSCI, V26, P1314, DOI 10.1523/JNEUROSCI.3733-05.2006; Wunderlich K, 2009, P NATL ACAD SCI USA, V106, P17199, DOI 10.1073/pnas.0901077106	14	118	118	0	21	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JUL	2012	15	7					960	961		10.1038/nn.3140	http://dx.doi.org/10.1038/nn.3140			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	966EE	22706268	Green Accepted			2022-12-28	WOS:000305819600013
J	Ziegenfuss, JS; Doherty, J; Freeman, MR				Ziegenfuss, Jennifer S.; Doherty, Johnna; Freeman, Marc R.			Distinct molecular pathways mediate glial activation and engulfment of axonal debris after axotomy	NATURE NEUROSCIENCE			English	Article							CELL CORPSE ENGULFMENT; DEAFFERENTATION-INDUCED ALTERATIONS; RAT DORSAL-HORN; APOPTOTIC CELLS; C-ELEGANS; MICROGLIAL CELLS; CRKII/DOCK180/RAC PATHWAY; CAENORHABDITIS-ELEGANS; PERIPHERAL-NERVE; CLEARANCE	Glial cells efficiently recognize and clear cellular debris after nervous system injury to maintain brain homeostasis, but pathways governing glial responses to neural injury remain poorly defined. We identify the Drosophila melanogaster guanine nucleotide exchange factor complex Crk/Mbc/dCed-12 and the small GTPase Rac1 as modulators of glial clearance of axonal debris. We found that Crk/Mbc/dCed-12 and Rac1 functioned in a non-redundant fashion with the Draper transmembrane receptor pathway: loss of either pathway fully suppressed clearance of axonal debris. Draper signaling was required early during glial responses, promoting glial activation, which included increased Draper and dCed-6 expression and extension of glial membranes to degenerating axons. In contrast, the Crk/Mbc/dCed-12 complex functioned at later phases, promoting glial phagocytosis of axonal debris. Our work identifies new components of the glial engulfment machinery and shows that glial activation, phagocytosis of axonal debris and termination of responses to injury are genetically separable events mediated by distinct signaling pathways.	[Ziegenfuss, Jennifer S.; Doherty, Johnna; Freeman, Marc R.] Univ Massachusetts, Sch Med, Dept Neurobiol, Worcester, MA 01605 USA; [Freeman, Marc R.] Univ Massachusetts, Sch Med, Howard Hughes Med Inst, Worcester, MA 01605 USA	University of Massachusetts System; University of Massachusetts Worcester; Howard Hughes Medical Institute; University of Massachusetts System; University of Massachusetts Worcester	Freeman, MR (corresponding author), Univ Massachusetts, Sch Med, Dept Neurobiol, Worcester, MA 01605 USA.	marc.freeman@umassmed.edu		Freeman, Marc/0000-0003-3481-3715	US National Institutes of Health [RO1 NS053538]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS053538] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank P. Rorth (Institute of Molecular and Cell Biology, Singapore), N. Franc, S. Waddell (University of Massachusetts Medical School, Worcester), T. Awasaki (Janelia Farm), H. Hing (University of Illinois, Urbana), Y.-N. Jan (University of California, San Francisco) and Y. Nakanishi (Kanazawa University) for fly strains and antibodies. We thank L. Neukomm and A.N. Fox for critical reading of the manuscript and the entire Freeman laboratory for discussions. This work was supported by US National Institutes of Health grant RO1 NS053538 to M.R.F., and M.R.F. is an Early Career Scientist with the Howard Hughes Medical Institute.	Aldskogius H, 1998, PROG NEUROBIOL, V55, P1, DOI 10.1016/S0301-0082(97)00093-2; Awasaki T, 2006, NEURON, V50, P855, DOI 10.1016/j.neuron.2006.04.027; Bechmann I, 1997, GLIA, V20, P145, DOI 10.1002/(SICI)1098-1136(199706)20:2<145::AID-GLIA6>3.0.CO;2-8; Block ML, 2007, NAT REV NEUROSCI, V8, P57, DOI 10.1038/nrn2038; Brugnera E, 2002, NAT CELL BIOL, V4, P574, DOI 10.1038/ncb824; Cabello J, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000297; Cuadros MA, 1998, PROG NEUROBIOL, V56, P173, DOI 10.1016/S0301-0082(98)00035-5; Doherty J, 2009, J NEUROSCI, V29, P4768, DOI 10.1523/JNEUROSCI.5951-08.2009; Freeman MR, 2003, NEURON, V38, P567, DOI 10.1016/S0896-6273(03)00289-7; Fuentes-Medel Y, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000184; Gumienny TL, 2001, CELL, V107, P27, DOI 10.1016/S0092-8674(01)00520-7; Hasegawa H, 1996, MOL CELL BIOL, V16, P1770; Hoopfer ED, 2006, NEURON, V50, P883, DOI 10.1016/j.neuron.2006.05.013; KAPADIA SE, 1987, J COMP NEUROL, V266, P183, DOI 10.1002/cne.902660205; Kinchen JM, 2007, J CELL SCI, V120, P2143, DOI 10.1242/jcs.03463; Kinchen JM, 2005, NATURE, V434, P93, DOI 10.1038/nature03263; Lalancette-Hebert M, 2007, J NEUROSCI, V27, P2596, DOI 10.1523/JNEUROSCI.5360-06.2007; LAMOTTE CC, 1987, J COMP NEUROL, V266, P198, DOI 10.1002/cne.902660206; Liu QA, 1998, CELL, V93, P961, DOI 10.1016/S0092-8674(00)81202-7; Logan MA, 2007, NEURON GLIA BIOL, V3, P63, DOI [10.1017/S1740925X0700049X, 10.1017/S1740925X07000646]; Logan MA, 2012, NAT NEUROSCI, V15, P722, DOI 10.1038/nn.3066; Luo LQ, 2005, ANNU REV NEUROSCI, V28, P127, DOI 10.1146/annurev.neuro.28.061604.135632; MacDonald JM, 2006, NEURON, V50, P869, DOI 10.1016/j.neuron.2006.04.028; Marin-Teva JL, 1999, J COMP NEUROL, V412, P255; Neumann H, 2009, BRAIN, V132, P288, DOI 10.1093/brain/awn109; Park D, 2007, NATURE, V450, P430, DOI 10.1038/nature06329; Parnaik R, 2000, CURR BIOL, V10, P857, DOI 10.1016/S0960-9822(00)00598-4; Petersen MA, 2004, GLIA, V46, P195, DOI 10.1002/glia.10362; Reddien PW, 2004, ANNU REV CELL DEV BI, V20, P193, DOI 10.1146/annurev.cellbio.20.022003.114619; Reddien PW, 2000, NAT CELL BIOL, V2, P131, DOI 10.1038/35004000; Savill J, 2002, NAT REV IMMUNOL, V2, P965, DOI 10.1038/nri957; Sofroniew MV, 2009, TRENDS NEUROSCI, V32, P638, DOI 10.1016/j.tins.2009.08.002; Williams DW, 2006, NAT NEUROSCI, V9, P1234, DOI 10.1038/nn1774; Wu HH, 2009, NAT NEUROSCI, V12, P1534, DOI 10.1038/nn.2446; Wu YC, 2001, DEV CELL, V1, P491, DOI 10.1016/S1534-5807(01)00056-9; Yu XM, 2008, PLOS BIOL, V6, P581, DOI 10.1371/journal.pbio.0060061; Zhou Z, 2001, DEV CELL, V1, P477, DOI 10.1016/S1534-5807(01)00058-2; Zhou Z, 2001, CELL, V104, P43, DOI 10.1016/S0092-8674(01)00190-8; Ziegenfuss JS, 2008, NATURE, V453, P935, DOI 10.1038/nature06901	39	51	51	0	11	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JUL	2012	15	7					979	987		10.1038/nn.3135	http://dx.doi.org/10.1038/nn.3135			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	966EE	22706267	Green Accepted			2022-12-28	WOS:000305819600016
J	Kim, WJ; Jan, LY; Jan, YN				Kim, Woo Jae; Jan, Lily Yeh; Jan, Yuh Nung			Contribution of visual and circadian neural circuits to memory for prolonged mating induced by rivals	NATURE NEUROSCIENCE			English	Article							MALE DROSOPHILA-MELANOGASTER; SPERM COMPETITION; MOLECULAR OSCILLATIONS; COPULATION DURATION; PLASTIC RESPONSES; ELLIPSOID BODY; PDF CELLS; NEURONS; RHYTHMS; PERIOD	Rival exposure causes Drosophila melanogaster males to prolong mating. Longer mating duration (LMD) may enhance reproductive success, but its underlying mechanism is currently unknown. We found that LMD is context dependent and can be induced solely via visual stimuli. In addition, we found that LMD involves neural circuits that are important for visual memory, including central neurons in the ellipsoid body, but not the mushroom bodies or the fan-shaped bodies, and may rely on the rival exposure memory lasting for several hours. LMD is affected by a subset of learning and memory mutants. LMD depends on the circadian clock genes timeless and period, but not Clock or cycle, and persists in many arrhythmic conditions. Moreover, LMD critically depends on a subset of pigment dispersing factor neurons rather than the entire circadian neural circuit. Our study thus delineates parts of the molecular and cellular basis for LMD, a plastic social behavior elicited by visual cues.	[Kim, Woo Jae; Jan, Lily Yeh; Jan, Yuh Nung] Univ Calif San Francisco, Dept Physiol, Howard Hughes Med Inst, Box 0444, San Francisco, CA 94143 USA; [Kim, Woo Jae; Jan, Lily Yeh; Jan, Yuh Nung] Univ Calif San Francisco, Dept Biochem, San Francisco, CA 94143 USA; [Kim, Woo Jae; Jan, Lily Yeh; Jan, Yuh Nung] Univ Calif San Francisco, Dept Biophys, San Francisco, CA 94143 USA	Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Jan, YN (corresponding author), Univ Calif San Francisco, Dept Physiol, Howard Hughes Med Inst, Box 0444, San Francisco, CA 94143 USA.	yuhnung.jan@ucsf.edu	Kim, Woo Jae/G-1989-2015	Kim, Woo Jae/0000-0002-2826-4177; Jan, Lily/0000-0003-3938-8498; Jan, Yuh Nung/0000-0003-1367-6299	US National Institutes of Health [2R37NS040929]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R37NS040929] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank S. Zhu for the unpublished fly line GAL414-94. We also thank A. Keene, J. Blau, M. Heisenberg, C. Helfrich-Forster, L. Griffith, R. Allada, M. Noll, J. L. Price, A. Sehgal, M. Young, J. D. Armstrong and M. Sato for kindly providing valuable flies. We are grateful to A. Keene for valuable discussion of this project and J. Berg for assisting with the writing of the manuscript. The work was supported by US National Institutes of Health grant 2R37NS040929 to Y.N.J. L.Y.J. and Y.N.J. are investigators of the Howard Hughes Medical Institute.	Beaver LM, 2004, CURR BIOL, V14, P1492, DOI 10.1016/j.cub.2004.08.022; Bretman A, 2011, CURR BIOL, V21, P617, DOI 10.1016/j.cub.2011.03.008; Bretman A, 2010, BEHAV ECOL, V21, P317, DOI 10.1093/beheco/arp189; Bretman A, 2009, P ROY SOC B-BIOL SCI, V276, P1705, DOI 10.1098/rspb.2008.1878; Choi C, 2010, CURR BIOL, V20, pR322, DOI 10.1016/j.cub.2010.02.036; Cook T, 2003, DEV CELL, V4, P853, DOI 10.1016/S1534-5807(03)00156-4; Darwin C., 1871, P475; De Crespigny FEC, 2006, J EVOLUTION BIOL, V19, P1964, DOI 10.1111/j.1420-9101.2006.01143.x; Emery P, 2000, NATURE, V404, P456, DOI 10.1038/35006558; Glaser FT, 2005, CURR BIOL, V15, P1352, DOI 10.1016/j.cub.2005.06.056; Gong ZF, 1998, J INSECT PHYSIOL, V44, P1149, DOI 10.1016/S0022-1910(98)00076-6; Guo A, 1997, LEARN MEMORY, V4, P192, DOI 10.1101/lm.4.2.192; Hall JC, 2005, METHOD ENZYMOL, V393, P61, DOI 10.1016/S0076-6879(05)93004-8; Hasegawa E, 2011, DEVELOPMENT, V138, P983, DOI 10.1242/dev.058370; Heisenberg M, 2003, NAT REV NEUROSCI, V4, P266, DOI 10.1038/nrn1074; Keene AC, 2010, CURR BIOL, V20, P1209, DOI 10.1016/j.cub.2010.05.029; Kent C, 2008, CURR BIOL, V18, P1384, DOI 10.1016/j.cub.2008.07.088; Kim YK, 2010, HANDBOOK OF BEHAVIOR GENETICS, P317, DOI 10.1007/978-0-387-76727-7_22; Koref-Santibanez S, 2001, BEHAV GENET, V31, P287, DOI 10.1023/A:1012279325621; Krstic D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004457; Krupp JJ, 2008, CURR BIOL, V18, P1373, DOI 10.1016/j.cub.2008.07.089; Lee T, 1999, NEURON, V22, P451, DOI 10.1016/S0896-6273(00)80701-1; Lefranc A, 2000, HEREDITAS, V132, P243, DOI 10.1111/j.1601-5223.2000.00243.x; Liu G, 2006, NATURE, V439, P551, DOI 10.1038/nature04381; Luck N, 2005, J INSECT SCI, V5, DOI 10.1093/jis/5.1.10; MACBEAN IT, 1967, GENETICS, V56, P233; Markow TA, 1996, EVOL BIOL, V29, P73; Mazzi D, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-132; MENNE D, 1977, J COMP PHYSIOL, V114, P301, DOI 10.1007/BF00657325; Nitabach MN, 2006, J NEUROSCI, V26, P479, DOI 10.1523/JNEUROSCI.3915-05.2006; Nitabach MN, 2002, CELL, V109, P485, DOI 10.1016/S0092-8674(02)00737-7; Pan YF, 2009, LEARN MEMORY, V16, P289, DOI 10.1101/lm.1331809; Parisky KM, 2008, NEURON, V60, P672, DOI 10.1016/j.neuron.2008.10.042; PARKER GA, 1970, BIOL REV, V45, P525, DOI 10.1111/j.1469-185X.1970.tb01176.x; Peschel N, 2011, FEBS LETT, V585, P1435, DOI 10.1016/j.febslet.2011.02.028; Popodi E., 2010, FLYBASE         0302; Preuss F, 2004, MOL CELL BIOL, V24, P886, DOI 10.1128/MCB.24.2.886-898.2004; Renn SCP, 1999, J NEUROBIOL, V41, P189; Ridley M, 1999, NATURE, V397, P576, DOI 10.1038/17518; Rieger D, 2009, J BIOL RHYTHM, V24, P271, DOI 10.1177/0748730409338508; Shafer OT, 2006, J COMP NEUROL, V498, P180, DOI 10.1002/cne.21021; Shang YH, 2008, P NATL ACAD SCI USA, V105, P19587, DOI 10.1073/pnas.0809577105; STOCKER RF, 1994, CELL TISSUE RES, V275, P3, DOI 10.1007/BF00305372; Tanoue S, 2004, CURR BIOL, V14, P638, DOI 10.1016/j.cub.2004.04.009; von Lintig J, 2001, P NATL ACAD SCI USA, V98, P1130, DOI 10.1073/pnas.031576398; Yamaguchi S, 2008, P NATL ACAD SCI USA, V105, P4910, DOI 10.1073/pnas.0711484105; Yang CH, 2009, NEURON, V61, P519, DOI 10.1016/j.neuron.2008.12.021; Yang ZH, 2001, NEURON, V29, P453, DOI 10.1016/S0896-6273(01)00218-5; Zhang LY, 2010, CURR BIOL, V20, P591, DOI 10.1016/j.cub.2010.02.056; Zheng XZ, 2008, GENETICS, V178, P1147, DOI 10.1534/genetics.107.088658	50	29	30	0	27	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUN	2012	15	6					876	+		10.1038/nn.3104	http://dx.doi.org/10.1038/nn.3104			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	949AI	22561453	Green Accepted, Green Submitted			2022-12-28	WOS:000304546700015
J	Vincis, R; Gschwend, O; Bhaukaurally, K; Beroud, J; Carleton, A				Vincis, Roberto; Gschwend, Olivier; Bhaukaurally, Khaleel; Beroud, Jonathan; Carleton, Alan			Dense representation of natural odorants in the mouse olfactory bulb	NATURE NEUROSCIENCE			English	Article							GLOMERULI; TOPOGRAPHY	In mammals, odorant molecules are thought to activate only a few glomeruli, leading to the hypothesis that odor representation in the olfactory bulb is sparse. However, the studies supporting this model used anesthetized animals or monomolecular odorants at limited concentration ranges. Using optical imaging and two-photon microscopy, we found that natural odorants at their native concentrations could elicit dense representations in the olfactory bulb. Both anesthesia and odorant concentration were found to modulate the representation density of natural odorants.	[Vincis, Roberto; Gschwend, Olivier; Bhaukaurally, Khaleel; Beroud, Jonathan; Carleton, Alan] Univ Geneva, Sch Med, Dept Basic Neurosci, CH-1211 Geneva, Switzerland; [Vincis, Roberto; Gschwend, Olivier; Bhaukaurally, Khaleel; Beroud, Jonathan; Carleton, Alan] Univ Geneva, Geneva Neurosci Ctr, Geneva, Switzerland	University of Geneva; University of Geneva	Carleton, A (corresponding author), Univ Geneva, Sch Med, Dept Basic Neurosci, CH-1211 Geneva, Switzerland.	alan.carleton@unige.ch	Vincis, Roberto/R-6469-2016; Carleton, Alan/C-9721-2010	Vincis, Roberto/0000-0002-5812-7624; Carleton, Alan/0000-0001-5633-9159	Swiss National Science Foundation (SNF) [PP0033_119169]; University of Geneva; European Research Council [ERC-2009-StG-243344-NEUROCHEMS]; Novartis foundation for medical research; Leenaards foundation; European Molecular Biology Organization	Swiss National Science Foundation (SNF)(Swiss National Science Foundation (SNSF)); University of Geneva; European Research Council(European Research Council (ERC)European Commission); Novartis foundation for medical research; Leenaards foundation; European Molecular Biology Organization(European Molecular Biology Organization (EMBO))	We thank I. Rodriguez for kindly providing the Omp-GFP mice. We thank I. Rodriguez, A. Holtmaat, S. Simon, M. Patterson and members of the Carleton laboratory for helpful discussions and comments on the manuscript. This work was supported by the Swiss National Science Foundation (SNF professor grant number PP0033_119169 and National Competence Center in Research "SYNAPSY"), the University of Geneva, the European Research Council (contract number ERC-2009-StG-243344-NEUROCHEMS), the Novartis foundation for medical research, the Leenaards foundation and the European Molecular Biology Organization (young investigator program).	Abraham NM, 2004, NEURON, V44, P865, DOI 10.1016/j.neuron.2004.11.017; Bathellier B, 2008, NEURON, V57, P586, DOI 10.1016/j.neuron.2008.02.011; Bathellier B, 2007, NEUROIMAGE, V34, P1020, DOI 10.1016/j.neuroimage.2006.10.038; Belluscio L, 2001, J NEUROSCI, V21, P2113, DOI 10.1523/JNEUROSCI.21-06-02113.2001; Bozza T, 2004, NEURON, V42, P9, DOI 10.1016/S0896-6273(04)00144-8; Davison IG, 2011, NEURON, V70, P82, DOI 10.1016/j.neuron.2011.02.047; Fantana AL, 2008, NEURON, V59, P802, DOI 10.1016/j.neuron.2008.07.039; Fried HU, 2002, P NATL ACAD SCI USA, V99, P3222, DOI 10.1073/pnas.052658399; Lin DY, 2006, NEURON, V50, P937, DOI 10.1016/j.neuron.2006.03.021; Meister M, 2001, J NEUROSCI, V21, P1351; Potter SM, 2001, J NEUROSCI, V21, P9713, DOI 10.1523/JNEUROSCI.21-24-09713.2001; Rubin BD, 1999, NEURON, V23, P499, DOI 10.1016/S0896-6273(00)80803-X; Spors H, 2002, NEURON, V34, P301, DOI 10.1016/S0896-6273(02)00644-X; Uchida N, 2000, NAT NEUROSCI, V3, P1035, DOI 10.1038/79857; Wachowiak M, 2001, NEURON, V32, P723, DOI 10.1016/S0896-6273(01)00506-2	15	60	60	0	16	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	APR	2012	15	4					537	539		10.1038/nn.3057	http://dx.doi.org/10.1038/nn.3057			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	916PA	22406552	Green Accepted			2022-12-28	WOS:000302114500011
J	Saha, D; Leong, K; Li, C; Peterson, S; Siegel, G; Raman, B				Saha, Debajit; Leong, Kevin; Li, Chao; Peterson, Steven; Siegel, Gregory; Raman, Baranidharan			A spatiotemporal coding mechanism for backgroundinvariant odor recognition	NATURE NEUROSCIENCE			English	Article							FIRING PATTERNS; SINGLE NEURONS; OLFACTORY-BULB; SENSORY INPUT; DYNAMICS; REPRESENTATIONS; DISCRIMINATION; ACCURACY; STIMULUS; SPEED	Sensory stimuli evoke neural activity that evolves over time. What features of these spatiotemporal responses allow the robust encoding of stimulus identity in a multistimulus environment? Here we examined this issue in the locust (Schistocerca americana) olfactory system. We found that sensory responses evoked by an odorant (foreground) varied when presented atop or after an ongoing stimulus (background). These inconsistent sensory inputs triggered dynamic reorganization of ensemble activity in the downstream antennal lobe. As a result, partial pattern matches between neural representations encoding the same foreground stimulus across conditions were achieved. The degree and segments of response overlaps varied; however, any overlap observed was sufficient to drive background-independent responses in the downstream neural population. Notably, recognition performance of locusts in behavioral assays correlated well with our physiological findings. Hence, our results reveal how background-independent recognition of odors can be achieved using spatiotemporal patterns of neural activity.	[Saha, Debajit; Leong, Kevin; Li, Chao; Peterson, Steven; Siegel, Gregory; Raman, Baranidharan] Washington Univ, Dept Biomed Engn, St Louis, MO 63130 USA	Washington University (WUSTL)	Raman, B (corresponding author), Washington Univ, Dept Biomed Engn, St Louis, MO 63130 USA.	barani@wustl.edu		Peterson, Steven/0000-0003-0782-5788; Raman, Baranidharan/0000-0002-7866-155X	McDonnell Center for Systems Neuroscience; Office of Naval Research [N00014-12-1-0089]; Department of Biomedical Engineering at Washington University	McDonnell Center for Systems Neuroscience; Office of Naval Research(Office of Naval Research); Department of Biomedical Engineering at Washington University	We thank N. Katta for performing double-blind behavior evaluation studies and D. Yang for help with behavioral experiments. We thank F. Gabbiani (Baylor College of Medicine), M. Stopfer and S. Reiter (Eunice Kennedy Shriver National Institute of Child Health and Human Development, US National Institutes of Health), D. Barbour, R. Wessel and members of Raman Lab (Washington University, St. Louis) for comments on previous versions of the manuscript. This research was supported by a McDonnell Center for Systems Neuroscience grant, an Office of Naval Research grant (N00014-12-1-0089) and startup funds from the Department of Biomedical Engineering at Washington University, St. Louis to B.R.	Abraham NM, 2004, NEURON, V44, P865, DOI 10.1016/j.neuron.2004.11.017; Ahissar E, 1997, P NATL ACAD SCI USA, V94, P11633, DOI 10.1073/pnas.94.21.11633; BAKER TC, 1989, PHYSIOL ENTOMOL, V14, P1, DOI 10.1111/j.1365-3032.1989.tb00931.x; Bathellier B, 2008, NEURON, V57, P586, DOI 10.1016/j.neuron.2008.02.011; Broome BM, 2006, NEURON, V51, P467, DOI 10.1016/j.neuron.2006.07.018; Brown SL, 2005, NAT NEUROSCI, V8, P1568, DOI 10.1038/nn1559; Carlson BA, 2009, J NEUROSCI, V29, P9417, DOI 10.1523/JNEUROSCI.1980-09.2009; Dayan P, 2001, COMPUTATIONAL NEUROS; De Palo G, 2013, SCI REP-UK, V3, DOI 10.1038/srep01251; Di Lorenzo PM, 2009, J NEUROSCI, V29, P9227, DOI 10.1523/JNEUROSCI.5995-08.2009; Ditzen M, 2003, CHEM SENSES, V28, P781, DOI 10.1093/chemse/bjg070; Friedrich RW, 2001, SCIENCE, V291, P889, DOI 10.1126/science.291.5505.889; Galan RF, 2004, NEURAL COMPUT, V16, P999, DOI 10.1162/089976604773135078; Griffiths TD, 2001, NAT NEUROSCI, V4, P633, DOI 10.1038/88459; Ito I, 2008, NAT NEUROSCI, V11, P1177, DOI 10.1038/nn.2192; Ito I, 2009, NEURON, V64, P692, DOI 10.1016/j.neuron.2009.10.004; Jones LM, 2007, P NATL ACAD SCI USA, V104, P18772, DOI 10.1073/pnas.0705546104; Kreher SA, 2008, NEURON, V59, P110, DOI 10.1016/j.neuron.2008.06.010; LAING DG, 1994, BRAIN RES, V651, P317, DOI 10.1016/0006-8993(94)90712-9; Laurent G, 1996, J NEUROSCI, V16, P3837; Machens CK, 2001, J NEUROSCI, V21, P3215, DOI 10.1523/JNEUROSCI.21-09-03215.2001; Martelli C, 2013, J NEUROSCI, V33, P6285, DOI 10.1523/JNEUROSCI.0426-12.2013; Mazor O, 2005, NEURON, V48, P661, DOI 10.1016/j.neuron.2005.09.032; MEREDITH M, 1978, J GEN PHYSIOL, V71, P615, DOI 10.1085/jgp.71.6.615; Nagel KI, 2011, NAT NEUROSCI, V14, P208, DOI 10.1038/nn.2725; Perez-Orive J, 2002, SCIENCE, V297, P359, DOI 10.1126/science.1070502; Raman B, 2010, J NEUROSCI, V30, P1994, DOI 10.1523/JNEUROSCI.5639-09.2010; Rinberg D, 2006, NEURON, V51, P351, DOI 10.1016/j.neuron.2006.07.013; Roweis ST, 2000, SCIENCE, V290, P2323, DOI 10.1126/science.290.5500.2323; Schnitzer MJ, 2003, NEURON, V37, P499, DOI 10.1016/S0896-6273(03)00004-7; Seifritz E, 2002, SCIENCE, V297, P1706, DOI 10.1126/science.1074355; Simoes P, 2011, J EXP BIOL, V214, P2495, DOI 10.1242/jeb.055806; Smear M, 2011, NATURE, V479, P397, DOI 10.1038/nature10521; Spors H, 2006, J NEUROSCI, V26, P1247, DOI 10.1523/JNEUROSCI.3100-05.2006; Spors H, 2002, NEURON, V34, P301, DOI 10.1016/S0896-6273(02)00644-X; Stopfer M, 1997, NATURE, V390, P70, DOI 10.1038/36335; Stopfer M, 2003, NEURON, V39, P991, DOI 10.1016/j.neuron.2003.08.011; Uchida N, 2003, NAT NEUROSCI, V6, P1224, DOI 10.1038/nn1142; Vickers NJ, 2001, NATURE, V410, P466, DOI 10.1038/35068559	39	59	59	1	31	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	DEC	2013	16	12					1830	1839		10.1038/nn.3570	http://dx.doi.org/10.1038/nn.3570			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	257VV	24185426				2022-12-28	WOS:000327416800021
J	Justinova, Z; Mascia, P; Wu, HQ; Secci, ME; Redhi, GH; Panlilio, LV; Scherma, M; Barnes, C; Parashos, A; Zara, T; Fratta, W; Solinas, M; Pistis, M; Bergman, J; Kangas, BD; Ferre, S; Tanda, G; Schwarcz, R; Goldberg, SR				Justinova, Zuzana; Mascia, Paola; Wu, Hui-Qiu; Secci, Maria E.; Redhi, Godfrey H.; Panlilio, Leigh V.; Scherma, Maria; Barnes, Chanel; Parashos, Alexandra; Zara, Tamara; Fratta, Walter; Solinas, Marcell; Pistis, Marco; Bergman, Jack; Kangas, Brian D.; Ferre, Sergi; Tanda, Gianluigi; Schwarcz, Robert; Goldberg, Steven R.			Reducing cannabinoid abuse and preventing relapse by enhancing endogenous brain levels of kynurenic acid	NATURE NEUROSCIENCE			English	Article							NICOTINIC ACETYLCHOLINE-RECEPTORS; VENTRAL TEGMENTAL AREA; NUCLEUS-ACCUMBENS; 3-MONOOXYGENASE INHIBITION; SYNAPTIC-TRANSMISSION; GLUTAMATE RELEASE; MAMMALIAN BRAIN; WORKING-MEMORY; BINDING-SITES; DOPAMINE	In the reward circuitry of the brain, alpha-7-nicotinic acetylcholine receptors (alpha 7nAChRs) modulate effects of Delta(9)-tetrahydrocannabinol (THC), marijuana's main psychoactive ingredient. Kynurenic acid (KYNA) is an endogenous negative allosteric modulator of alpha 7nAChRs. Here we report that the kynurenine 3-monooxygenase (KMO) inhibitor Ro 61-8048 increases brain KYNA levels and attenuates cannabinoid-induced increases in extracellular dopamine in reward-related brain areas. In the self-administration model of drug abuse, Ro 61-8048 reduced the rewarding effects of THC and the synthetic cannabinoid WIN 55,212-2 in squirrel monkeys and rats, respectively, and it also prevented relapse to drug-seeking induced by reexposure to cannabinoids or cannabinoid-associated cues. The effects of enhancing endogenous KYNA levels with Ro 61-8048 were prevented by positive allosteric modulators of alpha 7nAChRs. Despite a clear need, there are no medications approved for treatment of marijuana dependence. Modulation of KYNA offers a pharmacological strategy for achieving abstinence from marijuana and preventing relapse.	[Justinova, Zuzana; Mascia, Paola; Secci, Maria E.; Redhi, Godfrey H.; Panlilio, Leigh V.; Barnes, Chanel; Parashos, Alexandra; Goldberg, Steven R.] NIDA, Preclin Pharmacol Sect, Behav Neurosci Res Branch, Intramural Res Program,NIH,Dept Hlth & Human Serv, Baltimore, MD USA; [Justinova, Zuzana; Wu, Hui-Qiu; Schwarcz, Robert] Univ Maryland, Sch Med, Dept Psychiat, Maryland Psychiat Res Ctr, Baltimore, MD 21201 USA; [Scherma, Maria; Zara, Tamara; Fratta, Walter; Pistis, Marco] Univ Cagliari, Dept Biomed Sci, Sect Neurosci & Clin Pharmacol, Monserrato, Italy; [Solinas, Marcell] INSERM, U1084, Expt & Clin Neurosci Lab, Neurobiol & Neuropharmacol Addict Grp, Poitiers, France; [Solinas, Marcell] Univ Poitiers, Poitiers, France; [Pistis, Marco] CNR, Neurosci Inst, Cagliari, Italy; [Bergman, Jack; Kangas, Brian D.] Harvard Univ, Sch Med, McLean Hosp, Belmont, MA 02178 USA; [Ferre, Sergi] NIDA, Integrat Neurobiol Sect, Mol Targets & Medicat Discovery Branch, Intramural Res Program,NIH,Dept Hlth & Human Serv, Baltimore, MD USA; [Tanda, Gianluigi] NIDA, Psychobiol Sect, Mol Targets & Medicat Discovery Branch, Intramural Res Program,NIH,Dept Hlth & Human Serv, Baltimore, MD USA	National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); NIH National Institute on Drug Abuse (NIDA); University System of Maryland; University of Maryland Baltimore; University of Cagliari; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Poitiers; Universite de Poitiers; Consiglio Nazionale delle Ricerche (CNR); Harvard University; McLean Hospital; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); NIH National Institute on Drug Abuse (NIDA); National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); NIH National Institute on Drug Abuse (NIDA)	Goldberg, SR (corresponding author), NIDA, Preclin Pharmacol Sect, Behav Neurosci Res Branch, Intramural Res Program,NIH,Dept Hlth & Human Serv, Baltimore, MD USA.	sgoldber@mail.nih.gov	Tanda, Gianluigi/Q-4976-2019; Schwarcz, Robert/P-3134-2018; Ferre, Sergi/K-6115-2014; Solinas, Marcello/M-3500-2016; Tanda, Gianluigi/B-3318-2009; Scherma, Maria/AAJ-7294-2020; Pistis, Marco/A-3773-2013; Justinova, Zuzana/A-9109-2011	Tanda, Gianluigi/0000-0001-9526-9878; Ferre, Sergi/0000-0002-1747-1779; Solinas, Marcello/0000-0002-0664-5964; Tanda, Gianluigi/0000-0001-9526-9878; Pistis, Marco/0000-0002-4622-3205; Justinova, Zuzana/0000-0001-5793-7484	National Institute on Drug Abuse (NIDA), National Institutes of Health, Department of Health and Human Services, NIDA Residential Research Support Services [N01 DA59909]; Italian Ministry of University and Scientific Research [DA023142, DA035974]; Maryland Psychiatric Research Center, Department of Psychiatry, University of Maryland School of Medicine; Regione Autonoma della Sardegna; European Social Fund [LR7 2007]; NATIONAL INSTITUTE ON DRUG ABUSE [ZIADA000001, ZIADA000569, ZIADA000003, ZIADA000493, R37DA023142, K01DA035974] Funding Source: NIH RePORTER	National Institute on Drug Abuse (NIDA), National Institutes of Health, Department of Health and Human Services, NIDA Residential Research Support Services; Italian Ministry of University and Scientific Research(Ministry of Education, Universities and Research (MIUR)); Maryland Psychiatric Research Center, Department of Psychiatry, University of Maryland School of Medicine; Regione Autonoma della Sardegna(Regione Sardegna); European Social Fund(European Social Fund (ESF)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank E. Thorndike for excellent technical assistance during the rodent studies. We thank I. Baum, S. Stevens and P. White for excellent veterinary assistance during the primate studies. This study was supported in part by the Intramural Research Program of the National Institute on Drug Abuse (NIDA), National Institutes of Health, Department of Health and Human Services, NIDA Residential Research Support Services Contract N01 DA59909 (principal investigator D. Kelly), by the Italian Ministry of University and Scientific Research, by DA023142 (J.B.) and DA035974 (B.D.K.) and by the Maryland Psychiatric Research Center, Department of Psychiatry, University of Maryland School of Medicine. T.Z. was supported by a Grant from Regione Autonoma della Sardegna and by the European Social Fund, LR7 2007.	Alkondon M, 2004, J NEUROSCI, V24, P4635, DOI 10.1523/JNEUROSCI.5631-03.2004; Amaral M, 2013, NATURE, V496, P382, DOI 10.1038/nature12039; Amori L, 2009, NEUROSCIENCE, V159, P196, DOI 10.1016/j.neuroscience.2008.11.055; Arias HR, 2010, ADV PROTEIN CHEM STR, V80, P153, DOI [10.1016/S1876-1623(10)80005-7, 10.1016/B978-0-12-381264-3.00005-9]; Arias HR, 2009, INT J BIOCHEM CELL B, V41, P1441, DOI 10.1016/j.biocel.2009.01.013; Bertrand D, 2008, MOL PHARMACOL, V74, P1407, DOI 10.1124/mol.107.042820; Carpenedo R, 2001, EUR J NEUROSCI, V13, P2141, DOI 10.1046/j.0953-816x.2001.01592.x; CHEN JP, 1990, PSYCHOPHARMACOLOGY, V102, P156, DOI 10.1007/BF02245916; Chess AC, 2007, SCHIZOPHRENIA BULL, V33, P797, DOI 10.1093/schbul/sbl033; Christopoulos A, 2002, NAT REV DRUG DISCOV, V1, P198, DOI 10.1038/nrd746; Cozzi A, 1999, J CEREBR BLOOD F MET, V19, P771, DOI 10.1097/00004647-199907000-00007; Dani JA, 2007, ANNU REV PHARMACOL, V47, P699, DOI 10.1146/annurev.pharmtox.47.120505.105214; Diana M, 1998, EUR J NEUROSCI, V10, P2825, DOI 10.1111/j.1460-9568.1998.00292.x; French ED, 1997, NEUROREPORT, V8, P649, DOI 10.1097/00001756-199702100-00014; Fu YT, 2000, J PHARMACOL EXP THER, V294, P458; FUKUI S, 1991, J NEUROCHEM, V56, P2007, DOI 10.1111/j.1471-4159.1991.tb03460.x; Gardner EL, 2005, PHARMACOL BIOCHEM BE, V81, P263, DOI 10.1016/j.pbb.2005.01.032; Gregoire L, 2008, BEHAV BRAIN RES, V186, P161, DOI 10.1016/j.bbr.2007.08.007; Hilmas C, 2001, J NEUROSCI, V21, P7463, DOI 10.1523/JNEUROSCI.21-19-07463.2001; Hurst RS, 2005, J NEUROSCI, V25, P4396, DOI 10.1523/JNEUROSCI.5269-04.2005; Justinova Z, 2003, PSYCHOPHARMACOLOGY, V169, P135, DOI 10.1007/s00213-003-1484-0; Justinova Z, 2008, BIOL PSYCHIAT, V64, P930, DOI 10.1016/j.biopsych.2008.08.008; Kaiser S, 2000, MOL PHARMACOL, V58, P312, DOI 10.1124/mol.58.2.312; KESSLER M, 1989, J NEUROCHEM, V52, P1319, DOI 10.1111/j.1471-4159.1989.tb01881.x; Kiss C, 2003, J NEURAL TRANSM, V110, P1, DOI 10.1007/s00702-002-0770-z; Le Foll B, 2009, PSYCHOPHARMACOLOGY, V205, P171, DOI 10.1007/s00213-009-1506-7; Lopes C, 2007, J PHARMACOL EXP THER, V322, P48, DOI 10.1124/jpet.107.123109; MORONI F, 1988, J NEUROCHEM, V51, P177, DOI 10.1111/j.1471-4159.1988.tb04852.x; Moroni F, 1999, EUR J PHARMACOL, V375, P87, DOI 10.1016/S0014-2999(99)00196-X; Navarrete M, 2010, NEURON, V68, P113, DOI 10.1016/j.neuron.2010.08.043; Panlilio LV, 2012, BRIT J PHARMACOL, V165, P2529, DOI 10.1111/j.1476-5381.2011.01554.x; PERKINS MN, 1982, BRAIN RES, V247, P184, DOI 10.1016/0006-8993(82)91048-4; Pistis M, 2002, EUR J NEUROSCI, V15, P1795, DOI 10.1046/j.1460-9568.2002.02019.x; Pistis M, 2001, EUR J NEUROSCI, V14, P96, DOI 10.1046/j.0953-816x.2001.01612.x; Pocivavsek A, 2011, NEUROPSYCHOPHARMACOL, V36, P2357, DOI 10.1038/npp.2011.127; Rassoulpour A, 2005, J NEUROCHEM, V93, P762, DOI 10.1111/j.1471-4159.2005.03134.x; Roegge C. S., 2006, ANIMAL MODELS COGNIT; Rover S, 1997, J MED CHEM, V40, P4378, DOI 10.1021/jm970467t; Schwarcz R, 2012, NAT REV NEUROSCI, V13, P465, DOI 10.1038/nrn3257; Solinas M, 2008, BRIT J PHARMACOL, V154, P369, DOI 10.1038/bjp.2008.130; Solinas M, 2007, J NEUROSCI, V27, P5615, DOI 10.1523/JNEUROSCI.0027-07.2007; Substance Abuse and Mental Health Services Administration, 2009, RES 2009 NAT SURV DR, VI; Tanda G, 1997, SCIENCE, V276, P2048, DOI 10.1126/science.276.5321.2048; TURSKI WA, 1988, EXP BRAIN RES, V71, P563, DOI 10.1007/BF00248748; TURSKI WA, 1989, J NEUROCHEM, V52, P1629, DOI 10.1111/j.1471-4159.1989.tb09218.x; Uwai Y, 2012, PHARMACOL RES, V65, P254, DOI 10.1016/j.phrs.2011.11.003; Weinstein AM, 2011, CURR PHARM DESIGN, V17, P1351; Wu HQ, 2010, J MOL NEUROSCI, V40, P204, DOI 10.1007/s12031-009-9235-2; Zmarowski A, 2009, EUR J NEUROSCI, V29, P529, DOI 10.1111/j.1460-9568.2008.06594.x; Zwilling D, 2011, CELL, V145, P863, DOI 10.1016/j.cell.2011.05.020	50	59	61	0	20	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	NOV	2013	16	11					1652	1661		10.1038/nn.3540	http://dx.doi.org/10.1038/nn.3540			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	241YX	24121737	Green Submitted, Green Accepted			2022-12-28	WOS:000326205700023
J	Hayama, T; Noguchi, J; Watanabe, S; Takahashi, N; Hayashi-Takagi, A; Ellis-Davies, GCR; Matsuzaki, M; Kasai, H				Hayama, Tatsuya; Noguchi, Jun; Watanabe, Satoshi; Takahashi, Noriko; Hayashi-Takagi, Akiko; Ellis-Davies, Graham C. R.; Matsuzaki, Masanori; Kasai, Haruo			GABA promotes the competitive selection of dendritic spines by controlling local Ca2+ signaling	NATURE NEUROSCIENCE			English	Article							LONG-TERM DEPRESSION; TIMING-DEPENDENT PLASTICITY; CRITICAL PERIOD PLASTICITY; STRUCTURAL PLASTICITY; SYNAPTIC PLASTICITY; CALCIUM-BINDING; 2-PHOTON; GLUTAMATE; MEMORY; LTD	Activity-dependent competition of synapses plays a key role in neural organization and is often promoted by GABA; however, its cellular bases are poorly understood. Excitatory synapses of cortical pyramidal neurons are formed on small protrusions known as dendritic spines, which exhibit structural plasticity. We used two-color uncaging of glutamate and GABA in rat hippocampal CA1 pyramidal neurons and found that spine shrinkage and elimination were markedly promoted by the activation of GABA(A) receptors shortly before action potentials. GABA(ergic) inhibition suppressed bulk increases in cytosolic Ca2+ concentrations, whereas it preserved the Ca2+ nanodomains generated by NMDA-type receptors, both of which were necessary for spine shrinkage. Unlike spine enlargement, spine shrinkage spread to neighboring spines (< 15 mu m) and competed with their enlargement, and this process involved the actin-depolymerizing factor ADF/cofilin. Thus, GABA(ergic) inhibition directly suppresses local dendritic Ca2+ transients and strongly promotes the competitive selection of dendritic spines.	[Hayama, Tatsuya; Noguchi, Jun; Watanabe, Satoshi; Takahashi, Noriko; Hayashi-Takagi, Akiko; Kasai, Haruo] Univ Tokyo, Fac Med, Ctr Dis Biol & Integrat Med, Lab Struct Physiol,Bunkyo Ku, Tokyo 113, Japan; [Hayama, Tatsuya; Noguchi, Jun; Watanabe, Satoshi; Takahashi, Noriko; Hayashi-Takagi, Akiko; Matsuzaki, Masanori; Kasai, Haruo] Japan Sci & Technol Agcy, CREST, Kawaguchi, Saitama, Japan; [Hayashi-Takagi, Akiko; Matsuzaki, Masanori] Japan Sci & Technol Agcy, PRESTO, Kawaguchi, Saitama, Japan; [Ellis-Davies, Graham C. R.] Mt Sinai Sch Med, Dept Neurosci, New York, NY USA; [Matsuzaki, Masanori] Grad Univ Adv Studies Sokendai, Natl Inst Basic Biol, Div Brain Circuits, Okazaki, Aichi, Japan	University of Tokyo; Japan Science & Technology Agency (JST); Japan Science & Technology Agency (JST); Icahn School of Medicine at Mount Sinai; Graduate University for Advanced Studies - Japan; National Institutes of Natural Sciences (NINS) - Japan; National Institute for Basic Biology (NIBB)	Kasai, H (corresponding author), Univ Tokyo, Fac Med, Ctr Dis Biol & Integrat Med, Lab Struct Physiol,Bunkyo Ku, Tokyo 113, Japan.	hkasai@m.u-tokyo.ac.jp	Takahashi, Noriko/AAL-1011-2020	Noguchi, Jun/0000-0002-8350-791X; Kasai, Haruo/0000-0003-2327-9027; Matsuzaki, Masanori/0000-0003-3872-4322	Ministry of Education, Culture, Sports, Science, and Technology of Japan [21000009, 21500367, 20021008, 19680020, 22115005]; US National Institutes of Health [GM53395, NS69720]; Mitsubishi Foundation; Human Frontier Science Program; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM053395] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS069720] Funding Source: NIH RePORTER; Grants-in-Aid for Scientific Research [21000009, 24116003] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Mitsubishi Foundation; Human Frontier Science Program(Human Frontier Science Program); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank K. Mizuno, K. Ohashi, G.J. Augustine, C.O'Donnell, S. Okabe and J. Eilers for discussions and C. Maeda, M. Ogasawara, H. Ohno, M. Ishikawa and K. Tamura for technical assistance. This work was supported by Grants-in-Aid for Specially Promoted Area (no. 21000009 to H.K.), Scientific Research (C) (no. 21500367 to J.N.), Scientific Research on Priority Areas ('Elucidation of neural network function in the brain', no. 20021008 to M.M.), Young Scientist (A) (no. 19680020 to M.M.), Scientific Research on Innovative Areas 'Mesoscopic Neurocircuitry' (no. 22115005 to M.M.), the Global COE Program ('Integrative Life Science based on the study of Biosignaling Mechanisms' to H.K.) and the Strategic Research Program for Brain Sciences ('Neuroinformatics of Emotion' to H.K.) from the Ministry of Education, Culture, Sports, Science, and Technology of Japan and by the US National Institutes of Health (grants GM53395 and NS69720 to G.C.R.E.-D.). In addition, this work was supported by a Mitsubishi Foundation grant to M.M. and a Research Grant from the Human Frontier Science Program to H.K.	ABRAHAM WC, 1991, BRAIN RES, V546, P336, DOI 10.1016/0006-8993(91)91498-P; ABRAHAM WC, 1983, NATURE, V305, P717, DOI 10.1038/305717a0; ADLER EM, 1991, J NEUROSCI, V11, P1496; Bai DL, 2001, MOL PHARMACOL, V59, P814, DOI 10.1124/mol.59.4.814; Bernstein BW, 2010, TRENDS CELL BIOL, V20, P187, DOI 10.1016/j.tcb.2010.01.001; BIENENSTOCK EL, 1982, J NEUROSCI, V2, P32, DOI 10.1523/jneurosci.02-01-00032.1982; Chen TW, 2013, NATURE, V499, P295, DOI 10.1038/nature12354; Dan Y, 2006, PHYSIOL REV, V86, P1033, DOI 10.1152/physrev.00030.2005; Ellis-Davies GCR, 2007, J NEUROSCI, V27, P6601, DOI 10.1523/JNEUROSCI.1519-07.2007; Ellis-Davies GCR, 2011, NAT PROTOC, V6, DOI 10.1038/nprot.2010.193; Fiete IR, 2010, NEURON, V65, P563, DOI 10.1016/j.neuron.2010.02.003; Fino E, 2009, FRONT NEURAL CIRCUIT, V3, DOI 10.3389/neuro.04.002.2009; Govindarajan A, 2006, NAT REV NEUROSCI, V7, P575, DOI 10.1038/nrn1937; Harvey CD, 2007, NATURE, V450, P1195, DOI 10.1038/nature06416; Hensch TK, 2005, NAT REV NEUROSCI, V6, P877, DOI 10.1038/nrn1787; Hensch TK, 2005, PROG BRAIN RES, V147, P115, DOI 10.1016/S0079-6123(04)47009-5; Holtmaat A, 2009, NAT REV NEUROSCI, V10, P647, DOI 10.1038/nrn2699; Kanemoto Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022652; Kasai H, 2010, TRENDS NEUROSCI, V33, P121, DOI 10.1016/j.tins.2010.01.001; Klausberger T, 2008, SCIENCE, V321, P53, DOI 10.1126/science.1149381; Lai CSW, 2012, NATURE, V483, P87, DOI 10.1038/nature10792; Lai FP, 2008, EMBO J, V27, P982, DOI 10.1038/emboj.2008.34; Lee SJR, 2009, NATURE, V458, P299, DOI 10.1038/nature07842; LISMAN J, 1989, P NATL ACAD SCI USA, V86, P9574, DOI 10.1073/pnas.86.23.9574; Losonczy A, 2006, NEURON, V50, P291, DOI 10.1016/j.neuron.2006.03.016; Magee JC, 1997, SCIENCE, V275, P209, DOI 10.1126/science.275.5297.209; Markram H, 1998, J COMPUT NEUROSCI, V5, P331, DOI 10.1023/A:1008891229546; Markram H, 1997, SCIENCE, V275, P213, DOI 10.1126/science.275.5297.213; Mataga N, 2004, NEURON, V44, P1031, DOI 10.1016/j.neuron.2004.11.028; Matsuzaki M, 2001, NAT NEUROSCI, V4, P1086, DOI 10.1038/nn736; Matsuzaki M, 2004, NATURE, V429, P761, DOI 10.1038/nature02617; Matsuzaki M., 2011, COLD SPRING HARBOR P; Matsuzaki M, 2010, NAT CHEM BIOL, V6, P255, DOI [10.1038/nchembio.321, 10.1038/NCHEMBIO.321]; MORI H, 1995, NEUROPHARMACOLOGY, V34, P1219, DOI 10.1016/0028-3908(95)00109-J; Nakayama H, 2012, NEURON, V74, P384, DOI 10.1016/j.neuron.2012.02.032; Naraghi M, 1997, CELL CALCIUM, V22, P255, DOI 10.1016/S0143-4160(97)90064-6; Naraghi M, 1997, J NEUROSCI, V17, P6961; Nishiyama M, 2000, NATURE, V408, P584, DOI 10.1038/35046067; Nishiyama Makoto, 2010, Front Synaptic Neurosci, V2, P22, DOI 10.3389/fnsyn.2010.00022; Noguchi J, 2011, J PHYSIOL-LONDON, V589, P2447, DOI 10.1113/jphysiol.2011.207100; NOWAK L, 1984, NATURE, V307, P462, DOI 10.1038/307462a0; Oh WC, 2013, P NATL ACAD SCI USA, V110, pE305, DOI 10.1073/pnas.1214705110; Paulsen O, 1998, TRENDS NEUROSCI, V21, P273, DOI 10.1016/S0166-2236(97)01205-8; Pontrello CG, 2012, P NATL ACAD SCI USA, V109, pE442, DOI 10.1073/pnas.1118803109; Rusnak F, 2000, PHYSIOL REV, V80, P1483, DOI 10.1152/physrev.2000.80.4.1483; Rust MB, 2010, EMBO J, V29, P1889, DOI 10.1038/emboj.2010.72; Steele PM, 1999, J NEUROPHYSIOL, V81, P1559, DOI 10.1152/jn.1999.81.4.1559; Tanaka JI, 2008, SCIENCE, V319, P1683, DOI 10.1126/science.1152864; Verde EMR, 2008, FRONT NEURAL CIRCUIT, V2, DOI 10.3389/neuro.04.002.2008; Wang SSH, 2000, P NATL ACAD SCI USA, V97, P8635, DOI 10.1073/pnas.130414597; Wittenberg GM, 2006, J NEUROSCI, V26, P6610, DOI 10.1523/JNEUROSCI.5388-05.2006; Yang EJ, 2012, P NATL ACAD SCI USA, V109, P17213, DOI 10.1073/pnas.1200705109; Yang G, 2009, NATURE, V462, P920, DOI 10.1038/nature08577; Yang SN, 1999, J NEUROPHYSIOL, V81, P781, DOI 10.1152/jn.1999.81.2.781; Zhou Q, 2004, NEURON, V44, P749, DOI 10.1016/j.neuron.2004.11.011	55	127	127	2	38	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	OCT	2013	16	10					1409	+		10.1038/nn.3496	http://dx.doi.org/10.1038/nn.3496			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	223HM	23974706	Green Accepted			2022-12-28	WOS:000324795300013
J	Mohajerani, MH; Chan, AW; Mohsenvand, M; LeDue, J; Liu, R; McVea, DA; Boyd, JD; Wang, YT; Reimers, M; Murphy, TH				Mohajerani, Majid H.; Chan, Allen W.; Mohsenvand, Mostafa; LeDue, Jeffrey; Liu, Rui; McVea, David A.; Boyd, Jamie D.; Wang, Yu Tian; Reimers, Mark; Murphy, Timothy H.			Spontaneous cortical activity alternates between motifs defined by regional axonal projections	NATURE NEUROSCIENCE			English	Article							MONKEY VISUAL-CORTEX; FUNCTIONAL ARCHITECTURE; DYNAMICS; STATE; FLUCTUATIONS; INTEGRATION; RESOLUTION; RESPONSES; NETWORKS; WAVES	Using millisecond-timescale voltage-sensitive dye imaging in lightly anesthetized or awake adult mice, we show that a palette of sensory-evoked and hemisphere-wide activity motifs are represented in spontaneous activity. These motifs can reflect multiple modes of sensory processing, including vision, audition and touch. We found similar cortical networks with direct cortical activation using channelrhodopsin-2. Regional analysis of activity spread indicated modality-specific sources, such as primary sensory areas, a common posterior-medial cortical sink where sensory activity was extinguished within the parietal association area and a secondary anterior medial sink within the cingulate and secondary motor cortices for visual stimuli. Correlation analysis between functional circuits and intracortical axonal projections indicated a common framework corresponding to long-range monosynaptic connections between cortical regions. Maps of intracortical monosynaptic structural connections predicted hemisphere-wide patterns of spontaneous and sensory-evoked depolarization. We suggest that an intracortical monosynaptic connectome shapes the ebb and flow of spontaneous cortical activity.	[Mohajerani, Majid H.; Chan, Allen W.; Mohsenvand, Mostafa; LeDue, Jeffrey; Liu, Rui; McVea, David A.; Boyd, Jamie D.; Murphy, Timothy H.] Univ British Columbia, Dept Psychiat, Vancouver, BC, Canada; [Mohajerani, Majid H.; Chan, Allen W.; Mohsenvand, Mostafa; LeDue, Jeffrey; McVea, David A.; Boyd, Jamie D.; Wang, Yu Tian; Murphy, Timothy H.] Univ British Columbia, Brain Res Ctr, Vancouver, BC, Canada; [Chan, Allen W.; Wang, Yu Tian] Univ British Columbia, Dept Med, Vancouver, BC, Canada; [Chan, Allen W.; Wang, Yu Tian] Univ British Columbia, Vancouver Coastal Hlth Res Inst, Vancouver, BC, Canada; [Reimers, Mark] Virginia Commonwealth Univ, Dept Psychiat, Richmond, VA USA; [Murphy, Timothy H.] Univ British Columbia, Dep Cellular & Physiol Sci, Vancouver, BC, Canada	University of British Columbia; University of British Columbia; University of British Columbia; University of British Columbia; Vancouver Coastal Health Research Institute; Virginia Commonwealth University; University of British Columbia	Murphy, TH (corresponding author), Univ British Columbia, Dept Psychiat, Vancouver, BC, Canada.	thmurphy@mail.ubc.ca	Liu, Rui/AAC-5111-2020; Wang, Yu Tian/J-8255-2015; Chan, Allen/AAF-4718-2020; Murphy, Timothy H/I-4982-2014; LeDue, Jeffrey/C-9230-2012; Murphy, Timothy/AAW-1975-2021	Murphy, Timothy H/0000-0002-0093-4490; Murphy, Timothy/0000-0002-0093-4490; Liu, Rui/0000-0002-3634-0344; Mohajerani, Majid H./0000-0003-0964-2977	Canadian Institutes of Health Research (CIHR) [MOP-12675]; Human Frontier Science Program; Michael Smith Foundation for Health Research postdoctoral fellowships; Heart and Stroke Foundation of Canada postdoctoral fellowships; CIHR Focus on Stroke postdoctoral fellowship	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Human Frontier Science Program(Human Frontier Science Program); Michael Smith Foundation for Health Research postdoctoral fellowships; Heart and Stroke Foundation of Canada postdoctoral fellowships; CIHR Focus on Stroke postdoctoral fellowship(Canadian Institutes of Health Research (CIHR))	This work was supported by Canadian Institutes of Health Research (CIHR) Operating Grant MOP-12675 (T.H.M.), a Human Frontier Science Program grant (T.H.M.), Michael Smith Foundation for Health Research postdoctoral fellowships (M.H.M. and A.W.C.), a CIHR Operating Grant (Y.T.W.), Heart and Stroke Foundation of Canada postdoctoral fellowships (M.H.M. and A.W.C.) and a CIHR Focus on Stroke postdoctoral fellowship (M.H.M.). We thank the Allen Institute for Brain Science for providing a database of axonal projections. We thank P. Wang and C. Jiang for surgical assistance.	Akemann W, 2012, J NEUROPHYSIOL, V108, P2323, DOI 10.1152/jn.00452.2012; Alivisatos AP, 2012, NEURON, V74, P970, DOI 10.1016/j.neuron.2012.06.006; Allen Institute for Brain Science, 2012, ALL MOUS BRAIN CONN; Arieli A, 1996, SCIENCE, V273, P1868, DOI 10.1126/science.273.5283.1868; Azin M, 2011, IEEE T BIO-MED ENG, V58, P2589, DOI 10.1109/TBME.2011.2159603; Beier KT, 2011, P NATL ACAD SCI USA, V108, P15414, DOI 10.1073/pnas.1110854108; Bohland JW, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000334; Bullmore ET, 2009, NAT REV NEUROSCI, V10, P186, DOI 10.1038/nrn2575; BUZSAKI G, 1988, J NEUROSCI, V8, P4007; Cardin JA, 2009, NATURE, V459, P663, DOI 10.1038/nature08002; de Pasquale F, 2012, NEURON, V74, P753, DOI 10.1016/j.neuron.2012.03.031; Destexhe A, 2006, SCIENCE, V314, P85, DOI 10.1126/science.1127241; Douglas RJ, 2007, NEURON, V56, P226, DOI 10.1016/j.neuron.2007.10.017; Euston DR, 2007, SCIENCE, V318, P1147, DOI 10.1126/science.1148979; Ferezou I, 2007, NEURON, V56, P907, DOI 10.1016/j.neuron.2007.10.007; Frostig RD, 2008, J NEUROSCI, V28, P13274, DOI 10.1523/JNEUROSCI.4074-08.2008; Grandy TH, 2012, J NEUROPHYSIOL, V108, P2931, DOI 10.1152/jn.00512.2011; Grienberger C, 2012, J PHYSIOL-LONDON, V590, P899, DOI 10.1113/jphysiol.2011.222513; Grinvald A, 2004, NAT REV NEUROSCI, V5, P874, DOI 10.1038/nrn1536; Haider B, 2013, NATURE, V493, P97, DOI 10.1038/nature11665; Han F, 2008, NEURON, V60, P321, DOI 10.1016/j.neuron.2008.08.026; Harris KD, 2011, NAT REV NEUROSCI, V12, P509, DOI 10.1038/nrn3084; Hipp JF, 2012, NAT NEUROSCI, V15, P884, DOI 10.1038/nn.3101; Huang XY, 2010, NEURON, V68, P978, DOI 10.1016/j.neuron.2010.11.007; Kenet T, 2003, NATURE, V425, P954, DOI 10.1038/nature02078; Kleinfeld D, 1996, J COMP NEUROL, V375, P89, DOI 10.1002/(SICI)1096-9861(19961104)375:1<89::AID-CNE6>3.0.CO;2-K; Kleinfeld D, 2011, J NEUROSCI, V31, P16125, DOI 10.1523/JNEUROSCI.4077-11.2011; Leopold DA, 2003, CEREB CORTEX, V13, P422, DOI 10.1093/cercor/13.4.422; Li AA, 2010, SCIENCE, V330, P1404, DOI 10.1126/science.1191776; Lim DH, 2012, FRONT NEURAL CIRCUIT, V6, DOI 10.3389/fncir.2012.00011; Liu C., 2009, PIXELS EXPLORING NEW; Lu HB, 2012, P NATL ACAD SCI USA, V109, P3979, DOI [10.1073/pnas.1101934108, 10.1073/pnas.1200506109]; Luczak A, 2009, NEURON, V62, P413, DOI 10.1016/j.neuron.2009.03.014; Mao TY, 2011, NEURON, V72, P111, DOI 10.1016/j.neuron.2011.07.029; Mohajerani MH, 2010, J NEUROSCI, V30, P3745, DOI 10.1523/JNEUROSCI.6437-09.2010; Niell CM, 2010, NEURON, V65, P472, DOI 10.1016/j.neuron.2010.01.033; Osakada F, 2011, NEURON, V71, P617, DOI 10.1016/j.neuron.2011.07.005; Paxinos G, 2004, MOUSE BRAIN STEREOTA; Polack PO, 2012, J NEUROSCI, V32, P11120, DOI 10.1523/JNEUROSCI.6304-11.2012; Poulet JFA, 2008, NATURE, V454, P881, DOI 10.1038/nature07150; Reid RC, 2012, NEURON, V75, P209, DOI 10.1016/j.neuron.2012.06.031; Sato TK, 2012, NEURON, V75, P218, DOI 10.1016/j.neuron.2012.06.029; Shmuel A, 2008, HUM BRAIN MAPP, V29, P751, DOI 10.1002/hbm.20580; Shoham D, 1999, NEURON, V24, P791, DOI 10.1016/S0896-6273(00)81027-2; Takagaki K, 2011, J NEUROSCI METH, V200, P207, DOI 10.1016/j.jneumeth.2011.05.023; Tamamaki N, 2010, FRONT NEUROSCI-SWITZ, V4, DOI 10.3389/fnins.2010.00202; Vincent JL, 2007, NATURE, V447, P83, DOI 10.1038/nature05758; Waters J, 2006, J NEUROSCI, V26, P8267, DOI 10.1523/JNEUROSCI.2152-06.2006; Wedeen VJ, 2008, NEUROIMAGE, V41, P1267, DOI 10.1016/j.neuroimage.2008.03.036; White BR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016322; WILSON MA, 1994, SCIENCE, V265, P676, DOI 10.1126/science.8036517; Zhang DY, 2010, NAT REV NEUROL, V6, P15, DOI 10.1038/nrneurol.2009.198	52	224	228	0	49	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	OCT	2013	16	10					1426	+		10.1038/nn.3499	http://dx.doi.org/10.1038/nn.3499			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	223HM	23974708	Green Accepted			2022-12-28	WOS:000324795300015
J	McIlroy, G; Foldi, I; Aurikko, J; Wentzell, JS; Lim, MA; Fenton, JC; Gay, NJ; Hidalgo, A				McIlroy, Graham; Foldi, Istvan; Aurikko, Jukka; Wentzell, Jill S.; Lim, Mei Ann; Fenton, Janine C.; Gay, Nicholas J.; Hidalgo, Alicia			Toll-6 and Toll-7 function as neurotrophin receptors in the Drosophila melanogaster CNS	NATURE NEUROSCIENCE			English	Article							NF-KAPPA-B; CENTRAL-NERVOUS-SYSTEM; PROGRAMMED CELL-DEATH; CYSTINE-KNOT PROTEIN; AXON GUIDANCE; IMMUNE-RESPONSE; GROWTH-FACTOR; SPATZLE; MECHANISM; SURVIVAL	Neurotrophin receptors corresponding to vertebrate Trk, p75(NTR) or Sortilin have not been identified in Drosophila, thus it is unknown how neurotrophism may be implemented in insects. Two Drosophila neurotrophins, DNT1 and DNT2, have nervous system functions, but their receptors are unknown. The Toll receptor superfamily has ancient evolutionary origins and a universal function in innate immunity. Here we show that Toll paralogs unrelated to the mammalian neurotrophin receptors function as neurotrophin receptors in fruit flies. Toll-6 and Toll-7 are expressed in the CNS throughout development and regulate locomotion, motor axon targeting and neuronal survival. DNT1 (also known as NT1 and spz2) and DNT2 (also known as NT2 and spz5) interact genetically with Toll-6 and Toll-7, and DNT1 and DNT2 bind to Toll-6 and Toll-7 promiscuously and are distributed in vivo in domains complementary to or overlapping with those of Toll-6 and Toll-7. We conclude that in fruit flies, Tolls are not only involved in development and immunity but also in neurotrophism, revealing an unforeseen relationship between the neurotrophin and Toll protein families.	[McIlroy, Graham; Foldi, Istvan; Wentzell, Jill S.; Lim, Mei Ann; Fenton, Janine C.; Hidalgo, Alicia] Univ Birmingham, Sch Biosci, Birmingham, W Midlands, England; [Aurikko, Jukka; Gay, Nicholas J.] Univ Cambridge, Dept Biochem, Cambridge CB2 1QW, England	University of Birmingham; University of Cambridge	Hidalgo, A (corresponding author), Univ Birmingham, Sch Biosci, Birmingham, W Midlands, England.	a.hidalgo@bham.ac.uk	McIlroy, Graham/HIA-0680-2022; Hidalgo, Alicia/F-5930-2015	McIlroy, Graham/0000-0002-4731-1784; Hidalgo, Alicia/0000-0001-8041-5764; Lim, Mei Ann/0000-0001-9060-0058	UK Medical Research Council Career Establishment Grant [MRCG0200140]; Wellcome Trust [WT094175/Z/10/Z]; Wellcome Trust equipment grant [WT073228/Z/03/Z]; Wellcome Trust programme grant [WT081744MA]; European Union Marie Curie International Incoming Fellowship [PIIF-GA-2010-274193-NPN]; UK Medical Research Council studentship; Brunei government studentship; MRC [G1000133] Funding Source: UKRI; Medical Research Council [G1000133] Funding Source: researchfish; Wellcome Trust [100321/Z/12/Z] Funding Source: researchfish	UK Medical Research Council Career Establishment Grant(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome TrustEuropean Commission); Wellcome Trust equipment grant(Wellcome Trust); Wellcome Trust programme grant(Wellcome Trust); European Union Marie Curie International Incoming Fellowship; UK Medical Research Council studentship(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Brunei government studentship; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Wellcome Trust(Wellcome TrustEuropean Commission)	We thank C. Arnot, J. Wen and M. Wheatley for advice; S. Jondhale, J. Ng and S. Quayle for technical help; S. Bishop and K. Kato for comments on the manuscript; A. J. Courey (University of California, Los Angeles), J. L. Imler (Institut de Biologie Moleculaire et Cellulaire, CNRS, Strasbourg), T. Ip (University of Massachusetts), J. M. Reichhart (Institut de Biologie Moleculaire et Cellulaire, CNRS, Strasbourg), S. Sanyal (Emory University), R. Baines (University of Manchester), M. Freeman (University of Oxford), K. Ito (University of Tokyo), A. Chiba (University of Miami), B. Pfeiffer (Janelia Farm), M. Landgraf (University of Cambridge), C. Basler (University of Zurich), H. Broihier (Case Western Reserve University), D. Ferrandon (CNRS, Strasbourg), the Bloomington Stock Center and Iowa Hybridoma Bank for reagents; the Birmingham Mass Spectrometry Facility (Birmingham Science City, Advantage West Midlands); and Len Packman for mass spectrometry and Edman sequencing in Cambridge. The LTQ Orbitrap Velos ETD mass spectrometer used in this research was obtained through the Birmingham Science City Translational Medicine: Experimental Medicine Network of Excellence project, with support from Advantage West Midlands (AWM). This work was funded by a UK Medical Research Council Career Establishment Grant (MRCG0200140) to A.H., Wellcome Trust project grant (WT094175/Z/10/Z) to A.H. and N.J.G., Wellcome Trust equipment grant (WT073228/Z/03/Z) to A.H., Wellcome Trust programme grant (WT081744MA) to N.J.G., European Union Marie Curie International Incoming Fellowship (PIIF-GA-2010-274193-NPN) to J.S.W., UK Medical Research Council studentship to G.M. and Brunei government studentship to M.A.L.	Arnot CJ, 2010, J BIOL CHEM, V285, P19502, DOI 10.1074/jbc.M109.098186; Bergmann A, 2002, DEV CELL, V2, P159, DOI 10.1016/S1534-5807(02)00116-8; Blum R, 2005, PHYSIOLOGY, V20, P70, DOI 10.1152/physiol.00042.2004; Bothwell M, 2006, BRAIN BEHAV EVOLUT, V68, P124, DOI 10.1159/000094082; Broihier HT, 2002, NEURON, V35, P39, DOI 10.1016/S0896-6273(02)00743-2; Carter BD, 1996, SCIENCE, V272, P542, DOI 10.1126/science.272.5261.542; DeLotto Y, 1998, MECH DEVELOP, V72, P141, DOI 10.1016/S0925-4773(98)00024-0; Foehr ED, 2000, J NEUROSCI, V20, P7556; Forero MG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005441; Freudenthal R, 2000, BRAIN RES, V855, P274, DOI 10.1016/S0006-8993(99)02358-6; Gangloff M, 2008, J BIOL CHEM, V283, P14629, DOI 10.1074/jbc.M800112200; Gay NJ, 2007, ANNU REV BIOCHEM, V76, P141, DOI 10.1146/annurev.biochem.76.060305.151318; Gutierrez H, 2011, TRENDS NEUROSCI, V34, P316, DOI 10.1016/j.tins.2011.03.001; Heckscher ES, 2007, NEURON, V55, P859, DOI 10.1016/j.neuron.2007.08.005; Hidalgo A, 2001, DEV CELL, V1, P679, DOI 10.1016/S1534-5807(01)00074-0; Hidalgo A, 2011, GLIA, V59, P1296, DOI 10.1002/glia.21092; Hoffmann A, 2008, J BIOL CHEM, V283, P32598, DOI 10.1074/jbc.M801815200; Hoffmann A, 2008, ACTA CRYSTALLOGR F, V64, P707, DOI 10.1107/S1744309108018812; Hoffmann JA, 2003, NATURE, V426, P33, DOI 10.1038/nature02021; Huang EJ, 2003, ANNU REV BIOCHEM, V72, P609, DOI 10.1146/annurev.biochem.72.121801.161629; Imler JL, 2004, J LEUKOCYTE BIOL, V75, P18, DOI 10.1189/jlb.0403160; Jacobs JR, 2000, PROG NEUROBIOL, V62, P475, DOI 10.1016/S0301-0082(00)00016-2; Kambris Zakaria, 2002, Gene Expression Patterns, V2, P311, DOI 10.1016/S1567-133X(02)00020-0; Learte AR, 2008, GLIA, V56, P164, DOI 10.1002/glia.20601; Lemaitre B, 1996, CELL, V86, P973, DOI 10.1016/S0092-8674(00)80172-5; Levi-Montalcini R, 1990, PROG NEUROENDOCRINOL, V3, P1; Liu X, 2000, DEV DYNAM, V218, P94, DOI 10.1002/(SICI)1097-0177(200005)218:1<94::AID-DVDY8>3.0.CO;2-Z; Lu B, 2005, NAT REV NEUROSCI, V6, P603, DOI 10.1038/nrn1726; Ma YH, 2006, J CELL BIOL, V175, P209, DOI 10.1083/jcb.200606016; Mattson MP, 2006, CELL DEATH DIFFER, V13, P852, DOI 10.1038/sj.cdd.4401837; Nakamoto M, 2012, IMMUNITY, V36, P658, DOI 10.1016/j.immuni.2012.03.003; Newquist G, 2013, CELL REP, V3, P595, DOI 10.1016/j.celrep.2013.02.017; Okun E, 2011, TRENDS NEUROSCI, V34, P269, DOI 10.1016/j.tins.2011.02.005; Ooi JY, 2002, EMBO REP, V3, P82, DOI 10.1093/embo-reports/kvf004; Palgi M, 2009, P NATL ACAD SCI USA, V106, P2429, DOI 10.1073/pnas.0810996106; Parker JS, 2001, PROTEINS, V45, P71, DOI 10.1002/prot.1125; Pujol N, 2001, CURR BIOL, V11, P809, DOI 10.1016/S0960-9822(01)00241-X; Putnam NH, 2007, SCIENCE, V317, P86, DOI 10.1126/science.1139158; REICHHART JM, 1993, CR ACAD SCI III-VIE, V316, P1218; Rivest S, 2009, NAT REV IMMUNOL, V9, P429, DOI 10.1038/nri2565; Rogulja-Ortmann A, 2007, DEVELOPMENT, V134, P105, DOI 10.1242/dev.02707; Rutschmann S, 2000, IMMUNITY, V12, P569, DOI 10.1016/S1074-7613(00)80208-3; Sanyal S, 2009, GENE EXPR PATTERNS, V9, P371, DOI 10.1016/j.gep.2009.01.002; Seppo A, 2003, DEVELOPMENT, V130, P1439, DOI 10.1242/dev.00347; Sossin WS, 2006, BRAIN BEHAV EVOLUT, V68, P145, DOI 10.1159/000094084; Tauszig S, 2000, P NATL ACAD SCI USA, V97, P10520, DOI 10.1073/pnas.180130797; Weber ANR, 2007, J BIOL CHEM, V282, P13522, DOI 10.1074/jbc.M700068200; Weber ANR, 2003, NAT IMMUNOL, V4, P794, DOI 10.1038/ni955; WHITE K, 1994, SCIENCE, V264, P677, DOI 10.1126/science.8171319; Yagi Y, 2010, DEV GROWTH DIFFER, V52, P771, DOI 10.1111/j.1440-169X.2010.01213.x; Zhu BF, 2008, PLOS BIOL, V6, P2476, DOI 10.1371/journal.pbio.0060284	53	66	72	0	53	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	SEP	2013	16	9					1248	U124		10.1038/nn.3474	http://dx.doi.org/10.1038/nn.3474			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	207KN	23892553	Green Accepted, Green Published			2022-12-28	WOS:000323597500016
J	Figee, M; Luigjes, J; Smolders, R; Valencia-Alfonso, CE; van Wingen, G; de Kwaasteniet, B; Mantione, M; Ooms, P; de Koning, P; Vulink, N; Levar, N; Droge, L; van den Munckhof, P; Schuurman, PR; Nederveen, A; van den Brink, W; Mazaheri, A; Vink, M; Denys, D				Figee, Martijn; Luigjes, Judy; Smolders, Ruud; Valencia-Alfonso, Carlos-Eduardo; van Wingen, Guido; de Kwaasteniet, Bart; Mantione, Mariska; Ooms, Pieter; de Koning, Pelle; Vulink, Nienke; Levar, Nina; Droge, Lukas; van den Munckhof, Pepijn; Schuurman, P. Richard; Nederveen, Aart; van den Brink, Wim; Mazaheri, Ali; Vink, Matthijs; Denys, Damiaan			Deep brain stimulation restores frontostriatal network activity in obsessive-compulsive disorder	NATURE NEUROSCIENCE			English	Article							FUNCTIONAL CONNECTIVITY	Little is known about the underlying neural mechanism of deep brain stimulation (DBS). We found that DBS targeted at the nucleus accumbens (NAc) normalized NAc activity, reduced excessive connectivity between the NAc and prefrontal cortex, and decreased frontal low-frequency oscillations during symptom provocation in patients with obsessive-compulsive disorder. Our findings suggest that DBS is able to reduce maladaptive activity and connectivity of the stimulated region.	[Figee, Martijn; Luigjes, Judy; Smolders, Ruud; Valencia-Alfonso, Carlos-Eduardo; van Wingen, Guido; de Kwaasteniet, Bart; Mantione, Mariska; Ooms, Pieter; de Koning, Pelle; Vulink, Nienke; Levar, Nina; Droge, Lukas; van den Brink, Wim; Mazaheri, Ali; Denys, Damiaan] Univ Amsterdam, Acad Med Ctr, Dept Psychiat, NL-1105 AZ Amsterdam, Netherlands; [Figee, Martijn; Luigjes, Judy; Smolders, Ruud; van Wingen, Guido; de Kwaasteniet, Bart; Levar, Nina; Nederveen, Aart] Univ Amsterdam, Acad Med Ctr, Brain Imaging Ctr, NL-1105 AZ Amsterdam, Netherlands; [Valencia-Alfonso, Carlos-Eduardo; Denys, Damiaan] Royal Netherlands Acad Arts & Sci, Netherlands Inst Neurosci, Amsterdam, Netherlands; [van den Munckhof, Pepijn; Schuurman, P. Richard] Univ Amsterdam, Acad Med Ctr, Dept Neurosurg, NL-1105 AZ Amsterdam, Netherlands; [Nederveen, Aart] Univ Amsterdam, Acad Med Ctr, Dept Radiol, NL-1105 AZ Amsterdam, Netherlands; [Vink, Matthijs] Univ Med Ctr Utrecht, Rudolf Magnus Inst Neurosci, Dept Psychiat, Utrecht, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; Royal Netherlands Academy of Arts & Sciences; Netherlands Institute for Neuroscience (NIN-KNAW); University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; Utrecht University; Utrecht University Medical Center	Figee, M (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Psychiat, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.	m.figee@amc.nl; ddenys@gmail.com	Smolders, Ruud/H-4771-2013; de Koning, Pelle/F-2599-2013; Schuurman, Rick/ABE-9100-2021; Figee, Martijn/N-5659-2019; van Wingen, Guido/AAK-8462-2021; luigjes, judy/P-5161-2014; van den Munckhof, Pepijn/AAY-9259-2020; Figee, Martijn/C-7581-2012	Smolders, Ruud/0000-0002-1976-3775; Figee, Martijn/0000-0003-3679-284X; van Wingen, Guido/0000-0003-3076-5891; Figee, Martijn/0000-0003-3679-284X; Vink, Matthijs/0000-0002-1235-8347; Mazaheri, Ali/0000-0001-5732-7555; Vulink, Nienke/0000-0001-8991-9627	Netherlands Organization for Scientific Research ZON-MW VENI program [916.66.095]; VENI grant from the Netherlands Organization for Scientific Research [016.115.196]	Netherlands Organization for Scientific Research ZON-MW VENI program; VENI grant from the Netherlands Organization for Scientific Research	This study was supported by grant 916.66.095 from the Netherlands Organization for Scientific Research ZON-MW VENI program. A.M. was supported from a VENI grant 016.115.196 from the Netherlands Organization for Scientific Research.	Bewernick BH, 2010, BIOL PSYCHIAT, V67, P110, DOI 10.1016/j.biopsych.2009.09.013; Delorme A, 2011, COMPUT INTEL NEUROSC, V2011, DOI 10.1155/2011/130714; Denys D, 2010, ARCH GEN PSYCHIAT, V67, P1061, DOI 10.1001/archgenpsychiatry.2010.122; Di Martino A, 2008, CEREB CORTEX, V18, P2735, DOI 10.1093/cercor/bhn041; Figee M, 2011, BIOL PSYCHIAT, V69, P867, DOI 10.1016/j.biopsych.2010.12.003; GOODMAN WK, 1989, ARCH GEN PSYCHIAT, V46, P1006; Haber SN, 2006, J NEUROSCI, V26, P8368, DOI 10.1523/JNEUROSCI.0271-06.2006; HAMILTON M, 1960, J NEUROL NEUROSUR PS, V23, P56, DOI 10.1136/jnnp.23.1.56; Harrison BJ, 2009, ARCH GEN PSYCHIAT, V66, P1189, DOI 10.1001/archgenpsychiatry.2009.152; Knyazev GG, 2012, NEUROSCI BIOBEHAV R, V36, P677, DOI 10.1016/j.neubiorev.2011.10.002; Kringelbach ML, 2011, FRONT INTEGR NEUROSC, V5, DOI 10.3389/fnint.2011.00008; Lang P.J., 2008, A8 U FLOR; Lehman JF, 2011, J NEUROSCI, V31, P10392, DOI 10.1523/JNEUROSCI.0595-11.2011; McIntyre CC, 2010, NEUROBIOL DIS, V38, P329, DOI 10.1016/j.nbd.2009.09.022; Menzies L, 2008, NEUROSCI BIOBEHAV R, V32, P525, DOI 10.1016/j.neubiorev.2007.09.005; Oostenveld R, 2011, COMPUT INTEL NEUROSC, V2011, DOI 10.1155/2011/156869; Pogarell O, 2006, INT J PSYCHOPHYSIOL, V62, P87, DOI 10.1016/j.ijpsycho.2006.02.002; Sheehan DV, 1998, J CLIN PSYCHIAT, V59, P22, DOI 10.4088/JCP.09m05305whi; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; Van Laere K, 2006, J NUCL MED, V47, P740	20	274	277	2	85	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	APR	2013	16	4					386	U195		10.1038/nn.3344	http://dx.doi.org/10.1038/nn.3344			4	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	114EM	23434914				2022-12-28	WOS:000316723700006
J	McDermott, JH; Schemitsch, M; Simoncelli, EP				McDermott, Josh H.; Schemitsch, Michael; Simoncelli, Eero P.			Summary statistics in auditory perception	NATURE NEUROSCIENCE			English	Article							TEMPORAL INTEGRATION; NOISE; LATERALIZATION; DISCRIMINATION; REPRESENTATION; INTERFERENCE; SIGNALS; SPEECH; SOUNDS; MEMORY	Sensory signals are transduced at high resolution, but their structure must be stored in a more compact format. Here we provide evidence that the auditory system summarizes the temporal details of sounds using time-averaged statistics. We measured discrimination of 'sound textures' that were characterized by particular statistical properties, as normally result from the superposition of many acoustic features in auditory scenes. When listeners discriminated examples of different textures, performance improved with excerpt duration. In contrast, when listeners discriminated different examples of the same texture, performance declined with duration, a paradoxical result given that the information available for discrimination grows with duration. These results indicate that once these sounds are of moderate length, the brain's representation is limited to time-averaged statistics, which, for different examples of the same texture, converge to the same values with increasing duration. Such statistical representations produce good categorical discrimination, but limit the ability to discern temporal detail.	[McDermott, Josh H.] MIT, Dept Brain & Cognit Sci, Cambridge, MA 02139 USA; [Schemitsch, Michael; Simoncelli, Eero P.] NYU, Ctr Neural Sci, Howard Hughes Med Inst, New York, NY 10003 USA; [Schemitsch, Michael; Simoncelli, Eero P.] NYU, Courant Inst Math Sci, New York, NY USA	Massachusetts Institute of Technology (MIT); Howard Hughes Medical Institute; New York University; New York University	McDermott, JH (corresponding author), MIT, Dept Brain & Cognit Sci, E25-618, Cambridge, MA 02139 USA.	jhm@mit.edu		Simoncelli, Eero/0000-0002-1206-527X	Howard Hughes Medical Institute	Howard Hughes Medical Institute(Howard Hughes Medical Institute)	The authors thank B. Anderson, S. Keshvari and J. Traer for comments on earlier versions of the manuscript. Research was funded by the Howard Hughes Medical Institute.	Agus TR, 2010, NEURON, V66, P610, DOI 10.1016/j.neuron.2010.04.014; Alvarez GA, 2009, P NATL ACAD SCI USA, V106, P7345, DOI 10.1073/pnas.0808981106; Ariely D, 2001, PSYCHOL SCI, V12, P157, DOI 10.1111/1467-9280.00327; Athineos M, 2003, 2003 IEEE INTERNATIONAL CONFERENCE ON ACOUSTICS, SPEECH, AND SIGNAL PROCESSING, VOL V, PROCEEDINGS, P648; Balas B, 2009, J VISION, V9, DOI [10.1167/9.2.16, 10.1167/9.12.13]; Carlyon RP, 2004, J ACOUST SOC AM, V116, P3629, DOI 10.1121/1.1811474; Chong SC, 2003, VISION RES, V43, P393, DOI 10.1016/S0042-6989(02)00596-5; COBLE SF, 1992, J ACOUST SOC AM, V92, P2630, DOI 10.1121/1.404402; CUTTING JE, 1974, PERCEPT PSYCHOPHYS, V16, P564, DOI 10.3758/BF03198588; Demany L, 2008, PSYCHOL SCI, V19, P85, DOI 10.1111/j.1467-9280.2008.02050.x; DEUTSCH D, 1970, SCIENCE, V168, P1604, DOI 10.1126/science.168.3939.1604; Dubnov S, 2002, IEEE COMPUT GRAPH, V22, P38, DOI 10.1109/MCG.2002.1016697; DYE RH, 1984, J ACOUST SOC AM, V75, P1593, DOI 10.1121/1.390868; Elhilali M, 2008, J ACOUST SOC AM, V124, P3751, DOI 10.1121/1.3001672; Freeman J, 2011, NAT NEUROSCI, V14, P1195, DOI 10.1038/nn.2889; Geffen MN, 2011, FRONT INTEGR NEUROSC, V5, DOI 10.3389/fnint.2011.00015; GERKEN GM, 1990, J ACOUST SOC AM, V88, P767, DOI 10.1121/1.399726; Goossens T, 2008, J ACOUST SOC AM, V124, P2251, DOI 10.1121/1.2973184; Goossens T, 2009, J ACOUST SOC AM, V125, P3882, DOI 10.1121/1.3119626; Greenwood JA, 2009, P NATL ACAD SCI USA, V106, P13130, DOI 10.1073/pnas.0901352106; GUTTMAN N, 1963, J ACOUST SOC AM, V35, P610, DOI 10.1121/1.1918551; Haberman J, 2009, J EXP PSYCHOL HUMAN, V35, P718, DOI 10.1037/a0013899; HAFTER ER, 1979, J ACOUST SOC AM, V65, P471, DOI 10.1121/1.382346; HANNA TE, 1984, PERCEPT PSYCHOPHYS, V36, P409, DOI 10.3758/BF03207495; HELLER LM, 1995, J ACOUST SOC AM, V97, P3775, DOI 10.1121/1.412393; HOUTGAST T, 1968, J ACOUST SOC AM, V44, P807, DOI 10.1121/1.1911178; Hromadka T, 2008, PLOS BIOL, V6, P124, DOI 10.1371/journal.pbio.0060016; Kaernbach C, 2004, EXP PSYCHOL, V51, P240, DOI 10.1027/1618-3169.51.4.240; Klein DJ, 2003, EURASIP J APPL SIG P, V2003, P659, DOI 10.1155/S1110865703303051; Latinus M, 2011, CURR BIOL, V21, pR143, DOI 10.1016/j.cub.2010.12.033; Lie L, 2004, IEEE T SPEECH AUDI P, V12, P156, DOI 10.1109/TSA.2003.819947; Lyzenga J, 2005, HEARING RES, V210, P30, DOI 10.1016/j.heares.2005.07.002; McDermott Josh H., 2009, 2009 IEEE Workshop on Applications of Signal Processing to Audio and Acoustics (WASPAA), P297, DOI 10.1109/ASPAA.2009.5346467; McDermott JH, 2011, NEURON, V71, P926, DOI 10.1016/j.neuron.2011.06.032; McDermott JH, 2011, P NATL ACAD SCI USA, V108, P1188, DOI 10.1073/pnas.1004765108; MOORE BCJ, 1973, J ACOUST SOC AM, V54, P610, DOI 10.1121/1.1913640; Nahum M, 2008, PLOS BIOL, V6, P978, DOI 10.1371/journal.pbio.0060126; Parkes L, 2001, NAT NEUROSCI, V4, P739, DOI 10.1038/89532; PLOMP R, 1964, J ACOUST SOC AM, V36, P277, DOI 10.1121/1.1918946; Poeppel D, 2003, SPEECH COMMUN, V41, P245, DOI 10.1016/S0167-6393(02)00107-3; Popat K, 1995, P AJCAI WORKSH COMP, P293; Schwarz D., 2011, P 14 INT C DIG AUD E, P221; SHEFT S, 1990, J ACOUST SOC AM, V88, P796, DOI 10.1121/1.399729; Smith EC, 2006, NATURE, V439, P978, DOI 10.1038/nature04485; Starr GE, 1997, J ACOUST SOC AM, V102, P486, DOI 10.1121/1.419722; Tzanetakis G, 2002, IEEE T SPEECH AUDI P, V10, P293, DOI 10.1109/TSA.2002.800560; VIEMEISTER NF, 1979, J ACOUST SOC AM, V66, P1364, DOI 10.1121/1.383531; VIEMEISTER NF, 1991, J ACOUST SOC AM, V90, P858, DOI 10.1121/1.401953; Warren RM, 2001, PERCEPT PSYCHOPHYS, V63, P175, DOI 10.3758/BF03200511; Yabe H, 1998, PSYCHOPHYSIOLOGY, V35, P615, DOI 10.1017/S0048577298000183	50	130	130	2	50	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	APR	2013	16	4					493	U169		10.1038/nn.3347	http://dx.doi.org/10.1038/nn.3347			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	114EM	23434915	Green Published, Green Accepted			2022-12-28	WOS:000316723700021
J	Orenstein, SJ; Kuo, SH; Tasset, I; Arias, E; Koga, H; Fernandez-Carasa, I; Cortes, E; Honig, LS; Dauer, W; Consiglio, A; Raya, A; Sulzer, D; Cuervo, AM				Orenstein, Samantha J.; Kuo, Sheng-Han; Tasset, Inmaculada; Arias, Esperanza; Koga, Hiroshi; Fernandez-Carasa, Irene; Cortes, Etty; Honig, Lawrence S.; Dauer, William; Consiglio, Antonella; Raya, Angel; Sulzer, David; Cuervo, Ana Maria			Interplay of LRRK2 with chaperone-mediated autophagy	NATURE NEUROSCIENCE			English	Article							ALPHA-SYNUCLEIN; LYSOSOMAL DEGRADATION; PEPTIDE SEQUENCES; DISEASE; MUTANT; PROTEINS; LOCALIZATION; RECEPTOR; MICRODOMAINS; MUTATIONS	Mutations in leucine-rich repeat kinase 2 (LRRK2) are the most common cause of familial Parkinson's disease. We found LRRK2 to be degraded in lysosomes by chaperone-mediated autophagy (CMA), whereas the most common pathogenic mutant form of LRRK2, G2019S, was poorly degraded by this pathway. In contrast to the behavior of typical CMA substrates, lysosomal binding of both wild-type and several pathogenic mutant LRRK2 proteins was enhanced in the presence of other CMA substrates, which interfered with the organization of the CMA translocation complex, resulting in defective CMA. Cells responded to such LRRK2-mediated CMA compromise by increasing levels of the CMA lysosomal receptor, as seen in neuronal cultures and brains of LRRK2 transgenic mice, induced pluripotent stem cell-derived dopaminergic neurons and brains of Parkinson's disease patients with LRRK2 mutations. This newly described LRRK2 self-perpetuating inhibitory effect on CMA could underlie toxicity in Parkinson's disease by compromising the degradation of alpha-synuclein, another Parkinson's disease-related protein degraded by this pathway.	[Orenstein, Samantha J.; Tasset, Inmaculada; Arias, Esperanza; Koga, Hiroshi; Cuervo, Ana Maria] Albert Einstein Coll Med, Dept Dev & Mol Biol, Bronx, NY 10467 USA; [Orenstein, Samantha J.; Tasset, Inmaculada; Arias, Esperanza; Koga, Hiroshi; Cuervo, Ana Maria] Albert Einstein Coll Med, Inst Aging Studies, Bronx, NY 10467 USA; [Kuo, Sheng-Han; Cortes, Etty; Honig, Lawrence S.; Sulzer, David] Columbia Univ, Dept Neurol, Med Ctr, New York, NY USA; [Fernandez-Carasa, Irene; Consiglio, Antonella] Univ Barcelona, Institute Biomed IBUB, Barcelona, Spain; [Cortes, Etty; Honig, Lawrence S.] Columbia Univ, Sch Med, Taub Inst, New York, NY USA; [Dauer, William] Univ Michigan, Dept Cell & Dev Biol, Ann Arbor, MI 48109 USA; [Consiglio, Antonella] Univ Brescia, Dept Biomed Sci & Biotechnol, Brescia, Italy; [Raya, Angel] Inst Bioengn Catalonia IBEC, Control Stem Cell Potency Grp, Barcelona, Spain; [Raya, Angel] ICREA, Barcelona, Spain; [Raya, Angel] Ctr Networked Biomed Res Bioengn Biomat & Nanomed, Barcelona, Spain; [Sulzer, David] Columbia Univ, Dept Psychiat, Sch Med, New York, NY USA; [Sulzer, David] Columbia Univ, Dept Pharmacol, Med Ctr, New York, NY USA	Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Columbia University; University of Barcelona; Columbia University; University of Michigan System; University of Michigan; University of Brescia; Barcelona Institute of Science & Technology; Institut de Bioenginyeria de Catalunya; University of Barcelona; ICREA; Columbia University; Columbia University	Cuervo, AM (corresponding author), Albert Einstein Coll Med, Dept Dev & Mol Biol, Bronx, NY 10467 USA.	ds43@columbia.edu; ana-maria.cuervo@einstein.yu.edu	Cuevas, Inmaculada Tasset/R-4509-2019; consiglio, antonella/G-1815-2016; Fernandez-Carasa, Irene/R-4421-2018; Raya, Angel/E-6205-2010; consiglio, antonella/AAA-5864-2019	Cuevas, Inmaculada Tasset/0000-0003-0730-6750; consiglio, antonella/0000-0002-3988-6254; Fernandez-Carasa, Irene/0000-0002-8195-3510; Raya, Angel/0000-0003-2189-9775; consiglio, antonella/0000-0002-3988-6254; Arias, Esperanza/0000-0002-7836-5072; Kuo, Sheng-Han/0000-0002-9412-931X; Dauer, William/0000-0003-1775-7504; Cuervo, Ana Maria/0000-0002-0771-700X	US National Institutes of Health National Institute on Aging [AG031782, AG038072, AG08702, T32AG023475]; MINECO [SAF2012-33526, PLE2009-0144, ACI2010-1117, RyC-2008-02772, BFU2010-21823]; Beatrice and Roy Backus Foundation; Rainwaters Foundation; Robert and Renee Belfer gift; JPB Foundation; Parkinson's Disease Foundation; Fondazione Guido Berlucchi; CIBERNED Cooperative Project; US National Institute of Neurological Disorders and Stroke Udall Center of Excellence; Hirschl/Weill-Caulier Career Scientist Award; American Academy of Neurology Research Fellowship; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P50NS038370, K08NS083738] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P30AG038072, R01AG021904, T32AG023475, P01AG031782, R37AG021904, P50AG008702] Funding Source: NIH RePORTER; ICREA Funding Source: Custom	US National Institutes of Health National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); MINECO(Spanish Government); Beatrice and Roy Backus Foundation; Rainwaters Foundation; Robert and Renee Belfer gift; JPB Foundation; Parkinson's Disease Foundation; Fondazione Guido Berlucchi; CIBERNED Cooperative Project; US National Institute of Neurological Disorders and Stroke Udall Center of Excellence; Hirschl/Weill-Caulier Career Scientist Award; American Academy of Neurology Research Fellowship; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); ICREA(ICREA)	We thank the Michael J. Fox Foundation for kindly providing some of the LRRK2 antibodies, C. Calatayud for help with neuronal differentiation of iPSC, D. Arduino and B. Caballero for their help with the generation of the LRRK2 knockdown cells, J.P. Vonsattel and R. Alcalay for assistance with human tissue and A. Diaz and B. Patel for technical assistance in several aspects of this work. This work was supported by grants from the US National Institutes of Health National Institute on Aging (AG031782 and AG038072 (A.M.C.) and AG08702 (Alzheimer's Disease Research Center at Columbia University)), MINECO (SAF2012-33526, PLE2009-0144 and ACI2010-1117 (A.R.); RyC-2008-02772 and BFU2010-21823 (A.C.)), the Beatrice and Roy Backus Foundation (A.M.C.), the Rainwaters Foundation (A.M.C.), a Robert and Renee Belfer gift (A.M.C.), the JPB Foundation (D.S.), the Parkinson's Disease Foundation (D.S. and S.-H.K.), Fondazione Guido Berlucchi (A.C.), a CIBERNED Cooperative Project (A.R.), a US National Institute of Neurological Disorders and Stroke Udall Center of Excellence (A.M.C. and D.S.) and a Hirschl/Weill-Caulier Career Scientist Award (A.M.C.). S.J.O. was supported by US National Institutes of Health National Institute on Aging training grant T32AG023475 and S.-H.K. by an American Academy of Neurology Research Fellowship.	Alegre-Abarrategui J, 2009, HUM MOL GENET, V18, P4022, DOI 10.1093/hmg/ddp346; Alvarez-Erviti L, 2010, ARCH NEUROL-CHICAGO, V67, P1464, DOI 10.1001/archneurol.2010.198; Anglade P, 1997, HISTOL HISTOPATHOL, V12, P25; Balch WE, 2008, SCIENCE, V319, P916, DOI 10.1126/science.1141448; Bandyopadhyay U, 2008, MOL CELL BIOL, V28, P5747, DOI 10.1128/MCB.02070-07; Berger Z, 2010, BIOCHEMISTRY-US, V49, P5511, DOI 10.1021/bi100157u; Biskup S, 2006, ANN NEUROL, V60, P557, DOI 10.1002/ana.21019; Blake RA, 2000, MOL CELL BIOL, V20, P9018, DOI 10.1128/MCB.20.23.9018-9027.2000; CHIANG HL, 1988, J BIOL CHEM, V263, P6797; CHIANG HL, 1989, SCIENCE, V246, P382, DOI 10.1126/science.2799391; CUERVO AM, 1994, J BIOL CHEM, V269, P26374; Cuervo AM, 2000, TRAFFIC, V1, P570, DOI 10.1034/j.1600-0854.2000.010707.x; Cuervo AM, 2004, SCIENCE, V305, P1292, DOI 10.1126/science.1101738; Cuervo AM, 2003, EMBO J, V22, P47, DOI 10.1093/emboj/cdg002; Cuervo AM, 1996, SCIENCE, V273, P501, DOI 10.1126/science.273.5274.501; Cuervo AM, 2010, TRENDS ENDOCRIN MET, V21, P142, DOI 10.1016/j.tem.2009.10.003; DICE JF, 1990, TRENDS BIOCHEM SCI, V15, P305, DOI 10.1016/0968-0004(90)90019-8; Dodson MW, 2012, HUM MOL GENET, V21, P1350, DOI 10.1093/hmg/ddr573; Gomez-Suaga P, 2012, HUM MOL GENET, V21, P511, DOI 10.1093/hmg/ddr481; Greggio E, 2008, J BIOL CHEM, V283, P16906, DOI 10.1074/jbc.M708718200; Greggio E, 2006, NEUROBIOL DIS, V23, P329, DOI 10.1016/j.nbd.2006.04.001; Kabuta T, 2008, J BIOL CHEM, V283, P23731, DOI 10.1074/jbc.M801918200; Kaushik S, 2006, EMBO J, V25, P3921, DOI 10.1038/sj.emboj.7601283; Kaushik S, 2009, METHOD ENZYMOL, V452, P297, DOI 10.1016/S0076-6879(08)03619-7; Kett LR, 2012, HUM MOL GENET, V21, P890, DOI 10.1093/hmg/ddr526; Ko HS, 2009, P NATL ACAD SCI USA, V106, P2897, DOI 10.1073/pnas.0810123106; Koga H, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1393; Kon M, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3003182; Li YP, 2009, NAT NEUROSCI, V12, P826, DOI 10.1038/nn.2349; LOWRY CC, 1951, AM J SURG, V81, P676, DOI 10.1016/0002-9610(51)90161-4; Mak SK, 2010, J BIOL CHEM, V285, P13621, DOI 10.1074/jbc.M109.074617; Martinez-Vicente M, 2008, J CLIN INVEST, V118, P777, DOI 10.1172/JCI32806; Massey AC, 2006, P NATL ACAD SCI USA, V103, P5805, DOI 10.1073/pnas.0507436103; Michael A.C., 2007, ELECTROCHEMICAL METH; Mizushima N, 2008, NATURE, V451, P1069, DOI 10.1038/nature06639; Orenstein SJ, 2010, SEMIN CELL DEV BIOL, V21, P719, DOI 10.1016/j.semcdb.2010.02.005; Plowey ED, 2008, J NEUROCHEM, V105, P1048, DOI 10.1111/j.1471-4159.2008.05217.x; Poulopoulos M, 2012, J MOL NEUROSCI, V47, P139, DOI 10.1007/s12031-011-9696-y; Ramonet D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018568; Rubinsztein DC, 2009, AUTOPHAGY, V5, P585, DOI 10.4161/auto.5.5.8823; Sanchez-Danes A, 2012, EMBO MOL MED, V4, P380, DOI 10.1002/emmm.201200215; Sen S, 2009, J BIOL CHEM, V284, P36346, DOI 10.1074/jbc.M109.025437; Spillantini MG, 1997, NATURE, V388, P839, DOI 10.1038/42166; Stefanis L, 2001, J NEUROSCI, V21, P9549, DOI 10.1523/JNEUROSCI.21-24-09549.2001; STORRIE B, 1990, METHOD ENZYMOL, V182, P203; Sulzer D, 2013, MOVEMENT DISORD, V28, P41, DOI 10.1002/mds.25095; Tanida I, 2005, AUTOPHAGY, V1, P84, DOI 10.4161/auto.1.2.1697; Tong YR, 2010, P NATL ACAD SCI USA, V107, P9879, DOI 10.1073/pnas.1004676107; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; Vogiatzi T, 2008, J BIOL CHEM, V283, P23542, DOI 10.1074/jbc.M801992200; Wang YP, 2009, HUM MOL GENET, V18, P4153, DOI 10.1093/hmg/ddp367; West AB, 2005, P NATL ACAD SCI USA, V102, P16842, DOI 10.1073/pnas.0507360102; Zhang C, 2008, NAT MED, V14, P959, DOI 10.1038/nm.1851; Zhu JH, 2003, BRAIN PATHOL, V13, P473	54	411	422	7	108	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	APR	2013	16	4					394	U52		10.1038/nn.3350	http://dx.doi.org/10.1038/nn.3350			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	114EM	23455607	Green Accepted			2022-12-28	WOS:000316723700009
J	Visser, RM; Scholte, HS; Beemsterboer, T; Kindt, M				Visser, Renee M.; Scholte, H. Steven; Beemsterboer, Tinka; Kindt, Merel			Neural pattern similarity predicts long-term fear memory	NATURE NEUROSCIENCE			English	Article								Although certain changes in the brain may reflect fear learning, there are no known markers that indicate whether an aversive experience will develop into fear memory. We examined the moment-to-moment dynamics of human fear learning by applying multi-voxel pattern analysis to single-trial blood oxygen level-dependent magnetic resonance imaging data. We found that the long-term behavioral expression of fear memory could be predicted from neural patterns at the time of learning.	[Visser, Renee M.; Kindt, Merel] Univ Amsterdam, Dept Clin Psychol, NL-1018 WB Amsterdam, Netherlands; [Visser, Renee M.; Scholte, H. Steven; Kindt, Merel] Univ Amsterdam, Cognit Sci Ctr Amsterdam, Amsterdam, Netherlands; [Scholte, H. Steven; Beemsterboer, Tinka] Univ Amsterdam, Dept Brain & Cognit, Amsterdam, Netherlands	University of Amsterdam; University of Amsterdam; University of Amsterdam	Kindt, M (corresponding author), Univ Amsterdam, Dept Clin Psychol, NL-1018 WB Amsterdam, Netherlands.	m.kindt@uva.nl	Scholte, H.Steven/ABD-1737-2020	Scholte, H.Steven/0000-0002-9839-1788; Visser, Renee/0000-0003-0376-8165	Vici grant from the Netherlands Organization for Scientific Research	Vici grant from the Netherlands Organization for Scientific Research	The authors thank J. Wijnen and M. Spaan for technical assistance. This work was supported by a Vici grant (M.K.) from the Netherlands Organization for Scientific Research.	Bach DR, 2011, J NEUROSCI, V31, P9383, DOI 10.1523/JNEUROSCI.1524-11.2011; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Dudai Y, 2012, ANNU REV NEUROSCI, V35, P227, DOI 10.1146/annurev-neuro-062111-150500; Haxby JV, 2001, SCIENCE, V293, P2425, DOI 10.1126/science.1063736; Kriegeskorte N, 2008, FRONT SYST NEUROSCI, V2, DOI 10.3389/neuro.06.004.2008; LaBar KS, 2006, NAT REV NEUROSCI, V7, P54, DOI 10.1038/nrn1825; Li W, 2008, SCIENCE, V319, P1842, DOI 10.1126/science.1152837; Norman KA, 2006, TRENDS COGN SCI, V10, P424, DOI 10.1016/j.tics.2006.07.005; Op de Beeck HP, 2010, NEUROIMAGE, V49, P1943, DOI 10.1016/j.neuroimage.2009.02.047; Peterson RA., 1992, ANXIETY SENSITIVITY; Reinhard G, 2006, PSYCHOPHYSIOLOGY, V43, P73, DOI 10.1111/j.1469-8986.2006.00374.x; Schurger A, 2010, SCIENCE, V327, P97, DOI 10.1126/science.1180029; Sehlmeyer C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005865; Spielberger C., 1983, MANUAL STATE TRAIT I; Tottenham N, 2009, PSYCHIAT RES, V168, P242, DOI 10.1016/j.psychres.2008.05.006; Visser RM, 2011, J NEUROSCI, V31, P12021, DOI 10.1523/JNEUROSCI.2178-11.2011; Woolrich MW, 2001, NEUROIMAGE, V14, P1370, DOI 10.1006/nimg.2001.0931; Xue G, 2010, SCIENCE, V330, P97, DOI 10.1126/science.1193125	18	69	69	1	27	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	APR	2013	16	4					388	U200		10.1038/nn.3345	http://dx.doi.org/10.1038/nn.3345			5	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	114EM	23434912				2022-12-28	WOS:000316723700007
J	Ziv, Y; Burns, LD; Cocker, ED; Hamel, EO; Ghosh, KK; Kitch, LJ; El Gamal, A; Schnitzer, MJ				Ziv, Yaniv; Burns, Laurie D.; Cocker, Eric D.; Hamel, Elizabeth O.; Ghosh, Kunal K.; Kitch, Lacey J.; El Gamal, Abbas; Schnitzer, Mark J.			Long-term dynamics of CA1 hippocampal place codes	NATURE NEUROSCIENCE			English	Article							SPATIAL INFORMATION; STABILITY; MEMORY; CELLS; MICE; REPRESENTATION; EXPERIENCE	Using Ca2+ imaging in freely behaving mice that repeatedly explored a familiar environment, we tracked thousands of CA1 pyramidal cells' place fields over weeks. Place coding was dynamic, as each day the ensemble representation of this environment involved a unique subset of cells. However, cells in the similar to 15-25% overlap between any two of these subsets retained the same place fields, which sufficed to preserve an accurate spatial representation across weeks.	[Ziv, Yaniv; Burns, Laurie D.; Cocker, Eric D.; Hamel, Elizabeth O.; Kitch, Lacey J.; Schnitzer, Mark J.] Stanford Univ, James H Clark Ctr, Stanford, CA 94305 USA; [Ghosh, Kunal K.; El Gamal, Abbas] Stanford Univ, Stanford, CA 94305 USA; [Schnitzer, Mark J.] Stanford Univ, Howard Hughes Med Inst, Stanford, CA 94305 USA; [Schnitzer, Mark J.] Stanford Univ, CNC Program, Stanford, CA 94305 USA	Stanford University; Stanford University; Howard Hughes Medical Institute; Stanford University; Stanford University	Schnitzer, MJ (corresponding author), Stanford Univ, James H Clark Ctr, Stanford, CA 94305 USA.	yziv@stanford.edu; mschnitz@stanford.edu	Core, Vector/CAF-4832-2022		US National Science Foundation; Simons Foundation; Machiah Foundation; Paul G. Allen Family Foundation; US National Institutes of Health [DP1OD003560, R21AG038771, R21MH099469]; Div Of Biological Infrastructure [1063292] Funding Source: National Science Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH [R21MH099469] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R21AG038771] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD003560] Funding Source: NIH RePORTER	US National Science Foundation(National Science Foundation (NSF)); Simons Foundation; Machiah Foundation; Paul G. Allen Family Foundation; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Div Of Biological Infrastructure(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank L. Looger (Janelia Farm Research Campus) for GCaMP3 plasmid, and A. Attardo, T. Davidson, J. Fitzgerald, J. Li, J.Z. Li, A. Lui, C. Ramachandran, O. Yizhar and T. Zhang for conversations and assistance. We appreciate fellowships from the US National Science Foundation (L.D.B., L.J.K.), the Simons (L.J.K.) and Machiah (Y.Z.) Foundations and research funding to M.J.S. from the Paul G. Allen Family Foundation and the US National Institutes of Health (grants DP1OD003560, R21AG038771 and R21MH099469).	Barretto RPJ, 2011, NAT MED, V17, P223, DOI 10.1038/nm.2292; Cacucci F, 2007, J NEUROSCI, V27, P7854, DOI 10.1523/JNEUROSCI.1704-07.2007; Dombeck DA, 2010, NAT NEUROSCI, V13, P1433, DOI 10.1038/nn.2648; Ghosh KK, 2011, NAT METHODS, V8, P871, DOI [10.1038/NMETH.1694, 10.1038/nmeth.1694]; Kentros C, 1998, SCIENCE, V280, P2121, DOI 10.1126/science.280.5372.2121; Kentros CG, 2004, NEURON, V42, P283, DOI 10.1016/S0896-6273(04)00192-8; Leutgeb S, 2005, SCIENCE, V309, P619, DOI 10.1126/science.1114037; Lever C, 2002, NATURE, V416, P90, DOI 10.1038/416090a; Lisman JE, 1997, TRENDS NEUROSCI, V20, P38, DOI 10.1016/S0166-2236(96)10070-9; MARKUS EJ, 1994, HIPPOCAMPUS, V4, P410, DOI 10.1002/hipo.450040404; McHugh TJ, 1996, CELL, V87, P1339, DOI 10.1016/S0092-8674(00)81828-0; Mukamel EA, 2009, NEURON, V63, P747, DOI 10.1016/j.neuron.2009.08.009; MULLER RU, 1987, J NEUROSCI, V7, P1935; Muzzio IA, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000140; Nakazawa K, 2003, NEURON, V38, P305, DOI 10.1016/S0896-6273(03)00165-X; O'Keefe J, 1978, HIPPOCAMPUS COGNITIV; Rotenberg A, 1996, CELL, V87, P1351, DOI 10.1016/S0092-8674(00)81829-2; THOMPSON LT, 1990, BRAIN RES, V509, P299, DOI 10.1016/0006-8993(90)90555-P; Tian L, 2009, NAT METHODS, V6, P875, DOI 10.1038/nmeth.1398	19	550	555	2	77	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	MAR	2013	16	3					264	266		10.1038/nn.3329	http://dx.doi.org/10.1038/nn.3329			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	097LE	23396101	Green Accepted			2022-12-28	WOS:000315474800006
J	De la Rossa, A; Bellone, C; Golding, B; Vitali, I; Moss, J; Toni, N; Luscher, C; Jabaudon, D				De la Rossa, Andres; Bellone, Camilla; Golding, Bruno; Vitali, Ilaria; Moss, Jonathan; Toni, Nicolas; Luescher, Christian; Jabaudon, Denis			In vivo reprogramming of circuit connectivity in postmitotic neocortical neurons	NATURE NEUROSCIENCE			English	Article							CEREBRAL-CORTEX; SOMATOSENSORY CORTEX; DENDRITIC MORPHOLOGY; AXONAL PROJECTIONS; PYRAMIDAL NEURONS; SPINY NEURONS; MOTOR CORTEX; ROR-BETA; LAYER 4; CELLS	The molecular mechanisms that control how progenitors generate distinct subtypes of neurons, and how undifferentiated neurons acquire their specific identity during corticogenesis, are increasingly understood. However, whether postmitotic neurons can change their identity at late stages of differentiation remains unknown. To study this question, we developed an electrochemical in vivo gene delivery method to rapidly manipulate gene expression specifically in postmitotic neurons. Using this approach, we found that the molecular identity, morphology, physiology and functional input-output connectivity of layer 4 mouse spiny neurons could be specifically reprogrammed during the first postnatal week by ectopic expression of the layer 5B output neuron-specific transcription factor Fezf2. These findings reveal a high degree of plasticity in the identity of postmitotic neocortical neurons and provide a proof of principle for postnatal re-engineering of specific neural microcircuits in vivo.	[De la Rossa, Andres; Bellone, Camilla; Golding, Bruno; Vitali, Ilaria; Luescher, Christian; Jabaudon, Denis] Univ Geneva, Dept Basic Neurosci, Geneva, Switzerland; [Moss, Jonathan; Toni, Nicolas] Univ Lausanne, Dept Fundamental Neurosci, Lausanne, Switzerland; [Luescher, Christian; Jabaudon, Denis] Univ Hosp Geneva, Clin Neurol, Geneva, Switzerland	University of Geneva; University of Lausanne; University of Geneva	Jabaudon, D (corresponding author), Univ Geneva, Dept Basic Neurosci, Geneva, Switzerland.	denis.jabaudon@unige.ch	Lüscher, Christian/A-2496-2011; Jabaudon, Denis/B-8802-2014; Toni, Nicolas/M-2057-2014	Lüscher, Christian/0000-0001-7917-4596; Jabaudon, Denis/0000-0003-2438-4769; Toni, Nicolas/0000-0001-5585-268X; Vitali, Ilaria/0000-0001-9536-0292; bellone, camilla/0000-0002-6774-6275	Swiss National Science Foundation [PP00P3-123447, PP00A-119026]; Velux Foundation; 3R Foundation; Brain and Behavior Research Foundation; joint Leenaards Foundation for Scientific Research Award	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Velux Foundation(Velux Fonden); 3R Foundation; Brain and Behavior Research Foundation; joint Leenaards Foundation for Scientific Research Award	We thank G. Fishell (New York University) for the gift of the Dlx5/6 plasmid, C.L. Cepko (Harvard University) for the pCAGIG_IRES_GFP and pCAG_ERT2-CRE-ERT2 plasmids, and B. Sauer (US National Institutes of Health) for the pBS302_STOP plasmid, obtained through Addgene. We are thankful to E. Azim and A. Dayer for helpful comments on the manuscript, and to A. Zimmerman and F. Smets for help with the experiments. We thank B. Cerutti for help with the statistical analysis. C.B. is supported by an Ambizione grant from the Swiss National Science Foundation. C.L. is supported by the Swiss National Science Foundation. The Jabaudon laboratory is supported by the Swiss National Science Foundation (PP00P3-123447), the Velux Foundation, the 3R Foundation and the Brain and Behavior Research Foundation. N.T. and J.M. are supported by the Swiss National Science Foundation (PP00A-119026). D.J. and N.T. are supported by a joint Leenaards Foundation for Scientific Research Award.	Alcamo EA, 2008, NEURON, V57, P364, DOI 10.1016/j.neuron.2007.12.012; Andjelic S, 2009, J NEUROPHYSIOL, V101, P641, DOI 10.1152/jn.91094.2008; Arlotta P, 2005, NEURON, V45, P207, DOI 10.1016/j.neuron.2004.12.036; Barnabe-Heider F, 2008, NAT METHODS, V5, P189, DOI 10.1038/NMETH.1174; Britanova O, 2008, NEURON, V57, P378, DOI 10.1016/j.neuron.2007.12.028; Brown SP, 2009, NATURE, V457, P1133, DOI 10.1038/nature07658; Callaway EM, 2011, J NEUROSCI, V31, P7456, DOI 10.1523/JNEUROSCI.5222-10.2011; Chen B, 2005, P NATL ACAD SCI USA, V102, P17184, DOI 10.1073/pnas.0508732102; Chen JG, 2005, P NATL ACAD SCI USA, V102, P17792, DOI 10.1073/pnas.0509032102; CONNORS BW, 1990, TRENDS NEUROSCI, V13, P99, DOI 10.1016/0166-2236(90)90185-D; Cubelos B, 2010, NEURON, V66, P523, DOI 10.1016/j.neuron.2010.04.038; Czupryn A, 2011, SCIENCE, V334, P1133, DOI 10.1126/science.1209870; Flames N, 2009, NATURE, V458, P885, DOI 10.1038/nature07929; Garcia NVD, 2011, NATURE, V472, P351, DOI 10.1038/nature09865; Han WQ, 2011, P NATL ACAD SCI USA, V108, P3041, DOI 10.1073/pnas.1016723108; Hensch TK, 2005, NAT REV NEUROSCI, V6, P877, DOI 10.1038/nrn1787; Inda MC, 2006, P NATL ACAD SCI USA, V103, P2920, DOI 10.1073/pnas.0511197103; Jabaudon D, 2012, CEREB CORTEX, V22, P996, DOI 10.1093/cercor/bhr182; Kim J, 2012, CURR OPIN NEUROBIOL, V22, P778, DOI 10.1016/j.conb.2012.05.001; Kwan KY, 2008, P NATL ACAD SCI USA, V105, P16021, DOI 10.1073/pnas.0806791105; Lai T, 2008, NEURON, V57, P232, DOI 10.1016/j.neuron.2007.12.023; Lefort S, 2009, NEURON, V61, P301, DOI 10.1016/j.neuron.2008.12.020; Lorincz A, 2002, NAT NEUROSCI, V5, P1185, DOI 10.1038/nn962; Lowery RL, 2009, DEV NEUROBIOL, V69, P674, DOI 10.1002/dneu.20735; Lubke J, 2000, J NEUROSCI, V20, P5300, DOI 10.1523/JNEUROSCI.20-14-05300.2000; Madisen L, 2010, NAT NEUROSCI, V13, P133, DOI 10.1038/nn.2467; Martinez-Cerdeno V, 2010, CELL STEM CELL, V6, P238, DOI 10.1016/j.stem.2010.01.004; Matsuda T, 2007, P NATL ACAD SCI USA, V104, P1027, DOI 10.1073/pnas.0610155104; Mohn F, 2008, MOL CELL, V30, P755, DOI 10.1016/j.molcel.2008.05.007; Molnar Z, 2006, NEUROSCI RES, V55, P105, DOI 10.1016/j.neures.2006.02.008; Molyneaux BJ, 2005, NEURON, V47, P817, DOI 10.1016/j.neuron.2005.08.030; Molyneaux BJ, 2007, NAT REV NEUROSCI, V8, P427, DOI 10.1038/nrn2151; Nakagawa Y, 2003, DEV NEUROSCI-BASEL, V25, P234, DOI 10.1159/000072271; Narboux-Neme N, 2012, J NEUROSCI, V32, P6183, DOI 10.1523/JNEUROSCI.0343-12.2012; Nieto M, 2004, J COMP NEUROL, V479, P168, DOI 10.1002/cne.20322; Petreanu L, 2007, NAT NEUROSCI, V10, P663, DOI 10.1038/nn1891; Petreanu L, 2009, NATURE, V457, P1142, DOI 10.1038/nature07709; Putignano E, 2007, NEURON, V53, P747, DOI 10.1016/j.neuron.2007.02.007; Schubert D, 2007, BRAIN STRUCT FUNCT, V212, P107, DOI 10.1007/s00429-007-0147-z; Sheets PL, 2011, J NEUROPHYSIOL, V106, P2216, DOI 10.1152/jn.00232.2011; Sperry RW, 1943, J EXP ZOOL, V92, P263, DOI 10.1002/jez.1400920303; Staiger JF, 2004, CEREB CORTEX, V14, P690, DOI 10.1093/cercor/bhh029; SUR M, 1988, SCIENCE, V242, P1437, DOI 10.1126/science.2462279; TERASHIMA T, 1985, J COMP NEUROL, V232, P83, DOI 10.1002/cne.902320108; Vandenbroucke RE, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm440; VANDERLO.H, 1973, SCIENCE, V179, P395, DOI 10.1126/science.179.4071.395; Viaene AN, 2011, J NEUROSCI, V31, P12738, DOI 10.1523/JNEUROSCI.1565-11.2011; Weimann JM, 1999, NEURON, V24, P819, DOI 10.1016/S0896-6273(00)81030-2; Yoneshima H, 2006, NEUROSCIENCE, V137, P401, DOI 10.1016/j.neuroscience.2005.08.075; Yoshimura Y, 2005, NATURE, V433, P868, DOI 10.1038/nature03252	50	133	134	0	33	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	FEB	2013	16	2					193	200		10.1038/nn.3299	http://dx.doi.org/10.1038/nn.3299			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	080RE	23292682				2022-12-28	WOS:000314260200016
J	Arzi, A; Shedlesky, L; Ben-Shaul, M; Nasser, K; Oksenberg, A; Hairston, IS; Sobel, N				Arzi, Anat; Shedlesky, Limor; Ben-Shaul, Mor; Nasser, Khitam; Oksenberg, Arie; Hairston, Ilana S.; Sobel, Noam			Humans can learn new information during sleep	NATURE NEUROSCIENCE			English	Article							FUNCTIONAL CONNECTIVITY; MEMORY; RESPONSES; BRAIN; STATE; EEG; DISCRIMINATION; PATTERNS; IMPLICIT; CORTEX	During sleep, humans can strengthen previously acquired memories, but whether they can acquire entirely new information remains unknown. The nonverbal nature of the olfactory sniff response, in which pleasant odors drive stronger sniffs and unpleasant odors drive weaker sniffs, allowed us to test learning in humans during sleep. Using partial-reinforcement trace conditioning, we paired pleasant and unpleasant odors with different tones during sleep and then measured the sniff response to tones alone during the same nights' sleep and during ensuing wake. We found that sleeping subjects learned novel associations between tones and odors such that they then sniffed in response to tones alone. Moreover, these newly learned tone-induced sniffs differed according to the odor pleasantness that was previously associated with the tone during sleep. This acquired behavior persisted throughout the night and into ensuing wake, without later awareness of the learning process. Thus, humans learned new information during sleep.	[Arzi, Anat; Shedlesky, Limor; Ben-Shaul, Mor; Sobel, Noam] Weizmann Inst Sci, Dept Neurobiol, IL-76100 Rehovot, Israel; [Nasser, Khitam; Oksenberg, Arie] Loewenstein Hosp & Rehabil Ctr, Sleep Disorders Unit, Raanana, Israel; [Hairston, Ilana S.] Acad Coll Tel Aviv Jaffa, Sch Behav Sci, Jaffa, Israel	Weizmann Institute of Science	Arzi, A (corresponding author), Weizmann Inst Sci, Dept Neurobiol, IL-76100 Rehovot, Israel.	anat.arzi@gmail.com	Hairston, Ilana/AAT-7442-2021; Hairston, Ilana/J-3367-2019	Hairston, Ilana/0000-0002-8461-4389; Sobel, Noam/0000-0002-3232-9391; Arzi, Anat/0000-0003-1005-1752	James S. McDonnell Foundation	James S. McDonnell Foundation	We would like to thank R. Paz for advice. This work was supported by the James S. McDonnell Foundation.	Antony JW, 2012, NAT NEUROSCI, V15, P1114, DOI 10.1038/nn.3152; Arzi A, 2010, CHEM SENSES, V35, P31, DOI 10.1093/chemse/bjp079; BADIA P, 1990, PHYSIOL BEHAV, V48, P87, DOI 10.1016/0031-9384(90)90266-7; Barnes DC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018130; BEH HC, 1965, SCIENCE, V147, P1470, DOI 10.1126/science.147.3664.1470; Bekinschtein TA, 2009, NAT NEUROSCI, V12, P1343, DOI 10.1038/nn.2391; Bensafi M, 2003, NAT NEUROSCI, V6, P1142, DOI 10.1038/nn1145; BRAMHAM CR, 1989, BRAIN RES, V493, P74, DOI 10.1016/0006-8993(89)91001-9; Bruce D J, 1970, Nature, V225, P873, DOI 10.1038/225873a0; Carskadon MA, 2004, ANN NY ACAD SCI, V1021, P276, DOI 10.1196/annals.1308.032; Clark RE, 2002, TRENDS COGN SCI, V6, P524, DOI 10.1016/S1364-6613(02)02041-7; Deschenes M, 2012, CURR OPIN NEUROBIOL, V22, P243, DOI 10.1016/j.conb.2011.11.013; Dudai Y, 2012, ANNU REV NEUROSCI, V35, P227, DOI 10.1146/annurev-neuro-062111-150500; EMMONS WH, 1956, AM J PSYCHOL, V69, P76, DOI 10.2307/1418117; Fifer WP, 2010, P NATL ACAD SCI USA, V107, P10320, DOI 10.1073/pnas.1005061107; Gais S, 2004, LEARN MEMORY, V11, P679, DOI 10.1101/lm.80504; Goel N, 2005, CHRONOBIOL INT, V22, P889, DOI 10.1080/07420520500263276; HENNEVIN E, 1995, BEHAV BRAIN RES, V69, P125, DOI 10.1016/0166-4328(95)00013-J; Hennevin E, 2007, NEUROBIOL LEARN MEM, V87, P416, DOI 10.1016/j.nlm.2006.10.006; Iber C., 2007, AASM MANUAL SCORING; Ikeda K, 1996, SLEEP, V19, P72, DOI 10.1093/sleep/19.1.72; LAING DG, 1983, PERCEPTION, V12, P99, DOI 10.1068/p120099; LEHMANN D, 1974, ELECTROEN CLIN NEURO, V37, P73, DOI 10.1016/0013-4694(74)90246-6; Livneh U, 2010, J NEUROSCI METH, V192, P90, DOI 10.1016/j.jneumeth.2010.07.027; MAHO C, 1992, BRAIN RES, V581, P115, DOI 10.1016/0006-8993(92)90350-I; Mainland J, 2006, CHEM SENSES, V31, P181, DOI 10.1093/chemse/bjj012; Marshall L, 2006, NATURE, V444, P610, DOI 10.1038/nature05278; Mednick SC, 2011, TRENDS NEUROSCI, V34, P504, DOI 10.1016/j.tins.2011.06.003; Murakami M, 2005, NEURON, V46, P285, DOI 10.1016/j.neuron.2005.02.025; Nakano T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003912; Nir Y, 2011, NEURON, V70, P153, DOI 10.1016/j.neuron.2011.02.043; Nir Y, 2010, TRENDS COGN SCI, V14, P88, DOI 10.1016/j.tics.2009.12.001; Olbrich E, 2008, J BIOL PHYS, V34, P341, DOI 10.1007/s10867-008-9078-z; Peigneux P, 2001, NEUROREPORT, V12, pA111, DOI 10.1097/00001756-200112210-00001; Portas CM, 2000, NEURON, V28, P991, DOI 10.1016/S0896-6273(00)00169-0; Price JL, 1990, HUMAN NERVOUS SYSTEM, P979; Rasch B, 2007, SCIENCE, V315, P1426, DOI 10.1126/science.1138581; Resnik J, 2011, NAT NEUROSCI, V14, P791, DOI 10.1038/nn.2802; Rudoy JD, 2009, SCIENCE, V326, P1079, DOI 10.1126/science.1179013; SIMON CW, 1956, J EXP PSYCHOL, V51, P89, DOI 10.1037/h0043637; Stuck BA, 2007, SLEEP, V30, P506, DOI 10.1093/sleep/30.4.506; TANI K, 1970, BRAIN RES, V17, P277, DOI 10.1016/0006-8993(70)90082-X; Vyazovskiy VV, 2011, NATURE, V472, P443, DOI 10.1038/nature10009; Walker MP, 2006, ANNU REV PSYCHOL, V57, P139, DOI 10.1146/annurev.psych.56.091103.070307; Weinberger NM, 1998, NEUROBIOL LEARN MEM, V70, P226, DOI 10.1006/nlme.1998.3850; Wilson DA, 2011, NEUROSCI LETT, V497, P69, DOI 10.1016/j.neulet.2011.04.031; Wilson DA, 2010, J NEUROPHYSIOL, V104, P3231, DOI 10.1152/jn.00711.2010; Wilson DA, 2010, J NEUROSCI, V30, P1760, DOI 10.1523/JNEUROSCI.5636-09.2010; WOOD JM, 1992, PSYCHOL SCI, V3, P236, DOI 10.1111/j.1467-9280.1992.tb00035.x; Woodruff-Pak DS, 2008, TRENDS NEUROSCI, V31, P105, DOI 10.1016/j.tins.2007.11.006	50	130	137	4	117	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	OCT	2012	15	10					1460	1465		10.1038/nn.3193	http://dx.doi.org/10.1038/nn.3193			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	013VZ	22922782				2022-12-28	WOS:000309335300028
J	Um, JW; Nygaard, HB; Heiss, JK; Kostylev, MA; Stagi, M; Vortmeyer, A; Wisniewski, T; Gunther, EC; Strittmatter, SM				Um, Ji Won; Nygaard, Haakon B.; Heiss, Jacqueline K.; Kostylev, Mikhail A.; Stagi, Massimiliano; Vortmeyer, Alexander; Wisniewski, Thomas; Gunther, Erik C.; Strittmatter, Stephen M.			Alzheimer amyloid-beta oligomer bound to postsynaptic prion protein activates Fyn to impair neurons	NATURE NEUROSCIENCE			English	Article							LONG-TERM POTENTIATION; D-ASPARTATE RECEPTOR; NR2B-CONTAINING NMDA-RECEPTORS; TYROSINE PHOSPHORYLATION; SYNAPTIC PLASTICITY; SIGNAL-TRANSDUCTION; PROTEOMIC ANALYSIS; MASS-SPECTROMETRY; TRANSGENIC MICE; MOUSE MODELS	Amyloid-beta (A beta) oligomers are thought to trigger Alzheimer's disease pathophysiology. Cellular prion protein (PrPC) selectively binds oligomeric A beta and can mediate Alzheimer's disease-related phenotypes. We examined the specificity, distribution and signaling of A beta-PrPC complexes, seeking to understand how they might alter the function of NMDA receptors (NMDARs) in neurons. PrPC is enriched in postsynaptic densities, and A beta-PrPC interaction leads to Fyn kinase activation. Soluble A beta assemblies derived from the brains of individuals with Alzheimer's disease interacted with PrPC to activate Fyn. A beta engagement of PrPC-Fyn signaling yielded phosphorylation of the NR2B subunit of NMDARs, which was coupled to an initial increase and then a loss of surface NMDARs. A beta-induced dendritic spine loss and lactate dehydrogenase release required both PrPC and Fyn, and human familial Alzheimer's disease transgene-induced convulsive seizures did not occur in mice lacking PrPC. These results delineate an A beta oligomer signal transduction pathway that requires PrPC and Fyn to alter synaptic function, with deleterious consequences in Alzheimer's disease.	[Um, Ji Won; Nygaard, Haakon B.; Heiss, Jacqueline K.; Kostylev, Mikhail A.; Stagi, Massimiliano; Gunther, Erik C.; Strittmatter, Stephen M.] Yale Univ, Sch Med, Dept Neurol, Cellular Neurosci Neurodegenerat & Repair Program, New Haven, CT 06510 USA; [Um, Ji Won; Nygaard, Haakon B.; Heiss, Jacqueline K.; Kostylev, Mikhail A.; Stagi, Massimiliano; Gunther, Erik C.; Strittmatter, Stephen M.] Yale Univ, Sch Med, Dept Neurobiol, New Haven, CT 06510 USA; [Vortmeyer, Alexander] Yale Univ, Sch Med, Dept Pathol, New Haven, CT 06510 USA; [Wisniewski, Thomas] NYU, Sch Med, Dept Neurol, New York, NY USA	Yale University; Yale University; Yale University; New York University	Strittmatter, SM (corresponding author), Yale Univ, Sch Med, Dept Neurol, Cellular Neurosci Neurodegenerat & Repair Program, New Haven, CT 06510 USA.	stephen.strittmatter@yale.edu	Wisniewski, Thomas/Q-6525-2019; Stagi, Massimiliano/ABF-5894-2020; Strittmatter, Stephen/F-5739-2011	Wisniewski, Thomas/0000-0002-3379-8966; Stagi, Massimiliano/0000-0002-5827-902X; Kostylev, Mikhail/0000-0003-0435-8141; Strittmatter, Stephen/0000-0001-8188-3092	US National Institutes of Health [R01AG034924, R37NS033020, R01NS074319, P30DA018343, R01NS47433, R01NS073502]; Falk Medical Research Trust; Alzheimer's Association; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS073502, R37NS033020, R01NS074319, R01NS047433] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG034924, R01AG020245, P30AG008051] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [P30DA018343] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Falk Medical Research Trust; Alzheimer's Association(Alzheimer's Association); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	H.B.N. is an Ellison Medical Foundation American Federation for Aging Research Postdoctoral Fellow and S. M. S. is a member of the Kavli Institute for Neuroscience at Yale University. We acknowledge support from the US National Institutes of Health (R01AG034924, R37NS033020, R01NS074319 and P30DA018343), the Falk Medical Research Trust and the Alzheimer's Association (S. M. S.), and from the US National Institutes of Health (R01NS47433 and R01NS073502; T.W.).	Alier K, 2011, J NEUROSCI, V31, P16292, DOI 10.1523/JNEUROSCI.4367-11.2011; Balducci C, 2010, P NATL ACAD SCI USA, V107, P2295, DOI 10.1073/pnas.0911829107; Barry AE, 2011, J NEUROSCI, V31, P7259, DOI 10.1523/JNEUROSCI.6500-10.2011; Bate C, 2011, J BIOL CHEM, V286, P37955, DOI 10.1074/jbc.M111.248724; Bizat N, 2010, J NEUROSCI, V30, P5394, DOI 10.1523/JNEUROSCI.5831-09.2010; Calella AM, 2010, EMBO MOL MED, V2, P306, DOI 10.1002/emmm.201000082; Chen P, 2007, MOL PHARMACOL, V72, P40, DOI 10.1124/mol.107.034942; Chen SG, 2010, J BIOL CHEM, V285, P26377, DOI 10.1074/jbc.M110.145516; Chin J, 2005, J NEUROSCI, V25, P9694, DOI 10.1523/JNEUROSCI.2980-05.2005; Chung E, 2010, BMC NEUROSCI, V11, DOI 10.1186/1471-2202-11-130; Cisse M, 2011, J NEUROSCI, V31, P10427, DOI 10.1523/JNEUROSCI.1459-11.2011; Collins MO, 2006, J NEUROCHEM, V97, P16, DOI 10.1111/j.1471-4159.2005.03507.x; Freir DB, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1341; Gimbel DA, 2010, J NEUROSCI, V30, P6367, DOI 10.1523/JNEUROSCI.0395-10.2010; GRANT SGN, 1992, SCIENCE, V258, P1903, DOI 10.1126/science.1361685; Ittner LM, 2010, CELL, V142, P387, DOI 10.1016/j.cell.2010.06.036; Kessels HW, 2010, NATURE, V466, pE3, DOI 10.1038/nature09217; Kojima N, 1998, LEARN MEMORY, V5, P429; Kudo W, 2012, HUM MOL GENET, V21, P1138, DOI 10.1093/hmg/ddr542; Kuo YM, 1996, J BIOL CHEM, V271, P4077; Lambert MP, 1998, P NATL ACAD SCI USA, V95, P6448, DOI 10.1073/pnas.95.11.6448; Lauren J, 2009, NATURE, V457, P1128, DOI 10.1038/nature07761; Lesne S, 2006, NATURE, V440, P352, DOI 10.1038/nature04533; Li SM, 2011, J NEUROSCI, V31, P6627, DOI 10.1523/JNEUROSCI.0203-11.2011; Malaga-Trillo E, 2009, PLOS BIOL, V7, P576, DOI 10.1371/journal.pbio.1000055; Mc Donald JM, 2010, BRAIN, V133, P1328, DOI 10.1093/brain/awq065; Minkeviciene R, 2009, J NEUROSCI, V29, P3453, DOI 10.1523/JNEUROSCI.5215-08.2009; Mouillet-Richard S, 2007, ANN NY ACAD SCI, V1096, P106, DOI 10.1196/annals.1397.076; Nakazawa T, 2001, J BIOL CHEM, V276, P693, DOI 10.1074/jbc.M008085200; Palop JJ, 2007, NEURON, V55, P697, DOI 10.1016/j.neuron.2007.07.025; Pantera B, 2009, J NEUROCHEM, V110, P194, DOI 10.1111/j.1471-4159.2009.06123.x; Peng JM, 2004, J BIOL CHEM, V279, P21003, DOI 10.1074/jbc.M400103200; Prybylowski K, 2005, NEURON, V47, P845, DOI 10.1016/j.neuron.2005.08.016; Renner M, 2010, NEURON, V66, P739, DOI 10.1016/j.neuron.2010.04.029; Resenberger UK, 2011, EMBO J, V30, P2057, DOI 10.1038/emboj.2011.86; Salter MW, 2004, NAT REV NEUROSCI, V5, P317, DOI 10.1038/nrn1368; SCHEFF SW, 1990, NEUROBIOL AGING, V11, P29, DOI 10.1016/0197-4580(90)90059-9; Shankar GM, 2008, NAT MED, V14, P837, DOI 10.1038/nm1782; Snyder EM, 2005, NAT NEUROSCI, V8, P1051, DOI 10.1038/nn1503; STEIN PL, 1992, CELL, V70, P741, DOI 10.1016/0092-8674(92)90308-Y; Steinerman JR, 2008, ARCH NEUROL-CHICAGO, V65, P906, DOI 10.1001/archneur.65.7.906; Stuermer CAO, 2004, FASEB J, V18, P1731, DOI 10.1096/fj.04-2150fje; SUZUKI T, 1995, BIOCHEM BIOPH RES CO, V216, P582, DOI 10.1006/bbrc.1995.2662; Walsh DM, 2002, NATURE, V416, P535, DOI 10.1038/416535a; Williamson R, 2008, FASEB J, V22, P1552, DOI 10.1096/fj.07-9766com; Yoshimura Y, 2004, J NEUROCHEM, V88, P759, DOI 10.1046/j.1471-4159.2003.02136.x; You HT, 2012, P NATL ACAD SCI USA, V109, P1737, DOI 10.1073/pnas.1110789109; Zahn R, 1997, FEBS LETT, V417, P400, DOI 10.1016/S0014-5793(97)01330-6; Zhang YF, 2010, P NATL ACAD SCI USA, V107, P19014, DOI 10.1073/pnas.1013543107; Zou WQ, 2011, J BIOL CHEM, V286, P15095, DOI 10.1074/jbc.M110.199356	52	469	490	5	125	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	SEP	2012	15	9					1227	U85		10.1038/nn.3178	http://dx.doi.org/10.1038/nn.3178			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	996GJ	22820466	Green Accepted			2022-12-28	WOS:000308072600013
J	Dietrich, MO; Bober, J; Ferreira, JG; Tellez, LA; Mineur, YS; Souza, DO; Gao, XB; Picciotto, MR; Araujo, I; Liu, ZW; Horvath, TL				Dietrich, Marcelo O.; Bober, Jeremy; Ferreira, Jozelia G.; Tellez, Luis A.; Mineur, Yann S.; Souza, Diogo O.; Gao, Xiao-Bing; Picciotto, Marina R.; Araujo, Ivan; Liu, Zhong-Wu; Horvath, Tamas L.			AgRP neurons regulate development of dopamine neuronal plasticity and nonfood-associated behaviors	NATURE NEUROSCIENCE			English	Article							MICE; RAT	It is not known whether behaviors unrelated to feeding are affected by hypothalamic regulators of hunger. We found that impairment of Agouti-related protein (AgRP) circuitry by either Sirt1 knockdown in AgRP-expressing neurons or early postnatal ablation of these neurons increased exploratory behavior and enhanced responses to cocaine. In AgRP circuit-impaired mice, ventral tegmental dopamine neurons exhibited enhanced spike timing-dependent long-term potentiation, altered amplitude of miniature postsynaptic currents and elevated dopamine in basal forebrain. Thus, AgRP neurons determine the set point of the reward circuitry and associated behaviors.	[Dietrich, Marcelo O.; Bober, Jeremy; Gao, Xiao-Bing; Liu, Zhong-Wu; Horvath, Tamas L.] Yale Univ, Sch Med, Comparat Med Sect, Program Integrat Cell Signaling & Neurobiol Metab, New Haven, CT 06520 USA; [Dietrich, Marcelo O.; Souza, Diogo O.] Univ Fed Rio Grande do Sul, Dept Biochem, Porto Alegre, RS, Brazil; [Ferreira, Jozelia G.; Tellez, Luis A.; Mineur, Yann S.; Picciotto, Marina R.; Araujo, Ivan] Yale Univ, Sch Med, Dept Psychiat, New Haven, CT USA; [Ferreira, Jozelia G.; Tellez, Luis A.; Araujo, Ivan] John B Pierce Fdn Lab, New Haven, CT 06519 USA; [Horvath, Tamas L.] Yale Univ, Sch Med, Dept Obstet, New Haven, CT USA; [Horvath, Tamas L.] Yale Univ, Sch Med, Dept Gynecol & Reprod Sci, New Haven, CT USA; [Horvath, Tamas L.] Yale Univ, Sch Med, Dept Neurobiol, New Haven, CT USA	Yale University; Universidade Federal do Rio Grande do Sul; Yale University; Yale University; The John B Pierce Laboratory, Inc; Yale University; Yale University; Yale University	Horvath, TL (corresponding author), Yale Univ, Sch Med, Comparat Med Sect, Program Integrat Cell Signaling & Neurobiol Metab, New Haven, CT 06520 USA.	tamas.horvath@yale.edu	Ferreira, Jozelia/C-5724-2015; Liu, Zhong-Wu/C-2794-2011; Souza, Diogo O/J-8894-2014; Dietrich, Marcelo/A-9928-2009; Gao, Xiao-Bing/C-3121-2011; Picciotto, Marina R./F-8747-2012; Mineur, Yann/E-2487-2018	Ferreira, Jozelia/0000-0003-0097-3104; Souza, Diogo O/0000-0002-4322-0404; Dietrich, Marcelo/0000-0001-9781-2221; Gao, Xiao-Bing/0000-0002-2035-4936; Picciotto, Marina R./0000-0002-4404-1280; Mineur, Yann/0000-0002-8030-6776; Tellez, Luis A/0000-0002-3101-5817	US National Institutes of Health; National Institute on Deafness and Other Communication Disorders (US National Institutes of Health); Financiadora de Estudos e Projetos/Ministerio de Ciencia e Tecnologia (FINEP/MCT, Brazil); Instituto Nacional de Ciencia e Tecnologia em Excitotoxicidade e Neuroprotecao (Brazil); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (Brazil); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK080000, DP1DK098058] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute on Deafness and Other Communication Disorders (US National Institutes of Health)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); Financiadora de Estudos e Projetos/Ministerio de Ciencia e Tecnologia (FINEP/MCT, Brazil); Instituto Nacional de Ciencia e Tecnologia em Excitotoxicidade e Neuroprotecao (Brazil); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (Brazil)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank L. Kus from the GENSTAT Project, which provided important information on the AgRP-EGFP mouse (MT25), A. Xu for providing breeding pairs of AgRP-Cre mice (University of California San Francisco), R. Palmiter for providing breeding pairs of the AgRP-DTR mice (University of Washington), and the personnel of the Horvath laboratory for support. This work was supported by a US National Institutes of Health Director's Pioneer Award to T.L.H. I.A. was supported by National Institute on Deafness and Other Communication Disorders (US National Institutes of Health) grants. D.O.S. was supported by grants from Financiadora de Estudos e Projetos/Ministerio de Ciencia e Tecnologia (FINEP/MCT, Brazil) and Instituto Nacional de Ciencia e Tecnologia em Excitotoxicidade e Neuroprotecao (Brazil). M.O.D. was partially supported by Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (Brazil).	Abizaid A, 2006, J CLIN INVEST, V116, P3229, DOI 10.1172/JCI29867; Broberger C, 1998, P NATL ACAD SCI USA, V95, P15043, DOI 10.1073/pnas.95.25.15043; Brunzell DH, 2009, NEUROPSYCHOPHARMACOL, V34, P1993, DOI 10.1038/npp.2009.11; Dietrich MO, 2010, J NEUROSCI, V30, P11815, DOI 10.1523/JNEUROSCI.2234-10.2010; Dulawa SC, 1999, J NEUROSCI, V19, P9550; Gropp E, 2005, NAT NEUROSCI, V8, P1289, DOI 10.1038/nn1548; Horvath TL, 1997, BRAIN RES, V756, P283, DOI 10.1016/S0006-8993(97)00184-4; Kazlauckas V, 2005, BEHAV BRAIN RES, V162, P272, DOI 10.1016/j.bbr.2005.03.021; Korotkova TM, 2006, EUR J NEUROSCI, V23, P2677, DOI 10.1111/j.1460-9568.2006.04792.x; Liu QS, 2005, NATURE, V437, P1027, DOI 10.1038/nature04050; Luquet S, 2005, SCIENCE, V310, P683, DOI 10.1126/science.1115524; Tang-Christensen M, 2004, ENDOCRINOLOGY, V145, P4645, DOI 10.1210/en.2004-0529; Wu Q, 2008, J NEUROSCI, V28, P9218, DOI 10.1523/JNEUROSCI.2449-08.2008; Wu Q, 2009, CELL, V137, P1225, DOI 10.1016/j.cell.2009.04.022	14	108	111	0	18	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	AUG	2012	15	8					1108	+		10.1038/nn.3147	http://dx.doi.org/10.1038/nn.3147			5	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	979UE	22729177	Green Accepted			2022-12-28	WOS:000306844500014
J	Hu, JH; Yang, LL; Kammermeier, PJ; Moore, CG; Brakeman, PR; Tu, JC; Yu, SY; Petralia, RS; Li, Z; Zhang, PW; Park, JM; Dong, XZ; Xiao, B; Worley, PF				Hu, Jia-Hua; Yang, Linlin; Kammermeier, Paul J.; Moore, Chester G.; Brakeman, Paul R.; Tu, Jiancheng; Yu, Shouyang; Petralia, Ronald S.; Li, Zhe; Zhang, Ping-Wu; Park, Joo Min; Dong, Xinzhong; Xiao, Bo; Worley, Paul F.			Preso1 dynamically regulates group I metabotropic glutamate receptors	NATURE NEUROSCIENCE			English	Article							LONG-TERM DEPRESSION; PROTEIN-KINASES; HOMER BINDS; ACTIVATION; MGLUR5; DOMAIN; PDZ; PHOSPHORYLATION; DESENSITIZATION; POTENTIATION	Group I metabotropic glutamate receptors (mGluRs), including mGluR1 and mGluR5, are G protein-coupled receptors (GPCRs) that are expressed at excitatory synapses in brain and spinal cord. GPCRs are often negatively regulated by specific G protein-coupled receptor kinases and subsequent binding of arrestin-like molecules. Here we demonstrate an alternative mechanism in which group I mGluRs are negatively regulated by proline-directed kinases that phosphorylate the binding site for the adaptor protein Homer, and thereby enhance mGluR-Homer binding to reduce signaling. This mechanism is dependent on a multidomain scaffolding protein, Preso1, that binds mGluR, Homer and proline-directed kinases and that is required for their phosphorylation of mGluR at the Homer binding site. Genetic ablation of Preso1 prevents dynamic phosphorylation of mGluR5, and Preso1(-/-) mice exhibit sustained, mGluR5-dependent inflammatory pain that is linked to enhanced mGluR signaling. Preso1 creates a microdomain for proline-directed kinases with broad substrate specificity to phosphorylate mGluR and to mediate negative regulation.	[Hu, Jia-Hua; Yang, Linlin; Moore, Chester G.; Brakeman, Paul R.; Tu, Jiancheng; Li, Zhe; Zhang, Ping-Wu; Park, Joo Min; Dong, Xinzhong; Xiao, Bo; Worley, Paul F.] Johns Hopkins Univ, Sch Med, Solomon H Snyder Dept Neurosci, Baltimore, MD 21218 USA; [Kammermeier, Paul J.] Univ Rochester, Med Ctr, Dept Pharmacol & Physiol, Rochester, NY 14642 USA; [Yu, Shouyang; Xiao, Bo] Sichuan Univ, W China Hosp, State Key Lab Biotherapy, Chengdu 610064, Peoples R China; [Petralia, Ronald S.] US Natl Inst Hlth, Nat Inst Deafness & Other Commun Disorders, Bethesda, MD USA; [Dong, Xinzhong] Johns Hopkins Univ, Sch Med, Howard Hughes Med Inst, Baltimore, MD USA; [Worley, Paul F.] Johns Hopkins Univ Hosp, Sch Med, Dept Neurol, Baltimore, MD 21287 USA	Johns Hopkins University; University of Rochester; Sichuan University; National Institutes of Health (NIH) - USA; NIH National Institute on Deafness & Other Communication Disorders (NIDCD); Howard Hughes Medical Institute; Johns Hopkins University; Johns Hopkins University; Johns Hopkins Medicine	Worley, PF (corresponding author), Johns Hopkins Univ, Sch Med, Solomon H Snyder Dept Neurosci, Baltimore, MD 21218 USA.	pworley@jhmi.edu		Xiao, Bo/0000-0002-6161-9478	US National Institutes of Health from the National Institute on Drug Abuse [DA010309]; National Institute of Mental Health [MH084020]; National Institute of Neurological Disorders and Stroke [NS050274, NS054791, GM087369]; National 973 Basic Research Program of China [20009CB941400]; National Institute on Deafness and Other Communication Disorders; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM087369] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH084020] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [ZIADC000003, ZICDC000081] Funding Source: NIH RePORTER	US National Institutes of Health from the National Institute on Drug Abuse; National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National 973 Basic Research Program of China(National Basic Research Program of China); National Institute on Deafness and Other Communication Disorders(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	We thank J. Roder of University of Toronto for Grm5<SUP>-/-</SUP> mice, J. Worley for help with behavioral experiments and Y.-X. Wang for help with the immunogold. This work was supported by US National Institutes of Health grants from the National Institute on Drug Abuse (DA010309), National Institute of Mental Health (MH084020) and National Institute of Neurological Disorders and Stroke (NS050274 (P.F.W.); NS054791 and GM087369 (X.D.)); National 973 Basic Research Program of China (20009CB941400; B.X.); and the National Institute on Deafness and Other Communication Disorders Intramural Research Program (R.S.P.).	Alvarez FJ, 2000, J COMP NEUROL, V422, P464, DOI 10.1002/1096-9861(20000703)422:3<464::AID-CNE11>3.0.CO;2-#; An NF, 2008, J BIOL CHEM, V283, P24718, DOI 10.1074/jbc.M803497200; Ango F, 2001, NATURE, V411, P962, DOI 10.1038/35082096; Bear MF, 2005, GENES BRAIN BEHAV, V4, P393, DOI 10.1111/j.1601-183X.2005.00135.x; Bernier SG, 2000, J BIOL CHEM, V275, P30707, DOI 10.1074/jbc.M005116200; Bhave G, 2001, NAT NEUROSCI, V4, P417, DOI 10.1038/86075; Brakeman PR, 1997, NATURE, V386, P284, DOI 10.1038/386284a0; Chiamulera C, 2001, NAT NEUROSCI, V4, P873, DOI 10.1038/nn0901-873; CHOI KY, 1994, CELL, V78, P499; Cozzoli DK, 2009, J NEUROSCI, V29, P8655, DOI 10.1523/JNEUROSCI.5900-08.2009; Dhami GK, 2006, PHARMACOL THERAPEUT, V111, P260, DOI 10.1016/j.pharmthera.2005.01.008; Dhavan R, 2001, NAT REV MOL CELL BIO, V2, P749, DOI 10.1038/35096019; Ferreira LT, 2009, J BIOL CHEM, V284, P28986, DOI 10.1074/jbc.M109.050872; Gainetdinov RR, 2004, ANNU REV NEUROSCI, V27, P107, DOI 10.1146/annurev.neuro.27.070203.144206; Galante M, 2004, J NEUROSCI, V24, P4865, DOI 10.1523/JNEUROSCI.0403-04.2004; Gallagher SM, 2004, J NEUROSCI, V24, P4859, DOI 10.1523/JNEUROSCI.5407-03.2004; Hoover KB, 2000, CURR OPIN CELL BIOL, V12, P229, DOI 10.1016/S0955-0674(99)00080-0; Hou LF, 2004, J NEUROSCI, V24, P6352, DOI 10.1523/JNEUROSCI.0995-04.2004; Hu HJ, 2007, J NEUROSCI, V27, P13181, DOI 10.1523/JNEUROSCI.0269-07.2007; Hu JH, 2010, NEURON, V68, P1128, DOI 10.1016/j.neuron.2010.11.008; Huang GN, 2008, SCIENCE, V319, P476, DOI 10.1126/science.1151227; HUNSKAAR S, 1987, PAIN, V30, P103, DOI 10.1016/0304-3959(87)90088-1; Kammermeier PJ, 1999, NEURON, V22, P819, DOI 10.1016/S0896-6273(00)80740-0; Kammermeier PJ, 2000, J NEUROSCI, V20, P7238; Kim AY, 2008, CELL, V133, P475, DOI 10.1016/j.cell.2008.02.053; Kim SJ, 2008, J NEUROSCI, V28, P4350, DOI 10.1523/JNEUROSCI.0284-08.2008; Kitano J, 2002, J NEUROSCI, V22, P1280, DOI 10.1523/JNEUROSCI.22-04-01280.2002; Latremoliere A, 2009, J PAIN, V10, P895, DOI 10.1016/j.jpain.2009.06.012; Lee HW, 2008, J NEUROSCI, V28, P14546, DOI 10.1523/JNEUROSCI.3112-08.2008; Liu Q, 2009, CELL, V139, P1353, DOI 10.1016/j.cell.2009.11.034; Lu YM, 1997, J NEUROSCI, V17, P5196; Lujan R, 1996, EUR J NEUROSCI, V8, P1488, DOI 10.1111/j.1460-9568.1996.tb01611.x; Luscher C, 2010, NEURON, V65, P445, DOI 10.1016/j.neuron.2010.01.016; Neugebauer V, 2003, J NEUROSCI, V23, P52; Niswender CM, 2010, ANNU REV PHARMACOL, V50, P295, DOI 10.1146/annurev.pharmtox.011008.145533; Orlando LR, 2009, J NEUROCHEM, V110, P557, DOI 10.1111/j.1471-4159.2009.06139.x; Park S, 2008, NEURON, V59, P70, DOI 10.1016/j.neuron.2008.05.023; Petralia RS, 1999, NAT NEUROSCI, V2, P31, DOI 10.1038/4532; Puig S, 1996, PAIN, V64, P345, DOI 10.1016/0304-3959(95)00121-2; Rocher JP, 2011, CURR TOP MED CHEM, V11, P680, DOI 10.2174/1568026611109060680; Segal RA, 1996, ANNU REV NEUROSCI, V19, P463, DOI 10.1146/annurev.ne.19.030196.002335; Sharrocks AD, 2000, TRENDS BIOCHEM SCI, V25, P448, DOI 10.1016/S0968-0004(00)01627-3; SHENG M, 1990, NEURON, V4, P571, DOI 10.1016/0896-6273(90)90115-V; Torres GE, 2007, CURR OPIN NEUROBIOL, V17, P304, DOI 10.1016/j.conb.2007.05.002; Tronson NC, 2010, BIOL PSYCHIAT, V68, P1007, DOI 10.1016/j.biopsych.2010.09.004; Tu JC, 1998, NEURON, V21, P717, DOI 10.1016/S0896-6273(00)80589-9; Utreras Elias, 2009, Drug Discov Today Ther Strateg, V6, P105, DOI 10.1016/j.ddstr.2009.04.004; Wang H, 2009, SCIENCE, V326, P1554, DOI 10.1126/science.1178496; Wang JQ, 2007, J NEUROCHEM, V100, P1, DOI 10.1111/j.1471-4159.2006.04208.x; Wong W, 2004, NAT REV MOL CELL BIO, V5, P959, DOI 10.1038/nrm1527; Xiao B, 1998, NEURON, V21, P707, DOI 10.1016/S0896-6273(00)80588-7; Yuan JP, 2003, CELL, V114, P777, DOI 10.1016/S0092-8674(03)00716-5; Zhong HN, 2009, NEURON, V62, P363, DOI 10.1016/j.neuron.2009.03.013	53	67	67	5	22	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUN	2012	15	6					836	U55		10.1038/nn.3103	http://dx.doi.org/10.1038/nn.3103			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	949AI	22561452	Green Accepted			2022-12-28	WOS:000304546700010
J	Buckholtz, JW; Marois, R				Buckholtz, Joshua W.; Marois, Rene			The roots of modern justice: cognitive and neural foundations of social norms and their enforcement	NATURE NEUROSCIENCE			English	Article							ALTRUISTIC PUNISHMENT; EVOLUTION; COOPERATION; RECIPROCITY; MECHANISMS; FAIRNESS; REWARD; BLAME; BRAIN	Among animals, Homo sapiens is unique in its capacity for widespread cooperation and prosocial behavior among large and genetically heterogeneous groups of individuals. This ultra-sociality figures largely in our success as a species. It is also an enduring evolutionary mystery. There is considerable support for the hypothesis that this facility is a function of our ability to establish, and enforce through sanctions, social norms. Third-party punishment of norm violations ("I punish you because you harmed him") seems especially crucial for the evolutionary stability of cooperation and is the cornerstone of modern systems of criminal justice. In this commentary, we outline some potential cognitive and neural processes that may underlie the ability to learn norms, to follow norms and to enforce norms through third-party punishment. We propose that such processes depend on several domain-general cognitive functions that have been repurposed, through evolution's thrift, to perform these roles.	[Buckholtz, Joshua W.] Harvard Univ, Dept Psychol, Cambridge, MA 02138 USA; [Buckholtz, Joshua W.] Harvard Univ, Ctr Brain Sci, Cambridge, MA 02138 USA; [Buckholtz, Joshua W.] Massachusetts Gen Hosp, Dept Psychiat, Div Psychiat Neuroimaging, Boston, MA 02114 USA; [Marois, Rene] Vanderbilt Univ, Dept Psychol, Nashville, TN 37240 USA; [Marois, Rene] Vanderbilt Univ, Ctr Integrated & Cognit Neurosci, Nashville, TN USA	Harvard University; Harvard University; Harvard University; Massachusetts General Hospital; Vanderbilt University; Vanderbilt University	Buckholtz, JW (corresponding author), Harvard Univ, Dept Psychol, 33 Kirkland St, Cambridge, MA 02138 USA.	joshuabuckholtz@fas.harvard.edu; rene.marois@vanderbilt.edu	Carroll, Joseph/D-1158-2011; Buckholtz, Joshua/E-7299-2010	Carroll, Joseph/0000-0003-2656-1378; Buckholtz, Joshua/0000-0002-9418-8686	MacArthur Foundation Research Network on Law and Neuroscience [KK9127, KK1031]	MacArthur Foundation Research Network on Law and Neuroscience	We thank K. Jan for literature research and O. Jones for comments on an earlier draft of this manuscript, and the MacArthur Foundation Research Network on Law and Neuroscience for support (KK9127 and KK1031).	Balleine BW, 2007, J NEUROSCI, V27, P8161, DOI 10.1523/JNEUROSCI.1554-07.2007; Bendor J, 2001, AM J SOCIOL, V106, P1493, DOI 10.1086/321298; Bicchieri C., 2006, GRAMMAR SOC; Bowles S, 2004, THEOR POPUL BIOL, V65, P17, DOI 10.1016/j.tpb.2003.07.001; BOYD R, 1988, J THEOR BIOL, V132, P337, DOI 10.1016/S0022-5193(88)80219-4; Boyd R, 2011, P NATL ACAD SCI USA, V108, P10918, DOI 10.1073/pnas.1100290108; Boyd R, 2010, SCIENCE, V328, P617, DOI 10.1126/science.1183665; Bright DA, 2006, LAW HUMAN BEHAV, V30, P183, DOI 10.1007/s10979-006-9027-y; Buckholtz JW, 2008, NEURON, V60, P930, DOI 10.1016/j.neuron.2008.10.016; Buckner RL, 2008, ANN NY ACAD SCI, V1124, P1, DOI 10.1196/annals.1440.011; Burke CJ, 2010, P NATL ACAD SCI USA, V107, P14431, DOI 10.1073/pnas.1003111107; Churchland PS, 2011, BRAINTRUST: WHAT NEUROSCIENCE TELLS US ABOUT MORALITY, P27; Crockett MJ, 2010, EMOTION, V10, P855, DOI 10.1037/a0019861; Cushman F, 2012, SOC NEUROSCI-UK, V7, P269, DOI 10.1080/17470919.2011.614000; Darley JM, 2009, ANNU REV LAW SOC SCI, V5, P1, DOI 10.1146/annurev.lawsocsci.4.110707.172335; Dehaene S, 1999, SCIENCE, V284, P970, DOI 10.1126/science.284.5416.970; Duncan J, 2010, TRENDS COGN SCI, V14, P172, DOI 10.1016/j.tics.2010.01.004; Fehr E, 2002, NATURE, V415, P137, DOI 10.1038/415137a; Fehr E, 2004, TRENDS COGN SCI, V8, P185, DOI 10.1016/j.tics.2004.02.007; Fehr E, 2004, EVOL HUM BEHAV, V25, P63, DOI 10.1016/S1090-5138(04)00005-4; Feigenson N, 2006, LAW HUMAN BEHAV, V30, P143, DOI 10.1007/s10979-006-9026-z; Gospic K, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001054; Haidt J, 2003, SER AFFECTIVE SCI, P852; HAMILTON WD, 1964, J THEOR BIOL, V7, P1, DOI [10.1016/0022-5193(64)90038-4, 10.1016/0022-5193(64)90039-6]; Heekeren HR, 2005, NEUROIMAGE, V24, P887, DOI 10.1016/j.neuroimage.2004.09.026; Henrich J, 2006, SCIENCE, V312, P1767, DOI 10.1126/science.1127333; Henrich J, 2010, SCIENCE, V327, P1480, DOI 10.1126/science.1182238; Jensen K, 2007, P NATL ACAD SCI USA, V104, P13046, DOI 10.1073/pnas.0705555104; Kitcher P, 2011, ETHICAL PROJECT; Knoch D, 2006, SCIENCE, V314, P829, DOI 10.1126/science.1129156; Knoch D, 2009, P NATL ACAD SCI USA, V106, P20895, DOI 10.1073/pnas.0911619106; Koenigs M, 2010, NEUROPSYCHOLOGIA, V48, P2198, DOI 10.1016/j.neuropsychologia.2010.04.012; Krajbich I, 2009, J NEUROSCI, V29, P2188, DOI 10.1523/JNEUROSCI.5086-08.2009; LAFAVE WR, 2003, CRIMINAL LAW; Marlowe FW, 2011, P ROY SOC B-BIOL SCI, V278, P2159, DOI 10.1098/rspb.2010.2342; Mikhail J, 2007, TRENDS COGN SCI, V11, P143, DOI 10.1016/j.tics.2006.12.007; Miller EK, 2001, ANNU REV NEUROSCI, V24, P167, DOI 10.1146/annurev.neuro.24.1.167; O'Doherty JP, 2004, CURR OPIN NEUROBIOL, V14, P769, DOI 10.1016/j.conb.2004.10.016; Oswald ME, 2005, J APPL SOC PSYCHOL, V35, P718, DOI 10.1111/j.1559-1816.2005.tb02143.x; Pinker S., 2011, BETTER ANGELS OUR NA; Rand DG, 2009, SCIENCE, V325, P1272, DOI 10.1126/science.1177418; Reidl K., 2010, INT J PRIM ABSTR, V314; Robinson PH, 2007, VANDERBILT LAW REV, V60, P1633; Sanfey AG, 2003, SCIENCE, V300, P1755, DOI 10.1126/science.1082976; Seymour B, 2007, NAT REV NEUROSCI, V8, P300, DOI 10.1038/nrn2119; Shen FX, 2011, NEW YORK U LAW REV, V86, P1306; Spitzer M, 2007, NEURON, V56, P185, DOI 10.1016/j.neuron.2007.09.011; Tanaka SC, 2004, NAT NEUROSCI, V7, P887, DOI 10.1038/nn1279; Waytz A, 2011, CURR DIR PSYCHOL SCI, V20, P197, DOI 10.1177/0963721411409007; Young L, 2010, P NATL ACAD SCI USA, V107, P6753, DOI 10.1073/pnas.0914826107	50	182	195	7	72	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAY	2012	15	5					655	661		10.1038/nn.3087	http://dx.doi.org/10.1038/nn.3087			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	932DI	22534578				2022-12-28	WOS:000303270200006
J	Fluegge, D; Moeller, LM; Cichy, A; Gorin, M; Weth, A; Veitinger, S; Cainarca, S; Lohmer, S; Corazza, S; Neuhaus, EM; Baumgartner, W; Spehr, J; Spehr, M				Fluegge, Daniela; Moeller, Lisa M.; Cichy, Annika; Gorin, Monika; Weth, Agnes; Veitinger, Sophie; Cainarca, Silvia; Lohmer, Stefan; Corazza, Sabrina; Neuhaus, Eva M.; Baumgartner, Werner; Spehr, Jennifer; Spehr, Marc			Mitochondrial Ca2+ mobilization is a key element in olfactory signaling	NATURE NEUROSCIENCE			English	Article							NUCLEOTIDE-ACTIVATED CHANNEL; RESPONSE TERMINATION; ESSENTIAL COMPONENT; SENSORY NEURONS; PATCH-CLAMP; CALCIUM; ADAPTATION; TRANSDUCTION; CONDUCTANCE; SPECIFICITY	In olfactory sensory neurons (OSNs), cytosolic Ca2+ controls the gain and sensitivity of olfactory signaling. Important components of the molecular machinery that orchestrates OSN Ca2+ dynamics have been described, but key details are still missing. Here, we demonstrate a critical physiological role of mitochondrial Ca2+ mobilization in mouse OSNs. Combining a new mitochondria! Ca2+ imaging approach with patch-clamp recordings, organelle mobility assays and ultrastructural analyses, our study identifies mitochondria as key determinants of olfactory signaling. We show that mitochondrial Ca2+ mobilization during sensory stimulation shapes the cytosolic Ca2+ response profile in OSNs, ensures a broad dynamic response range and maintains sensitivity of the spike generation machinery. When mitochondrial function is impaired, olfactory neurons function as simple stimulus detectors rather than as intensity encoders. Moreover, we describe activity-dependent recruitment of mitochondria to olfactory knobs, a mechanism that provides a context-dependent tool for OSNs to maintain cellular homeostasis and signaling integrity.	[Fluegge, Daniela; Moeller, Lisa M.; Cichy, Annika; Gorin, Monika; Veitinger, Sophie; Spehr, Jennifer; Spehr, Marc] Rhein Westfal TH Aachen, Inst Biol 2, Dept Chemosensat, Aachen, Germany; [Weth, Agnes; Baumgartner, Werner] Rhein Westfal TH Aachen, Inst Biol 2, Dept Cellular Neurob, Aachen, Germany; [Cainarca, Silvia; Lohmer, Stefan; Corazza, Sabrina] Axxam SpA, Milan, Italy; [Neuhaus, Eva M.] Charite NeuroSci Res Ctr, Berlin, Germany	RWTH Aachen University; RWTH Aachen University; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Spehr, M (corresponding author), Rhein Westfal TH Aachen, Inst Biol 2, Dept Chemosensat, Aachen, Germany.	m.spehr@sensorik.rwth-aachen.de	Spehr, Marc/AAK-3162-2021; Neuhaus, Eva M./L-1428-2015; Spehr, Marc/B-3140-2011; Baumgartner, Werner/C-5013-2012	Spehr, Marc/0000-0001-6616-4196; Neuhaus, Eva M./0000-0003-3363-1231; Spehr, Marc/0000-0001-6616-4196; Baumgartner, Werner/0000-0002-3160-2050; Cichy, Annika/0000-0002-4620-7854; Cainarca, Silvia/0000-0002-4590-4420; Moeller, Lars/0000-0002-9330-9036	Volkswagen Foundation; Deutsche Forschungsgemeinschafi [SP724/2-1, Exc257]	Volkswagen Foundation(Volkswagen); Deutsche Forschungsgemeinschafi(German Research Foundation (DFG))	We thank C. Engelhardt, H. Bartel and S. Lipartowski for assistance, W. Kammerloher and H.-J. Behrendt (Olympus Life Science) for placing the LV200 microscope at our disposal, and K. Touhara (University of Tokyo, Japan) and P. Mombaerts (Max Planck Institute of Biophysics, Frankfurt, Germany) for providing mouse strains. This work was funded by grants from the Volkswagen Foundation (M.S.) and the Deutsche Forschungsgemeinschafi (M.S., SP724/2-1; F..M.N., Exc257). M.S. is a Lichtenberg Professor of the Volkswagen Foundation.	Antolin S, 2010, J GEN PHYSIOL, V135, P367, DOI 10.1085/jgp.200910337; BAKALYAR HA, 1990, SCIENCE, V250, P1403, DOI 10.1126/science.2255909; Baughman JM, 2011, NATURE, V476, P341, DOI 10.1038/nature10234; Ben-Chaim Y, 2011, P NATL ACAD SCI USA, V108, P822, DOI 10.1073/pnas.1017983108; Berridge MJ, 2003, NAT REV MOL CELL BIO, V4, P517, DOI 10.1038/nrm1155; Billig GM, 2011, NAT NEUROSCI, V14, P763, DOI 10.1038/nn.2821; Boccaccio A, 2006, J GEN PHYSIOL, V128, P171, DOI 10.1085/jgp.200609555; Bradley J, 2005, CURR OPIN NEUROBIOL, V15, P343, DOI 10.1016/j.conb.2005.05.014; Bradley J, 2004, NAT NEUROSCI, V7, P705, DOI 10.1038/nn1266; BUCK L, 1991, CELL, V65, P175, DOI 10.1016/0092-8674(91)90418-X; Cainarca S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008882; Chang DTW, 2006, PROG NEUROBIOL, V80, P241, DOI 10.1016/j.pneurobio.2006.09.003; CHEN TY, 1994, NATURE, V368, P545, DOI 10.1038/368545a0; Cygnar KD, 2009, NAT NEUROSCI, V12, P454, DOI 10.1038/nn.2289; De Stefani D, 2011, NATURE, V476, P336, DOI 10.1038/nature10230; Detmer SA, 2007, NAT REV MOL CELL BIO, V8, P870, DOI 10.1038/nrm2275; DHALLAN RS, 1990, NATURE, V347, P184, DOI 10.1038/347184a0; Fedrizzi L, 2010, NEUROMETHODS, V43, P81, DOI 10.1007/978-1-60761-476-0_4; Firestein S, 2001, NATURE, V413, P211, DOI 10.1038/35093026; Grosmaitre X, 2006, P NATL ACAD SCI USA, V103, P1970, DOI 10.1073/pnas.0508491103; Herrington J, 1996, NEURON, V16, P219, DOI 10.1016/S0896-6273(00)80038-0; Kirichok Y, 2004, NATURE, V427, P360, DOI 10.1038/nature02246; KLEENE SJ, 1991, J NEUROSCI, V11, P3624; Kleene SJ, 2008, CHEM SENSES, V33, P839, DOI 10.1093/chemse/bjn048; Kurahashi T, 1997, NATURE, V385, P725, DOI 10.1038/385725a0; Leinders-Zufall T, 1998, J NEUROSCI, V18, P5630; Li Z, 2004, CELL, V119, P873, DOI 10.1016/j.cell.2004.11.003; MacAskill AF, 2010, TRENDS CELL BIOL, V20, P102, DOI 10.1016/j.tcb.2009.11.002; Matthews HR, 2003, CURR OPIN NEUROBIOL, V13, P469, DOI 10.1016/S0959-4388(03)00097-7; MAUE RA, 1987, J GEN PHYSIOL, V90, P95, DOI 10.1085/jgp.90.1.95; Munger SD, 2001, SCIENCE, V294, P2172, DOI 10.1126/science.1063224; NAKAMURA T, 1987, NATURE, V325, P442, DOI 10.1038/325442a0; Noe J, 1997, NEUROCHEM INT, V30, P523, DOI 10.1016/S0197-0186(96)00090-3; Oka Y, 2006, NEURON, V52, P857, DOI 10.1016/j.neuron.2006.10.019; Palty R, 2010, P NATL ACAD SCI USA, V107, P436, DOI 10.1073/pnas.0908099107; Potter SM, 2001, J NEUROSCI, V21, P9713, DOI 10.1523/JNEUROSCI.21-24-09713.2001; Reisert J, 1999, J PHYSIOL-LONDON, V519, P801, DOI 10.1111/j.1469-7793.1999.0801n.x; Reisert J, 2003, J GEN PHYSIOL, V122, P349, DOI 10.1085/jgp.200308888; Reisert J, 2001, J PHYSIOL-LONDON, V530, P113, DOI 10.1111/j.1469-7793.2001.0113m.x; RESTREPO D, 1993, J GEN PHYSIOL, V102, P907, DOI 10.1085/jgp.102.5.907; RIZZUTO R, 1992, NATURE, V358, P325, DOI 10.1038/358325a0; Rizzuto R, 2006, PHYSIOL REV, V86, P369, DOI 10.1152/physrev.00004.2005; Song Y, 2008, NEURON, V58, P374, DOI 10.1016/j.neuron.2008.02.029; Spehr M, 2002, NEURON, V33, P731, DOI 10.1016/S0896-6273(02)00610-4; Spehr M, 2009, J NEUROCHEM, V109, P1570, DOI 10.1111/j.1471-4159.2009.06085.x; Stephan AB, 2012, NAT NEUROSCI, V15, P131, DOI 10.1038/nn.2943; Stephan AB, 2009, P NATL ACAD SCI USA, V106, P11776, DOI 10.1073/pnas.0903304106; Veitinger S, 2011, J PHYSIOL-LONDON, V589, P5033, DOI 10.1113/jphysiol.2011.216309; Weeraratne SD, 2006, CHEM SENSES, V31, P725, DOI 10.1093/chemse/bjl014; Zufall F, 2000, J NEUROPHYSIOL, V83, P501, DOI 10.1152/jn.2000.83.1.501	50	51	52	0	14	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAY	2012	15	5					754	762		10.1038/nn.3074	http://dx.doi.org/10.1038/nn.3074			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	932DI	22446879				2022-12-28	WOS:000303270200020
J	Saleem, AB; Ayaz, A; Jeffery, KJ; Harris, KD; Carandini, M				Saleem, Aman B.; Ayaz, Asli; Jeffery, Kathryn J.; Harris, Kenneth D.; Carandini, Matteo			Integration of visual motion and locomotion in mouse visual cortex	NATURE NEUROSCIENCE			English	Article							CELL ASSEMBLIES; SELF-MOTION; DYNAMICS; AWAKE; FIELD; SELECTIVITY; PERCEPTION; NAVIGATION; RESPONSES; STATE	Successful navigation through the world requires accurate estimation of one's own speed. To derive this estimate, animals integrate visual speed gauged from optic flow and run speed gauged from proprioceptive and locomotor systems. The primary visual cortex (V1) carries signals related to visual speed, and its responses are also affected by run speed. To study how V1 combines these signals during navigation, we recorded from mice that traversed a virtual environment. Nearly half of the V1 neurons were reliably driven by combinations of visual speed and run speed. These neurons performed a weighted sum of the two speeds. The weights were diverse across neurons, and typically positive. As a population, V1 neurons predicted a linear combination of visual and run speeds better than either visual or run speeds alone. These data indicate that V1 in the mouse participates in a multimodal processing system that integrates visual motion and locomotion during navigation.	[Saleem, Aman B.; Ayaz, Asli; Harris, Kenneth D.; Carandini, Matteo] UCL, UCL Inst Ophthalmol, London, England; [Saleem, Aman B.; Jeffery, Kathryn J.] UCL, Dept Cognit Perceptual & Brain Sci, London, England; [Harris, Kenneth D.] UCL, UCL Inst Neurol, London, England; [Harris, Kenneth D.] UCL, Dept Neurosci Physiol & Pharmacol, London, England	University of London; University College London; University of London; University College London; University of London; University College London; University of London; University College London	Saleem, AB (corresponding author), UCL, UCL Inst Ophthalmol, Mortimer St, London, England.	aman.saleem@ucl.ac.uk	Carandini, Matteo/ABD-8296-2021; AYAZ, ASLI/AAL-6577-2020; Jeffery, Kate/C-2409-2008	Carandini, Matteo/0000-0003-4880-7682; AYAZ, ASLI/0000-0002-6276-2516; Saleem, Aman/0000-0002-7100-1954; Harris, Kenneth/0000-0002-5930-6456; Jeffery, Kate/0000-0002-9495-0378	Wellcome Trust; Biotechnology and Biological Sciences Research Council [BB/J009792/1] Funding Source: researchfish; Engineering and Physical Sciences Research Council [EP/K015141/1, EP/I005102/2, EP/I005102/1] Funding Source: researchfish; Medical Research Council [G0800791, G1100669] Funding Source: researchfish; BBSRC [BB/J009792/1] Funding Source: UKRI; EPSRC [EP/K015141/1, EP/I005102/2, EP/I005102/1] Funding Source: UKRI; MRC [G0800791, G1100669] Funding Source: UKRI	Wellcome Trust(Wellcome TrustEuropean Commission); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank M. Scholvinck for help with pilot experiments, L. Muessig and F. Cacucci for sharing open-field behavioral data, B. Haider, D. Schulz and other members of the laboratory for helpful discussions, J. O'Keefe, N. Burgess and K.D. Longden for comments on the project. This work was supported by the Medical Research Council and by the European Research Council. M.C. and K.D.H. are jointly funded by the Wellcome Trust. K.J.J. is supported by the Biotechnology and Biological Sciences Research Council. M.C. is supported as a GlaxoSmithKline/Fight for Sight Chair in Visual Neuroscience.	Ahrens MB, 2012, NATURE, V485, P471, DOI 10.1038/nature11057; Angelaki DE, 2011, J PHYSIOL-LONDON, V589, P825, DOI 10.1113/jphysiol.2010.194720; Angelaki DE, 2009, CURR OPIN NEUROBIOL, V19, P452, DOI 10.1016/j.conb.2009.06.008; Ayaz A, 2013, CURR BIOL, V23, P890, DOI 10.1016/j.cub.2013.04.012; Bastos AM, 2012, NEURON, V76, P695, DOI 10.1016/j.neuron.2012.10.038; Bizley JK, 2007, CEREB CORTEX, V17, P2172, DOI 10.1093/cercor/bhl128; Carandini M, 2005, J NEUROSCI, V25, P10577, DOI 10.1523/JNEUROSCI.3726-05.2005; Chen GF, 2013, P NATL ACAD SCI USA, V110, P378, DOI 10.1073/pnas.1215834110; Crochet S, 2006, NAT NEUROSCI, V9, P608, DOI 10.1038/nn1690; DeAngelis G.C., 2012, NEURAL BASES MULTISE, P1; Deneve S, 2004, J PHYSIOLOGY-PARIS, V98, P249, DOI 10.1016/j.jphysparis.2004.03.011; Dombeck DA, 2007, NEURON, V56, P43, DOI 10.1016/j.neuron.2007.08.003; Domnisoru C, 2013, NATURE, V495, P199, DOI 10.1038/nature11973; DUFFY CJ, 1991, J NEUROPHYSIOL, V65, P1329, DOI 10.1152/jn.1991.65.6.1329; Ernst MO, 2002, NATURE, V415, P429, DOI 10.1038/415429a; Geisler C, 2007, P NATL ACAD SCI USA, V104, P8149, DOI 10.1073/pnas.0610121104; Ghazanfar AA, 2006, TRENDS COGN SCI, V10, P278, DOI 10.1016/j.tics.2006.04.008; Gu Y, 2011, NEURON, V71, P750, DOI 10.1016/j.neuron.2011.06.015; Harris KD, 2000, J NEUROPHYSIOL, V84, P401, DOI 10.1152/jn.2000.84.1.401; Harris KD, 2003, NATURE, V424, P552, DOI 10.1038/nature01834; Harris KD, 2011, NAT REV NEUROSCI, V12, P509, DOI 10.1038/nrn3084; Harvey CD, 2012, NATURE, V484, P62, DOI 10.1038/nature10918; Harvey CD, 2009, NATURE, V461, P941, DOI 10.1038/nature08499; Israel I, 1997, J NEUROPHYSIOL, V77, P3180, DOI 10.1152/jn.1997.77.6.3180; Itskov V, 2008, NEURAL COMPUT, V20, P644, DOI 10.1162/neco.2007.3179; Iurilli G, 2012, NEURON, V73, P814, DOI 10.1016/j.neuron.2011.12.026; Jeffery KJ, 2007, CURR OPIN NEUROBIOL, V17, P684, DOI 10.1016/j.conb.2007.11.008; Keller GB, 2012, NEURON, V74, P809, DOI 10.1016/j.neuron.2012.03.040; Lappe M, 1999, TRENDS COGN SCI, V3, P329, DOI 10.1016/S1364-6613(99)01364-9; McAdams CJ, 2005, J NEUROSCI, V25, P11023, DOI 10.1523/JNEUROSCI.2904-05.2005; Murayama M, 2009, P NATL ACAD SCI USA, V106, P20482, DOI 10.1073/pnas.0910379106; Niell CM, 2010, NEURON, V65, P472, DOI 10.1016/j.neuron.2010.01.033; Polack P.O., 2013, NAT NEUROSCI; Pouget A, 2002, NAT REV NEUROSCI, V3, P741, DOI 10.1038/nrn914; Rao RPN, 1999, NAT NEUROSCI, V2, P79, DOI 10.1038/4580; Rigotti M, 2013, NATURE, V497, P585, DOI 10.1038/nature12160; Sargolini F, 2006, SCIENCE, V312, P758, DOI 10.1126/science.1125572; Schmidt-Hieber C, 2013, NAT NEUROSCI, V16, P325, DOI 10.1038/nn.3340; Shuler MG, 2006, SCIENCE, V311, P1606, DOI 10.1126/science.1123513; Szuts TA, 2011, NAT NEUROSCI, V14, P263, DOI 10.1038/nn.2730; Terrazas A, 2005, J NEUROSCI, V25, P8085, DOI 10.1523/JNEUROSCI.0693-05.2005; Wallace DJ, 2013, NATURE, V498, P65, DOI 10.1038/nature12153; WOLPERT DM, 1995, SCIENCE, V269, P1880, DOI 10.1126/science.7569931; Xu NL, 2012, NATURE, V492, P247, DOI 10.1038/nature11601; ZIPSER D, 1988, NATURE, V331, P679, DOI 10.1038/331679a0	45	214	214	0	49	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	DEC	2013	16	12					1864	1869		10.1038/nn.3567	http://dx.doi.org/10.1038/nn.3567			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	257VV	24185423	Green Accepted			2022-12-28	WOS:000327416800025
J	Lee, S; Kruglikov, I; Huang, ZJ; Fishell, G; Rudy, B				Lee, Soohyun; Kruglikov, Illya; Huang, Z. Josh; Fishell, Gord; Rudy, Bernardo			A disinhibitory circuit mediates motor integration in the somatosensory cortex	NATURE NEUROSCIENCE			English	Article							EXPRESSING GABAERGIC NEURONS; CELLULAR MECHANISM; PYRAMIDAL NEURONS; BARREL CORTEX; UNIT-ACTIVITY; INTERNEURONS; PROJECTIONS; AFFERENT; ORGANIZATION; LAMINAR	The influence of motor activity on sensory processing is crucial for perception and motor execution. However, the underlying circuits are not known. To unravel the circuit by which activity in the primary vibrissal motor cortex (vM1) modulates sensory processing in the primary somatosensory barrel cortex (Si), we used optogenetics to examine the long-range inputs from vM1 to the various neuronal elements in Si. We found that Si-projecting vM1 pyramidal neurons strongly recruited vasointestinal peptide (VIP)-expressing GABAergic interneurons, a subset of serotonin receptor expressing interneurons. These VIP interneurons preferentially inhibited somatostatin-expressing interneurons, neurons that target the distal dendrites of pyramidal cells. Consistent with this vM1-mediated disinhibitory circuit, the activity of VIP interneurons in vivo increased and that of somatostatin interneurons decreased during whisking. These changes in firing rates during whisking depended on vM1 activity. Our results suggest previously unknown circuitry by which inputs from motor cortex influence sensory processing in sensory cortex.	[Lee, Soohyun; Kruglikov, Illya; Fishell, Gord; Rudy, Bernardo] NYU, Sch Med, Neurosci Inst, Dept Neurosci & Physiol,Smilow Res Ctr, New York, NY 10012 USA; [Huang, Z. Josh] Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA	New York University; Cold Spring Harbor Laboratory	Rudy, B (corresponding author), NYU, Sch Med, Neurosci Inst, Dept Neurosci & Physiol,Smilow Res Ctr, New York, NY 10012 USA.	soohyun.lee@nyumc.org; bernardo.rudy@nyumc.org	Kruglikov, Ilya/AAC-9131-2020	Kruglikov, Ilya/0000-0002-1575-4636; Rudy, Bernardo/0000-0001-5748-6900; Fishell, Gordon/0000-0002-9640-9278; Huang, Z. Josh/0000-0003-0592-028X; Lee, Soohyun/0000-0003-1532-7041	US National Institutes of Health [R01 NS30989, MH071679, P01 NS074972, 1F32NS076316]; Epilepsy Foundation [260691]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH071679] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS074972, R01NS030989, F32NS076316] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Epilepsy Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank all of the members of the Rudy and Fishell laboratories for helpful discussions. We thank K. Deisseroth (Stanford University) for DIO-ChR2-mCherry plasmids, Z. Talbot for help with intrinsic imaging and setting-up a camera for whisking behavior, and E. Merriam for advice on in vivo data analysis. This work was supported by grants from the US National Institutes of Health (R01 NS30989 and P01 NS074972 to B.R., MH071679 and P01 NS074972 to G.F., and 1F32NS076316 to S.L.). I.K. was supported by Epilepsy Foundation grant 260691.	Carvell GE, 1996, SOMATOSENS MOT RES, V13, P115, DOI 10.3109/08990229609051399; Chan CH, 2001, CEREB CORTEX, V11, P1191, DOI 10.1093/cercor/11.12.1191; Crochet S, 2006, NAT NEUROSCI, V9, P608, DOI 10.1038/nn1690; Cruikshank SJ, 2012, J NEUROSCI, V32, P17813, DOI 10.1523/JNEUROSCI.3231-12.2012; Dantzker JL, 2000, NAT NEUROSCI, V3, P701, DOI 10.1038/76656; David C, 2007, EUR J NEUROSCI, V25, P2329, DOI 10.1111/j.1460-9568.2007.05496.x; Diamond ME, 2008, NAT REV NEUROSCI, V9, P601, DOI 10.1038/nrn2411; DONOGHUE JP, 1983, J COMP NEUROL, V217, P390, DOI 10.1002/cne.902170404; FABRI M, 1991, J COMP NEUROL, V311, P405, DOI 10.1002/cne.903110310; Friedman WA, 2012, J NEUROPHYSIOL, V107, P551, DOI 10.1152/jn.01132.2010; Gentet LJ, 2012, NAT NEUROSCI, V15, P607, DOI 10.1038/nn.3051; Gentet LJ, 2010, NEURON, V65, P422, DOI 10.1016/j.neuron.2010.01.006; Gonchar Y, 1999, J COMP NEUROL, V406, P346, DOI 10.1002/(SICI)1096-9861(19990412)406:3<346::AID-CNE4>3.0.CO;2-E; HERKENHAM M, 1980, SCIENCE, V207, P532, DOI 10.1126/science.7352263; Hooks BM, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000572; Huber D, 2012, NATURE, V484, P473, DOI 10.1038/nature11039; Jiang XL, 2013, NAT NEUROSCI, V16, P210, DOI 10.1038/nn.3305; JONES EG, 1977, J COMP NEUROL, V175, P391, DOI 10.1002/cne.901750403; KAWAGUCHI Y, 1995, J NEUROSCI, V15, P2638; Kinnischtzke AK, 2014, CEREB CORTEX, V24, P2237, DOI 10.1093/cercor/bht085; Klausberger T, 2008, SCIENCE, V321, P53, DOI 10.1126/science.1149381; Kleinfeld D, 2006, CURR OPIN NEUROBIOL, V16, P435, DOI 10.1016/j.conb.2006.06.009; Larkum M, 2013, TRENDS NEUROSCI, V36, P141, DOI 10.1016/j.tins.2012.11.006; Larkum ME, 1999, NATURE, V398, P338, DOI 10.1038/18686; Lee S, 2010, J NEUROSCI, V30, P16796, DOI 10.1523/JNEUROSCI.1869-10.2010; Lee S, 2008, NAT NEUROSCI, V11, P1430, DOI 10.1038/nn.2227; Lisman JE, 1997, TRENDS NEUROSCI, V20, P38, DOI 10.1016/S0166-2236(96)10070-9; Ma YY, 2006, J NEUROSCI, V26, P5069, DOI 10.1523/JNEUROSCI.0661-06.2006; Masri R, 2008, J NEUROPHYSIOL, V100, P681, DOI 10.1152/jn.01322.2007; Mateo C, 2011, CURR BIOL, V21, P1593, DOI 10.1016/j.cub.2011.08.028; Miyoshi G, 2010, J NEUROSCI, V30, P1582, DOI 10.1523/JNEUROSCI.4515-09.2010; Murayama M, 2009, NATURE, V457, P1137, DOI 10.1038/nature07663; Ohno S, 2012, CEREB CORTEX, V22, P2840, DOI 10.1093/cercor/bhr356; Oliva AA, 2000, J NEUROSCI, V20, P3354, DOI 10.1523/JNEUROSCI.20-09-03354.2000; Petreanu L, 2012, NATURE, V489, P299, DOI 10.1038/nature11321; Petreanu L, 2009, NATURE, V457, P1142, DOI 10.1038/nature07709; Porter JT, 1998, EUR J NEUROSCI, V10, P3617, DOI 10.1046/j.1460-9568.1998.00367.x; PORTER LL, 1983, J COMP NEUROL, V214, P279, DOI 10.1002/cne.902140306; Rudy B, 2011, DEV NEUROBIOL, V71, P45, DOI 10.1002/dneu.20853; Shirvalkar P, 2006, P NATL ACAD SCI USA, V103, P17007, DOI 10.1073/pnas.0604811103; Tamas G, 2003, SCIENCE, V299, P1902, DOI 10.1126/science.1082053; Tsai HC, 2009, SCIENCE, V324, P1080, DOI 10.1126/science.1168878; Van der Werf YD, 2002, BRAIN RES REV, V39, P107, DOI 10.1016/S0165-0173(02)00181-9; Veinante P, 2003, J COMP NEUROL, V464, P98, DOI 10.1002/cne.10769; WHITE EL, 1977, J COMP NEUROL, V175, P455, DOI 10.1002/cne.901750405; Williams SR, 1999, J PHYSIOL-LONDON, V521, P467, DOI 10.1111/j.1469-7793.1999.00467.x; Wimmer VC, 2010, CEREB CORTEX, V20, P2265, DOI 10.1093/cercor/bhq068; Xu NL, 2012, NATURE, V492, P247, DOI 10.1038/nature11601; Yu CX, 2006, PLOS BIOL, V4, P819, DOI 10.1371/journal.pbio.0040124	49	429	433	4	58	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	NOV	2013	16	11					1662	1670		10.1038/nn.3544	http://dx.doi.org/10.1038/nn.3544			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	241YX	24097044	Green Accepted			2022-12-28	WOS:000326205700024
J	Ma, T; Wang, CM; Wang, L; Zhou, X; Tian, M; Zhang, QQ; Zhang, Y; Li, JW; Liu, ZD; Cai, YQ; Liu, F; You, Y; Chen, C; Campbell, K; Song, HJ; Ma, L; Rubenstein, JL; Yang, ZG				Ma, Tong; Wang, Congmin; Wang, Lei; Zhou, Xing; Tian, Miao; Zhang, Qiangqiang; Zhang, Yue; Li, Jiwen; Liu, Zhidong; Cai, Yuqun; Liu, Fang; You, Yan; Chen, Chao; Campbell, Kenneth; Song, Hongjun; Ma, Lan; Rubenstein, John L.; Yang, Zhengang			Subcortical origins of human and monkey neocortical interneurons	NATURE NEUROSCIENCE			English	Article							LATERAL/CAUDAL GANGLIONIC EMINENCE; COUP-TFII; CORTICAL INTERNEURONS; SUBVENTRICULAR ZONE; GABAERGIC NEURONS; RADIAL GLIA; EXPRESSION; SUBPOPULATION; DIVERSITY; NKX2-1	Cortical GABAergic inhibitory interneurons have crucial roles in the development and function of the cerebral cortex. In rodents, nearly all neocortical interneurons are generated from the subcortical ganglionic eminences. In humans and nonhuman primates, however, the developmental origin of neocortical GABAergic interneurons remains unclear. Here we show that the expression patterns of several key transcription factors in the developing primate telencephalon are very similar to those in rodents, delineating the three main subcortical progenitor domains (the medial, lateral and caudal ganglionic eminences) and the interneurons tangentially migrating from them. On the basis of the continuity of Sox6, COUP-TFII and Sp8 transcription factor expression and evidence from cell migration and cell fate analyses, we propose that the majority of primate neocortical GABAergic interneurons originate from ganglionic eminences of the ventral telencephalon. Our findings reveal that the mammalian neocortex shares basic rules for interneuron development, substantially reshaping our understanding of the origin and classification of primate neocortical interneurons.	[Ma, Tong; Wang, Congmin; Wang, Lei; Zhou, Xing; Tian, Miao; Zhang, Qiangqiang; Zhang, Yue; Li, Jiwen; Liu, Zhidong; Cai, Yuqun; Liu, Fang; You, Yan; Ma, Lan; Yang, Zhengang] Fudan Univ, Inst Brain Sci, Shanghai 200433, Peoples R China; [Ma, Tong; Wang, Congmin; Wang, Lei; Zhou, Xing; Tian, Miao; Zhang, Qiangqiang; Zhang, Yue; Li, Jiwen; Liu, Zhidong; Cai, Yuqun; Liu, Fang; You, Yan; Ma, Lan; Yang, Zhengang] Fudan Univ, State Key Lab Med Neurobiol, Shanghai 200433, Peoples R China; [Wang, Lei] Hebei Med Univ, Dept Human Anat, Shijiazhuang, Hebei, Peoples R China; [Chen, Chao] Fudan Univ, Childrens Hosp, Dept Neonatol, Shanghai 200433, Peoples R China; [Campbell, Kenneth] Univ Cincinnati, Med Ctr, Coll Med, Childrens Hosp,Div Dev Biol, Cincinnati, OH 45267 USA; [Song, Hongjun] Johns Hopkins Univ, Sch Med, Inst Cell Engn, Baltimore, MD USA; [Song, Hongjun] Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21205 USA; [Rubenstein, John L.] Univ Calif San Francisco, Dept Psychiat, Nina Ireland Lab Dev Neurobiol, San Francisco, CA USA	Fudan University; Fudan University; Hebei Medical University; Fudan University; Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; Johns Hopkins University; Johns Hopkins University; University of California System; University of California San Francisco	Yang, ZG (corresponding author), Fudan Univ, Inst Brain Sci, Shanghai 200433, Peoples R China.	yangz@fudan.edu.cn	Ma, Lan/B-9295-2009; Campbell, Kenneth/ABC-3570-2021	Ma, Lan/0000-0001-9034-5472; Wang, Lei/0000-0003-0741-8170; Li, Jiwen/0000-0002-1332-4763	National Basic Research Program of China [2011CB504400, 2010CB945500]; National Natural Science Foundation of China [30990261, 31028009, 31121061, 91232723]	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Basic Research Program of China (2011CB504400 and 2010CB945500) and the National Natural Science Foundation of China (30990261, 31028009, 31121061 and 91232723). We thank the staff at the Chinese Brain Bank Center, Wuhan, China and the Red Cross Society of China, Shanghai Branch at Fudan University for providing access to donated adult human brains.	Azim E, 2009, NAT NEUROSCI, V12, P1238, DOI 10.1038/nn.2387; Batista-Brito R, 2009, NEURON, V63, P466, DOI 10.1016/j.neuron.2009.08.005; Bayer SA, 2005, HUMAN BRAIN 2 TRIMES; Borello U, 2014, CEREB CORTEX, V24, P1409, DOI 10.1093/cercor/bhs412; Britz O, 2006, CEREB CORTEX, V16, pI138, DOI 10.1093/cercor/bhj168; Butt SJB, 2008, NEURON, V59, P722, DOI 10.1016/j.neuron.2008.07.031; Cai YQ, 2013, STEM CELLS, V31, P1193, DOI 10.1002/stem.1363; Cai YQ, 2013, J COMP NEUROL, V521, P479, DOI 10.1002/cne.23186; Fertuzinhos S, 2009, CEREB CORTEX, V19, P2196, DOI 10.1093/cercor/bhp009; Fietz SA, 2010, NAT NEUROSCI, V13, P690, DOI 10.1038/nn.2553; Flames N, 2007, J NEUROSCI, V27, P9682, DOI 10.1523/JNEUROSCI.2750-07.2007; Flandin P, 2010, J NEUROSCI, V30, P2812, DOI 10.1523/JNEUROSCI.4228-09.2010; Gelman DM, 2010, EUR J NEUROSCI, V31, P2136, DOI 10.1111/j.1460-9568.2010.07267.x; Gotz M, 1998, NEURON, V21, P1031, DOI 10.1016/S0896-6273(00)80621-2; Guerrero-Cazares H, 2011, J COMP NEUROL, V519, P1165, DOI 10.1002/cne.22566; Hansen DV, 2010, NATURE, V464, P554, DOI 10.1038/nature08845; Jakovcevski I, 2011, CEREB CORTEX, V21, P1771, DOI 10.1093/cercor/bhq245; Kanatani S, 2008, J NEUROSCI, V28, P13582, DOI 10.1523/JNEUROSCI.2132-08.2008; Kang HJ, 2011, NATURE, V478, P483, DOI 10.1038/nature10523; Kohwi M, 2007, J NEUROSCI, V27, P6878, DOI 10.1523/JNEUROSCI.0254-07.2007; Letinic K, 2002, NATURE, V417, P645, DOI 10.1038/nature00779; Lewis DA, 2005, NAT REV NEUROSCI, V6, P312, DOI 10.1038/nrn1648; Long JE, 2009, CEREB CORTEX S1, V19, P196; Lui JH, 2011, CELL, V146, P18, DOI 10.1016/j.cell.2011.06.030; Ma T, 2012, CEREB CORTEX, V22, P2120, DOI 10.1093/cercor/bhr296; Marin O, 2012, NAT REV NEUROSCI, V13, P107, DOI 10.1038/nrn3155; McKinsey GL, 2013, NEURON, V77, P83, DOI 10.1016/j.neuron.2012.11.035; Miyoshi G, 2010, J NEUROSCI, V30, P1582, DOI 10.1523/JNEUROSCI.4515-09.2010; Molnar Z, 2012, PROG BRAIN RES, V195, P45, DOI 10.1016/B978-0-444-53860-4.00003-9; Nieto M, 2001, NEURON, V29, P401, DOI 10.1016/S0896-6273(01)00214-8; Nobrega-Pereira S, 2008, NEURON, V59, P733, DOI 10.1016/j.neuron.2008.07.024; Pei ZL, 2011, P NATL ACAD SCI USA, V108, P1675, DOI 10.1073/pnas.1008824108; Petanjek Z, 2009, CEREB CORTEX, V19, P249, DOI 10.1093/cercor/bhn078; Puelles L, 2000, J COMP NEUROL, V424, P409, DOI 10.1002/1096-9861(20000828)424:3<409::AID-CNE3>3.0.CO;2-7; Reinchisi G, 2012, CEREB CORTEX, V22, P2820, DOI 10.1093/cercor/bhr359; Rubenstein JLR, 2003, GENES BRAIN BEHAV, V2, P255, DOI 10.1034/j.1601-183X.2003.00037.x; Rudy B, 2011, DEV NEUROBIOL, V71, P45, DOI 10.1002/dneu.20853; Sahara S, 2007, NEURAL DEV, V2, DOI 10.1186/1749-8104-2-10; Sanai N, 2011, NATURE, V478, P382, DOI 10.1038/nature10487; Stenman J, 2003, J NEUROSCI, V23, P167; Sussel L, 1999, DEVELOPMENT, V126, P3359; Taniguchi H, 2013, SCIENCE, V339, P70, DOI 10.1126/science.1227622; Waclaw RR, 2006, NEURON, V49, P503, DOI 10.1016/j.neuron.2006.01.018; Wang B, 2013, J COMP NEUROL, V521, P1561, DOI 10.1002/cne.23242; Wang CM, 2011, CELL RES, V21, P1534, DOI 10.1038/cr.2011.83; Wonders CP, 2006, NAT REV NEUROSCI, V7, P687, DOI 10.1038/nrn1954; Yu XJ, 2011, J NEUROSCI, V31, P2413, DOI 10.1523/JNEUROSCI.5249-10.2011; Zecevic N, 2011, DEV NEUROBIOL, V71, P18, DOI 10.1002/dneu.20812; Zembrzycki A, 2007, NEURAL DEV, V2, DOI 10.1186/1749-8104-2-8; Zeng HK, 2012, CELL, V149, P483, DOI 10.1016/j.cell.2012.02.052	50	188	189	1	47	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	NOV	2013	16	11					1588	1597		10.1038/nn.3536	http://dx.doi.org/10.1038/nn.3536			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	241YX	24097041				2022-12-28	WOS:000326205700016
J	Davis, RL				Davis, Ronald L.			Spermidine cures flies of senior moments	NATURE NEUROSCIENCE			English	Editorial Material							AUTOPHAGY; POLYAMINES; DROSOPHILA	Gupta et al. report in this issue that, in Drosophila melanogaster, a dietary supplement of spermidine-a polyamine originally isolated from semen-protects against cognitive aging by acting through the autophagic pathway.	Scripps Res Inst Florida, Dept Neurosci, Jupiter, FL USA	Scripps Research Institute	Davis, RL (corresponding author), Scripps Res Inst Florida, Dept Neurosci, Jupiter, FL USA.	rdavis@scripps.edu						Bishop NA, 2010, NATURE, V464, P529, DOI 10.1038/nature08983; DAS R, 1982, EXP GERONTOL, V17, P95, DOI 10.1016/0531-5565(82)90042-0; Davis RL, 2005, ANNU REV NEUROSCI, V28, P275, DOI 10.1146/annurev.neuro.28.061604.135651; Eisenberg T, 2009, NAT CELL BIOL, V11, P1305, DOI 10.1038/ncb1975; Graff J, 2013, ANNU REV PHARMACOL, V53, P311, DOI 10.1146/annurev-pharmtox-011112-140216; Gupta VK, 2013, NAT NEUROSCI, V16, P1453, DOI 10.1038/nn.3512; Iarashi K, 2010, INT J BIOCHEM CELL B, V42, P39, DOI 10.1016/j.biocel.2009.07.009; Li J, 2007, CURR MED CHEM, V14, P1807; Minois N, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.139; Partridge L, 2011, EXP GERONTOL, V46, P376, DOI 10.1016/j.exger.2010.09.003; Ramot Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022564; Rubinsztein DC, 2011, CELL, V146, P682, DOI 10.1016/j.cell.2011.07.030; Simonsen A, 2008, AUTOPHAGY, V4, P176, DOI 10.4161/auto.5269; Tomchik SM, 2013, HBK BEHAV NEUROSCI, V22, P359, DOI 10.1016/B978-0-12-415823-8.00027-7; Vivo M, 2001, NEUROSCI LETT, V304, P107, DOI 10.1016/S0304-3940(01)01776-1	15	2	2	1	14	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	OCT	2013	16	10					1363	1364		10.1038/nn.3518	http://dx.doi.org/10.1038/nn.3518			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	223HM	24067287				2022-12-28	WOS:000324795300004
J	Xu, DY; Shen, WP; Guo, R; Xue, YT; Peng, W; Sima, J; Yang, J; Sharov, A; Srikantan, S; Yang, JD; Fox, D; Qian, Y; Martindale, JL; Piao, YL; Machamer, J; Joshi, SR; Mohanty, S; Shaw, AC; Lloyd, TE; Brown, GW; Ko, MSH; Gorospe, M; Zou, SG; Wang, WD				Xu, Dongyi; Shen, Weiping; Guo, Rong; Xue, Yutong; Peng, Wei; Sima, Jian; Yang, Jay; Sharov, Alexei; Srikantan, Subramanya; Yang, Jiandong; Fox, David, III; Qian, Yong; Martindale, Jennifer L.; Piao, Yulan; Machamer, James; Joshi, Samit R.; Mohanty, Subhasis; Shaw, Albert C.; Lloyd, Thomas E.; Brown, Grant W.; Ko, Minoru S. H.; Gorospe, Myriam; Zou, Sige; Wang, Weidong			Top3 beta is an RNA topoisomerase that works with fragile X syndrome protein to promote synapse formation	NATURE NEUROSCIENCE			English	Article							MENTAL-RETARDATION PROTEIN; FOCAL ADHESION KINASE; MESSENGER-RNA; III-ALPHA; DNA-DAMAGE; FMRP; TRANSLATION; COMPLEX; EXPRESSION; HOMOLOG	Topoisomerases are crucial for solving DNA topological problems, but they have not been linked to RNA metabolism. Here we show that human topoisomerase 3 beta (Top3 beta) is an RNA topoisomerase that biochemically and genetically interacts with FMRP, a protein that is deficient in fragile X syndrome and is known to regulate the translation of mRNAs that are important for neuronal function, abnormalities of which are linked to autism. Notably, the FMRP-Top3 beta interaction is abolished by a disease-associated mutation of FMRP, suggesting that Top3 beta may contribute to the pathogenesis of mental disorders. Top3 beta binds multiple mRNAs encoded by genes with neuronal functions linked to schizophrenia and autism. Expression of one such gene, that encoding protein tyrosine kinase 2 (ptk2, also known as focal adhesion kinase or FAK), is reduced in the neuromuscular junctions of Top3 beta mutant flies. Synapse formation is defective in Top3 beta mutant flies and mice, as well as in FMRP mutant flies and mice. Our findings suggest that Top3 beta acts as an RNA topoisomerase and works with FMRP to promote the expression of mRNAs that are crucial for neurodevelopment and mental health.	[Xu, Dongyi; Shen, Weiping; Guo, Rong; Xue, Yutong; Peng, Wei; Yang, Jiandong; Fox, David, III; Wang, Weidong] NIA, Genome Instabil & Chromatin Remodeling Sect, NIH, Baltimore, MD 21224 USA; [Xu, Dongyi] Peking Univ, Sch Life Sci, State Key Lab Prot & Plant Gene Res, Beijing 100871, Peoples R China; [Sima, Jian] NIA, Human Genet Sect, NIH, Baltimore, MD 21224 USA; [Yang, Jay; Brown, Grant W.] Univ Toronto, Dept Biochem, Toronto, ON, Canada; [Sharov, Alexei; Qian, Yong; Piao, Yulan; Ko, Minoru S. H.] NIA, Dev Genom & Aging Sect, NIH, Baltimore, MD 21224 USA; [Srikantan, Subramanya; Martindale, Jennifer L.; Gorospe, Myriam] NIA, RNA Regulat Sect, Genet Lab, NIH, Baltimore, MD 21224 USA; [Machamer, James; Lloyd, Thomas E.] Johns Hopkins Univ, Sch Med, Dept Neurol & Neurosci, Baltimore, MD USA; [Joshi, Samit R.; Mohanty, Subhasis; Shaw, Albert C.] Yale Univ, Sch Med, Dept Internal Med, Infect Dis Sect, New Haven, CT 06510 USA; [Zou, Sige] NIA, Translat Gerontol Branch, NIH, Baltimore, MD 21224 USA	National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); Peking University; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); University of Toronto; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); Johns Hopkins University; Yale University; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA)	Zou, SG (corresponding author), NIA, Translat Gerontol Branch, NIH, Baltimore, MD 21224 USA.	zous@mail.nih.gov; wangw@grc.nia.nih.gov	Martindale, Jennifer Luethy/AAD-1963-2022; Ko, Minoru S. H./B-7969-2009; Wang, Weidong/AAV-2446-2021; Shaw, Albert/AAD-2567-2021	Martindale, Jennifer Luethy/0000-0002-3234-6861; Ko, Minoru S. H./0000-0002-3530-3015; Shaw, Albert/0000-0003-4970-7640; Xu, Dongyi/0000-0001-5711-2618; Wang, Weidong/0000-0002-0658-7928; Brown, Grant/0000-0002-9002-5003; Lloyd, Thomas/0000-0003-4756-3700; Sima, Jian/0000-0002-4127-1638; srikantan, subramanya/0000-0003-1810-6519	Intramural Research Program of the NIA [Z01 AG000657-08]; NIH; Johns Hopkins Center for Neuroscience Research [NS050274]; Canadian Institutes of Health research grant [MOP-79368]; National Basic Research Program of China [2013CB911002]; National Natural Science Foundation of China [31271435]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS050274, R01NS082563] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [ZIAAG000518, ZIAAG000657, ZIAAG000702, ZIAAG000365, K24AG042489, Z01AG000657, ZIAAG000689] Funding Source: NIH RePORTER	Intramural Research Program of the NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Johns Hopkins Center for Neuroscience Research; Canadian Institutes of Health research grant(Canadian Institutes of Health Research (CIHR)); National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank T. Hsieh (Duke University) for Drosophila Top3 beta reagents; J.C. Wang (Harvard University) for Top3 beta knockout mice; D. Zarnescu (University of Illinois), T. Jongens (University of Pennsylvania) and G. Dreyfuss (University of Pennsylvania) for dfmr1 fly strains and antibodies; S. Warren (Emory University), S. Ceman (University of Illinois) and Y. Feng (Emory University) for vectors of FMR1 variants; U. Fischer (University of Wuerzburg) for vectors of TDRD3 and FMR1 orthologs; A. Hoogeveen (Erasmus University) for FXR1 and FXR2 antibodies; R. Hynes (Massachusetts Institute of Technology) and R. Palmer (Umea University) for FAK reagents; T. Enomoto (Tohoku University) for Top3b<SUP>-/-</SUP>DT40 cells; and R. Hanai (Rikkyo University) for the Top3 beta vector. We thank E. Chen, D.J. Pan and Y. Feng for advice and assistance, S. K. Lee for assistance and D. Schlessinger for support and critical reading of the manuscript. This work is supported in part by the Intramural Research Program of the NIA (Z01 AG000657-08), the NIH, the Johns Hopkins Center for Neuroscience Research (NS050274), Canadian Institutes of Health research grant MOP-79368 (to G. W. B.), the National Basic Research Program of China (2013CB911002) and the National Natural Science Foundation of China (31271435). This study used the high-performance computational capabilities of the Biowulf Linux cluster at the NIH, Bethesda, Maryland, USA (http://biowulf.nih.gov).	Ascano M, 2012, NATURE, V492, P382, DOI 10.1038/nature11737; Bentley DR, 2006, CURR OPIN GENET DEV, V16, P545, DOI 10.1016/j.gde.2006.10.009; Bhakar AL, 2012, ANNU REV NEUROSCI, V35, P417, DOI 10.1146/annurev-neuro-060909-153138; Bhogal B, 2011, NAT NEUROSCI, V14, P1517, DOI 10.1038/nn.2950; Brierley I, 2008, BIOCHEM SOC T, V36, P684, DOI 10.1042/BST0360684; Buchan JR, 2009, MOL CELL, V36, P932, DOI 10.1016/j.molcel.2009.11.020; Chandrasekaran S., 2012, NETWORK BIOL, V2, P16; Chen J, 2010, GENE DEV, V24, P2146, DOI 10.1101/gad.1968910; Cote J, 2005, J BIOL CHEM, V280, P28476, DOI 10.1074/jbc.M414328200; Cziko AMJ, 2009, GENETICS, V182, P1051, DOI 10.1534/genetics.109.103234; Darnell JC, 2011, CELL, V146, P247, DOI 10.1016/j.cell.2011.06.013; Feng Y, 1997, MOL CELL, V1, P109, DOI 10.1016/S1097-2765(00)80012-X; Fox GL, 1999, P NATL ACAD SCI USA, V96, P14978, DOI 10.1073/pnas.96.26.14978; Gaengel Konstantin, 2008, V420, P277, DOI 10.1007/978-1-59745-583-1_17; Gilman SR, 2012, NAT NEUROSCI, V15, P1723, DOI 10.1038/nn.3261; Goulet I, 2008, HUM MOL GENET, V17, P3055, DOI 10.1093/hmg/ddn203; Hansen TB, 2013, NATURE, V495, P384, DOI 10.1038/nature11993; Iossifov I, 2012, NEURON, V74, P285, DOI 10.1016/j.neuron.2012.04.009; Islam MN, 2010, MOL CELL BIOL, V30, P2460, DOI 10.1128/MCB.01583-09; Khandjian EW, 1996, NAT GENET, V12, P91, DOI 10.1038/ng0196-91; Kim Yun-Gi, 2012, Exp Neurobiol, V21, P61, DOI 10.5607/en.2012.21.2.61; Kwan KY, 2007, P NATL ACAD SCI USA, V104, P9242, DOI 10.1073/pnas.0703587104; Kwan KY, 2012, CELL, V149, P899, DOI 10.1016/j.cell.2012.02.060; Kwan KY, 2001, P NATL ACAD SCI USA, V98, P5717, DOI 10.1073/pnas.101132498; Lee EK, 2010, NAT STRUCT MOL BIOL, V17, P732, DOI 10.1038/nsmb.1815; Li W, 1998, P NATL ACAD SCI USA, V95, P1010, DOI 10.1073/pnas.95.3.1010; Licatalosi DD, 2008, NATURE, V456, P464, DOI 10.1038/nature07488; Linder B, 2008, HUM MOL GENET, V17, P3236, DOI 10.1093/hmg/ddn219; Ling C, 2007, EMBO J, V26, P2104, DOI 10.1038/sj.emboj.7601666; Liu GF, 2004, NAT NEUROSCI, V7, P1222, DOI 10.1038/nn1331; Memczak S, 2013, NATURE, V495, P333, DOI 10.1038/nature11928; Mohanty S, 2008, P NATL ACAD SCI USA, V105, P5063, DOI 10.1073/pnas.0801235105; Pfeiffer BE, 2007, J NEUROSCI, V27, P3120, DOI 10.1523/JNEUROSCI.0054-07.2007; Plank JL, 2005, J BIOL CHEM, V280, P3564, DOI 10.1074/jbc.M411337200; Rico B, 2004, NAT NEUROSCI, V7, P1059, DOI 10.1038/nn1317; Ripke S, 2011, NAT GENET, V43, P969, DOI 10.1038/ng.940; Seki M, 2006, MOL CELL BIOL, V26, P6299, DOI 10.1128/MCB.00702-06; SIOMI H, 1994, CELL, V77, P33, DOI 10.1016/0092-8674(94)90232-1; Stetler A, 2006, HUM MOL GENET, V15, P87, DOI 10.1093/hmg/ddi429; Stoll G, 2013, NAT NEUROSCI, V16, P1228, DOI 10.1038/nn.3484; Sullivan PF, 2012, ARCH GEN PSYCHIAT, V69, P1099, DOI 10.1001/archgenpsychiatry.2012.730; Sun JC, 2009, BIOINFORMATICS, V25, P2595, DOI 10.1093/bioinformatics/btp428; Svoboda P, 2006, CELL MOL LIFE SCI, V63, P901, DOI 10.1007/s00018-005-5558-5; Tamanini F, 1996, HUM MOL GENET, V5, P809, DOI 10.1093/hmg/5.6.809; Tamanini F, 1997, HUM MOL GENET, V6, P1315, DOI 10.1093/hmg/6.8.1315; Todd PK, 2003, P NATL ACAD SCI USA, V100, P14374, DOI 10.1073/pnas.2336265100; Tsai PI, 2008, NEURAL DEV, V3, DOI 10.1186/1749-8104-3-26; VERKERK AJMH, 1991, CELL, V65, P905, DOI 10.1016/0092-8674(91)90397-H; Walsh T, 2008, SCIENCE, V320, P539, DOI 10.1126/science.1155174; Wan LL, 2000, MOL CELL BIOL, V20, P8536, DOI 10.1128/MCB.20.22.8536-8547.2000; Wang F, 2010, STRUCTURE, V18, P1159, DOI 10.1016/j.str.2010.06.008; Wang H, 1996, P NATL ACAD SCI USA, V93, P9477, DOI 10.1073/pnas.93.18.9477; Wang JC, 2002, NAT REV MOL CELL BIO, V3, P430, DOI 10.1038/nrm831; Wells SE, 1998, MOL CELL, V2, P135, DOI 10.1016/S1097-2765(00)80122-7; Wilson TM, 2000, J BIOL CHEM, V275, P1533, DOI 10.1074/jbc.275.3.1533; Wu JH, 2006, DEV BIOL, V296, P219, DOI 10.1016/j.ydbio.2006.04.459; Xu B, 2012, NAT GENET, V44, P1365, DOI 10.1038/ng.2446; Xu DY, 2008, GENE DEV, V22, P2843, DOI 10.1101/gad.1708608; Xu DY, 2010, EMBO J, V29, P3140, DOI 10.1038/emboj.2010.186; Yang J, 2010, J BIOL CHEM, V285, P21426, DOI 10.1074/jbc.M110.123216; Yin JH, 2005, EMBO J, V24, P1465, DOI 10.1038/sj.emboj.7600622; Zarnescu DC, 2005, DEV CELL, V8, P43, DOI 10.1016/j.devcel.2004.10.020; Zhang YQ, 2001, CELL, V107, P591, DOI 10.1016/S0092-8674(01)00589-X	63	93	93	0	29	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	SEP	2013	16	9					1238	U112		10.1038/nn.3479	http://dx.doi.org/10.1038/nn.3479			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	207KN	23912945	Green Accepted			2022-12-28	WOS:000323597500015
J	Aron, R; Tsvetkov, A; Finkbeiner, S				Aron, Rebecca; Tsvetkov, Andrey; Finkbeiner, Steven			NUB1 snubs huntingtin toxicity	NATURE NEUROSCIENCE			English	Editorial Material							MUTANT HUNTINGTIN; PROTEIN; DYSFUNCTION; INTERFERON; REVERSAL; DISEASE; NEDD8; P53	A screen now identifies a protein that regulates degradation of mutant huntingtin, which causes Huntington's disease, and manipulations show that promoting clearance of the toxic protein itself may be sufficient to halt disease.	[Aron, Rebecca; Tsvetkov, Andrey; Finkbeiner, Steven] Gladstone Inst, San Francisco, CA USA; [Aron, Rebecca; Tsvetkov, Andrey; Finkbeiner, Steven] Taube Koret Ctr Neurodegenerat Dis, San Francisco, CA USA; [Finkbeiner, Steven] Univ Calif San Francisco, Dept Neurol, San Francisco, CA USA; [Finkbeiner, Steven] Univ Calif San Francisco, Dept Physiol, San Francisco, CA USA	University of California System; University of California San Francisco; The J David Gladstone Institutes; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Aron, R (corresponding author), Gladstone Inst, San Francisco, CA USA.	sfinkbeiner@gladstone.ucsf.edu						Bae BI, 2005, NEURON, V47, P29, DOI 10.1016/j.neuron.2005.06.005; Bouchard J, 2012, J NEUROSCI, V32, P18259, DOI 10.1523/JNEUROSCI.4008-12.2012; Diaz-Hernandez M, 2003, J NEUROSCI, V23, P11653; Dragatsis I, 2000, NAT GENET, V26, P300, DOI 10.1038/81593; Kaltenbach LS, 2007, PLOS GENET, V3, P689, DOI 10.1371/journal.pgen.0030082; Kito K, 2001, J BIOL CHEM, V276, P20603, DOI 10.1074/jbc.M100920200; Kordasiewicz HB, 2012, NEURON, V74, P1031, DOI 10.1016/j.neuron.2012.05.009; Liu G, 2010, ONCOGENE, V29, P2252, DOI 10.1038/onc.2009.494; Lu BX, 2013, NAT NEUROSCI, V16, P562, DOI 10.1038/nn.3367; Mitra S, 2009, AUTOPHAGY, V5, P1037, DOI 10.4161/auto.5.7.9291; Richet E, 2012, HUM MOL GENET, V21, P5254, DOI 10.1093/hmg/dds376; Seifert U, 2010, CELL, V142, P613, DOI 10.1016/j.cell.2010.07.036; Tanji K, 2006, AM J PATHOL, V169, P553, DOI 10.2353/ajpath.2006.051067; Weiss A, 2009, ANAL BIOCHEM, V395, P8, DOI 10.1016/j.ab.2009.08.001; Yamamoto A, 2000, CELL, V101, P57, DOI 10.1016/S0092-8674(00)80623-6	15	6	7	0	11	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAY	2013	16	5					523	525		10.1038/nn.3380	http://dx.doi.org/10.1038/nn.3380			4	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	131WT	23619755	Green Published			2022-12-28	WOS:000318029300005
J	Picciotto, MR				Picciotto, Marina R.			An indirect resilience to addiction	NATURE NEUROSCIENCE			English	Editorial Material							COCAINE; RECEPTORS	What makes certain individuals more vulnerable to drug abuse than others? A study finds that potentiation of glutamatergic inputs to nucleus accumbens indirect pathway neurons may protect against compulsive drug-seeking.	Yale Univ, Sch Med, Dept Psychiat, New Haven, CT 06520 USA	Yale University	Picciotto, MR (corresponding author), Yale Univ, Sch Med, Dept Psychiat, New Haven, CT 06520 USA.	marina.picciotto@yale.edu	Picciotto, Marina R./F-8747-2012	Picciotto, Marina R./0000-0002-4404-1280				Bello EP, 2011, NAT NEUROSCI, V14, P1033, DOI 10.1038/nn.2862; Bock R, 2013, NAT NEUROSCI, V16, P632, DOI 10.1038/nn.3369; Chavkin C, 2013, MOL PHARMACOL, V83, P729, DOI 10.1124/mol.112.083337; Dalley JW, 2011, NEURON, V69, P680, DOI 10.1016/j.neuron.2011.01.020; Fredholm BB, 2010, EXP CELL RES, V316, P1284, DOI 10.1016/j.yexcr.2010.02.004; Hnasko TS, 2012, J NEUROSCI, V32, P15076, DOI 10.1523/JNEUROSCI.3128-12.2012; Lobo MK, 2010, SCIENCE, V330, P385, DOI 10.1126/science.1188472; Luscher C, 2011, NEURON, V69, P650, DOI 10.1016/j.neuron.2011.01.017; Nader MA, 2006, NAT NEUROSCI, V9, P1050, DOI 10.1038/nn1737; Papp E, 2012, BRAIN STRUCT FUNCT, V217, P37, DOI 10.1007/s00429-011-0331-z; PIAZZA PV, 1991, P NATL ACAD SCI USA, V88, P2088, DOI 10.1073/pnas.88.6.2088; Thomas MJ, 2008, BRIT J PHARMACOL, V154, P327, DOI 10.1038/bjp.2008.77; Volkow ND, 2009, NEUROPHARMACOLOGY, V56, P3, DOI 10.1016/j.neuropharm.2008.05.022	13	4	4	0	21	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAY	2013	16	5					521	523		10.1038/nn.3375	http://dx.doi.org/10.1038/nn.3375			4	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	131WT	23619754				2022-12-28	WOS:000318029300004
J	Cai, X; Kallarackal, AJ; Kvarta, MD; Goluskin, S; Gaylor, K; Bailey, AM; Lee, HK; Huganir, RL; Thompson, SM				Cai, Xiang; Kallarackal, Angy J.; Kvarta, Mark D.; Goluskin, Sasha; Gaylor, Kaitlin; Bailey, Aileen M.; Lee, Hey-Kyoung; Huganir, Richard L.; Thompson, Scott M.			Local potentiation of excitatory synapses by serotonin and its alteration in rodent models of depression	NATURE NEUROSCIENCE			English	Article							PHOSPHORYLATION SITES; NUCLEUS-ACCUMBENS; RECEPTOR AGONIST; BEHAVIOR; STRESS; HIPPOCAMPUS; ACTIVATION; FLUOXETINE; CA1; NEUROGENESIS	The causes of major depression remain unknown. Antidepressants elevate concentrations of monoamines, particularly serotonin, but it remains uncertain which downstream events are critical to their therapeutic effects. We found that endogenous serotonin selectively potentiated excitatory synapses formed by the temporoammonic pathway with CA1 pyramidal cells via activation of serotonin receptors (5-HT(1B)Rs), without affecting nearby Schaffer collateral synapses. This potentiation was expressed postsynaptically by AMPA-type glutamate receptors and required calmodulin-dependent protein kinase-mediated phosphorylation of GluA1 subunits. Because they share common expression mechanisms, long-term potentiation and serotonin-induced potentiation occluded each other. Long-term consolidation of spatial learning, a function of temporoammonic-CA1 synapses, was enhanced by 5-HT1BR antagonists. Serotonin-induced potentiation was quantitatively and qualitatively altered in a rat model of depression, restored by chronic antidepressants, and required for the ability of chronic antidepressants to reverse stress-induced anhedonia. Changes in serotonin-mediated potentiation, and its recovery by antidepressants, implicate excitatory synapses as a locus of plasticity in depression.	[Cai, Xiang; Kallarackal, Angy J.; Kvarta, Mark D.; Thompson, Scott M.] Univ Maryland, Sch Med, Dept Physiol, Baltimore, MD 21201 USA; [Kallarackal, Angy J.; Kvarta, Mark D.; Thompson, Scott M.] Univ Maryland, Sch Med, Program Neurosci, Baltimore, MD 21201 USA; [Kallarackal, Angy J.; Kvarta, Mark D.; Thompson, Scott M.] Univ Maryland, Sch Med, Program Membrane Biol, Baltimore, MD 21201 USA; [Kvarta, Mark D.] Univ Maryland, Sch Med, Med Scientist Training Program, Baltimore, MD 21201 USA; [Goluskin, Sasha; Gaylor, Kaitlin; Bailey, Aileen M.] St Marys Coll Maryland, Dept Psychol, St Marys City, MD 20686 USA; [Lee, Hey-Kyoung] Johns Hopkins Univ, Zanvyl Krieger Mind Brain Inst, Baltimore, MD USA; [Huganir, Richard L.] Johns Hopkins Univ, Sch Med, Howard Hughes Med Inst, Solomon H Snyder Dept Neurosci, Baltimore, MD 21205 USA; [Thompson, Scott M.] Univ Maryland, Sch Med, Dept Psychiat, Baltimore, MD 21201 USA	University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; Johns Hopkins University; Howard Hughes Medical Institute; Johns Hopkins University; University System of Maryland; University of Maryland Baltimore	Thompson, SM (corresponding author), Univ Maryland, Sch Med, Dept Physiol, Baltimore, MD 21201 USA.	sthom003@umaryland.edu	Kvarta, Mark/ABF-6151-2021; Thompson, Scott M/K-8921-2015; Cai, Xiang/AAD-8012-2021	Kvarta, Mark/0000-0002-1093-1648; Lee, Hey-Kyoung/0000-0002-5554-983X	Mr. and Mrs. Robert and Lee Peterson Southwest Florida National Alliance for Research on Schizophrenia and Depression; Howard Hughes Medical Institute; US National Institutes of Health; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008181] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH086828] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS036715] Funding Source: NIH RePORTER	Mr. and Mrs. Robert and Lee Peterson Southwest Florida National Alliance for Research on Schizophrenia and Depression; Howard Hughes Medical Institute(Howard Hughes Medical Institute); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank S. Ahmari and R. Hen (Columbia University) for providing Hrt1b<SUP>-/-</SUP> mice, B. Alger, T. Blanpied, T. Gould, J. Kim and M. McCarthy for their comments, S. Aungst for advice on immunohistochemistry, and H. Zimmerman, L. Mok and M. Taylor for technical assistance. This work was funded by a Mr. and Mrs. Robert and Lee Peterson Southwest Florida National Alliance for Research on Schizophrenia and Depression Young Investigator Award (X.C.), the Howard Hughes Medical Institute (R.L.H.) and the US National Institutes of Health (R.L.H., H.-K.L., X.C. and S.M.T.).	AMARA DA, 1995, BRAIN RES BULL, V38, P17, DOI 10.1016/0361-9230(95)00066-N; Autry AE, 2011, NATURE, V475, P91, DOI 10.1038/nature10130; Bechtholt AJ, 2008, PHYSIOL BEHAV, V93, P659, DOI 10.1016/j.physbeh.2007.11.006; BILLINGS AG, 1983, J ABNORM PSYCHOL, V92, P119, DOI 10.1037/0021-843X.92.2.119; Bondi CO, 2008, NEUROPSYCHOPHARMACOL, V33, P320, DOI 10.1038/sj.npp.1301410; Boulenguez P, 1996, NEUROPHARMACOLOGY, V35, P1521, DOI 10.1016/S0028-3908(96)00099-8; Buard I, 2010, J NEUROSCI, V30, P8214, DOI 10.1523/JNEUROSCI.1469-10.2010; Buhot MC, 2003, LEARN MEMORY, V10, P466, DOI 10.1101/lm.60203; Cai X, 2004, NEURON, V44, P351, DOI 10.1016/j.neuron.2004.09.026; Campbell S, 2004, J PSYCHIATR NEUROSCI, V29, P417; Chaudhury D, 2013, NATURE, V493, P532, DOI 10.1038/nature11713; Chourbaji S, 2008, FASEB J, V22, P3129, DOI 10.1096/fj.08-106450; David DJ, 2009, NEURON, V62, P479, DOI 10.1016/j.neuron.2009.04.017; DEWAR KM, 1992, J NEUROCHEM, V58, P250, DOI 10.1111/j.1471-4159.1992.tb09303.x; Duman RS, 2012, SCIENCE, V338, P68, DOI 10.1126/science.1222939; Gaster LM, 1998, J MED CHEM, V41, P1218, DOI 10.1021/jm970457s; Giese KP, 1998, SCIENCE, V279, P870, DOI 10.1126/science.279.5352.870; GOTHERT M, 1995, BRIT J PHARMACOL, V114, P269; Heninger GR, 1996, PHARMACOPSYCHIATRY, V29, P2, DOI 10.1055/s-2007-979535; Hickie I, 2005, BRIT J PSYCHIAT, V186, P197, DOI 10.1192/bjp.186.3.197; Hsu EH, 2001, J PHARMACOL EXP THER, V298, P825; IHARA N, 1988, ACTA ANAT, V132, P335; Jarsky T, 2005, NAT NEUROSCI, V8, P1667, DOI 10.1038/nn1599; Kobayashi K, 2008, J NEUROSCI, V28, P6272, DOI 10.1523/JNEUROSCI.1656-08.2008; Krishnan V, 2008, NATURE, V455, P894, DOI 10.1038/nature07455; Krugers Harmen J, 2010, Front Synaptic Neurosci, V2, P24, DOI 10.3389/fnsyn.2010.00024; Lambe EK, 2000, CEREB CORTEX, V10, P974, DOI 10.1093/cercor/10.10.974; Lee HK, 2010, J NEUROPHYSIOL, V103, P479, DOI 10.1152/jn.00835.2009; Lee HK, 2000, NATURE, V405, P955, DOI 10.1038/35016089; Lim BK, 2012, NATURE, V487, P183, DOI 10.1038/nature11160; Lione AM, 2000, J NEUROCHEM, V75, P934, DOI 10.1046/j.1471-4159.2000.0750934.x; Malatynska E, 2005, NEUROSCI BIOBEHAV R, V29, P715, DOI 10.1016/j.neubiorev.2005.03.014; Malinow R, 2002, ANNU REV NEUROSCI, V25, P103, DOI 10.1146/annurev.neuro.25.112701.142758; Nakashiba T, 2008, SCIENCE, V319, P1260, DOI 10.1126/science.1151120; O'Neill MF, 2001, NEUROPSYCHOPHARMACOL, V24, P391, DOI 10.1016/S0893-133X(00)00196-2; Pavlides C, 2002, HIPPOCAMPUS, V12, P245, DOI 10.1002/hipo.1116; PHILLIPSON OT, 1985, NEUROSCIENCE, V16, P275, DOI 10.1016/0306-4522(85)90002-8; Remondes M, 2004, NATURE, V431, P699, DOI 10.1038/nature02965; Roche KW, 1996, NEURON, V16, P1179, DOI 10.1016/S0896-6273(00)80144-0; Sanacora G, 2008, NAT REV DRUG DISCOV, V7, P426, DOI 10.1038/nrd2462; Santarelli L, 2003, SCIENCE, V301, P805, DOI 10.1126/science.1083328; Sari Y, 1999, NEUROSCIENCE, V88, P899, DOI 10.1016/S0306-4522(98)00256-5; SAUDOU F, 1994, SCIENCE, V265, P1875, DOI 10.1126/science.8091214; SHARP T, 1989, BRIT J PHARMACOL, V96, P283, DOI 10.1111/j.1476-5381.1989.tb11815.x; Svenningsson P, 2002, P NATL ACAD SCI USA, V99, P3182, DOI 10.1073/pnas.052712799; Svenningsson P, 2006, SCIENCE, V311, P77, DOI 10.1126/science.1117571; Sybirska E, 2000, J NEUROSCI, V20, P5827, DOI 10.1523/JNEUROSCI.20-15-05827.2000; Tatarczynska E, 2004, BEHAV PHARMACOL, V15, P523, DOI 10.1097/00008877-200412000-00001; WILLNER P, 1987, PSYCHOPHARMACOLOGY, V93, P358; Yuen EY, 2012, NEURON, V73, P962, DOI 10.1016/j.neuron.2011.12.033	50	105	134	0	47	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	APR	2013	16	4					464	U135		10.1038/nn.3355	http://dx.doi.org/10.1038/nn.3355			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	114EM	23502536	Green Accepted			2022-12-28	WOS:000316723700017
J	Huang, W; Zhu, PJ; Zhang, SX; Zhou, HY; Stoica, L; Galiano, M; Krnjevic, K; Roman, G; Costa-Mattioli, M				Huang, Wei; Zhu, Ping Jun; Zhang, Shixing; Zhou, Hongyi; Stoica, Loredana; Galiano, Mauricio; Krnjevic, Kresimir; Roman, Gregg; Costa-Mattioli, Mauro			mTORC2 controls actin polymerization required for consolidation of long-term memory	NATURE NEUROSCIENCE			English	Article							SYNAPTIC PLASTICITY; TUBEROUS SCLEROSIS; MAMMALIAN TARGET; AKT; PHOSPHORYLATION; RICTOR; DYNAMICS; REVEALS; DISEASE; GROWTH	A major goal of biomedical research is the identification of molecular and cellular mechanisms that underlie memory storage. Here we report a previously unknown signaling pathway that is necessary for the conversion from short- to long-term memory. The mammalian target of rapamycin (mTOR) complex 2 (mTORC2), which contains the regulatory protein Rictor (rapamycin-insensitive companion of mTOR), was discovered only recently and little is known about its function. We found that conditional deletion of Rictor in the postnatal murine forebrain greatly reduced mTORC2 activity and selectively impaired both long-term memory (LTM) and the late phase of hippocampal long-term potentiation (L-LTP). We also found a comparable impairment of LTM in dTORC2-deficient flies, highlighting the evolutionary conservation of this pathway. Actin polymerization was reduced in the hippocampus of mTORC2-deficient mice and its restoration rescued both L-LTP and LTM. Moreover, a compound that promoted mTORC2 activity converted early LTP into late LTP and enhanced LTM. Thus, mTORC2 could be a therapeutic target for the treatment of cognitive dysfunction.	[Huang, Wei; Zhu, Ping Jun; Zhou, Hongyi; Stoica, Loredana; Galiano, Mauricio; Costa-Mattioli, Mauro] Baylor Coll Med, Dept Neurosci, Houston, TX 77030 USA; [Huang, Wei; Zhu, Ping Jun; Zhou, Hongyi; Costa-Mattioli, Mauro] Baylor Coll Med, Ctr Addict Learning & Memory, Houston, TX 77030 USA; [Zhang, Shixing; Roman, Gregg] Univ Houston, Dept Biol & Biochem, Houston, TX USA; [Zhang, Shixing; Roman, Gregg] Univ Houston, Biol Behav Inst, Houston, TX USA; [Stoica, Loredana; Costa-Mattioli, Mauro] Baylor Coll Med, Dept Mol & Cell Biol, Houston, TX 77030 USA; [Krnjevic, Kresimir] McGill Univ, Dept Physiol, Montreal, PQ, Canada	Baylor College of Medicine; Baylor College of Medicine; University of Houston System; University of Houston; University of Houston System; University of Houston; Baylor College of Medicine; McGill University	Costa-Mattioli, M (corresponding author), Baylor Coll Med, Dept Neurosci, Houston, TX 77030 USA.	costamat@bcm.edu	Roman, Gregg/W-1586-2019	Roman, Gregg/0000-0003-1519-4699; Galiano, Mauricio/0000-0002-8245-1715	National Institute of Mental Health [MH 096816]; National Institute of Neurological Disorders and Stroke [NS 076708]; Searle award [09-SSP-211]; George and Cynthia Mitchell Foundation; US National Institutes of Health [MH091305]; Texas Norman Hackerman Advanced Research Program award; Whitehall award; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD024064] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH096816] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS076708] Funding Source: NIH RePORTER	National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Searle award; George and Cynthia Mitchell Foundation; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Texas Norman Hackerman Advanced Research Program award; Whitehall award; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank M. Magnuson (Vanderbilt University), I. Dragatsis (University of Tennessee) and K. Tolias (Baylor College of Medicine) who generously provided Rictor<SUP>loxP/loxP</SUP> mice, Camk2a-Cre mice and the Tiam1 constructs, respectively. We also thank A. Placzek and W. Sossin for comments on an early version of the manuscript. This work was supported by grants to M.C.-M. (National Institute of Mental Health grant MH 096816, National Institute of Neurological Disorders and Stroke grant NS 076708, Searle award grant 09-SSP-211, Whitehall award, grants from the George and Cynthia Mitchell Foundation) and G.R. (US National Institutes of Health grant MH091305 and a Texas Norman Hackerman Advanced Research Program award).	BOURTCHULADZE R, 1994, CELL, V79, P59, DOI 10.1016/0092-8674(94)90400-6; Carson RP, 2013, HUM MOL GENET, V22, P140, DOI 10.1093/hmg/dds414; Chen LY, 2007, J NEUROSCI, V27, P5363, DOI 10.1523/JNEUROSCI.0164-07.2007; Choe G, 2003, CANCER RES, V63, P2742; Cingolani LA, 2008, NAT REV NEUROSCI, V9, P344, DOI 10.1038/nrn2373; Costa-Mattioli M, 2007, CELL, V129, P195, DOI 10.1016/j.cell.2007.01.050; Costa-Mattioli M, 2009, NEURON, V61, P10, DOI 10.1016/j.neuron.2008.10.055; Dragatsis I, 2000, GENESIS, V26, P133, DOI 10.1002/(SICI)1526-968X(200002)26:2<133::AID-GENE10>3.0.CO;2-V; Ferris J, 2006, NAT NEUROSCI, V9, P1036, DOI 10.1038/nn1738; Fischer A, 2004, J NEUROSCI, V24, P1962, DOI 10.1523/JNEUROSCI.5112-03.2004; Fukazawa' Y, 2003, NEURON, V38, P447, DOI 10.1016/S0896-6273(03)00206-X; Griffin RJ, 2005, J NEUROCHEM, V93, P105, DOI 10.1111/j.1471-4159.2004.02949.x; Guertin DA, 2007, CANCER CELL, V12, P9, DOI 10.1016/j.ccr.2007.05.008; Guertin DA, 2006, DEV CELL, V11, P859, DOI 10.1016/j.devcel.2006.10.007; Han EKH, 2007, ONCOGENE, V26, P5655, DOI 10.1038/sj.onc.1210343; Heasman SJ, 2008, NAT REV MOL CELL BIO, V9, P690, DOI 10.1038/nrm2476; Hietakangas V, 2007, GENE DEV, V21, P632, DOI 10.1101/gad.416307; Holzinger A, 2009, METHODS MOL BIOL, V586, P71, DOI 10.1007/978-1-60761-376-3_4; Humbert S, 2002, DEV CELL, V2, P831, DOI 10.1016/S1534-5807(02)00188-0; Kandel ER, 2001, SCIENCE, V294, P1030, DOI 10.1126/science.1067020; Kim CH, 1999, J NEUROSCI, V19, P4314; Kopec CD, 2006, J NEUROSCI, V26, P2000, DOI 10.1523/JNEUROSCI.3918-05.2006; Kramar EA, 2006, P NATL ACAD SCI USA, V103, P5579, DOI 10.1073/pnas.0601354103; Krucker T, 2000, P NATL ACAD SCI USA, V97, P6856, DOI 10.1073/pnas.100139797; Lamprecht R, 2002, NEURON, V36, P727, DOI 10.1016/S0896-6273(02)01047-4; Lamprecht R, 2004, NAT REV NEUROSCI, V5, P45, DOI 10.1038/nrn1301; LeDoux JE, 2000, ANNU REV NEUROSCI, V23, P155, DOI 10.1146/annurev.neuro.23.1.155; Lynch G, 2007, NEUROPHARMACOLOGY, V52, P12, DOI 10.1016/j.neuropharm.2006.07.027; Ma XJM, 2009, NAT REV MOL CELL BIO, V10, P307, DOI 10.1038/nrm2672; Malagelada C, 2008, J NEUROSCI, V28, P14363, DOI 10.1523/JNEUROSCI.3928-08.2008; Mantzur L, 2009, NEUROBIOL LEARN MEM, V91, P85, DOI 10.1016/j.nlm.2008.09.001; Matsuzaki M, 2004, NATURE, V429, P761, DOI 10.1038/nature02617; Mazei-Robison MS, 2011, NEURON, V72, P977, DOI 10.1016/j.neuron.2011.10.012; McGaugh JL, 2000, SCIENCE, V287, P248, DOI 10.1126/science.287.5451.248; Meikle L, 2008, J NEUROSCI, V28, P5422, DOI 10.1523/JNEUROSCI.0955-08.2008; MORRIS RGM, 1982, NATURE, V297, P681, DOI 10.1038/297681a0; Oh WJ, 2011, CELL CYCLE, V10, P2305, DOI 10.4161/cc.10.14.16586; Okamoto KI, 2004, NAT NEUROSCI, V7, P1104, DOI 10.1038/nn1311; Olson EN, 2010, NAT REV MOL CELL BIO, V11, P353, DOI 10.1038/nrm2890; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Shamah SM, 2001, CELL, V105, P233, DOI 10.1016/S0092-8674(01)00314-2; Shiota C, 2006, DEV CELL, V11, P583, DOI 10.1016/j.devcel.2006.08.013; Siarey RJ, 2006, J NEUROCHEM, V98, P1266, DOI 10.1111/j.1471-4159.2006.03971.x; Siuta MA, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000393; Stoica L, 2011, P NATL ACAD SCI USA, V108, P3791, DOI 10.1073/pnas.1014715108; Tolias KF, 2005, NEURON, V45, P525, DOI 10.1016/j.neuron.2005.01.024; Tsai V, 2014, CEREB CORTEX, V24, P315, DOI 10.1093/cercor/bhs310; Tsien JZ, 1996, CELL, V87, P1317, DOI 10.1016/S0092-8674(00)81826-7; TULLY T, 1994, CELL, V79, P35, DOI 10.1016/0092-8674(94)90398-0; Van Horck FPG, 2008, SCI SIGNAL, V1, DOI 10.1126/stke.18pe11; Wang SH, 2010, ANNU REV PSYCHOL, V61, P49, DOI 10.1146/annurev.psych.093008.100523; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016; Zeng LH, 2007, J NEUROSCI, V27, P11604, DOI 10.1523/JNEUROSCI.0983-07.2007; Zhou J, 2009, J NEUROSCI, V29, P1773, DOI 10.1523/JNEUROSCI.5685-08.2009; Zhu PJ, 2011, CELL, V147, P1384, DOI 10.1016/j.cell.2011.11.029	55	203	208	0	50	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	APR	2013	16	4					441	U105		10.1038/nn.3351	http://dx.doi.org/10.1038/nn.3351			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	114EM	23455608	Green Accepted			2022-12-28	WOS:000316723700014
J	Klengel, T; Mehta, D; Anacker, C; Rex-Haffner, M; Pruessner, JC; Pariante, CM; Pace, TWW; Mercer, KB; Mayberg, HS; Bradley, B; Nemeroff, CB; Holsboer, F; Heim, CM; Ressler, KJ; Rein, T; Binder, EB				Klengel, Torsten; Mehta, Divya; Anacker, Christoph; Rex-Haffner, Monika; Pruessner, Jens C.; Pariante, Carmine M.; Pace, Thaddeus W. W.; Mercer, Kristina B.; Mayberg, Helen S.; Bradley, Bekh; Nemeroff, Charles B.; Holsboer, Florian; Heim, Christine M.; Ressler, Kerry J.; Rein, Theo; Binder, Elisabeth B.			Allele-specific FKBP5 DNA demethylation mediates gene-childhood trauma interactions	NATURE NEUROSCIENCE			English	Article							POSTTRAUMATIC-STRESS-DISORDER; GLUCOCORTICOID-RECEPTOR; ADULT DEPRESSION; POLYMORPHISMS; METHYLATION; MODERATION; ABUSE; RISK; EXPRESSION; INCREASES	Although the fact that genetic predisposition and environmental exposures interact to shape development and function of the human brain and, ultimately, the risk of psychiatric disorders has drawn wide interest, the corresponding molecular mechanisms have not yet been elucidated. We found that a functional polymorphism altering chromatin interaction between the transcription start site and long-range enhancers in the FK506 binding protein 5 (FKBP5) gene, an important regulator of the stress hormone system, increased the risk of developing stress-related psychiatric disorders in adulthood by allele-specific, childhood trauma-dependent DNA demethylation in functional glucocorticoid response elements of FKBP5. This demethylation was linked to increased stress-dependent gene transcription followed by a long-term dysregulation of the stress hormone system and a global effect on the function of immune cells and brain areas associated with stress regulation. This identification of molecular mechanisms of genotype-directed long-term environmental reactivity will be useful for designing more effective treatment strategies for stress-related disorders.	[Klengel, Torsten; Mehta, Divya; Rex-Haffner, Monika; Holsboer, Florian; Rein, Theo; Binder, Elisabeth B.] Max Planck Inst Psychiat, Munich, Germany; [Anacker, Christoph; Pariante, Carmine M.] Kings Coll London, Inst Psychiat, Sect Perinatal Psychiat & Stress Psychiat & Immun, Dept Psychol Med, London WC2R 2LS, England; [Pruessner, Jens C.] McGill Univ, Fac Med, McGill Ctr Studies Aging, Verdun, PQ, Canada; [Pace, Thaddeus W. W.; Mayberg, Helen S.; Bradley, Bekh; Heim, Christine M.; Ressler, Kerry J.; Binder, Elisabeth B.] Emory Univ, Sch Med, Dept Psychiat & Behav Sci, Atlanta, GA USA; [Mercer, Kristina B.; Ressler, Kerry J.] Howard Hughes Med Inst, Chevy Chase, MD USA; [Bradley, Bekh] Atlanta Vet Affairs Med Ctr, Decatur, GA USA; [Nemeroff, Charles B.] Univ Miami, Miller Sch Med, Dept Psychiat & Behav Sci, Miami, FL 33136 USA; [Heim, Christine M.] Charite, Inst Med Psychol, D-13353 Berlin, Germany; [Ressler, Kerry J.] Emory Univ, Yerkes Natl Primate Res Ctr, Atlanta, GA 30322 USA	Max Planck Society; University of London; King's College London; McGill University; Emory University; Howard Hughes Medical Institute; US Department of Veterans Affairs; Veterans Health Administration (VHA); Atlanta VA Health Care System; University of Miami; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Emory University	Klengel, T (corresponding author), Max Planck Inst Psychiat, Munich, Germany.	klengel@mpipsykl.mpg.de	Heim, Christine/J-4693-2014; Bradley, Bekh/H-8399-2012; Ressler, Kerry J/N-8741-2018; Klengel, Torsten/E-5629-2010; Pariante, Carmine Maria/B-1297-2011; Binder, Elisabeth B/K-8905-2014; Anacker, Christoph/V-6021-2019; Mehta, Divya/ABD-4551-2021	Ressler, Kerry J/0000-0002-5158-1103; Klengel, Torsten/0000-0001-7045-9229; Pariante, Carmine Maria/0000-0002-9132-5091; Heim, Christine/0000-0002-6580-6326; Nemeroff, Charles/0000-0001-7867-1160; Mehta, Divya Deepak/0000-0002-7359-348X; Mehta, Divya/0000-0001-7971-7255; Rein, Theo/0000-0003-2850-4289; Pruessner, Jens/0000-0002-8582-2980	European Research Council [281338]; National Alliance for Research in Schizophrenia and Affective Disorders; Behrens Weise Stiftung; National Institute of Mental Health [MH071538, MH58922]; National Institute for Health Research Biomedical Research Centre for Mental Health; Institute of Psychiatry; South London and Maudsley National Health System Foundation Trust; UK Medical Research Council [G108/603]; Commission of European Communities 7th Framework Programme Collaborative Project [22963]; Public Health Service from the Clinical and Translational Science Award program [UL1 RR025008]; US National Institutes of Health; National Center for Research Resources; K Award [K01 MH073698-01]; MRC [G108/603] Funding Source: UKRI; Medical Research Council [G108/603] Funding Source: researchfish; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000454] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025008] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH058922, K01MH073698] Funding Source: NIH RePORTER	European Research Council(European Research Council (ERC)European Commission); National Alliance for Research in Schizophrenia and Affective Disorders(NARSAD); Behrens Weise Stiftung; National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Institute for Health Research Biomedical Research Centre for Mental Health(National Institute for Health Research (NIHR)); Institute of Psychiatry; South London and Maudsley National Health System Foundation Trust; UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Commission of European Communities 7th Framework Programme Collaborative Project; Public Health Service from the Clinical and Translational Science Award program; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); K Award; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank T. Mletzko, K. Hafner and N.C. Gassen for their help in acquiring and interpreting data, and P. Weber for data visualization. Special thanks to A. W. Graham, A. Brown, D. Crain and D. Cross for their assistance in recruiting subjects and managing the Grady Trauma Project. This work was supported by a European Research Council starting grant (grant #281338, GxE molmech), a grant from the National Alliance for Research in Schizophrenia and Affective Disorders and a grant from the Behrens Weise Stiftung to E. B. B., a grant from the National Institute of Mental Health (MH071538) to K.J.R., and a grant from the National Institute of Mental Health (MH58922) to C.B.N., C. M. P. and C. A. have received funding from the National Institute for Health Research Biomedical Research Centre for Mental Health, Institute of Psychiatry and South London and Maudsley National Health System Foundation Trust, a Clinician Scientist Fellowship from the UK Medical Research Council (G108/603) to C. M. P., and the Commission of European Communities 7th Framework Programme Collaborative Project Grant Agreement n 22963 (Mood Inflame), also to C. M. P., C. M. H. is supported in part by Public Health Service Grant UL1 RR025008 from the Clinical and Translational Science Award program, the US National Institutes of Health, the National Center for Research Resources and by a K Award (K01 MH073698-01, Neural Substrates of Depression Risk after Child Abuse).	Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Anacker C, 2011, MOL PSYCHIATR, V16, P738, DOI 10.1038/mp.2011.26; Appel K, 2011, NEUROPSYCHOPHARMACOL, V36, P1982, DOI 10.1038/npp.2011.81; Attwood BK, 2011, NATURE, V473, P372, DOI 10.1038/nature09938; Binder EB, 2009, PSYCHONEUROENDOCRINO, V34, P99, DOI 10.1016/j.psyneuen.2009.05.021; Binder EB, 2004, NAT GENET, V36, P1319, DOI 10.1038/ng1479; Binder EB, 2008, JAMA-J AM MED ASSOC, V299, P1291, DOI 10.1001/jama.299.11.1291; Birney E, 2007, NATURE, V447, P799, DOI 10.1038/nature05874; Bradley RG, 2008, ARCH GEN PSYCHIAT, V65, P190, DOI 10.1001/archgenpsychiatry.2007.26; Caspi A, 2006, NAT REV NEUROSCI, V7, P583, DOI 10.1038/nrn1925; Caspi A, 2010, AM J PSYCHIAT, V167, P509, DOI 10.1176/appi.ajp.2010.09101452; COLLINS DL, 1994, J COMPUT ASSIST TOMO, V18, P192, DOI 10.1097/00004728-199403000-00005; Danese A, 2008, ARCH GEN PSYCHIAT, V65, P409, DOI 10.1001/archpsyc.65.4.409; DeRijk RH, 1996, J CLIN ENDOCR METAB, V81, P228, DOI 10.1210/jc.81.1.228; FINK LA, 1995, AM J PSYCHIAT, V152, P1329, DOI 10.1176/ajp.152.9.1329; Gillespie CF, 2009, GEN HOSP PSYCHIAT, V31, P505, DOI 10.1016/j.genhosppsych.2009.05.003; Hagege H, 2007, NAT PROTOC, V2, P1722, DOI 10.1038/nprot.2007.243; Heim C, 2008, PSYCHONEUROENDOCRINO, V33, P693, DOI 10.1016/j.psyneuen.2008.03.008; Heim C, 2009, FRONT BEHAV NEUROSCI, V3, DOI 10.3389/neuro.08.041.2009; Holsboer F, 2000, NEUROPSYCHOPHARMACOL, V23, P477, DOI 10.1016/S0893-133X(00)00159-7; Howie BN, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000529; Huber Wolfgang, 2002, Bioinformatics, V18 Suppl 1, pS96; Ising M, 2008, EUR J NEUROSCI, V28, P389, DOI 10.1111/j.1460-9568.2008.06332.x; Jaaskelainen T, 2011, CURR OPIN PHARMACOL, V11, P326, DOI 10.1016/j.coph.2011.04.006; Kelder T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006447; Klug M, 2006, EPIGENETICS-US, V1, P127, DOI 10.4161/epi.1.3.3327; Koenen KC, 2005, MOL PSYCHIATR, V10, P1058, DOI 10.1038/sj.mp.4001727; Lee RS, 2010, ENDOCRINOLOGY, V151, P4332, DOI 10.1210/en.2010-0225; McGowan PO, 2009, NAT NEUROSCI, V12, P342, DOI 10.1038/nn.2270; Mehta D, 2011, ARCH GEN PSYCHIAT, V68, P901, DOI 10.1001/archgenpsychiatry.2011.50; Miller GE, 2005, PSYCHOSOM MED, V67, P679, DOI 10.1097/01.psy.0000174172.82428.ce; Murgatroyd C, 2009, NAT NEUROSCI, V12, P1559, DOI 10.1038/nn.2436; O'Leary JC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024840; Paakinaho V, 2010, MOL ENDOCRINOL, V24, P511, DOI 10.1210/me.2009-0443; Pace TWW, 2006, AM J PSYCHIAT, V163, P1630, DOI 10.1176/appi.ajp.163.9.1630; Pace TWW, 2011, BRAIN BEHAV IMMUN, V25, P6, DOI 10.1016/j.bbi.2010.10.003; Pratt WB, 1997, ENDOCR REV, V18, P306, DOI 10.1210/er.18.3.306; Pruessner JC, 2000, CEREB CORTEX, V10, P433, DOI 10.1093/cercor/10.4.433; Ressler KJ, 2011, NATURE, V470, P492, DOI 10.1038/nature09856; Roy A, 2010, NEUROPSYCHOPHARMACOL, V35, P1674, DOI 10.1038/npp.2009.236; Scammell JG, 2001, GEN COMP ENDOCR, V124, P152, DOI 10.1006/gcen.2001.7696; Sled JG, 1998, IEEE T MED IMAGING, V17, P87, DOI 10.1109/42.668698; Sommershof A, 2009, BRAIN BEHAV IMMUN, V23, P1117, DOI 10.1016/j.bbi.2009.07.003; Thomassin H, 2001, EMBO J, V20, P1974, DOI 10.1093/emboj/20.8.1974; Touma C, 2011, BIOL PSYCHIAT, V70, P928, DOI 10.1016/j.biopsych.2011.07.023; Weaver ICG, 2004, NAT NEUROSCI, V7, P847, DOI 10.1038/nn1276; Wochnik GM, 2005, J BIOL CHEM, V280, P4609, DOI 10.1074/jbc.M407498200; Xie P, 2010, NEUROPSYCHOPHARMACOL, V35, P1684, DOI 10.1038/npp.2010.37; Zimmermann P, 2011, AM J PSYCHIAT, V168, P1107, DOI 10.1176/appi.ajp.2011.10111577	49	896	911	5	185	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JAN	2013	16	1					33	41		10.1038/nn.3275	http://dx.doi.org/10.1038/nn.3275			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	058KZ	23201972	Green Accepted			2022-12-28	WOS:000312633900010
J	Butko, MT; Yang, J; Geng, Y; Kim, HJ; Jeon, NL; Shu, XK; Mackey, MR; Ellisman, MH; Tsien, RY; Lin, MZ				Butko, Margaret T.; Yang, Jin; Geng, Yang; Kim, Hyung Joon; Jeon, Noo Li; Shu, Xiaokun; Mackey, Mason R.; Ellisman, Mark H.; Tsien, Roger Y.; Lin, Michael Z.			Fluorescent and photo-oxidizing TimeSTAMP tags track protein fates in light and electron microscopy	NATURE NEUROSCIENCE			English	Article							MENTAL-RETARDATION PROTEIN; RECEPTOR-DEPENDENT TRANSLATION; NEWLY SYNTHESIZED PROTEINS; LONG-TERM POTENTIATION; MEMORY CONSOLIDATION; MESSENGER-RNAS; AMPA RECEPTOR; PSD-95; REQUIRES; SYNAPSE	Protein synthesis is highly regulated throughout nervous system development, plasticity and regeneration. However, tracking the distributions of specific new protein species has not been possible in living neurons or at the ultrastructural level. Previously we created TimeSTAMP epitope tags, drug-controlled tags for immunohistochemical detection of specific new proteins synthesized at defined times. Here we extend TimeSTAMP to label new protein copies by fluorescence or photo-oxidation. Live microscopy of a fluorescent TimeSTAMP tag reveals that copies of the synaptic protein PSD95 are synthesized in response to local activation of growth factor and neurotransmitter receptors, and preferentially localize to stimulated synapses in rat neurons. Electron microscopy of a photo-oxidizing TimeSTAMP tag reveals new PSD95 at developing dendritic structures of immature neurons and at synapses in differentiated neurons. These results demonstrate the versatility of the TimeSTAMP approach for visualizing newly synthesized proteins in neurons.	[Butko, Margaret T.; Yang, Jin; Shu, Xiaokun; Tsien, Roger Y.; Lin, Michael Z.] Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92093 USA; [Butko, Margaret T.; Yang, Jin; Shu, Xiaokun; Tsien, Roger Y.; Lin, Michael Z.] Univ Calif San Diego, Howard Hughes Med Inst, La Jolla, CA 92093 USA; [Geng, Yang; Lin, Michael Z.] Stanford Univ, Dept Pediat, Palo Alto, CA 94304 USA; [Geng, Yang; Lin, Michael Z.] Stanford Univ, Dept Bioengn, Palo Alto, CA 94304 USA; [Kim, Hyung Joon; Jeon, Noo Li] Seoul Natl Univ, Sch Mech & Aerosp Engn, Seoul, South Korea; [Shu, Xiaokun] Univ Calif San Francisco, Dept Pharmaceut Chem, San Francisco, CA 94143 USA; [Shu, Xiaokun] Univ Calif San Francisco, Cardiovasc Res Inst, San Francisco, CA 94143 USA; [Mackey, Mason R.; Ellisman, Mark H.] Univ Calif San Diego, Natl Ctr Microscopy & Imaging Res, Ctr Res Biol Syst, La Jolla, CA 92093 USA; [Mackey, Mason R.; Ellisman, Mark H.] Univ Calif San Diego, Dept Neurosci, La Jolla, CA 92093 USA	University of California System; University of California San Diego; Howard Hughes Medical Institute; University of California System; University of California San Diego; Stanford University; Stanford University; Seoul National University (SNU); University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Diego; University of California System; University of California San Diego	Tsien, RY (corresponding author), Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92093 USA.	rtsien@ucsd.edu; mzlin@stanford.edu		Lin, Michael/0000-0002-0492-1961; shu, Xiaokun/0000-0001-9248-7095	US National Institutes of Health (NIH); US National Science Foundation; Lucille Packard Children's Hospital Pediatric Research Fund; Korea Research Foundation of the South Korea Ministry of Education, Science and Technology [R31-2008-000-10083-0]; Howard Hughes Medical Institute; NIH [4R37NS027177-23, P41GM103412-24, R01NS076860]; Burroughs Wellcome Fund; Rita Allen Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM086197, T32GM007752, P41GM103412] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R37NS027177, R01NS027177, R01NS076860] Funding Source: NIH RePORTER	US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US National Science Foundation(National Science Foundation (NSF)); Lucille Packard Children's Hospital Pediatric Research Fund; Korea Research Foundation of the South Korea Ministry of Education, Science and Technology; Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Burroughs Wellcome Fund(Burroughs Wellcome Fund); Rita Allen Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank members of the Tsien and Ellisman laboratories for helpful discussion, especially V. Lev-Ram, S. Adams and T. Deerinck. This work was supported by a US National Institutes of Health (NIH) Pharmacology Training grant (M. T. B.), the US National Science Foundation Graduate Research Fellowships Program (M. T. B.), the Lucille Packard Children's Hospital Pediatric Research Fund (Y.G.), World Class University Program grant R31-2008-000-10083-0 from the Korea Research Foundation of the South Korea Ministry of Education, Science and Technology (N.L.J.), the Howard Hughes Medical Institute and NIH grant 4R37NS027177-23 (R.Y.T.), NIH grant P41GM103412-24 (M. H. E.), NIH grant R01NS076860 (M.Z.L.), and the Burroughs Wellcome Fund (M.Z.L.). M.Z.L. is funded as a Rita Allen Foundation Scholar.	Abraham WC, 2008, NEUROBIOL LEARN MEM, V89, P260, DOI 10.1016/j.nlm.2007.10.001; Auerbach BD, 2010, J NEUROPHYSIOL, V104, P1047, DOI 10.1152/jn.00449.2010; Bekinschtein P, 2007, NEURON, V53, P261, DOI 10.1016/j.neuron.2006.11.025; Benarroch EE, 2008, NEUROLOGY, V70, P964, DOI 10.1212/01.wnl.0000306315.03021.2a; Bingol B, 2011, NEURON, V69, P22, DOI 10.1016/j.neuron.2010.11.006; Blanpied TA, 2008, P NATL ACAD SCI USA, V105, P12587, DOI 10.1073/pnas.0711669105; Bourtchouladze R, 1998, LEARN MEMORY, V5, P365; Bradshaw KD, 2003, EUR J NEUROSCI, V18, P3150, DOI 10.1111/j.1460-9568.2003.03054.x; Bramham CR, 2008, J NEUROSCI, V28, P11760, DOI 10.1523/JNEUROSCI.3864-08.2008; Bresler T, 2001, MOL CELL NEUROSCI, V18, P149, DOI 10.1006/mcne.2001.1012; Chen XB, 2011, J NEUROSCI, V31, P6329, DOI 10.1523/JNEUROSCI.5968-10.2011; Dieterich DC, 2010, NAT NEUROSCI, V13, P897, DOI 10.1038/nn.2580; Ehrlich I, 2004, J NEUROSCI, V24, P916, DOI 10.1523/JNEUROSCI.4733-03.2004; Gaietta G, 2002, SCIENCE, V296, P503, DOI 10.1126/science.1068793; Goellner B, 2012, DEV NEUROBIOL, V72, P111, DOI 10.1002/dneu.20892; Gold PE, 2008, NEUROBIOL LEARN MEM, V89, P201, DOI 10.1016/j.nlm.2007.10.006; Graf ER, 2004, CELL, V119, P1013, DOI 10.1016/j.cell.2004.11.035; Hernandez PJ, 2008, NEUROBIOL LEARN MEM, V89, P293, DOI 10.1016/j.nlm.2007.09.010; Jung H, 2011, CURR OPIN GENET DEV, V21, P458, DOI 10.1016/j.gde.2011.04.004; Kang HJ, 1996, SCIENCE, V273, P1402, DOI 10.1126/science.273.5280.1402; Kim MJ, 2007, NEURON, V56, P488, DOI 10.1016/j.neuron.2007.09.007; Lee CC, 2005, J BIOL CHEM, V280, P18543, DOI 10.1074/jbc.M414112200; Lin MZ, 2008, P NATL ACAD SCI USA, V105, P7744, DOI 10.1073/pnas.0803060105; Magliery TJ, 2005, J AM CHEM SOC, V127, P146, DOI 10.1021/ja046699g; Muddashetty RS, 2007, J NEUROSCI, V27, P5338, DOI 10.1523/JNEUROSCI.0937-07.2007; Noritake J, 2009, J CELL BIOL, V186, P147, DOI 10.1083/jcb.200903101; Okada D, 2009, SCIENCE, V324, P904, DOI 10.1126/science.1171498; PHILLIPS LL, 1990, J NEUROSCI RES, V26, P474, DOI 10.1002/jnr.490260410; Ronesi JA, 2008, J NEUROSCI, V28, P543, DOI 10.1523/JNEUROSCI.5019-07.2008; Schratt GM, 2004, J NEUROSCI, V24, P7366, DOI 10.1523/JNEUROSCI.1739-04.2004; Schuman EM, 2006, J NEUROSCI, V26, P7143, DOI 10.1523/JNEUROSCI.1796-06.2006; Sebeo J, 2009, J NEUROSCI, V29, P9778, DOI 10.1523/JNEUROSCI.2613-09.2009; Shepherd JD, 2006, NEURON, V52, P475, DOI 10.1016/j.neuron.2006.08.034; Shu XK, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001041; Smith WB, 2005, NEURON, V45, P765, DOI 10.1016/j.neuron.2005.01.015; Stepanenko OV, 2011, BIOTECHNIQUES, V51, P313, DOI 10.2144/000113765; Steward O, 1998, NEURON, V21, P741, DOI 10.1016/S0896-6273(00)80591-7; Sturgill JF, 2009, J NEUROSCI, V29, P12845, DOI 10.1523/JNEUROSCI.1841-09.2009; Taylor AM, 2005, NAT METHODS, V2, P599, DOI 10.1038/NMETH777; Todd PK, 2003, P NATL ACAD SCI USA, V100, P14374, DOI 10.1073/pnas.2336265100; Toni N, 2007, NAT NEUROSCI, V10, P727, DOI 10.1038/nn1908; Wang DO, 2009, SCIENCE, V324, P1536, DOI 10.1126/science.1173205; Wang KH, 2006, CELL, V126, P389, DOI 10.1016/j.cell.2006.06.038; Waterhouse EG, 2009, MOL CELL NEUROSCI, V42, P81, DOI 10.1016/j.mcn.2009.06.009; Waung MW, 2009, CURR OPIN NEUROBIOL, V19, P319, DOI 10.1016/j.conb.2009.03.011; Welshhans K, 2011, J NEUROSCI, V31, P9800, DOI 10.1523/JNEUROSCI.0166-11.2011; Yoshii A, 2007, NAT NEUROSCI, V10, P702, DOI 10.1038/nn1903; Zadran S, 2010, MOL NEUROBIOL, V42, P143, DOI 10.1007/s12035-010-8145-1; Zalfa F, 2007, NAT NEUROSCI, V10, P578, DOI 10.1038/nn1893; Zhang C, 2009, J NEUROSCI, V29, P10843, DOI 10.1523/JNEUROSCI.1248-09.2009	50	44	49	1	53	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	DEC	2012	15	12					1742	+		10.1038/nn.3246	http://dx.doi.org/10.1038/nn.3246			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	045OR	23103964	Green Accepted, Green Submitted			2022-12-28	WOS:000311706700022
J	Kwon, HB; Kozorovitskiy, Y; Oh, WJ; Peixoto, RT; Akhtar, N; Saulnier, JL; Gu, CH; Sabatini, BL				Kwon, Hyung-Bae; Kozorovitskiy, Yevgenia; Oh, Won-Jong; Peixoto, Rui T.; Akhtar, Nazia; Saulnier, Jessica L.; Gu, Chenghua; Sabatini, Bernardo L.			Neuroligin-1-dependent competition regulates cortical synaptogenesis and synapse number	NATURE NEUROSCIENCE			English	Article							CELL-ADHESION MOLECULE; INHIBITORY SYNAPSES; DENDRITIC SPINES; NEUROLIGIN; NEUREXIN; PLASTICITY; PSD-95; MECHANISMS; MUTATIONS; AMYGDALA	Members of the neuroligin family of cell-adhesion proteins are found at excitatory and inhibitory synapses and are mutated in some familial forms of autism spectrum disorders. Although they display synaptogenic properties in heterologous systems, the function of neuroligins in vivo in the regulation of synapse formation and synapse number has been difficult to establish. We found that neuroligin-1 (NL1), which is located at excitatory postsynaptic densities, regulates activity-dependent synaptogenesis and mature synapse number on cortical layer 2/3 pyramidal neurons in vivo. However, synapse number was not sensitive to absolute NL1 levels but instead depended on transcellular differences in the relative amounts of NL1. These effects were independent of the cell-autonomous regulation of NMDA-type glutamate receptors by absolute levels of NL1. Our data indicate that transcellular competitive processes govern synapse formation and number in developing cortex and that NL1 has a central function in these processes.	[Kwon, Hyung-Bae; Kozorovitskiy, Yevgenia; Peixoto, Rui T.; Akhtar, Nazia; Saulnier, Jessica L.; Sabatini, Bernardo L.] Harvard Univ, Sch Med, Dept Neurobiol, Howard Hughes Med Inst, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Howard Hughes Medical Institute	Sabatini, BL (corresponding author), Harvard Univ, Sch Med, Dept Neurobiol, Howard Hughes Med Inst, Boston, MA 02115 USA.	bsabatini@hms.harvard.edu	Kozorovitskiy, Yevgenia/GOP-1185-2022	Kozorovitskiy, Yevgenia/0000-0002-3710-1484	US National Institutes of Health [R01NS064583]; Leonard and Isabelle Goldenson Research Fellowship; SFARI grant from the Simons Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS064583, R01NS046579] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Leonard and Isabelle Goldenson Research Fellowship; SFARI grant from the Simons Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank members of the Sabatini laboratory for their constructive comments on the manuscript. We also thank A. Giessel, J.F. Sturgill and B. Bloodgood for helping us with data analysis. We are grateful to F. Varoqueaux and N. Brose (Max Planck Institute for Experimental Medicine) for providing mouse NL1 expression vector and Nlgn1<SUP>+/-</SUP> mice. This work was supported by US National Institutes of Health grant R01NS064583 (to C. G.), a Leonard and Isabelle Goldenson Research Fellowship (to Y.K.) and a SFARI grant from the Simons Foundation (to B.L.S.).	Alvarez VA, 2007, ANNU REV NEUROSCI, V30, P79, DOI 10.1146/annurev.neuro.30.051606.094222; Alvarez VA, 2006, J NEUROSCI, V26, P7820, DOI 10.1523/JNEUROSCI.1957-06.2006; Barrow SL, 2009, NEURAL DEV, V4, DOI 10.1186/1749-8104-4-17; Bloodgood BL, 2007, NEURON, V53, P249, DOI 10.1016/j.neuron.2006.12.017; Blundell J, 2010, J NEUROSCI, V30, P2115, DOI 10.1523/JNEUROSCI.4517-09.2010; Boucard AA, 2005, NEURON, V48, P229, DOI 10.1016/j.neuron.2005.08.026; Buffelli M, 2003, NATURE, V424, P430, DOI 10.1038/nature01844; Carter AG, 2004, NEURON, V44, P483, DOI 10.1016/j.neuron.2004.10.013; Chih B, 2005, SCIENCE, V307, P1324, DOI 10.1126/science.1107470; Chubykin AA, 2005, J BIOL CHEM, V280, P22365, DOI 10.1074/jbc.M410723200; Chubykin AA, 2007, NEURON, V54, P919, DOI 10.1016/j.neuron.2007.05.029; Contractor A, 2002, SCIENCE, V296, P1864, DOI 10.1126/science.1069081; Dalva MB, 2007, NAT REV NEUROSCI, V8, P206, DOI 10.1038/nrn2075; de Wit J, 2009, NEURON, V64, P799, DOI 10.1016/j.neuron.2009.12.019; Dean C, 2003, NAT NEUROSCI, V6, P708, DOI 10.1038/nn1074; Dresbach T, 2004, MOL CELL NEUROSCI, V27, P227, DOI 10.1016/j.mcn.2004.06.013; Durand CM, 2007, NAT GENET, V39, P25, DOI 10.1038/ng1933; Feng JN, 2006, NEUROSCI LETT, V409, P10, DOI 10.1016/j.neulet.2006.08.017; Graf ER, 2004, CELL, V119, P1013, DOI 10.1016/j.cell.2004.11.035; Grutzendler J, 2002, NATURE, V420, P812, DOI 10.1038/nature01276; Hofer SB, 2009, NATURE, V457, P313, DOI 10.1038/nature07487; Huberman AD, 2008, ANNU REV NEUROSCI, V31, P479, DOI 10.1146/annurev.neuro.31.060407.125533; Ichtchenko K, 1996, J BIOL CHEM, V271, P2676, DOI 10.1074/jbc.271.5.2676; ICHTCHENKO K, 1995, CELL, V81, P435, DOI 10.1016/0092-8674(95)90396-8; Jamain S, 2003, NAT GENET, V34, P27, DOI 10.1038/ng1136; Jamain S, 2008, P NATL ACAD SCI USA, V105, P1710, DOI 10.1073/pnas.0711555105; Jung SY, 2010, P NATL ACAD SCI USA, V107, P4710, DOI 10.1073/pnas.1001084107; Katz LC, 1996, SCIENCE, V274, P1133, DOI 10.1126/science.274.5290.1133; Kim J, 2008, P NATL ACAD SCI USA, V105, P9087, DOI 10.1073/pnas.0803448105; Ko J, 2009, NEURON, V64, P791, DOI 10.1016/j.neuron.2009.12.012; Kozorovitskiy Y, 2012, NATURE, V485, P646, DOI 10.1038/nature11052; Kwon HB, 2011, NATURE, V474, P100, DOI 10.1038/nature09986; Levinson JN, 2005, NEURON, V48, P171, DOI 10.1016/j.neuron.2005.09.017; McClelland AC, 2010, P NATL ACAD SCI USA, V107, P8830, DOI 10.1073/pnas.0910644107; Moody WJ, 2005, PHYSIOL REV, V85, P883, DOI 10.1152/physrev.00017.2004; Nam CI, 2005, P NATL ACAD SCI USA, V102, P6137, DOI 10.1073/pnas.0502038102; Poulopoulos A, 2009, NEURON, V63, P628, DOI 10.1016/j.neuron.2009.08.023; Prange O, 2004, P NATL ACAD SCI USA, V101, P13915, DOI 10.1073/pnas.0405939101; Sabatini BL, 2002, NEURON, V33, P439, DOI 10.1016/S0896-6273(02)00573-1; Sanes JR, 2009, ANNU REV CELL DEV BI, V25, P161, DOI 10.1146/annurev.cellbio.24.110707.175402; Santamaria F, 2006, NEURON, V52, P635, DOI 10.1016/j.neuron.2006.10.025; Scheiffele P, 2003, ANNU REV NEUROSCI, V26, P485, DOI 10.1146/annurev.neuro.26.043002.094940; Scheiffele P, 2000, CELL, V101, P657, DOI 10.1016/S0092-8674(00)80877-6; Soler-Llavina GJ, 2011, P NATL ACAD SCI USA, V108, P16502, DOI 10.1073/pnas.1114028108; Song JY, 1999, P NATL ACAD SCI USA, V96, P1100, DOI 10.1073/pnas.96.3.1100; STOPPINI L, 1991, J NEUROSCI METH, V37, P173, DOI 10.1016/0165-0270(91)90128-M; Sturgill JF, 2009, J NEUROSCI, V29, P12845, DOI 10.1523/JNEUROSCI.1841-09.2009; Sudhof TC, 2008, NATURE, V455, P903, DOI 10.1038/nature07456; Svoboda K, 1996, SCIENCE, V272, P716, DOI 10.1126/science.272.5262.716; Tavazoie SF, 2005, NAT NEUROSCI, V8, P1727, DOI 10.1038/nn1566; Trachtenberg JT, 2002, NATURE, V420, P788, DOI 10.1038/nature01273; Varoqueaux F, 2006, NEURON, V51, P741, DOI 10.1016/j.neuron.2006.09.003; Yamagata M, 2003, CURR OPIN CELL BIOL, V15, P621, DOI 10.1016/S0955-0674(03)00107-8; Zhong HN, 2009, NEURON, V62, P363, DOI 10.1016/j.neuron.2009.03.013	54	131	134	0	46	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	DEC	2012	15	12					1667	+		10.1038/nn.3256	http://dx.doi.org/10.1038/nn.3256			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	045OR	23143522	Green Accepted, Green Submitted			2022-12-28	WOS:000311706700012
J	Liu, J; Dietz, K; DeLoyht, JM; Pedre, X; Kelkar, D; Kaur, J; Vialou, V; Lobo, MK; Dietz, DM; Nestler, EJ; Dupree, J; Casaccia, P				Liu, Jia; Dietz, Karen; DeLoyht, Jacqueline M.; Pedre, Xiomara; Kelkar, Dipti; Kaur, Jasbir; Vialou, Vincent; Lobo, Mary Kay; Dietz, David M.; Nestler, Eric J.; Dupree, Jeffrey; Casaccia, Patrizia			Impaired adult myelination in the prefrontal cortex of socially isolated mice	NATURE NEUROSCIENCE			English	Article							WHITE-MATTER; DIFFERENTIATION; REMYELINATION	Protracted social isolation of adult mice induced behavioral, transcriptional and ultrastructural changes in oligodendrocytes of the prefrontal cortex (PFC) and impaired adult myelination. Social re-integration was sufficient to normalize behavioral and transcriptional changes. Short periods of isolation affected chromatin and myelin, but did not induce behavioral changes. Thus, myelinating oligodendrocytes in the adult PFC respond to social interaction with chromatin changes, suggesting that myelination acts as a form of adult plasticity.	[Liu, Jia; Dietz, Karen; Pedre, Xiomara; Kelkar, Dipti; Kaur, Jasbir; Vialou, Vincent; Lobo, Mary Kay; Dietz, David M.; Nestler, Eric J.; Casaccia, Patrizia] Mt Sinai Sch Med, Dept Neurosci, New York, NY USA; [Liu, Jia; Dietz, Karen; Pedre, Xiomara; Kelkar, Dipti; Kaur, Jasbir; Vialou, Vincent; Lobo, Mary Kay; Dietz, David M.; Nestler, Eric J.; Casaccia, Patrizia] Mt Sinai Sch Med, Friedman Brain Inst, New York, NY USA; [DeLoyht, Jacqueline M.; Dupree, Jeffrey] Virginia Commonwealth Univ, Dept Anat & Neurobiol, Richmond, VA USA	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Virginia Commonwealth University	Casaccia, P (corresponding author), Mt Sinai Sch Med, Dept Neurosci, New York, NY USA.	patrizia.casaccia@mssm.edu	Lobo, Mary Kay/K-7734-2015; Dietz, David/AAW-4574-2021; vialou, vincent/F-2968-2013; Dietz, David/J-9458-2015; Liu, Jia/AAN-2112-2020	Lobo, Mary Kay/0000-0002-9419-2079; Dietz, David/0000-0002-6927-9236; vialou, vincent/0000-0002-8212-751X; Dietz, David/0000-0002-6927-9236; Liu, Jia/0000-0001-6274-2710; Pedreiturria, Xiomara/0000-0002-3024-3826	US National Institutes of Health [R37-NS42925-10, P50-MH96890]; Center core grant [5P30NS047463]; National Multiple Sclerosis Society [FG1874-A-1]; NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH096890] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R37NS042925, P30NS047463] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Center core grant; National Multiple Sclerosis Society(National Multiple Sclerosis Society); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank A. Sharp, P. Garg and J. Huynh for help with statistical analysis and multiple correction tests. This work was funded by the US National Institutes of Health (R37-NS42925-10 to P. C. and P50-MH96890 to E.J.N.), a Center core grant to the Virginia Commonwealth University Microscopy Facility (5P30NS047463) and the National Multiple Sclerosis Society (FG1874-A-1 to J.L.).	Abr?moff M.D., 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; Arnett PA, 2008, J INT NEUROPSYCH SOC, V14, P691, DOI 10.1017/S1355617708081174; Berton O, 2006, SCIENCE, V311, P864, DOI 10.1126/science.1120972; Chari DM, 2006, J NEUROSCI RES, V83, P594, DOI 10.1002/jnr.20763; Fields RD, 2008, TRENDS NEUROSCI, V31, P361, DOI 10.1016/j.tins.2008.04.001; Fuster JM, 2002, J NEUROCYTOL, V31, P373, DOI 10.1023/A:1024190429920; He Y, 2007, NEURON, V55, P217, DOI 10.1016/j.neuron.2007.06.029; Kikusui T, 2007, BRAIN RES, V1133, P115, DOI 10.1016/j.brainres.2006.11.031; Makinodan M, 2012, SCIENCE, V337, P1357, DOI 10.1126/science.1220845; Marcus J, 2006, GLIA, V53, P372, DOI 10.1002/glia.20292; Pillai AM, 2009, J NEUROSCI RES, V87, P1773, DOI 10.1002/jnr.22015; Rajkowska G, 1999, BIOL PSYCHIAT, V45, P1085, DOI 10.1016/S0006-3223(99)00041-4; Regenold WT, 2006, BIPOLAR DISORD, V8, P188, DOI 10.1111/j.1399-5618.2006.00281.x; Sexton CE, 2009, BIOL PSYCHIAT, V66, P814, DOI 10.1016/j.biopsych.2009.05.024; Shen SM, 2008, NAT NEUROSCI, V11, P1024, DOI 10.1038/nn.2172; Shen SM, 2005, J CELL BIOL, V169, P577, DOI 10.1083/jcb.200412101; Shroff SM, 2009, J NEUROSCI RES, V87, P3403, DOI 10.1002/jnr.22003; Sokolov BP, 2007, INT J NEUROPSYCHOPH, V10, P547, DOI 10.1017/S1461145706007322; Wallace DL, 2009, NAT NEUROSCI, V12, P200, DOI 10.1038/nn.2257; Ye F, 2009, NAT NEUROSCI, V12, P829, DOI 10.1038/nn.2333	20	434	441	2	48	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	DEC	2012	15	12					1621	+		10.1038/nn.3263	http://dx.doi.org/10.1038/nn.3263			4	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	045OR	23143512	Green Accepted			2022-12-28	WOS:000311706700006
J	Lai, KO; Wong, ASL; Cheung, MC; Xu, P; Liang, ZY; Lok, KC; Xie, H; Palko, ME; Yung, WH; Tessarollo, L; Cheung, ZH; Ip, NY				Lai, Kwok-On; Wong, Alan S. L.; Cheung, Man-Chun; Xu, Pei; Liang, Zhuoyi; Lok, Ka-Chun; Xie, Hui; Palko, Mary E.; Yung, Wing-Ho; Tessarollo, Lino; Cheung, Zelda H.; Ip, Nancy Y.			TrkB phosphorylation by Cdk5 is required for activity-dependent structural plasticity and spatial memory	NATURE NEUROSCIENCE			English	Article							LONG-TERM POTENTIATION; SYNAPTIC PLASTICITY; DENDRITIC SPINE; PROTEIN-SYNTHESIS; NMDA RECEPTORS; BDNF; LTP; ROLES; EXPRESSION; TIAM1	The neurotrophin brain-derived neurotrophic factor (BDNF) and its receptor TrkB participate in diverse neuronal functions, including activity-dependent synaptic plasticity that is crucial for learning and memory. On binding to BDNF, TrkB is not only autophosphorylated at tyrosine residues but also undergoes serine phosphorylation at S478 by the serine/threonine kinase cyclin-dependent kinase 5 (Cdk5). However, the in vivo function of this serine phosphorylation remains unknown. We generated knock-in mice lacking this serine phosphorylation (Trkb(S478A/S478A) mice) and found that the TrkB phosphorylation deficient mice displayed impaired spatial memory and compromised hippocampal long-term potentiation (LIP). S478 phosphorylation of TrkB regulates its interaction with the Rac1-specific guanine nucleotide exchange factor TIAM1, leading to activation of Rac1 and phosphorylation of S6 ribosomal protein during activity-dependent dendritic spine remodeling. These findings reveal the importance of Cdk5-mediated S478 phosphorylation of TrkB in activity-dependent structural plasticity, which is crucial for LIP and spatial memory formation.	[Lai, Kwok-On; Wong, Alan S. L.; Cheung, Man-Chun; Xu, Pei; Liang, Zhuoyi; Lok, Ka-Chun; Cheung, Zelda H.; Ip, Nancy Y.] Hong Kong Univ Sci & Technol, Div Life Sci, Hong Kong, Hong Kong, Peoples R China; [Lai, Kwok-On; Wong, Alan S. L.; Cheung, Man-Chun; Xu, Pei; Liang, Zhuoyi; Lok, Ka-Chun; Cheung, Zelda H.; Ip, Nancy Y.] Hong Kong Univ Sci & Technol, Mol Neurosci Ctr, Hong Kong, Hong Kong, Peoples R China; [Lai, Kwok-On; Wong, Alan S. L.; Cheung, Man-Chun; Xu, Pei; Liang, Zhuoyi; Lok, Ka-Chun; Cheung, Zelda H.; Ip, Nancy Y.] Hong Kong Univ Sci & Technol, State Key Lab Mol Neurosci, Hong Kong, Hong Kong, Peoples R China; [Xie, Hui; Yung, Wing-Ho] Chinese Univ Hong Kong, Sch Biomed Sci, Hong Kong, Hong Kong, Peoples R China; [Palko, Mary E.; Tessarollo, Lino] NCI, Neural Dev Sect, Mouse Canc Genet Program, Ctr Canc Res, Frederick, MD 21701 USA	Hong Kong University of Science & Technology; Hong Kong University of Science & Technology; Hong Kong University of Science & Technology; Chinese University of Hong Kong; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Ip, NY (corresponding author), Hong Kong Univ Sci & Technol, Div Life Sci, Hong Kong, Hong Kong, Peoples R China.	boip@ust.hk	Lai, Kwok On/ABC-8046-2021; Yung, Ho/R-6161-2018; Lai, Kwok-On/L-7468-2019	Yung, Ho/0000-0002-5542-8173; Lai, Kwok-On/0000-0002-4069-054X; Ip, Nancy Yuk-Yu/0000-0002-2763-8907; Wong, Alan S.L./0000-0003-1790-3233; Cheung, Man Chun/0000-0001-5717-3322; Liang, Zhuoyi/0000-0003-1622-524X	Research Grants Council of Hong Kong [HKUST 661109, 661309, 660810, 661010, 661111]; University Grants Committee [AoE/B-15/01]; S.H. Ho Foundation; Croucher Foundation; National Cancer Institute, Center for Cancer Research, US National Institutes of Health; NATIONAL CANCER INSTITUTE [ZIABC010390] Funding Source: NIH RePORTER	Research Grants Council of Hong Kong(Hong Kong Research Grants Council); University Grants Committee; S.H. Ho Foundation; Croucher Foundation; National Cancer Institute, Center for Cancer Research, US National Institutes of Health; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We are grateful to A. Kulkarni (National Institutes of Health) and T. Curran (University of Pennsylvania) for the Cdk5<SUP>-/-</SUP> mice, L.-H. Tsai (Massachusetts Institute of Technology) for the p35<SUP>-/-</SUP> mice, M. Greenberg (Harvard Medical School) for the phospho-TIAM1 and phospho-PAK antibodies, W Mobley (University of California, San Diego) for TIAM1 expression constructs, and L. Reichardt (University of California, San Francisco) for the chicken antibody to TrkB. We thank C. Kwong, B. Lai, P. Sun, B. Butt, Y. Liang, H. Chuang, Y. Dai and K. Ho for their excellent technical assistance, Amy Fu and Ada Fu for critical reading of the manuscript, and members of the Ip laboratory for many helpful discussions. This study was supported in part by the Research Grants Council of Hong Kong (HKUST 661109,661309, 660810, 661010 and 661111), the Area of Excellence Scheme of the University Grants Committee (AoE/B-15/01) and the S.H. Ho Foundation. N.Y.I. was the recipient of Croucher Foundation Senior Research Fellowship, and K.-O.L. and Z.H.C. were the recipients of Croucher Foundation Research Fellowship. M.E.P. and L.T. were supported by the Intramural Research Program of the National Cancer Institute, Center for Cancer Research, US National Institutes of Health.	Abel T, 1997, CELL, V88, P615, DOI 10.1016/S0092-8674(00)81904-2; An JJ, 2008, CELL, V134, P175, DOI 10.1016/j.cell.2008.05.045; Barco A, 2005, NEURON, V48, P123, DOI 10.1016/j.neuron.2005.09.005; Bolton MM, 2000, J NEUROSCI, V20, P3221, DOI 10.1523/JNEUROSCI.20-09-03221.2000; Bramham CR, 2008, CURR OPIN NEUROBIOL, V18, P524, DOI 10.1016/j.conb.2008.09.013; Buchsbaum RJ, 2003, J BIOL CHEM, V278, P18833, DOI 10.1074/jbc.M207876200; Chen ZY, 2006, SCIENCE, V314, P140, DOI 10.1126/science.1129663; Cheung ZH, 2007, PLOS BIOL, V5, P865, DOI 10.1371/journal.pbio.0050063; Engert F, 1999, NATURE, V399, P66, DOI 10.1038/19978; Figurov A, 1996, NATURE, V381, P706, DOI 10.1038/381706a0; Fischer A, 2005, NEURON, V48, P825, DOI 10.1016/j.neuron.2005.10.033; Fu AKY, 2001, NAT NEUROSCI, V4, P374, DOI 10.1038/86019; Fukazawa' Y, 2003, NEURON, V38, P447, DOI 10.1016/S0896-6273(03)00206-X; Harvey CD, 2007, NATURE, V450, P1195, DOI 10.1038/nature06416; Hawasli AH, 2007, NAT NEUROSCI, V10, P880, DOI 10.1038/nn1914; Heldt SA, 2007, MOL PSYCHIATR, V12, P656, DOI 10.1038/sj.mp.4001957; Huang EJ, 2003, ANNU REV BIOCHEM, V72, P609, DOI 10.1146/annurev.biochem.72.121801.161629; Ji YY, 2005, NAT NEUROSCI, V8, P164, DOI 10.1038/nn1381; Kandel ER, 2001, SCIENCE, V294, P1030, DOI 10.1126/science.1067020; Kang HJ, 1997, NEURON, V19, P653, DOI 10.1016/S0896-6273(00)80378-5; Kelleher RJ, 2004, CELL, V116, P467, DOI 10.1016/S0092-8674(04)00115-1; Korkotian E, 2007, CELL CALCIUM, V42, P41, DOI 10.1016/j.ceca.2006.11.006; Lai KO, 2009, BBA-MOL BASIS DIS, V1792, P741, DOI 10.1016/j.bbadis.2009.05.001; Li BS, 2001, P NATL ACAD SCI USA, V98, P12742, DOI 10.1073/pnas.211428098; Lu WY, 2001, NEURON, V29, P243, DOI 10.1016/S0896-6273(01)00194-5; Lu Y, 2008, NEUROBIOL LEARN MEM, V89, P312, DOI 10.1016/j.nlm.2007.08.018; Maletic-Savatic M, 1999, SCIENCE, V283, P1923, DOI 10.1126/science.283.5409.1923; Matsuzaki M, 2001, NAT NEUROSCI, V4, P1086, DOI 10.1038/nn736; Matsuzaki M, 2004, NATURE, V429, P761, DOI 10.1038/nature02617; Miller S, 2002, NEURON, V36, P507, DOI 10.1016/S0896-6273(02)00978-9; Minichiello L, 1999, NEURON, V24, P401, DOI 10.1016/S0896-6273(00)80853-3; Minichiello L, 2002, NEURON, V36, P121, DOI 10.1016/S0896-6273(02)00942-X; Miyamoto Y, 2006, P NATL ACAD SCI USA, V103, P10444, DOI 10.1073/pnas.0603914103; Morabito MA, 2004, J NEUROSCI, V24, P865, DOI 10.1523/JNEUROSCI.4582-03.2004; Nakayama AY, 2000, HIPPOCAMPUS, V10, P582, DOI 10.1002/1098-1063(2000)10:5<582::AID-HIPO8>3.0.CO;2-K; Ninan I, 2010, J NEUROSCI, V30, P8866, DOI 10.1523/JNEUROSCI.1405-10.2010; Ohshima T, 2005, J NEUROCHEM, V94, P917, DOI 10.1111/j.1471-4159.2005.03233.x; Patterson SL, 2001, NEURON, V32, P123, DOI 10.1016/S0896-6273(01)00443-3; Rampon C, 2000, NAT NEUROSCI, V3, P238, DOI 10.1038/72945; Rex CS, 2007, J NEUROSCI, V27, P3017, DOI 10.1523/JNEUROSCI.4037-06.2007; Richter J.D., 2009, GENE DEV, V23, P1; Saneyoshi T, 2008, NEURON, V57, P94, DOI 10.1016/j.neuron.2007.11.016; Tanaka JI, 2008, SCIENCE, V319, P1683, DOI 10.1126/science.1152864; Tashiro A, 2000, CEREB CORTEX, V10, P927, DOI 10.1093/cercor/10.10.927; Todd PK, 2003, P NATL ACAD SCI USA, V100, P14374, DOI 10.1073/pnas.2336265100; Tolias KF, 2005, NEURON, V45, P525, DOI 10.1016/j.neuron.2005.01.024; Tyler WJ, 2001, J NEUROSCI, V21, P4249, DOI 10.1523/JNEUROSCI.21-12-04249.2001; VANDERGEER P, 1994, ANNU REV CELL BIOL, V10, P251, DOI 10.1146/annurev.cellbio.10.1.251; Wei FY, 2005, J NEUROCHEM, V93, P502, DOI 10.1111/j.1471-4159.2005.03058.x; Xie Z, 2007, NEURON, V56, P640, DOI 10.1016/j.neuron.2007.10.005	50	110	114	1	29	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	NOV	2012	15	11					1506	1515		10.1038/nn.3237	http://dx.doi.org/10.1038/nn.3237			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	028LX	23064382	Green Accepted			2022-12-28	WOS:000310424900010
J	Rodenas-Ruano, A; Chavez, AE; Cossio, MJ; Castillo, PE; Zukin, RS				Rodenas-Ruano, Alma; Chavez, Andres E.; Cossio, Maria J.; Castillo, Pablo E.; Zukin, R. Suzanne			REST-dependent epigenetic remodeling promotes the developmental switch in synaptic NMDA receptors	NATURE NEUROSCIENCE			English	Article							2B SUBUNIT GENE; TERM DEPRESSION; IN-VIVO; EXPRESSION; TRANSCRIPTION; EXPERIENCE; HIPPOCAMPAL; REPRESSION; SEQUENCES; BINDING	NMDA receptors (NMDARs) are critical to synaptogenesis, neural circuitry and higher cognitive functions. A hallmark feature of NMDARs is an early postnatal developmental switch from those containing primarily GluN2B to primarily GluN2A subunits. Although the switch in phenotype has been an area of intense interest for two decades, the mechanisms that trigger it and the link between experience and the switch are unclear. Here we show a new role for the transcriptional repressor REST in the developmental switch of synaptic NMDARs. REST is activated at a critical window of time and acts via epigenetic remodeling to repress Grin2b expression and alter NMDAR properties at rat hippocampal synapses. Knockdown of REST in vivo prevented the decline in GluN2B and developmental switch in NMDARs. Maternal deprivation impaired REST activation and acquisition of the mature NMDAR phenotype. Thus, REST is essential for experience-dependent fine-tuning of genes involved in synaptic plasticity.	[Rodenas-Ruano, Alma; Chavez, Andres E.; Cossio, Maria J.; Castillo, Pablo E.; Zukin, R. Suzanne] Albert Einstein Coll Med, Dominick P Purpura Dept Neurosci, Bronx, NY 10467 USA	Yeshiva University; Albert Einstein College of Medicine	Zukin, RS (corresponding author), Albert Einstein Coll Med, Dominick P Purpura Dept Neurosci, Bronx, NY 10467 USA.	pablo.castillo@einstein.yu.edu; suzanne.zukin@einstein.yu.edu		Castillo, Pablo/0000-0002-9834-1801	US National Institutes of Health [R01 NS46742, NS20752]; F.M. Kirby Foundation [R01 MH081935]; Ruth L. Kirschstein Award from the US National Institute of Neurological Disorders and Stroke [F32NS071821]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH081935] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS046742, R01NS020752, F32NS071821] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); F.M. Kirby Foundation; Ruth L. Kirschstein Award from the US National Institute of Neurological Disorders and Stroke; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by US National Institutes of Health grants to R.S.Z. (R01 NS46742 and NS20752) and P.E.C. (R01 MH081935) and support from the F.M. Kirby Foundation. A.E.C. was supported by a Ruth L. Kirschstein Award from the US National Institute of Neurological Disorders and Stroke (F32NS071821). We thank K.-M. Noh (Albert Einstein College of Medicine) for providing the shRNA REST lentiviral construct, and A. Etgen and all the members of the Zukin and Castillo laboratories for their constructive comments on the data and the manuscript.	Andres ME, 1999, P NATL ACAD SCI USA, V96, P9873, DOI 10.1073/pnas.96.17.9873; Ballas N, 2005, CELL, V121, P645, DOI 10.1016/j.cell.2005.03.013; Ballas N, 2005, CURR OPIN NEUROBIOL, V15, P500, DOI 10.1016/j.conb.2005.08.015; Barria A, 2002, NEURON, V35, P345, DOI 10.1016/S0896-6273(02)00776-6; Barria A, 2005, NEURON, V48, P289, DOI 10.1016/j.neuron.2005.08.034; Bellone C, 2007, NEURON, V55, P779, DOI 10.1016/j.neuron.2007.07.035; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Borrelli E, 2008, NEURON, V60, P961, DOI 10.1016/j.neuron.2008.10.012; Bruce AW, 2009, GENOME RES, V19, P994, DOI 10.1101/gr.089086.108; Bruce AW, 2004, P NATL ACAD SCI USA, V101, P10458, DOI 10.1073/pnas.0401827101; CARMIGNOTO G, 1992, SCIENCE, V258, P1007, DOI 10.1126/science.1279803; Cull-Candy Stuart G, 2004, Sci STKE, V2004, pre16, DOI 10.1126/stke.2552004re16; Desai A, 2002, J BIOL CHEM, V277, P46374, DOI 10.1074/jbc.M203032200; Espinosa JS, 2009, NEURON, V62, P205, DOI 10.1016/j.neuron.2009.03.006; Gray JA, 2011, NEURON, V71, P1085, DOI 10.1016/j.neuron.2011.08.007; Guardavaccaro D, 2008, NATURE, V452, P365, DOI 10.1038/nature06641; Hall BJ, 2007, J NEUROSCI, V27, P13446, DOI 10.1523/JNEUROSCI.3793-07.2007; Huang YF, 1999, NAT NEUROSCI, V2, P867, DOI 10.1038/13165; Huang Z, 2011, NAT CELL BIOL, V13, P142, DOI 10.1038/ncb2153; Huot RL, 2001, PSYCHOPHARMACOLOGY, V158, P366, DOI 10.1007/s002130100701; Ku HY, 2008, NEUROPSYCHOPHARMACOL, V33, P2847, DOI 10.1038/npp.2008.36; Lee MC, 2010, NEURON, V66, P859, DOI 10.1016/j.neuron.2010.05.015; Levenson JM, 2005, NAT REV NEUROSCI, V6, P108, DOI 10.1038/nrn1604; Liu D, 2000, NAT NEUROSCI, V3, P799, DOI 10.1038/77702; Matta JA, 2011, NEURON, V70, P339, DOI 10.1016/j.neuron.2011.02.045; Meaney MJ, 2010, NAT NEUROSCI, V13, P1313, DOI 10.1038/nn1110-1313; Mierau SB, 2004, P NATL ACAD SCI USA, V101, P15518, DOI 10.1073/pnas.0402916101; MONYER H, 1994, NEURON, V12, P529, DOI 10.1016/0896-6273(94)90210-0; Nase G, 1999, EUR J NEUROSCI, V11, P4320, DOI 10.1046/j.1460-9568.1999.00859.x; Noh KM, 2012, P NATL ACAD SCI USA, V109, pE962, DOI 10.1073/pnas.1121568109; Ooi L, 2007, NAT REV GENET, V8, P544, DOI 10.1038/nrg2100; Paoletti P, 2007, CURR OPIN PHARMACOL, V7, P39, DOI 10.1016/j.coph.2006.08.011; Philpot BD, 2001, NEURON, V29, P157, DOI 10.1016/S0896-6273(01)00187-8; Prybylowski K, 2002, J NEUROSCI, V22, P8902; Qiang M, 2005, MOL PHARMACOL, V67, P2115, DOI 10.1124/mol.104.010751; Quinlan EM, 1999, P NATL ACAD SCI USA, V96, P12876, DOI 10.1073/pnas.96.22.12876; Roopra A, 2004, MOL CELL, V14, P727, DOI 10.1016/j.molcel.2004.05.026; Sanz-Clemente A, 2010, NEURON, V67, P984, DOI 10.1016/j.neuron.2010.08.011; Sasner M, 1996, J BIOL CHEM, V271, P21316, DOI 10.1074/jbc.271.35.21316; SCHOENHERR CJ, 1995, SCIENCE, V267, P1360, DOI 10.1126/science.7871435; SHENG M, 1994, NATURE, V368, P144, DOI 10.1038/368144a0; Sobczyk A, 2005, J NEUROSCI, V25, P6037, DOI 10.1523/JNEUROSCI.1221-05.2005; Uchida S, 2010, J NEUROSCI, V30, P15007, DOI 10.1523/JNEUROSCI.1436-10.2010; von Engelhardt J, 2008, NEURON, V60, P846, DOI 10.1016/j.neuron.2008.09.039; Westbrook TF, 2008, NATURE, V452, P370, DOI 10.1038/nature06780; WILLIAMS K, 1993, NEURON, V10, P267, DOI 10.1016/0896-6273(93)90317-K; Xu Z, 2009, J NEUROSCI, V29, P8764, DOI 10.1523/JNEUROSCI.1014-09.2009; Yashiro K, 2008, NEUROPHARMACOLOGY, V55, P1081, DOI 10.1016/j.neuropharm.2008.07.046; Yeo M, 2009, J NEUROSCI, V29, P14652, DOI 10.1523/JNEUROSCI.2934-09.2009; Yu HB, 2011, GENOME RES, V21, P1284, DOI 10.1101/gr.114488.110	50	139	143	0	23	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	OCT	2012	15	10					1382	1390		10.1038/nn.3214	http://dx.doi.org/10.1038/nn.3214			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	013VZ	22960932	Green Accepted			2022-12-28	WOS:000309335300018
J	Yeo, GSH; Heisler, LK				Yeo, Giles S. H.; Heisler, Lora K.			Unraveling the brain regulation of appetite: lessons from genetics	NATURE NEUROSCIENCE			English	Review							AGOUTI-RELATED PROTEIN; BODY-MASS INDEX; CONGENITAL LEPTIN DEFICIENCY; NUCLEUS-TRACTUS-SOLITARIUS; EARLY-ONSET OBESITY; ENERGY-BALANCE; FOOD-INTAKE; MELANOCORTIN-4 RECEPTOR; NEUROTROPHIC FACTOR; NEUROPEPTIDE-Y	Over the past 20 years, genetic studies have illuminated critical pathways in the hypothalamus and brainstem mediating energy homeostasis, such as the melanocortin, leptin, 5-hydroxytryptamine and brain-derived neurotrophic factor signaling axes. The identification of these pathways necessary for appropriate appetitive responses to energy state has yielded insight into normal homeostatic processes. Although monogenic alterations in each of these axes result in severe obesity, such cases remain rare. The major burden of disease is carried by those with common obesity, which has so far resisted yielding meaningful biological insights. Recent progress into the etiology of common obesity has been made with genome-wide association studies. Such studies now reveal more than 32 different candidate obesity genes, most of which are highly expressed or known to act in the CNS, emphasizing, as in rare monogenic forms of obesity, the role of the brain in predisposition to obesity.	[Yeo, Giles S. H.] Univ Cambridge, Addenbrookes Hosp, Metab Res Labs, Inst Metab Sci, Cambridge CB2 2QQ, England; [Heisler, Lora K.] Univ Cambridge, Dept Pharmacol, Cambridge CB2 1QJ, England	Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; University of Cambridge	Yeo, GSH (corresponding author), Univ Cambridge, Addenbrookes Hosp, Metab Res Labs, Inst Metab Sci, Cambridge CB2 2QQ, England.	gshy2@cam.ac.uk; lkh30@medschl.cam.ac.uk		Heisler, Lora/0000-0002-7731-1419; Yeo, Giles See How/0000-0001-8823-3615	UK Medical Research Council Centre for Obesity and Related Metabolic Disorders (MRC-CORD); European Union [FP7-HEALTH-2009-241592 EurOCHIP, FP7-HEALTH-266408 Full4Health]; Wellcome Trust [WT081713, WT090812]; Medical Research Council [G0600717, G0600717B] Funding Source: researchfish; MRC [G0600717] Funding Source: UKRI	UK Medical Research Council Centre for Obesity and Related Metabolic Disorders (MRC-CORD)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); European Union(European Commission); Wellcome Trust(Wellcome TrustEuropean Commission); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	G.S.H.Y. is supported by the UK Medical Research Council Centre for Obesity and Related Metabolic Disorders (MRC-CORD) and the European Union (FP7-HEALTH-2009-241592 EurOCHIP and FP7-HEALTH-266408 Full4Health). L.K.H. is supported by the Wellcome Trust (WT081713; WT090812).	Ahima RS, 1996, NATURE, V382, P250, DOI 10.1038/382250a0; Aponte Y, 2011, NAT NEUROSCI, V14, P351, DOI 10.1038/nn.2739; Atasoy D, 2012, NATURE, V488, P172, DOI 10.1038/nature11270; Balthasar N, 2005, CELL, V123, P493, DOI 10.1016/j.cell.2005.08.035; Balthasar N, 2004, NEURON, V42, P983, DOI 10.1016/j.neuron.2004.06.004; BARDE Y-A, 1990, Progress in Growth Factor Research, V2, P237, DOI 10.1016/0955-2235(90)90021-B; Bariohay B, 2009, ENDOCRINOLOGY, V150, P2646, DOI 10.1210/en.2008-1184; BERTAGNA X, 1994, ENDOCRIN METAB CLIN, V23, P467, DOI 10.1016/S0889-8529(18)30079-3; Bewick GA, 2005, FASEB J, V19, P1680, DOI 10.1096/fj.04-3434fje; Boissel S, 2009, AM J HUM GENET, V85, P106, DOI 10.1016/j.ajhg.2009.06.002; Castro MG, 1997, CRIT REV NEUROBIOL, V11, P35; Challis BG, 2004, P NATL ACAD SCI USA, V101, P4695, DOI 10.1073/pnas.0306931101; Chen H, 1996, CELL, V84, P491, DOI 10.1016/S0092-8674(00)81294-5; Cone RD, 2005, NAT NEUROSCI, V8, P571, DOI 10.1038/nn1455; Cowley MA, 2001, NATURE, V411, P480, DOI 10.1038/35078085; Cowley MA, 1999, NEURON, V24, P155, DOI 10.1016/S0896-6273(00)80829-6; de Luca C, 2005, J CLIN INVEST, V115, P3484, DOI 10.1172/JCI24059; de Wall EV, 2008, ENDOCRINOLOGY, V149, P1773, DOI 10.1210/en.2007-1132; Dhillon H, 2006, NEURON, V49, P191, DOI 10.1016/j.neuron.2005.12.021; Erickson JC, 1996, SCIENCE, V274, P1704, DOI 10.1126/science.274.5293.1704; Erickson JC, 1996, NATURE, V381, P415, DOI 10.1038/381415a0; Fan W, 1997, NATURE, V385, P165, DOI 10.1038/385165a0; Farooqi IS, 1999, NEW ENGL J MED, V341, P879, DOI 10.1056/NEJM199909163411204; Farooqi IS, 2003, NEW ENGL J MED, V348, P1085, DOI 10.1056/NEJMoa022050; Fidler MC, 2011, J CLIN ENDOCR METAB, V96, P3067, DOI 10.1210/jc.2011-1256; Fischer J, 2009, NATURE, V458, P894, DOI 10.1038/nature07848; Frayling TM, 2007, SCIENCE, V316, P889, DOI 10.1126/science.1141634; Friedman JM, 1998, NATURE, V395, P763, DOI 10.1038/27376; Funatsu N, 1999, J BIOL CHEM, V274, P8224, DOI 10.1074/jbc.274.12.8224; Garfield AS, 2009, J PHYSIOL-LONDON, V587, P49, DOI 10.1113/jphysiol.2008.164152; Gerken T, 2007, SCIENCE, V318, P1469, DOI 10.1126/science.1151710; Godar R, 2011, NEUROSCIENCE, V194, P36, DOI 10.1016/j.neuroscience.2011.07.079; Gray J, 2006, DANCING TIMES, V96, P55; Gropp E, 2005, NAT NEUROSCI, V8, P1289, DOI 10.1038/nn1548; Hayes MR, 2010, CELL METAB, V11, P77, DOI 10.1016/j.cmet.2009.10.009; Heisler LK, 2002, SCIENCE, V297, P609, DOI 10.1126/science.1072327; Heisler LK, 2006, NEURON, V51, P239, DOI 10.1016/j.neuron.2006.06.004; Heymsfield SB, 1999, JAMA-J AM MED ASSOC, V282, P1568, DOI 10.1001/jama.282.16.1568; Hommel JD, 2006, NEURON, V51, P801, DOI 10.1016/j.neuron.2006.08.023; Huszar D, 1997, CELL, V88, P131, DOI 10.1016/S0092-8674(00)81865-6; Jurvansuu JM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025317; Kernie SG, 2000, EMBO J, V19, P1290, DOI 10.1093/emboj/19.6.1290; Kishi T, 2003, J COMP NEUROL, V457, P213, DOI 10.1002/cne.10454; Komori T, 2006, NEUROSCIENCE, V139, P1107, DOI 10.1016/j.neuroscience.2005.12.066; Krashes MJ, 2011, J CLIN INVEST, V121, P1424, DOI 10.1172/JCI46229; Krude H, 1998, NAT GENET, V19, P155, DOI 10.1038/509; Lam DD, 2011, CELL METAB, V13, P584, DOI 10.1016/j.cmet.2011.03.016; Lam Daniel D., 2007, Expert Reviews in Molecular Medicine, V9, DOI 10.1017/S1462399407000245; Leinninger GM, 2011, CELL METAB, V14, P313, DOI 10.1016/j.cmet.2011.06.016; Loos RJF, 2008, NAT GENET, V40, P768, DOI 10.1038/ng.140; Luquet S, 2005, SCIENCE, V310, P683, DOI 10.1126/science.1115524; Montague CT, 1997, NATURE, V387, P903, DOI 10.1038/43185; Morris HV, 2008, PHARMACOL BIOCHEM BE, V90, P9, DOI 10.1016/j.pbb.2008.02.010; Nicholson JR, 2007, J NEUROENDOCRINOL, V19, P974, DOI 10.1111/j.1365-2826.2007.01610.x; Ollmann MM, 1997, SCIENCE, V278, P135, DOI 10.1126/science.278.5335.135; PELLEYMOUNTER MA, 1995, EXP NEUROL, V131, P229, DOI 10.1016/0014-4886(95)90045-4; PELLEYMOUNTER MA, 1995, SCIENCE, V269, P540, DOI 10.1126/science.7624776; Qian S, 2002, MOL CELL BIOL, V22, P5027, DOI 10.1128/MCB.22.14.5027-5035.2002; Ren DC, 2007, J CLIN INVEST, V117, P397, DOI 10.1172/JCI29417; Rios M, 2001, MOL ENDOCRINOL, V15, P1748, DOI 10.1210/me.15.10.1748; Rossi J, 2011, CELL METAB, V13, P195, DOI 10.1016/j.cmet.2011.01.010; SNIDER WD, 1994, CELL, V77, P627, DOI 10.1016/0092-8674(94)90048-5; Sohn JW, 2011, NEURON, V71, P488, DOI 10.1016/j.neuron.2011.06.012; Spaeth AM, 2012, AM J PHYSIOL-ENDOC M, V302, pE1252, DOI 10.1152/ajpendo.00025.2012; Speliotes EK, 2010, NAT GENET, V42, P937, DOI 10.1038/ng.686; STUNKARD AJ, 1986, JAMA-J AM MED ASSOC, V256, P51, DOI 10.1001/jama.256.1.51; STUNKARD AJ, 1990, NEW ENGL J MED, V322, P1483, DOI 10.1056/NEJM199005243222102; Suviolahti E, 2003, J CLIN INVEST, V112, P1762, DOI 10.1172/JCI200317491; Tong QC, 2008, NAT NEUROSCI, V11, P998, DOI 10.1038/nn.2167; Tran PV, 2006, J COMP NEUROL, V498, P637, DOI 10.1002/cne.21070; Tung YCL, 2011, ANN NY ACAD SCI, V1220, P162, DOI 10.1111/j.1749-6632.2010.05903.x; Tung YCL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008771; Unger TJ, 2007, J NEUROSCI, V27, P14265, DOI 10.1523/JNEUROSCI.3308-07.2007; Vaisse C, 1998, NAT GENET, V20, P113, DOI 10.1038/2407; Vimaleswaran KS, 2010, INT J OBESITY, V34, P1028, DOI 10.1038/ijo.2009.292; Willer CJ, 2009, NAT GENET, V41, P25, DOI 10.1038/ng.287; Wortley KE, 2005, CELL METAB, V2, P421, DOI 10.1016/j.cmet.2005.11.004; Wu Q, 2012, NATURE, V483, P594, DOI 10.1038/nature10899; Wu Q, 2009, CELL, V137, P1225, DOI 10.1016/j.cell.2009.04.022; Xu AW, 2005, PLOS BIOL, V3, P2168, DOI 10.1371/journal.pbio.0030415; Xu BJ, 2003, NAT NEUROSCI, V6, P736, DOI 10.1038/nn1073; Xu Y, 2010, J NEUROSCI, V30, P14630, DOI 10.1523/JNEUROSCI.5412-09.2010; Xu Y, 2008, NEURON, V60, P582, DOI 10.1016/j.neuron.2008.09.033; Yadav VK, 2009, CELL, V138, P976, DOI 10.1016/j.cell.2009.06.051; Yaswen L, 1999, NAT MED, V5, P1066, DOI 10.1038/12506; Yeo GSH, 2004, NAT NEUROSCI, V7, P1187, DOI 10.1038/nn1336; Yeo GSH, 1998, NAT GENET, V20, P111, DOI 10.1038/2404; ZHANG YY, 1994, NATURE, V372, P425, DOI 10.1038/372425a0	88	181	188	1	47	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	OCT	2012	15	10					1343	1349		10.1038/nn.3211	http://dx.doi.org/10.1038/nn.3211			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	013VZ	23007189				2022-12-28	WOS:000309335300009
J	[Anonymous]				[Anonymous]			Focus on neural control of feeding	NATURE NEUROSCIENCE			English	Editorial Material																			0	0	0	0	1	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	OCT	2012	15	10					1321	1321						1	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	013VZ	23007181	Bronze			2022-12-28	WOS:000309335300001
J	Cole, CJ; Mercaldo, V; Restivo, L; Yiu, AP; Sekeres, MJ; Han, JH; Vetere, G; Pekar, T; Ross, PJ; Neve, RL; Frankland, PW; Josselyn, SA				Cole, Christina J.; Mercaldo, Valentina; Restivo, Leonardo; Yiu, Adelaide P.; Sekeres, Melanie J.; Han, Jin-Hee; Vetere, Gisella; Pekar, Tetyana; Ross, P. Joel; Neve, Rachael L.; Frankland, Paul W.; Josselyn, Sheena A.			MEF2 negatively regulates learning-induced structural plasticity and memory formation	NATURE NEUROSCIENCE			English	Article							AMPA RECEPTOR TRAFFICKING; LONG-TERM-MEMORY; MENTAL-RETARDATION PROTEIN; ANTERIOR CINGULATE CORTEX; MYOCYTE ENHANCER FACTOR-2; SYNAPTIC PLASTICITY; TRANSCRIPTION FACTOR; SPATIAL MEMORY; DENDRITIC SPINES; EXPRESSION	Memory formation is thought to be mediated by dendritic-spine growth and restructuring. Myocyte enhancer factor 2 (MEF2) restricts spine growth in vitro, suggesting that this transcription factor negatively regulates the spine remodeling necessary for memory formation. Here we show that memory formation in adult mice was associated with changes in endogenous MEF2 levels and function. Locally and acutely increasing MEF2 function in the dentate gyrus blocked both learning-induced increases in spine density and spatial-memory formation. Increasing MEF2 function in amygdala disrupted fear-memory formation. We rescued MEF2-induced memory disruption by interfering with AMPA receptor endocytosis, suggesting that AMPA receptor trafficking is a key mechanism underlying the effects of MEF2. In contrast, decreasing MEF2 function in dentate gyrus and amygdala facilitated the formation of spatial and fear memory, respectively. These bidirectional effects indicate that MEF2 is a key regulator of plasticity and that relieving the suppressive effects of MEF2-mediated transcription permits memory formation.	[Cole, Christina J.; Mercaldo, Valentina; Restivo, Leonardo; Yiu, Adelaide P.; Sekeres, Melanie J.; Han, Jin-Hee; Vetere, Gisella; Pekar, Tetyana; Ross, P. Joel; Frankland, Paul W.; Josselyn, Sheena A.] Hosp Sick Children, Program Neurosci & Mental Hlth, Toronto, ON M5G 1X8, Canada; [Cole, Christina J.; Mercaldo, Valentina; Restivo, Leonardo; Yiu, Adelaide P.; Sekeres, Melanie J.; Han, Jin-Hee; Vetere, Gisella; Frankland, Paul W.; Josselyn, Sheena A.] Univ Toronto, Dept Physiol, Toronto, ON, Canada; [Mercaldo, Valentina; Restivo, Leonardo; Yiu, Adelaide P.; Han, Jin-Hee; Vetere, Gisella; Frankland, Paul W.; Josselyn, Sheena A.] Univ Toronto, Inst Med Sci, Toronto, ON M5S 1A1, Canada; [Vetere, Gisella] Natl Res Council Italy, Cell Biol & Neurobiol Inst, S Lucia Fdn, Rome, Italy; [Neve, Rachael L.] MIT, Cambridge, MA 02139 USA	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University of Toronto; Consiglio Nazionale delle Ricerche (CNR); IRCCS Santa Lucia; Massachusetts Institute of Technology (MIT)	Josselyn, SA (corresponding author), Hosp Sick Children, Program Neurosci & Mental Hlth, 555 Univ Ave, Toronto, ON M5G 1X8, Canada.	sheena.josselyn@sickkids.ca	Ross, Joel/K-3361-2019; Mercaldo, Valentina/AAA-6000-2019; Vetere, Gisella/AFT-9030-2022; Han, Jin-Hee/C-2069-2011	Ross, Joel/0000-0001-7105-7117; Sekeres, Melanie/0000-0002-7952-3175; Han, Jin-Hee/0000-0002-2139-5596; Restivo, Leonardo/0000-0002-3709-5504	Canadian Institutes of Health Research (CIHR) [MOP-74650, MOP-86762]; EJLB Foundation; Natural Science and Engineering Research Council; Restracomp Fellowships (Hospital for Sick Children); Alzheimer's Society of Canada; Faculty of Medicine at the University of Toronto; Ontario Graduate Scholarship	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); EJLB Foundation; Natural Science and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC)); Restracomp Fellowships (Hospital for Sick Children); Alzheimer's Society of Canada; Faculty of Medicine at the University of Toronto(University of Toronto); Ontario Graduate Scholarship(Ontario Graduate Scholarship)	We thank A. DeCristofaro, R. Braybon and M. Yamamoto for excellent technical assistance. This work was supported by grants from the Canadian Institutes of Health Research (CIHR; MOP-74650 (S.A.J.), MOP-86762 (P. W. F.)), EJLB Foundation (S.A.J.) and Natural Science and Engineering Research Council (S.A.J.). C.J.C., A.P.Y. and M.J.S. were supported by Restracomp Fellowships (Hospital for Sick Children), A.P.Y. received support from the Alzheimer's Society of Canada, M.J.S. received a CIHR Frederick Banting and Charles Best Canada Graduate Scholarships Doctoral Award and a grant from the Faculty of Medicine at the University of Toronto, and C.J.C. received an Ontario Graduate Scholarship.	Abel T, 1998, SCIENCE, V279, P338, DOI 10.1126/science.279.5349.338; Alberini CM, 2009, PHYSIOL REV, V89, P121, DOI 10.1152/physrev.00017.2008; BAILEY CH, 1993, ANNU REV PHYSIOL, V55, P397, DOI 10.1146/annurev.ph.55.030193.002145; Barbosa AC, 2008, P NATL ACAD SCI USA, V105, P9391, DOI 10.1073/pnas.0802679105; Black BL, 1998, ANNU REV CELL DEV BI, V14, P167, DOI 10.1146/annurev.cellbio.14.1.167; Brebner K, 2005, SCIENCE, V310, P1340, DOI 10.1126/science.1116894; Bunch ME, 1933, J COMP PSYCHOL, V16, P385, DOI 10.1037/h0070466; Buzsaki G, 1996, CEREB CORTEX, V6, P81, DOI 10.1093/cercor/6.2.81; CAJAL SR, 1893, CR SOC BIOL, V45, P217; Chawla MK, 2005, HIPPOCAMPUS, V15, P579, DOI 10.1002/hipo.20091; Chowdhury S, 2006, NEURON, V52, P445, DOI 10.1016/j.neuron.2006.08.033; Clark MS, 2002, J NEUROSCI, V22, P4550, DOI 10.1523/JNEUROSCI.22-11-04550.2002; Collingridge GL, 2004, NAT REV NEUROSCI, V5, P952, DOI 10.1038/nrn1556; DAVIS M, 1992, ANNU REV NEUROSCI, V15, P353, DOI 10.1146/annurev.neuro.15.1.353; Ehlers MD, 2003, NAT NEUROSCI, V6, P231, DOI 10.1038/nn1013; Fanselow MS, 2003, ANN NY ACAD SCI, V985, P125; Fioravante D, 2011, BRAIN RES BULL, V85, P14, DOI 10.1016/j.brainresbull.2010.11.002; Flavell SW, 2008, NEURON, V60, P1022, DOI 10.1016/j.neuron.2008.11.029; Flavell SW, 2006, SCIENCE, V311, P1008, DOI 10.1126/science.1122511; Frankland PW, 2004, HIPPOCAMPUS, V14, P557, DOI 10.1002/hipo.10208; Gainey MA, 2009, J NEUROSCI, V29, P6479, DOI 10.1523/JNEUROSCI.3753-08.2009; Greer PL, 2010, CELL, V140, P704, DOI 10.1016/j.cell.2010.01.026; HARRIS KM, 1988, J NEUROSCI, V8, P4455; Josselyn SA, 2001, J NEUROSCI, V21, P2404, DOI 10.1523/JNEUROSCI.21-07-02404.2001; Kandel ER, 2009, J NEUROSCI, V29, P12748, DOI 10.1523/JNEUROSCI.3958-09.2009; Karamboulas Christina, 2006, J Cell Sci, V119, P4315, DOI 10.1242/jcs.03186; Keppel G., 2004, DESIGN ANAL RES HDB; Le Meur N, 2010, J MED GENET, V47, P22, DOI 10.1136/jmg.2009.069732; LeDoux JE, 2000, ANNU REV NEUROSCI, V23, P155, DOI 10.1146/annurev.neuro.23.1.155; Li H, 2008, P NATL ACAD SCI USA, V105, P9397, DOI 10.1073/pnas.0802876105; LYONS GE, 1995, J NEUROSCI, V15, P5727, DOI 10.1523/jneurosci.15-08-05727.1995; Maei HR, 2009, FRONT INTEGR NEUROSC, V3, DOI 10.3389/neuro.07.004.2009; Malinow R, 2002, ANNU REV NEUROSCI, V25, P103, DOI 10.1146/annurev.neuro.25.112701.142758; MCDONALD RJ, 1993, BEHAV NEUROSCI, V107, P3, DOI 10.1037/0735-7044.107.1.3; MCNAUGHTON BL, 1989, EXP BRAIN RES, V76, P485, DOI 10.1007/BF00248904; Migues PV, 2010, NAT NEUROSCI, V13, P630, DOI 10.1038/nn.2531; MILLER RR, 1991, ANAL BIOCHEM, V192, P380, DOI 10.1016/0003-2697(91)90552-5; Morrow EM, 2008, SCIENCE, V321, P218, DOI 10.1126/science.1157657; MOSER MB, 1994, P NATL ACAD SCI USA, V91, P12673, DOI 10.1073/pnas.91.26.12673; Neely MD, 2009, BRAIN RES, V1274, P55, DOI 10.1016/j.brainres.2009.03.067; Nimchinsky EA, 2002, ANNU REV PHYSIOL, V64, P313, DOI 10.1146/annurev.physiol.64.081501.160008; O'Malley A, 1998, NEUROSCIENCE, V87, P607, DOI 10.1016/S0306-4522(98)00178-X; Paxinos G., 2001, MOUSE BRAIN STEREOTA; Pfeiffer BE, 2010, NEURON, V66, P191, DOI 10.1016/j.neuron.2010.03.017; Pickens CL, 2009, BIOL PSYCHIAT, V65, P881, DOI 10.1016/j.biopsych.2008.12.010; Pulipparacharuvil S, 2008, NEURON, V59, P621, DOI 10.1016/j.neuron.2008.06.020; Russo SJ, 2009, J NEUROSCI, V29, P3529, DOI 10.1523/JNEUROSCI.6173-08.2009; Sekeres MJ, 2010, LEARN MEMORY, V17, P280, DOI 10.1101/lm.1785510; Shen JM, 1998, J SLEEP RES, V7, P6, DOI 10.1046/j.1365-2869.7.s1.2.x; Shepherd JD, 2006, NEURON, V52, P475, DOI 10.1016/j.neuron.2006.08.034; Shepherd JD, 2011, NAT NEUROSCI, V14, P279, DOI 10.1038/nn.2708; Simon DJ, 2008, CELL, V133, P903, DOI 10.1016/j.cell.2008.04.035; Teixeira CM, 2006, J NEUROSCI, V26, P7555, DOI 10.1523/JNEUROSCI.1068-06.2006; Verde EMR, 2006, NEURON, V52, P461, DOI 10.1016/j.neuron.2006.09.031; Vetere G, 2011, P NATL ACAD SCI USA, V108, P8456, DOI 10.1073/pnas.1016275108; WILSON MA, 1994, SCIENCE, V265, P676, DOI 10.1126/science.8036517; Wiltgen BJ, 2006, J NEUROSCI, V26, P5484, DOI 10.1523/JNEUROSCI.2685-05.2006; Yang Q, 2009, SCIENCE, V323, P124, DOI 10.1126/science.1166088; Yiu AP, 2011, NEUROPSYCHOPHARMACOL, V36, P2169, DOI 10.1038/npp.2011.107; Zalfa F, 2007, NAT NEUROSCI, V10, P578, DOI 10.1038/nn1893	60	96	98	0	26	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	SEP	2012	15	9					1255	U121		10.1038/nn.3189	http://dx.doi.org/10.1038/nn.3189			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	996GJ	22885849				2022-12-28	WOS:000308072600016
J	Su, SC; Tsai, LH				Su, Susan C.; Tsai, Li-Huei			DNA methylation in cognition comes of age	NATURE NEUROSCIENCE			English	Editorial Material							DE-NOVO METHYLATION; EPIGENETIC MECHANISMS; MEMORY; DNMT3A; DEMENTIA; RISK	A study reveals that aged mice have decreased hippocampal expression of the DNA methyltransferase Dnmt3a2; re-expression in aged mice reverses memory deficits, and knockdown in young mice impairs memory formation.	[Su, Susan C.; Tsai, Li-Huei] Howard Hughes Med Inst, Massachusetts Inst Technol, Dept Brain & Cognit Sci, Picower Inst Learning & Memory, Cambridge, MA USA	Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT); Northwell Health	Su, SC (corresponding author), Howard Hughes Med Inst, Massachusetts Inst Technol, Dept Brain & Cognit Sci, Picower Inst Learning & Memory, Cambridge, MA USA.	lhtsai@mit.edu						Bird A, 2002, GENE DEV, V16, P6, DOI 10.1101/gad.947102; Chen TP, 2002, J BIOL CHEM, V277, P38746, DOI 10.1074/jbc.M205312200; Day JJ, 2011, NEUROBIOL LEARN MEM, V96, P2, DOI 10.1016/j.nlm.2010.12.008; Feng J, 2010, NAT NEUROSCI, V13, P423, DOI 10.1038/nn.2514; Frankland PW, 2004, SCIENCE, V304, P881, DOI 10.1126/science.1094804; Franklin TB, 2010, BIOL PSYCHIAT, V68, P408, DOI 10.1016/j.biopsych.2010.05.036; Laurin D, 2001, ARCH NEUROL-CHICAGO, V58, P498, DOI 10.1001/archneur.58.3.498; Levenson JM, 2005, NAT REV NEUROSCI, V6, P108, DOI 10.1038/nrn1604; Miller CA, 2010, NAT NEUROSCI, V13, P664, DOI 10.1038/nn.2560; Okano M, 1999, CELL, V99, P247, DOI 10.1016/S0092-8674(00)81656-6; Oliveira AMM, 2012, NAT NEUROSCI, V15, P1111, DOI 10.1038/nn.3151; Penner MR, 2011, NEUROBIOL AGING, V32, P2198, DOI 10.1016/j.neurobiolaging.2010.01.009; Plath N, 2006, NEURON, V52, P437, DOI 10.1016/j.neuron.2006.08.024; Verghese J, 2003, NEW ENGL J MED, V348, P2508, DOI 10.1056/NEJMoa022252; WILSON VL, 1987, J BIOL CHEM, V262, P9948	15	13	14	0	9	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	AUG	2012	15	8					1061	1062		10.1038/nn.3169	http://dx.doi.org/10.1038/nn.3169			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	979UE	22837034				2022-12-28	WOS:000306844500005
J	Locatelli, G; Wortge, S; Buch, T; Ingold, B; Frommer, F; Sobottka, B; Kruger, M; Karram, K; Buhlmann, C; Bechmann, I; Heppner, FL; Waisman, A; Becher, B				Locatelli, Giuseppe; Woertge, Simone; Buch, Thorsten; Ingold, Barbara; Frommer, Friederike; Sobottka, Bettina; Krueger, Martin; Karram, Khalad; Buhlmann, Claudia; Bechmann, Ingo; Heppner, Frank L.; Waisman, Ari; Becher, Burkhard			Primary oligodendrocyte death does not elicit anti-CNS immunity	NATURE NEUROSCIENCE			English	Article							EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; MULTIPLE-SCLEROSIS; NERVOUS-SYSTEM; T-CELLS; DIPHTHERIA-TOXIN; LYMPH-NODES; MYELIN; DEMYELINATION; MICE; CUPRIZONE	Anti-myelin immunity is commonly thought to drive multiple sclerosis, yet the initial bigger of this autoreactivity remains elusive. One of the proposed factors for initiating this disease is the primary death of oligadendrecytess. To specifically test such oligodendrocyte death as a trigger for anti-CNS immunity, we inducibly killed olignodendrocytes in an in vivo manse model. Strong microglia-macrophage activation followed oligodendrocyte death, and myelin components in draining lymph nodes made CM antigens available to lymphocytes. However, even conditions farming countainity hystiander and memory removal of regadartoly T cells, presence of myelin-reactive T cells anti application of oligodendrocyte antibodies ad not result in the development of CNS inflammation after oligodendrocyte death. In addition, this lash of reactivity was not mediated by enhanced myelin-specific tolerance. Thus, in contrast with previously reputed in impaiments of oligodendroctye physiology, diffuse oligodendrocyte death alone or in conjunction with immune activation does not trigger immunity.	[Woertge, Simone; Frommer, Friederike; Karram, Khalad; Waisman, Ari] Johannes Gutenberg Univ Mainz, Univ Med Ctr Johannes Gutenberg, Inst Mol Med, Mainz, Germany; [Locatelli, Giuseppe; Buch, Thorsten; Sobottka, Bettina; Buhlmann, Claudia; Becher, Burkhard] Univ Zurich, Inst Expt Immunol, CH-8091 Zurich, Switzerland; [Buch, Thorsten] Tech Univ Munich, Inst Med Microbiol Immunol & Hyg, D-8000 Munich, Germany; [Ingold, Barbara] Univ Med Berlin, Inst Pathol, Berlin, Germany; [Krueger, Martin; Bechmann, Ingo; Waisman, Ari] Univ Leipzig, Inst Anat, Leipzig, Germany; [Heppner, Frank L.] Univ Med Berlin, Dept Neuropathol, Berlin, Germany	Johannes Gutenberg University of Mainz; University of Zurich; Technical University of Munich; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Leipzig University; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Wortge, S (corresponding author), Johannes Gutenberg Univ Mainz, Univ Med Ctr Johannes Gutenberg, Inst Mol Med, Mainz, Germany.	woertge@uni-mainz.de; thorsten.Buch@mikrobio.med.tum.de	Buch, Thorsten/P-1659-2019; Waisman, Ari/C-7383-2015; Heppner, Frank/ABH-8393-2020; Becher, Burkhard/ABE-4225-2020	Buch, Thorsten/0000-0002-2236-9074; Waisman, Ari/0000-0003-4304-8234; Heppner, Frank/0000-0001-9816-8917; Becher, Burkhard/0000-0002-1541-7867; Sobottka, Bettina/0000-0002-0890-5248; Locatelli, Giuseppe/0000-0002-2179-4407	COST action [BM603 NEURINFNET]; Deutsche Forschungsgemeinschaft (DFG) [1600/3-1, SFB/TR 52, FOR1336, TR43, Exc 25]; German Ministry for Education and Research (Consortium UNDERSTANDMS/German Competence Network of Multiple Sclerosis); Bonizzi-Theler foundation; State Secretariat for Education and Research of Switzerland; Schweizerische Nationalfonds (SNF) [CRSI33_125073]; National Center of Competence in Research (NCCR-Neuro); Swiss Multiple Sclerosis Society; US National Institutes of Health (National Institute of Neurological Disorders and Stroke) [R01 NS046006]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS046006] Funding Source: NIH RePORTER	COST action(European Cooperation in Science and Technology (COST)); Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); German Ministry for Education and Research (Consortium UNDERSTANDMS/German Competence Network of Multiple Sclerosis); Bonizzi-Theler foundation; State Secretariat for Education and Research of Switzerland; Schweizerische Nationalfonds (SNF)(Swiss National Science Foundation (SNSF)); National Center of Competence in Research (NCCR-Neuro)(Swiss National Science Foundation (SNSF)); Swiss Multiple Sclerosis Society; US National Institutes of Health (National Institute of Neurological Disorders and Stroke)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We are grateful for technical support to V Wortmann, A. Apladas, M. Perkovic, the Zentrum fur Mikroskopie und Bildanalyse, T. Bruggmann, J. Huppert and K. Fischer, as well as the mouse facility teams in Zurich and Mainz. We thank J.D. Laman and I. Parvanova for help with manuscript preparation. This work was supported by COST action BM603 NEURINFNET (B.B., TB., G.L. and I.B.), by Deutsche Forschungsgemeinschaft (DFG) grants 1600/3-1 and SFB/TR 52, and the German Ministry for Education and Research (Consortium UNDERSTANDMS/German Competence Network of Multiple Sclerosis) to A.W., by the DFG grant FOR1336 to I.B. and A.W., by a grant from the Bonizzi-Theler foundation to T.B., by the State Secretariat for Education and Research of Switzerland to T.B. and B.B., by the Schweizerische Nationalfonds (SNF) to TB. (CRSI33_125073) and B.B., the National Center of Competence in Research (NCCR-Neuro) to B.B., the Swiss Multiple Sclerosis Society to TB., and by DFG grants SFB TR43 and Exc 25 and the US National Institutes of Health (National Institute of Neurological Disorders and Stroke R01 NS046006) to F.L.H.	ADAMS CWM, 1989, J NEUROL SCI, V92, P291, DOI 10.1016/0022-510X(89)90144-5; Barnett MH, 2004, ANN NEUROL, V55, P458, DOI 10.1002/ana.20016; Barnett MH, 2006, CURR OPIN NEUROL, V19, P242, DOI 10.1097/01.wco.0000227032.47458.cb; Becher B, 1996, GLIA, V18, P1; Bedard A, 2007, GLIA, V55, P777, DOI 10.1002/glia.20477; Berger J, 2006, BBA-MOL CELL RES, V1763, P1721, DOI 10.1016/j.bbamcr.2006.07.010; Bettelli E, 2003, J EXP MED, V197, P1073, DOI 10.1084/jem.20021603; Buch T, 2005, NAT METHODS, V2, P419, DOI 10.1038/NMETH762; Carson MJ, 2002, GLIA, V40, P218, DOI 10.1002/glia.10145; CHERNOFF GF, 1981, J HERED, V72, P128, DOI 10.1093/oxfordjournals.jhered.a109442; Compston A, 2008, LANCET, V372, P1502, DOI 10.1016/S0140-6736(08)61620-7; de Vos AF, 2002, J IMMUNOL, V169, P5415, DOI 10.4049/jimmunol.169.10.5415; Elgueta R, 2009, IMMUNOL REV, V229, P152, DOI 10.1111/j.1600-065X.2009.00782.x; Elloso MM, 2005, J ENDOCRINOL, V185, P243, DOI 10.1677/joe.1.06063; Emerson MR, 2001, J NEUROIMMUNOL, V119, P205, DOI 10.1016/S0165-5728(01)00394-0; Fabriek BO, 2005, J NEUROIMMUNOL, V161, P190, DOI 10.1016/j.jneuroim.2004.12.018; Filippi M, 1998, ANN NEUROL, V43, P809, DOI 10.1002/ana.410430616; Frommer F, 2008, J IMMUNOL, V181, P5748, DOI 10.4049/jimmunol.181.8.5748; Gallucci S, 2001, CURR OPIN IMMUNOL, V13, P114, DOI 10.1016/S0952-7915(00)00191-6; Griffiths I, 1998, SCIENCE, V280, P1610, DOI 10.1126/science.280.5369.1610; HERNDON RM, 1978, ANN NEUROL, V4, P515, DOI 10.1002/ana.410040607; Hiremath MM, 2008, J NEUROIMMUNOL, V203, P23, DOI 10.1016/j.jneuroim.2008.06.034; HONJO T, 1971, J BIOL CHEM, V246, P4251; Hovelmeyer N, 2005, J IMMUNOL, V175, P5875, DOI 10.4049/jimmunol.175.9.5875; Ip CW, 2006, J NEUROSCI, V26, P8206, DOI 10.1523/JNEUROSCI.1921-06.2006; Kassmann CM, 2007, NAT GENET, V39, P969, DOI 10.1038/ng2070; Kim MD, 2004, J NEUROIMMUNOL, V151, P78, DOI 10.1016/j.jneuroim.2004.02.014; Lappe-Siefke C, 2003, NAT GENET, V33, P366, DOI 10.1038/ng1095; Lassmann H, 2007, BRAIN PATHOL, V17, P210, DOI 10.1111/j.1750-3639.2007.00064.x; LINK H, 1971, ARCH NEUROL-CHICAGO, V25, P326, DOI 10.1001/archneur.1971.00490040052007; Lucchinetti CF, 2004, ANN NEUROL, V56, P308, DOI 10.1002/ana.20182; Mana P, 2009, J NEUROIMMUNOL, V210, P13, DOI 10.1016/j.jneuroim.2009.02.013; Mueller DL, 2010, NAT IMMUNOL, V11, P21, DOI 10.1038/ni.1817; Narayana PA, 1998, ANN NEUROL, V43, P56, DOI 10.1002/ana.410430112; Pohl HBF, 2011, J NEUROSCI, V31, P1069, DOI 10.1523/JNEUROSCI.5035-10.2011; PRINEAS JW, 1978, LAB INVEST, V38, P409; Ransohoff RM, 2009, ANNU REV IMMUNOL, V27, P119, DOI 10.1146/annurev.immunol.021908.132528; Remington LT, 2007, AM J PATHOL, V170, P1713, DOI 10.2353/ajpath.2007.060783; Sakaguchi S, 2006, IMMUNOL REV, V212, P8, DOI 10.1111/j.0105-2896.2006.00427.x; Traka M, 2010, BRAIN, V133, P3017, DOI 10.1093/brain/awq247; Urich E, 2006, P NATL ACAD SCI USA, V103, P18697, DOI 10.1073/pnas.0607283103; van Zwam M, 2009, J PATHOL, V217, P543, DOI 10.1002/path.2476; Wang H, 2001, STROKE, V32, P1020, DOI 10.1161/01.STR.32.4.1020; Yin XH, 2006, J CELL BIOL, V172, P469, DOI 10.1083/jcb.200509174; Zatta P, 2005, CELL MOL LIFE SCI, V62, P1502, DOI 10.1007/s00018-005-5073-8	45	101	104	0	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	APR	2012	15	4					543	550		10.1038/nn.3062	http://dx.doi.org/10.1038/nn.3062			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	916PA	22366759				2022-12-28	WOS:000302114500013
J	Wu, LJ; Wu, GX; Sharif, MRA; Baker, A; Jia, YH; Fahey, FH; Luo, HBR; Feener, EP; Clapham, DE				Wu, Long-Jun; Wu, Gongxiong; Sharif, M. Reza Akhavan; Baker, Amanda; Jia, Yonghui; Fahey, Frederic H.; Luo, Hongbo R.; Feener, Edward P.; Clapham, David E.			The voltage-gated proton channel Hv1 enhances brain damage from ischemic stroke	NATURE NEUROSCIENCE			English	Article							NADPH OXIDASE; MICROGLIAL ACTIVATION; CEREBRAL-ISCHEMIA; INTRACELLULAR PH; ACID EXTRUSION; MECHANISMS; CELLS; MICE; CURRENTS; SLICES	Phagocytic cell NADPH oxidase (NOX) generates reactive oxygen species (ROS) as part of innate immunity. Unfortunately, ischemia can also induce this pathway and inflict damage on native cells. The voltage-gated proton channel Hv1 enables NOX function by compensating cellular loss of electrons with protons. Accordingly, we investigated whether NOX-mediated brain damage in stroke can be inhibited by suppression of Hv1. We found that mouse and human brain microglia, but not neurons or astrocytes, expressed large Hv1-mediated currents. Hv1 was required for NOX-dependent ROS generation in brain microglia in situ and in vivo. Mice lacking Hv1 were protected from NOX-mediated neuronal death and brain damage 24 h after stroke. These results indicate that Hv1-dependent ROS production is responsible for a substantial fraction of brain damage at early time points after ischemic stroke and provide a rationale for Hv1 as a therapeutic target for the treatment of ischemic stroke.	[Wu, Long-Jun; Clapham, David E.] Childrens Hosp Boston, Howard Hughes Med Inst, Dept Cardiol, Boston, MA 02115 USA; [Wu, Long-Jun; Clapham, David E.] Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA; [Wu, Gongxiong; Feener, Edward P.] Harvard Univ, Sch Med, Joslin Diabet Ctr, Div Res, Boston, MA USA; [Sharif, M. Reza Akhavan] Beth Israel Deaconess Med Ctr, Dept Radiol, Boston, MA 02215 USA; [Baker, Amanda; Fahey, Frederic H.] Childrens Hosp Boston, Dept Radiol, Boston, MA USA; [Jia, Yonghui; Luo, Hongbo R.] Childrens Hosp Boston, Dept Lab Med, Boston, MA USA; [Jia, Yonghui; Luo, Hongbo R.] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Howard Hughes Medical Institute; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Joslin Diabetes Center, Inc.; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School	Clapham, DE (corresponding author), Childrens Hosp Boston, Howard Hughes Med Inst, Dept Cardiol, Boston, MA 02115 USA.	dclapham@enders.tch.harvard.edu	Wu, Long-Jun/AAK-7113-2020; Baker, Amanda L/H-2966-2014; Clapham, David/R-5974-2019; Wu, Long-Jun/E-2684-2012; Clapham, David/S-1123-2019	Wu, Long-Jun/0000-0001-8019-3380; Baker, Amanda L/0000-0002-3328-7146; Clapham, David/0000-0002-4459-9428	US National Institutes of Health [R01 MH090293, R01 EY019029]; Harvard Medical School; American Heart Association [11SDG7340011]; NATIONAL EYE INSTITUTE [R01EY019029] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM076084] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH090293] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS072040] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Harvard Medical School; American Heart Association(American Heart Association); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank L. Silberstein, W. Yang and M. Kurtev for technical assistance, S. Doctrow (Boston University) for kindly providing us with EUK-207, Y. Kirichok (University of California, San Francisco) for Hv1 antibody, and D. Chaudhuri for critical reading of the manuscript. This work was supported by the US National Institutes of Health (R01 MH090293 to D.E.C. and R01 EY019029 to E.P.F.). L.-J.W. is supported by a Lefler postdoctoral fellowship from Harvard Medical School and a Scientist Development Grant from the American Heart Association (11SDG7340011).	Bedard K, 2007, PHYSIOL REV, V87, P245, DOI 10.1152/physrev.00044.2005; Block ML, 2007, NAT REV NEUROSCI, V8, P57, DOI 10.1038/nrn2038; BORON WF, 1976, J GEN PHYSIOL, V67, P91, DOI 10.1085/jgp.67.1.91; Brennan AM, 2009, NAT NEUROSCI, V12, P857, DOI 10.1038/nn.2334; Capasso M, 2010, NAT IMMUNOL, V11, P265, DOI 10.1038/ni.1843; Chan PH, 2001, J CEREBR BLOOD F MET, V21, P2, DOI 10.1097/00004647-200101000-00002; Cheng YM, 2008, NEUROSCIENCE, V151, P1084, DOI 10.1016/j.neuroscience.2007.12.007; Davalos D, 2005, NAT NEUROSCI, V8, P752, DOI 10.1038/nn1472; De Simoni A, 2008, EUR J NEUROSCI, V28, P1146, DOI 10.1111/j.1460-9568.2008.06417.x; DeCoursey TE, 2003, NATURE, V422, P531, DOI 10.1038/nature01523; Decoursey TE, 2003, PHYSIOL REV, V83, P475, DOI 10.1152/physrev.00028.2002; DeCoursey TE, 2008, J PHYSIOL-LONDON, V586, P5305, DOI 10.1113/jphysiol.2008.161703; Dringen R, 2005, ANTIOXID REDOX SIGN, V7, P1223, DOI 10.1089/ars.2005.7.1223; Gambhir SS, 2001, J NUCL MED, V42, p1S; Gelderblom M, 2009, STROKE, V40, P1849, DOI 10.1161/STROKEAHA.108.534503; Iadecola C, 2011, NAT MED, V17, P796, DOI 10.1038/nm.2399; Iovannisci D, 2010, J GEN PHYSIOL, V136, P35, DOI 10.1085/jgp.200910379; Jin R, 2010, J LEUKOCYTE BIOL, V87, P779, DOI 10.1189/jlb.1109766; Kleinschnitz C, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000479; Kraft R, 2004, AM J PHYSIOL-CELL PH, V286, pC129, DOI 10.1152/ajpcell.00331.2003; Lai AY, 2006, CAN J PHYSIOL PHARM, V84, P49, DOI 10.1139/y05-143; Lalancette-Hebert M, 2007, J NEUROSCI, V27, P2596, DOI 10.1523/JNEUROSCI.5360-06.2007; Lishko PV, 2010, CELL, V140, P327, DOI 10.1016/j.cell.2009.12.053; Liu RL, 2003, P NATL ACAD SCI USA, V100, P8526, DOI 10.1073/pnas.1332809100; Lyons SA, 2000, J CEREBR BLOOD F MET, V20, P1537, DOI 10.1097/00004647-200011000-00003; Moskowitz MA, 2010, NEURON, V67, P181, DOI 10.1016/j.neuron.2010.07.002; Musset B, 2008, P NATL ACAD SCI USA, V105, P11020, DOI 10.1073/pnas.0800886105; Nathan C, 2010, CELL, V140, DOI 10.1016/j.cell.2010.03.008; Okochi Y, 2009, BIOCHEM BIOPH RES CO, V382, P274, DOI 10.1016/j.bbrc.2009.03.036; Ramsey IS, 2009, P NATL ACAD SCI USA, V106, P7642, DOI 10.1073/pnas.0902761106; Ramsey IS, 2006, NATURE, V440, P1213, DOI 10.1038/nature04700; Ransohoff RM, 2007, NAT NEUROSCI, V10, P1507, DOI 10.1038/nn1207-1507; Sasaki M, 2006, SCIENCE, V312, P589, DOI 10.1126/science.1122352; Schilling M, 2003, EXP NEUROL, V183, P25, DOI 10.1016/S0014-4886(03)00082-7; Schilling T, 2007, BRAIN RES, V1186, P21, DOI 10.1016/j.brainres.2007.10.027; Sorce S, 2009, ANTIOXID REDOX SIGN, V11, P2481, DOI [10.1089/ars.2009.2578, 10.1089/ARS.2009.2578]; Steinhubl SR, 2008, AM J CARDIOL, V101, p14D, DOI 10.1016/j.amjcard.2008.02.003; THOMAS RC, 1982, NATURE, V299, P826, DOI 10.1038/299826a0; VISENTIN S, 1995, J NEUROSCI RES, V42, P439, DOI 10.1002/jnr.490420402; Walder CE, 1997, STROKE, V28, P2252, DOI 10.1161/01.STR.28.11.2252; WHITTINGHAM TS, 1984, J NEUROSCI, V4, P793; Wu LJ, 2007, GLIA, V55, P810, DOI 10.1002/glia.20500; Yenari MA, 2010, NEUROTHERAPEUTICS, V7, P378, DOI 10.1016/j.nurt.2010.07.005	43	169	174	1	65	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	APR	2012	15	4					565	573		10.1038/nn.3059	http://dx.doi.org/10.1038/nn.3059			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	916PA	22388960	Green Accepted, Green Submitted			2022-12-28	WOS:000302114500016
J	Yuan, Q; Song, Y; Yang, CH; Jan, LY; Jan, YN				Yuan, Quan; Song, Yuanquan; Yang, Chung-Hui; Jan, Lily Yeh; Jan, Yuh Nung			Female contact modulates male aggression via a sexually dimorphic GABAergic circuit in Drosophila	NATURE NEUROSCIENCE			English	Article							SENSORY NEURONS; BEHAVIOR; MELANOGASTER; MEMORY; SEROTONIN; PHEROMONE; COURTSHIP; RESPONSES	Intraspecific male-male aggression, which is important for sexual selection, is regulated by environment, experience and internal states through largely undefined molecular and cellular mechanisms. To understand the basic neural pathway underlying the modulation of this innate behavior, we established a behavioral assay in Drosophila melanogaster and investigated the relationship between sexual experience and aggression. In the presence of mating partners, adult male flies exhibited elevated levels of aggression, which was largely suppressed by prior exposure to females via a sexually dimorphic neural mechanism. The suppression involved the ability of male flies to detect females by contact chemosensation through the pheromone-sensing ion channel ppk29 and was mediated by male-specific GABAergic neurons acting on the GABA(A) receptor RDL in target cells. Silencing or activating this circuit led to dis-inhibition or elimination of sex-related aggression, respectively. We propose that the GABAergic inhibition represents a critical cellular mechanism that enables prior experience to modulate aggression.	[Yuan, Quan; Song, Yuanquan; Yang, Chung-Hui; Jan, Lily Yeh; Jan, Yuh Nung] Univ Calif San Francisco, Dept Physiol, San Francisco, CA 94143 USA; [Yuan, Quan; Song, Yuanquan; Yang, Chung-Hui; Jan, Lily Yeh; Jan, Yuh Nung] Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA USA	University of California System; University of California San Francisco; Howard Hughes Medical Institute; University of California System; University of California San Francisco	Jan, YN (corresponding author), Univ Calif San Francisco, Dept Physiol, Box 0444, San Francisco, CA 94143 USA.	yuhnung.jan@ucsf.edu	yuan, quan/GZM-5597-2022	Jan, Lily/0000-0003-3938-8498; Jan, Yuh Nung/0000-0003-1367-6299	US National Institutes of Health [2R37NS040929]; Howard Hughes Medical Institute; Autism Speaks postdoctoral fellowship; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [ZIANS003137, R37NS040929] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Autism Speaks postdoctoral fellowship; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank R. Greenspan (University of California, San Diego), J. Blau (New York University), S. Waddell (University of Oxford), L. Griffith (Brandeis University), K. Keleman (Research Institute of Molecular Pathology), L. Voshall (Rockefeller University), K. Scott (University of California, Berkeley), B. Dickson (IMP), T. Kitamoto (University of Iowa), J. Simpson (Howard Hughes Medial Institute, Janelia Farm), T. Aigaki (Tokyo Metropolitan University), E. Kravitz (Harvard University) and F. Jackson (Tufts University) for reagents and fly lines, K. Ori-McKenney, S. Rumpf and members of the Jan laboratory for helpful discussions, and C. Long and P. Haynes for technical assistance. Q.Y. was supported by an Autism Speaks postdoctoral fellowship. This work was supported by US National Institutes of Health grant 2R37NS040929 to Y.N.J. In addition, Q.Y., IS., L.Y.J. and Y.N.J. receive funding from the Howard Hughes Medical Institute.	Agosto J, 2008, NAT NEUROSCI, V11, P354, DOI 10.1038/nn2046; Anholt RRH, 2012, ANNU REV GENET, V46, P145, DOI 10.1146/annurev-genet-110711-155514; Baines RA, 2001, J NEUROSCI, V21, P1523, DOI 10.1523/JNEUROSCI.21-05-01523.2001; Blomquist GJ, 2010, INSECT HYDROCARBONS: BIOLOGY, BIOCHEMISTRY, AND CHEMICAL ECOLOGY, P1, DOI 10.1017/CBO9780511711909; Cachero S, 2010, CURR BIOL, V20, P1589, DOI 10.1016/j.cub.2010.07.045; Certel Sarah J, 2012, Cold Spring Harb Protoc, V2012, P319, DOI 10.1101/pdb.prot068130; Chiavegatto S, 2001, P NATL ACAD SCI USA, V98, P1277, DOI 10.1073/pnas.031487198; Dankert H, 2009, NAT METHODS, V6, P297, DOI [10.1038/NMETH.1310, 10.1038/nmeth.1310]; Datta SR, 2008, NATURE, V452, P473, DOI 10.1038/nature06808; Fernandez MD, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000541; Dierick HA, 2007, NAT GENET, V39, P678, DOI 10.1038/ng2029; Dierick HA, 2006, NAT GENET, V38, P1023, DOI 10.1038/ng1864; DOW MA, 1975, NATURE, V254, P511, DOI 10.1038/254511a0; GRETHER ME, 1995, GENE DEV, V9, P1694, DOI 10.1101/gad.9.14.1694; Ha TS, 2006, J NEUROSCI, V26, P8727, DOI 10.1523/JNEUROSCI.0876-06.2006; Hasemeyer M, 2009, NEURON, V61, P511, DOI 10.1016/j.neuron.2009.01.009; HOFFMANN AA, 1990, J INSECT BEHAV, V3, P1, DOI 10.1007/BF01049191; Keene AC, 2007, NAT REV NEUROSCI, V8, P341, DOI 10.1038/nrn2098; Kolodziejczyk A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002110; Krashes MJ, 2007, NEURON, V53, P103, DOI 10.1016/j.neuron.2006.11.021; Kravitz EA, 2003, CURR OPIN NEUROBIOL, V13, P736, DOI 10.1016/j.conb.2003.10.003; Larsson MC, 2004, NEURON, V43, P703, DOI 10.1016/j.neuron.2004.08.019; Liu WW, 2011, NAT NEUROSCI, V14, P896, DOI 10.1038/nn.2836; Liu X, 2007, NEURON, V56, P1090, DOI 10.1016/j.neuron.2007.10.036; Nelson RJ, 2007, NAT REV NEUROSCI, V8, P536, DOI 10.1038/nrn2174; Rosenzweig M, 2005, GENE DEV, V19, P419, DOI 10.1101/gad.1278205; SIEGEL RW, 1979, P NATL ACAD SCI USA, V76, P3430, DOI 10.1073/pnas.76.7.3430; Sturtevant A. H., 1915, Journal of Animal Behavior Boston, V5, DOI 10.1037/h0074109; Thistle R, 2012, CELL, V149, P1140, DOI 10.1016/j.cell.2012.03.045; Wang LM, 2010, NATURE, V463, P227, DOI 10.1038/nature08678; Wilson RI, 2005, J NEUROSCI, V25, P9069, DOI 10.1523/JNEUROSCI.2070-05.2005; Yang CH, 2009, NEURON, V61, P519, DOI 10.1016/j.neuron.2008.12.021; Yu DH, 2006, NEURON, V52, P845, DOI 10.1016/j.neuron.2006.10.030; Yu JY, 2010, CURR BIOL, V20, P1602, DOI 10.1016/j.cub.2010.08.025; Yuan Q, 2005, NEURON, V47, P115, DOI 10.1016/j.neuron.2005.05.027; Yurkovic A, 2006, P NATL ACAD SCI USA, V103, P17519, DOI 10.1073/pnas.0608211103; Zhou C, 2008, NAT NEUROSCI, V11, P1059, DOI 10.1038/nn.2164	37	56	56	0	46	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JAN	2014	17	1					81	88		10.1038/nn.3581	http://dx.doi.org/10.1038/nn.3581			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	281DL	24241395	Green Submitted, Green Accepted			2022-12-28	WOS:000329080000017
J	Michel, MM; Chen, YZ; Geisler, WS; Seidemann, E				Michel, Melchi M.; Chen, Yuzhi; Geisler, Wilson S.; Seidemann, Eyal			An illusion predicted by V1 population activity implicates cortical topography in shape perception	NATURE NEUROSCIENCE			English	Article							RECEPTIVE-FIELD SIZE; STRIATE-CORTEX; FUNCTIONAL ARCHITECTURE; MAGNIFICATION FACTOR; SPATIAL-FREQUENCY; MACAQUE MONKEY; REPRESENTATION; ORIENTATION; AREA; DISCRIMINATION	Mammalian primary visual cortex (V1) is topographically organized such that the pattern of neural activation in V1 reflects the location and spatial extent of visual elements in the retinal image, but it is unclear whether this organization contributes to visual perception. We combined computational modeling, voltage-sensitive dye imaging (VSDI) in behaving monkeys and behavioral measurements in humans to investigate whether the large-scale topography of V1 population responses influences shape judgments. Specifically, we used a computational model to design visual stimuli that had the same physical shape, but were predicted to elicit variable V1 response spread. We confirmed these predictions with VSDI. Finally, we designed a behavioral task in which human observers judged the shapes of these stimuli and found that their judgments were systematically distorted by the spread of V1 activity. This illusion suggests that the topographic pattern of neural population responses in visual cortex contributes to visual perception.	[Michel, Melchi M.] Rutgers State Univ, Dept Psychol, New Brunswick, NJ USA; [Chen, Yuzhi; Geisler, Wilson S.; Seidemann, Eyal] Univ Texas Austin, Ctr Perceptual Syst, Austin, TX 78712 USA; [Chen, Yuzhi; Geisler, Wilson S.; Seidemann, Eyal] Univ Texas Austin, Dept Psychol, Austin, TX 78712 USA; [Chen, Yuzhi; Seidemann, Eyal] Univ Texas Austin, Neurobiol Sect, Austin, TX 78712 USA	Rutgers State University New Brunswick; University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin	Michel, MM (corresponding author), Rutgers State Univ, Dept Psychol, New Brunswick, NJ USA.	melchi.michel@rutgers.edu		Geisler, Wilson/0000-0003-4630-6614; Seidemann, Eyal/0000-0003-2841-5948	National Eye Institute [R01EY016454, R01EY16752, R01EY02688, R01EY110747]; NATIONAL EYE INSTITUTE [R01EY002688, R01EY016454, R01EY011747, R01EY016752] Funding Source: NIH RePORTER	National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	We thank T. Cakic and other members of the Seidemann laboratory for their contributions to this project. This work was supported by grants from the National Eye Institute (R01EY016454 and R01EY16752 to E.S., and R01EY02688 and R01EY110747 to W.S.G.).	Adams DL, 2003, J NEUROSCI, V23, P3771; ADELSON EH, 1985, J OPT SOC AM A, V2, P284, DOI 10.1364/JOSAA.2.000284; Blasdel G, 2001, J NEUROSCI, V21, P8286, DOI 10.1523/JNEUROSCI.21-20-08286.2001; Chen YZ, 2008, J NEUROPHYSIOL, V99, P1366, DOI 10.1152/jn.00698.2007; Chen YZ, 2006, NAT NEUROSCI, V9, P1412, DOI 10.1038/nn1792; Chen YZ, 2012, J NEUROPHYSIOL, V107, P3281, DOI 10.1152/jn.00977.2011; Chklovskii DB, 2004, ANNU REV NEUROSCI, V27, P369, DOI 10.1146/annurev.neuro.27.070203.144226; DEVALOIS RL, 1982, VISION RES, V22, P545, DOI 10.1016/0042-6989(82)90113-4; DOW BM, 1981, EXP BRAIN RES, V44, P213; Dumoulin SO, 2007, VISION RES, V47, P1608, DOI 10.1016/j.visres.2007.01.031; Duncan RO, 2003, NEURON, V38, P659, DOI 10.1016/S0896-6273(03)00265-4; Fang F, 2008, CURR BIOL, V18, P1707, DOI 10.1016/j.cub.2008.09.025; FIELD DJ, 1993, VISION RES, V33, P173, DOI 10.1016/0042-6989(93)90156-Q; Graf ABA, 2011, NAT NEUROSCI, V14, P239, DOI 10.1038/nn.2733; Grinvald A, 2004, NAT REV NEUROSCI, V5, P874, DOI 10.1038/nrn1536; Harvey BM, 2011, J NEUROSCI, V31, P13604, DOI 10.1523/JNEUROSCI.2572-11.2011; Hegde J, 2007, CEREB CORTEX, V17, P1100, DOI 10.1093/cercor/bhl020; Hetherington PA, 1999, VISUAL NEUROSCI, V16, P637, DOI 10.1017/S0952523899164046; Horton JC, 2005, PHILOS T R SOC B, V360, P837, DOI 10.1098/rstb.2005.1623; HUBEL DH, 1977, PROC R SOC SER B-BIO, V198, P1, DOI 10.1098/rspb.1977.0085; Ito M, 2004, J NEUROSCI, V24, P3313, DOI 10.1523/JNEUROSCI.4364-03.2004; KAPADIA MK, 1995, NEURON, V15, P843, DOI 10.1016/0896-6273(95)90175-2; Ma WJ, 2006, NAT NEUROSCI, V9, P1432, DOI 10.1038/nn1790; MCILWAIN JT, 1986, TRENDS NEUROSCI, V9, P354; Morgan M, 2012, ATTEN PERCEPT PSYCHO, V74, P185, DOI 10.3758/s13414-011-0222-7; Motter BC, 2009, J NEUROSCI, V29, P5749, DOI 10.1523/JNEUROSCI.4496-08.2009; Murray SO, 2006, NAT NEUROSCI, V9, P429, DOI 10.1038/nn1641; Nachmias J, 2011, VISION RES, V51, P400, DOI 10.1016/j.visres.2010.12.007; Paik SB, 2012, P NATL ACAD SCI USA, V109, P7091, DOI 10.1073/pnas.1118926109; Palmer CR, 2012, J NEUROPHYSIOL, V107, P1857, DOI 10.1152/jn.00117.2011; PARADISO MA, 1988, BIOL CYBERN, V58, P35, DOI 10.1007/BF00363954; Pasupathy A, 2002, NAT NEUROSCI, V5, P1332, DOI 10.1038/nn972; POLAT U, 1993, VISION RES, V33, P993, DOI 10.1016/0042-6989(93)90081-7; Polat U, 1998, NATURE, V391, P580, DOI 10.1038/35372; REGAN D, 1992, VISION RES, V32, P1845, DOI 10.1016/0042-6989(92)90046-L; REGAN D, 1994, VISION RES, V34, P2277, DOI 10.1016/0042-6989(94)90107-4; Regan D, 1996, VISION RES, V36, P3695, DOI 10.1016/0042-6989(96)00083-1; Ringach DL, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000251; Ringach DL, 2002, J NEUROPHYSIOL, V88, P455, DOI 10.1152/jn.2002.88.1.455; Schwarzkopf DS, 2011, NAT NEUROSCI, V14, P28, DOI 10.1038/nn.2706; Seidemann E, 2002, SCIENCE, V295, P862, DOI 10.1126/science.1066641; SEUNG HS, 1993, P NATL ACAD SCI USA, V90, P10749, DOI 10.1073/pnas.90.22.10749; Teichert T, 2007, BMC NEUROSCI, V8, DOI 10.1186/1471-2202-8-38; TOOTELL RBH, 1988, J NEUROSCI, V8, P1531; van Aubel A, 2003, APPL MATH COMPUT, V141, P3, DOI 10.1016/S0096-3003(02)00316-8; VANESSEN DC, 1984, VISION RES, V24, P429, DOI 10.1016/0042-6989(84)90041-5; Wandell BA, 2007, NEURON, V56, P366, DOI 10.1016/j.neuron.2007.10.012; WEBSTER MA, 1985, J OPT SOC AM A, V2, P1124, DOI 10.1364/JOSAA.2.001124; White LE, 2007, NEURON, V56, P327, DOI 10.1016/j.neuron.2007.10.011; Williams CB, 1998, J OPT SOC AM A, V15, P2046, DOI 10.1364/JOSAA.15.002046; Wilson HR, 1998, VISION RES, V38, P2933, DOI 10.1016/S0042-6989(98)00109-6; Yang ZY, 2007, J NEUROPHYSIOL, V98, P1002, DOI 10.1152/jn.00417.2007	52	27	27	0	33	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	OCT	2013	16	10					1477	+		10.1038/nn.3517	http://dx.doi.org/10.1038/nn.3517			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	223HM	24036915	Green Accepted			2022-12-28	WOS:000324795300021
J	Blinder, P; Tsai, PS; Kaufhold, JP; Knutsen, PM; Suhl, H; Kleinfeld, D				Blinder, Pablo; Tsai, Philbert S.; Kaufhold, John P.; Knutsen, Per M.; Suhl, Harry; Kleinfeld, David			The cortical angiome: an interconnected vascular network with noncolumnar patterns of blood flow	NATURE NEUROSCIENCE			English	Article							CEREBRAL-CORTEX; FUNCTIONAL ARCHITECTURE; PENETRATING ARTERIOLES; NEURONAL-ACTIVITY; INTRINSIC SIGNAL; VISUAL-CORTEX; LASER-PULSES; BRAIN; OCCLUSION; MICROVASCULATURE	What is the nature of the vascular architecture in the cortex that allows the brain to meet the energy demands of neuronal computations? We used high-throughput histology to reconstruct the complete angioarchitecture and the positions of all neuronal somata of multiple cubic millimeter regions of vibrissa primary sensory cortex in mouse. Vascular networks were derived from the reconstruction. In contrast with the standard model of cortical columns that are tightly linked with the vascular network, graph-theoretical analyses revealed that the subsurface microvasculature formed interconnected loops with a topology that was invariant to the position and boundary of columns. Furthermore, the calculated patterns of blood flow in the networks were unrelated to location of columns. Rather, blood sourced by penetrating arterioles was effectively drained by the penetrating venules to limit lateral perfusion. This analysis provides the underpinning to understand functional imaging and the effect of penetrating vessels strokes on brain viability.	[Blinder, Pablo; Tsai, Philbert S.; Knutsen, Per M.; Suhl, Harry; Kleinfeld, David] Univ Calif San Diego, Dept Phys, La Jolla, CA 92093 USA; [Kaufhold, John P.] Sci Applicat Int Corp Intelligent Syst Div, Arlington, VA USA; [Kleinfeld, David] Univ Calif San Diego, Sect Neurobiol, La Jolla, CA 92093 USA	University of California System; University of California San Diego; Science Applications International Corporation (SAIC); University of California System; University of California San Diego	Kleinfeld, D (corresponding author), Univ Calif San Diego, Dept Phys, La Jolla, CA 92093 USA.	dk@physics.ucsd.edu	Blinder, Pablo/AAX-7980-2020; Blinder, Pablo/D-2472-2009; Blinder, Pablo/GQI-2237-2022	Blinder, Pablo/0000-0002-4042-214X; Kaufhold, John/0000-0002-2236-7909	Israeli Science Foundation (Bikura fellowship); US National Institutes of Health [EB003832, MH085499, MH072570, OD006831]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB003832] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH085499, R21MH072570] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD006831] Funding Source: NIH RePORTER	Israeli Science Foundation (Bikura fellowship); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank J. Lee for assistance in the analysis of the surface vasculature, J.D. Driscoll for assistance with the imaging acquisition software, N. Nishimura and C.B. Schaffer for sharing their data logs, S. Chien, W. Denk, P.J. Drew, A.L. Fairhall, B. Friedman, R.D. Frostig, H.J. Karten, H.S. Seung, T.W. Secomb, A.Y. Shih and B. Weber for critical discussions. This work was supported by the Israeli Science Foundation (Bikura fellowship to P.B.) and the US National Institutes of Health (grants EB003832, MH085499, MH072570 and OD006831).	Attwell D, 2002, TRENDS NEUROSCI, V25, P621, DOI 10.1016/S0166-2236(02)02264-6; Attwell D, 2001, J CEREBR BLOOD F MET, V21, P1133, DOI 10.1097/00004647-200110000-00001; Attwell D, 2010, NATURE, V468, P232, DOI 10.1038/nature09613; Blinder P, 2010, P NATL ACAD SCI USA, V107, P12670, DOI 10.1073/pnas.1007239107; Blondel VD, 2008, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2008/10/P10008; Boas DA, 2008, NEUROIMAGE, V40, P1116, DOI 10.1016/j.neuroimage.2007.12.061; BONHOEFFER T, 1993, J NEUROSCI, V13, P4157; Brundel M, 2012, J CEREBR BLOOD F MET, V32, P425, DOI 10.1038/jcbfm.2011.200; Cauli B, 2004, J NEUROSCI, V24, P8940, DOI 10.1523/JNEUROSCI.3065-04.2004; Chen-Bee CH, 2007, J NEUROSCI, V27, P4572, DOI 10.1523/JNEUROSCI.0326-07.2007; Cserti J, 2000, AM J PHYS, V68, P896, DOI 10.1119/1.1285881; DENK W, 1990, SCIENCE, V248, P73, DOI 10.1126/science.2321027; Derdikman D, 2003, J NEUROSCI, V23, P3100; Devor A, 2007, J NEUROSCI, V27, P4452, DOI 10.1523/JNEUROSCI.0134-07.2007; Drew PJ, 2010, NAT METHODS, V7, P981, DOI 10.1038/NMETH.1530; DUVERNOY HM, 1981, BRAIN RES BULL, V7, P519, DOI 10.1016/0361-9230(81)90007-1; Emmenlauer M, 2009, J MICROSC-OXFORD, V233, P42, DOI 10.1111/j.1365-2818.2008.03094.x; Eppihimer MJ, 1996, MICROVASC RES, V51, P187, DOI 10.1006/mvre.1996.0020; Fortunato S, 2010, PHYS REP, V486, P75, DOI 10.1016/j.physrep.2009.11.002; FROSTIG RD, 1990, P NATL ACAD SCI USA, V87, P6082, DOI 10.1073/pnas.87.16.6082; Gorelick PB, 2011, STROKE, V42, P2672, DOI 10.1161/STR.0b013e3182299496; GRINVALD A, 1991, P NATL ACAD SCI USA, V88, P11559, DOI 10.1073/pnas.88.24.11559; GRINVALD A, 1986, NATURE, V324, P361, DOI 10.1038/324361a0; Guibert R, 2010, J CEREBR BLOOD F MET, V30, P1860, DOI 10.1038/jcbfm.2010.105; Hirsch S, 2012, J CEREBR BLOOD F MET, V32, P952, DOI 10.1038/jcbfm.2012.39; Iadecola C, 2004, NAT REV NEUROSCI, V5, P347, DOI 10.1038/nrn1387; Nguyen J, 2011, J CEREBR BLOOD F MET, V31, P2243, DOI 10.1038/jcbfm.2011.95; Kaufhold JP, 2012, MED IMAGE ANAL, V16, P1241, DOI 10.1016/j.media.2012.06.004; Kim T, 2011, J CEREBR BLOOD F MET, V31, P1211, DOI 10.1038/jcbfm.2010.226; Kleinfeld David, 2011, Front Neuroenergetics, V3, P1, DOI 10.3389/fnene.2011.00001; Kohn A, 2000, NEUROSCIENCE, V95, P51; Lauwers F, 2008, NEUROIMAGE, V39, P936, DOI 10.1016/j.neuroimage.2007.09.024; Magistretti PJ, 1999, PHILOS T R SOC B, V354, P1155, DOI 10.1098/rstb.1999.0471; MAYHAN WG, 1986, CIRC RES, V59, P216, DOI 10.1161/01.RES.59.2.216; Mchedlishvili G., 1963, ARTERIAL BEHAV BLOOD; NAKAI K, 1981, STROKE, V12, P653, DOI 10.1161/01.STR.12.5.653; Newman MEJ, 2006, P NATL ACAD SCI USA, V103, P8577, DOI 10.1073/pnas.0601602103; Newman M.E.J., 2010, NETWORKS INTRO; Nguyen QT, 2006, J NEUROSCI METH, V156, P351, DOI 10.1016/j.jneumeth.2006.03.001; Nishimura N, 2006, NAT METHODS, V3, P99, DOI 10.1038/NMETH844; Nishimura N, 2007, P NATL ACAD SCI USA, V104, P365, DOI 10.1073/pnas.0609551104; Nishimura N, 2010, J CEREBR BLOOD F MET, V30, P1914, DOI 10.1038/jcbfm.2010.157; Oraevsky AA, 1996, IEEE J SEL TOP QUANT, V2, P801, DOI 10.1109/2944.577302; PRIES AR, 1990, CIRC RES, V67, P826, DOI 10.1161/01.RES.67.4.826; Risser L, 2009, INT J DEV NEUROSCI, V27, P185, DOI 10.1016/j.ijdevneu.2008.10.006; Schaffer CB, 2006, PLOS BIOL, V4, P258, DOI 10.1371/journal.pbio.0040022; Shih AY, 2013, NAT NEUROSCI, V16, P55, DOI 10.1038/nn.3278; Shih AY, 2009, J CEREBR BLOOD F MET, V29, P738, DOI 10.1038/jcbfm.2008.166; Sirotin YB, 2009, P NATL ACAD SCI USA, V106, P18390, DOI 10.1073/pnas.0905509106; Smith EE, 2012, LANCET NEUROL, V11, P272, DOI 10.1016/S1474-4422(11)70307-6; Strehl A., 2003, Journal of Machine Learning Research, V3, P583, DOI 10.1162/153244303321897735; Tsai PS, 2009, J NEUROSCI, V29, P14553, DOI 10.1523/JNEUROSCI.3287-09.2009; Tsai PS, 2003, NEURON, V39, P27, DOI 10.1016/S0896-6273(03)00370-2; Vazquez AL, 2012, J CEREBR BLOOD F MET, V32, P745, DOI 10.1038/jcbfm.2011.198; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Weber B, 2008, CEREB CORTEX, V18, P2318, DOI 10.1093/cercor/bhm259; Woolsey TA, 1996, CEREB CORTEX, V6, P647, DOI 10.1093/cercor/6.5.647; WOOLSEY TA, 1970, BRAIN RES, V17, P205, DOI 10.1016/0006-8993(70)90079-X; Wu FY, 2004, J PHYS A-MATH GEN, V37, P6653, DOI 10.1088/0305-4470/37/26/004; Zhang SX, 2007, PLOS BIOL, V5, P1152, DOI 10.1371/journal.pbio.0050119	60	330	341	2	72	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUL	2013	16	7					889	U150		10.1038/nn.3426	http://dx.doi.org/10.1038/nn.3426			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	174UM	23749145	Green Accepted			2022-12-28	WOS:000321180900022
J	Chesi, A; Staahl, BT; Jovicic, A; Couthouis, J; Fasolino, M; Raphael, AR; Yamazaki, T; Elias, L; Polak, M; Kelly, C; Williams, KL; Fifita, JA; Maragakis, NJ; Nicholson, GA; King, OD; Reed, R; Crabtree, GR; Blair, IP; Glass, JD; Gitler, AD				Chesi, Alessandra; Staahl, Brett T.; Jovicic, Ana; Couthouis, Julien; Fasolino, Maria; Raphael, Alya R.; Yamazaki, Tomohiro; Elias, Laura; Polak, Meraida; Kelly, Crystal; Williams, Kelly L.; Fifita, Jennifer A.; Maragakis, Nicholas J.; Nicholson, Garth A.; King, Oliver D.; Reed, Robin; Crabtree, Gerald R.; Blair, Ian P.; Glass, Jonathan D.; Gitler, Aaron D.			Exome sequencing to identify de novo mutations in sporadic ALS trios	NATURE NEUROSCIENCE			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; RNA-BINDING PROTEINS; PRION-LIKE DOMAINS; SODIUM PHENYLBUTYRATE; HEXANUCLEOTIDE REPEAT; GENE; COMPLEX; EXPRESSION; FRAMEWORK; PARADIGM	Amyotrophic lateral sclerosis (ALS) is a devastating neurodegenerative disease whose causes are still poorly understood. To identify additional genetic risk factors, we assessed the role of de novo mutations in ALS by sequencing the exomes of 47 ALS patients and both of their unaffected parents (n = 141 exomes). We found that amino acid-altering de novo mutations were enriched in genes encoding chromatin regulators, including the neuronal chromatin remodeling complex (nBAF) component SS18L1 (also known as CREST). CREST mutations inhibited activity-dependent neurite outgrowth in primary neurons, and CREST associated with the ALS protein FUS. These findings expand our understanding of the ALS genetic landscape and provide a resource for future studies into the pathogenic mechanisms contributing to sporadic ALS.	[Chesi, Alessandra; Jovicic, Ana; Couthouis, Julien; Raphael, Alya R.; Gitler, Aaron D.] Stanford Univ, Dept Genet, Sch Med, Stanford, CA 94305 USA; [Staahl, Brett T.; Elias, Laura; Crabtree, Gerald R.] Stanford Univ, Howard Hughes Med Inst, Sch Med, Stanford, CA 94305 USA; [Staahl, Brett T.; Elias, Laura; Crabtree, Gerald R.] Stanford Univ, Dept Dev Biol, Sch Med, Stanford, CA 94305 USA; [Fasolino, Maria] Univ Penn, Neurosci Grad Grp, Perelman Sch Med, Philadelphia, PA 19104 USA; [Yamazaki, Tomohiro; Reed, Robin] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA USA; [Polak, Meraida; Kelly, Crystal; Glass, Jonathan D.] Emory Univ, Dept Neurol, Atlanta, GA 30322 USA; [Williams, Kelly L.; Fifita, Jennifer A.; Nicholson, Garth A.; Blair, Ian P.] Australian & New Zealand Army Corps Res Inst, Northcott Neurosci Lab, Sydney, NSW, Australia; [Williams, Kelly L.; Nicholson, Garth A.; Blair, Ian P.] Univ Sydney, Sydney Med Sch, Sydney, NSW 2006, Australia; [Williams, Kelly L.; Fifita, Jennifer A.; Blair, Ian P.] Macquarie Univ, Australian Sch Adv Med, Sydney, NSW 2109, Australia; [Maragakis, Nicholas J.] Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21205 USA; [King, Oliver D.] Univ Massachusetts, Sch Med, Dept Cell & Dev Biol, Worcester, MA USA	Stanford University; Howard Hughes Medical Institute; Stanford University; Stanford University; University of Pennsylvania; Pennsylvania Medicine; Harvard University; Harvard Medical School; Emory University; University of Sydney; Macquarie University; Johns Hopkins University; University of Massachusetts System; University of Massachusetts Worcester	Gitler, AD (corresponding author), Stanford Univ, Dept Genet, Sch Med, Stanford, CA 94305 USA.	chesi@stanford.edu; agitler@stanford.edu	Chesi, Alessandra/AAT-8248-2020; Williams, Kelly L/A-5545-2010; COUTHOUIS, Julien/G-3895-2012; Chesi, Alessandra/N-7693-2017	Williams, Kelly L/0000-0001-6319-9473; COUTHOUIS, Julien/0000-0002-2378-4595; Blair, Ian/0000-0003-3083-0075; Gitler, Aaron/0000-0001-8603-1526; Fifita, Jennifer/0000-0002-0814-0118; Crabtree, Robert/0000-0002-6639-8707; Chesi, Alessandra/0000-0002-0954-7446; Nicholson, Garth/0000-0001-9694-066X	National Health and Medical Research Council of Australia [1004670, 511941]; Motor Neurone Disease Research Institute of Australia; US National Institutes of Health Director's New Innovator Award [1DP2OD004417]; US National Institutes of Health [1R01NS065317, R01NS046789, 5U01NS062713]; Department of Defense ALS Research Program; Biogen Idec ALS genome sequencing consortium; Pew Charitable Trusts; Rita Allen Foundation; Howard Hughes Medical Institute; Packard Center for ALS Research at Johns Hopkins; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM043375] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS046789, R01NS065317, R37NS046789, U01NS062713, R01NS073660] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD004417] Funding Source: NIH RePORTER	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Motor Neurone Disease Research Institute of Australia; US National Institutes of Health Director's New Innovator Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense ALS Research Program(United States Department of Defense); Biogen Idec ALS genome sequencing consortium; Pew Charitable Trusts; Rita Allen Foundation; Howard Hughes Medical Institute(Howard Hughes Medical Institute); Packard Center for ALS Research at Johns Hopkins; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by a US National Institutes of Health Director's New Innovator Award 1DP2OD004417 (A.D.G.), grants from the US National Institutes of Health (1R01NS065317 to A.D.G., R01NS046789 to G.R.C. and 5U01NS062713 to N.J.M.) and the Department of Defense ALS Research Program (N.J.M.). A.D.G. received funding from the Biogen Idec ALS genome sequencing consortium. A.D.G. received funding from The Pew Charitable Trusts and the Rita Allen Foundation. G.R.C. receives funding from the Howard Hughes Medical Institute. A.D.G. and J.D.G. are supported by the Packard Center for ALS Research at Johns Hopkins. This work was also supported by the National Health and Medical Research Council of Australia (1004670, 511941) and the Motor Neurone Disease Research Institute of Australia.	Aizawa H, 2004, SCIENCE, V303, P197, DOI 10.1126/science.1089845; Alexander MD, 2002, ANN NEUROL, V52, P680, DOI 10.1002/ana.10369; Andersen PM, 2011, NAT REV NEUROL, V7, P603, DOI 10.1038/nrneurol.2011.150; Bultman S, 2000, MOL CELL, V6, P1287, DOI 10.1016/S1097-2765(00)00127-1; Calvo AC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032632; Chio A, 2011, NEUROBIOL AGING, V32, DOI 10.1016/j.neurobiolaging.2010.05.016; Couthouis J, 2012, HUM MOL GENET, V21, P2899, DOI 10.1093/hmg/dds116; Couthouis J, 2011, P NATL ACAD SCI USA, V108, P20881, DOI 10.1073/pnas.1109434108; Cudkowicz ME, 2009, AMYOTROPH LATERAL SC, V10, P99, DOI 10.1080/17482960802320487; Cushman M, 2010, J CELL SCI, V123, P1191, DOI 10.1242/jcs.051672; DeJesus-Hernandez M, 2011, NEURON, V72, P245, DOI 10.1016/j.neuron.2011.09.011; DeJesus-Hernandez M, 2010, HUM MUTAT, V31, pE1377, DOI 10.1002/humu.21241; Deng HX, 2011, NATURE, V477, P211, DOI 10.1038/nature10353; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Dufu K, 2010, GENE DEV, V24, P2043, DOI 10.1101/gad.1898610; Folco EG, 2012, JOVE-J VIS EXP, DOI 10.3791/4140; Fujii R, 2005, CURR BIOL, V15, P587, DOI 10.1016/j.cub.2005.01.058; Gil OD, 1998, J NEUROSCI, V18, P9312; Girard SL, 2011, NAT GENET, V43, P860, DOI 10.1038/ng.886; Gitler AD, 2011, PRION, V5, P179, DOI 10.4161/pri.5.3.17230; Hosack DA, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-10-r70; Hoyer J, 2012, AM J HUM GENET, V90, P565, DOI 10.1016/j.ajhg.2012.02.007; Huang Da Wei, 2009, Curr Protoc Bioinformatics, VChapter 13, DOI 10.1002/0471250953.bi1311s27; Iossifov I, 2012, NEURON, V74, P285, DOI 10.1016/j.neuron.2012.04.009; Johnson JO, 2010, NEURON, V68, P857, DOI 10.1016/j.neuron.2010.11.036; Kabashi E, 2010, HUM MOL GENET, V19, P671, DOI 10.1093/hmg/ddp534; KHAVARI PA, 1993, NATURE, V366, P170, DOI 10.1038/366170a0; Kim HJ, 2013, NATURE, V495, P467, DOI 10.1038/nature11922; King OD, 2012, BRAIN RES, V1462, P61, DOI 10.1016/j.brainres.2012.01.016; Kwiatkowski TJ, 2009, SCIENCE, V323, P1205, DOI 10.1126/science.1166066; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Loe-Mie Y, 2010, HUM MOL GENET, V19, P2841, DOI 10.1093/hmg/ddq184; Lule D, 2008, MED HYPOTHESES, V70, P1133, DOI 10.1016/j.mehy.2007.11.002; Maruyama H, 2010, NATURE, V465, P223, DOI 10.1038/nature08971; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Monroy MA, 2001, J BIOL CHEM, V276, P40721, DOI 10.1074/jbc.M103615200; Neale BM, 2012, NATURE, V485, P242, DOI 10.1038/nature11011; O'Roak BJ, 2012, NATURE, V485, P246, DOI 10.1038/nature10989; Qiu Z, 2008, NEURON, V60, P775, DOI 10.1016/j.neuron.2008.09.040; Renton AE, 2011, NEURON, V72, P257, DOI 10.1016/j.neuron.2011.09.010; ROSEN DR, 1993, NATURE, V362, P59, DOI 10.1038/362059a0; Rouaux C, 2007, J NEUROSCI, V27, P5535, DOI 10.1523/JNEUROSCI.1139-07.2007; Ryu H, 2005, J NEUROCHEM, V93, P1087, DOI 10.1111/j.1471-4159.2005.03077.x; Sanders SJ, 2012, NATURE, V485, P237, DOI 10.1038/nature10945; Sreedharan J, 2008, SCIENCE, V319, P1668, DOI 10.1126/science.1154584; Tsurusaki Y, 2012, NAT GENET, V44, P376, DOI 10.1038/ng.2219; van Horck FPG, 2002, CURR BIOL, V12, P241, DOI 10.1016/S0960-9822(01)00660-1; Van Houdt JKJ, 2012, NAT GENET, V44, P445, DOI 10.1038/ng.1105; Vance C, 2009, SCIENCE, V323, P1208, DOI 10.1126/science.1165942; Vissers LELM, 2010, NAT GENET, V42, P1109, DOI 10.1038/ng.712; Wang XT, 2008, NATURE, V454, P126, DOI 10.1038/nature06992; Wolff D, 2011, MOL SYNDROMOL, V2, P237, DOI 10.1159/000337323; Wu CH, 2012, NATURE, V488, P499, DOI 10.1038/nature11280; Wu JI, 2007, NEURON, V56, P94, DOI 10.1016/j.neuron.2007.08.021; Xu B, 2011, NAT GENET, V43, P864, DOI 10.1038/ng.902	55	104	104	0	22	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUL	2013	16	7					851	U98		10.1038/nn.3412	http://dx.doi.org/10.1038/nn.3412			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	174UM	23708140	Green Submitted, Green Accepted			2022-12-28	WOS:000321180900017
J	Laje, R; Buonomano, DV				Laje, Rodrigo; Buonomano, Dean V.			Robust timing and motor patterns by taming chaos in recurrent neural networks	NATURE NEUROSCIENCE			English	Article							TEMPORAL INFORMATION; TRANSIENT DYNAMICS; TIME; MODEL; CEREBELLUM; SEQUENCES; VARIABILITY; MECHANISMS; SYSTEMS; MEMORY	The brain's ability to tell time and produce complex spatiotemporal motor patterns is critical for anticipating the next ring of a telephone or playing a musical instrument. One class of models proposes that these abilities emerge from dynamically changing patterns of neural activity generated in recurrent neural networks. However, the relevant dynamic regimes of recurrent networks are highly sensitive to noise; that is, chaotic. We developed a firing rate model that tells time on the order of seconds and generates complex spatiotemporal patterns in the presence of high levels of noise. This is achieved through the tuning of the recurrent connections. The network operates in a dynamic regime that exhibits coexisting chaotic and locally stable trajectories. These stable patterns function as 'dynamic attractors' and provide a feature that is characteristic of biological systems: the ability to 'return' to the pattern being generated in the face of perturbations.	[Laje, Rodrigo; Buonomano, Dean V.] Univ Calif Los Angeles, Dept Neurobiol, Los Angeles, CA 90024 USA; [Buonomano, Dean V.] Univ Calif Los Angeles, Dept Psychol, Los Angeles, CA 90024 USA; [Buonomano, Dean V.] Univ Calif Los Angeles, Brain Res Inst, Los Angeles, CA 90024 USA; [Buonomano, Dean V.] Univ Calif Los Angeles, Integrat Ctr Learning & Memory, Los Angeles, CA USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Buonomano, DV (corresponding author), Univ Calif Los Angeles, Dept Neurobiol, Los Angeles, CA 90024 USA.	dbuono@ucla.edu	Laje, Rodrigo/AAI-9793-2020	Laje, Rodrigo/0000-0003-1481-303X	US National Institutes of Health [NS077340]; National Science Foundation [II-1114833]; Pew Charitable Trusts; Consejo Nacional de Investigaciones Cientificas y Tecnicas (Argentina); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R03NS077340] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); Pew Charitable Trusts; Consejo Nacional de Investigaciones Cientificas y Tecnicas (Argentina)(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank A. Garfinkel and R. Huerta for helpful discussions and comments on the manuscript. This work was supported by the US National Institutes of Health (NS077340), the National Science Foundation (II-1114833), the Pew Charitable Trusts, and Consejo Nacional de Investigaciones Cientificas y Tecnicas (Argentina).	Ahrens MB, 2011, CURR BIOL, V21, P200, DOI 10.1016/j.cub.2010.12.043; Banerjee A, 2008, NEURAL COMPUT, V20, P974, DOI 10.1162/neco.2008.05-06-206; Boffetta G, 2001, PHYSICA D, V159, P58, DOI 10.1016/S0167-2789(01)00330-X; Brunel N, 2000, J PHYSIOLOGY-PARIS, V94, P445, DOI 10.1016/S0928-4257(00)01084-6; Bueti D, 2012, NEURON, V75, P725, DOI 10.1016/j.neuron.2012.07.019; Buhusi CV, 2005, NAT REV NEUROSCI, V6, P755, DOI 10.1038/nrn1764; Buonomano DV, 2010, TRENDS COGN SCI, V14, P520, DOI 10.1016/j.tics.2010.09.002; Buonomano DV, 2009, NAT REV NEUROSCI, V10, P113, DOI 10.1038/nrn2558; BUONOMANO DV, 1995, SCIENCE, V267, P1028, DOI 10.1126/science.7863330; BUONOMANO DV, 1994, NEURAL COMPUT, V6, P38, DOI 10.1162/neco.1994.6.1.38; Buonomano DV, 2000, J NEUROSCI, V20, P1129, DOI 10.1523/JNEUROSCI.20-03-01129.2000; CHURCH RM, 1994, J EXP PSYCHOL ANIM B, V20, P135, DOI 10.1037/0097-7403.20.2.135; Churchland MM, 2010, NAT NEUROSCI, V13, P369, DOI 10.1038/nn.2501; Coull JT, 2008, CURR OPIN NEUROBIOL, V18, P137, DOI 10.1016/j.conb.2008.07.011; Crowe DA, 2010, J NEUROSCI, V30, P11640, DOI 10.1523/JNEUROSCI.0954-10.2010; DOYA K, 1992, 1992 IEEE INTERNATIONAL SYMPOSIUM ON CIRCUITS AND SYSTEMS, VOLS 1-6, P2777, DOI 10.1109/ISCAS.1992.230622; Durstewitz D, 2003, J NEUROSCI, V23, P5342; Durstewitz D, 2008, EUR J NEUROSCI, V27, P217, DOI 10.1111/j.1460-9568.2007.05976.x; Fagiolo G, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.026107; Ganguli S, 2008, P NATL ACAD SCI USA, V105, P18970, DOI 10.1073/pnas.0804451105; Goldman MS, 2009, NEURON, V61, P621, DOI 10.1016/j.neuron.2008.12.012; Hahnloser RHR, 2002, NATURE, V419, P65, DOI 10.1038/nature00974; Haykin S., 2002, ADAPTIVE FILTER THEO, V4th ed.; HOPFIELD JJ, 1982, P NATL ACAD SCI-BIOL, V79, P2554, DOI 10.1073/pnas.79.8.2554; IVRY RB, 1988, EXP BRAIN RES, V73, P167, DOI 10.1007/BF00279670; Ivry RB, 2008, TRENDS COGN SCI, V12, P273, DOI 10.1016/j.tics.2008.04.002; Izhikevich EM, 2008, P NATL ACAD SCI USA, V105, P3593, DOI 10.1073/pnas.0712231105; Jaeger H, 2004, SCIENCE, V304, P78, DOI 10.1126/science.1091277; Jaeger H, 2001, BONN GER GER NATL RE, V148, P13; Jaeger H, 2007, NEURAL NETWORKS, V20, P287, DOI 10.1016/j.neunet.2007.04.001; Janssen P, 2005, NAT NEUROSCI, V8, P234, DOI 10.1038/nn1386; KANTZ H, 1994, PHYS LETT A, V185, P77, DOI 10.1016/0375-9601(94)90991-1; Li JX, 2011, NEURON, V69, P159, DOI 10.1016/j.neuron.2010.11.043; Litwin-Kumar A, 2012, NAT NEUROSCI, V15, P1498, DOI 10.1038/nn.3220; Liu JK, 2009, J NEUROSCI, V29, P13172, DOI 10.1523/JNEUROSCI.2358-09.2009; London M, 2010, NATURE, V466, P123, DOI 10.1038/nature09086; Long MA, 2010, NATURE, V468, P394, DOI 10.1038/nature09514; Matell MS, 2003, BEHAV NEUROSCI, V117, P760, DOI 10.1037/0735-7044.117.4.760; Mauk MD, 2004, ANNU REV NEUROSCI, V27, P307, DOI 10.1146/annurev.neuro.27.070203.144247; Medina JF, 2000, NAT NEUROSCI, V3, P1205, DOI 10.1038/81486; Medina JF, 2000, J NEUROSCI, V20, P5516, DOI 10.1523/JNEUROSCI.20-14-05516.2000; Merchant H, 2011, P NATL ACAD SCI USA, V108, P19784, DOI 10.1073/pnas.1112933108; Miall C, 1989, NEURAL COMPUT, V1, P359, DOI 10.1162/neco.1989.1.3.359; Monteforte M, 2012, PHYS REV X, V2, DOI 10.1103/PhysRevX.2.041007; Pastalkova E, 2008, SCIENCE, V321, P1322, DOI 10.1126/science.1159775; Rajan K, 2010, PHYS REV E, V82, DOI 10.1103/PhysRevE.82.011903; Simen P, 2011, J NEUROSCI, V31, P9238, DOI 10.1523/JNEUROSCI.3121-10.2011; SKARDA CA, 1987, BEHAV BRAIN SCI, V10, P161, DOI 10.1017/S0140525X00047336; SOMPOLINSKY H, 1988, PHYS REV LETT, V61, P259, DOI 10.1103/PhysRevLett.61.259; Song S, 2005, PLOS BIOL, V3, P507, DOI 10.1371/journal.pbio.0030068; Sussillo D, 2009, NEURON, V63, P544, DOI 10.1016/j.neuron.2009.07.018; vanVreeswijk C, 1996, SCIENCE, V274, P1724, DOI 10.1126/science.274.5293.1724; Wang XJ, 2001, TRENDS NEUROSCI, V24, P455, DOI 10.1016/S0166-2236(00)01868-3; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918	55	238	238	2	41	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUL	2013	16	7					925	U196		10.1038/nn.3405	http://dx.doi.org/10.1038/nn.3405			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	174UM	23708144	Green Submitted, Green Accepted			2022-12-28	WOS:000321180900027
J	Shohamy, D; Wimmer, GE				Shohamy, Daphna; Wimmer, G. Elliot			Dopamine and the cost of aging	NATURE NEUROSCIENCE			English	Editorial Material							PREDICTION ERRORS; AGE-DIFFERENCES; REWARD; MECHANISMS; CHOICE	Cognitive function declines as part of the normal aging process. A study finds that the dopamine-boosting drug L-DOPA changes value representation in the brain and improves reinforcement learning in older individuals.	[Shohamy, Daphna; Wimmer, G. Elliot] Columbia Univ, Dept Psychol, New York, NY 10027 USA	Columbia University	Shohamy, D (corresponding author), Columbia Univ, Dept Psychol, New York, NY 10027 USA.	ds2619@columbia.edu; gew2105@columbia.edu	Wimmer, G. Elliott/AAJ-8537-2020	Wimmer, G. Elliott/0000-0002-2227-119X				Backman L, 2006, NEUROSCI BIOBEHAV R, V30, P791, DOI 10.1016/j.neubiorev.2006.06.005; Chowdhury R, 2013, NAT NEUROSCI, V16, P648, DOI 10.1038/nn.3364; Chowdhury R, 2012, J NEUROSCI, V32, P14193, DOI 10.1523/JNEUROSCI.1278-12.2012; Greely H, 2008, NATURE, V456, P702, DOI 10.1038/456702a; Pessiglione M, 2006, NATURE, V442, P1042, DOI 10.1038/nature05051; Peters J, 2010, NEURON, V66, P138, DOI 10.1016/j.neuron.2010.03.026; Samanez-Larkin GR, 2007, NAT NEUROSCI, V10, P787, DOI 10.1038/nn1894; Samanez-Larkin GR, 2012, J NEUROSCI, V32, P5333, DOI 10.1523/JNEUROSCI.5756-11.2012; Samanez-Larkin GR, 2011, FRONT NEUROSCI-SWITZ, V5, DOI 10.3389/fnins.2011.00126; Samanez-Larkin GR, 2010, J NEUROSCI, V30, P1426, DOI 10.1523/JNEUROSCI.4902-09.2010; Schott BH, 2007, BRAIN, V130, P2412, DOI 10.1093/brain/awm147; Schultz W, 2006, ANNU REV PSYCHOL, V57, P87, DOI 10.1146/annurev.psych.56.091103.070229; Shohamy D, 2010, TRENDS COGN SCI, V14, P464, DOI 10.1016/j.tics.2010.08.002; Wimmer GE, 2012, SCIENCE, V338, P270, DOI 10.1126/science.1223252; Wunderlich K, 2012, NEURON, V75, P418, DOI 10.1016/j.neuron.2012.03.042	15	6	6	0	28	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAY	2013	16	5					519	521		10.1038/nn.3385	http://dx.doi.org/10.1038/nn.3385			4	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	131WT	23619753				2022-12-28	WOS:000318029300003
J	Bonnevie, T; Dunn, B; Fyhn, M; Hafting, T; Derdikman, D; Kubie, JL; Roudi, Y; Moser, EI; Moser, MB				Bonnevie, Tora; Dunn, Benjamin; Fyhn, Marianne; Hafting, Torkel; Derdikman, Dori; Kubie, John L.; Roudi, Yasser; Moser, Edvard I.; Moser, May-Britt			Grid cells require excitatory drive from the hippocampus	NATURE NEUROSCIENCE			English	Article							MEDIAL ENTORHINAL CORTEX; SPATIAL REPRESENTATION SYSTEM; PLACE CELLS; THETA OSCILLATIONS; PHASE PRECESSION; PATH-INTEGRATION; COGNITIVE MAP; RAT; NEURONS; FIELDS	To determine how hippocampal backprojections influence spatially periodic firing in grid cells, we recorded neural activity in the medial entorhinal cortex (MEC) of rats after temporary inactivation of the hippocampus. We report two major changes in entorhinal grid cells. First, hippocampal inactivation gradually and selectively extinguished the grid pattern. Second, the same grid cells that lost their grid fields acquired substantial tuning to the direction of the rat's head. This transition in firing properties was contingent on a drop in the average firing rate of the grid cells and could be replicated by the removal of an external excitatory drive in an attractor network model in which grid structure emerges by velocity-dependent translation of activity across a network with inhibitory connections. These results point to excitatory drive from the hippocampus, and possibly other regions, as one prerequisite for the formation and translocation of grid patterns in the MEC.	[Bonnevie, Tora; Dunn, Benjamin; Fyhn, Marianne; Hafting, Torkel; Derdikman, Dori; Roudi, Yasser; Moser, Edvard I.; Moser, May-Britt] Norwegian Univ Sci & Technol NTNU, Kavli Inst Syst Neurosci, Trondheim, Norway; [Bonnevie, Tora; Dunn, Benjamin; Fyhn, Marianne; Hafting, Torkel; Derdikman, Dori; Roudi, Yasser; Moser, Edvard I.; Moser, May-Britt] Norwegian Univ Sci & Technol NTNU, Ctr Biol Memory, Norwegian Brain Ctr, Trondheim, Norway; [Kubie, John L.] Suny Downstate Med Ctr, Dept Cell Biol, Brooklyn, NY 11203 USA	Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU); State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center	Moser, MB (corresponding author), Norwegian Univ Sci & Technol NTNU, Kavli Inst Syst Neurosci, Trondheim, Norway.	edvard.moser@ntnu.no; maybm@ntnu.no		Hafting, Torkel/0000-0002-0928-3487; Roudi, Yasser/0000-0002-6989-3420	Kavli Foundation; Faculty of Medicine at NTNU; Centre of Excellence from Research Council of Norway; European Research Council ('CIRCUIT') [232608]	Kavli Foundation; Faculty of Medicine at NTNU; Centre of Excellence from Research Council of Norway; European Research Council ('CIRCUIT')	We thank R. Skjerpeng for programming, M.P. Witter and C.B. Boccara for advice on tetrode locations, M. Mehta and M.P. Witter for discussion, N. Burgess for sharing code for dynamic autocorrelation analyses and A.M. Amundsgard, K. Haugen, K. Jenssen; E. Krakvik and H. Waade for technical assistance. This work was supported by the Kavli Foundation, a studentship to T.B. from the Faculty of Medicine at NTNU, a Centre of Excellence grant from the Research Council of Norway and an Advanced Investigator Grant to E.I.M. from the European Research Council ('CIRCUIT', grant agreement 232608).	Allen TA, 2008, J NEUROSCI METH, V171, P30, DOI 10.1016/j.jneumeth.2008.01.033; ALONSO A, 1993, J NEUROPHYSIOL, V70, P128, DOI 10.1152/jn.1993.70.1.128; Boccara CN, 2010, NAT NEUROSCI, V13, P987, DOI 10.1038/nn.2602; Brandon MP, 2011, SCIENCE, V332, P595, DOI 10.1126/science.1201652; Burak Y, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000291; Burgess N, 2007, HIPPOCAMPUS, V17, P801, DOI 10.1002/hipo.20327; Burwell RD, 2003, NEUROSCIENCE, V119, P577, DOI 10.1016/S0306-4522(03)00160-X; Couey JJ, 2013, NAT NEUROSCI, V16, P318, DOI 10.1038/nn.3310; de Almeida L, 2009, J NEUROSCI, V29, P7504, DOI 10.1523/JNEUROSCI.6048-08.2009; Fuhs MC, 2006, J NEUROSCI, V26, P4266, DOI 10.1523/JNEUROSCI.4353-05.2006; Fyhn M, 2004, SCIENCE, V305, P1258, DOI 10.1126/science.1099901; Fyhn M, 2007, NATURE, V446, P190, DOI 10.1038/nature05601; Giocomo LM, 2011, NEURON, V71, P589, DOI 10.1016/j.neuron.2011.07.023; Hafting T, 2005, NATURE, V436, P801, DOI 10.1038/nature03721; Hafting T, 2008, NATURE, V453, P1248, DOI 10.1038/nature06957; Kloosterman F, 2003, EUR J NEUROSCI, V18, P3037, DOI 10.1111/j.1460-9568.2003.03046.x; Koenig J, 2011, SCIENCE, V332, P592, DOI 10.1126/science.1201685; Kropff E, 2008, HIPPOCAMPUS, V18, P1256, DOI 10.1002/hipo.20520; Langston RF, 2010, SCIENCE, V328, P1576, DOI 10.1126/science.1188210; McNaughton BL, 2006, NAT REV NEUROSCI, V7, P663, DOI 10.1038/nrn1932; Molter C, 2008, HIPPOCAMPUS, V18, P919, DOI 10.1002/hipo.20450; Monaco JD, 2011, J NEUROSCI, V31, P11096; Moser EI, 2008, ANNU REV NEUROSCI, V31, P69, DOI 10.1146/annurev.neuro.31.061307.090723; O'Keefe J, 2005, HIPPOCAMPUS, V15, P853, DOI 10.1002/hipo.20115; OKEEFE J, 1971, BRAIN RES, V34, P171, DOI 10.1016/0006-8993(71)90358-1; OKEEFE J, 1993, HIPPOCAMPUS, V3, P317, DOI 10.1002/hipo.450030307; Rolls ET, 2006, NETWORK-COMP NEURAL, V17, P447, DOI 10.1080/09548980601064846; Samu D, 2009, BIOL CYBERN, V101, P19, DOI 10.1007/s00422-009-0311-z; Sargolini F, 2006, SCIENCE, V312, P758, DOI 10.1126/science.1125572; Savelli F, 2010, J NEUROPHYSIOL, V103, P3167, DOI 10.1152/jn.00932.2009; Savelli F, 2008, HIPPOCAMPUS, V18, P1270, DOI 10.1002/hipo.20511; Si B, 2009, COGN NEURODYNAMICS, V3, P177, DOI 10.1007/s11571-009-9079-z; Solstad T, 2006, HIPPOCAMPUS, V16, P1026, DOI 10.1002/hipo.20244; Solstad T, 2008, SCIENCE, V322, P1865, DOI 10.1126/science.1166466; Sreenivasan S, 2011, NAT NEUROSCI, V14, P1330, DOI 10.1038/nn.2901; Stensola H, 2012, NATURE, V492, P72, DOI 10.1038/nature11649; TAUBE JS, 1990, J NEUROSCI, V10, P420; van Haeften T, 2003, HIPPOCAMPUS, V13, P943, DOI 10.1002/hipo.10144; Wills TJ, 2010, SCIENCE, V328, P1573, DOI 10.1126/science.1188224; Yartsev MM, 2011, NATURE, V479, P103, DOI 10.1038/nature10583; Yoshida M, 2011, J NEUROSCI, V31, P12683, DOI 10.1523/JNEUROSCI.1654-11.2011; Zilli EA, 2010, J NEUROSCI, V30, P13850, DOI 10.1523/JNEUROSCI.0547-10.2010	42	227	232	0	98	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	MAR	2013	16	3					309	317		10.1038/nn.3311	http://dx.doi.org/10.1038/nn.3311			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	097LE	23334581				2022-12-28	WOS:000315474800013
J	Li, HH; Penzo, MA; Taniguchi, H; Kopec, CD; Huang, ZJ; Li, B				Li, Haohong; Penzo, Mario A.; Taniguchi, Hiroki; Kopec, Charles D.; Huang, Z. Josh; Li, Bo			Experience-dependent modification of a central amygdala fear circuit	NATURE NEUROSCIENCE			English	Article							LONG-TERM POTENTIATION; CENTRAL NUCLEUS; RECEPTOR TRAFFICKING; CONDITIONED FEAR; PROJECTIONS; NEURONS; RAT; EXPRESSION; COMPLEX; CONNECTIONS	The amygdala is essential for fear learning and expression. The central amygdala (CeA), once viewed as a passive relay between the amygdala complex and downstream fear effectors, has emerged as an active participant in fear conditioning. However, the mechanism by which CeA contributes to the learning and expression of fear is unclear. We found that fear conditioning in mice induced robust plasticity of excitatory synapses onto inhibitory neurons in the lateral subdivision of the CeA (CeL). This experience-dependent plasticity was cell specific, bidirectional and expressed presynaptically by inputs from the lateral amygdala. In particular, preventing synaptic potentiation onto somatostatin-positive neurons impaired fear memory formation. Furthermore, activation of these neurons was necessary for fear memory recall and was sufficient to drive fear responses. Our findings support a model in which fear conditioning-induced synaptic modifications in CeL favor the activation of somatostatin-positive neurons, which inhibit CeL output, thereby disinhibiting the medial subdivision of CeA and releasing fear expression.	[Li, Haohong; Penzo, Mario A.; Taniguchi, Hiroki; Huang, Z. Josh; Li, Bo] Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA; [Kopec, Charles D.] Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA	Cold Spring Harbor Laboratory; Princeton University	Li, B (corresponding author), Cold Spring Harbor Lab, POB 100, Cold Spring Harbor, NY 11724 USA.	bli@cshl.edu	Core, Vector/CAF-4832-2022; Penzo, Mario/AAP-8789-2021	Huang, Z. Josh/0000-0003-0592-028X; Li, Bo/0000-0002-0154-3088	US National Institutes of Health [5R01MH091903-03, 5U01MH078844-05]; Dana Foundation; National Alliance for Research on Schizophrenia and Depression; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH091903, U01MH078844] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Dana Foundation; National Alliance for Research on Schizophrenia and Depression(NARSAD); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank R.H. Paik for expert technical assistance, K. Deisseroth and M. Mirrione for the initial help with optogenetic methods, M. Luo (National Institute of Biological Sciences, Beijing) and S.H. Shi (Memorial Sloan-Kettering Cancer Center) for the AAV-DIO-hM4Di-mCherry construct, W Wei for help with the focal optogenetic stimulation, A. Zador (Cold Spring Harbor Laboratory) for sharing the AAV-DIO-ChR2(H134R)-YFP and AAV-DIO-Arch-GFP viruses, A. Reid (Cold Spring Harbor Laboratory) for sharing the Ai32 mice, and K. Pradhan for advice on statistic analysis. We thank S. Shea, L. Van Aelst and R. Malinow for critical reading of the manuscript, and members of the Li laboratory for discussions. This study was supported by the US National Institutes of Health (5R01MH091903-03 to B.L. and 5U01MH078844-05 to Z.J.H.), the Dana Foundation (B.L.) and the National Alliance for Research on Schizophrenia and Depression (B.L. and Z.J.H.).	Anglada-Figueroa D, 2005, J NEUROSCI, V25, P9680, DOI 10.1523/JNEUROSCI.2600-05.2005; Barth AL, 2004, J NEUROSCI, V24, P6466, DOI 10.1523/JNEUROSCI.4737-03.2004; CASSELL MD, 1989, J COMP NEUROL, V281, P320, DOI 10.1002/cne.902810212; Cassell MD, 1999, ANN NY ACAD SCI, V877, P217, DOI 10.1111/j.1749-6632.1999.tb09270.x; Chow BY, 2010, NATURE, V463, P98, DOI 10.1038/nature08652; Ciocchi S, 2010, NATURE, V468, P277, DOI 10.1038/nature09559; Clem RL, 2010, SCIENCE, V330, P1108, DOI 10.1126/science.1195298; Davis M, 2001, MOL PSYCHIATR, V6, P13, DOI 10.1038/sj.mp.4000812; Davis M., 2000, AMYGDALA, P213; Dong SY, 2010, MOL BIOSYST, V6, P1376, DOI 10.1039/c002568m; Dumont EC, 2002, EUR J NEUROSCI, V15, P545, DOI 10.1046/j.0953-816x.2001.01879.x; Duvarci S, 2011, J NEUROSCI, V31, P289, DOI 10.1523/JNEUROSCI.4985-10.2011; Ehrlich I, 2009, NEURON, V62, P757, DOI 10.1016/j.neuron.2009.05.026; Ferguson SM, 2011, NAT NEUROSCI, V14, P22, DOI 10.1038/nn.2703; Fu Y, 2005, J NEUROPHYSIOL, V93, P3012, DOI 10.1152/jn.00871.2004; Goosens KA, 2003, BEHAV NEUROSCI, V117, P738, DOI 10.1037/0735-7044.117.4.738; Haubensak W, 2010, NATURE, V468, P270, DOI 10.1038/nature09553; Huber D, 2005, SCIENCE, V308, P245, DOI 10.1126/science.1105636; Johansen JP, 2011, CELL, V147, P509, DOI 10.1016/j.cell.2011.10.009; LeDoux JE, 2000, ANNU REV NEUROSCI, V23, P155, DOI 10.1146/annurev.neuro.23.1.155; LEDOUX JE, 1988, J NEUROSCI, V8, P2517; LeDoux J, 2007, CURR BIOL, V17, pR868, DOI 10.1016/j.cub.2007.08.005; Lopez de Armentia M, 2007, J PHYSIOL-LONDON, V581, P961, DOI 10.1113/jphysiol.2007.101822; Madisen L, 2012, NAT NEUROSCI, V15, P793, DOI 10.1038/nn.3078; Madisen L, 2010, NAT NEUROSCI, V13, P133, DOI 10.1038/nn.2467; Maren S, 2004, NAT REV NEUROSCI, V5, P844, DOI 10.1038/nrn1535; McKernan MG, 1997, NATURE, V390, P607, DOI 10.1038/37605; OTTERSEN OP, 1979, J COMP NEUROL, V187, P401, DOI 10.1002/cne.901870209; Pape HC, 2010, PHYSIOL REV, V90, P419, DOI 10.1152/physrev.00037.2009; Pare D, 2004, J NEUROPHYSIOL, V92, P1, DOI 10.1152/jn.00153.2004; PITKANEN A, 1995, J COMP NEUROL, V356, P288, DOI 10.1002/cne.903560211; Quirk GJ, 1997, NEURON, V19, P613, DOI 10.1016/S0896-6273(00)80375-X; QUIRK GJ, 1995, NEURON, V15, P1029, DOI 10.1016/0896-6273(95)90092-6; Rogan MT, 1997, NATURE, V390, P604, DOI 10.1038/37601; Rumpel S, 2005, SCIENCE, V308, P83, DOI 10.1126/science.1103944; Sigurdsson T, 2007, NEUROPHARMACOLOGY, V52, P215, DOI 10.1016/j.neuropharm.2006.06.022; Taniguchi H, 2011, NEURON, V71, P995, DOI 10.1016/j.neuron.2011.07.026; TURNER BH, 1991, J COMP NEUROL, V313, P295, DOI 10.1002/cne.903130208; Wilensky AE, 2006, J NEUROSCI, V26, P12387, DOI 10.1523/JNEUROSCI.4316-06.2006; Zhang F, 2007, NAT REV NEUROSCI, V8, P577, DOI 10.1038/nrn2192; Zhang F, 2006, NAT METHODS, V3, P785, DOI 10.1038/nmeth936; Zhang F, 2010, NAT PROTOC, V5, P439, DOI 10.1038/nprot.2009.226; Zhu JJ, 2002, CELL, V110, P443, DOI 10.1016/S0092-8674(02)00897-8; Zucker RS, 2002, ANNU REV PHYSIOL, V64, P355, DOI 10.1146/annurev.physiol.64.092501.114547	44	297	299	3	75	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAR	2013	16	3					332	339		10.1038/nn.3322	http://dx.doi.org/10.1038/nn.3322			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	097LE	23354330	Green Accepted			2022-12-28	WOS:000315474800016
J	Shin, JB; Krey, JF; Hassan, A; Metlagel, Z; Tauscher, AN; Pagana, JM; Sherman, NE; Jeffery, ED; Spinelli, KJ; Zhao, HY; Wilmarth, PA; Choi, D; David, LL; Auer, M; Barr-Gillespie, PG				Shin, Jung-Bum; Krey, Jocelyn F.; Hassan, Ahmed; Metlagel, Zoltan; Tauscher, Andrew N.; Pagana, James M.; Sherman, Nicholas E.; Jeffery, Erin D.; Spinelli, Kateri J.; Zhao, Hongyu; Wilmarth, Phillip A.; Choi, Dongseok; David, Larry L.; Auer, Manfred; Barr-Gillespie, Peter G.			Molecular architecture of the chick vestibular hair bundle	NATURE NEUROSCIENCE			English	Article							SCAFFOLDING PROTEIN EBP50; CELL STEREOCILIA; INNER-EAR; SENSORY EPITHELIA; ACTIN; LOCALIZATION; PHOSPHORYLATION; ROOTLETS; TURNOVER; DYNAMICS	Hair bundles of the inner ear have a specialized structure and protein composition that underlies their sensitivity to mechanical stimulation. Using mass spectrometry, we identified and quantified >1,100 proteins, present from a few to 400,000 copies per stereocilium, from purified chick bundles; 336 of these were significantly enriched in bundles. Bundle proteins that we detected have been shown to regulate cytoskeleton structure and dynamics, energy metabolism, phospholipid synthesis and cell signaling. Three-dimensional imaging using electron tomography allowed us to count the number of actin-actin cross-linkers and actin-membrane connectors; these values compared well to those obtained from mass spectrometry. Network analysis revealed several hub proteins, including RDX (radixin) and SLC9A3R2 (NHERF2), which interact with many bundle proteins and may perform functions essential for bundle structure and function. The quantitative mass spectrometry of bundle proteins reported here establishes a framework for future characterization of dynamic processes that shape bundle structure and function.	[Shin, Jung-Bum; Pagana, James M.] Univ Virginia, Dept Neurosci, Charlottesville, VA USA; [Shin, Jung-Bum; Krey, Jocelyn F.; Pagana, James M.; Spinelli, Kateri J.; Zhao, Hongyu; Barr-Gillespie, Peter G.] Oregon Hlth & Sci Univ, Oregon Hearing Res Ctr, Portland, OR 97201 USA; [Hassan, Ahmed; Metlagel, Zoltan; Tauscher, Andrew N.; Auer, Manfred] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Div Life Sci, Berkeley, CA 94720 USA; [Sherman, Nicholas E.; Jeffery, Erin D.] Univ Virginia, WM Keck Biomed Mass Spectrometry Lab, Charlottesville, VA USA; [Wilmarth, Phillip A.] Oregon Hlth & Sci Univ, Dept Biochem & Mol Biol, Portland, OR 97201 USA; [Choi, Dongseok] Oregon Hlth & Sci Univ, Dept Publ Hlth & Prevent Med, Portland, OR 97201 USA; [Barr-Gillespie, Peter G.] Oregon Hlth & Sci Univ, Vollum Inst, Portland, OR 97201 USA	University of Virginia; Oregon Health & Science University; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; University of Virginia; Oregon Health & Science University; Oregon Health & Science University; Oregon Health & Science University	Barr-Gillespie, PG (corresponding author), Oregon Hlth & Sci Univ, Oregon Hearing Res Ctr, Portland, OR 97201 USA.	gillespp@ohsu.edu		Choi, Dongseok/0000-0002-1552-4072; Jeffery, Erin/0000-0001-9511-7719; Spinelli, Kateri/0000-0002-6290-0886; Barr-Gillespie, Peter/0000-0002-9787-5860; Sherman, Nicholas/0000-0003-3206-3113	US National Institutes of Health (NIH) National Center for Research Resources [RR017573]; National Center for Research Resources (NIH) [S10 RR023432, S10 RR025440]; NIH [K99/R00 DC009412, F32 DC012455, R01 DC002368, R01 DC011034, P30 DC005983, R01 EY007755, P30 EY10572, P01 GM051487]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR017573, S10RR025440, S10RR023432] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [P30EY010572, R01EY007755] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103310, P01GM051487] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R00DC009412, P30DC005983, R01DC011034, K99DC009412, R21DC008801, R21DC006097, R01DC002368, F32DC012455] Funding Source: NIH RePORTER	US National Institutes of Health (NIH) National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Center for Research Resources (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	Mass spectrometry was carried out by the W.M. Keck Biomedical Mass Spectrometry Laboratory and The University of Virginia Biomedical Research Facility. We thank K. McDonald, R. Zalpuri and G. Min of the University of California Berkeley Electron Microscopy Laboratory for assistance with high-pressure freezing and imaging; D. Jorgens provided mentoring in high-pressure freezing. We would like to thank A. Cheng, B. Carragher and C. Potter for help with electron microscopy data collection at the National Resource for Automated Molecular Microscopy, supported by US National Institutes of Health (NIH) National Center for Research Resources grant RR017573. For technical assistance, we acknowledge A. Snyder of the Advanced Light Microscopy Core at The Jungers Center (Oregon Health & Science University), supported by shared instrumentation grants S10 RR023432 and S10 RR025440 from the National Center for Research Resources (NIH). Work described here was supported by NIH grants K99/R00 DC009412 (J.B.S.), F32 DC012455 (J.F.K.), R01 DC002368 (P.G.B.-G.), R01 DC011034 (P.G.B.-G.), P30 DC005983 (P.G.B.-G.), R01 EY007755 (L.L.D.), P30 EY10572 (L L D) and P01 GM051487 (M.A.).	Auer M, 2008, JARO-J ASSOC RES OTO, V9, P215, DOI 10.1007/s10162-008-0114-2; Barabasi AL, 2004, NAT REV GENET, V5, P101, DOI 10.1038/nrg1272; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; BURNHAM JA, 1984, J NEUROCYTOL, V13, P617, DOI 10.1007/BF01148082; Chhabra ES, 2007, NAT CELL BIOL, V9, P1110, DOI 10.1038/ncb1007-1110; Cox J, 2011, J PROTEOME RES, V10, P1794, DOI 10.1021/pr101065j; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Domon B, 2010, NAT BIOTECHNOL, V28, P710, DOI 10.1038/nbt.1661; Donowitz M, 2005, J PHYSIOL-LONDON, V567, P3, DOI 10.1113/jphysiol.2005.090399; Dumont RA, 2001, J NEUROSCI, V21, P5066, DOI 10.1523/JNEUROSCI.21-14-05066.2001; Eppig JT, 2005, NUCLEIC ACIDS RES, V33, pD471, DOI 10.1093/nar/gki113; Fehon RG, 2010, NAT REV MOL CELL BIO, V11, P276, DOI 10.1038/nrm2866; Fischer RS, 2003, TRENDS CELL BIOL, V13, P593, DOI 10.1016/j.tcb.2003.09.007; FRUCHTERMAN TMJ, 1991, SOFTWARE PRACT EXPER, V21, P1129, DOI 10.1002/spe.4380211102; Furness DN, 2008, J NEUROSCI, V28, P6342, DOI 10.1523/JNEUROSCI.1154-08.2008; Gagnon LH, 2006, J NEUROSCI, V26, P10188, DOI 10.1523/JNEUROSCI.2166-06.2006; Garbett D, 2012, J CELL BIOL, V198, P195, DOI 10.1083/jcb.201204008; Garbett D, 2010, J CELL BIOL, V191, P397, DOI 10.1083/jcb.201004115; GILLESPIE PG, 1991, J CELL BIOL, V112, P625, DOI 10.1083/jcb.112.4.625; Grati M, 2012, J NEUROSCI, V32, P14288, DOI 10.1523/JNEUROSCI.3071-12.2012; Hasson T, 1997, J CELL BIOL, V137, P1287, DOI 10.1083/jcb.137.6.1287; Heo WD, 2006, SCIENCE, V314, P1458, DOI 10.1126/science.1134389; Higgs HN, 1999, BIOCHEMISTRY-US, V38, P15212, DOI 10.1021/bi991843+; Jones SM, 2000, JARO-J ASSOC RES OTO, V1, P232, DOI 10.1007/s101620010026; Kitajiri S, 2010, CELL, V141, P786, DOI 10.1016/j.cell.2010.03.049; Kruger RP, 1999, J NEUROSCI, V19, P4815; Ma'ayan A, 2009, J BIOL CHEM, V284, P5451, DOI 10.1074/jbc.R800056200; Maul RS, 2003, J CELL BIOL, V160, P399, DOI 10.1083/jcb.200212057; McKusick VA, 2007, AM J HUM GENET, V80, P588, DOI 10.1086/514346; Peng AW, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1533; Ponsioen B, 2009, MOL BIOL CELL, V20, P4664, DOI 10.1091/mbc.E09-06-0529; Rehman AU, 2010, AM J HUM GENET, V86, P378, DOI 10.1016/j.ajhg.2010.01.030; Rzadzinska AK, 2004, J CELL BIOL, V164, P887, DOI 10.1083/jcb.200310055; Sakaguchi H, 2008, CELL MOTIL CYTOSKEL, V65, P528, DOI 10.1002/cm.20275; SCHULTE BA, 1989, J HISTOCHEM CYTOCHEM, V37, P1787, DOI 10.1177/37.12.2685109; Schwander M, 2010, J CELL BIOL, V190, P9, DOI 10.1083/jcb.201001138; Schwanhausser B, 2011, NATURE, V473, P337, DOI 10.1038/nature10098; Shaw RJ, 1998, MOL BIOL CELL, V9, P403, DOI 10.1091/mbc.9.2.403; Shin JB, 2007, NEURON, V53, P371, DOI 10.1016/j.neuron.2006.12.021; Shin JB, 2010, J NEUROSCI, V30, P9683, DOI 10.1523/JNEUROSCI.1541-10.2010; Spinelli KJ, 2012, P NATL ACAD SCI USA, V109, pE268, DOI 10.1073/pnas.1115866109; Steel KP, 2007, GENES AND COMMON DISEASES: GENETICS IN MODERN MEDICINE, P505; TANAKA K, 1978, AM J ANAT, V153, P251, DOI 10.1002/aja.1001530206; TILNEY LG, 1992, ANNU REV CELL BIOL, V8, P257, DOI 10.1146/annurev.cb.08.110192.001353; Tonikian R, 2008, PLOS BIOL, V6, P2043, DOI 10.1371/journal.pbio.0060239; WALKER RG, 1993, P NATL ACAD SCI USA, V90, P2807, DOI 10.1073/pnas.90.7.2807; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Yin HL, 2003, ANNU REV PHYSIOL, V65, P761, DOI 10.1146/annurev.physiol.65.092101.142517; Zhang DS, 2012, NATURE, V481, P520, DOI 10.1038/nature10745; Zhao HY, 2012, J NEUROSCI, V32, P4600, DOI 10.1523/JNEUROSCI.6184-11.2012	50	122	124	0	28	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAR	2013	16	3					365	374		10.1038/nn.3312	http://dx.doi.org/10.1038/nn.3312			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	097LE	23334578	Green Accepted			2022-12-28	WOS:000315474800020
J	Stassart, RM; Fledrich, R; Velanac, V; Brinkmann, BG; Schwab, MH; Meijer, D; Sereda, MW; Nave, KA				Stassart, Ruth M.; Fledrich, Robert; Velanac, Viktorija; Brinkmann, Bastian G.; Schwab, Markus H.; Meijer, Dies; Sereda, Michael W.; Nave, Klaus-Armin			A role for Schwann cell-derived neuregulin-1 in remyelination	NATURE NEUROSCIENCE			English	Article							PERIPHERAL-NERVE REGENERATION; MYELIN SHEATH THICKNESS; GROWTH; EXPRESSION; RECEPTORS; INJURY; PROLIFERATION; ENSHEATHMENT; MAINTENANCE; MECHANISMS	After peripheral nerve injury, axons regenerate and become remyelinated by resident Schwann cells. However, myelin repair never results in the original myelin thickness, suggesting insufficient stimulation by neuronal growth factors. Upon testing this hypothesis, we found that axonal neuregulin-1 NRG1) type III and, unexpectedly, also NRG1 type I restored normal myelination when overexpressed in transgenic mice. This led to the observation that Wallerian degeneration induced de novo NRG1 type I expression in Schwann cells themselves. Mutant mice lacking a functional Nrg1 gene in Schwann cells are fully myelinated but exhibit impaired remyelination in adult life. We suggest a model in which loss of axonal contact triggers denervated Schwann cells to transiently express NRG1 as an autocrine/paracrine signal that promotes Schwann cell differentiation and remyelination.	[Stassart, Ruth M.; Fledrich, Robert; Velanac, Viktorija; Brinkmann, Bastian G.; Schwab, Markus H.; Sereda, Michael W.; Nave, Klaus-Armin] Max Planck Inst Expt Med, Dept Neurogenet, D-3400 Gottingen, Germany; [Stassart, Ruth M.] Univ Gottingen, Dept Neuropathol, Gottingen, Germany; [Velanac, Viktorija] German Ctr Neurodegenerat Dis, Bonn, Germany; [Brinkmann, Bastian G.] Charite, Dept Neurosurg, D-13353 Berlin, Germany; [Meijer, Dies] Erasmus MC, Dept Genet, Rotterdam, Netherlands; [Sereda, Michael W.] Univ Gottingen, Dept Clin Neurophysiol, Gottingen, Germany	Max Planck Society; University of Gottingen; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Erasmus University Rotterdam; Erasmus MC; University of Gottingen	Sereda, MW (corresponding author), Max Planck Inst Expt Med, Dept Neurogenet, Hermann Rein Str 3, D-3400 Gottingen, Germany.	sereda@em.mpg.de; nave@em.mpg.de	Fledrich, Robert/AAF-1590-2020; Fledrich, Robert/M-1911-2019; Meijer, Dies/C-7786-2012; Stassart, Ruth M/T-7093-2019	Meijer, Dies/0000-0002-8461-6341; 	Deutsche Forschungsgemeinschaft Research Center Molecular Physiology of the Brain; European Commission [FP7-201535]; Association Francaise contre Les Myopathies [15037]; German Ministry of Education and Research (BMBF) [FKZ: 01ES0812]; Deutsche Forschungsgemeinschaft; European Research Council	Deutsche Forschungsgemeinschaft Research Center Molecular Physiology of the Brain(German Research Foundation (DFG)); European Commission(European CommissionEuropean Commission Joint Research Centre); Association Francaise contre Les Myopathies(Association Francaise contre les Myopathies); German Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); European Research Council(European Research Council (ERC)European Commission)	We thank C. Birchmeier (Max Delbruck Center, Berlin) for providing NRG1 'floxed' mice, L. Role (Stony Brook University) for providing NRG1 type III mutants, and A. Fahrenholz for help with immunohistochemistry. This work was supported by grants from Deutsche Forschungsgemeinschaft Research Center Molecular Physiology of the Brain, European Commission FP7-201535 (Ngidd) to K.-A.N. and by the Association Francaise contre Les Myopathies (15037 to M. W. S.). M. W. S. and R. F. were supported by the German Ministry of Education and Research (BMBF, FKZ: 01ES0812 to M. W. S.). M. W. S. is funded through a Deutsche Forschungsgemeinschaft Heisenberg professorship. K.-A.N. is funded through a European Research Council Advanced Investigator grant.	Atanasoski S, 2006, J NEUROSCI, V26, P2124, DOI 10.1523/JNEUROSCI.4594-05.2006; Bermingham-McDonogh O, 1997, MOL CELL NEUROSCI, V10, P184, DOI 10.1006/mcne.1997.0654; Birchmeier C, 2008, GLIA, V56, P1491, DOI 10.1002/glia.20753; Bosse F, 2012, CELL TISSUE RES, V349, P5, DOI 10.1007/s00441-012-1389-5; BROCKES JP, 1979, BRAIN RES, V165, P105, DOI 10.1016/0006-8993(79)90048-9; CAMPENOT RB, 1982, DEV BIOL, V93, P1, DOI 10.1016/0012-1606(82)90232-9; Carroll SL, 1997, J NEUROSCI, V17, P1642; Chen ZL, 2007, ANNU REV NEUROSCI, V30, P209, DOI 10.1146/annurev.neuro.30.051606.094337; Falls DL, 2003, J NEUROCYTOL, V32, P619, DOI 10.1023/B:NEUR.0000020614.83883.be; FAWCETT JW, 1990, ANNU REV NEUROSCI, V13, P43, DOI 10.1146/annurev.neuro.13.1.43; Fricker FR, 2011, FUTUR NEUROL, V6, P809, DOI 10.2217/FNL.11.45; Fricker FR, 2011, J NEUROSCI, V31, P3225, DOI 10.1523/JNEUROSCI.2568-10.2011; Ghazvini M, 2002, EMBO J, V21, P4612, DOI 10.1093/emboj/cdf475; Hoke A, 2006, NAT CLIN PRACT NEURO, V2, P448, DOI 10.1038/ncpneuro0262; Inserra MM, 1998, MICROSURG, V18, P119, DOI 10.1002/(SICI)1098-2752(1998)18:2<119::AID-MICR10>3.3.CO;2-Z; Jaegle M, 2003, GENE DEV, V17, P1380, DOI 10.1101/gad.258203; Jessen KR, 2005, NAT REV NEUROSCI, V6, P671, DOI 10.1038/nrn1746; Jessen KR, 2008, GLIA, V56, P1552, DOI 10.1002/glia.20761; Kleitman N., 1998, CULTURING NERVE CELL, P545; Li L, 2002, ONCOGENE, V21, P4900, DOI 10.1038/sj.onc.1205634; Loeb JA, 1999, DEVELOPMENT, V126, P781; Michailov GV, 2004, SCIENCE, V304, P700, DOI 10.1126/science.1095862; Mirsky R, 2008, J PERIPHER NERV SYST, V13, P122, DOI 10.1111/j.1529-8027.2008.00168.x; Myers RR, 2003, EXP NEUROL, V184, P606, DOI 10.1016/S0014-4886(03)00297-8; Napoli I, 2012, NEURON, V73, P729, DOI 10.1016/j.neuron.2011.11.031; Nave KA, 2010, NATURE, V468, P244, DOI 10.1038/nature09614; Navel KA, 2006, CURR OPIN NEUROBIOL, V16, P492, DOI 10.1016/j.conb.2006.08.008; Pertusa M, 2007, J BIOL CHEM, V282, P28768, DOI 10.1074/jbc.M701878200; Rosenbaum C, 1997, EXP NEUROL, V148, P604, DOI 10.1006/exnr.1997.6696; SCHRODER JM, 1972, BRAIN RES, V45, P49, DOI 10.1016/0006-8993(72)90215-6; Sherman DL, 2005, NAT REV NEUROSCI, V6, P683, DOI 10.1038/nrn1743; Spiegel I, 2007, NAT NEUROSCI, V10, P861, DOI 10.1038/nn1915; Stonecypher MS, 2006, J NEUROPATH EXP NEUR, V65, P162, DOI 10.1097/01.jnen.0000199575.93794.2f; Taveggia C, 2005, NEURON, V47, P681, DOI 10.1016/j.neuron.2005.08.017; Taveggia C, 2010, NAT REV NEUROL, V6, P276, DOI 10.1038/nrneurol.2010.37; Velanac V, 2012, GLIA, V60, P203, DOI 10.1002/glia.21255; WELCHER AA, 1991, PHILOS T R SOC B, V331, P295, DOI 10.1098/rstb.1991.0020; Wolpowitz D, 2000, NEURON, V25, P79, DOI 10.1016/S0896-6273(00)80873-9	38	178	187	0	51	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JAN	2013	16	1					48	U76		10.1038/nn.3281	http://dx.doi.org/10.1038/nn.3281			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	058KZ	23222914				2022-12-28	WOS:000312633900012
J	Margolis, DJ; Lutcke, H; Schulz, K; Haiss, F; Weber, B; Kugler, S; Hasan, MT; Helmchen, F				Margolis, David J.; Luetcke, Henry; Schulz, Kristina; Haiss, Florent; Weber, Bruno; Kuegler, Sebastian; Hasan, Mazahir T.; Helmchen, Fritjof			Reorganization of cortical population activity imaged throughout long-term sensory deprivation	NATURE NEUROSCIENCE			English	Article							EXPERIENCE-DEPENDENT PLASTICITY; ENCODED CALCIUM INDICATOR; BARREL CORTEX; IN-VIVO; FUNCTIONAL-ORGANIZATION; SYNAPTIC MECHANISMS; INHIBITORY NEURONS; PYRAMIDAL CELLS; NEURAL ACTIVITY; VISUAL-CORTEX	Sensory maps are reshaped by experience. It is unknown how map plasticity occurs in vivo in functionally diverse neuronal populations because activity of the same cells has not been tracked over long time periods. Here we used repeated two-photon imaging of a genetic calcium indicator to measure whisker-evoked responsiveness of the same layer 2/3 neurons in adult mouse barrel cortex over weeks, first with whiskers intact, then during continued trimming of all but one whisker. Across the baseline period, neurons displayed heterogeneous yet stable responsiveness. During sensory deprivation, responses to trimmed whisker stimulation globally decreased, whereas responses to spared whisker stimulation increased for the least active neurons and decreased for the most active neurons. These findings suggest that recruitment of inactive, 'silent' neurons is part of a convergent redistribution of population activity underlying sensory map plasticity. Sensory-driven responsiveness is a key property controlling experience-dependent activity changes in individual neurons.	[Margolis, David J.; Luetcke, Henry; Schulz, Kristina; Helmchen, Fritjof] Univ Zurich, Brain Res Inst, Zurich, Switzerland; [Margolis, David J.; Schulz, Kristina; Weber, Bruno; Helmchen, Fritjof] Univ Zurich, Neurosci Ctr Zurich, Zurich, Switzerland; [Margolis, David J.; Schulz, Kristina; Weber, Bruno; Helmchen, Fritjof] Swiss Fed Inst Technol, Zurich, Switzerland; [Haiss, Florent; Weber, Bruno] Univ Zurich, Inst Pharmacol & Toxicol, Zurich, Switzerland; [Kuegler, Sebastian] Univ Med Gottingen, Dept Neurol, Ctr Mol Physiol Brain, Gottingen, Germany; [Hasan, Mazahir T.] Max Planck Inst Med Res, Heidelberg, Germany	University of Zurich; University of Zurich; Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Zurich; University of Gottingen; Max Planck Society	Helmchen, F (corresponding author), Univ Zurich, Brain Res Inst, Zurich, Switzerland.	helmchen@hifo.uzh.ch	Weber, Bruno/E-4400-2013; Haiss, Florent/L-1685-2015; Lütcke, Henry/J-7021-2012; Hasan, Mazahir/L-3679-2017; Helmchen, Fritjof/A-6255-2008	Haiss, Florent/0000-0001-8351-3685; Hasan, Mazahir/0000-0001-9985-7271; Lutcke, Henry/0000-0001-7225-4374; Helmchen, Fritjof/0000-0002-8867-9569	AMBIZIONE from the Swiss National Science Foundation (SNSF); German Academic Exchange Service (DAAD); SNSF [3100A0-114624]; EU [223524, 243914]; Swiss SystemsX.ch initiative; Max Planck Society; Fritz Thyssen Stiftung	AMBIZIONE from the Swiss National Science Foundation (SNSF)(Swiss National Science Foundation (SNSF)); German Academic Exchange Service (DAAD)(Deutscher Akademischer Austausch Dienst (DAAD)); SNSF(Swiss National Science Foundation (SNSF)); EU(European Commission); Swiss SystemsX.ch initiative; Max Planck Society(Max Planck SocietyFoundation CELLEX); Fritz Thyssen Stiftung	We thank H. Kasper, S. Giger and D. Gockeritz for technical assistance and A. Holtmaat, B. Gahwiler, M. Schwab, M. Thallmair and V. Planchamp for comments on an earlier version of the manuscript. This work was supported by an AMBIZIONE grant from the Swiss National Science Foundation (SNSF) to D.J.M.; a postdoctoral fellowship from the German Academic Exchange Service (DAAD) to H.L.; an SNSF grant to F. Helmchen (3100A0-114624); the EU-FP7 program (PLASTICISE project 223524 to F. Helmchen, and BRAIN-I-NETS project 243914 to F. Helmchen and F. Haiss); a grant from the Swiss SystemsX.ch initiative (project 2008/2011-Neurochoice) to F. Helmchen and B.W.; and the Max Planck Society and the Fritz Thyssen Stiftung (M.T.H.).	Andermann ML, 2010, FRONT CELL NEUROSCI, V4, DOI 10.3389/fncel.2010.00003; Barth AL, 2012, TRENDS NEUROSCI, V35, P345, DOI 10.1016/j.tins.2012.03.008; Brecht M, 2003, J PHYSIOL-LONDON, V553, P243, DOI 10.1113/jphysiol.2003.044222; Brecht Michael, 2005, P1; Buonomano DV, 1998, ANNU REV NEUROSCI, V21, P149, DOI 10.1146/annurev.neuro.21.1.149; Celikel T, 2004, NAT NEUROSCI, V7, P534, DOI 10.1038/nn1222; Cheetham CEJ, 2008, J NEUROSCI, V28, P9249, DOI 10.1523/JNEUROSCI.2974-08.2008; Cheetham CEJ, 2007, J NEUROSCI, V27, P3456, DOI 10.1523/JNEUROSCI.5143-06.2007; Clem RL, 2008, SCIENCE, V319, P101, DOI 10.1126/science.1143808; Crochet S, 2006, NAT NEUROSCI, V9, P608, DOI 10.1038/nn1690; Crochet S, 2011, NEURON, V69, P1160, DOI 10.1016/j.neuron.2011.02.022; DIAMOND ME, 1994, SCIENCE, V265, P1885, DOI 10.1126/science.8091215; DIAMOND ME, 1993, P NATL ACAD SCI USA, V90, P2082, DOI 10.1073/pnas.90.5.2082; Feldman DE, 2009, ANNU REV NEUROSCI, V32, P33, DOI 10.1146/annurev.neuro.051508.135516; Feldman DE, 2005, SCIENCE, V310, P810, DOI 10.1126/science.1115807; Fox K, 2002, NEUROSCIENCE, V111, P799, DOI 10.1016/S0306-4522(02)00027-1; Gandhi SP, 2008, P NATL ACAD SCI USA, V105, P16797, DOI 10.1073/pnas.0806159105; Gentet LJ, 2012, NAT NEUROSCI, V15, P607, DOI 10.1038/nn.3051; Glazewski S, 1996, SCIENCE, V272, P421, DOI 10.1126/science.272.5260.421; Glazewski S, 2000, NAT NEUROSCI, V3, P911, DOI 10.1038/78820; Glazewski S, 1996, J NEUROPHYSIOL, V75, P1714, DOI 10.1152/jn.1996.75.4.1714; Hebb D.O., 1949, ORG BEHAV NEUROPSYCH; Hofer SB, 2011, NAT NEUROSCI, V14, P1045, DOI 10.1038/nn.2876; Holtmaat A, 2009, NAT PROTOC, V4, P1128, DOI 10.1038/nprot.2009.89; Huber D, 2012, NATURE, V484, P473, DOI 10.1038/nature11039; Hubener M, 2010, NEURON, V67, P363, DOI 10.1016/j.neuron.2010.06.033; Jacob V, 2012, NEURON, V73, P391, DOI 10.1016/j.neuron.2011.11.034; Kerr JND, 2007, J NEUROSCI, V27, P13316, DOI 10.1523/JNEUROSCI.2210-07.2007; Lefort S, 2009, NEURON, V61, P301, DOI 10.1016/j.neuron.2008.12.020; Lutcke H, 2010, FRONT NEURAL CIRCUIT, V4, DOI 10.3389/fncir.2010.00009; Mank M, 2008, NAT METHODS, V5, P805, DOI 10.1038/NMETH.1243; Minderer M, 2012, J PHYSIOL-LONDON, V590, P99, DOI 10.1113/jphysiol.2011.219014; Mrsic-Flogel TD, 2007, NEURON, V54, P961, DOI 10.1016/j.neuron.2007.05.028; Nagai T, 2004, P NATL ACAD SCI USA, V101, P10554, DOI 10.1073/pnas.0400417101; Nelson SB, 2008, NEURON, V60, P477, DOI 10.1016/j.neuron.2008.10.020; O'Connor DH, 2010, NEURON, V67, P1048, DOI 10.1016/j.neuron.2010.08.026; Oberlaender M, 2012, NEURON, V74, P648, DOI 10.1016/j.neuron.2012.03.022; Petersen CCH, 2007, NEURON, V56, P339, DOI 10.1016/j.neuron.2007.09.017; Polley DB, 1999, NEURON, V24, P623, DOI 10.1016/S0896-6273(00)81117-4; Rothschild G, 2010, NAT NEUROSCI, V13, P353, DOI 10.1038/nn.2484; Sato TR, 2007, PLOS BIOL, V5, P1440, DOI 10.1371/journal.pbio.0050189; Shoham S, 2006, J COMP PHYSIOL A, V192, P777, DOI 10.1007/s00359-006-0117-6; SIMONS DJ, 1987, NATURE, V326, P694, DOI 10.1038/326694a0; Tian L, 2009, NAT METHODS, V6, P875, DOI 10.1038/nmeth.1398; Turrigiano GG, 2000, CURR OPIN NEUROBIOL, V10, P358, DOI 10.1016/S0959-4388(00)00091-X; Wallace DJ, 2008, NAT METHODS, V5, P797, DOI 10.1038/NMETH.1242; Wen JA, 2011, J NEUROSCI, V31, P4456, DOI 10.1523/JNEUROSCI.6042-10.2011; Yamada Y, 2011, FRONT CELL NEUROSCI, V5, DOI 10.3389/fncel.2011.00018; Yassin L, 2010, NEURON, V68, P1043, DOI 10.1016/j.neuron.2010.11.029; Yazaki-Sugiyama Y, 2009, NATURE, V462, P218, DOI 10.1038/nature08485	50	137	138	0	53	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	NOV	2012	15	11					1539	1546		10.1038/nn.3240	http://dx.doi.org/10.1038/nn.3240			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	028LX	23086335				2022-12-28	WOS:000310424900014
J	Kurita, M; Holloway, T; Garcia-Bea, A; Kozlenkov, A; Friedman, AK; Moreno, JL; Heshmati, M; Golden, SA; Kennedy, PJ; Takahashi, N; Dietz, DM; Mocci, G; Gabilondo, AM; Hanks, J; Umali, A; Callado, LF; Gallitano, AL; Neve, RL; Shen, L; Buxbaum, JD; Han, MH; Nestler, EJ; Meana, JJ; Russo, SJ; Gonzalez-Maeso, J				Kurita, Mitsumasa; Holloway, Terrell; Garcia-Bea, Aintzane; Kozlenkov, Alexey; Friedman, Allyson K.; Moreno, Jose L.; Heshmati, Mitra; Golden, Sam A.; Kennedy, Pamela J.; Takahashi, Nagahide; Dietz, David M.; Mocci, Giuseppe; Gabilondo, Ane M.; Hanks, James; Umali, Adrienne; Callado, Luis F.; Gallitano, Amelia L.; Neve, Rachael L.; Shen, Li; Buxbaum, Joseph D.; Han, Ming-Hu; Nestler, Eric J.; Meana, J. Javier; Russo, Scott J.; Gonzalez-Maeso, Javier			HDAC2 regulates atypical antipsychotic responses through the modulation of mGlu2 promoter activity	NATURE NEUROSCIENCE			English	Article							HISTONE DEACETYLASE; RECEPTOR AGONIST; ANIMAL-MODELS; SCHIZOPHRENIA; GLUTAMATE; ACTIVATION; CLOZAPINE; BRAIN; PHARMACOLOGY; DIVALPROEX	Histone deacetylases (HDACs) compact chromatin structure and repress gene transcription. In schizophrenia, clinical studies demonstrate that HDAC inhibitors are efficacious when given in combination with atypical antipsychotics. However, the molecular mechanism that integrates a better response to antipsychotics with changes in chromatin structure remains unknown. Here we found that chronic atypical antipsychotics downregulated the transcription of metabotropic glutamate 2 receptor (mGlu2, also known as Grm2), an effect that was associated with decreased histone acetylation at its promoter in mouse and human frontal cortex. This epigenetic change occurred in concert with a serotonin 5-HT2A receptor-dependent upregulation and increased binding of HDAC2 to the mGlu2 promoter. Virally mediated overexpression of HDAC2 in frontal cortex decreased mGlu2 transcription and its electrophysiological properties, thereby increasing psychosis-like behavior. Conversely, HDAC inhibitors prevented the repressive histone modifications induced at the mGlu2 promoter by atypical antipsychotics, and augmented their therapeutic-like effects. These observations support the view of HDAC2 as a promising new target for schizophrenia treatment.	[Kurita, Mitsumasa; Holloway, Terrell; Garcia-Bea, Aintzane; Kozlenkov, Alexey; Moreno, Jose L.; Heshmati, Mitra; Takahashi, Nagahide; Mocci, Giuseppe; Hanks, James; Umali, Adrienne; Buxbaum, Joseph D.; Nestler, Eric J.; Gonzalez-Maeso, Javier] Mt Sinai Sch Med, Dept Psychiat, New York, NY 10029 USA; [Garcia-Bea, Aintzane; Gabilondo, Ane M.; Callado, Luis F.; Meana, J. Javier] Univ Basque Country UPV EHU, Dept Pharmacol, Leioa, Spain; [Garcia-Bea, Aintzane; Gabilondo, Ane M.; Callado, Luis F.; Meana, J. Javier] Ctr Invest Biomed Red Salud Mental CIBERSAM, Leioa, Spain; [Friedman, Allyson K.; Han, Ming-Hu; Nestler, Eric J.] Mt Sinai Sch Med, Dept Pharmacol & Syst Therapeut, New York, NY USA; [Golden, Sam A.; Kennedy, Pamela J.; Dietz, David M.; Han, Ming-Hu; Nestler, Eric J.] Mt Sinai Sch Med, Dept Neurosci, New York, NY USA; [Gallitano, Amelia L.] Univ Arizona, Coll Med, Dept Basic Med Sci, Phoenix, AZ USA; [Gallitano, Amelia L.] Univ Arizona, Coll Med, Dept Psychiat, Phoenix, AZ USA; [Neve, Rachael L.] MIT, Dept Brain & Cognit Sci, Cambridge, MA 02139 USA; [Buxbaum, Joseph D.] Mt Sinai Sch Med, Dept Genet & Genom Sci, New York, NY USA; [Buxbaum, Joseph D.; Han, Ming-Hu; Nestler, Eric J.; Russo, Scott J.; Gonzalez-Maeso, Javier] Mt Sinai Sch Med, Friedman Brain Inst, New York, NY USA; [Gonzalez-Maeso, Javier] Mt Sinai Sch Med, Dept Neurol, New York, NY USA	Icahn School of Medicine at Mount Sinai; University of Basque Country; CIBER - Centro de Investigacion Biomedica en Red; CIBERSAM; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; University of Arizona; University of Arizona; Massachusetts Institute of Technology (MIT); Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai	Gonzalez-Maeso, J (corresponding author), Mt Sinai Sch Med, Dept Psychiat, New York, NY 10029 USA.	javier.maeso@mssm.edu	Gabilondo, Ane M./C-4417-2015; Russo, Scott/R-7107-2019; Dietz, David/AAW-4574-2021; Dietz, David/J-9458-2015; Moreno, Jose L/L-8981-2017; Gallitano, Amelia L./C-5591-2014; Shen, Li/B-3562-2008; Callado, Luis F./A-7024-2008; Buxbaum, Joseph D/G-6001-2010; Han, Ming-Hu/G-8836-2012; Takahashi, Nagahide/AAR-6268-2020	Gabilondo, Ane M./0000-0002-1892-3861; Russo, Scott/0000-0002-6470-1805; Dietz, David/0000-0002-6927-9236; Dietz, David/0000-0002-6927-9236; Gallitano, Amelia L./0000-0002-0544-7114; Shen, Li/0000-0002-5190-2851; Callado, Luis F./0000-0001-9941-012X; Takahashi, Nagahide/0000-0002-7711-0297; Golden, Sam/0000-0002-2104-2272; CALLADO HERNANDO, LUIS FELIPE/0000-0002-5564-3447; Buxbaum, Joseph/0000-0001-8898-8313; MEANA, JOSE JAVIER/0000-0002-7913-6714	US National Institutes of Health (NIH) [R01 MH084894]; Dainippon Sumitomo Pharma; NARSAD; Maltz Family Foundation; NIH [R01 MH090264, P50 MH090963, R01 MH092306, P50 MH066392, F32 MH096464]; MICINN [SAF2009-084609]; Basque Government [IT-199-07]; Ministerio de Ciencia e Innovacion; Consejo Superior de Investigaciones Cientificas (CSIC), Spain; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR029887] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH090963, R01MH084894, F32MH096464, T32MH087004, U01MH083545, R01MH090264, P50MH066392, P50MH096890, R01MH092306] Funding Source: NIH RePORTER	US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Dainippon Sumitomo Pharma(Dainippon Sumitomo Pharma Co., Ltd.); NARSAD(NARSAD); Maltz Family Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); MICINN(Ministry of Science and Innovation, Spain (MICINN)Spanish GovernmentEuropean Commission); Basque Government(Basque Government); Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Consejo Superior de Investigaciones Cientificas (CSIC), Spain; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	The authors would like to thank A. Chess, Y. Hurd, C. Alberini, P. Bos and J. Greally for critical review of the manuscript; M. Shapiro for help in working memory experiments; S. Morgello (Mount Sinai School of Medicine) and the Manhattan HIV Brain Bank for providing control brain cortex; P. Casaccia (Mount Sinai School of Medicine) for discussions and for providing the plasmid encoding mouse HDAC2; J. Gingrich (Columbia University) for his gift of 5HT2A<SUP>-/-</SUP> mice; V. Rayannavar for assistance with biochemical and behavioral assays; and the staff members of the Basque Institute of Legal Medicine for their cooperation in the study. US National Institutes of Health (NIH) R01 MH084894 (J.G.-M.), Dainippon Sumitomo Pharma (J.G.-M.), NARSAD (J.G.-M.), the Maltz Family Foundation (J.G.-M.), NIH R01 MH090264 (S. J. R.), MICINN SAF2009-084609 (J. J. M.), the Basque Government IT-199-07 (J. J. M.), NIH P50 MH090963 (E.J.N.), NIH R01 MH092306 (M.-H. H.) and NIH P50 MH066392 (J. D. B.) helped fund this study. A. K. F. was supported by NIH grant F32 MH096464. A.G.-B., J. L. M. and G. M. were recipients of predoctoral and postdoctoral fellowships from the Basque government, Ministerio de Ciencia e Innovacion, and Consejo Superior de Investigaciones Cientificas (CSIC), Spain.	Abdolmaleky HM, 2011, SCHIZOPHR RES, V129, P183, DOI 10.1016/j.schres.2011.04.007; Abe T, 2008, CURR OPIN PHARMACOL, V8, P57, DOI 10.1016/j.coph.2007.12.002; Aghajanian GK, 2009, PSYCHOPHARMACOLOGY, V206, P575, DOI 10.1007/s00213-009-1484-9; Agid O, 2003, ARCH GEN PSYCHIAT, V60, P1228, DOI 10.1001/archpsyc.60.12.1228; American Psychiatric Association, 2000, DSM 4 DIAGN STAT MAN, V4th ed., DOI DOI 10.1001/JAMA.1994.03520100096; Arrowsmith CH, 2012, NAT REV DRUG DISCOV, V11, P384, DOI 10.1038/nrd3674; Benneyworth MA, 2007, MOL PHARMACOL, V72, P477, DOI 10.1124/mol.107.035170; Borrelli E, 2008, NEURON, V60, P961, DOI 10.1016/j.neuron.2008.10.012; Cao JL, 2010, J NEUROSCI, V30, P16453, DOI 10.1523/JNEUROSCI.3177-10.2010; Chiechio S, 2009, MOL PHARMACOL, V75, P1014, DOI 10.1124/mol.108.054346; Citrome L, 2004, PSYCHIAT SERV, V55, P290, DOI 10.1176/appi.ps.55.3.290; Darcy MJ, 2010, J COMP NEUROL, V518, P722, DOI 10.1002/cne.22241; Deacon RMJ, 2006, NAT PROTOC, V1, P7, DOI 10.1038/nprot.2006.2; Dean B, 2003, J NEUROCHEM, V85, P1, DOI 10.1046/j.1471-4159.2003.01693.x; Dobbs D, 2010, NATURE, V468, P154, DOI 10.1038/468154a; Dong E, 2008, P NATL ACAD SCI USA, V105, P13614, DOI 10.1073/pnas.0805493105; Dong E, 2007, P NATL ACAD SCI USA, V104, P4676, DOI 10.1073/pnas.0700529104; Egan MF, 2004, P NATL ACAD SCI USA, V101, P12604, DOI 10.1073/pnas.0405077101; Fell MJ, 2008, J PHARMACOL EXP THER, V326, P209, DOI 10.1124/jpet.108.136861; Fribourg M, 2011, CELL, V147, P1011, DOI 10.1016/j.cell.2011.09.055; Geyer MA, 2008, TRENDS PHARMACOL SCI, V29, P445, DOI 10.1016/j.tips.2008.06.006; GOLDBERG TE, 1993, BRIT J PSYCHIAT, V162, P43, DOI 10.1192/bjp.162.1.43; Gonzalez-Maeso J, 2003, J NEUROSCI, V23, P8836; Gonzalez-Maeso J, 2002, MOL PSYCHIATR, V7, P755, DOI 10.1038/sj.mp.4001067; Gonzalez-Maeso J, 2008, NATURE, V452, P93, DOI 10.1038/nature06612; Gonzalez-Maeso J, 2007, NEURON, V53, P439, DOI 10.1016/j.neuron.2007.01.008; Gonzalez-Maeso J, 2009, TRENDS NEUROSCI, V32, P225, DOI 10.1016/j.tins.2008.12.005; Graff J, 2012, NATURE, V483, P222, DOI 10.1038/nature10849; Guan JS, 2009, NATURE, V459, P55, DOI 10.1038/nature07925; Gurvich N, 2004, CANCER RES, V64, P1079, DOI 10.1158/0008-5472.CAN-03-0799; Hof PR., 2000, COMP CYTOARCHITECTON; Huang HS, 2006, J NEUROSCI METH, V156, P284, DOI 10.1016/j.jneumeth.2006.02.018; Humphrey GW, 2008, DIFFERENTIATION, V76, P348, DOI 10.1111/j.1432-0436.2007.00232.x; Kelly DL, 2006, PSYCHIAT QUART, V77, P81, DOI 10.1007/s11126-006-7963-9; Kristiansen LV, 2007, CURR OPIN PHARMACOL, V7, P48, DOI 10.1016/j.coph.2006.08.013; Lieberman JA, 2005, NEW ENGL J MED, V353, P1209, DOI 10.1056/NEJMoa051688; Liu W, 2012, PHARMACOGENOMICS J, V12, P246, DOI 10.1038/tpj.2010.90; Loscher W, 1999, PROG NEUROBIOL, V58, P31, DOI 10.1016/S0301-0082(98)00075-6; Ludewig K, 2003, BIOL PSYCHIAT, V54, P121, DOI 10.1016/S0006-3223(02)01925-X; Marder E, 2011, NAT NEUROSCI, V14, P133, DOI 10.1038/nn.2735; MARTIN WR, 1963, PSYCHOPHARMACOLOGIA, V4, P247, DOI 10.1007/BF00408180; Matrisciano F, 2012, NEUROPSYCHOPHARMACOL, V37, P929, DOI 10.1038/npp.2011.274; Miyamoto S, 2005, MOL PSYCHIATR, V10, P79, DOI 10.1038/sj.mp.4001556; Moreno JL, 2011, J NEUROSCI, V31, P1863, DOI 10.1523/JNEUROSCI.4230-10.2011; Moreno JL, 2009, CELL MOL LIFE SCI, V66, P3777, DOI 10.1007/s00018-009-0130-3; Nestler EJ, 2010, NAT NEUROSCI, V13, P1161, DOI 10.1038/nn.2647; Patil ST, 2007, NAT MED, V13, P1102, DOI 10.1038/nm1632; Peter CJ, 2011, TRENDS MOL MED, V17, P372, DOI 10.1016/j.molmed.2011.02.003; Sawa A, 2002, SCIENCE, V296, P692, DOI 10.1126/science.1070532; SHAFFER JP, 1995, ANNU REV PSYCHOL, V46, P561, DOI 10.1146/annurev.ps.46.020195.003021; Stan AD, 2006, BRAIN RES, V1123, P1, DOI 10.1016/j.brainres.2006.09.025; Suzuki T, 2009, HUM PSYCHOPHARM CLIN, V24, P628, DOI 10.1002/hup.1073; Tamaru Y, 2001, NEUROSCIENCE, V106, P481, DOI 10.1016/S0306-4522(01)00305-0; Tsankova N, 2007, NAT REV NEUROSCI, V8, P355, DOI 10.1038/nrn2132; Tsankova NM, 2006, NAT NEUROSCI, V9, P519, DOI 10.1038/nn1659; Van Sant SP, 2011, EXPERT OPIN PHARMACO, V12, P411, DOI 10.1517/14656566.2011.528200; Vollenweider FX, 1998, NEUROREPORT, V9, P3897, DOI 10.1097/00001756-199812010-00024; Woolley ML, 2008, PSYCHOPHARMACOLOGY, V196, P431, DOI 10.1007/s00213-007-0974-x; Zhai Y, 2003, NEUROPSYCHOPHARMACOL, V28, P45, DOI 10.1038/sj.npp.1300013	60	195	218	0	44	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	SEP	2012	15	9					1245	U109		10.1038/nn.3181	http://dx.doi.org/10.1038/nn.3181			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	996GJ	22864611	Green Accepted			2022-12-28	WOS:000308072600015
J	Owald, D; Khorramshahi, O; Gupta, VK; Banovic, D; Depner, H; Fouquet, W; Wichmann, C; Mertel, S; Eimer, S; Reynolds, E; Holt, M; Aberle, H; Sigrist, SJ				Owald, David; Khorramshahi, Omid; Gupta, Varun K.; Banovic, Daniel; Depner, Harald; Fouquet, Wernher; Wichmann, Carolin; Mertel, Sara; Eimer, Stefan; Reynolds, Eric; Holt, Matthew; Aberle, Hermann; Sigrist, Stephan J.			Cooperation of Syd-1 with Neurexin synchronizes pre- with postsynaptic assembly	NATURE NEUROSCIENCE			English	Article							PRESYNAPTIC ACTIVE ZONE; LIPRIN-ALPHA; C. ELEGANS; NEUROMUSCULAR-JUNCTIONS; GLUTAMATE RECEPTORS; SYNAPSE MATURATION; AMPA RECEPTORS; IN-VIVO; DROSOPHILA; NEUROLIGIN	Synapse formation and maturation requires bidirectional communication across the synaptic cleft. The trans-synaptic Neurexin-Neuroligin complex can bridge this cleft, and severe synapse assembly deficits are found in Drosophila melanogaster neuroligin (Nlg1, dnlg1) and neurexin (Nrx-1, dnrx) mutants. We show that the presynaptic active zone protein Syd-1 interacts with Nrx-1 to control synapse formation at the Drosophila neuromuscular junction. Mutants in Syd-1 (RhoGAP100F, dsyd-1), Nrx-1 and Nlg1 shared active zone cytomatrix defects, which were nonadditive. Syd-1 and Nrx-1 formed a complex in vivo, and Syd-1 was important for synaptic clustering and immobilization of Nrx-1. Consequently, postsynaptic clustering of Nlg1 was affected in Syd-1 mutants, and in vivo glutamate receptor incorporation was changed in Syd-1, Nrx-1 and Nlg1 mutants. Stabilization of nascent Syd-1-Liprin-alpha (DLiprin-alpha) clusters, important to initialize active zone formation, was Nlg1 dependent. Thus, cooperation between Syd-1 and Nrx-1-Nlg1 seems to orchestrate early assembly processes between pre- and postsynaptic membranes, promoting avidity of newly forming synaptic scaffolds.	[Owald, David; Khorramshahi, Omid; Gupta, Varun K.; Depner, Harald; Fouquet, Wernher; Wichmann, Carolin; Mertel, Sara; Reynolds, Eric; Holt, Matthew; Sigrist, Stephan J.] Free Univ Berlin, Inst Biol Genet, Berlin, Germany; [Owald, David; Khorramshahi, Omid; Gupta, Varun K.; Mertel, Sara; Reynolds, Eric; Sigrist, Stephan J.] Charite, D-13353 Berlin, Germany; [Banovic, Daniel; Aberle, Hermann] Univ Munster, Inst Neurobiol, Munster, Germany; [Banovic, Daniel; Aberle, Hermann] Univ Dusseldorf, Funct Cell Morphol Lab, D-40225 Dusseldorf, Germany; [Eimer, Stefan] European Neurosci Inst, Gottingen, Germany; [Holt, Matthew] VIB Ctr Biol Dis, Louvain, Belgium	Free University of Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Munster; Heinrich Heine University Dusseldorf; Flanders Institute for Biotechnology (VIB)	Sigrist, SJ (corresponding author), Free Univ Berlin, Inst Biol Genet, Berlin, Germany.	stephan.sigrist@fu-berlin.de	Gupta, Varun/ABE-1876-2020; Eimer, Stefan/B-1865-2013; Aberle, Hermann/L-8461-2017; Owald, David/ABB-5432-2020; Holt, Matthew/AAJ-1813-2020	Aberle, Hermann/0000-0002-4864-6105; Holt, Matthew/0000-0002-8958-4027; Owald, David/0000-0001-7747-7884	Deutsche Forschungsgemeinschaft [Exc 257, SI849/2-1, SI849/2-2, TP A16/SFB 551, TP B23/SFB581, TP A3, A6/SFB 958, AB 116/3-2]; European Research Council	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); European Research Council(European Research Council (ERC)European Commission)	We would like to thank C. Quentin and A. Stawrakakis for excellent technical assistance and R. Jahn for the use of equipment. T. Andlauer and U. Thomas critically read the manuscript. We further thank M. Bhat (University of North Carolina) and W. Xie (Southeast University, Nanjing) for generously sharing reagents. This work was supported by grants from the Deutsche Forschungsgemeinschaft to S.J.S. (Exc 257, SI849/2-1 and 2-2, TP A16/SFB 551, TP B23/SFB581, TP A3 and A6/SFB 958) and H. A. (AB 116/3-2). M. H. is funded by a European Research Council Starting Grant (Astrofunc).	Aberle H, 2002, NEURON, V33, P545, DOI 10.1016/S0896-6273(02)00589-5; Banovic D, 2010, NEURON, V66, P724, DOI 10.1016/j.neuron.2010.05.020; Chia PH, 2012, NAT NEUROSCI, V15, P234, DOI 10.1038/nn.2991; Collins CA, 2007, CURR OPIN NEUROBIOL, V17, P35, DOI 10.1016/j.conb.2007.01.001; Dai Y, 2006, NAT NEUROSCI, V9, P1479, DOI 10.1038/nn1808; Fairless R, 2008, J NEUROSCI, V28, P12969, DOI 10.1523/JNEUROSCI.5294-07.2008; Fejtova Anna, 2006, V43, P49, DOI 10.1007/012; Fouquet W, 2009, J CELL BIOL, V186, P129, DOI 10.1083/jcb.200812150; Futai K, 2007, NAT NEUROSCI, V10, P186, DOI 10.1038/nn1837; Graf ER, 2004, CELL, V119, P1013, DOI 10.1016/j.cell.2004.11.035; GUARENTE L, 1983, METHOD ENZYMOL, V101, P181; Hallermann S, 2010, J NEUROSCI, V30, P14340, DOI 10.1523/JNEUROSCI.2495-10.2010; Heine M, 2008, P NATL ACAD SCI USA, V105, P20947, DOI 10.1073/pnas.0804007106; Hell SW, 2007, SCIENCE, V316, P1153, DOI 10.1126/science.1137395; HUTTNER WB, 1983, J CELL BIOL, V96, P1374, DOI 10.1083/jcb.96.5.1374; Jamain S, 2008, P NATL ACAD SCI USA, V105, P1710, DOI 10.1073/pnas.0711555105; Jin Y, 2008, ANNU REV CELL DEV BI, V24, P237, DOI 10.1146/annurev.cellbio.23.090506.123417; Johnson EL, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000193; Kaufmann N, 2002, NEURON, V34, P27, DOI 10.1016/S0896-6273(02)00643-8; Kittel RJ, 2006, SCIENCE, V312, P1051, DOI 10.1126/science.1126308; Lenfant N, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-671; Li J, 2007, NEURON, V55, P741, DOI 10.1016/j.neuron.2007.08.002; Lise MF, 2006, CELL MOL LIFE SCI, V63, P1833, DOI 10.1007/s00018-006-6061-3; Marrus SB, 2004, CURR BIOL, V14, P924, DOI 10.1016/j.cub.2004.05.047; Miller KE, 2005, CURR BIOL, V15, P684, DOI 10.1016/j.cub.2005.02.061; Mondin M, 2011, J NEUROSCI, V31, P13500, DOI 10.1523/JNEUROSCI.6439-10.2011; Nieratschker V, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000700; Owald D, 2010, J CELL BIOL, V188, P565, DOI 10.1083/jcb.200908055; Owald D, 2009, CURR OPIN NEUROBIOL, V19, P311, DOI 10.1016/j.conb.2009.03.003; Patel MR, 2006, NAT NEUROSCI, V9, P1488, DOI 10.1038/nn1806; Patel MR, 2009, SCIENCE, V323, P1500, DOI 10.1126/science.1169025; Rasse TM, 2005, NAT NEUROSCI, V8, P898, DOI 10.1038/nn1484; Scheiffele P, 2000, CELL, V101, P657, DOI 10.1016/S0092-8674(00)80877-6; Schmid A, 2008, NAT NEUROSCI, V11, P659, DOI 10.1038/nn.2122; Schmid A, 2006, J NEUROSCI, V26, P11267, DOI 10.1523/JNEUROSCI.2722-06.2006; Sigrist SJ, 2002, J NEUROSCI, V22, P7362; Spangler SA, 2007, BIOCHEM SOC T, V35, P1278, DOI 10.1042/BST0351278; Sudhof TC, 2008, NATURE, V455, P903, DOI 10.1038/nature07456; Sun MK, 2011, J NEUROSCI, V31, P687, DOI 10.1523/JNEUROSCI.3854-10.2011; Sun MK, 2009, NEUROSCI RES, V64, P362, DOI 10.1016/j.neures.2009.04.009; Swan LE, 2006, EMBO J, V25, P3640, DOI 10.1038/sj.emboj.7601216; Taru H, 2011, J NEUROSCI, V31, P16261, DOI 10.1523/JNEUROSCI.0002-11.2011; van Roessel P, 2004, CELL, V119, P707, DOI 10.1016/j.cell.2004.11.028; Varoqueaux F, 2006, NEURON, V51, P741, DOI 10.1016/j.neuron.2006.09.003; Wei ZY, 2011, MOL CELL, V43, P586, DOI 10.1016/j.molcel.2011.07.021; Wittenmayer N, 2009, P NATL ACAD SCI USA, V106, P13564, DOI 10.1073/pnas.0905819106	46	79	80	0	18	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	SEP	2012	15	9					1219	U74		10.1038/nn.3183	http://dx.doi.org/10.1038/nn.3183			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	996GJ	22864612	Green Accepted			2022-12-28	WOS:000308072600012
J	Schiemann, J; Schlaudraff, F; Klose, V; Bingmer, M; Seino, S; Magill, PJ; Zaghloul, KA; Schneider, G; Liss, B; Roeper, J				Schiemann, Julia; Schlaudraff, Falk; Klose, Verena; Bingmer, Markus; Seino, Susumu; Magill, Peter J.; Zaghloul, Kareem A.; Schneider, Gaby; Liss, Birgit; Roeper, Jochen			K-ATP channels in dopamine substantia nigra neurons control bursting and novelty-induced exploration	NATURE NEUROSCIENCE			English	Article							VENTRAL TEGMENTAL AREA; IN-VIVO; PARKINSONS-DISEASE; SPIKE TRAINS; DORSOMEDIAL STRIATUM; MIDBRAIN NEURONS; FIRING PATTERN; CELLS; EXPRESSION; RECEPTORS	Phasic activation of the dopamine (DA) midbrain system in response to unexpected reward or novelty is critical for adaptive behavioral strategies. This activation of DA midbrain neurons occurs via a synaptically triggered switch from low-frequency background spiking to transient high-frequency burst firing. We found that, in medial DA neurons of the substantia nigra (SN), activity of ATP-sensitive potassium (K-ATP) channels enabled NMDA-mediated bursting in vitro as well as spontaneous in vivo burst firing in anesthetized mice. Cell-selective silencing of K-ATP channel activity in medial SN DA neurons revealed that their K-ATP channel-gated burst firing was crucial for novelty-dependent exploratory behavior. We also detected a transcriptional upregulation of K-ATP channel and NMDA receptor subunits, as well as high in vivo burst firing, in surviving SN DA neurons from Parkinson's disease patients, suggesting that burst-gating K-ATP channel function in DA neurons affects phenotypes in both disease and health.	[Schiemann, Julia; Klose, Verena; Roeper, Jochen] Goethe Univ Frankfurt, Inst Neurophysiol, Neurosci Ctr, Frankfurt, Germany; [Schlaudraff, Falk; Liss, Birgit] Univ Ulm, Inst Appl Physiol, Ulm, Germany; [Bingmer, Markus; Schneider, Gaby] Goethe Univ Frankfurt, Dept Comp Sci & Math, Frankfurt, Germany; [Seino, Susumu] Kobe Univ, Div Cellular & Mol Med, Kobe, Hyogo 657, Japan; [Magill, Peter J.] Univ Oxford, Dept Pharmacol, MRC, Anat Neuropharmacol Unit, Oxford OX1 3QT, England; [Magill, Peter J.] Univ Oxford, Oxford Parkinsons Dis Ctr, Oxford, England; [Zaghloul, Kareem A.] NINDS, Surg Neurol Branch, US Natl Inst Hlth, Bethesda, MD 20892 USA	Goethe University Frankfurt; Ulm University; Goethe University Frankfurt; Kobe University; University of Oxford; University of Oxford; National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS)	Roeper, J (corresponding author), Goethe Univ Frankfurt, Inst Neurophysiol, Neurosci Ctr, Frankfurt, Germany.	birgit.liss@uni-ulm.de; roeper@em.uni-frankfurt.de	Zaghloul, Kareem/AAV-4208-2020	Magill, Peter/0000-0001-7141-7071; liss, Birgit/0000-0002-6733-9207; Roeper, Jochen/0000-0003-2145-8742	Gemeinnutzige Hertiestiftung; BMBF Nationales Genomforschungsnetzwerk NGFN-II/plus [01GS08134]; Alfried Krupp prize; LOEWE-Schwerpunkt Neuronale Koordination Forschungsschwerpunkt Frankfurt NeFF; Bernstein Fokus Neurotechnology Frankfurt; doctoral fellowship Studienstiftung des deutschen Volkes; Medical Research Council UK [U138197109];  [SFB815];  [SFB497]; MRC [MC_U138197109] Funding Source: UKRI; Medical Research Council [MC_U138197109] Funding Source: researchfish	Gemeinnutzige Hertiestiftung; BMBF Nationales Genomforschungsnetzwerk NGFN-II/plus; Alfried Krupp prize; LOEWE-Schwerpunkt Neuronale Koordination Forschungsschwerpunkt Frankfurt NeFF; Bernstein Fokus Neurotechnology Frankfurt; doctoral fellowship Studienstiftung des deutschen Volkes; Medical Research Council UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); ; ; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank S. Petzoldt, H. Schalk and A. Parg for assistance in immunohistochemistry, and M. Fauler for mRNA expression data analysis. The study was supported by Gemeinnutzige Hertiestiftung (J.R. and B. L.), SFB815 (J.R.), SFB497 (B. L.), BMBF Nationales Genomforschungsnetzwerk NGFN-II/plus (01GS08134, J.R. and B. L.), Alfried Krupp prize (B. L.), LOEWE-Schwerpunkt Neuronale Koordination Forschungsschwerpunkt Frankfurt NeFF (J.R. and G. S.), Bernstein Fokus Neurotechnology Frankfurt (G. S. and M. B.), doctoral fellowship Studienstiftung des deutschen Volkes (J.S.) and Medical Research Council UK (U138197109, P.J.M.).	Andrews ZB, 2009, J NEUROSCI, V29, P14057, DOI 10.1523/JNEUROSCI.3890-09.2009; Bayer HM, 2007, J NEUROPHYSIOL, V98, P1428, DOI 10.1152/jn.01140.2006; Bingmer M, 2011, J NEUROSCI METH, V201, P426, DOI 10.1016/j.jneumeth.2011.08.013; Bodi N, 2009, BRAIN, V132, P2385, DOI 10.1093/brain/awp094; Brazhnik E, 2008, J NEUROSCI, V28, P10386, DOI 10.1523/JNEUROSCI.2387-08.2008; Bromberg-Martin ES, 2010, NEURON, V68, P815, DOI 10.1016/j.neuron.2010.11.022; Brown MTC, 2009, J NEUROSCI, V29, P2915, DOI 10.1523/JNEUROSCI.4423-08.2009; Bunzeck N, 2006, NEURON, V51, P369, DOI 10.1016/j.neuron.2006.06.021; Burger C, 2004, MOL THER, V10, P302, DOI 10.1016/j.ymthe.2004.05.024; Chan CS, 2007, NATURE, V447, P1081, DOI 10.1038/nature05865; Dabrowski M, 2003, DIABETOLOGIA, V46, P1375, DOI 10.1007/s00125-003-1198-1; Deacon RMJ, 2006, PHYSIOL BEHAV, V87, P723, DOI 10.1016/j.physbeh.2006.01.013; Deister CA, 2009, J NEUROSCI, V29, P15888, DOI 10.1523/JNEUROSCI.4053-09.2009; Franklin K. B. J., 2001, MOUSE BRAIN STEREOTA; Fridlyand LE, 2010, AM J PHYSIOL-ENDOC M, V299, pE517, DOI 10.1152/ajpendo.00177.2010; Geng XH, 2011, AM J PHYSIOL-ENDOC M, V300, pE276, DOI 10.1152/ajpendo.00262.2010; Gomis A, 1998, BRIT J PHARMACOL, V123, P443, DOI 10.1038/sj.bjp.0701628; GRACE AA, 1984, J NEUROSCI, V4, P2877; Grundemann J, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn084; Grundemann J, 2011, METHODS MOL BIOL, V755, P363, DOI 10.1007/978-1-61779-163-5_30; Guzman JN, 2010, NATURE, V468, P696, DOI 10.1038/nature09536; Haber SN, 2010, NEUROPSYCHOPHARMACOL, V35, P4, DOI 10.1038/npp.2009.129; Harnett MT, 2009, NEURON, V62, P826, DOI 10.1016/j.neuron.2009.05.011; Henny P, 2012, NAT NEUROSCI, V15, P613, DOI 10.1038/nn.3048; Herrik KF, 2010, J NEUROPHYSIOL, V104, P1726, DOI 10.1152/jn.01126.2009; Hyland BI, 2002, NEUROSCIENCE, V114, P475, DOI 10.1016/S0306-4522(02)00267-1; Jin X, 2010, NATURE, V466, P457, DOI 10.1038/nature09263; JOHNSON SW, 1992, J NEUROSCI, V12, P2000; JOHNSON SW, 1992, SCIENCE, V258, P665, DOI 10.1126/science.1329209; Kravitz AV, 2010, NATURE, V466, P622, DOI 10.1038/nature09159; Krebs RM, 2011, NEUROIMAGE, V58, P647, DOI 10.1016/j.neuroimage.2011.06.038; Lammel S, 2008, NEURON, V57, P760, DOI 10.1016/j.neuron.2008.01.022; Lammel S, 2011, NEURON, V70, P855, DOI 10.1016/j.neuron.2011.03.025; Lex B, 2010, NEUROPSYCHOPHARMACOL, V35, P1788, DOI 10.1038/npp.2010.46; Lex B, 2010, CEREB CORTEX, V20, P873, DOI 10.1093/cercor/bhp151; Lisman JE, 2005, NEURON, V46, P703, DOI 10.1016/j.neuron.2005.05.002; Liss B, 1999, EMBO J, V18, P833, DOI 10.1093/emboj/18.4.833; Liss B, 2005, NAT NEUROSCI, V8, P1742, DOI 10.1038/nn1570; Mameli-Engvall M, 2006, NEURON, V50, P911, DOI 10.1016/j.neuron.2006.05.007; Martin-Ibanez R, 2006, EUR J NEUROSCI, V23, P1063, DOI 10.1111/j.1460-9568.2006.04601.x; Miki T, 1997, P NATL ACAD SCI USA, V94, P11969, DOI 10.1073/pnas.94.22.11969; Nichols CG, 2006, NATURE, V440, P470, DOI 10.1038/nature04711; Opland DM, 2010, BRAIN RES, V1350, P65, DOI 10.1016/j.brainres.2010.04.028; Parker JG, 2011, J NEUROSCI, V31, P11362, DOI 10.1523/JNEUROSCI.2411-11.2011; Pinault D, 1996, J NEUROSCI METH, V65, P113, DOI 10.1016/0165-0270(95)00144-1; Rutledge RB, 2009, J NEUROSCI, V29, P15104, DOI 10.1523/JNEUROSCI.3524-09.2009; Schultz W, 2007, ANNU REV NEUROSCI, V30, P259, DOI 10.1146/annurev.neuro.28.061604.135722; Shen KZ, 2010, J NEUROSCI, V30, P1882, DOI 10.1523/JNEUROSCI.3200-09.2010; Ulusoy A, 2009, MOL THER, V17, P1574, DOI 10.1038/mt.2009.142; Ungless MA, 2004, SCIENCE, V303, P2040, DOI 10.1126/science.1093360; WILSON CJ, 1977, BRAIN RES, V136, P243, DOI 10.1016/0006-8993(77)90801-0; Yamada K, 2001, SCIENCE, V292, P1543, DOI 10.1126/science.1059829; YAMADA T, 1990, BRAIN RES, V526, P303, DOI 10.1016/0006-8993(90)91236-A; Zaghloul KA, 2009, SCIENCE, V323, P1496, DOI 10.1126/science.1167342; Zerangue N, 1999, NEURON, V22, P537, DOI 10.1016/S0896-6273(00)80708-4; Zhang D, 2008, SYNAPSE, V62, P169, DOI 10.1002/syn.20479; Zweifel LS, 2009, P NATL ACAD SCI USA, V106, P7281, DOI 10.1073/pnas.0813415106	57	144	149	0	21	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	SEP	2012	15	9					1272	U141		10.1038/nn.3185	http://dx.doi.org/10.1038/nn.3185			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	996GJ	22902720	Green Accepted			2022-12-28	WOS:000308072600018
J	Kubota, JT; Banaji, MR; Phelps, EA				Kubota, Jennifer T.; Banaji, Mahzarin R.; Phelps, Elizabeth A.			The neuroscience of race	NATURE NEUROSCIENCE			English	Review							ANTERIOR CINGULATE CORTEX; IN-GROUP; IMPLEMENTATION INTENTIONS; INTERRACIAL CONTACT; AMYGDALA ACTIVITY; SOCIAL COGNITION; RACIAL-ATTITUDES; ERROR-DETECTION; OWN-RACE; IMPLICIT	As the racial composition of the population changes, intergroup interactions are increasingly common. To understand how we perceive and categorize race and the attitudes that flow from it, scientists have used brain imaging techniques to examine how social categories of race and ethnicity are processed, evaluated and incorporated in decision-making. We review these findings, focusing on black and white race categories. A network of interacting brain regions is important in the unintentional, implicit expression of racial attitudes and its control. On the basis of the overlap in the neural circuitry of race, emotion and decision-making, we speculate as to how this emerging research might inform how we recognize and respond to variations in race and its influence on unintended race-based attitudes and decisions.	[Kubota, Jennifer T.; Phelps, Elizabeth A.] NYU, Dept Psychol, New York, NY 10003 USA; [Banaji, Mahzarin R.] Harvard Univ, Dept Psychol, Cambridge, MA 02138 USA; [Phelps, Elizabeth A.] NYU, Ctr Neural Sci, New York, NY 10003 USA	New York University; Harvard University; New York University	Phelps, EA (corresponding author), NYU, Dept Psychol, 6 Washington Pl, New York, NY 10003 USA.	liz.phelps@nyu.edu			Macarthur Foundation Law and Neuroscience Network; National Institute of Mental Health [MIT080756]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH080756] Funding Source: NIH RePORTER	Macarthur Foundation Law and Neuroscience Network; National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We would like to thank L. Atlas for help with Figure 1, A. Meilich for help with Table 1 and J. Reitzes for feedback on various stages of this manuscript. We would like to acknowledge support by grants from the Macarthur Foundation Law and Neuroscience Network and the National Institute of Mental Health (MIT080756).	Amodio DM, 2006, SOC COGN AFFECT NEUR, V1, P26, DOI 10.1093/scan/nsl002; Amodio DM, 2004, PSYCHOL SCI, V15, P88, DOI 10.1111/j.0963-7214.2004.01502003.x; Anderson AK, 2003, NAT NEUROSCI, V6, P196, DOI 10.1038/nn1001; Barch DM, 2001, CEREB CORTEX, V11, P837, DOI 10.1093/cercor/11.9.837; Bargh JA, 1999, DUAL-PROCESS THEORIES IN SOCIAL PSYCHOLOGY, P361; BECHARA A, 1995, SCIENCE, V269, P1115, DOI 10.1126/science.7652558; Beer JS, 2008, NEUROIMAGE, V43, P775, DOI 10.1016/j.neuroimage.2008.08.033; Blair IV, 2002, PERS SOC PSYCHOL REV, V6, P242, DOI 10.1207/S15327957PSPR0603_8; Blair IV, 1996, J PERS SOC PSYCHOL, V70, P1142, DOI 10.1037/0022-3514.70.6.1142; Bodenhausen GV, 1998, INTENTIONAL FORGETTING: INTERDISCIPLINARY APPROACHES, P349; Botvinick MM, 2001, PSYCHOL REV, V108, P624, DOI 10.1037//0033-295X.108.3.624; BRIGHAM JC, 1985, J SOC ISSUES, V41, P139, DOI 10.1111/j.1540-4560.1985.tb01133.x; Brosch T., PSYCHOL SCI IN PRESS; Caldara R, 2003, CLIN NEUROPHYSIOL, V114, P515, DOI 10.1016/S1388-2457(02)00407-8; Caprariello PA, 2009, GROUP PROCESS INTERG, V12, P147, DOI 10.1177/1368430208101053; Carter CS, 1998, SCIENCE, V280, P747, DOI 10.1126/science.280.5364.747; Correll J, 2006, J EXP SOC PSYCHOL, V42, P120, DOI 10.1016/j.jesp.2005.02.006; Cuddy AJC, 2009, BRIT J SOC PSYCHOL, V48, P1, DOI 10.1348/014466608X314935; Cunningham WA, 2004, PSYCHOL SCI, V15, P806, DOI 10.1111/j.0956-7976.2004.00760.x; Curtis CE, 2003, TRENDS COGN SCI, V7, P415, DOI 10.1016/S1364-6613(03)00197-9; Dasgupta N, 2009, HDB PREJUDICE STEREO, P267, DOI DOI 10.4324/9781841697772.CH13; Davis M, 2001, MOL PSYCHIATR, V6, P13, DOI 10.1038/sj.mp.4000812; De Martino B, 2006, SCIENCE, V313, P684, DOI 10.1126/science.1128356; DEHAENE S, 1994, PSYCHOL SCI, V5, P303, DOI 10.1111/j.1467-9280.1994.tb00630.x; Delgado MR, 2008, NEURON, V59, P829, DOI 10.1016/j.neuron.2008.06.029; Delgado MR, 2009, FRONT BEHAV NEUROSCI, V3, DOI 10.3389/neuro.08.033.2009; Devine PG, 1999, DUAL-PROCESS THEORIES IN SOCIAL PSYCHOLOGY, P339; Dovidio JF, 2004, ADV EXP SOC PSYCHOL, V36, P1, DOI 10.1016/S0065-2601(04)36001-6; Dunton BC, 1997, PERS SOC PSYCHOL B, V23, P316, DOI 10.1177/0146167297233009; FAZIO RH, 1995, J PERS SOC PSYCHOL, V69, P1013, DOI 10.1037/0022-3514.69.6.1013; FISKE S T, 1989, P253; Fiske Susan T, 2009, Du Bois Rev, V6, DOI 10.1017/S1742058X0909002X; Forbes CE, 2012, SOC COGN AFFECT NEUR, V7, P771, DOI 10.1093/scan/nsr052; Galinsky AD, 2000, J PERS SOC PSYCHOL, V78, P708, DOI 10.1037//0022-3514.78.4.708; Glimcher PW, 2009, NEUROECONOMICS: DECISION MAKING AND THE BRAIN, P1; Golby AJ, 2001, NAT NEUROSCI, V4, P845, DOI 10.1038/90565; Gollwitzer PM, 1997, J PERS SOC PSYCHOL, V73, P186, DOI 10.1037/0022-3514.73.1.186; Green AR, 2007, J GEN INTERN MED, V22, P1231, DOI 10.1007/s11606-007-0258-5; Greenwald AG, 1998, J PERS SOC PSYCHOL, V74, P1464, DOI 10.1037/0022-3514.74.6.1464; Greenwald AG, 2009, J PERS SOC PSYCHOL, V97, P17, DOI 10.1037/a0015575; Gross J.J., 1998, REV GEN PSYCHOL, V2, P271, DOI [10.1037/1089-2680.2.3.271, DOI 10.1037/1089-2680.2.3.271]; Hamann SB, 2002, PSYCHOL SCI, V13, P135, DOI 10.1111/1467-9280.00425; Hart AJ, 2000, NEUROREPORT, V11, P2351, DOI 10.1097/00001756-200008030-00004; Hartley CA, 2010, NEUROPSYCHOPHARMACOL, V35, P136, DOI 10.1038/npp.2009.121; Ito TA, 2005, COGN AFFECT BEHAV NE, V5, P21, DOI 10.3758/CABN.5.1.21; Ito TA, 2004, PERS SOC PSYCHOL B, V30, P1267, DOI 10.1177/0146167204264335; Ito TA, 2009, TRENDS COGN SCI, V13, P524, DOI 10.1016/j.tics.2009.10.002; Kanwisher N, 1997, J NEUROSCI, V17, P4302; Knutson KM, 2007, HUM BRAIN MAPP, V28, P915, DOI 10.1002/hbm.20320; Korn HA, 2012, SOC NEUROSCI-UK, V7, P398, DOI 10.1080/17470919.2011.631739; Krill Austen, 2009, Front Evol Neurosci, V1, P1, DOI 10.3389/neuro.18.001.2009; LABAR KS, 1995, J NEUROSCI, V15, P6846; Lane KA, 2007, ANNU REV LAW SOC SCI, V3, P427, DOI 10.1146/annurev.lawsocsci.3.081806.112748; LANG PJ, 1990, PSYCHOL REV, V97, P377, DOI 10.1037/0033-295X.97.3.377; Ledoux JE, 2001, AM J PSYCHIAT, V158, P1953, DOI 10.1176/appi.ajp.158.12.1953; Lieberman MD, 2005, NAT NEUROSCI, V8, P720, DOI 10.1038/nn1465; MacDonald AW, 2000, SCIENCE, V288, P1835, DOI 10.1126/science.288.5472.1835; MALPASS RS, 1969, J PERS SOC PSYCHOL, V13, P330, DOI 10.1037/h0028434; Mathur VA, 2012, HUM BRAIN MAPP, V33, P1883, DOI 10.1002/hbm.21330; Mathur VA, 2010, NEUROIMAGE, V51, P1468, DOI 10.1016/j.neuroimage.2010.03.025; MCCONAHAY JB, 1981, J CONFLICT RESOLUT, V25, P563, DOI 10.1177/002200278102500401; Nader K, 2000, NATURE, V406, P722, DOI 10.1038/35021052; Nosek BA, 2002, GROUP DYN-THEOR RES, V6, P101, DOI 10.1037//1089-2699.6.1.101; Olsson A, 2005, SCIENCE, V309, P785, DOI 10.1126/science.1113551; Olsson A, 2007, SOC COGN AFFECT NEUR, V2, P3, DOI 10.1093/scan/nsm005; OSTROM TM, 1993, J PERS SOC PSYCHOL, V64, P21, DOI 10.1037/0022-3514.64.1.21; Payne BK, 2005, J PERS SOC PSYCHOL, V89, P488, DOI 10.1037/0022-3514.89.4.488; Phelps EA, 2006, ANNU REV PSYCHOL, V57, P27, DOI 10.1146/annurev.psych.56.091103.070234; Phelps EA, 2003, NEUROPSYCHOLOGIA, V41, P203, DOI 10.1016/S0028-3932(02)00150-1; Phelps EA, 2005, NEURON, V48, P175, DOI 10.1016/j.neuron.2005.09.025; Phelps EA, 2001, NAT NEUROSCI, V4, P775, DOI 10.1038/90467; Phelps EA, 2000, J COGNITIVE NEUROSCI, V12, P729, DOI 10.1162/089892900562552; Plant EA, 1998, J PERS SOC PSYCHOL, V75, P811, DOI 10.1037/0022-3514.75.3.811; Richeson JA, 2005, SOC COGNITION, V23, P336, DOI 10.1521/soco.2005.23.4.336; Richeson JA, 2003, NAT NEUROSCI, V6, P1323, DOI 10.1038/nn1156; Richeson JA, 2003, PSYCHOL SCI, V14, P287, DOI 10.1111/1467-9280.03437; Richeson JA, 2008, GROUP PROCESS INTERG, V11, P233, DOI 10.1177/1368430207088040; Ronquillo J, 2007, SOC COGN AFFECT NEUR, V2, P39, DOI 10.1093/scan/nsl043; Rooth DO, 2010, LABOUR ECON, V17, P523, DOI 10.1016/j.labeco.2009.04.005; Rossion B, 2003, NEUROIMAGE, V19, P877, DOI 10.1016/S1053-8119(03)00105-8; Rudman LA, 2001, J PERS SOC PSYCHOL, V81, P856, DOI 10.1037/0022-3514.81.5.856; Sabin JA, 2009, J HEALTH CARE POOR U, V20, P896, DOI 10.1353/hpu.0.0185; Sangrigoli S, 2005, PSYCHOL SCI, V16, P440; Santos A, 2010, CURR BIOL, V20, pR307, DOI 10.1016/j.cub.2010.02.009; Schiller D, 2011, FRONT BEHAV NEUROSCI, V5, DOI 10.3389/fnbeh.2011.00024; Snipes SA, 2011, BMC HEALTH SERV RES, V11, DOI 10.1186/1472-6963-11-183; Sokol-Hessner P, 2013, SOC COGN AFFECT NEUR, V8, P341, DOI 10.1093/scan/nss002; Sokol-Hessner P, 2009, P NATL ACAD SCI USA, V106, P5035, DOI 10.1073/pnas.0806761106; Stanley D, 2008, CURR DIR PSYCHOL SCI, V17, P164, DOI 10.1111/j.1467-8721.2008.00568.x; Stanley DA, 2012, PHILOS T R SOC B, V367, P744, DOI 10.1098/rstb.2011.0300; Stanley DA, 2011, P NATL ACAD SCI USA, V108, P7710, DOI 10.1073/pnas.1014345108; Stewart BD, 2008, PERS SOC PSYCHOL B, V34, P1332, DOI 10.1177/0146167208321269; Todorov A, 2008, COGN NEUROPSYCHOL, V25, P395, DOI 10.1080/02643290802044996; TRANEL D, 1985, SCIENCE, V228, P1453, DOI 10.1126/science.4012303; U.S. Census Bureau, 2010, OV RAC HISP OR 2010; Van Bavel JJ, 2009, PERS SOC PSYCHOL B, V35, P321, DOI 10.1177/0146167208327743; Van Bavel JJ, 2008, PSYCHOL SCI, V19, P1131, DOI 10.1111/j.1467-9280.2008.02214.x; Vuilleumier P, 2007, NEUROPSYCHOLOGIA, V45, P174, DOI 10.1016/j.neuropsychologia.2006.06.003; Wheeler ME, 2005, PSYCHOL SCI, V16, P56, DOI 10.1111/j.0956-7976.2005.00780.x; Young SG, 2012, SOC PSYCHOL PERS SCI, V3, P80, DOI 10.1177/1948550611409759	100	149	149	0	77	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUL	2012	15	7					940	948		10.1038/nn.3136	http://dx.doi.org/10.1038/nn.3136			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	966EE	22735516	Green Accepted, Bronze			2022-12-28	WOS:000305819600008
J	Madisen, L; Mao, TY; Koch, H; Zhuo, JM; Berenyi, A; Fujisawa, S; Hsu, YWA; Garcia, AJ; Gu, X; Zanella, S; Kidney, J; Gu, H; Mao, YM; Hooks, BM; Boyden, ES; Buzsaki, G; Ramirez, JM; Jones, AR; Svoboda, K; Han, X; Turner, EE; Zeng, HK				Madisen, Linda; Mao, Tianyi; Koch, Henner; Zhuo, Jia-min; Berenyi, Antal; Fujisawa, Shigeyoshi; Hsu, Yun-Wei A.; Garcia, Alfredo J., III; Gu, Xuan; Zanella, Sebastien; Kidney, Jolene; Gu, Hong; Mao, Yimei; Hooks, Bryan M.; Boyden, Edward S.; Buzsaki, Gyoergy; Ramirez, Jan Marino; Jones, Allan R.; Svoboda, Karel; Han, Xue; Turner, Eric E.; Zeng, Hongkui			A toolbox of Cre-dependent optogenetic transgenic mice for light-induced activation and silencing	NATURE NEUROSCIENCE			English	Article							NEURAL CIRCUITRY; IN-VIVO; MILLISECOND-TIMESCALE; GABAERGIC NEURONS; PYRAMIDAL CELLS; CEREBRAL-CORTEX; OPTICAL CONTROL; CHANNELRHODOPSIN-2; BRAIN; ORGANIZATION	Cell type specific expression of optogenetic molecules allows temporally precise manipulation of targeted neuronal activity. Here we present a toolbox of four knock-in mouse lines engineered for strong, Cre-dependent expression of channelrhodopsins ChR2-tdTomato and ChR2-EYFP, halorhodopsin eNpHR3.0 and archaerhodopsin Arch-ER2. All four transgenes mediated Cre-dependent, robust activation or silencing of cortical pyramidal neurons in vitro and in vivo upon light stimulation, with ChR2-EYFP and Arch-ER2 demonstrating light sensitivity approaching that of in utero or virally transduced neurons. We further show specific photoactivation of parvalbumin-positive interneurons in behaving ChR2-EYFP reporter mice. The robust, consistent and inducible nature of our ChR2 mice represents a significant advance over previous lines, and the Arch-ER2 and eNpHR3.0 mice are to our knowledge the first demonstration of successful conditional transgenic optogenetic silencing. When combined with the hundreds of available Cre driver lines, this optimized toolbox of reporter mice will enable widespread investigations of neural circuit function with unprecedented reliability and accuracy.	[Madisen, Linda; Kidney, Jolene; Gu, Hong; Jones, Allan R.; Zeng, Hongkui] Allen Inst Brain Sci, Seattle, WA USA; [Mao, Tianyi; Hooks, Bryan M.; Svoboda, Karel] Howard Hughes Med Inst, Ashburn, VA USA; [Koch, Henner; Hsu, Yun-Wei A.; Garcia, Alfredo J., III; Zanella, Sebastien; Ramirez, Jan Marino; Turner, Eric E.] Seattle Childrens Res Inst, Ctr Integrat Brain Res, Seattle, WA USA; [Zhuo, Jia-min; Gu, Xuan; Mao, Yimei; Han, Xue] Boston Univ, Dept Biomed Engn, Boston, MA 02215 USA; [Berenyi, Antal; Fujisawa, Shigeyoshi; Buzsaki, Gyoergy] Rutgers State Univ, Ctr Mol & Behav Neurosci, Newark, NJ 07102 USA; [Boyden, Edward S.] MIT, Media Lab, Cambridge, MA 02139 USA	Allen Institute for Brain Science; Howard Hughes Medical Institute; Seattle Children's Hospital; Boston University; Rutgers State University Newark; Rutgers State University New Brunswick; Massachusetts Institute of Technology (MIT)	Zeng, HK (corresponding author), Allen Inst Brain Sci, Seattle, WA USA.	hongkuiz@alleninstitute.org	Zhuo, Jia-Min/M-7546-2014; Fujisawa, Shigeyoshi/N-6439-2015; Turner, Eric e/K-3556-2015; Berényi, Antal/A-9174-2013; Chee, Melissa/G-4150-2014	Zhuo, Jia-Min/0000-0001-9199-5485; Fujisawa, Shigeyoshi/0000-0003-3963-4281; Turner, Eric e/0000-0001-5499-6788; Berényi, Antal/0000-0003-0084-8530; Chee, Melissa/0000-0003-3815-9095; Buzsaki, Gyorgy/0000-0002-3100-4800; Ramirez, Jan-Marino/0000-0002-5626-3999; Mao, Tianyi/0000-0002-3532-8319; Hsu, Yun-Wei/0000-0001-7851-2733	Allen Institute for Brain Science; Howard Hughes Medical Institute; US National Institutes of Health (NIH) [DA028298, MH085944, NS034994, MH54671]; Alfred P. Sloan Foundation; US National Science Foundation; Marie Curie Fellowship; EU [2009 IOF 254780]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL107084] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R00MH085944, R01MH093667, R21MH090478, R01MH054671, K99MH085944] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS034994] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA028298] Funding Source: NIH RePORTER	Allen Institute for Brain Science; Howard Hughes Medical Institute(Howard Hughes Medical Institute); US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Alfred P. Sloan Foundation(Alfred P. Sloan Foundation); US National Science Foundation(National Science Foundation (NSF)); Marie Curie Fellowship(European Commission); EU(European Commission); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We are grateful for the technical support of the Atlas Production Team, led by P. Wohnoutka, and the Technology Team, led by C. Dang, at the Allen Institute. We thank A. Nagy (Mount Sinai Hospital in Toronto) for providing the G4 ES cell line and K. Deisseroth (Stanford University) for providing the eNpHR3.0 construct. The authors wish to thank the Allen Institute founders, PG. Allen and J. Allen, for their vision, encouragement and support. This work was funded by the Allen Institute for Brain Science and the Howard Hughes Medical Institute, US National Institutes of Health (NIH) grant DA028298 to H.Z., NIH grants MH90478 and MH093667 to E.E.T., NIH grant MH085944 and an Alfred P. Sloan Foundation grant to X.H., NIH grants NS034994 and MH54671 and a US National Science Foundation grant to GB., and a Marie Curie Fellowship (EU FP7 PEOPLE 2009 IOF 254780) to A.B.	Arenkiel BR, 2007, NEURON, V54, P205, DOI 10.1016/j.neuron.2007.03.005; Atasoy D, 2008, J NEUROSCI, V28, P7025, DOI 10.1523/JNEUROSCI.1954-08.2008; Boyden ES, 2005, NAT NEUROSCI, V8, P1263, DOI 10.1038/nn1525; Chow BY, 2010, NATURE, V463, P98, DOI 10.1038/nature08652; Chuhma N, 2011, J NEUROSCI, V31, P1183, DOI 10.1523/JNEUROSCI.3833-10.2011; Csicsvari J, 1999, J NEUROSCI, V19, P274, DOI 10.1523/JNEUROSCI.19-01-00274.1999; Fujisawa S, 2008, NAT NEUROSCI, V11, P823, DOI 10.1038/nn.2134; Gong SC, 2007, J NEUROSCI, V27, P9817, DOI 10.1523/JNEUROSCI.2707-07.2007; Gradinaru V, 2010, CELL, V141, P154, DOI 10.1016/j.cell.2010.02.037; Gradinaru V, 2008, BRAIN CELL BIOL, V36, P129, DOI 10.1007/s11068-008-9027-6; Hagglund M, 2010, NAT NEUROSCI, V13, P246, DOI 10.1038/nn.2482; Halassa MM, 2011, NAT NEUROSCI, V14, P1118, DOI 10.1038/nn.2880; Han X, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000299; Han X, 2011, FRONT SYST NEUROSCI, V5, DOI 10.3389/fnsys.2011.00018; Han X, 2009, NEURON, V62, P191, DOI 10.1016/j.neuron.2009.03.011; Hegemann P, 2011, NAT METHODS, V8, P39, DOI 10.1038/NMETH.F.327; ISHIZUKA N, 1990, J COMP NEUROL, V295, P580, DOI 10.1002/cne.902950407; Katzel D, 2011, NAT NEUROSCI, V14, P100, DOI 10.1038/nn.2687; Klausberger T, 2003, NATURE, V421, P844, DOI 10.1038/nature01374; Kuhlman SJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002005; Lewis TL, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001021; Lewis TL, 2009, NAT NEUROSCI, V12, P568, DOI 10.1038/nn.2318; Li X, 2005, P NATL ACAD SCI USA, V102, P17816, DOI 10.1073/pnas.0509030102; Lima SQ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006099; Liu XB, 2011, J COMP NEUROL, V519, P1181, DOI 10.1002/cne.22567; Madisen L, 2010, NAT NEUROSCI, V13, P133, DOI 10.1038/nn.2467; Nagel G, 2003, P NATL ACAD SCI USA, V100, P13940, DOI 10.1073/pnas.1936192100; Nagel G, 2005, CURR BIOL, V15, P2279, DOI 10.1016/j.cub.2005.11.032; Peron S, 2011, NAT METHODS, V8, P30, DOI 10.1038/NMETH.F.325; Petreanu L, 2007, NAT NEUROSCI, V10, P663, DOI 10.1038/nn1891; Petreanu L, 2009, NATURE, V457, P1142, DOI 10.1038/nature07709; Ren J, 2011, NEURON, V69, P445, DOI 10.1016/j.neuron.2010.12.038; Royer S, 2010, EUR J NEUROSCI, V31, P2279, DOI 10.1111/j.1460-9568.2010.07250.x; Sirota A, 2008, NEURON, V60, P683, DOI 10.1016/j.neuron.2008.09.014; STERIADE M, 1993, SCIENCE, V262, P679, DOI 10.1126/science.8235588; Tanahira C, 2009, NEUROSCI RES, V63, P213, DOI 10.1016/j.neures.2008.12.007; Taniguchi H, 2011, NEURON, V71, P995, DOI 10.1016/j.neuron.2011.07.026; Tsunematsu T, 2011, J NEUROSCI, V31, P10529, DOI 10.1523/JNEUROSCI.0784-11.2011; Wang H, 2007, P NATL ACAD SCI USA, V104, P8143, DOI 10.1073/pnas.0700384104; Zhang F, 2007, NAT REV NEUROSCI, V8, P577, DOI 10.1038/nrn2192; Zhang F, 2007, NATURE, V446, P633, DOI 10.1038/nature05744; Zhao SL, 2011, NAT METHODS, V8, P745, DOI 10.1038/nmeth.1668; Zhao SL, 2008, BRAIN CELL BIOL, V36, P141, DOI 10.1007/s11068-008-9034-7	43	787	796	5	158	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	MAY	2012	15	5					793	802		10.1038/nn.3078	http://dx.doi.org/10.1038/nn.3078			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	932DI	22446880	Green Accepted, Green Submitted			2022-12-28	WOS:000303270200025
J	Kim, J; Kwon, JT; Kim, HS; Josselyn, SA; Han, JH				Kim, Jieun; Kwon, Jeong-Tae; Kim, Hyung-Su; Josselyn, Sheena A.; Han, Jin-Hee			Memory recall and modifications by activating neurons with elevated CREB	NATURE NEUROSCIENCE			English	Article							LATERAL AMYGDALA; RECEPTOR TRAFFICKING; FEAR MEMORIES; PHOSPHORYLATION; RECONSOLIDATION; EXPRESSION; PLASTICITY; RETRIEVAL; RATS; MICE	Memory is supported by a specific ensemble of neurons distributed in the brain that form a unique memory trace. We previously showed that neurons in the lateral amygdala expressing elevated levels of cAMP response-element binding protein are preferentially recruited into fear memory traces and are necessary for the expression of those memories. However, it is unknown whether artificially activating just these selected neurons in the absence of behavioral cues is sufficient to recall that fear memory. Using an ectopic rat vanilloid receptor TRPV1 and capsaicin system, we found that activating this specific ensemble of neurons was sufficient to recall established fear memory. Furthermore, this neuronal activation induced a reconsolidation-like reorganization process, or strengthening of the fear memory. Thus, our findings establish a direct link between the activation of specific ensemble of neurons in the lateral amygdala and the recall of fear memory and its subsequent modifications.	[Kim, Jieun; Kwon, Jeong-Tae; Kim, Hyung-Su; Han, Jin-Hee] Korea Adv Inst Sci & Technol, KAIST Inst BioCentury, Dept Biol Sci, Taejon 305701, South Korea; [Josselyn, Sheena A.] Hosp Sick Children, Program Neurosci & Mental Hlth, Toronto, ON M5G 1X8, Canada	Korea Advanced Institute of Science & Technology (KAIST); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids)	Han, JH (corresponding author), Korea Adv Inst Sci & Technol, KAIST Inst BioCentury, Dept Biol Sci, Taejon 305701, South Korea.	han.jinhee@kaist.ac.kr	Han, Jin-Hee/C-2069-2011; Josselyn, Sheena/F-3509-2013	Josselyn, Sheena/0000-0001-5451-489X; Han, Jin-Hee/0000-0002-2139-5596	National Research Foundation of Korea; Korean government [2011-0005755, 2011-0013173]; KAIST High Risk High Return Project; TJ Park Science Fellowship; BK21 project of Korean Research Foundation; World Class Institute program of the National Research Foundation of Korea; Ministry of Education, Science and Teclmology [WCI 2009-003]	National Research Foundation of Korea(National Research Foundation of Korea); Korean government(Korean Government); KAIST High Risk High Return Project; TJ Park Science Fellowship; BK21 project of Korean Research Foundation; World Class Institute program of the National Research Foundation of Korea(National Research Foundation of Korea); Ministry of Education, Science and Teclmology	We thank all our laboratory members for critical discussions and helpful comments on this study and U. Oh (Seoul National University) for rat TRPV1 cDNA plasmid. This work was supported by a National Research Foundation of Korea grant funded by the Korean government (2011-0005755 and 2011-0013173) and the KAIST High Risk High Return Project. J.-H.H. was supported by a TJ Park Science Fellowship, J.K. was supported by the BK21 project of Korean Research Foundation, J.-T.K. was supported by the project of Global Ph.D. Fellowship that National Research Foundation of Korea conducts from 2011, and H.-S.K. was supported by the World Class Institute program of the National Research Foundation of Korea funded by the Ministry of Education, Science and Teclmology (WCI 2009-003).	Arenkiel BR, 2008, NAT METHODS, V5, P299, DOI [10.1038/NMETH.1190, 10.1038/nmeth.1190]; Bunch ME, 1933, J COMP PSYCHOL, V16, P385, DOI 10.1037/h0070466; Buzsaki G, 1996, CEREB CORTEX, V6, P81, DOI 10.1093/cercor/6.2.81; Cavanaugh DJ, 2011, J NEUROSCI, V31, P5067, DOI 10.1523/JNEUROSCI.6451-10.2011; Cole CJ, 2012, NAT NEUROSCI, V15, P1255, DOI 10.1038/nn.3189; Dudai Y, 2012, ANNU REV NEUROSCI, V35, P227, DOI 10.1146/annurev-neuro-062111-150500; Esteban JA, 2003, NAT NEUROSCI, V6, P136, DOI 10.1038/nn997; Frankland PW, 2004, HIPPOCAMPUS, V14, P557, DOI 10.1002/hipo.10208; Goosens KA, 2003, NEURON, V40, P1013, DOI 10.1016/S0896-6273(03)00728-1; Guler AD, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1749; Guzowski JF, 1999, NAT NEUROSCI, V2, P1120, DOI 10.1038/16046; Han JH, 2007, SCIENCE, V316, P457, DOI [10.1126/science.1139438, 10.1126/science.1134697]; Han JH, 2009, SCIENCE, V323, P1492, DOI 10.1126/science.1164139; Hu HL, 2007, CELL, V131, P160, DOI 10.1016/j.cell.2007.09.017; Huff ML, 2013, P NATL ACAD SCI USA, V110, P3597, DOI 10.1073/pnas.1219593110; Inda MC, 2011, J NEUROSCI, V31, P1635, DOI 10.1523/JNEUROSCI.4736-10.2011; Johansen JP, 2010, P NATL ACAD SCI USA, V107, P12692, DOI 10.1073/pnas.1002418107; Josselyn SA, 2001, J NEUROSCI, V21, P2404, DOI 10.1523/JNEUROSCI.21-07-02404.2001; LeDoux JE, 2000, ANNU REV NEUROSCI, V23, P155, DOI 10.1146/annurev.neuro.23.1.155; Lee HK, 2003, CELL, V112, P631, DOI 10.1016/S0092-8674(03)00122-3; Liu X, 2012, NATURE, V484, P381, DOI 10.1038/nature11028; MISANIN JR, 1968, SCIENCE, V160, P554, DOI 10.1126/science.160.3827.554; Monfils MH, 2009, SCIENCE, V324, P951, DOI 10.1126/science.1167975; Nader K, 2000, NATURE, V406, P722, DOI 10.1038/35021052; Oh MC, 2006, J BIOL CHEM, V281, P752, DOI 10.1074/jbc.M509677200; Pickens CL, 2009, BIOL PSYCHIAT, V65, P881, DOI 10.1016/j.biopsych.2008.12.010; Quirk GJ, 1997, NEURON, V19, P613, DOI 10.1016/S0896-6273(00)80375-X; QUIRK GJ, 1995, NEURON, V15, P1029, DOI 10.1016/0896-6273(95)90092-6; Reijmers LG, 2007, SCIENCE, V317, P1230, DOI 10.1126/science.1143839; Repa JC, 2001, NAT NEUROSCI, V4, P724, DOI 10.1038/89512; Roediger H.L., 2007, SCI MEMORY CONCEPTS, DOI [10.1093/acprof:oso/9780195310443.001.0001, DOI 10.1093/ACPROF:OSO/9780195310443.001.0001]; Rumpel S, 2005, SCIENCE, V308, P83, DOI 10.1126/science.1103944; Sara SJ, 2000, NAT REV NEUROSCI, V1, P212, DOI 10.1038/35044575; Shapiro MG, 2012, ACS CHEM NEUROSCI, V3, P619, DOI 10.1021/cn300053q; WILSON MA, 1994, SCIENCE, V265, P676, DOI 10.1126/science.8036517; Zemelman BV, 2003, P NATL ACAD SCI USA, V100, P1352, DOI 10.1073/pnas.242738899; Zhou Y, 2009, NAT NEUROSCI, V12, P1438, DOI 10.1038/nn.2405	37	92	97	0	25	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JAN	2014	17	1					65	72		10.1038/nn.3592	http://dx.doi.org/10.1038/nn.3592			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	281DL	24212670				2022-12-28	WOS:000329080000015
J	Ladewig, J; Koch, P; Brustle, O				Ladewig, Julia; Koch, Philipp; Bruestle, Oliver			Auto-attraction of neural precursors and their neuronal progeny impairs neuronal migration	NATURE NEUROSCIENCE			English	Article							STEM-CELLS; RAT-BRAIN; DIFFERENTIATION; TRANSPLANTATION; INTEGRATION; DISEASE	Limited neuronal migration into host brain tissue is a key challenge in neural transplantation. We found that one important mechanism underlying this phenomenon is an intrinsic chemotactic interaction between the grafted neural precursor cells (NPCs) and their neuronal progeny. NPCs secrete the receptor tyrosine kinase ligands FGF2 and VEGF, which act as chemoattractants for neurons. Interference with these signaling pathways resulted in enhanced migration of human neurons from neural clusters.	[Ladewig, Julia; Koch, Philipp; Bruestle, Oliver] Univ Bonn, LIFE & BRAIN Ctr, Inst Reconstruct Neurobiol, Bonn, Germany; [Ladewig, Julia; Koch, Philipp; Bruestle, Oliver] Hertie Fdn, Bonn, Germany	University of Bonn	Brustle, O (corresponding author), Univ Bonn, LIFE & BRAIN Ctr, Inst Reconstruct Neurobiol, Bonn, Germany.	brustle@uni-bonn.de	Koch, Philipp/M-1186-2016; Koch, Philipp/AAZ-3751-2020	Koch, Philipp/0000-0003-3713-8786	European Union [222943, 2006-018739]; German Research Foundation (DFG) [SFB-TR3]; Hertie Foundation	European Union(European Commission); German Research Foundation (DFG)(German Research Foundation (DFG)); Hertie Foundation	We thank J. Itskovitz-Eldor (Technion, Israel Institute of Technology) for providing the human embryonic stem cells (line H9.2) used for generating the neural precursor cells, B. Steinfarz for preparing and culturing the hippocampal slice cultures, A. Leinhaas for support with the in vivo experiments, E. Endl at the flow cytometry facility of the University Hospital Bonn for cell sorting, the National Institute of Allergy and Infectious Diseases for contributing the C57BL/10SgSnAi[KO] gamma c-[KO]Rag2 mice, and J. Tailor and A. Smith (Wellcome Trust-Medical Research Council Stem Cell Institute) for providing human fetal neural stem cells. This work was supported by the European Union (grant 222943 Neurostemcell; LSHG-CT-2006-018739, ESTOOLS), the German Research Foundation (DFG; SFB-TR3) and the Hertie Foundation.	Barker RA, 2013, LANCET NEUROL, V12, P84, DOI 10.1016/S1474-4422(12)70295-8; Fricker RA, 1999, J NEUROSCI, V19, P5990, DOI 10.1523/JNEUROSCI.19-14-05990.1999; Hilberg F, 2008, CANCER RES, V68, P4774, DOI 10.1158/0008-5472.CAN-07-6307; Kinouchi R, 2003, NAT NEUROSCI, V6, P863, DOI 10.1038/nn1088; Koch P, 2009, LANCET NEUROL, V8, P819, DOI 10.1016/S1474-4422(09)70202-9; Koch P, 2009, P NATL ACAD SCI USA, V106, P3225, DOI 10.1073/pnas.0808387106; Ladewig J, 2008, STEM CELLS, V26, P1705, DOI 10.1634/stemcells.2008-0007; Lindvall O, 2009, TRENDS PHARMACOL SCI, V30, P260, DOI 10.1016/j.tips.2009.03.001; REIER PJ, 1983, DEV BRAIN RES, V10, P201, DOI 10.1016/0165-3806(83)90137-2; Roy NS, 2006, NAT MED, V12, P1259, DOI 10.1038/nm1495; Shi YC, 2012, NAT NEUROSCI, V15, P477, DOI 10.1038/nn.3041; Svendsen C N, 2000, Prog Brain Res, V127, P13; Tabar V, 2005, NAT BIOTECHNOL, V23, P601, DOI 10.1038/nbt1088; Tailor J, 2013, J NEUROSCI, V33, P12407, DOI 10.1523/JNEUROSCI.0130-13.2013; ZICHA D, 1991, J CELL SCI, V99, P769	15	28	28	0	12	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JAN	2014	17	1					24	26		10.1038/nn.3583	http://dx.doi.org/10.1038/nn.3583			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	281DL	24241396				2022-12-28	WOS:000329080000008
J	Vaidya, SP; Johnston, D				Vaidya, Sachin P.; Johnston, Daniel			Temporal synchrony and gamma-to-theta power conversion in the dendrites of CA1 pyramidal neurons	NATURE NEUROSCIENCE			English	Article							RAT HIPPOCAMPAL-NEURONS; I-H; INTRINSIC EXCITABILITY; FREQUENCY PREFERENCES; PHASE-PRECESSION; CELL ASSEMBLIES; OSCILLATIONS; RESONANCE; CURRENTS; RHYTHM	Timing is a crucial aspect of synaptic integration. For pyramidal neurons that integrate thousands of synaptic inputs spread across hundreds of microns, it is thus a challenge to maintain the timing of incoming inputs at the axo-somatic integration site. Here we show that pyramidal neurons in the rodent hippocampus use a gradient of inductance in the form of hyperpolarization-activated cation-nonselective (HCN) channels as an active mechanism to counteract location-dependent temporal differences of dendritic inputs at the soma. Using simultaneous multi-site whole-cell recordings complemented by computational modeling, we find that this intrinsic biophysical mechanism produces temporal synchrony of rhythmic inputs in the theta and gamma frequency ranges across wide regions of the dendritic tree. While gamma and theta oscillations are known to synchronize activity across space in neuronal networks, our results identify a new mechanism by which this synchrony extends to activity within single pyramidal neurons with complex dendritic arbors.	[Vaidya, Sachin P.] Univ Texas Austin, Inst Neurosci Grad Program, Austin, TX 78712 USA; [Vaidya, Sachin P.; Johnston, Daniel] Univ Texas Austin, Ctr Learning & Memory, Austin, TX 78712 USA	University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin	Johnston, D (corresponding author), Univ Texas Austin, Ctr Learning & Memory, Austin, TX 78712 USA.	djohnston@mail.clm.utexas.edu	Vaidya, Sachin/V-8570-2018	Vaidya, Sachin/0000-0002-4773-0487	US National Institutes of Health [MH 048432]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH094839, R01MH048432] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS084473] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank R. Chitwood, N. Dembrow, R. Gray and R. Narayanan for helpful discussions during the course of this study. We also thank members of the Johnston laboratory and L.L. Colgin for comments on earlier versions of this manuscript. This work was supported by grant MH 048432 from US National Institutes of Health to D.J.	Alexander C., 2004, FUNDAMENTALS ELECT C; Angelo K, 2007, J NEUROSCI, V27, P8643, DOI 10.1523/JNEUROSCI.5284-06.2007; Brager DH, 2007, J NEUROSCI, V27, P13926, DOI 10.1523/JNEUROSCI.3520-07.2007; BRAGIN A, 1995, J NEUROSCI, V15, P47; Buzsaki G, 2005, HIPPOCAMPUS, V15, P827, DOI 10.1002/hipo.20113; Buzsaki G, 2011, RHYTHMS BRAIN; Buzsaki G, 2013, NAT NEUROSCI, V16, P130, DOI 10.1038/nn.3304; Buzsaki G, 2010, NEURON, V68, P362, DOI 10.1016/j.neuron.2010.09.023; Cassenaer S, 2007, NATURE, V448, P709, DOI 10.1038/nature05973; Chrobak JJ, 2000, HIPPOCAMPUS, V10, P457, DOI 10.1002/1098-1063(2000)10:4<457::AID-HIPO12>3.0.CO;2-Z; Cole KS, 1941, J GEN PHYSIOL, V24, P535, DOI 10.1085/jgp.24.4.535; COLE KS, 1968, MEMBRANES IONS IMPUL; Colgin LL, 2010, PHYSIOLOGY, V25, P319, DOI 10.1152/physiol.00021.2010; Colgin LL, 2009, NATURE, V462, P353, DOI 10.1038/nature08573; Cook EP, 2007, J NEUROPHYSIOL, V98, P2943, DOI 10.1152/jn.00414.2007; Dougherty KA, 2012, J PHYSIOL-LONDON, V590, P5707, DOI 10.1113/jphysiol.2012.242693; Engel AK, 2001, NAT REV NEUROSCI, V2, P704, DOI 10.1038/35094565; Fan Y, 2005, NAT NEUROSCI, V8, P1542, DOI 10.1038/nn1568; Gasparini S, 2006, J NEUROSCI, V26, P2088, DOI 10.1523/JNEUROSCI.4428-05.2006; Golding NL, 2005, J PHYSIOL-LONDON, V568, P69, DOI 10.1113/jphysiol.2005.086793; Hahnloser RHR, 2002, NATURE, V419, P65, DOI 10.1038/nature00974; Harris KD, 2003, NATURE, V424, P552, DOI 10.1038/nature01834; Harvey CD, 2009, NATURE, V461, P941, DOI 10.1038/nature08499; Hu H, 2002, J PHYSIOL-LONDON, V545, P783, DOI 10.1113/jphysiol.2002.029249; Hu H, 2009, J NEUROSCI, V29, P14472, DOI 10.1523/JNEUROSCI.0187-09.2009; Hutcheon B, 2000, TRENDS NEUROSCI, V23, P216, DOI 10.1016/S0166-2236(00)01547-2; Jensen O, 2007, TRENDS COGN SCI, V11, P267, DOI 10.1016/j.tics.2007.05.003; Kamondi A, 1998, HIPPOCAMPUS, V8, P244, DOI 10.1002/(SICI)1098-1063(1998)8:3<244::AID-HIPO7>3.0.CO;2-J; LEUNG LWS, 1986, BRAIN RES, V367, P323, DOI 10.1016/0006-8993(86)91611-2; Magee JC, 2000, NAT NEUROSCI, V3, P895, DOI 10.1038/78800; Magee JC, 1999, NAT NEUROSCI, V2, P508, DOI 10.1038/9158; Magee JC, 1998, J NEUROSCI, V18, P7613; MAURO A, 1961, BIOPHYS J, V1, P353, DOI 10.1016/S0006-3495(61)86894-X; Megias M, 2001, NEUROSCIENCE, V102, P527, DOI 10.1016/S0306-4522(00)00496-6; Narayanan R, 2008, J NEUROSCI, V28, P5846, DOI 10.1523/JNEUROSCI.0835-08.2008; Narayanan R, 2007, NEURON, V56, P1061, DOI 10.1016/j.neuron.2007.10.033; OKEEFE J, 1993, HIPPOCAMPUS, V3, P317, DOI 10.1002/hipo.450030307; Oren I, 2006, J NEUROSCI, V26, P9923, DOI 10.1523/JNEUROSCI.1580-06.2006; Pike FG, 2000, J PHYSIOL-LONDON, V529, P205, DOI 10.1111/j.1469-7793.2000.00205.x; RALL W, 1967, J NEUROPHYSIOL, V30, P1138, DOI 10.1152/jn.1967.30.5.1138; Robinson RB, 2003, ANNU REV PHYSIOL, V65, P453, DOI 10.1146/annurev.physiol.65.092101.142734; SINGER W, 1995, ANNU REV NEUROSCI, V18, P555, DOI 10.1146/annurev.neuro.18.1.555; Skaggs WE, 1996, HIPPOCAMPUS, V6, P149, DOI 10.1002/(SICI)1098-1063(1996)6:2<149::AID-HIPO6>3.0.CO;2-K; Takahashi H, 2009, NEURON, V62, P102, DOI 10.1016/j.neuron.2009.03.007; Ulrich D, 2002, J NEUROPHYSIOL, V87, P2753, DOI 10.1152/jn.2002.87.6.2753; Wehr M, 1996, NATURE, V384, P162, DOI 10.1038/384162a0; Williams SR, 2000, J NEUROPHYSIOL, V83, P3177, DOI 10.1152/jn.2000.83.5.3177	47	84	84	0	17	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	DEC	2013	16	12					1812	1820		10.1038/nn.3562	http://dx.doi.org/10.1038/nn.3562			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	257VV	24185428	Green Accepted			2022-12-28	WOS:000327416800019
J	Smear, M; Resulaj, A; Zhang, JJ; Bozza, T; Rinberg, D				Smear, Matthew; Resulaj, Admir; Zhang, Jingji; Bozza, Thomas; Rinberg, Dmitry			Multiple perceptible signals from a single olfactory glomerulus	NATURE NEUROSCIENCE			English	Article							RECEPTOR NEURON INPUT; ODOR DISCRIMINATION; BULB GLOMERULI; DROSOPHILA; MOUSE; MAP; ACCURACY; SPEED; REPRESENTATIONS; ORGANIZATION	Glomeruli are functional units in the olfactory system. The mouse olfactory bulb contains roughly 2,000 glomeruli, each receiving inputs from olfactory sensory neurons (OSNs) that express a specific odorant receptor gene. Odors typically activate many glomeruli in complex combinatorial patterns and it is unknown which features of neuronal activity in individual glomeruli contribute to odor perception. To address this, we used optogenetics to selectively activate single, genetically identified glomeruli in behaving mice. We found that mice could perceive the stimulation of a single glomerulus. Single-glomerulus stimulation was also detected on an intense odor background. In addition, different input intensities and the timing of input relative to sniffing were discriminated through one glomerulus. Our data suggest that each glomerulus can transmit odor information using identity, intensity and temporal coding cues. These multiple modes of information transmission may enable the olfactory system to efficiently identify and localize odor sources.	[Smear, Matthew; Resulaj, Admir; Rinberg, Dmitry] Howard Hughes Med Inst, Ashburn, VA USA; [Resulaj, Admir; Rinberg, Dmitry] NYU, Langone Med Ctr, New York Univ Neurosci Inst, New York, NY USA; [Zhang, Jingji; Bozza, Thomas] Northwestern Univ, Dept Neurobiol, Evanston, IL USA	Howard Hughes Medical Institute; New York University; NYU Langone Medical Center; Northwestern University	Rinberg, D (corresponding author), Howard Hughes Med Inst, Janelia Farm Res Campus, Ashburn, VA USA.	bozza@northwestern.edu; dmitry.rinberg@nyumc.org			National Institute on Deafness and Other Communication Disorders [R01DC009640, R21DC010911]; Whitehall Foundation; Brain Research Foundation; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R21DC010911, R01DC009640] Funding Source: NIH RePORTER	National Institute on Deafness and Other Communication Disorders(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); Whitehall Foundation; Brain Research Foundation; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	We thank C. Guo and the gene targeting facility at Janelia Farm for generation of chimeric mice, B. Weiland for technical help with cloning and gene targeting, M. Karlsson for designing the behavioral controller box, and K. Svoboda, G. Fishell, R. Egnor and Y. Sirotin for comments on the manuscript. This work was supported by the Visiting Scientist Program at the Janelia Farm Research Center. T.B. was supported by funding from the National Institute on Deafness and Other Communication Disorders (R01DC009640 and R21DC010911), the Whitehall Foundation and the Brain Research Foundation.	Abraham NM, 2004, NEURON, V44, P865, DOI 10.1016/j.neuron.2004.11.017; Apicella A, 2010, J NEUROSCI, V30, P14255, DOI 10.1523/JNEUROSCI.2747-10.2010; Aungst JL, 2003, NATURE, V426, P623, DOI 10.1038/nature02185; Bozza T, 2004, NEURON, V42, P9, DOI 10.1016/S0896-6273(04)00144-8; Carey RM, 2009, J NEUROPHYSIOL, V101, P1073, DOI 10.1152/jn.90902.2008; CHAPUT M, 1980, J PHYSIOL-PARIS, V76, P551; DasGupta S, 2008, CURR BIOL, V18, P1668, DOI 10.1016/j.cub.2008.08.071; Davison IG, 2011, NEURON, V70, P82, DOI 10.1016/j.neuron.2011.02.047; Hildebrand JG, 1997, ANNU REV NEUROSCI, V20, P595, DOI 10.1146/annurev.neuro.20.1.595; Hopfield JJ, 1999, P NATL ACAD SCI USA, V96, P12506, DOI 10.1073/pnas.96.22.12506; Kato HK, 2012, NEURON, V76, P962, DOI 10.1016/j.neuron.2012.09.037; Koulakov A, 2007, J NEUROPHYSIOL, V98, P3134, DOI 10.1152/jn.00560.2007; Liu SL, 2013, J NEUROSCI, V33, P2916, DOI 10.1523/JNEUROSCI.3607-12.2013; MACRIDES F, 1972, SCIENCE, V175, P84, DOI 10.1126/science.175.4017.84; Malnic B, 1999, CELL, V96, P713, DOI 10.1016/S0092-8674(00)80581-4; Mombaerts P, 1996, CELL, V87, P675, DOI 10.1016/S0092-8674(00)81387-2; Mori K, 1999, SCIENCE, V286, P711, DOI 10.1126/science.286.5440.711; Mori K, 2011, ANNU REV NEUROSCI, V34, P467, DOI 10.1146/annurev-neuro-112210-112917; Potter SM, 2001, J NEUROSCI, V21, P9713, DOI 10.1523/JNEUROSCI.21-24-09713.2001; RESSLER KJ, 1994, CELL, V79, P1245, DOI 10.1016/0092-8674(94)90015-9; Rinberg D, 2006, J NEUROSCI, V26, P8857, DOI 10.1523/JNEUROSCI.0884-06.2006; Rinberg D, 2006, NEURON, V51, P351, DOI 10.1016/j.neuron.2006.07.013; Rubin BD, 1999, NEURON, V23, P499, DOI 10.1016/S0896-6273(00)80803-X; Semmelhack JL, 2009, NATURE, V459, P218, DOI 10.1038/nature07983; Shepherd G.M., 1998, SYNAPTIC ORG BRAIN, P159; Smear M, 2011, NATURE, V479, P397, DOI 10.1038/nature10521; SOBEL EC, 1993, J NEUROPHYSIOL, V69, P1331, DOI 10.1152/jn.1993.69.4.1331; Soucy ER, 2009, NAT NEUROSCI, V12, P210, DOI 10.1038/nn.2262; Spors H, 2006, J NEUROSCI, V26, P1247, DOI 10.1523/JNEUROSCI.3100-05.2006; Stensmyr MC, 2012, CELL, V151, P1345, DOI 10.1016/j.cell.2012.09.046; STEWART WB, 1979, J COMP NEUROL, V185, P715, DOI 10.1002/cne.901850407; Suh GSB, 2004, NATURE, V431, P854, DOI 10.1038/nature02980; Uchida N, 2003, NAT NEUROSCI, V6, P1224, DOI 10.1038/nn1142; VASSAR R, 1994, CELL, V79, P981, DOI 10.1016/0092-8674(94)90029-9; Wachowiak M, 2001, NEURON, V32, P723, DOI 10.1016/S0896-6273(01)00506-2; Wilson RI, 2006, ANNU REV NEUROSCI, V29, P163, DOI 10.1146/annurev.neuro.29.051605.112950; Zhang J., 2012, MOL CELL NEUROSCI	37	71	72	0	39	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	NOV	2013	16	11					1687	1691		10.1038/nn.3519	http://dx.doi.org/10.1038/nn.3519			5	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	241YX	24056698				2022-12-28	WOS:000326205700027
J	Picard, N; Matsuzaka, Y; Strick, PL				Picard, Nathalie; Matsuzaka, Yoshiya; Strick, Peter L.			Extended practice of a motor skill is associated with reduced metabolic activity in M1	NATURE NEUROSCIENCE			English	Article							CEREBRAL-BLOOD-FLOW; LONG-TERM PRACTICE; CORTICAL REPRESENTATION; NEURONAL-ACTIVITY; FUNCTIONAL MRI; SOMATOSENSORY CORTEX; MOVEMENT PARAMETERS; SYNAPTIC ACTIVITY; PIANO PLAYERS; NON-MUSICIANS	How does long-term training and the development of motor skills modify the activity of the primary motor cortex (M1)? To address this issue, we trained monkeys for similar to 1-6 years to perform visually guided and internally generated sequences of reaching movements. Then, we used [C-14] 2-deoxyglucose (2DG) uptake and single-neuron recording to measure metabolic and neuron activity in M1. After extended practice, we observed a profound reduction of metabolic activity in M1 for the performance of internally generated compared to visually guided tasks. In contrast, measures of neuron firing displayed little difference during the two tasks. These findings suggest that the development of skill through extended practice results in a reduction in the synaptic activity required to produce internally generated, but not visually guided, sequences of movements. Thus, practice leading to skilled performance results in more efficient generation of neuronal activity in M1.	[Picard, Nathalie; Strick, Peter L.] Univ Pittsburgh, Sch Med, Ctr Neural Basis Cognit, Pittsburgh, PA 15213 USA; [Picard, Nathalie; Strick, Peter L.] Univ Pittsburgh, Sch Med, Syst Neurosci Inst, Pittsburgh, PA USA; [Picard, Nathalie; Strick, Peter L.] Univ Pittsburgh, Sch Med, Dept Neurobiol, Pittsburgh, PA USA; [Strick, Peter L.] Dept Vet Affairs Med Ctr, Res Serv, Pittsburgh, PA USA; [Strick, Peter L.] Univ Pittsburgh, Sch Med, Dept Psychiat & Neurol Surg, Pittsburgh, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Strick, PL (corresponding author), Univ Pittsburgh, Sch Med, Ctr Neural Basis Cognit, Pittsburgh, PA 15213 USA.	strickp@pitt.edu			Office of Research and Development, Medical Research Service, Department of Veterans Affairs, US National Institutes of Health [R01 NS24328, P30 NS076405, P01 NS044393]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS024328, P30NS076405, P01NS044393] Funding Source: NIH RePORTER	Office of Research and Development, Medical Research Service, Department of Veterans Affairs, US National Institutes of Health; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This material is based on work supported in part by the Office of Research and Development, Medical Research Service, Department of Veterans Affairs, US National Institutes of Health grants R01 NS24328 (P.L.S.), P30 NS076405 (P.L.S.) and P01 NS044393 (P.L.S.). The contents do not represent the views of the Department of Veterans Affairs or the US Government. We are grateful to M. Page for the development of computer programs, and to M. O'Malley and K. McDonald for their expert technical assistance.	ADAMS JA, 1987, PSYCHOL BULL, V101, P41, DOI 10.1037/0033-2909.101.1.41; Adkins DL, 2006, J APPL PHYSIOL, V101, P1776, DOI 10.1152/japplphysiol.00515.2006; Amunts K, 1997, HUM BRAIN MAPP, V5, P206, DOI 10.1002/(SICI)1097-0193(1997)5:3<206::AID-HBM5>3.0.CO;2-7; ASHE J, 1994, CEREB CORTEX, V4, P590, DOI 10.1093/cercor/4.6.590; Ben-Shaul Y, 2004, J NEUROPHYSIOL, V91, P1748, DOI 10.1152/jn.00957.2003; Crammond DJ, 2000, J NEUROPHYSIOL, V84, P986, DOI 10.1152/jn.2000.84.2.986; Dayan E, 2011, NEURON, V72, P443, DOI 10.1016/j.neuron.2011.10.008; Devor A, 2008, J NEUROSCI, V28, P14347, DOI 10.1523/JNEUROSCI.4307-08.2008; ELBERT T, 1995, SCIENCE, V270, P305, DOI 10.1126/science.270.5234.305; Floyer-Lea A, 2004, J NEUROPHYSIOL, V92, P2405, DOI 10.1152/jn.01092.2003; Fu M, 2012, NATURE, V483, P92, DOI 10.1038/nature10844; FU QG, 1993, J NEUROPHYSIOL, V70, P2097, DOI 10.1152/jn.1993.70.5.2097; Gaser C, 2003, J NEUROSCI, V23, P9240; Gregoriou GG, 2005, NEUROIMAGE, V27, P442, DOI 10.1016/j.neuroimage.2005.02.038; Grill-Spector K, 2006, TRENDS COGN SCI, V10, P14, DOI 10.1016/j.tics.2005.11.006; Hamilton AFD, 2009, HUM BRAIN MAPP, V30, P2898, DOI 10.1002/hbm.20717; Hanakawa T, 2008, CEREB CORTEX, V18, P2775, DOI 10.1093/cercor/bhn036; Haslinger B, 2004, HUM BRAIN MAPP, V22, P206, DOI 10.1002/hbm.20028; Hlustik P, 2004, J CLIN NEUROPHYSIOL, V21, P180; Hund-Georgiadis M, 1999, EXP BRAIN RES, V125, P417, DOI 10.1007/s002210050698; Jancke L, 2000, COGNITIVE BRAIN RES, V10, P177, DOI 10.1016/S0926-6410(00)00028-8; Johnson PB, 1996, CEREB CORTEX, V6, P102, DOI 10.1093/cercor/6.2.102; JUEPTNER M, 1995, NEUROIMAGE, V2, P148, DOI 10.1006/nimg.1995.1017; JULIANO SL, 1987, J COMP NEUROL, V263, P514, DOI 10.1002/cne.902630405; KARNI A, 1995, NATURE, V377, P155; Kelly AMC, 2005, CEREB CORTEX, V15, P1089, DOI 10.1093/cercor/bhi005; Kilavik BE, 2009, J NEUROSCI, V29, P12653, DOI 10.1523/JNEUROSCI.1554-09.2009; Kim DS, 2004, NEUROIMAGE, V21, P876, DOI 10.1016/j.neuroimage.2003.10.018; Krings T, 2000, NEUROSCI LETT, V278, P189, DOI 10.1016/S0304-3940(99)00930-1; Landau SM, 2006, COGN AFFECT BEHAV NE, V6, P246, DOI 10.3758/CABN.6.3.246; Li CSR, 2001, NEURON, V30, P593, DOI 10.1016/S0896-6273(01)00301-4; Logothetis NK, 2008, NATURE, V453, P869, DOI 10.1038/nature06976; Lu XF, 2005, NEURON, V45, P967, DOI 10.1016/j.neuron.2005.01.036; Magistretti PJ, 2006, J EXP BIOL, V209, P2304, DOI 10.1242/jeb.02208; MATSUNAMI K, 1995, NEUROSCI RES, V23, P365, DOI 10.1016/0168-0102(95)00964-U; Matsuzaka Y, 2007, J NEUROPHYSIOL, V97, P1819, DOI 10.1152/jn.00784.2006; Meister I, 2005, HUM BRAIN MAPP, V25, P345, DOI 10.1002/hbm.20112; Moran DW, 1999, J NEUROPHYSIOL, V82, P2676, DOI 10.1152/jn.1999.82.5.2676; MUSHIAKE H, 1993, J NEUROPHYSIOL, V70, P2660, DOI 10.1152/jn.1993.70.6.2660; MUSHIAKE H, 1991, J NEUROPHYSIOL, V66, P705, DOI 10.1152/jn.1991.66.3.705; NUDO RJ, 1986, J COMP NEUROL, V245, P553, DOI 10.1002/cne.902450410; Orban P, 2011, NEUROSCIENCE, V179, P94, DOI 10.1016/j.neuroscience.2011.01.040; Paz R, 2003, NAT NEUROSCI, V6, P882, DOI 10.1038/nn1097; Picard N, 2003, CEREB CORTEX, V13, P977, DOI 10.1093/cercor/13.9.977; Poldrack RA, 2000, NEUROIMAGE, V12, P1, DOI 10.1006/nimg.2000.0596; Proctor R. W., 1995, SKILL ACQUISITION HU; Rathelot JA, 2009, P NATL ACAD SCI USA, V106, P918, DOI 10.1073/pnas.0808362106; Rioult-Pedotti MS, 2000, SCIENCE, V290, P533, DOI 10.1126/science.290.5491.533; Savaki HE, 1999, PROG NEUROBIOL, V58, P473, DOI 10.1016/S0301-0082(98)00080-X; Schwenkreis P, 2007, EUR J NEUROSCI, V26, P3291, DOI 10.1111/j.1460-9568.2007.05894.x; Shulman RG, 1999, P NATL ACAD SCI USA, V96, P3245, DOI 10.1073/pnas.96.6.3245; Smith AJ, 2002, P NATL ACAD SCI USA, V99, P10765, DOI 10.1073/pnas.132272199; SOKOLOFF L, 1977, J NEUROCHEM, V28, P897, DOI 10.1111/j.1471-4159.1977.tb10649.x; SOKOLOFF L, 1993, DEV NEUROSCI-BASEL, V15, P194, DOI 10.1159/000111335; Stark E, 2007, EUR J NEUROSCI, V26, P1055, DOI 10.1111/j.1460-9568.2007.05711.x; Swain RA, 2003, NEUROSCIENCE, V117, P1037, DOI 10.1016/S0306-4522(02)00664-4; Turner RS, 2003, J NEUROPHYSIOL, V90, P3958, DOI 10.1152/jn.00323.2003; Wang W, 2007, J NEUROPHYSIOL, V97, P4258, DOI 10.1152/jn.01180.2006; Xiong JH, 2009, NEUROIMAGE, V45, P75, DOI 10.1016/j.neuroimage.2008.11.016	59	74	74	0	28	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	SEP	2013	16	9					1340	U237		10.1038/nn.3477	http://dx.doi.org/10.1038/nn.3477			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	207KN	23912947	Green Accepted			2022-12-28	WOS:000323597500027
J	Rudebeck, PH; Saunders, RC; Prescott, AT; Chau, LS; Murray, EA				Rudebeck, Peter H.; Saunders, Richard C.; Prescott, Anna T.; Chau, Lily S.; Murray, Elisabeth A.			Prefrontal mechanisms of behavioral flexibility, emotion regulation and value updating	NATURE NEUROSCIENCE			English	Article							PRIMATE ORBITOFRONTAL CORTEX; DECISION-MAKING; RHESUS-MONKEYS; BASOLATERAL AMYGDALA; FRONTAL-CORTEX; FIBER PATHWAYS; REWARD VALUE; REVERSAL; LESIONS; NEURONS	Two ideas have dominated neuropsychology concerning the orbitofrontal cortex (OFC). One holds that OFC regulates emotion and enhances behavioral flexibility through inhibitory control. The other ascribes to OFC a role in updating valuations on the basis of current motivational states. Neuroimaging, neurophysiological and clinical observations are consistent with either or both hypotheses. Although these hypotheses are compatible in principle, we present results supporting the latter view of OFC function and arguing against the former. We found that excitotoxic, fiber-sparing lesions confined to OFC in monkeys did not alter either behavioral flexibility, as measured by object reversal learning, or emotion regulation, as assessed by fear of snakes. A follow-up experiment indicated that a previously reported loss of inhibitory control resulted from damage to nearby fiber tracts and not from OFC dysfunction. Thus, OFC has a more specialized role in reward-guided behavior and emotion than has been thought, a function that includes value updating.	[Rudebeck, Peter H.; Saunders, Richard C.; Prescott, Anna T.; Chau, Lily S.; Murray, Elisabeth A.] NIMH, Sect Neurobiol Learning & Memory, Neuropsychol Lab, US Natl Inst Hlth, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH)	Rudebeck, PH (corresponding author), NIMH, Sect Neurobiol Learning & Memory, Neuropsychol Lab, US Natl Inst Hlth, Bethesda, MD 20892 USA.	rudebeckp@mail.nih.gov	Murray, Elisabeth A./X-2051-2019	Rudebeck, Peter/0000-0002-1411-7555; Murray, Elisabeth/0000-0003-1450-1642	Intramural Research Program of the US National Institute of Mental Health; NATIONAL INSTITUTE OF MENTAL HEALTH [ZIAMH002887] Funding Source: NIH RePORTER	Intramural Research Program of the US National Institute of Mental Health; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank D. Lundgren and E. Howland for assistance with data collection and R. Reoli for help performing surgery. We also thank S. Wise and M. Walton for comments on an earlier version of the manuscript. This work was supported by the Intramural Research Program of the US National Institute of Mental Health.	Baxter MG, 2009, EUR J NEUROSCI, V29, P2049, DOI 10.1111/j.1460-9568.2009.06740.x; Bechara A, 2000, CEREB CORTEX, V10, P295, DOI 10.1093/cercor/10.3.295; Blair RJR, 2010, BRIT J PSYCHOL, V101, P383, DOI 10.1348/000712609X418480; Burke KA, 2008, NATURE, V454, P340, DOI 10.1038/nature06993; Bush EC, 2004, ANAT REC PART A, V281A, P1083, DOI 10.1002/ar.a.20113; BUTTER CM, 1969, PHYSIOL BEHAV, V4, P163, DOI 10.1016/0031-9384(69)90075-4; Chudasama Y, 2003, J NEUROSCI, V23, P8771; Chudasama Y., 2012, CEREB, DOI DOI 10.1093/CERC0R/BHS266; Chudasama Y, 2009, EUR J NEUROSCI, V30, P2327, DOI 10.1111/j.1460-9568.2009.07012.x; Clark L, 2004, BRAIN COGNITION, V55, P41, DOI 10.1016/s0278-2626(03)00284-7; Croxson PL, 2005, J NEUROSCI, V25, P8854, DOI 10.1523/JNEUROSCI.1311-05.2005; Davidson RJ, 2000, SCIENCE, V289, P591, DOI 10.1126/science.289.5479.591; Dias R, 1996, NATURE, V380, P69, DOI 10.1038/380069a0; Fellows LK, 2003, BRAIN, V126, P1830, DOI 10.1093/brain/awg180; Frank MJ, 2006, PSYCHOL REV, V113, P300, DOI 10.1037/0033-295X.113.2.300; Gottfried JA, 2003, SCIENCE, V301, P1104, DOI 10.1126/science.1087919; Haber SN, 2006, J NEUROSCI, V26, P8368, DOI 10.1523/JNEUROSCI.0271-06.2006; Holland PC, 2004, CURR OPIN NEUROBIOL, V14, P148, DOI 10.1016/j.conb.2004.03.007; Hornak J, 2004, J COGNITIVE NEUROSCI, V16, P463, DOI 10.1162/089892904322926791; IVERSEN SD, 1970, EXP BRAIN RES, V11, P376; Izquierdo A, 2005, J NEUROSCI, V25, P8534, DOI 10.1523/JNEUROSCI.1232-05.2005; Izquierdo A, 2004, J NEUROSCI, V24, P7540, DOI 10.1523/JNEUROSCI.1921-04.2004; Izquierdo A, 2007, J NEUROSCI, V27, P1054, DOI 10.1523/JNEUROSCI.3616-06.2007; Kazama A, 2009, J NEUROSCI, V29, P2794, DOI 10.1523/JNEUROSCI.4655-08.2009; KITT CA, 1987, BRAIN RES, V406, P192, DOI 10.1016/0006-8993(87)90783-9; Mineka S., 1987, THEORETICAL FDN BEHA; Mishkin M., 1964, FRONTAL GRANULAR COR, P219; Morrison SE, 2009, J NEUROSCI, V29, P11471, DOI 10.1523/JNEUROSCI.1815-09.2009; Murray EA, 1998, BEHAV NEUROSCI, V112, P1291, DOI 10.1037/0735-7044.112.6.1291; Murray EA, 2007, J NEUROSCI, V27, P8166, DOI 10.1523/JNEUROSCI.1556-07.2007; Murray EA, 2011, BIOL PSYCHIAT, V69, pE43, DOI 10.1016/j.biopsych.2010.09.041; Padoa-Schioppa C, 2006, NATURE, V441, P223, DOI 10.1038/nature04676; Passingham REP, 2012, NEUROBIOLOGY PREFRON; Roberts AC, 2000, CEREB CORTEX, V10, P252, DOI 10.1093/cercor/10.3.252; ROLLS ET, 1994, J NEUROL NEUROSUR PS, V57, P1518, DOI 10.1136/jnnp.57.12.1518; ROLLS ET, 1999, BRAIN EMOTION; Rudebeck PH, 2006, SCIENCE, V313, P1310, DOI 10.1126/science.1128197; Rudebeck PH, 2011, J NEUROSCI, V31, P10569, DOI 10.1523/JNEUROSCI.0091-11.2011; SAVER JL, 1991, NEUROPSYCHOLOGIA, V29, P1241, DOI 10.1016/0028-3932(91)90037-9; Schmahmann JD, 2007, BRAIN, V130, P630, DOI 10.1093/brain/awl359; Schoenbaum G, 2003, LEARN MEMORY, V10, P129, DOI 10.1101/lm.55203; Schoenbaum G, 1999, J NEUROSCI, V19, P1876; Schoenbaum G, 2009, NAT REV NEUROSCI, V10, P885, DOI 10.1038/nrn2753; Stevens JR, 2005, BIOL LETTERS, V1, P223, DOI 10.1098/rsbl.2004.0285; Tremblay L, 1999, NATURE, V398, P704, DOI 10.1038/19525; Wallis JD, 2007, ANNU REV NEUROSCI, V30, P31, DOI 10.1146/annurev.neuro.30.051606.094334; Walton ME, 2010, NEURON, V65, P927, DOI 10.1016/j.neuron.2010.02.027; Watson KK, 2012, CURR BIOL, V22, P2268, DOI 10.1016/j.cub.2012.10.016	49	251	255	1	66	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	AUG	2013	16	8					1140	U225		10.1038/nn.3440	http://dx.doi.org/10.1038/nn.3440			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	190EV	23792944	Green Accepted			2022-12-28	WOS:000322323000026
J	McNamee, D; Rangel, A; O'Doherty, JP				McNamee, Daniel; Rangel, Antonio; O'Doherty, John P.			Category-dependent and category-independent goal-value codes in human ventromedial prefrontal cortex	NATURE NEUROSCIENCE			English	Article							HUMAN ORBITOFRONTAL CORTEX; CONNECTIVITY-BASED PARCELLATION; DECISION-MAKING; SUBJECTIVE VALUE; REWARD; REPRESENTATION; CHOICE; NEUROBIOLOGY; COMPUTATIONS; CLASSIFIERS	To choose between manifestly distinct options, it is suggested that the brain assigns values to goals using a common currency. Although previous studies have reported activity in ventromedial prefrontal cortex (vmPFC) correlating with the value of different goal stimuli, it remains unclear whether such goal-value representations are independent of the associated stimulus categorization, as required by a common currency. Using multivoxel pattern analyses on functional magnetic resonance imaging (fMRI) data, we found a region of medial prefrontal cortex to contain a distributed goal-value code that is independent of stimulus category. More ventrally in the vmPFC, we found spatially distinct areas of the medial orbitofrontal cortex to contain unique category-dependent distributed value codes for food and consumer items. These results implicate the medial prefrontal cortex in the implementation of a common currency and suggest a ventral versus dorsal topographical organization of value signals in the vmPFC.	[McNamee, Daniel; O'Doherty, John P.] Trinity Coll Dublin, Inst Neurosci, Dublin, Ireland; [McNamee, Daniel; Rangel, Antonio; O'Doherty, John P.] CALTECH, Pasadena, CA 91125 USA; [Rangel, Antonio; O'Doherty, John P.] CALTECH, Div Humanities & Social Sci, Pasadena, CA 91125 USA	Trinity College Dublin; California Institute of Technology; California Institute of Technology	McNamee, D (corresponding author), Trinity Coll Dublin, Inst Neurosci, Dublin, Ireland.	dmcnamee@caltech.edu	McNamee, Daniel/AAK-4700-2020; O'Doherty, John P/F-1204-2013	McNamee, Daniel/0000-0001-9928-4960; 	Science Foundation Ireland [08/IN.1/B1844]; Gordon and Betty foundation; NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH094258] Funding Source: NIH RePORTER; Direct For Biological Sciences [0922982] Funding Source: National Science Foundation	Science Foundation Ireland(Science Foundation IrelandEuropean Commission); Gordon and Betty foundation; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	We thank V. Chib and E. Boorman for helpful discussions, and J. Stanley for assistance. This work was funded by Science Foundation Ireland grant 08/IN.1/B1844 and a grant from the Gordon and Betty foundation (to J.P.O.).	Balleine BW, 1998, NEUROPHARMACOLOGY, V37, P407, DOI 10.1016/S0028-3908(98)00033-1; BECHARA A, 1994, COGNITION, V50, P7, DOI 10.1016/0010-0277(94)90018-3; BECKER GM, 1964, BEHAV SCI, V9, P226, DOI 10.1002/bs.3830090304; Beckmann M, 2009, J NEUROSCI, V29, P1175, DOI 10.1523/JNEUROSCI.3328-08.2009; Cai XY, 2012, J NEUROSCI, V32, P3791, DOI 10.1523/JNEUROSCI.3864-11.2012; Chib VS, 2009, J NEUROSCI, V29, P12315, DOI 10.1523/JNEUROSCI.2575-09.2009; Chumbley J, 2010, NEUROIMAGE, V49, P3057, DOI 10.1016/j.neuroimage.2009.10.090; Clithero JA, 2011, NEUROIMAGE, V56, P699, DOI 10.1016/j.neuroimage.2010.03.057; Croxson PL, 2005, J NEUROSCI, V25, P8854, DOI 10.1523/JNEUROSCI.1311-05.2005; Duarte A, 2010, J COGNITIVE NEUROSCI, V22, P1819, DOI 10.1162/jocn.2009.21316; Elliott R, 2000, CEREB CORTEX, V10, P308, DOI 10.1093/cercor/10.3.308; Fellows LK, 2005, CEREB CORTEX, V15, P58, DOI 10.1093/cercor/bhh108; FitzGerald THB, 2009, J NEUROSCI, V29, P8388, DOI 10.1523/JNEUROSCI.0717-09.2009; Formisano E, 2012, NEUROIMAGE, V62, P1249, DOI 10.1016/j.neuroimage.2012.02.078; Hampton AN, 2007, P NATL ACAD SCI USA, V104, P1377, DOI 10.1073/pnas.0606297104; Hanke M, 2009, NEUROINFORMATICS, V7, P37, DOI 10.1007/s12021-008-9041-y; Hare TA, 2008, J NEUROSCI, V28, P5623, DOI 10.1523/JNEUROSCI.1309-08.2008; Hare TA, 2011, P NATL ACAD SCI USA, V108, P18120, DOI 10.1073/pnas.1109322108; Hare TA, 2010, J NEUROSCI, V30, P583, DOI 10.1523/JNEUROSCI.4089-09.2010; Hare TA, 2009, SCIENCE, V324, P646, DOI 10.1126/science.1168450; Harris A., 2011, PLOS ONE, V6; Hastie T., 2008, ELEMENTS STAT LEARNI; Jimura K, 2012, NEUROPSYCHOLOGIA, V50, P544, DOI 10.1016/j.neuropsychologia.2011.11.007; Kable JW, 2007, NAT NEUROSCI, V10, P1625, DOI 10.1038/nn2007; Kahnt T, 2012, J NEUROSCI, V32, P6240, DOI 10.1523/JNEUROSCI.0257-12.2012; Kahnt T, 2010, P NATL ACAD SCI USA, V107, P6010, DOI 10.1073/pnas.0912838107; Kim H, 2011, CEREB CORTEX, V21, P769, DOI 10.1093/cercor/bhq145; Krajbich I, 2009, SCIENCE, V326, P596, DOI 10.1126/science.1177302; Kriegeskorte N, 2006, P NATL ACAD SCI USA, V103, P3863, DOI 10.1073/pnas.0600244103; Kriegeskorte N, 2009, NAT NEUROSCI, V12, P535, DOI 10.1038/nn.2303; Kringelbach ML, 2004, PROG NEUROBIOL, V72, P341, DOI 10.1016/j.pneurobio.2004.03.006; Levy DJ, 2011, J NEUROSCI, V31, P14693, DOI 10.1523/JNEUROSCI.2218-11.2011; Levy I, 2011, J NEUROSCI, V31, P118, DOI 10.1523/JNEUROSCI.3214-10.2011; Lin A, 2012, SOC COGN AFFECT NEUR, V7, P274, DOI 10.1093/scan/nsr006; Louie K, 2012, ANN NY ACAD SCI, V1251, P13, DOI [10.1111/j.1749-6632.2012.06496.x, 10.1111/j.1749-6632.2012.06496]; Mackey S, 2010, EUR J NEUROSCI, V32, P1940, DOI 10.1111/j.1460-9568.2010.07465.x; Misaki M, 2010, NEUROIMAGE, V53, P103, DOI 10.1016/j.neuroimage.2010.05.051; Mitchell T.M, 2003, MACH LEARN; Montague PR, 2002, NEURON, V36, P265, DOI 10.1016/S0896-6273(02)00974-1; Mukherjee S, 2003, J MACH LEARN RES, V1, P1; Nichols T, 2005, NEUROIMAGE, V25, P653, DOI 10.1016/j.neuroimage.2004.12.005; O'Doherty J, 2001, NAT NEUROSCI, V4, P95, DOI 10.1038/82959; O'Doherty JP, 2007, ANN NY ACAD SCI, V1121, P254, DOI 10.1196/annals.1401.036; O'Doherty JP, 2011, ANN NY ACAD SCI, V1239, P118, DOI 10.1111/j.1749-6632.2011.06290.x; Ongur D, 2000, CEREB CORTEX, V10, P206, DOI 10.1093/cercor/10.3.206; Padoa-Schioppa C, 2006, NATURE, V441, P223, DOI 10.1038/nature04676; Padoa-Schioppa C, 2011, ANNU REV NEUROSCI, V34, P333, DOI 10.1146/annurev-neuro-061010-113648; Pereira F, 2011, NEUROIMAGE, V56, P476, DOI 10.1016/j.neuroimage.2010.05.026; Pereira F, 2009, NEUROIMAGE, V45, pS199, DOI 10.1016/j.neuroimage.2008.11.007; Plassmann H, 2007, J NEUROSCI, V27, P9984, DOI 10.1523/JNEUROSCI.2131-07.2007; Rangel A, 2008, NAT REV NEUROSCI, V9, P545, DOI 10.1038/nrn2357; Rangel A, 2010, CURR OPIN NEUROBIOL, V20, P262, DOI 10.1016/j.conb.2010.03.001; Rushworth MFS, 2008, NAT NEUROSCI, V11, P389, DOI 10.1038/nn2066; Sescousse G, 2010, J NEUROSCI, V30, P13095, DOI 10.1523/JNEUROSCI.3501-10.2010; Tom SM, 2007, SCIENCE, V315, P515, DOI 10.1126/science.1134239; Tremblay L, 1999, NATURE, V398, P704, DOI 10.1038/19525; Tusche A, 2010, J NEUROSCI, V30, P8024, DOI 10.1523/JNEUROSCI.0064-10.2010; Wallis JD, 2007, ANNU REV NEUROSCI, V30, P31, DOI 10.1146/annurev.neuro.30.051606.094334; Wallis JD, 2012, NAT NEUROSCI, V15, P13, DOI 10.1038/nn.2956; Walton ME, 2010, NEURON, V65, P927, DOI 10.1016/j.neuron.2010.02.027	60	134	141	0	47	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	APR	2013	16	4					479	U152		10.1038/nn.3337	http://dx.doi.org/10.1038/nn.3337			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	114EM	23416449	Green Accepted, Green Submitted			2022-12-28	WOS:000316723700019
J	Feinstein, JS; Buzza, C; Hurlemann, R; Follmer, RL; Dahdaleh, NS; Coryell, WH; Welsh, MJ; Tranel, D; Wemmie, JA				Feinstein, Justin S.; Buzza, Colin; Hurlemann, Rene; Follmer, Robin L.; Dahdaleh, Nader S.; Coryell, William H.; Welsh, Michael J.; Tranel, Daniel; Wemmie, John A.			Fear and panic in humans with bilateral amygdala damage	NATURE NEUROSCIENCE			English	Article							DOUBLE DISSOCIATION; CARBON-DIOXIDE; DISORDER; RECOGNITION; EMOTION; FMRI	Decades of research have highlighted the amygdala's influential role in fear. We found that inhalation of 35% CO2 evoked not only fear, but also panic attacks, in three rare patients with bilateral amygdala damage. These results indicate that the amygdala is not required for fear and panic, and make an important distinction between fear triggered by external threats from the environment versus fear triggered internally by CO2.	[Feinstein, Justin S.; Tranel, Daniel] Univ Iowa, Dept Neurol, Iowa City, IA 52242 USA; [Feinstein, Justin S.; Tranel, Daniel] Univ Iowa, Dept Psychol, Iowa City, IA 52242 USA; [Buzza, Colin; Hurlemann, Rene; Follmer, Robin L.; Coryell, William H.; Wemmie, John A.] Univ Iowa, Dept Psychiat, Iowa City, IA 52242 USA; [Hurlemann, Rene] Univ Bonn, Dept Psychiat, Bonn, Germany; [Dahdaleh, Nader S.; Welsh, Michael J.; Wemmie, John A.] Univ Iowa, Dept Neurosurg, Iowa City, IA USA; [Welsh, Michael J.] Univ Iowa, Dept Internal Med, Iowa City, IA 52242 USA; [Welsh, Michael J.; Wemmie, John A.] Univ Iowa, Dept Mol Physiol & Biophys, Iowa City, IA USA; [Welsh, Michael J.; Tranel, Daniel; Wemmie, John A.] Univ Iowa, Interdisciplinary Grad Program Neurosci, Iowa City, IA USA; [Welsh, Michael J.] Howard Hughes Med Inst, Chevy Chase, MD USA; [Wemmie, John A.] Dept Vet Affairs Med Ctr, Iowa City, IA 52242 USA	University of Iowa; University of Iowa; University of Iowa; University of Bonn; University of Iowa; University of Iowa; University of Iowa; University of Iowa; Howard Hughes Medical Institute; US Department of Veterans Affairs; Veterans Health Administration (VHA); Iowa City VA Health Care System	Tranel, D (corresponding author), Univ Iowa, Dept Neurol, Iowa City, IA 52242 USA.	daniel.tranel@uiowa.edu; john-wemmie@uiowa.edu	Hurlemann, Rene/AAL-5515-2020; Hurlemann, Rene/G-4164-2012	Hurlemann, Rene/0000-0003-2628-565X; Hurlemann, Rene/0000-0003-2628-565X; Wemmie, John/0000-0001-7531-9065; Tranel, Daniel/0000-0002-1338-1389; coryell, william/0000-0003-3989-7276; Welsh, Michael/0000-0002-1646-6206	Doris Duke Clinical Research Fellowship; National Institute of Neurological Disorders and Stroke [P50 NS19632]; Department of Veterans Affairs; National Institutes of Mental Health [5RO1MH085724]; McKnight Neuroscience of Brain Disorders Award; Ministry of Innovation, Science, Research and Technology of the German State of North Rhine-Westphalia (MIWFT); University of Bonn; Howard Hughes Medical Institute; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH085724] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS019632, P50NS019632] Funding Source: NIH RePORTER	Doris Duke Clinical Research Fellowship(Doris Duke Charitable Foundation (DDCF)); National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Department of Veterans Affairs(US Department of Veterans Affairs); National Institutes of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); McKnight Neuroscience of Brain Disorders Award; Ministry of Innovation, Science, Research and Technology of the German State of North Rhine-Westphalia (MIWFT); University of Bonn; Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank A. Wunsch for technical support and M. Coryell and J. Potash for critically reading this manuscript. C.B. was supported by a Doris Duke Clinical Research Fellowship. D.T. was supported by the National Institute of Neurological Disorders and Stroke (P50 NS19632). J.A.W. was supported by the Department of Veterans Affairs (Merit Award), the National Institutes of Mental Health (5RO1MH085724) and a McKnight Neuroscience of Brain Disorders Award. R.H. was supported by a Starting Independent Researcher Grant (NEMO-Neuromodulation of Emotion) jointly provided by the Ministry of Innovation, Science, Research and Technology of the German State of North Rhine-Westphalia (MIWFT) and the University of Bonn. M.J.W. receives funding from the Howard Hughes Medical Institute.	Adolphs R, 1999, NEUROPSYCHOLOGIA, V37, P1111, DOI 10.1016/S0028-3932(99)00039-1; Adolphs R., 2000, AMYGDALA FUNCTIONAL, P587; BECHARA A, 1995, SCIENCE, V269, P1115, DOI 10.1126/science.7652558; Becker B, 2012, BIOL PSYCHIAT, V72, P70, DOI 10.1016/j.biopsych.2011.11.024; Ciocchi S, 2010, NATURE, V468, P277, DOI 10.1038/nature09559; Colasanti A, 2008, NEUROPSYCHOPHARMACOL, V33, P3103, DOI 10.1038/npp.2008.31; Damasio A, 2003, ANN NY ACAD SCI, V1001, P253, DOI 10.1196/annals.1279.014; Davis M, 2010, NEUROPSYCHOPHARMACOL, V35, P105, DOI 10.1038/npp.2009.109; Del-Ben CM, 2009, NEURAL PLAST, V2009, DOI 10.1155/2009/108135; Feinstein JS, 2011, CURR BIOL, V21, P34, DOI 10.1016/j.cub.2010.11.042; Funayama ES, 2001, J COGNITIVE NEUROSCI, V13, P721, DOI 10.1162/08989290152541395; Khalsa SS, 2009, NAT NEUROSCI, V12, P1494, DOI 10.1038/nn.2411; Massana G, 2003, NEUROIMAGE, V19, P80, DOI 10.1016/S1053-8119(03)00036-3; Ottaviani C, 2012, PSYCHIAT RES-NEUROIM, V203, P159, DOI 10.1016/j.pscychresns.2011.12.010; Pillay SS, 2006, J AFFECT DISORDERS, V94, P173, DOI 10.1016/j.jad.2006.04.007; Preter M, 2008, PROG NEURO-PSYCHOPH, V32, P603, DOI 10.1016/j.pnpbp.2007.07.029; Rassovsky Y, 2003, J ANXIETY DISORD, V17, P1, DOI 10.1016/S0887-6185(02)00181-0; Wemmie John A, 2011, Dialogues Clin Neurosci, V13, P475; Wiest G, 2006, ARCH NEUROL-CHICAGO, V63, P1798, DOI 10.1001/archneur.63.12.1798; Ziemann AE, 2009, CELL, V139, P1012, DOI 10.1016/j.cell.2009.10.029	20	167	171	1	86	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAR	2013	16	3					270	272		10.1038/nn.3323	http://dx.doi.org/10.1038/nn.3323			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	097LE	23377128	Green Accepted, Green Submitted			2022-12-28	WOS:000315474800008
J	Leung, LC; Urbancic, V; Baudet, ML; Dwivedy, A; Bayley, TG; Lee, AC; Harris, WA; Holt, CE				Leung, Louis C.; Urbancic, Vasja; Baudet, Marie-Laure; Dwivedy, Asha; Bayley, Timothy G.; Lee, Aih Cheun; Harris, William A.; Holt, Christine E.			Coupling of NF-protocadherin signaling to axon guidance by cue-induced translation	NATURE NEUROSCIENCE			English	Article							RETINAL GROWTH CONES; EMBRYONIC XENOPUS BRAIN; PROTEIN-SYNTHESIS; CADHERIN SUPERFAMILY; LOCAL TRANSLATION; NEURITE GROWTH; SEMAPHORIN 3A; CELL-ADHESION; COLLAPSE; L1	Cell adhesion molecules and diffusible cues both regulate axon pathfinding, yet how these two modes of signaling interact is poorly understood. The homophilic cell adhesion molecule NF-protocadherin (NFPC) is expressed in the mid-dorsal optic tract neuroepithelium and in the axons of developing retinal ganglion cells (RGC) in Xenopus laevis. Here we report that targeted disruption of NFPC function in RGC axons or the optic tract neuroepithelium results in unexpectedly localized pathfinding defects at the caudal turn in the mid-optic tract. Semaphorin 3A (Sema3A), which lies adjacent to this turn, stimulates rapid, protein synthesis-dependent increases in growth cone NFPC and its cofactor, TAF1, in vitro. In vivo, growth cones exhibit marked increases in NFPC translation reporter activity in this mid-optic tract region that are attenuated by blocking neuropilin-1 function. Our results suggest that translation-linked coupling between regionally localized diffusible cues and cell adhesion can help axons navigate discrete segments of the pathway.	[Leung, Louis C.; Urbancic, Vasja; Baudet, Marie-Laure; Dwivedy, Asha; Bayley, Timothy G.; Lee, Aih Cheun; Harris, William A.; Holt, Christine E.] Univ Cambridge, Dept Physiol Dev & Neurosci, Cambridge, England	University of Cambridge	Holt, CE (corresponding author), Univ Cambridge, Dept Physiol Dev & Neurosci, Cambridge, England.	ceh@mole.bio.cam.ac.uk	Baudet, Marie-Laure/B-1437-2015; Baudet, Marie-Laure/H-6343-2019	Baudet, Marie-Laure/0000-0001-8957-5545; Baudet, Marie-Laure/0000-0001-8957-5545; Urbancic, Vasja/0000-0001-8955-5923; Holt, Christine Elizabeth/0000-0003-2829-121X	Wellcome Trust [085314/Z/08/Z]; UK Medical Research Council; Wellcome Trust; National Science and Engineering Research Council of Canada; Alberta Heritage Foundation for Medical Research; UK Medical Research Council studentship; EMBO; Medical Research Council [983063] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome TrustEuropean Commission); National Science and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); Alberta Heritage Foundation for Medical Research(Alberta Heritage Foundation for Medical ResearchGeneral Electric); UK Medical Research Council studentship(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); EMBO(European Molecular Biology Organization (EMBO)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank R. Bradley (Montana State University) for kind gifts of NFPC antibody and sharing constructs, S. McFarlane for advice on the Slit1 in situ hybridization, and E van Horck for NFPC in situ hybridization data. We thank A. Pungaliya, A. McNabb, T. DyI, G. Stooke-Vaughan, C. Purmann, K. Holmes, H. Lynn, G. Lupo, D. Maurus and N. Coutts for technical assistance. We thank members of the Harris and Holt laboratories for assistance and comments on the manuscript. This work was funded by Wellcome Trust Programme grant no. 085314/Z/08/Z (C.E.H., W.A.H.), a UK Medical Research Council Doctoral Training Grant (L.C.L.), a Wellcome Trust Studentship (V.U.), the National Science and Engineering Research Council of Canada and the Alberta Heritage Foundation for Medical Research (M-L.B.), a UK Medical Research Council studentship (T.G.B.) and an EMBO fellowship (A.C.L.).	Arikkath J, 2008, TRENDS NEUROSCI, V31, P487, DOI 10.1016/j.tins.2008.07.001; Atkinson-Leadbeater K, 2010, J NEUROSCI, V30, P685, DOI 10.1523/JNEUROSCI.4165-09.2010; Barnes SH, 2010, DEVELOPMENT, V137, P805, DOI 10.1242/dev.042457; Bechara A, 2008, EMBO J, V27, P1549, DOI 10.1038/emboj.2008.86; Bradley RS, 1998, CURR BIOL, V8, P325, DOI 10.1016/S0960-9822(98)70132-0; Brittis PA, 2002, CELL, V110, P223, DOI 10.1016/S0092-8674(02)00813-9; Campbell DS, 2001, NEURON, V32, P1013, DOI 10.1016/S0896-6273(01)00551-7; Campbell DS, 2001, J NEUROSCI, V21, P8538, DOI 10.1523/JNEUROSCI.21-21-08538.2001; Castellani V, 2004, MOL CELL NEUROSCI, V26, P89, DOI 10.1016/j.mcn.2004.01.010; Castellani V, 2002, EMBO J, V21, P6348, DOI 10.1093/emboj/cdf645; CHIEN CB, 1993, NEURON, V11, P237, DOI 10.1016/0896-6273(93)90181-P; Falk J, 2005, NEURON, V48, P63, DOI 10.1016/j.neuron.2005.08.033; Falk J, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-107; Garrett AM, 2012, NEURON, V74, P269, DOI 10.1016/j.neuron.2012.01.028; Garrett AM, 2009, J NEUROSCI, V29, P11723, DOI 10.1523/JNEUROSCI.2818-09.2009; Goodman CS, 1996, ANNU REV NEUROSCI, V19, P341, DOI 10.1146/annurev.ne.19.030196.002013; HARRIS WA, 1989, NATURE, V339, P218, DOI 10.1038/339218a0; Heggem MA, 2003, DEV CELL, V4, P419, DOI 10.1016/S1534-5807(03)00036-4; Hirano S, 2003, FRONT BIOSCI-LANDMRK, V8, pD306, DOI 10.2741/972; HOLT CE, 1989, J NEUROSCI, V9, P3123; Kuwajima T, 2012, NEURON, V74, P676, DOI 10.1016/j.neuron.2012.03.025; Kuwako K, 2010, NEURON, V67, P407, DOI 10.1016/j.neuron.2010.07.005; Lefebvre JL, 2012, NATURE, V488, P517, DOI 10.1038/nature11305; Lefebvre JL, 2008, DEVELOPMENT, V135, P4141, DOI 10.1242/dev.027912; LEMMON V, 1992, J NEUROSCI, V12, P818; Leung KM, 2008, NAT PROTOC, V3, P1318, DOI 10.1038/nprot.2008.113; Leung KM, 2006, NAT NEUROSCI, V9, P1247, DOI 10.1038/nn1775; Lin AC, 2007, EMBO J, V26, P3729, DOI 10.1038/sj.emboj.7601808; Lin AC, 2009, NEURAL DEV, V4, DOI 10.1186/1749-8104-4-8; Nakao S, 2008, J CELL BIOL, V182, P395, DOI 10.1083/jcb.200802069; Nawabi H, 2010, GENE DEV, V24, P396, DOI 10.1101/gad.542510; Piper M, 2005, NAT NEUROSCI, V8, P179, DOI 10.1038/nn1380; Piper M, 2006, NEURON, V49, P215, DOI 10.1016/j.neuron.2005.12.008; Piper M, 2008, J NEUROSCI, V28, P100, DOI 10.1523/JNEUROSCI.4490-07.2008; Rashid D, 2006, DEV BIOL, V291, P170, DOI 10.1016/j.ydbio.2005.12.027; Seo SB, 2001, CELL, V104, P119, DOI 10.1016/S0092-8674(01)00196-9; Shima Y, 2007, NAT NEUROSCI, V10, P963, DOI 10.1038/nn1933; Takeichi M, 2007, NAT REV NEUROSCI, V8, P11, DOI 10.1038/nrn2043; Uemura M, 2007, NAT NEUROSCI, V10, P1151, DOI 10.1038/nn1960; Williams EO, 2011, FRONT NEURAL CIRCUIT, V5, DOI 10.3389/fncir.2011.00009; Wolman MA, 2007, J NEUROSCI, V27, P9653, DOI 10.1523/JNEUROSCI.1741-07.2007; Wu KY, 2005, NATURE, V436, P1020, DOI 10.1038/nature03885; Yao JQ, 2006, NAT NEUROSCI, V9, P1265, DOI 10.1038/nn1773; Yasuda S, 2007, NEURON, V56, P456, DOI 10.1016/j.neuron.2007.08.020; Zivraj KH, 2010, J NEUROSCI, V30, P15464, DOI 10.1523/JNEUROSCI.1800-10.2010	45	57	57	0	21	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	FEB	2013	16	2					166	173		10.1038/nn.3290	http://dx.doi.org/10.1038/nn.3290			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	080RE	23292679	Green Accepted			2022-12-28	WOS:000314260200013
J	Staresina, BP; Fell, J; Do Lam, ATA; Axmacher, N; Henson, RN				Staresina, Bernhard P.; Fell, Juergen; Do Lam, Anne T. A.; Axmacher, Nikolai; Henson, Richard N.			Memory signals are temporally dissociated in and across human hippocampus and perirhinal cortex	NATURE NEUROSCIENCE			English	Article							RECOGNITION MEMORY; ASSOCIATIVE MEMORY; LOBE ACTIVITY; FAMILIARITY; POTENTIALS; RETRIEVAL; RECOLLECTION; INFORMATION; NEURONS; NOVELTY	In the endeavor to understand how our brains enable our multifaceted memories, much controversy surrounds the contributions of the hippocampus and perirhinal cortex (PrC). We recorded functional magnetic resonance imaging (fMRI) in healthy controls and intracranial electroencephalography (EEG) in patients during a recognition memory task. Although conventional fMRI analysis showed indistinguishable roles of the hippocampus and PrC in familiarity-based item recognition and recollection-based source retrieval, event-related fMRI and EEG time courses revealed a clear temporal dissociation of memory signals in and across these regions. An early source retrieval effect was followed by a late, post-decision item novelty effect in hippocampus, whereas an early item novelty effect was followed by a sustained source retrieval effect in PrC. Although factors such as memory strength were not experimentally controlled, the temporal pattern across regions suggests that a rapid item recognition signal in PrC triggers a source retrieval process in the hippocampus, which in turn recruits PrC representations and/or mechanisms, evidenced here by increased hippocampal-PrC coupling during source recognition.	[Staresina, Bernhard P.; Henson, Richard N.] Med Res Council Cognit, Cambridge, England; [Staresina, Bernhard P.; Henson, Richard N.] Brain Sci Unit, Cambridge, England; [Staresina, Bernhard P.; Fell, Juergen; Do Lam, Anne T. A.; Axmacher, Nikolai] Univ Bonn, Dept Epidemiol, Bonn, Germany; [Axmacher, Nikolai] German Ctr Neurodegenerat Dis DZNE, Bonn, Germany	UK Research & Innovation (UKRI); Medical Research Council UK (MRC); University of Bonn; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE)	Staresina, BP (corresponding author), Med Res Council Cognit, Cambridge, England.	bernhard.staresina@mrc-cbu.cam.ac.uk	Henson, Richard/H-8822-2019; Staresina, Bernhard P/N-4496-2014	Henson, Richard/0000-0002-0712-2639; Staresina, Bernhard P/0000-0002-0558-9745; Axmacher, Nikolai/0000-0002-0475-6492	Sir Henry Wellcome Postdoctoral Fellowship; UK Medical Research Council Program [MC_A060_5PR10]; German Research Foundation [DFG FE 366/5-1]; MRC [MC_U105579226] Funding Source: UKRI; Medical Research Council [MC_U105579226] Funding Source: researchfish	Sir Henry Wellcome Postdoctoral Fellowship; UK Medical Research Council Program(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); German Research Foundation(German Research Foundation (DFG)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank A. Greve for helpful discussion. This work was supported by a Sir Henry Wellcome Postdoctoral Fellowship to B.P.S., the UK Medical Research Council Program (MC_A060_5PR10 to R.N.H.) and the German Research Foundation (DFG FE 366/5-1 to A.T.A.D.L.)	Aggleton JP, 1999, BEHAV BRAIN SCI, V22, P425; Axmacher N, 2010, NEURON, V65, P541, DOI 10.1016/j.neuron.2010.02.006; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Brett M., 2002, NEUROIMAGE, V16, P497; Buckley MJ, 1998, NEUROPSYCHOLOGIA, V36, P535, DOI 10.1016/S0028-3932(97)00120-6; Buckner RL, 2001, J COGNITIVE NEUROSCI, V13, P406, DOI 10.1162/08989290151137430; Cohen N. J., 1993, MEMORY AMNESIA HIPPO; Curran T, 2000, MEM COGNITION, V28, P923, DOI 10.3758/BF03209340; Dale AM, 1999, HUM BRAIN MAPP, V8, P109, DOI 10.1002/(SICI)1097-0193(1999)8:2/3<109::AID-HBM7>3.3.CO;2-N; Davachi L, 2006, CURR OPIN NEUROBIOL, V16, P693, DOI 10.1016/j.conb.2006.10.012; Diana RA, 2008, J EXP PSYCHOL LEARN, V34, P730, DOI 10.1037/0278-7393.34.4.730; Diana RA, 2007, TRENDS COGN SCI, V11, P379, DOI 10.1016/j.tics.2007.08.001; Diana RA, 2010, J COGNITIVE NEUROSCI, V22, P1808, DOI 10.1162/jocn.2009.21335; Duarte A, 2011, BRAIN RES, V1373, P110, DOI 10.1016/j.brainres.2010.11.086; Eichenbaum H, 2007, ANNU REV NEUROSCI, V30, P123, DOI 10.1146/annurev.neuro.30.051606.094328; Fell J, 2001, NAT NEUROSCI, V4, P1259, DOI 10.1038/nn759; Gelbard-Sagiv H, 2008, SCIENCE, V322, P96, DOI 10.1126/science.1164685; Gonsalves BD, 2005, NEURON, V47, P751, DOI 10.1016/j.neuron.2005.07.013; Grunwald T, 2003, NEUROIMAGE, V20, pS139, DOI 10.1016/j.neuroimage.2003.09.004; Grunwald T, 1998, P NATL ACAD SCI USA, V95, P3193, DOI 10.1073/pnas.95.6.3193; Haegens S, 2011, P NATL ACAD SCI USA, V108, P19377, DOI 10.1073/pnas.1117190108; Henson RNA, 2003, HIPPOCAMPUS, V13, P301, DOI 10.1002/hipo.10117; Henson RNA, 2002, NEUROIMAGE, V17, P543, DOI 10.1006/nimg.2002.1229; Higuchi S, 1996, P NATL ACAD SCI USA, V93, P739, DOI 10.1073/pnas.93.2.739; Insausti R, 1998, AM J NEURORADIOL, V19, P659; JACOBY LL, 1991, J MEM LANG, V30, P513, DOI 10.1016/0749-596X(91)90025-F; JOHNSON MK, 1993, PSYCHOL BULL, V114, P3, DOI 10.1037/0033-2909.114.1.3; Jokisch D, 2007, J NEUROSCI, V27, P3244, DOI 10.1523/JNEUROSCI.5399-06.2007; Jutras MJ, 2009, J NEUROSCI, V29, P12521, DOI 10.1523/JNEUROSCI.0640-09.2009; Kirwan CB, 2004, HIPPOCAMPUS, V14, P919, DOI 10.1002/hipo.20014; Kohler S, 2005, HIPPOCAMPUS, V15, P763, DOI 10.1002/hipo.20098; Konkel A, 2009, FRONT NEUROSCI-SWITZ, V3, P166, DOI 10.3389/neuro.01.023.2009; Kumaran D, 2009, TRENDS COGN SCI, V13, P47, DOI 10.1016/j.tics.2008.11.004; Ludowig E, 2008, J COGNITIVE NEUROSCI, V20, P841, DOI 10.1162/jocn.2008.20507; MANDLER G, 1980, PSYCHOL REV, V87, P252, DOI 10.1037/0033-295X.87.3.252; Manns JR, 2003, NEURON, V37, P171, DOI 10.1016/S0896-6273(02)01147-9; Maris E, 2007, J NEUROSCI METH, V164, P177, DOI 10.1016/j.jneumeth.2007.03.024; Mayes A, 2007, TRENDS COGN SCI, V11, P126, DOI 10.1016/j.tics.2006.12.003; MCCARTHY G, 1995, J NEUROSCI, V15, P1080; McElree B, 1999, J EXP PSYCHOL LEARN, V25, P563, DOI 10.1037/0278-7393.25.3.563; Meeuwissen EB, 2011, HUM BRAIN MAPP, V32, P2045, DOI 10.1002/hbm.21167; MEUNIER M, 1993, J NEUROSCI, V13, P5418, DOI 10.1523/JNEUROSCI.13-12-05418.1993; Montaldi D, 2006, HIPPOCAMPUS, V16, P504, DOI 10.1002/hipo.20178; Murray EA, 2001, CURR OPIN NEUROBIOL, V11, P188, DOI 10.1016/S0959-4388(00)00195-1; Oostenveld R, 2011, COMPUT INTEL NEUROSC, V2011, DOI 10.1155/2011/156869; Rutishauser U, 2008, P NATL ACAD SCI USA, V105, P329, DOI 10.1073/pnas.0706015105; SCOVILLE WB, 1957, J NEUROL NEUROSUR PS, V20, P11, DOI 10.1136/jnnp.20.1.11; SMITH ME, 1986, ELECTROEN CLIN NEURO, V63, P145, DOI 10.1016/0013-4694(86)90008-8; Squire LR, 2007, NAT REV NEUROSCI, V8, P872, DOI 10.1038/nrn2154; Squire LR, 2004, ANNU REV NEUROSCI, V27, P279, DOI 10.1146/annurev.neuro.27.070203.144130; Staresina BP, 2006, J NEUROSCI, V26, P9162, DOI 10.1523/JNEUROSCI.2877-06.2006; Staresina BP, 2010, J NEUROSCI, V30, P9890, DOI 10.1523/JNEUROSCI.0826-10.2010; Stark CEL, 2001, P NATL ACAD SCI USA, V98, P12760, DOI 10.1073/pnas.221462998; Stark CEL, 2003, J NEUROSCI, V23, P6748; Stark CEL, 2002, LEARN MEMORY, V9, P238, DOI 10.1101/lm.51802; Takeuchi D, 2011, SCIENCE, V331, P1443, DOI 10.1126/science.1199967; Viskontas IV, 2006, J COGNITIVE NEUROSCI, V18, P1654, DOI 10.1162/jocn.2006.18.10.1654; Wais PE, 2010, J COGNITIVE NEUROSCI, V22, P109, DOI 10.1162/jocn.2009.21190; Xiang JZ, 1998, NEUROPHARMACOLOGY, V37, P657, DOI 10.1016/S0028-3908(98)00030-6; Yonelinas AP, 2002, J MEM LANG, V46, P441, DOI 10.1006/jmla.2002.2864	60	88	88	0	43	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	AUG	2012	15	8					1167	+		10.1038/nn.3154	http://dx.doi.org/10.1038/nn.3154			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	979UE	22751037	Green Accepted			2022-12-28	WOS:000306844500024
J	Aguzzi, A; Falsig, J				Aguzzi, Adriano; Falsig, Jeppe			PERSPECTIVE Prion propagation, toxicity and degradation	NATURE NEUROSCIENCE			English	Article							AMYLOID-BETA OLIGOMERS; SYNAPTIC PLASTICITY; ALZHEIMERS-DISEASE; DENDRITIC CELLS; TRANSGENIC MICE; SCRAPIE PRIONS; CULTURED-CELLS; IN-VITRO; PROTEIN; PRP	Prion science has been on a rollercoaster for two decades. In the mid 1990s, the specter of mad cow disease (bovine spongiform encephalopathy, BSE) provoked an unprecedented public scare that was first precipitated by the realization that this animal prion disease could be transmitted to humans and then rekindled by the evidence that BSE-infected humans could pass on the infection through blood transfusions. Along with the gradual disappearance of BSE, the interest in prions has waned with the general public, funding agencies and prospective PhD students. In the past few years, however, a bewildering variety of diseases have been found to share features with prion infections, including cell-to-cell transmission. Here we review these developments and summarize those open questions that we currently deem most interesting in prion biology: how do prions damage their hosts, and how do hosts attempt to neutralize invading prions?	[Aguzzi, Adriano; Falsig, Jeppe] Univ Zurich Hosp, Inst Neuropathol, CH-8091 Zurich, Switzerland	University of Zurich; University Zurich Hospital	Aguzzi, A (corresponding author), Univ Zurich Hosp, Inst Neuropathol, CH-8091 Zurich, Switzerland.	adriano.aguzzi@usz.ch	Aguzzi, Adriano/A-3351-2008	Aguzzi, Adriano/0000-0002-0344-6708	European Research Council; European Union (PRIORITY, LUPAS); Swiss National Foundation; National Competence Center on Neural Plasticity and Repair; Stammbach Foundation; Novartis Research Foundation; Swiss Center of Transgenic Expertise; University of Zurich	European Research Council(European Research Council (ERC)European Commission); European Union (PRIORITY, LUPAS); Swiss National Foundation(Swiss National Science Foundation (SNSF)); National Competence Center on Neural Plasticity and Repair; Stammbach Foundation; Novartis Research Foundation; Swiss Center of Transgenic Expertise; University of Zurich	A.A. is the recipient of an Advanced Grant of the European Research Council and is supported by grants from the European Union (PRIORITY, LUPAS), the Swiss National Foundation, the National Competence Center on Neural Plasticity and Repair, the Stammbach Foundation, and the Novartis Research Foundation. J.F. is supported by a grant from the Swiss Center of Transgenic Expertise and by a career development award of the University of Zurich.	Aguzzi A, 2009, PHYSIOL REV, V89, P1105, DOI 10.1152/physrev.00006.2009; Aguzzi A, 2009, CELL, V137, P994, DOI 10.1016/j.cell.2009.05.041; Baker CA, 2002, J VIROL, V76, P10905, DOI 10.1128/JVI.76.21.10905-10913.2002; Balducci C, 2010, P NATL ACAD SCI USA, V107, P2295, DOI 10.1073/pnas.0911829107; Barry AE, 2011, J NEUROSCI, V31, P7259, DOI 10.1523/JNEUROSCI.6500-10.2011; Behrens A, 2002, TRENDS NEUROSCI, V25, P150, DOI 10.1016/S0166-2236(00)02089-0; BELLINGERKAWAHARA C, 1987, J VIROL, V61, P159, DOI 10.1128/JVI.61.1.159-166.1987; Benilova I, 2012, NAT NEUROSCI, V15, P349, DOI 10.1038/nn.3028; Beringue V, 2000, J PATHOL, V190, P495, DOI 10.1002/(SICI)1096-9896(200003)190:4&lt;495::AID-PATH535&gt;3.0.CO;2-T; Brandner S, 1996, NATURE, V379, P339, DOI 10.1038/379339a0; BROWN P, 1991, LANCET, V337, P269, DOI 10.1016/0140-6736(91)90873-N; BUELER H, 1993, CELL, V73, P1339, DOI 10.1016/0092-8674(93)90360-3; BUELER H, 1994, MOL MED, V1, P19; Calella AM, 2010, EMBO MOL MED, V2, P306, DOI 10.1002/emmm.201000082; Castilla J, 2005, CELL, V121, P195, DOI 10.1016/j.cell.2005.02.011; Chakrabarti O, 2009, CELL, V137, P1136, DOI 10.1016/j.cell.2009.03.042; CHERNOFF YO, 1995, SCIENCE, V268, P880, DOI 10.1126/science.7754373; Chesebro B, 2005, SCIENCE, V308, P1435, DOI 10.1126/science.1110837; Cisse M, 2011, J NEUROSCI, V31, P10427, DOI 10.1523/JNEUROSCI.1459-11.2011; Deleault NR, 2007, P NATL ACAD SCI USA, V104, P9741, DOI 10.1073/pnas.0702662104; Falsig J, 2008, NAT NEUROSCI, V11, P109, DOI 10.1038/nn2028; Flores-Langarica A, 2009, J IMMUNOL, V182, P1305, DOI 10.4049/jimmunol.182.3.1305; Freir DB, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1341; Ghaemmaghami S, 2007, P NATL ACAD SCI USA, V104, P17971, DOI 10.1073/pnas.0708372104; Gimbel DA, 2010, J NEUROSCI, V30, P6367, DOI 10.1523/JNEUROSCI.0395-10.2010; Hegde RS, 1998, SCIENCE, V279, P827, DOI 10.1126/science.279.5352.827; Khosravani H, 2008, J CELL BIOL, V181, P551, DOI 10.1083/jcb.200711002; Knowles TPJ, 2009, SCIENCE, V326, P1533, DOI 10.1126/science.1178250; Kranich J, 2010, J EXP MED, V207, P2271, DOI 10.1084/jem.20092401; Lauren J, 2009, NATURE, V457, P1128, DOI 10.1038/nature07761; Lesne S, 2006, NATURE, V440, P352, DOI 10.1038/nature04533; Luhr KM, 2004, J VIROL, V78, P4776, DOI 10.1128/JVI.78.9.4776-4782.2004; Ma JY, 2001, P NATL ACAD SCI USA, V98, P14955, DOI 10.1073/pnas.011578098; Mahal SP, 2007, P NATL ACAD SCI USA, V104, P20908, DOI 10.1073/pnas.0710054104; Mallucci G, 2003, SCIENCE, V302, P871, DOI 10.1126/science.1090187; Peretz D, 2001, NATURE, V412, P739, DOI 10.1038/35089090; PRUSINER SB, 1982, SCIENCE, V216, P136, DOI 10.1126/science.6801762; Riek R, 1997, FEBS LETT, V413, P282, DOI 10.1016/S0014-5793(97)00920-4; Saborio GP, 2001, NATURE, V411, P810, DOI 10.1038/35081095; Safar JG, 2005, J GEN VIROL, V86, P2913, DOI 10.1099/vir.0.80947-0; Sandberg MK, 2011, NATURE, V470, P540, DOI 10.1038/nature09768; Shankar GM, 2008, NAT MED, V14, P837, DOI 10.1038/nm1782; Shmerling D, 1998, CELL, V93, P203, DOI 10.1016/S0092-8674(00)81572-X; Solforosi L, 2004, SCIENCE, V303, P1514, DOI 10.1126/science.1094273; Solomon IH, 2012, PRION, V6, P40, DOI 10.4161/pri.6.1.18627; Solomon IH, 2011, J BIOL CHEM, V286, P14724, DOI 10.1074/jbc.M110.214973; Solomon IH, 2010, J BIOL CHEM, V285, P26719, DOI 10.1074/jbc.M110.134619; Stohr J, 2011, P NATL ACAD SCI USA, V108, P21223, DOI 10.1073/pnas.1117827108; Wang F, 2010, SCIENCE, V327, P1132, DOI 10.1126/science.1183748; You HT, 2012, P NATL ACAD SCI USA, V109, P1737, DOI 10.1073/pnas.1110789109	50	89	89	0	77	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JUL	2012	15	7					936	939		10.1038/nn.3120	http://dx.doi.org/10.1038/nn.3120			4	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	966EE	22735515				2022-12-28	WOS:000305819600007
J	Akam, T; Oren, I; Mantoan, L; Ferenczi, E; Kullmann, DM				Akam, Thomas; Oren, Iris; Mantoan, Laura; Ferenczi, Emily; Kullmann, Dimitri M.			Oscillatory dynamics in the hippocampus support dentate gyrus-CA3 coupling	NATURE NEUROSCIENCE			English	Article							GAMMA-OSCILLATIONS; IN-VITRO; NETWORK OSCILLATIONS; RAT HIPPOCAMPUS; NEURAL-NETWORKS; BEHAVING RAT; NEURONS; INFORMATION; INHIBITION; FREQUENCY	Gamma oscillations in the dentate gyrus and hippocampal CA3 show variable coherence in vivo, but the mechanisms and relevance for information flow are unknown. We found that carbachol-induced oscillations in rat CA3 have biphasic phase-response curves, consistent with the ability to couple with oscillations in afferent projections. Differences in response to stimulation of either the intrinsic feedback circuit or the dentate gyrus were well described by varying an impulse vector in a two-dimensional dynamical system, representing the relative input to excitatory and inhibitory neurons. Responses to sinusoidally modulated optogenetic stimulation confirmed that the CA3 network oscillation can entrain to periodic inputs, with a steep dependence of entrainment phase on input frequency. CA3 oscillations are therefore suited to coupling with oscillations in the dentate gyrus over a broad range of frequencies.	[Akam, Thomas; Oren, Iris; Mantoan, Laura; Ferenczi, Emily; Kullmann, Dimitri M.] UCL, Inst Neurol, London, England	University of London; University College London	Akam, T (corresponding author), Champalimaud Ctr, Lisbon, Portugal.	thomas.akam@neuro.fchampalimaud.org; d.kullmann@ucl.ac.uk	Core, Vector/CAF-4832-2022; Kullmann, Dimitri M/A-3162-2009	Kullmann, Dimitri M/0000-0001-6696-3545; Oren, Iris/0000-0003-1427-1402; Mantoan Ritter, Laura/0000-0003-1406-6118; Akam, Thomas/0000-0002-1810-0494	Wellcome Trust; European Research Council; Brain Research Trust; Guarantors of Brain.; MRC [G116/147] Funding Source: UKRI; Medical Research Council [G116/147] Funding Source: researchfish; National Institute for Health Research [ACF-2008-18-020] Funding Source: researchfish; Action Medical Research [1725] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); European Research Council(European Research Council (ERC)European Commission); Brain Research Trust; Guarantors of Brain.; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); Action Medical Research	We are grateful to N. Burgess for comments on the manuscript and to K. Deisseroth for the ChR2 plasmid. This work was supported by the Wellcome Trust, the European Research Council, the Brain Research Trust and the Guarantors of Brain.	Acsady L, 1998, J NEUROSCI, V18, P3386; Adesnik H, 2010, NATURE, V464, P1155, DOI 10.1038/nature08935; Akam T, 2010, NEURON, V67, P308, DOI 10.1016/j.neuron.2010.06.019; Atallah BV, 2009, NEURON, V62, P566, DOI 10.1016/j.neuron.2009.04.027; BRAGIN A, 1995, J NEUROSCI, V15, P47; Brunel N, 1999, NEURAL COMPUT, V11, P1621, DOI 10.1162/089976699300016179; Brunel N, 2000, J COMPUT NEUROSCI, V8, P183, DOI 10.1023/A:1008925309027; Brunel N, 2008, CHAOS, V18, DOI 10.1063/1.2779858; Cardin JA, 2009, NATURE, V459, P663, DOI 10.1038/nature08002; Coombes S, 2010, NEUROIMAGE, V52, P731, DOI 10.1016/j.neuroimage.2010.01.045; Csicsvari J, 2003, NEURON, V37, P311, DOI 10.1016/S0896-6273(02)01169-8; Ermentrout B, 1996, NEURAL COMPUT, V8, P979, DOI 10.1162/neco.1996.8.5.979; Fell J, 2001, NAT NEUROSCI, V4, P1259, DOI 10.1038/nn759; Fries P, 2005, TRENDS COGN SCI, V9, P474, DOI 10.1016/j.tics.2005.08.011; Hajos N, 2004, J NEUROSCI, V24, P9127, DOI 10.1523/JNEUROSCI.2113-04.2004; HANSEL D, 1995, NEURAL COMPUT, V7, P307, DOI 10.1162/neco.1995.7.2.307; Hasenstaub A, 2005, NEURON, V47, P423, DOI 10.1016/j.neuron.2005.06.016; lzhikevich E.M, 2006, DYNAMICAL SYSTEMS NE; Mann EO, 2005, NEURON, V45, P105, DOI 10.1016/j.neuron.2004.12.016; Montgomery SM, 2008, J NEUROSCI, V28, P6731, DOI 10.1523/JNEUROSCI.1227-08.2008; Montgomery SM, 2007, P NATL ACAD SCI USA, V104, P14495, DOI 10.1073/pnas.0701826104; Mori M, 2004, NATURE, V431, P453, DOI 10.1038/nature02854; Oren I, 2006, J NEUROSCI, V26, P9923, DOI 10.1523/JNEUROSCI.1580-06.2006; Palhalmi J, 2004, NEUROPHARMACOLOGY, V47, P381, DOI 10.1016/j.neuropharm.2004.04.010; Salinas E, 2001, NAT REV NEUROSCI, V2, P539, DOI 10.1038/35086012; Smeal RM, 2010, PHILOS T R SOC B, V365, P2407, DOI 10.1098/rstb.2009.0292; WILSON HR, 1972, BIOPHYS J, V12, P1, DOI 10.1016/S0006-3495(72)86068-5; Winfree A.T., 2000, GEOMETRY BIOL TIME	28	64	65	0	20	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	MAY	2012	15	5					763	768		10.1038/nn.3081	http://dx.doi.org/10.1038/nn.3081			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	932DI	22466505	Green Accepted			2022-12-28	WOS:000303270200021
J	Kennerley, SW				Kennerley, Steven W.			Is the reward really worth it?	NATURE NEUROSCIENCE			English	Editorial Material							ANTERIOR CINGULATE CORTEX; DECISION-MAKING; DOUBLE DISSOCIATION; FRONTAL-CORTEX; NEURONS	How does the brain evaluate whether the benefits of a decision outweigh the costs? A study now reveals that neurons in the anterior cingulate cortex encode costs and benefits, and altering brain activity here biases choices away from negative outcomes. These results link anterior cingulate cortex with the regulation of emotional states.	UCL, Inst Neurol, London, England	University of London; University College London	Kennerley, SW (corresponding author), UCL, Inst Neurol, London, England.	s.kennerley@ucl.ac.uk	Kennerley, Steven W/E-3330-2018	Kennerley, Steven W/0000-0002-5696-7507				Amemori KI, 2012, NAT NEUROSCI, V15, P776, DOI 10.1038/nn.3088; Cai XY, 2012, J NEUROSCI, V32, P3791, DOI 10.1523/JNEUROSCI.3864-11.2012; Camille N, 2011, J NEUROSCI, V31, P15048, DOI 10.1523/JNEUROSCI.3164-11.2011; Kennerley SW, 2011, NAT NEUROSCI, V14, P1581, DOI 10.1038/nn.2961; Kennerley SW, 2011, BEHAV NEUROSCI, V125, P297, DOI 10.1037/a0023575; Kobayashi S, 2006, NEURON, V51, P861, DOI 10.1016/j.neuron.2006.08.031; Leiphart JW, 2010, J NEUROSURG, V113, P1204, DOI 10.3171/2010.5.JNS091277; Machens CK, 2005, SCIENCE, V307, P1121, DOI 10.1126/science.1104171; Mayberg HS, 2005, NEURON, V45, P651, DOI 10.1016/j.neuron.2005.02.014; Millan MJ, 2003, PROG NEUROBIOL, V70, P83, DOI 10.1016/s0301-0082(03)00087-X; Morrison SE, 2009, J NEUROSCI, V29, P11471, DOI 10.1523/JNEUROSCI.1815-09.2009; Papez JW, 1937, ARCH NEURO PSYCHIATR, V38, P725, DOI 10.1001/archneurpsyc.1937.02260220069003; Paus T, 2001, NAT REV NEUROSCI, V2, P417, DOI 10.1038/35077500; Rushworth MFS, 2011, NEURON, V70, P1054, DOI 10.1016/j.neuron.2011.05.014; Walton ME, 2006, NEURAL NETWORKS, V19, P1302, DOI 10.1016/j.neunet.2006.03.005	15	1	1	2	14	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	MAY	2012	15	5					647	649		10.1038/nn.3096	http://dx.doi.org/10.1038/nn.3096			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	932DI	22534574				2022-12-28	WOS:000303270200002
J	Lo Sardo, V; Zuccato, C; Gaudenzi, G; Vitali, B; Ramos, C; Tartari, M; Myre, MA; Walker, JA; Pistocchi, A; Conti, L; Valenza, M; Drung, B; Schmidt, B; Gusella, J; Zeitlin, S; Cotelli, F; Cattaneo, E				Lo Sardo, Valentina; Zuccato, Chiara; Gaudenzi, Germano; Vitali, Barbara; Ramos, Catarina; Tartari, Marzia; Myre, Michael A.; Walker, James A.; Pistocchi, Anna; Conti, Luciano; Valenza, Marta; Drung, Binia; Schmidt, Boris; Gusella, James; Zeitlin, Scott; Cotelli, Franco; Cattaneo, Elena			An evolutionary recent neuroepithelial cell adhesion function of huntingtin implicates ADAM10-Ncadherin	NATURE NEUROSCIENCE			English	Article							WILD-TYPE HUNTINGTIN; EMBRYONIC STEM-CELLS; N-CADHERIN; MUTANT HUNTINGTIN; TARGETED DISRUPTION; LACKING HUNTINGTIN; DISEASE; ADAM10; GENE; NEUROGENESIS	The Huntington's disease gene product, huntingtin, is indispensable for neural tube formation, but its role is obscure. We studied neurulation in htt-null embryonic stem cells and htt-morpholino zebrafish embryos and found a previously unknown, evolutionarily recent function for this ancient protein. We found that htt was essential for homotypic interactions between neuroepithelial cells; it permitted neurulation and rosette formation by regulating metalloprotease ADAM 10 activity and Ncadherin cleavage. This function was embedded in the N terminus of htt and was phenocopied by treatment of htt knockdown zebrafish with an ADAM 10 inhibitor. Notably, in htt-null cells, reversion of the rosetteless phenotype occurred only with expression of evolutionarily recent htt heterologues from deuterostome organisms. Conversely, all of the heterologues that we tested, including htt from Drosophila melanogaster and Dictyostelium discoideum, exhibited anti-apoptotic activity. Thus, anti-apoptosis may have been one of htt's ancestral function(s), but, in deuterostomes, htt evolved to acquire a unique regulatory activity for controlling neural adhesion via ADAM10-Ncadherin, with implications for brain evolution and development.	[Lo Sardo, Valentina; Zuccato, Chiara; Vitali, Barbara; Ramos, Catarina; Tartari, Marzia; Conti, Luciano; Valenza, Marta; Cattaneo, Elena] Univ Milan, Dept Pharmacol Sci, Milan, Italy; [Lo Sardo, Valentina; Zuccato, Chiara; Vitali, Barbara; Ramos, Catarina; Tartari, Marzia; Conti, Luciano; Valenza, Marta; Cattaneo, Elena] Univ Milan, Ctr Stem Cell Res, Milan, Italy; [Gaudenzi, Germano; Pistocchi, Anna; Cotelli, Franco] Univ Milan, Dept Biol, Milan, Italy; [Myre, Michael A.; Walker, James A.; Gusella, James] Massachusetts Gen Hosp, Ctr Human Genet Res, Boston, MA 02114 USA; [Drung, Binia; Schmidt, Boris] Tech Univ Darmstadt, Clemens Schopf Inst Chem & Biochem, Darmstadt, Germany; [Zeitlin, Scott] Univ Virginia, Sch Med, Dept Neurosci, Charlottesville, VA 22908 USA	University of Milan; University of Milan; University of Milan; Harvard University; Massachusetts General Hospital; Technical University of Darmstadt; University of Virginia	Cattaneo, E (corresponding author), Univ Milan, Dept Pharmacol Sci, Milan, Italy.	elena.cattaneo@unimi.it	Conti, Luciano/H-4184-2012; gaudenzi, Germano/H-4705-2014; Pistocchi, Anna/A-6228-2014; Schmidt, Boris/M-7886-2019; Schmidt, Boris/D-3293-2009; Zeitlin, Scott/P-5787-2019; VALENZA, MARTA/B-7763-2017	Conti, Luciano/0000-0002-2050-9846; Pistocchi, Anna/0000-0001-9467-2542; Schmidt, Boris/0000-0003-1662-2392; Schmidt, Boris/0000-0003-1662-2392; gaudenzi, germano/0000-0003-3516-8471; ZUCCATO, CHIARA/0000-0003-1771-3392; Lo Sardo, Valentina/0000-0003-0573-9878; CATTANEO, ELENA/0000-0002-0755-4917; VALENZA, MARTA/0000-0002-7048-9257	Huntington's Disease Society of America Coalition for the Cure; Italian Telethon Foundation [GGP06250]; Ministero dell'Istruzione, dell'Universita e della Ricerca Scientifica, Programmi di Ricerca Scientifica di Rilevante Interesse Nazionale [2006052993]; Fundacao para a Ciencia e Tecnologia through University of Porto [SERH/BD/9627/2002];  [NS16367]	Huntington's Disease Society of America Coalition for the Cure; Italian Telethon Foundation(Fondazione Telethon); Ministero dell'Istruzione, dell'Universita e della Ricerca Scientifica, Programmi di Ricerca Scientifica di Rilevante Interesse Nazionale; Fundacao para a Ciencia e Tecnologia through University of Porto; 	We thank M. MacDonald (Massachusetts General Hospital) for the Hdh<SUP>+/+</SUP> and Hdh<SUP>ex4-5</SUP> cells, P. Saftig for the ADAM 10 antibody (University of Kiel), E. Ruthazer for the zebrafish Ncadherin antibody (McGill University), F. Gardoni and E. Marcello for helpful technical advice on the use of ADAM 10 and SAP97 antibodies, A. Badaloni for help with subcloning, and G. Simonutti for assistance with initial imaging analysis. This work has progressed at a very slow pace because it was mostly unfunded. In the beginning, this work was partially supported by the Huntington's Disease Society of America Coalition for the Cure (2007-2009) and by Italian Telethon Foundation (GGP06250, 2007-2009). Some additional support was provided by the Ministero dell'Istruzione, dell'Universita e della Ricerca Scientifica, Programmi di Ricerca Scientifica di Rilevante Interesse Nazionale (2006052993, 2006). Since 2009, progress of this work has relied entirely on occasional donations. We wish to thank one donor that in 2009 collected a considerable amount of small donations for us to continue this work and another donor that has been following our progress for 10 years. C.A. was supported by the Fundacao para a Ciencia e Tecnologia (grant number SERH/BD/9627/2002) through the GABBA Programme (University of Porto). E.C., J.G. and S.Z. were members of the Huntington's Disease Society of America Coalition for the Cure and J.G. received support from NS16367.	Abranches E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006286; Adolf B, 2004, GENE EXPR PATTERNS, V5, P35, DOI 10.1016/j.modgep.2004.06.009; Auerbach W, 2001, HUM MOL GENET, V10, P2515, DOI 10.1093/hmg/10.22.2515; Bhide PG, 1996, J NEUROSCI, V16, P5523; Chen YYY, 2007, J NEUROSCI, V27, P8448, DOI 10.1523/JNEUROSCI.1841-07.2007; Diekmann H, 2009, J NEUROSCI, V29, P1343, DOI 10.1523/JNEUROSCI.6039-08.2009; Dragatsis I, 1998, DEVELOPMENT, V125, P1529; Dragatsis I, 2000, NAT GENET, V26, P300, DOI 10.1038/81593; DUYAO MP, 1995, SCIENCE, V269, P407, DOI 10.1126/science.7618107; Elkabetz Y, 2008, GENE DEV, V22, P152, DOI 10.1101/gad.1616208; Godin JD, 2010, NEURON, V67, P392, DOI 10.1016/j.neuron.2010.06.027; Halbleib JM, 2006, GENE DEV, V20, P3199, DOI 10.1101/gad.1486806; Henshall TL, 2009, HUM MOL GENET, V18, P4830, DOI 10.1093/hmg/ddp455; Ho LW, 2001, J MED GENET, V38, P450, DOI 10.1136/jmg.38.7.450; Hoettecke N, 2010, NEURODEGENER DIS, V7, P232, DOI 10.1159/000267865; Inoshima I, 2011, NAT MED, V17, P1310, DOI 10.1038/nm.2451; KELLY GM, 1995, DEV GENET, V17, P129, DOI 10.1002/dvg.1020170205; Leavitt BR, 2006, J NEUROCHEM, V96, P1121, DOI 10.1111/j.1471-4159.2005.03605.x; Lele Z, 2002, DEVELOPMENT, V129, P3281; Li Z, 1999, HUM MOL GENET, V8, P1807, DOI 10.1093/hmg/8.9.1807; MACDONALD ME, 1993, CELL, V72, P971, DOI 10.1016/0092-8674(93)90585-E; Malinverno M, 2010, J NEUROSCI, V30, P16343, DOI 10.1523/JNEUROSCI.1984-10.2010; Marambaud P, 2002, EMBO J, V21, P1948, DOI 10.1093/emboj/21.8.1948; Marcello E, 2007, J NEUROSCI, V27, P1682, DOI 10.1523/JNEUROSCI.3439-06.2007; Miller JP, 2010, NEURON, V67, P199, DOI 10.1016/j.neuron.2010.06.021; Muraguchi T, 2007, NAT NEUROSCI, V10, P838, DOI 10.1038/nn1922; Myre MA, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002052; NASIR J, 1995, CELL, V81, P811, DOI 10.1016/0092-8674(95)90542-1; O'Kusky JR, 1999, BRAIN RES, V818, P468, DOI 10.1016/S0006-8993(98)01312-2; Palidwor GA, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000304; Postina R, 2004, J CLIN INVEST, V113, P1456, DOI 10.1172/JCI200420864; Prinzen C, 2008, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-66; Radice GL, 1997, DEV BIOL, V181, P64, DOI 10.1006/dbio.1996.8443; Reiner A, 2001, J NEUROSCI, V21, P7608, DOI 10.1523/JNEUROSCI.21-19-07608.2001; Reis SA, 2011, HUM MOL GENET, V20, P2344, DOI 10.1093/hmg/ddr127; Reiss K, 2005, EMBO J, V24, P742, DOI 10.1038/sj.emboj.7600548; Rigamonti D, 2001, J BIOL CHEM, V276, P14545, DOI 10.1074/jbc.C100044200; Rigamonti D, 2000, J NEUROSCI, V20, P3705, DOI 10.1523/JNEUROSCI.20-10-03705.2000; Tartari M, 2008, MOL BIOL EVOL, V25, P330, DOI 10.1093/molbev/msm258; Uemura K, 2006, NEUROSCI LETT, V402, P278, DOI 10.1016/j.neulet.2006.04.018; White JK, 1997, NAT GENET, V17, P404, DOI 10.1038/ng1297-404; Yang P, 2006, PROG NEUROBIOL, V79, P73, DOI 10.1016/j.pneurobio.2006.05.001; Ying QL, 2003, NAT BIOTECHNOL, V21, P183, DOI 10.1038/nbt780; ZEITLIN S, 1995, NAT GENET, V11, P155, DOI 10.1038/ng1095-155; Zhang S, 2009, DIS MODEL MECH, V2, P247, DOI 10.1242/dmm.000653; Zhang Y, 2006, EMBO J, V25, P5896, DOI 10.1038/sj.emboj.7601445; Zhang YU, 2003, J NEUROCHEM, V87, P101, DOI 10.1046/j.1471-4159.2003.01980.x; Zuccato C, 2010, PHYSIOL REV, V90, P905, DOI 10.1152/physrev.00041.2009	48	70	71	2	21	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAY	2012	15	5					713	721		10.1038/nn.3080	http://dx.doi.org/10.1038/nn.3080			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	932DI	22466506				2022-12-28	WOS:000303270200015
J	Sperandio, I; Chouinard, PA; Goodale, MA				Sperandio, Irene; Chouinard, Philippe A.; Goodale, Melvyn A.			Retinotopic activity in V1 reflects the perceived and not the retinal size of an afterimage	NATURE NEUROSCIENCE			English	Article							REPRESENTATION; ILLUSION	An afterimage looks larger when one fixates on a distant than on a closer surface. We show that the retinotopic activity in the primary visual cortex (V1) associated with viewing an afterimage is modulated by perceived size, even when the size of the retinal image remains constant. This suggests that V1 has an important role in size constancy when the viewing distance of the stimulus changes.	[Sperandio, Irene; Chouinard, Philippe A.; Goodale, Melvyn A.] Univ Western Ontario, Brain & Mind Inst, London, ON, Canada; [Sperandio, Irene; Chouinard, Philippe A.; Goodale, Melvyn A.] Univ Western Ontario, Dept Psychol, London, ON, Canada	Western University (University of Western Ontario); Western University (University of Western Ontario)	Goodale, MA (corresponding author), Univ Western Ontario, Brain & Mind Inst, London, ON, Canada.	mgoodale@uwo.ca	Goodale, Melvyn A/M-5907-2013; Chouinard, Philippe/AEP-6474-2022	Goodale, Melvyn A/0000-0001-6748-0561; Chouinard, Philippe/0000-0001-9817-0689	Ontario Ministry of Research and Innovation; Ontario Mental Health Foundation; Natural Sciences and Engineering Research Council of Canada	Ontario Ministry of Research and Innovation(Ministry of Research and Innovation, Ontario); Ontario Mental Health Foundation; Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	This work is dedicated to the memory of Prof. Richard Gregory, whose scientific curiosity was a great source of inspiration for us. We would also like to thank D. Vendramini and L. Strother for their technical support, J. Ladich for constructing our apparatus, A. McLean and K. Krueger for operating the MRI scanner and G. Buckingham for comments. This research was supported by an Ontario Ministry of Research and Innovation Postdoctoral Award to IS., by an Ontario Mental Health Foundation Postdoctoral Award to P.A.C. and by a Discovery Grant from the Natural Sciences and Engineering Research Council of Canada to M.A.G.	Emmert E, 1881, KLIN MONATSBL AUGENH, V19, P443; Fang F, 2008, CURR BIOL, V18, P1707, DOI 10.1016/j.cub.2008.09.025; Gregory R., 1998, EYE BRAIN, V5th; Holway AH, 1941, AM J PSYCHOL, V54, P21, DOI 10.2307/1417790; LEIBOWITZ H, 1969, SCIENCE, V166, P1174, DOI 10.1126/science.166.3909.1174; Liu Q, 2009, NEUROREPORT, V20, P809, DOI 10.1097/WNR.0b013e32832be7c0; Murray SO, 2006, NAT NEUROSCI, V9, P429, DOI 10.1038/nn1641; Schwarzkopf DS, 2011, NAT NEUROSCI, V14, P28, DOI 10.1038/nn.2706; SERENO MI, 1995, SCIENCE, V268, P889, DOI 10.1126/science.7754376	9	96	97	0	30	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	APR	2012	15	4					540	542		10.1038/nn.3069	http://dx.doi.org/10.1038/nn.3069			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	916PA	22406550				2022-12-28	WOS:000302114500012
J	Apostolides, PF; Trussell, LO				Apostolides, Pierre F.; Trussell, Laurence O.			Regulation of interneuron excitability by gap junction coupling with principal cells	NATURE NEUROSCIENCE			English	Article							DORSAL COCHLEAR NUCLEUS; INHIBITORY INTERNEURONS; HORSERADISH-PEROXIDASE; ELECTRICAL SYNAPSES; NEURONAL CIRCUITS; NETWORKS; LIGHT; FEEDFORWARD; ACTIVATION; PLASTICITY	Electrical coupling of inhibitory interneurons can synchronize activity across multiple neurons, thereby enhancing the reliability of inhibition onto principal cell targets. It is unclear whether downstream activity in principal cells controls the excitability of such inhibitory networks. Using paired patch-clamp recordings, we show that excitatory projection neurons (fusiform cells) and inhibitory stellate interneurons of the dorsal cochlear nucleus form an electrically coupled network through gap junctions containing connexin36 (Cxc36, also called Gjd2). Remarkably, stellate cells were more strongly coupled to fusiform cells than to other stellate cells. This heterologous coupling was functionally asymmetric, biasing electrical transmission from the principal cell to the interneuron. Optogenetically activated populations of fusiform cells reliably enhanced interneuron excitability and generated GABAergic inhibition onto the postsynaptic targets of stellate cells, whereas deep afterhyperpolarizations following fusiform cell spike trains potently inhibited stellate cells over several hundred milliseconds. Thus, the excitability of an interneuron network is bidirectionally controlled by distinct epochs of activity in principal cells.	[Apostolides, Pierre F.] Oregon Hlth & Sci Univ, Grad Program Neurosci, Portland, OR 97201 USA; [Apostolides, Pierre F.; Trussell, Laurence O.] Oregon Hlth & Sci Univ, Vollum Inst, Portland, OR 97201 USA; [Apostolides, Pierre F.; Trussell, Laurence O.] Oregon Hlth & Sci Univ, Oregon Hearing Res Ctr, Portland, OR 97201 USA	Oregon Health & Science University; Oregon Health & Science University; Oregon Health & Science University	Trussell, LO (corresponding author), Oregon Hlth & Sci Univ, Vollum Inst, L474, Portland, OR 97201 USA.	trussell@ohsu.edu			US National Institutes of Health [01DC004450, F31DC012222, P30 DC005983]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS028901] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [P30DC005983, R01DC004450, F31DC012222] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	We thank M. Roberts and S. Kuo for preliminary observations that led us to search for electrical coupling in the DCN; M. Bateschell and R. Larisch for help with mouse colony management and genotyping; C. Borges-Merjane (Vollum Institute/Oregon Hearing Research Center) for initially genotyping the Thyl-ChR2 mice and providing the cerebellum slices used in Supplementary Figure 2; H.-W Lu for writing the macros used to analyze the calcium imaging data; S. Foster for performing the auditory brainstem response measurements; and K. Bender, W Giardino and N. Sawtell for critical comments on the manuscript. Funding was provided by US National Institutes of Health grants R01DC004450 to Dal, F31DC012222 to P.F.A. and P30 DC005983 to the Oregon Hearing Research Center.	Arenkiel BR, 2007, NEURON, V54, P205, DOI 10.1016/j.neuron.2007.03.005; Bell CC, 1997, J NEUROSCI, V17, P6409; Bell CC, 1997, NATURE, V387, P278, DOI 10.1038/387278a0; Bell CC, 2008, ANNU REV NEUROSCI, V31, P1, DOI 10.1146/annurev.neuro.30.051606.094225; Bennett MVL, 2004, NEURON, V41, P495, DOI 10.1016/S0896-6273(04)00043-1; BENNETT MVL, 1966, ANN NY ACAD SCI, V137, P509, DOI 10.1111/j.1749-6632.1966.tb50178.x; CHRISTIE MJ, 1989, J NEUROSCI, V9, P3584; Coddington LT, 2013, NEURON, V78, P1050, DOI 10.1016/j.neuron.2013.04.019; Davis KA, 2000, J NEUROPHYSIOL, V83, P926, DOI 10.1152/jn.2000.83.2.926; Dean P, 2010, NAT REV NEUROSCI, V11, P30, DOI 10.1038/nrn2756; Dugue GP, 2009, NEURON, V61, P126, DOI 10.1016/j.neuron.2008.11.028; Gibson JR, 2005, J NEUROPHYSIOL, V93, P467, DOI 10.1152/jn.00520.2004; Gibson JR, 1999, NATURE, V402, P75, DOI 10.1038/47035; Hagglund M, 2010, NAT NEUROSCI, V13, P246, DOI 10.1038/nn.2482; Han VZ, 2000, NEURON, V27, P611, DOI 10.1016/S0896-6273(00)00070-2; Hancock KE, 2002, J NEUROPHYSIOL, V87, P2505, DOI 10.1152/jn.2002.87.5.2505; Hansel C, 2006, NEURON, V51, P835, DOI 10.1016/j.neuron.2006.08.013; Hestrin S, 2005, TRENDS NEUROSCI, V28, P304, DOI 10.1016/j.tins.2005.04.001; Isaacson JS, 2011, NEURON, V72, P231, DOI 10.1016/j.neuron.2011.09.027; Ito T, 2010, FRONT NEUROANAT, V4, DOI 10.3389/fnana.2010.00135; Leao RM, 2012, J NEUROPHYSIOL, V107, P3008, DOI 10.1152/jn.00660.2011; Ma WLD, 2012, J NEUROPHYSIOL, V107, P824, DOI 10.1152/jn.00427.2011; Maher BJ, 2009, P NATL ACAD SCI USA, V106, P16865, DOI 10.1073/pnas.0808946106; Mann-Metzer P, 1999, J NEUROSCI, V19, P3298; Mathews PJ, 2012, J NEUROSCI, V32, P17988, DOI 10.1523/JNEUROSCI.3916-12.2012; MERCHAN MA, 1985, J ANAT, V141, P121; Mitchell SJ, 2003, NEURON, V38, P433, DOI 10.1016/S0896-6273(03)00200-9; Molitor SC, 2003, J NEUROPHYSIOL, V89, P2225, DOI 10.1152/jn.00709.2002; MUGNAINI E, 1985, J COMP NEUROL, V235, P61, DOI 10.1002/cne.902350106; Nagel G, 2003, P NATL ACAD SCI USA, V100, P13940, DOI 10.1073/pnas.1936192100; Oertel D, 2004, TRENDS NEUROSCI, V27, P104, DOI 10.1016/j.tins.2003.12.001; Requarth T, 2011, CURR OPIN NEUROBIOL, V21, P602, DOI 10.1016/j.conb.2011.05.031; RHODE WS, 1983, J COMP NEUROL, V213, P426, DOI 10.1002/cne.902130407; Roberts MT, 2010, J NEUROPHYSIOL, V104, P2462, DOI 10.1152/jn.00312.2010; Rubio ME, 2005, J COMP NEUROL, V485, P266, DOI 10.1002/cne.20559; Rubio ME, 2004, J COMP NEUROL, V477, P253, DOI 10.1002/cne.20248; Sawtell NB, 2008, J NEUROSCI, V28, P1598, DOI 10.1523/JNEUROSCI.4946-07.2008; Storm-Mathisen J., 1990, GLYCINE NEUROTRANSMI, P417; Szapiro G, 2007, NAT NEUROSCI, V10, P735, DOI 10.1038/nn1907; Tzounopoulos T, 2004, NAT NEUROSCI, V7, P719, DOI 10.1038/nn1272; Vervaeke K, 2010, NEURON, V67, P435, DOI 10.1016/j.neuron.2010.06.028; WOUTERLOOD FG, 1984, J NEUROCYTOL, V13, P639, DOI 10.1007/BF01148083; ZHANG S, 1994, J NEUROPHYSIOL, V71, P914, DOI 10.1152/jn.1994.71.3.914	43	36	36	0	11	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	DEC	2013	16	12					1764	1772		10.1038/nn.3569	http://dx.doi.org/10.1038/nn.3569			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	257VV	24185427	Green Accepted			2022-12-28	WOS:000327416800014
J	Peden, AS; Mac, P; Fei, YJ; Castro, C; Jiang, GL; Murfitt, KJ; Miska, EA; Griffin, JL; Ganapathy, V; Jorgensen, EM				Peden, Aude S.; Mac, Patrick; Fei, You-Jun; Castro, Cecilia; Jiang, Guoliang; Murfitt, Kenneth J.; Miska, Eric A.; Griffin, Julian L.; Ganapathy, Vadivel; Jorgensen, Erik M.			Betaine acts on a ligand-gated ion channel in the nervous system of the nematode C. elegans	NATURE NEUROSCIENCE			English	Article							MELOIDOGYNE-JAVANICA; ASCOPHYLLUM-NODOSUM; CHLORIDE CHANNEL; TRANSPORTER; ENCODES; CLONING; SENSITIVITY; MODULATION; EXPRESSION; REDUCTION	Prior to the advent of synthetic nematocides, natural products such as seaweed were used to control nematode infestations. The nematocidal agent in seaweed is betaine, an amino acid that functions as an osmolyte and methyl donor. However, the molecular mechanisms of betaine toxicity are unknown. We identified the betaine transporter SNF-3 and the betaine receptor ACR-23 in the nematode C. elegans. Mutating snf-3 in a sensitized background caused the worms to be hypercontracted and paralyzed, presumably as a result of excess extracellular betaine. These behavioral defects were suppressed by mutations in acr-23, which encodes a ligand-gated cation channel of the cys-loop family. ACR-23 was activated by betaine and functioned in the mechanosensory neurons to maintain basal levels of locomotion. However, overactivation of the receptor by excess betaine or by the allosteric modulator monepantel resulted in hypercontraction and death of the nematode. Thus, moneriantel targets a betaine signaling pathway in nematodes.	[Peden, Aude S.; Mac, Patrick; Jorgensen, Erik M.] Univ Utah, Dept Biol, Salt Lake City, UT 84112 USA; [Peden, Aude S.; Mac, Patrick; Jorgensen, Erik M.] Univ Utah, Howard Hughes Med Inst, Salt Lake City, UT 84112 USA; [Fei, You-Jun; Jiang, Guoliang; Ganapathy, Vadivel] Georgia Regents Univ, Dept Biochem & Mol Biol, Augusta, GA USA; [Castro, Cecilia; Murfitt, Kenneth J.; Miska, Eric A.; Griffin, Julian L.] Univ Cambridge, Dept Biochem, Cambridge CB2 1QW, England; [Castro, Cecilia; Griffin, Julian L.] Univ Cambridge, Cambridge Syst Biol Ctr, Cambridge, England; [Murfitt, Kenneth J.; Miska, Eric A.] Univ Cambridge, Wellcome Trust Canc Res UK Gurdon Inst, Cambridge, England; [Griffin, Julian L.] Elsie Widdowson Lab, Med Res Council Human Nutr Res, Cambridge, England	Utah System of Higher Education; University of Utah; Howard Hughes Medical Institute; Utah System of Higher Education; University of Utah; University System of Georgia; Augusta University; University of Cambridge; University of Cambridge; University of Cambridge; UK Research & Innovation (UKRI); Medical Research Council UK (MRC); MRC Human Nutrition Research; University of Cambridge	Jorgensen, EM (corresponding author), Univ Utah, Dept Biol, Salt Lake City, UT 84112 USA.	jorgensen@biology.utah.edu		Miska, Eric/0000-0002-4450-576X	US National Institutes of Health [AG22468, NS034307]; National Research Service Award [F32GM084596]; National Science Foundation [I0S-0920069]; Howard Hughes Medical Institute; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM084596] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R37NS034307, R01NS034307] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG022468] Funding Source: NIH RePORTER; Cancer Research UK [11832] Funding Source: researchfish; Medical Research Council [MC_UP_A090_1006] Funding Source: researchfish; MRC [MC_UP_A090_1006] Funding Source: UKRI	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Research Service Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank E.M. Peden (University of Utah) for comments and input on the manuscript, J. Rand and G. Mullen (Oklahoma Medical Research Foundation) and the Caenorhabditis Genetics Center for providing strains, M.W. Davis and C. Thacker (University of Utah) for Illumina sequencing analysis, A. Fire (Stanford University) for providing the GFP expression vectors, Z.W. Wang (University of Connecticut) for the worm tracker, and H.-F. Han, J.W. Gardner and D. Maxfield (University of Utah) for help with locomotion assays. We also thank R. Gasser (University of Melbourne) for his generous gift of Zolvix. This work was supported by grants from the US National Institutes of Health (AG22468 to Y.-J.F., NS034307 to E.M.J. and National Research Service Award F32GM084596 to A.S.P.) and the National Science Foundation (I0S-0920069 to E.M.J.). E.M.J. receives funding from the Howard Hughes Medical Institute.	ARENA JP, 1992, MOL BRAIN RES, V15, P339, DOI 10.1016/0169-328X(92)90127-W; Bamber BA, 1999, J NEUROSCI, V19, P5348; BORDEN LA, 1995, J NEUROCHEM, V64, P977; CHALFIE M, 1985, J NEUROSCI, V5, P956; CHALFIE M, 1981, DEV BIOL, V82, P358, DOI 10.1016/0012-1606(81)90459-0; Craig SAS, 2004, AM J CLIN NUTR, V80, P539; CULLY DF, 1994, NATURE, V371, P707, DOI 10.1038/371707a0; Dent JA, 1997, EMBO J, V16, P5867, DOI 10.1093/emboj/16.19.5867; DRISCOLL M, 1997, C ELEGANS, pCH23; FREED WJ, 1979, EPILEPSIA, V20, P209, DOI 10.1111/j.1528-1157.1979.tb04797.x; GALZI JL, 1992, NATURE, V359, P500, DOI 10.1038/359500a0; GHOZ EH, 1985, PHARMACOL BIOCHEM BE, V22, P635, DOI 10.1016/0091-3057(85)90287-4; Giros B, 1996, NATURE, V379, P606, DOI 10.1038/379606a0; Hahn MK, 2007, ANNU REV PHARMACOL, V47, P401, DOI 10.1146/annurev.pharmtox.47.120505.105242; Hoffmann EK, 2009, PHYSIOL REV, V89, P193, DOI 10.1152/physrev.00037.2007; Kaminsky R, 2008, NATURE, V452, P176, DOI 10.1038/nature06722; Keramidas A, 2004, PROG BIOPHYS MOL BIO, V86, P161, DOI 10.1016/j.pbiomolbio.2003.09.002; Lackner MR, 1999, NEURON, V24, P335, DOI 10.1016/S0896-6273(00)80848-X; LEWIS JA, 1980, GENETICS, V95, P905; LEWIS JA, 1980, NEUROSCIENCE, V5, P967, DOI 10.1016/0306-4522(80)90180-3; McDonald PW, 2007, J NEUROSCI, V27, P14216, DOI 10.1523/JNEUROSCI.2992-07.2007; Miller KG, 1999, NEURON, V24, P323, DOI 10.1016/S0896-6273(00)80847-8; Morgan K. T., 1980, Proceedings of the Florida State Horticultural Society, V93, P97; Mullen GP, 2006, MOL BIOL CELL, V17, P3021, DOI 10.1091/mbc.E06-02-0155; Reinke SN, 2010, MOL GENET METAB, V100, P274, DOI 10.1016/j.ymgme.2010.03.013; Rufener L, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003524; Rufener L, 2010, MOL PHARMACOL, V78, P895, DOI 10.1124/mol.110.066498; Rufener L, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001091; Sawin ER, 2000, NEURON, V26, P619, DOI 10.1016/S0896-6273(00)81199-X; Torres GE, 2003, NAT REV NEUROSCI, V4, P13, DOI 10.1038/nrn1008; TREININ M, 1995, NEURON, V14, P871, DOI 10.1016/0896-6273(95)90231-7; VERNINO S, 1992, NEURON, V8, P127, DOI 10.1016/0896-6273(92)90114-S; WHAPHAM CA, 1994, FUND APPL NEMATOL, V17, P181; Wu Y, 1997, FUND APPL NEMATOL, V20, P99; Wu Y, 1998, J APPL PHYCOL, V10, P91, DOI 10.1023/A:1008067420092; WUERTHELE SE, 1982, LIFE SCI, V31, P2683, DOI 10.1016/0024-3205(82)90712-3; YAMAUCHI A, 1992, J BIOL CHEM, V267, P649; Zhu XM, 2004, J NEUROCYTOL, V33, P233, DOI 10.1023/B:NEUR.0000030698.66675.90	38	29	36	1	25	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	DEC	2013	16	12					1794	1801		10.1038/nn.3575	http://dx.doi.org/10.1038/nn.3575			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	257VV	24212673	Green Submitted, Green Accepted			2022-12-28	WOS:000327416800017
J	Chittajallu, R; Craig, MT; McFarland, A; Yuan, XQ; Geffen, S; Tricoire, L; Erkkila, B; Barron, SC; Lopez, CM; Liang, BJ; Jeffries, BW; Pelkey, KA; McBain, CJ				Chittajallu, Ramesh; Craig, Michael T.; McFarland, Ashley; Yuan, Xiaoqing; Geffen, Scott; Tricoire, Ludovic; Erkkila, Brian; Barron, Sean C.; Lopez, Carla M.; Liang, Barry J.; Jeffries, Brian W.; Pelkey, Kenneth A.; McBain, Chris J.			Dual origins of functionally distinct O-LM interneurons revealed by differential 5-HT3AR expression	NATURE NEUROSCIENCE			English	Article							OSCILLATIONS IN-VITRO; STRATUM-ORIENS INTERNEURONS; CORTICAL INTERNEURONS; GABAERGIC INTERNEURONS; NETWORK OSCILLATIONS; RAT HIPPOCAMPUS; PERISOMATIC INHIBITION; RECEPTOR ACTIVATION; TRANSGENIC MICE; BASKET CELLS	Forebrain circuits rely upon a relatively small but remarkably diverse population of GABAergic interneurons to bind and entrain large principal cell assemblies for network synchronization and rhythmogenesis. Despite the high degree of heterogeneity across cortical interneurons, members of a given subtype typically exhibit homogeneous developmental origins, neuromodulatory response profiles, morphological characteristics, neurochemical signatures and electrical features. Here we report a surprising divergence among hippocampal oriens-lacunosum moleculare (O-LM) projecting interneurons that have hitherto been considered a homogeneous cell population. Combined immunocytochemical, anatomical and electrophysiological interrogation of Htr3a-GFP and Nkx2-1-cre:RCE mice revealed that O-LM cells parse into a caudal ganglionic eminence-derived subpopulation expressing 5-HT3A receptors (5-HT(3A)Rs) and a medial ganglionic eminence-derived subpopulation lacking 5-HT(3A)Rs. These two cohorts differentially participate in network oscillations, with 5-HT3AR-containing O-LM cell recruitment dictated by serotonergic tone. Thus, members of a seemingly uniform interneuron population can exhibit unique circuit functions and neuromodulatory properties dictated by disparate developmental origins.	[Chittajallu, Ramesh; Craig, Michael T.; McFarland, Ashley; Yuan, Xiaoqing; Geffen, Scott; Tricoire, Ludovic; Erkkila, Brian; Barron, Sean C.; Lopez, Carla M.; Liang, Barry J.; Jeffries, Brian W.; Pelkey, Kenneth A.; McBain, Chris J.] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Program Dev Neurobiol, NIH, Bethesda, MD USA	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	Pelkey, KA (corresponding author), Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Program Dev Neurobiol, NIH, Bethesda, MD USA.	pelkeyk2@mail.nih.gov	Chittajallu, Ramesh/AAX-3749-2020; Craig, Michael/E-7070-2011; Craig, Michael/O-8267-2019	Chittajallu, Ramesh/0000-0002-9794-0052; Craig, Michael/0000-0001-8481-6709; Craig, Michael/0000-0001-8481-6709	NICHD; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD001205] Funding Source: NIH RePORTER	NICHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	We thank D. Abebe for expert technical assistance. We are grateful to S. Anderson (University of Pennsylvania) and a Fishell (New York University) for providing the Nkx2-1-cre and the RCE reporter mouse lines, respectively. The GENSAT BAC-Cre driver line (Htr3a-NO152) mice were obtained from C. Gerfen (National Institute of Mental Health). We would also like to thank E. Mann (University of Oxford) for providing the code for the wavelet analyses. This work was supported by an NICHD intramural award to C.J.M.	Ascoli GA, 2008, NAT REV NEUROSCI, V9, P557, DOI 10.1038/nrn2402; Bartos M, 2012, J PHYSIOL-LONDON, V590, P669, DOI 10.1113/jphysiol.2011.226175; Close J, 2012, J NEUROSCI, V32, P17690, DOI 10.1523/JNEUROSCI.3583-12.2012; Denaxa M, 2012, CELL REP, V2, P1351, DOI 10.1016/j.celrep.2012.10.003; Dugladze T, 2012, SCIENCE, V336, P1458, DOI 10.1126/science.1222017; Ferraguti F, 2004, HIPPOCAMPUS, V14, P193, DOI 10.1002/hipo.10163; Fishell G, 2011, ANNU REV NEUROSCI, V34, P535, DOI 10.1146/annurev-neuro-061010-113717; Fogarty M, 2007, J NEUROSCI, V27, P10935, DOI 10.1523/JNEUROSCI.1629-07.2007; Freund TF, 2007, NEURON, V56, P33, DOI 10.1016/j.neuron.2007.09.012; Freund TF, 2003, TRENDS NEUROSCI, V26, P489, DOI 10.1016/S0166-2236(03)00227-3; Freund TF, 1996, HIPPOCAMPUS, V6, P347, DOI 10.1002/(SICI)1098-1063(1996)6:4<347::AID-HIPO1>3.0.CO;2-I; FREUND TF, 1990, P NATL ACAD SCI USA, V87, P8501, DOI 10.1073/pnas.87.21.8501; Fuentealba P, 2010, J NEUROSCI, V30, P1595, DOI 10.1523/JNEUROSCI.4199-09.2010; Gloveli T, 2005, J PHYSIOL-LONDON, V562, P131, DOI 10.1113/jphysiol.2004.073007; Gong SC, 2007, J NEUROSCI, V27, P9817, DOI 10.1523/JNEUROSCI.2707-07.2007; Gulyas AI, 2010, J NEUROSCI, V30, P15134, DOI 10.1523/JNEUROSCI.4104-10.2010; Hajos N, 2004, J NEUROSCI, V24, P9127, DOI 10.1523/JNEUROSCI.2113-04.2004; HALASY K, 1992, EUR J NEUROSCI, V4, P144, DOI 10.1111/j.1460-9568.1992.tb00861.x; Klausberger T, 2003, NATURE, V421, P844, DOI 10.1038/nature01374; Klausberger T, 2008, SCIENCE, V321, P53, DOI 10.1126/science.1149381; Lawrence JJ, 2008, TRENDS NEUROSCI, V31, P317, DOI 10.1016/j.tins.2008.03.008; Lawrence JJ, 2006, J PHYSIOL-LONDON, V570, P595, DOI 10.1113/jphysiol.2005.100875; Lawrence JJ, 2006, J PHYSIOL-LONDON, V571, P555, DOI 10.1113/jphysiol.2005.103218; Lee S, 2010, J NEUROSCI, V30, P16796, DOI 10.1523/JNEUROSCI.1869-10.2010; Ma YY, 2006, J NEUROSCI, V26, P5069, DOI 10.1523/JNEUROSCI.0661-06.2006; Maccaferri G, 2005, J PHYSIOL-LONDON, V562, P73, DOI 10.1113/jphysiol.2004.077081; Madisen L, 2010, NAT NEUROSCI, V13, P133, DOI 10.1038/nn.2467; MCBAIN CJ, 1994, J NEUROSCI, V14, P4433; McBain CJ, 2001, NAT REV NEUROSCI, V2, P11, DOI 10.1038/35049047; Miyoshi G, 2007, J NEUROSCI, V27, P7786, DOI 10.1523/JNEUROSCI.1807-07.2007; Miyoshi G, 2010, J NEUROSCI, V30, P1582, DOI 10.1523/JNEUROSCI.4515-09.2010; Oliva AA, 2000, J NEUROSCI, V20, P3354, DOI 10.1523/JNEUROSCI.20-09-03354.2000; Reznic J, 1997, J NEUROPHYSIOL, V77, P517, DOI 10.1152/jn.1997.77.1.517; Rio CACD, 2012, J PHYSIOL-LONDON, V590, P695, DOI 10.1113/jphysiol.2011.225342; ROPERT N, 1991, J PHYSIOL-LONDON, V441, P121, DOI 10.1113/jphysiol.1991.sp018742; Rudy B, 2011, DEV NEUROBIOL, V71, P45, DOI 10.1002/dneu.20853; Somogyi P, 2005, J PHYSIOL-LONDON, V562, P9, DOI 10.1113/jphysiol.2004.078915; Sousa VH, 2009, CEREB CORTEX, V19, pI1, DOI 10.1093/cercor/bhp038; Spampanato J, 2007, J NEUROPHYSIOL, V98, P96, DOI 10.1152/jn.00188.2007; Tricoire L, 2011, J NEUROSCI, V31, P10948, DOI 10.1523/JNEUROSCI.0323-11.2011; Tricoire L, 2010, J NEUROSCI, V30, P2165, DOI 10.1523/JNEUROSCI.5123-09.2010; Tukker JJ, 2007, J NEUROSCI, V27, P8184, DOI 10.1523/JNEUROSCI.1685-07.2007; Varga C, 2012, P NATL ACAD SCI USA, V109, pE2726, DOI 10.1073/pnas.1210929109; Varga V, 2009, SCIENCE, V326, P449, DOI 10.1126/science.1178307; Verney C, 2000, DEV NEUROSCI-BASEL, V22, P125, DOI 10.1159/000017434; Vucurovic K, 2010, CEREB CORTEX, V20, P2333, DOI 10.1093/cercor/bhp310; Whittington MA, 2011, DEV NEUROBIOL, V71, P92, DOI 10.1002/dneu.20814; Wierenga CJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015915; Wonders CP, 2006, NAT REV NEUROSCI, V7, P687, DOI 10.1038/nrn1954; Xu Q, 2008, J COMP NEUROL, V506, P16, DOI 10.1002/cne.21529	50	77	78	0	10	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	NOV	2013	16	11					1598	1607		10.1038/nn.3538	http://dx.doi.org/10.1038/nn.3538			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	241YX	24097043	Green Accepted			2022-12-28	WOS:000326205700017
J	Lien, AD; Scanziani, M				Lien, Anthony D.; Scanziani, Massimo			Tuned thalamic excitation is amplified by visual cortical circuits	NATURE NEUROSCIENCE			English	Article							LATERAL GENICULATE-NUCLEUS; NEURONS IN-VIVO; ORIENTATION SELECTIVITY; SIMPLE CELLS; RECEPTIVE-FIELDS; FUNCTIONAL ARCHITECTURE; STRIATE CORTEX; CONNECTIONS; INPUT; SPECIFICITY	Cortical neurons in thalamic recipient layers receive excitation from the thalamus and the cortex. The relative contribution of these two sources of excitation to sensory tuning is poorly understood. We optogenetically silenced the visual cortex of mice to isolate thalamic excitation onto layer 4 neurons during visual stimulation. Thalamic excitation contributed to a third of the total excitation and was organized in spatially offset, yet overlapping, ON and OFF receptive fields. This receptive field structure predicted the orientation tuning of thalamic excitation. Finally, both thalamic and total excitation were similarly tuned to orientation and direction and had the same temporal phase relationship to the visual stimulus. Our results indicate that tuning of thalamic excitation is unlikely to be imparted by direction- or orientation-selective thalamic neurons and that a principal role of cortical circuits is to amplify tuned thalamic excitation.	[Lien, Anthony D.; Scanziani, Massimo] Univ Calif San Diego, Grad Program Neurosci, La Jolla, CA 92093 USA; [Lien, Anthony D.; Scanziani, Massimo] Univ Calif San Diego, Ctr Neural Circuits & Behav, Neurobiol Sect, La Jolla, CA 92093 USA; [Lien, Anthony D.; Scanziani, Massimo] Univ Calif San Diego, Dept Neurosci, La Jolla, CA 92093 USA; [Lien, Anthony D.; Scanziani, Massimo] Univ Calif San Diego, Howard Hughes Med Inst, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; Howard Hughes Medical Institute; University of California System; University of California San Diego	Lien, AD (corresponding author), Univ Calif San Diego, Grad Program Neurosci, La Jolla, CA 92093 USA.	anthony.d.lien@gmail.com; massimo@ucsd.edu		Lien, Anthony/0000-0003-3989-3881	Gatsby charitable foundation; Brain and Behavior Research Foundation; Howard Hughes Medical Institute	Gatsby charitable foundation; Brain and Behavior Research Foundation; Howard Hughes Medical Institute(Howard Hughes Medical Institute)	We thank J. Evora for help with genotyping and mouse husbandry, J. Isaacson, E. Chichilnisky and the members of the Scanziani and Isaacson laboratories for helpful discussions of this project, and S. Olsen and K. Reinhold for help with dLGN recordings. This project was supported by the Gatsby charitable foundation, the Brain and Behavior Research Foundation and the Howard Hughes Medical Institute.	Adesnik H, 2012, NATURE, V490, P226, DOI 10.1038/nature11526; Anderson JS, 2000, J NEUROPHYSIOL, V84, P909, DOI 10.1152/jn.2000.84.2.909; Atallah BV, 2012, NEURON, V73, P159, DOI 10.1016/j.neuron.2011.12.013; Bock DD, 2011, NATURE, V471, P177, DOI 10.1038/nature09802; Bosking WH, 1997, J NEUROSCI, V17, P2112; Boyden ES, 2005, NAT NEUROSCI, V8, P1263, DOI 10.1038/nn1525; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Brecht M, 2002, J PHYSIOL-LONDON, V543, P49, DOI 10.1113/jphysiol.2002.018465; Briggman KL, 2011, NATURE, V471, P183, DOI 10.1038/nature09818; CHAPMAN B, 1991, J NEUROSCI, V11, P1347; Chung S, 1998, NEURON, V20, P1177, DOI 10.1016/S0896-6273(00)80498-5; Cudeiro J, 2006, TRENDS NEUROSCI, V29, P298, DOI 10.1016/j.tins.2006.05.002; Ferster D, 1996, NATURE, V380, P249, DOI 10.1038/380249a0; GILBERT CD, 1989, J NEUROSCI, V9, P2432; Grubb MS, 2003, J NEUROPHYSIOL, V90, P3594, DOI 10.1152/jn.00699.2003; Haider B, 2013, NATURE, V493, P97, DOI 10.1038/nature11665; HUBEL DH, 1962, J PHYSIOL-LONDON, V160, P106, DOI 10.1113/jphysiol.1962.sp006837; Jia HB, 2010, NATURE, V464, P1307, DOI 10.1038/nature08947; Jin JZ, 2011, NAT NEUROSCI, V14, P232, DOI 10.1038/nn.2729; Kitamura K, 2008, NAT METHODS, V5, P61, DOI 10.1038/NMETH1150; Ko H, 2011, NATURE, V473, P87, DOI 10.1038/nature09880; Lampl I, 2001, NEURON, V30, P263, DOI 10.1016/S0896-6273(01)00278-1; Lien AD, 2011, FRONT NEURAL CIRCUIT, V5, DOI 10.3389/fncir.2011.00016; Liu BH, 2007, NAT NEUROSCI, V10, P1594, DOI 10.1038/nn2012; Liu BH, 2011, NEURON, V71, P542, DOI 10.1016/j.neuron.2011.06.017; Liu BH, 2010, NAT NEUROSCI, V13, P89, DOI 10.1038/nn.2443; MALACH R, 1993, P NATL ACAD SCI USA, V90, P10469, DOI 10.1073/pnas.90.22.10469; Margrie TW, 2002, PFLUG ARCH EUR J PHY, V444, P491, DOI 10.1007/s00424-002-0831-z; Marshel JH, 2012, NEURON, V76, P713, DOI 10.1016/j.neuron.2012.09.021; Marshel JH, 2010, NEURON, V67, P562, DOI 10.1016/j.neuron.2010.08.001; Nagel G, 2003, P NATL ACAD SCI USA, V100, P13940, DOI 10.1073/pnas.1936192100; NELSON S, 1994, SCIENCE, V265, P774, DOI 10.1126/science.8047882; Niell CM, 2010, NEURON, V65, P472, DOI 10.1016/j.neuron.2010.01.033; Olsen SR, 2012, NATURE, V483, P47, DOI 10.1038/nature10835; Piscopo DM, 2013, J NEUROSCI, V33, P4642, DOI 10.1523/JNEUROSCI.5187-12.2013; REID RC, 1995, NATURE, V378, P281, DOI 10.1038/378281a0; Ringach DL, 2002, J NEUROSCI, V22, P5639; Swindale NV, 1998, BIOL CYBERN, V78, P45, DOI 10.1007/s004220050411; Usrey WM, 2000, J NEUROSCI, V20, P5461, DOI 10.1523/JNEUROSCI.20-14-05461.2000	39	201	202	0	25	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	SEP	2013	16	9					1315	U207		10.1038/nn.3488	http://dx.doi.org/10.1038/nn.3488			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	207KN	23933748	Green Submitted, Green Accepted			2022-12-28	WOS:000323597500024
J	Aizenberg, M; Geffen, MN				Aizenberg, Mark; Geffen, Maria Neimark			Bidirectional effects of aversive learning on perceptual acuity are mediated by the sensory cortex	NATURE NEUROSCIENCE			English	Article							AUDITORY-CORTEX; DISCRIMINATION; PLASTICITY; FREQUENCY	Although emotional learning affects sensory acuity, little is known about how these changes are facilitated in the brain. We found that auditory fear conditioning in mice elicited either an increase or a decrease in frequency discrimination acuity depending on how specific the learned response was to the conditioned tone. Using reversible pharmacological inactivation, we found that the auditory cortex mediated learning-evoked changes in acuity in both directions.	[Aizenberg, Mark; Geffen, Maria Neimark] Univ Penn, Perelman Sch Med, Dept Otorhinolaryngol & Head & Neck Surg, Philadelphia, PA 19104 USA; [Geffen, Maria Neimark] Univ Penn, Perelman Sch Med, Dept Neurosci, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine	Geffen, MN (corresponding author), Univ Penn, Perelman Sch Med, Dept Otorhinolaryngol & Head & Neck Surg, Philadelphia, PA 19104 USA.	mgeffen@med.upenn.edu		Aizenberg, Mark/0000-0002-0010-0453	Burroughs Wellcome Fund Career Award at the Scientific Interface; Klingenstein Award in Neuroscience; Pennsylvania Lions Club Hearing Fellowship; Penn Medicine Neuroscience Center Pilot grant	Burroughs Wellcome Fund Career Award at the Scientific Interface(Burroughs Wellcome Fund); Klingenstein Award in Neuroscience(Klingenstein Philanthropies); Pennsylvania Lions Club Hearing Fellowship; Penn Medicine Neuroscience Center Pilot grant	We thank L. Mwilambwe- Tshilobo, D. Mohabir, A. Nguyen and L. Liu for technical assistance. M.N.G. is the recipient of the Burroughs Wellcome Fund Career Award at the Scientific Interface. The work was supported by the Klingenstein Award in Neuroscience, the Pennsylvania Lions Club Hearing Fellowship and the Penn Medicine Neuroscience Center Pilot grant to M.N.G.	Allen TA, 2008, J NEUROSCI METH, V171, P30, DOI 10.1016/j.jneumeth.2008.01.033; Asutay E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038660; Bajo VM, 2010, NAT NEUROSCI, V13, P253, DOI 10.1038/nn.2466; Basavaraj S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045123; BUTLER RA, 1957, J NEUROPHYSIOL, V20, P108, DOI 10.1152/jn.1957.20.1.108; Chapuis J, 2012, NAT NEUROSCI, V15, P155, DOI 10.1038/nn.2966; Clause A, 2011, J NEUROSCI METH, V200, P63, DOI 10.1016/j.jneumeth.2011.05.027; Froemke RC, 2011, HEARING RES, V279, P149, DOI 10.1016/j.heares.2011.03.005; Koch M, 1997, BEHAV BRAIN RES, V89, P35, DOI 10.1016/S0166-4328(97)02296-1; Krupa DJ, 1999, P NATL ACAD SCI USA, V96, P8200, DOI 10.1073/pnas.96.14.8200; Krusemark EA, 2012, CHEMOSENS PERCEPT, V5, P37, DOI 10.1007/s12078-011-9111-7; Li L, 2009, NEUROSCI BIOBEHAV R, V33, P1157, DOI 10.1016/j.neubiorev.2009.02.001; Li W, 2008, SCIENCE, V319, P1842, DOI 10.1126/science.1152837; Pape HC, 2010, PHYSIOL REV, V90, P419, DOI 10.1152/physrev.00037.2009; Resnik J, 2011, NAT NEUROSCI, V14, P791, DOI 10.1038/nn.2802; Suga N, 2012, NEUROSCI BIOBEHAV R, V36, P969, DOI 10.1016/j.neubiorev.2011.11.006; Talwar SK, 2001, J NEUROPHYSIOL, V85, P2350, DOI 10.1152/jn.2001.85.6.2350; Xu W, 2013, SCIENCE, V339, P1290, DOI 10.1126/science.1229534	18	53	54	0	29	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	AUG	2013	16	8					994	U30		10.1038/nn.3443	http://dx.doi.org/10.1038/nn.3443			5	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	190EV	23817548				2022-12-28	WOS:000322323000007
J	Sandoe, J; Eggan, K				Sandoe, Jackson; Eggan, Kevin			Opportunities and challenges of pluripotent stem cell neurodegenerative disease models	NATURE NEUROSCIENCE			English	Review							TARGETED GENE CORRECTION; MOTOR-NEURONS; ALZHEIMERS-DISEASE; HUMAN FIBROBLASTS; GLIAL-CELLS; DIFFERENTIATION; LINES; ALS; GENERATION; DERIVATION	Human neurodegenerative disorders are among the most difficult to study. In particular, the inability to readily obtain the faulty cell types most relevant to these diseases has impeded progress for decades. Recent advances in pluripotent stem cell technology now grant access to substantial quantities of disease-pertinent neurons both with and without predisposing mutations. While this suite of technologies has revolutionized the field of 'in vitro disease modeling', great care must be taken in their deployment if robust, durable discoveries are to be made. Here we review what we perceive to be several of the stumbling blocks in the use of stem cells for the study of neurological disease and offer strategies to overcome them.	[Sandoe, Jackson] Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA; [Sandoe, Jackson; Eggan, Kevin] Harvard Univ, Harvard Stem Cell Inst, Dept Stem Cell & Regenerat Biol, Cambridge, MA 02138 USA; [Eggan, Kevin] Harvard Univ, Howard Hughes Med Inst, Cambridge, MA 02138 USA	Harvard University; Harvard University; Harvard University; Howard Hughes Medical Institute	Eggan, K (corresponding author), Harvard Univ, Harvard Stem Cell Inst, Dept Stem Cell & Regenerat Biol, Cambridge, MA 02138 USA.	keggan@scrb.harvard.edu	Eggan, Kevin/P-7119-2018		Howard Hughes Medical Institute Funding Source: Medline	Howard Hughes Medical Institute(Howard Hughes Medical Institute)		Aizawa E, 2012, MOL THER, V20, P424, DOI 10.1038/mt.2011.266; Alegre-Abarrategui J, 2008, NEUROPATH APPL NEURO, V34, P272, DOI 10.1111/j.1365-2990.2007.00888.x; Amoroso MW, 2013, J NEUROSCI, V33, P574, DOI 10.1523/JNEUROSCI.0906-12.2013; An MC, 2012, CELL STEM CELL, V11, P253, DOI 10.1016/j.stem.2012.04.026; Andersen MS, 2002, J MOL MED-JMM, V80, P770, DOI 10.1007/s00109-002-0393-8; Bellin M, 2012, NAT REV MOL CELL BIO, V13, P713, DOI 10.1038/nrm3448; Bilican B, 2012, P NATL ACAD SCI USA, V109, P5803, DOI 10.1073/pnas.1202922109; Bock C, 2011, CELL, V144, P439, DOI 10.1016/j.cell.2010.12.032; Boulting GL, 2011, NAT BIOTECHNOL, V29, P279, DOI 10.1038/nbt.1783; Brennand KJ, 2011, NATURE, V473, P221, DOI 10.1038/nature09915; Brockington A, 2013, ACTA NEUROPATHOL, V125, P95, DOI 10.1007/s00401-012-1058-5; Chambers SM, 2012, NAT BIOTECHNOL, V30, P715, DOI 10.1038/nbt.2249; Chang T, 2011, STEM CELLS, V29, P2090, DOI 10.1002/stem.749; Chen AE, 2009, CELL STEM CELL, V4, P103, DOI 10.1016/j.stem.2008.12.001; Cheung I, 2010, P NATL ACAD SCI USA, V107, P8824, DOI 10.1073/pnas.1001702107; Chin MH, 2009, CELL STEM CELL, V5, P111, DOI 10.1016/j.stem.2009.06.008; Christopherson KS, 2005, CELL, V120, P421, DOI 10.1016/j.cell.2004.12.020; Cooper O., 2012, SCI TRANSL MED, V4; Corti S, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004108; Daley GQ, 2009, CELL STEM CELL, V4, P200, DOI 10.1016/j.stem.2009.02.009; Dawson TM, 2002, NAT NEUROSCI, V5, P1058, DOI 10.1038/nn941; Delaloy C, 2010, CELL STEM CELL, V6, P323, DOI 10.1016/j.stem.2010.02.015; Di Giorgio FP, 2007, NAT NEUROSCI, V10, P608, DOI 10.1038/nn1885; Di Giorgio FP, 2008, CELL STEM CELL, V3, P637, DOI 10.1016/j.stem.2008.09.017; Dimos JT, 2008, SCIENCE, V321, P1218, DOI 10.1126/science.1158799; Ding QR, 2013, CELL STEM CELL, V12, P238, DOI 10.1016/j.stem.2012.11.011; Double KL, 2010, PROG NEUROBIOL, V92, P316, DOI 10.1016/j.pneurobio.2010.06.001; Ebert AD, 2009, NATURE, V457, P277, DOI 10.1038/nature07677; Egawa N, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004052; Erraji-Benchekroun L, 2005, BIOL PSYCHIAT, V57, P549, DOI 10.1016/j.biopsych.2004.10.034; Fabian MA, 2005, NAT BIOTECHNOL, V23, P329, DOI 10.1038/nbt1068; Ha NN, 2011, CELL STEM CELL, V8, P267, DOI 10.1016/j.stem.2011.01.013; Han SSW, 2011, NEURON, V70, P626, DOI 10.1016/j.neuron.2011.05.003; HD iPSC Consortium, 2012, CELL STEM CELL, V11, P264, DOI 10.1016/j.stem.2012.04.027; Hester ME, 2011, MOL THER, V19, P1905, DOI 10.1038/mt.2011.135; Hockemeyer D, 2011, NAT BIOTECHNOL, V29, P731, DOI 10.1038/nbt.1927; Hockemeyer D, 2009, NAT BIOTECHNOL, V27, P851, DOI 10.1038/nbt.1562; Hu BY, 2010, P NATL ACAD SCI USA, V107, P4335, DOI 10.1073/pnas.0910012107; Jeon I, 2012, STEM CELLS, V30, P2054, DOI 10.1002/stem.1135; Juurlink B. H. J., 1998, NEUROMETH, V33, P53; Kanning KC, 2010, ANNU REV NEUROSCI, V33, P409, DOI 10.1146/annurev.neuro.051508.135722; Keller JN, 2000, NEUROSCIENCE, V98, P149, DOI 10.1016/S0306-4522(00)00067-1; Khan IF, 2011, NAT PROTOC, V6, P482, DOI 10.1038/nprot.2011.301; Kim JE, 2011, P NATL ACAD SCI USA, V108, P3005, DOI 10.1073/pnas.1007753108; Kiskinis E, 2010, J CLIN INVEST, V120, P51, DOI 10.1172/JCI40553; Koch P, 2011, NATURE, V480, P543, DOI 10.1038/nature10671; Kondo T, 2013, CELL STEM CELL, V12, P487, DOI 10.1016/j.stem.2013.01.009; Kriks S., 2011, NATURE, V418, P50; Lister R, 2011, NATURE, V471, P68, DOI 10.1038/nature09798; Liu GH, 2012, NATURE, V491, P603, DOI 10.1038/nature11557; Lobsiger CS, 2007, NAT NEUROSCI, V10, P1355, DOI 10.1038/nn1988; Lombardo A, 2011, NAT METHODS, V8, P861, DOI [10.1038/NMETH.1674, 10.1038/nmeth.1674]; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Marchetto MCN, 2010, CELL, V143, P527, DOI 10.1016/j.cell.2010.10.016; Marchetto MCN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007076; Marchetto MCN, 2008, CELL STEM CELL, V3, P649, DOI 10.1016/j.stem.2008.10.001; Mateizel I, 2006, HUM REPROD, V21, P503, DOI 10.1093/humrep/dei345; Matus S, 2011, CURR OPIN CELL BIOL, V23, P239, DOI 10.1016/j.ceb.2011.01.003; Mekhoubad S, 2012, CELL STEM CELL, V10, P595, DOI 10.1016/j.stem.2012.02.014; Molyneaux BJ, 2007, NAT REV NEUROSCI, V8, P427, DOI 10.1038/nrn2151; Muller FJ, 2011, NAT METHODS, V8, P315, DOI 10.1038/NMETH.1580; Murry CE, 2008, CELL, V132, P661, DOI 10.1016/j.cell.2008.02.008; Nunes I, 2003, P NATL ACAD SCI USA, V100, P4245, DOI 10.1073/pnas.0230529100; Ohi Y, 2011, NAT CELL BIOL, V13, P541, DOI 10.1038/ncb2239; Osafune K, 2008, NAT BIOTECHNOL, V26, P313, DOI 10.1038/nbt1383; Pang ZPP, 2011, NATURE, V476, P220, DOI 10.1038/nature10202; Park IH, 2008, CELL, V134, P877, DOI 10.1016/j.cell.2008.07.041; Polo JM, 2010, NAT BIOTECHNOL, V28, P848, DOI 10.1038/nbt.1667; Reinhardt P, 2013, CELL STEM CELL, V12, P354, DOI 10.1016/j.stem.2013.01.008; Renton AE, 2011, NEURON, V72, P257, DOI 10.1016/j.neuron.2011.09.010; ROSEN DR, 1993, NATURE, V362, P59, DOI 10.1038/362059a0; Roy NS, 2005, EXP NEUROL, V196, P224, DOI 10.1016/j.expneurol.2005.06.021; Sanchez-Danes A, 2012, EMBO MOL MED, V4, P380, DOI 10.1002/emmm.201200215; Saxena S, 2009, NAT NEUROSCI, V12, P627, DOI 10.1038/nn.2297; Seeley WW, 2006, ANN NEUROL, V60, P660, DOI 10.1002/ana.21055; Sergent-Tanguy S, 2003, J NEUROSCI METH, V129, P73, DOI 10.1016/S0165-0270(03)00210-3; Shi YC, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003771; Shi YC, 2012, NAT NEUROSCI, V15, P477, DOI 10.1038/nn.3041; Silva SS, 2008, P NATL ACAD SCI USA, V105, P4820, DOI 10.1073/pnas.0712136105; Soldner F, 2011, CELL, V146, P318, DOI 10.1016/j.cell.2011.06.019; Son EY, 2011, CELL STEM CELL, V9, P205, DOI 10.1016/j.stem.2011.07.014; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takazawa T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040154; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Tomoda K, 2012, CELL STEM CELL, V11, P91, DOI 10.1016/j.stem.2012.05.019; Urnov FD, 2010, NAT REV GENET, V11, P636, DOI 10.1038/nrg2842; Verlinsky Y, 2005, REPROD BIOMED ONLINE, V10, P105, DOI 10.1016/S1472-6483(10)60810-3; Vodyanik MA, 2006, BLOOD, V108, P2095, DOI 10.1182/blood-2006-02-003327; von Steyern FV, 1999, EUR J NEUROSCI, V11, P2093, DOI 10.1046/j.1460-9568.1999.00631.x; Wataya T, 2008, P NATL ACAD SCI USA, V105, P11796, DOI 10.1073/pnas.0803078105; Wichterle H, 2002, CELL, V110, P385, DOI 10.1016/S0092-8674(02)00835-8; Wong E, 2010, NAT NEUROSCI, V13, P805, DOI 10.1038/nn.2575; Xu CH, 2001, NAT BIOTECHNOL, V19, P971, DOI 10.1038/nbt1001-971; Yagi T, 2011, HUM MOL GENET, V20, P4530, DOI 10.1093/hmg/ddr394; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Yuan SH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017540; Yusa K, 2011, NATURE, V478, P391, DOI 10.1038/nature10424; Zhang SC, 2001, NAT BIOTECHNOL, V19, P1129, DOI 10.1038/nbt1201-1129; Zou JZ, 2009, CELL STEM CELL, V5, P97, DOI 10.1016/j.stem.2009.05.023	99	146	150	0	45	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUL	2013	16	7					780	789		10.1038/nn.3425	http://dx.doi.org/10.1038/nn.3425			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	174UM	23799470				2022-12-28	WOS:000321180900007
J	Bock, R; Shin, JH; Kaplan, AR; Dobi, A; Markey, E; Kramer, PF; Gremel, CM; Christensen, CH; Adrover, MF; Alvarez, VA				Bock, Roland; Shin, J. Hoon; Kaplan, Alanna R.; Dobi, Alice; Markey, Eric; Kramer, Paul F.; Gremel, Christina M.; Christensen, Christine H.; Adrover, Martin F.; Alvarez, Veronica A.			Strengthening the accumbal indirect pathway promotes resilience to compulsive cocaine use	NATURE NEUROSCIENCE			English	Article							D2-LIKE AGONISTS; OPTOGENETIC CONTROL; NUCLEUS-ACCUMBENS; DOPAMINE D1-LIKE; DISTINCT ROLES; D2 RECEPTORS; ADDICTION; REWARD; RATS; IMPULSIVITY	A hallmark of addiction is the loss of control over drug intake, which is seen in only a fraction of those exposed to stimulant drugs such as cocaine. The cellular mechanisms underlying vulnerability or resistance to compulsive drug use remain unknown. We found that individual variability in the development of highly motivated and perseverative behavior toward cocaine is associated with synaptic plasticity in medium spiny neurons expressing dopamine D2 receptors (D2-MSNs) in the nucleus accumbens (NAc) of mice. Potentiation of glutamatergic inputs onto indirect pathway D2-MSNs was associated with resilience toward compulsive cocaine seeking. Inhibition of D2-MSNs using a chemicogenetic approach enhanced the motivation to obtain cocaine, whereas optogenetic activation of D2-MSNs suppressed cocaine self-administration. These results indicate that recruitment of D2-MSNs in NAc functions to restrain cocaine self-administration and serves as a natural protective mechanism in drug-exposed individuals.	[Bock, Roland; Shin, J. Hoon; Kaplan, Alanna R.; Dobi, Alice; Markey, Eric; Kramer, Paul F.; Gremel, Christina M.; Christensen, Christine H.; Adrover, Martin F.; Alvarez, Veronica A.] NIAAA, Lab Integrat Neurosci, US NIH, Bethesda, MD USA; [Alvarez, Veronica A.] NINDS, US NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute on Alcohol Abuse & Alcoholism (NIAAA); National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS)	Alvarez, VA (corresponding author), NIAAA, Lab Integrat Neurosci, US NIH, Bethesda, MD USA.	alvarezva@mail.nih.gov	Alvarez, Veronica A/E-9745-2015; Bock, Roland/G-2982-2016; Core, Vector/CAF-4832-2022	Alvarez, Veronica A/0000-0003-2611-8675; Bock, Roland/0000-0002-8654-1080; Kramer, Paul/0000-0002-0095-3712; Kaplan, Alanna/0000-0002-2612-4736	Intramural Program of the National Institute on Alcohol Abuse and Alcoholism; Intramural Program of the National Institute of Neurological Disorders and Stroke [ZIA-AA000421]; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [ZIAAA000421] Funding Source: NIH RePORTER	Intramural Program of the National Institute on Alcohol Abuse and Alcoholism; Intramural Program of the National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	We are grateful to the staff of Fishers Lane Animal Center and to L. Chedester for technical support. We thank the members of the Alvarez laboratory, J.T. Williams, D.M. Lovinger and B.L. Sabatini for helpful comments on the manuscript. We also thank B. Roth (University of North Carolina) and K. Deisseroth (Stanford University) for their generosity in providing the constructs for hM4Di and ChR2, respectively, and B. Harvey (Optogenetics and Transgenic Technology Core at the National Institute on Drug Abuse) for the viral vector preparation. This study was funded by the Intramural Programs of the National Institute on Alcohol Abuse and Alcoholism and the National Institute of Neurological Disorders and Stroke (ZIA-AA000421).	Alexander GM, 2009, NEURON, V63, P27, DOI 10.1016/j.neuron.2009.06.014; Barrett AC, 2004, NEUROPHARMACOLOGY, V47, P256, DOI 10.1016/j.neuropharm.2004.07.007; Beckmann JS, 2011, BEHAV BRAIN RES, V216, P159, DOI 10.1016/j.bbr.2010.07.022; Belin D, 2008, SCIENCE, V320, P1352, DOI 10.1126/science.1158136; Bello EP, 2011, NAT NEUROSCI, V14, P1033, DOI 10.1038/nn.2862; Caine SB, 2000, PSYCHOPHARMACOLOGY, V148, P41, DOI 10.1007/s002130050023; Caine SB, 1999, J PHARMACOL EXP THER, V291, P353; Corbit LH, 2010, EUR J NEUROSCI, V31, P1312, DOI 10.1111/j.1460-9568.2010.07153.x; Deroche-Gamonet V, 2004, SCIENCE, V305, P1014, DOI 10.1126/science.1099020; Dobi A, 2011, J NEUROSCI, V31, P1895, DOI 10.1523/JNEUROSCI.5375-10.2011; Dong SY, 2010, NAT PROTOC, V5, P561, DOI 10.1038/nprot.2009.239; Durieux PF, 2009, NAT NEUROSCI, V12, P393, DOI 10.1038/nn.2286; Ersche KD, 2011, BRAIN, V134, P2013, DOI 10.1093/brain/awr138; Ferguson SM, 2011, NAT NEUROSCI, V14, P22, DOI 10.1038/nn.2703; Gerfen CR, 2011, ANNU REV NEUROSCI, V34, P441, DOI 10.1146/annurev-neuro-061010-113641; Giessel AJ, 2010, NEURON, V68, P936, DOI 10.1016/j.neuron.2010.09.004; Kasanetz F, 2010, SCIENCE, V328, P1709, DOI 10.1126/science.1187801; Kozorovitskiy Y, 2012, NATURE, V485, P646, DOI 10.1038/nature11052; Kramer PF, 2011, J NEUROSCI, V31, P126, DOI 10.1523/JNEUROSCI.4287-10.2011; Kravitz AV, 2012, NAT NEUROSCI, V15, P816, DOI 10.1038/nn.3100; Kravitz AV, 2010, NATURE, V466, P622, DOI 10.1038/nature09159; Lobo MK, 2011, FRONT NEUROANAT, V5, DOI 10.3389/fnana.2011.00041; Lobo MK, 2010, SCIENCE, V330, P385, DOI 10.1126/science.1188472; Nader MA, 2006, NAT NEUROSCI, V9, P1050, DOI 10.1038/nn1737; Napolitano F, 2010, J NEUROSCI, V30, P11043, DOI 10.1523/JNEUROSCI.1682-10.2010; Pascoli V, 2012, NATURE, V481, P71, DOI 10.1038/nature10709; Pologruto TA, 2003, BIOMED ENG ONLINE, V2, DOI 10.1186/1475-925X-2-13; Ralph RJ, 2005, J PHARMACOL EXP THER, V312, P733, DOI 10.1124/jpet.104.074468; Richardson NR, 1996, J NEUROSCI METH, V66, P1, DOI 10.1016/0165-0270(95)00153-0; Root DH, 2013, J COMP NEUROL, V521, P558, DOI 10.1002/cne.23191; Saunders BT, 2011, NEUROPSYCHOPHARMACOL, V36, P1668, DOI 10.1038/npp.2011.48; Tang XC, 2005, J NEUROSCI, V25, P4512, DOI 10.1523/JNEUROSCI.0685-05.2005; Thomsen Morgane, 2005, Curr Protoc Neurosci, VChapter 9, DOI 10.1002/0471142301.ns0920s32; Torregrossa MM, 2008, NEUROSCI LETT, V438, P142, DOI 10.1016/j.neulet.2008.04.016; Volkow ND, 2009, NEUROPHARMACOLOGY, V56, P3, DOI 10.1016/j.neuropharm.2008.05.022; Volkow ND, 2002, SYNAPSE, V46, P79, DOI 10.1002/syn.10137	36	212	216	1	37	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAY	2013	16	5					632	+		10.1038/nn.3369	http://dx.doi.org/10.1038/nn.3369			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	131WT	23542690	Green Accepted			2022-12-28	WOS:000318029300020
J	Herrup, K; Chen, JM; Li, JL				Herrup, Karl; Chen, Jianmin; Li, Jiali			Breaking news: thinking may be bad for DNA	NATURE NEUROSCIENCE			English	Editorial Material							PROGRAMMED CELL-DEATH; REPAIR; REGIONS; DAMAGE; H2AX	A study in this issue suggests that neuronal DNA double-strand breaks can result from natural behaviors. The breaks occur in the circuits that are activated and are enhanced in a model of Alzheimer's disease. The implications of this finding are far-reaching.	[Herrup, Karl; Chen, Jianmin; Li, Jiali] Rutgers State Univ, Dept Cell Biol & Neurosci, Piscataway, NJ 08854 USA; [Herrup, Karl] Hong Kong Univ Sci & Technol, Div Life Sci, Kowloon, Hong Kong, Peoples R China	Rutgers State University New Brunswick; Hong Kong University of Science & Technology	Herrup, K (corresponding author), Rutgers State Univ, Dept Cell Biol & Neurosci, Piscataway, NJ 08854 USA.	jli@dls.rutgers.edu	li, Jiali/HGF-2395-2022; Herrup, Karl/C-5313-2014	li, Jiali/0000-0001-6202-7741; Herrup, Karl/0000-0001-7786-5844; Li, Jiali/0000-0002-0039-3671				Blaschke AJ, 1996, DEVELOPMENT, V122, P1165; Blaschke AJ, 1998, J COMP NEUROL, V396, P39, DOI 10.1002/(SICI)1096-9861(19980622)396:1<39::AID-CNE4>3.0.CO;2-J; Bonner WM, 2008, NAT REV CANCER, V8, P957, DOI 10.1038/nrc2523; Chapman JR, 2012, MOL CELL, V47, P497, DOI 10.1016/j.molcel.2012.07.029; CHUN JJM, 1991, CELL, V64, P189, DOI 10.1016/0092-8674(91)90220-S; Fernando RN, 2011, P NATL ACAD SCI USA, V108, P5837, DOI 10.1073/pnas.1014993108; Lieber MR, 2010, ANNU REV BIOCHEM, V79, P181, DOI 10.1146/annurev.biochem.052308.093131; Lu T, 2004, NATURE, V429, P883, DOI 10.1038/nature02661; McKinnon PJ, 2009, NAT REV NEUROSCI, V10, P100, DOI 10.1038/nrn2559; McManus KJ, 2005, MOL BIOL CELL, V16, P5013, DOI 10.1091/mbc.E05-01-0065; STERNBERGER LA, 1982, P NATL ACAD SCI-BIOL, V79, P1326, DOI 10.1073/pnas.79.4.1326; Suberbielle E, 2013, NAT NEUROSCI, V16, P613, DOI 10.1038/nn.3356	12	3	3	1	25	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAY	2013	16	5					518	519		10.1038/nn.3384	http://dx.doi.org/10.1038/nn.3384			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	131WT	23619752				2022-12-28	WOS:000318029300002
J	Pan, WX; Brown, J; Dudman, JT				Pan, Wei-Xing; Brown, Jennifer; Dudman, Joshua Tate			Neural signals of extinction in the inhibitory microcircuit of the ventral midbrain	NATURE NEUROSCIENCE			English	Article							PEDUNCULOPONTINE TEGMENTAL NUCLEUS; NIGRA DOPAMINERGIC-NEURONS; NEGATIVE REWARD SIGNALS; SUBSTANTIA-NIGRA; PARS RETICULATA; LATERAL HABENULA; SHORT-LATENCY; SUBTHALAMIC NUCLEUS; SUPERIOR COLLICULUS; RAT	Midbrain dopaminergic (DA) neurons are thought to guide learning via phasic elevations of firing in response to reward predicting stimuli. The mechanism for these signals remains unclear. Using extracellular recording during associative learning, we found that inhibitory neurons in the ventral midbrain of mice responded to salient auditory stimuli with a burst of activity that occurred before the onset of the phasic response of DA neurons. This population of inhibitory neurons exhibited enhanced responses during extinction and was anticorrelated with the phasic response of simultaneously recorded DA neurons. Optogenetic stimulation revealed that this population was, in part, derived from inhibitory projection neurons of the substantia nigra that provide a robust monosynaptic inhibition of DA neurons. Thus, our results elaborate on the dynamic upstream circuits that shape the phasic activity of DA neurons and suggest that the inhibitory microcircuit of the midbrain is critical for new learning in extinction.	[Pan, Wei-Xing; Brown, Jennifer; Dudman, Joshua Tate] Howard Hughes Med Inst, Ashburn, VA USA; [Brown, Jennifer] Univ Cambridge, Dept Physiol Dev & Neurosci, Cambridge, England	Howard Hughes Medical Institute; University of Cambridge	Dudman, JT (corresponding author), Howard Hughes Med Inst, Janelia Farm Res Campus, Ashburn, VA USA.	dudmanj@janelia.hhmi.org		Dudman, Joshua/0000-0002-4436-1057	Cambridge-Janelia Farm Graduate Program; Howard Hughes Medical Institute	Cambridge-Janelia Farm Graduate Program; Howard Hughes Medical Institute(Howard Hughes Medical Institute)	J. Paton, W. Denk, A. Karpova, A. Lee, J. Magee and G. Murphy provided critical feedback at various stages of preparation of the manuscript and progression of the project. We are indebted to the extensive feedback from our colleagues following presentation of this work at internal seminars on the Janelia Farm Research Campus. We thank members of our laboratory for critical reading and feedback on the manuscript. J.B. receives funding from the Cambridge-Janelia Farm Graduate Program. This work was supported by funding from the Howard Hughes Medical Institute.	Atasoy D, 2008, J NEUROSCI, V28, P7025, DOI 10.1523/JNEUROSCI.1954-08.2008; Balcita-Pedicino JJ, 2011, J COMP NEUROL, V519, P1143, DOI 10.1002/cne.22561; Bayer HM, 2007, J NEUROPHYSIOL, V98, P1428, DOI 10.1152/jn.01140.2006; BEVAN MD, 1995, J NEUROSCI, V15, P7105; Brazhnik E, 2008, J NEUROSCI, V28, P10386, DOI 10.1523/JNEUROSCI.2387-08.2008; Bromberg-Martin ES, 2010, NEURON, V68, P815, DOI 10.1016/j.neuron.2010.11.022; Bromberg-Martin ES, 2010, NEURON, V67, P144, DOI 10.1016/j.neuron.2010.06.016; Bryden DW, 2011, EUR J NEUROSCI, V33, P2308, DOI 10.1111/j.1460-9568.2011.07705.x; Cebrian C, 2005, J COMP NEUROL, V492, P349, DOI 10.1002/cne.20741; Cohen JY, 2012, NATURE, V482, P85, DOI 10.1038/nature10754; Coizet V, 2009, J NEUROSCI, V29, P5701, DOI 10.1523/JNEUROSCI.0247-09.2009; Conde H, 1998, EXP BRAIN RES, V121, P411, DOI 10.1007/s002210050475; Deniau JM, 2007, PROG BRAIN RES, V160, P151, DOI 10.1016/S0079-6123(06)60009-5; Dommett E, 2005, SCIENCE, V307, P1476, DOI 10.1126/science.1107026; Fan D, 2012, J NEUROSCI, V32, P5534, DOI 10.1523/JNEUROSCI.5924-11.2012; Grace AA, 2007, TRENDS NEUROSCI, V30, P220, DOI 10.1016/j.tins.2007.03.003; Gulley JM, 2002, NEUROSCIENCE, V111, P337, DOI 10.1016/S0306-4522(02)00018-0; Gutkin BS, 1998, NEURAL COMPUT, V10, P1047, DOI 10.1162/089976698300017331; Hong S, 2011, J NEUROSCI, V31, P11457, DOI 10.1523/JNEUROSCI.1384-11.2011; INGLIS WL, 1995, PROG NEUROBIOL, V47, P1, DOI 10.1016/0301-0082(95)00013-L; Jin X, 2010, NATURE, V466, P457, DOI 10.1038/nature09263; Kolomiets BP, 2001, J NEUROSCI, V21, P5764, DOI 10.1523/JNEUROSCI.21-15-05764.2001; Matsumoto M, 2007, NATURE, V447, P1111, DOI 10.1038/nature05860; Matsumoto M, 2009, NATURE, V459, P837, DOI 10.1038/nature08028; Mirenowicz J, 1996, NATURE, V379, P449, DOI 10.1038/379449a0; Nair-Roberts RG, 2008, NEUROSCIENCE, V152, P1024, DOI 10.1016/j.neuroscience.2008.01.046; Pan WX, 2008, J NEUROSCI, V28, P9619, DOI 10.1523/JNEUROSCI.0255-08.2008; Pan WX, 2005, J NEUROSCI, V25, P6235, DOI 10.1523/JNEUROSCI.1478-05.2005; Pan WX, 2005, J NEUROSCI, V25, P4725, DOI 10.1523/JNEUROSCI.0277-05.2005; Parker JG, 2010, P NATL ACAD SCI USA, V107, P13491, DOI 10.1073/pnas.1007827107; Pavlov I.P., 1927, CONDITIONED REFLEXES; Paxinos G., 2004, RAT NERVOUS SYSTEM, V3rd; Redgrave P, 2006, NAT REV NEUROSCI, V7, P967, DOI 10.1038/nrn2022; Roesch MR, 2007, NAT NEUROSCI, V10, P1615, DOI 10.1038/nn2013; Schultz W, 1997, SCIENCE, V275, P1593, DOI 10.1126/science.275.5306.1593; Schultz W, 1997, CURR OPIN NEUROBIOL, V7, P191, DOI 10.1016/S0959-4388(97)80007-4; Schultz W, 1998, J NEUROPHYSIOL, V80, P1, DOI 10.1152/jn.1998.80.1.1; SCHULTZ W, 1993, J NEUROSCI, V13, P900; Schultz W, 1998, Adv Pharmacol, V42, P686; Schultz W, 2007, TRENDS NEUROSCI, V30, P203, DOI 10.1016/j.tins.2007.03.007; Shen WX, 2008, SCIENCE, V321, P848, DOI 10.1126/science.1160575; Stuber GD, 2008, SCIENCE, V321, P1690, DOI 10.1126/science.1160873; Tepper JM, 2007, PROG BRAIN RES, V160, P189, DOI 10.1016/S0079-6123(06)60011-3; TEPPER JM, 1995, J NEUROSCI, V15, P3092; Tobler PN, 2003, J NEUROSCI, V23, P10402; Waelti P, 2001, NATURE, V412, P43, DOI 10.1038/35083500; Winer J.A., 2005, INFERIOR COLLICULUS, DOI [10.1007/b138578, DOI 10.1007/B138578]; Yu LP, 2009, J NEUROSCI, V29, P15910, DOI 10.1523/JNEUROSCI.4041-09.2009	48	42	43	0	28	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JAN	2013	16	1					71	U108		10.1038/nn.3283	http://dx.doi.org/10.1038/nn.3283			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	058KZ	23222913	Green Accepted			2022-12-28	WOS:000312633900015
J	Russo, SJ; Murroughl, JW; Han, MH; Charney, DS; Nestler, EJ				Russo, Scott J.; Murroughl, James W.; Han, Ming-Hu; Charney, Dennis S.; Nestler, Eric J.			Neurobiology of resilience	NATURE NEUROSCIENCE			English	Review							POSTTRAUMATIC-STRESS-DISORDER; SOCIAL DEFEAT STRESS; MOUSE NUCLEUS-ACCUMBENS; SEX-DIFFERENCES; ENVIRONMENTAL ENRICHMENT; CHROMATIN REGULATION; GENETIC-VARIATION; ADULT DEPRESSION; DOPAMINE NEURONS; FEAR EXTINCTION	Humans exhibit a remarkable degree of resilience in the face of extreme stress, with most resisting the development of neuropsychiatric disorders. Over the past 5 years, there has been increasing interest in the active, adaptive coping mechanisms of resilience; however, in humans, most published work focuses on correlative neuroendocrine markers that are associated with a resilient phenotype. In this review, we highlight a growing literature in rodents that is starting to complement the human work by identifying the active behavioral, neural, molecular and hormonal basis of resilience. The therapeutic implications of these findings are important and can pave the way for an innovative approach to drug development for a range of stress-related syndromes.	[Russo, Scott J.; Murroughl, James W.; Han, Ming-Hu; Charney, Dennis S.; Nestler, Eric J.] Mt Sinai Sch Med, Friedman Brain Inst, Dept Neurosci, New York, NY USA; [Murroughl, James W.; Charney, Dennis S.; Nestler, Eric J.] Mt Sinai Sch Med, Friedman Brain Inst, Dept Psychiat, New York, NY USA; [Han, Ming-Hu; Charney, Dennis S.; Nestler, Eric J.] Mt Sinai Sch Med, Friedman Brain Inst, Dept Pharmacol & Syst Therapeut, New York, NY USA	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai	Russo, SJ (corresponding author), Mt Sinai Sch Med, Friedman Brain Inst, Dept Neurosci, New York, NY USA.	scott.russo@mssm.edu	Han, Ming-Hu/G-8836-2012; Russo, Scott/R-7107-2019; Murrough, James/J-7129-2013	Russo, Scott/0000-0002-6470-1805; Murrough, James/0000-0001-6286-1242	US National Institute of Mental Health [R01 MH090264, K23 MH094707, R01 MH092306, R01 MH51399, P50 MH66172, P50 MH96890]; NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH096890, R01MH051399, K23MH094707, R01MH090264, P50MH066172, R01MH092306] Funding Source: NIH RePORTER	US National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	Preparation of this review was supported by grants from the US National Institute of Mental Health: R01 MH090264 (S.J.R.); K23 MH094707 (J.W.M.); R01 MH092306 (M.-H.H.); and R01 MH51399, P50 MH66172 and P50 MH96890 (E.J.N.).	Adamec R, 2012, PHYSIOL BEHAV, V105, P628, DOI 10.1016/j.physbeh.2011.09.016; Andrus BM, 2012, MOL PSYCHIATR, V17, P49, DOI 10.1038/mp.2010.119; Autry AE, 2009, BIOL PSYCHIAT, V66, P84, DOI 10.1016/j.biopsych.2009.02.007; Balana B, 2011, P NATL ACAD SCI USA, V108, P5831, DOI 10.1073/pnas.1018645108; Berton O, 2006, SCIENCE, V311, P864, DOI 10.1126/science.1120972; Berton O, 2007, NEURON, V55, P289, DOI 10.1016/j.neuron.2007.06.033; Binder EB, 2008, JAMA-J AM MED ASSOC, V299, P1291, DOI 10.1001/jama.299.11.1291; Bonanno GA, 2004, AM PSYCHOL, V59, P20, DOI 10.1037/0003-066X.59.1.20; Bowman RE, 2003, HORM BEHAV, V43, P48, DOI 10.1016/S0018-506X(02)00022-3; Bowman RE, 2002, NEUROSCIENCE, V113, P401, DOI 10.1016/S0306-4522(02)00156-2; Bradley RG, 2008, ARCH GEN PSYCHIAT, V65, P190, DOI 10.1001/archgenpsychiatry.2007.26; Brischoux F, 2009, P NATL ACAD SCI USA, V106, P4894, DOI 10.1073/pnas.0811507106; Butterfield MI, 2005, AM J PSYCHIAT, V162, P380, DOI 10.1176/appi.ajp.162.2.380; Cao JL, 2010, J NEUROSCI, V30, P16453, DOI 10.1523/JNEUROSCI.3177-10.2010; Caspi A, 2010, AM J PSYCHIAT, V167, P509, DOI 10.1176/appi.ajp.2010.09101452; Charney DS, 2004, AM J PSYCHIAT, V161, P195, DOI 10.1176/appi.ajp.161.2.195; Christoffel DJ, 2012, NEUROPSYCHOPHARMACOL, V37, P2615, DOI 10.1038/npp.2012.121; Christoffel DJ, 2011, REV NEUROSCIENCE, V22, P535, DOI 10.1515/RNS.2011.044; Christoffel DJ, 2011, J NEUROSCI, V31, P314, DOI 10.1523/JNEUROSCI.4763-10.2011; Cohen H, 2012, NEUROPSYCHOPHARMACOL, V37, P350, DOI 10.1038/npp.2011.230; Conrad CD, 2003, NEUROBIOL LEARN MEM, V79, P32, DOI 10.1016/S1074-7427(02)00018-7; Covington HE, 2011, NEUROSCI LETT, V493, P122, DOI 10.1016/j.neulet.2011.02.022; Covington HE, 2010, J NEUROSCI, V30, P16082, DOI 10.1523/JNEUROSCI.1731-10.2010; Covington HE, 2009, J NEUROSCI, V29, P11451, DOI 10.1523/JNEUROSCI.1758-09.2009; Palacios RDY, 2011, BIOL PSYCHIAT, V70, P449, DOI 10.1016/j.biopsych.2011.05.014; Domschke K, 2010, EUR NEUROPSYCHOPHARM, V20, P301, DOI 10.1016/j.euroneuro.2009.09.006; Douglas AJ, 2003, ENDOCRINOLOGY, V144, P5268, DOI 10.1210/en.2003-0461; Edwards DA, 2006, PHYSIOL BEHAV, V87, P135, DOI 10.1016/j.physbeh.2005.09.007; Elliott E, 2010, NAT NEUROSCI, V13, P1351, DOI 10.1038/nn.2642; Feder A, 2009, NAT REV NEUROSCI, V10, P446, DOI 10.1038/nrn2649; Fleshner M, 2011, STRESS, V14, P498, DOI 10.3109/10253890.2011.596865; Galea LAM, 1997, NEUROSCIENCE, V81, P689, DOI 10.1016/S0306-4522(97)00233-9; Golden SA, 2011, NAT PROTOC, V6, P1183, DOI 10.1038/nprot.2011.361; Goto Y, 2007, NEUROPHARMACOLOGY, V53, P583, DOI 10.1016/j.neuropharm.2007.07.007; Grace AA, 2007, TRENDS NEUROSCI, V30, P220, DOI 10.1016/j.tins.2007.03.003; Heim C, 2000, JAMA-J AM MED ASSOC, V284, P2322; Heim C, 2008, PSYCHONEUROENDOCRINO, V33, P693, DOI 10.1016/j.psyneuen.2008.03.008; Herman JP, 1997, TRENDS NEUROSCI, V20, P78, DOI 10.1016/S0166-2236(96)10069-2; Katz M, 2009, DEV NEUROSCI-BASEL, V31, P293, DOI 10.1159/000216540; KESSLER RC, 1995, ARCH GEN PSYCHIAT, V52, P1048, DOI 10.1001/archpsyc.1995.03950240066012; Kozorovitskiy Y, 2005, P NATL ACAD SCI USA, V102, P17478, DOI 10.1073/pnas.0508817102; Krishnan V, 2007, CELL, V131, P391, DOI 10.1016/j.cell.2007.09.018; Lammel S, 2011, NEURON, V70, P855, DOI 10.1016/j.neuron.2011.03.025; LaPlant Q, 2009, BIOL PSYCHIAT, V65, P874, DOI 10.1016/j.biopsych.2009.01.024; Lehmann ML, 2011, J NEUROSCI, V31, P6159, DOI 10.1523/JNEUROSCI.0577-11.2011; LEVINE S, 1962, SCIENCE, V135, P795, DOI 10.1126/science.135.3506.795-a; Linden DEJ, 2006, MOL PSYCHIATR, V11, P528, DOI 10.1038/sj.mp.4001816; Luscher C, 2010, NAT REV NEUROSCI, V11, P301, DOI 10.1038/nrn2834; Luine V, 2002, STRESS, V5, P205, DOI 10.1080/1025389021000010549; Lupien SJ, 2009, NAT REV NEUROSCI, V10, P434, DOI 10.1038/nrn2639; Lutter M, 2008, NAT NEUROSCI, V11, P752, DOI 10.1038/nn.2139; Lyons DM, 2010, DEV PSYCHOBIOL, V52, P616, DOI 10.1002/dev.20500; Masten AS, 2001, AM PSYCHOL, V56, P227, DOI 10.1037/0003-066X.56.3.227; Mayberg HS, 2009, J CLIN INVEST, V119, P717, DOI 10.1172/JCI38454; McEwen BS, 2011, ANNU REV MED, V62, P431, DOI 10.1146/annurev-med-052209-100430; Meaney Michael J, 2005, Dialogues Clin Neurosci, V7, P103; Meewisse ML, 2007, BRIT J PSYCHIAT, V191, P387, DOI 10.1192/bjp.bp.106.024877; Mickey BJ, 2011, ARCH GEN PSYCHIAT, V68, P158, DOI 10.1001/archgenpsychiatry.2010.197; Milad MR, 2005, PSYCHOPHYSIOLOGY, V42, P456, DOI 10.1111/j.1469-8986.2005.00302.x; Moncek F, 2004, J NEUROENDOCRINOL, V16, P423, DOI 10.1111/j.1365-2826.2004.01173.x; Morgan CA, 2002, BIOL PSYCHIAT, V52, P136, DOI 10.1016/S0006-3223(02)01319-7; Morgan CA, 2000, BIOL PSYCHIAT, V47, P902, DOI 10.1016/S0006-3223(99)00239-5; Morgan CA, 2000, BIOL PSYCHIAT, V47, P891, DOI 10.1016/S0006-3223(99)00307-8; Mozhui K, 2010, J NEUROSCI, V30, P5357, DOI 10.1523/JNEUROSCI.5017-09.2010; Mulchahey JJ, 2001, PSYCHONEUROENDOCRINO, V26, P273, DOI 10.1016/S0306-4530(00)00052-4; Murrough JW, 2011, NEUROBIOL LEARN MEM, V96, P553, DOI 10.1016/j.nlm.2011.06.006; Murrough JW, 2011, BIOL PSYCHIAT, V69, P510, DOI 10.1016/j.biopsych.2011.01.019; Nesse RM, 2000, ARCH GEN PSYCHIAT, V57, P14, DOI 10.1001/archpsyc.57.1.14; Oliveira T, 2009, PSYCHONEUROENDOCRINO, V34, P1056, DOI 10.1016/j.psyneuen.2009.02.006; Ono Y, 2012, STRESS, V15, P207, DOI 10.3109/10253890.2011.614296; Parker KJ, 2005, BIOL PSYCHIAT, V57, P848, DOI 10.1016/j.biopsych.2004.12.024; Parker KJ, 2004, ARCH GEN PSYCHIAT, V61, P933, DOI 10.1001/archpsyc.61.9.933; Polanczyk G, 2009, ARCH GEN PSYCHIAT, V66, P978, DOI 10.1001/archgenpsychiatry.2009.114; Pope HG, 2003, AM J PSYCHIAT, V160, P105, DOI 10.1176/appi.ajp.160.1.105; Price JL, 2010, NEUROPSYCHOPHARMACOL, V35, P192, DOI 10.1038/npp.2009.104; Rasmusson AM, 2003, CNS SPECTRUMS, V8, P651, DOI 10.1017/S1092852900008841; Rauch SL, 2005, NEUROREPORT, V16, P1909, DOI 10.1097/01.wnr.0000186599.66243.50; Ressler KJ, 2011, NATURE, V470, P492, DOI 10.1038/nature09856; Ricon T, 2012, STRESS, V15, P11, DOI 10.3109/10253890.2011.572207; Shumake J, 2010, J NEUROSCI, V30, P5876, DOI 10.1523/JNEUROSCI.3604-09.2010; Stein MB, 2009, AM J MED GENET B, V150B, P900, DOI 10.1002/ajmg.b.30916; Stetler C, 2011, PSYCHOSOM MED, V73, P114, DOI 10.1097/PSY.0b013e31820ad12b; Taliaz D, 2011, J NEUROSCI, V31, P4475, DOI 10.1523/JNEUROSCI.5725-10.2011; Taylor MK, 2012, STRESS, V15, P85, DOI 10.3109/10253890.2011.585189; Tsankova NM, 2006, NAT NEUROSCI, V9, P519, DOI 10.1038/nn1659; Uchida S, 2011, NEURON, V69, P359, DOI 10.1016/j.neuron.2010.12.023; van Tol MJ, 2012, BIOL PSYCHIAT, V71, P593, DOI 10.1016/j.biopsych.2011.11.016; Vialou V, 2010, J NEUROSCI, V30, P14585, DOI 10.1523/JNEUROSCI.2496-10.2010; Vialou V, 2010, NAT NEUROSCI, V13, P745, DOI 10.1038/nn.2551; Vidal J, 2011, BEHAV PROCESS, V88, P76, DOI 10.1016/j.beproc.2011.08.005; Wallace DL, 2009, NAT NEUROSCI, V12, P200, DOI 10.1038/nn.2257; Weaver ICG, 2005, J NEUROSCI, V25, P11045, DOI 10.1523/JNEUROSCI.3652-05.2005; Wilkinson MB, 2011, J NEUROSCI, V31, P9084, DOI 10.1523/JNEUROSCI.0039-11.2011; Wilkinson MB, 2009, J NEUROSCI, V29, P7820, DOI 10.1523/JNEUROSCI.0932-09.2009; Wood GE, 1998, P NATL ACAD SCI USA, V95, P4066, DOI 10.1073/pnas.95.7.4066; Wood GE, 2001, BEHAV NEUROSCI, V115, P175, DOI 10.1037//0735-7044.115.1.175; Wood SK, 2010, ENDOCRINOLOGY, V151, P1795, DOI 10.1210/en.2009-1026; Yehuda R, 2006, ACTA PSYCHIAT SCAND, V114, P187, DOI 10.1111/j.1600-0447.2006.00801.x; Yehuda R, 2005, AM J PSYCHIAT, V162, P998, DOI 10.1176/appi.ajp.162.5.998; Zhou ZF, 2008, NATURE, V452, P997, DOI 10.1038/nature06858	100	620	628	14	226	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	NOV	2012	15	11					1475	1484		10.1038/nn.3234	http://dx.doi.org/10.1038/nn.3234			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	028LX	23064380	Green Accepted			2022-12-28	WOS:000310424900006
J	Di Leone, RJ; Taylor, JR; Picciotto, MR				Di Leone, Ralph J.; Taylor, Jane R.; Picciotto, Marina R.			The drive to eat: comparisons and distinctions between mechanisms of food reward and drug addiction	NATURE NEUROSCIENCE			English	Review							MU-OPIOID RECEPTOR; MELANIN-CONCENTRATING HORMONE; NEUROPEPTIDE-Y; COCAINE SEEKING; DOPAMINE; LEPTIN; BEHAVIOR; ENERGY; STRESS; BRAIN	The growing rates of obesity have prompted comparisons between the uncontrolled intake of food and drugs; however, an evaluation of the equivalence of food- and drug-related behaviors requires a thorough understanding of the underlying neural circuits driving each behavior. Although it has been attractive to borrow neurobiological concepts from addiction to explore compulsive food seeking, a more integrated model is needed to understand how food and drugs differ in their ability to drive behavior. In this Review, we will examine the commonalities and differences in the systems-level and behavioral responses to food and to drugs of abuse, with the goal of identifying areas of research that would address gaps in our understanding and ultimately identify new treatments for obesity or drug addiction.	[Di Leone, Ralph J.; Taylor, Jane R.; Picciotto, Marina R.] Yale Univ, Sch Med, Dept Psychiat, New Haven, CT 06520 USA	Yale University	Picciotto, MR (corresponding author), Yale Univ, Sch Med, Dept Psychiat, New Haven, CT 06520 USA.	marina.picciotto@yale.edu	Picciotto, Marina R./F-8747-2012	Picciotto, Marina R./0000-0002-4404-1280; DiLeone, Ralph/0000-0002-4770-2590	US National Institutes of Health [DK076964, DA011017, DA015222, DA15425, DA014241]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK076964] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA015222, R01DA014241, R01DA015425, R01DA011717] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by US National Institutes of Health grants DK076964 (R.J.D.), DA011017 (J.R.T.), DA015222 (J.R.T.) DA15425 (M.R.P.) and DA014241 (M.R.P.).	Abizaid A, 2011, NEUROSCIENCE, V192, P500, DOI 10.1016/j.neuroscience.2011.06.001; Abizaid A, 2006, J CLIN INVEST, V116, P3229, DOI 10.1172/JCI29867; Ahmed SH, 1998, SCIENCE, V282, P298, DOI 10.1126/science.282.5387.298; Ahmed SH, 1997, PSYCHOPHARMACOLOGY, V132, P289, DOI 10.1007/s002130050347; Aponte Y, 2011, NAT NEUROSCI, V14, P351, DOI 10.1038/nn.2739; Avena NM, 2003, NEUROSCIENCE, V122, P17, DOI 10.1016/S0306-4522(03)00502-5; Baldo BA, 2002, BEHAV BRAIN RES, V137, P165, DOI 10.1016/S0166-4328(02)00293-0; Baldo BA, 2007, PSYCHOPHARMACOLOGY, V191, P439, DOI 10.1007/s00213-007-0741-z; Belin D, 2008, NEURON, V57, P432, DOI 10.1016/j.neuron.2007.12.019; Benoit SC, 2000, J NEUROSCI, V20, P3442, DOI 10.1523/JNEUROSCI.20-09-03442.2000; Berridge KC, 2007, PSYCHOPHARMACOLOGY, V191, P391, DOI 10.1007/s00213-006-0578-x; BLANCHARD DC, 1995, PSYCHONEUROENDOCRINO, V20, P117, DOI 10.1016/0306-4530(94)E0045-B; Boules M, 2007, BRAIN RES, V1127, P90, DOI 10.1016/j.brainres.2006.10.025; Brabant C, 2010, BEHAV NEUROSCI, V124, P828, DOI 10.1037/a0021221; Cannon CM, 2003, J NEUROSCI, V23, P10827; Chung SJ, 2009, P NATL ACAD SCI USA, V106, P6772, DOI 10.1073/pnas.0811331106; Dalley JW, 2011, NEURON, V69, P680, DOI 10.1016/j.neuron.2011.01.020; Dar R, 2004, PSYCHOPHARMACOLOGY, V173, P18, DOI 10.1007/s00213-004-1781-2; Davidson TL, 2009, HIPPOCAMPUS, V19, P235, DOI 10.1002/hipo.20499; DiLeone RJ, 2003, LIFE SCI, V73, P759, DOI 10.1016/S0024-3205(03)00408-9; Dulawa SC, 2005, NEUROSCI BIOBEHAV R, V29, P771, DOI 10.1016/j.neubiorev.2005.03.017; Edwards CMB, 1999, J ENDOCRINOL, V160, pR7, DOI 10.1677/joe.0.160R007; Everitt BJ, 2005, NAT NEUROSCI, V8, P1481, DOI 10.1038/nn1579; Forlano PM, 2007, J COMP NEUROL, V505, P235, DOI 10.1002/cne.21447; Fowler CD, 2011, NATURE, V471, P597, DOI 10.1038/nature09797; Frahm S, 2011, NEURON, V70, P522, DOI 10.1016/j.neuron.2011.04.013; Fulton S, 2006, NEURON, V51, P811, DOI 10.1016/j.neuron.2006.09.006; Gearhardt AN, 2009, J ADDICT MED, V3, P1, DOI 10.1097/ADM.0b013e318193c993; Goeders NE, 2002, J PHARMACOL EXP THER, V301, P785, DOI 10.1124/jpet.301.3.785; Grakalic I, 2010, NEUROSCIENCE, V165, P313, DOI 10.1016/j.neuroscience.2009.10.051; Gray MA, 2007, NEURON, V54, P183, DOI 10.1016/j.neuron.2007.03.024; Guegan T, 2013, EUR NEUROPSYCHOPHARM, V23, P240, DOI 10.1016/j.euroneuro.2012.04.009; Guegan T, 2013, EUR NEUROPSYCHOPHARM, V23, P146, DOI 10.1016/j.euroneuro.2012.04.004; Havel PJ, 2001, EXP BIOL MED, V226, P963, DOI 10.1177/153537020122601102; Hommel JD, 2006, NEURON, V51, P801, DOI 10.1016/j.neuron.2006.08.023; Horvath TL, 2004, NAT REV NEUROSCI, V5, P662, DOI 10.1038/nrn1479; Hsu R, 2005, EUR J NEUROSCI, V21, P2233, DOI 10.1111/j.1460-9568.2005.04038.x; Hunter RG, 2003, CNS NEUROL DISORD-DR, V2, P201, DOI 10.2174/1568007033482896; Jentsch JD, 1999, PSYCHOPHARMACOLOGY, V146, P373, DOI 10.1007/PL00005483; Jerlhag E, 2010, PSYCHOPHARMACOLOGY, V211, P415, DOI 10.1007/s00213-010-1907-7; Johnson PM, 2010, NAT NEUROSCI, V13, P635, DOI 10.1038/nn.2519; Kalivas PW, 2005, NEURON, V45, P647, DOI 10.1016/j.neuron.2005.02.005; Kearns David N, 2011, Curr Drug Abuse Rev, V4, P261; Kelley AE, 2005, PHYSIOL BEHAV, V86, P773, DOI 10.1016/j.physbeh.2005.08.066; Kenny PJ, 2011, NAT REV NEUROSCI, V12, P638, DOI 10.1038/nrn3105; Koob George F., 1995, P759; KOOB GF, 1992, TRENDS PHARMACOL SCI, V13, P177, DOI 10.1016/0165-6147(92)90060-J; KYRKOULI SE, 1990, PEPTIDES, V11, P995, DOI 10.1016/0196-9781(90)90023-X; Lenoir M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000698; Lof E, 2010, PSYCHOPHARMACOLOGY, V212, P321, DOI 10.1007/s00213-010-1957-x; Lu L, 2004, NEUROPHARMACOLOGY, V47, P214, DOI 10.1016/j.neuropharm.2004.06.027; Maric T, 2009, PEPTIDES, V30, P721, DOI 10.1016/j.peptides.2008.11.006; Mena JD, 2011, J NEUROSCI, V31, P3249, DOI 10.1523/JNEUROSCI.2050-10.2011; Mineur YS, 2011, SCIENCE, V332, P1330, DOI 10.1126/science.1201889; Nair SG, 2006, PHYSIOL BEHAV, V88, P559, DOI 10.1016/j.physbeh.2006.05.014; Narasimhaiah R, 2009, PSYCHOPHARMACOLOGY, V204, P95, DOI 10.1007/s00213-008-1438-7; Palmiter RD, 2007, TRENDS NEUROSCI, V30, P375, DOI 10.1016/j.tins.2007.06.004; Pickens CL, 2012, PSYCHOPHARMACOLOGY, V221, P341, DOI 10.1007/s00213-011-2585-9; Pierce RC, 2010, NEUROSCI BIOBEHAV R, V35, P212, DOI 10.1016/j.neubiorev.2010.01.007; Piguet O, 2011, J MOL NEUROSCI, V45, P589, DOI 10.1007/s12031-011-9547-x; Ren XY, 2010, J NEUROSCI, V30, P8012, DOI 10.1523/JNEUROSCI.5749-09.2010; Richelson E, 2003, LIFE SCI, V73, P679, DOI 10.1016/S0024-3205(03)00388-6; SALAMONE JD, 1993, PHARMACOL BIOCHEM BE, V44, P605, DOI 10.1016/0091-3057(93)90174-R; Schultz W, 2007, TRENDS NEUROSCI, V30, P203, DOI 10.1016/j.tins.2007.03.007; Schwartz GJ, 2000, NUTRITION, V16, P866, DOI 10.1016/S0899-9007(00)00464-0; Seymour B, 2006, J NEUROSCI, V26, P1061, DOI 10.1523/JNEUROSCI.4418-05.2006; Shalev U, 2001, J NEUROSCI, V21; Shiraishi T, 2000, PHYSIOL BEHAV, V71, P251, DOI 10.1016/S0031-9384(00)00341-3; Singh A, 2009, P NATL ACAD SCI USA, V106, P13100, DOI 10.1073/pnas.0903723106; Smagin GN, 1999, AM J PHYSIOL-REG I, V276, pR1461, DOI 10.1152/ajpregu.1999.276.5.R1461; Small DM, 2008, NEURON, V57, P786, DOI 10.1016/j.neuron.2008.01.021; Smith RJ, 2010, NEUROPHARMACOLOGY, V58, P179, DOI 10.1016/j.neuropharm.2009.06.042; Sorensen LB, 2003, INT J OBESITY, V27, P1152, DOI 10.1038/sj.ijo.0802391; STANLEY BG, 1985, P NATL ACAD SCI USA, V82, P3940, DOI 10.1073/pnas.82.11.3940; Stark R, 2005, BIOL PSYCHOL, V70, P19, DOI 10.1016/j.biopsycho.2004.11.014; STEWART J, 1984, PSYCHOL REV, V91, P251, DOI 10.1037/0033-295X.91.2.251; Torregrossa MM, 2008, BIOL PSYCHIAT, V63, P253, DOI 10.1016/j.biopsych.2007.11.014; Troop NA, 1997, BRIT J MED PSYCHOL, V70, P373, DOI 10.1111/j.2044-8341.1997.tb01913.x; van den Pol AN, 2003, NEURON, V40, P1059, DOI 10.1016/S0896-6273(03)00809-2; Vucetic Z, 2011, NEUROPSYCHOPHARMACOL, V36, P1199, DOI 10.1038/npp.2011.4; Wheeler RA, 2011, BIOL PSYCHIAT, V69, P1067, DOI 10.1016/j.biopsych.2011.02.014; WISE RA, 1978, CAN J PSYCHOL, V32, P77, DOI 10.1037/h0081678; Wise RA, 2004, NAT REV NEUROSCI, V5, P483, DOI 10.1038/nrn1406; Wise RA, 2006, PHILOS T R SOC B, V361, P1149, DOI 10.1098/rstb.2006.1854; Wise RA, 2011, NAT REV NEUROSCI, V12, P479, DOI 10.1038/nrn3043; WRIGHT C, 1990, AM J MED, V88, P647, DOI 10.1016/0002-9343(90)90534-K; Wu Q, 2009, CELL, V137, P1225, DOI 10.1016/j.cell.2009.04.022; Yamamoto T, 2007, CHEM SENSES, V32, P105, DOI 10.1093/chemse/bjj045; Zapata A, 2010, J NEUROSCI, V30, P15457, DOI 10.1523/JNEUROSCI.4072-10.2010; Zhang M, 1998, J PHARMACOL EXP THER, V285, P908; Zhou QY, 1995, CELL, V83, P1197, DOI 10.1016/0092-8674(95)90145-0; Ziauddeen H, 2012, NAT REV NEUROSCI, V13, P279, DOI 10.1038/nrn3212	92	154	157	1	78	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	OCT	2012	15	10					1330	1335		10.1038/nn.3202	http://dx.doi.org/10.1038/nn.3202			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	013VZ	23007187	Green Accepted			2022-12-28	WOS:000309335300007
J	Kokaia, Z; Martino, G; Schwartz, M; Lindvall, O				Kokaia, Zaal; Martino, Gianvito; Schwartz, Michal; Lindvall, Olle			Cross-talk between neural stem cells and immune cells: the key to better brain repair?	NATURE NEUROSCIENCE			English	Review							ADULT HIPPOCAMPAL NEUROGENESIS; SPINAL-CORD-INJURY; PROMOTES NEURONAL DIFFERENTIATION; OLIGODENDROCYTE PRECURSOR CELLS; ENDOTHELIAL GROWTH-FACTOR; PROGENITOR-CELLS; SUBVENTRICULAR ZONE; MULTIPLE-SCLEROSIS; IN-VITRO; AUTOIMMUNE ENCEPHALOMYELITIS	Systemic or intracerebral delivery of neural stem and progenitor cells (NSPCs) and activation of endogenous NSPCs hold much promise as potential treatments for diseases in the human CNS. Recent studies have shed new light on the interaction between the NSPCs and cells belonging to the innate and adaptive arms of the immune system. According to these studies, the immune cells can be both beneficial and detrimental for cell genesis from grafted and endogenous NSPCs in the CNS, and the NSPCs exert their beneficial effects not only by cell replacement but also by immunomodulation and trophic support. The crosstalk between immune cells and NSPCs and their progeny seems to determine both the efficacy of endogenous regenerative responses and the mechanism of action as well as the fate and functional integration of grafted NSPCs. Better understanding of the dialog between NSPCs and innate and adaptive immune cells is crucial for further development of effective strategies for CNS repair.	[Kokaia, Zaal; Lindvall, Olle] Univ Hosp, Lund Stem Cell Ctr, Lund, Sweden; [Martino, Gianvito] Hosp San Raffaele, Div Neurosci, I-20132 Milan, Italy; [Schwartz, Michal] Weizmann Inst Sci, Dept Neurobiol, IL-76100 Rehovot, Israel	Lund University; Skane University Hospital; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Weizmann Institute of Science	Lindvall, O (corresponding author), Univ Hosp, Lund Stem Cell Ctr, Lund, Sweden.	olle.lindvall@med.lu.se	Kokaia, Zaal/AAL-6009-2020; martino, gianvito/AAL-2682-2020	Kokaia, Zaal/0000-0003-2296-2449; martino, gianvito/0000-0003-1295-9131	European Union [279017]	European Union(European Commission)	All authors are supported by European Union FP7 collaborative grant TargetBraIn (no. 279017).	Aberg MAI, 2003, MOL CELL NEUROSCI, V24, P23, DOI 10.1016/S1044-7431(03)00082-4; AHMED S, 1995, J NEUROSCI, V15, P5765; Bachoud-Levi A, 2000, LANCET, V356, P1975, DOI 10.1016/S0140-6736(00)03310-9; Bacigaluppi M, 2009, BRAIN, V132, P2239, DOI 10.1093/brain/awp174; Batchelor PE, 1999, J NEUROSCI, V19, P1708; Ben-Hur T, 2003, MOL CELL NEUROSCI, V24, P623, DOI 10.1016/S1044-7431(03)00218-5; Bernaudin M, 1999, J CEREBR BLOOD F MET, V19, P643, DOI 10.1097/00004647-199906000-00007; Blakemore WF, 2008, CURR TOP MICROBIOL, V318, P193; Bonde S, 2006, EUR J NEUROSCI, V23, P965, DOI 10.1111/j.1460-9568.2006.04635.x; Butovsky O, 2006, MOL CELL NEUROSCI, V31, P149, DOI 10.1016/j.mcn.2005.10.006; Butovsky O, 2006, P NATL ACAD SCI USA, V103, P11784, DOI 10.1073/pnas.0604681103; Cacci E, 2008, GLIA, V56, P412, DOI 10.1002/glia.20616; Cao W, 2011, IMMUNITY, V35, P273, DOI 10.1016/j.immuni.2011.06.011; Cho YK, 2012, BIOCHEM BIOPH RES CO, V417, P753, DOI 10.1016/j.bbrc.2011.12.029; Chu K, 2004, BRAIN RES, V1016, P145, DOI 10.1016/j.brainres.2004.04.038; Curtis MA, 2007, SCIENCE, V315, P1243, DOI 10.1126/science.1136281; Cusimano M, 2012, BRAIN, V135, P447, DOI 10.1093/brain/awr339; Darsalia V, 2011, J CEREBR BLOOD F MET, V31, P235, DOI 10.1038/jcbfm.2010.81; Derecki NC, 2010, J EXP MED, V207, P1067, DOI 10.1084/jem.20091419; Einstein O, 2003, MOL CELL NEUROSCI, V24, P1074, DOI 10.1016/j.mcn.2003.08.009; Einstein O, 2007, ANN NEUROL, V61, P209, DOI 10.1002/ana.21033; Ekdahl CT, 2003, P NATL ACAD SCI USA, V100, P13632, DOI 10.1073/pnas.2234031100; Emsley JG, 2003, EXP NEUROL, V183, P298, DOI 10.1016/S0014-4886(03)00129-8; Erlandsson A, 2001, J NEUROSCI, V21, P3483, DOI 10.1523/JNEUROSCI.21-10-03483.2001; Gaughwin PM, 2006, EUR J NEUROSCI, V23, P945, DOI 10.1111/j.1460-9568.2006.04625.x; Ginhoux F, 2010, SCIENCE, V330, P841, DOI 10.1126/science.1194637; Gomez-Nicola D, 2011, MOL BIOL CELL, V22, P1960, DOI 10.1091/mbc.E11-01-0053; Gomi M, 2011, J NEUROSCI RES, V89, P1388, DOI 10.1002/jnr.22667; Guan YT, 2008, EXP MOL PATHOL, V85, P232, DOI 10.1016/j.yexmp.2008.07.003; Hauben E, 2001, P NATL ACAD SCI USA, V98, P15173, DOI 10.1073/pnas.011585298; Hoehn BD, 2005, STROKE, V36, P2718, DOI 10.1161/01.STR.0000190020.30282.cc; Horie N, 2011, STEM CELLS, V29, P274, DOI 10.1002/stem.584; Hsieh J, 2004, J CELL BIOL, V164, P111, DOI 10.1083/jcb.200308101; Imitola J, 2004, P NATL ACAD SCI USA, V101, P18117, DOI 10.1073/pnas.0408258102; Iosif RE, 2008, J CEREBR BLOOD F MET, V28, P1574, DOI 10.1038/jcbfm.2008.47; Iosif RE, 2006, J NEUROSCI, V26, P9703, DOI 10.1523/JNEUROSCI.2723-06.2006; Jakubs K, 2006, NEURON, V52, P1047, DOI 10.1016/j.neuron.2006.11.004; Jakubs K, 2008, J NEUROSCI, V28, P12477, DOI 10.1523/JNEUROSCI.3240-08.2008; Joannides A, 2004, LANCET, V364, P172, DOI 10.1016/S0140-6736(04)16630-0; Kelly S, 2004, P NATL ACAD SCI USA, V101, P11839, DOI 10.1073/pnas.0404474101; Kondo T, 2000, SCIENCE, V289, P1754, DOI 10.1126/science.289.5485.1754; Koo JW, 2008, P NATL ACAD SCI USA, V105, P751, DOI 10.1073/pnas.0708092105; Kordower JH, 1996, J COMP NEUROL, V370, P203; Krathwohl MD, 2004, STEM CELLS, V22, P109, DOI 10.1634/stemcells.22-1-109; Lee ST, 2008, BRAIN, V131, P616, DOI 10.1093/brain/awm306; Li E, 2002, NAT REV GENET, V3, P662, DOI 10.1038/nrg887; Lindvall O, 2010, J CLIN INVEST, V120, P29, DOI 10.1172/JCI40543; Lindvall O, 2009, TRENDS PHARMACOL SCI, V30, P260, DOI 10.1016/j.tips.2009.03.001; London A, 2011, J EXP MED, V208, P23, DOI 10.1084/jem.20101202; Lu P, 2003, EXP NEUROL, V181, P115, DOI 10.1016/S0014-4886(03)00037-2; Martino G, 2006, NAT REV NEUROSCI, V7, P395, DOI 10.1038/nrn1908; Martino G, 2004, LANCET NEUROL, V3, P372, DOI 10.1016/S1474-4422(04)00771-9; Martino G, 2011, PHYSIOL REV, V91, P1281, DOI 10.1152/physrev.00032.2010; McBride JL, 2004, J COMP NEUROL, V475, P211, DOI 10.1002/cne.20176; Moalem G, 1999, NAT MED, V5, P49, DOI 10.1038/4734; Monje ML, 2003, SCIENCE, V302, P1760, DOI 10.1126/science.1088417; Moriyama M, 2011, J NEUROSCI, V31, P3981, DOI 10.1523/JNEUROSCI.3617-10.2011; Oki K, 2012, STEM CELLS, V30, P1120, DOI 10.1002/stem.1104; Ourednik J, 2002, NAT BIOTECHNOL, V20, P1103, DOI 10.1038/nbt750; Payne NL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035093; Pluchino S, 2005, NATURE, V436, P266, DOI 10.1038/nature03889; Pluchino S, 2003, NATURE, V422, P688, DOI 10.1038/nature01552; Pluchino S, 2008, BRAIN, V131, P2564, DOI 10.1093/brain/awn198; Pluchino S, 2009, ANN NEUROL, V66, P343, DOI 10.1002/ana.21745; Pluchino S, 2009, NEUROSCI LETT, V456, P101, DOI 10.1016/j.neulet.2008.03.097; Rafuse VF, 2005, NEUROSCIENCE, V131, P899, DOI 10.1016/j.neuroscience.2004.11.048; Ramos-Cabrer P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012779; Redmond DE, 2007, P NATL ACAD SCI USA, V104, P12175, DOI 10.1073/pnas.0704091104; Reiss K, 2002, NEUROSCIENCE, V115, P295, DOI 10.1016/S0306-4522(02)00307-X; Rolls A, 2007, NAT CELL BIOL, V9, P1081, DOI 10.1038/ncb1629; Ron-Hare N, 2011, BRAIN BEHAV IMMUN, V25, P1036, DOI 10.1016/j.bbi.2010.12.011; Roussa E, 2004, NEUROSCI LETT, V361, P52, DOI 10.1016/j.neulet.2003.12.106; Ryu JK, 2004, NEUROBIOL DIS, V16, P68, DOI 10.1016/j.nbd.2004.01.016; Saino O, 2010, J NEUROSCI RES, V88, P2385, DOI 10.1002/jnr.22410; Sanai N, 2011, NATURE, V478, P382, DOI 10.1038/nature10487; Schanzer A, 2004, BRAIN PATHOL, V14, P237; Schmidt NO, 2005, NEOPLASIA, V7, P623, DOI 10.1593/neo.04781; Seminatore C, 2010, STROKE, V41, P153, DOI 10.1161/STROKEAHA.109.563015; Shechter R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027969; Shechter R, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000113; Shingo T, 2001, J NEUROSCI, V21, P9733, DOI 10.1523/JNEUROSCI.21-24-09733.2001; Sierra A, 2010, CELL STEM CELL, V7, P483, DOI 10.1016/j.stem.2010.08.014; Skihar V, 2009, P NATL ACAD SCI USA, V106, P17992, DOI 10.1073/pnas.0909607106; Song SH, 2002, NATURE, V417, P39, DOI 10.1038/417039a; Stipursky J, 2007, GLIA, V55, P1023, DOI 10.1002/glia.20522; Takata M, 2012, CELL DEATH DIFFER, V19, P756, DOI 10.1038/cdd.2011.145; Teng YD, 2002, P NATL ACAD SCI USA, V99, P3024, DOI 10.1073/pnas.052678899; Tepavcevic V, 2011, J CLIN INVEST, V121, P4722, DOI 10.1172/JCI59145; Thored P, 2009, GLIA, V57, P835, DOI 10.1002/glia.20810; Thored P, 2006, STEM CELLS, V24, P739, DOI 10.1634/stemcells.2005-0281; Villeda SA, 2011, NATURE, V477, P90, DOI 10.1038/nature10357; Walton NM, 2006, GLIA, V54, P815, DOI 10.1002/glia.20419; Wolf SA, 2009, FASEB J, V23, P3121, DOI 10.1096/fj.08-113944; Wood JC, 2011, EXP NEUROL, V229, P484, DOI 10.1016/j.expneurol.2011.03.019; Yan YP, 2009, NEUROCHEM INT, V55, P826, DOI 10.1016/j.neuint.2009.08.007; Yan YP, 2009, J NEUROCHEM, V109, P1624, DOI 10.1111/j.1471-4159.2009.06059.x; Yang JX, 2009, J CLIN INVEST, V119, P3678, DOI 10.1172/JCI37914; Ziv Y, 2006, NAT NEUROSCI, V9, P268, DOI 10.1038/nn1629; Ziv Y, 2006, P NATL ACAD SCI USA, V103, P13174, DOI 10.1073/pnas.0603747103	100	230	237	1	68	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	AUG	2012	15	8					1078	1087		10.1038/nn.3163	http://dx.doi.org/10.1038/nn.3163			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	979UE	22837038				2022-12-28	WOS:000306844500009
J	Saper, CB; Romanovsky, AA; Scammell, TE				Saper, Clifford B.; Romanovsky, Andrej A.; Scammell, Thomas E.			Neural circuitry engaged by prostaglandins during the sickness syndrome	NATURE NEUROSCIENCE			English	Review							LIPOPOLYSACCHARIDE-INDUCED FEVER; EYE-MOVEMENT SLEEP; SLOW-WAVE SLEEP; VENTROLATERAL PREOPTIC NEURONS; LATERAL HYPOTHALAMIC AREA; BRAIN ENDOTHELIAL-CELLS; RAT-BRAIN; BACTERIAL LIPOPOLYSACCHARIDE; MESSENGER-RNA; THERMOREGULATORY RESPONSE	During illnesses caused by infectious disease or other sources of inflammation, a suite of brain-mediated responses called the sickness syndrome occurs, which includes fever, anorexia, sleepiness, hyperalgesia and elevated corticosteroid secretion. Much of the sickness syndrome is mediated by prostaglandins acting on the brain and can be prevented by nonsteroidal anti-inflammatory drugs, such as aspirin or ibuprofen, that block prostaglandin synthesis. By examining which prostaglandins are produced at which sites and how they interact with the nervous system, researchers have identified specific neural circuits that underlie the sickness syndrome.	[Saper, Clifford B.; Scammell, Thomas E.] Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Dept Neurol, Boston, MA 02115 USA; [Saper, Clifford B.; Scammell, Thomas E.] Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Div Sleep Med, Boston, MA USA; [Romanovsky, Andrej A.] St Josephs Hosp, Informat Syst Lab, Phoenix, AZ USA; [Romanovsky, Andrej A.] Med Ctr, Phoenix, AZ USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; St. Joseph's Hospital and Medical Center	Saper, CB (corresponding author), Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Dept Neurol, Boston, MA 02115 USA.	csaper@bidmc.harvard.edu	Saper, Clifford/L-3815-2019	Romanovsky, Andrej/0000-0003-3772-8575	US Public Health Service [NS055367, HL095491, NS072337, NS41233]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL095491] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS055367, R01NS041233, R01NS072337] Funding Source: NIH RePORTER	US Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The authors acknowledge support from US Public Health Service grants NS055367 (T.E.S.), HL095491 (C.B.S., T.E.S.), NS072337 (C.B.S.) and NS41233 (A.A.R.).	Abe M, 2001, BRAIN RES, V916, P41, DOI 10.1016/S0006-8993(01)02861-X; Almeida MC, 2006, EUR J NEUROSCI, V23, P3359, DOI 10.1111/j.1460-9568.2006.04854.x; Banks WA, 2010, NEUROBIOL DIS, V37, P26, DOI 10.1016/j.nbd.2009.07.031; Bjorness TE, 2009, CURR NEUROPHARMACOL, V7, P238, DOI 10.2174/157015909789152182; Bode JG, 2012, CELL SIGNAL, V24, P1185, DOI 10.1016/j.cellsig.2012.01.018; Breder CD, 1996, BRAIN RES, V713, P64, DOI 10.1016/0006-8993(95)01474-8; Chamberlin NL, 2003, NEUROSCIENCE, V119, P913, DOI 10.1016/S0306-4522(03)00246-X; Craig AD, 2002, NAT REV NEUROSCI, V3, P655, DOI 10.1038/nrn894; DUNN AJ, 1992, LIFE SCI, V51, P219, DOI 10.1016/0024-3205(92)90078-4; Elias CF, 1999, NEURON, V23, P775, DOI 10.1016/S0896-6273(01)80035-0; Elias CF, 1998, J COMP NEUROL, V402, P442, DOI 10.1002/(SICI)1096-9861(19981228)402:4<442::AID-CNE2>3.0.CO;2-R; Elmquist JK, 1997, TRENDS NEUROSCI, V20, P565, DOI 10.1016/S0166-2236(97)01138-7; Elmquist JK, 1996, J COMP NEUROL, V371, P85, DOI 10.1002/(SICI)1096-9861(19960715)371:1<85::AID-CNE5>3.0.CO;2-H; Engblom D, 2003, NAT NEUROSCI, V6, P1137, DOI 10.1038/nn1137; ERICSSON A, 1994, J NEUROSCI, V14, P897; Gadek-Michalska A, 2005, J PHYSIOL PHARMACOL, V56, P287; Garcia-Bueno B, 2009, J NEUROSCI, V29, P12970, DOI 10.1523/JNEUROSCI.2373-09.2009; Hansen MK, 2000, AUTON NEUROSCI-BASIC, V85, P83, DOI 10.1016/S1566-0702(00)00224-1; Hori T, 2000, ANN NY ACAD SCI, V917, P106; Huang QH, 1999, AM J PHYSIOL-REG I, V276, pR864, DOI 10.1152/ajpregu.1999.276.3.R864; Huang ZL, 2003, J NEUROSCI, V23, P5975, DOI 10.1523/JNEUROSCI.23-14-05975.2003; Imeri L, 2009, NAT REV NEUROSCI, V10, P199, DOI 10.1038/nrn2576; Inoue W, 2002, NEUROSCI RES, V44, P51, DOI 10.1016/S0168-0102(02)00083-4; Ivanov AI, 2004, FRONT BIOSCI-LANDMRK, V9, P1977, DOI 10.2741/1383; Kalinski P, 2012, J IMMUNOL, V188, P21, DOI 10.4049/jimmunol.1101029; Kishi T, 2003, J COMP NEUROL, V457, P213, DOI 10.1002/cne.10454; Kluger MJ, 1998, ANN NY ACAD SCI, V856, P224, DOI 10.1111/j.1749-6632.1998.tb08329.x; Konsman JP, 2002, TRENDS NEUROSCI, V25, P154, DOI 10.1016/S0166-2236(00)02088-9; KOZAK W, 1995, AM J PHYSIOL-REG I, V269, pR969, DOI 10.1152/ajpregu.1995.269.5.R969; KOZAK W, 1994, AM J PHYSIOL, V266, pR125, DOI 10.1152/ajpregu.1994.266.1.R125; Krueger JM, 2011, PROG BRAIN RES, V193, P39, DOI 10.1016/B978-0-444-53839-0.00003-X; KRUEGER JM, 1986, AM J PHYSIOL, V251, pR591, DOI 10.1152/ajpregu.1986.251.3.R591; Lazarus M, 2007, NAT NEUROSCI, V10, P1131, DOI 10.1038/nn1949; Lazarus M, 2011, J NEUROSCI, V31, P10067, DOI 10.1523/JNEUROSCI.6730-10.2011; Luheshi GN, 2000, AUTON NEUROSCI-BASIC, V85, P127, DOI 10.1016/S1566-0702(00)00231-9; Maness LM, 1998, AM J PHYSIOL-ENDOC M, V275, pE207, DOI 10.1152/ajpendo.1998.275.2.E207; MATSUMURA H, 1994, P NATL ACAD SCI USA, V91, P11998, DOI 10.1073/pnas.91.25.11998; Matsumura K, 1998, J NEUROSCI, V18, P6279; Matsuoka Y, 2003, P NATL ACAD SCI USA, V100, P4132, DOI 10.1073/pnas.0633341100; Mizoguchi A, 2001, P NATL ACAD SCI USA, V98, P11674, DOI 10.1073/pnas.201398898; Morrison SF, 2011, J APPL PHYSIOL, V110, P1137, DOI 10.1152/japplphysiol.01227.2010; Morrow JD, 2005, BRAIN BEHAV IMMUN, V19, P40, DOI 10.1016/j.bbi.2004.04.001; Mullington J, 2000, AM J PHYSIOL-REG I, V278, pR947, DOI 10.1152/ajpregu.2000.278.4.R947; Nadjar A, 2010, NEUROBIOL DIS, V39, P393, DOI 10.1016/j.nbd.2010.05.005; Nakamura K, 2000, J COMP NEUROL, V421, P543, DOI 10.1002/(SICI)1096-9861(20000612)421:4<543::AID-CNE6>3.0.CO;2-3; Nakamura K, 2002, J NEUROSCI, V22, P4600, DOI 10.1523/JNEUROSCI.22-11-04600.2002; Nakamura K, 2011, AM J PHYSIOL-REG I, V301, pR1207, DOI 10.1152/ajpregu.00109.2011; Ohinata K, 2008, FEBS LETT, V582, P679, DOI 10.1016/j.febslet.2008.01.050; Ohinata K, 2006, PROSTAG OTH LIPID M, V81, P31, DOI 10.1016/j.prostaglandins.2006.06.008; Oishi Y, 2008, P NATL ACAD SCI USA, V105, P19992, DOI 10.1073/pnas.0810926105; Oka T, 2000, J COMP NEUROL, V428, P20, DOI 10.1002/1096-9861(20001204)428:1<20::AID-CNE3>3.0.CO;2-X; Oka T, 2003, J PHYSIOL-LONDON, V551, P945, DOI 10.1113/jphysiol.2003.048140; ONOE H, 1992, J NEUROSCI, V12, P2715; Parsadaniantz SM, 2000, J NEUROENDOCRINOL, V12, P766, DOI 10.1046/j.1365-2826.2000.00517.x; Pecchi E, 2006, PHYSIOL GENOMICS, V25, P485, DOI 10.1152/physiolgenomics.00306.2005; Rizvi TA, 1996, J NEUROSCI, V16, P333; Romanovsky AA, 1997, AM J PHYSIOL-REG I, V273, pR407, DOI 10.1152/ajpregu.1997.273.1.R407; Romanovsky AA, 1996, AM J PHYSIOL-REG I, V271, pR244, DOI 10.1152/ajpregu.1996.271.1.R244; Romanovsky AA, 1997, AM J PHYSIOL-REG I, V273, pR777, DOI 10.1152/ajpregu.1997.273.2.R777; Romanovsky AA, 2004, FRONT BIOSCI-LANDMRK, V9, P494, DOI 10.2741/1247; Romanovsky AA, 2000, AUTON NEUROSCI-BASIC, V85, P133, DOI 10.1016/S1566-0702(00)00232-0; Romanovsky AA, 1998, AM J PHYSIOL-REG I, V275, pR323, DOI 10.1152/ajpregu.1998.275.1.R323; Romanovsky AA, 2007, AM J PHYSIOL-REG I, V292, pR37, DOI 10.1152/ajpregu.00668.2006; Rorato R, 2009, EXP PHYSIOL, V94, P371, DOI 10.1113/expphysiol.2008.045435; Roth J, 2002, PFLUG ARCH EUR J PHY, V443, P411, DOI 10.1007/s004240100718; Saper CB, 2010, NEURON, V68, P1023, DOI 10.1016/j.neuron.2010.11.032; Satoh S, 1996, P NATL ACAD SCI USA, V93, P5980, DOI 10.1073/pnas.93.12.5980; Scammell TE, 1998, AM J PHYSIOL-REG I, V274, pR783, DOI 10.1152/ajpregu.1998.274.3.R783; Scammell TE, 2001, NEUROSCIENCE, V107, P653, DOI 10.1016/S0306-4522(01)00383-9; Scammell TE, 1996, J NEUROSCI, V16, P6246; Schiltz JC, 2002, J NEUROSCI, V22, P5606; Schiltz JC, 2007, J COMP NEUROL, V502, P455, DOI 10.1002/cne.21329; Schmelzer KR, 2006, P NATL ACAD SCI USA, V103, P13646, DOI 10.1073/pnas.0605908103; Serrats J, 2010, NEURON, V65, P94, DOI 10.1016/j.neuron.2009.11.032; Steiner AA, 2005, AM J PHYSIOL-REG I, V289, pR1253, DOI 10.1152/ajpregu.00371.2005; Steiner AA, 2006, PLOS BIOL, V4, P1517, DOI 10.1371/journal.pbio.0040284; Swiergiel AH, 2002, J PHARMACOL EXP THER, V302, P1031, DOI 10.1124/jpet.102.036640; SZEKELY M, 1979, ACTA PHYSIOL HUNG, V53, P265; SZELENYI Z, 1994, BRAIN RES, V638, P69, DOI 10.1016/0006-8993(94)90634-3; Tanaka M, 2009, AM J PHYSIOL-REG I, V296, pR1248, DOI 10.1152/ajpregu.91010.2008; Terao A, 1998, NEUROREPORT, V9, P3791, DOI 10.1097/00001756-199812010-00005; Ueno A, 2001, BIOCHEM PHARMACOL, V62, P157, DOI 10.1016/S0006-2952(01)00654-2; UENO R, 1982, P NATL ACAD SCI-BIOL, V79, P6093, DOI 10.1073/pnas.79.19.6093; URADE Y, 1993, P NATL ACAD SCI USA, V90, P9070, DOI 10.1073/pnas.90.19.9070; Urade Y, 2011, SLEEP MED REV, V15, P411, DOI 10.1016/j.smrv.2011.08.003; Uschakov A, 2007, NEUROSCIENCE, V150, P104, DOI 10.1016/j.neuroscience.2007.05.055; Ushikubi F, 1998, NATURE, V395, P281, DOI 10.1038/26233; Vasilache AM, 2007, NEUROSCI LETT, V423, P179, DOI 10.1016/j.neulet.2007.06.048; Wang LX, 2006, AM J PHYSIOL-GASTR L, V291, pG611, DOI 10.1152/ajpgi.00533.2005; Wang LX, 2002, NEUROSCI LETT, V325, P47; WATKINS LR, 1994, BRAIN RES, V654, P15, DOI 10.1016/0006-8993(94)91566-0; Wieczorek M, 2005, PHYSIOL BEHAV, V85, P500, DOI 10.1016/j.physbeh.2005.05.012; Williams G, 2001, PHYSIOL BEHAV, V74, P683, DOI 10.1016/S0031-9384(01)00612-6; Woodward DF, 2011, PHARMACOL REV, V63, P471, DOI 10.1124/pr.110.003517; Wu Q, 2011, EUR J PHARMACOL, V660, P21, DOI 10.1016/j.ejphar.2010.10.110; Yamagata K, 2001, J NEUROSCI, V21, P2669, DOI 10.1523/JNEUROSCI.21-08-02669.2001; Yates DT, 2011, J ANIM SCI, V89, P4286, DOI 10.2527/jas.2011-3969; Yoshida H, 2003, AM J PHYSIOL-REG I, V285, pR99, DOI 10.1152/ajpregu.00609.2002; Yoshida K, 2009, J NEUROSCI, V29, P11954, DOI 10.1523/JNEUROSCI.2643-09.2009; Zhang YH, 2003, J COMP NEUROL, V463, P3, DOI 10.1002/cne.10743	100	155	162	0	28	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	AUG	2012	15	8					1088	1095		10.1038/nn.3159	http://dx.doi.org/10.1038/nn.3159			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	979UE	22837039	Green Accepted			2022-12-28	WOS:000306844500010
J	Alonso, M; Lepousez, G; Wagner, S; Bardy, C; Gabellec, MM; Torquet, N; Lledo, PM				Alonso, Mariana; Lepousez, Gabriel; Wagner, Sebastien; Bardy, Cedric; Gabellec, Marie-Madeleine; Torquet, Nicolas; Lledo, Pierre-Marie			Activation of adult-born neurons facilitates learning and memory	NATURE NEUROSCIENCE			English	Article							MAMMALIAN OLFACTORY-BULB; ODOR DISCRIMINATION; CONTINUOUS NEUROGENESIS; SYNAPTIC INHIBITION; MICE; PLASTICITY; INCREASES; ACCURACY; SPEED; RAT	Thousand of local interneurons reach the olfactory bulb of adult rodents every day, but the functional effect of this process remains elusive. By selectively expressing channelrhodopsin in postnatal-born mouse neurons, we found that their activation accelerated difficult odor discrimination learning and improved memory. This amelioration was seen when photoactivation occurred simultaneously with odor presentation, but not when odor delivery lagged by 500 ms. In addition, learning was facilitated when light flashes were delivered at 40 Hz, but not at 10 Hz. Both in vitro and in vivo electrophysiological recordings of mitral cells revealed that 40-Hz stimuli produced enhanced GABAergic inhibition compared with 10-Hz stimulation. Facilitation of learning occurred specifically when photoactivated neurons were generated during adulthood. Taken together, our results demonstrate an immediate causal relationship between the activity of adult-born neurons and the function of the olfactory bulb circuit.	[Alonso, Mariana; Lepousez, Gabriel; Wagner, Sebastien; Bardy, Cedric; Gabellec, Marie-Madeleine; Torquet, Nicolas; Lledo, Pierre-Marie] Inst Pasteur, Lab Percept & Memory, Paris, France; [Alonso, Mariana; Lepousez, Gabriel; Wagner, Sebastien; Bardy, Cedric; Gabellec, Marie-Madeleine; Torquet, Nicolas; Lledo, Pierre-Marie] Ctr Natl Rech Sci, Unit Rech Assoc 2182, Paris, France	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS)	Lledo, PM (corresponding author), Inst Pasteur, Lab Percept & Memory, Paris, France.	pmlledo@pasteur.fr	Bardy, Cedric/F-1182-2019; Torquet, Nicolas/ABF-9755-2020	Bardy, Cedric/0000-0001-8321-0852; Torquet, Nicolas/0000-0001-9032-193X	NovalisTaitbout; Letten Foundation; Foundation pour la Recherche Medical; Agence Nationale de la Recherche [ANR-BLAN-SVSE4-LS-110624, ANR-09-NEUR-004]	NovalisTaitbout; Letten Foundation; Foundation pour la Recherche Medical; Agence Nationale de la Recherche(French National Research Agency (ANR))	We thank G. Gheusi for his advice regarding the use of olfactometers, L. Petreanu for the manipulation of the LEDs during behavioral experiments, K. Murray and N. Maffey for technical assistance, and M. Valley and G. Gheusi for their critical reading of the manuscript. We thank the ENP Network for Viral Transfer for viral vector production. This work was supported by NovalisTaitbout, the Letten Foundation, the Foundation pour la Recherche Medical, the Agence Nationale de la Recherche (ANR-BLAN-SVSE4-LS-110624 and ANR-09-NEUR-004 in the frame of "ERA-NET NEURON" of FP7 program by the European Commission).	Abraham NM, 2010, NEURON, V65, P399, DOI 10.1016/j.neuron.2010.01.009; Abraham NM, 2004, NEURON, V44, P865, DOI 10.1016/j.neuron.2004.11.017; Alonso M, 2008, J NEUROSCI, V28, P11089, DOI 10.1523/JNEUROSCI.3713-08.2008; Alonso M, 2006, J NEUROSCI, V26, P10508, DOI 10.1523/JNEUROSCI.2633-06.2006; Bardy C, 2010, J NEUROSCI, V30, P17023, DOI 10.1523/JNEUROSCI.4543-10.2010; Breton-Provencher V, 2009, J NEUROSCI, V29, P15245, DOI 10.1523/JNEUROSCI.3606-09.2009; Cang JH, 2003, J NEUROSCI, V23, P4108; Chapuis J, 2012, NAT NEUROSCI, V15, P155, DOI 10.1038/nn.2966; Cleland TA, 2010, TRENDS NEUROSCI, V33, P130, DOI 10.1016/j.tins.2009.12.004; Dhawale AK, 2010, NAT NEUROSCI, V13, P1404, DOI 10.1038/nn.2673; Dietz SB, 2005, J PHYSIOL-LONDON, V569, P475, DOI 10.1113/jphysiol.2005.095844; Doucette W, 2011, NEURON, V69, P1176, DOI 10.1016/j.neuron.2011.02.024; Doucette W, 2008, PLOS BIOL, V6, P2266, DOI 10.1371/journal.pbio.0060258; Enwere E, 2004, J NEUROSCI, V24, P8354, DOI 10.1523/JNEUROSCI.2751-04.2004; Franks KM, 2006, NEURON, V49, P357, DOI 10.1016/j.neuron.2005.12.026; Gheusi C, 2000, P NATL ACAD SCI USA, V97, P1823, DOI 10.1073/pnas.97.4.1823; Imayoshi I, 2008, NAT NEUROSCI, V11, P1153, DOI 10.1038/nn.2185; Isaacson JS, 1998, NEURON, V20, P749, DOI 10.1016/S0896-6273(00)81013-2; Kay LM, 2006, SEMIN CELL DEV BIOL, V17, P433, DOI 10.1016/j.semcdb.2006.04.012; Koulakov AA, 2011, NEURON, V72, P124, DOI 10.1016/j.neuron.2011.07.031; Laurent G, 2002, NAT REV NEUROSCI, V3, P884, DOI 10.1038/nrn964; Lazarini F, 2011, TRENDS NEUROSCI, V34, P20, DOI 10.1016/j.tins.2010.09.006; Lazarini F, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007017; Lepousez G, 2011, JOVE-J VIS EXP, DOI 10.3791/3380; Linster C, 2001, J NEUROSCI, V21, P9837, DOI 10.1523/JNEUROSCI.21-24-09837.2001; Lledo PM, 2006, SEMIN CELL DEV BIOL, V17, P443, DOI 10.1016/j.semcdb.2006.04.011; Mandairon N, 2006, P NATL ACAD SCI USA, V103, P13543, DOI 10.1073/pnas.0602750103; Mandairon N, 2006, EUR J NEUROSCI, V24, P3578, DOI 10.1111/j.1460-9568.2006.05235.x; Mandairon N, 2009, J NEUROPHYSIOL, V101, P2204, DOI 10.1152/jn.00076.2009; Matsutani S, 2008, ANAT SCI INT, V83, P218, DOI 10.1111/j.1447-073X.2007.00223.x; Moreno MM, 2009, P NATL ACAD SCI USA, V106, P17980, DOI 10.1073/pnas.0907063106; Mouret A, 2008, J NEUROSCI, V28, P11511, DOI 10.1523/JNEUROSCI.2954-08.2008; Mouret A, 2009, J NEUROSCI, V29, P12302, DOI 10.1523/JNEUROSCI.3383-09.2009; Mouret A, 2009, ANN NY ACAD SCI, V1170, P239, DOI 10.1111/j.1749-6632.2009.03913.x; Murthy VN, 2011, ANNU REV NEUROSCI, V34, P233, DOI 10.1146/annurev-neuro-061010-113738; Mwilaria EK, 2008, CHEM SENSES, V33, P267, DOI 10.1093/chemse/bjm085; Neville KR, 2003, J NEUROPHYSIOL, V90, P3921, DOI 10.1152/jn.00475.2003; Nissant A, 2009, NAT NEUROSCI, V12, P728, DOI 10.1038/nn.2298; Rinberg D, 2006, J NEUROSCI, V26, P8857, DOI 10.1523/JNEUROSCI.0884-06.2006; Rinberg D, 2006, NEURON, V51, P351, DOI 10.1016/j.neuron.2006.07.013; Rochefort C, 2002, J NEUROSCI, V22, P2679, DOI 10.1523/JNEUROSCI.22-07-02679.2002; Sahay A, 2011, NEURON, V70, P582, DOI 10.1016/j.neuron.2011.05.012; Sakamoto M, 2011, P NATL ACAD SCI USA, V108, P8479, DOI 10.1073/pnas.1018782108; Shepherd GM, 2007, BRAIN RES REV, V55, P373, DOI 10.1016/j.brainresrev.2007.03.005; Stopfer M, 1997, NATURE, V390, P70, DOI 10.1038/36335; Sultan S, 2010, FASEB J, V24, P2355, DOI 10.1096/fj.09-151456; Tan J, 2010, NEURON, V65, P912, DOI 10.1016/j.neuron.2010.02.011; Uchida N, 2003, NAT NEUROSCI, V6, P1224, DOI 10.1038/nn1142; Valley MT, 2009, FRONT NEUROSCI-SWITZ, V3, DOI 10.3389/neuro.22.003.2009; Wilson DA, 2003, NEUROSCI BIOBEHAV R, V27, P307, DOI 10.1016/S0149-7634(03)00050-2; YOKOI M, 1995, P NATL ACAD SCI USA, V92, P3371, DOI 10.1073/pnas.92.8.3371	51	150	152	0	21	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUN	2012	15	6					897	U127		10.1038/nn.3108	http://dx.doi.org/10.1038/nn.3108			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	949AI	22581183				2022-12-28	WOS:000304546700018
J	Helfinstein, SM; Poldrack, RA				Helfinstein, Sarah M.; Poldrack, Russell A.			The young and the reckless	NATURE NEUROSCIENCE			English	Editorial Material							ORBITOFRONTAL CORTEX; INHIBITORY CONTROL; BEHAVIOR; REWARD; BRAIN	A large study of impulsivity in 14-year-olds finds that substance use and ADHD symptoms are associated with different brain networks that inhibit motor responses. Genetic analysis implicates the noradrenergic system in activity levels in one of these networks, which is centered on the right frontal cortex.	[Helfinstein, Sarah M.; Poldrack, Russell A.] Univ Texas Austin, Imaging Res Ctr, Austin, TX 78712 USA; Univ Texas Austin, Dept Psychol, Austin, TX 78712 USA; Univ Texas Austin, Dept Neurobiol, Austin, TX 78712 USA	University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin	Helfinstein, SM (corresponding author), Univ Texas Austin, Imaging Res Ctr, Austin, TX 78712 USA.	shelfins@gmail.com		Poldrack, Russell/0000-0001-6755-0259				Alderson RM, 2007, J ABNORM CHILD PSYCH, V35, P745, DOI 10.1007/s10802-007-9131-6; Aron AR, 2004, TRENDS COGN SCI, V8, P170, DOI 10.1016/j.tics.2004.02.010; Chamberlain SR, 2006, SCIENCE, V311, P861, DOI 10.1126/science.1121218; Congdon E, 2010, NEURON, V68, P218, DOI 10.1016/j.neuron.2010.10.007; Congdon E, 2010, NEUROIMAGE, V53, P653, DOI 10.1016/j.neuroimage.2010.06.062; Fillmore MT, 2002, DRUG ALCOHOL DEPEN, V66, P265, DOI 10.1016/S0376-8716(01)00206-X; Goudriaan AE, 2006, ADDICTION, V101, P534, DOI 10.1111/j.1360-0443.2006.01380.x; Kringelbach ML, 2005, NAT REV NEUROSCI, V6, P691, DOI 10.1038/nrn1747; Rolls ET, 2000, CEREB CORTEX, V10, P284, DOI 10.1093/cercor/10.3.284; Rubia K, 2005, AM J PSYCHIAT, V162, P1067, DOI 10.1176/appi.ajp.162.6.1067; Whelan R, 2012, NAT NEUROSCI, V15, P920, DOI 10.1038/nn.3092	11	2	2	0	9	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JUN	2012	15	6					803	805		10.1038/nn.3116	http://dx.doi.org/10.1038/nn.3116			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	949AI	22627789				2022-12-28	WOS:000304546700001
J	Royer, S; Zemelman, BV; Losonczy, A; Kim, J; Chance, F; Magee, JC; Buzsaki, G				Royer, Sebastien; Zemelman, Boris V.; Losonczy, Attila; Kim, Jinhyun; Chance, Frances; Magee, Jeffrey C.; Buzsaki, Gyoergy			Control of timing, rate and bursts of hippocampal place cells by dendritic and somatic inhibition	NATURE NEUROSCIENCE			English	Article							CA1 PYRAMIDAL NEURONS; PHASE-PRECESSION; THETA OSCILLATIONS; IN-VIVO; SYNAPTIC PLASTICITY; INTERNEURONS; DYNAMICS; MECHANISMS; SEQUENCES; CORTEX	A consortium of inhibitory neurons control the firing patterns of pyramidal cells, but their specific roles in the behaving animal are largely unknown. We performed simultaneous physiological recordings and optogenetic silencing of either perisomatic (parvalbumin (PV) expressing) or dendrite-targeting (somatostatin (SOM) expressing) interneurons in hippocampal area CA1 of head-fixed mice actively moving a treadmill belt rich with visual-tactile stimuli. Silencing of either PV or SOM interneurons increased the firing rates of pyramidal cells selectively in their place fields, with PV and SOM interneurons having their largest effect during the rising and decaying parts of the place field, respectively. SOM interneuron silencing powerfully increased burst firing without altering the theta phase of spikes. In contrast, PV interneuron silencing had no effect on burst firing, but instead shifted the spikes' theta phase toward the trough of theta. These findings indicate that perisomatic and dendritic inhibition have distinct roles in controlling the rate, burst and timing of hippocampal pyramidal cells.	[Royer, Sebastien; Zemelman, Boris V.; Losonczy, Attila; Kim, Jinhyun; Chance, Frances; Magee, Jeffrey C.; Buzsaki, Gyoergy] Howard Hughes Med Inst, Ashburn, VA USA; [Royer, Sebastien; Kim, Jinhyun] Korea Inst Sci & Technol, Ctr Funct Connect, Seoul, South Korea; [Losonczy, Attila] Columbia Univ, Dept Neurosci, New York, NY USA; [Buzsaki, Gyoergy] Rutgers State Univ, Ctr Mol & Behav Neurosci, Newark, NJ 07102 USA	Howard Hughes Medical Institute; Korea Institute of Science & Technology (KIST); Columbia University; Rutgers State University Newark; Rutgers State University New Brunswick	Magee, JC (corresponding author), Howard Hughes Med Inst, Janelia Farm Res Campus, Ashburn, VA USA.	mageej@janelia.hhmi.org; gyorgy.buzsaki@nyumc.org		Zemelman, Boris/0000-0003-2463-4887; Buzsaki, Gyorgy/0000-0002-3100-4800; Chance, Frances/0000-0003-1420-4664	Howard Hughes Medical Institute; US National Institutes of Health [NS34994, MH54671]; James S. McDonnell Foundation; National Research Foundation of Korea (NRF); Ministry of Education, Science and Technology of Korea (NRF) [WCI 2009-003]; Kavli and Searle Foundations; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH054671] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS034994] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); James S. McDonnell Foundation; National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Ministry of Education, Science and Technology of Korea (NRF)(Ministry of Education, Science & Technology (MEST), Republic of Korea); Kavli and Searle Foundations; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank G.F. Turi, T. Adelman and T. Tabachnik for technical contributions, and D. Huber for useful advice. This work was supported by the Howard Hughes Medical Institute, the US National Institutes of Health (NS34994, MH54671), the James S. McDonnell Foundation and the World Class Institute (WCI) Program of the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology of Korea (NRF grant number: WCI 2009-003). A.L. was supported by the Kavli and Searle Foundations.	Azouz R, 1996, J PHYSIOL-LONDON, V492, P211, DOI 10.1113/jphysiol.1996.sp021302; Buzsaki G, 2003, NEUROSCIENCE, V116, P201, DOI 10.1016/S0306-4522(02)00669-3; Buzsaki G, 1996, P NATL ACAD SCI USA, V93, P9921, DOI 10.1073/pnas.93.18.9921; Cardin JA, 2009, NATURE, V459, P663, DOI 10.1038/nature08002; Csicsvari J, 1999, J NEUROSCI, V19, P274, DOI 10.1523/JNEUROSCI.19-01-00274.1999; Dragoi G, 2006, NEURON, V50, P145, DOI 10.1016/j.neuron.2006.02.023; Dupret D, 2010, NAT NEUROSCI, V13, P995, DOI 10.1038/nn.2599; Freund TF, 2003, TRENDS NEUROSCI, V26, P489, DOI 10.1016/S0166-2236(03)00227-3; Freund TF, 1996, HIPPOCAMPUS, V6, P347, DOI 10.1002/(SICI)1098-1063(1996)6:4<347::AID-HIPO1>3.0.CO;2-I; Geisler C, 2007, P NATL ACAD SCI USA, V104, P8149, DOI 10.1073/pnas.0610121104; Geisler C, 2010, P NATL ACAD SCI USA, V107, P7957, DOI 10.1073/pnas.0912478107; Hangya B, 2010, J PHYSIOL-LONDON, V588, P4165, DOI 10.1113/jphysiol.2010.194274; Harris KD, 2002, NATURE, V417, P738, DOI 10.1038/nature00808; Harris KD, 2001, NEURON, V32, P141, DOI 10.1016/S0896-6273(01)00447-0; Harvey CD, 2009, NATURE, V461, P941, DOI 10.1038/nature08499; Hirase H, 1999, EUR J NEUROSCI, V11, P4373, DOI 10.1046/j.1460-9568.1999.00853.x; Huxter J, 2003, NATURE, V425, P828, DOI 10.1038/nature02058; Huxter JR, 2008, NAT NEUROSCI, V11, P587, DOI 10.1038/nn.2106; Isaacson JS, 2011, NEURON, V72, P231, DOI 10.1016/j.neuron.2011.09.027; Jensen O, 1996, LEARN MEMORY, V3, P279, DOI 10.1101/lm.3.2-3.279; Kamondi A, 1998, HIPPOCAMPUS, V8, P244, DOI 10.1002/(SICI)1098-1063(1998)8:3<244::AID-HIPO7>3.0.CO;2-J; Klausberger T, 2003, NATURE, V421, P844, DOI 10.1038/nature01374; Klausberger T, 2008, SCIENCE, V321, P53, DOI 10.1126/science.1149381; Kullmann DM, 2007, NAT REV NEUROSCI, V8, P687, DOI 10.1038/nrn2207; Lisman JE, 1997, TRENDS NEUROSCI, V20, P38, DOI 10.1016/S0166-2236(96)10070-9; Losonczy A, 2010, NAT NEUROSCI, V13, P967, DOI 10.1038/nn.2597; Lovett-Barron M, 2012, NAT NEUROSCI, V15, P423, DOI 10.1038/nn.3024; Magee JC, 2001, J NEUROPHYSIOL, V86, P528, DOI 10.1152/jn.2001.86.1.528; Markram H, 2004, NAT REV NEUROSCI, V5, P793, DOI 10.1038/nrn1519; Maurer AP, 2006, J NEUROSCI, V26, P13485, DOI 10.1523/JNEUROSCI.2882-06.2006; McNaughton BL, 2006, NAT REV NEUROSCI, V7, P663, DOI 10.1038/nrn1932; Mehta MR, 2002, NATURE, V417, P741, DOI 10.1038/nature00807; Miles R, 1996, NEURON, V16, P815, DOI 10.1016/S0896-6273(00)80101-4; Mizuseki K, 2009, NEURON, V64, P267, DOI 10.1016/j.neuron.2009.08.037; O'Connor DH, 2009, NATURE, V461, P923, DOI 10.1038/nature08539; O'Keefe J, 2006, NEUROSCIENCE, P475; OKEEFE J, 1993, HIPPOCAMPUS, V3, P317, DOI 10.1002/hipo.450030307; OLTON DS, 1979, BEHAV BRAIN SCI, V2, P313, DOI 10.1017/S0140525X00062713; Pouille F, 2004, NATURE, V429, P717, DOI 10.1038/nature02615; RANCK JB, 1973, EXP NEUROL, V41, P462, DOI 10.1016/0014-4886(73)90290-2; Royer S, 2010, EUR J NEUROSCI, V31, P2279, DOI 10.1111/j.1460-9568.2010.07250.x; Royer S, 2010, J NEUROSCI, V30, P1777, DOI 10.1523/JNEUROSCI.4681-09.2010; Runyan CA, 2010, NEURON, V67, P847, DOI 10.1016/j.neuron.2010.08.006; SILLITO AM, 1975, J PHYSIOL-LONDON, V250, P305, DOI 10.1113/jphysiol.1975.sp011056; Skaggs WE, 1996, HIPPOCAMPUS, V6, P149, DOI 10.1002/(SICI)1098-1063(1996)6:2<149::AID-HIPO6>3.0.CO;2-K; Takahashi H, 2009, NEURON, V62, P102, DOI 10.1016/j.neuron.2009.03.007; Vinogradova OS, 2001, HIPPOCAMPUS, V11, P578, DOI 10.1002/hipo.1073; Wehr M, 2003, NATURE, V426, P442, DOI 10.1038/nature02116	48	390	392	6	57	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAY	2012	15	5					769	775		10.1038/nn.3077	http://dx.doi.org/10.1038/nn.3077			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	932DI	22446878	Green Accepted			2022-12-28	WOS:000303270200022
J	Lee, BR; Ma, YY; Huang, YHH; Wang, XS; Otaka, M; Ishikawa, M; Neumann, PA; Graziane, NM; Brown, TE; Suska, A; Guo, CY; Lobo, MK; Sesack, SR; Wolf, ME; Nestler, EJ; Shaham, Y; Schluter, OM; Dong, Y				Lee, Brian R.; Ma, Yao-Ying; Huang, Yanhua H.; Wang, Xiusong; Otaka, Mami; Ishikawa, Masago; Neumann, Peter A.; Graziane, Nicholas M.; Brown, Travis E.; Suska, Anna; Guo, Changyong; Lobo, Mary Kay; Sesack, Susan R.; Wolf, Marina E.; Nestler, Eric J.; Shaham, Yavin; Schlueter, Oliver M.; Dong, Yan			Maturation of silent synapses in amygdala-accumbens projection contributes to incubation of cocaine craving	NATURE NEUROSCIENCE			English	Article							PERMEABLE AMPA RECEPTORS; NUCLEUS-ACCUMBENS; REINSTATEMENT MODEL; DRUG RELAPSE; EXPOSURE; TRANSMISSION; PLASTICITY; WITHDRAWAL; SEEKING; ADAPTATIONS	In rat models of drug relapse and craving, cue-induced cocaine seeking progressively increases after withdrawal from the drug. This 'incubation of cocaine craving' is partially mediated by time-dependent adaptations at glutamatergic synapses in nucleus accumbens (NAc). However, the circuit-level adaptations mediating this plasticity remain elusive. We studied silent synapses, often regarded as immature synapses that express stable NMDA receptors with AMPA receptors being either absent or labile, in the projection from the basolateral amygdala to the NAc in incubation of cocaine craving. Silent synapses were detected in this projection during early withdrawal from cocaine. As the withdrawal period progressed, these silent synapses became unsilenced, a process that involved synaptic insertion of calcium-permeable AMPA receptors (CP-AMPARs). In vivo optogenetic stimulation-induced downregulation of CP-AMPARs at amygdala-to-NAc synapses, which re-silenced some of the previously silent synapses after prolonged withdrawal, decreased incubation of cocaine craving. Our findings indicate that silent synapse-based reorganization of the amygdala-to-NAc projection is critical for persistent cocaine craving and relapse after withdrawal.	[Lee, Brian R.] Scripps Res Inst, Dept Mol Therapeut, Jupiter, FL USA; [Lee, Brian R.; Brown, Travis E.; Dong, Yan] Washington State Univ, Program Neurosci, Pullman, WA 99164 USA; [Ma, Yao-Ying; Otaka, Mami; Ishikawa, Masago; Neumann, Peter A.; Graziane, Nicholas M.; Guo, Changyong; Sesack, Susan R.; Dong, Yan] Univ Pittsburgh, Dept Neurosci, Pittsburgh, PA USA; [Huang, Yanhua H.; Wang, Xiusong] Univ Pittsburgh, Dept Psychiat, Pittsburgh, PA USA; [Suska, Anna; Schlueter, Oliver M.] European Neurosci Inst, Gottingen, Germany; [Lobo, Mary Kay; Nestler, Eric J.] Mt Sinai Sch Med, Fishberg Dept Neurosci, New York, NY USA; [Lobo, Mary Kay; Nestler, Eric J.] Mt Sinai Sch Med, Friedman Brain Inst, New York, NY USA; [Wolf, Marina E.] Rosalind Franklin Univ Med & Sci, Dept Neurosci, N Chicago, IL USA; [Shaham, Yavin] NIDA, Behav Neurosci Branch, Intramural Res Program, US NIH, Baltimore, MD USA	Scripps Research Institute; Washington State University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Rosalind Franklin University Medical & Science; National Institutes of Health (NIH) - USA; NIH National Institute on Drug Abuse (NIDA)	Dong, Y (corresponding author), Washington State Univ, Program Neurosci, Pullman, WA 99164 USA.	yandong@pitt.edu	Sesack, Susan R/H-8013-2018; shaham, yavin/G-1306-2014; Dong, Yan/A-4154-2016; Beroun, Anna/P-6322-2016; Huang, Yanhua/P-1583-2015; Lobo, Mary Kay/K-7734-2015	Sesack, Susan R/0000-0002-2852-7440; Dong, Yan/0000-0003-0016-9028; Beroun, Anna/0000-0003-4376-5241; Huang, Yanhua/0000-0003-1770-0196; Lobo, Mary Kay/0000-0002-9419-2079; Graziane, Nicholas/0000-0002-7055-7029; Lee, Brian/0000-0002-3210-5638	National Institute on Drug Abuse [DA028020, DA029565, DA036303, DA030379, DA009621, DA029099, DA007359, DA014133, DA023206, DA031551, DA034856]; German Research Foundation through the Cluster of Excellence "Nanoscale Microscopy and Molecular Physiology of the Brain"; Gottingen University Medical School; Max Planck Society;  [SCHL592/4]; NATIONAL INSTITUTE ON DRUG ABUSE [R21DA031551, R01DA009621, F31DA028020, R37DA015835, R01DA015835, R01DA023206, R01DA030379, R01DA034856, ZIADA000434, P01DA008227, R00DA029565, R01DA014133, K99DA029565, R37DA007359, R01DA007359, K05DA029099, R21DA036303] Funding Source: NIH RePORTER	National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); German Research Foundation through the Cluster of Excellence "Nanoscale Microscopy and Molecular Physiology of the Brain"; Gottingen University Medical School; Max Planck Society(Max Planck SocietyFoundation CELLEX); ; NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank B. Sorg, D. Dietz, R.L. Brown and H. Jansen for technical consultations. This research was supported by the Intramural Research Program of the National Institute on Drug Abuse (Y.S.), extramural funds DA028020 (B.R.L.), DA029565 and DA036303 (Y.H.H.), DA030379 (M.E.W. and Y.D.), DA009621 and DA029099 (M.E.W.), DA007359 and DA014133 (E.J.N.), DA023206, DA031551 and DA034856 (Y.D.) from the National Institute on Drug Abuse, the German Research Foundation through the Cluster of Excellence "Nanoscale Microscopy and Molecular Physiology of the Brain" and grant SCHL592/4 (O.M.S.). The European Neuroscience Institute Gottingen is jointly funded by the Gottingen University Medical School and the Max Planck Society.	Barria A, 2002, NEURON, V35, P345, DOI 10.1016/S0896-6273(02)00776-6; Belin D, 2009, BEHAV BRAIN RES, V199, P89, DOI 10.1016/j.bbr.2008.09.027; Bossert JM, 2013, PSYCHOPHARMACOLOGY, V229, P453, DOI 10.1007/s00213-013-3120-y; Brown TE, 2011, J NEUROSCI, V31, P8163, DOI 10.1523/JNEUROSCI.0016-11.2011; Carlezon WA, 2005, TRENDS NEUROSCI, V28, P436, DOI 10.1016/j.tins.2005.06.005; Carroll RC, 2001, NAT REV NEUROSCI, V2, P315, DOI 10.1038/35072500; Conrad KL, 2008, NATURE, V454, P118, DOI 10.1038/nature06995; Cull-Candy S, 2006, CURR OPIN NEUROBIOL, V16, P288, DOI 10.1016/j.conb.2006.05.012; Durand GM, 1996, NATURE, V381, P71, DOI 10.1038/381071a0; Ferrario CR, 2011, NEUROPHARMACOLOGY, V61, P1141, DOI 10.1016/j.neuropharm.2011.01.021; GAWIN FH, 1986, ARCH GEN PSYCHIAT, V43, P107; Grimm JW, 2001, NATURE, V412, P141, DOI 10.1038/35084134; Hollander JA, 2005, NEUROPSYCHOPHARMACOL, V30, P1464, DOI 10.1038/sj.npp.1300748; Hollander JA, 2007, J NEUROSCI, V27, P3535, DOI 10.1523/JNEUROSCI.3667-06.2007; Huang YHH, 2009, NEURON, V63, P40, DOI 10.1016/j.neuron.2009.06.007; HUNT WA, 1971, J CLIN PSYCHOL, V27, P455, DOI 10.1002/1097-4679(197110)27:4<455::AID-JCLP2270270412>3.0.CO;2-R; Isaac JTR, 1997, NEURON, V18, P269, DOI 10.1016/S0896-6273(00)80267-6; Kalivas PW, 2009, NAT REV NEUROSCI, V10, P561, DOI 10.1038/nrn2515; Kerchner GA, 2008, NAT REV NEUROSCI, V9, P813, DOI 10.1038/nrn2501; Koya E, 2012, NAT NEUROSCI, V15, P1556, DOI 10.1038/nn.3232; Lee BR, 2011, NEUROPHARMACOLOGY, V61, P1060, DOI 10.1016/j.neuropharm.2010.12.033; LIAO DZ, 1995, NATURE, V375, P400, DOI 10.1038/375400a0; Lonze BE, 2002, NEURON, V35, P605, DOI 10.1016/S0896-6273(02)00828-0; Loweth JA, 2013, CURR OPIN NEUROBIOL, V23, P500, DOI 10.1016/j.conb.2013.01.009; Lu L, 2004, NEUROPHARMACOLOGY, V47, P214, DOI 10.1016/j.neuropharm.2004.06.027; Lu L, 2004, PSYCHOPHARMACOLOGY, V176, P101, DOI 10.1007/s00213-004-1860-4; Lu L, 2009, BIOL PSYCHIAT, V66, P137, DOI 10.1016/j.biopsych.2009.02.009; Mameli M, 2009, NAT NEUROSCI, V12, P1036, DOI 10.1038/nn.2367; Marchant NJ, 2013, CURR OPIN NEUROBIOL, V23, P675, DOI 10.1016/j.conb.2013.01.003; Martin M, 2006, NAT NEUROSCI, V9, P868, DOI 10.1038/nn1713; McCutcheon JE, 2011, J NEUROSCI, V31, P14536, DOI 10.1523/JNEUROSCI.3625-11.2011; McCutcheon JE, 2011, J NEUROSCI, V31, P5737, DOI 10.1523/JNEUROSCI.0350-11.2011; Mu P, 2010, J NEUROSCI, V30, P3689, DOI 10.1523/JNEUROSCI.4063-09.2010; Otaka M, 2013, J NEUROSCI, V33, P6753, DOI 10.1523/JNEUROSCI.4577-12.2013; Pickens CL, 2011, TRENDS NEUROSCI, V34, P411, DOI 10.1016/j.tins.2011.06.001; Pitkanen A., 2000, AMYGDALA FUNCTIONAL; Purgianto A, 2013, NEUROPSYCHOPHARMACOL, V38, P1789, DOI 10.1038/npp.2013.78; Robinson TE, 2004, NEUROPHARMACOLOGY, V47, P33, DOI 10.1016/j.neuropharm.2004.06.025; Russo SJ, 2010, TRENDS NEUROSCI, V33, P267, DOI 10.1016/j.tins.2010.02.002; Setlow B, 2002, BEHAV NEUROSCI, V116, P267, DOI 10.1037//0735-7044.116.2.267; Shaham Y, 2003, PSYCHOPHARMACOLOGY, V168, P3, DOI 10.1007/s00213-002-1224-x; Sorge RE, 2005, PSYCHOPHARMACOLOGY, V183, P210, DOI 10.1007/s00213-005-0160-y; Stuber GD, 2011, NATURE, V475, P377, DOI 10.1038/nature10194; Suska A, 2013, P NATL ACAD SCI USA, V110, P713, DOI 10.1073/pnas.1206287110; Theberge FR, 2013, BIOL PSYCHIAT, V73, P729, DOI 10.1016/j.biopsych.2012.12.019; Thomas MJ, 2001, NAT NEUROSCI, V4, P1217, DOI 10.1038/nn757; Voorn P, 2004, TRENDS NEUROSCI, V27, P468, DOI 10.1016/j.tins.2004.06.006; Waites CL, 2005, ANNU REV NEUROSCI, V28, P251, DOI 10.1146/annurev.neuro.27.070203.144336; Wolf ME, 2012, FRONT MOL NEUROSCI, V5, DOI 10.3389/fnmol.2012.00072; Wolf ME, 2010, NEUROSCI BIOBEHAV R, V35, P185, DOI 10.1016/j.neubiorev.2010.01.013	50	207	207	0	28	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	NOV	2013	16	11					1644	1651		10.1038/nn.3533	http://dx.doi.org/10.1038/nn.3533			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	241YX	24077564	Green Accepted			2022-12-28	WOS:000326205700022
J	Li, YT; Ibrahim, LA; Liu, BH; Zhang, LI; Tao, HW				Li, Ya-tang; Ibrahim, Leena A.; Liu, Bao-hua; Zhang, Li I.; Tao, Huizhong Whit			Linear transformation of thalamocortical input by intracortical excitation	NATURE NEUROSCIENCE			English	Article							PRIMARY VISUAL-CORTEX; LATERAL GENICULATE-NUCLEUS; PRIMARY AUDITORY-CORTEX; ORIENTATION SELECTIVITY; SIMPLE CELLS; RECEPTIVE-FIELDS; RESPONSE PROPERTIES; GABA(B) RECEPTORS; THALAMIC INPUT; NEURONS	Neurons in thalamorecipient layers of sensory cortices integrate thalamocortical and intracortical inputs. Although we know that their functional properties can arise from the convergence of thalamic inputs, intracortical circuits could also be involved in thalamocortical transformations of sensory information. We silenced intracortical excitatory circuits with optogenetic activation of parvalbumin-positive inhibitory neurons in mouse primary visual cortex and compared visually evoked thalamocortical input with total excitation in the same layer 4 pyramidal neurons. We found that intracortical excitatory circuits preserved the orientation and direction tuning of thalamocortical excitation, with a linear amplification of thalamocortical signals of about threefold. The spatial receptive field of thalamocortical input was slightly elongated and was expanded by intracortical excitation in an approximately proportional manner. Thus, intracortical excitatory circuits faithfully reinforce the representation of thalamocortical information and may influence the size of the receptive field by recruiting additional inputs.	[Li, Ya-tang; Ibrahim, Leena A.; Liu, Bao-hua; Zhang, Li I.; Tao, Huizhong Whit] Univ So Calif, Keck Sch Med, Zilkha Neurogenet Inst, Los Angeles, CA 90033 USA; [Li, Ya-tang; Ibrahim, Leena A.; Liu, Bao-hua] Univ So Calif, Keck Sch Med, Grad Programs, Los Angeles, CA 90033 USA; [Zhang, Li I.] Univ So Calif, Keck Sch Med, Dept Physiol & Biophys, Los Angeles, CA 90033 USA; [Tao, Huizhong Whit] Univ So Calif, Keck Sch Med, Dept Cell & Neurobiol, Los Angeles, CA 90033 USA	University of Southern California; University of Southern California; University of Southern California; University of Southern California	Tao, HW (corresponding author), Univ So Calif, Keck Sch Med, Zilkha Neurogenet Inst, Los Angeles, CA 90033 USA.	htao@usc.edu	Li, Ya-tang/AAF-2573-2020; Tao, Huizhong W/HDM-9767-2022; Li, Ya-tang/A-9583-2011	Ibrahim, Leena Ali/0000-0001-8255-3423; Li, Ya-tang/0000-0003-2763-1534	US National Institutes of Health [EY019049, EY022478]; Kirchgessner Foundation; NATIONAL EYE INSTITUTE [R21EY022478, R01EY019049] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC008983] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Kirchgessner Foundation; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	We thank M. Scanziani for the help on viral injection setup. This work was supported by grants to H.W.T. from the US National Institutes of Health (EY019049 and EY022478) and the Kirchgessner Foundation.	Adorjan P, 1999, VISUAL NEUROSCI, V16, P303, DOI 10.1017/S0952523899162114; ALLMAN J, 1985, ANNU REV NEUROSCI, V8, P407, DOI 10.1146/annurev.ne.08.030185.002203; Atallah BV, 2012, NEURON, V73, P159, DOI 10.1016/j.neuron.2011.12.013; BENYISHAI R, 1995, P NATL ACAD SCI USA, V92, P3844, DOI 10.1073/pnas.92.9.3844; BenYishai R, 1997, J COMPUT NEUROSCI, V4, P57, DOI 10.1023/A:1008816611284; Bernstein JG, 2012, CURR OPIN NEUROBIOL, V22, P61, DOI 10.1016/j.conb.2011.10.023; Branco T, 2010, SCIENCE, V329, P1671, DOI 10.1126/science.1189664; Bruno RM, 2006, SCIENCE, V312, P1622, DOI 10.1126/science.1124593; Callaway EM, 1998, ANNU REV NEUROSCI, V21, P47, DOI 10.1146/annurev.neuro.21.1.47; Chisum HJ, 2003, J NEUROSCI, V23, P2947; Chung S, 1998, NEURON, V20, P1177, DOI 10.1016/S0896-6273(00)80498-5; Clopath C, 2010, NAT NEUROSCI, V13, P344, DOI 10.1038/nn.2479; Cruikshank SJ, 2010, NEURON, V65, P230, DOI 10.1016/j.neuron.2009.12.025; DOUGLAS RJ, 1991, J PHYSIOL-LONDON, V440, P735, DOI 10.1113/jphysiol.1991.sp018733; DOUGLAS RJ, 1995, SCIENCE, V269, P981, DOI 10.1126/science.7638624; Ferster D, 2000, ANNU REV NEUROSCI, V23, P441, DOI 10.1146/annurev.neuro.23.1.441; Ferster D, 1996, NATURE, V380, P249, DOI 10.1038/380249a0; GILBERT CD, 1990, VISION RES, V30, P1689, DOI 10.1016/0042-6989(90)90153-C; Grubb MS, 2003, J NEUROPHYSIOL, V90, P3594, DOI 10.1152/jn.00699.2003; HUBEL DH, 1962, J PHYSIOL-LONDON, V160, P106, DOI 10.1113/jphysiol.1962.sp006837; Jin JZ, 2011, NAT NEUROSCI, V14, P232, DOI 10.1038/nn.2729; Katzner S, 2011, J NEUROSCI, V31, P5931, DOI 10.1523/JNEUROSCI.5753-10.2011; Katzner S, 2009, NEURON, V61, P35, DOI 10.1016/j.neuron.2008.11.016; Kerlin AM, 2010, NEURON, V67, P858, DOI 10.1016/j.neuron.2010.08.002; Khibnik LA, 2010, NEURON, V66, P493, DOI 10.1016/j.neuron.2010.04.012; Ko H, 2013, NATURE, V496, P96, DOI 10.1038/nature12015; Ko H, 2011, NATURE, V473, P87, DOI 10.1038/nature09880; Lampl I, 2001, NEURON, V30, P263, DOI 10.1016/S0896-6273(01)00278-1; Lee SH, 2012, NATURE, V488, P379, DOI 10.1038/nature11312; Levitt JB, 1997, NATURE, V387, P73, DOI 10.1038/387073a0; Li YT, 2012, J NEUROSCI, V32, P16466, DOI 10.1523/JNEUROSCI.3221-12.2012; Li YT, 2012, J NEUROSCI, V32, P3981, DOI 10.1523/JNEUROSCI.5514-11.2012; Lin JY, 2009, BIOPHYS J, V96, P1803, DOI 10.1016/j.bpj.2008.11.034; Liu BH, 2007, NAT NEUROSCI, V10, P1594, DOI 10.1038/nn2012; Liu BH, 2011, NEURON, V71, P542, DOI 10.1016/j.neuron.2011.06.017; Liu BH, 2010, NAT NEUROSCI, V13, P89, DOI 10.1038/nn.2443; Liu BH, 2009, J NEUROSCI, V29, P10520, DOI 10.1523/JNEUROSCI.1915-09.2009; Ma WP, 2010, J NEUROSCI, V30, P14371, DOI 10.1523/JNEUROSCI.3248-10.2010; McLaughlin D, 2000, P NATL ACAD SCI USA, V97, P8087, DOI 10.1073/pnas.110135097; Niell CM, 2008, J NEUROSCI, V28, P7520, DOI 10.1523/JNEUROSCI.0623-08.2008; Ohki K, 2005, NATURE, V433, P597, DOI 10.1038/nature03274; Olsen SR, 2012, NATURE, V483, P47, DOI 10.1038/nature10835; Petreanu L, 2009, NATURE, V457, P1142, DOI 10.1038/nature07709; PFRIEGER FW, 1994, NEURON, V12, P97, DOI 10.1016/0896-6273(94)90155-4; Piscopo DM, 2013, J NEUROSCI, V33, P4642, DOI 10.1523/JNEUROSCI.5187-12.2013; Porter JT, 2004, J NEUROPHYSIOL, V92, P2762, DOI 10.1152/jn.00196.2004; Priebe NJ, 2008, NEURON, V57, P482, DOI 10.1016/j.neuron.2008.02.005; REID RC, 1995, NATURE, V378, P281, DOI 10.1038/378281a0; SOMERS DC, 1995, J NEUROSCI, V15, P5448; Tan AYY, 2011, J NEUROSCI, V31, P12339, DOI 10.1523/JNEUROSCI.2039-11.2011; Tan AYY, 2004, J NEUROPHYSIOL, V92, P630, DOI 10.1152/jn.01020.2003; Volgushev M, 1996, J PHYSIOL-LONDON, V496, P597, DOI 10.1113/jphysiol.1996.sp021711; Wehr M, 2003, NATURE, V426, P442, DOI 10.1038/nature02116; Wilson NR, 2012, NATURE, V488, P343, DOI 10.1038/nature11347; Wu GY, 2006, NEURON, V52, P705, DOI 10.1016/j.neuron.2006.10.009; Wu GYK, 2011, NEUROSCI BIOBEHAV R, V35, P2094, DOI 10.1016/j.neubiorev.2011.05.004; Yamauchi T, 2000, EUR J NEUROSCI, V12, P3433, DOI 10.1046/j.1460-9568.2000.00248.x; Zhang F, 2007, NAT REV NEUROSCI, V8, P577, DOI 10.1038/nrn2192; Zhang M, 2011, J NEUROSCI, V31, P5460, DOI 10.1523/JNEUROSCI.6220-10.2011	59	104	104	0	21	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	SEP	2013	16	9					1324	U216		10.1038/nn.3494	http://dx.doi.org/10.1038/nn.3494			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	207KN	23933750	Green Accepted			2022-12-28	WOS:000323597500025
J	Liston, C; Cichon, JM; Jeanneteau, F; Jia, ZP; Chao, MV; Gan, WB				Liston, Conor; Cichon, Joseph M.; Jeanneteau, Freddy; Jia, Zhengping; Chao, Moses V.; Gan, Wen-Biao			Circadian glucocorticoid oscillations promote learning-dependent synapse formation and maintenance	NATURE NEUROSCIENCE			English	Article							MEDIAL PREFRONTAL CORTEX; BASOLATERAL AMYGDALA; GENE-EXPRESSION; IN-VIVO; NORADRENERGIC ACTIVATION; PYRAMIDAL NEURONS; MEMORY STORAGE; STRESS; RECEPTOR; PLASTICITY	Excessive glucocorticoid exposure during chronic stress causes synapse loss and learning impairment. Under normal physiological conditions, glucocorticoid activity oscillates in synchrony with the circadian rhythm. Whether and how endogenous glucocorticoid oscillations modulate synaptic plasticity and learning is unknown. Here we show that circadian glucocorticoid peaks promote postsynaptic dendritic spine formation in the mouse cortex after motor skill learning, whereas troughs are required for stabilizing newly formed spines that are important for long-term memory retention. Conversely, chronic and excessive exposure to glucocorticoids eliminates learning-associated new spines and disrupts previously acquired memories. Furthermore, we show that glucocorticoids promote rapid spine formation through a non-transcriptional mechanism by means of the LIM kinase-cofilin pathway and increase spine elimination through transcriptional mechanisms involving mineralocorticoid receptor activation. Together, these findings indicate that tightly regulated circadian glucocorticoid oscillations are important for learning-dependent synaptic formation and maintenance. They also delineate a new signaling mechanism underlying these effects.	[Liston, Conor; Cichon, Joseph M.; Chao, Moses V.; Gan, Wen-Biao] NYU, Sch Med, Mol Neurobiol Program, Dept Physiol & Neurosci,Skirball Inst, New York, NY 10012 USA; [Liston, Conor] Stanford Univ, Sch Med, Dept Psychiat & Behav Sci, Stanford, CA 94305 USA; [Jeanneteau, Freddy] CNRS, INSERM, Inst Genom Fonct, UMR 5203,U661, Montpellier, France; [Jia, Zhengping] Hosp Sick Children, Program Brain & Behav, Toronto, ON M5G 1X8, Canada	New York University; Stanford University; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids)	Liston, C (corresponding author), NYU, Sch Med, Mol Neurobiol Program, Dept Physiol & Neurosci,Skirball Inst, New York, NY 10012 USA.	cliston@stanford.edu; gan@saturn.med.nyu.edu	Jeanneteau, Freddy/AAC-7052-2021; Jia, zhengping/AAZ-4190-2021; , Conor Liston/GQH-8931-2022	Chao, Moses/0000-0002-6969-3744; Jeanneteau, freddy/0000-0002-9606-2892	US National Institutes of Health [R01 NS047325, R01MH085324, MH086651, NS21072]; US National Institute of Mental Health [K99 MH097822]; DeWitt Wallace Reader's Digest Foundation at Weill Cornell Medical College; NATIONAL INSTITUTE OF MENTAL HEALTH [K99MH097822, R01MH085324, R00MH097822, R01MH086651] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS047325, R56NS021072, R01NS021072] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); DeWitt Wallace Reader's Digest Foundation at Weill Cornell Medical College; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank B.S. McEwen and Gan laboratory members for critical comments on this manuscript. This work was supported by grants from the US National Institutes of Health (R01 NS047325 and a subcontract of R01MH085324) to W.-B.G.C.L. is supported by grants from the US National Institute of Mental Health (K99 MH097822) and the DeWitt Wallace Reader's Digest Foundation at Weill Cornell Medical College. F.J. and M.V.C. are supported by grants from the US National Institutes of Health (MH086651 and NS21072).	Atkinson G, 1996, SPORTS MED, V21, P292, DOI 10.2165/00007256-199621040-00005; BAILEY CH, 1993, ANNU REV PHYSIOL, V55, P397, DOI 10.1146/annurev.ph.55.030193.002145; Bangasser DA, 2007, NAT NEUROSCI, V10, P1401, DOI 10.1038/nn1973; Bellugi U, 1999, TRENDS NEUROSCI, V22, P197, DOI 10.1016/S0166-2236(99)01397-1; Binder DK, 2004, J NEUROSCI, V24, P8049, DOI 10.1523/JNEUROSCI.2294-04.2004; Buffelli M, 2003, NATURE, V424, P430, DOI 10.1038/nature01844; Buitrago MM, 2004, NEUROBIOL LEARN MEM, V81, P211, DOI 10.1016/j.nlm.2004.01.001; Campolongo P, 2009, P NATL ACAD SCI USA, V106, P4888, DOI 10.1073/pnas.0900835106; Chaudhury D, 2002, BEHAV BRAIN RES, V133, P95, DOI 10.1016/S0166-4328(01)00471-5; Colman H, 1997, SCIENCE, V275, P356, DOI 10.1126/science.275.5298.356; Dailey ME, 1996, J NEUROSCI, V16, P2983; Datson NA, 2001, EUR J NEUROSCI, V14, P675, DOI 10.1046/j.0953-816x.2001.01685.x; De Kloet ER, 1998, ENDOCR REV, V19, P269, DOI 10.1210/er.19.3.269; de Quervain DJF, 1998, NATURE, V394, P787, DOI 10.1038/29542; Di S, 2003, J NEUROSCI, V23, P4850; Dias-Ferreira E, 2009, SCIENCE, V325, P621, DOI 10.1126/science.1171203; Engert F, 1999, NATURE, V399, P66, DOI 10.1038/19978; Feng GP, 2000, NEURON, V28, P41, DOI 10.1016/S0896-6273(00)00084-2; Flavell SW, 2008, ANNU REV NEUROSCI, V31, P563, DOI 10.1146/annurev.neuro.31.060407.125631; Flavell SW, 2006, SCIENCE, V311, P1008, DOI 10.1126/science.1122511; Gu JP, 2010, NAT NEUROSCI, V13, P1208, DOI 10.1038/nn.2634; Guan JS, 2009, NATURE, V459, P55, DOI 10.1038/nature07925; Hill MN, 2011, J NEUROSCI, V31, P10506, DOI 10.1523/JNEUROSCI.0496-11.2011; Holsboer F, 2000, NEUROPSYCHOPHARMACOL, V23, P477, DOI 10.1016/S0893-133X(00)00159-7; Hubener M, 2010, NEURON, V67, P363, DOI 10.1016/j.neuron.2010.06.033; Jeanneteau F, 2008, P NATL ACAD SCI USA, V105, P4862, DOI 10.1073/pnas.0709102105; Jeanneteau F, 2010, NAT NEUROSCI, V13, P1373, DOI 10.1038/nn.2655; Jiang M, 2006, NAT PROTOC, V1, P695, DOI 10.1038/nprot.2006.86; Karssen AM, 2005, ENDOCRINOLOGY, V146, P5587, DOI 10.1210/en.2005-0501; Karst H, 2005, P NATL ACAD SCI USA, V102, P19204, DOI 10.1073/pnas.0507572102; Knott GW, 2006, NAT NEUROSCI, V9, P1117, DOI 10.1038/nn1747; Lai CSW, 2012, NATURE, V483, P87, DOI 10.1038/nature10792; LI CX, 1991, CAN J NEUROL SCI, V18, P28, DOI 10.1017/S0317167100031267; Liston C, 2006, J NEUROSCI, V26, P7870, DOI 10.1523/JNEUROSCI.1184-06.2006; Liston C, 2011, P NATL ACAD SCI USA, V108, P16074, DOI 10.1073/pnas.1110444108; Lohmann C, 2008, NEURON, V59, P253, DOI 10.1016/j.neuron.2008.05.025; Losel R, 2003, NAT REV MOL CELL BIO, V4, P46, DOI 10.1038/nrm1009; Lupien SJ, 1998, NAT NEUROSCI, V1, P69, DOI 10.1038/271; McEwen BS, 1998, NEW ENGL J MED, V338, P171, DOI 10.1056/NEJM199801153380307; McNally JG, 2000, SCIENCE, V287, P1262, DOI 10.1126/science.287.5456.1262; Meng YH, 2002, NEURON, V35, P121, DOI 10.1016/S0896-6273(02)00758-4; Miller NL, 2012, SLEEP, V35, P1123, DOI 10.5665/sleep.2002; Morsink MC, 2006, J NEUROENDOCRINOL, V18, P239, DOI 10.1111/j.1365-2826.2006.01413.x; Popoli M, 2012, NAT REV NEUROSCI, V13, P22, DOI 10.1038/nrn3138; Quirarte GL, 1997, P NATL ACAD SCI USA, V94, P14048, DOI 10.1073/pnas.94.25.14048; Radley JJ, 2006, CEREB CORTEX, V16, P313, DOI 10.1093/cercor/bhi104; Renthal W, 2007, NEURON, V56, P517, DOI 10.1016/j.neuron.2007.09.032; REUL JMHM, 1985, ENDOCRINOLOGY, V117, P2505, DOI 10.1210/endo-117-6-2505; Roozendaal B, 2006, P NATL ACAD SCI USA, V103, P6741, DOI 10.1073/pnas.0601874103; Ruby NF, 2008, P NATL ACAD SCI USA, V105, P15593, DOI 10.1073/pnas.0808259105; SHORS TJ, 1992, SCIENCE, V257, P537, DOI 10.1126/science.1636089; Stavreva DA, 2009, NAT CELL BIOL, V11, P1093, DOI 10.1038/ncb1922; Tsankova NM, 2006, NAT NEUROSCI, V9, P519, DOI 10.1038/nn1659; WATANABE Y, 1992, BRAIN RES, V588, P341, DOI 10.1016/0006-8993(92)91597-8; Wellman CL, 2001, J NEUROBIOL, V49, P245, DOI 10.1002/neu.1079; Wright KP, 2006, J COGNITIVE NEUROSCI, V18, P508, DOI 10.1162/jocn.2006.18.4.508; Xu TH, 2009, NATURE, V462, P915, DOI 10.1038/nature08389; Yang G, 2010, NAT PROTOC, V5, P201, DOI 10.1038/nprot.2009.222; Yang G, 2009, NATURE, V462, P920, DOI 10.1038/nature08577; Yuen EY, 2009, P NATL ACAD SCI USA, V106, P14075, DOI 10.1073/pnas.0906791106	60	240	242	1	60	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JUN	2013	16	6					698	+		10.1038/nn.3387	http://dx.doi.org/10.1038/nn.3387			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	152DE	23624512	Green Accepted			2022-12-28	WOS:000319509600011
J	Inoue, W; Baimoukhametova, DV; Fuzesi, T; Wamsteeker Cusulin, JI; Koblinger, K; Whelan, PJ; Pittman, QJ; Bains, JS				Inoue, Wataru; Baimoukhametova, Dinara V.; Fuezesi, Tamas; Wamsteeker Cusulin, Jaclyn I.; Koblinger, Kathrin; Whelan, Patrick J.; Pittman, Quentin J.; Bains, Jaideep S.			Noradrenaline is a stress-associated metaplastic signal at GABA synapses	NATURE NEUROSCIENCE			English	Article							LONG-TERM POTENTIATION; METABOTROPIC GLUTAMATE-RECEPTOR; HYPOTHALAMIC PARAVENTRICULAR NUCLEUS; BETA-ADRENERGIC-RECEPTORS; PARVOCELLULAR NEURONS; PROTEIN-KINASE; PHYSIOLOGICAL-RESPONSE; GENE-EXPRESSION; PLASTICITY; ACTIVATION	Exposure to a stressor sensitizes behavioral and hormonal responses to future stressors. Stress-associated release of noradrenaline enhances the capacity of central synapses to show plasticity (metaplasticity). We found noradrenaline-dependent metaplasticity at GABA synapses in the paraventricular nucleus of the hypothalamus in rat and mouse that controls the hypothalamic-pituitary-adrenal axis. In vivo stress exposure was required for these synapses to undergo activity-dependent long-term potentiation (LTPGABA). The activation of beta-adrenergic receptors during stress functionally upregulated metabotropic glutamate receptor 1 (mGluR1), allowing for mGluR1-dependent LTPGABA during afferent bursts. LTPGABA was expressed postsynaptically and manifested as the emergence of new functional synapses. Our findings provide, to the best of our knowledge, the first demonstration that noradrenaline release during an in vivo challenge alters information storage capacity at GABA synapses. Because these GABA synapses become excitatory following acute stress, this metaplasticity may contribute to neuroendocrine sensitization to stress.	[Inoue, Wataru; Baimoukhametova, Dinara V.; Fuezesi, Tamas; Wamsteeker Cusulin, Jaclyn I.; Koblinger, Kathrin; Whelan, Patrick J.; Pittman, Quentin J.; Bains, Jaideep S.] Hotchkiss Brain Inst, Calgary, AB, Canada; [Inoue, Wataru; Baimoukhametova, Dinara V.; Fuezesi, Tamas; Wamsteeker Cusulin, Jaclyn I.; Koblinger, Kathrin; Whelan, Patrick J.; Pittman, Quentin J.; Bains, Jaideep S.] Univ Calgary, Dept Physiol & Pharmacol, Calgary, AB, Canada	University of Calgary	Bains, JS (corresponding author), Hotchkiss Brain Inst, Calgary, AB, Canada.	jsbains@ucalgary.ca	Inoue, Wataru/M-2163-2015	Inoue, Wataru/0000-0002-2438-5123; Whelan, Patrick/0000-0002-1234-5415; Bains, Jaideep/0000-0002-3634-6463; Pittman, Quentin/0000-0003-0984-7665	Alberta Innovates-Health Solutions (AI-HS); Hotchkiss Brain Institute; Canadian Institute for Health Research; Alberta Innovates [201100359] Funding Source: researchfish	Alberta Innovates-Health Solutions (AI-HS); Hotchkiss Brain Institute; Canadian Institute for Health Research(Canadian Institutes of Health Research (CIHR)); Alberta Innovates	We thank members of the Bains laboratory for comments and discussion regarding the manuscript and C. Sank for technical assistance. We are grateful to the Hotchkiss Brain Institute for providing optogenetics core resources. AAV vectors carrying the ChR2 gene were developed by K. Deisseroth (Stanford University) and distributed by Addgene. W.I. and T.F. are supported by a postdoctoral fellowship, and J.I.W.C. and K.K. by a PhD scholarship from the Alberta Innovates-Health Solutions (AI-HS). W.I., K.K. and J.I.W.C. also received fellowship and/or scholarship support from the Hotchkiss Brain Institute. J.S.B. and P.J.W. are AI-HS Senior Scholars. Q.J.P. is an AI-HS Scientist. This work was funded by operating grants from the Canadian Institute for Health Research (J.S.B., P.J.W. and Q.J.P.).	Abraham WC, 2008, NAT REV NEUROSCI, V9, P387, DOI 10.1038/nrn2356; Armario A, 2004, STRESS, V7, P157, DOI 10.1080/10253890400010721; Berridge CW, 2003, BRAIN RES REV, V42, P33, DOI 10.1016/S0165-0173(03)00143-7; Chaouloff F, 2007, J NEUROSCI, V27, P7130, DOI 10.1523/JNEUROSCI.1150-07.2007; Crosby KM, 2011, NEURON, V71, P529, DOI 10.1016/j.neuron.2011.06.006; Cullinan WE, 2008, BRAIN STRUCT FUNCT, V213, P63, DOI 10.1007/s00429-008-0192-2; Daftary SS, 2000, NEUROSCIENCE, V96, P743, DOI 10.1016/S0306-4522(00)00003-8; Day HEW, 1999, J NEUROSCI, V19, P10098; Dobie FA, 2011, J NEUROSCI, V31, P10481, DOI 10.1523/JNEUROSCI.6023-10.2011; Flak JN, 2009, J COMP NEUROL, V517, P156, DOI 10.1002/cne.22142; Hewitt SA, 2009, NAT NEUROSCI, V12, P438, DOI 10.1038/nn.2274; Huang YY, 2000, J NEUROSCI, V20, P6317, DOI 10.1523/JNEUROSCI.20-17-06317.2000; ITOI K, 1994, ENDOCRINOLOGY, V135, P2177, DOI 10.1210/en.135.5.2177; Joels M, 2009, NAT REV NEUROSCI, V10, P459, DOI 10.1038/nrn2632; Kano M, 1996, P NATL ACAD SCI USA, V93, P13351, DOI 10.1073/pnas.93.23.13351; Kocsis K, 1998, NEUROREPORT, V9, P4029, DOI 10.1097/00001756-199812210-00008; KORN H, 1991, TRENDS NEUROSCI, V14, P439, DOI 10.1016/0166-2236(91)90042-S; Kuzmiski JB, 2010, NAT NEUROSCI, V13, P1257, DOI 10.1038/nn.2629; Kwon MS, 2006, NEUROSCIENCE, V142, P1281, DOI 10.1016/j.neuroscience.2006.07.027; Luther JA, 2002, J NEUROENDOCRINOL, V14, P929, DOI 10.1046/j.1365-2826.2002.00867.x; Marsden KC, 2007, J NEUROSCI, V27, P14326, DOI 10.1523/JNEUROSCI.4433-07.2007; Marsden KC, 2010, P NATL ACAD SCI USA, V107, P20559, DOI 10.1073/pnas.1010346107; Miklos IH, 2002, NEUROSCIENCE, V113, P581, DOI 10.1016/S0306-4522(02)00147-1; Miklos IH, 2012, BIOL PSYCHIAT, V71, P301, DOI 10.1016/j.biopsych.2011.10.027; Mundell SJ, 2004, MOL PHARMACOL, V65, P1507, DOI 10.1124/mol.65.6.1507; Nicoll RA, 1999, ANN NY ACAD SCI, V868, P515, DOI 10.1111/j.1749-6632.1999.tb11320.x; Oliet SHR, 1996, SCIENCE, V271, P1294, DOI 10.1126/science.271.5253.1294; Ouardouz M, 2000, J NEUROPHYSIOL, V84, P1414, DOI 10.1152/jn.2000.84.3.1414; Pacak K, 2001, ENDOCR REV, V22, P502, DOI 10.1210/er.22.4.502; Pacak K, 1995, ANN NY ACAD SCI, V771, P115, DOI 10.1111/j.1749-6632.1995.tb44675.x; Patenaude C, 2003, J PHYSIOL-LONDON, V553, P155, DOI 10.1113/jphysiol.2003.049015; SAPHIER D, 1991, BRAIN RES BULL, V26, P863, DOI 10.1016/0361-9230(91)90250-N; Sarkar J, 2011, J NEUROSCI, V31, P18198, DOI 10.1523/JNEUROSCI.2560-11.2011; Savitt JM, 2005, J NEUROSCI, V25, P6721, DOI 10.1523/JNEUROSCI.0760-05.2005; SAWCHENKO PE, 1982, BRAIN RES REV, V4, P275, DOI 10.1016/0165-0173(82)90010-8; Seidenbecher T, 1997, P NATL ACAD SCI USA, V94, P1494, DOI 10.1073/pnas.94.4.1494; Strawn JR, 2008, DEPRESS ANXIETY, V25, P260, DOI 10.1002/da.20292; Sugiyama Y, 2008, EUR J NEUROSCI, V27, P884, DOI 10.1111/j.1460-9568.2008.06063.x; TAKANO T, 1989, BRAIN RES, V499, P174, DOI 10.1016/0006-8993(89)91149-9; Tenorio G, 2010, LEARN MEMORY, V17, P627, DOI 10.1101/lm.1974510; Thomas MJ, 1996, NEURON, V17, P475, DOI 10.1016/S0896-6273(00)80179-8; Tyagarajan SK, 2011, P NATL ACAD SCI USA, V108, P379, DOI 10.1073/pnas.1011824108; Ulrich-Lai YM, 2009, NAT REV NEUROSCI, V10, P397, DOI 10.1038/nrn2647; Verkuyl JM, 2005, EUR J NEUROSCI, V21, P113, DOI 10.1111/j.1460-9568.2004.03846.x; Verkuyl JM, 2004, EUR J NEUROSCI, V20, P1665, DOI 10.1111/j.1460-9568.2004.03568.x; Vithlani M, 2011, PHYSIOL REV, V91, P1009, DOI 10.1152/physrev.00015.2010; Wamsteeker Cusulin JI, 2013, NAT NEUROSCI, V16, P596, DOI 10.1038/nn.3374; Wamsteeker JI, 2010, J NEUROSCI, V30, P11188, DOI 10.1523/JNEUROSCI.1046-10.2010; Wierenga CJ, 2008, NAT NEUROSCI, V11, P1044, DOI 10.1038/nn.2180; Zhang F, 2010, NAT PROTOC, V5, P439, DOI 10.1038/nprot.2009.226; Zhao JP, 2006, J NEUROSCI, V26, P12647, DOI 10.1523/JNEUROSCI.3678-06.2006	51	68	68	1	34	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAY	2013	16	5					605	+		10.1038/nn.3373	http://dx.doi.org/10.1038/nn.3373			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	131WT	23563580	Green Accepted			2022-12-28	WOS:000318029300017
J	Dillman, AA; Hauser, DN; Gibbs, JR; Nalls, MA; McCoy, MK; Rudenko, IN; Galter, D; Cookson, MR				Dillman, Allissa A.; Hauser, David N.; Gibbs, J. Raphael; Nalls, Michael A.; McCoy, Melissa K.; Rudenko, Iakov N.; Galter, Dagmar; Cookson, Mark R.			mRNA expression, splicing and editing in the embryonic and adult mouse cerebral cortex	NATURE NEUROSCIENCE			English	Article							GLOBAL REGULATION; GENOME; POINT	The complexity of the adult brain is a result of both developmental processes and experience-dependent circuit formation. One way to look at the differences between embryonic and adult brain is to examine gene expression. Previous studies have used microarrays to address this in a global manner. However, the transcriptome is more complex than gene expression levels alone, as alternative splicing and RNA editing generate a diverse set of mature transcripts. Here we report a high-resolution transcriptome data set of mouse cerebral cortex at embryonic and adult stages using RNA sequencing (RNA-Seq). We found many differences in gene expression, splicing and RNA editing between embryonic and adult cerebral cortex. Each data set was validated technically and biologically, and in each case we found our RNA-Seq observations to have predictive validity. We provide this data set and analysis as a resource for understanding gene expression in the embryonic and adult cerebral cortex.	[Dillman, Allissa A.; Hauser, David N.; McCoy, Melissa K.; Rudenko, Iakov N.; Cookson, Mark R.] NIA, Cell Biol & Gene Express Sect, Neurogenet Lab, NIH, Bethesda, MD 20892 USA; [Dillman, Allissa A.; Galter, Dagmar] Karolinska Inst, Dept Neurosci, Stockholm, Sweden; [Hauser, David N.] Brown Univ, Natl Inst Hlth Grad Partnership Program, Dept Neurosci, Providence, RI 02912 USA; [Gibbs, J. Raphael] NIA, Computat Biol Unit, Neurogenet Lab, NIH, Bethesda, MD 20892 USA; [Gibbs, J. Raphael] UCL, Inst Neurol, Reta Lila Weston Labs, London, England; [Gibbs, J. Raphael] UCL, Inst Neurol, Dept Mol Neurosci, London, England; [Nalls, Michael A.] NIA, Mol Genet Sect, Neurogenet Lab, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); Karolinska Institutet; Brown University; National Institutes of Health (NIH) - USA; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); University of London; University College London; University of London; University College London; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA)	Cookson, MR (corresponding author), NIA, Cell Biol & Gene Express Sect, Neurogenet Lab, NIH, Bethesda, MD 20892 USA.	cookson@mail.nih.gov	Cookson, Mark/AAW-2516-2021; Hauser, David/AAJ-1536-2020; Galter, Dagmar/C-4826-2011; Gibbs, J. Raphael/A-3984-2010; Hauser, David/I-4933-2012	Cookson, Mark/0000-0002-1058-3831; Galter, Dagmar/0000-0001-6485-6244; Gibbs, J. Raphael/0000-0002-6985-0658; Hauser, David/0000-0002-9500-5255	US National Institutes of Health, National Institute on Aging [AG000947]; Swedish Research Council; Swedish Brain Power; NATIONAL INSTITUTE ON AGING [ZIAAG000947, K01AG000947] Funding Source: NIH RePORTER	US National Institutes of Health, National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Brain Power; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The authors would like to thank E. Lindquist for excellent technical assistance. We would also like to thank M. Do for assistance with cloning experiments. This research was supported in part by the Intramural Research Program of the US National Institutes of Health, National Institute on Aging (project AG000947) and by the Swedish Research Council and Swedish Brain Power.	Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Athanasiadis A, 2004, PLOS BIOL, V2, P2144, DOI 10.1371/journal.pbio.0020391; Blanc V, 2010, WIRES SYST BIOL MED, V2, P594, DOI 10.1002/wsbm.82; Bland CS, 2010, NUCLEIC ACIDS RES, V38, P7651, DOI 10.1093/nar/gkq614; Colantuoni C, 2011, NATURE, V478, P519, DOI 10.1038/nature10524; DeCerbo J, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-4-216; Gu TJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033720; Higuchi M, 2000, NATURE, V406, P78, DOI 10.1038/35017558; Hogg M, 2011, ADV GENET, V73, P87, DOI 10.1016/B978-0-12-380860-8.00003-3; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Innocenti GM, 2005, NAT REV NEUROSCI, V6, P955, DOI 10.1038/nrn1790; Itoh K, 2002, BRAIN RES PROTOC, V10, P23; Kagami Yoshihiro, 2001, Gene Expression Patterns, V1, P39, DOI 10.1016/S1567-133X(01)00007-2; Kalsotra A, 2011, NAT REV GENET, V12, P715, DOI 10.1038/nrg3052; Kang HJ, 2011, NATURE, V478, P483, DOI 10.1038/nature10523; Keane TM, 2011, NATURE, V477, P289, DOI 10.1038/nature10413; Li MY, 2011, SCIENCE, V333, P53, DOI 10.1126/science.1207018; Li Q, 2007, NAT REV NEUROSCI, V8, P819, DOI 10.1038/nrn2237; Licatalosi DD, 2010, NAT REV GENET, V11, P75, DOI 10.1038/nrg2673; Matsuki T, 2005, MOL BRAIN RES, V136, P231, DOI 10.1016/j.molbrainres.2005.02.008; Mckee AE, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-8-r159; McMillan P, 2008, J COMP NEUROL, V511, P788, DOI 10.1002/cne.21867; Mody M, 2001, P NATL ACAD SCI USA, V98, P8862, DOI 10.1073/pnas.141244998; Neeman Y, 2006, RNA, V12, P1802, DOI 10.1261/rna.165106; Nishikura K, 2010, ANNU REV BIOCHEM, V79, P321, DOI 10.1146/annurev-biochem-060208-105251; Peng ZY, 2012, NAT BIOTECHNOL, V30, P253, DOI 10.1038/nbt.2122; Pickrell JK, 2012, SCIENCE, V335, DOI 10.1126/science.1210484; Price DJ, 2006, EUR J NEUROSCI, V23, P910, DOI 10.1111/j.1460-9568.2006.04620.x; Ramskold D, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000598; Rosenthal JJC, 2012, NEURON, V74, P432, DOI 10.1016/j.neuron.2012.04.010; Rueter SM, 1999, NATURE, V399, P75, DOI 10.1038/19992; Semeralul MO, 2006, J NEUROBIOL, V66, P1646, DOI 10.1002/neu.20302; Serra MJ, 2004, NUCLEIC ACIDS RES, V32, P1824, DOI 10.1093/nar/gkh501; Stefl R, 2005, RNA, V11, P592, DOI 10.1261/rna.7276805; t Hoen PAC, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn705; ULLRICH B, 1995, NEURON, V14, P497, DOI 10.1016/0896-6273(95)90306-2; Wahlstedt H, 2009, GENOME RES, V19, P978, DOI 10.1101/gr.089409.108; Wojtowicz WM, 2004, CELL, V118, P619, DOI 10.1016/j.cell.2004.08.021; Zhang Z, 2001, CELL, V106, P465, DOI 10.1016/S0092-8674(01)00466-4	40	104	106	2	37	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	APR	2013	16	4					499	U178		10.1038/nn.3332	http://dx.doi.org/10.1038/nn.3332			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	114EM	23416452	Green Accepted			2022-12-28	WOS:000316723700022
J	Watrous, AJ; Tandon, N; Conner, CR; Pieters, T; Ekstrom, AD				Watrous, Andrew J.; Tandon, Nitin; Conner, Chris R.; Pieters, Thomas; Ekstrom, Arne D.			Frequency-specific network connectivity increases underlie accurate spatiotemporal memory retrieval	NATURE NEUROSCIENCE			English	Article							MEDIAL TEMPORAL-LOBE; COMPLEMENTARY-LEARNING-SYSTEMS; HUMAN NEOCORTICAL OSCILLATIONS; THETA OSCILLATIONS; PARIETAL CORTEX; PREFRONTAL CORTEX; EPISODIC MEMORY; WORKING-MEMORY; PHASE-LOCKING; HIPPOCAMPAL	The medial temporal lobes, prefrontal cortex and parts of parietal cortex form the neural underpinnings of episodic memory, which includes remembering both where and when an event occurred. However, the manner in which these three regions interact during retrieval of spatial and temporal context remains untested. We employed simultaneous electrocorticographical recordings across multilobular regions in patients undergoing seizure monitoring while they retrieved spatial and temporal context associated with an episode, and we used phase synchronization as a measure of network connectivity. Successful memory retrieval was characterized by greater global connectivity compared with incorrect retrieval, with the medial temporal lobe acting as a hub for these interactions. Spatial versus temporal context retrieval resulted in prominent differences in both the spectral and temporal patterns of network interactions. These results emphasize dynamic network interactions as being central to episodic memory retrieval, providing insight into how multiple contexts underlying a single event can be recreated in the same network.	[Watrous, Andrew J.; Ekstrom, Arne D.] Univ Calif Davis, Neurosci Grad Grp, Davis, CA 95616 USA; [Watrous, Andrew J.; Ekstrom, Arne D.] Univ Calif, Ctr Neurosci, Davis, CA USA; [Tandon, Nitin; Conner, Chris R.; Pieters, Thomas] Univ Texas Houston, Sch Med, Dept Neurosurg, Houston, TX USA; [Tandon, Nitin] Memorial Hermann Hosp, Texas Med Ctr, Houston, TX USA; [Ekstrom, Arne D.] Univ Calif, Dept Psychol, Davis, CA USA	University of California System; University of California Davis; University of California System; University of California Davis; University of Texas System; University of Texas Health Science Center Houston; Baylor College of Medicine; University of Texas System; University of Texas Health Science Center Houston; University of California System; University of California Davis	Ekstrom, AD (corresponding author), Univ Calif Davis, Neurosci Grad Grp, Davis, CA 95616 USA.	adekstrom@ucdavis.edu	Ekstrom, Arne/A-1329-2013	Ekstrom, Arne/0000-0002-6812-2368; Tandon, Nitin/0000-0002-2752-2365; Conner, Christopher R/0000-0003-0176-9025	Sloan Foundation; Hellman Young Investigator Award; National Institute of Neurological Disorders and Stroke [RO1NS076856]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS076856] Funding Source: NIH RePORTER	Sloan Foundation(Alfred P. Sloan Foundation); Hellman Young Investigator Award; National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank C. Ranganath and A. Yonelinas, as well as members of their laboratories, for helpful comments on this manuscript. This work was supported by the Sloan Foundation, a Hellman Young Investigator Award and National Institute of Neurological Disorders and Stroke grant RO1NS076856.	Anderson KL, 2010, CEREB CORTEX, V20, P1604, DOI 10.1093/cercor/bhp223; Benchenane K, 2010, NEURON, V66, P921, DOI 10.1016/j.neuron.2010.05.013; Blumenfeld RS, 2007, NEUROSCIENTIST, V13, P280, DOI 10.1177/1073858407299290; Bullmore ET, 2009, NAT REV NEUROSCI, V10, P186, DOI 10.1038/nrn2575; Buzsaki G, 1996, CEREB CORTEX, V6, P81, DOI 10.1093/cercor/6.2.81; Canolty RT, 2010, P NATL ACAD SCI USA, V107, P17356, DOI 10.1073/pnas.1008306107; Donner TH, 2011, TRENDS COGN SCI, V15, P191, DOI 10.1016/j.tics.2011.03.007; Duarte A, 2005, J NEUROSCI, V25, P8333, DOI 10.1523/JNEUROSCI.1392-05.2005; Eichenbaum H, 2007, ANNU REV NEUROSCI, V30, P123, DOI 10.1146/annurev.neuro.30.051606.094328; Eichenbaum H, 2000, NAT REV NEUROSCI, V1, P41, DOI 10.1038/35036213; Ekstrom AD, 2011, NEUROIMAGE, V56, P1803, DOI 10.1016/j.neuroimage.2011.02.033; Fell J, 2011, NAT REV NEUROSCI, V12, P105, DOI 10.1038/nrn2979; Hipp JF, 2012, NAT NEUROSCI, V15, P884, DOI 10.1038/nn.3101; Howard MW, 2002, J MATH PSYCHOL, V46, P269, DOI 10.1006/jmps.2001.1388; Hutchinson JB, 2009, LEARN MEMORY, V16, P343, DOI 10.1101/lm.919109; Lavenex P, 2000, HIPPOCAMPUS, V10, P420, DOI 10.1002/1098-1063(2000)10:4<420::AID-HIPO8>3.3.CO;2-X; Lega BC, 2012, HIPPOCAMPUS, V22, P748, DOI 10.1002/hipo.20937; Libby LA, 2012, J NEUROSCI, V32, P6550, DOI 10.1523/JNEUROSCI.3711-11.2012; Maris E, 2011, NEUROIMAGE, V54, P836, DOI 10.1016/j.neuroimage.2010.09.029; Marshuetz C, 2006, NEUROSCIENCE, V139, P311, DOI 10.1016/j.neuroscience.2005.04.071; MCCLELLAND JL, 1995, PSYCHOL REV, V102, P419, DOI 10.1037/0033-295X.102.3.419; Mitchell KJ, 2009, PSYCHOL BULL, V135, P638, DOI 10.1037/a0015849; Mormann F, 2008, FRONT HUM NEUROSCI, V2, DOI 10.3389/neuro.09.003.2008; Nadel L, 1997, CURR OPIN NEUROBIOL, V7, P217, DOI 10.1016/S0959-4388(97)80010-4; Norman KA, 2003, PSYCHOL REV, V110, P611, DOI 10.1037/0033-295X.110.4.611; Ranganath C, 2004, NEUROPSYCHOLOGIA, V42, P2, DOI 10.1016/j.neuropsychologia.2003.07.006; Rizzuto DS, 2006, NEUROIMAGE, V31, P1352, DOI 10.1016/j.neuroimage.2006.01.009; Rizzuto DS, 2003, P NATL ACAD SCI USA, V100, P7931, DOI 10.1073/pnas.0732061100; Rutishauser U, 2010, NATURE, V464, P903, DOI 10.1038/nature08860; SCOVILLE WB, 1957, J NEUROL NEUROSUR PS, V20, P11, DOI 10.1136/jnnp.20.1.11; Siapas AG, 2005, NEURON, V46, P141, DOI 10.1016/j.neuron.2005.02.028; Siegel M, 2012, NAT REV NEUROSCI, V13, P121, DOI 10.1038/nrn3137; Simons JS, 2003, NAT REV NEUROSCI, V4, P637, DOI 10.1038/nrn1178; Sirota A, 2008, NEURON, V60, P683, DOI 10.1016/j.neuron.2008.09.014; Spaniol J, 2009, NEUROPSYCHOLOGIA, V47, P1765, DOI 10.1016/j.neuropsychologia.2009.02.028; Spiers HJ, 2001, BRAIN, V124, P2476, DOI 10.1093/brain/124.12.2476; Squire LR, 2004, ANNU REV NEUROSCI, V27, P279, DOI 10.1146/annurev.neuro.27.070203.144130; TEYLER TJ, 1986, BEHAV NEUROSCI, V100, P147, DOI 10.1037/0735-7044.100.2.147; TOLMAN EC, 1948, PSYCHOL REV, V55, P189, DOI 10.1037/h0061626; Tulving E, 2002, ANNU REV PSYCHOL, V53, P1, DOI 10.1146/annurev.psych.53.100901.135114; van der Meij R, 2012, J NEUROSCI, V32, P111, DOI 10.1523/JNEUROSCI.4816-11.2012; VarghaKhadem F, 1997, SCIENCE, V277, P376, DOI 10.1126/science.277.5324.376; Vilberg KL, 2008, NEUROPSYCHOLOGIA, V46, P1787, DOI 10.1016/j.neuropsychologia.2008.01.004; Watrous AJ, 2011, J NEUROPHYSIOL, V105, P1747, DOI 10.1152/jn.00921.2010; Womelsdorf T, 2007, SCIENCE, V316, P1609, DOI [10.1126/science.1139597, 10.1126/science.1139178]; Yonelinas AP, 2002, NAT NEUROSCI, V5, P1236, DOI 10.1038/nn961; Zhang H, 2013, HUM BRAIN MAPP, V34, P1070, DOI 10.1002/hbm.21494	47	190	194	0	47	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAR	2013	16	3					349	356		10.1038/nn.3315	http://dx.doi.org/10.1038/nn.3315			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	097LE	23354333	Green Accepted, Green Submitted			2022-12-28	WOS:000315474800018
J	Parsons, RG; Ressler, KJ				Parsons, Ryan G.; Ressler, Kerry J.			Implications of memory modulation for post-traumatic stress and fear disorders	NATURE NEUROSCIENCE			English	Review							VENTROMEDIAL PREFRONTAL CORTEX; BDNF VAL66MET POLYMORPHISM; D-CYCLOSERINE; CONDITIONED FEAR; POTENTIATED STARTLE; BASOLATERAL AMYGDALA; PROTEIN-SYNTHESIS; EXPOSURE THERAPY; MOLECULAR-MECHANISMS; HIPPOCAMPAL ACTIVITY	Post-traumatic stress disorder, panic disorder and phobia manifest in ways that are consistent with an uncontrollable state of fear. Their development involves heredity, previous sensitizing experiences, association of aversive events with previous neutral stimuli, and inability to inhibit or extinguish fear after it is chronic and disabling. We highlight recent progress in fear learning and memory, differential susceptibility to disorders of fear, and how these findings are being applied to the understanding, treatment and possible prevention of fear disorders. Promising advances are being translated from basic science to the clinic, including approaches to distinguish risk versus resilience before trauma exposure, methods to interfere with fear development during memory consolidation after a trauma, and techniques to inhibit fear reconsolidation and to enhance extinction of chronic fear. It is hoped that this new knowledge will translate to more successful, neuroscientifically informed and rationally designed approaches to disorders of fear regulation.	[Parsons, Ryan G.; Ressler, Kerry J.] Emory Univ, Dept Psychiat & Behav Sci, Yerkes Natl Primate Res Ctr, Atlanta, GA 30322 USA; [Ressler, Kerry J.] Howard Hughes Med Inst, Chevy Chase, MD USA	Emory University; Howard Hughes Medical Institute	Ressler, KJ (corresponding author), Emory Univ, Dept Psychiat & Behav Sci, Yerkes Natl Primate Res Ctr, Atlanta, GA 30322 USA.	kressle@emory.edu	Ressler, Kerry J/N-8741-2018	Ressler, Kerry J/0000-0002-5158-1103; Parsons, Ryan/0000-0001-8136-9413	US National Institutes of Health [F32MH090700, R01MH071537, R01MH094757, R01MH096764]; Burroughs Wellcome Fund; US National Institutes of Health National Center for Research Resources base grant [P51RR000165]; NATIONAL CENTER FOR RESEARCH RESOURCES [P51RR000165] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH094757, R01MH071537, F32MH090700, R01MH096764] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Burroughs Wellcome Fund(Burroughs Wellcome Fund); US National Institutes of Health National Center for Research Resources base grant; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	Support was provided by the US National Institutes of Health (F32MH090700, R01MH071537, R01MH094757 and R01MH096764), the Burroughs Wellcome Fund and a US National Institutes of Health National Center for Research Resources base grant (P51RR000165) to Yerkes National Primate Research Center.	Alvarez RP, 2008, J NEUROSCI, V28, P6211, DOI 10.1523/JNEUROSCI.1246-08.2008; American Psychiatric Association, 2000, DIAGN STAT MAN MENT; Andero R, 2012, GENES BRAIN BEHAV, V11, P503, DOI 10.1111/j.1601-183X.2012.00801.x; Andero R, 2011, AM J PSYCHIAT, V168, P163, DOI 10.1176/appi.ajp.2010.10030326; BECHARA A, 1995, SCIENCE, V269, P1115, DOI 10.1126/science.7652558; Binder EB, 2008, JAMA-J AM MED ASSOC, V299, P1291, DOI 10.1001/jama.299.11.1291; Bontempo A, 2012, J CLIN PSYCHIAT, V73, P533, DOI 10.4088/JCP.11r07356; BOUTON ME, 1983, J EXP PSYCHOL ANIM B, V9, P248, DOI 10.1037/0097-7403.9.3.248; Bremner JD, 2007, NEUROIMAG CLIN N AM, V17, P523, DOI 10.1016/j.nic.2007.07.003; Breslau N, 1998, ARCH GEN PSYCHIAT, V55, P626, DOI 10.1001/archpsyc.55.7.626; Britton JC, 2005, BIOL PSYCHIAT, V57, P832, DOI 10.1016/j.biopsych.2004.12.025; Brunet A, 2008, J PSYCHIATR RES, V42, P503, DOI 10.1016/j.jpsychires.2007.05.006; Cain CK, 2012, EXPERT OPIN INV DRUG, V21, P1323, DOI 10.1517/13543784.2012.704020; CAMPEAU S, 1995, J NEUROSCI, V15, P2312, DOI 10.1523/JNEUROSCI.15-03-02312.1995; Carrion VG, 2010, J PEDIATR PSYCHOL, V35, P559, DOI 10.1093/jpepsy/jsp112; Chan Wan Yee Macy, 2010, Learn Mem, V17, P512, DOI 10.1101/lm.1912510; Cheng DT, 2006, BEHAV NEUROSCI, V120, P1187, DOI 10.1037/0735-7044.120.5.1187; Chhatwal JP, 2006, NAT NEUROSCI, V9, P870, DOI 10.1038/nn1718; Choi DC, 2010, P NATL ACAD SCI USA, V107, P2675, DOI 10.1073/pnas.0909359107; Ciocchi S, 2010, NATURE, V468, P277, DOI 10.1038/nature09559; Clem RL, 2010, SCIENCE, V330, P1108, DOI 10.1126/science.1195298; Corcoran KA, 2005, J NEUROSCI, V25, P8978, DOI 10.1523/JNEUROSCI.2246-05.2005; DAVIS M, 1992, ANNU REV NEUROSCI, V15, P353, DOI 10.1146/annurev.neuro.15.1.353; de Kleine RA, 2012, BIOL PSYCHIAT, V71, P962, DOI 10.1016/j.biopsych.2012.02.033; Drabant EM, 2009, BIOL PSYCHIAT, V65, P367, DOI 10.1016/j.biopsych.2008.09.007; Duvarci S, 2009, J NEUROSCI, V29, P10357, DOI 10.1523/JNEUROSCI.2119-09.2009; Egan MF, 2003, CELL, V112, P257, DOI 10.1016/S0092-8674(03)00035-7; Etkin A, 2007, AM J PSYCHIAT, V164, P1476, DOI 10.1176/appi.ajp.2007.07030504; FALLS WA, 1992, J NEUROSCI, V12, P854; Fiorenza NG, 2011, AN ACAD BRAS CIENC, V83, P1363, DOI 10.1590/S0001-37652011000400023; Frustaci A, 2008, NEUROPSYCHOBIOLOGY, V58, P163, DOI 10.1159/000182892; GOOD AJ, 1995, BEHAV NEUROSCI, V109, P631, DOI 10.1037/0735-7044.109.4.631; Goosens KA, 2003, BEHAV NEUROSCI, V117, P738, DOI 10.1037/0735-7044.117.4.738; Haubensak W, 2010, NATURE, V468, P270, DOI 10.1038/nature09553; Heldt SA, 2007, MOL PSYCHIATR, V12, P656, DOI 10.1038/sj.mp.4001957; Hofmann SG, 2006, ARCH GEN PSYCHIAT, V63, P298, DOI 10.1001/archpsyc.63.3.298; Holbrook TL, 2010, NEW ENGL J MED, V362, P110, DOI 10.1056/NEJMoa0903326; Hurlemann R, 2010, PSYCHOL MED, V40, P1839, DOI 10.1017/S0033291709992376; Inda MC, 2011, J NEUROSCI, V31, P1635, DOI 10.1523/JNEUROSCI.4736-10.2011; Johansen JP, 2011, CELL, V147, P509, DOI 10.1016/j.cell.2011.10.009; Johansen JP, 2010, NAT NEUROSCI, V13, P979, DOI 10.1038/nn.2594; Jovanovic T, 2013, CORTEX, V49, P1884, DOI 10.1016/j.cortex.2012.08.011; Jovanovic T, 2010, AM J PSYCHIAT, V167, P648, DOI 10.1176/appi.ajp.2009.09071074; KESSLER RC, 1995, ARCH GEN PSYCHIAT, V52, P1048, DOI 10.1001/archpsyc.1995.03950240066012; KIM JJ, 1992, SCIENCE, V256, P675, DOI 10.1126/science.1585183; Kindt M, 2009, NAT NEUROSCI, V12, P256, DOI 10.1038/nn.2271; Knight DC, 2004, COGN AFFECT BEHAV NE, V4, P317, DOI 10.3758/CABN.4.3.317; Knoll AT, 2011, BIOL PSYCHIAT, V70, P425, DOI 10.1016/j.biopsych.2011.03.017; Kushner MG, 2007, BIOL PSYCHIAT, V62, P835, DOI 10.1016/j.biopsych.2006.12.020; LaBar KS, 1998, NEURON, V20, P937, DOI 10.1016/S0896-6273(00)80475-4; LaLumiere RT, 2003, J NEUROSCI, V23, P6754; Lanuza E, 2004, NEUROSCIENCE, V125, P305, DOI 10.1016/j.neuroscience.2003.12.034; LEDOUX JE, 1990, J NEUROSCI, V10, P1062; LEDOUX JE, 1988, J NEUROSCI, V8, P2517; Lin CH, 2003, MOL PHARMACOL, V63, P44, DOI 10.1124/mol.63.1.44; Mao SC, 2006, J NEUROSCI, V26, P8892, DOI 10.1523/JNEUROSCI.0365-06.2006; Maren S, 1996, BEHAV NEUROSCI, V110, P1365, DOI 10.1037/0735-7044.110.6.1365; Maren S, 2006, P NATL ACAD SCI USA, V103, P18020, DOI 10.1073/pnas.0608398103; McGhee LL, 2009, J BURN CARE RES, V30, P92, DOI 10.1097/BCR.0b013e3181921f51; McNally GP, 2003, BEHAV NEUROSCI, V117, P1292, DOI 10.1037/0735-7044.117.6.1292; McTeague LM, 2010, BIOL PSYCHIAT, V67, P346, DOI 10.1016/j.biopsych.2009.08.023; Milad MR, 2007, BIOL PSYCHIAT, V62, P446, DOI 10.1016/j.biopsych.2006.10.011; Milad MR, 2002, NATURE, V420, P70, DOI 10.1038/nature01138; Milekic MH, 2002, NEURON, V36, P521, DOI 10.1016/S0896-6273(02)00976-5; Monfils MH, 2009, SCIENCE, V324, P951, DOI 10.1126/science.1167975; Moriceau S, 2006, J NEUROSCI, V26, P6737, DOI 10.1523/JNEUROSCI.0499-06.2006; Muller J, 1997, BEHAV NEUROSCI, V111, P683, DOI 10.1037/0735-7044.111.4.683; Myers KM, 2006, LEARN MEMORY, V13, P216, DOI 10.1101/lm.119806; Nader K, 2000, NATURE, V406, P722, DOI 10.1038/35021052; Nader K, 2009, NAT REV NEUROSCI, V10, P224, DOI 10.1038/nrn2590; Norberg MM, 2008, BIOL PSYCHIAT, V63, P1118, DOI 10.1016/j.biopsych.2008.01.012; Orsini CA, 2012, NEUROSCI BIOBEHAV R, V36, P1773, DOI 10.1016/j.neubiorev.2011.12.014; Otto MW, 2010, BIOL PSYCHIAT, V67, P365, DOI 10.1016/j.biopsych.2009.07.036; Pape HC, 2010, PHYSIOL REV, V90, P419, DOI 10.1152/physrev.00037.2009; Peters J, 2010, SCIENCE, V328, P1288, DOI 10.1126/science.1186909; Phelps EA, 2004, NEURON, V43, P897, DOI 10.1016/j.neuron.2004.08.042; Pitman RK, 2002, BIOL PSYCHIAT, V51, P189, DOI 10.1016/S0006-3223(01)01279-3; Quirk GJ, 2002, LEARN MEMORY, V9, P402, DOI 10.1101/lm.49602; Quirk GJ, 2000, J NEUROSCI, V20, P6225, DOI 10.1523/JNEUROSCI.20-16-06225.2000; Rakofsky JJ, 2012, MOL PSYCHIATR, V17, P22, DOI 10.1038/mp.2011.121; RESCORLA RA, 1975, J EXP PSYCHOL-ANIM B, V104, P88, DOI 10.1037/0097-7403.1.1.88; Ressler KJ, 2004, ARCH GEN PSYCHIAT, V61, P1136, DOI 10.1001/archpsyc.61.11.1136; Richardson R, 2004, LEARN MEMORY, V11, P510, DOI 10.1101/lm.78204; Rothbaum BO, 2012, BIOL PSYCHIAT, V72, P957, DOI 10.1016/j.biopsych.2012.06.002; Sanders MJ, 2003, NEUROBIOL LEARN MEM, V80, P123, DOI 10.1016/S1074-7427(03)00040-6; Saxe G, 2001, J AM ACAD CHILD PSY, V40, P915, DOI 10.1097/00004583-200108000-00013; Schafe GE, 2000, J NEUROSCI, V20, part. no., DOI 10.1523/JNEUROSCI.20-18-j0003.2000; Schiller D, 2010, NATURE, V463, P49, DOI 10.1038/nature08637; Sharp S, 2010, J TRAUMA, V68, P193, DOI 10.1097/TA.0b013e3181a8b326; Shi CJ, 1999, J NEUROSCI, V19, P420, DOI 10.1523/JNEUROSCI.19-01-00420.1999; Soliman F, 2010, SCIENCE, V327, P863, DOI 10.1126/science.1181886; Steckler T, 2012, NEUROPHARMACOLOGY, V62, P617, DOI 10.1016/j.neuropharm.2011.06.012; Stein MB, 2007, J TRAUMA STRESS, V20, P923, DOI 10.1002/jts.20270; Suzuki A, 2004, J NEUROSCI, V24, P4787, DOI 10.1523/JNEUROSCI.5491-03.2004; Tronson NC, 2007, NAT REV NEUROSCI, V8, P262, DOI 10.1038/nrn2090; Van't Veer A, 2012, NEUROPSYCHOPHARMACOL, V37, P2809, DOI 10.1038/npp.2012.151; Walker DL, 2002, J NEUROSCI, V22, P2343, DOI 10.1523/JNEUROSCI.22-06-02343.2002; Wilensky AE, 2006, J NEUROSCI, V26, P12387, DOI 10.1523/JNEUROSCI.4316-06.2006; Yehuda R, 2007, NEURON, V56, P19, DOI 10.1016/j.neuron.2007.09.006	99	296	306	7	186	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	FEB	2013	16	2					146	153		10.1038/nn.3296	http://dx.doi.org/10.1038/nn.3296			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	080RE	23354388	Green Accepted			2022-12-28	WOS:000314260200010
J	Trenholm, S; Schwab, DJ; Balasubramanian, V; Awatramani, GB				Trenholm, Stuart; Schwab, David J.; Balasubramanian, Vijay; Awatramani, Gautam B.			Lag normalization in an electrically coupled neural network	NATURE NEUROSCIENCE			English	Article							RETINAL GANGLION-CELLS; RABBIT RETINA; GAP-JUNCTIONS; MOUSE RETINA; IMAGE MOTION; DIRECTION; LATENCIES	Moving objects can cover large distances while they are processed by the eye, usually resulting in a spatially lagged retinal response. We identified a network of electrically coupled motion-coding neurons in mouse retina that act collectively to register the leading edges of moving objects at a nearly constant spatial location, regardless of their velocity. These results reveal a previously unknown neurophysiological substrate for lag normalization in the visual system.	[Trenholm, Stuart; Awatramani, Gautam B.] Univ Victoria, Dept Biol, Victoria, BC V8W 2Y2, Canada; [Schwab, David J.] Princeton Univ, Dept Phys, Princeton, NJ 08544 USA; [Balasubramanian, Vijay] Univ Penn, David Rittenhouse Lab, Philadelphia, PA 19104 USA; [Balasubramanian, Vijay] Ecole Normale Super, Phys Theor Lab, F-75231 Paris, France	University of Victoria; Princeton University; University of Pennsylvania; UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS)	Awatramani, GB (corresponding author), Univ Victoria, Dept Biol, POB 1700, Victoria, BC V8W 2Y2, Canada.	gautam@uvic.ca		Trenholm, Stuart/0000-0001-5792-0957	US National Science Foundation [PHY-1058202, EF-0928048]; National Science Foundation [PHY-1066293]; Canadian Institutes of Health Research [342202-2007]; Foundation for Fighting Blindness (Canada); Division Of Physics [1058202] Funding Source: National Science Foundation; Emerging Frontiers [0928048] Funding Source: National Science Foundation	US National Science Foundation(National Science Foundation (NSF)); National Science Foundation(National Science Foundation (NSF)); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Foundation for Fighting Blindness (Canada); Division Of Physics(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS)); Emerging Frontiers(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	We thank W.H. Baldridge, B. Chow and K.R. Delaney for comments, K. Johnson for writing routines in Matlab and Z. Shi for maintaining mouse colonies. This work was supported in part by US National Science Foundation PHY-1058202 and EF-0928048 (V.B.) and was completed at the Aspen Center for Physics, which is supported by National Science Foundation PHY-1066293. This work was also supported by Canadian Institutes of Health Research 342202-2007 and Foundation for Fighting Blindness (Canada) (G.B.A.).	ANDERSON CH, 1987, P NATL ACAD SCI USA, V84, P6297, DOI 10.1073/pnas.84.17.6297; BARLOW HB, 1964, J PHYSIOL-LONDON, V173, P377, DOI 10.1113/jphysiol.1964.sp007463; Berry MJ, 1999, NATURE, V398, P334, DOI 10.1038/18678; Bloomfield SA, 2009, NAT REV NEUROSCI, V10, P495, DOI 10.1038/nrn2636; Gollisch T, 2008, SCIENCE, V319, P1108, DOI 10.1126/science.1149639; Krekelberg B, 2001, TRENDS NEUROSCI, V24, P335, DOI 10.1016/S0166-2236(00)01795-1; Nijhawan R, 2002, TRENDS COGN SCI, V6, P387, DOI 10.1016/S1364-6613(02)01963-0; NIJHAWAN R, 1994, NATURE, V370, P256, DOI 10.1038/370256b0; Oesch N, 2005, NEURON, V47, P739, DOI 10.1016/j.neuron.2005.06.036; OYSTER CW, 1968, J PHYSIOL-LONDON, V199, P613, DOI 10.1113/jphysiol.1968.sp008671; SHAPLEY RM, 1978, J PHYSIOL-LONDON, V285, P275, DOI 10.1113/jphysiol.1978.sp012571; Trenholm S, 2011, NEURON, V71, P683, DOI 10.1016/j.neuron.2011.06.020; Vaney DI, 2012, NAT REV NEUROSCI, V13, P194, DOI 10.1038/nrn3165; VANEY DI, 1994, J NEUROSCI, V14, P6301; Vervaeke K, 2012, SCIENCE, V335, P1624, DOI 10.1126/science.1215101; Volgyi B, 2009, J COMP NEUROL, V512, P664, DOI 10.1002/cne.21912; Wassle H, 2009, J NEUROSCI, V29, P106, DOI 10.1523/JNEUROSCI.4442-08.2009; YANG G, 1994, J NEUROSCI, V14, P5267	18	45	45	0	42	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	FEB	2013	16	2					154	156		10.1038/nn.3308	http://dx.doi.org/10.1038/nn.3308			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	080RE	23313908				2022-12-28	WOS:000314260200011
J	Philippidou, P; Walsh, CM; Aubin, J; Jeannotte, L; Dasen, JS				Philippidou, Polyxeni; Walsh, Carolyn M.; Aubin, Josee; Jeannotte, Lucie; Dasen, Jeremy S.			Sustained Hox5 gene activity is required for respiratory motor neuron development	NATURE NEUROSCIENCE			English	Article							SPINAL-CORD; AXON FASCICULATION; SYNAPSE FORMATION; IDENTIFICATION; MICE; SYNAPTOGENESIS; ORGANIZATION; SUPERFAMILY; INNERVATION; PROTEINS	Respiration in mammals relies on the rhythmic firing of neurons in the phrenic motor column (PMC), a motor neuron group that provides the sole source of diaphragm innervation. Despite their essential role in breathing, the specific determinants of PMC identity and patterns of connectivity are largely unknown. We show that two Hox genes, Hoxa5 and Hoxc5, control diverse aspects of PMC development including their clustering, intramuscular branching, and survival. In mice lacking Hox5 genes in motor neurons, axons extend to the diaphragm, but fail to arborize, leading to respiratory failure. Genetic rescue of cell death fails to restore columnar organization and branching patterns, indicating these defects are independent of neuronal loss. Unexpectedly, late Hox5 removal preserves columnar organization but depletes PMC number and branches, demonstrating a continuous requirement for Hox function in motor neurons. These findings indicate that Hox5 genes orchestrate PMC development through deployment of temporally distinct wiring programs.	[Philippidou, Polyxeni; Walsh, Carolyn M.; Dasen, Jeremy S.] NYU, Howard Hughes Med Inst, Dept Physiol & Neurosci, Smilow Neurosci Program,Sch Med, New York, NY 10003 USA; [Aubin, Josee; Jeannotte, Lucie] Univ Laval, Ctr Rech Cancerol, Ctr Hosp Univ Quebec, Hotel Dieu Quebec, Quebec City, PQ, Canada	Howard Hughes Medical Institute; New York University; Laval University	Dasen, JS (corresponding author), NYU, Howard Hughes Med Inst, Dept Physiol & Neurosci, Smilow Neurosci Program,Sch Med, New York, NY 10003 USA.	jeremy.dasen@nyumc.org		Jeannotte, Lucie/0000-0001-5578-420X; Philippidou, Polyxeni/0000-0002-0733-3591	Canadian Institutes of Health Research [MOP-15139]; McKnight Foundation; Alfred P. Sloan; Project ALS; NYSTEM; Howard Hughes Medical Institute; US National Institutes of Health [R01 NS062822]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS062822] Funding Source: NIH RePORTER	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); McKnight Foundation; Alfred P. Sloan(Alfred P. Sloan Foundation); Project ALS; NYSTEM; Howard Hughes Medical Institute(Howard Hughes Medical Institute); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank C. Henderson, K. Kanning and I. Lieberam for discussions and sharing unpublished observations, M. Baek, H. Jung and C. Catela for comments on the manuscript, and P. Hallock and S. Burden for assistance with diaphragm preparations. L.J. is supported by a grant from the Canadian Institutes of Health Research (MOP-15139). J.S.D. is supported by grants from the McKnight Foundation, Alfred P. Sloan, Project ALS, NYSTEM, Howard Hughes Medical Institute and the US National Institutes of Health (R01 NS062822).	Agalliu D, 2009, NEURON, V61, P708, DOI 10.1016/j.neuron.2008.12.026; Allan DW, 1997, J COMP NEUROL, V382, P469, DOI 10.1002/(SICI)1096-9861(19970616)382:4<469::AID-CNE4>3.0.CO;2-0; Allan DW, 1997, J COMP NEUROL, V382, P459, DOI 10.1002/(SICI)1096-9861(19970616)382:4<459::AID-CNE3>3.0.CO;2-1; Arber S, 1999, NEURON, V23, P659, DOI 10.1016/S0896-6273(01)80026-X; Aubin J, 1997, DEV BIOL, V192, P432, DOI 10.1006/dbio.1997.8746; Bermingham JR, 1996, GENE DEV, V10, P1751, DOI 10.1101/gad.10.14.1751; Bouvier J, 2010, NAT NEUROSCI, V13, P1066, DOI 10.1038/nn.2622; Bruce A., 1901, TOPOGRAPHICAL ATLAS; Burgess RW, 2006, J NEUROSCI, V26, P5756, DOI 10.1523/JNEUROSCI.0736-06.2006; Caubit X, 2010, J NEUROSCI, V30, P9465, DOI 10.1523/JNEUROSCI.1765-10.2010; Chen HX, 2005, J BIOL CHEM, V280, P19373, DOI 10.1074/jbc.M413528200; Dasen JS, 2008, CELL, V134, P304, DOI 10.1016/j.cell.2008.06.019; Dasen JS, 2005, CELL, V123, P477, DOI 10.1016/j.cell.2005.09.009; Dasen JS, 2003, NATURE, V425, P926, DOI 10.1038/nature02051; Dessaud E, 2006, MOL CELL NEUROSCI, V31, P232, DOI 10.1016/j.mcn.2005.09.010; Dessaud E, 2007, NATURE, V450, P717, DOI 10.1038/nature06347; Dillon AK, 2005, J NEUROSCI, V25, P10119, DOI 10.1523/JNEUROSCI.3455-05.2005; Feng GP, 2000, NEURON, V25, P295, DOI 10.1016/S0896-6273(00)80895-8; Garcia NVDM, 2008, NEURON, V57, P217, DOI 10.1016/j.neuron.2007.11.033; Glebova NO, 2004, J NEUROSCI, V24, P743, DOI 10.1523/JNEUROSCI.4523-03.2004; GOSHGARIAN HG, 1981, J COMP NEUROL, V201, P441, DOI 10.1002/cne.902010309; GrandPre T, 2000, NATURE, V403, P439, DOI 10.1038/35000226; Haase G, 2002, NEURON, V35, P893, DOI 10.1016/S0896-6273(02)00864-4; Hallock PT, 2010, GENE DEV, V24, P2451, DOI 10.1101/gad.1977710; Iizuka M, 2004, NEUROSCI RES, V50, P263, DOI 10.1016/j.neures.2004.07.011; Jaworski A, 2012, NAT NEUROSCI, V15, P367, DOI 10.1038/nn.3037; Jessell TM, 2000, NAT REV GENET, V1, P20, DOI 10.1038/35049541; Jung H, 2010, NEURON, V67, P781, DOI 10.1016/j.neuron.2010.08.008; KNUDSON CM, 1995, SCIENCE, V270, P96, DOI 10.1126/science.270.5233.96; Livet J, 2002, NEURON, V35, P877, DOI 10.1016/S0896-6273(02)00863-2; Lowell B., 2006, MGI DIRECT DATA SUBM; McIntyre DC, 2007, DEVELOPMENT, V134, P2981, DOI 10.1242/dev.007567; Mi RF, 2007, P NATL ACAD SCI USA, V104, P4664, DOI 10.1073/pnas.0603243104; Misgeld T, 2002, NEURON, V36, P635, DOI 10.1016/S0896-6273(02)01020-6; OPPENHEIM RW, 1989, DEVELOPMENT, V107, P331; Petrinovic MM, 2010, DEVELOPMENT, V137, P2539, DOI 10.1242/dev.048371; Romanes GJ, 1941, J ANAT, V76, P112; Rose MF, 2009, NEURON, V64, P341, DOI 10.1016/j.neuron.2009.10.023; Rousso DL, 2008, NEURON, V59, P226, DOI 10.1016/j.neuron.2008.06.025; Sharma K, 2000, NATURE, V406, P515, DOI 10.1038/35020078; Shirasaki R, 2002, ANNU REV NEUROSCI, V25, P251, DOI 10.1146/annurev.neuro.25.112701.142916; SMITH JC, 1990, J NEUROPHYSIOL, V64, P1149, DOI 10.1152/jn.1990.64.4.1149; Smith JC, 2009, PHILOS T R SOC B, V364, P2577, DOI 10.1098/rstb.2009.0081; Stolt CC, 2006, DEV CELL, V11, P697, DOI 10.1016/j.devcel.2006.08.011; Surmeli G, 2011, CELL, V147, P653, DOI 10.1016/j.cell.2011.10.012; Sun W, 2003, J NEUROSCI, V23, P7298, DOI 10.1523/jneurosci.23-19-07298.2003; Tabaries S, 2007, GENESIS, V45, P218, DOI 10.1002/dvg.20292; Thaler J, 1999, NEURON, V23, P675, DOI 10.1016/S0896-6273(01)80027-1; Tripodi M, 2011, NATURE, V479, P61, DOI 10.1038/nature10538; TSUCHIDA T, 1994, CELL, V79, P957, DOI 10.1016/0092-8674(94)90027-2; Weiner JA, 2004, MOL CELL NEUROSCI, V27, P59, DOI 10.1016/j.mcn.2004.06.005; Woldeyesus MT, 1999, GENE DEV, V13, P2538, DOI 10.1101/gad.13.19.2538	52	78	78	0	17	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	DEC	2012	15	12					1636	+		10.1038/nn.3242	http://dx.doi.org/10.1038/nn.3242			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	045OR	23103965	Green Accepted			2022-12-28	WOS:000311706700009
J	Shin, SM; Zhang, N; Hansen, J; Gerges, NZ; Pak, DTS; Sheng, M; Lee, SH				Shin, Seung Min; Zhang, Nanyan; Hansen, Jonathan; Gerges, Nashaat Z.; Pak, Daniel T. S.; Sheng, Morgan; Lee, Sang H.			GKAP orchestrates activity-dependent postsynaptic protein remodeling and homeostatic scaling	NATURE NEUROSCIENCE			English	Article							DENDRITIC SPINE MORPHOLOGY; SYNAPTIC FUNCTION; KINASE-II; ALPHA-CAMKII; LIGHT-CHAIN; BETA-CAMKII; PLASTICITY; PHOSPHORYLATION; FAMILY; SHANK	How does chronic activity modulation lead to global remodeling of proteins at synapses and synaptic scaling? Here we report that guanylate kinase-associated protein (GKAP; also known as SAPAP), a scaffolding molecule linking NMDA receptor-PSD-95 to Shank-Homer complexes, acts in these processes. Overexcitation removes GKAP from synapses via the ubiquitin-proteasome system, whereas inactivity induces synaptic accumulation of GKAP in rat hippocampal neurons. Bidirectional changes in synaptic GKAP amounts are controlled by specific CaMKII isoforms coupled to different Ca2+ channels. CaMKII alpha activated by the NMDA receptor phosphorylates GKAP Ser54 to induce polyubiquitination of GKAP. In contrast, CaMKII beta activation via L-type voltage-dependent calcium channels promotes GKAP recruitment by phosphorylating GKAP Ser340 and Ser384, which uncouples GKAP from myosin Va motor complex. Overexpressing GKAP turnover mutants not only hampers activity-dependent remodeling of PSD-95 and Shank but also blocks bidirectional synaptic scaling. Therefore, activity-dependent turnover of PSD proteins orchestrated by GKAP is critical for homeostatic plasticity.	[Shin, Seung Min; Zhang, Nanyan; Hansen, Jonathan; Lee, Sang H.] Med Coll Wisconsin, Dept Pharmacol & Toxicol, Milwaukee, WI 53226 USA; [Gerges, Nashaat Z.] Med Coll Wisconsin, Dept Cell Biol & Neurobiol, Milwaukee, WI 53226 USA; [Pak, Daniel T. S.] Georgetown Univ, Med Ctr, Dept Pharmacol, Washington, DC 20007 USA; [Sheng, Morgan] MIT, Picower Inst Learning & Memory, Cambridge, MA 02139 USA	Medical College of Wisconsin; Medical College of Wisconsin; Georgetown University; Massachusetts Institute of Technology (MIT); Northwell Health	Lee, SH (corresponding author), Med Coll Wisconsin, Dept Pharmacol & Toxicol, Milwaukee, WI 53226 USA.	shlee@mcw.edu	Lee, Sang/R-7518-2019	Lee, Sang H./0000-0001-5467-0331; Sheng, Morgan/0000-0002-8703-5366	US National Institutes of Health [R01 MH078135, R01 AG032320]; Whitehall Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH078135] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG032320] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Whitehall Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank Q.-S. Liu for technical advice on electrophysiology, and A. Tamada and H. Kamiguchi (RIKEN Brain Science Institute) for providing MyoV expression vectors. This work was supported by US National Institutes of Health grant R01 MH078135 and Whitehall Foundation grant to S. H. L and by US National Institutes of Health grant R01 AG032320 to N.Z.G.	Beique JC, 2011, P NATL ACAD SCI USA, V108, P816, DOI 10.1073/pnas.1017914108; Bingol B, 2011, NEURON, V69, P22, DOI 10.1016/j.neuron.2010.11.006; Bingol B, 2010, CELL, V140, P567, DOI 10.1016/j.cell.2010.01.024; Borgesius NZ, 2011, J NEUROSCI, V31, P10141, DOI 10.1523/JNEUROSCI.5105-10.2011; BRAUN AP, 1995, ANNU REV PHYSIOL, V57, P417, DOI 10.1146/annurev.ph.57.030195.002221; Brocke L, 1999, J BIOL CHEM, V274, P22713, DOI 10.1074/jbc.274.32.22713; Collingridge GL, 2004, NAT REV NEUROSCI, V5, P952, DOI 10.1038/nrn1556; Correia SS, 2008, NAT NEUROSCI, V11, P457, DOI 10.1038/nn2063; DiAntonio A, 2004, ANNU REV NEUROSCI, V27, P223, DOI 10.1146/annurev.neuro.27.070203.144317; Ehlers MD, 2003, NAT NEUROSCI, V6, P231, DOI 10.1038/nn1013; Evers DM, 2010, NAT NEUROSCI, V13, P1199, DOI 10.1038/nn.2624; Fink CC, 2003, NEURON, V39, P283, DOI 10.1016/S0896-6273(03)00428-8; Funke L, 2005, ANNU REV BIOCHEM, V74, P219, DOI 10.1146/annurev.biochem.74.082803.133339; Groth RD, 2011, P NATL ACAD SCI USA, V108, P828, DOI 10.1073/pnas.1018022108; Guillaud L, 2008, NAT CELL BIOL, V10, P19, DOI 10.1038/ncb1665; Honkura N, 2008, NEURON, V57, P719, DOI 10.1016/j.neuron.2008.01.013; Hudmon A, 2002, ANNU REV BIOCHEM, V71, P473, DOI 10.1146/annurev.biochem.71.110601.135410; Hung AY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009842; Kim E, 1997, J CELL BIOL, V136, P669, DOI 10.1083/jcb.136.3.669; Kim MJ, 2007, NEURON, V56, P488, DOI 10.1016/j.neuron.2007.09.007; Kopito RR, 2000, TRENDS CELL BIOL, V10, P524, DOI 10.1016/S0962-8924(00)01852-3; Kuriu T, 2006, J NEUROSCI, V26, P7693, DOI 10.1523/JNEUROSCI.0522-06.2006; Lim S, 1999, J BIOL CHEM, V274, P29510, DOI 10.1074/jbc.274.41.29510; Lisman J, 2012, NAT REV NEUROSCI, V13, P169, DOI 10.1038/nrn3192; Lo KWH, 2005, J BIOL CHEM, V280, P8172, DOI 10.1074/jbc.M411408200; Naisbitt S, 2000, J NEUROSCI, V20, P4524, DOI 10.1523/JNEUROSCI.20-12-04524.2000; Naisbitt S, 1999, NEURON, V23, P569, DOI 10.1016/S0896-6273(00)80809-0; Okamoto KI, 2007, P NATL ACAD SCI USA, V104, P6418, DOI 10.1073/pnas.0701656104; Omkumar RV, 1996, J BIOL CHEM, V271, P31670, DOI 10.1074/jbc.271.49.31670; Pak DTS, 2003, SCIENCE, V302, P1368, DOI 10.1126/science.1082475; Passafaro M, 1999, NAT NEUROSCI, V2, P1063, DOI 10.1038/15990; Pozo K, 2010, NEURON, V66, P337, DOI 10.1016/j.neuron.2010.04.028; Puram SV, 2011, NAT NEUROSCI, V14, P973, DOI 10.1038/nn.2857; Romorini S, 2004, J NEUROSCI, V24, P9391, DOI 10.1523/JNEUROSCI.3314-04.2004; Roselli F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023097; Sala C, 2001, NEURON, V31, P115, DOI 10.1016/S0896-6273(01)00339-7; Satoh K, 1997, GENES CELLS, V2, P415, DOI 10.1046/j.1365-2443.1997.1310329.x; Seeburg DP, 2008, NEURON, V58, P571, DOI 10.1016/j.neuron.2008.03.021; Sheng M, 2007, ANNU REV BIOCHEM, V76, P823, DOI 10.1146/annurev.biochem.76.060805.160029; Sheng M, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a005678; Shepherd JD, 2006, NEURON, V52, P475, DOI 10.1016/j.neuron.2006.08.034; Songyang Z, 1996, MOL CELL BIOL, V16, P6486; Sutton MA, 2006, CELL, V125, P785, DOI 10.1016/j.cell.2006.03.040; Takeuchi M, 1997, J BIOL CHEM, V272, P11943, DOI 10.1074/jbc.272.18.11943; Thiagarajan TC, 2007, NEUROPHARMACOLOGY, V52, P156, DOI 10.1016/j.neuropharm.2006.07.030; Thiagarajan TC, 2005, NEURON, V47, P725, DOI 10.1016/j.neuron.2005.06.037; Thiagarajan TC, 2002, NEURON, V36, P1103, DOI 10.1016/S0896-6273(02)01049-8; Tippens AL, 2008, J COMP NEUROL, V506, P569, DOI 10.1002/cne.21567; Trinidad JC, 2005, J NEUROCHEM, V92, P1306, DOI 10.1111/j.1471-4159.2004.02943.x; Turrigiano GG, 2008, CELL, V135, P422, DOI 10.1016/j.cell.2008.10.008; Welch JM, 2007, NATURE, V448, P894, DOI 10.1038/nature06104	51	92	93	0	19	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	DEC	2012	15	12					1655	+		10.1038/nn.3259	http://dx.doi.org/10.1038/nn.3259			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	045OR	23143515	Green Accepted			2022-12-28	WOS:000311706700011
J	Lapray, D; Lasztoczi, B; Lagler, M; Viney, TJ; Katona, L; Valenti, O; Hartwich, K; Borhegyi, Z; Somogyi, P; Klausberger, T				Lapray, Damien; Lasztoczi, Balint; Lagler, Michael; Viney, Tim James; Katona, Linda; Valenti, Ornella; Hartwich, Katja; Borhegyi, Zsolt; Somogyi, Peter; Klausberger, Thomas			Behavior-dependent specialization of identified hippocampal interneurons	NATURE NEUROSCIENCE			English	Article							EXPRESSING GABAERGIC NEURONS; OSCILLATIONS IN-VITRO; NETWORK OSCILLATIONS; PYRAMIDAL CELLS; PLACE CELLS; POSITIVE INTERNEURONS; GAMMA OSCILLATIONS; PHASE PRECESSION; RAT HIPPOCAMPUS; BARREL CORTEX	A large variety of GABAergic interneurons control information processing in the hippocampal circuits governing the formation of neuronal representations. Whether distinct hippocampal interneuron types contribute differentially to information processing during behavior is not known. We employed a new technique for recording and labeling interneurons and pyramidal cells in drug-free, freely moving rats. Recorded parvalbumin-expressing basket interneurons innervated somata and proximal pyramidal cell dendrites, whereas nitric oxide synthase- and neuropeptide Y-expressing ivy cells provided synaptic and extrasynaptic dendritic modulation. Basket and ivy cells showed distinct spike-timing dynamics, firing at different rates and times during theta and ripple oscillations. Basket, but not ivy, cells changed their firing rates during movement, sleep and quiet wakefulness, suggesting that basket cells coordinate cell assemblies in a behavioral state-contingent manner, whereas persistently firing ivy cells might control network excitability and homeostasis. Different interneuron types provide GABA to specific subcellular domains at defined times and rates, thereby differentially controlling network activity during behavior.	[Lapray, Damien; Lasztoczi, Balint; Viney, Tim James; Katona, Linda; Hartwich, Katja; Somogyi, Peter; Klausberger, Thomas] Univ Oxford, MRC, Anat Neuropharmacol Unit, Oxford, England; [Lapray, Damien; Lasztoczi, Balint; Lagler, Michael; Valenti, Ornella; Borhegyi, Zsolt; Somogyi, Peter; Klausberger, Thomas] Med Univ Vienna, Ctr Brain Res, Dept Cognit Neurobiol, Vienna, Austria	University of Oxford; Medical University of Vienna	Lapray, D (corresponding author), Univ Oxford, MRC, Anat Neuropharmacol Unit, Oxford, England.	damien.lapray@pharm.ox.ac.uk; peter.somogyi@pharm.ox.ac.uk; thomas.klausberger@meduniwien.ac.at	Borhegyi, Zsolt/G-2152-2010; Katona, Linda/ABB-7768-2021	Borhegyi, Zsolt/0000-0001-5556-8742; Katona, Linda/0000-0002-9942-4502; Valenti, Ornella/0000-0003-3647-6046; Viney, Tim/0000-0001-6444-1188	European Research Council [242689]; Vienna Science and Technology Fund [SCIC03]; Austrian Science Fund [W1205]; MRC [MC_U138197107, MC_U138197110] Funding Source: UKRI; Medical Research Council [MC_U138197107, MC_U138197110] Funding Source: researchfish	European Research Council(European Research Council (ERC)European Commission); Vienna Science and Technology Fund; Austrian Science Fund(Austrian Science Fund (FWF)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The authors thank A. Koroknai for the reconstruction of the dendritic tree of cell D26p, I. Lukacs for the reconstruction of cell TV08k, J. Somogyi for confocal microscopic data acquisition and illustrations, K. Detzner for electron microscopy and immunohistochemistry, R. Hauer and E. Borok for histological processing, T. Sakatani for contributions to microdrive development, B. Micklem for help with the preparation of illustrations, J. O'Neill for help with place cell analysis, Y. Dalezios and G. Dorffner for advice on statistics, and R. Guillery, D. Dupret, M. Capogna, J. Csicsvari and L. Marton for comments on an earlier version of the manuscript. This work was supported in part by grant 242689 of the European Research Council, grant SCIC03 of the Vienna Science and Technology Fund and grant W1205 of the Austrian Science Fund.	Berens P, 2009, J STAT SOFTW, V31, P1, DOI 10.18637/jss.v031.i10; BUHL EH, 1994, NATURE, V368, P823, DOI 10.1038/368823a0; Buzsaki G., 2006, RHYTHMS BRAIN; Cardin JA, 2009, NATURE, V459, P663, DOI 10.1038/nature08002; COBB SR, 1995, NATURE, V378, P75, DOI 10.1038/378075a0; Cossart R, 2006, HIPPOCAMPUS, V16, P408, DOI 10.1002/hipo.20169; Csicsvari J, 1999, J NEUROSCI, V19, P274, DOI 10.1523/JNEUROSCI.19-01-00274.1999; Diba K, 2007, NAT NEUROSCI, V10, P1241, DOI 10.1038/nn1961; Ego-Stengel V, 2007, HIPPOCAMPUS, V17, P161, DOI 10.1002/hipo.20253; Epsztein J, 2011, NEURON, V70, P109, DOI 10.1016/j.neuron.2011.03.006; Fazzari P, 2010, NATURE, V464, P1376, DOI 10.1038/nature08928; Foster DJ, 2006, NATURE, V440, P680, DOI 10.1038/nature04587; Freund TF, 1996, HIPPOCAMPUS, V6, P347, DOI 10.1002/(SICI)1098-1063(1996)6:4<347::AID-HIPO1>3.0.CO;2-I; Fuchs EC, 2007, NEURON, V53, P591, DOI 10.1016/j.neuron.2007.01.031; Fuentealba P, 2008, NEURON, V57, P917, DOI 10.1016/j.neuron.2008.01.034; Gentet LJ, 2012, NAT NEUROSCI, V15, P607, DOI 10.1038/nn.3051; Gentet LJ, 2010, NEURON, V65, P422, DOI 10.1016/j.neuron.2010.01.006; Glickfeld LL, 2006, NAT NEUROSCI, V9, P807, DOI 10.1038/nn1688; Gloveli T, 2005, J PHYSIOL-LONDON, V562, P131, DOI 10.1113/jphysiol.2004.073007; Gulyas AI, 2010, J NEUROSCI, V30, P15134, DOI 10.1523/JNEUROSCI.4104-10.2010; Hacker SO, 2005, CONTEMP TOP LAB ANIM, V44, P7; Haiss F, 2010, J NEUROSCI METH, V187, P67, DOI 10.1016/j.jneumeth.2009.12.015; Hajos N, 2004, J NEUROSCI, V24, P9127, DOI 10.1523/JNEUROSCI.2113-04.2004; Hartwich K, 2009, J NEUROSCI, V29, P9563, DOI 10.1523/JNEUROSCI.1397-09.2009; Harvey CD, 2009, NATURE, V461, P941, DOI 10.1038/nature08499; Hu H, 2010, SCIENCE, V327, P52, DOI 10.1126/science.1177876; Klausberger T, 2003, NATURE, V421, P844, DOI 10.1038/nature01374; Klausberger T, 2005, J NEUROSCI, V25, P9782, DOI 10.1523/JNEUROSCI.3269-05.2005; Klausberger T, 2008, SCIENCE, V321, P53, DOI 10.1126/science.1149381; Lamsa KP, 2007, SCIENCE, V315, P1262, DOI 10.1126/science.1137450; Lasztoczi B, 2011, J NEUROSCI, V31, P18073, DOI 10.1523/JNEUROSCI.3573-11.2011; Lee AK, 2006, NEURON, V51, P399, DOI 10.1016/j.neuron.2006.07.004; Losonczy A, 2010, NAT NEUROSCI, V13, P967, DOI 10.1038/nn.2597; Louie K, 2001, NEURON, V29, P145, DOI 10.1016/S0896-6273(01)00186-6; Lovett-Barron M, 2012, NAT NEUROSCI, V15, P423, DOI 10.1038/nn.3024; Lubenov EV, 2009, NATURE, V459, P534, DOI 10.1038/nature08010; Mann EO, 2005, NEURON, V45, P105, DOI 10.1016/j.neuron.2004.12.016; Markwardt SJ, 2011, NAT NEUROSCI, V14, P1407, DOI 10.1038/nn.2935; Maurer AP, 2006, J NEUROSCI, V26, P13485, DOI 10.1523/JNEUROSCI.2882-06.2006; OKEEFE J, 1976, EXP NEUROL, V51, P78, DOI 10.1016/0014-4886(76)90055-8; Olah S, 2009, NATURE, V461, P1278, DOI 10.1038/nature08503; Pawelzik H, 2002, J COMP NEUROL, V443, P346, DOI 10.1002/cne.10118; Pinault D, 1996, J NEUROSCI METH, V65, P113, DOI 10.1016/0165-0270(95)00144-1; Pouille F, 2001, SCIENCE, V293, P1159, DOI 10.1126/science.1060342; Royer S, 2012, NAT NEUROSCI, V15, P769, DOI 10.1038/nn.3077; Szabadics J, 2009, J NEUROSCI, V29, P4239, DOI 10.1523/JNEUROSCI.5390-08.2009; Tricoire L, 2010, J NEUROSCI, V30, P2165, DOI 10.1523/JNEUROSCI.5123-09.2010; Vida I, 2006, NEURON, V49, P107, DOI 10.1016/j.neuron.2005.11.036; Vizi ES, 2000, PHARMACOL REV, V52, P63; YLINEN A, 1995, J NEUROSCI, V15, P30	50	170	171	0	41	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	SEP	2012	15	9					1265	U130		10.1038/nn.3176	http://dx.doi.org/10.1038/nn.3176			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	996GJ	22864613	Green Accepted			2022-12-28	WOS:000308072600017
J	Nishiyama, C; Uesaka, T; Manabe, T; Yonekura, Y; Nagasawa, T; Newgreen, DF; Young, HM; Enomoto, H				Nishiyama, Chihiro; Uesaka, Toshihiro; Manabe, Takayuki; Yonekura, Yohei; Nagasawa, Takashi; Newgreen, Donald F.; Young, Heather M.; Enomoto, Hideki			Trans-mesenteric neural crest cells are the principal source of the colonic enteric nervous system	NATURE NEUROSCIENCE			English	Article							ENDOTHELIN RECEPTOR-B; HIRSCHSPRUNGS-DISEASE; GDNF FAMILY; RET; MIGRATION; NEURONS; GENE; PROLIFERATION; PATHOGENESIS; PRECURSORS	Cell migration is fundamental to organogenesis. During development, the enteric neural crest cells (ENCCs) that give rise to the enteric nervous system (ENS) migrate and colonize the entire length of the gut, which undergoes substantial growth and morphological rearrangement. How ENCCs adapt to such changes during migration, however, is not fully understood. Using time-lapse imaging analyses of mouse ENCCs, we show that a population of ENCCs crosses from the midgut to the hindgut via the mesentery during a developmental time period in which these gut regions are transiently juxtaposed, and that such 'trans-mesenteric' ENCCs constitute a large part of the hindgut ENS. This migratory process requires GDNF signaling, and evidence suggests that impaired trans-mesenteric migration of ENCCs may underlie the pathogenesis of Hirschsprung disease (intestinal aganglionosis). The discovery of this trans-mesenteric ENCC population provides a basis for improving our understanding of ENS development and pathogenesis.	[Nishiyama, Chihiro; Uesaka, Toshihiro; Yonekura, Yohei; Enomoto, Hideki] RIKEN, Ctr Dev Biol, Lab Neuronal Differentiat & Regenerat, Kobe, Hyogo, Japan; [Manabe, Takayuki] Fujita Hlth Univ, Inst Comprehens Med Sci, Div Gene Express Mech, Toyoake, Aichi, Japan; [Nagasawa, Takashi] Kyoto Univ, Inst Frontier Med Sci, Dept Immunobiol & Hematol, Kyoto, Japan; [Newgreen, Donald F.] Murdoch Children Res Inst, Parkville, Vic, Australia; [Young, Heather M.] Univ Melbourne, Dept Anat & Neurosci, Melbourne, Vic, Australia	RIKEN; Fujita Health University; Kyoto University; Murdoch Children's Research Institute; University of Melbourne	Enomoto, H (corresponding author), RIKEN, Ctr Dev Biol, Lab Neuronal Differentiat & Regenerat, Kobe, Hyogo, Japan.	enomoto@cdb.riken.jp	Uesaka, Toshihiro/L-6310-2013; Young, Heather/A-2652-2013	Young, Heather/0000-0002-0457-8710; Uesaka, Toshihiro/0000-0002-3420-1746; Nagasawa, Takashi/0000-0002-1085-0960; Newgreen, Donald/0000-0002-3467-6389	RIKEN; Ministry of Education, Science, Sports and Culture, Japan [21390122, 22122005]; Grants-in-Aid for Scientific Research [24700358, 22390096] Funding Source: KAKEN	RIKEN; Ministry of Education, Science, Sports and Culture, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We are indebted to T. Attie-Bitach (Hopital Necker-Enfants Malades) and J. Milbrandt (Washington University in St. Louis) for supplying human embryos and Ret-EGFP knock-in mice, respectively. We also thank H. Niwa, members of the Enomoto laboratory and the Laboratory for Animal Resources and Genetic Engineering for their excellent technical assistance. We are also grateful to D. Sipp for editing this manuscript. This work was supported by RIKEN and by a Grant-in-Aid for Scientific Research (B, 21390122, H. E.) and Scientific Research on Innovative Areas "Cellular and Molecular Basis for Neuro-Vascular Wiring" (22122005) from the Ministry of Education, Science, Sports and Culture, Japan.	Airaksinen MS, 2002, NAT REV NEUROSCI, V3, P383, DOI 10.1038/nrn812; Amiel J, 2008, J MED GENET, V45, P1, DOI 10.1136/jmg.2007.053959; BADNER JA, 1990, AM J HUM GENET, V46, P568; Baloh RH, 2000, CURR OPIN NEUROBIOL, V10, P103, DOI 10.1016/S0959-4388(99)00048-3; Burns AJ, 1998, DEVELOPMENT, V125, P4335; Burzynski G, 2009, NEUROGASTROENT MOTIL, V21, P113, DOI 10.1111/j.1365-2982.2008.01256.x; COVENTRY S, 1994, LAB INVEST, V71, P82; Druckenbrod NR, 2007, DEV DYNAM, V236, P84, DOI 10.1002/dvdy.20974; Emison ES, 2005, NATURE, V434, P857, DOI 10.1038/nature03467; Enomoto H, 2001, DEVELOPMENT, V128, P3963; Enomoto H, 1998, NEURON, V21, P317, DOI 10.1016/S0896-6273(00)80541-3; Fernandez RM, 2009, ANN HUM GENET, V73, P19, DOI 10.1111/j.1469-1809.2008.00479.x; Furness J.B., 2006, ENTERIC NERVOUS SYST; Garcia-Barcelo MM, 2009, P NATL ACAD SCI USA, V106, P2694, DOI 10.1073/pnas.0809630105; Hayashi S, 2002, DEV BIOL, V244, P305, DOI 10.1006/dbio.2002.0597; Hearn CJ, 1999, DEV DYNAM, V214, P239, DOI 10.1002/(SICI)1097-0177(199903)214:3<239::AID-AJA7>3.0.CO;2-O; Jain S, 2006, J NEUROSCI, V26, P11230, DOI 10.1523/JNEUROSCI.1876-06.2006; KAPUR RP, 1995, PEDIATR PATHOL LAB M, V15, P23, DOI 10.3109/15513819509026937; Kulesa PM, 2008, DEV BIOL, V316, P275, DOI 10.1016/j.ydbio.2008.01.029; Laranjeira C, 2009, AUTON NEUROSCI-BASIC, V151, P61, DOI 10.1016/j.autneu.2009.09.001; LEDOUARIN NM, 1986, SCIENCE, V231, P1515, DOI 10.1126/science.3952494; Lee HO, 2003, DEV BIOL, V259, P162, DOI 10.1016/S0012-1606(03)00160-X; Moore MW, 1996, NATURE, V382, P76, DOI 10.1038/382076a0; Natarajan D, 2002, DEVELOPMENT, V129, P5151; Okamoto N, 1997, J MED GENET, V34, P670, DOI 10.1136/jmg.34.8.670; Plaza-Menacho I, 2006, TRENDS GENET, V22, P627, DOI 10.1016/j.tig.2006.09.005; Popsueva A, 2003, J CELL BIOL, V161, P119, DOI 10.1083/jcb.200212174; Ruiz-Ferrer M, 2008, J PEDIATR SURG, V43, P1308, DOI 10.1016/j.jpedsurg.2008.02.076; Simpson MJ, 2007, DEV BIOL, V302, P553, DOI 10.1016/j.ydbio.2006.10.017; Tachibana K, 1998, NATURE, V393, P591, DOI 10.1038/31261; Tsutsui H, 2005, EMBO REP, V6, P233, DOI 10.1038/sj.embor.7400361; Uesaka T, 2008, J CLIN INVEST, V118, P1890, DOI 10.1172/JCI34425; Uesaka T, 2007, DEVELOPMENT, V134, P2171, DOI 10.1242/dev.001388; YNTEMA CL, 1954, J COMP NEUROL, V101, P515, DOI 10.1002/cne.901010212; Young HM, 2004, DEV BIOL, V270, P455, DOI 10.1016/j.ydbio.2004.03.015; Young HM, 1998, DEV BIOL, V202, P67, DOI 10.1006/dbio.1998.8987; Young HM, 2003, J COMP NEUROL, V456, P1, DOI 10.1002/cne.10448; Young HM, 2001, DEV BIOL, V229, P503, DOI 10.1006/dbio.2000.0100; Zhu L, 2004, NAT GENET, V36, P732, DOI 10.1038/ng1371	39	106	109	0	33	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	SEP	2012	15	9					1211	U64		10.1038/nn.3184	http://dx.doi.org/10.1038/nn.3184			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	996GJ	22902718				2022-12-28	WOS:000308072600011
J	Bats, C; Soto, D; Studniarczyk, D; Farrant, M; Cull-Candy, SG				Bats, Cecile; Soto, David; Studniarczyk, Dorota; Farrant, Mark; Cull-Candy, Stuart G.			Channel properties reveal differential expression of TARPed and TARPless AMPARs in stargazer neurons	NATURE NEUROSCIENCE			English	Article							CEREBELLAR STELLATE CELLS; MUTANT MOUSE STARGAZER; 2 DISTINCT MECHANISMS; SYNAPTIC PLASTICITY; RECEPTOR FUNCTION; GLUTAMATE RECEPTORS; NEUROTRANSMITTER RELEASE; DEPENDENT SWITCH; GAMMA-SUBUNIT; TRAFFICKING	Dynamic regulation of calcium-permeable AMPA receptors (CP-AMPARs) is important for normal synaptic transmission, plasticity and pathological changes. Although the involvement of transmembrane AMPAR regulatory proteins (TARPs) in trafficking of calcium-impermeable AMPARs (CI-AMPARs) has been extensively studied, their role in the surface expression and function of CP-AMPARs remains unclear. We examined AMPAR-mediated currents in cerebellar stellate cells from stargazer mice, which lack the prototypical TARP stargazin (gamma-2). We found a marked increase in the contribution of CP-AMPARs to synaptic responses, indicating that, unlike CI-AMPARs, these can localize at synapses in the absence of gamma-2. In contrast with CP-AMPARs in extrasynaptic regions, synaptic CP-AMPARs displayed an unexpectedly low channel conductance and strong block by intracellular spermine, suggesting that they were 'TARPless'. As a proof of principle that TARP association is not an absolute requirement for AMPAR clustering at synapses, miniature excitatory postsynaptic currents mediated by TARPless AMPARs were readily detected in stargazer granule cells following knockdown of their only other TARP, gamma-7.	[Bats, Cecile; Soto, David; Studniarczyk, Dorota; Farrant, Mark; Cull-Candy, Stuart G.] UCL, Dept Neurosci Physiol & Pharmacol, London, England	University of London; University College London	Farrant, M (corresponding author), UCL, Dept Neurosci Physiol & Pharmacol, London, England.	m.farrant@ucl.ac.uk; s.cull-candy@ucl.ac.uk	Soto, David/L-4403-2014	Soto, David/0000-0001-7995-3805; Farrant, Mark/0000-0002-9918-0376; Studniarczyk, Dorota/0000-0003-4109-7956; Cull-Candy, Stuart G/0000-0002-0831-8326; Bats, Cecile/0000-0002-2246-7248	Wellcome Trust; Medical Research Council; Marie Curie Intra-European Fellowship; MRC [MR/J002976/1] Funding Source: UKRI; Medical Research Council [MR/J002976/1] Funding Source: researchfish	Wellcome Trust(Wellcome Trust); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Marie Curie Intra-European Fellowship(European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank all members of the S.G.C.-C./M.F. laboratory for invaluable discussions. We are grateful to L. Kelly and A.V. Stempel for help during the early stages of the project and to I. Coombs for assistance with molecular biology. M. Yamasaki and M. Watanabe (Hokkaido University Graduate School of Medicine) generously shared unpublished data with us. We thank G. Szab6 (Institute of Experimental Medicine) for GAD65-eGFP mice, kindly provided by M. Hausser (Wolfson Institute, University College London), and M. Hastings (Medical Research Council, Laboratory of Molecular Biology) for stargazer mice. This work was supported by a Wellcome Trust Programme Grant (S.G.C.-C. and M.F.) and a Medical Research Council Programme Grant (S.G.C.-C. and M.F.). C.B. was supported by a Marie Curie Intra-European Fellowship.	Bats C, 2007, NEURON, V53, P719, DOI 10.1016/j.neuron.2007.01.030; Bedoukian MA, 2006, J BIOL CHEM, V281, P23908, DOI 10.1074/jbc.M600679200; Bellone C, 2006, NAT NEUROSCI, V9, P636, DOI 10.1038/nn1682; Bowie D, 1998, J NEUROSCI, V18, P8175; Cathala L, 2005, NAT NEUROSCI, V8, P1310, DOI 10.1038/nn1534; Chavez AE, 2006, NATURE, V443, P705, DOI 10.1038/nature05123; Chen L, 2000, NATURE, V408, P936, DOI 10.1038/35050030; Cho CH, 2007, NEURON, V55, P890, DOI 10.1016/j.neuron.2007.08.024; Chung CH, 2008, J NEUROPHYSIOL, V100, P2089, DOI 10.1152/jn.90404.2008; Clark BA, 2002, J NEUROSCI, V22, P4428, DOI 10.1523/JNEUROSCI.22-11-04428.2002; Cull-Candy S, 2006, CURR OPIN NEUROBIOL, V16, P288, DOI 10.1016/j.conb.2006.05.012; Feldmeyer D, 1999, NAT NEUROSCI, V2, P57, DOI 10.1038/4561; Fiszman ML, 2005, J NEUROSCI, V25, P2024, DOI 10.1523/JNEUROSCI.4980-04.2005; Fukaya M, 2005, NEUROSCI RES, V53, P376, DOI 10.1016/j.neures.2005.08.009; Gardner SM, 2005, NEURON, V45, P903, DOI 10.1016/j.neuron.2005.02.026; Gill MB, 2011, J NEUROSCI, V31, P6928, DOI 10.1523/JNEUROSCI.6271-10.2011; Hashimoto K, 1999, J NEUROSCI, V19, P6027, DOI 10.1523/JNEUROSCI.19-14-06027.1999; Isaac JTR, 2007, NEURON, V54, P859, DOI 10.1016/j.neuron.2007.06.001; Jackson AC, 2011, J NEUROSCI, V31, P3939, DOI 10.1523/JNEUROSCI.5134-10.2011; Kato AS, 2007, J NEUROSCI, V27, P4969, DOI 10.1523/JNEUROSCI.5561-06.2007; Kelly L, 2009, NAT NEUROSCI, V12, P593, DOI 10.1038/nn.2309; Korber C, 2007, J NEUROSCI, V27, P8442, DOI 10.1523/JNEUROSCI.0424-07.2007; Kott S, 2009, NEUROSCIENCE, V158, P78, DOI 10.1016/j.neuroscience.2007.12.047; Kudoh SN, 2002, BIOSENS BIOELECTRON, V17, P773, DOI 10.1016/S0956-5663(02)00053-2; Kwak S, 2006, CURR OPIN NEUROBIOL, V16, P281, DOI 10.1016/j.conb.2006.05.004; Leitch B, 2009, J COMP NEUROL, V512, P52, DOI 10.1002/cne.21890; Letts VA, 1998, NAT GENET, V19, P340, DOI 10.1038/1228; Liu SJ, 2007, TRENDS NEUROSCI, V30, P126, DOI 10.1016/j.tins.2007.01.006; Liu SQJ, 2005, NAT NEUROSCI, V8, P768, DOI 10.1038/nn1468; Liu SQJ, 2002, J NEUROSCI, V22, P3881, DOI 10.1523/JNEUROSCI.22-10-03881.2002; Liu SQJ, 2000, NATURE, V405, P454, DOI 10.1038/35013064; Liu Y, 2010, NAT NEUROSCI, V13, P223, DOI 10.1038/nn.2474; Lopez-Bendito G, 2004, CEREB CORTEX, V14, P1122, DOI 10.1093/cercor/bhh072; Meng HD, 2006, BRAIN RES, V1124, P197, DOI 10.1016/j.brainres.2006.09.086; Menuz K, 2008, J NEUROSCI, V28, P8740, DOI 10.1523/JNEUROSCI.1319-08.2008; Menuz K, 2007, SCIENCE, V318, P815, DOI 10.1126/science.1146317; Milstein AD, 2007, NEURON, V55, P905, DOI 10.1016/j.neuron.2007.08.022; Priel A, 2005, J NEUROSCI, V25, P2682, DOI 10.1523/JNEUROSCI.4834-04.2005; Richardson CA, 2005, J COMP NEUROL, V481, P145, DOI 10.1002/cne.20386; Rossi B, 2008, J PHYSIOL-LONDON, V586, P5129, DOI 10.1113/jphysiol.2008.159921; Rozov A, 1999, NATURE, V401, P594, DOI 10.1038/44151; Schnell E, 2002, P NATL ACAD SCI USA, V99, P13902, DOI 10.1073/pnas.172511199; Soto D, 2007, NAT NEUROSCI, V10, P1260, DOI 10.1038/nn1966; Soto D, 2009, NAT NEUROSCI, V12, P277, DOI 10.1038/nn.2266; Sun L, 2007, J PHYSIOL-LONDON, V583, P537, DOI 10.1113/jphysiol.2007.136788; Swanson GT, 1997, J NEUROSCI, V17, P58, DOI 10.1523/JNEUROSCI.17-01-00058.1997; Tardin C, 2003, EMBO J, V22, P4656, DOI 10.1093/emboj/cdg463; Tomita S, 2005, NATURE, V435, P1052, DOI 10.1038/nature03624; Tomita S, 2003, J CELL BIOL, V161, P805, DOI 10.1083/jcb.200212116; Toth K, 1998, NAT NEUROSCI, V1, P572, DOI 10.1038/2807; TRAYNELIS SF, 1993, NEURON, V11, P279, DOI 10.1016/0896-6273(93)90184-S; Traynelis SF, 2010, PHARMACOL REV, V62, P405, DOI 10.1124/pr.109.002451; Turetsky D, 2005, J NEUROSCI, V25, P7438, DOI 10.1523/JNEUROSCI.1108-05.2005; Vandenberghe W, 2005, P NATL ACAD SCI USA, V102, P485, DOI 10.1073/pnas.0408269102; Yamazaki M, 2010, EUR J NEUROSCI, V31, P2204, DOI 10.1111/j.1460-9568.2010.07254.x	55	42	43	0	10	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JUN	2012	15	6					853	U76		10.1038/nn.3107	http://dx.doi.org/10.1038/nn.3107			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	949AI	22581185	Green Accepted			2022-12-28	WOS:000304546700012
J	Eisenberger, NI; Cole, SW				Eisenberger, Naomi I.; Cole, Steve W.			Social neuroscience and health: neurophysiological mechanisms linking social ties with physical health	NATURE NEUROSCIENCE			English	Article							ANTERIOR CINGULATE CORTEX; AUTONOMIC ACTIVITY; FEAR EXPRESSION; BRAIN MEDIATORS; LIMBIC SYSTEM; STRESS; RESPONSES; SUPPORT; HUMANS; PAIN	Although considerable research has shown the importance of social connection for physical health, little is known about the higher-level neurocognitive processes that link experiences of social connection or disconnection with health-relevant physiological responses. Here we review the key physiological systems implicated in the link between social ties and health and the neural mechanisms that may translate social experiences into downstream health-relevant physiological responses. Specifically, we suggest that threats to social connection may tap into the same neural and physiological 'alarm system' that responds to other critical survival threats, such as the threat or experience of physical harm. Similarly, experiences of social connection may tap into basic reward-related mechanisms that have inhibitory relationships with threat-related responding. Indeed, the neurocognitive correlates of social disconnection and connection may be important mediators for understanding the relationships between social ties and health.	[Eisenberger, Naomi I.] Univ Calif Los Angeles, Dept Psychol, Los Angeles, CA 90024 USA; [Cole, Steve W.] Univ Calif Los Angeles, Sch Med, Dept Med, Div Hematol Oncol, Los Angeles, CA 90024 USA; [Cole, Steve W.] Univ Calif Los Angeles, Jonsson Comprehens Canc Ctr, Los Angeles, CA 90024 USA; [Cole, Steve W.] Univ Calif Los Angeles, Cousins Ctr Psychoneuroimmunol, Semel Inst Neurosci & Human Behav, Los Angeles, CA USA; [Cole, Steve W.] Univ Calif Los Angeles, Inst Mol Biol, Los Angeles, CA 90024 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; UCLA Jonsson Comprehensive Cancer Center; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Eisenberger, NI (corresponding author), Univ Calif Los Angeles, Dept Psychol, Los Angeles, CA 90024 USA.	neisenbe@ucla.edu	Carroll, Joseph/D-1158-2011	Carroll, Joseph/0000-0003-2656-1378				Atlas LY, 2010, J NEUROSCI, V30, P12964, DOI 10.1523/JNEUROSCI.0057-10.2010; Bandler R, 2000, BRAIN RES BULL, V53, P95, DOI 10.1016/S0361-9230(00)00313-0; Bonnet MP, 2008, ANESTH ANALG, V106, P1142, DOI 10.1213/ane.0b013e318165de89; Bosch JA, 2009, PSYCHOSOM MED, V71, P877, DOI 10.1097/PSY.0b013e3181baef05; Brown SL, 2003, PSYCHOL SCI, V14, P320, DOI 10.1111/1467-9280.14461; Buchanan TW, 2010, PSYCHONEUROENDOCRINO, V35, P56, DOI 10.1016/j.psyneuen.2009.09.006; Burgos-Robles A, 2009, J NEUROSCI, V29, P8474, DOI 10.1523/JNEUROSCI.0378-09.2009; Cacioppo JT, 2009, TRENDS COGN SCI, V13, P447, DOI 10.1016/j.tics.2009.06.005; Cole SW, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-9-r189; Critchley HD, 2000, J PHYSIOL-LONDON, V523, P259, DOI 10.1111/j.1469-7793.2000.t01-1-00259.x; Critchley HD, 2005, J COMP NEUROL, V493, P154, DOI 10.1002/cne.20749; Critchley HD, 2003, BRAIN, V126, P2139, DOI 10.1093/brain/awg216; Delgado MR, 2006, BIOL PSYCHOL, V73, P39, DOI 10.1016/j.biopsycho.2006.01.006; Dickerson SS, 2004, PSYCHOL BULL, V130, P355, DOI 10.1037/0033-2909.130.3.355; Drolet G, 2001, PROG NEURO-PSYCHOPH, V25, P729, DOI 10.1016/S0278-5846(01)00161-0; Eisenberger N.I, NAT REV NEU IN PRESS; Eisenberger NI, 2007, NEUROIMAGE, V35, P1601, DOI 10.1016/j.neuroimage.2007.01.038; Eisenberger NI, 2011, J COGNITIVE NEUROSCI, V23, P3448, DOI 10.1162/jocn_a_00027; Eisenberger NI, 2011, P NATL ACAD SCI USA, V108, P11721, DOI 10.1073/pnas.1108239108; Eisenberger NI, 2003, SCIENCE, V302, P290, DOI 10.1126/science.1089134; Finch CE, 2007, BIOL HUMAN LONGEVITY; Gianaros PJ, 2004, PSYCHOPHYSIOLOGY, V41, P521, DOI 10.1111/1469-8986.2004.00179.x; HENKE PG, 1982, NEUROSCI BIOBEHAV R, V6, P381, DOI 10.1016/0149-7634(82)90047-1; Holt-Lunstad J, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000316; Inagaki TK, 2012, PSYCHOSOM MED, V74, P3, DOI 10.1097/PSY.0b013e3182359335; INSEL TR, 1992, P NATL ACAD SCI USA, V89, P5981, DOI 10.1073/pnas.89.13.5981; Irwin MR, 2011, NAT REV IMMUNOL, V11, P625, DOI 10.1038/nri3042; Kross E, 2011, P NATL ACAD SCI USA, V108, P6270, DOI 10.1073/pnas.1102693108; LUNDBERG U, 1980, J PSYCHOSOM RES, V24, P125, DOI 10.1016/0022-3999(80)90033-1; Milad MR, 2007, BIOL PSYCHIAT, V62, P1191, DOI 10.1016/j.biopsych.2007.04.032; Milad MR, 2002, NATURE, V420, P70, DOI 10.1038/nature01138; Miller G, 2009, ANNU REV PSYCHOL, V60, P501, DOI 10.1146/annurev.psych.60.110707.163551; Miller GE, 2008, BIOL PSYCHIAT, V64, P266, DOI 10.1016/j.biopsych.2008.03.017; Mobbs D, 2010, P NATL ACAD SCI USA, V107, P20582, DOI 10.1073/pnas.1009076107; Mobbs D, 2009, J NEUROSCI, V29, P12236, DOI 10.1523/JNEUROSCI.2378-09.2009; O'Connor MF, 2008, NEUROIMAGE, V42, P969, DOI 10.1016/j.neuroimage.2008.04.256; Onoda K, 2009, SOC NEUROSCI-UK, V4, P443, DOI 10.1080/17470910902955884; Panksepp J., 1998, AFFECTIVE NEUROSCIEN; Phelps EA, 2004, NEURON, V43, P897, DOI 10.1016/j.neuron.2004.08.042; Piferi RL, 2006, INT J PSYCHOPHYSIOL, V62, P328, DOI 10.1016/j.ijpsycho.2006.06.002; Pruessner JC, 2008, BIOL PSYCHIAT, V63, P234, DOI 10.1016/j.biopsych.2007.04.041; Slavich GM, 2010, P NATL ACAD SCI USA, V107, P14817, DOI 10.1073/pnas.1009164107; Sloan EK, 2007, J NEUROSCI, V27, P8857, DOI 10.1523/JNEUROSCI.1247-07.2007; Thayer JF, 2012, NEUROSCI BIOBEHAV R, V36, P747, DOI 10.1016/j.neubiorev.2011.11.009; THOMAS E, 1988, PSYCHOBIOLOGY, V16, P36; Uvnas-Moberg K, 1998, PSYCHONEUROENDOCRINO, V23, P819, DOI 10.1016/S0306-4530(98)00056-0; Wager TD, 2009, NEUROIMAGE, V47, P836, DOI 10.1016/j.neuroimage.2009.05.044; Wang JJ, 2005, P NATL ACAD SCI USA, V102, P17804, DOI 10.1073/pnas.0503082102; Zubieta JK, 2001, SCIENCE, V293, P311, DOI 10.1126/science.1060952	49	273	275	6	88	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	MAY	2012	15	5					669	674		10.1038/nn.3086	http://dx.doi.org/10.1038/nn.3086			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	932DI	22504347				2022-12-28	WOS:000303270200008
J	[Anonymous]				[Anonymous]			Focus on social neuroscience	NATURE NEUROSCIENCE			English	Editorial Material								We present a special focus on social neuroscience, bringing together several strands of research to highlight recent progress in the field.					Carroll, Joseph/D-1158-2011	Carroll, Joseph/0000-0003-2656-1378					0	6	6	0	3	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	MAY	2012	15	5					645	645						1	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	932DI	22534573	Bronze			2022-12-28	WOS:000303270200001
J	Carandini, M				Carandini, Matteo			From circuits to behavior: a bridge too far?	NATURE NEUROSCIENCE			English	Article							NEUROSCIENCE; SELECTIVITY; INHIBITION; BRAIN; MODEL	Neuroscience seeks to understand how neural circuits lead to behavior. However, the gap between circuits and behavior is too wide. An intermediate level is one of neural computations, which occur in individual neurons and populations of neurons. Some computations seem to be canonical: repeated and combined in different ways across the brain. To understand neural computations, we must record from a myriad of neurons in multiple brain regions. Understanding computation guides research in the underlying circuits and provides a language for theories of behavior.	UCL, London, England	University of London; University College London	Carandini, M (corresponding author), UCL, London, England.	matteo@carandinilab.net	Carandini, Matteo/ABD-8296-2021	Carandini, Matteo/0000-0003-4880-7682	MRC [G0800791] Funding Source: UKRI; Medical Research Council [G0800791] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		ANDERSON PW, 1972, SCIENCE, V177, P393, DOI 10.1126/science.177.4047.393; Benucci A, 2009, NAT NEUROSCI, V12, P1317, DOI 10.1038/nn.2398; BIZZI E, 1995, TRENDS NEUROSCI, V18, P442, DOI 10.1016/0166-2236(95)94494-P; Blakemore C. B., 1988, MIND MACHINE; Bower J. M, 1998, BOOK GENESIS EXPLORI; Bower J. M., 1993, BOOK GENESIS; Briggman KL, 2011, NATURE, V471, P183, DOI 10.1038/nature09818; Busse L, 2009, NEURON, V64, P931, DOI 10.1016/j.neuron.2009.11.004; Buzsaki G, 2004, NAT NEUROSCI, V7, P446, DOI 10.1038/nn1233; Carandini M, 2005, J NEUROSCI, V25, P10577, DOI 10.1523/JNEUROSCI.3726-05.2005; Carandini M, 2012, NAT REV NEUROSCI, V13, P51, DOI 10.1038/nrn3136; Depireux DA, 2001, J NEUROPHYSIOL, V85, P1220, DOI 10.1152/jn.2001.85.3.1220; DiCarlo JJ, 2002, BEHAV BRAIN RES, V135, P167, DOI 10.1016/S0166-4328(02)00162-6; DOUGLAS RJ, 1995, SCIENCE, V269, P981, DOI 10.1126/science.7638624; Graham N.V.S, 1989, VISUAL PATTERN ANAL; Grothe B, 2003, NAT REV NEUROSCI, V4, P540, DOI 10.1038/nrn1136; Harris KD, 2011, HEARING RES, V271, P37, DOI 10.1016/j.heares.2010.06.006; KOCH C, 1999, BIOPHYS COMPUTATION; Laughlin RB, 2000, P NATL ACAD SCI USA, V97, P32, DOI 10.1073/pnas.97.1.32; Laughlin RB, 2000, P NATL ACAD SCI USA, V97, P28, DOI 10.1073/pnas.97.1.28; Mainen ZF, 1996, NATURE, V382, P363, DOI 10.1038/382363a0; Markram H, 2006, NAT REV NEUROSCI, V7, P153, DOI 10.1038/nrn1848; Marr D., 1982, VISION; Marshel JH, 2010, NEURON, V67, P562, DOI 10.1016/j.neuron.2010.08.001; Priebe NJ, 2008, NEURON, V57, P482, DOI 10.1016/j.neuron.2008.02.005; Prinz AA, 2004, NAT NEUROSCI, V7, P1345, DOI 10.1038/nn1352; SEJNOWSKI TJ, 1988, SCIENCE, V241, P1299, DOI 10.1126/science.3045969; Seung HS, 2011, NATURE, V471, P170, DOI 10.1038/471170a; Waldrop MM, 2012, NATURE, V482, P456, DOI 10.1038/482456a; Watson AB, 2005, J VISION, V5, P717, DOI 10.1167/5.9.6; Weisberg DS, 2008, J COGNITIVE NEUROSCI, V20, P470, DOI 10.1162/jocn.2008.20.3.470; WHITE JG, 1986, PHILOS T R SOC B, V314, P1, DOI 10.1098/rstb.1986.0056	32	128	129	0	39	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	APR	2012	15	4					507	509		10.1038/nn.3043	http://dx.doi.org/10.1038/nn.3043			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	916PA	22449960				2022-12-28	WOS:000302114500007
J	Song, J; Sun, JQ; Moss, J; Wen, ZX; Sun, GJ; Hsu, D; Zhong, C; Davoudi, H; Christian, KM; Toni, N; Ming, GL; Song, HJ				Song, Juan; Sun, Jiaqi; Moss, Jonathan; Wen, Zhexing; Sun, Gerald J.; Hsu, Derek; Zhong, Chun; Davoudi, Heydar; Christian, Kimberly M.; Toni, Nicolas; Ming, Guo-li; Song, Hongjun			Parvalbumin interneurons mediate neuronal circuitry-neurogenesis coupling in the adult hippocampus	NATURE NEUROSCIENCE			English	Article							GENERATED NEURONS; PROLIFERATION; INTEGRATION; BEHAVIOR	Using immunohistology, electron microscopy, electrophysiology and optogenetics, we found that proliferating adult mouse hippocampal neural precursors received immature GABAergic synaptic inputs from parvalbumin-expressing interneurons. Recently shown to suppress adult quiescent neural stem cell activation, parvalbumin interneuron activation promoted newborn neuronal progeny survival and development. Our results suggest a niche mechanism involving parvalbumin interneurons that couples local circuit activity to the diametric regulation of two critical early phases of adult hippocampal neurogenesis.	[Song, Juan; Sun, Jiaqi; Wen, Zhexing; Sun, Gerald J.; Hsu, Derek; Zhong, Chun; Davoudi, Heydar; Christian, Kimberly M.; Ming, Guo-li; Song, Hongjun] Johns Hopkins Univ, Sch Med, Inst Cell Engn, Baltimore, MD 21218 USA; [Song, Juan; Wen, Zhexing; Zhong, Chun; Christian, Kimberly M.; Ming, Guo-li; Song, Hongjun] Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21205 USA; [Song, Juan] Univ N Carolina, Sch Med, Dept Pharmacol, Chapel Hill, NC USA; [Song, Juan] Univ N Carolina, Sch Med, Ctr Neurosci, Chapel Hill, NC USA; [Sun, Jiaqi] Tsinghua Univ, Sch Life Sci, Beijing 100084, Peoples R China; [Moss, Jonathan; Toni, Nicolas] Univ Lausanne, Dept Fundamental Neurosci, Lausanne, Switzerland; [Sun, Gerald J.; Ming, Guo-li; Song, Hongjun] Johns Hopkins Univ, Sch Med, Solomon H Snyder Dept Neurosci, Baltimore, MD USA; [Davoudi, Heydar] Johns Hopkins Univ, Sch Med, Dept Biomed Engn, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins University; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; Tsinghua University; University of Lausanne; Johns Hopkins University; Johns Hopkins University	Song, HJ (corresponding author), Johns Hopkins Univ, Sch Med, Inst Cell Engn, Baltimore, MD 21218 USA.	nicolas.toni@unil.ch; gming1@jhmi.edu; shongju1@jhmi.edu	Toni, Nicolas/M-2057-2014; Wen, Zhexing/B-9313-2014; Wen, Zhexing/L-1228-2018	Toni, Nicolas/0000-0001-5585-268X; Wen, Zhexing/0000-0002-1518-3845; Davoudi, Heydar/0000-0003-0094-8494; Ming, Guo-li/0000-0002-2517-6075	US National Institutes of Health [NS047344, ES021957, NS048271, HD069184]; Brain & Behavior Research Foundation; Dr. Miriam and Sheldon G. Adelson Medical Research Foundation; Maryland Stem Cell Research Fund; Swiss National Science Foundation [PP00A-119026/1]; The Brain & Behavior Research Foundationand Maryland Stem Cell Research Fund; Fondation Leenaards; Children's Tumor Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD069184] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R21ES021957] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [P20MH084018, R21MH087874, R33MH087874] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R56NS047344, R01NS047344, R37NS047344, R01NS048271] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG024984] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Brain & Behavior Research Foundation(NARSAD); Dr. Miriam and Sheldon G. Adelson Medical Research Foundation; Maryland Stem Cell Research Fund; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); The Brain & Behavior Research Foundationand Maryland Stem Cell Research Fund; Fondation Leenaards; Children's Tumor Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank members of the Song and Ming laboratories for discussion, L. Tsai and K. Deisseroth for initial help with optogenetics, and Q. Hussaini, Y. Cai and L. Liu for technical support. The electron microscopy images were acquired at the electron microscopy facility of the University of Lausanne. This work was supported by grants from the US National Institutes of Health (NS047344, ES021957) and The Brain & Behavior Research Foundation to H.S., from the US National Institutes of Health (NS048271, HD069184), the Dr. Miriam and Sheldon G. Adelson Medical Research Foundation, The Brain & Behavior Research Foundation and Maryland Stem Cell Research Fund to G.M., from the Swiss National Science Foundation (PP00A-119026/1) to N.T., from The Brain & Behavior Research Foundationand Maryland Stem Cell Research Fund to K.M.C., by postdoctoral fellowships from Maryland Stem Cell Research Fund to J. Song, Z.W. and C.Z., from the Fondation Leenaards to J.M., and by a pre-doctoral fellowship from The Children's Tumor Foundation to G.J.S.	Chambers RA, 2004, NEUROPSYCHOPHARMACOL, V29, P747, DOI 10.1038/sj.npp.1300358; Deisseroth K, 2004, NEURON, V42, P535, DOI 10.1016/S0896-6273(04)00266-1; Gao ZL, 2009, NAT NEUROSCI, V12, P1090, DOI 10.1038/nn.2385; Ge SY, 2006, NATURE, V439, P589, DOI 10.1038/nature04404; KAPLAN MS, 1984, J NEUROSCI, V4, P1429; Kim WR, 2009, EUR J NEUROSCI, V29, P1408, DOI 10.1111/j.1460-9568.2009.06693.x; Kronenberg G, 2003, J COMP NEUROL, V467, P455, DOI 10.1002/cne.10945; Kuwabara T, 2009, NAT NEUROSCI, V12, P1097, DOI 10.1038/nn.2360; Liu S, 2013, NAT NEUROSCI, V16, P89, DOI 10.1038/nn.3267; Liu XX, 2005, NAT NEUROSCI, V8, P1179, DOI 10.1038/nn1522; Mandyam CD, 2007, NEUROSCIENCE, V146, P108, DOI 10.1016/j.neuroscience.2006.12.064; Mann EO, 2007, TRENDS NEUROSCI, V30, P343, DOI 10.1016/j.tins.2007.05.003; Markwardt SJ, 2011, NAT NEUROSCI, V14, P1407, DOI 10.1038/nn.2935; Ming GL, 2011, NEURON, V70, P687, DOI 10.1016/j.neuron.2011.05.001; Sahay A, 2011, NATURE, V472, P466, DOI 10.1038/nature09817; Sierra A, 2010, CELL STEM CELL, V7, P483, DOI 10.1016/j.stem.2010.08.014; Snyder JS, 2009, J NEUROSCI, V29, P14484, DOI 10.1523/JNEUROSCI.1768-09.2009; Song J, 2012, NATURE, V489, P150, DOI 10.1038/nature11306; Tashiro A, 2006, NATURE, V442, P929, DOI 10.1038/nature05028; Tozuka Y, 2005, NEURON, V47, P803, DOI 10.1016/j.neuron.2005.08.023	20	147	151	0	33	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	DEC	2013	16	12					1728	1730		10.1038/nn.3572	http://dx.doi.org/10.1038/nn.3572			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	257VV	24212671	Green Submitted, Green Accepted			2022-12-28	WOS:000327416800008
J	Flavahan, WA; Wu, QL; Hitomi, M; Rahim, N; Kim, Y; Sloan, AE; Weil, RJ; Nakano, I; Sarkaria, JN; Stringer, BW; Day, BW; Li, MZ; Lathia, JD; Rich, JN; Hjelmeland, AB				Flavahan, William A.; Wu, Qiulian; Hitomi, Masahiro; Rahim, Nasiha; Kim, Youngmi; Sloan, Andrew E.; Weil, Robert J.; Nakano, Ichiro; Sarkaria, Jann N.; Stringer, Brett W.; Day, Bryan W.; Li, Meizhang; Lathia, Justin D.; Rich, Jeremy N.; Hjelmeland, Anita B.			Brain tumor initiating cells adapt to restricted nutrition through preferential glucose uptake	NATURE NEUROSCIENCE			English	Article							INTEGRATED GENOMIC ANALYSIS; GENE-EXPRESSION; STEM-CELLS; GLIOMA; CANCER; GLIOBLASTOMA; GLUT3; IDH1; CARCINOMA; SURVIVAL	Like all cancers, brain tumors require a continuous source of energy and molecular resources for new cell production. In normal brain, glucose is an essential neuronal fuel, but the blood-brain barrier limits its delivery. We now report that nutrient restriction contributes to tumor progression by enriching for brain tumor initiating cells (BTICs) owing to preferential BTIC survival and to adaptation of non-BTICs through acquisition of BTIC features. BTICs outcompete for glucose uptake by co-opting the high affinity neuronal glucose transporter, type 3 (Glut3, SLC2A3). BTICs preferentially express Glut3, and targeting Glut3 inhibits BTIC growth and tumorigenic potential. Glut3, but not Glut1, correlates with poor survival in brain tumors and other cancers; thus, tumor initiating cells may extract nutrients with high affinity. As altered metabolism represents a cancer hallmark, metabolic reprogramming may maintain the tumor hierarchy and portend poor prognosis.	[Flavahan, William A.; Lathia, Justin D.; Rich, Jeremy N.; Hjelmeland, Anita B.] Case Western Reserve Univ, Cleveland Clin, Dept Mol Med, Lerner Coll Med, Cleveland, OH 44106 USA; [Flavahan, William A.; Wu, Qiulian; Hitomi, Masahiro; Rahim, Nasiha; Kim, Youngmi; Lathia, Justin D.; Rich, Jeremy N.; Hjelmeland, Anita B.] Cleveland Clin, Dept Stem Cell Biol & Regenerat Med, Lerner Res Inst, Cleveland, OH 44106 USA; [Sloan, Andrew E.] Case Western Reserve Univ, Sch Med, Dept Neurol Surg, Cleveland, OH USA; [Sloan, Andrew E.] Univ Hosp Cleveland, Cleveland, OH 44106 USA; [Sloan, Andrew E.] Case Western Reserve Univ, Sch Med, Dept Pathol, Cleveland, OH 44106 USA; [Sloan, Andrew E.] Case Western Reserve Univ, Sch Med, Dept Translat Neurosci, Cleveland, OH USA; [Weil, Robert J.] Cleveland Clin, Neurol Inst, Dept Neurosurg, Cleveland, OH 44106 USA; [Weil, Robert J.] Cleveland Clin, Burkhardt Brain Tumor & Neurooncol Ctr, Neurol Inst, Cleveland, OH 44106 USA; [Nakano, Ichiro] Ohio State Univ, Med Ctr, Dardinger Lab Neurosci, Dept Neurol Surg, Columbus, OH 43210 USA; [Sarkaria, Jann N.] Mayo Clin, Dept Radiat Oncol, Rochester, MN USA; [Stringer, Brett W.; Day, Bryan W.] Queensland Inst Med Res, Brain Canc Res Unit, Brisbane, Qld 4006, Australia; [Stringer, Brett W.; Day, Bryan W.] Queensland Inst Med Res, Res Unit, Leukaemia Fdn, Brisbane, Qld 4006, Australia; [Li, Meizhang; Lathia, Justin D.] Cleveland Clin, Lerner Res Inst, Dept Cellular & Mol Med, Cleveland, OH 44106 USA	Case Western Reserve University; Cleveland Clinic Foundation; Cleveland Clinic Foundation; Case Western Reserve University; University Hospitals of Cleveland; Case Western Reserve University; Case Western Reserve University; Cleveland Clinic Foundation; Cleveland Clinic Foundation; University System of Ohio; Ohio State University; Mayo Clinic; QIMR Berghofer Medical Research Institute; QIMR Berghofer Medical Research Institute; Cleveland Clinic Foundation	Rich, JN (corresponding author), Case Western Reserve Univ, Cleveland Clin, Dept Mol Med, Lerner Coll Med, Cleveland, OH 44106 USA.	richj@ccf.org	Sloan, Andrew/AAE-9842-2020; Nakano, Ichiro/F-2076-2014; Day, Bryan/AAV-6170-2020; Day, Bryan/O-4469-2015; Rich, Jeremy/AAM-1445-2021; Lathia, Justin/AHB-8296-2022; Nakano, Ichiro/AAR-9562-2020; Stringer, Brett/GZB-1390-2022	Nakano, Ichiro/0000-0002-6734-3468; Nakano, Ichiro/0000-0002-0916-3207; Hjelmeland, Anita/0000-0003-2200-3248; Stringer, Brett/0000-0003-4552-9736; Day, Bryan/0000-0002-8948-9089	NCI NIH HHS [CA128269, CA157948, CA137443, R01 CA154130, CA101954, R01 CA129958, P30 CA016058, R01 CA169117, CA129958, U01 CA137443, R42 CA128269, K08 CA101954, K99 CA157948, R01 CA116659, CA116257, R00 CA157948, R01 CA116257, CA151522, CA116659, CA154130, UM1 CA137443, R01 CA151522] Funding Source: Medline; NINDS NIH HHS [NS063971, R01 NS063971] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA154130, R00CA157948, K08CA101954, R01CA116257, P30CA016058, K99CA157948, U01CA137443, UM1CA137443, R01CA151522, R01CA116659, R01CA129958, R01CA169117, R42CA128269] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS063971] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Baer S, 2002, LARYNGOSCOPE, V112, P393, DOI 10.1097/00005537-200202000-00034; Bao SD, 2006, NATURE, V444, P756, DOI 10.1038/nature05236; BOADO RJ, 1994, MOL BRAIN RES, V27, P51, DOI 10.1016/0169-328X(94)90183-X; BURGESS EA, 1962, CANCER RES, V22, P581; Charnley N, 2008, ONCOL REP, V20, P537, DOI 10.3892/or_00000039; Chen YJ, 2013, ENDOCRINOLOGY, V154, P1598, DOI 10.1210/en.2012-2076; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Chung JK, 2004, NUCL MED COMMUN, V25, P11, DOI 10.1097/00006231-200401000-00003; Derr RL, 2009, J CLIN ONCOL, V27, P1082, DOI 10.1200/JCO.2008.19.1098; FELLOWS LK, 1993, BRAIN RES, V604, P225, DOI 10.1016/0006-8993(93)90373-U; Freije WA, 2004, CANCER RES, V64, P6503, DOI 10.1158/0008-5472.CAN-04-0452; Galli R, 2004, CANCER RES, V64, P7011, DOI 10.1158/0008-5472.CAN-04-1364; GOULD GW, 1993, BIOCHEM J, V295, P329, DOI 10.1042/bj2950329; Heddleston JM, 2009, CELL CYCLE, V8, P3274, DOI 10.4161/cc.8.20.9701; Hjelmeland AB, 2011, CELL DEATH DIFFER, V18, P829, DOI 10.1038/cdd.2010.150; Laks DR, 2009, STEM CELLS, V27, P980, DOI 10.1002/stem.15; Lathia JD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024807; Li Z, 2009, CANCER CELL, V15, P501, DOI 10.1016/j.ccr.2009.03.018; Liu GT, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-67; Loncaster JA, 2001, CANCER RES, V61, P6394; Lu C, 2012, NATURE, V483, P474, DOI 10.1038/nature10860; Madhavan S, 2009, MOL CANCER RES, V7, P157, DOI 10.1158/1541-7786.MCR-08-0435; Mathews EH, 2011, MED HYPOTHESES, V76, P157, DOI 10.1016/j.mehy.2010.09.006; NAGAMATSU S, 1993, J NEUROCHEM, V61, P2048, DOI 10.1111/j.1471-4159.1993.tb07441.x; Noushmehr H, 2010, CANCER CELL, V17, P510, DOI 10.1016/j.ccr.2010.03.017; Novakovic B, 2013, J NUTR BIOCHEM, V24, P282, DOI 10.1016/j.jnutbio.2012.06.006; Nutt CL, 2003, CANCER RES, V63, P1602; Panopoulos AD, 2012, CELL RES, V22, P168, DOI 10.1038/cr.2011.177; Parsons DW, 2008, SCIENCE, V321, P1807, DOI 10.1126/science.1164382; Peters A, 2004, NEUROSCI BIOBEHAV R, V28, P143, DOI 10.1016/j.neubiorev.2004.03.002; Phillips HS, 2006, CANCER CELL, V9, P157, DOI 10.1016/j.ccr.2006.02.019; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; Rohle D, 2013, SCIENCE, V340, P626, DOI 10.1126/science.1236062; Ayala FRR, 2010, MOLECULES, V15, P2374, DOI 10.3390/molecules15042374; Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128; Song J, 2012, NATURE, V489, P150, DOI 10.1038/nature11306; STOPPINI L, 1991, J NEUROSCI METH, V37, P173, DOI 10.1016/0165-0270(91)90128-M; Stupp R, 2009, LANCET ONCOL, V10, P459, DOI 10.1016/S1470-2045(09)70025-7; Sun LX, 2006, CANCER CELL, V9, P287, DOI 10.1016/j.ccr.2006.03.003; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Turcan S, 2012, NATURE, V483, P479, DOI 10.1038/nature10866; Vannucci SJ, 1997, GLIA, V21, P2, DOI 10.1002/(SICI)1098-1136(199709)21:1<2::AID-GLIA2>3.0.CO;2-C; Verhaak RGW, 2010, CANCER CELL, V17, P98, DOI 10.1016/j.ccr.2009.12.020; Warburg O, 1927, J GEN PHYSIOL, V8, P519, DOI 10.1085/jgp.8.6.519; Ward PS, 2012, CANCER CELL, V21, P297, DOI 10.1016/j.ccr.2012.02.014; Widschwendter M, 2007, NAT GENET, V39, P157, DOI 10.1038/ng1941; Wong DJ, 2008, CELL STEM CELL, V2, P333, DOI 10.1016/j.stem.2008.02.009; Yan H, 2009, NEW ENGL J MED, V360, P765, DOI 10.1056/NEJMoa0808710; Yoshioka K, 1996, BBA-GEN SUBJECTS, V1289, P5, DOI 10.1016/0304-4165(95)00153-0; Younes M, 1997, ANTICANCER RES, V17, P2747; Younes M, 1997, CANCER-AM CANCER SOC, V80, P1046, DOI 10.1002/(SICI)1097-0142(19970915)80:6<1046::AID-CNCR6>3.0.CO;2-7; Yu JY, 2009, SCIENCE, V324, P797, DOI 10.1126/science.1172482	52	310	317	1	78	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	OCT	2013	16	10					1373	+		10.1038/nn.3510	http://dx.doi.org/10.1038/nn.3510			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	223HM	23995067	Green Accepted			2022-12-28	WOS:000324795300009
J	Gupta, VK; Scheunemann, L; Eisenberg, T; Mertel, S; Bhukel, A; Koemans, TS; Kramer, JM; Liu, KSY; Schroeder, S; Stunnenberg, HG; Sinner, F; Magnes, C; Pieber, TR; Dipt, S; Fiala, A; Schenck, A; Schwaerzel, M; Madeo, F; Sigrist, SJ				Gupta, Varun K.; Scheunemann, Lisa; Eisenberg, Tobias; Mertel, Sara; Bhukel, Anuradha; Koemans, Tom S.; Kramer, Jamie M.; Liu, Karen S. Y.; Schroeder, Sabrina; Stunnenberg, Hendrik G.; Sinner, Frank; Magnes, Christoph; Pieber, Thomas R.; Dipt, Shubham; Fiala, Andre; Schenck, Annette; Schwaerzel, Martin; Madeo, Frank; Sigrist, Stephan J.			Restoring polyamines protects from age-induced memory impairment in an autophagy-dependent manner	NATURE NEUROSCIENCE			English	Article							DROSOPHILA-MELANOGASTER; LIFE-SPAN; ORNITHINE-DECARBOXYLASE; DIETARY RESTRICTION; C-ELEGANS; MICE; BRAIN; SPERMIDINE; LONGEVITY; DISEASE	Age-dependent memory impairment is known to occur in several organisms, including Drosophila, mouse and human. However, the fundamental cellular mechanisms that underlie these impairments are still poorly understood, effectively hampering the development of pharmacological strategies to treat the condition. Polyamines are among the substances found to decrease with age in the human brain. We found that levels of polyamines (spermidine, putrescine) decreased in aging fruit flies, concomitant with declining memory abilities. Simple spermidine feeding not only restored juvenile polyamine levels, but also suppressed age-induced memory impairment. Ornithine decarboxylase-1, the rate-limiting enzyme for de novo polyamine synthesis, also protected olfactory memories in aged flies when expressed specifically in Kenyon cells, which are crucial for olfactory memory formation. Spermidine-fed flies showed enhanced autophagy (a form of cellular self-digestion), and genetic deficits in the autophagic machinery prevented spermidine-mediated rescue of memory impairments. Our findings indicate that autophagy is critical for suppression of memory impairments by spermidine and that polyamines, which are endogenously present, are candidates for pharmacological intervention.	[Gupta, Varun K.; Scheunemann, Lisa; Mertel, Sara; Bhukel, Anuradha; Koemans, Tom S.; Liu, Karen S. Y.; Schwaerzel, Martin; Sigrist, Stephan J.] Free Univ Berlin, Inst Biol Genet, Berlin, Germany; [Gupta, Varun K.; Bhukel, Anuradha; Liu, Karen S. Y.; Sigrist, Stephan J.] NeuroCure Charite, Berlin, Germany; [Eisenberg, Tobias; Schroeder, Sabrina; Madeo, Frank] Graz Univ, Inst Mol Biosci, Graz, Austria; [Koemans, Tom S.; Kramer, Jamie M.; Schenck, Annette] Radboud Univ Nijmegen, Med Ctr, Donders Inst Brain Cognit & Behav, Dept Human Genet,Nijmegen Ctr Mol Life Sci, NL-6525 ED Nijmegen, Netherlands; [Stunnenberg, Hendrik G.] Radboud Univ Nijmegen, Nijmegen Ctr Mol Life Sci, Fac Sci, Dept Mol Biol, NL-6525 ED Nijmegen, Netherlands; [Sinner, Frank; Magnes, Christoph; Pieber, Thomas R.] Joanneum Res Forsch GesmBH, Hlth Inst Biomed & Hlth Sci, Graz, Austria; [Sinner, Frank; Pieber, Thomas R.] Med Univ Graz, Dept Internal Med, Div Endocrinol & Metab, Graz, Austria; [Dipt, Shubham; Fiala, Andre] Univ Gottingen, D-37073 Gottingen, Germany	Free University of Berlin; University of Graz; Radboud University Nijmegen; Radboud University Nijmegen; Medical University of Graz; University of Gottingen	Sigrist, SJ (corresponding author), Free Univ Berlin, Inst Biol Genet, Berlin, Germany.	stephan.sigrist@fu-berlin.de	Gupta, Varun/ABE-1876-2020; Bhukel, Anuradha/AAU-8586-2020; Schenck, Annette/E-4514-2012; Eisenberg, Tobias/AAV-7806-2021; Fiala, André/AAA-3852-2019; Stunnenberg, Hendrik G./D-6875-2012	Bhukel, Anuradha/0000-0002-4269-1466; Schenck, Annette/0000-0002-6918-3314; Fiala, André/0000-0002-9745-5145; Stunnenberg, Hendrik G./0000-0002-0066-1576; Pieber, Thomas/0000-0003-3554-0405; Magnes, Christoph/0000-0002-5153-7444; Kramer, Jamie/0000-0002-0924-1279; Sinner, Frank Michael/0000-0002-9292-4512; Eisenberg, Tobias/0000-0003-3559-1130; Madeo, Frank/0000-0002-5070-1329	Deutsche Forschungsgemeinschaft [Exc257, FOR1363]; DynAge Focus Area (Freie Universitat Berlin); European Union [HEALTH-241995]; Netherlands Organization for Scientific Research [917-96-346]; BMBF (BCCNII) [01GQ1005A]; Emmy Noether Program; FWF [LIPOTOX, P23490, P24381, I1000]; Austrian Academy of Sciences;  [A6/SFB 958]; Austrian Science Fund (FWF) [P 23490, P 24381] Funding Source: researchfish	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); DynAge Focus Area (Freie Universitat Berlin); European Union(European Commission); Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO)); BMBF (BCCNII)(Federal Ministry of Education & Research (BMBF)); Emmy Noether Program(German Research Foundation (DFG)); FWF(Austrian Science Fund (FWF)); Austrian Academy of Sciences; ; Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	We would like to thank T. Neufeld (University of Minnesota), L. Luo (Stanford University) and the Bloomington Stock Center for fly stocks, and S. Gaumer (University Versailles) for ref(2) P antibody. We are also grateful to M.G. Holt and B. Gerber for critically reading the manuscript. This work was supported by grants from the Deutsche Forschungsgemeinschaft to S.J.S. (Exc257, FOR1363), as well as A6/SFB 958 and DynAge Focus Area (Freie Universitat Berlin) to S.J.S., the European Union (FP7 Gencodys HEALTH-241995) to H.G.S. and A.S., a VIDI grant from the Netherlands Organization for Scientific Research (917-96-346) to A.S., the BMBF (BCCNII, grant number 01GQ1005A) to A.F., and the Emmy Noether Program to M.S. F.M. is grateful to the FWF for grants LIPOTOX, P23490, P24381 and I1000 (DACH). T.E. is recipient of an APART fellowship of the Austrian Academy of Sciences.	Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Bartlett BJ, 2011, AUTOPHAGY, V7, P572, DOI 10.4161/auto.7.6.14943; Bateman JR, 2006, GENETICS, V173, P769, DOI 10.1534/genetics.106.056945; Bishop NA, 2010, NATURE, V464, P529, DOI 10.1038/nature08983; Burger JMS, 2010, AGING CELL, V9, P327, DOI 10.1111/j.1474-9726.2010.00560.x; Byun JA, 2008, BIOMED CHROMATOGR, V22, P73, DOI 10.1002/bmc.898; Chang YY, 2009, MOL BIOL CELL, V20, P2004, DOI 10.1091/mbc.E08-12-1250; DAS R, 1982, EXP GERONTOL, V17, P95, DOI 10.1016/0531-5565(82)90042-0; Davis RL, 2005, ANNU REV NEUROSCI, V28, P275, DOI 10.1146/annurev.neuro.28.061604.135651; Demontis F, 2010, CELL, V143, P813, DOI 10.1016/j.cell.2010.10.007; Dubnau J, 2003, CURR BIOL, V13, P286, DOI 10.1016/S0960-9822(03)00064-2; Eisenberg T, 2009, NAT CELL BIOL, V11, P1305, DOI 10.1038/ncb1975; Elliott DA, 2010, CLIN LIPIDOL, V5, P555, DOI 10.2217/CLP.10.37; Estes PS, 1996, J NEUROSCI, V16, P5443; Feany MB, 2000, NATURE, V404, P394, DOI 10.1038/35006074; Fischer A, 2007, NATURE, V447, P178, DOI 10.1038/nature05772; Groth AC, 2004, GENETICS, V166, P1775, DOI 10.1534/genetics.166.4.1775; Hansen M, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0040024; Hara T, 2006, NATURE, V441, P885, DOI 10.1038/nature04724; HEISENBERG M, 1985, J NEUROGENET, V2, P1, DOI 10.3109/01677068509100140; Heisenberg M, 2003, NAT REV NEUROSCI, V4, P266, DOI 10.1038/nrn1074; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Hulsen T, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-488; Isabel G, 2004, SCIENCE, V304, P1024, DOI 10.1126/science.1094932; Juhasz G, 2007, GENE DEV, V21, P3061, DOI 10.1101/gad.1600707; Keleman K, 2012, NATURE, V489, P145, DOI 10.1038/nature11345; Klionsky DJ, 2008, AUTOPHAGY, V4, P151, DOI 10.4161/auto.5338; Komatsu M, 2007, CELL, V131, P1149, DOI 10.1016/j.cell.2007.10.035; Komatsu M, 2006, NATURE, V441, P880, DOI 10.1038/nature04723; Lee J.A., 2012, EXP NEUROBIOL, V21, P1, DOI DOI 10.5607/EN.2012.21.1.1; Liu P, 2008, NEUROSCIENCE, V155, P789, DOI 10.1016/j.neuroscience.2008.06.033; Liu X, 2009, NAT NEUROSCI, V12, P53, DOI 10.1038/nn.2235; McGuire SE, 2003, SCIENCE, V302, P1765, DOI 10.1126/science.1089035; Melendez A, 2003, SCIENCE, V301, P1387, DOI 10.1126/science.1087782; MINOCHA R, 1994, J PLANT GROWTH REGUL, V13, P187, DOI 10.1007/BF00226036; Minois N, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.139; Minois N, 2011, AGING-US, V3, P716, DOI 10.18632/aging.100361; Mizushima N, 1998, NATURE, V395, P395, DOI 10.1038/26506; Morselli E, 2011, J CELL BIOL, V192, P615, DOI 10.1083/jcb.201008167; Nakatogawa H, 2007, CELL, V130, P165, DOI 10.1016/j.cell.2007.05.021; Nezis IP, 2008, J CELL BIOL, V180, P1065, DOI 10.1083/jcb.200711108; Pankiv S, 2007, J BIOL CHEM, V282, P24131, DOI 10.1074/jbc.M702824200; Pegg AE, 2006, J BIOL CHEM, V281, P14529, DOI 10.1074/jbc.R500031200; Peleg S, 2010, SCIENCE, V328, P753, DOI 10.1126/science.1186088; QUINN WG, 1976, NATURE, V262, P576, DOI 10.1038/262576a0; Rubinsztein DC, 2011, CELL, V146, P682, DOI 10.1016/j.cell.2011.07.030; Saitoe M, 2005, REV NEUROSCIENCE, V16, P137; Schwartz CE, 2011, METHODS MOL BIOL, V720, P437, DOI 10.1007/978-1-61779-034-8_28; Simonsen A, 2008, AUTOPHAGY, V4, P176, DOI 10.4161/auto.5269; Tamura T, 2003, NEURON, V40, P1003, DOI 10.1016/S0896-6273(03)00732-3; Tian L, 2009, NAT METHODS, V6, P875, DOI 10.1038/nmeth.1398; Tonoki A, 2012, P NATL ACAD SCI USA, V109, P6319, DOI 10.1073/pnas.1118126109; TULLY T, 1985, J COMP PHYSIOL A, V157, P263, DOI 10.1007/BF01350033; Vivo M, 2001, NEUROSCI LETT, V304, P107, DOI 10.1016/S0304-3940(01)01776-1; Wang IF, 2012, P NATL ACAD SCI USA, V109, P15024, DOI 10.1073/pnas.1206362109; Xia SZ, 2005, CURR BIOL, V15, P603, DOI 10.1016/j.cub.2005.02.059; Xie ZP, 2008, MOL BIOL CELL, V19, P3290, DOI 10.1091/mbc.E07-12-1292; Yamazaki D, 2007, NAT NEUROSCI, V10, P478, DOI 10.1038/nn1863; Zarnack K, 2013, CELL, V152, P453, DOI 10.1016/j.cell.2012.12.023; Zhou C, 2012, J NEUROSCI, V32, P14281, DOI 10.1523/JNEUROSCI.0517-12.2012	60	213	224	5	52	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	OCT	2013	16	10					1453	+		10.1038/nn.3512	http://dx.doi.org/10.1038/nn.3512			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	223HM	23995066				2022-12-28	WOS:000324795300018
J	Korb, E; Wilkinson, CL; Delgado, RN; Lovero, KL; Finkbeiner, S				Korb, Erica; Wilkinson, Carol L.; Delgado, Ryan N.; Lovero, Kathryn L.; Finkbeiner, Steven			Arc in the nucleus regulates PML-dependent GluA1 transcription and homeostatic plasticity	NATURE NEUROSCIENCE			English	Article							LONG-TERM POTENTIATION; CYTOSKELETON-ASSOCIATED PROTEIN; EARLY GENE ARC/ARG3.1; SYNAPTIC PLASTICITY; MESSENGER-RNA; ACTIN POLYMERIZATION; DENTATE GYRUS; EXPRESSION; CONSOLIDATION; TRANSLATION	The activity-regulated cytoskeletal protein Arc (also known as Arg3.1) is required for long-term memory formation and synaptic plasticity. Arc expression is robustly induced by activity, and Arc protein localizes to both active synapses and the nucleus. Whereas its synaptic function has been examined, it is not clear why or how Arc is localized to the nucleus. We found that murine Arc nuclear expression is regulated by synaptic activity in vivo and in vitro. We identified distinct regions of Arc that control its localization, including a nuclear localization signal, a nuclear retention domain and a nuclear export signal. Arc localization to the nucleus promotes an activity-induced increase in the expression of promyelocytic leukemia nuclear bodies, which decreases GluA1 (also called Gria1) transcription and synaptic strength. We further show that Arc nuclear localization regulates homeostatic plasticity. Thus, Arc mediates the homeostatic response to increased activity by translocating to the nucleus, increasing promyelocytic leukemia protein expression and decreasing GluA1 transcription, ultimately downscaling synaptic strength.	[Korb, Erica; Finkbeiner, Steven] Gladstone Inst Neurol Dis, San Francisco, CA USA; [Korb, Erica; Wilkinson, Carol L.; Lovero, Kathryn L.; Finkbeiner, Steven] Univ Calif San Francisco, Neurosci Grad Program, San Francisco, CA 94143 USA; [Delgado, Ryan N.; Finkbeiner, Steven] Univ Calif San Francisco, Biomed Sci Program, San Francisco, CA 94143 USA; [Finkbeiner, Steven] Gladstone Inst, Taube Koret Ctr Neurodegenerat Dis, San Francisco, CA USA; [Finkbeiner, Steven] Gladstone Inst, Hellman Family Fdn Program Alzheimers Dis Res, San Francisco, CA USA; [Finkbeiner, Steven] Univ Calif San Francisco, Dept Neurol, San Francisco, CA USA; [Finkbeiner, Steven] Univ Calif San Francisco, Dept Physiol, San Francisco, CA USA	University of California System; University of California San Francisco; The J David Gladstone Institutes; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; The J David Gladstone Institutes; University of California System; University of California San Francisco; The J David Gladstone Institutes; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Finkbeiner, S (corresponding author), Gladstone Inst Neurol Dis, San Francisco, CA USA.	sfinkbeiner@gladstone.ucsf.edu		Korb, Erica/0000-0002-7064-8123	Ruth L. Kirschstein Fellowship [5 F31 MH087009]; National Institute of Neurological Disease and Stroke [2 R01 NS39074)]; National Institute on Aging [2 P01 AG022074]; J. David Gladstone Institutes; Keck Foundation; US National Institutes of Health Extramural Research Facilities Improvement Project [RR018928]; NATIONAL CENTER FOR RESEARCH RESOURCES [C06RR018928] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007618] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [F31MH087009] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS045191, R01NS039074] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG022074] Funding Source: NIH RePORTER	Ruth L. Kirschstein Fellowship(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Neurological Disease and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); J. David Gladstone Institutes(University of California System); Keck Foundation(W.M. Keck Foundation); US National Institutes of Health Extramural Research Facilities Improvement Project(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank R. Truant (McMaster University) for the GFP-beta-gal construct, B. Henderson (University of Sydney) for the GFP-NLS-NES construct, R. Dingledine (Emory University) for the GluA1-luciferase and GluA2-luciferase constructs, P. Pandolfi (Sloan-Kettering Institute) for the eGFP-PML construct, D. Bredt (University of California San Francisco) for the eGFP-PSD95 construct, R. Everett (MRC-Universit of Glasgow Centre for Virus Research) for the PML and ICP0 construct and J. Ahn (Sungkyunkwan University School of Medicine) for the IE1 constructs. We thank members of the Finkbeiner lab, L. Jan, R. Edwards and N. Krogan for helpful suggestions and G. Howard for editorial input. E. K. was supported by a Ruth L. Kirschstein Fellowship (5 F31 MH087009). Primary support for this work was provided by the National Institute of Neurological Disease and Stroke (2 R01 NS39074), the National Institute on Aging (2 P01 AG022074) and the J. David Gladstone Institutes (S.F.), as well as the Keck Foundation (S.F.). The animal care facility was partly supported by a US National Institutes of Health Extramural Research Facilities Improvement Project (RR018928).	Alberi L, 2011, NEURON, V69, P437, DOI 10.1016/j.neuron.2011.01.004; Anggono V, 2011, J NEUROSCI, V31, P2188, DOI 10.1523/JNEUROSCI.5633-10.2011; Arrasate M, 2005, P NATL ACAD SCI USA, V102, P3840, DOI 10.1073/pnas.0409777102; Beique JC, 2011, P NATL ACAD SCI USA, V108, P816, DOI 10.1073/pnas.1017914108; Bernardi R, 2007, NAT REV MOL CELL BIO, V8, P1006, DOI 10.1038/nrm2277; Bloomer WAC, 2008, J BIOL CHEM, V283, P582, DOI 10.1074/jbc.M702451200; Bloomer WAC, 2007, BRAIN RES, V1153, P20, DOI 10.1016/j.brainres.2007.03.079; Borden KLB, 2002, MOL CELL BIOL, V22, P5259, DOI 10.1128/MCB.22.15.5259-5269.2002; Borges K, 2001, J BIOL CHEM, V276, P25929, DOI 10.1074/jbc.M009105200; Boutell C, 2003, J VIROL, V77, P8686, DOI 10.1128/JVI.77.16.8686-8694.2003; Bramham CR, 2011, EXP BRAIN RES, V209, P317, DOI 10.1007/s00221-011-2570-x; Bramham CR, 2010, EXP BRAIN RES, V200, P125, DOI 10.1007/s00221-009-1959-2; Brough D, 2005, J CELL SCI, V118, P3019, DOI 10.1242/jcs.02426; Chai YH, 1999, HUM MOL GENET, V8, P673, DOI 10.1093/hmg/8.4.673; Chowdhury S, 2006, NEURON, V52, P445, DOI 10.1016/j.neuron.2006.08.033; Everett RD, 2006, J VIROL, V80, P7995, DOI 10.1128/JVI.00734-06; Gao M, 2010, J NEUROSCI, V30, P7168, DOI 10.1523/JNEUROSCI.1067-10.2010; Goold CP, 2010, NEURON, V68, P512, DOI 10.1016/j.neuron.2010.09.020; Greer PL, 2010, CELL, V140, P704, DOI 10.1016/j.cell.2010.01.026; Guzowski JF, 2000, J NEUROSCI, V20, P3993; Henderson BR, 2000, EXP CELL RES, V256, P213, DOI 10.1006/excr.2000.4825; Huang F, 2007, J NEUROSCI, V27, P9054, DOI 10.1523/JNEUROSCI.2410-07.2007; Ibata K, 2008, NEURON, V57, P819, DOI 10.1016/j.neuron.2008.02.031; Kawashima T, 2009, P NATL ACAD SCI USA, V106, P316, DOI 10.1073/pnas.0806518106; Korb E, 2011, TRENDS NEUROSCI, V34, P591, DOI 10.1016/j.tins.2011.08.007; Lee HR, 2004, J VIROL, V78, P6527, DOI 10.1128/JVI.78.12.6527-6542.2004; Lu B, 2003, LEARN MEMORY, V10, P86, DOI 10.1101/lm.54603; LYFORD GL, 1995, NEURON, V14, P433, DOI 10.1016/0896-6273(95)90299-6; McAllister AK, 1999, ANNU REV NEUROSCI, V22, P295, DOI 10.1146/annurev.neuro.22.1.295; Messaoudi E, 2007, J NEUROSCI, V27, P10445, DOI 10.1523/JNEUROSCI.2883-07.2007; Moga DE, 2004, NEUROSCIENCE, V125, P7, DOI 10.1016/j.neuroscience.2004.02.004; O'Brien RJ, 1998, NEURON, V21, P1067, DOI 10.1016/S0896-6273(00)80624-8; Panja D, 2009, J BIOL CHEM, V284, P31498, DOI 10.1074/jbc.M109.056077; Park S, 2008, NEURON, V59, P70, DOI 10.1016/j.neuron.2008.05.023; Peebles CL, 2010, P NATL ACAD SCI USA, V107, P18173, DOI 10.1073/pnas.1006546107; Pintchovski SA, 2009, J NEUROSCI, V29, P1525, DOI 10.1523/JNEUROSCI.5575-08.2009; Plath N, 2006, NEURON, V52, P437, DOI 10.1016/j.neuron.2006.08.024; Ramirez-Amaya V, 2005, J NEUROSCI, V25, P1761, DOI 10.1523/JNEUROSCI.4342-04.2005; Rao VR, 2006, NAT NEUROSCI, V9, P887, DOI 10.1038/nn1708; Regad T, 2009, NAT NEUROSCI, V12, P132, DOI 10.1038/nn.2251; Rodriguez JJ, 2005, EUR J NEUROSCI, V21, P2384, DOI 10.1111/j.1460-9568.2005.04068.x; Shepherd JD, 2006, NEURON, V52, P475, DOI 10.1016/j.neuron.2006.08.034; Skinner PJ, 1997, NATURE, V389, P971, DOI 10.1038/40153; Sorg G, 1999, BIOTECHNIQUES, V26, P858, DOI 10.2144/99265bm12; St-Germain JR, 2008, EPIGENETICS-US, V3, P342, DOI 10.4161/epi.3.6.7203; Steward O, 1998, NEURON, V21, P741, DOI 10.1016/S0896-6273(00)80591-7; Sun Q, 2011, J NEUROSCI, V31, P6800, DOI 10.1523/JNEUROSCI.5616-10.2011; Tyler WJ, 2002, LEARN MEMORY, V9, P224, DOI 10.1101/lm.51202; Verde EMR, 2006, NEURON, V52, P461, DOI 10.1016/j.neuron.2006.09.031; Wang KH, 2006, CELL, V126, P389, DOI 10.1016/j.cell.2006.06.038; Waung MW, 2008, NEURON, V59, P84, DOI 10.1016/j.neuron.2008.05.014; Yamada M, 2001, AM J PATHOL, V159, P1785, DOI 10.1016/S0002-9440(10)63025-8; Yamada M, 2001, ANN NEUROL, V49, P14, DOI 10.1002/1531-8249(200101)49:1<14::AID-ANA5>3.0.CO;2-X; Zhong S, 2000, NAT CELL BIOL, V2, pE85, DOI 10.1038/35010583	54	96	97	0	21	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUL	2013	16	7					874	U266		10.1038/nn.3429	http://dx.doi.org/10.1038/nn.3429			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	174UM	23749147	Green Accepted, Green Submitted			2022-12-28	WOS:000321180900020
J	Bahl, A; Ammer, G; Schilling, T; Borst, A				Bahl, Armin; Ammer, Georg; Schilling, Tabea; Borst, Alexander			Object tracking in motion-blind flies	NATURE NEUROSCIENCE			English	Article							FIGURE-GROUND DISCRIMINATION; VISUAL ORIENTATION BEHAVIOR; DROSOPHILA-MELANOGASTER; RELATIVE MOTION; NEURONAL BASIS; MOVEMENT DETECTORS; MUSCA-DOMESTICA; NEURAL CIRCUIT; FLIGHT TORQUE; LOBULA PLATE	Different visual features of an object, such as its position and direction of motion, are important elements for animal orientation, but the neural circuits extracting them are generally not well understood. We analyzed this problem in Drosophila, focusing on two well-studied behaviors known as optomotor response and fixation response. In the neural circuit controlling the optomotor response, columnar T4 and T5 cells are thought to be crucial. We found that blocking T4 and T5 cells resulted in a complete loss of the optomotor response. Nevertheless, these flies were still able to fixate a black bar, although at a reduced performance level. Further analysis revealed that flies in which T4 and T5 cells were blocked possess an intact position circuit that is implemented in parallel to the motion circuit; the optomotor response is exclusively controlled by the motion circuit, whereas the fixation response is supported by both the position and the motion circuit.	[Bahl, Armin; Ammer, Georg; Schilling, Tabea; Borst, Alexander] Max Planck Inst Neurobiol, D-82152 Martinsried, Germany	Max Planck Society	Bahl, A (corresponding author), Max Planck Inst Neurobiol, D-82152 Martinsried, Germany.	bahl@neuro.mpg.de; borst@neuro.mpg.de		Bahl, Armin/0000-0001-7591-5860				Aptekar JW, 2012, CURR BIOL, V22, P482, DOI 10.1016/j.cub.2012.01.044; BAUSENWEIN B, 1992, CELL TISSUE RES, V270, P25, DOI 10.1007/BF00381876; BAUSENWEIN B, 1992, CELL TISSUE RES, V267, P17, DOI 10.1007/BF00318687; BAUSENWEIN B, 1986, J NEUROGENET, V3, P87, DOI 10.3109/01677068609106897; BLONDEAU J, 1982, J COMP PHYSIOL, V145, P321, DOI 10.1007/BF00619336; Borst A, 2009, CURR BIOL, V19, pR36, DOI 10.1016/j.cub.2008.11.001; BRAND AH, 1993, DEVELOPMENT, V118, P401; BUCHNER E, 1976, BIOL CYBERN, V24, P85, DOI 10.1007/BF00360648; Cuntz H, 2003, P NATL ACAD SCI USA, V100, P11082, DOI 10.1073/pnas.1830705100; EGELHAAF M, 1985, BIOL CYBERN, V52, P267, DOI 10.1007/BF00336983; EGELHAAF M, 1985, BIOL CYBERN, V52, P195; EGELHAAF M, 1985, BIOL CYBERN, V52, P123, DOI 10.1007/BF00364003; Eichner H, 2011, NEURON, V70, P1155, DOI 10.1016/j.neuron.2011.03.028; GEIGER G, 1981, NATURE, V293, P398, DOI 10.1038/293398a0; GOTZ KG, 1964, KYBERNETIK, V2, P77, DOI 10.1007/BF00288561; Gotz KG, 1980, DEV NEUROBIOLOGY DRO, P391; HAUSEN K, 1990, J NEUROSCI, V10, P351; HEISENBERG M, 1978, J COMP PHYSIOL, V124, P287, DOI 10.1007/BF00661379; Heisenberg M., 1984, VISION DROSOPHILA GE; Joesch M, 2008, CURR BIOL, V18, P368, DOI 10.1016/j.cub.2008.02.022; Joesch M, 2010, NATURE, V468, P300, DOI 10.1038/nature09545; Kitamoto T, 2001, J NEUROBIOL, V47, P81, DOI 10.1002/neu.1018; Liang P, 2012, J NEUROPHYSIOL, V107, P3446, DOI 10.1152/jn.00530.2011; Maimon G, 2008, CURR BIOL, V18, P464, DOI 10.1016/j.cub.2008.02.054; MEINERTZHAGEN IA, 1991, J COMP NEUROL, V305, P232, DOI 10.1002/cne.903050206; Mronz M, 2008, J EXP BIOL, V211, P2026, DOI 10.1242/jeb.008268; Pfeiffer BD, 2008, P NATL ACAD SCI USA, V105, P9715, DOI 10.1073/pnas.0803697105; PICK B, 1974, Z NATURFORSCH C, VC 29, P310; POGGIO T, 1973, KYBERNETIK, V12, P185, DOI 10.1007/BF00270572; REICHARDT W, 1987, J COMP PHYSIOL A, V161, P533, DOI 10.1007/BF00603660; REICHARDT W, 1969, NATURWISSENSCHAFTEN, V56, P424, DOI 10.1007/BF00593644; REICHARDT W, 1979, BIOL CYBERN, V35, P81, DOI 10.1007/BF00337434; Reiser MB, 2010, J EXP BIOL, V213, P1771, DOI 10.1242/jeb.035147; Rister J, 2007, NEURON, V56, P155, DOI 10.1016/j.neuron.2007.09.014; Schnell B, 2010, J NEUROPHYSIOL, V103, P1646, DOI 10.1152/jn.00950.2009; Schnell B, 2012, J COMP PHYSIOL A, V198, P389, DOI 10.1007/s00359-012-0716-3; Seelig JD, 2010, NAT METHODS, V7, P535, DOI [10.1038/NMETH.1468, 10.1038/nmeth.1468]; Strauss R, 1998, J COMP PHYSIOL A, V182, P411, DOI 10.1007/s003590050190; Tammero LF, 2002, J EXP BIOL, V205, P327; WARZECHA AK, 1992, NEUROSCI LETT, V141, P119, DOI 10.1016/0304-3940(92)90348-B; WEHRHAHN C, 1978, BIOL CYBERN, V29, P237, DOI 10.1007/BF00337281; WEHRHAHN C, 1981, BIOL CYBERN, V40, P213, DOI 10.1007/BF00453371; WOLF R, 1986, NATURE, V323, P154, DOI 10.1038/323154a0	43	98	98	1	27	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JUN	2013	16	6					730	+		10.1038/nn.3386	http://dx.doi.org/10.1038/nn.3386			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	152DE	23624513				2022-12-28	WOS:000319509600015
J	Goldberg, JA; Guzman, JN; Estep, CM; Ilijic, E; Kondapalli, J; Sanchez-Padilla, J; Surmeier, DJ				Goldberg, Joshua A.; Guzman, Jaime N.; Estep, Chad M.; Ilijic, Ema; Kondapalli, Jyothisri; Sanchez-Padilla, Javier; Surmeier, D. James			Calcium entry induces mitochondrial oxidant stress in vagal neurons at risk in Parkinson's disease	NATURE NEUROSCIENCE			English	Article							DORSAL MOTOR NUCLEUS; CHANNEL BLOCKERS; I-H; CA2+; HYPERPOLARIZATION; PACEMAKING; CURRENTS; VAGUS	Mitochondrial oxidant stress is widely viewed as being critical to pathogenesis in Parkinson's disease. But the origins of this stress are poorly defined. One possibility is that it arises from the metabolic demands associated with regenerative activity. To test this hypothesis, we characterized neurons in the dorsal motor nucleus of the vagus (DMV), a population of cholinergic neurons that show signs of pathology in the early stages of Parkinson's disease, in mouse brain slices. DMV neurons were slow, autonomous pacemakers with broad spikes, leading to calcium entry that was weakly buffered. Using a transgenic mouse expressing a redox-sensitive optical probe targeted to the mitochondrial matrix, we found that calcium entry during pacemaking created a basal mitochondrial oxidant stress. Knocking out DJ-1 (also known as PARK7), a gene associated with early-onset Parkinson's disease, exacerbated this stress. These results point to a common mechanism underlying mitochondrial oxidant stress in Parkinson's disease and a therapeutic strategy to ameliorate it.	[Goldberg, Joshua A.; Guzman, Jaime N.; Estep, Chad M.; Ilijic, Ema; Kondapalli, Jyothisri; Sanchez-Padilla, Javier; Surmeier, D. James] NW Univ Chicago, Feinberg Sch Med, Dept Physiol, Chicago, IL USA	Northwestern University; Feinberg School of Medicine	Surmeier, DJ (corresponding author), NW Univ Chicago, Feinberg Sch Med, Dept Physiol, Chicago, IL USA.	j-surmeier@northwestern.edu	Goldberg, Joshua/B-3398-2009	Goldberg, Joshua/0000-0002-5740-4087	Hartman Foundation; IDP Foundation; Picower Foundation; US National Institutes of Health [P50 NS047085, T32 NS041234]; Department of Defense [W81XWH-11-1-051]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [T32NS041234, P30NS054850, P50NS047085] Funding Source: NIH RePORTER	Hartman Foundation; IDP Foundation; Picower Foundation; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense(United States Department of Defense); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank Y. Chen, S. Ulrich, K. Saporito and D. Ren for their expert technical help. We thank R. Miller for valuable discussions. This work was supported by grants from the Hartman Foundation, the IDP Foundation, the Picower Foundation, the US National Institutes of Health (P50 NS047085 and T32 NS041234) and the Department of Defense (W81XWH-11-1-051) to D.J.S.	ALBIN RL, 1995, TRENDS NEUROSCI, V18, P63; Bean BP, 2007, NAT REV NEUROSCI, V8, P451, DOI 10.1038/nrn2148; Becker C, 2008, NEUROLOGY, V70, P1438, DOI 10.1212/01.wnl.0000303818.38960.44; Biskup S, 2006, BIOESSAYS, V28, P963, DOI 10.1002/bies.20471; Bohnen NI, 2011, BEHAV BRAIN RES, V221, P564, DOI 10.1016/j.bbr.2009.12.048; Braak H, 2004, CELL TISSUE RES, V318, P121, DOI 10.1007/s00441-004-0956-9; BROWN GC, 1992, BIOCHEM J, V284, P1; de Lau LML, 2006, LANCET NEUROL, V5, P525, DOI 10.1016/S1474-4422(06)70471-9; DELEON M, 1993, BRAIN RES BULL, V32, P639, DOI 10.1016/0361-9230(93)90167-A; Dickson DW, 2008, ACTA NEUROPATHOL, V115, P437, DOI 10.1007/s00401-008-0345-7; Dooley CT, 2004, J BIOL CHEM, V279, P22284, DOI 10.1074/jbc.M312847200; Foehring RC, 2009, J NEUROPHYSIOL, V102, P2326, DOI 10.1152/jn.00038.2009; Gao H, 2009, BRAIN RES, V1291, P40, DOI 10.1016/j.brainres.2009.07.024; GRACE AA, 1984, J NEUROSCI, V4, P2866; Guzman JN, 2010, NATURE, V468, P696, DOI 10.1038/nature09536; Guzman JN, 2009, J NEUROSCI, V29, P11011, DOI 10.1523/JNEUROSCI.2519-09.2009; Helmchen F, 1996, BIOPHYS J, V70, P1069, DOI 10.1016/S0006-3495(96)79653-4; Helton TD, 2005, J NEUROSCI, V25, P10247, DOI 10.1523/JNEUROSCI.1089-05.2005; Hirsch EC, 2009, LANCET NEUROL, V8, P382, DOI 10.1016/S1474-4422(09)70062-6; HOCHERMAN SD, 1992, J PHYSIOL-LONDON, V456, P325, DOI 10.1113/jphysiol.1992.sp019339; Ilijic E, 2011, NEUROBIOL DIS, V43, P364, DOI 10.1016/j.nbd.2011.04.007; Jellinger KA, 2008, ACTA NEUROPATHOL, V116, P1, DOI 10.1007/s00401-008-0406-y; Kahle PJ, 2009, FREE RADICAL BIO MED, V47, P1354, DOI 10.1016/j.freeradbiomed.2009.08.003; Khaliq ZM, 2010, J NEUROSCI, V30, P7401, DOI 10.1523/JNEUROSCI.0143-10.2010; Koschak A, 2001, J BIOL CHEM, V276, P22100, DOI 10.1074/jbc.M101469200; LANG DG, 1990, J PHYSIOL-LONDON, V425, P117, DOI 10.1113/jphysiol.1990.sp018095; Lees AJ, 2009, LANCET, V373, P2055, DOI 10.1016/S0140-6736(09)60492-X; Lips MB, 1999, J NEUROPHYSIOL, V82, P2936, DOI 10.1152/jn.1999.82.6.2936; Lu BX, 2007, CELL, V129, P371, DOI 10.1016/j.cell.2007.02.041; Maravall M, 2000, BIOPHYS J, V78, P2655, DOI 10.1016/S0006-3495(00)76809-3; Marras C, 2012, ANN NEUROL, V71, P362, DOI 10.1002/ana.22616; Meissner WG, 2011, NAT REV DRUG DISCOV, V10, P377, DOI 10.1038/nrd3430; MERCURI NB, 1995, EUR J NEUROSCI, V7, P462, DOI 10.1111/j.1460-9568.1995.tb00342.x; Miller VM, 2009, BRAIN RES, V1286, P165, DOI 10.1016/j.brainres.2009.05.083; MO ZL, 1992, J PHYSIOL-LONDON, V458, P561, DOI 10.1113/jphysiol.1992.sp019434; Natale G, 2008, NEUROGASTROENT MOTIL, V20, P741, DOI 10.1111/j.1365-2982.2008.01162.x; NEDERGAARD S, 1993, J PHYSIOL-LONDON, V466, P727; NEHER E, 1992, J PHYSIOL-LONDON, V450, P273, DOI 10.1113/jphysiol.1992.sp019127; Nicholls DG, 2000, PHYSIOL REV, V80, P315, DOI 10.1152/physrev.2000.80.1.315; Pasternak B, 2012, AM J EPIDEMIOL, V175, P627, DOI 10.1093/aje/kwr362; Puopolo M, 2007, J NEUROSCI, V27, P645, DOI 10.1523/JNEUROSCI.4341-06.2007; Putzier I, 2009, J NEUROSCI, V29, P15414, DOI 10.1523/JNEUROSCI.4742-09.2009; Ritz B, 2010, ANN NEUROL, V67, P600, DOI 10.1002/ana.21937; SAH P, 1991, NEURON, V7, P257, DOI 10.1016/0896-6273(91)90264-Z; Schapira AHV, 2008, LANCET NEUROL, V7, P97, DOI 10.1016/S1474-4422(07)70327-7; Sulzer D, 2007, TRENDS NEUROSCI, V30, P244, DOI 10.1016/j.tins.2007.03.009; Surmeier DJ, 2011, ANTIOXID REDOX SIGN, V14, P1289, DOI 10.1089/ars.2010.3521; TRAVAGLI RA, 1994, J NEUROPHYSIOL, V71, P1308, DOI 10.1152/jn.1994.71.4.1308; von Lewinski F, 2005, TRENDS NEUROSCI, V28, P494, DOI 10.1016/j.tins.2005.07.001; Yi MQ, 2004, J CELL BIOL, V167, P661, DOI 10.1083/jcb.200406038	50	118	119	0	39	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	OCT	2012	15	10					1414	1421		10.1038/nn.3209	http://dx.doi.org/10.1038/nn.3209			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	013VZ	22941107	Green Accepted			2022-12-28	WOS:000309335300022
J	Herb, BR; Wolschin, F; Hansen, KD; Aryee, MJ; Langmead, B; Irizarry, R; Amdam, GV; Feinberg, AP				Herb, Brian R.; Wolschin, Florian; Hansen, Kasper D.; Aryee, Martin J.; Langmead, Ben; Irizarry, Rafael; Amdam, Gro V.; Feinberg, Andrew P.			Reversible switching between epigenetic states in honeybee behavioral subcastes	NATURE NEUROSCIENCE			English	Article							GENE-EXPRESSION; DNA METHYLATION; ENCODES; MEMORY; SYSTEM; FAMILY	In honeybee societies, distinct caste phenotypes are created from the same genotype, suggesting a role for epigenetics in deriving these behaviorally different phenotypes. We found no differences in DNA methylation between irreversible worker and queen castes, but substantial differences between nurses and forager subcastes. Reverting foragers back to nurses reestablished methylation levels for a majority of genes and provides, to the best of our knowledge, the first evidence in any organism of reversible epigenetic changes associated with behavior.	[Wolschin, Florian; Amdam, Gro V.] Norwegian Univ Life Sci, Dept Chem Biotechnol & Food Sci, As, Norway; [Herb, Brian R.; Hansen, Kasper D.; Aryee, Martin J.; Feinberg, Andrew P.] Johns Hopkins Univ, Sch Med, Ctr Epigenet, Baltimore, MD USA; [Herb, Brian R.; Feinberg, Andrew P.] Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA; [Wolschin, Florian; Amdam, Gro V.] Arizona State Univ, Sch Life Sci, Tempe, AZ USA; [Hansen, Kasper D.; Langmead, Ben; Irizarry, Rafael; Feinberg, Andrew P.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Biostat, Baltimore, MD USA; [Aryee, Martin J.] Johns Hopkins Univ, Sch Med, Dept Oncol, Baltimore, MD 21205 USA; [Feinberg, Andrew P.] Johns Hopkins Univ, Sch Med, Dept Mol Biol & Genet, Baltimore, MD 21205 USA	Norwegian University of Life Sciences; Johns Hopkins University; Johns Hopkins University; Arizona State University; Arizona State University-Tempe; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins University	Amdam, GV (corresponding author), Norwegian Univ Life Sci, Dept Chem Biotechnol & Food Sci, As, Norway.	gro.amdam@asu.edu; afeinberg@jhu.edu	Langmead, Ben/F-4218-2012; Hansen, Kasper D/E-6094-2011; Aryee, Martin/AAC-8113-2020; Feinberg, Andrew/AAY-7666-2020	Langmead, Ben/0000-0003-2437-1976; Hansen, Kasper D/0000-0003-0086-0687; Feinberg, Andrew/0000-0002-8364-1991	Research Council of Norway [191699]; PEW Charitable Trust [2009-000068001]; US National Institutes of Health [1DPIOD008324]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [DP1ES022579] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD008324] Funding Source: NIH RePORTER	Research Council of Norway(Research Council of Norway); PEW Charitable Trust; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank E. Fennern, N. Baker, K. Flores and O. Kaftanoglu for assistance with colonies, bees and brain dissections, and A. Doi for reviewing the manuscript. We thank G. Klein for serving as scientific schadchen to AYE and G.V.A. after hearing them lecture on different occasions at I. Ernberg's "What is Life" series at the Karolinska Institute, without which this research would not have taken place. G.V.A. was funded by the Research Council of Norway #191699 and the PEW Charitable Trust #2009-000068001. A.P.F. was funded by US National Institutes of Health grant 1DPIOD008324.	Amdam GV, 2011, AGING CELL, V10, P18, DOI 10.1111/j.1474-9726.2010.00647.x; Barak O, 2003, EMBO J, V22, P6089, DOI 10.1093/emboj/cdg582; Elango N, 2009, P NATL ACAD SCI USA, V106, P11206, DOI 10.1073/pnas.0900301106; GoldmanLevi R, 1996, NUCLEIC ACIDS RES, V24, P3121, DOI 10.1093/nar/24.16.3121; Guo JJU, 2011, NAT NEUROSCI, V14, P1345, DOI 10.1038/nn.2900; Ji H, 2010, NATURE, V467, P338, DOI 10.1038/nature09367; Linder P, 2006, NUCLEIC ACIDS RES, V34, P4168, DOI 10.1093/nar/gkl468; Lyko F, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000506; Melicharek DJ, 2010, HUM MOL GENET, V19, P4253, DOI 10.1093/hmg/ddq348; Miller CA, 2007, NEURON, V53, P857, DOI 10.1016/j.neuron.2007.02.022; Parsyan A, 2011, NAT REV MOL CELL BIO, V12, P235, DOI 10.1038/nrm3083; ROBINSON GE, 1992, ETHOLOGY, V90, P336, DOI 10.1111/j.1439-0310.1992.tb00844.x; Suganuma T, 2008, NAT STRUCT MOL BIOL, V15, P364, DOI 10.1038/nsmb.1397; Terriente-Felix A, 2011, DEV BIOL, V350, P382, DOI 10.1016/j.ydbio.2010.12.003; TSUKIYAMA T, 1995, CELL, V83, P1021, DOI 10.1016/0092-8674(95)90217-1; Wang Y, 2006, SCIENCE, V314, P645, DOI 10.1126/science.1135213; Weaver ICG, 2004, NAT NEUROSCI, V7, P847, DOI 10.1038/nn1276; Whitfield CW, 2003, SCIENCE, V302, P296, DOI 10.1126/science.1086807; Winston M.L., 1991, BIOL HONEY BEE; Wolf C, 2012, GENES BRAIN BEHAV, V11, P3, DOI 10.1111/j.1601-183X.2011.00752.x	20	223	228	1	151	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	OCT	2012	15	10					1371	1373		10.1038/nn.3218	http://dx.doi.org/10.1038/nn.3218			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	013VZ	22983211	Green Accepted			2022-12-28	WOS:000309335300016
J	Cardoso, MMB; Sirotin, YB; Lima, B; Glushenkova, E; Das, A				Cardoso, Mariana M. B.; Sirotin, Yevgeniy B.; Lima, Bruss; Glushenkova, Elena; Das, Aniruddha			The neuroimaging signal is a linear sum of neurally distinct stimulus- and task-related components	NATURE NEUROSCIENCE			English	Article							HUMAN VISUAL-CORTEX; RAT SOMATOSENSORY CORTEX; EVENT-RELATED FMRI; NEURONAL-ACTIVITY; INTRINSIC SIGNAL; HEMODYNAMIC-RESPONSES; FUNCTIONAL-PROPERTIES; SPATIAL ATTENTION; BEHAVING MONKEYS; HUMAN V1	Neuroimaging (for example, functional magnetic resonance imaging) signals are taken as a uniform proxy for local neural activity. By simultaneously recording electrode and neuroimaging (intrinsic optical imaging) signals in alert, task-engaged macaque visual cortex, we recently observed a large anticipatory trial-related neuroimaging signal that was poorly related to local spiking or field potentials. We used these same techniques to study the interactions of this trial-related signal with stimulus-evoked responses over the full range of stimulus intensities, including total darkness. We found that the two signals could be separated, and added linearly over this full range. The stimulus-evoked component was related linearly to local spiking and, consequently, could be used to obtain precise and reliable estimates of local neural activity. The trial-related signal likely has a distinct neural mechanism, however, and failure to account for it properly could lead to substantial errors when estimating local neural spiking from the neuroimaging signal.	[Cardoso, Mariana M. B.; Lima, Bruss; Glushenkova, Elena; Das, Aniruddha] Columbia Univ, Dept Neurosci, New York, NY 10027 USA; [Cardoso, Mariana M. B.] Champalimaud Fdn, Int Neurosci Doctoral Programme, Champalimaud Neurosci Programme, Lisbon, Portugal; [Cardoso, Mariana M. B.] Inst Gulbenkian Ciencias, Oeiras, Portugal; [Sirotin, Yevgeniy B.] Rockefeller Univ, New York, NY 10021 USA	Columbia University; Fundacao Champalimaud; Instituto Gulbenkian de Ciencia; Rockefeller University	Das, A (corresponding author), Columbia Univ, Dept Neurosci, New York, NY 10027 USA.	aniruddha.das@columbia.edu	Lima, Bruss/I-9164-2016	Lima, Bruss/0000-0001-6865-2900	US National Institutes of Health [R01 EY019500, R01 NS063226]; National Research Service Award; Columbia Research Initiatives in Science and Engineering; Gatsby Initiative in Brain Circuitry; Dana Foundation Program in Brain and Immuno Imaging; Fundacao para a Ciencia e a Tecnologia [SFRH/BD/33276/2007]; NATIONAL EYE INSTITUTE [R01EY019500, P30EY019007] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS063226] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Research Service Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Columbia Research Initiatives in Science and Engineering; Gatsby Initiative in Brain Circuitry; Dana Foundation Program in Brain and Immuno Imaging; Fundacao para a Ciencia e a Tecnologia(Portuguese Foundation for Science and TechnologyEuropean Commission); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We would like to thank J. Krakauer, F. Pestili, T. Teichert, L. Paninski, G. Patel and S. Small for critical comments. The work was supported by US National Institutes of Health grants R01 EY019500 and R01 NS063226 to A. D., a National Research Service Award to Y.B.S., and grants from the Columbia Research Initiatives in Science and Engineering, the Gatsby Initiative in Brain Circuitry, and The Dana Foundation Program in Brain and Immuno Imaging to A. D. M. M. B. C. was supported by Fundacao para a Ciencia e a Tecnologia scholarship SFRH/BD/33276/2007.	ALBRECHT DG, 1982, J NEUROPHYSIOL, V48, P217, DOI 10.1152/jn.1982.48.1.217; Arieli A, 2002, J NEUROSCI METH, V114, P119, DOI 10.1016/S0165-0270(01)00507-6; ARIELI A, 1995, J NEUROPHYSIOL, V73, P2072, DOI 10.1152/jn.1995.73.5.2072; Bonhoeffer T., 1996, BRAIN MAPPING METHOD; Boynton GM, 2011, J VISION, V11, DOI 10.1167/11.5.12; Boynton GM, 1999, VISION RES, V39, P257, DOI 10.1016/S0042-6989(98)00113-8; Boynton GM, 1996, J NEUROSCI, V16, P4207, DOI 10.1523/jneurosci.16-13-04207.1996; Buckner RL, 1998, NEURON, V20, P285, DOI 10.1016/S0896-6273(00)80456-0; Cheng K, 2001, NEURON, V32, P359, DOI 10.1016/S0896-6273(01)00477-9; Cohen MS, 1997, NEUROIMAGE, V6, P93, DOI 10.1006/nimg.1997.0278; Dale AM, 1997, HUM BRAIN MAPP, V5, P329, DOI 10.1002/(SICI)1097-0193(1997)5:5<329::AID-HBM1>3.0.CO;2-5; Das A, 2011, NEUROIMAGE, V55, P1413, DOI 10.1016/j.neuroimage.2010.07.005; Devor A, 2003, NEURON, V39, P353, DOI 10.1016/S0896-6273(03)00403-3; Donner TH, 2008, J NEUROSCI, V28, P10298, DOI 10.1523/JNEUROSCI.2371-08.2008; Engel S, 1997, NATURE, V388, P68, DOI 10.1038/40398; Fox MD, 2006, NAT NEUROSCI, V9, P23, DOI 10.1038/nn1616; Friston K.J., 1994, HUM BRAIN MAPP, V1, P153, DOI DOI 10.1002/HBM.460010207; Fukuda M, 2006, J NEUROSCI, V26, P11821, DOI 10.1523/JNEUROSCI.3098-06.2006; Gardner JL, 2005, NEURON, V47, P607, DOI 10.1016/j.neuron.2005.07.016; Glover GH, 1999, NEUROIMAGE, V9, P416, DOI 10.1006/nimg.1998.0419; Grill-Spector K, 2001, ACTA PSYCHOL, V107, P293, DOI 10.1016/S0001-6918(01)00019-1; Grinvald A, 1999, MODERN TECHNIQUES NE, P893, DOI 10.1007/978-3-642-58552-4_34; Heeger DJ, 2000, NAT NEUROSCI, V3, P631, DOI 10.1038/76572; Heeger DJ, 2002, NAT REV NEUROSCI, V3, P142, DOI 10.1038/nrn730; Jack AI, 2006, NEURON, V51, P135, DOI 10.1016/j.neuron.2006.06.003; Josephs O, 1997, HUM BRAIN MAPP, V5, P243, DOI 10.1002/(SICI)1097-0193(1997)5:4<243::AID-HBM7>3.0.CO;2-3; Kalatsky VA, 2003, NEURON, V38, P529, DOI 10.1016/S0896-6273(03)00286-1; Kastner S, 1999, NEURON, V22, P751, DOI 10.1016/S0896-6273(00)80734-5; Kennerley AJ, 2009, NEUROIMAGE, V47, P1608, DOI 10.1016/j.neuroimage.2009.05.092; Krimer LS, 1998, NAT NEUROSCI, V1, P286, DOI 10.1038/1099; Larsson J, 2006, J NEUROPHYSIOL, V95, P862, DOI 10.1152/jn.00668.2005; Lee JH, 2010, NATURE, V465, P788, DOI 10.1038/nature09108; Logothetis NK, 2008, NATURE, V453, P869, DOI 10.1038/nature06976; Logothetis NK, 2001, NATURE, V412, P150, DOI 10.1038/35084005; Lucas B.D., 1981, P 7 INT JOINT C ARTI, P674, DOI DOI 10.5555/1623264.1623280; Luck SJ, 1997, J NEUROPHYSIOL, V77, P24, DOI 10.1152/jn.1997.77.1.24; MADSEN MT, 1992, PHYS MED BIOL, V37, P1597, DOI 10.1088/0031-9155/37/7/010; Maier A, 2008, NAT NEUROSCI, V11, P1193, DOI 10.1038/nn.2173; Mandeville JB, 2001, MAGNET RESON MED, V45, P443, DOI 10.1002/1522-2594(200103)45:3<443::AID-MRM1058>3.0.CO;2-3; Matsuda K, 2000, SOC NEUR ABSTR, V26, P7442; Meng M, 2005, NAT NEUROSCI, V8, P1248, DOI 10.1038/nn1518; Mukamel R, 2005, SCIENCE, V309, P951, DOI 10.1126/science.1110913; Nemoto M, 2004, J NEUROSCI, V24, P3850, DOI 10.1523/JNEUROSCI.4870-03.2004; Pestilli F, 2011, NEURON, V72, P832, DOI 10.1016/j.neuron.2011.09.025; Rees G, 2000, NAT NEUROSCI, V3, P716, DOI 10.1038/76673; Ress D, 2000, NAT NEUROSCI, V3, P940, DOI 10.1038/78856; Ress David, 2009, Front Neuroenergetics, V1, P3, DOI 10.3389/neuro.14.003.2009; Serences JT, 2004, J NEUROPHYSIOL, V92, P3538, DOI 10.1152/jn.00435.2004; Sheth SA, 2004, NEURON, V42, P347, DOI 10.1016/S0896-6273(04)00221-1; Shtoyerman E, 2000, J NEUROSCI, V20, P8111; Silver MA, 2007, J NEUROPHYSIOL, V97, P229, DOI 10.1152/jn.00677.2006; Sirotin YB, 2012, NEUROIMAGE, V59, P2783, DOI 10.1016/j.neuroimage.2011.10.019; Sirotin YB, 2009, P NATL ACAD SCI USA, V106, P18390, DOI 10.1073/pnas.0905509106; Sirotin YB, 2009, NATURE, V457, P475, DOI 10.1038/nature07664; Sylvester CM, 2007, J NEUROSCI, V27, P14424, DOI 10.1523/JNEUROSCI.3759-07.2007; Zhao FQ, 2012, NEUROIMAGE, V59, P1168, DOI 10.1016/j.neuroimage.2011.08.002	56	69	70	0	31	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	SEP	2012	15	9					1298	U172		10.1038/nn.3170	http://dx.doi.org/10.1038/nn.3170			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	996GJ	22842146	Green Accepted			2022-12-28	WOS:000308072600021
J	Effertz, T; Nadrowski, B; Piepenbrock, D; Albert, JT; Gopfert, MC				Effertz, Thomas; Nadrowski, Bjoern; Piepenbrock, David; Albert, Joerg T.; Goepfert, Martin C.			Direct gating and mechanical integrity of Drosophila auditory transducers require TRPN1	NATURE NEUROSCIENCE			English	Article							HAIR CELL; CHANNEL; NOMPC; MECHANOTRANSDUCTION; HEARING; SOUND; EAR	The elusive transduction channels for hearing are directly gated mechanically by the pull of gating springs. We found that the transient receptor potential (TRP) channel TRPN1 (NOMPC) is essential for this direct gating of Drosophila auditory transduction channels and that the channel-spring complex was disrupted if TRPN1 was lost. Our results identify TRPN1 as a mechanical constituent of the fly's auditory transduction complex that may act as the channel and/or gating spring.	[Albert, Joerg T.] UCL, Ear Inst, London, England; [Effertz, Thomas; Nadrowski, Bjoern; Piepenbrock, David; Goepfert, Martin C.] Univ Gottingen, Dept Cellular Neurobiol, Gottingen, Germany	University of London; University College London; University of Gottingen	Albert, JT (corresponding author), UCL, Ear Inst, London, England.	joerg.albert@ucl.ac.uk; mgoepfe@gwdg.de	Effertz, Thomas/E-2930-2010	Gopfert, Martin/0000-0001-8201-5334	Volkswagen Foundation; German National Academic Foundation; Biotechnology and Biological Sciences Research Council [BB/G004455/1]; German Science Foundation (DFG) [SFB889-A1]; BBSRC [BB/G004455/1] Funding Source: UKRI	Volkswagen Foundation(Volkswagen); German National Academic Foundation; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); German Science Foundation (DFG)(German Research Foundation (DFG)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	We thank R. Walker, L. Cheng, Y.-N. Jan, the Bloomington Stock Center, the Exelixis Collection at Harvard Medical School and the Nippon Consortium for fly strains. This work was supported by the Volkswagen Foundation (B.N.), the German National Academic Foundation (D. P.), Biotechnology and Biological Sciences Research Council (BB/G004455/1, J.T.A.), and the German Science Foundation (DFG, SFB889-A1, M.C.G.).	Albert JT, 2007, CURR BIOL, V17, P1000, DOI 10.1016/j.cub.2007.05.004; Arnadottir J, 2010, ANNU REV BIOPHYS, V39, P111, DOI 10.1146/annurev.biophys.37.032807.125836; Burnham K.P., 2002, MODEL SELECTION MULT, VSecond edition; Cheng LE, 2010, NEURON, V67, P373, DOI 10.1016/j.neuron.2010.07.004; Effertz T, 2011, CURR BIOL, V21, P592, DOI 10.1016/j.cub.2011.02.048; Gopfert MC, 2006, NAT NEUROSCI, V9, P999, DOI 10.1038/nn1735; Gopfert MC, 2005, P NATL ACAD SCI USA, V102, P325, DOI 10.1073/pnas.0405741102; Howard J, 2004, CURR BIOL, V14, pR224, DOI 10.1016/j.cub.2004.02.050; HOWARD J, 1988, NEURON, V1, P189, DOI 10.1016/0896-6273(88)90139-0; Kamikouchi A, 2009, NATURE, V458, P165, DOI 10.1038/nature07810; Kang LJ, 2010, NEURON, V67, P381, DOI 10.1016/j.neuron.2010.06.032; Lee J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011012; Nadrowski B, 2008, CURR BIOL, V18, P1365, DOI 10.1016/j.cub.2008.07.095; Shin JB, 2005, P NATL ACAD SCI USA, V102, P12572, DOI 10.1073/pnas.0502403102; Sidi S, 2003, SCIENCE, V301, P96, DOI 10.1126/science.1084370; Tinevez JY, 2007, BIOPHYS J, V93, P4053, DOI 10.1529/biophysj.107.108498; Walker RG, 2000, SCIENCE, V287, P2229, DOI 10.1126/science.287.5461.2229; Yorozu S, 2009, NATURE, V458, P201, DOI 10.1038/nature07843	19	57	58	2	31	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	SEP	2012	15	9					1198	U43		10.1038/nn.3175	http://dx.doi.org/10.1038/nn.3175			5	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	996GJ	22842145	Green Submitted			2022-12-28	WOS:000308072600009
J	Gruntman, E; Turner, GC				Gruntman, Eyal; Turner, Glenn C.			Integration of the olfactory code across dendritic claws of single mushroom body neurons	NATURE NEUROSCIENCE			English	Article							ODOR REPRESENTATIONS; NEURAL ACTIVITY; GAIN-CONTROL; DROSOPHILA; INPUT; MAP; ORGANIZATION; MECHANISMS; BODIES; TRANSFORMATION	In the olfactory system, sensory inputs are arranged in different glomerular channels, which respond in combinatorial ensembles to the various chemical features of an odor. We investigated where and how this combinatorial code is read out deeper in the brain. We exploited the unique morphology of neurons in the Drosophila mushroom body, which receive input on large dendritic claws. Imaging odor responses of these dendritic claws revealed that input channels with distinct odor tuning converge on individual mushroom body neurons. We determined how these inputs interact to drive the cell to spike threshold using intracellular recordings to examine mushroom body responses to optogenetically controlled input. Our results provide an elegant explanation for the characteristic selectivity of mushroom body neurons: these cells receive different types of input and require those inputs to be coactive to spike. These results establish the mushroom body as an important site of integration in the fly olfactory system.	[Gruntman, Eyal; Turner, Glenn C.] Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA; [Gruntman, Eyal; Turner, Glenn C.] Cold Spring Harbor Lab, Watson Sch Biol Sci, Cold Spring Harbor, NY 11724 USA	Cold Spring Harbor Laboratory; Cold Spring Harbor Laboratory	Turner, GC (corresponding author), Cold Spring Harbor Lab, POB 100, Cold Spring Harbor, NY 11724 USA.	turner@cshl.edu		Turner, Glenn/0000-0002-5341-2784; Gruntman, Eyal/0000-0003-1383-7347	Elisabeth Sloan Livingston fellowship; Watson School of Biological Sciences; US National Institutes of Health [R01 DC010403-01A1]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC010403] Funding Source: NIH RePORTER	Elisabeth Sloan Livingston fellowship; Watson School of Biological Sciences(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	We thank D. Tracey (Duke University), T. Clandinin (Stanford University) and the Bloomington Drosophila Stock Center for fly strains, G. Jefferis for advice on MARCM experiments, T. Hige for support with whole-cell recordings, and T. Clandinin, V. Jayaraman, G. Jefferis, S. Ranade, Y. Zhong and members of the Turner laboratory for comments on the manuscript. E.G. is supported by the Elisabeth Sloan Livingston fellowship from the Watson School of Biological Sciences. This work was funded by US National Institutes of Health grant R01 DC010403-01A1.	Akerboom J, 2012, J NEUROSCI, V32, P13819, DOI 10.1523/JNEUROSCI.2601-12.2012; Aso Y, 2009, J NEUROGENET, V23, P156, DOI 10.1080/01677060802471718; Benton R, 2009, CELL, V136, P149, DOI 10.1016/j.cell.2008.12.001; Bhandawat V, 2007, NAT NEUROSCI, V10, P1474, DOI 10.1038/nn1976; Blumhagen F, 2011, NATURE, V479, P493, DOI 10.1038/nature10633; Butcher NJ, 2012, J COMP NEUROL, V520, P2185, DOI 10.1002/cne.23037; Caron SJC, 2013, NATURE, V497, P113, DOI 10.1038/nature12063; Chou YH, 2010, NAT NEUROSCI, V13, P439, DOI 10.1038/nn.2489; Davis RL, 2011, NEURON, V70, P8, DOI 10.1016/j.neuron.2011.03.012; Davison IG, 2011, NEURON, V70, P82, DOI 10.1016/j.neuron.2011.02.047; Demmer H, 2009, J NEUROPHYSIOL, V102, P1538, DOI 10.1152/jn.00183.2009; Fiala A, 2007, CURR OPIN NEUROBIOL, V17, P720, DOI 10.1016/j.conb.2007.11.009; Hallem EA, 2006, CELL, V125, P143, DOI 10.1016/j.cell.2006.01.050; Heisenberg M, 2003, NAT REV NEUROSCI, V4, P266, DOI 10.1038/nrn1074; Honegger KS, 2011, J NEUROSCI, V31, P11772, DOI 10.1523/JNEUROSCI.1099-11.2011; Jayaraman V, 2007, FRONT NEURAL CIRCUIT, V1, DOI [10.3389/neuro.04/003.2007, 10.3389/neuro.04.003.2007]; Kazama H, 2009, NAT NEUROSCI, V12, P1136, DOI 10.1038/nn.2376; Keene AC, 2007, NAT REV NEUROSCI, V8, P341, DOI 10.1038/nrn2098; Kremer MC, 2010, CURR BIOL, V20, P1938, DOI 10.1016/j.cub.2010.09.060; LAURENT G, 1994, J NEUROSCI, V14, P2993; Laurent G, 2002, NAT REV NEUROSCI, V3, P884, DOI 10.1038/nrn964; Lee T, 1999, NEURON, V22, P451, DOI 10.1016/S0896-6273(00)80701-1; Leiss F, 2009, J COMP NEUROL, V517, P808, DOI 10.1002/cne.22184; Li H, 2013, P NATL ACAD SCI USA, V110, P12084, DOI 10.1073/pnas.1305857110; Lin HH, 2007, CELL, V128, P1205, DOI 10.1016/j.cell.2007.03.006; Marin EC, 2002, CELL, V109, P243, DOI 10.1016/S0092-8674(02)00700-6; Miura K, 2012, NEURON, V74, P1087, DOI 10.1016/j.neuron.2012.04.021; Miyamichi K, 2011, NATURE, V472, P191, DOI 10.1038/nature09714; Murthy M, 2008, NEURON, V59, P1009, DOI 10.1016/j.neuron.2008.07.040; Oertner TG, 2001, J NEUROPHYSIOL, V85, P439, DOI 10.1152/jn.2001.85.1.439; Olsen SR, 2008, NATURE, V452, P956, DOI 10.1038/nature06864; Olsen SR, 2010, NEURON, V66, P287, DOI 10.1016/j.neuron.2010.04.009; Papadopoulou M, 2011, SCIENCE, V332, P721, DOI 10.1126/science.1201835; Perez-Orive J, 2004, J NEUROSCI, V24, P6037, DOI 10.1523/JNEUROSCI.1084-04.2004; Perez-Orive J, 2002, SCIENCE, V297, P359, DOI 10.1126/science.1070502; Poo C, 2009, NEURON, V62, P850, DOI 10.1016/j.neuron.2009.05.022; Root CM, 2008, NEURON, V59, P311, DOI 10.1016/j.neuron.2008.07.003; Stettler DD, 2009, NEURON, V63, P854, DOI 10.1016/j.neuron.2009.09.005; Strausfeld NJ, 2003, MICROSC RES TECHNIQ, V62, P151, DOI 10.1002/jemt.10368; Szyszka P, 2005, J NEUROPHYSIOL, V94, P3303, DOI 10.1152/jn.00397.2005; Tanaka NK, 2004, CURR BIOL, V14, P449, DOI 10.1016/j.cub.2004.03.006; Tian L, 2009, NAT METHODS, V6, P875, DOI 10.1038/nmeth.1398; Turner GC, 2008, J NEUROPHYSIOL, V99, P734, DOI 10.1152/jn.01283.2007; Vosshall LB, 2000, CELL, V102, P147, DOI 10.1016/S0092-8674(00)00021-0; Wilson RI, 2004, SCIENCE, V303, P366, DOI 10.1126/science.1090782; Wong AM, 2002, CELL, V109, P229, DOI 10.1016/S0092-8674(02)00707-9; Xu NL, 2012, NATURE, V492, P247, DOI 10.1038/nature11601; Yaksi E, 2006, NAT METHODS, V3, P377, DOI 10.1038/NMETH874; Yu HH, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000461; Zhu SJ, 2003, DEVELOPMENT, V130, P2603, DOI 10.1242/dev.00466	50	91	91	1	24	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	DEC	2013	16	12					1821	1829		10.1038/nn.3547	http://dx.doi.org/10.1038/nn.3547			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	257VV	24141312	Green Accepted			2022-12-28	WOS:000327416800020
J	Li, LY; Li, YT; Zhou, M; Tao, HZW; Zhang, LI				Li, Ling-yun; Li, Ya-tang; Zhou, Mu; Tao, Huizhong W.; Zhang, Li I.			Intracortical multiplication of thalamocortical signals in mouse auditory cortex	NATURE NEUROSCIENCE			English	Article							VISUAL-CORTEX; ORIENTATION SELECTIVITY; RECEPTIVE-FIELDS; SIMPLE CELLS; LAYER 6; CIRCUITS; NEURONS; INHIBITION; TECHNOLOGIES; CONVERGENCE	Cortical processing of sensory information begins with the transformation of thalamically relayed signals. We optogenetically silenced intracortical circuits to isolate thalamic inputs to layer 4 neurons and found that intracortical excitation linearly amplified thalamocortical responses underlying frequency and direction selectivity, with spectral range and tuning preserved, and prolonged the response duration. This signal pre-amplification and prolongation enhanced the salience of thalamocortically relayed information and ensured its robust, faithful and more persistent representation.	[Li, Ling-yun; Li, Ya-tang; Zhou, Mu; Tao, Huizhong W.; Zhang, Li I.] Univ So Calif, Keck Sch Med, Zilkha Neurogenet Inst, Los Angeles, CA 90033 USA; [Li, Ling-yun; Li, Ya-tang; Zhou, Mu] Univ So Calif, Keck Sch Med, Grad Programs, Los Angeles, CA 90033 USA; [Tao, Huizhong W.] Univ So Calif, Keck Sch Med, Dept Cell & Neurobiol, Los Angeles, CA 90033 USA; [Zhang, Li I.] Univ So Calif, Keck Sch Med, Dept Physiol & Biophys, Los Angeles, CA 90033 USA	University of Southern California; University of Southern California; University of Southern California; University of Southern California	Zhang, LI (corresponding author), Univ So Calif, Keck Sch Med, Zilkha Neurogenet Inst, Los Angeles, CA 90033 USA.	liizhang@usc.edu	Zhou, Mu/K-8137-2016; Li, Ya-tang/AAF-2573-2020; Tao, Huizhong W/HDM-9767-2022; Li, Ya-tang/A-9583-2011	Zhou, Mu/0000-0001-5326-4884; Li, Lingyun/0000-0002-0616-6074; Li, Ya-tang/0000-0003-2763-1534	US National Institutes of Health [DC008983, EY019049]; David and Lucile Packard Foundation; NATIONAL EYE INSTITUTE [R01EY019049] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC008983] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); David and Lucile Packard Foundation(The David & Lucile Packard Foundation); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported by grants from the US National Institutes of Health (DC008983 to L.I.Z., EY019049 to H.W.T.) and the David and Lucile Packard Foundation (L.I.Z.).	Adesnik H, 2012, NATURE, V490, P226, DOI 10.1038/nature11526; Bernstein JG, 2012, CURR OPIN NEUROBIOL, V22, P61, DOI 10.1016/j.conb.2011.10.023; Bruno RM, 2006, SCIENCE, V312, P1622, DOI 10.1126/science.1124593; Callaway EM, 1998, ANNU REV NEUROSCI, V21, P47, DOI 10.1146/annurev.neuro.21.1.47; DOUGLAS RJ, 1995, SCIENCE, V269, P981, DOI 10.1126/science.7638624; Douglas RJ, 2004, ANNU REV NEUROSCI, V27, P419, DOI 10.1146/annurev.neuro.27.070203.144152; Ferster D, 1996, NATURE, V380, P249, DOI 10.1038/380249a0; Hackett TA, 2011, J NEUROSCI, V31, P2983, DOI 10.1523/JNEUROSCI.5333-10.2011; Happel MFK, 2010, J NEUROSCI, V30, P11114, DOI 10.1523/JNEUROSCI.0689-10.2010; Kaur S, 2004, J NEUROPHYSIOL, V91, P2551, DOI 10.1152/jn.01121.2003; Li YT, 2012, J NEUROSCI, V32, P16466, DOI 10.1523/JNEUROSCI.3221-12.2012; Lin JY, 2009, BIOPHYS J, V96, P1803, DOI 10.1016/j.bpj.2008.11.034; Liu BH, 2007, NAT NEUROSCI, V10, P1594, DOI 10.1038/nn2012; Liu BH, 2009, J NEUROSCI, V29, P10520, DOI 10.1523/JNEUROSCI.1915-09.2009; Ma WP, 2010, J NEUROSCI, V30, P14371, DOI 10.1523/JNEUROSCI.3248-10.2010; Margrie TW, 2002, PFLUG ARCH EUR J PHY, V444, P491, DOI 10.1007/s00424-002-0831-z; Miller KD, 2001, CURR OPIN NEUROBIOL, V11, P488, DOI 10.1016/S0959-4388(00)00239-7; Miller LM, 2001, NEURON, V32, P151, DOI 10.1016/S0896-6273(01)00445-7; Olsen SR, 2012, NATURE, V483, P47, DOI 10.1038/nature10835; SOMERS DC, 1995, J NEUROSCI, V15, P5448; Sun YJ, 2013, J NEUROSCI, V33, P5326, DOI 10.1523/JNEUROSCI.4810-12.2013; Wehr M, 2003, NATURE, V426, P442, DOI 10.1038/nature02116; Winer JA, 2005, TRENDS NEUROSCI, V28, P255, DOI 10.1016/j.tins.2005.03.009; Wu GYK, 2011, NEUROSCI BIOBEHAV R, V35, P2094, DOI 10.1016/j.neubiorev.2011.05.004; Zhang F, 2007, NAT REV NEUROSCI, V8, P577, DOI 10.1038/nrn2192; Zhang LI, 2003, NATURE, V424, P201, DOI 10.1038/nature01796; Zhang M, 2011, J NEUROSCI, V31, P5460, DOI 10.1523/JNEUROSCI.6220-10.2011; Zhou M, 2012, J NEUROSCI, V32, P18068, DOI 10.1523/JNEUROSCI.3647-12.2012; Zhou Y, 2012, J NEUROSCI, V32, P9969, DOI 10.1523/JNEUROSCI.1384-12.2012; Zhou Y, 2010, NEURON, V65, P706, DOI 10.1016/j.neuron.2010.02.021	30	79	79	2	16	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	SEP	2013	16	9					1179	U25		10.1038/nn.3493	http://dx.doi.org/10.1038/nn.3493			5	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	207KN	23933752	Green Accepted			2022-12-28	WOS:000323597500006
J	Kress, GJ; Yamawaki, N; Wokosin, DL; Wickersham, IR; Shepherd, GMG; Surmeier, DJ				Kress, Geraldine J.; Yamawaki, Naoki; Wokosin, David L.; Wickersham, Ian R.; Shepherd, Gordon M. G.; Surmeier, D. James			Convergent cortical innervation of striatal projection neurons	NATURE NEUROSCIENCE			English	Article							MOUSE MOTOR CORTEX; CORTICOSTRIATAL NEURONS; BASAL GANGLIA; CONNECTIVITY; MORPHOLOGY; PATHWAYS; RATS	Anatomical studies have led to the assertion that intratelencephalic and pyramidal tract cortical neurons innervate different striatal projection neurons. To test this hypothesis, we measured the responses of mouse striatal neurons to optogenetic activation of intratelencephalic and pyramidal tract axons. Contrary to expectation, direct and indirect pathway striatal spiny projection neurons responded to both intratelencephalic and pyramidal tract activation, arguing that these cortical networks innervate both striatal projection neurons.	[Kress, Geraldine J.; Yamawaki, Naoki; Wokosin, David L.; Shepherd, Gordon M. G.; Surmeier, D. James] Northwestern Univ, Feinberg Sch Med, Dept Physiol, Chicago, IL 60611 USA; [Wickersham, Ian R.] MIT, Media Lab, Cambridge, MA 02139 USA	Northwestern University; Feinberg School of Medicine; Massachusetts Institute of Technology (MIT)	Surmeier, DJ (corresponding author), Northwestern Univ, Feinberg Sch Med, Dept Physiol, Chicago, IL 60611 USA.	j-surmeier@northwestern.edu	Yamawaki, Naoki/AAD-5044-2022	Yamawaki, Naoki/0000-0001-8253-2059; Kress, Geraldine/0000-0001-9442-8734	National Institute of Neurological Disorders and Stroke [T32NS041234, R01NS034696, R01NS061963, P30NS054850]; CHDI Foundation; JPB Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [T32NS041234, R01NS034696, P30NS054850, R01NS061963] Funding Source: NIH RePORTER	National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); CHDI Foundation; JPB Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank S. Ulrich, K. Saporito, Y. Chen and L. Fisher for animal husbandry and genotyping, as well as members of the Shepherd and Surmeier laboratories for helpful discussions. We thank H.S. Seung (Massachusetts Institute of Technology) for providing the virus. This work is supported by grants from the National Institute of Neurological Disorders and Stroke (T32NS041234 to G.J.K., R01NS034696 to D.J.S., R01NS061963 to G.M.G.S. and P30NS054850 to D.L.W.), the CHDI Foundation and the JPB Foundation.	ALBIN RL, 1989, TRENDS NEUROSCI, V12, P366, DOI 10.1016/0166-2236(89)90074-X; Apicella AJ, 2012, J NEUROSCI, V32, P7021, DOI 10.1523/JNEUROSCI.0011-12.2012; Ballion B, 2008, EUR J NEUROSCI, V27, P2313, DOI 10.1111/j.1460-9568.2008.06192.x; Cui GH, 2013, NATURE, V494, P238, DOI 10.1038/nature11846; Gerfen CR, 2011, ANNU REV NEUROSCI, V34, P441, DOI 10.1146/annurev-neuro-061010-113641; Gerfen CR, 2010, HBK BEHAV NEUROSCI, V20, P3; GRAYBIEL AM, 1994, SCIENCE, V265, P1826, DOI 10.1126/science.8091209; Heintz N, 2001, NAT REV NEUROSCI, V2, P861, DOI 10.1038/35104049; Kiritani T, 2012, J NEUROSCI, V32, P4992, DOI 10.1523/JNEUROSCI.4759-11.2012; Lei WL, 2004, J NEUROSCI, V24, P8289, DOI 10.1523/JNEUROSCI.1990-04.2004; Morita K, 2012, TRENDS NEUROSCI, V35, P457, DOI 10.1016/j.tins.2012.04.009; Reiner A, 2003, J COMP NEUROL, V457, P420, DOI 10.1002/cne.10541; Reiner A, 2010, FRONT NEUROANAT, V4, DOI 10.3389/fnana.2010.00142; Shepherd GMG, 2013, NAT REV NEUROSCI, V14, P278, DOI 10.1038/nrn3469; Suter BA, 2010, FRONT NEURAL CIRCUIT, V4, P100, DOI DOI 10.3389/FNCIR.2010.00100; Wickersham IR, 2010, NAT PROTOC, V5, P595, DOI 10.1038/nprot.2009.248; WILSON CJ, 1987, J COMP NEUROL, V263, P567, DOI 10.1002/cne.902630408	17	99	103	2	35	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JUN	2013	16	6					665	+		10.1038/nn.3397	http://dx.doi.org/10.1038/nn.3397			4	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	152DE	23666180	Green Accepted			2022-12-28	WOS:000319509600006
J	Savtchenko, LP; Sylantyev, S; Rusakov, DA				Savtchenko, Leonid P.; Sylantyev, Sergiy; Rusakov, Dmitri A.			Central synapses release a resource-efficient amount of glutamate	NATURE NEUROSCIENCE			English	Article							MULTIVESICULAR RELEASE; PYRAMIDAL NEURONS; SYNAPTIC CLEFT; EPSCS; RECEPTORS; PATCHES; BRAIN	Why synapses release a certain amount of neurotransmitter is poorly understood. We combined patch-clamp electrophysiology with computer simulations to estimate how much glutamate is discharged at two distinct central synapses of the rat. We found that, regardless of some uncertainty over synaptic microenvironment, synapses generate the maximal current per released glutamate molecule while maximizing signal information content. Our result suggests that synapses operate on a principle of resource optimization.	[Savtchenko, Leonid P.; Sylantyev, Sergiy; Rusakov, Dmitri A.] UCL, Inst Neurol, London, England	University of London; University College London	Rusakov, DA (corresponding author), UCL, Inst Neurol, London, England.	d.rusakov@ucl.ac.uk	Rusakov, Dmitri A/E-1987-2011; Rusakov, Dmitri/AAH-4529-2021	Rusakov, Dmitri A/0000-0001-9539-9947; Rusakov, Dmitri/0000-0001-9539-9947; Sylantyev, Sergiy/0000-0002-1358-0601	Wellcome Trust; UK Medical Research Council; European Research Council Advanced Grant; Biotechnology and UK Biological Sciences Research Council; Medical Research Council [G0900613, G0802216] Funding Source: researchfish; MRC [G0900613, G0802216] Funding Source: UKRI	Wellcome Trust(Wellcome TrustEuropean Commission); UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); European Research Council Advanced Grant(European Research Council (ERC)); Biotechnology and UK Biological Sciences Research Council; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The authors thank A. Silver, D. Kullmann and K. Volynski for comments, and P. Michaluk for help with granule cell cultures. This work was supported by the Wellcome Trust, UK Medical Research Council, European Research Council Advanced Grant, and Biotechnology and UK Biological Sciences Research Council.	Alle H, 2009, SCIENCE, V325, P1405, DOI 10.1126/science.1174331; Cathala L, 2005, NAT NEUROSCI, V8, P1310, DOI 10.1038/nn1534; Christie JM, 2006, J NEUROSCI, V26, P210, DOI 10.1523/JNEUROSCI.4307-05.2006; COLQUHOUN D, 1992, J PHYSIOL-LONDON, V458, P261, DOI 10.1113/jphysiol.1992.sp019417; Cover Thomas M, 1991, ELEMENTS INFORM; Cuntz H, 2012, P NATL ACAD SCI USA, V109, P11014, DOI 10.1073/pnas.1200430109; Friston KJ, 2010, NAT REV NEUROSCI, V11, P127, DOI 10.1038/nrn2787; Harris JJ, 2012, NEURON, V75, P762, DOI 10.1016/j.neuron.2012.08.019; Hines ML, 2001, NEUROSCIENTIST, V7, P123, DOI 10.1177/107385840100700207; Magee JC, 2000, NAT NEUROSCI, V3, P895, DOI 10.1038/78800; Migliore M, 2003, J COMPUT NEUROSCI, V14, P185, DOI 10.1023/A:1021906818333; Nielsen TA, 2004, NEURON, V42, P757, DOI 10.1016/j.neuron.2004.04.003; Oertner TG, 2002, NAT NEUROSCI, V5, P657, DOI 10.1038/nn867; Savtchenko LP, 2007, P NATL ACAD SCI USA, V104, P1823, DOI 10.1073/pnas.0606636104; Silver RA, 1996, J PHYSIOL-LONDON, V493, P167, DOI 10.1113/jphysiol.1996.sp021372; Stevens CF, 1995, CURR BIOL, V5, P1370, DOI 10.1016/S0960-9822(95)00273-9; Sylantyev S, 2008, SCIENCE, V319, P1845, DOI 10.1126/science.1154330; Takamori S, 2006, CELL, V127, P831, DOI 10.1016/j.cell.2006.10.030; Wadiche JI, 2001, NEURON, V32, P301, DOI 10.1016/S0896-6273(01)00488-3; Williams SR, 2008, NAT NEUROSCI, V11, P790, DOI 10.1038/nn.2137; Zador A, 1998, J NEUROPHYSIOL, V79, P1219, DOI 10.1152/jn.1998.79.3.1219; Zheng KY, 2008, BIOPHYS J, V95, P4584, DOI 10.1529/biophysj.108.129874	22	38	38	0	19	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JAN	2013	16	1					10	U163		10.1038/nn.3285	http://dx.doi.org/10.1038/nn.3285			5	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	058KZ	23242311	Green Accepted, Green Submitted			2022-12-28	WOS:000312633900006
J	Litwin-Kumar, A; Doiron, B				Litwin-Kumar, Ashok; Doiron, Brent			Slow dynamics and high variability in balanced cortical networks with clustered connections	NATURE NEUROSCIENCE			English	Article							VISUAL-CORTEX; NEURAL VARIABILITY; COMPLEX NETWORKS; DECISION-MAKING; NEURONAL GROUPS; BEHAVING MICE; IN-VIVO; RESPONSES; CIRCUITS; MACAQUE	Anatomical studies demonstrate that excitatory connections in cortex are not uniformly distributed across a network but instead exhibit clustering into groups of highly connected neurons. The implications of clustering for cortical activity are unclear. We studied the effect of clustered excitatory connections on the dynamics of neuronal networks that exhibited high spike time variability owing to a balance between excitation and inhibition. Even modest clustering substantially changed the behavior of these networks, introducing slow dynamics during which clusters of neurons transiently increased or decreased their firing rate. Consequently, neurons exhibited both fast spiking variability and slow firing rate fluctuations. A simplified model shows how stimuli bias networks toward particular activity states, thereby reducing firing rate variability as observed experimentally in many cortical areas. Our model thus relates cortical architecture to the reported variability in spontaneous and evoked spiking activity.	[Litwin-Kumar, Ashok; Doiron, Brent] Ctr Neural Basis Cognit, Pittsburgh, PA USA; [Doiron, Brent] Univ Pittsburgh, Dept Math, Pittsburgh, PA 15260 USA; [Litwin-Kumar, Ashok] Carnegie Mellon Univ, Program Neural Computat, Pittsburgh, PA 15213 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Carnegie Mellon University	Doiron, B (corresponding author), Ctr Neural Basis Cognit, Pittsburgh, PA USA.	alk@cmu.edu; bdoiron@pitt.edu		Litwin-Kumar, Ashok/0000-0003-2422-6576	US National Science Foundation [NSFDMS-1121784]; Sloan research fellowship; US National Defense Science & Engineering Graduate Fellowship program; NATIONAL INSTITUTE ON DRUG ABUSE [T90DA022762] Funding Source: NIH RePORTER	US National Science Foundation(National Science Foundation (NSF)); Sloan research fellowship(Alfred P. Sloan Foundation); US National Defense Science & Engineering Graduate Fellowship program; NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank R. da Silveira and H. Sompolinsky for discussions that helped shape an early version of this work. We also thank B. Yu and J. de la Rocha for comments. B.D. was supported by the US National Science Foundation (NSFDMS-1121784) and a Sloan research fellowship. A.L.-K. was supported by the US National Defense Science & Engineering Graduate Fellowship program.	ABELES M, 1995, P NATL ACAD SCI USA, V92, P8616, DOI 10.1073/pnas.92.19.8616; Albert R, 2002, REV MOD PHYS, V74, P47, DOI 10.1103/RevModPhys.74.47; Amit DJ, 1997, CEREB CORTEX, V7, P237, DOI 10.1093/cercor/7.3.237; Arieli A, 1996, SCIENCE, V273, P1868, DOI 10.1126/science.273.5283.1868; Boccaletti S, 2006, PHYS REP, V424, P175, DOI 10.1016/j.physrep.2005.10.009; BRITTEN KH, 1993, VISUAL NEUROSCI, V10, P1157, DOI 10.1017/S0952523800010269; Brunel N, 2003, J NEUROPHYSIOL, V90, P415, DOI 10.1152/jn.01095.2002; Buesing L, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002211; Churchland AK, 2011, NEURON, V69, P818, DOI 10.1016/j.neuron.2010.12.037; Churchland MM, 2010, NAT NEUROSCI, V13, P369, DOI 10.1038/nn.2501; Churchland MM, 2006, J NEUROSCI, V26, P3697, DOI 10.1523/JNEUROSCI.3762-05.2006; Cohen MR, 2011, NAT NEUROSCI, V14, P811, DOI 10.1038/nn.2842; Coombes S, 2005, BIOL CYBERN, V93, P91, DOI 10.1007/s00422-005-0574-y; Deco G, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002395; Destexhe A, 2003, NAT REV NEUROSCI, V4, P739, DOI 10.1038/nrn1198; Ecker AS, 2010, SCIENCE, V327, P584, DOI 10.1126/science.1179867; Ferezou I, 2007, NEURON, V56, P907, DOI 10.1016/j.neuron.2007.10.007; Fino E, 2011, NEURON, V69, P1188, DOI 10.1016/j.neuron.2011.02.025; Gentet LJ, 2010, NEURON, V65, P422, DOI 10.1016/j.neuron.2010.01.006; Han F, 2008, NEURON, V60, P321, DOI 10.1016/j.neuron.2008.08.026; HANGGI P, 1990, REV MOD PHYS, V62, P251, DOI 10.1103/RevModPhys.62.251; Hofer SB, 2011, NAT NEUROSCI, V14, P1045, DOI 10.1038/nn.2876; Hromadka T, 2008, PLOS BIOL, V6, P124, DOI 10.1371/journal.pbio.0060016; Izhikevich EM, 2004, CEREB CORTEX, V14, P933, DOI 10.1093/cercor/bhh053; Ko H, 2011, NATURE, V473, P87, DOI 10.1038/nature09880; Kohn A, 2005, J NEUROSCI, V25, P3661, DOI 10.1523/JNEUROSCI.5106-04.2005; London M, 2010, NATURE, V466, P123, DOI 10.1038/nature09086; Luczak A, 2009, NEURON, V62, P413, DOI 10.1016/j.neuron.2009.03.014; Ma WJ, 2006, NAT NEUROSCI, V9, P1432, DOI 10.1038/nn1790; Mitchell JF, 2007, NEURON, V55, P131, DOI 10.1016/j.neuron.2007.06.018; Morrison A, 2007, NEURAL COMPUT, V19, P1437, DOI 10.1162/neco.2007.19.6.1437; Oswald AMM, 2009, J NEUROSCI, V29, P10321, DOI 10.1523/JNEUROSCI.1703-09.2009; Perin R, 2011, P NATL ACAD SCI USA, V108, P5419, DOI 10.1073/pnas.1016051108; Rajan K, 2010, PHYS REV E, V82, DOI 10.1103/PhysRevE.82.011903; Renart A, 2007, NEURAL COMPUT, V19, P1, DOI 10.1162/neco.2007.19.1.1; Renart A, 2010, SCIENCE, V327, P587, DOI 10.1126/science.1179850; Roudi Y, 2007, PLOS COMPUT BIOL, V3, P1679, DOI 10.1371/journal.pcbi.0030141; Shadlen Michael N., 1994, Current Opinion in Neurobiology, V4, P569, DOI 10.1016/0959-4388(94)90059-0; Shu YS, 2003, NATURE, V423, P288, DOI 10.1038/nature01616; Sompolinsky H., 2005, HOUCHES LECT 80 METH, P341; Song S, 2005, PLOS BIOL, V3, P507, DOI 10.1371/journal.pbio.0030068; Teich MC, 1997, J OPT SOC AM A, V14, P529, DOI 10.1364/JOSAA.14.000529; TOLHURST DJ, 1983, VISION RES, V23, P775, DOI 10.1016/0042-6989(83)90200-6; Tsodyks M, 1999, SCIENCE, V286, P1943, DOI 10.1126/science.286.5446.1943; van Vreeswijk C, 1998, NEURAL COMPUT, V10, P1321, DOI 10.1162/089976698300017214; Vogels TP, 2005, J NEUROSCI, V25, P10786, DOI 10.1523/JNEUROSCI.3508-05.2005; Wang XJ, 2002, NEURON, V36, P955, DOI 10.1016/S0896-6273(02)01092-9; Yassin L, 2010, NEURON, V68, P1043, DOI 10.1016/j.neuron.2010.11.029; Yoshimura Y, 2005, NATURE, V433, P868, DOI 10.1038/nature03252; Yoshimura Y, 2005, NAT NEUROSCI, V8, P1552, DOI 10.1038/nn1565	50	301	306	0	54	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	NOV	2012	15	11					1498	1505		10.1038/nn.3220	http://dx.doi.org/10.1038/nn.3220			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	028LX	23001062	Green Accepted			2022-12-28	WOS:000310424900009
J	Ashton, RS; Conway, A; Pangarkar, C; Bergen, J; Lim, KI; Shah, P; Bissell, M; Schaffer, DV				Ashton, Randolph S.; Conway, Anthony; Pangarkar, Chinmay; Bergen, Jamie; Lim, Kwang-Il; Shah, Priya; Bissell, Mina; Schaffer, David V.			Astrocytes regulate adult hippocampal neurogenesis through ephrin-B signaling	NATURE NEUROSCIENCE			English	Article							NEURAL STEM-CELLS; PROGENITOR CELLS; IN-VIVO; SUBVENTRICULAR ZONE; ANALYSIS REVEALS; NERVOUS-SYSTEM; SELF-RENEWAL; DIFFERENTIATION; PROLIFERATION; BRAIN	Neurogenesis in the adult hippocampus involves activation of quiescent neural stem cells (NSCs) to yield transiently amplifying NSCs, progenitors, and, ultimately, neurons that affect learning and memory. This process is tightly controlled by microenvironmental cues, although a few endogenous factors are known to regulate neuronal differentiation. Astrocytes have been implicated, but their role in juxtacrine (that is, cell-cell contact dependent) signaling in NSC niches has not been investigated. We found that ephrin-B2 presented from rodent hippocampal astrocytes regulated neurogenesis in vivo. Furthermore, clonal analysis in NSC fate-mapping studies revealed a previously unknown role for ephrin-B2 in instructing neuronal differentiation. In addition, ephrin-B2 signaling, transduced by EphB4 receptors on NSCs, activated beta-catenin in vitro and in vivo independently of Wnt signaling and upregulated proneural transcription factors. Ephrin-B2(+) astrocytes therefore promote neuronal differentiation of adult NSCs through juxtacrine signaling, findings that advance our understanding of adult neurogenesis and may have future regenerative medicine implications.	[Ashton, Randolph S.; Conway, Anthony; Bergen, Jamie; Lim, Kwang-Il; Shah, Priya; Schaffer, David V.] Univ Calif Berkeley, Dept Chem & Biomol Engn, Berkeley, CA 94720 USA; [Pangarkar, Chinmay; Bissell, Mina] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Div Life Sci, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	Schaffer, DV (corresponding author), Univ Calif Berkeley, Dept Chem & Biomol Engn, Berkeley, CA 94720 USA.	schaffer@berkeley.edu		Shah, Priya/0000-0001-7518-2839	US National Institutes of Health grant [EB007295]; Lawrence Berkeley National Lab Laboratory Directed Research and Development grant [3668DS]; California Institute of Regenerative Medicine training grant [T1-00007]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R21EB007295] Funding Source: NIH RePORTER	US National Institutes of Health grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Lawrence Berkeley National Lab Laboratory Directed Research and Development grant; California Institute of Regenerative Medicine training grant; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	We thank R. Fletcher for his guidance in mouse breeding and genotyping. This research was supported by US National Institutes of Health grant EB007295, Lawrence Berkeley National Lab Laboratory Directed Research and Development grant 3668DS and California Institute of Regenerative Medicine training grant T1-00007.	Ables JL, 2010, J NEUROSCI, V30, P10484, DOI 10.1523/JNEUROSCI.4721-09.2010; Aguirre A, 2010, NATURE, V467, P323, DOI 10.1038/nature09347; Aoki M, 2004, J BIOL CHEM, V279, P32643, DOI 10.1074/jbc.M313247200; Barkho BZ, 2006, STEM CELLS DEV, V15, P407, DOI 10.1089/scd.2006.15.407; Barrios A, 2003, CURR BIOL, V13, P1571, DOI 10.1016/j.cub.2003.08.030; Batlle E, 2002, CELL, V111, P251, DOI 10.1016/S0092-8674(02)01015-2; Bonaguidi MA, 2011, CELL, V145, P1142, DOI 10.1016/j.cell.2011.05.024; Cao L, 2004, NAT GENET, V36, P827, DOI 10.1038/ng1395; Chumley MJ, 2007, J NEUROSCI, V27, P13481, DOI 10.1523/JNEUROSCI.4158-07.2007; Conover JC, 2000, NAT NEUROSCI, V3, P1091, DOI 10.1038/80606; Davis S., 1994, DEVELOPMENT, V266, P816; del Valle K, 2011, INT J DEV NEUROSCI, V29, P9, DOI 10.1016/j.ijdevneu.2010.10.005; Ehm O, 2010, J NEUROSCI, V30, P13794, DOI 10.1523/JNEUROSCI.1567-10.2010; Ekdahl CT, 2003, P NATL ACAD SCI USA, V100, P13632, DOI 10.1073/pnas.2234031100; Elmi M, 2010, MOL CELL NEUROSCI, V45, P121, DOI 10.1016/j.mcn.2010.06.003; Eriksson PS, 1998, NAT MED, V4, P1313, DOI 10.1038/3305; Fuerer C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009370; GAGE FH, 1995, P NATL ACAD SCI USA, V92, P11879, DOI 10.1073/pnas.92.25.11879; Hara Y, 2010, STEM CELLS, V28, P974, DOI 10.1002/stem.427; Holmberg J, 2005, GENE DEV, V19, P462, DOI 10.1101/gad.326905; Jacobs S, 2006, P NATL ACAD SCI USA, V103, P3902, DOI 10.1073/pnas.0511294103; Jessberger S, 2007, J NEUROSCI, V27, P9400, DOI 10.1523/JNEUROSCI.2002-07.2007; Jiao JW, 2008, P NATL ACAD SCI USA, V105, P8778, DOI 10.1073/pnas.0708861105; Jin KL, 2003, AGING CELL, V2, P175, DOI 10.1046/j.1474-9728.2003.00046.x; Kim WY, 2009, NAT NEUROSCI, V12, P1390, DOI 10.1038/nn.2408; Knoll B, 2002, TRENDS NEUROSCI, V25, P145, DOI 10.1016/S0166-2236(00)02093-2; Kuwabara T, 2009, NAT NEUROSCI, V12, P1097, DOI 10.1038/nn.2360; Lai K, 2003, NAT NEUROSCI, V6, P21, DOI 10.1038/nn983; Lie DC, 2005, NATURE, V437, P1370, DOI 10.1038/nature04108; LOIS C, 1994, SCIENCE, V264, P1145, DOI 10.1126/science.8178174; Lugert S, 2010, CELL STEM CELL, V6, P445, DOI 10.1016/j.stem.2010.03.017; Manganas LN, 2007, SCIENCE, V318, P980, DOI 10.1126/science.1147851; Martinez A, 2005, BRAIN RES REV, V49, P211, DOI 10.1016/j.brainresrev.2005.02.001; Mira H, 2010, CELL STEM CELL, V7, P78, DOI 10.1016/j.stem.2010.04.016; Nomura T, 2010, CELL STEM CELL, V7, P730, DOI 10.1016/j.stem.2010.11.009; Pasquale EB, 2005, NAT REV MOL CELL BIO, V6, P462, DOI 10.1038/nrm1662; Picco V, 2007, DEVELOPMENT, V134, P1491, DOI 10.1242/dev.003939; Qu QH, 2010, NAT CELL BIOL, V12, P31, DOI 10.1038/ncb2001; Song SH, 2002, NATURE, V417, P39, DOI 10.1038/417039a; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Spalding KL, 2005, CELL, V122, P133, DOI 10.1016/j.cell.2005.04.028; STAMBOLIC V, 1994, BIOCHEM J, V303, P701, DOI 10.1042/bj3030701; Suh H, 2007, CELL STEM CELL, V1, P515, DOI 10.1016/j.stem.2007.09.002; Suh H, 2009, ANNU REV CELL DEV BI, V25, P253, DOI 10.1146/annurev.cellbio.042308.113256; Tattersfield AS, 2004, NEUROSCIENCE, V127, P319, DOI 10.1016/j.neuroscience.2004.04.061; Tozuka Y, 2005, NEURON, V47, P803, DOI 10.1016/j.neuron.2005.08.023; Wu HH, 2003, NEURON, V37, P197, DOI 10.1016/S0896-6273(02)01172-8; Xu NJ, 2011, NAT NEUROSCI, V14, P1421, DOI 10.1038/nn.2931	48	155	160	0	38	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	OCT	2012	15	10					1399	1406		10.1038/nn.3212	http://dx.doi.org/10.1038/nn.3212			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	013VZ	22983209	Green Accepted, Green Submitted			2022-12-28	WOS:000309335300020
J	Valerio, S; Taube, JS				Valerio, Stephane; Taube, Jeffrey S.			Path integration: how the head direction signal maintains and corrects spatial orientation	NATURE NEUROSCIENCE			English	Article							FREELY MOVING RATS; CINGULATE CORTEX; PLACE CELLS; NAVIGATION; LANDMARKS; POSTSUBICULUM; DYNAMICS; VELOCITY; MEMORY; SENSE	Head-direction cells have frequently been regarded as an internal 'compass' that can be used for navigation, although there is little evidence showing a link between their activity and spatial behavior. In a navigational task requiring the use of internal cues to return to a home location without vision (path integration), we found a robust correlation between head-direction cell activity and the rat's heading error in the rat's homing behavior. We observed two different correction processes that rats used to improve performance after an error. The more frequent one consists of 'resetting' the cell whenever the rat returns to the home location. However, we found that when large errors occur, the head-direction system has the ability to `remap' and set a new reference frame, which is then used in subsequent trials. We also offer some insight into how these two correction processes operate when rats make an error.	[Valerio, Stephane; Taube, Jeffrey S.] Dartmouth Coll, Dept Psychol & Brain Sci, Hanover, NH 03755 USA	Dartmouth College	Taube, JS (corresponding author), Dartmouth Coll, Dept Psychol & Brain Sci, Hanover, NH 03755 USA.	jeffrey.taube@dartmouth.edu			US National Institutes of Health [DC009318, NS053907]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS053907] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC009318] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	We thank R. Leaton, P. Trifieff and E. Lesburgueres for their valuable comments on the manuscript. These experiments were supported by US National Institutes of Health grants DC009318 and NS053907.	Balcita-Pedicino JJ, 2011, J COMP NEUROL, V519, P1143, DOI 10.1002/cne.22561; Bassett JP, 2001, J NEUROSCI, V21, P5740, DOI 10.1523/JNEUROSCI.21-15-05740.2001; Bouret S, 2005, TRENDS NEUROSCI, V28, P574, DOI 10.1016/j.tins.2005.09.002; Cheng K, 2008, TRENDS COGN SCI, V12, P355, DOI 10.1016/j.tics.2008.06.004; Clark BJ, 2012, HIPPOCAMPUS, V22, P172, DOI 10.1002/hipo.20880; Collett TS, 2004, CURR BIOL, V14, pR475, DOI 10.1016/j.cub.2004.06.013; Darwin C., 1873, NATURE, V7, P417, DOI [10.1038/007417a0, DOI 10.1038/007417A0]; Derdikman D, 2009, NAT NEUROSCI, V12, P1325, DOI 10.1038/nn.2396; Etienne AS, 2004, J EXP BIOL, V207, P1491, DOI 10.1242/jeb.00906; Etienne AS, 2004, HIPPOCAMPUS, V14, P180, DOI 10.1002/hipo.10173; Etienne AS, 2000, NATURWISSENSCHAFTEN, V87, P494, DOI 10.1007/s001140050766; Fiorillo CD, 2003, SCIENCE, V299, P1898, DOI 10.1126/science.1077349; Gallistel C. R., 1990, ORG LEARNING; Golob EJ, 2001, BEHAV NEUROSCI, V115, P285, DOI 10.1037/0735-7044.115.2.285; Goodridge JP, 1998, BEHAV NEUROSCI, V112, P749, DOI 10.1037/0735-7044.112.4.749; GOODRIDGE JP, 1995, BEHAV NEUROSCI, V109, P49, DOI 10.1037/0735-7044.109.1.49; Gothard KM, 1996, J NEUROSCI, V16, P8027; Gothard KM, 1996, J NEUROSCI, V16, P823; Hafting T, 2005, NATURE, V436, P801, DOI 10.1038/nature03721; Hasselmo ME, 2008, HIPPOCAMPUS, V18, P1213, DOI 10.1002/hipo.20512; Ito S, 2003, SCIENCE, V302, P120, DOI 10.1126/science.1087847; Knaden M, 2006, J EXP BIOL, V209, P26, DOI 10.1242/jeb.01976; Knierim JJ, 1998, J NEUROPHYSIOL, V80, P425, DOI 10.1152/jn.1998.80.1.425; KNIERIM JJ, 1995, J NEUROSCI, V15, P1648, DOI 10.1523/JNEUROSCI.15-03-01648.1995; Leutgeb S, 2005, SCIENCE, V309, P619, DOI 10.1126/science.1114037; MARKUS EJ, 1995, J NEUROSCI, V15, P7079; Matsumoto M, 2007, NATURE, V447, P1111, DOI 10.1038/nature05860; MCNAUGHTON BL, 1991, J COGNITIVE NEUROSCI, V3, P192, DOI 10.1162/jocn.1991.3.2.190; McNaughton BL, 2006, NAT REV NEUROSCI, V7, P663, DOI 10.1038/nrn1932; Michelet T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006240; MITTELSTAEDT ML, 1980, NATURWISSENSCHAFTEN, V67, P566, DOI 10.1007/BF00450672; Muir Gary M, 2002, Behav Cogn Neurosci Rev, V1, P297, DOI 10.1177/1534582302238339; MULLER RU, 1987, J NEUROSCI, V7, P1951; OKEEFE J, 1971, BRAIN RES, V34, P171, DOI 10.1016/0006-8993(71)90358-1; Save E., 2008, HIPPOCAMPAL PLACE FI, P138; Schultz W, 2000, ANNU REV NEUROSCI, V23, P473, DOI 10.1146/annurev.neuro.23.1.473; Sharp PE, 2001, BEHAV NEUROSCI, V115, P571, DOI 10.1037/0735-7044.115.3.571; Souman JL, 2009, CURR BIOL, V19, P1538, DOI 10.1016/j.cub.2009.07.053; Steck K, 2011, J EXP BIOL, V214, P1307, DOI 10.1242/jeb.053579; Taube JS, 2007, ANNU REV NEUROSCI, V30, P181, DOI 10.1146/annurev.neuro.29.051605.112854; Taube JS, 1998, PROG NEUROBIOL, V55, P225, DOI 10.1016/S0301-0082(98)00004-5; TAUBE JS, 1990, J NEUROSCI, V10, P420; TAUBE JS, 1995, J NEUROSCI, V15, P70; TAUBE JS, 1990, J NEUROSCI, V10, P436; van der Meer MAA, 2010, BEHAV NEUROSCI, V124, P164, DOI 10.1037/a0018446; Whishaw IQ, 2001, BEHAV BRAIN RES, V118, P67, DOI 10.1016/S0166-4328(00)00312-0; WHISHAW IQ, 1995, J NEUROSCI METH, V61, P139, DOI 10.1016/0165-0270(95)00035-S; Wiener SI, 2005, HEAD DIRECTION CELLS	48	80	80	0	23	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	OCT	2012	15	10					1445	1453		10.1038/nn.3215	http://dx.doi.org/10.1038/nn.3215			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	013VZ	22983210	Green Accepted			2022-12-28	WOS:000309335300026
J	Kishi, Y; Fujii, Y; Hirabayashi, Y; Gotoh, Y				Kishi, Yusuke; Fujii, Yuki; Hirabayashi, Yusuke; Gotoh, Yukiko			HMGA regulates the global chromatin state and neurogenic potential in neocortical precursor cells	NATURE NEUROSCIENCE			English	Article							NEURAL STEM-CELLS; PROGENITOR CELLS; SELF-RENEWAL; HISTONE H1; LET-7; PROTEINS; DIFFERENTIATION; FATE; MYC; SPECIFICATION	Neural precursor cells (NPCs) in the mouse neocortex generate various neuronal and glial cell types in a developmental stage-dependent manner. Most NPCs lose their neurogenic potential during development, although the underlying mechanisms of this process are not fully understood. We found that the chromatin of mouse NPCs gradually becomes more condensed and less dynamic on a global scale during neocortical development. Furthermore, we found high mobility group A (HMGA) proteins to be essential for the open chromatin state of NPCs at early developmental stages. Knockdown of HMGA proteins in early-stage NPCs reduced their neurogenic potential. Conversely, overexpression of HMGA proteins conferred neurogenic potential on late-stage NPCs, an effect that was antagonized by coexpression of a histone H1 mutant that inhibits chromatin opening. Thus, HMGA proteins contribute to the neurogenic potential of NPCs in the early stages of neocortical development, possibly through induction of an open chromatin state.	[Kishi, Yusuke; Fujii, Yuki; Hirabayashi, Yusuke; Gotoh, Yukiko] Univ Tokyo, Inst Mol & Cellular Biosci, Tokyo 1138654, Japan	University of Tokyo	Gotoh, Y (corresponding author), Univ Tokyo, Inst Mol & Cellular Biosci, Tokyo 1138654, Japan.	ygotoh@iam.u-tokyo.ac.jp	Kishi, Yusuke/ABG-2737-2020	Hirabayashi, Yusuke/0000-0003-3950-6781; Kishi, Yusuke/0000-0003-2846-5400	Ministry of Education, Culture, Sports, Science, and Technology (MEXT) of Japan; Innovative Areas "Neural Diversity and Neocortical Organization" of MEXT; Core Research for Evolutional Science and Technology of the Japan Science and Technology Agency; Japan Society for the Promotion of Science; MEXT; Grants-in-Aid for Scientific Research [22123003] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science, and Technology (MEXT) of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Innovative Areas "Neural Diversity and Neocortical Organization" of MEXT; Core Research for Evolutional Science and Technology of the Japan Science and Technology Agency(Core Research for Evolutional Science and Technology (CREST)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank C.L. Cepko (Harvard University), T. Matsuda (Kyoto University), T. Kitamura (The University of Tokyo), M. Nakafuku (Cincinnati Children's Hospital Medical Center and University of Cincinnati), H. Song (Johns Hopkins University) and H. Okano (Keio University) for plasmids, K. Ohsumi (Nagoya University) for antibodies, K. Tyssowski and E. Nigh for editing the manuscript, H. Okano for Nes-d4Venus mice, A. Miyajima for FACS, and members of the Gotoh laboratory for helpful discussion. This work was supported by Grants-in-Aid for Scientific Research (A) from the Ministry of Education, Culture, Sports, Science, and Technology (MEXT) of Japan, Innovative Areas "Neural Diversity and Neocortical Organization" of MEXT, by Core Research for Evolutional Science and Technology of the Japan Science and Technology Agency, by the Japan Society for the Promotion of Science, and by the Global COE Program "Integrative Life Science Based on the Study of Biosignaling Mechanisms" of MEXT.	Catez F, 2004, MOL CELL BIOL, V24, P4321, DOI 10.1128/MCB.24.10.4321-4328.2004; Chang TC, 2009, P NATL ACAD SCI USA, V106, P3384, DOI 10.1073/pnas.0808300106; Frisch M, 2002, GENOME RES, V12, P349, DOI 10.1101/gr.206602.ArticlepublishedonlinebeforeprintinJanuary2002; Fusco A, 2007, NAT REV CANCER, V7, P899, DOI 10.1038/nrc2271; Gaspar-Maia A, 2009, NATURE, V460, P863, DOI 10.1038/nature08212; GLOSTER A, 1994, J NEUROSCI, V14, P7319; Goldberg AD, 2007, CELL, V128, P635, DOI 10.1016/j.cell.2007.02.006; Hajkova P, 2008, NATURE, V452, P877, DOI 10.1038/nature06714; Heo I, 2008, MOL CELL, V32, P276, DOI 10.1016/j.molcel.2008.09.014; Hirabayashi Y, 2004, DEVELOPMENT, V131, P2791, DOI 10.1242/dev.01165; Hirabayashi Y, 2005, NEUROSCI RES, V51, P331, DOI 10.1016/j.neures.2005.01.004; Hirabayashi Y, 2010, NAT REV NEUROSCI, V11, P377, DOI 10.1038/nrn2810; Hirabayashi Y, 2009, NEURON, V63, P600, DOI 10.1016/j.neuron.2009.08.021; Kamakura S, 2004, NAT CELL BIOL, V6, P547, DOI 10.1038/ncb1138; Knoepfler PS, 2006, EMBO J, V25, P2723, DOI 10.1038/sj.emboj.7601152; Konno D, 2008, NAT CELL BIOL, V10, P93, DOI 10.1038/ncb1673; Kuwahara A, 2010, DEVELOPMENT, V137, P1035, DOI 10.1242/dev.046417; Lee YS, 2007, GENE DEV, V21, P1025, DOI 10.1101/gad.1540407; Mayr C, 2007, SCIENCE, V315, P1576, DOI 10.1126/science.1137999; Meshorer E, 2006, DEV CELL, V10, P105, DOI 10.1016/j.devcel.2005.10.017; Miller FD, 2007, NEURON, V54, P357, DOI 10.1016/j.neuron.2007.04.019; Miyata T, 2007, CURR BIOL, V17, P146, DOI 10.1016/j.cub.2006.11.023; Nagao M, 2008, J CELL BIOL, V183, P1243, DOI 10.1083/jcb.200807130; Naka H, 2008, NAT NEUROSCI, V11, P1014, DOI 10.1038/nn.2168; Newman MA, 2008, RNA, V14, P1539, DOI 10.1261/rna.1155108; Nishino J, 2008, CELL, V135, P227, DOI 10.1016/j.cell.2008.09.017; Ochiai W, 2009, MOL CELL NEUROSCI, V40, P225, DOI 10.1016/j.mcn.2008.10.007; Piskounova E, 2008, J BIOL CHEM, V283, P21310, DOI 10.1074/jbc.C800108200; Qian XM, 2000, NEURON, V28, P69, DOI 10.1016/S0896-6273(00)00086-6; Ramirez-Carrozzi VR, 2009, CELL, V138, P114, DOI 10.1016/j.cell.2009.04.020; Reeves R, 2001, GENE, V277, P63, DOI 10.1016/S0378-1119(01)00689-8; Rybak A, 2008, NAT CELL BIOL, V10, P987, DOI 10.1038/ncb1759; Sanosaka T, 2008, NEUROSCIENCE, V155, P780, DOI 10.1016/j.neuroscience.2008.06.039; Sawamoto K, 2001, J NEUROSCI RES, V65, P220, DOI 10.1002/jnr.1145; Seki Y, 2005, DEV BIOL, V278, P440, DOI 10.1016/j.ydbio.2004.11.025; Sunabori T, 2008, J CELL SCI, V121, P1204, DOI 10.1242/jcs.025064; Tabata H, 2001, NEUROSCIENCE, V103, P865, DOI 10.1016/S0306-4522(01)00016-1; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Viswanathan SR, 2008, SCIENCE, V320, P97, DOI 10.1126/science.1154040; Watakabe A, 2007, CEREB CORTEX, V17, P1918, DOI 10.1093/cercor/bhl102; Waterston RH, 2002, NATURE, V420, P520, DOI 10.1038/nature01262; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; ZHAO K, 1993, EMBO J, V12, P3237, DOI 10.1002/j.1460-2075.1993.tb05993.x; ZHOU XJ, 1995, NATURE, V376, P771, DOI 10.1038/376771a0	45	91	91	0	17	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	AUG	2012	15	8					1127	+		10.1038/nn.3165	http://dx.doi.org/10.1038/nn.3165			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	979UE	22797695				2022-12-28	WOS:000306844500019
J	[Anonymous]				[Anonymous]			Focus on neuro-immune interactions	NATURE NEUROSCIENCE			English	Editorial Material																			0	1	1	0	1	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	AUG	2012	15	8					1055	1055		10.1038/nn0812-1055	http://dx.doi.org/10.1038/nn0812-1055			1	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	979UE	22837030	Bronze			2022-12-28	WOS:000306844500001
J	Wyatt, RM; Tring, E; Trachtenberg, JT				Wyatt, Ryan M.; Tring, Elaine; Trachtenberg, Joshua T.			Pattern and not magnitude of neural activity determines dendritic spine stability in awake mice	NATURE NEUROSCIENCE			English	Article							SYNAPTIC PLASTICITY; CORTEX; CIRCUITS; NEURONS; INPUT	The stability of dendritic spines in the neocortex is profoundly influenced by sensory experience, which determines the magnitude and pattern of neural firing. By optically manipulating the temporal structure of neural activity in vivo using channelrhodopsin-2 and repeatedly imaging dendritic spines along these stimulated neurons over a period of weeks, we show that the specific pattern, rather than the total amount of activity, determines spine stability in awake mice.	[Wyatt, Ryan M.; Tring, Elaine; Trachtenberg, Joshua T.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurobiol, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Trachtenberg, JT (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurobiol, Los Angeles, CA 90095 USA.	jtrachtenberg@mednet.ucla.edu			US National Eye Institute [EY016052]; US National Institute for Mental Health [MH077972]; NATIONAL EYE INSTITUTE [R01EY016052, R01EY023871] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH077972] Funding Source: NIH RePORTER	US National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); US National Institute for Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We wish to thank S.T. Carmichael for his help with quantitative real-time PCR, A. Silva for generously providing access to his two-photon microscope for some of these experiments, S. Kuhlman for her help with spike wave-form analysis, E. Ruthazer for critical comments on earlier versions of this manuscript and G. Feng (Massachusetts Institute of Technology) for generously supplying the Thy1-Chr2-YFP mice. This work was funded by grants from the US National Eye Institute (EY016052) and from the US National Institute for Mental Health (MH077972).	Dantzker JL, 2000, NAT NEUROSCI, V3, P701, DOI 10.1038/76656; Di Cristo G, 2004, NAT NEUROSCI, V7, P1184, DOI 10.1038/nn1334; Fiser J, 2004, NATURE, V431, P573, DOI 10.1038/nature02907; Hofer SB, 2009, NATURE, V457, P313, DOI 10.1038/nature07487; Holtmaat A, 2009, NAT REV NEUROSCI, V10, P647, DOI 10.1038/nrn2699; Kasai H, 2003, TRENDS NEUROSCI, V26, P360, DOI 10.1016/S0166-2236(03)00162-0; Komiyama T, 2010, NATURE, V464, P1182, DOI 10.1038/nature08897; Linden ML, 2009, NAT NEUROSCI, V12, P390, DOI 10.1038/nn.2284; O'Connor DH, 2010, NEURON, V67, P1048, DOI 10.1016/j.neuron.2010.08.026; Roberts TF, 2010, NATURE, V463, P948, DOI 10.1038/nature08759; Sohal VS, 2009, NATURE, V459, P698, DOI 10.1038/nature07991; THOMPSON W, 1983, NATURE, V302, P614, DOI 10.1038/302614a0; Trachtenberg JT, 2002, NATURE, V420, P788, DOI 10.1038/nature01273; Zhang JY, 2012, NAT NEUROSCI, V15, P298, DOI 10.1038/nn.3007; Zuo Y, 2005, NATURE, V436, P261, DOI 10.1038/nature03715	15	19	19	0	18	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JUL	2012	15	7					949	951		10.1038/nn.3134	http://dx.doi.org/10.1038/nn.3134			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	966EE	22706266	Green Accepted			2022-12-28	WOS:000305819600009
J	Raingo, J; Khvotchev, M; Liu, P; Darios, F; Li, YC; Ramirez, DMO; Adachi, M; Lemieux, P; Toth, K; Davletov, B; Kavalali, ET				Raingo, Jesica; Khvotchev, Mikhail; Liu, Pei; Darios, Frederic; Li, Ying C.; Ramirez, Denise M. O.; Adachi, Megumi; Lemieux, Philippe; Toth, Katalin; Davletov, Bazbek; Kavalali, Ege T.			VAMP4 directs synaptic vesicles to a pool that selectively maintains asynchronous neurotransmission	NATURE NEUROSCIENCE			English	Article							TRANSMITTER RELEASE; MEMBRANE-FUSION; CA2+ SENSOR; FLUORESCENT PROTEINS; RECYCLING PATHWAYS; CENTRAL SYNAPSES; SYNAPTOTAGMIN-I; SNARE; INHIBITION; TRANSMISSION	Synaptic vesicles in the brain harbor several soluble N-ethylmaleimide-sensitive-factor attachment protein receptor (SNARE) proteins. With the exception of synaptobrevin2, or VAMP2 (syb2), which is directly involved in vesicle fusion, the role of these SNAREs in neurotransmission is unclear. Here we show that in mice syb2 drives rapid Ca2+-dependent synchronous neurotransmission, whereas the structurally homologous SNARE protein VAMP4 selectively maintains bulk Ca2+-dependent asynchronous release. At inhibitory nerve terminals, up- or downregulation of VAMP4 causes a correlated change in asynchronous release. Biochemically, VAMP4 forms a stable complex with SNAREs syntaxin-1 and SNAP-25 that does not interact with complexins or synaptotagmin-1, proteins essential for synchronous neurotransmission. Optical imaging of individual synapses indicates that trafficking of VAMP4 and syb2 show minimal overlap. Taken together, these findings suggest that VAMP4 and syb2 diverge functionally, traffic independently and support distinct forms of neurotransmission. These results provide molecular insight into how synapses diversify their release properties by taking advantage of distinct synaptic vesicle associated SNAREs.	[Raingo, Jesica; Khvotchev, Mikhail; Liu, Pei; Li, Ying C.; Ramirez, Denise M. O.; Kavalali, Ege T.] Univ Texas UT SW Med Ctr, Dept Neurosci, Dallas, TX USA; [Raingo, Jesica] Multidisciplinary Inst Cellular Biol, Electrophysiol Lab, Buenos Aires, DF, Argentina; [Darios, Frederic; Davletov, Bazbek] MRC, Mol Biol Lab, Cambridge CB2 2QH, England; [Adachi, Megumi] UT SW Med Ctr, Dept Psychiat, Dallas, TX USA; [Lemieux, Philippe; Toth, Katalin] Univ Laval Robert Giffard, Ctr Rech, Quebec City, PQ, Canada; [Kavalali, Ege T.] UT SW Med Ctr, Dept Physiol, Dallas, TX USA	MRC Laboratory Molecular Biology; University of Texas System; University of Texas Southwestern Medical Center Dallas; Laval University; University of Texas System; University of Texas Southwestern Medical Center Dallas	Kavalali, ET (corresponding author), Univ Texas UT SW Med Ctr, Dept Neurosci, Dallas, TX USA.	ege.kavalali@utsouthwestern.edu	Khvotchev, Mikhail/G-5411-2013; Davletov, Bazbek/ABA-8569-2021; Adachi, Megumi/M-7746-2017	Khvotchev, Mikhail/0000-0001-9328-8549; Adachi, Megumi/0000-0003-3404-6640; Li, Ying/0000-0003-4216-6183; Darios, Frederic/0000-0001-9800-5990; Davletov, Bazbek/0000-0003-4658-3275; Ramirez, Denise/0000-0003-4090-033X	US National Institute of Mental Health [MH066198]; MRC [MC_U105178791] Funding Source: UKRI; NATIONAL INSTITUTE OF MENTAL HEALTH [F32MH093109, R01MH068437, R01MH066198] Funding Source: NIH RePORTER; Medical Research Council [MC_U105178791] Funding Source: researchfish	US National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank J. Leitz for technical assistance and H. Kramer, L. Monteggia, E. Nelson and E. Nosyreva for advice and discussions. We also thank T.C. Sudhof (Stanford University) for the gift of synaptobrevin2 knockout mice and M.C. Wilson (University of New Mexico) for the gift of SNAP-25 knockout mice. This work was supported by grants from the US National Institute of Mental Health to E.T.K. (MH066198). E.T.K. is an established investigator of the American Heart Association.	Atasoy D, 2008, J NEUROSCI, V28, P10151, DOI 10.1523/JNEUROSCI.2432-08.2008; Bethani I, 2009, TRAFFIC, V10, P1543, DOI 10.1111/j.1600-0854.2009.00959.x; Bronk P, 2007, J NEUROPHYSIOL, V98, P794, DOI 10.1152/jn.00226.2007; Chung CH, 2008, J NEUROPHYSIOL, V100, P2089, DOI 10.1152/jn.90404.2008; Chung C, 2010, J NEUROSCI, V30, P1363, DOI 10.1523/JNEUROSCI.3427-09.2010; Clayton EL, 2010, NAT NEUROSCI, V13, P845, DOI 10.1038/nn.2571; Daw MI, 2009, J NEUROSCI, V29, P11112, DOI 10.1523/JNEUROSCI.5760-08.2009; Deak F, 2004, NAT CELL BIOL, V6, P1102, DOI 10.1038/ncb1185; Deak F, 2006, EMBO J, V25, P2856, DOI 10.1038/sj.emboj.7601165; Deak F, 2006, J NEUROSCI, V26, P6668, DOI 10.1523/JNEUROSCI.5272-05.2006; Fredj NB, 2009, NAT NEUROSCI, V12, P751, DOI 10.1038/nn.2317; GEPPERT M, 1994, CELL, V79, P717, DOI 10.1016/0092-8674(94)90556-8; Groffen AJ, 2010, SCIENCE, V327, P1614, DOI 10.1126/science.1183765; Hefft S, 2005, NAT NEUROSCI, V8, P1319, DOI 10.1038/nn1542; Hua ZL, 2011, NEURON, V71, P474, DOI 10.1016/j.neuron.2011.06.010; Iremonger KJ, 2007, J NEUROSCI, V27, P6684, DOI 10.1523/JNEUROSCI.0934-07.2007; Jahn R, 2003, CELL, V112, P519, DOI 10.1016/S0092-8674(03)00112-0; Jahn R, 2006, NAT REV MOL CELL BIO, V7, P631, DOI 10.1038/nrm2002; Kavalali ET, 2007, J PHYSIOL-LONDON, V585, P669, DOI 10.1113/jphysiol.2007.137745; Liu HS, 2009, J NEUROSCI, V29, P7395, DOI 10.1523/JNEUROSCI.1341-09.2009; Maximov A, 2005, NEURON, V48, P547, DOI 10.1016/j.neuron.2005.09.006; Miesenbock G, 1998, NATURE, V394, P192, DOI 10.1038/28190; Mutch SA, 2011, J NEUROSCI, V31, P1461, DOI 10.1523/JNEUROSCI.3805-10.2011; Otsu Y, 2004, J NEUROSCI, V24, P420, DOI 10.1523/JNEUROSCI.4452-03.2004; Peden AA, 2001, J BIOL CHEM, V276, P49183, DOI 10.1074/jbc.M106646200; Ramirez DMO, 2012, NEURON, V73, P121, DOI 10.1016/j.neuron.2011.10.034; Ramirez DMO, 2011, CURR OPIN NEUROBIOL, V21, P275, DOI 10.1016/j.conb.2011.01.007; Reim K, 2001, CELL, V104, P71, DOI 10.1016/S0092-8674(01)00192-1; Rizo J, 2002, NAT REV NEUROSCI, V3, P641, DOI 10.1038/nrn898; Rizzoli SO, 2005, NAT REV NEUROSCI, V6, P57, DOI 10.1038/nrn1583; Sakaba T, 2001, J NEUROSCI, V21, P462, DOI 10.1523/JNEUROSCI.21-02-00462.2001; Sara Y, 2005, NEURON, V45, P563, DOI 10.1016/j.neuron.2004.12.056; Schoch S, 2001, SCIENCE, V294, P1117, DOI 10.1126/science.1064335; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; SOLLNER T, 1993, CELL, V75, P409, DOI 10.1016/0092-8674(93)90376-2; Steegmaier M, 1999, MOL BIOL CELL, V10, P1957, DOI 10.1091/mbc.10.6.1957; Sudhof TC, 2009, SCIENCE, V323, P474, DOI 10.1126/science.1161748; Sun J, 2007, NATURE, V450, P676, DOI 10.1038/nature06308; Takamori S, 2006, CELL, V127, P831, DOI 10.1016/j.cell.2006.10.030; Virmani T, 2003, EMBO J, V22, P5347, DOI 10.1093/emboj/cdg514; Voglmaier SM, 2006, NEURON, V51, P71, DOI 10.1016/j.neuron.2006.05.027; Washbourne P, 2002, NAT NEUROSCI, V5, P19, DOI 10.1038/nn783; Wolfel M, 2007, J NEUROSCI, V27, P3198, DOI 10.1523/JNEUROSCI.4471-06.2007; Xu J, 2009, NAT NEUROSCI, V12, P759, DOI 10.1038/nn.2320; Xu T, 1999, CELL, V99, P713, DOI 10.1016/S0092-8674(00)81669-4	45	110	113	0	27	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	MAY	2012	15	5					738	745		10.1038/nn.3067	http://dx.doi.org/10.1038/nn.3067			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	932DI	22406549	Green Accepted			2022-12-28	WOS:000303270200018
J	Zufall, F				Zufall, Frank			On the scent of mitochondrial calcium	NATURE NEUROSCIENCE			English	Editorial Material							OLFACTORY CILIA; ODOR ADAPTATION; TRANSDUCTION; INHIBITION; TRANSIENTS; NEURONS	Odorants are now shown to elevate mitochondrial Ca2+ in sensory neurons; moreover, blocking this Ca2+ sequestration impairs dynamic range. Acute stimulation rapidly recruits mitochondria from the soma to the dendritic knob.	Univ Saarland, Sch Med, Dept Physiol, D-6650 Homburg, Germany	Saarland University	Zufall, F (corresponding author), Univ Saarland, Sch Med, Dept Physiol, D-6650 Homburg, Germany.	frank.zufall@uks.eu	Zufall, Frank/AAE-5290-2021	Zufall, Frank/0000-0002-4383-8618				Billig GM, 2011, NAT NEUROSCI, V14, P763, DOI 10.1038/nn.2821; Drago I, 2011, EMBO J, V30, P4119, DOI 10.1038/emboj.2011.337; Fluegge D, 2012, NAT NEUROSCI, V15, P754, DOI 10.1038/nn.3074; Kleene SJ, 2008, CHEM SENSES, V33, P839, DOI 10.1093/chemse/bjn048; KURAHASHI T, 1990, BRAIN RES, V515, P261, DOI 10.1016/0006-8993(90)90605-B; Leinders-Zufall T, 1999, J NEUROSCI, V19, DOI 10.1523/JNEUROSCI.19-14-j0005.1999; Leinders-Zufall T, 1998, J NEUROSCI, V18, P5630; Matthews HR, 2003, CURR OPIN NEUROBIOL, V13, P469, DOI 10.1016/S0959-4388(03)00097-7; Menini A, 1999, CURR OPIN NEUROBIOL, V9, P419, DOI 10.1016/S0959-4388(99)80063-4; Reisert J, 1998, J GEN PHYSIOL, V112, P529, DOI 10.1085/jgp.112.5.529; Stephan AB, 2012, NAT NEUROSCI, V15, P131, DOI 10.1038/nn.2943; ZUFALL F, 1991, P ROY SOC B-BIOL SCI, V246, P225, DOI 10.1098/rspb.1991.0148; Zufall F, 2000, CHEM SENSES, V25, P473, DOI 10.1093/chemse/25.4.473; Zufall F, 2000, J NEUROPHYSIOL, V83, P501, DOI 10.1152/jn.2000.83.1.501	14	1	1	0	2	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	MAY	2012	15	5					653	654		10.1038/nn.3090	http://dx.doi.org/10.1038/nn.3090			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	932DI	22534577				2022-12-28	WOS:000303270200005
J	Walsh, JJ; Friedman, AK; Sun, HS; Heller, EA; Ku, SM; Juarez, B; Burnham, VL; Mazei-Robison, MS; Ferguson, D; Golden, SA; Koo, JW; Chaudhury, D; Christoffe, DJ; Pomeranz, L; Friedman, JM; Russo, SJ; Nestler, EJ; Han, MH				Walsh, Jessica J.; Friedman, Allyson K.; Sun, Haosheng; Heller, Elizabeth A.; Ku, Stacy M.; Juarez, Barbara; Burnham, Veronica L.; Mazei-Robison, Michelle S.; Ferguson, Deveroux; Golden, Sam A.; Koo, Ja Wook; Chaudhury, Dipesh; Christoffe, Daniel J.; Pomeranz, Lisa; Friedman, Jeffrey M.; Russo, Scott J.; Nestler, Eric J.; Han, Ming-Hu			Stress and CRF gate neural activation of BDNF in the mesolimbic reward pathway	NATURE NEUROSCIENCE			English	Article							SOCIAL DEFEAT; DOPAMINERGIC-NEURONS; SUSCEPTIBILITY; CIRCUIT	Mechanisms controlling release of brain-derived neurotrophic factor (BDNF) in the mesolimbic dopamine reward pathway remain unknown. We report that phasic optogenetic activation of this pathway increases BDNF amounts in the nucleus accumbens (NAc) of socially stressed mice but not of stress-naive mice. This stress gating of BDNF signaling is mediated by corticotrophin-releasing factor (CRF) acting in the NAc. These results unravel a stress context-detecting function of the brain's mesolimbic circuit.	[Walsh, Jessica J.; Friedman, Allyson K.; Ku, Stacy M.; Juarez, Barbara; Burnham, Veronica L.; Chaudhury, Dipesh; Nestler, Eric J.; Han, Ming-Hu] Icahn Sch Med Mt Sinai, Dept Pharmacol & Syst Therapeut, New York, NY 10029 USA; [Walsh, Jessica J.; Sun, Haosheng; Heller, Elizabeth A.; Ku, Stacy M.; Juarez, Barbara; Burnham, Veronica L.; Mazei-Robison, Michelle S.; Ferguson, Deveroux; Golden, Sam A.; Koo, Ja Wook; Christoffe, Daniel J.; Russo, Scott J.; Nestler, Eric J.; Han, Ming-Hu] Icahn Sch Med Mt Sinai, Friedman Brain Inst, Fishberg Dept Neurosci, New York, NY USA; [Pomeranz, Lisa; Friedman, Jeffrey M.] Rockefeller Univ, Howard Hughes Med Inst, Mol Genet Lab, New York, NY 10021 USA	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Howard Hughes Medical Institute; Rockefeller University	Han, MH (corresponding author), Icahn Sch Med Mt Sinai, Dept Pharmacol & Syst Therapeut, New York, NY 10029 USA.	ming-hu.han@mssm.edu	Mazei-Robison, Michelle/I-4304-2017; Heller, Elizabeth A/W-4653-2019; Core, Vector/CAF-4832-2022; Russo, Scott/R-7107-2019; Han, Ming-Hu/G-8836-2012	Mazei-Robison, Michelle/0000-0002-2372-1420; Heller, Elizabeth A/0000-0002-2984-8705; Russo, Scott/0000-0002-6470-1805; Pomeranz, Lisa/0000-0002-8117-7355; Ferguson, Deveroux/0000-0001-9302-5992; Friedman, Allyson/0000-0002-8190-3011; Christoffel, Dan/0000-0002-6303-5134; Walsh, Jessica/0000-0001-8466-8451; Golden, Sam/0000-0002-2104-2272; Juarez, Barbara/0000-0001-7897-8031; Sun, Haosheng/0000-0003-3919-559X	National Institute of Mental Health [R01 MH092306]; Johnson & Johnson/International Mental Health Research Organization Rising Star Translational Research Award; National Research Service Awards [F31 MH095425, F32 MH096464]; NATIONAL INSTITUTE OF MENTAL HEALTH [K99MH094405, P50MH096890, T32MH096678, F31MH108326, F31MH095425, T32MH087004, R01MH051399, F32MH096464, R01MH092306] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA022445] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [T32DA007135, R01DA014133] Funding Source: NIH RePORTER	National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Johnson & Johnson/International Mental Health Research Organization Rising Star Translational Research Award; National Research Service Awards(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by the National Institute of Mental Health (R01 MH092306: D.C. and M.-H.H.), Johnson & Johnson/International Mental Health Research Organization Rising Star Translational Research Award (M.-H.H.) and National Research Service Awards (F31 MH095425: J.J.W.; F32 MH096464: A.K.F.).	Berton O, 2006, SCIENCE, V311, P864, DOI 10.1126/science.1120972; Cao JL, 2010, J NEUROSCI, V30, P16453, DOI 10.1523/JNEUROSCI.3177-10.2010; Cazorla M, 2011, J CLIN INVEST, V121, P1846, DOI 10.1172/JCI43992; Chaudhury D, 2013, NATURE, V493, P532, DOI 10.1038/nature11713; Grace AA, 2007, TRENDS NEUROSCI, V30, P220, DOI 10.1016/j.tins.2007.03.003; Koo JW, 2012, SCIENCE, V338, P124, DOI 10.1126/science.1222265; Koob GF, 2004, NEUROSCI BIOBEHAV R, V27, P739, DOI 10.1016/j.neubiorev.2003.11.007; Krishnan V, 2007, CELL, V131, P391, DOI 10.1016/j.cell.2007.09.018; Lammel S, 2011, NEURON, V70, P855, DOI 10.1016/j.neuron.2011.03.025; Lemos JC, 2012, NATURE, V490, P402, DOI 10.1038/nature11436; Lobo MK, 2010, SCIENCE, V330, P385, DOI 10.1126/science.1188472; Matsuda N, 2009, J NEUROSCI, V29, P14185, DOI 10.1523/JNEUROSCI.1863-09.2009; Nestler EJ, 2002, NEURON, V34, P13, DOI 10.1016/S0896-6273(02)00653-0; Nestler EJ, 2006, BIOL PSYCHIAT, V59, P1151, DOI 10.1016/j.biopsych.2005.09.018; Park H, 2013, NAT REV NEUROSCI, V14, P7, DOI 10.1038/nrn3379; Pecina S, 2006, BMC BIOL, V4, DOI 10.1186/1741-7007-4-8; Schnitzer MJ, 2002, NATURE, V416, P683, DOI 10.1038/416683a; Tsai HC, 2009, SCIENCE, V324, P1080, DOI 10.1126/science.1168878; Tye KM, 2013, NATURE, V493, P537, DOI 10.1038/nature11740; Wanat MJ, 2013, NAT NEUROSCI, V16, P383, DOI 10.1038/nn.3335	20	141	142	0	32	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JAN	2014	17	1					27	29		10.1038/nn.3591	http://dx.doi.org/10.1038/nn.3591			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	281DL	24270188	Green Accepted			2022-12-28	WOS:000329080000009
J	Kaplan, JS; Mohr, C; Rossi, DJ				Kaplan, Joshua S.; Mohr, Claudia; Rossi, David J.			Opposite actions of alcohol on tonic GABA(A) receptor currents mediated by nNOS and PKC activity	NATURE NEUROSCIENCE			English	Article							CEREBELLAR GRANULE CELLS; GABAERGIC TRANSMISSION; NITRIC-OXIDE; NEURONAL EXCITABILITY; NEUROACTIVE STEROIDS; INDUCED ATAXIA; ETHANOL; INHIBITION; SUBUNIT; MICE	The molecular mechanisms that mediate genetic variability in response to alcohol are unclear. We found that alcohol had opposite actions (enhancement or suppression) on GABA(A) receptor (GABA(A)R) inhibition in granule cells from the cerebellum of behaviorally sensitive, low alcohol consuming Sprague-Dawley rats and DBA/2 mice and behaviorally insensitive, high alcohol consuming C57BU6 mice, respectively. The effect of alcohol on granule cell GABA(A)R inhibition was determined by a balance between two opposing effects: enhanced presynaptic vesicular release of GABA via alcohol inhibition of nitric oxide synthase (NOS) and a direct suppression of the activity of postsynaptic GABA(A)Rs. The balance of these two processes was determined by differential expression of neuronal NOS (nNOS) and postsynaptic PKC activity, both of which varied across the rodent genotypes. These findings identify opposing molecular processes that differentially control the magnitude and polarity of GABA(A)R responses to alcohol across rodent genotypes.	[Kaplan, Joshua S.; Mohr, Claudia; Rossi, David J.] Oregon Hlth & Sci Univ, Dept Behav Neurosci, Portland, OR 97201 USA	Oregon Health & Science University	Rossi, DJ (corresponding author), Oregon Hlth & Sci Univ, Dept Behav Neurosci, Portland, OR 97201 USA.	rossid@ohsu.edu		Kaplan, Joshua/0000-0003-3482-5003; Kaplan, Joshua S/0000-0002-8005-8442	National Institute of Neurological Disorders and Stroke [R0INS051561]; National Institute on Alcohol Abuse and Alcoholism [R01AA012439]; American Heart Association; Research Foundation of Oregon [T32 AA007468, F31 AA022267]; National Institute on Alcohol Abuse and Alcoholism; Oregon Health and Science University Research Scholars Award; Neuroscience Imaging Center at Oregon Health and Science University [P30NS061800]; National Institute of Neurological Disorders and Stroke; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS061800, R01NS051561] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [F31AA022267, R01AA012439, T32AA007468] Funding Source: NIH RePORTER	National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Institute on Alcohol Abuse and Alcoholism(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); American Heart Association(American Heart Association); Research Foundation of Oregon; National Institute on Alcohol Abuse and Alcoholism(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); Oregon Health and Science University Research Scholars Award; Neuroscience Imaging Center at Oregon Health and Science University; National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	We thank J. Crabbe, D. Finn and K. Wiren (Oregon Health and Science University) for discussions about the research and D. Attwell (University College London) for comments on the manuscript. This study was supported by National Institute of Neurological Disorders and Stroke grant R0INS051561, National Institute on Alcohol Abuse and Alcoholism grant R01AA012439, an American Heart Association Grant in Aid, and a Medical Research Foundation of Oregon grant to D.J.R., training grants T32 AA007468 and F31 AA022267 from the National Institute on Alcohol Abuse and Alcoholism, and an Oregon Health and Science University Research Scholars Award to J.S.K., and the Neuroscience Imaging Center at Oregon Health and Science University grant P30NS061800 from the National Institute of Neurological Disorders and Stroke.	Al-Rejaie S, 2006, BRAIN RES BULL, V69, P187, DOI 10.1016/j.brainresbull.2005.12.002; Bell RL, 2001, ALCOHOL CLIN EXP RES, V25, P644, DOI 10.1111/j.1530-0277.2001.tb02262.x; Botta P, 2007, ALCOHOL, V41, P187, DOI 10.1016/j.alcohol.2007.04.004; Botta P, 2012, ALCOHOL CLIN EXP RES, V36, P616, DOI 10.1111/j.1530-0277.2011.01658.x; Brickley SG, 2001, NATURE, V409, P88, DOI 10.1038/35051086; Carta M, 2004, J NEUROSCI, V24, P3746, DOI 10.1523/JNEUROSCI.0067-04.2004; Criswell HE, 2008, J PHARMACOL EXP THER, V326, P596, DOI 10.1124/jpet.107.135418; DESCHUTTER E, 1994, J NEUROPHYSIOL, V71, P401, DOI 10.1152/jn.1994.71.1.401; Duguid I, 2012, J NEUROSCI, V32, P11132, DOI 10.1523/JNEUROSCI.0460-12.2012; Fataccioli V, 1997, ALCOHOL ALCOHOLISM, V32, P683; Fidler TL, 2011, GENES BRAIN BEHAV, V10, P264, DOI 10.1111/j.1601-183X.2010.00664.x; Ford MM, 2011, ALCOHOL CLIN EXP RES, V35, P326, DOI 10.1111/j.1530-0277.2010.01348.x; Gallaher EJ, 1996, J PHARMACOL EXP THER, V277, P604; Hamann M, 2002, NEURON, V33, P625, DOI 10.1016/S0896-6273(02)00593-7; Hanchar HJ, 2005, NAT NEUROSCI, V8, P339, DOI 10.1038/nn1398; HARRIS RA, 1995, P NATL ACAD SCI USA, V92, P3658, DOI 10.1073/pnas.92.9.3658; Harwood H. J., 2000, UPDATING ESTIMATES E; Herting MM, 2011, NEUROIMAGE, V54, P2582, DOI 10.1016/j.neuroimage.2010.10.030; Hill SY, 2010, INT REV NEUROBIOL, V91, P53, DOI 10.1016/S0074-7742(10)91003-9; Jia F, 2008, J PHARMACOL EXP THER, V326, P475, DOI 10.1124/jpet.108.139303; Johnson WD, 2012, J PHARMACOL EXP THER, V340, P445, DOI 10.1124/jpet.111.188037; KORPI ER, 1995, MOL PHARMACOL, V47, P283; Korpi ER, 1999, EUR J NEUROSCI, V11, P233, DOI 10.1046/j.1460-9568.1999.00421.x; Kumar S, 2009, PSYCHOPHARMACOLOGY, V205, P529, DOI 10.1007/s00213-009-1562-z; Liang J, 2006, J NEUROSCI, V26, P1749, DOI 10.1523/JNEUROSCI.4702-05.2006; MALILA A, 1978, PHARMACOL BIOCHEM BE, V8, P197, DOI 10.1016/0091-3057(78)90337-4; McClearn G.E., 1981, RES MONOGRAPH, V6; McCool BA, 2012, ADDICT BIOL, V17, P121, DOI 10.1111/j.1369-1600.2010.00260.x; Meera P, 2011, J NEUROPHYSIOL, V106, P2057, DOI 10.1152/jn.00450.2011; MELCHIOR CL, 1976, PHARMACOL BIOCHEM BE, V5, P63, DOI 10.1016/0091-3057(76)90289-6; Mihalek RM, 2001, ALCOHOL CLIN EXP RES, V25, P1708, DOI 10.1111/j.1530-0277.2001.tb02179.x; Mihic SJ, 1997, NATURE, V389, P385, DOI 10.1038/38738; Naik MU, 2000, J COMP NEUROL, V426, P243, DOI 10.1002/1096-9861(20001016)426:2<243::AID-CNE6>3.0.CO;2-8; Nie ZG, 2000, J PHARMACOL EXP THER, V293, P654; PERIS J, 1992, ALCOHOL CLIN EXP RES, V16, P311, DOI 10.1111/j.1530-0277.1992.tb01383.x; Porcu P, 2010, ALCOHOL CLIN EXP RES, V34, P432, DOI 10.1111/j.1530-0277.2009.01123.x; Prescott CA, 1999, AM J PSYCHIAT, V156, P34, DOI 10.1176/ajp.156.1.34; Rossi DJ, 2003, J PHYSIOL-LONDON, V548, P97, DOI 10.1113/jphysiol.2002.036459; Salapatek AMF, 1998, AM J PHYSIOL-CELL PH, V274, pC1145, DOI 10.1152/ajpcell.1998.274.4.C1145; Saxena NC, 1996, MOL PHARMACOL, V49, P567; Schuckit MA, 2005, ALCOHOL CLIN EXP RES, V29, P1921, DOI 10.1097/01.alc.0000187154.94681.65; Schuckit MA, 1996, J STUD ALCOHOL, V57, P368, DOI 10.15288/jsa.1996.57.368; Stell BM, 2003, P NATL ACAD SCI USA, V100, P14439, DOI 10.1073/pnas.2435457100; Theile JW, 2009, J PHARMACOL EXP THER, V329, P625, DOI 10.1124/jpet.108.147793; Ueno S, 2000, BRIT J PHARMACOL, V131, P296, DOI 10.1038/sj.bjp.0703504; Wall MJ, 2003, EUR J NEUROSCI, V18, P869, DOI 10.1046/j.1460-9568.2003.02822.x; Wang WH, 1997, ANNU REV PHYSIOL, V59, P413, DOI 10.1146/annurev.physiol.59.1.413; White CN, 2008, AM J PHYSIOL-CELL PH, V294, pC572, DOI 10.1152/ajpcell.00242.2007; Yamashita M, 2006, J PHARMACOL EXP THER, V319, P431, DOI 10.1124/jpet.106.106260; Yoneyama N, 2008, ALCOHOL, V42, P149, DOI 10.1016/j.alcohol.2007.12.006	50	31	32	0	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	DEC	2013	16	12					1783	1793		10.1038/nn.3559	http://dx.doi.org/10.1038/nn.3559			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	257VV	24162656	Green Accepted			2022-12-28	WOS:000327416800016
J	Sachidhanandam, S; Sreenivasan, V; Kyriakatos, A; Kremer, Y; Petersen, CCH				Sachidhanandam, Shankar; Sreenivasan, Varun; Kyriakatos, Alexandros; Kremer, Yves; Petersen, Carl C. H.			Membrane potential correlates of sensory perception in mouse barrel cortex	NATURE NEUROSCIENCE			English	Article							PRIMARY SOMATOSENSORY CORTEX; AUDITORY-CORTEX; BEHAVING MICE; CORTICAL MICROSTIMULATION; GABAERGIC NEURONS; NEURAL ACTIVITY; VISUAL-CORTEX; SINGLE NEURON; MOTOR CORTEX; LAYER 2/3	Neocortical activity can evoke sensory percepts, but the cellular mechanisms remain poorly understood. We trained mice to detect single brief whisker stimuli and report perceived stimuli by licking to obtain a reward. Pharmacological inactivation and optogenetic stimulation demonstrated a causal role for the primary somatosensory barrel cortex. Whole-cell recordings from barrel cortex neurons revealed membrane potential correlates of sensory perception. Sensory responses depended strongly on prestimulus cortical state, but both slow-wave and desynchronized cortical states were compatible with task performance. Whisker deflection evoked an early (<50 ms) reliable sensory response that was encoded through cell-specific reversal potentials. A secondary late (50-400 ms) depolarization was enhanced on hit trials compared to misses. Optogenetic inactivation revealed a causal role for late excitation. Our data reveal dynamic processing in the sensory cortex during task performance, with an early sensory response reliably encoding the stimulus and later secondary activity contributing to driving the subjective percept.	[Sachidhanandam, Shankar; Sreenivasan, Varun; Kyriakatos, Alexandros; Kremer, Yves; Petersen, Carl C. H.] Ecole Polytech Fed Lausanne, Lab Sensory Proc, Brain Mind Inst, Fac Life Sci, CH-1015 Lausanne, Switzerland	Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne	Petersen, CCH (corresponding author), Ecole Polytech Fed Lausanne, Lab Sensory Proc, Brain Mind Inst, Fac Life Sci, CH-1015 Lausanne, Switzerland.	carl.petersen@epfl.ch	Petersen, Carl/M-5123-2017	Petersen, Carl/0000-0003-3344-4495; Kremer, Yves/0000-0002-2319-1394; Sreenivasan, Varun/0000-0003-0559-9713; Sachidhanandam, Shankar/0000-0002-9359-6653	Swiss National Science Foundation [31003A-116027, 310030-146252, BaCoFun 310030E-147486]; Deutsche Forschungsgemeinschaft [BaCoFun 310030E-147486]; Human Frontier Science Program [RGP0041/2009]; SystemsX.ch (Neurochoice); National Competence Centre for Research (Synapsy); European Research Council [ERC-2011-AdG-293660]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Human Frontier Science Program(Human Frontier Science Program); SystemsX.ch (Neurochoice); National Competence Centre for Research (Synapsy); European Research Council(European Research Council (ERC)European Commission)	This work was funded by grants from the Swiss National Science Foundation (31003A-116027 and 310030-146252), a joint grant between the Swiss National Science Foundation and the Deutsche Forschungsgemeinschaft (BaCoFun 310030E-147486), the Human Frontier Science Program (RGP0041/2009), SystemsX.ch (Neurochoice), the National Competence Centre for Research (Synapsy) and the European Research Council (ERC-2011-AdG-293660 Sensorimotor).	Avermann M, 2012, J NEUROPHYSIOL, V107, P3116, DOI 10.1152/jn.00917.2011; Boyden ES, 2005, NAT NEUROSCI, V8, P1263, DOI 10.1038/nn1525; Branco T, 2010, CURR OPIN NEUROBIOL, V20, P494, DOI 10.1016/j.conb.2010.07.009; Cardin JA, 2009, NATURE, V459, P663, DOI 10.1038/nature08002; Chen JL, 2013, NATURE, V499, P336, DOI 10.1038/nature12236; Chubykin AA, 2013, NEURON, V77, P723, DOI 10.1016/j.neuron.2012.12.039; Crochet S, 2006, NAT NEUROSCI, V9, P608, DOI 10.1038/nn1690; Crochet S, 2011, NEURON, V69, P1160, DOI 10.1016/j.neuron.2011.02.022; de Kock CPJ, 2009, P NATL ACAD SCI USA, V106, P16446, DOI 10.1073/pnas.0904143106; de Lafuente V, 2006, P NATL ACAD SCI USA, V103, P14266, DOI 10.1073/pnas.0605826103; Diamond ME, 2008, NAT REV NEUROSCI, V9, P601, DOI 10.1038/nrn2411; Feldmeyer D, 2013, PROG NEUROBIOL, V103, P3, DOI 10.1016/j.pneurobio.2012.11.002; Ferezou I, 2007, NEURON, V56, P907, DOI 10.1016/j.neuron.2007.10.007; Gdalyahu A, 2012, NEURON, V75, P121, DOI 10.1016/j.neuron.2012.04.035; Gentet LJ, 2012, NAT NEUROSCI, V15, P607, DOI 10.1038/nn.3051; Gentet LJ, 2010, NEURON, V65, P422, DOI 10.1016/j.neuron.2010.01.006; Gilbert CD, 2013, NAT REV NEUROSCI, V14, P350, DOI 10.1038/nrn3476; Haider B, 2013, NATURE, V493, P97, DOI 10.1038/nature11665; Houweling AR, 2008, NATURE, V451, P65, DOI 10.1038/nature06447; Huber D, 2012, NATURE, V484, P473, DOI 10.1038/nature11039; Huber D, 2008, NATURE, V451, P61, DOI 10.1038/nature06445; HUTSON KA, 1986, J NEUROPHYSIOL, V56, P1196, DOI 10.1152/jn.1986.56.4.1196; Larkum ME, 2009, SCIENCE, V325, P756, DOI 10.1126/science.1171958; Lee SH, 2012, NEURON, V76, P209, DOI 10.1016/j.neuron.2012.09.012; Lee SH, 2012, NATURE, V488, P379, DOI 10.1038/nature11312; Lee S, 2013, NAT NEUROSCI, V16, P1662, DOI 10.1038/nn.3544; Letzkus JJ, 2011, NATURE, V480, P331, DOI 10.1038/nature10674; Luna R, 2005, NAT NEUROSCI, V8, P1210, DOI 10.1038/nn1513; Mao TY, 2011, NEURON, V72, P111, DOI 10.1016/j.neuron.2011.07.029; Matyas F, 2010, SCIENCE, V330, P1240, DOI 10.1126/science.1195797; Miyashita T, 2013, CEREB CORTEX, V23, P1655, DOI 10.1093/cercor/bhs155; Nienborg H, 2012, ANNU REV NEUROSCI, V35, P463, DOI 10.1146/annurev-neuro-062111-150403; O'Connor DH, 2013, NAT NEUROSCI, V16, P958, DOI 10.1038/nn.3419; O'Connor DH, 2010, NEURON, V67, P1048, DOI 10.1016/j.neuron.2010.08.026; Okun M, 2010, J NEUROSCI, V30, P4440, DOI 10.1523/JNEUROSCI.5062-09.2010; Otazu GH, 2009, NAT NEUROSCI, V12, P646, DOI 10.1038/nn.2306; Parker AJ, 1998, ANNU REV NEUROSCI, V21, P227, DOI 10.1146/annurev.neuro.21.1.227; Petersen CCH, 2007, NEURON, V56, P339, DOI 10.1016/j.neuron.2007.09.017; Petersen CCH, 2013, NEURON, V78, P28, DOI 10.1016/j.neuron.2013.03.020; Polack PO, 2013, NAT NEUROSCI, V16, P1331, DOI 10.1038/nn.3464; Poulet JFA, 2008, NATURE, V454, P881, DOI 10.1038/nature07150; Poulet JFA, 2012, NAT NEUROSCI, V15, P370, DOI 10.1038/nn.3035; Romo R, 1998, NATURE, V392, P387, DOI 10.1038/32891; SALZMAN CD, 1990, NATURE, V346, P174, DOI 10.1038/346174a0; Schultz W, 2002, NEURON, V36, P241, DOI 10.1016/S0896-6273(02)00967-4; Stuttgen MC, 2008, NAT NEUROSCI, V11, P1091, DOI 10.1038/nn.2162; Timofeev I, 2001, P NATL ACAD SCI USA, V98, P1924, DOI 10.1073/pnas.041430398; Xu NL, 2012, NATURE, V492, P247, DOI 10.1038/nature11601; Znamenskiy P, 2013, NATURE, V497, P482, DOI 10.1038/nature12077	50	216	216	2	39	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	NOV	2013	16	11					1671	1677		10.1038/nn.3532	http://dx.doi.org/10.1038/nn.3532			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	241YX	24097038				2022-12-28	WOS:000326205700025
J	Hermanson, DJ; Hartley, ND; Gamble-George, J; Brown, N; Shonesy, BC; Kingsley, PJ; Colbran, RJ; Reese, J; Marnett, LJ; Patel, S				Hermanson, Daniel J.; Hartley, Nolan D.; Gamble-George, Joyonna; Brown, Naoko; Shonesy, Brian C.; Kingsley, Phillip J.; Colbran, Roger J.; Reese, Jeffrey; Marnett, Lawrence J.; Patel, Sachin			Substrate-selective COX-2 inhibition decreases anxiety via endocannabinoid activation	NATURE NEUROSCIENCE			English	Article							AMIDE HYDROLASE INHIBITION; REPEATED HOMOTYPIC STRESS; MOLECULAR CHARACTERIZATION; MONOACYLGLYCEROL LIPASE; CATABOLIC ENZYMES; ARACHIDONIC-ACID; MOUSE-BRAIN; SYSTEM; 2-ARACHIDONOYLGLYCEROL; CYCLOOXYGENASE-2	Augmentation of endogenous cannabinoid (eCB) signaling represents an emerging approach to the treatment of affective disorders. Cyclooxygenase-2 (COX-2) oxygenates arachidonic acid to form prostaglandins, but also inactivates eCBs in vitro. However, the viability of COX-2 as a therapeutic target for in vivo eCB augmentation has not been explored. Using medicinal chemistry and in vivo analytical and behavioral pharmacological approaches, we found that COX-2 is important for the regulation of eCB levels in vivo. We used a pharmacological strategy involving substrate-selective inhibition of COX-2 to augment eCB signaling without affecting related non-eCB lipids or prostaglandin synthesis. Behaviorally, substrate-selective inhibition of COX-2 reduced anxiety-like behaviors in mice via increased eCB signaling. Our data suggest a key role for COX-2 in the regulation of eCB signaling and indicate that substrate-selective pharmacology represents a viable approach for eCB augmentation with broad therapeutic potential.	[Hermanson, Daniel J.; Kingsley, Phillip J.; Marnett, Lawrence J.] Vanderbilt Univ, Sch Med, AB Hancock Jr Mem Lab Canc Res,Ctr Mol Toxicol, Vanderbilt Inst Chem Biol,Dept Biochem, Nashville, TN 37212 USA; [Hermanson, Daniel J.; Kingsley, Phillip J.; Marnett, Lawrence J.] Vanderbilt Univ, Sch Med, AB Hancock Jr Mem Lab Canc Res,Ctr Mol Toxicol, Vanderbilt Inst Chem Biol,Dept Chem, Nashville, TN 37212 USA; [Hermanson, Daniel J.; Kingsley, Phillip J.; Marnett, Lawrence J.] Vanderbilt Univ, Sch Med, AB Hancock Jr Mem Lab Canc Res,Ctr Mol Toxicol, Vanderbilt Inst Chem Biol,Dept Pharmacol, Nashville, TN 37212 USA; [Hermanson, Daniel J.; Kingsley, Phillip J.; Marnett, Lawrence J.] Vanderbilt Univ, Sch Med, Vanderbilt Ingram Canc Ctr, Nashville, TN 37212 USA; [Hartley, Nolan D.; Gamble-George, Joyonna; Patel, Sachin] Vanderbilt Univ, Sch Med, Dept Psychiat, Nashville, TN 37212 USA; [Brown, Naoko; Reese, Jeffrey] Vanderbilt Univ, Sch Med, Dept Pediat, Nashville, TN 37212 USA; [Shonesy, Brian C.; Colbran, Roger J.; Patel, Sachin] Vanderbilt Univ, Sch Med, Dept Mol Physiol & Biophys, Nashville, TN 37212 USA	Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University	Marnett, LJ (corresponding author), Vanderbilt Univ, Sch Med, AB Hancock Jr Mem Lab Canc Res,Ctr Mol Toxicol, Vanderbilt Inst Chem Biol,Dept Biochem, Nashville, TN 37212 USA.	larry.marnett@vanderbilt.edu; sachin.patel@vanderbilt.edu	Gamble-George, Joyonna/AAM-7598-2021; Colbran, Roger/AAU-7708-2021; Shonesy, Brian/AAP-7569-2021; Gamble-George, Joyonna Carrie/GQA-7423-2022	Gamble-George, Joyonna/0000-0002-5492-9216; Colbran, Roger/0000-0001-7401-8244; Reese, Jeff/0000-0001-8751-6146; Shonesy, Brian/0000-0003-3791-9339	US National Institutes of Health [MH090412, MH100096, CA89450, GM15431, NS064278, DA031572, HL96967, HL109199, NS078291, T32-MH065215]; A.B. Hancock Jr. Memorial Laboratory for Cancer Research; NATIONAL CANCER INSTITUTE [R01CA089450] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL109199, R01HL096967] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM015431, R25GM062459, P01GM015431] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH100096, K08MH090412, R01MH063232, T32MH065215] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS078291, R01NS064278] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [F31DA031572] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); A.B. Hancock Jr. Memorial Laboratory for Cancer Research; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank K. Masuda, M. Brown, R. Stevens and B. Cravatt (Scripps Research Institute) for FAAH knockout mice. This work was supported by US National Institutes of Health grants MH090412 and MH100096 (S.P.), CA89450, GM15431, NS064278 (L.J.M.), DA031572 (D.J.H.), HL96967, HL109199 (J.R.), NS078291 (R.J.C.) and T32-MH065215 (B.C.S.), and the A.B. Hancock Jr. Memorial Laboratory for Cancer Research. Analytical studies were conducted in the Vanderbilt University Mass Spectrometry Core facility and all behavioral experiments were conducted in the Vanderbilt University Medical Center Mouse Neurobehavioral Core facility. The content of this article is solely the responsibility of the authors and does not necessarily represent the official views of the US National Institutes of Health.	Ahn K, 2008, CHEM REV, V108, P1687, DOI 10.1021/cr0782067; Ahn K, 2009, CHEM BIOL, V16, P411, DOI 10.1016/j.chembiol.2009.02.013; Bifulco M, 2007, ONCOL REP, V17, P813; Bishay P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010628; Bisogno T, 2010, CNS NEUROL DISORD-DR, V9, P564, DOI 10.2174/187152710793361568; Blankman JL, 2007, CHEM BIOL, V14, P1347, DOI 10.1016/j.chembiol.2007.11.006; Centonze D, 2007, TRENDS PHARMACOL SCI, V28, P180, DOI 10.1016/j.tips.2007.02.004; Cravatt BF, 1996, NATURE, V384, P83, DOI 10.1038/384083a0; Cristino L, 2008, NEUROSCIENCE, V151, P955, DOI 10.1016/j.neuroscience.2007.11.047; Di Marzo V, 2008, REV PHYSIOL BIOCH P, V160, P1, DOI 10.1007/112_0505; Di Marzo V, 2011, HANDB EXP PHARMACOL, V203, P75, DOI 10.1007/978-3-642-17214-4_4; Di Marzo V, 2009, PHARMACOL RES, V60, P77, DOI 10.1016/j.phrs.2009.02.010; Duggan KC, 2011, NAT CHEM BIOL, V7, P803, DOI 10.1038/nchembio.663; Fride E, 2006, METH MOLEC MED, V123, P269; Gaetani S, 2009, INT REV NEUROBIOL, V85, P57, DOI 10.1016/S0074-7742(09)85005-8; Glaser ST, 2010, J PHARMACOL EXP THER, V335, P380, DOI 10.1124/jpet.110.168831; Guindon J, 2009, CNS NEUROL DISORD-DR, V8, P403, DOI 10.2174/187152709789824660; Hohmann AG, 2006, AAPS J, V8, pE693, DOI 10.1208/aapsj080479; Kalgutkar AS, 2000, P NATL ACAD SCI USA, V97, P925, DOI 10.1073/pnas.97.2.925; Kalgutkar AS, 2000, J MED CHEM, V43, P2860, DOI 10.1021/jm000004e; Kathuria S, 2003, NAT MED, V9, P76, DOI 10.1038/nm803; Kim J, 2004, NAT NEUROSCI, V7, P697, DOI 10.1038/nn1262; Kingsley PJ, 2007, METHOD ENZYMOL, V433, P91, DOI 10.1016/s0076-6879(07)33005-X; Kinsey SG, 2011, PHARMACOL BIOCHEM BE, V98, P21, DOI 10.1016/j.pbb.2010.12.002; Kozak KR, 2000, J BIOL CHEM, V275, P33744, DOI 10.1074/jbc.M007088200; Kunos G, 2007, AM J MED, V120, P18, DOI 10.1016/j.amjmed.2007.06.007; Lichtman AH, 2002, PROSTAG LEUKOTR ESS, V66, P269, DOI 10.1054/plef.2001.0351; Long JZ, 2009, P NATL ACAD SCI USA, V106, P20270, DOI 10.1073/pnas.0909411106; Long JZ, 2009, NAT CHEM BIOL, V5, P37, DOI 10.1038/nchembio.129; Lopez-Rodriguez ML, 2005, MINI-REV MED CHEM, V5, P97, DOI 10.2174/1389557053402819; Lutz B, 2009, CURR OPIN PHARMACOL, V9, P46, DOI 10.1016/j.coph.2008.12.001; Makriyannis A, 2005, NEUROPHARMACOLOGY, V48, P1068, DOI 10.1016/j.neuropharm.2005.03.012; Mangleri RA, 2007, PHARMACOL RES, V56, P360, DOI 10.1016/j.phrs.2007.09.003; Moreira FA, 2008, NEUROPHARMACOLOGY, V54, P141, DOI 10.1016/j.neuropharm.2007.07.005; Muller N, 2008, CURR PHARM DESIGN, V14, P1452, DOI 10.2174/138161208784480243; Naidu PS, 2007, PSYCHOPHARMACOLOGY, V192, P61, DOI 10.1007/s00213-006-0689-4; O'Sullivan SE, 2007, BRIT J PHARMACOL, V152, P576, DOI 10.1038/sj.bjp.0707423; Pan B, 2008, J NEUROSCI, V28, P14018, DOI 10.1523/JNEUROSCI.4035-08.2008; Patel S, 2008, EUR J NEUROSCI, V27, P2821, DOI 10.1111/j.1460-9568.2008.06266.x; Patel S, 2006, J PHARMACOL EXP THER, V318, P304, DOI 10.1124/jpet.106.101287; Patel S, 2009, NEUROPSYCHOPHARMACOL, V34, P2699, DOI 10.1038/npp.2009.101; Patrignani Paola, 2011, Expert Rev Clin Pharmacol, V4, P605, DOI 10.1586/ecp.11.36; Pedicord DL, 2011, BIOCHEM BIOPH RES CO, V411, P809, DOI 10.1016/j.bbrc.2011.07.037; Piomelli D, 2003, NAT REV NEUROSCI, V4, P873, DOI 10.1038/nrn1247; Piomelli Daniele, 2005, Curr Opin Investig Drugs, V6, P672; Prusakiewicz JJ, 2009, BIOCHEMISTRY-US, V48, P7353, DOI 10.1021/bi900999z; Rossi S, 2010, MOL PHARMACOL, V78, P260, DOI 10.1124/mol.110.064196; Rouzer CA, 2006, PROSTAG OTH LIPID M, V79, P146; Rouzer CA, 2008, J BIOL CHEM, V283, P8065, DOI 10.1074/jbc.R800005200; Rowlinson SW, 1999, J BIOL CHEM, V274, P23305, DOI 10.1074/jbc.274.33.23305; Sciolino NR, 2011, PHARMACOL RES, V64, P226, DOI 10.1016/j.phrs.2011.04.010; Staniaszek LE, 2010, BRIT J PHARMACOL, V160, P669, DOI 10.1111/j.1476-5381.2010.00703.x; Sumislawski JJ, 2011, NEUROPSYCHOPHARMACOL, V36, P2750, DOI 10.1038/npp.2011.166; Tam J, 2006, MOL PHARMACOL, V70, P786, DOI 10.1124/mol.106.026435; Uddin MJ, 2011, CANCER PREV RES, V4, P1536, DOI 10.1158/1940-6207.CAPR-11-0120; Yu Y., 2012, SCI TRANSL MED, V4	56	90	92	0	13	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	SEP	2013	16	9					1291	U176		10.1038/nn.3480	http://dx.doi.org/10.1038/nn.3480			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	207KN	23912944	Green Accepted			2022-12-28	WOS:000323597500021
J	Lim, S; Goldman, MS				Lim, Sukbin; Goldman, Mark S.			Balanced cortical microcircuitry for maintaining information in working memory	NATURE NEUROSCIENCE			English	Article							PERSISTENT NEURAL ACTIVITY; RAT PREFRONTAL CORTEX; SHORT-TERM-MEMORY; NMDA RECEPTORS; DECISION-MAKING; IN-VIVO; NEURONS; NETWORK; INTEGRATOR; MODEL	Persistent neural activity in the absence of a stimulus has been identified as a neural correlate of working memory, but how such activity is maintained by neocortical circuits remains unknown. We used a computational approach to show that the inhibitory and excitatory microcircuitry of neocortical memory-storing regions is sufficient to implement a corrective feedback mechanism that enables persistent activity to be maintained stably for prolonged durations. When recurrent excitatory and inhibitory inputs to memory neurons were balanced in strength and offset in time, drifts in activity triggered a corrective signal that counteracted memory decay. Circuits containing this mechanism temporally integrated their inputs, generated the irregular neural firing observed during persistent activity and were robust against common perturbations that severely disrupted previous models of short-term memory storage. These results reveal a mechanism for the accumulation and storage of memories in neocortical circuits based on principles of corrective negative feedback that are widely used in engineering applications.	[Lim, Sukbin; Goldman, Mark S.] Univ Calif Davis, Ctr Neurosci, Davis, CA 95616 USA; [Goldman, Mark S.] Univ Calif Davis, Dept Neurobiol Physiol & Behav, Davis, CA 95616 USA; [Goldman, Mark S.] Univ Calif Davis, Dept Ophthalmol & Visual Sci, Davis, CA 95616 USA	University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis	Goldman, MS (corresponding author), Univ Calif Davis, Ctr Neurosci, Davis, CA 95616 USA.	msgoldman@ucdavis.edu			US National Institutes of Health [R01 MH069726, R01 MH065034]; Sloan Foundation fellowship; University of California Davis Ophthalmology Research to Prevent Blindness grant; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH069726, R01MH065034] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Sloan Foundation fellowship(Alfred P. Sloan Foundation); University of California Davis Ophthalmology Research to Prevent Blindness grant; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank D. Fisher for valuable discussions and E. Aksay, K. Britten, N. Brunel, D. Butts, J. Ditterich, R. Froemke, A. Goddard, D. Kastner, B. Lankow, S. Luck, B. Mulloney, J. Raymond, J. Rinzel and M. Usrey for valuable discussions and feedback on the manuscript. We thank A. Lerchner for providing code for our initial simulations of spiking network models. This research was supported by US National Institutes of Health grants R01 MH069726 and R01 MH065034, a Sloan Foundation fellowship, and a University of California Davis Ophthalmology Research to Prevent Blindness grant.	Barbieri F, 2008, FRONT NEUROSCI-SWITZ, V2, P114, DOI 10.3389/neuro.01.003.2008; Boerlin M, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001080; Brody CD, 2003, CURR OPIN NEUROBIOL, V13, P204, DOI 10.1016/S0959-4388(03)00050-3; CANNON SC, 1983, BIOL CYBERN, V49, P127, DOI 10.1007/BF00320393; Compte A, 2003, J NEUROPHYSIOL, V90, P3441, DOI 10.1152/jn.00949.2002; Coyle JT, 2003, ANN NY ACAD SCI, V1003, P318, DOI 10.1196/annals.1300.020; Destexhe A, 2003, NAT REV NEUROSCI, V4, P739, DOI 10.1038/nrn1198; Durstewitz D, 2000, NAT NEUROSCI, V3, P1184, DOI 10.1038/81460; FUSTER JM, 1971, SCIENCE, V173, P652, DOI 10.1126/science.173.3997.652; Ganguli S, 2008, NEURON, V58, P15, DOI 10.1016/j.neuron.2008.01.038; Goldman MS, 2003, CEREB CORTEX, V13, P1185, DOI 10.1093/cercor/bhg095; Haider B, 2006, J NEUROSCI, V26, P4535, DOI 10.1523/JNEUROSCI.5297-05.2006; Haider B, 2009, NEURON, V62, P171, DOI 10.1016/j.neuron.2009.04.008; Hansel D, 1998, NEURAL COMPUT, V10, P467, DOI 10.1162/089976698300017845; Jonides J, 2008, ANNU REV PSYCHOL, V59, P193, DOI 10.1146/annurev.psych.59.103006.093615; Knill DC, 2004, TRENDS NEUROSCI, V27, P712, DOI 10.1016/j.tins.2004.10.007; Koulakov AA, 2002, NAT NEUROSCI, V5, P775, DOI 10.1038/nn893; Lisman JE, 1998, NAT NEUROSCI, V1, P273, DOI 10.1038/1086; Liu GS, 2004, NAT NEUROSCI, V7, P373, DOI 10.1038/nn1206; Machens CK, 2005, SCIENCE, V307, P1121, DOI 10.1126/science.1104171; Major G, 2004, CURR OPIN NEUROBIOL, V14, P675, DOI 10.1016/j.conb.2004.10.017; Major G, 2008, J NEUROPHYSIOL, V99, P2584, DOI 10.1152/jn.00011.2008; MCCORMICK DA, 1985, J NEUROPHYSIOL, V54, P782, DOI 10.1152/jn.1985.54.4.782; Mongillo G, 2008, SCIENCE, V319, P1543, DOI 10.1126/science.1150769; Murphy BK, 2009, NEURON, V61, P635, DOI 10.1016/j.neuron.2009.02.005; Nikitchenko M, 2008, NEURAL COMPUT, V20, P2379, DOI 10.1162/neco.2008.12-06-416; Renart A, 2007, NEURAL COMPUT, V19, P1, DOI 10.1162/neco.2007.19.1.1; ROBINSON DA, 1989, ANNU REV NEUROSCI, V12, P33, DOI 10.1146/annurev.neuro.12.1.33; Roitman JD, 2002, J NEUROSCI, V22, P9475; Romo R, 1999, NATURE, V399, P470, DOI 10.1038/20939; Rotaru DC, 2011, J NEUROSCI, V31, P142, DOI 10.1523/JNEUROSCI.1970-10.2011; Roudi Y, 2007, PLOS COMPUT BIOL, V3, P1679, DOI 10.1371/journal.pcbi.0030141; Salin PA, 1996, J NEUROPHYSIOL, V75, P1573, DOI 10.1152/jn.1996.75.4.1573; Seung HS, 1996, P NATL ACAD SCI USA, V93, P13339, DOI 10.1073/pnas.93.23.13339; Shadlen Michael N., 1994, Current Opinion in Neurobiology, V4, P569, DOI 10.1016/0959-4388(94)90059-0; Shadlen MN, 1996, J NEUROSCI, V16, P1486; SHEN L, 1989, BIOL CYBERN, V61, P319, DOI 10.1007/BF00203180; Shu YS, 2003, NATURE, V423, P288, DOI 10.1038/nature01616; SOFTKY WR, 1993, J NEUROSCI, V13, P334; Tao HW, 2005, NEURON, V45, P829, DOI 10.1016/j.neuron.2005.01.046; vanVreeswijk C, 1996, SCIENCE, V274, P1724, DOI 10.1126/science.274.5293.1724; Vogels TP, 2011, SCIENCE, V334, P1569, DOI 10.1126/science.1211095; Vogels TP, 2005, ANNU REV NEUROSCI, V28, P357, DOI 10.1146/annurev.neuro.28.061604.135637; Wang HX, 2009, NEUROPSYCHOPHARMACOL, V34, P2028, DOI 10.1038/npp.2009.20; Wang HX, 2008, P NATL ACAD SCI USA, V105, P16791, DOI 10.1073/pnas.0804318105; Wang M, 2013, NEURON, V77, P736, DOI 10.1016/j.neuron.2012.12.032; Wang XJ, 2008, NEURON, V60, P215, DOI 10.1016/j.neuron.2008.09.034; Wang XJ, 2001, TRENDS NEUROSCI, V24, P455, DOI 10.1016/S0166-2236(00)01868-3; Wang XJ, 1999, J NEUROSCI, V19, P9587; Wang Y, 2006, NAT NEUROSCI, V9, P534, DOI 10.1038/nn1670; Wilson H.R., 1999, SPIKES DECISIONS ACT; Xiang ZX, 1998, J PHYSIOL-LONDON, V506, P715, DOI 10.1111/j.1469-7793.1998.715bv.x; Xie XH, 2000, ADV NEUR IN, V12, P199	54	113	115	1	47	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	SEP	2013	16	9					1306	U196		10.1038/nn.3492	http://dx.doi.org/10.1038/nn.3492			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	207KN	23955560	Green Accepted			2022-12-28	WOS:000323597500023
J	Hunt, DL; Puente, N; Grandes, P; Castillo, PE				Hunt, David L.; Puente, Nagore; Grandes, Pedro; Castillo, Pablo E.			Bidirectional NMDA receptor plasticity controls CA3 output and heterosynaptic metaplasticity	NATURE NEUROSCIENCE			English	Article							MOSSY FIBER SYNAPSES; TIMING-DEPENDENT PLASTICITY; LONG-TERM POTENTIATION; METABOTROPIC GLUTAMATE-RECEPTOR; SYNAPTIC PLASTICITY; PYRAMIDAL CELLS; FEEDFORWARD INHIBITION; MEDIATED TRANSMISSION; RAT HIPPOCAMPUS; MEMORY	NMDA receptors (NMDARs) are classically known as coincidence detectors for the induction of long-term synaptic plasticity and have been implicated in hippocampal CA3 cell-dependent spatial memory functions that likely rely on dynamic cellular ensemble encoding of space. The unique functional properties of both NMDARs and mossy fiber projections to CA3 pyramidal cells place mossy fiber NMDARs in a prime position to influence CA3 ensemble dynamics. By mimicking presynaptic and postsynaptic activity patterns observed in vivo, we found a burst timing-dependent pattern of activity that triggered bidirectional long-term NMDAR plasticity at mossy fiber-CA3 synapses in rat hippocampal slices. This form of plasticity imparts bimodal control of mossy fiber-driven CA3 burst firing and spike temporal fidelity. Moreover, we found that mossy fiber NMDARs mediate heterosynaptic metaplasticity between mossy fiber and associational-commissural synapses. Thus, bidirectional NMDAR plasticity at mossy fiber-CA3 synapses could substantially contribute to the formation, storage and recall of CA3 cell assembly patterns.	[Hunt, David L.; Castillo, Pablo E.] Albert Einstein Coll Med, Dominick P Purpura Dept Neurosci, Bronx, NY 10467 USA; [Puente, Nagore; Grandes, Pedro] Univ Basque Country, Fac Med & Dent, Dept Neurosci, Leioa, Spain	Yeshiva University; Albert Einstein College of Medicine; University of Basque Country	Castillo, PE (corresponding author), Albert Einstein Coll Med, Dominick P Purpura Dept Neurosci, Bronx, NY 10467 USA.	pablo.castillo@einstein.yu.edu	Grandes, Pedro/H-7494-2015; Puente, Nagore/H-7054-2015; Grandes, Pedro/AAA-1627-2019	Grandes, Pedro/0000-0003-3947-4230; Puente, Nagore/0000-0003-0866-5747; Hunt, David/0000-0002-7567-5649; Castillo, Pablo/0000-0002-9834-1801	US National Institutes of Health [R01 MH081935, R01 DA017392]; Ministerio de Economia y Competitividad [BFU2012-33334]; Basque Country Government [IT764-13]; University of the Basque Country; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH081935] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA017392] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ministerio de Economia y Competitividad(Spanish Government); Basque Country Government(Basque Government); University of the Basque Country; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank members of the Castillo lab (in particular, A. Chavez, T. Younts, P. Haeger and S. Makani) for their constructive discussions on the data and helpful comments on the manuscript. This work was supported by US National Institutes of Health grants to P.E.C. (R01 MH081935 and R01 DA017392). Funding for P.G.'s laboratory is provided by Ministerio de Economia y Competitividad (BFU2012-33334), Basque Country Government (IT764-13) and University of the Basque Country.	Abraham WC, 2008, NAT REV NEUROSCI, V9, P387, DOI 10.1038/nrn2356; Astori S, 2010, J PHYSIOL-LONDON, V588, P4475, DOI 10.1113/jphysiol.2010.198366; Bains JS, 1999, NAT NEUROSCI, V2, P720, DOI 10.1038/11184; Branco T, 2011, NEURON, V69, P885, DOI 10.1016/j.neuron.2011.02.006; Buzsaki G, 2010, NEURON, V68, P362, DOI 10.1016/j.neuron.2010.09.023; Caporale N, 2008, ANNU REV NEUROSCI, V31, P25, DOI 10.1146/annurev.neuro.31.060407.125639; DAW NW, 1993, ANNU REV NEUROSCI, V16, P207, DOI 10.1146/annurev.ne.16.030193.001231; Debanne D, 1998, J PHYSIOL-LONDON, V507, P237, DOI 10.1111/j.1469-7793.1998.237bu.x; Frausto SF, 2011, J NEUROSCI, V31, P16897, DOI 10.1523/JNEUROSCI.1264-11.2011; Harnett MT, 2009, NEURON, V62, P826, DOI 10.1016/j.neuron.2009.05.011; Henze DA, 2002, NAT NEUROSCI, V5, P790, DOI 10.1038/nn887; HERRON CE, 1986, NATURE, V322, P265, DOI 10.1038/322265a0; Hulme SR, 2012, J NEUROSCI, V32, P6785, DOI 10.1523/JNEUROSCI.0634-12.2012; Hunt DL, 2012, CURR OPIN NEUROBIOL, V22, P496, DOI 10.1016/j.conb.2012.01.007; Ireland DR, 2009, J NEUROPHYSIOL, V101, P1375, DOI 10.1152/jn.90643.2008; JONAS P, 1993, J PHYSIOL-LONDON, V472, P615, DOI 10.1113/jphysiol.1993.sp019965; JUNG MW, 1993, HIPPOCAMPUS, V3, P165, DOI 10.1002/hipo.450030209; Kapur A, 2001, NEUROSCIENCE, V107, P59, DOI 10.1016/S0306-4522(01)00293-7; Kobayashi K, 2004, NEURON, V41, P445, DOI 10.1016/S0896-6273(03)00873-0; Kumar A, 2010, NAT REV NEUROSCI, V11, P615, DOI 10.1038/nrn2886; Kwon HB, 2008, NEURON, V57, P108, DOI 10.1016/j.neuron.2007.11.024; Lawrence JJ, 2003, TRENDS NEUROSCI, V26, P631, DOI 10.1016/j.tins.2003.09.007; Leutgeb S, 2005, CURR OPIN NEUROBIOL, V15, P738, DOI 10.1016/j.conb.2005.10.002; LISMAN J, 1989, P NATL ACAD SCI USA, V86, P9574, DOI 10.1073/pnas.86.23.9574; Lisman JE, 1997, TRENDS NEUROSCI, V20, P38, DOI 10.1016/S0166-2236(96)10070-9; Lujan R, 1996, EUR J NEUROSCI, V8, P1488, DOI 10.1111/j.1460-9568.1996.tb01611.x; Major G, 2008, J NEUROPHYSIOL, V99, P2584, DOI 10.1152/jn.00011.2008; MARR D, 1971, PHILOS T ROY SOC B, V262, P23, DOI 10.1098/rstb.1971.0078; Mateos JM, 1998, J COMP NEUROL, V390, P225, DOI 10.1002/(SICI)1096-9861(19980112)390:2<225::AID-CNE5>3.0.CO;2-3; Mori M, 2004, NATURE, V431, P453, DOI 10.1038/nature02854; Morishita W, 2005, NAT NEUROSCI, V8, P1043, DOI 10.1038/nn1506; Nakashiba T, 2009, NEURON, V62, P781, DOI 10.1016/j.neuron.2009.05.013; Nakazawa K, 2002, SCIENCE, V297, P211, DOI 10.1126/science.1071795; Nakazawa K, 2003, NEURON, V38, P305, DOI 10.1016/S0896-6273(03)00165-X; Nicoll RA, 2005, NAT REV NEUROSCI, V6, P863, DOI 10.1038/nrn1786; Nishiyama M, 2000, NATURE, V408, P584, DOI 10.1038/35046067; Peng Y, 2010, HIPPOCAMPUS, V20, P646, DOI 10.1002/hipo.20654; Pouille F, 2001, SCIENCE, V293, P1159, DOI 10.1126/science.1060342; Rebola N, 2008, NEURON, V57, P121, DOI 10.1016/j.neuron.2007.11.023; Rebola N, 2011, NAT NEUROSCI, V14, P691, DOI 10.1038/nn.2809; Ross WN, 2012, NAT REV NEUROSCI, V13, P157, DOI 10.1038/nrn3168; Schiller J, 2001, CURR OPIN NEUROBIOL, V11, P343, DOI 10.1016/S0959-4388(00)00217-8; Sjostrom PJ, 2002, CURR OPIN NEUROBIOL, V12, P305, DOI 10.1016/S0959-4388(02)00325-2; Song S, 2000, NAT NEUROSCI, V3, P919, DOI 10.1038/78829; Tanaka J, 2000, EUR J NEUROSCI, V12, P781, DOI 10.1046/j.1460-9568.2000.00959.x; Topolnik L, 2006, J PHYSIOL-LONDON, V575, P115, DOI 10.1113/jphysiol.2006.112896; Torborg CL, 2010, J NEUROSCI, V30, P15628, DOI 10.1523/JNEUROSCI.3099-10.2010; Traynelis SF, 2010, PHARMACOL REV, V62, P405, DOI 10.1124/pr.109.002451; Uchigashima M, 2007, J NEUROSCI, V27, P3663, DOI 10.1523/JNEUROSCI.0448-07.2007; Valenti O, 2002, J CELL PHYSIOL, V191, P125, DOI 10.1002/jcp.10081; Wang HX, 2005, NAT NEUROSCI, V8, P187, DOI 10.1038/nn1387	51	36	36	2	28	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	AUG	2013	16	8					1049	U109		10.1038/nn.3461	http://dx.doi.org/10.1038/nn.3461			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	190EV	23852115	Green Accepted			2022-12-28	WOS:000322323000015
J	Levitz, J; Pantoja, C; Gaub, B; Janovjak, H; Reiner, A; Hoagland, A; Schoppik, D; Kane, B; Stawski, P; Schier, AF; Trauner, D; Isacoff, EY				Levitz, Joshua; Pantoja, Carlos; Gaub, Benjamin; Janovjak, Harald; Reiner, Andreas; Hoagland, Adam; Schoppik, David; Kane, Brian; Stawski, Philipp; Schier, Alexander F.; Trauner, Dirk; Isacoff, Ehud Y.			Optical control of metabotropic glutamate receptors	NATURE NEUROSCIENCE			English	Article							LONG-TERM DEPRESSION; HETEROLOGOUS EXPRESSION; REMOTE-CONTROL; ACTIVATION; INHIBITION; RHODOPSIN; CHANNELS; ROLES; TRANSGENESIS; MECHANISMS	G protein-coupled receptors (GPCRs), the largest family of membrane signaling proteins, respond to neurotransmitters, hormones and small environmental molecules. The neuronal function of many GPCRs has been difficult to resolve because of an inability to gate them with subtype specificity, spatial precision, speed and reversibility. To address this, we developed an approach for opto-chemical engineering of native GPCRs. We applied this to the metabotropic glutamate receptors (mGluRs) to generate light-agonized and light-antagonized mGluRs (LimGluRs). The light-agonized LimGluR2, on which we focused, was fast, bistable and supported multiple rounds of on/off switching. Light gated two of the primary neuronal functions of mGluR2: suppression of excitability and inhibition of neurotransmitter release. We found that the light-antagonized tool LimGluR2-block was able to manipulate negative feedback of synaptically released glutamate on transmitter release. We generalized the optical control to two additional family members: mGluR3 and mGluR6. This system worked in rodent brain slices and in zebrafish in vivo, where we found that mGluR2 modulated the threshold for escape behavior. These light-gated mGluRs pave the way for determining the roles of mGluRs in synaptic plasticity, memory and disease.	[Levitz, Joshua; Isacoff, Ehud Y.] Univ Calif Berkeley, Biophys Grad Grp, Berkeley, CA 94720 USA; [Pantoja, Carlos; Janovjak, Harald; Reiner, Andreas; Hoagland, Adam; Isacoff, Ehud Y.] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; [Gaub, Benjamin; Isacoff, Ehud Y.] Univ Calif Berkeley, Helen Wills Neurosci Grad Program, Berkeley, CA 94720 USA; [Schoppik, David; Schier, Alexander F.] Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA; [Kane, Brian; Trauner, Dirk] Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA; [Stawski, Philipp; Trauner, Dirk] Univ Munich, Dept Chem, Munich, Germany; [Stawski, Philipp; Trauner, Dirk] Univ Munich, Ctr Integrated Prot Sci, Munich, Germany; [Isacoff, Ehud Y.] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Phys Biosci Div, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California Berkeley; Harvard University; University of California System; University of California Berkeley; University of Munich; University of Munich; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	Trauner, D (corresponding author), Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA.	dirk.trauner@lmu.de; ehud@berkeley.edu	isacoff, ehud/AAP-1459-2020; Reiner, Andreas/AGK-2170-2022; Janovjak, Harald/O-9070-2016	Reiner, Andreas/0000-0003-0802-7278; Janovjak, Harald/0000-0002-8023-9315; Schoppik, David/0000-0001-7969-9632; Erdmann, Philipp/0000-0001-8289-9133; Isacoff, Ehud Y./0000-0003-4775-9359; Schier, Alexander Franz/0000-0001-7645-5325	Nanomedicine Development Center for the Optical Control of Biological Function; US National Institutes of Health [PN2EY018241, R01HL109525]; Human Frontier Science Program [RGP0013/2010]; Deutsche Forschungsgemeinschaft [FOR 1279]; Fond der Chemischen Industrie; National Science Foundation [CHE-0233882, CHE-0840505]; European Molecular Biology Organization; Helen Hay Whitney postdoctoral fellowship; McKnight Endowment Fund for Neuroscience; Fulbright Foundation; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR028971] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [PN2EY018241] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL109525] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM085357] Funding Source: NIH RePORTER; Direct For Biological Sciences [1041078] Funding Source: National Science Foundation	Nanomedicine Development Center for the Optical Control of Biological Function; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Human Frontier Science Program(Human Frontier Science Program); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Fond der Chemischen Industrie(Fonds der Chemischen Industrie); National Science Foundation(National Science Foundation (NSF)); European Molecular Biology Organization(European Molecular Biology Organization (EMBO)); Helen Hay Whitney postdoctoral fellowship; McKnight Endowment Fund for Neuroscience; Fulbright Foundation; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	We thank A.P. Mariani (National Eye Institute) for 11-cis retinal, J.P. Pin (University of Montpellier) for the mGluR plasmids and E. Reuveny (Weizmann Institute) for the GIRK1 plasmid, K. Durkin, K. Dubay, T. Berger, G. Sandoz and S. Berlin for helpful discussions, A. Guyon, Z. Fu and S. Szobota for help with slice cultures, Z. Fu for molecular biology assistance, K. McDaniel, J. Maxfield, J. Saint-Hillaire and D. Weinman for fish care, E. Carroll for discussion and help with zebrafish set up, P. Gut (University of California, San Francisco) for zebrafish plasmids, H. Baier (University of California, San Francisco) for fish lines, and the College of Chemistry (University of California, Berkeley) for computing resources for the Monte Carlo simulations. Support for the work was provided by the Nanomedicine Development Center for the Optical Control of Biological Function, US National Institutes of Health grant PN2EY018241 (D.T. and E.Y.I.), the Human Frontier Science Program (RGP0013/2010 to E.Y.I.), the Deutsche Forschungsgemeinschaft (FOR 1279, D.T.), the Fond der Chemischen Industrie (Kekule fellowship to P.S.), National Science Foundation grants CHE-0233882 and CHE-0840505 (to the College of Chemistry at the University of California, Berkeley), a postdoctoral fellowship of the European Molecular Biology Organization (H.J.), a Helen Hay Whitney postdoctoral fellowship (D.S.), the McKnight Endowment Fund for Neuroscience and US National Institutes of Health grant R01HL109525 (A.F.S.), and a predoctoral fellowship from the Fulbright Foundation (B.G.).	Airan RD, 2009, NATURE, V458, P1025, DOI 10.1038/nature07926; Alexander GM, 2009, NEURON, V63, P27, DOI 10.1016/j.neuron.2009.06.014; Altinbilek B, 2009, NEUROSCIENCE, V158, P149, DOI 10.1016/j.neuroscience.2008.07.045; Anwyl R, 2009, NEUROPHARMACOLOGY, V56, P735, DOI 10.1016/j.neuropharm.2009.01.002; Bailes HJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030774; Banghart M, 2004, NAT NEUROSCI, V7, P1381, DOI 10.1038/nn1356; BEKKERS JM, 1991, P NATL ACAD SCI USA, V88, P7834, DOI 10.1073/pnas.88.17.7834; Bockaert J, 2010, ANNU REV PHARMACOL, V50, P89, DOI 10.1146/annurev.pharmtox.010909.105705; Bordoli L, 2009, NAT PROTOC, V4, P1, DOI 10.1038/nprot.2008.197; Bradley SJ, 2012, BIOCHEM PHARMACOL, V84, P249, DOI 10.1016/j.bcp.2012.04.009; Burgess HA, 2007, J NEUROSCI, V27, P4984, DOI 10.1523/JNEUROSCI.0615-07.2007; Caporale N, 2011, MOL THER, V19, P1212, DOI 10.1038/mt.2011.103; CHANG G, 1989, J AM CHEM SOC, V111, P4379, DOI 10.1021/ja00194a035; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; Deisseroth K, 2011, NAT METHODS, V8, P26, DOI 10.1038/NMETH.F.324; Ehrengruber MU, 1997, P NATL ACAD SCI USA, V94, P7070, DOI 10.1073/pnas.94.13.7070; Fehrentz T, 2011, ANGEW CHEM INT EDIT, V50, P12156, DOI 10.1002/anie.201103236; Gainetdinov RR, 2004, ANNU REV NEUROSCI, V27, P107, DOI 10.1146/annurev.neuro.27.070203.144206; Gorostiza P, 2007, P NATL ACAD SCI USA, V104, P10865, DOI 10.1073/pnas.0701274104; Grabher C, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-S1-S10; Grauer SM, 1999, PSYCHOPHARMACOLOGY, V141, P405, DOI 10.1007/s002130050850; Gutierrez DV, 2011, J BIOL CHEM, V286, P25848, DOI 10.1074/jbc.M111.253674; Hanna L, 2013, NEUROPHARMACOLOGY, V66, P114, DOI 10.1016/j.neuropharm.2012.02.023; Haug MF, 2013, J COMP NEUROL, V521, P1533, DOI 10.1002/cne.23240; Iacovelli L, 2009, MOL PHARMACOL, V75, P991, DOI 10.1124/mol.108.052316; IKEDA SR, 1995, NEURON, V14, P1029, DOI 10.1016/0896-6273(95)90341-0; Janovjak H, 2010, NAT NEUROSCI, V13, P1027, DOI 10.1038/nn.2589; Kaminski GA, 2001, J PHYS CHEM B, V105, P6474, DOI 10.1021/jp003919d; Kim JM, 2005, BIOCHEMISTRY-US, V44, P2284, DOI 10.1021/bi048328i; Kobilka BK, 2011, TRENDS PHARMACOL SCI, V32, P213, DOI 10.1016/j.tips.2011.02.005; Koch M, 1999, PROG NEUROBIOL, V59, P107, DOI 10.1016/S0301-0082(98)00098-7; Kurita R, 2003, DEV BIOL, V255, P113, DOI 10.1016/S0012-1606(02)00079-9; Kwan KM, 2007, DEV DYNAM, V236, P3088, DOI 10.1002/dvdy.21343; Leaney JL, 2003, EUR J NEUROSCI, V18, P2110, DOI 10.1046/j.1460-9568.2003.02933.x; Li X, 2005, P NATL ACAD SCI USA, V102, P17816, DOI 10.1073/pnas.0509030102; Lin B, 2008, P NATL ACAD SCI USA, V105, P16009, DOI 10.1073/pnas.0806114105; Luscher C, 2010, NEURON, V65, P445, DOI 10.1016/j.neuron.2010.01.016; Marek GJ, 2004, CURR OPIN PHARMACOL, V4, P18, DOI 10.1016/j.coph.2003.10.003; Melyan Z, 2005, NATURE, V433, P741, DOI 10.1038/nature03344; Muto T, 2007, P NATL ACAD SCI USA, V104, P3759, DOI 10.1073/pnas.0611577104; Niswender CM, 2010, ANNU REV PHARMACOL, V50, P295, DOI 10.1146/annurev.pharmtox.011008.145533; Oh E, 2010, J BIOL CHEM, V285, P30825, DOI 10.1074/jbc.M110.147298; Panatier A, 2011, CELL, V146, P785, DOI 10.1016/j.cell.2011.07.022; Pei Y, 2008, PHYSIOLOGY, V23, P313, DOI 10.1152/physiol.00025.2008; Pierce KL, 2002, NAT REV MOL CELL BIO, V3, P639, DOI 10.1038/nrm908; Qiu XD, 2005, NATURE, V433, P745, DOI 10.1038/nature03345; Raveh A, 2010, CELL, V143, P750, DOI 10.1016/j.cell.2010.10.018; Saugstad JA, 1996, J NEUROSCI, V16, P5979; Shigemoto R, 1997, J NEUROSCI, V17, P7503, DOI 10.1523/jneurosci.17-19-07503.1997; Szobota S, 2010, ANNU REV BIOPHYS, V39, P329, DOI 10.1146/annurev.biophys.093008.131400; Takahashi T, 1996, SCIENCE, V274, P594, DOI 10.1126/science.274.5287.594; TANABE Y, 1992, NEURON, V8, P169, DOI 10.1016/0896-6273(92)90118-W; Tsuji T, 2001, J PHYS CHEM A, V105, P9347, DOI 10.1021/jp004418v; Vivaudou M, 1997, J BIOL CHEM, V272, P31553, DOI 10.1074/jbc.272.50.31553; Volgraf M, 2006, NAT CHEM BIOL, V2, P47, DOI 10.1038/nchembio756; Yamashita T, 2000, J BIOL CHEM, V275, P34272, DOI 10.1074/jbc.M002954200; Yamashita T, 2001, J BIOCHEM-TOKYO, V130, P149, DOI 10.1093/oxfordjournals.jbchem.a002954; Zemelman BV, 2002, NEURON, V33, P15, DOI 10.1016/S0896-6273(01)00574-8	58	152	171	0	106	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	APR	2013	16	4					507	U190		10.1038/nn.3346	http://dx.doi.org/10.1038/nn.3346			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	114EM	23455609	Green Submitted, Green Accepted			2022-12-28	WOS:000316723700023
J	Tao, YM; Chen, YJ; Shen, CY; Luo, ZY; Bates, CR; Lee, D; Marchetto, S; Gao, TM; Borg, JP; Xiong, WC; Mei, L				Tao, Yanmei; Chen, Yong-Jun; Shen, Chengyong; Luo, Zhengyi; Bates, C. Ryan; Lee, Daehoon; Marchetto, Sylvie; Gao, Tian-Ming; Borg, Jean-Paul; Xiong, Wen-Cheng; Mei, Lin			Erbin interacts with TARP gamma-2 for surface expression of AMPA receptors in cortical interneurons	NATURE NEUROSCIENCE			English	Article							BASOLATERAL PDZ PROTEIN; RAT PREFRONTAL CORTEX; SYNAPTIC PLASTICITY; REGULATORY PROTEINS; AUXILIARY SUBUNITS; GABAERGIC NEURONS; NMDA RECEPTORS; HIPPOCAMPAL; TRAFFICKING; STARGAZIN	Inhibitory neurons control the firing of glutamatergic neurons and synchronize brain activity. However, little is known about mechanisms of excitatory synapse formation in inhibitory neurons. Here we demonstrate that Erbin is specifically expressed in cortical inhibitory neurons. It localizes at excitatory synapses and regulates AMPA receptor (AMPAR) surface expression. Erbin mutation reduced mEPSCs and AMPAR currents specifically in parvalbumin (PV)-positive interneurons but not in pyramidal neurons. We found that the AMPAR auxiliary protein TARP gamma-2 was specifically expressed in cortical interneurons. Erbin interacts with TARP gamma-2 and is crucial for its stability. Deletion of the gamma-2-interacting domain in Erbin attenuated surface AMPAR and excitatory transmission in PV-positive interneurons. Furthermore, we observed behavioral deficits in Erbin-null mice and in mice expressing an Erbin truncation mutant that is unable to interact with TARP gamma-2. These observations demonstrate a crucial function for Erbin in AMPAR surface expression in cortical PV-positive interneurons and may contribute to a better understanding of psychiatric disorders.	[Tao, Yanmei] Hangzhou Normal Univ, Coll Life & Environm Sci, Inst Dev & Regenerat Biol, Hangzhou, Zhejiang, Peoples R China; [Tao, Yanmei; Chen, Yong-Jun; Shen, Chengyong; Bates, C. Ryan; Lee, Daehoon; Xiong, Wen-Cheng; Mei, Lin] Georgia Regents Univ, Med Coll Georgia, Inst Mol Med & Genet, Augusta, GA USA; [Mei, Lin] Georgia Regents Univ, Med Coll Georgia, Dept Neurol, Augusta, GA USA; [Luo, Zhengyi; Gao, Tian-Ming; Mei, Lin] So Med Univ, Dept Neurobiol, Guangzhou, Guangdong, Peoples R China; [Marchetto, Sylvie; Borg, Jean-Paul] Aix Marseille Univ, Inst Paoli Calmettes, CNRS, CRCM,Inserm,U1068,UMR 7258, Marseille, France; [Xiong, Wen-Cheng; Mei, Lin] Charlie Norwood VA Med Ctr, Augusta, GA USA	Hangzhou Normal University; University System of Georgia; Augusta University; University System of Georgia; Augusta University; Southern Medical University - China; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; UNICANCER; Institut Paoli-Calmette (IPC); US Department of Veterans Affairs; Veterans Health Administration (VHA)	Mei, L (corresponding author), Georgia Regents Univ, Med Coll Georgia, Inst Mol Med & Genet, Augusta, GA USA.	lmei@grc.edu	Lee, Daehoon/AAP-3260-2020; Tao, Yanmei/AFL-9494-2022; Tao, Yanmei/AAH-1601-2022; Borg, Jean-Paul/AAX-8096-2020	Borg, Jean-Paul/0000-0001-8418-3382; Tao, Yanmei/0000-0002-4456-5447	VA Merit Awards; US National Institutes of Health (NIH); La Ligue Contre le Cancer; National Nature Sciences foundation of China [NSFC 31271137]; NSFC [81030022, U1201225]	VA Merit Awards; US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); La Ligue Contre le Cancer(Ligue nationale contre le cancer); National Nature Sciences foundation of China(National Natural Science Foundation of China (NSFC)); NSFC(National Natural Science Foundation of China (NSFC))	We thank S. Tomita (Yale University) and R.A. Nicoll (University of California, San Francisco) for TARP subunit constructs, Y. Yanagawa (National Institute for Physiological Sciences) for Gad-GFP mice, R. Huganir (John Hopkins University) for rabbit polyclonal antibodies to GluA1, GluA2/3 and GluN1, B.-S. Chen (Georgia Regents University) for the GluA1 antibody and A. Terry and K. Bouchard (Georgia Regents University) for assistance on behavioral tests. This work is supported in part by grants from VA Merit Awards and the US National Institutes of Health (NIH) (L.M. and W.-C.X.). L.M. is the Georgia Research Alliance Eminent Scholar in Neuroscience. J.-P.B. is supported by La Ligue Contre le Cancer (Label Ligue 2010). Y.T. is supported by National Nature Sciences foundation of China (NSFC 31271137). T.-M.G. is supported by NSFC 81030022, U1201225.	Apperson ML, 1996, J NEUROSCI, V16, P6839; Beattie EC, 2002, SCIENCE, V295, P2282, DOI 10.1126/science.1067859; Belforte JE, 2010, NAT NEUROSCI, V13, P76, DOI 10.1038/nn.2447; Beneyto M, 2006, SYNAPSE, V60, P585, DOI 10.1002/syn.20329; Bilder D, 2000, NATURE, V403, P676, DOI 10.1038/35001108; Borg JP, 2000, NAT CELL BIOL, V2, P407, DOI 10.1038/35017038; Bredt DS, 2003, NEURON, V40, P361, DOI 10.1016/S0896-6273(03)00640-8; Calin-Jageman I, 2007, J NEUROSCI, V27, P1374, DOI 10.1523/JNEUROSCI.5191-06.2007; Chen L, 2000, NATURE, V408, P936, DOI 10.1038/35050030; Dai FY, 2007, MOL CELL BIOL, V27, P6183, DOI 10.1128/MCB.00132-07; Dakoji S, 2003, NEUROPHARMACOLOGY, V45, P849, DOI 10.1016/S0028-3908(03)00267-3; Fuchs EC, 2007, NEURON, V53, P591, DOI 10.1016/j.neuron.2007.01.031; Fukaya M, 2005, NEUROSCI RES, V53, P376, DOI 10.1016/j.neures.2005.08.009; Fukaya M, 2006, EUR J NEUROSCI, V24, P2177, DOI 10.1111/j.1460-9568.2006.05081.x; Gonchar Y, 1997, CEREB CORTEX, V7, P347, DOI 10.1093/cercor/7.4.347; Hashimoto K, 1999, J NEUROSCI, V19, P6027, DOI 10.1523/JNEUROSCI.19-14-06027.1999; Huang YZ, 2003, J BIOL CHEM, V278, P1108, DOI 10.1074/jbc.M205413200; Huang YZ, 2001, J BIOL CHEM, V276, P19318, DOI 10.1074/jbc.M100494200; Huang ZJ, 2007, NAT REV NEUROSCI, V8, P673, DOI 10.1038/nrn2188; Inamura M, 2006, NEUROSCI RES, V55, P45, DOI 10.1016/j.neures.2006.01.004; Jackson AC, 2011, NEURON, V70, P178, DOI 10.1016/j.neuron.2011.04.007; Jackson AC, 2011, J NEUROSCI, V31, P3939, DOI 10.1523/JNEUROSCI.5134-10.2011; Kato AS, 2007, J NEUROSCI, V27, P4969, DOI 10.1523/JNEUROSCI.5561-06.2007; Kawaguchi Y, 1997, CEREB CORTEX, V7, P476, DOI 10.1093/cercor/7.6.476; Knight HM, 2008, EUR J HUM GENET, V16, P750, DOI 10.1038/ejhg.2008.11; Korotkova T, 2010, NEURON, V68, P557, DOI 10.1016/j.neuron.2010.09.017; Laura RP, 2002, J BIOL CHEM, V277, P12906, DOI 10.1074/jbc.M200818200; Legouis R, 2000, NAT CELL BIOL, V2, P415, DOI 10.1038/35017046; Levitt P, 2004, TRENDS NEUROSCI, V27, P400, DOI 10.1016/j.tins.2004.05.008; Lewis DA, 2005, NAT REV NEUROSCI, V6, P312, DOI 10.1038/nrn1648; Li XB, 2004, EUR J NEUROSCI, V19, P2132, DOI 10.1111/j.0953-816X.2004.03283.x; Liu SQJ, 2000, NATURE, V405, P454, DOI 10.1038/35013064; Liu YL, 2008, BIOL PSYCHIAT, V64, P789, DOI 10.1016/j.biopsych.2008.04.035; Markram H, 2004, NAT REV NEUROSCI, V5, P793, DOI 10.1038/nrn1519; Menuz K, 2008, J NEUROSCI, V28, P10599, DOI 10.1523/JNEUROSCI.2732-08.2008; Menuz K, 2009, NEUROPHARMACOLOGY, V56, P22, DOI 10.1016/j.neuropharm.2008.06.037; Milstein AD, 2008, TRENDS PHARMACOL SCI, V29, P333, DOI 10.1016/j.tips.2008.04.004; Milstein AD, 2007, NEURON, V55, P905, DOI 10.1016/j.neuron.2007.08.022; Rouach N, 2005, NAT NEUROSCI, V8, P1525, DOI 10.1038/nn1551; Rudy B, 2011, DEV NEUROBIOL, V71, P45, DOI 10.1002/dneu.20853; Shepherd JD, 2007, ANNU REV CELL DEV BI, V23, P613, DOI 10.1146/annurev.cellbio.23.090506.123516; Silberberg G, 2008, PHARMACOGENET GENOM, V18, P403, DOI 10.1097/FPC.0b013e3282f974ca; Soto D, 2009, NAT NEUROSCI, V12, P277, DOI 10.1038/nn.2266; Tamamaki N, 2003, J COMP NEUROL, V467, P60, DOI 10.1002/cne.10905; Tao YM, 2009, P NATL ACAD SCI USA, V106, P9477, DOI 10.1073/pnas.0901844106; Tomita S, 2005, NATURE, V435, P1052, DOI 10.1038/nature03624; Tomita S, 2003, J CELL BIOL, V161, P805, DOI 10.1083/jcb.200212116; Wang HX, 2010, J PHYSIOL-LONDON, V588, P2823, DOI 10.1113/jphysiol.2010.187591; Wang HX, 2009, NEUROPSYCHOPHARMACOL, V34, P2028, DOI 10.1038/npp.2009.20; WEIDEMANN A, 1989, CELL, V57, P115, DOI 10.1016/0092-8674(89)90177-3	50	38	39	3	25	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	MAR	2013	16	3					290	299		10.1038/nn.3320	http://dx.doi.org/10.1038/nn.3320			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	097LE	23354328				2022-12-28	WOS:000315474800011
J	Burghy, CA; Stodola, DE; Ruttle, PL; Molloy, EK; Armstrong, JM; Oler, JA; Fox, ME; Hayes, AS; Kalin, NH; Essex, MJ; Davidson, RJ; Birn, RM				Burghy, Cory A.; Stodola, Diane E.; Ruttle, Paula L.; Molloy, Erin K.; Armstrong, Jeffrey M.; Oler, Jonathan A.; Fox, Michelle E.; Hayes, Andrea S.; Kalin, Ned H.; Essex, Marilyn J.; Davidson, Richard J.; Birn, Rasmus M.			Developmental pathways to amygdala-prefrontal function and internalizing symptoms in adolescence	NATURE NEUROSCIENCE			English	Article							STRUCTURAL CONNECTIVITY; LIFE EVENTS; STRESS; CORTISOL; CORTEX; BRAIN; CHILDHOOD; DIFFICULTIES; CHILDREN; BEHAVIOR	Early life stress (ELS) and function of the hypothalamic-pituitary-adrenal axis predict later psychopathology. Animal studies and cross-sectional human studies suggest that this process might operate through amygdala-ventromedial prefrontal cortex (vmPFC) circuitry implicated in the regulation of emotion. Here we prospectively investigated the roles of ELS and childhood basal cortisol amounts in the development of adolescent resting-state functional connectivity (rs-FC), assessed by functional connectivity magnetic resonance imaging (fcMRI), in the amygdala-PFC circuit. In females only, greater ELS predicted increased childhood cortisol levels, which predicted decreased amygdala-vmPFC rs-FC 14 years later. For females, adolescent amygdala-vmPFC functional connectivity was inversely correlated with concurrent anxiety symptoms but positively associated with depressive symptoms, suggesting differing pathways from childhood cortisol levels function through adolescent amygdala-vmPFC functional connectivity to anxiety and depression. These data highlight that, for females, the effects of ELS and early HPA-axis function may be detected much later in the intrinsic processing of emotion-related brain circuits.	[Burghy, Cory A.; Stodola, Diane E.; Fox, Michelle E.; Hayes, Andrea S.; Davidson, Richard J.] Univ Wisconsin Madison, Waisman Lab Brain Imaging & Behav, Madison, WI USA; [Ruttle, Paula L.; Molloy, Erin K.; Armstrong, Jeffrey M.; Oler, Jonathan A.; Kalin, Ned H.; Essex, Marilyn J.; Davidson, Richard J.] Univ Wisconsin Madison, Dept Psychiat, Madison, WI USA; [Kalin, Ned H.; Davidson, Richard J.] Univ Wisconsin Madison, Dept Psychol, Madison, WI USA; [Birn, Rasmus M.] Univ Wisconsin Madison, Dept Med Phys, Madison, WI USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Burghy, CA (corresponding author), Univ Wisconsin Madison, Waisman Lab Brain Imaging & Behav, Madison, WI USA.	caburghy@wisc.edu	Molloy, Erin K/AAG-4086-2021	Molloy, Erin K/0000-0001-5553-3312; Davidson, Richard/0000-0002-8506-4964; Kalin, Ned/0000-0003-1184-0868	US National Institutes of Health [P50 MH084051, R01-MH044340, P50-MH052354]; John D. and Catherine T. MacArthur Foundation Research Network on Psychopathology and Development; HealthEmotions Research Institute, Department of Psychiatry, University of Wisconsin School of Medicine and Public Health; Canadian Institutes for Health Research; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD003352] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T15HL097789] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH043454, P50MH084051, P50MH052354, R01MH044340] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); John D. and Catherine T. MacArthur Foundation Research Network on Psychopathology and Development; HealthEmotions Research Institute, Department of Psychiatry, University of Wisconsin School of Medicine and Public Health; Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by US National Institutes of Health grants P50 MH084051, R01-MH044340 and P50-MH052354; the John D. and Catherine T. MacArthur Foundation Research Network on Psychopathology and Development; and the HealthEmotions Research Institute, Department of Psychiatry, University of Wisconsin School of Medicine and Public Health. Support for P. L. R. was provided by the Canadian Institutes for Health Research post-doctoral fellowship. We thank M. Anderle, R. Fisher, L. Angelos, C. Hermes, A. Koppenhaver and C. Boldt for assistance with data collection and recruitment, and D. Jackson, J. Ollinger, G. Kirk, N. Vack, J. Koger and I. Dolski for general, technical and administrative assistance.	Amunts K, 2005, ANAT EMBRYOL, V210, P343, DOI 10.1007/s00429-005-0025-5; Anisman H, 1998, INT J DEV NEUROSCI, V16, P149, DOI 10.1016/S0736-5748(98)00025-2; [Anonymous], 2008, MPLUS USERS GUIDE; Barrett P, 2007, PERS INDIV DIFFER, V42, P815, DOI 10.1016/j.paid.2006.09.018; Beesdo K, 2009, ARCH GEN PSYCHIAT, V66, P275, DOI 10.1001/archgenpsychiatry.2008.545; BENTLER PM, 1987, SOCIOL METHOD RES, V16, P78, DOI 10.1177/0049124187016001004; BISWAL B, 1995, MAGNET RESON MED, V34, P537, DOI 10.1002/mrm.1910340409; Bourke CH, 2012, HORM BEHAV, V62, P210, DOI 10.1016/j.yhbeh.2012.02.024; Christianson John P, 2009, Stress, V12, P445, DOI 10.1080/10253890802510302; COMPAS BE, 1987, PSYCHOL BULL, V101, P393, DOI 10.1037/0033-2909.101.3.393; Cox RW, 1996, COMPUT BIOMED RES, V29, P162, DOI 10.1006/cbmr.1996.0014; Damoiseaux JS, 2009, BRAIN STRUCT FUNCT, V213, P525, DOI 10.1007/s00429-009-0208-6; Davidson RJ, 2012, NAT NEUROSCI, V15, P689, DOI 10.1038/nn.3093; Essex MJ, 2011, DEV PSYCHOPATHOL, V23, P1039, DOI 10.1017/S0954579411000484; Essex MJ, 2002, J AM ACAD CHILD PSY, V41, P588, DOI 10.1097/00004583-200205000-00017; Essex MJ, 2002, BIOL PSYCHIAT, V52, P776, DOI 10.1016/S0006-3223(02)01553-6; Gunnar M, 2007, ANNU REV PSYCHOL, V58, P145, DOI 10.1146/annurev.psych.58.110405.085605; Hakamata Y, 2009, PSYCHIAT RES-NEUROIM, V173, P206, DOI 10.1016/j.pscychresns.2008.10.002; Hu LT, 1999, STRUCT EQU MODELING, V6, P1, DOI 10.1080/10705519909540118; Kim MJ, 2011, BEHAV BRAIN RES, V223, P403, DOI 10.1016/j.bbr.2011.04.025; Kim MJ, 2011, CEREB CORTEX, V21, P1667, DOI 10.1093/cercor/bhq237; Kim MJ, 2009, J NEUROSCI, V29, P11614, DOI 10.1523/JNEUROSCI.2335-09.2009; Lui S, 2011, AM J PSYCHIAT, V168, P642, DOI 10.1176/appi.ajp.2010.10101419; Lupien SJ, 2011, P NATL ACAD SCI USA, V108, P14324, DOI 10.1073/pnas.1105371108; Lupien SJ, 2009, NAT REV NEUROSCI, V10, P434, DOI 10.1038/nrn2639; McEwen BS, 1998, ANN NY ACAD SCI, V840, P33, DOI 10.1111/j.1749-6632.1998.tb09546.x; Michels N, 2012, PSYCHONEUROENDOCRINO, V37, P1506, DOI 10.1016/j.psyneuen.2012.02.004; Murgatroyd C, 2011, STRESS, V14, P581, DOI 10.3109/10253890.2011.602146; Myers-Schulz B, 2012, MOL PSYCHIATR, V17, P132, DOI 10.1038/mp.2011.88; Northoff G, 2011, NEUROSCI BIOBEHAV R, V35, P1929, DOI 10.1016/j.neubiorev.2010.12.007; Ochsner KN, 2005, TRENDS COGN SCI, V9, P242, DOI 10.1016/j.tics.2005.03.010; Preacher KJ, 2008, BEHAV RES METHODS, V40, P879, DOI 10.3758/BRM.40.3.879; Price JL, 2010, NEUROPSYCHOPHARMACOL, V35, P192, DOI 10.1038/npp.2009.104; Pruessner JC, 2010, PSYCHONEUROENDOCRINO, V35, P179, DOI 10.1016/j.psyneuen.2009.02.016; Saad ZS, 2009, NEUROIMAGE, V44, P839, DOI 10.1016/j.neuroimage.2008.09.037; Sanchez MM, 2000, J NEUROSCI, V20, P4657, DOI 10.1523/JNEUROSCI.20-12-04657.2000; SARASON IG, 1978, J CONSULT CLIN PSYCH, V46, P932, DOI 10.1037/0022-006X.46.5.932; Schreiber JE, 2006, PSYCHONEUROENDOCRINO, V31, P1131, DOI 10.1016/j.psyneuen.2006.07.005; Sheline YI, 2009, P NATL ACAD SCI USA, V106, P1942, DOI 10.1073/pnas.0812686106; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Talairach J., 1988, COPLANAR STEREOTAXIC; Thomason ME, 2011, J CHILD PSYCHOL PSYC, V52, P1026, DOI 10.1111/j.1469-7610.2011.02422.x; Urry HL, 2006, J NEUROSCI, V26, P4415, DOI 10.1523/JNEUROSCI.3215-05.2006; van den Heuvel MP, 2009, HUM BRAIN MAPP, V30, P3127, DOI 10.1002/hbm.20737; Veer IM, 2012, PSYCHONEUROENDOCRINO, V37, P1039, DOI 10.1016/j.psyneuen.2011.12.001; Weinstock M, 2007, NEUROCHEM RES, V32, P1730, DOI 10.1007/s11064-007-9339-4; Zhang YY, 2001, IEEE T MED IMAGING, V20, P45, DOI 10.1109/42.906424	47	274	281	0	93	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	DEC	2012	15	12					1736	+		10.1038/nn.3257	http://dx.doi.org/10.1038/nn.3257			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	045OR	23143517	Green Accepted			2022-12-28	WOS:000311706700021
J	Chen, DY; Bambah-Mukku, D; Pollonini, G; Alberini, CM				Chen, Dillon Y.; Bambah-Mukku, Dhananjay; Pollonini, Gabriella; Alberini, Cristina M.			Glucocorticoid receptors recruit the CaMKII alpha-BDNF-CREB pathways to mediate memory consolidation	NATURE NEUROSCIENCE			English	Article							LONG-TERM-MEMORY; IMMEDIATE-EARLY GENE; STRESS; ACTIVATION; TRKB; PHOSPHORYLATION; HIPPOCAMPUS; PLASTICITY; BRAIN; TRANSCRIPTION	Emotionally important events are well remembered. Although memories of emotional experiences are known to be mediated and modulated by stress hormones such as glucocorticoids, little is known about the underlying molecular mechanisms. We found that the hippocampal glucocorticoid receptors that are critically engaged during the formation of long-term inhibitory avoidance memory in rats were coupled to the activation of CaMKII alpha, TrkB, ERK, Akt, PLC gamma and CREB, as well as a to a substantial induction of Arc and synaptic GluA1. Most of these changes, which are initiated by a nongenomic effect of glucocorticoid receptors, were also downstream of the activation of brain-derived neurotrophic factor (BDNF). Hippocampal administration of BDNF, but not of other neurotrophins, selectively rescued both the amnesia and the molecular impairments produced by glucocorticoid receptor inhibition. Thus, glucocorticoid receptors mediate long-term memory formation by recruiting the CaMKII alpha-BDNF-CREB-dependent neural plasticity pathways.	[Bambah-Mukku, Dhananjay; Pollonini, Gabriella; Alberini, Cristina M.] NYU, Ctr Neural Sci, New York, NY 10003 USA; [Chen, Dillon Y.; Bambah-Mukku, Dhananjay] Mt Sinai Sch Med, Dept Neurosci, New York, NY USA; [Chen, Dillon Y.; Bambah-Mukku, Dhananjay] Mt Sinai Sch Med, Friedman Brain Inst, New York, NY USA	New York University; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai	Alberini, CM (corresponding author), NYU, Ctr Neural Sci, New York, NY 10003 USA.	ca60@nyu.edu		Bambah-Mukku, Dhananjay/0000-0001-5822-6326	US National Institutes of Health [RO1-MH065635, F31-MH816213]; National Alliance for Research on Schizophrenia and Depression (NARSAD); Philoctetes Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH [R37MH065635, R01MH065635] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Alliance for Research on Schizophrenia and Depression (NARSAD)(French National Research Agency (ANR)NARSAD); Philoctetes Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank S. Stern, S. Sheng, S. Taubenfeld and S. Katz for technical assistance, A. Suzuki and X. Ye for comments on the manuscript, and R. Testi for valuable discussions. This work was supported by grants from the US National Institutes of Health (RO1-MH065635), National Alliance for Research on Schizophrenia and Depression (NARSAD) and the Philoctetes Foundation to C. M. A. and US National Institutes of Health grant F31-MH816213 to D.Y.C.	Alberini CM, 2009, PHYSIOL REV, V89, P121, DOI 10.1152/physrev.00017.2008; Allaman I, 2004, J NEUROCHEM, V88, P900, DOI 10.1046/j.1471-4159.2003.02235.x; Alonso M, 2002, HIPPOCAMPUS, V12, P551, DOI 10.1002/hipo.10035; Arthur JSC, 2004, J NEUROSCI, V24, P4324, DOI 10.1523/JNEUROSCI.5227-03.2004; Bekinschtein P, 2008, NEUROSCIENTIST, V14, P147, DOI 10.1177/1073858407305850; Bekinschtein P, 2007, NEURON, V53, P261, DOI 10.1016/j.neuron.2006.11.025; BLACK JW, 1964, LANCET, V1, P1081; Bramham CR, 2008, J NEUROSCI, V28, P11760, DOI 10.1523/JNEUROSCI.3864-08.2008; BROGDEN RN, 1993, DRUGS, V45, P384, DOI 10.2165/00003495-199345030-00007; CAHILL L, 1994, NATURE, V371, P702, DOI 10.1038/371702a0; Chameau P, 2007, J NEUROPHYSIOL, V97, P5, DOI 10.1152/jn.00821.2006; Chen DY, 2011, NATURE, V469, P491, DOI 10.1038/nature09667; De Kloet ER, 2004, ANN NY ACAD SCI, V1018, P1, DOI 10.1196/annals.1296.001; Dudai Y, 2002, CURR OPIN NEUROBIOL, V12, P211, DOI 10.1016/S0959-4388(02)00305-7; DUNCAN GE, 1991, BRAIN RES, V561, P84, DOI 10.1016/0006-8993(91)90752-H; FANSELOW MS, 1993, J EXP PSYCHOL ANIM B, V19, P121, DOI 10.1037/0097-7403.19.2.121; Garcia-Osta A, 2006, J NEUROSCI, V26, P7919, DOI 10.1523/JNEUROSCI.1674-06.2006; Groeneweg FL, 2011, J ENDOCRINOL, V209, P153, DOI 10.1530/JOE-10-0472; Hosaka M, 1999, NEURON, V24, P377, DOI 10.1016/S0896-6273(00)80851-X; Hu HL, 2007, CELL, V131, P160, DOI 10.1016/j.cell.2007.09.017; Impey S, 1998, NAT NEUROSCI, V1, P595, DOI 10.1038/2830; Jeanneteau F, 2008, P NATL ACAD SCI USA, V105, P4862, DOI 10.1073/pnas.0709102105; Ji JZ, 2003, EUR J NEUROSCI, V17, P1947, DOI 10.1046/j.1460-9568.2003.02620.x; Ji YY, 2005, NAT NEUROSCI, V8, P164, DOI 10.1038/nn1381; Lee JLC, 2004, SCIENCE, V304, P839, DOI 10.1126/science.1095760; Lisman J, 2002, NAT REV NEUROSCI, V3, P175, DOI 10.1038/nrn753; Liu WH, 2010, J BIOL CHEM, V285, P6101, DOI 10.1074/jbc.M109.050229; Lu B, 2003, LEARN MEMORY, V10, P86, DOI 10.1101/lm.54603; McEwen BS, 2007, PHYSIOL REV, V87, P873, DOI 10.1152/physrev.00041.2006; McEwen BS, 2012, NEUROPHARMACOLOGY, V62, P3, DOI 10.1016/j.neuropharm.2011.07.014; McGaugh J. L., 2003, MEMORY EMOTION MAKIN; MCGUINNESS TL, 1989, J NEUROSCI, V9, P4138; McReynolds JR, 2010, NEUROBIOL LEARN MEM, V93, P312, DOI 10.1016/j.nlm.2009.11.005; Meyer-Franke A, 1998, NEURON, V21, P681, DOI 10.1016/S0896-6273(00)80586-3; Minichiello L, 2009, NAT REV NEUROSCI, V10, P850, DOI 10.1038/nrn2738; Molteni R, 2010, J PSYCHOPHARMACOL, V24, P595, DOI 10.1177/0269881108099815; Morimoto M, 1996, NEUROSCI RES, V26, P235, DOI 10.1016/S0168-0102(96)01105-4; Numakawa T, 2009, P NATL ACAD SCI USA, V106, P647, DOI 10.1073/pnas.0800888106; Ou LC, 2010, NEUROBIOL LEARN MEM, V93, P372, DOI 10.1016/j.nlm.2009.12.003; Pevzner A, 2012, NEUROBIOL LEARN MEM, V97, P313, DOI 10.1016/j.nlm.2012.02.004; Revest JM, 2010, MOL PSYCHIATR, V15, P1140, DOI 10.1038/mp.2010.40; Revest JM, 2005, NAT NEUROSCI, V8, P664, DOI 10.1038/nn1441; Roozendaal B, 2000, PSYCHONEUROENDOCRINO, V25, P213, DOI 10.1016/S0306-4530(99)00058-X; Roozendaal B, 1997, EUR J NEUROSCI, V9, P76, DOI 10.1111/j.1460-9568.1997.tb01355.x; Sandi C, 2011, TRENDS NEUROSCI, V34, P165, DOI 10.1016/j.tins.2011.01.006; Sapolsky RM, 2000, ARCH GEN PSYCHIAT, V57, P925, DOI 10.1001/archpsyc.57.10.925; Sindreu CB, 2007, NEURON, V53, P79, DOI 10.1016/j.neuron.2006.11.024; Takahashi T, 2002, J NEUROCHEM, V83, P1441, DOI 10.1046/j.1471-4159.2002.01251.x; Taubenfeld SM, 1999, NAT NEUROSCI, V2, P309, DOI 10.1038/7217; Vazdarjanova A, 2006, J COMP NEUROL, V498, P317, DOI 10.1002/cne.21003	50	163	169	0	47	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	DEC	2012	15	12					1707	+		10.1038/nn.3266	http://dx.doi.org/10.1038/nn.3266			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	045OR	23160045	Green Accepted			2022-12-28	WOS:000311706700017
J	Gilja, V; Nuyujukian, P; Chestek, CA; Cunningham, JP; Yu, BM; Fan, JM; Churchland, MM; Kaufman, MT; Kao, JC; Ryu, SI; Shenoy, KV				Gilja, Vikash; Nuyujukian, Paul; Chestek, Cindy A.; Cunningham, John P.; Yu, Byron M.; Fan, Joline M.; Churchland, Mark M.; Kaufman, Matthew T.; Kao, Jonathan C.; Ryu, Stephen I.; Shenoy, Krishna V.			A high-performance neural prosthesis enabled by control algorithm design	NATURE NEUROSCIENCE			English	Article							CORTICAL CONTROL; MOVEMENT; INTERFACES; FEEDBACK; HUMANS; CORTEX; SYSTEM	Neural prostheses translate neural activity from the brain into control signals for guiding prosthetic devices, such as computer cursors and robotic limbs, and thus offer individuals with disabilities greater interaction with the world. However, relatively low performance remains a critical barrier to successful clinical translation; current neural prostheses are considerably slower, with less accurate control, than the native arm. Here we present a new control algorithm, the recalibrated feedback intention-trained Kalman filter (ReFIT-KF) that incorporates assumptions about the nature of closed-loop neural prosthetic control. When tested in rhesus monkeys implanted with motor cortical electrode arrays, the ReFIT-KF algorithm outperformed existing neural prosthetic algorithms in all measured domains and halved target acquisition time. This control algorithm permits sustained, uninterrupted use for hours and generalizes to more challenging tasks without retraining. Using this algorithm, we demonstrate repeatable high performance for years after implantation in two monkeys, thereby increasing the clinical viability of neural prostheses.	[Gilja, Vikash] Stanford Univ, Dept Comp Sci, Stanford, CA 94305 USA; [Gilja, Vikash; Chestek, Cindy A.; Shenoy, Krishna V.] Stanford Univ, Stanford Inst Neuroinnovat & Translat Neurosci, Stanford, CA 94305 USA; [Nuyujukian, Paul; Fan, Joline M.; Shenoy, Krishna V.] Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA; [Nuyujukian, Paul] Stanford Univ, Sch Med, Stanford, CA 94305 USA; [Chestek, Cindy A.] Stanford Univ, Dept Elect Engn, Stanford, CA 94305 USA; [Yu, Byron M.; Churchland, Mark M.; Kaufman, Matthew T.; Shenoy, Krishna V.] Stanford Univ, Neurosci Program, Stanford, CA 94305 USA; [Cunningham, John P.; Yu, Byron M.] Univ Cambridge, Dept Engn, Cambridge CB2 1PZ, England; [Yu, Byron M.] UCL, Gatsby Computat Neurosci Unit, London, England; [Yu, Byron M.] Carnegie Mellon Univ, Dept Elect & Comp Engn, Pittsburgh, PA 15213 USA; [Yu, Byron M.] Carnegie Mellon Univ, Dept Biomed Engn, Pittsburgh, PA 15213 USA; [Ryu, Stephen I.] Palo Alto Med Fdn, Dept Neurosurg, Palo Alto, CA USA; [Shenoy, Krishna V.] Stanford Univ, Dept Neurobiol, Stanford, CA 94305 USA	Stanford University; Stanford University; Stanford University; Stanford University; Stanford University; Stanford University; University of Cambridge; University of London; University College London; Carnegie Mellon University; Carnegie Mellon University; Palo Alto Medical Foundation Research Institute; Stanford University	Gilja, V (corresponding author), Stanford Univ, Dept Comp Sci, Stanford, CA 94305 USA.	gilja@stanford.edu	Kaufman, Matthew T/B-6273-2014; Kaufman, Matthew/AAK-2860-2020	Kaufman, Matthew T/0000-0002-8072-023X; Kaufman, Matthew/0000-0002-8072-023X; Nuyujukian, Paul/0000-0001-7778-5473	US National Defense Science and Engineering Graduate Fellowship; National Science Foundation Graduate Research Fellowships; Stanford Medical Scholars Program; Howard Hughes Medical Institute Medical Research Fellows Program; Paul and Daisy Soros Fellowship; Stanford Medical Scientist Training Program; Stanford Graduate Fellowship; Gatsby Charitable Foundation; Helen Hay Whitney postdoctoral fellowship; Burroughs Welcome Fund Career Awards in the Biomedical Sciences; Christopher and Dana Reeve Paralysis Foundation; Defense Advanced Research Projects Agency [N66001-06-C-8005, N66001-10-C-2010]; US National Institutes of Health, National Institute of Neurological Disorders and Stroke Collaborative Research in Computational Neuroscience [R01-NS054283]; National Institutes of Health Directors Pioneer Award [1DP1OD006409]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [DP1HD075623] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS054283] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD006409] Funding Source: NIH RePORTER; Engineering and Physical Sciences Research Council [EP/H019472/1] Funding Source: researchfish; EPSRC [EP/H019472/1] Funding Source: UKRI	US National Defense Science and Engineering Graduate Fellowship; National Science Foundation Graduate Research Fellowships(National Science Foundation (NSF)); Stanford Medical Scholars Program; Howard Hughes Medical Institute Medical Research Fellows Program(Howard Hughes Medical Institute); Paul and Daisy Soros Fellowship; Stanford Medical Scientist Training Program; Stanford Graduate Fellowship(Stanford University); Gatsby Charitable Foundation; Helen Hay Whitney postdoctoral fellowship; Burroughs Welcome Fund Career Awards in the Biomedical Sciences(Burroughs Wellcome Fund); Christopher and Dana Reeve Paralysis Foundation; Defense Advanced Research Projects Agency(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); US National Institutes of Health, National Institute of Neurological Disorders and Stroke Collaborative Research in Computational Neuroscience; National Institutes of Health Directors Pioneer Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	We thank M. Mazariegos, J. Aguayo, W. Kalkus, S. Kang, E. Morgan and C. Sherman for surgical assistance and veterinary care, D. Haven and B. Oskotsky for information technology support, S. Eisensee, B. Davis and E. Castaneda for administrative assistance, P. Ortega for mathematical insight, and S. Stavisky for data-collection assistance. This work was supported by a US National Defense Science and Engineering Graduate Fellowship (V. G.), National Science Foundation Graduate Research Fellowships (V. G., C. A. C., J. M. F., M. T. K. and J. C. K.), Stanford Medical Scholars Program, Howard Hughes Medical Institute Medical Research Fellows Program, Paul and Daisy Soros Fellowship, Stanford Medical Scientist Training Program (P.N.), Stanford Graduate Fellowship (C. A. C., J. P. C. and J. M. F.), Gatsby Charitable Foundation (B.M.Y.), a Helen Hay Whitney postdoctoral fellowship (M. M. C.), Burroughs Welcome Fund Career Awards in the Biomedical Sciences (M. M. C. and K. V. S.), the Christopher and Dana Reeve Paralysis Foundation (S. I. R. and K. V. S.), Defense Advanced Research Projects Agency Revolutionizing Prosthetics 2009 N66001-06-C-8005, Reorganization and Plasticity to Accelerate Injury Recovery N66001-10-C-2010, US National Institutes of Health, National Institute of Neurological Disorders and Stroke Collaborative Research in Computational Neuroscience grant R01-NS054283, and National Institutes of Health Directors Pioneer Award 1DP1OD006409 (K.V.S.).	CARD SK, 1978, ERGONOMICS, V21, P601, DOI 10.1080/00140137808931762; Carmena JM, 2003, PLOS BIOL, V1, P193, DOI 10.1371/journal.pbio.0000042; Chase SM, 2009, NEURAL NETWORKS, V22, P1203, DOI 10.1016/j.neunet.2009.05.005; Chestek CA, 2009, IEEE ENG MED BIO, P3369, DOI 10.1109/IEMBS.2009.5332822; Chestek CA, 2011, J NEURAL ENG, V8, DOI 10.1088/1741-2560/8/4/045005; Churchland MM, 2010, NEURON, V68, P387, DOI 10.1016/j.neuron.2010.09.015; Cunningham JP, 2011, J NEUROPHYSIOL, V105, P1932, DOI 10.1152/jn.00503.2010; Fraser GW, 2009, J NEURAL ENG, V6, DOI 10.1088/1741-2560/6/5/055004; Gage GJ, 2005, J NEURAL ENG, V2, P52, DOI 10.1088/1741-2560/2/2/006; Ganguly K, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000153; Gilja V, 2011, IEEE T BIO-MED ENG, V58, P1891, DOI 10.1109/TBME.2011.2107553; Golub MD, 2012, IEEE ENG MED BIO, P1327, DOI 10.1109/EMBC.2012.6346182; Hochberg LR, 2008, NEW ENGL J MED, V359, P1175, DOI 10.1056/NEJMcibr0805122; Hochberg LR, 2006, NATURE, V442, P164, DOI 10.1038/nature04970; Hochberg LR, 2012, NATURE, V485, P372, DOI 10.1038/nature11076; Judy JW, 2012, IEEE PULSE, V3, P57, DOI 10.1109/MPUL.2011.2181026; Kalaska JF, 2009, ADV EXP MED BIOL, V629, P139, DOI 10.1007/978-0-387-77064-2_8; Kaufman MT, 2010, J NEUROPHYSIOL, V104, P799, DOI 10.1152/jn.00231.2009; Kim SP, 2011, IEEE T NEUR SYS REH, V19, P193, DOI 10.1109/TNSRE.2011.2107750; Kim SP, 2008, J NEURAL ENG, V5, P455, DOI 10.1088/1741-2560/5/4/010; Li Z, 2011, NEURAL COMPUT, V23, P3162, DOI 10.1162/NECO_a_00207; McFarland DJ, 2010, J NEURAL ENG, V7, DOI 10.1088/1741-2560/7/3/036007; Mulliken GH, 2008, J NEUROSCI, V28, P12913, DOI 10.1523/JNEUROSCI.1463-08.2008; Sadtler PT, 2011, I IEEE EMBS C NEUR E, P601, DOI 10.1109/NER.2011.5910620; Santhanam G, 2007, IEEE T BIO-MED ENG, V54, P2037, DOI 10.1109/TBME.2007.895753; Schalk G, 2008, J NEURAL ENG, V5, P75, DOI 10.1088/1741-2560/5/1/008; Serruya MD, 2002, NATURE, V416, P141, DOI 10.1038/416141a; Shpigelman L., 2009, ADV NEURAL INFORM PR, V21, P1489; Srinivasan L, 2007, J NEUROPHYSIOL, V98, P2456, DOI 10.1152/jn.01118.2006; Suminski AJ, 2010, J NEUROSCI, V30, P16777, DOI 10.1523/JNEUROSCI.3967-10.2010; Taylor DM, 2002, SCIENCE, V296, P1829, DOI 10.1126/science.1070291; Velliste M, 2008, NATURE, V453, P1098, DOI 10.1038/nature06996; Yu BM, 2007, J NEUROPHYSIOL, V97, P3763, DOI 10.1152/jn.00482.2006	33	318	324	5	100	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	DEC	2012	15	12					1752	1757		10.1038/nn.3265	http://dx.doi.org/10.1038/nn.3265			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	045OR	23160043	Green Accepted			2022-12-28	WOS:000311706700023
J	Raimondo, JV; Kay, L; Ellender, TJ; Akerman, CJ				Raimondo, Joseph V.; Kay, Louise; Ellender, Tommas J.; Akerman, Colin J.			Optogenetic silencing strategies differ in their effects on inhibitory synaptic transmission	NATURE NEUROSCIENCE			English	Article							MODULATION; ACTIVATION; CULTURES; NEURONS; PH	Optogenetic silencing using light-driven ion fluxes permits rapid and effective inhibition of neural activity. Using rodent hippocampal neurons, we found that silencing activity with a chloride pump can increase the probability of synaptically evoked spiking after photoactivation; this did not occur with a proton pump. This effect can be accounted for by changes to the GABA(A) receptor reversal potential and demonstrates an important difference between silencing strategies.	[Akerman, Colin J.] Univ Oxford, Dept Pharmacol, Oxford OX1 3QT, England	University of Oxford	Akerman, CJ (corresponding author), Univ Oxford, Dept Pharmacol, S Parks Rd, Oxford OX1 3QT, England.	colin.akerman@pharm.ox.ac.uk	Raimondo, Joseph/AAS-7890-2020; Ellender, Tommas/N-9927-2014	Raimondo, Joseph/0000-0002-8266-3128; Ellender, Tommas/0000-0001-9787-3307	Medical Research Council [G0601503]; European Community; MRC [G0601503] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); European Community(European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank P. Bolam (Oxford University) for resources, and K. Deisseroth (Stanford University) and E. Boyden (Massachusetts Institute of Technology) for DNA constructs. We also thank G. Miesenbock, D. Katzel and B. Richards for comments. Supported by a grant from the Medical Research Council (G0601503); research leading to these results received funding under the European Community's Seventh Framework Programme (FP7/2007-2013).	Ascoli GA, 2010, J NEUROSCI, V30, P6434, DOI 10.1523/JNEUROSCI.4066-09.2010; Boyden ES, 2005, NAT NEUROSCI, V8, P1263, DOI 10.1038/nn1525; Cardin JA, 2012, J PHYSIOL-PARIS, V106, P104, DOI 10.1016/j.jphysparis.2011.09.005; Chesler M, 2003, PHYSIOL REV, V83, P1183, DOI 10.1152/physrev.00010.2003; Chow BY, 2010, NATURE, V463, P98, DOI 10.1038/nature08652; De Simoni A, 2003, J PHYSIOL-LONDON, V550, P135, DOI 10.1113/jphysiol.2003.039099; Fenno L, 2011, ANNU REV NEUROSCI, V34, P389, DOI 10.1146/annurev-neuro-061010-113817; Gourine AV, 2010, SCIENCE, V329, P571, DOI 10.1126/science.1190721; Gradinaru V, 2007, J NEUROSCI, V27, P14231, DOI 10.1523/JNEUROSCI.3578-07.2007; Gradinaru V, 2010, CELL, V141, P154, DOI 10.1016/j.cell.2010.02.037; Han X, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000299; Hartmann Anna-Maria, 2011, BMC Res Notes, V4, P526, DOI 10.1186/1756-0500-4-526; Jin XM, 2005, J NEUROPHYSIOL, V93, P2117, DOI 10.1152/jn.00728.2004; Madisen L, 2012, NAT NEUROSCI, V15, P793, DOI 10.1038/nn.3078; Mattis J, 2012, NAT METHODS, V9, P159, DOI [10.1038/nmeth.1808, 10.1038/NMETH.1808]; Olsen SR, 2012, NATURE, V483, P47, DOI 10.1038/nature10835; Pouille F, 2001, SCIENCE, V293, P1159, DOI 10.1126/science.1060342; Staley KJ, 1999, J PHYSIOL-LONDON, V519, P693, DOI 10.1111/j.1469-7793.1999.0693n.x; STOPPINI L, 1991, J NEUROSCI METH, V37, P173, DOI 10.1016/0165-0270(91)90128-M; STREIT P, 1989, EUR J NEUROSCI, V1, P603, DOI 10.1111/j.1460-9568.1989.tb00366.x; Tonnesen J, 2009, P NATL ACAD SCI USA, V106, P12162, DOI 10.1073/pnas.0901915106; Tyzio R, 2007, EPILEPSIA, V48, P96, DOI 10.1111/j.1528-1167.2007.01295.x; Wright R, 2011, NEURAL PLAST, V2011, DOI 10.1155/2011/728395; Zemelman BV, 2002, NEURON, V33, P15, DOI 10.1016/S0896-6273(01)00574-8; Zhang F, 2007, NATURE, V446, P633, DOI 10.1038/nature05744	25	151	155	0	25	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	AUG	2012	15	8					1102	+		10.1038/nn.3143	http://dx.doi.org/10.1038/nn.3143			5	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	979UE	22729174	Green Accepted			2022-12-28	WOS:000306844500012
J	Hipp, JF; Hawellek, DJ; Corbetta, M; Siegel, M; Engel, AK				Hipp, Joerg F.; Hawellek, David J.; Corbetta, Maurizio; Siegel, Markus; Engel, Andreas K.			Large-scale cortical correlation structure of spontaneous oscillatory activity	NATURE NEUROSCIENCE			English	Article							RESTING STATE NETWORKS; FUNCTIONAL CONNECTIVITY; HUMAN BRAIN; ACTIVITY FLUCTUATIONS; CORTEX; SYNCHRONIZATION; ORGANIZATION; SPECIFICITY; SIGNATURES; STABILITY	Little is known about the brain-wide correlation of electrophysiological signals. We found that spontaneous oscillatory neuronal activity exhibited frequency-specific spatial correlation structure in the human brain. We developed an analysis approach that discounts spurious correlation of signal power caused by the limited spatial resolution of electrophysiological measures. We applied this approach to source estimates of spontaneous neuronal activity reconstructed from magnetoencephalography. Overall, correlation of power across cortical regions was strongest in the alpha to beta frequency range (8-32 Hz) and correlation patterns depended on the underlying oscillation frequency. Global hubs resided in the medial temporal lobe in the theta frequency range (4-6 Hz), in lateral parietal areas in the alpha to beta frequency range (8-23 Hz) and in sensorimotor areas for higher frequencies (32-45 Hz). Our data suggest that interactions in various large-scale cortical networks may be reflected in frequency-specific power envelope correlations.	[Hipp, Joerg F.; Hawellek, David J.; Engel, Andreas K.] Univ Med Ctr Hamburg Eppendorf, Dept Neurophysiol & Pathophysiol, Hamburg, Germany; [Hipp, Joerg F.; Corbetta, Maurizio] Univ Tubingen, Ctr Integrat Neurosci, Tubingen, Germany; [Corbetta, Maurizio] Washington Univ, Sch Med, Dept Neurol, St Louis, MO 63110 USA; [Corbetta, Maurizio] Washington Univ, Sch Med, Dept Radiol, St Louis, MO 63110 USA; [Corbetta, Maurizio] Washington Univ, Sch Med, Dept Anat, St Louis, MO 63110 USA; [Corbetta, Maurizio] Washington Univ, Sch Med, Dept Neurobiol, St Louis, MO 63110 USA	University of Hamburg; University Medical Center Hamburg-Eppendorf; Eberhard Karls University of Tubingen; Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL)	Hipp, JF (corresponding author), Univ Med Ctr Hamburg Eppendorf, Dept Neurophysiol & Pathophysiol, Hamburg, Germany.	joerg.hipp@cin.uni-tuebingen.de	Hipp, Joerg F/D-8936-2014; Engel, Andreas K./AAH-6384-2019; Siegel, Markus/H-5225-2012; Corbetta, Maurizio/AAZ-5219-2020; Engel, Andreas K/C-7781-2012	Hipp, Joerg F/0000-0002-7875-2988; Engel, Andreas K./0000-0003-4899-8466; Siegel, Markus/0000-0001-5115-936X; Engel, Andreas K/0000-0003-4899-8466; Hawellek, David J/0000-0002-2529-3351; CORBETTA, MAURIZIO/0000-0001-8295-3304	European Union [NEST-PATH-043457, HEALTH-F2-2008-200728]; National Institute of Mental Health [R01 MH096482-01]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH096482] Funding Source: NIH RePORTER	European Union(European Commission); National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank C. Hipp for helpful discussions and comments on the manuscript, and the bwGRiD project (http://www.bw-grid.de) for the computational resources. This work was supported by grants from the European Union (NEST-PATH-043457 to A. K. E. and HEALTH-F2-2008-200728 to M. C. and A. K. E.) and the National Institute of Mental Health (R01 MH096482-01 to M.C.).	Bassettt DS, 2006, P NATL ACAD SCI USA, V103, P19518, DOI 10.1073/pnas.0606005103; Battaglia FP, 2011, TRENDS COGN SCI, V15, P310, DOI 10.1016/j.tics.2011.05.008; BISWAL B, 1995, MAGNET RESON MED, V34, P537, DOI 10.1002/mrm.1910340409; Brookes MJ, 2011, P NATL ACAD SCI USA, V108, P16783, DOI 10.1073/pnas.1112685108; Brookes MJ, 2011, NEUROIMAGE, V56, P1082, DOI 10.1016/j.neuroimage.2011.02.054; Bruns A, 2000, NEUROREPORT, V11, P1509, DOI 10.1097/00001756-200005150-00028; Buckner RL, 2009, J NEUROSCI, V29, P1860, DOI 10.1523/JNEUROSCI.5062-08.2009; Buzsaki G, 2002, NEURON, V33, P325, DOI 10.1016/S0896-6273(02)00586-X; Cordes D, 2001, AM J NEURORADIOL, V22, P1326; de Pasquale F, 2010, P NATL ACAD SCI USA, V107, P6040, DOI 10.1073/pnas.0913863107; Deco G, 2011, NAT REV NEUROSCI, V12, P43, DOI 10.1038/nrn2961; Donner TH, 2011, TRENDS COGN SCI, V15, P191, DOI 10.1016/j.tics.2011.03.007; Donner TH, 2009, CURR BIOL, V19, P1581, DOI 10.1016/j.cub.2009.07.066; Dosenbach NUF, 2007, P NATL ACAD SCI USA, V104, P11073, DOI 10.1073/pnas.0704320104; Fell J, 2011, NAT REV NEUROSCI, V12, P105, DOI 10.1038/nrn2979; Fox MD, 2005, P NATL ACAD SCI USA, V102, P9673, DOI 10.1073/pnas.0504136102; Fox MD, 2007, NAT REV NEUROSCI, V8, P700, DOI 10.1038/nrn2201; Fries P, 2009, ANNU REV NEUROSCI, V32, P209, DOI 10.1146/annurev.neuro.051508.135603; Goense JBM, 2008, CURR BIOL, V18, P631, DOI 10.1016/j.cub.2008.03.054; Greicius MD, 2003, P NATL ACAD SCI USA, V100, P253, DOI 10.1073/pnas.0135058100; Gross J, 2001, P NATL ACAD SCI USA, V98, P694, DOI 10.1073/pnas.98.2.694; Hawellek DJ, 2011, P NATL ACAD SCI USA, V108, P19066, DOI 10.1073/pnas.1110024108; He BYJ, 2008, P NATL ACAD SCI USA, V105, P16039, DOI 10.1073/pnas.0807010105; Heeger DJ, 2002, NAT REV NEUROSCI, V3, P142, DOI 10.1038/nrn730; Hipp JF, 2011, NEURON, V69, P387, DOI 10.1016/j.neuron.2010.12.027; Jann K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012945; Kahn I, 2008, J NEUROPHYSIOL, V100, P129, DOI 10.1152/jn.00077.2008; Laird Angela R, 2009, Front Neuroinform, V3, P23, DOI 10.3389/neuro.11.023.2009; Laufs H, 2003, P NATL ACAD SCI USA, V100, P11053, DOI 10.1073/pnas.1831638100; Leopold DA, 2003, CEREB CORTEX, V13, P422, DOI 10.1093/cercor/13.4.422; Lewisa CM, 2009, P NATL ACAD SCI USA, V106, P17558, DOI 10.1073/pnas.0902455106; Liu ZM, 2010, NEUROIMAGE, V51, P102, DOI 10.1016/j.neuroimage.2010.01.092; Logothetis NK, 2008, NATURE, V453, P869, DOI 10.1038/nature06976; Logothetis NK, 2001, NATURE, V412, P150, DOI 10.1038/35084005; Magri C, 2012, J NEUROSCI, V32, P1395, DOI 10.1523/JNEUROSCI.3985-11.2012; Mantini D, 2007, P NATL ACAD SCI USA, V104, P13170, DOI 10.1073/pnas.0700668104; Maslov S, 2002, SCIENCE, V296, P910, DOI 10.1126/science.1065103; Miller KJ, 2009, P NATL ACAD SCI USA, V106, P12174, DOI 10.1073/pnas.0902071106; Mukamel R, 2005, SCIENCE, V309, P951, DOI 10.1126/science.1110913; Nir Y, 2008, NAT NEUROSCI, V11, P1100, DOI 10.1038/nn.2177; Nolte G, 2004, CLIN NEUROPHYSIOL, V115, P2292, DOI 10.1016/j.clinph.2004.04.029; Nolte G, 2003, PHYS MED BIOL, V48, P3637, DOI 10.1088/0031-9155/48/22/002; Oostenveld R, 2011, COMPUT INTEL NEUROSC, V2011, DOI 10.1155/2011/156869; Power JD, 2011, NEURON, V72, P665, DOI 10.1016/j.neuron.2011.09.006; Rubinov M, 2010, NEUROIMAGE, V52, P1059, DOI 10.1016/j.neuroimage.2009.10.003; Scheeringa R, 2011, NEURON, V69, P572, DOI 10.1016/j.neuron.2010.11.044; Schepers IM, 2012, BRAIN, V135, P922, DOI 10.1093/brain/aws014; Scholvinck ML, 2010, P NATL ACAD SCI USA, V107, P10238, DOI 10.1073/pnas.0913110107; Schoffelen JM, 2009, HUM BRAIN MAPP, V30, P1857, DOI 10.1002/hbm.20745; Siegel M, 2012, NAT REV NEUROSCI, V13, P121, DOI 10.1038/nrn3137; Siegel M, 2008, NEURON, V60, P709, DOI 10.1016/j.neuron.2008.09.010; Sirotin YB, 2009, NATURE, V457, P475, DOI 10.1038/nature07664; TallonBaudry C, 1996, J NEUROSCI, V16, P4240; Van Essen DC, 2005, NEUROIMAGE, V28, P635, DOI 10.1016/j.neuroimage.2005.06.058; VanVeen BD, 1997, IEEE T BIO-MED ENG, V44, P867, DOI 10.1109/10.623056; Vincent JL, 2006, J NEUROPHYSIOL, V96, P3517, DOI 10.1152/jn.00048.2006; Vincent JL, 2008, J NEUROPHYSIOL, V100, P3328, DOI 10.1152/jn.90355.2008; Wang XJ, 2010, PHYSIOL REV, V90, P1195, DOI 10.1152/physrev.00035.2008; Zhang DY, 2010, NAT REV NEUROL, V6, P15, DOI 10.1038/nrneurol.2009.198	60	615	616	6	118	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUN	2012	15	6					884	U110		10.1038/nn.3101	http://dx.doi.org/10.1038/nn.3101			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	949AI	22561454	Green Accepted			2022-12-28	WOS:000304546700016
J	Kravitz, AV; Tye, LD; Kreitzer, AC				Kravitz, Alexxai V.; Tye, Lynne D.; Kreitzer, Anatol C.			Distinct roles for direct and indirect pathway striatal neurons in reinforcement	NATURE NEUROSCIENCE			English	Article							OPTOGENETIC CONTROL; REWARD; DOPAMINE	Dopamine signaling is implicated in reinforcement learning, but the neural substrates targeted by dopamine are poorly understood. We bypassed dopamine signaling itself and tested how optogenetic activation of dopamine D1 or D2 receptor-expressing striatal projection neurons influenced reinforcement learning in mice. Stimulating D1 receptor-expressing neurons induced persistent reinforcement, whereas stimulating D2 receptor-expressing neurons induced transient punishment, indicating that activation of these circuits is sufficient to modify the probability of performing future actions.	[Kravitz, Alexxai V.; Tye, Lynne D.; Kreitzer, Anatol C.] Univ Calif San Francisco, Gladstone Inst Neurol Dis, San Francisco, CA 94143 USA; [Tye, Lynne D.; Kreitzer, Anatol C.] Univ Calif San Francisco, Dept Physiol, San Francisco, CA 94143 USA; [Tye, Lynne D.; Kreitzer, Anatol C.] Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94143 USA; [Kreitzer, Anatol C.] Univ Calif San Francisco, Grad Program Neurosci, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; The J David Gladstone Institutes; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Kreitzer, AC (corresponding author), Univ Calif San Francisco, Gladstone Inst Neurol Dis, San Francisco, CA 94143 USA.	akreitzer@gladstone.ucsf.edu	Core, Vector/CAF-4832-2022	Kravitz, Alexxai/0000-0001-5983-0218	W.M. Keck Foundation; Pew Biomedical Scholars Program; McKnight Foundation; US National Institutes of Health; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK075099, ZIADK075096, ZIADK075101, ZIADK075103] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS064984, R01NS078435] Funding Source: NIH RePORTER	W.M. Keck Foundation(W.M. Keck Foundation); Pew Biomedical Scholars Program; McKnight Foundation; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank the Nikon Imaging Center at the University of California San Francisco for assistance with image acquisition, K. Deisseroth for optogenetic constructs and K. Tye for helpful comments on the manuscript. A.C.K. and co-workers are funded by the W.M. Keck Foundation, the Pew Biomedical Scholars Program, the McKnight Foundation and the US National Institutes of Health.	Abe M, 2011, CURR BIOL, V21, P557, DOI 10.1016/j.cub.2011.02.030; Azrin N. H., 1966, OPERANT BEHAVIOR ARE, P380; Balleine BW, 2007, J NEUROSCI, V27, P8161, DOI 10.1523/JNEUROSCI.1554-07.2007; Bromberg-Martin ES, 2010, NEURON, V68, P815, DOI 10.1016/j.neuron.2010.11.022; Eshel N, 2010, BIOL PSYCHIAT, V68, P118, DOI 10.1016/j.biopsych.2010.01.027; Ferguson SM, 2011, NAT NEUROSCI, V14, P22, DOI 10.1038/nn.2703; Frank MJ, 2004, SCIENCE, V306, P1940, DOI 10.1126/science.1102941; Hikida T, 2010, NEURON, V66, P896, DOI 10.1016/j.neuron.2010.05.011; Koob GF, 2010, NEUROPSYCHOPHARMACOL, V35, P217, DOI 10.1038/npp.2009.110; Kravitz AV, 2010, NATURE, V466, P622, DOI 10.1038/nature09159; Kreitzer AC, 2008, NEURON, V60, P543, DOI 10.1016/j.neuron.2008.11.005; Lobo MK, 2010, SCIENCE, V330, P385, DOI 10.1126/science.1188472; Nakatani Y, 2009, NEUROBIOL LEARN MEM, V92, P370, DOI 10.1016/j.nlm.2009.05.003; Schultz W, 2007, ANNU REV NEUROSCI, V30, P259, DOI 10.1146/annurev.neuro.28.061604.135722; Skinner BF., 1953, SCI HUMAN BEHAV; Sohal VS, 2009, NATURE, V459, P698, DOI 10.1038/nature07991	16	601	604	10	109	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JUN	2012	15	6					816	U23		10.1038/nn.3100	http://dx.doi.org/10.1038/nn.3100			4	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	949AI	22544310	Green Accepted, Green Submitted			2022-12-28	WOS:000304546700007
J	Wandell, BA; Chichilnisky, EJ				Wandell, Brian A.; Chichilnisky, E. J.			Squaring cortex with color	NATURE NEUROSCIENCE			English	Editorial Material							PRIMATE VISUAL-CORTEX; CHROMATIC MECHANISMS; MACAQUE; VISION; MONKEY; SYSTEM	A long-standing puzzle has been the seeming inconsistency between neuronal responses in primary visual cortex to colored stimuli and the elementary perceptual attributes of color vision. Nonlinear analysis resolves this paradox.	[Wandell, Brian A.] Stanford Univ, Dept Psychol, Stanford, CA 94305 USA; [Chichilnisky, E. J.] Salk Inst Biol Studies, La Jolla, CA 92037 USA	Stanford University; Salk Institute	Wandell, BA (corresponding author), Stanford Univ, Dept Psychol, Stanford, CA 94305 USA.	wandell@stanford.edu		Chichilnisky, E.J./0000-0002-5613-0248				BAYLOR DA, 1984, J PHYSIOL-LONDON, V357, P575, DOI 10.1113/jphysiol.1984.sp015518; CARANDINI M, 1994, SCIENCE, V264, P1333, DOI 10.1126/science.8191289; DERRINGTON AM, 1984, J PHYSIOL-LONDON, V357, P241, DOI 10.1113/jphysiol.1984.sp015499; DEVALOIS RL, 1965, COLD SPRING HARB SYM, V30, P567, DOI 10.1101/SQB.1965.030.01.055; Field GD, 2010, NATURE, V467, P673, DOI 10.1038/nature09424; Hering E., 1920, GRUNDZUGE LEHRE LICH; Horwitz GD, 2012, NAT NEUROSCI, V15, P913, DOI 10.1038/nn.3105; HURVICH LM, 1957, PSYCHOL REV, V64, P384, DOI 10.1037/h0041403; LENNIE P, 1990, J NEUROSCI, V10, P649; LIVINGSTONE MS, 1984, J NEUROSCI, V4, P309; MACLEOD DIA, 1979, J OPT SOC AM, V69, P1183, DOI 10.1364/JOSA.69.001183; Smith T., 1931, T OPT SOC, V33, P73, DOI [10.1088/1475-4878/33/3/301, DOI 10.1088/1475-4878/33/3/301]; SVAETICHIN G, 1956, ACTA PHYSIOL SCAND, V39, P19; Wandell B., 1995, FDN VISION; WIESEL TN, 1966, J NEUROPHYSIOL, V29, P1115, DOI 10.1152/jn.1966.29.6.1115	15	1	1	1	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUN	2012	15	6					809	810		10.1038/nn.3124	http://dx.doi.org/10.1038/nn.3124			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	949AI	22627792				2022-12-28	WOS:000304546700004
J	Pitkow, X; Meister, M				Pitkow, Xaq; Meister, Markus			Decorrelation and efficient coding by retinal ganglion cells	NATURE NEUROSCIENCE			English	Article							RECEPTIVE-FIELDS; BIPOLAR CELLS; SPIKE TRAINS; INFORMATION; NEURONS; POPULATION; ADAPTATION; STATISTICS; PRECISION; IMAGES	An influential theory of visual processing asserts that retinal center-surround receptive fields remove spatial correlations in the visual world, producing ganglion cell spike trains that are less redundant than the corresponding image pixels. For bright, high-contrast images, this decorrelation would enhance coding efficiency in optic nerve fibers of limited capacity. We tested the central prediction of the theory and found that the spike trains of retinal ganglion cells were indeed decorrelated compared with the visual input. However, most of the decorrelation was accomplished not by the receptive fields, but by nonlinear processing in the retina. We found that a steep response threshold enhanced efficient coding by noisy spike trains and that the effect of this nonlinearity was near optimal in both salamander and macaque retina. These results offer an explanation for the sparseness of retinal spike trains and highlight the importance of treating the full nonlinear character of neural codes.	[Meister, Markus] Harvard Univ, Ctr Brain Sci, Cambridge, MA 02138 USA; [Pitkow, Xaq] Univ Rochester, Dept Brain & Cognit Sci, Rochester, NY USA	Harvard University; University of Rochester	Meister, M (corresponding author), Harvard Univ, Ctr Brain Sci, Cambridge, MA 02138 USA.	meister@fas.harvard.edu		Meister, Markus/0000-0003-2136-6506	US National Institutes of Health; NATIONAL EYE INSTITUTE [R01EY014737] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	We thank the members of the Meister laboratory, M. Berry, T. Toyozumi and J.-P. Nadal for helpful advice. This work was funded by grants from the US National Institutes of Health to M.M.	ATICK JJ, 1992, NEURAL COMPUT, V4, P196, DOI 10.1162/neco.1992.4.2.196; ATICK JJ, 1993, NEURAL COMPUT, V5, P45, DOI 10.1162/neco.1993.5.1.45; Atick JJ, 1990, NEURAL COMPUT, V2, P308, DOI 10.1162/neco.1990.2.3.308; Aticky JJ, 2011, NETWORK-COMP NEURAL, V22, P4, DOI [10.1088/0954-898X/3/2/009, 10.3109/0954898X.2011.638888]; ATTNEAVE F, 1954, PSYCHOL REV, V61, P183, DOI 10.1037/h0054663; Balasubramanian V, 2002, NETWORK-COMP NEURAL, V13, P531, DOI 10.1088/0954-898X/13/4/306; Barlow H. B., 1961, SENS COMMUN, P217, DOI DOI 10.7551/MITPRESS/9780262518420.003.0013; BARLOW HB, 1965, J PHYSIOL-LONDON, V178, P477, DOI 10.1113/jphysiol.1965.sp007638; Berry MJ, 1998, J NEUROSCI, V18, P2200; Burrone J, 2000, J NEUROSCI, V20, P568, DOI 10.1523/JNEUROSCI.20-02-00568.2000; Chichilnisky EJ, 2002, J NEUROSCI, V22, P2737, DOI 10.1523/JNEUROSCI.22-07-02737.2002; Chichilnisky EJ, 2001, NETWORK-COMP NEURAL, V12, P199, DOI 10.1088/0954-898X/12/2/306; Cleland TA, 2010, TRENDS NEUROSCI, V33, P130, DOI 10.1016/j.tins.2009.12.004; CRONER LJ, 1993, P NATL ACAD SCI USA, V90, P8128, DOI 10.1073/pnas.90.17.8128; CRONER LJ, 1995, VISION RES, V35, P7, DOI 10.1016/0042-6989(94)E0066-T; Dacey D, 2004, COGNITIVE NEUROSCIENCES III, THIRD EDITION, P281; Dan Y, 1996, J NEUROSCI, V16, P3351; de la Rocha J, 2007, NATURE, V448, P802, DOI 10.1038/nature06028; Demb JB, 2001, J NEUROSCI, V21, P7447, DOI 10.1523/JNEUROSCI.21-19-07447.2001; ENROTHCUGELL C, 1984, INVEST OPHTH VIS SCI, V25, P250; FIELD DJ, 1987, J OPT SOC AM A, V4, P2379, DOI 10.1364/JOSAA.4.002379; Field GD, 2002, NEURON, V34, P773, DOI 10.1016/S0896-6273(02)00700-6; Gollisch T, 2010, NEURON, V65, P150, DOI 10.1016/j.neuron.2009.12.009; Hosoya T, 2005, NATURE, V436, P71, DOI 10.1038/nature03689; Keat J, 2001, NEURON, V30, P803, DOI 10.1016/S0896-6273(01)00322-1; LANCASTER HO, 1957, BIOMETRIKA, V44, P289; LAUGHLIN S, 1981, Z NATURFORSCH C, V36, P910; LEVICK WR, 1967, J PHYSIOL-LONDON, V188, P285, DOI 10.1113/jphysiol.1967.sp008140; Olshausen BA, 2004, CURR OPIN NEUROBIOL, V14, P481, DOI 10.1016/j.conb.2004.07.007; Olveczky BP, 2003, NATURE, V423, P401, DOI 10.1038/nature01652; Pillow JW, 2008, NATURE, V454, P995, DOI 10.1038/nature07140; Puchalla JL, 2005, NEURON, V46, P493, DOI 10.1016/j.neuron.2005.03.026; Reinagel P, 2001, CURR OPIN NEUROBIOL, V11, P437, DOI 10.1016/S0959-4388(00)00231-2; Ringach DL, 2007, J NEUROSCI, V27, P7673, DOI 10.1523/JNEUROSCI.1048-07.2007; Rucci M, 2005, NETWORK-COMP NEURAL, V16, P121, DOI 10.1080/09548980500300507; Schwartz O, 2006, J VISION, V6, P484, DOI 10.1167/6.4.13; Segev R, 2006, J NEUROPHYSIOL, V95, P2277, DOI 10.1152/jn.00928.2005; SHAMAI S, 1990, IEE PROC-I, V137, P424, DOI 10.1049/ip-i-2.1990.0056; SRINIVASAN MV, 1982, PROC R SOC SER B-BIO, V216, P427, DOI 10.1098/rspb.1982.0085; STEIN RB, 1967, BIOPHYS J, V7, P797, DOI 10.1016/S0006-3495(67)86623-2; Uzzell VJ, 2004, J NEUROPHYSIOL, V92, P780, DOI 10.1152/jn.01171.2003; van Vreeswijk C, 2001, ADV NEUR IN, V13, P180; VANHATEREN JH, 1992, NATURE, V360, P68, DOI 10.1038/360068a0; VANHATEREN JH, 1993, VISION RES, V33, P257, DOI 10.1016/0042-6989(93)90163-Q; Vinje WE, 2000, SCIENCE, V287, P1273, DOI 10.1126/science.287.5456.1273; Wang XJ, 2003, J NEUROPHYSIOL, V89, P3279, DOI 10.1152/jn.00242.2003; Warland DK, 1997, J NEUROPHYSIOL, V78, P2336, DOI 10.1152/jn.1997.78.5.2336; Wiechert MT, 2010, NAT NEUROSCI, V13, P1003, DOI 10.1038/nn.2591	50	111	111	0	28	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	APR	2012	15	4					628	635		10.1038/nn.3064	http://dx.doi.org/10.1038/nn.3064			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	916PA	22406548	Green Accepted			2022-12-28	WOS:000302114500024
J	Lafer-Sousa, R; Conway, BR				Lafer-Sousa, Rosa; Conway, Bevil R.			Parallel, multi-stage processing of colors, faces and shapes in macaque inferior temporal cortex	NATURE NEUROSCIENCE			English	Article							INFEROTEMPORAL CORTEX; CHROMATIC MECHANISMS; NEURAL BASIS; RESPONSES; BRAIN; ARCHITECTURE; NEURONS; REPRESENTATIONS; DISCRIMINATION; ORGANIZATION	Visual-object processing culminates in inferior temporal cortex (IT). To assess the organization of IT, we measured functional magnetic resonance imaging responses in alert monkeys to achromatic images (faces, fruit, bodies and places) and colored gratings. IT contained multiple color-biased regions, which were typically ventral to face patches and yoked to them, spaced regularly at four locations predicted by known anatomy. Color and face selectivity increased for more anterior regions, indicative of a broad hierarchical arrangement. Responses to non-face shapes were found across IT, but were stronger outside color-biased regions and face patches, consistent with multiple parallel streams. IT also contained multiple coarse eccentricity maps: face patches overlapped central representations, color-biased regions spanned mid-peripheral representations and place-biased regions overlapped peripheral representations. These results show that IT comprises parallel, multi-stage processing networks subject to one organizing principle.	[Lafer-Sousa, Rosa; Conway, Bevil R.] Wellesley Coll, Neurosci Program, Wellesley, MA 02181 USA; [Conway, Bevil R.] Harvard Univ, Sch Med, Dept Neurobiol, Cambridge, MA 02138 USA	Wellesley College; Harvard University	Conway, BR (corresponding author), Wellesley Coll, Neurosci Program, Wellesley, MA 02181 USA.	bconway@wellesley.edu	Conway, Bevil/AAG-2412-2020	Conway, Bevil/0000-0001-7715-9253	National Science Foundation [0918064]; US National Institutes of Health [EY023322]; Whitehall Foundation; Radcliffe Institute for Advanced Study (Harvard University); Wellesley College; National Institute of Biomedical Imaging and Bioengineering; US National Institutes of Health Shared Instrumentation Grant Program and/or High-End Instrumentation Grant Program [S1ORR021110]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR021110] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY023322] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P41EB015896] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007484] Funding Source: NIH RePORTER; Direct For Biological Sciences [0918064] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Whitehall Foundation; Radcliffe Institute for Advanced Study (Harvard University); Wellesley College; National Institute of Biomedical Imaging and Bioengineering(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); US National Institutes of Health Shared Instrumentation Grant Program and/or High-End Instrumentation Grant Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	fMRI data were analyzed using the jip toolbox generously provided by J. Mandeville (Massachusetts General Hospital, http://www.nitrc.org/projects/jip/), and analysisscripts compiled by S. Moeller (RWTH Aachen University). We thank J. Maunsell, D. Hubel and M. Livingstone for research space, helpful discussions and assistance with animal protocols. A. Rehding, N. Kanwisher, J. Di Carlo and P. Mayo provided valuable comments on the manuscript. B.R.C. gratefully acknowledges seminal conversations that took place with D. Tsao, with whom the idea to map multiple stimulus dimensions in IT was conceived and initially begun. We thank Y. Liu for implementing the simulation shown in Figure 5 and help with MRI analysis. We thank J. McCready and E. Erzinger, who designed and built the fMRI primate chair, and C. Stoughton and G. Gagin, who trained the animals. We thank L. Wald and A. Mareyam for providing the four-channel magnetic resonance coil. We thank W. Vanduffel, J. Mandeville, J. Polimeni, T. Witzel, M. O'Hara, G. Khandewal, M. Histed and P. Mayo for help running the experiments and conducting the analyses. This paper is dedicated to the memory of our mentor and beloved friend, David Hubel, who died September 22, 2013 (age 87). This work was supported by grants from the National Science Foundation (0918064), the US National Institutes of Health (EY023322), the Whitehall Foundation, the Radcliffe Institute for Advanced Study (Harvard University) and Wellesley College. This research was carried out at the Athinoula A. Martinos Center for Biomedical Imaging at the Massachusetts General Hospital, using resources provided by the Center for Functional Neuroimaging Technologies (P41EB015896) and a P41 Biotechnology Resource grant supported by the National Institute of Biomedical Imaging and Bioengineering. This work also involved the use of instrumentation supported by the US National Institutes of Health Shared Instrumentation Grant Program and/or High-End Instrumentation Grant Program (S1ORR021110).	ALLMAN JM, 1974, BRAIN RES, V81, P199, DOI 10.1016/0006-8993(74)90936-6; Baker CI, 2007, P NATL ACAD SCI USA, V104, P9087, DOI 10.1073/pnas.0703300104; Bartels A, 2000, EUR J NEUROSCI, V12, P172, DOI 10.1046/j.1460-9568.2000.00905.x; Bell AH, 2009, J NEUROPHYSIOL, V101, P688, DOI 10.1152/jn.90657.2008; BOUSSAOUD D, 1991, J COMP NEUROL, V306, P554, DOI 10.1002/cne.903060403; Bouvier SE, 2006, CEREB CORTEX, V16, P183, DOI 10.1093/cercor/bhi096; CAVANAGH P, 1989, J EXP PSYCHOL HUMAN, V15, P3, DOI 10.1037/0096-1523.15.1.3; CONOVER W. J, 1980, PRACTICAL NONPARAMET; Conway BR, 2007, NEURON, V56, P560, DOI 10.1016/j.neuron.2007.10.008; Conway BR, 2006, CEREB CORTEX, V16, P1604, DOI 10.1093/cercor/bhj099; Conway BR, 2010, J NEUROSCI, V30, P14955, DOI 10.1523/JNEUROSCI.4348-10.2010; Conway BR, 2009, P NATL ACAD SCI USA, V106, P18034, DOI 10.1073/pnas.0810943106; Cox D, 2004, SCIENCE, V304, P115, DOI 10.1126/science.1093110; DERRINGTON AM, 1984, J PHYSIOL-LONDON, V357, P241, DOI 10.1113/jphysiol.1984.sp015499; DiCarlo JJ, 2012, NEURON, V73, P415, DOI 10.1016/j.neuron.2012.01.010; Freiwald WA, 2010, SCIENCE, V330, P845, DOI 10.1126/science.1194908; Hadjikhani N, 1998, NAT NEUROSCI, V1, P235, DOI 10.1038/681; Harada T, 2009, EUR J NEUROSCI, V30, P1960, DOI 10.1111/j.1460-9568.2009.06995.x; Hasson U, 2003, NEURON, V37, P1027, DOI 10.1016/S0896-6273(03)00144-2; Heywood CA, 2003, NEUROL CLIN, V21, P483, DOI 10.1016/S0733-8619(02)00102-0; IWAI E, 1988, BRAIN RES, V444, P397, DOI 10.1016/0006-8993(88)90955-9; IWAI E, 1987, J COMP NEUROL, V261, P362, DOI 10.1002/cne.902610304; Kanwisher N, 2010, P NATL ACAD SCI USA, V107, P11163, DOI 10.1073/pnas.1005062107; Karnath HO, 2001, NAT REV NEUROSCI, V2, P568, DOI 10.1038/35086057; Katsuyama N, 2010, NEUROSCI LETT, V484, P168, DOI 10.1016/j.neulet.2010.08.040; Kemp R, 1996, PERCEPTION, V25, P37, DOI 10.1068/p250037; Koida K, 2007, NAT NEUROSCI, V10, P108, DOI 10.1038/nn1823; Konkle T, 2012, NEURON, V74, P1114, DOI 10.1016/j.neuron.2012.04.036; Kravitz DJ, 2013, TRENDS COGN SCI, V17, P26, DOI 10.1016/j.tics.2012.10.011; Ku SP, 2011, NEURON, V70, P352, DOI 10.1016/j.neuron.2011.02.048; Matsumora T, 2008, J NEUROPHYSIOL, V100, P3361, DOI 10.1152/jn.90551.2008; Moro V, 2008, NEURON, V60, P235, DOI 10.1016/j.neuron.2008.09.022; Op de Beeck HP, 2008, CEREB CORTEX, V18, P1676, DOI 10.1093/cercor/bhm196; Pinsk MA, 2005, P NATL ACAD SCI USA, V102, P6996, DOI 10.1073/pnas.0502605102; Roe AW, 2012, NEURON, V74, P12, DOI 10.1016/j.neuron.2012.03.011; Rolls ET, 2008, J NEUROPSYCHOL, V2, P325, DOI 10.1348/174866407X258903; Sereno Martin I., 1991, P160; Srihasam K, 2012, NEURON, V73, P608, DOI 10.1016/j.neuron.2011.12.022; Stoughton CM, 2008, CURR BIOL, V18, pR698, DOI 10.1016/j.cub.2008.06.018; Stoughton CM, 2012, J NEUROSCI, V32, P15216, DOI 10.1523/JNEUROSCI.2048-12.2012; TANAKA K, 1991, J NEUROPHYSIOL, V66, P170, DOI 10.1152/jn.1991.66.1.170; Tootell RBH, 2004, CEREB CORTEX, V14, P353, DOI 10.1093/cercor/bhh001; Tsao DY, 2008, P NATL ACAD SCI USA, V105, P19514, DOI 10.1073/pnas.0809662105; Tsao DY, 2003, NAT NEUROSCI, V6, P989, DOI 10.1038/nn1111; VanEssen DC, 1997, NATURE, V385, P313, DOI 10.1038/385313a0; VANESSEN DC, 1990, COLD SPRING HARB SYM, V55, P679; Yasuda M, 2010, CEREB CORTEX, V20, P1630, DOI 10.1093/cercor/bhp227; ZEKI S, 1980, NATURE, V284, P412, DOI 10.1038/284412a0	49	137	138	1	25	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	DEC	2013	16	12					1870	1878		10.1038/nn.3555	http://dx.doi.org/10.1038/nn.3555			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	257VV	24141314	Green Submitted, Green Accepted			2022-12-28	WOS:000327416800026
J	Anderson, EB; Mitchell, JF; Reynolds, JH				Anderson, Emily B.; Mitchell, Jude F.; Reynolds, John H.			Attention-dependent reductions in burstiness and action-potential height in macaque area V4	NATURE NEUROSCIENCE			English	Article							PRIMARY VISUAL-CORTEX; HIPPOCAMPAL PYRAMIDAL CELLS; FAST-SPIKING INTERNEURONS; IN-VIVO; NEOCORTICAL NEURONS; CORTICAL-NEURONS; INTERSPIKE INTERVALS; ORIENTATION; INACTIVATION; INFORMATION	Attention improves the encoding of visual stimuli. One mechanism that is implicated in facilitating sensory encoding is the firing of action potentials in bursts. We tested the hypothesis that when spatial attention is directed to a stimulus, this causes an increase in burst firing to the attended stimulus. To the contrary, we found an attention-dependent reduction in 'burstiness' among putative pyramidal neurons in macaque area V4. We accounted for this using a conductance-based Hodgkin-Huxley style model in which attentional modulation stems from scaling excitation and inhibition. The model exhibited attention-dependent increases in firing rate and made the surprising and correct prediction that when attention is directed into a neuron's receptive field, this reduces action-potential height. The model thus provided a unified explanation for three distinct forms of attentional modulation, two of them previously undescribed, and implicates scaling of the responses of excitatory and inhibitory input populations in mediating attention.	[Anderson, Emily B.; Mitchell, Jude F.; Reynolds, John H.] Salk Inst Biol Studies, San Diego, CA 92138 USA; [Anderson, Emily B.] Univ Calif San Francisco, Ctr Integrat Neurosci, San Francisco, CA 94143 USA; [Anderson, Emily B.] Univ Calif San Francisco, Dept Physiol, San Francisco, CA USA	Salk Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Reynolds, JH (corresponding author), Salk Inst Biol Studies, San Diego, CA 92138 USA.	emily@phy.ucsf.edu; reynolds@salk.edu		Mitchell, Jude/0000-0003-0197-7545	US National Eye Institute [EY13802]; Gatsby Charitable Foundation; NATIONAL EYE INSTITUTE [R01EY013802] Funding Source: NIH RePORTER	US National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Gatsby Charitable Foundation; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported in part by US National Eye Institute grant EY13802 (J.F.M. and J.H.R.) and The Gatsby Charitable Foundation (E. B. A. and J.H.R.). We thank K. Sundberg for help in data collection, and C. Williams and J. Reyes for help with animal care.	Anderson EB, 2011, J NEUROSCI, V31, P10983, DOI 10.1523/JNEUROSCI.0027-11.2011; Anderson JS, 2000, J NEUROPHYSIOL, V84, P909, DOI 10.1152/jn.2000.84.2.909; Aracri P, 2006, J NEUROPHYSIOL, V95, P3460, DOI 10.1152/jn.00588.2005; Arieli A, 1996, SCIENCE, V273, P1868, DOI 10.1126/science.273.5283.1868; Bartho P, 2004, J NEUROPHYSIOL, V92, P600, DOI 10.1152/jn.01170.2003; Bean BP, 2007, NAT REV NEUROSCI, V8, P451, DOI 10.1038/nrn2148; Brumberg JC, 2000, J NEUROSCI, V20, P4829; Caporale N, 2008, ANNU REV NEUROSCI, V31, P25, DOI 10.1146/annurev.neuro.31.060407.125639; Carter BC, 2009, NEURON, V64, P898, DOI 10.1016/j.neuron.2009.12.011; CATTANEO A, 1981, PROC R SOC SER B-BIO, V212, P279, DOI 10.1098/rspb.1981.0039; Cavanagh P, 2005, TRENDS COGN SCI, V9, P349, DOI 10.1016/j.tics.2005.05.009; Colbert CM, 1997, J NEUROSCI, V17, P6512; de Polavieja GG, 2005, J NEUROSCI, V25, P5657, DOI 10.1523/JNEUROSCI.0242-05.2005; De Weerd P, 1999, NAT NEUROSCI, V2, P753, DOI 10.1038/11234; Destexhe A, 2001, NEUROSCIENCE, V107, P13, DOI 10.1016/S0306-4522(01)00344-X; Gold C, 2006, J NEUROPHYSIOL, V95, P3113, DOI 10.1152/jn.00979.2005; Golomb D, 2006, J NEUROPHYSIOL, V96, P1912, DOI 10.1152/jn.00205.2006; Gonzalez-Burgos G, 2005, J NEUROPHYSIOL, V93, P942, DOI 10.1152/jn.00787.2004; Harris KD, 2001, NEURON, V32, P141, DOI 10.1016/S0896-6273(01)00447-0; Harris KD, 2011, NAT REV NEUROSCI, V12, P509, DOI 10.1038/nrn3084; Henze DA, 2000, J NEUROPHYSIOL, V84, P390, DOI 10.1152/jn.2000.84.1.390; Izhikevich EM, 2003, TRENDS NEUROSCI, V26, P161, DOI 10.1016/S0166-2236(03)00034-1; Jung HY, 1997, J NEUROSCI, V17, P6639; Kepecs A, 2000, NEUROCOMPUTING, V32, P181, DOI 10.1016/S0925-2312(00)00162-4; Krahe R, 2004, NAT REV NEUROSCI, V5, P13, DOI 10.1038/nrn1296; Mainen ZF, 1996, NATURE, V382, P363, DOI 10.1038/382363a0; Martina M, 1997, J PHYSIOL-LONDON, V505, P593, DOI 10.1111/j.1469-7793.1997.593ba.x; Matsumura M, 1996, J NEUROSCI, V16, P7757; McAdams CJ, 1999, J NEUROSCI, V19, P431, DOI 10.1523/JNEUROSCI.19-01-00431.1999; MCCORMICK DA, 1985, J NEUROPHYSIOL, V54, P782, DOI 10.1152/jn.1985.54.4.782; Mitchell JF, 2007, NEURON, V55, P131, DOI 10.1016/j.neuron.2007.06.018; Mitchell JF, 2009, NEURON, V63, P879, DOI 10.1016/j.neuron.2009.09.013; Noudoost B, 2010, CURR OPIN NEUROBIOL, V20, P183, DOI 10.1016/j.conb.2010.02.003; Nowak LG, 2003, J NEUROPHYSIOL, V89, P1541, DOI 10.1152/jn.00580.2002; Pinsky P F, 1994, J Comput Neurosci, V1, P39, DOI 10.1007/BF00962717; PYLYSHYN Z W, 1988, Spatial Vision, V3, P179, DOI 10.1163/156856888X00122; Quirk MC, 2001, J NEUROSCI, V21, P240, DOI 10.1523/JNEUROSCI.21-01-00240.2001; Reich DS, 2000, J NEUROSCI, V20, P1964; Reynolds JH, 1999, J NEUROSCI, V19, P1736; Reynolds JH, 2009, NEURON, V61, P168, DOI 10.1016/j.neuron.2009.01.002; Ringach DL, 1997, NATURE, V387, P281, DOI 10.1038/387281a0; Samonds JM, 2004, J NEUROPHYSIOL, V91, P1193, DOI 10.1152/jn.00829.2003; Sherman SM, 2001, TRENDS NEUROSCI, V24, P122, DOI 10.1016/S0166-2236(00)01714-8; Shih JY, 2011, J NEUROPHYSIOL, V105, P1908, DOI 10.1152/jn.01055.2010; Sjostrom PJ, 2008, PHYSIOL REV, V88, P769, DOI 10.1152/physrev.00016.2007; Smith MA, 2008, J NEUROSCI, V28, P12591, DOI 10.1523/JNEUROSCI.2929-08.2008; Steriade M, 2001, J NEUROPHYSIOL, V85, P1969, DOI 10.1152/jn.2001.85.5.1969; Vigneswaran G, 2011, J NEUROSCI, V31, P14235, DOI 10.1523/JNEUROSCI.3142-11.2011; WANG Z, 1993, J NEUROSCI, V13, P2199; Yue CY, 2004, J NEUROSCI, V24, P4614, DOI 10.1523/JNEUROSCI.0765-04.2004	50	23	23	0	11	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	AUG	2013	16	8					1125	U203		10.1038/nn.3463	http://dx.doi.org/10.1038/nn.3463			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	190EV	23852114	Green Accepted			2022-12-28	WOS:000322323000024
J	Donner, TH; Nieuwenhuis, S				Donner, Tobias H.; Nieuwenhuis, Sander			Brain-wide gain modulation: the rich get richer	NATURE NEUROSCIENCE			English	Editorial Material							PUPIL DIAMETER; ADAPTIVE GAIN; NOREPINEPHRINE; BEHAVIOR; SYSTEMS	A study now shows how brain-wide gain modulation, indexed by pupil diameter, shapes the structure of brain-wide neural interactions and, consequently, trial-and-error learning.	[Donner, Tobias H.] Univ Amsterdam, Dept Psychol & Cognit Sci Ctr Amsterdam, Amsterdam, Netherlands; [Nieuwenhuis, Sander] Leiden Univ, Leiden Inst Brain & Cognit, Leiden, Netherlands	University of Amsterdam; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Donner, TH (corresponding author), Univ Amsterdam, Dept Psychol & Cognit Sci Ctr Amsterdam, Amsterdam, Netherlands.	t.h.donner@uva.nl; snieuwenhuis@fsw.leidenuniv.nl		Donner, Tobias H./0000-0002-7559-6019				Aston-Jones G, 2005, ANNU REV NEUROSCI, V28, P403, DOI 10.1146/annurev.neuro.28.061604.135709; Bullmore ET, 2009, NAT REV NEUROSCI, V10, P186, DOI 10.1038/nrn2575; Eldar E, 2013, NAT NEUROSCI, V16, P1146, DOI 10.1038/nn.3428; Gilzenrat MS, 2010, COGN AFFECT BEHAV NE, V10, P252, DOI 10.3758/CABN.10.2.252; Hermans EJ, 2011, SCIENCE, V334, P1151, DOI 10.1126/science.1209603; Jepma M, 2011, J COGNITIVE NEUROSCI, V23, P1587, DOI 10.1162/jocn.2010.21548; KAHNEMAN D, 1966, SCIENCE, V154, P1583, DOI 10.1126/science.154.3756.1583; Logothetis NK, 2008, NATURE, V453, P869, DOI 10.1038/nature06976; Nassar MR, 2012, NAT NEUROSCI, V15, P1040, DOI 10.1038/nn.3130; Sarter M, 2009, NAT REV NEUROSCI, V10, P383, DOI 10.1038/nrn2635; Schwabe L, 2010, J NEUROSCI, V30, P8190, DOI 10.1523/JNEUROSCI.0734-10.2010; SERVANSCHREIBER D, 1990, SCIENCE, V249, P892, DOI 10.1126/science.2392679; Siegel M, 2012, NAT REV NEUROSCI, V13, P121, DOI 10.1038/nrn3137; WATERHOUSE BD, 1980, EXP NEUROL, V67, P11, DOI 10.1016/0014-4886(80)90159-4	14	13	13	0	24	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	AUG	2013	16	8					989	990		10.1038/nn.3471	http://dx.doi.org/10.1038/nn.3471			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	190EV	23887133				2022-12-28	WOS:000322323000005
J	Amiry-Moghaddam, M; Ottersen, OP				Amiry-Moghaddam, Mahmood; Ottersen, Ole Petter			Immunogold cytochemistry in neuroscience	NATURE NEUROSCIENCE			English	Review							POSTSYNAPTIC DENSITY; ELECTRON-MICROSCOPE; NMDA RECEPTORS; RAT CEREBELLUM; AMPA RECEPTORS; GLUTAMATE; IMMUNOCYTOCHEMISTRY; SYNAPSES; ANTIBODY; BRAIN	The complexity of the central nervous system calls for immunocytochemical procedures that allow target proteins to be localized with high precision and with opportunities for quantitation. Immunogold procedures stand out as particularly powerful in this regard. Although these procedures have found wide application in the neuroscience community, they present limitations and pitfalls that must be taken into account. At the same time, these procedures offer potentials that remain to be fully realized.	[Amiry-Moghaddam, Mahmood; Ottersen, Ole Petter] Univ Oslo, Inst Basic Med Sci, Lab Mol Neurosci, Oslo, Norway	University of Oslo	Ottersen, OP (corresponding author), Univ Oslo, Inst Basic Med Sci, Lab Mol Neurosci, Oslo, Norway.	o.p.ottersen@medisin.uio.no		Amiry-Moghaddam, Mahmood/0000-0003-1071-1247	Norwegian Research Council; European Union framework programmes; Letten Fund	Norwegian Research Council(Research Council of NorwayEuropean Commission); European Union framework programmes; Letten Fund	We thank G. Lothe and C. Knudsen for technical assistance, P. Laake for comments, and D. Frydenlund for providing Figure 5. We gratefully acknowledge support from the Norwegian Research Council, the European Union framework programmes and the Letten Fund.	Alelu-Paz R, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003378; Amiry-Moghaddam M, 2003, P NATL ACAD SCI USA, V100, P2106, DOI 10.1073/pnas.0437946100; Amiry-Moghaddam M, 2004, NEUROSCIENCE, V129, P999, DOI 10.1016/j.neuroscience.2004.08.049; Baleviciute I, 2013, BIOSENS BIOELECTRON, V39, P170, DOI 10.1016/j.bios.2012.07.017; Bergersen LH, 2012, CEREB CORTEX, V22, P1690, DOI 10.1093/cercor/bhr254; BLACKSTAD TW, 1990, COMPUT BIOL MED, V20, P15, DOI 10.1016/0010-4825(90)90041-M; Bloss EB, 2013, NEUROBIOL AGING, V34, P200, DOI 10.1016/j.neurobiolaging.2012.05.014; Burry RW, 2011, J HISTOCHEM CYTOCHEM, V59, P6, DOI 10.1369/jhc.2010.956920; CAMPAGNE MV, 1991, J HISTOCHEM CYTOCHEM, V39, P1267, DOI 10.1177/39.9.1833448; CHAN J, 1990, J NEUROSCI METH, V33, P113, DOI 10.1016/0165-0270(90)90015-8; CHAUDHRY FA, 1995, NEURON, V15, P711, DOI 10.1016/0896-6273(95)90158-2; Chen XB, 2008, P NATL ACAD SCI USA, V105, P4453, DOI 10.1073/pnas.0800897105; COONS AH, 1951, FED PROC, V10, P558; Coons AH, 1941, P SOC EXP BIOL MED, V47, P200, DOI 10.3181/00379727-47-13084P; D'Amico F, 2008, J MICROSC-OXFORD, V230, P9, DOI 10.1111/j.1365-2818.2008.01949.x; DALE N, 1986, NATURE, V324, P255, DOI 10.1038/324255a0; DAVANGER S, 1994, GASTROENTEROLOGY, V107, P137, DOI 10.1016/0016-5085(94)90071-X; DUTTON AH, 1979, P NATL ACAD SCI USA, V76, P3392, DOI 10.1073/pnas.76.7.3392; FAULK WP, 1971, IMMUNOCHEMISTRY, V8, P1081; Franciosi S, 2007, J NEUROSCI METH, V163, P76, DOI 10.1016/j.jneumeth.2007.02.020; Fritschy JM, 2008, EUR J NEUROSCI, V28, P2365, DOI 10.1111/j.1460-9568.2008.06552.x; Ganeshina O, 2004, NEUROSCIENCE, V125, P615, DOI 10.1016/j.neuroscience.2004.02.025; Ganeshina O, 2004, J COMP NEUROL, V468, P86, DOI 10.1002/cne.10950; GINGRAS D, 1994, BIOL CELL, V81, P153, DOI 10.1016/S0248-4900(94)80006-5; GRIFFITHS G, 1993, FINE STRUCTURE IMMUN; Haj-Yasein NN, 2011, P NATL ACAD SCI USA, V108, P17815, DOI 10.1073/pnas.1110655108; Hara Y, 2012, J NEUROSCI, V32, P7336, DOI 10.1523/JNEUROSCI.0605-12.2012; Hayat M.A., 1990, COLLOIDAL GOLD PRINC, V3; Holmseth S, 2006, ANAT EMBRYOL, V211, P257, DOI 10.1007/s00429-005-0077-6; Holmseth S, 2005, NEUROSCIENCE, V136, P649, DOI 10.1016/j.neuroscience.2005.07.022; Holmseth S, 2012, J HISTOCHEM CYTOCHEM, V60, P174, DOI 10.1369/0022155411434828; Hu H, 2001, J NEUROSCI, V21, P9585, DOI 10.1523/JNEUROSCI.21-24-09585.2001; Jackson AL, 2010, NAT REV DRUG DISCOV, V9, P57, DOI 10.1038/nrd3010; JI ZQ, 1991, J COMP NEUROL, V307, P296, DOI 10.1002/cne.903070210; Kharazia VN, 1999, J COMP NEUROL, V412, P292, DOI 10.1002/(SICI)1096-9861(19990920)412:2<292::AID-CNE8>3.0.CO;2-G; KRAEHENBUHL JP, 1980, HISTOCHEM J, V12, P317, DOI 10.1007/BF01006953; Landsend AS, 1997, J NEUROSCI, V17, P834, DOI 10.1523/jneurosci.17-02-00834.1997; Lorincz A, 2008, J NEUROSCI, V28, P9083, DOI 10.1523/JNEUROSCI.2494-08.2008; Maglione M, 2013, NAT NEUROSCI, V16, P790, DOI 10.1038/nn.3403; Matsubara A, 1996, J NEUROSCI, V16, P4457; Maunsbach A, 1999, BIOMEDICAL ELECT MIC; Mayer G, 2001, PROG HISTOCHEM CYTO, V36, P11, DOI 10.1016/S0079-6336(01)80002-4; Mayhew TM, 2009, ANN ANAT, V191, P153, DOI 10.1016/j.aanat.2008.11.001; Nagelhus EA, 1998, J NEUROSCI, V18, P2506; Newman G.R., 1993, RESIN MICROSCOPY ON; Nusser Z, 1998, NEURON, V21, P545, DOI 10.1016/S0896-6273(00)80565-6; OTTERSEN OP, 1989, J CHEM NEUROANAT, V2, P57; OTTERSEN OP, 1987, EXP BRAIN RES, V69, P167; OTTERSEN OP, 1992, NEUROSCIENCE, V46, P519, DOI 10.1016/0306-4522(92)90141-N; Pool C.W., 1983, NEUROIMMUNOCYTOCHEMI, V3, P1; POSTHUMA G, 1987, J HISTOCHEM CYTOCHEM, V35, P405, DOI 10.1177/35.4.2434559; POSTHUMA G, 1988, EUR J CELL BIOL, V46, P327; Pradidarcheep W, 2008, J HISTOCHEM CYTOCHEM, V56, P1099, DOI 10.1369/jhc.2008.952101; PRASAD BVV, 1990, NATURE, V343, P476, DOI 10.1038/343476a0; REMACLE J, 1976, J CELL BIOL, V71, P551, DOI 10.1083/jcb.71.2.551; Rhodes KJ, 2008, J GEN PHYSIOL, V131, P407, DOI 10.1085/jgp.200709926; Rhodes KJ, 2006, J NEUROSCI, V26, P8017, DOI 10.1523/JNEUROSCI.2728-06.2006; Roth J, 1996, HISTOCHEM CELL BIOL, V106, P131; Saper CB, 2003, J COMP NEUROL, V465, P161, DOI 10.1002/cne.10858; SESACK SR, 1995, NEUROSCIENCE, V67, P993, DOI 10.1016/0306-4522(95)00087-Y; SHUPLIAKOV O, 1992, J NEUROSCI, V12, P3789; SINGER SJ, 1959, NATURE, V183, P1523, DOI 10.1038/1831523a0; SLOT JW, 1989, AM J ANAT, V185, P271, DOI 10.1002/aja.1001850220; SOMOGYI P, 1986, NEUROSCIENCE, V19, P1045, DOI 10.1016/0306-4522(86)90121-1; STERNBERGER LA, 1965, EXP MOL PATHOL, V4, P112, DOI 10.1016/0014-4800(65)90027-4; STERNBERGER LA, 1986, IMMUNOCYTOCHEMISTRY; STORMMATHISEN J, 1983, NATURE, V301, P517, DOI 10.1038/301517a0; Sugiyama Y, 2005, NAT METHODS, V2, P677, DOI 10.1038/NMETH783; Takumi Y, 1999, NAT NEUROSCI, V2, P618, DOI 10.1038/10172; Tonnesen J, 2013, EXP NEUROL, V242, P33, DOI 10.1016/j.expneurol.2012.10.004; Valtschanoff JG, 2001, J NEUROSCI, V21, P1211; VANDENPOL AN, 1989, J MICROSC-OXFORD, V155, P27, DOI 10.1111/j.1365-2818.1989.tb04297.x; Watanabe M, 1998, EUR J NEUROSCI, V10, P478, DOI 10.1046/j.1460-9568.1998.00063.x	73	42	42	0	16	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUL	2013	16	7					798	804		10.1038/nn.3418	http://dx.doi.org/10.1038/nn.3418			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	174UM	23799472				2022-12-28	WOS:000321180900009
J	Wang, AY; Miura, K; Uchida, N				Wang, Alice Y.; Miura, Keiji; Uchida, Naoshige			The dorsomedial striatum encodes net expected return, critical for energizing performance vigor	NATURE NEUROSCIENCE			English	Article							REACTION-TIME PERFORMANCE; NUCLEUS-ACCUMBENS; VENTRAL STRIATUM; ACTION SELECTION; DECISION-MAKING; CAUDATE-NUCLEUS; DORSAL STRIATUM; BASAL GANGLIA; REWARD; DOPAMINE	Decision making requires an actor to not only steer behavior toward specific goals but also determine the optimal vigor of performance. Current research and models have largely focused on the former problem of how actions are directed while overlooking the latter problem of how they are energized. Here we designed a self-paced decision-making paradigm, which showed that rats' performance vigor globally fluctuates with the net value of their options, suggesting that they maintain long-term estimates of the value of their current state. Lesions of the dorsomedial striatum (DMS) and, to a lesser degree, in the ventral striatum impaired such state-dependent modulation of vigor, rendering vigor to depend more exclusively on the outcomes of immediately preceding trials. The lesions, however, spared choice biases. Neuronal recordings showed that the DMS is enriched in net value-coding neurons. In sum, the DMS encodes one's net expected return, which drives the general motivation to perform.	[Wang, Alice Y.; Miura, Keiji; Uchida, Naoshige] Harvard Univ, Dept Mol & Cellular Biol, Ctr Brain Sci, Cambridge, MA 02138 USA; [Miura, Keiji] Japan Sci & Technol Agcy, Precursory Res Embryon Sci & Technol PRESTO, Saitama, Japan; [Miura, Keiji] Tohoku Univ, Grad Sch Informat Sci, Sendai, Miyagi 980, Japan	Harvard University; Japan Science & Technology Agency (JST); Tohoku University	Uchida, N (corresponding author), Harvard Univ, Dept Mol & Cellular Biol, Ctr Brain Sci, Cambridge, MA 02138 USA.	uchida@mcb.harvard.edu		Uchida, Naoshige/0000-0002-5755-9409	National Science Foundation; Precursory Research for Embryonic Science and Technology; Smith Family New Investigator Award; Alfred Sloan Foundation; Milton Fund; Startup Fund from Harvard University; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH095953] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); Precursory Research for Embryonic Science and Technology; Smith Family New Investigator Award; Alfred Sloan Foundation(Alfred P. Sloan Foundation); Milton Fund; Startup Fund from Harvard University; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank J. Assad, K. Blum, O. Hikosaka, D. Lee, M. Livingstone, J. Maunsell and M. Meister for their comments on the manuscript; R. Born and the members of the Uchida laboratory for discussions; and S. Kim for support in behavioral experiments. This work was supported by a fellowship from National Science Foundation (A.Y.W.), Precursory Research for Embryonic Science and Technology (K.M.), a Smith Family New Investigator Award, the Alfred Sloan Foundation, the Milton Fund and the Startup Fund from Harvard University (N.U.).	AMALRIC M, 1987, J NEUROSCI, V7, P2129; Bailey KR, 2006, J NEUROSCI, V26, P1016, DOI 10.1523/JNEUROSCI.3883-05.2006; Balleine BW, 2010, NEUROPSYCHOPHARMACOL, V35, P48, DOI 10.1038/npp.2009.131; BROWN VJ, 1989, J NEUROSCI, V9, P3760; Cai XY, 2011, NEURON, V69, P170, DOI 10.1016/j.neuron.2010.11.041; Cury KM, 2010, NEURON, V68, P570, DOI 10.1016/j.neuron.2010.09.040; Delgado MR, 2004, CEREB CORTEX, V14, P1022, DOI 10.1093/cercor/bhh062; Ding L, 2012, NEURON, V75, P865, DOI 10.1016/j.neuron.2012.07.021; Draper NR., 1998, APPL REGRESSION ANAL, DOI [10.1002/9781118625590, DOI 10.1002/9781118625590]; Ferster C.B., 1957, SCHEDULES REINFORCEM, DOI 10.1037/10627-000; Guitart-Masip M, 2011, J COGNITIVE NEUROSCI, V23, P3933, DOI 10.1162/jocn_a_00090; Gurney K, 2001, BIOL CYBERN, V84, P401, DOI 10.1007/PL00007984; HAUBER W, 1994, BEHAV BRAIN RES, V60, P211, DOI 10.1016/0166-4328(94)90149-X; HEBB DO, 1955, PSYCHOL REV, V62, P243, DOI 10.1037/h0041823; Hikosaka O, 2006, J NEUROPHYSIOL, V95, P567, DOI 10.1152/jn.00458.2005; Hull C.L., 1943, PRINCIPLES BEHAV INT, DOI DOI 10.2307/1416955; IMPERATO A, 1986, J PHARMACOL EXP THER, V239, P219; Ito M, 2009, J NEUROSCI, V29, P9861, DOI 10.1523/JNEUROSCI.6157-08.2009; Jongen-Relo AL, 2002, PHYSIOL BEHAV, V76, P449, DOI 10.1016/S0031-9384(02)00732-1; Kable JW, 2009, NEURON, V63, P733, DOI 10.1016/j.neuron.2009.09.003; Kelley AE, 2004, NEUROSCI BIOBEHAV R, V27, P765, DOI 10.1016/j.neubiorev.2003.11.015; Kimchi EY, 2009, J NEUROSCI, V29, P3148, DOI 10.1523/JNEUROSCI.5206-08.2009; Lau B, 2008, NEURON, V58, P451, DOI 10.1016/j.neuron.2008.02.021; Lee D, 2012, ANNU REV NEUROSCI, V35, P287, DOI 10.1146/annurev-neuro-062111-150512; MOGENSON GJ, 1979, BRAIN RES, V171, P247, DOI 10.1016/0006-8993(79)90331-7; MOGENSON GJ, 1980, PROG NEUROBIOL, V14, P69, DOI 10.1016/0301-0082(80)90018-0; Nakamura K, 2006, J NEUROSCI, V26, P5360, DOI 10.1523/JNEUROSCI.4853-05.2006; NEWMAN R, 1980, J COMP NEUROL, V191, P167, DOI 10.1002/cne.901910203; Niv Y, 2007, PSYCHOPHARMACOLOGY, V191, P507, DOI 10.1007/s00213-006-0502-4; Niv Y, 2006, TRENDS COGN SCI, V10, P375, DOI 10.1016/j.tics.2006.06.010; Palmiter RD, 2008, ANN NY ACAD SCI, V1129, P35, DOI 10.1196/annals.1417.003; Roesch MR, 2004, SCIENCE, V304, P307, DOI 10.1126/science.1093223; Rorie AE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009308; Salamone JD, 2009, FRONT BEHAV NEUROSCI, V3, DOI 10.3389/neuro.08.013.2009; Samejima K, 2005, SCIENCE, V310, P1337, DOI 10.1126/science.1115270; Seo H, 2007, J NEUROSCI, V27, P8366, DOI 10.1523/JNEUROSCI.2369-07.2007; Skinner B.F, 1938, BEHAV ORGANISMS EXPT; Tai LH, 2012, NAT NEUROSCI, V15, P1281, DOI 10.1038/nn.3188; Thorn CA, 2010, NEURON, V66, P781, DOI 10.1016/j.neuron.2010.04.036; Turner RS, 2010, CURR OPIN NEUROBIOL, V20, P704, DOI 10.1016/j.conb.2010.08.022; Uchida N, 2003, NAT NEUROSCI, V6, P1224, DOI 10.1038/nn1142; Volkow ND, 2002, SYNAPSE, V44, P175, DOI 10.1002/syn.10075; Yin HH, 2005, EUR J NEUROSCI, V22, P505, DOI 10.1111/j.1460-9568.2005.04219.x; Yin HH, 2005, EUR J NEUROSCI, V22, P513, DOI 10.1111/j.1460-9568.2005.04218.x	44	78	78	1	21	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAY	2013	16	5					639	+		10.1038/nn.3377	http://dx.doi.org/10.1038/nn.3377			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	131WT	23584742	Green Accepted, Green Submitted			2022-12-28	WOS:000318029300021
J	Itoh, Y; Moriyama, Y; Hasegawa, T; Endo, TA; Toyoda, T; Gotoh, Y				Itoh, Yasuhiro; Moriyama, Yasunobu; Hasegawa, Tsuyoshi; Endo, Takaho A.; Toyoda, Tetsuro; Gotoh, Yukiko			Scratch regulates neuronal migration onset via an epithelial-mesenchymal transition-like mechanism	NATURE NEUROSCIENCE			English	Article							OUTER SUBVENTRICULAR ZONE; NEURAL STEM; E-CADHERIN; TRANSCRIPTION FACTORS; ASYMMETRIC DIVISION; ADHERENS JUNCTIONS; PLANAR DIVISIONS; PROGENITOR CELLS; RADIAL GLIA; NEUROGENESIS	During neocortical development, the neuroepithelial or neural precursor cells that commit to neuronal fate need to delaminate and start migration toward the pial surface. However, the mechanism that couples neuronal fate commitment to detachment from the neuroepithelium remains largely unknown. Here we show that Scratch1 and Scratch2, members of the Snail superfamily of transcription factors, are expressed upon neuronal fate commitment under the control of proneural genes and promote apical process detachment and radial migration in the developing mouse neocortex. Scratch-induced delamination from the apical surface was mediated by transcriptional repression of the adhesion molecule E-cadherin. These findings suggest that Scratch proteins constitute a molecular link between neuronal fate commitment and the onset of neuronal migration. On the basis of their similarity to proteins involved in the epithelial-mesenchymal transition (EMT), we propose that Scratch proteins mediate the conversion of neuroepithelial cells to migrating neurons or intermediate neuronal progenitors through an EMT-related mechanism.	[Itoh, Yasuhiro; Moriyama, Yasunobu; Hasegawa, Tsuyoshi; Gotoh, Yukiko] Univ Tokyo, Inst Mol & Cellular Biosci, Tokyo, Japan; [Endo, Takaho A.; Toyoda, Tetsuro] RIKEN Bioinformat & Syst Engn Div, Kanagawa, Japan	University of Tokyo; RIKEN	Gotoh, Y (corresponding author), Univ Tokyo, Inst Mol & Cellular Biosci, Tokyo, Japan.	yasu-itoh@iam.u-tokyo.ac.jp; ygotoh@iam.u-tokyo.ac.jp	Endo, Takaho/B-5763-2017	Endo, Takaho/0000-0002-2801-2463; Ito, Yasuhiro/0000-0001-8590-9122	"Neural Diversity and Neocortical Organization" from the Ministry of Education, Culture, Sports, Science, and Technology (MEXT) of Japan; CREST of the Japan Science and Technology Agency; MEXT	"Neural Diversity and Neocortical Organization" from the Ministry of Education, Culture, Sports, Science, and Technology (MEXT) of Japan; CREST of the Japan Science and Technology Agency(Core Research for Evolutional Science and Technology (CREST)); MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	We thank J.A. Cooper and R.N. Eisenman for critical reading of the manuscript; C.L. Cepko (Harvard University), T. Matsuda (Kyoto University), T. Kitamura (University of Tokyo), M. Nakafuku (University of Cincinnati), A. Nagafuchi (Kumamoto University), F. Matsuzaki (RIKEN Center for Developmental Biology), H. Okano (Keio University) and A. Garcia de Herreros (Institut Hospital del Mar d'Investigacions Mediques) for providing reagents; T. Sunabori for technical advice; H. Kosako and K. Ishiguro for generation of antibodies to Scratch1; Y. Hirabayashi, N. Masuyama, T. Yoshimatsu and T. Kato for technical assistance; K. Tyssowski for editing the manuscript; and members of the Gotoh laboratory for helpful discussion. This work was supported by a Grant-in-Aid for Scientific Research on Innovative Areas "Neural Diversity and Neocortical Organization" from the Ministry of Education, Culture, Sports, Science, and Technology (MEXT) of Japan, by CREST of the Japan Science and Technology Agency, and in part by the Global COE program (Integrative Life Science Based on the Study of Biosignaling Mechanisms) of MEXT.	Arnold SJ, 2008, GENE DEV, V22, P2479, DOI 10.1101/gad.475408; Arnold SJ, 2008, DEVELOPMENT, V135, P501, DOI 10.1242/dev.014357; Ayala R, 2007, CELL, V128, P29, DOI 10.1016/j.cell.2006.12.021; Batlle E, 2000, NAT CELL BIOL, V2, P84, DOI 10.1038/35000034; Bonaglia MC, 2005, EUR J HUM GENET, V13, P586, DOI 10.1038/sj.ejhg.5201369; Boussadia O, 2002, MECH DEVELOP, V115, P53, DOI 10.1016/S0925-4773(02)00090-4; Britz O, 2006, CEREB CORTEX, V16, pI138, DOI 10.1093/cercor/bhj168; Bultje RS, 2009, NEURON, V63, P189, DOI 10.1016/j.neuron.2009.07.004; Chae TH, 2004, NAT GENET, V36, P264, DOI 10.1038/ng1302; Fietz SA, 2011, CURR OPIN NEUROBIOL, V21, P23, DOI 10.1016/j.conb.2010.10.002; Fode C, 2000, GENE DEV, V14, P67; Franco SJ, 2011, NEURON, V69, P482, DOI 10.1016/j.neuron.2011.01.003; Ge WH, 2006, P NATL ACAD SCI USA, V103, P1319, DOI 10.1073/pnas.0510419103; Gotz M, 2005, NAT REV MOL CELL BIO, V6, P777, DOI 10.1038/nrm1739; Guillemot F, 2007, DEVELOPMENT, V134, P3771, DOI 10.1242/dev.006379; Hand R, 2005, NEURON, V48, P45, DOI 10.1016/j.neuron.2005.08.032; Hansen DV, 2010, NATURE, V464, P554, DOI 10.1038/nature08845; Heng JIT, 2008, NATURE, V455, P114, DOI 10.1038/nature07198; Hevner RF, 2006, NEUROSCI RES, V55, P223, DOI 10.1016/j.neures.2006.03.004; Hirabayashi Y, 2009, NEURON, V63, P600, DOI 10.1016/j.neuron.2009.08.021; Imai F, 2006, DEVELOPMENT, V133, P1735, DOI 10.1242/dev.02330; Itoh Y, 2007, J BIOL CHEM, V282, P390, DOI 10.1074/jbc.M609944200; Jossin Y, 2011, NAT NEUROSCI, V14, P697, DOI 10.1038/nn.2816; Kadowaki M, 2007, DEV BIOL, V304, P22, DOI 10.1016/j.ydbio.2006.12.014; Karpowicz P, 2009, J NEUROSCI, V29, P3885, DOI 10.1523/JNEUROSCI.0037-09.2009; Kato TM, 2010, MOL CELL NEUROSCI, V45, P12, DOI 10.1016/j.mcn.2010.05.004; Kawauchi T, 2010, NEURON, V67, P588, DOI 10.1016/j.neuron.2010.07.007; Kishi Y, 2012, NAT NEUROSCI, V15, P1127, DOI 10.1038/nn.3165; Konno D, 2008, NAT CELL BIOL, V10, P93, DOI 10.1038/ncb1673; Kriegstein A, 2009, ANNU REV NEUROSCI, V32, P149, DOI 10.1146/annurev.neuro.051508.135600; Marin F, 2006, DEV DYNAM, V235, P2586, DOI 10.1002/dvdy.20869; Marthiens V, 2009, EMBO REP, V10, P515, DOI 10.1038/embor.2009.36; Mizuhara E, 2005, J BIOL CHEM, V280, P26499, DOI 10.1074/jbc.M500375200; Morin X, 2007, NAT NEUROSCI, V10, P1440, DOI 10.1038/nn1984; Morita S, 2000, GENE THER, V7, P1063, DOI 10.1038/sj.gt.3301206; Morrison SJ, 2008, CELL, V132, P598, DOI 10.1016/j.cell.2008.01.038; Nagano T, 2004, J NEUROSCI, V24, P9648, DOI 10.1523/JNEUROSCI.2363-04.2004; Nakakura EK, 2001, P NATL ACAD SCI USA, V98, P4010, DOI 10.1073/pnas.051014098; Neumuller RA, 2009, GENE DEV, V23, P2675, DOI 10.1101/gad.1850809; Nieto MA, 2002, NAT REV MOL CELL BIO, V3, P155, DOI 10.1038/nrm757; Noctor SC, 2008, J COMP NEUROL, V508, P28, DOI 10.1002/cne.21669; Ochiai W, 2009, MOL CELL NEUROSCI, V40, P225, DOI 10.1016/j.mcn.2008.10.007; Ohtsuka T, 2001, J BIOL CHEM, V276, P30467, DOI 10.1074/jbc.M102420200; Okazaki Y, 2002, NATURE, V420, P563, DOI 10.1038/nature01266; Pacary E, 2011, NEURON, V69, P1069, DOI 10.1016/j.neuron.2011.02.018; Rasin MR, 2007, NAT NEUROSCI, V10, P819, DOI 10.1038/nn1924; ROCHA J, 1988, HUM GENET, V80, P299, DOI 10.1007/BF01790102; Rousso DL, 2012, NEURON, V74, P314, DOI 10.1016/j.neuron.2012.02.024; Sarkisian MR, 2008, TRENDS NEUROSCI, V31, P54, DOI 10.1016/j.tins.2007.11.009; Sawamoto K, 2001, J NEUROSCI RES, V65, P220, DOI 10.1002/jnr.1145; Sessa A, 2008, NEURON, V60, P56, DOI 10.1016/j.neuron.2008.09.028; Shitamukai A, 2011, J NEUROSCI, V31, P3683, DOI 10.1523/JNEUROSCI.4773-10.2011; Tabata H, 2009, CEREB CORTEX, V19, P2092, DOI 10.1093/cercor/bhn227; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Yamashita YM, 2010, CURR OPIN CELL BIOL, V22, P605, DOI 10.1016/j.ceb.2010.07.009; Zhang JN, 2010, DEV CELL, V18, P472, DOI 10.1016/j.devcel.2009.12.025	56	90	91	1	18	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	APR	2013	16	4					416	U75		10.1038/nn.3336	http://dx.doi.org/10.1038/nn.3336			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	114EM	23434913				2022-12-28	WOS:000316723700011
J	Wanat, MJ; Bonci, A; Phillips, PEM				Wanat, Matthew J.; Bonci, Antonello; Phillips, Paul E. M.			CRF acts in the midbrain to attenuate accumbens dopamine release to rewards but not their predictors	NATURE NEUROSCIENCE			English	Article							VENTRAL TEGMENTAL AREA; STRESS; COCAINE; ENHANCEMENT; DEPRESSION; NUCLEUS; NEURONS; PROTEIN	Stressors affect dopamine-dependent behaviors such as motivation, although the underlying neurobiological mechanism is not well defined. We report that corticotropin-releasing factor (CRF) acts in the ventral tegmental area (VTA) to reduce the motivation to work for food rewards. CRF in the VTA regulates dopamine output in a stimulus- and pathway-specific manner, offering a mechanism by which acute stress selectively regulates information transmission via the VTA to reprioritize motivated behavior.	[Wanat, Matthew J.; Phillips, Paul E. M.] Univ Washington, Dept Psychiat & Behav Sci, Seattle, WA 98195 USA; [Wanat, Matthew J.; Phillips, Paul E. M.] Univ Washington, Dept Pharmacol, Seattle, WA 98195 USA; [Bonci, Antonello] NIDA, Intramural Res Program, Baltimore, MD USA; [Bonci, Antonello] Univ Calif San Francisco, Dept Neurol, San Francisco, CA USA; [Bonci, Antonello] Johns Hopkins Sch Med, Solomon H Snyder Neurosci Inst, Baltimore, MD USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; National Institutes of Health (NIH) - USA; NIH National Institute on Drug Abuse (NIDA); University of California System; University of California San Francisco; Johns Hopkins University; Johns Hopkins Medicine	Phillips, PEM (corresponding author), Univ Washington, Dept Psychiat & Behav Sci, Seattle, WA 98195 USA.	pemp@uw.edu	Phillips, Paul E. M./A-4463-2008; Phillips, Paul/E-7813-2013	Phillips, Paul E. M./0000-0002-8749-7026; Phillips, Paul/0000-0002-8749-7026; Wanat, Matthew/0000-0003-1643-6557	US National Institutes of Health [R01-MH079292, R01-DA016782, T32-AA009455, F32-DA026273]; NARSAD; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH079292] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [F32DA026273, K99DA033386, R01DA016782] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NARSAD(NARSAD); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We would like to thank S. Ng-Evans for invaluable technical support and C. Akers for technical assistance. We thank N. Hollon, J. Clark and S. Sandberg for scientific discussion. This work was funded by the US National Institutes of Health (R01-MH079292, P.E.M.P.; R01-DA016782, A.B. and P.E.M.P.; T32-AA009455 and F32-DA026273, M.J.W.) and NARSAD (P.E.M.P.).	Beckstead MJ, 2009, NEUROPSYCHOPHARMACOL, V34, P1926, DOI 10.1038/npp.2009.25; Blacktop JM, 2011, J NEUROSCI, V31, P11396, DOI 10.1523/JNEUROSCI.1393-11.2011; Cabib S, 1996, PSYCHOPHARMACOLOGY, V128, P331, DOI 10.1007/s002130050142; Clark JJ, 2010, NAT METHODS, V7, P126, DOI [10.1038/NMETH.1412, 10.1038/nmeth.1412]; Georges F, 2002, J NEUROSCI, V22, P5173, DOI 10.1523/JNEUROSCI.22-12-05173.2002; Heien MLAV, 2005, P NATL ACAD SCI USA, V102, P10023, DOI 10.1073/pnas.0504657102; Inglis FM, 1999, J NEUROCHEM, V72, P1088, DOI 10.1046/j.1471-4159.1999.0721088.x; KALIVAS PW, 1987, J PHARMACOL EXP THER, V242, P757; Lemos JC, 2012, NATURE, V490, P402, DOI 10.1038/nature11436; Meyer SE, 2001, DEV PSYCHOPATHOL, V13, P565, DOI 10.1017/S095457940100308X; Phillips PEM, 2003, NATURE, V422, P614, DOI 10.1038/nature01566; Roitman MF, 2004, J NEUROSCI, V24, P1265, DOI 10.1523/JNEUROSCI.3823-03.2004; Salamone JD, 2009, FRONT BEHAV NEUROSCI, V3, DOI 10.3389/neuro.08.013.2009; SCARNATI E, 1984, BRAIN RES, V304, P351, DOI 10.1016/0006-8993(84)90339-1; Shafiei N, 2012, NEUROPSYCHOPHARMACOL, V37, P2194, DOI 10.1038/npp.2012.69; Sinha R, 2001, PSYCHOPHARMACOLOGY, V158, P343, DOI 10.1007/s002130100917; Tidey JW, 1996, BRAIN RES, V721, P140, DOI 10.1016/0006-8993(96)00159-X; Ungless MA, 2003, NEURON, V39, P401, DOI 10.1016/S0896-6273(03)00461-6; Wanat MJ, 2008, J PHYSIOL-LONDON, V586, P2157, DOI 10.1113/jphysiol.2007.150078; Wanat MJ, 2010, J NEUROSCI, V30, P12020, DOI 10.1523/JNEUROSCI.2691-10.2010; Wang B, 2005, J NEUROSCI, V25, P5389, DOI 10.1523/JNEUROSCI.0955-05.2005; ZACHARKO RM, 1991, NEUROSCI BIOBEHAV R, V15, P391, DOI 10.1016/S0149-7634(05)80032-6; Zweifel LS, 2009, P NATL ACAD SCI USA, V106, P7281, DOI 10.1073/pnas.0813415106	23	76	77	1	28	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	APR	2013	16	4					383	U191		10.1038/nn.3335	http://dx.doi.org/10.1038/nn.3335			4	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	114EM	23416448	Green Accepted			2022-12-28	WOS:000316723700005
J	Couey, JJ; Witoelar, A; Zhang, SJ; Zheng, K; Ye, J; Dunn, B; Czajkowski, R; Moser, MB; Moser, EI; Roudi, Y; Witter, MP				Couey, Jonathan J.; Witoelar, Aree; Zhang, Sheng-Jia; Zheng, Kang; Ye, Jing; Dunn, Benjamin; Czajkowski, Rafal; Moser, May-Britt; Moser, Edvard I.; Roudi, Yasser; Witter, Menno P.			Recurrent inhibitory circuitry as a mechanism for grid formation	NATURE NEUROSCIENCE			English	Article							MEDIAL ENTORHINAL CORTEX; LAYER-II; PATH-INTEGRATION; DISYNAPTIC INHIBITION; RAT; NEURONS; CELLS; MODEL; DIRECTION; DYNAMICS	Grid cells in layer II of the medial entorhinal cortex form a principal component of the mammalian neural representation of space. The firing pattern of a single grid cell has been hypothesized to be generated through attractor dynamics in a network with a specific local connectivity including both excitatory and inhibitory connections. However, experimental evidence supporting the presence of such connectivity among grid cells in layer II is limited. Here we report recordings from more than 600 neuron pairs in rat entorhinal slices, demonstrating that stellate cells, the principal cell type in the layer II grid network, are mainly interconnected via inhibitory interneurons. Using a model attractor network, we demonstrate that stable grid firing can emerge from a simple recurrent inhibitory network. Our findings thus suggest that the observed inhibitory microcircuitry between stellate cells is sufficient to generate grid-cell firing patterns in layer II of the medial entorhinal cortex.	[Couey, Jonathan J.; Witoelar, Aree; Zhang, Sheng-Jia; Zheng, Kang; Ye, Jing; Dunn, Benjamin; Czajkowski, Rafal; Moser, May-Britt; Moser, Edvard I.; Roudi, Yasser; Witter, Menno P.] Norwegian Univ Sci & Technol, Kavli Inst Syst Neurosci, N-7034 Trondheim, Norway; [Couey, Jonathan J.; Witoelar, Aree; Zhang, Sheng-Jia; Zheng, Kang; Ye, Jing; Dunn, Benjamin; Czajkowski, Rafal; Moser, May-Britt; Moser, Edvard I.; Roudi, Yasser; Witter, Menno P.] Norwegian Univ Sci & Technol, Ctr Biol Memory, Norwegian Brain Ctr, N-7034 Trondheim, Norway	Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU)	Witter, MP (corresponding author), Norwegian Univ Sci & Technol, Kavli Inst Syst Neurosci, N-7034 Trondheim, Norway.	yasser.roudi@ntnu.no; menno.witter@ntnu.no	Ye, Jing/M-3366-2017; Couey, Jonathan/GXG-6340-2022	Ye, Jing/0000-0002-6364-4124; Roudi, Yasser/0000-0002-6989-3420; Couey, Jonathan/0000-0003-2658-692X; Czajkowski, Rafal/0000-0002-9793-5421	Kavli Foundation; EU [200873]; Centre of Excellence from Norwegian Research Council [145993, 181676, 191929]; European Research Council ('CIRCUIT') [232608]	Kavli Foundation; EU(European Commission); Centre of Excellence from Norwegian Research Council; European Research Council ('CIRCUIT')	We thank K. Deisseroth (Stanford University) for providing the ChR2(H134R) plasmid, I.E.J. Assebo for histological reconstructions, P. Gird for programming and A. Treves for comments on the manuscript. This work was supported by the Kavli Foundation, an EU 7th framework grant ('Spacebrain' grant agreement 200873), and Centre of Excellence (145993), equipment (181676) and research (191929) grants from the Norwegian Research Council, and an Advanced Investigator Grant from the European Research Council ('CIRCUIT', grant 232608).	Acsady L, 1998, J NEUROSCI, V18, P3386; ALONSO A, 1993, J NEUROPHYSIOL, V70, P128, DOI 10.1152/jn.1993.70.1.128; AMARI SI, 1977, BIOL CYBERN, V27, P77, DOI 10.1007/BF00337259; Beed P, 2010, NEURON, V68, P1059, DOI 10.1016/j.neuron.2010.12.009; BENYISHAI R, 1995, P NATL ACAD SCI USA, V92, P3844, DOI 10.1073/pnas.92.9.3844; Berger TK, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000473; Berger TK, 2009, J PHYSIOL-LONDON, V587, P5411, DOI 10.1113/jphysiol.2009.176552; Boccara CN, 2010, NAT NEUROSCI, V13, P987, DOI 10.1038/nn.2602; Bonnevie T, 2013, NAT NEUROSCI, V16, P309, DOI 10.1038/nn.3311; Boucheny C, 2005, J COMPUT NEUROSCI, V18, P205, DOI 10.1007/s10827-005-6559-y; Brun VH, 2008, HIPPOCAMPUS, V18, P1200, DOI 10.1002/hipo.20504; Burak Y, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000291; Burgalossi A, 2011, NEURON, V70, P773, DOI 10.1016/j.neuron.2011.04.003; Burgess N, 2007, HIPPOCAMPUS, V17, P801, DOI 10.1002/hipo.20327; Canto CB, 2012, HIPPOCAMPUS, V22, P1277, DOI 10.1002/hipo.20993; Compte A, 2000, CEREB CORTEX, V10, P910, DOI 10.1093/cercor/10.9.910; Danglot L, 2006, HIPPOCAMPUS, V16, P1032, DOI 10.1002/hipo.20225; Dhillon A, 2000, NEUROSCIENCE, V99, P413, DOI 10.1016/S0306-4522(00)00225-6; Fuhs MC, 2006, J NEUROSCI, V26, P4266, DOI 10.1523/JNEUROSCI.4353-05.2006; Gatome CW, 2010, NEUROSCIENCE, V170, P156, DOI 10.1016/j.neuroscience.2010.06.048; Giocomo LM, 2008, J NEUROSCI, V28, P9414, DOI 10.1523/JNEUROSCI.3196-08.2008; Hafting T, 2005, NATURE, V436, P801, DOI 10.1038/nature03721; Hoffman DA, 1997, NATURE, V387, P869, DOI 10.1038/43119; JONES RSG, 1993, NEUROSCI LETT, V149, P35, DOI 10.1016/0304-3940(93)90341-H; Kang KJ, 2003, P NATL ACAD SCI USA, V100, P2848, DOI 10.1073/pnas.0138051100; Kapfer C, 2007, NAT NEUROSCI, V10, P743, DOI 10.1038/nn1909; Klink R, 1997, HIPPOCAMPUS, V7, P571; Kloosterman F, 2003, EUR J NEUROSCI, V18, P3037, DOI 10.1111/j.1460-9568.2003.03046.x; Kropff E, 2008, HIPPOCAMPUS, V18, P1256, DOI 10.1002/hipo.20520; Kumar SS, 2007, J NEUROSCI, V27, P1239, DOI 10.1523/JNEUROSCI.3182-06.2007; Langston RF, 2010, SCIENCE, V328, P1576, DOI 10.1126/science.1188210; McNaughton BL, 2006, NAT REV NEUROSCI, V7, P663, DOI 10.1038/nrn1932; Morgan RJ, 2007, PROG BRAIN RES, V163, P639, DOI 10.1016/S0079-6123(07)63035-0; Petreanu L, 2009, NATURE, V457, P1142, DOI 10.1038/nature07709; Quilichini P, 2010, J NEUROSCI, V30, P11128, DOI 10.1523/JNEUROSCI.1327-10.2010; Sargolini F, 2006, SCIENCE, V312, P758, DOI 10.1126/science.1125572; Silberberg G, 2007, NEURON, V53, P735, DOI 10.1016/j.neuron.2007.02.012; Sills JB, 2012, HIPPOCAMPUS, V22, P1912, DOI 10.1002/hipo.22026; Song PC, 2005, J NEUROSCI, V25, P1002, DOI 10.1523/JNEUROSCI.4172-04.2005; TAMAMAKI N, 1993, HIPPOCAMPUS, V3, P471, DOI 10.1002/hipo.450030408; van Haeften T, 2003, HIPPOCAMPUS, V13, P943, DOI 10.1002/hipo.10144; Varga C, 2010, NAT NEUROSCI, V13, P822, DOI 10.1038/nn.2570; Witter MP, 2007, PROG BRAIN RES, V163, P43, DOI 10.1016/S0079-6123(07)63003-9; Yizhar O, 2011, NEURON, V71, P9, DOI 10.1016/j.neuron.2011.06.004; Zhang K, 1996, J NEUROSCI, V16, P2112; Zilli EA, 2010, J NEUROSCI, V30, P13850, DOI 10.1523/JNEUROSCI.0547-10.2010	46	240	244	0	65	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAR	2013	16	3					318	324		10.1038/nn.3310	http://dx.doi.org/10.1038/nn.3310			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	097LE	23334580				2022-12-28	WOS:000315474800014
J	Kierdorf, K; Erny, D; Goldmann, T; Sander, V; Schulz, C; Perdiguero, EG; Wieghofer, P; Heinrich, A; Riemke, P; Holscher, C; Muller, DN; Luckow, B; Brocker, T; Debowski, K; Fritz, G; Opdenakker, G; Diefenbach, A; Biber, K; Heikenwalder, M; Geissmann, F; Rosenbauer, F; Prinz, M				Kierdorf, Katrin; Erny, Daniel; Goldmann, Tobias; Sander, Victor; Schulz, Christian; Perdiguero, Elisa Gomez; Wieghofer, Peter; Heinrich, Annette; Riemke, Pia; Hoelscher, Christoph; Mueller, Dominik N.; Luckow, Bruno; Brocker, Thomas; Debowski, Katharina; Fritz, Guenter; Opdenakker, Ghislain; Diefenbach, Andreas; Biber, Knut; Heikenwalder, Mathias; Geissmann, Frederic; Rosenbauer, Frank; Prinz, Marco			Microglia emerge from erythromyeloid precursors via Pu.1- and Irf8-dependent pathways	NATURE NEUROSCIENCE			English	Article							TRANSCRIPTION FACTORS; FRACTALKINE RECEPTOR; MYELOID CELLS; YOLK-SAC; MACROPHAGES; DIFFERENTIATION; HETEROGENEITY; PROGENITORS; MONOCYTES; SURVIVAL	Microglia are crucial for immune responses in the brain. Although their origin from the yolk sac has been recognized for some time, their precise precursors and the transcription program that is used are not known. We found that mouse microglia were derived from primitive c-kit(+) erythromyeloid precursors that were detected in the yolk sac as early as 8 d post conception. These precursors developed into CD45(+) c-kit(lo) CX(3)CR1(-) immature (A1) cells and matured into CD45(+) c-kit(-) CX(3)CR1(+) (A2) cells, as evidenced by the downregulation of CD31 and concomitant upregulation of F4/80 and macrophage colony stimulating factor receptor (MCSF-R). Proliferating A2 cells became microglia and invaded the developing brain using specific matrix metalloproteinases. Notably, microgliogenesis was not only dependent on the transcription factor Pu.1 (also known as Sfpi), but also required Irf8, which was vital for the development of the A2 population, whereas Myb, Id2, Batf3 and Klf4 were not required. Our data provide cellular and molecular insights into the origin and development of microglia.	[Kierdorf, Katrin; Erny, Daniel; Goldmann, Tobias; Sander, Victor; Wieghofer, Peter; Fritz, Guenter; Prinz, Marco] Univ Freiburg, Dept Neuropathol, D-79106 Freiburg, Germany; [Kierdorf, Katrin; Wieghofer, Peter] Univ Freiburg, Fac Biol, D-79106 Freiburg, Germany; [Schulz, Christian; Perdiguero, Elisa Gomez; Geissmann, Frederic] Kings Coll London, Ctr Mol & Cellular Biol Inflammat, London WC2R 2LS, England; [Schulz, Christian; Perdiguero, Elisa Gomez; Geissmann, Frederic] Kings Coll London, Peter Gorer Dept Immunobiol, London WC2R 2LS, England; [Heinrich, Annette; Biber, Knut] Univ Freiburg, Dept Psychiat, D-79106 Freiburg, Germany; [Riemke, Pia; Rosenbauer, Frank] Univ Munster, Inst Mol Tumor Biol, D-48149 Munster, Germany; [Hoelscher, Christoph] Res Ctr Borstel, Div Infect Immunol, Borstel, Germany; [Hoelscher, Christoph] Cluster Excellence Inflammat Interfaces Borstel K, Kiel, Germany; [Mueller, Dominik N.] Fac Med Charite, Expt & Clin Res Ctr, Berlin, Germany; [Mueller, Dominik N.] Max Delbruck Ctr Mol Med, Berlin, Germany; [Luckow, Bruno] Klinikum Univ Munchen, Klin & Poliklin 4, Arbeitsgrp Klin Biochem, Munich, Germany; [Brocker, Thomas] Univ Munich, Inst Immunol, D-80539 Munich, Germany; [Debowski, Katharina] German Primate Ctr, Cell Res Grp, Gottingen, Germany; [Opdenakker, Ghislain] Katholieke Univ Leuven, Dept Microbiol & Immunol, Rega Inst Med Res, Louvain, Belgium; [Diefenbach, Andreas] Univ Freiburg, Dept Microbiol, D-79106 Freiburg, Germany; [Biber, Knut] Univ Groningen, Univ Med Ctr Groningen, Dept Neurosci, NL-9713 AV Groningen, Netherlands; [Heikenwalder, Mathias] Tech Univ Munich, Inst Virol, Helmholtz Zentrum Munich, D-80290 Munich, Germany; [Prinz, Marco] Univ Freiburg, Ctr Biol Signaling Studies, D-79106 Freiburg, Germany	University of Freiburg; University of Freiburg; University of London; King's College London; University of London; King's College London; University of Freiburg; University of Munster; Forschungszentrum Borstel; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Helmholtz Association; Max Delbruck Center for Molecular Medicine; University of Munich; University of Munich; Deutsches Primatenzentrum (DPZ); KU Leuven; University of Freiburg; University of Groningen; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Technical University of Munich; University of Freiburg	Prinz, M (corresponding author), Univ Freiburg, Dept Neuropathol, Hugstetter Str 55, D-79106 Freiburg, Germany.	marco.prinz@uniklinik-freiburg.de	Fritz, Guenter/E-2933-2013; Diefenbach, Andreas/T-2589-2018; Hölscher, Christoph/O-1732-2018; Kierdorf, Katrin/AAO-6288-2021; Opdenakker, Ghislain/V-8562-2019; Schulz, Christian/J-8545-2012; Erny, Daniel/AAU-7015-2020; Opdenakker, Ghislain/Q-3130-2017; Wieghofer, Peter/AAV-9572-2020; Heikenwalder, Mathias/AAA-2269-2020; Perdiguero, Elisa Gomez/U-2120-2018	Fritz, Guenter/0000-0002-4571-8812; Diefenbach, Andreas/0000-0002-9176-9530; Hölscher, Christoph/0000-0002-7520-9146; Opdenakker, Ghislain/0000-0003-1714-2294; Schulz, Christian/0000-0003-3878-7833; Erny, Daniel/0000-0001-6000-8838; Opdenakker, Ghislain/0000-0003-1714-2294; Perdiguero, Elisa Gomez/0000-0002-7717-7897; Masuch, Annette/0000-0002-8168-5042; Kierdorf, Katrin/0000-0002-9272-4780; Brocker, Thomas/0000-0001-7060-5433; geissmann, frederic/0000-0001-5029-2468; Rosenbauer, Frank/0000-0001-7977-9421; Goldmann, Tobias/0000-0001-9754-9144; Muller, Dominik N/0000-0003-3650-5644	Deutsche Forschungsgemeinschaft (DFG); Bundesministerium fur Bildung und Forschung; Competence Network of Neurodegenerative Disorders (Deutsches Zentrum fur Neurodegenerative Erkrankungen); Centre of Chronic Immunodeficiency; DFG [SFB 620, PR 577/8-1]; Heisenberg fellowship [DFG FR 1488/3-2]; Helmholtz-Zentrum Munchen, a European Research Council; Swiss National Foundation; Geconcentreerde OnderzoeksActies [2012/017]; Fund for Scientific Research-Flanders; German National Academy of Sciences Leopoldina [LPDS 2009-31]; Medical Research Council [MRCG0900867]; European Research Council [ERC-2010-StG-261299]; Medical Research Council [G0900867] Funding Source: researchfish; MRC [G0900867] Funding Source: UKRI	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Bundesministerium fur Bildung und Forschung(Federal Ministry of Education & Research (BMBF)); Competence Network of Neurodegenerative Disorders (Deutsches Zentrum fur Neurodegenerative Erkrankungen); Centre of Chronic Immunodeficiency; DFG(German Research Foundation (DFG)); Heisenberg fellowship(German Research Foundation (DFG)); Helmholtz-Zentrum Munchen, a European Research Council; Swiss National Foundation(Swiss National Science Foundation (SNSF)); Geconcentreerde OnderzoeksActies; Fund for Scientific Research-Flanders(FWO); German National Academy of Sciences Leopoldina; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); European Research Council(European Research Council (ERC)European Commission); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We would like to thank M. Oberle, A. Holscher and U. Muller for excellent technical assistance, M. Mann for help with the heat map, A. Muller for assistance with the electron microscopy and S. Brendecke for critical reading and editing. The authors are indebted to S. McKercher (Sanford-Burnham Medical Research Institute) for providing Sfpi<SUP>+/-</SUP> mice and to J. Frampton (University of Birmingham) for providing Myb<SUP>+/-</SUP> mice. We thank S. Heck and the Flow facility of the Biomedical Research Centre at King's Health Partners. M.P., K.B. and ER. are supported by the Deutsche Forschungsgemeinschaft (DFG)-funded research unit 1336 "From monocytes to brain macrophages-conditions influencing the fate of myeloid cells in the brain". M.P. is supported by the Bundesministerium fur Bildung und Forschung-funded Competence Network of Multiple Sclerosis (Kompetenznetz Multiple Sklerose), the Competence Network of Neurodegenerative Disorders (Deutsches Zentrum fur Neurodegenerative Erkrankungen), the Centre of Chronic Immunodeficiency and the DFG (SFB 620, PR 577/8-1). G.F. is supported by a Heisenberg fellowship (DFG FR 1488/3-2). M.H. is supported by the Helmholtz-Zentrum Munchen, a European Research Council starting grant and the Swiss National Foundation. G.O. is supported by the Geconcentreerde OnderzoeksActies 2012/017 and the Fund for Scientific Research-Flanders. CS. is supported by a fellowship program of the German National Academy of Sciences Leopoldina (LPDS 2009-31). F.G. is supported by grants MRCG0900867 from the Medical Research Council and ERC-2010-StG-261299 from the European Research Council.	Alliot F, 1999, DEV BRAIN RES, V117, P145, DOI 10.1016/S0165-3806(99)00113-3; Anderson KL, 2000, J IMMUNOL, V164, P1855, DOI 10.4049/jimmunol.164.4.1855; Bakri Y, 2005, BLOOD, V105, P2707, DOI 10.1182/blood-2004-04-1448; Beers DR, 2006, P NATL ACAD SCI USA, V103, P16021, DOI 10.1073/pnas.0607423103; Bertrand JY, 2005, BLOOD, V106, P3004, DOI 10.1182/blood-2005-02-0461; Chan WY, 2007, BRAIN RES REV, V53, P344, DOI 10.1016/j.brainresrev.2006.11.002; Geissmann F, 2003, IMMUNITY, V19, P71, DOI 10.1016/S1074-7613(03)00174-2; Geissmann F, 2010, SCIENCE, V327, P656, DOI 10.1126/science.1178331; Ginhoux F, 2010, SCIENCE, V330, P841, DOI 10.1126/science.1194637; Hambleton S, 2011, NEW ENGL J MED, V365, P127, DOI 10.1056/NEJMoa1100066; Hanisch UK, 2007, NAT NEUROSCI, V10, P1387, DOI 10.1038/nn1997; Herbomel P, 2001, DEV BIOL, V238, P274, DOI 10.1006/dbio.2001.0393; Hu JL, 2007, NAT REV DRUG DISCOV, V6, P480, DOI 10.1038/nrd2308; Hu JL, 2006, COMB CHEM HIGH T SCR, V9, P599, DOI 10.2174/138620706778249758; Jung S, 2000, MOL CELL BIOL, V20, P4106, DOI 10.1128/MCB.20.11.4106-4114.2000; McKercher SR, 1996, EMBO J, V15, P5647, DOI 10.1002/j.1460-2075.1996.tb00949.x; Mizutani M, 2012, J IMMUNOL, V188, P29, DOI 10.4049/jimmunol.1100421; Otero K, 2009, NAT IMMUNOL, V10, P734, DOI 10.1038/ni.1744; Palis J, 1999, DEVELOPMENT, V126, P5073; Palis J, 2001, P NATL ACAD SCI USA, V98, P4528, DOI 10.1073/pnas.071002398; Prinz M, 2011, NAT NEUROSCI, V14, P1227, DOI 10.1038/nn.2923; Prinz M, 2011, GLIA, V59, P177, DOI 10.1002/glia.21104; Ransohoff RM, 2009, ANNU REV IMMUNOL, V27, P119, DOI 10.1146/annurev.immunol.021908.132528; Rosenbauer F, 2007, NAT REV IMMUNOL, V7, P105, DOI 10.1038/nri2024; Schulz C, 2012, SCIENCE, V336, P86, DOI 10.1126/science.1219179; Serbina NV, 2006, NAT IMMUNOL, V7, P311, DOI 10.1038/ni1309; Takahashi K, 1996, PATHOL INT, V46, P473, DOI 10.1111/j.1440-1827.1996.tb03641.x; Taniguchi T, 2001, ANNU REV IMMUNOL, V19, P623, DOI 10.1146/annurev.immunol.19.1.623; Vinet J, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-27; Wegiel J, 1998, BRAIN RES, V804, P135, DOI 10.1016/S0006-8993(98)00618-0	30	871	897	1	107	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAR	2013	16	3					273	280		10.1038/nn.3318	http://dx.doi.org/10.1038/nn.3318			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	097LE	23334579				2022-12-28	WOS:000315474800009
J	Mander, BA; Rao, V; Lu, B; Saletin, JM; Lindquist, JR; Ancoli-Israel, S; Jagust, W; Walker, MP				Mander, Bryce A.; Rao, Vikram; Lu, Brandon; Saletin, Jared M.; Lindquist, John R.; Ancoli-Israel, Sonia; Jagust, William; Walker, Matthew P.			Prefrontal atrophy, disrupted NREM slow waves and impaired hippocampal-dependent memory in aging	NATURE NEUROSCIENCE			English	Article							GROWTH-HORMONE; EEG SLEEP; CONSOLIDATION; YOUNG; MEN; DYNAMICS; DECLINE; SCALE	Aging has independently been associated with regional brain atrophy, reduced slow wave activity (SWA) during non rapid eye movement (NREM) sleep and impaired long-term retention of episodic memories. However, whether the interaction of these factors represents a neuropatholgical pathway associated with cognitive decline in later life remains unknown. We found that age-related medial prefrontal cortex (mPFC) gray-matter atrophy was associated with reduced NREM SWA in older adults, the extent to which statistically mediated the impairment of overnight sleep dependent memory retention. Moreover, this memory impairment was further associated with persistent hippocampal activation and reduced task-related hippocampal-prefrontal cortex functional connectivity, potentially representing impoverished hippocampal-neocortical memory transformation. Together, these data support a model in which age-related mPFC atrophy diminishes SWA, the functional consequence of which is impaired long-term memory. Such findings suggest that sleep disruption in the elderly, mediated by structural brain changes, represents a contributing factor to age-related cognitive decline in later life	[Mander, Bryce A.; Rao, Vikram; Saletin, Jared M.; Lindquist, John R.; Walker, Matthew P.] Univ Calif Berkeley, Sleep & Neuroimaging Lab, Berkeley, CA 94720 USA; [Lu, Brandon] Calif Pacific Med Ctr, Div Pulm & Crit Care Med, San Francisco, CA USA; [Ancoli-Israel, Sonia] Univ Calif San Diego, Dept Psychiat, La Jolla, CA 92093 USA; [Jagust, William; Walker, Matthew P.] Univ Calif Berkeley, Helen Wills Neurosci Inst, Berkeley, CA 94720 USA; [Jagust, William] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Life Sci Div, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; California Pacific Medical Center; University of California System; University of California San Diego; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	Mander, BA (corresponding author), Univ Calif Berkeley, Sleep & Neuroimaging Lab, Berkeley, CA 94720 USA.	bamander@berkeley.edu; mpwalker@berkeley.edu	Rao, Vikram/J-6931-2016; Jagust, William/ABE-6426-2020	Mander, Bryce/0000-0002-0831-7980; Saletin, Jared/0000-0002-8547-0161	US National Institutes of Health [R01-AG031164, R01-AG034570, R01-AG08415, F32-AG039170]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH093537] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [F32AG039170, R01AG034570, R01AG008415, R01AG031164] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank M. Belshe, M. Shatter, M. Binod, S. Bowditch, C. Dang, A. Hayenga, A. Horn, E. Hur, C. Markeley, E. Mormino, M. Nicholas, L. Zhang and A. Zhu for their assistance, A. Mander for his aid in task design, and M. Rubens and A. Gazzaley for use of their aging template brain. This work was supported by awards R01-AG031164 (M.P.W.), R01-AG034570 (W.J.), R01-AG08415 (S.A.-I.) and F32-AG039170 (B.A.M.) from the US National Institutes of Health.	Albert MS, 1997, PHILOS T ROY SOC B, V352, P1703, DOI 10.1098/rstb.1997.0152; Backhaus J, 2007, LEARN MEMORY, V14, P336, DOI 10.1101/lm.470507; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Buchmann A, 2011, CEREB CORTEX, V21, P607, DOI 10.1093/cercor/bhq129; Buckner RL, 2004, NEURON, V44, P195, DOI 10.1016/j.neuron.2004.09.006; Buzsaki G, 1996, CEREB CORTEX, V6, P81, DOI 10.1093/cercor/6.2.81; Davis HP, 2003, CORTEX, V39, P1063, DOI 10.1016/S0010-9452(08)70878-5; Diekelmann S, 2010, NAT REV NEUROSCI, V11, P114, DOI 10.1038/nrn2762; DIJK DJ, 1989, NEUROBIOL AGING, V10, P677, DOI 10.1016/0197-4580(89)90004-3; DIJK DJ, 1993, BRAIN RES, V626, P190, DOI 10.1016/0006-8993(93)90579-C; Frankland PW, 2005, NAT REV NEUROSCI, V6, P119, DOI 10.1038/nrn1607; Gais S, 2007, P NATL ACAD SCI USA, V104, P18778, DOI 10.1073/pnas.0705454104; HORNE J A, 1976, International Journal of Chronobiology, V4, P97; JOHNS MW, 1991, SLEEP, V14, P540, DOI 10.1093/sleep/14.6.540; Kang JE, 2009, SCIENCE, V326, P1005, DOI 10.1126/science.1180962; MACKINNON DP, 1995, MULTIVAR BEHAV RES, V30, P41, DOI 10.1207/s15327906mbr3001_3; Mander BA, 2011, CURR BIOL, V21, pR183, DOI 10.1016/j.cub.2011.01.019; Marshall L, 2006, NATURE, V444, P610, DOI 10.1038/nature05278; Marzano C, 2010, J SLEEP RES, V19, P260, DOI 10.1111/j.1365-2869.2009.00776.x; MONK TH, 1989, PSYCHIAT RES, V27, P89, DOI 10.1016/0165-1781(89)90013-9; Mormino EC, 2009, BRAIN, V132, P1310, DOI 10.1093/brain/awn320; Murphy M, 2009, P NATL ACAD SCI USA, V106, P1608, DOI 10.1073/pnas.0807933106; Nadel L, 1997, CURR OPIN NEUROBIOL, V7, P217, DOI 10.1016/S0959-4388(97)80010-4; Nadel Lynn, 2007, Neural Plasticity, V2007, P1, DOI 10.1155/2007/90472; Naylor E, 2000, SLEEP, V23, P87; Nelson DL, 2004, BEHAV RES METH INS C, V36, P402, DOI 10.3758/BF03195588; Otten LJ, 2007, J COGNITIVE NEUROSCI, V19, P1776, DOI 10.1162/jocn.2007.19.11.1776; Sowell ER, 2003, NAT NEUROSCI, V6, P309, DOI 10.1038/nn1008; Takashima A, 2006, P NATL ACAD SCI USA, V103, P756, DOI 10.1073/pnas.0507774103; Van Cauter E, 2000, JAMA-J AM MED ASSOC, V284, P861, DOI 10.1001/jama.284.7.861; VanCauter E, 1997, J CLIN INVEST, V100, P745, DOI 10.1172/JCI119587; Vitiello MV, 2009, CURR DIR PSYCHOL SCI, V18, P316, DOI 10.1111/j.1467-8721.2009.01659.x; Walker MP, 2009, ANN NY ACAD SCI, V1156, P168, DOI 10.1111/j.1749-6632.2009.04416.x; Westerberg CE, 2012, J INT NEUROPSYCH SOC, V18, P490, DOI 10.1017/S135561771200001X	34	302	312	5	109	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAR	2013	16	3					357	364		10.1038/nn.3324	http://dx.doi.org/10.1038/nn.3324			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	097LE	23354332	Green Accepted, Green Submitted			2022-12-28	WOS:000315474800019
J	Ferrini, F; Trang, T; Mattioli, TAM; Laffray, S; Del'Guidice, T; Lorenzo, LE; Castonguay, A; Doyon, N; Zhang, WB; Godin, AG; Mohr, D; Beggs, S; Vandal, K; Beaulieu, JM; Cahill, CM; Salter, MW; De Koninck, Y				Ferrini, Francesco; Trang, Tuan; Mattioli, Theresa-Alexandra M.; Laffray, Sophie; Del'Guidice, Thomas; Lorenzo, Louis-Etienne; Castonguay, Annie; Doyon, Nicolas; Zhang, Wenbo; Godin, Antoine G.; Mohr, Daniela; Beggs, Simon; Vandal, Karen; Beaulieu, Jean-Martin; Cahill, Catherine M.; Salter, Michael W.; De Koninck, Yves			Morphine hyperalgesia gated through microglia-mediated disruption of neuronal Cl- homeostasis	NATURE NEUROSCIENCE			English	Article							LAMINA-I NEURONS; ALTERED CHLORIDE HOMEOSTASIS; INDUCED ABNORMAL PAIN; NEUROTROPHIC FACTOR; SPINAL MICROGLIA; P2X(4) RECEPTORS; DOWN-REGULATION; ANION GRADIENT; UP-REGULATION; NERVE INJURY	A major unresolved issue in treating pain is the paradoxical hyperalgesia produced by the gold-standard analgesic morphine and other opiates. We found that hyperalgesia-inducing treatment with morphine resulted in downregulation of the K+-Cl- co-transporter KCC2, impairing Cl- homeostasis in rat spinal lamina I neurons. Restoring the anion equilibrium potential reversed the morphine-induced hyperalgesia without affecting tolerance. The hyperalgesia was also reversed by ablating spinal microglia. Morphine hyperalgesia, but not tolerance, required mu opioid receptor-dependent expression of P2X4 receptors (P2X4Rs) in microglia and mu-independent gating of the release of brain-derived neurotrophic factor (BDNF) by P2X4Rs. Blocking BDNF-TrkB signaling preserved Cl- homeostasis and reversed the hyperalgesia. Gene-targeted mice in which Bdnf was deleted from microglia did not develop hyperalgesia to morphine. However, neither morphine antinociception nor tolerance was affected in these mice. Our findings dissociate morphine-induced hyperalgesia from tolerance and suggest the microglia-to-neuron P2X4-BDNF-KCC2 pathway as a therapeutic target for preventing hyperalgesia without affecting morphine analgesia.	[Ferrini, Francesco; Laffray, Sophie; Del'Guidice, Thomas; Lorenzo, Louis-Etienne; Castonguay, Annie; Doyon, Nicolas; Godin, Antoine G.; Vandal, Karen; Beaulieu, Jean-Martin; De Koninck, Yves] Inst Univ Sante Mentale Quebec, Quebec City, PQ, Canada; [Ferrini, Francesco; Laffray, Sophie; Del'Guidice, Thomas; Lorenzo, Louis-Etienne; Castonguay, Annie; Doyon, Nicolas; Godin, Antoine G.; Beaulieu, Jean-Martin; De Koninck, Yves] Univ Laval, Dept Psychiat & Neurosci, Quebec City, PQ, Canada; [Ferrini, Francesco] Univ Turin, Dept Vet Sci, Turin, Italy; [Ferrini, Francesco; Zhang, Wenbo; Mohr, Daniela; Beggs, Simon; Salter, Michael W.] Hosp Sick Children, Program Neurosci & Mental Hlth, Toronto, ON M5G 1X8, Canada; [Trang, Tuan; Zhang, Wenbo; Mohr, Daniela; Beggs, Simon; Salter, Michael W.] Univ Toronto, Dept Physiol, Toronto, ON, Canada; [Trang, Tuan] Univ Calgary, Dept Comparat Biol & Expt Med, Calgary, AB, Canada; [Trang, Tuan] Univ Calgary, Dept Physiol & Pharmacol, Hotchkiss Brain Inst, Calgary, AB, Canada; [Mattioli, Theresa-Alexandra M.; Cahill, Catherine M.] Queens Univ, Dept Biomed & Mol Sci, Kingston, ON, Canada; [Cahill, Catherine M.] Univ Calif Irvine, Dept Anesthesiol & Perioperat Care, Irvine, CA USA	Laval University; Laval University; University of Turin; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University of Calgary; University of Calgary; Queens University - Canada; University of California System; University of California Irvine	De Koninck, Y (corresponding author), Inst Univ Sante Mentale Quebec, Quebec City, PQ, Canada.	yves.dekoninck@crulrg.ulaval.ca	Beaulieu, Jean-Martin/A-7598-2008; De Koninck, Yves/C-2659-2008; Lorenzo, Louis-Etienne/A-5409-2012; Ferrini, Francesco/T-9903-2019; Beggs, Simon/AAI-4438-2021; Cahill, Catherine/AAA-1611-2019; Laffray, Sophie/AAA-4792-2019; Cahill, Catherine M/J-6524-2019; Castonguay, Annie/E-4068-2010	Beaulieu, Jean-Martin/0000-0002-0446-7447; De Koninck, Yves/0000-0002-5779-9330; Lorenzo, Louis-Etienne/0000-0002-5514-0049; Ferrini, Francesco/0000-0002-4779-005X; Beggs, Simon/0000-0002-1582-8391; Laffray, Sophie/0000-0002-1562-0304; Castonguay, Annie/0000-0001-8065-3359; Godin, Antoine/0000-0003-2417-2563; Mohr, Daniela/0000-0001-8129-2604; Del'Guidice, Thomas/0000-0003-4969-7016	Canadian Institutes for Health Research (CIHR); Krembil Foundation; Regione Piemonte/University of Turin Fellowship Program; CIHR Fellowship program; Howard Hughes Medical Institute; Anne and Max Tanenbaum Chair Program; Canada Research Chairs Program; Fonds de la recherche en sante du Quebec Chercheur National Program; Ontario Research Fund Research Excellence Program	Canadian Institutes for Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Krembil Foundation; Regione Piemonte/University of Turin Fellowship Program; CIHR Fellowship program(Canadian Institutes of Health Research (CIHR)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Anne and Max Tanenbaum Chair Program; Canada Research Chairs Program(Canada Research Chairs); Fonds de la recherche en sante du Quebec Chercheur National Program; Ontario Research Fund Research Excellence Program	We thank K. Bachand for technical assistance with behavior, F. Rassendren (INSERM) for P2rx4<SUP>-/-</SUP>mice, C.J. Evans (National Institute on Drug Abuse) for (+)naloxone and J. Vlahakis for (+)naloxone polarimetric analysis. This paper is dedicated to the memory of Karen Vandal, who passed away during the course of this study. This work was supported by Canadian Institutes for Health Research (CIHR) grants to Y.D.K., M.W.S., C.M.C. and J.-M.B., by the Krembil Foundation (Y.D.K. and M.W.S.), the Regione Piemonte/University of Turin Fellowship Program (F.F.), the CIHR Fellowship program (T.T. and L.-E.L.), the Howard Hughes Medical Institute (M.W.S.), the Anne and Max Tanenbaum Chair Program (M.W.S.), the Canada Research Chairs Program (C.M.C., J.-M.B. and M.W.S.), the Fonds de la recherche en sante du Quebec Chercheur National Program (Y.D.K.) and the Ontario Research Fund Research Excellence Program (M.W.S.).	Asiedu M, 2010, PAIN, V148, P302, DOI 10.1016/j.pain.2009.11.015; Beggs S, 2010, CURR OPIN NEUROBIOL, V20, P474, DOI 10.1016/j.conb.2010.08.005; Bekhit MH, 2010, AM J THER, V17, P498, DOI 10.1097/MJT.0b013e3181ed83a0; Blaesse P, 2006, J NEUROSCI, V26, P10407, DOI 10.1523/JNEUROSCI.3257-06.2006; Bohn LM, 2000, NATURE, V408, P720, DOI 10.1038/35047086; Boillee S, 2006, SCIENCE, V312, P1389, DOI 10.1126/science.1123511; Boulenguez P, 2010, NAT MED, V16, P302, DOI 10.1038/nm.2107; Chorin E, 2011, J NEUROSCI, V31, P12916, DOI 10.1523/JNEUROSCI.2205-11.2011; Cordero-Erausquin M, 2005, J NEUROSCI, V25, P9613, DOI 10.1523/JNEUROSCI.1488-05.2005; Coull JAM, 2005, NATURE, V438, P1017, DOI 10.1038/nature04223; Coull JAM, 2003, NATURE, V424, P938, DOI 10.1038/nature01868; Craig AD, 2003, ANNU REV NEUROSCI, V26, P1, DOI 10.1146/annurev.neuro.26.041002.131022; De Koninck Y, 2007, CURR OPIN PHARMACOL, V7, P93, DOI 10.1016/j.coph.2006.11.005; Doyon N, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002149; Drdla R, 2009, SCIENCE, V325, P207, DOI 10.1126/science.1171759; Heinke B, 2011, J NEUROSCI, V31, P1313, DOI 10.1523/JNEUROSCI.4060-10.2011; Hewitt SA, 2009, NAT NEUROSCI, V12, P438, DOI 10.1038/nn.2274; Horvath RJ, 2010, PAIN, V150, P401, DOI 10.1016/j.pain.2010.02.042; Horvath RJ, 2009, J NEUROSCI, V29, P998, DOI 10.1523/JNEUROSCI.4595-08.2009; Hutchinson MR, 2011, PHARMACOL REV, V63, P772, DOI 10.1124/pr.110.004135; Keller AF, 2007, MOL PAIN, V3, DOI 10.1186/1744-8069-3-27; Kemp T, 1996, NEUROSCIENCE, V75, P1231, DOI 10.1016/0306-4522(96)00333-8; Knabl J, 2008, NATURE, V451, P330, DOI 10.1038/nature06493; Lee M, 2011, PAIN PHYSICIAN, V14, P145; Mannion RJ, 1999, P NATL ACAD SCI USA, V96, P9385, DOI 10.1073/pnas.96.16.9385; Mao JR, 2002, PAIN, V100, P213, DOI 10.1016/S0304-3959(02)00422-0; Mao JR, 2002, J NEUROSCI, V22, P8312; Matthes HWD, 1996, NATURE, V383, P819, DOI 10.1038/383819a0; Merighi A, 2008, PROG NEUROBIOL, V85, P297, DOI 10.1016/j.pneurobio.2008.04.004; Prescott SA, 2006, MOL PAIN, V2, DOI 10.1186/1744-8069-2-32; Rios M, 2001, MOL ENDOCRINOL, V15, P1748, DOI 10.1210/me.15.10.1748; Sandkuhler J, 2009, PHYSIOL REV, V89, P707, DOI 10.1152/physrev.00025.2008; SJOGREN P, 1993, PAIN, V55, P93, DOI 10.1016/0304-3959(93)90188-U; Smirnov S, 1999, J NEUROSCI, V19, P9252; STALEY KJ, 1995, SCIENCE, V269, P977, DOI 10.1126/science.7638623; Takayama N, 2005, J NEUROSCI, V25, P430, DOI 10.1523/JNEUROSCI.3170-04.2005; Trang T, 2009, J NEUROSCI, V29, P3518, DOI 10.1523/JNEUROSCI.5714-08.2009; Tsuda M, 2003, NATURE, V424, P778, DOI 10.1038/nature01786; Tsuda M, 2010, BRAIN RES REV, V63, P222, DOI 10.1016/j.brainresrev.2009.11.003; Ulmann L, 2008, J NEUROSCI, V28, P11263, DOI 10.1523/JNEUROSCI.2308-08.2008; Vanderah TW, 2001, J NEUROSCI, V21, P279, DOI 10.1523/JNEUROSCI.21-01-00279.2001; Vargas-Perez H, 2009, SCIENCE, V324, P1732, DOI 10.1126/science.1168501; Wang XH, 2012, P NATL ACAD SCI USA, V109, P6325, DOI 10.1073/pnas.1200130109; Wang Y, 2012, NAT MED, V18, P385, DOI 10.1038/nm.2633; Woolf CJ, 2000, SCIENCE, V288, P1765, DOI 10.1126/science.288.5472.1765; Xu J, 2011, MOL PAIN, V7, DOI 10.1186/1744-8069-7-9; Zeilhofer HU, 2012, ANNU REV PHARMACOL, V52, P111, DOI 10.1146/annurev-pharmtox-010611-134636; Zeng JS, 2006, J NEUROSCI, V26, P12033, DOI 10.1523/JNEUROSCI.2530-06.2006; Zhao J, 2006, MOL CELL NEUROSCI, V31, P539, DOI 10.1016/j.mcn.2005.11.008; Zhao P, 2007, J NEUROSCI, V27, P2357, DOI 10.1523/JNEUROSCI.0138-07.2007	50	279	289	3	117	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	FEB	2013	16	2					183	192		10.1038/nn.3295	http://dx.doi.org/10.1038/nn.3295			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	080RE	23292683	Green Accepted, Green Submitted			2022-12-28	WOS:000314260200015
J	Han, L; Ma, C; Liu, Q; Weng, HJ; Cui, YY; Tang, ZX; Kim, YS; Nie, H; Qu, LT; Patel, KN; Li, Z; McNeil, B; He, SQ; Guan, Y; Xiao, B; LaMotte, RH; Dong, XZ				Han, Liang; Ma, Chao; Liu, Qin; Weng, Hao-Jui; Cui, Yiyuan; Tang, Zongxiang; Kim, Yushin; Nie, Hong; Qu, Lintao; Patel, Kush N.; Li, Zhe; McNeil, Benjamin; He, Shaoqiu; Guan, Yun; Xiao, Bo; LaMotte, Robert H.; Dong, Xinzhong			A subpopulation of nociceptors specifically linked to itch	NATURE NEUROSCIENCE			English	Article							DIPHTHERIA-TOXIN RECEPTOR; NEURONS; PAIN; MICE; PRURITOGENS; SENSATIONS; EXPRESSION; HISTAMINE; CAPSAICIN; RESPONSES	Itch-specific neurons have been sought for decades. The existence of such neurons has been doubted recently as a result of the observation that itch-mediating neurons also respond to painful stimuli. We genetically labeled and manipulated MrgprA3(+) neurons in the dorsal root ganglion (DRG) and found that they exclusively innervated the epidermis of the skin and responded to multiple pruritogens. Ablation of MrgprA3(+) neurons led to substantial reductions in scratching evoked by multiple pruritogens and occurring spontaneously under chronic itch conditions, whereas pain sensitivity remained intact. Notably, mice in which TRPV1 was exclusively expressed in MrgprA3(+) neurons exhibited itch, but not pain, behavior in response to capsaicin. Although MrgprA3(+) neurons were sensitive to noxious heat, activation of TRPV1 in these-neurons by noxious heat did not alter pain behavior. These data suggest that MrgprA3 defines a specific subpopulation of DRG neurons mediating itch. Our study opens new avenues for studying itch and developing anti-pruritic therapies.	[Han, Liang; Liu, Qin; Weng, Hao-Jui; Tang, Zongxiang; Kim, Yushin; Patel, Kush N.; Li, Zhe; McNeil, Benjamin; Dong, Xinzhong] Johns Hopkins Univ, Sch Med, Ctr Sensory Biol, Solomon H Snyder Dept Neurosci, Baltimore, MD USA; [Ma, Chao] Chinese Acad Med Sci, Inst Basic Med Sci, Dept Anat Histol & Embryol, Sch Basic Med,Peking Union Med Coll, Beijing 100730, Peoples R China; [Ma, Chao; Nie, Hong; Qu, Lintao; LaMotte, Robert H.] Yale Univ, Sch Med, Dept Anesthesiol, New Haven, CT 06510 USA; [Liu, Qin; Weng, Hao-Jui; Tang, Zongxiang; Patel, Kush N.; Dong, Xinzhong] Johns Hopkins Univ, Sch Med, Howard Hughes Med Inst, Baltimore, MD 21205 USA; [Cui, Yiyuan; Xiao, Bo] Sichuan Univ, W China Hosp, State Key Lab Biotherapy, Chengdu 610064, Peoples R China; [Nie, Hong] Jinan Univ, Coll Pharm, Guangdong Prov Key Lab Pharmacodynam Constituents, Guangzhou, Guangdong, Peoples R China; [He, Shaoqiu; Guan, Yun] Johns Hopkins Univ, Sch Med, Dept Anesthesiol & Crit Care Med, Baltimore, MD 21205 USA	Johns Hopkins University; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Institute of Basic Medical Sciences - CAMS; Yale University; Howard Hughes Medical Institute; Johns Hopkins University; Sichuan University; Jinan University; Johns Hopkins University	LaMotte, RH (corresponding author), Yale Univ, Sch Med, Dept Anesthesiol, New Haven, CT 06510 USA.	robert.lamotte@yale.edu; xdong2@jhmi.edu		McNeil, Benjamin/0000-0001-7545-3598; Weng, Hao-Jui/0000-0002-7006-7599; Han, Liang/0000-0001-8674-6433; Xiao, Bo/0000-0002-6161-9478	US National Institutes of Health [NS054791, GM087369, NS047399, NS014624, NS070814]; NATIONAL EYE INSTITUTE [T32EY017203] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM087369] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS014624, R01NS070814, R01NS054791, P01NS047399] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank C. Hawkins and the staff of Transgenic Mouse Core at Johns Hopkins University School of Medicine for assistance with BAC transgenic mouse generation. We thank D. Anderson (California Institute of Technology) and M. Zylka (University of North Carolina at Chapel Hill) for providing Mrgprd<SUP>GFP/+</SUP> mice and A. Guler (University of Washington) for providing Rosa26<SUP>Trpv1</SUP> mice. The work was supported by grants from the US National Institutes of Health to X.D. (NS054791 and GM087369), R.L. (NS047399 and NS014624) and Y.G. (NS070814). X.D. is an Early Career Scientist of the Howard Hughes Medical Institute.	Abrahamsen B, 2008, SCIENCE, V321, P702, DOI 10.1126/science.1156916; Akiyama T, 2010, J NEUROPHYSIOL, V104, P2442, DOI 10.1152/jn.00563.2010; Arenkiel BR, 2008, NAT METHODS, V5, P299, DOI [10.1038/NMETH.1190, 10.1038/nmeth.1190]; Barth AL, 2004, J NEUROSCI, V24, P6466, DOI 10.1523/JNEUROSCI.4737-03.2004; Basbaum AI, 2009, CELL, V139, P267, DOI 10.1016/j.cell.2009.09.028; Buch T, 2005, NAT METHODS, V2, P419, DOI 10.1038/NMETH762; Caterina MJ, 2000, SCIENCE, V288, P306, DOI 10.1126/science.288.5464.306; Davidson S, 2010, TRENDS NEUROSCI, V33, P550, DOI 10.1016/j.tins.2010.09.002; Di Nardo A, 1998, ACTA DERM-VENEREOL, V78, P27; Dong XZ, 2001, CELL, V106, P619, DOI 10.1016/S0092-8674(01)00483-4; Finger Stanley, 2002, J Hist Neurosci, V11, P234, DOI 10.1076/jhin.11.3.234.10392; GREEN BG, 1990, PERCEPT PSYCHOPHYS, V48, P12, DOI 10.3758/BF03205007; Guler AD, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1749; Ikoma A, 2006, NAT REV NEUROSCI, V7, P535, DOI 10.1038/nrn1950; Imamachi N, 2009, P NATL ACAD SCI USA, V106, P11330, DOI 10.1073/pnas.0905605106; Johanek LM, 2008, J NEUROSCI, V28, P7659, DOI 10.1523/JNEUROSCI.1760-08.2008; Krajnik M, 2001, J PAIN SYMPTOM MANAG, V21, P151, DOI 10.1016/S0885-3924(00)00256-6; Lagerstrom MC, 2010, NEURON, V68, P529, DOI 10.1016/j.neuron.2010.09.016; LaMotte RH, 2009, J NEUROPHYSIOL, V101, P1430, DOI 10.1152/jn.91268.2008; Liu Q, 2012, J NEUROSCI, V32, P14532, DOI 10.1523/JNEUROSCI.3509-12.2012; Liu Q, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001925; Liu Q, 2009, CELL, V139, P1353, DOI 10.1016/j.cell.2009.11.034; Liu Y, 2008, J NEUROSCI, V28, P125, DOI 10.1523/JNEUROSCI.4472-07.2008; Liu Y, 2010, NEURON, V68, P543, DOI 10.1016/j.neuron.2010.09.008; Ma C, 2012, J NEUROPHYSIOL, V107, P357, DOI 10.1152/jn.00801.2011; Ma C, 2010, J NEUROSCI METH, V191, P60, DOI 10.1016/j.jneumeth.2010.06.010; Madisen L, 2010, NAT NEUROSCI, V13, P133, DOI 10.1038/nn.2467; MCMAHON SB, 1992, TRENDS NEUROSCI, V15, P497, DOI 10.1016/0166-2236(92)90102-E; McQueen DS, 2007, BRIT J PHARMACOL, V151, P278, DOI 10.1038/sj.bjp.0707216; Miyamoto T, 2002, JPN J PHARMACOL, V88, P285, DOI 10.1254/jjp.88.285; NAGLICH JG, 1992, CELL, V69, P1051, DOI 10.1016/0092-8674(92)90623-K; Namer B, 2008, J NEUROPHYSIOL, V100, P2062, DOI 10.1152/jn.90482.2008; Ono SJ, 2005, J ALLERGY CLIN IMMUN, V115, P118, DOI 10.1016/j.jaci.2004.10.042; Ross SE, 2010, NEURON, V65, P886, DOI 10.1016/j.neuron.2010.02.025; Saint-Mezard P, 2004, EUR J DERMATOL, V14, P284; Saito M, 2001, NAT BIOTECHNOL, V19, P746, DOI 10.1038/90795; Schmelz M, 2003, J NEUROPHYSIOL, V89, P2441, DOI 10.1152/jn.01139.2002; Schmelz M, 1997, J NEUROSCI, V17, P8003; Shimada SG, 2008, PAIN, V139, P681, DOI 10.1016/j.pain.2008.08.002; Shinohara T, 2004, J BIOL CHEM, V279, P23559, DOI 10.1074/jbc.M314240200; Sikand P, 2011, PAIN, V152, P2485, DOI 10.1016/j.pain.2011.06.001; Sikand P, 2011, J NEUROSCI, V31, P7563, DOI 10.1523/JNEUROSCI.1192-11.2011; Sikand P, 2009, PAIN, V144, P66, DOI 10.1016/j.pain.2009.03.001; Skoner DR, 2001, J ALLERGY CLIN IMMUN, V108, pS2, DOI 10.1067/mai.2001.115569; Sun YG, 2007, NATURE, V448, P700, DOI 10.1038/nature06029; Sun YG, 2009, SCIENCE, V325, P1531, DOI 10.1126/science.1174868; Wilson SR, 2011, NAT NEUROSCI, V14, P595, DOI 10.1038/nn.2789; Yamaguchi T, 1999, NEUROSCI RES, V35, P77, DOI 10.1016/S0168-0102(99)00070-X; Zylka MJ, 2005, NEURON, V45, P17, DOI 10.1016/j.neuron.2004.12.015; Zylka MJ, 2003, P NATL ACAD SCI USA, V100, P10043, DOI 10.1073/pnas.1732949100	50	356	371	1	145	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	FEB	2013	16	2					174	182		10.1038/nn.3289	http://dx.doi.org/10.1038/nn.3289			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	080RE	23263443	Green Accepted			2022-12-28	WOS:000314260200014
J	Froemke, RC; Carcea, I; Barker, AJ; Yuan, K; Seybold, BA; Martins, ARO; Zaika, N; Bernstein, H; Wachs, M; Levis, PA; Polley, DB; Merzenich, MM; Schreiner, CE				Froemke, Robert C.; Carcea, Ioana; Barker, Alison J.; Yuan, Kexin; Seybold, Bryan A.; Martins, Ana Raquel O.; Zaika, Natalya; Bernstein, Hannah; Wachs, Megan; Levis, Philip A.; Polley, Daniel B.; Merzenich, Michael M.; Schreiner, Christoph E.			Long-term modification of cortical synapses improves sensory perception	NATURE NEUROSCIENCE			English	Article							PRIMARY AUDITORY-CORTEX; SPECTROTEMPORAL RECEPTIVE-FIELDS; VISUAL-CORTEX; SYNAPTIC PLASTICITY; NUCLEUS BASALIS; DEPENDENT PLASTICITY; MAP PLASTICITY; DISCRIMINATION; STIMULATION; RAT	Synapses and receptive fields of the cerebral cortex are plastic. However, changes to specific inputs must be coordinated within neural networks to ensure that excitability and feature selectivity are appropriately configured for perception of the sensory environment. We induced long-lasting enhancements and decrements to excitatory synaptic strength in rat primary auditory cortex by pairing acoustic stimuli with activation of the nucleus basalis neuromodulatory system. Here we report that these synaptic modifications were approximately balanced across individual receptive fields, conserving mean excitation while reducing overall response variability. Decreased response variability should increase detection and recognition of near-threshold or previously imperceptible stimuli. We confirmed both of these hypotheses in behaving animals. Thus, modification of cortical inputs leads to wide-scale synaptic changes, which are related to improved sensory perception and enhanced behavioral performance.	[Froemke, Robert C.; Carcea, Ioana; Martins, Ana Raquel O.; Zaika, Natalya; Bernstein, Hannah] NYU, Sch Med, Dept Physiol & Neurosci,Skirball Inst Biomol Med, Mol Neurobiol Program,Helen & Martin Kimmel Ctr B, New York, NY 10012 USA; [Froemke, Robert C.; Carcea, Ioana; Martins, Ana Raquel O.; Zaika, Natalya; Bernstein, Hannah] NYU, Sch Med, Dept Otolaryngol, New York, NY USA; [Froemke, Robert C.; Carcea, Ioana; Martins, Ana Raquel O.] NYU, Ctr Neural Sci, New York, NY 10003 USA; [Froemke, Robert C.; Barker, Alison J.; Yuan, Kexin; Seybold, Bryan A.; Merzenich, Michael M.; Schreiner, Christoph E.] Univ Calif San Francisco, Coleman Mem Lab, San Francisco, CA 94143 USA; [Froemke, Robert C.; Barker, Alison J.; Yuan, Kexin; Seybold, Bryan A.; Merzenich, Michael M.; Schreiner, Christoph E.] Univ Calif San Francisco, Dept Otolaryngol, Neurosci Grad Grp, WM Keck Fdn Ctr Integrat Neurosci, San Francisco, CA 94143 USA; [Martins, Ana Raquel O.] Univ Coimbra, Ctr Neurosci & Cell Biol, PhD Program Expt Biol & Biomed, P-3000 Coimbra, Portugal; [Wachs, Megan; Levis, Philip A.] Stanford Univ, Dept Elect Engn, Comp Syst Lab, Palo Alto, CA 94304 USA; [Wachs, Megan; Levis, Philip A.] Stanford Univ, Dept Comp Sci, Comp Syst Lab, Palo Alto, CA 94304 USA; [Polley, Daniel B.] Harvard Univ, Sch Med, Dept Otol & Laryngol, Eaton Peabody Lab,Massachusetts Eye & Ear Infirm, Boston, MA 02115 USA	New York University; New York University; New York University; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Universidade de Coimbra; Stanford University; Stanford University; Harvard University; Harvard Medical School; Massachusetts Eye & Ear Infirmary	Froemke, RC (corresponding author), NYU, Sch Med, Dept Physiol & Neurosci,Skirball Inst Biomol Med, Mol Neurobiol Program,Helen & Martin Kimmel Ctr B, New York, NY 10012 USA.	robert.froemke@med.nyu.edu	Barker, Alison/AAH-1905-2021	Barker, Alison/0000-0001-9103-9258; Froemke, Robert/0000-0002-1230-6811; Seybold, Bryan/0000-0001-6081-8347; Polley, Daniel/0000-0002-5120-2409; Schreiner, Christoph/0000-0002-4571-4328; Bernstein, Hannah/0000-0002-6512-1378	US National Institute on Deafness and Other Communication Disorders [DC009635, DC009836, DC02260]; US National Science Foundation [0615308, 0627126]; Intel Research; DoCoMo Capital; Conte Center for Neuroscience Research at the University of California, San Francisco [MH077970]; Hearing Research Inc.; John C. and Edward Coleman Fund; US National Academies Keck Future Initiatives; US National Science Foundation Predoctoral Fellowship; Sequoia Capital Stanford Graduate Fellowship; US National Institute of Mental Health training grant; Microsoft Research New Faculty Fellowship; Sloan Research Fellowship; Foundation Capital; NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH077970] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC009836, K99DC009635, R01DC012557, R01DC002260, R00DC009635] Funding Source: NIH RePORTER; Division Of Computer and Network Systems [0846014] Funding Source: National Science Foundation	US National Institute on Deafness and Other Communication Disorders(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); US National Science Foundation(National Science Foundation (NSF)); Intel Research(Intel Corporation); DoCoMo Capital; Conte Center for Neuroscience Research at the University of California, San Francisco; Hearing Research Inc.; John C. and Edward Coleman Fund; US National Academies Keck Future Initiatives; US National Science Foundation Predoctoral Fellowship(National Science Foundation (NSF)); Sequoia Capital Stanford Graduate Fellowship; US National Institute of Mental Health training grant; Microsoft Research New Faculty Fellowship(Microsoft); Sloan Research Fellowship(Alfred P. Sloan Foundation); Foundation Capital; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); Division Of Computer and Network Systems(National Science Foundation (NSF)NSF - Directorate for Computer & Information Science & Engineering (CISE))	We thank L. F. Abbott, T. Babcock, M. Berry, E. Chang, Z. Chen, E. de Villers-Sidani, A. L. Dorrn, P. Dutta, A. Fairhall, S. P. Gandhi, G. Glassner, C. A. Hoeffer, K. Imaizumi, B.J. Jones, N. Kopell, R. Liu, G. Myers, P. O'Hara, J. Shih, A.Y. Tan, C.-L. Teng and L. Wilbrecht for comments, discussions and technical assistance. J. Pivkova created the artwork in Figure 1a. This work was supported by the US National Institute on Deafness and Other Communication Disorders (grant DC009635 to R. C. F., grant DC009836 to D. B. P. and grant DC02260 to C. E. S.), US National Science Foundation (grants 0615308 and 0627126 to P. A. L.), Intel Research (P. A. L.), DoCoMo Capital and Foundation Capital (P. A. L.), the Conte Center for Neuroscience Research at the University of California, San Francisco (grant MH077970 to M. M. M. and C. E. S.), Hearing Research Inc. (C. E. S.), the John C. and Edward Coleman Fund (M. M. M. and C. E. S.) and the US National Academies Keck Future Initiatives (R. C. F. and P. A. L.). A. J. B. is supported by a US National Science Foundation Predoctoral Fellowship. M. W. is supported by a Sequoia Capital Stanford Graduate Fellowship. I. C. is supported by an US National Institute of Mental Health training grant. P. A. L. is supported by a Microsoft Research New Faculty Fellowship. R. C. F. is supported by a Sloan Research Fellowship.	Abbott LF, 2000, NAT NEUROSCI, V3, P1178, DOI 10.1038/81453; Averbeck BB, 2006, NAT REV NEUROSCI, V7, P358, DOI 10.1038/nrn1888; Bakin JS, 1996, P NATL ACAD SCI USA, V93, P11219, DOI 10.1073/pnas.93.20.11219; Brown M, 2004, CEREB CORTEX, V14, P952, DOI 10.1093/cercor/bhh056; Buonomano DV, 1998, ANNU REV NEUROSCI, V21, P149, DOI 10.1146/annurev.neuro.21.1.149; Cohen MR, 2009, NAT NEUROSCI, V12, P1594, DOI 10.1038/nn.2439; Dahmen Johannes C, 2008, J Neurosci, V28, P13629, DOI 10.1523/JNEUROSCI.4429-08.2008; Dan Y, 2006, PHYSIOL REV, V86, P1033, DOI 10.1152/physrev.00030.2005; de Villers-Sidani E, 2007, J NEUROSCI, V27, P180, DOI 10.1523/JNEUROSCI.3227-06.2007; Desai NS, 2002, NAT NEUROSCI, V5, P783, DOI 10.1038/nn878; Deweese MR, 2004, J NEUROPHYSIOL, V92, P1840, DOI 10.1152/jn.00197.2004; Dorrn AL, 2010, NATURE, V465, P932, DOI 10.1038/nature09119; EDELINE JM, 1993, BEHAV NEUROSCI, V107, P82, DOI 10.1037/0735-7044.107.1.82; Elhilali M, 2007, J NEUROSCI, V27, P10372, DOI 10.1523/JNEUROSCI.1462-07.2007; Feldman DE, 2005, SCIENCE, V310, P810, DOI 10.1126/science.1115807; FREGNAC Y, 1988, NATURE, V333, P367, DOI 10.1038/333367a0; Fries P, 2001, SCIENCE, V291, P1560, DOI 10.1126/science.1055465; Fritz J, 2005, HEARING RES, V206, P159, DOI 10.1016/j.heares.2005.01.015; Fritz J, 2003, NAT NEUROSCI, V6, P1216, DOI 10.1038/nn1141; Froemke RC, 2007, NATURE, V450, P425, DOI 10.1038/nature06289; Goard M, 2009, NAT NEUROSCI, V12, P1444, DOI 10.1038/nn.2402; GREUEL JM, 1988, SCIENCE, V242, P74, DOI 10.1126/science.2902687; Han YK, 2007, NAT NEUROSCI, V10, P1191, DOI 10.1038/nn1941; Hasselmo ME, 2011, NEUROPSYCHOPHARMACOL, V36, P52, DOI 10.1038/npp.2010.104; Hirsch JA, 2006, TRENDS NEUROSCI, V29, P30, DOI 10.1016/j.tins.2005.11.001; HUBEL DH, 1962, J PHYSIOL-LONDON, V160, P106, DOI 10.1113/jphysiol.1962.sp006837; Huberman AD, 2008, ANNU REV NEUROSCI, V31, P479, DOI 10.1146/annurev.neuro.31.060407.125533; Hubener M, 2010, NEURON, V67, P363, DOI 10.1016/j.neuron.2010.06.033; Jacob V, 2007, J NEUROSCI, V27, P1271, DOI 10.1523/JNEUROSCI.4264-06.2007; Katz LC, 1996, SCIENCE, V274, P1133, DOI 10.1126/science.274.5290.1133; Lee MG, 2005, J NEUROSCI, V25, P4365, DOI 10.1523/JNEUROSCI.0178-05.2005; Li Y, 2008, NATURE, V456, P952, DOI 10.1038/nature07417; Lin SC, 2008, NEURON, V59, P138, DOI 10.1016/j.neuron.2008.04.031; Liu RC, 2007, PLOS BIOL, V5, P1426, DOI 10.1371/journal.pbio.0050173; Martin SJ, 2000, ANNU REV NEUROSCI, V23, P649, DOI 10.1146/annurev.neuro.23.1.649; McLin DE, 2002, P NATL ACAD SCI USA, V99, P4002, DOI 10.1073/pnas.062057099; Meliza CD, 2006, NEURON, V49, P183, DOI 10.1016/j.neuron.2005.12.009; METHERATE R, 1993, SYNAPSE, V14, P132, DOI 10.1002/syn.890140206; Polley DB, 2004, P NATL ACAD SCI USA, V101, P16351, DOI 10.1073/pnas.0407586101; Reed A, 2011, NEURON, V70, P121, DOI 10.1016/j.neuron.2011.02.038; Royer S, 2003, NATURE, V422, P518, DOI 10.1038/nature01530; Rumsey CC, 2004, J NEUROPHYSIOL, V91, P2273, DOI 10.1152/jn.00900.2003; Shuler MG, 2006, SCIENCE, V311, P1606, DOI 10.1126/science.1123513; Smith GB, 2009, PHILOS T R SOC B, V364, P357, DOI 10.1098/rstb.2008.0198; Talwar SK, 2001, J NEUROPHYSIOL, V86, P1555, DOI 10.1152/jn.2001.86.4.1555; TANNER WP, 1954, PSYCHOL REV, V61, P401, DOI 10.1037/h0058700; Toyoizumi T, 2009, J NEUROSCI, V29, P6514, DOI 10.1523/JNEUROSCI.0492-08.2009; Wright BA, 2010, J NEUROSCI, V30, P12868, DOI 10.1523/JNEUROSCI.0487-10.2010; Ye CQ, 2010, J NEUROSCI, V30, P1861, DOI 10.1523/JNEUROSCI.3088-09.2010; Zaborszky L, 1999, ANN NY ACAD SCI, V877, P339, DOI 10.1111/j.1749-6632.1999.tb09276.x	50	130	133	1	44	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JAN	2013	16	1					79	U120		10.1038/nn.3274	http://dx.doi.org/10.1038/nn.3274			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	058KZ	23178974	Green Accepted, Green Submitted			2022-12-28	WOS:000312633900016
J	Barker, JM; Torregrossa, MM; Taylor, JR				Barker, Jacqueline M.; Torregrossa, Mary M.; Taylor, Jane R.			Low prefrontal PSA-NCAM confers risk for alcoholism-related behavior	NATURE NEUROSCIENCE			English	Article							INDUCTION; BDNF	The factors underlying vulnerability to alcoholism are largely unknown. We identified in rodents an innate endophenotype predicting individual risk for alcohol-related behaviors that was associated with decreased expression of the neuroplasticity-related polysialylated neural cell adhesion molecule (PSA-NCAM). Depletion of PSA-NCAM in the ventromedial prefrontal cortex was sufficient to render mice unable to extinguish alcohol seeking, indicating a causal role of naturally occurring variation. These data suggest a mechanism of aberrant prefrontal neuroplasticity that underlies enhanced propensity for inflexible addiction-related behavior.	[Barker, Jacqueline M.; Torregrossa, Mary M.; Taylor, Jane R.] Yale Univ, Sch Med, Dept Psychiat,Connecticut Mental Hlth Ctr, Div Mol Psychiat,Ctr Genes & Behav,Abraham Ribico, New Haven, CT 06520 USA; [Barker, Jacqueline M.] Yale Univ, Interdept Neurosci Program, New Haven, CT USA	Yale University; Yale University	Taylor, JR (corresponding author), Yale Univ, Sch Med, Dept Psychiat,Connecticut Mental Hlth Ctr, Div Mol Psychiat,Ctr Genes & Behav,Abraham Ribico, New Haven, CT 06520 USA.	jane.taylor@yale.edu	Barker, Jacqueline/AAK-9907-2021; Torregrossa, Mary/AAW-6740-2020; Torregrossa, Mary/N-6053-2017	Torregrossa, Mary/0000-0003-2083-0231; Torregrossa, Mary/0000-0003-2083-0231; Barker, Jacqueline/0000-0002-1176-5397	National Institutes of Health grants [P50 AA012870, R01 DA011717, F31 AA020135, K01 DA031745]; Connecticut Department of Mental Health and Addiction Services; National Institute of Child Health and Human Development; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [P50AA012870, F31AA020135] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA011717, K01DA031745] Funding Source: NIH RePORTER	National Institutes of Health grants(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Connecticut Department of Mental Health and Addiction Services; National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This research was supported by National Institutes of Health grants P50 AA012870 (J.R.T.), R01 DA011717 (J.R.T.), F31 AA020135 (J.M.B.) and K01 DA031745 (M.M.T.), and the Connecticut Department of Mental Health and Addiction Services. The PSA-NCAM antibody developed by T.M. Jessell, J. Dodd and S. Brenner-Morton (Center for Neurobiology and Behavior, Columbia University) was obtained from the Developmental Studies Hybridoma Bank developed under the auspices of the National Institute of Child Health and Human Development and maintained by the University of Iowa.	Balleine BW, 1998, NEUROPHARMACOLOGY, V37, P407, DOI 10.1016/S0028-3908(98)00033-1; Berridge KC, 2003, TRENDS NEUROSCI, V26, P507, DOI 10.1016/S0166-2236(03)00233-9; Bontanti L., 2006, PROG NEUROBIOL, V80, P129; Conboy L, 2010, ADV EXP MED BIOL, V663, P271, DOI 10.1007/978-1-4419-1170-4_18; Gourley Shannon L, 2011, Commun Integr Biol, V4, P30, DOI 10.4161/cib.4.1.14083; Graybeal C, 2011, NAT NEUROSCI, V14, P1507, DOI 10.1038/nn.2954; Kareken DA, 2010, NEUROIMAGE, V50, P267, DOI 10.1016/j.neuroimage.2009.11.076; Kochlamazashvili G, 2012, J NEUROSCI, V32, P2263, DOI 10.1523/JNEUROSCI.5103-11.2012; McCool BA, 2011, NEUROPHARMACOLOGY, V61, P1097, DOI 10.1016/j.neuropharm.2010.12.028; Peters J, 2010, SCIENCE, V328, P1288, DOI 10.1126/science.1186909; Senkov O, 2006, J NEUROSCI, V26, P10888, DOI 10.1523/JNEUROSCI.0878-06.2006; Stavro K, 2013, ADDICT BIOL, V18, P203, DOI 10.1111/j.1369-1600.2011.00418.x; Talmi D, 2008, J NEUROSCI, V28, P360, DOI 10.1523/JNEUROSCI.4028-07.2008; Wiggins A, 2011, J NEUROSCI, V31, P16177, DOI 10.1523/JNEUROSCI.3816-11.2011; Yang BZ, 2007, HUM MOL GENET, V16, P2844, DOI 10.1093/hmg/ddm240	15	44	45	0	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	OCT	2012	15	10					1356	1358		10.1038/nn.3194	http://dx.doi.org/10.1038/nn.3194			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	013VZ	22922785	Green Accepted			2022-12-28	WOS:000309335300011
J	Hyde, RA; Strowbridge, BW				Hyde, Robert A.; Strowbridge, Ben W.			Mnemonic representations of transient stimuli and temporal sequences in the rodent hippocampus in vitro	NATURE NEUROSCIENCE			English	Article							WORKING-MEMORY; DENTATE GYRUS; RECURRENT NETWORK; PERSISTENT ACTIVITY; PATTERN SEPARATION; GRANULE CELLS; TO-SAMPLE; MODEL; DYNAMICS; NEURONS	A primary function of the brain is the storage and retrieval of information. Except for working memory, where extracellular recordings have shown persistent discharges during delay-response tasks, it has been difficult to link memories with changes in individual neurons or specific synaptic connections. We found that transient stimuli are reliably encoded in the ongoing activity of brain tissue in vitro. Patterns of synaptic input onto dentate hilar neurons predicted which of four pathways were stimulated with an accuracy of 76% and performed significantly better than chance for > 15 s. Dentate gyrus neurons were also able to accurately encode temporal sequences using population representations that were robust to variation in sequence interval. These results demonstrate direct neural encoding of temporal sequences in the spontaneous activity of brain tissue and suggest a local circuit mechanism that may contribute to diverse forms of short-term memory.	[Hyde, Robert A.; Strowbridge, Ben W.] Case Western Reserve Univ, Dept Neurosci, Cleveland, OH 44106 USA	Case Western Reserve University	Strowbridge, BW (corresponding author), Case Western Reserve Univ, Dept Neurosci, Cleveland, OH 44106 USA.	bens@case.edu			US National Institutes of Health grants [NS33590, DC04285]; US National Institutes of Health training grant [T32-GM007250]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007250] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS033590, R29NS033590] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC004285] Funding Source: NIH RePORTER	US National Institutes of Health grants(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US National Institutes of Health training grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	We thank S. Solla for helpful discussions, and R. Galan and P. Larimer for comments on the manuscript. This work was supported by US National Institutes of Health grants NS33590 and DC04285. R.A.H. was supported by US National Institutes of Health training grant T32-GM007250.	Abbott LF, 1996, CEREB CORTEX, V6, P406, DOI 10.1093/cercor/6.3.406; Acsady L, 1998, J NEUROSCI, V18, P3386; Aksay E, 2007, NAT NEUROSCI, V10, P494, DOI 10.1038/nn1877; Averbeck BB, 2007, J NEUROSCI, V27, P2204, DOI 10.1523/JNEUROSCI.4483-06.2007; Baeg EH, 2003, NEURON, V40, P177, DOI 10.1016/S0896-6273(03)00597-X; Barak O, 2010, J NEUROSCI, V30, P9424, DOI 10.1523/JNEUROSCI.1875-10.2010; BATUEV AS, 1990, BEHAV BRAIN RES, V41, P95, DOI 10.1016/0166-4328(90)90145-5; Beggs JM, 2003, J NEUROSCI, V23, P11167; Branco T, 2010, SCIENCE, V329, P1671, DOI 10.1126/science.1189664; Brunel N, 2001, J COMPUT NEUROSCI, V11, P63, DOI 10.1023/A:1011204814320; Buckmaster PS, 1996, J COMP NEUROL, V366, P270, DOI 10.1002/(SICI)1096-9861(19960304)366:2<270::AID-CNE7>3.0.CO;2-2; Camperi M, 1998, J COMPUT NEUROSCI, V5, P383, DOI 10.1023/A:1008837311948; COLOMBO M, 1994, BEHAV NEUROSCI, V108, P443, DOI 10.1037/0735-7044.108.3.443; Compte A, 2000, CEREB CORTEX, V10, P910, DOI 10.1093/cercor/10.9.910; Crowe DA, 2010, J NEUROSCI, V30, P11640, DOI 10.1523/JNEUROSCI.0954-10.2010; DEADWYLER SA, 1975, J NEUROPHYSIOL, V38, P167, DOI 10.1152/jn.1975.38.1.167; Diesmann M, 1999, NATURE, V402, P529, DOI 10.1038/990101; Egorov AV, 2002, NATURE, V420, P173, DOI 10.1038/nature01171; Fortin NJ, 2002, NAT NEUROSCI, V5, P458, DOI 10.1038/nn834; FUNAHASHI S, 1993, NATURE, V365, P753, DOI 10.1038/365753a0; FUNAHASHI S, 1989, J NEUROPHYSIOL, V61, P331, DOI 10.1152/jn.1989.61.2.331; FUSTER JM, 1981, SCIENCE, V212, P952, DOI 10.1126/science.7233192; Goldman MS, 2009, NEURON, V61, P621, DOI 10.1016/j.neuron.2008.12.012; Goldman MS, 2003, CEREB CORTEX, V13, P1185, DOI 10.1093/cercor/bhg095; Gupta A, 2012, J NEUROSCI, V32, P2523, DOI 10.1523/JNEUROSCI.4141-11.2012; HAMPSON RE, 1993, BEHAV NEUROSCI, V107, P715, DOI 10.1037/0735-7044.107.5.715; Hebb D.O., 1949, ORG BEHAV NEUROPSYCH; Johnson HA, 2010, NAT NEUROSCI, V13, P917, DOI 10.1038/nn.2579; Koulakov AA, 2002, NAT NEUROSCI, V5, P775, DOI 10.1038/nn893; KRNJEVIC K, 1963, J PHYSIOL-LONDON, V166, P328, DOI 10.1113/jphysiol.1963.sp007107; Larimer P, 2010, NAT NEUROSCI, V13, P213, DOI 10.1038/nn.2458; Larimer P, 2008, J NEUROSCI, V28, P12212, DOI 10.1523/JNEUROSCI.3612-08.2008; Leutgeb JK, 2007, SCIENCE, V315, P961, DOI 10.1126/science.1135801; MacLean JN, 2005, NEURON, V48, P811, DOI 10.1016/j.neuron.2005.09.035; MACVICAR BA, 1980, BRAIN RES, V184, P220, DOI 10.1016/0006-8993(80)90602-2; MARR D, 1971, PHILOS T ROY SOC B, V262, P23, DOI 10.1098/rstb.1971.0078; McHugh TJ, 2007, SCIENCE, V317, P94, DOI 10.1126/science.1140263; Mensh BD, 2004, VISION RES, V44, P711, DOI 10.1016/j.visres.2003.10.015; MILES R, 1986, J PHYSIOL-LONDON, V373, P397, DOI 10.1113/jphysiol.1986.sp016055; Miller P, 2003, CEREB CORTEX, V13, P1208, DOI 10.1093/cercor/bhg101; MIYASHITA Y, 1988, NATURE, V331, P68, DOI 10.1038/331068a0; Mongillo G, 2008, SCIENCE, V319, P1543, DOI 10.1126/science.1150769; Nikolic D, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000260; Pressler RT, 2006, NEURON, V49, P889, DOI 10.1016/j.neuron.2006.02.019; ROLLS ET, 1994, PROG BRAIN RES, V102, P335; Seung HS, 1996, P NATL ACAD SCI USA, V93, P13339, DOI 10.1073/pnas.93.23.13339; Seung HS, 2000, NEURON, V26, P259, DOI 10.1016/S0896-6273(00)81155-1; Shu YS, 2003, NATURE, V423, P288, DOI 10.1038/nature01616; Song S, 2005, PLOS BIOL, V3, P507, DOI 10.1371/journal.pbio.0030068; Williams PA, 2007, J NEUROSCI, V27, P13756, DOI 10.1523/JNEUROSCI.4053-07.2007	50	29	29	0	18	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	OCT	2012	15	10					1430	1438		10.1038/nn.3208	http://dx.doi.org/10.1038/nn.3208			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	013VZ	22960934	Green Accepted			2022-12-28	WOS:000309335300024
J	Zeltser, LM; Seeley, RJ; Tschop, MH				Zeltser, Lori M.; Seeley, Randy J.; Tschoep, Matthias H.			Synaptic plasticity in neuronal circuits regulating energy balance	NATURE NEUROSCIENCE			English	Review							ARCUATE NUCLEUS NEURONS; VENTRAL TEGMENTAL AREA; AGOUTI-RELATED PROTEIN; NEUROPEPTIDE-Y; PROOPIOMELANOCORTIN NEURONS; INPUT ORGANIZATION; NPY/AGRP NEURONS; POMC NEURONS; MELANOCORTIN SYSTEM; FRAMESHIFT MUTATION	Maintaining energy balance is of paramount importance for metabolic health and survival. It is achieved through the coordinated regulation of neuronal circuits that control a wide range of physiological processes affecting energy intake and expenditure, such as feeding, metabolic rate, locomotor activity, arousal, growth and reproduction. Neuronal populations distributed throughout the CNS but highly enriched in the mediobasal hypothalamus, sense hormonal, nutrient and neuronal signals of systemic energy status and relay this information to secondary neurons that integrate the information and regulate distinct physiological parameters in a manner that promotes energy homeostasis. To achieve this, it is critical that neuronal circuits provide information about short-term changes in nutrient availability in the larger context of long-term energy status. For example, the same signals lead to different cellular and physiological responses if delivered under fasted versus fed conditions. Thus, there is a clear need to have mechanisms that rapidly and reversibly adjust responsiveness of hypothalamic circuits to acute changes in nutrient availability.	[Tschoep, Matthias H.] Tech Univ Munich, Helmholtz Zentrum Munchen, Inst Diabet & Obes, Munich, Germany; [Tschoep, Matthias H.] Tech Univ Munich, Dept Med, Div Metab Dis, Munich, Germany; [Zeltser, Lori M.] Columbia Univ, Div Mol Genet, Naomi Berrie Diabet Ctr, New York, NY USA; [Zeltser, Lori M.] Columbia Univ, Dept Pathol & Cell Biol, New York, NY USA; [Seeley, Randy J.] Univ Cincinnati, Metab Dis Inst, Cincinnati, OH USA	Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Technical University of Munich; Technical University of Munich; Columbia University; Columbia University; University System of Ohio; University of Cincinnati	Tschop, MH (corresponding author), Tech Univ Munich, Helmholtz Zentrum Munchen, Inst Diabet & Obes, Munich, Germany.	tschoep@helmholtz-muenchen.de	Tschoep, Matthias H/I-5443-2014	Seeley, Randy/0000-0002-3721-5625; Tschoep, Matthias/0000-0002-4744-371X	NIDDK NIH HHS [R01 DK093848, R01 DK089038] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK089038, R01DK093848] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Abizaid A, 2006, NEURON, V51, P691, DOI 10.1016/j.neuron.2006.08.025; Andrews ZB, 2008, NATURE, V454, P846, DOI 10.1038/nature07181; Appelbaum L, 2010, NEURON, V68, P87, DOI 10.1016/j.neuron.2010.09.006; Atasoy D, 2008, J NEUROSCI, V28, P7025, DOI 10.1523/JNEUROSCI.1954-08.2008; Atasoy D, 2012, NATURE, V488, P172, DOI 10.1038/nature11270; Bagnol D, 1999, J NEUROSCI, V19; Baskin DG, 1999, BRAIN RES, V828, P154, DOI 10.1016/S0006-8993(99)01252-4; Baskin DG, 1998, DIABETES, V47, P538, DOI 10.2337/diabetes.47.4.538; Betley JN, 2009, CELL, V139, P161, DOI 10.1016/j.cell.2009.08.027; Chemelli RM, 1999, CELL, V98, P437, DOI 10.1016/S0092-8674(00)81973-X; Cone RD, 2001, INT J OBESITY, V25, pS63, DOI 10.1038/sj.ijo.0801913; Cowley MA, 2003, NEURON, V37, P649, DOI 10.1016/S0896-6273(03)00063-1; Cowley MA, 2003, ANN NY ACAD SCI, V994, P175, DOI 10.1111/j.1749-6632.2003.tb03178.x; Cowley MA, 2001, NATURE, V411, P480, DOI 10.1038/35078085; Crosby KM, 2011, NEURON, V71, P529, DOI 10.1016/j.neuron.2011.06.006; Diano S, 2006, NAT NEUROSCI, V9, P381, DOI 10.1038/nn1656; Diano S, 2011, NAT MED, V17, P1121, DOI 10.1038/nm.2421; Dietrich MO, 2012, NAT NEUROSCI, V15, P1108, DOI 10.1038/nn.3147; Dietrich MO, 2010, J NEUROSCI, V30, P11815, DOI 10.1523/JNEUROSCI.2234-10.2010; Elias CF, 1999, NEURON, V23, P775, DOI 10.1016/S0896-6273(01)80035-0; Enriori PJ, 2007, CELL METAB, V5, P181, DOI 10.1016/j.cmet.2007.02.004; FACCHINETTI F, 1993, DEV BRAIN RES, V74, P219, DOI 10.1016/0165-3806(93)90007-W; Fan W, 1997, NATURE, V385, P165, DOI 10.1038/385165a0; Feldman DE, 2009, ANNU REV NEUROSCI, V32, P33, DOI 10.1146/annurev.neuro.051508.135516; Fioramonti X, 2007, DIABETES, V56, P1219, DOI 10.2337/db06-0567; Gao Q, 2007, NAT MED, V13, P89, DOI 10.1038/nm1525; Glaum SR, 1996, MOL PHARMACOL, V50, P230; Gyengesi E, 2010, ENDOCRINOLOGY, V151, P5395, DOI 10.1210/en.2010-0681; Halaas JL, 1997, P NATL ACAD SCI USA, V94, P8878, DOI 10.1073/pnas.94.16.8878; Hentges ST, 2009, J NEUROSCI, V29, P13684, DOI 10.1523/JNEUROSCI.3770-09.2009; Herlenius E, 2004, EXP NEUROL, V190, pS8, DOI 10.1016/j.expneurol.2004.03.027; Holtmaat A, 2009, NAT REV NEUROSCI, V10, P647, DOI 10.1038/nrn2699; Horvath TL, 2006, OBESITY, V14, P228; Horvath TL, 2010, P NATL ACAD SCI USA, V107, P14875, DOI 10.1073/pnas.1004282107; Horvath TL, 2005, NAT NEUROSCI, V8, P561, DOI 10.1038/nn1453; Horvath TL, 2005, CELL METAB, V1, P279, DOI 10.1016/j.cmet.2005.03.003; Horvath TL, 2004, NAT REV NEUROSCI, V5, P662, DOI 10.1038/nrn1479; HORVATH TL, 1992, ENDOCRINOLOGY, V131, P2461, DOI 10.1210/en.131.5.2461; Horvath TL, 1999, J NEUROSCI, V19, P1072; Huszar D, 1997, CELL, V88, P131, DOI 10.1016/S0092-8674(00)81865-6; Jo YH, 2005, NEURON, V48, P1055, DOI 10.1016/j.neuron.2005.10.021; King CM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025864; Kohno D, 2008, BIOCHEM BIOPH RES CO, V366, P388, DOI 10.1016/j.bbrc.2007.11.166; Korotkova TM, 2006, EUR J NEUROSCI, V23, P2677, DOI 10.1111/j.1460-9568.2006.04792.x; Lim BK, 2012, NATURE, V487, P183, DOI 10.1038/nature11160; Liu J, 2007, ENDOCRINOLOGY, V148, P5531, DOI 10.1210/en.2007-0745; Liu TM, 2012, NEURON, V73, P511, DOI 10.1016/j.neuron.2011.11.027; Luckman SM, 1999, NEUROENDOCRINOLOGY, V70, P93, DOI 10.1159/000054463; Luquet S, 2005, SCIENCE, V310, P683, DOI 10.1126/science.1115524; MATSUMOTO A, 1978, EXP NEUROL, V59, P404, DOI 10.1016/0014-4886(78)90232-7; Mizuno TM, 1998, DIABETES, V47, P294, DOI 10.2337/diabetes.47.2.294; Mountjoy KG, 2003, ANN NY ACAD SCI, V994, P58, DOI 10.1111/j.1749-6632.2003.tb03162.x; MOUNTJOY KG, 1994, MOL ENDOCRINOL, V8, P1298, DOI 10.1210/me.8.10.1298; Munzberg H, 2003, ENDOCRINOLOGY, V144, P2121, DOI 10.1210/en.2002-221037; Munzberg H, 2007, J NEUROSCI, V27, P69, DOI 10.1523/JNEUROSCI.3168-06.2007; Myers MG, 2010, TRENDS ENDOCRIN MET, V21, P643, DOI 10.1016/j.tem.2010.08.002; Naleid AM, 2005, PEPTIDES, V26, P2274, DOI 10.1016/j.peptides.2005.04.025; Ollmann MM, 1997, SCIENCE, V278, P135, DOI 10.1126/science.278.5335.135; Padilla SL, 2012, ENDOCRINOLOGY, V153, P1219, DOI 10.1210/en.2011-1665; Padilla SL, 2010, NAT MED, V16, P403, DOI 10.1038/nm.2126; Pinto S, 2004, SCIENCE, V304, P110, DOI 10.1126/science.1089459; Qiu J, 2010, J NEUROSCI, V30, P1560, DOI 10.1523/JNEUROSCI.4816-09.2010; Roseberry AG, 2004, NEURON, V41, P711, DOI 10.1016/S0896-6273(04)00074-1; Sakurai T, 1998, CELL, V92, P573, DOI 10.1016/S0092-8674(00)80949-6; Saper CB, 2002, NEURON, V36, P199, DOI 10.1016/S0896-6273(02)00969-8; Schwartz MW, 2005, SCIENCE, V307, P375, DOI 10.1126/science.1104344; Smith MA, 2007, J PHYSIOL-LONDON, V578, P425, DOI 10.1113/jphysiol.2006.119479; Sohn JW, 2011, NEURON, V71, P488, DOI 10.1016/j.neuron.2011.06.012; Spanswick D, 1997, NATURE, V390, P521, DOI 10.1038/37379; Sternson SM, 2005, NAT NEUROSCI, V8, P1356, DOI 10.1038/nn1550; Takahashi KA, 2005, ENDOCRINOLOGY, V146, P1043, DOI 10.1210/en.2004-1397; Turrigiano GG, 2004, NAT REV NEUROSCI, V5, P97, DOI 10.1038/nrn1327; Vaisse C, 1998, NAT GENET, V20, P113, DOI 10.1038/2407; van den Top M, 2004, NAT NEUROSCI, V7, P493, DOI 10.1038/nn1226; Vong L, 2011, NEURON, V71, P142, DOI 10.1016/j.neuron.2011.05.028; Williams KW, 2010, J NEUROSCI, V30, P2472, DOI 10.1523/JNEUROSCI.3118-09.2010; Xu YZ, 2012, ENDOCRINOLOGY, V153, P2223, DOI 10.1210/en.2011-2071; Yang YL, 2011, CELL, V146, P991, DOI 10.1016/j.cell.2011.07.039; Yeo GSH, 1998, NAT GENET, V20, P111, DOI 10.1038/2404; Zhang W, 2003, NAT REV NEUROSCI, V4, P885, DOI 10.1038/nrn1248	80	88	88	0	39	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	OCT	2012	15	10					1336	1342		10.1038/nn.3219	http://dx.doi.org/10.1038/nn.3219			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	013VZ	23007188				2022-12-28	WOS:000309335300008
J	Antony, JW; Gobel, EW; O'Hare, JK; Reber, PJ; Paller, KA				Antony, James W.; Gobel, Eric W.; O'Hare, Justin K.; Reber, Paul J.; Paller, Ken A.			Cued memory reactivation during sleep influences skill learning	NATURE NEUROSCIENCE			English	Article							AUDITORY-STIMULATION; PREMOTOR CORTEX; SLOW WAVES; CONSOLIDATION; INTEGRATION; SPINDLES; RECOGNITION; IMPROVEMENT; NETWORK; HUMANS	Information acquired during waking can be reactivated during sleep, promoting memory stabilization. After people learned to produce two melodies in time with moving visual symbols, we enhanced relative performance by presenting one melody during an afternoon nap. Electrophysiological signs of memory processing during sleep corroborated the notion that appropriate auditory stimulation that does not disrupt sleep can nevertheless bias memory consolidation in relevant brain circuitry.	[Antony, James W.; Gobel, Eric W.; Reber, Paul J.; Paller, Ken A.] Northwestern Univ, Interdept Neurosci Program, Evanston, IL 60208 USA; [O'Hare, Justin K.; Reber, Paul J.; Paller, Ken A.] Northwestern Univ, Dept Psychol, Evanston, IL USA	Northwestern University; Northwestern University	Paller, KA (corresponding author), Northwestern Univ, Interdept Neurosci Program, Evanston, IL 60208 USA.	kap@northwestern.edu	Paller, Ken/M-2676-2019	O'Hare, Justin/0000-0002-7363-6064; Paller, Ken/0000-0003-4415-4143	National Science Foundation [BCS1025697]; National Institute of Aging [T32-AG020418]; National Institute of Neurological Diseases and Stroke [T32-NS047987]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [T32NS047987] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [T32AG020506, T32AG020418] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); National Institute of Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Institute of Neurological Diseases and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank B. Mander, J. Saletin, S. Greer and D. Oudiette for technical help. This material is based on work supported by National Science Foundation grant BCS1025697, National Institute of Aging grant T32-AG020418 and National Institute of Neurological Diseases and Stroke grant T32-NS047987.	Baumann S, 2005, ANN NY ACAD SCI, V1060, P186, DOI 10.1196/annals.1360.038; Brawn TP, 2008, LEARN MEMORY, V15, P815, DOI 10.1101/lm.1180908; Dave AS, 2000, SCIENCE, V290, P812, DOI 10.1126/science.290.5492.812; Diekelmann S, 2011, NAT NEUROSCI, V14, P381, DOI 10.1038/nn.2744; Diekelmann S, 2010, NAT REV NEUROSCI, V11, P114, DOI 10.1038/nrn2762; Ferrarelli F, 2007, AM J PSYCHIAT, V164, P483, DOI 10.1176/appi.ajp.164.3.483; Fischer S, 2005, J NEUROSCI, V25, P11248, DOI 10.1523/JNEUROSCI.1743-05.2005; Gallese V, 1996, BRAIN, V119, P593, DOI 10.1093/brain/119.2.593; Gobel EW, 2011, J EXP PSYCHOL LEARN, V37, P994, DOI 10.1037/a0022959; GUERRIEN A, 1989, PHYSIOL BEHAV, V45, P947, DOI 10.1016/0031-9384(89)90219-9; HARS B, 1985, BEHAV BRAIN RES, V18, P241, DOI 10.1016/0166-4328(85)90032-4; Huber R, 2004, NATURE, V430, P78, DOI 10.1038/nature02663; Lahav A, 2007, J NEUROSCI, V27, P308, DOI 10.1523/JNEUROSCI.4822-06.2007; Landsness EC, 2009, SLEEP, V32, P1273; Mander BA, 2011, CURR BIOL, V21, pR183, DOI 10.1016/j.cub.2011.01.019; Nir Y, 2011, NEURON, V70, P153, DOI 10.1016/j.neuron.2011.02.043; Nishida M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000341; Rasch B, 2007, SCIENCE, V315, P1426, DOI 10.1126/science.1138581; Rudoy JD, 2009, SCIENCE, V326, P1079, DOI 10.1126/science.1179013; Sanchez DJ, 2010, PSYCHON B REV, V17, P790, DOI 10.3758/PBR.17.6.790; Shank SS, 2009, NATURE, V458, P73, DOI 10.1038/nature07615; SMITH C, 1990, PSYCHIAT J U OTTAWA, V15, P85; Tamaki M, 2009, CLIN NEUROPHYSIOL, V120, P878, DOI 10.1016/j.clinph.2009.03.006; Walker MP, 2002, NEURON, V35, P205, DOI 10.1016/S0896-6273(02)00746-8; WILSON MA, 1994, SCIENCE, V265, P676, DOI 10.1126/science.8036517	25	177	181	2	67	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	AUG	2012	15	8					1114	+		10.1038/nn.3152	http://dx.doi.org/10.1038/nn.3152			5	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	979UE	22751035	Green Accepted			2022-12-28	WOS:000306844500016
J	Beauchamp, MS; Sun, P; Baum, SH; Tolias, AS; Yoshor, D				Beauchamp, Michael S.; Sun, Ping; Baum, Sarah H.; Tolias, Andreas S.; Yoshor, Daniel			Electrocorticography links human temporoparietal junction to visual perception	NATURE NEUROSCIENCE			English	Article							SPATIAL NEGLECT; ATTENTION; CORTEX	Electrical stimulation of visual cortex can produce a visual percept (phosphene). We electrically stimulated visual cortex in humans implanted with subdural electrodes while recording from other brain sites. Phosphene perception occurred only if stimulation evoked high-frequency gamma oscillations in the temporoparietal junction (TPJ), a brain region associated with visual extinction and neglect. Electrical stimulation of TPJ modified the detectability of low-contrast visual stimuli.	[Beauchamp, Michael S.; Baum, Sarah H.] Univ Texas Hlth Sci Ctr Houston, Dept Neurobiol & Anat, Houston, TX USA; [Sun, Ping; Yoshor, Daniel] Baylor Coll Med, Dept Neurosurg, Houston, TX 77030 USA; [Tolias, Andreas S.] Baylor Coll Med, Dept Neurosci, Houston, TX 77030 USA; [Yoshor, Daniel] St Lukes Episcopal Hosp, Ctr Neurosci, Houston, TX 77030 USA	University of Texas System; University of Texas Health Science Center Houston; Baylor College of Medicine; Baylor College of Medicine; Saint Lukes Episcopal Hospital	Beauchamp, MS (corresponding author), Univ Texas Hlth Sci Ctr Houston, Dept Neurobiol & Anat, Houston, TX USA.	michael.s.beauchamp@uth.tmc.edu; dyoshor@bcm.edu	Beauchamp, Michael/AAK-9813-2020; Miller, Sarah H. Baum/H-3252-2019	Beauchamp, Michael/0000-0002-7599-9934; Miller, Sarah H. Baum/0000-0002-5588-5876	US National Institutes of Health [5R01NS065395]; Veterans Administration Merit Award; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS065395] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Veterans Administration Merit Award; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We are grateful to X. Pei and I. Schepers for assistance with experiment 3. We thank the patients, their families and the staff of St. Luke's Episcopal Hospital for their help. This research was supported by a grant from the US National Institutes of Health (5R01NS065395 to M.S.B.) and a Veterans Administration Merit Award to D.Y.	Corbetta M, 2002, NAT REV NEUROSCI, V3, P201, DOI 10.1038/nrn755; Corbetta M, 2011, ANNU REV NEUROSCI, V34, P569, DOI 10.1146/annurev-neuro-061010-113731; Engel AK, 2001, NAT REV NEUROSCI, V2, P704, DOI 10.1038/35094565; Hilgetag CC, 2001, NAT NEUROSCI, V4, P953, DOI 10.1038/nn0901-953; Karnath HO, 2012, NEUROPSYCHOLOGIA, V50, P1010, DOI 10.1016/j.neuropsychologia.2011.06.027; Kinsbourne M, 1970, Trans Am Neurol Assoc, V95, P143; Murphey DK, 2008, CURR BIOL, V18, P216, DOI 10.1016/j.cub.2008.01.013; Murphey DK, 2009, P NATL ACAD SCI USA, V106, P5389, DOI 10.1073/pnas.0804998106; Penfield W., 1950, CEREBRAL CORTEX MAN; Ray S, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000610; Schiller PH, 2008, PERCEPTION, V37, P1529, DOI 10.1068/p6100; Soltani Maryam, 2000, Critical Reviews in Neurobiology, V14, P199; Umarova RM, 2011, BRAIN, V134, P3310, DOI 10.1093/brain/awr220; Whittingstall K, 2009, NEURON, V64, P281, DOI 10.1016/j.neuron.2009.08.016	14	50	50	0	16	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JUL	2012	15	7					957	959		10.1038/nn.3131	http://dx.doi.org/10.1038/nn.3131			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	966EE	22660480	Green Accepted			2022-12-28	WOS:000305819600012
J	Holderith, N; Lorincz, A; Katona, G; Rozsa, B; Kulik, A; Watanabe, M; Nusser, Z				Holderith, Noemi; Lorincz, Andrea; Katona, Gergely; Rozsa, Balazs; Kulik, Akos; Watanabe, Masahiko; Nusser, Zoltan			Release probability of hippocampal glutamatergic terminals scales with the size of the active zone	NATURE NEUROSCIENCE			English	Article							TRANSMITTER RELEASE; PYRAMIDAL CELLS; NERVE-TERMINALS; SINGLE SYNAPSES; FREEZE-FRACTURE; CALCIUM CURRENT; CA2+ CHANNELS; RECEPTORS; AMPA; DEPENDENCE	Cortical synapses have structural, molecular and functional heterogeneity; our knowledge regarding the relationship between their ultrastructural and functional parameters is still fragmented. Here we asked how the neurotransmitter release probability and presynaptic [Ca2+] transients relate to the ultrastructure of rat hippocampal glutamatergic axon terminals. Two-photon Ca2+ imaging derived optical quantal analysis and correlated electron microscopic reconstructions revealed a tight correlation between the release probability and the active-zone area. Peak amplitude of [Ca2+] transients in single boutons also positively correlated with the active-zone area. Freeze-fracture immunogold labeling revealed that the voltage-gated calcium channel subunit Cav2.1 and the presynaptic protein Rim 1/2 are confined to the active zone and their numbers scale linearly with the active-zone area. Gold particles labeling Cav2.1 were nonrandomly distributed in the active zones. Our results demonstrate that the numbers of several active-zone proteins, including presynaptic calcium channels, as well as the number of docked vesicles and the release probability, scale linearly with the active-zone area.	[Holderith, Noemi; Lorincz, Andrea; Nusser, Zoltan] Hungarian Acad Sci, Inst Expt Med, Lab Cellular Neurophysiol, Budapest, Hungary; [Katona, Gergely; Rozsa, Balazs] Hungarian Acad Sci, Inst Expt Med, Photon Imaging Ctr 2, Budapest, Hungary; [Kulik, Akos] Univ Freiburg, Inst Anat & Cell Biol, Dept Neuroanat, Dept Physiol 2, D-79106 Freiburg, Germany; [Kulik, Akos] Univ Freiburg, Ctr Biol Signaling Studies, D-79106 Freiburg, Germany; [Watanabe, Masahiko] Hokkaido Univ, Sch Med, Dept Anat, Sapporo, Hokkaido 060, Japan	Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Institute of Experimental Medicine; Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Institute of Experimental Medicine; University of Freiburg; University of Freiburg; Hokkaido University	Nusser, Z (corresponding author), Hungarian Acad Sci, Inst Expt Med, Lab Cellular Neurophysiol, Budapest, Hungary.	nusser@koki.hu	Watanabe, Masahiko/S-3614-2019; Nusser, Zoltan/K-8587-2014; WATANABE, Masahiko/A-4055-2012; Balazs, Rozsa/C-6306-2015	Watanabe, Masahiko/0000-0001-5037-7138; WATANABE, Masahiko/0000-0001-5037-7138; Balazs, Rozsa/0000-0003-1427-7003; Nusser, Zoltan/0000-0001-7004-4111; Katona, Gergely/0000-0002-4173-0355	Hungarian Academy of Sciences; Wellcome Trust [083484/Z/07/Z, 090197/Z/09/Z, 094513/Z/10/Z]; European Research Council; Hungarian National Office for Research and Technology-French National Research Agency TeT Fund (NKTH-Neurogen); GOP [1.1.1-08/1-2008-0085]; Deutsche Forschungsgemeinschaft [SFB 780]	Hungarian Academy of Sciences(Hungarian Academy of Sciences); Wellcome Trust(Wellcome TrustEuropean Commission); European Research Council(European Research Council (ERC)European Commission); Hungarian National Office for Research and Technology-French National Research Agency TeT Fund (NKTH-Neurogen)(French National Research Agency (ANR)); GOP; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	N.H. and A.L. are funded by Janos Bolyai Scholarships of the Hungarian Academy of Sciences. Z.N. is supported by Wellcome Trust Equipment (083484/Z/07/Z) and Project Grants (090197/Z/09/Z; 094513/Z/10/Z), a European Research Council Advanced Grant, and a Hungarian National Office for Research and Technology-French National Research Agency TeT Fund (NKTH-Neurogen). B.R. was supported by a GOP grant (1.1.1-08/1-2008-0085). A.K. is supported by a Deutsche Forschungsgemeinschaft (SFB 780) grant. We thank N. Suzuki (Mie University, Japan) for providing Cav2.1<SUP>-/-</SUP> mice, A. Unger for helping with the Cav2.1<SUP>-/-</SUP> replica labeling, E. Dobai and D. Ronaszeki for technical assistance, M. Sumegi for his help with the modeling, members of Synaptic Systems GmbH for providing the rabbit anti-Car2.1 antibody, E. Neher and M. Eyre for their comments on the manuscript, and H. Koester for helpful discussions.	Atwood HL, 2002, NAT REV NEUROSCI, V3, P497, DOI 10.1038/nrn876; ATWOOD HL, 1983, CELL TISSUE RES, V231, P103; Bollmann JH, 2000, SCIENCE, V289, P953, DOI 10.1126/science.289.5481.953; Branco T, 2010, J STRUCT BIOL, V172, P203, DOI 10.1016/j.jsb.2009.10.014; Bucurenciu I, 2008, NEURON, V57, P536, DOI 10.1016/j.neuron.2007.12.026; Bucurenciu I, 2010, NAT NEUROSCI, V13, P19, DOI 10.1038/nn.2461; Christie JM, 2011, NAT NEUROSCI, V14, P62, DOI 10.1038/nn.2718; DELCASTILLO J, 1954, J PHYSIOL-LONDON, V124, P560, DOI 10.1113/jphysiol.1954.sp005129; DiGregorio DA, 1999, J NEUROSCI, V19, P7846; Eggermann E, 2012, NAT REV NEUROSCI, V13, P7, DOI 10.1038/nrn3125; Fedchyshyn MJ, 2005, J NEUROSCI, V25, P4131, DOI 10.1523/JNEUROSCI.0350-05.2005; FIELDS RD, 1985, SCIENCE, V228, P197, DOI 10.1126/science.3975637; Frank T, 2009, P NATL ACAD SCI USA, V106, P4483, DOI 10.1073/pnas.0813213106; Hagiwara A, 2005, J COMP NEUROL, V489, P195, DOI 10.1002/cne.20633; HARRIS KM, 1989, J NEUROSCI, V9, P2982; Hefft S, 2005, NAT NEUROSCI, V8, P1319, DOI 10.1038/nn1542; KATZ B, 1968, J PHYSIOL-LONDON, V195, P481, DOI 10.1113/jphysiol.1968.sp008469; Koester HJ, 2005, SCIENCE, V308, P863, DOI 10.1126/science.1100815; Koester HJ, 2000, J PHYSIOL-LONDON, V529, P625, DOI 10.1111/j.1469-7793.2000.00625.x; KORN H, 1982, J NEUROPHYSIOL, V48, P679, DOI 10.1152/jn.1982.48.3.679; Kulik A, 2004, EUR J NEUROSCI, V19, P2169, DOI 10.1111/j.0953-816X.2004.03319.x; Lisman J, 2003, PHILOS T ROY SOC B, V358, P829, DOI 10.1098/rstb.2002.1242; Liu KSY, 2011, SCIENCE, V334, P1565, DOI 10.1126/science.1212991; LLINAS R, 1992, SCIENCE, V256, P677, DOI 10.1126/science.1350109; LLINAS R, 1981, BIOPHYS J, V33, P323, DOI 10.1016/S0006-3495(81)84899-0; Losonczy A, 2002, J PHYSIOL-LONDON, V542, P193, DOI 10.1113/jphysiol.2002.020024; Masugi-Tokita M, 2007, CURR OPIN NEUROBIOL, V17, P387, DOI 10.1016/j.conb.2007.04.012; Matsuzaki M, 2001, NAT NEUROSCI, V4, P1086, DOI 10.1038/nn736; Meinrenken CJ, 2002, J NEUROSCI, V22, P1648, DOI 10.1523/JNEUROSCI.22-05-01648.2002; Mennerick S, 1996, NEURON, V17, P1241, DOI 10.1016/S0896-6273(00)80254-8; Murthy VN, 2001, NEURON, V32, P673, DOI 10.1016/S0896-6273(01)00500-1; Neher E, 1998, NEURON, V20, P389, DOI 10.1016/S0896-6273(00)80983-6; Nimchinsky EA, 2004, J NEUROSCI, V24, P2054, DOI 10.1523/JNEUROSCI.5066-03.2004; Nusser Z, 1998, NEURON, V21, P545, DOI 10.1016/S0896-6273(00)80565-6; Oertner TG, 2002, NAT NEUROSCI, V5, P657, DOI 10.1038/nn867; Ohana O, 1998, J PHYSIOL-LONDON, V513, P135, DOI 10.1111/j.1469-7793.1998.135by.x; PROPST JW, 1987, J NEUROSCI, V7, P3654; Racca C, 2000, J NEUROSCI, V20, P2512; Reid CA, 1997, J NEUROSCI, V17, P2738; Reyes A, 1998, NAT NEUROSCI, V1, P279, DOI 10.1038/1092; Rozov A, 2001, J PHYSIOL-LONDON, V531, P807, DOI 10.1111/j.1469-7793.2001.0807h.x; Schikorski T, 1997, J NEUROSCI, V17, P5858; Schneggenburger R, 2000, NATURE, V406, P889, DOI 10.1038/35022702; Shepherd GMG, 1998, J NEUROSCI, V18, P8300; Takumi Y, 1999, NAT NEUROSCI, V2, P618, DOI 10.1038/10172; Tanaka J, 2005, J NEUROSCI, V25, P799, DOI 10.1523/JNEUROSCI.4256-04.2005; Thomson AM, 1997, J PHYSIOL-LONDON, V502, P131, DOI 10.1111/j.1469-7793.1997.131bl.x; WHEELER DB, 1994, SCIENCE, V264, P107, DOI 10.1126/science.7832825; WU LG, 1994, J NEUROSCI, V14, P5613; Xu-Friedman MA, 2001, J NEUROSCI, V21, P6666, DOI 10.1523/JNEUROSCI.21-17-06666.2001	50	274	277	0	29	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUL	2012	15	7					988	997		10.1038/nn.3137	http://dx.doi.org/10.1038/nn.3137			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	966EE	22683683	Green Accepted			2022-12-28	WOS:000305819600017
J	Min, R; Nevian, T				Min, Rogier; Nevian, Thomas			Astrocyte signaling controls spike timing-dependent depression at neocortical synapses	NATURE NEUROSCIENCE			English	Article							LONG-TERM POTENTIATION; RAT SOMATOSENSORY CORTEX; SYNAPTIC-TRANSMISSION; D-SERINE; NEUROTRANSMITTER RELEASE; INHIBITORY SYNAPSES; PRESYNAPTIC NMDA; PYRAMIDAL CELLS; GLIAL-CELLS; PLASTICITY	Endocannabinoid mediated spike timing dependent depression (t-LTD) is crucially involved in the development of the sensory neocortex. t-LTD at excitatory synapses in the developing rat barrel cortex requires cannabinoid CBI receptor (CB1R) activation, as well as activation of NMDA receptors located on the presynaptic terminal, but the exact signaling cascade leading to t-LTD remains unclear. We found that astrocytes are critically involved in t-LTD. Astrocytes gradually increased their Ca2+ signaling specifically during the induction of t-LTD in a CB1R-dependent manner. In this way, astrocytes might act as a memory buffer for previous coincident neuronal activity. Following activation, astrocytes released glutamate, which activated presynaptic NMDA receptors to induce t-LTD. Astrocyte stimulation coincident with afferent activity resulted in long-term depression, indicating that astrocyte activation is sufficient for the induction of synaptic depression. Taken together, our findings describe the retrograde signaling cascade underlying neocortical t-LTD. The critical involvement of astrocytes in this process highlights their importance for experience-dependent sensory remodeling.	[Min, Rogier; Nevian, Thomas] Univ Bern, Dept Physiol, CH-3012 Bern, Switzerland	University of Bern	Nevian, T (corresponding author), Univ Bern, Dept Physiol, Buhlpl 5, CH-3012 Bern, Switzerland.	nevian@pyl.unibe.ch	Min, Rogier/C-7137-2012	Min, Rogier/0000-0002-3574-7599; Nevian, Thomas/0000-0001-9804-608X	Swiss National Science Foundation [3100A0-118395]; Berne University Research Foundation	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Berne University Research Foundation	We thank A. Volterra, H.D. Mansvelder, H.-R. Luscher, M. Santello, L.M. Palmer and E. Perez-Garci for their comments on the manuscript. This work was supported by the Swiss National Science Foundation (T.N., grant 3100A0-118395) and an Equipment grant of the Berne University Research Foundation.	Araque A, 1999, TRENDS NEUROSCI, V22, P208, DOI 10.1016/S0166-2236(98)01349-6; Bellocchio EE, 2000, SCIENCE, V289, P957, DOI 10.1126/science.289.5481.957; Bender KJ, 2006, J NEUROSCI, V26, P4155, DOI 10.1523/JNEUROSCI.0175-06.2006; Bender VA, 2006, J NEUROSCI, V26, P4166, DOI 10.1523/JNEUROSCI.0176-06.2006; Bezzi P, 2004, NAT NEUROSCI, V7, P613, DOI 10.1038/nn1246; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; Bodor AL, 2005, J NEUROSCI, V25, P6845, DOI 10.1523/JNEUROSCI.0442-05.2005; Castillo PE, 1997, NATURE, V388, P590, DOI 10.1038/41574; Castillo PE, 2002, NATURE, V415, P327, DOI 10.1038/415327a; Chevaleyre V, 2003, NEURON, V38, P461, DOI 10.1016/S0896-6273(03)00235-6; Chevaleyre V, 2007, NEURON, V54, P801, DOI 10.1016/j.neuron.2007.05.020; Corlew R, 2007, J NEUROSCI, V27, P9835, DOI 10.1523/JNEUROSCI.5494-06.2007; Dan Y, 2006, PHYSIOL REV, V86, P1033, DOI 10.1152/physrev.00030.2005; Duguid I, 2006, CURR OPIN NEUROBIOL, V16, P312, DOI 10.1016/j.conb.2006.05.008; Feldman DE, 2005, SCIENCE, V310, P810, DOI 10.1126/science.1115807; Feldman DE, 2000, NEURON, V27, P45, DOI 10.1016/S0896-6273(00)00008-8; Fortin DA, 2007, CEREB CORTEX, V17, P163, DOI 10.1093/cercor/bhj133; Fourcaudot E, 2008, P NATL ACAD SCI USA, V105, P15130, DOI 10.1073/pnas.0806938105; Froemke RC, 2005, NATURE, V434, P221, DOI 10.1038/nature03366; Genoud C, 2006, PLOS BIOL, V4, P2057, DOI 10.1371/journal.pbio.0040343; Gordon GRJ, 2009, NEURON, V64, P391, DOI 10.1016/j.neuron.2009.10.021; Grosche J, 1999, NAT NEUROSCI, V2, P139, DOI 10.1038/5692; Halassa MM, 2007, J NEUROSCI, V27, P6473, DOI 10.1523/JNEUROSCI.1419-07.2007; Harkany T, 2004, J NEUROSCI, V24, P4978, DOI 10.1523/JNEUROSCI.4884-03.2004; Harvey CD, 2008, SCIENCE, V321, P136, DOI 10.1126/science.1159675; Hashimotodani Y, 2005, NEURON, V45, P257, DOI 10.1016/j.neuron.2005.01.004; Haydon PG, 2006, PHYSIOL REV, V86, P1009, DOI 10.1152/physrev.00049.2005; Heifets BD, 2008, P NATL ACAD SCI USA, V105, P10250, DOI 10.1073/pnas.0711880105; Heifets BD, 2009, ANNU REV PHYSIOL, V71, P283, DOI 10.1146/annurev.physiol.010908.163149; Henneberger C, 2010, NATURE, V463, P232, DOI 10.1038/nature08673; Hill EL, 2007, J NEUROPHYSIOL, V97, P2580, DOI 10.1152/jn.00603.2006; Huang Y, 2008, J NEUROSCI, V28, P7074, DOI 10.1523/JNEUROSCI.0899-08.2008; Jourdain P, 2007, NAT NEUROSCI, V10, P331, DOI 10.1038/nn1849; Kakegawa W, 2011, NAT NEUROSCI, V14, P603, DOI 10.1038/nn.2791; Kang J, 1998, NAT NEUROSCI, V1, P683, DOI 10.1038/3684; Larsen RS, 2011, NAT NEUROSCI, V14, P338, DOI 10.1038/nn.2750; Li L, 2009, NEURON, V64, P537, DOI 10.1016/j.neuron.2009.10.005; Navarrete M, 2008, NEURON, V57, P883, DOI 10.1016/j.neuron.2008.01.029; Navarrete M, 2010, NEURON, V68, P113, DOI 10.1016/j.neuron.2010.08.043; Nevian T, 2006, J NEUROSCI, V26, P11001, DOI 10.1523/JNEUROSCI.1749-06.2006; Panatier A, 2006, CELL, V125, P775, DOI 10.1016/j.cell.2006.02.051; PARPURA V, 1994, NATURE, V369, P744, DOI 10.1038/369744a0; Perea G, 2007, SCIENCE, V317, P1083, DOI 10.1126/science.1144640; Rodriguez-Moreno A, 2008, NAT NEUROSCI, V11, P744, DOI 10.1038/nn.2125; Santello M, 2011, NEURON, V69, P988, DOI 10.1016/j.neuron.2011.02.003; SCHIAVO G, 1992, NATURE, V359, P832, DOI 10.1038/359832a0; Sjostrom PJ, 2003, NEURON, V39, P641, DOI 10.1016/S0896-6273(03)00476-8; Tsetsenis T, 2011, P NATL ACAD SCI USA, V108, P14300, DOI 10.1073/pnas.1112237108; Verkhratsky A, 1996, TRENDS NEUROSCI, V19, P346, DOI 10.1016/0166-2236(96)10048-5; Zilberter M, 2009, CEREB CORTEX, V19, P2308, DOI 10.1093/cercor/bhn247	50	235	236	1	32	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	MAY	2012	15	5					746	753		10.1038/nn.3075	http://dx.doi.org/10.1038/nn.3075			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	932DI	22446881				2022-12-28	WOS:000303270200019
J	Zaki, J; Ochsner, K				Zaki, Jamil; Ochsner, Kevin			The neuroscience of empathy: progress, pitfalls and promise	NATURE NEUROSCIENCE			English	Article							AUTISM SPECTRUM DISORDERS; SOCIAL COGNITION; INDIVIDUAL-DIFFERENCES; NEURAL RESPONSES; MIRROR; OTHERS; SYSTEMS; PAIN; SELF; SIMULATION	The last decade has witnessed enormous growth in the neuroscience of empathy. Here, we survey research in this domain with an eye toward evaluating its strengths and weaknesses. First, we take stock of the notable progress made by early research in characterizing the neural systems supporting two empathic sub-processes: sharing others' internal states and explicitly considering those states. Second, we describe methodological and conceptual pitfalls into which this work has sometimes fallen, which can limit its validity. These include the use of relatively artificial stimuli that differ qualitatively from the social cues people typically encounter and a lack of focus on the relationship between brain activity and social behavior. Finally, we describe current research trends that are overcoming these pitfalls through simple but important adjustments in focus, and the future promise of empathy research if these trends continue and expand.	[Zaki, Jamil] Harvard Univ, Dept Psychol, Cambridge, MA 02138 USA; [Ochsner, Kevin] Columbia Univ, Dept Psychol, New York, NY 10027 USA	Harvard University; Columbia University	Zaki, J (corresponding author), Harvard Univ, Dept Psychol, 33 Kirkland St, Cambridge, MA 02138 USA.	zaki@wjh.harvard.edu; ochsner@psych.columbia.edu	Carroll, Joseph/D-1158-2011	Carroll, Joseph/0000-0003-2656-1378	Templeton Positive Neuroscience Award; National Institute on Drug Abuse [1R01 DA022541-01]; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA022541] Funding Source: NIH RePORTER	Templeton Positive Neuroscience Award; National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	Writing of this paper was supported by a Templeton Positive Neuroscience Award (to J.Z.) and National Institute on Drug Abuse Grant 1R01 DA022541-01 (to K.O.).	Avenanti A, 2005, NAT NEUROSCI, V8, P955, DOI 10.1038/nn1481; Bartz JA, 2011, TRENDS COGN SCI, V15, P301, DOI 10.1016/j.tics.2011.05.002; Batson C.D., 2011, ALTRUISM HUMANS; Blair RJR, 2005, CONSCIOUS COGN, V14, P698, DOI 10.1016/j.concog.2005.06.004; Buckner RL, 2007, TRENDS COGN SCI, V11, P49, DOI 10.1016/j.tics.2006.11.004; Cialdini RB, 1997, J PERS SOC PSYCHOL, V73, P481, DOI 10.1037/0022-3514.73.3.481; Courchesne E, 2005, CURR OPIN NEUROBIOL, V15, P225, DOI 10.1016/j.conb.2005.03.001; Dapretto M, 2006, NAT NEUROSCI, V9, P28, DOI 10.1038/nn1611; DAVIS MH, 1983, J PERS SOC PSYCHOL, V44, P113, DOI 10.1037/0022-3514.44.1.113; de Waal FBM, 2008, ANNU REV PSYCHOL, V59, P279, DOI 10.1146/annurev.psych.59.103006.093625; Ebstein RP, 2010, NEURON, V65, P831, DOI 10.1016/j.neuron.2010.02.020; Fan Y, 2008, NEUROPSYCHOLOGIA, V46, P160, DOI 10.1016/j.neuropsychologia.2007.07.023; Gallese V, 2004, TRENDS COGN SCI, V8, P396, DOI 10.1016/j.tics.2004.07.002; Golan O, 2006, DEV PSYCHOPATHOL, V18, P591, DOI 10.1017/S0954579406060305; Harbaugh WT, 2007, SCIENCE, V316, P1622, DOI 10.1126/science.1140738; Harris LT, 2006, PSYCHOL SCI, V17, P847, DOI 10.1111/j.1467-9280.2006.01793.x; Harvey P.O., SCHIZOPHR B IN PRESS; Hein G, 2010, NEURON, V68, P149, DOI 10.1016/j.neuron.2010.09.003; Henson R, 2006, TRENDS COGN SCI, V10, P64, DOI 10.1016/j.tics.2005.12.005; Ickes W.J., 1997, EMPATHIC ACCURACY; Keysers C, 2007, TRENDS COGN SCI, V11, P194, DOI 10.1016/j.tics.2007.02.002; Keysers C, 2010, NAT REV NEUROSCI, V11, P417, DOI 10.1038/nrn2833; Lamm C, 2010, BRAIN STRUCT FUNCT, V214, P579, DOI 10.1007/s00429-010-0251-3; Leslie AM, 2004, TRENDS COGN SCI, V8, P528, DOI 10.1016/j.tics.2004.10.001; Lombardo MV, 2010, J COGNITIVE NEUROSCI, V22, P1623, DOI 10.1162/jocn.2009.21287; Masten CL, 2011, NEUROIMAGE, V55, P381, DOI 10.1016/j.neuroimage.2010.11.060; Neisser U., 1976, COGNITION REALITY PR; Oberman LM, 2007, PSYCHOL BULL, V133, P310, DOI 10.1037/0033-2909.133.2.310; Philip RCM, 2012, NEUROSCI BIOBEHAV R, V36, P901, DOI 10.1016/j.neubiorev.2011.10.008; Poldrack RA, 2006, TRENDS COGN SCI, V10, P59, DOI 10.1016/j.tics.2005.12.004; Preston S. D., 2002, BEHAV BRAIN SCI, V25, P20, DOI [10.1017/S0140525X02380014, DOI 10.1017/S0140525X023]; Preston SD, 2002, BEHAV BRAIN SCI, V25, P1, DOI 10.1017/S0140525X02000018; Redcay E, 2010, NEUROIMAGE, V50, P1639, DOI 10.1016/j.neuroimage.2010.01.052; Rizzolatti G, 2010, NAT REV NEUROSCI, V11, P264, DOI 10.1038/nrn2805; Saxe R, 2005, TRENDS COGN SCI, V9, P174, DOI 10.1016/j.tics.2005.01.012; Shamay-Tsoory SG, 2009, BRAIN, V132, P617, DOI 10.1093/brain/awn279; Singer T, 2004, SCIENCE, V303, P1157, DOI 10.1126/science.1093535; Spreng RN, 2009, J COGNITIVE NEUROSCI, V21, P489, DOI 10.1162/jocn.2008.21029; Spunt RP, 2012, NEUROIMAGE, V59, P3050, DOI 10.1016/j.neuroimage.2011.10.005; Tomasello M, 2000, CULTURAL ORIGIN HUMA; Van Overwalle F, 2009, NEUROIMAGE, V48, P564, DOI 10.1016/j.neuroimage.2009.06.009; Wagner D.D., 2011, CEREB CORTEX; Wheatley T, 2007, PSYCHOL SCI, V18, P469, DOI 10.1111/j.1467-9280.2007.01923.x; WISPE L, 1986, J PERS SOC PSYCHOL, V50, P314, DOI 10.1037/0022-3514.50.2.314; Wolf I, 2010, NEUROIMAGE, V49, P894, DOI 10.1016/j.neuroimage.2009.08.060; Zaki J, 2007, SOC NEUROSCI-UK, V2, P276, DOI 10.1080/17470910701401973; Zaki J, 2011, PSYCHOL INQ, V22, P159, DOI 10.1080/1047840X.2011.551743; Zaki J, 2011, P NATL ACAD SCI USA, V108, P19761, DOI 10.1073/pnas.1112324108; Zaki J, 2010, J NEUROSCI, V30, P8481, DOI 10.1523/JNEUROSCI.0382-10.2010; Zaki J, 2009, ANN NY ACAD SCI, V1167, P16, DOI 10.1111/j.1749-6632.2009.04601.x; Zaki J, 2009, P NATL ACAD SCI USA, V106, P11382, DOI 10.1073/pnas.0902666106	51	585	591	9	166	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	MAY	2012	15	5					675	680		10.1038/nn.3085	http://dx.doi.org/10.1038/nn.3085			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	932DI	22504346				2022-12-28	WOS:000303270200009
J	Ermolyuk, YS; Alder, FG; Surges, R; Pavlov, IY; Timofeeva, Y; Kullmann, DM; Volynski, KE				Ermolyuk, Yaroslav S.; Alder, Felicity G.; Surges, Rainer; Pavlov, Ivan Y.; Timofeeva, Yulia; Kullmann, Dimitri M.; Volynski, Kirill E.			Differential triggering of spontaneous glutamate release by P/Q-, N- and R-type Ca2+ channels	NATURE NEUROSCIENCE			English	Article							EXCITATORY SYNAPTIC CURRENTS; TRANSMITTER RELEASE; NEUROTRANSMITTER RELEASE; ACTIVE ZONE; CALCIUM-CHANNELS; NERVE-TERMINALS; PYRAMIDAL CELLS; GRANULE CELL; SYNAPSES; MINIATURE	The role of voltage-gated Ca2+ channels (VGCCs) in spontaneous miniature neurotransmitter release is incompletely understood. We found that stochastic opening of P/Q-, N- and R-type VGCCs accounts for -50% of all spontaneous glutamate release at rat cultured hippocampal synapses, and that R-type channels have a far greater role in spontaneous than in action potentialevoked exocytosis. VGCC-dependent miniature neurotransmitter release (minis) showed similar sensitivity to presynaptic Ca2+ chelation as evoked release, arguing for direct triggering of spontaneous release by transient spatially localized Ca2+ domains. Experimentally constrained three-dimensional diffusion modeling of Ca2+ influx-exocytosis coupling was consistent with clustered distribution of VGCCs in the active zone of small hippocampal synapses and revealed that spontaneous VGCCs openings can account for the experimentally observed VGCC-dependent minis, although single channel openings triggered release with low probability. Uncorrelated stochastic VGCC opening is therefore a major trigger for spontaneous glutamate release, with differential roles for distinct channel subtypes.	[Ermolyuk, Yaroslav S.; Alder, Felicity G.; Surges, Rainer; Pavlov, Ivan Y.; Kullmann, Dimitri M.; Volynski, Kirill E.] UCL, Inst Neurol, London, England; [Timofeeva, Yulia] Univ Warwick, Dept Comp Sci, Coventry CV4 7AL, W Midlands, England; [Timofeeva, Yulia] Univ Warwick, Ctr Complex Sci, Coventry CV4 7AL, W Midlands, England	University of London; University College London; University of Warwick; University of Warwick	Volynski, KE (corresponding author), UCL, Inst Neurol, Mortimer St, London, England.	k.volynski@ucl.ac.uk	Pavlov, Ivan/GVT-5113-2022; Timofeeva, Yulia/Z-1618-2019; Kullmann, Dimitri M/A-3162-2009; Pavlov, Ivan/B-5939-2008	Timofeeva, Yulia/0000-0003-3178-7830; Kullmann, Dimitri M/0000-0001-6696-3545; Pavlov, Ivan/0000-0002-9559-4600; Surges, Rainer/0000-0002-3177-8582; Pavlov, Ivan/0000-0003-1266-6988; Volynski, Kirill/0000-0001-8208-1905	Medical Research Council; Wellcome Trust; Biotechnology and Biological Sciences Research Council; German Research Foundation; Brain Research Trust; Special Trustees of the University College London Hospitals National Health Service Foundation Trust; Epilepsy Research UK; Worshipful Company of Pewterers; European Research Council; BBSRC [BB/H011900/1] Funding Source: UKRI; MRC [G0801316, G0600089, G116/147, MR/K000608/1, G0200373] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/H011900/1] Funding Source: researchfish; Medical Research Council [G0801316, G0600089, MR/K000608/1, G0200373, G116/147] Funding Source: researchfish; Action Medical Research [1725] Funding Source: researchfish; Epilepsy Research UK [F0905] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); German Research Foundation(German Research Foundation (DFG)); Brain Research Trust; Special Trustees of the University College London Hospitals National Health Service Foundation Trust; Epilepsy Research UK; Worshipful Company of Pewterers; European Research Council(European Research Council (ERC)European Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Action Medical Research; Epilepsy Research UK	We are grateful to L. Savtchenko for help with stochastic VGCC modeling, to P. Volynslcy for help with Monte-Carlo simulations of VGCC distributions in the active zone, to M. Casio for help with neuronal cultures, to V. Uebele (Merck) for the gift of TTA-P2, and to Y. Ushkaryov, D. Rusakov, C. Henneberger and M. Walker for critical reading of the manuscript. The study was supported by the Medical Research Council, the Wellcome Trust, the Biotechnology and Biological Sciences Research Council, the German Research Foundation, the Brain Research Trust, the European Research Council, the Special Trustees of the University College London Hospitals National Health Service Foundation Trust, Epilepsy Research UK, and The Worshipful Company of Pewterers.	Alle H, 2008, CURR OPIN NEUROBIOL, V18, P314, DOI 10.1016/j.conb.2008.08.006; Ariel P, 2010, FRONT NEURAL CIRCUIT, V4, DOI 10.3389/fncir.2010.00018; Atasoy D, 2008, J NEUROSCI, V28, P10151, DOI 10.1523/JNEUROSCI.2432-08.2008; Atluri PP, 1996, J NEUROSCI, V16, P5661; Banke TG, 2006, J NEUROSCI, V26, P11720, DOI 10.1523/JNEUROSCI.2887-06.2006; Bao JP, 1998, J NEUROSCI, V18, P8740; Bucurenciu I, 2008, NEURON, V57, P536, DOI 10.1016/j.neuron.2007.12.026; Bucurenciu I, 2010, NAT NEUROSCI, V13, P19, DOI 10.1038/nn.2461; Eggermann E, 2012, NAT REV NEUROSCI, V13, P7, DOI 10.1038/nrn3125; Emptage NJ, 2001, NEURON, V29, P197, DOI 10.1016/S0896-6273(01)00190-8; Ermolyuk YS, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001396; Gaffield MA, 2006, NAT PROTOC, V1, P2916, DOI 10.1038/nprot.2006.476; GEPPERT M, 1994, CELL, V79, P717, DOI 10.1016/0092-8674(94)90556-8; Goswami SP, 2012, J NEUROSCI, V32, P14294, DOI 10.1523/JNEUROSCI.6104-11.2012; Groffen AJ, 2010, SCIENCE, V327, P1614, DOI 10.1126/science.1183765; Holderith N, 2012, NAT NEUROSCI, V15, P988, DOI 10.1038/nn.3137; Hoppa MB, 2012, NATURE, V486, P122, DOI 10.1038/nature11033; Kaeser PS, 2011, CELL, V144, P282, DOI 10.1016/j.cell.2010.12.029; Li LY, 2007, J NEUROSCI, V27, P13420, DOI 10.1523/JNEUROSCI.1709-07.2007; Lou XL, 2005, NATURE, V435, P497, DOI 10.1038/nature03568; Matveev V, 2011, BRAIN RES, V1398, P126, DOI 10.1016/j.brainres.2011.05.011; McKinney RA, 1999, NAT NEUROSCI, V2, P44, DOI 10.1038/4548; Meinrenken CJ, 2002, J NEUROSCI, V22, P1648, DOI 10.1523/JNEUROSCI.22-05-01648.2002; MINTZ IM, 1995, NEURON, V15, P675, DOI 10.1016/0896-6273(95)90155-8; Mochida S, 2003, P NATL ACAD SCI USA, V100, P2819, DOI 10.1073/pnas.262787699; Murthy VN, 2001, NEURON, V32, P673, DOI 10.1016/S0896-6273(01)00500-1; Murthy VN, 1999, NAT NEUROSCI, V2, P503, DOI 10.1038/9149; Neher E, 1998, CELL CALCIUM, V24, P345, DOI 10.1016/S0143-4160(98)90058-6; Novak P, 2013, NEURON, V79, P1067, DOI 10.1016/j.neuron.2013.07.012; Ohana O, 1998, J PHYSIOL-LONDON, V513, P135, DOI 10.1111/j.1469-7793.1998.135by.x; Pavlov I, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1202; REGEHR WG, 1995, BIOPHYS J, V68, P2156, DOI 10.1016/S0006-3495(95)80398-X; Reid CA, 1998, J NEUROSCI, V18, P2849; Rozov A, 2001, J PHYSIOL-LONDON, V531, P807, DOI 10.1111/j.1469-7793.2001.0807h.x; Ruiz A, 2010, NAT NEUROSCI, V13, P431, DOI 10.1038/nn.2512; SCANZIANI M, 1992, NEURON, V9, P919, DOI 10.1016/0896-6273(92)90244-8; Schikorski T, 1997, J NEUROSCI, V17, P5858; Scimemi A, 2012, J NEUROSCI, V32, P18157, DOI 10.1523/JNEUROSCI.3827-12.2012; Sharma G, 2003, NEURON, V38, P929, DOI 10.1016/S0896-6273(03)00322-2; Sheng JS, 2012, NAT NEUROSCI, V15, P998, DOI 10.1038/nn.3129; Shepherd GMG, 1998, J NEUROSCI, V18, P8300; Siksou L, 2007, J NEUROSCI, V27, P6868, DOI 10.1523/JNEUROSCI.1773-07.2007; SOONG TW, 1993, SCIENCE, V260, P1133, DOI 10.1126/science.8388125; Sutton MA, 2004, SCIENCE, V304, P1979, DOI 10.1126/science.1096202; Vyleta NP, 2011, J NEUROSCI, V31, P4593, DOI 10.1523/JNEUROSCI.6398-10.2011; Weber AM, 2010, NAT NEUROSCI, V13, P1348, DOI 10.1038/nn.2657; WILLIAMS C, 2012, AM POETRY REV, V41, P15; WU LG, 1994, J NEUROSCI, V14, P5613; Xu BS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019052; Xu J, 2009, NAT NEUROSCI, V12, P759, DOI 10.1038/nn.2320	50	96	96	0	20	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	DEC	2013	16	12					1754	1763		10.1038/nn.3563	http://dx.doi.org/10.1038/nn.3563			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	257VV	24185424	Green Accepted			2022-12-28	WOS:000327416800013
J	Costa-Mattioli, M; Monteggia, LM				Costa-Mattioli, Mauro; Monteggia, Lisa M.			mTOR complexes in neurodevelopmental and neuropsychiatric disorders	NATURE NEUROSCIENCE			English	Review							TUBEROUS SCLEROSIS COMPLEX; TRANSLATION REPRESSOR 4E-BP2; TERM SYNAPTIC PLASTICITY; GIANT-CELL ASTROCYTOMAS; MAMMALIAN TARGET; NEUROTROPHIC FACTOR; MOUSE MODEL; ACTIN CYTOSKELETON; SIGNALING PATHWAY; MICE LACKING	The mechanistic target of rapamycin (mTOR) acts as a highly conserved signaling "hub" that integrates neuronal activity and a variety of synaptic inputs. mTOR is found in two functionally distinct complexes, mTORC1 and mTORC2, that crucially control long-term synaptic efficacy and memory storage. Dysregulation of mTOR signaling is associated with neurodevelopmental and neuropsychiatric disorders. In this Review, we describe the most recent advances in studies of mTOR signaling in the brain and the possible mechanisms underlying the many different functions of the mTOR complexes in neurological diseases. In addition, we discuss the medical relevance of these findings.	[Costa-Mattioli, Mauro] Baylor Coll Med, Dept Neurosci, Houston, TX 77030 USA; [Monteggia, Lisa M.] Univ Texas SW Med Ctr Dallas, Dept Neurosci, Dallas, TX 75390 USA	Baylor College of Medicine; University of Texas System; University of Texas Southwestern Medical Center Dallas	Costa-Mattioli, M (corresponding author), Baylor Coll Med, Dept Neurosci, Houston, TX 77030 USA.	costamat@bcm.edu; lisa.monteggia@utsouthwestern.edu			US National Institutes of Health [NS076708, MH096816, MH070727]; Department of Defense [AR10254]; Searle award [09-SSP-211]; Whitehall Foundation; International Mental Health Research Organization; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH096816, R01MH070727] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS076708] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense(United States Department of Defense); Searle award; Whitehall Foundation; International Mental Health Research Organization; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank members of M.C.-M.'s laboratory, K. Krnjevic and E.T. Kavalali for comments and discussion. The figures were designed by S. Buffington. This work was supported by US National Institutes of Health grants NS076708 (M.C.-M.), MH096816 (M.C.-M.) and MH070727 (L.M.M.), Department of Defense grant AR10254 (M.C.-M.), Searle award grant 09-SSP-211 (M.C.-M.), the Whitehall Foundation (M.C.-M.) and the International Mental Health Research Organization (L.M.M.).	Adachi M, 2008, BIOL PSYCHIAT, V63, P642, DOI 10.1016/j.biopsych.2007.09.019; Antion MD, 2008, LEARN MEMORY, V15, P29, DOI 10.1101/lm.661908; Antion MD, 2008, MOL CELL BIOL, V28, P2996, DOI 10.1128/MCB.00201-08; Auerbach BD, 2011, NATURE, V480, P63, DOI 10.1038/nature10658; Autry AE, 2012, PHARMACOL REV, V64, P238, DOI 10.1124/pr.111.005108; Autry AE, 2011, NATURE, V475, P91, DOI 10.1038/nature10130; Banko JL, 2007, NEUROBIOL LEARN MEM, V87, P248, DOI 10.1016/j.nlm.2006.08.012; Banko JL, 2005, J NEUROSCI, V25, P9581, DOI 10.1523/JNEUROSCI.2423-05.2005; Barak S, 2013, NAT NEUROSCI, V16, P1111, DOI 10.1038/nn.3439; Bateup HS, 2013, NEURON, V78, P510, DOI 10.1016/j.neuron.2013.03.017; Bateup HS, 2011, J NEUROSCI, V31, P8862, DOI 10.1523/JNEUROSCI.1617-11.2011; Bauman ML, 2005, INT J DEV NEUROSCI, V23, P183, DOI 10.1016/j.ijdevneu.2004.09.006; Bidinosti M, 2010, MOL CELL, V37, P797, DOI 10.1016/j.molcel.2010.02.022; Bissler JJ, 2008, NEW ENGL J MED, V358, P140, DOI 10.1056/NEJMoa063564; BROWN EJ, 1994, NATURE, V369, P756, DOI 10.1038/369756a0; Busquets-Garcia A, 2013, NAT MED, V19, P603, DOI 10.1038/nm.3127; Carson RP, 2013, HUM MOL GENET, V22, P140, DOI 10.1093/hmg/dds414; Carson RP, 2012, NEUROBIOL DIS, V45, P369, DOI 10.1016/j.nbd.2011.08.024; Cingolani LA, 2008, NAT REV NEUROSCI, V9, P344, DOI 10.1038/nrn2373; Costa-Mattioli M, 2009, NEURON, V61, P10, DOI 10.1016/j.neuron.2008.10.055; Cui YJ, 2008, CELL, V135, P549, DOI 10.1016/j.cell.2008.09.060; Cybulski N, 2009, TRENDS BIOCHEM SCI, V34, P620, DOI 10.1016/j.tibs.2009.09.004; Darnell JC, 2011, CELL, V146, P247, DOI 10.1016/j.cell.2011.06.013; Ehninger D, 2008, NAT MED, V14, P843, DOI 10.1038/nm1788; Ehninger D, 2008, NEURON, V60, P950, DOI 10.1016/j.neuron.2008.12.007; Emamian ES, 2004, NAT GENET, V36, P131, DOI 10.1038/ng1296; Feldman ME, 2009, PLOS BIOL, V7, P371, DOI 10.1371/journal.pbio.1000038; Fernandez F, 2007, NAT NEUROSCI, V10, P411, DOI 10.1038/nn1860; Fombonne E, 1999, PSYCHOL MED, V29, P769, DOI 10.1017/S0033291799008508; Franz DN, 2013, LANCET, V381, P125, DOI 10.1016/S0140-6736(12)61134-9; Franz DN, 2006, ANN NEUROL, V59, P490, DOI 10.1002/ana.20784; Gkogkas CG, 2013, NATURE, V493, P371, DOI 10.1038/nature11628; Goncharova E, 2004, J CELL BIOL, V167, P1171, DOI 10.1083/jcb.200405130; Goorden SMI, 2007, ANN NEUROL, V62, P648, DOI 10.1002/ana.21317; HEITMAN J, 1991, SCIENCE, V253, P905, DOI 10.1126/science.1715094; Henderson C, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004218; Hernandez-Negrete I, 2007, J BIOL CHEM, V282, P23708, DOI 10.1074/jbc.M703771200; Hou LF, 2004, J NEUROSCI, V24, P6352, DOI 10.1523/JNEUROSCI.0995-04.2004; Hsieh AC, 2012, NATURE, V485, P55, DOI 10.1038/nature10912; Huang W, 2013, NAT NEUROSCI, V16, P441, DOI 10.1038/nn.3351; Jacinto E, 2004, NAT CELL BIOL, V6, P1122, DOI 10.1038/ncb1183; Kaizuka T, 2010, J BIOL CHEM, V285, P20109, DOI 10.1074/jbc.M110.121699; Kandel ER, 2001, SCIENCE, V294, P1030, DOI 10.1126/science.1067020; Kim JY, 2012, CELL, V148, P1051, DOI 10.1016/j.cell.2011.12.037; Kim JY, 2009, NEURON, V63, P761, DOI 10.1016/j.neuron.2009.08.008; Kirchner GI, 2004, CLIN PHARMACOKINET, V43, P83, DOI 10.2165/00003088-200443020-00002; Koike H, 2011, NEUROPHARMACOLOGY, V61, P1419, DOI 10.1016/j.neuropharm.2011.08.034; Krueger D.A., 2013, ANN NEUROL, DOI [10.1002/ana 23960, DOI 10.1002/ANA]; Krueger DA, 2010, NEW ENGL J MED, V363, P1801, DOI 10.1056/NEJMoa1001671; Kwon CH, 2003, P NATL ACAD SCI USA, V100, P12923, DOI 10.1073/pnas.2132711100; Kwon CH, 2006, NEURON, V50, P377, DOI 10.1016/j.neuron.2006.03.023; Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017; Li NX, 2010, SCIENCE, V329, P959, DOI 10.1126/science.1190287; Liliental J, 2000, CURR BIOL, V10, P401, DOI 10.1016/S0960-9822(00)00417-6; Ljungberg MC, 2006, ANN NEUROL, V60, P420, DOI 10.1002/ana.20949; Ma XJM, 2009, NAT REV MOL CELL BIO, V10, P307, DOI 10.1038/nrm2672; Max X, 2008, CELL, V133, P303, DOI 10.1016/j.cell.2008.02.031; Mazei-Robison MS, 2011, NEURON, V72, P977, DOI 10.1016/j.neuron.2011.10.012; Mefford HC, 2012, NEW ENGL J MED, V366, P733, DOI 10.1056/NEJMra1114194; Meikle L, 2008, J NEUROSCI, V28, P5422, DOI 10.1523/JNEUROSCI.0955-08.2008; Mita M, 2008, EXPERT OPIN INV DRUG, V17, P1947, DOI [10.1517/13543780802556485, 10.1517/13543780802556485 ]; Monteggia LM, 2004, P NATL ACAD SCI USA, V101, P10827, DOI 10.1073/pnas.0402141101; Nibuya M, 1996, J NEUROSCI, V16, P2365; Nosyreva E, 2013, J NEUROSCI, V33, P6990, DOI 10.1523/JNEUROSCI.4998-12.2013; Oh WJ, 2011, CELL CYCLE, V10, P2305, DOI 10.4161/cc.10.14.16586; Parker WE, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005271; Pearce LR, 2011, BIOCHEM J, V436, P169, DOI 10.1042/BJ20102103; Peterson TR, 2009, CELL, V137, P873, DOI 10.1016/j.cell.2009.03.046; Punt CJA, 2003, ANN ONCOL, V14, P931, DOI 10.1093/annonc/mdg248; Ran I, 2013, J NEUROSCI, V33, P1872, DOI 10.1523/JNEUROSCI.3264-12.2013; SABATINI DM, 1994, CELL, V78, P35, DOI 10.1016/0092-8674(94)90570-3; SABERS CJ, 1995, J BIOL CHEM, V270, P815, DOI 10.1074/jbc.270.2.815; Santini E, 2013, NATURE, V493, P411, DOI 10.1038/nature11782; Sarbassov DD, 2006, MOL CELL, V22, P159, DOI 10.1016/j.molcel.2006.03.029; Sarbassov DD, 2004, CURR BIOL, V14, P1296, DOI 10.1016/j.cub.2004.06.054; Shirayama Y, 2002, J NEUROSCI, V22, P3251, DOI 10.1523/JNEUROSCI.22-08-03251.2002; Siuta MA, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000393; Sonenberg N, 2009, CELL, V136, P731, DOI 10.1016/j.cell.2009.01.042; Song MS, 2012, NAT REV MOL CELL BIO, V13, P283, DOI 10.1038/nrm3330; Stoica L, 2011, P NATL ACAD SCI USA, V108, P3791, DOI 10.1073/pnas.1014715108; Sunnen CN, 2011, EPILEPSIA, V52, P2065, DOI 10.1111/j.1528-1167.2011.03280.x; Tafet GE, 2003, PROG NEURO-PSYCHOPH, V27, P893, DOI 10.1016/S0278-5846(03)00162-3; Takeuchi K, 2013, P NATL ACAD SCI USA, V110, P4738, DOI 10.1073/pnas.1222803110; Tang SJ, 2002, P NATL ACAD SCI USA, V99, P467, DOI 10.1073/pnas.012605299; Thomanetz V, 2013, J CELL BIOL, V201, P293, DOI 10.1083/jcb.201205030; Thoreen CC, 2012, NATURE, V485, P109, DOI 10.1038/nature11083; Thoreen CC, 2009, J BIOL CHEM, V284, P8023, DOI 10.1074/jbc.M900301200; Tsai PT, 2012, NATURE, V488, P647, DOI 10.1038/nature11310; Uhlmann EJ, 2002, ANN NEUROL, V52, P285, DOI 10.1002/ana.10283; Wang YL, 2007, ANN NEUROL, V61, P139, DOI 10.1002/ana.21058; Wang Y, 2006, NEUROMOL MED, V8, P329, DOI 10.1385/NMM:8:3:329; Way SW, 2012, HUM MOL GENET, V21, P3226, DOI 10.1093/hmg/dds156; Wong M, 2010, EPILEPSIA, V51, P27, DOI 10.1111/j.1528-1167.2009.02341.x; Yang HJ, 2013, NATURE, V497, P217, DOI 10.1038/nature12122; Zeng LH, 2008, ANN NEUROL, V63, P444, DOI 10.1002/ana.21331; Zhou J, 2012, CURR OPIN NEUROBIOL, V22, P873, DOI 10.1016/j.conb.2012.05.004; Zhou J, 2009, J NEUROSCI, V29, P1773, DOI 10.1523/JNEUROSCI.5685-08.2009; Zhou MO, 2013, NEURON, V77, P647, DOI 10.1016/j.neuron.2012.12.033; Zinzalla V, 2011, CELL, V144, P757, DOI 10.1016/j.cell.2011.02.014; Zoghbi HY, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a009886	100	220	229	1	36	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	NOV	2013	16	11					1537	1543		10.1038/nn.3546	http://dx.doi.org/10.1038/nn.3546			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	241YX	24165680				2022-12-28	WOS:000326205700009
J	Lim, C; Allada, R				Lim, Chunghun; Allada, Ravi			Emerging roles for post-transcriptional regulation in circadian clocks	NATURE NEUROSCIENCE			English	Review							TRANSLATIONAL PROFILING APPROACH; NONOPTIMAL CODON USAGE; MESSENGER-RNA; HNRNP-Q; DROSOPHILA-MELANOGASTER; GENE; PROTEIN; PERIOD; TEMPERATURE; EXPRESSION	Circadian clocks temporally organize behavior and physiology across the 24-h day. Great progress has been made in understanding the molecular basis of timekeeping, with a focus on transcriptional feedback networks that are post-translationally modulated. Yet emerging evidence indicates an important role for post-transcriptional regulation, from splicing, polyadenylation and mRNA stability to translation and non-coding functions exemplified by microRNAs. This level of regulation affects virtually all aspects of circadian systems, from the core timing mechanism and input pathways that synchronize clocks to the environment and output pathways that control overt rhythmicity. We hypothesize that post-transcriptional control confers on circadian clocks enhanced robustness as well as the ability to adapt to different environments. As much of what is known derives from nonneural cells or tissues, future work will be required to investigate the role of post-transcriptional regulation in neural clocks.	[Lim, Chunghun] Ulsan Natl Inst Sci & Technol, Sch Nanobiosci & Chem Engn, Ulsan, South Korea; [Allada, Ravi] Northwestern Univ, Dept Neurobiol, Evanston, IL USA	Ulsan National Institute of Science & Technology (UNIST); Northwestern University	Lim, C (corresponding author), Ulsan Natl Inst Sci & Technol, Sch Nanobiosci & Chem Engn, Ulsan, South Korea.	clim@unist.ac.kr; r-allada@northwestern.edu	Lim, Chunghun/AAB-1253-2020	Lim, Chunghun/0000-0001-8473-9272	UNIST (Ulsan National Institute of Science and Technology) [1.130009, 1.130036]; US National Institutes of Health NINDS [R01NS059042]; US National Institutes of Health NIMH [R01MH 092273]; Defense Advanced Projects Research Agency (DARPA) [D12AP00023]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH092273] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS059042] Funding Source: NIH RePORTER	UNIST (Ulsan National Institute of Science and Technology); US National Institutes of Health NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); US National Institutes of Health NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Defense Advanced Projects Research Agency (DARPA)(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank V. Kilman for helpful comments on the manuscript and M. Flourakis for providing an image in Figure id. This work was supported by the year of 2013 Research Fund (project no. 1.130009) and the 2013 Creativity & Innovation Research Fund (project no. 1.130036) of UNIST (Ulsan National Institute of Science and Technology) (C.L.) and by US National Institutes of Health NINDS (R01NS059042) and NIMH (R01MH 092273), and Defense Advanced Projects Research Agency (DARPA; D12AP00023) (R.A). R.A.'s effort is in part sponsored by DARPA, and the content of the information does not necessarily reflect the position or the policy of the Government and no official endorsement should be inferred.	Abruzzi KC, 2011, GENE DEV, V25, P2374, DOI [10.1101/gad.178079.111, 10.1101/gad.174110.111]; Baggs JE, 2003, CURR BIOL, V13, P189, DOI 10.1016/S0960-9822(03)00014-9; Bradley S, 2012, GENETICS, V192, P943, DOI 10.1534/genetics.112.143248; Brown SA, 2002, CURR BIOL, V12, P1574, DOI 10.1016/S0960-9822(02)01145-4; Brown SA, 2012, DEV CELL, V22, P477, DOI 10.1016/j.devcel.2012.02.007; Cao R, 2011, NEUROSCIENCE, V181, P79, DOI 10.1016/j.neuroscience.2011.03.005; Cao RF, 2010, J NEUROSCI, V30, P6302, DOI 10.1523/JNEUROSCI.5482-09.2010; Cheng HYM, 2007, NEURON, V54, P813, DOI 10.1016/j.neuron.2007.05.017; Clokie SJH, 2012, J BIOL CHEM, V287, P25312, DOI 10.1074/jbc.M112.356733; Collins BH, 2004, P NATL ACAD SCI USA, V101, P1945, DOI 10.1073/pnas.0308240100; Colot HV, 2005, MOL BIOL CELL, V16, P5563, DOI 10.1091/mbc.E05-08-0756; Coon SL, 2012, P NATL ACAD SCI USA, V109, P13319, DOI 10.1073/pnas.1207748109; Darnell JC, 2011, CELL, V146, P247, DOI 10.1016/j.cell.2011.06.013; Decker CJ, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a012286; Dibner C, 2010, ANNU REV PHYSIOL, V72, P517, DOI 10.1146/annurev-physiol-021909-135821; Diernfellner ACR, 2005, GENE DEV, V19, P1968, DOI 10.1101/gad.345905; Dockendorff TC, 2002, NEURON, V34, P973, DOI 10.1016/S0896-6273(02)00724-9; Doyle JP, 2008, CELL, V135, P749, DOI 10.1016/j.cell.2008.10.029; Elia M, 2000, BRAIN DEV-JPN, V22, P88, DOI 10.1016/S0387-7604(99)00119-9; Gatfield D, 2009, GENE DEV, V23, P1313, DOI 10.1101/gad.1781009; Green CB, 2007, P NATL ACAD SCI USA, V104, P9888, DOI 10.1073/pnas.0702448104; Green CB, 1996, P NATL ACAD SCI USA, V93, P14884, DOI 10.1073/pnas.93.25.14884; Green CB, 2003, J NEUROENDOCRINOL, V15, P350, DOI 10.1046/j.1365-2826.2003.00999.x; Grima B, 2004, NATURE, V431, P869, DOI 10.1038/nature02935; Hardin PE, 2005, CURR BIOL, V15, pR714, DOI 10.1016/j.cub.2005.08.019; Harms E, 2004, J BIOL RHYTHM, V19, P361, DOI 10.1177/0748730404268111; Heiman M, 2008, CELL, V135, P738, DOI 10.1016/j.cell.2008.10.028; Helfrich-Forster C, 2005, GENES BRAIN BEHAV, V4, P65, DOI 10.1111/j.1601-183X.2004.00092.X; Huang YM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001107; Hughes ME, 2012, GENOME RES, V22, P1266, DOI 10.1101/gr.128876.111; Inoue SB, 2002, CURR BIOL, V12, P1331, DOI 10.1016/S0960-9822(02)01036-9; Jin P, 2004, NAT NEUROSCI, V7, P113, DOI 10.1038/nn1174; Jouffe C, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001455; Kadener S, 2009, GENE DEV, V23, P2179, DOI 10.1101/gad.1819509; Kim DY, 2011, NUCLEIC ACIDS RES, V39, P8901, DOI 10.1093/nar/gkr605; Kim DY, 2010, NUCLEIC ACIDS RES, V38, P7068, DOI 10.1093/nar/gkq569; Kim TD, 2007, GENE DEV, V21, P797, DOI 10.1101/gad.1519507; Konig J, 2012, NAT REV GENET, V13, P77, DOI 10.1038/nrg3141; Koike N, 2012, SCIENCE, V338, P349, DOI 10.1126/science.1226339; Kojima S, 2007, P NATL ACAD SCI USA, V104, P1859, DOI 10.1073/pnas.0607567104; Kojima S, 2012, GENE DEV, V26, P2724, DOI 10.1101/gad.208306.112; Kojima S, 2011, J CELL SCI, V124, P311, DOI 10.1242/jcs.065771; Lee KH, 2012, MOL CELL BIOL, V32, P717, DOI 10.1128/MCB.06177-11; Lim C, 2013, SCIENCE, V340, P875, DOI 10.1126/science.1234785; Lim C, 2011, NATURE, V470, P399, DOI 10.1038/nature09728; Liu Y, 1997, CELL, V89, P477, DOI 10.1016/S0092-8674(00)80228-7; Low KH, 2008, NEURON, V60, P1054, DOI 10.1016/j.neuron.2008.10.048; Luo WY, 2012, CELL, V148, P765, DOI 10.1016/j.cell.2011.12.024; Majercak J, 1999, NEURON, V24, P219, DOI 10.1016/S0896-6273(00)80834-X; Majercak J, 2004, MOL CELL BIOL, V24, P3359, DOI 10.1128/MCB.24.8.3359-3372.2004; McGlincy NJ, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-6-r54; McNeil GP, 1998, NEURON, V20, P297, DOI 10.1016/S0896-6273(00)80457-2; Menet JS, 2012, ELIFE, V1, DOI 10.7554/eLife.00011; Miano S, 2008, CLIN NEUROPHYSIOL, V119, P1242, DOI 10.1016/j.clinph.2008.03.004; Michael TP, 2002, PLANT PHYSIOL, V130, P627, DOI 10.1104/pp.004929; MILLAR AJ, 1991, PLANT CELL, V3, P541, DOI 10.1105/tpc.3.5.541; Millevoi S, 2010, NUCLEIC ACIDS RES, V38, P2757, DOI 10.1093/nar/gkp1176; Mohawk JA, 2012, ANNU REV NEUROSCI, V35, P445, DOI 10.1146/annurev-neuro-060909-153128; Mohawk JA, 2011, TRENDS NEUROSCI, V34, P349, DOI 10.1016/j.tins.2011.05.003; Morales J, 2002, NEURON, V34, P961, DOI 10.1016/S0896-6273(02)00731-6; Morf J, 2012, SCIENCE, V338, P379, DOI 10.1126/science.1217726; Na YJ, 2009, EXP MOL MED, V41, P638, DOI 10.3858/emm.2009.41.9.070; Nagel R, 2009, FEBS J, V276, P5447, DOI 10.1111/j.1742-4658.2009.07229.x; Nagoshi E, 2010, NAT NEUROSCI, V13, P60, DOI 10.1038/nn.2451; NEWBY LM, 1993, GENETICS, V135, P1077; Padmanabhan K, 2012, SCIENCE, V337, P599, DOI 10.1126/science.1221592; PILGRIM ML, 1993, PLANT MOL BIOL, V23, P349, DOI 10.1007/BF00029010; Reddy AB, 2006, CURR BIOL, V16, P1107, DOI 10.1016/j.cub.2006.04.026; Reischl S, 2011, FEBS LETT, V585, P1393, DOI 10.1016/j.febslet.2011.02.038; Richter JD, 2007, TRENDS BIOCHEM SCI, V32, P279, DOI 10.1016/j.tibs.2007.04.004; ROBINSON BG, 1988, SCIENCE, V241, P342, DOI 10.1126/science.3388044; Rodriguez J, 2013, P NATL ACAD SCI USA, V110, pE275, DOI 10.1073/pnas.1219969110; Sanchez SE, 2010, NATURE, V468, P112, DOI 10.1038/nature09470; Shende VR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022586; Sire C, 2009, FEBS LETT, V583, P1039, DOI 10.1016/j.febslet.2009.02.024; So WV, 1997, EMBO J, V16, P7146, DOI 10.1093/emboj/16.23.7146; Sonenberg N, 2009, CELL, V136, P731, DOI 10.1016/j.cell.2009.01.042; Staiger D, 2011, TRENDS PLANT SCI, V16, P517, DOI 10.1016/j.tplants.2011.06.002; Staiger D, 2011, CELL MOL LIFE SCI, V68, P71, DOI 10.1007/s00018-010-0513-5; Stoleru D, 2004, NATURE, V431, P862, DOI 10.1038/nature02926; Sundram V, 2012, J BIOL RHYTHM, V27, P183, DOI 10.1177/0748730412440667; Thomas A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040276; Turek FW, 2005, SCIENCE, V308, P1043, DOI 10.1126/science.1108750; Vatine G, 2011, FEBS LETT, V585, P1485, DOI 10.1016/j.febslet.2011.04.007; Vodala S, 2012, CELL METAB, V16, P601, DOI 10.1016/j.cmet.2012.10.002; Vollmers C, 2012, CELL METAB, V16, P833, DOI 10.1016/j.cmet.2012.11.004; Wang Y, 2001, BMC Dev Biol, V1, P9, DOI 10.1186/1471-213X-1-9; Wells DG, 2012, CURR OPIN CELL BIOL, V24, P554, DOI 10.1016/j.ceb.2012.06.005; Woo KC, 2010, MOL CELL BIOL, V30, P197, DOI 10.1128/MCB.01154-09; Woo KC, 2009, NUCLEIC ACIDS RES, V37, P26, DOI 10.1093/nar/gkn893; Xu SB, 2007, J BIOL CHEM, V282, P25053, DOI 10.1074/jbc.M700501200; Xu SL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037937; Xu Y, 2013, NATURE, V495, P116, DOI 10.1038/nature11942; Yakir E, 2007, PLANT PHYSIOL, V145, P925, DOI 10.1104/pp.107.103812; Yang M, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-83; Zhang J, 2008, AM J HUM GENET, V83, P43, DOI 10.1016/j.ajhg.2008.06.003; Zhang Y, 2013, SCIENCE, V340, P879, DOI 10.1126/science.1234746; Zheng XZ, 2012, TRENDS NEUROSCI, V35, P574, DOI 10.1016/j.tins.2012.05.007; Zhong HH, 1997, PLANT CELL, V9, P947, DOI 10.1105/tpc.9.6.947; Zhou M, 2013, NATURE, V495, P111, DOI 10.1038/nature11833	100	98	101	0	42	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	NOV	2013	16	11					1544	1550		10.1038/nn.3543	http://dx.doi.org/10.1038/nn.3543			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	241YX	24165681				2022-12-28	WOS:000326205700010
J	Porlan, E; Morante-Redolat, JM; Marques-Torrejon, MA; Andreu-Agullo, C; Carneiro, C; Gomez-Ibarlucea, E; Soto, A; Vidal, A; Ferron, SR; Farinas, I				Porlan, Eva; Manuel Morante-Redolat, Jose; Angeles Marques-Torrejon, Maria; Andreu-Agullo, Celia; Carneiro, Carmen; Gomez-Ibarlucea, Esther; Soto, Atenea; Vidal, Anxo; Ferron, Sacri R.; Farinas, Isabel			Transcriptional repression of Bmp2 by p21(Waf1/Cip1) links quiescence to neural stem cell maintenance	NATURE NEUROSCIENCE			English	Article							BONE MORPHOGENETIC PROTEINS; GFAP-EXPRESSING CELLS; ADULT NEUROGENESIS; SUBVENTRICULAR ZONE; LINEAGE COMMITMENT; PROGENITOR CELLS; GENE-EXPRESSION; INHIBITOR; DIFFERENTIATION; MICE	Relative quiescence and self renewal are defining features of adult stem cells, but their potential coordination remains unclear. Subependymal neural stem cells (NSCs) lacking cyclin-dependent kinase (CDK) inhibitor (CKI) 1a (p21) exhibit rapid expansion that is followed by their permanent loss later in life. Here we demonstrate that transcription of the gene encoding bone morphogenetic protein 2 (Bmp2) in NSCs is under the direct negative control of p21 through actions that are independent of CDK. Loss of p21 in NSCs results in increased levels of secreted BMP2, which induce premature terminal differentiation of multipotent NSCs into mature non-neurogenic astrocytes in an autocrine and/or paracrine manner. We also show that the cell-nonautonomous p21-null phenotype is modulated by the Noggin-rich environment of the subependymal niche. The dual function that we describe here provides a physiological example of combined cell-autonomous and cell-nonautonomous functions of p21 with implications in self renewal, linking the relative quiescence of adult stem cells to their longevity and potentiality.	[Porlan, Eva; Manuel Morante-Redolat, Jose; Angeles Marques-Torrejon, Maria; Andreu-Agullo, Celia; Farinas, Isabel] Ctr Invest Biomed Red Enfermedades Neurodegenerat, Madrid, Spain; [Porlan, Eva; Manuel Morante-Redolat, Jose; Angeles Marques-Torrejon, Maria; Andreu-Agullo, Celia; Ferron, Sacri R.; Farinas, Isabel] Univ Valencia, Dept Biol Celular, Valencia, Spain; [Carneiro, Carmen; Gomez-Ibarlucea, Esther; Soto, Atenea; Vidal, Anxo] Univ Santiago de Compostela, Dept Fisiol, Santiago De Compostela, Spain; [Carneiro, Carmen; Gomez-Ibarlucea, Esther; Soto, Atenea; Vidal, Anxo] Univ Santiago de Compostela, Ctr Invest Med Mol CIMUS, Fac Med, Inst Invest Sanitaria Santiago IDIS, Santiago De Compostela, Spain	CIBERNED; University of Valencia; Universidade de Santiago de Compostela; Universidade de Santiago de Compostela	Ferron, SR (corresponding author), Univ Valencia, Dept Biol Celular, Valencia, Spain.	sacramento.rodriguez@uv.es; isabel.farinas@uv.es	Ferrón, Sacri R./I-2958-2015; Marques, Maria Angeles/AAH-2720-2019; Vidal, Anxo/B-5010-2015; Gómez-Ibarlucea, Esther/AAA-8536-2020; porlan, Eva/AAE-6561-2022; Morante-Redolat, Jose Manuel/L-9397-2014; Farinas, Isabel/L-7118-2014	Ferrón, Sacri R./0000-0003-0854-8575; Vidal, Anxo/0000-0002-0866-4202; porlan, Eva/0000-0003-0934-9711; Morante-Redolat, Jose Manuel/0000-0003-0610-1665; Farinas, Isabel/0000-0003-2903-4960	Ministerio de Economia y Competitividad (MINECO) (SAF program); Ministerio de Sanidad (Red TerCel); Ministerio de Sanidad (CIBERNED); Generalitat Valenciana (Programas Prometeo); Generalitat Valenciana (ISIC); Generalitat Valenciana (ACOMP); Ministerio de Educacion y Ciencia (FPI program); Ministerio de Educacion y Ciencia (FPU program); Xunta de Galicia	Ministerio de Economia y Competitividad (MINECO) (SAF program); Ministerio de Sanidad (Red TerCel); Ministerio de Sanidad (CIBERNED); Generalitat Valenciana (Programas Prometeo)(Center for Forestry Research & Experimentation (CIEF)); Generalitat Valenciana (ISIC)(Center for Forestry Research & Experimentation (CIEF)); Generalitat Valenciana (ACOMP)(Center for Forestry Research & Experimentation (CIEF)); Ministerio de Educacion y Ciencia (FPI program)(German Research Foundation (DFG)National Health and Medical Research Council (NHMRC) of Australia); Ministerio de Educacion y Ciencia (FPU program)(Spanish Government); Xunta de Galicia(Xunta de GaliciaEuropean Commission)	We thank C. Gallego (Institut de Biologia Molecular de Barcelona), M.R. Campanero (Instituto de Investigaciones Biomedicas Alberto Sols, Madrid), S. Harris (University of Texas Health Science Center at San Antonio), S. Hitoshi (Shiga University of Medical Science), D. van der Kooy (University of Toronto) and W Zhang (The Johns Hopkins University School of Medicine) for generously providing constructs. We also thank the Servicios Centrales de Soporte a la Investigacion Experimental of the Universidad de Valencia for technical support. This work was supported by grants from the Ministerio de Economia y Competitividad (MINECO) (SAF program) to I.F., S.R.F. and A.V. and the Ministerio de Sanidad (Red TerCel and CIBERNED) and Generalitat Valenciana (Programas Prometeo, ISIC and ACOMP) to LE M.A.M.-T. was a recipient of a predoctoral fellowship from the Ministerio de Educacion y Ciencia (FPI program), CA-A. was a recipient of a predoctoral fellowship from the Ministerio de Educacion y Ciencia (FPU program), E.G.-I. is supported by a predoctoral fellowship from Xunta de Galicia, and C.C. was a 'Parga Pondal' investigator supported by Xunta de Galicia.	Marques-Torrejon MA, 2013, CELL STEM CELL, V12, P88, DOI 10.1016/j.stem.2012.12.001; Besson A, 2008, DEV CELL, V14, P159, DOI 10.1016/j.devcel.2008.01.013; Bonaguidi MA, 2005, DEVELOPMENT, V132, P5503, DOI 10.1242/dev.02166; Bond AM, 2012, DEV NEUROBIOL, V72, P1068, DOI 10.1002/dneu.22022; BRUGAROLAS J, 1995, NATURE, V377, P552, DOI 10.1038/377552a0; Chang BD, 2000, P NATL ACAD SCI USA, V97, P4291, DOI 10.1073/pnas.97.8.4291; Cheng T, 2000, SCIENCE, V287, P1804, DOI 10.1126/science.287.5459.1804; Colak D, 2008, J NEUROSCI, V28, P434, DOI 10.1523/JNEUROSCI.4374-07.2008; Cooper-Kuhn CM, 2002, MOL CELL NEUROSCI, V21, P312, DOI 10.1006/mcne.2002.1176; Coqueret O, 2000, J BIOL CHEM, V275, P18794, DOI 10.1074/jbc.M001601200; Delavaine L, 1999, ONCOGENE, V18, P5381, DOI 10.1038/sj.onc.1202923; Devgan V, 2005, GENE DEV, V19, P1485, DOI 10.1101/gad.341405; Doetsch F, 2002, J NEUROSCI, V22, P2255, DOI 10.1523/JNEUROSCI.22-06-02255.2002; Encinas JM, 2011, CELL STEM CELL, V8, P566, DOI 10.1016/j.stem.2011.03.010; Fern A.L., 2004, DEVELOPMENT, V131, P3805; Ferrandiz N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037759; Ferron SR, 2007, NAT PROTOC, V2, P849, DOI 10.1038/nprot.2007.104; Ghosh-Choudhury N, 2001, BIOCHEM BIOPH RES CO, V286, P101, DOI 10.1006/bbrc.2001.5351; Gobeske KT, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007506; Gomes WA, 2003, DEV BIOL, V255, P164, DOI 10.1016/S0012-1606(02)00037-4; Gross RE, 1996, NEURON, V17, P595, DOI 10.1016/S0896-6273(00)80193-2; Kippin TE, 2005, GENE DEV, V19, P756, DOI 10.1101/gad.1272305; Korchynskyi O, 2002, J BIOL CHEM, V277, P4883, DOI 10.1074/jbc.M111023200; Le Dreau G, 2012, DEVELOPMENT, V139, P259, DOI 10.1242/dev.074948; Lim DA, 2000, NEURON, V28, P713, DOI 10.1016/S0896-6273(00)00148-3; Lin JY, 1996, MOL CELL BIOL, V16, P1786; Ma YH, 2008, CANCER RES, V68, P6292, DOI 10.1158/0008-5472.CAN-08-0121; Mabie PC, 1997, J NEUROSCI, V17, P4112; Maslov AY, 2004, J NEUROSCI, V24, P1726, DOI 10.1523/JNEUROSCI.4608-03.2004; Mira H, 2010, CELL STEM CELL, V7, P78, DOI 10.1016/j.stem.2010.04.016; Muller H, 2001, GENE DEV, V15, P267, DOI 10.1101/gad.864201; NAKANISHI M, 1995, J BIOL CHEM, V270, P17060, DOI 10.1074/jbc.270.29.17060; Nam HS, 2009, CELL STEM CELL, V5, P515, DOI 10.1016/j.stem.2009.08.017; Raponi E, 2007, GLIA, V55, P165, DOI 10.1002/glia.20445; Snowden AW, 2000, MOL CELL BIOL, V20, P2676, DOI 10.1128/MCB.20.8.2676-2686.2000; SNYDER EY, 1992, CELL, V68, P33, DOI 10.1016/0092-8674(92)90204-P; Tevosian SG, 1996, CELL GROWTH DIFFER, V7, P43; Wilson PA, 1997, NEURON, V18, P699, DOI 10.1016/S0896-6273(00)80311-6; Yu H, 2006, BLOOD, V107, P1200, DOI 10.1182/blood-2005-02-0685; Yuan YZ, 2004, NAT CELL BIOL, V6, P436, DOI 10.1038/ncb1126; Zezula J, 2001, EMBO REP, V2, P27, DOI 10.1093/embo-reports/kve008; Zhao CM, 2008, CELL, V132, P645, DOI 10.1016/j.cell.2008.01.033	42	51	51	2	23	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	NOV	2013	16	11					1567	1575		10.1038/nn.3545	http://dx.doi.org/10.1038/nn.3545			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	241YX	24097040				2022-12-28	WOS:000326205700014
J	[Anonymous]				[Anonymous]			Unconventional gene regulation in the CNS	NATURE NEUROSCIENCE			English	Editorial Material								Dysregulation of protein translation and RNA processing mechanisms in the brain can result in subtle, but widespread, neurological disorders. A collection of Review and Perspective articles in this issue of Nature Neuroscience highlights some of the more unconventional mechanisms of post-transcriptional modifications in the CNS.										CRICK F, 1970, NATURE, V227, P561, DOI 10.1038/227561a0	1	0	0	0	2	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	NOV	2013	16	11					1509	1509						1	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	241YX	24165673	Bronze			2022-12-28	WOS:000326205700001
J	Biederer, T				Biederer, Thomas			Synaptic uSIRPation: the active neuron reigns over presynaptic partners	NATURE NEUROSCIENCE			English	Editorial Material							NEUROLIGIN-1; CLEAVAGE; PROTEINS	A study reveals that SIRP alpha is released from postsynaptic neurons to induce and mature their synaptic inputs, using CD47 as the presynaptic receptor. SIRP alpha is cleaved in an activity-dependent manner to act as retrograde signal.	[Biederer, Thomas] Yale Univ, Dept Mol Biophys & Biochem, New Haven, CT 06520 USA; [Biederer, Thomas] Yale Univ, Program Cellular Neurosci Neurodegenerat & Repair, New Haven, CT USA	Yale University; Yale University	Biederer, T (corresponding author), Yale Univ, Dept Mol Biophys & Biochem, New Haven, CT 06520 USA.	thomas.biederer@yale.edu	Biederer, Thomas/AAZ-6133-2021	Biederer, Thomas/0000-0003-0912-1514				Christopherson KS, 2005, CELL, V120, P421, DOI 10.1016/j.cell.2004.12.020; Clarke LE, 2013, NAT REV NEUROSCI, V14, P311, DOI 10.1038/nrn3484; Dean C, 2003, NAT NEUROSCI, V6, P708, DOI 10.1038/nn1074; Fogel AI, 2011, EMBO J, V30, P4728, DOI 10.1038/emboj.2011.336; Jiang PH, 1999, J BIOL CHEM, V274, P559, DOI 10.1074/jbc.274.2.559; Lawler PR, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006627; MISSLER M, 2012, SYNAPTIC CELL ADHESI; Peixoto RT, 2012, NEURON, V76, P396, DOI 10.1016/j.neuron.2012.07.006; Suzuki K, 2012, NEURON, V76, P410, DOI 10.1016/j.neuron.2012.10.003; Toth AB, 2013, NAT NEUROSCI, V16, P1417, DOI 10.1038/nn.3516; Umemori H, 2008, J BIOL CHEM, V283, P34053, DOI 10.1074/jbc.M805729200	11	0	0	0	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	OCT	2013	16	10					1361	1362		10.1038/nn.3523	http://dx.doi.org/10.1038/nn.3523			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	223HM	24067286				2022-12-28	WOS:000324795300003
J	Eldar, E; Cohen, JD; Niv, Y				Eldar, Eran; Cohen, Jonathan D.; Niv, Yael			The effects of neural gain on attention and learning	NATURE NEUROSCIENCE			English	Article							BRAIN NETWORKS; NORADRENERGIC MODULATION; INSTRUMENTAL BEHAVIOR; PUPILLARY DILATION; RECONFIGURATION; NOREPINEPHRINE; RESPONSES; SIGNALS; INDEX	Attention is commonly thought to be manifest through local variations in neural gain. However, what would be the effects of brain-wide changes in gain? We hypothesized that global fluctuations in gain modulate the breadth of attention and the degree to which processing is focused on aspects of the environment to which one is predisposed to attend. We found that measures of pupil diameter, which are thought to track levels of locus coeruleus norepinephrine activity and neural gain, were correlated with the degree to which learning was focused on stimulus dimensions that individual human participants were more predisposed to process. In support of our interpretation of this effect in terms of global changes in gain, we found that the measured pupillary and behavioral variables were strongly correlated with global changes in the strength and clustering of functional connectivity, as brain-wide fluctuations of gain would predict.	[Eldar, Eran; Cohen, Jonathan D.; Niv, Yael] Princeton Univ, Princeton Neurosci Inst, Princeton, NJ 08544 USA; [Cohen, Jonathan D.; Niv, Yael] Princeton Univ, Dept Psychol, Princeton, NJ 08544 USA	Princeton University; Princeton University	Eldar, E (corresponding author), Princeton Univ, Princeton Neurosci Inst, Princeton, NJ 08544 USA.	eeldar@princeton.edu			US National Institutes of Health [R03 DA029073, R01 MH098861]; Howard Hughes Medical Institute International Student Research fellowship; Sloan Research Fellowship; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH098861] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R03DA029073] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute International Student Research fellowship(Howard Hughes Medical Institute); Sloan Research Fellowship(Alfred P. Sloan Foundation); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank N. Turk-Browne and P. Dayan for helpful comments on earlier versions of the manuscript. This research was funded by US National Institutes of Health grants R03 DA029073 and R01 MH098861, a Howard Hughes Medical Institute International Student Research fellowship to E.E. and a Sloan Research Fellowship to Y.N. The authors also wish to thank the generous support of the Regina and John Scully Center for the Neuroscience of Mind and Behavior in the Princeton Neuroscience Institute.	Alexander JK, 2007, J COGNITIVE NEUROSCI, V19, P468, DOI 10.1162/jocn.2007.19.3.468; Bassett DS, 2011, P NATL ACAD SCI USA, V108, P7641, DOI 10.1073/pnas.1018985108; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Bullmore ET, 2012, NAT REV NEUROSCI, V13, P336, DOI 10.1038/nrn3214; Bullmore ET, 2009, NAT REV NEUROSCI, V10, P186, DOI 10.1038/nrn2575; Campbell HL, 2008, PHARMACOL BIOCHEM BE, V88, P222, DOI 10.1016/j.pbb.2007.08.003; Coffield F., 2004, LEARNING STYLES PEDA; Dayan P, 2006, ADV NEURAL INFORM PR, V18, P243; Dias-Ferreira E, 2009, SCIENCE, V325, P621, DOI 10.1126/science.1171203; EASTERBROOK JA, 1959, PSYCHOL REV, V66, P183, DOI 10.1037/h0047707; Eguiluz VM, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.018102; Einhauser W, 2008, P NATL ACAD SCI USA, V105, P1704, DOI 10.1073/pnas.0707727105; Felder RM, 2005, INT J ENG EDUC, V21, P103; FELDER RM, 1988, ENG EDUC, V78, P674; Fisher R. A., 1921, METRON             4, V1, P3, DOI DOI 10.1093/BIOMET/9.1-2.22; Gilzenrat MS, 2010, COGN AFFECT BEHAV NE, V10, P252, DOI 10.3758/CABN.10.2.252; Haider B, 2009, NEURON, V62, P171, DOI 10.1016/j.neuron.2009.04.008; HOEKS B, 1993, BEHAV RES METH INSTR, V25, P16, DOI 10.3758/BF03204445; Jepma M, 2011, J COGNITIVE NEUROSCI, V23, P1587, DOI 10.1162/jocn.2010.21548; Kitzbichler MG, 2011, J NEUROSCI, V31, P8259, DOI 10.1523/JNEUROSCI.0440-11.2011; KOSS MC, 1986, J PHARMACOL METHOD, V15, P1, DOI 10.1016/0160-5402(86)90002-1; Lambert A, 2003, PERCEPT PSYCHOPHYS, V65, P495, DOI 10.3758/BF03194578; Logothetis NK, 2008, NATURE, V453, P869, DOI 10.1038/nature06976; Maier A, 2008, NAT NEUROSCI, V11, P1193, DOI 10.1038/nn.2173; McClelland J. L., 1988, EXPLORATIONS PARALLE; Murphy PR, 2011, PSYCHOPHYSIOLOGY, V48, P1531, DOI 10.1111/j.1469-8986.2011.01226.x; Nicol RM, 2012, J NEUROPHYSIOL, V107, P1421, DOI 10.1152/jn.00817.2011; Reas C., 2014, PROCESSING PROGRAMMI, V2nd ed., P642; Salinas E, 2004, J NEUROSCI, V24, P1113, DOI 10.1523/JNEUROSCI.4569-03.2004; Salinas E, 2009, SPR SER COMPUT NEURO, V3, P121, DOI 10.1007/978-1-4419-0389-1_7; Schwabe L, 2011, J NEUROSCI, V31, P17317, DOI 10.1523/JNEUROSCI.3304-11.2011; Schwabe L, 2011, BEHAV BRAIN RES, V219, P321, DOI 10.1016/j.bbr.2010.12.038; Schwabe L, 2010, J NEUROSCI, V30, P8190, DOI 10.1523/JNEUROSCI.0734-10.2010; SERVANSCHREIBER D, 1990, SCIENCE, V249, P892, DOI 10.1126/science.2392679; Sirotin YB, 2009, NATURE, V457, P475, DOI 10.1038/nature07664; Staal MA, 2004, STRESS COGNITION HUM; WATERHOUSE BD, 1980, EXP NEUROL, V69, P30, DOI 10.1016/0014-4886(80)90141-7; WATERHOUSE BD, 1980, EXP NEUROL, V67, P11, DOI 10.1016/0014-4886(80)90159-4; WATERHOUSE BD, 1984, J PHARMACOL EXP THER, V228, P257	40	238	239	2	53	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	AUG	2013	16	8					1146	U236		10.1038/nn.3428	http://dx.doi.org/10.1038/nn.3428			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	190EV	23770566	Green Accepted			2022-12-28	WOS:000322323000027
J	Matta, JA; Pelkey, KA; Craig, MT; Chittajallu, R; Jeffries, BW; McBain, CJ				Matta, Jose A.; Pelkey, Kenneth A.; Craig, Michael T.; Chittajallu, Ramesh; Jeffries, Brian W.; McBain, Chris J.			Developmental origin dictates interneuron AMPA and NMDA receptor subunit composition and plasticity	NATURE NEUROSCIENCE			English	Article							LONG-TERM POTENTIATION; SILENT SYNAPSES; GLUTAMATERGIC SYNAPSES; HIPPOCAMPAL; EXPERIENCE; TRANSMISSION; PARVALBUMIN; EXPRESSION; SUBTYPES; ACTIVATION	Disrupted excitatory synapse maturation in GABAergic interneurons may promote neuropsychiatric disorders such as schizophrenia. However, establishing developmental programs for nascent synapses in GABAergic cells is confounded by their sparsity, heterogeneity and late acquisition of subtype-defining characteristics. We investigated synaptic development in mouse interneurons targeting cells by lineage from medial ganglionic eminence (MGE) or caudal ganglionic eminence (CGE) progenitors. MGE-derived interneuron synapses were dominated by GluA2-lacking AMPA-type glutamate receptors (AMPARs), with little contribution from NMDA-type receptors (NMDARs) throughout development. In contrast, CGE-derived cell synapses had large NMDAR components and used GluA2-containing AMPARs. In neonates, both MGE-and CGE-derived interneurons expressed primarily GluN2B subunit-containing NMDARs, which most CGE-derived interneurons retained into adulthood. However, MGE-derived interneuron NMDARs underwent a GluN2B-to-GluN2A switch that could be triggered acutely with repetitive synaptic activity. Our findings establish ganglionic eminence-dependent rules for early synaptic integration programs of distinct interneuron cohorts, including parvalbumin-and cholecystokinin-expressing basket cells.	[Matta, Jose A.; Pelkey, Kenneth A.; Craig, Michael T.; Chittajallu, Ramesh; Jeffries, Brian W.; McBain, Chris J.] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Program Dev Neurobiol, NIH, Bethesda, MD USA	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	Pelkey, KA (corresponding author), Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Program Dev Neurobiol, NIH, Bethesda, MD USA.	pelkeyk2@mail.nih.gov	Chittajallu, Ramesh/AAX-3749-2020; Craig, Michael/E-7070-2011; Craig, Michael/O-8267-2019	Chittajallu, Ramesh/0000-0002-9794-0052; Craig, Michael/0000-0001-8481-6709; Craig, Michael/0000-0001-8481-6709	Eunice Kennedy-Shriver National Institute of Child Health and Human Development; PRAT Fellowship; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD001205] Funding Source: NIH RePORTER	Eunice Kennedy-Shriver National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); PRAT Fellowship; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	D. Abebe and X. Yuan provided expert technical assistance. We thank S. Anderson (University of Pennsylvania) for providing the Nkx2-1-cre driver line and G. Fishell (New York University) for providing the RCE reporter line. This work was supported by a Eunice Kennedy-Shriver National Institute of Child Health and Human Development intramural award to C.J.M. and a PRAT Fellowship to J.A.M.	Belforte JE, 2010, NAT NEUROSCI, V13, P76, DOI 10.1038/nn.2447; Bellone C, 2007, NEURON, V55, P779, DOI 10.1016/j.neuron.2007.07.035; Bellone C, 2011, NAT NEUROSCI, V14, P1439, DOI 10.1038/nn.2930; Chavis P, 2001, NATURE, V411, P317, DOI 10.1038/35077101; Daw MI, 2009, J NEUROSCI, V29, P11112, DOI 10.1523/JNEUROSCI.5760-08.2009; Doischer D, 2008, J NEUROSCI, V28, P12956, DOI 10.1523/JNEUROSCI.2890-08.2008; Eybalin M, 2004, EUR J NEUROSCI, V20, P2981, DOI 10.1111/j.1460-9568.2004.03772.x; Fuchs EC, 2007, NEURON, V53, P591, DOI 10.1016/j.neuron.2007.01.031; Ho MT, 2009, J PHYSIOL-LONDON, V587, P5798, DOI 10.1113/jphysiol.2009.182634; Isaac JTR, 2003, NEUROPHARMACOLOGY, V45, P450, DOI 10.1016/S0028-3908(03)00229-6; Isaac JTR, 1997, NEURON, V18, P269, DOI 10.1016/S0896-6273(00)80267-6; Ito I, 2000, NEUROPHARMACOLOGY, V39, P943, DOI 10.1016/S0028-3908(99)00217-8; Kerchner GA, 2008, NAT REV NEUROSCI, V9, P813, DOI 10.1038/nrn2501; Korotkova T, 2010, NEURON, V68, P557, DOI 10.1016/j.neuron.2010.09.017; Kullmann DM, 2007, NAT REV NEUROSCI, V8, P687, DOI 10.1038/nrn2207; Kumar SS, 2002, J NEUROSCI, V22, P3005, DOI 10.1523/JNEUROSCI.22-08-03005.2002; Lee S, 2010, J NEUROSCI, V30, P16796, DOI 10.1523/JNEUROSCI.1869-10.2010; Lei SB, 2002, NEURON, V33, P921, DOI 10.1016/S0896-6273(02)00608-6; Mahanty NK, 1998, NATURE, V394, P683, DOI 10.1038/29312; Matta JA, 2011, NEURON, V70, P339, DOI 10.1016/j.neuron.2011.02.045; MCBAIN CJ, 1993, J PHYSIOL-LONDON, V462, P373, DOI 10.1113/jphysiol.1993.sp019560; Mierau SB, 2004, P NATL ACAD SCI USA, V101, P15518, DOI 10.1073/pnas.0402916101; MILES R, 1983, NATURE, V306, P371, DOI 10.1038/306371a0; Morin F, 1996, J NEUROPHYSIOL, V76, P1; Morozov YM, 2009, CEREB CORTEX, V19, pI78, DOI 10.1093/cercor/bhp028; Nissen W, 2010, J NEUROSCI, V30, P1337, DOI 10.1523/JNEUROSCI.3481-09.2010; Oren I, 2009, J NEUROSCI, V29, P939, DOI 10.1523/JNEUROSCI.3251-08.2009; Petralia RS, 1997, J COMP NEUROL, V385, P456, DOI 10.1002/(SICI)1096-9861(19970901)385:3<456::AID-CNE9>3.0.CO;2-2; Philpot BD, 2001, NEURON, V29, P157, DOI 10.1016/S0896-6273(01)00187-8; Pickard L, 2001, NEUROPHARMACOLOGY, V41, P700, DOI 10.1016/S0028-3908(01)00127-7; Quinlan EM, 1999, NAT NEUROSCI, V2, P352, DOI 10.1038/7263; Sanchez-Vives MV, 2000, NAT NEUROSCI, V3, P1027, DOI 10.1038/79848; Sanz-Clemente A, 2010, NEURON, V67, P984, DOI 10.1016/j.neuron.2010.08.011; SHENG M, 1994, NATURE, V368, P144, DOI 10.1038/368144a0; Somogyi P, 2005, J PHYSIOL-LONDON, V562, P9, DOI 10.1113/jphysiol.2004.078915; Stoop R, 2003, J NEUROSCI, V23, P5634; Szabo A, 2012, J NEUROSCI, V32, P6511, DOI 10.1523/JNEUROSCI.0206-12.2012; Topolnik L, 2005, J NEUROSCI, V25, P990, DOI 10.1523/JNEUROSCI.4388-04.2005; Toth K, 1998, NAT NEUROSCI, V1, P572, DOI 10.1038/2807; Toth K, 2000, J PHYSIOL-LONDON, V525, P41, DOI 10.1111/j.1469-7793.2000.00041.x; Traynelis SF, 2010, PHARMACOL REV, V62, P405, DOI 10.1124/pr.109.002451; Tricoire L, 2011, J NEUROSCI, V31, P10948, DOI 10.1523/JNEUROSCI.0323-11.2011; Vucurovic K, 2010, CEREB CORTEX, V20, P2333, DOI 10.1093/cercor/bhp310; WILLIAMS K, 1993, NEURON, V10, P267, DOI 10.1016/0896-6273(93)90317-K; Wonders CP, 2006, NAT REV NEUROSCI, V7, P687, DOI 10.1038/nrn1954; Zhang L, 2008, NEUROSCIENCE, V154, P1440, DOI 10.1016/j.neuroscience.2008.05.002	46	76	77	1	21	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	AUG	2013	16	8					1032	U87		10.1038/nn.3459	http://dx.doi.org/10.1038/nn.3459			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	190EV	23852113	Green Accepted			2022-12-28	WOS:000322323000013
J	Lyst, MJ; Ekiert, R; Ebert, DH; Merusi, C; Nowak, J; Selfridge, J; Guy, J; Kastan, NR; Robinson, ND; Alves, FD; Rappsilber, J; Greenberg, ME; Bird, A				Lyst, Matthew J.; Ekiert, Robert; Ebert, Daniel H.; Merusi, Cara; Nowak, Jakub; Selfridge, Jim; Guy, Jacky; Kastan, Nathaniel R.; Robinson, Nathaniel D.; Alves, Flavia de Lima; Rappsilber, Juri; Greenberg, Michael E.; Bird, Adrian			Rett syndrome mutations abolish the interaction of MeCP2 with the NCoR/SMRT co-repressor	NATURE NEUROSCIENCE			English	Article							CPG-BINDING PROTEIN-2; EMBRYONIC STEM-CELLS; TRANSCRIPTIONAL REPRESSION; METHYLATED DNA; CHROMATIN; BRAIN; MICE; PHOSPHORYLATION; GENERATION; NEURONS	Rett syndrome (RTT) is a severe neurological disorder that is caused by mutations in the MECP2 gene. Many missense mutations causing RTT are clustered in the DNA-binding domain of MeCP2, suggesting that association with chromatin is critical for its function. We identified a second mutational cluster in a previously uncharacterized region of MeCP2. We found that RTT mutations in this region abolished the interaction between MeCP2 and the NCoR/SMRT co-repressor complexes. Mice bearing a common missense RTT mutation in this domain exhibited severe RTT-like phenotypes. Our data are compatible with the hypothesis that brain dysfunction in RTT is caused by a loss of the MeCP2 'bridge' between the NCoR/SMRT co-repressors and chromatin.	[Lyst, Matthew J.; Ekiert, Robert; Merusi, Cara; Nowak, Jakub; Selfridge, Jim; Guy, Jacky; Alves, Flavia de Lima; Rappsilber, Juri; Bird, Adrian] Univ Edinburgh, Wellcome Trust Ctr Cell Biol, Edinburgh, Midlothian, Scotland; [Ebert, Daniel H.; Kastan, Nathaniel R.; Robinson, Nathaniel D.; Greenberg, Michael E.] Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA	University of Edinburgh; Harvard University; Harvard Medical School	Bird, A (corresponding author), Univ Edinburgh, Wellcome Trust Ctr Cell Biol, Edinburgh, Midlothian, Scotland.	a.bird@ed.ac.uk	Rappsilber, Juri/B-7265-2015; Rappsilber, Juri/ABF-3328-2020; Nowak, Jakub Stanislaw/AFZ-0547-2022	Rappsilber, Juri/0000-0001-5999-1310; Nowak, Jakub Stanislaw/0000-0001-6536-2940; Ekiert, Robert/0000-0002-8879-0646; Bird, Adrian/0000-0002-8600-0372; SELFRIDGE, JIM/0000-0003-2473-4386; Guy, Jacky/0000-0002-8440-5667; Lyst, Matthew/0000-0001-9018-4138	Rett Syndrome Research Trust; Wellcome Trust; NIH [R01NS048276, K08MH90306]; NIHP30-HD [18655]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD018655] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [K08MH090306] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS048276] Funding Source: NIH RePORTER	Rett Syndrome Research Trust; Wellcome Trust(Wellcome TrustEuropean Commission); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIHP30-HD; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank Harrison Gabel for advice and materials, and Martha Koerner, Thomas Clouaire and Sabine Lagger for comments on the manuscript. The work was supported by a grant to A.B. and M.E.G. from the Rett Syndrome Research Trust and by grants from the Wellcome Trust (to A.B.) and the NIH R01NS048276 (to M.E.G.). D.H.E. was supported by NIH grant K08MH90306. The Mouse Gene Manipulation Facility of the Boston Children's Hospital Intellectual and Developmental Disabilities Research Center (IDDRC) was supported by grant NIHP30-HD 18655. R.E. and J.N. were funded by Wellcome Trust 4 year PhD studentships and J.R. holds a Wellcome Trust Senior Fellowship.	Agarwal N, 2011, HUM MOL GENET, V20, P4187, DOI 10.1093/hmg/ddr346; Amir RE, 1999, NAT GENET, V23, P185, DOI 10.1038/13810; ARAKI K, 1995, P NATL ACAD SCI USA, V92, P160, DOI 10.1073/pnas.92.1.160; BAIN G, 1995, DEV BIOL, V168, P342, DOI 10.1006/dbio.1995.1085; Chahrour M, 2008, SCIENCE, V320, P1224, DOI 10.1126/science.1153252; Chen RZ, 2001, NAT GENET, V27, P327, DOI 10.1038/85906; Christodoulou J, 2003, HUM MUTAT, V21, P466, DOI 10.1002/humu.10194; Cohen S, 2011, NEURON, V72, P72, DOI 10.1016/j.neuron.2011.08.022; COOPER DN, 1990, HUM GENET, V85, P55; Dragatsis I, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.3.e10; Drewell RA, 2002, NUCLEIC ACIDS RES, V30, P1139, DOI 10.1093/nar/30.5.1139; Ebert DH, 2013, NATURE, V499, P341, DOI 10.1038/nature12348; Fyfe S, 2003, J CHILD NEUROL, V18, P709, DOI 10.1177/08830738030180100301; Goffin D, 2012, NAT NEUROSCI, V15, P274, DOI 10.1038/nn.2997; Guy J, 2001, NAT GENET, V27, P322, DOI 10.1038/85899; Guy J, 2007, SCIENCE, V315, P1143, DOI 10.1126/science.1138389; Guy J, 2011, ANNU REV CELL DEV BI, V27, P631, DOI 10.1146/annurev-cellbio-092910-154121; Horike S, 2005, NAT GENET, V37, P31, DOI 10.1038/ng1491; Jiang Y, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-42; Klose RJ, 2004, J BIOL CHEM, V279, P46490, DOI 10.1074/jbc.M408284200; Kokura K, 2001, J BIOL CHEM, V276, P34115, DOI 10.1074/jbc.M105747200; Kudo S, 2003, J MED GENET, V40, P487, DOI 10.1136/jmg.40.7.487; LEWIS JD, 1992, CELL, V69, P905, DOI 10.1016/0092-8674(92)90610-O; Li M, 1998, CURR BIOL, V8, P971, DOI 10.1016/S0960-9822(98)70399-9; Muotri AR, 2010, NATURE, V468, P443, DOI 10.1038/nature09544; Nan XS, 1997, CELL, V88, P471, DOI 10.1016/S0092-8674(00)81887-5; Nan XS, 1998, NATURE, V393, P386, DOI 10.1038/30764; Ricciardi S, 2011, HUM MOL GENET, V20, P1182, DOI 10.1093/hmg/ddq563; Rothbauer U, 2008, MOL CELL PROTEOMICS, V7, P282, DOI 10.1074/mcp.M700342-MCP200; Schanen C, 2004, AM J MED GENET A, V126A, P129, DOI 10.1002/ajmg.a.20571; Schmiedeberg L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004636; Shahbazian MD, 2002, NEURON, V35, P243, DOI 10.1016/S0896-6273(02)00768-7; Skene PJ, 2010, MOL CELL, V37, P457, DOI 10.1016/j.molcel.2010.01.030; Stancheva I, 2003, MOL CELL, V12, P425, DOI 10.1016/S1097-2765(03)00276-4; Watson PJ, 2012, MOL CELL ENDOCRINOL, V348, P440, DOI 10.1016/j.mce.2011.08.033; Young JI, 2005, P NATL ACAD SCI USA, V102, P17551, DOI 10.1073/pnas.0507856102; Yusufzai TM, 2000, NUCLEIC ACIDS RES, V28, P4172, DOI 10.1093/nar/28.21.4172; Zhou ZL, 2006, NEURON, V52, P255, DOI 10.1016/j.neuron.2006.09.037	38	239	243	1	65	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JUL	2013	16	7					898	U268		10.1038/nn.3434	http://dx.doi.org/10.1038/nn.3434			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	174UM	23770565	Green Accepted			2022-12-28	WOS:000321180900023
J	O'Connor, DH; Hires, SA; Guo, ZCV; Li, N; Yu, JN; Sun, QQ; Huber, D; Svoboda, K				O'Connor, Daniel H.; Hires, S. Andrew; Guo, Zengcai V.; Li, Nuo; Yu, Jianing; Sun, Qian-Quan; Huber, Daniel; Svoboda, Karel			Neural coding during active somatosensation revealed using illusory touch	NATURE NEUROSCIENCE			English	Article							RAT BARREL CORTEX; SCANNING SENSORIMOTOR SYSTEM; OBJECT LOCALIZATION; CORTICAL MICROSTIMULATION; VIBRISSA CORTEX; TRANSGENIC MICE; MOTOR CORTEX; LAYER 5; WHISKER; BEHAVIOR	Active sensation requires the convergence of external stimuli with representations of body movements. We used mouse behavior, electrophysiology and optogenetics to dissect the temporal interactions among whisker movement, neural activity and sensation of touch. We photostimulated layer 4 activity in single barrels in a closed loop with whisking. Mimicking touch-related neural activity caused illusory perception of an object at a particular location, but scrambling the timing of the spikes over one whisking cycle (tens of milliseconds) did not abolish the illusion, indicating that knowledge of instantaneous whisker position is unnecessary for discriminating object locations. The illusions were induced only during bouts of directed whisking, when mice expected touch, and in the relevant barrel. Reducing activity biased behavior, consistent with a spike count code for object detection at a particular location. Our results show that mice integrate coding of touch with movement over timescales of a whisking bout to produce perception of active touch.	[O'Connor, Daniel H.; Hires, S. Andrew; Guo, Zengcai V.; Li, Nuo; Yu, Jianing; Sun, Qian-Quan; Huber, Daniel; Svoboda, Karel] Howard Hughes Med Inst, Ashburn, VA USA	Howard Hughes Medical Institute	Svoboda, K (corresponding author), Howard Hughes Med Inst, Janelia Farm Res Campus, Ashburn, VA USA.	svobodak@janelia.hhmi.org	Huber, Daniel/C-2932-2013; Hires, Samuel/E-4717-2015	Sun, Qian-Quan/0000-0002-5807-9327; Huber, Daniel/0000-0002-0744-7679	Howard Hughes Medical Institute Funding Source: Medline	Howard Hughes Medical Institute(Howard Hughes Medical Institute)		Armbruster BN, 2007, P NATL ACAD SCI USA, V104, P5163, DOI 10.1073/pnas.0700293104; ARMSTRONGJAMES M, 1992, J NEUROPHYSIOL, V68, P1345, DOI 10.1152/jn.1992.68.4.1345; Atasoy D, 2008, J NEUROSCI, V28, P7025, DOI 10.1523/JNEUROSCI.1954-08.2008; Bagdasarian K, 2013, NAT NEUROSCI, V16, P622, DOI 10.1038/nn.3378; Boyden ES, 2005, NAT NEUROSCI, V8, P1263, DOI 10.1038/nn1525; Clack NG, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002591; Crochet S, 2006, NAT NEUROSCI, V9, P608, DOI 10.1038/nn1690; Curtis JC, 2009, NAT NEUROSCI, V12, P492, DOI 10.1038/nn.2283; de Kock CPJ, 2007, J PHYSIOL-LONDON, V581, P139, DOI 10.1113/jphysiol.2006.124321; Diamond ME, 2008, NAT REV NEUROSCI, V9, P601, DOI 10.1038/nrn2411; Fee MS, 1997, J NEUROPHYSIOL, V78, P1144, DOI 10.1152/jn.1997.78.2.1144; Hill DN, 2011, NEURON, V72, P344, DOI 10.1016/j.neuron.2011.09.020; Hill DN, 2011, J NEUROSCI, V31, P8699, DOI 10.1523/JNEUROSCI.0971-11.2011; Histed MH, 2013, PROG NEUROBIOL, V103, P115, DOI 10.1016/j.pneurobio.2012.01.006; Huber D, 2012, NATURE, V484, P473, DOI 10.1038/nature11039; Huber D, 2008, NATURE, V451, P61, DOI 10.1038/nature06445; HUTSON KA, 1986, J NEUROPHYSIOL, V56, P1196, DOI 10.1152/jn.1986.56.4.1196; Jadhav SP, 2009, NAT NEUROSCI, V12, P792, DOI 10.1038/nn.2328; Karlsson MP, 2008, J NEUROSCI, V28, P14271, DOI 10.1523/JNEUROSCI.4261-08.2008; Kleinfeld D, 2011, NEURON, V72, P455, DOI 10.1016/j.neuron.2011.10.009; Knutsen PM, 2006, J NEUROSCI, V26, P8451, DOI 10.1523/JNEUROSCI.1516-06.2006; Knutsen PM, 2009, TRENDS NEUROSCI, V32, P101, DOI 10.1016/j.tins.2008.10.002; Larkum ME, 2004, CEREB CORTEX, V14, P1059, DOI 10.1093/cercor/bhh065; Lefort S, 2009, NEURON, V61, P301, DOI 10.1016/j.neuron.2008.12.020; Letzkus JJ, 2011, NATURE, V480, P331, DOI 10.1038/nature10674; Li X, 2005, P NATL ACAD SCI USA, V102, P17816, DOI 10.1073/pnas.0509030102; Liao GY, 2008, GENESIS, V46, P289, DOI 10.1002/dvg.20393; LU SM, 1993, SOMATOSENS MOT RES, V10, P1, DOI 10.3109/08990229309028819; Luo L, 2008, NEURON, V57, P634, DOI 10.1016/j.neuron.2008.01.002; Madisen L, 2012, NAT NEUROSCI, V15, P793, DOI 10.1038/nn.3078; Madisen L, 2010, NAT NEUROSCI, V13, P133, DOI 10.1038/nn.2467; Maier DL, 1999, P NATL ACAD SCI USA, V96, P9397, DOI 10.1073/pnas.96.16.9397; MASINO SA, 1993, P NATL ACAD SCI USA, V90, P9998, DOI 10.1073/pnas.90.21.9998; Mehta SB, 2007, PLOS BIOL, V5, P309, DOI 10.1371/journal.pbio.0050015; Mitchinson B, 2011, PHILOS T R SOC B, V366, P3037, DOI 10.1098/rstb.2011.0156; Nagel G, 2003, P NATL ACAD SCI USA, V100, P13940, DOI 10.1073/pnas.1936192100; O'Connor DH, 2010, NEURON, V67, P1048, DOI 10.1016/j.neuron.2010.08.026; O'Connor DH, 2010, J NEUROSCI, V30, P1947, DOI 10.1523/JNEUROSCI.3762-09.2010; O'Connor DH, 2009, NATURE, V461, P923, DOI 10.1038/nature08539; Pammer L, 2013, J NEUROSCI, V33, P6726, DOI 10.1523/JNEUROSCI.4316-12.2013; Panzeri S, 2001, NEURON, V29, P769, DOI 10.1016/S0896-6273(01)00251-3; Petreanu L, 2012, NATURE, V489, P299, DOI 10.1038/nature11321; Petreanu L, 2009, NATURE, V457, P1142, DOI 10.1038/nature07709; Pinto DJ, 2000, J NEUROPHYSIOL, V83, P1158, DOI 10.1152/jn.2000.83.3.1158; Poulet JFA, 2012, NAT NEUROSCI, V15, P370, DOI 10.1038/nn.3035; Romo R, 2000, NEURON, V26, P273, DOI 10.1016/S0896-6273(00)81156-3; SALZMAN CD, 1990, NATURE, V346, P174, DOI 10.1038/346174a0; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; SIMONS DJ, 1985, J NEUROPHYSIOL, V54, P615, DOI 10.1152/jn.1985.54.3.615; Slotnick B, 2009, J EXP ANAL BEHAV, V91, P253, DOI 10.1901/jeab.2009.91-253; Veinante P, 2000, J COMP NEUROL, V424, P197, DOI 10.1002/1096-9861(20000821)424:2<197::AID-CNE1>3.0.CO;2-6; Voigts J, 2008, J NEUROPHYSIOL, V100, P504, DOI 10.1152/jn.00012.2008; Wolpert DM, 2001, CURR BIOL, V11, pR729, DOI 10.1016/S0960-9822(01)00432-8; Xu NL, 2012, NATURE, V492, P247, DOI 10.1038/nature11601; Yarbus A.L., 1967, EYE MOVEMENTS VISION, DOI 10.1007/978-1-4899-5379-7; Yu CX, 2006, PLOS BIOL, V4, P819, DOI 10.1371/journal.pbio.0040124; Zhao SL, 2011, NAT METHODS, V8, P745, DOI 10.1038/nmeth.1668	57	148	149	1	62	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JUL	2013	16	7					958	U238		10.1038/nn.3419	http://dx.doi.org/10.1038/nn.3419			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	174UM	23727820	Green Accepted, Green Published			2022-12-28	WOS:000321180900031
J	Wang, CR; Liang, CC; Bian, ZC; Zhu, Y; Guan, JL				Wang, Chenran; Liang, Chun-Chi; Bian, Z. Christine; Zhu, Yuan; Guan, Jun-Lin			FIP200 is required for maintenance and differentiation of postnatal neural stem cells	NATURE NEUROSCIENCE			English	Article							SELF-RENEWAL; P53; AUTOPHAGY; NEUROGENESIS; SUPPRESSION; MECHANISMS; DELETION; NEURONS; ASTROCYTES; INDUCTION	Despite recent studies showing that inhibition of autophagy depletes the hematopoietic stem cell pool and increases intracellular reactive oxygen species (ROS), it remains unknown whether autophagy is essential in the maintenance of other stem cells. Moreover, it is unclear whether and how the aberrant ROS increase causes depletion of stem cells. Here we report that ablation of FIP200 (also known as Rb1cc1), a gene essential for autophagy induction in mammalian cells, results in a progressive loss of neural stem cells (NSCs) and impairment in neuronal differentiation specifically in the postnatal brain, but not the embryonic brain, in mice. The defect in maintaining the postnatal NSC pool was caused by p53-dependent apoptotic responses and cell cycle arrest. However, the impaired neuronal differentiation was rescued by treatment with the antioxidant N-acetylcysteine but not by p53 inactivation. These data reveal that FIP200-mediated autophagy contributes to the maintenance and functions of NSCs through regulation of oxidative state.	[Wang, Chenran; Liang, Chun-Chi; Bian, Z. Christine; Zhu, Yuan; Guan, Jun-Lin] Univ Michigan, Sch Med, Dept Internal Med, Div Mol Med & Genet, Ann Arbor, MI 48109 USA; [Zhu, Yuan; Guan, Jun-Lin] Univ Michigan, Sch Med, Dept Cell & Dev Biol, Ann Arbor, MI USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Guan, JL (corresponding author), Univ Michigan, Sch Med, Dept Internal Med, Div Mol Med & Genet, Ann Arbor, MI 48109 USA.	jlguan@umich.edu	Zhu, Yuan/ABF-8405-2020; wang, chenran/N-6629-2013; Liang, Chun-Chi/D-7986-2016	Liang, Chun-Chi/0000-0002-8345-8564	US National Institutes of Health [GM052890]; NATIONAL CANCER INSTITUTE [R01CA150926] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM052890] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We are grateful to J. Yuan of Harvard Medical School for Spautin-1. We thank our laboratory colleagues for their discussions, help throughout the project and comments of the manuscript. This research was supported by US National Institutes of Health grant GM052890 to J.-L.G.	Assaily W, 2011, MOL CELL, V44, P491, DOI 10.1016/j.molcel.2011.08.038; Chuikov S, 2010, NAT CELL BIOL, V12, P999, DOI 10.1038/ncb2101; Doetsch F, 1999, CELL, V97, P703, DOI 10.1016/S0092-8674(00)80783-7; Fukuda S, 2007, MOL CELL BIOL, V27, P4931, DOI 10.1128/MCB.02435-06; Gage FH, 2000, SCIENCE, V287, P1433, DOI 10.1126/science.287.5457.1433; Gan BY, 2006, J CELL BIOL, V175, P121, DOI 10.1083/jcb.200604129; Gil-Perotin S, 2006, J NEUROSCI, V26, P1107, DOI 10.1523/JNEUROSCI.3970-05.2006; Gross RE, 1996, NEURON, V17, P595, DOI 10.1016/S0896-6273(00)80193-2; Hack MA, 2005, NAT NEUROSCI, V8, P865, DOI 10.1038/nn1479; Hara T, 2008, J CELL BIOL, V181, P497, DOI 10.1083/jcb.200712064; Hara T, 2006, NATURE, V441, P885, DOI 10.1038/nature04724; He CC, 2009, ANNU REV GENET, V43, P67, DOI 10.1146/annurev-genet-102808-114910; Heins N, 2002, NAT NEUROSCI, V5, P308, DOI 10.1038/nn828; Imayoshi I, 2008, NAT NEUROSCI, V11, P1153, DOI 10.1038/nn.2185; Ito K, 2006, NAT MED, V12, P446, DOI 10.1038/nm1388; Kippin TE, 2005, GENE DEV, V19, P756, DOI 10.1101/gad.1272305; Komatsu M, 2006, NATURE, V441, P880, DOI 10.1038/nature04723; Kriegstein A, 2009, ANNU REV NEUROSCI, V32, P149, DOI 10.1146/annurev.neuro.051508.135600; Lane D, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000893; Le Belle JE, 2011, CELL STEM CELL, V8, P59, DOI 10.1016/j.stem.2010.11.028; Liang CC, 2010, J BIOL CHEM, V285, P3499, DOI 10.1074/jbc.M109.072389; Liu DP, 2010, NAT CELL BIOL, V12, P993, DOI 10.1038/ncb2100; Liu F, 2010, BLOOD, V116, P4806, DOI 10.1182/blood-2010-06-288589; Liu JL, 2011, CELL, V147, P223, DOI 10.1016/j.cell.2011.08.037; Louvi A, 2006, NAT REV NEUROSCI, V7, P93, DOI 10.1038/nrn1847; Madhavan L, 2006, STEM CELLS, V24, P2110, DOI 10.1634/stemcells.2006-0018; Mammucari C, 2007, CELL METAB, V6, P458, DOI 10.1016/j.cmet.2007.11.001; Mazumdar J, 2010, NAT CELL BIOL, V12, P1007, DOI 10.1038/ncb2102; Meletis K, 2006, DEVELOPMENT, V133, P363, DOI 10.1242/dev.02208; Merkle FT, 2004, P NATL ACAD SCI USA, V101, P17528, DOI 10.1073/pnas.0407893101; Ming GL, 2011, NEURON, V70, P687, DOI 10.1016/j.neuron.2011.05.001; Mizushima N, 2004, INT J BIOCHEM CELL B, V36, P2491, DOI 10.1016/j.biocel.2004.02.005; Mizushima N, 2011, CELL, V147, P728, DOI 10.1016/j.cell.2011.10.026; Mortensen M, 2011, J EXP MED, V208, P455, DOI 10.1084/jem.20101145; Noble M, 2005, ANTIOXID REDOX SIGN, V7, P1456, DOI 10.1089/ars.2005.7.1456; Paik JH, 2009, CELL STEM CELL, V5, P540, DOI 10.1016/j.stem.2009.09.013; Prozorovski T, 2008, NAT CELL BIOL, V10, P385, DOI 10.1038/ncb1700; Quick KL, 2001, ANN NEUROL, V49, P627, DOI 10.1002/ana.1005; Renault VM, 2009, CELL STEM CELL, V5, P527, DOI 10.1016/j.stem.2009.09.014; REYNOLDS BA, 1992, SCIENCE, V255, P1707, DOI 10.1126/science.1553558; Singh R, 2009, J CLIN INVEST, V119, P3329, DOI 10.1172/JCI39228; Tothova Z, 2007, CELL, V128, P325, DOI 10.1016/j.cell.2007.01.003; Ueda H, 2000, J CELL BIOL, V149, P423, DOI 10.1083/jcb.149.2.423; Vazquez A, 2008, NAT REV DRUG DISCOV, V7, P979, DOI 10.1038/nrd2656; Vousden KH, 2009, CELL, V137, P413, DOI 10.1016/j.cell.2009.04.037; Wang Y, 2009, CANCER CELL, V15, P514, DOI 10.1016/j.ccr.2009.04.001; Wei HJ, 2011, GENE DEV, V25, P1510, DOI 10.1101/gad.2051011; Wei HJ, 2009, J BIOL CHEM, V284, P6004, DOI 10.1074/jbc.M806375200; Zhang Y, 2009, P NATL ACAD SCI USA, V106, P19860, DOI 10.1073/pnas.0906048106; Zhao CM, 2008, CELL, V132, P645, DOI 10.1016/j.cell.2008.01.033; Zhao Y, 2010, NAT CELL BIOL, V12, P665, DOI 10.1038/ncb2069; Zhu Y, 2005, CANCER CELL, V8, P119, DOI 10.1016/j.ccr.2005.07.004	52	118	121	0	28	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAY	2013	16	5					532	+		10.1038/nn.3365	http://dx.doi.org/10.1038/nn.3365			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	131WT	23542691	Green Accepted			2022-12-28	WOS:000318029300009
J	[Anonymous]				[Anonymous]			Focus on memory	NATURE NEUROSCIENCE			English	Editorial Material																			0	1	1	0	8	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	FEB	2013	16	2					111	111						1	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	080RE	23354379	Bronze			2022-12-28	WOS:000314260200001
J	MacAskill, AF; Little, JP; Cassel, JM; Carter, AG				MacAskill, Andrew F.; Little, Justin P.; Cassel, John M.; Carter, Adam G.			Subcellular connectivity underlies pathway-specific signaling in the nucleus accumbens	NATURE NEUROSCIENCE			English	Article							PREFRONTAL CORTEX; GENE-EXPRESSION; DISTINCT ROLES; NEURONS; HIPPOCAMPAL; SPINES; INPUTS; TRANSMISSION; MODULATION; AMYGDALA	We found that medium spiny neurons (MSNs) in both the direct and indirect pathways of the mouse nucleus accumbens (NAc) receive inputs from the cortex, thalamus and hippocampus. However, hippocampal inputs were much weaker onto indirect MSNs, where they contacted small spines located in the distal dendrites. This selective targeting means that these inputs must be gated by subthreshold depolarization to trigger action potentials and influence NAc output.	[MacAskill, Andrew F.; Little, Justin P.; Cassel, John M.; Carter, Adam G.] NYU, Ctr Neural Sci, New York, NY 10003 USA	New York University	Carter, AG (corresponding author), NYU, Ctr Neural Sci, New York, NY 10003 USA.	adam.carter@nyu.edu	MacAskill, Andrew/AFO-2061-2022	MacAskill, Andrew/0000-0002-0196-3779	Whitehall Foundation; Dana Foundation; McKnight Foundation	Whitehall Foundation; Dana Foundation; McKnight Foundation	We thank members of the Carter laboratory, M. Farrant, B. Sabatini and R. Tsien for helpful discussions and comments on the manuscript. This work was supported by the Whitehall Foundation, Dana Foundation and McKnight Foundation (A. G. C.). A. F. M. is a Sir Henry Wellcome Postdoctoral Fellow.	ALBIN RL, 1989, TRENDS NEUROSCI, V12, P366, DOI 10.1016/0166-2236(89)90074-X; Belujon P, 2008, J NEUROSCI, V28, P9797, DOI 10.1523/JNEUROSCI.2200-08.2008; Boyden ES, 2005, NAT NEUROSCI, V8, P1263, DOI 10.1038/nn1525; Carter AG, 2004, NEURON, V44, P483, DOI 10.1016/j.neuron.2004.10.013; Carter AG, 2002, NAT NEUROSCI, V5, P1309, DOI 10.1038/nn970; Chalifoux JR, 2011, J NEUROSCI, V31, P4221, DOI 10.1523/JNEUROSCI.4561-10.2011; Chen XW, 2011, NATURE, V475, P501, DOI 10.1038/nature10193; Dayan P, 2001, COMPUTATIONAL NEUROS; Finch DM, 1996, HIPPOCAMPUS, V6, P495; Franklin K.B.J., 2008, MOUSE BRAIN STEREOTA; French SJ, 2002, J COMP NEUROL, V446, P151, DOI 10.1002/cne.10191; GERFEN CR, 1990, SCIENCE, V250, P1429, DOI 10.1126/science.2147780; Gong SC, 2003, NATURE, V425, P917, DOI 10.1038/nature02033; Goto Y, 2005, NAT NEUROSCI, V8, P805, DOI 10.1038/nn1471; Groenewegen HJ, 1999, ANN NY ACAD SCI, V877, P49, DOI 10.1111/j.1749-6632.1999.tb09260.x; Hikida T, 2010, NEURON, V66, P896, DOI 10.1016/j.neuron.2010.05.011; Jaffe DB, 1999, J NEUROPHYSIOL, V82, P3268, DOI 10.1152/jn.1999.82.6.3268; Kravitz AV, 2012, NAT NEUROSCI, V15, P816, DOI 10.1038/nn.3100; Little JP, 2012, J NEUROSCI, V32, P12808, DOI 10.1523/JNEUROSCI.1616-12.2012; Lobo MK, 2010, SCIENCE, V330, P385, DOI 10.1126/science.1188472; London M, 2005, ANNU REV NEUROSCI, V28, P503, DOI 10.1146/annurev.neuro.28.061604.135703; ODONNELL P, 1995, J NEUROSCI, V15, P3622; Petreanu L, 2007, NAT NEUROSCI, V10, P663, DOI 10.1038/nn1891; Plotkin JL, 2011, NAT NEUROSCI, V14, P881, DOI 10.1038/nn.2848; Rodriguez A, 2006, NAT PROTOC, V1, P2152, DOI 10.1038/nprot.2006.313; Russo SJ, 2010, TRENDS NEUROSCI, V33, P267, DOI 10.1016/j.tins.2010.02.002; Sesack SR, 2010, NEUROPSYCHOPHARMACOL, V35, P27, DOI 10.1038/npp.2009.93; Shuen JA, 2008, J NEUROSCI, V28, P2681, DOI 10.1523/JNEUROSCI.5492-07.2008; Stuber GD, 2011, NATURE, V475, P377, DOI 10.1038/nature10194; YASUDA R, 2004, SCI STKE, pPL5	30	62	64	0	28	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	DEC	2012	15	12					1624	+		10.1038/nn.3254	http://dx.doi.org/10.1038/nn.3254			5	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	045OR	23143514	Green Accepted			2022-12-28	WOS:000311706700007
J	Simoncini, C; Perrinet, LU; Montagnini, A; Mamassian, P; Masson, GS				Simoncini, Claudio; Perrinet, Laurent U.; Montagnini, Anna; Mamassian, Pascal; Masson, Guillaume S.			More is not always better: adaptive gain control explains dissociation between perception and action	NATURE NEUROSCIENCE			English	Article							OCULAR-FOLLOWING RESPONSES; MOTION PERCEPTION; NORMALIZATION; DYNAMICS; MT; REPRESENTATION; MECHANISMS; MASKING; NEURONS; MODEL	Moving objects generate motion information at different scales, which are processed in the visual system with a bank of spatiotemporal frequency channels. It is not known how the brain pools this information to reconstruct object speed and whether this pooling is generic or adaptive; that is, dependent on the behavioral task. We used rich textured motion stimuli of varying bandwidths to decipher how the human visual motion system computes object speed in different behavioral contexts. We found that, although a simple visuomotor behavior such as short-latency ocular following responses takes advantage of the full distribution of motion signals, perceptual speed discrimination is impaired for stimuli with large bandwidths. Such opposite dependencies can be explained by an adaptive gain control mechanism in which the divisive normalization pool is adjusted to meet the different constraints of perception and action.	[Mamassian, Pascal] CNRS, Lab Psychol Percept, UMR8158, Paris, France; [Mamassian, Pascal] Univ Paris 05, Paris, France; [Simoncini, Claudio; Perrinet, Laurent U.; Montagnini, Anna; Masson, Guillaume S.] CNRS, Team InViBe, Inst Neurosci Timone, UMR 7289, Marseille, France; [Simoncini, Claudio; Perrinet, Laurent U.; Montagnini, Anna; Masson, Guillaume S.] Aix Marseille Univ, Marseille, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; UDICE-French Research Universities; Aix-Marseille Universite	Mamassian, P (corresponding author), CNRS, Lab Psychol Percept, UMR8158, Paris, France.	pascal.mamassian@parisdescartes.fr; guillaume.masson@univ-amu.fr	Perrinet, Laurent U./C-4900-2009; MASSON, Guillaume S/G-4615-2012; Mamassian, Pascal/F-4781-2012	Perrinet, Laurent U./0000-0002-9536-010X; MASSON, Guillaume S/0000-0001-9227-0777; Mamassian, Pascal/0000-0002-1605-4607	EU [PITN-2008-214728, IST-FET-2005-15879, IST-FET-2011-269921]; Centre National de la Recherche Scientifique	EU(European Commission); Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS))	We thank J. Colombet, F. Barthelemy and X. DeGiovanni for their excellent technical support and A. Meso for improving the readability of the manuscript. We are grateful to Y. Fregnac, P. Cavanagh, K. Gegenfurtner, A. Movshon and T. Freeman for helpful comments and discussions in the preparation of the manuscript. This work was supported by the EU grant CODDE (VIIth Framework, Marie Curie Program, PITN-2008-214728), by the Centre National de la Recherche Scientifique and by the EU projects FACETS (VIth Framework, IST-FET-2005-15879) and BrainScales (VIth Framework, IST-FET-2011-269921).	Barthelemy FV, 2008, VISION RES, V48, P501, DOI 10.1016/j.visres.2007.10.020; Beutter BR, 1998, VISION RES, V38, P1273, DOI 10.1016/S0042-6989(97)00276-9; BRITTEN KH, 1993, VISUAL NEUROSCI, V10, P1157, DOI 10.1017/S0952523800010269; Busse L, 2009, NEURON, V64, P931, DOI 10.1016/j.neuron.2009.11.004; Candy TR, 2001, J NEUROSCI, V21, P4530, DOI 10.1523/JNEUROSCI.21-12-04530.2001; Carandini M, 2012, NAT REV NEUROSCI, V13, P51, DOI 10.1038/nrn3136; Cardoso-Leite P, 2010, SEEING PERCEIVING, V23, P89, DOI 10.1163/187847510X503588; Chen YZ, 2006, NAT NEUROSCI, V9, P1412, DOI 10.1038/nn1792; Churchland AK, 2003, NEURON, V37, P1001, DOI 10.1016/S0896-6273(03)00145-4; GELLMAN RS, 1990, VISUAL NEUROSCI, V5, P107, DOI 10.1017/S0952523800000158; Green DM, 1966, SIGNAL DETECTION THE; Hautus MJ, 2002, PERCEPT PSYCHOPHYS, V64, P89, DOI 10.3758/BF03194559; HEEGER DJ, 1992, VISUAL NEUROSCI, V9, P181, DOI 10.1017/S0952523800009640; Jazayeri M, 2006, NAT NEUROSCI, V9, P690, DOI 10.1038/nn1691; Jazayeri M, 2007, J VISION, V7, DOI 10.1167/7.12.7; Krauzlis RJ, 2001, VISUAL NEUROSCI, V18, P365, DOI 10.1017/S0952523801183033; Leon PS, 2012, J NEUROPHYSIOL, V107, P3217, DOI 10.1152/jn.00737.2011; Lisberger SG, 2010, NEURON, V66, P477, DOI 10.1016/j.neuron.2010.03.027; Masson GS, 2002, J NEUROSCI, V22, P5149, DOI 10.1523/JNEUROSCI.22-12-05149.2002; Masson GS, 2012, NEUROSCI BIOBEHAV R, V36, P1, DOI 10.1016/j.neubiorev.2011.03.009; MCKEE SP, 1981, VISION RES, V21, P491, DOI 10.1016/0042-6989(81)90095-X; MILES FA, 1986, J NEUROPHYSIOL, V56, P1321, DOI 10.1152/jn.1986.56.5.1321; Milner AD, 2006, VISUAL BRAIN ACTION, DOI 10.1093/acprof:oso/9780198524724.001.0001; Ohshiro T, 2011, NAT NEUROSCI, V14, P775, DOI 10.1038/nn.2815; Perrone JA, 2001, NAT NEUROSCI, V4, P526, DOI 10.1038/87480; Priebe NJ, 2006, J NEUROSCI, V26, P2941, DOI 10.1523/JNEUROSCI.3936-05.2006; Reisbeck TE, 1999, VISION RES, V39, P3267, DOI 10.1016/S0042-6989(99)00017-6; Reynaud A, 2012, J NEUROSCI, V32, P12558, DOI 10.1523/JNEUROSCI.1618-12.2012; Rust NC, 2005, NEURON, V46, P945, DOI 10.1016/j.neuron.2005.05.021; Rust NC, 2006, NAT NEUROSCI, V9, P1421, DOI 10.1038/nn1786; Schenk T, 2011, VISION RES, V51, P812, DOI 10.1016/j.visres.2011.02.003; Schrater PR, 2000, NAT NEUROSCI, V3, P64, DOI 10.1038/71134; Schwartz O, 2001, NAT NEUROSCI, V4, P819, DOI 10.1038/90526; Sheliga BM, 2006, VISION RES, V46, P2041, DOI 10.1016/j.visres.2005.11.033; Spering M, 2007, J NEUROPHYSIOL, V98, P1355, DOI 10.1152/jn.00476.2007; Spering M, 2011, PSYCHOL SCI, V22, P216, DOI 10.1177/0956797610394659; Spering M, 2011, VISION RES, V51, P836, DOI 10.1016/j.visres.2010.10.017; Tavassoli A, 2010, CURR BIOL, V20, pR93, DOI 10.1016/j.cub.2009.11.048; Tsai JJ, 2012, J NEUROSCI, V32, P2783, DOI 10.1523/JNEUROSCI.4485-11.2012; Vinje WE, 2000, SCIENCE, V287, P1273, DOI 10.1126/science.287.5456.1273; Webb BS, 2010, VISION RES, V50, P2274, DOI 10.1016/j.visres.2010.04.019	41	45	45	0	32	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	NOV	2012	15	11					1596	1603		10.1038/nn.3229	http://dx.doi.org/10.1038/nn.3229			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	028LX	23023292				2022-12-28	WOS:000310424900021
J	Baliki, MN; Petre, B; Torbey, S; Herrmann, KM; Huang, LJ; Schnitzer, TJ; Fields, HL; Apkarian, AV				Baliki, Marwan N.; Petre, Bogdan; Torbey, Souraya; Herrmann, Kristina M.; Huang, Lejian; Schnitzer, Thomas J.; Fields, Howard L.; Apkarian, A. Vania			Corticostriatal functional connectivity predicts transition to chronic back pain	NATURE NEUROSCIENCE			English	Article							BRAIN	The mechanism of brain reorganization in pain chronification is unknown. In a longitudinal brain imaging study, subacute back pain (SBP) patients were followed over the course of 1 year. When pain persisted (SBPp, in contrast to recovering SBP and healthy controls), brain gray matter density decreased. Initially greater functional connectivity of nucleus accumbens with prefrontal cortex predicted pain persistence, implying that corticostriatal circuitry is causally involved in the transition from acute to chronic pain.	[Baliki, Marwan N.; Petre, Bogdan; Torbey, Souraya; Herrmann, Kristina M.; Huang, Lejian; Apkarian, A. Vania] Northwestern Univ, Feinberg Sch Med, Dept Physiol, Chicago, IL 60611 USA; [Schnitzer, Thomas J.] Northwestern Univ, Feinberg Sch Med, Dept Rheumatol, Chicago, IL 60611 USA; [Fields, Howard L.] Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94143 USA; [Fields, Howard L.] Univ Calif San Francisco, Ernest Gallo Clin & Res Ctr, San Francisco, CA 94143 USA; [Apkarian, A. Vania] Northwestern Univ, Feinberg Sch Med, Dept Anesthesia, Chicago, IL 60611 USA; [Apkarian, A. Vania] Northwestern Univ, Feinberg Sch Med, Dept Surg, Chicago, IL 60611 USA	Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Ernest Gallo Clinic & Research Center; Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine	Apkarian, AV (corresponding author), Northwestern Univ, Feinberg Sch Med, Dept Physiol, Chicago, IL 60611 USA.	a-apkarian@northwestern.edu	Petre, Bogdan/L-5927-2019; Fields, Howard/ABG-9073-2020	Apkarian, A. Vania/0000-0002-9788-7458	National Institute of Neurological Disorders and Stroke [NS35115]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS035115] Funding Source: NIH RePORTER	National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank all of the patients and healthy volunteers that participated in the study. The study was funded by the National Institute of Neurological Disorders and Stroke (NS35115). M.N.B. was funded by an anonymous foundation.	Apkarian AV, 2011, PAIN, V152, pS49, DOI 10.1016/j.pain.2010.11.010; Baliki MN, 2009, J NEUROPHYSIOL, V101, P875, DOI 10.1152/jn.91100.2008; Baliki MN, 2008, J NEUROSCI, V28, P1398, DOI 10.1523/JNEUROSCI.4123-07.2008; Baliki MN, 2006, J NEUROSCI, V26, P12165, DOI 10.1523/JNEUROSCI.3576-06.2006; Baliki MN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026010; Baliki MN, 2010, NEURON, V66, P149, DOI 10.1016/j.neuron.2010.03.002; Chanda ML, 2011, J PAIN, V12, P792, DOI 10.1016/j.jpain.2011.01.008; Chou R, 2010, JAMA-J AM MED ASSOC, V303, P1295, DOI 10.1001/jama.2010.344; Fox MD, 2005, P NATL ACAD SCI USA, V102, P9673, DOI 10.1073/pnas.0504136102; Isnard J, 2011, PAIN, V152, P946, DOI 10.1016/j.pain.2010.12.025; Johansen JP, 2004, NAT NEUROSCI, V7, P398, DOI 10.1038/nn1207; Seminowicz DA, 2011, J NEUROSCI, V31, P7540, DOI 10.1523/JNEUROSCI.5280-10.2011; Seymour B, 2004, NATURE, V429, P664, DOI 10.1038/nature02581; Smith SM, 2009, NEUROIMAGE, V44, P83, DOI 10.1016/j.neuroimage.2008.03.061; Ungless MA, 2004, SCIENCE, V303, P2040, DOI 10.1126/science.1093360; Woolf CJ, 2000, SCIENCE, V288, P1765, DOI 10.1126/science.288.5472.1765; Yarkoni T, 2011, NAT METHODS, V8, P665, DOI [10.1038/NMETH.1635, 10.1038/nmeth.1635]; Zubieta JK, 2005, J NEUROSCI, V25, P7754, DOI 10.1523/JNEUROSCI.0439-05.2005	18	615	636	4	75	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	AUG	2012	15	8					1117	+		10.1038/nn.3153	http://dx.doi.org/10.1038/nn.3153			5	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	979UE	22751038	Green Submitted, Green Accepted			2022-12-28	WOS:000306844500017
J	Cho, H; Yang, YD; Lee, J; Lee, B; Kim, T; Jang, Y; Back, SK; Na, HS; Harfe, BD; Wang, F; Raouf, R; Wood, JN; Oh, U				Cho, Hawon; Yang, Young Duk; Lee, Jesun; Lee, Byeongjoon; Kim, Tahnbee; Jang, Yongwoo; Back, Seung Keun; Na, Heung Sik; Harfe, Brian D.; Wang, Fan; Raouf, Ramin; Wood, John N.; Oh, Uhtaek			The calcium-activated chloride channel anoctamin 1 acts as a heat sensor in nociceptive neurons	NATURE NEUROSCIENCE			English	Article							CAPSAICIN-RECEPTOR; NOXIOUS HEAT; ION CHANNELS; PAIN PATHWAY; IN-VITRO; MEMBRANE; CURRENTS; TMEM16A; TRPV1; RAT	Nociceptors are a subset of small primary afferent neurons that respond to noxious chemical, thermal and mechanical stimuli. Ion channels in nociceptors respond differently to noxious stimuli and generate electrical signals in different ways. Anoctamin 1 (ANO1 also known as TMEM16A) is a Ca2+-activated chloride channel that is essential for numerous physiological functions. We found that ANO1 was activated by temperatures over 44 degrees C with steep heat sensitivity. ANO1 was expressed in small sensory neurons and was highly colocalized with nociceptor markers, which suggests that it may be involved in nociception. Application of heat ramps to dorsal root ganglion (DRG) neurons elicited robust ANO1-dependent depolarization. Furthermore, knockdown or deletion of ANO1 in DRG neurons substantially reduced nociceptive behavior in thermal pain models. These results indicate that ANO1 is a heat sensor that detects nociceptive thermal stimuli in sensory neurons and possibly mediates nociception.	[Cho, Hawon; Lee, Jesun; Lee, Byeongjoon; Kim, Tahnbee; Jang, Yongwoo; Oh, Uhtaek] Seoul Natl Univ, Coll Pharm, Creat Res Initiat, Sensory Res Ctr, Seoul, South Korea; [Yang, Young Duk] CHA Univ, Coll Pharm, Dept Pharm, Gyeonggi Do, South Korea; [Back, Seung Keun; Na, Heung Sik] Korea Univ, Coll Med, Dept Physiol, Seoul 136705, South Korea; [Harfe, Brian D.] Univ Florida, Coll Med, Dept Mol Genet & Microbiol, Gainesville, FL USA; [Harfe, Brian D.] Univ Florida, Coll Med, Genet Inst, Gainesville, FL USA; [Wang, Fan] Duke Univ, Med Ctr, Dept Cell Biol, Durham, NC 27710 USA; [Raouf, Ramin; Wood, John N.] UCL, Wolfson Inst Biomed Res, Mol Nocicept Grp, London, England; [Oh, Uhtaek] Seoul Natl Univ, Grad Sch Convergence Sci & Technol, Dept Mol Med & Biopharmaceut Sci, Seoul, South Korea	Seoul National University (SNU); Pochon Cha University; Korea University; Korea University Medicine (KU Medicine); State University System of Florida; University of Florida; State University System of Florida; University of Florida; Duke University; University of London; University College London; Seoul National University (SNU)	Oh, U (corresponding author), Seoul Natl Univ, Coll Pharm, Creat Res Initiat, Sensory Res Ctr, Seoul, South Korea.	utoh@snu.ac.kr	Jang, Yongwoo/Y-9854-2018	Jang, Yongwoo/0000-0003-1574-9009; Kim, Tahnbee/0000-0001-8090-4269; Raouf, Ramin/0000-0002-5890-2221	World Class University [R31-2011-00101030]; Creative Research Initiatives Program [20120001246]; Brain Research Center [2011K000275]; Ministry of Education and Science and Technology; National Research Foundation of the Republic of Korea; Biotechnology and Biological Sciences Research Council [BB/F000227/1] Funding Source: researchfish; Medical Research Council [G0901905] Funding Source: researchfish; BBSRC [BB/F000227/1] Funding Source: UKRI; MRC [G0901905] Funding Source: UKRI	World Class University; Creative Research Initiatives Program; Brain Research Center; Ministry of Education and Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea); National Research Foundation of the Republic of Korea(National Research Foundation of Korea); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by the World Class University project (R31-2011-00101030), the Creative Research Initiatives Program (20120001246) and a grant (2011K000275) from the Brain Research Center of the 21st Century Frontier Research Program funded by of the Ministry of Education and Science and Technology and the National Research Foundation of the Republic of Korea.	Alvarez-Leefmans FJ, 2009, PHYSIOLOGY AND PATHOLOGY OF CHLORIDE TRANSPORTERS AND CHANNELS IN THE NERVOUS SYSTEM: FROM MOLECULES TO DISEASES, P439; Basbaum AI, 2009, CELL, V139, P267, DOI 10.1016/j.cell.2009.09.028; Caputo A, 2008, SCIENCE, V322, P590, DOI 10.1126/science.1163518; Caterina MJ, 2007, AM J PHYSIOL-REG I, V292, pR64, DOI 10.1152/ajpregu.00446.2006; Caterina MJ, 2000, SCIENCE, V288, P306, DOI 10.1126/science.288.5464.306; Caterina MJ, 1997, NATURE, V389, P816, DOI 10.1038/39807; Caterina MJ, 1999, NATURE, V398, P436, DOI 10.1038/18906; Cia D, 2005, J NEUROPHYSIOL, V93, P1468, DOI 10.1152/jn.00874.2004; Davis JB, 2000, NATURE, V405, P183, DOI 10.1038/35012076; Dhaka A, 2006, ANNU REV NEUROSCI, V29, P135, DOI 10.1146/annurev.neuro.29.051605.112958; Frings S, 2000, PROG NEUROBIOL, V60, P247, DOI 10.1016/S0301-0082(99)00027-1; Hans G, 2008, NEUROPEPTIDES, V42, P119, DOI 10.1016/j.npep.2007.12.001; Hartzell C, 2005, ANNU REV PHYSIOL, V67, P719, DOI 10.1146/annurev.physiol.67.032003.154341; Hasegawa H, 2007, J NEUROSCI, V27, P14404, DOI 10.1523/JNEUROSCI.4908-07.2007; Hu HZ, 2004, J BIOL CHEM, V279, P35741, DOI 10.1074/jbc.M404164200; Jordt SE, 2004, NATURE, V427, P260, DOI 10.1038/nature02282; Kaneko H, 2002, CURR TOP MEMBR, V53, P167, DOI 10.1016/S1063-5823(02)53033-7; Karashima Y, 2009, P NATL ACAD SCI USA, V106, P1273, DOI 10.1073/pnas.0808487106; Kleene SJ, 1997, BIOPHYS J, V73, P1110, DOI 10.1016/S0006-3495(97)78143-8; Labrakakis C, 2003, J PHYSIOL-LONDON, V549, P131, DOI 10.1113/jphysiol.2002.031963; Lalonde MR, 2008, CHANNELS, V2, P252, DOI 10.4161/chan.2.4.6704; Lang PM, 2003, J NEUROPHYSIOL, V90, P3295, DOI 10.1152/jn.00512.2003; Large WA, 1996, AM J PHYSIOL-CELL PH, V271, pC435; LOWE G, 1993, NATURE, V366, P283, DOI 10.1038/366283a0; Macpherson LJ, 2005, CURR BIOL, V15, P929, DOI 10.1016/j.cub.2005.04.018; Perl ER, 2007, NAT REV NEUROSCI, V8, P71, DOI 10.1038/nrn2042; Price TJ, 2009, BRAIN RES REV, V60, P149, DOI 10.1016/j.brainresrev.2008.12.015; Rocha-Gonzalez HI, 2008, J NEUROPHYSIOL, V100, P169, DOI 10.1152/jn.01007.2007; Rock JR, 2008, DEV BIOL, V321, P141, DOI 10.1016/j.ydbio.2008.06.009; Schroeder BC, 2008, CELL, V134, P1019, DOI 10.1016/j.cell.2008.09.003; SCOTT RH, 1995, PHARMACOL THERAPEUT, V66, P535, DOI 10.1016/0163-7258(95)00018-C; Shibata M, 2004, J BIOL CHEM, V279, P40084, DOI 10.1074/jbc.M403844200; Story GM, 2003, CELL, V112, P819, DOI 10.1016/S0092-8674(03)00158-2; Talavera K, 2008, TRENDS NEUROSCI, V31, P287, DOI 10.1016/j.tins.2008.03.002; Tominaga M, 1998, NEURON, V21, P531, DOI 10.1016/S0896-6273(00)80564-4; Voets T, 2003, J MEMBRANE BIOL, V192, P1, DOI 10.1007/s00232-002-1059-8; Vriens J, 2011, NEURON, V70, P482, DOI 10.1016/j.neuron.2011.02.051; Vyklicky L, 1999, J PHYSIOL-LONDON, V517, P181, DOI 10.1111/j.1469-7793.1999.0181z.x; Willis EF, 2004, CLIN EXP ALLERGY, V34, P450, DOI 10.1111/j.1365-2222.2004.01898.x; Willis WD, 2006, PROG NEUROBIOL, V78, P189, DOI 10.1016/j.pneurobio.2006.02.007; Woodbury CJ, 2004, J NEUROSCI, V24, P6410, DOI 10.1523/JNEUROSCI.1421-04.2004; Xiao BL, 2011, NAT CHEM BIOL, V7, P351, DOI [10.1038/NCHEMBIO.558, 10.1038/nchembio.558]; Yang YD, 2008, NATURE, V455, P1210, DOI 10.1038/nature07313; Zhang SYL, 2005, NATURE, V437, P902, DOI 10.1038/nature04147; Zholos A, 2005, J GEN PHYSIOL, V125, P197, DOI 10.1085/jgp.200409161	45	255	264	1	41	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUL	2012	15	7					1015	1021		10.1038/nn.3111	http://dx.doi.org/10.1038/nn.3111			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	966EE	22634729				2022-12-28	WOS:000305819600020
J	Sheng, JS; He, LM; Zheng, HW; Xue, L; Luo, FJ; Shin, W; Sun, T; Kuner, T; Yue, DT; Wu, LG				Sheng, Jiansong; He, Liming; Zheng, Hongwei; Xue, Lei; Luo, Fujun; Shin, Wonchul; Sun, Tao; Kuner, Thomas; Yue, David T.; Wu, Ling-Gang			Calcium-channel number critically influences synaptic strength and plasticity at the active zone	NATURE NEUROSCIENCE			English	Article							READILY RELEASABLE POOL; CALYX-TYPE SYNAPSE; FAST CNS SYNAPSE; TRANSMITTER RELEASE; CA2+ CHANNELS; NEUROTRANSMITTER RELEASE; PRESYNAPTIC CAPACITANCE; DETERMINES FAST; TRAPEZOID BODY; MEDIAL NUCLEUS	How synaptic-vesicle release is controlled at the basic release structure, the active zone, is poorly understood. By performing cell-attached current and capacitance recordings predominantly at single active zones in rat calyces, we found that single active zones contained 5-218 (mean, 42) calcium channels and 1-10 (mean, 5) readily releasable vesicles (RRVs) and released 0-5 vesicles during a 2-ms depolarization. Large variation in the number of calcium channels caused wide variation in release strength (measured during a 2-ms depolarization) by regulating the RRV release probability (P-RRV) and the RRV number. Consequently, an action potential opened similar to 1-35 (mean, similar to 7) channels, resulting in different release probabilities at different active zones. As the number of calcium-channels determined P-RRV, it critically influenced whether subsequent release would be facilitated or depressed. Regulating calcium channel density at active zones may thus be a major mechanism to yield synapses with different release properties and plasticity. These findings may explain large differences reported at synapses regarding release strength (release of 0,1 or multiple vesicles), P-RRV, short-term plasticity, calcium transients and the requisite calcium-channel number for triggering release.	[Sheng, Jiansong; He, Liming; Xue, Lei; Luo, Fujun; Shin, Wonchul; Sun, Tao; Wu, Ling-Gang] Natl Inst Neurol Disorders & Stroke, Bethesda, MD USA; [Zheng, Hongwei] Heidelberg Univ, Interdisciplinary Ctr Sci Comp, Inst Pharmacol, Heidelberg, Germany; [Zheng, Hongwei; Kuner, Thomas] Heidelberg Univ, Inst Anat & Cell Biol, Heidelberg, Germany; [Yue, David T.] Johns Hopkins Univ, Sch Med, Dept Biomed Engn, Baltimore, MD 21205 USA; [Yue, David T.] Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS); Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; Johns Hopkins University; Johns Hopkins University	Wu, LG (corresponding author), Natl Inst Neurol Disorders & Stroke, Bethesda, MD USA.	wul@ninds.nih.gov	SHENG, JIANSONG/K-1914-2013; Luo, Fujun/I-1016-2013	Luo, Fujun/0000-0001-9487-6545	US National Institute of Neurological Disorders and Stroke Intramural Research Program; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [ZIANS003009] Funding Source: NIH RePORTER	US National Institute of Neurological Disorders and Stroke Intramural Research Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank K. Ritzier and J. Lubke for providing the electron microscopy data for analysis, and J. Diamond, J. Xu and M. Baydyuk for comments on the manuscript. This work was supported by the US National Institute of Neurological Disorders and Stroke Intramural Research Program.	Abbott LF, 2004, NATURE, V431, P796, DOI 10.1038/nature03010; ADLER EM, 1991, J NEUROSCI, V11, P1496; Borst JGG, 1995, J PHYSIOL-LONDON, V489, P825, DOI 10.1113/jphysiol.1995.sp021095; Borst JGG, 1998, J PHYSIOL-LONDON, V506, P143, DOI 10.1111/j.1469-7793.1998.143bx.x; Borst JGG, 1996, NATURE, V383, P431, DOI 10.1038/383431a0; Brenowitz SD, 2007, J NEUROSCI, V27, P7888, DOI 10.1523/JNEUROSCI.1064-07.2007; Bucurenciu I, 2010, NAT NEUROSCI, V13, P19, DOI 10.1038/nn.2461; Dobrunz LE, 1997, NEURON, V18, P995, DOI 10.1016/S0896-6273(00)80338-4; Dolphin AC, 2009, CURR OPIN NEUROBIOL, V19, P237, DOI 10.1016/j.conb.2009.06.006; Dondzillo A, 2010, J COMP NEUROL, V518, P1008, DOI 10.1002/cne.22260; Fedchyshyn MJ, 2005, J NEUROSCI, V25, P4131, DOI 10.1523/JNEUROSCI.0350-05.2005; Gentet LJ, 2000, BIOPHYS J, V79, P314, DOI 10.1016/S0006-3495(00)76293-X; Han YY, 2011, NEURON, V69, P304, DOI 10.1016/j.neuron.2010.12.014; He LM, 2006, NATURE, V444, P102, DOI 10.1038/nature05250; He LM, 2009, NATURE, V459, P93, DOI 10.1038/nature07860; Helmchen F, 1997, BIOPHYS J, V72, P1458, DOI 10.1016/S0006-3495(97)78792-7; Kaeser PS, 2011, CELL, V144, P282, DOI 10.1016/j.cell.2010.12.029; Koester HJ, 2005, SCIENCE, V308, P863, DOI 10.1126/science.1100815; Luo FJ, 2011, J NEUROSCI, V31, P11268, DOI 10.1523/JNEUROSCI.1394-11.2011; Moulder KL, 2005, J NEUROSCI, V25, P3842, DOI 10.1523/JNEUROSCI.5231-04.2005; Murthy VN, 1997, NEURON, V18, P599, DOI 10.1016/S0896-6273(00)80301-3; Neher E, 2001, J NEUROSCI, V21, P444, DOI 10.1523/JNEUROSCI.21-02-00444.2001; Reyes A, 1998, NAT NEUROSCI, V1, P279, DOI 10.1038/1092; Sakaba T, 2001, NEURON, V32, P1119, DOI 10.1016/S0896-6273(01)00543-8; Sakmann Bert, 1995, P637; Satzler K, 2002, J NEUROSCI, V22, P10567; Schikorski T, 2001, NAT NEUROSCI, V4, P391, DOI 10.1038/86042; Schikorski T, 1997, J NEUROSCI, V17, P5858; Schneggenburger R, 1999, NEURON, V23, P399, DOI 10.1016/S0896-6273(00)80789-8; Shahrezaei V, 2006, J NEUROSCI, V26, P13240, DOI 10.1523/JNEUROSCI.1418-06.2006; Stanley EF, 1997, NATURE, V385, P340, DOI 10.1038/385340a0; STANLEY EF, 1993, NEURON, V11, P1007, DOI 10.1016/0896-6273(93)90214-C; Sudhof TC, 2004, ANNU REV NEUROSCI, V27, P509, DOI 10.1146/annurev.neuro.26.041002.131412; Suh BC, 2010, NEURON, V67, P224, DOI 10.1016/j.neuron.2010.07.001; Sun JY, 2002, NATURE, V417, P555, DOI 10.1038/417555a; Sun JY, 2001, NEURON, V30, P171, DOI 10.1016/S0896-6273(01)00271-9; Taschenberger H, 2002, NEURON, V36, P1127, DOI 10.1016/S0896-6273(02)01137-6; Wadel K, 2007, NEURON, V53, P563, DOI 10.1016/j.neuron.2007.01.021; Wadiche JI, 2001, NEURON, V32, P301, DOI 10.1016/S0896-6273(01)00488-3; Weber AM, 2010, NAT NEUROSCI, V13, P1348, DOI 10.1038/nn.2657; Wolfel M, 2007, J NEUROSCI, V27, P3198, DOI 10.1523/JNEUROSCI.4471-06.2007; Wolfel M, 2003, J NEUROSCI, V23, P7059, DOI 10.1523/JNEUROSCI.23-18-07059.2003; Wu LG, 1999, J NEUROSCI, V19, P726; Wu LG, 1999, NEURON, V23, P821, DOI 10.1016/S0896-6273(01)80039-8; Wu XS, 2007, J NEUROSCI, V27, P3046, DOI 10.1523/JNEUROSCI.4415-06.2007; Wu XS, 2009, J NEUROSCI, V29, P11038, DOI 10.1523/JNEUROSCI.2367-09.2009; Wu XS, 2004, ANESTHESIOLOGY, V100, P663, DOI 10.1097/00000542-200403000-00029; Xu JH, 2005, NEURON, V46, P633, DOI 10.1016/j.neuron.2005.03.024; Xu-Friedman MA, 2001, J NEUROSCI, V21, P6666, DOI 10.1523/JNEUROSCI.21-17-06666.2001; Zucker RS, 2002, ANNU REV PHYSIOL, V64, P355, DOI 10.1146/annurev.physiol.64.092501.114547	50	90	90	0	20	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUL	2012	15	7					998	1006		10.1038/nn.3129	http://dx.doi.org/10.1038/nn.3129			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	966EE	22683682	Green Accepted			2022-12-28	WOS:000305819600018
J	Vigano, F; Mobius, W; Gotz, M; Dimou, L				Vigano, Francesca; Moebius, Wiebke; Goetz, Magdalena; Dimou, Leda			Transplantation reveals regional differences in oligodendrocyte differentiation in the adult brain	NATURE NEUROSCIENCE			English	Article							CEREBRAL-CORTEX; NERVOUS-SYSTEM; WHITE-MATTER; RAT CNS; CELLS; PROGENITORS; LINEAGE; MOUSE; MICE; EXPRESSION	To examine the role of gray and white matter niches for oligodendrocyte differentiation, we used homo- and heterotopic transplantations into the adult mouse cerebral cortex. White matter-derived cells differentiated into mature oligodendrocytes in both niches with equal efficiency, whereas gray matter-derived cells did not. Thus, white matter promotes oligodendrocyte differentiation, and cells from this niche differentiate more easily, even in the less supportive gray matter environment.	[Vigano, Francesca; Goetz, Magdalena; Dimou, Leda] Univ Munich, Inst Physiol, D-80539 Munich, Germany; [Vigano, Francesca; Goetz, Magdalena; Dimou, Leda] HelmholtzZentrum, Inst Stem Cell Res, Neuherberg, Germany; [Vigano, Francesca] Univ Milan, Dept Pharmacol Sci, Milan, Italy; [Moebius, Wiebke] Max Planck Inst Expt Med, Dept Neurogenet, D-37075 Gottingen, Germany; [Moebius, Wiebke] Ctr Nanoscale Microscopy & Mol Physiol Brain, Gottingen, Germany; [Goetz, Magdalena] Munich Cluster Syst Neurol SyNergy, Munich, Germany	University of Munich; University of Milan; Max Planck Society; University of Munich	Dimou, L (corresponding author), Univ Munich, Inst Physiol, Pettenkoferstr 12, D-80539 Munich, Germany.	leda.dimou@lrz.uni-muenchen.de	Dimou, Leda/E-7968-2012	/0000-0002-2902-7165; Gotz, Magdalena/0000-0003-1551-9203	European Research Council Advanced Investigator Grant AXOGLIA; Cluster of Excellence; DFG research Center Nanoscale Microscopy and Molecular Physiology of the Brain; University of Milan; International Brain Research Organization InEurope grant; Deutsche Forschungsgemeinschaft [SFB 596, SFB 870]; Helmholtz Association of Mental Aging; Friedrich Bauer Stiftung	European Research Council Advanced Investigator Grant AXOGLIA; Cluster of Excellence; DFG research Center Nanoscale Microscopy and Molecular Physiology of the Brain(German Research Foundation (DFG)); University of Milan; International Brain Research Organization InEurope grant; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Helmholtz Association of Mental Aging; Friedrich Bauer Stiftung	We thank J. Trotter (Johannes Gutenberg-University) for the NG2-EYFP and F. Kirchhoff (University of Saarland) for the PLP-DsRed mouse lines, K. Karram for advice regarding cell isolation procedures, J. Ninkovic for help with the statistics, and E. Violette and S. Sirko for carefully reading the manuscript. We are also grateful to B. Sadowski for technical help with the electron microscope, as well as the technical assistants in the Physiological Genomics. W.M. is funded by the European Research Council Advanced Investigator Grant AXOGLIA to K.-A. Nave and is supported by the Cluster of Excellence and DFG research Center Nanoscale Microscopy and Molecular Physiology of the Brain. F.V. was, in part, supported by a doctorate fellowship from the University of Milan and an International Brain Research Organization InEurope grant. This work was mainly supported by the SFB 596 and the SFB 870 of the Deutsche Forschungsgemeinschaft, the Helmholtz Association of Mental Aging and the Friedrich Bauer Stiftung.	Albert M, 2007, BRAIN PATHOL, V17, P129, DOI 10.1111/j.1750-3639.2006.00043.x; Dawson MRL, 2003, MOL CELL NEUROSCI, V24, P476, DOI 10.1016/S1044-7431(03)00210-0; Dimou L, 2008, J NEUROSCI, V28, P10434, DOI 10.1523/JNEUROSCI.2831-08.2008; Emery B, 2010, SCIENCE, V330, P779, DOI 10.1126/science.1190927; Fancy SPJ, 2011, ANNU REV NEUROSCI, V34, P21, DOI 10.1146/annurev-neuro-061010-113629; Fischer J, 2011, NAT PROTOC, V6, P1981, DOI 10.1038/nprot.2011.412; Gudi V, 2009, BRAIN RES, V1283, P127, DOI 10.1016/j.brainres.2009.06.005; Hirrlinger PG, 2005, MOL CELL NEUROSCI, V30, P291, DOI 10.1016/j.mcn.2005.08.011; Kang SH, 2010, NEURON, V68, P668, DOI 10.1016/j.neuron.2010.09.009; Karram K, 2008, GENESIS, V46, P743, DOI 10.1002/dvg.20440; Okabe M, 1997, FEBS LETT, V407, P313, DOI 10.1016/S0014-5793(97)00313-X; Peters PJ, 2008, METHOD CELL BIOL, V88, P131, DOI [10.1016/S0091-679X(08)00409-1, 10.1016/S0091-679X(08)00408-1]; PRINGLE NP, 1992, DEVELOPMENT, V115, P535; Rivers LE, 2008, NAT NEUROSCI, V11, P1392, DOI 10.1038/nn.2220; Rosenberg SS, 2008, P NATL ACAD SCI USA, V105, P14662, DOI 10.1073/pnas.0805640105; Simon C, 2011, GLIA, V59, P869, DOI 10.1002/glia.21156; Werner HB, 2007, J NEUROSCI, V27, P7717, DOI 10.1523/JNEUROSCI.1254-07.2007; Zhu XQ, 2011, DEVELOPMENT, V138, P745, DOI 10.1242/dev.047951	18	125	126	0	13	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	OCT	2013	16	10					1370	+		10.1038/nn.3503	http://dx.doi.org/10.1038/nn.3503			5	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	223HM	23995069				2022-12-28	WOS:000324795300008
J	Barak, S; Liu, F; Ben Hamida, S; Yowell, QV; Neasta, J; Kharazia, V; Janak, PH; Ron, D				Barak, Segev; Liu, Feng; Ben Hamida, Sami; Yowell, Quinn V.; Neasta, Jeremie; Kharazia, Viktor; Janak, Patricia H.; Ron, Dorit			Disruption of alcohol-related memories by mTORC1 inhibition prevents relapse	NATURE NEUROSCIENCE			English	Article							RAPAMYCIN SIGNALING PATHWAY; AMYGDALA CENTRAL NUCLEUS; MAMMALIAN TARGET; SYNAPTIC PLASTICITY; FEAR MEMORY; TRANSLATIONAL CONTROL; PLACE PREFERENCE; NMDA RECEPTORS; RECONSOLIDATION; HIPPOCAMPUS	Relapse to alcohol abuse is an important clinical issue that is frequently caused by cue-induced drug craving. Therefore, disruption of the memory for the cue-alcohol association is expected to prevent relapse. It is increasingly accepted that memories become labile and erasable soon after their reactivation through retrieval during a memory reconsolidation process that depends on protein synthesis. Here we show that reconsolidation of alcohol-related memories triggered by the sensory properties of alcohol itself (odor and taste) activates mammalian target of rapamycin complex 1 (mTORC1) in select amygdalar and cortical regions in rats, resulting in increased levels of several synaptic proteins. Furthermore, systemic or central amygdalar inhibition of mTORC1 during reconsolidation disrupts alcohol-associated memories, leading to a long-lasting suppression of relapse. Our findings provide evidence that the mTORC1 pathway and its downstream substrates are crucial in alcohol-related memory reconsolidation and highlight this pathway as a therapeutic target to prevent relapse.	[Barak, Segev; Liu, Feng; Ben Hamida, Sami; Yowell, Quinn V.; Neasta, Jeremie; Kharazia, Viktor; Janak, Patricia H.; Ron, Dorit] Univ Calif San Francisco, Dept Neurol, Ernest Gallo Res Ctr, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; Ernest Gallo Clinic & Research Center	Ron, D (corresponding author), Univ Calif San Francisco, Dept Neurol, Ernest Gallo Res Ctr, San Francisco, CA 94143 USA.	pjanak@gallo.ucsf.edu; dron@gallo.ucsf.edu	Hamida, Sami Ben/V-1010-2017; Barak, Segev/ABG-4080-2020; Hamida, Sami Ben/AAB-4767-2021	Hamida, Sami Ben/0000-0001-9636-9432; Barak, Segev/0000-0002-3143-6777; Hamida, Sami Ben/0000-0001-9636-9432; Neasta, Jeremie/0000-0002-7801-4176; Kharazia, Viktor/0000-0003-0642-6080; Janak, Patricia/0000-0002-3333-9049	US National Institutes of Health National Institute on Alcohol Abuse and Alcoholism [P50 AA017072]; State of California for Medical Research on Alcohol and Substance Abuse through the University of California, San Francisco; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [P50AA017072] Funding Source: NIH RePORTER	US National Institutes of Health National Institute on Alcohol Abuse and Alcoholism; State of California for Medical Research on Alcohol and Substance Abuse through the University of California, San Francisco(University of California System); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was supported by US National Institutes of Health National Institute on Alcohol Abuse and Alcoholism grant P50 AA017072 (D.R. and P.H.J.) and funds from the State of California for Medical Research on Alcohol and Substance Abuse through the University of California, San Francisco (D.R. and P.H.J.). We thank S. Carnicella for critical review of the manuscript.	[Anonymous], 2004, WHO GLOB STAT REP AL; Bailey J, 2012, ADDICT BIOL, V17, P248, DOI 10.1111/j.1369-1600.2010.00311.x; Banko JL, 2005, J NEUROSCI, V25, P9581, DOI 10.1523/JNEUROSCI.2423-05.2005; Barak S, 2011, TRANSL PSYCHIAT, V1, DOI 10.1038/tp.2011.57; Barak S, 2011, J NEUROSCI, V31, P9885, DOI 10.1523/JNEUROSCI.1750-11.2011; Besheer J, 2010, BIOL PSYCHIAT, V67, P812, DOI 10.1016/j.biopsych.2009.09.016; Blundell J, 2008, NEUROBIOL LEARN MEM, V90, P28, DOI 10.1016/j.nlm.2007.12.004; Calu DJ, 2010, NEURON, V68, P991, DOI 10.1016/j.neuron.2010.11.019; Camicella S, 2009, ALCOHOL, V43, P35, DOI 10.1016/j.alcohol.2008.12.001; Carnicella S, 2008, P NATL ACAD SCI USA, V105, P8114, DOI 10.1073/pnas.0711755105; Costa-Mattioli M, 2009, NEURON, V61, P10, DOI 10.1016/j.neuron.2008.10.055; Cunningham CL, 2006, NAT PROTOC, V1, P1662, DOI 10.1038/nprot.2006.279; Davis M, 2010, NEUROPSYCHOPHARMACOL, V35, P105, DOI 10.1038/npp.2009.109; Dudai Y, 2006, CURR OPIN NEUROBIOL, V16, P174, DOI 10.1016/j.conb.2006.03.010; Everitt B.J., 2000, AMYGDALA FUNCTIONAL, P353; Gafford GM, 2011, NEUROSCIENCE, V182, P98, DOI 10.1016/j.neuroscience.2011.03.023; Glover EM, 2010, LEARN MEMORY, V17, P577, DOI 10.1101/lm.1908310; Hoeffer CA, 2010, TRENDS NEUROSCI, V33, P67, DOI 10.1016/j.tins.2009.11.003; Hopf FW, 2010, NEURON, V65, P682, DOI 10.1016/j.neuron.2010.02.015; Jobim PFC, 2012, BEHAV BRAIN RES, V228, P151, DOI 10.1016/j.bbr.2011.12.004; Jobim PFC, 2012, NEUROBIOL LEARN MEM, V97, P105, DOI 10.1016/j.nlm.2011.10.002; Johnson BA, 2008, BIOCHEM PHARMACOL, V75, P34, DOI 10.1016/j.bcp.2007.08.005; Koob GF, 2013, CURR TOP BEHAV NEURO, V13, P3, DOI 10.1007/7854_2011_129; Korb E, 2011, TRENDS NEUROSCI, V34, P591, DOI 10.1016/j.tins.2011.08.007; Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017; Lee CC, 2005, J BIOL CHEM, V280, P18543, DOI 10.1074/jbc.M414112200; Lee JLC, 2006, J NEUROSCI, V26, P10051, DOI 10.1523/JNEUROSCI.2466-06.2006; Li NX, 2010, SCIENCE, V329, P959, DOI 10.1126/science.1190287; Lingawi NW, 2012, J NEUROSCI, V32, P1073, DOI 10.1523/JNEUROSCI.4806-11.2012; Liu-Yesucevitz L, 2011, J NEUROSCI, V31, P16086, DOI 10.1523/JNEUROSCI.4105-11.2011; Mahler SV, 2009, J NEUROSCI, V29, P6500, DOI 10.1523/JNEUROSCI.3875-08.2009; Maren S, 2005, NEURON, V47, P783, DOI 10.1016/j.neuron.2005.08.009; Miller CA, 2006, LEARN MEMORY, V13, P498, DOI 10.1101/lm.304606; Milton A., 2012, CURR OPIN NEUROBIOL, DOI DOI 10.1016/J.C0NB.2012.11.008; Milton AL, 2012, PSYCHOPHARMACOLOGY, V219, P751, DOI 10.1007/s00213-011-2399-9; Nader K, 2009, NAT REV NEUROSCI, V10, P224, DOI 10.1038/nrn2590; Neasta J, 2010, P NATL ACAD SCI USA, V107, P20093, DOI 10.1073/pnas.1005554107; Parsons RG, 2006, J NEUROSCI, V26, P12977, DOI 10.1523/JNEUROSCI.4209-06.2006; Pickens CL, 2011, TRENDS NEUROSCI, V34, P411, DOI 10.1016/j.tins.2011.06.001; Plath N, 2006, NEURON, V52, P437, DOI 10.1016/j.neuron.2006.08.024; Puighermanal E, 2009, NAT NEUROSCI, V12, P1152, DOI 10.1038/nn.2369; Purgert RJ, 2012, J NEUROSCI, V32, P2461, DOI 10.1523/JNEUROSCI.5090-11.2012; Schratt GM, 2004, J NEUROSCI, V24, P7366, DOI 10.1523/JNEUROSCI.1739-04.2004; Sinha R, 2011, CURR PSYCHIAT REP, V13, P398, DOI 10.1007/s11920-011-0224-0; Stoica L, 2011, P NATL ACAD SCI USA, V108, P3791, DOI 10.1073/pnas.1014715108; Takei N, 2004, J NEUROSCI, V24, P9760, DOI 10.1523/JNEUROSCI.1427-04.2004; Tronson NC, 2007, NAT REV NEUROSCI, V8, P262, DOI 10.1038/nrn2090; Wang DO, 2010, TRENDS NEUROSCI, V33, P173, DOI 10.1016/j.tins.2010.01.005; Wang J, 2010, J NEUROSCI, V30, P10187, DOI 10.1523/JNEUROSCI.2268-10.2010; Wang X, 2010, J NEUROSCI, V30, P12632, DOI 10.1523/JNEUROSCI.1264-10.2010; Xu WF, 2011, CURR OPIN NEUROBIOL, V21, P306, DOI 10.1016/j.conb.2011.03.001; Xue YX, 2012, SCIENCE, V336, P241, DOI 10.1126/science.1215070	52	116	121	0	26	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	AUG	2013	16	8					1111	U185		10.1038/nn.3439	http://dx.doi.org/10.1038/nn.3439			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	190EV	23792945	Green Submitted, Green Published, Green Accepted			2022-12-28	WOS:000322323000022
J	Gire, DH; Whitesell, JD; Doucette, W; Restrepo, D				Gire, David H.; Whitesell, Jennifer D.; Doucette, Wilder; Restrepo, Diego			Information for decision-making and stimulus identification is multiplexed in sensory cortex	NATURE NEUROSCIENCE			English	Article							FALSE DISCOVERY RATE; OLFACTORY-BULB; ODOR REPRESENTATIONS; PERCEPTION; RESPONSES; PHASE	In recordings from anterior piriform cortex in awake behaving mice, we found that neuronal firing early in the olfactory pathway simultaneously conveyed fundamentally different information: odor value (is the odor rewarded?) and identity (what is the smell?). Thus, this sensory system performs early multiplexing of information reflecting stimulus-specific characteristics with that used for decision-making.	[Gire, David H.; Doucette, Wilder; Restrepo, Diego] Univ Colorado, Sch Med, Dept Cell & Dev Biol, Aurora, CO USA; [Gire, David H.; Whitesell, Jennifer D.; Doucette, Wilder; Restrepo, Diego] Univ Colorado, Sch Med, Neurosci Program, Aurora, CO USA; [Whitesell, Jennifer D.] Univ Colorado, Sch Med, Dept Physiol & Biophys, Aurora, CO USA	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus	Restrepo, D (corresponding author), Univ Colorado, Sch Med, Dept Cell & Dev Biol, Aurora, CO USA.	diego.restrepo@ucdenver.edu	Doucette, Wilder/S-2019-2016	Doucette, Wilder/0000-0003-2249-0461; Gire, David/0000-0003-4119-4270; Whitesell, Jennifer/0000-0002-2961-5207	US National Institutes of Health; National Institute on Deafness and Other Communication Disorders [F32 DC011980, F31 DC011202, F30 DC008066, R01 DC00566, P30 DC04657]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [T32NS099042] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [F30DC008066, R01DC000566, F32DC011980, F31DC011202, P30DC004657] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute on Deafness and Other Communication Disorders(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	We thank G. Felsen and N. Schoppa for discussions. This work was funded by grants from the US National Institutes of Health and the National Institute on Deafness and Other Communication Disorders (F32 DC011980 to D. H. G., F31 DC011202 to J.D.W., F30 DC008066 to W.D., R01 DC00566 to D.R. and P30 DC04657 to D.R.).	Benjamini Y, 2001, ANN STAT, V29, P1165; Benjamini Y, 2005, GENETICS, V171, P783, DOI 10.1534/genetics.104.036699; Blumhagen F, 2011, NATURE, V479, P493, DOI 10.1038/nature10633; CHAPUT MA, 1986, PHYSIOL BEHAV, V36, P319, DOI 10.1016/0031-9384(86)90023-5; Curran-Everett D, 2000, AM J PHYSIOL-REG I, V279, pR1, DOI 10.1152/ajpregu.2000.279.1.R1; Cury KM, 2010, NEURON, V68, P570, DOI 10.1016/j.neuron.2010.09.040; Doucette W, 2011, NEURON, V69, P1176, DOI 10.1016/j.neuron.2011.02.024; Doucette W, 2008, PLOS BIOL, V6, P2266, DOI 10.1371/journal.pbio.0060258; Gottfried JA, 2010, NAT REV NEUROSCI, V11, P628, DOI 10.1038/nrn2883; Gschwend O, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030155; Kay LM, 1999, NAT NEUROSCI, V2, P1003, DOI 10.1038/14801; Miura K, 2012, NEURON, V74, P1087, DOI 10.1016/j.neuron.2012.04.021; PAGER J, 1985, BEHAV BRAIN RES, V16, P81, DOI 10.1016/0166-4328(85)90084-1; Piette CE, 2012, J NEUROSCI, V32, P9981, DOI 10.1523/JNEUROSCI.0669-12.2012; Rennaker RL, 2007, J NEURAL ENG, V4, pL1, DOI 10.1088/1741-2560/4/2/L01; Rennaker RL, 2007, J NEUROSCI, V27, P1534, DOI 10.1523/JNEUROSCI.4072-06.2007; Roesch MR, 2007, CEREB CORTEX, V17, P643, DOI 10.1093/cercor/bhk009; Shusterman R, 2011, NAT NEUROSCI, V14, P1039, DOI 10.1038/nn.2877; Slotnick B., 2005, CURR PROTOC NEUROSCI, V33, P8, DOI [10.1002/0471142301.ns0820s33., DOI 10.1002/0471142301.NS0820S33]; Smear M, 2011, NATURE, V479, P397, DOI 10.1038/nature10521; Wesson DW, 2008, CHEM SENSES, V33, P581, DOI 10.1093/chemse/bjn029; Zhang XH, 2009, RESULTS PROBL CELL D, V47, P25, DOI 10.1007/400_2008_28	22	55	55	3	22	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	AUG	2013	16	8					991	U25		10.1038/nn.3432	http://dx.doi.org/10.1038/nn.3432			4	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	190EV	23792942	Green Accepted			2022-12-28	WOS:000322323000006
J	Carandini, M; Churchland, AK				Carandini, Matteo; Churchland, Anne K.			Probing perceptual decisions in rodents	NATURE NEUROSCIENCE			English	Review							POSTERIOR PARIETAL CORTEX; PREFRONTAL CORTEX; MOTOR CORTEX; FUNCTIONAL SPECIALIZATION; OBJECT LOCALIZATION; SUPERIOR COLLICULUS; SINGLE NEURON; RATS; DISCRIMINATION; REPRESENTATION	The study of perceptual decision-making offers insight into how the brain uses complex, sometimes ambiguous information to guide actions. Understanding the underlying processes and their neural bases requires that one pair recordings and manipulations of neural activity with rigorous psychophysics. Though this research has been traditionally performed in primates, it seems increasingly promising to pursue it at least partly in mice and rats. However, rigorous psychophysical methods are not yet as developed for these rodents as they are for primates. Here we give a brief overview of the sensory capabilities of rodents and of their cortical areas devoted to sensation and decision. We then review methods of psychophysics, focusing on the technical issues that arise in their implementation in rodents. These methods represent a rich set of challenges and opportunities.	[Carandini, Matteo] UCL, UCL Inst Ophthalmol, London, England; [Churchland, Anne K.] Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA	University of London; University College London; Cold Spring Harbor Laboratory	Churchland, AK (corresponding author), Cold Spring Harbor Lab, POB 100, Cold Spring Harbor, NY 11724 USA.	churchland@cshl.edu	Carandini, Matteo/ABD-8296-2021	Carandini, Matteo/0000-0003-4880-7682	European Research Council; Wellcome Trust; GlaxoSmithKline/Fight for Sight Chair in Visual Neuroscience; US National Eye Institute [EY022979, EY019072]; US National Science Foundation; McKnight Foundation; John Merck Fund; Chapman Foundation; Marie Robertson Memorial Fund of Cold Spring Harbor Laboratory; NATIONAL EYE INSTITUTE [R01EY022979, K99EY019072, R00EY019072] Funding Source: NIH RePORTER	European Research Council(European Research Council (ERC)European Commission); Wellcome Trust(Wellcome TrustEuropean Commission); GlaxoSmithKline/Fight for Sight Chair in Visual Neuroscience(GlaxoSmithKline); US National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); US National Science Foundation(National Science Foundation (NSF)); McKnight Foundation; John Merck Fund; Chapman Foundation; Marie Robertson Memorial Fund of Cold Spring Harbor Laboratory; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	We thank A. Kepecs, A. Zador and L. Busse for comments. M.C.'s research is supported by the European Research Council, by the Wellcome Trust, and by the GlaxoSmithKline/Fight for Sight Chair in Visual Neuroscience. A.K.C.'s research is supported by the US National Eye Institute (grants EY022979 and EY019072), the US National Science Foundation, the McKnight Foundation, the John Merck Fund, the Chapman Foundation and the Marie Robertson Memorial Fund of Cold Spring Harbor Laboratory.	Abraham NM, 2004, NEURON, V44, P865, DOI 10.1016/j.neuron.2004.11.017; Andermann ML, 2011, NEURON, V72, P1025, DOI 10.1016/j.neuron.2011.11.013; Andermann ML, 2010, FRONT CELL NEUROSCI, V4, DOI 10.3389/fncel.2010.00003; Balleine BW, 2007, J NEUROSCI, V27, P8161, DOI 10.1523/JNEUROSCI.1554-07.2007; Bennur S, 2011, J NEUROSCI, V31, P913, DOI 10.1523/JNEUROSCI.4417-10.2011; Bourne M C, 1938, Br J Ophthalmol, V22, P613, DOI 10.1136/bjo.22.10.613; BRITTEN KH, 1992, J NEUROSCI, V12, P4745; Brunton BW, 2013, SCIENCE, V340, P95, DOI 10.1126/science.1233912; Busse L, 2011, J NEUROSCI, V31, P11351, DOI 10.1523/JNEUROSCI.6689-10.2011; Chambers RA, 1996, NEUROPSYCHOPHARMACOL, V15, P587, DOI 10.1016/S0893-133X(96)00132-7; Chen GF, 2013, P NATL ACAD SCI USA, V110, P378, DOI 10.1073/pnas.1215834110; Clark L, 2004, BRAIN COGNITION, V55, P41, DOI 10.1016/s0278-2626(03)00284-7; Daan S, 2011, J BIOL RHYTHM, V26, P118, DOI 10.1177/0748730410397645; Dawkins R., 2004, ANCESTORS TALE PILGR; Dombeck DA, 2010, NAT NEUROSCI, V13, P1433, DOI 10.1038/nn.2648; Erlich JC, 2011, NEURON, V72, P330, DOI 10.1016/j.neuron.2011.07.010; Everitt BJ, 2007, ANN NY ACAD SCI, V1121, P576, DOI 10.1196/annals.1401.022; Felleman DJ, 1991, CEREB CORTEX, V1, P1, DOI 10.1093/cercor/1.1.1; Felsen G, 2012, J NEUROPHYSIOL, V108, P135, DOI 10.1152/jn.01181.2011; Fetsch CR, 2009, J NEUROSCI, V29, P15601, DOI 10.1523/JNEUROSCI.2574-09.2009; Gold JI, 2007, ANNU REV NEUROSCI, V30, P535, DOI 10.1146/annurev.neuro.29.051605.113038; Green DM, 1966, SIGNAL DETECTION THE; Grinband J, 2006, NEURON, V49, P757, DOI 10.1016/j.neuron.2006.01.032; Harvey CD, 2012, NATURE, V484, P62, DOI 10.1038/nature10918; Helmchen F, 2005, NAT METHODS, V2, P932, DOI 10.1038/NMETH818; Histed MH, 2012, J NEUROPHYSIOL, V107, P758, DOI 10.1152/jn.00609.2011; Holscher C, 2005, J EXP BIOL, V208, P561, DOI 10.1242/jeb.01371; Horwitz GD, 2004, J NEUROPHYSIOL, V91, P2281, DOI 10.1152/jn.00872.2003; Houweling AR, 2008, NATURE, V451, P65, DOI 10.1038/nature06447; Hsu M, 2005, SCIENCE, V310, P1680, DOI 10.1126/science.1115327; Huber D, 2008, NATURE, V451, P61, DOI 10.1038/nature06445; Huberman AD, 2011, TRENDS NEUROSCI, V34, P464, DOI 10.1016/j.tins.2011.07.002; Hut RA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017527; Jaramillo S, 2011, NAT NEUROSCI, V14, P246, DOI 10.1038/nn.2688; Kato HK, 2012, NEURON, V76, P962, DOI 10.1016/j.neuron.2012.09.037; Kepecs A, 2008, NATURE, V455, P227, DOI 10.1038/nature07200; Kerr JND, 2012, CURR OPIN NEUROBIOL, V22, P45, DOI 10.1016/j.conb.2011.12.002; Kesner RP, 2011, NEUROBIOL LEARN MEM, V96, P417, DOI 10.1016/j.nlm.2011.07.002; Kiani R, 2008, J NEUROSCI, V28, P3017, DOI 10.1523/JNEUROSCI.4761-07.2008; Kim B, 2008, J NEUROSCI, V28, P2991, DOI 10.1523/JNEUROSCI.5424-07.2008; KOLB B, 1987, BEHAV BRAIN RES, V23, P127, DOI 10.1016/0166-4328(87)90050-7; Komiyama T, 2010, NATURE, V464, P1182, DOI 10.1038/nature08897; Krubitzer L, 2007, NEURON, V56, P201, DOI 10.1016/j.neuron.2007.10.002; Kvitsiani D., NATURE IN PRESS; Lammel S, 2012, NATURE, V491, P212, DOI 10.1038/nature11527; Lee SH, 2012, NATURE, V488, P379, DOI 10.1038/nature11312; Lepora NF, 2012, J R SOC INTERFACE, V9, P1517, DOI 10.1098/rsif.2011.0750; Letzkus JJ, 2011, NATURE, V480, P331, DOI 10.1038/nature10674; Luo L, 2008, NEURON, V57, P634, DOI 10.1016/j.neuron.2008.01.002; Macmillan NA., 1991, DETECTION THEORY USE; Marshel JH, 2011, NEURON, V72, P1040, DOI 10.1016/j.neuron.2011.12.004; Meier P, 2011, J VISION, V11, DOI 10.1167/11.9.1; Merten K, 2012, P NATL ACAD SCI USA, V109, P6289, DOI 10.1073/pnas.1121084109; MORRIS RGM, 1982, NATURE, V297, P681, DOI 10.1038/297681a0; Nakamura K, 1999, J NEUROPHYSIOL, V82, P2503, DOI 10.1152/jn.1999.82.5.2503; Narayanan NS, 2006, NEURON, V52, P921, DOI 10.1016/j.neuron.2006.10.021; Navalpakkam V, 2010, P NATL ACAD SCI USA, V107, P5232, DOI 10.1073/pnas.0911972107; Newton JR, 2004, NAT NEUROSCI, V7, P968, DOI 10.1038/nn1306; Ng L, 2010, METHODS, V50, P55, DOI 10.1016/j.ymeth.2009.10.001; Nitz DA, 2012, NAT NEUROSCI, V15, P1365, DOI 10.1038/nn.3213; O'Connor DH, 2010, NEURON, V67, P1048, DOI 10.1016/j.neuron.2010.08.026; O'Connor DH, 2010, J NEUROSCI, V30, P1947, DOI 10.1523/JNEUROSCI.3762-09.2010; Otazu GH, 2009, NAT NEUROSCI, V12, P646, DOI 10.1038/nn.2306; Parker AJ, 1998, ANNU REV NEUROSCI, V21, P227, DOI 10.1146/annurev.neuro.21.1.227; Peron S, 2011, NAT METHODS, V8, P30, DOI 10.1038/NMETH.F.325; Petersen CCH, 2007, NEURON, V56, P339, DOI 10.1016/j.neuron.2007.09.017; Platt ML, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001092; Prakash R, 2012, NAT METHODS, V9, P1171, DOI 10.1038/NMETH.2215; PREUSS TM, 1995, J COGNITIVE NEUROSCI, V7, P1, DOI 10.1162/jocn.1995.7.1.1; Prusky GT, 2000, VISION RES, V40, P2201, DOI 10.1016/S0042-6989(00)00081-X; Raposo D, 2012, J NEUROSCI, V32, P3726, DOI 10.1523/JNEUROSCI.4998-11.2012; REEP RL, 1994, EXP BRAIN RES, V100, P67; Resulaj A, 2009, NATURE, V461, P263, DOI 10.1038/nature08275; Roitman JD, 2002, J NEUROSCI, V22, P9475; Romo R, 2001, ANNU REV NEUROSCI, V24, P107, DOI 10.1146/annurev.neuro.24.1.107; Sanders JI, 2012, J NEUROPHYSIOL, V108, P3416, DOI 10.1152/jn.00669.2012; Save E, 2009, NEUROBIOL LEARN MEM, V91, P172, DOI 10.1016/j.nlm.2008.08.005; Scanziani M, 2009, NATURE, V461, P930, DOI 10.1038/nature08540; Schoenbaum G, 2005, NEURON, V47, P633, DOI 10.1016/j.neuron.2005.07.018; Schwarz C, 2010, SOMATOSENS MOT RES, V27, P131, DOI 10.3109/08990220.2010.513111; Sheppard JP, 2013, J VISION, V13, DOI 10.1167/13.6.4; SINNAMON HM, 1984, PHYSIOL BEHAV, V33, P185, DOI 10.1016/0031-9384(84)90098-2; Smear M, 2011, NATURE, V479, P397, DOI 10.1038/nature10521; Sparks DL, 1999, CURR OPIN NEUROBIOL, V9, P698, DOI 10.1016/S0959-4388(99)00039-2; Stuttgen MC, 2011, FRONT NEUROSCI-SWITZ, V5, DOI 10.3389/fnins.2011.00125; Sul JH, 2011, NAT NEUROSCI, V14, P1202, DOI 10.1038/nn.2881; Sul JH, 2010, NEURON, V66, P449, DOI 10.1016/j.neuron.2010.03.033; Tafazoli S, 2012, J NEUROSCI, V32, P21, DOI 10.1523/JNEUROSCI.3932-11.2012; Taniguchi H, 2011, NEURON, V71, P995, DOI 10.1016/j.neuron.2011.07.026; Uchida N, 2003, NAT NEUROSCI, V6, P1224, DOI 10.1038/nn1142; Umeda T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015500; Uylings HBM, 2003, BEHAV BRAIN RES, V146, P3, DOI 10.1016/j.bbr.2003.09.028; Wang QX, 2007, J COMP NEUROL, V502, P339, DOI 10.1002/cne.21286; Whitlock JR, 2012, NEURON, V73, P789, DOI 10.1016/j.neuron.2011.12.028; Witten IB, 2011, NEURON, V72, P721, DOI 10.1016/j.neuron.2011.10.028; Zeng HK, 2012, PROG BRAIN RES, V196, P193, DOI 10.1016/B978-0-444-59426-6.00010-0; Znamenskiy P, 2013, NATURE, V497, P482, DOI 10.1038/nature12077; Zoccolan D, 2009, P NATL ACAD SCI USA, V106, P8748, DOI 10.1073/pnas.0811583106	98	162	162	1	76	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUL	2013	16	7					824	831		10.1038/nn.3410	http://dx.doi.org/10.1038/nn.3410			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	174UM	23799475	Green Accepted			2022-12-28	WOS:000321180900012
J	Roberson, DP; Gudes, S; Sprague, JM; Patoski, HAW; Robson, VK; Blasl, F; Duan, B; Oh, SB; Bean, BP; Ma, QF; Binshtok, AM; Woolf, CJ				Roberson, David P.; Gudes, Sagi; Sprague, Jared M.; Patoski, Haley A. W.; Robson, Victoria K.; Blasl, Felix; Duan, Bo; Oh, Seog Bae; Bean, Bruce P.; Ma, Qiufu; Binshtok, Alexander M.; Woolf, Clifford J.			Activity-dependent silencing reveals functionally distinct itch-generating sensory neurons	NATURE NEUROSCIENCE			English	Article							SODIUM-CHANNEL BLOCKERS; DRY SKIN ITCH; BEHAVIORAL-RESPONSES; PAR-2 AGONIST; HISTAMINE H1; SPINAL-CORD; NOCICEPTORS; RECEPTOR; MICE; MOUSE	The peripheral terminals of primary sensory neurons detect histamine and non-histamine itch-provoking ligands through molecularly distinct transduction mechanisms. It remains unclear, however, whether these distinct pruritogens activate the same or different afferent fibers. Using a strategy of reversibly silencing specific subsets of murine pruritogen-sensitive sensory axons by targeted delivery of a charged sodium-channel blocker, we found that functional blockade of histamine itch did not affect the itch evoked by chloroquine or SLIGRL-NH2, and vice versa. Notably, blocking itch-generating fibers did not reduce pain-associated behavior. However, silencing TRPV1(+) or TRPA1(+) neurons allowed allyl isothiocyanate or capsaicin, respectively, to evoke itch, implying that certain peripheral afferents may normally indirectly inhibit algogens from eliciting itch. These findings support the presence of functionally distinct sets of itch-generating neurons and suggest that targeted silencing of activated sensory fibers may represent a clinically useful anti-pruritic therapeutic approach for histaminergic and non-histaminergic pruritus.	[Roberson, David P.; Sprague, Jared M.; Patoski, Haley A. W.; Robson, Victoria K.; Oh, Seog Bae; Woolf, Clifford J.] Childrens Hosp, FM Kirby Neurobiol Ctr, Boston, MA 02115 USA; [Roberson, David P.; Sprague, Jared M.; Patoski, Haley A. W.; Robson, Victoria K.; Oh, Seog Bae; Woolf, Clifford J.] Childrens Hosp, Dept Neurol, Boston, MA 02115 USA; [Roberson, David P.; Duan, Bo; Bean, Bruce P.; Ma, Qiufu; Woolf, Clifford J.] Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA; [Gudes, Sagi; Blasl, Felix; Binshtok, Alexander M.] Hebrew Univ Jerusalem, Fac Med, Inst Med Res Israel Canada, Dept Med Neurobiol, Jerusalem, Israel; [Gudes, Sagi; Binshtok, Alexander M.] Hebrew Univ Jerusalem, Edmond & Lily Safra Ctr Brain Sci, Jerusalem, Israel; [Sprague, Jared M.] Harvard Univ, Sch Dent Med, Boston, MA 02115 USA; [Duan, Bo; Ma, Qiufu] Dana Farber Canc Inst, Boston, MA 02115 USA; [Oh, Seog Bae] Seoul Natl Univ, Natl Res Lab Pain, Dent Res Inst, Seoul, South Korea; [Oh, Seog Bae] Seoul Natl Univ, Sch Dent, Dept Neurobiol & Physiol, Seoul, South Korea	Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; Hebrew University of Jerusalem; Hebrew University of Jerusalem; Harvard University; Harvard School of Dental Medicine; Harvard University; Dana-Farber Cancer Institute; Seoul National University (SNU); Seoul National University (SNU)	Binshtok, AM (corresponding author), Hebrew Univ Jerusalem, Fac Med, Inst Med Res Israel Canada, Dept Med Neurobiol, Jerusalem, Israel.	alexanderb@ekmd.huji.ac.il; clifford.woolf@childrens.harvard.edu	OH, Seog Bae/AAQ-2478-2020; Woolf, Clifford/A-9784-2010	Bradford, Victoria/0000-0003-1825-0035; Binshtok, Alexander/0000-0002-3620-8116; Oh, Seog Bae/0000-0001-7975-6895	US National Institutes of Health [NS072040, NS047710]; Ruth L Kirschstein National Research Service Award from the National Institute of Dental and Craniofacial Research; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD018655] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [F30DE023033] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [T32MH020017] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS047710, P01NS072040] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ruth L Kirschstein National Research Service Award from the National Institute of Dental and Craniofacial Research; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank N. Ghasemlou and S. Ross for discussion and O. Viramontes for technical assistance. This study was supported by the US National Institutes of Health (NS072040 to B.P.B., Q.M., B.D. and C.J.W.; NS047710 to B.D. and Q.M.). J.M.S. is a recipient of a Ruth L Kirschstein National Research Service Award from the National Institute of Dental and Craniofacial Research.	Akiyama T, 2012, NEUROSCIENCE, V226, P305, DOI 10.1016/j.neuroscience.2012.09.019; Akiyama T, 2010, J NEUROPHYSIOL, V104, P2442, DOI 10.1152/jn.00563.2010; Akiyama T, 2010, PAIN, V151, P378, DOI 10.1016/j.pain.2010.07.024; Akiyama T, 2011, J NEUROPHYSIOL, V105, P2811, DOI 10.1152/jn.01124.2010; Akiyama T, 2010, ACTA DERM-VENEREOL, V90, P575, DOI 10.2340/00015555-0962; Binshtok AM, 2007, NATURE, V449, P607, DOI 10.1038/nature06191; Binshtok AM, 2009, ANESTHESIOLOGY, V111, P127, DOI 10.1097/ALN.0b013e3181a915e7; Brenneis C, 2013, J NEUROSCI, V33, P315, DOI 10.1523/JNEUROSCI.2804-12.2013; Brenner DS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039765; CHAPLAN SR, 1994, J NEUROSCI METH, V53, P55, DOI 10.1016/0165-0270(94)90144-9; Chen J, 2009, MOL PAIN, V5, DOI 10.1186/1744-8069-5-3; Grundmann S, 2011, ANN DERMATOL, V23, P1, DOI 10.5021/ad.2011.23.1.1; Han L, 2013, NAT NEUROSCI, V16, P174, DOI 10.1038/nn.3289; Han SK, 2006, NEURON, V52, P691, DOI 10.1016/j.neuron.2006.09.036; HARGREAVES K, 1988, PAIN, V32, P77, DOI 10.1016/0304-3959(88)90026-7; Imamachi N, 2009, P NATL ACAD SCI USA, V106, P11330, DOI 10.1073/pnas.0905605106; Khalil IF, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-249; Kim HY, 2010, PAIN, V150, P29, DOI 10.1016/j.pain.2010.02.016; KOPPERT W, 1993, NEUROSCI LETT, V152, P117, DOI 10.1016/0304-3940(93)90497-9; Lee MG, 2008, J IMMUNOL, V180, P2251, DOI 10.4049/jimmunol.180.4.2251; Leffler A, 2008, J CLIN INVEST, V118, P763, DOI 10.1172/JCI32751; Liu Q, 2012, J NEUROSCI, V32, P14532, DOI 10.1523/JNEUROSCI.3509-12.2012; Liu Q, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001925; Liu Q, 2009, CELL, V139, P1353, DOI 10.1016/j.cell.2009.11.034; Liu T, 2012, NEUROSCI BULL, V28, P145, DOI 10.1007/s12264-012-1207-9; Liu Y, 2010, NEURON, V68, P543, DOI 10.1016/j.neuron.2010.09.008; Malin SA, 2007, NAT PROTOC, V2, P152, DOI 10.1038/nprot.2006.461; Namer B, 2008, J NEUROPHYSIOL, V100, P2062, DOI 10.1152/jn.90482.2008; Namer B, 2013, NAT NEUROSCI, V16, P117, DOI 10.1038/nn.3316; Ogle ME, 2012, NEUROBIOL DIS, V45, P733, DOI 10.1016/j.nbd.2011.10.020; Ohsawa Y, 2012, ALLERGY, V67, P1014, DOI 10.1111/j.1398-9995.2012.02854.x; Papoiu ADP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017786; Patel KN, 2011, ACS CHEM NEUROSCI, V2, P17, DOI 10.1021/cn100085g; Petersen LJ, 1997, ALLERGY, V52, P547, DOI 10.1111/j.1398-9995.1997.tb02598.x; Puopolo M, 2013, J NEUROPHYSIOL, V109, P1704, DOI 10.1152/jn.00012.2013; Roberson DP, 2011, BRIT J PHARMACOL, V164, P48, DOI 10.1111/j.1476-5381.2011.01391.x; Ross SE, 2010, NEURON, V65, P886, DOI 10.1016/j.neuron.2010.02.025; Rudick CN, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002096; Schmelz M, 2003, J NEUROPHYSIOL, V89, P2441, DOI 10.1152/jn.01139.2002; Shim WS, 2007, J NEUROSCI, V27, P2331, DOI 10.1523/JNEUROSCI.4643-06.2007; Shimada SG, 2008, PAIN, V139, P681, DOI 10.1016/j.pain.2008.08.002; Sikand P, 2009, PAIN, V144, P66, DOI 10.1016/j.pain.2009.03.001; Sun YG, 2007, NATURE, V448, P700, DOI 10.1038/nature06029; Sun YG, 2009, SCIENCE, V325, P1531, DOI 10.1126/science.1174868; Wilson SR, 2011, NAT NEUROSCI, V14, P595, DOI 10.1038/nn.2789; Yosipovitch G, 2008, CURR ALLERGY ASTHM R, V8, P306, DOI 10.1007/s11882-008-0049-z	46	98	100	1	43	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUL	2013	16	7					910	U176		10.1038/nn.3404	http://dx.doi.org/10.1038/nn.3404			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	174UM	23685721	Green Submitted, Green Accepted			2022-12-28	WOS:000321180900025
J	Suberbielle, E; Sanchez, PE; Kravitz, AV; Wang, X; Ho, K; Eilertson, K; Devidze, N; Kreitzer, AC; Mucke, L				Suberbielle, Elsa; Sanchez, Pascal E.; Kravitz, Alexxai V.; Wang, Xin; Ho, Kaitlyn; Eilertson, Kirsten; Devidze, Nino; Kreitzer, Anatol C.; Mucke, Lennart			Physiologic brain activity causes DNA double-strand breaks in neurons, with exacerbation by amyloid-beta	NATURE NEUROSCIENCE			English	Article							SYNTHETIC SUPEROXIDE-DISMUTASE; ALZHEIMERS-DISEASE; MOUSE MODELS; COGNITIVE IMPAIRMENTS; OXIDATIVE STRESS; HISTONE H2A.X; DAMAGE; DYSFUNCTION; REPAIR; PHOSPHORYLATION	We show that a natural behavior, exploration of a novel environment, causes DNA double-strand breaks (DSBs) in neurons of young adult wild-type mice. DSBs occurred in multiple brain regions, were most abundant in the dentate gyrus, which is involved in learning and memory, and were repaired within 24 h. Increasing neuronal activity by sensory or optogenetic stimulation increased neuronal DSBs in relevant but not irrelevant networks. Mice transgenic for human amyloid precursor protein (hAPP), which simulate key aspects of Alzheimer's disease, had increased neuronal DSBs at baseline and more severe and prolonged DSBs after exploration. Interventions that suppress aberrant neuronal activity and improve learning and memory in hAPP mice normalized their levels of DSBs. Blocking extrasynaptic NMDA-type glutamate receptors prevented amyloid-beta (A beta)-induced DSBs in neuronal cultures. Thus, transient increases in neuronal DSBs occur as a result of physiological brain activity, and A beta exacerbates DNA damage, most likely by eliciting synaptic dysfunction.	[Suberbielle, Elsa; Sanchez, Pascal E.; Kravitz, Alexxai V.; Wang, Xin; Ho, Kaitlyn; Devidze, Nino; Kreitzer, Anatol C.; Mucke, Lennart] Gladstone Inst Neurol Dis, San Francisco, CA USA; [Suberbielle, Elsa; Sanchez, Pascal E.; Kravitz, Alexxai V.; Kreitzer, Anatol C.; Mucke, Lennart] Univ Calif San Francisco, Dept Neurol, San Francisco, CA USA; [Eilertson, Kirsten] Gladstone Inst Cardiovasc Dis, San Francisco, CA USA	University of California System; University of California San Francisco; The J David Gladstone Institutes; University of California System; University of California San Francisco; University of California System; University of California San Francisco; The J David Gladstone Institutes	Mucke, L (corresponding author), Gladstone Inst Neurol Dis, San Francisco, CA USA.	lmucke@gladstone.ucsf.edu	Suberbielle, Elsa/K-5416-2014	Suberbielle, Elsa/0000-0002-4554-471X; Eilertson, Kirsten/0000-0003-4850-1210; Kravitz, Alexxai/0000-0001-5983-0218	US National Institutes of Health [AG011385, AG022074, NS065780]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS065780] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG022074, R37AG011385, R01AG011385] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank D.J. Selkoe (Harvard Medical School) and D.M. Walsh (Conway Institute and University College Dublin) for CHO-7PA2 cells; N. Sakane, E. Verdin and L. Verret for comments on the manuscript; H. Kassler for advice on gamma-irradiation; D. Davalos for advice on confocal imaging; D. Pathak for advice on live cell imaging; H. Solanoy, M. Thwin, C. Wang and G.-Q. Yu for technical support; A.L. Lucido for editorial review; J. Carroll, T. Roberts, G. Maki and C. Goodfellow for preparation of graphics; and M. Dela Cruz for administrative assistance. The study was supported by US National Institutes of Health grants AG011385, AG022074 and NS065780 to L.M. and a gift from the S.D. Bechtel, Jr. Foundation.	Anderson L, 2001, MOL CELL BIOL, V21, P1719, DOI 10.1128/MCB.21.5.1719-1729.2001; Bhogal N, 2009, INT J RADIAT BIOL, V85, P732, DOI 10.1080/09553000902785791; Bonner WM, 2008, NAT REV CANCER, V8, P957, DOI 10.1038/nrc2523; Brasnjevic I, 2008, DNA REPAIR, V7, P1087, DOI 10.1016/j.dnarep.2008.03.010; Canugovi C, 2012, P NATL ACAD SCI USA, V109, P14948, DOI 10.1073/pnas.1204156109; Cheng IH, 2007, J BIOL CHEM, V282, P23818, DOI 10.1074/jbc.M701078200; Cheng JS, 2009, NAT NEUROSCI, V12, P119, DOI 10.1038/nn.2240; Cisse M, 2011, NATURE, V469, P47, DOI 10.1038/nature09635; Crowe SL, 2006, EUR J NEUROSCI, V23, P2351, DOI 10.1111/j.1460-9568.2006.04768.x; Crowe SL, 2011, J NEUROSCI, V31, P7648, DOI 10.1523/JNEUROSCI.0092-11.2011; Day JJ, 2011, NEURON, V70, P813, DOI 10.1016/j.neuron.2011.05.019; Esposito L, 2006, J NEUROSCI, V26, P5167, DOI 10.1523/JNEUROSCI.0482-06.2006; Fernandez-Capetillo O, 2003, DEV CELL, V4, P497, DOI 10.1016/S1534-5807(03)00093-5; Fernando RN, 2011, P NATL ACAD SCI USA, V108, P5837, DOI 10.1073/pnas.1014993108; Fillingham J, 2006, BIOCHEM CELL BIOL, V84, P568, DOI 10.1139/O06-072; Flint MS, 2007, PSYCHONEUROENDOCRINO, V32, P470, DOI 10.1016/j.psyneuen.2007.02.013; Graeff J, 2011, PHYSIOL REV, V91, P603, DOI 10.1152/physrev.00012.2010; Grudzenski S, 2010, P NATL ACAD SCI USA, V107, P14205, DOI 10.1073/pnas.1002213107; Hardingham GE, 2010, NAT REV NEUROSCI, V11, P682, DOI 10.1038/nrn2911; Harris JA, 2010, NEURON, V68, P428, DOI 10.1016/j.neuron.2010.10.020; Ismail IH, 2008, ENVIRON MOL MUTAGEN, V49, P73, DOI 10.1002/em.20358; Kim D, 2008, NEURON, V60, P803, DOI 10.1016/j.neuron.2008.10.015; Kobayashi DT, 2005, GENES BRAIN BEHAV, V4, P173, DOI 10.1111/j.1601-183X.2005.00124.x; Kravitz AV, 2010, NATURE, V466, P622, DOI 10.1038/nature09159; Lange J, 2011, NATURE, V479, P237, DOI 10.1038/nature10508; Lee HG, 2009, NEUROCHEM INT, V54, P84, DOI 10.1016/j.neuint.2008.10.013; Lee SY, 2010, J BIOL CHEM, V285, P29525, DOI 10.1074/jbc.M110.127233; Li Luming, 2011, Int J Alzheimers Dis, V2011, P171464, DOI 10.4061/2011/171464; Li SM, 2011, J NEUROSCI, V31, P6627, DOI 10.1523/JNEUROSCI.0203-11.2011; Li SM, 2009, NEURON, V62, P788, DOI 10.1016/j.neuron.2009.05.012; Lu T, 2004, NATURE, V429, P883, DOI 10.1038/nature02661; Marchetti C, 2011, REV NEUROSCIENCE, V22, P373, DOI 10.1515/RNS.2011.035; Morelra PI, 2008, FREE RADICAL BIO MED, V44, P1493, DOI 10.1016/j.freeradbiomed.2008.01.002; Morris M, 2013, NEUROBIOL AGING, V34, P1523, DOI 10.1016/j.neurobiolaging.2012.12.003; Morris M, 2011, NEURON, V70, P410, DOI 10.1016/j.neuron.2011.04.009; Olive PL, 2006, NAT PROTOC, V1, P23, DOI 10.1038/nprot.2006.5; Palop JJ, 2005, J NEUROSCI, V25, P9686, DOI 10.1523/JNEUROSCI.2829-05.2005; Palop JJ, 2003, P NATL ACAD SCI USA, V100, P9572, DOI 10.1073/pnas.1133381100; Palop JJ, 2007, NEURON, V55, P697, DOI 10.1016/j.neuron.2007.07.025; Palop JJ, 2010, NAT NEUROSCI, V13, P812, DOI 10.1038/nn.2583; Palop JJ, 2009, ARCH NEUROL-CHICAGO, V66, P435, DOI 10.1001/archneurol.2009.15; PINHEIRO JC, 2011, NLME LINEAR NONLINEA, V3, P1, DOI DOI 10.1371/J0URNAL.P0NE.0018860; Pong K, 2001, EXP NEUROL, V171, P84, DOI 10.1006/exnr.2001.7747; Roberson E.D., 2007, NAT REV NEUROSCI, V316, P750; Roberson ED, 2011, J NEUROSCI, V31, P700, DOI 10.1523/JNEUROSCI.4152-10.2011; Rong YQ, 1999, P NATL ACAD SCI USA, V96, P9897, DOI 10.1073/pnas.96.17.9897; Sanchez PE, 2012, P NATL ACAD SCI USA, V109, pE2895, DOI 10.1073/pnas.1121081109; Shull ERP, 2009, GENE DEV, V23, P171, DOI 10.1101/gad.1746609; Spink AJ, 2001, PHYSIOL BEHAV, V73, P731, DOI 10.1016/S0031-9384(01)00530-3; Vazdarjanova A, 2006, J COMP NEUROL, V498, P317, DOI 10.1002/cne.21003; Verret L, 2012, CELL, V149, P708, DOI 10.1016/j.cell.2012.02.046; Ward IM, 2003, J BIOL CHEM, V278, P19579, DOI 10.1074/jbc.C300117200; Yang JL, 2010, J BIOL CHEM, V285, P28191, DOI 10.1074/jbc.M109.082883; Yin B, 2009, J EXP MED, V206, P2625, DOI 10.1084/jem.20091320; Zhang Y, 2000, J NEUROSCI, V20, P8384, DOI 10.1523/JNEUROSCI.20-22-08384.2000	55	293	307	2	63	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAY	2013	16	5					613	+		10.1038/nn.3356	http://dx.doi.org/10.1038/nn.3356			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	131WT	23525040	Green Accepted, Green Submitted			2022-12-28	WOS:000318029300018
J	Peck, CJ; Lau, B; Salzman, CD				Peck, Christopher J.; Lau, Brian; Salzman, C. Daniel			The primate amygdala combines information about space and value	NATURE NEUROSCIENCE			English	Article							ORBITOFRONTAL CORTEX; PREFRONTAL CORTEX; AVERSIVE STIMULI; PARIETAL CORTEX; RHESUS-MONKEY; NEURAL BASES; ATTENTION; REWARD; EMOTION; NEURONS	A stimulus predicting reinforcement can trigger emotional responses, such as arousal, and cognitive ones, such as increased attention toward the stimulus. Neuroscientists have long appreciated that the amygdala mediates spatially nonspecific emotional responses, but it remains unclear whether the amygdala links motivational and spatial representations. To test whether amygdala neurons encode spatial and motivational information, we presented reward-predictive cues in different spatial configurations to monkeys and assessed how these cues influenced spatial attention. Cue configuration and predicted reward magnitude modulated amygdala neural activity in a coordinated fashion. Moreover, fluctuations in activity were correlated with trial-to-trial variability in spatial attention. Thus, the amygdala integrates spatial and motivational information, which may influence the spatial allocation of cognitive resources. These results suggest that amygdala dysfunction may contribute to deficits in cognitive processes normally coordinated with emotional responses, such as the directing of attention toward the location of emotionally relevant stimuli.	[Peck, Christopher J.; Lau, Brian; Salzman, C. Daniel] Columbia Univ, Dept Neurosci, New York, NY 10027 USA; [Salzman, C. Daniel] Columbia Univ, Dept Psychiat, New York, NY USA; [Salzman, C. Daniel] Columbia Univ, Kavli Inst Brain Sci, New York, NY USA; [Salzman, C. Daniel] Columbia Univ, WM Keck Ctr Brain Plast & Cognit, New York, NY USA; [Salzman, C. Daniel] Columbia Univ, Mahoney Ctr Brain & Behav, New York, NY USA; [Salzman, C. Daniel] New York State Psychiat Inst & Hosp, New York, NY 10032 USA	Columbia University; Columbia University; Columbia University; Columbia University; Columbia University; New York State Psychiatry Institute	Salzman, CD (corresponding author), Columbia Univ, Dept Neurosci, New York, NY 10027 USA.	cds2005@columbia.edu	Lau, Brian/D-6991-2011	Lau, Brian/0000-0001-8615-8244	US National Institute of Mental Health (NIMH) [R01 MH082017]; US National Institute on Drug Abuse [R01 DA020656]; US National Eye Institute (NEI) [P30-EY19007]; NIH [T32-HD07430, T32-NS06492, T32-EY139333]; NIMH [T32-MH015144]; Helen Hay Whitney Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD007430] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [P30EY019007] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [T32MH015144, R01MH082017, T32MH015174] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA020656] Funding Source: NIH RePORTER	US National Institute of Mental Health (NIMH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); US National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); US National Eye Institute (NEI); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Helen Hay Whitney Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank E. Kandel and K. Louie for discussions and comments on the manuscript, S. Dashnaw for MRI support, G. Asfaw for veterinary support, and K. Marmon and N. Macfarlane for technical support. This research was supported by grants to C.D.S. from the US National Institute of Mental Health (NIMH) (R01 MH082017) and the US National Institute on Drug Abuse (R01 DA020656), and by a core grant from the US National Eye Institute (NEI) (P30-EY19007) to Columbia University; C.J.P. received support from NIH (T32-HD07430, T32-NS06492 and T32-EY139333); B.L. received support from the NIMH (T32-MH015144) and the Helen Hay Whitney Foundation.	Adolphs R, 2005, NATURE, V433, P68, DOI 10.1038/nature03086; Anderson AK, 2005, J EXP PSYCHOL GEN, V134, P258, DOI 10.1037/0096-3445.134.2.258; Anderson BA, 2011, P NATL ACAD SCI USA, V108, P10367, DOI 10.1073/pnas.1104047108; Armony JL, 2002, NEUROPSYCHOLOGIA, V40, P817, DOI 10.1016/S0028-3932(01)00178-6; Baron-Cohen S, 2000, NEUROSCI BIOBEHAV R, V24, P355, DOI 10.1016/S0149-7634(00)00011-7; Belova MA, 2008, J NEUROSCI, V28, P10023, DOI 10.1523/JNEUROSCI.1400-08.2008; Belova MA, 2007, NEURON, V55, P970, DOI 10.1016/j.neuron.2007.08.004; Cai XY, 2012, J NEUROSCI, V32, P3791, DOI 10.1523/JNEUROSCI.3864-11.2012; Cai XY, 2011, NEURON, V69, P170, DOI 10.1016/j.neuron.2010.11.041; Corbetta M, 2008, NEURON, V58, P306, DOI 10.1016/j.neuron.2008.04.017; Davis M, 2001, MOL PSYCHIATR, V6, P13, DOI 10.1038/sj.mp.4000812; DEMETER S, 1990, J COMP NEUROL, V302, P29, DOI 10.1002/cne.903020104; DESIMONE R, 1995, ANNU REV NEUROSCI, V18, P193, DOI 10.1146/annurev.ne.18.030195.001205; DiCarlo JJ, 2003, J NEUROPHYSIOL, V89, P3264, DOI 10.1152/jn.00358.2002; Freese J.L., 2009, HUMAN AMYGDALA; Ghashghaei H, 2007, NEUROIMAGE, V34, P905, DOI 10.1016/j.neuroimage.2006.09.046; Ghashghaei HT, 2002, NEUROSCIENCE, V115, P1261, DOI 10.1016/S0306-4522(02)00446-3; Holland PC, 1999, TRENDS COGN SCI, V3, P65, DOI 10.1016/S1364-6613(98)01271-6; Kable JW, 2009, NEURON, V63, P733, DOI 10.1016/j.neuron.2009.09.003; Kaping D, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001224; KAPP BS, 1994, BEHAV NEUROSCI, V108, P81, DOI 10.1037/0735-7044.108.1.81; Kennerley SW, 2009, J NEUROSCI, V29, P3259, DOI 10.1523/JNEUROSCI.5353-08.2009; Klein JT, 2009, CURR BIOL, V19, pR958, DOI 10.1016/j.cub.2009.08.010; Lang PJ, 2006, PROG BRAIN RES, V156, P3, DOI 10.1016/S0079-6123(06)56001-7; Lau B, 2008, NEURON, V58, P451, DOI 10.1016/j.neuron.2008.02.021; Liu Z, 2000, J NEUROPHYSIOL, V83, P1677, DOI 10.1152/jn.2000.83.3.1677; Louie K, 2011, J NEUROSCI, V31, P10627, DOI 10.1523/JNEUROSCI.1237-11.2011; Maunsell JHR, 2004, TRENDS COGN SCI, V8, P261, DOI 10.1016/j.tics.2004.04.003; Morrison SE, 2011, NEURON, V71, P1127, DOI 10.1016/j.neuron.2011.07.016; Morrison SE, 2009, J NEUROSCI, V29, P11471, DOI 10.1523/JNEUROSCI.1815-09.2009; Ohman A., 2003, HDB AFFECTIVE SCI; Padmala S, 2008, J NEUROSCI, V28, P6202, DOI 10.1523/JNEUROSCI.1233-08.2008; Padoa-Schioppa C, 2006, NATURE, V441, P223, DOI 10.1038/nature04676; Paton JJ, 2006, NATURE, V439, P865, DOI 10.1038/nature04490; Peck CJ, 2009, J NEUROSCI, V29, P11182, DOI 10.1523/JNEUROSCI.1929-09.2009; Pessoa L, 2010, NAT REV NEUROSCI, V11, P773, DOI 10.1038/nrn2920; Phelps EA, 2006, PSYCHOL SCI, V17, P292, DOI 10.1111/j.1467-9280.2006.01701.x; Phelps EA, 2005, NEURON, V48, P175, DOI 10.1016/j.neuron.2005.09.025; Pinkham AE, 2008, SCHIZOPHR RES, V99, P164, DOI 10.1016/j.schres.2007.10.024; POSNER MI, 1980, J EXP PSYCHOL GEN, V109, P160, DOI 10.1037/0096-3445.109.2.160; Reason J. T., 1984, VARIETIES ATTENTION; Roesch MR, 2010, J NEUROPHYSIOL, V104, P587, DOI 10.1152/jn.00173.2010; ROLLS ET, 1977, BRAIN RES, V130, P229, DOI 10.1016/0006-8993(77)90272-4; Samejima K, 2005, SCIENCE, V310, P1337, DOI 10.1126/science.1115270; Schultz W, 2006, ANNU REV PSYCHOL, V57, P87, DOI 10.1146/annurev.psych.56.091103.070229; Sugrue LP, 2005, NAT REV NEUROSCI, V6, P363, DOI 10.1038/nrn1666; SWADLOW HA, 1978, EXP BRAIN RES, V33, P455; Tamietto M, 2010, NAT REV NEUROSCI, V11, P697, DOI 10.1038/nrn2889; URSIN H, 1960, ELECTROEN CLIN NEURO, V12, P1, DOI 10.1016/0013-4694(60)90058-4; Vuilleumier P, 2004, NAT NEUROSCI, V7, P1271, DOI 10.1038/nn1341	50	94	94	0	31	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	MAR	2013	16	3					340	348		10.1038/nn.3328	http://dx.doi.org/10.1038/nn.3328			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	097LE	23377126	Green Accepted			2022-12-28	WOS:000315474800017
J	Belgard, TG; Geschwind, DH				Belgard, T. Grant; Geschwind, Daniel H.			Retooling spare parts: gene duplication and cognition	NATURE NEUROSCIENCE			English	Editorial Material							MICE; SCHIZOPHRENIA; FOXP2	Two new studies provide experimental evidence of how ancient genomic duplications of synaptic genes provided the substrate for diversification that ultimately expanded vertebrate cognitive complexity.	[Belgard, T. Grant] Univ Calif Los Angeles, Ctr Autism Res & Treatment, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Inst Neurosci & Human Behav, Program Neurobehav Genet, Los Angeles, CA USA; [Geschwind, Daniel H.] Univ Calif Los Angeles, Dept Human Genet, Los Angeles, CA USA; [Geschwind, Daniel H.] Univ Calif Los Angeles, Dept Neurol, Los Angeles, CA 90024 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Belgard, TG (corresponding author), Univ Calif Los Angeles, Ctr Autism Res & Treatment, Los Angeles, CA 90095 USA.	dhg@mednet.ucla.edu		Belgard, Tildon/0000-0002-6962-7894	NATIONAL INSTITUTE OF MENTAL HEALTH [R37MH060233] Funding Source: NIH RePORTER; NIMH NIH HHS [R37 MH060233] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Bussey TJ, 2012, NEUROPHARMACOLOGY, V62, P1191, DOI 10.1016/j.neuropharm.2011.04.011; Conant GC, 2008, NAT REV GENET, V9, P938, DOI 10.1038/nrg2482; Enard W, 2009, CELL, V137, P961, DOI 10.1016/j.cell.2009.03.041; Gillespie J. H., 2004, POPULATION GENETICS; Gottesman II, 2003, AM J PSYCHIAT, V160, P636, DOI 10.1176/appi.ajp.160.4.636; Khaitovich P, 2004, PLOS BIOL, V2, P682, DOI 10.1371/journal.pbio.0020132; Konopka G, 2012, NEURON, V75, P601, DOI 10.1016/j.neuron.2012.05.034; Konopka G, 2009, NATURE, V462, P213, DOI 10.1038/nature08549; Nithianantharajah J, 2013, NAT NEUROSCI, V16, P16, DOI 10.1038/nn.3276; Penagarikano O, 2012, TRENDS MOL MED, V18, P156, DOI 10.1016/j.molmed.2012.01.003; ROBBINS TW, 1994, DEMENTIA, V5, P266, DOI 10.1159/000106735; Ryan TJ, 2013, NAT NEUROSCI, V16, P25, DOI 10.1038/nn.3277; Tinbergen N., 1963, Zeitschrift fuer Tierpsychologie, V20, P410; Won H, 2012, NATURE, V486, P261, DOI 10.1038/nature11208; Young JW, 2010, CURR TOP BEHAV NEURO, V4, P391, DOI 10.1007/7854_2010_62	15	6	6	0	16	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JAN	2013	16	1					6	8		10.1038/nn.3292	http://dx.doi.org/10.1038/nn.3292			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	058KZ	23257927	Green Accepted			2022-12-28	WOS:000312633900004
J	Tiberi, L; van den Ameele, J; Dimidschstein, J; Piccirilli, J; Gall, D; Herpoel, A; Bilheu, A; Bonnefont, J; Iacovino, M; Kyba, M; Bouschet, T; Vanderhaeghen, P				Tiberi, Luca; van den Ameele, Jelle; Dimidschstein, Jordane; Piccirilli, Julie; Gall, David; Herpoel, Adele; Bilheu, Angeline; Bonnefont, Jerome; Iacovino, Michelina; Kyba, Michael; Bouschet, Tristan; Vanderhaeghen, Pierre			BCL6 controls neurogenesis through Sirt1-dependent epigenetic repression of selective Notch targets	NATURE NEUROSCIENCE			English	Article							NEURAL STEM-CELLS; GENE-EXPRESSION; EMBRYONIC STEM; CORTICAL-NEURONS; SIRT1; DIFFERENTIATION; ACTIVATION; IDENTIFICATION; ACETYLATION; CONTRIBUTES	During neurogenesis, neural stem/progenitor cells (NPCs) undergo an irreversible fate transition to become neurons. The Notch pathway is important for this process, and repression of Notch-dependent Hes genes is essential for triggering differentiation. However, Notch signaling often remains active throughout neuronal differentiation, implying a change in the transcriptional responsiveness to Notch during the neurogenic transition. We identified Bcl6, an oncogene, as encoding a proneurogenic factor that is required for proper neurogenesis of the mouse cerebral cortex. BCL6 promoted the neurogenic conversion by switching the composition of Notch-dependent transcriptional complexes at the Hes5 promoter. BCL6 triggered exclusion of the co-activator Mastermind-like 1 and recruitment of the NAD(+)-dependent deacetylase Sirt1, which was required for BCL6-dependent neurogenesis. The resulting epigenetic silencing of Hes5 led to neuronal differentiation despite active Notch signaling. Our findings suggest a role for BCL6 in neurogenesis and uncover Notch-BCL6-Sirt1 interactions that may affect other aspects of physiology and disease.	[Tiberi, Luca; van den Ameele, Jelle; Dimidschstein, Jordane; Piccirilli, Julie; Herpoel, Adele; Bilheu, Angeline; Bonnefont, Jerome; Bouschet, Tristan; Vanderhaeghen, Pierre] Univ Libre Bruxelles, ULB Neurosci Inst, Inst Interdisciplinary Res, Brussels, Belgium; [van den Ameele, Jelle] Ghent Univ Hosp, Dept Neurol, Ghent, Belgium; [Gall, David] Univ Libre Bruxelles, Neurophysiol Lab, Brussels, Belgium; [Iacovino, Michelina; Kyba, Michael] Univ Minnesota, Lillehei Heart Inst, Minneapolis, MN USA; [Vanderhaeghen, Pierre] Univ Libre Bruxelles, Welbio, Brussels, Belgium	Universite Libre de Bruxelles; Ghent University; Ghent University Hospital; Universite Libre de Bruxelles; University of Minnesota System; University of Minnesota Twin Cities; Universite Libre de Bruxelles; WELBIO	Vanderhaeghen, P (corresponding author), Univ Libre Bruxelles, ULB Neurosci Inst, Inst Interdisciplinary Res, Brussels, Belgium.	pierre.vanderhaeghen@ulb.ac.be	Bonnefont, Jerome/J-6767-2012; Tiberi, Luca/AAQ-4253-2021; Bouschet, Tristan/C-8265-2019	Bonnefont, Jerome/0000-0003-1996-8452; Bouschet, Tristan/0000-0002-7858-6115; Dimidschstein, Jordane/0000-0001-6289-6891; van den Ameele, Jelle/0000-0002-2744-0810; Bonnefont, Jerome/0000-0001-5283-8428; Kyba, Michael/0000-0002-5579-7534; Vanderhaeghen, Pierre/0000-0001-7899-5720; Tiberi, Luca/0000-0002-5983-3782; iacovino, michelina/0000-0002-1076-3146	Belgian Queen Elizabeth Medical Foundation; Fondation Pierre Clerdent; Fondation Roger de Spoelberch; Action de Recherches Concertees Programs; Interuniversity Attraction Poles Program, Belgian State, Federal Office for Scientific, Technical and Cultural Affairs; Belgian FNRS; Fonds pour la Recherche Scientifique Medicale; Welbio and Programme d'Excellence CIBLES of the Walloon Region; EMBO Long-Term Fellowship; Marie Curie Fellowship	Belgian Queen Elizabeth Medical Foundation; Fondation Pierre Clerdent; Fondation Roger de Spoelberch; Action de Recherches Concertees Programs; Interuniversity Attraction Poles Program, Belgian State, Federal Office for Scientific, Technical and Cultural Affairs; Belgian FNRS(Fonds de la Recherche Scientifique - FNRS); Fonds pour la Recherche Scientifique Medicale(Fonds de la Recherche Scientifique - FNRS); Welbio and Programme d'Excellence CIBLES of the Walloon Region(WELBIO); EMBO Long-Term Fellowship(European Molecular Biology Organization (EMBO)); Marie Curie Fellowship(European Commission)	We thank G. Vassart for continuous support and interest, D. Christophe and members of the Vanderhaeghen lab and Institute for Interdisciplinary Research for helpful discussions and advice, F. Bollet-Quivogne (Fonds National de la Recherche Scientifique (FNRS) Logistic Scientist) of the Light Microscopy Facility for his support with imaging, R. Dalla-Favera (Columbia University) for generously sharing Bcl6<SUP>-/-</SUP> mice, F. Guillemot (National Institute of Medical Research) for kindly providing P19 cells, and G. Del Sal ((Laboratorio Nazionale CIB) Trieste) for the pCS2-N Delta E construct, and B. Hassan, A. Soldano and K. De Backer for critically reading the manuscript. This work was funded by grants from the Belgian Queen Elizabeth Medical Foundation, the Fondations Pierre Clerdent and Roger de Spoelberch, the Action de Recherches Concertees Programs, the Interuniversity Attraction Poles Program, Belgian State, Federal Office for Scientific, Technical and Cultural Affairs, the Belgian FNRS and Fonds pour la Recherche Scientifique Medicale, and the Welbio and Programme d'Excellence CIBLES of the Walloon Region (to P. V.), as well as an EMBO Long-Term Fellowship (to L. T.) and a Marie Curie Fellowship (to T. B.). P. V. is Research Director, L. T. Postdoctoral Fellow, and J.v.d.A. and J.P. Research Fellows of the FNRS.	Bedogni F, 2010, P NATL ACAD SCI USA, V107, P13129, DOI 10.1073/pnas.1002285107; Bertrand N, 2002, NAT REV NEUROSCI, V3, P517, DOI 10.1038/nrn874; Borggrefe T, 2012, CELL CYCLE, V11, P264, DOI 10.4161/cc.11.2.18995; Bray S, 2010, CURR TOP DEV BIOL, V92, P253, DOI 10.1016/S0070-2153(10)92008-5; Chang CC, 1996, P NATL ACAD SCI USA, V93, P6947, DOI 10.1073/pnas.93.14.6947; Depaepe V, 2005, NATURE, V435, P1244, DOI 10.1038/nature03651; Donmez G, 2010, CELL, V142, P320, DOI 10.1016/j.cell.2010.06.020; Dufour A, 2003, NEURON, V39, P453, DOI 10.1016/S0896-6273(03)00440-9; Endo K, 2012, NAT NEUROSCI, V15, P224, DOI 10.1038/nn.2998; Funatsu N, 2004, CEREB CORTEX, V14, P1031, DOI 10.1093/cercor/bhh063; Gao J, 2010, NATURE, V466, P1105, DOI 10.1038/nature09271; Gaspard N, 2008, NATURE, V455, P351, DOI 10.1038/nature07287; Gaspard N, 2009, NAT PROTOC, V4, P1454, DOI 10.1038/nprot.2009.157; Gaspard N, 2010, CURR OPIN NEUROBIOL, V20, P37, DOI 10.1016/j.conb.2009.12.001; Gotz M, 2005, NAT REV MOL CELL BIO, V6, P777, DOI 10.1038/nrm1739; Guarani V, 2011, NATURE, V473, P234, DOI 10.1038/nature09917; Hashimoto-Torii K, 2008, NEURON, V60, P273, DOI 10.1016/j.neuron.2008.09.026; Heng JIT, 2008, NATURE, V455, P114, DOI 10.1038/nature07198; Herranz D, 2010, NAT REV CANCER, V10, P819, DOI 10.1038/nrc2962; Hirabayashi Y, 2010, NAT REV NEUROSCI, V11, P377, DOI 10.1038/nrn2810; Hisahara S, 2008, P NATL ACAD SCI USA, V105, P15599, DOI 10.1073/pnas.0800612105; Hoeck JD, 2010, NAT NEUROSCI, V13, P1365, DOI 10.1038/nn.2644; Hsieh J, 2005, CURR OPIN CELL BIOL, V17, P664, DOI 10.1016/j.ceb.2005.09.002; Iacovino M, 2011, STEM CELLS, V29, P1580, DOI 10.1002/stem.715; Kageyama R, 2008, NAT NEUROSCI, V11, P1247, DOI 10.1038/nn.2208; Kawaguchi D, 2008, DEVELOPMENT, V135, P3849, DOI 10.1242/dev.024570; Kopan R, 2009, CELL, V137, P216, DOI 10.1016/j.cell.2009.03.045; Kriegstein A, 2009, ANNU REV NEUROSCI, V32, P149, DOI 10.1146/annurev.neuro.051508.135600; Leamey CA, 2008, CEREB CORTEX, V18, P53, DOI 10.1093/cercor/bhm031; Louvi A, 2006, NAT REV NEUROSCI, V7, P93, DOI 10.1038/nrn1847; Malatesta P, 2000, DEVELOPMENT, V127, P5253; Min SW, 2010, NEURON, V67, P953, DOI 10.1016/j.neuron.2010.08.044; Miyata T, 2004, DEVELOPMENT, V131, P3133, DOI 10.1242/dev.01173; Mizutani K, 2007, NATURE, V449, P351, DOI 10.1038/nature06090; Mulligan P, 2011, MOL CELL, V42, P689, DOI 10.1016/j.molcel.2011.04.020; Noctor SC, 2004, NAT NEUROSCI, V7, P136, DOI 10.1038/nn1172; Ohtsuka T, 2001, J BIOL CHEM, V276, P30467, DOI 10.1074/jbc.M102420200; Okano H, 2009, CURR OPIN NEUROBIOL, V19, P112, DOI 10.1016/j.conb.2009.04.003; Ong CT, 2006, J BIOL CHEM, V281, P5106, DOI 10.1074/jbc.M506108200; Otaki JM, 2010, DEV NEUROBIOL, V70, P424, DOI 10.1002/dneu.20786; Phan RT, 2004, NATURE, V432, P635, DOI 10.1038/nature03147; Pierfelice T, 2011, NEURON, V69, P840, DOI 10.1016/j.neuron.2011.02.031; Prozorovski T, 2008, NAT CELL BIOL, V10, P385, DOI 10.1038/ncb1700; Redmond L, 2000, NAT NEUROSCI, V3, P30, DOI 10.1038/71104; Rustighi A, 2009, NAT CELL BIOL, V11, P133, DOI 10.1038/ncb1822; Sabharwal P, 2011, NEURON, V71, P1058, DOI 10.1016/j.neuron.2011.07.028; Saito T, 2001, DEV BIOL, V240, P237, DOI 10.1006/dbio.2001.0439; Sakano D, 2010, DEV CELL, V18, P450, DOI 10.1016/j.devcel.2009.12.023; Sestan N, 1999, SCIENCE, V286, P741, DOI 10.1126/science.286.5440.741; Shimojo H, 2008, NEURON, V58, P52, DOI 10.1016/j.neuron.2008.02.014; Takeda N, 2003, J IMMUNOL, V171, P426, DOI 10.4049/jimmunol.171.1.426; Tiberi L, 2012, CURR OPIN CELL BIOL, V24, P269, DOI 10.1016/j.ceb.2012.01.010; van den Ameele J, 2012, EMBO REP, V13, P355, DOI 10.1038/embor.2012.23; Ye BH, 1997, NAT GENET, V16, P161, DOI 10.1038/ng0697-161; YE BH, 1993, SCIENCE, V262, P747, DOI 10.1126/science.8235596; Yoo AS, 2009, CURR OPIN NEUROBIOL, V19, P120, DOI 10.1016/j.conb.2009.04.006; Zhang SJ, 2007, NEURON, V53, P549, DOI 10.1016/j.neuron.2007.01.025	57	84	92	1	21	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	DEC	2012	15	12					1627	+		10.1038/nn.3264	http://dx.doi.org/10.1038/nn.3264			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	045OR	23160044				2022-12-28	WOS:000311706700008
J	Leao, RN; Mikulovic, S; Leao, KE; Munguba, H; Gezelius, H; Enjin, A; Patra, K; Eriksson, A; Loew, LM; Tort, ABL; Kullander, K				Leao, Richardson N.; Mikulovic, Sanja; Leao, Katarina E.; Munguba, Hermany; Gezelius, Henrik; Enjin, Anders; Patra, Kalicharan; Eriksson, Anders; Loew, Leslie M.; Tort, Adriano B. L.; Kullander, Klas			OLM interneurons differentially modulate CA3 and entorhinal inputs to hippocampal CA1 neurons	NATURE NEUROSCIENCE			English	Article							LONG-TERM POTENTIATION; STRATUM-ORIENS; THETA-RHYTHM; GABAERGIC NEURONS; FAST INHIBITION; CELLS; MODEL; GAMMA; ACETYLCHOLINE; FEEDFORWARD	The vast diversity of GABAergic interneurons is believed to endow hippocampal microcircuits with the required flexibility for memory encoding and retrieval. However, dissection of the functional roles of defined interneuron types has been hampered by the lack of cell-specific tools. We identified a precise molecular marker for a population of hippocampal GABAergic interneurons known as oriens lacunosum-moleculare (OLM) cells. By combining transgenic mice and optogenetic tools, we found that OLM cells are important for gating the information flow in CA1, facilitating the transmission of intrahippocampal information (from CA3) while reducing the influence of extrahippocampal inputs (from the entorhinal cortex). Furthermore, we found that OLM cells were interconnected by gap junctions, received direct cholinergic inputs from subcortical afferents and accounted for the effect of nicotine on synaptic plasticity of the Schaffer collateral pathway. Our results suggest that acetylcholine acting through OLM cells can control the mnemonic processes executed by the hippocampus.	[Leao, Richardson N.; Mikulovic, Sanja; Leao, Katarina E.; Gezelius, Henrik; Enjin, Anders; Patra, Kalicharan; Eriksson, Anders; Kullander, Klas] Uppsala Univ, Dept Neurosci, Uppsala, Sweden; [Leao, Richardson N.; Leao, Katarina E.; Munguba, Hermany; Tort, Adriano B. L.] Univ Fed Rio Grande do Norte, Brain Inst, BR-59072970 Natal, RN, Brazil; [Loew, Leslie M.] UConn Hlth Ctr, RD Berlin Ctr Cell Anal & Modeling, Farmington, CT USA; [Kullander, Klas] Uppsala Univ, Dept Neurosci, Sci Life Lab, Uppsala, Sweden	Uppsala University; Universidade Federal do Rio Grande do Norte; University of Connecticut; Uppsala University	Kullander, K (corresponding author), Uppsala Univ, Dept Neurosci, Uppsala, Sweden.	richardson.leao@neuro.uu.se; klas.kullander@neuro.uu.se	Enjin, Anders/J-9706-2014; Leao, Richardson/AAX-4985-2020; Tort, Adriano/A-9945-2009	Leao, Richardson/0000-0001-8496-1965; Tort, Adriano/0000-0002-9877-7816; Leao, Katarina/0000-0001-7295-1233; Kullander, Klas/0000-0001-6418-5460; Gezelius, Henrik/0000-0002-6242-6344; Enjin, Anders/0000-0001-7167-9434; Munguba, Hermany/0000-0002-8480-8423; Loew, Leslie/0000-0002-1851-4646	foundation of Marta och Kjell Beijer; foundation of Hallsten; foundation of Goran Gustafsson; Swedish Foundation for International Cooperation in Research and Higher Education; Brazilian Federal Agency for Support and Evaluation of Graduate Education; Brazilian National Council of Technological and Scientific Development; Research Support Agency of the State of Rio Grande do Norte, US National Institutes of Health [R01EB001963]; Swedish Medical Research Council; Swedish Brain Foundation; Uppsala University; Knut and Alice Wallenberg Foundation; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR000954] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB001963] Funding Source: NIH RePORTER	foundation of Marta och Kjell Beijer; foundation of Hallsten; foundation of Goran Gustafsson; Swedish Foundation for International Cooperation in Research and Higher Education; Brazilian Federal Agency for Support and Evaluation of Graduate Education; Brazilian National Council of Technological and Scientific Development; Research Support Agency of the State of Rio Grande do Norte, US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Swedish Medical Research Council(Swedish Medical Research Council (SMRC)); Swedish Brain Foundation; Uppsala University; Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	We thank G. Buzsaki, P. Ascher, B. Lamotte d'Incamps, O. Amaral and E. Hanse for comments on earlier versions of this manuscript. This work was supported by the foundations of Marta och Kjell Beijer, Hallsten and Goran Gustafsson, The Swedish Foundation for International Cooperation in Research and Higher Education, the Brazilian Federal Agency for Support and Evaluation of Graduate Education, the Brazilian National Council of Technological and Scientific Development, the Research Support Agency of the State of Rio Grande do Norte, US National Institutes of Health grant R01EB001963, the Swedish Medical Research Council, the Swedish Brain Foundation, and Uppsala University. K.K. is a Royal Swedish Academy of Sciences Research Fellow supported by a grant from the Knut and Alice Wallenberg Foundation.	Ascoli GA, 2008, NAT REV NEUROSCI, V9, P557, DOI 10.1038/nrn2402; BLASCOIBANEZ JM, 1995, EUR J NEUROSCI, V7, P2170, DOI 10.1111/j.1460-9568.1995.tb00638.x; Cardin JA, 2010, NAT PROTOC, V5, P247, DOI 10.1038/nprot.2009.228; Cardin JA, 2009, NATURE, V459, P663, DOI 10.1038/nature08002; Colom LV, 2006, J NEUROCHEM, V96, P609, DOI 10.1111/j.1471-4159.2005.03630.x; Cutsuridis V, 2010, HIPPOCAMPUS, V20, P423, DOI 10.1002/hipo.20661; Davis Jennifer A, 2008, Curr Drug Abuse Rev, V1, P9; Dugladze T, 2007, P NATL ACAD SCI USA, V104, P17530, DOI 10.1073/pnas.0708301104; Eichenbaum H, 2004, NEURON, V44, P109, DOI 10.1016/j.neuron.2004.08.028; Elfant D, 2008, EUR J NEUROSCI, V27, P104, DOI 10.1111/j.1460-9568.2007.06001.x; Franklin K., 2007, MOUSE BRAIN STEREOTA; Freund TF, 1996, HIPPOCAMPUS, V6, P347, DOI 10.1002/(SICI)1098-1063(1996)6:4<347::AID-HIPO1>3.0.CO;2-I; Fuchs EC, 2007, NEURON, V53, P591, DOI 10.1016/j.neuron.2007.01.031; Gloveli T, 2005, P NATL ACAD SCI USA, V102, P13295, DOI 10.1073/pnas.0506259102; Gradinaru V, 2010, CELL, V141, P154, DOI 10.1016/j.cell.2010.02.037; GULYAS AI, 1990, NEUROSCIENCE, V37, P31, DOI 10.1016/0306-4522(90)90189-B; Gulyas AI, 2010, J NEUROSCI, V30, P15134, DOI 10.1523/JNEUROSCI.4104-10.2010; Hasselmo ME, 1999, TRENDS COGN SCI, V3, P351, DOI 10.1016/S1364-6613(99)01365-0; Ishii K, 2005, J COMP NEUROL, V493, P241, DOI 10.1002/cne.20762; Jia YS, 2010, EUR J NEUROSCI, V31, P463, DOI 10.1111/j.1460-9568.2009.07058.x; Jia YS, 2009, EUR J NEUROSCI, V29, P1588, DOI 10.1111/j.1460-9568.2009.06706.x; Kee MZL, 2008, BRAIN CELL BIOL, V36, P157, DOI 10.1007/s11068-009-9039-x; Kim S, 2012, NAT NEUROSCI, V15, P600, DOI [10.1038/nn.3060, 10.1038/nn.3173]; Klausberger T, 2004, NAT NEUROSCI, V7, P41, DOI 10.1038/nn1159; Korotkova T, 2010, NEURON, V68, P557, DOI 10.1016/j.neuron.2010.09.017; Lovett-Barron M, 2012, NAT NEUROSCI, V15, P423, DOI 10.1038/nn.3024; Lynch MA, 2004, PHYSIOL REV, V84, P87, DOI 10.1152/physrev.00014.2003; Maccaferri G, 2002, J NEUROSCI, V22, P5462; Maccaferri G, 2000, J PHYSIOL-LONDON, V524, P91, DOI 10.1111/j.1469-7793.2000.t01-3-00091.x; MACCAFERRI G, 1995, NEURON, V15, P137, DOI 10.1016/0896-6273(95)90071-3; Maccaferri G, 1996, J PHYSIOL-LONDON, V497, P119, DOI 10.1113/jphysiol.1996.sp021754; Minneci F, 2007, HIPPOCAMPUS, V17, P538, DOI 10.1002/hipo.20291; MORRIS RGM, 1982, NATURE, V297, P681, DOI 10.1038/297681a0; Murray AJ, 2011, NAT NEUROSCI, V14, P297, DOI 10.1038/nn.2751; Nakauchi S, 2007, EUR J NEUROSCI, V25, P2666, DOI 10.1111/j.1460-9568.2007.05513.x; Neymotin SA, 2011, J NEUROSCI, V31, P11733, DOI 10.1523/JNEUROSCI.0501-11.2011; Palmer LM, 2006, J NEUROSCI, V26, P1854, DOI 10.1523/JNEUROSCI.4812-05.2006; Pouille F, 2001, SCIENCE, V293, P1159, DOI 10.1126/science.1060342; Rotstein HG, 2005, J NEUROPHYSIOL, V94, P1509, DOI 10.1152/jn.00957.2004; Somogyi P, 2005, J PHYSIOL-LONDON, V562, P9, DOI 10.1113/jphysiol.2004.078915; Stanley EM, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2010.12.014; Taniguchi H, 2011, NEURON, V71, P995, DOI 10.1016/j.neuron.2011.07.026; Tong QC, 2008, NAT NEUROSCI, V11, P998, DOI 10.1038/nn.2167; Tort ABL, 2007, P NATL ACAD SCI USA, V104, P13490, DOI 10.1073/pnas.0705708104; Tu B, 2009, J NEUROSCI, V29, P10436, DOI 10.1523/JNEUROSCI.2580-09.2009; Veruki ML, 2010, J NEUROPHYSIOL, V103, P1456, DOI 10.1152/jn.01105.2009; Wulff P, 2009, P NATL ACAD SCI USA, V106, P3561, DOI 10.1073/pnas.0813176106	47	200	200	0	41	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	NOV	2012	15	11					1524	1530		10.1038/nn.3235	http://dx.doi.org/10.1038/nn.3235			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	028LX	23042082	Green Accepted, Green Published			2022-12-28	WOS:000310424900012
J	Mangin, JM; Li, PJ; Scafidi, J; Gallo, V				Mangin, Jean-Marie; Li, Peijun; Scafidi, Joseph; Gallo, Vittorio			Experience-dependent regulation of NG2 progenitors in the developing barrel cortex	NATURE NEUROSCIENCE			English	Article							DIVIDING GLIAL-CELLS; SYNAPSES; MOUSE; INTERNEURONS; PLASTICITY; RECEPTORS; GLUTAMATE; COMPLEX; PROTEIN; INPUTS	We found that, during the formation of the mouse barrel cortex, NG2 cells received glutamatergic synapses from thalamocortical fibers and preferentially accumulated along septa separating the barrels. Sensory deprivation reduced thalamocortical inputs on NG2 cells and increased their proliferation, leading to a more uniform distribution in the deprived barrels. Thus, early sensory experience regulates thalamocortical innervation on NG2 cells, as well as their proliferation and distribution during development.	[Mangin, Jean-Marie; Li, Peijun; Scafidi, Joseph; Gallo, Vittorio] Childrens Natl Med Ctr, Ctr Neurosci Res, Washington, DC 20010 USA; [Mangin, Jean-Marie] Univ Paris 06, INSERM URMS 952, CNRS UMR 7224, Paris, France	Children's National Health System; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite	Mangin, JM (corresponding author), Childrens Natl Med Ctr, Ctr Neurosci Res, Washington, DC 20010 USA.	jean-marie.mangin@inserm.fr; vgallo@cnmcresearch.org		Li, Peijun/0000-0003-0701-3122; Scafidi, Joseph/0000-0003-2379-1370; Mangin, Jean-Marie/0000-0002-7804-0251	US National Institutes of Health (NIH) [R01NS045702, R01NS056427]; NIH Intellectual and Developmental Disabilities Research Center [P30HD40677]; NIH [K08NS073793]; Agence Nationale de la Recherche Jeune Chercheuse Jeune Chercheur Grant Oligospine; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD040677] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS056427, K08NS073793, R01NS045702] Funding Source: NIH RePORTER	US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH Intellectual and Developmental Disabilities Research Center; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Agence Nationale de la Recherche Jeune Chercheuse Jeune Chercheur Grant Oligospine(French National Research Agency (ANR)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank D. Bergles and M. Huntsman for discussion. We thank L.-J. Chew, J. Corbin, M. Huntsman and J. Liu for critically reading an earlier version of this manuscript. We thank E. Quinlan (University of Maryland) for her advice on the dark-rearing experiments. We also thank R. Chittajallu and J. Isaac for their help with the thalamocortical slice preparation. This work was supported by grants from the US National Institutes of Health (NIH; R01NS045702, R01NS056427) and NIH Intellectual and Developmental Disabilities Research Center (P30HD40677) to V. G., an NIH grant (K08NS073793) to J. S., and by Agence Nationale de la Recherche Jeune Chercheuse Jeune Chercheur Grant Oligospine (J.-M.M.).	Datwani A, 2002, J NEUROSCI, V22, P9171; Daw MI, 2007, NAT NEUROSCI, V10, P453, DOI 10.1038/nn1866; Dawson MRL, 2003, MOL CELL NEUROSCI, V24, P476, DOI 10.1016/S1044-7431(03)00210-0; ERZURUMLU RS, 1990, DEV BRAIN RES, V56, P229; Erzurumlu RS, 2001, TRENDS NEUROSCI, V24, P589, DOI 10.1016/S0166-2236(00)01958-5; Finnerty GT, 1999, NATURE, V400, P367, DOI 10.1038/22553; Ge WP, 2009, P NATL ACAD SCI USA, V106, P328, DOI 10.1073/pnas.0811353106; Gudz TI, 2006, J NEUROSCI, V26, P2458, DOI 10.1523/JNEUROSCI.4054-05.2006; Houades V, 2008, J NEUROSCI, V28, P5207, DOI 10.1523/JNEUROSCI.5100-07.2008; Jain N, 2003, J NEUROSCI, V23, P10321; Kukley M, 2008, FASEB J, V22, P2957, DOI 10.1096/fj.07-090985; Laurent A, 2002, J NEUROSCI, V22, P886, DOI 10.1523/JNEUROSCI.22-03-00886.2002; Mangin JM, 2008, J NEUROSCI, V28, P7610, DOI 10.1523/JNEUROSCI.1355-08.2008; Mangin JM, 2011, ASN NEURO, V3, P37, DOI 10.1042/AN20110001; Sugiyama S, 2008, CELL, V134, P508, DOI 10.1016/j.cell.2008.05.054; Tanaka Y, 2009, CEREB CORTEX, V19, P2181, DOI 10.1093/cercor/bhn238; Yuan XQ, 2002, J NEUROSCI RES, V70, P529, DOI 10.1002/jnr.10368; Yuan XQ, 1998, DEVELOPMENT, V125, P2901	18	105	108	0	12	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	SEP	2012	15	9					1192	U34		10.1038/nn.3190	http://dx.doi.org/10.1038/nn.3190			5	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	996GJ	22885848	Green Accepted			2022-12-28	WOS:000308072600007
J	Stamatakis, AM; Stuber, GD				Stamatakis, Alice M.; Stuber, Garret D.			Activation of lateral habenula inputs to the ventral midbrain promotes behavioral avoidance	NATURE NEUROSCIENCE			English	Article							DOPAMINE NEURONS; NUCLEUS-ACCUMBENS; TEGMENTAL AREA; GABA NEURONS; REWARD; VTA; PREDICTION; AVERSION; STIMULI	Lateral habenula (LHb) projections to the ventral midbrain, including the rostromedial tegmental nucleus (RMTg), convey negative reward-related information, but the behavioral ramifications of selective activation of this pathway remain unexplored. We found that exposure to aversive stimuli in mice increased LHb excitatory drive onto RMTg neurons. Furthermore, optogenetic activation of this pathway promoted active, passive and conditioned behavioral avoidance. Thus, activity of LHb efferents to the midbrain is aversive but can also serve to negatively reinforce behavioral responding.	[Stamatakis, Alice M.; Stuber, Garret D.] UNC, UNC Neurobiol Curriculum, UNC Neurosci Ctr, Chapel Hill, NC 27515 USA; [Stuber, Garret D.] UNC, UNC Neurosci Ctr, Dept Psychiat, Chapel Hill, NC USA; [Stuber, Garret D.] UNC, UNC Neurosci Ctr, Dept Cellular & Mol Physiol, Chapel Hill, NC USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Stuber, GD (corresponding author), UNC, UNC Neurobiol Curriculum, UNC Neurosci Ctr, Chapel Hill, NC 27515 USA.	gstuber@med.unc.edu	Core, Vector/CAF-4832-2022; Stuber, Garret/E-1160-2011; , UNC Neuroscience Microscopy Core/AAE-8305-2022	Stuber, Garret/0000-0003-1730-4855	Brain and Behavior Research Foundation; Foundation for Alcohol Research; Whitehall Foundation; Foundation of Hope; National Institute on Drug Abuse [DA029325, DA032750]; UNC Neurobiology Curriculum training grant [T32 NS007431]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS045892, T32NS007431] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R21DA029325, F31DA034472, R01DA032750] Funding Source: NIH RePORTER	Brain and Behavior Research Foundation; Foundation for Alcohol Research; Whitehall Foundation; Foundation of Hope; National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); UNC Neurobiology Curriculum training grant; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank R. Ung, V. Gukassyan and the UNC Neuroscience Center Microscopy Facility, and the members of the Stuber laboratory for discussion. We thank K. Deisseroth (Stanford University) for opsin constructs and the UNC Vector Core for viral packaging. We thank C. Good for sagittal slice preparation advice. This study was supported by the Brain and Behavior Research Foundation, the Foundation for Alcohol Research, the Whitehall Foundation, the Foundation of Hope and the National Institute on Drug Abuse (DA029325 and DA032750; G.D.S.). A.M.S. was supported by the UNC Neurobiology Curriculum training grant (T32 NS007431).	Brischoux F, 2009, P NATL ACAD SCI USA, V106, P4894, DOI 10.1073/pnas.0811507106; Bromberg-Martin ES, 2011, NAT NEUROSCI, V14, P1209, DOI 10.1038/nn.2902; Cunningham CL, 2006, NAT PROTOC, V1, P1662, DOI 10.1038/nprot.2006.279; Jhou TC, 2009, NEURON, V61, P786, DOI 10.1016/j.neuron.2009.02.001; Ji HF, 2007, J NEUROSCI, V27, P6923, DOI 10.1523/JNEUROSCI.0958-07.2007; Koob GF, 2010, NEUROPSYCHOPHARMACOL, V35, P217, DOI 10.1038/npp.2009.110; Li B, 2011, NATURE, V470, P535, DOI 10.1038/nature09742; Matsui A, 2011, J NEUROSCI, V31, P17729, DOI 10.1523/JNEUROSCI.4570-11.2011; Matsumoto M, 2009, NAT NEUROSCI, V12, P77, DOI 10.1038/nn.2233; Perrotti LI, 2005, EUR J NEUROSCI, V21, P2817, DOI 10.1111/j.1460-9568.2005.04110.x; Schultz W, 1997, SCIENCE, V275, P1593, DOI 10.1126/science.275.5306.1593; Shabel SJ, 2012, NEURON, V74, P475, DOI 10.1016/j.neuron.2012.02.037; Shin LM, 2010, NEUROPSYCHOPHARMACOL, V35, P169, DOI 10.1038/npp.2009.83; Sparta DR, 2012, NAT PROTOC, V7, P12, DOI 10.1038/nprot.2011.413; Stephenson-Jones M, 2012, P NATL ACAD SCI USA, V109, pE164, DOI 10.1073/pnas.1119348109; Stuber GD, 2008, ALCOHOL CLIN EXP RES, V32, P1714, DOI 10.1111/j.1530-0277.2008.00749.x; Stuber GD, 2011, NATURE, V475, P377, DOI 10.1038/nature10194; Stuber GD, 2010, J NEUROSCI, V30, P8229, DOI 10.1523/JNEUROSCI.1754-10.2010; Tan KR, 2012, NEURON, V73, P1173, DOI 10.1016/j.neuron.2012.02.015; van Zessen R, 2012, NEURON, V73, P1184, DOI 10.1016/j.neuron.2012.02.016	20	354	366	1	43	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	AUG	2012	15	8					1105	+		10.1038/nn.3145	http://dx.doi.org/10.1038/nn.3145			5	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	979UE	22729176	Green Submitted, Green Accepted			2022-12-28	WOS:000306844500013
J	Lehmann, SM; Kruger, C; Park, B; Derkow, K; Rosenberger, K; Baumgart, J; Trimbuch, T; Eom, G; Hinz, M; Kaul, D; Habbel, P; Kalin, R; Franzoni, E; Rybak, A; Nguyen, D; Veh, R; Ninnemann, O; Peters, O; Nitsch, R; Heppner, FL; Golenbock, D; Schott, E; Ploegh, HL; Wulczyn, FG; Lehnardt, S				Lehmann, Sabrina M.; Krueger, Christina; Park, Boyoun; Derkow, Katja; Rosenberger, Karen; Baumgart, Jan; Trimbuch, Thorsten; Eom, Gina; Hinz, Michael; Kaul, David; Habbel, Piet; Kaelin, Roland; Franzoni, Eleonora; Rybak, Agnieszka; Nguyen, Duong; Veh, Ruediger; Ninnemann, Olaf; Peters, Oliver; Nitsch, Robert; Heppner, Frank L.; Golenbock, Douglas; Schott, Eckart; Ploegh, Hidde L.; Wulczyn, F. Gregory; Lehnardt, Seija			An unconventional role for miRNA: let-7 activates Toll-like receptor 7 and causes neurodegeneration	NATURE NEUROSCIENCE			English	Article							ALZHEIMERS-DISEASE; IMMUNE-RESPONSES; MICRORNAS; CELLS; IDENTIFICATION; RNA; INFLAMMATION; BIOMARKERS; MICROGLIA; APOPTOSIS	Activation of innate immune receptors by host-derived factors exacerbates CNS damage, but the identity of these factors remains elusive. We uncovered an unconventional role for the microRNA let-7, a highly abundant regulator of gene expression in the CNS, in which extracellular let-7 activates the RNA-sensing Toll-like receptor (TLR) 7 and induces neurodegeneration through neuronal TLR7. Cerebrospinal fluid (CSF) from individuals with Alzheimer's disease contains increased amounts of let-7b, and extracellular introduction of let-7b into the CSF of wild-type mice by intrathecal injection resulted in neurodegeneration. Mice lacking TLR7 were resistant to this neurodegenerative effect, but this susceptibility to let-7 was restored in neurons transfected with TLR7 by intrauterine electroporation of Tlr7(-/-) fetuses. Our results suggest that microRNAs can function as signaling molecules and identify TLR7 as an essential element in a pathway that contributes to the spread of CNS damage.	[Lehmann, Sabrina M.; Krueger, Christina; Derkow, Katja; Rosenberger, Karen; Kaul, David; Habbel, Piet; Lehnardt, Seija] Charite, Dept Neurol, D-13353 Berlin, Germany; [Park, Boyoun] Yonsei Univ, Dept Biol, Seoul 120749, South Korea; [Baumgart, Jan; Nitsch, Robert] Johannes Gutenberg Univ Mainz, Inst Microscop Anat & Neurobiol, Mainz, Germany; [Trimbuch, Thorsten; Heppner, Frank L.; Lehnardt, Seija] Charite, Cluster Excellence NeuroCure, D-13353 Berlin, Germany; [Eom, Gina; Kaelin, Roland; Heppner, Frank L.] Charite, Inst Neuropathol, D-13353 Berlin, Germany; [Hinz, Michael; Rybak, Agnieszka] Max Delbruck Ctr Mol Med, Berlin, Germany; [Franzoni, Eleonora; Nguyen, Duong; Ninnemann, Olaf; Wulczyn, F. Gregory; Lehnardt, Seija] Charite, Inst Cell Biol & Neurobiol, D-13353 Berlin, Germany; [Veh, Ruediger] Charite, Ctr Anat, D-13353 Berlin, Germany; [Peters, Oliver] Charite, Dept Psychiat, D-13353 Berlin, Germany; [Golenbock, Douglas] Univ Massachusetts, Sch Med, Dept Med, Div Infect Dis & Immunol, Worcester, MA 01605 USA; [Schott, Eckart] Charite, Dept Hepatol & Gastroenterol, D-13353 Berlin, Germany; [Ploegh, Hidde L.] Whitehead Inst Biomed Res, Cambridge, MA 02142 USA	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Yonsei University; Johannes Gutenberg University of Mainz; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Helmholtz Association; Max Delbruck Center for Molecular Medicine; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Massachusetts System; University of Massachusetts Worcester; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Massachusetts Institute of Technology (MIT); Whitehead Institute	Lehmann, SM (corresponding author), Charite, Dept Neurol, D-13353 Berlin, Germany.	seija.lehnardt@charite.de	Kälin, Roland/AAG-9161-2020; Lehnardt, Seija/AAA-4113-2022; Hinz, Michael/HCI-0550-2022; Heppner, Frank/ABH-8393-2020; Nitsch, Robert/AAI-9129-2021	Heppner, Frank/0000-0001-9816-8917; Peters, Oliver/0000-0003-0568-2998; Veh, Rudiger/0000-0002-6253-9808; Trimbuch, Thorsten/0000-0001-7512-8955; Hinz, Michael/0000-0003-2611-4121; Baumgart, Jan/0000-0003-1996-4267	Deutsche Forschungsgemeinschaft [SFB-TRR43/A1]; NeuroCure Exc 257 [SFB-TRR43/A6];  [SFB665/A2];  [GRK1123]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); NeuroCure Exc 257; ; 	We thank M. Brinkmann (Helmholtz Centre for Infection Research) for providing immortalized bone marrow-derived macrophages. We also thank C. Schipke, A.-M. Rohde, D. Ludecke and J. Schuler for helpful discussions and excellent technical assistance. This work was supported by Deutsche Forschungsgemeinschaft SFB-TRR43/A1 and NeuroCure Exc 257 (to S.L.), SFB-TRR43/A6 (to F.L.H.), and by SFB665/A2 and GRK1123 (to F.G.W.).	Aliprantis AO, 1999, SCIENCE, V285, P736, DOI 10.1126/science.285.5428.736; Baraniskin A, 2011, BLOOD, V117, P3140, DOI 10.1182/blood-2010-09-308684; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Berezikov E, 2006, NAT GENET, V38, P1375, DOI 10.1038/ng1914; Butchi NB, 2008, J IMMUNOL, V180, P7604, DOI 10.4049/jimmunol.180.11.7604; Carlsbecker A, 2010, NATURE, V465, P316, DOI 10.1038/nature08977; Chen X, 2008, CELL RES, V18, P997, DOI 10.1038/cr.2008.282; Chiang HR, 2010, GENE DEV, V24, P992, DOI 10.1101/gad.1884710; Cogswell JP, 2008, J ALZHEIMERS DIS, V14, P27, DOI 10.3233/jad-2008-14103; Cortez MA, 2009, EXPERT OPIN BIOL TH, V9, P703, DOI [10.1517/14712590902932889, 10.1517/14712590902932889 ]; Diebold SS, 2004, SCIENCE, V303, P1529, DOI 10.1126/science.1093616; Eacker SM, 2009, NAT REV NEUROSCI, V10, P837, DOI 10.1038/nrn2726; Forsbach A, 2008, J IMMUNOL, V180, P3729, DOI 10.4049/jimmunol.180.6.3729; Ghidoni R, 2011, NEURODEGENER DIS, V8, P413, DOI 10.1159/000327756; Ginsberg SD, 1997, ANN NEUROL, V41, P200, DOI 10.1002/ana.410410211; Grathwohl SA, 2009, NAT NEUROSCI, V12, P1361, DOI 10.1038/nn.2432; Heil F, 2003, EUR J IMMUNOL, V33, P2987, DOI 10.1002/eji.200324238; Heil F, 2004, SCIENCE, V303, P1526, DOI 10.1126/science.1093620; Heppner FL, 2005, NAT MED, V11, P146, DOI 10.1038/nm1177; Hinz M, 2007, J BIOL CHEM, V282, P32311, DOI 10.1074/jbc.M705785200; Hoffmann O, 2007, J IMMUNOL, V178, P6476, DOI 10.4049/jimmunol.178.10.6476; Hornung V, 2005, NAT MED, V11, P263, DOI 10.1038/nm1191; Judge AD, 2005, NAT BIOTECHNOL, V23, P457, DOI 10.1038/nbt1081; Kauppinen S, 2006, HANDB EXP PHARM, V173, P405; Kawauchi T, 2003, EMBO J, V22, P4190, DOI 10.1093/emboj/cdg413; Kono H, 2008, NAT REV IMMUNOL, V8, P279, DOI 10.1038/nri2215; Kreutzberg GW, 1996, TRENDS NEUROSCI, V19, P312, DOI 10.1016/0166-2236(96)10049-7; Kroh EM, 2010, METHODS, V50, P298, DOI 10.1016/j.ymeth.2010.01.032; Lagos-Quintana M, 2002, CURR BIOL, V12, P735, DOI 10.1016/S0960-9822(02)00809-6; Lehnardt S, 2003, P NATL ACAD SCI USA, V100, P8514, DOI 10.1073/pnas.1432609100; Lehnardt S, 2008, J NEUROSCI, V28, P2320, DOI 10.1523/JNEUROSCI.4760-07.2008; Lehnardt S, 2007, J IMMUNOL, V179, P6134, DOI 10.4049/jimmunol.179.9.6134; Liu T, 2010, NAT NEUROSCI, V13, P1460, DOI 10.1038/nn.2683; Mittelbrunn M, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1285; Olson JK, 2004, J IMMUNOL, V173, P3916, DOI 10.4049/jimmunol.173.6.3916; Owens T, 2009, CURR TOP MICROBIOL, V336, P105, DOI 10.1007/978-3-642-00549-7_6; Prehaud C, 2005, J VIROL, V79, P12893, DOI 10.1128/JVI.79.20.12893-12904.2005; ROBERSON SM, 1988, CELL IMMUNOL, V116, P341, DOI 10.1016/0008-8749(88)90236-5; Roush S, 2008, TRENDS CELL BIOL, V18, P505, DOI 10.1016/j.tcb.2008.07.007; Rybak A, 2008, NAT CELL BIOL, V10, P987, DOI 10.1038/ncb1759; Rybak A, 2009, NAT CELL BIOL, V11, P1411, DOI 10.1038/ncb1987; Scaffidi P, 2002, NATURE, V418, P191, DOI 10.1038/nature00858; Smirnova L, 2005, EUR J NEUROSCI, V21, P1469, DOI 10.1111/j.1460-9568.2005.03978.x; Stein CA, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkp841; Tahara K, 2006, BRAIN, V129, P3006, DOI 10.1093/brain/awl249; Takeuchi O, 2010, CELL, V140, P805, DOI 10.1016/j.cell.2010.01.022; Tang SC, 2008, EXP NEUROL, V213, P114, DOI 10.1016/j.expneurol.2008.05.014; Trang P, 2010, ONCOGENE, V29, P1580, DOI 10.1038/onc.2009.445; Walter S, 2007, CELL PHYSIOL BIOCHEM, V20, P947, DOI 10.1159/000110455; Zhang YJ, 2010, MOL CELL, V39, P133, DOI 10.1016/j.molcel.2010.06.010	50	510	539	3	144	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JUN	2012	15	6					827	U44		10.1038/nn.3113	http://dx.doi.org/10.1038/nn.3113			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	949AI	22610069				2022-12-28	WOS:000304546700009
J	Meyer-Lindenberg, A; Tost, H				Meyer-Lindenberg, Andreas; Tost, Heike			Neural mechanisms of social risk for psychiatric disorders	NATURE NEUROSCIENCE			English	Article							OXYTOCIN RECEPTOR GENE; EARLY-LIFE STRESS; ENVIRONMENT INTERACTIONS; DOPAMINE RELEASE; SCHIZOPHRENIA; HUMANS; BRAIN; OXTR; VASOPRESSIN; SYMPTOMS	Mental health and social life are intimately inter-related, as demonstrated by the frequent social deficits of psychiatric patients and the increased rate of psychiatric disorders in people exposed to social environmental adversity. Here, we review emerging evidence that combines epidemiology, social psychology and neuroscience to bring neural mechanisms of social risk factors for mental illness into focus. In doing so, we discuss existing evidence on the effects of common genetic risk factors in social neural pathways and outline the need for integrative approaches to identify the converging mechanisms of social environmental and genetic risk in brain.	[Meyer-Lindenberg, Andreas; Tost, Heike] Heidelberg Univ, Cent Inst Mental Hlth, Med Fac Mannheim, D-6800 Mannheim, Germany	Central Institute of Mental Health; Ruprecht Karls University Heidelberg	Meyer-Lindenberg, A (corresponding author), Heidelberg Univ, Cent Inst Mental Hlth, Med Fac Mannheim, D-6800 Mannheim, Germany.	a.meyer-lindenberg@zi-mannheim.de; heike.tost@zi-mannheim.de	Carroll, Joseph/D-1158-2011; Tost, med. Dr. phil. Heike/AAX-8305-2020; Meyer-Lindenberg, Andreas/H-1076-2011	Carroll, Joseph/0000-0003-2656-1378; Meyer-Lindenberg, Andreas/0000-0001-5619-1123	Deutsche Forschungsgemeinschaft [SFB 636, KFO 256]; German Federal Ministry of Education and Research (BMBF) [01GQ1003B, 01GQ1102]; European Union (NEWMEDS, OPTIMIZE, EU-GEI, EU-AIMS)	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); European Union (NEWMEDS, OPTIMIZE, EU-GEI, EU-AIMS)	A.M.-L. gratefully acknowledges grant support by Deutsche Forschungsgemeinschaft (SFB 636, KFO 256), German Federal Ministry of Education and Research (BMBF NGFN-MooDs, Bernstein-Programm funding number 01GQ1003B) and European Union (NEWMEDS, OPTIMIZE, EU-GEI, EU-AIMS) during the preparation of this manuscript. H.T. gratefully acknowledges grant support by the German Federal Ministry of Education and Research (BMBF 01GQ1102).	Adolphs R, 2009, ANNU REV PSYCHOL, V60, P693, DOI 10.1146/annurev.psych.60.110707.163514; [Anonymous], 2010, NATURE, V463, P9, DOI 10.1038/463009a; Armbruster D, 2012, INT J NEUROPSYCHOPH, V15, P1229, DOI 10.1017/S1461145711001763; Bakermans-Kranenburg MJ, 2008, SOC COGN AFFECT NEUR, V3, P128, DOI 10.1093/scan/nsn004; Bigos KL, 2010, ARCH GEN PSYCHIAT, V67, P939, DOI 10.1001/archgenpsychiatry.2010.96; Bourque F, 2011, PSYCHOL MED, V41, P897, DOI 10.1017/S0033291710001406; Brennand KJ, 2011, NATURE, V473, P221, DOI 10.1038/nature09915; Buckholtz JW, 2008, TRENDS NEUROSCI, V31, P120, DOI 10.1016/j.tins.2007.12.006; Chen FS, 2011, P NATL ACAD SCI USA, V108, P19937, DOI 10.1073/pnas.1113079108; Coplan JD, 2011, PSYCHONEUROENDOCRINO, V36, P289, DOI 10.1016/j.psyneuen.2010.07.011; Corcoran CM, 2012, SCHIZOPHR RES, V135, P170, DOI 10.1016/j.schres.2011.11.035; Erk S, 2010, ARCH GEN PSYCHIAT, V67, P803, DOI 10.1001/archgenpsychiatry.2010.94; Gillis RF, 2011, MOL AUTISM, V2, DOI 10.1186/2040-2392-2-12; Hammock EAD, 2005, SCIENCE, V308, P1630, DOI 10.1126/science.1111427; Heim C, 2009, MOL PSYCHIATR, V14, P954, DOI 10.1038/mp.2008.112; Heim C, 2012, EXP NEUROL, V233, P102, DOI 10.1016/j.expneurol.2011.10.032; Inoue H, 2010, BIOL PSYCHIAT, V68, P1066, DOI 10.1016/j.biopsych.2010.07.019; Kirsch P, 2005, J NEUROSCI, V25, P11489, DOI 10.1523/JNEUROSCI.3984-05.2005; Knafo A, 2006, DEV PSYCHOL, V42, P771, DOI 10.1037/0012-1649.42.5.771; Krabbendam L, 2005, SCHIZOPHRENIA BULL, V31, P795, DOI 10.1093/schbul/sbi060; Kurth F, 2011, BIOL PSYCHIAT, V70, P278, DOI 10.1016/j.biopsych.2011.03.026; Lederbogen F, 2011, NATURE, V474, P498, DOI 10.1038/nature10190; Martin DJ, 2000, J CONSULT CLIN PSYCH, V68, P438, DOI 10.1037//0022-006X.68.3.438; McGowan PO, 2009, NAT NEUROSCI, V12, P342, DOI 10.1038/nn.2270; Meyer-Lindenberg A, 2009, MOL PSYCHIATR, V14, P968, DOI 10.1038/mp.2008.54; Meyer-Lindenberg A, 2006, NAT REV NEUROSCI, V7, P818, DOI 10.1038/nrn1993; Meyer-Lindenberg A, 2011, NAT REV NEUROSCI, V12, P524, DOI 10.1038/nrn3044; Miczek KA, 2011, J NEUROSCI, V31, P9848, DOI 10.1523/JNEUROSCI.0637-11.2011; Mizrahi R, 2012, BIOL PSYCHIAT, V71, P561, DOI 10.1016/j.biopsych.2011.10.009; Montague PR, 2002, NEUROIMAGE, V16, P1159, DOI 10.1006/nimg.2002.1150; O'Donovan MC, 2009, HUM GENET, V126, P3, DOI 10.1007/s00439-009-0703-0; Pedersen CB, 2001, ARCH GEN PSYCHIAT, V58, P1039, DOI 10.1001/archpsyc.58.11.1039; Penn DL, 2008, SCHIZOPHRENIA BULL, V34, P408, DOI 10.1093/schbul/sbn014; Pruessner JC, 2004, J NEUROSCI, V24, P2825, DOI 10.1523/JNEUROSCI.3422-03.2004; Ressler KJ, 2010, AM J MED GENET B, V153B, P812, DOI 10.1002/ajmg.b.31052; Selten JP, 2007, BRIT J PSYCHIAT, V191, pS9, DOI 10.1192/bjp.191.51.s9; Szyf M, 2012, CLIN GENET      1213, DOI [10.1111/0399-0004.2012.01843.x, DOI 10.1111/J.0399-0004.2012.01843.X]; Thompson RJ, 2011, PSYCHONEUROENDOCRINO, V36, P144, DOI 10.1016/j.psyneuen.2010.07.003; Tost H, 2012, NEUROIMAGE, V62, P2250, DOI 10.1016/j.neuroimage.2011.11.007; Tost H, 2011, BIOL PSYCHIAT, V70, pE37, DOI 10.1016/j.biopsych.2011.06.034; Tost H, 2010, P NATL ACAD SCI USA, V107, P13936, DOI 10.1073/pnas.1003296107; van Os J, 2008, SCHIZOPHRENIA BULL, V34, P1066, DOI 10.1093/schbul/sbn117; Viviani D, 2011, SCIENCE, V333, P104, DOI 10.1126/science.1201043; Walum H, 2008, P NATL ACAD SCI USA, V105, P14153, DOI 10.1073/pnas.0803081105; WEINBERGER DR, 1987, ARCH GEN PSYCHIAT, V44, P660, DOI 10.1001/archpsyc.1987.01800190080012; Wu SP, 2005, BIOL PSYCHIAT, V58, P74, DOI 10.1016/j.biopsych.2005.03.013; Zammit S, 2010, ARCH GEN PSYCHIAT, V67, P914, DOI 10.1001/archgenpsychiatry.2010.101; Zink CF, 2008, NEURON, V58, P273, DOI 10.1016/j.neuron.2008.01.025; Zink CF, 2010, J NEUROSCI, V30, P7017, DOI 10.1523/JNEUROSCI.4899-09.2010	50	220	225	1	66	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAY	2012	15	5					663	668		10.1038/nn.3083	http://dx.doi.org/10.1038/nn.3083			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	932DI	22504349				2022-12-28	WOS:000303270200007
J	Huynh, JL; Garg, P; Thin, TH; Yoo, S; Dutta, R; Trapp, BD; Haroutunian, V; Zhu, J; Donovan, MJ; Sharp, AJ; Casaccia, P				Huynh, Jimmy L.; Garg, Paras; Thin, Tin Htwe; Yoo, Seungyeul; Dutta, Ranjan; Trapp, Bruce D.; Haroutunian, Vahram; Zhu, Jun; Donovan, Michael J.; Sharp, Andrew J.; Casaccia, Patrizia			Epigenome-wide differences in pathology-free regions of multiple sclerosis-affected brains	NATURE NEUROSCIENCE			English	Article							APPEARING WHITE-MATTER; MONOZYGOTIC TWINS DISCORDANT; CPG ISLAND SHORES; DNA METHYLATION; CATHEPSIN-X; BCL-W; GENETIC RISK; STEM-CELLS; GENOME; DISEASE	Using the Illumina 450K array and a stringent statistical analysis with age and gender correction, we report genome-wide differences in DNA methylation between pathology-free regions derived from human multiple sclerosis-affected and control brains. Differences were subtle, but widespread and reproducible in an independent validation cohort. The transcriptional consequences of differential DNA methylation were further defined by genome-wide RNA-sequencing analysis and validated in two independent cohorts. Genes regulating oligodendrocyte survival, such as BCL2L2 and NDRG1, were hypermethylated and expressed at lower levels in multiple sclerosis-affected brains than in controls, while genes related to proteolytic processing (for example, LGMN, CTSZ) were hypomethylated and expressed at higher levels. These results were not due to differences in cellular composition between multiple sclerosis and controls. Thus, epigencimic changes in genes affecting oligodendrocyte susceptibility to damage are detected in pathology-free areas of multiple sclerosis-affected brains.	[Huynh, Jimmy L.; Casaccia, Patrizia] Icahn Sch Med Mt Sinai, Dept Neurosci, New York, NY 10029 USA; [Huynh, Jimmy L.; Garg, Paras; Yoo, Seungyeul; Zhu, Jun; Sharp, Andrew J.; Casaccia, Patrizia] Icahn Sch Med Mt Sinai, Dept Genet & Genom Sci, New York, NY USA; [Thin, Tin Htwe; Donovan, Michael J.] Icahn Sch Med Mt Sinai, Dept Pathol, New York, NY USA; [Dutta, Ranjan; Trapp, Bruce D.] Cleveland Clin, Lerner Res Inst, Dept Neurosci, Cleveland, OH 44106 USA; [Haroutunian, Vahram] Icahn Sch Med Mt Sinai, Dept Psychiat, New York, NY USA; [Casaccia, Patrizia] Icahn Sch Med Mt Sinai, Dept Neurol, New York, NY USA	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Cleveland Clinic Foundation; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai	Casaccia, P (corresponding author), Icahn Sch Med Mt Sinai, Dept Neurosci, New York, NY 10029 USA.	patrizia.casaccia@mssm.edu	Yoo, Seungyeul/GOJ-7783-2022	Yoo, Seungyeul/0000-0001-5616-2293	Icahn School of Medicine seed funds; US National Institutes of Health (NIH) NINDS [R01NS052738-06, R37NSO42925-10]; NIH NIMH [R01MH090948-01]; NIH NINDS [R01NS38667]; NIH NIA [PO lAG02219]; VA-MIRECC; NIH Fellowship [F31NS077504-01]; scholarship from the Foundation of the Consortium of Multiple Sclerosis Centers' MS Workforce of the Future; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R03HD073731] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG006696] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH066392, R01MH090948] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS038667, R01NS052738, F31NS077504, R37NS042925, R01NS042925] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG002219, P50AG005138] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA033660] Funding Source: NIH RePORTER	Icahn School of Medicine seed funds; US National Institutes of Health (NIH) NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIH NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIH NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIH NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); VA-MIRECC; NIH Fellowship(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); scholarship from the Foundation of the Consortium of Multiple Sclerosis Centers' MS Workforce of the Future; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We are grateful to all the members of the Casaccia and Sharp laboratory for technical help, to C. Watson for assistance with the CETS analysis, to F. Zhang and W Zhang for advice and assistance with the RNA-seq alignment, to F. Lublin and G. John for critical reading of the manuscript and to P.L. De Jager (Brigham and Women's Hospital), S. Baranzini (University of California at San Francisco) and N. Schaeren-Wiemers (University Hospital, Basel) for discussions. The Work has been funded by Icahn School of Medicine seed funds and grants from the US National Institutes of Health (NIH) NINDS (R01NS052738-06 and R37NSO42925-10) to P.C., from NIH NIDA (R01DA033660) and NIH NHGRI (R01HG006696) to A.J.S., from NIH NIMH (R01MH090948-01) to J.Z., from NIH NINDS (R01NS38667) to B.D.T. and from NIH NIA (PO lAG02219), NIH NIMH (P50MH066392) and VA-MIRECC to V.H. J.L.H. is the recipient of NIH Fellowship F31NS077504-01 and a scholarship from the Foundation of the Consortium of Multiple Sclerosis Centers' MS Workforce of the Future. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH. We thank R. Reynolds and the UK Multiple Sclerosis Tissue Bank at Imperial College London (funded by the UK MS Society, grant no.910/09) for the provision of multiple sclerosis tissue samples, as well as the Human Brain and Spinal Fluid Resource Center, Veterans Affairs West Los Angeles Healthcare Center, which is sponsored by NINDS, NIMH, National Multiple Sclerosis Society and Department of Veterans Affairs.	Amir RE, 1999, NAT GENET, V23, P185, DOI 10.1038/13810; Ascherio A, 2012, NAT REV NEUROL, V8, P602, DOI 10.1038/nrneurol.2012.198; Bakulski KM, 2012, J ALZHEIMERS DIS, V29, P571, DOI 10.3233/JAD-2012-111223; Baranzini SE, 2010, NATURE, V464, P1351, DOI 10.1038/nature08990; Beck H, 2001, EUR J IMMUNOL, V31, P3726, DOI 10.1002/1521-4141(200112)31:12<3726::AID-IMMU3726>3.0.CO;2-O; Bock C, 2012, NAT REV GENET, V13, P705, DOI 10.1038/nrg3273; Bock C, 2012, MOL CELL, V47, P633, DOI 10.1016/j.molcel.2012.06.019; Chapman HA, 1998, CURR OPIN IMMUNOL, V10, P93, DOI 10.1016/S0952-7915(98)80038-1; Cosker KE, 2013, J NEUROSCI, V33, P5195, DOI 10.1523/JNEUROSCI.3862-12.2013; Dempster EL, 2011, HUM MOL GENET, V20, P4786, DOI 10.1093/hmg/ddr416; Doi A, 2009, NAT GENET, V41, P1350, DOI 10.1038/ng.471; Ebers GC, 2004, LANCET, V363, P1773, DOI 10.1016/S0140-6736(04)16304-6; Ebers GC, 2008, LANCET NEUROL, V7, P268, DOI 10.1016/S1474-4422(08)70042-5; Esteller M, 2008, NEW ENGL J MED, V358, P1148, DOI 10.1056/NEJMra072067; Graumann U, 2003, BRAIN PATHOL, V13, P554, DOI 10.1111/j.1750-3639.2003.tb00485.x; Guintivano J, 2013, EPIGENETICS-US, V8, P290, DOI 10.4161/epi.23924; Hafler DA, 2007, NEW ENGL J MED, V357, P851, DOI 10.1056/NEJMoa073493; Hansen RS, 1999, P NATL ACAD SCI USA, V96, P14412, DOI 10.1073/pnas.96.25.14412; Hedstrom AK, 2011, MULT SCLER J, V17, P788, DOI 10.1177/1352458511399610; Hernandez DG, 2011, HUM MOL GENET, V20, P1164, DOI 10.1093/hmg/ddq561; Hu XL, 2004, EUR J NEUROSCI, V20, P1177, DOI 10.1111/j.1460-9568.2004.03554.x; Irizarry RA, 2009, NAT GENET, V41, P178, DOI 10.1038/ng.298; Jevnikar Z, 2008, J CELL SCI, V121, P2652, DOI 10.1242/jcs.023721; Kos J, 2009, CELL ADHES MIGR, V3, P164, DOI 10.4161/cam.3.2.7403; Lim AL, 2012, J MED GENET, V49, P689, DOI 10.1136/jmedgenet-2012-100858; Lindberg RLP, 2004, J NEUROIMMUNOL, V152, P154, DOI 10.1016/j.jneuroim.2004.03.011; Liu Y, 2013, NAT BIOTECHNOL, V31, P142, DOI 10.1038/nbt.2487; Mastronardi FG, 2006, J NEUROSCI, V26, P11387, DOI 10.1523/JNEUROSCI.3349-06.2006; Melotte V, 2010, FASEB J, V24, P4153, DOI 10.1096/fj.09-151464; Murphy B, 2007, AM J PATHOL, V171, P1258, DOI 10.2353/ajpath.2007.070269; Noonan JP, 2010, ANNU REV GENOM HUM G, V11, P1, DOI 10.1146/annurev-genom-082509-141651; Numata S, 2012, AM J HUM GENET, V90, P260, DOI 10.1016/j.ajhg.2011.12.020; Obermajer N, 2008, CONNECT TISSUE RES, V49, P193, DOI 10.1080/03008200802143158; Obermajer N, 2009, INT J BIOCHEM CELL B, V41, P1685, DOI 10.1016/j.biocel.2009.02.019; Patsopoulos NA, 2011, ANN NEUROL, V70, P897, DOI 10.1002/ana.22609; Pedre X, 2011, J NEUROSCI, V31, P3435, DOI 10.1523/JNEUROSCI.4507-10.2011; PRINCIPATO GB, 1984, BIOCHEM INT, V9, P351; Ramagopalan SV, 2010, LANCET NEUROL, V9, P727, DOI 10.1016/S1474-4422(10)70094-6; Ratovitski T, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.185348; Ross AJ, 2001, DEV BIOL, V239, P295, DOI 10.1006/dbio.2001.0445; Sandoval J, 2011, EPIGENETICS-US, V6, P692, DOI 10.4161/epi.6.6.16196; Santamaria I, 1998, J BIOL CHEM, V273, P16816, DOI 10.1074/jbc.273.27.16816; Sawcer S, 2011, NATURE, V476, P214, DOI 10.1038/nature10251; Sharp AJ, 2011, GENOME RES, V21, P1592, DOI 10.1101/gr.112680.110; Sheffield NC, 2013, GENOME RES, V23, P777, DOI 10.1101/gr.152140.112; Stadler MB, 2011, NATURE, V480, P490, DOI 10.1038/nature10716; SWANK RL, 1990, LANCET, V336, P37, DOI 10.1016/0140-6736(90)91533-G; von Geldern G, 2012, NAT REV NEUROL, V8, P678, DOI 10.1038/nrneurol.2012.194; Wendt W, 2007, EXP NEUROL, V204, P525, DOI 10.1016/j.expneurol.2007.01.007; Yao MZ, 2005, J NEUROSCI, V25, P1149, DOI 10.1523/JNEUROSCI.4736-04.2005	50	174	178	0	30	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JAN	2014	17	1					121	130		10.1038/nn.3588	http://dx.doi.org/10.1038/nn.3588			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	281DL	24270187	Green Accepted			2022-12-28	WOS:000329080000022
J	Stange, A; Myoga, MH; Lingner, A; Ford, MC; Alexandrova, O; Felmy, F; Pecka, M; Siveke, I; Grothe, B				Stange, Annette; Myoga, Michael H.; Lingner, Andrea; Ford, Marc C.; Alexandrova, Olga; Felmy, Felix; Pecka, Michael; Siveke, Ida; Grothe, Benedikt			Adaptation in sound localization: from GABA(B) receptor-mediated synaptic modulation to perception	NATURE NEUROSCIENCE			English	Article							SUPERIOR PARAOLIVARY NUCLEUS; INTERAURAL TIME DIFFERENCES; DYNAMIC-RANGE ADAPTATION; GLYCINERGIC INHIBITION; INFERIOR COLLICULUS; AUDITORY-NERVE; BRAIN-STEM; OLIVE; GERBIL; NEURONS	Across all sensory modalities, the effect of context-dependent neural adaptation can be observed at every level, from receptors to perception. Nonetheless, it has long been assumed that the processing of interaural time differences, which is the primary cue for sound localization, is nonadaptive, as its outputs are mapped directly onto a hard-wired representation of space. Here we present evidence derived from in vitro and in vivo experiments in gerbils indicating that the coincidence-detector neurons in the medial superior olive modulate their sensitivity to interaural time differences through a rapid, GABAB receptor-mediated feedback mechanism. We show that this mechanism provides a gain control in the form of output normalization, which influences the neuronal population code of auditory space. Furthermore, psychophysical tests showed that the paradigm used to evoke neuronal GABAB receptor-mediated adaptation causes the perceptual shift in sound localization in humans that was expected on the basis of our physiological results in gerbils.	[Stange, Annette; Myoga, Michael H.; Lingner, Andrea; Ford, Marc C.; Alexandrova, Olga; Felmy, Felix; Pecka, Michael; Siveke, Ida; Grothe, Benedikt] Univ Munich, Div Neurol, Dept Biol 2, Planegg Martinsried, Germany; [Lingner, Andrea; Grothe, Benedikt] Univ Hosp Munich Grosshadern, German Ctr Vertigo & Balance Disorders IFB, Munich, Germany; [Felmy, Felix] Univ Munich, Grad Sch Syst Neurosci GSN LMU, Planegg Martinsried, Germany; [Felmy, Felix] Univ Munich, BioImaging Zentrum Biz, Planegg Martinsried, Germany	University of Munich; University of Munich; University of Munich; University of Munich	Grothe, B (corresponding author), Univ Munich, Div Neurol, Dept Biol 2, Planegg Martinsried, Germany.	grothe@lmu.de	Grothe, Benedikt/A-7877-2010	Grothe, Benedikt/0000-0001-7317-0615; Ford, Marc/0000-0003-0472-2652; Pecka, Michael/0000-0001-8960-1651; Lingner, Andrea/0000-0002-3570-7386	Deutsche Forschungsgemeinschaft (DFG) [DFG-SFB870 TP-B02]; Alexander von Humboldt Foundation [DFG-SFB870 TP-B01]; Bundesministerium fur Bildung und Forschung (BMBF)-funded German Center for Vertigo and Balance Disorders (IFB)	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Alexander von Humboldt Foundation(Alexander von Humboldt Foundation); Bundesministerium fur Bildung und Forschung (BMBF)-funded German Center for Vertigo and Balance Disorders (IFB)	The in vivo experiments and anatomical studies were funded by Deutsche Forschungsgemeinschaft (DFG) grant DFG-SFB870 TP-B02, the in vitro recordings were funded by DFG-SFB870 TP-B01 and the Alexander von Humboldt Foundation, and the psychophysical study was funded by the Bundesministerium fur Bildung und Forschung (BMBF)-funded German Center for Vertigo and Balance Disorders (IFB). We thank T. Jennings and H. Gleiss for help with stimulus programming and P. Hardy for helpful suggestions concerning the text.	Behrend O, 2002, J NEUROPHYSIOL, V87, P2915, DOI 10.1152/jn.2002.87.6.2915; Brand A, 2002, NATURE, V417, P543, DOI 10.1038/417543a; Carandini M, 1997, J NEUROSCI, V17, P8621; Carandini M, 2012, NAT REV NEUROSCI, V13, P51, DOI 10.1038/nrn3136; Couchman K, 2012, J NEUROPHYSIOL, V107, P1186, DOI 10.1152/jn.00586.2011; Dahmen JC, 2010, NEURON, V66, P937, DOI 10.1016/j.neuron.2010.05.018; Dehmel S, 2002, HEARING RES, V172, P18, DOI 10.1016/S0378-5955(02)00353-2; Felix RA, 2011, J NEUROSCI, V31, P12566, DOI 10.1523/JNEUROSCI.2450-11.2011; Fischl MJ, 2012, J PHYSIOL-LONDON, V590, P3047, DOI 10.1113/jphysiol.2011.226233; Ford MC, 2009, J COMP NEUROL, V514, P92, DOI 10.1002/cne.21998; Getzmann S, 2004, HEARING RES, V191, P14, DOI 10.1016/j.heares.2003.12.020; GOLDBERG JM, 1969, J NEUROPHYSIOL, V32, P613, DOI 10.1152/jn.1969.32.4.613; GROTHE B, 1994, J NEUROSCI, V14, P1701, DOI 10.1523/JNEUROSCI.14-03-01701.1994; Grothe B, 2003, NAT REV NEUROSCI, V4, P540, DOI 10.1038/nrn1136; Grothe B, 2010, PHYSIOL REV, V90, P983, DOI 10.1152/physrev.00026.2009; Hassfurth B, 2010, J NEUROSCI, V30, P9715, DOI 10.1523/JNEUROSCI.1552-10.2010; HEEGER DJ, 1992, VISUAL NEUROSCI, V9, P181, DOI 10.1017/S0952523800009640; Ingham NJ, 2004, J NEUROPHYSIOL, V91, P632, DOI 10.1152/jn.00779.2003; Ito T, 2010, FRONT NEUROANAT, V4, DOI 10.3389/fnana.2010.00135; Kashino M, 1998, J ACOUST SOC AM, V103, P3597, DOI 10.1121/1.423064; Kopp-Scheinpflug C, 2011, NEURON, V71, P911, DOI 10.1016/j.neuron.2011.06.028; Kuwabara N, 1999, BRAIN RES, V846, P59, DOI 10.1016/S0006-8993(99)01942-3; Magnusson AK, 2005, J PHYSIOL-LONDON, V568, P497, DOI 10.1113/jphysiol.2005.094763; Magnusson AK, 2008, NEURON, V59, P125, DOI 10.1016/j.neuron.2008.05.011; Maier JK, 2012, J NEUROPHYSIOL, V108, P1856, DOI 10.1152/jn.00652.2011; MAY BJ, 1992, J NEUROPHYSIOL, V68, P1589, DOI 10.1152/jn.1992.68.5.1589; McAlpine D, 2003, TRENDS NEUROSCI, V26, P347, DOI 10.1016/S0166-2236(03)00140-1; Park TJ, 2008, HEARING RES, V238, P58, DOI 10.1016/j.heares.2007.10.009; Park TJ, 1996, J NEUROSCI, V16, P6554; Pecka M, 2008, J NEUROSCI, V28, P6914, DOI 10.1523/JNEUROSCI.1660-08.2008; Pecka M, 2010, J NEUROPHYSIOL, V103, P38, DOI 10.1152/jn.00628.2009; Phillips DP, 2005, HEARING RES, V202, P188, DOI 10.1016/j.heares.2004.11.001; Pouille F, 2009, NAT NEUROSCI, V12, P1577, DOI 10.1038/nn.2441; Rabinowitz NC, 2011, NEURON, V70, P1178, DOI 10.1016/j.neuron.2011.04.030; ROBERTS RC, 1987, J COMP NEUROL, V258, P267, DOI 10.1002/cne.902580207; Robinson BL, 2009, CURR OPIN NEUROBIOL, V19, P402, DOI 10.1016/j.conb.2009.07.006; Sanes DH, 1998, J NEUROSCI, V18, P794; Smith AJ, 2000, J PHYSIOL-LONDON, V529, P681, DOI 10.1111/j.1469-7793.2000.00681.x; Vigneault-MacLean BK, 2007, HEARING RES, V224, P93, DOI 10.1016/j.heares.2006.12.001; Wark B, 2007, CURR OPIN NEUROBIOL, V17, P423, DOI 10.1016/j.conb.2007.07.001; Wen B, 2012, J NEUROPHYSIOL, V108, P69, DOI 10.1152/jn.00055.2012; Wen B, 2009, J NEUROSCI, V29, P13797, DOI 10.1523/JNEUROSCI.5610-08.2009; WIGHTMAN FL, 1992, J ACOUST SOC AM, V91, P1648, DOI 10.1121/1.402445; YIN TCT, 1990, J NEUROPHYSIOL, V64, P465, DOI 10.1152/jn.1990.64.2.465	44	42	43	0	17	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	DEC	2013	16	12					1840	1847		10.1038/nn.3548	http://dx.doi.org/10.1038/nn.3548			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	257VV	24141311				2022-12-28	WOS:000327416800022
J	Li, JB; Church, GM				Li, Jin Billy; Church, George M.			Deciphering the functions and regulation of brain-enriched A-to-I RNA editing	NATURE NEUROSCIENCE			English	Review							WIDESPREAD RNA; ADENOSINE; SITES; IDENTIFICATION; DROSOPHILA; GENE; DNA; DEFICIENT; LETHALITY; TARGETS	Adenosine-to-inosine (A-to-I) RNA editing, in which genomically encoded adenosine is changed to inosine in RNA, is catalyzed by adenosine deaminase acting on RNA (ADAR). This fine-tuning mechanism is critical during normal development and diseases, particularly in relation to brain functions. A-to-I RNA editing has also been hypothesized to be a driving force in, human brain evolution. A large number of RNA editing sites have recently been identified, mostly as a result of the development of deep sequencing and bioinformatic analyses. Deciphering the functional consequences of RNA editing events is challenging, but emerging genome engineering approaches may expedite new discoveries. To understand how RNA editing is dynamically regulated, it is imperative to construct a spatiotemporal atlas at the species, tissue and cell levels. Future studies will need to identify the cis and trans regulatory factors that drive the selectivity and frequency of RNA editing. We anticipate that recent technological advancements will aid researchers in acquiring a much deeper understanding of the functions and regulation of RNA editing.	[Li, Jin Billy] Stanford Univ, Dept Genet, Stanford, CA 94305 USA; [Church, George M.] Harvard Univ, Sch Med, Dept Genet, Boston, MA USA	Stanford University; Harvard University; Harvard Medical School	Li, JB (corresponding author), Stanford Univ, Dept Genet, Stanford, CA 94305 USA.	jin.billy.li@stanford.edu		church, george/0000-0001-6232-9969	US National Institutes of Health [GM102484]; Ellison Medical Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM102484] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ellison Medical Foundation(Lawrence Ellison Foundation); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank members of the Li laboratory for discussions and critical reading of the manuscript, and particularly R. Zhang for making Figure 2. This work was funded by US National Institutes of Health (GM102484) and the Ellison Medical Foundation (to J.B.L.).	Alivisatos AP, 2013, SCIENCE, V339, P1284, DOI 10.1126/science.1236939; Athanasiadis A, 2004, PLOS BIOL, V2, P2144, DOI 10.1371/journal.pbio.0020391; Bhogal B, 2011, NAT NEUROSCI, V14, P1517, DOI 10.1038/nn.2950; BRUSA R, 1995, SCIENCE, V270, P1677, DOI 10.1126/science.270.5242.1677; Burns CM, 1997, NATURE, V387, P303, DOI 10.1038/387303a0; Chen CX, 2000, RNA, V6, P755, DOI 10.1017/S1355838200000170; Chen LL, 2013, NAT MED, V19, P209, DOI 10.1038/nm.3043; da Silva UBO, 2010, FRONT NEUROSCI-SWITZ, V4, DOI 10.3389/neuro.23.001.2010; Daniel C, 2012, NUCLEIC ACIDS RES, V40, P9876, DOI 10.1093/nar/gks691; Eggington JM, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1324; Eran A, 2013, MOL PSYCHIATR, V18, P1041, DOI 10.1038/mp.2012.118; Gaj T, 2013, TRENDS BIOTECHNOL, V31, P397, DOI 10.1016/j.tibtech.2013.04.004; Garncarz W, 2013, RNA BIOL, V10, P192, DOI 10.4161/rna.23208; Hartner JC, 2004, J BIOL CHEM, V279, P4894, DOI 10.1074/jbc.M311347200; Heiman M, 2008, CELL, V135, P738, DOI 10.1016/j.cell.2008.10.028; Higuchi M, 2000, NATURE, V406, P78, DOI 10.1038/35017558; Hoopengardner B, 2003, SCIENCE, V301, P832, DOI 10.1126/science.1086763; Hughes ME, 2012, GENOME RES, V22, P1266, DOI 10.1101/gr.128876.111; Jepson JEC, 2012, NAT METHODS, V9, P189, DOI [10.1038/NMETH.1827, 10.1038/nmeth.1827]; Kawahara Y, 2008, J NEUROSCI, V28, P12834, DOI 10.1523/JNEUROSCI.3896-08.2008; Ke RQ, 2013, NAT METHODS, V10, P857, DOI 10.1038/nmeth.2563; Kim DDY, 2004, GENOME RES, V14, P1719, DOI 10.1101/gr.2855504; Kleinman CL, 2012, SCIENCE, V335, DOI [10.1126/science.1209658, 10.1126/science.1210624]; Levanon EY, 2005, NUCLEIC ACIDS RES, V33, P1162, DOI 10.1093/nar/gki239; Levanon EY, 2004, NAT BIOTECHNOL, V22, P1001, DOI 10.1038/nbt996; Li JB, 2009, SCIENCE, V324, P1210, DOI 10.1126/science.1170995; Li MY, 2011, SCIENCE, V333, P53, DOI 10.1126/science.1207018; Lin W, 2012, SCIENCE, V335, DOI 10.1126/science.1210624; LOMELI H, 1994, SCIENCE, V266, P1709, DOI 10.1126/science.7992055; Maas Stefan, 2006, RNA Biol, V3, P1; Marcucci R, 2011, EMBO J, V30, P4211, DOI 10.1038/emboj.2011.303; Mizrahi RA, 2013, ACS CHEM BIOL, V8, P832, DOI 10.1021/cb300692k; Nishikura K, 2010, ANNU REV BIOCHEM, V79, P321, DOI 10.1146/annurev-biochem-060208-105251; Palladino MJ, 2000, CELL, V102, P437, DOI 10.1016/S0092-8674(00)00049-0; Paz-Yaacov N, 2010, P NATL ACAD SCI USA, V107, P12174, DOI 10.1073/pnas.1006183107; Peng PL, 2006, NEURON, V49, P719, DOI 10.1016/j.neuron.2006.01.025; Peng ZY, 2012, NAT BIOTECHNOL, V30, P253, DOI 10.1038/nbt.2122; Pickrell JK, 2012, SCIENCE, V335, DOI 10.1126/science.1210484; Piskol R, 2013, NAT BIOTECHNOL, V31, P19, DOI 10.1038/nbt.2472; Ramaswami G, 2013, NAT METHODS, V10, P128, DOI [10.1038/nmeth.2330, 10.1038/NMETH.2330]; Ramaswami G, 2012, NAT METHODS, V9, P579, DOI [10.1038/NMETH.1982, 10.1038/nmeth.1982]; Sanjana NE, 2012, GENETICS, V192, P281, DOI 10.1534/genetics.112.141200; Silberberg G, 2012, HUM MOL GENET, V21, P311, DOI 10.1093/hmg/ddr461; SOMMER B, 1991, CELL, V67, P11, DOI 10.1016/0092-8674(91)90568-J; Steiner FA, 2012, GENOME RES, V22, P766, DOI 10.1101/gr.131748.111; Taft RJ, 2007, BIOESSAYS, V29, P288, DOI 10.1002/bies.20544; Tariq A, 2013, NUCLEIC ACIDS RES, V41, P2581, DOI 10.1093/nar/gks1353; Tonkin LA, 2002, EMBO J, V21, P6025, DOI 10.1093/emboj/cdf607; Wahlstedt H, 2009, GENOME RES, V19, P978, DOI 10.1101/gr.089409.108; Wang Q, 2000, SCIENCE, V290, P1765, DOI 10.1126/science.290.5497.1765	50	102	105	0	29	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	NOV	2013	16	11					1518	1522		10.1038/nn.3539	http://dx.doi.org/10.1038/nn.3539			5	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	241YX	24165678	Green Accepted			2022-12-28	WOS:000326205700006
J	Ilkhanizadeh, S; Weiss, WA				Ilkhanizadeh, Shirin; Weiss, William A.			Starvation favors glioma stem cells	NATURE NEUROSCIENCE			English	Editorial Material							GLIOBLASTOMA; GLUCOSE; BRAIN; TUMORS	High-grade glioblastomas survive glucose-poor environments by becoming more stem cell-like. Increased glucose uptake by the transporter Glut3, a new biomarker of poor clinical outcome, drives this enhanced malignant progression.	[Ilkhanizadeh, Shirin] Univ Calif San Francisco, Dept Neurol, San Francisco, CA USA; Univ Calif San Francisco, Dept Pediat, San Francisco, CA USA; Univ Calif San Francisco, Dept Neurosurg, San Francisco, CA USA; Univ Calif San Francisco, Helen Diller Family Comprehens Canc Ctr, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Helen Diller Family Comprehensive Cancer Center	Ilkhanizadeh, S (corresponding author), Univ Calif San Francisco, Dept Neurol, San Francisco, CA USA.	shirin.ilkhanizadeh@ucsf.edu; waweiss@gmail.com		Weiss, William/0000-0003-2230-9132				Bao SD, 2006, NATURE, V444, P756, DOI 10.1038/nature05236; BOADO RJ, 1994, MOL BRAIN RES, V27, P51, DOI 10.1016/0169-328X(94)90183-X; Chen J, 2012, CELL, V149, P36, DOI 10.1016/j.cell.2012.03.009; Eramo A, 2006, CELL DEATH DIFFER, V13, P1238, DOI 10.1038/sj.cdd.4401872; Flavahan WA, 2013, NAT NEUROSCI, V16, P1373, DOI 10.1038/nn.3510; Li Z, 2009, CANCER CELL, V15, P501, DOI 10.1016/j.ccr.2009.03.018; Oudard S, 1996, BRIT J CANCER, V74, P839, DOI 10.1038/bjc.1996.446; Peters A, 2004, NEUROSCI BIOBEHAV R, V28, P143, DOI 10.1016/j.neubiorev.2004.03.002; Phillips HS, 2006, CANCER CELL, V9, P157, DOI 10.1016/j.ccr.2006.02.019; Seidel S, 2010, BRAIN, V133, P983, DOI 10.1093/brain/awq042; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; Vannucci SJ, 1997, GLIA, V21, P2, DOI 10.1002/(SICI)1098-1136(199709)21:1<2::AID-GLIA2>3.0.CO;2-C; Verhaak RGW, 2010, CANCER CELL, V17, P98, DOI 10.1016/j.ccr.2009.12.020; Warburg O, 1927, J GEN PHYSIOL, V8, P519, DOI 10.1085/jgp.8.6.519; Yoshioka K, 1996, BBA-GEN SUBJECTS, V1289, P5, DOI 10.1016/0304-4165(95)00153-0	15	4	4	0	17	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	OCT	2013	16	10					1359	1361		10.1038/nn.3524	http://dx.doi.org/10.1038/nn.3524			4	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	223HM	24067285				2022-12-28	WOS:000324795300002
J	Kang, ZH; Wang, CH; Zepp, J; Wu, L; Sun, K; Zhao, JJ; Chandrasekharan, U; DiCorleto, PE; Trapp, BD; Ransohoff, RM; Li, XX				Kang, Zizhen; Wang, Chenhui; Zepp, Jarod; Wu, Ling; Sun, Kevin; Zhao, Junjie; Chandrasekharan, Unni; DiCorleto, Paul E.; Trapp, Bruce D.; Ransohoff, Richard M.; Li, Xiaoxia			Act1 mediates IL-17-induced EAE pathogenesis selectively in NG2(+) glial cells	NATURE NEUROSCIENCE			English	Article							EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; CENTRAL-NERVOUS-SYSTEM; NF-KAPPA-B; MULTIPLE-SCLEROSIS; ANIMAL-MODELS; ADULT BRAIN; T-CELLS; OLIGODENDROCYTE; MYELIN; CNS	Interleukin 17 (IL-17) is a signature cytokine of Th17 cells. We previously reported that deletion of NF-kappa B activator 1 (Act1), the key transducer of IL-17 receptor signaling, from the neuroectodermal lineage in mice (neurons, oligodendrocytes and astrocytes) results in attenuated severity of experimental autoimmune encephalomyelitis (EAE). Here we examined the cellular basis of this observation. EAE disease course was unaffected by deletion of Act1 in neurons or mature oligodendrocytes, and Act1 deletion in astrocytes only modestly affected disease course. Deletion of Act1 in NG2(+) glia resulted in markedly reduced EAE severity. Furthermore, IL-17 induced characteristic inflammatory mediator expression in NG2(+) glial cells. IL-17 also exhibited strong inhibitory effects on the maturation of oligodendrocyte lineage cells in vitro and reduced their survival. These data identify NG2(+) glia as the major CNS cellular target of IL-17 in EAE. The sensitivity of oligodendrocyte lineage cells to IL-17-mediated toxicity further suggests a direct link between inflammation and neurodegeneration in multiple sclerosis.	[Kang, Zizhen] Shanghai Jiao Tong Univ, Sch Med, Shanghai Inst Immunol, Shanghai 200030, Peoples R China; [Kang, Zizhen; Wang, Chenhui; Zepp, Jarod; Wu, Ling; Sun, Kevin; Zhao, Junjie; Li, Xiaoxia] Cleveland Clin, Dept Immunol, Cleveland, OH 44106 USA; [Chandrasekharan, Unni; DiCorleto, Paul E.] Cleveland Clin, Dept Cellular & Mol Med, Cleveland, OH 44106 USA; [Trapp, Bruce D.; Ransohoff, Richard M.] Cleveland Clin, Dept Neurosci, Cleveland, OH 44106 USA; [Ransohoff, Richard M.] Cleveland Clin, Neuroinflammat Res Ctr, Cleveland, OH 44106 USA; [Ransohoff, Richard M.] Cleveland Clin, Mellen Ctr Mississippi Treatment & Res, Cleveland, OH 44106 USA	Chinese Academy of Sciences; Shanghai Jiao Tong University; Cleveland Clinic Foundation; Cleveland Clinic Foundation; Cleveland Clinic Foundation; Cleveland Clinic Foundation; Cleveland Clinic Foundation	Li, XX (corresponding author), Cleveland Clin, Dept Immunol, Cleveland, OH 44106 USA.	lix@ccf.org	Zhao, Junjie/AAH-1152-2021	, Zizhen/0000-0001-5621-8912; Wang, Chenhui/0000-0002-3186-3066	US National Institutes of Health [R01NS071996, P01HL103453]; NATIONAL CANCER INSTITUTE [P01CA062220] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL103453] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI089474] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007250, T32GM088088] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS071996] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R21AG046399] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We gratefully acknowledge W.B. Stallcup (Burnham Institute for Medical Research) for providing antibodies to NG2 and K.-A. Nave for providing Cnp1-cre transgenic mice (Max Planck Institute of Experimental Medicine). We also thank the Dana-Farber Cancer Institute for providing the Olig2-cre transgenic mice. This investigation was supported by grants from the US National Institutes of Health (R01NS071996 and P01HL103453).	Bajenaru ML, 2002, MOL CELL BIOL, V22, P5100, DOI 10.1128/MCB.22.14.5100-5113.2002; Baumann N, 2001, PHYSIOL REV, V81, P871, DOI 10.1152/physrev.2001.81.2.871; Becher B, 2006, J MOL MED, V84, P532, DOI 10.1007/s00109-006-0065-1; Butts BD, 2008, CELL DEATH DIFFER, V15, P1178, DOI 10.1038/cdd.2008.70; Chen Y, 2007, NAT PROTOC, V2, P1044, DOI 10.1038/nprot.2007.149; Cua DJ, 2003, NATURE, V421, P744, DOI 10.1038/nature01355; Dugas JC, 2010, NEURON, V65, P597, DOI 10.1016/j.neuron.2010.01.027; Emery B, 2009, CELL, V138, P172, DOI 10.1016/j.cell.2009.04.031; Fancy SPJ, 2011, ANNU REV NEUROSCI, V34, P21, DOI 10.1146/annurev-neuro-061010-113629; Franklin RJM, 2008, NAT REV NEUROSCI, V9, P839, DOI 10.1038/nrn2480; Frugier T, 2000, HUM MOL GENET, V9, P849, DOI 10.1093/hmg/9.5.849; Funfschilling U, 2012, NATURE, V485, P517, DOI 10.1038/nature11007; Furuta S, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001374; Gold R, 2006, BRAIN, V129, P1953, DOI 10.1093/brain/awl075; Hara H, 2011, J NEUROIMMUNOL, V233, P135, DOI 10.1016/j.jneuroim.2010.12.011; Hisahara S, 2003, NEUROSCI RES, V46, P387, DOI 10.1016/S0168-0102(03)00127-5; Hu Y, 2010, J IMMUNOL, V184, P4307, DOI 10.4049/jimmunol.0903614; Kaga Y, 2006, J NEUROSCI, V26, P12339, DOI 10.1523/JNEUROSCI.3573-06.2006; Kang ZZ, 2010, IMMUNITY, V32, P414, DOI 10.1016/j.immuni.2010.03.004; Komiyama Y, 2006, J IMMUNOL, V177, P566, DOI 10.4049/jimmunol.177.1.566; Kroenke MA, 2008, J EXP MED, V205, P1535, DOI 10.1084/jem.20080159; Lappe-Siefke C, 2003, NAT GENET, V33, P366, DOI 10.1038/ng1095; Lee YJ, 2012, NATURE, V487, P443, DOI 10.1038/nature11314; Leonardi A, 2000, P NATL ACAD SCI USA, V97, P10494, DOI 10.1073/pnas.190245697; Lev N, 2004, NEUROSCI LETT, V359, P139, DOI 10.1016/j.neulet.2004.01.076; Li XX, 2000, P NATL ACAD SCI USA, V97, P10489, DOI 10.1073/pnas.160265197; Mangan PR, 2006, NATURE, V441, P231, DOI 10.1038/nature04754; Mc Guire C, 2011, TRENDS NEUROSCI, V34, P619, DOI 10.1016/j.tins.2011.09.002; Menn B, 2006, J NEUROSCI, V26, P7907, DOI 10.1523/JNEUROSCI.1299-06.2006; Nishiyama A, 1999, J NEUROPATH EXP NEUR, V58, P1113, DOI 10.1097/00005072-199911000-00001; Nishiyama A, 2009, NAT REV NEUROSCI, V10, P9, DOI 10.1038/nrn2495; Paintlia MK, 2011, J NEUROCHEM, V116, P508, DOI 10.1111/j.1471-4159.2010.07136.x; Patel J, 2012, INT J MOL SCI, V13, P10647, DOI 10.3390/ijms130810647; Pedraza CE, 2008, GLIA, V56, P1339, DOI 10.1002/glia.20702; Qian YC, 2004, IMMUNITY, V21, P575, DOI 10.1016/j.immuni.2004.09.001; Qian YC, 2002, P NATL ACAD SCI USA, V99, P9386, DOI 10.1073/pnas.142294499; Qian YC, 2007, NAT IMMUNOL, V8, P247, DOI 10.1038/ni1439; Raasch J, 2011, BRAIN, V134, P1184, DOI 10.1093/brain/awq359; Ransohoff RM, 2012, NAT NEUROSCI, V15, P1074, DOI 10.1038/nn.3168; Richardson WD, 2011, NEURON, V70, P661, DOI 10.1016/j.neuron.2011.05.013; Sawcer S, 2011, NATURE, V476, P214, DOI 10.1038/nature10251; Schuller U, 2008, CANCER CELL, V14, P123, DOI 10.1016/j.ccr.2008.07.005; Siffrin V, 2010, IMMUNITY, V33, P424, DOI 10.1016/j.immuni.2010.08.018; Simon C, 2011, GLIA, V59, P869, DOI 10.1002/glia.21156; Sospedra M, 2005, ANNU REV IMMUNOL, V23, P683, DOI 10.1146/annurev.immunol.23.021704.115707; Steinman L, 2001, NAT IMMUNOL, V2, P762, DOI 10.1038/ni0901-762; Stromnes IM, 2008, NAT MED, V14, P337, DOI 10.1038/nm1715; Trotter J, 2010, BRAIN RES REV, V63, P72, DOI 10.1016/j.brainresrev.2009.12.006; van Loo G, 2006, NAT IMMUNOL, V7, P954, DOI 10.1038/ni1372; Veldhoen M, 2006, IMMUNITY, V24, P179, DOI 10.1016/j.immuni.2006.01.001; Weaver A, 2005, FASEB J, V19, P1668, DOI 10.1096/fj.04-2030fje; Yan YP, 2012, MOL THER, V20, P1338, DOI 10.1038/mt.2012.12; YU WP, 1994, NEURON, V12, P1353, DOI 10.1016/0896-6273(94)90450-2; Zhou Q, 2000, NEURON, V25, P331, DOI 10.1016/S0896-6273(00)80898-3; Zhu XQ, 2008, DEVELOPMENT, V135, P145, DOI 10.1242/dev.004895	55	132	137	1	19	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	OCT	2013	16	10					1401	+		10.1038/nn.3505	http://dx.doi.org/10.1038/nn.3505			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	223HM	23995070	Green Accepted			2022-12-28	WOS:000324795300012
J	Goncalves, JT; Anstey, JE; Golshani, P; Portera-Cailliau, C				Goncalves, J. Tiago; Anstey, James E.; Golshani, Peyman; Portera-Cailliau, Carlos			Circuit level defects in the developing neocortex of Fragile X mice	NATURE NEUROSCIENCE			English	Article							CRITICAL PERIOD PLASTICITY; BARREL CORTEX; MOUSE MODEL; MENTAL-RETARDATION; GABA(A) RECEPTOR; VISUAL-CORTEX; STATES; NETWORK; NEURONS; SLEEP	Subtle alterations in how cortical network dynamics are modulated by different behavioral states could disrupt normal brain function and underlie symptoms of neuropsychiatric disorders, including Fragile X syndrome (FXS). Using two-photon calcium imaging and electrophysiology, we recorded spontaneous neuronal ensemble activity in mouse somatosensory cortex. Unanesthetized Fmr1(-/-) mice exhibited abnormally high synchrony of neocortical network activity, especially during the first two postnatal weeks. Neuronal firing rates were threefold higher in Fmr1(-/-) mice than in wild-type mice during whole-cell recordings manifesting Up/Down states (slow-wave sleep, quiet wakefulness), probably as a result of a higher firing probability during Up states. Combined electroencephalography and calcium imaging experiments confirmed that neurons in mutant mice had abnormally high firing and synchrony during sleep. We conclude that cortical networks in FXS are hyperexcitable in a brain state-dependent manner during a critical period for experience-dependent plasticity. These state-dependent network defects could explain the intellectual, sleep and sensory integration dysfunctions associated with FXS.	[Goncalves, J. Tiago; Anstey, James E.; Golshani, Peyman; Portera-Cailliau, Carlos] Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurol, Los Angeles, CA 90095 USA; [Portera-Cailliau, Carlos] Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurobiol, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Portera-Cailliau, C (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurol, Los Angeles, CA 90095 USA.	cpcailliau@mednet.ucla.edu		Anstey, James/0000-0001-6422-0086; Goncalves, J. Tiago/0000-0003-2303-1822	National Institute of Child Health and Human Development [R01HD054453]; National Institute of Neurological Disorders and Stroke [RC1NS068093]; FRAXA Research Foundation; Dana Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD054453] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [RC1NS068093] Funding Source: NIH RePORTER	National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); FRAXA Research Foundation; Dana Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank D. Buonomano, C. Houser, I. Mody and R. Mostany, as well as D. Cantu for helpful discussions and/or valuable comments on the manuscript. We also thank A. Bragin and M. Blumberg for help with EEG recordings and interpretation, J. Gornbein and D. Markovich for help with statistical analyses, and W. Greenough for providing the Fmr1<SUP>-/-</SUP> mice. This work was supported by grants from the National Institute of Child Health and Human Development (R01HD054453), the National Institute of Neurological Disorders and Stroke (RC1NS068093), the FRAXA Research Foundation and the Dana Foundation.	Arieli A, 1996, SCIENCE, V273, P1868, DOI 10.1126/science.273.5283.1868; BAKKER CE, 1994, CELL, V78, P23; Bassell GJ, 2008, NEURON, V60, P201, DOI 10.1016/j.neuron.2008.10.004; Bureau I, 2008, J NEUROSCI, V28, P5178, DOI 10.1523/JNEUROSCI.1076-08.2008; Bushey D, 2009, J NEUROSCI, V29, P1948, DOI 10.1523/JNEUROSCI.4830-08.2009; Castro-Alamancos MA, 2009, NEUROSCIENTIST, V15, P625, DOI 10.1177/1073858409333074; Constantinople CM, 2011, NEURON, V69, P1061, DOI 10.1016/j.neuron.2011.02.040; Cossart R, 2003, NATURE, V423, P283, DOI 10.1038/nature01614; COWAN RL, 1994, J NEUROPHYSIOL, V71, P17, DOI 10.1152/jn.1994.71.1.17; Crochet S, 2006, NAT NEUROSCI, V9, P608, DOI 10.1038/nn1690; Cruz-Martin A, 2010, J NEUROSCI, V30, P7793, DOI 10.1523/JNEUROSCI.0577-10.2010; Curia G, 2009, CEREB CORTEX, V19, P1515, DOI 10.1093/cercor/bhn159; D'Hulst C, 2007, TRENDS NEUROSCI, V30, P425, DOI 10.1016/j.tins.2007.06.003; El Idrissi A, 2005, NEUROSCI LETT, V377, P141, DOI 10.1016/j.neulet.2004.11.087; FRANKS NP, 1994, NATURE, V367, P607, DOI 10.1038/367607a0; Gentet LJ, 2012, NAT NEUROSCI, V15, P607, DOI 10.1038/nn.3051; Geschwind DH, 2007, CURR OPIN NEUROBIOL, V17, P103, DOI 10.1016/j.conb.2007.01.009; Gibson JR, 2008, J NEUROPHYSIOL, V100, P2615, DOI 10.1152/jn.90752.2008; Gilbert CD, 2007, NEURON, V54, P677, DOI 10.1016/j.neuron.2007.05.019; Golshani Peyman, 2008, J Vis Exp, DOI 10.3791/681; Golshani P, 2009, J NEUROSCI, V29, P10890, DOI 10.1523/JNEUROSCI.2012-09.2009; Grienberger C, 2012, NEURON, V73, P862, DOI 10.1016/j.neuron.2012.02.011; Guizar-Sicairos M, 2008, OPT LETT, V33, P156, DOI 10.1364/OL.33.000156; Hagerman R, 2010, MOL AUTISM, V1, DOI 10.1186/2040-2392-1-12; Harlow EG, 2010, NEURON, V65, P385, DOI 10.1016/j.neuron.2010.01.024; Hays SA, 2011, J NEUROSCI, V31, P14223, DOI 10.1523/JNEUROSCI.3157-11.2011; He CX, 2013, NEUROSCIENCE, V251, P120, DOI 10.1016/j.neuroscience.2012.03.049; Hensch TK, 2005, NAT REV NEUROSCI, V6, P877, DOI 10.1038/nrn1787; Ji DY, 2007, NAT NEUROSCI, V10, P100, DOI 10.1038/nn1825; Katz LC, 1996, SCIENCE, V274, P1133, DOI 10.1126/science.274.5290.1133; Kronk R, 2010, SLEEP, V33, P679, DOI 10.1093/sleep/33.5.679; LeBlanc JJ, 2011, NEURAL PLAST, V2011, DOI 10.1155/2011/921680; Li CYT, 2009, SCIENCE, V324, P643, DOI 10.1126/science.1169957; Markram K, 2010, FRONT HUM NEUROSCI, V4, DOI 10.3389/fnhum.2010.00224; Meredith RM, 2012, TRENDS NEUROSCI, V35, P335, DOI 10.1016/j.tins.2012.03.005; Miller LJ, 1999, AM J MED GENET, V83, P268, DOI 10.1002/(SICI)1096-8628(19990402)83:4<268::AID-AJMG7>3.0.CO;2-K; Mitra P., 2007, OBSERVED BRAIN DYNAM; Musumeci SA, 2000, EPILEPSIA, V41, P19, DOI 10.1111/j.1528-1157.2000.tb01499.x; Olmos-Serrano JL, 2010, J NEUROSCI, V30, P9929, DOI 10.1523/JNEUROSCI.1714-10.2010; Olshausen BA, 2004, CURR OPIN NEUROBIOL, V14, P481, DOI 10.1016/j.conb.2004.07.007; Pfeiffer BE, 2009, NEUROSCIENTIST, V15, P549, DOI 10.1177/1073858409333075; Pologruto TA, 2003, BIOMED ENG ONLINE, V2, DOI 10.1186/1475-925X-2-13; Portera-Cailliau C, 2012, NEUROSCIENTIST, V18, P28, DOI 10.1177/1073858410395322; Poulet JFA, 2008, NATURE, V454, P881, DOI 10.1038/nature07150; Rapin I, 1998, ANN NEUROL, V43, P7, DOI 10.1002/ana.410430106; Rochefort NL, 2009, P NATL ACAD SCI USA, V106, P15049, DOI 10.1073/pnas.0907660106; Selby L, 2007, NEUROSCI LETT, V412, P227, DOI 10.1016/j.neulet.2006.11.062; STERIADE M, 1993, J NEUROSCI, V13, P3252, DOI 10.1523/jneurosci.13-08-03252.1993; Stern EA, 2001, NEURON, V31, P305, DOI 10.1016/S0896-6273(01)00360-9; TANELIAN DL, 1993, ANESTHESIOLOGY, V78, P757, DOI 10.1097/00000542-199304000-00020; Testa-Silva G, 2012, CEREB CORTEX, V22, P1333, DOI 10.1093/cercor/bhr224; Van der Molen MJW, 2013, BIOL PSYCHOL, V92, P216, DOI 10.1016/j.biopsycho.2012.11.013; Veasey SC, 2000, SLEEP, V23, P1025; Yaksi E, 2006, NAT METHODS, V3, P377, DOI 10.1038/NMETH874; Zhang J, 2008, AM J HUM GENET, V83, P43, DOI 10.1016/j.ajhg.2008.06.003; Zhang L, 2008, HIPPOCAMPUS, V18, P294, DOI 10.1002/hipo.20389	56	190	193	0	28	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUL	2013	16	7					903	U166		10.1038/nn.3415	http://dx.doi.org/10.1038/nn.3415			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	174UM	23727819	Green Accepted, Green Submitted			2022-12-28	WOS:000321180900024
J	Steinberg, EE; Keiflin, R; Boivin, JR; Witten, IB; Deisseroth, K; Janak, PH				Steinberg, Elizabeth E.; Keiflin, Ronald; Boivin, Josiah R.; Witten, Ilana B.; Deisseroth, Karl; Janak, Patricia H.			A causal link between prediction errors, dopamine neurons and learning	NATURE NEUROSCIENCE			English	Article							VENTRAL TEGMENTAL AREA; NUCLEUS-ACCUMBENS; ORBITOFRONTAL CORTEX; OPTICAL CONTROL; REWARD; RESPONSES; RAT; REINFORCEMENT; BEHAVIOR; MODULATION	Situations in which rewards are unexpectedly obtained or withheld represent opportunities for new learning. Often, this learning includes identifying cues that predict reward availability. Unexpected rewards strongly activate midbrain dopamine neurons. This phasic signal is proposed to support learning about antecedent cues by signaling discrepancies between actual and expected outcomes, termed a reward prediction error. However, it is unknown whether dopamine neuron prediction error signaling and cue-reward learning are causally linked. To test this hypothesis, we manipulated dopamine neuron activity in rats in two behavioral procedures, associative blocking and extinction, that illustrate the essential function of prediction errors in learning. We observed that optogenetic activation of dopamine neurons concurrent with reward delivery, mimicking a prediction error, was sufficient to cause long-lasting increases in cue-elicited reward-seeking behavior. Our findings establish a causal role for temporally precise dopamine neuron signaling in cue-reward learning, bridging a critical gap between experimental evidence and influential theoretical frameworks.	[Steinberg, Elizabeth E.; Keiflin, Ronald; Boivin, Josiah R.; Janak, Patricia H.] Univ Calif San Francisco, Ernest Gallo Clin & Res Ctr, San Francisco, CA 94143 USA; [Steinberg, Elizabeth E.; Boivin, Josiah R.; Janak, Patricia H.] Univ Calif San Francisco, Grad Program Neurosci, San Francisco, CA 94143 USA; [Witten, Ilana B.] Princeton Univ, Princeton Neurosci Inst, Princeton, NJ 08544 USA; [Deisseroth, Karl] Princeton Univ, Dept Psychol, Princeton, NJ 08544 USA; [Deisseroth, Karl] Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA; [Deisseroth, Karl] Stanford Univ, Dept Psychiat & Behav Sci, Stanford, CA 94305 USA; [Deisseroth, Karl] Stanford Univ, Howard Hughes Med Inst, Stanford, CA 94305 USA; [Deisseroth, Karl] Stanford Univ, Crack Neural Code Program, Stanford, CA 94305 USA; [Janak, Patricia H.] Univ Calif San Francisco, Dept Neurol, San Francisco, CA USA; [Janak, Patricia H.] Univ Calif San Francisco, Wheeler Ctr Neurobiol Addict, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; Ernest Gallo Clinic & Research Center; University of California System; University of California San Francisco; Princeton University; Princeton University; Stanford University; Stanford University; Howard Hughes Medical Institute; Stanford University; Stanford University; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Janak, PH (corresponding author), Univ Calif San Francisco, Ernest Gallo Clin & Res Ctr, San Francisco, CA 94143 USA.	pjanak@gallo.ucsf.edu		Boivin, Josiah/0000-0001-9895-4141; Keiflin, Ronald/0000-0001-5347-7337; Janak, Patricia/0000-0002-3333-9049	US National Institutes of Health [DA015096, AA17072]; State of California for medical research on alcohol and substance abuse through the University of California, San Francisco; National Science Foundation Graduate Research Fellowship; National Institute of Mental Health; National Institute on Drug Abuse; Michael J Fox Foundation; Howard Hughes Medical Institute; Defense Advanced Research Projects Agency Reorganization and Plasticity to Accelerate Injury Recovery Program; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [P50AA017072] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [DP2DA035149, R01DA015096] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); State of California for medical research on alcohol and substance abuse through the University of California, San Francisco(University of California System); National Science Foundation Graduate Research Fellowship(National Science Foundation (NSF)); National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); Michael J Fox Foundation; Howard Hughes Medical Institute(Howard Hughes Medical Institute); Defense Advanced Research Projects Agency Reorganization and Plasticity to Accelerate Injury Recovery Program(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We are grateful for the technical assistance of M. Olsman, L. Sahuque and R. Reese, and for critical feedback from H. Fields during manuscript preparation. This research was supported by the US National Institutes of Health (grants DA015096 and AA17072 to P.H.J. and a New Innovator award to I.B.W.), funds from the State of California for medical research on alcohol and substance abuse through the University of California, San Francisco (P.H.J.), a National Science Foundation Graduate Research Fellowship (E.E.S.), and grants from the National Institute of Mental Health, the National Institute on Drug Abuse, the Michael J Fox Foundation, the Howard Hughes Medical Institute, and the Defense Advanced Research Projects Agency Reorganization and Plasticity to Accelerate Injury Recovery Program (K.D.).	Adamantidis AR, 2011, J NEUROSCI, V31, P10829, DOI 10.1523/JNEUROSCI.2246-11.2011; Becker JB, 1999, PHARMACOL BIOCHEM BE, V64, P803, DOI 10.1016/S0091-3057(99)00168-9; BECKSTEAD RM, 1979, BRAIN RES, V175, P191, DOI 10.1016/0006-8993(79)91001-1; Berridge KC, 1998, BRAIN RES REV, V28, P309, DOI 10.1016/S0165-0173(98)00019-8; Boyden ES, 2005, NAT NEUROSCI, V8, P1263, DOI 10.1038/nn1525; Brown MTC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015870; Burke KA, 2008, NATURE, V454, P340, DOI 10.1038/nature06993; Cohen JY, 2012, NATURE, V482, P85, DOI 10.1038/nature10754; Daw ND, 2002, NEURAL NETWORKS, V15, P603, DOI 10.1016/S0893-6080(02)00052-7; Day JJ, 2007, NAT NEUROSCI, V10, P1020, DOI 10.1038/nn1923; Domingos AI, 2011, NAT NEUROSCI, V14, P1562, DOI 10.1038/nn.2977; Fields HL, 2007, ANNU REV NEUROSCI, V30, P289, DOI 10.1146/annurev.neuro.30.051606.094341; Flagel SB, 2011, NATURE, V469, P53, DOI 10.1038/nature09588; Gerfen CR, 2011, ANNU REV NEUROSCI, V34, P441, DOI 10.1146/annurev-neuro-061010-113641; Glimcher PW, 2011, P NATL ACAD SCI USA, V108, P15647, DOI 10.1073/pnas.1014269108; HOLLAND PC, 1984, J EXP PSYCHOL ANIM B, V10, P476, DOI 10.1037/0097-7403.10.4.476; Hollerman JR, 1998, NAT NEUROSCI, V1, P304, DOI 10.1038/1124; Iordanova MD, 2006, EUR J NEUROSCI, V24, P3265, DOI 10.1111/j.1460-9568.2006.05195.x; Kamin L. J., 1969, FUNDAMENTAL ISSUES A, P42; Kamin L. J., 1969, PUNISHMENT AVERSIVE, P279, DOI DOI 10.2105/AJPH.2006.090910; Kamin L. J., 1968, MIAMI S PREDICTION B, P9; Karim BO, 2003, COMPARATIVE MED, V53, P532; MIRENOWICZ J, 1994, J NEUROPHYSIOL, V72, P1024, DOI 10.1152/jn.1994.72.2.1024; Montague PR, 1996, J NEUROSCI, V16, P1936, DOI 10.1523/jneurosci.16-05-01936.1996; O'Tuathaigh CMP, 2003, BEHAV PHARMACOL, V14, P315, DOI 10.1097/01.fbp.0000080416.18561.3e; Parker JG, 2010, P NATL ACAD SCI USA, V107, P13491, DOI 10.1073/pnas.1007827107; Peters J, 2009, LEARN MEMORY, V16, P279, DOI 10.1101/lm.1041309; Rescorla R.A., 1972, CLASSICAL CONDITION, P64, DOI DOI 10.1101/GR.110528.110; Reynolds JNJ, 2001, NATURE, V413, P67, DOI 10.1038/35092560; Reynolds JNJ, 2002, NEURAL NETWORKS, V15, P507, DOI 10.1016/S0893-6080(02)00045-X; Roesch MR, 2007, NAT NEUROSCI, V10, P1615, DOI 10.1038/nn2013; Schultz W, 1997, SCIENCE, V275, P1593, DOI 10.1126/science.275.5306.1593; Schultz W, 2000, ANNU REV NEUROSCI, V23, P473, DOI 10.1146/annurev.neuro.23.1.473; Schultz W, 1998, J NEUROPHYSIOL, V80, P1, DOI 10.1152/jn.1998.80.1.1; SCHULTZ W, 1993, J NEUROSCI, V13, P900; Stuber GD, 2008, SCIENCE, V321, P1690, DOI 10.1126/science.1160873; Suri RE, 2002, NEURAL NETWORKS, V15, P523, DOI 10.1016/S0893-6080(02)00046-1; SUTTON RS, 1981, PSYCHOL REV, V88, P135, DOI 10.1037/0033-295X.88.2.135; SWANSON LW, 1982, BRAIN RES BULL, V9, P321, DOI 10.1016/0361-9230(82)90145-9; Takahashi YK, 2009, NEURON, V62, P269, DOI 10.1016/j.neuron.2009.03.005; Tsai HC, 2009, SCIENCE, V324, P1080, DOI 10.1126/science.1168878; Tye KM, 2010, NAT NEUROSCI, V13, P475, DOI 10.1038/nn.2506; Waelti P, 2001, NATURE, V412, P43, DOI 10.1038/35083500; Wassum KM, 2011, LEARN MEMORY, V18, P475, DOI 10.1101/lm.2229311; Wickens JR, 2007, J NEUROSCI, V27, P8181, DOI 10.1523/JNEUROSCI.1671-07.2007; Witten IB, 2011, NEURON, V72, P721, DOI 10.1016/j.neuron.2011.10.028; Zhang F, 2006, NAT METHODS, V3, P785, DOI 10.1038/nmeth936; Zweifel LS, 2009, P NATL ACAD SCI USA, V106, P7281, DOI 10.1073/pnas.0813415106	48	495	500	6	156	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JUL	2013	16	7					966	U248		10.1038/nn.3413	http://dx.doi.org/10.1038/nn.3413			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	174UM	23708143	Green Submitted, Green Accepted			2022-12-28	WOS:000321180900032
J	Chang, SWC; Gariepy, JF; Platt, ML				Chang, Steve W. C.; Gariepy, Jean-Francois; Platt, Michael L.			Neuronal reference frames for social decisions in primate frontal cortex	NATURE NEUROSCIENCE			English	Article							ANTERIOR CINGULATE CORTEX; MEDIAL PREFRONTAL CORTEX; ORBITOFRONTAL CORTEX; VENTRAL STRIATUM; NEURAL BASIS; CHARITABLE DONATION; VALUE COMPUTATIONS; REWARD; COGNITION; BEHAVIOR	Social decisions are crucial for the success of individuals and the groups that they comprise. Group members respond vicariously to benefits obtained by others, and impairments in this capacity contribute to neuropsychiatric disorders such as autism and sociopathy. We examined the manner in which neurons in three frontal cortical areas encoded the outcomes of social decisions as monkeys performed a reward-allocation task. Neurons in the orbitofrontal cortex (OFC) predominantly encoded rewards that were delivered to oneself. Neurons in the anterior cingulate gyrus (ACCg) encoded reward allocations to the other monkey, to oneself or to both. Neurons in the anterior cingulate sulcus (ACCs) signaled reward allocations to the other monkey or to no one. In this network of received (OFC) and foregone (ACCs) reward signaling, ACCg emerged as an important nexus for the computation of shared experience and social reward. Individual and species-specific variations in social decision-making might result from the relative activation and influence of these areas.	[Chang, Steve W. C.; Platt, Michael L.] Duke Univ, Sch Med, Dept Neurobiol, Durham, NC 27708 USA; [Chang, Steve W. C.; Gariepy, Jean-Francois; Platt, Michael L.] Duke Univ, Ctr Cognit Neurosci, Durham, NC USA; [Platt, Michael L.] Duke Univ, Dept Psychol & Neurosci, Duke Inst Brain Sci, Durham, NC USA; [Platt, Michael L.] Duke Univ, Dept Evolutionary Anthropol, Duke Inst Brain Sci, Durham, NC USA	Duke University; Duke University; Duke University; Duke University	Chang, SWC (corresponding author), Duke Univ, Sch Med, Dept Neurobiol, Durham, NC 27708 USA.	steve.chang@duke.edu	Chang, Steve Fuhwa/HIR-3815-2022	Chang, Steve Wohn Chul/0000-0003-4160-7549	T32 Postdoctoral Training Grant on Fundamental and Translational Neuroscience [2T32NS051156-06]; Ruth K. Broad Biomedical Foundation Postdoctoral Grant; Canadian Institutes of Health Research Doctoral research award [84765]; National Institute of Mental Health [MH095894]; Department of Defense [W81XVVH-11-1-0584]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH095894, R00MH099093, R01MH086712, K99MH099093] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [T32NS051156] Funding Source: NIH RePORTER	T32 Postdoctoral Training Grant on Fundamental and Translational Neuroscience; Ruth K. Broad Biomedical Foundation Postdoctoral Grant; Canadian Institutes of Health Research Doctoral research award(Canadian Institutes of Health Research (CIHR)); National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Department of Defense(United States Department of Defense); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank J.M. Groh, J.M. Pearson, D.L. Barack, R.B. Ebitz, E.S. Bromberg-Martin, K.K. Watson and B.Y. Hayden for helpful discussions. We are very grateful to S.P. Wise and C. Padoa-Schioppa for insightful discussions and comments on earlier versions of the manuscript. We also thank M.L. Carlson for general technical assistance. This work was supported by a T32 Postdoctoral Training Grant on Fundamental and Translational Neuroscience (S.W.C.C., 2T32NS051156-06), a Ruth K. Broad Biomedical Foundation Postdoctoral Grant (S.W.C.C.), a Canadian Institutes of Health Research Doctoral research award (J.-F.G., 84765), the National Institute of Mental Health (M.L.P. and S.W.C.C., MH095894) and the Department of Defense (M.L.P. and S.W.C.C., W81XVVH-11-1-0584).	Abe H, 2011, NEURON, V70, P731, DOI 10.1016/j.neuron.2011.03.026; Adolphs R, 2003, NAT REV NEUROSCI, V4, P165, DOI 10.1038/nrn1056; Alexander WH, 2011, NAT NEUROSCI, V14, P1338, DOI 10.1038/nn.2921; Amodio DM, 2006, NAT REV NEUROSCI, V7, P268, DOI 10.1038/nrn1884; Azzi JCB, 2012, P NATL ACAD SCI USA, V109, P2126, DOI 10.1073/pnas.1111715109; BARONCOHEN S, 1985, COGNITION, V21, P37, DOI 10.1016/0010-0277(85)90022-8; Behrens TEJ, 2009, SCIENCE, V324, P1160, DOI 10.1126/science.1169694; BERGER SM, 1962, PSYCHOL REV, V69, P450, DOI 10.1037/h0046466; Bowman EM, 1996, J NEUROPHYSIOL, V75, P1061, DOI 10.1152/jn.1996.75.3.1061; Burke CJ, 2010, P NATL ACAD SCI USA, V107, P14431, DOI 10.1073/pnas.1003111107; Carter CS, 1998, SCIENCE, V280, P747, DOI 10.1126/science.280.5364.747; Chang SWC, 2012, P NATL ACAD SCI USA, V109, P959, DOI 10.1073/pnas.1114621109; Chang SWC, 2011, FRONT NEUROSCI-SWITZ, V5, DOI 10.3389/fnins.2011.00027; Cohen YE, 2002, NAT REV NEUROSCI, V3, P553, DOI 10.1038/nrn873; de Quervain DJF, 2004, SCIENCE, V305, P1254, DOI 10.1126/science.1100735; Fehr E, 2003, NATURE, V425, P785, DOI 10.1038/nature02043; Gallese V, 2004, TRENDS COGN SCI, V8, P396, DOI 10.1016/j.tics.2004.07.002; Gold JI, 2007, ANNU REV NEUROSCI, V30, P535, DOI 10.1146/annurev.neuro.29.051605.113038; Hampton AN, 2008, P NATL ACAD SCI USA, V105, P6741, DOI 10.1073/pnas.0711099105; Harbaugh WT, 2007, SCIENCE, V316, P1622, DOI 10.1126/science.1140738; Hare TA, 2010, J NEUROSCI, V30, P583, DOI 10.1523/JNEUROSCI.4089-09.2010; Hayden BY, 2009, SCIENCE, V324, P948, DOI 10.1126/science.1168488; Ito S, 2003, SCIENCE, V302, P120, DOI 10.1126/science.1087847; Izuma K, 2010, J COGNITIVE NEUROSCI, V22, P621, DOI 10.1162/jocn.2009.21228; Jeon D, 2010, NAT NEUROSCI, V13, P482, DOI 10.1038/nn.2504; Kennerley SW, 2006, NAT NEUROSCI, V9, P940, DOI 10.1038/nn1724; Kennerley SW, 2011, NAT NEUROSCI, V14, P1581, DOI 10.1038/nn.2961; Kuss K, 2013, SOC COGN AFFECT NEUR, V8, P216, DOI 10.1093/scan/nsr088; Matsumoto M, 2009, NAT NEUROSCI, V12, P77, DOI 10.1038/nn.2233; Mobbs D, 2009, SCIENCE, V324, P900, DOI 10.1126/science.1170539; Moll J, 2006, P NATL ACAD SCI USA, V103, P15623, DOI 10.1073/pnas.0604475103; O'Doherty J, 2004, SCIENCE, V304, P452, DOI 10.1126/science.1094285; Padoa-Schioppa C, 2006, NATURE, V441, P223, DOI 10.1038/nature04676; Paton JJ, 2006, NATURE, V439, P865, DOI 10.1038/nature04490; Paxinos G., 2000, RHESUS MONKEY BRAIN; Rilling JK, 2002, NEURON, V35, P395, DOI 10.1016/S0896-6273(02)00755-9; Rudebeck PH, 2006, SCIENCE, V313, P1310, DOI 10.1126/science.1128197; Santos GS, 2012, SOC NEUROSCI-UK, V7, P42, DOI 10.1080/17470919.2011.578465; Sato M, 2002, J NEUROSCI, V22, P2363, DOI 10.1523/JNEUROSCI.22-06-02363.2002; Saxe R, 2006, CURR OPIN NEUROBIOL, V16, P235, DOI 10.1016/j.conb.2006.03.001; Schoenbaum G, 2009, NAT REV NEUROSCI, V10, P885, DOI 10.1038/nrn2753; Schultz W, 1997, SCIENCE, V275, P1593, DOI 10.1126/science.275.5306.1593; Seo H, 2008, PHILOS T R SOC B, V363, P3845, DOI 10.1098/rstb.2008.0158; Shidara M, 1998, J NEUROSCI, V18, P2613; Singer T, 2004, SCIENCE, V303, P1157, DOI 10.1126/science.1093535; Sohn J, 2006, NEURAL NETWORKS, V19, P1181, DOI 10.1016/j.neunet.2006.04.005; Tremblay L, 1999, NATURE, V398, P704, DOI 10.1038/19525; Tsujimoto S, 2009, J NEUROSCI, V29, P2569, DOI 10.1523/JNEUROSCI.5777-08.2009; Waytz A, 2012, J NEUROSCI, V32, P7646, DOI 10.1523/JNEUROSCI.6193-11.2012; Yoshida K, 2011, CURR BIOL, V21, P249, DOI 10.1016/j.cub.2011.01.004	50	197	199	2	63	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	FEB	2013	16	2					243	250		10.1038/nn.3287	http://dx.doi.org/10.1038/nn.3287			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	080RE	23263442	Green Accepted			2022-12-28	WOS:000314260200022
J	Stickgold, R; Walker, MP				Stickgold, Robert; Walker, Matthew P.			Sleep-dependent memory triage: evolving generalization through selective processing	NATURE NEUROSCIENCE			English	Review							MEDIAL TEMPORAL-LOBE; EYE-MOVEMENT SLEEP; REM-SLEEP; EMOTIONAL MEMORY; FALSE MEMORIES; ENHANCES MEMORY; CONSOLIDATION; EXPERIENCE; FUTURE; BRAIN	The brain does not retain all the information it encodes in a day. Much is forgotten, and of those memories retained, their subsequent evolution can follow any of a number of pathways. Emerging data makes clear that sleep is a compelling candidate for performing many of these operations. But how does the sleeping brain know which information to preserve and which to forget? What should sleep do with that information it chooses to keep? For information that is retained, sleep can integrate it into existing memory networks, look for common patterns and distill overarching rules, or simply stabilize and strengthen the memory exactly as it was learned. We suggest such 'memory triage' lies at the heart of a sleep-dependent memory processing system that selects new information, in a discriminatory manner, and assimilates it into the brain's vast armamentarium of evolving knowledge, helping guide each organism through its own, unique life.	[Stickgold, Robert] Beth Israel Deaconess Med Ctr, Ctr Sleep & Cognit, Boston, MA 02215 USA; [Stickgold, Robert] Harvard Univ, Sch Med, Boston, MA USA; [Walker, Matthew P.] Univ Calif Berkeley, Dept Psychol, Sleep & Neuroimaging Lab, Berkeley, CA 94720 USA; [Walker, Matthew P.] Univ Calif Berkeley, Helen Wills Neurosci Inst, Berkeley, CA 94720 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School; University of California System; University of California Berkeley; University of California System; University of California Berkeley	Stickgold, R (corresponding author), Beth Israel Deaconess Med Ctr, Ctr Sleep & Cognit, Boston, MA 02215 USA.	rstickgo@bidmc.harvard.edu; mpwalker@berkeley.edu			US National Institutes of Health [MH48832, MH92638, AG031164, MH093537, DA031939]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH048832, R01MH092638, R01MH093537] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG031164] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R21DA031939] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	Support provided by US National Institutes of Health grants MH48832 and MH92638 (R.S.) and AG031164, MH093537 and DA031939 (M.P.W.). We thank E. Robertson, J. Chamberlain, M. Tucker, E. Wamsley, J. Saletin and I. Nieuwenhuis for discussions on these concepts and comments on this manuscript.	Anderson MC, 2012, NEBR SYM MOTIV, V58, P53, DOI 10.1007/978-1-4614-1195-6_3; Atienza M, 2008, J SLEEP RES, V17, P285, DOI 10.1111/j.1365-2869.2008.00661.x; Baran B, 2012, J NEUROSCI, V32, P1035, DOI 10.1523/JNEUROSCI.2532-11.2012; Born J, 2004, TRENDS COGN SCI, V8, P242, DOI 10.1016/j.tics.2004.04.010; Brawn TP, 2010, J NEUROSCI, V30, P13977, DOI 10.1523/JNEUROSCI.3295-10.2010; Buckmaster CA, 2004, J NEUROSCI, V24, P9811, DOI 10.1523/JNEUROSCI.1532-04.2004; Cai DJ, 2009, P NATL ACAD SCI USA, V106, P10130, DOI 10.1073/pnas.0900271106; Darsaud A, 2011, J COGNITIVE NEUROSCI, V23, P26, DOI 10.1162/jocn.2010.21448; Diekelmann S, 2010, BEHAV BRAIN RES, V208, P425, DOI 10.1016/j.bbr.2009.12.021; Diekelmann S, 2010, NAT REV NEUROSCI, V11, P114, DOI 10.1038/nrn2762; Djonlagic I, 2009, LEARN MEMORY, V16, P751, DOI 10.1101/lm.1634509; Durrant SJ, 2011, NEUROPSYCHOLOGIA, V49, P1322, DOI 10.1016/j.neuropsychologia.2011.02.015; Dusek JA, 1997, P NATL ACAD SCI USA, V94, P7109, DOI 10.1073/pnas.94.13.7109; Eichenbaum H, 2007, ANNU REV NEUROSCI, V30, P123, DOI 10.1146/annurev.neuro.30.051606.094328; Ellenbogen JM, 2007, P NATL ACAD SCI USA, V104, P7723, DOI 10.1073/pnas.0700094104; Fenn KM, 2009, LEARN MEMORY, V16, P509, DOI 10.1101/lm.1500808; Fischer S, 2011, J SLEEP RES, V20, P267, DOI 10.1111/j.1365-2869.2010.00881.x; Fischer S, 2009, J EXP PSYCHOL LEARN, V35, P1586, DOI 10.1037/a0017256; Foster DJ, 2006, NATURE, V440, P680, DOI 10.1038/nature04587; Frey S, 1997, NEUROSCI RES, V28, P285, DOI 10.1016/S0168-0102(97)00048-5; Gaskell MG, 2003, COGNITION, V89, P105, DOI 10.1016/S0010-0277(03)00070-2; GIUDITTA A, 1995, BEHAV BRAIN RES, V69, P157, DOI 10.1016/0166-4328(95)00012-I; Gluck MA, 2002, LEARN MEMORY, V9, P408, DOI 10.1101/lm.45202; Gomez RL, 2006, PSYCHOL SCI, V17, P670, DOI 10.1111/j.1467-9280.2006.01764.x; Grosmark AD, 2012, NEURON, V75, P1001, DOI 10.1016/j.neuron.2012.08.015; HASSELMO ME, 1993, TRENDS NEUROSCI, V16, P218, DOI 10.1016/0166-2236(93)90159-J; Hu P, 2006, PSYCHOL SCI, V17, P891, DOI 10.1111/j.1467-9280.2006.01799.x; Hupbach A, 2009, DEVELOPMENTAL SCI, V12, P1007, DOI 10.1111/j.1467-7687.2009.00837.x; Jenkins JG, 1924, AM J PSYCHOL, V35, P605, DOI 10.2307/1414040; Knowlton B J, 1994, Learn Mem, V1, P106; Knutson B, 2005, NEURON, V45, P331, DOI 10.1016/j.neuron.2005.01.020; Lee AK, 2002, NEURON, V36, P1183, DOI 10.1016/S0896-6273(02)01096-6; Lewis PA, 2011, NEUROPSYCHOLOGIA, V49, P2619, DOI 10.1016/j.neuropsychologia.2011.05.009; Louie K, 2001, NEURON, V29, P145, DOI 10.1016/S0896-6273(01)00186-6; Maquet P, 2001, SCIENCE, V294, P1048, DOI 10.1126/science.1062856; McGaugh JL, 2000, SCIENCE, V287, P248, DOI 10.1126/science.287.5451.248; MEDNICK SA, 1962, PSYCHOL REV, V69, P220, DOI 10.1037/h0048850; Mednick SC, 2011, TRENDS NEUROSCI, V34, P504, DOI 10.1016/j.tins.2011.06.003; Muller G. E., 1900, Z PSYCHOLOGIE, V1, P1; Nishida M, 2009, CEREB CORTEX, V19, P1158, DOI 10.1093/cercor/bhn155; Payne JD, 2008, PSYCHOL SCI, V19, P781, DOI 10.1111/j.1467-9280.2008.02157.x; Payne JD, 2011, J COGNITIVE NEUROSCI, V23, P1285, DOI 10.1162/jocn.2010.21526; Payne JD, 2009, NEUROBIOL LEARN MEM, V92, P327, DOI 10.1016/j.nlm.2009.03.007; Piaget J., 1952, ORIGINS INTELLIGENCE; Poe GR, 2000, BRAIN RES, V855, P176, DOI 10.1016/S0006-8993(99)02310-0; Rauchs G, 2011, J NEUROSCI, V31, P2563, DOI 10.1523/JNEUROSCI.3972-10.2011; ROEDIGER HL, 1995, J EXP PSYCHOL LEARN, V21, P803, DOI 10.1037/0278-7393.21.4.803; Saletin Jared M, 2012, Front Neurol, V3, P59, DOI 10.3389/fneur.2012.00059; Saletin JM, 2011, CEREB CORTEX, V21, P2534, DOI 10.1093/cercor/bhr034; Schacter DL, 2007, NAT REV NEUROSCI, V8, P657, DOI 10.1038/nrn2213; Schacter DL, 2009, PHILOS T R SOC B, V364, P1245, DOI 10.1098/rstb.2008.0308; Shadmehr R, 1997, J NEUROSCI, V17, P409, DOI 10.1523/JNEUROSCI.17-01-00409.1997; Shimamura AP, 2011, COGN AFFECT BEHAV NE, V11, P277, DOI 10.3758/s13415-011-0031-4; Smith C, 2003, SLEEP, V26, P185; SMITH C, 1974, BRAIN RES, V77, P221, DOI 10.1016/0006-8993(74)90786-0; SQUIRE LR, 1975, SCIENCE, V187, P77, DOI 10.1126/science.1109228; Stickgold R, 2000, NAT NEUROSCI, V3, P1237, DOI 10.1038/81756; Stickgold R, 2005, NATURE, V437, P1272, DOI 10.1038/nature04286; Stickgold R, 1999, J COGNITIVE NEUROSCI, V11, P182, DOI 10.1162/089892999563319; Tambini A, 2010, NEURON, V65, P280, DOI 10.1016/j.neuron.2010.01.001; Tamminen J, 2010, J NEUROSCI, V30, P14356, DOI 10.1523/JNEUROSCI.3028-10.2010; Tse D, 2007, SCIENCE, V316, P76, DOI 10.1126/science.1135935; van Dongen EV, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043426; van Kesteren MTR, 2012, TRENDS NEUROSCI, V35, P211, DOI 10.1016/j.tins.2012.02.001; Wagner U, 2001, LEARN MEMORY, V8, P112, DOI 10.1101/lm.36801; Wagner U, 2004, NATURE, V427, P352, DOI 10.1038/nature02223; Walker MP, 2004, NEURON, V44, P121, DOI 10.1016/j.neuron.2004.08.031; Walker MP, 2003, LEARN MEMORY, V10, P275, DOI 10.1101/lm.58503; Walker MP, 2002, COGNITIVE BRAIN RES, V14, P317, DOI 10.1016/S0926-6410(02)00134-9; Wamsley EJ, 2010, LEARN MEMORY, V17, P332, DOI 10.1101/lm.1828310; Wamsley EJ, 2010, CURR BIOL, V20, P850, DOI 10.1016/j.cub.2010.03.027; Wang G, 2011, TRENDS NEUROSCI, V34, P452, DOI 10.1016/j.tins.2011.07.005; Wilhelm I, 2011, J NEUROSCI, V31, P1563, DOI 10.1523/JNEUROSCI.3575-10.2011; WILSON MA, 1994, SCIENCE, V265, P676, DOI 10.1126/science.8036517; Wylie GR, 2008, CEREB CORTEX, V18, P670, DOI 10.1093/cercor/bhm101; Yoo SS, 2007, CURR BIOL, V17, pR877, DOI 10.1016/j.cub.2007.08.007	76	383	388	5	222	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	FEB	2013	16	2					139	145		10.1038/nn.3303	http://dx.doi.org/10.1038/nn.3303			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	080RE	23354387	Green Accepted			2022-12-28	WOS:000314260200009
J	Koya, E; Cruz, FC; Ator, R; Golden, SA; Hoffman, AF; Lupica, CR; Hope, BT				Koya, Eisuke; Cruz, Fabio C.; Ator, Robert; Golden, Sam A.; Hoffman, Alexander F.; Lupica, Carl R.; Hope, Bruce T.			Silent synapses in selectively activated nucleus accumbens neurons following cocaine sensitization	NATURE NEUROSCIENCE			English	Article							LONG-TERM DEPRESSION; CONTEXT-SPECIFIC SENSITIZATION; RECEPTOR SUBUNIT COMPOSITION; INDUCED LOCOMOTOR-ACTIVITY; VENTRAL TEGMENTAL AREA; SYNAPTIC PLASTICITY; IN-VIVO; DOPAMINE NEURONS; BEHAVIORAL SENSITIZATION; GLUTAMATE TRANSMISSION	Cocaine-induced alterations in synaptic glutamate function in nucleus accumbens are thought to mediate drug-related behaviors such as psychomotor sensitization. However, previous studies have examined global alterations in randomly selected accumbens neurons regardless of their activation state during cocaine-induced behavior. We recently found that a minority of strongly activated Fos-expressing accumbens neurons are necessary for cocaine-induced psychomotor sensitization, whereas the majority of accumbens neurons are less directly involved. We assessed synaptic alterations in these strongly activated accumbens neurons in Fos-GFP mice, which express a fusion protein of Fos and GFP in strongly activated neurons, and compared these alterations with those in surrounding non-activated neurons. Cocaine sensitization produced higher levels of 'silent synapses', which contained functional NMDA receptors and nonfunctional AMPA receptors only in GFP-positive neurons, 6-11 d after sensitization. Thus, distinct synaptic alterations are induced in the most strongly activated accumbens neurons that mediate psychomotor sensitization.	[Koya, Eisuke; Cruz, Fabio C.; Ator, Robert; Golden, Sam A.; Hope, Bruce T.] NIDA, Behav Neurosci Branch, Intramural Res Program, US NIH,US Dept HHS, Baltimore, MD USA; [Hoffman, Alexander F.; Lupica, Carl R.] NIDA, Electrophysiol Res Sect, Intramural Res Program, US NIH,US Dept HHS, Baltimore, MD USA	National Institutes of Health (NIH) - USA; NIH National Institute on Drug Abuse (NIDA); National Institutes of Health (NIH) - USA; NIH National Institute on Drug Abuse (NIDA)	Hope, BT (corresponding author), NIDA, Behav Neurosci Branch, Intramural Res Program, US NIH,US Dept HHS, Baltimore, MD USA.	bhope@intra.nida.nih.gov	Cruz, Fabio/K-1497-2013; Hoffman, Alex/H-3035-2012; Hope, Bruce T/A-9223-2010; Hoffman, Alex/AIF-4544-2022; Lupica, Carl/AAY-3193-2021	Hoffman, Alex/0000-0002-2676-0628; Hope, Bruce T/0000-0001-5804-7061; Hoffman, Alex/0000-0002-2676-0628; Lupica, Carl/0000-0002-5375-3263; Koya, Eisuke/0000-0002-5039-4875; Golden, Sam/0000-0002-2104-2272	National Institute on Drug Abuse; NATIONAL INSTITUTE ON DRUG ABUSE [ZIADA000437, ZIADA000467] Funding Source: NIH RePORTER	National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank A. Barth for providing the first line of Fos-GFP mice, K. Knestaut and J. Hug for breeding the Fos-GFP mice, and E. Goldart and R. Ator for genotyping assistance. We thank S. Hall and T. Shippenberg for the use of their locomotor activity chambers. We thank S. Kourrich for many fruitful discussions regarding synaptic plasticity in the nucleus accumbens. This research was supported by the National Institute on Drug Abuse, Intramural Research Program.	Anagnostaras SG, 1996, BEHAV NEUROSCI, V110, P1397, DOI 10.1037/0735-7044.110.6.1397; Argilli E, 2008, J NEUROSCI, V28, P9092, DOI 10.1523/JNEUROSCI.1001-08.2008; Barria A, 2002, NEURON, V35, P345, DOI 10.1016/S0896-6273(02)00776-6; Barria A, 2005, NEURON, V48, P289, DOI 10.1016/j.neuron.2005.08.034; Barth AL, 2004, J NEUROSCI, V24, P6466, DOI 10.1523/JNEUROSCI.4737-03.2004; Bellone C, 2006, NAT NEUROSCI, V9, P636, DOI 10.1038/nn1682; Bertran-Gonzalez J, 2008, J NEUROSCI, V28, P5671, DOI 10.1523/JNEUROSCI.1039-08.2008; Boudreau AC, 2005, J NEUROSCI, V25, P9144, DOI 10.1523/JNEUROSCI.2252-05.2005; Boudreau AC, 2007, J NEUROSCI, V27, P10621, DOI 10.1523/JNEUROSCI.2163-07.2007; Bowers MS, 2010, NEURON, V67, P11, DOI 10.1016/j.neuron.2010.06.004; Brown TE, 2011, J NEUROSCI, V31, P8163, DOI 10.1523/JNEUROSCI.0016-11.2011; Crombag HS, 2002, BEHAV BRAIN RES, V136, P455, DOI 10.1016/S0166-4328(02)00196-1; Cull-Candy S, 2006, CURR OPIN NEUROBIOL, V16, P288, DOI 10.1016/j.conb.2006.05.012; Cull-Candy Stuart G, 2004, Sci STKE, V2004, pre16, DOI 10.1126/stke.2552004re16; Everitt BJ, 2001, BRAIN RES REV, V36, P129, DOI 10.1016/S0165-0173(01)00088-1; Fischer G, 1997, J PHARMACOL EXP THER, V283, P1285; Fourgeaud L, 2004, J NEUROSCI, V24, P6939, DOI 10.1523/JNEUROSCI.0671-04.2004; Good CH, 2010, J NEUROSCI, V30, P7900, DOI 10.1523/JNEUROSCI.1507-10.2010; Hope BT, 2006, EUR J NEUROSCI, V24, P867, DOI 10.1111/j.1460-9568.2006.04969.x; Huang CC, 2011, J NEUROSCI, V31, P4194, DOI 10.1523/JNEUROSCI.5239-10.2011; Huang YH, 2011, BEHAV BRAIN RES, V216, P9, DOI 10.1016/j.bbr.2010.07.039; Huang YHH, 2009, NEURON, V63, P40, DOI 10.1016/j.neuron.2009.06.007; ISAAC JTR, 1995, NEURON, V15, P427, DOI 10.1016/0896-6273(95)90046-2; Kerchner GA, 2008, NAT REV NEUROSCI, V9, P813, DOI 10.1038/nrn2501; Kourrich S, 2007, J NEUROSCI, V27, P7921, DOI 10.1523/JNEUROSCI.1859-07.2007; Koya E, 2009, NAT NEUROSCI, V12, P1069, DOI 10.1038/nn.2364; Lee BR, 2011, NEUROPHARMACOLOGY, V61, P1060, DOI 10.1016/j.neuropharm.2010.12.033; Liao DZ, 1996, LEARN MEMORY, V3, P138, DOI 10.1101/lm.3.2-3.138; LIAO DZ, 1995, NATURE, V375, P400, DOI 10.1038/375400a0; Mameli M, 2007, SCIENCE, V317, P530, DOI 10.1126/science.1142365; Mameli M, 2011, NAT NEUROSCI, V14, P414, DOI 10.1038/nn.2763; Mameli M, 2009, NAT NEUROSCI, V12, P1036, DOI 10.1038/nn.2367; Marie H, 2005, NEURON, V45, P741, DOI 10.1016/j.neuron.2005.01.039; Matamales M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004770; Mattson BJ, 2008, EUR J NEUROSCI, V27, P202, DOI 10.1111/j.1460-9568.2007.05984.x; Rumpel S, 1998, J NEUROSCI, V18, P8863; Saal D, 2003, NEURON, V37, P577, DOI 10.1016/S0896-6273(03)00021-7; Sametsky EA, 2010, NEUROBIOL AGING, V31, P813, DOI 10.1016/j.neurobiolaging.2008.05.029; Thomas MJ, 2008, BRIT J PHARMACOL, V154, P327, DOI 10.1038/bjp.2008.77; Thomas MJ, 2001, NAT NEUROSCI, V4, P1217, DOI 10.1038/nn757; Turrigiano GG, 2004, NAT REV NEUROSCI, V5, P97, DOI 10.1038/nrn1327; Ungless MA, 2001, NATURE, V411, P583, DOI 10.1038/35079077; Uslaner J, 2001, EUR J NEUROSCI, V13, P1977, DOI 10.1046/j.0953-816x.2001.01574.x; Wise RA, 2002, NEURON, V36, P229, DOI 10.1016/S0896-6273(02)00965-0; Wolf ME, 2010, NEUROSCI BIOBEHAV R, V35, P185, DOI 10.1016/j.neubiorev.2010.01.013; Wu LJ, 2009, MOL BRAIN, V2, DOI 10.1186/1756-6606-2-9	46	68	70	0	10	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	NOV	2012	15	11					1556	1562		10.1038/nn.3232	http://dx.doi.org/10.1038/nn.3232			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	028LX	23023294	Green Accepted			2022-12-28	WOS:000310424900016
J	de Chevigny, A; Core, N; Follert, P; Gaudin, M; Barbry, P; Beclin, C; Cremer, H				de Chevigny, Antoine; Core, Nathalie; Follert, Philipp; Gaudin, Marion; Barbry, Pascal; Beclin, Christophe; Cremer, Harold			miR-7a regulation of Pax6 controls spatial origin of forebrain dopaminergic neurons	NATURE NEUROSCIENCE			English	Article							ALPHA-SYNUCLEIN EXPRESSION; NEURAL STEM-CELLS; POSTTRANSCRIPTIONAL REGULATION; MICRORNAS; ELECTROPORATION; DIFFERENTIATION; SPECIFICATION; NEUROGENESIS; PROGENITORS; REPRESSION	In the postnatal and adult mouse forebrain, a mosaic of spatially separated neural stem cells along the lateral wall of the ventricles generates defined types of olfactory bulb neurons. To understand the mechanisms underlying the regionalization of the stem cell pool, we focused on the transcription factor Pax6, a determinant of the dopaminergic phenotype in this system. We found that, although Pax6 mRNA was transcribed widely along the ventricular walls, Pax6 protein was restricted to the dorsal aspect. This dorsal restriction was a result of inhibition of protein expression by miR-7a, a microRNA (miRNA) that was expressed in a gradient opposing Pax6. In vivo inhibition of miR-7a in Pax6-negative regions of the lateral wall induced Pax6 protein expression and increased dopaminergic neurons in the olfactory bulb. These findings establish miRNA-mediated fine-tuning of protein expression as a mechanism for controlling neuronal stem cell diversity and, consequently, neuronal phenotype.	[de Chevigny, Antoine; Core, Nathalie; Follert, Philipp; Gaudin, Marion; Beclin, Christophe; Cremer, Harold] Aix Marseille Univ, Inst Biol Dev Marseille Luminy, Marseille, France; [de Chevigny, Antoine; Core, Nathalie; Follert, Philipp; Gaudin, Marion; Beclin, Christophe; Cremer, Harold] CNRS, UMR 7288, Marseille, France; [Barbry, Pascal] Univ Nice Sophia Antipolis, Inst Pharmacol Mol & Cellulaire, Sophia Antipolis, France; [Barbry, Pascal] CNRS, Sophia Antipolis, France	UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Aix-Marseille Universite; UDICE-French Research Universities; Universite Cote d'Azur; Centre National de la Recherche Scientifique (CNRS)	Core, N (corresponding author), Aix Marseille Univ, Inst Biol Dev Marseille Luminy, Marseille, France.	nathalie.core@univmed.fr; harold.cremer@univmed.fr	Follert, Philipp/I-5761-2014; Barbry, Pascal/O-5021-2016; de Chevigny, Antoine/M-7477-2016	Follert, Philipp/0000-0001-7462-5079; Barbry, Pascal/0000-0001-9632-6483; de Chevigny, Antoine/0000-0002-7413-0591; Cremer, Harold/0000-0002-8673-5176; beclin, christophe/0000-0003-1923-7238	Agence National de la Recherche (ANR, FORDOPA); Foundation pour la Recherche Medicale (Label Equipe FRM); Fondation de France; European Commission; Region PACA [CG06]; ANR; Vaincre la Mucoviscidose; Association pour la Recherche sur le Cancer; Institut National du Cancer	Agence National de la Recherche (ANR, FORDOPA)(French National Research Agency (ANR)); Foundation pour la Recherche Medicale (Label Equipe FRM); Fondation de France(Fondation de France); European Commission(European CommissionEuropean Commission Joint Research Centre); Region PACA(Region Provence-Alpes-Cote d'Azur); ANR(French National Research Agency (ANR)); Vaincre la Mucoviscidose; Association pour la Recherche sur le Cancer(Fondation ARC pour la Recherche sur le CancerAustralian Research Council); Institut National du Cancer(Institut National du Cancer (INCA) France)	We thank D. Price (University of Edinburgh) for tissue from PAX6-GFP mice, D. van Vector (Harvard Medical School) for miR-7a sponge plasmid, U. Bissels (Miltenyi Biotec) for advice on luciferase assays, Y. Manhoun for help with deep-sequencing data analyses, A. Barani (Precym platform of Centre d'Oceanologie de Marseille) for fluorescence-activated cell sorting, J. Ninkovic for helpful tips on antibody labeling and X. Morin (Ecole Normale Superieure) for plasmids. We acknowledge the expertise of V. Magnone and K. Lebrigand (Functional Genomics Platform of Nice Sophia Antipolis), and R. Waldmann and L.-E. Zaragosi for fruitful discussions. We thank A. Bosio, R. Kelly and M. C. Tiveron for critical reading of the manuscript. This work was supported by funds from the Agence National de la Recherche (ANR, FORDOPA), Foundation pour la Recherche Medicale (Label Equipe FRM), Fondation de France and the European Commission (Marie-Curie: ITN AXREGEN and IAPP DopaNew) to H. C. P. B. was supported by Region PACA, CG06 and by grants from ANR, Vaincre la Mucoviscidose, Association pour la Recherche sur le Cancer and Institut National du Cancer.	Alonso M, 2008, J NEUROSCI, V28, P11089, DOI 10.1523/JNEUROSCI.3713-08.2008; Barkai N, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a001990; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bhattacharyya SN, 2006, CELL, V125, P1111, DOI 10.1016/j.cell.2006.04.031; Boutin C, 2010, P NATL ACAD SCI USA, V107, P1201, DOI 10.1073/pnas.0909015107; Boutin C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001883; Brill MS, 2008, J NEUROSCI, V28, P6439, DOI 10.1523/JNEUROSCI.0700-08.2008; Chen JA, 2011, NEURON, V69, P721, DOI 10.1016/j.neuron.2011.01.014; Cheng LC, 2009, NAT NEUROSCI, V12, P399, DOI 10.1038/nn.2294; Dellovade TL, 1998, J COMP NEUROL, V402, P402; Doxakis E, 2010, J BIOL CHEM, V285, P12726, DOI 10.1074/jbc.M109.086827; Ebert MS, 2010, CURR BIOL, V20, pR858, DOI 10.1016/j.cub.2010.08.052; Fernandez ME, 2011, NEURAL DEV, V6, DOI 10.1186/1749-8104-6-13; Filipowicz W, 2008, NAT REV GENET, V9, P102, DOI 10.1038/nrg2290; Gao FB, 2010, NEURAL DEV, V5, DOI 10.1186/1749-8104-5-25; Hack MA, 2005, NAT NEUROSCI, V8, P865, DOI 10.1038/nn1479; Ihrie RA, 2011, NEURON, V71, P250, DOI 10.1016/j.neuron.2011.05.018; Imitola J, 2004, P NATL ACAD SCI USA, V101, P18117, DOI 10.1073/pnas.0408258102; Inui M, 2010, NAT REV MOL CELL BIO, V11, P252, DOI 10.1038/nrm2868; Johnston RJ, 2003, NATURE, V426, P845, DOI 10.1038/nature02255; Junn E, 2009, P NATL ACAD SCI USA, V106, P13052, DOI 10.1073/pnas.0906277106; Kelsch W, 2007, PLOS BIOL, V5, P2501, DOI 10.1371/journal.pbio.0050300; Kohwi M, 2005, J NEUROSCI, V25, P6997, DOI 10.1523/JNEUROSCI.1435-05.2005; Lagos-Quintana M, 2002, CURR BIOL, V12, P735, DOI 10.1016/S0960-9822(02)00809-6; Loya CM, 2009, NAT METHODS, V6, P897, DOI 10.1038/nmeth.1402; Merkle FT, 2007, SCIENCE, V317, P381, DOI 10.1126/science.1144914; Mignone F, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-3-reviews0004; Morin X, 2007, NAT NEUROSCI, V10, P1440, DOI 10.1038/nn1984; Ninkovic J, 2010, NEURON, V68, P682, DOI 10.1016/j.neuron.2010.09.030; Pasquinelli AE, 2005, CURR OPIN GENET DEV, V15, P200, DOI 10.1016/j.gde.2005.01.002; Rogers KW, 2011, ANNU REV CELL DEV BI, V27, P377, DOI 10.1146/annurev-cellbio-092910-154148; Schratt GM, 2006, NATURE, V439, P283, DOI 10.1038/nature04367; Sousa VH, 2010, CURR OPIN GENET DEV, V20, P391, DOI 10.1016/j.gde.2010.04.008; Tonelli DD, 2008, DEVELOPMENT, V135, P3911, DOI 10.1242/dev.025080; Tyas DA, 2006, BMC DEV BIOL, V6, DOI 10.1186/1471-213X-6-21; Whitman MC, 2009, PROG NEUROBIOL, V89, P162, DOI 10.1016/j.pneurobio.2009.07.003; Yoo AS, 2011, NATURE, V476, P228, DOI 10.1038/nature10323; Zhao C, 2009, NAT STRUCT MOL BIOL, V16, P365, DOI 10.1038/nsmb.1576	38	105	107	0	15	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	AUG	2012	15	8					1120	+		10.1038/nn.3142	http://dx.doi.org/10.1038/nn.3142			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	979UE	22729175				2022-12-28	WOS:000306844500018
J	Palmiter, RD				Palmiter, Richard D.			New game for hunger neurons	NATURE NEUROSCIENCE			English	Editorial Material							AGOUTI-RELATED PROTEIN; AGRP NEURONS; NEUROPEPTIDE-Y; LEPTIN; SYSTEM; MICE	Hypothalamic neurons that express agouti-related protein have been thought to regulate appetite by counteracting the melanocortin signaling pathway. Evidence now indicates that these neurons can also modulate dopamine signaling.	[Palmiter, Richard D.] Univ Washington, Howard Hughes Med Inst, Seattle, WA 98195 USA; [Palmiter, Richard D.] Univ Washington, Dept Biochem, Seattle, WA 98195 USA	Howard Hughes Medical Institute; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Palmiter, RD (corresponding author), Univ Washington, Howard Hughes Med Inst, Seattle, WA 98195 USA.	palmiter@uw.edu						Aponte Y, 2011, NAT NEUROSCI, V14, P351, DOI 10.1038/nn.2739; Broberger C, 1998, P NATL ACAD SCI USA, V95, P15043, DOI 10.1073/pnas.95.25.15043; Cone RD, 2005, NAT NEUROSCI, V8, P571, DOI 10.1038/nn1455; Dietrich MO, 2012, NAT NEUROSCI, V15, P1108, DOI 10.1038/nn.3147; Dietrich MO, 2010, J NEUROSCI, V30, P11815, DOI 10.1523/JNEUROSCI.2234-10.2010; Gropp E, 2005, NAT NEUROSCI, V8, P1289, DOI 10.1038/nn1548; Israel DD, 2012, ENDOCRINOLOGY, V153, P2408, DOI 10.1210/en.2011-1822; Johnson PM, 2010, NAT NEUROSCI, V13, P635, DOI 10.1038/nn.2519; Krashes MJ, 2011, J CLIN INVEST, V121, P1424, DOI 10.1172/JCI46229; Luquet S, 2005, SCIENCE, V310, P683, DOI 10.1126/science.1115524; Morton GJ, 2006, NATURE, V443, P289, DOI 10.1038/nature05026; Qian S, 2002, MOL CELL BIOL, V22, P5027, DOI 10.1128/MCB.22.14.5027-5035.2002; Tong QC, 2008, NAT NEUROSCI, V11, P998, DOI 10.1038/nn.2167; Wu Q, 2012, P NATL ACAD SCI USA, V109, P3155, DOI 10.1073/pnas.1120501109; Wu Q, 2009, CELL, V137, P1225, DOI 10.1016/j.cell.2009.04.022	15	3	3	0	12	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	AUG	2012	15	8					1060	1061		10.1038/nn.3167	http://dx.doi.org/10.1038/nn.3167			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	979UE	22837033				2022-12-28	WOS:000306844500004
J	Knuckles, P; Vogt, MA; Lugert, S; Milo, M; Chong, MMW; Hautbergue, GM; Wilson, SA; Littman, DR; Taylor, V				Knuckles, Philip; Vogt, Miriam A.; Lugert, Sebastian; Milo, Marta; Chong, Mark M. W.; Hautbergue, Guillaume M.; Wilson, Stuart A.; Littman, Dan R.; Taylor, Verdon			Drosha regulates neurogenesis by controlling Neurogenin 2 expression independent of microRNAs	NATURE NEUROSCIENCE			English	Article							PROMOTES NEURONAL DIFFERENTIATION; NEURAL STEM-CELLS; POSTTRANSCRIPTIONAL REGULATION; MICROPROCESSOR COMPLEX; SMALL RNAS; DICER; BIOGENESIS; MOUSE; PROGENITORS; PATHWAY	Temporal regulation of embryonic neurogenesis is controlled by hypostable transcription factors. The mechanism of the process is unclear. Here we show that the RNase III Drosha and DGCR8 (also known as Pasha), key components of the microRNA (miRNA) microprocessor, have important functions in mouse neurogenesis. Loss of microprocessor in forebrain neural progenitors resulted in a loss of stem cell character and precocious differentiation whereas Dicer deficiency did not. Drosha negatively regulated expression of the transcription factors Neurogenin 2 (Ngn2) and NeuroD1 whereas forced Ngn2 expression phenocopied the loss of Drosha. Neurog2 mRNA contains evolutionarily conserved hairpins with similarities to pri-miRNAs, and associates with the microprocessor in neural progenitors. We uncovered a Drosha-dependent destabilization of Neurog2 mRNAs consistent with microprocessor cleavage at hairpins. Our findings implicate direct and miRNA-independent destabilization of proneural mRNAs by the microprocessor, which facilitates neural stem cell (NSC) maintenance by blocking accumulation of differentiation and determination factors.	[Knuckles, Philip; Vogt, Miriam A.; Lugert, Sebastian; Taylor, Verdon] Max Planck Inst Immunol, Dept Mol Embryol, Freiburg, Germany; [Vogt, Miriam A.; Lugert, Sebastian; Taylor, Verdon] Univ Basel, Dept Biomed, Basel, Switzerland; [Milo, Marta] Univ Sheffield, Sheffield Teaching Hosp Natl Hlth Serv Trust, Natl Inst Hlth Res Cardiovasc Biomed Res Unit, Sheffield, S Yorkshire, England; [Chong, Mark M. W.; Littman, Dan R.] NYU, Sch Med, Skirball Inst Biomol Med, Mol Pathogenesis Program,Kimmel Ctr Biol & Med, New York, NY USA; [Chong, Mark M. W.] Royal Melbourne Hosp, Walter & Eliza Hall Inst Med Res, Parkville, Vic 3050, Australia; [Hautbergue, Guillaume M.; Wilson, Stuart A.] Univ Sheffield, Dept Mol Biol & Biotechnol, Sheffield S10 2TN, S Yorkshire, England; [Littman, Dan R.] NYU, Sch Med, Howard Hughes Med Inst, New York, NY USA	Max Planck Society; University of Basel; University of Sheffield; New York University; Royal Melbourne Hospital; Walter & Eliza Hall Institute; University of Sheffield; Howard Hughes Medical Institute; New York University	Taylor, V (corresponding author), Max Planck Inst Immunol, Dept Mol Embryol, Freiburg, Germany.	verdon.taylor@unibas.ch	Chong, Mark/H-6684-2016	Chong, Mark/0000-0002-3701-7397; wilson, stuart/0000-0003-3073-258X; Taylor, Verdon/0000-0003-3497-5976; Knuckles, Philip/0000-0001-5254-8244	Deutsche Forschungsgemeinschaft [TA-310-1, TA-310-2, SFB592]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	We thank N. Kim (Seoul National University) for Drosha constructs, F. Guillemot (UK National Institute for Medical Research) for Neurog2 and shRNA constructs, and P. Herrare for beta2/NeuroD promoter, members of the Taylor laboratory for helpful discussions, and F. Sager for excellent technical assistance. P.K. and S.L. were PhD students of the International Max Planck Research School Molecular and Cellular Biology and of the Faculty of Biology, University of Freiburg, M.A.V. is a PhD student of the Department of Biomedical Science, University of Sheffield. This work was supported by the Deutsche Forschungsgemeinschaft (TA-310-1, TA-310-2 and SFB592 to V.T.).	Anthony TE, 2004, NEURON, V41, P881, DOI 10.1016/S0896-6273(04)00140-0; Babiarz JE, 2008, GENE DEV, V22, P2773, DOI 10.1101/gad.1705308; Babiarz JE, 2011, RNA, V17, P1489, DOI 10.1261/rna.2442211; Cheloufi S, 2010, NATURE, V465, P584, DOI 10.1038/nature09092; Chendrimada TP, 2005, NATURE, V436, P740, DOI 10.1038/nature03868; Cheung TH, 2012, NATURE, V482, P524, DOI 10.1038/nature10834; Chong MMW, 2010, GENE DEV, V24, P1951, DOI 10.1101/gad.1953310; Cifuentes D, 2010, SCIENCE, V328, P1694, DOI 10.1126/science.1190809; Denli AM, 2004, NATURE, V432, P231, DOI 10.1038/nature03049; Ender C, 2008, MOL CELL, V32, P519, DOI 10.1016/j.molcel.2008.10.017; Eulalio A, 2008, CELL, V132, P9, DOI 10.1016/j.cell.2007.12.024; Filipowicz W, 2008, NAT REV GENET, V9, P102, DOI 10.1038/nrg2290; Ganesan G, 2008, RNA, V14, P1399, DOI 10.1261/rna.838308; Gantier MP, 2011, NUCLEIC ACIDS RES, V39, P5692, DOI 10.1093/nar/gkr148; Georgi SA, 2010, J NEUROSCI, V30, P4048, DOI 10.1523/JNEUROSCI.4982-09.2010; Gohlke JM, 2008, BMC BIOL, V6, DOI 10.1186/1741-7007-6-15; Gotz M, 2005, NAT REV MOL CELL BIO, V6, P777, DOI 10.1038/nrm1739; Gregory RI, 2004, NATURE, V432, P235, DOI 10.1038/nature03120; Guillemot F, 2005, CURR OPIN CELL BIOL, V17, P639, DOI 10.1016/j.ceb.2005.09.006; Guillemot F, 2007, DEVELOPMENT, V134, P3771, DOI 10.1242/dev.006379; Han J, 2009, CELL, V136, P75, DOI 10.1016/j.cell.2008.10.053; Han JJ, 2004, GENE DEV, V18, P3016, DOI 10.1101/gad.1262504; Heng JIT, 2008, NATURE, V455, P114, DOI 10.1038/nature07198; Heo I, 2009, CELL, V138, P696, DOI 10.1016/j.cell.2009.08.002; Imayoshi I, 2010, J NEUROSCI, V30, P3489, DOI 10.1523/JNEUROSCI.4987-09.2010; Kadener S, 2009, RNA, V15, P537, DOI 10.1261/rna.1319309; Kageyama R, 2010, CURR TOP DEV BIOL, V92, P311, DOI 10.1016/S0070-2153(10)92010-3; Kageyama R, 2009, CURR OPIN CELL BIOL, V21, P733, DOI 10.1016/j.ceb.2009.08.009; Kaneko H, 2011, NATURE, V471, P325, DOI 10.1038/nature09830; Karginov FV, 2010, MOL CELL, V38, P781, DOI 10.1016/j.molcel.2010.06.001; Kawase-Koga Y, 2010, J CELL SCI, V123, P586, DOI 10.1242/jcs.059659; Kim VN, 2009, NAT REV MOL CELL BIO, V10, P126, DOI 10.1038/nrm2632; Lai EC, 2002, NAT GENET, V30, P363, DOI 10.1038/ng865; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Lutolf S, 2002, DEVELOPMENT, V129, P373; Makeyev EV, 2007, MOL CELL, V27, P435, DOI 10.1016/j.molcel.2007.07.015; Masamizu Y, 2006, P NATL ACAD SCI USA, V103, P1313, DOI 10.1073/pnas.0508658103; Miyata T, 2010, CURR OPIN NEUROBIOL, V20, P22, DOI 10.1016/j.conb.2010.01.001; Nguyen L, 2006, GENE DEV, V20, P1511, DOI 10.1101/gad.377106; Nieto M, 2001, NEURON, V29, P401, DOI 10.1016/S0896-6273(01)00214-8; Noctor SC, 2004, NAT NEUROSCI, V7, P136, DOI 10.1038/nn1172; Okamura K, 2007, CELL, V130, P89, DOI 10.1016/j.cell.2007.06.028; Ruby JG, 2007, NATURE, V448, P83, DOI 10.1038/nature05983; Salomoni P, 2010, TRENDS CELL BIOL, V20, P233, DOI 10.1016/j.tcb.2010.01.006; Shenoy A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006971; Shimojo H, 2008, NEURON, V58, P52, DOI 10.1016/j.neuron.2008.02.014; Tonelli DD, 2008, DEVELOPMENT, V135, P3911, DOI 10.1242/dev.025080; Wang YM, 2009, CANCER RES, V69, P4093, DOI 10.1158/0008-5472.CAN-09-0309; Yang JS, 2011, MOL CELL, V43, P892, DOI 10.1016/j.molcel.2011.07.024; Yang JS, 2010, P NATL ACAD SCI USA, V107, P15163, DOI 10.1073/pnas.1006432107	50	89	91	1	11	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JUL	2012	15	7					962	969		10.1038/nn.3139	http://dx.doi.org/10.1038/nn.3139			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	966EE	22706270				2022-12-28	WOS:000305819600014
J	Wunderlich, K; Dayan, P; Dolan, RJ				Wunderlich, Klaus; Dayan, Peter; Dolan, Raymond J.			Mapping value based planning and extensively trained choice in the human brain	NATURE NEUROSCIENCE			English	Article							VENTROMEDIAL PREFRONTAL CORTEX; TEMPORAL DIFFERENCE MODELS; ORBITOFRONTAL CORTEX; BASAL GANGLIA; DECISION-MAKING; PREDICTION ERRORS; STRIATUM; REWARD; REPRESENTATION; COMPUTATIONS	Investigations of the underlying mechanisms of choice in humans have focused on learning from prediction errors, leaving the computational structure of value based planning comparatively underexplored. Using behavioral and neuroimaging analyses of a minimax decision task, we found that the computational processes underlying forward planning are expressed in the anterior caudate nucleus as values of individual branching steps in a decision tree. In contrast, values represented in the putamen pertain solely to values learned during extensive training. During actual choice, both striatal areas showed a functional coupling to ventromedial prefrontal cortex, consistent with this region acting as a value comparator. Our findings point toward an architecture of choice in which segregated value systems operate in parallel in the striatum for planning and extensively trained choices, with medial prefrontal cortex integrating their outputs.	[Wunderlich, Klaus; Dolan, Raymond J.] UCL, Wellcome Trust Ctr Neuroimaging, London, England; [Dayan, Peter] UCL, Gatsby Computat Neurosci Unit, London, England	University of London; University College London; University of London; University College London	Wunderlich, K (corresponding author), UCL, Wellcome Trust Ctr Neuroimaging, London, England.	kwunder@gmail.com		Dolan, Ray/0000-0001-9356-761X; Dayan, Peter/0000-0003-3476-1839	Wellcome Trust [091593/Z/10/Z]; Max Planck Award; Gatsby Charitable Foundation	Wellcome Trust(Wellcome TrustEuropean Commission); Max Planck Award(Max Planck Society); Gatsby Charitable Foundation	We thank W. Yoshida and J. Oberg for help with data acquisition, and N. Daw and M. Guitart Masip for their valuable and insightful comments on the manuscript. This study was supported by a Wellcome Trust Program Grant and Max Planck Award (RID. and KM.) and the Gatsby Charitable Foundation (P.D.). The Wellcome Trust Centre for Neuroimaging is supported by core funding from the Wellcome Trust (091593/Z/10/Z).	Balleine BW, 2010, NEUROPSYCHOPHARMACOL, V35, P48, DOI 10.1038/npp.2009.131; Basten U, 2010, P NATL ACAD SCI USA, V107, P21767, DOI 10.1073/pnas.0908104107; Beiser, 1995, MODELS INFORM PROCES, P215; Berns GS, 2001, J NEUROSCI, V21, P2793, DOI 10.1523/JNEUROSCI.21-08-02793.2001; Boorman ED, 2009, NEURON, V62, P733, DOI 10.1016/j.neuron.2009.05.014; Chib VS, 2009, J NEUROSCI, V29, P12315, DOI 10.1523/JNEUROSCI.2575-09.2009; Daw ND, 2006, NATURE, V441, P876, DOI 10.1038/nature04766; Daw ND, 2011, NEURON, V69, P1204, DOI 10.1016/j.neuron.2011.02.027; Daw ND, 2005, NAT NEUROSCI, V8, P1704, DOI 10.1038/nn1560; Doya K, 1999, NEURAL NETWORKS, V12, P961, DOI 10.1016/S0893-6080(99)00046-5; FitzGerald THB, 2010, CURR BIOL, V20, P1823, DOI 10.1016/j.cub.2010.08.048; FitzGerald THB, 2009, J NEUROSCI, V29, P8388, DOI 10.1523/JNEUROSCI.0717-09.2009; Glascher J, 2010, NEURON, V66, P585, DOI 10.1016/j.neuron.2010.04.016; Hampton AN, 2006, J NEUROSCI, V26, P8360, DOI 10.1523/JNEUROSCI.1010-06.2006; Hare TA, 2008, J NEUROSCI, V28, P5623, DOI 10.1523/JNEUROSCI.1309-08.2008; Jueptner M, 1997, J NEUROPHYSIOL, V77, P1325, DOI 10.1152/jn.1997.77.3.1325; Kable JW, 2007, NAT NEUROSCI, V10, P1625, DOI 10.1038/nn2007; Knutson B, 2005, CURR OPIN NEUROL, V18, P411, DOI 10.1097/01.wco.0000173463.24758.f6; Knutson B, 2005, J NEUROSCI, V25, P4806, DOI 10.1523/JNEUROSCI.0642-05.2005; Lau B, 2007, J NEUROSCI, V27, P14502, DOI 10.1523/JNEUROSCI.3060-07.2007; Lehericy S, 2005, P NATL ACAD SCI USA, V102, P12566, DOI 10.1073/pnas.0502762102; Noonan MP, 2010, P NATL ACAD SCI USA, V107, P20547, DOI 10.1073/pnas.1012246107; O'Doherty J, 2004, SCIENCE, V304, P452, DOI 10.1126/science.1094285; O'Doherty JP, 2003, NEURON, V38, P329, DOI 10.1016/S0896-6273(03)00169-7; Padoa-Schioppa C, 2006, NATURE, V441, P223, DOI 10.1038/nature04676; Plassmann H, 2007, J NEUROSCI, V27, P9984, DOI 10.1523/JNEUROSCI.2131-07.2007; Redgrave P, 2010, NAT REV NEUROSCI, V11, P760, DOI 10.1038/nrn2915; Samejima K, 2005, SCIENCE, V310, P1337, DOI 10.1126/science.1115270; SAMUEL AL, 1959, IBM J RES DEV, V3, P211, DOI 10.1147/rd.441.0206; Schultz W, 1997, SCIENCE, V275, P1593, DOI 10.1126/science.275.5306.1593; Seymour B, 2004, NATURE, V429, P664, DOI 10.1038/nature02581; SHALLICE T, 1982, PHILOS T ROY SOC B, V298, P199, DOI 10.1098/rstb.1982.0082; Stephan KE, 2009, NEUROIMAGE, V46, P1004, DOI 10.1016/j.neuroimage.2009.03.025; Sutton RS, 1990, NEURAL NETWORKS CONT, P179; Tanaka SC, 2008, J NEUROSCI, V28, P6750, DOI 10.1523/JNEUROSCI.1808-08.2008; Tanaka SC, 2004, NAT NEUROSCI, V7, P887, DOI 10.1038/nn1279; Tricomi E, 2009, EUR J NEUROSCI, V29, P2225, DOI 10.1111/j.1460-9568.2009.06796.x; Tricomi EM, 2004, NEURON, V41, P281, DOI 10.1016/S0896-6273(03)00848-1; Valentin VV, 2007, J NEUROSCI, V27, P4019, DOI 10.1523/JNEUROSCI.0564-07.2007; Wunderlich K, 2010, P NATL ACAD SCI USA, V107, P15005, DOI 10.1073/pnas.1002258107; Wunderlich K, 2009, P NATL ACAD SCI USA, V106, P17199, DOI 10.1073/pnas.0901077106; Yin HH, 2005, EUR J NEUROSCI, V22, P513, DOI 10.1111/j.1460-9568.2005.04218.x	43	198	200	2	38	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAY	2012	15	5					786	791		10.1038/nn.3068	http://dx.doi.org/10.1038/nn.3068			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	932DI	22406551	Green Accepted, Green Published			2022-12-28	WOS:000303270200024
J	Zatorre, RJ; Fields, RD; Johansen-Berg, H				Zatorre, Robert J.; Fields, R. Douglas; Johansen-Berg, Heidi			Plasticity in gray and white: neuroimaging changes in brain structure during learning	NATURE NEUROSCIENCE			English	Review							IN-VIVO; VAL66MET POLYMORPHISM; CORTICAL THICKNESS; STRUCTURE PREDICTS; ACTION-POTENTIALS; CORPUS-CALLOSUM; HESCHLS GYRUS; MATTER; NEUROGENESIS; MYELINATION	Human brain imaging has identified structural changes in gray and white matter that occur with learning. However, ascribing imaging measures to underlying cellular and molecular events is challenging. Here we review human neuroimaging findings of structural plasticity and then discuss cellular and molecular level changes that could underlie observed imaging effects. Greater dialog between researchers in these different fields would help to facilitate cross-talk between cellular and systems level explanations of how learning sculpts brain structure.	[Johansen-Berg, Heidi] John Radcliffe Hosp, Oxford Ctr Funct MRI Brain FMRIB, Nuffield Dept Clin Neurosci, Oxford OX3 9DU, England; [Zatorre, Robert J.] McGill Univ, Montreal Neurol Inst, Montreal, PQ, Canada; [Fields, R. Douglas] NICHHD, Nervous Syst Dev, US Natl Inst Hlth, Bethesda, MD 20892 USA; [Fields, R. Douglas] NICHHD, Plast Sect, US Natl Inst Hlth, Bethesda, MD 20892 USA	University of Oxford; McGill University; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	Johansen-Berg, H (corresponding author), John Radcliffe Hosp, Oxford Ctr Funct MRI Brain FMRIB, Nuffield Dept Clin Neurosci, Oxford OX3 9DU, England.	heidi@fmrib.ox.ac.uk		Johansen-Berg, Heidi/0000-0002-4134-9730	Canadian Institutes of Health Research; Natural Sciences and Engineering Research Council of Canada; US National Institutes of Health; Wellcome Trust; MRC [G0700399] Funding Source: UKRI; Medical Research Council [G0700399] Funding Source: researchfish; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD000713] Funding Source: NIH RePORTER	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Wellcome Trust(Wellcome TrustEuropean Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	R.J.Z. is supported by the Canadian Institutes of Health Research and the Natural Sciences and Engineering Research Council of Canada; R.D.F. is supported by funds for intramural research at the US National Institutes of Health; H.J.-B. is supported by the Wellcome Trust.	Adams B, 1997, BRAIN RES, V775, P193, DOI 10.1016/S0006-8993(97)01061-5; Aimone JB, 2009, NEURON, V61, P187, DOI 10.1016/j.neuron.2008.11.026; Ashburner J, 1998, HUM BRAIN MAPP, V6, P348, DOI 10.1002/(SICI)1097-0193(1998)6:5/6<348::AID-HBM4>3.3.CO;2-G; Avram AV, 2010, NEUROIMAGE, V53, P132, DOI 10.1016/j.neuroimage.2010.06.019; Back SA, 2002, J NEUROPATH EXP NEUR, V61, P197, DOI 10.1093/jnen/61.2.197; Barazany D, 2009, BRAIN, V132, P1210, DOI 10.1093/brain/awp042; Barbier EL, 2001, J MAGN RESON IMAGING, V13, P496, DOI 10.1002/jmri.1073; Beaulieu C, 2009, DIFFUSION MRI: FROM QUANTITATIVE MEASUREMENT TO IN VIVO NEUROANATOMY, P105, DOI 10.1016/B978-0-12-374709-9.00006-7; Bengtsson SL, 2005, NAT NEUROSCI, V8, P1148, DOI 10.1038/nn1516; Bermudez P, 2009, CEREB CORTEX, V19, P1583, DOI 10.1093/cercor/bhn196; Blumenfeld-Katzir T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020678; Bohbot VD, 2007, J NEUROSCI, V27, P10078, DOI 10.1523/JNEUROSCI.1763-07.2007; Boyke J, 2008, J NEUROSCI, V28, P7031, DOI 10.1523/JNEUROSCI.0742-08.2008; Canu MH, 2009, BRAIN RES, V1252, P45, DOI 10.1016/j.brainres.2008.10.079; Cheeran B, 2008, J PHYSIOL-LONDON, V586, P5717, DOI 10.1113/jphysiol.2008.159905; Chiang MC, 2009, J NEUROSCI, V29, P2212, DOI 10.1523/JNEUROSCI.4184-08.2009; Cohen JE, 2008, NEURON GLIA BIOL, V4, P43, DOI 10.1017/S1740925X09000076; Concha L, 2010, J NEUROSCI, V30, P996, DOI 10.1523/JNEUROSCI.1619-09.2010; Dancause N, 2005, J NEUROSCI, V25, P10167, DOI 10.1523/JNEUROSCI.3256-05.2005; Datwani A, 2009, NEURON, V64, P463, DOI 10.1016/j.neuron.2009.10.015; Deng W, 2009, J NEUROSCI, V29, P13532, DOI 10.1523/JNEUROSCI.3362-09.2009; Dong WK, 2004, MENT RETARD DEV D R, V10, P85, DOI 10.1002/mrdd.20016; Draganski B, 2004, NATURE, V427, P311, DOI 10.1038/427311a; Draganski B, 2006, J NEUROSCI, V26, P6314, DOI 10.1523/JNEUROSCI.4628-05.2006; Driemeyer J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002669; Dutta R, 2007, NEUROLOGY, V68, pS22, DOI 10.1212/01.wnl.0000275229.13012.32; Duyn JH, 2007, P NATL ACAD SCI USA, V104, P11796, DOI 10.1073/pnas.0610821104; Egan MF, 2003, CELL, V112, P257, DOI 10.1016/S0092-8674(03)00035-7; Emery B, 2010, SCIENCE, V330, P779, DOI 10.1126/science.1190927; Fields RD, 2008, TRENDS NEUROSCI, V31, P361, DOI 10.1016/j.tins.2008.04.001; Fields RD, 2010, SCIENCE, V330, P768, DOI 10.1126/science.1199139; Fields RD, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2001128; Floel A, 2009, NEUROIMAGE, V47, P1974, DOI 10.1016/j.neuroimage.2009.05.046; Foster NEV, 2010, NEUROIMAGE, V53, P26, DOI 10.1016/j.neuroimage.2010.06.042; Golestani N, 2007, CEREB CORTEX, V17, P575, DOI 10.1093/cercor/bhk001; Gould E, 1999, SCIENCE, V286, P548, DOI 10.1126/science.286.5439.548; He Y, 2007, CEREB CORTEX, V17, P2407, DOI 10.1093/cercor/bhl149; Horsfield MA, 2005, J NEUROIMAGING, V15, p58S, DOI 10.1177/1051228405282242; Hyde KL, 2009, J NEUROSCI, V29, P3019, DOI 10.1523/JNEUROSCI.5118-08.2009; Iordanova B, 2012, NEUROIMAGE, V59, P1004, DOI 10.1016/j.neuroimage.2011.08.068; Ishibashi T, 2006, NEURON, V49, P823, DOI 10.1016/j.neuron.2006.02.006; ITOH K, 1995, SCIENCE, V270, P1369, DOI 10.1126/science.270.5240.1369; Johansen-Berg H, 2007, NEUROIMAGE, V36, pT16, DOI 10.1016/j.neuroimage.2007.03.041; Johansen-Berg H, 2007, CURR BIOL, V17, pR141, DOI 10.1016/j.cub.2006.12.022; Johansen-Berg H, 2010, CURR OPIN NEUROL, V23, P351, DOI 10.1097/WCO.0b013e32833b7631; JohansenBerg H, 2009, DIFFUSION MRI: FROM QUANTITATIVE MEASUREMENT TO IN VIVO NEUROANATOMY, P1; Kang XJ, 2011, NEUROIMAGE, V56, P2011, DOI 10.1016/j.neuroimage.2011.03.016; Kleim JA, 2002, NEUROBIOL LEARN MEM, V77, P63, DOI 10.1006/nlme.2000.4004; Kleim JA, 2007, BEHAV BRAIN RES, V178, P244, DOI 10.1016/j.bbr.2006.12.022; Klintsova AY, 2004, BRAIN RES, V1028, P92, DOI 10.1016/j.brainres.2004.09.003; Kolb B, 2008, NEUROBIOL LEARN MEM, V90, P295, DOI 10.1016/j.nlm.2008.04.012; Kukley M, 2007, NAT NEUROSCI, V10, P311, DOI 10.1038/nn1850; Laule C, 2006, MULT SCLER, V12, P747, DOI 10.1177/1352458506070928; Laule C, 2007, NEUROTHERAPEUTICS, V4, P460, DOI 10.1016/j.nurt.2007.05.004; Lee HJ, 2008, J NEUROSCI, V28, P2753, DOI 10.1523/JNEUROSCI.5586-07.2008; Lerch JP, 2011, NEUROIMAGE, V54, P2086, DOI 10.1016/j.neuroimage.2010.09.086; Licht T, 2011, P NATL ACAD SCI USA, V108, P5081, DOI 10.1073/pnas.1007640108; Lohmann G, 1999, CEREB CORTEX, V9, P754, DOI 10.1093/cercor/9.7.754; Maguire EA, 2003, HIPPOCAMPUS, V13, P250, DOI 10.1002/hipo.10087; Maguire EA, 2000, P NATL ACAD SCI USA, V97, P4398, DOI 10.1073/pnas.070039597; Markham JA, 2009, BRAIN RES, V1288, P9, DOI 10.1016/j.brainres.2009.06.087; Nave KA, 2010, NATURE, V468, P244, DOI 10.1038/nature09614; Nieman BJ, 2010, NEUROIMAGE, V50, P456, DOI 10.1016/j.neuroimage.2009.12.107; Pereira AC, 2007, P NATL ACAD SCI USA, V104, P5638, DOI 10.1073/pnas.0611721104; Peters A, 2008, GLIA, V56, P1151, DOI 10.1002/glia.20686; Petrinovic MM, 2010, DEVELOPMENT, V137, P2539, DOI 10.1242/dev.048371; Pezawas L, 2004, J NEUROSCI, V24, P10099, DOI 10.1523/JNEUROSCI.2680-04.2004; Psachoulia K, 2009, NEURON GLIA BIOL, V5, P57, DOI 10.1017/S1740925X09990354; Rakic P, 2002, NAT REV NEUROSCI, V3, P65, DOI 10.1038/nrn700; Ramirez-Amaya V, 1999, HIPPOCAMPUS, V9, P631, DOI 10.1002/(SICI)1098-1063(1999)9:6<631::AID-HIPO3>3.0.CO;2-3; Raznahan A, 2011, NEURON, V72, P873, DOI 10.1016/j.neuron.2011.09.028; Rhyu IJ, 2010, NEUROSCIENCE, V167, P1239, DOI 10.1016/j.neuroscience.2010.03.003; Ruegg DG, 2003, CLIN NEUROPHYSIOL, V114, P86, DOI 10.1016/S1388-2457(02)00329-2; Sahay A, 2011, NATURE, V472, P466, DOI 10.1038/nature09817; Schneider P, 2002, NAT NEUROSCI, V5, P688, DOI 10.1038/nn871; Scholz J, 2009, NAT NEUROSCI, V12, P1370, DOI 10.1038/nn.2412; Stankoff B, 2011, ANN NEUROL, V69, P673, DOI 10.1002/ana.22320; Stevens B, 2002, NEURON, V36, P855, DOI 10.1016/S0896-6273(02)01067-X; Stevens B, 2000, SCIENCE, V287, P2267, DOI 10.1126/science.287.5461.2267; Stevens B, 2007, CELL, V131, P1164, DOI 10.1016/j.cell.2007.10.036; Takahashi M, 2002, P NATL ACAD SCI USA, V99, P16192, DOI 10.1073/pnas.252249999; Takeuchi H, 2010, J NEUROSCI, V30, P3297, DOI 10.1523/JNEUROSCI.4611-09.2010; Taubert M, 2010, J NEUROSCI, V30, P11670, DOI 10.1523/JNEUROSCI.2567-10.2010; Taveggia C, 2010, NAT REV NEUROL, V6, P276, DOI 10.1038/nrneurol.2010.37; Thomas AG, 2009, NEUROIMAGE, V48, P117, DOI 10.1016/j.neuroimage.2009.05.097; Thompson PM, 2001, NAT NEUROSCI, V4, P1253, DOI 10.1038/nn758; Toscano-Silva M, 2010, PHYSIOL BEHAV, V101, P302, DOI 10.1016/j.physbeh.2010.05.012; Tremblay ME, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000527; Tronel S, 2010, P NATL ACAD SCI USA, V107, P7963, DOI 10.1073/pnas.0914613107; Van Leemput K, 2009, HIPPOCAMPUS, V19, P549, DOI 10.1002/hipo.20615; Wake H, 2011, SCIENCE, V333, P1647, DOI 10.1126/science.1206998; Wake H, 2009, J NEUROSCI, V29, P3974, DOI 10.1523/JNEUROSCI.4363-08.2009; Wang Xiaohai, 2009, V489, P93, DOI 10.1007/978-1-59745-543-5_5; Wedeen VJ, 2005, MAGN RESON MED, V54, P1377, DOI 10.1002/mrm.20642; Wong PCM, 2008, CEREB CORTEX, V18, P828, DOI 10.1093/cercor/bhm115; Wright IC, 1995, NEUROIMAGE, V2, P244, DOI 10.1006/nimg.1995.1032; Xiao JH, 2010, NEUROSIGNALS, V18, P186, DOI 10.1159/000323170; Yang G, 2009, NATURE, V462, P920, DOI 10.1038/nature08577; Yasuda M, 2011, NEURON, V70, P1128, DOI 10.1016/j.neuron.2011.04.027; Ziskin JL, 2007, NAT NEUROSCI, V10, P321, DOI 10.1038/nn1854	100	1022	1038	9	216	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	APR	2012	15	4					528	536		10.1038/nn.3045	http://dx.doi.org/10.1038/nn.3045			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	916PA	22426254	Green Accepted			2022-12-28	WOS:000302114500010
J	Sato, TK; Hausser, M; Carandini, M				Sato, Tatsuo K.; Haeusser, Michael; Carandini, Matteo			Distal connectivity causes summation and division across mouse visual cortex	NATURE NEUROSCIENCE			English	Article							HORIZONTAL CONNECTIONS; SPATIAL SUMMATION; CORTICOCORTICAL CONNECTIONS; CIRCUIT; V1; FEEDFORWARD; RESPONSES; NEURONS; AREAS	Neurons in different locations across the cortex are connected through polysynaptic networks involving both excitation and inhibition. To probe the functional effect of such networks, we used optogenetic stimulation to trigger antidromic spikes in a local region of primary visual cortex (V1). This local activity had two effects at distal V1 locations: summation and division. The balance between the two depended on visual contrast, and a normalization model precisely captured these effects.	[Sato, Tatsuo K.; Carandini, Matteo] UCL, UCL Inst Ophthalmol, London, England; [Haeusser, Michael] UCL, Wolfson Inst Biomed Res, London, England; [Haeusser, Michael] UCL, Dept Neurosci Physiol & Pharmacol, London, England	University of London; University College London; University of London; University College London; University of London; University College London	Sato, TK (corresponding author), UCL, UCL Inst Ophthalmol, London, England.	t.sato@ucl.ac.uk	Carandini, Matteo/ABD-8296-2021; Hausser, Michael/AAW-6827-2020; Sato, Tatsuo/AAC-2729-2019	Carandini, Matteo/0000-0003-4880-7682; Hausser, Michael/0000-0002-2673-8957; Sato, Tatsuo/0000-0002-1279-5125	Medical Research Council; Gatsby Charitable Foundation; European Research Council; Wellcome Trust	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Gatsby Charitable Foundation; European Research Council(European Research Council (ERC)European Commission); Wellcome Trust(Wellcome Trust)	We thank T, Hosoya and H. Maruoka for training us in in utero electroporation, A. Benucci for help with intrinsic imaging, S. Kadir, M. Krumin, N. Dhruv and K. Harris for help with spike sorting, C. Reddy, B. Haider, J. Cottam, I. Smith, M. Rizzi and members of the laboratory of R. Ali for technical help, K. Svoboda (Howard Hughes Medical Institute, Janelia Farm) for the gift of pCAGGS-ChR2-Venus, H. Kawasaki (Tokyo University) for the gift of pCAG-mCherry, and M. Scanziani and members of our laboratories for helpful suggestions. This work was supported by the Medical Research Council, the Gatsby Charitable Foundation, the European Research Council and the Wellcome Trust. M.C. holds the GlaxoSmithKline/Fight for Sight chair in Visual Neuroscience.	Adesnik H, 2012, NATURE, V490, P226, DOI 10.1038/nature11526; Adesnik H, 2010, NATURE, V464, P1155, DOI 10.1038/nature08935; Anderson JC, 2009, J NEUROSCI, V29, P11283, DOI 10.1523/JNEUROSCI.5757-08.2009; Angelucci A, 2006, PROG BRAIN RES, V154, P93, DOI 10.1016/S0079-6123(06)54005-1; Bosking WH, 1997, J NEUROSCI, V17, P2112; Carandini M, 2012, NAT REV NEUROSCI, V13, P51, DOI 10.1038/nrn3136; Dong HW, 2004, J COMP NEUROL, V475, P361, DOI 10.1002/cne.20164; GILBERT CD, 1989, J NEUROSCI, V9, P2432; HIRSCH JA, 1991, J NEUROSCI, V11, P1800; Kapadia MK, 1999, P NATL ACAD SCI USA, V96, P12073, DOI 10.1073/pnas.96.21.12073; Lee JH, 2010, NATURE, V465, P788, DOI 10.1038/nature09108; Levitt JB, 1997, NATURE, V387, P73, DOI 10.1038/387073a0; MCGUIRE BA, 1991, J COMP NEUROL, V305, P370, DOI 10.1002/cne.903050303; Nauhaus I, 2009, NAT NEUROSCI, V12, P70, DOI 10.1038/nn.2232; Olavarria JF, 2003, J COMP NEUROL, V459, P156, DOI 10.1002/cne.10615; Petreanu L, 2007, NAT NEUROSCI, V10, P663, DOI 10.1038/nn1891; Polat U, 1998, NATURE, V391, P580, DOI 10.1038/35372; Sceniak MP, 1999, NAT NEUROSCI, V2, P733, DOI 10.1038/11197; Schuz A, 2006, CEREB CORTEX, V16, P1474, DOI 10.1093/cercor/bhj085; Somers DC, 1998, CEREB CORTEX, V8, P204, DOI 10.1093/cercor/8.3.204	20	40	40	0	18	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JAN	2014	17	1					30	32		10.1038/nn.3585	http://dx.doi.org/10.1038/nn.3585			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	281DL	24241394	Green Accepted			2022-12-28	WOS:000329080000010
J	Stopper, CM; Floresco, SB				Stopper, Colin M.; Floresco, Stan B.			What's better for me? Fundamental role for lateral habenula in promoting subjective decision biases	NATURE NEUROSCIENCE			English	Article							ROSTROMEDIAL TEGMENTAL NUCLEUS; MIDBRAIN DOPAMINE NEURONS; DEEP BRAIN-STIMULATION; REWARD; DEPRESSION; SIGNALS; AREA	The lateral habenula (LHb) is believed to convey an aversive or 'anti-reward' signal, but its contribution to reward-related action selection is unknown. We found that LHb inactivation abolished choice biases, making rats indifferent when choosing between rewards associated with different subjective costs and magnitudes, but not larger or smaller rewards of equal cost. Thus, instead of serving as an aversion center, the evolutionarily conserved LHb acts as a preference center that is integral for expressing subjective decision biases.	[Floresco, Stan B.] Univ British Columbia, Dept Psychol, Vancouver, BC, Canada; Univ British Columbia, Brain Res Ctr, Vancouver, BC V5Z 1M9, Canada	University of British Columbia; University of British Columbia	Floresco, SB (corresponding author), Univ British Columbia, Dept Psychol, Vancouver, BC, Canada.	floresco@psych.ubc.ca	Floresco, Stan B/F-8160-2012	Floresco, Stan B/0000-0002-5633-243X	Canadian Institutes of Health Research [MOP 89861]; Michael Smith Foundation for Heath Research	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Michael Smith Foundation for Heath Research(Michael Smith Foundation for Health Research)	We are indebted to D. Montes, C. Wiedman, M Tse, G. Dalton and P. Piantadosi for their outstanding technical support. This work was supported by a grant from the Canadian Institutes of Health Research (MOP 89861) to S.B.F. S.B.F. receives funding from the Michael Smith Foundation for Heath Research.	Barrot M, 2012, J NEUROSCI, V32, P14094, DOI 10.1523/JNEUROSCI.3370-12.2012; Bromberg-Martin ES, 2011, NAT NEUROSCI, V14, P1209, DOI 10.1038/nn.2902; Bromberg-Martin ES, 2010, NEURON, V68, P815, DOI 10.1016/j.neuron.2010.11.022; Bromberg-Martin ES, 2010, J NEUROPHYSIOL, V104, P1068, DOI 10.1152/jn.00158.2010; Floresco SB, 2008, COGN AFFECT BEHAV NE, V8, P375, DOI 10.3758/CABN.8.4.375; Hikosaka O, 2008, J NEUROSCI, V28, P11825, DOI 10.1523/JNEUROSCI.3463-08.2008; Jhou TC, 2009, NEURON, V61, P786, DOI 10.1016/j.neuron.2009.02.001; Jhou TC, 2009, J COMP NEUROL, V513, P566, DOI 10.1002/cne.21891; Ji HF, 2007, J NEUROSCI, V27, P6923, DOI 10.1523/JNEUROSCI.0958-07.2007; Lammel S, 2012, NATURE, V491, P212, DOI 10.1038/nature11527; Lecourtier L, 2008, EUR J NEUROSCI, V27, P1755, DOI 10.1111/j.1460-9568.2008.06130.x; Matsumoto M, 2007, NATURE, V447, P1111, DOI 10.1038/nature05860; Matsumoto M, 2009, NAT NEUROSCI, V12, P77, DOI 10.1038/nn.2233; Meng HM, 2011, BRAIN RES, V1422, P32, DOI 10.1016/j.brainres.2011.08.041; SALAMONE JD, 1994, BEHAV BRAIN RES, V65, P221, DOI 10.1016/0166-4328(94)90108-2; Sartorius A, 2007, MED HYPOTHESES, V69, P1305, DOI 10.1016/j.mehy.2007.03.021; St Onge JR, 2012, J NEUROSCI, V32, P2886, DOI 10.1523/JNEUROSCI.5625-11.2012; St Onge JR, 2010, CEREB CORTEX, V20, P1816, DOI 10.1093/cercor/bhp250; St Onge JR, 2009, NEUROPSYCHOPHARMACOL, V34, P681, DOI 10.1038/npp.2008.121; Stamatakis AM, 2012, NAT NEUROSCI, V15, P1105, DOI 10.1038/nn.3145	20	80	81	0	12	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JAN	2014	17	1					33	35		10.1038/nn.3587	http://dx.doi.org/10.1038/nn.3587			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	281DL	24270185	Green Accepted			2022-12-28	WOS:000329080000011
J	Li, P; Du, F; Yuelling, LW; Lin, T; Muradimova, RE; Tricarico, R; Wang, J; Enikolopov, G; Bellacosa, A; Wechsler-Reya, RJ; Yang, ZJ				Li, Peng; Du, Fang; Yuelling, Larra W.; Lin, Tiffany; Muradimova, Renata E.; Tricarico, Rossella; Wang, Jun; Enikolopov, Grigori; Bellacosa, Alfonso; Wechsler-Reya, Robert J.; Yang, Zeng-jie			A population of Nestin-expressing progenitors in the cerebellum exhibits increased tumorigenicity	NATURE NEUROSCIENCE			English	Article							NEURAL STEM-CELLS; SONIC HEDGEHOG; MEDULLOBLASTOMA FORMATION; PRECURSOR PROLIFERATION; NEURONAL PROGENITORS; GENOME INSTABILITY; NERVOUS-SYSTEM; RHOMBIC-LIP; MOUSE; NEUROGENESIS	It is generally believed that cerebellar granule neurons originate exclusively from granule neuron precursors (GNPs) in the external germinal layer (EGL). Here we identified a rare population of neuronal progenitors in mouse developing cerebellum that expresses Nestin. Although Nestin is widely considered a marker for multipotent stem cells, these Nestin-expressing progenitors (NEPs) are committed to the granule neuron lineage. Unlike conventional GNPs, which reside in the outer EGL and proliferate extensively, NEPs reside in the deep part of the EGL and are quiescent. Expression profiling revealed that NEPs are distinct from GNPs and, in particular, express markedly reduced levels of genes associated with DNA repair. Consistent with this, upon aberrant activation of Sonic hedgehog (Shh) signaling, NEPs exhibited more severe genomic instability and gave rise to tumors more efficiently than GNPs. These studies revealed a previously unidentified progenitor for cerebellar granule neurons and a cell of origin for medulloblastoma.	[Li, Peng; Du, Fang; Yuelling, Larra W.; Muradimova, Renata E.; Tricarico, Rossella; Bellacosa, Alfonso; Yang, Zeng-jie] Temple Univ Hlth Syst, Fox Chase Canc Ctr, Canc Biol Program, Philadelphia, PA USA; [Li, Peng] Third Mil Med Univ, Dept Clin Biochem, Southwest Hosp, Chongqing, Peoples R China; [Lin, Tiffany; Wechsler-Reya, Robert J.] Duke Univ, Dept Pharmacol & Canc Biol, Med Ctr, Durham, NC 27710 USA; [Wang, Jun; Wechsler-Reya, Robert J.] Sanford Burnham Med Res Inst, Natl Canc Inst Designated Canc Ctr, Tumor Initiat & Maintenance Program, La Jolla, CA USA; [Enikolopov, Grigori] Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA	Fox Chase Cancer Center; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Army Medical University; Duke University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Sanford Burnham Prebys Medical Discovery Institute; Cold Spring Harbor Laboratory	Wechsler-Reya, RJ (corresponding author), Duke Univ, Dept Pharmacol & Canc Biol, Med Ctr, Durham, NC 27710 USA.	rwreya@sanfordburnham.org; zengjie.yang@fccc.edu	Enikolopov, Grigori/P-5731-2019	Enikolopov, Grigori/0000-0001-8178-8917; TRICARICO, ROSSELLA/0000-0001-7055-7208; Gordon, Renata/0000-0002-4495-045X	US National Institutes of Health Postdoctoral training [5T32CA009035-37]; US National Cancer institute [R01-CA178380, R0I-CAl22759]; US National Institutes of Health [U19-AI067798]; California Institute for Regenerative Medicine [LA1-01747]; NATIONAL CANCER INSTITUTE [R01CA178380, R01CA122759, T32CA009035, P30CA006927, R01CA078412] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI067798] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS052323] Funding Source: NIH RePORTER	US National Institutes of Health Postdoctoral training; US National Cancer institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); California Institute for Regenerative Medicine(California Institute for Regenerative Medicine); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank J. Oesterling for flow cytometric analysis; Z. Liu, J. Pei and J. Testa for cytogenetic analysis; A. Efimov for microscopy analysis; Q. Cai for histological analysis; R. Segal (Dana Farber Cancer Institute) for Zicl antibody; and D. Wiest, F. Roegiers and T. Yen for helpful discussions. This research was supported bythe W.W. Smith Charitable Trust (Z.Y.), a generous gift from Cathie and Pete Getchell (Z.Y.), a US National Institutes of Health Postdoctoral training grant (5T32CA009035-37, L.W.Y.), grants from the US National Cancer institute (R01-CA178380, Z.Y.; R0I-CAl22759, R.J.W.-R.), pilot funding from the US National Institutes of Health (U19-AI067798, R.J.W.-R.) and the California Institute for Regenerative Medicine (LA1-01747, R.J.W.-R.).	Aguilera A, 2008, NAT REV GENET, V9, P204, DOI 10.1038/nrg2268; Ahn S, 2005, NATURE, V437, P894, DOI 10.1038/nature03994; Alder J, 1996, NEURON, V17, P389, DOI 10.1016/S0896-6273(00)80172-5; ARUGA J, 1994, J NEUROCHEM, V63, P1880; Balordi F, 2007, J NEUROSCI, V27, P14248, DOI 10.1523/JNEUROSCI.4531-07.2007; Balordi F, 2007, J NEUROSCI, V27, P5936, DOI 10.1523/JNEUROSCI.1040-07.2007; Beer S, 2004, PLOS BIOL, V2, P1785, DOI 10.1371/journal.pbio.0020332; BenArie N, 1997, NATURE, V390, P169, DOI 10.1038/36579; Burhans WC, 2007, NUCLEIC ACIDS RES, V35, P7545, DOI 10.1093/nar/gkm1059; Ellis T, 2003, GENESIS, V36, P158, DOI 10.1002/gene.10208; Encinas JM, 2006, P NATL ACAD SCI USA, V103, P8233, DOI 10.1073/pnas.0601992103; Fernandez A, 2012, ONCOGENE, V31, P1923, DOI 10.1038/onc.2011.379; Fogarty MP, 2005, J NEUROBIOL, V64, P458, DOI 10.1002/neu.20166; Frappart PO, 2007, EMBO J, V26, P2732, DOI 10.1038/sj.emboj.7601703; Frappart PO, 2009, P NATL ACAD SCI USA, V106, P1880, DOI 10.1073/pnas.0806882106; Hyder CL, 2011, J CELL SCI, V124, P1363, DOI 10.1242/jcs.041244; Jasin M, 2000, CANCER INVEST, V18, P78, DOI 10.3109/07357900009023065; Kaye JA, 2004, CURR BIOL, V14, P2096, DOI 10.1016/j.cub.2004.10.051; Kenney AM, 2003, DEVELOPMENT, V130, P15, DOI 10.1242/dev.00182; Lee A, 2005, NAT NEUROSCI, V8, P723, DOI 10.1038/nn1473; Lee Y, 2002, CANCER RES, V62, P6395; LENDAHL U, 1990, CELL, V60, P585, DOI 10.1016/0092-8674(90)90662-X; Lombard DB, 2005, CELL, V120, P497, DOI 10.1016/j.cell.2005.01.028; Lumpkin EA, 2003, GENE EXPR PATTERNS, V3, P389, DOI 10.1016/S1567-133X(03)00089-9; Machold R, 2005, NEURON, V48, P17, DOI 10.1016/j.neuron.2005.08.028; Mao XH, 2001, BLOOD, V97, P324, DOI 10.1182/blood.V97.1.324; Mills J, 2006, J NEUROSCI, V26, P830, DOI 10.1523/JNEUROSCI.1852-05.2006; MORSHEAD CM, 1994, NEURON, V13, P1071, DOI 10.1016/0896-6273(94)90046-9; Nicot A, 2002, J NEUROSCI, V22, P9244; Oliver TG, 2005, DEVELOPMENT, V132, P2425, DOI 10.1242/dev.01793; Orford KW, 2008, NAT REV GENET, V9, P115, DOI 10.1038/nrg2269; Pazzaglia S, 2002, RADIAT RES, V158, P78, DOI 10.1667/0033-7587(2002)158[0078:TGCOCA]2.0.CO;2; Pazzaglia S, 2002, ONCOGENE, V21, P7580, DOI 10.1038/sj.onc.1205973; Pons S, 2001, DEVELOPMENT, V128, P1481; Rao G, 2004, ONCOGENE, V23, P6156, DOI 10.1038/sj.onc.1207818; Rao G, 2003, NEOPLASIA, V5, P198, DOI 10.1016/S1476-5586(03)80052-0; REYNOLDS BA, 1992, SCIENCE, V255, P1707, DOI 10.1126/science.1553558; Rios I, 2004, DEVELOPMENT, V131, P3159, DOI 10.1242/dev.01188; Schuller U, 2008, CANCER CELL, V14, P123, DOI 10.1016/j.ccr.2008.07.005; Shi HL, 2008, J COMP NEUROL, V508, P867, DOI 10.1002/cne.21719; Silbereis J, 2010, MOL CELL NEUROSCI, V44, P362, DOI 10.1016/j.mcn.2010.05.001; SOTELO C, 1994, J NEUROSCI, V14, P124; Sutter R, 2010, ONCOGENE, V29, P1845, DOI 10.1038/onc.2009.472; Tanori M, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-53; Uchida N, 2000, P NATL ACAD SCI USA, V97, P14720, DOI 10.1073/pnas.97.26.14720; Vintersten K, 2004, GENESIS, V40, P241, DOI 10.1002/gene.20095; Vukojevic K, 2010, GENE EXPR PATTERNS, V10, P144, DOI 10.1016/j.gep.2009.12.001; Wechsler-Reya RJ, 1999, NEURON, V22, P103, DOI 10.1016/S0896-6273(00)80682-0; Yang ZJ, 2008, CANCER CELL, V14, P135, DOI 10.1016/j.ccr.2008.07.003	49	78	78	0	18	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	DEC	2013	16	12					1737	1744		10.1038/nn.3553	http://dx.doi.org/10.1038/nn.3553			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	257VV	24141309	Green Accepted			2022-12-28	WOS:000327416800011
J	Burchell, VS; Nelson, DE; Sanchez-Martinez, A; Delgado-Camprubi, M; Ivatt, RM; Pogson, JH; Randle, SJ; Wray, S; Lewis, PA; Houlden, H; Abramov, AY; Hardy, J; Wood, NW; Whitworth, AJ; Laman, H; Plun-Favreau, H				Burchell, Victoria S.; Nelson, David E.; Sanchez-Martinez, Alvaro; Delgado-Camprubi, Marta; Ivatt, Rachael M.; Pogson, Joe H.; Randle, Suzanne J.; Wray, Selina; Lewis, Patrick A.; Houlden, Henry; Abramov, Andrey Y.; Hardy, John; Wood, Nicholas W.; Whitworth, Alexander J.; Laman, Heike; Plun-Favreau, Helene			The Parkinson's disease-linked proteins Fbxo7 and Parkin interact to mediate mitophagy	NATURE NEUROSCIENCE			English	Article							F-BOX PROTEIN; MITOCHONDRIAL PATHOLOGY; MONITORING AUTOPHAGY; TARGETING SEQUENCES; PYRAMIDAL SYNDROME; DROSOPHILA; PINK1; COMPLEX; CELLS; PROTEASOME	Compelling evidence indicates that two autosomal recessive Parkinson's disease genes, PINK1 (PARK6) and Parkin (PARK2), cooperate to mediate the autophagic clearance of damaged mitochondria (mitophagy). Mutations in the F-box domain-containing protein Fbxo7 (encoded by PARK15) also cause early-onset autosomal recessive Parkinson's disease, by an unknown mechanism. Here we show that Fbxo7 participates in mitochondrial maintenance through direct interaction with PINK1 and Parkin and acts in Parkin-mediated mitophagy. Cells with reduced Fbxo7 expression showed deficiencies in translocation of Parkin to mitochondria, ubiquitination of mitofusin 1 and mitophagy. In Drosophila, ectopic overexpression of Fbxo7 rescued loss of Parkin, supporting a functional relationship between the two proteins. Parkinson's disease-causing mutations in Fbxo7 interfered with this process, emphasizing the importance of mitochondrial dysfunction in Parkinson's disease pathogenesis.	[Burchell, Victoria S.; Delgado-Camprubi, Marta; Wray, Selina; Lewis, Patrick A.; Houlden, Henry; Abramov, Andrey Y.; Hardy, John; Wood, Nicholas W.; Plun-Favreau, Helene] UCL, Inst Neurol, Dept Mol Neurosci, London, England; [Nelson, David E.; Randle, Suzanne J.; Laman, Heike] Univ Cambridge, Dept Pathol, Cambridge CB2 1QP, England; [Sanchez-Martinez, Alvaro; Ivatt, Rachael M.; Pogson, Joe H.; Whitworth, Alexander J.] Ctr Dev & Biomed Genet, MRC, Sheffield, S Yorkshire, England; [Sanchez-Martinez, Alvaro; Ivatt, Rachael M.; Pogson, Joe H.; Whitworth, Alexander J.] Univ Sheffield, Dept Biomed Sci, Sheffield S10 2TN, S Yorkshire, England	University of London; University College London; University of Cambridge; University of Sheffield	Plun-Favreau, H (corresponding author), UCL, Inst Neurol, Dept Mol Neurosci, London, England.	a.whitworth@sheffield.ac.uk; hl316@cam.ac.uk; h.plun-favreau@ucl.ac.uk	Plun-Favreau, Helene/Q-4111-2016; Wray, Selina/C-3682-2009; Lewis, Patrick A./C-3674-2009; Abramov, Andrey Y/H-9053-2012; Nelson, David/AAX-5648-2021; Sanchez-Martinez, Alvaro/L-3851-2019; Houlden, Henry J/C-1532-2008; Wood, Nicholas W/C-2505-2009; Abramov, Andrey/AAC-6712-2019; Sanchez-Martinez, Alvaro/L-1395-2013; Hardy, John/C-2451-2009	Plun-Favreau, Helene/0000-0002-1401-9656; Wray, Selina/0000-0003-3062-7050; Abramov, Andrey Y/0000-0002-7646-7235; Nelson, David/0000-0002-5034-0885; Sanchez-Martinez, Alvaro/0000-0002-2728-6251; Houlden, Henry J/0000-0002-2866-7777; Wood, Nicholas W/0000-0002-9500-3348; Abramov, Andrey/0000-0002-7646-7235; Hardy, John/0000-0002-3122-0423; Laman, Heike/0000-0002-6089-171X; Whitworth, Alexander/0000-0002-1154-6629; Lewis, Patrick/0000-0003-4537-0489	Wellcome/Medical Research Council (MRC) Parkinson's Disease Consortium grant; MRC Protein Phosphorylation Unit at the University of Dundee [WT089698]; MRC Career Development Award [G0700183]; European Union; ERC Starting Grant [309742]; UK National Institute for Health Research University College London Hospitals Biomedical Research Centre; MRC Doctoral Training Account; Biotechnology and Biological Sciences Research Council [BB/F012764/1, BB/J007846/1]; University of Sheffield;  [G070091]; BBSRC [BB/J007846/1] Funding Source: UKRI; MRC [MC_G1000735, MR/J004758/1, G0701075, G0802760, G108/638, G0700183, G1001253] Funding Source: UKRI; Medical Research Council [G0802760, G0700183, G1001253, MR/J004758/1, G0701075, MC_G1000735, G108/638, G0700091B] Funding Source: researchfish; National Institute for Health Research [NF-SI-0507-10376] Funding Source: researchfish; Parkinson&quot;s UK [F-1002, H-1006] Funding Source: researchfish	Wellcome/Medical Research Council (MRC) Parkinson's Disease Consortium grant(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC Protein Phosphorylation Unit at the University of Dundee(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC Career Development Award(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); European Union(European Commission); ERC Starting Grant(European Research Council (ERC)); UK National Institute for Health Research University College London Hospitals Biomedical Research Centre; MRC Doctoral Training Account(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); University of Sheffield; ; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); Parkinson&quot;s UK(Parkinson&apos;s UK)	We would like to thank M. Mehrabian and E. Elahi for obtaining patient biopsies, H. Ardley (Leeds Institute of Molecular Medicine) for donating the Flag-Parkin construct and cell line, K. Holmstrpom and A. Isaacs for discussions and M. Gegg for technical advice. We thank C. Hill for technical assistance within the University of Sheffield Electron Microscopy Facility. We thank the H. Steller (Rockefeller University) laboratory for kind provision of the ntc mutant lines. The work was funded by a Wellcome/Medical Research Council (MRC) Parkinson's Disease Consortium grant to the University College London Institute of Neurology, the University of Sheffield and the MRC Protein Phosphorylation Unit at the University of Dundee (grant number WT089698), an MRC Career Development Award (G0700183; H.P.-F.), the MEFOPA project funded through the European Union FP7 research program (A.J.W.), and an ERC Starting Grant (no. 309742; A.J.W.). This research was supported by the UK National Institute for Health Research University College London Hospitals Biomedical Research Centre. V.S.B. is funded by the MRC Doctoral Training Account. D.E.N. is funded by the Biotechnology and Biological Sciences Research Council (BB/F012764/1; BB/J007846/1). The Wellcome Trust is acknowledged for support of the Sheffield Light Microscopy Facility (GR077544AIA). The MRC Centre for Developmental and Biomedical Genetics is supported by grant G070091.	Ardley HC, 2003, MOL BIOL CELL, V14, P4541, DOI 10.1091/mbc.E03-02-0078; Bader M, 2011, CELL, V145, P371, DOI 10.1016/j.cell.2011.03.021; Bader M, 2010, DEVELOPMENT, V137, P1679, DOI 10.1242/dev.050088; Chang YF, 2006, BIOCHEM BIOPH RES CO, V342, P1022, DOI 10.1016/j.bbrc.2006.02.061; Clark IE, 2006, NATURE, V441, P1162, DOI 10.1038/nature04779; Claros MG, 1996, EUR J BIOCHEM, V241, P779, DOI 10.1111/j.1432-1033.1996.00779.x; Deas E, 2011, BBA-MOL CELL RES, V1813, P623, DOI 10.1016/j.bbamcr.2010.08.007; Di Fonzo A, 2009, NEUROLOGY, V72, P240, DOI 10.1212/01.wnl.0000338144.10967.2b; Dickins RA, 2005, NAT GENET, V37, P1289, DOI 10.1038/ng1651; Ding WX, 2010, J BIOL CHEM, V285, P27879, DOI 10.1074/jbc.M110.119537; Exner N, 2007, J NEUROSCI, V27, P12413, DOI 10.1523/JNEUROSCI.0719-07.2007; Gegg ME, 2010, HUM MOL GENET, V19, P4861, DOI 10.1093/hmg/ddq419; Geisler S, 2010, NAT CELL BIOL, V12, P119, DOI 10.1038/ncb2012; Greene JC, 2003, P NATL ACAD SCI USA, V100, P4078, DOI 10.1073/pnas.0737556100; Hsu JM, 2004, J BIOL CHEM, V279, P32592, DOI 10.1074/jbc.M404950200; Jin SM, 2010, J CELL BIOL, V191, P933, DOI 10.1083/jcb.201008084; Kirk R, 2008, J BIOL CHEM, V283, P22325, DOI 10.1074/jbc.M709900200; Klionsky DJ, 2008, AUTOPHAGY, V4, P151, DOI 10.4161/auto.5338; Klionsky DJ, 2012, AUTOPHAGY, V8, P445, DOI 10.4161/auto.19496; Kondapalli C, 2012, OPEN BIOL, V2, DOI 10.1098/rsob.120080; Kuiken HJ, 2012, J CELL MOL MED, V16, P2140, DOI 10.1111/j.1582-4934.2012.01524.x; Laman H, 2005, EMBO J, V24, P3104, DOI 10.1038/sj.emboj.7600775; Lee SJ, 2010, EMBO REP, V11, P226, DOI 10.1038/embor.2010.7; NAKAI K, 1992, GENOMICS, V14, P897, DOI 10.1016/S0888-7543(05)80111-9; Narendra D, 2008, J CELL BIOL, V183, P795, DOI 10.1083/jcb.200809125; Narendra DP, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000298; Nelson DE, 2011, J BIOL CHEM, V286, P19804, DOI 10.1074/jbc.M111.220079; Paisan-Ruiz C, 2010, MOVEMENT DISORD, V25, P1791, DOI 10.1002/mds.23221; Park J, 2006, NATURE, V441, P1157, DOI 10.1038/nature04788; Plun-Favreau H, 2007, NAT CELL BIOL, V9, P1243, DOI 10.1038/ncb1644; Poole AC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010054; Rakovic A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016746; Samali A, 1999, EMBO J, V18, P2040, DOI 10.1093/emboj/18.8.2040; Sarraf SA, 2013, NATURE, V496, P372, DOI 10.1038/nature12043; Shojaee S, 2008, AM J HUM GENET, V82, P1375, DOI 10.1016/j.ajhg.2008.05.005; Skowyra D, 1997, CELL, V91, P209, DOI 10.1016/S0092-8674(00)80403-1; Small I, 2004, PROTEOMICS, V4, P1581, DOI 10.1002/pmic.200300776; Song S, 2013, J BIOL CHEM, V288, P5660, DOI 10.1074/jbc.M112.430801; Sullivan W., 2000, DROSOPHILA PROTOCOLS, P240; Tain LS, 2009, CELL DEATH DIFFER, V16, P1118, DOI 10.1038/cdd.2009.23; Tanaka A, 2010, J CELL BIOL, V191, P1367, DOI 10.1083/jcb.201007013; Tanaka A, 2010, FEBS LETT, V584, P1386, DOI 10.1016/j.febslet.2010.02.060; Vives-Bauza C, 2010, P NATL ACAD SCI USA, V107, P378, DOI 10.1073/pnas.0911187107; Whitworth AJ, 2005, P NATL ACAD SCI USA, V102, P8024, DOI 10.1073/pnas.0501078102; Whitworth AJ, 2008, DIS MODEL MECH, V1, P168, DOI 10.1242/dmm.000109; Yang YF, 2006, P NATL ACAD SCI USA, V103, P10793, DOI 10.1073/pnas.0602493103; Ziviani E, 2010, P NATL ACAD SCI USA, V107, P5018, DOI 10.1073/pnas.0913485107	47	213	219	1	54	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	SEP	2013	16	9					1257	U135		10.1038/nn.3489	http://dx.doi.org/10.1038/nn.3489			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	207KN	23933751	Green Accepted, Green Submitted			2022-12-28	WOS:000323597500017
J	Polack, PO; Friedman, J; Golshani, P				Polack, Pierre-Olivier; Friedman, Jonathan; Golshani, Peyman			Cellular mechanisms of brain state-dependent gain modulation in visual cortex	NATURE NEUROSCIENCE			English	Article							BASAL FOREBRAIN; BARREL CORTEX; GABAERGIC NEURONS; BEHAVIORAL STATE; ACETYLCHOLINE; ACTIVATION; NOREPINEPHRINE; OSCILLATIONS; SELECTIVITY; INHIBITION	Visual cortical neurons fire at higher rates to visual stimuli during locomotion than during immobility, while maintaining orientation selectivity. The mechanisms underlying this change in gain are not understood. We performed whole-cell recordings from layer 2/3 and layer 4 visual cortical excitatory neurons and from parvalbumin-positive and somatostatin-positive inhibitory neurons in mice that were free to rest or run on a spherical treadmill. We found that the membrane potential of all cell types became more depolarized and (with the exception of somatostatin-positive interneurons) less variable during locomotion. Cholinergic input was essential for maintaining the unimodal membrane potential distribution during immobility, whereas noradrenergic input was necessary for the tonic depolarization associated with locomotion. Our results provide a mechanism for how neuromodulation controls the gain and signal-to-noise ratio of visual cortical neurons during changes in the state of vigilance.	[Polack, Pierre-Olivier; Friedman, Jonathan; Golshani, Peyman] Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurol, Los Angeles, CA 90095 USA; [Polack, Pierre-Olivier; Golshani, Peyman] W Los Angeles Vet Affairs Med Ctr, Dept Neurol, Los Angeles, CA 90073 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Greater Los Angeles Healthcare System; West Los Angeles VA Medical Center	Golshani, P (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurol, Los Angeles, CA 90095 USA.	pgolshani@mednet.ucla.edu		Polack, Pierre-Olivier/0000-0003-1716-6595	US National Institutes of Health [KO8 NS0562101]; Whitehall Foundation [2012-05-83]; Veterans Affairs Merit Review Award [1I01BX001524-01A1]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH101198] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K08NS056210] Funding Source: NIH RePORTER; Veterans Affairs [I01BX001524] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Whitehall Foundation; Veterans Affairs Merit Review Award(US Department of Veterans Affairs); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Veterans Affairs(US Department of Veterans Affairs)	We acknowledge R. Gruver for technical assistance on visual stimulation, Z. Peng and C. Houser for histology, and D. Contreras, M. Einstein, T. Indersmitten, M. Javaherian, C. Kaba, S. Mahon, A. Silva and S. Singh for their thoughtful comments on the manuscript. This work was supported by the US National Institutes of Health (KO8 NS0562101), the Whitehall Foundation (grant 2012-05-83) and a Veterans Affairs Merit Review Award (1I01BX001524-01A1).	Alitto HJ, 2013, FRONT SYST NEUROSCI, V6, DOI 10.3389/fnsys.2012.00079; Anderson JS, 2000, SCIENCE, V290, P1968, DOI 10.1126/science.290.5498.1968; Aston-Jones G, 2005, ANNU REV NEUROSCI, V28, P403, DOI 10.1146/annurev.neuro.28.061604.135709; Atallah BV, 2012, NEURON, V73, P159, DOI 10.1016/j.neuron.2011.12.013; Bereshpolova Y, 2007, J NEUROSCI, V27, P9392, DOI 10.1523/JNEUROSCI.2218-07.2007; BERRIDGE CW, 1993, NEUROSCIENCE, V55, P381, DOI 10.1016/0306-4522(93)90507-C; Berridge CW, 2003, BRAIN RES REV, V42, P33, DOI 10.1016/S0165-0173(03)00143-7; Botly LCP, 2012, CEREB CORTEX, V22, P2441, DOI 10.1093/cercor/bhr331; Buchanan JAM, 1997, BRAIN RES, V771, P63, DOI 10.1016/S0006-8993(97)00778-6; Buzsaki G, 2004, SCIENCE, V304, P1926, DOI 10.1126/science.1099745; Chance FS, 2002, NEURON, V35, P773, DOI 10.1016/S0896-6273(02)00820-6; Constantinople CM, 2011, NEURON, V69, P1061, DOI 10.1016/j.neuron.2011.02.040; Crochet S, 2006, NAT NEUROSCI, V9, P608, DOI 10.1038/nn1690; Fellous JM, 2003, NEUROSCIENCE, V122, P811, DOI 10.1016/j.neuroscience.2003.08.027; FOOTE SL, 1980, P NATL ACAD SCI-BIOL, V77, P3033, DOI 10.1073/pnas.77.5.3033; Gentet LJ, 2012, NAT NEUROSCI, V15, P607, DOI 10.1038/nn.3051; Gentet LJ, 2010, NEURON, V65, P422, DOI 10.1016/j.neuron.2010.01.006; Goard M, 2009, NAT NEUROSCI, V12, P1444, DOI 10.1038/nn.2402; Gonchar Yuri, 2007, Front Neuroanat, V1, P3, DOI 10.3389/neuro.05.003.2007; Haider B, 2007, J NEUROPHYSIOL, V97, P4186, DOI 10.1152/jn.01114.2006; Harris KD, 2011, NAT REV NEUROSCI, V12, P509, DOI 10.1038/nrn3084; Hasenstaub A, 2005, NEURON, V47, P423, DOI 10.1016/j.neuron.2005.06.016; Hasenstaub A, 2007, J NEUROSCI, V27, P9607, DOI 10.1523/JNEUROSCI.2184-07.2007; Herrero JL, 2008, NATURE, V454, P1110, DOI 10.1038/nature07141; Kawaguchi Y, 1998, J NEUROSCI, V18, P6963; Keller GB, 2012, NEURON, V74, P809, DOI 10.1016/j.neuron.2012.03.040; Kirkwood A, 1999, J NEUROSCI, V19, P1599; Klinkenberg I, 2011, BEHAV BRAIN RES, V221, P430, DOI 10.1016/j.bbr.2010.11.033; Langlois M, 2010, J NEUROSCI, V30, P16523, DOI 10.1523/JNEUROSCI.1109-10.2010; Lee SH, 2012, NATURE, V488, P379, DOI 10.1038/nature11312; Madisen L, 2010, NAT NEUROSCI, V13, P133, DOI 10.1038/nn.2467; MCCORMICK DA, 1993, CEREB CORTEX, V3, P387, DOI 10.1093/cercor/3.5.387; MCCORMICK DA, 1992, PROG NEUROBIOL, V39, P337, DOI 10.1016/0301-0082(92)90012-4; METHERATE R, 1992, J NEUROSCI, V12, P4701; Mueller D, 2008, J NEUROSCI, V28, P369, DOI 10.1523/JNEUROSCI.3248-07.2008; MULLER CM, 1989, BRAIN RES, V487, P335, DOI 10.1016/0006-8993(89)90837-8; Niell CM, 2010, NEURON, V65, P472, DOI 10.1016/j.neuron.2010.01.033; Pologruto TA, 2003, BIOMED ENG ONLINE, V2, DOI 10.1186/1475-925X-2-13; Poulet JFA, 2008, NATURE, V454, P881, DOI 10.1038/nature07150; Ringach DL, 2009, CURR OPIN NEUROBIOL, V19, P439, DOI 10.1016/j.conb.2009.07.005; Ringach DL, 2002, J NEUROSCI, V22, P5639; Rodriguez R, 2010, NEUROSCIENCE, V165, P944, DOI 10.1016/j.neuroscience.2009.10.059; Sanchez-Vives MV, 2010, J NEUROPHYSIOL, V104, P1314, DOI 10.1152/jn.00178.2010; Sanchez-Vives MV, 2000, NAT NEUROSCI, V3, P1027, DOI 10.1038/79848; Sarter M, 2000, NEUROSCIENCE, V95, P933; SATO H, 1987, J NEUROPHYSIOL, V58, P781, DOI 10.1152/jn.1987.58.4.781; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Soma S, 2012, J NEUROPHYSIOL, V107, P283, DOI 10.1152/jn.00330.2011; Steriade M, 2000, NEUROSCIENCE, V101, P243, DOI 10.1016/S0306-4522(00)00353-5; STERIADE M, 1993, J NEUROPHYSIOL, V70, P1385, DOI 10.1152/jn.1993.70.4.1385; Szuts TA, 2011, NAT NEUROSCI, V14, P263, DOI 10.1038/nn.2730; WANG Z, 1993, J NEUROSCI, V13, P2199; Wilson NR, 2012, NATURE, V488, P343, DOI 10.1038/nature11347	53	354	354	4	61	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	SEP	2013	16	9					1331	U227		10.1038/nn.3464	http://dx.doi.org/10.1038/nn.3464			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	207KN	23872595	Green Accepted, Green Submitted			2022-12-28	WOS:000323597500026
J	Yoon, KJ; Buice, MA; Barry, C; Hayman, R; Burgess, N; Fiete, IR				Yoon, KiJung; Buice, Michael A.; Barry, Caswell; Hayman, Robin; Burgess, Neil; Fiete, Ila R.			Specific evidence of low-dimensional continuous attractor dynamics in grid cells	NATURE NEUROSCIENCE			English	Article							PARAMETRIC WORKING-MEMORY; MEDIAL ENTORHINAL CORTEX; PERSISTENT ACTIVITY; PATH-INTEGRATION; HEAD-DIRECTION; OSCILLATORY INTERFERENCE; NEURAL INTEGRATOR; PREFRONTAL CORTEX; VISUAL-CORTEX; NETWORK MODEL	We examined simultaneously recorded spikes from multiple rat grid cells, to explain mechanisms underlying their activity. Among grid cells with similar spatial periods, the population activity was confined to lie close to a two-dimensional (2D) manifold: grid cells differed only along two dimensions of their responses and otherwise were nearly identical. Relationships between cell pairs were conserved despite extensive deformations of single-neuron responses. Results from novel environments suggest such structure is not inherited from hippocampal or external sensory inputs. Across conditions, cell-cell relationships are better conserved than responses of single cells. Finally, the system is continually subject to perturbations that, were the 2D manifold not attractive, would drive the system to inhabit a different region of state space than observed. These findings have strong implications for theories of grid-cell activity and substantiate the general hypothesis that the brain computes using low-dimensional continuous attractors.	[Yoon, KiJung; Buice, Michael A.; Fiete, Ila R.] Univ Texas Austin, Ctr Learning & Memory, Austin, TX 78712 USA; [Barry, Caswell; Burgess, Neil] UCL, Inst Cognit Neurosci, London, England; [Burgess, Neil] UCL, Inst Neurol, London, England; [Barry, Caswell; Hayman, Robin] UCL, Div Psychol & Language Sci, Inst Behav Neurosci, London, England	University of Texas System; University of Texas Austin; University of London; University College London; University of London; University College London; University of London; University College London	Fiete, IR (corresponding author), Univ Texas Austin, Ctr Learning & Memory, Austin, TX 78712 USA.	ilafiete@mail.clm.utexas.edu	Burgess, Neil/B-2420-2009	Burgess, Neil/0000-0003-0646-6584; Fiete, Ila/0000-0003-4738-2539	Sloan Foundation; Searle Scholar; McKnight Scholar; Wellcome Trust, UK; Office of Naval Research through ONR MURI [N00014-10-1-0936]; ONR-Young Investigator Program; MRC [G1000854] Funding Source: UKRI; Medical Research Council [G1000854] Funding Source: researchfish	Sloan Foundation(Alfred P. Sloan Foundation); Searle Scholar; McKnight Scholar; Wellcome Trust, UK(Wellcome Trust); Office of Naval Research through ONR MURI; ONR-Young Investigator Program; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We are grateful to D. Tank for insightful comments. We thank members of the Moser laboratory for public release of some of their data sets, which we used in this study. I. R. F. is funded as a Sloan Foundation Fellow, a Searle Scholar and a McKnight Scholar. We acknowledge funding from the Wellcome Trust, UK and the Office of Naval Research through ONR MURI N00014-10-1-0936 and the ONR-Young Investigator Program to I.R.F.	Aksay E, 2003, CEREB CORTEX, V13, P1173, DOI 10.1093/cercor/bhg099; Aksay E, 2001, NAT NEUROSCI, V4, P184, DOI 10.1038/84023; Artin M, 2011, ALGEBRA; Barry C, 2007, NAT NEUROSCI, V10, P682, DOI 10.1038/nn1905; Barry C, 2012, P NATL ACAD SCI USA, V109, P17687, DOI 10.1073/pnas.1209918109; BENYISHAI R, 1995, P NATL ACAD SCI USA, V92, P3844, DOI 10.1073/pnas.92.9.3844; BLAIR HT, 1995, J NEUROSCI, V15, P6260; Bonnevie T, 2013, NAT NEUROSCI, V16, P309, DOI 10.1038/nn.3311; Bostock E, 1991, Hippocampus, V1, P193, DOI 10.1002/hipo.450010207; Brandon MP, 2011, SCIENCE, V332, P595, DOI 10.1126/science.1201652; Burak Y, 2012, P NATL ACAD SCI USA, V109, P17645, DOI 10.1073/pnas.1117386109; Burak Y, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000291; Burgess N, 2007, HIPPOCAMPUS, V17, P801, DOI 10.1002/hipo.20327; CANNON SC, 1987, J NEUROPHYSIOL, V57, P1383, DOI 10.1152/jn.1987.57.5.1383; Couey JJ, 2013, NAT NEUROSCI, V16, P318, DOI 10.1038/nn.3310; Domnisoru C, 2013, NATURE, V495, P199, DOI 10.1038/nature11973; Fiete IR, 2008, J NEUROSCI, V28, P6858, DOI 10.1523/JNEUROSCI.5684-07.2008; Frank LM, 2004, J NEUROSCI, V24, P7681, DOI 10.1523/JNEUROSCI.1958-04.2004; Fuhs MC, 2006, J NEUROSCI, V26, P4266, DOI 10.1523/JNEUROSCI.4353-05.2006; Fyhn M, 2007, NATURE, V446, P190, DOI 10.1038/nature05601; Guanella A, 2007, INT J NEURAL SYST, V17, P231, DOI 10.1142/S0129065707001093; Hafting T, 2005, NATURE, V436, P801, DOI 10.1038/nature03721; HOPFIELD JJ, 1982, P NATL ACAD SCI-BIOL, V79, P2554, DOI 10.1073/pnas.79.8.2554; Karlsson MP, 2008, J NEUROSCI, V28, P14271, DOI 10.1523/JNEUROSCI.4261-08.2008; Langston RF, 2010, SCIENCE, V328, P1576, DOI 10.1126/science.1188210; Latham PE, 2003, J PHYSIOL-PARIS, V97, P683, DOI 10.1016/j.jphysparis.2004.01.022; MARKUS EJ, 1995, J NEUROSCI, V15, P7079; McNaughton BL, 2006, NAT REV NEUROSCI, V7, P663, DOI 10.1038/nrn1932; Miller P, 2003, CEREB CORTEX, V13, P1208, DOI 10.1093/cercor/bhg101; MORRIS RGM, 1981, LEARN MOTIV, V12, P239, DOI 10.1016/0023-9690(81)90020-5; MULLER RU, 1987, J NEUROSCI, V7, P1951; O'Keefe J, 2005, HIPPOCAMPUS, V15, P853, DOI 10.1002/hipo.20115; Pastoll H, 2013, NEURON, V77, P141, DOI 10.1016/j.neuron.2012.11.032; Ringach DL, 1997, NATURE, V387, P281, DOI 10.1038/387281a0; Romo R, 1999, NATURE, V399, P470, DOI 10.1038/20939; Samsonovich A, 1997, J NEUROSCI, V17, P5900; Sargolini F, 2006, SCIENCE, V312, P758, DOI 10.1126/science.1125572; Schmidt-Hieber C, 2013, NAT NEUROSCI, V16, P325, DOI 10.1038/nn.3340; Seung HS, 1996, P NATL ACAD SCI USA, V93, P13339, DOI 10.1073/pnas.93.23.13339; Seung HS, 2000, SCIENCE, V290, P2268, DOI 10.1126/science.290.5500.2268; Sreenivasan S, 2011, NAT NEUROSCI, V14, P1330, DOI 10.1038/nn.2901; Steele RJ, 1999, HIPPOCAMPUS, V9, P118, DOI 10.1002/(SICI)1098-1063(1999)9:2<118::AID-HIPO4>3.0.CO;2-8; Stensola H, 2012, NATURE, V492, P72, DOI 10.1038/nature11649; STEVENS CF, 1994, NATURE, V371, P704, DOI 10.1038/371704a0; TAUBE JS, 1990, J NEUROSCI, V10, P436; Welday AC, 2011, J NEUROSCI, V31, P16157, DOI 10.1523/JNEUROSCI.0712-11.2011; Welinder PE, 2008, HIPPOCAMPUS, V18, P1283, DOI 10.1002/hipo.20519; WILSON MA, 1993, SCIENCE, V261, P1055, DOI 10.1126/science.8351520; Zhang K, 1996, J NEUROSCI, V16, P2112	50	147	147	2	35	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	AUG	2013	16	8					1077	U141		10.1038/nn.3450	http://dx.doi.org/10.1038/nn.3450			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	190EV	23852111	Green Accepted			2022-12-28	WOS:000322323000018
J	Packer, AM; Roska, B; Hausser, M				Packer, Adam M.; Roska, Botond; Haeusser, Michael			Targeting neurons and photons for optogenetics	NATURE NEUROSCIENCE			English	Review							SINGLE-CELL ELECTROPORATION; IN-VIVO; GENE-EXPRESSION; NEURAL CIRCUITS; OPTICAL CONTROL; HIGH-SPEED; SYNAPTIC CONNECTIVITY; MILLISECOND-TIMESCALE; 2-PHOTON EXCITATION; TRANSGENIC MICE	Optogenetic approaches promise to revolutionize neuroscience by using light to manipulate neural activity in genetically or functionally defined neurons with millisecond precision. Harnessing the full potential of optogenetic tools, however, requires light to be targeted to the right neurons at the right time. Here we discuss some barriers and potential solutions to this problem. We review methods for targeting the expression of light-activatable molecules to specific cell types, under genetic, viral or activity-dependent control. Next we explore new ways to target light to individual neurons to allow their precise activation and inactivation. These techniques provide a precision in the temporal and spatial activation of neurons that was not achievable in previous experiments. In combination with simultaneous recording and imaging techniques, these strategies will allow us to mimic the natural activity patterns of neurons in vivo, enabling previously impossible 'dream experiments'.	[Packer, Adam M.; Haeusser, Michael] UCL, Wolfson Inst Biomed Res, London, England; [Packer, Adam M.; Haeusser, Michael] UCL, Dept Neurosci Physiol & Pharmacol, London, England; [Roska, Botond] Friedrich Miescher Inst Biomed Res, Neural Circuit Labs, Basel, Switzerland	University of London; University College London; University of London; University College London; Friedrich Miescher Institute for Biomedical Research	Roska, B (corresponding author), Friedrich Miescher Inst Biomed Res, Neural Circuit Labs, Basel, Switzerland.	botond.roska@fmi.ch; m.hausser@ucl.ac.uk	Hausser, Michael/AAW-6827-2020; Roska, Botond/AAD-7268-2021	Hausser, Michael/0000-0002-2673-8957; Packer, Adam/0000-0001-5884-794X	EMBO Long-Term Fellowship; Friedrich Miescher Institute; Alcon; European Research Council; European Union; Wellcome Trust; ERC; Gatsby Charitable Foundation	EMBO Long-Term Fellowship(European Molecular Biology Organization (EMBO)); Friedrich Miescher Institute; Alcon(Novartis); European Research Council(European Research Council (ERC)European Commission); European Union(European Commission); Wellcome Trust(Wellcome TrustEuropean Commission); ERC(European Research Council (ERC)European Commission); Gatsby Charitable Foundation	We are grateful to B. Clark, B. Judkewitz, D. Peterka, A. Roth, T. Sato, S. Smith, D. Sosulski, C. Wilms, K. Yonehara, R. Yuste and F. Zhang for discussions and for comments on the manuscript. We thank B. Judkewitz for help with Figure 4. This work was supported by an EMBO Long-Term Fellowship (A.M.P.) and by grants from the Friedrich Miescher Institute, Alcon, European Research Council and the European Union (B.R.) and from the Wellcome Trust, ERC and Gatsby Charitable Foundation (M.H.).	Akerboom J, 2013, FRONT MOL NEUROSCI, V6, DOI 10.3389/fnmol.2013.00002; Andrasfalvy BK, 2010, P NATL ACAD SCI USA, V107, P11981, DOI 10.1073/pnas.1006620107; Anikeeva P, 2012, NAT NEUROSCI, V15, P163, DOI 10.1038/nn.2992; Arlotta P, 2005, NEURON, V45, P207, DOI 10.1016/j.neuron.2004.12.036; Atasoy D, 2008, J NEUROSCI, V28, P7025, DOI 10.1523/JNEUROSCI.1954-08.2008; Bamann C, 2010, CURR OPIN NEUROBIOL, V20, P610, DOI 10.1016/j.conb.2010.07.003; Beier KT, 2013, J NEUROSCI, V33, P35, DOI 10.1523/JNEUROSCI.0245-12.2013; Beier KT, 2011, P NATL ACAD SCI USA, V108, P15414, DOI 10.1073/pnas.1110854108; Blumhagen F, 2011, NATURE, V479, P493, DOI 10.1038/nature10633; Boyden ES, 2005, NAT NEUROSCI, V8, P1263, DOI 10.1038/nn1525; Busskamp V, 2012, GENE THER, V19, P169, DOI 10.1038/gt.2011.155; Busskamp V, 2010, SCIENCE, V329, P413, DOI 10.1126/science.1190897; Calame M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023782; CALLAWAY EM, 1993, P NATL ACAD SCI USA, V90, P7661, DOI 10.1073/pnas.90.16.7661; Cardin JA, 2010, NAT PROTOC, V5, P247, DOI 10.1038/nprot.2009.228; Cardin JA, 2009, NATURE, V459, P663, DOI 10.1038/nature08002; Cavanaugh J, 2012, NEURON, V76, P901, DOI 10.1016/j.neuron.2012.10.016; Cohen JY, 2012, NATURE, V482, P85, DOI 10.1038/nature10754; Cronin J, 2005, CURR GENE THER, V5, P387, DOI 10.2174/1566523054546224; DeFelipe J., 2013, NAT REV NEUROSCI; DENK W, 1990, SCIENCE, V248, P73, DOI 10.1126/science.2321027; Diester I, 2011, NAT NEUROSCI, V14, P387, DOI 10.1038/nn.2749; Dymecki SM, 2010, METHOD ENZYMOL, V477, P183, DOI 10.1016/S0076-6879(10)77011-7; Enquist LW, 2003, CURR OPIN NEUROBIOL, V13, P603, DOI 10.1016/j.conb.2003.08.001; Farrow K, 2013, NEURON, V78, P325, DOI 10.1016/j.neuron.2013.02.014; Flusberg BA, 2008, NAT METHODS, V5, P935, DOI 10.1038/nmeth.1256; Foutz TJ, 2012, J NEUROPHYSIOL, V107, P3235, DOI 10.1152/jn.00501.2011; Fried SI, 2002, NATURE, V420, P411, DOI 10.1038/nature01179; Gerits A, 2012, CURR BIOL, V22, P1722, DOI 10.1016/j.cub.2012.07.023; Gradinaru V, 2010, CELL, V141, P154, DOI 10.1016/j.cell.2010.02.037; Grewe BF, 2010, NAT METHODS, V7, P399, DOI 10.1038/nmeth.1453; Guo ZV, 2009, NAT METHODS, V6, P891, DOI 10.1038/nmeth.1397; Han X, 2011, FRONT SYST NEUROSCI, V5, DOI 10.3389/fnsys.2011.00018; Han X, 2009, NEURON, V62, P191, DOI 10.1016/j.neuron.2009.03.011; Helmchen F, 2001, NEURON, V31, P903, DOI 10.1016/S0896-6273(01)00421-4; Hirase H, 2002, J NEUROBIOL, V51, P237, DOI 10.1002/neu.10056; Houweling AR, 2008, NATURE, V451, P65, DOI 10.1038/nature06447; Huber D, 2008, NATURE, V451, P61, DOI 10.1038/nature06445; Iwai Y, 2011, NEUROSCI RES, V70, P124, DOI 10.1016/j.neures.2011.01.007; Jazayeri M, 2012, NAT NEUROSCI, V15, P1368, DOI 10.1038/nn.3210; Jia N, 2012, P NATL ACAD SCI USA, V109, P22, DOI 10.1073/pnas.1109202108; Judkewitz B, 2009, NAT PROTOC, V4, P862, DOI 10.1038/nprot.2009.56; Katona G, 2012, NAT METHODS, V9, P201, DOI [10.1038/NMETH.1851, 10.1038/nmeth.1851]; Kienle E., 2012, JOVE-J VIS EXP, V62, P3819; Kirkby PA, 2010, OPT EXPRESS, V18, P13720, DOI 10.1364/OE.18.013720; Kitamura K, 2008, NAT METHODS, V5, P61, DOI 10.1038/NMETH1150; Kravitz AV, 2010, NATURE, V466, P622, DOI 10.1038/nature09159; LeChasseur Y, 2011, NAT METHODS, V8, P319, DOI 10.1038/NMETH.1572; Lee SH, 2012, NATURE, V488, P379, DOI 10.1038/nature11312; Leifer AM, 2011, NAT METHODS, V8, P147, DOI 10.1038/NMETH.1554; Lim DH, 2012, FRONT NEURAL CIRCUIT, V6, DOI 10.3389/fncir.2012.00011; Lima SQ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006099; Little JP, 2012, J NEUROSCI, V32, P12808, DOI 10.1523/JNEUROSCI.1616-12.2012; Liu X, 2012, NATURE, V484, P381, DOI 10.1038/nature11028; Lo LC, 2011, NEURON, V72, P938, DOI 10.1016/j.neuron.2011.12.002; Madisen L, 2012, NAT NEUROSCI, V15, P793, DOI 10.1038/nn.3078; Marshel JH, 2010, NEURON, V67, P562, DOI 10.1016/j.neuron.2010.08.001; Mattis J, 2012, NAT METHODS, V9, P159, DOI [10.1038/nmeth.1808, 10.1038/NMETH.1808]; Miesenbock G, 2009, SCIENCE, V326, P395, DOI 10.1126/science.1174520; Miyashita T, 2013, FRONT NEURAL CIRCUIT, V7, DOI 10.3389/fncir.2013.00008; Munch TA, 2009, NAT NEUROSCI, V12, P1308, DOI 10.1038/nn.2389; Nagel G, 2003, P NATL ACAD SCI USA, V100, P13940, DOI 10.1073/pnas.1936192100; Nikolenko V, 2008, FRONT NEURAL CIRCUIT, V2, DOI 10.3389/neuro.04.005.2008; Osakada F, 2011, NEURON, V71, P617, DOI 10.1016/j.neuron.2011.07.005; Packer AM, 2012, NAT METHODS, V9, P1202, DOI [10.1038/NMETH.2249, 10.1038/nmeth.2249]; Papagiakoumou E, 2013, NAT PHOTONICS, V7, P274, DOI [10.1038/nphoton.2013.9, 10.1038/NPHOTON.2013.9]; Papagiakoumou E, 2010, NAT METHODS, V7, P848, DOI [10.1038/NMETH.1505, 10.1038/nmeth.1505]; Peron S, 2011, NAT METHODS, V8, P30, DOI 10.1038/NMETH.F.325; Petreanu L., 2007, FRONT SYST NEUROSCI, V10, P663; Petreanu L, 2009, NATURE, V457, P1142, DOI 10.1038/nature07709; Prakash R, 2012, NAT METHODS, V9, P1171, DOI 10.1038/NMETH.2215; Reddy GD, 2008, NAT NEUROSCI, V11, P713, DOI 10.1038/nn.2116; Reijmers L, 2009, FRONT MOL NEUROSCI, V2, DOI 10.3389/neuro.02.027.2009; Reutsky-Gefen I, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2500; Rickgauer JP, 2009, P NATL ACAD SCI USA, V106, P15025, DOI 10.1073/pnas.0907084106; Royer S, 2012, NAT NEUROSCI, V15, P769, DOI 10.1038/nn.3077; Royer S, 2010, EUR J NEUROSCI, V31, P2279, DOI 10.1111/j.1460-9568.2010.07250.x; Scanziani M, 2009, NATURE, V461, P930, DOI 10.1038/nature08540; Schoenenberger P, 2011, EXP PHYSIOL, V96, P34, DOI 10.1113/expphysiol.2009.051219; Shepherd GMG, 2003, NEURON, V38, P277, DOI 10.1016/S0896-6273(03)00152-1; Siegert S, 2012, NAT NEUROSCI, V15, P487, DOI 10.1038/nn.3032; Stirman JN, 2011, NAT METHODS, V8, P153, DOI 10.1038/NMETH.1555; Stroh A, 2013, NEURON, V77, P1136, DOI 10.1016/j.neuron.2013.01.031; Theer P, 2006, J OPT SOC AM A, V23, P3139, DOI 10.1364/JOSAA.23.003139; Toledo-Rodriguez M, 2004, CEREB CORTEX, V14, P1310, DOI 10.1093/cercor/bhh092; Tripodi M, 2011, NATURE, V479, P61, DOI 10.1038/nature10538; Tye KM, 2012, NAT REV NEUROSCI, V13, P251, DOI 10.1038/nrn3171; Wall NR, 2010, P NATL ACAD SCI USA, V107, P21848, DOI 10.1073/pnas.1011756107; Wang H, 2007, P NATL ACAD SCI USA, V104, P8143, DOI 10.1073/pnas.0700384104; Wang X, 2012, NAT METHODS, V9, P266, DOI [10.1038/NMETH.1892, 10.1038/nmeth.1892]; Wickersham IR, 2007, NEURON, V53, P639, DOI 10.1016/j.neuron.2007.01.033; Wilson NR, 2012, NATURE, V488, P343, DOI 10.1038/nature11347; Xu W, 2013, SCIENCE, V339, P1290, DOI 10.1126/science.1229534; Yizhar O, 2011, NEURON, V71, P9, DOI 10.1016/j.neuron.2011.06.004; Yonehara K, 2011, NATURE, V469, P407, DOI 10.1038/nature09711; Zhang F, 2010, NAT PROTOC, V5, P439, DOI 10.1038/nprot.2009.226; Zhu PX, 2012, NAT PROTOC, V7, P1410, DOI 10.1038/nprot.2012.072; Zhu PX, 2009, FRONT NEURAL CIRCUIT, V3, DOI 10.3389/neuro.04.021.2009	98	224	260	6	263	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUL	2013	16	7					805	815		10.1038/nn.3427	http://dx.doi.org/10.1038/nn.3427			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	174UM	23799473	Green Accepted			2022-12-28	WOS:000321180900010
J	Schoenbaum, G; Esber, GR; Iordanova, MD				Schoenbaum, Geoffrey; Esber, Guillem R.; Iordanova, Mihaela D.			Dopamine signals mimic reward prediction errors	NATURE NEUROSCIENCE			English	Editorial Material							SUFFICIENT; RESPONSES; NEURONS	Modern theories of associative learning center on a prediction error. A study finds that artificial activation of dopamine neurons can substitute for missing reward prediction errors to rescue blocked learning.	[Schoenbaum, Geoffrey; Esber, Guillem R.] NIDA, Behav Neurosci Branch, Intramural Res Branch, US Natl Inst Hlth, Baltimore, MD USA; [Schoenbaum, Geoffrey] Univ Maryland, Sch Med, Dept Anat & Neurobiol, Baltimore, MD 21201 USA; [Iordanova, Mihaela D.] Univ Maryland Baltimore Cty, Dept Psychol, Baltimore, MD 21228 USA	National Institutes of Health (NIH) - USA; NIH National Institute on Drug Abuse (NIDA); University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore County	Schoenbaum, G (corresponding author), NIDA, Behav Neurosci Branch, Intramural Res Branch, US Natl Inst Hlth, Baltimore, MD USA.	geoffrey.schoenbaum@nih.gov	Esber, Guillem/AAL-9246-2020	Esber, Guillem/0000-0001-8874-4255; Iordanova, Mihaela/0000-0001-6232-448X	Intramural NIH HHS [ZIA DA000587-01, ZIA DA000587-02, Z99 DA999999] Funding Source: Medline; NATIONAL INSTITUTE ON DRUG ABUSE [ZIADA000587] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)		Adamantidis AR, 2011, J NEUROSCI, V31, P10829, DOI 10.1523/JNEUROSCI.2246-11.2011; Darvas M, 2009, P NATL ACAD SCI USA, V106, P14664, DOI 10.1073/pnas.0907299106; Iordanova MD, 2006, EUR J NEUROSCI, V24, P3265, DOI 10.1111/j.1460-9568.2006.05195.x; Kamin LJ, 1969, PUNISHMENT AVERSIVE, P242; Matsumoto M, 2009, NATURE, V459, P837, DOI 10.1038/nature08028; MIRENOWICZ J, 1994, J NEUROPHYSIOL, V72, P1024, DOI 10.1152/jn.1994.72.2.1024; PEARCE JM, 1980, PSYCHOL REV, V87, P532, DOI 10.1037/0033-295X.87.6.532; RAZRAN G, 1965, PSYCHOL BULL, V63, P42, DOI 10.1037/h0021566; Rescorla R.A., 1972, CLASSICAL CONDITION, P64, DOI DOI 10.1101/GR.110528.110; Schultz W, 1997, SCIENCE, V275, P1593, DOI 10.1126/science.275.5306.1593; Steinberg EE, 2013, NAT NEUROSCI, V16, P966, DOI 10.1038/nn.3413; SUTTON RS, 1981, PSYCHOL REV, V88, P135, DOI 10.1037/0033-295X.88.2.135; Takahashi YK, 2009, NEURON, V62, P269, DOI 10.1016/j.neuron.2009.03.005; Tsai HC, 2009, SCIENCE, V324, P1080, DOI 10.1126/science.1168878; Waelti P, 2001, NATURE, V412, P43, DOI 10.1038/35083500	15	4	4	0	25	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JUL	2013	16	7					777	779		10.1038/nn.3448	http://dx.doi.org/10.1038/nn.3448			4	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	174UM	23799468	Green Accepted			2022-12-28	WOS:000321180900005
J	Cukur, T; Nishimoto, S; Huth, AG; Gallant, JL				Cukur, Tolga; Nishimoto, Shinji; Huth, Alexander G.; Gallant, Jack L.			Attention during natural vision warps semantic representation across the human brain	NATURE NEUROSCIENCE			English	Article							PREFRONTAL CORTEX; SCENE CATEGORIZATION; NEURAL MECHANISMS; SPATIAL ATTENTION; VISUAL-CORTEX; V4 NEURONS; AREA V4; OBJECTS; SEARCH; IMAGES	Little is known about how attention changes the cortical representation of sensory information in humans. On the basis of neurophysiological evidence, we hypothesized that attention causes tuning changes to expand the representation of attended stimuli at the cost of unattended stimuli. To investigate this issue, we used functional magnetic resonance imaging to measure how semantic representation changed during visual search for different object categories in natural movies. We found that many voxels across occipito-temporal and fronto-parietal cortex shifted their tuning toward the attended category. These tuning shifts expanded the representation of the attended category and of semantically related, but unattended, categories, and compressed the representation of categories that were semantically dissimilar to the target. Attentional warping of semantic representation occurred even when the attended category was not present in the movie; thus, the effect was not a target-detection artifact. These results suggest that attention dynamically alters visual representation to optimize processing of behaviorally relevant objects during natural vision.	[Cukur, Tolga; Nishimoto, Shinji; Huth, Alexander G.; Gallant, Jack L.] Univ Calif Berkeley, Helen Wills Neurosci Inst, Berkeley, CA 94720 USA; [Gallant, Jack L.] Univ Calif Berkeley, Program Bioengn, Berkeley, CA 94720 USA; [Gallant, Jack L.] Univ Calif Berkeley, Dept Psychol, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California Berkeley	Gallant, JL (corresponding author), Univ Calif Berkeley, Helen Wills Neurosci Inst, Berkeley, CA 94720 USA.	gallant@berkeley.edu	Cukur, Tolga/Z-5452-2019	Cukur, Tolga/0000-0002-2296-851X; Nishimoto, Shinji/0000-0001-8015-340X	National Eye Institute [EY019684, EY022454]; Center for Science of Information; Center for Science of Information, a National Science Foundation Science and Technology Center [CCF-0939370]; NATIONAL EYE INSTITUTE [R01EY022454, R01EY019684] Funding Source: NIH RePORTER	National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Center for Science of Information; Center for Science of Information, a National Science Foundation Science and Technology Center; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	We thank D. Whitney for discussions regarding this manuscript. We also thank J. Gao, N. Bilenko, T. Naselaris, A. Vu and M. Oliver for their help in various aspects of this research. This work was supported by the National Eye Institute (EY019684 and EY022454) and the Center for Science of Information, a National Science Foundation Science and Technology Center, under grant agreement CCF-0939370.	Asaad WF, 2000, J NEUROPHYSIOL, V84, P451, DOI 10.1152/jn.2000.84.1.451; Bartels A, 2004, HUM BRAIN MAPP, V21, P75, DOI 10.1002/hbm.10153; Benjamini Y, 2001, ANN STAT, V29, P1165; Carter CS, 1998, SCIENCE, V280, P747, DOI 10.1126/science.280.5364.747; Conner CE, 1997, J NEUROSCI, V17, P3201; Corbetta M, 2002, NAT REV NEUROSCI, V3, P201, DOI 10.1038/nrn755; David SV, 2008, NEURON, V59, P509, DOI 10.1016/j.neuron.2008.07.001; David SV, 2005, NETWORK-COMP NEURAL, V16, P239, DOI 10.1080/09548980500464030; Hasson U, 2004, SCIENCE, V303, P1634, DOI 10.1126/science.1089506; Haxby JV, 2001, SCIENCE, V293, P2425, DOI 10.1126/science.1063736; Huth AG, 2012, NEURON, V76, P1210, DOI 10.1016/j.neuron.2012.10.014; Johnston K, 2006, J COGNITIVE NEUROSCI, V18, P749, DOI 10.1162/jocn.2006.18.5.749; Kay KN, 2008, NATURE, V452, P352, DOI 10.1038/nature06713; Li FF, 2002, P NATL ACAD SCI USA, V99, P9596, DOI 10.1073/pnas.092277599; Luck SJ, 1997, J NEUROPHYSIOL, V77, P24, DOI 10.1152/jn.1997.77.1.24; Mazer JA, 2003, NEURON, V40, P1241, DOI 10.1016/S0896-6273(03)00764-5; McAdams CJ, 1999, J NEUROSCI, V19, P431, DOI 10.1523/JNEUROSCI.19-01-00431.1999; MILLER GA, 1995, COMMUN ACM, V38, P39, DOI 10.1145/219717.219748; Mitchell TM, 2008, SCIENCE, V320, P1191, DOI 10.1126/science.1152876; Naselaris T, 2009, NEURON, V63, P902, DOI 10.1016/j.neuron.2009.09.006; Navalpakkam V, 2007, NEURON, V53, P605, DOI 10.1016/j.neuron.2007.01.018; Nishimoto S, 2011, CURR BIOL, V21, P1641, DOI 10.1016/j.cub.2011.08.031; O'Craven KM, 1999, NATURE, V401, P584, DOI 10.1038/44134; OLSHAUSEN BA, 1993, J NEUROSCI, V13, P4700; Peelen MV, 2009, NATURE, V460, P94, DOI 10.1038/nature08103; Reddy L, 2007, CURR BIOL, V17, P2067, DOI 10.1016/j.cub.2007.10.043; Reynolds JH, 2000, NEURON, V26, P703, DOI 10.1016/S0896-6273(00)81206-4; TURIN GL, 1960, IRE T INFORM THEOR, V6, P311, DOI 10.1109/TIT.1960.1057571; Warden MR, 2010, J NEUROSCI, V30, P15801, DOI 10.1523/JNEUROSCI.1569-10.2010; Womelsdorf T, 2006, NAT NEUROSCI, V9, P1156, DOI 10.1038/nn1748	30	199	199	2	59	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JUN	2013	16	6					763	+		10.1038/nn.3381	http://dx.doi.org/10.1038/nn.3381			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	152DE	23603707	Green Accepted, Green Submitted			2022-12-28	WOS:000319509600019
J	Lagier-Tourenne, C; Polymenidou, M; Hutt, KR; Vu, AQ; Baughn, M; Huelga, SC; Clutario, KM; Ling, SC; Liang, TY; Mazur, C; Wancewicz, E; Kim, AS; Watt, A; Freier, S; Hicks, GG; Donohue, JP; Shiue, L; Bennett, CF; Ravits, J; Cleveland, DW; Yeo, GW				Lagier-Tourenne, Clotilde; Polymenidou, Magdalini; Hutt, Kasey R.; Vu, Anthony Q.; Baughn, Michael; Huelga, Stephanie C.; Clutario, Kevin M.; Ling, Shuo-Chien; Liang, Tiffany Y.; Mazur, Curt; Wancewicz, Edward; Kim, Aneeza S.; Watt, Andy; Freier, Sue; Hicks, Geoffrey G.; Donohue, John Paul; Shiue, Lily; Bennett, C. Frank; Ravits, John; Cleveland, Don W.; Yeo, Gene W.			Divergent roles of ALS-linked proteins FUS/TLS and TDP-43 intersect in processing long pre-mRNAs	NATURE NEUROSCIENCE			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; FRONTOTEMPORAL LOBAR DEGENERATION; NEURODEGENERATIVE DISEASE; NASCENT TRANSCRIPTION; FAMILY PROTEINS; FUS PATHOLOGY; MUTATIONS; BINDING; GENE; BRAIN	FUS/TLS (fused in sarcoma/translocated in liposarcoma) and TDP-43 are integrally involved in amyotrophic lateral sclerosis (ALS) and frontotemporal dementia. We found that FUS/TLS binds to RNAs from >5,500 genes in mouse and human brain, primarily through a GUGGU-binding motif. We identified a sawtooth-like binding pattern, consistent with co-transcriptional deposition of FUS/TLS. Depletion of FUS/TLS from the adult nervous system altered the levels or splicing of >950 mRNAs, most of which are distinct from RNAs dependent on TDP-43. Abundance of only 45 RNAs was reduced after depletion of either TDP-43 or FUS/TLS from mouse brain, but among these were mRNAs that were transcribed from genes with exceptionally long introns and that encode proteins that are essential for neuronal integrity. Expression levels of a subset of these were lowered after TDP-43 or FUS/TLS depletion in stem cell derived human neurons and in TDP-43 aggregate containing motor neurons in sporadic ALS, supporting a common loss-of-function pathway as one component underlying motor neuron death from misregulation of TDP-43 or FUS/TLS.	[Lagier-Tourenne, Clotilde; Polymenidou, Magdalini; Clutario, Kevin M.; Ling, Shuo-Chien; Cleveland, Don W.] Univ Calif San Diego, Ludwig Inst Canc Res, La Jolla, CA 92093 USA; [Lagier-Tourenne, Clotilde; Polymenidou, Magdalini; Hutt, Kasey R.; Vu, Anthony Q.; Huelga, Stephanie C.; Clutario, Kevin M.; Ling, Shuo-Chien; Liang, Tiffany Y.; Cleveland, Don W.; Yeo, Gene W.] Univ Calif San Diego, Dept Cellular & Mol Med, La Jolla, CA 92093 USA; [Hutt, Kasey R.; Vu, Anthony Q.; Huelga, Stephanie C.; Liang, Tiffany Y.; Yeo, Gene W.] Univ Calif San Diego, Stem Cell Program, La Jolla, CA 92093 USA; [Hutt, Kasey R.; Vu, Anthony Q.; Huelga, Stephanie C.; Liang, Tiffany Y.; Yeo, Gene W.] Univ Calif San Diego, Inst Genom Med, La Jolla, CA 92093 USA; [Baughn, Michael; Ravits, John] Univ Calif San Diego, Dept Neurosci, La Jolla, CA 92093 USA; [Mazur, Curt; Wancewicz, Edward; Kim, Aneeza S.; Watt, Andy; Freier, Sue; Bennett, C. Frank] ISIS Pharmaceut, Carlsbad, CA 92008 USA; [Hicks, Geoffrey G.] Univ Manitoba, MB Inst Cell Biol, Winnipeg, MB, Canada; [Donohue, John Paul; Shiue, Lily] Univ Calif Santa Cruz, Sinsheimer Labs, Dept Mol Cell & Dev Biol, RNA Ctr, Santa Cruz, CA 95064 USA; [Yeo, Gene W.] Natl Univ Singapore, Dept Biol Sci, Singapore 117548, Singapore; [Yeo, Gene W.] ASTAR, Mol Engn Lab, Singapore, Singapore	Ludwig Institute for Cancer Research; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; Isis Pharmaceuticals Inc; University of Manitoba; University of California System; University of California Santa Cruz; National University of Singapore; Agency for Science Technology & Research (A*STAR)	Cleveland, DW (corresponding author), Univ Calif San Diego, Ludwig Inst Canc Res, La Jolla, CA 92093 USA.	dcleveland@ucsd.edu; geneyeo@ucsd.edu	lagier-Tourenne, Clotilde/ABE-6303-2020; Cleveland, Don/AAN-9783-2021; Polymenidou, Magdalini/D-2254-2014; Yeo, Gene/AAE-7676-2019	lagier-Tourenne, Clotilde/0000-0002-3058-8322; Yeo, Gene/0000-0002-0799-6037; Hicks, Geoffrey/0000-0003-4688-2312; LING, Shuo-Chien/0000-0002-0300-8812; Liang, Tiffany/0000-0002-1986-5966; Cleveland, Don/0000-0002-1934-3682; Baughn, Michael/0000-0001-8525-8024	US National Institutes of Health [R37NS27036, K99NS075216, HG004659, GM084317]; international Human Frontier Science Program Organization; Muscular Dystrophy Association; Amyotrophic Lateral Sclerosis Association; Ludwig Institute for Cancer Research; US National Science Foundation; US National Institute of Neurological Disorders and Stroke [R01NS075449]; California Institute for Regenerative Medicine [RB1-01413, RB3-05009]; Alfred P. Sloan Research Fellowship; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG004659] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM084317] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS075449, R01NS027036, R37NS027036, K99NS075216] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); international Human Frontier Science Program Organization(Human Frontier Science Program); Muscular Dystrophy Association(Muscular Dystrophy Association); Amyotrophic Lateral Sclerosis Association; Ludwig Institute for Cancer Research; US National Science Foundation(National Science Foundation (NSF)); US National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); California Institute for Regenerative Medicine(California Institute for Regenerative Medicine); Alfred P. Sloan Research Fellowship(Alfred P. Sloan Foundation); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The authors would like to thank members of B. Ren's laboratory, especially Z. Ye, S. Kuan, U. Wagner and L. Edsall, for technical help with the Illumina sequencing, M. Ares Jr. for generous support, as well as the members of the Yeo and Cleveland laboratories and the team at Isis Pharmaceuticals for critical comments and suggestions on this project. This work was supported by grants from the US National Institutes of Health (R37NS27036 to D.W.C. and K99NS075216 to M.P.). M.P. is the recipient of a long-term fellowship from the international Human Frontier Science Program Organization. C.L.-T. is the recipient of a Career Development Award from the Muscular Dystrophy Association and the Milton-Safenowitz post-doctoral fellowship from the Amyotrophic Lateral Sclerosis Association. D.W.C. receives salary support from the Ludwig Institute for Cancer Research. S.C.H. is funded by a US National Science Foundation Graduate Research Fellowship. This work was also supported by grant number R01NS075449 from the US National Institute of Neurological Disorders and Stroke, and seas partially supported by grants from the US National Institutes of Health (HG004659 and GM084317) and the California Institute for Regenerative Medicine (RB1-01413 and RB3-05009) to G.W.Y. G.W.Y. is a recipient of the Alfred P. Sloan Research Fellowship.	Ameur A, 2011, NAT STRUCT MOL BIOL, V18, P1435, DOI 10.1038/nsmb.2143; Arai T, 2006, BIOCHEM BIOPH RES CO, V351, P602, DOI 10.1016/j.bbrc.2006.10.093; Bertolotti A, 1998, MOL CELL BIOL, V18, P1489, DOI 10.1128/MCB.18.3.1489; Bodansky A, 2010, AMYOTROPH LATERAL SC, V11, P321, DOI 10.3109/17482961003602363; Colombrita C, 2012, J BIOL CHEM, V287, P15635, DOI 10.1074/jbc.M111.333450; Couthouis J, 2012, HUM MOL GENET, V21, P2899, DOI 10.1093/hmg/dds116; Couthouis J, 2011, P NATL ACAD SCI USA, V108, P20881, DOI 10.1073/pnas.1109434108; Da Cruz S, 2011, CURR OPIN NEUROBIOL, V21, P904, DOI 10.1016/j.conb.2011.05.029; Fujii R, 2005, CURR BIOL, V15, P587, DOI 10.1016/j.cub.2005.01.058; Gitcho MA, 2008, ANN NEUROL, V63, P535, DOI 10.1002/ana.21344; Goldberg MS, 2003, J BIOL CHEM, V278, P43628, DOI 10.1074/jbc.M308947200; Hicks GG, 2000, NAT GENET, V24, P175, DOI 10.1038/72842; Hoell JI, 2011, NAT STRUCT MOL BIOL, V18, P1428, DOI 10.1038/nsmb.2163; Huelga SC, 2012, CELL REP, V1, P167, DOI 10.1016/j.celrep.2012.02.001; Hutton M, 1998, NATURE, V393, P702, DOI 10.1038/31508; Ishigaki S, 2012, SCI REP-UK, V2, DOI 10.1038/srep00529; Itier JM, 2003, HUM MOL GENET, V12, P2277, DOI 10.1093/hmg/ddg239; Kabashi E, 2008, NAT GENET, V40, P572, DOI 10.1038/ng.132; Kitada T, 1998, NATURE, V392, P605, DOI 10.1038/33416; Kordasiewicz HB, 2012, NEURON, V74, P1031, DOI 10.1016/j.neuron.2012.05.009; Kwiatkowski TJ, 2009, SCIENCE, V323, P1205, DOI 10.1126/science.1166066; Lagier-Tourenne C, 2010, HUM MOL GENET, V19, pR46, DOI 10.1093/hmg/ddq137; Lerga A, 2001, J BIOL CHEM, V276, P6807, DOI 10.1074/jbc.M008304200; Lin SR, 2008, NAT STRUCT MOL BIOL, V15, P819, DOI 10.1038/nsmb.1461; Ling SC, 2010, P NATL ACAD SCI USA, V107, P13318, DOI 10.1073/pnas.1008227107; Liu BP, 2002, SCIENCE, V297, P1190, DOI 10.1126/science.1073031; Mackenzie IRA, 2011, ACTA NEUROPATHOL, V122, P87, DOI 10.1007/s00401-011-0838-7; Massone S, 2011, J CELL BIOL, V193, P851, DOI 10.1083/jcb.201011053; Mitchelmore C, 2004, NEUROBIOL DIS, V16, P48, DOI 10.1016/j.nbd.2004.01.003; Morohashi Y, 2002, J BIOL CHEM, V277, P14965, DOI 10.1074/jbc.M200897200; Munoz DG, 2009, ACTA NEUROPATHOL, V118, P617, DOI 10.1007/s00401-009-0598-9; Neumann M, 2006, SCIENCE, V314, P130, DOI 10.1126/science.1134108; Neumann M, 2011, BRAIN, V134, P2595, DOI 10.1093/brain/awr201; Neumann M, 2009, BRAIN, V132, P2922, DOI 10.1093/brain/awp214; Okuda T, 2008, J HISTOCHEM CYTOCHEM, V56, P175, DOI 10.1369/jhc.7A7323.2007; Polymenidou M, 2012, BRAIN RES, V1462, P3, DOI 10.1016/j.brainres.2012.02.059; Polymenidou M, 2011, NAT NEUROSCI, V14, P459, DOI 10.1038/nn.2779; Rabin SJ, 2010, HUM MOL GENET, V19, P313, DOI 10.1093/hmg/ddp498; Rogelj B, 2012, SCI REP-UK, V2, DOI 10.1038/srep00603; Smith RA, 2006, J CLIN INVEST, V116, P2290, DOI 10.1172/JCI25424; Sreedharan J, 2008, SCIENCE, V319, P1668, DOI 10.1126/science.1154584; Tan AY, 2012, P NATL ACAD SCI USA, V109, P6030, DOI 10.1073/pnas.1203028109; Ticozzi N, 2011, AM J MED GENET B, V156B, P285, DOI 10.1002/ajmg.b.31158; Tollervey JR, 2011, NAT NEUROSCI, V14, P452, DOI 10.1038/nn.2778; Trcek T, 2011, CELL, V147, P1484, DOI 10.1016/j.cell.2011.11.051; Vance C, 2009, SCIENCE, V323, P1208, DOI 10.1126/science.1165942; Wada Y, 2009, P NATL ACAD SCI USA, V106, P18357, DOI 10.1073/pnas.0902573106; Wang XT, 2008, NATURE, V454, P126, DOI 10.1038/nature06992; Woulfe J, 2010, BRAIN PATHOL, V20, P589, DOI 10.1111/j.1750-3639.2009.00337.x; Zhang CL, 2010, SCIENCE, V329, P439, DOI 10.1126/science.1191150	50	461	466	3	79	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	NOV	2012	15	11					1488	1497		10.1038/nn.3230	http://dx.doi.org/10.1038/nn.3230			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	028LX	23023293	Green Published, Green Accepted			2022-12-28	WOS:000310424900008
J	Wan, Q; Jiang, XY; Negroiu, AM; Lu, SG; Mckay, KS; Abrams, TW				Wan, Qin; Jiang, Xue-Ying; Negroiu, Andreea M.; Lu, Shao-Gang; Mckay, Kimberly S.; Abrams, Thomas W.			Protein kinase C acts as a molecular detector of firing patterns to mediate sensory gating in Aplysia	NATURE NEUROSCIENCE			English	Article							GILL-WITHDRAWAL REFLEX; RELATING CELLULAR EVENTS; PRESYNAPTIC FACILITATION; SENSORIMOTOR SYNAPSES; POSTTETANIC POTENTIATION; SYNAPTIC PLASTICITY; SIPHON-WITHDRAWAL; ISOFORM SPECIFICITY; ADENYLYL-CYCLASE; NEURONS	Habituation of a behavioral response to a repetitive stimulus enables animals to ignore irrelevant stimuli and focus on behaviorally important events. In Aplysia, habituation is mediated by rapid depression of sensory synapses, which could leave an animal unresponsive to important repetitive stimuli, making it vulnerable to injury. We identified a form of plasticity that prevents synaptic depression depending on the precise stimulus strength. Burst-dependent protection from depression is initiated by trains of 2-4 action potentials and is distinct from previously described forms of synaptic enhancement. The blockade of depression is mediated by presynaptic Ca2+ influx and protein kinase C (PKC) and requires localization of PKC via a PDZ domain interaction with Aplysia PICK1. During protection from depression, PKC acts as a highly sensitive detector of the precise pattern of sensory neuron firing. Behaviorally, burst-dependent protection reduces habituation, enabling animals to maintain responsiveness to stimuli that are functionally important.	[Wan, Qin; Jiang, Xue-Ying; Negroiu, Andreea M.; Lu, Shao-Gang; Abrams, Thomas W.] Univ Maryland, Sch Med, Dept Pharmacol, Baltimore, MD 21201 USA; [Mckay, Kimberly S.; Abrams, Thomas W.] Univ Maryland, Sch Med, Program Neurosci, Baltimore, MD 21201 USA	University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore	Abrams, TW (corresponding author), Univ Maryland, Sch Med, Dept Pharmacol, Baltimore, MD 21201 USA.	tabrams@umaryland.edu		Abrams, Tom/0000-0001-8929-978X	US National Institutes of Health [R01 MH-55880]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH055880] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank W. Sossin, S. Thompson and E. Walters for commenting on an earlier version of this manuscript. We thank P. Shrestha for performing the co-immunoprecipitation and immunoblot experiments. We thank I. Antonov and R. Hawkins for introducing us to their behavioral preparation. This work was supported by US National Institutes of Health grant R01 MH-55880 to T.W.A.	ADLER EM, 1991, J NEUROSCI, V11, P1496; Antonov I, 2003, NEURON, V37, P135, DOI 10.1016/S0896-6273(02)01129-7; Antonov I, 1999, J NEUROSCI, V19, P10438; Antonov I, 2007, J NEUROSCI, V27, P10993, DOI 10.1523/JNEUROSCI.2357-07.2007; BAILEY CH, 1988, J NEUROSCI, V8, P2452; Bao JX, 1997, SCIENCE, V275, P969, DOI 10.1126/science.275.5302.969; Bougie JK, 2009, J NEUROCHEM, V109, P1129, DOI 10.1111/j.1471-4159.2009.06045.x; BYRNE JH, 1982, J NEUROPHYSIOL, V48, P431, DOI 10.1152/jn.1982.48.2.431; Byrne JH, 1996, J NEUROSCI, V16, P425; CASTELLUCCI VF, 1974, P NATL ACAD SCI USA, V71, P5004, DOI 10.1073/pnas.71.12.5004; Cohen TE, 1997, J NEUROSCI, V17, P2886; DOMINGUEZ I, 1993, MOL CELL BIOL, V13, P1290, DOI 10.1128/MCB.13.2.1290; Dumitriu B, 2006, J NEUROPHYSIOL, V95, P2713, DOI 10.1152/jn.00642.2005; ELIOT LS, 1994, J NEUROSCI, V14, P3280; ELIOT LS, 1993, NATURE, V361, P634, DOI 10.1038/361634a0; Frost L, 1997, J NEUROSCI, V17, P2900; FROST WN, 1988, J NEUROBIOL, V19, P297, DOI 10.1002/neu.480190402; GINGRICH KJ, 1985, J NEUROPHYSIOL, V53, P652, DOI 10.1152/jn.1985.53.3.652; Gover TD, 2002, J NEUROSCI, V22, P1942, DOI 10.1523/JNEUROSCI.22-05-01942.2002; Guizzetti M, 2000, BIOCHEM PHARMACOL, V60, P1457, DOI 10.1016/S0006-2952(00)00468-8; HAWKINS RD, 1983, SCIENCE, V219, P400, DOI 10.1126/science.6294833; Illich PA, 1997, J NEUROSCI, V17, P459, DOI 10.1523/JNEUROSCI.17-01-00459.1997; JARRARD HE, 1993, BRAIN RES, V616, P188, DOI 10.1016/0006-8993(93)90209-6; Jiang XY, 1998, J NEUROSCI, V18, P10310; KLEIN M, 1980, J EXP BIOL, V89, P117; Knudsen EI, 2011, EUR J NEUROSCI, V33, P1961, DOI 10.1111/j.1460-9568.2011.07696.x; Kohout SC, 2002, BIOCHEMISTRY-US, V41, P11411, DOI 10.1021/bi026041k; KRUGER KE, 1991, J NEUROSCI, V11, P2303; Lin AH, 2010, P NATL ACAD SCI USA, V107, P15607, DOI 10.1073/pnas.1004451107; Manseau F, 2001, J NEUROSCI, V21, P1247; Marinesco S, 2002, J NEUROSCI, V22, P2299, DOI 10.1523/JNEUROSCI.22-06-02299.2002; Moore T, 2003, NATURE, V421, P370, DOI 10.1038/nature01341; Murphy GG, 1997, SCIENCE, V278, P467, DOI 10.1126/science.278.5337.467; Murphy GG, 1996, P NATL ACAD SCI USA, V93, P9931, DOI 10.1073/pnas.93.18.9931; Oancea E, 1998, CELL, V95, P307, DOI 10.1016/S0092-8674(00)81763-8; Pashler H, 2001, ANNU REV PSYCHOL, V52, P629, DOI 10.1146/annurev.psych.52.1.629; PINSKER H, 1970, SCIENCE, V167, P1740, DOI 10.1126/science.167.3926.1740; Royer S, 2000, J NEUROSCI, V20, P626, DOI 10.1523/JNEUROSCI.20-02-00626.2000; SIEGELBAUM SA, 1982, NATURE, V299, P413, DOI 10.1038/299413a0; Sossin WS, 2007, LEARN MEMORY, V14, P236, DOI 10.1101/lm.469707; SOSSIN WS, 1993, J BIOL CHEM, V268, P5763; Stark LL, 1996, J NEUROPHYSIOL, V75, P855, DOI 10.1152/jn.1996.75.2.855; Staudinger J, 1997, J BIOL CHEM, V272, P32019, DOI 10.1074/jbc.272.51.32019; Tang YG, 2000, BIOPHYS J, V78, P2735, DOI 10.1016/S0006-3495(00)76819-6; Tank DW, 1995, J NEUROSCI, V15, P7940; WALTERS ET, 1983, SCIENCE, V219, P405, DOI 10.1126/science.6294834; WALTERS ET, 1984, BRAIN RES, V293, P377, DOI 10.1016/0006-8993(84)91247-2; Winkowski DE, 2007, J NEUROSCI, V27, P13279, DOI 10.1523/JNEUROSCI.3937-07.2007; Zhao YL, 2006, J NEUROSCI, V26, P8847, DOI 10.1523/JNEUROSCI.1919-06.2006; Zhao YL, 2002, J NEUROSCI, V22, P10671; Zucker RS, 2002, ANNU REV PHYSIOL, V64, P355, DOI 10.1146/annurev.physiol.64.092501.114547	51	25	25	1	5	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	AUG	2012	15	8					1144	+		10.1038/nn.3158	http://dx.doi.org/10.1038/nn.3158			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	979UE	22772333	Green Accepted			2022-12-28	WOS:000306844500021
J	Dajas-Bailador, F; Bonev, B; Garcez, P; Stanley, P; Guillemot, F; Papalopulu, N				Dajas-Bailador, Federico; Bonev, Boyan; Garcez, Patricia; Stanley, Peter; Guillemot, Francois; Papalopulu, Nancy			microRNA-9 regulates axon extension and branching by targeting Map1b in mouse cortical neurons	NATURE NEUROSCIENCE			English	Article							LOCAL TRANSLATION; BDNF; POLARITY; PROTEIN	The capacity of neurons to develop a long axon and multiple dendrites defines neuron connectivity in the CNS. The highly conserved microRNA-9 (miR-9) is expressed in both neuronal precursors and some post-mitotic neurons, and we detected miR-9 expression in the axons of primary cortical neurons. We found that miR-9 controlled axonal extension and branching by regulating the levels of Map1b, an important protein for microtubule stability. Following microfluidic separation of the axon and the soma, we found that miR-9 repressed Map1b translation and was a functional target for the BDNF-dependent control of axon extension and branching. We propose that miR-9 links regulatory signaling processes with dynamic translation mechanisms, controlling Map 1b protein levels and axon development.	[Dajas-Bailador, Federico; Bonev, Boyan; Stanley, Peter; Papalopulu, Nancy] Univ Manchester, Fac Life Sci, Manchester, Lancs, England; [Garcez, Patricia; Guillemot, Francois] Natl Inst Med Res, Div Mol Neurobiol, London NW7 1AA, England	University of Manchester; MRC National Institute for Medical Research	Dajas-Bailador, F (corresponding author), Univ Manchester, Fac Life Sci, Michael Smith Bldg, Manchester, Lancs, England.	f.dajas-bailador@manchester.ac.uk; nancy.papalopulu@manchester.ac.uk	Guillemot, Francois/AAV-1482-2021; Garcez, Patricia/F-8026-2012; Neurociencia, Inct/I-1011-2013	Garcez, Patricia/0000-0002-9107-1335; Papalopulu, Nancy/0000-0001-6992-6870; Bonev, Boyan/0000-0002-7502-9399; Dajas-Bailador, Federico/0000-0002-2212-1482	Wellcome Trust [090868, GR083272]; Medical Research Council [G0900584]; MRC [MC_U117570528, G0900584] Funding Source: UKRI; Medical Research Council [MC_U117570528] Funding Source: researchfish	Wellcome Trust(Wellcome Trust); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The Wellcome Trust (090868, NP.; GR083272, B.B.), and Medical Research Council (grant G0900584, F.D.-B., P.S. and NP.; institutional funds, PG., PG.) funded this work.	Barnes AP, 2009, ANNU REV NEUROSCI, V32, P347, DOI 10.1146/annurev.neuro.31.060407.125536; Baudet ML, 2012, NAT NEUROSCI, V15, P29, DOI 10.1038/nn.2979; BLACK MM, 1994, J NEUROSCI, V14, P857; Bonev B, 2011, DEV CELL, V20, P19, DOI 10.1016/j.devcel.2010.11.018; Bouquet C, 2004, J NEUROSCI, V24, P7204, DOI 10.1523/JNEUROSCI.2254-04.2004; Gao FB, 2010, NEURAL DEV, V5, DOI 10.1186/1749-8104-5-25; Gibson DA, 2011, DEVELOPMENT, V138, P183, DOI 10.1242/dev.046441; Hengst U, 2009, NAT CELL BIOL, V11, P1024, DOI 10.1038/ncb1916; Hoshino N, 2010, DEV NEUROSCI-BASEL, V32, P184, DOI 10.1159/000313902; Ji YY, 2010, NAT NEUROSCI, V13, P302, DOI 10.1038/nn.2505; Montenegro-Venegas C, 2010, MOL BIOL CELL, V21, P3518, DOI 10.1091/mbc.E09-08-0709; Natera-Naranjo O, 2010, RNA, V16, P1516, DOI 10.1261/rna.1833310; Olsson-Carter K, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001054; Panagiotaki N, 2010, DEVELOPMENT, V137, P4005, DOI 10.1242/dev.053173; Santos AR, 2010, PROG NEUROBIOL, V92, P505, DOI 10.1016/j.pneurobio.2010.08.004	15	186	187	0	33	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	MAY	2012	15	5					697	699		10.1038/nn.3082	http://dx.doi.org/10.1038/nn.3082			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	932DI	22484572				2022-12-28	WOS:000303270200012
J	Sarkar, C; Chandra, G; Peng, SY; Zhang, ZJ; Liu, AY; Mukherjee, AB				Sarkar, Chinmoy; Chandra, Goutam; Peng, Shiyong; Zhang, Zhongjian; Liu, Aiyi; Mukherjee, Anil B.			Neuroprotection and lifespan extension in Ppt1(-/-) mice by NtBuHA: therapeutic implications for INCL	NATURE NEUROSCIENCE			English	Article							PALMITOYL-PROTEIN THIOESTERASE; NEURONAL CEROID-LIPOFUSCINOSIS; ENZYME REPLACEMENT THERAPY; MOUSE MODEL; LYSOSOMAL STORAGE; HYDROXYLAMINE; ACTIVATION; EXPRESSION; BRAIN; NEURODEGENERATION	Infantile neuronal ceroid lipofuscinosis (INCL) is a devastating childhood neurodegenerative lysosomal storage disease (LSD) that has no effective treatment. It is caused by inactivating mutations in the palmitoyl-protein thioesterase-1 (PPT1) gene. PPT1 deficiency impairs the cleavage of thioester linkage in palmitoylated proteins (constituents of ceroid), preventing degradation by lysosomal hydrolases. Consequently, accumulation of lysosomal ceroid leads to INCL. Thioester linkage is cleaved by nucleophilic attack. Hydroxylamine, a potent nucleophilic cellular metabolite, may have therapeutic potential for INCL, but its toxicity precludes clinical application. We found that a hydroxylamine derivative, N-(tert-Butyl) hydroxylamine (NtBuHA), was non-toxic, cleaved thioester linkage in palmitoylated proteins and mediated lysosomal ceroid depletion in cultured cells from INCL patients. In Ppt1(-/-) mice, which mimic INCL, NtBuHA crossed the blood-brain barrier, depleted lysosomal ceroid, suppressed neuronal apoptosis, slowed neurological deterioration and extended lifespan. Our findings provide a proof of concept that thioesterase-mimetic and antioxidant small molecules such as NtBuHA are potential drug targets for thioesterase deficiency diseases such as INCL.	[Sarkar, Chinmoy; Chandra, Goutam; Peng, Shiyong; Zhang, Zhongjian; Mukherjee, Anil B.] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Sect Dev Genet, Program Dev Endocrinol & Genet, NIH, Bethesda, MD USA; [Liu, Aiyi] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Biostat & Bioinformat Branch, NIH, Bethesda, MD USA	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	Mukherjee, AB (corresponding author), Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Sect Dev Genet, Program Dev Endocrinol & Genet, NIH, Bethesda, MD USA.	mukherja@exchange.nih.gov	Sarkar, Chinmoy/AAI-2461-2019; Peng, Shiyong/D-6391-2014	Peng, Shiyong/0000-0003-0697-3674; Liu, Aiyi/0000-0002-6618-5082	Eunice Kennedy Shriver National Institute of Child Health and Human Development; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD000910] Funding Source: NIH RePORTER	Eunice Kennedy Shriver National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	We thank S.L. Hofmann (University of Texas Southwestern Medical Center) for the generous gift of Ppt1<SUP>-/-</SUP> mice and for a sample of recombinant human PPT1 enzyme that we used as a positive control. M. Sands (Washington University School of Medicine) provided a pair of C57 congenic Ppt1<SUP>-/-</SUP> mice that we used to establish our colony at the US National Institutes of Health. We thank S.W. Levin, J.Y. Chou and I. Owens for critical review of the manuscript and helpful suggestions. We also thank A. Bouchelion and A. Chen for editorial assistance. We thank L. Dye at the Microscopy and Imaging Core facility for his expert assistance in performing TEM of cultured lymphoblasts and mouse brain tissues. We are grateful to H.-S. fun for helping us with the FACS analysis. The mass spectrometric analyses for the detection of NtBuHA in brain tissues were performed in the laboratory of A.K. Cheema (Georgetown University School of Medicine). This research was supported in whole by the Intramural Research Program of the Eunice Kennedy Shriver National Institute of Child Health and Human Development.	Anderson GW, 2013, BBA-MOL BASIS DIS, V1832, P1807, DOI 10.1016/j.bbadis.2012.11.014; Atamna H, 2001, FASEB J, V15, P2196, DOI 10.1096/fj.01-0134com; CAMP LA, 1993, J BIOL CHEM, V268, P22566; CAMP LA, 1994, J BIOL CHEM, V269, P23212; Chen YH, 2009, NAT MED, V15, P1215, DOI 10.1038/nm.2025; Cox TM, 2012, J PATHOL, V226, P241, DOI 10.1002/path.3021; CRAWLEY JN, 1985, NEUROSCI BIOBEHAV R, V9, P37, DOI 10.1016/0149-7634(85)90030-2; Drisdel RC, 2006, METHODS, V40, P127, DOI 10.1016/j.ymeth.2006.04.015; Duncan JA, 1998, J BIOL CHEM, V273, P15830, DOI 10.1074/jbc.273.25.15830; El-Husseini AED, 2002, NAT REV NEUROSCI, V3, P791, DOI 10.1038/nrn940; Greaves J, 2012, J BIOL CHEM, V287, P37330, DOI 10.1074/jbc.M112.389098; Griffey MA, 2006, MOL THER, V13, P538, DOI 10.1016/j.ymthe.2005.11.008; GROSS P, 1985, CRC CR REV TOXICOL, V14, P87, DOI 10.3109/10408448509023765; Gupta P, 2001, P NATL ACAD SCI USA, V98, P13566, DOI 10.1073/pnas.251485198; Haltia M, 2013, BBA-MOL BASIS DIS, V1832, P1795, DOI 10.1016/j.bbadis.2012.08.012; HAMM RJ, 1994, J NEUROTRAUM, V11, P187, DOI 10.1089/neu.1994.11.187; Hellsten E, 1996, EMBO J, V15, P5240, DOI 10.1002/j.1460-2075.1996.tb00909.x; HOFMANN SL, 2001, METABOLIC MOL BASES, P3877; Hu J, 2012, MOL GENET METAB, V107, P213, DOI 10.1016/j.ymgme.2012.05.009; Isosomppi J, 1999, DEV BRAIN RES, V118, P1, DOI 10.1016/S0165-3806(99)00115-7; Iwanaga T, 2009, PROG LIPID RES, V48, P117, DOI 10.1016/j.plipres.2009.02.001; JARVELA I, 1991, GENOMICS, V9, P170, DOI 10.1016/0888-7543(91)90235-7; Jeyakumar Mylvaganam, 2005, Nat Rev Neurosci, V6, P713; Jocelyn P.C., 1972, BIOCH SH GROUPS; Kaur P, 2012, INT J MASS SPECTROM, V310, P44, DOI 10.1016/j.ijms.2011.11.005; Kim SJ, 2006, HUM MOL GENET, V15, P1580, DOI 10.1093/hmg/ddl078; Kirby AJ, 2006, J AM CHEM SOC, V128, P12374, DOI 10.1021/ja065147q; Kohan R, 2011, CURR PHARM BIOTECHNO, V12, P867, DOI 1389-2010/11 $58.00+.00; Kousi M, 2012, HUM MUTAT, V33, P42, DOI 10.1002/humu.21624; Lonnqvist T, 2001, NEUROLOGY, V57, P1411, DOI 10.1212/WNL.57.8.1411; Lu JY, 2010, MOL GENET METAB, V99, P374, DOI 10.1016/j.ymgme.2009.12.002; Lu JY, 1996, P NATL ACAD SCI USA, V93, P10046, DOI 10.1073/pnas.93.19.10046; Macauley SL, 2011, J NEUROSCI, V31, P15575, DOI 10.1523/JNEUROSCI.3579-11.2011; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Munasinghe J, 2012, NEURODEGENER DIS, V9, P159, DOI 10.1159/000334838; Platt FM, 2009, BBA-MOL CELL RES, V1793, P737, DOI 10.1016/j.bbamcr.2008.08.009; Resh Marilyn D, 2006, Sci STKE, V2006, pre14, DOI 10.1126/stke.3592006re14; Riikonen R, 2000, NEUROLOGY, V54, P1828, DOI 10.1212/WNL.54.9.1828; Salaun C, 2010, J CELL BIOL, V191, P1229, DOI 10.1083/jcb.201008160; Smotrys JE, 2004, ANNU REV BIOCHEM, V73, P559, DOI 10.1146/annurev.biochem.73.011303.073954; Srikanth M, 2012, NAT REV NEUROL, V8, P307, DOI 10.1038/nrneurol.2012.76; Tamaki SJ, 2009, CELL STEM CELL, V5, P310, DOI 10.1016/j.stem.2009.05.022; Tomatis VM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015045; Verkruyse LA, 1996, J BIOL CHEM, V271, P15831, DOI 10.1074/jbc.271.26.15831; VESA J, 1995, NATURE, V376, P584, DOI 10.1038/376584a0; Wei H, 2008, HUM MOL GENET, V17, P469, DOI 10.1093/hmg/ddm324; Wong AMS, 2010, BIOCHEM SOC T, V38, P1484, DOI 10.1042/BST0381484; Zhang ZJ, 2006, HUM MOL GENET, V15, P337, DOI 10.1093/hmg/ddi451; Zhang ZJ, 1999, GENE, V231, P203, DOI 10.1016/S0378-1119(99)00050-5	49	49	50	0	10	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	NOV	2013	16	11					1608	1617		10.1038/nn.3526	http://dx.doi.org/10.1038/nn.3526			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	241YX	24056696	Green Accepted			2022-12-28	WOS:000326205700018
J	Simmons, WK; Rapuano, KM; Kallman, SJ; Ingeholm, JE; Miller, B; Gotts, SJ; Avery, JA; Hall, KD; Martin, A				Simmons, W. Kyle; Rapuano, Kristina M.; Kallman, Seth J.; Ingeholm, John E.; Miller, Bernard; Gotts, Stephen J.; Avery, Jason A.; Hall, Kevin D.; Martin, Alex			Category-specific integration of homeostatic signals in caudal but not rostral human insula	NATURE NEUROSCIENCE			English	Article							HUMAN AWARENESS; ACTIVATION; FEELINGS; NUCLEUS; FOODS; TASTE; BODY	Prevailing theories hold that the insula is functionally organized along its caudal-to-rostral axis, with posterior regions coding lower-level sensory information and anterior regions coding higher-level stimulus significance relative to the body's homeostatic needs. Contrary to predictions of this model, the response of the taste-sensitive region of the caudal, but not rostral, insula to food images was directly related to the body's homeostatic state as indexed by levels of peripheral glucose.	[Simmons, W. Kyle; Avery, Jason A.] Laureate Inst Brain Res, Tulsa, OK USA; [Simmons, W. Kyle] Univ Tulsa, Fac Community Med, Tulsa, OK 74104 USA; [Simmons, W. Kyle; Rapuano, Kristina M.; Kallman, Seth J.; Ingeholm, John E.; Gotts, Stephen J.; Martin, Alex] NIHM, Lab Brain & Cognit, NIH, Bethesda, MD USA; [Miller, Bernard; Hall, Kevin D.] NIDDK, Lab Biol Modeling, NIH, Bethesda, MD 20892 USA; [Avery, Jason A.] Univ Tulsa, Dept Biol Sci, Tulsa, OK 74104 USA	Laureate Institute for Brain Research, Inc.; University of Tulsa; National Institutes of Health (NIH) - USA; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); University of Tulsa	Simmons, WK (corresponding author), Laureate Inst Brain Res, Tulsa, OK USA.	wksimmons@laureateinstitute.org	Simmons, William/K-8925-2015; Rapuano, Kristina/J-6489-2019; Simmons, W. Kyle/V-6846-2019; Hall, Kevin/F-2383-2010	Simmons, William/0000-0002-0399-9003; Simmons, W. Kyle/0000-0002-0399-9003; Hall, Kevin/0000-0003-4062-3133; Avery, Jason/0000-0003-4097-2819	NIMH [K01MH096175-01]; NIDDK; Oklahoma Center for the Advancement of Science and Technology [OCAST HR10-141]; NARSAD; Oklahoma Tobacco Research Center; William K. Warren Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK075107] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [K01MH096175, ZIAMH002588] Funding Source: NIH RePORTER	NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Oklahoma Center for the Advancement of Science and Technology; NARSAD(NARSAD); Oklahoma Tobacco Research Center; William K. Warren Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We would like to thank K. Burrows for help with data management and analysis of the high-sweetness and low-sweetness food pictures. This research supported by the Intramural Research Programs of the NIMH and the NIDDK, as well as by NIMH grant K01MH096175-01 to W.K.S., a grant from the Oklahoma Center for the Advancement of Science and Technology (OCAST HR10-141) to W.K.S., a NARSAD Young Investigator Award to W.K.S., a grant to W.K.S. from the Oklahoma Tobacco Research Center, and The William K. Warren Foundation. The study was conducted under NIH Clinical Study Protocol 09-DK-0081 (ClinicalTrials.gov ID NCT00846040).	BECKSTEAD RM, 1980, J COMP NEUROL, V190, P259, DOI 10.1002/cne.901900205; Craig AD, 2011, ANN NY ACAD SCI, V1225, P72, DOI 10.1111/j.1749-6632.2011.05990.x; Craig AD, 2009, NAT REV NEUROSCI, V10, P59, DOI 10.1038/nrn2555; Craig AD, 2002, NAT REV NEUROSCI, V3, P655, DOI 10.1038/nrn894; Damasio A, 2013, CEREB CORTEX, V23, P833, DOI 10.1093/cercor/bhs077; Feinstein JS, 2010, J CLIN EXP NEUROPSYC, V32, P88, DOI 10.1080/13803390903066873; Grayson BE, 2013, NAT REV NEUROSCI, V14, P24, DOI 10.1038/nrn3409; Khalsa SS, 2009, NAT NEUROSCI, V12, P1494, DOI 10.1038/nn.2411; Killgore WDS, 2003, NEUROIMAGE, V19, P1381, DOI 10.1016/S1053-8119(03)00191-5; LaBar KS, 2001, BEHAV NEUROSCI, V115, P493, DOI 10.1037//0735-7044.115.2.493; Philippi CL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038413; Simmons WK, 2005, CEREB CORTEX, V15, P1602, DOI 10.1093/cercor/bhi038; Small DM, 2010, BRAIN STRUCT FUNCT, V214, P551, DOI 10.1007/s00429-010-0266-9; van der Laan LN, 2011, NEUROIMAGE, V55, P296, DOI 10.1016/j.neuroimage.2010.11.055; Veldhuizen MG, 2011, HUM BRAIN MAPP, V32, P2256, DOI 10.1002/hbm.21188; Yettefti K, 1997, PHYSIOL BEHAV, V61, P93, DOI 10.1016/S0031-9384(96)00358-7	16	67	68	1	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	NOV	2013	16	11					1551	1552		10.1038/nn.3535	http://dx.doi.org/10.1038/nn.3535			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	241YX	24077565	Green Accepted			2022-12-28	WOS:000326205700011
J	Gundersen, B				Gundersen, Brigitta			Context-dependent plasticity in a sensory circuit	NATURE NEUROSCIENCE			English	Editorial Material														Gundersen, Brigitta/0000-0002-7801-9348					0	2	2	0	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	OCT	2013	16	10					1366	1366		10.1038/nn1013-1366	http://dx.doi.org/10.1038/nn1013-1366			1	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	223HM	24067289	Bronze			2022-12-28	WOS:000324795300006
J	Ma, T; Trinh, MA; Wexler, AJ; Bourbon, C; Gatti, E; Pierre, P; Cavener, DR; Klann, E				Ma, Tao; Trinh, Mimi A.; Wexler, Alyse J.; Bourbon, Clarisse; Gatti, Evelina; Pierre, Philippe; Cavener, Douglas R.; Klann, Eric			Suppression of eIF2 alpha kinases alleviates Alzheimer's disease-related plasticity and memory deficits	NATURE NEUROSCIENCE			English	Article							HIPPOCAMPAL SYNAPTIC PLASTICITY; TRANSLATIONAL CONTROL; OXIDATIVE STRESS; EIF2 KINASES; PHOSPHORYLATION; ACTIVATION; PERK; MECHANISMS; DISRUPTION; EXPRESSION	Expression of long-lasting synaptic plasticity and long-term memory requires protein synthesis, which can be repressed by phosphorylation of eukaryotic initiation factor 2 alpha-subunit (eIF2 alpha). Elevated phosphorylation of eIF2 alpha has been observed in the brains of Alzheimer's disease patients and Alzheimer's disease model mice. Therefore, we tested whether suppressing eIF2 alpha kinases could alleviate synaptic plasticity and memory deficits in Alzheimer's disease model mice. Genetic deletion of eIF2 alpha kinase PERK prevented enhanced phosphorylation of eIF2 alpha and deficits in protein synthesis, synaptic plasticity and spatial memory in mice that express familial Alzheimer's disease-related mutations in APP and PSEN1. Similarly, deletion of another eIF2 alpha kinase, GCN2, prevented impairments of synaptic plasticity and defects in spatial memory exhibited by the Alzheimer's disease model mice. Our findings implicate aberrant eIF2 alpha phosphorylation as a previously unidentified molecular mechanism underlying Alzheimer's disease-related synaptic pathophysioloy and memory dysfunction and suggest that PERK and GCN2 are potential therapeutic targets for treatment of individuals with Alzheimer's disease.	[Ma, Tao; Trinh, Mimi A.; Wexler, Alyse J.; Klann, Eric] NYU, Ctr Neural Sci, New York, NY 10003 USA; [Bourbon, Clarisse; Gatti, Evelina; Pierre, Philippe] Univ Mediterranee, Ctr Immunol Marseille Luminy, CNRS, Unite Mixte Rech 6102, Marseille, France; [Bourbon, Clarisse; Gatti, Evelina; Pierre, Philippe] INSERM, U1104, F-13258 Marseille, France; [Bourbon, Clarisse; Gatti, Evelina; Pierre, Philippe] CNRS, Unite Mixte Rech 7280, Marseille, France; [Cavener, Douglas R.] Penn State Univ, Dept Biol, University Pk, PA 16802 USA	New York University; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Klann, E (corresponding author), NYU, Ctr Neural Sci, New York, NY 10003 USA.	eklann@cns.nyu.edu	Gatti, Evelina/B-7941-2012	Gatti, Evelina/0000-0002-0667-0799; pierre, philippe/0000-0003-0863-8255	US National Institutes of Health [NS034007, NS047834]; Alzheimer's Association Investigator grant; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS047384, R37NS034007, R01NS034007, R21NS078718, R29NS034007] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Alzheimer's Association Investigator grant; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank the late Dr. Mark A. Smith (Case Western Reserve University) for providing postmortem Alzheimer's disease brain samples, R.C. Wek (Indiana University School of Medicine) for providing the ATF4 antibody, C.A. Hoeffer for help with the design of the mouse breeding, H. Bowling and M.V. Chao (New York University School of Medicine) for providing primary cultured neurons, E. Santini for advice on the statistical analyses for the mouse behavioral tests, Y. Chen for technical help, M. Dorsey for keeping colonies of transgenic mice, and all members of the Klann laboratory for comments on the manuscript. This work was supported by US National Institutes of Health grants NS034007 and NS047834, and Alzheimer's Association Investigator grant to E. K.	Alberini CM, 2008, NEUROBIOL LEARN MEM, V89, P234, DOI 10.1016/j.nlm.2007.08.007; Banko JL, 2005, J NEUROSCI, V25, P9581, DOI 10.1523/JNEUROSCI.2423-05.2005; Barker GRI, 2011, J NEUROSCI, V31, P10721, DOI 10.1523/JNEUROSCI.6413-10.2011; Bonda DJ, 2010, REDOX REP, V15, P161, DOI 10.1179/174329210X12650506623645; Bramham CR, 2010, EXP BRAIN RES, V200, P125, DOI 10.1007/s00221-009-1959-2; Chang RCC, 2002, NEUROREPORT, V13, P2429, DOI 10.1097/00001756-200212200-00011; Cohen E, 2009, CELL, V139, P1157, DOI 10.1016/j.cell.2009.11.014; Costa-Mattioli M, 2005, NATURE, V436, P1166, DOI 10.1038/nature03897; Costa-Mattioli M, 2007, CELL, V129, P195, DOI 10.1016/j.cell.2007.01.050; Costa-Mattioli M, 2009, NEURON, V61, P10, DOI 10.1016/j.neuron.2008.10.055; Cullinan SB, 2003, MOL CELL BIOL, V23, P7198, DOI 10.1128/MCB.23.20.7198-7209.2003; Haass C, 2007, NAT REV MOL CELL BIO, V8, P101, DOI 10.1038/nrm2101; Hamanaka RB, 2005, MOL BIOL CELL, V16, P5493, DOI 10.1091/mbc.E05-03-0268; Hetz C, 2012, NAT REV MOL CELL BIO, V13, P89, DOI 10.1038/nrm3270; Hoeffer CA, 2008, NEURON, V60, P832, DOI 10.1016/j.neuron.2008.09.037; Holtzman DM, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002369; Jankowsky JL, 2001, BIOMOL ENG, V17, P157, DOI 10.1016/S1389-0344(01)00067-3; Jiang HY, 2004, MOL CELL BIOL, V24, P1365, DOI 10.1128/MCB.24.3.1365-1377.2004; Jiang Z, 2010, J NEUROSCI, V30, P2582, DOI 10.1523/JNEUROSCI.3971-09.2010; Kim SM, 2010, NEUROSCIENCE, V169, P1831, DOI 10.1016/j.neuroscience.2010.06.016; Klann E, 2004, LEARN MEMORY, V11, P365, DOI 10.1101/lm.79004; Klann E, 2004, NAT REV NEUROSCI, V5, P931, DOI 10.1038/nrn1557; KLANN E, 2007, TRANSLATIONAL CONTRO, P485; Leuba G, 2008, J ALZHEIMERS DIS, V15, P139; Li G, 2010, J CELL BIOL, V191, P1113, DOI 10.1083/jcb.201006121; Lin MT, 2006, NATURE, V443, P787, DOI 10.1038/nature05292; Lisman J, 2002, NAT REV NEUROSCI, V3, P175, DOI 10.1038/nrn753; Ma T, 2012, J NEUROCHEM, V120, P140, DOI 10.1111/j.1471-4159.2011.07506.x; Ma T, 2011, J NEUROSCI, V31, P5589, DOI 10.1523/JNEUROSCI.6566-10.2011; Ma T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012845; Moreno JA, 2012, NATURE, V485, P507, DOI 10.1038/nature11058; O'Connor T, 2008, NEURON, V60, P988, DOI 10.1016/j.neuron.2008.10.047; Palam LR, 2011, J BIOL CHEM, V286, P10939, DOI 10.1074/jbc.M110.216093; Paschen W, 2007, CURR PHARM DESIGN, V13, P1887; Querfurth HW, 2010, NEW ENGL J MED, V362, P329, DOI 10.1056/NEJMra0909142; Sacktor TC, 2011, NAT REV NEUROSCI, V12, P9, DOI 10.1038/nrn2949; Schmidt EK, 2009, NAT METHODS, V6, P275, DOI [10.1038/NMETH.1314, 10.1038/nmeth.1314]; Selkoe DJ, 2011, NAT MED, V17, P1060, DOI 10.1038/nm.2460; Sidrauski C, 2013, ELIFE, V2, DOI 10.7554/eLife.00498; Trinh MA, 2012, CELL REP, V1, P676, DOI 10.1016/j.celrep.2012.04.010; Tsaytler P, 2013, FEBS J, V280, P766, DOI 10.1111/j.1742-4658.2012.08535.x; Tsien JZ, 1996, CELL, V87, P1317, DOI 10.1016/S0092-8674(00)81826-7; Wang SQ, 2010, J NEUROCHEM, V115, P47, DOI 10.1111/j.1471-4159.2010.06899.x; Wek RC, 2006, BIOCHEM SOC T, V34, P7, DOI 10.1042/BST0340007; Wek RC, 2007, ANTIOXID REDOX SIGN, V9, P2357, DOI 10.1089/ars.2007.1764; Zhan K, 2004, GENETICS, V168, P1867, DOI 10.1534/genetics.104.031443; Zhang PC, 2002, MOL CELL BIOL, V22, P3864, DOI 10.1128/MCB.22.11.3864-3874.2002; Zhang PC, 2002, MOL CELL BIOL, V22, P6681, DOI 10.1128/MCB.22.19.6681-6688.2002	48	374	384	10	111	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	SEP	2013	16	9					1299	U185		10.1038/nn.3486	http://dx.doi.org/10.1038/nn.3486			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	207KN	23933749	Green Accepted			2022-12-28	WOS:000323597500022
J	Mathur, BN; Tanahira, C; Tamamaki, N; Lovinger, DM				Mathur, Brian N.; Tanahira, Chiyoko; Tamamaki, Nobuaki; Lovinger, David M.			Voltage drives diverse endocannabinoid signals to mediate striatal microcircuit-specific plasticity	NATURE NEUROSCIENCE			English	Article							ACID AMIDE HYDROLASE; PARVALBUMIN-IMMUNOREACTIVE NEURONS; DIACYLGLYCEROL LIPASE-ALPHA; FAST-SPIKING INTERNEURONS; MEDIUM SPINY NEURONS; MICE LACKING; SYNAPTIC CONNECTIONS; PROJECTION NEURONS; RAT NEOSTRIATUM; BASAL GANGLIA	The dorsolateral striatum and cannabinoid type 1 receptor (CB1) signaling mediate habitual action learning, which is thought to require a balance of activity in the direct and indirect striatal output pathways. However, very little is known about how the high CB1-expressing striatal inhibitory microcircuitry might contribute to long-term plasticity capable of sculpting direct and indirect pathway output. Using optogenetic and molecular interrogation of striatal GABAergic microcircuits, we examined voltage-dependent long-term depression of inhibitory synapses (iLTD) onto mouse and rat medium spiny projection neurons (MSNs). The observed iLTD involved recruitment of different endocannabinoid types and showed both presynaptic and postsynaptic selectivity for MSN subtypes, ultimately resulting in a powerful disinhibition of direct pathway MSNs. These results suggest a new role for voltage states in gating circuit-specific forms of synaptic plasticity and illuminate possible circuit dynamics underlying action control.	[Mathur, Brian N.; Lovinger, David M.] NIAAA, Sect Synapt Pharmacol, Lab Integrat Neurosci, US Natl Inst Hlth, Bethesda, MD USA; [Tanahira, Chiyoko; Tamamaki, Nobuaki] Kumamoto Univ, Grad Sch Med, Dept Morphol Neural Sci, Honjo, Kumamoto, Japan	National Institutes of Health (NIH) - USA; NIH National Institute on Alcohol Abuse & Alcoholism (NIAAA); Kumamoto University	Lovinger, DM (corresponding author), NIAAA, Sect Synapt Pharmacol, Lab Integrat Neurosci, US Natl Inst Hlth, Bethesda, MD USA.	lovindav@mail.nih.gov	Mathur, Brian/P-5986-2018	Mathur, Brian/0000-0003-2912-8625	Intramural NIH HHS [Z99 AA999999] Funding Source: Medline; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [ZIAAA000407] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))		Adermark L, 2007, J NEUROSCI, V27, P6781, DOI 10.1523/JNEUROSCI.0280-07.2007; Adermark L, 2009, J NEUROSCI, V29, P1375, DOI 10.1523/JNEUROSCI.3842-08.2009; ALBIN RL, 1989, TRENDS NEUROSCI, V12, P366, DOI 10.1016/0166-2236(89)90074-X; BENNETT BD, 1994, NEUROSCIENCE, V62, P707, DOI 10.1016/0306-4522(94)90471-5; Bolam JP, 2000, J ANAT, V196, P527, DOI 10.1046/j.1469-7580.2000.19640527.x; Bracci E, 2006, J NEUROPHYSIOL, V95, P1285, DOI 10.1152/jn.00598.2005; Carter AG, 2004, NEURON, V44, P483, DOI 10.1016/j.neuron.2004.10.013; Caterina MJ, 2000, SCIENCE, V288, P306, DOI 10.1126/science.288.5464.306; Cravatt BF, 2001, P NATL ACAD SCI USA, V98, P9371, DOI 10.1073/pnas.161191698; Cui GH, 2013, NATURE, V494, P238, DOI 10.1038/nature11846; Dang MT, 2006, P NATL ACAD SCI USA, V103, P15254, DOI 10.1073/pnas.0601758103; Egertova M, 2003, NEUROSCIENCE, V119, P481, DOI 10.1016/S0306-4522(03)00145-3; Egertova M, 1998, P ROY SOC B-BIOL SCI, V265, P2081, DOI 10.1098/rspb.1998.0543; Egertova M, 2008, J COMP NEUROL, V506, P604, DOI 10.1002/cne.21568; Freiman I, 2006, J PHYSIOL-LONDON, V575, P789, DOI 10.1113/jphysiol.2006.114272; Gerfen CR, 2011, ANNU REV NEUROSCI, V34, P441, DOI 10.1146/annurev-neuro-061010-113641; Hilario MRF, 2007, FRONT INTEGR NEUROSC, V1, DOI [10.3389/neuro.07/006.2007, 10.3389/neuro.07.006.2007]; KITA H, 1990, BRAIN RES, V536, P1, DOI 10.1016/0006-8993(90)90002-S; Koos T, 1999, NAT NEUROSCI, V2, P467, DOI 10.1038/8138; Koos T, 2004, J NEUROSCI, V24, P7916, DOI 10.1523/JNEUROSCI.2163-04.2004; Kubota Y, 2000, J NEUROSCI, V20, P375, DOI 10.1523/JNEUROSCI.20-01-00375.2000; Lerner TN, 2012, NEURON, V73, P347, DOI 10.1016/j.neuron.2011.11.015; Maccarrone M, 2003, J NEUROCHEM, V85, P1018, DOI 10.1046/j.1471-4159.2003.01759.x; Maccarrone M, 2008, NAT NEUROSCI, V11, P152, DOI 10.1038/nn2042; Maejima T, 2005, J NEUROSCI, V25, P6826, DOI 10.1523/JNEUROSCI.0945-05.2005; Mahon S, 2006, J NEUROSCI, V26, P12587, DOI 10.1523/JNEUROSCI.3987-06.2006; Malone DT, 2008, NEUROSCIENCE, V152, P265, DOI 10.1016/j.neuroscience.2007.10.043; Marsicano G, 2003, SCIENCE, V302, P84, DOI 10.1126/science.1088208; Mathur BN, 2008, NEUROSCI LETT, V435, P90, DOI 10.1016/j.neulet.2008.01.082; Mathur BN, 2011, J NEUROSCI, V31, P7402, DOI 10.1523/JNEUROSCI.6250-10.2011; Mink JW, 2003, ARCH NEUROL-CHICAGO, V60, P1365, DOI 10.1001/archneur.60.10.1365; Narushima M, 2006, EUR J NEUROSCI, V24, P2246, DOI 10.1111/j.1460-9568.2006.05119.x; Plenz D, 2003, TRENDS NEUROSCI, V26, P436, DOI 10.1016/S0166-2236(03)00196-6; Plenz D, 1998, J NEUROSCI, V18, P266; Puente N, 2011, NAT NEUROSCI, V14, P1542, DOI 10.1038/nn.2974; SCHULTZ W, 1993, J NEUROSCI, V13, P900; Stern EA, 1998, NATURE, V394, P475, DOI 10.1038/28848; Tanahira C, 2009, NEUROSCI RES, V63, P213, DOI 10.1016/j.neures.2008.12.007; Tanimura A, 2010, NEURON, V65, P320, DOI 10.1016/j.neuron.2010.01.021; Tepper JM, 2004, TRENDS NEUROSCI, V27, P662, DOI 10.1016/j.tins.2004.08.007; Tsou K, 1998, NEUROSCI LETT, V254, P137, DOI 10.1016/S0304-3940(98)00700-9; Uchigashima M, 2007, J NEUROSCI, V27, P3663, DOI 10.1523/JNEUROSCI.0448-07.2007; Watts A, 2012, J NEUROSCI, V32, P13411, DOI 10.1523/JNEUROSCI.0170-12.2012; Wilson CJ, 2007, PROG BRAIN RES, V160, P91, DOI 10.1016/S0079-6123(06)60006-X; Wilson CJ, 1996, J NEUROSCI, V16, P2397; WILSON CJ, 1980, J COMP NEUROL, V194, P599, DOI 10.1002/cne.901940308; Winters BD, 2012, P NATL ACAD SCI USA, V109, pE2717, DOI 10.1073/pnas.1206303109; Xu WF, 2001, J NEUROSCI, V21, P5944, DOI 10.1523/JNEUROSCI.21-16-05944.2001; Yin HH, 2004, LEARN MEMORY, V11, P459, DOI 10.1101/lm.81004; Yoshida T, 2006, J NEUROSCI, V26, P4740, DOI 10.1523/JNEUROSCI.0054-06.2006	50	44	44	0	20	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	SEP	2013	16	9					1275	U157		10.1038/nn.3478	http://dx.doi.org/10.1038/nn.3478			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	207KN	23892554	Green Accepted			2022-12-28	WOS:000323597500019
J	Baxter, MG; Croxson, PL				Baxter, Mark G.; Croxson, Paula L.			Behavioral control by the orbital prefrontal cortex: reversal of fortune	NATURE NEUROSCIENCE			English	Editorial Material							ORBITOFRONTAL CORTEX; NEUROTOXIC LESIONS; RHESUS-MONKEYS; FLEXIBILITY; MEMORY	A study shows that selective lesions of the orbital prefrontal cortex in macaques spare behavioral flexibility and emotional processing but impair a test of outcome expectation, suggesting that some psychiatric disorders ascribed to a disrupted orbital prefrontal cortex may instead be caused by more widespread dysfunction.	[Baxter, Mark G.] Icahn Sch Med Mt Sinai, Dept Neurosci, Glickenhaus Lab Neuropsychol, New York, NY USA; Icahn Sch Med Mt Sinai, Friedman Brain Inst, New York, NY USA	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai	Baxter, MG (corresponding author), Icahn Sch Med Mt Sinai, Dept Neurosci, Glickenhaus Lab Neuropsychol, New York, NY USA.	mark.baxter@mssm.edu		Croxson, Paula/0000-0002-4649-980X				Baxter MG, 2001, EUR J NEUROSCI, V13, P1228, DOI 10.1046/j.0953-816x.2001.01491.x; Browning PGF, 2008, J NEUROSCI, V28, P3934, DOI 10.1523/JNEUROSCI.0633-08.2008; Clark L, 2004, BRAIN COGNITION, V55, P41, DOI 10.1016/s0278-2626(03)00284-7; Dias R, 1996, NATURE, V380, P69, DOI 10.1038/380069a0; ESLINGER PJ, 1985, NEUROLOGY, V35, P1731, DOI 10.1212/WNL.35.12.1731; Izquierdo A, 2004, J NEUROSCI, V24, P7540, DOI 10.1523/JNEUROSCI.1921-04.2004; Jbabdi S, 2013, J NEUROSCI, V33, P3190, DOI 10.1523/JNEUROSCI.2457-12.2013; Kehagia AA, 2010, CURR OPIN NEUROBIOL, V20, P199, DOI 10.1016/j.conb.2010.01.007; McAlonan K, 2003, BEHAV BRAIN RES, V146, P97, DOI 10.1016/j.bbr.2003.09.019; Rudebeck PH, 2013, NAT NEUROSCI, V16, P1140, DOI 10.1038/nn.3440; Schoenbaum G, 2011, ANN NY ACAD SCI, V1239, P87, DOI 10.1111/j.1749-6632.2011.06210.x; Tsuchida A, 2010, J NEUROSCI, V30, P16868, DOI 10.1523/JNEUROSCI.1958-10.2010; Walton ME, 2010, NEURON, V65, P927, DOI 10.1016/j.neuron.2010.02.027; Wilson CRE, 2008, J NEUROSCI, V28, P5529, DOI 10.1523/JNEUROSCI.0952-08.2008; Wilson CRE, 2007, EUR J NEUROSCI, V25, P2514, DOI 10.1111/j.1460-9568.2007.05468.x	15	6	7	0	11	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	AUG	2013	16	8					984	985		10.1038/nn.3472	http://dx.doi.org/10.1038/nn.3472			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	190EV	23887130				2022-12-28	WOS:000322323000002
J	Higginbotham, H; Guo, JM; Yokota, Y; Umberger, NL; Su, CY; Li, JJ; Verma, N; Hirt, J; Ghukasyan, V; Caspary, T; Anton, ES				Higginbotham, Holden; Guo, Jiami; Yokota, Yukako; Umberger, Nicole L.; Su, Chen-Ying; Li, Jingjun; Verma, Nisha; Hirt, Joshua; Ghukasyan, Vladimir; Caspary, Tamara; Anton, E. S.			Arl13b-regulated cilia activities are essential for polarized radial glial scaffold formation	NATURE NEUROSCIENCE			English	Article							DEVELOPING CEREBRAL-CORTEX; JOUBERT-SYNDROME; CEREBROSPINAL-FLUID; BASAL PROGENITORS; CORTICAL-NEURONS; ARL13B; DIFFERENTIATION; PROTEIN; NEUROGENESIS; CILIOGENESIS	The construction of cerebral cortex begins with the formation of radial glia. Once formed, polarized radial glial cells divide either symmetrically or asymmetrically to balance appropriate production of progenitor cells and neurons. Following birth, neurons use the processes of radial glia as scaffolding for oriented migration. Radial glia therefore provide an instructive structural matrix to coordinate the generation and placement of distinct groups of cortical neurons in the developing cerebral cortex. We found that Arl13b, a cilia-enriched small GTPase that is mutated in Joubert syndrome, was critical for the initial formation of the polarized radial progenitor scaffold. Using developmental stage-specific deletion of Arl13b in mouse cortical progenitors, we found that early neuroepithelial deletion of ciliary Arl13b led to a reversal of the apical-basal polarity of radial progenitors and aberrant neuronal placement. Arl13b modulated ciliary signaling necessary for radial glial polarity. Our findings indicate that Arl13b signaling in primary cilia is crucial for the initial formation of a polarized radial glial scaffold and suggest that disruption of this process may contribute to aberrant neurodevelopment and brain abnormalities in Joubert syndrome-related ciliopathies.	[Higginbotham, Holden; Guo, Jiami; Yokota, Yukako; Li, Jingjun; Verma, Nisha; Hirt, Joshua; Ghukasyan, Vladimir; Anton, E. S.] Univ N Carolina, Sch Med, Ctr Neurosci, Chapel Hill, NC USA; [Higginbotham, Holden; Guo, Jiami; Yokota, Yukako; Li, Jingjun; Verma, Nisha; Hirt, Joshua; Ghukasyan, Vladimir; Anton, E. S.] Univ N Carolina, Sch Med, Dept Cell Biol & Physiol, Chapel Hill, NC USA; [Umberger, Nicole L.; Su, Chen-Ying; Caspary, Tamara] Emory Univ, Sch Med, Dept Human Genet, Atlanta, GA 30322 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; Emory University	Caspary, T (corresponding author), Emory Univ, Sch Med, Dept Human Genet, Atlanta, GA 30322 USA.	tcaspar@emory.edu; anton@med.unc.edu	Caspary, Tamara/AAH-5625-2020; , UNC Neuroscience Microscopy Core/AAE-8305-2022	Caspary, Tamara/0000-0002-6579-7589; 	US National Institutes of Health [MH060929, NS056380]; NARSAD Young Investigator Award; US National Institutes of Health predoctoral training grant [T32GM008490]; National Institute of Neurological Disorders and Stroke [P30 NS045892]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008490] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [T32MH087977, R01MH060929] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS045892, R01NS056380] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NARSAD Young Investigator Award(NARSAD); US National Institutes of Health predoctoral training grant; National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank A.-S. Lamantia, L. Pevny, M. Deshmukh and W. Snider for helpful comments and C. T. Strauss for editing. This research was supported by US National Institutes of Health grants MH060929 to E. S. A. and NS056380 to T. C., a NARSAD Young Investigator Award to H. H., a US National Institutes of Health predoctoral training grant to N.L.U. (T32GM008490) and the confocal imaging core of a National Institute of Neurological Disorders and Stroke institutional center core grant (P30 NS045892).	Amador-Arjona A, 2011, J NEUROSCI, V31, P9933, DOI 10.1523/JNEUROSCI.1062-11.2011; Aruga J, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-79; Berbari NF, 2008, MOL BIOL CELL, V19, P1540, DOI 10.1091/mbc.E07-09-0942; Brancati F, 2010, ORPHANET J RARE DIS, V5, DOI 10.1186/1750-1172-5-20; Breunig JJ, 2008, P NATL ACAD SCI USA, V105, P13127, DOI 10.1073/pnas.0804558105; Cantagrel V, 2008, AM J HUM GENET, V83, P170, DOI 10.1016/j.ajhg.2008.06.023; Caspary T, 2007, DEV CELL, V12, P767, DOI 10.1016/j.devcel.2007.03.004; Cevik S, 2010, J CELL BIOL, V188, P953, DOI 10.1083/jcb.200908133; Christensen ST, 2012, J PATHOL, V226, P172, DOI 10.1002/path.3004; Eggenschwiler JT, 2007, ANNU REV CELL DEV BI, V23, P345, DOI 10.1146/annurev.cellbio.23.090506.123249; Gotz M, 2005, NAT REV MOL CELL BIO, V6, P777, DOI 10.1038/nrm1739; Han YG, 2010, CURR OPIN NEUROBIOL, V20, P58, DOI 10.1016/j.conb.2009.12.002; Han YG, 2009, NAT MED, V15, P1062, DOI 10.1038/nm.2020; Hebert JM, 2000, DEV BIOL, V222, P296, DOI 10.1006/dbio.2000.9732; Higginbotham H, 2012, DEV CELL, V23, P925, DOI 10.1016/j.devcel.2012.09.019; Hildebrandt F, 2011, NEW ENGL J MED, V364, P1533, DOI 10.1056/NEJMra1010172; Horner VL, 2011, DEV BIOL, V355, P43, DOI 10.1016/j.ydbio.2011.04.019; Kim J, 2010, NATURE, V464, P1048, DOI 10.1038/nature08895; Lancaster MA, 2009, CURR OPIN GENET DEV, V19, P220, DOI 10.1016/j.gde.2009.04.008; Lehtinen MK, 2011, NEURON, V69, P893, DOI 10.1016/j.neuron.2011.01.023; Louvi A, 2011, NEURON, V69, P1046, DOI 10.1016/j.neuron.2011.03.002; Manzini MC, 2011, CURR OPIN GENET DEV, V21, P333, DOI 10.1016/j.gde.2011.01.006; Miyata T, 2001, NEURON, V31, P727, DOI 10.1016/S0896-6273(01)00420-2; Mukhopadhyay S, 2008, DEV CELL, V14, P762, DOI 10.1016/j.devcel.2008.03.002; Noctor SC, 2004, NAT NEUROSCI, V7, P136, DOI 10.1038/nn1172; Oh EC, 2012, DEVELOPMENT, V139, P443, DOI 10.1242/dev.050054; RAKIC P, 1988, SCIENCE, V241, P170, DOI 10.1126/science.3291116; Reiter JF, 2008, DEV CELL, V14, P635, DOI 10.1016/j.devcel.2008.04.011; Sahara S, 2009, NEURON, V63, P48, DOI 10.1016/j.neuron.2009.06.006; Sawamoto K, 2006, SCIENCE, V311, P629, DOI 10.1126/science.1119133; Schmid RS, 2003, P NATL ACAD SCI USA, V100, P4251, DOI 10.1073/pnas.0630496100; Scholey JM, 2006, CELL, V125, P439, DOI 10.1016/j.cell.2006.04.013; Siegenthaler JA, 2011, CURR OPIN GENET DEV, V21, P249, DOI 10.1016/j.gde.2010.12.005; Su CY, 2012, DEVELOPMENT, V139, P4062, DOI 10.1242/dev.082321; Tabata H, 2009, CEREB CORTEX, V19, P2092, DOI 10.1093/cercor/bhn227; Tissir F, 2010, NAT NEUROSCI, V13, P700, DOI 10.1038/nn.2555; Tronche F, 1999, NAT GENET, V23, P99, DOI 10.1038/12703; Valiente M, 2010, CURR OPIN NEUROBIOL, V20, P68, DOI 10.1016/j.conb.2009.12.003; Willaredt MA, 2008, J NEUROSCI, V28, P12887, DOI 10.1523/JNEUROSCI.2084-08.2008; Wilsch-Brauninger M, 2012, DEVELOPMENT, V139, P95, DOI 10.1242/dev.069294; Wilson SL, 2012, DEV NEUROBIOL, V72, P1196, DOI 10.1002/dneu.20985; Wong SY, 2009, NAT MED, V15, P1055, DOI 10.1038/nm.2011; Yokota Y, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000794; Yokota Y, 2007, NEURON, V54, P429, DOI 10.1016/j.neuron.2007.04.016; Yokota Y, 2009, NEURON, V61, P42, DOI 10.1016/j.neuron.2008.10.053; Zhu D, 2009, J CELL SCI, V122, P2760, DOI 10.1242/jcs.046276; Zhuo L, 2001, GENESIS, V31, P85, DOI 10.1002/gene.10008	47	128	131	0	19	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	AUG	2013	16	8					1000	U44		10.1038/nn.3451	http://dx.doi.org/10.1038/nn.3451			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	190EV	23817546	Green Accepted, Green Submitted			2022-12-28	WOS:000322323000009
J	Cho, M				Cho, Min			Oligodendrocyte failure in ALS	NATURE NEUROSCIENCE			English	Editorial Material														Cho, Min/0000-0003-4696-0173					0	4	4	0	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	MAY	2013	16	5					525	525		10.1038/nn1305-525	http://dx.doi.org/10.1038/nn1305-525			1	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	131WT	23619756	Bronze			2022-12-28	WOS:000318029300006
J	De Martino, B; Fleming, SM; Garrett, N; Dolan, RJ				De Martino, Benedetto; Fleming, Stephen M.; Garrett, Neil; Dolan, Raymond J.			Confidence in value-based choice	NATURE NEUROSCIENCE			English	Article							DECISION-MAKING; ORBITOFRONTAL CORTEX; FRONTOPOLAR CORTEX; FREE-ENERGY; BRAIN; COMPUTATION; PERFORMANCE; UNCERTAINTY; VALUATION; TASKS	Decisions are never perfect, with confidence in one's choices fluctuating over time. How subjective confidence and valuation of choice options interact at the level of brain and behavior is unknown. Using a dynamic model of the decision process, we show that confidence reflects the evolution of a decision variable over time, explaining the observed relation between confidence, value, accuracy and reaction time. As predicted by our dynamic model, we show that a functional magnetic resonance imaging signal in human ventromedial prefrontal cortex (vmPFC) reflects both value comparison and confidence in the value comparison process. Crucially, individuals varied in how they related confidence to accuracy, allowing us to show that this introspective ability is predicted by a measure of functional connectivity between vmPFC and rostrolateral prefrontal cortex. Our findings provide a mechanistic link between noise in value comparison and metacognitive awareness of choice, enabling us both to want and to express knowledge of what we want.	[De Martino, Benedetto; Fleming, Stephen M.; Dolan, Raymond J.] UCL, Wellcome Trust Ctr Neuroimaging, London, England; [De Martino, Benedetto] CALTECH, Div Humanities & Social Sci, Pasadena, CA 91125 USA; [Fleming, Stephen M.] NYU, Ctr Neural Sci, New York, NY 10003 USA; [Fleming, Stephen M.] Univ Oxford, Dept Expt Psychol, Oxford OX1 3UD, England	University of London; University College London; California Institute of Technology; New York University; University of Oxford	De Martino, B (corresponding author), UCL, Wellcome Trust Ctr Neuroimaging, London, England.	b.martino@ucl.ac.uk; fleming.sm@gmail.com		De Martino, Benedetto/0000-0002-3555-2732; Dolan, Ray/0000-0001-9356-761X; Fleming, Stephen/0000-0003-0233-4891; Garrett, Neil/0000-0003-1440-472X	Wellcome Trust [098362/Z/12/Z, 091593/Z/10/Z]; Sir Henry Wellcome Fellowships [082674/Z/07/Z, WT096185]	Wellcome Trust(Wellcome TrustEuropean Commission); Sir Henry Wellcome Fellowships	We thank T. Fitzgerald, D. Kumaran and T. Sharot for comments on a previous draft of this manuscript, and T. Behrens and N. Daw for discussions. This work was supported by a Wellcome Trust Senior Investigator Award, 098362/Z/12/Z to R.J.D.; S. M. F. and B. D. M. are supported by Sir Henry Wellcome Fellowships (B. D. M., 082674/Z/07/Z; S. M. F., WT096185). The Wellcome Trust Centre for Neuroimaging is supported by core funding from the Wellcome Trust, 091593/Z/10/Z.	Bahrami B, 2010, SCIENCE, V329, P1081, DOI 10.1126/science.1185718; Basten U, 2010, P NATL ACAD SCI USA, V107, P21767, DOI 10.1073/pnas.0908104107; BECKER GM, 1964, BEHAV SCI, V9, P226, DOI 10.1002/bs.3830090304; Bogacz R, 2006, PSYCHOL REV, V113, P700, DOI 10.1037/0033-295X.113.4.700; Boorman ED, 2009, NEURON, V62, P733, DOI 10.1016/j.neuron.2009.05.014; De Martino B, 2009, J NEUROSCI, V29, P3833, DOI 10.1523/JNEUROSCI.4832-08.2009; Feldman H, 2010, FRONT HUM NEUROSCI, V4, DOI 10.3389/fnhum.2010.00215; FitzGerald THB, 2009, J NEUROSCI, V29, P8388, DOI 10.1523/JNEUROSCI.0717-09.2009; Fleming SM, 2012, J NEUROSCI, V32, P6117, DOI 10.1523/JNEUROSCI.6489-11.2012; Fleming SM, 2010, SCIENCE, V329, P1541, DOI 10.1126/science.1191883; Friston KJ, 2010, NAT REV NEUROSCI, V11, P127, DOI 10.1038/nrn2787; Glascher J, 2009, NEUROINFORMATICS, V7, P73, DOI 10.1007/s12021-008-9042-x; Glimcher PW, 2005, ANNU REV PSYCHOL, V56, P25, DOI 10.1146/annurev.psych.55.090902.141429; Hare TA, 2008, J NEUROSCI, V28, P5623, DOI 10.1523/JNEUROSCI.1309-08.2008; Hare TA, 2009, SCIENCE, V324, P646, DOI 10.1126/science.1168450; Hunt LT, 2012, NAT NEUROSCI, V15, P470, DOI 10.1038/nn.3017; Insabato A, 2010, J NEUROPHYSIOL, V104, P539, DOI 10.1152/jn.01068.2009; Kable JW, 2007, NAT NEUROSCI, V10, P1625, DOI 10.1038/nn2007; KASS RE, 1995, J AM STAT ASSOC, V90, P773, DOI 10.1080/01621459.1995.10476572; Kepecs A, 2008, NATURE, V455, P227, DOI 10.1038/nature07200; Kepecs A, 2012, PHILOS T R SOC B, V367, P1322, DOI 10.1098/rstb.2012.0037; Kiani R, 2009, SCIENCE, V324, P759, DOI 10.1126/science.1169405; Knill DC, 2004, TRENDS NEUROSCI, V27, P712, DOI 10.1016/j.tins.2004.10.007; Lau H, 2011, TRENDS COGN SCI, V15, P365, DOI 10.1016/j.tics.2011.05.009; Maniscalco B., 2010, J VIS, V10, P213, DOI DOI 10.1167/10.7.213; Pasquali A, 2010, COGNITION, V117, P182, DOI 10.1016/j.cognition.2010.08.010; Plassmann H, 2007, J NEUROSCI, V27, P9984, DOI 10.1523/JNEUROSCI.2131-07.2007; Pleskac TJ, 2010, PSYCHOL REV, V117, P864, DOI 10.1037/a0019737; Rangel A, 2010, CURR OPIN NEUROBIOL, V20, P262, DOI 10.1016/j.conb.2010.03.001; Rolls ET, 2010, NEUROIMAGE, V53, P694, DOI 10.1016/j.neuroimage.2010.06.073; Smith DV, 2010, J NEUROSCI, V30, P2490, DOI 10.1523/JNEUROSCI.3319-09.2010; Song C, 2011, CONSCIOUS COGN, V20, P1787, DOI 10.1016/j.concog.2010.12.011; Sugrue LP, 2005, NAT REV NEUROSCI, V6, P363, DOI 10.1038/nrn1666; Summerfield C, 2012, FRONT NEUROSCI-SWITZ, V6, DOI 10.3389/fnins.2012.00070; VICKERS D, 1970, Ergonomics, V13, P37, DOI 10.1080/00140137008931117; Vickers D., 1979, DECISION PROCESSES V; Yokoyama O, 2010, NEUROSCI RES, V68, P199, DOI 10.1016/j.neures.2010.07.2041	37	276	276	3	60	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JAN	2013	16	1					105	U147		10.1038/nn.3279	http://dx.doi.org/10.1038/nn.3279			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	058KZ	23222911	Green Accepted, Green Published			2022-12-28	WOS:000312633900019
J	Paz, JT; Davidson, TJ; Frechette, ES; Delord, B; Parada, I; Peng, K; Deisseroth, K; Huguenard, JR				Paz, Jeanne T.; Davidson, Thomas J.; Frechette, Eric S.; Delord, Bruno; Parada, Isabel; Peng, Kathy; Deisseroth, Karl; Huguenard, John R.			Closed-loop optogenetic control of thalamus as a tool for interrupting seizures after cortical injury	NATURE NEUROSCIENCE			English	Article							PHOTOTHROMBOTIC BRAIN INFARCTION; RELAY NEURONS; EPILEPTIFORM ACTIVITY; IN-VITRO; EPILEPSY; STROKE; RATS; EPILEPTOGENESIS; BIOCYTIN; MODEL	Cerebrocortical injuries such as stroke are a major source of disability. Maladaptive consequences can result from post-injury local reorganization of cortical circuits. For example, epilepsy is a common sequela of cortical stroke, but the mechanisms responsible for seizures following cortical injuries remain unknown. In addition to local reorganization, long-range, extra-cortical connections might be critical for seizure maintenance. In rats, we found that the thalamus, a structure that is remote from, but connected to, the injured cortex, was required to maintain cortical seizures. Thalamocortical neurons connected to the injured epileptic cortex underwent changes in HCN channel expression and became hyperexcitable. Targeting these neurons with a closed-loop optogenetic strategy revealed that reducing their activity in real-time was sufficient to immediately interrupt electrographic and behavioral seizures. This approach is of therapeutic interest for intractable epilepsy, as it spares cortical function between seizures, in contrast with existing treatments, such as surgical lesioning or drugs.	[Paz, Jeanne T.; Frechette, Eric S.; Parada, Isabel; Peng, Kathy; Huguenard, John R.] Stanford Univ, Sch Med, Dept Neurol & Neurol Sci, Stanford, CA 94305 USA; [Davidson, Thomas J.; Deisseroth, Karl] Stanford Univ, Sch Med, Dept Bioengn, Stanford, CA 94305 USA; [Delord, Bruno] Univ Paris 06, CNRS, Unite Mixte Rech 7222, Inst Syst Intelligents & Robot, Paris, France	Stanford University; Stanford University; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite	Huguenard, JR (corresponding author), Stanford Univ, Sch Med, Dept Neurol & Neurol Sci, Stanford, CA 94305 USA.	jtpaz@stanford.edu; john.huguenard@stanford.edu	Ritter, Stefanie L/D-9312-2012; Huguenard, John/K-6429-2019; Huguenard, John/I-5016-2012	Huguenard, John/0000-0002-6950-1191; Huguenard, John/0000-0002-6950-1191; Davidson, Thomas/0000-0003-0836-6333	US National Institute of Neurological Disorders and Stroke [K99NS078118-01, 5R01NS006477, 5R01NS034774]; Epilepsy Foundation; Berry Foundation; Howard Hughes Medical Institute; California Institute for Regenerative Medicine; US National Institutes of Health; Defence Advanced Research Projects Agency (DARPA) Reorganization and Plasticity to Accelerate Injury Recovery (REPAIR) Program; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K99NS078118, R01NS006477, R01NS034774] Funding Source: NIH RePORTER	US National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Epilepsy Foundation; Berry Foundation; Howard Hughes Medical Institute(Howard Hughes Medical Institute); California Institute for Regenerative Medicine(California Institute for Regenerative Medicine); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Defence Advanced Research Projects Agency (DARPA) Reorganization and Plasticity to Accelerate Injury Recovery (REPAIR) Program; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank C. Pisaturo for designing and fabricating custom electronics, A. Herbert and S. Jin for their help with animal husbandry, and K. Graber and D. Prince for discussions related to clinical aspects of post-stroke epilepsy. J.T.P. is supported by the US National Institute of Neurological Disorders and Stroke (grant K99NS078118-01) and the Epilepsy Foundation. J.R.H. is supported by grants from the US National Institute of Neurological Disorders and Stroke (5R01NS006477 and 5R01NS034774). T.J.D. is supported by a Berry Foundation Postdoctoral fellowship. K. D. is supported by the Howard Hughes Medical Institute, the California Institute for Regenerative Medicine, the US National Institutes of Health and the Defence Advanced Research Projects Agency (DARPA) Reorganization and Plasticity to Accelerate Injury Recovery (REPAIR) Program. E. S. F. is supported by a Epilepsy Foundation Postdoctoral Fellowship.	BRUEHL C, 1995, EUR J NEUROSCI, V7, P192, DOI 10.1111/j.1460-9568.1995.tb01055.x; Bryant AS, 2009, J NEUROPHYSIOL, V102, P2880, DOI 10.1152/jn.00476.2009; Clarkson AN, 2010, NATURE, V468, P305, DOI 10.1038/nature09511; Detre JA, 1996, EPILEPSIA, V37, P657, DOI 10.1111/j.1528-1157.1996.tb00630.x; Esteller R, 2001, P ANN INT IEEE EMBS, V23, P1707, DOI 10.1109/IEMBS.2001.1020545; GASTEIGER EL, 1985, EXP NEUROL, V88, P349, DOI 10.1016/0014-4886(85)90197-9; Gradinaru V, 2010, CELL, V141, P154, DOI 10.1016/j.cell.2010.02.037; HOFFMAN SN, 1994, J NEUROPHYSIOL, V71, P1762, DOI 10.1152/jn.1994.71.5.1762; HORIKAWA K, 1988, J NEUROSCI METH, V25, P1, DOI 10.1016/0165-0270(88)90114-8; HUGUENARD JR, 1994, J NEUROSCI, V14, P5485; HUGUENARD JR, 1992, J NEUROPHYSIOL, V68, P1373, DOI 10.1152/jn.1992.68.4.1373; Huguenard JR., 1997, THALAMUS, P295; Karhunen H, 2007, NEUROSCIENCE, V148, P314, DOI 10.1016/j.neuroscience.2007.05.047; Kelly Kevin M, 2007, Epilepsy Curr, V7, P159, DOI 10.1111/j.1535-7511.2007.00211.x; Kelly KM, 2001, EPILEPSY RES, V47, P189, DOI 10.1016/S0920-1211(01)00294-7; Kharlamov EA, 2003, EPILEPSY RES, V56, P185, DOI 10.1016/j.eplepsyres.2003.09.005; KOTILA M, 1992, EPILEPSIA, V33, P495, DOI 10.1111/j.1528-1157.1992.tb01698.x; Kwan P, 2000, NEW ENGL J MED, V342, P314, DOI 10.1056/NEJM200002033420503; Lee JC, 2009, BRAIN DEV-JPN, V31, P294, DOI 10.1016/j.braindev.2008.05.006; Loiseau P., 1997, SEIZURES EPILEPSY EL, P63; Marder E, 2006, NAT REV NEUROSCI, V7, P563, DOI 10.1038/nrn1949; MCCORMICK DA, 1990, J PHYSIOL-LONDON, V431, P291, DOI 10.1113/jphysiol.1990.sp018331; MONDRAGON S, 1990, EPILEPSY RES, V5, P137, DOI 10.1016/0920-1211(90)90030-Y; Paz JT, 2011, NAT NEUROSCI, V14, P1167, DOI 10.1038/nn.2896; Paz JT, 2010, J NEUROSCI, V30, P5465, DOI 10.1523/JNEUROSCI.5083-09.2010; Redecker C, 1997, EPILEPSY RES, V27, P127, DOI 10.1016/S0920-1211(97)01029-2; Reid CA, 2012, BRIT J PHARMACOL, V165, P49, DOI 10.1111/j.1476-5381.2011.01507.x; Schofield CM, 2009, P NATL ACAD SCI USA, V106, P7630, DOI 10.1073/pnas.0811326106; Tonnesen J, 2009, P NATL ACAD SCI USA, V106, P12162, DOI 10.1073/pnas.0901915106; Torrence C, 1998, B AM METEOROL SOC, V79, P61, DOI 10.1175/1520-0477(1998)079<0061:APGTWA>2.0.CO;2; TSENG GF, 1991, J NEUROSCI METH, V37, P121, DOI 10.1016/0165-0270(91)90122-G; Tye KM, 2012, NAT REV NEUROSCI, V13, P251, DOI 10.1038/nrn3171; WANG XJ, 1994, NEUROSCIENCE, V59, P21, DOI 10.1016/0306-4522(94)90095-7; Yizhar O, 2011, NATURE, V477, P171, DOI 10.1038/nature10360	34	361	374	6	92	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JAN	2013	16	1					64	U98		10.1038/nn.3269	http://dx.doi.org/10.1038/nn.3269			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	058KZ	23143518	Green Submitted, Green Accepted			2022-12-28	WOS:000312633900014
J	Hahn, TTG; McFarland, JM; Berberich, S; Sakmann, B; Mehta, MR				Hahn, Thomas T. G.; McFarland, James M.; Berberich, Sven; Sakmann, Bert; Mehta, Mayank R.			Spontaneous persistent activity in entorhinal cortex modulates cortico-hippocampal interaction in vivo	NATURE NEUROSCIENCE			English	Article							UP-DOWN STATES; LAYER-III NEURONS; NEOCORTICAL NEURONS; PRINCIPAL NEURONS; SPATIAL REPRESENTATION; CELLULAR PROPERTIES; SLOW OSCILLATIONS; SLEEP STATES; MEMORY; INPUT	Persistent activity is thought to mediate working memory during behavior. Can it also occur during sleep? We found that the membrane potential of medial entorhinal cortex layer III (MECIII) neurons, a gateway between neocortex and hippocampus, showed spontaneous, stochastic persistent activity in vivo in mice during Up-Down state oscillations (UDS). This persistent activity was locked to the neocortical Up states with a short delay, but persisted over several cortical UDS cycles. Lateral entorhinal neurons did not show substantial persistence, and current injections similar to those used in vitro failed to elicit persistence in vivo, implicating network mechanisms. Hippocampal CA1 neurons' spiking activity was reduced during neocortical Up states, but was increased during MECIII persistent states. These results provide, to the best of our knowledge, the first direct evidence for persistent activity in MECIII neurons in vivo and reveal its contribution to cortico-hippocampal interaction that could be involved in working memory and learning of long behavioral sequences during behavior, and memory consolidation during sleep.	[McFarland, James M.; Mehta, Mayank R.] Univ Calif Los Angeles, Dept Phys & Astron, Keck Ctr Neurophys, Los Angeles, CA 90024 USA; [McFarland, James M.; Mehta, Mayank R.] Univ Calif Los Angeles, Integrat Ctr Learning & Memory, Los Angeles, CA USA; [Hahn, Thomas T. G.; Berberich, Sven] Univ Heidelberg, Med Fac Mannheim, Cent Inst Mental Hlth, Dept Psychiat, D-6800 Mannheim, Germany; [Hahn, Thomas T. G.; Berberich, Sven] Max Planck Inst Med Res, Behav Neurophysiol Grp, Heidelberg, Germany; [McFarland, James M.] Brown Univ, Dept Phys, Providence, RI 02912 USA; [Sakmann, Bert] Max Planck Inst Neurobiol, Dept Neurobiol, Munich, Germany; [Mehta, Mayank R.] Univ Calif Los Angeles, Dept Neurol, Los Angeles, CA 90024 USA; [Mehta, Mayank R.] Univ Calif Los Angeles, Dept Neurobiol, Los Angeles, CA USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; Central Institute of Mental Health; Ruprecht Karls University Heidelberg; Max Planck Society; Brown University; Max Planck Society; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Mehta, MR (corresponding author), Univ Calif Los Angeles, Dept Phys & Astron, Keck Ctr Neurophys, Los Angeles, CA 90024 USA.	mayankmehta@ucla.edu		Mehta, Mayank/0000-0003-2005-2468	Whitehall Foundation; National Science Foundation; W.M. Keck Foundation; German Ministry of Education and Research (BMBF) [01GQ1007, 01GQ1003B]; Max Planck Society; group of A. Schafer at the Max Planck Institute for Medical Research; NIH-BMBF-CRCNS [5R01MH092925-02]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH092925] Funding Source: NIH RePORTER	Whitehall Foundation; National Science Foundation(National Science Foundation (NSF)); W.M. Keck Foundation(W.M. Keck Foundation); German Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); Max Planck Society(Max Planck SocietyFoundation CELLEX); group of A. Schafer at the Max Planck Institute for Medical Research; NIH-BMBF-CRCNS; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank T. Fucke for extensive support with experiments. J.M.M. and M.R.M. were supported by the Whitehall Foundation, a National Science Foundation career award and the W.M. Keck Foundation. T.T.G.H. and S.B. were supported by the German Ministry of Education and Research (BMBF grants 01GQ1007 and 01GQ1003B), and supported by the Max Planck Society and the group of A. Schafer at the Max Planck Institute for Medical Research. All of the authors were supported by NIH-BMBF-CRCNS grant 5R01MH092925-02 to M.R.M.	Ahmed OJ, 2009, TRENDS NEUROSCI, V32, P329, DOI 10.1016/j.tins.2009.01.009; Brun VH, 2008, NEURON, V57, P290, DOI 10.1016/j.neuron.2007.11.034; Canto CB, 2012, HIPPOCAMPUS, V22, P1256, DOI 10.1002/hipo.20997; Canto CB, 2012, HIPPOCAMPUS, V22, P1277, DOI 10.1002/hipo.20993; Clement EA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002004; Deshmukh SS, 2011, FRONT BEHAV NEUROSCI, V5, DOI 10.3389/fnbeh.2011.00069; Destexhe A, 1999, J NEUROSCI, V19, P4595, DOI 10.1523/jneurosci.19-11-04595.1999; Diekelmann S, 2010, NAT REV NEUROSCI, V11, P114, DOI 10.1038/nrn2762; Egorov AV, 2002, NATURE, V420, P173, DOI 10.1038/nature01171; Fransen E, 2006, NEURON, V49, P735, DOI 10.1016/j.neuron.2006.01.036; Friedberg MH, 1999, J NEUROPHYSIOL, V81, P2243, DOI 10.1152/jn.1999.81.5.2243; Ghorbani M, 2012, PHYS REV E, V85, DOI 10.1103/PhysRevE.85.021908; Giocomo LM, 2007, SCIENCE, V315, P1719, DOI 10.1126/science.1139207; Gloveli T, 1997, NEUROSCIENCE, V77, P629, DOI 10.1016/S0306-4522(96)00494-0; GOLDMANRAKIC PS, 1995, NEURON, V14, P477, DOI 10.1016/0896-6273(95)90304-6; Hafting T, 2005, NATURE, V436, P801, DOI 10.1038/nature03721; Hahn TTG, 2007, P NATL ACAD SCI USA, V104, P5169, DOI 10.1073/pnas.0700222104; Hahn TTG, 2006, NAT NEUROSCI, V9, P1359, DOI 10.1038/nn1788; Hargreaves EL, 2005, SCIENCE, V308, P1792, DOI 10.1126/science.1110449; Henriksen EJ, 2010, NEURON, V68, P127, DOI 10.1016/j.neuron.2010.08.042; Isomura Y, 2006, NEURON, V52, P871, DOI 10.1016/j.neuron.2006.10.023; Ji DY, 2007, NAT NEUROSCI, V10, P100, DOI 10.1038/nn1825; Knierim JJ, 2006, LEARN MEMORY, V13, P405, DOI 10.1101/lm.224606; Major G, 2004, CURR OPIN NEUROBIOL, V14, P675, DOI 10.1016/j.conb.2004.10.017; Mann EO, 2009, J NEUROSCI, V29, P7513, DOI 10.1523/JNEUROSCI.6162-08.2009; Manns JR, 2006, HIPPOCAMPUS, V16, P795, DOI 10.1002/hipo.20205; MARR D, 1971, PHILOS T ROY SOC B, V262, P23, DOI 10.1098/rstb.1971.0078; Marshall L, 2006, NATURE, V444, P610, DOI 10.1038/nature05278; MCCLELLAND JL, 1995, PSYCHOL REV, V102, P419, DOI 10.1037/0033-295X.102.3.419; Mehta MR, 2007, NAT NEUROSCI, V10, P13, DOI 10.1038/nn0107-13; Mehta MR, 2002, NATURE, V417, P741, DOI 10.1038/nature00807; Mehta MR, 2000, NEURON, V25, P707, DOI 10.1016/S0896-6273(00)81072-7; Mehta MR, 1997, P NATL ACAD SCI USA, V94, P8918, DOI 10.1073/pnas.94.16.8918; O'Keefe J, 1979, HIPPOCAMPUS COGNITIV; Petersen CCH, 2003, P NATL ACAD SCI USA, V100, P13638, DOI 10.1073/pnas.2235811100; Remondes M, 2004, NATURE, V431, P699, DOI 10.1038/nature02965; Sargolini F, 2006, SCIENCE, V312, P758, DOI 10.1126/science.1125572; Sirota A, 2003, P NATL ACAD SCI USA, V100, P2065, DOI 10.1073/pnas.0437938100; SQUIRE LR, 1992, PSYCHOL REV, V99, P195, DOI 10.1037/0033-295X.99.2.195; Steriade M, 2001, J NEUROPHYSIOL, V85, P1969, DOI 10.1152/jn.2001.85.5.1969; STERIADE M, 1993, J NEUROSCI, V13, P3252, DOI 10.1523/jneurosci.13-08-03252.1993; Suh J, 2011, SCIENCE, V334, P1415, DOI 10.1126/science.1210125; Tahvildari B, 2005, J COMP NEUROL, V491, P123, DOI 10.1002/cne.20706; Tahvildari B, 2007, HIPPOCAMPUS, V17, P257, DOI 10.1002/hipo.20270; van Strien NM, 2009, NAT REV NEUROSCI, V10, P272, DOI 10.1038/nrn2614; Volgushev M, 2006, J NEUROSCI, V26, P5665, DOI 10.1523/JNEUROSCI.0279-06.2006; WITTER MP, 1993, HIPPOCAMPUS, V3, P33; Wolansky T, 2006, J NEUROSCI, V26, P6213, DOI 10.1523/JNEUROSCI.5594-05.2006; Yoshida M, 2008, EUR J NEUROSCI, V28, P1116, DOI 10.1111/j.1460-9568.2008.06409.x	49	81	81	0	32	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	NOV	2012	15	11					1531	1538		10.1038/nn.3236	http://dx.doi.org/10.1038/nn.3236			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	028LX	23042081	Green Accepted			2022-12-28	WOS:000310424900013
J	Ji, J; Kline, AE; Amoscato, A; Samhan-Arias, AK; Sparvero, LJ; Tyurin, VA; Tyurina, YY; Fink, B; Manole, MD; Puccio, AM; Okonkwo, DO; Cheng, JP; Alexander, H; Clark, RSB; Kochanek, PM; Wipf, P; Kagan, VE; Bayir, H				Ji, Jing; Kline, Anthony E.; Amoscato, Andrew; Samhan-Arias, Alejandro K.; Sparvero, Louis J.; Tyurin, Vladimir A.; Tyurina, Yulia Y.; Fink, Bruno; Manole, Mioara D.; Puccio, Ava M.; Okonkwo, David O.; Cheng, Jeffrey P.; Alexander, Henry; Clark, Robert S. B.; Kochanek, Patrick M.; Wipf, Peter; Kagan, Valerian E.; Bayir, Huelya			Lipidomics identifies cardiolipin oxidation as a mitochondrial target for redox therapy of brain injury	NATURE NEUROSCIENCE			English	Article							CYTOCHROME-C RELEASE; PERMEABILITY TRANSITION; SUPEROXIDE-DISMUTASE; PEROXIDATION; NITROXIDE; DAMAGE; STRESS; LIPIDS; SCAVENGERS; REDUCTION	The brain contains a highly diversified complement of molecular species of a mitochondria-specific phospholipid, cardiolipin, which, because of its polyunsaturation, can readily undergo oxygenation. Using global lipidomics analysis in experimental traumatic brain injury (TBI), we found that TBI was accompanied by oxidative consumption of polyunsaturated cardiolipin and the accumulation of more than 150 new oxygenated molecular species of cardiolipin. RNAi-based manipulations of cardiolipin synthase and cardiolipin levels conferred resistance to mechanical stretch, an in vitro model of traumatic neuronal injury, in primary rat cortical neurons. By applying a brain-permeable mitochondria-targeted electron scavenger, we prevented cardiolipin oxidation in the brain, achieved a substantial reduction in neuronal death both in vitro and in vivo, and markedly reduced behavioral deficits and cortical lesion volume. We conclude that cardiolipin oxygenation generates neuronal death signals and that prevention of it by mitochondria-targeted small molecule inhibitors represents a new target for neuro-drug discovery.	[Ji, Jing; Alexander, Henry; Clark, Robert S. B.; Kochanek, Patrick M.; Bayir, Huelya] Univ Pittsburgh, Dept Crit Care Med, Pittsburgh, PA 15260 USA; [Ji, Jing; Amoscato, Andrew; Samhan-Arias, Alejandro K.; Sparvero, Louis J.; Tyurin, Vladimir A.; Tyurina, Yulia Y.; Kagan, Valerian E.; Bayir, Huelya] Univ Pittsburgh, Dept Environm & Occupat Hlth, Pittsburgh, PA USA; [Ji, Jing; Amoscato, Andrew; Samhan-Arias, Alejandro K.; Sparvero, Louis J.; Tyurin, Vladimir A.; Tyurina, Yulia Y.; Kagan, Valerian E.; Bayir, Huelya] Univ Pittsburgh, Ctr Free Rad & Antioxidant Hlth, Pittsburgh, PA USA; [Ji, Jing; Kline, Anthony E.; Manole, Mioara D.; Cheng, Jeffrey P.; Alexander, Henry; Clark, Robert S. B.; Kochanek, Patrick M.; Bayir, Huelya] Univ Pittsburgh, Safar Ctr Resuscitat Res, Pittsburgh, PA USA; [Kline, Anthony E.; Cheng, Jeffrey P.] Univ Pittsburgh, Dept Phys Med & Rehabil, Pittsburgh, PA USA; [Kline, Anthony E.] Univ Pittsburgh, Ctr Neurosci, Pittsburgh, PA USA; [Fink, Bruno] Noxygen Sci Transfer & Diagnost GmbH, Elzach, Germany; [Manole, Mioara D.; Clark, Robert S. B.; Kochanek, Patrick M.; Bayir, Huelya] Univ Pittsburgh, Childrens Hosp Pittsburgh, Med Ctr, Pittsburgh, PA 15213 USA; [Puccio, Ava M.; Okonkwo, David O.] Univ Pittsburgh, Dept Neurol Surg, Pittsburgh, PA 15260 USA; [Wipf, Peter] Univ Pittsburgh, Dept Chem, Pittsburgh, PA 15260 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Bayir, H (corresponding author), Univ Pittsburgh, Dept Crit Care Med, Pittsburgh, PA 15260 USA.	bayihx@ccm.upmc.edu	Samhan-Arias, Alejandro/J-3593-2014; Wipf, Peter/AAG-1771-2021; Ji, J/O-2816-2013; Kochanek, Patrick M/D-2371-2015; Cheng, Jeffrey P/HHS-7221-2022	Samhan-Arias, Alejandro/0000-0001-9602-4848; Wipf, Peter/0000-0001-7693-5863; Kochanek, Patrick M/0000-0002-2627-913X; Tyurina, Yulia/0000-0003-0287-2091; Kagan, Valerian E./0000-0002-7245-1885; Amoscato, Andrew/0000-0002-1340-9150; Cheng, Jeffrey/0000-0001-8285-3207; Tyurin, Vladimir/0000-0002-3474-1697	US National Institutes of Health [NS061817, NS060005, HL070755, ES020693, NS076511, U19AI068021]; US National Institute for Occupational Safety and Health [OH008282]; US Army [W81XWH-09-0187]; La Junta de Extremadura y el Fondo Social Europeo [2010063090]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD069620] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL070755] Funding Source: NIH RePORTER; NATIONAL INSTITUTE FOR OCCUPATIONAL SAFETY AND HEALTH [R01OH008282] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI068021] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES020693] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS060005, R01NS061817, R01NS076511] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US National Institute for Occupational Safety and Health(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USANational Institute for Occupational Safety & Health (NIOSH)); US Army(United States Department of DefenseUnited States Army); La Junta de Extremadura y el Fondo Social Europeo; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE FOR OCCUPATIONAL SAFETY AND HEALTH(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USANational Institute for Occupational Safety & Health (NIOSH)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The authors would like to thank J. Lewis for the technical assistance of unbiased stereology for cortical lesion volume, J. Davoren for the preparation of XJB-5-131 and Y.M. Frapart (Laboratoire de Chimie Biochimie Pharmacologique et Toxicologique, Universite Paris Descartes) for providing an L-band EPR spectrometer for in vivo imaging. This study was supported in part by grants from the US National Institutes of Health (NS061817 (H.B.), NS060005 (A.E.K.), HL070755 (V.E.K.), ES020693 (Y.Y.T. and V.E.K.), NS076511 and U19AI068021 (H.B. and V.E.K.)), the US National Institute for Occupational Safety and Health (OH008282 to V.E.K.) and the US Army (W81XWH-09-0187 to P.M.K.). A.K.S.-A. is a recipient of a research fellowship from La Junta de Extremadura y el Fondo Social Europeo (2010063090).	Alessandri B, 2002, J NEUROTRAUM, V19, P829, DOI 10.1089/08977150260190429; Bayir H, 2002, PEDIATR RES, V51, P571, DOI 10.1203/00006450-200205000-00005; Bayir H, 2007, ANN NEUROL, V62, P154, DOI 10.1002/ana.21168; Betaneli V, 2012, BIOPHYS J, V102, P523, DOI 10.1016/j.bpj.2011.12.049; Bobko AA, 2007, FREE RADICAL BIO MED, V42, P404, DOI 10.1016/j.freeradbiomed.2006.11.007; Broadhurst CL, 2002, COMP BIOCHEM PHYS B, V131, P653, DOI 10.1016/S1096-4959(02)00002-7; CHAN PH, 1980, J NEUROCHEM, V35, P1004, DOI 10.1111/j.1471-4159.1980.tb07100.x; DeKosky ST, 2010, NEW ENGL J MED, V363, P1293, DOI 10.1056/NEJMp1007051; Deng-Bryant Y, 2008, J CEREBR BLOOD F MET, V28, P1114, DOI 10.1038/jcbfm.2008.10; Fan P, 2003, J NEUROTRAUM, V20, P437, DOI 10.1089/089771503765355513; Faul M, 2010, TRAUMATIC BRAIN INJU, DOI DOI 10.15620/CDC.5571; Ghajar J, 2000, LANCET, V356, P923, DOI 10.1016/S0140-6736(00)02689-1; HAMM RJ, 1992, J NEUROTRAUM, V9, P11, DOI 10.1089/neu.1992.9.11; Kagan VE, 2005, NAT CHEM BIOL, V1, P223, DOI 10.1038/nchembio727; Kiebish MA, 2008, J NEUROCHEM, V106, P299, DOI 10.1111/j.1471-4159.2008.05383.x; Kline AE, 2004, J NEUROTRAUM, V21, P1712, DOI 10.1089/neu.2004.21.1712; Korytowski W, 2011, J BIOL CHEM, V286, P26334, DOI 10.1074/jbc.M110.188516; Lewen A, 2001, J CEREBR BLOOD F MET, V21, P914, DOI 10.1097/00004647-200108000-00003; Lo EH, 2001, BRAIN RES REV, V38, P140, DOI 10.1016/S0165-0173(01)00083-2; Maas AIR, 2010, NEUROTHERAPEUTICS, V7, P115, DOI 10.1016/j.nurt.2009.10.022; McKee AC, 2010, J NEUROPATH EXP NEUR, V69, P918, DOI 10.1097/NEN.0b013e3181ee7d85; MITCHELL JB, 1990, BIOCHEMISTRY-US, V29, P2802, DOI 10.1021/bi00463a024; MUIZELAAR JP, 1993, J NEUROSURG, V78, P375, DOI 10.3171/jns.1993.78.3.0375; Nakagawa Y, 2004, ANN NY ACAD SCI, V1011, P177, DOI 10.1196/annals.1293.018; Nomura K, 2000, BIOCHEM J, V351, P183, DOI 10.1042/0264-6021:3510183; Ott M, 2002, P NATL ACAD SCI USA, V99, P1259, DOI 10.1073/pnas.241655498; Petrosillo G, 2006, FEBS LETT, V580, P6311, DOI 10.1016/j.febslet.2006.10.036; Petrosillo G, 2010, J PINEAL RES, V48, P340, DOI 10.1111/j.1600-079X.2010.00758.x; Ran QT, 2004, J BIOL CHEM, V279, P55137, DOI 10.1074/jbc.M410387200; RAND, 2011, INV WOUNDS WAR STUD; Rostovtseva TK, 2006, J BIOL CHEM, V281, P37496, DOI 10.1074/jbc.M602548200; Scafidi S, 2010, DEV NEUROSCI-BASEL, V32, P480, DOI 10.1159/000323178; Scheff SW, 1999, J NEUROTRAUM, V16, P783, DOI 10.1089/neu.1999.16.783; Schmued LC, 2005, BRAIN RES, V1035, P24, DOI 10.1016/j.brainres.2004.11.054; SIESJO BK, 1981, J CEREBR BLOOD F MET, V1, P155, DOI 10.1038/jcbfm.1981.18; Singh IN, 2007, J NEUROSCI RES, V85, P2216, DOI 10.1002/jnr.21360; Sorice M, 2004, CELL DEATH DIFFER, V11, P1133, DOI 10.1038/sj.cdd.4401457; Soule BP, 2007, FREE RADICAL BIO MED, V42, P1632, DOI 10.1016/j.freeradbiomed.2007.02.030; Stoica BA, 2010, NEUROTHERAPEUTICS, V7, P3, DOI 10.1016/j.nurt.2009.10.023; Stoyanovsky DA, 1998, FREE RADICAL BIO MED, V25, P536, DOI 10.1016/S0891-5849(98)00081-1; Thurman DJ, 1999, J HEAD TRAUMA REHAB, V14, P602, DOI 10.1097/00001199-199912000-00009; Trnka J, 2008, FREE RADICAL BIO MED, V44, P1406, DOI 10.1016/j.freeradbiomed.2007.12.036; Verweij BH, 2000, J NEUROSURG, V93, P815, DOI 10.3171/jns.2000.93.5.0815; WEI EP, 1981, CIRC RES, V48, P95, DOI 10.1161/01.RES.48.1.95; Wilcox CS, 2008, PHARMACOL REV, V60, P418, DOI 10.1124/pr.108.000240; Wipf P, 2005, J AM CHEM SOC, V127, P12460, DOI 10.1021/ja053679l; Zhang RL, 1999, FREE RADICAL BIO MED, V26, P1245, DOI 10.1016/S0891-5849(98)00328-1; Zhao ZS, 2010, ENDOCRINOLOGY, V151, P3038, DOI 10.1210/en.2010-0016	48	214	223	3	94	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	OCT	2012	15	10					1407	1413		10.1038/nn.3195	http://dx.doi.org/10.1038/nn.3195			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	013VZ	22922784	Green Accepted			2022-12-28	WOS:000309335300021
J	Williams, KW; Elmquist, JK				Williams, Kevin W.; Elmquist, Joel K.			From neuroanatomy to behavior: central integration of peripheral signals regulating feeding behavior	NATURE NEUROSCIENCE			English	Review							GLUCAGON-LIKE PEPTIDE-1; NUCLEUS-TRACTUS-SOLITARIUS; LEPTIN RECEPTOR GENE; FOOD-INTAKE; PROOPIOMELANOCORTIN NEURONS; BODY-WEIGHT; ENERGY-BALANCE; GLUCOSE-HOMEOSTASIS; INSULIN SENSITIVITY; ARCUATE NUCLEUS	Over the past two centuries, prevalent models of energy and glucose homeostasis have emerged from careful anatomical descriptions in tandem with an understanding of cellular physiology. More recent technological advances have culminated in the identification of peripheral and central factors that influence neural circuits regulating metabolism. This Review highlights contributions to our understanding of peripheral and central factors regulating food intake and energy expenditure.	[Williams, Kevin W.; Elmquist, Joel K.] Univ Texas SW Med Ctr Dallas, Div Hypothalam Res, Dept Internal Med, Dallas, TX 75390 USA; [Elmquist, Joel K.] Univ Texas SW Med Ctr Dallas, Dept Pharmacol, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	Williams, KW (corresponding author), Univ Texas SW Med Ctr Dallas, Div Hypothalam Res, Dept Internal Med, Dallas, TX 75390 USA.	kevin.williams@utsouthwestern.edu	Williams, Kevin W/ABD-5818-2021; Williams, Kevin W/AAA-4243-2020	Williams, Kevin W/0000-0002-8434-8658; Williams, Kevin W/0000-0002-8434-8658	US National Institutes of Health [K01 DK087780, DK53301, MH61583, DK08876, DK081185, DK71320]; American Diabetes Association; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK071320, R01DK053301, RL1DK081185, K01DK087780, F32DK008876, R37DK053301] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH061583] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Diabetes Association(American Diabetes Association); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	The authors gratefully acknowledge M.M. Scott and L. Gautron for comments on the manuscript. This work was supported by the US National Institutes of Health (K01 DK087780 to K.W.W. and DK53301, MH61583, DK08876, DK081185 and DK71320 to J.K.E.) and by an award from the American Diabetes Association to J.K.E.	Accili D, 1996, NAT GENET, V12, P106, DOI 10.1038/ng0196-106; Aponte Y, 2011, NAT NEUROSCI, V14, P351, DOI 10.1038/nn.2739; Arvat E, 2000, J ENDOCRINOL INVEST, V23, P493, DOI 10.1007/BF03343763; Atasoy D, 2012, NATURE, V488, P172, DOI 10.1038/nature11270; Baldock PA, 2007, J BIOL CHEM, V282, P19092, DOI 10.1074/jbc.M700644200; Balthasar N, 2005, CELL, V123, P493, DOI 10.1016/j.cell.2005.08.035; Balthasar N, 2004, NEURON, V42, P983, DOI 10.1016/j.neuron.2004.06.004; Baptista V, 2005, J NEUROPHYSIOL, V94, P2763, DOI 10.1152/jn.00351.2005; Barrera JG, 2011, NAT REV ENDOCRINOL, V7, P507, DOI 10.1038/nrendo.2011.77; Barsh GS, 2000, NATURE, V404, P644, DOI 10.1038/35007519; Bates SH, 2003, NATURE, V421, P856, DOI 10.1038/nature01388; Berglund ED, 2012, J CLIN INVEST, V122, P1000, DOI 10.1172/JCI59816; Bernard C., 1855, LECONS PHYSL EXPT AP, DOI [10.5962/bhl.title.1818, DOI 10.5962/BHL.TITLE.1818]; Berthoud HR, 2008, REGUL PEPTIDES, V149, P15, DOI 10.1016/j.regpep.2007.08.024; Bingham NC, 2008, ENDOCRINOLOGY, V149, P2138, DOI 10.1210/en.2007-1200; Bruning JC, 2000, SCIENCE, V289, P2122, DOI 10.1126/science.289.5487.2122; Butler AA, 2000, ENDOCRINOLOGY, V141, P3518, DOI 10.1210/en.141.9.3518; Chen H, 1996, CELL, V84, P491, DOI 10.1016/S0092-8674(00)81294-5; COLEMAN DL, 1969, AM J PHYSIOL, V217, P1298; COLEMAN DL, 1973, DIABETOLOGIA, V9, P294, DOI 10.1007/BF01221857; Coppari R, 2005, CELL METAB, V1, P63, DOI 10.1016/j.cmet.2004.12.004; de Wall EV, 2008, ENDOCRINOLOGY, V149, P1773, DOI 10.1210/en.2007-1132; Deisseroth K, 2011, NAT METHODS, V8, P26, DOI 10.1038/NMETH.F.324; Dhillon H, 2006, NEURON, V49, P191, DOI 10.1016/j.neuron.2005.12.021; Elias CF, 2000, J COMP NEUROL, V423, P261; Fan W, 1997, NATURE, V385, P165, DOI 10.1038/385165a0; Fan W, 2004, NAT NEUROSCI, V7, P335, DOI 10.1038/nn1214; Farooqi IS, 2003, NEW ENGL J MED, V348, P1085, DOI 10.1056/NEJMoa022050; GIBBS J, 1973, J COMP PHYSIOL PSYCH, V84, P488, DOI 10.1037/h0034870; GOKE R, 1995, EUR J NEUROSCI, V7, P2294, DOI 10.1111/j.1460-9568.1995.tb00650.x; Gradinaru V, 2010, CELL, V141, P154, DOI 10.1016/j.cell.2010.02.037; Grill HJ, 2002, ENDOCRINOLOGY, V143, P239, DOI 10.1210/en.143.1.239; Hansotia T, 2007, J CLIN INVEST, V117, P143, DOI 10.1172/JCI25483; Hayes MR, 2010, CELL METAB, V11, P77, DOI 10.1016/j.cmet.2009.10.009; Hill JW, 2008, J CLIN INVEST, V118, P1796, DOI 10.1172/JCI32964; Hill JW, 2010, CELL METAB, V11, P286, DOI 10.1016/j.cmet.2010.03.002; Holst JJ, 2007, PHYSIOL REV, V87, P1409, DOI 10.1152/physrev.00034.2006; Horvath TL, 2001, ENDOCRINOLOGY, V142, P4163, DOI 10.1210/en.142.10.4163; Huo L, 2009, CELL METAB, V9, P537, DOI 10.1016/j.cmet.2009.05.003; Joshi RL, 1996, EMBO J, V15, P1542, DOI 10.1002/j.1460-2075.1996.tb00498.x; Klockener T, 2011, NAT NEUROSCI, V14, P911, DOI 10.1038/nn.2847; Konner AC, 2007, CELL METAB, V5, P438, DOI 10.1016/j.cmet.2007.05.004; Krashes MJ, 2011, J CLIN INVEST, V121, P1424, DOI 10.1172/JCI46229; Lee GH, 1996, NATURE, V379, P632, DOI 10.1038/379632a0; Liu TM, 2012, NEURON, V73, P511, DOI 10.1016/j.neuron.2011.11.027; Luquet S, 2005, SCIENCE, V310, P683, DOI 10.1126/science.1115524; Luquet S, 2007, PEPTIDES, V28, P214, DOI 10.1016/j.peptides.2006.08.036; Merchenthaler I, 1999, J COMP NEUROL, V403, P261, DOI 10.1002/(SICI)1096-9861(19990111)403:2<261::AID-CNE8>3.0.CO;2-5; Michel MC, 1998, PHARMACOL REV, V50, P143; Moran TH, 2001, INT J OBESITY, V25, pS39, DOI 10.1038/sj.ijo.0801910; Morton GJ, 2005, CELL METAB, V2, P411, DOI 10.1016/j.cmet.2005.10.009; Morton GJ, 2003, ENDOCRINOLOGY, V144, P2016, DOI 10.1210/en.2002-0115; Noble F, 1999, PHARMACOL REV, V51, P745; Nonogaki K, 1998, NAT MED, V4, P1152, DOI 10.1038/2647; Padilla SL, 2010, NAT MED, V16, P403, DOI 10.1038/nm.2126; Pinto S, 2004, SCIENCE, V304, P110, DOI 10.1126/science.1089459; Qian S, 2002, MOL CELL BIOL, V22, P5027, DOI 10.1128/MCB.22.14.5027-5035.2002; Qiu J, 2010, J NEUROSCI, V30, P1560, DOI 10.1523/JNEUROSCI.4816-09.2010; Ramnanan CJ, 2012, CELL METAB, V15, P656, DOI 10.1016/j.cmet.2012.03.006; Rinaman L, 1999, AM J PHYSIOL-REG I, V277, pR582, DOI 10.1152/ajpregu.1999.277.2.R582; ROGERS RC, 1995, AM J PHYSIOL-GASTR L, V268, pG1, DOI 10.1152/ajpgi.1995.268.1.G1; Rossi J, 2011, CELL METAB, V13, P195, DOI 10.1016/j.cmet.2011.01.010; Sainsbury A, 2002, P NATL ACAD SCI USA, V99, P8938, DOI 10.1073/pnas.132043299; Schwartz GJ, 2000, NUTRITION, V16, P866, DOI 10.1016/S0899-9007(00)00464-0; Schwartz MW, 2005, SCIENCE, V307, P375, DOI 10.1126/science.1104344; Scott MM, 2011, J CLIN INVEST, V121, P2413, DOI 10.1172/JCI43703; Scrocchi LA, 1996, NAT MED, V2, P1254, DOI 10.1038/nm1196-1254; Shi HF, 2008, AM J PHYSIOL-ENDOC M, V294, pE630, DOI 10.1152/ajpendo.00704.2007; Shi YC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011361; Skibicka KP, 2009, ENDOCRINOLOGY, V150, P1705, DOI 10.1210/en.2008-1316; Smith GP, 2006, OBESITY, V14, p168S, DOI 10.1038/oby.2006.300; SMITH GP, 1981, SCIENCE, V213, P1036, DOI 10.1126/science.7268408; Sohn JW, 2011, NEURON, V71, P488, DOI 10.1016/j.neuron.2011.06.012; SOUTH EH, 1988, PEPTIDES, V9, P601, DOI 10.1016/0196-9781(88)90171-4; Spanswick D, 1997, NATURE, V390, P521, DOI 10.1038/37379; Spanswick D, 2000, NAT NEUROSCI, V3, P757, DOI 10.1038/77660; Sutton GM, 2006, ENDOCRINOLOGY, V147, P2183, DOI 10.1210/en.2005-1209; Tartaglia LA, 1995, CELL, V83, P1263, DOI 10.1016/0092-8674(95)90151-5; TECOTT LH, 1995, NATURE, V374, P542, DOI 10.1038/374542a0; Tong QC, 2008, NAT NEUROSCI, V11, P998, DOI 10.1038/nn.2167; Tschop MH, 2012, NAT METHODS, V9, P57, DOI [10.1038/NMETH.1806, 10.1038/nmeth.1806]; Turton MD, 1996, NATURE, V379, P69, DOI 10.1038/379069a0; van den Pol AN, 2003, NEURON, V40, P1059, DOI 10.1016/S0896-6273(03)00809-2; Vong L, 2011, NEURON, V71, P142, DOI 10.1016/j.neuron.2011.05.028; Williams KW, 2011, EUR J PHARMACOL, V660, P2, DOI 10.1016/j.ejphar.2010.11.042; Williams KW, 2010, J NEUROSCI, V30, P2472, DOI 10.1523/JNEUROSCI.3118-09.2010; WOODS SC, 1979, NATURE, V282, P503, DOI 10.1038/282503a0; Woods SC, 1998, SCIENCE, V280, P1378, DOI 10.1126/science.280.5368.1378; Woods SC, 2009, CELL METAB, V9, P489, DOI 10.1016/j.cmet.2009.04.007; Wu Q, 2012, NATURE, V483, P594, DOI 10.1038/nature10899; Wu Q, 2011, EUR J PHARMACOL, V660, P21, DOI 10.1016/j.ejphar.2010.10.110; Xu AW, 2007, ENDOCRINOLOGY, V148, P72, DOI 10.1210/en.2006-1119; Xu Y, 2010, NAT NEUROSCI, V13, P1457, DOI 10.1038/nn.2664; Xu Y, 2008, NEURON, V60, P582, DOI 10.1016/j.neuron.2008.09.033; Yeo GSH, 2012, NAT NEUROSCI, V15, P1343, DOI 10.1038/nn.3211; Zeltser LM, 2012, NAT NEUROSCI, V15, P1336, DOI 10.1038/nn.3219; ZHANG YY, 1994, NATURE, V372, P425, DOI 10.1038/372425a0; Zheng HY, 2010, AM J PHYSIOL-REG I, V298, pR720, DOI 10.1152/ajpregu.00619.2009; Zigman JM, 2003, ENDOCRINOLOGY, V144, P3749, DOI 10.1210/en.2003-0241; Zigman JM, 2005, J CLIN INVEST, V115, P3564, DOI 10.1172/JCI26002	100	286	290	0	78	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	OCT	2012	15	10					1350	1355		10.1038/nn.3217	http://dx.doi.org/10.1038/nn.3217			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	013VZ	23007190	Green Accepted			2022-12-28	WOS:000309335300010
J	Blakemore, SJ; Robbins, TW				Blakemore, Sarah-Jayne; Robbins, Trevor W.			Decision-making in the adolescent brain	NATURE NEUROSCIENCE			English	Review							HUMAN CORTICAL DEVELOPMENT; HUMAN PREFRONTAL CORTEX; RISK-TAKING; DEVELOPMENTAL-CHANGES; COGNITIVE CONTROL; NEURAL SYSTEMS; NEURODEVELOPMENTAL TRAJECTORIES; ORBITOFRONTAL CORTEX; PERSPECTIVE-TAKING; PREDICTION ERRORS	Adolescence is characterized by making risky decisions. Early lesion and neuroimaging studies in adults pointed to the ventromedial prefrontal cortex and related structures as having a key role in decision-making. More recent studies have fractionated decision-making processes into its various components, including the representation of value, response selection (including inter-temporal choice and cognitive control), associative learning, and affective and social aspects. These different aspects of decision-making have been the focus of investigation in recent studies of the adolescent brain. Evidence points to a dissociation between the relatively slow, linear development of impulse control and response inhibition during adolescence versus the nonlinear development of the reward system, which is often hyper-responsive to rewards in adolescence. This suggests that decision-making in adolescence may be particularly modulated by emotion and social factors, for example, when adolescents are with peers or in other affective ('hot') contexts.	[Blakemore, Sarah-Jayne] UCL, Inst Cognit Neurosci, London, England; [Robbins, Trevor W.] Univ Cambridge, Behav & Clin Neurosci Inst, Cambridge, England; [Robbins, Trevor W.] Univ Cambridge, Dept Expt Psychol, Cambridge CB2 3EB, England	University of London; University College London; University of Cambridge; University of Cambridge	Blakemore, SJ (corresponding author), UCL, Inst Cognit Neurosci, London, England.	s.blakemore@ucl.ac.uk	Robbins, Trevor W/A-7551-2008; Blakemore, Sarah-Jayne/A-1792-2010	Robbins, Trevor/0000-0003-0642-5977; Blakemore, Sarah-Jayne/0000-0002-1690-2805	Royal Society; Leverhulme Trust, UK; Medical Research Council; Wellcome Trust	Royal Society(Royal Society of London); Leverhulme Trust, UK(Leverhulme Trust); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust)	S.-J.B. is funded by the Royal Society and the Leverhulme Trust, UK. The Behavioural and Clinical Neuroscience Institute, Cambridge, UK is co-funded by the Medical Research Council and the Wellcome Trust. We thank S. Burnett Heyes, I. Dumontheil, A. L. Goddings, E.J. Kilford, K. Mills and N. Wright for commenting on previous versions of the manuscript, T. Wager for help with the meta-analysis using Neurosynth (http://neurosynth.org/), and L. Clark, J. Chein and L. Somerville for help with figures.	Aron AR, 2007, J NEUROSCI, V27, P3743, DOI 10.1523/JNEUROSCI.0519-07.2007; Baird AA, 2004, PHILOS T R SOC B, V359, P1797, DOI 10.1098/rstb.2004.1549; Ball WS, 2012, CEREB CORTEX, V22, P1, DOI 10.1093/cercor/bhr018; BECHARA A, 1994, COGNITION, V50, P7, DOI 10.1016/0010-0277(94)90018-3; Bernoulli D, 1954, ECONOMETRICA, V22, P22; Billieux J, 2010, BEHAV RES THER, V48, P1085, DOI 10.1016/j.brat.2010.07.008; Bjork JM, 2004, J NEUROSCI, V24, P1793, DOI 10.1523/JNEUROSCI.4862-03.2004; Blakemore SJ, 2008, NAT REV NEUROSCI, V9, P267, DOI 10.1038/nrn2353; Blakemore SJ, 2007, SOC COGN AFFECT NEUR, V2, P130, DOI 10.1093/scan/nsm009; Blakemore SJ, 2012, NEUROIMAGE, V61, P397, DOI 10.1016/j.neuroimage.2011.11.080; Breiter HC, 2001, NEURON, V30, P619, DOI 10.1016/S0896-6273(01)00303-8; Burnett S, 2010, COGNITIVE DEV, V25, P183, DOI 10.1016/j.cogdev.2009.11.003; Burnett S, 2009, J COGNITIVE NEUROSCI, V21, P1736, DOI 10.1162/jocn.2009.21121; Camerer C.F., 2011, BEHAV GAME THEORY EX, DOI 10.1257/jep.9.2.209; Camille N, 2010, COGN AFFECT BEHAV NE, V10, P460, DOI 10.3758/CABN.10.4.460; Casey BJ, 2008, ANN NY ACAD SCI, V1124, P111, DOI 10.1196/annals.1440.010; Casey BJ, 2011, P NATL ACAD SCI USA, V108, P14998, DOI 10.1073/pnas.1108561108; Cauffman E, 2010, DEV PSYCHOL, V46, P193, DOI 10.1037/a0016128; Chein J, 2011, DEVELOPMENTAL SCI, V14, pF1, DOI 10.1111/j.1467-7687.2010.01035.x; Christakou A, 2011, NEUROIMAGE, V54, P1344, DOI 10.1016/j.neuroimage.2010.08.067; Clark L, 2008, BRAIN, V131, P1311, DOI 10.1093/brain/awn066; Clark L, 2003, NEUROPSYCHOLOGIA, V41, P1474, DOI 10.1016/S0028-3932(03)00081-2; Clark L, 2007, BIOL PSYCHIAT, V61, P1395, DOI 10.1016/j.biopsych.2006.07.020; Clark L, 2009, NEURON, V61, P481, DOI 10.1016/j.neuron.2008.12.031; Clarke HF, 2008, J NEUROSCI, V28, P10972, DOI 10.1523/JNEUROSCI.1521-08.2008; Cohen JR, 2010, NAT NEUROSCI, V13, P669, DOI 10.1038/nn.2558; Coricelli G, 2005, NAT NEUROSCI, V8, P1255, DOI 10.1038/nn1514; Crone EA, 2008, DEV PSYCHOPATHOL, V20, P1213, DOI 10.1017/S0954579408000588; Damasio A.R., 2005, DESCARTES ERROR EMOT; Daw ND, 2002, NEURAL NETWORKS, V15, P603, DOI 10.1016/S0893-6080(02)00052-7; Doremus-Fitzwater TL, 2010, BRAIN COGNITION, V72, P114, DOI 10.1016/j.bandc.2009.08.008; Dumontheil I, 2010, DEVELOPMENTAL SCI, V13, P331, DOI 10.1111/j.1467-7687.2009.00888.x; Durston S, 2006, DEVELOPMENTAL SCI, V9, P1, DOI 10.1111/j.1467-7687.2005.00454.x; Everitt BJ, 2005, NAT NEUROSCI, V8, P1481, DOI 10.1038/nn1579; EYSENCK SBG, 1978, PSYCHOL REP, V43, P1247, DOI 10.2466/pr0.1978.43.3f.1247; Fellows LK, 2003, BRAIN, V126, P1830, DOI 10.1093/brain/awg180; Figner B, 2009, J EXP PSYCHOL LEARN, V35, P709, DOI 10.1037/a0014983; Frith CD, 2007, PHILOS T R SOC B, V362, P671, DOI 10.1098/rstb.2006.2003; Galvan A, 2006, J NEUROSCI, V26, P6885, DOI 10.1523/JNEUROSCI.1062-06.2006; Gardner M, 2005, DEV PSYCHOL, V41, P625, DOI 10.1037/0012-1649.41.4.625; Geier CF, 2010, CEREB CORTEX, V20, P1613, DOI 10.1093/cercor/bhp225; Giedd JN, 1999, NAT NEUROSCI, V2, P861, DOI 10.1038/13158; Gladwin TE, 2011, DEV COGN NEUROS-NETH, V1, P364, DOI 10.1016/j.dcn.2011.06.008; Gogtay N, 2004, P NATL ACAD SCI USA, V101, P8174, DOI 10.1073/pnas.0402680101; Greene JD, 2001, SCIENCE, V293, P2105, DOI 10.1126/science.1062872; Guroglu B, 2009, J EXP CHILD PSYCHOL, V104, P398, DOI 10.1016/j.jecp.2009.07.002; GUTH W, 1982, J ECON BEHAV ORGAN, V3, P367, DOI 10.1016/0167-2681(82)90011-7; Haber SN, 2010, NEUROPSYCHOPHARMACOL, V35, P4, DOI 10.1038/npp.2009.129; Harbaugh WT, 2002, EXP ECON, V5, P53, DOI 10.1023/A:1016316725855; Hare TA, 2008, BIOL PSYCHIAT, V63, P927, DOI 10.1016/j.biopsych.2008.03.015; Harris JJ, 2011, DEV COGN NEUROS-NETH, V1, P199, DOI 10.1016/j.dcn.2011.04.001; Houde O, 2010, DEVELOPMENTAL SCI, V13, P876, DOI 10.1111/j.1467-7687.2009.00938.x; Hsu M, 2005, SCIENCE, V310, P1680, DOI 10.1126/science.1115327; Huettel SA, 2005, J NEUROSCI, V25, P3304, DOI 10.1523/JNEUROSCI.5070-04.2005; Jensen K, 2007, SCIENCE, V318, P107, DOI 10.1126/science.1145850; Kable JW, 2007, NAT NEUROSCI, V10, P1625, DOI 10.1038/nn2007; KAHNEMAN D, 1979, ECONOMETRICA, V47, P263, DOI 10.2307/1914185; Kennerley SW, 2011, NAT NEUROSCI, V14, P1581, DOI 10.1038/nn.2961; Levy I, 2010, J NEUROPHYSIOL, V103, P1036, DOI 10.1152/jn.00853.2009; Logan Gordon D., 1994, P189; Luna B, 2001, NEUROIMAGE, V13, P786, DOI 10.1006/nimg.2000.0743; Manes F, 2002, BRAIN, V125, P624, DOI 10.1093/brain/awf049; McClure SM, 2004, SCIENCE, V306, P503, DOI 10.1126/science.1100907; MISCHEL W, 1989, SCIENCE, V244, P933, DOI 10.1126/science.2658056; Moor BG, 2012, SOC COGN AFFECT NEUR, V7, P44, DOI 10.1093/scan/nsr020; Paulsen DJ, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00072; Paus T, 2008, NAT REV NEUROSCI, V9, P947, DOI 10.1038/nrn2513; Petanjek Z, 2011, P NATL ACAD SCI USA, V108, P13281, DOI 10.1073/pnas.1105108108; Pfeifer JH, 2007, J COGNITIVE NEUROSCI, V19, P1323, DOI 10.1162/jocn.2007.19.8.1323; Pfeifer JH, 2012, TRENDS COGN SCI, V16, P322, DOI 10.1016/j.tics.2012.04.011; Pfeifer JH, 2009, CHILD DEV, V80, P1016, DOI 10.1111/j.1467-8624.2009.01314.x; Philpot RM, 2008, BEHAV NEUROSCI, V122, P861, DOI 10.1037/0735-7044.122.4.861; Platt ML, 1999, NATURE, V400, P233, DOI 10.1038/22268; RACHLIN H, 1991, J EXP ANAL BEHAV, V55, P233, DOI 10.1901/jeab.1991.55-233; Rangel A, 2008, NAT REV NEUROSCI, V9, P545, DOI 10.1038/nrn2357; Raznahan A, 2011, NEURON, V72, P873, DOI 10.1016/j.neuron.2011.09.028; Rogers RD, 1999, NEUROPSYCHOPHARMACOL, V20, P322, DOI 10.1016/S0893-133X(98)00091-8; Rubia K, 2000, NEUROSCI BIOBEHAV R, V24, P13, DOI 10.1016/S0149-7634(99)00055-X; Rubia K, 2001, NEUROIMAGE, V13, P250, DOI 10.1006/nimg.2000.0685; Rubia K, 2006, HUM BRAIN MAPP, V27, P973, DOI 10.1002/hbm.20237; Sanfey AG, 2003, SCIENCE, V300, P1755, DOI 10.1126/science.1082976; Scheres A, 2006, NEUROPSYCHOLOGIA, V44, P2092, DOI 10.1016/j.neuropsychologia.2005.10.012; Schultz W, 2000, ANNU REV NEUROSCI, V23, P473, DOI 10.1146/annurev.neuro.23.1.473; Sebastian CL, 2012, SOC COGN AFFECT NEUR, V7, P53, DOI 10.1093/scan/nsr023; Sesack SR, 2010, NEUROPSYCHOPHARMACOL, V35, P27, DOI 10.1038/npp.2009.93; Shaw P, 2008, J NEUROSCI, V28, P3586, DOI 10.1523/JNEUROSCI.5309-07.2008; Somerville LH, 2011, J COGNITIVE NEUROSCI, V23, P2123, DOI 10.1162/jocn.2010.21572; Somerville LH, 2010, BRAIN COGNITION, V72, P124, DOI 10.1016/j.bandc.2009.07.003; Steinberg L, 2010, ADOLESCENCE; Sturman DA, 2012, P NATL ACAD SCI USA, V109, P1719, DOI 10.1073/pnas.1114137109; TVERSKY A, 1981, SCIENCE, V211, P453, DOI 10.1126/science.7455683; TVERSKY A, 1991, Q J ECON, V106, P1039, DOI 10.2307/2937956; van den Bos W, 2011, PSYCHOL SCI, V22, P60, DOI 10.1177/0956797610391102; Van Leijenhorst L, 2008, DEV NEUROPSYCHOL, V33, P179, DOI 10.1080/87565640701884287; Van Leijenhorst L, 2010, NEUROIMAGE, V51, P345, DOI 10.1016/j.neuroimage.2010.02.038; Viner RM, 2012, LANCET, V379, P1641, DOI 10.1016/S0140-6736(12)60149-4; Wang AT, 2006, SOC COGN AFFECT NEUR, V1, P107, DOI 10.1093/scan/nsl018; Whelan R., NAT NEUROSC IN PRESS; Wise RA, 2004, NAT REV NEUROSCI, V5, P483, DOI 10.1038/nrn1406	100	374	383	15	272	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	SEP	2012	15	9					1184	1191		10.1038/nn.3177	http://dx.doi.org/10.1038/nn.3177			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	996GJ	22929913				2022-12-28	WOS:000308072600006
J	Lee, DA; Bedont, JL; Pak, T; Wang, H; Song, J; Miranda-Angulo, A; Takiar, V; Charubhumi, V; Balordi, F; Takebayashi, H; Aja, S; Ford, E; Fishell, G; Blackshaw, S				Lee, Daniel A.; Bedont, Joseph L.; Pak, Thomas; Wang, Hong; Song, Juan; Miranda-Angulo, Ana; Takiar, Vani; Charubhumi, Vanessa; Balordi, Francesca; Takebayashi, Hirohide; Aja, Susan; Ford, Eric; Fishell, Gordon; Blackshaw, Seth			Tanycytes of the hypothalamic median eminence form a diet-responsive neurogenic niche	NATURE NEUROSCIENCE			English	Article							ENERGY-BALANCE; BRAIN; 3RD-VENTRICLE; CELLS; RAT	Adult hypothalamic neurogenesis has recently been reported, but the cell of origin and the function of these newborn neurons are unknown. Using genetic fate mapping, we found that median eminence tanycytes generate newborn neurons. Blocking this neurogenesis altered the weight and metabolic activity of adult mice. These findings reveal a previously unreported neurogenic niche in the mammalian hypothalamus with important implications for metabolism.	[Lee, Daniel A.; Bedont, Joseph L.; Pak, Thomas; Wang, Hong; Miranda-Angulo, Ana; Takiar, Vani; Charubhumi, Vanessa; Aja, Susan; Blackshaw, Seth] Johns Hopkins Univ, Sch Med, Solomon H Snyder Dept Neurosci, Baltimore, MD 21218 USA; [Lee, Daniel A.; Song, Juan; Blackshaw, Seth] Johns Hopkins Univ, Sch Med, Inst Cell Engn, Baltimore, MD USA; [Song, Juan; Blackshaw, Seth] Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21205 USA; [Miranda-Angulo, Ana] Univ Antioquia, Medellin, Colombia; [Balordi, Francesca; Fishell, Gordon] NYU, Sch Med, Smilow Res Ctr, Neurosci Program, New York, NY USA; [Balordi, Francesca; Fishell, Gordon] NYU, Sch Med, Smilow Res Ctr, Dept Cell Biol, New York, NY USA; [Takebayashi, Hirohide] Niigata Univ, Grad Sch Med & Dent Sci, Div Neurobiol & Anat, Niigata, Japan; [Aja, Susan] Johns Hopkins Univ, Sch Med, Ctr Metab & Obes Res, Baltimore, MD USA; [Ford, Eric] Johns Hopkins Univ, Sch Med, Dept Radiat Oncol, Baltimore, MD USA; [Blackshaw, Seth] Johns Hopkins Univ, Sch Med, Dept Ophthalmol, Baltimore, MD 21205 USA; [Blackshaw, Seth] Johns Hopkins Univ, Sch Med, Ctr High Throughput Biol, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Universidad de Antioquia; New York University; New York University; Niigata University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University	Blackshaw, S (corresponding author), Johns Hopkins Univ, Sch Med, Solomon H Snyder Dept Neurosci, Baltimore, MD 21218 USA.	sblack@jhmi.edu	Takebayashi, Hirohide/AAO-1693-2020	Miranda-Angulo, Ana L./0000-0003-4938-3033; Lee, Daniel/0000-0001-7411-2740; Pak, Thomas/0000-0003-2716-1210; Fishell, Gordon/0000-0002-9640-9278	US National Institutes of Health [F31 NS063550]; NSF; Basil O'Connor Starter Scholar Award; Klingenstein Fund; NARSAD; NATIONAL EYE INSTITUTE [T32EY007143, T32EY017203] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F31NS063550] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); Basil O'Connor Starter Scholar Award; Klingenstein Fund(Klingenstein Philanthropies); NARSAD(NARSAD); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank J. Nathans, S. Hattar, N. Gaiano, P. Achanta, C. Montojo, D. McClellan, T Shimogori, T. Moran, E. Newman, M. Taylor and W. Yap for comments on the manuscript. We also thank M. Bonaguidi, C. Montojo, J. Reyes, M. Armour, E. Velarde, N. Forbes-McBean, WE Han and the Johns Hopkins School of Medicine Microscope Facility for technical advice and assistance. This work was supported by US National Institutes of Health grant F31 NS063550 and an NSF Graduate Fellowship (to D.A.L.), a Basil O'Connor Starter Scholar Award and grants from the Klingenstein Fund and NARSAD (to S.B.). S.B. is a W.M. Keck Distinguished Young Scholar in Medical Research.	Balordi F, 2007, J NEUROSCI, V27, P14248, DOI 10.1523/JNEUROSCI.4531-07.2007; Cowley MA, 2001, NATURE, V411, P480, DOI 10.1038/35078085; DAVELLA D, 1994, J NEUROSURG, V81, P774, DOI 10.3171/jns.1994.81.5.0774; Ford EC, 2011, RADIAT RES, V175, P774, DOI 10.1667/RR2214.1; Kokoeva MV, 2005, SCIENCE, V310, P679, DOI 10.1126/science.1115360; Masahira N, 2006, DEV BIOL, V293, P358, DOI 10.1016/j.ydbio.2006.02.029; Mathew TC, 2008, ANAT HISTOL EMBRYOL, V37, P9, DOI 10.1111/j.1439-0264.2007.00786.x; Matinfar M, 2007, LECT NOTES COMPUT SC, V4792, P926; Miller I, 2004, NEUROREPORT, V15, P925, DOI 10.1097/00001756-200404090-00038; Pierce AA, 2010, J NEUROSCI, V30, P723, DOI 10.1523/JNEUROSCI.2479-09.2010; Rodriguez EM, 2005, INT REV CYTOL, V247, P89, DOI 10.1016/S0074-7696(05)47003-5; Shimogori T, 2010, NAT NEUROSCI, V13, P767, DOI 10.1038/nn.2545; Simerly RB, 2008, PHYSIOL BEHAV, V94, P79, DOI 10.1016/j.physbeh.2007.11.023; Srinivas S, 2001, BMC Dev Biol, V1, P4, DOI 10.1186/1471-213X-1-4; Xu Y, 2005, EXP NEUROL, V192, P251, DOI 10.1016/j.expneurol.2004.12.021	15	322	331	1	43	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAY	2012	15	5					700	702		10.1038/nn.3079	http://dx.doi.org/10.1038/nn.3079			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	932DI	22446882	Green Accepted			2022-12-28	WOS:000303270200013
J	Giraud, AL; Poeppel, D				Giraud, Anne-Lise; Poeppel, David			Cortical oscillations and speech processing: emerging computational principles and operations	NATURE NEUROSCIENCE			English	Article							TIME-COMPRESSED SPEECH; AUDITORY-CORTEX; TEMPORAL ENVELOPE; PERCEPTION; SENSITIVITY; PATTERNS; RHYTHMS; SPECIALIZATION; COMPREHENSION	Neuronal oscillations are ubiquitous in the brain and may contribute to cognition in several ways: for example, by segregating information and organizing spike timing. Recent data show that delta, theta and gamma oscillations are specifically engaged by the multi-timescale, quasi-rhythmic properties of speech and can track its dynamics. We argue that they are foundational in speech and language processing, 'packaging' incoming information into units of the appropriate temporal granularity. Such stimulus-brain alignment arguably results from auditory and motor tuning throughout the evolution of speech and language and constitutes a natural model system allowing auditory research to make a unique contribution to the issue of how neural oscillatory activity affects human cognition.	[Giraud, Anne-Lise] Ecole Normale Super, INSERM, U960, Dept Etud Cognit, F-75231 Paris, France; [Poeppel, David] NYU, Dept Psychol, New York, NY 10003 USA	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS); New York University	Giraud, AL (corresponding author), Ecole Normale Super, INSERM, U960, Dept Etud Cognit, 24 Rue Lhomond, F-75231 Paris, France.	annelise.giraud@gmail.com			Centre National de la Recherche Scientifique of France; European Research Council; US National Institutes of Health [2R01 DC05660]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC005660] Funding Source: NIH RePORTER	Centre National de la Recherche Scientifique of France(Centre National de la Recherche Scientifique (CNRS)); European Research Council(European Research Council (ERC)European Commission); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	We are deeply grateful to C. Liegeois-Chauvel for providing stereotactic EEG data and C.-G. Benar for related methodological support. In A.-L.G.'s team we thank Y. Beigneux, B. Morillon and L. Arnal, who analyzed these data; A. Hyafil, C. Kapdebon and L. Fontolan, who carried out the computational modeling work; and K. Lehongre and D. Roussillon, who conducted the experiments in human subjects. In D.P.'s team, we thank H. Luo, M. Howard and G. Cogan for pioneering work and many discussions of these issues. We also thank our colleagues O. Ghitza, S. Greenberg, B. Gutkin, V. Wyart, C. Lorenzi, F. Ramus and C. Schroeder for motivating and discussing various aspects of this research. This work is supported by the Centre National de la Recherche Scientifique of France and the European Research Council (A.-L.G.), and US National Institutes of Health grant 2R01 DC05660 (D.P.).	Abrams DA, 2008, J NEUROSCI, V28, P3958, DOI 10.1523/JNEUROSCI.0187-08.2008; Adank P, 2009, J ACOUST SOC AM, V126, P2649, DOI 10.1121/1.3216914; Ahissar E, 2001, P NATL ACAD SCI USA, V98, P13367, DOI 10.1073/pnas.201400998; Atencio CA, 2008, NEURON, V58, P956, DOI 10.1016/j.neuron.2008.04.026; Atencio CA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009521; Boemio A, 2005, NAT NEUROSCI, V8, P389, DOI 10.1038/nn1409; Borgers C, 2005, P NATL ACAD SCI USA, V102, P7002, DOI 10.1073/pnas.0502366102; Canolty RT, 2010, TRENDS COGN SCI, V14, P506, DOI 10.1016/j.tics.2010.09.001; Chandrasekaran C, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002165; Chang EF, 2010, NAT NEUROSCI, V13, P1428, DOI 10.1038/nn.2641; Chi T, 2005, J ACOUST SOC AM, V118, P887, DOI 10.1121/1.1945807; Ding N, 2009, J NEUROPHYSIOL, V102, P2731, DOI 10.1152/jn.00523.2009; Eliades SJ, 2008, NATURE, V453, P1102, DOI 10.1038/nature06910; Fries P, 2007, TRENDS NEUROSCI, V30, P309, DOI 10.1016/j.tins.2007.05.005; Ghitza O, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00130; Ghitza O, 2009, PHONETICA, V66, P113, DOI 10.1159/000208934; Giraud AL, 2007, NEURON, V56, P1127, DOI 10.1016/j.neuron.2007.09.038; Gireesh ED, 2008, P NATL ACAD SCI USA, V105, P7576, DOI 10.1073/pnas.0800537105; Goswami U, 2011, TRENDS COGN SCI, V15, P3, DOI 10.1016/j.tics.2010.10.001; Heimbauer LA, 2011, CURR BIOL, V21, P1210, DOI 10.1016/j.cub.2011.06.007; Hickok G, 2007, NAT REV NEUROSCI, V8, P393, DOI 10.1038/nrn2113; Holcombe AO, 2009, TRENDS COGN SCI, V13, P216, DOI 10.1016/j.tics.2009.02.005; Hutsler J, 2003, TRENDS NEUROSCI, V26, P429, DOI 10.1016/S0166-2236(03)00198-X; Jamison HL, 2006, CEREB CORTEX, V16, P1266, DOI 10.1093/cercor/bhj068; Kayser C, 2010, P NATL ACAD SCI USA, V107, P16976, DOI 10.1073/pnas.1012656107; Kopell N, 2011, HIPPOCAMPAL MICROCIR; Lehongre K, 2011, NEURON, V72, P1080, DOI 10.1016/j.neuron.2011.11.002; LIBERMAN AM, 1985, COGNITION, V21, P1, DOI 10.1016/0010-0277(85)90021-6; Liegeois-Chauvel C, 2004, CEREB CORTEX, V14, P731, DOI 10.1093/cercor/bhh033; Lorenzi C, 2006, P NATL ACAD SCI USA, V103, P18866, DOI 10.1073/pnas.0607364103; Luo H, 2007, NEURON, V54, P1001, DOI 10.1016/j.neuron.2007.06.004; Morillon B, 2010, P NATL ACAD SCI USA, V107, P18688, DOI 10.1073/pnas.1007189107; Nourski KV, 2009, J NEUROSCI, V29, P15564, DOI 10.1523/JNEUROSCI.3065-09.2009; Oberlaender M, 2012, CEREB CORTEX, V22, P2375, DOI 10.1093/cercor/bhr317; Obleser J, 2008, J NEUROSCI, V28, P8116, DOI 10.1523/JNEUROSCI.1290-08.2008; Pagnamenta AT, 2010, BIOL PSYCHIAT, V68, P320, DOI 10.1016/j.biopsych.2010.02.002; Peschansky VJ, 2010, CEREB CORTEX, V20, P884, DOI 10.1093/cercor/bhp154; Poeppel D, 2003, SPEECH COMMUN, V41, P245, DOI 10.1016/S0167-6393(02)00107-3; Ramus F, 2008, Q J EXP PSYCHOL, V61, P129, DOI 10.1080/17470210701508822; Rauschecker JP, 2009, NAT NEUROSCI, V12, P718, DOI 10.1038/nn.2331; Sakata S, 2009, NEURON, V64, P404, DOI 10.1016/j.neuron.2009.09.020; Schroeder CE, 2010, CURR OPIN NEUROBIOL, V20, P172, DOI 10.1016/j.conb.2010.02.010; Schroeder CE, 2009, TRENDS NEUROSCI, V32, P9, DOI 10.1016/j.tins.2008.09.012; Shamir M, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000370; SHANNON RV, 1995, SCIENCE, V270, P303, DOI 10.1126/science.270.5234.303; Telkemeyer S, 2009, J NEUROSCI, V29, P14726, DOI 10.1523/JNEUROSCI.1246-09.2009; Wang XJ, 2010, PHYSIOL REV, V90, P1195, DOI 10.1152/physrev.00035.2008; Wang Y, 2011, NEUROSCIENCE, V190, P398, DOI 10.1016/j.neuroscience.2011.06.010; Zatorre RJ, 2002, TRENDS COGN SCI, V6, P37, DOI 10.1016/S1364-6613(00)01816-7; Ziegler JC, 2009, DEVELOPMENTAL SCI, V12, P732, DOI 10.1111/j.1467-7687.2009.00817.x	50	956	966	8	142	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	APR	2012	15	4					511	517		10.1038/nn.3063	http://dx.doi.org/10.1038/nn.3063			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	916PA	22426255	Green Accepted, Green Published			2022-12-28	WOS:000302114500008
J	Kisiswa, L; Osorio, C; Erice, C; Vizard, T; Wyatt, S; Davies, AM				Kisiswa, Lilian; Osorio, Catarina; Erice, Clara; Vizard, Thomas; Wyatt, Sean; Davies, Alun M.			TNF alpha reverse signaling promotes sympathetic axon growth and target innervation	NATURE NEUROSCIENCE			English	Article							TUMOR-NECROSIS-FACTOR; NEURITE GROWTH; MONOCYTIC CELLS; FACTOR-RECEPTOR; NERVOUS-SYSTEM; ACTIVATION; NEURONS; DEATH; NGF; SURVIVAL	Reverse signaling via members of the tumor necrosis factor (TNF) superfamily controls multiple aspects of immune function. Here we document TNF alpha reverse signaling in the nervous system to our knowledge for the first time and show that it has a crucial role in establishing sympathetic innervation. During postnatal development, sympathetic axons express TNF alpha as they grow and branch in their target tissues, which in turn express TNF receptor 1 (TNFR1). In culture, soluble forms of TNFR1 act directly on postnatal sympathetic axons to promote growth and branching by a mechanism that depends on membrane-integrated TNF alpha and on downstream activation of ERK. Sympathetic innervation density is substantially lower in several tissues in postnatal and adult mice lacking either TNF alpha or TNFR1. These findings reveal that target-derived TNFR1 acts as a reverse-signaling ligand for membrane- integrated TNF alpha to promote growth and branching of sympathetic axons.	[Kisiswa, Lilian; Osorio, Catarina; Erice, Clara; Vizard, Thomas; Wyatt, Sean; Davies, Alun M.] Cardiff Univ, Sch Biosci, Div Mol Biosci, Cardiff CF10 3AX, S Glam, Wales	Cardiff University	Davies, AM (corresponding author), Cardiff Univ, Sch Biosci, Div Mol Biosci, Cardiff CF10 3AX, S Glam, Wales.	daviesalun@cf.ac.uk	Davies, Alun M/A-4334-2010; Osorio, Catarina/G-1700-2017; Wyatt, Sean/A-5266-2010; Erice, Clara/ABI-5816-2020	Davies, Alun M/0000-0001-5841-8176; Wyatt, Sean/0000-0002-0572-234X; Erice, Clara/0000-0001-9681-6861; Osorio, Catarina/0000-0002-5228-0599; Kisiswa, Lilian/0000-0002-1800-0645	Wellcome Trust [085984]; Fundacao para a Ciencia e a Tecnologia; Neuroscience and Mental Health Research Institute of Cardiff University	Wellcome Trust(Wellcome TrustEuropean Commission); Fundacao para a Ciencia e a Tecnologia(Portuguese Foundation for Science and TechnologyEuropean Commission); Neuroscience and Mental Health Research Institute of Cardiff University	We thank M. White for providing RNA samples and K. Fox (Cardiff University), A. Dick (Bristol University) and the late S. Korsmeyer for providing Tnf, Tnfrsf1a and Bax mutant mice, respectively. This work was supported by a Wellcome Trust grant (grant no. 085984). C.O. was supported by a grant from the Fundacao para a Ciencia e a Tecnologia. C.E. was supported by a studentship from the Neuroscience and Mental Health Research Institute of Cardiff University.	Barker V, 2001, NAT NEUROSCI, V4, P1194, DOI 10.1038/nn755; Black RA, 1997, NATURE, V385, P729, DOI 10.1038/385729a0; Davies AM, 2009, AUTON NEUROSCI-BASIC, V151, P39, DOI 10.1016/j.autneu.2009.07.011; DAVIES AM, 1993, NEURON, V11, P565, DOI 10.1016/0896-6273(93)90069-4; Deckwerth TL, 1996, NEURON, V17, P401, DOI 10.1016/S0896-6273(00)80173-7; Desbarats J, 2003, NAT CELL BIOL, V5, P118, DOI 10.1038/ncb916; Eissner G, 2000, J IMMUNOL, V164, P6193, DOI 10.4049/jimmunol.164.12.6193; Favata MF, 1998, J BIOL CHEM, V273, P18623, DOI 10.1074/jbc.273.29.18623; Gallagher D, 2007, J NEUROSCI, V27, P9664, DOI 10.1523/JNEUROSCI.0608-07.2007; Gavalda N, 2009, J NEUROSCI, V29, P1599, DOI 10.1523/JNEUROSCI.3566-08.2009; Glebova NO, 2004, J NEUROSCI, V24, P743, DOI 10.1523/JNEUROSCI.4523-03.2004; Glebova NO, 2005, ANNU REV NEUROSCI, V28, P191, DOI 10.1146/annurev.neuro.28.061604.135659; GOMEZ N, 1991, NATURE, V353, P170, DOI 10.1038/353170a0; Goold RG, 2005, MOL CELL NEUROSCI, V28, P524, DOI 10.1016/j.mcn.2004.11.005; Gutierrez H, 2008, J NEUROSCI, V28, P8246, DOI 10.1523/JNEUROSCI.1941-08.2008; Gutierrez H, 2007, J NEUROSCI METH, V163, P24, DOI 10.1016/j.jneumeth.2007.02.002; Gutierrez H, 2013, OPEN BIOL, V3, DOI 10.1098/rsob.120150; Harashima S, 2001, J IMMUNOL, V166, P130, DOI 10.4049/jimmunol.166.1.130; Hehlgans T, 2005, IMMUNOLOGY, V115, P1, DOI 10.1111/j.1365-2567.2005.02143.x; Huber AB, 2003, ANNU REV NEUROSCI, V26, P509, DOI 10.1146/annurev.neuro.26.010302.081139; Islam A, 2006, J BIOL CHEM, V281, P6860, DOI 10.1074/jbc.M509397200; Kirchner S, 2004, J LEUKOCYTE BIOL, V75, P324, DOI 10.1189/jlb.0703343; Korner H, 1997, EUR J IMMUNOL, V27, P2600, DOI 10.1002/eji.1830271020; Neumann H, 2002, J NEUROSCI, V22, P854, DOI 10.1523/JNEUROSCI.22-03-00854.2002; O'Keeffe GW, 2008, NAT NEUROSCI, V11, P135, DOI 10.1038/nn2034; Park KM, 2010, CELL SIGNAL, V22, P977, DOI 10.1016/j.cellsig.2010.01.010; PFEFFER K, 1993, CELL, V73, P457, DOI 10.1016/0092-8674(93)90134-C; Reich A, 2008, TRENDS NEUROSCI, V31, P478, DOI 10.1016/j.tins.2008.06.007; Ronn LCB, 2000, J NEUROSCI METH, V100, P25, DOI 10.1016/S0165-0270(00)00228-4; Sun M, 2007, J IMMUNOL, V179, P4307, DOI 10.4049/jimmunol.179.7.4307; Takei Y, 2008, MOL BIOL CELL, V19, P855, DOI 10.1091/mbc.E07-06-0624; Thompson J, 2004, MOL CELL NEUROSCI, V27, P441, DOI 10.1016/j.mcn.2004.07.007; Vizard TN, 2008, NAT NEUROSCI, V11, P285, DOI 10.1038/nn2044; Waetzig GH, 2004, FASEB J, V18, P91, DOI 10.1096/fj.04-2073fje; Watts AD, 1999, EMBO J, V18, P2119, DOI 10.1093/emboj/18.8.2119; Wiegert JS, 2011, CELL CALCIUM, V49, P296, DOI 10.1016/j.ceca.2010.11.009; Xanthoulea S, 2004, J EXP MED, V200, P367, DOI 10.1084/jem.20040435; Xin LJ, 2006, INT J MOL MED, V18, P885; Yu MX, 2009, EUR J CELL BIOL, V88, P181, DOI 10.1016/j.ejcb.2008.09.001; Zuliani C, 2006, CELL DEATH DIFFER, V13, P31, DOI 10.1038/sj.cdd.4401720	40	46	48	0	14	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUL	2013	16	7					865	U264		10.1038/nn.3430	http://dx.doi.org/10.1038/nn.3430			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	174UM	23749144	Green Accepted			2022-12-28	WOS:000321180900019
J	Renton, AE; Traynor, BJ				Renton, Alan E.; Traynor, Bryan J.			CRESTing the ALS mountain	NATURE NEUROSCIENCE			English	Editorial Material							PRION-LIKE DOMAINS; MUTATIONS; GENE; PROTEINS; FUS	Chesi et al. use exome sequencing of trios consisting of subjects with amyotrophic lateral sclerosis and their parents to find de novo variants in 25 genes, one of which is the chromatin regulator SS18L1 (CREST).	[Renton, Alan E.] NIA, Neuromuscular Dis Res Unit, Neurogenet Lab, NIH, Bethesda, MD 20892 USA; [Traynor, Bryan J.] Johns Hopkins Univ Hosp, Dept Neurol, Brain Sci Inst, Baltimore, MD 21287 USA	National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); Johns Hopkins University; Johns Hopkins Medicine	Renton, AE (corresponding author), NIA, Neuromuscular Dis Res Unit, Neurogenet Lab, NIH, Bethesda, MD 20892 USA.	alan.renton@nih.gov	Traynor, Bryan J/G-5690-2010	Renton, Alan E./0000-0001-6702-8268	NATIONAL INSTITUTE ON AGING [ZIAAG000933] Funding Source: NIH RePORTER; Intramural NIH HHS [ZIA AG000933-02] Funding Source: Medline	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Alexander MD, 2002, ANN NEUROL, V52, P680, DOI 10.1002/ana.10369; Chesi A, 2013, NAT NEUROSCI, V16, P851, DOI 10.1038/nn.3412; Chio A, 2011, NEUROBIOL AGING, V32, DOI 10.1016/j.neurobiolaging.2010.05.016; DeJesus-Hernandez M, 2010, HUM MUTAT, V31, pE1377, DOI 10.1002/humu.21241; Hardy J, 2005, BIOCHEM SOC T, V33, P578, DOI 10.1042/BST0330578; Kim HJ, 2013, NATURE, V495, P467, DOI 10.1038/nature11922; King OD, 2012, BRAIN RES, V1462, P61, DOI 10.1016/j.brainres.2012.01.016; Kwiatkowski TJ, 2009, SCIENCE, V323, P1205, DOI 10.1126/science.1166066; O'Roak BJ, 2012, NATURE, V485, P246, DOI 10.1038/nature10989; Ronan JL, 2013, NAT REV GENET, V14, P347, DOI 10.1038/nrg3413; Selvi BR, 2010, BBA-GENE REGUL MECH, V1799, P840, DOI 10.1016/j.bbagrm.2010.08.012; Vance C, 2009, SCIENCE, V323, P1208, DOI 10.1126/science.1165942; Vogel-Ciernia A, 2013, NAT NEUROSCI, V16, P552, DOI 10.1038/nn.3359; Wu JI, 2007, NEURON, V56, P94, DOI 10.1016/j.neuron.2007.08.021; Xu B, 2012, NAT GENET, V44, P1365, DOI 10.1038/ng.2446	15	0	0	0	11	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUL	2013	16	7					774	775		10.1038/nn.3444	http://dx.doi.org/10.1038/nn.3444			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	174UM	23799466	Green Accepted			2022-12-28	WOS:000321180900003
J	[Anonymous]				[Anonymous]			Focus on neurotechniques	NATURE NEUROSCIENCE			English	Editorial Material																			0	1	1	0	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JUL	2013	16	7					771	771						1	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	174UM	23799464	Bronze			2022-12-28	WOS:000321180900001
J	Kang, SH; Li, Y; Fukaya, M; Lorenzini, I; Cleveland, DW; Ostrow, LW; Rothstein, JD; Bergles, DE				Kang, Shin H.; Li, Ying; Fukaya, Masahiro; Lorenzini, Ileana; Cleveland, Don W.; Ostrow, Lyle W.; Rothstein, Jeffrey D.; Bergles, Dwight E.			Degeneration and impaired regeneration of gray matter oligodendrocytes in amyotrophic lateral sclerosis	NATURE NEUROSCIENCE			English	Article							MOTOR-NEURONS; SPINAL-CORD; SUPEROXIDE-DISMUTASE; PROGENITOR CELLS; TRANSGENIC MICE; IFN-GAMMA; EXPRESSION; MODEL; ALS; ASTROCYTES	Oligodendrocytes associate with axons to establish myelin and provide metabolic support to neurons. In the spinal cord of amyotrophic lateral sclerosis (ALS) mice, oligodendrocytes downregulate transporters that transfer glycolytic substrates to neurons and oligodendrocyte progenitors (NG2(+) cells) exhibit enhanced proliferation and differentiation, although the cause of these changes in oligodendroglia is unknown. We found extensive degeneration of gray matter oligodendrocytes in the spinal cord of SOD1 (G93A) ALS mice prior to disease onset. Although new oligodendrocytes were formed, they failed to mature, resulting in progressive demyelination. Oligodendrocyte dysfunction was also prevalent in human ALS, as gray matter demyelination and reactive changes in NG2(+) cells were observed in motor cortex and spinal cord of ALS patients. Selective removal of mutant SOD1 from oligodendroglia substantially delayed disease onset and prolonged survival in ALS mice, suggesting that ALS-linked genes enhance the vulnerability of motor neurons and accelerate disease by directly impairing the function of oligodendrocytes.	[Kang, Shin H.; Lorenzini, Ileana; Rothstein, Jeffrey D.; Bergles, Dwight E.] Johns Hopkins Univ, Sch Med, Solomon H Snyder Dept Neurosci, Baltimore, MD 21218 USA; [Li, Ying; Ostrow, Lyle W.; Rothstein, Jeffrey D.] Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21205 USA; [Fukaya, Masahiro] Kitasato Univ, Sch Med, Dept Anat, Sagamihara, Kanagawa 228, Japan; [Lorenzini, Ileana; Ostrow, Lyle W.; Rothstein, Jeffrey D.] Johns Hopkins Univ, Sch Med, Brain Sci Inst, Baltimore, MD USA; [Cleveland, Don W.] Univ Calif San Diego, Ludwig Inst, San Diego, CA 92103 USA	Johns Hopkins University; Johns Hopkins University; Kitasato University; Johns Hopkins University; Ludwig Institute for Cancer Research; University of California System; University of California San Diego	Rothstein, JD (corresponding author), Johns Hopkins Univ, Sch Med, Solomon H Snyder Dept Neurosci, Baltimore, MD 21218 USA.	jrothstein@jhmi.edu; dbergles@jhmi.edu	Bergles, Dwight/U-8343-2019; Cleveland, Don/AAN-9783-2021	Bergles, Dwight/0000-0002-7133-7378; Cleveland, Don/0000-0002-1934-3682; Ostrow, Lyle/0000-0001-7158-5243	P2ALS; US National Institutes of Health [NS27036, NS33958, NS051509]; ALS Association [4ZMUDE]; Robert Packard Center for ALS Research at Johns Hopkins; Brain Science Institute; NATIONAL EYE INSTITUTE [T32EY017203] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS051509, R37NS027036, R01NS033958, R01NS027036] Funding Source: NIH RePORTER	P2ALS; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ALS Association; Robert Packard Center for ALS Research at Johns Hopkins; Brain Science Institute; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank N. Ye, I. Srivastava, S. Singh and T. Le for their excellent technical support, M. Pucak for help with Imaris software operation and quantitative analysis, J. Carmen for her contributions to the Cre/lox animal study, and H. Zhang at the Johns Hopkins University School of Public Health FACS core for assistance with NG2<SUP>+</SUP> cell isolation. We thank B. Trapp (Cleveland Clinic Lerner Research Institute) for advice regarding human NG2<SUP>+</SUP> cell staining, R. Dutta (Cleveland Clinic Lerner Research Institute) for advice regarding protein extraction from human tissues and B. Popko (University of Chicago) for providing Plp1-creER mice. Human samples were provided by R. Bowser (Barrow Neurological Institute), K. Trevor (SACTL-VA Biorepository Trust), T. Hyde (Lieber Institute for Brain Development and the Johns Hopkins School of Medicine), J. Glass (Emory Alzheimer's Disease Research Center, 5P50AG025688-07), and the Johns Hopkins School of Medicine Department of Neuropathology. We thank E. Mosmiller for helping with patient demographic information. We also thank A. Agarwal and A. Langseth for critical discussions. This work was supported by grants from P<SUP>2</SUP>ALS (D.E.B. and J.D.R.), the US National Institutes of Health (NS27036 to D.W.C., NS33958 to J.D.R. and NS051509 to D.E.B.), the ALS Association (4ZMUDE to Y.L.), the Robert Packard Center for ALS Research at Johns Hopkins, and the Brain Science Institute.	Aebischer J, 2012, EUR J NEUROL, V19, P752, DOI 10.1111/j.1468-1331.2011.03623.x; Bauer J, 2002, J NEUROPATH EXP NEUR, V61, P12, DOI 10.1093/jnen/61.1.12; Boillee S, 2006, SCIENCE, V312, P1389, DOI 10.1126/science.1123511; Bruijn LI, 1997, NEURON, V18, P327, DOI 10.1016/S0896-6273(00)80272-X; Bu J, 2001, GLIA, V34, P296, DOI 10.1002/glia.1063; Buntinx M, 2004, J NEUROSCI RES, V76, P834, DOI 10.1002/jnr.20118; Chang A, 2000, J NEUROSCI, V20, P6404, DOI 10.1523/JNEUROSCI.20-17-06404.2000; Chong SYC, 2012, P NATL ACAD SCI USA, V109, P1299, DOI 10.1073/pnas.1113540109; Clement AM, 2003, SCIENCE, V302, P113, DOI 10.1126/science.1086071; Cosottini M, 2011, AM J NEURORADIOL, V32, P704, DOI 10.3174/ajnr.A2356; Coutts M, 2010, J NEUROTRAUM, V27, P1333, DOI 10.1089/neu.2010.1285; DALCANTO MC, 1995, BRAIN RES, V676, P25, DOI 10.1016/0006-8993(95)00063-V; Davalos D, 2005, NAT NEUROSCI, V8, P752, DOI 10.1038/nn1472; Doerflinger NH, 2003, GENESIS, V35, P63, DOI 10.1002/gene.10154; Dutta R, 2007, NEUROLOGY, V68, pS22, DOI 10.1212/01.wnl.0000275229.13012.32; Funfschilling U, 2012, NATURE, V485, P517, DOI 10.1038/nature11007; Gong SC, 2003, NATURE, V425, P917, DOI 10.1038/nature02033; Gong YH, 2000, J NEUROSCI, V20, P660, DOI 10.1523/JNEUROSCI.20-02-00660.2000; Guo FZ, 2010, J NEUROSCI, V30, P12036, DOI 10.1523/JNEUROSCI.1360-10.2010; GURNEY ME, 1994, SCIENCE, V264, P1772, DOI 10.1126/science.8209258; Henson PM, 2001, CURR BIOL, V11, pR795, DOI 10.1016/S0960-9822(01)00474-2; Higuchi M, 2005, J NEUROSCI, V25, P9434, DOI 10.1523/JNEUROSCI.2691-05.2005; Horner PJ, 2002, J NEUROCYTOL, V31, P469, DOI 10.1023/A:1025739630398; Ilieva H, 2009, J CELL BIOL, V187, P761, DOI 10.1083/jcb.200908164; Jamin N, 2001, EXP NEUROL, V172, P17, DOI 10.1006/exnr.2001.7752; Kang SH, 2010, NEURON, V68, P668, DOI 10.1016/j.neuron.2010.09.009; Komori T, 1999, BRAIN PATHOL, V9, P663; Lee YJ, 2012, NATURE, V487, P443, DOI 10.1038/nature11314; Locatelli G, 2012, NAT NEUROSCI, V15, P543, DOI 10.1038/nn.3062; Magnus T, 2008, GLIA, V56, P200, DOI 10.1002/glia.20604; Muzumdar MD, 2007, GENESIS, V45, P593, DOI 10.1002/dvg.20335; Nagai M, 2007, NAT NEUROSCI, V10, P615, DOI 10.1038/nn1876; Nave KA, 2008, ANNU REV NEUROSCI, V31, P535, DOI 10.1146/annurev.neuro.30.051606.094309; Nave KA, 2010, NATURE, V468, P244, DOI 10.1038/nature09614; Neumann M, 2007, J NEUROPATH EXP NEUR, V66, P177, DOI 10.1097/01.jnen.0000248554.45456.58; Niebroj-Dobosz I, 2007, FOLIA NEUROPATHOL, V45, P236; Novak A, 2000, GENESIS, V28, P147, DOI 10.1002/1526-968X(200011/12)28:3/4<147::AID-GENE90>3.0.CO;2-G; Pohl HBF, 2011, J NEUROSCI, V31, P1069, DOI 10.1523/JNEUROSCI.5035-10.2011; Pouly S, 1999, GLIA, V27, P259, DOI 10.1002/(SICI)1098-1136(199909)27:3<259::AID-GLIA7>3.0.CO;2-8; Pramatarova A, 2001, J NEUROSCI, V21, P3369, DOI 10.1523/JNEUROSCI.21-10-03369.2001; Rinholm JE, 2011, J NEUROSCI, V31, P538, DOI 10.1523/JNEUROSCI.3516-10.2011; Rivers LE, 2008, NAT NEUROSCI, V11, P1392, DOI 10.1038/nn.2220; ROTHSTEIN JD, 1995, ANN NEUROL, V38, P73, DOI 10.1002/ana.410380114; Rudick RA, 2009, NEW ENGL J MED, V361, P1505, DOI 10.1056/NEJMcibr0905482; Srinivas S, 2001, BMC Dev Biol, V1, P4, DOI 10.1186/1471-213X-1-4; Suzuki A, 2011, CELL, V144, P810, DOI 10.1016/j.cell.2011.02.018; Tu PH, 1998, ANN NEUROL, V44, P415, DOI 10.1002/ana.410440324; Woodruff RH, 2001, INT J DEV NEUROSCI, V19, P379, DOI 10.1016/S0736-5748(00)00083-6; Woodruff RH, 2004, MOL CELL NEUROSCI, V25, P252, DOI 10.1016/j.mcn.2003.10.014; Wu Yu-Huan, 2008, P3; Yamanaka K, 2008, P NATL ACAD SCI USA, V105, P7594, DOI 10.1073/pnas.0802556105; Yamanaka K, 2008, NAT NEUROSCI, V11, P251, DOI 10.1038/nn2047; Yazawa I, 2005, NEURON, V45, P847, DOI 10.1016/j.neuron.2005.01.032; Zhu XQ, 2011, DEVELOPMENT, V138, P745, DOI 10.1242/dev.047951	54	365	381	6	73	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAY	2013	16	5					571	+		10.1038/nn.3357	http://dx.doi.org/10.1038/nn.3357			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	131WT	23542689	Green Submitted, Green Accepted			2022-12-28	WOS:000318029300013
J	Silson, EH; McKeefry, DJ; Rodgers, J; Gouws, AD; Hymers, M; Morland, AB				Silson, Edward H.; McKeefry, Declan J.; Rodgers, Jessica; Gouws, Andre D.; Hymers, Mark; Morland, Antony B.			Specialized and independent processing of orientation and shape in visual field maps LO1 and LO2	NATURE NEUROSCIENCE			English	Article							FUSIFORM FACE AREA; OCCIPITAL CORTEX; EXTRASTRIATE CORTEX; OBJECTS; DISSOCIATION; PERCEPTION; FMRI	We identified human visual field maps, LO1 and LO2, in object-selective lateral occipital cortex. Using transcranial magnetic stimulation (TMS), we assessed the functions of these maps in the perception of orientation and shape. TMS of LO1 disrupted orientation, but not shape, discrimination, whereas TMS of LO2 disrupted shape, but not orientation, discrimination. This double dissociation suggests that specialized and independent processing of different visual attributes occurs in LO1 and LO2.	[Silson, Edward H.; Rodgers, Jessica; Gouws, Andre D.; Hymers, Mark; Morland, Antony B.] Univ York, Dept Psychol, York Neuroimaging Ctr, York YO10 5DD, N Yorkshire, England; [McKeefry, Declan J.] Univ Bradford, Bradford Sch Optometry & Vis Sci, Bradford BD7 1DP, W Yorkshire, England; [Morland, Antony B.] Hull York Med Sch, Ctr Neurosci, York, N Yorkshire, England	University of York - UK; University of Bradford; University of Hull; University of York - UK	Morland, AB (corresponding author), Univ York, Dept Psychol, York Neuroimaging Ctr, York YO10 5DD, N Yorkshire, England.	antony.morland@york.ac.uk		Gouws, Andre/0000-0003-0674-7829; Morland, Antony/0000-0002-6754-5545	Department of Psychology, University of York	Department of Psychology, University of York	We are grateful to T. Andrews, H. Baseler and A. Wade for their useful discussion of the study and earlier drafts of the manuscript. We also thank R. Baker, J. Blake, C. Breare, E. Cooper, E. Reeves, E. Shah and S. Strong for their assistance in performing the experiments. We thank the Department of Psychology, University of York, which funds the PhD studentship award to E.H.S. and summer bursary award to J.R.	Brewer AA, 2005, NAT NEUROSCI, V8, P1102, DOI 10.1038/nn1507; Ellison A, 2009, NEUROPSYCHOLOGIA, V47, P1609, DOI 10.1016/j.neuropsychologia.2008.12.013; Epstein R, 1998, NATURE, V392, P598, DOI 10.1038/33402; Felleman DJ, 1991, CEREB CORTEX, V1, P1, DOI 10.1093/cercor/1.1.1; GOODALE MA, 1991, NATURE, V349, P154, DOI 10.1038/349154a0; Grill-Spector K, 1999, NEURON, V24, P187, DOI 10.1016/S0896-6273(00)80832-6; James TW, 2003, BRAIN, V126, P2463, DOI 10.1093/brain/awg248; Kanwisher N, 1997, J NEUROSCI, V17, P4302; Larsson J, 2006, J NEUROPHYSIOL, V95, P862, DOI 10.1152/jn.00668.2005; Larsson J, 2006, J NEUROSCI, V26, P13128, DOI 10.1523/JNEUROSCI.1657-06.2006; MALACH R, 1995, P NATL ACAD SCI USA, V92, P8135, DOI 10.1073/pnas.92.18.8135; McKeefry DJ, 2008, J NEUROSCI, V28, P6848, DOI 10.1523/JNEUROSCI.1287-08.2008; Op de Beeck HP, 2008, NAT REV NEUROSCI, V9, P123, DOI 10.1038/nrn2314; PERENIN MT, 1988, BRAIN, V111, P643, DOI 10.1093/brain/111.3.643; Pitcher D, 2009, CURR BIOL, V19, P319, DOI 10.1016/j.cub.2009.01.007; SHIPP S, 1985, NATURE, V315, P322, DOI 10.1038/315322a0; Wandell BA, 2007, NEURON, V56, P366, DOI 10.1016/j.neuron.2007.10.012; ZEKI S, 1990, COLD SPRING HARB SYM, V55, P651	19	43	43	1	41	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	MAR	2013	16	3					267	269		10.1038/nn.3327	http://dx.doi.org/10.1038/nn.3327			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	097LE	23377127				2022-12-28	WOS:000315474800007
J	Ueno, T; Tomita, J; Tanimoto, H; Endo, K; Ito, K; Kume, S; Kume, K				Ueno, Taro; Tomita, Jun; Tanimoto, Hiromu; Endo, Keita; Ito, Kei; Kume, Shoen; Kume, Kazuhiko			Identification of a dopamine pathway that regulates sleep and arousal in Drosophila	NATURE NEUROSCIENCE			English	Article							MUSHROOM BODIES; OLFACTORY MEMORY; CENTRAL COMPLEX; NEURAL CIRCUIT; FRUIT-FLY; RECEPTOR; NEURONS; MELANOGASTER; BODY; WAKEFULNESS	Sleep is required to maintain physiological functions, including memory, and is regulated by monoamines across species. Enhancement of dopamine signals by a mutation in the dopamine transporter (DAT) decreases sleep, but the underlying dopamine circuit responsible for this remains unknown. We found that the D1 dopamine receptor (DA1) in the dorsal fan-shaped body (dFSB) mediates the arousal effect of dopamine in Drosophila. The short sleep phenotype of the DAT mutant was completely rescued by an additional mutation in the DA1 (also known as DopR) gene, but expression of wild-type DA1 in the dFSB restored the short sleep phenotype. We found anatomical and physiological connections between dopamine neurons and the dFSB neuron. Finally, we used mosaic analysis with a repressive marker and found that a single dopamine neuron projecting to the FSB activated arousal. These results suggest that a local dopamine pathway regulates sleep.	[Ueno, Taro; Tomita, Jun; Kume, Shoen; Kume, Kazuhiko] Kumamoto Univ, Inst Mol Embryol & Genet, Kumamoto, Japan; [Tanimoto, Hiromu] Max Planck Inst Neurobiol, Martinsried, Germany; [Endo, Keita; Ito, Kei] Univ Tokyo, Inst Mol & Cellular Biosci, Tokyo, Japan; [Kume, Shoen] Kumamoto Univ, Global Ctr Excellence, Kumamoto, Japan	Kumamoto University; Max Planck Society; University of Tokyo; Kumamoto University	Kume, K (corresponding author), Kumamoto Univ, Inst Mol Embryol & Genet, Kumamoto, Japan.	kkume@kumamoto-u.ac.jp	Tanimoto, Hiromu/J-6810-2016; Kume, Shoen/M-4356-2016; Ueno, Taro/AAN-7260-2021	Kume, Shoen/0000-0002-4292-205X; Ueno, Taro/0000-0003-3697-4301; Kume, Kazuhiko/0000-0003-4232-1657	Japanese Society for the Promotion of Science (JSPS) [22300132]	Japanese Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	We thank M. Wu and Q. Liu for sharing unpublished results, K. Ueno, T. Sakai and S. Sato for encouraging advice, M. Yamazaki, A. Miyoshi, Y. Kawahara and W Honghang for technical assistance, F.W. Wolf for the kind gift of an antibody, R. Jackson and the members of Kume laboratory for discussion and critical reading of the manuscript, and P. Garrity, D. Armstrong, J. Hirsh, K. Scott, the Kyoto Drosophila Genetic Resource Center and the Bloomington Stock Center for fly stocks. This work was supported by a grant (22300132) from the Japanese Society for the Promotion of Science (JSPS). T.U. is a JSPS fellow. S.K. is a member of the Global COE Program (Cell Fate Regulation Research and Education Unit).	Agosto J, 2008, NAT NEUROSCI, V11, P354, DOI 10.1038/nn2046; Andretic R, 2005, CURR BIOL, V15, P1165, DOI 10.1016/j.cub.2005.05.025; Andretic R, 2008, P NATL ACAD SCI USA, V105, P20392, DOI 10.1073/pnas.0806776105; Aso Y, 2010, CURR BIOL, V20, P1445, DOI 10.1016/j.cub.2010.06.048; Bushey D, 2007, J NEUROSCI, V27, P5384, DOI 10.1523/JNEUROSCI.0108-07.2007; Bushey D, 2011, SCIENCE, V332, P1576, DOI 10.1126/science.1202839; Claridge-Chang A, 2009, CELL, V139, P405, DOI 10.1016/j.cell.2009.08.034; Connolly JB, 1996, SCIENCE, V274, P2104, DOI 10.1126/science.274.5295.2104; Crocker A, 2010, NEURON, V65, P670, DOI 10.1016/j.neuron.2010.01.032; Diekelmann S, 2010, NAT REV NEUROSCI, V11, P114, DOI 10.1038/nrn2762; Donlea JM, 2011, SCIENCE, V332, P1571, DOI 10.1126/science.1202249; Donlea JM, 2009, SCIENCE, V324, P105, DOI 10.1126/science.1166657; Draper I, 2007, DEV NEUROBIOL, V67, P378, DOI 10.1002/dneu.20355; Feinberg EH, 2008, NEURON, V57, P353, DOI 10.1016/j.neuron.2007.11.030; Friggi-Grelin F, 2003, J NEUROBIOL, V54, P618, DOI 10.1002/neu.10185; Gilestro GF, 2009, SCIENCE, V324, P109, DOI 10.1126/science.1166673; Gordon MD, 2009, NEURON, V61, P373, DOI 10.1016/j.neuron.2008.12.033; Hendricks JC, 2000, NEURON, V25, P129, DOI 10.1016/S0896-6273(00)80877-6; Joiner WJ, 2006, NATURE, V441, P757, DOI 10.1038/nature04811; Kim YC, 2007, J NEUROSCI, V27, P7640, DOI 10.1523/JNEUROSCI.1167-07.2007; Kohatsu S, 2011, NEURON, V69, P498, DOI 10.1016/j.neuron.2010.12.017; Kong EC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009954; Kume K, 2005, J NEUROSCI, V25, P7377, DOI 10.1523/JNEUROSCI.2048-05.2005; Kume K., 2006, SLEEP BIOL RHYTHMS, V4, P263, DOI DOI 10.1111/J.1479-8425.2006.00225.X; Lai SL, 2006, NAT NEUROSCI, V9, P703, DOI 10.1038/nn1681; Lebestky T, 2009, NEURON, V64, P522, DOI 10.1016/j.neuron.2009.09.031; Lee T, 1999, NEURON, V22, P451, DOI 10.1016/S0896-6273(00)80701-1; Li XJ, 2009, SLEEP, V32, P1417, DOI 10.1093/sleep/32.11.1417; Liu C, 2012, NATURE, V488, P512, DOI 10.1038/nature11304; Liu G, 2006, NATURE, V439, P551, DOI 10.1038/nature04381; Mao ZM, 2009, FRONT NEURAL CIRCUIT, V3, DOI 10.3389/neuro.04.005.2009; Neve KA, 2004, J RECEPT SIG TRANSD, V24, P165, DOI 10.1081/LRST-200029981; Pan YF, 2009, LEARN MEMORY, V16, P289, DOI 10.1101/lm.1331809; Pitman JL, 2006, NATURE, V441, P753, DOI 10.1038/nature04739; Seugnet L, 2008, CURR BIOL, V18, P1110, DOI 10.1016/j.cub.2008.07.028; Shafer OT, 2008, NEURON, V58, P223, DOI 10.1016/j.neuron.2008.02.018; Shang YH, 2011, NAT NEUROSCI, V14, P889, DOI 10.1038/nn.2860; Shaw PJ, 2000, SCIENCE, V287, P1834, DOI 10.1126/science.287.5459.1834; Shinomiya K, 2011, J COMP NEUROL, V519, P807, DOI 10.1002/cne.22540; SUGAMORI KS, 1995, FEBS LETT, V362, P131, DOI 10.1016/0014-5793(95)00224-W; Tomita J, 2011, J NEUROSCI, V31, P13137, DOI 10.1523/JNEUROSCI.5860-10.2011; Ueno T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032007; Ueno T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031513; Van Swinderen B, 2011, P ROY SOC B-BIOL SCI, V278, P906, DOI 10.1098/rspb.2010.2564; Waddell S, 2010, TRENDS NEUROSCI, V33, P457, DOI 10.1016/j.tins.2010.07.001; Wisor JP, 2001, J NEUROSCI, V21, P1787, DOI 10.1523/JNEUROSCI.21-05-01787.2001; Young JM, 2010, J COMP NEUROL, V518, P1500, DOI 10.1002/cne.22284; Yuan N, 2007, EUR J NEUROSCI, V26, P2417, DOI 10.1111/j.1460-9568.2007.05870.x; Yuan Q, 2006, CURR BIOL, V16, P1051, DOI 10.1016/j.cub.2006.04.032; Zhang S, 2008, BIOCHEM BIOPH RES CO, V370, P82, DOI 10.1016/j.bbrc.2008.03.015	50	184	190	0	62	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	NOV	2012	15	11					1516	1523		10.1038/nn.3238	http://dx.doi.org/10.1038/nn.3238			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	028LX	23064381				2022-12-28	WOS:000310424900011
J	Jazayeri, M; Lindbloom-Brown, Z; Horwitz, GD				Jazayeri, Mehrdad; Lindbloom-Brown, Zachary; Horwitz, Gregory D.			Saccadic eye movements evoked by optogenetic activation of primate V1	NATURE NEUROSCIENCE			English	Article							MOTOR CORTEX; IN-VIVO; NEURONS	Optogenetics has advanced our understanding of the neural basis of simple behaviors in rodents and small animals. In primates, however, for which more sophisticated behavioral assays exist, optogenetic manipulations of behavior have been unsuccessful. We found that monkeys reliably shifted their gaze toward the receptive field of optically driven channelrhodopsin-2-expressing neurons of the primary visual cortex. This result establishes optogenetics as a viable tool for the causal analysis of behavior in primate brain.	[Jazayeri, Mehrdad] Univ Washington, Howard Hughes Med Inst, Seattle, WA 98195 USA; [Jazayeri, Mehrdad; Lindbloom-Brown, Zachary; Horwitz, Gregory D.] Univ Washington, Dept Physiol & Biophys, Washington Natl Primate Res Ctr, Seattle, WA 98195 USA	Howard Hughes Medical Institute; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Jazayeri, M (corresponding author), Univ Washington, Howard Hughes Med Inst, Seattle, WA 98195 USA.	mjaz@u.washington.edu		Horwitz, Gregory/0000-0001-5130-5259	The McKnight Foundation; US National Institutes of Health [EY001730, EY018849, RK000166]; NATIONAL CENTER FOR RESEARCH RESOURCES [P51RR000166] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [P30EY001730, R01EY018849] Funding Source: NIH RePORTER	The McKnight Foundation; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	We would like to thank K. Deisseroth and M. Shadlen for sharing resources, F. Robinson, J. Garlid, E. Grover, J. Huang, D. Possin and L. Tait for technical assistance, and C. Fetch and C. Hass for help with the experiments. This work was supported by The McKnight Foundation and research grants EY001730, EY018849 and RK000166 from the US National Institutes of Health.	Aravanis AM, 2007, J NEURAL ENG, V4, pS143, DOI 10.1088/1741-2560/4/3/S02; Bernstein JG, 2011, TRENDS COGN SCI, V15, P592, DOI 10.1016/j.tics.2011.10.003; Britten KH, 1996, VISUAL NEUROSCI, V13, P87, DOI 10.1017/S095252380000715X; Churchland MM, 2007, J NEUROPHYSIOL, V97, P4235, DOI 10.1152/jn.00095.2007; Diester I, 2011, NAT NEUROSCI, V14, P387, DOI 10.1038/nn.2749; Fenno L, 2011, ANNU REV NEUROSCI, V34, P389, DOI 10.1146/annurev-neuro-061010-113817; Gerits A, 2012, CURR BIOL, V22, P1722, DOI 10.1016/j.cub.2012.07.023; Gradinaru V, 2007, J NEUROSCI, V27, P14231, DOI 10.1523/JNEUROSCI.3578-07.2007; Han X, 2011, FRONT SYST NEUROSCI, V5, DOI 10.3389/fnsys.2011.00018; Han X, 2009, NEURON, V62, P191, DOI 10.1016/j.neuron.2009.03.011; Schafer RJ, 2011, SCIENCE, V332, P1568, DOI 10.1126/science.1199892; Shadlen MN, 1996, P NATL ACAD SCI USA, V93, P628, DOI 10.1073/pnas.93.2.628; Tehovnik EJ, 2003, EUR J NEUROSCI, V17, P870, DOI 10.1046/j.1460-9568.2003.02489.x	13	107	108	0	25	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	OCT	2012	15	10					1368	1370		10.1038/nn.3210	http://dx.doi.org/10.1038/nn.3210			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	013VZ	22941109	Green Accepted			2022-12-28	WOS:000309335300015
J	Gupta, AS; van der Meer, MAA; Touretzky, DS; Redish, AD				Gupta, Anoopum S.; van der Meer, Matthijs A. A.; Touretzky, David S.; Redish, A. David			Segmentation of spatial experience by hippocampal theta sequences	NATURE NEUROSCIENCE			English	Article							PHASE PRECESSION; PLACE CELLS; AWAKE STATE; MEMORY; DYNAMICS; NEURONS; FUTURE; REPLAY; INFORMATION; CA3	The encoding and storage of experience by the hippocampus is essential for the formation of episodic memories and the transformation of individual experiences into semantic structures such as maps and schemas. The rodent hippocampus compresses ongoing experience into repeating theta sequences, but the factors determining the content of theta sequences are not understood. Here we first show that the spatial paths represented by theta sequences in rats extend farther in front of the rat during acceleration and higher running speeds and begin farther behind the rat during deceleration. Second, the length of the path is directly related to the length of the theta cycle and the number of gamma cycles in it. Finally, theta sequences represent the environment in segments or 'chunks'. These results imply that information encoded in theta sequences is subject to powerful modulation by behavior and task variables. Furthermore, these findings suggest a potential mechanism for the cognitive 'chunking' of experience.	[Redish, A. David] Univ Minnesota, Dept Neurosci, Minneapolis, MN 55455 USA; [Gupta, Anoopum S.] Carnegie Mellon Univ, Inst Robot, Pittsburgh, PA 15213 USA; [Gupta, Anoopum S.; Touretzky, David S.] Carnegie Mellon Univ, Ctr Neural Basis Cognit, Pittsburgh, PA 15213 USA; [Gupta, Anoopum S.] Univ Pittsburgh, Sch Med, Pittsburgh, PA USA; [van der Meer, Matthijs A. A.] Univ Waterloo, Dept Biol, Waterloo, ON N2L 3G1, Canada; [van der Meer, Matthijs A. A.] Univ Waterloo, Ctr Theoret Neurosci, Waterloo, ON N2L 3G1, Canada; [Touretzky, David S.] Carnegie Mellon Univ, Dept Comp Sci, Pittsburgh, PA 15213 USA	University of Minnesota System; University of Minnesota Twin Cities; Carnegie Mellon University; Carnegie Mellon University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Waterloo; University of Waterloo; Carnegie Mellon University	Redish, AD (corresponding author), Univ Minnesota, Dept Neurosci, Minneapolis, MN 55455 USA.	redish@umn.edu		van der Meer, Matthijs/0000-0002-2206-4473	US National Institutes of Health [R01 MH-080318, F30 MH-091821]; Pennsylvania Department of Health; US National Science Foundation Integrative Graduate Education and Research Traineeship grant [DGE-0549352]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH080318, F30MH091821] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Pennsylvania Department of Health; US National Science Foundation Integrative Graduate Education and Research Traineeship grant; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank C. Boldt, K.D. Seeland and A.P. Steiner for technical assistance and A. Johnson and the members of the Redish lab for discussion. This work was supported by US National Institutes of Health grants (R01 MH-080318 and F30 MH-091821), the Pennsylvania Department of Health and a US National Science Foundation Integrative Graduate Education and Research Traineeship grant (DGE-0549352).	Battaglia FP, 2004, J NEUROSCI, V24, P4541, DOI 10.1523/JNEUROSCI.4896-03.2004; Buzsaki G, 2005, HIPPOCAMPUS, V15, P827, DOI 10.1002/hipo.20113; Carr MF, 2011, NAT NEUROSCI, V14, P147, DOI 10.1038/nn.2732; Cohen N. J., 1993, MEMORY AMNESIA HIPPO; Davidson TJ, 2009, NEURON, V63, P497, DOI 10.1016/j.neuron.2009.07.027; Diba K, 2007, NAT NEUROSCI, V10, P1241, DOI 10.1038/nn1961; Dragoi G, 2006, NEURON, V50, P145, DOI 10.1016/j.neuron.2006.02.023; Ferbinteanu J, 2003, NEURON, V40, P1227, DOI 10.1016/S0896-6273(03)00752-9; Foster DJ, 2007, HIPPOCAMPUS, V17, P1093, DOI 10.1002/hipo.20345; Foster DJ, 2006, NATURE, V440, P680, DOI 10.1038/nature04587; Frank LM, 2000, NEURON, V27, P169, DOI 10.1016/S0896-6273(00)00018-0; Geisler C, 2007, P NATL ACAD SCI USA, V104, P8149, DOI 10.1073/pnas.0610121104; Geisler C, 2010, P NATL ACAD SCI USA, V107, P7957, DOI 10.1073/pnas.0912478107; Gothard KM, 2001, J NEUROSCI, V21, P7284, DOI 10.1523/JNEUROSCI.21-18-07284.2001; Gupta AS, 2010, NEURON, V65, P695, DOI 10.1016/j.neuron.2010.01.034; Gupta AS, 2011, THESIS CARNEGIE MELL; Hassabis D, 2007, P NATL ACAD SCI USA, V104, P1726, DOI 10.1073/pnas.0610561104; Hasselmo ME, 2005, BEHAV NEUROSCI, V119, P342, DOI 10.1037/0735-7044.119.1.342; Hasselmo ME, 2009, NEUROBIOL LEARN MEM, V92, P559, DOI 10.1016/j.nlm.2009.07.005; Huxter JR, 2008, NAT NEUROSCI, V11, P587, DOI 10.1038/nn.2106; Jensen O, 1996, LEARN MEMORY, V3, P279, DOI 10.1101/lm.3.2-3.279; Ji DY, 2008, J NEUROSCI, V28, P4679, DOI 10.1523/JNEUROSCI.4597-07.2008; Johnson A, 2007, J NEUROSCI, V27, P12176, DOI 10.1523/JNEUROSCI.3761-07.2007; Lisman J, 2005, HIPPOCAMPUS, V15, P913, DOI 10.1002/hipo.20121; LISMAN JE, 1995, SCIENCE, V267, P1512, DOI 10.1126/science.7878473; Lisman J, 2009, PHILOS T R SOC B, V364, P1193, DOI 10.1098/rstb.2008.0316; Malhotra S, 2012, REV NEUROSCIENCE, V23, P39, DOI 10.1515/revneuro-2011-0064; Maurer AP, 2007, TRENDS NEUROSCI, V30, P325, DOI 10.1016/j.tins.2007.05.002; Maurer AP, 2012, HIPPOCAMPUS, V22, P737, DOI 10.1002/hipo.20936; MILLER GA, 1956, PSYCHOL REV, V63, P81, DOI 10.1037/h0043158; Morris G, 2006, NAT NEUROSCI, V9, P1057, DOI 10.1038/nn1743; Mulder AB, 2004, EUR J NEUROSCI, V19, P1923, DOI 10.1111/j.1460-9568.2004.03301.x; MULLER RU, 1989, J NEUROSCI, V9, P4101; Newell A., 1990, UNIFIED THEORIES COG; Newell A., 1972, HUMAN PROBLEM SOLVIN; O'Keefe J., 1993, HIPPOCAMPUS, V3, P317, DOI DOI 10.1002/HIP0.450030307); O'Keefe J, 1978, HIPPOCAMPUS COGNITIV; Redish A. D., 1999, COGNITIVE MAP PLACE, DOI DOI 10.1038/nature14445; Robbe D, 2009, J NEUROSCI, V29, P12597, DOI 10.1523/JNEUROSCI.2407-09.2009; Royer S, 2010, J NEUROSCI, V30, P1777, DOI 10.1523/JNEUROSCI.4681-09.2010; Schacter DL, 2007, NAT REV NEUROSCI, V8, P657, DOI 10.1038/nrn2213; Schmidt R, 2009, J NEUROSCI, V29, P13232, DOI 10.1523/JNEUROSCI.2270-09.2009; Skaggs WE, 1996, HIPPOCAMPUS, V6, P149, DOI 10.1002/(SICI)1098-1063(1996)6:2<149::AID-HIPO6>3.0.CO;2-K; Tsodyks MV, 1996, HIPPOCAMPUS, V6, P271, DOI 10.1002/(SICI)1098-1063(1996)6:3<271::AID-HIPO5>3.3.CO;2-Q; van der Meer MAA, 2011, J NEUROSCI, V31, P2843, DOI 10.1523/JNEUROSCI.4869-10.2011; VANDERWOLF CH, 1969, ELECTROEN CLIN NEURO, V26, P407, DOI 10.1016/0013-4694(69)90092-3; Wood ER, 2000, NEURON, V27, P623, DOI 10.1016/S0896-6273(00)00071-4; Yartsev MM, 2008, J NEUROSCI, V28, P8383, DOI 10.1523/JNEUROSCI.2442-08.2008	48	196	199	1	27	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JUL	2012	15	7					1032	1039		10.1038/nn.3138	http://dx.doi.org/10.1038/nn.3138			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	966EE	22706269	Green Accepted			2022-12-28	WOS:000305819600022
